-DOCSTART- (25847295)

Nonylphenol	O	O	B-T131
diethoxylate	O	O	I-T131
inhibits	O	O	B-T052
apoptosis	O	O	B-T043
induced	O	O	B-T169
in	O	O	O
PC12	O	O	O
cells	O	O	O

Nonylphenol	O	O	B-T131
and	O	O	O
short-chain	O	O	B-T131
nonylphenol	O	O	I-T131
ethoxylates	O	O	I-T131
such	O	O	O
as	O	O	O
NP2	O	O	B-T131
EO	O	O	I-T131
are	O	O	O
present	O	O	B-T033
in	O	O	O
aquatic	O	O	B-T067
environment	O	O	I-T067
as	O	O	O
wastewater	O	O	B-T069
contaminants	O	O	B-T167
,	O	O	O
and	O	O	O
their	O	O	O
toxic	O	O	B-T037
effects	O	O	I-T037
on	O	O	O
aquatic	O	O	B-T001
species	O	O	I-T001
have	O	O	O
been	O	O	O
reported	O	O	O
.	O	O	O

Apoptosis	O	O	B-T043
has	O	O	O
been	O	O	O
shown	O	O	O
to	O	O	O
be	O	O	O
induced	O	O	B-T169
by	O	O	O
serum	O	O	B-T031
deprivation	O	O	B-T080
or	O	O	O
copper	O	O	B-T121
treatment	O	O	B-T169
.	O	O	O

To	O	O	O
understand	O	O	O
the	O	O	O
toxicity	O	O	B-T080
of	O	O	O
nonylphenol	O	O	B-T131
diethoxylate	O	O	I-T131
,	O	O	O
we	O	O	O
investigated	O	O	O
the	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
NP2	O	O	B-T131
EO	O	O	I-T131
on	O	O	O
apoptosis	O	O	B-T043
induced	O	O	B-T169
by	O	O	O
serum	O	O	B-T031
deprivation	O	O	B-T080
and	O	O	O
copper	O	O	B-T121
by	O	O	O
using	O	O	O
PC12	O	O	B-T025
cell	O	O	I-T025
system	O	O	I-T025
.	O	O	O

Nonylphenol	O	O	B-T131
diethoxylate	O	O	I-T131
itself	O	O	O
showed	O	O	O
no	O	O	O
toxicity	O	O	O
and	O	O	O
recovered	O	O	O
cell	O	O	B-T043
viability	O	O	I-T043
from	O	O	O
apoptosis	O	O	B-T043
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
nonylphenol	O	O	B-T131
diethoxylate	O	O	I-T131
decreased	O	O	B-T081
DNA	O	O	B-T044
fragmentation	O	O	I-T044
caused	O	O	O
by	O	O	O
apoptosis	O	O	B-T043
in	O	O	O
PC12	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

This	O	O	O
phenomenon	O	O	B-T067
was	O	O	O
confirmed	O	O	O
after	O	O	O
treating	O	O	B-T169
apoptotic	O	O	B-T080
PC12	O	O	B-T025
cells	O	O	I-T025
with	O	O	O
nonylphenol	O	O	B-T131
diethoxylate	O	O	I-T131
,	O	O	O
whereas	O	O	O
the	O	O	O
cytochrome	O	O	B-T116
c	O	O	I-T116
release	O	O	O
into	O	O	O
the	O	O	O
cytosol	O	O	B-T026
decreased	O	O	B-T081
as	O	O	O
compared	O	O	O
to	O	O	O
that	O	O	O
in	O	O	O
apoptotic	O	O	B-T025
cells	O	O	I-T025
not	O	O	O
treated	O	O	B-T169
with	O	O	O
nonylphenol	O	O	O
diethoxylate	O	O	O
s.	O	O	O
Furthermore	O	O	O
,	O	O	O
Bax	O	O	B-T116
contents	O	O	B-T077
in	O	O	O
apoptotic	O	O	O
cells	O	O	O
were	O	O	O
reduced	O	O	B-T080
after	O	O	O
exposure	O	O	B-T080
to	O	O	I-T080
nonylphenol	O	O	O
diethoxylate	O	O	O
.	O	O	O

Thus	O	O	O
,	O	O	O
nonylphenol	O	O	B-T131
diethoxylate	O	O	I-T131
has	O	O	O
the	O	O	O
opposite	O	O	B-T080
effect	O	O	I-T080
on	O	O	O
apoptosis	O	O	B-T043
in	O	O	O
PC12	O	O	B-T025
cells	O	O	I-T025
compared	O	O	O
to	O	O	O
nonylphenol	O	O	O
,	O	O	O
which	O	O	O
enhances	O	O	B-T052
apoptosis	O	O	O
induced	O	O	B-T169
by	O	O	O
serum	O	O	B-T031
deprivation	O	O	B-T080
.	O	O	O

The	O	O	O
difference	O	O	B-T080
in	O	O	O
structure	O	O	B-T082
of	O	O	O
the	O	O	O
two	O	O	O
compounds	O	O	B-T103
is	O	O	O
hypothesized	O	O	B-T078
to	O	O	O
be	O	O	O
responsible	O	O	O
for	O	O	O
this	O	O	O
phenomenon	O	O	B-T067
.	O	O	O

These	O	O	O
results	O	O	B-T033
indicated	O	O	O
that	O	O	O
nonylphenol	O	O	B-T131
diethoxylate	O	O	I-T131
has	O	O	O
capability	O	O	B-T080
to	O	O	O
affect	O	O	O
cell	O	O	B-T043
differentiation	O	O	I-T043
and	O	O	O
development	O	O	B-T039
and	O	O	O
has	O	O	O
potentially	O	O	B-T080
harmful	O	O	B-T037
effect	O	O	I-T037
on	O	O	O
organisms	O	O	B-T001
because	O	O	O
of	O	O	O
its	O	O	O
unexpected	O	O	O
impact	O	O	B-T080
on	O	O	O
apoptosis	O	O	B-T043
.	O	O	O

Â©	O	O	O
2015	O	O	O
Wiley	O	O	O
Periodicals	O	O	O
,	O	O	O
Inc.	O	O	O
Environ	O	O	O
Toxicol	O	O	O
31	O	O	O
:	O	O	O
1389	O	O	O
-	O	O	O
1398	O	O	O
,	O	O	O
2016	O	O	O
.	O	O	O

-DOCSTART- (26876532)

EZH2	O	O	B-T028
and	O	O	O
ZFX	O	O	B-T028
oncogenes	O	O	B-T028
in	O	O	O
malignant	O	O	B-T080
behaviour	O	O	I-T080
of	O	O	O
parathyroid	O	O	O
neoplasms	O	O	O

Several	O	O	O
studies	O	O	B-T062
reported	O	O	O
somatic	O	O	B-T049
mutations	O	O	I-T049
of	O	O	O
many	O	O	O
genes	O	O	B-T028
(	O	O	O
MEN1	O	O	B-T028
,	O	O	O
CTNNB1	O	O	B-T028
,	O	O	O
CDKIs	O	O	B-T028
and	O	O	O
others	O	O	O
)	O	O	O
in	O	O	O
parathyroid	O	O	B-T191
adenoma	O	O	I-T191
,	O	O	O
although	O	O	O
with	O	O	O
different	O	O	B-T080
prevalence	O	O	B-T081
.	O	O	O

Recently	O	O	O
,	O	O	O
activating	O	O	B-T052
mutations	O	O	B-T045
of	O	O	O
the	O	O	O
EZH2	O	O	B-T028
and	O	O	O
ZFX	O	O	B-T028
oncogenes	O	O	B-T028
were	O	O	O
identified	O	O	O
in	O	O	O
benign	O	O	B-T080
parathyroid	O	O	B-T191
adenoma	O	O	I-T191
by	O	O	O
whole	O	O	B-T063
exome	O	O	I-T063
sequencing	O	O	I-T063
.	O	O	O

The	O	O	O
same	O	O	O
mutations	O	O	B-T045
had	O	O	O
been	O	O	O
found	O	O	O
in	O	O	O
blood	O	O	B-T031
and	O	O	O
ovary	O	O	B-T023
malignant	O	O	B-T191
tumours	O	O	I-T191
.	O	O	O

On	O	O	O
one	O	O	O
hand	O	O	O
,	O	O	O
this	O	O	O
result	O	O	O
raised	O	O	O
the	O	O	O
hypothesis	O	O	B-T078
that	O	O	O
these	O	O	O
oncogenes	O	O	B-T028
may	O	O	O
play	O	O	O
a	O	O	O
role	O	O	O
in	O	O	O
the	O	O	O
onset	O	O	B-T080
of	O	O	O
parathyroid	O	O	B-T191
tumour	O	O	I-T191
,	O	O	O
but	O	O	O
it	O	O	O
would	O	O	O
also	O	O	O
suggest	O	O	O
they	O	O	O
may	O	O	O
be	O	O	O
involved	O	O	O
in	O	O	O
malignant	O	O	B-T080
,	O	O	O
rather	O	O	O
benign	O	O	B-T080
,	O	O	O
parathyroid	O	O	B-T191
neoplasm	O	O	I-T191
.	O	O	O

Our	O	O	O
aim	O	O	B-T078
was	O	O	O
to	O	O	O
verify	O	O	O
the	O	O	O
occurrence	O	O	B-T079
of	O	O	O
selected	O	O	O
mutations	O	O	B-T045
of	O	O	O
the	O	O	O
EZH2	O	O	B-T028
and	O	O	O
ZFX	O	O	B-T028
genes	O	O	I-T028
in	O	O	O
an	O	O	O
Italian	O	O	B-T098
cohort	O	O	B-T098
of	O	O	O
23	O	O	O
sporadic	O	O	B-T079
parathyroid	O	O	B-T191
carcinomas	O	O	I-T191
,	O	O	O
12	O	O	O
atypical	O	O	B-T080
and	O	O	O
45	O	O	O
typical	O	O	B-T080
adenomas	O	O	B-T191
.	O	O	O

DNA	O	O	B-T114
was	O	O	O
extracted	O	O	B-T061
from	O	O	O
paraffin-embedded	O	O	B-T024
tissues	O	O	I-T024
,	O	O	O
PCR	O	O	B-T063
amplified	O	O	B-T067
and	O	O	O
directly	O	O	O
sequenced	O	O	B-T169
.	O	O	O

No	O	O	B-T033
mutations	O	O	B-T045
were	O	O	O
detected	O	O	B-T033
in	O	O	O
the	O	O	O
coding	O	O	B-T114
sequence	O	O	I-T114
and	O	O	O
boundaries	O	O	B-T114
of	O	O	O
both	O	O	O
genes	O	O	B-T028
in	O	O	O
any	O	O	O
of	O	O	O
the	O	O	O
samples	O	O	B-T167
.	O	O	O

Two	O	O	O
polymorphisms	O	O	B-T045
of	O	O	O
the	O	O	O
EZH2	O	O	B-T028
gene	O	O	I-T028
were	O	O	O
identified	O	O	B-T080
with	O	O	O
different	O	O	B-T080
prevalence	O	O	B-T081
:	O	O	O
the	O	O	O
rs2072407	O	O	B-T028
variant	O	O	I-T028
was	O	O	O
present	O	O	B-T033
in	O	O	O
the	O	O	O
30	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
samples	O	O	B-T167
,	O	O	O
in	O	O	O
keeping	O	O	O
with	O	O	O
the	O	O	O
overall	O	O	B-T080
frequency	O	O	B-T079
in	O	O	O
larger	O	O	B-T081
populations	O	O	B-T081
,	O	O	O
while	O	O	O
the	O	O	O
rs78589034	O	O	B-T028
variant	O	O	I-T028
,	O	O	O
located	O	O	O
close	O	O	O
to	O	O	O
the	O	O	O
5	O	O	B-T114
'	O	O	I-T114
end	O	O	I-T114
of	O	O	O
the	O	O	O
exon	O	O	B-T114
16	O	O	I-T114
,	O	O	O
was	O	O	O
detected	O	O	B-T033
in	O	O	O
only	O	O	O
one	O	O	O
proband	O	O	B-T099
with	O	O	O
familial	O	O	B-T169
isolated	O	O	B-T169
hyperparathyroidism	O	O	B-T047
;	O	O	O
we	O	O	O
investigated	O	O	B-T169
the	O	O	O
possible	O	O	O
outcome	O	O	B-T169
on	O	O	O
the	O	O	O
splicing	O	O	B-T045
process	O	O	I-T045
.	O	O	O

EZH2	O	O	B-T028
and	O	O	O
ZFX	O	O	B-T028
genes	O	O	I-T028
do	O	O	O
not	O	O	O
seem	O	O	O
to	O	O	O
have	O	O	O
an	O	O	O
impact	O	O	B-T080
on	O	O	O
the	O	O	O
onset	O	O	B-T080
of	O	O	O
most	O	O	O
parathyroid	O	O	B-T191
tumours	O	O	I-T191
,	O	O	O
both	O	O	O
benign	O	O	B-T080
and	O	O	O
malignant	O	O	B-T080
,	O	O	O
though	O	O	O
further	O	O	O
studies	O	O	O
on	O	O	O
larger	O	O	B-T081
cohorts	O	O	B-T098
of	O	O	O
different	O	O	B-T080
ethnicity	O	O	B-T080
are	O	O	O
needed	O	O	O
.	O	O	O

-DOCSTART- (27059693)

Patient	O	O	B-T101
-	O	O	O
Physician	O	O	B-T097
Discordance	O	O	B-T080
in	O	O	O
Global	O	O	B-T062
Assessment	O	O	I-T062
in	O	O	O
Rheumatoid	O	O	B-T047
Arthritis	O	O	I-T047
:	O	O	O
A	O	O	O
Systematic	O	O	B-T169
Literature	O	O	B-T170
Review	O	O	I-T170
With	O	O	O
Meta-Analysis	O	O	O

The	O	O	O
integration	O	O	O
of	O	O	O
the	O	O	O
patient	O	O	B-T101
in	O	O	O
therapeutic	O	O	B-T169
decision-making	O	O	B-T041
is	O	O	O
important	O	O	O
in	O	O	O
the	O	O	O
management	O	O	B-T058
of	O	O	O
rheumatoid	O	O	B-T047
arthritis	O	O	I-T047
(	O	O	O
RA	O	O	B-T047
)	O	O	O
,	O	O	O
but	O	O	O
the	O	O	O
patient	O	O	O
opinion	O	O	B-T041
regarding	O	O	O
disease	O	O	B-T047
status	O	O	B-T080
may	O	O	O
differ	O	O	O
from	O	O	O
the	O	O	O
physician	O	O	B-T097
's	O	O	I-T097
opinion	O	O	O
.	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
assess	O	O	B-T052
in	O	O	O
the	O	O	O
published	O	O	B-T170
literature	O	O	I-T170
the	O	O	O
frequency	O	O	B-T079
and	O	O	O
drivers	O	O	O
of	O	O	O
patient	O	O	B-T101
-	O	O	O
physician	O	O	B-T097
discordance	O	O	B-T080
in	O	O	O
global	O	O	B-T062
assessment	O	O	I-T062
in	O	O	O
RA	O	O	B-T047
.	O	O	O

A	O	O	O
systematic	O	O	B-T169
literature	O	O	B-T170
review	O	O	I-T170
of	O	O	O
all	O	O	O
articles	O	O	B-T170
published	O	O	B-T057
up	O	O	O
to	O	O	O
January	O	O	O
2015	O	O	O
in	O	O	O
Medline	O	O	B-T170
or	O	O	O
Embase	O	O	B-T170
,	O	O	O
reporting	O	O	O
discordance	O	O	B-T080
in	O	O	O
RA	O	O	B-T047
,	O	O	O
was	O	O	O
conducted	O	O	O
by	O	O	O
2	O	O	O
investigators	O	O	B-T097
.	O	O	O

Discordance	O	O	B-T080
was	O	O	O
defined	O	O	O
based	O	O	O
on	O	O	O
the	O	O	O
absolute	O	O	B-T080
difference	O	O	I-T080
of	O	O	O
patient	O	O	B-T170
global	O	O	I-T170
(	O	O	O
PGA	O	O	B-T170
)	O	O	O
and	O	O	O
physician	O	O	B-T062
global	O	O	I-T062
assessments	O	O	I-T062
(	O	O	O
PhGA	O	O	B-T062
)	O	O	O
on	O	O	O
0	O	O	O
-	O	O	O
10-cm	O	O	O
scales	O	O	O
.	O	O	O

The	O	O	O
frequency	O	O	B-T079
of	O	O	O
discordance	O	O	B-T080
and	O	O	O
its	O	O	O
predictors	O	O	B-T033
were	O	O	O
collected	O	O	O
in	O	O	O
each	O	O	O
study	O	O	B-T062
.	O	O	O

Frequencies	O	O	B-T079
of	O	O	O
discordance	O	O	B-T080
were	O	O	O
pooled	O	O	B-T169
by	O	O	O
meta-analysis	O	O	B-T062
using	O	O	O
random	O	O	B-T080
effect	O	O	B-T080
.	O	O	O

In	O	O	O
all	O	O	O
,	O	O	O
12	O	O	O
studies	O	O	B-T062
were	O	O	O
selected	O	O	O
(	O	O	O
i.e.	O	O	O
,	O	O	O
11,879	O	O	O
patients	O	O	B-T101
):	O	O	O
weighted	O	O	B-T081
mean	O	O	I-T081
Â±	O	O	O
SD	O	O	O
age	O	O	B-T032
was	O	O	O
55.1	O	O	O
Â±	O	O	O
13.9	O	O	O
years	O	O	B-T079
,	O	O	O
weighted	O	O	O
mean	O	O	O
Â±	O	O	O
SD	O	O	O
disease	O	O	B-T079
duration	O	O	I-T079
was	O	O	O
10.4	O	O	O
Â±	O	O	O
9.3	O	O	O
years	O	O	O
,	O	O	O
and	O	O	O
80.7	O	O	O
%	O	O	O
were	O	O	O
women	O	O	B-T098
.	O	O	O

The	O	O	O
value	O	O	B-T081
of	O	O	O
the	O	O	O
difference	O	O	B-T081
|	O	O	O
PGA	O	O	B-T170
-	O	O	O
PhGA	O	O	B-T062
|	O	O	O
defining	O	O	O
discordance	O	O	B-T080
varied	O	O	O
between	O	O	O
â¥0.5	O	O	O
cm	O	O	O
(	O	O	O
n	O	O	O
=	O	O	O
2	O	O	O
studies	O	O	O
)	O	O	O
to	O	O	O
â¥3	O	O	O
cm	O	O	O
(	O	O	O
n	O	O	O
=	O	O	O
5	O	O	O
studies	O	O	O
)	O	O	O
;	O	O	O
the	O	O	O
weighted	O	O	B-T081
mean	O	O	I-T081
value	O	O	I-T081
was	O	O	O
2.7	O	O	O
cm	O	O	O
.	O	O	O

The	O	O	O
pooled	O	O	B-T169
percentage	O	O	B-T081
of	O	O	O
patients	O	O	B-T101
with	O	O	O
discordance	O	O	B-T080
was	O	O	O
43	O	O	O
%	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
confidence	O	O	B-T081
interval	O	O	I-T081
36%-51	O	O	O
%	O	O	O
;	O	O	O
range	O	O	B-T081
25%-76	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

PGA	O	O	B-T170
was	O	O	O
usually	O	O	O
higher	O	O	B-T080
than	O	O	O
PhGA	O	O	B-T062
.	O	O	O

The	O	O	O
drivers	O	O	O
of	O	O	O
PGA	O	O	B-T170
were	O	O	O
pain	O	O	B-T184
and	O	O	O
functional	O	O	B-T169
incapacity	O	O	B-T201
,	O	O	O
whereas	O	O	O
drivers	O	O	O
of	O	O	O
PhGA	O	O	B-T062
were	O	O	O
joint	O	O	B-T170
counts	O	O	I-T170
and	O	O	O
acute-phase	O	O	B-T116
reactants	O	O	I-T116
.	O	O	O

Discordance	O	O	B-T080
in	O	O	O
global	O	O	B-T062
assessment	O	O	I-T062
was	O	O	O
most	O	O	O
frequently	O	O	B-T079
defined	O	O	O
as	O	O	O
a	O	O	O
difference	O	O	B-T080
of	O	O	O
3	O	O	O
points	O	O	O
or	O	O	O
more	O	O	O
;	O	O	O
even	O	O	O
with	O	O	O
such	O	O	O
a	O	O	O
stringent	O	O	O
definition	O	O	O
,	O	O	O
up	O	O	O
to	O	O	O
half	O	O	B-T081
the	O	O	O
patients	O	O	B-T101
were	O	O	O
found	O	O	O
to	O	O	O
be	O	O	O
discordant	O	O	B-T080
.	O	O	O

The	O	O	O
long-term	O	O	B-T079
consequences	O	O	B-T169
of	O	O	O
this	O	O	O
discordance	O	O	B-T080
remain	O	O	O
to	O	O	O
be	O	O	O
determined	O	O	O
.	O	O	O

-DOCSTART- (27117874)

A	O	O	O
Randomized	O	O	B-T062
Controlled	O	O	I-T062
Noninferiority	O	O	I-T062
Trial	O	O	I-T062
of	O	O	O
Single	O	O	B-T081
Dose	O	O	I-T081
of	O	O	O
Oral	O	O	B-T200
Dexamethasone	O	O	I-T200
Versus	O	O	O
5	O	O	O
Days	O	O	B-T079
of	O	O	O
Oral	O	O	B-T200
Prednisone	O	O	I-T200
in	O	O	O
Acute	O	O	O
Adult	O	O	B-T100
Asthma	O	O	O

Oral	O	O	B-T200
dexamethasone	O	O	I-T200
demonstrates	O	O	B-T052
bioavailability	O	O	B-T081
similar	O	O	B-T080
to	O	O	O
that	O	O	O
of	O	O	O
oral	O	O	B-T200
prednisone	O	O	I-T200
but	O	O	O
has	O	O	O
a	O	O	O
longer	O	O	O
half-life	O	O	B-T079
.	O	O	O

We	O	O	O
evaluate	O	O	O
whether	O	O	O
a	O	O	O
single	O	O	B-T081
dose	O	O	I-T081
of	O	O	O
oral	O	O	B-T200
dexamethasone	O	O	I-T200
plus	O	O	B-T169
4	O	O	O
days	O	O	B-T079
of	O	O	O
placebo	O	O	B-T122
is	O	O	O
not	O	O	O
inferior	O	O	B-T082
to	O	O	O
5	O	O	O
days	O	O	O
of	O	O	O
oral	O	O	B-T200
prednisone	O	O	I-T200
in	O	O	O
treatment	O	O	B-T169
of	O	O	O
adults	O	O	B-T100
with	O	O	O
mild	O	O	B-T033
to	O	O	O
moderate	O	O	B-T033
asthma	O	O	B-T047
exacerbations	O	O	I-T033
to	O	O	O
prevent	O	O	B-T169
relapse	O	O	B-T067
defined	O	O	O
as	O	O	O
an	O	O	O
unscheduled	O	O	B-T079
return	O	O	O
visit	O	O	O
for	O	O	O
additional	O	O	B-T033
treatment	O	O	I-T033
for	O	O	O
persistent	O	O	B-T047
or	O	O	O
worsening	O	O	B-T080
asthma	O	O	O
within	O	O	O
14	O	O	O
days	O	O	O
.	O	O	O

Adult	O	O	B-T100
emergency	O	O	B-T093
department	O	O	I-T093
patients	O	O	B-T101
(	O	O	O
aged	O	O	B-T032
18	O	O	O
to	O	O	O
55	O	O	O
years	O	O	B-T079
)	O	O	O
were	O	O	O
randomized	O	O	B-T062
to	O	O	O
receive	O	O	B-T080
either	O	O	O
a	O	O	O
single	O	O	B-T081
dose	O	O	I-T081
of	O	O	O
12	O	O	O
mg	O	O	O
of	O	O	O
oral	O	O	B-T200
dexamethasone	O	O	I-T200
with	O	O	O
4	O	O	O
days	O	O	B-T079
of	O	O	O
placebo	O	O	B-T122
or	O	O	O
a	O	O	O
5-	O	O	O
day	O	O	B-T079
course	O	O	B-T079
of	O	O	O
oral	O	O	B-T200
prednisone	O	O	I-T200
60	O	O	O
mg	O	O	O
a	O	O	O
day	O	O	O
.	O	O	O

Outcomes	O	O	B-T169
including	O	O	B-T169
relapse	O	O	B-T067
were	O	O	O
assessed	O	O	B-T052
by	O	O	O
a	O	O	O
follow-up	O	O	B-T058
telephone	O	O	I-T058
interview	O	O	I-T058
at	O	O	O
2	O	O	O
weeks	O	O	B-T079
.	O	O	O

One	O	O	O
hundred	O	O	B-T081
seventy-three	O	O	I-T081
dexamethasone	O	O	B-T109
and	O	O	O
203	O	O	O
prednisone	O	O	B-T125
subjects	O	O	B-T096
completed	O	O	B-T080
the	O	O	O
study	O	O	O
regimen	O	O	O
and	O	O	O
telephone	O	O	B-T058
follow-up	O	O	I-T058
.	O	O	O

The	O	O	O
dexamethasone	O	O	B-T109
group	O	O	B-UnknownType
by	O	O	O
a	O	O	O
small	O	O	O
margin	O	O	O
surpassed	O	O	O
the	O	O	O
preset	O	O	O
8	O	O	O
%	O	O	O
difference	O	O	B-T080
between	O	O	O
groups	O	O	B-UnknownType
for	O	O	O
noninferiority	O	O	B-T080
in	O	O	O
relapse	O	O	B-T067
rates	O	O	B-T081
within	O	O	O
14	O	O	O
days	O	O	B-T079
(	O	O	O
12.1	O	O	O
%	O	O	O
versus	O	O	O
9.8	O	O	O
%	O	O	O
;	O	O	O
difference	O	O	O
2.3	O	O	O
%	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
confidence	O	O	B-T081
interval	O	O	I-T081
-4.1	O	O	O
%	O	O	O
to	O	O	O
8.6	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

Subjects	O	O	B-T096
in	O	O	O
the	O	O	O
2	O	O	O
groups	O	O	B-UnknownType
had	O	O	O
similar	O	O	O
rates	O	O	B-T081
of	O	O	O
hospitalization	O	O	B-T058
for	O	O	O
their	O	O	O
relapse	O	O	B-T067
visit	O	O	B-T058
(	O	O	O
dexamethasone	O	O	B-T109
3.4	O	O	O
%	O	O	O
versus	O	O	O
prednisone	O	O	B-T125
2.9	O	O	O
%	O	O	O
;	O	O	O
difference	O	O	B-T080
0.5	O	O	O
%	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
confidence	O	O	B-T081
interval	O	O	I-T081
-4.1	O	O	O
%	O	O	O
to	O	O	O
3.1	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

Adverse	O	O	B-T080
effect	O	O	I-T080
rates	O	O	B-T081
were	O	O	O
generally	O	O	O
the	O	O	O
same	O	O	O
in	O	O	O
the	O	O	O
2	O	O	O
groups	O	O	B-UnknownType
.	O	O	O

A	O	O	O
single	O	O	B-T081
dose	O	O	I-T081
of	O	O	O
oral	O	O	B-T200
dexamethasone	O	O	I-T200
did	O	O	O
not	O	O	O
demonstrate	O	O	B-T052
noninferiority	O	O	B-T080
to	O	O	O
prednisone	O	O	B-T125
for	O	O	O
5	O	O	O
days	O	O	B-T079
by	O	O	O
a	O	O	O
very	O	O	O
small	O	O	O
margin	O	O	O
for	O	O	O
treatment	O	O	B-T169
of	O	O	O
adults	O	O	B-T100
with	O	O	O
mild	O	O	B-T033
to	O	O	O
moderate	O	O	B-T033
asthma	O	O	B-T033
exacerbations	O	O	I-T033
.	O	O	O

Enhanced	O	O	B-T052
compliance	O	O	B-T033
and	O	O	O
convenience	O	O	B-T080
may	O	O	O
support	O	O	O
the	O	O	O
use	O	O	B-T169
of	O	O	O
dexamethasone	O	O	B-T109
regardless	O	O	O
.	O	O	O

-DOCSTART- (27172917)

Malignancy	O	O	B-T191
is	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
microcalcification	O	O	B-T046
and	O	O	O
higher	O	O	B-T081
AP/T	O	O	I-T081
ratio	O	O	I-T081
in	O	O	O
ultrasonography	O	O	B-T060
,	O	O	O
but	O	O	O
not	O	O	O
with	O	O	O
Hashimoto	O	O	B-T047
's	O	O	I-T047
thyroiditis	O	O	I-T047
in	O	O	O
histopathology	O	O	B-T059
in	O	O	O
patients	O	O	B-T101
with	O	O	O
thyroid	O	O	B-T191
nodules	O	O	I-T191
evaluated	O	O	O
as	O	O	O
Bethesda	O	O	B-T191
Category	O	O	I-T191
III	O	O	I-T191
(	O	O	O
AUS	O	O	B-T049
/	O	O	O
FLUS	O	O	B-T033
)	O	O	O
in	O	O	O
cytology	O	O	O

The	O	O	O
predictors	O	O	B-T170
of	O	O	O
malignancy	O	O	B-T191
are	O	O	O
important	O	O	O
for	O	O	O
the	O	O	O
decision	O	O	O
of	O	O	O
appropriate	O	O	O
management	O	O	B-T058
in	O	O	O
nodules	O	O	B-T191
with	O	O	O
atypia	O	O	B-T049
of	O	O	I-T049
undetermined	O	O	I-T049
significance	O	O	I-T049
/	O	O	O
follicular	O	O	B-T033
lesion	O	O	I-T033
of	O	O	I-T033
undetermined	O	O	I-T033
significance	O	O	I-T033
(	O	O	O
AUS	O	O	B-T049
/	O	O	O
FLUS	O	O	B-T033
)	O	O	O
.	O	O	O

Our	O	O	O
aim	O	O	O
was	O	O	O
to	O	O	O
determine	O	O	O
the	O	O	O
ultrasonographical	O	O	B-T170
,	O	O	O
clinical	O	O	B-T170
,	O	O	O
and	O	O	O
biochemical	O	O	B-T170
predictors	O	O	I-T170
of	O	O	O
malignancy	O	O	B-T191
in	O	O	O
these	O	O	O
patients	O	O	B-T101
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
427	O	O	O
patients	O	O	B-T101
with	O	O	O
cytologically	O	O	B-T191
Bethesda	O	O	I-T191
Category	O	O	I-T191
III	O	O	I-T191
(	O	O	O
AUS	O	O	B-T049
/	O	O	O
FLUS	O	O	B-T033
)	O	O	O
thyroid	O	O	B-T191
nodules	O	O	I-T191
were	O	O	O
included	O	O	O
in	O	O	O
this	O	O	O
retrospective	O	O	B-T062
study	O	O	I-T062
.	O	O	O

We	O	O	O
divided	O	O	O
the	O	O	O
nodules	O	O	B-T191
into	O	O	O
two	O	O	O
subgroups	O	O	B-T098
according	O	O	O
to	O	O	O
the	O	O	O
histopathology	O	O	B-T059
as	O	O	O
benign	O	O	B-T080
and	O	O	O
malignant	O	O	B-T080
,	O	O	O
and	O	O	O
compared	O	O	O
the	O	O	O
preoperative	O	O	B-T079
ultrasonographical	O	O	B-T201
,	O	O	O
clinical	O	O	B-T201
,	O	O	O
and	O	O	O
biochemical	O	O	B-T033
findings	O	O	I-T033
.	O	O	O

In	O	O	O
overall	O	O	O
,	O	O	O
427	O	O	O
patients	O	O	B-T101
with	O	O	O
449	O	O	O
AUS	O	O	B-T049
/	O	O	O
FLUS	O	O	B-T033
nodules	O	O	B-T191
who	O	O	O
had	O	O	O
undergone	O	O	O
surgery	O	O	B-T061
,	O	O	O
the	O	O	O
rate	O	O	O
of	O	O	O
malignancy	O	O	B-T191
was	O	O	O
23.4	O	O	O
%	O	O	O
(	O	O	O
105/449	O	O	O
)	O	O	O
.	O	O	O

When	O	O	O
evaluated	O	O	O
separately	O	O	O
,	O	O	O
the	O	O	O
rate	O	O	O
of	O	O	O
malignancy	O	O	B-T191
was	O	O	O
25.8	O	O	O
%	O	O	O
in	O	O	O
nodules	O	O	B-T191
with	O	O	O
AUS	O	O	B-T049
(	O	O	O
82/318	O	O	O
)	O	O	O
and	O	O	O
17.6	O	O	O
%	O	O	O
in	O	O	O
nodules	O	O	O
with	O	O	O
FLUS	O	O	B-T033
(	O	O	O
23/131	O	O	O
)	O	O	O
(	O	O	O
p	O	O	O
=	O	O	O
0.061	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
vast	O	O	O
majority	O	O	O
of	O	O	O
malignant	O	O	B-T077
specimens	O	O	I-T077
in	O	O	O
histopathology	O	O	B-T059
consisted	O	O	O
of	O	O	O
papillary	O	O	B-T191
thyroid	O	O	I-T191
carcinoma	O	O	I-T191
(	O	O	O
PTC	O	O	B-T191
)	O	O	O
(	O	O	O
n	O	O	O
=	O	O	O
91	O	O	O
,	O	O	O
86.7	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

Preoperative	O	O	B-T079
ultrasonographic	O	O	B-T201
features	O	O	I-T201
of	O	O	O
105	O	O	O
malignant	O	O	B-T191
nodules	O	O	I-T191
in	O	O	O
histopathology	O	O	B-T059
were	O	O	O
compared	O	O	O
with	O	O	O
the	O	O	O
344	O	O	O
benign	O	O	B-T191
nodules	O	O	I-T191
in	O	O	O
histopathology	O	O	O
.	O	O	O

Anteroposterior/Transverse	O	O	B-T081
(	O	O	I-T081
AP/T	O	O	I-T081
)	O	O	I-T081
ratio	O	O	I-T081
was	O	O	O
significantly	O	O	O
higher	O	O	O
in	O	O	O
malignant	O	O	B-T098
group	O	O	I-T098
compared	O	O	O
to	O	O	O
benign	O	O	B-T098
group	O	O	I-T098
(	O	O	O
p	O	O	O
=	O	O	O
0.013	O	O	O
)	O	O	O
.	O	O	O

In	O	O	O
multiple	O	O	B-T062
logistic	O	O	I-T062
analysis	O	O	I-T062
,	O	O	O
we	O	O	O
found	O	O	O
that	O	O	O
higher	O	O	B-T081
AP/T	O	O	I-T081
ratio	O	O	I-T081
and	O	O	O
microcalcification	O	O	B-T046
were	O	O	O
independently	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
malignancy	O	O	B-T191
(	O	O	O
p	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
malignancy	O	O	B-T191
-associated	O	O	O
cut-off	O	O	O
value	O	O	O
of	O	O	O
AP/T	O	O	B-T081
ratio	O	O	I-T081
at	O	O	O
maximum	O	O	O
sensitivity	O	O	B-T081
and	O	O	I-T081
specificity	O	O	I-T081
was	O	O	O
â¥0.81	O	O	O
.	O	O	O

We	O	O	O
did	O	O	O
not	O	O	O
find	O	O	O
any	O	O	O
correlation	O	O	B-T080
between	O	O	O
malignancy	O	O	B-T191
and	O	O	O
Hashimoto	O	O	B-T047
's	O	O	I-T047
thyroiditis	O	O	I-T047
in	O	O	O
histopathology	O	O	B-T059
in	O	O	O
multivariate	O	O	B-T081
analysis	O	O	I-T081
(	O	O	O
p	O	O	O
>	O	O	O
0.05	O	O	O
)	O	O	O
.	O	O	O

In	O	O	O
Bethesda	O	O	B-T191
Category	O	O	I-T191
III	O	O	I-T191
nodules	O	O	I-T191
with	O	O	O
higher	O	O	B-T081
AP/T	O	O	I-T081
ratio	O	O	I-T081
and	O	O	O
microcalcification	O	O	B-T046
,	O	O	O
surgery	O	O	B-T061
might	O	O	O
be	O	O	O
considered	O	O	O
as	O	O	O
a	O	O	O
first	O	O	O
therapeutic	O	O	O
option	O	O	O
instead	O	O	O
of	O	O	O
repeat	O	O	O
fine-needle	O	O	B-T060
aspiration	O	O	I-T060
biopsy	O	O	I-T060
or	O	O	O
observation	O	O	B-T062
.	O	O	O

-DOCSTART- (27233131)

Impact	O	O	B-T080
of	O	O	O
cofactor	O	O	B-T123
-	O	O	O
binding	O	O	B-T087
loop	O	O	I-T087
mutations	O	O	B-T045
on	O	O	O
thermotolerance	O	O	B-T039
and	O	O	O
activity	O	O	B-T044
of	O	O	O
E.	O	O	B-T007
coli	O	O	I-T007
transketolase	O	O	O

Improvement	O	O	B-T077
of	O	O	O
thermostability	O	O	B-T070
in	O	O	O
engineered	O	O	B-T116
enzymes	O	O	I-T116
can	O	O	O
allow	O	O	O
biocatalysis	O	O	B-T070
on	O	O	O
substrates	O	O	B-T167
with	O	O	O
poor	O	O	O
aqueous	O	O	B-T080
solubility	O	O	B-T080
.	O	O	O

Denaturation	O	O	B-T044
of	O	O	O
the	O	O	O
cofactor	O	O	B-T123
-	O	O	O
binding	O	O	B-T087
loops	O	O	I-T087
of	O	O	O
Escherichia	O	O	B-T007
coli	O	O	I-T007
transketolase	O	O	B-T116
(	O	O	O
TK	O	O	B-T116
)	O	O	O
was	O	O	O
previously	O	O	O
linked	O	O	O
to	O	O	O
the	O	O	O
loss	O	O	B-T081
of	O	O	O
enzyme	O	O	B-T044
activity	O	O	I-T044
under	O	O	O
conditions	O	O	B-T080
of	O	O	O
high	O	O	B-T080
pH	O	O	B-T081
or	O	O	O
urea	O	O	B-T109
.	O	O	O

Incubation	O	O	B-T059
at	O	O	O
temperatures	O	O	B-T081
just	O	O	O
below	O	O	O
the	O	O	O
thermal	O	O	B-T070
melting	O	O	I-T070
transition	O	O	I-T070
,	O	O	O
above	O	O	O
which	O	O	O
the	O	O	O
protein	O	O	B-T116
aggregates	O	O	B-T169
,	O	O	O
was	O	O	O
also	O	O	O
found	O	O	O
to	O	O	O
anneal	O	O	B-T169
the	O	O	O
enzyme	O	O	B-T116
to	O	O	O
give	O	O	O
an	O	O	O
increased	O	O	B-T081
specific	O	O	O
activity	O	O	B-T044
.	O	O	O

The	O	O	O
potential	O	O	O
role	O	O	B-T077
of	O	O	O
cofactor	O	O	B-T123
-	O	O	O
binding	O	O	B-T087
loop	O	O	I-T087
instability	O	O	B-T033
in	O	O	O
this	O	O	O
process	O	O	O
remained	O	O	O
unclear	O	O	O
.	O	O	O

In	O	O	O
this	O	O	O
work	O	O	O
,	O	O	O
the	O	O	O
two	O	O	O
cofactor	O	O	B-T123
-	O	O	O
binding	O	O	B-T087
loops	O	O	I-T087
(	O	O	O
residues	O	O	B-T087
185	O	O	I-T087
-	O	O	I-T087
192	O	O	I-T087
and	O	O	O
382	O	O	B-T087
-	O	O	I-T087
392	O	O	I-T087
)	O	O	O
were	O	O	O
progressively	O	O	O
mutated	O	O	O
towards	O	O	O
the	O	O	O
equivalent	O	O	O
sequence	O	O	B-T086
from	O	O	O
the	O	O	O
thermostable	O	O	B-T080
Thermus	O	O	B-T007
thermophilus	O	O	I-T007
TK	O	O	B-T116
and	O	O	O
variants	O	O	B-T028
assessed	O	O	B-T052
for	O	O	O
their	O	O	O
impact	O	O	B-T080
on	O	O	O
both	O	O	O
thermostability	O	O	B-T070
and	O	O	O
activity	O	O	B-T052
.	O	O	O

Cofactor-binding	O	O	B-T086
loop	O	O	I-T086
2	O	O	I-T086
variants	O	O	B-T028
had	O	O	O
detrimental	O	O	B-T080
effects	O	O	I-T080
on	O	O	O
specific	O	O	O
activity	O	O	B-T052
at	O	O	O
elevated	O	O	B-T080
temperatures	O	O	B-T081
,	O	O	O
whereas	O	O	O
the	O	O	O
H192P	O	O	B-T045
mutation	O	O	I-T045
in	O	O	O
cofactor-binding	O	O	B-T086
loop	O	O	I-T086
1	O	O	I-T086
resulted	O	O	O
in	O	O	O
a	O	O	O
two-fold	O	O	O
improved	O	O	O
stability	O	O	B-T070
to	O	O	O
inactivation	O	O	B-T169
at	O	O	O
elevated	O	O	O
temperatures	O	O	O
,	O	O	O
and	O	O	O
increased	O	O	B-T081
the	O	O	O
critical	O	O	B-T081
onset	O	O	I-T081
temperature	O	O	I-T081
for	O	O	O
aggregation	O	O	B-T169
.	O	O	O

The	O	O	O
specific	O	O	O
activity	O	O	B-T052
of	O	O	O
H192P	O	O	B-T045
was	O	O	O
3-fold	O	O	O
and	O	O	O
19-fold	O	O	O
higher	O	O	B-T080
than	O	O	O
that	O	O	O
for	O	O	O
wild-type	O	O	B-T028
at	O	O	O
60	O	O	O
Â°	O	O	O
C	O	O	O
and	O	O	O
65	O	O	O
Â°	O	O	O
C	O	O	O
respectively	O	O	O
,	O	O	O
and	O	O	O
also	O	O	O
remained	O	O	O
2.7	O	O	O
-	O	O	O
4	O	O	O
fold	O	O	O
higher	O	O	O
after	O	O	O
re-cooling	O	O	B-T070
from	O	O	O
pre-incubations	O	O	B-T059
at	O	O	O
either	O	O	O
55	O	O	O
Â°	O	O	O
C	O	O	O
or	O	O	O
60	O	O	O
Â°	O	O	O
C	O	O	O
for	O	O	O
1h	O	O	O
.	O	O	O

Interestingly	O	O	O
,	O	O	O
H192P	O	O	B-T045
was	O	O	O
also	O	O	O
2-times	O	O	O
more	O	O	O
active	O	O	B-T169
than	O	O	O
wild-type	O	O	B-T028
TK	O	O	B-T116
at	O	O	O
25	O	O	O
Â°	O	O	O
C	O	O	O
.	O	O	O

Optimal	O	O	B-T080
activity	O	O	B-T052
was	O	O	O
achieved	O	O	O
at	O	O	O
60	O	O	O
Â°	O	O	O
C	O	O	O
for	O	O	O
H192P	O	O	B-T045
compared	O	O	O
to	O	O	O
55	O	O	O
Â°	O	O	O
C	O	O	O
for	O	O	O
wild	O	O	B-T028
type	O	O	I-T028
.	O	O	O

These	O	O	O
results	O	O	O
show	O	O	O
that	O	O	O
cofactor-binding	O	O	B-T086
loop	O	O	I-T086
1	O	O	I-T086
,	O	O	O
plays	O	O	O
a	O	O	O
pivotal	O	O	O
role	O	O	B-T077
in	O	O	O
partial	O	O	B-T081
denaturation	O	O	B-T044
and	O	O	O
aggregation	O	O	B-T169
at	O	O	O
elevated	O	O	B-T080
temperatures	O	O	B-T081
.	O	O	O

Furthermore	O	O	O
,	O	O	O
a	O	O	O
single	O	O	B-T045
rigidifying	O	O	I-T045
mutation	O	O	I-T045
within	O	O	O
this	O	O	O
loop	O	O	B-T086
can	O	O	O
significantly	O	O	O
improve	O	O	O
the	O	O	O
enzyme	O	O	B-T044
specific	O	O	I-T044
activity	O	O	B-T044
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
the	O	O	O
stability	O	O	B-T070
to	O	O	O
thermal	O	O	B-T070
denaturation	O	O	B-T044
and	O	O	O
aggregation	O	O	B-T169
,	O	O	O
to	O	O	O
give	O	O	O
an	O	O	O
increased	O	O	B-T081
temperature	O	O	B-T081
optimum	O	O	B-T080
for	O	O	O
activity	O	O	O
.	O	O	O

-DOCSTART- (27234220)

Safety	O	O	B-T062
of	O	O	O
transradial	O	O	B-T060
diagnostic	O	O	I-T060
cardiac	O	O	I-T060
catheterization	O	O	I-T060
in	O	O	O
patients	O	O	B-T101
under	O	O	O
oral	O	O	B-T082
anticoagulant	O	O	O
therapy	O	O	O

Cardiac	O	O	B-T058
catheterization	O	O	I-T058
in	O	O	O
anticoagulated	O	O	B-UnknownType
patients	O	O	B-T101
is	O	O	O
usually	O	O	O
performed	O	O	B-T169
after	O	O	O
the	O	O	O
anticoagulation	O	O	B-T061
has	O	O	O
been	O	O	O
withdrawn	O	O	B-T061
,	O	O	O
at	O	O	O
least	O	O	O
in	O	O	O
the	O	O	O
previous	O	O	O
48h	O	O	O
,	O	O	O
and	O	O	O
sometimes	O	O	O
bridging	O	O	B-T061
therapy	O	O	I-T061
with	O	O	I-T061
heparin	O	O	I-T061
is	O	O	O
used	O	O	O
.	O	O	O

A	O	O	O
prospective	O	O	O
observational	O	O	B-T062
study	O	O	I-T062
including	O	O	O
489	O	O	O
patients	O	O	B-T101
undergoing	O	O	O
transradial	O	O	B-T058
catheterization	O	O	I-T058
was	O	O	O
conducted	O	O	O
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
140	O	O	O
patients	O	O	B-T101
were	O	O	O
under	O	O	O
acenocoumarol	O	O	B-T109
(	O	O	O
group	O	O	B-T185
A	O	O	I-T185
)	O	O	O
and	O	O	O
they	O	O	O
were	O	O	O
compared	O	O	B-T052
with	O	O	O
the	O	O	O
remainder	O	O	B-T080
(	O	O	O
group	O	O	B-T185
B	O	O	I-T185
)	O	O	O
for	O	O	O
complications	O	O	B-T046
after	O	O	O
the	O	O	O
procedure	O	O	B-T058
(	O	O	O
bleeding	O	O	B-T046
and	O	O	O
vascular	O	O	B-T046
access	O	O	I-T046
complications	O	O	I-T046
)	O	O	O
.	O	O	O

Patients	O	O	B-T101
in	O	O	O
group	O	O	B-T185
A	O	O	I-T185
were	O	O	O
older	O	O	B-T098
(	O	O	O
74Â±12	O	O	O
years	O	O	O
vs.	O	O	O
68Â±17	O	O	O
years	O	O	O
,	O	O	O
p<0.01	O	O	O
)	O	O	O
and	O	O	O
the	O	O	O
main	O	O	O
indication	O	O	B-T078
for	O	O	O
anticoagulation	O	O	B-T061
was	O	O	O
atrial	O	O	B-T047
fibrillation	O	O	I-T047
(	O	O	O
58.6	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

No	O	O	B-T033
complications	O	O	B-T046
occurred	O	O	O
during	O	O	O
the	O	O	O
procedures	O	O	B-T058
.	O	O	O

There	O	O	O
were	O	O	O
no	O	O	B-T033
acute	O	O	B-T046
bleedings	O	O	I-T046
just	O	O	O
after	O	O	B-T079
the	O	O	O
bandage	O	O	B-T074
removal	O	O	B-T052
.	O	O	O

During	O	O	O
the	O	O	O
first	O	O	O
24h	O	O	O
,	O	O	O
only	O	O	O
3	O	O	O
(	O	O	O
2.1	O	O	O
%	O	O	O
)	O	O	O
radial	O	O	B-T046
occlusions	O	O	I-T046
in	O	O	O
group	O	O	B-T185
A	O	O	I-T185
and	O	O	O
2	O	O	O
(	O	O	O
0.6	O	O	O
%	O	O	O
)	O	O	O
in	O	O	O
group	O	O	B-T185
B	O	O	I-T185
(	O	O	O
p=0.14	O	O	O
)	O	O	O
were	O	O	O
recorded	O	O	B-T080
.	O	O	O

Hematomas	O	O	B-T046
between	O	O	O
5	O	O	O
and	O	O	O
10	O	O	O
cm	O	O	O
appeared	O	O	O
in	O	O	O
5	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
group	O	O	B-T078
A	O	O	I-T185
vs.	O	O	O
4.6	O	O	O
%	O	O	O
in	O	O	O
group	O	O	O
B.	O	O	O
During	O	O	O
the	O	O	O
1-month	O	O	B-T079
follow-up	O	O	B-T058
period	O	O	B-T079
,	O	O	O
one	O	O	O
more	O	O	O
radial	O	O	B-T046
occlusion	O	O	I-T046
in	O	O	O
each	O	O	O
group	O	O	O
was	O	O	O
recorded	O	O	B-T080
and	O	O	O
there	O	O	O
were	O	O	O
4	O	O	O
(	O	O	O
1.1	O	O	O
%	O	O	O
)	O	O	O
additional	O	O	O
mild	O	O	B-T080
hematomas	O	O	B-T046
in	O	O	O
group	O	O	B-T185
B	O	O	I-T185
and	O	O	O
none	O	O	O
in	O	O	O
group	O	O	B-T185
A	O	O	I-T185
(	O	O	O
p=0.48	O	O	O
)	O	O	O
.	O	O	O

Performing	O	O	B-T169
a	O	O	O
transradial	O	O	B-T060
diagnostic	O	O	I-T060
cardiac	O	O	I-T060
catheterization	O	O	I-T060
without	O	O	B-T080
removal	O	O	B-T052
of	O	O	O
the	O	O	O
oral	O	O	B-T082
chronic	O	O	B-UnknownType
anticoagulation	O	O	I-UnknownType
appears	O	O	O
safe	O	O	B-T033
in	O	O	O
patients	O	O	B-T101
under	O	O	O
acenocumarol	O	O	B-T109
therapy	O	O	B-T061
.	O	O	O

-DOCSTART- (27235559)

Does	O	O	O
infrared	O	O	B-T074
visualization	O	O	B-T169
improve	O	O	O
selection	O	O	B-T052
of	O	O	O
venipuncture	O	O	B-T060
sites	O	O	B-T082
for	O	O	O
indwelling	O	O	B-T169
needle	O	O	B-T074
at	O	O	O
the	O	O	O
forearm	O	O	B-T023
in	O	O	O
second-year	O	O	O
nursing	O	O	B-T097
students	O	O	I-T097
?	O	O	O

To	O	O	O
evaluate	O	O	O
the	O	O	O
effectiveness	O	O	B-T080
of	O	O	O
a	O	O	O
vein	O	O	B-T074
visualization	O	O	I-T074
display	O	O	I-T074
system	O	O	I-T074
using	O	O	O
near-infrared	O	O	B-T070
light	O	O	I-T070
(	O	O	O
"	O	O	O
Vein	O	O	B-T074
Display	O	O	I-T074
"	O	O	O
)	O	O	O
for	O	O	O
the	O	O	O
safe	O	O	O
and	O	O	O
proper	O	O	O
selection	O	O	B-T052
of	O	O	O
venipuncture	O	O	B-T060
sites	O	O	B-T082
for	O	O	O
indwelling	O	O	B-T169
needle	O	O	B-T074
placement	O	O	O
in	O	O	O
the	O	O	O
forearm	O	O	B-T023
.	O	O	O

Ten	O	O	O
second	O	O	O
year	O	O	O
nursing	O	O	B-T097
students	O	O	I-T097
were	O	O	O
recruited	O	O	O
to	O	O	O
apply	O	O	O
an	O	O	O
indwelling	O	O	B-T169
needle	O	O	B-T074
line	O	O	O
with	O	O	O
and	O	O	O
without	O	O	O
Vein	O	O	B-T023
Display	O	O	B-T169
.	O	O	O

Another	O	O	O
ten	O	O	O
participants	O	O	B-T098
were	O	O	O
recruited	O	O	O
from	O	O	O
various	O	O	O
faculty	O	O	B-T097
to	O	O	O
serve	O	O	O
as	O	O	O
patients	O	O	B-T101
.	O	O	O

The	O	O	O
quality	O	O	O
of	O	O	O
the	O	O	O
venipuncture	O	O	B-T060
procedure	O	O	I-T060
at	O	O	O
various	O	O	O
selected	O	O	O
sites	O	O	B-T082
was	O	O	O
evaluated	O	O	O
according	O	O	O
to	O	O	O
a	O	O	O
scale	O	O	B-T170
developed	O	O	O
by	O	O	O
the	O	O	O
authors	O	O	B-T097
.	O	O	O

Time	O	O	B-T079
,	O	O	O
scores	O	O	B-T081
and	O	O	O
patterns	O	O	B-T080
of	O	O	O
puncture	O	O	B-T060
-	O	O	O
site	O	O	B-T082
selection	O	O	B-T052
were	O	O	O
compared	O	O	O
with	O	O	O
respect	O	O	O
to	O	O	O
three	O	O	O
different	O	O	O
methods	O	O	O
:	O	O	O
[	O	O	O
1	O	O	O
]	O	O	O
attempt	O	O	O
1	O	O	O
(	O	O	O
tourniquet	O	O	B-T074
only	O	O	O
)	O	O	O
,	O	O	O
[	O	O	O
2	O	O	O
]	O	O	O
attempt	O	O	O
2	O	O	O
(	O	O	O
Vein	O	O	B-T074
Display	O	O	I-T074
only	O	O	O
)	O	O	O
and	O	O	O
[	O	O	O
3	O	O	O
]	O	O	O
attempt	O	O	O
3	O	O	O
(	O	O	O
both	O	O	O
)	O	O	O
.	O	O	O

To	O	O	O
validate	O	O	O
the	O	O	O
effectiveness	O	O	B-T080
of	O	O	O
Vein	O	O	B-T023
Display	O	O	B-T169
,	O	O	O
52	O	O	O
trials	O	O	O
were	O	O	O
conducted	O	O	O
in	O	O	O
total	O	O	O
.	O	O	O

We	O	O	O
found	O	O	O
that	O	O	O
venipuncture	O	O	B-T060
site	O	O	B-T082
selection	O	O	B-T052
time	O	O	O
was	O	O	O
significantly	O	O	O
improved	O	O	O
with	O	O	O
the	O	O	O
Vein	O	O	B-T074
Display	O	O	I-T074
,	O	O	O
particularly	O	O	O
in	O	O	O
the	O	O	O
case	O	O	O
of	O	O	O
difficult	O	O	O
to	O	O	O
administer	O	O	B-T169
venipuncture	O	O	O
sites	O	O	B-T082
.	O	O	O

Overall	O	O	O
,	O	O	O
we	O	O	O
found	O	O	O
no	O	O	O
significant	O	O	O
difference	O	O	O
with	O	O	O
respect	O	O	O
to	O	O	O
venipuncture	O	O	B-T060
quality	O	O	B-T080
,	O	O	O
as	O	O	O
determined	O	O	O
by	O	O	O
our	O	O	O
scale	O	O	B-T170
.	O	O	O

These	O	O	O
results	O	O	O
suggest	O	O	O
that	O	O	O
equipment	O	O	O
such	O	O	O
as	O	O	O
the	O	O	O
Vein	O	O	B-T074
Display	O	O	I-T074
can	O	O	O
contribute	O	O	O
immensely	O	O	O
to	O	O	O
the	O	O	O
improvement	O	O	O
of	O	O	O
practical	O	O	B-T080
skills	O	O	I-T080
,	O	O	O
such	O	O	O
as	O	O	O
venipuncture	O	O	B-T060
,	O	O	O
especially	O	O	O
in	O	O	O
the	O	O	O
context	O	O	O
of	O	O	O
elderly	O	O	B-T098
patients	O	O	B-T101
.	O	O	O

-DOCSTART- (27235789)

Elective	O	O	B-T061
Nephron	O	O	B-T061
Sparing	O	O	I-T061
Surgery	O	O	I-T061
Decreases	O	O	B-T081
Other	O	O	B-T033
Cause	O	O	I-T033
Mortality	O	O	I-T033
Relative	O	O	B-T080
to	O	O	O
Radical	O	O	B-T061
Nephrectomy	O	O	I-T061
Only	O	O	O
in	O	O	O
Specific	O	O	B-T080
Subgroups	O	O	B-T185
of	O	O	O
Patients	O	O	B-T101
with	O	O	O
Renal	O	O	O
Cell	O	O	O
Carcinoma	O	O	O

There	O	O	O
is	O	O	O
no	O	O	O
consensus	O	O	B-T054
regarding	O	O	O
a	O	O	O
protective	O	O	B-T033
effect	O	O	I-T033
on	O	O	O
mortality	O	O	B-T081
due	O	O	O
to	O	O	O
a	O	O	O
cause	O	O	O
other	O	O	O
than	O	O	O
cancer	O	O	B-T191
in	O	O	O
patients	O	O	B-T101
treated	O	O	B-T061
with	O	O	I-T061
elective	O	O	B-T061
nephron	O	O	B-T061
sparing	O	O	I-T061
surgery	O	O	I-T061
relative	O	O	B-T080
to	O	O	O
their	O	O	O
radical	O	O	B-T061
nephrectomy	O	O	I-T061
counterparts	O	O	O
.	O	O	O

We	O	O	O
test	O	O	B-T169
whether	O	O	O
the	O	O	O
protective	O	O	B-T033
effect	O	O	I-T033
of	O	O	O
nephron	O	O	B-T061
sparing	O	O	I-T061
surgery	O	O	I-T061
relative	O	O	B-T080
to	O	O	O
radical	O	O	B-T061
nephrectomy	O	O	I-T061
is	O	O	O
universal	O	O	B-T080
or	O	O	O
present	O	O	O
in	O	O	O
specific	O	O	B-T080
subgroups	O	O	B-T185
of	O	O	O
patients	O	O	B-T101
.	O	O	O

A	O	O	O
collaborative	O	O	B-T081
database	O	O	B-T170
of	O	O	O
5	O	O	O
institutions	O	O	B-T078
was	O	O	O
queried	O	O	B-T170
to	O	O	O
evaluate	O	O	B-T058
1,783	O	O	O
patients	O	O	B-T101
without	O	O	O
chronic	O	O	B-T047
kidney	O	O	I-T047
disease	O	O	I-T047
diagnosed	O	O	B-T033
with	O	O	O
a	O	O	O
clinical	O	O	B-T080
T1	O	O	B-T191
renal	O	O	I-T191
mass	O	O	I-T191
that	O	O	O
was	O	O	O
treated	O	O	B-T061
with	O	O	I-T061
nephron	O	O	B-T061
sparing	O	O	I-T061
surgery	O	O	I-T061
or	O	O	O
radical	O	O	B-T061
nephrectomy	O	O	I-T061
.	O	O	O

Multivariable	O	O	B-T170
Cox	O	O	I-T170
regression	O	O	I-T170
analysis	O	O	I-T170
was	O	O	O
done	O	O	O
to	O	O	O
assess	O	O	B-T058
the	O	O	O
impact	O	O	B-T080
of	O	O	O
surgery	O	O	B-T061
type	O	O	O
(	O	O	O
nephron	O	O	B-T061
sparing	O	O	I-T061
surgery	O	O	I-T061
vs	O	O	O
radical	O	O	B-T061
nephrectomy	O	O	I-T061
)	O	O	O
on	O	O	O
other	O	O	B-T033
cause	O	O	I-T033
mortality	O	O	I-T033
after	O	O	O
adjustment	O	O	O
for	O	O	O
patient	O	O	B-T101
and	O	O	O
cancer	O	O	B-T191
characteristics	O	O	B-T080
.	O	O	O

Interaction	O	O	B-T169
terms	O	O	O
were	O	O	O
used	O	O	O
to	O	O	O
test	O	O	B-T169
the	O	O	O
hypothesis	O	O	O
that	O	O	O
the	O	O	O
impact	O	O	B-T080
of	O	O	O
surgery	O	O	B-T061
type	O	O	O
varies	O	O	O
according	O	O	O
to	O	O	O
specific	O	O	B-T080
subcohorts	O	O	B-T098
of	O	O	O
patients	O	O	B-T101
.	O	O	O

Ten-year	O	O	B-T079
other	O	O	B-T033
cause	O	O	I-T033
mortality	O	O	I-T033
-free	O	O	O
survival	O	O	B-T081
rates	O	O	I-T081
were	O	O	O
90	O	O	O
%	O	O	O
and	O	O	O
88	O	O	O
%	O	O	O
after	O	O	O
nephron	O	O	B-T061
sparing	O	O	I-T061
surgery	O	O	I-T061
and	O	O	O
radical	O	O	B-T061
nephrectomy	O	O	I-T061
,	O	O	O
respectively	O	O	O
.	O	O	O

In	O	O	O
the	O	O	O
overall	O	O	B-T080
population	O	O	B-T098
radical	O	O	B-T061
nephrectomy	O	O	I-T061
was	O	O	O
not	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
an	O	O	O
increased	O	O	B-T081
risk	O	O	B-T078
of	O	O	O
other	O	O	B-T033
cause	O	O	I-T033
mortality	O	O	I-T033
on	O	O	O
multivariable	O	O	B-T081
analysis	O	O	I-T081
compared	O	O	O
to	O	O	O
nephron	O	O	B-T061
sparing	O	O	I-T061
surgery	O	O	I-T061
(	O	O	O
HR	O	O	B-T081
0.91	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
0.6	O	O	O
-	O	O	O
1.38	O	O	O
,	O	O	O
p	O	O	O
=	O	O	O
0.6	O	O	O
)	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
radical	O	O	B-T061
nephrectomy	O	O	I-T061
increased	O	O	B-T081
the	O	O	O
risk	O	O	B-T078
of	O	O	O
other	O	O	B-T033
cause	O	O	I-T033
mortality	O	O	I-T033
according	O	O	O
to	O	O	O
the	O	O	O
increasing	O	O	B-T081
baseline	O	O	B-T081
Charlson	O	O	B-T170
comorbidity	O	O	I-T170
index	O	O	I-T170
(	O	O	O
interaction	O	O	B-T169
test	O	O	B-T169
p	O	O	O
=	O	O	O
0.0008	O	O	O
)	O	O	O
.	O	O	O

For	O	O	O
example	O	O	O
,	O	O	O
in	O	O	O
a	O	O	O
patient	O	O	B-T101
with	O	O	O
a	O	O	O
Charlson	O	O	B-T170
comorbidity	O	O	I-T170
index	O	O	I-T170
of	O	O	O
4	O	O	O
the	O	O	O
probability	O	O	B-T081
of	O	O	O
10-year	O	O	B-T079
other	O	O	B-T033
cause	O	O	I-T033
mortality	O	O	I-T033
-free	O	O	O
survival	O	O	B-T052
was	O	O	O
86	O	O	O
%	O	O	O
after	O	O	O
nephron	O	O	B-T061
sparing	O	O	I-T061
surgery	O	O	I-T061
and	O	O	O
60	O	O	O
%	O	O	O
after	O	O	O
radical	O	O	B-T061
nephrectomy	O	O	I-T061
.	O	O	O

Elective	O	O	B-T061
nephron	O	O	B-T061
sparing	O	O	I-T061
surgery	O	O	I-T061
does	O	O	O
not	O	O	O
improve	O	O	B-T033
other	O	O	O
cause	O	O	O
survival	O	O	B-T052
relative	O	O	B-T080
to	O	O	O
radical	O	O	B-T061
nephrectomy	O	O	I-T061
consistently	O	O	O
in	O	O	O
all	O	O	O
patients	O	O	B-T101
with	O	O	O
kidney	O	O	B-T191
cancer	O	O	I-T191
.	O	O	O

Patients	O	O	B-T101
who	O	O	O
are	O	O	O
more	O	O	O
ill	O	O	B-T184
with	O	O	O
relevant	O	O	B-T080
comorbidities	O	O	B-T078
are	O	O	O
those	O	O	O
who	O	O	O
benefit	O	O	B-T081
the	O	O	O
most	O	O	O
from	O	O	O
nephron	O	O	B-T061
sparing	O	O	I-T061
surgery	O	O	I-T061
in	O	O	O
terms	O	O	O
of	O	O	O
other	O	O	B-T033
cause	O	O	I-T033
mortality	O	O	I-T033
.	O	O	O

-DOCSTART- (27237609)

Prospective	O	O	O
study	O	O	O
of	O	O	O
dietary	O	O	B-T168
Non	O	O	B-T059
Enzymatic	O	O	I-T059
Antioxidant	O	O	I-T059
Capacity	O	O	I-T059
on	O	O	O
the	O	O	O
risk	O	O	B-T078
of	O	O	O
hip	O	O	B-T037
fracture	O	O	I-T037
in	O	O	O
the	O	O	O
elderly	O	O	O

Dietary	O	O	B-T168
antioxidants	O	O	I-T168
may	O	O	O
play	O	O	O
an	O	O	O
important	O	O	O
role	O	O	O
in	O	O	O
the	O	O	O
prevention	O	O	O
of	O	O	O
bone	O	O	B-T047
loss	O	O	I-T047
and	O	O	O
associated	O	O	O
fractures	O	O	B-T037
by	O	O	O
reducing	O	O	O
levels	O	O	O
of	O	O	O
oxidative	O	O	B-T049
stress	O	O	I-T049
.	O	O	O

We	O	O	O
prospectively	O	O	O
investigated	O	O	O
the	O	O	O
association	O	O	O
between	O	O	O
dietary	O	O	B-T168
Non	O	O	B-T059
Enzymatic	O	O	I-T059
Antioxidant	O	O	I-T059
Capacity	O	O	I-T059
(	O	O	O
NEAC	O	O	B-T059
)	O	O	O
and	O	O	O
the	O	O	O
risk	O	O	B-T078
of	O	O	O
hip	O	O	B-T037
fracture	O	O	I-T037
and	O	O	O
whether	O	O	O
this	O	O	O
effect	O	O	O
was	O	O	O
modified	O	O	O
by	O	O	O
smoking	O	O	B-T055
.	O	O	O

In	O	O	O
the	O	O	O
Swedish	O	O	B-T098
National	O	O	I-T098
March	O	O	I-T098
Cohort	O	O	I-T098
13,409	O	O	O
men	O	O	B-T098
and	O	O	O
women	O	O	B-T098
over	O	O	O
the	O	O	O
age	O	O	O
of	O	O	O
55	O	O	O
who	O	O	O
had	O	O	O
not	O	O	O
experienced	O	O	O
cancer	O	O	B-T191
,	O	O	O
cardiovascular	O	O	B-T047
disease	O	O	I-T047
or	O	O	O
hip	O	O	B-T037
fracture	O	O	I-T037
,	O	O	O
were	O	O	O
followed	O	O	O
through	O	O	O
record-linkages	O	O	B-T062
from	O	O	O
1997	O	O	O
through	O	O	O
2010	O	O	O
.	O	O	O

NEAC	O	O	B-T059
was	O	O	O
assessed	O	O	O
by	O	O	O
a	O	O	O
validated	O	O	O
food	O	O	B-T170
frequency	O	O	I-T170
questionnaire	O	O	I-T170
collected	O	O	O
at	O	O	O
baseline	O	O	B-T081
.	O	O	O

We	O	O	O
categorized	O	O	O
the	O	O	O
distribution	O	O	O
of	O	O	O
NEAC	O	O	B-T059
into	O	O	O
sex	O	O	B-T032
-	O	O	O
specific	O	O	B-T080
quartiles	O	O	B-T080
and	O	O	O
used	O	O	O
multivariable	O	O	B-T081
adjusted	O	O	I-T081
Cox	O	O	I-T081
proportional	O	O	I-T081
hazards	O	O	I-T081
regression	O	O	I-T081
models	O	O	I-T081
to	O	O	O
estimate	O	O	O
hazard	O	O	B-T081
ratios	O	O	I-T081
(	O	O	O
HRs	O	O	B-T081
)	O	O	O
with	O	O	O
95	O	O	O
%	O	O	O
confidence	O	O	B-T081
intervals	O	O	I-T081
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
)	O	O	O
.	O	O	O

During	O	O	O
a	O	O	O
mean	O	O	O
follow-up	O	O	B-T058
time	O	O	B-T079
of	O	O	O
12.4years	O	O	O
,	O	O	O
we	O	O	O
identified	O	O	O
491	O	O	O
incident	O	O	O
cases	O	O	O
of	O	O	O
first	O	O	O
hip	O	O	B-T037
fracture	O	O	I-T037
.	O	O	O

Subjects	O	O	O
in	O	O	O
the	O	O	O
highest	O	O	O
quartile	O	O	B-T080
of	O	O	O
dietary	O	O	B-T168
NEAC	O	O	B-T059
had	O	O	O
a	O	O	O
39	O	O	O
%	O	O	O
lower	O	O	B-T033
risk	O	O	I-T033
of	O	O	O
incident	O	O	O
hip	O	O	B-T037
fracture	O	O	I-T037
compared	O	O	O
to	O	O	O
those	O	O	O
in	O	O	O
the	O	O	O
lowest	O	O	O
quartile	O	O	O
(	O	O	O
HR	O	O	B-T081
:	O	O	O
0.61	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
:	O	O	O
0.44	O	O	O
-	O	O	O
0.85	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
association	O	O	O
was	O	O	O
non-linear	O	O	O
(	O	O	O
p	O	O	O
for	O	O	O
non-linearity	O	O	O
:	O	O	O
0.004	O	O	O
)	O	O	O
with	O	O	O
a	O	O	O
potential	O	O	O
threshold	O	O	O
between	O	O	O
the	O	O	O
first	O	O	O
and	O	O	O
the	O	O	O
second	O	O	O
quartile	O	O	B-T080
and	O	O	O
no	O	O	O
further	O	O	O
risk	O	O	B-T055
reduction	O	O	I-T055
at	O	O	O
higher	O	O	O
levels	O	O	O
of	O	O	O
dietary	O	O	B-T168
NEAC	O	O	B-T059
.	O	O	O

Due	O	O	O
to	O	O	O
a	O	O	O
low	O	O	O
smoking	O	O	B-T055
prevalence	O	O	O
in	O	O	O
our	O	O	O
study	O	O	O
population	O	O	O
,	O	O	O
we	O	O	O
had	O	O	O
limited	O	O	O
power	O	O	O
to	O	O	O
detect	O	O	O
effect	O	O	O
modification	O	O	O
between	O	O	O
dietary	O	O	B-T168
NEAC	O	O	B-T059
and	O	O	O
smoking	O	O	O
on	O	O	O
a	O	O	O
multiplicative	O	O	B-T081
or	O	O	O
additive	O	O	B-T081
scale	O	O	I-T081
.	O	O	O

Higher	O	O	O
dietary	O	O	O
NEAC	O	O	B-T059
intake	O	O	O
is	O	O	O
associated	O	O	O
with	O	O	O
lower	O	O	O
risk	O	O	B-T078
of	O	O	O
hip	O	O	B-T037
fracture	O	O	I-T037
in	O	O	O
the	O	O	O
elderly	O	O	O
.	O	O	O

-DOCSTART- (27239541)

Function	O	O	B-T041
and	O	O	O
clinical	O	O	B-T080
meaningfulness	O	O	B-T080
of	O	O	O
treatments	O	O	B-T061
for	O	O	O
mild	O	O	B-T080
Alzheimer	O	O	O
's	O	O	O
disease	O	O	O

Effectiveness	O	O	B-T080
of	O	O	O
Alzheimer	O	O	B-T047
's	O	O	I-T047
disease	O	O	I-T047
(	O	O	O
AD	O	O	B-T047
)	O	O	O
treatments	O	O	B-T061
is	O	O	O
commonly	O	O	O
evaluated	O	O	O
with	O	O	O
coprimary	O	O	B-T169
outcomes	O	O	I-T169
;	O	O	O
cognition	O	O	B-T041
with	O	O	O
function	O	O	B-T041
to	O	O	O
ensure	O	O	O
clinical	O	O	B-T080
meaningfulness	O	O	B-T080
of	O	O	O
a	O	O	O
cognitive	O	O	B-T041
effect	O	O	B-T080
.	O	O	O

We	O	O	O
reviewed	O	O	B-T080
the	O	O	O
literature	O	O	B-T170
for	O	O	O
functional	O	O	B-T041
outcomes	O	O	B-T169
in	O	O	O
mild	O	O	B-T080
AD	O	O	B-T047
or	O	O	O
mild	O	O	B-T048
cognitive	O	O	I-T048
impairment	O	O	I-T048
(	O	O	O
MCI	O	O	B-T048
)	O	O	O
patients	O	O	B-T101
(	O	O	O
distinct	O	O	O
from	O	O	O
combined	O	O	O
mild-moderate	O	O	B-T080
/	O	O	O
severe	O	O	B-T080
AD	O	O	O
)	O	O	O
treated	O	O	B-T061
with	O	O	I-T061
approved	O	O	O
AD	O	O	O
drugs	O	O	B-T121
.	O	O	O

Cognitive	O	O	B-T061
and	O	O	O
functional	O	O	B-T041
treatment	O	O	B-T061
differences	O	O	O
in	O	O	O
mild	O	O	B-T080
AD	O	O	B-T047
patients	O	O	B-T101
in	O	O	O
solanezumab	O	O	B-T116
EXPEDITION	O	O	B-T052
/	O	O	O
EXPEDITION2	O	O	B-T052
studies	O	O	B-T062
were	O	O	O
compared	O	O	B-T052
across	O	O	O
time	O	O	B-T079
.	O	O	O

Seven	O	O	O
publications	O	O	B-T073
provided	O	O	O
MCI	O	O	B-T048
/	O	O	O
mild	O	O	B-T080
AD	O	O	B-T047
functional	O	O	B-T041
outcomes	O	O	B-T169
,	O	O	O
one	O	O	O
of	O	O	O
which	O	O	O
reported	O	O	O
a	O	O	O
significant	O	O	O
functional	O	O	O
treatment	O	O	B-T033
effect	O	O	I-T033
.	O	O	O

Secondary	O	O	B-UnknownType
analyses	O	O	I-UnknownType
of	O	O	O
EXPEDITION	O	O	B-T052
studies	O	O	B-T062
suggested	O	O	O
a	O	O	O
smaller	O	O	O
functional	O	O	B-T041
effect	O	O	B-T080
of	O	O	O
solanezumab	O	O	B-T116
relative	O	O	O
to	O	O	O
cognition	O	O	B-T041
.	O	O	O

An	O	O	O
increasing	O	O	B-T169
effect	O	O	B-T080
of	O	O	O
solanezumab	O	O	B-T116
over	O	O	O
18	O	O	O
months	O	O	B-T079
was	O	O	O
shown	O	O	O
for	O	O	O
cognition	O	O	B-T041
and	O	O	O
function	O	O	B-T041
.	O	O	O

Function	O	O	B-T041
as	O	O	O
the	O	O	O
sole	O	O	O
measure	O	O	B-T081
to	O	O	O
demonstrate	O	O	O
clinical	O	O	B-T080
meaningfulness	O	O	B-T080
of	O	O	O
cognitive	O	O	B-T041
effects	O	O	B-T080
in	O	O	O
mild	O	O	B-T080
AD	O	O	B-T047
may	O	O	O
have	O	O	O
limitations	O	O	B-T169
.	O	O	O

For	O	O	O
disease	O	O	B-T047
-	O	O	O
modifying	O	O	B-T169
treatments	O	O	B-T061
,	O	O	O
point	O	O	O
differences	O	O	O
on	O	O	O
cognitive	O	O	B-T041
and	O	O	O
functional	O	O	B-T041
scales	O	O	B-T170
should	O	O	O
be	O	O	O
qualified	O	O	O
with	O	O	O
duration	O	O	B-T079
of	O	O	I-T079
treatment	O	O	I-T079
.	O	O	O

-DOCSTART- (27241291)

In	O	O	O
Search	O	O	O
of	O	O	O
the	O	O	O
E.	O	O	B-T007
coli	O	O	I-T007
Compounds	O	O	B-T123
that	O	O	O
Change	O	O	O
the	O	O	O
Antibiotic	O	O	B-T195
Production	O	O	B-T169
Pattern	O	O	O
of	O	O	O
Streptomyces	O	O	B-T007
coelicolor	O	O	I-T007
During	O	O	O
Inter-species	O	O	O
Interaction	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
this	O	O	O
work	O	O	O
was	O	O	O
to	O	O	O
investigate	O	O	B-T169
the	O	O	O
interaction	O	O	B-T169
between	O	O	O
E.coli	O	O	B-T007
and	O	O	O
Streptomyces	O	O	B-T007
coelicolor	O	O	I-T007
A3	O	O	I-T007
(	O	O	I-T007
2	O	O	I-T007
)	O	O	I-T007
for	O	O	O
the	O	O	O
increased	O	O	B-T081
production	O	O	B-T169
of	O	O	O
undecylprodigiosin	O	O	B-T109
and	O	O	O
identify	O	O	O
the	O	O	O
E.	O	O	B-T007
coli	O	O	I-T007
actives	O	O	B-T169
mediating	O	O	B-T054
this	O	O	O
inter-species	O	O	B-T054
interaction	O	O	I-T054
.	O	O	O

The	O	O	O
antibiotics	O	O	B-T195
of	O	O	O
interest	O	O	O
were	O	O	O
the	O	O	O
red-pigmented	O	O	B-T109
undecylprodigiosin	O	O	I-T109
and	O	O	O
blue-pigmented	O	O	B-T080
actinorhodin	O	O	B-T195
.	O	O	O

Pure	O	O	O
cultures	O	O	B-T059
of	O	O	O
S.	O	O	B-T007
coelicolor	O	O	I-T007
in	O	O	O
a	O	O	O
defined	O	O	O
medium	O	O	B-T130
produced	O	O	O
higher	O	O	O
concentrations	O	O	B-T081
of	O	O	O
actinorhodin	O	O	B-T195
compared	O	O	B-T052
to	O	O	O
those	O	O	O
of	O	O	O
undecylprodigiosin	O	O	B-T109
.	O	O	O

The	O	O	O
latter	O	O	O
however	O	O	O
,	O	O	O
is	O	O	O
more	O	O	O
important	O	O	O
due	O	O	O
to	O	O	O
its	O	O	O
immunosuppressive	O	O	B-T040
and	O	O	O
antitumor	O	O	B-T042
properties	O	O	I-T042
.	O	O	O

As	O	O	O
a	O	O	O
strategy	O	O	O
to	O	O	O
increase	O	O	B-T169
undecylprodigiosin	O	O	B-T109
production	O	O	B-T169
,	O	O	O
we	O	O	O
added	O	O	O
separately	O	O	O
,	O	O	O
live	O	O	B-T025
cells	O	O	B-T025
and	O	O	O
heat-killed	O	O	B-T067
cells	O	O	O
of	O	O	O
E.	O	O	B-T007
coli	O	O	I-T007
C600	O	O	I-T007
,	O	O	O
and	O	O	O
the	O	O	O
cell-free	O	O	B-T031
supernatant	O	O	I-T031
of	O	O	O
E.	O	O	O
coli	O	O	O
culture	O	O	B-T059
to	O	O	O
S.	O	O	B-T007
coelicolor	O	O	I-T007
cultures	O	O	B-T059
in	O	O	I-T059
shake	O	O	I-T059
flasks	O	O	I-T059
.	O	O	O

The	O	O	O
interaction	O	O	B-T169
with	O	O	O
live	O	O	B-T025
cells	O	O	I-T025
of	O	O	O
E.	O	O	B-T007
coli	O	O	I-T007
altered	O	O	O
the	O	O	O
antibiotic	O	O	B-T195
production	O	O	B-T169
pattern	O	O	O
and	O	O	O
undecylprodigiosin	O	O	B-T109
production	O	O	O
was	O	O	O
enhanced	O	O	B-T052
by	O	O	O
3.5-fold	O	O	O
compared	O	O	O
to	O	O	O
the	O	O	O
pure	O	O	B-T059
cultures	O	O	I-T059
of	O	O	O
S.	O	O	B-T007
coelicolor	O	O	I-T007
and	O	O	O
actinorhodin	O	O	B-T195
decreased	O	O	B-T081
by	O	O	O
15-fold	O	O	O
.	O	O	O

The	O	O	O
heat-killed	O	O	B-T067
cells	O	O	B-T025
of	O	O	O
E.	O	O	B-T007
coli	O	O	I-T007
however	O	O	O
,	O	O	O
had	O	O	O
no	O	O	B-T080
effect	O	O	I-T080
on	O	O	O
antibiotic	O	O	B-T195
production	O	O	B-T169
.	O	O	O

In	O	O	O
all	O	O	O
cases	O	O	O
,	O	O	O
growth	O	O	B-T040
and	O	O	O
glucose	O	O	B-T033
consumption	O	O	I-T033
of	O	O	O
S.	O	O	B-T007
coelicolor	O	O	I-T007
remained	O	O	O
almost	O	O	O
the	O	O	O
same	O	O	B-T080
as	O	O	O
those	O	O	O
observed	O	O	B-T169
in	O	O	O
the	O	O	O
pure	O	O	B-T059
culture	O	O	I-T059
indicating	O	O	O
that	O	O	O
the	O	O	O
changes	O	O	B-T169
in	O	O	O
antibiotic	O	O	B-T195
production	O	O	B-T169
were	O	O	O
not	O	O	O
due	O	O	O
to	O	O	O
nutritional	O	O	B-T040
stress	O	O	B-T033
.	O	O	O

Results	O	O	B-T169
with	O	O	O
cell-free	O	O	B-T031
supernatant	O	O	I-T031
of	O	O	O
E.	O	O	B-T007
coli	O	O	I-T007
culture	O	O	B-T059
indicated	O	O	O
that	O	O	O
the	O	O	O
interaction	O	O	B-T169
between	O	O	O
S.	O	O	B-T007
coelicolor	O	O	I-T007
and	O	O	O
E.	O	O	O
coli	O	O	O
was	O	O	O
mediated	O	O	B-T054
via	O	O	O
diffusible	O	O	B-T123
molecule(s	O	O	I-T123
)	O	O	I-T123
.	O	O	O

Using	O	O	O
a	O	O	O
set	O	O	O
of	O	O	O
extraction	O	O	B-T059
procedures	O	O	I-T059
and	O	O	O
agar-well	O	O	B-T059
diffusion	O	O	I-T059
bioassays	O	O	I-T059
,	O	O	O
we	O	O	O
isolated	O	O	B-T169
and	O	O	O
preliminarily	O	O	O
identified	O	O	B-T080
a	O	O	O
class	O	O	B-T123
of	O	O	I-T123
compounds	O	O	I-T123
.	O	O	O

For	O	O	O
the	O	O	O
preliminary	O	O	O
verification	O	O	B-T169
,	O	O	O
we	O	O	O
added	O	O	O
the	O	O	O
compound	O	O	B-T123
which	O	O	O
was	O	O	O
the	O	O	O
common	O	O	O
chemical	O	O	B-T104
structural	O	O	I-T104
moiety	O	O	I-T104
in	O	O	O
this	O	O	O
class	O	O	B-T123
of	O	O	I-T123
compounds	O	O	I-T123
to	O	O	O
the	O	O	O
pure	O	O	O
S.	O	O	B-T007
coelicolor	O	O	I-T007
cultures	O	O	B-T059
.	O	O	O

We	O	O	O
observed	O	O	O
similar	O	O	O
effects	O	O	B-T080
on	O	O	O
antibiotic	O	O	B-T195
production	O	O	B-T169
as	O	O	O
with	O	O	O
the	O	O	O
live	O	O	O
E.	O	O	B-T007
coli	O	O	I-T007
cells	O	O	B-T025
and	O	O	O
their	O	O	O
supernatant	O	O	B-T031
indicating	O	O	O
that	O	O	O
this	O	O	O
class	O	O	B-T123
of	O	O	I-T123
compounds	O	O	I-T123
secreted	O	O	B-T043
by	O	O	O
E.	O	O	O
coli	O	O	O
indeed	O	O	O
could	O	O	O
act	O	O	O
as	O	O	O
actives	O	O	B-T169
during	O	O	O
interspecies	O	O	B-T054
interaction	O	O	I-T054
and	O	O	O
increase	O	O	B-T169
the	O	O	O
production	O	O	O
of	O	O	O
undecylprodigiosin	O	O	B-T109
.	O	O	O

-DOCSTART- (27241818)

Group	O	O	B-T024
III/IV	O	O	I-T024
muscle	O	O	I-T024
afferents	O	O	B-T025
limit	O	O	B-T169
the	O	O	O
intramuscular	O	O	B-T082
metabolic	O	O	B-T169
perturbation	O	O	B-T169
during	O	O	O
whole	O	O	B-T017
body	O	O	I-T017
exercise	O	O	B-T056
in	O	O	O
humans	O	O	O

The	O	O	O
purpose	O	O	B-T169
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
determine	O	O	B-T059
the	O	O	O
role	O	O	B-T077
of	O	O	O
group	O	O	B-T024
III/IV	O	O	I-T024
muscle	O	O	B-T024
afferents	O	O	B-T025
in	O	O	O
limiting	O	O	B-T169
the	O	O	O
endurance	O	O	B-T033
exercise	O	O	B-T056
-	O	O	O
induced	O	O	B-T169
metabolic	O	O	B-T169
perturbation	O	O	B-T169
assayed	O	O	B-T059
in	O	O	O
muscle	O	O	O
biopsy	O	O	B-T024
samples	O	O	I-T024
taken	O	O	O
from	O	O	O
locomotor	O	O	B-T040
muscle	O	O	O
.	O	O	O

Lumbar	O	O	B-T029
intrathecal	O	O	B-T030
fentanyl	O	O	B-T109
was	O	O	O
used	O	O	O
to	O	O	O
attenuate	O	O	B-T052
the	O	O	O
central	O	O	B-T082
projection	O	O	B-T082
of	O	O	O
Î¼-opioid	O	O	B-T116
receptor	O	O	I-T116
-	O	O	O
sensitive	O	O	B-T169
locomotor	O	O	B-T040
muscle	O	O	B-T024
afferents	O	O	B-T025
during	O	O	O
a	O	O	O
5	O	O	O
km	O	O	O
cycling	O	O	B-T079
time	O	O	B-T079
trial	O	O	B-T062
.	O	O	O

The	O	O	O
findings	O	O	B-T033
suggest	O	O	O
that	O	O	O
the	O	O	O
central	O	O	B-T082
projection	O	O	B-T082
of	O	O	O
group	O	O	B-T024
III/IV	O	O	I-T024
muscle	O	O	B-T024
afferent	O	O	B-T025
feedback	O	O	B-T039
constrains	O	O	B-T077
voluntary	O	O	B-T055
neural	O	O	B-T169
'	O	O	O
drive	O	O	B-T041
'	O	O	O
to	O	O	O
working	O	O	B-T169
locomotor	O	O	B-T040
muscle	O	O	O
and	O	O	O
limits	O	O	B-T169
the	O	O	O
exercise	O	O	B-T056
-	O	O	O
induced	O	O	B-T169
intramuscular	O	O	B-T082
metabolic	O	O	B-T169
perturbation	O	O	B-T169
.	O	O	O

Therefore	O	O	O
,	O	O	O
the	O	O	O
CNS	O	O	B-T022
might	O	O	O
regulate	O	O	B-T038
the	O	O	O
degree	O	O	B-T081
of	O	O	O
metabolic	O	O	B-T169
perturbation	O	O	B-T169
within	O	O	O
locomotor	O	O	B-T040
muscle	O	O	B-T024
and	O	O	O
thereby	O	O	O
limit	O	O	B-T169
peripheral	O	O	B-T082
fatigue	O	O	B-T184
.	O	O	O

It	O	O	O
appears	O	O	B-T080
that	O	O	O
the	O	O	O
group	O	O	B-T024
III/IV	O	O	I-T024
muscle	O	O	B-T024
afferents	O	O	B-T025
are	O	O	O
an	O	O	O
important	O	O	B-T080
neural	O	O	B-T169
link	O	O	B-T030
in	O	O	O
this	O	O	O
regulatory	O	O	B-T038
mechanism	O	O	B-T169
,	O	O	O
which	O	O	O
probably	O	O	B-T078
serves	O	O	O
to	O	O	O
protect	O	O	B-T033
locomotor	O	O	B-T040
muscle	O	O	O
from	O	O	O
the	O	O	O
potentially	O	O	B-T080
severe	O	O	B-T080
functional	O	O	B-T033
impairment	O	O	I-T033
as	O	O	O
a	O	O	O
consequence	O	O	B-T169
of	O	O	O
severe	O	O	O
intramuscular	O	O	B-T082
metabolic	O	O	B-T169
disturbance	O	O	B-T080
.	O	O	O

To	O	O	O
investigate	O	O	B-T169
the	O	O	O
role	O	O	B-T077
of	O	O	O
metabo	O	O	B-T040
-	O	O	O
and	O	O	O
mechanosensitive	O	O	B-T080
group	O	O	B-T024
III/IV	O	O	I-T024
muscle	O	O	B-T024
afferents	O	O	B-T025
in	O	O	O
limiting	O	O	B-T169
the	O	O	O
intramuscular	O	O	B-T082
metabolic	O	O	B-T169
perturbation	O	O	B-T169
during	O	O	O
whole	O	O	B-T017
body	O	O	I-T017
endurance	O	O	B-T033
exercise	O	O	B-T056
,	O	O	O
eight	O	O	O
subjects	O	O	B-T096
performed	O	O	B-T169
5	O	O	O
km	O	O	O
cycling	O	O	B-T079
time	O	O	B-T079
trials	O	O	B-T062
under	O	O	B-T033
control	O	O	I-T033
conditions	O	O	I-T033
(	O	O	O
CTRL	O	O	B-T033
)	O	O	O
and	O	O	O
with	O	O	O
lumbar	O	O	B-T029
intrathecal	O	O	B-T030
fentanyl	O	O	B-T109
impairing	O	O	B-T169
lower	O	O	B-T023
limb	O	O	I-T023
muscle	O	O	O
afferent	O	O	B-T025
feedback	O	O	B-T039
(	O	O	O
FENT	O	O	B-T039
)	O	O	O
.	O	O	O

Vastus	O	O	B-T023
lateralis	O	O	I-T023
muscle	O	O	B-T024
biopsies	O	O	B-T024
were	O	O	O
obtained	O	O	B-T169
before	O	O	B-T079
and	O	O	O
immediately	O	O	B-T079
after	O	O	B-T079
exercise	O	O	B-T056
.	O	O	O

Motoneuronal	O	O	B-T025
output	O	O	B-T060
was	O	O	I-T060
estimated	O	O	I-T060
through	O	O	O
vastus	O	O	B-T023
lateralis	O	O	I-T023
surface	O	O	I-T023
electromyography	O	O	B-T060
(	O	O	O
EMG	O	O	B-T060
)	O	O	O
.	O	O	O

Exercise	O	O	B-T056
-	O	O	O
induced	O	O	B-T169
changes	O	O	B-T169
in	O	O	O
intramuscular	O	O	B-T082
metabolites	O	O	B-T123
were	O	O	O
determine	O	O	B-T059
d	O	O	O
using	O	O	O
liquid	O	O	B-T167
and	O	O	O
gas	O	O	B-T059
chromatography-mass	O	O	I-T059
spectrometry	O	O	I-T059
.	O	O	O

Quadriceps	O	O	B-T023
fatigue	O	O	B-T184
was	O	O	O
quantified	O	O	B-T081
by	O	O	O
pre	O	O	B-T079
-	O	O	O
to	O	O	O
post	O	O	B-T079
-	O	O	O
exercise	O	O	B-T056
changes	O	O	B-T169
in	O	O	O
potentiated	O	O	B-T067
quadriceps	O	O	I-T067
twitch	O	O	I-T067
torque	O	O	I-T067
(	O	O	O
ÎQTsingle	O	O	B-T067
)	O	O	O
evoked	O	O	B-T080
by	O	O	O
electrical	O	O	B-T169
femoral	O	O	B-T023
nerve	O	O	I-T023
stimulation	O	O	B-T061
.	O	O	O

Although	O	O	O
motoneuronal	O	O	B-T025
output	O	O	B-T052
was	O	O	O
21	O	O	O
Â±	O	O	O
12	O	O	O
%	O	O	O
higher	O	O	B-T080
during	O	O	O
FENT	O	O	B-T039
compared	O	O	B-T052
to	O	O	O
CTRL	O	O	B-T033
(	O	O	O
P	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
,	O	O	O
time	O	O	B-T079
to	O	O	O
complete	O	O	B-T080
the	O	O	O
time	O	O	O
trial	O	O	B-T062
was	O	O	O
similar	O	O	B-T080
(	O	O	O
â¼8.8	O	O	O
min	O	O	O
)	O	O	O
.	O	O	O

Compared	O	O	B-T052
to	O	O	O
CTRL	O	O	B-T033
,	O	O	O
power	O	O	B-T070
output	O	O	I-T070
during	O	O	O
FENT	O	O	B-T039
was	O	O	O
10	O	O	O
Â±	O	O	O
4	O	O	O
%	O	O	O
higher	O	O	B-T080
in	O	O	O
the	O	O	O
first	O	O	B-T033
half	O	O	I-T033
of	O	O	O
the	O	O	O
time	O	O	B-T079
trial	O	O	B-T062
,	O	O	O
but	O	O	O
11	O	O	O
Â±	O	O	O
5	O	O	O
%	O	O	O
lower	O	O	B-T080
in	O	O	O
the	O	O	O
second	O	O	B-T033
half	O	O	I-T033
(	O	O	O
both	O	O	O
P	O	O	O
<	O	O	O
0.01	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
exercise	O	O	B-T056
-	O	O	O
induced	O	O	B-T169
increase	O	O	B-T169
in	O	O	O
intramuscular	O	O	B-T082
inorganic	O	O	B-T121
phosphate	O	O	I-T121
,	O	O	O
H(+	O	O	B-T196
)	O	O	I-T196
,	O	O	O
adenosine	O	O	B-T114
diphosphate	O	O	I-T114
,	O	O	O
lactate	O	O	B-T109
and	O	O	O
phosphocreatine	O	O	B-T116
depletion	O	O	B-T169
was	O	O	O
55	O	O	O
Â±	O	O	O
30	O	O	O
,	O	O	O
62	O	O	O
Â±	O	O	O
18	O	O	O
,	O	O	O
129	O	O	O
Â±	O	O	O
63	O	O	O
,	O	O	O
47	O	O	O
Â±	O	O	O
14	O	O	O
(	O	O	O
P	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
and	O	O	O
27	O	O	O
Â±	O	O	O
14	O	O	O
%	O	O	O
(	O	O	O
P	O	O	O
<	O	O	O
0.01	O	O	O
)	O	O	O
greater	O	O	B-T081
in	O	O	O
FENT	O	O	B-T039
than	O	O	O
CTRL	O	O	B-T033
.	O	O	O

ÎQTsingle	O	O	B-T067
was	O	O	O
greater	O	O	B-T081
following	O	O	O
FENT	O	O	B-T039
than	O	O	O
CTRL	O	O	B-T033
(	O	O	O
-52	O	O	O
Â±	O	O	O
2	O	O	O
vs	O	O	O
-31	O	O	O
Â±	O	O	O
1	O	O	O
%	O	O	O
,	O	O	O
P	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
and	O	O	O
this	O	O	O
difference	O	O	B-T081
was	O	O	O
positively	O	O	B-T033
correlated	O	O	B-T080
with	O	O	O
the	O	O	O
difference	O	O	O
in	O	O	O
inorganic	O	O	B-T121
phosphate	O	O	I-T121
(	O	O	O
r(2	O	O	O
)	O	O	O
=	O	O	O
0.79	O	O	O
;	O	O	O
P	O	O	O
<	O	O	O
0.01	O	O	O
)	O	O	O
and	O	O	O
H(+	O	O	O
)	O	O	O
(	O	O	O
r(2	O	O	O
)	O	O	O
=	O	O	O
0.92	O	O	O
;	O	O	O
P	O	O	O
<	O	O	O
0.01	O	O	O
)	O	O	O
.	O	O	O

In	O	O	O
conclusion	O	O	B-T078
,	O	O	O
during	O	O	O
whole	O	O	B-T017
body	O	O	I-T017
exercise	O	O	B-T056
,	O	O	O
group	O	O	B-T024
III/IV	O	O	I-T024
muscle	O	O	I-T024
afferents	O	O	B-T025
provide	O	O	B-T052
feedback	O	O	B-T039
to	O	O	O
the	O	O	O
CNS	O	O	B-T022
which	O	O	O
,	O	O	O
in	O	O	O
turn	O	O	O
,	O	O	O
constrains	O	O	B-T077
motoneuronal	O	O	B-T025
output	O	O	B-T052
to	O	O	O
the	O	O	O
active	O	O	B-T169
skeletal	O	O	B-T024
muscle	O	O	I-T024
.	O	O	O

This	O	O	O
regulatory	O	O	B-T038
mechanism	O	O	B-T169
limits	O	O	B-T169
the	O	O	O
exercise	O	O	B-T056
-	O	O	O
induced	O	O	B-T169
intramuscular	O	O	B-T082
metabolic	O	O	B-T169
perturbation	O	O	B-T169
,	O	O	O
preventing	O	O	O
an	O	O	O
abnormal	O	O	B-T033
homeostatic	O	O	I-T033
challenge	O	O	B-T058
and	O	O	O
excessive	O	O	B-T080
peripheral	O	O	B-T082
fatigue	O	O	B-T184
.	O	O	O

-DOCSTART- (27242550)

Mitochondrial	O	O	B-T026
Ultrastructure	O	O	B-T025
and	O	O	O
Glucose	O	O	B-T044
Signaling	O	O	I-T044
Pathways	O	O	I-T044
Attributed	O	O	O
to	O	O	O
the	O	O	O
Kv1.3	O	O	O
Ion	O	O	O
Channel	O	O	O

Gene-targeted	O	O	B-T063
deletion	O	O	B-T045
of	O	O	O
the	O	O	O
potassium	O	O	B-T116
channel	O	O	I-T116
Kv1.3	O	O	I-T116
(	O	O	O
Kv1.3(-â-	O	O	B-T034
)	O	O	I-T034
)	O	O	I-T034
results	O	O	I-T034
i	O	O	I-T034
n	O	O	O
"	O	O	O
S	O	O	O
uper-smeller	O	O	B-T015
"	O	O	I-T015
mice	O	O	I-T015
with	O	O	O
a	O	O	O
se	O	O	O
nsory	O	O	B-T080
p	O	O	I-T080
h	O	O	O
enotype	O	O	B-T032
t	O	O	I-T032
hat	O	O	O
includes	O	O	O
an	O	O	O
increased	O	O	B-T081
olfactory	O	O	B-T040
ability	O	O	B-T032
linked	O	O	O
to	O	O	O
changes	O	O	O
in	O	O	O
olfactory	O	O	O
circuitry	O	O	B-UnknownType
,	O	O	O
increased	O	O	O
abundance	O	O	B-T080
of	O	O	O
olfactory	O	O	B-T026
cilia	O	O	I-T026
,	O	O	O
and	O	O	O
increased	O	O	O
expression	O	O	B-T045
of	O	O	O
odorant	O	O	B-T116
receptors	O	O	I-T116
and	O	O	O
the	O	O	O
G-protein	O	O	B-T116
,	O	O	I-T116
Golf	O	O	I-T116
.	O	O	O

Kv1.3(-â-	O	O	B-T015
)	O	O	I-T015
mice	O	O	I-T015
a	O	O	I-T015
lso	O	O	O
have	O	O	O
a	O	O	O
metabolic	O	O	B-T169
p	O	O	I-T169
h	O	O	O
enotype	O	O	B-T032
i	O	O	I-T032
ncluding	O	O	O
lo	O	O	O
wer	O	O	B-T081
b	O	O	I-T081
o	O	O	O
dy	O	O	B-T032
weight	O	O	I-T032
a	O	O	I-T032
nd	O	O	O
de	O	O	O
creased	O	O	B-T081
a	O	O	I-T081
d	O	O	O
iposity	O	O	B-T032
,	O	O	I-T032
in	O	O	O
creased	O	O	B-T033
total	O	O	I-T033
energy	O	O	I-T033
expenditure	O	O	I-T033
(	O	O	O
TEE	O	O	B-T033
)	O	O	O
,	O	O	O
increased	O	O	B-T081
locomotor	O	O	B-T040
activity	O	O	I-T040
,	O	O	O
and	O	O	O
resistance	O	O	B-T041
to	O	O	O
both	O	O	O
diet	O	O	B-T168
-	O	O	O
and	O	O	O
genetic-induced	O	O	B-T045
obesity	O	O	B-T047
.	O	O	O

We	O	O	O
explored	O	O	O
two	O	O	O
cellular	O	O	B-T080
aspects	O	O	I-T080
to	O	O	O
elucidate	O	O	O
the	O	O	O
mechanism	O	O	B-T169
by	O	O	O
which	O	O	O
loss	O	O	B-T081
of	O	O	O
Kv1.3	O	O	B-T116
channel	O	O	I-T116
in	O	O	O
the	O	O	O
olfactory	O	O	B-T023
bulb	O	O	I-T023
(	O	O	O
OB	O	O	B-T023
)	O	O	O
may	O	O	O
enhance	O	O	O
glucose	O	O	B-T044
utilization	O	O	I-T044
and	O	O	O
metabolic	O	O	B-T039
rate	O	O	I-T039
.	O	O	O

First	O	O	O
,	O	O	O
using	O	O	O
in	O	O	B-T063
situ	O	O	I-T063
hybridization	O	O	I-T063
we	O	O	O
find	O	O	O
that	O	O	O
Kv1.3	O	O	B-T116
and	O	O	O
the	O	O	O
insulin	O	O	B-T116
-	O	O	O
dependent	O	O	B-T080
glucose	O	O	B-T116
transporter	O	O	I-T116
type	O	O	I-T116
4	O	O	I-T116
(	O	O	O
GLUT4	O	O	B-T116
)	O	O	O
are	O	O	O
co-localized	O	O	O
to	O	O	O
the	O	O	O
mitral	O	O	B-T023
cell	O	O	B-T025
layer	O	O	I-T025
of	O	O	O
the	O	O	O
OB	O	O	B-T023
.	O	O	O

Disruption	O	O	B-T169
of	O	O	O
Kv1.3	O	O	B-T116
conduction	O	O	B-T070
via	O	O	O
construction	O	O	O
of	O	O	O
a	O	O	O
pore	O	O	B-T045
mutation	O	O	I-T045
(	O	O	O
W386F	O	O	B-T045
Kv1.3	O	O	I-T045
)	O	O	O
was	O	O	O
sufficient	O	O	O
to	O	O	O
independently	O	O	O
translocate	O	O	B-T043
GLUT4	O	O	B-T116
to	O	O	O
the	O	O	O
plasma	O	O	B-T026
membrane	O	O	I-T026
in	O	O	O
HEK	O	O	B-T025
293	O	O	I-T025
cells	O	O	I-T025
.	O	O	O

Because	O	O	O
olfactory	O	O	B-T040
sensory	O	O	I-T040
perception	O	O	I-T040
and	O	O	O
the	O	O	O
maintenance	O	O	B-T052
of	O	O	O
action	O	O	B-T043
potential	O	O	I-T043
(	O	O	I-T043
AP	O	O	I-T043
)	O	O	I-T043
firing	O	O	O
frequency	O	O	O
by	O	O	O
mitral	O	O	B-T023
cells	O	O	B-T025
of	O	O	O
the	O	O	O
OB	O	O	B-T023
is	O	O	O
highly	O	O	O
energy	O	O	O
demanding	O	O	O
and	O	O	O
Kv1.3	O	O	B-T116
is	O	O	O
also	O	O	O
expressed	O	O	O
in	O	O	O
mitochondria	O	O	B-T026
,	O	O	O
we	O	O	O
next	O	O	O
explored	O	O	O
the	O	O	O
structure	O	O	O
of	O	O	O
this	O	O	O
organelle	O	O	B-T026
in	O	O	O
mitral	O	O	O
cells	O	O	O
.	O	O	O

We	O	O	O
challenged	O	O	O
wildtype	O	O	B-T015
(	O	O	O
WT	O	O	B-T015
)	O	O	O
and	O	O	O
Kv1.3(-â-	O	O	B-T015
)	O	O	I-T015
male	O	O	I-T015
mice	O	O	I-T015
with	O	O	O
a	O	O	O
m	O	O	O
oderately	O	O	B-T061
high-fat	O	O	I-T061
diet	O	O	I-T061
(	O	O	I-T061
M	O	O	O
HF	O	O	B-T061
,	O	O	I-T061
31.8	O	O	O
%	O	O	O
kcal	O	O	O
fat	O	O	O
)	O	O	O
for	O	O	O
4	O	O	O
months	O	O	B-T079
and	O	O	O
then	O	O	O
examined	O	O	O
OB	O	O	B-T023
ultrastructure	O	O	B-T025
using	O	O	O
transmission	O	O	B-T059
electron	O	O	I-T059
microscopy	O	O	I-T059
.	O	O	O

In	O	O	O
WT	O	O	B-T015
mice	O	O	I-T015
,	O	O	O
mitochondria	O	O	B-T026
were	O	O	O
significantly	O	O	O
enlarged	O	O	B-T080
following	O	O	O
diet-induced	O	O	B-T047
obesity	O	O	I-T047
(	O	O	O
DIO	O	O	B-T047
)	O	O	O
and	O	O	O
there	O	O	O
were	O	O	O
fewer	O	O	O
mitochondria	O	O	O
,	O	O	O
likely	O	O	O
due	O	O	O
to	O	O	O
mitophagy	O	O	B-T043
.	O	O	O

Interestingly	O	O	O
,	O	O	O
mitochondria	O	O	B-T026
were	O	O	O
significantly	O	O	O
smaller	O	O	B-T080
in	O	O	O
Kv1.3(-â-	O	O	B-T015
)	O	O	I-T015
mice	O	O	I-T015
c	O	O	I-T015
ompared	O	O	O
with	O	O	O
that	O	O	O
of	O	O	O
W	O	O	O
T	O	O	O
mice	O	O	O
.	O	O	O

Similar	O	O	O
to	O	O	O
their	O	O	O
m	O	O	O
etabolic	O	O	B-T169
r	O	O	I-T169
esistance	O	O	O
to	O	O	O
D	O	O	O
IO	O	O	B-T047
,	O	O	I-T047
the	O	O	O
K	O	O	O
v1.3(-â-	O	O	B-T015
)	O	O	I-T015
mice	O	O	I-T015
ha	O	O	I-T015
d	O	O	O
unchanged	O	O	O
mit	O	O	O
ochondria	O	O	B-T026
in	O	O	I-T026
terms	O	O	O
of	O	O	O
cros	O	O	O
s	O	O	B-T082
sectional	O	O	I-T082
area	O	O	B-T082
and	O	O	O
abundance	O	O	B-T080
following	O	O	O
a	O	O	O
challenge	O	O	O
with	O	O	O
modified	O	O	B-T061
diet	O	O	I-T061
.	O	O	O

We	O	O	O
are	O	O	O
very	O	O	O
interested	O	O	O
to	O	O	O
understand	O	O	O
how	O	O	O
targeted	O	O	O
disruption	O	O	B-T169
of	O	O	O
the	O	O	O
Kv1.3	O	O	B-T116
channel	O	O	I-T116
in	O	O	O
the	O	O	O
OB	O	O	B-T023
can	O	O	O
modify	O	O	O
TEE	O	O	B-T033
.	O	O	O

Our	O	O	O
study	O	O	O
demonstrates	O	O	O
that	O	O	O
Kv1.3	O	O	B-T116
regulates	O	O	O
mitochondrial	O	O	B-T026
structure	O	O	I-T026
and	O	O	O
alters	O	O	O
glucose	O	O	B-T044
utilization	O	O	I-T044
;	O	O	O
two	O	O	O
important	O	O	O
metabolic	O	O	B-T169
changes	O	O	O
that	O	O	O
could	O	O	O
drive	O	O	O
whole	O	O	O
system	O	O	O
changes	O	O	O
in	O	O	O
metabolism	O	O	B-T040
initiated	O	O	O
at	O	O	O
the	O	O	O
OB	O	O	B-T023
.	O	O	O

-DOCSTART- (27245335)

The	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
paternal	O	O	B-T080
high-fat	O	O	B-T168
diet	O	O	I-T168
exposure	O	O	B-T080
on	O	O	O
offspring	O	O	B-T099
metabolism	O	O	B-T040
with	O	O	O
epigenetic	O	O	B-T045
changes	O	O	I-T045
in	O	O	O
the	O	O	O
mouse	O	O	O
adiponectin	O	O	B-T028
and	O	O	O
leptin	O	O	B-T028
gene	O	O	O
promoters	O	O	O

Recent	O	O	O
studies	O	O	B-T062
have	O	O	O
demonstrated	O	O	O
that	O	O	O
epigenetic	O	O	B-T045
changes	O	O	I-T045
resulting	O	O	O
from	O	O	O
malnutrition	O	O	B-T047
might	O	O	O
play	O	O	O
important	O	O	O
roles	O	O	B-T077
in	O	O	O
transgenerational	O	O	B-T102
links	O	O	I-T102
with	O	O	O
metabolic	O	O	B-T047
diseases	O	O	I-T047
.	O	O	O

Previously	O	O	O
,	O	O	O
we	O	O	O
observed	O	O	B-T169
that	O	O	O
exposure	O	O	B-T080
to	O	O	O
a	O	O	O
high-fat	O	O	B-T168
diet	O	O	I-T168
(	O	O	O
HFD	O	O	B-T168
)	O	O	O
in	O	O	B-T100
utero	O	O	I-T100
caused	O	O	B-T169
a	O	O	O
metabolic	O	O	B-T169
syndrome	O	O	B-T047
-like	O	O	O
phenomenon	O	O	B-T067
through	O	O	B-T169
epigenetic	O	O	B-T045
modifications	O	O	I-T045
of	O	O	O
the	O	O	O
adiponectin	O	O	B-T028
and	O	O	O
leptin	O	O	B-T028
genes	O	O	I-T028
that	O	O	O
persisted	O	O	O
for	O	O	O
multiple	O	O	B-T081
generations	O	O	B-T079
.	O	O	O

Recent	O	O	O
etiological	O	O	B-T169
studies	O	O	B-T062
indicated	O	O	B-T033
that	O	O	O
paternal	O	O	B-T080
BMI	O	O	B-T201
had	O	O	O
effects	O	O	B-T080
on	O	O	O
offspring	O	O	B-T099
BMI	O	O	O
that	O	O	O
were	O	O	O
independent	O	O	B-T169
of	O	O	I-T169
but	O	O	O
additive	O	O	B-T080
to	O	O	O
maternal	O	O	B-T033
BMI	O	O	O
effects	O	O	O
.	O	O	O

Thus	O	O	O
,	O	O	O
we	O	O	O
examined	O	O	O
whether	O	O	O
paternal	O	O	B-T080
HFD	O	O	B-T168
-	O	O	O
induced	O	O	B-T169
obesity	O	O	B-T047
affected	O	O	B-T080
the	O	O	O
metabolic	O	O	B-T169
status	O	O	B-T080
of	O	O	O
offspring	O	O	B-T099
through	O	O	B-T169
epigenetic	O	O	B-T045
changes	O	O	I-T045
in	O	O	O
the	O	O	O
adiponectin	O	O	B-T028
and	O	O	O
leptin	O	O	B-T028
genes	O	O	I-T028
.	O	O	O

Additionally	O	O	O
,	O	O	O
we	O	O	O
investigated	O	O	B-T169
whether	O	O	O
a	O	O	O
normal	O	O	B-T056
diet	O	O	I-T056
during	O	O	B-T079
subsequent	O	O	B-T078
generations	O	O	I-T078
abolished	O	O	B-T052
the	O	O	O
epigenetic	O	O	B-T045
changes	O	O	I-T045
associated	O	O	B-T080
with	O	O	I-T080
paternal	O	O	B-T080
HFD	O	O	B-T168
exposure	O	O	B-T080
before	O	O	B-T079
conception	O	O	B-T040
.	O	O	O

We	O	O	O
observed	O	O	B-T169
the	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
paternal	O	O	B-T080
HFD	O	O	B-T168
exposure	O	O	B-T080
before	O	O	B-T079
conception	O	O	B-T040
over	O	O	O
multiple	O	O	B-T081
generations	O	O	B-T079
on	O	O	O
offspring	O	O	B-T099
metabolic	O	O	B-T169
traits	O	O	B-T032
,	O	O	O
including	O	O	B-T169
weight	O	O	B-T033
and	O	O	O
fat	O	O	B-T109
gain	O	O	B-T081
,	O	O	O
glucose	O	O	B-T047
intolerance	O	O	I-T047
,	O	O	O
hypertriglyceridemia	O	O	B-T047
,	O	O	O
abnormal	O	O	B-T116
adipocytokine	O	O	I-T116
levels	O	O	B-T080
,	O	O	O
hypertension	O	O	B-T047
,	O	O	O
and	O	O	O
adiponectin	O	O	B-T028
and	O	O	O
leptin	O	O	B-T028
gene	O	O	I-T028
expression	O	O	B-T045
and	O	O	O
epigenetic	O	O	B-T045
changes	O	O	I-T045
.	O	O	O

Normal	O	O	B-T056
diet	O	O	I-T056
consumption	O	O	B-T052
by	O	O	O
male	O	O	O
offspring	O	O	B-T099
during	O	O	O
the	O	O	O
subsequent	O	O	O
generation	O	O	O
following	O	O	O
paternal	O	O	B-T080
HFD	O	O	B-T168
exposure	O	O	B-T080
diminished	O	O	B-T081
whereas	O	O	O
consumption	O	O	O
for	O	O	O
two	O	O	O
generations	O	O	B-T079
completely	O	O	O
abolished	O	O	B-T052
the	O	O	O
effect	O	O	B-T080
of	O	O	O
paternal	O	O	O
HFD	O	O	O
exposure	O	O	O
on	O	O	O
metabolic	O	O	B-T169
traits	O	O	B-T032
and	O	O	O
adipocytokine	O	O	B-T116
promoter	O	O	O
epigenetic	O	O	B-T045
changes	O	O	I-T045
in	O	O	O
the	O	O	O
offspring	O	O	O
.	O	O	O

The	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
paternal	O	O	B-T080
HFD	O	O	B-T168
exposure	O	O	B-T080
on	O	O	O
offspring	O	O	B-T099
were	O	O	O
relatively	O	O	O
weaker	O	O	B-T080
than	O	O	O
those	O	O	O
following	O	O	B-T079
HFD	O	O	O
exposure	O	O	O
in	O	O	B-T100
utero	O	O	I-T100
.	O	O	O

However	O	O	O
,	O	O	O
paternal	O	O	B-T080
HFD	O	O	B-T168
exposure	O	O	B-T080
had	O	O	O
an	O	O	O
additive	O	O	B-T080
metabolic	O	O	B-T169
effect	O	O	B-T080
for	O	O	O
two	O	O	O
generations	O	O	B-T079
,	O	O	O
suggesting	O	O	O
that	O	O	O
both	O	O	O
paternal	O	O	O
and	O	O	O
maternal	O	O	B-T033
nutrition	O	O	B-T040
might	O	O	O
affect	O	O	B-T080
offspring	O	O	B-T099
metabolism	O	O	B-T040
through	O	O	B-T169
epigenetic	O	O	B-T045
modifications	O	O	I-T045
of	O	O	O
adipocytokine	O	O	B-T028
genes	O	O	I-T028
for	O	O	O
multiple	O	O	B-T081
generations	O	O	O
.	O	O	O

-DOCSTART- (27249559)

Study	O	O	B-T059
of	O	O	O
the	O	O	O
Microfocus	O	O	B-T082
X-Ray	O	O	B-T074
Tube	O	O	I-T074
Based	O	O	O
on	O	O	O
a	O	O	O
Point-Like	O	O	B-T169
Target	O	O	I-T169
Used	O	O	O
for	O	O	O
Micro-Computed	O	O	O
Tomography	O	O	O

For	O	O	O
a	O	O	O
micro-Computed	O	O	B-T060
Tomography	O	O	I-T060
(	O	O	I-T060
Micro-CT	O	O	I-T060
)	O	O	I-T060
system	O	O	I-T060
,	O	O	O
the	O	O	O
microfocus	O	O	B-T082
X-ray	O	O	B-T060
tube	O	O	I-T074
is	O	O	O
an	O	O	O
essential	O	O	B-T080
component	O	O	O
because	O	O	O
the	O	O	O
spatial	O	O	B-T082
resolution	O	O	B-T081
of	O	O	O
CT	O	O	B-T060
images	O	O	B-T170
,	O	O	O
in	O	O	O
theory	O	O	B-T078
,	O	O	O
is	O	O	O
mainly	O	O	O
determined	O	O	O
by	O	O	O
the	O	O	O
size	O	O	B-T082
and	O	O	O
stability	O	O	B-T080
of	O	O	O
the	O	O	O
X-ray	O	O	O
focal	O	O	B-T082
spot	O	O	I-T082
of	O	O	O
the	O	O	O
microfocus	O	O	O
X-ray	O	O	B-T074
tube	O	O	I-T074
.	O	O	O

However	O	O	O
,	O	O	O
many	O	O	O
factors	O	O	B-T169
,	O	O	O
including	O	O	O
voltage	O	O	B-T081
fluctuations	O	O	B-T079
,	O	O	O
mechanical	O	O	B-T070
vibrations	O	O	B-T070
,	O	O	O
and	O	O	O
temperature	O	O	B-T080
changes	O	O	I-T080
,	O	O	O
can	O	O	O
cause	O	O	B-T078
the	O	O	O
size	O	O	B-T082
and	O	O	O
the	O	O	O
stability	O	O	B-T080
of	O	O	O
the	O	O	O
X-ray	O	O	B-T060
focal	O	O	B-T082
spot	O	O	I-T082
to	O	O	O
degrade	O	O	B-T067
.	O	O	O

A	O	O	O
new	O	O	O
microfocus	O	O	B-T082
X-ray	O	O	B-T060
tube	O	O	I-T074
based	O	O	O
on	O	O	O
a	O	O	O
point-like	O	O	B-T169
micro-target	O	O	I-T169
in	O	O	O
which	O	O	O
the	O	O	O
X-ray	O	O	O
target	O	O	B-T169
is	O	O	O
irradiated	O	O	B-T067
with	O	O	O
an	O	O	O
unfocused	O	O	O
electron	O	O	B-T073
beam	O	O	I-T073
was	O	O	O
investigated	O	O	B-T169
.	O	O	O

EGS4	O	O	B-T081
Monte	O	O	I-T081
Carlo	O	O	I-T081
simulation	O	O	I-T081
code	O	O	I-T081
was	O	O	O
employed	O	O	O
for	O	O	O
the	O	O	O
calculation	O	O	B-T052
of	O	O	O
the	O	O	O
X-ray	O	O	B-T060
intensity	O	O	B-T070
produced	O	O	O
from	O	O	O
the	O	O	O
point-like	O	O	B-T169
micro-target	O	O	I-T169
and	O	O	O
the	O	O	O
substrate	O	O	B-T167
.	O	O	O

The	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
several	O	O	O
arrangements	O	O	O
of	O	O	O
the	O	O	O
target	O	O	B-T169
material	O	O	B-T167
,	O	O	O
target	O	O	O
and	O	O	O
beam	O	O	B-T073
size	O	O	B-T082
were	O	O	O
studied	O	O	B-T059
.	O	O	O

The	O	O	O
simulation	O	O	B-T062
results	O	O	B-T169
demonstrated	O	O	O
that	O	O	O
if	O	O	O
the	O	O	O
intensity	O	O	B-T070
of	O	O	O
X-rays	O	O	B-T060
generated	O	O	B-T080
at	O	O	O
the	O	O	O
point-like	O	O	B-T169
target	O	O	I-T169
is	O	O	O
greater	O	O	B-T081
than	O	O	I-T081
half	O	O	O
of	O	O	O
the	O	O	O
X-ray	O	O	B-T060
intensity	O	O	O
produced	O	O	O
on	O	O	O
the	O	O	O
substrate	O	O	B-T167
,	O	O	O
the	O	O	O
X-ray	O	O	O
focal	O	O	B-T082
spot	O	O	I-T082
is	O	O	O
determined	O	O	O
in	O	O	O
part	O	O	O
by	O	O	O
the	O	O	O
point-like	O	O	O
target	O	O	O
rather	O	O	O
than	O	O	O
by	O	O	O
the	O	O	O
electron	O	O	B-T073
beam	O	O	I-T073
in	O	O	O
the	O	O	O
conventional	O	O	B-T080
X-ray	O	O	B-T074
tube	O	O	I-T074
.	O	O	O

In	O	O	O
theory	O	O	B-T078
,	O	O	O
since	O	O	O
it	O	O	O
is	O	O	O
able	O	O	O
to	O	O	O
reduce	O	O	B-T080
those	O	O	O
unfavorable	O	O	O
effects	O	O	B-T080
such	O	O	O
as	O	O	O
the	O	O	O
electron	O	O	B-T033
beam	O	O	B-T073
trajectory	O	O	I-T033
swinging	O	O	I-T033
and	O	O	O
the	O	O	O
beam	O	O	O
size	O	O	B-T082
changing	O	O	B-T169
for	O	O	O
the	O	O	O
microfocus	O	O	B-T082
X-ray	O	O	B-T060
tube	O	O	I-T074
,	O	O	O
it	O	O	O
could	O	O	O
alleviate	O	O	B-T080
CT	O	O	B-T060
image	O	O	B-T170
artifacts	O	O	B-T068
caused	O	O	B-T078
by	O	O	O
the	O	O	O
X-ray	O	O	O
focal	O	O	B-T082
spot	O	O	I-T082
shift	O	O	B-T033
and	O	O	O
size	O	O	B-T081
change	O	O	I-T081
.	O	O	O

-DOCSTART- (27251800)

Early	O	O	B-T079
assessment	O	O	B-T058
of	O	O	O
bilateral	O	O	B-T061
inguinal	O	O	I-T061
hernia	O	O	I-T061
repair	O	O	I-T061
:	O	O	O
A	O	O	O
comparison	O	O	B-T052
between	O	O	O
the	O	O	O
laparoscopic	O	O	B-T061
total	O	O	I-T061
extraperitoneal	O	O	I-T061
and	O	O	O
Stoppa	O	O	O
approaches	O	O	O

The	O	O	O
present	O	O	B-T079
clinical	O	O	B-T062
trial	O	O	I-T062
was	O	O	O
designed	O	O	O
to	O	O	O
compare	O	O	B-T052
the	O	O	O
results	O	O	B-T169
of	O	O	O
bilateral	O	O	B-T061
inguinal	O	O	I-T061
hernia	O	O	I-T061
repair	O	O	I-T061
between	O	O	O
patients	O	O	B-T101
who	O	O	O
underwent	O	O	O
the	O	O	O
conventional	O	O	B-T169
Stoppa	O	O	B-T061
technique	O	O	I-T061
and	O	O	O
laparoscopic	O	O	B-T061
total	O	O	I-T061
extraperitoneal	O	O	I-T061
repair	O	O	I-T061
(	O	O	O
LTE	O	O	B-T061
)	O	O	O
with	O	O	O
a	O	O	O
single	O	O	O
mesh	O	O	B-T074
and	O	O	O
without	O	O	O
staple	O	O	B-T061
fixation	O	O	I-T061
.	O	O	O

This	O	O	O
controlled	O	O	O
,	O	O	O
randomised	O	O	B-T062
clinical	O	O	B-T062
trial	O	O	I-T062
was	O	O	O
conducted	O	O	O
at	O	O	O
General	O	O	B-T093
Surgery	O	O	I-T093
and	O	O	I-T093
Trauma	O	O	I-T093
of	O	O	I-T093
the	O	O	I-T093
Clinics	O	O	I-T093
Hospital	O	O	I-T093
,	O	O	O
Medical	O	O	B-T093
School	O	O	I-T093
,	O	O	O
the	O	O	O
University	O	O	B-T093
of	O	O	I-T093
SÎ³o	O	O	I-T093
Paulo	O	O	I-T093
between	O	O	O
September	O	O	O
2010	O	O	O
and	O	O	O
February	O	O	O
2011	O	O	O
.	O	O	O

Totally	O	O	O
,	O	O	O
50	O	O	O
male	O	O	B-T032
patients	O	O	B-T101
,	O	O	O
with	O	O	O
a	O	O	O
bilateral	O	O	B-T190
inguinal	O	O	I-T190
hernia	O	O	I-T190
,	O	O	O
older	O	O	O
than	O	O	O
25	O	O	O
years	O	O	B-T079
were	O	O	O
considered	O	O	O
eligible	O	O	B-T080
for	O	O	O
the	O	O	O
study	O	O	B-T062
.	O	O	O

The	O	O	O
following	O	O	O
parameters	O	O	B-T077
were	O	O	O
analysed	O	O	B-T062
during	O	O	O
the	O	O	O
early	O	O	B-T079
post-operative	O	O	B-T079
period	O	O	I-T079
:	O	O	O
(	O	O	O
1	O	O	O
)	O	O	O
The	O	O	O
intensity	O	O	B-T080
of	O	O	O
surgical	O	O	B-T033
trauma	O	O	I-T033
,	O	O	O
operation	O	O	B-T079
time	O	O	I-T079
,	O	O	O
C-reactive	O	O	B-T116
protein	O	O	I-T116
(	O	O	O
CRP	O	O	B-T116
)	O	O	O
levels	O	O	B-T080
,	O	O	O
white	O	O	B-T059
blood	O	O	I-T059
cell	O	O	I-T059
count	O	O	I-T059
,	O	O	O
bleeding	O	O	B-T046
and	O	O	O
pain	O	O	B-T201
intensity	O	O	I-T201
;	O	O	O
(	O	O	O
2	O	O	O
)	O	O	O
quality	O	O	B-T078
of	O	O	I-T078
life	O	O	I-T078
assessment	O	O	B-T058
;	O	O	O
and	O	O	O
(	O	O	O
3	O	O	O
)	O	O	O
post-operative	O	O	B-T046
complications	O	O	I-T046
.	O	O	O

LTE	O	O	B-T061
procedure	O	O	I-T061
was	O	O	O
longer	O	O	B-T080
than	O	O	O
the	O	O	O
Stoppa	O	O	B-T061
procedure	O	O	I-T061
(	O	O	O
134.6	O	O	O
min	O	O	O
Î	O	O	O
38.3	O	O	O
vs.	O	O	O
90.6	O	O	O
min	O	O	O
Î	O	O	O
41.3	O	O	O
;	O	O	O
P	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
levels	O	O	B-T080
of	O	O	O
CRP	O	O	B-T116
were	O	O	O
higher	O	O	B-T080
in	O	O	O
the	O	O	O
Stoppa	O	O	B-T061
group	O	O	B-T078
(	O	O	O
P	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
but	O	O	O
the	O	O	O
number	O	O	O
of	O	O	O
leucocytes	O	O	B-T025
,	O	O	O
haematocrit	O	O	B-T033
,	O	O	O
and	O	O	O
haemoglobin	O	O	B-T116
were	O	O	O
similar	O	O	B-T080
between	O	O	O
the	O	O	O
groups	O	O	B-T078
(	O	O	O
P	O	O	O
>	O	O	O
0.05	O	O	O
)	O	O	O
.	O	O	O

There	O	O	O
was	O	O	O
no	O	O	B-T033
difference	O	O	I-T033
in	O	O	O
pain	O	O	B-T184
during	O	O	O
the	O	O	O
1	O	O	O
st	O	O	O
and	O	O	O
7	O	O	O
th	O	O	O
post-operative	O	O	B-T033
,	O	O	O
physical	O	O	B-T033
functioning	O	O	I-T033
,	O	O	O
physical	O	O	B-T169
limitation	O	O	I-T169
,	O	O	O
the	O	O	O
impact	O	O	B-T080
of	O	O	O
pain	O	O	O
on	O	O	O
daily	O	O	B-T056
activities	O	O	I-T056
,	O	O	O
and	O	O	O
the	O	O	O
Carolinas	O	O	B-T170
Comfort	O	O	I-T170
Scale	O	O	I-T170
during	O	O	O
the	O	O	O
7	O	O	O
th	O	O	O
and	O	O	O
15	O	O	O
th	O	O	O
post-operative	O	O	O
(	O	O	O
P	O	O	O
>	O	O	O
0.05	O	O	O
)	O	O	O
.	O	O	O

Complications	O	O	B-T046
occurred	O	O	O
in	O	O	O
88	O	O	O
%	O	O	O
of	O	O	O
Stoppa	O	O	B-T061
group	O	O	B-T078
(	O	O	O
22	O	O	O
patients	O	O	B-T101
)	O	O	O
and	O	O	O
64	O	O	O
%	O	O	O
in	O	O	O
LTE	O	O	B-T061
group	O	O	O
(	O	O	O
16	O	O	O
patients	O	O	O
)	O	O	O
(	O	O	O
P	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
comparative	O	O	B-T062
study	O	O	I-T062
between	O	O	O
the	O	O	O
Stoppa	O	O	B-T061
and	O	O	O
LTE	O	O	B-T061
approaches	O	O	O
for	O	O	O
the	O	O	O
bilateral	O	O	B-T061
inguinal	O	O	I-T061
hernia	O	O	I-T061
repair	O	O	I-T061
demonstrated	O	O	O
that	O	O	O
:	O	O	O
(	O	O	O
1	O	O	O
)	O	O	O
The	O	O	O
LTE	O	O	O
approach	O	O	O
showed	O	O	O
less	O	O	O
surgical	O	O	B-T033
trauma	O	O	I-T033
despite	O	O	O
the	O	O	O
longer	O	O	B-T080
operation	O	O	B-T079
time	O	O	I-T079
;	O	O	O
(	O	O	O
2	O	O	O
)	O	O	O
Quality	O	O	B-T078
of	O	O	I-T078
life	O	O	I-T078
during	O	O	O
the	O	O	O
early	O	O	B-T079
post-operative	O	O	B-T079
period	O	O	I-T079
were	O	O	O
similar	O	O	B-T080
;	O	O	O
and	O	O	O
(	O	O	O
3	O	O	O
)	O	O	O
Complication	O	O	B-T046
rates	O	O	B-T081
were	O	O	O
higher	O	O	B-T080
in	O	O	O
the	O	O	O
Stoppa	O	O	O
group	O	O	B-T078
.	O	O	O

-DOCSTART- (27252199)

Morphological	O	O	B-T082
characteristics	O	O	B-T080
regulating	O	O	O
phallic	O	O	B-T023
glans	O	O	I-T023
engorgement	O	O	B-T047
in	O	O	O
the	O	O	O
American	O	O	O
alligator	O	O	O

The	O	O	O
distal	O	O	B-T082
part	O	O	I-T082
of	O	O	O
the	O	O	O
crocodilian	O	O	B-T014
phallus	O	O	B-T023
consists	O	O	O
of	O	O	O
a	O	O	O
bulbous	O	O	B-T023
glans	O	O	B-T023
containing	O	O	O
well-developed	O	O	O
vascular	O	O	B-T024
tissues	O	O	I-T024
that	O	O	O
can	O	O	O
inflate	O	O	O
before	O	O	O
or	O	O	O
during	O	O	O
sexual	O	O	B-T053
activity	O	O	I-T053
,	O	O	O
enlarging	O	O	B-T080
and	O	O	O
elaborating	O	O	O
the	O	O	O
glans	O	O	O
into	O	O	O
a	O	O	O
complex	O	O	B-T080
,	O	O	O
though	O	O	O
still	O	O	O
functionally	O	O	B-T169
undefined	O	O	B-T078
,	O	O	O
copulatory	O	O	B-T054
structure	O	O	O
.	O	O	O

An	O	O	O
enlarged	O	O	B-T080
glans	O	O	B-T023
putatively	O	O	O
interacts	O	O	B-T169
with	O	O	O
the	O	O	O
female	O	O	B-T032
cloaca	O	O	B-T023
and	O	O	O
may	O	O	O
change	O	O	B-T169
the	O	O	O
shape	O	O	B-T082
of	O	O	O
her	O	O	B-T022
reproductive	O	O	I-T022
tract	O	O	I-T022
to	O	O	O
facilitate	O	O	O
insemination	O	O	B-T042
and	O	O	O
increase	O	O	B-T169
the	O	O	O
probability	O	O	B-T081
of	O	O	O
fertilization	O	O	B-T040
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
investigated	O	O	O
the	O	O	O
cellular-level	O	O	B-T043
properties	O	O	I-T043
of	O	O	O
the	O	O	O
glans	O	O	B-T023
and	O	O	O
other	O	O	O
inflatable	O	O	B-T024
phallic	O	O	I-T024
tissues	O	O	I-T024
associated	O	O	O
with	O	O	O
the	O	O	O
sperm	O	O	B-T025
-conducting	O	O	O
sulcus	O	O	B-T030
spermaticus	O	O	B-T023
in	O	O	O
the	O	O	O
American	O	O	B-T014
alligator	O	O	I-T014
(	O	O	O
Alligator	O	O	B-T014
mississippiensis	O	O	I-T014
)	O	O	O
.	O	O	O

Using	O	O	O
histochemical	O	O	B-T059
staining	O	O	I-T059
,	O	O	O
we	O	O	O
visualized	O	O	O
and	O	O	O
defined	O	O	O
collagen	O	O	B-T116
and	O	O	O
elastin	O	O	B-T024
fiber	O	O	I-T024
densities	O	O	B-T081
and	O	O	O
orientations	O	O	B-T082
in	O	O	O
these	O	O	O
tissues	O	O	B-T024
.	O	O	O

Extracellular	O	O	B-T024
matrix	O	O	I-T024
architectures	O	O	O
provided	O	O	O
insights	O	O	O
about	O	O	O
phallic	O	O	B-T023
glans	O	O	I-T023
material	O	O	O
properties	O	O	O
and	O	O	O
how	O	O	O
they	O	O	O
may	O	O	O
affect	O	O	B-T169
tissue	O	O	B-T024
strength	O	O	B-T081
and	O	O	O
flexibility	O	O	B-T080
during	O	O	O
inflation	O	O	O
and	O	O	O
in	O	O	O
response	O	O	O
to	O	O	O
copulatory	O	O	B-T054
forces	O	O	B-T067
.	O	O	O

We	O	O	O
also	O	O	O
investigated	O	O	O
the	O	O	O
potential	O	O	B-T080
sources	O	O	O
of	O	O	O
fluids	O	O	B-T167
that	O	O	O
induce	O	O	B-T169
inflation	O	O	O
in	O	O	O
alligator	O	O	B-T014
phalli	O	O	B-T023
.	O	O	O

Combining	O	O	O
serial	O	O	B-T059
sectioning	O	O	I-T059
and	O	O	O
three-dimensional	O	O	B-T059
reconstruction	O	O	I-T059
,	O	O	O
we	O	O	O
identified	O	O	O
a	O	O	O
pair	O	O	O
of	O	O	O
supracrucal	O	O	B-T023
plexus	O	O	I-T023
vascular	O	O	I-T023
bodies	O	O	B-T026
at	O	O	O
the	O	O	O
proximal	O	O	O
end	O	O	O
of	O	O	O
the	O	O	O
alligator	O	O	B-T014
phallus	O	O	B-T023
that	O	O	O
extend	O	O	O
distally	O	O	B-T082
adjacent	O	O	I-T082
to	O	O	O
ventro-medial	O	O	B-T024
sulcus	O	O	I-T024
tissues	O	O	I-T024
.	O	O	O

Together	O	O	O
,	O	O	O
our	O	O	O
gross	O	O	B-T080
and	O	O	O
histological	O	O	B-T033
examination	O	O	I-T033
of	O	O	O
the	O	O	O
American	O	O	B-T014
alligator	O	O	I-T014
phallic	O	O	B-T023
glans	O	O	B-T023
suggests	O	O	O
that	O	O	O
its	O	O	O
tissues	O	O	B-T024
are	O	O	O
arranged	O	O	O
in	O	O	O
a	O	O	O
manner	O	O	O
that	O	O	O
would	O	O	O
allow	O	O	O
vascular	O	O	B-T023
inflation	O	O	O
to	O	O	O
expand	O	O	O
the	O	O	O
glans	O	O	O
to	O	O	O
a	O	O	O
specific	O	O	O
and	O	O	O
repeatable	O	O	O
shape	O	O	B-T082
,	O	O	O
and	O	O	O
potentially	O	O	B-T080
release	O	O	O
secretory	O	O	B-T026
products	O	O	I-T026
into	O	O	O
the	O	O	O
female	O	O	B-T022
reproductive	O	O	I-T022
tract	O	O	I-T022
.	O	O	O

Both	O	O	O
elements	O	O	O
could	O	O	O
play	O	O	O
roles	O	O	O
in	O	O	O
postcopulatory	O	O	B-T054
sexual	O	O	B-T054
selection	O	O	I-T054
,	O	O	O
by	O	O	O
mechanically	O	O	B-T169
and/or	O	O	O
chemically	O	O	O
affecting	O	O	B-T039
female	O	O	I-T039
reproductive	O	O	I-T039
physiology	O	O	I-T039
.	O	O	O

-DOCSTART- (27257056)

A	O	O	O
novel	O	O	O
role	O	O	B-T077
for	O	O	O
poly(C	O	O	B-T116
)	O	O	I-T116
binding	O	O	I-T116
proteins	O	O	I-T116
in	O	O	O
programmed	O	O	O
ribosomal	O	O	O
frameshifting	O	O	O

Translational	O	O	B-T045
control	O	O	B-T080
through	O	O	O
programmed	O	O	B-T045
ribosomal	O	O	I-T045
frameshifting	O	O	I-T045
(	O	O	O
PRF	O	O	B-T045
)	O	O	O
is	O	O	O
exploited	O	O	O
widely	O	O	O
by	O	O	O
viruses	O	O	B-T005
and	O	O	O
increasingly	O	O	O
documented	O	O	O
in	O	O	O
cellular	O	O	B-T025
genes	O	O	B-T028
.	O	O	O

Frameshifting	O	O	B-T045
is	O	O	O
induced	O	O	B-T169
by	O	O	O
mRNA	O	O	B-T114
secondary	O	O	I-T114
structures	O	O	I-T114
that	O	O	O
compromise	O	O	O
ribosome	O	O	B-T026
fidelity	O	O	B-T043
during	O	O	O
decoding	O	O	B-T169
of	O	O	O
a	O	O	O
heptanucleotide	O	O	B-T086
'	O	O	I-T086
slippery	O	O	I-T086
'	O	O	I-T086
sequence	O	O	I-T086
.	O	O	O

The	O	O	O
nsp2	O	O	B-T116
PRF	O	O	B-T045
signal	O	O	B-T044
of	O	O	O
porcine	O	O	B-T005
reproductive	O	O	I-T005
and	O	O	I-T005
respiratory	O	O	I-T005
syndrome	O	O	I-T005
virus	O	O	I-T005
is	O	O	O
distinctive	O	O	O
in	O	O	O
directing	O	O	O
both	O	O	O
-2	O	O	B-T045
and	O	O	O
-1	O	O	B-T045
PRF	O	O	I-T045
and	O	O	O
in	O	O	O
its	O	O	O
requirement	O	O	B-T169
for	O	O	O
a	O	O	O
trans-acting	O	O	B-T116
protein	O	O	I-T116
factor	O	O	I-T116
,	O	O	O
the	O	O	O
viral	O	O	B-T005
replicase	O	O	B-T116
subunit	O	O	I-T116
nsp1Î²	O	O	I-T116
.	O	O	O

Here	O	O	O
we	O	O	O
show	O	O	O
that	O	O	O
the	O	O	O
the	O	O	O
trans-activation	O	O	B-T045
of	O	O	O
frameshifting	O	O	B-T045
is	O	O	O
carried	O	O	O
out	O	O	O
by	O	O	O
a	O	O	O
protein	O	O	B-T116
complex	O	O	I-T116
composed	O	O	O
of	O	O	O
nsp1Î²	O	O	B-T116
and	O	O	O
a	O	O	O
cellular	O	O	B-T025
poly(C	O	O	B-T116
)	O	O	I-T116
binding	O	O	I-T116
protein	O	O	I-T116
(	O	O	O
PCBP	O	O	B-T116
)	O	O	O
.	O	O	O

From	O	O	O
the	O	O	O
results	O	O	O
of	O	O	O
in	O	O	B-T080
vitro	O	O	I-T080
translation	O	O	B-T045
and	O	O	O
electrophoretic	O	O	B-T059
mobility	O	O	I-T059
shift	O	O	I-T059
assays	O	O	I-T059
,	O	O	O
we	O	O	O
demonstrate	O	O	O
that	O	O	O
a	O	O	O
PCBP	O	O	B-T116
/	O	O	O
nsp1Î²	O	O	B-T116
complex	O	O	B-T116
binds	O	O	O
to	O	O	O
a	O	O	O
C-rich	O	O	B-T086
sequence	O	O	I-T086
downstream	O	O	B-T082
of	O	O	O
the	O	O	O
slippery	O	O	B-T086
sequence	O	O	I-T086
and	O	O	O
here	O	O	O
mimics	O	O	O
the	O	O	O
activity	O	O	B-T052
of	O	O	O
a	O	O	O
structured	O	O	O
mRNA	O	O	B-T114
stimulator	O	O	B-T123
of	O	O	O
PRF	O	O	B-T045
.	O	O	O

This	O	O	O
is	O	O	O
the	O	O	O
first	O	O	O
description	O	O	O
of	O	O	O
a	O	O	O
role	O	O	B-T077
for	O	O	O
a	O	O	O
trans-acting	O	O	B-T116
cellular	O	O	I-T116
protein	O	O	I-T116
in	O	O	O
PRF	O	O	B-T045
.	O	O	O

The	O	O	O
discovery	O	O	O
broadens	O	O	O
the	O	O	O
repertoire	O	O	O
of	O	O	O
activities	O	O	B-T052
associated	O	O	B-T080
with	O	O	I-T080
poly(C	O	O	B-T116
)	O	O	I-T116
binding	O	O	I-T116
proteins	O	O	I-T116
and	O	O	O
prototypes	O	O	B-T080
a	O	O	O
new	O	O	O
class	O	O	O
of	O	O	O
virus	O	O	B-T005
-	O	O	O
host	O	O	B-T001
interactions	O	O	B-T169
.	O	O	O

-DOCSTART- (27259647)

Production	O	O	O
of	O	O	O
bioactive	O	O	B-T167
conjugated	O	O	B-T109
linoleic	O	O	I-T109
acid	O	O	I-T109
by	O	O	O
the	O	O	O
multifunctional	O	O	B-T116
enolase	O	O	B-T116
from	O	O	O
Lactobacillus	O	O	O
plantarum	O	O	O

Lactobacillus	O	O	B-T007
plantarum	O	O	I-T007
Î±-enolase	O	O	B-T116
,	O	O	O
a	O	O	O
multifunctional	O	O	B-T116
-anchorless-	O	O	O
surface	O	O	B-T116
protein	O	O	I-T116
belonging	O	O	O
to	O	O	O
the	O	O	O
conserved	O	O	O
family	O	O	O
of	O	O	O
enolases	O	O	B-T116
with	O	O	O
a	O	O	O
central	O	O	O
role	O	O	O
in	O	O	O
glycolytic	O	O	B-T044
metabolism	O	O	B-T040
,	O	O	O
was	O	O	O
characterized	O	O	B-T052
to	O	O	O
have	O	O	O
a	O	O	O
side	O	O	O
role	O	O	O
in	O	O	O
the	O	O	O
intricate	O	O	B-T040
metabolism	O	O	I-T040
of	O	O	O
biohydrogenation	O	O	B-T070
of	O	O	O
linoleic	O	O	B-T109
acid	O	O	I-T109
,	O	O	O
catalyzing	O	O	B-T070
the	O	O	O
formation	O	O	B-T169
of	O	O	O
bioactive	O	O	B-T167
9-cis-11-trans-CLA	O	O	B-T109
through	O	O	O
dehydration	O	O	B-T067
and	O	O	O
isomerization	O	O	B-T044
of	O	O	O
10-hydroxy-12-cis-octadecenoic	O	O	B-T109
acid	O	O	I-T109
.	O	O	O

The	O	O	O
identity	O	O	O
of	O	O	O
the	O	O	O
enolase	O	O	B-T116
was	O	O	O
confirmed	O	O	O
through	O	O	O
mass	O	O	B-T059
spectrometric	O	O	I-T059
analysis	O	O	I-T059
that	O	O	O
showed	O	O	O
the	O	O	O
characteristic	O	O	O
442	O	O	O
amino	O	O	B-T087
acid	O	O	I-T087
sequence	O	O	I-T087
with	O	O	O
a	O	O	O
molecular	O	O	B-T081
mass	O	O	I-T081
of	O	O	O
48.03	O	O	O
kDa	O	O	B-T081
.	O	O	O

The	O	O	O
enolase	O	O	B-T116
was	O	O	O
not	O	O	O
capable	O	O	O
of	O	O	O
using	O	O	O
linoleic	O	O	B-T109
acid	O	O	I-T109
directly	O	O	O
as	O	O	O
a	O	O	O
substrate	O	O	B-T167
but	O	O	O
instead	O	O	O
uses	O	O	O
its	O	O	O
hydroxyl	O	O	B-T197
derivative	O	O	B-T169
10-hydroxi-12-cis-octadecenoic	O	O	B-T109
acid	O	O	I-T109
to	O	O	O
finally	O	O	O
form	O	O	O
bioactive	O	O	B-T167
conjugated	O	O	B-T109
linoleic	O	O	I-T109
acid	O	O	I-T109
.	O	O	O

Biochemical	O	O	B-T169
optimization	O	O	B-T052
studies	O	O	B-T062
were	O	O	O
carried	O	O	O
out	O	O	O
to	O	O	O
elucidate	O	O	O
the	O	O	O
conditions	O	O	O
for	O	O	O
maximum	O	O	O
production	O	O	O
of	O	O	O
9-cis-11-trans-CLA	O	O	B-T109
and	O	O	O
maximum	O	O	O
stability	O	O	B-T044
of	O	O	O
Î±-enolase	O	O	B-T116
when	O	O	O
catalyzing	O	O	B-T070
this	O	O	O
reaction	O	O	B-T067
.	O	O	O

Furthermore	O	O	O
,	O	O	O
through	O	O	O
structural	O	O	B-T061
analysis	O	O	I-T061
of	O	O	O
the	O	O	O
protein	O	O	B-T116
,	O	O	O
we	O	O	O
propose	O	O	O
the	O	O	O
binding	O	O	B-T192
sites	O	O	I-T192
of	O	O	O
substrate	O	O	B-T167
and	O	O	O
product	O	O	B-T071
molecules	O	O	B-T167
that	O	O	O
were	O	O	O
characterized	O	O	B-T052
as	O	O	O
two	O	O	O
hydrophobic	O	O	B-T080
superficial	O	O	O
pockets	O	O	O
located	O	O	O
at	O	O	O
opposite	O	O	O
ends	O	O	O
of	O	O	O
the	O	O	O
enolase	O	O	B-T116
connected	O	O	O
through	O	O	O
a	O	O	O
channel	O	O	B-T116
where	O	O	O
the	O	O	O
catalysis	O	O	B-T070
of	O	O	O
dehydration	O	O	B-T067
and	O	O	O
isomerization	O	O	B-T044
might	O	O	O
occur	O	O	O
.	O	O	O

These	O	O	O
results	O	O	O
prove	O	O	O
that	O	O	O
multifunctional	O	O	B-T116
Î±-enolase	O	O	B-T116
also	O	O	O
plays	O	O	O
a	O	O	O
role	O	O	O
in	O	O	O
cell	O	O	B-T043
detoxification	O	O	I-T043
from	O	O	O
polyunsaturated	O	O	B-T109
fatty	O	O	I-T109
acids	O	O	I-T109
such	O	O	O
as	O	O	O
linoleic	O	O	B-T109
acid	O	O	I-T109
,	O	O	O
along	O	O	O
with	O	O	O
the	O	O	O
linoleate	O	O	B-T116
isomerase	O	O	I-T116
complex	O	O	B-T104
.	O	O	O

-DOCSTART- (27260627)

Associations	O	O	B-T080
of	O	O	O
Body	O	O	B-T201
Mass	O	O	I-T201
Index	O	O	I-T201
and	O	O	O
Physical	O	O	B-T056
Activity	O	O	I-T056
With	O	O	O
Sexual	O	O	B-T047
Dysfunction	O	O	I-T047
in	O	O	O
Breast	O	O	B-T191
Cancer	O	O	I-T191
Survivors	O	O	O

Sexual	O	O	B-T047
dysfunction	O	O	I-T047
is	O	O	O
a	O	O	O
common	O	O	O
and	O	O	O
distressing	O	O	B-T033
consequence	O	O	B-T169
of	O	O	I-T169
breast	O	O	B-T191
cancer	O	O	I-T191
(	O	O	O
BC	O	O	B-T191
)	O	O	O
treatment	O	O	B-T061
.	O	O	O

In	O	O	O
the	O	O	O
present	O	O	O
study	O	O	B-T062
,	O	O	O
we	O	O	O
investigated	O	O	O
the	O	O	O
sexual	O	O	B-T040
functioning	O	O	I-T040
of	O	O	O
BC	O	O	B-T191
patients	O	O	B-T101
and	O	O	O
its	O	O	O
association	O	O	B-T041
with	O	O	O
women	O	O	B-T098
's	O	O	I-T098
personal	O	O	B-T032
characteristics	O	O	B-T080
and	O	O	O
cancer	O	O	B-T061
treatments	O	O	I-T061
.	O	O	O

In	O	O	O
this	O	O	O
cross-sectional	O	O	B-T062
study	O	O	I-T062
,	O	O	O
sexual	O	O	B-T040
function	O	O	I-T040
was	O	O	O
assessed	O	O	O
using	O	O	O
the	O	O	O
Female	O	O	B-T170
Sexual	O	O	I-T170
Function	O	O	I-T170
Index	O	O	I-T170
(	O	O	O
FSFI	O	O	B-T170
)	O	O	O
.	O	O	O

The	O	O	O
health-related	O	O	B-T078
quality	O	O	I-T078
of	O	O	I-T078
life	O	O	I-T078
(	O	O	O
HRQOL	O	O	B-T078
)	O	O	O
was	O	O	O
measured	O	O	O
using	O	O	O
the	O	O	O
European	O	O	B-T093
Organization	O	O	I-T093
for	O	O	I-T093
Research	O	O	I-T093
and	O	O	I-T093
Treatment	O	O	I-T093
of	O	O	I-T093
Cancer	O	O	I-T093
(	O	O	O
EORTC	O	O	B-T093
)	O	O	O
QLQ-C30	O	O	B-T170
and	O	O	O
its	O	O	O
breast	O	O	B-T170
module	O	O	I-T170
BR-23	O	O	I-T170
.	O	O	O

Of	O	O	O
the	O	O	O
235	O	O	O
participants	O	O	B-T098
approached	O	O	O
,	O	O	O
216	O	O	O
participants	O	O	O
were	O	O	O
included	O	O	O
in	O	O	O
the	O	O	O
study	O	O	O
.	O	O	O

Of	O	O	O
these	O	O	O
,	O	O	O
63	O	O	O
patients	O	O	B-T101
reported	O	O	O
no	O	O	B-T033
sexual	O	O	I-T033
activity	O	O	I-T033
in	O	O	O
the	O	O	O
last	O	O	O
month	O	O	B-T079
and	O	O	O
thus	O	O	O
were	O	O	O
analyzed	O	O	O
only	O	O	O
in	O	O	O
relation	O	O	O
to	O	O	O
the	O	O	O
sexual	O	O	B-T041
desire	O	O	I-T041
domain	O	O	B-T169
of	O	O	O
FSFI	O	O	B-T170
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
154	O	O	O
(	O	O	O
71.3	O	O	O
%	O	O	O
)	O	O	O
patients	O	O	B-T101
were	O	O	O
classified	O	O	O
with	O	O	O
hypoactive	O	O	B-T048
sexual	O	O	I-T048
desire	O	O	I-T048
disorder	O	O	I-T048
(	O	O	O
HSDD	O	O	B-T048
)	O	O	O
.	O	O	O

From	O	O	O
those	O	O	O
patients	O	O	B-T101
reporting	O	O	O
sexual	O	O	B-T053
activity	O	O	I-T053
in	O	O	O
the	O	O	O
last	O	O	O
month	O	O	B-T079
,	O	O	O
63.3	O	O	O
%	O	O	O
(	O	O	O
97	O	O	O
out	O	O	O
of	O	O	O
153	O	O	O
)	O	O	O
were	O	O	O
classified	O	O	O
with	O	O	O
sexual	O	O	B-T047
dysfunction	O	O	I-T047
.	O	O	O

Using	O	O	O
hierarchical	O	O	B-T062
logistic	O	O	I-T062
regression	O	O	I-T062
,	O	O	O
the	O	O	O
variance	O	O	O
explained	O	O	O
(	O	O	O
change	O	O	O
in	O	O	O
R	O	O	O
(	O	O	O
2	O	O	O
)	O	O	O
)	O	O	O
by	O	O	O
the	O	O	O
addition	O	O	O
of	O	O	O
body	O	O	B-T201
mass	O	O	I-T201
index	O	O	I-T201
(	O	O	O
BMI	O	O	B-T201
)	O	O	O
and	O	O	O
mild	O	O	O
to	O	O	O
moderate	O	O	O
physical	O	O	B-T056
activity	O	O	I-T056
in	O	O	O
the	O	O	O
prediction	O	O	B-T078
models	O	O	B-T170
of	O	O	O
sexual	O	O	B-T047
dysfunction	O	O	I-T047
and	O	O	O
HSDD	O	O	B-T048
were	O	O	O
6.8	O	O	O
and	O	O	O
7.2	O	O	O
%	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

Age	O	O	B-T032
,	O	O	O
BMI	O	O	B-T201
,	O	O	O
and	O	O	O
physical	O	O	B-T056
activity	O	O	I-T056
were	O	O	O
independently	O	O	O
associated	O	O	O
with	O	O	O
sexual	O	O	B-T047
dysfunction	O	O	I-T047
and	O	O	O
HSDD	O	O	B-T048
.	O	O	O

Additionally	O	O	O
,	O	O	O
BC	O	O	B-T191
patients	O	O	B-T101
with	O	O	O
sexual	O	O	B-T047
dysfunction	O	O	I-T047
reported	O	O	O
lower	O	O	B-T081
scores	O	O	B-T081
on	O	O	O
global	O	O	O
HRQOL	O	O	B-T078
,	O	O	O
role	O	O	O
functioning	O	O	B-T169
,	O	O	O
and	O	O	O
fatigue	O	O	B-T184
.	O	O	O

Based	O	O	O
on	O	O	O
our	O	O	O
findings	O	O	B-T033
,	O	O	O
BC	O	O	B-T191
survivors	O	O	B-T101
should	O	O	O
be	O	O	O
encouraged	O	O	O
to	O	O	O
practice	O	O	B-T041
regular	O	O	O
physical	O	O	B-T056
activity	O	O	I-T056
and	O	O	O
to	O	O	O
lose	O	O	B-UnknownType
weight	O	O	I-UnknownType
in	O	O	O
order	O	O	O
to	O	O	O
avoid	O	O	O
sexual	O	O	B-T047
dysfunction	O	O	I-T047
.	O	O	O

However	O	O	O
,	O	O	O
future	O	O	O
clinical	O	O	B-T062
trials	O	O	I-T062
are	O	O	O
needed	O	O	O
to	O	O	O
confirm	O	O	O
these	O	O	O
findings	O	O	B-T033
.	O	O	O

-DOCSTART- (27261587)

Combination	O	O	B-T121
of	O	O	O
telmisartan	O	O	B-T109
with	O	O	O
sildenafil	O	O	B-T109
ameliorate	O	O	B-T080
progression	O	O	B-T046
of	O	O	O
diabetic	O	O	B-T033
nephropathy	O	O	I-T047
in	O	O	O
streptozotocin	O	O	B-T195
-	O	O	O
induced	O	O	B-T169
diabetic	O	O	O
model	O	O	O

Diabetic	O	O	B-T047
nephropathy	O	O	I-T047
(	O	O	O
DN	O	O	B-T047
)	O	O	O
is	O	O	O
a	O	O	O
leading	O	O	O
cause	O	O	O
of	O	O	O
end-stage	O	O	B-T047
renal	O	O	I-T047
disease	O	O	I-T047
in	O	O	O
the	O	O	O
world	O	O	O
.	O	O	O

Several	O	O	O
signaling	O	O	B-T044
pathways	O	O	I-T044
are	O	O	O
involved	O	O	O
in	O	O	O
the	O	O	O
pathogenesis	O	O	B-T046
of	O	O	O
DN	O	O	B-T047
including	O	O	O
elevation	O	O	B-T082
in	O	O	O
level	O	O	O
of	O	O	O
angiotensin	O	O	B-T116
II	O	O	I-T116
,	O	O	O
formation	O	O	B-T169
of	O	O	O
advanced	O	O	B-T109
glycation	O	O	I-T109
end	O	O	I-T109
products	O	O	I-T109
(	O	O	O
AGE	O	O	B-T109
)	O	O	O
,	O	O	O
activation	O	O	B-T043
of	O	O	O
protein	O	O	B-T116
kinase	O	O	I-T116
c	O	O	I-T116
(	O	O	O
PKC	O	O	B-T116
)	O	O	O
,	O	O	O
and	O	O	O
lipid	O	O	B-T033
accumulation	O	O	I-T033
.	O	O	O

These	O	O	O
pathways	O	O	B-T044
activate	O	O	B-T052
one	O	O	O
another	O	O	O
mutually	O	O	O
leading	O	O	O
to	O	O	O
oxidative	O	O	B-T049
stress	O	O	I-T049
,	O	O	O
increasing	O	O	O
expression	O	O	B-T045
of	O	O	O
transforming	O	O	B-T116
growth	O	O	I-T116
factor	O	O	I-T116
beta-1	O	O	I-T116
(	O	O	O
TGF-Î²	O	O	B-T116
1	O	O	I-T116
)	O	O	O
and	O	O	O
release	O	O	B-T169
of	O	O	O
interleukins	O	O	B-T116
and	O	O	O
adhesion	O	O	B-T116
molecules	O	O	I-T116
,	O	O	O
so	O	O	O
the	O	O	O
aim	O	O	O
of	O	O	O
this	O	O	O
study	O	O	O
is	O	O	O
to	O	O	O
interrupt	O	O	O
more	O	O	O
than	O	O	O
pathogenic	O	O	B-T033
pathway	O	O	B-T077
to	O	O	O
ameliorate	O	O	B-T080
the	O	O	O
progression	O	O	B-T046
of	O	O	O
DN	O	O	B-T047
.	O	O	O

In	O	O	O
the	O	O	O
present	O	O	O
study	O	O	B-T062
,	O	O	O
white	O	O	B-T015
male	O	O	I-T015
rats	O	O	B-T015
(	O	O	O
N=48	O	O	O
)	O	O	O
were	O	O	O
divided	O	O	O
into	O	O	O
six	O	O	O
groups	O	O	O
(	O	O	O
8	O	O	O
rats	O	O	O
each	O	O	O
)	O	O	O
,	O	O	O
the	O	O	O
first	O	O	O
two	O	O	O
groups	O	O	O
served	O	O	O
as	O	O	O
normal	O	O	B-T096
control	O	O	I-T096
and	O	O	O
a	O	O	O
control	O	O	B-T096
vehicle	O	O	I-T096
group	O	O	I-T096
while	O	O	O
the	O	O	O
remaining	O	O	O
four	O	O	O
groups	O	O	O
were	O	O	O
rendered	O	O	O
diabetic	O	O	B-T033
by	O	O	O
a	O	O	O
single	O	O	O
intraperitoneal	O	O	B-T061
injection	O	O	I-T061
of	O	O	O
Streptozotocin	O	O	B-T195
(	O	O	O
STZ	O	O	B-T195
)	O	O	O
and	O	O	O
being	O	O	O
left	O	O	O
for	O	O	O
4	O	O	O
weeks	O	O	O
to	O	O	O
develop	O	O	O
DN	O	O	B-T047
.	O	O	O

Thereafter	O	O	O
,	O	O	O
the	O	O	O
rats	O	O	B-T015
were	O	O	O
divided	O	O	O
into	O	O	O
DN	O	O	B-T047
group	O	O	O
,	O	O	O
DN	O	O	O
group	O	O	O
receiving	O	O	O
Telmisartan	O	O	B-T109
or	O	O	O
Sildenafil	O	O	B-T109
or	O	O	O
Telmisartan	O	O	O
Sildenafil	O	O	O
combination	O	O	B-T121
.	O	O	O

After	O	O	O
the	O	O	O
specified	O	O	B-T080
treatment	O	O	B-T169
period	O	O	B-T079
,	O	O	O
urine	O	O	B-T031
samples	O	O	I-T031
were	O	O	O
collected	O	O	B-T078
(	O	O	O
using	O	O	O
metabolic	O	O	B-T073
cages	O	O	I-T073
)	O	O	O
to	O	O	O
measure	O	O	O
proteinuria	O	O	B-T033
,	O	O	O
animals	O	O	B-T008
were	O	O	O
then	O	O	O
euthanized	O	O	B-T054
,	O	O	O
blood	O	O	B-T031
and	O	O	O
tissue	O	O	B-T024
samples	O	O	I-T024
were	O	O	O
collected	O	O	O
for	O	O	O
measurement	O	O	B-T059
of	O	O	I-T059
Blood	O	O	I-T059
glucose	O	O	I-T059
,	O	O	O
BUN	O	O	B-T059
,	O	O	O
S.Cr	O	O	B-T059
,	O	O	O
LDL	O	O	B-T059
,	O	O	O
NO	O	O	B-T059
,	O	O	O
TGF-Î²1	O	O	B-T059
,	O	O	O
IL-1Î²	O	O	B-T059
,	O	O	O
AGEPs	O	O	B-T059
,	O	O	O
and	O	O	O
SOD	O	O	B-T059
.	O	O	O

The	O	O	O
combination	O	O	B-T061
therapy	O	O	I-T061
showed	O	O	O
significant	O	O	O
decrease	O	O	O
in	O	O	O
BUN	O	O	B-T123
,	O	O	O
S.Cr	O	O	B-T109
,	O	O	O
LDL	O	O	B-T109
,	O	O	O
TGF-Î²1	O	O	B-T116
,	O	O	O
IL-1Î²	O	O	B-T116
,	O	O	O
Proteinuria	O	O	B-T033
and	O	O	O
AGEPs	O	O	B-T109
and	O	O	O
significant	O	O	O
increase	O	O	O
in	O	O	O
SOD	O	O	B-T116
and	O	O	O
NO	O	O	B-T121
.	O	O	O

The	O	O	O
findings	O	O	O
showed	O	O	O
that	O	O	O
combination	O	O	B-T061
therapy	O	O	I-T061
was	O	O	O
able	O	O	O
to	O	O	O
ameliorate	O	O	B-T080
DN	O	O	B-T047
and	O	O	O
that	O	O	O
the	O	O	O
effects	O	O	O
were	O	O	O
superior	O	O	B-T080
to	O	O	O
the	O	O	O
single	O	O	O
drugs	O	O	B-T121
alone	O	O	O
.	O	O	O

-DOCSTART- (27261783)

Analysis	O	O	B-T062
of	O	O	O
Low-Biomass	O	O	B-T081
Microbial	O	O	B-T001
Communities	O	O	I-T001
in	O	O	O
the	O	O	O
Deep	O	O	O
Biosphere	O	O	O

Over	O	O	O
the	O	O	O
past	O	O	O
few	O	O	B-T081
decades	O	O	I-T081
,	O	O	O
the	O	O	O
subseafloor	O	O	B-UnknownType
biosphere	O	O	I-UnknownType
has	O	O	O
been	O	O	O
explored	O	O	O
by	O	O	O
scientific	O	O	B-T169
ocean	O	O	I-T169
drilling	O	O	I-T169
to	O	O	O
depths	O	O	B-T082
of	O	O	O
about	O	O	O
2.5	O	O	O
km	O	O	O
below	O	O	O
the	O	O	O
seafloor	O	O	B-UnknownType
.	O	O	O

Although	O	O	O
organic-rich	O	O	B-T082
anaerobic	O	O	I-T082
sedimentary	O	O	I-T082
habitats	O	O	I-T082
in	O	O	O
the	O	O	O
ocean	O	O	B-T082
margins	O	O	I-T082
harbor	O	O	I-T082
large	O	O	O
numbers	O	O	O
of	O	O	O
microbial	O	O	B-T001
cells	O	O	I-T001
,	O	O	O
microbial	O	O	B-T001
populations	O	O	I-T001
in	O	O	O
ultraoligotrophic	O	O	B-T082
aerobic	O	O	I-T082
sedimentary	O	O	I-T082
habitats	O	O	I-T082
in	O	O	O
the	O	O	O
open	O	O	O
ocean	O	O	B-T169
gyres	O	O	I-T169
are	O	O	O
several	O	O	O
orders	O	O	O
of	O	O	O
magnitude	O	O	B-T081
less	O	O	O
abundant	O	O	B-T080
.	O	O	O

Despite	O	O	O
advances	O	O	O
in	O	O	O
cultivation-independent	O	O	B-T169
molecular	O	O	I-T169
ecological	O	O	I-T169
techniques	O	O	I-T169
,	O	O	O
exploring	O	O	O
the	O	O	O
low-biomass	O	O	B-T081
environment	O	O	B-T082
remains	O	O	O
technologically	O	O	B-T080
challenging	O	O	I-T080
,	O	O	O
especially	O	O	O
in	O	O	O
the	O	O	O
deep	O	O	B-UnknownType
subseafloor	O	O	I-UnknownType
biosphere	O	O	I-UnknownType
.	O	O	O

Reviewing	O	O	B-T080
the	O	O	O
historical	O	O	B-T170
background	O	O	I-T170
of	O	O	O
deep-biosphere	O	O	B-UnknownType
analytical	O	O	B-T170
methods	O	O	B-T170
,	O	O	O
the	O	O	O
importance	O	O	B-T080
of	O	O	O
obtaining	O	O	O
clean	O	O	B-T167
samples	O	O	I-T167
and	O	O	O
tracing	O	O	B-T033
contamination	O	O	B-T078
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
methods	O	O	O
for	O	O	O
detecting	O	O	B-T033
microbial	O	O	B-T001
life	O	O	B-T078
,	O	O	O
technological	O	O	B-UnknownType
aspects	O	O	I-UnknownType
of	O	O	O
molecular	O	O	B-T091
microbiology	O	O	I-T091
,	O	O	O
and	O	O	O
detecting	O	O	O
subseafloor	O	O	B-UnknownType
metabolic	O	O	B-T040
activity	O	O	I-T040
will	O	O	O
be	O	O	O
discussed	O	O	O
.	O	O	O

-DOCSTART- (27266283)

The	O	O	O
sensitivity	O	O	B-T081
and	O	O	I-T081
specifity	O	O	I-T081
of	O	O	O
DR-70	O	O	B-T123
immunoassay	O	O	B-T059
as	O	O	O
a	O	O	O
tumor	O	O	B-T123
marker	O	O	I-T123
for	O	O	O
non-small	O	O	O
cell	O	O	O
lung	O	O	O
cancer	O	O	O

Lung	O	O	B-T191
cancer	O	O	I-T191
is	O	O	O
the	O	O	O
most	O	O	O
important	O	O	O
causes	O	O	O
of	O	O	O
the	O	O	O
cancer	O	O	B-T081
related	O	O	I-T081
mortality	O	O	I-T081
.	O	O	O

Patients	O	O	B-T101
with	O	O	O
lung	O	O	B-T191
cancer	O	O	I-T191
are	O	O	O
usually	O	O	O
diagnosed	O	O	B-T060
at	O	O	O
advanced	O	O	B-T029
or	O	O	O
locally	O	O	B-T029
advanced	O	O	I-T029
stage	O	O	I-T029
,	O	O	O
for	O	O	O
this	O	O	O
reason	O	O	O
early	O	O	B-T060
diagnosis	O	O	I-T060
of	O	O	O
lung	O	O	O
cancer	O	O	O
is	O	O	O
very	O	O	O
important	O	O	O
.	O	O	O

For	O	O	O
early	O	O	B-T060
detection	O	O	I-T060
of	O	O	O
lung	O	O	B-T191
cancer	O	O	I-T191
some	O	O	O
methods	O	O	O
are	O	O	O
emphasized	O	O	O
such	O	O	O
as	O	O	O
low-dose	O	O	B-T060
computed	O	O	I-T060
tomography	O	O	I-T060
or	O	O	O
tumor	O	O	B-T123
biomarkers	O	O	I-T123
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	O
we	O	O	O
aimed	O	O	O
to	O	O	O
evaluate	O	O	B-T058
DR-70	O	O	B-T123
sensitivity	O	O	B-T081
and	O	O	I-T081
specificity	O	O	I-T081
as	O	O	O
a	O	O	O
tumor	O	O	B-T123
marker	O	O	I-T123
in	O	O	O
detection	O	O	B-T061
of	O	O	O
non-small	O	O	B-T191
cell	O	O	I-T191
lung	O	O	I-T191
cancers	O	O	I-T191
.	O	O	O

Between	O	O	O
May	O	O	B-T079
2013	O	O	O
and	O	O	O
April	O	O	B-T079
2014	O	O	O
,	O	O	O
the	O	O	O
serum	O	O	B-T031
samples	O	O	I-T031
from	O	O	O
88	O	O	O
non	O	O	B-T191
lung	O	O	I-T191
cancer	O	O	I-T191
patients	O	O	B-T101
,	O	O	O
86	O	O	O
patients	O	O	O
with	O	O	O
chronic	O	O	B-T047
obstructive	O	O	I-T047
pulmonary	O	O	I-T047
disesase	O	O	I-T047
were	O	O	O
obtained	O	O	O
.	O	O	O

Blood	O	O	B-T031
samples	O	O	I-T031
from	O	O	O
each	O	O	O
participant	O	O	B-T098
were	O	O	O
analyzed	O	O	B-T062
for	O	O	O
DR-70	O	O	B-T123
level	O	O	B-T080
.	O	O	O

Totally	O	O	O
174	O	O	O
patients	O	O	B-T101
were	O	O	O
enrolled	O	O	O
to	O	O	O
the	O	O	O
study	O	O	B-T062
(	O	O	O
152	O	O	O
male	O	O	B-T098
,	O	O	O
22	O	O	O
female	O	O	B-T098
)	O	O	O
.	O	O	O

Histopathologically	O	O	B-T169
47(53.4	O	O	O
%	O	O	O
)	O	O	O
patients	O	O	B-T101
were	O	O	O
diagnosed	O	O	B-T060
with	O	O	O
squamous	O	O	B-T191
cell	O	O	I-T191
lung	O	O	I-T191
cancer	O	O	I-T191
,	O	O	O
34	O	O	O
(	O	O	O
38.6	O	O	O
%	O	O	O
)	O	O	O
with	O	O	O
adenocarcinoma	O	O	B-T191
,	O	O	O
and	O	O	O
7	O	O	O
(	O	O	O
8	O	O	O
%	O	O	O
)	O	O	O
with	O	O	O
non-small	O	O	B-T191
cell	O	O	I-T191
lung	O	O	I-T191
cancer	O	O	I-T191
.	O	O	O

The	O	O	O
mean	O	O	B-T123
serum	O	O	I-T123
DR-70	O	O	I-T123
levels	O	O	B-T080
in	O	O	O
lung	O	O	B-T191
cancer	O	O	I-T191
patients	O	O	B-T101
(	O	O	O
2.43	O	O	O
Â±	O	O	O
1.82	O	O	O
Âµg/mL	O	O	O
)	O	O	O
was	O	O	O
significantly	O	O	B-T033
higher	O	O	I-T033
compared	O	O	B-T052
to	O	O	O
the	O	O	O
86	O	O	O
non-cancerous	O	O	B-T033
subjects	O	O	B-T098
(	O	O	O
1.15	O	O	O
Â±	O	O	O
0.70	O	O	O
Âµg/mL	O	O	O
)	O	O	O
(	O	O	O
p	O	O	O
<	O	O	O
0.01	O	O	O
)	O	O	O
.	O	O	O

DR-70	O	O	B-T123
exhibited	O	O	O
clinical	O	O	B-T080
sensitivity	O	O	B-T081
and	O	O	I-T081
specificity	O	O	I-T081
of	O	O	O
54.5	O	O	O
and	O	O	O
83.7	O	O	O
%	O	O	O
,	O	O	O
respectively	O	O	O
,	O	O	O
at	O	O	O
an	O	O	O
optimal	O	O	B-T080
cut	O	O	B-T169
off	O	O	I-T169
at	O	O	O
1.98	O	O	O
Âµg/mL.	O	O	O
It	O	O	O
could	O	O	O
be	O	O	O
said	O	O	O
that	O	O	O
the	O	O	O
risk	O	O	O
of	O	O	O
the	O	O	O
presence	O	O	O
of	O	O	O
the	O	O	O
disease	O	O	B-T047
is	O	O	O
6.171	O	O	O
times	O	O	O
higher	O	O	O
in	O	O	O
the	O	O	O
cases	O	O	O
where	O	O	O
DR-70	O	O	O
level	O	O	B-T080
is	O	O	O
1.98	O	O	O
Âµg/mL	O	O	O
and	O	O	O
higher	O	O	O
.	O	O	O

DR-70	O	O	B-T123
,	O	O	O
a	O	O	O
marker	O	O	B-T123
used	O	O	O
to	O	O	O
measure	O	O	B-T081
fibrin	O	O	B-T116
degradation	O	O	I-T116
products	O	O	I-T116
,	O	O	O
generated	O	O	O
by	O	O	O
all	O	O	O
major	O	O	O
cancers	O	O	B-T191
,	O	O	O
may	O	O	O
helps	O	O	O
to	O	O	O
find	O	O	O
high	O	O	B-T033
risk	O	O	I-T033
lung	O	O	B-T191
cancer	O	O	I-T191
patients	O	O	B-T101
.	O	O	O

-DOCSTART- (27266878)

Catastrophic	O	O	B-T081
expenditure	O	O	I-T081
and	O	O	O
impoverishment	O	O	B-T081
of	O	O	O
patients	O	O	B-T101
affected	O	O	O
by	O	O	O
7	O	O	O
rare	O	O	B-T047
diseases	O	O	I-T047
in	O	O	O
China	O	O	O

China	O	O	B-T083
is	O	O	O
actively	O	O	O
promoting	O	O	B-T052
regulation	O	O	O
of	O	O	O
rare	O	O	B-T047
diseases	O	O	I-T047
,	O	O	O
rare	O	O	B-T047
disease	O	O	I-T047
and	O	O	O
orphan	O	O	B-T121
drugs	O	O	I-T121
have	O	O	O
been	O	O	O
formally	O	O	O
incorporated	O	O	O
into	O	O	O
the	O	O	O
national	O	O	B-UnknownType
planning	O	O	I-UnknownType
.	O	O	O

However	O	O	O
,	O	O	O
few	O	O	O
studies	O	O	B-T062
have	O	O	O
been	O	O	O
done	O	O	O
to	O	O	O
evaluate	O	O	O
the	O	O	O
affordability	O	O	B-T081
of	O	O	O
rare	O	O	B-T047
disease	O	O	I-T047
patients	O	O	B-T101
in	O	O	O
China	O	O	B-T083
.	O	O	O

This	O	O	O
study	O	O	O
aims	O	O	O
to	O	O	O
provide	O	O	O
policy	O	O	B-T170
recommendations	O	O	B-T078
for	O	O	O
the	O	O	O
establishment	O	O	B-T080
of	O	O	O
social	O	O	B-T170
security	O	O	I-T170
mechanism	O	O	I-T170
for	O	O	O
rare	O	O	B-T047
diseases	O	O	B-T047
in	O	O	O
China	O	O	B-T083
,	O	O	O
so	O	O	O
as	O	O	O
to	O	O	O
address	O	O	O
the	O	O	O
problem	O	O	O
of	O	O	O
poverty	O	O	B-T102
caused	O	O	O
by	O	O	O
these	O	O	O
diseases	O	O	O
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
7	O	O	O
rare	O	O	B-T047
diseases	O	O	I-T047
were	O	O	O
selected	O	O	O
by	O	O	O
Delphi	O	O	B-T062
method	O	O	I-T062
.	O	O	O

Affordability	O	O	B-T081
of	O	O	O
treatment	O	O	B-T061
for	O	O	O
the	O	O	O
7	O	O	O
rare	O	O	B-T047
diseases	O	O	I-T047
was	O	O	O
assessed	O	O	B-T052
through	O	O	O
annual	O	O	B-T081
per	O	O	I-T081
capital	O	O	I-T081
income	O	O	I-T081
,	O	O	O
catastrophic	O	O	B-T081
expenditure	O	O	B-T081
and	O	O	O
impoverishment	O	O	B-T081
expenditure	O	O	O
among	O	O	O
urban	O	O	B-T098
and	O	O	O
rural	O	O	B-T098
residents	O	O	I-T098
in	O	O	O
China	O	O	B-T083
.	O	O	O

Assessed	O	O	B-T052
through	O	O	O
annual	O	O	B-T081
per	O	O	I-T081
capital	O	O	I-T081
income	O	O	I-T081
,	O	O	O
health	O	O	B-T081
expenditure	O	O	I-T081
for	O	O	O
the	O	O	O
7	O	O	O
rare	O	O	B-T047
diseases	O	O	I-T047
are	O	O	O
all	O	O	O
rather	O	O	O
high	O	O	O
.	O	O	O

The	O	O	O
highest	O	O	O
health	O	O	B-T081
expenditure	O	O	I-T081
is	O	O	O
equivalent	O	O	O
to	O	O	O
income	O	O	B-T081
of	O	O	O
69.34	O	O	O
years	O	O	B-T079
of	O	O	O
one	O	O	O
urban	O	O	B-T098
resident	O	O	I-T098
,	O	O	O
and	O	O	O
the	O	O	O
burden	O	O	O
is	O	O	O
heavier	O	O	O
for	O	O	O
rural	O	O	B-T098
residents	O	O	I-T098
.	O	O	O

Through	O	O	O
catastrophic	O	O	B-T081
expenditure	O	O	I-T081
assessment	O	O	B-T052
,	O	O	O
proportions	O	O	B-T081
of	O	O	O
the	O	O	O
population	O	O	B-T098
experiencing	O	O	O
catastrophic	O	O	O
expenditure	O	O	O
caused	O	O	O
by	O	O	O
the	O	O	O
7	O	O	O
rare	O	O	B-T047
diseases	O	O	I-T047
are	O	O	O
all	O	O	O
under	O	O	O
0.167	O	O	O
â°.	O	O	O
However	O	O	O
,	O	O	O
once	O	O	O
one	O	O	O
is	O	O	O
ill	O	O	B-T184
and	O	O	O
taking	O	O	O
medications	O	O	B-T170
,	O	O	O
he	O	O	O
will	O	O	O
suffer	O	O	O
from	O	O	O
catastrophic	O	O	B-T081
health	O	O	I-T081
expenditure	O	O	I-T081
.	O	O	O

Through	O	O	O
impoverishment	O	O	B-T081
expenditure	O	O	B-T081
assessment	O	O	B-T052
,	O	O	O
the	O	O	O
proportions	O	O	B-T081
of	O	O	O
impoverishment	O	O	O
payment	O	O	B-T081
are	O	O	O
low	O	O	O
among	O	O	O
both	O	O	O
urban	O	O	B-T098
and	O	O	O
rural	O	O	B-T098
residents	O	O	I-T098
,	O	O	O
but	O	O	O
the	O	O	O
7	O	O	O
rare	O	O	B-T047
diseases	O	O	I-T047
could	O	O	O
lead	O	O	O
nearly	O	O	O
4.6	O	O	O
million	O	O	O
people	O	O	B-T098
into	O	O	O
poverty	O	O	B-T102
on	O	O	O
a	O	O	O
national	O	O	O
scale	O	O	O
.	O	O	O

The	O	O	O
affordability	O	O	B-T081
of	O	O	O
treatment	O	O	B-T061
for	O	O	O
rare	O	O	B-T047
disease	O	O	I-T047
as	O	O	O
well	O	O	O
as	O	O	O
orphan	O	O	B-T121
drugs	O	O	I-T121
is	O	O	O
rather	O	O	O
poor	O	O	B-T080
.	O	O	O

Residents	O	O	B-T098
of	O	O	O
different	O	O	O
income	O	O	B-T080
levels	O	O	I-T080
all	O	O	O
have	O	O	O
difficulties	O	O	O
to	O	O	O
afford	O	O	O
the	O	O	O
treatment	O	O	B-T061
for	O	O	O
rare	O	O	B-T047
diseases	O	O	I-T047
,	O	O	O
so	O	O	O
poverty	O	O	B-T102
caused	O	O	O
by	O	O	O
rare	O	O	O
diseases	O	O	O
is	O	O	O
quite	O	O	O
widespread	O	O	B-T082
.	O	O	O

Therefore	O	O	O
,	O	O	O
social	O	O	B-T170
security	O	O	I-T170
mechanism	O	O	I-T170
for	O	O	O
rare	O	O	B-T047
disease	O	O	I-T047
patients	O	O	B-T101
should	O	O	O
be	O	O	O
established	O	O	O
and	O	O	O
specific	O	O	O
payment	O	O	B-T081
pattern	O	O	O
for	O	O	O
orphan	O	O	B-T121
drugs	O	O	I-T121
should	O	O	O
be	O	O	O
set	O	O	O
up	O	O	O
.	O	O	O

-DOCSTART- (27273231)

Experimental	O	O	B-T062
study	O	O	I-T062
in	O	O	O
pulmonary	O	O	B-T023
artery	O	O	I-T023
sealing	O	O	B-T061
with	O	O	O
a	O	O	O
vessel-sealing	O	O	O
device	O	O	O

The	O	O	O
development	O	O	O
of	O	O	O
vessel-sealing	O	O	B-T074
devices	O	O	I-T074
will	O	O	O
facilitate	O	O	O
safety	O	O	B-T068
in	O	O	O
video-assisted	O	O	B-T061
thoracoscopic	O	O	I-T061
surgery	O	O	I-T061
.	O	O	O

Our	O	O	O
objective	O	O	O
was	O	O	O
to	O	O	O
evaluate	O	O	O
the	O	O	O
feasibility	O	O	B-T080
and	O	O	O
safety	O	O	B-T068
of	O	O	O
sealing	O	O	B-T061
pulmonary	O	O	B-T023
arteries	O	O	I-T023
with	O	O	O
the	O	O	O
Enseal	O	O	B-T074
tissue-sealing	O	O	I-T074
device	O	O	I-T074
.	O	O	O

Pulmonary	O	O	B-T023
arteries	O	O	I-T023
from	O	O	O
beagle	O	O	B-T015
dogs	O	O	I-T015
(	O	O	O
mean	O	O	O
body	O	O	O
weight	O	O	O
13.1	O	O	O
kg	O	O	O
,	O	O	O
range	O	O	O
10.5	O	O	O
-	O	O	O
15.4	O	O	O
kg	O	O	O
)	O	O	O
were	O	O	O
divided	O	O	O
into	O	O	O
3	O	O	O
groups	O	O	B-T096
according	O	O	O
to	O	O	O
the	O	O	O
in-vivo	O	O	B-T082
sealing	O	O	B-T170
method	O	O	I-T170
used	O	O	O
(	O	O	O
Enseal	O	O	B-T074
,	O	O	O
ligation	O	O	B-T061
,	O	O	O
and	O	O	O
proximal	O	O	B-T082
ligation	O	O	O
plus	O	O	O
distal	O	O	B-T082
Enseal	O	O	O
)	O	O	O
and	O	O	O
extracted	O	O	O
to	O	O	O
evaluate	O	O	O
the	O	O	O
pressure	O	O	B-T067
tolerance	O	O	B-T080
up	O	O	O
to	O	O	O
75	O	O	O
mm	O	O	O
Hg	O	O	O
at	O	O	O
the	O	O	O
sealed	O	O	B-T169
end	O	O	B-T082
.	O	O	O

A	O	O	O
left	O	O	O
lower	O	O	O
lobectomy	O	O	B-T061
was	O	O	O
performed	O	O	O
to	O	O	O
evaluate	O	O	O
chronic-phase	O	O	B-T079
durability	O	O	O
of	O	O	O
the	O	O	O
sealed	O	O	B-T074
stumps	O	O	I-T074
in	O	O	O
a	O	O	O
survival	O	O	B-T008
model	O	O	I-T008
.	O	O	O

Two	O	O	O
or	O	O	O
three	O	O	O
branches	O	O	O
of	O	O	O
the	O	O	O
pulmonary	O	O	B-T023
arteries	O	O	I-T023
in	O	O	O
each	O	O	O
dog	O	O	B-T015
were	O	O	O
allocated	O	O	O
to	O	O	O
each	O	O	O
of	O	O	O
the	O	O	O
3	O	O	O
groups	O	O	B-T096
.	O	O	O

After	O	O	O
the	O	O	O
scheduled	O	O	O
survival	O	O	B-T052
period	O	O	B-T079
,	O	O	O
the	O	O	O
pulmonary	O	O	B-T023
arteries	O	O	I-T023
were	O	O	O
sampled	O	O	O
.	O	O	O

Pressure	O	O	B-T067
tolerance	O	O	B-T080
at	O	O	O
the	O	O	O
sealed	O	O	B-T169
end	O	O	B-T082
was	O	O	O
evaluated	O	O	O
in	O	O	O
91	O	O	O
pulmonary	O	O	B-T023
artery	O	O	I-T023
sections	O	O	O
.	O	O	O

All	O	O	O
sealed	O	O	B-T169
ends	O	O	B-T082
showed	O	O	O
pressure	O	O	B-T067
tolerance	O	O	B-T080
>	O	O	O
75	O	O	O
mm	O	O	O
Hg	O	O	O
.	O	O	O

A	O	O	O
left	O	O	O
lower	O	O	O
lobectomy	O	O	B-T061
was	O	O	O
performed	O	O	O
in	O	O	O
13	O	O	O
dogs	O	O	B-T015
in	O	O	O
which	O	O	O
35	O	O	O
pulmonary	O	O	B-T023
artery	O	O	I-T023
sections	O	O	O
had	O	O	O
been	O	O	O
allocated	O	O	O
into	O	O	O
the	O	O	O
3	O	O	O
groups	O	O	B-T096
.	O	O	O

No	O	O	B-T033
sealing	O	O	B-T061
failure	O	O	B-T169
was	O	O	O
found	O	O	O
,	O	O	O
and	O	O	O
pathological	O	O	B-T169
findings	O	O	B-T033
showed	O	O	O
healing	O	O	B-T040
and	O	O	O
persistent	O	O	B-T079
hemostasis	O	O	B-T042
at	O	O	O
all	O	O	O
sealed	O	O	B-T169
ends	O	O	B-T082
of	O	O	O
the	O	O	O
pulmonary	O	O	B-T023
arteries	O	O	I-T023
after	O	O	O
2	O	O	O
and	O	O	O
4	O	O	O
weeks	O	O	B-T079
of	O	O	O
the	O	O	O
survival	O	O	B-T052
period	O	O	B-T079
.	O	O	O

Pulmonary	O	O	B-T023
arteries	O	O	I-T023
sealed	O	O	B-T169
in	O	O	B-T082
vivo	O	O	I-T082
with	O	O	O
the	O	O	O
Enseal	O	O	B-T074
device	O	O	I-T074
showed	O	O	O
pressure	O	O	B-T067
tolerance	O	O	B-T080
>	O	O	O
75	O	O	O
mm	O	O	O
Hg	O	O	O
in	O	O	O
the	O	O	O
acute	O	O	B-T079
phase	O	O	I-T079
,	O	O	O
and	O	O	O
persistent	O	O	B-T079
hemostasis	O	O	B-T042
after	O	O	O
2	O	O	O
or	O	O	O
4	O	O	O
weeks	O	O	B-T079
.	O	O	O

Pulmonary	O	O	B-T023
artery	O	O	I-T023
sealing	O	O	B-T061
with	O	O	O
the	O	O	O
Enseal	O	O	B-T074
device	O	O	I-T074
is	O	O	O
feasible	O	O	B-T080
and	O	O	O
safe	O	O	B-T068
in	O	O	O
thoracic	O	O	B-T061
surgery	O	O	I-T061
settings	O	O	O
.	O	O	O

-DOCSTART- (27273307)

Pathophysiology	O	O	B-T169
,	O	O	O
treatment	O	O	B-T061
and	O	O	O
prevention	O	O	B-T061
of	O	O	O
ovarian	O	O	O
hyperstimulation	O	O	O
syndrome	O	O	O

Severe	O	O	B-T080
ovarian	O	O	B-T047
hyperstimulation	O	O	I-T047
syndrome	O	O	I-T047
(	O	O	O
OHSS	O	O	B-T047
)	O	O	O
is	O	O	O
an	O	O	O
iatrogenic	O	O	B-T080
condition	O	O	B-T080
that	O	O	O
affects	O	O	B-T077
1	O	O	O
%	O	O	O
of	O	O	O
women	O	O	B-T098
that	O	O	O
undergo	O	O	O
treatment	O	O	B-T061
with	O	O	O
assisted	O	O	B-T061
reproductive	O	O	I-T061
technology	O	O	I-T061
.	O	O	O

The	O	O	O
review	O	O	B-T170
aims	O	O	B-T078
to	O	O	O
summarize	O	O	B-T170
recent	O	O	B-T079
evidence	O	O	B-T078
on	O	O	O
pathophysiology	O	O	B-T169
,	O	O	O
treatment	O	O	B-T061
,	O	O	O
and	O	O	O
prevention	O	O	B-T061
of	O	O	O
OHSS	O	O	B-T047
.	O	O	O

The	O	O	O
pathophysiology	O	O	B-T169
is	O	O	O
still	O	O	O
not	O	O	O
completely	O	O	B-T080
understood	O	O	B-T041
;	O	O	O
however	O	O	O
,	O	O	O
vascular	O	O	B-T116
endothelial	O	O	I-T116
growth	O	O	I-T116
factor	O	O	I-T116
is	O	O	O
likely	O	O	O
to	O	O	O
be	O	O	O
an	O	O	O
important	O	O	B-T080
mediator	O	O	O
.	O	O	O

Human	O	O	B-T116
chorionic	O	O	I-T116
gonadotropin	O	O	I-T116
was	O	O	O
previously	O	O	O
thought	O	O	B-T041
to	O	O	O
be	O	O	O
necessary	O	O	O
for	O	O	O
OHSS	O	O	B-T047
to	O	O	O
occur	O	O	B-T052
;	O	O	O
however	O	O	O
,	O	O	O
recent	O	O	B-T170
case	O	O	I-T170
reports	O	O	I-T170
have	O	O	O
proven	O	O	B-T080
otherwise	O	O	O
.	O	O	O

The	O	O	O
contribution	O	O	B-T052
of	O	O	O
an	O	O	O
attenuated	O	O	B-T052
anti-Mullerian	O	O	B-T116
hormone	O	O	I-T116
signalling	O	O	B-T043
pathway	O	O	I-T043
and	O	O	O
CD11c	O	O	B-T116
+	O	O	O
HLA-DR	O	O	B-T116
+	O	O	O
dendritic	O	O	B-T025
cells	O	O	I-T025
and	O	O	O
associated	O	O	B-T080
interleukins	O	O	B-T116
has	O	O	O
been	O	O	O
explored	O	O	O
recently	O	O	B-T079
as	O	O	O
contributors	O	O	B-T052
to	O	O	O
pathogenesis	O	O	B-T046
.	O	O	O

Treatment	O	O	B-T061
is	O	O	O
largely	O	O	O
supportive	O	O	B-T061
and	O	O	O
is	O	O	O
based	O	O	B-T078
mainly	O	O	O
on	O	O	O
consensus	O	O	B-T054
statements	O	O	B-T078
rather	O	O	O
than	O	O	O
evidence	O	O	B-T078
.	O	O	O

Therefore	O	O	O
,	O	O	O
it	O	O	O
is	O	O	O
important	O	O	B-T080
to	O	O	O
prevent	O	O	B-T169
this	O	O	O
condition	O	O	B-T080
by	O	O	O
identifying	O	O	B-T058
women	O	O	B-T098
at	O	O	B-T080
risk	O	O	I-T080
,	O	O	O
allowing	O	O	B-T054
the	O	O	O
clinician	O	O	B-T097
to	O	O	O
implement	O	O	B-T052
preventive	O	O	B-T170
strategies	O	O	I-T170
,	O	O	O
including	O	O	B-T169
the	O	O	O
use	O	O	O
of	O	O	O
GnRH	O	O	B-T125
antagonist	O	O	I-T125
cycles	O	O	B-T079
with	O	O	O
agonist	O	O	B-T121
triggers	O	O	O
.	O	O	O

More	O	O	O
research	O	O	B-T062
is	O	O	O
required	O	O	B-T169
to	O	O	O
elucidate	O	O	O
the	O	O	O
pathophysiology	O	O	B-T169
behind	O	O	O
the	O	O	O
condition	O	O	B-T080
.	O	O	O

Clinicians	O	O	B-T097
should	O	O	O
employ	O	O	B-T169
strategies	O	O	B-T041
to	O	O	O
prevent	O	O	B-T061
OHSS	O	O	B-T047
.	O	O	O

-DOCSTART- (27274524)

Eosinophilic	O	O	B-T047
Gastroenteritis	O	O	I-T047
as	O	O	O
a	O	O	O
Rare	O	O	B-T080
Cause	O	O	B-T169
of	O	O	O
Recurrent	O	O	O
Epigastric	O	O	O
Pain	O	O	O

Eosinophilic	O	O	B-T047
gastroenteritis	O	O	I-T047
(	O	O	O
EGE	O	O	B-T047
)	O	O	O
is	O	O	O
a	O	O	O
rare	O	O	O
inflammatory	O	O	B-T047
disorder	O	O	I-T047
of	O	O	O
gastrointestinal	O	O	B-T022
tract	O	O	I-T022
characterized	O	O	B-T052
by	O	O	O
eosinophilic	O	O	B-T046
infiltration	O	O	I-T046
of	O	O	O
the	O	O	O
bowel	O	O	B-T023
wall	O	O	I-T023
.	O	O	O

It	O	O	O
can	O	O	O
mimic	O	O	O
many	O	O	O
gastrointestinal	O	O	B-T047
disorders	O	O	I-T047
due	O	O	O
to	O	O	O
its	O	O	O
wide	O	O	B-T033
spectrum	O	O	I-T033
of	O	O	I-T033
presentations	O	O	I-T033
.	O	O	O

Diagnose	O	O	B-T033
is	O	O	O
mostly	O	O	O
based	O	O	O
on	O	O	O
excluding	O	O	B-T169
other	O	O	B-T080
disorders	O	O	B-T047
and	O	O	O
a	O	O	O
high	O	O	B-T080
suspicion	O	O	B-T041
.	O	O	O

Here	O	O	O
we	O	O	O
report	O	O	B-T170
a	O	O	I-T170
case	O	O	I-T170
of	O	O	O
26	O	O	O
year	O	O	B-T079
old	O	O	B-T079
man	O	O	B-T098
with	O	O	O
a	O	O	O
history	O	O	B-T033
of	O	O	O
sever	O	O	B-T184
epigastric	O	O	I-T184
pain	O	O	I-T184
followed	O	O	O
by	O	O	O
nausea	O	O	B-T184
,	O	O	O
vomiting	O	O	B-T184
since	O	O	O
a	O	O	O
few	O	O	B-T081
days	O	O	B-T079
before	O	O	B-T079
admission	O	O	B-T058
with	O	O	O
final	O	O	O
diagnosis	O	O	B-T033
of	O	O	O
EGE	O	O	B-T047
.	O	O	O

-DOCSTART- (27274893)

Comparison	O	O	O
of	O	O	O
sonoelastography	O	O	B-T060
with	O	O	O
sonourethrography	O	O	B-T060
and	O	O	O
retrograde	O	O	B-T060
urethrography	O	O	I-T060
in	O	O	O
the	O	O	O
evaluation	O	O	B-T058
of	O	O	O
male	O	O	B-T032
anterior	O	O	O
urethral	O	O	O
strictures	O	O	O

Retrograde	O	O	B-T060
urethrography	O	O	I-T060
(	O	O	O
RUG	O	O	B-T060
)	O	O	O
is	O	O	O
the	O	O	O
most	O	O	O
common	O	O	O
and	O	O	O
preferred	O	O	O
imaging	O	O	B-T060
modality	O	O	I-T169
for	O	O	O
imaging	O	O	O
of	O	O	O
the	O	O	O
anterior	O	O	B-T190
urethral	O	O	I-T190
strictures	O	O	I-T190
despite	O	O	O
its	O	O	O
well-known	O	O	O
limitations	O	O	B-T169
and	O	O	O
disadvantages	O	O	O
.	O	O	O

Sonourethrography	O	O	B-T060
(	O	O	O
SUG	O	O	B-T060
)	O	O	O
was	O	O	O
introduced	O	O	O
in	O	O	O
1988	O	O	O
to	O	O	O
overcome	O	O	B-T052
the	O	O	O
limitations	O	O	B-T169
of	O	O	O
RUG	O	O	B-T060
and	O	O	O
to	O	O	O
provide	O	O	O
more	O	O	O
accurate	O	O	B-T080
results	O	O	I-T080
.	O	O	O

As	O	O	O
proper	O	O	O
selection	O	O	O
of	O	O	O
imaging	O	O	B-T169
modality	O	O	I-T169
is	O	O	O
very	O	O	O
important	O	O	O
for	O	O	O
planning	O	O	B-T170
the	O	O	I-T170
treatment	O	O	I-T170
,	O	O	O
various	O	O	O
advances	O	O	O
in	O	O	O
this	O	O	O
area	O	O	O
are	O	O	O
required	O	O	O
.	O	O	O

One	O	O	O
of	O	O	O
the	O	O	O
major	O	O	O
factors	O	O	O
for	O	O	O
recurrence	O	O	B-T067
of	O	O	O
stricture	O	O	B-T047
disease	O	O	I-T047
is	O	O	O
spongiofibrosis	O	O	B-T046
.	O	O	O

Sonoelastography	O	O	B-T060
(	O	O	O
SE	O	O	B-T060
)	O	O	O
is	O	O	O
a	O	O	O
newer	O	O	B-T062
technique	O	O	I-T062
,	O	O	O
tried	O	O	O
in	O	O	O
various	O	O	O
other	O	O	O
pathologies	O	O	B-T091
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	O
,	O	O	O
we	O	O	O
have	O	O	O
used	O	O	O
this	O	O	O
technique	O	O	O
for	O	O	O
the	O	O	O
first	O	O	O
time	O	O	O
to	O	O	O
assess	O	O	O
its	O	O	O
efficacy	O	O	B-T080
in	O	O	O
the	O	O	O
evaluation	O	O	O
of	O	O	O
anterior	O	O	B-T190
urethral	O	O	I-T190
stricture	O	O	I-T190
disease	O	O	I-T190
by	O	O	O
comparison	O	O	O
with	O	O	O
RUG	O	O	B-T060
and	O	O	O
SUG	O	O	B-T060
.	O	O	O

Between	O	O	O
August	O	O	O
2014	O	O	O
and	O	O	O
May	O	O	O
2015	O	O	O
,	O	O	O
77	O	O	O
patients	O	O	B-T101
with	O	O	O
clinical	O	O	O
features	O	O	O
of	O	O	O
anterior	O	O	B-T190
urethral	O	O	I-T190
stricture	O	O	B-T047
disease	O	O	I-T190
were	O	O	O
included	O	O	O
in	O	O	O
the	O	O	O
study	O	O	O
and	O	O	O
evaluated	O	O	O
by	O	O	O
RUG	O	O	B-T060
followed	O	O	O
by	O	O	O
SUG	O	O	B-T060
and	O	O	O
SE	O	O	B-T060
for	O	O	O
stricture	O	O	O
location	O	O	B-T082
,	O	O	O
length	O	O	B-T081
,	O	O	O
depth	O	O	B-T201
of	O	O	O
spongiofibrosis	O	O	B-T046
and	O	O	O
periurethral	O	O	B-T029
pathologies	O	O	B-T091
.	O	O	O

The	O	O	O
results	O	O	O
were	O	O	O
then	O	O	O
correlated	O	O	O
with	O	O	O
operative	O	O	O
and	O	O	O
histopathological	O	O	B-T169
findings	O	O	I-T169
.	O	O	O

Overall	O	O	O
diagnostic	O	O	B-T080
accuracy	O	O	I-T080
of	O	O	O
SE	O	O	B-T060
,	O	O	O
SUG	O	O	B-T060
,	O	O	O
and	O	O	O
RGU	O	O	B-T060
for	O	O	O
the	O	O	O
estimation	O	O	O
of	O	O	O
stricture	O	O	B-T047
location	O	O	B-T082
,	O	O	O
and	O	O	O
length	O	O	B-T081
were	O	O	O
estimated	O	O	O
92.68	O	O	O
%	O	O	O
vs.	O	O	O
91.54	O	O	O
%	O	O	O
,	O	O	O
79	O	O	O
%	O	O	O
vs.	O	O	O
78.87	O	O	O
%	O	O	O
and	O	O	O
80.48	O	O	O
%	O	O	O
vs.	O	O	O
43.66	O	O	O
%	O	O	O
,	O	O	O
respectively	O	O	O
,	O	O	O
while	O	O	O
for	O	O	O
depth	O	O	B-T201
of	O	O	O
spongiofibrosis	O	O	B-T046
SE	O	O	O
,	O	O	O
and	O	O	O
SUG	O	O	O
had	O	O	O
accuracy	O	O	B-T080
rates	O	O	I-T080
of	O	O	O
87.3	O	O	O
%	O	O	O
,	O	O	O
48	O	O	O
%	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

The	O	O	O
mean	O	O	O
length	O	O	B-T081
measured	O	O	O
on	O	O	O
SE	O	O	B-T060
was	O	O	O
nearest	O	O	O
to	O	O	O
the	O	O	O
mean	O	O	O
intra-operative	O	O	B-T079
stricture	O	O	B-T047
length	O	O	O
(	O	O	O
21.34	O	O	O
+	O	O	O
11.8	O	O	O
mm	O	O	O
)	O	O	O
.	O	O	O

SE	O	O	B-T060
findings	O	O	O
significantly	O	O	O
correlated	O	O	O
with	O	O	O
the	O	O	O
colour	O	O	B-T033
of	O	O	I-T033
bladder	O	O	I-T033
mucosa	O	O	I-T033
on	O	O	O
cystoscopic	O	O	B-T060
examination	O	O	I-T060
(	O	O	O
p=0.003	O	O	O
)	O	O	O
whereas	O	O	O
the	O	O	O
association	O	O	O
was	O	O	O
non-significant	O	O	O
(	O	O	O
p=0.127	O	O	O
)	O	O	O
for	O	O	O
difficulty	O	O	O
in	O	O	O
incision	O	O	B-T061
.	O	O	O

While	O	O	O
a	O	O	O
nonsignificant	O	O	O
correlation	O	O	O
existed	O	O	O
between	O	O	O
SUG	O	O	B-T060
findings	O	O	O
related	O	O	O
both	O	O	O
to	O	O	O
the	O	O	O
colour	O	O	B-T033
of	O	O	I-T033
the	O	O	I-T033
bladder	O	O	I-T033
mucosa	O	O	I-T033
and	O	O	O
difficulty	O	O	O
in	O	O	O
incision	O	O	B-T061
on	O	O	O
cystoscopy	O	O	B-T060
,	O	O	O
SE	O	O	B-T060
findings	O	O	O
had	O	O	O
a	O	O	O
significant	O	O	O
association	O	O	O
(	O	O	O
p<0.001	O	O	O
)	O	O	O
with	O	O	O
histopathology	O	O	B-T169
findings	O	O	I-T169
for	O	O	O
severe	O	O	O
degree	O	O	B-T060
of	O	O	I-T060
fibrosis	O	O	I-T060
.	O	O	O

Sonoelastography	O	O	B-T060
estimates	O	O	O
stricture	O	O	B-T082
site	O	O	I-T082
and	O	O	I-T082
length	O	O	I-T082
better	O	O	O
in	O	O	O
comparison	O	O	O
with	O	O	O
RUG	O	O	B-T060
and	O	O	O
SUG	O	O	B-T060
.	O	O	O

It	O	O	O
estimates	O	O	O
degree	O	O	O
of	O	O	O
spongiofibrosis	O	O	B-T046
which	O	O	O
serves	O	O	O
as	O	O	O
an	O	O	O
important	O	O	O
prognostic	O	O	B-T201
factor	O	O	I-T201
for	O	O	O
stricture	O	O	B-T067
recurrence	O	O	I-T067
more	O	O	O
accurately	O	O	B-T080
than	O	O	O
SUG	O	O	B-T060
.	O	O	O

-DOCSTART- (27280034)

Changes	O	O	B-T169
in	O	O	O
risk	O	O	B-T033
factors	O	O	I-T033
for	O	O	O
young	O	O	B-T079
male	O	O	B-T032
suicide	O	O	B-T033
in	O	O	O
Newcastle	O	O	B-T083
upon	O	O	I-T083
Tyne	O	O	I-T083
,	O	O	O
1961	O	O	O
-	O	O	O
2009	O	O	O

Aims	O	O	B-T078
and	O	O	O
method	O	O	B-T170
To	O	O	O
ascertain	O	O	O
differences	O	O	B-T080
in	O	O	O
patterns	O	O	B-T033
of	O	O	I-T033
suicide	O	O	B-T033
in	O	O	O
young	O	O	B-T079
men	O	O	B-T098
over	O	O	O
three	O	O	O
decades	O	O	B-T081
(	O	O	O
1960s	O	O	O
,	O	O	O
1990s	O	O	O
and	O	O	O
2000s	O	O	O
)	O	O	O
and	O	O	O
discuss	O	O	O
implications	O	O	B-T080
for	O	O	O
suicide	O	O	O
prevention	O	O	B-T080
.	O	O	O

Data	O	O	B-T078
on	O	O	O
suicides	O	O	B-T033
and	O	O	O
open	O	O	B-T064
verdicts	O	O	I-T064
in	O	O	O
men	O	O	B-T098
aged	O	O	O
15	O	O	O
-	O	O	O
34	O	O	O
were	O	O	O
obtained	O	O	O
from	O	O	O
coroner	O	O	B-T170
's	O	O	I-T170
records	O	O	I-T170
in	O	O	O
Newcastle	O	O	B-T083
upon	O	O	I-T083
Tyne	O	O	I-T083
and	O	O	O
analysed	O	O	B-T062
using	O	O	O
SPSS	O	O	B-T073
software	O	O	I-T073
.	O	O	O

Results	O	O	B-T169
An	O	O	O
increase	O	O	B-T169
in	O	O	O
suicide	O	O	B-T033
rates	O	O	I-T033
from	O	O	O
the	O	O	O
first	O	O	O
to	O	O	O
the	O	O	O
second	O	O	O
decade	O	O	B-T081
was	O	O	O
followed	O	O	O
by	O	O	O
a	O	O	O
fall	O	O	O
in	O	O	O
the	O	O	O
third	O	O	O
decade	O	O	O
.	O	O	O

This	O	O	O
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
an	O	O	O
increasing	O	O	B-T169
proportion	O	O	B-T081
of	O	O	O
single	O	O	B-T081
men	O	O	B-T098
,	O	O	O
those	O	O	O
living	O	O	B-T033
alone	O	O	I-T033
,	O	O	O
unemployment	O	O	B-T033
,	O	O	O
consumption	O	O	B-T055
of	O	O	I-T055
alcohol	O	O	I-T055
,	O	O	O
use	O	O	O
of	O	O	O
hanging	O	O	B-T037
,	O	O	O
previous	O	O	B-T079
suicide	O	O	B-T033
attempt	O	O	I-T033
and	O	O	O
history	O	O	B-UnknownType
of	O	O	I-UnknownType
treatment	O	O	I-UnknownType
for	O	O	O
mental	O	O	B-T048
illness	O	O	I-T048
.	O	O	O

Clinical	O	O	B-T080
implications	O	O	B-T080
This	O	O	O
study	O	O	B-T062
highlights	O	O	O
the	O	O	O
need	O	O	O
for	O	O	O
more	O	O	O
interventions	O	O	B-T061
and	O	O	O
focus	O	O	B-T041
to	O	O	O
be	O	O	O
given	O	O	O
to	O	O	O
young	O	O	B-T079
males	O	O	B-T032
in	O	O	O
the	O	O	O
suicide	O	O	B-T033
prevention	O	O	B-T080
area	O	O	I-T080
and	O	O	O
is	O	O	O
of	O	O	O
high	O	O	O
importance	O	O	O
in	O	O	O
the	O	O	O
field	O	O	B-T170
of	O	O	I-T170
public	O	O	I-T170
health	O	O	I-T170
.	O	O	O

Areas	O	O	O
that	O	O	O
could	O	O	O
be	O	O	O
tackled	O	O	O
include	O	O	O
reducing	O	O	B-T080
access	O	O	B-T082
to	O	O	O
means	O	O	B-T077
of	O	O	O
suicide	O	O	B-T033
,	O	O	O
reducing	O	O	O
alcohol	O	O	B-T055
use	O	O	I-T055
,	O	O	O
support	O	O	B-T077
for	O	O	O
relationship	O	O	B-T080
difficulties	O	O	B-T080
,	O	O	O
engagement	O	O	B-T058
with	O	O	O
mental	O	O	B-T058
health	O	O	I-T058
services	O	O	I-T058
and	O	O	O
management	O	O	B-T058
of	O	O	O
chronic	O	O	B-T047
illness	O	O	I-T047
.	O	O	O

-DOCSTART- (27280525)

Social	O	O	B-T054
cognition	O	O	I-T054
in	O	O	O
schizophrenia	O	O	B-T048
:	O	O	O
Factor	O	O	B-T081
structure	O	O	I-T081
of	O	O	O
emotion	O	O	B-T041
processing	O	O	B-T041
and	O	O	O
theory	O	O	O
of	O	O	O
mind	O	O	O

Factor	O	O	B-T081
analytic	O	O	I-T081
studies	O	O	I-T081
examining	O	O	O
social	O	O	B-T054
cognition	O	O	I-T054
in	O	O	O
schizophrenia	O	O	B-T048
have	O	O	O
yielded	O	O	O
inconsistent	O	O	O
results	O	O	B-T169
most	O	O	O
likely	O	O	O
due	O	O	O
to	O	O	O
the	O	O	O
varying	O	O	O
number	O	O	O
and	O	O	O
quality	O	O	B-T170
of	O	O	I-T170
measures	O	O	I-T170
.	O	O	O

With	O	O	O
the	O	O	O
recent	O	O	O
conclusion	O	O	O
of	O	O	O
Phase	O	O	B-T079
3	O	O	I-T079
of	O	O	O
the	O	O	O
Social	O	O	B-T054
Cognition	O	O	I-T054
Psychometric	O	O	B-T060
Evaluation	O	O	I-T060
(	O	O	I-T060
SCOPE	O	O	I-T060
)	O	O	I-T060
Study	O	O	I-T060
,	O	O	O
the	O	O	O
most	O	O	O
psychometrically	O	O	B-T060
sound	O	O	B-T060
measures	O	O	I-T060
of	O	O	O
social	O	O	B-T054
cognition	O	O	I-T054
have	O	O	O
been	O	O	O
identified	O	O	O
.	O	O	O

Therefore	O	O	O
,	O	O	O
the	O	O	O
aims	O	O	O
of	O	O	O
the	O	O	O
present	O	O	O
study	O	O	B-T062
were	O	O	O
to	O	O	O
:	O	O	O
1	O	O	O
)	O	O	O
examine	O	O	B-T033
the	O	O	O
factor	O	O	B-T081
structure	O	O	I-T081
of	O	O	O
social	O	O	B-T054
cognition	O	O	I-T054
in	O	O	O
schizophrenia	O	O	B-T048
through	O	O	O
the	O	O	O
utilization	O	O	O
of	O	O	O
psychometrically	O	O	B-T060
sound	O	O	B-T060
measures	O	O	I-T060
,	O	O	O
2	O	O	O
)	O	O	O
examine	O	O	O
the	O	O	O
stability	O	O	B-T080
of	O	O	O
the	O	O	O
factor	O	O	O
structure	O	O	O
across	O	O	O
two	O	O	O
study	O	O	O
visits	O	O	O
,	O	O	O
3	O	O	O
)	O	O	O
compare	O	O	O
the	O	O	O
factor	O	O	O
structure	O	O	O
of	O	O	O
social	O	O	O
cognition	O	O	O
in	O	O	O
schizophrenia	O	O	O
to	O	O	O
that	O	O	O
in	O	O	O
healthy	O	O	B-T080
controls	O	O	I-T080
,	O	O	O
and	O	O	O
4	O	O	O
)	O	O	O
examine	O	O	O
the	O	O	O
relationship	O	O	O
between	O	O	O
the	O	O	O
factors	O	O	B-T081
and	O	O	O
relevant	O	O	O
outcome	O	O	B-T081
measures	O	O	I-T081
including	O	O	O
social	O	O	B-T054
functioning	O	O	I-T054
and	O	O	O
symptoms	O	O	B-T184
.	O	O	O

Results	O	O	B-T169
supported	O	O	O
a	O	O	O
one-factor	O	O	B-T170
model	O	O	I-T170
for	O	O	O
the	O	O	O
patient	O	O	B-T101
and	O	O	O
healthy	O	O	B-T080
control	O	O	I-T080
samples	O	O	O
at	O	O	O
both	O	O	O
visits	O	O	B-T058
.	O	O	O

This	O	O	O
single	O	O	O
factor	O	O	O
was	O	O	O
significantly	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
negative	O	O	B-T184
symptoms	O	O	I-T184
in	O	O	O
the	O	O	O
schizophrenia	O	O	B-T048
sample	O	O	B-T167
and	O	O	O
with	O	O	O
social	O	O	B-T054
functioning	O	O	I-T054
in	O	O	O
both	O	O	O
groups	O	O	B-T098
at	O	O	O
both	O	O	O
study	O	O	B-T062
visits	O	O	B-T058
.	O	O	O

-DOCSTART- (27282845)

Assessment	O	O	B-T058
of	O	O	O
Residual	O	O	B-T191
Disease	O	O	I-T191
With	O	O	O
Molecular	O	O	B-T080
Breast	O	O	I-T060
Imaging	O	O	I-T060
in	O	O	O
Patients	O	O	B-T101
Undergoing	O	O	O
Neoadjuvant	O	O	B-T061
Therapy	O	O	I-T061
:	O	O	O
Association	O	O	O
With	O	O	O
Molecular	O	O	O
Subtypes	O	O	O

Assessment	O	O	B-T058
of	O	O	O
residual	O	O	B-T191
disease	O	O	I-T191
after	O	O	O
neoadjuvant	O	O	B-T061
therapy	O	O	I-T061
for	O	O	O
breast	O	O	B-T023
cancer	O	O	I-T191
is	O	O	O
an	O	O	O
ongoing	O	O	O
challenge	O	O	O
of	O	O	O
breast	O	O	O
imaging	O	O	B-T060
.	O	O	O

This	O	O	O
study	O	O	B-T062
evaluates	O	O	B-T058
the	O	O	O
accuracy	O	O	B-T080
of	O	O	O
a	O	O	O
novel	O	O	O
dedicated	O	O	O
system	O	O	O
for	O	O	O
molecular	O	O	B-T060
breast	O	O	I-T060
imaging	O	O	I-T060
(	O	O	O
MBI	O	O	B-T060
)	O	O	O
composed	O	O	O
of	O	O	O
the	O	O	O
new	O	O	O
generation	O	O	O
of	O	O	O
cadmium	O	O	B-T197
zinc	O	O	I-T197
telluride	O	O	I-T197
detectors	O	O	B-T073
in	O	O	O
assessing	O	O	O
residual	O	O	B-T191
disease	O	O	I-T191
after	O	O	O
neoadjuvant	O	O	B-T061
therapy	O	O	I-T061
in	O	O	O
patients	O	O	B-T101
with	O	O	O
breast	O	O	B-T191
cancer	O	O	I-T191
.	O	O	O

Clinical	O	O	B-T170
data	O	O	I-T170
,	O	O	O
imaging	O	O	B-T060
,	O	O	O
surgical	O	O	B-T169
,	O	O	O
and	O	O	O
pathological	O	O	B-T169
findings	O	O	B-T033
of	O	O	O
51	O	O	O
women	O	O	B-T098
with	O	O	O
breast	O	O	B-T191
cancer	O	O	I-T191
undergoing	O	O	O
neoadjuvant	O	O	B-T061
therapy	O	O	I-T061
were	O	O	O
recorded	O	O	O
.	O	O	O

MBI	O	O	B-T060
findings	O	O	B-T033
were	O	O	O
correlated	O	O	B-T080
with	O	O	O
surgical	O	O	B-T170
pathology	O	O	I-T170
results	O	O	I-T170
.	O	O	O

Accuracy	O	O	B-T080
of	O	O	O
MBI	O	O	B-T060
in	O	O	O
predicting	O	O	O
complete	O	O	B-T033
pathological	O	O	I-T033
response	O	O	I-T033
and	O	O	O
size	O	O	B-T082
of	O	O	O
residual	O	O	B-T191
disease	O	O	I-T191
was	O	O	O
assessed	O	O	O
according	O	O	O
to	O	O	O
molecular	O	O	B-T080
subtypes	O	O	B-T185
.	O	O	O

The	O	O	O
size	O	O	B-T082
of	O	O	O
the	O	O	O
largest	O	O	O
focus	O	O	O
of	O	O	O
uptake	O	O	O
on	O	O	O
MBI	O	O	B-T060
correlated	O	O	B-T080
with	O	O	O
the	O	O	O
largest	O	O	O
dimension	O	O	O
measured	O	O	O
on	O	O	O
pathology	O	O	B-T169
(	O	O	O
r	O	O	O
=	O	O	O
0.55	O	O	O
;	O	O	O
P	O	O	O
<	O	O	O
.001	O	O	O
)	O	O	O
.	O	O	O

This	O	O	O
correlation	O	O	B-T080
was	O	O	O
stronger	O	O	O
for	O	O	O
triple	O	O	B-T191
negative	O	O	I-T191
and	O	O	O
HER2/neu	O	O	B-T201
positive	O	O	I-T201
subtypes	O	O	B-T185
(	O	O	O
r	O	O	O
=	O	O	O
0.92	O	O	O
and	O	O	O
0.62	O	O	O
,	O	O	O
respectively	O	O	O
)	O	O	O
.	O	O	O

Sixteen	O	O	O
patients	O	O	B-T101
(	O	O	O
31	O	O	O
%	O	O	O
)	O	O	O
had	O	O	O
complete	O	O	B-T033
pathological	O	O	I-T033
response	O	O	I-T033
.	O	O	O

The	O	O	O
sensitivity	O	O	B-T081
and	O	O	O
specificity	O	O	B-T081
of	O	O	O
MBI	O	O	B-T060
for	O	O	O
detecting	O	O	O
residual	O	O	B-T191
disease	O	O	I-T191
were	O	O	O
83	O	O	O
%	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
confidence	O	O	B-T081
interval	O	O	I-T081
[	O	O	O
CI	O	O	B-T081
]	O	O	O
,	O	O	O
66	O	O	O
-	O	O	O
93	O	O	O
)	O	O	O
and	O	O	O
69	O	O	O
%	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
,	O	O	O
42	O	O	O
-	O	O	O
88	O	O	O
)	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

For	O	O	O
triple	O	O	B-T191
negative	O	O	I-T191
or	O	O	O
HER2/neu	O	O	B-T201
positive	O	O	I-T201
disease	O	O	O
the	O	O	O
sensitivity	O	O	B-T081
and	O	O	O
specificity	O	O	B-T081
were	O	O	O
88	O	O	O
%	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
,	O	O	O
62	O	O	O
-	O	O	O
98	O	O	O
)	O	O	O
and	O	O	O
75	O	O	O
%	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
,	O	O	O
43	O	O	O
-	O	O	O
93	O	O	O
)	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

The	O	O	O
accuracy	O	O	B-T080
of	O	O	O
MBI	O	O	B-T060
in	O	O	O
assessing	O	O	O
residual	O	O	B-T191
disease	O	O	I-T191
after	O	O	O
neoadjuvant	O	O	B-T061
treatment	O	O	I-T061
might	O	O	O
be	O	O	O
related	O	O	O
to	O	O	O
the	O	O	O
molecular	O	O	B-T080
subtype	O	O	B-T185
.	O	O	O

Accuracy	O	O	B-T080
is	O	O	O
highest	O	O	O
in	O	O	O
the	O	O	O
triple	O	O	B-T191
negative	O	O	I-T191
and	O	O	O
HER2/neu	O	O	B-T201
positive	O	O	I-T201
subtypes	O	O	B-T185
.	O	O	O

-DOCSTART- (27286118)

The	O	O	O
relationship	O	O	B-T080
between	O	O	O
histological	O	O	B-T169
prostatitis	O	O	B-T047
and	O	O	O
lower	O	O	B-T184
urinary	O	O	I-T184
tract	O	O	I-T184
symptoms	O	O	I-T184
and	O	O	O
sexual	O	O	O
function	O	O	O

This	O	O	O
prospective	O	O	B-T062
analysis	O	O	I-T062
assessed	O	O	B-T052
the	O	O	O
effect	O	O	B-T080
of	O	O	O
histological	O	O	B-T169
prostatitis	O	O	B-T047
on	O	O	O
lower	O	O	B-T022
urinary	O	O	I-T022
tract	O	O	I-T022
functions	O	O	B-T169
and	O	O	O
sexual	O	O	B-T040
function	O	O	I-T040
.	O	O	O

The	O	O	O
patients	O	O	B-T101
were	O	O	O
separated	O	O	B-T080
into	O	O	O
two	O	O	O
groups	O	O	B-T078
as	O	O	O
histologically	O	O	B-T169
observed	O	O	B-T169
prostatitis	O	O	B-T047
(	O	O	O
Group	O	O	B-T078
A	O	O	I-T078
)	O	O	O
and	O	O	O
no	O	O	B-T033
prostatitis	O	O	I-T033
(	O	O	O
Group	O	O	B-T078
B	O	O	I-T078
)	O	O	O
according	O	O	O
to	O	O	O
the	O	O	O
biopsy	O	O	B-T060
outcomes	O	O	B-T169
.	O	O	O

International	O	O	B-T170
prostate	O	O	I-T170
symptom	O	O	I-T170
score	O	O	I-T170
,	O	O	O
international	O	O	B-T201
index	O	O	I-T201
of	O	O	I-T201
erectile	O	O	I-T201
function-5	O	O	I-T201
scores	O	O	I-T201
,	O	O	O
maximal	O	O	B-T033
and	O	O	O
average	O	O	B-T033
flow	O	O	I-T033
rate	O	O	I-T033
,	O	O	O
and	O	O	O
residual	O	O	B-T033
urine	O	O	I-T033
volumes	O	O	I-T033
were	O	O	O
compared	O	O	B-T052
statistically	O	O	O
between	O	O	O
groups	O	O	B-T078
.	O	O	O

There	O	O	O
was	O	O	O
no	O	O	O
significant	O	O	B-T081
difference	O	O	B-T080
(	O	O	O
P>0.05	O	O	O
)	O	O	O
in	O	O	O
baseline	O	O	B-T081
age	O	O	B-T032
(	O	O	O
t=0.64	O	O	O
)	O	O	O
,	O	O	O
body	O	O	B-T201
mass	O	O	I-T201
index	O	O	I-T201
value	O	O	I-T201
(	O	O	O
t=0.51	O	O	O
)	O	O	O
,	O	O	O
prostate	O	O	B-T081
volume	O	O	I-T081
(	O	O	O
t=0.87	O	O	O
)	O	O	O
,	O	O	O
prostate-specific	O	O	B-T059
antigen	O	O	I-T059
levels	O	O	I-T059
(	O	O	O
t=0.43	O	O	O
)	O	O	O
,	O	O	O
maximal	O	O	B-T033
(	O	O	O
t=0.84	O	O	O
)	O	O	O
and	O	O	O
average	O	O	B-T033
flow	O	O	I-T033
rate	O	O	I-T033
(	O	O	O
t=0.59	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
post-void	O	O	B-T079
residual	O	O	B-T033
urine	O	O	I-T033
volume	O	O	I-T033
(	O	O	O
t=0.71	O	O	O
)	O	O	O
.	O	O	O

Mean	O	O	B-T081
international	O	O	B-T170
prostate	O	O	I-T170
symptom	O	O	I-T170
score	O	O	I-T170
in	O	O	O
patients	O	O	B-T101
with	O	O	O
prostatitis	O	O	B-T047
was	O	O	O
numerically	O	O	B-T081
but	O	O	O
not	O	O	O
significantly	O	O	B-T081
higher	O	O	I-T081
than	O	O	O
that	O	O	O
in	O	O	O
those	O	O	O
without	O	O	B-T080
prostatitis	O	O	O
(	O	O	O
t=0.794	O	O	O
,	O	O	O
P=0.066	O	O	O
)	O	O	O
.	O	O	O

Mean	O	O	B-T081
international	O	O	B-T201
index	O	O	I-T201
of	O	O	I-T201
erectile	O	O	I-T201
function-5	O	O	I-T201
score	O	O	I-T201
in	O	O	O
the	O	O	O
prostatitis	O	O	B-T047
group	O	O	B-T078
was	O	O	O
significantly	O	O	B-T081
lower	O	O	I-T081
than	O	O	O
that	O	O	O
in	O	O	O
those	O	O	O
without	O	O	B-T080
prostatitis	O	O	O
(	O	O	O
t=1.854	O	O	O
,	O	O	O
P=0.013	O	O	O
)	O	O	O
.	O	O	O

Histological	O	O	B-T169
prostatitis	O	O	B-T047
notably	O	O	O
affected	O	O	B-T169
sexual	O	O	B-T040
function	O	O	I-T040
of	O	O	O
patients	O	O	B-T101
and	O	O	O
may	O	O	O
serve	O	O	O
as	O	O	O
a	O	O	O
major	O	O	B-T080
risk	O	O	B-T033
factor	O	O	I-T033
for	O	O	O
sexual	O	O	B-T047
dysfunction	O	O	I-T047
while	O	O	O
having	O	O	O
little	O	O	O
effect	O	O	B-T080
on	O	O	O
lower	O	O	B-T184
urinary	O	O	I-T184
tract	O	O	I-T184
symptoms	O	O	I-T184
.	O	O	O

-DOCSTART- (27286174)

Beyond	O	O	O
"	O	O	O
Median	O	O	B-T081
Waiting	O	O	B-T079
Time	O	O	I-T079
"	O	O	O
:	O	O	O
Development	O	O	B-T169
and	O	O	O
Validation	O	O	B-T062
of	O	O	O
a	O	O	O
Competing	O	O	O
Risk	O	O	B-UnknownType
Model	O	O	I-UnknownType
to	O	O	O
Predict	O	O	B-T078
Outcomes	O	O	B-T169
on	O	O	O
the	O	O	O
Kidney	O	O	B-T023
Transplant	O	O	O
Waiting	O	O	O
List	O	O	O

Median	O	O	B-T081
historical	O	O	B-T079
time	O	O	B-T079
to	O	O	O
kidney	O	O	B-T061
transplant	O	O	I-T061
is	O	O	O
misleading	O	O	O
because	O	O	O
it	O	O	O
does	O	O	O
not	O	O	O
convey	O	O	O
the	O	O	O
competing	O	O	O
risks	O	O	B-T078
of	O	O	O
death	O	O	B-T040
or	O	O	O
removal	O	O	B-T033
from	O	O	I-T033
the	O	O	I-T033
waiting	O	O	I-T033
list	O	O	I-T033
.	O	O	O

We	O	O	O
developed	O	O	O
and	O	O	O
validated	O	O	O
a	O	O	O
competing	O	O	O
risk	O	O	B-UnknownType
model	O	O	I-UnknownType
to	O	O	O
calculate	O	O	B-T052
likelihood	O	O	O
of	O	O	O
outcomes	O	O	B-T080
for	O	O	O
kidney	O	O	B-T061
transplant	O	O	B-T061
candidates	O	O	B-T098
and	O	O	O
demonstrate	O	O	O
how	O	O	O
this	O	O	O
information	O	O	B-T078
differs	O	O	B-T080
from	O	O	O
median	O	O	B-T081
time	O	O	B-T079
to	O	O	O
transplant	O	O	O
.	O	O	O

Data	O	O	B-T078
were	O	O	O
obtained	O	O	B-T169
from	O	O	O
the	O	O	O
US	O	O	B-T170
Scientific	O	O	I-T170
Registry	O	O	I-T170
of	O	O	O
Transplant	O	O	B-T101
Recipients	O	O	I-T101
.	O	O	O

The	O	O	O
retrospective	O	O	B-T062
cohort	O	O	I-T062
included	O	O	O
163	O	O	O
636	O	O	O
adults	O	O	B-T100
listed	O	O	O
for	O	O	O
kidney	O	O	B-T061
transplant	O	O	I-T061
before	O	O	O
December	O	O	O
31	O	O	O
,	O	O	O
2011	O	O	O
.	O	O	O

Predictors	O	O	B-T033
were	O	O	O
age	O	O	B-T032
,	O	O	O
sex	O	O	B-T032
,	O	O	O
blood	O	O	B-T201
type	O	O	I-T201
,	O	O	O
calculated	O	O	B-T059
panel-reactive	O	O	B-T059
antibodies	O	O	I-T059
,	O	O	O
donation	O	O	B-T061
service	O	O	B-T083
area	O	O	I-T083
,	O	O	O
dialysis	O	O	B-T061
duration	O	O	B-T079
,	O	O	O
comorbid	O	O	B-T033
conditions	O	O	I-T033
,	O	O	O
and	O	O	O
body	O	O	B-T201
mass	O	O	I-T201
index	O	O	I-T201
.	O	O	O

Outcomes	O	O	B-T080
were	O	O	O
deceased	O	O	O
or	O	O	O
living	O	O	B-T098
donor	O	O	I-T098
transplant	O	O	B-T061
,	O	O	O
death	O	O	B-T040
or	O	O	O
removal	O	O	B-T033
from	O	O	I-T033
the	O	O	I-T033
list	O	O	I-T033
due	O	O	B-T169
to	O	O	I-T169
deteriorating	O	O	B-T080
medical	O	O	B-T169
condition	O	O	B-T080
,	O	O	O
or	O	O	O
removal	O	O	O
due	O	O	O
to	O	O	O
other	O	O	B-T033
reasons	O	O	I-T033
.	O	O	O

We	O	O	O
calculated	O	O	B-T169
hazards	O	O	B-T080
for	O	O	O
the	O	O	O
possible	O	O	B-T033
outcomes	O	O	B-T080
,	O	O	O
then	O	O	O
the	O	O	O
cumulative	O	O	B-T080
incidence	O	O	B-T081
function	O	O	B-T039
for	O	O	O
a	O	O	O
given	O	O	O
candidate	O	O	B-T098
using	O	O	O
competing	O	O	O
risk	O	O	B-T078
methodology	O	O	B-T078
.	O	O	O

Discrimination	O	O	B-T041
and	O	O	O
calibration	O	O	B-T081
were	O	O	O
assessed	O	O	B-T052
through	O	O	B-T169
C	O	O	B-UnknownType
statistics	O	O	I-UnknownType
and	O	O	O
calibration	O	O	O
plots	O	O	B-T169
for	O	O	O
each	O	O	B-T081
cause	O	O	B-T169
-	O	O	O
specific	O	O	B-T080
Cox	O	O	B-T081
proportional	O	O	I-T081
hazard	O	O	I-T081
model	O	O	I-T081
.	O	O	O

C	O	O	B-UnknownType
statistics	O	O	I-UnknownType
ranged	O	O	O
from	O	O	O
0.64	O	O	O
to	O	O	O
0.73	O	O	O
.	O	O	O

Calibration	O	O	B-T081
plots	O	O	B-T169
showed	O	O	O
good	O	O	B-T080
calibration	O	O	B-T081
.	O	O	O

The	O	O	O
competing	O	O	O
risk	O	O	B-UnknownType
model	O	O	I-UnknownType
shows	O	O	O
probability	O	O	B-T081
of	O	O	O
all	O	O	O
possible	O	O	B-T033
outcomes	O	O	B-T080
for	O	O	O
up	O	O	O
to	O	O	O
12	O	O	B-T079
years	O	O	I-T079
given	O	O	O
a	O	O	O
candidate	O	O	B-T098
's	O	O	I-T098
characteristics	O	O	B-T080
,	O	O	O
contrasted	O	O	O
with	O	O	O
the	O	O	O
median	O	O	B-T081
waiting	O	O	B-T079
time	O	O	I-T079
for	O	O	O
that	O	O	O
candidate	O	O	O
's	O	O	O
donation	O	O	B-T061
service	O	O	B-T083
area	O	O	I-T083
.	O	O	O

A	O	O	O
competing	O	O	O
risk	O	O	B-UnknownType
model	O	O	I-UnknownType
conveys	O	O	O
more	O	O	O
relevant	O	O	B-T080
information	O	O	B-T078
than	O	O	O
the	O	O	O
median	O	O	B-T081
waiting	O	O	B-T079
time	O	O	I-T079
for	O	O	O
a	O	O	O
given	O	O	B-T077
transplant	O	O	B-T093
center	O	O	I-T093
.	O	O	O

This	O	O	O
model	O	O	B-T081
will	O	O	O
be	O	O	O
updated	O	O	B-T079
to	O	O	O
create	O	O	B-T052
a	O	O	O
calculator	O	O	O
reflecting	O	O	O
the	O	O	O
most	O	O	O
recent	O	O	B-T079
outcomes	O	O	B-T080
and	O	O	O
changes	O	O	B-T169
in	O	O	O
allocation	O	O	B-T052
policy	O	O	B-T170
.	O	O	O

It	O	O	O
illustrates	O	O	O
the	O	O	O
conversations	O	O	B-T054
that	O	O	O
should	O	O	O
be	O	O	O
initiated	O	O	B-T169
with	O	O	O
transplant	O	O	B-T061
candidates	O	O	B-T098
.	O	O	O

-DOCSTART- (27288457)

Tead1	O	O	B-T028
regulates	O	O	O
the	O	O	O
expression	O	O	B-T045
of	O	O	O
Peripheral	O	O	B-T028
Myelin	O	O	I-T028
Protein	O	O	I-T028
22	O	O	I-T028
during	O	O	O
Schwann	O	O	O
cell	O	O	O
development	O	O	O

Schwann	O	O	B-T025
cells	O	O	I-T025
are	O	O	O
myelinating	O	O	B-T025
glia	O	O	I-T025
in	O	O	O
the	O	O	O
peripheral	O	O	B-T022
nervous	O	O	I-T022
system	O	O	I-T022
that	O	O	O
form	O	O	O
the	O	O	O
myelin	O	O	B-T026
sheath	O	O	I-T026
.	O	O	O

A	O	O	O
major	O	O	O
cause	O	O	O
of	O	O	O
peripheral	O	O	B-T047
neuropathy	O	O	I-T047
is	O	O	O
a	O	O	O
copy	O	O	B-T086
number	O	O	I-T086
variant	O	O	I-T086
involving	O	O	O
the	O	O	O
Peripheral	O	O	B-T028
Myelin	O	O	I-T028
Protein	O	O	I-T028
22	O	O	I-T028
(	O	O	I-T028
PMP22	O	O	I-T028
)	O	O	I-T028
gene	O	O	I-T028
,	O	O	O
which	O	O	O
is	O	O	O
located	O	O	O
within	O	O	O
a	O	O	O
1.4-Mb	O	O	O
duplication	O	O	B-T045
on	O	O	O
chromosome	O	O	B-T026
17	O	O	I-T026
associated	O	O	O
with	O	O	O
the	O	O	O
most	O	O	O
common	O	O	O
form	O	O	O
of	O	O	O
Charcot-Marie-Tooth	O	O	B-T047
Disease	O	O	I-T047
(	O	O	O
CMT1A	O	O	B-T047
)	O	O	O
.	O	O	O

Rodent	O	O	B-T050
models	O	O	I-T050
of	O	O	O
CMT1A	O	O	B-T047
have	O	O	O
been	O	O	O
used	O	O	O
to	O	O	O
show	O	O	O
that	O	O	O
reducing	O	O	O
Pmp22	O	O	B-T028
overexpression	O	O	B-T045
mitigates	O	O	O
several	O	O	O
aspects	O	O	O
of	O	O	O
a	O	O	O
CMT1A	O	O	O
-related	O	O	O
phenotype	O	O	B-T032
.	O	O	O

Mechanistic	O	O	B-T169
studies	O	O	B-T062
of	O	O	O
Pmp22	O	O	B-T028
regulation	O	O	B-T045
identified	O	O	O
enhancers	O	O	B-T114
regulated	O	O	O
by	O	O	O
the	O	O	O
Sox10	O	O	B-T116
(	O	O	O
SRY	O	O	B-T116
sex	O	O	I-T116
determining	O	O	I-T116
region	O	O	I-T116
Y-box	O	O	I-T116
10	O	O	I-T116
)	O	O	O
and	O	O	O
Egr2	O	O	B-T116
/	O	O	O
Krox20	O	O	B-T116
(	O	O	O
Early	O	O	B-T116
growth	O	O	I-T116
response	O	O	I-T116
protein	O	O	I-T116
2	O	O	I-T116
)	O	O	O
transcription	O	O	B-T116
factors	O	O	I-T116
in	O	O	O
myelinated	O	O	B-T026
nerves	O	O	I-T026
.	O	O	O

However	O	O	O
,	O	O	O
relatively	O	O	O
little	O	O	O
is	O	O	O
known	O	O	O
regarding	O	O	O
how	O	O	O
other	O	O	O
transcription	O	O	B-T116
factors	O	O	I-T116
induce	O	O	B-T169
Pmp22	O	O	B-T028
expression	O	O	B-T045
during	O	O	O
Schwann	O	O	B-T043
cell	O	O	I-T043
development	O	O	I-T043
and	O	O	O
myelination	O	O	B-T043
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
examined	O	O	O
Pmp22	O	O	B-T028
enhancers	O	O	B-T114
as	O	O	O
a	O	O	O
function	O	O	O
of	O	O	O
cell	O	O	B-T044
type-specificity	O	O	I-T044
,	O	O	O
nerve	O	O	B-T037
injury	O	O	I-T037
and	O	O	O
development	O	O	B-T169
.	O	O	O

While	O	O	O
Pmp22	O	O	B-T028
enhancers	O	O	B-T114
marked	O	O	O
by	O	O	O
active	O	O	B-T169
histone	O	O	B-T044
modifications	O	O	I-T044
were	O	O	O
lost	O	O	B-T169
or	O	O	O
remodeled	O	O	O
after	O	O	O
injury	O	O	B-T037
,	O	O	O
we	O	O	O
found	O	O	O
that	O	O	O
these	O	O	O
enhancers	O	O	O
were	O	O	O
permissive	O	O	O
in	O	O	O
early	O	O	O
development	O	O	B-T169
prior	O	O	O
to	O	O	O
Pmp22	O	O	O
upregulation	O	O	B-T044
.	O	O	O

Pmp22	O	O	B-T028
enhancers	O	O	B-T114
contain	O	O	O
binding	O	O	B-T116
motifs	O	O	I-T116
for	O	O	O
TEA	O	O	B-T116
domain	O	O	I-T116
(	O	O	O
Tead	O	O	B-T116
)	O	O	O
transcription	O	O	B-T116
factors	O	O	I-T116
of	O	O	O
the	O	O	O
Hippo	O	O	B-T043
signaling	O	O	I-T043
pathway	O	O	I-T043
.	O	O	O

We	O	O	O
discovered	O	O	O
that	O	O	O
Tead1	O	O	B-T028
and	O	O	O
co-activators	O	O	O
Yap	O	O	B-T028
and	O	O	O
Taz	O	O	B-T028
are	O	O	O
required	O	O	O
for	O	O	O
Pmp22	O	O	B-T028
expression	O	O	B-T045
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
for	O	O	O
the	O	O	O
expression	O	O	O
of	O	O	O
Egr2	O	O	B-T028
Tead1	O	O	O
directly	O	O	O
binds	O	O	O
Pmp22	O	O	O
and	O	O	O
Egr2	O	O	O
enhancers	O	O	B-T114
early	O	O	O
in	O	O	O
development	O	O	B-T169
and	O	O	O
Tead1	O	O	O
binding	O	O	B-T044
is	O	O	O
induced	O	O	B-T169
during	O	O	O
myelination	O	O	B-T043
,	O	O	O
correlating	O	O	O
with	O	O	O
Pmp22	O	O	O
expression	O	O	O
.	O	O	O

The	O	O	O
data	O	O	B-T078
identify	O	O	O
Tead1	O	O	B-T028
as	O	O	O
a	O	O	O
novel	O	O	O
regulator	O	O	B-T028
of	O	O	O
Pmp22	O	O	B-T028
expression	O	O	B-T045
during	O	O	O
development	O	O	B-T169
in	O	O	O
concert	O	O	O
with	O	O	O
Sox10	O	O	B-T028
and	O	O	O
Egr2	O	O	B-T028
.	O	O	O

-DOCSTART- (27291966)

Neutrophil	O	O	B-T116
gelatinase-associated	O	O	I-T116
lipocalin	O	O	I-T116
in	O	O	O
a	O	O	O
triphasic	O	O	B-T079
rat	O	O	B-T008
model	O	O	I-T008
of	O	O	O
adenine	O	O	B-T114
-	O	O	O
induced	O	O	B-T169
kidney	O	O	O
injury	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
this	O	O	O
study	O	O	O
is	O	O	O
to	O	O	O
investigate	O	O	O
whether	O	O	O
NGAL	O	O	B-T116
,	O	O	O
given	O	O	O
its	O	O	O
advantages	O	O	O
over	O	O	O
traditional	O	O	O
biomarkers	O	O	B-T201
,	O	O	O
can	O	O	O
be	O	O	O
used	O	O	O
to	O	O	O
describe	O	O	O
the	O	O	O
dynamic	O	O	O
characteristics	O	O	O
of	O	O	O
the	O	O	O
renal	O	O	B-T047
tubulointerstitial	O	O	I-T047
insult	O	O	I-T047
caused	O	O	O
by	O	O	O
adenine	O	O	B-T114
.	O	O	O

Subsequently	O	O	O
,	O	O	O
it	O	O	O
will	O	O	O
be	O	O	O
possible	O	O	O
to	O	O	O
assess	O	O	O
NGAL	O	O	B-T116
as	O	O	O
a	O	O	O
biomarker	O	O	B-T201
of	O	O	O
any	O	O	O
acute	O	O	B-T037
kidney	O	O	I-T037
injury	O	O	I-T037
,	O	O	O
on	O	O	O
top	O	O	O
of	O	O	O
chronic	O	O	B-T047
interstitial	O	O	I-T047
disease	O	O	I-T047
,	O	O	O
if	O	O	O
NGAL	O	O	O
levels	O	O	B-T080
are	O	O	O
stable	O	O	B-T080
through	O	O	B-T169
the	O	O	O
chronic	O	O	B-T079
phase	O	O	I-T079
of	O	O	O
our	O	O	O
adenine	O	O	B-T008
model	O	O	I-T008
.	O	O	O

Study	O	O	B-T098
group	O	O	I-T098
rats	O	O	B-T015
were	O	O	O
fed	O	O	O
an	O	O	O
adenine	O	O	B-T114
diet	O	O	B-T168
,	O	O	O
and	O	O	O
control	O	O	B-T096
group	O	O	I-T096
rats	O	O	O
were	O	O	O
fed	O	O	O
a	O	O	O
regular	O	O	B-T056
diet	O	O	I-T056
only	O	O	O
.	O	O	O

Blood	O	O	B-T031
and	O	O	O
urine	O	O	B-T031
samples	O	O	I-T031
for	O	O	O
urea	O	O	B-T109
,	O	O	O
creatinine	O	O	B-T109
and	O	O	O
NGAL	O	O	B-T116
were	O	O	O
drawn	O	O	O
from	O	O	O
each	O	O	O
rat	O	O	B-T015
at	O	O	O
the	O	O	O
beginning	O	O	B-T079
of	O	O	O
the	O	O	O
study	O	O	B-T062
and	O	O	O
after	O	O	O
1	O	O	O
,	O	O	O
3	O	O	O
,	O	O	O
4	O	O	O
,	O	O	O
5	O	O	O
,	O	O	O
6	O	O	O
,	O	O	O
7	O	O	O
and	O	O	O
8	O	O	O
weeks	O	O	O
.	O	O	O

Kidney	O	O	B-T023
slices	O	O	B-T167
from	O	O	O
these	O	O	O
rats	O	O	B-T015
were	O	O	O
stained	O	O	B-T059
with	O	O	O
Hematoxylin-eosin	O	O	B-T059
(	O	O	O
HE	O	O	B-T059
)	O	O	O
and	O	O	O
Î²-actin	O	O	B-T116
stainings	O	O	B-T059
.	O	O	O

Serum	O	O	B-T034
urea	O	O	I-T034
,	O	O	O
creatinine	O	O	B-T059
and	O	O	O
NGAL	O	O	B-T116
levels	O	O	B-T080
and	O	O	O
urinary	O	O	B-T201
NGAL/creatinine	O	O	I-T201
ratio	O	O	I-T201
in	O	O	O
the	O	O	O
study	O	O	O
group	O	O	O
were	O	O	O
higher	O	O	O
than	O	O	O
baseline	O	O	B-T081
and	O	O	O
than	O	O	O
in	O	O	O
the	O	O	O
control	O	O	B-T096
group	O	O	I-T096
;	O	O	O
these	O	O	O
differences	O	O	O
were	O	O	O
statistically	O	O	B-T081
significant	O	O	I-T081
in	O	O	O
some	O	O	O
of	O	O	O
the	O	O	O
intervals	O	O	B-T079
.	O	O	O

Tubulointerstitial	O	O	B-T047
changes	O	O	O
and	O	O	O
adenine	O	O	B-T114
crystals	O	O	O
were	O	O	O
evident	O	O	O
in	O	O	O
the	O	O	O
study	O	O	O
group	O	O	O
rats	O	O	B-T015
.	O	O	O

In	O	O	O
the	O	O	O
rats	O	O	B-T015
fed	O	O	O
adenine	O	O	B-T114
,	O	O	O
serum	O	O	B-T034
urea	O	O	I-T034
,	O	O	O
creatinine	O	O	B-T059
and	O	O	O
NGAL	O	O	B-T116
levels	O	O	B-T080
and	O	O	O
urinary	O	O	B-T201
NGAL/creatinine	O	O	I-T201
ratio	O	O	I-T201
followed	O	O	O
a	O	O	O
triphasic	O	O	B-T033
pattern	O	O	I-T033
of	O	O	O
kidney	O	O	B-T037
injury	O	O	I-T037
:	O	O	O
an	O	O	O
acute	O	O	B-T079
phase	O	O	B-T079
while	O	O	O
on	O	O	O
the	O	O	O
adenine	O	O	O
diet	O	O	B-T168
,	O	O	O
a	O	O	O
partial	O	O	B-T081
recovery	O	O	B-T040
phase	O	O	O
after	O	O	O
switching	O	O	O
to	O	O	O
the	O	O	O
regular	O	O	B-T056
diet	O	O	I-T056
and	O	O	O
a	O	O	O
chronic	O	O	B-T047
kidney	O	O	I-T047
disease	O	O	I-T047
phase	O	O	O
after	O	O	O
stabilization	O	O	O
of	O	O	O
renal	O	O	B-T042
function	O	O	I-T042
.	O	O	O

NGAL	O	O	B-T116
can	O	O	O
serve	O	O	O
a	O	O	O
biomarker	O	O	B-T201
for	O	O	O
acute	O	O	B-T037
kidney	O	O	I-T037
injury	O	O	I-T037
and	O	O	O
possibly	O	O	O
for	O	O	O
chronic	O	O	B-T047
kidney	O	O	I-T047
disease	O	O	I-T047
in	O	O	O
the	O	O	O
tubulointerstitial	O	O	B-T047
rat	O	O	B-T008
model	O	O	I-T008
.	O	O	O

-DOCSTART- (27292374)

Talking	O	O	B-T056
or	O	O	O
Keeping	O	O	B-T080
Silent	O	O	I-T080
About	O	O	O
Parental	O	O	B-T099
Mental	O	O	B-T033
Health	O	O	I-T033
Problems	O	O	I-T033
-A	O	O	O
Grounded	O	O	B-T170
Theory	O	O	I-T170
of	O	O	O
Parents	O	O	B-T099
'	O	O	O
Decision	O	O	B-T041
Making	O	O	I-T041
and	O	O	O
Experiences	O	O	B-T041
with	O	O	O
Their	O	O	O
Children	O	O	O

This	O	O	O
grounded	O	O	B-T170
theory	O	O	I-T170
study	O	O	B-T062
explored	O	O	O
parents	O	O	B-T099
'	O	O	O
experiences	O	O	B-T041
of	O	O	O
responding	O	O	O
to	O	O	O
their	O	O	O
children	O	O	B-T100
's	O	O	I-T100
need	O	O	O
for	O	O	O
understanding	O	O	O
parental	O	O	B-T099
mental	O	O	B-T041
health	O	O	I-T041
concerns	O	O	B-T078
.	O	O	O

Fifteen	O	O	O
parents	O	O	B-T099
with	O	O	O
severe	O	O	B-T080
and	O	O	O
enduring	O	O	O
mental	O	O	B-T033
health	O	O	I-T033
difficulties	O	O	I-T033
participated	O	O	O
in	O	O	O
the	O	O	O
study	O	O	B-T062
.	O	O	O

The	O	O	O
findings	O	O	B-T033
suggest	O	O	O
four	O	O	O
main	O	O	O
social	O	O	B-T068
processes	O	O	I-T068
that	O	O	O
influence	O	O	O
parents	O	O	B-T099
'	O	O	O
talk	O	O	B-T056
with	O	O	O
their	O	O	O
children	O	O	B-T100
about	O	O	O
parental	O	O	B-T099
mental	O	O	B-T033
health	O	O	I-T033
issues	O	O	I-T033
,	O	O	O
namely	O	O	O
"	O	O	O
Protecting	O	O	B-T041
and	O	O	O
being	O	O	B-T041
protected	O	O	I-T041
,	O	O	O
"	O	O	O
"	O	O	O
Responding	O	O	B-T032
to	O	O	O
children	O	O	B-T100
's	O	O	I-T100
search	O	O	B-T052
for	O	O	O
understanding	O	O	B-T041
,	O	O	O
"	O	O	O
"	O	O	O
Prioritizing	O	O	B-T079
family	O	O	B-T054
life	O	O	I-T054
,	O	O	O
"	O	O	O
and	O	O	O
"	O	O	O
Relating	O	O	B-T053
to	O	O	I-T053
others	O	O	I-T053
.	O	O	O

"	O	O	O
Implications	O	O	O
of	O	O	O
the	O	O	O
findings	O	O	B-T033
for	O	O	O
clinical	O	O	B-T058
practice	O	O	I-T058
and	O	O	O
future	O	O	O
research	O	O	B-T062
are	O	O	O
considered	O	O	O
.	O	O	O

In	O	O	O
particular	O	O	O
,	O	O	O
the	O	O	O
need	O	O	O
for	O	O	O
more	O	O	O
family-orientated	O	O	B-T058
services	O	O	I-T058
where	O	O	O
parents	O	O	B-T099
experience	O	O	B-T041
parental	O	O	B-T099
mental	O	O	B-T033
health	O	O	I-T033
problems	O	O	I-T033
is	O	O	O
highlighted	O	O	O
.	O	O	O

-DOCSTART- (27297523)

A	O	O	O
case	O	O	B-T077
of	O	O	O
bilateral	O	O	B-T082
pneumothoraces	O	O	B-T047
resulting	O	O	O
from	O	O	O
tracheostomy	O	O	B-T061
for	O	O	O
advanced	O	O	B-UnknownType
laryngeal	O	O	O
cancer	O	O	O

Pneumothorax	O	O	B-T047
is	O	O	O
a	O	O	O
possible	O	O	O
complication	O	O	B-T046
of	O	O	O
tracheostomy	O	O	B-T061
.	O	O	O

We	O	O	O
report	O	O	B-T058
a	O	O	O
rare	O	O	O
case	O	O	O
of	O	O	O
bilateral	O	O	B-T082
pneumothoraces	O	O	B-T047
resulting	O	O	O
from	O	O	O
tracheostomy	O	O	B-T061
in	O	O	O
an	O	O	O
advanced	O	O	B-UnknownType
laryngeal	O	O	B-T191
cancer	O	O	I-T191
patient	O	O	B-T101
.	O	O	O

A	O	O	O
59-year-old	O	O	O
man	O	O	B-T032
was	O	O	O
referred	O	O	O
to	O	O	O
our	O	O	O
clinic	O	O	B-T093
for	O	O	O
evaluation	O	O	B-T058
and	O	O	O
treatment	O	O	B-T061
of	O	O	O
laryngeal	O	O	B-T191
tumor	O	O	I-T191
.	O	O	O

Laryngeal	O	O	B-T060
endoscopy	O	O	I-T060
showed	O	O	O
limited	O	O	B-T033
movement	O	O	I-T033
of	O	O	O
bilateral	O	O	B-T023
vocal	O	O	B-T023
cords	O	O	I-T023
,	O	O	O
and	O	O	O
computed	O	O	B-T060
tomography	O	O	I-T060
revealed	O	O	O
a	O	O	O
tumor	O	O	B-T191
lesion	O	O	B-T033
extending	O	O	O
from	O	O	O
the	O	O	O
vocal	O	O	O
cords	O	O	O
to	O	O	O
the	O	O	O
subglottic	O	O	B-T023
area	O	O	I-T023
.	O	O	O

Three	O	O	O
days	O	O	B-T079
after	O	O	O
the	O	O	O
first	O	O	B-T033
visit	O	O	I-T033
,	O	O	O
the	O	O	O
patient	O	O	B-T101
developed	O	O	O
respiratory	O	O	B-T184
difficulty	O	O	I-T184
,	O	O	O
and	O	O	O
we	O	O	O
elected	O	O	O
to	O	O	O
perform	O	O	O
emergency	O	O	B-T061
tracheostomy	O	O	I-T061
for	O	O	O
airway	O	O	B-T061
management	O	O	I-T061
.	O	O	O

Immediately	O	O	O
after	O	O	O
the	O	O	O
start	O	O	O
of	O	O	O
the	O	O	O
procedure	O	O	B-T061
,	O	O	O
he	O	O	O
began	O	O	O
hyperventilating	O	O	B-T033
,	O	O	O
and	O	O	O
complained	O	O	O
of	O	O	O
respiratory	O	O	B-T033
discomfort	O	O	I-T033
and	O	O	O
chest	O	O	B-T184
pain	O	O	I-T184
.	O	O	O

We	O	O	O
then	O	O	O
recognized	O	O	O
a	O	O	O
mediastinal	O	O	B-T029
air	O	O	B-T047
leak	O	O	I-T047
,	O	O	O
and	O	O	O
we	O	O	O
suspected	O	O	B-T080
pneumothorax	O	O	B-T047
resulting	O	O	O
from	O	O	O
the	O	O	O
tracheostomy	O	O	B-T061
.	O	O	O

Chest	O	O	B-T060
X-ray	O	O	I-T060
showed	O	O	O
bilateral	O	O	B-T082
pneumothoraces	O	O	B-T047
;	O	O	O
therefore	O	O	O
,	O	O	O
we	O	O	O
inserted	O	O	B-T058
bilateral	O	O	O
chest	O	O	B-T029
drainage	O	O	B-T074
tubes	O	O	I-T074
,	O	O	O
which	O	O	O
stabilized	O	O	B-T033
his	O	O	O
respiratory	O	O	B-T033
condition	O	O	I-T033
.	O	O	O

We	O	O	O
speculated	O	O	O
that	O	O	O
the	O	O	O
pathogenesis	O	O	B-T046
of	O	O	O
the	O	O	O
bilateral	O	O	B-T082
pneumothoraces	O	O	B-T047
was	O	O	O
weakened	O	O	B-T080
alveolar	O	O	B-T023
walls	O	O	I-T023
secondary	O	O	O
to	O	O	O
long-term	O	O	B-T079
smoking	O	O	B-T055
,	O	O	O
and	O	O	O
a	O	O	O
significant	O	O	O
rise	O	O	B-T169
in	O	O	O
airway	O	O	B-T201
pressure	O	O	I-T201
because	O	O	O
of	O	O	O
airway	O	O	B-T184
constriction	O	O	I-T184
by	O	O	O
the	O	O	O
neck-extended	O	O	B-T082
position	O	O	I-T082
and	O	O	O
hyperventilation	O	O	B-T033
,	O	O	O
during	O	O	O
tracheostomy	O	O	B-T061
.	O	O	O

-DOCSTART- (27297967)

Arsenic	O	O	B-T116
Triglutathione	O	O	I-T116
[	O	O	O
As(GS)3	O	O	B-T116
]	O	O	O
Transport	O	O	B-T043
by	O	O	O
Multidrug	O	O	B-T116
Resistance	O	O	I-T116
Protein	O	O	I-T116
1	O	O	I-T116
(	O	O	O
MRP1	O	O	B-T116
/	O	O	O
ABCC1	O	O	B-T116
)	O	O	O
Is	O	O	O
Selectively	O	O	O
Modified	O	O	B-T169
by	O	O	O
Phosphorylation	O	O	B-T044
of	O	O	O
Tyr920/Ser921	O	O	B-T087
and	O	O	O
Glycosylation	O	O	B-T044
of	O	O	O
Asn19/Asn23	O	O	O

The	O	O	O
ATP-binding	O	O	B-T116
cassette	O	O	I-T116
(	O	O	I-T116
ABC	O	O	I-T116
)	O	O	I-T116
transporter	O	O	I-T116
multidrug	O	O	B-T116
resistance	O	O	I-T116
protein	O	O	I-T116
1	O	O	I-T116
(	O	O	O
MRP1	O	O	B-T116
/	O	O	O
ABCC1	O	O	B-T116
)	O	O	O
is	O	O	O
responsible	O	O	O
for	O	O	O
the	O	O	O
cellular	O	O	B-T025
export	O	O	B-T067
of	O	O	O
a	O	O	O
chemically	O	O	O
diverse	O	O	B-T080
array	O	O	B-T082
of	O	O	O
xenobiotics	O	O	B-T123
and	O	O	O
endogenous	O	O	B-T169
compounds	O	O	B-T167
.	O	O	O

Arsenic	O	O	B-T121
,	O	O	O
a	O	O	O
human	O	O	B-T016
carcinogen	O	O	B-T131
,	O	O	O
is	O	O	O
a	O	O	O
high-affinity	O	O	B-T080
MRP1	O	O	B-T116
substrate	O	O	B-T167
as	O	O	O
arsenic	O	O	B-T116
triglutathione	O	O	I-T116
[	O	O	O
As(GS)3	O	O	B-T116
]	O	O	O
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	O
,	O	O	O
marked	O	O	O
differences	O	O	O
in	O	O	O
As(GS)3	O	O	B-T116
transport	O	O	B-T043
kinetics	O	O	B-T090
were	O	O	O
observed	O	O	O
between	O	O	O
MRP1	O	O	B-T116
-enriched	O	O	O
membrane	O	O	B-T026
vesicles	O	O	B-T026
prepared	O	O	B-T052
from	O	O	O
human	O	O	B-T016
embryonic	O	O	B-T018
kidney	O	O	B-T023
293	O	O	B-T025
(	O	O	I-T025
HEK	O	O	I-T025
)	O	O	I-T025
(	O	O	O
Km	O	O	B-T081
3.8	O	O	O
ÂµM	O	O	O
and	O	O	O
Vmax	O	O	B-T067
307	O	O	O
pmol/mg	O	O	O
per	O	O	O
minute	O	O	O
)	O	O	O
and	O	O	O
HeLa	O	O	B-T025
(	O	O	O
Km	O	O	O
0.32	O	O	O
ÂµM	O	O	O
and	O	O	O
Vmax	O	O	O
42	O	O	O
pmol/mg	O	O	O
per	O	O	O
minute	O	O	O
)	O	O	O
cells	O	O	B-T025
.	O	O	O

Mutant	O	O	B-T116
MRP1	O	O	B-T116
lacking	O	O	O
N-linked	O	O	O
glycosylation	O	O	B-T044
[	O	O	O
Asn19/23/1006Gln	O	O	B-T087
;	O	O	O
sugar-free	O	O	O
(SF)-MRP1	O	O	B-T116
]	O	O	O
expressed	O	O	B-T045
in	O	O	O
either	O	O	O
HEK293	O	O	B-T025
or	O	O	O
HeLa	O	O	B-T025
cells	O	O	I-T025
had	O	O	O
low	O	O	O
Km	O	O	B-T081
and	O	O	O
Vmax	O	O	B-T067
values	O	O	O
for	O	O	O
As(GS)3	O	O	B-T116
,	O	O	O
similar	O	O	B-T080
to	O	O	O
HeLa	O	O	B-T025
wild-type	O	O	I-T025
(	O	O	O
WT	O	O	O
)	O	O	O
MRP1	O	O	O
.	O	O	O

When	O	O	O
prepared	O	O	B-T052
in	O	O	O
the	O	O	O
presence	O	O	B-T033
of	O	O	O
phosphatase	O	O	B-T121
inhibitors	O	O	I-T121
,	O	O	O
both	O	O	O
WT-	O	O	B-T116
and	O	O	O
SF-MRP1	O	O	B-T116
-enriched	O	O	O
membrane	O	O	B-T026
vesicles	O	O	B-T026
had	O	O	O
a	O	O	O
high	O	O	O
Km	O	O	B-T081
value	O	O	O
for	O	O	O
As(GS)3	O	O	B-T116
(	O	O	O
3	O	O	O
-	O	O	O
6	O	O	O
ÂµM	O	O	O
)	O	O	O
,	O	O	O
regardless	O	O	O
of	O	O	O
the	O	O	O
cell	O	O	B-T025
line	O	O	I-T025
.	O	O	O

Kinetic	O	O	B-T033
parameters	O	O	I-T033
of	O	O	O
As(GS)3	O	O	B-T116
for	O	O	O
HEK	O	O	B-T025
-	O	O	O
Asn19/23Gln-MRP1	O	O	B-T116
were	O	O	O
similar	O	O	B-T080
to	O	O	O
those	O	O	O
of	O	O	O
HeLa	O	O	B-T025
/	O	O	O
HEK	O	O	O
-	O	O	O
SF-MRP1	O	O	B-T116
and	O	O	O
HeLa-WT	O	O	B-T025
-	O	O	O
MRP1	O	O	B-T116
,	O	O	O
whereas	O	O	O
those	O	O	O
of	O	O	O
single	O	O	B-T081
glycosylation	O	O	B-T044
mutants	O	O	B-T116
were	O	O	O
like	O	O	O
those	O	O	O
of	O	O	O
HEK-WT	O	O	B-T025
-MRP1	O	O	O
.	O	O	O

Mutation	O	O	B-T045
of	O	O	O
19	O	O	O
potential	O	O	B-T080
MRP1	O	O	B-T116
phosphorylation	O	O	B-T044
sites	O	O	B-T082
revealed	O	O	O
that	O	O	O
HEK	O	O	B-T025
-	O	O	O
Tyr920Phe/Ser921Ala-MRP1	O	O	B-T116
transported	O	O	B-T043
As(GS)3	O	O	B-T116
like	O	O	O
HeLa-WT	O	O	B-T025
-	O	O	O
MRP1	O	O	O
,	O	O	O
whereas	O	O	O
individual	O	O	O
HEK	O	O	O
-	O	O	O
Tyr920Phe-	O	O	B-T116
and	O	O	O
-	O	O	O
Ser921Ala-MRP1	O	O	B-T116
mutants	O	O	B-T116
were	O	O	O
similar	O	O	B-T080
to	O	O	O
HEK-WT	O	O	B-T025
-	O	O	O
MRP1	O	O	O
.	O	O	O

Together	O	O	O
,	O	O	O
these	O	O	O
results	O	O	B-T033
suggest	O	O	O
that	O	O	O
Asn19/Asn23	O	O	B-T087
glycosylation	O	O	B-T044
and	O	O	O
Tyr920/Ser921	O	O	B-T087
phosphorylation	O	O	B-T044
are	O	O	O
responsible	O	O	O
for	O	O	O
altering	O	O	B-T169
the	O	O	O
kinetics	O	O	B-T090
of	O	O	O
MRP1	O	O	B-T116
-mediated	O	O	O
As(GS)3	O	O	B-T116
transport	O	O	B-T043
.	O	O	O

The	O	O	O
kinetics	O	O	B-T090
of	O	O	O
As(GS)3	O	O	B-T116
transport	O	O	B-T043
by	O	O	O
HEK	O	O	B-T025
-	O	O	O
Asn19/23Gln/Tyr920Glu/Ser921Glu	O	O	B-T087
were	O	O	O
similar	O	O	B-T080
to	O	O	O
HEK-WT	O	O	B-T025
-	O	O	O
MRP1	O	O	B-T116
,	O	O	O
indicating	O	O	O
that	O	O	O
the	O	O	O
phosphorylation	O	O	B-T044
-mimicking	O	O	O
substitutions	O	O	O
abrogated	O	O	O
the	O	O	O
influence	O	O	B-T077
of	O	O	O
Asn19/23Gln	O	O	B-T087
glycosylation	O	O	B-T044
.	O	O	O

Overall	O	O	O
,	O	O	O
these	O	O	O
data	O	O	O
suggest	O	O	O
that	O	O	O
cross-talk	O	O	O
between	O	O	O
MRP1	O	O	B-T116
glycosylation	O	O	B-T044
and	O	O	O
phosphorylation	O	O	B-T044
occurs	O	O	O
and	O	O	O
that	O	O	O
phosphorylation	O	O	O
of	O	O	O
Tyr920	O	O	B-T087
and	O	O	O
Ser921	O	O	B-T087
can	O	O	O
switch	O	O	O
MRP1	O	O	O
to	O	O	O
a	O	O	O
lower-affinity	O	O	B-T080
,	O	O	O
higher-capacity	O	O	B-T080
As(GS)3	O	O	B-T116
transporter	O	O	B-T116
,	O	O	O
allowing	O	O	O
arsenic	O	O	B-T121
detoxification	O	O	B-T043
over	O	O	O
a	O	O	O
broad	O	O	B-T082
concentration	O	O	B-T081
range	O	O	B-T081
.	O	O	O

-DOCSTART- (27298278)

Naphthohydroquinones	O	O	B-T121
,	O	O	O
naphthoquinones	O	O	B-T109
,	O	O	O
anthraquinones	O	O	B-T109
,	O	O	O
and	O	O	O
a	O	O	O
naphthohydroquinone	O	O	B-T121
dimer	O	O	B-T104
isolated	O	O	B-T169
from	O	O	O
the	O	O	O
aerial	O	O	B-T002
parts	O	O	I-T002
of	O	O	O
Morinda	O	O	B-T002
parvifolia	O	O	I-T002
and	O	O	O
their	O	O	O
cytotoxic	O	O	B-T049
effects	O	O	I-T049
through	O	O	O
up-regulation	O	O	B-T045
of	O	O	O
p53	O	O	O

Five	O	O	O
unknown	O	O	B-T080
compounds	O	O	B-T121
,	O	O	O
morindaparvins	O	O	B-T121
C-G	O	O	I-T121
,	O	O	O
consisting	O	O	O
of	O	O	O
naphthohydroquinones	O	O	B-T121
,	O	O	O
a	O	O	O
naphthoquinone	O	O	B-T109
,	O	O	O
an	O	O	O
anthraquinone	O	O	B-T109
,	O	O	O
and	O	O	O
a	O	O	O
naphthohydroquinone	O	O	B-T121
dimer	O	O	B-T104
,	O	O	O
together	O	O	O
with	O	O	O
three	O	O	O
known	O	O	O
quinones	O	O	B-T109
and	O	O	O
seven	O	O	O
other	O	O	O
known	O	O	O
compounds	O	O	O
,	O	O	O
were	O	O	O
isolated	O	O	B-T169
from	O	O	O
the	O	O	O
aerial	O	O	B-T002
parts	O	O	I-T002
of	O	O	O
Morinda	O	O	B-T002
parvifolia	O	O	I-T002
.	O	O	O

The	O	O	O
structures	O	O	O
of	O	O	O
morindaparvins	O	O	B-T121
C	O	O	I-T121
,	O	O	O
D	O	O	B-T121
,	O	O	O
E	O	O	B-T121
,	O	O	O
F	O	O	B-T121
,	O	O	O
and	O	O	O
G	O	O	B-T121
were	O	O	O
elucidated	O	O	O
on	O	O	O
the	O	O	O
basis	O	O	O
of	O	O	O
spectroscopic	O	O	B-T059
or	O	O	O
X-ray	O	O	B-T059
diffraction	O	O	I-T059
analysis	O	O	I-T059
as	O	O	O
methyl	O	O	B-T121
4-hydroxy-1,6-dimethoxy-naphthalene-2-carboxylate	O	O	I-T121
,	O	O	O
methyl	O	O	B-T121
4,8-dihydroxy-1-methoxy-naphthalene-2-carboxylate	O	O	I-T121
,	O	O	O
3-amino-6-methoxy-2-methoxycarbonyl-1,4-naphthoquinone	O	O	B-T121
,	O	O	O
1,4-dihydroxy-7-hydroxymethyl-anthraquinone	O	O	B-T121
,	O	O	O
and	O	O	O
dimethyl	O	O	B-T121
1,1'-dihydroxy-4,4',7,7'-tetramethoxy-2,2'-binaphthalene-3,3'-dicarboxylate	O	O	I-T121
,	O	O	O
respectively	O	O	O
.	O	O	O

Naphthoquinones	O	O	B-T109
and	O	O	O
naphthohydroquinone	O	O	B-T121
dimers	O	O	B-T104
were	O	O	O
previously	O	O	O
unknown	O	O	B-T080
in	O	O	O
the	O	O	O
genus	O	O	B-T185
Morinda	O	O	B-T002
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
the	O	O	O
compounds	O	O	B-T121
were	O	O	O
tested	O	O	B-T169
for	O	O	O
cytotoxicity	O	O	B-T049
against	O	O	O
four	O	O	O
human	O	O	B-T016
cancer	O	O	B-T025
cell	O	O	I-T025
lines	O	O	I-T025
HeLa	O	O	B-T025
,	O	O	O
A2780	O	O	B-T025
,	O	O	O
Ketr3	O	O	B-T025
and	O	O	O
MCF-7	O	O	B-T025
and	O	O	O
their	O	O	O
effects	O	O	B-T080
on	O	O	O
p53	O	O	B-T028
-	O	O	O
activated	O	O	B-T052
transcription	O	O	B-T045
.	O	O	O

Three	O	O	O
naphthoquinones	O	O	B-T109
had	O	O	O
moderate	O	O	B-T080
cytotoxic	O	O	B-T049
effects	O	O	I-T049
with	O	O	O
IC50	O	O	B-T081
values	O	O	O
ranging	O	O	B-T081
from	O	O	O
1.51	O	O	O
to	O	O	O
9.56	O	O	O
Î¼M	O	O	O
,	O	O	O
through	O	O	O
up-regulation	O	O	B-T045
of	O	O	O
p53	O	O	B-T028
transcriptional	O	O	B-T045
activity	O	O	I-T045
.	O	O	O

-DOCSTART- (27299916)

Identification	O	O	B-T041
and	O	O	O
SAR	O	O	B-T080
Evaluation	O	O	B-T058
of	O	O	O
Hemozoin	O	O	B-T109
-	O	O	O
Inhibiting	O	O	B-T052
Benzamides	O	O	B-T109
Active	O	O	B-T169
against	O	O	O
Plasmodium	O	O	O
falciparum	O	O	O

Quinoline	O	O	B-T109
antimalarials	O	O	B-T121
target	O	O	B-T169
hemozoin	O	O	B-T109
formation	O	O	B-T169
causing	O	O	O
a	O	O	O
cytotoxic	O	O	B-T169
accumulation	O	O	B-T033
of	O	O	O
ferriprotoporphyrin	O	O	B-T109
IX	O	O	I-T109
(	O	O	O
Fe(III)PPIX	O	O	B-T109
)	O	O	O
.	O	O	O

Well-developed	O	O	O
SAR	O	O	B-T080
models	O	O	B-T170
exist	O	O	O
for	O	O	O
Î²-hematin	O	O	B-T109
inhibition	O	O	B-T052
,	O	O	O
parasite	O	O	B-T204
activity	O	O	B-T052
,	O	O	O
and	O	O	O
cellular	O	O	B-T044
mechanisms	O	O	I-T044
for	O	O	O
this	O	O	O
compound	O	O	B-T170
class	O	O	I-T170
,	O	O	O
but	O	O	O
no	O	O	O
comparably	O	O	O
detailed	O	O	O
investigations	O	O	B-T033
exist	O	O	O
for	O	O	O
other	O	O	O
hemozoin	O	O	B-T109
inhibiting	O	O	B-T052
chemotypes	O	O	B-T121
.	O	O	O

Here	O	O	O
,	O	O	O
benzamide	O	O	B-T109
analogues	O	O	B-T104
based	O	O	O
on	O	O	O
previous	O	O	O
HTS	O	O	B-T059
hits	O	O	O
have	O	O	O
been	O	O	O
purchased	O	O	B-T052
or	O	O	O
synthesized	O	O	B-T052
.	O	O	O

Only	O	O	O
derivatives	O	O	B-T104
containing	O	O	I-T104
an	O	O	I-T104
electron	O	O	I-T104
deficient	O	O	I-T104
aromatic	O	O	I-T104
ring	O	O	I-T104
and	O	O	O
capable	O	O	O
of	O	O	O
adopting	O	O	O
flat	O	O	B-T082
conformations	O	O	I-T082
,	O	O	O
optimal	O	O	O
for	O	O	O
Ï-Ï	O	O	B-T169
interactions	O	O	I-T169
with	O	O	O
Fe(III)PPIX	O	O	B-T109
,	O	O	O
inhibited	O	O	B-T080
Î²-hematin	O	O	B-T109
formation	O	O	B-T169
.	O	O	O

The	O	O	O
two	O	O	O
most	O	O	O
potent	O	O	O
analogues	O	O	B-T104
showed	O	O	O
nanomolar	O	O	B-T081
parasite	O	O	B-T204
activity	O	O	B-T052
,	O	O	O
with	O	O	O
little	O	O	O
CQ	O	O	B-T109
cross-resistance	O	O	B-T046
,	O	O	O
low	O	O	O
cytotoxicity	O	O	B-T049
,	O	O	O
and	O	O	O
high	O	O	O
in	O	O	B-T080
vitro	O	O	I-T080
microsomal	O	O	B-T080
stability	O	O	B-T080
.	O	O	O

Selected	O	O	O
analogues	O	O	B-T104
inhibited	O	O	B-T080
hemozoin	O	O	B-T109
formation	O	O	B-T169
in	O	O	O
Plasmodium	O	O	B-T204
falciparum	O	O	I-T204
causing	O	O	O
high	O	O	O
levels	O	O	B-T080
of	O	O	O
free	O	O	O
heme	O	O	B-T109
.	O	O	O

In	O	O	O
contrast	O	O	O
to	O	O	O
quinolines	O	O	B-T109
,	O	O	O
introduction	O	O	B-T169
of	O	O	O
amine	O	O	B-T104
side	O	O	I-T104
chains	O	O	I-T104
did	O	O	O
not	O	O	O
lead	O	O	O
to	O	O	O
benzamide	O	O	B-T109
accumulation	O	O	B-T033
in	O	O	O
the	O	O	O
parasite	O	O	B-T204
.	O	O	O

These	O	O	O
data	O	O	B-T078
reveal	O	O	O
complex	O	O	O
relationships	O	O	B-T080
between	O	O	O
heme	O	O	B-T109
binding	O	O	I-T044
,	O	O	O
free	O	O	O
heme	O	O	O
levels	O	O	B-T080
,	O	O	O
cellular	O	O	B-T043
accumulation	O	O	I-T043
,	O	O	O
and	O	O	O
in	O	O	B-T080
vitro	O	O	I-T080
activity	O	O	B-T052
of	O	O	O
potential	O	O	O
novel	O	O	B-T080
antimalarials	O	O	B-T121
.	O	O	O

-DOCSTART- (27300947)

Shear	O	O	B-T081
modulus	O	O	I-T081
of	O	O	O
structured	O	O	B-T082
electrorheological	O	O	B-T167
fluid	O	O	I-T167
mixtures	O	O	O

Some	O	O	O
immiscible	O	O	B-T167
blends	O	O	I-T167
under	O	O	O
a	O	O	O
strong	O	O	O
electric	O	O	B-T070
field	O	O	I-T070
often	O	O	O
exhibit	O	O	O
periodic	O	O	B-T079
structures	O	O	B-T082
,	O	O	O
bridging	O	O	O
the	O	O	O
gap	O	O	O
between	O	O	O
two	O	O	O
electrodes	O	O	B-T074
.	O	O	O

Upon	O	O	O
shear	O	O	B-T070
,	O	O	O
the	O	O	O
structures	O	O	B-T082
tilt	O	O	B-T080
,	O	O	O
and	O	O	O
exhibit	O	O	O
an	O	O	O
elastic	O	O	B-T169
response	O	O	O
which	O	O	O
is	O	O	O
mostly	O	O	O
governed	O	O	O
by	O	O	O
the	O	O	O
electric	O	O	B-T070
energy	O	O	I-T070
.	O	O	O

Assuming	O	O	O
a	O	O	O
two-dimensional	O	O	B-T081
stripe	O	O	B-T082
structure	O	O	I-T082
,	O	O	O
we	O	O	O
calculate	O	O	O
the	O	O	O
Maxwell	O	O	B-T070
stress	O	O	I-T070
,	O	O	O
and	O	O	O
derive	O	O	O
an	O	O	O
expression	O	O	B-T078
for	O	O	O
the	O	O	O
shear	O	O	B-T081
modulus	O	O	I-T081
,	O	O	O
demonstrating	O	O	O
how	O	O	O
it	O	O	O
depends	O	O	O
on	O	O	O
the	O	O	O
external	O	O	O
electric	O	O	B-T070
field	O	O	I-T070
,	O	O	O
the	O	O	O
composition	O	O	B-T070
,	O	O	O
and	O	O	O
the	O	O	O
dielectric	O	O	B-T081
properties	O	O	I-T081
of	O	O	O
the	O	O	O
blend	O	O	B-T167
.	O	O	O

We	O	O	O
also	O	O	O
suggest	O	O	O
the	O	O	O
notion	O	O	O
of	O	O	O
effective	O	O	O
interfacial	O	O	B-T070
tension	O	O	I-T070
,	O	O	O
which	O	O	O
renormalizes	O	O	O
the	O	O	O
effect	O	O	B-T080
of	O	O	I-T080
the	O	O	O
electric	O	O	B-T070
field	O	O	I-T070
.	O	O	O

This	O	O	O
leads	O	O	O
to	O	O	O
a	O	O	O
simple	O	O	O
derivation	O	O	B-T080
of	O	O	O
the	O	O	O
scaling	O	O	B-T170
law	O	O	I-T170
for	O	O	O
the	O	O	O
selection	O	O	O
of	O	O	O
the	O	O	O
wavelength	O	O	B-T081
of	O	O	O
the	O	O	O
structure	O	O	B-T082
formed	O	O	O
under	O	O	O
an	O	O	O
electric	O	O	B-T070
field	O	O	I-T070
.	O	O	O

-DOCSTART- (27301681)

Sequence-specific	O	O	B-T045
DNA	O	O	I-T045
binding	O	O	I-T045
by	O	O	O
long	O	O	B-T104
hairpin	O	O	I-T104
pyrrole-imidazole	O	O	B-T109
polyamides	O	O	I-T109
containing	O	O	O
an	O	O	O
8-amino-3,6-dioxaoctanoic	O	O	B-T109
acid	O	O	I-T109
unit	O	O	O

With	O	O	O
the	O	O	O
aim	O	O	O
of	O	O	O
improving	O	O	O
aqueous	O	O	B-T081
solubility	O	O	I-T081
,	O	O	O
we	O	O	O
designed	O	O	B-T052
and	O	O	O
synthesized	O	O	B-T052
five	O	O	O
N-methylpyrrole	O	O	B-T109
(Py)-N-methylimidazole	O	O	I-T109
(	O	O	I-T109
I	O	O	I-T109
m	O	O	I-T109
)	O	O	I-T109
polyamides	O	O	I-T109
capable	O	O	O
of	O	O	O
recognizing	O	O	O
9-bp	O	O	B-T086
sequences	O	O	I-T086
.	O	O	O

Their	O	O	O
DNA-binding	O	O	B-T045
affinities	O	O	B-T070
and	O	O	O
sequence	O	O	B-T086
specificities	O	O	B-T081
were	O	O	O
evaluated	O	O	O
by	O	O	O
SPR	O	O	B-T063
and	O	O	O
Bind-n-Seq	O	O	B-T062
analyses	O	O	I-T062
.	O	O	O

The	O	O	O
design	O	O	B-T052
of	O	O	O
polyamide	O	O	B-T109
1	O	O	I-T109
was	O	O	O
based	O	O	O
on	O	O	O
a	O	O	O
conventional	O	O	O
model	O	O	B-T170
,	O	O	O
with	O	O	O
three	O	O	O
consecutive	O	O	O
Py	O	O	B-T109
or	O	O	O
I	O	O	B-T109
m	O	O	I-T109
rings	O	O	O
separated	O	O	O
by	O	O	O
a	O	O	O
Î²-alanine	O	O	B-T116
to	O	O	O
match	O	O	O
the	O	O	O
curvature	O	O	O
and	O	O	O
twist	O	O	B-T082
of	O	O	O
long	O	O	O
DNA	O	O	B-T114
helices	O	O	B-T082
.	O	O	O

Polyamides	O	O	B-T109
2	O	O	I-T109
and	O	O	I-T109
3	O	O	I-T109
contained	O	O	O
an	O	O	O
8-amino-3,6-dioxaoctanoic	O	O	B-T109
acid	O	O	I-T109
(	O	O	O
AO	O	O	B-T109
)	O	O	O
unit	O	O	O
,	O	O	O
which	O	O	O
has	O	O	O
previously	O	O	O
only	O	O	O
been	O	O	O
used	O	O	O
as	O	O	O
a	O	O	O
linker	O	O	B-T109
within	O	O	O
linear	O	O	O
Py-Im	O	O	B-T109
polyamides	O	O	I-T109
or	O	O	O
between	O	O	O
Py	O	O	B-T104
-	O	O	I-T104
I	O	O	B-T109
m	O	O	I-T109
hairpin	O	O	I-T104
motifs	O	O	I-T104
for	O	O	O
tandem	O	O	B-T104
hairpin	O	O	I-T104
.	O	O	O

It	O	O	O
is	O	O	O
demonstrated	O	O	O
herein	O	O	O
that	O	O	O
AO	O	O	B-T109
also	O	O	O
functions	O	O	O
as	O	O	O
a	O	O	O
linker	O	O	B-T109
element	O	O	I-T109
that	O	O	O
can	O	O	O
extend	O	O	O
to	O	O	O
2-bp	O	O	B-T086
in	O	O	O
hairpin	O	O	B-T104
motifs	O	O	I-T104
.	O	O	O

Notably	O	O	O
,	O	O	O
although	O	O	O
the	O	O	O
AO	O	O	B-T109
-containing	O	O	O
unit	O	O	O
can	O	O	O
fail	O	O	B-T169
to	O	O	O
bind	O	O	B-T052
the	O	O	O
expected	O	O	O
sequence	O	O	B-T086
,	O	O	O
polyamide	O	O	B-T109
4	O	O	I-T109
,	O	O	O
which	O	O	O
has	O	O	O
two	O	O	O
AO	O	O	O
units	O	O	O
facing	O	O	O
each	O	O	O
other	O	O	O
in	O	O	O
a	O	O	O
hairpin	O	O	B-T082
form	O	O	I-T082
,	O	O	O
successfully	O	O	O
showed	O	O	O
the	O	O	O
expected	O	O	O
motif	O	O	B-T082
and	O	O	O
a	O	O	O
KD	O	O	B-T081
value	O	O	I-T081
of	O	O	O
16nM	O	O	O
was	O	O	O
recorded	O	O	O
.	O	O	O

Polyamide	O	O	B-T109
5	O	O	I-T109
,	O	O	O
containing	O	O	O
a	O	O	O
Î²-alanine-Î²-alanine	O	O	B-T116
unit	O	O	O
instead	O	O	O
of	O	O	O
the	O	O	O
AO	O	O	B-T109
of	O	O	O
polyamide	O	O	B-T109
2	O	O	I-T109
,	O	O	O
was	O	O	O
synthesized	O	O	B-T052
for	O	O	O
comparison	O	O	B-T052
.	O	O	O

The	O	O	O
aqueous	O	O	B-T081
solubilities	O	O	I-T081
and	O	O	O
nuclear	O	O	B-T038
localization	O	O	I-T038
of	O	O	O
three	O	O	O
of	O	O	O
the	O	O	O
polyamides	O	O	B-T109
were	O	O	O
also	O	O	O
examined	O	O	O
.	O	O	O

The	O	O	O
results	O	O	B-T169
suggest	O	O	O
the	O	O	O
possibility	O	O	O
of	O	O	O
applying	O	O	O
the	O	O	O
AO	O	O	B-T109
unit	O	O	O
in	O	O	O
the	O	O	O
core	O	O	B-T082
of	O	O	O
Py-Im	O	O	B-T109
polyamide	O	O	I-T109
compounds	O	O	I-T109
.	O	O	O

-DOCSTART- (27304832)

Causes	O	O	B-T033
of	O	O	I-T033
Death	O	O	I-T033
among	O	O	O
Children	O	O	B-T100
Aged	O	O	B-T032
5	O	O	O
to	O	O	O
14	O	O	O
Years	O	O	B-T079
Old	O	O	B-T079
from	O	O	O
2008	O	O	O
to	O	O	O
2013	O	O	O
in	O	O	O
Kersa	O	O	O
Health	O	O	O
and	O	O	O
Demographic	O	O	O
Surveillance	O	O	O
System	O	O	O
(	O	O	O
Kersa	O	O	O
HDSS	O	O	O
)	O	O	O
,	O	O	O
Ethiopia	O	O	O

The	O	O	O
global	O	O	O
burden	O	O	O
of	O	O	O
mortality	O	O	B-T081
among	O	O	I-T081
children	O	O	I-T081
is	O	O	O
still	O	O	O
very	O	O	O
huge	O	O	O
though	O	O	O
its	O	O	O
trend	O	O	B-T079
has	O	O	O
started	O	O	O
declining	O	O	O
following	O	O	O
the	O	O	O
improvements	O	O	B-T077
in	O	O	O
the	O	O	O
living	O	O	B-T081
standard	O	O	I-T081
.	O	O	O

It	O	O	O
presents	O	O	O
serious	O	O	O
challenges	O	O	B-T058
to	O	O	O
the	O	O	O
well-being	O	O	O
of	O	O	O
children	O	O	B-T100
in	O	O	O
many	O	O	O
African	O	O	B-T083
countries	O	O	I-T083
.	O	O	O

Today	O	O	O
,	O	O	O
Sub-Saharan	O	O	B-T083
Africa	O	O	I-T083
alone	O	O	O
accounts	O	O	O
for	O	O	O
about	O	O	O
50	O	O	O
%	O	O	O
of	O	O	O
global	O	O	B-T080
child	O	O	B-T081
mortality	O	O	I-T081
.	O	O	O

The	O	O	O
overall	O	O	O
objective	O	O	B-T170
of	O	O	O
this	O	O	O
study	O	O	O
was	O	O	O
to	O	O	O
determine	O	O	O
the	O	O	O
magnitude	O	O	B-T081
and	O	O	O
distribution	O	O	B-T169
of	O	O	O
causes	O	O	B-T033
of	O	O	I-T033
death	O	O	I-T033
among	O	O	O
children	O	O	B-T100
aged	O	O	B-T032
5	O	O	O
to	O	O	O
14	O	O	O
year	O	O	O
olds	O	O	O
in	O	O	O
the	O	O	O
population	O	O	B-T098
of	O	O	O
Kersa	O	O	O
HDSS	O	O	O
using	O	O	O
verbal	O	O	B-T080
autopsy	O	O	B-T060
method	O	O	O
for	O	O	O
the	O	O	O
period	O	O	B-T079
2008	O	O	O
to	O	O	O
2013	O	O	O
.	O	O	O

Kersa	O	O	O
Health	O	O	O
and	O	O	O
Demographic	O	O	O
Surveillance	O	O	O
System	O	O	O
(	O	O	O
Kersa	O	O	O
HDSS	O	O	O
)	O	O	O
was	O	O	O
established	O	O	O
in	O	O	O
September	O	O	B-T079
2007	O	O	O
.	O	O	O

The	O	O	O
center	O	O	O
consists	O	O	O
of	O	O	O
10	O	O	O
rural	O	O	B-T082
and	O	O	O
2	O	O	O
urban	O	O	B-T082
kebeles	O	O	B-T098
which	O	O	O
were	O	O	O
selected	O	O	O
randomly	O	O	O
from	O	O	O
38	O	O	O
kebeles	O	O	O
in	O	O	O
the	O	O	O
district	O	O	B-T083
.	O	O	O

Thus	O	O	O
this	O	O	O
study	O	O	O
was	O	O	O
conducted	O	O	O
in	O	O	O
Kersa	O	O	O
HDSS	O	O	O
and	O	O	O
data	O	O	B-T078
was	O	O	O
taken	O	O	O
from	O	O	O
Kersa	O	O	B-T170
HDSS	O	O	I-T170
database	O	O	I-T170
.	O	O	O

The	O	O	O
study	O	O	B-T062
population	O	O	B-T098
included	O	O	O
all	O	O	O
children	O	O	B-T100
aged	O	O	B-T032
5	O	O	O
to	O	O	O
14	O	O	O
years	O	O	O
registered	O	O	O
during	O	O	O
the	O	O	O
period	O	O	B-T079
of	O	O	O
2008	O	O	O
to	O	O	O
2013	O	O	O
in	O	O	O
Kersa	O	O	O
HDSS	O	O	O
using	O	O	O
age	O	O	B-T032
specific	O	O	O
VA	O	O	O
questionnaires	O	O	B-T170
.	O	O	O

Data	O	O	B-T078
were	O	O	O
extracted	O	O	O
from	O	O	O
SPSS	O	O	B-T170
database	O	O	I-T170
and	O	O	O
analyzed	O	O	O
using	O	O	O
STATA	O	O	B-T170
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
229	O	O	O
deaths	O	O	B-T033
were	O	O	O
recorded	O	O	O
over	O	O	O
the	O	O	O
period	O	O	B-T079
of	O	O	O
six	O	O	O
years	O	O	O
with	O	O	O
a	O	O	O
crude	O	O	O
death	O	O	B-T081
rate	O	O	I-T081
of	O	O	O
219.6	O	O	O
per	O	O	O
100,000	O	O	O
population	O	O	B-T098
of	O	O	O
this	O	O	O
age	O	O	B-T100
group	O	O	I-T100
over	O	O	O
the	O	O	O
study	O	O	B-T062
period	O	O	O
.	O	O	O

This	O	O	O
death	O	O	B-T081
rate	O	O	I-T081
was	O	O	O
217.5	O	O	O
and	O	O	O
221.5	O	O	O
per	O	O	O
100,000	O	O	O
populations	O	O	B-T098
for	O	O	O
females	O	O	B-T032
and	O	O	O
males	O	O	B-T032
,	O	O	O
respectively	O	O	O
.	O	O	O

75	O	O	O
%	O	O	O
of	O	O	O
deaths	O	O	B-T033
took	O	O	O
place	O	O	O
at	O	O	O
home	O	O	O
.	O	O	O

The	O	O	O
study	O	O	B-T062
identified	O	O	O
severe	O	O	O
malnutrition	O	O	B-T047
(	O	O	O
33.9	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
intestinal	O	O	B-T047
infectious	O	O	I-T047
diseases	O	O	I-T047
(	O	O	O
13.8	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
acute	O	O	B-T047
lower	O	O	I-T047
respiratory	O	O	I-T047
infections	O	O	I-T047
(	O	O	O
9.2	O	O	O
%	O	O	O
)	O	O	O
to	O	O	O
be	O	O	O
the	O	O	O
three	O	O	O
most	O	O	O
leading	O	O	O
causes	O	O	B-T033
of	O	O	I-T033
death	O	O	I-T033
.	O	O	O

In	O	O	O
broad	O	O	O
causes	O	O	B-T033
of	O	O	I-T033
death	O	O	I-T033
classification	O	O	B-T185
,	O	O	O
injuries	O	O	B-T037
have	O	O	O
been	O	O	O
found	O	O	O
to	O	O	O
be	O	O	O
the	O	O	O
second	O	O	O
most	O	O	O
cause	O	O	B-T033
of	O	O	I-T033
death	O	O	I-T033
next	O	O	O
to	O	O	O
communicable	O	O	B-T047
diseases	O	O	I-T047
(	O	O	O
56.3	O	O	O
%	O	O	O
)	O	O	O
attributing	O	O	O
to	O	O	O
13.1	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
total	O	O	O
deaths	O	O	B-T033
.	O	O	O

In	O	O	O
specific	O	O	O
causes	O	O	B-T033
of	O	O	I-T033
death	O	O	I-T033
classification	O	O	B-T185
severe	O	O	O
malnutrition	O	O	B-T047
,	O	O	O
intestinal	O	O	B-T047
infectious	O	O	I-T047
diseases	O	O	I-T047
and	O	O	O
acute	O	O	B-T047
lower	O	O	I-T047
respiratory	O	O	I-T047
infections	O	O	I-T047
were	O	O	O
the	O	O	O
three	O	O	O
leading	O	O	O
causes	O	O	O
of	O	O	O
death	O	O	O
where	O	O	O
,	O	O	O
in	O	O	O
broad	O	O	O
causes	O	O	O
of	O	O	O
death	O	O	O
communicable	O	O	B-T047
diseases	O	O	I-T047
and	O	O	O
injuries	O	O	B-T037
were	O	O	O
among	O	O	O
the	O	O	O
leading	O	O	O
causes	O	O	O
of	O	O	O
death	O	O	O
.	O	O	O

Hence	O	O	O
,	O	O	O
concerned	O	O	O
bodies	O	O	O
should	O	O	O
take	O	O	O
measures	O	O	O
to	O	O	O
avert	O	O	O
the	O	O	O
situation	O	O	O
of	O	O	O
mortality	O	O	B-T081
from	O	O	O
these	O	O	O
causes	O	O	B-T033
of	O	O	I-T033
death	O	O	I-T033
and	O	O	O
further	O	O	O
inferential	O	O	B-T062
analysis	O	O	I-T062
into	O	O	O
the	O	O	O
prevention	O	O	B-T061
and	O	O	O
management	O	O	B-T058
of	O	O	O
infectious	O	O	B-T047
diseases	O	O	I-T047
should	O	O	O
also	O	O	O
be	O	O	O
taken	O	O	O
.	O	O	O

-DOCSTART- (27306834)

NaÃ¯ve	O	O	B-T025
CD8(+	O	O	B-T025
)	O	O	I-T025
T	O	O	I-T025
cell	O	O	I-T025
derived	O	O	O
tumor	O	O	B-T191
-	O	O	O
specific	O	O	B-T080
cytotoxic	O	O	B-T025
effectors	O	O	I-T025
as	O	O	O
a	O	O	O
potential	O	O	O
remedy	O	O	B-T077
for	O	O	O
overcoming	O	O	O
TGF-Î²	O	O	B-T116
immunosuppression	O	O	B-T047
in	O	O	O
the	O	O	O
tumor	O	O	O
microenvironment	O	O	O

Despite	O	O	O
of	O	O	O
the	O	O	O
potential	O	O	O
implications	O	O	O
for	O	O	O
cancer	O	O	B-T061
immunotherapy	O	O	I-T061
,	O	O	O
conventional	O	O	B-T080
approaches	O	O	B-T169
using	O	O	O
in	O	O	B-T080
vitro	O	O	I-T080
expanded	O	O	B-T082
CD8(+	O	O	B-T025
)	O	O	I-T025
T	O	O	I-T025
cells	O	O	I-T025
have	O	O	O
suboptimal	O	O	B-T080
outcomes	O	O	B-T080
,	O	O	O
mostly	O	O	O
due	O	O	O
to	O	O	O
loss	O	O	B-T081
of	O	O	O
functionality	O	O	B-T169
from	O	O	O
cellular	O	O	B-T025
exhaustion	O	O	B-UnknownType
.	O	O	O

We	O	O	O
therefore	O	O	O
investigated	O	O	O
the	O	O	O
phenotypic	O	O	B-T032
and	O	O	O
functional	O	O	B-T169
differences	O	O	B-T080
among	O	O	O
in	O	O	B-T080
vitro	O	O	I-T080
activated	O	O	B-T052
CD8(+	O	O	B-T025
)	O	O	I-T025
T	O	O	I-T025
cells	O	O	I-T025
of	O	O	O
three	O	O	O
different	O	O	O
sources	O	O	B-T033
,	O	O	O
namely	O	O	O
naÃ¯ve	O	O	B-T025
(	O	O	O
NTeff	O	O	B-T025
)	O	O	O
,	O	O	O
memory	O	O	B-T025
(	O	O	O
MTeff	O	O	B-T025
)	O	O	O
and	O	O	O
tumor-infiltrating	O	O	B-T025
lymphocytes	O	O	I-T025
(	O	O	O
TILeff	O	O	B-T025
)	O	O	O
from	O	O	O
human	O	O	B-T016
and	O	O	O
mice	O	O	B-T015
,	O	O	O
to	O	O	O
better	O	O	O
understand	O	O	O
mechanisms	O	O	B-T169
behind	O	O	O
potent	O	O	O
effector	O	O	B-T025
functions	O	O	B-T169
and	O	O	O
potential	O	O	O
for	O	O	O
overcoming	O	O	O
current	O	O	O
limitations	O	O	B-T169
.	O	O	O

In	O	O	O
line	O	O	O
with	O	O	O
the	O	O	O
greater	O	O	O
proliferation	O	O	B-T043
activity	O	O	B-T052
and	O	O	O
longer	O	O	O
telomere	O	O	B-T026
lengths	O	O	B-T081
of	O	O	O
NTeff	O	O	B-T025
populations	O	O	I-T025
,	O	O	O
cells	O	O	B-T025
of	O	O	O
naÃ¯ve	O	O	B-T079
origin	O	O	I-T079
exhibited	O	O	O
significantly	O	O	O
less	O	O	O
amounts	O	O	O
of	O	O	O
T	O	O	B-T025
cell	O	O	I-T025
exhaustion	O	O	B-UnknownType
markers	O	O	B-T201
than	O	O	O
those	O	O	O
of	O	O	O
MTeff	O	O	B-T025
and	O	O	O
TILeff	O	O	B-T025
,	O	O	O
and	O	O	O
moreover	O	O	O
,	O	O	O
acquired	O	O	O
distinct	O	O	O
expression	O	O	B-T045
patterns	O	O	I-T045
of	O	O	O
memory-promoting	O	O	B-T116
transcription	O	O	I-T116
factors	O	O	I-T116
,	O	O	O
T-bet	O	O	B-T116
and	O	O	O
Eomes	O	O	B-T116
,	O	O	O
induced	O	O	B-T169
in	O	O	O
a	O	O	O
rapid	O	O	B-T080
and	O	O	O
sustainable	O	O	B-T169
manner	O	O	B-T169
.	O	O	O

NTeff	O	O	B-T025
cells	O	O	I-T025
appeared	O	O	O
to	O	O	O
have	O	O	O
lower	O	O	O
expression	O	O	B-T045
of	O	O	O
Foxp1	O	O	B-T116
and	O	O	O
were	O	O	O
refractory	O	O	O
to	O	O	O
apoptosis	O	O	B-T043
upon	O	O	O
TGF-Î²	O	O	B-T116
conditioning	O	O	B-T169
,	O	O	O
implying	O	O	O
better	O	O	O
survival	O	O	B-T043
potential	O	O	B-T080
and	O	O	O
resistance	O	O	B-T169
to	O	O	O
tumor	O	O	B-T191
-	O	O	O
induced	O	O	B-T169
immune	O	O	B-T047
suppression	O	O	I-T047
.	O	O	O

Of	O	O	O
CD8(+	O	O	B-T025
)	O	O	I-T025
T	O	O	I-T025
cell	O	O	I-T025
pools	O	O	O
activated	O	O	B-T052
to	O	O	O
tumor	O	O	B-T191
-	O	O	O
specific	O	O	B-T080
CTLs	O	O	B-T025
,	O	O	O
naÃ¯ve	O	O	B-T025
cell	O	O	I-T025
generated	O	O	B-T052
effectors	O	O	B-T025
possessed	O	O	O
the	O	O	O
most	O	O	O
potent	O	O	O
cytotoxic	O	O	B-T033
activity	O	O	I-T033
,	O	O	O
validating	O	O	O
implications	O	O	O
for	O	O	O
use	O	O	O
in	O	O	O
rational	O	O	O
design	O	O	B-T052
of	O	O	O
adoptive	O	O	B-T061
immunotherapy	O	O	I-T061
.	O	O	O

-DOCSTART- (27309274)

Antiadipogenic	O	O	B-T033
Activity	O	O	I-T033
of	O	O	O
Î³-Oryzanol	O	O	B-T109
and	O	O	O
Its	O	O	O
Stability	O	O	B-T080
in	O	O	O
Pigmented	O	O	B-T080
Rice	O	O	O

Î³-Oryzanol	O	O	B-T109
,	O	O	O
a	O	O	O
prevalent	O	O	O
compound	O	O	O
in	O	O	O
pigmented	O	O	B-T080
rice	O	O	B-T168
varieties	O	O	B-T080
,	O	O	O
has	O	O	O
been	O	O	O
reported	O	O	O
to	O	O	O
ameliorate	O	O	O
obesity-associated	O	O	B-T047
metabolic	O	O	I-T047
disorders	O	O	I-T047
.	O	O	O

Antiadipogenic	O	O	B-T033
activities	O	O	I-T033
of	O	O	O
Î³-oryzanol	O	O	B-T109
were	O	O	O
determined	O	O	O
in	O	O	O
human	O	O	B-T016
adipose	O	O	B-T024
-	O	O	O
derived	O	O	B-T078
mesenchymal	O	O	B-T025
stem	O	O	I-T025
cells	O	O	I-T025
and	O	O	O
mouse	O	O	B-T015
-	O	O	O
derived	O	O	O
3T3-L1	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

Î³-Oryzanol	O	O	B-T109
significantly	O	O	O
decreased	O	O	B-T081
lipid	O	O	B-T033
accumulation	O	O	I-T033
and	O	O	O
reduced	O	O	B-T080
glycerol-3-phosphate	O	O	B-T044
dehydrogenase	O	O	I-T044
activities	O	O	I-T044
in	O	O	O
both	O	O	O
adipocytes	O	O	B-T025
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
Î³-oryzanol	O	O	B-T109
in	O	O	O
four	O	O	O
pigmented	O	O	B-T080
rice	O	O	B-T168
varieties	O	O	B-T080
(	O	O	O
black	O	O	B-T168
with	O	O	I-T168
giant	O	O	I-T168
embryo	O	O	I-T168
,	O	O	O
brown	O	O	B-T168
,	O	O	O
sugary	O	O	B-T168
brown	O	O	I-T168
,	O	O	O
and	O	O	O
red	O	O	B-T168
)	O	O	O
was	O	O	O
stable	O	O	B-T080
when	O	O	O
stored	O	O	B-T169
at	O	O	O
4	O	O	O
Â°	O	O	O
C	O	O	O
and	O	O	O
also	O	O	O
at	O	O	O
room	O	O	B-T080
temperature	O	O	I-T080
for	O	O	O
22	O	O	O
weeks	O	O	O
,	O	O	O
whereas	O	O	O
other	O	O	O
bioactives	O	O	B-T167
such	O	O	O
as	O	O	O
lutein	O	O	B-T109
and	O	O	O
Î²-carotene	O	O	B-T127
were	O	O	O
stable	O	O	O
only	O	O	O
at	O	O	O
-80	O	O	O
Â°	O	O	O
C	O	O	O
.	O	O	O

Furthermore	O	O	O
,	O	O	O
the	O	O	O
yield	O	O	B-T081
of	O	O	O
Î³-oryzanol	O	O	B-T109
from	O	O	O
these	O	O	O
rice	O	O	B-T168
varieties	O	O	B-T080
was	O	O	O
significantly	O	O	O
increased	O	O	O
through	O	O	O
steaming	O	O	B-T067
and	O	O	O
roasting	O	O	B-T067
processes	O	O	I-T067
.	O	O	O

Therefore	O	O	O
,	O	O	O
Î³-oryzanol	O	O	B-T109
exerts	O	O	O
antiadipogenic	O	O	B-T033
activity	O	O	I-T033
by	O	O	O
suppressing	O	O	B-T169
adipocyte	O	O	B-T043
differentiations	O	O	I-T043
and	O	O	O
is	O	O	O
stable	O	O	B-T080
in	O	O	O
pigmented	O	O	B-T080
rice	O	O	B-T168
for	O	O	O
an	O	O	O
extended	O	O	B-T169
period	O	O	B-T079
of	O	O	I-T079
time	O	O	I-T079
during	O	O	O
storage	O	O	B-T169
and	O	O	O
after	O	O	B-T079
cooking	O	O	B-T056
.	O	O	O

Thus	O	O	O
,	O	O	O
the	O	O	O
intake	O	O	B-T169
of	O	O	O
pigmented	O	O	B-T080
rice	O	O	B-T168
may	O	O	O
be	O	O	O
a	O	O	O
useful	O	O	O
strategy	O	O	O
for	O	O	O
preventing	O	O	B-T169
obesity	O	O	B-T047
.	O	O	O

-DOCSTART- (27310615)

Impact	O	O	B-T080
of	O	O	O
Chemotherapy	O	O	B-T061
on	O	O	O
Diet	O	O	B-T168
and	O	O	O
Nutritional	O	O	B-T033
Status	O	O	I-T033
of	O	O	O
Women	O	O	B-T098
with	O	O	O
Breast	O	O	B-T191
Cancer	O	O	I-T191
:	O	O	O
A	O	O	O
Prospective	O	O	O
Study	O	O	O

Certain	O	O	O
food	O	O	B-T168
groups	O	O	I-T168
are	O	O	O
often	O	O	O
rejected	O	O	B-T080
during	O	O	O
chemotherapy	O	O	B-T061
(	O	O	O
CT	O	O	B-T061
)	O	O	O
due	O	O	O
to	O	O	O
the	O	O	O
side	O	O	B-T046
effects	O	O	I-T046
of	O	O	I-T046
treatment	O	O	I-T046
,	O	O	O
which	O	O	O
may	O	O	O
interfere	O	O	B-T169
with	O	O	I-T169
adequate	O	O	B-UnknownType
diet	O	O	I-UnknownType
and	O	O	O
nutritional	O	O	B-T033
status	O	O	I-T033
.	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
evaluate	O	O	B-T058
the	O	O	O
treatment	O	O	B-T169
impact	O	O	B-T080
on	O	O	O
the	O	O	O
diet	O	O	B-T168
and	O	O	O
nutritional	O	O	B-T033
status	O	O	I-T033
of	O	O	O
women	O	O	B-T098
with	O	O	O
breast	O	O	B-T191
cancer	O	O	I-T191
(	O	O	O
BC	O	O	B-T191
)	O	O	O
.	O	O	O

In	O	O	O
this	O	O	O
prospective	O	O	B-T062
longitudinal	O	O	I-T062
study	O	O	I-T062
,	O	O	O
conducted	O	O	O
in	O	O	O
2014	O	O	O
-	O	O	O
2015	O	O	O
,	O	O	O
55	O	O	O
women	O	O	B-T098
diagnosed	O	O	O
with	O	O	O
BC	O	O	B-T191
,	O	O	O
with	O	O	O
a	O	O	O
mean	O	O	O
age	O	O	B-T032
51.5Â±10.1	O	O	O
years	O	O	B-T079
,	O	O	O
were	O	O	O
followed	O	O	O
and	O	O	O
data	O	O	B-T078
were	O	O	O
collected	O	O	O
at	O	O	O
three	O	O	O
different	O	O	O
times	O	O	O
.	O	O	O

Anthropometric	O	O	B-T081
and	O	O	O
dietary	O	O	B-T060
assessments	O	O	I-T060
were	O	O	O
performed	O	O	O
,	O	O	O
the	O	O	O
latter	O	O	O
by	O	O	O
applying	O	O	O
nine	O	O	O
24h	O	O	O
dietary	O	O	B-T061
recall	O	O	I-T061
s	O	O	O
,	O	O	O
by	O	O	O
using	O	O	O
the	O	O	O
Brazilian	O	O	B-T170
Healthy	O	O	I-T170
Eating	O	O	I-T170
Index	O	O	I-T170
Revised	O	O	I-T170
(	O	O	O
BHEI-R	O	O	B-T170
)	O	O	O
,	O	O	O
and	O	O	O
calculating	O	O	B-T052
the	O	O	O
prevalence	O	O	B-T081
of	O	O	O
inadequacy	O	O	B-T080
by	O	O	O
the	O	O	O
EAR	O	O	B-T170
cut-off	O	O	I-T170
point	O	O	I-T170
method	O	O	I-T170
.	O	O	O

Regarding	O	O	O
the	O	O	O
BHEI-R	O	O	B-T170
analysis	O	O	B-T062
,	O	O	O
the	O	O	O
majority	O	O	O
of	O	O	O
women	O	O	B-T098
had	O	O	O
a	O	O	O
"	O	O	O
diet	O	O	B-T168
requires	O	O	O
modification	O	O	B-T033
'	O	O	O
,	O	O	O
both	O	O	O
at	O	O	O
the	O	O	O
beginning	O	O	B-T079
(	O	O	O
T0	O	O	O
,	O	O	O
58.2	O	O	O
%	O	O	O
,	O	O	O
n	O	O	O
=	O	O	O
32	O	O	O
)	O	O	O
and	O	O	O
during	O	O	B-T079
treatment	O	O	I-T079
(	O	O	O
T1	O	O	O
,	O	O	O
54.5	O	O	O
%	O	O	O
,	O	O	O
n	O	O	O
=	O	O	O
30	O	O	O
)	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
after	O	O	O
the	O	O	O
end	O	O	O
of	O	O	O
the	O	O	O
CT	O	O	B-T061
,	O	O	O
the	O	O	O
greater	O	O	B-T081
percentage	O	O	I-T081
of	O	O	O
patients	O	O	B-T101
(	O	O	O
T2	O	O	O
,	O	O	O
49.1	O	O	O
%	O	O	O
,	O	O	O
n	O	O	O
=	O	O	O
27	O	O	O
)	O	O	O
were	O	O	O
classified	O	O	O
as	O	O	O
having	O	O	O
an	O	O	O
"	O	O	O
inadequate	O	O	B-T033
diet	O	O	I-T033
"	O	O	O
,	O	O	O
since	O	O	O
the	O	O	O
Total	O	O	B-T080
Fruit	O	O	B-T168
consumption	O	O	B-T052
as	O	O	O
well	O	O	O
as	O	O	O
the	O	O	O
Dark	O	O	B-T168
Green	O	O	I-T168
and	O	O	O
Orange	O	O	B-T168
Vegetable	O	O	I-T168
and	O	O	O
Legume	O	O	B-T002
consumption	O	O	O
decreased	O	O	B-T081
significantly	O	O	I-T081
during	O	O	B-T079
treatment	O	O	I-T079
(	O	O	O
p	O	O	O
=	O	O	O
0.043	O	O	O
and	O	O	O
p	O	O	O
=	O	O	O
0.026	O	O	O
,	O	O	O
respectively	O	O	O
)	O	O	O
.	O	O	O

There	O	O	O
was	O	O	O
a	O	O	O
significant	O	O	B-T080
reduction	O	O	I-T080
in	O	O	O
the	O	O	O
intake	O	O	B-T169
of	O	O	O
macro	O	O	B-T077
and	O	O	O
micronutrients	O	O	B-T123
,	O	O	O
with	O	O	O
a	O	O	O
high	O	O	O
prevalence	O	O	B-T081
of	O	O	O
inadequacy	O	O	B-T080
,	O	O	O
of	O	O	O
up	O	O	O
to	O	O	O
100	O	O	O
%	O	O	O
,	O	O	O
for	O	O	O
calcium	O	O	B-T197
,	O	O	O
iron	O	O	B-T197
,	O	O	O
phosphorus	O	O	B-T196
,	O	O	O
magnesium	O	O	B-T196
,	O	O	O
niacin	O	O	B-T127
,	O	O	O
riboflavin	O	O	B-T127
,	O	O	O
thiamin	O	O	B-T127
,	O	O	O
vitamin	O	O	B-T127
B6	O	O	I-T127
,	O	O	O
vitamin	O	O	B-T127
C	O	O	I-T127
and	O	O	O
zinc	O	O	B-T196
.	O	O	O

Assessment	O	O	B-T060
of	O	O	O
the	O	O	O
nutritional	O	O	B-T033
status	O	O	I-T033
indicated	O	O	O
that	O	O	O
56	O	O	O
%	O	O	O
(	O	O	O
n	O	O	O
=	O	O	O
31	O	O	O
)	O	O	O
of	O	O	O
patients	O	O	B-T101
were	O	O	O
overweight	O	O	B-T184
at	O	O	O
these	O	O	O
three	O	O	O
different	O	O	O
times	O	O	O
.	O	O	O

Weight	O	O	B-T032
,	O	O	O
BMI	O	O	B-T201
and	O	O	O
Waist	O	O	B-T201
Circumference	O	O	I-T201
increased	O	O	B-T081
significantly	O	O	I-T081
,	O	O	O
indicating	O	O	O
a	O	O	O
worse	O	O	B-T033
nutritional	O	O	B-T033
status	O	O	I-T033
,	O	O	O
and	O	O	O
there	O	O	O
was	O	O	O
a	O	O	O
correlation	O	O	B-T080
between	O	O	O
poor	O	O	B-T080
diet	O	O	I-T080
quality	O	O	I-T080
and	O	O	O
higher	O	O	B-T080
values	O	O	I-T080
for	O	O	O
BMI	O	O	O
,	O	O	O
Waist-Hip	O	O	B-T032
Ratio	O	O	I-T032
and	O	O	O
Waist-to-Height	O	O	B-T033
Ratio	O	O	I-T033
.	O	O	O

Chemotherapy	O	O	B-T061
interferes	O	O	B-T169
in	O	O	O
the	O	O	O
patients	O	O	B-T101
'	O	O	O
diet	O	O	B-T168
generating	O	O	O
a	O	O	O
negative	O	O	B-T080
impact	O	O	B-T080
on	O	O	O
the	O	O	O
quality	O	O	B-T080
and	O	O	O
intake	O	O	B-T169
of	O	O	O
micro	O	O	B-T123
and	O	O	O
macronutrients	O	O	B-T077
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
an	O	O	O
impact	O	O	O
on	O	O	O
their	O	O	O
nutritional	O	O	B-T033
status	O	O	I-T033
,	O	O	O
with	O	O	O
an	O	O	O
increase	O	O	O
in	O	O	O
anthropometric	O	O	B-T081
measurements	O	O	I-T081
.	O	O	O

-DOCSTART- (27311447)

Benefit	O	O	O
and	O	O	O
risk	O	O	B-T058
in	O	O	O
short	O	O	O
term	O	O	O
after	O	O	O
total	O	O	B-T061
hip	O	O	I-T061
arthroplasty	O	O	I-T061
by	O	O	O
direct	O	O	B-T082
anterior	O	O	I-T082
approach	O	O	I-T082
combined	O	O	O
with	O	O	O
dual	O	O	O
mobility	O	O	O
cup	O	O	O

No	O	O	O
previous	O	O	O
reports	O	O	O
have	O	O	O
described	O	O	O
the	O	O	O
benefits	O	O	O
and	O	O	O
risks	O	O	B-T058
associated	O	O	O
with	O	O	O
the	O	O	O
dual	O	O	B-T074
mobility	O	O	I-T074
cup	O	O	I-T074
(	O	O	O
DMC	O	O	B-T074
)	O	O	O
in	O	O	O
primary	O	O	O
THA	O	O	B-T061
via	O	O	O
direct	O	O	B-T082
anterior	O	O	I-T082
approach	O	O	I-T082
(	O	O	O
DAA	O	O	B-T082
)	O	O	O
.	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
compare	O	O	O
the	O	O	O
safety	O	O	B-T062
and	O	O	O
rate	O	O	O
of	O	O	O
early	O	O	O
postoperative	O	O	B-T046
complication	O	O	I-T046
of	O	O	O
the	O	O	O
DAA	O	O	B-T082
with	O	O	O
the	O	O	O
DMC	O	O	B-T074
for	O	O	O
THA	O	O	B-T061
with	O	O	O
those	O	O	O
of	O	O	O
the	O	O	O
DAA	O	O	O
with	O	O	O
a	O	O	O
single	O	O	B-T074
standard	O	O	I-T074
cup	O	O	I-T074
,	O	O	O
and	O	O	O
to	O	O	O
investigate	O	O	O
the	O	O	O
influence	O	O	O
of	O	O	O
the	O	O	O
learning	O	O	O
curve	O	O	O
of	O	O	O
the	O	O	O
use	O	O	O
of	O	O	O
DMC	O	O	O
on	O	O	O
intra	O	O	B-T079
-	O	O	O
and	O	O	O
perioperative	O	O	B-T079
outcomes	O	O	B-T169
.	O	O	O

We	O	O	O
retrospectively	O	O	O
investigated	O	O	O
60	O	O	O
hips	O	O	B-T023
treated	O	O	B-T061
in	O	O	O
the	O	O	O
single-	O	O	O
DAA	O	O	B-T082
group	O	O	B-T078
and	O	O	O
60	O	O	O
hips	O	O	O
treated	O	O	O
in	O	O	O
the	O	O	O
dual-	O	O	O
DAA	O	O	O
group	O	O	O
.	O	O	O

A	O	O	O
primary	O	O	B-T080
/	O	O	O
secondary	O	O	B-T081
outcome	O	O	B-T169
variable	O	O	O
was	O	O	O
the	O	O	O
presence	O	O	O
of	O	O	O
any	O	O	O
intra	O	O	B-T046
-	O	O	O
or	O	O	O
perioperative	O	O	B-T079
complication	O	O	B-T046
within	O	O	O
the	O	O	O
first	O	O	O
6	O	O	O
months	O	O	B-T079
/the	O	O	O
operative	O	O	B-T079
time	O	O	I-T079
and	O	O	O
hip	O	O	O
function	O	O	O
at	O	O	O
6	O	O	O
months	O	O	O
postoperatively	O	O	B-T079
.	O	O	O

We	O	O	O
also	O	O	O
analyzed	O	O	O
influence	O	O	O
of	O	O	O
the	O	O	O
learning	O	O	O
curve	O	O	O
of	O	O	O
the	O	O	O
use	O	O	O
of	O	O	O
DMC	O	O	B-T074
on	O	O	O
intra	O	O	B-T079
-	O	O	O
and	O	O	O
perioperative	O	O	B-T079
outcomes	O	O	B-T169
.	O	O	O

No	O	O	B-T033
intraoperative	O	O	B-T046
complications	O	O	I-T046
were	O	O	O
observed	O	O	O
in	O	O	O
either	O	O	O
group	O	O	B-T078
.	O	O	O

One	O	O	O
anterior	O	O	B-T037
dislocation	O	O	I-T037
and	O	O	O
one	O	O	O
periprosthetic	O	O	B-T037
hip	O	O	I-T037
fracture	O	O	I-T037
were	O	O	O
occurred	O	O	O
in	O	O	O
the	O	O	O
single-	O	O	O
DAA	O	O	B-T082
group	O	O	B-T078
.	O	O	O

The	O	O	O
surgical	O	O	B-T079
times	O	O	I-T079
in	O	O	O
the	O	O	O
single-	O	O	O
DAA	O	O	B-T082
and	O	O	O
dual-	O	O	O
DAA	O	O	O
groups	O	O	B-T078
were	O	O	O
112.0	O	O	O
Â±	O	O	O
20.9	O	O	O
and	O	O	O
121.0	O	O	O
Â±	O	O	O
26.9	O	O	O
min	O	O	O
(	O	O	O
p	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
.	O	O	O

There	O	O	O
was	O	O	O
no	O	O	O
significant	O	O	O
difference	O	O	O
in	O	O	O
the	O	O	O
6-	O	O	O
month	O	O	B-T079
postoperative	O	O	B-T079
hip	O	O	B-T081
function	O	O	I-T081
scores	O	O	I-T081
between	O	O	O
the	O	O	O
two	O	O	O
groups	O	O	B-T078
.	O	O	O

There	O	O	O
was	O	O	O
no	O	O	O
influence	O	O	O
of	O	O	O
the	O	O	O
learning	O	O	O
curve	O	O	O
of	O	O	O
the	O	O	O
use	O	O	O
of	O	O	O
DMC	O	O	B-T074
on	O	O	O
intra	O	O	B-T079
-	O	O	O
and	O	O	O
perioperative	O	O	B-T079
outcomes	O	O	B-T169
.	O	O	O

We	O	O	O
have	O	O	O
demonstrated	O	O	O
the	O	O	O
short-term	O	O	O
safety	O	O	B-T062
and	O	O	O
lack	O	O	O
of	O	O	O
inferiority	O	O	O
of	O	O	O
using	O	O	O
the	O	O	O
DMC	O	O	B-T074
in	O	O	O
the	O	O	O
DAA	O	O	B-T082
compared	O	O	O
with	O	O	O
the	O	O	O
standard	O	O	B-T074
single	O	O	I-T074
mobility	O	O	I-T074
cup	O	O	I-T074
.	O	O	O

-DOCSTART- (27317610)

Diffuse	O	O	B-T037
traumatic	O	O	I-T037
brain	O	O	I-T037
injury	O	O	I-T037
affects	O	O	O
chronic	O	O	B-T079
corticosterone	O	O	B-T125
function	O	O	B-T169
in	O	O	O
the	O	O	O
rat	O	O	O

As	O	O	O
many	O	O	O
as	O	O	O
20	O	O	O
-	O	O	O
55	O	O	O
%	O	O	O
of	O	O	O
patients	O	O	B-T101
with	O	O	O
a	O	O	O
history	O	O	B-T033
of	O	O	O
traumatic	O	O	B-T037
brain	O	O	I-T037
injury	O	O	I-T037
(	O	O	O
TBI	O	O	B-T037
)	O	O	O
experience	O	O	O
chronic	O	O	B-T079
endocrine	O	O	B-T047
dysfunction	O	O	I-T047
,	O	O	O
leading	O	O	O
to	O	O	O
impaired	O	O	B-T169
quality	O	O	I-T054
of	O	O	I-T054
life	O	O	I-T054
,	O	O	O
impaired	O	O	O
rehabilitation	O	O	B-T169
efforts	O	O	B-T051
and	O	O	O
lowered	O	O	B-T033
life	O	O	I-T033
expectancy	O	O	I-T033
.	O	O	O

Endocrine	O	O	B-T047
dysfunction	O	O	B-T046
after	O	O	O
TBI	O	O	B-T037
is	O	O	O
thought	O	O	O
to	O	O	O
result	O	O	B-T169
from	O	O	O
acceleration	O	O	B-T067
-	O	O	O
deceleration	O	O	B-T070
forces	O	O	B-T067
to	O	O	O
the	O	O	O
brain	O	O	B-T023
within	O	O	O
the	O	O	O
skull	O	O	B-T023
,	O	O	O
creating	O	O	O
enduring	O	O	O
hypothalamic	O	O	B-T023
and	O	O	O
pituitary	O	O	B-T023
neuropathology	O	O	B-T046
,	O	O	O
and	O	O	O
subsequent	O	O	O
hypothalamic	O	O	B-T022
-pituitary	O	O	I-T022
endocrine	O	O	I-T022
(	O	O	O
HPE	O	O	B-T022
)	O	O	O
dysfunction	O	O	O
.	O	O	O

These	O	O	O
experiments	O	O	B-T062
were	O	O	O
designed	O	O	O
to	O	O	O
test	O	O	O
the	O	O	O
hypothesis	O	O	B-T078
that	O	O	O
a	O	O	O
single	O	O	O
diffuse	O	O	B-T037
TBI	O	O	I-T037
results	O	O	B-T169
in	O	O	O
chronic	O	O	B-T079
dysfunction	O	O	B-T046
of	O	O	O
corticosterone	O	O	B-T125
(	O	O	O
CORT	O	O	B-T125
)	O	O	O
,	O	O	O
a	O	O	O
glucocorticoid	O	O	B-T125
released	O	O	B-T169
in	O	O	O
response	O	O	O
to	O	O	O
stress	O	O	B-T046
and	O	O	O
testosterone	O	O	B-T125
.	O	O	O

We	O	O	O
used	O	O	O
a	O	O	O
rodent	O	O	B-T050
model	O	O	I-T050
of	O	O	O
diffuse	O	O	B-T037
TBI	O	O	I-T037
induced	O	O	O
by	O	O	O
midline	O	O	B-T037
fluid	O	O	I-T037
percussion	O	O	I-T037
injury	O	O	I-T037
(	O	O	O
mFPI	O	O	B-T037
)	O	O	O
.	O	O	O

At	O	O	O
2	O	O	O
months	O	O	B-T079
postinjury	O	O	B-T079
compared	O	O	B-T052
with	O	O	O
uninjured	O	O	B-T008
control	O	O	I-T008
animals	O	O	I-T008
,	O	O	O
circulating	O	O	B-T169
levels	O	O	B-T080
of	O	O	O
CORT	O	O	B-T125
were	O	O	O
evaluated	O	O	O
at	O	O	B-T169
rest	O	O	I-T169
,	O	O	O
under	O	O	O
restraint	O	O	B-T046
stress	O	O	I-T046
and	O	O	O
in	O	O	O
response	O	O	O
to	O	O	O
dexamethasone	O	O	B-T109
,	O	O	O
a	O	O	O
synthetic	O	O	B-T109
glucocorticoid	O	O	I-T109
commonly	O	O	O
used	O	O	O
to	O	O	O
test	O	O	O
HPE	O	O	B-T022
axis	O	O	B-T082
regulation	O	O	B-T038
.	O	O	O

Testosterone	O	O	B-T125
was	O	O	O
evaluated	O	O	B-T169
at	O	O	B-T169
rest	O	O	I-T169
.	O	O	O

Further	O	O	O
,	O	O	O
we	O	O	O
assessed	O	O	O
changes	O	O	B-T169
in	O	O	O
injury	O	O	B-T037
-	O	O	O
induced	O	O	B-T169
neuron	O	O	B-T025
morphology	O	O	B-T080
(	O	O	O
Golgi	O	O	B-T059
stain	O	O	I-T059
)	O	O	O
,	O	O	O
neuropathology	O	O	B-T046
(	O	O	O
silver	O	O	B-T059
stain	O	O	I-T059
)	O	O	O
and	O	O	O
activated	O	O	B-T043
astrocytes	O	O	B-T025
(	O	O	O
GFAP	O	O	B-T059
)	O	O	O
in	O	O	O
the	O	O	O
paraventricular	O	O	B-T023
nucleus	O	O	I-T023
(	O	O	O
PVN	O	O	B-T023
)	O	O	O
of	O	O	O
the	O	O	O
hypothalamus	O	O	B-T023
.	O	O	O

Resting	O	O	O
plasma	O	O	B-T031
CORT	O	O	B-T125
levels	O	O	B-T080
were	O	O	O
decreased	O	O	B-T081
at	O	O	O
2	O	O	O
months	O	O	B-T079
postinjury	O	O	B-T079
and	O	O	O
there	O	O	O
was	O	O	O
a	O	O	O
blunted	O	O	O
CORT	O	O	O
increase	O	O	B-T081
in	O	O	O
response	O	O	O
to	O	O	O
restraint	O	O	B-T046
induced	O	O	I-T046
stress	O	O	I-T046
.	O	O	O

No	O	O	B-T033
changes	O	O	I-T033
in	O	O	O
testosterone	O	O	B-T125
were	O	O	O
measured	O	O	B-T080
.	O	O	O

These	O	O	O
changes	O	O	B-T169
in	O	O	O
CORT	O	O	B-T125
were	O	O	O
observed	O	O	O
concomitantly	O	O	B-T079
with	O	O	O
altered	O	O	B-T169
complexity	O	O	B-T080
of	O	O	O
neuron	O	O	B-T025
processes	O	O	B-T043
in	O	O	O
the	O	O	O
PVN	O	O	B-T023
over	O	O	O
time	O	O	B-T079
,	O	O	O
devoid	O	O	O
of	O	O	O
neuropathology	O	O	B-T046
or	O	O	O
astrocytosis	O	O	B-T046
.	O	O	O

Results	O	O	B-T169
provide	O	O	O
evidence	O	O	O
that	O	O	O
a	O	O	O
single	O	O	O
moderate	O	O	O
diffuse	O	O	B-T037
TBI	O	O	I-T037
leads	O	O	O
to	O	O	O
changes	O	O	B-T169
in	O	O	O
CORT	O	O	B-T125
function	O	O	B-T169
,	O	O	O
which	O	O	O
can	O	O	O
contribute	O	O	O
to	O	O	O
the	O	O	O
persistence	O	O	B-T033
of	O	O	I-T033
symptoms	O	O	I-T033
related	O	O	O
to	O	O	O
endocrine	O	O	B-T047
dysfunction	O	O	I-T047
.	O	O	O

Future	O	O	O
experiments	O	O	B-T062
aim	O	O	O
to	O	O	O
evaluate	O	O	B-T169
additional	O	O	O
HP-related	O	O	B-T125
hormones	O	O	I-T125
and	O	O	O
endocrine	O	O	B-T022
circuit	O	O	B-T169
pathology	O	O	I-T169
following	O	O	O
diffuse	O	O	B-T037
TBI	O	O	I-T037
.	O	O	O

-DOCSTART- (27320055)

Methamphetamine	O	O	B-T109
,	O	O	O
3,4-methylenedioxymethamphetamine	O	O	B-T109
(	O	O	O
MDMA	O	O	B-T109
)	O	O	O
and	O	O	O
3,4-methylenedioxypyrovalerone	O	O	B-T109
(	O	O	O
MDPV	O	O	B-T109
)	O	O	O
induce	O	O	B-T169
differential	O	O	B-T080
cytotoxic	O	O	B-T049
effects	O	O	I-T049
in	O	O	O
bovine	O	O	B-T015
brain	O	O	B-T023
microvessel	O	O	B-T023
endothelial	O	O	O
cells	O	O	O

Designer	O	O	B-T131
drugs	O	O	I-T131
such	O	O	O
as	O	O	O
synthetic	O	O	B-T121
psychostimulants	O	O	I-T121
are	O	O	O
indicative	O	O	O
of	O	O	O
a	O	O	O
worldwide	O	O	O
problem	O	O	B-T033
of	O	O	O
drug	O	O	B-T048
abuse	O	O	I-T048
and	O	O	O
addiction	O	O	B-T048
.	O	O	O

In	O	O	O
addition	O	O	O
to	O	O	O
methamphetamine	O	O	B-T109
(	O	O	O
METH	O	O	B-T109
)	O	O	O
,	O	O	O
these	O	O	O
drugs	O	O	B-T131
include	O	O	O
3,4-methylenedioxy-methamphetamine	O	O	B-T109
(	O	O	O
MDMA	O	O	B-T109
)	O	O	O
and	O	O	O
commercial	O	O	B-T170
preparations	O	O	B-T052
of	O	O	O
synthetic	O	O	B-T109
cathinones	O	O	I-T109
including	O	O	O
3,4-methylenedioxypyrovalerone	O	O	B-T109
(	O	O	O
MDPV	O	O	B-T109
)	O	O	O
,	O	O	O
typically	O	O	O
referred	O	O	O
to	O	O	O
as	O	O	O
"	O	O	O
bath	O	O	B-T109
salts	O	O	I-T109
.	O	O	O
"	O	O	O
These	O	O	O
psychostimulants	O	O	B-T121
exert	O	O	O
neurotoxic	O	O	B-T037
effects	O	O	I-T037
by	O	O	O
altering	O	O	B-T078
monoamine	O	O	B-UnknownType
systems	O	O	I-UnknownType
in	O	O	O
the	O	O	O
brain	O	O	B-T023
.	O	O	O

Additionally	O	O	O
,	O	O	O
METH	O	O	B-T109
and	O	O	O
MDMA	O	O	B-T109
adversely	O	O	B-T046
affect	O	O	I-T046
the	O	O	O
integrity	O	O	B-T080
of	O	O	O
the	O	O	O
blood-brain	O	O	B-T023
barrier	O	O	I-T023
(	O	O	O
BBB	O	O	B-T023
):	O	O	O
there	O	O	O
are	O	O	O
no	O	O	O
current	O	O	O
reports	O	O	B-T170
on	O	O	O
the	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
MDPV	O	O	B-T109
on	O	O	O
the	O	O	O
BBB	O	O	O
.	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
compare	O	O	B-T052
the	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
METH	O	O	B-T109
,	O	O	O
MDMA	O	O	B-T109
and	O	O	O
MDPV	O	O	B-T109
on	O	O	O
bovine	O	O	B-T015
brain	O	O	B-T023
microvessel	O	O	B-T023
endothelial	O	O	B-T025
cells	O	O	I-T025
(	O	O	O
bBMVECs	O	O	B-T025
)	O	O	O
,	O	O	O
an	O	O	O
accepted	O	O	O
in	O	O	B-T062
vitro	O	O	I-T062
model	O	O	I-T062
of	O	O	O
the	O	O	O
BBB	O	O	B-T023
.	O	O	O

Confluent	O	O	B-T080
bBMVEC	O	O	B-T025
monolayers	O	O	B-T023
were	O	O	O
treated	O	O	B-T169
with	O	O	O
METH	O	O	B-T109
,	O	O	O
MDMA	O	O	B-T109
and	O	O	O
MDPV	O	O	B-T109
(	O	O	O
0.5mM-2.5mM	O	O	O
)	O	O	O
for	O	O	O
24h	O	O	O
.	O	O	O

METH	O	O	B-T109
and	O	O	O
MDMA	O	O	B-T109
increased	O	O	B-T081
lactate	O	O	B-T116
dehydrogenase	O	O	I-T116
release	O	O	B-T169
only	O	O	O
at	O	O	O
the	O	O	O
highest	O	O	B-T080
concentration	O	O	B-T081
(	O	O	O
2.5mM	O	O	O
)	O	O	O
,	O	O	O
whereas	O	O	O
MDPV	O	O	B-T109
induced	O	O	B-T169
cytotoxicity	O	O	B-T049
at	O	O	O
all	O	O	O
concentration	O	O	O
s.	O	O	O
MDMA	O	O	O
and	O	O	O
METH	O	O	O
decreased	O	O	B-T081
cellular	O	O	B-T043
proliferation	O	O	I-T043
only	O	O	O
at	O	O	O
2.5mM	O	O	O
,	O	O	O
with	O	O	O
similar	O	O	O
effects	O	O	B-T080
observed	O	O	O
after	O	O	O
MDPV	O	O	O
exposures	O	O	B-T080
starting	O	O	O
at	O	O	O
1mM.	O	O	O
Only	O	O	O
MDPV	O	O	O
increased	O	O	O
reactive	O	O	B-T123
oxygen	O	O	I-T123
species	O	O	I-T123
production	O	O	B-T052
at	O	O	O
all	O	O	O
concentrations	O	O	B-T081
tested	O	O	B-T169
whereas	O	O	O
all	O	O	O
3	O	O	O
drugs	O	O	B-T131
increased	O	O	O
nitric	O	O	B-T121
oxide	O	O	I-T121
production	O	O	O
.	O	O	O

Morphological	O	O	B-T062
analysis	O	O	I-T062
revealed	O	O	O
different	O	O	B-T080
patterns	O	O	O
of	O	O	O
compound	O	O	B-T103
-	O	O	O
induced	O	O	B-T169
cell	O	O	B-T049
damage	O	O	I-T049
.	O	O	O

METH	O	O	B-T109
induced	O	O	B-T169
vacuole	O	O	B-T026
formatio	O	O	B-T169
n	O	O	O
at	O	O	O
1mM	O	O	O
and	O	O	O
disruption	O	O	B-T169
of	O	O	O
the	O	O	O
monolayer	O	O	B-T023
at	O	O	O
2.5mM.	O	O	O
MDMA	O	O	B-T109
induced	O	O	O
disruption	O	O	O
of	O	O	O
the	O	O	O
endothelial	O	O	B-T025
monolayer	O	O	O
from	O	O	O
1mM	O	O	O
without	O	O	O
vacuolization	O	O	B-T033
.	O	O	O

On	O	O	O
the	O	O	O
other	O	O	O
hand	O	O	O
,	O	O	O
MDPV	O	O	B-T109
induced	O	O	B-T169
monolayer	O	O	B-T023
disruption	O	O	B-T169
at	O	O	O
doses	O	O	B-T081
â¥0.5mM	O	O	O
without	O	O	O
vacuole	O	O	B-T026
formation	O	O	B-T169
;	O	O	O
at	O	O	O
2.5mM	O	O	O
,	O	O	O
the	O	O	O
few	O	O	O
remaining	O	O	O
cells	O	O	B-T025
lacked	O	O	O
endothelial	O	O	B-T080
morphology	O	O	I-T080
.	O	O	O

These	O	O	O
data	O	O	B-T078
suggest	O	O	O
that	O	O	O
even	O	O	O
though	O	O	O
these	O	O	O
synthetic	O	O	B-T121
psychostimulants	O	O	I-T121
alter	O	O	O
monoaminergic	O	O	B-UnknownType
systems	O	O	I-UnknownType
,	O	O	O
they	O	O	O
each	O	O	O
induce	O	O	B-T169
BBB	O	O	B-T023
toxicity	O	O	B-T037
by	O	O	O
different	O	O	B-T080
mechanisms	O	O	B-T169
with	O	O	O
MDPV	O	O	B-T109
being	O	O	O
the	O	O	O
most	O	O	O
toxic	O	O	B-T080
.	O	O	O

-DOCSTART- (27320863)

Alleviation	O	O	B-T080
of	O	O	O
hepatic	O	O	B-T029
fat	O	O	B-T033
accumulation	O	O	I-T033
by	O	O	O
betaine	O	O	B-T109
involves	O	O	O
reduction	O	O	B-T080
of	O	O	O
homocysteine	O	O	B-T116
via	O	O	O
up-regulation	O	O	B-T044
of	O	O	O
betaine-homocysteine	O	O	B-T116
methyltransferase	O	O	I-T116
(	O	O	O
BHMT	O	O	B-T116
)	O	O	O

We	O	O	O
investigated	O	O	B-T169
the	O	O	O
anti-lipogenic	O	O	B-T169
effect	O	O	I-T169
of	O	O	O
betaine	O	O	B-T109
in	O	O	O
rats	O	O	B-T015
fed	O	O	O
methionine	O	O	B-T116
and	O	O	O
choline	O	O	B-T109
-	O	O	O
deficient	O	O	B-T080
diet	O	O	B-T168
(	O	O	O
MCD	O	O	B-T168
)	O	O	O
.	O	O	O

Intake	O	O	O
of	O	O	O
MCD	O	O	B-T168
for	O	O	O
3	O	O	O
wk	O	O	O
resulted	O	O	O
in	O	O	O
a	O	O	O
significant	O	O	B-T078
accumulation	O	O	B-T033
of	O	O	O
hepatic	O	O	B-T029
lipids	O	O	B-T109
,	O	O	O
which	O	O	O
was	O	O	O
prevented	O	O	B-T080
by	O	O	O
betaine	O	O	B-T109
supplementation	O	O	B-T061
in	O	O	O
drinking	O	O	B-T167
water	O	O	I-T167
(	O	O	O
1	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

Phosphorylation	O	O	B-T044
of	O	O	O
AMP-activated	O	O	B-T116
protein	O	O	I-T116
kinase	O	O	I-T116
(	O	O	O
AMPK	O	O	B-T116
)	O	O	O
,	O	O	O
acetyl-CoA	O	O	B-T116
carboxylase	O	O	I-T116
(	O	O	O
ACC	O	O	B-T116
)	O	O	O
,	O	O	O
sterol	O	O	B-T116
regulatory	O	O	I-T116
element-binding	O	O	I-T116
protein	O	O	I-T116
1c	O	O	I-T116
(	O	O	O
SREBP-1c	O	O	B-T116
)	O	O	O
,	O	O	O
and	O	O	O
liver	O	O	B-T116
kinase	O	O	I-T116
B1	O	O	I-T116
(	O	O	O
LKB1	O	O	B-T116
)	O	O	O
was	O	O	O
inhibited	O	O	B-T080
by	O	O	O
MCD	O	O	B-T168
intake	O	O	B-T169
,	O	O	O
and	O	O	O
these	O	O	O
changes	O	O	O
were	O	O	O
all	O	O	O
inhibited	O	O	O
by	O	O	O
betaine	O	O	B-T109
feeding	O	O	B-T058
.	O	O	O

Meanwhile	O	O	O
,	O	O	O
betaine	O	O	B-T109
supplementation	O	O	B-T061
reversed	O	O	B-T169
the	O	O	O
reduction	O	O	B-T080
of	O	O	O
methionine	O	O	B-T044
and	O	O	I-T044
S-adenosylmethionine	O	O	I-T044
(	O	O	O
SAM	O	O	B-T044
)	O	O	O
,	O	O	O
and	O	O	O
the	O	O	O
elevation	O	O	B-T080
of	O	O	O
homocysteine	O	O	B-T059
levels	O	O	I-T059
in	O	O	O
the	O	O	O
liver	O	O	B-T023
,	O	O	I-T023
which	O	O	O
could	O	O	O
be	O	O	O
attributable	O	O	O
to	O	O	O
the	O	O	O
induction	O	O	B-T045
of	O	O	O
betaine-homocysteine	O	O	B-T116
methyltransfease	O	O	I-T116
(	O	O	O
BHMT	O	O	B-T116
)	O	O	O
and	O	O	O
methionine	O	O	B-T116
adenosyltransferase	O	O	I-T116
(	O	O	O
MAT	O	O	B-T116
)	O	O	O
.	O	O	O

Different	O	O	B-T080
cell	O	O	B-T025
lines	O	O	I-T025
were	O	O	O
used	O	O	O
to	O	O	O
clarify	O	O	O
the	O	O	O
role	O	O	O
of	O	O	O
homocysteine	O	O	B-T116
on	O	O	O
activation	O	O	B-T044
of	O	O	O
the	O	O	O
AMPK	O	O	B-T116
pathway	O	O	B-T044
.	O	O	O

Homocysteine	O	O	B-T116
treatment	O	O	B-T169
decreased	O	O	B-T081
pAMPK	O	O	B-T116
,	O	O	O
pACC	O	O	B-T116
,	O	O	O
pSREBP-1c	O	O	B-T116
and	O	O	O
pLKB1	O	O	B-T116
in	O	O	O
HepG2	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

Metformin	O	O	B-T109
-	O	O	O
induced	O	O	B-T169
activation	O	O	B-T044
of	O	O	O
AMPK	O	O	B-T116
was	O	O	O
also	O	O	O
inhibited	O	O	B-T080
by	O	O	O
homocysteine	O	O	B-T116
.	O	O	O

Treatment	O	O	B-T169
with	O	O	O
hydroxylamine	O	O	B-T197
,	O	O	O
a	O	O	O
cystathionine	O	O	B-T116
Î²-synthase	O	O	I-T116
inhibitor	O	O	B-T121
,	O	O	O
resulted	O	O	O
in	O	O	O
a	O	O	O
reduction	O	O	B-T080
of	O	O	O
pAMPK	O	O	B-T116
,	O	O	O
pACC	O	O	B-T116
and	O	O	O
pSREBP-1c	O	O	B-T116
,	O	O	O
accompanied	O	O	O
by	O	O	O
an	O	O	O
elevation	O	O	B-T080
of	O	O	O
intracellular	O	O	B-T082
homocysteine	O	O	B-T116
.	O	O	O

Betaine	O	O	B-T109
treatment	O	O	B-T061
prevented	O	O	B-T080
the	O	O	O
homocysteine	O	O	B-T116
-	O	O	O
induced	O	O	B-T169
reduction	O	O	B-T080
of	O	O	O
pAMPK	O	O	B-T116
,	O	O	O
pACC	O	O	B-T116
,	O	O	O
pSREBP-1c	O	O	B-T116
and	O	O	O
pLKB1	O	O	B-T116
in	O	O	O
H4IIE	O	O	B-T025
cells	O	O	I-T025
,	O	O	O
but	O	O	O
not	O	O	O
in	O	O	O
HepG2	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

Also	O	O	O
the	O	O	O
elevation	O	O	B-T080
of	O	O	O
cellular	O	O	O
homocysteine	O	O	B-T116
and	O	O	O
inhibition	O	O	B-T052
of	O	O	O
protein	O	O	B-T045
expression	O	O	I-T045
of	O	O	O
BHMT	O	O	B-T116
were	O	O	O
prevented	O	O	B-T080
by	O	O	O
betaine	O	O	B-T109
only	O	O	O
in	O	O	O
H4IIE	O	O	B-T025
cells	O	O	I-T025
which	O	O	O
express	O	O	B-T045
BHMT	O	O	O
.	O	O	O

The	O	O	O
results	O	O	O
suggest	O	O	O
that	O	O	O
the	O	O	O
beneficial	O	O	O
effect	O	O	O
of	O	O	O
betaine	O	O	B-T109
against	O	O	O
hepatic	O	O	B-T029
lipid	O	O	B-T109
accumulation	O	O	B-T033
may	O	O	O
be	O	O	O
attributed	O	O	B-T078
,	O	O	O
at	O	O	O
least	O	O	O
in	O	O	O
part	O	O	O
,	O	O	O
to	O	O	O
the	O	O	O
depletion	O	O	B-T169
of	O	O	O
homocysteine	O	O	B-T116
via	O	O	O
up-regulation	O	O	B-T044
of	O	O	O
BHMT	O	O	B-T116
in	O	O	O
hepatocytes	O	O	B-T025
.	O	O	O

-DOCSTART- (27321892)

Dual-color	O	O	B-T059
STED	O	O	I-T059
microscopy	O	O	I-T059
reveals	O	O	O
a	O	O	O
sandwich	O	O	B-T082
structure	O	O	I-T082
of	O	O	O
Bassoon	O	O	B-T116
and	O	O	O
Piccolo	O	O	B-T116
in	O	O	O
active	O	O	B-T026
zones	O	O	I-T026
of	O	O	O
adult	O	O	B-T100
and	O	O	O
aged	O	O	B-T032
mice	O	O	O

Presynaptic	O	O	B-T026
active	O	O	B-T026
zones	O	O	I-T026
play	O	O	O
a	O	O	O
pivotal	O	O	O
role	O	O	O
as	O	O	O
synaptic	O	O	B-T026
vesicle	O	O	I-T026
release	O	O	B-T029
sites	O	O	I-T029
for	O	O	O
synaptic	O	O	B-T043
transmission	O	O	I-T043
,	O	O	O
but	O	O	O
the	O	O	O
molecular	O	O	B-T082
architecture	O	O	I-T082
of	O	O	O
active	O	O	O
zones	O	O	O
in	O	O	O
mammalian	O	O	B-T015
neuromuscular	O	O	B-T026
junctions	O	O	I-T026
(	O	O	O
NMJs	O	O	B-T026
)	O	O	O
at	O	O	O
sub-diffraction	O	O	B-T077
limited	O	O	I-T077
resolution	O	O	I-T077
remains	O	O	O
unknown	O	O	O
.	O	O	O

Bassoon	O	O	B-T116
and	O	O	O
Piccolo	O	O	B-T116
are	O	O	O
active	O	O	B-T026
zone	O	O	I-T026
specific	O	O	O
cytosolic	O	O	B-T026
proteins	O	O	B-T116
essential	O	O	O
for	O	O	O
active	O	O	B-T043
zone	O	O	I-T043
assembly	O	O	I-T043
in	O	O	O
NMJs	O	O	B-T026
,	O	O	O
ribbon	O	O	B-T030
synapses	O	O	B-T030
,	O	O	O
and	O	O	O
brain	O	O	B-T023
synapses	O	O	O
.	O	O	O

These	O	O	O
proteins	O	O	B-T116
are	O	O	O
thought	O	O	O
to	O	O	O
colocalize	O	O	B-T082
and	O	O	O
share	O	O	O
some	O	O	O
functions	O	O	O
at	O	O	O
active	O	O	B-T026
zones	O	O	I-T026
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
report	O	O	O
an	O	O	O
unexpected	O	O	O
finding	O	O	O
of	O	O	O
non-overlapping	O	O	B-T043
localization	O	O	I-T043
of	O	O	O
these	O	O	O
two	O	O	O
proteins	O	O	B-T116
in	O	O	O
mouse	O	O	B-T015
NMJs	O	O	B-T026
revealed	O	O	O
using	O	O	O
dual-color	O	O	B-T070
stimulated	O	O	I-T070
emission	O	O	I-T070
depletion	O	O	I-T070
(	O	O	O
STED	O	O	B-T070
)	O	O	O
super	O	O	B-T059
resolution	O	O	I-T059
microscopy	O	O	I-T059
.	O	O	O

Piccolo	O	O	B-T116
puncta	O	O	B-T033
sandwiched	O	O	O
Bassoon	O	O	B-T116
puncta	O	O	O
and	O	O	O
aligned	O	O	B-T081
in	O	O	O
a	O	O	O
Piccolo	O	O	O
-	O	O	O
Bassoon	O	O	O
-	O	O	O
Piccolo	O	O	O
structure	O	O	B-T082
in	O	O	O
adult	O	O	B-T100
NMJs	O	O	B-T026
.	O	O	O

P/Q-type	O	O	B-T116
voltage-gated	O	O	I-T116
calcium	O	O	I-T116
channel	O	O	I-T116
(	O	O	O
VGCC	O	O	B-T116
)	O	O	O
puncta	O	O	B-T033
colocalized	O	O	B-T082
with	O	O	O
Bassoon	O	O	B-T116
puncta	O	O	O
.	O	O	O

The	O	O	O
P/Q-type	O	O	B-T116
VGCC	O	O	I-T116
and	O	O	O
Bassoon	O	O	B-T116
protein	O	O	B-T034
levels	O	O	I-T034
decreased	O	O	B-T081
significantly	O	O	O
in	O	O	O
NMJs	O	O	B-T026
from	O	O	O
aged	O	O	B-T032
mouse	O	O	B-T015
.	O	O	O

In	O	O	O
contrast	O	O	O
,	O	O	O
the	O	O	O
Piccolo	O	O	B-T116
levels	O	O	B-T034
in	O	O	O
NMJs	O	O	B-T026
from	O	O	O
aged	O	O	B-T032
mice	O	O	B-T015
were	O	O	O
comparable	O	O	O
to	O	O	O
levels	O	O	O
in	O	O	O
adult	O	O	B-T100
mice	O	O	O
.	O	O	O

This	O	O	O
study	O	O	O
revealed	O	O	O
the	O	O	O
molecular	O	O	B-T082
architecture	O	O	I-T082
of	O	O	O
active	O	O	B-T026
zones	O	O	I-T026
in	O	O	O
mouse	O	O	B-T015
NMJs	O	O	B-T026
at	O	O	O
sub-diffraction	O	O	B-T077
limited	O	O	I-T077
resolution	O	O	I-T077
,	O	O	O
and	O	O	O
described	O	O	O
the	O	O	O
selective	O	O	B-T043
degeneration	O	O	I-T043
mechanism	O	O	I-T043
of	O	O	O
active	O	O	B-T026
zone	O	O	I-T026
proteins	O	O	B-T116
in	O	O	O
NMJs	O	O	O
from	O	O	O
aged	O	O	B-T032
mice	O	O	B-T015
.	O	O	O

Interestingly	O	O	O
,	O	O	O
the	O	O	O
localization	O	O	B-T043
pattern	O	O	I-T043
of	O	O	O
active	O	O	B-T026
zone	O	O	I-T026
proteins	O	O	B-T116
described	O	O	O
herein	O	O	O
is	O	O	O
similar	O	O	O
to	O	O	O
active	O	O	O
zone	O	O	O
structures	O	O	B-T082
described	O	O	O
using	O	O	O
electron	O	O	B-T059
microscope	O	O	I-T059
tomography	O	O	I-T059
.	O	O	O

-DOCSTART- (27325393)

Molecular	O	O	B-T080
serum	O	O	B-T031
signature	O	O	B-T201
of	O	O	O
treatment	O	O	O
resistant	O	O	O
depression	O	O	O

A	O	O	O
substantial	O	O	O
number	O	O	O
of	O	O	O
patients	O	O	O
suffering	O	O	O
from	O	O	O
major	O	O	B-T048
depressive	O	O	I-T048
disorder	O	O	I-T048
(	O	O	O
MDD	O	O	B-T048
)	O	O	O
do	O	O	O
not	O	O	O
respond	O	O	O
to	O	O	O
multiple	O	O	B-T081
trials	O	O	B-T062
of	O	O	O
anti-depressants	O	O	B-T121
,	O	O	O
develop	O	O	O
a	O	O	O
chronic	O	O	B-T079
course	O	O	B-T046
of	O	O	I-T046
disease	O	O	I-T046
and	O	O	O
become	O	O	O
treatment	O	O	B-T061
resistant	O	O	B-T039
.	O	O	O

Most	O	O	O
of	O	O	O
the	O	O	O
studies	O	O	O
investigating	O	O	O
molecular	O	O	B-T080
changes	O	O	B-T169
in	O	O	O
treatment-resistant	O	O	B-T048
depression	O	O	I-T048
(	O	O	O
TRD	O	O	B-T048
)	O	O	O
have	O	O	O
only	O	O	O
examined	O	O	O
a	O	O	O
limited	O	O	O
number	O	O	O
of	O	O	O
molecules	O	O	O
and	O	O	O
genes	O	O	B-T028
.	O	O	O

Consequently	O	O	O
,	O	O	O
biomarkers	O	O	B-T201
associated	O	O	O
with	O	O	O
TRD	O	O	B-T048
are	O	O	O
still	O	O	O
lacking	O	O	O
.	O	O	O

This	O	O	O
study	O	O	O
aimed	O	O	O
to	O	O	O
use	O	O	O
recently	O	O	O
advanced	O	O	O
high-throughput	O	O	B-T091
proteomic	O	O	I-T091
platforms	O	O	I-T091
to	O	O	O
identify	O	O	O
peripheral	O	O	B-T082
biomarkers	O	O	B-T201
of	O	O	O
TRD	O	O	B-T048
defined	O	O	O
by	O	O	O
two	O	O	O
staging	O	O	B-T170
models	O	O	I-T170
,	O	O	O
the	O	O	O
Thase	O	O	B-T170
and	O	O	I-T170
Rush	O	O	I-T170
staging	O	O	I-T170
model	O	O	I-T170
(	O	O	O
TRM	O	O	B-T170
)	O	O	O
and	O	O	O
the	O	O	O
Maudsley	O	O	B-T170
Staging	O	O	I-T170
Model	O	O	I-T170
(	O	O	O
MSM	O	O	B-T170
)	O	O	O
.	O	O	O

Serum	O	O	B-T031
collected	O	O	O
from	O	O	O
an	O	O	O
inpatient	O	O	B-T101
cohort	O	O	O
of	O	O	O
65	O	O	O
individuals	O	O	B-T098
suffering	O	O	O
from	O	O	O
MDD	O	O	B-T048
was	O	O	O
analysed	O	O	O
using	O	O	O
two	O	O	O
different	O	O	O
mass	O	O	B-T059
spectrometric-based	O	O	I-T059
platforms	O	O	I-T059
,	O	O	O
label-free	O	O	B-T059
liquid	O	O	I-T059
chromatography	O	O	I-T059
mass	O	O	I-T059
spectrometry	O	O	I-T059
(	O	O	O
LC-MS(E	O	O	B-T059
)	O	O	I-T059
)	O	O	O
and	O	O	O
selective	O	O	B-T169
reaction	O	O	I-T169
monitoring	O	O	I-T169
(	O	O	O
SRM	O	O	B-T169
)	O	O	O
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
a	O	O	O
multiplex	O	O	B-T059
bead	O	O	I-T059
based	O	O	I-T059
assay	O	O	I-T059
.	O	O	O

In	O	O	O
the	O	O	O
LC-MS(E	O	O	B-T059
)	O	O	I-T059
analysis	O	O	I-T059
,	O	O	O
proteins	O	O	B-T116
involved	O	O	O
in	O	O	O
the	O	O	O
acute	O	O	B-T046
phase	O	O	I-T046
response	O	O	I-T046
and	O	O	O
complement	O	O	B-T044
activation	O	O	I-T044
and	O	O	O
coagulation	O	O	B-T039
were	O	O	O
significantly	O	O	O
different	O	O	O
between	O	O	O
the	O	O	O
staging	O	O	B-T170
groups	O	O	I-T170
in	O	O	O
both	O	O	O
models	O	O	B-T170
.	O	O	O

In	O	O	O
the	O	O	O
multiplex	O	O	B-T059
bead-based	O	O	I-T059
assay	O	O	I-T059
analysis	O	O	O
TNF-Î±	O	O	B-T059
levels	O	O	I-T059
(	O	O	O
log(odds	O	O	B-T081
)	O	O	I-T081
=	O	O	O
-4.95	O	O	O
,	O	O	O
p	O	O	O
=	O	O	O
0.045	O	O	O
)	O	O	O
were	O	O	O
significantly	O	O	B-T081
different	O	O	B-T080
in	O	O	O
the	O	O	O
TRM	O	O	B-T170
comparison	O	O	B-T052
.	O	O	O

Using	O	O	O
SRM	O	O	B-T169
,	O	O	O
significant	O	O	B-T081
changes	O	O	B-T169
of	O	O	O
three	O	O	O
apolipoproteins	O	O	B-T116
A-I	O	O	I-T116
(	O	O	O
Î²	O	O	O
=	O	O	O
0.029	O	O	O
,	O	O	O
p	O	O	O
=	O	O	O
0.035	O	O	O
)	O	O	O
,	O	O	O
M	O	O	B-T116
(	O	O	O
Î²	O	O	O
=	O	O	O
-0.017	O	O	O
,	O	O	O
p	O	O	O
=	O	O	O
0.009	O	O	O
)	O	O	O
and	O	O	O
F	O	O	B-T116
(	O	O	O
Î²	O	O	O
=	O	O	O
-0.031	O	O	O
,	O	O	O
p	O	O	O
=	O	O	O
0.024	O	O	O
)	O	O	O
were	O	O	O
associated	O	O	O
with	O	O	O
the	O	O	O
TRM	O	O	B-T170
but	O	O	O
not	O	O	O
the	O	O	O
MSM	O	O	B-T170
.	O	O	O

Overall	O	O	O
,	O	O	O
our	O	O	O
findings	O	O	B-T033
suggest	O	O	O
that	O	O	O
proteins	O	O	B-T116
,	O	O	O
which	O	O	O
are	O	O	O
involved	O	O	O
in	O	O	O
immune	O	O	B-T043
and	O	O	O
complement	O	O	B-T044
activation	O	O	I-T044
,	O	O	O
may	O	O	O
represent	O	O	O
potential	O	O	O
biomarkers	O	O	B-T201
that	O	O	O
could	O	O	O
be	O	O	O
used	O	O	O
by	O	O	O
clinicians	O	O	B-T097
to	O	O	O
identify	O	O	O
high-risk	O	O	B-T033
patients	O	O	B-T101
.	O	O	O

Nevertheless	O	O	O
,	O	O	O
given	O	O	O
that	O	O	O
the	O	O	O
molecular	O	O	B-T080
changes	O	O	B-T169
between	O	O	O
the	O	O	O
staging	O	O	B-T170
groups	O	O	I-T170
were	O	O	O
subtle	O	O	O
,	O	O	O
the	O	O	O
results	O	O	O
need	O	O	O
to	O	O	O
be	O	O	O
interpreted	O	O	B-T169
cautiously	O	O	O
.	O	O	O

-DOCSTART- (27325547)

Benchmark	O	O	O
study	O	O	B-T062
on	O	O	O
fine-mode	O	O	B-T073
aerosol	O	O	I-T073
in	O	O	O
a	O	O	O
big	O	O	B-UnknownType
urban	O	O	I-UnknownType
area	O	O	I-UnknownType
and	O	O	O
relevant	O	O	B-T081
doses	O	O	I-T081
deposited	O	O	B-T169
in	O	O	O
the	O	O	O
human	O	O	B-T016
respiratory	O	O	O
tract	O	O	O

It	O	O	O
is	O	O	O
well-known	O	O	O
that	O	O	O
the	O	O	O
health	O	O	B-T078
effects	O	O	B-T080
of	O	O	O
PM	O	O	B-T131
increase	O	O	O
as	O	O	O
particle	O	O	B-T081
size	O	O	I-T081
decreases	O	O	O
:	O	O	O
particularly	O	O	O
,	O	O	O
great	O	O	O
concern	O	O	O
has	O	O	O
risen	O	O	O
on	O	O	O
the	O	O	O
role	O	O	O
of	O	O	O
UltraFine	O	O	B-T104
Particles	O	O	I-T104
(	O	O	O
UFPs	O	O	B-T104
)	O	O	O
.	O	O	O

Starting	O	O	O
from	O	O	O
the	O	O	O
knowledge	O	O	O
that	O	O	O
the	O	O	O
main	O	O	O
fraction	O	O	B-T081
of	O	O	I-T081
atmospheric	O	O	B-T070
aerosol	O	O	B-T073
in	O	O	O
Rome	O	O	B-T083
is	O	O	O
characterized	O	O	O
by	O	O	O
significant	O	O	O
levels	O	O	B-T080
of	O	O	O
PM2.5	O	O	B-T131
(	O	O	O
almost	O	O	O
75	O	O	O
%	O	O	O
of	O	O	O
PM10	O	O	B-T131
fraction	O	O	O
is	O	O	O
PM2.5	O	O	O
)	O	O	O
,	O	O	O
the	O	O	O
paper	O	O	O
is	O	O	O
focused	O	O	O
on	O	O	O
submicron	O	O	B-T104
particles	O	O	I-T104
in	O	O	O
such	O	O	O
great	O	O	B-UnknownType
urban	O	O	I-UnknownType
area	O	O	I-UnknownType
.	O	O	O

The	O	O	O
daytime	O	O	B-T079
/	O	O	O
nighttime	O	O	B-T079
,	O	O	O
work-	O	O	B-T079
/	O	O	O
weekdays	O	O	B-T079
and	O	O	O
cold	O	O	B-T070
/	O	O	O
hot	O	O	B-T070
seasonal	O	O	B-T079
trends	O	O	I-T079
of	O	O	O
submicron	O	O	B-T104
particles	O	O	I-T104
will	O	O	O
be	O	O	O
investigated	O	O	O
and	O	O	O
discussed	O	O	O
along	O	O	O
with	O	O	O
NOx	O	O	B-T197
and	O	O	O
total	O	O	O
PAH	O	O	B-T109
drifts	O	O	O
demonstrating	O	O	O
the	O	O	O
primary	O	O	O
origin	O	O	O
of	O	O	O
UFPs	O	O	B-T104
from	O	O	O
combustion	O	O	B-T067
processes	O	O	I-T067
.	O	O	O

Furthermore	O	O	O
,	O	O	O
moving	O	O	O
from	O	O	O
these	O	O	O
data	O	O	O
,	O	O	O
the	O	O	O
total	O	O	O
dose	O	O	B-T081
of	O	O	O
submicron	O	O	B-T104
particles	O	O	I-T104
deposited	O	O	B-T169
in	O	O	O
the	O	O	O
respiratory	O	O	B-T022
system	O	O	I-T022
(	O	O	O
i.e.	O	O	O
,	O	O	O
head	O	O	B-T029
,	O	O	O
tracheobronchial	O	O	B-T023
and	O	O	O
alveolar	O	O	B-T023
regions	O	O	I-T023
in	O	O	O
different	O	O	O
lung	O	O	B-T023
lobes	O	O	I-T023
)	O	O	O
has	O	O	O
been	O	O	O
estimated	O	O	O
.	O	O	O

Dosimeter	O	O	B-T074
estimates	O	O	B-T081
were	O	O	O
performed	O	O	O
with	O	O	O
the	O	O	O
Multiple-Path	O	O	B-T170
Particle	O	O	I-T170
Dosimetry	O	O	I-T170
model	O	O	I-T170
(	O	O	O
MPPD	O	O	B-T170
v.2.1	O	O	I-T170
)	O	O	O
.	O	O	O

The	O	O	O
paper	O	O	O
discusses	O	O	O
the	O	O	O
aerosol	O	O	B-T073
doses	O	O	B-T081
deposited	O	O	B-T169
in	O	O	O
the	O	O	O
respiratory	O	O	B-T022
system	O	O	I-T022
of	O	O	O
individuals	O	O	B-T098
exposed	O	O	B-T080
in	O	O	O
proximity	O	O	O
of	O	O	O
traffic	O	O	B-T033
.	O	O	O

During	O	O	O
traffic	O	O	B-T033
peak	O	O	O
hours	O	O	B-T079
,	O	O	O
about	O	O	O
6.6	O	O	O
Ã	O	O	O
10(10	O	O	O
)	O	O	O
particles	O	O	B-T104
are	O	O	O
deposited	O	O	B-T169
into	O	O	O
the	O	O	O
respiratory	O	O	B-T022
system	O	O	I-T022
.	O	O	O

Such	O	O	O
dose	O	O	B-T081
is	O	O	O
almost	O	O	O
entirely	O	O	O
made	O	O	O
of	O	O	O
UFPs	O	O	B-T104
.	O	O	O

According	O	O	O
to	O	O	O
the	O	O	O
greater	O	O	O
dose	O	O	B-T081
estimated	O	O	B-T081
,	O	O	O
right	O	O	B-T023
lung	O	O	I-T023
lobes	O	O	I-T023
are	O	O	O
expected	O	O	O
to	O	O	O
be	O	O	O
more	O	O	O
susceptible	O	O	B-T169
to	O	O	O
respiratory	O	O	B-T169
pathologies	O	O	B-T046
than	O	O	O
left	O	O	B-T023
lobes	O	O	I-T023
.	O	O	O

-DOCSTART- (27326810)

International	O	O	B-T170
Liver	O	O	I-T170
Transplant	O	O	I-T170
Society	O	O	I-T170
Practice	O	O	I-T170
Guidelines	O	O	I-T170
:	O	O	O
Diagnosis	O	O	B-T033
and	O	O	O
Management	O	O	B-T058
of	O	O	O
Hepatopulmonary	O	O	B-T047
Syndrome	O	O	I-T047
and	O	O	O
Portopulmonary	O	O	O
Hypertension	O	O	O

Two	O	O	O
distinct	O	O	O
pulmonary	O	O	B-T047
vascular	O	O	I-T047
disorders	O	O	I-T047
,	O	O	O
hepatopulmonary	O	O	B-T047
syndrome	O	O	I-T047
(	O	O	O
HPS	O	O	B-T047
)	O	O	O
and	O	O	O
portopulmonary	O	O	B-T047
hypertension	O	O	I-T047
(	O	O	O
POPH	O	O	B-T047
)	O	O	O
may	O	O	O
occur	O	O	O
as	O	O	O
a	O	O	O
consequence	O	O	B-T169
of	O	O	I-T169
hepatic	O	O	B-T023
parenchymal	O	O	I-T023
or	O	O	O
vascular	O	O	B-T033
abnormalities	O	O	I-T033
.	O	O	O

HPS	O	O	B-T047
and	O	O	O
POPH	O	O	B-T047
have	O	O	O
major	O	O	O
clinical	O	O	B-T080
implications	O	O	B-T033
for	O	O	O
liver	O	O	B-T061
transplantation	O	O	I-T061
.	O	O	O

A	O	O	O
European	O	O	B-T064
Respiratory	O	O	I-T064
Society	O	O	I-T064
Task	O	O	I-T064
Force	O	O	I-T064
on	O	O	O
Pulmonary-Hepatic	O	O	B-T047
Disorders	O	O	I-T047
convened	O	O	O
in	O	O	O
2002	O	O	O
to	O	O	O
standardize	O	O	O
the	O	O	O
diagnosis	O	O	B-T033
and	O	O	O
guide	O	O	B-T170
management	O	O	I-T170
of	O	O	O
these	O	O	O
disorders	O	O	B-T047
.	O	O	O

These	O	O	O
International	O	O	B-T170
Liver	O	O	I-T170
Transplant	O	O	I-T170
Society	O	O	I-T170
diagnostic	O	O	I-T170
and	O	O	I-T170
management	O	O	I-T170
guidelines	O	O	I-T170
are	O	O	O
based	O	O	O
on	O	O	O
that	O	O	O
task	O	O	B-T064
force	O	O	I-T064
consensus	O	O	O
and	O	O	O
should	O	O	O
continue	O	O	O
to	O	O	O
evolve	O	O	O
as	O	O	O
clinical	O	O	B-T080
experience	O	O	O
dictates	O	O	O
.	O	O	O

Based	O	O	O
on	O	O	O
a	O	O	O
review	O	O	O
of	O	O	O
over	O	O	O
1000	O	O	O
published	O	O	O
HPS	O	O	B-T047
and	O	O	O
POPH	O	O	B-T047
articles	O	O	O
identified	O	O	O
via	O	O	O
a	O	O	O
MEDLINE	O	O	B-T170
search	O	O	I-T170
(	O	O	O
1985	O	O	O
-	O	O	O
2015	O	O	O
)	O	O	O
,	O	O	O
clinical	O	O	B-T170
guidelines	O	O	I-T170
were	O	O	O
based	O	O	O
on	O	O	O
,	O	O	O
selected	O	O	B-T058
single	O	O	I-T058
care	O	O	I-T058
reports	O	O	I-T058
,	O	O	O
small	O	O	B-T081
series	O	O	I-T081
,	O	O	O
registries	O	O	B-T170
,	O	O	O
databases	O	O	B-T170
,	O	O	O
and	O	O	O
expert	O	O	B-T077
opinion	O	O	I-T077
.	O	O	O

The	O	O	O
paucity	O	O	O
of	O	O	O
randomized	O	O	B-T062
,	O	O	I-T062
controlled	O	O	I-T062
trials	O	O	I-T062
in	O	O	O
either	O	O	O
of	O	O	O
these	O	O	O
disorders	O	O	B-T047
was	O	O	O
noted	O	O	O
.	O	O	O

Guidelines	O	O	B-T170
are	O	O	O
presented	O	O	O
in	O	O	O
5	O	O	O
parts	O	O	O
;	O	O	O
I.	O	O	O
Definitions	O	O	B-T170
/	O	O	O
Diagnostic	O	O	B-T170
criteria	O	O	I-T170
;	O	O	O
II	O	O	O
.	O	O	O

Hepatopulmonary	O	O	B-T047
syndrome	O	O	I-T047
;	O	O	O
III	O	O	O
.	O	O	O

Portopulmonary	O	O	B-T047
hypertension	O	O	I-T047
;	O	O	O
IV	O	O	O
.	O	O	O

Implications	O	O	B-T033
for	O	O	O
liver	O	O	B-T061
transplantation	O	O	I-T061
;	O	O	O
and	O	O	O
V.	O	O	O
Suggestions	O	O	B-T078
for	O	O	O
future	O	O	O
clinical	O	O	B-T062
research	O	O	I-T062
.	O	O	O

-DOCSTART- (27328333)

Uveitis	O	O	B-T047
in	O	O	O
children	O	O	O

The	O	O	O
review	O	O	O
provides	O	O	O
updates	O	O	O
on	O	O	O
novel	O	O	B-T080
risk	O	O	B-T080
markers	O	O	I-T080
for	O	O	O
the	O	O	O
development	O	O	B-T169
of	O	O	O
pediatric	O	O	B-T080
inflammatory	O	O	B-T047
uveitis	O	O	I-T047
and	O	O	O
a	O	O	O
severe	O	O	B-T046
disease	O	O	I-T046
course	O	O	I-T046
,	O	O	O
on	O	O	O
treatment	O	O	B-T061
of	O	O	O
refractory	O	O	B-T033
disease	O	O	I-T033
,	O	O	O
and	O	O	O
on	O	O	O
the	O	O	O
measurement	O	O	B-T169
of	O	O	O
visual	O	O	B-T169
outcomes	O	O	I-T169
.	O	O	O

There	O	O	O
are	O	O	O
several	O	O	O
new	O	O	O
genetic	O	O	B-T045
markers	O	O	I-T045
,	O	O	O
biomarkers	O	O	B-T201
,	O	O	O
and	O	O	O
clinical	O	O	B-T080
factors	O	O	B-T169
that	O	O	O
may	O	O	O
influence	O	O	O
a	O	O	O
child	O	O	B-T100
's	O	O	I-T100
uveitis	O	O	B-T047
disease	O	O	B-T046
course	O	O	I-T046
.	O	O	O

It	O	O	O
is	O	O	O
important	O	O	O
to	O	O	O
identify	O	O	O
children	O	O	B-T100
at	O	O	O
risk	O	O	B-T078
for	O	O	O
poor	O	O	B-T169
visual	O	O	I-T169
outcomes	O	O	I-T169
and	O	O	O
who	O	O	O
are	O	O	O
refractory	O	O	B-T169
to	O	O	O
traditional	O	O	B-T061
therapy	O	O	I-T061
.	O	O	O

Racial	O	O	B-T033
disparities	O	O	I-T033
have	O	O	O
recently	O	O	O
been	O	O	O
reported	O	O	B-T170
.	O	O	O

We	O	O	O
describe	O	O	O
agents	O	O	B-T120
of	O	O	O
potential	O	O	B-T081
benefit	O	O	I-T081
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
we	O	O	O
discuss	O	O	O
the	O	O	O
importance	O	O	O
of	O	O	O
patient	O	O	B-T170
reported	O	O	I-T170
outcomes	O	O	I-T170
in	O	O	O
this	O	O	O
population	O	O	B-T101
.	O	O	O

Uveitis	O	O	B-T047
can	O	O	O
lead	O	O	O
to	O	O	O
vision-threatening	O	O	B-T046
complications	O	O	I-T046
.	O	O	O

Timely	O	O	B-T061
and	O	O	I-T061
aggressive	O	O	I-T061
treatment	O	O	I-T061
of	O	O	O
children	O	O	B-T100
identified	O	O	O
to	O	O	O
be	O	O	O
at	O	O	O
risk	O	O	B-T078
for	O	O	O
a	O	O	O
severe	O	O	B-T046
uveitis	O	O	I-T046
course	O	O	I-T046
may	O	O	O
lead	O	O	O
to	O	O	O
improved	O	O	B-T169
outcomes	O	O	I-T169
.	O	O	O

-DOCSTART- (27329050)

Utility	O	O	B-T169
of	O	O	O
a	O	O	O
mHealth	O	O	B-T170
App	O	O	I-T170
for	O	O	O
Self-Management	O	O	B-T058
and	O	O	O
Education	O	O	B-T065
of	O	O	O
Cardiac	O	O	B-T047
Diseases	O	O	I-T047
in	O	O	O
Spanish	O	O	B-T083
Urban	O	O	O
and	O	O	O
Rural	O	O	O
Areas	O	O	O

Analyze	O	O	B-T062
the	O	O	O
utility	O	O	B-T169
of	O	O	O
a	O	O	O
mobile	O	O	B-T170
health	O	O	I-T170
app	O	O	I-T170
named	O	O	O
HeartKeeper	O	O	B-T170
in	O	O	O
several	O	O	B-T098
groups	O	O	I-T098
of	O	O	I-T098
population	O	O	I-T098
and	O	O	O
obtain	O	O	B-T169
conclusions	O	O	B-T078
to	O	O	O
be	O	O	O
applied	O	O	B-T169
to	O	O	O
other	O	O	B-T170
similar	O	O	I-T170
apps	O	O	I-T170
.	O	O	O

A	O	O	O
questionnaire	O	O	B-T170
has	O	O	O
been	O	O	O
designed	O	O	B-T052
to	O	O	O
evaluate	O	O	O
the	O	O	O
usage	O	O	B-T169
and	O	O	O
utility	O	O	B-T169
of	O	O	O
the	O	O	O
HeartKeeper	O	O	B-T170
app	O	O	I-T170
.	O	O	O

The	O	O	O
questionnaire	O	O	B-T170
information	O	O	B-T078
was	O	O	O
collected	O	O	B-T169
by	O	O	O
collaborating	O	O	O
cardiologists	O	O	B-T097
from	O	O	O
32	O	O	O
patients	O	O	B-T101
before	O	O	B-UnknownType
and	O	O	I-UnknownType
after	O	O	I-UnknownType
they	O	O	O
used	O	O	B-T169
the	O	O	O
app	O	O	B-T170
.	O	O	O

Patients	O	O	B-T101
were	O	O	O
randomly	O	O	B-T062
selected	O	O	I-T062
with	O	O	O
established	O	O	O
quotas	O	O	B-T062
within	O	O	O
interest	O	O	B-T098
groups	O	O	I-T098
,	O	O	O
so	O	O	O
that	O	O	O
men	O	O	B-T098
and	O	O	O
women	O	O	B-T098
,	O	O	O
patients	O	O	B-T101
older	O	O	B-T098
or	O	O	O
younger	O	O	B-T079
than	O	O	O
60	O	O	O
years	O	O	B-T079
old	O	O	I-T079
and	O	O	O
patients	O	O	O
living	O	O	O
in	O	O	O
urban	O	O	B-T083
or	O	O	I-T083
rural	O	O	I-T083
areas	O	O	I-T083
were	O	O	O
equally	O	O	B-T052
represented	O	O	I-T052
.	O	O	O

Using	O	O	O
the	O	O	O
appropriate	O	O	O
statistical	O	O	B-T062
techniques	O	O	I-T062
we	O	O	O
see	O	O	O
that	O	O	O
the	O	O	O
HeartKeeper	O	O	B-T170
app	O	O	B-T170
was	O	O	O
useful	O	O	O
for	O	O	O
patients	O	O	B-T101
as	O	O	O
they	O	O	O
qualify	O	O	B-T080
with	O	O	O
70	O	O	O
points	O	O	O
(	O	O	O
out	O	O	O
of	O	O	O
100	O	O	O
)	O	O	O
the	O	O	O
overall	O	O	B-T033
opinion	O	O	I-T033
of	O	O	O
the	O	O	O
app	O	O	O
,	O	O	O
it	O	O	O
helps	O	O	O
them	O	O	O
remember	O	O	B-T041
more	O	O	O
easily	O	O	O
taking	O	O	O
their	O	O	O
pills	O	O	B-T122
with	O	O	O
a	O	O	O
mean	O	O	O
improvement	O	O	B-T077
of	O	O	O
20.94	O	O	O
points	O	O	O
(	O	O	O
p	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
and	O	O	O
they	O	O	O
perceive	O	O	O
a	O	O	O
global	O	O	B-T077
improvement	O	O	I-T077
of	O	O	O
their	O	O	O
health	O	O	O
(	O	O	O
8.28	O	O	O
points	O	O	O
,	O	O	O
p	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
.	O	O	O

We	O	O	O
also	O	O	O
observe	O	O	B-T169
that	O	O	O
these	O	O	O
improvements	O	O	B-T077
do	O	O	O
not	O	O	O
depend	O	O	O
,	O	O	O
in	O	O	O
general	O	O	O
,	O	O	O
on	O	O	O
the	O	O	O
area	O	O	B-T083
(	O	O	I-T083
urban	O	O	I-T083
or	O	O	I-T083
rural	O	O	I-T083
)	O	O	I-T083
where	O	O	O
the	O	O	O
patient	O	O	B-T101
comes	O	O	O
from	O	O	O
or	O	O	O
on	O	O	O
their	O	O	O
sex	O	O	B-T032
.	O	O	O

Although	O	O	O
older	O	O	B-T098
patients	O	O	I-T098
needed	O	O	B-T080
more	O	O	O
help	O	O	O
to	O	O	O
use	O	O	B-T169
the	O	O	O
app	O	O	B-T170
and	O	O	O
used	O	O	B-T169
it	O	O	O
slightly	O	O	O
less	O	O	B-T079
frequently	O	O	I-T079
,	O	O	O
the	O	O	O
improvements	O	O	B-T077
on	O	O	O
several	O	O	B-T081
measures	O	O	I-T081
considered	O	O	O
,	O	O	O
such	O	O	O
as	O	O	O
remembering	O	O	B-T041
taking	O	O	O
pills	O	O	B-T122
,	O	O	O
breathing	O	O	B-T184
problems	O	O	I-T184
or	O	O	O
trouble	O	O	B-T184
developing	O	O	I-T184
activities	O	O	I-T184
,	O	O	O
depend	O	O	O
significantly	O	O	O
(	O	O	O
p	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
on	O	O	O
age	O	O	O
with	O	O	O
older	O	O	O
patients	O	O	O
reporting	O	O	O
higher	O	O	B-T080
improvements	O	O	O
than	O	O	O
younger	O	O	B-T100
ones	O	O	I-T100
.	O	O	O

The	O	O	O
results	O	O	B-T169
obtained	O	O	O
with	O	O	O
the	O	O	O
sample	O	O	B-T081
of	O	O	O
patients	O	O	B-T101
considered	O	O	O
in	O	O	O
this	O	O	O
research	O	O	B-T062
prove	O	O	O
the	O	O	O
utility	O	O	B-T169
of	O	O	O
the	O	O	O
HeartKeeper	O	O	B-T170
app	O	O	I-T170
.	O	O	O

This	O	O	O
utility	O	O	B-T169
is	O	O	O
similar	O	O	O
in	O	O	O
urban	O	O	B-T083
and	O	O	I-T083
rural	O	O	I-T083
areas	O	O	I-T083
and	O	O	O
for	O	O	O
patients	O	O	B-T101
of	O	O	O
both	O	O	B-T032
sexes	O	O	I-T032
and	O	O	O
,	O	O	O
to	O	O	B-T080
some	O	O	I-T080
extent	O	O	I-T080
,	O	O	O
depends	O	O	O
on	O	O	O
the	O	O	O
age	O	O	B-T100
of	O	O	O
the	O	O	O
patient	O	O	B-T101
with	O	O	O
older	O	O	B-T098
patients	O	O	I-T098
reporting	O	O	O
slightly	O	O	B-T079
lower	O	O	I-T079
frequency	O	O	I-T079
of	O	O	O
use	O	O	B-T169
but	O	O	O
higher	O	O	B-T080
health	O	O	B-T077
improvements	O	O	I-T077
than	O	O	O
younger	O	O	B-T100
ones	O	O	I-T100
.	O	O	O

-DOCSTART- (27333847)

A	O	O	O
holistic	O	O	B-T078
approach	O	O	I-T078
to	O	O	O
age	O	O	B-T032
estimation	O	O	B-T041
in	O	O	O
refugee	O	O	B-T098
children	O	O	O

Many	O	O	O
refugee	O	O	B-T098
children	O	O	B-T100
arriving	O	O	O
in	O	O	O
Australia	O	O	B-T083
have	O	O	O
an	O	O	O
inaccurately	O	O	B-T080
documented	O	O	B-T058
date	O	O	B-T170
of	O	O	I-T170
birth	O	O	I-T170
(	O	O	O
DOB	O	O	B-T170
)	O	O	O
.	O	O	O

A	O	O	O
medical	O	O	B-T058
assessment	O	O	I-T058
of	O	O	O
a	O	O	O
child	O	O	B-T032
's	O	O	I-T032
age	O	O	I-T032
is	O	O	O
often	O	O	O
requested	O	O	O
when	O	O	O
there	O	O	O
is	O	O	O
a	O	O	O
concern	O	O	B-T078
that	O	O	O
their	O	O	O
documented	O	O	B-T058
DOB	O	O	B-T170
is	O	O	O
incorrect	O	O	B-T080
.	O	O	O

This	O	O	O
study	O	O	O
's	O	O	O
aim	O	O	O
was	O	O	O
to	O	O	O
assess	O	O	B-T058
the	O	O	O
accuracy	O	O	B-T080
a	O	O	O
holistic	O	O	B-T170
age	O	O	B-T032
assessment	O	O	I-T170
tool	O	O	I-T170
(	O	O	O
AAT	O	O	B-T170
)	O	O	O
in	O	O	O
estimating	O	O	B-T041
the	O	O	O
age	O	O	O
of	O	O	O
refugee	O	O	B-T098
children	O	O	B-T100
newly	O	O	O
settled	O	O	O
in	O	O	O
Australia	O	O	B-T083
.	O	O	O

A	O	O	O
holistic	O	O	B-T170
AAT	O	O	I-T170
that	O	O	O
combines	O	O	O
medical	O	O	B-UnknownType
and	O	O	O
non-medical	O	O	B-T078
approaches	O	O	I-T078
was	O	O	O
used	O	O	O
to	O	O	O
estimate	O	O	B-T041
the	O	O	O
ages	O	O	B-T032
of	O	O	O
60	O	O	O
refugee	O	O	B-T098
children	O	O	B-T100
with	O	O	O
a	O	O	O
known	O	O	O
DOB	O	O	B-T170
.	O	O	O

The	O	O	O
tool	O	O	B-T170
used	O	O	O
four	O	O	O
components	O	O	B-T077
to	O	O	O
assess	O	O	B-T058
age	O	O	B-T032
:	O	O	O
an	O	O	O
oral	O	O	B-T082
narrative	O	O	B-T054
,	O	O	O
developmental	O	O	B-T080
assessment	O	O	B-T058
,	O	O	O
anthropometric	O	O	B-T170
measures	O	O	I-T170
and	O	O	O
pubertal	O	O	B-T033
assessment	O	O	O
.	O	O	O

Assessors	O	O	B-T097
were	O	O	O
blinded	O	O	B-T062
to	O	O	O
the	O	O	O
true	O	O	B-T080
age	O	O	B-T032
of	O	O	O
the	O	O	O
child	O	O	B-T100
.	O	O	O

Correlation	O	O	B-T081
coefficients	O	O	I-T081
for	O	O	O
the	O	O	O
actual	O	O	B-T080
and	O	O	O
estimated	O	O	B-T041
age	O	O	B-T032
were	O	O	O
calculated	O	O	B-T052
for	O	O	O
the	O	O	O
tool	O	O	B-T170
overall	O	O	B-T077
and	O	O	I-T077
individual	O	O	I-T077
components	O	O	I-T077
.	O	O	O

The	O	O	O
correlation	O	O	B-T081
coefficient	O	O	I-T081
between	O	O	O
the	O	O	O
actual	O	O	B-T080
and	O	O	O
estimated	O	O	B-T041
age	O	O	B-T032
from	O	O	O
the	O	O	O
AAT	O	O	B-T170
was	O	O	O
very	O	O	O
strong	O	O	O
at	O	O	O
0.9802	O	O	O
(	O	O	O
boys	O	O	B-T100
0.9748	O	O	O
,	O	O	O
girls	O	O	B-T100
0.9876	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
oral	O	O	B-T082
narrative	O	O	B-T054
component	O	O	B-T077
of	O	O	O
the	O	O	O
tool	O	O	B-T170
performed	O	O	O
best	O	O	O
(	O	O	O
R	O	O	O
=	O	O	O
0.9603	O	O	O
)	O	O	O
.	O	O	O

Overall	O	O	O
,	O	O	O
86.7	O	O	O
%	O	O	O
of	O	O	O
age	O	O	B-T032
estimates	O	O	B-T041
were	O	O	O
within	O	O	O
1	O	O	O
year	O	O	B-T079
of	O	O	O
the	O	O	O
true	O	O	B-T080
age	O	O	O
.	O	O	O

The	O	O	O
range	O	O	O
of	O	O	O
differences	O	O	O
was	O	O	O
-1.43	O	O	O
to	O	O	O
3.92	O	O	O
years	O	O	B-T079
with	O	O	O
a	O	O	O
standard	O	O	B-T081
deviation	O	O	I-T081
of	O	O	O
0.77	O	O	O
years	O	O	O
(	O	O	O
9.24	O	O	O
months	O	O	B-T079
)	O	O	O
.	O	O	O

The	O	O	O
AAT	O	O	B-T170
is	O	O	O
a	O	O	O
holistic	O	O	B-T078
,	O	O	O
simple	O	O	B-T080
and	O	O	O
safe	O	O	B-UnknownType
instrument	O	O	O
that	O	O	O
can	O	O	O
be	O	O	O
used	O	O	O
to	O	O	O
estimate	O	O	B-T041
age	O	O	B-T032
in	O	O	O
refugee	O	O	B-T098
children	O	O	B-T100
with	O	O	O
results	O	O	O
comparable	O	O	O
with	O	O	O
radiological	O	O	B-T091
methods	O	O	I-T091
currently	O	O	O
used	O	O	O
.	O	O	O

-DOCSTART- (27334471)

CAGEd-oPOSSUM	O	O	B-T170
:	O	O	O
motif	O	O	B-T062
enrichment	O	O	I-T062
analysis	O	O	I-T062
from	O	O	O
CAGE	O	O	B-T170
-derived	O	O	O
TSSs	O	O	O

With	O	O	O
the	O	O	O
emergence	O	O	O
of	O	O	O
large-scale	O	O	B-T170
Cap	O	O	I-T170
Analysis	O	O	I-T170
of	O	O	I-T170
Gene	O	O	I-T170
Expression	O	O	I-T170
(	O	O	I-T170
CAGE	O	O	I-T170
)	O	O	I-T170
datasets	O	O	I-T170
from	O	O	O
individual	O	O	B-T093
labs	O	O	I-T093
and	O	O	O
the	O	O	O
FANTOM	O	O	B-T077
consortium	O	O	I-T077
,	O	O	O
one	O	O	O
can	O	O	O
now	O	O	O
analyze	O	O	O
the	O	O	O
cis-regulatory	O	O	B-T114
regions	O	O	I-T114
associated	O	O	O
with	O	O	O
gene	O	O	B-T045
transcription	O	O	I-T045
at	O	O	O
an	O	O	O
unprecedented	O	O	B-T080
level	O	O	I-T080
of	O	O	I-T080
refinement	O	O	I-T080
.	O	O	O

By	O	O	O
coupling	O	O	O
transcription	O	O	B-T044
factor	O	O	I-T044
binding	O	O	I-T044
site	O	O	I-T044
(	O	O	O
TFBS	O	O	B-T044
)	O	O	O
enrichment	O	O	B-T062
analysis	O	O	I-T062
with	O	O	O
CAGE	O	O	B-T170
-derived	O	O	O
genomic	O	O	B-T028
regions	O	O	I-T028
,	O	O	O
CAGEd-oPOSSUM	O	O	B-T170
can	O	O	O
identify	O	O	B-T080
TFs	O	O	B-T116
that	O	O	O
act	O	O	O
as	O	O	O
key	O	O	B-T077
regulators	O	O	B-T077
of	O	O	O
genes	O	O	B-T028
involved	O	O	O
in	O	O	O
specific	O	O	B-T080
mammalian	O	O	B-T025
cell	O	O	I-T025
and	O	O	O
tissue	O	O	B-T024
types	O	O	I-T024
.	O	O	O

The	O	O	O
webtool	O	O	B-T170
allows	O	O	O
for	O	O	O
the	O	O	O
analysis	O	O	B-T062
of	O	O	O
CAGE	O	O	B-T170
-derived	O	O	O
transcription	O	O	B-T114
start	O	O	I-T114
sites	O	O	I-T114
(	O	O	O
TSSs	O	O	B-T114
)	O	O	O
either	O	O	O
provided	O	O	O
by	O	O	O
the	O	O	O
user	O	O	B-T098
or	O	O	O
selected	O	O	O
from	O	O	O
â¼1300	O	O	O
mammalian	O	O	B-T015
samples	O	O	B-T167
from	O	O	O
the	O	O	O
FANTOM5	O	O	B-T077
project	O	O	I-T077
with	O	O	O
pre-computed	O	O	B-T052
TFBS	O	O	B-T044
predicted	O	O	O
with	O	O	O
JASPAR	O	O	B-T170
TF	O	O	I-T170
binding	O	O	I-T170
profiles	O	O	I-T170
.	O	O	O

The	O	O	O
tool	O	O	B-T170
helps	O	O	O
power	O	O	O
insights	O	O	B-T041
into	O	O	O
the	O	O	O
regulation	O	O	B-T045
of	O	O	I-T045
genes	O	O	I-T045
through	O	O	O
the	O	O	O
study	O	O	B-T062
of	O	O	O
the	O	O	O
specific	O	O	B-T080
usage	O	O	B-T169
of	O	O	O
TSSs	O	O	B-T114
within	O	O	O
specific	O	O	O
cell	O	O	B-T170
types	O	O	I-T170
and/or	O	O	O
under	O	O	O
specific	O	O	B-T080
conditions	O	O	I-T080
.	O	O	O

The	O	O	O
CAGEd-oPOSUM	O	O	B-T170
web	O	O	I-T170
tool	O	O	I-T170
is	O	O	O
implemented	O	O	O
in	O	O	O
Perl	O	O	B-T170
,	O	O	O
MySQL	O	O	B-T170
and	O	O	O
Apache	O	O	B-T170
and	O	O	O
is	O	O	O
available	O	O	O
at	O	O	O
http://cagedop.cmmt.ubc.ca/CAGEd_oPOSSUM	O	O	B-T170
CONTACTS	O	O	O
:	O	O	O
anthony.mathelier@ncmm.uio.no	O	O	B-T170
or	O	O	O
wyeth@cmmt.ubc.ca	O	O	B-T170
Supplementary	O	O	B-T170
information	O	O	I-T170
:	O	O	O
Supplementary	O	O	B-T170
data	O	O	I-T170
are	O	O	O
available	O	O	O
at	O	O	O
Bioinformatics	O	O	B-T170
online	O	O	B-T073
.	O	O	O

-DOCSTART- (27334669)

Self-assembled	O	O	B-T044
polymeric	O	O	B-T122
vectors	O	O	B-T074
mixtures	O	O	B-T167
:	O	O	O
characterization	O	O	B-T052
of	O	O	O
the	O	O	O
polymorphism	O	O	B-T080
and	O	O	O
existence	O	O	O
of	O	O	O
synergistic	O	O	B-T080
effects	O	O	B-T080
in	O	O	O
photodynamic	O	O	O
therapy	O	O	O

The	O	O	O
objective	O	O	O
of	O	O	O
this	O	O	O
work	O	O	O
was	O	O	O
to	O	O	O
assess	O	O	O
the	O	O	O
relation	O	O	O
between	O	O	O
the	O	O	O
purity	O	O	B-T081
of	O	O	O
polymeric	O	O	B-T122
self-assemblies	O	O	B-T044
vectors	O	O	B-T074
solution	O	O	B-T167
and	O	O	O
their	O	O	O
photodynamic	O	O	B-T061
therapeutic	O	O	I-T061
efficiency	O	O	B-T081
.	O	O	O

For	O	O	O
this	O	O	O
,	O	O	O
several	O	O	O
amphiphilic	O	O	B-T121
block	O	O	B-T104
copolymers	O	O	I-T104
of	O	O	O
poly(ethyleneoxide-b-Îµ-caprolactone	O	O	B-T109
)	O	O	I-T109
have	O	O	O
been	O	O	O
used	O	O	O
to	O	O	O
form	O	O	O
self-assemblies	O	O	B-T044
with	O	O	O
different	O	O	O
morphologies	O	O	B-T080
(	O	O	O
micelles	O	O	B-T109
,	O	O	O
worm-like	O	O	B-T109
micelles	O	O	I-T109
or	O	O	O
vesicles	O	O	B-T080
)	O	O	O
.	O	O	O

In	O	O	O
a	O	O	O
first	O	O	O
step	O	O	O
,	O	O	O
controlled	O	O	B-T167
mixtures	O	O	I-T167
of	O	O	O
preformed	O	O	O
micelles	O	O	B-T109
and	O	O	O
vesicles	O	O	B-T080
have	O	O	O
been	O	O	O
characterized	O	O	O
both	O	O	O
by	O	O	O
dynamic	O	O	B-T059
light	O	O	I-T059
scattering	O	O	I-T059
and	O	O	O
asymmetrical	O	O	B-T059
flow	O	O	I-T059
field	O	O	I-T059
flow	O	O	I-T059
fractionation	O	O	I-T059
(	O	O	O
AsFlFFF	O	O	B-T059
)	O	O	O
.	O	O	O

For	O	O	O
this	O	O	O
,	O	O	O
a	O	O	O
custom-made	O	O	B-T052
program	O	O	B-T073
,	O	O	O
STORMS	O	O	B-T073
,	O	O	O
was	O	O	O
developed	O	O	O
to	O	O	O
analyze	O	O	O
DLS	O	O	B-T059
data	O	O	B-T078
in	O	O	O
a	O	O	O
thorough	O	O	O
manner	O	O	O
by	O	O	O
providing	O	O	O
a	O	O	O
large	O	O	O
set	O	O	O
of	O	O	O
fitting	O	O	O
parameters	O	O	B-T077
.	O	O	O

This	O	O	O
showed	O	O	O
that	O	O	O
DLS	O	O	B-T059
only	O	O	O
sensed	O	O	O
the	O	O	O
larger	O	O	B-T081
vesicles	O	O	B-T080
when	O	O	O
the	O	O	O
micelles	O	O	B-T109
/	O	O	O
vesicles	O	O	O
ratio	O	O	B-T081
was	O	O	O
80/20	O	O	O
w/w	O	O	O
.	O	O	O

On	O	O	O
the	O	O	O
other	O	O	O
hand	O	O	O
,	O	O	O
AsFlFFF	O	O	B-T059
allowed	O	O	O
clear	O	O	O
detection	O	O	B-T033
of	O	O	O
the	O	O	O
presence	O	O	O
of	O	O	O
micelles	O	O	B-T109
when	O	O	O
this	O	O	O
same	O	O	O
ratio	O	O	B-T081
was	O	O	O
as	O	O	O
low	O	O	O
as	O	O	O
10/90	O	O	O
.	O	O	O

Subsequently	O	O	O
,	O	O	O
the	O	O	O
photodynamic	O	O	B-T061
therapy	O	O	I-T061
efficiency	O	O	B-T081
of	O	O	O
various	O	O	O
controlled	O	O	B-T167
mixtures	O	O	I-T167
was	O	O	O
assessed	O	O	O
using	O	O	O
multicellular	O	O	O
spheroids	O	O	B-T033
when	O	O	O
a	O	O	O
photosensitizer	O	O	B-T121
,	O	O	O
pheophorbide	O	O	B-T109
a	O	O	I-T109
,	O	O	O
was	O	O	O
encapsulated	O	O	B-T080
in	O	O	O
the	O	O	O
polymer	O	O	B-T122
self-assemblies	O	O	B-T044
.	O	O	O

Some	O	O	O
mixtures	O	O	O
were	O	O	O
shown	O	O	O
to	O	O	O
be	O	O	O
as	O	O	O
efficient	O	O	B-T080
as	O	O	O
monomorphous	O	O	B-T033
systems	O	O	I-T033
.	O	O	O

In	O	O	O
some	O	O	O
cases	O	O	O
,	O	O	O
mixtures	O	O	B-T167
were	O	O	O
found	O	O	O
to	O	O	O
exhibit	O	O	O
a	O	O	O
higher	O	O	O
PDT	O	O	B-T061
efficiency	O	O	B-T081
compared	O	O	O
to	O	O	O
the	O	O	O
individual	O	O	O
nano	O	O	B-T081
-	O	O	O
objects	O	O	B-T072
,	O	O	O
revealing	O	O	O
a	O	O	O
synergistic	O	O	B-T080
effect	O	O	B-T080
for	O	O	O
the	O	O	O
efficient	O	O	O
delivery	O	O	B-T070
of	O	O	O
the	O	O	O
photosensitizer	O	O	B-T121
.	O	O	O

Polymorphous	O	O	B-T080
vectors	O	O	B-T074
can	O	O	O
therefore	O	O	O
be	O	O	O
superior	O	O	O
in	O	O	O
therapeutic	O	O	B-T169
applications	O	O	I-T169
.	O	O	O

-DOCSTART- (27335087)

Fuzheng	O	O	B-T123
Qingjie	O	O	I-T123
Granules	O	O	I-T123
Inhibit	O	O	B-T052
Growth	O	O	B-T039
of	O	O	O
Hepatoma	O	O	B-T025
Cells	O	O	I-T025
via	O	O	O
Inducing	O	O	B-T169
Mitochondria	O	O	B-T026
-Mediated	O	O	O
Apoptosis	O	O	B-T043
and	O	O	O
Enhancing	O	O	B-T052
Immune	O	O	O
Function	O	O	O

Fuzheng	O	O	B-T123
Qingjie	O	O	I-T123
(	O	O	B-T123
FZQJ	O	O	I-T123
)	O	O	I-T123
granules	O	O	I-T123
,	O	O	O
a	O	O	O
compound	O	O	B-T103
Chinese	O	O	B-T091
medicine	O	O	I-T091
,	O	O	O
have	O	O	O
been	O	O	O
used	O	O	O
as	O	O	O
an	O	O	O
adjuvant	O	O	B-T061
therapy	O	O	I-T061
for	O	O	O
alimentary	O	O	B-T022
tract	O	O	I-T022
cancers	O	O	B-T191
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
underlying	O	O	O
anticancer	O	O	B-T033
mechanisms	O	O	B-T169
are	O	O	O
still	O	O	O
not	O	O	O
well	O	O	O
understood	O	O	O
.	O	O	O

In	O	O	O
the	O	O	O
present	O	O	B-T079
study	O	O	B-T062
,	O	O	O
HepG2	O	O	B-T025
cells	O	O	I-T025
were	O	O	O
treated	O	O	B-T169
with	O	O	O
FZQJ	O	O	B-T123
-	O	O	O
containing	O	O	B-T052
serum	O	O	B-T031
.	O	O	O

Cell	O	O	B-T043
proliferation	O	O	I-T043
was	O	O	O
evaluated	O	O	B-T058
using	O	O	O
MTT	O	O	B-T062
assay	O	O	I-T062
.	O	O	O

Apoptosis	O	O	B-T043
was	O	O	O
analyzed	O	O	B-T062
using	O	O	O
a	O	O	O
flow	O	O	B-T074
cytometer	O	O	I-T074
.	O	O	O

Cell	O	O	B-T025
ultrastructure	O	O	I-T025
was	O	O	O
observed	O	O	B-T169
under	O	O	O
a	O	O	O
transmission	O	O	B-T074
electron	O	O	I-T074
microscope	O	O	I-T074
.	O	O	O

The	O	O	O
mitochondrial	O	O	B-T043
membrane	O	O	I-T043
potential	O	O	I-T043
(	O	O	O
ÎÏ	O	O	B-T043
)	O	O	O
was	O	O	O
examined	O	O	B-T033
with	O	O	O
JC-1	O	O	B-T130
dye	O	O	I-T130
.	O	O	O

In	O	O	O
H22	O	O	B-T191
tumor-bearing	O	O	I-T191
mice	O	O	I-T191
,	O	O	O
CD4(+	O	O	B-T025
)	O	O	I-T025
T	O	O	I-T025
cells	O	O	I-T025
,	O	O	O
CD8(+	O	O	B-T025
)	O	O	I-T025
T	O	O	I-T025
cells	O	O	I-T025
,	O	O	O
CD3(+	O	O	B-T025
)	O	O	I-T025
T	O	O	I-T025
cells	O	O	I-T025
,	O	O	O
and	O	O	O
natural	O	O	B-T025
killer	O	O	I-T025
cells	O	O	I-T025
(	O	O	O
NK	O	O	B-T025
)	O	O	O
in	O	O	O
peripheral	O	O	B-T031
blood	O	O	I-T031
were	O	O	O
evaluated	O	O	O
cytometrically	O	O	B-T074
.	O	O	O

Interleukin	O	O	B-T116
(IL)-2	O	O	I-T116
and	O	O	O
tumor	O	O	B-T116
necrosis	O	O	I-T116
factor	O	O	I-T116
(TNF)-Î±	O	O	B-T116
levels	O	O	B-T080
were	O	O	O
measured	O	O	B-T080
using	O	O	O
radioimmunoassay	O	O	B-T059
.The	O	O	O

mRNA	O	O	B-T114
levels	O	O	B-T080
of	O	O	O
Bax	O	O	B-T028
and	O	O	O
Bcl-2	O	O	B-T028
were	O	O	O
examined	O	O	B-T033
by	O	O	O
reverse	O	O	B-T063
transcription-polymerase	O	O	I-T063
chain	O	O	I-T063
reaction	O	O	I-T063
.	O	O	O

The	O	O	O
protein	O	O	B-T116
levels	O	O	B-T080
of	O	O	O
Bax	O	O	B-T116
,	O	O	O
Bcl-2	O	O	B-T116
,	O	O	O
cytochrome	O	O	B-T116
C	O	O	I-T116
,	O	O	O
caspase	O	O	B-T116
3	O	O	I-T116
and	O	O	O
9	O	O	B-T116
,	O	O	O
PARP	O	O	B-T116
,	O	O	O
and	O	O	O
CD69	O	O	B-T116
were	O	O	O
examined	O	O	B-T033
by	O	O	O
Western	O	O	B-T059
blotting	O	O	I-T059
.	O	O	O

The	O	O	O
apoptotic	O	O	B-T080
cells	O	O	B-T025
in	O	O	O
tissues	O	O	B-T024
were	O	O	O
observed	O	O	B-T169
using	O	O	O
TUNEL	O	O	B-T063
method	O	O	I-T063
.	O	O	O

Alanine	O	O	B-T116
transaminase	O	O	I-T116
(	O	O	O
ALT	O	O	B-T116
)	O	O	O
,	O	O	O
aspartate	O	O	B-T116
transaminase	O	O	I-T116
(	O	O	O
AST	O	O	B-T116
)	O	O	O
,	O	O	O
blood	O	O	B-T123
urea	O	O	I-T123
nitrogen	O	O	I-T123
(	O	O	O
BUN	O	O	B-T123
)	O	O	O
,	O	O	O
and	O	O	O
creatinine	O	O	B-T109
(	O	O	O
CRE	O	O	B-T109
)	O	O	O
were	O	O	O
detected	O	O	B-T033
by	O	O	O
an	O	O	O
automatic	O	O	B-T169
biochemical	O	O	B-T169
analyzer	O	O	B-T074
.	O	O	O

The	O	O	O
results	O	O	B-T169
showed	O	O	O
that	O	O	O
FZQJ	O	O	B-T123
-	O	O	O
containing	O	O	B-T052
serum	O	O	B-T031
remarkably	O	O	O
inhibited	O	O	B-T052
proliferation	O	O	B-T043
of	O	O	O
HepG2	O	O	B-T025
cells	O	O	I-T025
in	O	O	O
dose	O	O	B-T081
-	O	O	O
and	O	O	O
time	O	O	B-T079
-	O	O	O
dependent	O	O	B-T080
manners	O	O	O
,	O	O	O
induced	O	O	B-T169
HepG2	O	O	B-T025
cell	O	O	I-T025
apoptosis	O	O	B-T043
and	O	O	O
caused	O	O	O
a	O	O	O
decrease	O	O	B-T081
of	O	O	O
ÎÏ	O	O	B-T043
.	O	O	O

Analysis	O	O	B-T062
of	O	O	O
tumor	O	O	B-T024
tissue	O	O	I-T024
showed	O	O	O
that	O	O	O
FZQJ	O	O	B-T123
-	O	O	O
induced	O	O	B-T169
apoptosis	O	O	B-T043
was	O	O	O
accompanied	O	O	O
by	O	O	O
downregulation	O	O	B-T044
of	O	O	O
Bcl-2	O	O	B-T116
and	O	O	O
upregulation	O	O	B-T044
of	O	O	O
Bax	O	O	B-T116
,	O	O	O
release	O	O	B-T169
of	O	O	O
cytochrome	O	O	B-T116
c	O	O	I-T116
,	O	O	O
activation	O	O	B-T044
of	O	O	O
caspase	O	O	B-T116
3	O	O	I-T116
and	O	O	O
9	O	O	B-T116
,	O	O	O
and	O	O	O
cleavage	O	O	B-T044
of	O	O	O
PARP	O	O	B-T116
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
FZQJ	O	O	B-T123
increased	O	O	B-T081
the	O	O	O
percentages	O	O	B-T081
of	O	O	O
CD4(+	O	O	B-T025
)	O	O	I-T025
T	O	O	I-T025
and	O	O	O
NK	O	O	B-T025
cells	O	O	I-T025
,	O	O	O
the	O	O	O
ratio	O	O	B-T081
of	O	O	O
CD4(+	O	O	O
)	O	O	O
/	O	O	O
CD8(+	O	O	B-T025
)	O	O	I-T025
T	O	O	I-T025
cells	O	O	I-T025
as	O	O	O
well	O	O	O
as	O	O	O
the	O	O	O
levels	O	O	B-T080
of	O	O	O
serum	O	O	B-T031
TNF-Î±	O	O	B-T116
.	O	O	O

FZQJ	O	O	B-T123
also	O	O	O
increased	O	O	B-T081
CD69	O	O	B-T116
expression	O	O	B-T045
in	O	O	O
tumor	O	O	B-T024
tissue	O	O	I-T024
.	O	O	O

No	O	O	B-T033
hepatorenal	O	O	I-T033
toxicity	O	O	I-T033
was	O	O	O
observed	O	O	B-T169
in	O	O	O
H22	O	O	B-T191
tumor-bearing	O	O	I-T191
mice	O	O	I-T191
.	O	O	O

These	O	O	O
results	O	O	B-T169
indicated	O	O	B-T033
that	O	O	O
FZQJ	O	O	B-T123
could	O	O	O
inhibit	O	O	B-T052
the	O	O	O
growth	O	O	B-T039
of	O	O	O
hepatoma	O	O	B-T025
cells	O	O	I-T025
via	O	O	O
regulating	O	O	O
immune	O	O	B-T042
function	O	O	I-T042
and	O	O	O
inducing	O	O	B-T169
mitochondria	O	O	B-T026
mediated	O	O	O
apoptosis	O	O	B-T043
.	O	O	O

-DOCSTART- (27336239)

Professional	O	O	B-T170
reinventions	O	O	I-T170
:	O	O	O
Swedish	O	O	B-T098
psychologists	O	O	B-T097
,	O	O	O
1990	O	O	O
-	O	O	O
2010	O	O	O

Since	O	O	O
the	O	O	O
early	O	O	O
20th	O	O	B-T079
century	O	O	I-T079
,	O	O	O
the	O	O	O
Swedish	O	O	B-T098
psychology	O	O	B-T091
profession	O	O	I-T091
has	O	O	O
undergone	O	O	O
several	O	O	O
changes	O	O	B-T169
in	O	O	O
its	O	O	O
essential	O	O	B-T052
tasks	O	O	I-T052
,	O	O	O
epistemological	O	O	B-T170
foundations	O	O	I-T170
,	O	O	O
and	O	O	O
social	O	O	B-T054
roles	O	O	I-T054
.	O	O	O

These	O	O	O
changes	O	O	B-T169
occurred	O	O	B-T052
through	O	O	O
an	O	O	O
ongoing	O	O	O
"	O	O	O
tuning	O	O	O
"	O	O	O
with	O	O	O
Swedish	O	O	B-T098
society	O	O	B-T092
,	O	O	O
in	O	O	O
which	O	O	O
the	O	O	O
profession	O	O	B-T090
strove	O	O	O
to	O	O	O
appear	O	O	O
relevant	O	O	O
to	O	O	O
society	O	O	B-T092
's	O	O	I-T092
concerns	O	O	B-T078
and	O	O	O
problems	O	O	B-T033
as	O	O	O
well	O	O	O
as	O	O	O
enroll	O	O	O
others	O	O	O
to	O	O	O
share	O	O	O
the	O	O	O
profession	O	O	B-T090
's	O	O	I-T090
goals	O	O	B-T170
and	O	O	O
aims	O	O	B-T078
.	O	O	O

Studying	O	O	O
the	O	O	O
history	O	O	B-T169
of	O	O	O
the	O	O	O
profession	O	O	B-T090
can	O	O	O
thus	O	O	O
shed	O	O	O
light	O	O	O
on	O	O	O
the	O	O	O
changing	O	O	B-T169
definitions	O	O	B-T170
and	O	O	O
contours	O	O	B-T082
of	O	O	O
the	O	O	O
psychology	O	O	B-T091
profession	O	O	I-T091
itself	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
on	O	O	O
the	O	O	O
organization	O	O	B-T169
of	O	O	O
the	O	O	O
society	O	O	B-T092
in	O	O	O
which	O	O	O
it	O	O	O
acts	O	O	O
.	O	O	O

This	O	O	O
article	O	O	B-T170
examines	O	O	O
the	O	O	O
history	O	O	B-T169
of	O	O	O
the	O	O	O
Swedish	O	O	B-T098
psychology	O	O	B-T091
profession	O	O	I-T091
from	O	O	O
1990	O	O	O
to	O	O	O
2010	O	O	O
,	O	O	O
through	O	O	O
an	O	O	O
analysis	O	O	B-T062
of	O	O	O
the	O	O	O
discussions	O	O	B-T054
and	O	O	O
debates	O	O	B-T052
taking	O	O	O
place	O	O	O
in	O	O	O
the	O	O	O
Swedish	O	O	O
Psychological	O	O	B-T073
Association	O	O	I-T073
's	O	O	I-T073
journal	O	O	I-T073
.	O	O	O

The	O	O	O
analytical	O	O	B-T077
framework	O	O	I-T077
used	O	O	O
draws	O	O	O
on	O	O	O
work	O	O	O
done	O	O	O
within	O	O	O
actor-network	O	O	B-T170
theory	O	O	I-T170
and	O	O	O
science	O	O	B-T062
studies	O	O	I-T062
.	O	O	O

We	O	O	O
argue	O	O	O
that	O	O	O
the	O	O	O
profession	O	O	B-T090
's	O	O	I-T090
institutional	O	O	B-T080
connections	O	O	I-T080
,	O	O	O
defining	O	O	O
tasks	O	O	B-T052
,	O	O	O
epistemological	O	O	B-T170
underpinnings	O	O	B-T078
,	O	O	O
and	O	O	O
social	O	O	B-UnknownType
position	O	O	I-UnknownType
have	O	O	O
changed	O	O	B-T169
in	O	O	O
major	O	O	O
ways	O	O	O
during	O	O	O
these	O	O	O
2	O	O	O
decades	O	O	B-T081
.	O	O	O

Overall	O	O	O
,	O	O	O
as	O	O	O
a	O	O	O
result	O	O	O
of	O	O	O
an	O	O	O
increasingly	O	O	O
felt	O	O	O
insecurity	O	O	B-T041
,	O	O	O
the	O	O	O
profession	O	O	B-T090
has	O	O	O
turned	O	O	O
outward	O	O	O
and	O	O	O
tried	O	O	O
to	O	O	O
find	O	O	O
new	O	O	O
ways	O	O	O
to	O	O	O
legitimize	O	O	B-T169
itself	O	O	O
to	O	O	O
politicians	O	O	B-T097
,	O	O	O
the	O	O	O
media	O	O	B-T170
,	O	O	O
patients	O	O	B-T101
,	O	O	O
and	O	O	O
customers	O	O	B-T077
through	O	O	O
means	O	O	O
such	O	O	O
as	O	O	O
a	O	O	O
more	O	O	O
economized	O	O	B-T169
vocabulary	O	O	B-T170
and	O	O	O
novel	O	O	B-T080
forms	O	O	O
of	O	O	O
empirical	O	O	B-T062
research	O	O	I-T062
.	O	O	O

These	O	O	O
changes	O	O	B-T169
have	O	O	O
led	O	O	O
to	O	O	O
a	O	O	O
more	O	O	O
socialized	O	O	B-T054
profession	O	O	B-T090
,	O	O	O
now	O	O	O
more	O	O	O
closely	O	O	O
tuned	O	O	O
to	O	O	O
other	O	O	O
actors	O	O	B-T097
in	O	O	O
Swedish	O	O	B-T098
society	O	O	B-T092
,	O	O	O
leading	O	O	O
to	O	O	O
conflicts	O	O	B-T080
within	O	O	O
the	O	O	O
profession	O	O	O
over	O	O	O
whether	O	O	O
this	O	O	O
is	O	O	O
an	O	O	O
opportunity	O	O	O
to	O	O	O
better	O	O	O
control	O	O	B-T080
their	O	O	O
own	O	O	O
destiny	O	O	O
or	O	O	O
if	O	O	O
it	O	O	O
will	O	O	O
lead	O	O	O
to	O	O	O
a	O	O	O
loss	O	O	B-T033
of	O	O	I-T033
autonomy	O	O	I-T033
.	O	O	O

(	O	O	O
PsycINFO	O	O	O
Database	O	O	O
Record	O	O	O

-DOCSTART- (27337055)

Personally	O	O	B-T053
Meaningful	O	O	I-T053
Rituals	O	O	I-T053
:	O	O	O
A	O	O	O
Way	O	O	O
to	O	O	O
Increase	O	O	B-T169
Compassion	O	O	B-T054
and	O	O	O
Decrease	O	O	B-T081
Burnout	O	O	B-T033
among	O	O	O
Hospice	O	O	B-T058
Staff	O	O	B-T097
and	O	O	O
Volunteers	O	O	O

Rituals	O	O	B-T053
can	O	O	O
increase	O	O	B-T169
a	O	O	O
sense	O	O	B-UnknownType
of	O	O	I-UnknownType
connectedness	O	O	I-UnknownType
,	O	O	O
meaning	O	O	B-T078
,	O	O	O
and	O	O	O
support	O	O	B-T054
,	O	O	O
especially	O	O	O
after	O	O	O
the	O	O	O
death	O	O	B-T040
of	O	O	O
those	O	O	O
for	O	O	O
whom	O	O	O
we	O	O	O
care	O	O	O
.	O	O	O

Hospice	O	O	B-T058
staff	O	O	B-T097
may	O	O	O
benefit	O	O	O
from	O	O	O
the	O	O	O
use	O	O	O
of	O	O	O
personal	O	O	B-T053
rituals	O	O	I-T053
as	O	O	O
they	O	O	O
cope	O	O	B-T055
with	O	O	I-T055
the	O	O	O
frequent	O	O	B-T081
deaths	O	O	I-T081
of	O	O	O
their	O	O	O
patients	O	O	B-T101
,	O	O	O
ultimately	O	O	O
aiming	O	O	O
to	O	O	O
provide	O	O	O
compassionate	O	O	B-T052
care	O	O	I-T052
while	O	O	O
minimizing	O	O	O
burnout	O	O	B-T033
.	O	O	O

This	O	O	O
study	O	O	O
investigated	O	O	O
the	O	O	O
role	O	O	O
of	O	O	O
personally	O	O	B-T053
meaningful	O	O	I-T053
rituals	O	O	I-T053
in	O	O	O
increasing	O	O	B-T169
compassion	O	O	B-T054
and	O	O	O
decreasing	O	O	B-T080
burnout	O	O	B-T033
among	O	O	O
hospice	O	O	B-T058
staff	O	O	B-T097
and	O	O	O
volunteers	O	O	B-T098
.	O	O	O

An	O	O	O
online	O	O	B-T170
survey	O	O	I-T170
was	O	O	O
completed	O	O	O
by	O	O	O
members	O	O	O
of	O	O	O
the	O	O	O
National	O	O	B-T093
Hospice	O	O	B-T058
and	O	O	I-T093
Palliative	O	O	I-T093
Care	O	O	I-T093
Organization	O	O	I-T093
(	O	O	O
NHPCO	O	O	B-T093
)	O	O	O
which	O	O	O
inquired	O	O	O
about	O	O	O
personal	O	O	B-T053
ritual	O	O	I-T053
practices	O	O	O
,	O	O	O
and	O	O	O
included	O	O	O
the	O	O	O
Professional	O	O	B-T170
Quality	O	O	I-T170
of	O	O	I-T170
Life	O	O	I-T170
(	O	O	I-T170
ProQOL	O	O	B-T170
)	O	O	I-T170
scale	O	O	I-T170
to	O	O	O
measure	O	O	O
current	O	O	O
levels	O	O	O
of	O	O	O
Compassion	O	O	B-T054
Satisfaction	O	O	B-T041
,	O	O	O
Burnout	O	O	B-T033
,	O	O	O
and	O	O	O
Secondary	O	O	B-T048
Traumatic	O	O	I-T048
Stress	O	O	I-T048
.	O	O	O

Three	O	O	O
hundred	O	O	O
ninety	O	O	O
hospice	O	O	B-T058
staff	O	O	B-T097
and	O	O	O
volunteers	O	O	B-T098
from	O	O	O
across	O	O	O
38	O	O	O
states	O	O	B-T083
completed	O	O	O
the	O	O	O
online	O	O	B-T170
survey	O	O	I-T170
.	O	O	O

The	O	O	O
majority	O	O	O
of	O	O	O
participants	O	O	B-T098
were	O	O	O
Caucasian	O	O	B-T098
and	O	O	O
female	O	O	B-T032
,	O	O	O
with	O	O	O
an	O	O	O
average	O	O	O
of	O	O	O
nine	O	O	O
years	O	O	O
of	O	O	O
experience	O	O	O
in	O	O	O
hospice	O	O	B-T093
and	O	O	I-T093
palliative	O	O	I-T093
care	O	O	I-T093
.	O	O	O

The	O	O	O
majority	O	O	O
of	O	O	O
hospice	O	O	B-T058
staff	O	O	B-T097
and	O	O	O
volunteers	O	O	B-T098
used	O	O	O
personally	O	O	O
meaningful	O	O	O
rituals	O	O	B-T053
after	O	O	O
the	O	O	O
death	O	O	B-T040
of	O	O	O
their	O	O	O
patients	O	O	B-T101
to	O	O	O
help	O	O	O
them	O	O	O
cope	O	O	B-T055
(	O	O	O
71	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

Those	O	O	O
who	O	O	O
used	O	O	O
rituals	O	O	B-T053
demonstrated	O	O	O
significantly	O	O	O
higher	O	O	O
Compassion	O	O	B-T054
Satisfaction	O	O	B-T041
and	O	O	O
significantly	O	O	O
lower	O	O	O
Burnout	O	O	B-T033
as	O	O	O
measured	O	O	O
by	O	O	O
the	O	O	O
ProQOL	O	O	B-T170
,	O	O	O
with	O	O	O
professional	O	O	B-T033
support	O	O	I-T033
,	O	O	O
social	O	O	B-T054
support	O	O	I-T054
,	O	O	O
and	O	O	O
age	O	O	B-T032
playing	O	O	O
significant	O	O	B-T033
roles	O	O	I-T033
as	O	O	O
well	O	O	O
.	O	O	O

Rituals	O	O	B-T053
may	O	O	O
be	O	O	O
an	O	O	O
important	O	O	O
way	O	O	O
to	O	O	O
increase	O	O	B-T169
compassion	O	O	B-T054
and	O	O	O
decrease	O	O	B-T081
burnout	O	O	B-T033
among	O	O	O
hospice	O	O	B-T058
staff	O	O	B-T097
and	O	O	O
volunteers	O	O	B-T098
.	O	O	O

Organizations	O	O	B-T093
may	O	O	O
benefit	O	O	O
from	O	O	O
providing	O	O	O
training	O	O	B-T065
and	O	O	I-T065
support	O	O	I-T065
for	O	O	O
personalized	O	O	B-T053
rituals	O	O	I-T053
among	O	O	O
team	O	O	O
members	O	O	O
,	O	O	O
especially	O	O	O
new	O	O	B-T097
staff	O	O	I-T097
who	O	O	O
may	O	O	O
be	O	O	O
at	O	O	B-T080
greater	O	O	I-T080
risk	O	O	I-T080
for	O	O	O
burnout	O	O	B-T033
.	O	O	O

-DOCSTART- (27340777)

Activation	O	O	B-T052
of	O	O	O
the	O	O	O
orphan	O	O	B-T116
receptor	O	O	I-T116
GPR55	O	O	I-T116
by	O	O	O
lysophosphatidylinositol	O	O	B-T109
promotes	O	O	B-T052
metastasis	O	O	B-T191
in	O	O	O
triple-negative	O	O	O
breast	O	O	O
cancer	O	O	O

The	O	O	O
orphan	O	O	B-T116
G	O	O	I-T116
protein-coupled	O	O	I-T116
receptor	O	O	I-T116
GPR55	O	O	B-T116
has	O	O	O
been	O	O	O
directly	O	O	B-T080
or	O	O	O
indirectly	O	O	B-T080
related	O	O	B-T080
to	O	O	O
basic	O	O	O
alterations	O	O	B-T078
that	O	O	O
drive	O	O	O
malignant	O	O	B-T080
growth	O	O	B-T040
:	O	O	O
uncontrolled	O	O	B-T080
cancer	O	O	O
cell	O	O	B-T043
proliferation	O	O	I-T043
,	O	O	O
sustained	O	O	B-T042
angiogenesis	O	O	I-T042
,	O	O	O
and	O	O	O
cancer	O	O	O
cell	O	O	B-T043
adhesion	O	O	I-T043
and	O	O	O
migration	O	O	B-T067
.	O	O	O

However	O	O	O
,	O	O	O
little	O	O	B-T081
is	O	O	O
known	O	O	B-T080
about	O	O	O
the	O	O	O
involvement	O	O	B-T169
of	O	O	O
this	O	O	O
receptor	O	O	B-T116
in	O	O	O
metastasis	O	O	B-T191
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
show	O	O	O
that	O	O	O
elevated	O	O	B-T080
GPR55	O	O	B-T045
expression	O	O	I-T045
in	O	O	O
human	O	O	B-T016
tumors	O	O	B-T191
is	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
the	O	O	O
aggressive	O	O	B-T191
basal	O	O	I-T191
/	O	O	O
triple-negative	O	O	B-T191
breast	O	O	I-T191
cancer	O	O	I-T191
population	O	O	B-T098
,	O	O	O
higher	O	O	B-T081
probability	O	O	I-T081
to	O	O	O
develop	O	O	O
metastases	O	O	B-T191
,	O	O	O
and	O	O	O
therefore	O	O	O
poor	O	O	B-T080
patient	O	O	B-T101
prognosis	O	O	B-T058
.	O	O	O

Activation	O	O	B-T052
of	O	O	O
GPR55	O	O	B-T116
by	O	O	O
its	O	O	O
proposed	O	O	O
endogenous	O	O	B-T169
ligand	O	O	B-T103
lysophosphatidylinositol	O	O	B-T109
confers	O	O	O
pro-invasive	O	O	B-T080
features	O	O	B-T080
on	O	O	O
breast	O	O	B-T025
cancer	O	O	I-T025
cells	O	O	I-T025
both	O	O	O
in	O	O	B-T080
vitro	O	O	I-T080
and	O	O	O
in	O	O	B-T082
vivo	O	O	I-T082
.	O	O	O

Specifically	O	O	O
,	O	O	O
this	O	O	O
effect	O	O	B-T080
is	O	O	O
elicited	O	O	B-T080
by	O	O	I-T080
coupling	O	O	B-T169
to	O	O	O
Gq/11	O	O	B-T116
heterotrimeric	O	O	I-T116
proteins	O	O	I-T116
and	O	O	O
the	O	O	O
subsequent	O	O	B-T079
activation	O	O	B-T052
,	O	O	O
through	O	O	O
ERK	O	O	B-T116
,	O	O	O
of	O	O	O
the	O	O	O
transcription	O	O	B-T116
factor	O	O	I-T116
ETV4	O	O	I-T116
/	O	O	O
PEA3	O	O	B-T116
.	O	O	O

Together	O	O	B-T080
,	O	O	O
these	O	O	O
data	O	O	B-T078
show	O	O	O
that	O	O	O
GPR55	O	O	B-T116
promotes	O	O	B-T052
breast	O	O	B-T191
cancer	O	O	I-T191
metastasis	O	O	B-T191
,	O	O	O
and	O	O	O
supports	O	O	B-T077
the	O	O	O
notion	O	O	O
that	O	O	O
this	O	O	O
orphan	O	O	B-T116
receptor	O	O	I-T116
may	O	O	O
constitute	O	O	O
a	O	O	O
new	O	O	B-T080
therapeutic	O	O	B-T169
target	O	O	B-T169
and	O	O	O
potential	O	O	B-T080
biomarker	O	O	B-T201
in	O	O	O
the	O	O	O
highly	O	O	O
aggressive	O	O	B-T185
triple-negative	O	O	I-T185
subtype	O	O	I-T185
.	O	O	O

-DOCSTART- (27342634)

Effect	O	O	B-T080
of	O	O	O
ultrasonic	O	O	B-T169
processing	O	O	B-T052
on	O	O	O
the	O	O	O
changes	O	O	O
in	O	O	O
activity	O	O	B-T044
,	O	O	O
aggregation	O	O	B-T169
and	O	O	O
the	O	O	O
secondary	O	O	B-T082
and	O	O	O
tertiary	O	O	B-T082
structure	O	O	I-T082
of	O	O	O
polyphenol	O	O	B-T116
oxidase	O	O	I-T116
in	O	O	O
oriental	O	O	B-T083
sweet	O	O	B-T168
melon	O	O	I-T168
(	O	O	O
Cucumis	O	O	B-T002
melo	O	O	I-T002
var	O	O	I-T002
.	O	O	I-T002
makuwa	O	O	I-T002
Makino	O	O	I-T002
)	O	O	O

makuwa	O	O	O
Makino	O	O	O
)	O	O	O
Polyphenol	O	O	B-T116
oxidase	O	O	I-T116
(	O	O	O
PPO	O	O	B-T116
)	O	O	O
mainly	O	O	O
contributes	O	O	B-T052
to	O	O	O
the	O	O	O
browning	O	O	B-T070
reaction	O	O	I-T070
of	O	O	O
fruits	O	O	B-T168
and	O	O	O
vegetables	O	O	B-T168
and	O	O	O
causes	O	O	O
serious	O	O	B-T080
damage	O	O	B-T169
to	O	O	O
the	O	O	O
quality	O	O	B-T080
of	O	O	O
sweet	O	O	B-T168
melon	O	O	I-T168
products	O	O	B-T071
.	O	O	O

However	O	O	O
,	O	O	O
traditional	O	O	B-T169
methods	O	O	B-T169
to	O	O	O
inactivate	O	O	B-T169
browning	O	O	B-T070
may	O	O	O
induce	O	O	B-T169
more	O	O	O
unexpected	O	O	B-T170
risks	O	O	B-T078
than	O	O	O
ultrasonic	O	O	B-T169
processing	O	O	B-T052
.	O	O	O

Meanwhile	O	O	O
,	O	O	O
there	O	O	O
are	O	O	O
no	O	O	O
reports	O	O	B-T170
on	O	O	O
the	O	O	O
effect	O	O	B-T080
of	O	O	O
ultrasound	O	O	B-T070
on	O	O	O
PPO	O	O	B-T116
directly	O	O	O
purified	O	O	B-T169
from	O	O	O
sweet	O	O	B-T168
melon	O	O	I-T168
.	O	O	O

The	O	O	O
PPO	O	O	B-T116
in	O	O	O
the	O	O	O
original	O	O	B-T078
juice	O	O	B-T168
was	O	O	O
less	O	O	O
inactivated	O	O	B-T169
than	O	O	O
the	O	O	O
purified	O	O	B-T169
form	O	O	O
when	O	O	O
treated	O	O	B-T061
with	O	O	I-T061
ultrasound	O	O	B-T070
.	O	O	O

As	O	O	O
for	O	O	O
purified	O	O	B-T169
PPO	O	O	B-T116
,	O	O	O
superior	O	O	O
to	O	O	O
thermal	O	O	B-T061
treatment	O	O	B-T061
,	O	O	O
less	O	O	O
heat	O	O	B-T070
was	O	O	O
needed	O	O	O
to	O	O	O
inactivate	O	O	B-T169
the	O	O	O
PPO	O	O	O
with	O	O	O
ultrasonic	O	O	B-T169
treatment	O	O	O
.	O	O	O

At	O	O	O
intensity	O	O	B-T033
lower	O	O	I-T033
than	O	O	O
200	O	O	O
W	O	O	O
,	O	O	O
ultrasound	O	O	B-T070
did	O	O	O
not	O	O	O
significantly	O	O	B-T078
affect	O	O	O
the	O	O	O
structure	O	O	B-T082
and	O	O	O
activity	O	O	B-T078
of	O	O	O
PPO	O	O	B-T116
(	O	O	O
P	O	O	O
>	O	O	O
0.05	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
latent	O	O	B-T080
PPO	O	O	O
was	O	O	O
activated	O	O	B-T052
.	O	O	O

At	O	O	O
intensity	O	O	B-T033
higher	O	O	I-T033
than	O	O	O
200	O	O	O
W	O	O	O
,	O	O	O
ultrasound	O	O	B-T070
inactivated	O	O	B-T169
PPO	O	O	B-T116
,	O	O	O
induced	O	O	B-T169
aggregation	O	O	B-T169
and	O	O	O
dissociation	O	O	B-T044
of	O	O	O
PPO	O	O	O
particles	O	O	B-T104
and	O	O	O
significantly	O	O	B-T081
decreased	O	O	I-T081
the	O	O	O
Î±-helix	O	O	B-T082
structure	O	O	I-T082
content	O	O	O
.	O	O	O

Low-frequency	O	O	B-T079
high-intensity	O	O	B-T185
ultrasound	O	O	B-T070
caused	O	O	O
an	O	O	O
inactivation	O	O	B-T169
effect	O	O	B-T080
and	O	O	O
conformational	O	O	B-T044
changes	O	O	I-T044
of	O	O	O
purified	O	O	B-T169
PPO	O	O	B-T116
from	O	O	O
oriental	O	O	B-T083
sweet	O	O	B-T168
melons	O	O	I-T168
.	O	O	O

Changes	O	O	B-T169
in	O	O	O
the	O	O	O
PPO	O	O	B-T116
structure	O	O	B-T082
induced	O	O	B-T169
by	O	O	O
ultrasound	O	O	B-T070
eventually	O	O	O
inactivated	O	O	B-T169
the	O	O	O
enzyme	O	O	B-T116
.	O	O	O

Ultrasound	O	O	B-T070
may	O	O	O
be	O	O	O
a	O	O	O
potential	O	O	B-T080
method	O	O	B-T169
to	O	O	O
inactivate	O	O	B-T169
PPO	O	O	B-T116
in	O	O	O
oriental	O	O	B-T083
sweet	O	O	B-T168
melons	O	O	I-T168
.	O	O	O

Â©	O	O	O
2016	O	O	O
Society	O	O	O
of	O	O	O
Chemical	O	O	O
Industry	O	O	O
.	O	O	O

-DOCSTART- (27342978)

Phylogeography	O	O	B-T090
of	O	O	O
the	O	O	O
Spanish	O	O	B-T098
Moon	O	O	B-T204
Moth	O	O	I-T204
Graellsia	O	O	B-T204
isabellae	O	O	I-T204
(	O	O	O
Lepidoptera	O	O	B-T204
,	O	O	O
Saturniidae	O	O	B-T204
)	O	O	O

Geographic	O	O	B-T077
and	O	O	O
demographic	O	O	B-T078
factors	O	O	I-T078
as	O	O	O
well	O	O	O
as	O	O	O
specialisation	O	O	B-T090
to	O	O	O
a	O	O	O
new	O	O	O
host-plant	O	O	B-UnknownType
may	O	O	O
lead	O	O	O
to	O	O	O
host	O	O	B-UnknownType
-	O	O	O
associated	O	O	B-T080
differentiation	O	O	B-T169
in	O	O	O
plant	O	O	B-T002
-feeding	O	O	O
insects	O	O	B-T204
.	O	O	O

We	O	O	O
explored	O	O	O
the	O	O	O
phylogeography	O	O	B-T090
of	O	O	O
a	O	O	O
protected	O	O	B-T169
moth	O	O	B-T204
,	O	O	O
Graellsia	O	O	B-T204
isabellae	O	O	I-T204
,	O	O	O
and	O	O	O
its	O	O	O
two	O	O	O
recognised	O	O	O
host-plant	O	O	B-UnknownType
species	O	O	B-T185
(	O	O	O
Pinus	O	O	B-T002
sylvestris	O	O	I-T002
and	O	O	O
P.	O	O	B-T002
nigra	O	O	I-T002
)	O	O	O
in	O	O	O
order	O	O	O
to	O	O	O
seek	O	O	O
for	O	O	O
any	O	O	O
concordance	O	O	O
useful	O	O	O
to	O	O	O
disentangle	O	O	O
the	O	O	O
evolutionary	O	O	B-T169
history	O	O	I-T169
of	O	O	O
this	O	O	O
iconic	O	O	O
lepidopteran	O	O	B-T204
.	O	O	O

DNA	O	O	B-T114
variation	O	O	B-T070
in	O	O	O
one	O	O	O
mitochondrial	O	O	B-T026
marker	O	O	B-T086
and	O	O	O
nine	O	O	O
nuclear	O	O	B-T026
microsatellite	O	O	B-T028
loci	O	O	I-T028
revealed	O	O	O
a	O	O	O
strong	O	O	O
phylogeographic	O	O	B-T033
pattern	O	O	I-T033
across	O	O	O
28	O	O	O
populations	O	O	O
of	O	O	O
G.	O	O	B-T204
isabellae	O	O	I-T204
studied	O	O	O
in	O	O	O
Spain	O	O	B-T083
and	O	O	O
France	O	O	B-T083
comprising	O	O	O
six	O	O	O
groups	O	O	B-T078
mostly	O	O	O
distributed	O	O	B-T169
along	O	O	O
different	O	O	B-T080
mountain	O	O	B-T083
ranges	O	O	I-T083
.	O	O	O

Reanalysis	O	O	B-T062
of	O	O	O
a	O	O	O
previously	O	O	O
published	O	O	O
chloroplast	O	O	B-T026
microsatellite	O	O	B-T170
dataset	O	O	I-T170
revealed	O	O	B-T080
a	O	O	O
three	O	O	O
and	O	O	O
two-	O	O	O
group	O	O	B-T102
structure	O	O	I-T102
for	O	O	O
Spanish	O	O	B-T098
P.	O	O	B-T002
sylvestris	O	O	I-T002
and	O	O	O
P.	O	O	B-T002
nigra	O	O	I-T002
,	O	O	O
respectively	O	O	O
.	O	O	O

Overall	O	O	O
,	O	O	O
the	O	O	O
population	O	O	O
groupings	O	O	O
of	O	O	O
this	O	O	O
protected	O	O	B-T169
moth	O	O	B-T204
did	O	O	O
not	O	O	O
match	O	O	B-T080
the	O	O	O
ones	O	O	O
of	O	O	O
P.	O	O	B-T002
sylvestris	O	O	I-T002
and	O	O	O
P.	O	O	B-T002
nigra	O	O	I-T002
.	O	O	O

There	O	O	O
was	O	O	O
no	O	O	B-T080
evidence	O	O	I-T080
of	O	O	I-T080
host	O	O	B-UnknownType
-	O	O	O
associated	O	O	B-T080
differentiation	O	O	B-T169
between	O	O	O
populations	O	O	O
using	O	O	O
P.	O	O	B-T002
sylvestris	O	O	I-T002
and	O	O	O
the	O	O	O
ones	O	O	O
inhabiting	O	O	B-T169
P.	O	O	B-T002
nigra	O	O	I-T002
.	O	O	O

The	O	O	O
two	O	O	O
major	O	O	B-T080
mitochondrial	O	O	B-T026
clades	O	O	B-T078
of	O	O	O
G.	O	O	B-T204
isabellae	O	O	I-T204
likely	O	O	O
diverged	O	O	O
before	O	O	O
the	O	O	O
Last	O	O	B-T079
Glacial	O	O	I-T079
Maximum	O	O	I-T079
and	O	O	O
geographically	O	O	B-T082
separated	O	O	B-T080
the	O	O	O
species	O	O	B-T185
into	O	O	O
a	O	O	O
"	O	O	O
southern	O	O	B-T082
"	O	O	O
(	O	O	O
Central	O	O	B-T081
and	O	O	I-T081
Southern	O	O	I-T081
Iberian	O	O	I-T081
clusters	O	O	I-T081
)	O	O	O
and	O	O	O
a	O	O	O
"	O	O	O
northern	O	O	B-T082
"	O	O	O
lineage	O	O	B-T077
(	O	O	O
Eastern	O	O	B-T081
Iberian	O	O	I-T081
,	O	O	O
Pyrenean	O	O	B-T081
and	O	O	O
French	O	O	B-T081
Alpine	O	O	I-T081
clusters	O	O	I-T081
)	O	O	O
.	O	O	O

The	O	O	O
Eastern	O	O	B-T081
Iberian	O	O	I-T081
System	O	O	I-T081
,	O	O	O
where	O	O	O
this	O	O	O
insect	O	O	B-T204
uses	O	O	O
both	O	O	O
host-plants	O	O	B-UnknownType
,	O	O	O
harboured	O	O	O
the	O	O	O
highest	O	O	B-T080
level	O	O	B-T080
of	O	O	O
genetic	O	O	B-T169
diversity	O	O	B-T080
.	O	O	O

Such	O	O	O
a	O	O	O
group	O	O	B-T078
independently	O	O	O
colonised	O	O	B-T033
the	O	O	O
West	O	O	B-T082
and	O	O	O
East	O	O	B-T082
parts	O	O	I-T082
of	O	O	O
the	O	O	O
Pyrenees	O	O	B-UnknownType
.	O	O	O

Our	O	O	O
results	O	O	O
point	O	O	O
to	O	O	O
a	O	O	O
native	O	O	B-T169
origin	O	O	B-T079
for	O	O	O
the	O	O	O
French	O	O	B-T081
populations	O	O	I-T081
occurring	O	O	B-T079
in	O	O	O
the	O	O	O
Alps	O	O	B-T083
,	O	O	O
genetically	O	O	B-T169
related	O	O	O
to	O	O	O
the	O	O	O
Eastern	O	O	B-UnknownType
Iberian	O	O	I-UnknownType
and	O	O	O
Pyrenean	O	O	B-UnknownType
sites	O	O	I-UnknownType
.	O	O	O

The	O	O	O
Central	O	O	B-T078
Iberian	O	O	I-T078
group	O	O	I-T078
derived	O	O	O
from	O	O	O
Southern	O	O	B-UnknownType
Iberian	O	O	I-UnknownType
ancestors	O	O	B-T099
.	O	O	O

Secondary	O	O	B-T081
contacts	O	O	B-T080
were	O	O	O
inferred	O	O	O
between	O	O	O
the	O	O	O
Southern/Central	O	O	B-T081
Iberian	O	O	I-T081
populations	O	O	I-T081
and	O	O	O
Eastern	O	O	B-T081
Iberian	O	O	I-T081
cluster	O	O	I-T081
as	O	O	O
well	O	O	O
as	O	O	O
between	O	O	O
the	O	O	O
two	O	O	O
Pyrenean	O	O	B-T081
ones	O	O	I-T081
.	O	O	O

The	O	O	O
mito-nuclear	O	O	B-T081
discordance	O	O	I-T081
observed	O	O	O
with	O	O	O
regard	O	O	O
to	O	O	O
the	O	O	O
Eastern	O	O	B-T081
Iberian	O	O	I-T081
cluster	O	O	I-T081
is	O	O	O
congruent	O	O	B-T080
with	O	O	O
a	O	O	O
secondary	O	O	B-T081
contact	O	O	B-T080
after	O	O	O
the	O	O	O
evolution	O	O	B-T045
of	O	O	O
mito-nuclear	O	O	B-T080
incompatibilities	O	O	I-T080
in	O	O	O
geographically	O	O	B-UnknownType
isolated	O	O	I-UnknownType
areas	O	O	I-UnknownType
.	O	O	O

-DOCSTART- (27343229)

Prevalence	O	O	B-T081
of	O	O	O
Physical	O	O	B-T056
Activity	O	O	I-T056
and	O	O	O
Sitting	O	O	B-T039
Time	O	O	B-T079
Among	O	O	O
South	O	O	B-T098
Korean	O	O	B-T098
Adolescents	O	O	B-T100
:	O	O	O
Results	O	O	B-T033
From	O	O	O
the	O	O	O
Korean	O	O	O
National	O	O	B-T062
Health	O	O	I-T062
and	O	O	I-T062
Nutrition	O	O	I-T062
Examination	O	O	I-T062
Survey	O	O	I-T062
,	O	O	O
2013	O	O	O

This	O	O	O
study	O	O	O
aimed	O	O	O
to	O	O	O
describe	O	O	O
physical	O	O	B-T056
activity	O	O	I-T056
(	O	O	O
PA	O	O	B-T056
)	O	O	O
and	O	O	O
sitting	O	O	B-T039
time	O	O	B-T079
,	O	O	O
and	O	O	O
to	O	O	O
examine	O	O	O
associations	O	O	B-T080
between	O	O	O
sociodemographic	O	O	B-T078
factors	O	O	I-T078
,	O	O	O
weight	O	O	B-T032
status	O	O	B-T080
,	O	O	O
PA	O	O	O
,	O	O	O
and	O	O	O
sitting	O	O	O
time	O	O	O
among	O	O	O
South	O	O	B-T098
Korean	O	O	I-T098
adolescents	O	O	B-T100
(	O	O	O
12	O	O	O
-	O	O	O
18	O	O	O
years	O	O	B-T079
)	O	O	O
.	O	O	O

Findings	O	O	B-T169
are	O	O	O
based	O	O	O
on	O	O	O
self-report	O	O	B-T062
data	O	O	I-T062
from	O	O	O
638	O	O	O
participants	O	O	B-T098
in	O	O	O
the	O	O	O
2013	O	O	O
Korea	O	O	B-T083
National	O	O	B-T062
Health	O	O	I-T062
and	O	O	I-T062
Nutrition	O	O	I-T062
Examination	O	O	I-T062
Survey	O	O	I-T062
.	O	O	O

Only	O	O	O
4.9	O	O	O
%	O	O	O
of	O	O	O
adolescents	O	O	B-T100
accumulated	O	O	O
60	O	O	O
minutes	O	O	B-T079
of	O	O	O
moderate-to-vigorous	O	O	B-T056
PA	O	O	I-T056
daily	O	O	B-T079
.	O	O	O

Adolescents	O	O	B-T100
spent	O	O	O
532.4	O	O	O
Â±	O	O	O
9.3	O	O	O
mins/d	O	O	B-T079
sitting	O	O	B-T039
.	O	O	O

After	O	O	O
controlling	O	O	O
for	O	O	O
age	O	O	B-T032
and	O	O	O
sex	O	O	B-T032
,	O	O	O
individuals	O	O	B-T098
in	O	O	O
higher	O	O	B-T098
income	O	O	I-T098
groups	O	O	I-T098
compared	O	O	B-T052
with	O	O	O
the	O	O	O
lowest	O	O	B-T098
income	O	O	I-T098
group	O	O	I-T098
,	O	O	O
living	O	O	B-T052
in	O	O	O
nonmetro	O	O	B-T082
Seoul	O	O	B-T083
compared	O	O	O
with	O	O	O
metro	O	O	B-T082
Seoul	O	O	O
,	O	O	O
and	O	O	O
who	O	O	O
were	O	O	O
overweight	O	O	B-T184
compared	O	O	O
with	O	O	O
nonoverweight	O	O	B-T032
were	O	O	O
more	O	O	O
likely	O	O	O
to	O	O	O
meet	O	O	O
PA	O	O	B-T056
guidelines	O	O	B-T170
.	O	O	O

Participants	O	O	B-T098
in	O	O	O
the	O	O	O
highest	O	O	B-T098
income	O	O	I-T098
group	O	O	B-T078
compared	O	O	B-T052
with	O	O	O
lowest	O	O	B-T098
income	O	O	I-T098
group	O	O	I-T098
,	O	O	O
and	O	O	O
residing	O	O	B-T052
in	O	O	O
nonmetro	O	O	B-T082
Seoul	O	O	B-T083
compared	O	O	O
with	O	O	O
metro	O	O	B-T082
Seoul	O	O	O
were	O	O	O
more	O	O	O
likely	O	O	O
to	O	O	O
be	O	O	O
in	O	O	O
the	O	O	O
high	O	O	O
sitting	O	O	B-T039
time	O	O	B-T079
group	O	O	O
(	O	O	O
>	O	O	O
720	O	O	O
min/d	O	O	B-T079
)	O	O	O
(	O	O	O
P	O	O	O
<	O	O	O
.05	O	O	O
)	O	O	O
.	O	O	O

Increasing	O	O	B-T169
PA	O	O	B-T056
and	O	O	O
reducing	O	O	B-T080
sitting	O	O	B-T039
should	O	O	O
be	O	O	O
a	O	O	O
public	O	O	B-T170
health	O	O	I-T170
priority	O	O	B-T079
in	O	O	O
South	O	O	B-T083
Korea	O	O	I-T083
.	O	O	O

-DOCSTART- (27343573)

Graphene	O	O	B-T196
/	O	O	O
Nafion	O	O	B-T109
composite	O	O	B-T167
film	O	O	I-T167
modified	O	O	O
glassy	O	O	B-T080
carbon	O	O	B-T074
electrode	O	O	I-T074
for	O	O	O
simultaneous	O	O	B-T079
determination	O	O	B-T059
of	O	O	O
paracetamol	O	O	B-T109
,	O	O	O
aspirin	O	O	B-T109
and	O	O	O
caffeine	O	O	B-T109
in	O	O	O
pharmaceutical	O	O	O
formulations	O	O	O

A	O	O	O
graphene	O	O	B-T196
-	O	O	O
Nafion	O	O	B-T109
composite	O	O	B-T167
film	O	O	I-T167
was	O	O	O
fabricated	O	O	B-T057
on	O	O	O
the	O	O	O
glassy	O	O	B-T080
carbon	O	O	B-T074
electrode	O	O	I-T074
(	O	O	O
GR-NF/GCE	O	O	B-T074
)	O	O	O
,	O	O	O
and	O	O	O
used	O	O	O
for	O	O	O
simultaneous	O	O	B-T079
determination	O	O	B-T059
of	O	O	O
paracetamol	O	O	B-T109
(	O	O	O
PAR	O	O	B-T109
)	O	O	O
,	O	O	O
aspirin	O	O	B-T109
(	O	O	O
ASA	O	O	B-T109
)	O	O	O
and	O	O	O
caffeine	O	O	B-T109
(	O	O	O
CAF	O	O	B-T109
)	O	O	O
.	O	O	O

The	O	O	O
electrochemical	O	O	B-T080
behaviors	O	O	I-T080
of	O	O	O
PAR	O	O	B-T109
,	O	O	O
ASA	O	O	B-T109
and	O	O	O
CAF	O	O	B-T109
were	O	O	O
investigated	O	O	B-T169
by	O	O	O
cyclic	O	O	B-UnknownType
voltammetry	O	O	I-UnknownType
and	O	O	O
square-wave	O	O	B-T059
adsorptive	O	O	I-T059
anodic	O	O	I-T059
stripping	O	O	I-T059
voltammetry	O	O	I-T059
.	O	O	O

By	O	O	O
using	O	O	O
stripping	O	O	B-T059
one	O	O	O
for	O	O	O
simultaneous	O	O	B-T079
determination	O	O	B-T059
of	O	O	O
PAR	O	O	B-T109
,	O	O	O
ASA	O	O	B-T109
and	O	O	O
CAF	O	O	B-T109
,	O	O	O
their	O	O	O
electrochemical	O	O	B-T080
oxidation	O	O	I-T080
peaks	O	O	I-T080
appeared	O	O	B-T080
at	O	O	O
+	O	O	O
0.64	O	O	O
,	O	O	O
1.04	O	O	O
and	O	O	O
1.44V	O	O	O
,	O	O	O
and	O	O	O
good	O	O	B-T080
linear	O	O	B-T080
current	O	O	I-T080
responses	O	O	I-T080
were	O	O	O
obtained	O	O	B-T169
with	O	O	O
the	O	O	O
detection	O	O	B-T081
limits	O	O	I-T081
of	O	O	O
18ngmL(-1	O	O	O
)	O	O	O
(	O	O	O
1.2	O	O	O
Ã	O	O	O
10(-9)M	O	O	O
)	O	O	O
,	O	O	O
11.7ngmL(-1	O	O	O
)	O	O	O
(	O	O	O
6.5	O	O	O
Ã	O	O	O
10(-8)M	O	O	O
)	O	O	O
and	O	O	O
7.3ngmL(-1	O	O	O
)	O	O	O
(	O	O	O
3.8	O	O	O
Ã	O	O	O
10(-8)M	O	O	O
)	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

Finally	O	O	O
,	O	O	O
the	O	O	O
proposed	O	O	B-T078
electrochemical	O	O	B-T073
sensor	O	O	I-T073
was	O	O	O
successfully	O	O	B-T080
applied	O	O	B-T169
for	O	O	O
quantifying	O	O	B-T081
PAR	O	O	B-T109
,	O	O	O
ASA	O	O	B-T109
and	O	O	O
CAF	O	O	B-T109
in	O	O	O
commercial	O	O	B-T170
tablet	O	O	B-T077
formulations	O	O	I-T077
.	O	O	O

-DOCSTART- (27346839)

Long-term	O	O	B-T079
antibiofilm	O	O	B-T052
activity	O	O	I-T052
of	O	O	O
carboxymethyl	O	O	B-T109
chitosan	O	O	I-T109
on	O	O	O
mixed	O	O	B-T007
biofilm	O	O	I-T007
on	O	O	O
silicone	O	O	O

Silicone	O	O	B-T109
voice	O	O	B-T074
prostheses	O	O	I-T074
are	O	O	O
most	O	O	O
frequently	O	O	B-T079
used	O	O	O
in	O	O	O
voice	O	O	B-T061
rehabilitation	O	O	I-T061
of	O	O	O
laryngectomized	O	O	B-T061
patients	O	O	B-T101
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
functional	O	O	B-T033
device	O	O	I-T033
lifetimes	O	O	B-T079
are	O	O	O
limited	O	O	B-T169
due	O	O	B-T169
to	O	O	I-T169
formation	O	O	B-T169
of	O	O	O
mixed	O	O	B-T007
biofilms	O	O	I-T007
.	O	O	O

Existing	O	O	O
in	O	O	B-T062
vitro	O	O	I-T062
models	O	O	I-T062
simulating	O	O	O
biofilm	O	O	B-T043
formation	O	O	I-T043
are	O	O	O
restricted	O	O	B-T169
to	O	O	O
only	O	O	O
short-term	O	O	B-T079
periods	O	O	B-T079
.	O	O	O

The	O	O	O
goal	O	O	B-T170
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
determine	O	O	O
the	O	O	O
effect	O	O	B-T080
of	O	O	O
carboxymethyl	O	O	B-T109
chitosan	O	O	I-T109
on	O	O	O
mixed	O	O	B-T043
biofilm	O	O	I-T043
formation	O	O	I-T043
of	O	O	O
fungi	O	O	B-T004
and	O	O	O
bacteria	O	O	B-T007
on	O	O	O
silicone	O	O	B-T109
over	O	O	O
a	O	O	O
long-term	O	O	B-T079
period	O	O	B-T079
.	O	O	O

Mixed	O	O	O
species	O	O	B-T185
biofilms	O	O	B-T007
of	O	O	O
Candida	O	O	B-T004
albicans	O	O	I-T004
,	O	O	O
Candida	O	O	B-T004
tropicalis	O	O	I-T004
,	O	O	O
Lactobacillus	O	O	B-T007
gasseri	O	O	I-T007
,	O	O	O
Streptococcus	O	O	B-T007
salivarius	O	O	I-T007
,	O	O	O
Rothia	O	O	B-T007
dentocariosa	O	O	I-T007
,	O	O	O
and	O	O	O
Staphylococcus	O	O	B-T007
epidermidis	O	O	I-T007
were	O	O	O
cultivated	O	O	B-T067
on	O	O	O
the	O	O	O
surfaces	O	O	B-T082
of	O	O	O
medical-grade	O	O	B-T109
silicone	O	O	I-T109
with	O	O	O
and	O	O	O
without	O	O	O
addition	O	O	O
of	O	O	O
carboxymethyl	O	O	B-T109
chitosan	O	O	I-T109
.	O	O	O

Biofilm	O	O	B-T070
kinetics	O	O	I-T070
was	O	O	O
monitored	O	O	O
using	O	O	O
specially	O	O	O
designed	O	O	B-T170
image	O	O	I-T170
analysis	O	O	I-T170
software	O	O	I-T170
to	O	O	O
calculate	O	O	B-T052
the	O	O	O
percentual	O	O	B-T169
surface	O	O	I-T169
covering	O	O	I-T169
of	O	O	O
each	O	O	O
platelet	O	O	B-T025
.	O	O	O

Biofilm	O	O	B-T082
architecture	O	O	I-T082
was	O	O	O
investigated	O	O	B-T169
by	O	O	O
scanning	O	O	B-T059
electron	O	O	I-T059
microscopy	O	O	I-T059
.	O	O	O

A	O	O	O
cover	O	O	B-T169
of	O	O	O
living	O	O	B-T078
mixed	O	O	B-T007
biofilm	O	O	B-T007
could	O	O	O
be	O	O	O
generated	O	O	O
over	O	O	O
22	O	O	O
days	O	O	B-T079
on	O	O	O
silicone	O	O	B-T109
and	O	O	O
the	O	O	O
maximum	O	O	B-T081
of	O	O	O
22	O	O	O
%	O	O	O
biofilm	O	O	O
surface	O	O	B-T169
covering	O	O	I-T169
at	O	O	O
day	O	O	B-T079
22	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
less	O	O	B-T081
than	O	O	I-T081
4	O	O	O
%	O	O	O
surface	O	O	B-T169
coverage	O	O	I-T169
was	O	O	O
observed	O	O	B-T169
on	O	O	O
the	O	O	O
carboxymethyl	O	O	B-T109
chitosan	O	O	I-T109
-	O	O	O
treated	O	O	B-T169
plates	O	O	O
in	O	O	O
the	O	O	O
testing	O	O	B-T169
period	O	O	B-T079
.	O	O	O

Scanning	O	O	B-T059
electron	O	O	I-T059
microscopy	O	O	I-T059
confirms	O	O	B-T033
that	O	O	O
,	O	O	O
on	O	O	O
surfaces	O	O	B-T082
treated	O	O	B-T169
by	O	O	O
carboxymethyl	O	O	B-T109
chitosan	O	O	I-T109
,	O	O	O
the	O	O	O
biofilm	O	O	B-T007
was	O	O	O
less	O	O	B-T080
dense	O	O	B-T080
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
there	O	O	O
were	O	O	O
fewer	O	O	B-T081
layers	O	O	O
of	O	O	O
cells	O	O	B-T025
and	O	O	O
profuse	O	O	B-T033
cellular	O	O	I-T033
debris	O	O	I-T033
,	O	O	O
together	O	O	B-T080
with	O	O	O
degrading	O	O	O
and	O	O	O
morphologically	O	O	B-T190
altered	O	O	I-T190
yeast	O	O	B-T004
cells	O	O	O
.	O	O	O

Carboxymethyl	O	O	B-T109
chitosan	O	O	I-T109
may	O	O	O
serve	O	O	O
as	O	O	O
a	O	O	O
possible	O	O	B-T033
antibiofilm	O	O	B-T167
agent	O	O	I-T167
to	O	O	O
limit	O	O	O
biofilm	O	O	B-T043
formation	O	O	I-T043
on	O	O	O
voice	O	O	B-T074
prostheses	O	O	I-T074
.	O	O	O

NA	O	O	O
Laryngoscope	O	O	B-T074
,	O	O	O
126:E404-E408	O	O	O
,	O	O	O
2016	O	O	O
.	O	O	O

-DOCSTART- (27347668)

Spectral	O	O	B-T059
fingerprints	O	O	I-T059
of	O	O	O
large-scale	O	O	O
cortical	O	O	B-T023
dynamics	O	O	B-T070
during	O	O	B-T079
ambiguous	O	O	B-T080
motion	O	O	O
perception	O	O	O

Ambiguous	O	O	B-T169
stimuli	O	O	B-T067
have	O	O	O
been	O	O	O
widely	O	O	O
used	O	O	O
to	O	O	O
study	O	O	O
the	O	O	O
neuronal	O	O	B-T025
correlates	O	O	B-T080
of	O	O	O
consciousness	O	O	B-T041
.	O	O	O

Recently	O	O	O
,	O	O	O
it	O	O	O
has	O	O	O
been	O	O	O
suggested	O	O	O
that	O	O	O
conscious	O	O	B-T041
perception	O	O	B-T041
might	O	O	O
arise	O	O	O
from	O	O	O
the	O	O	O
dynamic	O	O	B-T169
interplay	O	O	O
of	O	O	O
functionally	O	O	O
specialized	O	O	O
but	O	O	O
widely	O	O	O
distributed	O	O	O
cortical	O	O	B-T023
areas	O	O	I-T023
.	O	O	O

While	O	O	O
previous	O	O	O
research	O	O	O
mainly	O	O	O
focused	O	O	O
on	O	O	O
phase	O	O	B-T042
coupling	O	O	I-T042
as	O	O	O
a	O	O	O
correlate	O	O	B-T080
of	O	O	O
cortical	O	O	B-T023
communication	O	O	O
,	O	O	O
more	O	O	O
recent	O	O	O
findings	O	O	O
indicated	O	O	O
that	O	O	O
additional	O	O	O
coupling	O	O	B-T042
modes	O	O	I-T042
might	O	O	O
coexist	O	O	O
and	O	O	O
possibly	O	O	O
subserve	O	O	O
distinct	O	O	O
cortical	O	O	B-T042
functions	O	O	I-T042
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
studied	O	O	O
two	O	O	O
coupling	O	O	B-T042
modes	O	O	I-T042
,	O	O	O
namely	O	O	O
phase	O	O	B-T042
and	O	O	I-T042
envelope	O	O	I-T042
coupling	O	O	I-T042
,	O	O	O
which	O	O	O
might	O	O	O
differ	O	O	O
in	O	O	O
their	O	O	O
origins	O	O	O
,	O	O	O
putative	O	O	O
functions	O	O	O
and	O	O	O
dynamics	O	O	B-T070
.	O	O	O

Therefore	O	O	O
,	O	O	O
we	O	O	O
recorded	O	O	O
128-channel	O	O	O
EEG	O	O	B-T060
while	O	O	O
participants	O	O	B-T098
performed	O	O	O
a	O	O	O
bistable	O	O	B-T060
motion	O	O	I-T060
task	O	O	I-T060
and	O	O	O
utilized	O	O	O
state-of-the-art	O	O	O
source-space	O	O	O
connectivity	O	O	B-T169
analysis	O	O	B-T062
techniques	O	O	B-T169
to	O	O	O
study	O	O	O
the	O	O	O
functional	O	O	B-T077
relevance	O	O	I-T077
of	O	O	O
different	O	O	O
coupling	O	O	B-T042
modes	O	O	I-T042
for	O	O	O
cortical	O	O	B-T023
communication	O	O	O
.	O	O	O

Our	O	O	O
results	O	O	O
indicate	O	O	O
that	O	O	O
gamma-band	O	O	B-T042
phase	O	O	I-T042
coupling	O	O	I-T042
in	O	O	O
extrastriate	O	O	B-T029
visual	O	O	B-T023
cortex	O	O	I-T023
might	O	O	O
mediate	O	O	O
the	O	O	O
integration	O	O	O
of	O	O	O
visual	O	O	B-T060
tokens	O	O	I-T060
into	O	O	O
a	O	O	O
moving	O	O	B-T040
stimulus	O	O	B-T067
during	O	O	O
ambiguous	O	O	B-T080
visual	O	O	B-T060
stimulation	O	O	I-T060
.	O	O	O

Furthermore	O	O	O
,	O	O	O
our	O	O	O
results	O	O	O
suggest	O	O	O
that	O	O	O
long-range	O	O	O
fronto-occipital	O	O	O
gamma-band	O	O	O
envelope	O	O	B-T042
coupling	O	O	I-T042
sustains	O	O	O
the	O	O	O
horizontal	O	O	O
percept	O	O	O
during	O	O	O
ambiguous	O	O	B-T080
motion	O	O	B-T041
perception	O	O	I-T041
.	O	O	O

Additionally	O	O	O
,	O	O	O
our	O	O	O
results	O	O	O
support	O	O	O
the	O	O	O
idea	O	O	O
that	O	O	O
local	O	O	B-T023
parieto-occipital	O	O	I-T023
alpha-band	O	O	B-T042
phase	O	O	I-T042
coupling	O	O	I-T042
controls	O	O	O
the	O	O	O
inter-	O	O	O
hemispheric	O	O	B-T082
information	O	O	B-T169
transfer	O	O	I-T169
.	O	O	O

These	O	O	O
findings	O	O	O
provide	O	O	O
correlative	O	O	B-T080
evidence	O	O	B-T078
for	O	O	O
the	O	O	O
notion	O	O	O
that	O	O	O
synchronized	O	O	B-T079
oscillatory	O	O	O
brain	O	O	B-T039
activity	O	O	I-T039
reflects	O	O	O
the	O	O	O
processing	O	O	B-T042
of	O	O	I-T042
sensory	O	O	I-T042
input	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
the	O	O	O
information	O	O	B-T040
integration	O	O	I-T040
across	O	O	O
several	O	O	O
spatiotemporal	O	O	B-T062
scales	O	O	I-T062
.	O	O	O

The	O	O	O
results	O	O	O
indicate	O	O	O
that	O	O	O
distinct	O	O	B-T081
coupling	O	O	I-T081
modes	O	O	I-T081
are	O	O	O
involved	O	O	O
in	O	O	O
different	O	O	O
cortical	O	O	B-T023
computations	O	O	B-T052
and	O	O	O
that	O	O	O
the	O	O	O
rich	O	O	O
spatiotemporal	O	O	B-T062
correlation	O	O	I-T062
structure	O	O	B-T023
of	O	O	I-T023
the	O	O	I-T023
brain	O	O	I-T023
might	O	O	O
constitute	O	O	O
the	O	O	O
functional	O	O	B-T169
architecture	O	O	O
for	O	O	O
cortical	O	O	O
processing	O	O	O
and	O	O	O
specific	O	O	O
multi-site	O	O	O
communication	O	O	O
.	O	O	O

Hum	O	O	O
Brain	O	O	O
Mapp	O	O	O
37:4099	O	O	O
-	O	O	O
4111	O	O	O
,	O	O	O
2016	O	O	O
.	O	O	O

Â©	O	O	O
2016	O	O	O
Wiley	O	O	O
Periodicals	O	O	O
,	O	O	O
Inc.	O	O	O

-DOCSTART- (27349182)

Beneficial	O	O	B-UnknownType
effects	O	O	I-UnknownType
of	O	O	O
voglibose	O	O	B-T109
administration	O	O	B-T061
on	O	O	O
body	O	O	B-T032
weight	O	O	I-T032
and	O	O	O
lipid	O	O	B-T044
metabolism	O	O	I-T044
via	O	O	O
gastrointestinal	O	O	B-T022
bile	O	O	B-T109
acid	O	O	I-T109
modification	O	O	O

This	O	O	O
study	O	O	B-T062
was	O	O	O
designed	O	O	O
with	O	O	O
the	O	O	O
goal	O	O	B-T170
of	O	O	O
examining	O	O	O
the	O	O	O
effects	O	O	B-T169
of	O	O	O
voglibose	O	O	B-T109
administration	O	O	B-T061
on	O	O	O
body	O	O	B-T032
weight	O	O	I-T032
and	O	O	O
lipid	O	O	B-T044
metabolism	O	O	I-T044
and	O	O	O
underlying	O	O	O
mechanism	O	O	B-T169
high	O	O	B-T061
fat	O	O	I-T061
diet	O	O	I-T061
-induced	O	O	O
obese	O	O	B-T015
mice	O	O	I-T015
.	O	O	O

Male	O	O	B-T032
C57BL/6	O	O	B-T015
mice	O	O	I-T015
were	O	O	O
randomly	O	O	O
assigned	O	O	O
to	O	O	O
one	O	O	O
of	O	O	O
four	O	O	O
groups	O	O	B-T096
:	O	O	O
a	O	O	O
control	O	O	B-T096
diet	O	O	I-T096
(	O	O	O
CTL	O	O	B-T096
)	O	O	O
,	O	O	O
high-fat	O	O	B-T096
diet	O	O	I-T096
(	O	O	O
HF	O	O	B-T096
)	O	O	O
,	O	O	O
high-fat	O	O	B-T096
diet	O	O	I-T096
supplemented	O	O	I-T096
with	O	O	I-T096
voglibose	O	O	I-T096
(	O	O	O
VO	O	O	B-T096
)	O	O	O
,	O	O	O
and	O	O	O
high	O	O	B-T096
fat	O	O	I-T096
diet	O	O	I-T096
pair-fed	O	O	I-T096
group	O	O	I-T096
(	O	O	O
PF	O	O	B-T096
)	O	O	O
.	O	O	O

After	O	O	O
12	O	O	O
weeks	O	O	B-T079
,	O	O	O
the	O	O	O
following	O	O	O
characteristics	O	O	B-T080
were	O	O	O
investigated	O	O	O
:	O	O	O
serum	O	O	B-T059
lipid	O	O	B-T044
and	O	O	O
glucose	O	O	B-T034
levels	O	O	I-T034
,	O	O	O
serum	O	O	O
polar	O	O	O
metabolite	O	O	O
profiles	O	O	O
,	O	O	O
and	O	O	O
expression	O	O	B-T081
levels	O	O	I-T081
of	O	O	O
genes	O	O	B-T028
involved	O	O	O
in	O	O	O
lipid	O	O	O
and	O	O	O
bile	O	O	B-T044
acid	O	O	I-T044
metabolism	O	O	I-T044
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
pyrosequencing	O	O	B-T059
was	O	O	O
used	O	O	O
to	O	O	O
analyze	O	O	O
the	O	O	O
composition	O	O	B-T201
of	O	O	O
gut	O	O	B-T001
microbiota	O	O	I-T001
found	O	O	O
in	O	O	O
feces	O	O	B-T031
.	O	O	O

Total	O	O	B-T033
body	O	O	I-T033
weight	O	O	I-T033
gain	O	O	I-T033
was	O	O	O
significantly	O	O	B-T081
lower	O	O	I-T081
in	O	O	O
the	O	O	O
VO	O	O	B-T096
group	O	O	I-T096
than	O	O	O
in	O	O	O
the	O	O	O
CTL	O	O	B-T096
,	O	O	O
HF	O	O	B-T096
,	O	O	O
and	O	O	O
PF	O	O	B-T096
groups	O	O	I-T096
.	O	O	O

The	O	O	O
VO	O	O	B-T096
group	O	O	I-T096
exhibited	O	O	O
improved	O	O	O
metabolic	O	O	B-T039
profiles	O	O	I-T039
including	O	O	O
those	O	O	O
of	O	O	O
blood	O	O	B-T059
glucose	O	O	I-T059
,	O	O	O
triglyceride	O	O	B-T034
,	O	O	O
and	O	O	O
total	O	O	B-T034
cholesterol	O	O	I-T034
levels	O	O	I-T034
.	O	O	O

The	O	O	O
12-	O	O	O
week	O	O	B-T079
voglibose	O	O	B-T109
administration	O	O	B-T061
decreased	O	O	O
the	O	O	O
ratio	O	O	O
of	O	O	O
Firmicutes	O	O	B-T007
to	O	O	O
Bacteroidetes	O	O	B-T007
found	O	O	O
in	O	O	O
feces	O	O	B-T031
.	O	O	O

Circulating	O	O	O
levels	O	O	B-T080
of	O	O	O
taurocholic	O	O	B-T109
and	O	O	O
cholic	O	O	B-T109
acid	O	O	I-T109
were	O	O	O
significantly	O	O	B-T081
higher	O	O	I-T081
in	O	O	O
the	O	O	O
VO	O	O	B-T096
group	O	O	I-T096
than	O	O	O
in	O	O	O
the	O	O	O
HF	O	O	B-T096
and	O	O	O
CTL	O	O	B-T096
groups	O	O	I-T096
.	O	O	O

Deoxycholic	O	O	B-T109
acid	O	O	I-T109
levels	O	O	B-T080
tended	O	O	O
to	O	O	O
be	O	O	O
higher	O	O	O
in	O	O	O
the	O	O	O
VO	O	O	B-T096
group	O	O	I-T096
than	O	O	O
in	O	O	O
the	O	O	O
HF	O	O	B-T096
group	O	O	I-T096
.	O	O	O

Voglibose	O	O	B-T109
administration	O	O	B-T061
downregulated	O	O	B-T044
expression	O	O	B-T081
levels	O	O	I-T081
of	O	O	O
CYP8B1	O	O	B-T028
and	O	O	O
HNF4Î±	O	O	B-T028
genes	O	O	I-T028
and	O	O	O
upregulated	O	O	B-T044
those	O	O	O
of	O	O	O
PGC1Î±	O	O	B-T028
,	O	O	O
whereas	O	O	O
FXRÎ±	O	O	B-T028
was	O	O	O
not	O	O	O
affected	O	O	O
.	O	O	O

Voglibose	O	O	B-T109
administration	O	O	B-T061
elicits	O	O	O
changes	O	O	O
in	O	O	O
the	O	O	O
composition	O	O	B-T201
of	O	O	O
the	O	O	O
intestinal	O	O	B-T001
microbiota	O	O	I-T001
and	O	O	O
circulating	O	O	B-T123
metabolites	O	O	I-T123
,	O	O	O
which	O	O	O
ultimately	O	O	O
has	O	O	O
systemic	O	O	B-UnknownType
effects	O	O	I-UnknownType
on	O	O	O
body	O	O	B-T032
weight	O	O	I-T032
and	O	O	O
lipid	O	O	B-T044
metabolism	O	O	I-T044
in	O	O	O
mice	O	O	B-T015
.	O	O	O

-DOCSTART- (27349365)

Supramolecular	O	O	B-T044
Recognition	O	O	I-T044
of	O	O	O
Amino	O	O	B-T116
Acids	O	O	I-T116
by	O	O	O
Twisted	O	O	O
Cucurbit[14]uril	O	O	O

Binding	O	O	B-T044
interactions	O	O	B-T169
between	O	O	B-T082
twisted	O	O	B-T109
cucurbit[14]uril	O	O	I-T109
(	O	O	B-T109
tQ[14	O	O	I-T109
]	O	O	I-T109
)	O	O	I-T109
and	O	O	O
twenty	O	O	O
standard	O	O	B-T080
amino	O	O	B-T116
acids	O	O	I-T116
(	O	O	B-T116
AAs	O	O	I-T116
)	O	O	I-T116
have	O	O	O
been	O	O	O
investigated	O	O	B-T169
by	O	O	O
NMR	O	O	B-T060
spectroscopy	O	O	I-T060
and	O	O	O
isothermal	O	O	B-T059
titration	O	O	I-T059
calorimetry	O	O	I-T059
(	O	O	B-T059
ITC	O	O	I-T059
)	O	O	I-T059
in	O	O	O
aqueous	O	O	B-T121
HCl	O	O	B-T130
solutions	O	O	I-T130
and	O	O	O
in	O	O	O
DMSO	O	O	B-T109
.	O	O	O

The	O	O	O
results	O	O	B-T169
showed	O	O	O
that	O	O	O
tQ[14	O	O	B-T109
]	O	O	I-T109
displays	O	O	B-T169
clear	O	O	O
binding	O	O	B-T044
affinity	O	O	B-T070
for	O	O	O
AAs	O	O	B-T116
with	O	O	O
a	O	O	O
positively	O	O	B-T104
charged	O	O	I-T104
side	O	O	B-T104
chain	O	O	I-T104
or	O	O	O
containing	O	O	B-T169
an	O	O	O
aromatic	O	O	B-T109
ring	O	O	I-T109
,	O	O	O
but	O	O	O
weaker	O	O	B-T080
binding	O	O	O
affinity	O	O	O
for	O	O	O
AAs	O	O	O
with	O	O	O
hydrophobic	O	O	B-T120
or	O	O	O
polar	O	O	B-T120
side	O	O	I-T120
chains	O	O	I-T120
,	O	O	O
with	O	O	O
the	O	O	O
binding	O	O	O
mode	O	O	B-T169
depending	O	O	O
on	O	O	O
the	O	O	O
type	O	O	O
of	O	O	O
side	O	O	O
chain	O	O	O
present	O	O	O
in	O	O	O
the	O	O	O
AAs	O	O	O
.	O	O	O

-DOCSTART- (27350860)

Comparison	O	O	B-T052
of	O	O	O
alkaline	O	O	B-T044
phosphatase	O	O	I-T044
activity	O	O	I-T044
of	O	O	O
MC3T3-E1	O	O	B-T025
cells	O	O	I-T025
cultured	O	O	O
on	O	O	O
different	O	O	O
Ti	O	O	B-T196
surfaces	O	O	B-T082
:	O	O	O
modified	O	O	O
sandblasted	O	O	B-T067
with	O	O	O
large	O	O	O
grit	O	O	B-T104
and	O	O	O
acid-etched	O	O	B-T067
(	O	O	O
MSLA	O	O	B-T196
)	O	O	O
,	O	O	O
laser-treated	O	O	B-T067
,	O	O	O
and	O	O	O
laser	O	O	B-T067
and	O	O	I-T067
acid-treated	O	O	I-T067
Ti	O	O	O
surfaces	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
the	O	O	O
aim	O	O	O
of	O	O	O
this	O	O	O
study	O	O	O
was	O	O	O
to	O	O	O
evaluate	O	O	B-T058
the	O	O	O
effect	O	O	O
of	O	O	O
implant	O	O	O
surface	O	O	B-T082
treatment	O	O	O
on	O	O	O
cell	O	O	B-T043
differentiation	O	O	I-T043
of	O	O	O
osteoblast	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

For	O	O	O
this	O	O	O
purpose	O	O	O
,	O	O	O
three	O	O	O
surfaces	O	O	B-T082
were	O	O	O
compared	O	O	O
:	O	O	O
(	O	O	O
1	O	O	O
)	O	O	O
a	O	O	O
modified	O	O	O
SLA	O	O	O
(	O	O	O
MSLA	O	O	O
:	O	O	O
sand-blasted	O	O	O
with	O	O	O
large	O	O	O
grit	O	O	B-T104
,	O	O	O
acid-etched	O	O	O
,	O	O	O
and	O	O	O
immersed	O	O	O
in	O	O	O
0.9	O	O	O
%	O	O	O
NaCl	O	O	B-T121
)	O	O	O
,	O	O	O
(	O	O	O
2	O	O	O
)	O	O	O
a	O	O	O
laser	O	O	B-T067
treatment	O	O	I-T067
(	O	O	O
LT	O	O	B-T067
:	O	O	O
laser	O	O	O
treatment	O	O	O
)	O	O	O
titanium	O	O	B-T196
surface	O	O	B-T082
and	O	O	O
(	O	O	O
3	O	O	O
)	O	O	O
a	O	O	O
laser	O	O	B-T067
and	O	O	I-T067
acid-treated	O	O	I-T067
(	O	O	O
LAT	O	O	O
:	O	O	O
laser	O	O	B-T067
treatment	O	O	I-T067
,	O	O	I-T067
acid-etched	O	O	I-T067
)	O	O	O
titanium	O	O	O
surface	O	O	O
.	O	O	O

The	O	O	O
MSLA	O	O	B-T196
surfaces	O	O	B-T082
were	O	O	O
considered	O	O	O
as	O	O	O
the	O	O	O
control	O	O	B-T096
group	O	O	I-T096
,	O	O	O
and	O	O	O
LT	O	O	B-T196
and	O	O	O
LAT	O	O	B-T196
surfaces	O	O	O
as	O	O	O
test	O	O	B-T078
groups	O	O	I-T078
.	O	O	O

Alkaline	O	O	B-T116
phosphatase	O	O	I-T116
expression	O	O	B-T045
(	O	O	O
ALP	O	O	B-T116
)	O	O	O
was	O	O	O
used	O	O	O
to	O	O	O
quantify	O	O	O
osteoblastic	O	O	B-T043
differentiation	O	O	I-T043
of	O	O	O
MC3T3-E1	O	O	B-T025
cell	O	O	I-T025
.	O	O	O

Surface	O	O	B-T082
roughness	O	O	B-T080
was	O	O	O
evaluated	O	O	B-T058
by	O	O	O
a	O	O	O
contact	O	O	B-T074
profilometer	O	O	I-T074
(	O	O	O
URFPAK-SV	O	O	O
;	O	O	O
Mitutoyo	O	O	O
,	O	O	O
Kawasaki	O	O	O
,	O	O	O
Japan	O	O	B-T083
)	O	O	O
and	O	O	O
characterized	O	O	O
by	O	O	O
two	O	O	O
parameters	O	O	O
:	O	O	O
mean	O	O	B-T080
roughness	O	O	I-T080
(	O	O	O
Ra	O	O	B-T080
)	O	O	O
and	O	O	O
maximum	O	O	B-T081
peak-to-valley	O	O	I-T081
height	O	O	I-T081
(	O	O	O
Rt	O	O	B-T081
)	O	O	O
.	O	O	O

Scanning	O	O	B-T074
electron	O	O	I-T074
microscope	O	O	I-T074
revealed	O	O	O
that	O	O	O
MSLA	O	O	O
(	O	O	O
control	O	O	B-T096
group	O	O	I-T096
)	O	O	O
surface	O	O	B-T082
was	O	O	O
not	O	O	O
as	O	O	O
rough	O	O	B-T080
as	O	O	O
LT	O	O	B-T196
,	O	O	O
LAT	O	O	B-T196
surface	O	O	O
(	O	O	O
test	O	O	B-T078
groups	O	O	I-T078
)	O	O	O
.	O	O	O

Alkaline	O	O	B-T116
phosphatase	O	O	I-T116
expression	O	O	B-T045
,	O	O	O
the	O	O	O
measure	O	O	O
of	O	O	O
osteoblastic	O	O	B-T043
differentiation	O	O	I-T043
,	O	O	O
and	O	O	O
total	O	O	O
ALP	O	O	B-T116
expression	O	O	O
by	O	O	O
surface-adherent	O	O	B-T025
cells	O	O	I-T025
were	O	O	O
found	O	O	O
to	O	O	O
be	O	O	O
highest	O	O	O
at	O	O	O
21	O	O	O
days	O	O	B-T079
for	O	O	O
all	O	O	O
three	O	O	O
surfaces	O	O	B-T082
tested	O	O	O
(	O	O	O
P<.05	O	O	O
)	O	O	O
.	O	O	O

Furthermore	O	O	O
,	O	O	O
ALP	O	O	B-T116
expression	O	O	B-T045
levels	O	O	B-T080
of	O	O	O
MSLA	O	O	B-T196
and	O	O	O
LAT	O	O	B-T196
surfaces	O	O	B-T082
were	O	O	O
significantly	O	O	O
higher	O	O	O
than	O	O	O
expression	O	O	O
levels	O	O	O
of	O	O	O
LT	O	O	B-T196
surface-adherent	O	O	B-T025
cells	O	O	I-T025
at	O	O	O
7	O	O	O
,	O	O	O
14	O	O	O
,	O	O	O
and	O	O	O
21	O	O	O
days	O	O	B-T079
,	O	O	O
respectively	O	O	O
(	O	O	O
P<.05	O	O	O
)	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
ALP	O	O	B-T116
expression	O	O	B-T045
levels	O	O	B-T080
between	O	O	O
MSLA	O	O	B-T196
and	O	O	O
LAT	O	O	B-T196
surface	O	O	B-T082
were	O	O	O
equal	O	O	O
at	O	O	O
7	O	O	O
,	O	O	O
14	O	O	O
,	O	O	O
and	O	O	O
21	O	O	O
days	O	O	B-T079
(	O	O	O
P>.05	O	O	O
)	O	O	O
.	O	O	O

This	O	O	O
study	O	O	B-T062
suggested	O	O	O
that	O	O	O
MSLA	O	O	B-T196
and	O	O	O
LAT	O	O	B-T196
surfaces	O	O	B-T082
exhibited	O	O	O
more	O	O	O
favorable	O	O	B-T080
environment	O	O	B-T082
for	O	O	O
osteoblast	O	O	B-T043
differentiation	O	O	I-T043
when	O	O	O
compared	O	O	O
with	O	O	O
LT	O	O	B-T196
surface	O	O	B-T082
,	O	O	O
the	O	O	O
results	O	O	O
that	O	O	O
are	O	O	O
important	O	O	O
for	O	O	O
implant	O	O	B-T074
surface	O	O	O
modification	O	O	B-T169
studies	O	O	B-T062
.	O	O	O

-DOCSTART- (27352476)

Overcoming	O	O	B-T052
structural	O	O	B-T082
inequalities	O	O	B-T080
in	O	O	O
oral	O	O	B-T058
health	O	O	I-T058
:	O	O	O
the	O	O	O
role	O	O	O
of	O	O	O
dental	O	O	B-T058
curricula	O	O	O

To	O	O	O
date	O	O	O
the	O	O	O
role	O	O	O
of	O	O	O
health	O	O	B-T093
professional	O	O	I-T093
schools	O	O	I-T093
in	O	O	O
addressing	O	O	O
oral	O	O	B-T058
health	O	O	I-T058
inequalities	O	O	B-T080
have	O	O	O
been	O	O	O
minimal	O	O	O
,	O	O	O
as	O	O	O
attempts	O	O	B-T051
have	O	O	O
focused	O	O	B-T169
principally	O	O	O
upon	O	O	O
systemic	O	O	B-T169
reform	O	O	B-T078
and	O	O	O
broader	O	O	O
societal	O	O	B-T078
obligations	O	O	I-T078
.	O	O	O

Professionalism	O	O	B-T078
is	O	O	O
a	O	O	O
broad	O	O	O
competency	O	O	B-T080
that	O	O	O
is	O	O	O
taught	O	O	O
throughout	O	O	O
dental	O	O	B-T093
schools	O	O	I-T093
and	O	O	O
encompasses	O	O	O
a	O	O	O
range	O	O	B-T081
of	O	O	O
attributes	O	O	O
.	O	O	O

Professionalism	O	O	B-T078
as	O	O	O
a	O	O	O
competency	O	O	B-T080
draws	O	O	O
some	O	O	O
debate	O	O	B-T052
and	O	O	O
appears	O	O	O
to	O	O	O
be	O	O	O
a	O	O	O
shifting	O	O	B-T169
phenomenon	O	O	I-T169
.	O	O	O

We	O	O	O
may	O	O	O
ask	O	O	O
if	O	O	O
professionalism	O	O	B-T078
in	O	O	O
the	O	O	O
dental	O	O	B-T058
curricula	O	O	B-T170
may	O	O	O
be	O	O	O
better	O	O	O
addressed	O	O	O
by	O	O	O
social	O	O	B-T078
accountability	O	O	I-T078
?	O	O	O

Social	O	O	B-T078
accountability	O	O	I-T078
directs	O	O	O
oral	O	O	B-T058
health	O	O	B-T078
professional	O	O	B-T170
curricula	O	O	I-T170
(	O	O	O
education	O	O	B-T185
,	O	O	O
research	O	O	B-T062
,	O	O	O
and	O	O	O
service	O	O	B-T058
activities	O	O	I-T058
)	O	O	O
towards	O	O	O
addressing	O	O	O
the	O	O	O
priority	O	O	B-T079
health	O	O	O
concerns	O	O	B-T078
of	O	O	O
the	O	O	O
community	O	O	B-T096
,	O	O	O
in	O	O	O
our	O	O	O
case	O	O	O
oral	O	O	O
health	O	O	O
inequalities	O	O	B-T080
.	O	O	O

Although	O	O	O
working	O	O	O
toward	O	O	O
dental	O	O	B-T093
schools	O	O	I-T093
becoming	O	O	O
more	O	O	O
socially	O	O	B-T078
accountable	O	O	I-T078
seems	O	O	O
like	O	O	O
a	O	O	O
sensible	O	O	O
way	O	O	O
to	O	O	O
address	O	O	B-T170
oral	O	O	B-T058
health	O	O	I-T058
inequalities	O	O	B-T080
,	O	O	O
it	O	O	O
might	O	O	O
have	O	O	O
limitations	O	O	O
.	O	O	O

We	O	O	O
will	O	O	O
consider	O	O	O
some	O	O	O
of	O	O	O
the	O	O	O
challenges	O	O	O
in	O	O	O
the	O	O	O
dental	O	O	B-T058
curricula	O	O	B-T170
by	O	O	O
considering	O	O	O
some	O	O	O
of	O	O	O
the	O	O	O
political	O	O	B-T068
,	O	O	O
structural	O	O	B-T082
,	O	O	O
social	O	O	B-T102
and	O	O	O
ethical	O	O	B-T078
factors	O	O	B-T169
that	O	O	O
influence	O	O	B-T077
our	O	O	O
institutions	O	O	B-T093
and	O	O	O
our	O	O	O
graduates	O	O	B-T098
.	O	O	O

-DOCSTART- (27354201)

Function	O	O	B-T169
analysis	O	O	B-T062
of	O	O	O
Mef2c	O	O	B-T028
promoter	O	O	B-T114
in	O	O	O
muscle	O	O	O
differentiation	O	O	O

Regeneration	O	O	B-T042
of	O	O	I-T042
adult	O	O	I-T042
skeletal	O	O	I-T042
muscle	O	O	I-T042
following	O	O	O
injury	O	O	B-T037
occurs	O	O	O
through	O	O	O
the	O	O	O
activation	O	O	B-T043
of	O	O	O
satellite	O	O	B-T025
cells	O	O	I-T025
,	O	O	O
that	O	O	O
proliferates	O	O	B-T043
,	O	O	O
differentiates	O	O	B-T043
,	O	O	O
and	O	O	O
fuses	O	O	B-T043
with	O	O	O
injured	O	O	B-T169
myofibers	O	O	B-T023
.	O	O	O

Myocyte	O	O	B-T116
enhancer	O	O	I-T116
factor	O	O	I-T116
2	O	O	I-T116
(	O	O	I-T116
MEF2	O	O	I-T116
)	O	O	I-T116
proteins	O	O	I-T116
are	O	O	O
reported	O	O	O
that	O	O	O
they	O	O	O
have	O	O	O
the	O	O	O
potential	O	O	O
contributions	O	O	O
to	O	O	O
adult	O	O	B-T100
muscle	O	O	B-T033
regeneration	O	O	I-T033
.	O	O	O

In	O	O	O
order	O	O	O
to	O	O	O
further	O	O	O
understand	O	O	O
Mef2c	O	O	B-T028
gene	O	O	I-T028
,	O	O	O
the	O	O	O
promoter	O	O	B-T114
of	O	O	O
pig	O	O	B-T015
Mef2c	O	O	O
gene	O	O	O
was	O	O	O
analyzed	O	O	O
in	O	O	O
this	O	O	O
paper	O	O	O
.	O	O	O

Quantitative	O	O	B-T063
real-time	O	O	I-T063
PCR	O	O	I-T063
(	O	O	O
qRT-PCR	O	O	B-T063
)	O	O	O
revealed	O	O	O
the	O	O	O
expression	O	O	B-T045
pattern	O	O	O
of	O	O	O
Mef2c	O	O	B-T028
gene	O	O	I-T028
in	O	O	O
muscle	O	O	B-T024
of	O	O	O
eight	O	O	O
tissues	O	O	B-T024
.	O	O	O

The	O	O	O
Mef2c	O	O	B-T028
promoter	O	O	B-T114
had	O	O	O
the	O	O	O
higher	O	O	O
transcriptional	O	O	B-T045
activity	O	O	I-T045
in	O	O	O
differentiated	O	O	B-T043
C2C12	O	O	B-T025
cells	O	O	I-T025
than	O	O	O
that	O	O	O
in	O	O	O
proliferating	O	O	B-T043
C2C12	O	O	O
cells	O	O	O
,	O	O	O
which	O	O	O
was	O	O	O
accompanied	O	O	O
by	O	O	O
the	O	O	O
up-regulation	O	O	B-T045
of	O	O	O
mRNA	O	O	B-T045
expression	O	O	I-T045
of	O	O	O
Mef2c	O	O	B-T028
gene	O	O	I-T028
.	O	O	O

Function	O	O	B-T169
deletion	O	O	B-T045
and	O	O	O
mutation	O	O	B-T045
analyses	O	O	B-T062
showed	O	O	O
that	O	O	O
MyoD	O	O	B-T116
and	O	O	O
MEF2	O	O	B-T116
binding	O	O	B-T087
sites	O	O	I-T087
within	O	O	O
the	O	O	O
Mef2c	O	O	B-T028
promoter	O	O	B-T114
were	O	O	O
responsible	O	O	O
for	O	O	O
the	O	O	O
regulation	O	O	B-T045
of	O	O	O
Mef2c	O	O	O
transcription	O	O	B-T045
.	O	O	O

MEF2C	O	O	B-T028
could	O	O	O
up-regulate	O	O	B-T045
the	O	O	I-T045
transcriptional	O	O	I-T045
activities	O	O	I-T045
of	O	O	O
Mef2c	O	O	B-T028
promoter	O	O	B-T114
constructs	O	O	I-T114
which	O	O	O
contained	O	O	O
a	O	O	O
3'-end	O	O	B-T086
nucleotide	O	O	I-T086
sequence	O	O	I-T086
with	O	O	O
p300	O	O	B-T116
binding	O	O	B-T086
site	O	O	I-T086
.	O	O	O

The	O	O	O
Electrophoretic	O	O	B-T059
mobility	O	O	I-T059
shift	O	O	I-T059
assays	O	O	I-T059
(	O	O	O
EMSA	O	O	B-T059
)	O	O	O
and	O	O	O
chromatin	O	O	B-T059
immunoprecipitation	O	O	I-T059
(	O	O	I-T059
ChIP	O	O	I-T059
)	O	O	I-T059
assays	O	O	I-T059
determined	O	O	O
the	O	O	O
MyoD	O	O	B-T116
binding	O	O	B-T087
site	O	O	I-T087
in	O	O	O
Mef2c	O	O	B-T028
promoter	O	O	B-T114
.	O	O	O

These	O	O	O
results	O	O	O
advanced	O	O	O
our	O	O	O
knowledge	O	O	O
of	O	O	O
the	O	O	O
promoter	O	O	B-T114
of	O	O	O
the	O	O	O
pig	O	O	B-T015
Mef2c	O	O	B-T028
gene	O	O	I-T028
.	O	O	O

And	O	O	O
the	O	O	O
study	O	O	O
of	O	O	O
Mef2c	O	O	B-T028
promoter	O	O	B-T114
regulator	O	O	O
elements	O	O	O
helped	O	O	O
to	O	O	O
elucidating	O	O	O
the	O	O	O
regulation	O	O	B-T045
mechanisms	O	O	I-T045
of	O	O	O
Mef2c	O	O	O
in	O	O	O
muscle	O	O	B-T043
differentiation	O	O	I-T043
or	O	O	O
muscle	O	O	B-T061
repair	O	O	I-T061
and	O	O	O
regeneration	O	O	B-T033
.	O	O	O

This	O	O	O
article	O	O	O
is	O	O	O
protected	O	O	O
by	O	O	O
copyright	O	O	O
.	O	O	O

All	O	O	O
rights	O	O	O
reserved	O	O	O
.	O	O	O

-DOCSTART- (27354236)

Novel	O	O	O
insights	O	O	O
into	O	O	O
development	O	O	O
of	O	O	O
diabetic	O	O	B-T033
bladder	O	O	B-T047
disorder	O	O	I-T047
provided	O	O	O
by	O	O	O
metabolomic	O	O	B-T091
analysis	O	O	I-T091
of	O	O	O
the	O	O	O
rat	O	O	B-T015
nondiabetic	O	O	O
and	O	O	O
diabetic	O	O	O
detrusor	O	O	B-T023
and	O	O	O
urothelial	O	O	O
layer	O	O	O

There	O	O	O
are	O	O	O
at	O	O	O
present	O	O	O
no	O	O	O
published	O	O	O
studies	O	O	O
providing	O	O	O
a	O	O	O
global	O	O	O
overview	O	O	O
of	O	O	O
changes	O	O	B-T169
in	O	O	O
bladder	O	O	B-T023
metabolism	O	O	B-T040
resulting	O	O	O
from	O	O	O
diabetes	O	O	B-T047
.	O	O	O

Such	O	O	O
studies	O	O	O
have	O	O	O
the	O	O	O
potential	O	O	O
to	O	O	O
provide	O	O	O
mechanistic	O	O	O
insight	O	O	O
into	O	O	O
the	O	O	O
development	O	O	O
of	O	O	O
diabetic	O	O	B-T033
bladder	O	O	B-T047
disorder	O	O	I-T047
(	O	O	I-T047
DBD	O	O	I-T047
)	O	O	I-T047
.	O	O	O

In	O	O	O
the	O	O	O
present	O	O	O
study	O	O	O
,	O	O	O
we	O	O	O
compared	O	O	O
the	O	O	O
metabolome	O	O	B-T070
of	O	O	O
detrusor	O	O	B-T023
and	O	O	O
urothelial	O	O	B-T024
layer	O	O	I-T024
in	O	O	O
a	O	O	O
1-mo	O	O	O
streptozotocin	O	O	B-T195
-induced	O	O	O
rat	O	O	B-T015
model	O	O	B-T050
of	O	O	O
type	O	O	B-T047
1	O	O	I-T047
diabetes	O	O	I-T047
with	O	O	O
nondiabetic	O	O	B-T096
controls	O	O	I-T096
.	O	O	O

Our	O	O	O
studies	O	O	O
revealed	O	O	O
that	O	O	O
diabetes	O	O	B-T047
caused	O	O	O
both	O	O	O
common	O	O	O
and	O	O	O
differential	O	O	O
changes	O	O	B-T169
in	O	O	O
the	O	O	O
detrusor	O	O	B-T023
and	O	O	O
urothelial	O	O	B-T024
layer	O	O	I-T024
's	O	O	I-T024
metabolome	O	O	B-T070
.	O	O	O

Diabetes	O	O	B-T047
resulted	O	O	O
in	O	O	O
similar	O	O	O
changes	O	O	B-T169
in	O	O	O
the	O	O	O
levels	O	O	O
of	O	O	O
previously	O	O	O
described	O	O	O
diabetic	O	O	B-T047
markers	O	O	B-T201
in	O	O	O
both	O	O	O
tissues	O	O	B-T024
,	O	O	O
such	O	O	O
as	O	O	O
glucose	O	O	B-T109
,	O	O	O
lactate	O	O	B-T109
,	O	O	O
2-hydroxybutyrate	O	O	B-T109
,	O	O	O
branched-chain	O	O	B-T116
amino	O	O	I-T116
acid	O	O	I-T116
degradation	O	O	I-T116
products	O	O	I-T116
,	O	O	O
bile	O	O	B-T109
acids	O	O	I-T109
,	O	O	O
and	O	O	O
1,5-anhydroglucitol	O	O	B-T109
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
markers	O	O	O
of	O	O	O
oxidative	O	O	B-T049
stress	O	O	I-T049
.	O	O	O

In	O	O	O
the	O	O	O
detrusor	O	O	B-T023
(	O	O	O
but	O	O	O
not	O	O	O
the	O	O	O
urothelial	O	O	B-T024
layer	O	O	I-T024
)	O	O	O
,	O	O	O
diabetes	O	O	B-T047
caused	O	O	O
activation	O	O	O
of	O	O	O
the	O	O	O
pentose-phosphate	O	O	B-T109
and	O	O	O
polyol	O	O	B-T109
pathways	O	O	B-T044
,	O	O	O
concomitant	O	O	O
with	O	O	O
a	O	O	O
reduction	O	O	O
in	O	O	O
the	O	O	O
TCA	O	O	B-T044
cycle	O	O	I-T044
and	O	O	O
Î²-oxidation	O	O	B-T044
.	O	O	O

Changes	O	O	B-T169
in	O	O	O
detrusor	O	O	B-T023
energy-generating	O	O	B-T044
pathways	O	O	I-T044
resulted	O	O	O
in	O	O	O
an	O	O	O
accumulation	O	O	O
of	O	O	O
sorbitol	O	O	B-T109
that	O	O	O
,	O	O	O
through	O	O	O
generation	O	O	O
of	O	O	O
advanced	O	O	B-T109
glycation	O	O	I-T109
end	O	O	I-T109
products	O	O	I-T109
,	O	O	O
is	O	O	O
likely	O	O	O
to	O	O	O
play	O	O	O
a	O	O	O
central	O	O	O
role	O	O	O
in	O	O	O
the	O	O	O
development	O	O	O
of	O	O	O
DBD	O	O	B-T047
.	O	O	O

In	O	O	O
the	O	O	O
diabetic	O	O	B-T033
urothelial	O	O	B-T024
layer	O	O	I-T024
there	O	O	O
was	O	O	O
decreased	O	O	O
flux	O	O	B-T070
of	O	O	O
glucose	O	O	B-T109
via	O	O	O
glycolysis	O	O	B-T044
and	O	O	O
changes	O	O	B-T169
in	O	O	O
lipid	O	O	B-T044
metabolism	O	O	I-T044
,	O	O	O
particularly	O	O	O
prostaglandin	O	O	B-T125
synthesis	O	O	B-T052
,	O	O	O
which	O	O	O
also	O	O	O
potentially	O	O	O
contributes	O	O	O
to	O	O	O
detrusor	O	O	B-T023
dysfunction	O	O	B-T046
.	O	O	O

-DOCSTART- (27355340)

Proximal	O	O	B-T059
Soil	O	O	I-T059
Sensing	O	O	I-T059
-	O	O	O
A	O	O	O
Contribution	O	O	B-T052
for	O	O	O
Species	O	O	B-T185
Habitat	O	O	B-T082
Distribution	O	O	B-T169
Modelling	O	O	B-T062
of	O	O	O
Earthworms	O	O	B-T204
in	O	O	O
Agricultural	O	O	B-T082
Soils	O	O	B-T167
?	O	O	O

Earthworms	O	O	B-T204
are	O	O	O
important	O	O	O
for	O	O	O
maintaining	O	O	O
soil	O	O	B-T167
ecosystem	O	O	B-T070
functioning	O	O	B-T169
and	O	O	O
serve	O	O	O
as	O	O	O
indicators	O	O	B-T130
of	O	O	O
soil	O	O	O
fertility	O	O	B-T080
.	O	O	O

However	O	O	O
,	O	O	O
detection	O	O	O
of	O	O	O
earthworms	O	O	B-T204
is	O	O	O
time-consuming	O	O	B-T080
,	O	O	O
which	O	O	O
hinders	O	O	O
the	O	O	O
assessment	O	O	B-T052
of	O	O	O
earthworm	O	O	B-T204
abundances	O	O	B-T080
with	O	O	O
high	O	O	O
sampling	O	O	B-T078
density	O	O	B-T081
over	O	O	O
entire	O	O	O
fields	O	O	B-T082
.	O	O	O

Recent	O	O	O
developments	O	O	O
of	O	O	O
mobile	O	O	B-T073
terrestrial	O	O	I-T073
sensor	O	O	I-T073
platforms	O	O	I-T073
for	O	O	O
proximal	O	O	B-T059
soil	O	O	I-T059
sensing	O	O	I-T059
(	O	O	O
PSS	O	O	B-T059
)	O	O	O
provided	O	O	O
new	O	O	O
tools	O	O	B-T073
for	O	O	O
collecting	O	O	O
dense	O	O	O
spatial	O	O	O
information	O	O	B-T078
of	O	O	O
soils	O	O	B-T167
using	O	O	O
various	O	O	O
sensing	O	O	B-T170
principles	O	O	I-T170
.	O	O	O

Yet	O	O	O
,	O	O	O
the	O	O	O
potential	O	O	O
of	O	O	O
PSS	O	O	B-T059
for	O	O	O
assessing	O	O	B-T052
earthworm	O	O	B-T204
habitats	O	O	B-T082
is	O	O	O
largely	O	O	O
unexplored	O	O	O
.	O	O	O

This	O	O	O
study	O	O	B-T062
investigates	O	O	B-T169
whether	O	O	O
PSS	O	O	B-T059
data	O	O	B-T078
contribute	O	O	O
to	O	O	O
the	O	O	O
spatial	O	O	O
prediction	O	O	B-T078
of	O	O	O
earthworm	O	O	B-T204
abundances	O	O	B-T080
in	O	O	O
species	O	O	B-T185
distribution	O	O	B-T169
models	O	O	B-T170
of	O	O	O
agricultural	O	O	B-T082
soils	O	O	B-T167
.	O	O	O

Proximal	O	O	B-T059
soil	O	O	B-T167
sensing	O	O	I-T059
data	O	O	B-T078
,	O	O	O
e.g.	O	O	O
,	O	O	O
soil	O	O	O
electrical	O	O	B-T081
conductivity	O	O	I-T081
(	O	O	O
EC	O	O	B-T081
)	O	O	O
,	O	O	O
pH	O	O	B-T081
,	O	O	O
and	O	O	O
near	O	O	B-T059
infrared	O	O	I-T059
absorbance	O	O	I-T059
(	O	O	O
NIR	O	O	B-T059
)	O	O	O
,	O	O	O
were	O	O	O
collected	O	O	B-T078
in	O	O	O
real-time	O	O	B-T079
in	O	O	O
a	O	O	O
field	O	O	B-T082
with	O	O	O
two	O	O	O
management	O	O	B-T170
strategies	O	O	I-T170
(	O	O	O
reduced	O	O	B-T080
tillage	O	O	B-T067
/	O	O	O
conventional	O	O	O
tillage	O	O	O
)	O	O	O
and	O	O	O
sandy	O	O	B-T167
to	O	O	O
loam	O	O	B-T167
soils	O	O	I-T167
.	O	O	O

PSS	O	O	B-T059
was	O	O	O
related	O	O	O
to	O	O	O
observations	O	O	B-T062
from	O	O	O
a	O	O	O
long-term	O	O	B-T079
(	O	O	O
11	O	O	O
years	O	O	B-T079
)	O	O	O
earthworm	O	O	B-T204
observation	O	O	B-T033
study	O	O	I-T033
conducted	O	O	O
at	O	O	O
42	O	O	O
plots	O	O	B-T082
.	O	O	O

Earthworms	O	O	B-T204
were	O	O	O
sampled	O	O	B-T078
from	O	O	O
0.5	O	O	O
x	O	O	O
0.5	O	O	O
x	O	O	O
0.2	O	O	O
mÂ³	O	O	O
soil	O	O	B-T167
blocks	O	O	O
and	O	O	O
identified	O	O	B-T080
to	O	O	O
species	O	O	B-T185
level	O	O	B-T080
.	O	O	O

Sensor	O	O	B-T075
data	O	O	B-T078
were	O	O	O
highly	O	O	O
correlated	O	O	B-T080
with	O	O	O
earthworm	O	O	B-T204
abundances	O	O	B-T080
observed	O	O	B-T169
in	O	O	O
reduced	O	O	B-T080
tillage	O	O	B-T067
but	O	O	O
less	O	O	O
correlated	O	O	O
with	O	O	O
earthworm	O	O	O
abundances	O	O	O
observed	O	O	O
in	O	O	O
conventional	O	O	B-T067
tillage	O	O	I-T067
.	O	O	O

This	O	O	O
may	O	O	O
indicate	O	O	O
that	O	O	O
management	O	O	B-T057
influences	O	O	B-T077
the	O	O	O
sensor	O	O	B-T075
-	O	O	O
earthworm	O	O	B-T204
relationship	O	O	O
.	O	O	O

Generalized	O	O	O
additive	O	O	O
models	O	O	B-T170
and	O	O	O
state-space	O	O	B-T170
models	O	O	I-T170
showed	O	O	O
that	O	O	O
modelling	O	O	B-T062
based	O	O	O
on	O	O	O
data	O	O	B-T078
fusion	O	O	O
from	O	O	O
EC	O	O	B-T081
,	O	O	O
pH	O	O	B-T081
,	O	O	O
and	O	O	O
NIR	O	O	B-T059
sensors	O	O	B-T075
produced	O	O	O
better	O	O	O
results	O	O	B-T033
than	O	O	O
modelling	O	O	O
without	O	O	O
sensor	O	O	B-T075
data	O	O	O
or	O	O	O
data	O	O	O
from	O	O	O
just	O	O	O
a	O	O	O
single	O	O	O
sensor	O	O	O
.	O	O	O

Regarding	O	O	O
the	O	O	O
individual	O	O	O
earthworm	O	O	B-T204
species	O	O	B-T185
,	O	O	O
particular	O	O	O
sensor	O	O	B-T075
combinations	O	O	O
were	O	O	O
more	O	O	O
appropriate	O	O	O
than	O	O	O
others	O	O	O
due	O	O	O
to	O	O	O
the	O	O	O
different	O	O	O
habitat	O	O	B-T082
requirements	O	O	B-T169
of	O	O	O
the	O	O	O
earthworms	O	O	B-T204
.	O	O	O

Earthworm	O	O	B-T204
species	O	O	B-T185
with	O	O	O
soil	O	O	B-T167
-specific	O	O	O
habitat	O	O	B-T082
preferences	O	O	B-T078
were	O	O	O
spatially	O	O	O
predicted	O	O	O
with	O	O	O
higher	O	O	O
accuracy	O	O	B-T080
by	O	O	O
PSS	O	O	B-T059
than	O	O	O
more	O	O	O
ubiquitous	O	O	B-T080
species	O	O	O
.	O	O	O

Our	O	O	O
findings	O	O	B-T033
suggest	O	O	O
that	O	O	O
PSS	O	O	B-T059
contributes	O	O	O
to	O	O	O
the	O	O	O
spatial	O	O	O
modelling	O	O	B-T062
of	O	O	O
earthworm	O	O	B-T204
abundances	O	O	B-T080
at	O	O	O
field	O	O	B-UnknownType
scale	O	O	I-UnknownType
and	O	O	O
that	O	O	O
it	O	O	O
will	O	O	O
support	O	O	O
species	O	O	B-T185
distribution	O	O	B-T169
modelling	O	O	O
in	O	O	O
the	O	O	O
attempt	O	O	O
to	O	O	O
understand	O	O	O
the	O	O	O
soil	O	O	B-T167
-	O	O	O
earthworm	O	O	O
relationships	O	O	O
in	O	O	O
agroecosystems	O	O	B-T070
.	O	O	O

-DOCSTART- (27355434)

Size	O	O	B-T081
matters	O	O	O
to	O	O	O
function	O	O	O
:	O	O	O
Brain	O	O	B-T081
volume	O	O	I-T081
correlates	O	O	B-T080
with	O	O	O
intrinsic	O	O	B-T082
brain	O	O	B-T039
activity	O	O	I-T039
across	O	O	O
healthy	O	O	B-T080
individuals	O	O	O

A	O	O	O
fundamental	O	O	O
issue	O	O	O
in	O	O	O
neuroscience	O	O	B-T091
is	O	O	O
to	O	O	O
understand	O	O	O
the	O	O	O
structural	O	O	B-T082
substrates	O	O	B-T169
of	O	O	O
neural	O	O	O
activities	O	O	O
.	O	O	O

Intrinsic	O	O	B-T082
brain	O	O	B-T039
activity	O	O	I-T039
has	O	O	O
been	O	O	O
increasingly	O	O	O
recognized	O	O	O
as	O	O	O
an	O	O	O
important	O	O	O
functional	O	O	O
activity	O	O	O
mode	O	O	O
and	O	O	O
is	O	O	O
tightly	O	O	O
linked	O	O	O
with	O	O	O
various	O	O	O
cognitive	O	O	B-T041
functions	O	O	I-T041
.	O	O	O

Structurally	O	O	O
,	O	O	O
cognitive	O	O	B-T041
functions	O	O	I-T041
have	O	O	O
also	O	O	O
shown	O	O	O
a	O	O	O
relation	O	O	O
with	O	O	O
brain	O	O	B-T081
volume	O	O	I-T081
/	O	O	O
size	O	O	B-T081
.	O	O	O

Therefore	O	O	O
,	O	O	O
an	O	O	O
association	O	O	B-T080
between	O	O	O
intrinsic	O	O	B-T082
brain	O	O	B-T039
activities	O	O	I-T039
and	O	O	O
brain	O	O	B-T081
volume	O	O	I-T081
/	O	O	O
size	O	O	B-T081
can	O	O	O
be	O	O	O
hypothesized	O	O	O
,	O	O	O
and	O	O	O
brain	O	O	O
volume	O	O	O
/	O	O	O
size	O	O	O
may	O	O	O
impact	O	O	B-T080
intrinsic	O	O	O
brain	O	O	B-T039
activity	O	O	I-T039
in	O	O	O
human	O	O	B-T016
brains	O	O	B-T023
.	O	O	O

The	O	O	O
present	O	O	O
study	O	O	B-T062
aimed	O	O	O
to	O	O	O
explicitly	O	O	O
investigate	O	O	B-T169
this	O	O	O
brain	O	O	B-T023
structure	O	O	I-T023
-	O	O	O
function	O	O	B-T039
relationship	O	O	B-T080
using	O	O	O
two	O	O	O
large	O	O	O
independent	O	O	O
cohorts	O	O	B-T098
of	O	O	O
176	O	O	O
and	O	O	O
236	O	O	O
young	O	O	B-T100
adults	O	O	I-T100
.	O	O	O

Structural	O	O	B-T082
-	O	O	O
MRI	O	O	B-T060
was	O	O	O
performed	O	O	B-T169
to	O	O	O
estimate	O	O	B-T081
the	O	O	O
brain	O	O	B-T081
volume	O	O	I-T081
,	O	O	O
and	O	O	O
resting-state	O	O	B-T060
functional-MRI	O	O	I-T060
was	O	O	O
applied	O	O	O
to	O	O	O
extract	O	O	O
the	O	O	O
amplitude	O	O	B-T081
of	O	O	I-T081
low-frequency	O	O	I-T081
fluctuations	O	O	I-T081
(	O	O	O
ALFF	O	O	B-T081
)	O	O	O
,	O	O	O
an	O	O	O
imaging	O	O	O
measure	O	O	O
of	O	O	O
intrinsic	O	O	B-T082
brain	O	O	B-T039
activity	O	O	I-T039
.	O	O	O

Intriguingly	O	O	O
,	O	O	O
our	O	O	O
results	O	O	O
revealed	O	O	O
a	O	O	O
robust	O	O	O
linear	O	O	B-T082
correlation	O	O	B-T080
between	O	O	O
whole-brain	O	O	B-T081
size	O	O	I-T081
and	O	O	O
ALFF	O	O	B-T081
.	O	O	O

Moreover	O	O	O
,	O	O	O
specific	O	O	B-T080
brain	O	O	B-T023
lobes	O	O	I-T023
/	O	O	O
regions	O	O	B-T029
,	O	O	O
including	O	O	O
the	O	O	O
frontal	O	O	B-T023
lobe	O	O	I-T023
,	O	O	O
the	O	O	O
left	O	O	B-T023
middle	O	O	I-T023
frontal	O	O	I-T023
gyrus	O	O	I-T023
,	O	O	O
anterior	O	O	B-T023
cingulate	O	O	I-T023
gyrus	O	O	I-T023
,	O	O	O
Rolandic	O	O	B-T023
operculum	O	O	I-T023
,	O	O	O
and	O	O	O
insula	O	O	B-T023
,	O	O	O
also	O	O	O
showed	O	O	O
a	O	O	O
reliable	O	O	B-T080
,	O	O	O
positive	O	O	B-T033
volume	O	O	B-T081
-	O	O	O
ALFF	O	O	B-T081
correlation	O	O	B-T080
in	O	O	O
the	O	O	O
two	O	O	O
cohorts	O	O	B-T098
.	O	O	O

These	O	O	O
findings	O	O	O
offer	O	O	O
direct	O	O	B-T080
,	O	O	O
empirical	O	O	B-T080
evidence	O	O	B-T169
of	O	O	I-T169
a	O	O	O
strong	O	O	B-T080
association	O	O	B-T080
between	O	O	O
brain	O	O	B-T023
size	O	O	I-T081
/	O	O	O
volume	O	O	B-T081
and	O	O	O
intrinsic	O	O	B-T082
brain	O	O	B-T039
activity	O	O	I-T039
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
provide	O	O	O
novel	O	O	O
insight	O	O	O
into	O	O	O
the	O	O	O
structural	O	O	B-T082
substrates	O	O	B-T169
of	O	O	O
the	O	O	O
intrinsic	O	O	O
brain	O	O	O
activity	O	O	O
of	O	O	O
the	O	O	O
human	O	O	B-T016
brain	O	O	O
.	O	O	O

-DOCSTART- (27356521)

On	O	O	O
the	O	O	O
Control	O	O	B-T169
of	O	O	O
Social	O	O	B-T169
Approach-Avoidance	O	O	B-T033
Behavior	O	O	I-T033
:	O	O	O
Neural	O	O	B-T169
and	O	O	O
Endocrine	O	O	B-T169
Mechanisms	O	O	O

The	O	O	O
ability	O	O	B-T032
to	O	O	O
control	O	O	B-T169
our	O	O	O
automatic	O	O	B-T169
action	O	O	B-T052
tendencies	O	O	B-T078
is	O	O	O
crucial	O	O	B-T080
for	O	O	O
adequate	O	O	B-T080
social	O	O	B-T033
interactions	O	O	I-T033
.	O	O	O

Emotional	O	O	B-T033
events	O	O	B-T051
trigger	O	O	B-T080
automatic	O	O	B-T169
approach	O	O	B-T033
and	O	O	I-T033
avoidance	O	O	I-T033
tendencies	O	O	B-T078
.	O	O	O

Although	O	O	O
these	O	O	O
actions	O	O	B-T052
may	O	O	O
be	O	O	O
generally	O	O	O
adaptive	O	O	B-T169
,	O	O	O
the	O	O	O
capacity	O	O	B-T081
to	O	O	O
override	O	O	B-T052
these	O	O	O
emotional	O	O	B-T033
reactions	O	O	I-T033
may	O	O	O
be	O	O	O
key	O	O	B-T077
to	O	O	O
flexible	O	O	B-T080
behavior	O	O	B-T053
during	O	O	O
social	O	O	B-T033
interaction	O	O	I-T033
.	O	O	O

The	O	O	O
present	O	O	B-T079
chapter	O	O	B-T078
provides	O	O	B-T052
a	O	O	O
review	O	O	B-T078
of	O	O	O
the	O	O	O
neuroendocrine	O	O	B-T022
mechanisms	O	O	B-T169
underlying	O	O	O
this	O	O	O
ability	O	O	B-T032
and	O	O	O
their	O	O	O
relation	O	O	B-T080
to	O	O	O
social	O	O	B-T169
psychopathologies	O	O	B-T091
.	O	O	O

Aberrant	O	O	B-T080
social	O	O	B-T054
behavior	O	O	I-T054
,	O	O	O
such	O	O	O
as	O	O	O
observed	O	O	B-T169
in	O	O	O
social	O	O	B-T048
anxiety	O	O	I-T048
or	O	O	O
psychopathy	O	O	B-T048
,	O	O	O
is	O	O	O
marked	O	O	B-T080
by	O	O	O
abnormalities	O	O	B-T033
in	O	O	O
approach-avoidance	O	O	B-T033
tendencies	O	O	B-T078
and	O	O	O
the	O	O	O
ability	O	O	B-T032
to	O	O	O
control	O	O	B-T169
them	O	O	O
.	O	O	O

Key	O	O	B-T077
neural	O	O	B-T169
regions	O	O	B-T082
involved	O	O	B-T169
in	O	O	O
the	O	O	O
regulation	O	O	B-T038
of	O	O	O
approach-avoidance	O	O	B-T033
behavior	O	O	I-T033
are	O	O	O
the	O	O	O
amygdala	O	O	B-T023
,	O	O	O
widely	O	O	O
implicated	O	O	B-T080
in	O	O	O
automatic	O	O	B-T169
emotional	O	O	B-T033
processing	O	O	B-T041
,	O	O	O
and	O	O	O
the	O	O	O
anterior	O	O	B-T082
prefrontal	O	O	B-T023
cortex	O	O	I-T023
,	O	O	O
which	O	O	O
exerts	O	O	B-T040
control	O	O	B-T169
over	O	O	O
the	O	O	O
amygdala	O	O	O
.	O	O	O

Hormones	O	O	B-T125
,	O	O	O
especially	O	O	O
testosterone	O	O	B-T125
and	O	O	O
cortisol	O	O	B-T125
,	O	O	O
have	O	O	O
been	O	O	O
shown	O	O	O
to	O	O	O
affect	O	O	B-T041
approach-avoidance	O	O	B-T033
behavior	O	O	I-T033
and	O	O	O
the	O	O	O
associated	O	O	B-T080
neural	O	O	B-T169
mechanisms	O	O	B-T169
.	O	O	O

The	O	O	O
present	O	O	B-T079
chapter	O	O	B-T078
also	O	O	O
discusses	O	O	O
ways	O	O	O
to	O	O	O
directly	O	O	B-T080
influence	O	O	B-T077
social	O	O	B-T169
approach	O	O	B-T033
and	O	O	I-T033
avoidance	O	O	I-T033
behavior	O	O	I-T033
and	O	O	O
will	O	O	O
end	O	O	O
with	O	O	O
a	O	O	O
research	O	O	B-T062
agenda	O	O	B-T170
to	O	O	O
further	O	O	O
advance	O	O	B-T169
this	O	O	O
important	O	O	B-T080
research	O	O	B-T062
field	O	O	I-T062
.	O	O	O

Control	O	O	B-T169
over	O	O	O
approach-avoidance	O	O	B-T033
tendencies	O	O	B-T078
may	O	O	O
serve	O	O	O
as	O	O	O
an	O	O	O
exemplar	O	O	B-T170
of	O	O	O
emotional	O	O	B-T033
action	O	O	B-T052
regulation	O	O	B-T038
and	O	O	O
might	O	O	O
have	O	O	O
a	O	O	O
great	O	O	B-T081
value	O	O	B-T080
in	O	O	O
understanding	O	O	B-T041
the	O	O	O
underlying	O	O	O
mechanisms	O	O	B-T169
of	O	O	O
the	O	O	O
development	O	O	B-T169
of	O	O	O
affective	O	O	B-T048
disorders	O	O	I-T048
.	O	O	O

-DOCSTART- (27356693)

High	O	O	O
Occurrence	O	O	O
of	O	O	O
Non-Clear	O	O	B-T191
Cell	O	O	I-T191
Renal	O	O	I-T191
Cell	O	O	I-T191
Carcinoma	O	O	I-T191
in	O	O	O
Oman	O	O	O

It	O	O	O
is	O	O	O
conventionally	O	O	O
accepted	O	O	O
that	O	O	O
renal	O	O	B-T191
cell	O	O	I-T191
carcinoma	O	O	I-T191
(	O	O	O
RCC	O	O	B-T191
)	O	O	O
occurs	O	O	O
in	O	O	O
older	O	O	B-T101
patients	O	O	I-T101
and	O	O	O
the	O	O	O
clear	O	O	B-T191
cell	O	O	I-T191
type	O	O	I-T191
is	O	O	O
the	O	O	O
most	O	O	O
common	O	O	O
histology	O	O	B-T091
.	O	O	O

However	O	O	O
,	O	O	O
ethnic	O	O	B-T080
variations	O	O	I-T080
exist	O	O	O
and	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
carried	O	O	O
out	O	O	O
to	O	O	O
determine	O	O	O
the	O	O	O
epidemiological	O	O	B-UnknownType
pattern	O	O	I-UnknownType
of	O	O	O
RCC	O	O	B-T191
in	O	O	O
Oman	O	O	B-T083
.	O	O	O

Ninety	O	O	O
RCC	O	O	B-T191
patients	O	O	B-T101
who	O	O	O
presented	O	O	B-T078
to	O	O	O
a	O	O	O
tertiary	O	O	B-T093
care	O	O	I-T093
center	O	O	I-T093
in	O	O	O
the	O	O	O
Sultanate	O	O	B-T083
of	O	O	I-T083
Oman	O	O	I-T083
from	O	O	O
2010	O	O	O
to	O	O	O
2014	O	O	O
were	O	O	O
studied	O	O	B-T062
.	O	O	O

The	O	O	O
main	O	O	B-T033
findings	O	O	I-T033
were	O	O	O
that	O	O	O
the	O	O	O
median	O	O	B-T032
age	O	O	I-T032
of	O	O	O
presentation	O	O	B-T078
was	O	O	O
low	O	O	B-T080
,	O	O	O
more	O	O	O
patients	O	O	B-T101
presented	O	O	B-T078
with	O	O	O
localized	O	O	B-T082
stage	O	O	B-T079
,	O	O	O
and	O	O	O
there	O	O	O
was	O	O	O
a	O	O	O
higher	O	O	O
incidence	O	O	O
of	O	O	O
non-clear	O	O	B-T191
(	O	O	O
especially	O	O	O
papillary	O	O	B-T191
)	O	O	O
histology	O	O	B-T091
.	O	O	O

Data	O	O	B-T078
from	O	O	O
other	O	O	O
Gulf	O	O	B-T083
countries	O	O	I-T083
and	O	O	O
possible	O	O	O
reasons	O	O	O
for	O	O	O
the	O	O	O
different	O	O	O
profile	O	O	O
are	O	O	O
discussed	O	O	O
.	O	O	O

-DOCSTART- (27357394)

Patient	O	O	B-T061
Mobility	O	O	I-T061
for	O	O	O
Elective	O	O	B-UnknownType
Secondary	O	O	B-T058
Health	O	O	I-T058
Care	O	O	I-T058
Services	O	O	I-T058
in	O	O	O
Response	O	O	B-T041
to	O	O	O
Patient	O	O	B-T089
Choice	O	O	I-T089
Policies	O	O	I-T089
:	O	O	O
A	O	O	O
Systematic	O	O	O
Review	O	O	O

Our	O	O	O
review	O	O	O
establishes	O	O	O
the	O	O	O
empirical	O	O	B-T080
evidence	O	O	B-T078
for	O	O	O
patient	O	O	B-T061
mobility	O	O	I-T061
for	O	O	O
elective	O	O	B-T058
secondary	O	O	I-T058
care	O	O	I-T058
services	O	O	I-T058
in	O	O	O
countries	O	O	B-T083
that	O	O	O
allow	O	O	O
patients	O	O	B-T101
to	O	O	O
choose	O	O	O
their	O	O	O
health	O	O	B-T097
care	O	O	I-T097
provider	O	O	I-T097
.	O	O	O

PubMed	O	O	B-T170
and	O	O	O
Embase	O	O	B-T170
were	O	O	O
searched	O	O	O
for	O	O	O
relevant	O	O	O
articles	O	O	B-T170
between	O	O	O
1990	O	O	O
and	O	O	O
2015	O	O	O
.	O	O	O

Of	O	O	O
5,994	O	O	O
titles	O	O	B-T170
/	O	O	O
abstracts	O	O	B-T170
reviewed	O	O	B-T080
,	O	O	O
26	O	O	O
studies	O	O	B-T062
were	O	O	O
included	O	O	O
.	O	O	O

The	O	O	O
studies	O	O	B-T062
used	O	O	O
three	O	O	O
main	O	O	O
methodological	O	O	B-T057
models	O	O	B-T170
to	O	O	O
establish	O	O	O
mobility	O	O	B-T033
.	O	O	O

Variation	O	O	B-T080
in	O	O	O
the	O	O	O
extent	O	O	O
of	O	O	O
patient	O	O	B-T061
mobility	O	O	I-T061
was	O	O	O
observed	O	O	O
across	O	O	O
the	O	O	O
studies	O	O	O
.	O	O	O

Mobility	O	O	B-T033
was	O	O	O
positively	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
lower	O	O	B-T079
waiting	O	O	I-T079
times	O	O	I-T079
,	O	O	O
indicators	O	O	B-T169
of	O	O	O
better	O	O	B-T058
service	O	O	I-T058
quality	O	O	I-T058
,	O	O	O
and	O	O	O
access	O	O	O
to	O	O	O
advanced	O	O	B-T092
technology	O	O	I-T092
.	O	O	O

It	O	O	O
was	O	O	O
negatively	O	O	O
associated	O	O	O
with	O	O	O
advanced	O	O	B-T098
age	O	O	I-T098
or	O	O	O
lower	O	O	O
socioeconomic	O	O	B-T077
backgrounds	O	O	O
.	O	O	O

From	O	O	O
a	O	O	O
policy	O	O	B-T170
perspective	O	O	B-T170
we	O	O	O
demonstrate	O	O	O
that	O	O	O
a	O	O	O
significant	O	O	O
proportion	O	O	B-T081
of	O	O	O
patients	O	O	B-T101
are	O	O	O
prepared	O	O	O
to	O	O	O
travel	O	O	B-T056
beyond	O	O	O
their	O	O	O
nearest	O	O	O
provider	O	O	B-T097
for	O	O	O
elective	O	O	B-UnknownType
services	O	O	I-UnknownType
.	O	O	O

As	O	O	O
a	O	O	O
consequence	O	O	O
,	O	O	O
some	O	O	O
providers	O	O	B-T097
are	O	O	O
likely	O	O	O
to	O	O	O
be	O	O	O
"	O	O	O
winners	O	O	B-T058
"	O	O	O
and	O	O	O
others	O	O	O
"	O	O	O
losers	O	O	B-T033
,	O	O	O
"	O	O	O
which	O	O	O
could	O	O	O
result	O	O	O
in	O	O	O
overall	O	O	O
decreased	O	O	B-T081
provider	O	O	B-T097
capacity	O	O	B-T081
or	O	O	O
inefficient	O	O	B-T169
utilization	O	O	O
of	O	O	O
existing	O	O	O
services	O	O	B-T058
.	O	O	O

Equity	O	O	B-T080
also	O	O	O
remains	O	O	O
a	O	O	O
key	O	O	O
concern	O	O	O
.	O	O	O

-DOCSTART- (27358525)

New	O	O	B-T080
Breast	O	O	B-T184
Pain	O	O	I-T184
Chart	O	O	B-T074
for	O	O	O
Objective	O	O	B-T170
Record	O	O	I-T170
of	O	O	O
Mastalgia	O	O	O

Mastalgia	O	O	B-T184
is	O	O	O
the	O	O	O
commonest	O	O	B-T081
affliction	O	O	B-T041
of	O	O	O
mammary	O	O	B-T023
gland	O	O	I-T023
among	O	O	O
ladies	O	O	B-T098
of	O	O	O
the	O	O	O
reproductive	O	O	B-T079
age	O	O	B-T100
group	O	O	I-T100
.	O	O	O

Since	O	O	O
etiopathogenesis	O	O	B-T169
and	O	O	O
therapy	O	O	B-T061
are	O	O	O
different	O	O	B-T080
for	O	O	O
cyclical	O	O	B-T184
and	O	O	O
noncyclical	O	O	B-T184
pain	O	O	I-T184
,	O	O	O
it	O	O	O
is	O	O	O
imperative	O	O	O
to	O	O	O
ascertain	O	O	O
the	O	O	O
exact	O	O	O
type	O	O	O
correctly	O	O	O
.	O	O	O

This	O	O	O
is	O	O	O
usually	O	O	O
done	O	O	O
in	O	O	O
the	O	O	O
breast	O	O	B-T093
clinics	O	O	I-T093
by	O	O	O
advising	O	O	O
the	O	O	O
patient	O	O	B-T101
to	O	O	O
fill	O	O	O
a	O	O	O
pain	O	O	B-T170
diary	O	O	I-T170
over	O	O	O
a	O	O	O
period	O	O	B-T079
of	O	O	O
2	O	O	O
months	O	O	B-T079
over	O	O	O
two	O	O	O
menstrual	O	O	B-T040
cycles	O	O	I-T040
.	O	O	O

The	O	O	O
Cardiff	O	O	B-T074
pain	O	O	B-T184
chart	O	O	I-T074
records	O	O	I-T074
the	O	O	O
severity	O	O	B-T080
of	O	O	O
pain	O	O	O
in	O	O	O
the	O	O	O
form	O	O	O
of	O	O	O
a	O	O	O
triangle	O	O	B-T077
for	O	O	O
mild	O	O	B-T080
to	O	O	O
moderate	O	O	B-T184
pain	O	O	I-T184
and	O	O	O
a	O	O	O
square	O	O	B-T082
for	O	O	O
severe	O	O	B-T033
pain	O	O	I-T033
.	O	O	O

Moreover	O	O	O
,	O	O	O
Cardiff	O	O	B-T074
pain	O	O	B-T184
chart	O	O	I-T074
does	O	O	O
not	O	O	O
allow	O	O	O
a	O	O	O
patient	O	O	B-T101
to	O	O	O
record	O	O	B-T080
the	O	O	O
severity	O	O	B-T080
of	O	O	O
pain	O	O	O
on	O	O	O
days	O	O	B-T079
of	O	O	O
menses	O	O	B-T040
,	O	O	O
as	O	O	O
she	O	O	O
has	O	O	O
to	O	O	O
put	O	O	O
the	O	O	O
letter	O	O	O
"	O	O	O
P	O	O	O
"	O	O	O
in	O	O	O
the	O	O	O
box	O	O	O
.	O	O	O

These	O	O	O
problems	O	O	B-T033
have	O	O	O
been	O	O	O
resolved	O	O	B-T077
in	O	O	O
the	O	O	O
new	O	O	B-T080
breast	O	O	B-T184
pain	O	O	I-T184
chart	O	O	B-T074
.	O	O	O

In	O	O	O
the	O	O	O
new	O	O	B-T080
pain	O	O	B-T184
chart	O	O	I-T074
,	O	O	O
the	O	O	O
lady	O	O	B-T098
records	O	O	B-T080
pain	O	O	O
severity	O	O	B-T080
in	O	O	O
the	O	O	O
form	O	O	O
of	O	O	O
visual	O	O	B-T201
linear	O	O	I-T201
analogue	O	O	I-T201
scale	O	O	I-T201
score	O	O	I-T201
on	O	O	O
every	O	O	B-T079
day	O	O	I-T079
of	O	O	O
menstrual	O	O	B-T040
cycle	O	O	I-T040
.	O	O	O

She	O	O	O
enters	O	O	O
her	O	O	O
menstrual	O	O	B-T040
experience	O	O	B-T041
on	O	O	O
a	O	O	O
separate	O	O	O
part	O	O	O
of	O	O	O
chart	O	O	B-T074
,	O	O	O
which	O	O	O
allows	O	O	O
us	O	O	O
to	O	O	O
visualize	O	O	B-T082
the	O	O	O
full	O	O	O
month	O	O	B-T079
's	O	O	I-T079
pain	O	O	B-T184
severity	O	O	B-T080
in	O	O	O
an	O	O	O
uncluttered	O	O	O
way	O	O	O
.	O	O	O

-DOCSTART- (27358905)

The	O	O	O
Demand	O	O	O
for	O	O	O
Cigarettes	O	O	B-T073
in	O	O	O
Tanzania	O	O	B-T083
and	O	O	O
Implications	O	O	B-UnknownType
for	O	O	O
Tobacco	O	O	B-T109
Taxation	O	O	O
Policy	O	O	O

The	O	O	O
study	O	O	B-T062
attempts	O	O	O
to	O	O	O
estimate	O	O	O
the	O	O	O
demand	O	O	O
for	O	O	O
cigarettes	O	O	B-T073
in	O	O	O
Tanzania	O	O	B-T083
and	O	O	O
presents	O	O	O
simulation	O	O	B-T062
results	O	O	B-T169
on	O	O	O
the	O	O	O
effect	O	O	B-T080
of	O	O	O
the	O	O	O
cigarette	O	O	B-T073
excise	O	O	B-UnknownType
tax	O	O	I-UnknownType
on	O	O	O
smoking	O	O	B-T055
participation	O	O	B-T169
,	O	O	O
government	O	O	B-UnknownType
revenue	O	O	I-UnknownType
,	O	O	O
and	O	O	O
related	O	O	O
topics	O	O	O
.	O	O	O

After	O	O	O
briefly	O	O	O
summarizing	O	O	O
the	O	O	O
magnitude	O	O	B-T081
and	O	O	O
spread	O	O	O
of	O	O	O
cigarette	O	O	B-T033
consumption	O	O	I-T033
in	O	O	O
the	O	O	O
country	O	O	B-T083
,	O	O	O
the	O	O	O
paper	O	O	O
reviews	O	O	O
some	O	O	O
empirical	O	O	O
estimates	O	O	O
from	O	O	O
African	O	O	B-T083
and	O	O	O
other	O	O	O
countries	O	O	B-T083
.	O	O	O

The	O	O	O
2008	O	O	O
Tanzanian	O	O	B-T083
household	O	O	B-T170
budget	O	O	I-T170
survey	O	O	B-T170
was	O	O	O
used	O	O	O
to	O	O	O
estimate	O	O	O
the	O	O	O
demand	O	O	O
for	O	O	O
cigarettes	O	O	B-T073
in	O	O	O
Tanzania	O	O	B-T083
.	O	O	O

The	O	O	O
descriptive	O	O	O
statistics	O	O	O
suggest	O	O	O
that	O	O	O
the	O	O	O
smoking	O	O	B-T055
prevalence	O	O	O
for	O	O	O
Tanzania	O	O	B-T083
is	O	O	O
15.35	O	O	O
percent	O	O	O
with	O	O	O
low	O	O	O
variability	O	O	O
across	O	O	O
expenditure	O	O	B-UnknownType
(	O	O	I-UnknownType
income	O	O	I-UnknownType
)	O	O	I-UnknownType
groups	O	O	I-UnknownType
.	O	O	O

Smoking	O	O	B-T055
intensity	O	O	O
and	O	O	O
per	O	O	B-UnknownType
capita	O	O	I-UnknownType
consumption	O	O	I-UnknownType
were	O	O	O
estimated	O	O	O
at	O	O	O
7.08	O	O	O
cigarettes	O	O	B-T073
and	O	O	O
1.33	O	O	O
cigarettes	O	O	O
,	O	O	O
respectively	O	O	O
,	O	O	O
a	O	O	O
relatively	O	O	O
low	O	O	O
value	O	O	O
.	O	O	O

A	O	O	O
two-part	O	O	B-T170
demand	O	O	I-T170
equation	O	O	I-T170
model	O	O	I-T170
was	O	O	O
used	O	O	O
to	O	O	O
estimate	O	O	O
various	O	O	O
elasticities	O	O	B-UnknownType
.	O	O	O

For	O	O	O
the	O	O	O
overall	O	O	O
equation	O	O	B-T077
,	O	O	O
the	O	O	O
price	O	O	B-UnknownType
elasticities	O	O	I-UnknownType
of	O	O	O
smoking	O	O	B-T055
participation	O	O	B-T169
,	O	O	O
smoking	O	O	O
intensity	O	O	O
,	O	O	O
and	O	O	O
total	O	O	O
elasticity	O	O	B-UnknownType
were	O	O	O
estimated	O	O	O
at	O	O	O
-0.879	O	O	O
,	O	O	O
-0.853	O	O	O
,	O	O	O
and	O	O	O
-1.732	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

Compared	O	O	O
to	O	O	O
similar	O	O	O
results	O	O	O
in	O	O	O
other	O	O	O
developing	O	O	B-T080
countries	O	O	I-T080
,	O	O	O
the	O	O	O
estimates	O	O	O
appear	O	O	O
quite	O	O	O
high	O	O	O
.	O	O	O

When	O	O	O
estimated	O	O	O
by	O	O	O
expenditure	O	O	B-UnknownType
(	O	O	I-UnknownType
income	O	O	I-UnknownType
)	O	O	I-UnknownType
groups	O	O	I-UnknownType
,	O	O	O
the	O	O	O
magnitude	O	O	B-T081
of	O	O	O
the	O	O	O
elasticity	O	O	B-UnknownType
appears	O	O	O
higher	O	O	O
among	O	O	O
high	O	O	B-UnknownType
expenditure	O	O	I-UnknownType
groups	O	O	I-UnknownType
than	O	O	O
among	O	O	O
low	O	O	B-UnknownType
expenditure	O	O	I-UnknownType
groups	O	O	I-UnknownType
.	O	O	O

Two	O	O	O
simulation	O	O	B-T062
exercises	O	O	O
were	O	O	O
undertaken	O	O	O
.	O	O	O

First	O	O	O
,	O	O	O
the	O	O	O
effect	O	O	B-T080
of	O	O	O
different	O	O	O
excise	O	O	B-UnknownType
rates	O	O	B-T081
on	O	O	O
smoking	O	O	B-T055
participation	O	O	B-T081
rate	O	O	I-T081
,	O	O	O
cigarette	O	O	B-T033
consumption	O	O	I-T033
,	O	O	O
tax	O	O	B-UnknownType
revenue	O	O	I-UnknownType
,	O	O	O
and	O	O	O
related	O	O	O
responses	O	O	O
was	O	O	O
estimated	O	O	O
and	O	O	O
highlighted	O	O	O
.	O	O	O

Second	O	O	O
,	O	O	O
the	O	O	O
same	O	O	O
exercise	O	O	O
was	O	O	O
undertaken	O	O	O
to	O	O	O
determine	O	O	O
the	O	O	O
effect	O	O	B-T080
of	O	O	O
a	O	O	O
given	O	O	O
increase	O	O	B-T169
in	O	O	O
the	O	O	O
cigarette	O	O	B-T073
excise	O	O	B-UnknownType
tax	O	O	I-UnknownType
on	O	O	O
various	O	O	O
expenditure	O	O	B-UnknownType
groups	O	O	I-UnknownType
.	O	O	O

The	O	O	O
overall	O	O	O
results	O	O	B-T169
suggest	O	O	O
that	O	O	O
an	O	O	O
increase	O	O	B-T169
in	O	O	O
the	O	O	O
excise	O	O	B-UnknownType
tax	O	O	I-UnknownType
on	O	O	O
cigarettes	O	O	B-T073
in	O	O	O
Tanzania	O	O	B-T083
would	O	O	O
reduce	O	O	O
cigarette	O	O	B-T033
consumption	O	O	I-T033
and	O	O	O
increase	O	O	O
government	O	O	B-UnknownType
tax	O	O	I-UnknownType
revenue	O	O	I-UnknownType
.	O	O	O

-DOCSTART- (27364111)

Physicians	O	O	B-T097
'	O	O	I-T097
knowledge	O	O	O
on	O	O	O
the	O	O	O
work-related	O	O	B-T047
chronic	O	O	O
obstructive	O	O	O
pulmonary	O	O	O
disease	O	O	O

Chronic	O	O	B-T047
obstructive	O	O	I-T047
pulmonary	O	O	I-T047
disease	O	O	I-T047
(	O	O	O
COPD	O	O	B-T047
)	O	O	O
may	O	O	O
be	O	O	O
induced	O	O	O
by	O	O	O
the	O	O	O
work	O	O	B-T082
environment	O	O	I-T082
conditions	O	O	B-T080
.	O	O	O

According	O	O	O
to	O	O	O
the	O	O	O
estimates	O	O	B-T081
,	O	O	O
10	O	O	O
-	O	O	O
20	O	O	O
%	O	O	O
of	O	O	O
all	O	O	O
COPD	O	O	B-T047
cases	O	O	B-T169
are	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
occupational	O	O	B-T037
exposure	O	O	I-T037
to	O	O	O
dusts	O	O	B-T167
and	O	O	O
irritant	O	O	B-T131
gases	O	O	B-T104
.	O	O	O

However	O	O	O
,	O	O	O
in	O	O	O
2014	O	O	O
,	O	O	O
only	O	O	O
11	O	O	O
cases	O	O	B-T169
of	O	O	O
work-related	O	O	B-T047
COPD	O	O	B-T047
were	O	O	O
recognized	O	O	O
in	O	O	O
Poland	O	O	B-T083
.	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
the	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
analyze	O	O	B-T062
the	O	O	O
reasons	O	O	O
for	O	O	O
the	O	O	O
low	O	O	B-T080
incidence	O	O	B-T081
of	O	O	O
work-related	O	O	B-T047
COPD	O	O	B-T047
in	O	O	O
the	O	O	O
context	O	O	B-T078
of	O	O	O
pulmonologists	O	O	B-T097
'	O	O	O
knowledge	O	O	O
about	O	O	O
occupational	O	O	B-T169
risk	O	O	B-T033
factors	O	O	I-T033
and	O	O	O
procedures	O	O	B-T169
on	O	O	O
reporting	O	O	B-T058
suspected	O	O	B-T047
occupational	O	O	B-T047
diseases	O	O	I-T047
.	O	O	O

A	O	O	O
survey	O	O	B-T170
included	O	O	O
94	O	O	O
pulmonologists	O	O	B-T097
randomly	O	O	B-T080
selected	O	O	O
out	O	O	O
of	O	O	O
225	O	O	O
specialists	O	O	B-T097
registered	O	O	O
at	O	O	O
the	O	O	O
Local	O	O	B-T093
Physicians	O	O	I-T093
Chamber	O	O	I-T093
in	O	O	O
ÅÃ³dÅº	O	O	B-UnknownType
.	O	O	O

The	O	O	O
study	O	O	B-T062
was	O	O	O
performed	O	O	B-T169
anonymously	O	O	B-T080
with	O	O	O
the	O	O	O
use	O	O	O
of	O	O	O
original	O	O	O
questionnaire	O	O	B-T170
.	O	O	O

More	O	O	O
than	O	O	O
a	O	O	O
half	O	O	O
of	O	O	O
the	O	O	O
surveyed	O	O	B-T170
pulmonologists	O	O	B-T097
identified	O	O	B-T080
environmental	O	O	B-T082
risk	O	O	B-T033
factors	O	O	I-T033
for	O	O	O
COPD	O	O	B-T047
correctly	O	O	O
,	O	O	O
while	O	O	O
only	O	O	O
23.4	O	O	O
%	O	O	O
properly	O	O	O
identified	O	O	O
the	O	O	O
main	O	O	O
occupational	O	O	B-T169
risk	O	O	O
factors	O	O	O
as	O	O	O
the	O	O	O
cause	O	O	B-T078
of	O	O	O
COPD	O	O	O
.	O	O	O

Only	O	O	O
58.5	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
pulmonologists	O	O	B-T097
always	O	O	O
asked	O	O	O
their	O	O	O
patients	O	O	B-T101
suffering	O	O	B-T033
from	O	O	O
COPD	O	O	B-T047
about	O	O	O
their	O	O	O
job	O	O	B-T090
/	O	O	O
profession	O	O	B-T090
and	O	O	O
60.6	O	O	O
%	O	O	O
of	O	O	O
them	O	O	O
did	O	O	O
not	O	O	O
have	O	O	O
any	O	O	O
knowledge	O	O	O
about	O	O	O
procedures	O	O	B-T169
on	O	O	O
reporting	O	O	B-T058
suspected	O	O	B-T047
occupational	O	O	B-T047
diseases	O	O	I-T047
.	O	O	O

The	O	O	O
physicians	O	O	B-T097
rarely	O	O	B-T080
ask	O	O	O
patients	O	O	B-T101
suffering	O	O	B-T033
from	O	O	O
COPD	O	O	B-T047
about	O	O	O
their	O	O	O
job	O	O	B-T090
/	O	O	O
profession	O	O	B-T090
and	O	O	O
the	O	O	O
relationship	O	O	B-T080
between	O	O	O
their	O	O	O
ailments	O	O	B-T184
and	O	O	O
occupational	O	O	B-T037
exposure	O	O	I-T037
.	O	O	O

What	O	O	O
is	O	O	O
more	O	O	O
,	O	O	O
they	O	O	O
do	O	O	O
not	O	O	O
know	O	O	O
legal	O	O	B-T089
regulations	O	O	I-T089
on	O	O	O
proper	O	O	O
referral	O	O	B-T058
of	O	O	I-T058
a	O	O	I-T058
patient	O	O	I-T058
with	O	O	O
a	O	O	O
suspected	O	O	B-T047
case	O	O	B-T169
of	O	O	O
occupational	O	O	B-T047
disease	O	O	I-T047
.	O	O	O

The	O	O	O
results	O	O	B-T169
of	O	O	O
the	O	O	O
study	O	O	B-T062
clearly	O	O	O
indicate	O	O	B-T078
that	O	O	O
there	O	O	O
is	O	O	O
an	O	O	O
urgent	O	O	O
need	O	O	O
for	O	O	O
increasing	O	O	B-T169
pulmonologists	O	O	B-T097
'	O	O	O
knowledge	O	O	O
on	O	O	O
work-related	O	O	B-T047
COPD	O	O	B-T047
.	O	O	O

Med	O	O	O
Pr	O	O	O
2016;67(3):375	O	O	O
-	O	O	O
384	O	O	O
.	O	O	O

-DOCSTART- (27366176)

Case	O	O	B-T170
Report	O	O	I-T170
of	O	O	O
Necrotizing	O	O	B-T047
Fasciitis	O	O	I-T047
Associated	O	O	B-T080
with	O	O	I-T080
Streptococcus	O	O	O
pneumoniae	O	O	O

Necrotizing	O	O	B-T047
fasciitis	O	O	I-T047
,	O	O	O
caused	O	O	O
by	O	O	O
Streptococcus	O	O	B-T007
pneumoniae	O	O	I-T007
,	O	O	O
is	O	O	O
an	O	O	O
extremely	O	O	B-T080
rare	O	O	I-T080
and	O	O	O
life-threatening	O	O	B-T033
bacterial	O	O	B-T007
soft	O	O	B-T047
tissue	O	O	I-T047
infection	O	O	I-T047
.	O	O	O

We	O	O	O
report	O	O	B-T058
a	O	O	O
case	O	O	B-T169
of	O	O	O
early	O	O	O
necrotizing	O	O	B-T047
fasciitis	O	O	I-T047
associated	O	O	B-T080
with	O	O	I-T080
Streptococcus	O	O	B-T007
pneumoniae	O	O	I-T007
infection	O	O	B-T046
in	O	O	O
a	O	O	O
26-	O	O	O
year	O	O	B-T079
-old	O	O	O
man	O	O	B-T098
who	O	O	O
was	O	O	O
immunocompromised	O	O	B-T033
with	O	O	O
mixed	O	O	B-T047
connective	O	O	I-T047
tissue	O	O	I-T047
disease	O	O	I-T047
.	O	O	O

The	O	O	O
patient	O	O	B-T101
presented	O	O	O
with	O	O	O
acute	O	O	B-T079
,	O	O	O
painful	O	O	B-T184
,	O	O	O
erythematous	O	O	B-T169
,	O	O	O
and	O	O	O
edematous	O	O	B-T046
skin	O	O	I-T046
lesions	O	O	B-T033
of	O	O	O
his	O	O	O
right	O	O	B-T029
lower	O	O	I-T029
back	O	O	I-T029
,	O	O	O
which	O	O	O
rapidly	O	O	O
progressed	O	O	B-T169
to	O	O	O
the	O	O	O
right	O	O	B-T023
knee	O	O	I-T023
.	O	O	O

The	O	O	O
patient	O	O	B-T101
underwent	O	O	O
surgical	O	O	B-T060
exploration	O	O	I-T060
,	O	O	O
and	O	O	O
a	O	O	O
diagnosis	O	O	B-T033
of	O	O	O
necrotizing	O	O	B-T047
fasciitis	O	O	I-T047
was	O	O	O
confirmed	O	O	O
by	O	O	O
pathological	O	O	B-T169
evidence	O	O	B-T078
of	O	O	O
necrosis	O	O	B-T042
of	O	O	O
the	O	O	O
fascia	O	O	B-T024
and	O	O	O
neutrophil	O	O	B-T039
infiltration	O	O	I-T039
in	O	O	O
tissue	O	O	B-T060
biopsies	O	O	I-T060
.	O	O	O

Cultures	O	O	B-T059
of	O	O	O
fascial	O	O	B-T029
tissue	O	O	B-T060
biopsies	O	O	I-T060
and	O	O	O
blood	O	O	B-T031
samples	O	O	I-T031
were	O	O	O
positive	O	O	B-T033
for	O	O	O
Streptococcus	O	O	B-T007
pneumoniae	O	O	I-T007
.	O	O	O

To	O	O	O
our	O	O	O
knowledge	O	O	O
,	O	O	O
this	O	O	O
is	O	O	O
the	O	O	O
first	O	O	O
report	O	O	B-T058
of	O	O	O
necrotizing	O	O	B-T047
fasciitis	O	O	I-T047
resulting	O	O	O
from	O	O	O
Streptococcus	O	O	B-T007
pneumoniae	O	O	I-T007
diagnosed	O	O	B-T033
at	O	O	O
early	O	O	O
phase	O	O	B-T079
;	O	O	O
the	O	O	O
patient	O	O	B-T032
recovered	O	O	I-T032
well	O	O	O
without	O	O	O
surgical	O	O	B-T061
debridement	O	O	I-T061
.	O	O	O

-DOCSTART- (27366491)

A	O	O	O
Comparative	O	O	B-T062
Study	O	O	I-T062
of	O	O	O
the	O	O	O
Efficacy	O	O	B-T080
of	O	O	O
IV	O	O	B-T082
Dexketoprofen	O	O	B-T109
,	O	O	O
Lornoxicam	O	O	B-T109
,	O	O	O
and	O	O	O
Diclophenac	O	O	B-T121
Sodium	O	O	I-T121
on	O	O	O
Postoperative	O	O	B-T061
Analgesia	O	O	I-T061
and	O	O	O
Tramadol	O	O	B-T109
Consumption	O	O	B-UnknownType
in	O	O	O
Patients	O	O	B-T101
Receiving	O	O	O
Patient-Controlled	O	O	B-T061
Tramadol	O	O	O

This	O	O	O
study	O	O	B-T062
was	O	O	O
designed	O	O	B-T052
to	O	O	O
compare	O	O	B-T052
the	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
dexketoprofen	O	O	B-T109
,	O	O	O
lornoxicam	O	O	B-T109
,	O	O	O
and	O	O	O
diclophenac	O	O	B-T121
sodium	O	O	I-T121
on	O	O	O
postoperative	O	O	B-T079
analgesia	O	O	I-T061
and	O	O	O
tramadol	O	O	B-T109
consumption	O	O	B-UnknownType
in	O	O	O
patients	O	O	B-T101
receiving	O	O	O
postoperative	O	O	O
patient-controlled	O	O	B-T061
tramadol	O	O	O
after	O	O	O
a	O	O	O
major	O	O	B-T080
abdominal	O	O	B-T061
surgery	O	O	I-T061
.	O	O	O

Eighty	O	O	O
patients	O	O	B-T101
were	O	O	O
randomized	O	O	B-T033
to	O	O	O
receive	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
four	O	O	O
study	O	O	B-T062
drugs	O	O	B-T121
.	O	O	O

Patients	O	O	B-T101
in	O	O	O
group	O	O	B-T078
dexketoprofen	O	O	B-T109
(	O	O	O
DT	O	O	B-T109
)	O	O	O
received	O	O	O
IV	O	O	B-T082
50	O	O	O
mg	O	O	O
dexketoprofen	O	O	O
,	O	O	O
group	O	O	O
lornoxicam	O	O	B-T109
(	O	O	O
LR	O	O	B-T109
)	O	O	O
received	O	O	O
IV	O	O	O
8	O	O	O
mg	O	O	O
lornoxicam	O	O	O
,	O	O	O
group	O	O	O
diclophenac	O	O	B-T121
sodium	O	O	I-T121
(	O	O	O
DS	O	O	B-T121
)	O	O	O
received	O	O	O
75	O	O	O
mg	O	O	O
IV	O	O	O
diclophenac	O	O	O
sodium	O	O	O
and	O	O	O
group	O	O	O
saline	O	O	B-T167
(	O	O	O
S	O	O	B-T167
)	O	O	O
received	O	O	O
0.9	O	O	O
%	O	O	O
saline	O	O	O
in	O	O	O
2	O	O	O
mL	O	O	O
syringes	O	O	B-T074
,	O	O	O
20	O	O	O
min	O	O	B-T079
before	O	O	O
the	O	O	O
end	O	O	O
of	O	O	O
anaesthesia	O	O	B-T061
.	O	O	O

A	O	O	O
standardized	O	O	B-T080
(	O	O	O
1	O	O	O
mg	O	O	O
kg(-1	O	O	O
)	O	O	O
)	O	O	O
dose	O	O	B-T081
of	O	O	O
tramadol	O	O	B-T109
was	O	O	O
routinely	O	O	B-T080
administered	O	O	B-T169
to	O	O	O
all	O	O	O
patients	O	O	B-T101
as	O	O	O
the	O	O	O
loading	O	O	B-T081
dose	O	O	I-T081
at	O	O	O
the	O	O	O
end	O	O	O
of	O	O	O
surgery	O	O	B-T061
.	O	O	O

Postoperatively	O	O	B-T079
,	O	O	O
whenever	O	O	O
patients	O	O	B-T101
requested	O	O	O
,	O	O	O
they	O	O	O
were	O	O	O
allowed	O	O	O
to	O	O	O
use	O	O	O
a	O	O	O
tramadol	O	O	B-T109
patient-controlled	O	O	B-T033
analgesia	O	O	I-T033
device	O	O	I-T033
giving	O	O	O
a	O	O	O
bolus	O	O	B-T061
dose	O	O	I-T061
(	O	O	O
0.2	O	O	O
mg	O	O	O
kg(-1	O	O	O
)	O	O	O
)	O	O	O
of	O	O	O
tramadol	O	O	O
.	O	O	O

Pain	O	O	B-T184
,	O	O	O
discomfort	O	O	B-T184
,	O	O	O
and	O	O	O
sedation	O	O	B-T033
scores	O	O	B-T081
,	O	O	O
cumulative	O	O	B-T080
tramadol	O	O	B-T109
consumption	O	O	B-UnknownType
,	O	O	O
supplemental	O	O	B-T169
meperidine	O	O	B-T109
requirement	O	O	B-T169
,	O	O	O
and	O	O	O
side	O	O	B-T046
effects	O	O	I-T046
were	O	O	O
recorded	O	O	O
.	O	O	O

Visual	O	O	B-T081
rating	O	O	I-T081
scale	O	O	I-T081
and	O	O	O
patient	O	O	B-T101
discomfort	O	O	B-T184
scores	O	O	B-T081
were	O	O	O
significantly	O	O	B-T078
lower	O	O	B-T052
in	O	O	O
DT	O	O	B-T109
,	O	O	O
LR	O	O	B-T109
and	O	O	O
DS	O	O	B-T121
groups	O	O	B-T078
compared	O	O	O
to	O	O	O
those	O	O	O
in	O	O	O
in	O	O	O
group	O	O	B-T078
S	O	O	B-T167
(	O	O	O
p<0.001	O	O	O
)	O	O	O
.	O	O	O

Cumulative	O	O	B-T080
tramadol	O	O	B-T109
consumption	O	O	B-UnknownType
was	O	O	O
significantly	O	O	B-T078
lower	O	O	B-T052
in	O	O	O
non-steroidal	O	O	B-T121
anti-inflammatory	O	O	I-T121
drug	O	O	I-T121
(NSAID)-	O	O	O
treated	O	O	B-T169
groups	O	O	B-T078
at	O	O	O
each	O	O	O
study	O	O	B-T062
period	O	O	I-T062
after	O	O	O
the	O	O	O
second	O	O	O
postoperative	O	O	B-T079
hour	O	O	B-T079
than	O	O	O
in	O	O	O
group	O	O	B-T078
S	O	O	B-T167
(	O	O	O
p<0.001	O	O	O
)	O	O	O
.	O	O	O

Supplemental	O	O	B-T169
meperidine	O	O	B-T109
requirement	O	O	B-T169
was	O	O	O
significantly	O	O	B-T078
higher	O	O	O
in	O	O	O
group	O	O	B-T078
S	O	O	B-T167
at	O	O	O
each	O	O	O
study	O	O	B-T062
period	O	O	I-T062
after	O	O	O
postoperative	O	O	B-T079
30	O	O	O
min	O	O	B-T079
than	O	O	O
in	O	O	O
NSAID	O	O	B-T121
-	O	O	O
treated	O	O	B-T169
groups	O	O	B-T078
(	O	O	O
p<0.01	O	O	O
)	O	O	O
.	O	O	O

After	O	O	O
major	O	O	B-T080
abdominal	O	O	B-T061
surgery	O	O	I-T061
,	O	O	O
adding	O	O	O
IV	O	O	B-T082
diclophenac	O	O	B-T109
,	O	O	O
lornoxicam	O	O	B-T109
or	O	O	O
dexketoprofen	O	O	B-T109
to	O	O	O
patient-controlled	O	O	B-T061
tramadol	O	O	B-T109
resulted	O	O	O
in	O	O	O
lower	O	O	B-T052
pain	O	O	B-T184
scores	O	O	B-T081
,	O	O	O
smaller	O	O	B-T080
tramadol	O	O	O
consumption	O	O	B-UnknownType
,	O	O	O
less	O	O	O
rescue	O	O	O
supplemental	O	O	B-T169
analgesic	O	O	B-T109
requirement	O	O	B-T169
,	O	O	O
and	O	O	O
fewer	O	O	O
side	O	O	B-T046
effects	O	O	I-T046
compared	O	O	O
with	O	O	O
the	O	O	O
tramadol	O	O	O
alone	O	O	O
group	O	O	B-T078
.	O	O	O

-DOCSTART- (27366556)

Perioperative	O	O	B-T058
Management	O	O	I-T058
of	O	O	O
Severe	O	O	B-T033
Hypertension	O	O	I-T033
during	O	O	O
Laparoscopic	O	O	B-T061
Surgery	O	O	I-T061
for	O	O	O
Pheochromocytoma	O	O	O

Phaeochromocytoma	O	O	B-T191
is	O	O	O
a	O	O	O
catecholamine-secreting	O	O	B-T043
vascular	O	O	B-T191
tumour	O	O	I-T191
that	O	O	O
is	O	O	O
derived	O	O	O
from	O	O	O
chromaffin	O	O	B-T025
cell	O	O	I-T025
.	O	O	O

Lethal	O	O	B-T033
cardiovascular	O	O	B-T046
complications	O	O	I-T046
,	O	O	O
such	O	O	O
as	O	O	O
serious	O	O	O
hypertension	O	O	B-T047
,	O	O	O
myocardial	O	O	B-T047
infarction	O	O	I-T047
and	O	O	O
aortic	O	O	B-T047
dissection	O	O	I-T047
,	O	O	O
may	O	O	O
occur	O	O	O
because	O	O	O
of	O	O	O
uncontrolled	O	O	B-T191
catecholamine	O	O	I-T191
release	O	O	I-T191
.	O	O	O

Each	O	O	O
stage	O	O	B-T079
of	O	O	O
anaesthesia	O	O	B-T061
management	O	O	I-T061
has	O	O	O
vital	O	O	O
importance	O	O	O
because	O	O	O
of	O	O	O
this	O	O	O
destructive	O	O	B-T191
catecholamine	O	O	I-T191
secretion	O	O	I-T191
that	O	O	O
may	O	O	O
occur	O	O	O
during	O	O	O
induction	O	O	B-T061
,	O	O	O
perioperative	O	O	B-T079
stage	O	O	I-T079
and	O	O	O
surgical	O	O	B-T061
manipulation	O	O	I-T061
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	O
,	O	O	O
we	O	O	O
report	O	O	O
regarding	O	O	O
the	O	O	O
preoperative	O	O	B-T058
preparation	O	O	I-T058
and	O	O	O
severe	O	O	B-T058
,	O	O	I-T058
persistent	O	O	I-T058
hypertension	O	O	I-T058
attack	O	O	I-T058
management	O	O	I-T058
with	O	O	O
a	O	O	O
combination	O	O	O
of	O	O	O
Î±-adrenergic	O	O	B-T121
blockade	O	O	I-T121
,	O	O	O
Î²-adrenergic	O	O	B-T121
blockade	O	O	I-T121
,	O	O	O
sodium	O	O	B-T109
nitroprusside	O	O	I-T109
and	O	O	O
remifentanil	O	O	B-T109
in	O	O	O
a	O	O	O
patient	O	O	B-T101
who	O	O	O
underwent	O	O	O
laparoscopic	O	O	B-T061
surgery	O	O	I-T061
for	O	O	O
phaeochromocytoma	O	O	B-T191
.	O	O	O

-DOCSTART- (27370179)

A	O	O	O
case	O	O	B-T169
based	O	O	O
reflection	O	O	B-T033
on	O	O	O
communicating	O	O	B-T169
end	O	O	I-T169
of	O	O	O
life	O	O	B-T078
information	O	O	B-T078
in	O	O	O
non-English	O	O	B-T033
speaking	O	O	I-T033
patients	O	O	O

Mr	O	O	O
X	O	O	O
was	O	O	O
a	O	O	O
56	O	O	O
year	O	O	B-T079
old	O	O	I-T079
Chinese	O	O	B-T098
man	O	O	B-T098
(	O	O	O
non-English	O	O	B-T033
speaking	O	O	I-T033
)	O	O	O
,	O	O	O
who	O	O	O
presented	O	O	O
to	O	O	O
the	O	O	O
emergency	O	O	B-T093
department	O	O	I-T093
with	O	O	O
a	O	O	O
range	O	O	O
of	O	O	O
non-specific	O	O	B-T080
symptoms	O	O	B-T184
.	O	O	O

On	O	O	O
full	O	O	O
workup	O	O	O
,	O	O	O
he	O	O	O
was	O	O	O
diagnosed	O	O	B-T033
with	O	O	O
an	O	O	O
advanced	O	O	B-T191
cancer	O	O	I-T191
of	O	O	I-T191
the	O	O	I-T191
pancreas	O	O	I-T191
.	O	O	O

It	O	O	O
was	O	O	O
an	O	O	O
aggressive	O	O	B-T191
,	O	O	O
highly	O	O	O
treatment	O	O	B-T047
resistant	O	O	I-T047
cancer	O	O	I-T047
,	O	O	O
with	O	O	O
an	O	O	O
alarmingly	O	O	O
poor	O	O	B-T033
prognosis	O	O	I-T033
.	O	O	O

Before	O	O	O
the	O	O	O
diagnosis	O	O	B-T033
had	O	O	O
been	O	O	O
made	O	O	O
,	O	O	O
the	O	O	O
family	O	O	B-T099
had	O	O	O
informed	O	O	O
our	O	O	O
team	O	O	B-T058
that	O	O	O
we	O	O	O
were	O	O	O
not	O	O	O
to	O	O	O
discuss	O	O	O
medical	O	O	B-T169
issues	O	O	B-T033
with	O	O	O
Mr	O	O	O
X	O	O	O
directly	O	O	O
,	O	O	O
and	O	O	O
that	O	O	O
upon	O	O	O
arriving	O	O	O
on	O	O	O
a	O	O	O
diagnosis	O	O	O
we	O	O	O
were	O	O	O
to	O	O	O
come	O	O	O
to	O	O	O
them	O	O	O
first	O	O	O
and	O	O	O
they	O	O	O
would	O	O	O
subsequently	O	O	O
inform	O	O	O
him	O	O	O
.	O	O	O

They	O	O	O
reported	O	O	O
that	O	O	O
Mr	O	O	O
X	O	O	O
was	O	O	O
in	O	O	O
support	O	O	B-T077
of	O	O	O
this	O	O	O
arrangement	O	O	O
.	O	O	O

Eventually	O	O	O
we	O	O	O
told	O	O	O
the	O	O	O
family	O	O	B-T099
about	O	O	O
Mr	O	O	O
X	O	O	O
's	O	O	O
diagnosis	O	O	B-T033
,	O	O	O
and	O	O	O
they	O	O	O
asserted	O	O	O
their	O	O	O
collective	O	O	B-UnknownType
will	O	O	I-UnknownType
to	O	O	O
keep	O	O	O
this	O	O	O
information	O	O	B-T078
from	O	O	O
him	O	O	O
,	O	O	O
reaffirming	O	O	O
that	O	O	O
all	O	O	O
medical	O	O	B-T169
discussion	O	O	B-T061
go	O	O	O
through	O	O	O
them	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
doctor	O	O	B-T097
in	O	O	I-T097
charge	O	O	I-T097
explained	O	O	O
the	O	O	O
diagnosis	O	O	B-T033
to	O	O	O
Mr	O	O	O
X	O	O	O
using	O	O	O
an	O	O	O
interpreter	O	O	B-T097
while	O	O	O
his	O	O	O
family	O	O	B-T099
were	O	O	O
away	O	O	O
from	O	O	O
his	O	O	O
bed	O	O	B-T073
.	O	O	O

In	O	O	O
this	O	O	O
discussion	O	O	O
,	O	O	O
I	O	O	O
consider	O	O	O
this	O	O	O
case	O	O	B-T169
from	O	O	O
the	O	O	O
perspective	O	O	O
of	O	O	O
respecting	O	O	B-T061
patients	O	O	I-T061
'	O	O	I-T061
and	O	O	I-T061
families	O	O	I-T061
'	O	O	I-T061
preferences	O	O	I-T061
around	O	O	O
medical	O	O	B-T058
treatment	O	O	I-T058
and	O	O	I-T058
care	O	O	I-T058
.	O	O	O

-DOCSTART- (27371369)

Difference-in-Differences	O	O	B-T062
Method	O	O	I-T062
in	O	O	O
Comparative	O	O	B-T062
Effectiveness	O	O	I-T062
Research	O	O	I-T062
:	O	O	O
Utility	O	O	O
with	O	O	O
Unbalanced	O	O	O
Groups	O	O	O

Comparative	O	O	B-T062
effectiveness	O	O	I-T062
research	O	O	I-T062
(	O	O	O
CER	O	O	B-T062
)	O	O	O
often	O	O	O
includes	O	O	O
observational	O	O	B-T170
studies	O	O	I-T170
utilizing	O	O	O
administrative	O	O	B-T033
data	O	O	I-T033
.	O	O	O

Multiple	O	O	O
conditioning	O	O	O
methods	O	O	O
can	O	O	O
be	O	O	O
used	O	O	O
for	O	O	O
CER	O	O	B-T062
to	O	O	O
adjust	O	O	O
for	O	O	O
group	O	O	B-UnknownType
differences	O	O	B-T080
,	O	O	O
including	O	O	O
difference-in-differences	O	O	B-T062
(	O	O	I-T062
DiD	O	O	I-T062
)	O	O	I-T062
estimation	O	O	I-T062
.	O	O	O

This	O	O	O
study	O	O	O
presents	O	O	O
DiD	O	O	B-T062
and	O	O	O
demonstrates	O	O	O
how	O	O	O
to	O	O	O
apply	O	O	O
this	O	O	O
conditioning	O	O	O
method	O	O	B-T170
to	O	O	O
estimate	O	O	O
treatment	O	O	B-T080
outcomes	O	O	I-T080
in	O	O	O
the	O	O	O
CER	O	O	B-T062
setting	O	O	O
by	O	O	O
utilizing	O	O	O
the	O	O	O
MarketScan	O	O	B-T170
Â®	O	O	I-T170
Databases	O	O	I-T170
for	O	O	O
multiple	O	O	B-T047
sclerosis	O	O	I-T047
(	O	O	O
MS	O	O	B-T047
)	O	O	O
patients	O	O	B-T101
receiving	O	O	O
different	O	O	O
therapies	O	O	B-T061
.	O	O	O

The	O	O	O
sample	O	O	O
included	O	O	O
6762	O	O	O
patients	O	O	B-T101
,	O	O	O
with	O	O	O
363	O	O	O
in	O	O	O
the	O	O	O
Test	O	O	B-T098
Cohort	O	O	I-T098
[	O	O	O
glatiramer	O	O	B-T116
acetate	O	O	I-T116
(	O	O	O
GA	O	O	B-T116
)	O	O	O
switched	O	O	B-T058
to	O	O	O
fingolimod	O	O	B-T129
(	O	O	O
FTY	O	O	B-T129
)	O	O	O
]	O	O	O
and	O	O	O
6399	O	O	O
in	O	O	O
the	O	O	O
Control	O	O	B-T096
Cohort	O	O	I-T096
(	O	O	O
GA	O	O	O
only	O	O	O
,	O	O	O
no	O	O	B-T033
switch	O	O	I-T033
)	O	O	O
from	O	O	O
a	O	O	O
US	O	O	B-T170
administrative	O	O	I-T170
claims	O	O	I-T170
database	O	O	I-T170
.	O	O	O

A	O	O	O
trend	O	O	B-UnknownType
analysis	O	O	I-UnknownType
was	O	O	O
conducted	O	O	O
to	O	O	O
rule	O	O	O
out	O	O	O
concerns	O	O	O
regarding	O	O	O
regression	O	O	B-T170
to	O	O	O
the	O	O	O
mean	O	O	B-T081
and	O	O	O
to	O	O	O
compare	O	O	O
relapse	O	O	B-T067
rates	O	O	O
among	O	O	O
treatment	O	O	B-T098
cohorts	O	O	I-T098
.	O	O	O

DiD	O	O	B-T062
analysis	O	O	I-T062
was	O	O	O
used	O	O	O
to	O	O	O
enable	O	O	O
comparisons	O	O	B-T052
among	O	O	O
the	O	O	O
Test	O	O	B-T098
and	O	O	O
Control	O	O	B-T096
Cohorts	O	O	I-T096
.	O	O	O

Logistic	O	O	B-T062
regression	O	O	I-T062
was	O	O	O
used	O	O	O
to	O	O	O
estimate	O	O	O
the	O	O	O
probability	O	O	B-T081
of	O	O	O
relapse	O	O	B-T067
after	O	O	O
switching	O	O	B-T058
from	O	O	O
GA	O	O	B-T116
to	O	O	O
FTY	O	O	B-T129
,	O	O	O
and	O	O	O
to	O	O	O
compare	O	O	B-T052
group	O	O	B-UnknownType
differences	O	O	B-T080
in	O	O	O
the	O	O	O
pre	O	O	B-T079
-	O	O	O
and	O	O	O
post	O	O	B-T079
-	O	O	O
index	O	O	B-T079
periods	O	O	I-T079
.	O	O	O

Crude	O	O	O
DiD	O	O	B-T062
analysis	O	O	I-T062
showed	O	O	O
that	O	O	O
in	O	O	O
the	O	O	O
pre	O	O	B-T079
-	O	O	O
index	O	O	B-T079
period	O	O	I-T079
more	O	O	O
patients	O	O	B-T101
in	O	O	O
the	O	O	O
Test	O	O	B-T098
Cohort	O	O	I-T098
experienced	O	O	O
an	O	O	O
MS	O	O	B-T047
relapse	O	O	B-T067
and	O	O	O
had	O	O	O
a	O	O	O
higher	O	O	O
mean	O	O	B-T081
number	O	O	I-T081
of	O	O	O
relapses	O	O	B-T067
than	O	O	O
in	O	O	O
the	O	O	O
Control	O	O	B-T096
Cohort	O	O	I-T096
.	O	O	O

During	O	O	O
the	O	O	O
pre	O	O	B-T079
-	O	O	O
index	O	O	B-T079
period	O	O	I-T079
,	O	O	O
numeric	O	O	B-T080
and	O	O	O
relative	O	O	O
data	O	O	O
for	O	O	O
MS	O	O	B-T047
relapses	O	O	B-T067
in	O	O	O
patients	O	O	B-T101
in	O	O	O
the	O	O	O
Test	O	O	B-T098
Cohort	O	O	I-T098
were	O	O	O
significantly	O	O	O
higher	O	O	O
than	O	O	O
in	O	O	O
the	O	O	O
Control	O	O	B-T096
Cohort	O	O	I-T096
,	O	O	O
while	O	O	O
no	O	O	B-T033
significant	O	O	I-T033
between-	O	O	O
group	O	O	B-UnknownType
differences	O	O	B-T080
emerged	O	O	O
during	O	O	O
the	O	O	O
post	O	O	B-T079
-	O	O	O
index	O	O	O
period	O	O	O
.	O	O	O

Generalized	O	O	O
linear	O	O	B-T081
modeling	O	O	I-T081
with	O	O	O
DiD	O	O	B-T062
regression	O	O	B-UnknownType
estimation	O	O	I-UnknownType
showed	O	O	O
that	O	O	O
the	O	O	O
mean	O	O	O
number	O	O	O
of	O	O	O
MS	O	O	B-T047
relapses	O	O	B-T067
decreased	O	O	O
significantly	O	O	O
in	O	O	O
the	O	O	O
post	O	O	B-T079
-	O	O	O
index	O	O	B-T079
period	O	O	I-T079
among	O	O	O
patients	O	O	B-T101
in	O	O	O
the	O	O	O
Test	O	O	B-T098
Cohort	O	O	I-T098
compared	O	O	O
with	O	O	O
patients	O	O	O
in	O	O	O
the	O	O	O
Control	O	O	B-T096
Cohort	O	O	I-T096
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	O
,	O	O	O
an	O	O	O
MS	O	O	B-T047
population	O	O	B-T098
was	O	O	O
utilized	O	O	O
to	O	O	O
demonstrate	O	O	O
how	O	O	O
DiD	O	O	B-T062
can	O	O	O
be	O	O	O
applied	O	O	O
to	O	O	O
estimate	O	O	O
treatment	O	O	B-T033
effects	O	O	I-T033
in	O	O	O
a	O	O	O
heterogeneous	O	O	B-T080
population	O	O	O
,	O	O	O
where	O	O	O
the	O	O	O
Test	O	O	B-T098
and	O	O	O
Control	O	O	B-T096
Cohorts	O	O	I-T096
varied	O	O	O
greatly	O	O	O
.	O	O	O

The	O	O	O
results	O	O	O
show	O	O	O
that	O	O	O
DiD	O	O	B-T062
offers	O	O	O
a	O	O	O
robust	O	O	O
method	O	O	O
for	O	O	O
comparing	O	O	B-T052
diverse	O	O	B-T080
cohorts	O	O	B-T098
when	O	O	O
other	O	O	O
risk-adjustment	O	O	B-T081
methods	O	O	I-T081
may	O	O	O
not	O	O	O
be	O	O	O
adequate	O	O	O
.	O	O	O

-DOCSTART- (27371817)

Metabolomic	O	O	B-T091
analysis	O	O	B-T169
of	O	O	O
glycerophospholipid	O	O	B-T109
signatures	O	O	O
of	O	O	O
inflammation	O	O	B-T046
treated	O	O	B-T061
with	O	O	I-T061
non-steroidal	O	O	B-T121
anti-inflammatory	O	O	I-T121
drugs	O	O	I-T121
-induced-	O	O	O
RAW264.7	O	O	B-T025
cells	O	O	I-T025
using	O	O	O
(1)H	O	O	B-T060
NMR	O	O	I-T060
and	O	O	O
U-HPLC	O	O	B-T059
/	O	O	O
Q-TOF-MS	O	O	O

Non-destructive	O	O	B-T060
proton	O	O	I-T060
nuclear	O	O	I-T060
magnetic	O	O	I-T060
resonance	O	O	I-T060
(	O	O	I-T060
(1)H	O	O	I-T060
NMR	O	O	I-T060
)	O	O	I-T060
spectroscopy	O	O	I-T060
and	O	O	O
highly	O	O	B-T080
sensitive	O	O	I-T080
ultra-performance	O	O	B-T059
liquid	O	O	I-T059
chromatography	O	O	I-T059
quadrupole	O	O	B-T059
time-of-flight	O	O	I-T059
mass	O	O	I-T059
spectrometry	O	O	I-T059
(	O	O	O
U-HPLC	O	O	B-T059
/	O	O	O
Q-TOF-MS	O	O	B-T059
)	O	O	O
coupled	O	O	O
to	O	O	O
data	O	O	B-T066
processing	O	O	I-T066
methods	O	O	B-T170
were	O	O	O
applied	O	O	O
to	O	O	O
analyze	O	O	O
the	O	O	O
metabolic	O	O	B-T091
profiling	O	O	I-T091
changes	O	O	O
of	O	O	O
glycerophospholipids	O	O	B-T109
(	O	O	O
GPLs	O	O	B-T109
)	O	O	O
in	O	O	O
RAW264.7	O	O	B-T025
cells	O	O	I-T025
from	O	O	O
inflammation	O	O	B-T046
to	O	O	O
prognosis	O	O	B-T058
.	O	O	O

Analysis	O	O	B-T062
of	O	O	O
(1)H	O	O	B-T060
NMR	O	O	I-T060
was	O	O	O
shown	O	O	O
that	O	O	O
the	O	O	O
models	O	O	B-T170
were	O	O	O
grouped	O	O	B-T169
successfully	O	O	O
,	O	O	O
illustrating	O	O	O
that	O	O	O
all	O	O	O
of	O	O	O
them	O	O	O
had	O	O	O
significant	O	O	O
differences	O	O	B-T080
.	O	O	O

Based	O	O	O
on	O	O	O
the	O	O	O
highly	O	O	B-T080
simple	O	O	I-T080
,	O	O	O
accurate	O	O	B-T080
,	O	O	O
non-targeted	O	O	O
and	O	O	O
non-destructively	O	O	O
advantages	O	O	O
of	O	O	O
(1)H	O	O	B-T060
NMR	O	O	I-T060
,	O	O	O
it	O	O	O
could	O	O	O
be	O	O	O
used	O	O	O
as	O	O	O
a	O	O	O
new	O	O	O
screening	O	O	O
tool	O	O	O
of	O	O	O
anti-inflammatory	O	O	B-T121
drugs	O	O	I-T121
in	O	O	O
the	O	O	O
metabolic	O	O	B-T091
profiling	O	O	I-T091
of	O	O	O
GPLs	O	O	B-T109
.	O	O	O

58	O	O	O
GPLs	O	O	B-T109
were	O	O	O
identified	O	O	B-T080
by	O	O	O
U-HPLC	O	O	B-T059
/	O	O	O
Q-TOF-MS	O	O	B-T059
,	O	O	O
and	O	O	O
19	O	O	O
components	O	O	O
were	O	O	O
firstly	O	O	O
identified	O	O	O
in	O	O	O
this	O	O	O
study	O	O	B-T062
compared	O	O	O
with	O	O	O
our	O	O	O
previous	O	O	O
results	O	O	O
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
ten	O	O	O
potential	O	O	B-T080
biomarkers	O	O	B-T201
were	O	O	O
proved	O	O	O
,	O	O	O
of	O	O	O
which	O	O	O
phosphatidylcholine	O	O	B-T109
(	O	O	O
PC	O	O	B-T109
)	O	O	O
(	O	O	O
16:0/18:1	O	O	O
)	O	O	O
and	O	O	O
(	O	O	O
18:0/18:1	O	O	O
)	O	O	O
changed	O	O	B-T081
consistently	O	O	O
in	O	O	O
three	O	O	O
drug-induced	O	O	B-T169
groups	O	O	B-T078
and	O	O	O
might	O	O	O
be	O	O	O
the	O	O	O
important	O	O	O
biomarkers	O	O	O
.	O	O	O

Compared	O	O	O
with	O	O	O
(1)H	O	O	B-T060
NMR	O	O	I-T060
,	O	O	O
U-HPLC	O	O	B-T059
/	O	O	O
Q-TOF-MS	O	O	B-T059
showed	O	O	O
higher	O	O	B-T080
sensitivity	O	O	B-T081
and	O	O	I-T081
specificity	O	O	I-T081
and	O	O	O
was	O	O	O
more	O	O	O
suitable	O	O	O
for	O	O	O
the	O	O	O
determination	O	O	B-T059
of	O	O	O
biomarkers	O	O	B-T201
apart	O	O	O
from	O	O	O
the	O	O	O
deficiency	O	O	B-T080
of	O	O	O
time-consuming	O	O	B-T080
sample	O	O	B-T059
preparation	O	O	I-T059
steps	O	O	I-T059
and	O	O	O
unambiguous	O	O	O
metabolite	O	O	B-T123
identification	O	O	B-T080
.	O	O	O

Therefore	O	O	O
,	O	O	O
it	O	O	O
is	O	O	O
feasible	O	O	O
to	O	O	O
analyze	O	O	O
the	O	O	O
changes	O	O	B-T081
of	O	O	O
GPLs	O	O	B-T109
during	O	O	O
inflammation	O	O	B-T046
by	O	O	O
combining	O	O	O
(1)H	O	O	B-T060
NMR	O	O	I-T060
spectroscopy	O	O	I-T060
with	O	O	O
U-HPLC	O	O	B-T059
/	O	O	O
Q-TOF-MS	O	O	B-T059
.	O	O	O

The	O	O	O
metabolic	O	O	B-T091
profiling	O	O	I-T091
of	O	O	O
GPLs	O	O	B-T109
provides	O	O	O
valuable	O	O	O
evidence	O	O	B-T078
for	O	O	O
inflammation	O	O	B-T046
diagnosis	O	O	B-T033
and	O	O	O
prognosis	O	O	B-T058
,	O	O	O
and	O	O	O
might	O	O	O
unravel	O	O	O
the	O	O	O
mechanisms	O	O	B-T169
involved	O	O	O
in	O	O	O
inflammation	O	O	O
progression	O	O	B-T046
.	O	O	O

-DOCSTART- (27372076)

Characterization	O	O	B-T052
of	O	O	O
novel	O	O	B-T080
DeoR-family	O	O	B-T116
member	O	O	B-T096
from	O	O	O
the	O	O	O
Streptomyces	O	O	B-T007
ahygroscopicus	O	O	I-T007
strain	O	O	B-T001
CK-15	O	O	I-T001
that	O	O	O
acts	O	O	O
as	O	O	O
a	O	O	O
repressor	O	O	B-T116
of	O	O	O
morphological	O	O	B-T082
development	O	O	O

Wuyiencin	O	O	B-T131
is	O	O	O
produced	O	O	B-T052
by	O	O	O
Streptomyces	O	O	O
ahygroscopicus	O	O	O
var	O	O	O
.	O	O	O

wuyiensis	O	O	O
,	O	O	O
which	O	O	O
has	O	O	O
been	O	O	O
widely	O	O	O
used	O	O	O
in	O	O	O
China	O	O	B-T083
as	O	O	O
an	O	O	O
industrially	O	O	B-T092
produced	O	O	B-T057
biopesticide	O	O	B-T131
to	O	O	O
control	O	O	B-T080
various	O	O	O
fungal	O	O	B-T047
diseases	O	O	I-T047
.	O	O	O

Although	O	O	O
its	O	O	O
mechanism	O	O	B-T169
of	O	O	O
action	O	O	B-T052
,	O	O	O
breeding	O	O	B-T040
,	O	O	O
and	O	O	O
fermentation	O	O	B-T044
had	O	O	O
been	O	O	O
extensively	O	O	O
characterized	O	O	B-T052
,	O	O	O
less	O	O	O
is	O	O	O
known	O	O	O
about	O	O	O
the	O	O	O
regulatory	O	O	B-T044
functions	O	O	I-T044
that	O	O	O
affect	O	O	O
its	O	O	O
biosynthesis	O	O	B-T169
or	O	O	O
morphological	O	O	B-T082
development	O	O	B-T169
.	O	O	O

The	O	O	O
wysR3	O	O	B-T028
gene	O	O	I-T028
of	O	O	O
S.	O	O	B-T007
ahygroscopicus	O	O	I-T007
strain	O	O	B-T001
CK-15	O	O	I-T001
,	O	O	O
a	O	O	O
novel	O	O	B-T080
member	O	O	B-T096
of	O	O	O
the	O	O	O
DeoR	O	O	B-T116
family	O	O	I-T116
of	O	O	O
regulatory	O	O	B-T028
genes	O	O	I-T028
,	O	O	O
was	O	O	O
assessed	O	O	B-T052
to	O	O	O
determine	O	O	O
its	O	O	O
function	O	O	B-T169
by	O	O	O
gene	O	O	B-T063
knockdown	O	O	I-T063
.	O	O	O

Herein	O	O	O
,	O	O	O
we	O	O	O
demonstrate	O	O	O
for	O	O	O
the	O	O	O
first	O	O	O
time	O	O	O
that	O	O	O
DeoR	O	O	B-T116
family	O	O	I-T116
proteins	O	O	I-T116
derived	O	O	O
from	O	O	O
the	O	O	O
same	O	O	O
source	O	O	B-T033
are	O	O	O
likely	O	O	O
to	O	O	O
be	O	O	O
a	O	O	O
single	O	O	B-T081
branch	O	O	B-T082
in	O	O	O
a	O	O	O
phylogenetic	O	O	B-T080
tree	O	O	I-T080
and	O	O	O
show	O	O	O
that	O	O	O
wysR3	O	O	B-T028
acts	O	O	O
as	O	O	O
a	O	O	O
repressor	O	O	B-T116
for	O	O	O
its	O	O	O
morphological	O	O	B-T082
development	O	O	B-T169
without	O	O	O
effecting	O	O	O
wuyiencin	O	O	B-T131
production	O	O	B-T052
.	O	O	O

We	O	O	O
found	O	O	O
that	O	O	O
the	O	O	O
ÎwysR3	O	O	B-T028
strain	O	O	B-T001
can	O	O	O
grow	O	O	O
quickly	O	O	O
to	O	O	O
reach	O	O	O
a	O	O	O
plateau	O	O	B-T081
stage	O	O	B-T079
of	O	O	O
maximum	O	O	O
biomass	O	O	B-T081
at	O	O	O
60	O	O	O
h	O	O	O
,	O	O	O
which	O	O	O
is	O	O	O
~12	O	O	O
h	O	O	O
faster	O	O	B-T080
than	O	O	O
the	O	O	O
wild-type	O	O	B-T028
strain	O	O	O
.	O	O	O

In	O	O	O
the	O	O	O
industrial	O	O	B-T092
fermentation	O	O	B-T044
production	O	O	B-T057
process	O	O	B-T067
,	O	O	O
the	O	O	O
ÎwysR3	O	O	B-T028
strain	O	O	B-T001
can	O	O	O
reduce	O	O	B-T080
consumption	O	O	B-T052
and	O	O	O
save	O	O	O
both	O	O	O
time	O	O	B-T079
and	O	O	O
money	O	O	B-T073
.	O	O	O

-DOCSTART- (27372861)

Targeting	O	O	B-T169
the	O	O	O
ecology	O	O	B-T090
within	O	O	O
:	O	O	O
The	O	O	O
role	O	O	B-T077
of	O	O	O
the	O	O	O
gut-brain	O	O	B-T082
axis	O	O	I-T082
and	O	O	O
human	O	O	B-T016
microbiota	O	O	B-T001
in	O	O	O
drug	O	O	O
addiction	O	O	O

Despite	O	O	O
major	O	O	B-T079
advances	O	O	I-T079
in	O	O	O
our	O	O	O
understanding	O	O	B-T041
of	O	O	O
the	O	O	O
brain	O	O	B-T023
using	O	O	B-T169
traditional	O	O	B-T091
neuroscience	O	O	I-T091
,	O	O	O
reliable	O	O	B-T170
and	O	O	O
efficacious	O	O	B-T080
treatments	O	O	B-T061
for	O	O	O
drug	O	O	B-T048
addiction	O	O	I-T048
have	O	O	O
remained	O	O	B-T033
elusive	O	O	I-T033
.	O	O	O

Hence	O	O	O
,	O	O	O
the	O	O	O
time	O	O	B-T079
has	O	O	O
come	O	O	O
to	O	O	O
utilize	O	O	B-T169
novel	O	O	B-T080
approaches	O	O	B-T082
,	O	O	O
particularly	O	O	O
those	O	O	O
drawing	O	O	B-T080
upon	O	O	O
contemporary	O	O	B-T079
advances	O	O	B-T079
in	O	O	O
fields	O	O	B-T077
outside	O	O	O
of	O	O	O
established	O	O	B-T080
neuroscienc	O	O	B-T091
e	O	O	O
and	O	O	O
psychiatry	O	O	B-T091
.	O	O	O

Put	O	O	O
another	O	O	O
way	O	O	O
,	O	O	O
the	O	O	O
time	O	O	B-T079
has	O	O	O
come	O	O	O
for	O	O	O
a	O	O	O
paradigm	O	O	B-T062
shift	O	O	I-T062
in	O	O	O
the	O	O	O
addiction	O	O	B-T048
sciences	O	O	B-T090
.	O	O	O

Apropos	O	O	B-T080
,	O	O	O
a	O	O	O
revolution	O	O	B-T169
in	O	O	O
the	O	O	O
area	O	O	B-T082
of	O	O	O
human	O	O	B-T016
health	O	O	B-T078
is	O	O	O
underway	O	O	B-T169
,	O	O	O
which	O	O	O
is	O	O	O
occurring	O	O	B-T052
at	O	O	O
the	O	O	O
nexus	O	O	B-T080
between	O	O	O
enteric	O	O	B-T082
microbiology	O	O	B-T091
and	O	O	O
neuroscience	O	O	B-T091
.	O	O	O

It	O	O	O
has	O	O	O
become	O	O	O
increasingly	O	O	B-T169
clear	O	O	B-T080
that	O	O	O
the	O	O	O
human	O	O	B-T016
microbiota	O	O	B-T001
(	O	O	O
the	O	O	O
vast	O	O	O
ecology	O	O	B-T090
of	O	O	O
bacteria	O	O	B-T007
residing	O	O	B-T052
within	O	O	O
the	O	O	O
human	O	O	O
organism	O	O	B-T001
)	O	O	O
,	O	O	O
plays	O	O	O
an	O	O	O
important	O	O	B-T080
role	O	O	B-T077
in	O	O	O
health	O	O	B-T078
and	O	O	O
disease	O	O	B-T047
.	O	O	O

This	O	O	O
is	O	O	O
not	O	O	O
surprising	O	O	O
,	O	O	O
as	O	O	O
it	O	O	O
has	O	O	O
been	O	O	O
estimated	O	O	B-T081
that	O	O	O
bacteria	O	O	B-T007
living	O	O	B-T052
in	O	O	O
the	O	O	O
human	O	O	B-T016
body	O	O	I-T016
(	O	O	O
approximately	O	O	B-T080
1	O	O	O
kg	O	O	O
of	O	O	O
mass	O	O	B-T081
,	O	O	O
roughly	O	O	O
equivalent	O	O	B-T080
to	O	O	O
that	O	O	O
of	O	O	O
the	O	O	O
human	O	O	O
brain	O	O	B-T023
)	O	O	O
outnumber	O	O	O
human	O	O	B-T034
cells	O	O	I-T034
10	O	O	O
to	O	O	O
1	O	O	O
.	O	O	O

While	O	O	O
advances	O	O	O
in	O	O	O
the	O	O	O
understanding	O	O	B-T041
of	O	O	O
the	O	O	O
role	O	O	B-T077
of	O	O	O
microbiota	O	O	B-T001
in	O	O	O
other	O	O	O
areas	O	O	B-T082
of	O	O	O
human	O	O	B-T016
health	O	O	B-T078
have	O	O	O
yielded	O	O	B-T081
intriguing	O	O	B-T080
results	O	O	B-T169
(	O	O	O
e.g.	O	O	O
,	O	O	O
Clostridium	O	O	B-T047
difficile	O	O	I-T047
,	O	O	O
irritable	O	O	B-T047
bowel	O	O	I-T047
syndrome	O	O	I-T047
,	O	O	O
autism	O	O	B-T048
,	O	O	O
etc	O	O	O
.	O	O	O
)	O	O	O
,	O	O	O
to	O	O	O
date	O	O	B-T079
,	O	O	O
no	O	O	O
systematic	O	O	B-T169
programs	O	O	B-T169
of	O	O	O
research	O	O	B-T062
have	O	O	O
examined	O	O	B-T033
the	O	O	O
role	O	O	O
of	O	O	O
microbiota	O	O	O
in	O	O	O
drug	O	O	B-T048
addiction	O	O	I-T048
.	O	O	O

The	O	O	O
current	O	O	B-T079
hypothesis	O	O	B-T078
,	O	O	O
therefore	O	O	O
,	O	O	O
is	O	O	O
that	O	O	O
gut	O	O	B-T184
dysbiosis	O	O	I-T184
plays	O	O	O
a	O	O	O
key	O	O	O
role	O	O	B-T077
in	O	O	O
addictive	O	O	B-T048
disorders	O	O	B-T047
.	O	O	O

In	O	O	O
the	O	O	O
context	O	O	B-T078
of	O	O	O
this	O	O	O
hypothesis	O	O	B-T078
,	O	O	O
this	O	O	O
paper	O	O	B-T170
provides	O	O	B-T052
a	O	O	O
rationale	O	O	B-T078
for	O	O	O
future	O	O	B-T079
research	O	O	B-T062
to	O	O	O
target	O	O	B-T169
the	O	O	O
"	O	O	O
gut	O	O	B-T023
-	O	O	O
brain	O	O	B-T023
axis	O	O	B-T082
"	O	O	O
in	O	O	O
addiction	O	O	B-T048
.	O	O	O

A	O	O	O
brief	O	O	O
background	O	O	B-T077
of	O	O	O
the	O	O	O
gut	O	O	B-T023
-	O	O	O
brain	O	O	B-T023
axis	O	O	B-T082
is	O	O	O
provided	O	O	B-T052
,	O	O	O
along	O	O	O
with	O	O	O
a	O	O	O
series	O	O	B-T081
of	O	O	O
hypothesis-driven	O	O	B-T078
ideas	O	O	B-T078
outlining	O	O	O
potential	O	O	B-T080
treatments	O	O	B-T061
for	O	O	O
addiction	O	O	B-T048
via	O	O	O
manipulations	O	O	B-T033
of	O	O	O
the	O	O	O
"	O	O	O
ecology	O	O	B-T090
within	O	O	O
.	O	O	O
"	O	O	O

-DOCSTART- (27373429)

Homogeneous	O	O	B-T080
synthesis	O	O	B-T052
of	O	O	O
Ag	O	O	B-T073
nanoparticles	O	O	I-T073
-doped	O	O	O
water-soluble	O	O	B-T109
cellulose	O	O	I-T109
acetate	O	O	I-T109
for	O	O	O
versatile	O	O	B-T080
applications	O	O	O

We	O	O	O
report	O	O	B-T170
a	O	O	O
facile	O	O	B-T080
and	O	O	O
efficient	O	O	B-T080
approach	O	O	B-T082
for	O	O	O
synthesis	O	O	B-T052
of	O	O	O
well-dispersed	O	O	B-T082
and	O	O	O
stable	O	O	B-T080
silver	O	O	B-T073
nanoparticles	O	O	I-T073
(	O	O	O
Ag	O	O	B-T073
NPs	O	O	I-T073
)	O	O	O
using	O	O	O
water-soluble	O	O	B-T109
cellulose	O	O	I-T109
acetate	O	O	I-T109
(	O	O	O
CA	O	O	B-T109
)	O	O	O
as	O	O	O
both	O	O	O
reductant	O	O	B-T130
and	O	O	O
stabilizer	O	O	B-T167
.	O	O	O

Partially	O	O	B-T081
substituted	O	O	O
CA	O	O	B-T109
with	O	O	O
highly	O	O	B-T080
active	O	O	B-T169
hydroxyl	O	O	B-T197
groups	O	O	I-T197
and	O	O	O
excellent	O	O	B-T080
water-solubility	O	O	B-T081
is	O	O	O
able	O	O	B-T033
to	O	O	O
reduce	O	O	B-T070
silver	O	O	B-T196
ions	O	O	I-T196
in	O	O	O
homogeneous	O	O	B-T080
aqueous	O	O	B-T080
medium	O	O	B-T167
effectively	O	O	B-T080
.	O	O	O

The	O	O	O
synthesized	O	O	B-T052
Ag	O	O	B-T073
NPs	O	O	I-T073
were	O	O	O
characterized	O	O	B-T052
by	O	O	O
UV-vis	O	O	B-T059
spectroscopy	O	O	I-T059
,	O	O	O
X-ray	O	O	B-T059
diffraction	O	O	I-T059
,	O	O	O
X-ray	O	O	B-T059
photoelectron	O	O	I-T059
spectroscopy	O	O	I-T059
,	O	O	O
transmission	O	O	B-T059
electron	O	O	I-T059
microscopy	O	O	I-T059
and	O	O	O
energy	O	O	B-T059
dispersive	O	O	I-T059
X-ray	O	O	I-T059
spectroscope	O	O	I-T059
analysis	O	O	B-T059
.	O	O	O

The	O	O	O
as-	O	O	O
prepared	O	O	B-T033
Ag	O	O	B-T073
NPs	O	O	I-T073
were	O	O	O
well-dispersed	O	O	B-T082
,	O	O	O
showing	O	O	O
a	O	O	O
surface	O	O	B-T063
plasmon	O	O	I-T063
resonance	O	O	I-T063
peak	O	O	B-T080
at	O	O	O
426	O	O	O
nm	O	O	B-T081
.	O	O	O

The	O	O	O
resulted	O	O	O
Ag	O	O	B-T073
NPs	O	O	I-T073
@	O	O	O
CA	O	O	B-T109
nanohybrids	O	O	B-T073
exhibit	O	O	O
high	O	O	B-T080
catalytic	O	O	B-T169
activity	O	O	I-T169
for	O	O	O
the	O	O	O
reduction	O	O	B-T070
of	O	O	O
4-nitrophenol	O	O	B-T109
to	O	O	O
4-aminophenol	O	O	B-T109
in	O	O	O
the	O	O	O
presence	O	O	O
of	O	O	O
NaBH4	O	O	B-T130
.	O	O	O

Meanwhile	O	O	O
,	O	O	O
the	O	O	O
nanohybrids	O	O	B-T073
are	O	O	O
also	O	O	O
effective	O	O	B-T080
in	O	O	O
inhibiting	O	O	B-T052
the	O	O	O
growth	O	O	B-T040
of	O	O	O
bacterial	O	O	B-T007
.	O	O	O

This	O	O	O
environmentally	O	O	B-T057
friendly	O	O	I-T057
method	O	O	I-T057
promotes	O	O	B-T052
the	O	O	O
use	O	O	B-T169
of	O	O	I-T169
renewable	O	O	B-T078
natural	O	O	I-T078
resources	O	O	I-T078
to	O	O	O
prepare	O	O	B-T052
a	O	O	O
variety	O	O	B-T077
of	O	O	O
inorganic-organic	O	O	B-T167
materials	O	O	I-T167
for	O	O	O
catalysis	O	O	B-T070
,	O	O	O
antibacterial	O	O	B-T195
,	O	O	O
sensors	O	O	B-T073
and	O	O	O
other	O	O	O
applications	O	O	B-T169
.	O	O	O

-DOCSTART- (27373772)

ISX-9	O	O	B-T109
can	O	O	O
potentiate	O	O	O
cell	O	O	B-T043
proliferation	O	O	I-T043
and	O	O	O
neuronal	O	O	B-T025
commitment	O	O	B-T043
in	O	O	O
the	O	O	O
rat	O	O	B-T015
dentate	O	O	O
gyrus	O	O	O

Adult	O	O	B-T100
hippocampal	O	O	B-T023
neurogenesis	O	O	B-T040
can	O	O	O
be	O	O	O
modulated	O	O	B-T082
by	O	O	O
various	O	O	O
physiological	O	O	B-T039
and	O	O	O
pathological	O	O	B-T046
conditions	O	O	B-T080
,	O	O	O
including	O	O	O
stress	O	O	B-T033
,	O	O	O
affective	O	O	B-T048
disorders	O	O	I-T048
,	O	O	O
and	O	O	O
several	O	O	O
neurological	O	O	B-T080
conditions	O	O	O
.	O	O	O

Given	O	O	O
the	O	O	O
proposed	O	O	O
role	O	O	O
of	O	O	O
this	O	O	O
form	O	O	O
of	O	O	O
structural	O	O	B-T042
plasticity	O	O	I-T042
in	O	O	O
the	O	O	O
functioning	O	O	B-T039
of	O	O	O
the	O	O	O
hippocampus	O	O	B-T023
(	O	O	O
namely	O	O	O
learning	O	O	B-T041
and	O	O	O
memory	O	O	B-T041
and	O	O	O
affective	O	O	B-T078
behaviors	O	O	B-T053
)	O	O	O
,	O	O	O
it	O	O	O
is	O	O	O
believed	O	O	O
that	O	O	O
alterations	O	O	B-T078
in	O	O	O
hippocampal	O	O	B-T023
neurogenesis	O	O	B-T040
might	O	O	O
underlie	O	O	O
some	O	O	O
of	O	O	O
the	O	O	O
behavioral	O	O	B-T053
deficits	O	O	B-T080
associated	O	O	B-T080
with	O	O	I-T080
these	O	O	O
psychiatric	O	O	B-T169
and	O	O	O
neurological	O	O	B-T080
conditions	O	O	B-T080
.	O	O	O

Thus	O	O	O
,	O	O	O
the	O	O	O
search	O	O	B-T052
for	O	O	O
compounds	O	O	B-T121
that	O	O	O
can	O	O	O
reverse	O	O	B-T169
these	O	O	O
deficits	O	O	B-T080
with	O	O	O
minimal	O	O	B-T080
side	O	O	B-T046
effects	O	O	I-T046
has	O	O	O
become	O	O	O
a	O	O	O
recognized	O	O	O
priority	O	O	O
.	O	O	O

In	O	O	O
the	O	O	O
present	O	O	O
study	O	O	B-T062
we	O	O	O
tested	O	O	B-T169
the	O	O	O
pro-neurogenic	O	O	B-T080
effects	O	O	B-T080
of	O	O	O
isoxazole	O	O	B-T109
9	O	O	I-T109
(	O	O	O
Isx-9	O	O	B-T109
)	O	O	O
,	O	O	O
a	O	O	O
small	O	O	O
synthetic	O	O	B-T052
molecule	O	O	B-T167
that	O	O	O
has	O	O	O
been	O	O	O
recently	O	O	O
identified	O	O	B-T080
through	O	O	O
the	O	O	O
screening	O	O	B-T059
of	O	O	I-T059
chemical	O	O	I-T059
libraries	O	O	I-T059
in	O	O	O
stem	O	O	B-T059
cell-based	O	O	I-T059
assays	O	O	I-T059
.	O	O	O

We	O	O	O
found	O	O	O
that	O	O	O
administration	O	O	B-T061
of	O	O	O
Isx-9	O	O	B-T109
for	O	O	O
14days	O	O	O
was	O	O	O
able	O	O	O
to	O	O	O
potentiate	O	O	O
cell	O	O	B-T043
proliferation	O	O	I-T043
and	O	O	O
increase	O	O	B-T169
the	O	O	O
number	O	O	B-T081
of	O	O	O
immature	O	O	B-T080
neurons	O	O	B-T025
in	O	O	O
the	O	O	O
hippocampal	O	O	B-T023
DG	O	O	B-T023
of	O	O	O
adult	O	O	B-T100
rats	O	O	B-T015
.	O	O	O

In	O	O	B-T169
addition	O	O	I-T169
,	O	O	O
Isx-9	O	O	B-T109
treatment	O	O	B-T061
was	O	O	O
able	O	O	O
to	O	O	O
completely	O	O	B-T080
reverse	O	O	B-T169
the	O	O	O
marked	O	O	B-T080
reduction	O	O	B-T080
in	O	O	O
these	O	O	O
initial	O	O	B-T079
stages	O	O	B-T079
of	O	O	O
the	O	O	O
neurogenic	O	O	B-T042
process	O	O	I-T042
observed	O	O	B-T169
in	O	O	O
vehicle	O	O	B-T122
-	O	O	O
treated	O	O	B-T169
animals	O	O	B-T008
(	O	O	O
which	O	O	O
were	O	O	O
submitted	O	O	O
to	O	O	O
repeated	O	O	B-T169
handling	O	O	B-T059
and	O	O	O
exposure	O	O	B-T080
to	O	O	I-T080
daily	O	O	B-T079
intraperitoneal	O	O	B-T061
injections	O	O	I-T061
)	O	O	O
.	O	O	O

Based	O	O	O
on	O	O	O
these	O	O	O
results	O	O	B-T034
,	O	O	O
we	O	O	O
recommend	O	O	O
that	O	O	O
future	O	O	O
neurogenesis	O	O	B-T040
studies	O	O	B-T062
that	O	O	O
require	O	O	O
repeated	O	O	B-T169
handling	O	O	B-T059
and	O	O	O
manipulation	O	O	B-T061
of	O	O	O
animals	O	O	B-T008
should	O	O	O
include	O	O	O
a	O	O	O
naÃ¯ve	O	O	O
(	O	O	O
non-manipulated	O	O	O
)	O	O	O
control	O	O	B-T080
to	O	O	O
determine	O	O	O
the	O	O	O
baseline	O	O	B-T081
levels	O	O	B-T080
of	O	O	O
hippocampal	O	O	B-T023
cell	O	O	B-T043
proliferation	O	O	I-T043
and	O	O	O
neuronal	O	O	B-T025
differentiation	O	O	B-T043
.	O	O	O

Overall	O	O	O
,	O	O	O
these	O	O	O
findings	O	O	B-T033
demonstrate	O	O	O
that	O	O	O
Isx-9	O	O	B-T109
is	O	O	O
a	O	O	O
promising	O	O	O
synthetic	O	O	B-T052
compound	O	O	B-T121
for	O	O	O
the	O	O	O
mitigation	O	O	B-T067
of	O	O	O
stress	O	O	B-T033
-	O	O	O
induced	O	O	B-T169
deficits	O	O	B-T080
in	O	O	O
adult	O	O	B-T100
hippocampal	O	O	B-T023
neurogenesis	O	O	B-T040
.	O	O	O

Future	O	O	O
studies	O	O	B-T062
are	O	O	O
thus	O	O	O
warranted	O	O	O
to	O	O	O
evaluate	O	O	B-T058
the	O	O	O
pro-neurogenic	O	O	B-T080
properties	O	O	B-T080
of	O	O	O
Isx-9	O	O	B-T109
in	O	O	O
animal	O	O	B-T008
models	O	O	I-T008
of	O	O	O
affective	O	O	B-T048
and	O	O	O
neurological	O	O	B-T047
disorders	O	O	I-T047
associated	O	O	B-T080
with	O	O	I-T080
impaired	O	O	B-T169
hippocampal	O	O	B-T023
structural	O	O	B-T042
plasticity	O	O	I-T042
.	O	O	O

-DOCSTART- (27375774)

Changes	O	O	B-T169
in	O	O	O
parenting	O	O	B-T054
strategies	O	O	B-T041
after	O	O	O
a	O	O	O
young	O	O	B-T079
person	O	O	B-T098
's	O	O	I-T098
self-harm	O	O	B-T037
:	O	O	O
a	O	O	O
qualitative	O	O	O
study	O	O	O

When	O	O	O
faced	O	O	O
with	O	O	O
the	O	O	O
discovery	O	O	B-T052
of	O	O	O
their	O	O	O
child	O	O	B-T100
's	O	O	I-T100
self-harm	O	O	B-T037
,	O	O	O
mothers	O	O	B-T099
and	O	O	O
fathers	O	O	B-T099
may	O	O	O
re-evaluate	O	O	B-T058
their	O	O	O
parenting	O	O	B-T054
strategies	O	O	B-T041
.	O	O	O

This	O	O	O
can	O	O	O
include	O	O	O
changes	O	O	B-T169
to	O	O	O
the	O	O	O
amount	O	O	O
of	O	O	O
support	O	O	B-T054
they	O	O	O
provide	O	O	O
their	O	O	O
child	O	O	B-T100
and	O	O	O
changes	O	O	O
to	O	O	O
the	O	O	O
degree	O	O	B-T081
to	O	O	O
which	O	O	O
they	O	O	O
control	O	O	B-T080
and	O	O	O
monitor	O	O	B-T052
their	O	O	O
child	O	O	O
.	O	O	O

We	O	O	O
conducted	O	O	O
an	O	O	O
in-depth	O	O	B-T062
qualitative	O	O	I-T062
study	O	O	I-T062
with	O	O	O
37	O	O	O
parents	O	O	B-T099
of	O	O	O
young	O	O	B-T079
people	O	O	B-T098
who	O	O	O
had	O	O	O
self-harmed	O	O	B-T037
in	O	O	O
which	O	O	O
we	O	O	O
explored	O	O	O
how	O	O	O
and	O	O	O
why	O	O	O
their	O	O	O
parenting	O	O	B-T054
changed	O	O	B-T169
after	O	O	O
the	O	O	O
discovery	O	O	B-T052
of	O	O	O
self-harm	O	O	B-T037
.	O	O	O

Early	O	O	B-T079
on	O	O	O
,	O	O	O
parents	O	O	B-T099
often	O	O	O
found	O	O	O
themselves	O	O	O
"	O	O	O
walking	O	O	O
on	O	O	O
eggshells	O	O	O
"	O	O	O
so	O	O	O
as	O	O	O
not	O	O	O
to	O	O	O
upset	O	O	B-T041
their	O	O	O
child	O	O	B-T100
,	O	O	O
but	O	O	O
later	O	O	O
they	O	O	O
felt	O	O	O
more	O	O	O
able	O	O	O
to	O	O	O
take	O	O	O
some	O	O	O
control	O	O	B-T080
.	O	O	O

Parents	O	O	B-T099
'	O	O	O
reactions	O	O	B-T169
to	O	O	O
the	O	O	O
self-harm	O	O	B-T037
often	O	O	O
depended	O	O	O
on	O	O	O
how	O	O	O
they	O	O	O
conceptualised	O	O	O
it	O	O	O
:	O	O	O
as	O	O	O
part	O	O	O
of	O	O	O
adolescence	O	O	B-T079
,	O	O	O
as	O	O	O
a	O	O	O
mental	O	O	B-T048
health	O	O	I-T048
issue	O	O	I-T048
or	O	O	O
as	O	O	O
"	O	O	O
naughty	O	O	B-T053
behaviour	O	O	I-T053
"	O	O	O
.	O	O	O

Parenting	O	O	B-T054
of	O	O	O
other	O	O	O
children	O	O	B-T100
in	O	O	O
the	O	O	O
family	O	O	B-T099
could	O	O	O
also	O	O	O
be	O	O	O
affected	O	O	O
,	O	O	O
with	O	O	O
parents	O	O	B-T099
worrying	O	O	O
about	O	O	O
less	O	O	O
of	O	O	O
their	O	O	O
time	O	O	B-T079
being	O	O	O
available	O	O	O
for	O	O	O
siblings	O	O	B-T099
.	O	O	O

Many	O	O	O
parents	O	O	B-T099
developed	O	O	O
specific	O	O	O
strategies	O	O	B-T041
they	O	O	O
felt	O	O	O
helped	O	O	O
them	O	O	O
to	O	O	O
be	O	O	O
more	O	O	O
effective	O	O	O
parents	O	O	O
,	O	O	O
such	O	O	O
as	O	O	O
learning	O	O	B-T041
to	O	O	O
avoid	O	O	O
blaming	O	O	B-T041
themselves	O	O	O
or	O	O	O
their	O	O	O
child	O	O	B-T100
for	O	O	O
the	O	O	O
self-harm	O	O	B-T037
and	O	O	O
developing	O	O	O
new	O	O	O
ways	O	O	O
to	O	O	O
communicate	O	O	B-T033
with	O	O	O
their	O	O	O
child	O	O	O
.	O	O	O

Parents	O	O	B-T099
were	O	O	O
generally	O	O	O
eager	O	O	O
to	O	O	O
pass	O	O	O
their	O	O	O
knowledge	O	O	B-T170
on	O	O	O
to	O	O	O
other	O	O	O
people	O	O	B-T098
in	O	O	O
the	O	O	O
same	O	O	O
situation	O	O	B-T169
.	O	O	O

Parents	O	O	B-T099
reported	O	O	O
changes	O	O	B-T169
in	O	O	O
their	O	O	O
parenting	O	O	B-T054
behaviours	O	O	B-T053
after	O	O	O
the	O	O	O
discovery	O	O	B-T052
of	O	O	O
a	O	O	O
child	O	O	B-T100
's	O	O	O
self-harm	O	O	B-T037
.	O	O	O

Professionals	O	O	B-T097
involved	O	O	O
in	O	O	O
the	O	O	O
care	O	O	B-T052
of	O	O	O
young	O	O	B-T079
people	O	O	B-T098
who	O	O	O
self-harm	O	O	B-T037
might	O	O	O
use	O	O	O
this	O	O	O
information	O	O	B-T078
in	O	O	O
supporting	O	O	B-T077
and	O	O	O
advising	O	O	B-T052
parents	O	O	B-T099
.	O	O	O

-DOCSTART- (27378175)

Optimizing	O	O	B-T052
Survival	O	O	B-T169
of	O	O	O
Patients	O	O	B-T101
With	O	O	B-T169
Marginally	O	O	B-T080
Operable	O	O	I-T080
Stage	O	O	B-T191
IIIA	O	O	I-T191
Non-Small-Cell	O	O	I-T191
Lung	O	O	I-T191
Cancer	O	O	I-T191
Receiving	O	O	O
Chemoradiotherapy	O	O	B-T061
With	O	O	O
or	O	O	O
Without	O	O	B-T080
Surgery	O	O	O

For	O	O	O
marginally	O	O	B-T080
operable	O	O	I-T080
stage	O	O	B-T191
IIIA	O	O	I-T191
non-small-cell	O	O	I-T191
lung	O	O	I-T191
cancer	O	O	I-T191
(	O	O	O
NSCLC	O	O	B-T191
)	O	O	O
,	O	O	O
surgery	O	O	B-T169
might	O	O	O
not	O	O	O
be	O	O	O
done	O	O	O
as	O	O	O
planned	O	O	O
after	O	O	O
neoadjuvant	O	O	B-T061
concurrent	O	O	B-T061
chemoradiotherapy	O	O	I-T061
(	O	O	O
CCRT	O	O	B-T061
)	O	O	O
for	O	O	O
reasons	O	O	O
(	O	O	O
unresectable	O	O	B-T201
or	O	O	O
medically	O	O	B-T080
inoperable	O	O	I-T080
conditions	O	O	B-T080
,	O	O	O
or	O	O	O
patient	O	O	B-T055
refusal	O	O	I-T055
)	O	O	O
.	O	O	O

This	O	O	O
study	O	O	B-T062
aims	O	O	O
to	O	O	O
investigate	O	O	B-T169
the	O	O	O
outcomes	O	O	B-T169
of	O	O	O
a	O	O	O
phased	O	O	B-T061
CCRT	O	O	I-T061
protocol	O	O	I-T061
established	O	O	O
to	O	O	O
maximize	O	O	O
the	O	O	O
operability	O	O	B-T169
of	O	O	O
marginally	O	O	B-T080
operable	O	O	I-T080
stage	O	O	B-T191
IIIA	O	O	I-T191
NSCLC	O	O	I-T191
and	O	O	O
to	O	O	O
care	O	O	O
for	O	O	O
reassessed	O	O	B-T052
inoperable	O	O	B-T101
patients	O	O	I-T101
,	O	O	O
in	O	O	O
comparison	O	O	O
with	O	O	O
continuous-course	O	O	B-T061
definitive	O	O	I-T061
CCRT	O	O	I-T061
.	O	O	O

Forty-seven	O	O	O
patients	O	O	B-T101
with	O	O	O
marginally	O	O	B-T080
operable	O	O	I-T080
stage	O	O	B-T191
IIIA	O	O	I-T191
NSCLC	O	O	I-T191
receiving	O	O	O
CCRT	O	O	B-T061
were	O	O	O
included	O	O	O
.	O	O	O

Twenty-eight	O	O	O
patients	O	O	B-T101
were	O	O	O
treated	O	O	B-T169
with	O	O	O
our	O	O	O
phased	O	O	B-T061
CCRT	O	O	B-T061
protocol	O	O	I-T061
,	O	O	O
including	O	O	O
neoadjuvant	O	O	B-T061
CCRT	O	O	O
followed	O	O	O
by	O	O	O
surgery	O	O	B-T169
(	O	O	O
group	O	O	B-T078
A	O	O	I-T078
,	O	O	O
n	O	O	O
=	O	O	O
16	O	O	O
)	O	O	O
or	O	O	O
,	O	O	O
for	O	O	O
reassessed	O	O	B-T052
inoperable	O	O	B-T101
patients	O	O	I-T101
,	O	O	O
maintenance	O	O	B-T033
chemotherapy	O	O	I-T033
and	O	O	O
split-course	O	O	B-T061
CCRT	O	O	I-T061
boost	O	O	B-T169
(	O	O	O
group	O	O	B-T078
B	O	O	I-T078
,	O	O	O
n	O	O	O
=	O	O	O
12	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
other	O	O	O
19	O	O	O
were	O	O	O
treated	O	O	B-T169
with	O	O	O
continuous-course	O	O	B-T061
definitive	O	O	I-T061
CCRT	O	O	I-T061
(	O	O	O
group	O	O	B-T078
C	O	O	I-T078
)	O	O	O
.	O	O	O

Overall	O	O	B-T081
survival	O	O	I-T081
(	O	O	O
OS	O	O	B-T081
)	O	O	O
and	O	O	O
progression-free	O	O	B-T081
survival	O	O	I-T081
(	O	O	O
PFS	O	O	B-T081
)	O	O	O
were	O	O	O
analyzed	O	O	B-T062
.	O	O	O

Among	O	O	O
all	O	O	O
,	O	O	O
median	O	O	B-T081
OS	O	O	B-T081
and	O	O	O
PFS	O	O	B-T081
were	O	O	O
35.6	O	O	O
and	O	O	O
12.8	O	O	O
months	O	O	B-T079
,	O	O	O
respectively	O	O	O
(	O	O	O
median	O	O	O
follow-up	O	O	B-T058
,	O	O	O
22.3	O	O	O
months	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
median	O	O	B-T081
OS	O	O	B-T081
of	O	O	O
group	O	O	B-T078
A	O	O	I-T078
(	O	O	O
not	O	O	O
reached	O	O	O
)	O	O	O
was	O	O	O
better	O	O	O
than	O	O	O
that	O	O	O
of	O	O	O
group	O	O	B-T078
B	O	O	I-T078
(	O	O	O
34.4	O	O	O
months	O	O	B-T079
)	O	O	O
and	O	O	O
group	O	O	B-T078
C	O	O	I-T078
(	O	O	O
15.2	O	O	O
months	O	O	O
)	O	O	O
(	O	O	O
P	O	O	O
=	O	O	O
.009	O	O	O
)	O	O	O
.	O	O	O

On	O	O	O
multivariate	O	O	B-T081
analysis	O	O	I-T081
,	O	O	O
performance	O	O	B-T201
status	O	O	I-T201
0	O	O	O
to	O	O	O
1	O	O	O
(	O	O	O
hazard	O	O	B-T081
ratio	O	O	I-T081
[	O	O	O
HR	O	O	B-T081
]	O	O	O
,	O	O	O
0.026	O	O	O
;	O	O	O
P	O	O	O
<	O	O	O
.001	O	O	O
)	O	O	O
,	O	O	O
adenocarcinoma	O	O	B-T191
(	O	O	O
HR	O	O	O
,	O	O	O
0.156	O	O	O
;	O	O	O
P	O	O	O
=	O	O	O
.003	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
group	O	O	B-T078
A	O	O	I-T078
(	O	O	O
HR	O	O	O
,	O	O	O
0.199	O	O	O
;	O	O	O
P	O	O	O
=	O	O	O
.033	O	O	O
)	O	O	O
were	O	O	O
independent	O	O	B-T201
prognostic	O	O	I-T201
factors	O	O	I-T201
.	O	O	O

The	O	O	O
OS	O	O	B-T081
of	O	O	O
group	O	O	B-T078
B	O	O	I-T078
(	O	O	O
HR	O	O	B-T081
,	O	O	O
0.450	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
confidence	O	O	B-T081
interval	O	O	I-T081
,	O	O	O
0.118	O	O	O
-	O	O	O
1.717	O	O	O
;	O	O	O
P	O	O	O
=	O	O	O
.243	O	O	O
)	O	O	O
was	O	O	O
not	O	O	O
statistically	O	O	B-T080
different	O	O	I-T080
from	O	O	O
that	O	O	O
of	O	O	O
group	O	O	O
C.	O	O	O
For	O	O	O
marginally	O	O	B-T080
operable	O	O	I-T080
stage	O	O	B-T191
IIIA	O	O	I-T191
NSCLC	O	O	I-T191
,	O	O	O
our	O	O	O
phased	O	O	B-T061
CCRT	O	O	I-T061
strategy	O	O	I-T061
may	O	O	O
optimize	O	O	B-T052
survival	O	O	B-T169
by	O	O	O
maximizing	O	O	O
operability	O	O	B-T169
and	O	O	O
maintain	O	O	O
an	O	O	O
acceptable	O	O	O
survival	O	O	O
for	O	O	O
reassessed	O	O	B-T052
inoperable	O	O	B-T101
patients	O	O	I-T101
by	O	O	O
split-course	O	O	B-T061
CCRT	O	O	I-T061
boost	O	O	B-T169
following	O	O	O
maintenance	O	O	B-T033
chemotherapy	O	O	I-T033
.	O	O	O

-DOCSTART- (27379139)

Evaluation	O	O	O
of	O	O	O
Three	O	O	B-T081
Protein-Extraction	O	O	B-T059
Methods	O	O	I-T059
for	O	O	O
Proteome	O	O	B-T116
Analysis	O	O	B-T059
of	O	O	O
Maize	O	O	B-T002
Leaf	O	O	B-T002
Midrib	O	O	B-T185
,	O	O	O
a	O	O	O
Compound	O	O	B-T025
Tissue	O	O	I-T025
Rich	O	O	O
in	O	O	O
Sclerenchyma	O	O	O
Cells	O	O	O

Leaf	O	O	B-T002
morphology	O	O	B-T080
is	O	O	O
closely	O	O	O
related	O	O	O
to	O	O	O
the	O	O	O
growth	O	O	B-T040
and	O	O	I-T040
development	O	O	I-T040
of	O	O	O
maize	O	O	B-T002
(	O	O	I-T002
Zea	O	O	I-T002
mays	O	O	I-T002
L.	O	O	I-T002
)	O	O	I-T002
plants	O	O	I-T002
and	O	O	O
final	O	O	O
kernel	O	O	B-T168
production	O	O	O
.	O	O	O

As	O	O	O
an	O	O	O
important	O	O	O
part	O	O	O
of	O	O	O
the	O	O	O
maize	O	O	B-T002
leaf	O	O	B-T002
,	O	O	O
the	O	O	O
midrib	O	O	B-T185
holds	O	O	O
leaf	O	O	O
blades	O	O	O
in	O	O	O
the	O	O	O
aerial	O	O	B-T002
position	O	O	I-T002
for	O	O	O
maximum	O	O	O
sunlight	O	O	B-T070
capture	O	O	O
.	O	O	O

Leaf	O	O	B-T002
midrib	O	O	B-T185
s	O	O	O
of	O	O	O
adult	O	O	B-T079
plants	O	O	B-T002
contain	O	O	O
substantial	O	O	O
sclerenchyma	O	O	B-T025
cells	O	O	I-T025
with	O	O	O
heavily	O	O	B-T080
thickened	O	O	I-T080
and	O	O	O
lignified	O	O	B-T109
secondary	O	O	B-T026
walls	O	O	I-T026
and	O	O	O
have	O	O	O
a	O	O	O
high	O	O	O
amount	O	O	O
of	O	O	O
phenolics	O	O	B-T109
,	O	O	O
making	O	O	O
protein	O	O	B-T059
extraction	O	O	I-T059
and	O	O	O
proteome	O	O	B-T116
analysis	O	O	B-T059
difficult	O	O	O
in	O	O	O
leaf	O	O	B-T002
midrib	O	O	O
tissue	O	O	O
.	O	O	O

In	O	O	O
the	O	O	O
present	O	O	O
study	O	O	O
,	O	O	O
three	O	O	O
protein-extraction	O	O	B-T059
methods	O	O	I-T059
that	O	O	O
are	O	O	O
commonly	O	O	O
used	O	O	O
in	O	O	O
plant	O	O	B-T002
proteomics	O	O	B-T091
,	O	O	O
i.e.	O	O	O
,	O	O	O
phenol	O	O	B-T109
extraction	O	O	B-T059
,	O	O	O
TCA	O	O	B-T109
/	O	O	O
acetone	O	O	B-T109
extraction	O	O	O
,	O	O	O
and	O	O	O
TCA	O	O	O
/	O	O	O
acetone	O	O	O
/	O	O	O
phenol	O	O	O
extraction	O	O	O
,	O	O	O
were	O	O	O
qualitatively	O	O	B-T080
and	O	O	O
quantitatively	O	O	B-T081
evaluated	O	O	I-T081
based	O	O	O
on	O	O	O
2DE	O	O	O
maps	O	O	O
and	O	O	O
MS/MS	O	O	B-T059
analysis	O	O	I-T059
using	O	O	O
the	O	O	O
midribs	O	O	B-T185
of	O	O	O
the	O	O	O
10th	O	O	O
newly	O	O	O
expanded	O	O	O
leaves	O	O	B-T002
of	O	O	O
maize	O	O	B-T002
plants	O	O	I-T002
.	O	O	O

Microscopy	O	O	B-T059
revealed	O	O	O
the	O	O	O
existence	O	O	O
of	O	O	O
substantial	O	O	O
amounts	O	O	O
of	O	O	O
sclerenchyma	O	O	B-T025
underneath	O	O	O
maize	O	O	B-T002
midrib	O	O	B-T185
epidermises	O	O	B-T002
(	O	O	O
particularly	O	O	O
abaxial	O	O	B-T082
epidermises	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
spot-number	O	O	O
order	O	O	O
obtained	O	O	O
via	O	O	O
2DE	O	O	B-T059
mapping	O	O	I-T059
was	O	O	O
as	O	O	O
follows	O	O	O
:	O	O	O
phenol	O	O	B-T109
extraction	O	O	B-T059
(	O	O	O
655	O	O	O
)	O	O	O
>	O	O	O
TCA	O	O	B-T109
/	O	O	O
acetone	O	O	B-T109
extraction	O	O	O
(	O	O	O
589	O	O	O
)	O	O	O
>	O	O	O
TCA	O	O	O
/	O	O	O
acetone	O	O	O
/	O	O	O
phenol	O	O	O
extraction	O	O	O
(	O	O	O
545	O	O	O
)	O	O	O
.	O	O	O

MS/MS	O	O	B-T059
analysis	O	O	I-T059
identified	O	O	O
a	O	O	O
total	O	O	O
of	O	O	O
17	O	O	O
spots	O	O	B-T077
that	O	O	O
exhibited	O	O	O
2-fold	O	O	O
changes	O	O	O
in	O	O	O
abundance	O	O	O
among	O	O	O
the	O	O	O
three	O	O	B-T081
methods	O	O	O
(	O	O	O
using	O	O	O
phenol	O	O	B-T109
extraction	O	O	B-T059
as	O	O	O
a	O	O	O
control	O	O	B-T096
)	O	O	O
.	O	O	O

Sixteen	O	O	O
of	O	O	O
the	O	O	O
proteins	O	O	B-T116
identified	O	O	O
were	O	O	O
hydrophilic	O	O	B-T080
,	O	O	O
with	O	O	O
GRAVY	O	O	B-T081
values	O	O	I-T081
ranging	O	O	O
from	O	O	O
-0.026	O	O	O
to	O	O	O
-0.487	O	O	O
.	O	O	O

For	O	O	O
all	O	O	O
three	O	O	B-T081
methods	O	O	O
,	O	O	O
we	O	O	O
were	O	O	O
able	O	O	O
to	O	O	O
obtain	O	O	O
high-quality	O	O	O
protein	O	O	B-T116
samples	O	O	O
and	O	O	O
good	O	O	O
2DE	O	O	B-T059
maps	O	O	I-T059
for	O	O	O
the	O	O	O
maize	O	O	B-T002
leaf	O	O	B-T002
midrib	O	O	B-T185
.	O	O	O

However	O	O	O
,	O	O	O
phenol	O	O	B-T109
extraction	O	O	B-T059
produced	O	O	O
a	O	O	O
better	O	O	O
2DE	O	O	B-T059
map	O	O	I-T059
with	O	O	O
greater	O	O	O
resolution	O	O	B-T077
between	O	O	O
spots	O	O	B-T077
,	O	O	O
and	O	O	O
TCA	O	O	B-T109
/	O	O	O
acetone	O	O	B-T109
extraction	O	O	O
produced	O	O	O
higher	O	O	O
protein	O	O	B-T116
yields	O	O	B-T081
.	O	O	O

Thus	O	O	O
,	O	O	O
this	O	O	O
paper	O	O	O
includes	O	O	O
a	O	O	O
discussion	O	O	O
regarding	O	O	O
the	O	O	O
possible	O	O	O
reasons	O	O	O
for	O	O	O
differential	O	O	B-T080
protein	O	O	B-T059
extraction	O	O	I-T059
among	O	O	O
the	O	O	O
three	O	O	B-T081
methods	O	O	O
.	O	O	O

This	O	O	O
study	O	O	O
provides	O	O	O
useful	O	O	O
information	O	O	O
that	O	O	O
can	O	O	O
be	O	O	O
used	O	O	O
to	O	O	O
select	O	O	O
suitable	O	O	O
protein	O	O	B-T059
extraction	O	O	I-T059
methods	O	O	O
for	O	O	O
the	O	O	O
proteome	O	O	B-T116
analysis	O	O	B-T059
of	O	O	O
recalcitrant	O	O	O
plant	O	O	B-T025
tissues	O	O	I-T025
that	O	O	O
are	O	O	O
rich	O	O	O
in	O	O	O
sclerenchyma	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

-DOCSTART- (27383174)

Dominant	O	O	B-T033
and	O	O	O
Non-	O	O	O
Dominant	O	O	O
Frequency	O	O	B-T079
Structure	O	O	O
of	O	O	O
Evoked	O	O	B-T080
Ventricular	O	O	B-T047
Fibrillation	O	O	I-T047
in	O	O	O
Dogs	O	O	B-T015
with	O	O	O
Myocardial	O	O	O
Ischemia	O	O	O

The	O	O	O
first	O	O	O
10	O	O	O
min	O	O	O
of	O	O	O
electrically	O	O	B-T061
provoked	O	O	I-T061
ventricular	O	O	B-T047
fibrillation	O	O	I-T047
in	O	O	O
dogs	O	O	B-T015
with	O	O	O
ischemic	O	O	B-T047
heart	O	O	I-T047
disease	O	O	I-T047
were	O	O	O
characterized	O	O	B-T052
by	O	O	O
organized	O	O	B-T169
myocardial	O	O	B-T042
activity	O	O	I-T042
evidenced	O	O	O
by	O	O	O
the	O	O	O
dominant	O	O	B-T033
ECG	O	O	I-T033
frequency	O	O	I-T033
structure	O	O	O
.	O	O	O

During	O	O	O
the	O	O	O
first	O	O	O
2	O	O	O
min	O	O	O
of	O	O	O
ventricular	O	O	B-T047
fibrillation	O	O	B-T047
,	O	O	O
low-frequency	O	O	B-T080
oscillations	O	O	I-T080
(	O	O	O
4	O	O	O
-	O	O	O
7	O	O	O
Hz	O	O	O
)	O	O	O
dominated	O	O	O
,	O	O	O
while	O	O	O
on	O	O	O
min	O	O	O
3	O	O	O
to	O	O	O
10	O	O	O
after	O	O	O
the	O	O	O
onset	O	O	O
of	O	O	O
fibrillation	O	O	O
,	O	O	O
the	O	O	O
dominant	O	O	B-T033
frequencies	O	O	I-T033
were	O	O	O
low	O	O	B-T080
and	O	O	O
medium	O	O	B-T081
(	O	O	O
4	O	O	O
-	O	O	O
12	O	O	O
Hz	O	O	O
)	O	O	O
.	O	O	O

After	O	O	O
10-min	O	O	O
fibrillation	O	O	B-T047
,	O	O	O
the	O	O	O
oscillations	O	O	B-T061
became	O	O	O
non-	O	O	O
dominant	O	O	B-T033
.	O	O	O

Thus	O	O	O
,	O	O	O
ischemic	O	O	B-T033
myocardium	O	O	I-T033
maintains	O	O	B-T052
the	O	O	O
organized	O	O	B-T079
structure	O	O	I-T079
of	O	O	O
ventricular	O	O	B-T047
fibrillation	O	O	I-T047
for	O	O	O
the	O	O	O
first	O	O	O
10	O	O	O
min	O	O	O
,	O	O	O
which	O	O	O
is	O	O	O
important	O	O	O
for	O	O	O
the	O	O	O
development	O	O	B-T169
of	O	O	O
automatic	O	O	B-T060
diagnostics	O	O	I-T060
of	O	O	O
abnormal	O	O	B-T033
cardiac	O	O	I-T033
activity	O	O	I-T033
in	O	O	O
humans	O	O	B-T016
.	O	O	O

-DOCSTART- (27383326)

Adverse	O	O	B-T046
events	O	O	I-T046
risk	O	O	B-T078
associated	O	O	B-T080
with	O	O	I-T080
angiogenesis	O	O	B-T121
inhibitors	O	O	I-T121
addition	O	O	O
to	O	O	O
therapy	O	O	B-T061
in	O	O	O
ovarian	O	O	B-T191
cancer	O	O	I-T191
:	O	O	O
a	O	O	O
meta-analysis	O	O	B-T062
of	O	O	O
randomized	O	O	O
controlled	O	O	O
trials	O	O	O

Inhibition	O	O	B-T043
of	O	O	I-T043
angiogenesis	O	O	I-T043
has	O	O	O
been	O	O	O
regarded	O	O	O
as	O	O	O
an	O	O	O
attractive	O	O	O
treatment	O	O	B-T061
strategy	O	O	I-T061
for	O	O	O
advanced	O	O	B-T191
or	O	O	O
recurrent	O	O	B-T191
ovarian	O	O	I-T191
cancer	O	O	I-T191
.	O	O	O

We	O	O	O
conduct	O	O	O
this	O	O	O
meta-analysis	O	O	B-T062
to	O	O	O
investigate	O	O	B-T169
the	O	O	O
risk	O	O	B-T078
of	O	O	O
adverse	O	O	B-T046
events	O	O	I-T046
of	O	O	O
special	O	O	O
interest	O	O	O
related	O	O	O
to	O	O	O
angiogenesis	O	O	B-T121
inhibitors	O	O	I-T121
(	O	O	O
AIs	O	O	B-T121
)	O	O	O
in	O	O	O
ovarian	O	O	B-T191
cancer	O	O	I-T191
.	O	O	O

Databases	O	O	B-T170
from	O	O	O
PubMed	O	O	B-T170
,	O	O	O
Web	O	O	B-T170
of	O	O	I-T170
Science	O	O	I-T170
and	O	O	O
Cochrane	O	O	B-T073
library	O	O	I-T073
up	O	O	O
to	O	O	O
December	O	O	O
2015	O	O	O
were	O	O	O
searched	O	O	O
to	O	O	O
identify	O	O	O
relevant	O	O	B-T080
studies	O	O	B-T062
.	O	O	O

Eligible	O	O	O
studies	O	O	B-T062
included	O	O	O
prospective	O	O	B-T062
randomized	O	O	I-T062
controlled	O	O	I-T062
phase	O	O	I-T062
II/III	O	O	I-T062
clinical	O	O	I-T062
trials	O	O	I-T062
evaluating	O	O	B-T058
therapy	O	O	B-T061
with	O	O	O
or	O	O	O
without	O	O	O
AIs	O	O	B-T121
for	O	O	O
ovarian	O	O	B-T191
cancer	O	O	I-T191
.	O	O	O

Summary	O	O	O
relative	O	O	B-T081
risk	O	O	I-T081
(	O	O	O
RR	O	O	B-T081
)	O	O	O
and	O	O	O
95	O	O	O
%	O	O	O
confidence	O	O	B-T081
intervals	O	O	I-T081
(	O	O	O
CIs	O	O	B-T081
)	O	O	O
were	O	O	O
calculated	O	O	B-T052
using	O	O	O
random-effects	O	O	B-T080
or	O	O	O
fixed-effects	O	O	B-T080
according	O	O	O
to	O	O	O
the	O	O	O
heterogeneity	O	O	B-T080
among	O	O	O
included	O	O	O
trials	O	O	B-T062
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
7,761	O	O	O
patients	O	O	B-T101
from	O	O	O
ten	O	O	O
clinical	O	O	B-T062
trials	O	O	I-T062
were	O	O	O
included	O	O	O
in	O	O	O
the	O	O	O
meta-analysis	O	O	B-T062
.	O	O	O

Pooled	O	O	B-T169
RR	O	O	B-T081
showed	O	O	O
that	O	O	O
the	O	O	O
use	O	O	B-T169
of	O	O	I-T169
AIs	O	O	B-T121
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
a	O	O	O
statistically	O	O	O
increased	O	O	B-T081
risk	O	O	B-T078
in	O	O	O
four	O	O	O
of	O	O	O
the	O	O	O
adverse	O	O	B-T169
outcomes	O	O	B-T080
studied	O	O	O
:	O	O	O
arterial	O	O	B-T046
thromboembolic	O	O	I-T046
events	O	O	B-T051
(	O	O	O
RR	O	O	O
=	O	O	O
2.0	O	O	O
)	O	O	O
,	O	O	O
gastrointestinal	O	O	B-T047
(	O	O	I-T047
GI	O	O	I-T047
)	O	O	I-T047
perforation	O	O	I-T047
(	O	O	O
RR	O	O	O
=	O	O	O
3.86	O	O	O
)	O	O	O
,	O	O	O
proteinuria	O	O	B-T033
(	O	O	O
RR	O	O	O
=	O	O	O
2.44	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
hypertension	O	O	B-T047
(	O	O	O
RR	O	O	O
=	O	O	O
5.39	O	O	O
)	O	O	O
.	O	O	O

No	O	O	B-T033
statistically	O	O	I-T033
significant	O	O	I-T033
differences	O	O	B-T080
were	O	O	O
found	O	O	O
for	O	O	O
hemorrhagic	O	O	B-T046
events	O	O	B-T051
(	O	O	O
p	O	O	O
=	O	O	O
0.07	O	O	O
)	O	O	O
,	O	O	O
venous	O	O	B-T047
thromboembolic	O	O	I-T047
events	O	O	O
(	O	O	O
p	O	O	O
=	O	O	O
0.13	O	O	O
)	O	O	O
,	O	O	O
or	O	O	O
fatal	O	O	B-T080
adverse	O	O	B-T046
events	O	O	I-T046
(	O	O	O
p	O	O	O
=	O	O	O
0.26	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
addition	O	O	O
of	O	O	O
AIs	O	O	B-T121
to	O	O	O
therapy	O	O	B-T061
in	O	O	O
ovarian	O	O	B-T191
cancer	O	O	I-T191
did	O	O	O
significantly	O	O	O
increase	O	O	B-T169
the	O	O	O
risk	O	O	B-T078
of	O	O	O
arterial	O	O	B-T046
thromboembolic	O	O	I-T046
events	O	O	B-T051
,	O	O	O
GI	O	O	B-T047
perforation	O	O	I-T047
,	O	O	O
proteinuria	O	O	B-T033
and	O	O	O
hypertension	O	O	B-T047
,	O	O	O
but	O	O	O
not	O	O	O
for	O	O	O
venous	O	O	B-T047
thromboembolic	O	O	I-T047
events	O	O	O
,	O	O	O
hemorrhagic	O	O	B-T046
events	O	O	O
,	O	O	O
or	O	O	O
fatal	O	O	B-T080
adverse	O	O	B-T046
events	O	O	I-T046
.	O	O	O

-DOCSTART- (27384489)

Relationship	O	O	B-T080
between	O	O	O
LRRK2	O	O	B-T028
R1628P	O	O	B-T086
polymorphism	O	O	I-T086
and	O	O	O
Parkinson	O	O	B-T047
's	O	O	I-T047
disease	O	O	I-T047
in	O	O	O
Asian	O	O	O
populations	O	O	O

Although	O	O	O
the	O	O	O
leucine-rich	O	O	B-T028
repeat	O	O	I-T028
kinase	O	O	I-T028
2	O	O	I-T028
(	O	O	O
LRRK2	O	O	B-T028
)	O	O	O
R1628P	O	O	B-T086
polymorphism	O	O	I-T086
has	O	O	O
been	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
the	O	O	O
risk	O	O	B-T078
of	O	O	O
Parkinson	O	O	B-T047
's	O	O	I-T047
disease	O	O	I-T047
(	O	O	O
PD	O	O	B-T047
)	O	O	O
in	O	O	O
Taiwan	O	O	B-T083
,	O	O	O
China	O	O	B-T083
,	O	O	O
and	O	O	O
Singapore	O	O	B-T083
,	O	O	O
there	O	O	O
are	O	O	O
conflicting	O	O	O
findings	O	O	O
regarding	O	O	O
this	O	O	O
relationship	O	O	B-T080
.	O	O	O

Thus	O	O	O
,	O	O	O
the	O	O	O
aim	O	O	O
of	O	O	O
the	O	O	O
present	O	O	O
meta-analysis	O	O	B-T062
was	O	O	O
to	O	O	O
evaluate	O	O	O
the	O	O	O
associations	O	O	B-T080
between	O	O	O
the	O	O	O
LRRK2	O	O	B-T028
R1628P	O	O	B-T086
polymorphism	O	O	I-T086
(	O	O	O
rs33949390	O	O	B-T086
)	O	O	O
and	O	O	O
PD	O	O	B-T047
in	O	O	O
Asian	O	O	B-T098
populations	O	O	I-T098
.	O	O	O

A	O	O	O
search	O	O	O
for	O	O	O
eligible	O	O	O
studies	O	O	B-T062
was	O	O	O
performed	O	O	O
in	O	O	O
PubMed	O	O	B-T170
,	O	O	O
Embase	O	O	B-T170
,	O	O	O
SinoMed	O	O	B-T170
,	O	O	O
and	O	O	O
the	O	O	O
China	O	O	B-T170
Knowledge	O	O	I-T170
Resource	O	O	I-T170
Integrated	O	O	I-T170
Database	O	O	I-T170
,	O	O	O
and	O	O	O
pooled	O	O	O
odds	O	O	O
ratios	O	O	O
and	O	O	O
95	O	O	O
%	O	O	O
confidence	O	O	B-T081
intervals	O	O	I-T081
were	O	O	O
used	O	O	O
to	O	O	O
evaluate	O	O	O
the	O	O	O
strength	O	O	O
of	O	O	O
the	O	O	O
association	O	O	B-T080
between	O	O	O
the	O	O	O
R1628P	O	O	B-T086
polymorphism	O	O	I-T086
and	O	O	O
PD	O	O	B-T047
.	O	O	O

This	O	O	O
meta-analysis	O	O	B-T062
assessed	O	O	O
19	O	O	O
studies	O	O	B-T062
from	O	O	O
14	O	O	O
papers	O	O	O
that	O	O	O
involved	O	O	O
a	O	O	O
total	O	O	O
of	O	O	O
9,927	O	O	O
PD	O	O	B-T047
patients	O	O	B-T101
and	O	O	O
8,602	O	O	O
controls	O	O	B-T096
and	O	O	O
found	O	O	O
that	O	O	O
the	O	O	O
R1628P	O	O	B-T086
polymorphism	O	O	I-T086
was	O	O	O
significantly	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
the	O	O	O
risk	O	O	B-T078
of	O	O	O
PD	O	O	O
in	O	O	O
Asian	O	O	B-T098
populations	O	O	I-T098
.	O	O	O

Moreover	O	O	O
,	O	O	O
stratification	O	O	B-T062
analyses	O	O	I-T062
indicated	O	O	O
that	O	O	O
the	O	O	O
R1628P	O	O	B-T086
polymorphism	O	O	I-T086
was	O	O	O
significantly	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
an	O	O	O
increased	O	O	O
risk	O	O	B-T078
of	O	O	O
PD	O	O	B-T047
among	O	O	O
Chinese	O	O	B-T098
as	O	O	O
well	O	O	O
as	O	O	O
non-Chinese	O	O	B-T098
Asian	O	O	I-T098
populations	O	O	I-T098
and	O	O	O
an	O	O	O
increased	O	O	O
risk	O	O	O
of	O	O	O
PD	O	O	O
in	O	O	O
Chinese	O	O	B-T101
patients	O	O	I-T101
from	O	O	O
China	O	O	B-T083
,	O	O	O
Taiwan	O	O	B-T083
,	O	O	O
and	O	O	O
Singapore	O	O	B-T083
.	O	O	O

In	O	O	O
a	O	O	O
stratified	O	O	B-T062
analysis	O	O	I-T062
conducted	O	O	O
according	O	O	O
to	O	O	O
age	O	O	B-T032
,	O	O	O
significant	O	O	O
associations	O	O	B-T080
were	O	O	O
found	O	O	O
for	O	O	O
both	O	O	O
late-onset	O	O	O
PD	O	O	B-T047
and	O	O	O
early-onset	O	O	O
PD	O	O	O
.	O	O	O

The	O	O	O
present	O	O	O
data	O	O	O
indicate	O	O	O
that	O	O	O
the	O	O	O
R1628P	O	O	B-T086
polymorphism	O	O	I-T086
of	O	O	O
the	O	O	O
LRRK2	O	O	B-T028
gene	O	O	I-T028
contributes	O	O	O
to	O	O	O
PD	O	O	B-T047
susceptibility	O	O	B-T201
in	O	O	O
Asian	O	O	B-T098
,	O	O	O
especially	O	O	O
Chinese	O	O	B-T098
,	O	O	O
populations	O	O	B-T098
.	O	O	O

-DOCSTART- (27384676)

Efficacy	O	O	B-T080
and	O	O	O
safety	O	O	B-T080
of	O	O	O
cisplatin	O	O	B-T121
,	O	O	O
dexamethasone	O	O	B-T109
,	O	O	O
gemcitabine	O	O	B-T114
and	O	O	O
pegaspargase	O	O	B-T116
(	O	O	O
DDGP	O	O	B-T121
)	O	O	O
regimen	O	O	B-T061
in	O	O	O
newly	O	O	B-T080
diagnosed	O	O	I-T080
,	O	O	O
advanced-stage	O	O	B-T080
extranodal	O	O	B-T191
natural	O	O	I-T191
killer/T-cell	O	O	I-T191
lymphoma	O	O	I-T191
:	O	O	O
interim	O	O	B-T079
analysis	O	O	B-T062
of	O	O	O
a	O	O	O
phase	O	O	B-T079
4	O	O	I-T079
study	O	O	B-T062
NCT01501149	O	O	O

To	O	O	O
explore	O	O	O
a	O	O	O
more	O	O	O
effective	O	O	B-T080
treatment	O	O	B-T169
for	O	O	O
newly	O	O	B-T080
diagnosed	O	O	I-T080
,	O	O	O
advanced-stage	O	O	B-T080
extranodal	O	O	B-T191
natural	O	O	I-T191
killer/T-cell	O	O	I-T191
lymphoma	O	O	I-T191
,	O	O	I-T191
nasal	O	O	I-T191
type	O	O	I-T191
(	O	O	O
ENKTL	O	O	B-T191
)	O	O	O
,	O	O	O
we	O	O	O
conducted	O	O	O
a	O	O	O
phase	O	O	B-T079
4	O	O	I-T079
study	O	O	B-T062
of	O	O	O
the	O	O	O
cisplatin	O	O	B-T121
,	O	O	O
dexamethasone	O	O	B-T109
,	O	O	O
gemcitabine	O	O	B-T114
,	O	O	O
pegaspargase	O	O	B-T116
(	O	O	O
DDGP	O	O	B-T121
)	O	O	O
regimen	O	O	B-T061
.	O	O	O

The	O	O	O
primary	O	O	O
end	O	O	B-T080
point	O	O	I-T080
was	O	O	O
the	O	O	O
2-year	O	O	O
progression-free	O	O	B-T081
survival	O	O	I-T081
(	O	O	O
PFS	O	O	B-T081
)	O	O	O
after	O	O	O
the	O	O	O
protocol	O	O	B-T061
treatment	O	O	I-T061
.	O	O	O

Secondary	O	O	O
endpoints	O	O	B-T080
included	O	O	O
response	O	O	B-T079
rate	O	O	I-T079
(	O	O	O
RR	O	O	B-T079
)	O	O	O
,	O	O	O
overall	O	O	B-T081
survival	O	O	I-T081
(	O	O	O
OS	O	O	B-T081
)	O	O	O
and	O	O	O
median	O	O	B-T079
survival	O	O	I-T079
time	O	O	I-T079
(	O	O	O
MST	O	O	B-T079
)	O	O	O
.	O	O	O

The	O	O	O
interim	O	O	B-T079
analysis	O	O	B-T062
included	O	O	O
data	O	O	B-T078
only	O	O	O
from	O	O	O
March	O	O	O
2011	O	O	O
to	O	O	O
September	O	O	O
2013	O	O	O
,	O	O	O
who	O	O	O
received	O	O	B-T080
six	O	O	O
cycles	O	O	O
of	O	O	O
DDGP	O	O	B-T121
chemotherapy	O	O	B-T061
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
25	O	O	O
eligible	O	O	B-T080
patients	O	O	B-T101
were	O	O	O
enrolled	O	O	O
.	O	O	O

Seventeen	O	O	O
patients	O	O	B-T101
(	O	O	O
17/24	O	O	O
,	O	O	O
70.83	O	O	O
%	O	O	O
)	O	O	O
achieved	O	O	O
complete	O	O	B-T033
response	O	O	I-T033
(	O	O	O
CR	O	O	B-T033
)	O	O	O
and	O	O	O
four	O	O	O
(	O	O	O
4/24	O	O	O
,	O	O	O
16.67	O	O	O
%	O	O	O
)	O	O	O
achieved	O	O	O
partial	O	O	B-T033
response	O	O	I-T033
(	O	O	O
PR	O	O	B-T033
)	O	O	O
,	O	O	O
three	O	O	O
(	O	O	O
3/24	O	O	O
,	O	O	O
12.50	O	O	O
%	O	O	O
)	O	O	O
had	O	O	O
progressive	O	O	B-T047
disease	O	O	I-T047
(	O	O	O
PD	O	O	B-T047
)	O	O	O
.	O	O	O

The	O	O	O
RR	O	O	B-T079
after	O	O	O
treatment	O	O	B-T169
was	O	O	O
87.50	O	O	O
%	O	O	O
.	O	O	O

After	O	O	O
a	O	O	O
median	O	O	B-T081
follow-up	O	O	B-T058
duration	O	O	B-T079
of	O	O	O
24.67	O	O	O
months	O	O	B-T079
(	O	O	O
range	O	O	O
4	O	O	O
-	O	O	O
48	O	O	O
months	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
2-year	O	O	O
PFS	O	O	B-T081
and	O	O	O
OS	O	O	B-T081
rate	O	O	I-T081
were	O	O	O
61.80	O	O	O
%	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
,	O	O	O
42.00	O	O	O
%	O	O	O
to	O	O	O
81.60	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
68.50	O	O	O
%	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
,	O	O	O
48.70	O	O	O
%	O	O	O
to	O	O	O
88.30	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

The	O	O	O
MST	O	O	B-T079
was	O	O	O
36.55	O	O	O
months	O	O	B-T079
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
,	O	O	O
29.41	O	O	O
months	O	O	O
to	O	O	O
43.70	O	O	O
months	O	O	O
)	O	O	O
.	O	O	O

Grade	O	O	B-T185
3/4	O	O	O
leukopenia	O	O	B-T047
occurred	O	O	B-T079
in	O	O	O
fourteen	O	O	O
patients	O	O	B-T101
(	O	O	O
58.33	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
grade	O	O	B-T185
3/4	O	O	O
thrombocytopenia	O	O	B-T047
occurred	O	O	O
in	O	O	O
eleven	O	O	O
patients	O	O	O
(	O	O	O
45.83	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

Twelve	O	O	O
patients	O	O	B-T101
(	O	O	O
50.00	O	O	O
%	O	O	O
)	O	O	O
experienced	O	O	O
Activated	O	O	B-T059
Partial	O	O	I-T059
Phromboplastin	O	O	I-T059
Ptime	O	O	I-T059
(	O	O	O
APTT	O	O	B-T059
)	O	O	O
elongation	O	O	B-T033
and	O	O	O
fourteen	O	O	O
patients	O	O	O
(	O	O	O
58.33	O	O	O
%	O	O	O
)	O	O	O
experienced	O	O	O
hypofibrinogenemia	O	O	B-T047
.	O	O	O

In	O	O	O
conclusion	O	O	O
,	O	O	O
DDGP	O	O	B-T121
regimen	O	O	B-T061
is	O	O	O
an	O	O	O
effective	O	O	B-T080
and	O	O	O
tolerated	O	O	B-T033
treatment	O	O	B-T169
for	O	O	O
newly	O	O	B-T080
diagnosed	O	O	I-T080
,	O	O	O
advanced-stage	O	O	B-T080
ENKTL	O	O	B-T191
.	O	O	O

This	O	O	O
trial	O	O	B-T062
was	O	O	O
registered	O	O	B-T058
at	O	O	O
www	O	O	O
.	O	O	O

ClinicalTrials.gov	O	O	O
as	O	O	O
#	O	O	O
NCT01501149	O	O	O
.	O	O	O

-DOCSTART- (27388630)

Effect	O	O	B-T080
of	O	O	O
Hepatitis	O	O	B-T047
C	O	O	I-T047
Virus	O	O	I-T047
Coinfection	O	O	I-T047
on	O	O	O
the	O	O	O
Content	O	O	O
of	O	O	O
CD4(+	O	O	B-T025
)	O	O	I-T025
and	O	O	I-T025
CD8(+	O	O	I-T025
)	O	O	I-T025
T	O	O	B-T025
Cell	O	O	I-T025
Subpopulations	O	O	B-T185
in	O	O	O
HIV	O	O	B-T005
-	O	O	O
Infected	O	O	B-T033
Patients	O	O	B-T101
Receiving	O	O	B-T080
Antiretroviral	O	O	O
Therapy	O	O	O

We	O	O	O
studied	O	O	O
the	O	O	O
effect	O	O	B-T080
of	O	O	O
hepatitis	O	O	B-T047
C	O	O	I-T047
virus	O	O	I-T047
coinfection	O	O	I-T047
on	O	O	O
T	O	O	B-T025
cell	O	O	I-T025
subpopulations	O	O	B-T185
in	O	O	O
HIV	O	O	B-T005
-	O	O	O
infected	O	O	B-T033
patients	O	O	B-T101
receiving	O	O	O
antiretroviral	O	O	B-T061
therapy	O	O	I-T061
.	O	O	O

Coinfection	O	O	B-T047
with	O	O	O
hepatitis	O	O	B-T005
C	O	O	I-T005
virus	O	O	I-T005
was	O	O	O
followed	O	O	O
by	O	O	O
a	O	O	O
decrease	O	O	B-T081
in	O	O	O
the	O	O	O
number	O	O	O
of	O	O	O
naive	O	O	B-T025
CD4(+	O	O	I-T025
)	O	O	I-T025
T	O	O	I-T025
cells	O	O	I-T025
and	O	O	O
an	O	O	O
increase	O	O	B-T169
in	O	O	O
the	O	O	O
count	O	O	B-T081
of	O	O	O
central	O	O	O
CD8(+	O	O	B-T025
)	O	O	I-T025
memory	O	O	I-T025
T	O	O	I-T025
cells	O	O	I-T025
in	O	O	O
these	O	O	O
patients	O	O	B-T101
.	O	O	O

Hepatitis	O	O	B-T005
C	O	O	I-T005
virus	O	O	I-T005
had	O	O	O
no	O	O	B-T080
effect	O	O	I-T080
on	O	O	O
the	O	O	O
number	O	O	O
of	O	O	O
CD4(+	O	O	B-T025
)	O	O	I-T025
memory	O	O	I-T025
T	O	O	I-T025
cells	O	O	I-T025
(	O	O	O
main	O	O	O
target	O	O	O
for	O	O	O
HIV	O	O	B-T005
)	O	O	O
.	O	O	O

This	O	O	O
can	O	O	O
explain	O	O	O
the	O	O	O
absence	O	O	O
of	O	O	O
strong	O	O	O
negative	O	O	B-T033
effect	O	O	B-T080
of	O	O	O
hepatitis	O	O	B-T005
C	O	O	I-T005
virus	O	O	I-T005
on	O	O	O
the	O	O	O
course	O	O	B-T079
of	O	O	O
HIV	O	O	B-T005
infection	O	O	B-T046
.	O	O	O

-DOCSTART- (27388786)

Examining	O	O	B-T169
the	O	O	O
contribution	O	O	B-T052
of	O	O	O
motor	O	O	B-T169
movement	O	O	I-T169
and	O	O	O
language	O	O	B-T171
dominance	O	O	B-T078
to	O	O	O
increased	O	O	B-T081
left	O	O	B-T082
lateralization	O	O	B-T042
during	O	O	O
sign	O	O	B-T171
generation	O	O	B-T052
in	O	O	O
native	O	O	B-T169
signers	O	O	O

The	O	O	O
neural	O	O	B-T022
systems	O	O	I-T022
supporting	O	O	O
speech	O	O	B-T040
and	O	O	O
sign	O	O	B-T078
processing	O	O	B-T041
are	O	O	O
very	O	O	O
similar	O	O	B-T080
,	O	O	O
although	O	O	O
not	O	O	O
identical	O	O	O
.	O	O	O

In	O	O	O
a	O	O	O
previous	O	O	O
fTCD	O	O	B-T062
study	O	O	I-T062
of	O	O	O
hearing	O	O	B-T041
native	O	O	B-T169
signers	O	O	B-T098
(	O	O	O
Gutierrez-Sigut	O	O	O
,	O	O	O
Daws	O	O	O
,	O	O	O
et	O	O	O
al.	O	O	O
,	O	O	O
2015	O	O	O
)	O	O	O
we	O	O	O
found	O	O	O
stronger	O	O	O
left	O	O	B-T082
lateralization	O	O	B-T042
for	O	O	O
sign	O	O	B-T078
than	O	O	O
speech	O	O	B-T040
.	O	O	O

Given	O	O	O
that	O	O	O
this	O	O	O
increased	O	O	B-T081
lateralization	O	O	B-T042
could	O	O	O
not	O	O	O
be	O	O	O
explained	O	O	O
by	O	O	O
hand	O	O	B-T023
movement	O	O	B-T040
alone	O	O	O
,	O	O	O
the	O	O	O
contribution	O	O	O
of	O	O	O
motor	O	O	B-T169
movement	O	O	I-T169
versus	O	O	O
'	O	O	O
linguistic	O	O	B-T171
'	O	O	O
processes	O	O	B-T041
to	O	O	O
the	O	O	O
strength	O	O	B-T078
of	O	O	O
hemispheric	O	O	B-T082
lateralization	O	O	O
during	O	O	O
sign	O	O	B-T078
production	O	O	B-T041
remains	O	O	O
unclear	O	O	O
.	O	O	O

Here	O	O	O
we	O	O	O
directly	O	O	O
contrast	O	O	B-T080
lateralization	O	O	B-T042
strength	O	O	B-T078
of	O	O	O
covert	O	O	B-T078
versus	O	O	O
overt	O	O	B-T080
signing	O	O	B-T078
during	O	O	O
phonological	O	O	B-T169
and	O	O	O
semantic	O	O	B-T078
fluency	O	O	B-T080
tasks	O	O	B-T169
.	O	O	O

To	O	O	O
address	O	O	O
the	O	O	O
possibility	O	O	O
that	O	O	O
hearing	O	O	B-T041
native	O	O	B-T169
signers	O	O	B-T098
'	O	O	O
elevated	O	O	B-T080
lateralization	O	O	B-T081
indices	O	O	I-T081
(	O	O	O
LIs	O	O	B-T081
)	O	O	O
were	O	O	O
due	O	O	O
to	O	O	O
performing	O	O	O
a	O	O	O
task	O	O	B-T169
in	O	O	O
their	O	O	O
less	O	O	O
dominant	O	O	B-T169
language	O	O	B-T171
,	O	O	O
here	O	O	O
we	O	O	O
test	O	O	O
deaf	O	O	B-T101
native	O	O	O
signers	O	O	O
,	O	O	O
whose	O	O	O
dominant	O	O	O
language	O	O	O
is	O	O	O
British	O	O	B-T171
Sign	O	O	I-T171
Language	O	O	I-T171
(	O	O	O
BSL	O	O	B-T171
)	O	O	O
.	O	O	O

Signers	O	O	B-T098
were	O	O	O
more	O	O	O
strongly	O	O	O
left	O	O	B-T082
lateralized	O	O	B-T042
for	O	O	O
overt	O	O	B-T080
than	O	O	O
covert	O	O	B-T078
sign	O	O	B-T078
generation	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
strength	O	O	B-T078
of	O	O	O
lateralization	O	O	B-T042
was	O	O	O
not	O	O	O
correlated	O	O	B-T080
with	O	O	O
the	O	O	O
amount	O	O	O
of	O	O	O
time	O	O	O
producing	O	O	O
movements	O	O	B-T040
of	O	O	O
the	O	O	O
right	O	O	B-T023
hand	O	O	I-T023
.	O	O	O

Comparisons	O	O	B-T052
with	O	O	O
previous	O	O	O
data	O	O	B-T078
from	O	O	O
hearing	O	O	B-T041
native	O	O	B-T169
English	O	O	B-T171
speakers	O	O	B-T098
suggest	O	O	O
stronger	O	O	O
laterality	O	O	B-T081
indices	O	O	I-T081
for	O	O	O
sign	O	O	B-T078
than	O	O	O
speech	O	O	B-T040
in	O	O	O
both	O	O	O
covert	O	O	B-T078
and	O	O	O
overt	O	O	B-T080
tasks	O	O	B-T169
.	O	O	O

This	O	O	O
increased	O	O	B-T081
left	O	O	B-T082
lateralization	O	O	B-T042
may	O	O	O
be	O	O	O
driven	O	O	O
by	O	O	O
specific	O	O	O
properties	O	O	B-T080
of	O	O	O
sign	O	O	B-T078
production	O	O	B-T041
such	O	O	O
as	O	O	O
the	O	O	O
increased	O	O	O
use	O	O	B-T169
of	O	O	O
self-monitoring	O	O	B-T055
mechanisms	O	O	B-T169
or	O	O	O
the	O	O	O
nature	O	O	B-T078
of	O	O	O
phonological	O	O	B-T041
encoding	O	O	I-T041
of	O	O	O
signs	O	O	B-T078
.	O	O	O

-DOCSTART- (27392740)

Hard	O	O	B-T204
ticks	O	O	I-T204
(	O	O	O
Acari	O	O	B-T204
:	O	O	I-T204
Ixodidae	O	O	I-T204
)	O	O	O
of	O	O	O
livestock	O	O	B-T008
in	O	O	O
Nicaragua	O	O	B-T083
,	O	O	O
with	O	O	O
notes	O	O	B-T170
about	O	O	O
distribution	O	O	O

We	O	O	O
document	O	O	B-T170
the	O	O	O
species	O	O	B-T185
of	O	O	O
ticks	O	O	B-T204
that	O	O	O
parasitize	O	O	B-T047
livestock	O	O	B-T008
in	O	O	O
Nicaragua	O	O	B-T083
.	O	O	O

The	O	O	O
study	O	O	B-T062
was	O	O	O
based	O	O	O
on	O	O	O
tick	O	O	B-T204
collection	O	O	B-T169
on	O	O	O
cattle	O	O	B-T015
and	O	O	O
horses	O	O	B-T015
from	O	O	O
437	O	O	O
farms	O	O	B-T082
in	O	O	O
nine	O	O	O
departments	O	O	B-T092
.	O	O	O

Of	O	O	O
4841	O	O	O
animals	O	O	B-T008
examined	O	O	O
(	O	O	O
4481	O	O	O
cows	O	O	B-T015
and	O	O	O
360	O	O	O
horses	O	O	B-T015
)	O	O	O
,	O	O	O
3299	O	O	O
were	O	O	O
parasitized	O	O	B-T047
,	O	O	O
which	O	O	O
represent	O	O	O
68	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
bovines	O	O	B-T015
and	O	O	O
67	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
equines	O	O	B-T015
in	O	O	O
study	O	O	B-T062
:	O	O	O
59	O	O	O
cows	O	O	O
and	O	O	O
25	O	O	O
horses	O	O	O
were	O	O	O
parasitized	O	O	O
by	O	O	O
more	O	O	O
than	O	O	O
one	O	O	O
species	O	O	B-T185
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
280	O	O	O
specimens	O	O	B-T167
of	O	O	O
the	O	O	O
entomological	O	O	B-T090
museum	O	O	B-T073
in	O	O	O
LeÃ³n	O	O	B-T083
were	O	O	O
examined	O	O	O
.	O	O	O

The	O	O	O
ticks	O	O	B-T204
found	O	O	O
on	O	O	O
cattle	O	O	B-T015
were	O	O	O
Rhipicephalus	O	O	B-T204
microplus	O	O	I-T204
(	O	O	O
75.2	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
ticks	O	O	O
collected	O	O	B-T169
)	O	O	O
,	O	O	O
Amblyomma	O	O	B-T204
mixtum	O	O	I-T204
(	O	O	O
20.8	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
A.	O	O	B-T204
parvum	O	O	I-T204
(	O	O	O
2.6	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
A.	O	O	B-T204
tenellum	O	O	I-T204
(	O	O	O
0.7	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
A.	O	O	B-T204
maculatum	O	O	I-T204
(	O	O	O
0.7	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

While	O	O	O
the	O	O	O
ticks	O	O	B-T204
collected	O	O	B-T169
from	O	O	O
the	O	O	O
horses	O	O	B-T015
were	O	O	O
:	O	O	O
Dermacentor	O	O	B-T204
nitens	O	O	I-T204
(	O	O	O
41.5	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
A.	O	O	B-T204
mixtum	O	O	I-T204
(	O	O	O
31.7	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
R.	O	O	B-T204
microplus	O	O	I-T204
(	O	O	O
13.8	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
A.	O	O	B-T204
parvum	O	O	I-T204
(	O	O	O
6.5	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
A.	O	O	B-T204
tenellum	O	O	I-T204
(	O	O	O
3.3	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
D.	O	O	B-T204
dissimilis	O	O	I-T204
(	O	O	O
2.4	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
A.	O	O	B-T204
maculatum	O	O	I-T204
(	O	O	O
0.8	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

-DOCSTART- (27394918)

Assessment	O	O	B-T058
the	O	O	O
Exposure	O	O	B-T080
Level	O	O	B-T080
of	O	O	O
Rare	O	O	B-T196
Earth	O	O	I-T196
Elements	O	O	I-T196
in	O	O	O
Workers	O	O	B-T098
Producing	O	O	B-T057
Cerium	O	O	B-T109
,	O	O	O
Lanthanum	O	O	B-T197
Oxide	O	O	I-T197
Ultrafine	O	O	B-T109
and	O	O	O
Nanoparticles	O	O	O

In	O	O	O
order	O	O	O
to	O	O	O
assess	O	O	B-T058
occupational	O	O	B-T169
exposure	O	O	B-T080
level	O	O	B-T080
of	O	O	O
15	O	O	O
rare	O	O	B-T196
earth	O	O	I-T196
elements	O	O	I-T196
(	O	O	O
REEs	O	O	B-T196
)	O	O	O
and	O	O	O
identify	O	O	B-T080
the	O	O	O
associated	O	O	B-T080
influence	O	O	B-T077
,	O	O	O
we	O	O	O
used	O	O	O
inductively	O	O	B-T059
coupled	O	O	I-T059
plasma	O	O	I-T059
mass	O	O	I-T059
spectrometry	O	O	I-T059
(	O	O	O
ICP-MS	O	O	B-T059
)	O	O	O
based	O	O	B-T169
on	O	O	O
closed	O	O	B-T169
-	O	O	O
vessel	O	O	B-T073
microwave	O	O	B-T070
-	O	O	O
assisted	O	O	B-T080
wet	O	O	B-T169
digestion	O	O	I-T169
procedure	O	O	I-T169
to	O	O	O
determinate	O	O	B-T059
the	O	O	O
concentration	O	O	B-T081
of	O	O	O
Y	O	O	B-T196
,	O	O	O
La	O	O	B-T197
,	O	O	O
Ce	O	O	B-T109
,	O	O	O
Pr	O	O	B-T196
,	O	O	O
Nd	O	O	B-T196
,	O	O	O
Sm	O	O	B-T121
,	O	O	O
Eu	O	O	B-T196
,	O	O	O
Gd	O	O	B-T130
,	O	O	O
Tb	O	O	B-T196
,	O	O	O
Dy	O	O	B-T196
,	O	O	O
Ho	O	O	B-T196
,	O	O	O
Er	O	O	B-T196
,	O	O	O
Tm	O	O	B-T196
,	O	O	O
Yb	O	O	B-T121
and	O	O	O
Lu	O	O	B-T196
in	O	O	O
urinary	O	O	B-T031
samples	O	O	I-T031
obtained	O	O	B-T169
from	O	O	O
workers	O	O	B-T098
producing	O	O	B-T057
ultrafine	O	O	B-T109
and	O	O	O
nanoparticles	O	O	B-T073
containing	O	O	O
cerium	O	O	B-T109
and	O	O	O
lanthanum	O	O	B-T197
oxide	O	O	I-T197
.	O	O	O

The	O	O	O
results	O	O	B-T034
suggest	O	O	B-T078
that	O	O	O
La	O	O	B-T197
and	O	O	O
Ce	O	O	B-T109
were	O	O	O
the	O	O	O
primary	O	O	B-T080
component	O	O	B-T077
,	O	O	O
together	O	O	O
accounting	O	O	B-UnknownType
for	O	O	O
97	O	O	O
%	O	O	O
of	O	O	O
total	O	O	O
REEs	O	O	B-T196
in	O	O	O
workers	O	O	B-T098
.	O	O	O

The	O	O	O
urinary	O	O	B-T031
levels	O	O	B-T080
of	O	O	O
La	O	O	B-T197
,	O	O	O
and	O	O	O
Ce	O	O	B-T109
among	O	O	O
the	O	O	O
workers	O	O	B-T098
(	O	O	O
6.36	O	O	O
,	O	O	O
15.32	O	O	O
Î¼g.g(-1	O	O	O
)	O	O	O
creatinine	O	O	B-T109
,	O	O	O
respectively	O	O	O
)	O	O	O
were	O	O	O
significantly	O	O	B-T078
enriched	O	O	B-T080
compared	O	O	B-T052
to	O	O	O
those	O	O	O
levels	O	O	O
measured	O	O	B-T080
in	O	O	O
the	O	O	O
control	O	O	B-T096
subjects	O	O	B-T096
(	O	O	O
1.52	O	O	O
,	O	O	O
4.04	O	O	O
Î¼g.g(-1	O	O	O
)	O	O	O
creatinine	O	O	O
,	O	O	O
respectively	O	O	O
)	O	O	O
(	O	O	O
p	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
.	O	O	O

This	O	O	O
study	O	O	B-T062
simultaneously	O	O	B-T079
identified	O	O	B-T080
the	O	O	O
associated	O	O	B-T080
individual	O	O	B-T098
factors	O	O	B-T169
,	O	O	O
the	O	O	O
results	O	O	B-T034
indicate	O	O	B-T078
that	O	O	O
the	O	O	O
concentrations	O	O	B-T081
in	O	O	O
over	O	O	O
5	O	O	O
years	O	O	O
group	O	O	B-T078
(	O	O	O
11.64	O	O	O
Â±	O	O	O
10.93	O	O	O
for	O	O	O
La	O	O	B-T197
,	O	O	O
27.83	O	O	O
Â±	O	O	O
24.38	O	O	O
for	O	O	O
Ce	O	O	B-T109
)	O	O	O
were	O	O	O
significantly	O	O	B-T078
elevated	O	O	B-T080
compared	O	O	B-T052
to	O	O	O
1	O	O	O
-	O	O	O
5	O	O	O
years	O	O	O
group	O	O	O
(	O	O	O
2.58	O	O	O
Â±	O	O	O
1.51	O	O	O
for	O	O	O
La	O	O	O
,	O	O	O
6.87	O	O	O
Â±	O	O	O
3.90	O	O	O
for	O	O	O
Ce	O	O	O
)	O	O	O
(	O	O	O
p	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
.	O	O	O

Compared	O	O	B-T052
the	O	O	O
urinary	O	O	B-T031
levels	O	O	B-T080
of	O	O	O
La	O	O	B-T197
and	O	O	O
Ce	O	O	B-T109
at	O	O	O
the	O	O	O
separation	O	O	B-T169
and	O	O	O
packaging	O	O	B-T068
locations	O	O	B-T082
(	O	O	O
9.10	O	O	O
Â±	O	O	O
9.51	O	O	O
for	O	O	O
La	O	O	O
,	O	O	O
22.29	O	O	O
Â±	O	O	O
21.01	O	O	O
for	O	O	O
Ce	O	O	O
)	O	O	O
with	O	O	O
the	O	O	O
other	O	O	O
locations	O	O	O
(	O	O	O
2.85	O	O	O
Â±	O	O	O
0.98	O	O	O
for	O	O	O
La	O	O	O
,	O	O	O
6.37	O	O	O
Â±	O	O	O
2.12	O	O	O
for	O	O	O
Ce	O	O	O
)	O	O	O
,	O	O	O
the	O	O	O
results	O	O	B-T034
show	O	O	O
urinary	O	O	O
concentrations	O	O	B-T081
were	O	O	O
significantly	O	O	B-T078
higher	O	O	B-T080
in	O	O	O
workers	O	O	B-T098
at	O	O	O
separation	O	O	O
and	O	O	O
packaging	O	O	O
locations	O	O	O
(	O	O	O
p	O	O	O
<	O	O	O
0.01	O	O	O
)	O	O	O
.	O	O	O

Inter	O	O	B-T079
-	O	O	O
individual	O	O	B-T098
variation	O	O	B-T080
in	O	O	O
levels	O	O	B-T080
of	O	O	O
La	O	O	B-T197
and	O	O	O
Ce	O	O	B-T109
in	O	O	O
urine	O	O	B-T031
is	O	O	O
the	O	O	O
result	O	O	B-T169
of	O	O	O
multi-factorial	O	O	B-T081
comprehensive	O	O	B-T080
action	O	O	B-T052
.	O	O	O

Further	O	O	O
researches	O	O	B-T097
should	O	O	O
focus	O	O	B-T169
on	O	O	O
the	O	O	O
multiple	O	O	B-T081
factors	O	O	B-T169
contributing	O	O	B-T052
to	O	O	O
the	O	O	O
REEs	O	O	B-T196
levels	O	O	B-T080
of	O	O	O
the	O	O	O
occupationally	O	O	B-T169
exposed	O	O	B-T080
workers	O	O	B-T098
.	O	O	O

-DOCSTART- (27395231)

Two	O	O	O
known	O	O	B-T080
and	O	O	O
one	O	O	O
new	O	O	B-T080
species	O	O	B-T185
of	O	O	O
Draconematidae	O	O	B-T204
and	O	O	O
Epsilonematida	O	O	B-T204
(	O	O	O
Nematoda	O	O	B-T204
,	O	O	O
Desmodorida	O	O	B-T204
)	O	O	O
from	O	O	O
the	O	O	O
White	O	O	B-T083
Sea	O	O	I-T083
,	O	O	O
North	O	O	O
Russia	O	O	O

Morphological	O	O	B-T082
descriptions	O	O	B-T170
of	O	O	O
three	O	O	O
"	O	O	O
walking	O	O	B-T204
nematode	O	O	I-T204
"	O	O	O
species	O	O	B-T185
found	O	O	O
for	O	O	O
the	O	O	O
first	O	O	O
time	O	O	O
in	O	O	O
the	O	O	O
White	O	O	B-T083
Sea	O	O	I-T083
are	O	O	O
presented	O	O	O
.	O	O	O

Draconema	O	O	B-T204
ophicephalum	O	O	I-T204
(	O	O	O
ClaparÃ¨de	O	O	B-T170
,	O	O	O
1863	O	O	O
)	O	O	O
(	O	O	O
Draconematidae	O	O	B-T204
)	O	O	O
and	O	O	O
Epsilonema	O	O	B-T204
steineri	O	O	I-T204
Chitwood	O	O	B-T170
,	O	O	O
1935	O	O	O
(	O	O	O
Epsilonematidae	O	O	B-T204
)	O	O	O
,	O	O	O
both	O	O	O
known	O	O	O
from	O	O	O
insufficient	O	O	B-T080
material	O	O	O
and	O	O	O
females	O	O	B-T032
only	O	O	O
,	O	O	O
are	O	O	O
re-described	O	O	O
and	O	O	O
problems	O	O	B-T033
of	O	O	O
their	O	O	O
taxonomic	O	O	B-T169
identification	O	O	B-T080
as	O	O	O
well	O	O	O
as	O	O	O
species	O	O	B-T185
compositions	O	O	B-T201
of	O	O	O
respective	O	O	O
genera	O	O	B-T185
are	O	O	O
discussed	O	O	O
.	O	O	O

The	O	O	O
new	O	O	B-T080
species	O	O	B-T185
Prochaetosoma	O	O	O
marisalbi	O	O	O
sp.	O	O	O
n.	O	O	O
(	O	O	O
Draconematidae	O	O	B-T204
)	O	O	O
differs	O	O	O
from	O	O	O
other	O	O	O
Prochaetosoma	O	O	B-T204
species	O	O	I-T204
except	O	O	O
P.	O	O	B-T204
longicapitatum	O	O	I-T204
(	O	O	O
AllgÃ©n	O	O	B-T170
,	O	O	O
1935	O	O	O
)	O	O	O
in	O	O	O
that	O	O	O
the	O	O	O
pharyngeal	O	O	B-T023
bulb	O	O	B-T017
lumen	O	O	B-T030
is	O	O	O
not	O	O	B-T033
cuticularised	O	O	I-T033
,	O	O	O
from	O	O	O
P.	O	O	O
longicapitatum	O	O	O
by	O	O	O
shape	O	O	B-T017
of	O	O	I-T017
body	O	O	I-T017
and	O	O	O
rostrum	O	O	B-T026
,	O	O	O
greater	O	O	B-T081
number	O	O	O
of	O	O	O
cephalic	O	O	B-T082
adhesive	O	O	B-T026
tubes	O	O	I-T026
,	O	O	O
and	O	O	O
from	O	O	O
P.	O	O	B-T204
maertensi	O	O	I-T204
Decraemer	O	O	B-T170
,	O	O	O
1989	O	O	O
by	O	O	O
having	O	O	O
a	O	O	O
relatively	O	O	O
longer	O	O	B-T080
tail	O	O	B-T023
,	O	O	O
fewer	O	O	O
anterior	O	O	B-T082
adhesive	O	O	O
tubes	O	O	O
and	O	O	O
longer	O	O	O
spicules	O	O	B-T077
,	O	O	O
besides	O	O	O
lacking	O	O	O
cuticular	O	O	B-T042
thickening	O	O	I-T042
in	O	O	O
the	O	O	O
pharyngeal	O	O	O
bulb	O	O	O
.	O	O	O

Draconema	O	O	B-T204
hoonsooi	O	O	I-T204
,	O	O	O
D.	O	O	B-T204
youngeouni	O	O	I-T204
,	O	O	O
P.rochaetosoma	O	O	B-T204
beomseomense	O	O	I-T204
,	O	O	O
P.	O	O	B-T204
brevicaudatum	O	O	I-T204
,	O	O	O
P.	O	O	B-T204
byungilli	O	O	I-T204
,	O	O	O
P.	O	O	B-T204
cracense	O	O	I-T204
,	O	O	O
P.	O	O	B-T204
saheungi	O	O	I-T204
,	O	O	O
P.	O	O	B-T204
sujungi	O	O	I-T204
,	O	O	O
P.	O	O	B-T204
supseomense	O	O	I-T204
erected	O	O	B-T080
by	O	O	O
Rho	O	O	B-T170
&	O	O	O
Min	O	O	B-T170
(	O	O	O
2011	O	O	O
)	O	O	O
are	O	O	O
considered	O	O	O
as	O	O	O
invalid	O	O	B-T080
species	O	O	B-T185
while	O	O	O
Prochaetosoma	O	O	B-T204
arcticum	O	O	I-T204
,	O	O	O
P.	O	O	B-T204
lugubre	O	O	I-T204
and	O	O	O
Epsilonema	O	O	B-T204
cygnoides	O	O	I-T204
are	O	O	O
assumed	O	O	O
as	O	O	O
species	O	O	B-T185
inquirenda	O	O	I-T185
.	O	O	O

From	O	O	O
a	O	O	O
phylogenetic	O	O	B-T062
tree	O	O	I-T062
based	O	O	O
on	O	O	O
the	O	O	O
18S	O	O	B-T028
rRNA	O	O	I-T028
gene	O	O	I-T028
,	O	O	O
all	O	O	O
three	O	O	O
White	O	O	B-T083
Sea	O	O	I-T083
species	O	O	B-T185
adjoin	O	O	B-T082
to	O	O	O
unidentified	O	O	B-T080
species	O	O	O
of	O	O	O
their	O	O	O
respective	O	O	O
genera	O	O	B-T185
.	O	O	O

-DOCSTART- (27395442)

Differential	O	O	B-T080
effects	O	O	B-T080
of	O	O	I-T080
crude	O	O	B-T109
oil	O	O	I-T109
on	O	O	O
denitrification	O	O	B-T067
and	O	O	O
anammox	O	O	B-T044
,	O	O	O
and	O	O	O
the	O	O	O
impact	O	O	B-T080
on	O	O	O
N2O	O	O	B-T121
production	O	O	O

Denitrification	O	O	B-T067
and	O	O	O
anammox	O	O	B-T044
are	O	O	O
key	O	O	O
processes	O	O	B-T067
for	O	O	O
reducing	O	O	B-T080
the	O	O	O
external	O	O	B-T082
nitrogen	O	O	B-T123
loads	O	O	O
delivered	O	O	B-T169
to	O	O	O
coastal	O	O	B-T082
ecosystems	O	O	B-T070
,	O	O	O
and	O	O	O
these	O	O	O
processes	O	O	O
can	O	O	O
be	O	O	O
affected	O	O	B-T169
by	O	O	O
pollutants	O	O	B-T131
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
we	O	O	O
investigated	O	O	B-T169
the	O	O	O
effect	O	O	B-T080
of	O	O	I-T080
crude	O	O	B-T109
oil	O	O	I-T109
on	O	O	O
denitrification	O	O	B-T067
and	O	O	O
anammox	O	O	B-T044
.	O	O	O

Controlled	O	O	B-T062
laboratory	O	O	I-T062
experiments	O	O	I-T062
were	O	O	O
performed	O	O	O
using	O	O	O
sediment	O	O	B-T167
slurries	O	O	B-T167
from	O	O	O
the	O	O	O
Lima	O	O	B-T083
Estuary	O	O	B-T070
(	O	O	O
NW	O	O	B-T082
Portugal	O	O	B-T083
)	O	O	O
.	O	O	O

Anammox	O	O	B-T044
and	O	O	O
denitrification	O	O	B-T067
rates	O	O	B-T081
were	O	O	O
measured	O	O	O
using	O	O	O
(15)N-labeled	O	O	B-T196
NO3(-	O	O	B-T197
)	O	O	I-T197
,	O	O	O
and	O	O	O
the	O	O	O
production	O	O	B-T070
of	O	O	O
(29)N2	O	O	B-T123
and	O	O	O
(30)N2	O	O	B-T123
quantified	O	O	O
by	O	O	O
membrane	O	O	B-T059
inlet	O	O	I-T059
mass	O	O	I-T059
spectrometry	O	O	I-T059
.	O	O	O

Results	O	O	O
revealed	O	O	O
that	O	O	O
while	O	O	O
denitrification	O	O	B-T067
rates	O	O	B-T081
were	O	O	O
stimulated	O	O	O
between	O	O	O
10	O	O	O
and	O	O	O
25	O	O	O
000	O	O	O
times	O	O	O
after	O	O	O
crude	O	O	B-T109
oil	O	O	I-T109
amendment	O	O	B-T170
,	O	O	O
anammox	O	O	B-T044
activity	O	O	B-T052
was	O	O	O
partially	O	O	O
(	O	O	O
between	O	O	O
2	O	O	O
and	O	O	O
5	O	O	O
times	O	O	O
)	O	O	O
or	O	O	O
completely	O	O	B-T080
inhibited	O	O	B-T080
by	O	O	O
the	O	O	O
addition	O	O	B-T169
of	O	O	O
crude	O	O	O
oil	O	O	O
when	O	O	O
comparing	O	O	O
to	O	O	O
rates	O	O	O
in	O	O	O
unamended	O	O	B-T077
controls	O	O	I-T077
.	O	O	O

Similar	O	O	O
results	O	O	O
were	O	O	O
observed	O	O	O
across	O	O	O
four	O	O	O
estuarine	O	O	B-T082
sediment	O	O	B-T167
types	O	O	B-T080
,	O	O	O
despite	O	O	O
their	O	O	O
different	O	O	O
physical-chemical	O	O	B-T080
characteristics	O	O	I-T080
.	O	O	O

Moreover	O	O	O
,	O	O	O
N2O	O	O	B-T121
production	O	O	B-T070
was	O	O	O
reduced	O	O	B-T080
by	O	O	O
2	O	O	O
-	O	O	O
36	O	O	O
times	O	O	O
following	O	O	O
crude	O	O	B-T109
oil	O	O	I-T109
addition	O	O	B-T169
.	O	O	O

Further	O	O	O
work	O	O	O
is	O	O	O
required	O	O	O
to	O	O	O
fully	O	O	O
understand	O	O	O
the	O	O	O
mechanism(s	O	O	B-T169
)	O	O	I-T169
of	O	O	O
the	O	O	O
observed	O	O	B-T169
reduction	O	O	B-T080
in	O	O	O
N2O	O	O	B-T121
production	O	O	B-T070
.	O	O	O

This	O	O	O
study	O	O	B-T062
represents	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
first	O	O	O
contributions	O	O	B-T052
to	O	O	O
the	O	O	O
understanding	O	O	O
of	O	O	O
the	O	O	O
impact	O	O	B-T080
of	O	O	O
crude	O	O	B-T109
oil	O	O	I-T109
pollution	O	O	B-T069
on	O	O	O
denitrification	O	O	B-T067
and	O	O	O
anammox	O	O	B-T044
,	O	O	O
with	O	O	O
profound	O	O	O
implications	O	O	O
for	O	O	O
the	O	O	O
management	O	O	B-T057
of	O	O	O
aquatic	O	O	B-T067
ecosystems	O	O	B-T070
regarding	O	O	O
eutrophication	O	O	B-T067
(	O	O	O
N-removal	O	O	B-T052
)	O	O	O
.	O	O	O

-DOCSTART- (27397752)

Shining	O	O	O
the	O	O	O
light	O	O	O
on	O	O	O
the	O	O	O
dark	O	O	O
side	O	O	O
of	O	O	O
medical	O	O	B-T169
leadership	O	O	B-T054
-	O	O	O
a	O	O	O
qualitative	O	O	B-T062
study	O	O	I-T062
in	O	O	O
Australia	O	O	O

Purpose	O	O	O
The	O	O	O
paper	O	O	O
aims	O	O	B-T078
to	O	O	O
explore	O	O	O
the	O	O	O
beliefs	O	O	B-T078
of	O	O	O
doctors	O	O	B-T097
in	O	O	O
leadership	O	O	B-T054
roles	O	O	O
of	O	O	O
the	O	O	O
concept	O	O	B-T078
of	O	O	O
"	O	O	O
the	O	O	O
dark	O	O	O
side	O	O	O
"	O	O	O
,	O	O	O
using	O	O	O
data	O	O	B-T078
collected	O	O	O
from	O	O	O
interviews	O	O	B-T052
carried	O	O	O
out	O	O	O
with	O	O	O
45	O	O	O
doctors	O	O	O
in	O	O	O
medical	O	O	B-T169
leadership	O	O	O
roles	O	O	O
across	O	O	O
Australia	O	O	B-T083
.	O	O	O

The	O	O	O
paper	O	O	O
looks	O	O	O
at	O	O	O
the	O	O	O
beliefs	O	O	B-T078
from	O	O	O
the	O	O	O
perspectives	O	O	B-T078
of	O	O	O
doctors	O	O	B-T097
who	O	O	O
are	O	O	O
already	O	O	O
in	O	O	O
leadership	O	O	B-T054
roles	O	O	O
themselves	O	O	O
;	O	O	O
to	O	O	O
identify	O	O	O
potential	O	O	O
barriers	O	O	B-T033
they	O	O	O
might	O	O	O
have	O	O	O
encountered	O	O	O
and	O	O	O
to	O	O	O
arrive	O	O	O
at	O	O	O
better-informed	O	O	O
strategies	O	O	O
to	O	O	O
engage	O	O	O
more	O	O	O
doctors	O	O	O
in	O	O	O
the	O	O	O
leadership	O	O	O
of	O	O	O
the	O	O	O
Australian	O	O	B-T098
health	O	O	B-T064
system	O	O	I-T064
.	O	O	O

The	O	O	O
research	O	O	B-T062
question	O	O	O
is	O	O	O
:	O	O	O
"	O	O	O
What	O	O	O
are	O	O	O
the	O	O	O
beliefs	O	O	B-T078
of	O	O	O
medical	O	O	B-T169
leaders	O	O	B-T097
that	O	O	O
form	O	O	O
the	O	O	O
key	O	O	O
themes	O	O	B-UnknownType
or	O	O	O
dimensions	O	O	B-T081
of	O	O	O
the	O	O	O
negative	O	O	O
perception	O	O	O
of	O	O	O
the	O	O	O
'	O	O	O
dark	O	O	O
side	O	O	O
'	O	O	O
?	O	O	O
"	O	O	O
.	O	O	O

Design/methodology/approach	O	O	O
The	O	O	O
paper	O	O	O
analysed	O	O	O
data	O	O	B-T078
from	O	O	O
two	O	O	O
similar	O	O	O
qualitative	O	O	B-T062
studies	O	O	I-T062
examining	O	O	O
medical	O	O	B-T169
leadership	O	O	B-T054
and	O	O	O
engagement	O	O	O
in	O	O	O
Australia	O	O	B-T083
by	O	O	O
the	O	O	O
same	O	O	O
author	O	O	O
,	O	O	O
in	O	O	O
collaboration	O	O	B-T054
with	O	O	O
other	O	O	O
researchers	O	O	B-T097
,	O	O	O
which	O	O	O
used	O	O	O
in-depth	O	O	O
semi-structured	O	O	B-UnknownType
interviews	O	O	I-UnknownType
with	O	O	O
45	O	O	O
purposively	O	O	O
sampled	O	O	O
senior	O	O	O
medical	O	O	O
leaders	O	O	B-T097
in	O	O	O
leadership	O	O	O
roles	O	O	O
across	O	O	O
Australia	O	O	O
in	O	O	O
health	O	O	B-T058
services	O	O	I-T058
,	O	O	O
private	O	O	B-T093
and	O	O	O
public	O	O	B-T093
hospitals	O	O	I-T093
,	O	O	O
professional	O	O	B-T094
associations	O	O	I-T094
and	O	O	O
health	O	O	B-T093
departments	O	O	I-T093
.	O	O	O

The	O	O	O
data	O	O	B-T078
were	O	O	O
analysed	O	O	O
using	O	O	O
deductive	O	O	O
and	O	O	O
inductive	O	O	O
approaches	O	O	B-T082
through	O	O	O
a	O	O	O
coding	O	O	B-T057
framework	O	O	O
based	O	O	O
on	O	O	O
the	O	O	O
interview	O	O	B-T052
data	O	O	O
and	O	O	O
literature	O	O	B-T170
review	O	O	I-T170
,	O	O	O
with	O	O	O
all	O	O	O
sections	O	O	O
of	O	O	O
coded	O	O	B-T057
data	O	O	O
grouped	O	O	B-T078
into	O	O	O
themes	O	O	B-UnknownType
.	O	O	O

Findings	O	O	O
Medical	O	O	B-T169
leaders	O	O	B-T097
had	O	O	O
four	O	O	O
key	O	O	O
beliefs	O	O	B-T078
about	O	O	O
the	O	O	O
"	O	O	O
dark	O	O	O
side	O	O	O
"	O	O	O
as	O	O	O
perceived	O	O	O
through	O	O	O
the	O	O	O
eyes	O	O	B-T023
of	O	O	O
their	O	O	O
own	O	O	O
past	O	O	O
clinical	O	O	B-T080
experience	O	O	I-T080
and/or	O	O	O
their	O	O	O
clinical	O	O	O
colleagues	O	O	B-T098
.	O	O	O

These	O	O	O
four	O	O	O
beliefs	O	O	B-T078
or	O	O	O
dimensions	O	O	B-T081
of	O	O	O
the	O	O	O
negative	O	O	O
perception	O	O	O
colloquially	O	O	O
known	O	O	O
as	O	O	O
"	O	O	O
the	O	O	O
dark	O	O	O
side	O	O	O
"	O	O	O
are	O	O	O
the	O	O	O
belief	O	O	B-T078
that	O	O	O
they	O	O	O
lack	O	O	O
both	O	O	O
managerial	O	O	B-T090
and	O	O	O
clinical	O	O	B-T080
credibility	O	O	B-T080
,	O	O	O
they	O	O	O
have	O	O	O
confused	O	O	O
identities	O	O	O
,	O	O	O
they	O	O	O
may	O	O	O
be	O	O	O
in	O	O	O
conflict	O	O	B-T078
with	O	O	O
clinicians	O	O	B-T097
,	O	O	O
their	O	O	O
clinical	O	O	O
colleagues	O	O	B-T098
lack	O	O	O
insight	O	O	O
into	O	O	O
the	O	O	O
complexities	O	O	O
of	O	O	O
medical	O	O	B-T169
leadership	O	O	B-T054
and	O	O	O
,	O	O	O
as	O	O	O
a	O	O	O
result	O	O	O
,	O	O	O
doctors	O	O	B-T097
are	O	O	O
actively	O	O	O
discouraged	O	O	O
from	O	O	O
making	O	O	O
the	O	O	O
transition	O	O	O
from	O	O	O
clinical	O	O	B-T080
practice	O	O	I-T080
to	O	O	O
medical	O	O	O
leadership	O	O	O
roles	O	O	O
in	O	O	O
the	O	O	O
first	O	O	O
place	O	O	O
.	O	O	O

Research	O	O	O
limitations/implications	O	O	O
This	O	O	O
research	O	O	B-T062
was	O	O	O
conducted	O	O	O
within	O	O	O
the	O	O	O
Western	O	O	B-T082
developed-nation	O	O	B-T080
setting	O	O	O
of	O	O	O
Australia	O	O	B-T083
and	O	O	O
only	O	O	O
involved	O	O	O
interviews	O	O	B-T052
with	O	O	O
doctors	O	O	B-T097
in	O	O	O
medical	O	O	B-T169
leadership	O	O	B-T054
roles	O	O	O
.	O	O	O

The	O	O	O
findings	O	O	O
are	O	O	O
therefore	O	O	O
limited	O	O	O
to	O	O	O
the	O	O	O
doctors	O	O	B-T097
'	O	O	O
own	O	O	O
perceptions	O	O	O
of	O	O	O
themselves	O	O	O
based	O	O	O
on	O	O	O
their	O	O	O
past	O	O	O
experiences	O	O	O
and	O	O	O
beliefs	O	O	B-T078
.	O	O	O

Future	O	O	O
research	O	O	B-T062
involving	O	O	O
doctors	O	O	B-T097
who	O	O	O
have	O	O	O
not	O	O	O
chosen	O	O	O
to	O	O	O
transition	O	O	B-T052
to	O	O	O
leadership	O	O	B-T054
roles	O	O	O
,	O	O	O
or	O	O	O
other	O	O	O
health	O	O	B-T097
practitioners	O	O	I-T097
in	O	O	O
other	O	O	O
settings	O	O	O
,	O	O	O
may	O	O	O
provide	O	O	O
a	O	O	O
broader	O	O	O
perspective	O	O	B-T078
.	O	O	O

Also	O	O	O
,	O	O	O
this	O	O	O
research	O	O	B-T062
was	O	O	O
exploratory	O	O	O
and	O	O	O
descriptive	O	O	B-T033
in	O	O	O
nature	O	O	O
using	O	O	O
qualitative	O	O	B-T062
methods	O	O	I-T062
,	O	O	O
and	O	O	O
quantitative	O	O	B-T062
research	O	O	I-T062
can	O	O	O
be	O	O	O
carried	O	O	O
out	O	O	O
in	O	O	O
the	O	O	O
future	O	O	O
to	O	O	O
extend	O	O	O
this	O	O	O
research	O	O	O
for	O	O	O
statistical	O	O	B-T062
generalisation	O	O	I-T062
.	O	O	O

Practical	O	O	O
implications	O	O	O
The	O	O	O
paper	O	O	O
includes	O	O	O
implications	O	O	O
for	O	O	O
health	O	O	B-T093
organisations	O	O	I-T093
,	O	O	O
training	O	O	O
providers	O	O	O
,	O	O	O
medical	O	O	B-T169
employers	O	O	B-T097
and	O	O	O
health	O	O	B-T093
departments	O	O	I-T093
and	O	O	O
describes	O	O	O
a	O	O	O
multi-prong	O	O	O
strategy	O	O	O
to	O	O	O
address	O	O	O
this	O	O	O
important	O	O	O
issue	O	O	O
.	O	O	O

Originality/value	O	O	O
This	O	O	O
paper	O	O	O
fulfils	O	O	O
an	O	O	O
identified	O	O	O
need	O	O	O
to	O	O	O
study	O	O	B-T062
the	O	O	O
concept	O	O	B-T078
of	O	O	O
"	O	O	O
moving	O	O	O
to	O	O	O
the	O	O	O
dark	O	O	O
side	O	O	O
"	O	O	O
as	O	O	O
a	O	O	O
negative	O	O	O
perception	O	O	O
of	O	O	O
medical	O	O	B-T169
leadership	O	O	B-T054
and	O	O	O
contributes	O	O	O
to	O	O	O
the	O	O	O
evidence	O	O	B-T078
in	O	O	O
this	O	O	O
under-	O	O	O
researched	O	O	B-T062
area	O	O	O
.	O	O	O

This	O	O	O
paper	O	O	O
has	O	O	O
used	O	O	O
data	O	O	B-T078
from	O	O	O
two	O	O	O
similar	O	O	O
studies	O	O	B-T062
,	O	O	O
combined	O	O	O
together	O	O	O
for	O	O	O
the	O	O	O
first	O	O	O
time	O	O	O
,	O	O	O
with	O	O	O
new	O	O	O
analysis	O	O	B-T062
and	O	O	O
coding	O	O	B-T057
,	O	O	O
looking	O	O	O
at	O	O	O
the	O	O	O
concept	O	O	B-T078
of	O	O	O
the	O	O	O
"	O	O	O
dark	O	O	O
side	O	O	O
"	O	O	O
to	O	O	O
discover	O	O	O
new	O	O	O
emergent	O	O	O
findings	O	O	O
.	O	O	O

-DOCSTART- (27400734)

Erlotinib	O	O	B-T109
plus	O	O	O
gemcitabine	O	O	B-T114
versus	O	O	O
gemcitabine	O	O	O
for	O	O	O
pancreatic	O	O	B-T191
cancer	O	O	I-T191
:	O	O	O
real	O	O	B-T080
-	O	O	O
world	O	O	B-T098
analysis	O	O	B-T062
of	O	O	O
Korean	O	O	B-T083
national	O	O	B-T092
database	O	O	O

A	O	O	O
randomized	O	O	B-T062
clinical	O	O	I-T062
trial	O	O	I-T062
has	O	O	O
found	O	O	O
that	O	O	O
the	O	O	O
addition	O	O	B-T067
of	O	O	O
erlotinib	O	O	B-T109
to	O	O	O
gemcitabine	O	O	B-T114
(	O	O	O
GEM	O	O	B-T114
-	O	O	O
E	O	O	B-T109
)	O	O	O
for	O	O	O
pancreatic	O	O	B-T191
cancer	O	O	I-T191
led	O	O	O
to	O	O	O
a	O	O	O
modest	O	O	B-T080
increase	O	O	B-T169
in	O	O	O
survival	O	O	B-T052
.	O	O	O

The	O	O	O
aim	O	O	B-T078
of	O	O	O
this	O	O	O
national	O	O	B-T082
population	O	O	B-T098
-	O	O	O
based	O	O	B-T169
retrospective	O	O	B-T062
study	O	O	I-T062
was	O	O	O
to	O	O	O
compare	O	O	B-T052
the	O	O	O
effectiveness	O	O	B-T080
of	O	O	O
GEM	O	O	B-T114
-	O	O	O
E	O	O	B-T109
to	O	O	O
GEM	O	O	O
alone	O	O	O
for	O	O	O
pancreatic	O	O	B-T191
cancer	O	O	I-T191
patients	O	O	B-T101
in	O	O	O
real	O	O	B-T057
clinical	O	O	I-T057
practice	O	O	I-T057
.	O	O	O

Patients	O	O	B-T101
with	O	O	O
pancreatic	O	O	B-T191
cancer	O	O	I-T191
(	O	O	B-T170
ICD-10	O	O	I-T170
:	O	O	O
C25	O	O	O
)	O	O	O
with	O	O	O
prescription	O	O	B-T170
claims	O	O	O
of	O	O	O
gemcitabine	O	O	B-T114
or	O	O	O
erlotinib	O	O	B-T109
between	O	O	O
Jan	O	O	O
1	O	O	O
,	O	O	O
2007	O	O	O
and	O	O	O
Dec	O	O	O
31	O	O	O
,	O	O	O
2012	O	O	O
were	O	O	O
retrospectively	O	O	B-T080
identified	O	O	B-T080
from	O	O	O
the	O	O	O
Korean	O	O	B-T083
Health	O	O	B-T058
Insurance	O	O	I-T058
claims	O	O	O
database	O	O	B-T170
.	O	O	O

To	O	O	O
be	O	O	O
included	O	O	O
in	O	O	O
the	O	O	O
study	O	O	B-T062
population	O	O	B-T098
,	O	O	O
patients	O	O	B-T101
were	O	O	O
required	O	O	B-T169
to	O	O	O
have	O	O	O
had	O	O	O
a	O	O	O
histological	O	O	B-UnknownType
or	O	O	O
cytological	O	O	B-T033
diagnosis	O	O	I-T033
within	O	O	O
one	O	O	O
year	O	O	O
before	O	O	O
chemotherapy	O	O	B-T061
.	O	O	O

Patients	O	O	B-T101
treated	O	O	B-T033
with	O	O	I-T033
prior	O	O	O
radiotherapy	O	O	B-T061
,	O	O	O
surgery	O	O	B-T058
,	O	O	O
or	O	O	O
chemotherapy	O	O	B-T061
were	O	O	O
excluded	O	O	B-T078
to	O	O	O
reduce	O	O	B-T061
heterogeneity	O	O	B-T080
.	O	O	O

Overall	O	O	O
survival	O	O	B-T052
from	O	O	O
the	O	O	O
initiation	O	O	B-T169
of	O	O	O
therapy	O	O	B-T061
and	O	O	O
the	O	O	O
medical	O	O	B-T081
costs	O	O	I-T081
of	O	O	O
GEM	O	O	B-T114
-	O	O	O
E	O	O	B-T109
and	O	O	O
GEM	O	O	O
were	O	O	O
compared	O	O	B-T052
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
4,267	O	O	O
patients	O	O	B-T101
were	O	O	O
included	O	O	O
in	O	O	O
the	O	O	O
analysis	O	O	B-T062
.	O	O	O

Overall	O	O	O
survival	O	O	B-T052
was	O	O	O
not	O	O	O
significantly	O	O	B-T078
longer	O	O	B-T080
in	O	O	O
patients	O	O	B-T101
treated	O	O	B-T033
with	O	O	O
GEM	O	O	B-T114
-	O	O	O
E	O	O	B-T109
(	O	O	O
median	O	O	B-T081
6.77	O	O	O
months	O	O	O
for	O	O	O
GEM	O	O	O
-	O	O	O
E	O	O	O
vs.	O	O	O
6.68	O	O	O
months	O	O	O
for	O	O	O
GEM	O	O	O
,	O	O	O
p	O	O	O
=	O	O	O
0.0977	O	O	O
)	O	O	O
.	O	O	O

There	O	O	O
was	O	O	O
also	O	O	O
no	O	O	B-T033
significant	O	O	I-T033
difference	O	O	B-T081
in	O	O	O
the	O	O	O
respective	O	O	O
one-year	O	O	O
survival	O	O	B-T081
rates	O	O	I-T081
(	O	O	O
27.0	O	O	O
%	O	O	O
vs.	O	O	O
27.3	O	O	O
%	O	O	O
;	O	O	O
p	O	O	O
=	O	O	O
0.5988	O	O	O
)	O	O	O
.	O	O	O

Multivariate	O	O	B-T081
analysis	O	O	I-T081
using	O	O	O
age	O	O	B-T032
,	O	O	O
gender	O	O	B-T032
,	O	O	O
and	O	O	O
comorbidities	O	O	B-T078
as	O	O	O
covariates	O	O	B-UnknownType
did	O	O	O
not	O	O	O
reveal	O	O	B-T080
any	O	O	O
significant	O	O	B-T078
differences	O	O	B-T081
in	O	O	O
survival	O	O	B-T052
.	O	O	O

Based	O	O	B-T169
on	O	O	O
this	O	O	O
relative	O	O	B-T081
effectiveness	O	O	I-T081
,	O	O	O
the	O	O	O
incremental	O	O	B-T081
cost	O	O	B-T081
per	O	O	O
life	O	O	B-T078
year	O	O	B-T079
gained	O	O	B-T081
over	O	O	O
GEM	O	O	B-T114
was	O	O	O
estimated	O	O	B-T081
at	O	O	O
USD	O	O	B-T081
70,843.64	O	O	O
for	O	O	O
GEM	O	O	O
-	O	O	O
E.	O	O	O
GEM	O	O	O
-	O	O	O
E	O	O	B-T109
for	O	O	O
pancreatic	O	O	B-T191
cancer	O	O	I-T191
is	O	O	O
not	O	O	O
more	O	O	O
effective	O	O	B-T080
than	O	O	O
GEM	O	O	O
in	O	O	O
a	O	O	O
real	O	O	B-T080
-	O	O	O
world	O	O	B-T098
setting	O	O	B-T078
,	O	O	O
and	O	O	O
it	O	O	O
does	O	O	O
not	O	O	O
provide	O	O	B-T052
reasonable	O	O	B-T033
cost-effectiveness	O	O	B-T081
over	O	O	O
GEM	O	O	O
.	O	O	O

-DOCSTART- (27401409)

Development	O	O	O
of	O	O	O
a	O	O	O
Novel	O	O	O
Quantitative	O	O	B-T081
Structure-Activity	O	O	I-T081
Relationship	O	O	I-T081
Model	O	O	B-T170
to	O	O	O
Accurately	O	O	O
Predict	O	O	O
Pulmonary	O	O	B-T042
Absorption	O	O	I-T042
and	O	O	O
Replace	O	O	O
Routine	O	O	O
Use	O	O	O
of	O	O	O
the	O	O	O
Isolated	O	O	B-T169
Perfused	O	O	B-T169
Respiring	O	O	B-T039
Rat	O	O	B-T023
Lung	O	O	I-T023
Model	O	O	O

We	O	O	O
developed	O	O	O
and	O	O	O
tested	O	O	O
a	O	O	O
novel	O	O	O
Quantitative	O	O	B-T081
Structure-Activity	O	O	I-T081
Relationship	O	O	I-T081
(	O	O	O
QSAR	O	O	B-T081
)	O	O	O
model	O	O	B-T170
to	O	O	O
better	O	O	O
understand	O	O	O
the	O	O	O
physicochemical	O	O	B-T070
drivers	O	O	O
of	O	O	O
pulmonary	O	O	B-T042
absorption	O	O	B-T067
,	O	O	O
and	O	O	O
to	O	O	O
facilitate	O	O	O
compound	O	O	B-T090
design	O	O	I-T090
through	O	O	O
improved	O	O	O
prediction	O	O	B-T078
of	O	O	O
absorption	O	O	O
.	O	O	O

The	O	O	O
model	O	O	B-T170
was	O	O	O
tested	O	O	O
using	O	O	O
a	O	O	O
large	O	O	O
array	O	O	O
of	O	O	O
both	O	O	O
existing	O	O	O
and	O	O	O
newly	O	O	O
designed	O	O	O
compounds	O	O	B-T121
.	O	O	O

Pulmonary	O	O	B-T042
absorption	O	O	I-T042
data	O	O	O
was	O	O	O
generated	O	O	O
using	O	O	O
the	O	O	O
isolated	O	O	B-T169
perfused	O	O	B-T169
respiring	O	O	B-T039
rat	O	O	B-T023
lung	O	O	I-T023
(	O	O	O
IPRLu	O	O	B-T023
)	O	O	O
model	O	O	B-T170
for	O	O	O
82	O	O	O
drug	O	O	B-T062
discovery	O	O	I-T062
compounds	O	O	B-T121
and	O	O	O
17	O	O	O
marketed	O	O	B-T121
drugs	O	O	I-T121
.	O	O	O

This	O	O	O
dataset	O	O	O
was	O	O	O
used	O	O	O
to	O	O	O
build	O	O	O
a	O	O	O
novel	O	O	O
QSAR	O	O	B-T081
model	O	O	B-T170
based	O	O	O
on	O	O	O
calculated	O	O	O
physicochemical	O	O	B-T070
properties	O	O	I-T070
.	O	O	O

A	O	O	O
further	O	O	O
9	O	O	O
compounds	O	O	B-T121
were	O	O	O
used	O	O	O
to	O	O	O
test	O	O	O
the	O	O	O
model	O	O	B-T170
's	O	O	I-T170
predictive	O	O	O
capability	O	O	B-T080
.	O	O	O

The	O	O	O
QSAR	O	O	B-T081
model	O	O	B-T170
performed	O	O	O
well	O	O	O
on	O	O	O
the	O	O	O
9	O	O	O
compounds	O	O	B-T121
in	O	O	O
the	O	O	O
"	O	O	O
Test	O	O	B-T170
set	O	O	I-T170
"	O	O	O
with	O	O	O
a	O	O	O
predicted	O	O	O
versus	O	O	O
observed	O	O	O
correlation	O	O	B-T081
of	O	O	O
R(2	O	O	O
)	O	O	O
=	O	O	O
0.85	O	O	O
,	O	O	O
and	O	O	O
>	O	O	O
65	O	O	O
%	O	O	O
of	O	O	O
compounds	O	O	O
correctly	O	O	O
categorised	O	O	O
.	O	O	O

Calculated	O	O	O
descriptors	O	O	O
associated	O	O	O
with	O	O	O
permeability	O	O	B-T070
and	O	O	O
hydrophobicity	O	O	B-T080
positively	O	O	O
correlated	O	O	O
with	O	O	O
pulmonary	O	O	B-T042
absorption	O	O	I-T042
,	O	O	O
whereas	O	O	O
those	O	O	O
associated	O	O	O
with	O	O	O
charge	O	O	B-T080
,	O	O	O
ionisation	O	O	B-T067
and	O	O	O
size	O	O	B-T082
negatively	O	O	O
correlated	O	O	O
.	O	O	O

The	O	O	O
novel	O	O	O
QSAR	O	O	B-T081
model	O	O	B-T170
described	O	O	O
here	O	O	O
can	O	O	O
replace	O	O	O
routine	O	O	O
generation	O	O	O
of	O	O	O
IPRLu	O	O	B-T023
model	O	O	O
data	O	O	O
for	O	O	O
ranking	O	O	B-T170
and	O	O	O
classifying	O	O	B-T185
compounds	O	O	B-T121
prior	O	O	O
to	O	O	O
synthesis	O	O	B-T052
.	O	O	O

It	O	O	O
will	O	O	O
also	O	O	O
provide	O	O	O
scientists	O	O	O
working	O	O	O
in	O	O	O
the	O	O	O
field	O	O	O
of	O	O	O
inhaled	O	O	B-T062
drug	O	O	I-T062
discovery	O	O	I-T062
with	O	O	O
a	O	O	O
deeper	O	O	O
understanding	O	O	O
of	O	O	O
the	O	O	O
physicochemical	O	O	B-T070
drivers	O	O	O
of	O	O	O
pulmonary	O	O	B-T042
absorption	O	O	I-T042
based	O	O	O
on	O	O	O
a	O	O	O
relevant	O	O	O
respiratory	O	O	O
compound	O	O	B-T121
dataset	O	O	B-T170
.	O	O	O

-DOCSTART- (27402480)

The	O	O	O
EpiDerm	O	O	B-T170
â¢	O	O	I-T170
3D	O	O	B-T059
human	O	O	I-T059
reconstructed	O	O	I-T059
skin	O	O	I-T059
micronucleus	O	O	I-T059
(	O	O	I-T059
RSMN	O	O	I-T059
)	O	O	I-T059
assay	O	O	I-T059
:	O	O	O
Historical	O	O	B-T062
control	O	O	I-T062
data	O	O	B-T078
and	O	O	O
proof	O	O	B-T033
of	O	O	O
principle	O	O	B-T062
studies	O	O	I-T062
for	O	O	O
mechanistic	O	O	B-T059
assay	O	O	I-T059
adaptations	O	O	O

The	O	O	O
in	O	O	B-T059
vitro	O	O	I-T059
human	O	O	I-T059
reconstructed	O	O	I-T059
skin	O	O	I-T059
micronucleus	O	O	I-T059
(	O	O	I-T059
RSMN	O	O	I-T059
)	O	O	I-T059
assay	O	O	I-T059
in	O	O	O
EpiDerm	O	O	B-T170
â¢	O	O	I-T170
is	O	O	O
a	O	O	O
promising	O	O	O
novel	O	O	O
animal	O	O	B-T062
alternative	O	O	I-T062
for	O	O	O
evaluating	O	O	O
genotoxicity	O	O	B-T049
of	O	O	O
topically	O	O	B-T061
applied	O	O	I-T061
chemicals	O	O	B-T103
.	O	O	O

It	O	O	O
is	O	O	O
particularly	O	O	O
useful	O	O	O
for	O	O	O
assessing	O	O	B-T058
cosmetic	O	O	B-T120
ingredients	O	O	I-T120
that	O	O	O
can	O	O	O
no	O	O	O
longer	O	O	O
be	O	O	O
tested	O	O	B-T169
using	O	O	O
in	O	O	B-T082
vivo	O	O	I-T082
assays	O	O	B-T059
.	O	O	O

To	O	O	O
advance	O	O	O
the	O	O	O
use	O	O	O
of	O	O	O
this	O	O	O
test	O	O	B-T170
especially	O	O	O
for	O	O	O
regulatory	O	O	B-T089
decision-making	O	O	B-T041
,	O	O	O
we	O	O	O
have	O	O	O
established	O	O	O
the	O	O	O
RSMN	O	O	B-T059
assay	O	O	I-T059
in	O	O	O
our	O	O	O
laboratory	O	O	B-T093
according	O	O	O
to	O	O	O
Good	O	O	B-T185
Laboratory	O	O	I-T185
Practice	O	O	I-T185
and	O	O	O
following	O	O	O
the	O	O	O
principles	O	O	O
of	O	O	O
the	O	O	O
OECD	O	O	B-T093
test	O	O	B-T170
guideline	O	O	I-T170
487	O	O	I-T170
in	O	O	B-T080
vitro	O	O	I-T080
mammalian	O	O	B-T025
cell	O	O	I-T025
micronucleus	O	O	B-T059
test	O	O	I-T059
.	O	O	O

Proficiency	O	O	O
with	O	O	O
the	O	O	O
assay	O	O	B-T059
was	O	O	O
established	O	O	O
by	O	O	O
correctly	O	O	O
identifying	O	O	O
direct-acting	O	O	B-T131
genotoxins	O	O	B-T131
and	O	O	O
genotoxins	O	O	O
requiring	O	O	O
metabolism	O	O	B-T040
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
non-genotoxic	O	O	B-T033
/	O	O	O
non-carcinogenic	O	O	B-T033
chemicals	O	O	B-T103
.	O	O	O

We	O	O	O
also	O	O	O
report	O	O	B-T170
the	O	O	O
analysis	O	O	B-T062
of	O	O	O
our	O	O	O
historical	O	O	B-T062
control	O	O	I-T062
data	O	O	B-T078
that	O	O	O
demonstrate	O	O	O
vehicle	O	O	O
control	O	O	O
and	O	O	O
positive	O	O	B-T077
control	O	O	I-T077
values	O	O	B-T081
for	O	O	O
%	O	O	O
micronuclei	O	O	B-T026
in	O	O	O
binucleated	O	O	B-T049
cells	O	O	I-T049
are	O	O	O
in	O	O	O
the	O	O	O
ranges	O	O	O
reported	O	O	O
previously	O	O	O
.	O	O	O

Technical	O	O	B-T067
issues	O	O	I-T067
including	O	O	O
evaluating	O	O	O
various	O	O	O
solvents	O	O	B-T130
with	O	O	O
both	O	O	O
48h	O	O	O
and	O	O	O
72h	O	O	O
treatment	O	O	B-T061
regimens	O	O	I-T061
were	O	O	O
investigated	O	O	B-T169
.	O	O	O

For	O	O	O
the	O	O	O
first	O	O	O
time	O	O	O
,	O	O	O
mechanistic	O	O	B-T089
studies	O	O	I-T089
using	O	O	O
CREST	O	O	B-T062
analysis	O	O	I-T062
revealed	O	O	O
that	O	O	O
the	O	O	O
RSMN	O	O	B-T059
assay	O	O	I-T059
is	O	O	O
suitable	O	O	O
for	O	O	O
distinguishing	O	O	O
aneugens	O	O	B-T120
and	O	O	O
clastogens	O	O	B-T131
.	O	O	O

Moreover	O	O	O
,	O	O	O
the	O	O	O
assay	O	O	B-T059
is	O	O	O
also	O	O	O
suitable	O	O	O
for	O	O	O
measuring	O	O	O
cytokines	O	O	B-T116
as	O	O	O
markers	O	O	B-T080
for	O	O	O
proliferative	O	O	B-T046
and	O	O	O
toxic	O	O	B-T037
effects	O	O	I-T037
of	O	O	O
chemicals	O	O	B-T103
.	O	O	O

-DOCSTART- (27402827)

Wnt-5a	O	O	B-T116
/	O	O	O
Frizzled9	O	O	B-T116
receptor	O	O	B-T044
signaling	O	O	I-T044
through	O	O	O
the	O	O	O
GÎ±o	O	O	B-T116
/	O	O	O
GÎ²Î³	O	O	B-T116
complex	O	O	I-T116
regulates	O	O	B-T038
dendritic	O	O	B-T026
spine	O	O	I-T026
formation	O	O	O

Wnt	O	O	B-T116
ligands	O	O	I-T116
play	O	O	O
crucial	O	O	O
roles	O	O	O
in	O	O	O
the	O	O	O
development	O	O	B-T042
and	O	O	O
regulation	O	O	B-T042
of	O	O	I-T042
synapse	O	O	I-T042
structure	O	O	I-T042
and	O	O	I-T042
function	O	O	I-T042
.	O	O	O

Specifically	O	O	O
,	O	O	O
Wnt-5a	O	O	B-T116
acts	O	O	O
as	O	O	O
a	O	O	O
secreted	O	O	B-T116
growth	O	O	I-T116
factor	O	O	I-T116
that	O	O	O
regulates	O	O	B-T038
dendritic	O	O	B-T026
spine	O	O	I-T026
formation	O	O	B-T043
in	O	O	O
rodent	O	O	B-T015
hippocampal	O	O	B-T023
neurons	O	O	B-T025
,	O	O	O
resulting	O	O	O
in	O	O	O
postsynaptic	O	O	B-T026
development	O	O	B-T042
that	O	O	O
promotes	O	O	O
the	O	O	O
clustering	O	O	B-T043
of	O	O	I-T043
the	O	O	I-T043
postsynaptic	O	O	I-T043
density	O	O	I-T043
protein-95	O	O	I-T043
(	O	O	I-T043
PSD-95	O	O	I-T043
)	O	O	I-T043
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
focused	O	O	O
on	O	O	O
the	O	O	O
early	O	O	B-T079
events	O	O	B-T051
occurring	O	O	O
after	O	O	O
the	O	O	O
interaction	O	O	B-T044
between	O	O	O
Wnt-5a	O	O	B-T116
and	O	O	O
its	O	O	O
Frizzled	O	O	B-T116
receptor	O	O	I-T116
at	O	O	O
the	O	O	O
neuronal	O	O	B-T025
cell	O	O	B-T026
surface	O	O	I-T026
.	O	O	O

Additionally	O	O	O
,	O	O	O
we	O	O	O
studied	O	O	O
the	O	O	O
role	O	O	B-T077
of	O	O	O
heterotrimeric	O	O	B-T116
G	O	O	I-T116
proteins	O	O	I-T116
in	O	O	O
Wnt-5a	O	O	B-T116
-dependent	O	O	O
synaptic	O	O	B-T026
development	O	O	B-T042
.	O	O	O

We	O	O	O
report	O	O	O
that	O	O	O
Frizzled9	O	O	B-T116
(	O	O	O
FZD9	O	O	B-T116
)	O	O	O
,	O	O	O
a	O	O	O
Wnt	O	O	B-T116
receptor	O	O	B-T116
related	O	O	O
to	O	O	O
Williams	O	O	B-T047
'	O	O	I-T047
syndrome	O	O	I-T047
,	O	O	O
is	O	O	O
localized	O	O	O
in	O	O	O
the	O	O	O
postsynaptic	O	O	B-UnknownType
region	O	O	I-UnknownType
,	O	O	O
where	O	O	O
it	O	O	O
interacts	O	O	B-T044
with	O	O	O
Wnt-5a	O	O	B-T116
.	O	O	O

Functionally	O	O	O
,	O	O	O
FZD9	O	O	B-T116
is	O	O	O
required	O	O	O
for	O	O	O
the	O	O	O
Wnt-5a	O	O	B-T116
-mediated	O	O	O
increase	O	O	B-T169
in	O	O	O
dendritic	O	O	B-T026
spine	O	O	I-T026
density	O	O	I-T026
.	O	O	O

FZD9	O	O	B-T116
forms	O	O	O
a	O	O	O
pre-coupled	O	O	B-T026
complex	O	O	I-T026
with	O	O	O
GÎ±o	O	O	B-T116
under	O	O	O
basal	O	O	B-T070
conditions	O	O	I-T070
that	O	O	O
dissociates	O	O	B-T044
after	O	O	O
Wnt-5a	O	O	B-T116
stimulation	O	O	B-T044
.	O	O	O

Accordingly	O	O	O
,	O	O	O
we	O	O	O
found	O	O	O
that	O	O	O
G-protein	O	O	B-T043
inhibition	O	O	I-T043
abrogates	O	O	I-T043
Wnt-5a	O	O	B-T116
-dependent	O	O	O
pathway	O	O	B-T044
in	O	O	O
hippocampal	O	O	B-T023
neurons	O	O	B-T025
.	O	O	O

In	O	O	O
particular	O	O	O
,	O	O	O
the	O	O	O
activation	O	O	B-T052
of	O	O	O
GÎ±o	O	O	B-T116
appears	O	O	O
to	O	O	O
be	O	O	O
a	O	O	O
key	O	O	O
factor	O	O	O
controlling	O	O	B-T067
the	O	O	O
Wnt-5a	O	O	B-T116
-	O	O	O
induced	O	O	B-T169
dendritic	O	O	B-T026
spine	O	O	I-T026
density	O	O	I-T026
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
we	O	O	O
found	O	O	O
that	O	O	O
GÎ²Î³	O	O	B-T116
is	O	O	O
required	O	O	O
for	O	O	O
the	O	O	O
Wnt-5a	O	O	B-T116
-mediated	O	O	O
increase	O	O	B-T169
in	O	O	O
cytosolic	O	O	B-T026
calcium	O	O	B-T121
levels	O	O	B-T080
and	O	O	O
spinogenesis	O	O	B-T043
.	O	O	O

Our	O	O	O
findings	O	O	B-T169
reveal	O	O	O
that	O	O	O
FZD9	O	O	B-T116
and	O	O	O
heterotrimeric	O	O	B-T116
G	O	O	I-T116
proteins	O	O	I-T116
regulate	O	O	B-T038
Wnt-5a	O	O	B-T116
signaling	O	O	B-T044
and	O	O	O
dendritic	O	O	B-T026
spines	O	O	I-T026
in	O	O	O
cultured	O	O	B-T025
hippocampal	O	O	B-T023
neurons	O	O	B-T025
.	O	O	O

-DOCSTART- (27403105)

A	O	O	O
Delayed	O	O	B-T079
Diagnosis	O	O	B-T033
of	O	O	O
Chronic	O	O	B-T047
Mesenteric	O	O	I-T047
Ischaemia	O	O	I-T047
:	O	O	O
The	O	O	O
Role	O	O	O
of	O	O	O
Clinicians	O	O	B-T097
'	O	O	O
Cognitive	O	O	B-T169
Errors	O	O	O

Chronic	O	O	B-T079
diarrhoeal	O	O	B-T047
illnesses	O	O	I-T047
with	O	O	O
nausea	O	O	B-T184
and	O	O	O
weight	O	O	B-T033
loss	O	O	I-T033
are	O	O	O
a	O	O	O
common	O	O	B-T081
indication	O	O	B-T078
for	O	O	O
gastroenterology	O	O	B-T091
review	O	O	B-T078
.	O	O	O

While	O	O	O
many	O	O	O
such	O	O	O
cases	O	O	O
have	O	O	O
intra-luminal	O	O	B-T082
aetiologies	O	O	B-T169
,	O	O	O
such	O	O	O
as	O	O	O
inflammatory	O	O	B-T047
bowel	O	O	I-T047
disease	O	O	I-T047
,	O	O	O
coeliac	O	O	B-T047
disease	O	O	I-T047
or	O	O	O
other	O	O	O
malabsorptive	O	O	B-T033
conditions	O	O	I-T033
,	O	O	O
with	O	O	O
many	O	O	O
other	O	O	O
cases	O	O	O
due	O	O	O
to	O	O	O
functional	O	O	B-T169
gut	O	O	B-T023
disorders	O	O	B-T047
or	O	O	O
systemic	O	O	B-T169
malignancy	O	O	B-T191
,	O	O	O
clinicians	O	O	B-T097
must	O	O	O
also	O	O	O
keep	O	O	O
vascular	O	O	B-T047
disorders	O	O	I-T047
in	O	O	O
mind	O	O	O
.	O	O	O

Here	O	O	O
we	O	O	O
report	O	O	O
a	O	O	O
patient	O	O	B-T101
with	O	O	O
a	O	O	O
delayed	O	O	B-T079
diagnosis	O	O	B-T033
of	O	O	O
chronic	O	O	B-T047
mesenteric	O	O	I-T047
ischaemia	O	O	I-T047
after	O	O	O
6	O	O	O
months	O	O	B-T079
of	O	O	O
gastrointestinal	O	O	B-T184
symptoms	O	O	I-T184
strongly	O	O	O
mimicking	O	O	O
an	O	O	O
alternative	O	O	B-T077
diagnosis	O	O	O
such	O	O	O
as	O	O	O
inflammatory	O	O	B-T047
bowel	O	O	I-T047
disease	O	O	I-T047
due	O	O	O
an	O	O	O
atypical	O	O	B-T080
predominance	O	O	B-T169
of	O	O	O
nausea	O	O	B-T184
and	O	O	O
diarrhoea	O	O	B-T184
rather	O	O	O
than	O	O	O
pain	O	O	B-T184
.	O	O	O

We	O	O	O
briefly	O	O	O
review	O	O	B-T078
the	O	O	O
literature	O	O	B-T170
on	O	O	O
treatment	O	O	B-T169
of	O	O	O
this	O	O	O
condition	O	O	B-T047
but	O	O	O
also	O	O	O
discuss	O	O	O
with	O	O	O
particular	O	O	O
attention	O	O	O
the	O	O	O
sequence	O	O	B-T169
of	O	O	O
cognitive	O	O	B-T169
errors	O	O	B-T080
made	O	O	O
by	O	O	O
clinicians	O	O	B-T097
that	O	O	O
led	O	O	O
to	O	O	O
a	O	O	O
diagnostic	O	O	B-T033
delay	O	O	B-T079
,	O	O	O
inviting	O	O	O
readers	O	O	O
to	O	O	O
thus	O	O	O
reflect	O	O	O
on	O	O	O
how	O	O	O
such	O	O	O
errors	O	O	O
can	O	O	O
be	O	O	O
minimised	O	O	B-T080
in	O	O	O
their	O	O	O
practice	O	O	B-T057
.	O	O	O

-DOCSTART- (27403338)

Evaluation	O	O	B-T058
of	O	O	O
Choroidal	O	O	B-T023
Thickness	O	O	B-T080
in	O	O	O
Patients	O	O	B-T101
with	O	O	O
Pseudoexfoliation	O	O	B-T047
Syndrome	O	O	I-T047
and	O	O	O
Pseudoexfoliation	O	O	O
Glaucoma	O	O	O

Purpose	O	O	B-T169
.	O	O	O

To	O	O	O
compare	O	O	B-T052
the	O	O	O
macular	O	O	B-T082
and	O	O	O
peripapillary	O	O	B-T082
choroidal	O	O	B-T023
thickness	O	O	B-T080
in	O	O	O
eyes	O	O	B-T023
with	O	O	O
pseudoexfoliation	O	O	B-T047
(	O	O	I-T047
PEX	O	O	I-T047
)	O	O	I-T047
syndrome	O	O	I-T047
and	O	O	O
PEX	O	O	B-T047
glaucoma	O	O	I-T047
with	O	O	O
the	O	O	O
normal	O	O	B-T080
eyes	O	O	O
of	O	O	O
healthy	O	O	B-T080
controls	O	O	B-T096
.	O	O	O

Materials	O	O	O
and	O	O	O
Methods	O	O	O
.	O	O	O

In	O	O	O
this	O	O	O
prospective	O	O	B-T062
study	O	O	I-T062
,	O	O	O
30	O	O	O
eyes	O	O	B-T023
of	O	O	O
30	O	O	O
patients	O	O	B-T101
with	O	O	O
PEX	O	O	B-T047
syndrome	O	O	I-T047
,	O	O	O
28	O	O	O
eyes	O	O	O
of	O	O	O
28	O	O	O
patients	O	O	O
with	O	O	O
PEX	O	O	B-T047
glaucoma	O	O	I-T047
,	O	O	O
and	O	O	O
30	O	O	O
eyes	O	O	O
of	O	O	O
30	O	O	O
age	O	O	B-T032
-matched	O	O	O
healthy	O	O	B-T080
subjects	O	O	B-T096
were	O	O	O
enrolled	O	O	O
.	O	O	O

Choroidal	O	O	B-T023
thicknesses	O	O	B-T080
in	O	O	O
the	O	O	O
macular	O	O	B-T082
and	O	O	O
peripapillary	O	O	B-T082
areas	O	O	B-T082
were	O	O	O
measured	O	O	B-T080
by	O	O	O
using	O	O	O
spectral	O	O	B-T074
domain	O	O	I-T074
optical	O	O	I-T074
coherence	O	O	I-T074
tomography	O	O	I-T074
.	O	O	O

Results	O	O	O
.	O	O	O

Gender	O	O	B-T032
,	O	O	O
age	O	O	B-T032
,	O	O	O
and	O	O	O
axial	O	O	B-T081
length	O	O	I-T081
did	O	O	O
not	O	O	B-T033
significantly	O	O	I-T033
differ	O	O	O
between	O	O	O
the	O	O	O
groups	O	O	B-UnknownType
(	O	O	O
all	O	O	O
,	O	O	O
p	O	O	O
>	O	O	O
0.05	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
mean	O	O	B-T081
values	O	O	I-T081
of	O	O	O
choroidal	O	O	B-T023
thickness	O	O	B-T080
in	O	O	O
the	O	O	O
macular	O	O	B-T082
and	O	O	O
peripapillary	O	O	B-T082
areas	O	O	B-T082
(	O	O	O
except	O	O	B-T169
the	O	O	O
superior	O	O	B-T082
quadrant	O	O	B-T082
)	O	O	O
in	O	O	O
the	O	O	O
patients	O	O	B-T101
with	O	O	O
PEX	O	O	B-T047
syndrome	O	O	I-T047
and	O	O	O
PEX	O	O	B-T047
glaucoma	O	O	I-T047
were	O	O	O
lower	O	O	B-T052
compared	O	O	B-T052
with	O	O	O
controls	O	O	B-T096
(	O	O	O
all	O	O	O
p	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
mean	O	O	B-T081
values	O	O	I-T081
of	O	O	O
the	O	O	O
macular	O	O	B-T082
and	O	O	O
peripapillary	O	O	B-T082
choroidal	O	O	B-T023
thickness	O	O	B-T080
in	O	O	O
the	O	O	O
PEX	O	O	B-T047
glaucoma	O	O	I-T047
group	O	O	B-UnknownType
were	O	O	O
lower	O	O	B-T052
compared	O	O	B-T052
with	O	O	O
PEX	O	O	B-T047
syndrome	O	O	I-T047
group	O	O	O
;	O	O	O
however	O	O	O
this	O	O	O
difference	O	O	B-T080
was	O	O	O
not	O	O	B-T033
significant	O	O	I-T033
.	O	O	O

Conclusions	O	O	O
.	O	O	O

The	O	O	O
findings	O	O	B-T033
of	O	O	O
this	O	O	O
study	O	O	B-T062
revealed	O	O	B-T080
that	O	O	O
macular	O	O	B-T082
and	O	O	O
peripapillary	O	O	B-T082
choroidal	O	O	B-T023
thicknesses	O	O	B-T080
were	O	O	O
decreased	O	O	B-T081
in	O	O	O
PEX	O	O	B-T047
syndrome	O	O	I-T047
and	O	O	O
PEX	O	O	B-T047
glaucoma	O	O	I-T047
cases	O	O	B-T169
.	O	O	O

The	O	O	O
role	O	O	O
of	O	O	O
choroid	O	O	B-T023
in	O	O	O
the	O	O	O
development	O	O	B-T169
of	O	O	O
glaucomatous	O	O	B-T047
damage	O	O	B-T169
in	O	O	O
patients	O	O	B-T101
with	O	O	O
PEX	O	O	B-T047
syndrome	O	O	I-T047
remains	O	O	O
unclear	O	O	B-T033
.	O	O	O

-DOCSTART- (27404944)

Clinical	O	O	B-T184
Features	O	O	I-T184
and	O	O	O
Complications	O	O	B-T046
of	O	O	O
the	O	O	O
HLA-B27	O	O	B-T116
-associated	O	O	O
Acute	O	O	B-T047
Anterior	O	O	I-T047
Uveitis	O	O	I-T047
:	O	O	O
A	O	O	O
Metanalysis	O	O	O

In	O	O	O
this	O	O	O
article	O	O	B-T170
,	O	O	O
we	O	O	O
report	O	O	O
a	O	O	O
literature-based	O	O	B-T170
metanalysis	O	O	B-T062
we	O	O	O
have	O	O	O
conducted	O	O	O
to	O	O	O
outline	O	O	O
the	O	O	O
clinical	O	O	B-T184
features	O	O	I-T184
of	O	O	O
the	O	O	O
HLA-B27	O	O	B-T116
Acute	O	O	B-T047
Anterior	O	O	I-T047
Uveitis	O	O	I-T047
(	O	O	O
AAU	O	O	B-T047
)	O	O	O
.	O	O	O

The	O	O	O
examined	O	O	B-T033
material	O	O	O
was	O	O	O
based	O	O	O
on	O	O	O
observational	O	O	B-T062
studies	O	O	I-T062
in	O	O	O
which	O	O	O
participants	O	O	B-T098
were	O	O	O
affected	O	O	O
by	O	O	O
Acute	O	O	B-T047
Anterior	O	O	I-T047
Uveitis	O	O	I-T047
and	O	O	O
divided	O	O	O
into	O	O	O
HLA	O	O	B-T034
B27	O	O	I-T034
+	O	O	I-T034
and	O	O	O
HLA	O	O	B-T034
B27-	O	O	I-T034
.	O	O	O

We	O	O	O
performed	O	O	O
a	O	O	O
search	O	O	O
on	O	O	O
articles	O	O	B-T170
with	O	O	O
the	O	O	O
words	O	O	O
"	O	O	O
HLA	O	O	B-T047
B27	O	O	I-T047
uveitis	O	O	I-T047
"	O	O	O
dated	O	O	O
before	O	O	O
May	O	O	O
2014	O	O	O
.	O	O	O

Among	O	O	O
these	O	O	O
,	O	O	O
29	O	O	O
articles	O	O	B-T170
were	O	O	O
selected	O	O	O
for	O	O	O
a	O	O	O
second	O	O	O
review	O	O	B-T078
.	O	O	O

After	O	O	O
a	O	O	O
further	O	O	O
evaluation	O	O	O
,	O	O	O
22	O	O	O
articles	O	O	B-T170
were	O	O	O
analyzed	O	O	B-T062
.	O	O	O

The	O	O	O
clinical	O	O	B-T201
characteristics	O	O	I-T201
studied	O	O	O
in	O	O	O
the	O	O	O
metanalysis	O	O	B-T062
were	O	O	O
:	O	O	O
(	O	O	O
1	O	O	O
)	O	O	O
systemic	O	O	B-T047
disease	O	O	I-T047
;	O	O	O
(	O	O	O
2	O	O	O
)	O	O	O
sex	O	O	B-T081
distribution	O	O	I-T081
;	O	O	O
(	O	O	O
3	O	O	O
)	O	O	O
laterality	O	O	B-T032
;	O	O	O
(	O	O	O
4	O	O	O
)	O	O	O
visual	O	O	B-T201
acuity	O	O	I-T201
;	O	O	O
(	O	O	O
5	O	O	O
)	O	O	O
hypopion	O	O	B-T047
;	O	O	O
(	O	O	O
6	O	O	O
)	O	O	O
anterior	O	O	B-T116
chamber	O	O	I-T116
's	O	O	I-T116
fibrin	O	O	I-T116
;	O	O	O
(	O	O	O
7	O	O	O
)	O	O	O
elevated	O	O	B-T033
intraocular	O	O	I-T033
pressure	O	O	I-T033
(	O	O	O
IOP	O	O	B-T042
)	O	O	O
during	O	O	O
inflammation	O	O	B-T046
;	O	O	O
(	O	O	O
8)	O	O	O
glaucoma	O	O	B-T047
;	O	O	O
(	O	O	O
9	O	O	O
)	O	O	O
posterior	O	O	B-T047
synechiae	O	O	I-T047
;	O	O	O
(	O	O	O
10	O	O	O
)	O	O	O
cataract	O	O	B-T020
;	O	O	O
(	O	O	O
11	O	O	O
)	O	O	O
cystoid	O	O	B-T047
macular	O	O	I-T047
edema	O	O	I-T047
;	O	O	O
(	O	O	O
12	O	O	O
)	O	O	O
papillitis	O	O	B-T047
.	O	O	O

We	O	O	O
have	O	O	O
calculated	O	O	O
a	O	O	O
relative	O	O	B-T081
risk	O	O	I-T081
(	O	O	O
RR	O	O	B-T081
)	O	O	O
for	O	O	O
each	O	O	O
outcome	O	O	B-T081
measured	O	O	I-T081
.	O	O	O

The	O	O	O
results	O	O	B-T169
obtained	O	O	O
remark	O	O	O
some	O	O	O
of	O	O	O
the	O	O	O
peculiar	O	O	O
features	O	O	O
linked	O	O	O
to	O	O	O
the	O	O	O
HLA	O	O	B-T116
B27	O	O	I-T116
Acute	O	O	B-T047
Anterior	O	O	I-T047
Uveitis	O	O	I-T047
,	O	O	O
such	O	O	O
as	O	O	O
strong	O	O	O
association	O	O	B-T080
with	O	O	I-T080
ankylosing	O	O	B-T047
spondylitis	O	O	I-T047
(	O	O	O
RR	O	O	B-T081
=	O	O	O
6.80	O	O	O
)	O	O	O
and	O	O	O
systemic	O	O	B-T047
diseases	O	O	I-T047
(	O	O	O
RR	O	O	O
=	O	O	O
9.9	O	O	O
)	O	O	O
,	O	O	O
male	O	O	B-T032
prevalence	O	O	B-T081
(	O	O	O
RR	O	O	O
=	O	O	O
1.2	O	O	O
)	O	O	O
,	O	O	O
unilateral	O	O	B-T082
(	O	O	O
RR	O	O	O
=	O	O	O
1.1	O	O	O
)	O	O	O
or	O	O	O
alternating	O	O	O
bilateral	O	O	B-T082
(	O	O	O
RR	O	O	O
=	O	O	O
2.2	O	O	O
)	O	O	O
involvement	O	O	B-T169
,	O	O	O
hypopion	O	O	B-T047
(	O	O	O
RR	O	O	O
=	O	O	O
5.5	O	O	O
)	O	O	O
,	O	O	O
fibrinous	O	O	B-T116
reaction	O	O	B-T169
and	O	O	O
even	O	O	O
papillitis	O	O	B-T047
(	O	O	O
R	O	O	O
=	O	O	O
7.7	O	O	O
)	O	O	O
.	O	O	O

Simultaneous	O	O	O
bilateral	O	O	B-T082
(	O	O	O
RR	O	O	B-T081
=	O	O	O
0.3	O	O	O
)	O	O	O
AAU	O	O	B-T047
is	O	O	O
more	O	O	O
frequent	O	O	B-T079
in	O	O	O
HLA-B27	O	O	B-T116
negative	O	O	B-T033
form	O	O	O
.	O	O	O

We	O	O	O
report	O	O	O
higher	O	O	O
risk	O	O	B-T078
of	O	O	O
elevated	O	O	B-T033
IOP	O	O	I-T033
and	O	O	O
glaucoma	O	O	B-T047
(	O	O	O
RR	O	O	B-T081
=	O	O	O
0.6	O	O	O
)	O	O	O
in	O	O	O
B27-	O	O	B-T047
Acute	O	O	I-T047
Anterior	O	O	I-T047
Uveitis	O	O	I-T047
.	O	O	O

No	O	O	O
significant	O	O	O
difference	O	O	O
between	O	O	O
HLA	O	O	B-T033
B	O	O	I-T033
27	O	O	I-T033
positive	O	O	I-T033
and	O	O	O
negative	O	O	B-T033
AAU	O	O	B-T047
was	O	O	O
observed	O	O	B-T169
according	O	O	O
to	O	O	O
final	O	O	O
visual	O	O	B-T201
acuity	O	O	I-T201
and	O	O	O
complications	O	O	B-T046
such	O	O	O
as	O	O	O
posterior	O	O	B-T047
synechiae	O	O	I-T047
,	O	O	O
cataract	O	O	B-T020
,	O	O	O
and	O	O	O
maculare	O	O	B-T047
edema	O	O	I-T047
.	O	O	O

We	O	O	O
trust	O	O	O
that	O	O	O
this	O	O	O
will	O	O	O
inform	O	O	O
on	O	O	O
the	O	O	O
clinical	O	O	B-T058
evaluation	O	O	I-T058
and	O	O	O
therapeutic	O	O	B-T169
decision	O	O	B-T041
in	O	O	O
addressing	O	O	O
a	O	O	O
still	O	O	O
ill-defined	O	O	O
ophthalmologic	O	O	B-T169
condition	O	O	B-T080
.	O	O	O

-DOCSTART- (27408381)

A	O	O	O
Case	O	O	O
Presenting	O	O	O
with	O	O	O
Splenic	O	O	B-T047
Infarct	O	O	I-T047
Diagnosed	O	O	B-T033
as	O	O	O
Primary	O	O	B-T024
Bone	O	O	I-T024
Marrow	O	O	I-T024
CD5	O	O	B-T025
Positive	O	O	I-T025
DLBCL	O	O	B-T191
:	O	O	O
A	O	O	O
Clinicopathological	O	O	O
Correlation	O	O	O

De	O	O	B-T078
novo	O	O	I-T078
CD5	O	O	B-T025
+	O	O	I-T025
Diffuse	O	O	B-T033
large	O	O	I-T033
B	O	O	I-T033
cell	O	O	I-T033
lymphoma	O	O	I-T033
(	O	O	O
DLBCL	O	O	B-T191
)	O	O	O
is	O	O	O
a	O	O	O
rare	O	O	B-T080
and	O	O	O
aggressive	O	O	B-T033
subtype	O	O	I-T033
of	O	O	O
DLBCL	O	O	O
.	O	O	O

It	O	O	O
is	O	O	O
a	O	O	O
distinct	O	O	O
clinicopathologic	O	O	B-T033
entity	O	O	B-T071
with	O	O	O
complex	O	O	B-T169
molecular	O	O	I-T169
profile	O	O	I-T169
and	O	O	O
poor	O	O	B-T033
prognosis	O	O	I-T033
.	O	O	O

A	O	O	O
59	O	O	O
year	O	O	B-T079
old	O	O	O
female	O	O	B-T032
presented	O	O	B-T033
with	O	O	I-T033
pyrexia	O	O	B-T184
of	O	O	I-T184
unknown	O	O	I-T184
origin	O	O	I-T184
since	O	O	O
1	O	O	O
month	O	O	B-T079
.	O	O	O

On	O	O	O
examination	O	O	B-T058
,	O	O	O
there	O	O	O
was	O	O	O
severe	O	O	B-T033
pallor	O	O	I-T033
,	O	O	O
hepatosplenomegaly	O	O	B-T184
and	O	O	O
no	O	O	B-T080
palpable	O	O	I-T080
lymphadenopathy	O	O	B-T047
.	O	O	O

Complete	O	O	B-T059
blood	O	O	I-T059
count	O	O	I-T059
revealed	O	O	B-T080
bicytopenia	O	O	B-T034
with	O	O	O
normal	O	O	B-T033
total	O	O	I-T033
leucocyte	O	O	I-T033
count	O	O	I-T033
.	O	O	O

Liver	O	O	B-T059
and	O	O	O
renal	O	O	B-T059
function	O	O	I-T059
tests	O	O	I-T059
were	O	O	O
normal	O	O	B-T080
.	O	O	O

Ultrasonography	O	O	B-T060
abdomen	O	O	I-T060
revealed	O	O	B-T080
splenic	O	O	B-T033
enlargement	O	O	I-T033
with	O	O	O
two	O	O	B-T033
focal	O	O	I-T033
lesions	O	O	I-T033
attributed	O	O	O
to	O	O	O
either	O	O	O
splenic	O	O	B-T047
abscess	O	O	I-T047
or	O	O	O
infarcts	O	O	B-T047
.	O	O	O

Patient	O	O	B-T101
was	O	O	O
being	O	O	O
managed	O	O	O
as	O	O	O
splenic	O	O	B-T047
infarct	O	O	I-T047
but	O	O	O
continued	O	O	O
to	O	O	O
have	O	O	O
bicytopenia	O	O	B-T034
.	O	O	O

Further	O	O	O
investigation	O	O	B-T058
showed	O	O	O
elevated	O	O	B-T033
serum	O	O	I-T033
ferritin	O	O	I-T033
,	O	O	O
triglycerides	O	O	B-T033
and	O	O	O
LDH	O	O	B-T034
.	O	O	O

With	O	O	O
a	O	O	O
clinical	O	O	B-T080
suspicion	O	O	B-T041
of	O	O	O
infection	O	O	B-T046
and	O	O	O
haemophagocytic	O	O	B-T047
lymphohistiocytosis	O	O	I-T047
bone	O	O	B-T060
marrow	O	O	I-T060
aspiration	O	O	I-T060
(	O	O	I-T060
BMA	O	O	B-T060
)	O	O	I-T060
and	O	O	I-T060
biopsy	O	O	B-T060
(	O	O	I-T060
BMBx	O	O	I-T060
)	O	O	I-T060
was	O	O	O
done	O	O	O
.	O	O	O

BMA	O	O	O
showed	O	O	O
extensive	O	O	B-T080
haemophagocytosis	O	O	B-T047
and	O	O	O
~7.4	O	O	O
%	O	O	O
large	O	O	B-T191
lymphoma-like	O	O	I-T191
cells	O	O	I-T191
.	O	O	O

On	O	O	O
this	O	O	O
basis	O	O	O
PET-CT	O	O	B-T060
was	O	O	O
suggested	O	O	O
which	O	O	O
showed	O	O	O
enlarged	O	O	B-T033
spleen	O	O	I-T033
with	O	O	O
diffuse	O	O	B-T033
uptake	O	O	I-T033
.	O	O	O

BMBx	O	O	B-T060
showed	O	O	O
nodular	O	O	B-T020
and	O	O	O
intrasinusoidal	O	O	B-T082
collection	O	O	O
of	O	O	O
abnormal	O	O	B-T025
lymphoid	O	O	I-T025
cells	O	O	I-T025
.	O	O	O

On	O	O	O
immunohistochemistry	O	O	B-T060
,	O	O	O
these	O	O	O
cells	O	O	B-T025
were	O	O	O
positive	O	O	B-T034
for	O	O	I-T034
CD20	O	O	I-T034
,	O	O	O
CD5	O	O	B-T116
,	O	O	O
MUM1	O	O	B-T116
,	O	O	O
BCL-2	O	O	B-T129
,	O	O	O
BCL-6	O	O	B-T129
and	O	O	O
negative	O	O	B-T033
for	O	O	O
CD3	O	O	B-T116
,	O	O	O
CD10	O	O	B-T116
and	O	O	O
CD23	O	O	B-T116
.	O	O	O

CD34	O	O	B-T116
highlighted	O	O	O
focal	O	O	B-T082
intrasinusoidal	O	O	B-T082
pattern	O	O	B-T082
.	O	O	O

The	O	O	O
complete	O	O	O
clinicopathological	O	O	B-T058
profile	O	O	I-T058
suggested	O	O	O
the	O	O	O
diagnosis	O	O	B-T033
of	O	O	O
de	O	O	B-T078
novo	O	O	I-T078
CD5	O	O	B-T025
+	O	O	I-T025
DLBCL	O	O	B-T191
,	O	O	O
with	O	O	O
primary	O	O	B-T047
hepatosplenic	O	O	I-T047
pattern	O	O	B-T082
of	O	O	O
involvement	O	O	O
.	O	O	O

CD5	O	O	B-T025
+	O	O	I-T025
DLBCL	O	O	B-T191
presenting	O	O	O
as	O	O	O
splenic	O	O	B-T047
infarct	O	O	I-T047
is	O	O	O
very	O	O	B-T033
rare	O	O	I-T033
.	O	O	O

This	O	O	O
case	O	O	O
was	O	O	O
unusual	O	O	B-T080
as	O	O	O
the	O	O	O
diagnosis	O	O	B-T033
of	O	O	O
a	O	O	O
primary	O	O	B-T191
aggressive	O	O	I-T191
lymphoma	O	O	I-T191
with	O	O	O
haemophagocytosis	O	O	B-T047
was	O	O	O
established	O	O	B-T080
in	O	O	O
a	O	O	O
patient	O	O	B-T101
who	O	O	O
presented	O	O	O
with	O	O	O
fever	O	O	B-T184
and	O	O	O
splenic	O	O	B-T047
infarct	O	O	I-T047
without	O	O	O
lymphadenopathy	O	O	B-T047
.	O	O	O

This	O	O	O
indicates	O	O	O
the	O	O	O
importance	O	O	O
of	O	O	O
good	O	O	O
morphological	O	O	B-T082
assessment	O	O	B-T052
of	O	O	O
a	O	O	O
bone	O	O	B-T031
marrow	O	O	I-T031
aspirate	O	O	I-T031
and	O	O	O
biopsy	O	O	B-T060
to	O	O	O
make	O	O	O
a	O	O	O
correct	O	O	B-T033
diagnosis	O	O	I-T033
.	O	O	O

-DOCSTART- (27412612)

The	O	O	O
cost-effectiveness	O	O	B-T081
of	O	O	O
family	O	O	B-T099
/	O	O	O
family-based	O	O	B-T061
therapy	O	O	I-T061
for	O	O	O
treatment	O	O	B-T169
of	O	O	O
externalizing	O	O	B-T048
disorders	O	O	I-T048
,	O	O	O
substance	O	O	B-T048
use	O	O	I-T048
disorders	O	O	I-T048
and	O	O	O
delinquency	O	O	B-T048
:	O	O	O
a	O	O	O
systematic	O	O	O
review	O	O	O

Family	O	O	B-T061
therapy	O	O	I-T061
and	O	O	O
family-based	O	O	B-T169
treatment	O	O	I-T169
has	O	O	O
been	O	O	O
commonly	O	O	O
applied	O	O	O
in	O	O	O
children	O	O	B-T100
and	O	O	O
adolescents	O	O	B-T100
in	O	O	O
mental	O	O	B-T061
health	O	O	I-T061
care	O	O	I-T061
and	O	O	O
has	O	O	O
been	O	O	O
proven	O	O	O
to	O	O	O
be	O	O	O
effective	O	O	O
.	O	O	O

There	O	O	O
is	O	O	O
an	O	O	O
increased	O	O	O
interest	O	O	O
in	O	O	O
economic	O	O	B-T057
evaluations	O	O	I-T057
of	O	O	O
these	O	O	O
,	O	O	O
often	O	O	O
expensive	O	O	O
,	O	O	O
interventions	O	O	B-T061
.	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
this	O	O	O
systematic	O	O	O
review	O	O	B-T170
is	O	O	O
to	O	O	O
summarize	O	O	O
and	O	O	O
evaluate	O	O	B-T058
the	O	O	O
evidence	O	O	O
on	O	O	O
cost-effectiveness	O	O	B-T081
of	O	O	O
family	O	O	B-T099
/	O	O	O
family-based	O	O	B-T061
therapy	O	O	I-T061
for	O	O	O
externalizing	O	O	B-T048
disorders	O	O	I-T048
,	O	O	O
substance	O	O	B-T048
use	O	O	I-T048
disorders	O	O	I-T048
and	O	O	O
delinquency	O	O	B-T048
.	O	O	O

A	O	O	O
systematic	O	O	O
literature	O	O	O
search	O	O	O
was	O	O	O
performed	O	O	O
in	O	O	O
PubMed	O	O	B-T170
,	O	O	O
Education	O	O	B-T073
Resource	O	O	I-T073
information	O	O	I-T073
Centre	O	O	I-T073
(	O	O	O
ERIC	O	O	B-T073
)	O	O	O
,	O	O	O
Psycinfo	O	O	B-T170
and	O	O	O
Cochrane	O	O	B-T170
reviews	O	O	B-T170
including	O	O	O
studies	O	O	B-T059
conducted	O	O	O
after	O	O	O
1990	O	O	O
and	O	O	O
before	O	O	O
the	O	O	O
first	O	O	O
of	O	O	O
August	O	O	O
of	O	O	O
2013	O	O	O
.	O	O	O

Full	O	O	O
economic	O	O	B-T057
evaluations	O	O	I-T057
investigating	O	O	O
family	O	O	B-T099
/	O	O	O
family-based	O	O	B-T061
interventions	O	O	I-T061
for	O	O	O
adolescents	O	O	B-T100
between	O	O	O
10	O	O	O
and	O	O	O
20	O	O	O
years	O	O	B-T079
treated	O	O	B-T169
for	O	O	O
substance	O	O	B-T048
use	O	O	I-T048
disorders	O	O	I-T048
,	O	O	O
delinquency	O	O	B-T048
or	O	O	O
externalizing	O	O	B-T048
disorders	O	O	I-T048
were	O	O	O
included	O	O	O
.	O	O	O

Seven	O	O	O
hundred	O	O	O
thirty-one	O	O	O
articles	O	O	B-T170
met	O	O	O
the	O	O	O
search	O	O	O
criteria	O	O	O
and	O	O	O
51	O	O	O
studies	O	O	B-T059
were	O	O	O
initially	O	O	O
selected	O	O	O
.	O	O	O

The	O	O	O
final	O	O	O
selection	O	O	O
resulted	O	O	O
in	O	O	O
the	O	O	O
inclusion	O	O	O
of	O	O	O
11	O	O	O
studies	O	O	B-T059
.	O	O	O

The	O	O	O
quality	O	O	B-T080
of	O	O	O
these	O	O	O
studies	O	O	B-T059
was	O	O	O
assessed	O	O	B-T052
.	O	O	O

Within	O	O	O
the	O	O	O
identified	O	O	O
studies	O	O	B-T059
,	O	O	O
there	O	O	O
was	O	O	O
great	O	O	O
variation	O	O	O
in	O	O	O
the	O	O	O
specific	O	O	O
type	O	O	O
of	O	O	O
family	O	O	B-T099
/	O	O	O
family-based	O	O	B-T061
interventions	O	O	I-T061
and	O	O	O
disorders	O	O	B-T047
.	O	O	O

According	O	O	O
to	O	O	O
the	O	O	O
outcomes	O	O	B-T057
of	O	O	O
the	O	O	O
checklists	O	O	O
,	O	O	O
the	O	O	O
overall	O	O	O
quality	O	O	B-T080
of	O	O	O
the	O	O	O
economic	O	O	B-T057
evaluations	O	O	I-T057
was	O	O	O
low	O	O	O
.	O	O	O

Results	O	O	O
varied	O	O	O
by	O	O	O
study	O	O	B-T059
.	O	O	O

Due	O	O	O
to	O	O	O
the	O	O	O
variations	O	O	O
in	O	O	O
setting	O	O	O
,	O	O	O
design	O	O	O
and	O	O	O
outcome	O	O	O
it	O	O	O
was	O	O	O
not	O	O	O
feasible	O	O	O
to	O	O	O
pool	O	O	O
results	O	O	O
using	O	O	O
a	O	O	O
meta-analysis	O	O	B-T062
.	O	O	O

The	O	O	O
quality	O	O	B-T080
of	O	O	O
the	O	O	O
identified	O	O	O
economic	O	O	B-T057
evaluations	O	O	I-T057
of	O	O	O
family	O	O	B-T099
/	O	O	O
family-based	O	O	B-T061
therapy	O	O	I-T061
for	O	O	O
treatment	O	O	B-T169
of	O	O	O
externalizing	O	O	B-T048
disorders	O	O	I-T048
,	O	O	O
adolescent	O	O	B-T100
substance	O	O	B-T048
use	O	O	I-T048
disorders	O	O	I-T048
and	O	O	O
delinquency	O	O	B-T048
was	O	O	O
insufficient	O	O	O
to	O	O	O
determine	O	O	O
the	O	O	O
cost-effectiveness	O	O	B-T081
.	O	O	O

Although	O	O	O
commonly	O	O	O
applied	O	O	O
,	O	O	O
family	O	O	B-T099
/	O	O	O
family-based	O	O	B-T061
therapy	O	O	I-T061
is	O	O	O
costly	O	O	O
and	O	O	O
more	O	O	O
research	O	O	O
of	O	O	O
higher	O	O	O
quality	O	O	B-T080
is	O	O	O
needed	O	O	O
.	O	O	O

-DOCSTART- (27420620)

Regulation	O	O	B-T045
of	O	O	O
ABCA1	O	O	B-T028
and	O	O	O
ABCG1	O	O	B-T028
gene	O	O	B-T045
expression	O	O	I-T045
in	O	O	O
the	O	O	O
intraabdominal	O	O	O
adipose	O	O	O
tissue	O	O	O

Tissue	O	O	B-T045
specific	O	O	I-T045
expression	O	O	I-T045
of	O	O	I-T045
genes	O	O	B-T028
encoding	O	O	B-T052
cholesterol	O	O	B-T109
transporters	O	O	B-T116
ABCA1	O	O	B-T116
and	O	O	O
ABCG1	O	O	B-T116
as	O	O	O
well	O	O	O
as	O	O	O
genes	O	O	O
encoding	O	O	O
the	O	O	O
most	O	O	O
important	O	O	O
transcriptional	O	O	B-T045
regulators	O	O	B-T116
of	O	O	O
adipogenesis	O	O	B-T044
-	O	O	O
LXRa	O	O	B-T116
,	O	O	O
LXRb	O	O	B-T116
,	O	O	O
PPARg	O	O	B-T116
and	O	O	O
RORa	O	O	B-T116
has	O	O	O
been	O	O	O
investigated	O	O	B-T169
in	O	O	O
intraabdominal	O	O	B-T024
adipose	O	O	I-T024
tissue	O	O	I-T024
(	O	O	O
IAT	O	O	B-T024
)	O	O	O
samples	O	O	B-T167
.A	O	O	O

direct	O	O	O
correlation	O	O	B-T080
between	O	O	O
the	O	O	O
content	O	O	O
of	O	O	O
ABCA1	O	O	B-T116
and	O	O	O
ABCG1	O	O	B-T116
proteins	O	O	I-T116
with	O	O	O
RORa	O	O	B-T116
protein	O	O	I-T116
level	O	O	B-T080
(	O	O	O
r=0.480	O	O	O
,	O	O	O
p<0.05	O	O	O
;	O	O	O
r=0.435	O	O	O
,	O	O	O
p<0.05	O	O	O
,	O	O	O
respectively	O	O	O
)	O	O	O
suggests	O	O	B-T078
the	O	O	O
role	O	O	O
of	O	O	O
the	O	O	O
transcription	O	O	B-T116
factor	O	O	I-T116
RORa	O	O	O
in	O	O	O
the	O	O	O
regulation	O	O	B-T038
of	O	O	O
IAT	O	O	B-T024
ABCA1	O	O	O
and	O	O	O
ABCG1	O	O	B-T116
protein	O	O	I-T116
levels	O	O	B-T080
.	O	O	O

ABCA1	O	O	B-T028
and	O	O	O
ABCG1	O	O	B-T028
gene	O	O	B-T045
expression	O	O	I-T045
positively	O	O	O
correlated	O	O	B-T080
with	O	O	O
obesity	O	O	B-T047
indicators	O	O	B-T130
such	O	O	O
as	O	O	O
body	O	O	B-T201
mass	O	O	I-T201
index	O	O	I-T201
(	O	O	O
BMI	O	O	B-T201
)	O	O	O
(	O	O	O
r=0.522	O	O	O
,	O	O	O
p=0.004	O	O	O
;	O	O	O
r=0.594	O	O	O
,	O	O	O
p=0.001	O	O	O
,	O	O	O
respectively	O	O	O
)	O	O	O
and	O	O	O
waist	O	O	B-T201
circumference	O	O	I-T201
(	O	O	O
r=0.403	O	O	O
,	O	O	O
p=0.033	O	O	O
;	O	O	O
r=0.474	O	O	O
,	O	O	O
p=0.013	O	O	O
,	O	O	O
respectively	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
development	O	O	B-T169
of	O	O	O
obesity	O	O	B-T047
is	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
decreased	O	O	B-T081
IAT	O	O	B-T024
levels	O	O	B-T080
of	O	O	O
RORa	O	O	B-T028
and	O	O	O
LXRb	O	O	B-T028
mRNA	O	O	B-T114
(	O	O	O
p=0.016	O	O	O
and	O	O	O
p=0.002	O	O	O
,	O	O	O
respectively	O	O	O
)	O	O	O
.	O	O	O

These	O	O	O
data	O	O	B-T078
suggest	O	O	B-T078
that	O	O	O
the	O	O	O
nuclear	O	O	B-T116
factor	O	O	I-T116
RORa	O	O	I-T116
can	O	O	O
play	O	O	O
a	O	O	O
significant	O	O	B-T078
role	O	O	O
in	O	O	O
the	O	O	O
regulation	O	O	B-T038
of	O	O	O
cholesterol	O	O	B-T044
metabolism	O	O	I-T044
and	O	O	O
control	O	O	B-T080
IAT	O	O	B-T024
expression	O	O	B-T045
of	O	O	O
ABCA1	O	O	B-T116
and	O	O	O
ABCG1	O	O	B-T116
,	O	O	O
while	O	O	O
the	O	O	O
level	O	O	B-T080
of	O	O	O
IAT	O	O	O
LXRb	O	O	B-T028
gene	O	O	B-T045
expression	O	O	I-T045
may	O	O	O
be	O	O	O
an	O	O	O
important	O	O	O
factor	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
the	O	O	O
development	O	O	B-T169
of	O	O	O
obesity	O	O	B-T047
.	O	O	O

-DOCSTART- (27425447)

Triterpenoids	O	O	B-T109
from	O	O	O
the	O	O	O
stems	O	O	B-T002
of	O	O	O
Tripterygium	O	O	O
regelii	O	O	O

Three	O	O	O
new	O	O	O
triterpenoids	O	O	B-T109
,	O	O	O
triregelolides	O	O	B-T109
A	O	O	O
,	O	O	O
B	O	O	O
(	O	O	O
1	O	O	O
,	O	O	O
2	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
triregeloic	O	O	B-T109
acid	O	O	I-T109
(	O	O	O
3	O	O	O
)	O	O	O
,	O	O	O
were	O	O	O
isolated	O	O	B-T169
from	O	O	O
the	O	O	O
stems	O	O	B-T002
of	O	O	O
Tripterygium	O	O	B-T002
regelii	O	O	I-T002
along	O	O	O
with	O	O	O
twenty	O	O	O
known	O	O	O
triterpene	O	O	B-T109
analogues	O	O	B-T104
(	O	O	O
4	O	O	O
-	O	O	O
23	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
structures	O	O	O
of	O	O	O
three	O	O	O
new	O	O	O
compounds	O	O	B-T109
were	O	O	O
identified	O	O	O
by	O	O	O
analyzing	O	O	O
their	O	O	O
NMR	O	O	B-T060
spectroscopic	O	O	I-T060
and	O	O	O
HRESIMS	O	O	B-T059
data	O	O	O
.	O	O	O

Compounds	O	O	B-T109
4	O	O	B-T109
,	O	O	O
7	O	O	B-T109
,	O	O	O
8	O	O	B-T109
,	O	O	O
10	O	O	B-T109
,	O	O	O
13	O	O	B-T109
,	O	O	O
14	O	O	B-T109
,	O	O	O
17	O	O	B-T109
,	O	O	O
21	O	O	B-T109
-	O	O	I-T109
23	O	O	I-T109
were	O	O	O
isolated	O	O	B-T169
from	O	O	O
T.	O	O	B-T002
regelii	O	O	I-T002
for	O	O	O
the	O	O	O
first	O	O	O
time	O	O	O
.	O	O	O

Compounds	O	O	B-T109
3	O	O	B-T109
,	O	O	O
5	O	O	B-T109
,	O	O	O
6	O	O	B-T109
,	O	O	O
8	O	O	B-T109
,	O	O	O
9	O	O	B-T109
,	O	O	O
10	O	O	B-T109
,	O	O	O
14	O	O	B-T109
and	O	O	O
16	O	O	B-T109
showed	O	O	O
inhibitory	O	O	B-T043
effects	O	O	I-T043
on	O	O	I-T043
the	O	O	I-T043
proliferation	O	O	I-T043
of	O	O	O
human	O	O	B-T025
breast	O	O	I-T025
cancer	O	O	I-T025
cells	O	O	I-T025
MCF-7	O	O	B-T025
by	O	O	O
24.1	O	O	O
%	O	O	O
,	O	O	O
69.6	O	O	O
%	O	O	O
,	O	O	O
72.8	O	O	O
%	O	O	O
,	O	O	O
21.6	O	O	O
%	O	O	O
,	O	O	O
23.1	O	O	O
%	O	O	O
,	O	O	O
43.3	O	O	O
%	O	O	O
,	O	O	O
25.5	O	O	O
%	O	O	O
and	O	O	O
23.5	O	O	O
%	O	O	O
(	O	O	O
p<0.05	O	O	O
)	O	O	O
at	O	O	O
a	O	O	O
concentration	O	O	B-T081
of	O	O	O
10Î¼M	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

-DOCSTART- (27427386)

Biochemical	O	O	B-T169
evidence	O	O	O
for	O	O	O
a	O	O	O
mitochondrial	O	O	B-T026
genetic	O	O	B-T169
modifier	O	O	B-T028
in	O	O	O
the	O	O	O
phenotypic	O	O	B-T032
manifestation	O	O	B-T169
of	O	O	O
Leber	O	O	B-T047
's	O	O	I-T047
hereditary	O	O	I-T047
optic	O	O	I-T047
neuropathy	O	O	I-T047
-associated	O	O	O
mitochondrial	O	O	O
DNA	O	O	O
mutation	O	O	O

Leber	O	O	B-T047
's	O	O	I-T047
hereditary	O	O	I-T047
optic	O	O	I-T047
neuropathy	O	O	I-T047
(	O	O	O
LHON	O	O	B-T047
)	O	O	O
is	O	O	O
the	O	O	O
most	O	O	O
common	O	O	O
mitochondrial	O	O	B-T047
disease	O	O	I-T047
.	O	O	O

Mitochondrial	O	O	B-T026
modifiers	O	O	B-T028
are	O	O	O
proposed	O	O	O
to	O	O	O
modify	O	O	O
the	O	O	O
phenotypic	O	O	B-T032
expression	O	O	I-T032
of	O	O	O
primary	O	O	O
LHON	O	O	B-T047
-associated	O	O	O
mitochondrial	O	O	B-T114
DNA	O	O	I-T114
(	O	O	O
mtDNA	O	O	B-T114
)	O	O	O
mutations	O	O	B-T019
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
we	O	O	O
demonstrated	O	O	O
that	O	O	O
the	O	O	O
LHON	O	O	B-T047
susceptibility	O	O	B-T201
allele	O	O	B-T028
(	O	O	O
m.14502	O	O	B-T028
T	O	O	I-T028
>	O	O	I-T028
C	O	O	I-T028
,	O	O	O
p.	O	O	B-T028
58I	O	O	I-T028
>	O	O	I-T028
V	O	O	I-T028
)	O	O	O
in	O	O	O
the	O	O	O
ND6	O	O	B-T028
gene	O	O	I-T028
modulated	O	O	B-T082
the	O	O	O
phenotypic	O	O	B-T032
expression	O	O	I-T032
of	O	O	O
primary	O	O	O
LHON	O	O	O
-associated	O	O	O
m.11778	O	O	B-T045
G	O	O	I-T045
>	O	O	I-T045
A	O	O	I-T045
mutation	O	O	I-T045
.	O	O	O

Twenty-two	O	O	O
Han	O	O	B-UnknownType
Chinese	O	O	I-UnknownType
pedigrees	O	O	B-T170
carrying	O	O	O
m.14502	O	O	B-T045
T	O	O	I-T045
>	O	O	I-T045
C	O	O	I-T045
and	O	O	O
m.11778	O	O	B-T045
G	O	O	I-T045
>	O	O	I-T045
A	O	O	I-T045
mutations	O	O	I-T045
exhibited	O	O	O
significantly	O	O	O
higher	O	O	O
penetrance	O	O	B-T081
of	O	O	O
optic	O	O	B-T047
neuropathy	O	O	I-T047
than	O	O	O
those	O	O	O
carrying	O	O	O
only	O	O	O
m.11778	O	O	B-T045
G	O	O	I-T045
>	O	O	I-T045
A	O	O	I-T045
mutation	O	O	I-T045
.	O	O	O

We	O	O	O
performed	O	O	O
functional	O	O	B-T169
assays	O	O	B-T059
using	O	O	O
the	O	O	O
cybrid	O	O	B-T025
cell	O	O	I-T025
models	O	O	I-T025
,	O	O	O
generated	O	O	O
by	O	O	O
fusing	O	O	O
mtDNA-less	O	O	B-T025
Ï(o	O	O	I-T025
)	O	O	I-T025
cells	O	O	I-T025
with	O	O	O
enucleated	O	O	B-T025
cells	O	O	I-T025
from	O	O	O
LHON	O	O	B-T047
patients	O	O	B-T101
carrying	O	O	O
both	O	O	O
m.11778	O	O	B-T045
G	O	O	I-T045
>	O	O	I-T045
A	O	O	I-T045
and	O	O	O
m.14502	O	O	B-T045
T	O	O	I-T045
>	O	O	I-T045
C	O	O	I-T045
mutations	O	O	I-T045
,	O	O	O
only	O	O	O
m.14502	O	O	O
T	O	O	O
>	O	O	O
C	O	O	O
or	O	O	O
m.11778	O	O	B-T045
G	O	O	I-T045
>	O	O	I-T045
A	O	O	I-T045
mutation	O	O	I-T045
and	O	O	O
a	O	O	O
control	O	O	O
belonging	O	O	O
to	O	O	O
the	O	O	O
same	O	O	O
mtDNA	O	O	B-T114
haplogroup	O	O	B-T032
.	O	O	O

These	O	O	O
cybrids	O	O	B-T025
cell	O	O	I-T025
lines	O	O	I-T025
bearing	O	O	O
m.14502	O	O	B-T045
T	O	O	I-T045
>	O	O	I-T045
C	O	O	I-T045
mutation	O	O	I-T045
exhibited	O	O	O
mild	O	O	O
effects	O	O	B-T080
on	O	O	O
mitochondrial	O	O	B-T026
functions	O	O	B-T169
compared	O	O	O
with	O	O	O
those	O	O	O
carrying	O	O	O
only	O	O	O
m.11778	O	O	B-T045
G	O	O	I-T045
>	O	O	I-T045
A	O	O	I-T045
mutation	O	O	I-T045
.	O	O	O

However	O	O	O
,	O	O	O
more	O	O	O
severe	O	O	O
mitochondrial	O	O	B-T026
dysfunctions	O	O	B-T077
were	O	O	O
observed	O	O	O
in	O	O	O
cell	O	O	B-T025
lines	O	O	I-T025
bearing	O	O	O
both	O	O	O
m.14502	O	O	B-T045
T	O	O	I-T045
>	O	O	I-T045
C	O	O	I-T045
and	O	O	O
m.11778	O	O	B-T045
G	O	O	I-T045
>	O	O	I-T045
A	O	O	I-T045
mutations	O	O	I-T045
than	O	O	O
those	O	O	O
carrying	O	O	O
only	O	O	O
m.11778	O	O	O
G	O	O	O
>	O	O	O
A	O	O	O
or	O	O	O
m.14502	O	O	B-T045
T	O	O	I-T045
>	O	O	I-T045
C	O	O	I-T045
mutation	O	O	I-T045
.	O	O	O

In	O	O	O
particular	O	O	O
,	O	O	O
the	O	O	O
m.14502	O	O	B-T045
T	O	O	I-T045
>	O	O	I-T045
C	O	O	I-T045
mutation	O	O	I-T045
altered	O	O	O
assemble	O	O	O
of	O	O	O
complex	O	O	B-T116
I	O	O	I-T116
,	O	O	O
thereby	O	O	O
aggravating	O	O	O
the	O	O	O
respiratory	O	O	B-T169
phenotypes	O	O	B-T032
associated	O	O	O
with	O	O	O
m.11778	O	O	B-T045
G	O	O	I-T045
>	O	O	I-T045
A	O	O	I-T045
mutation	O	O	I-T045
,	O	O	O
resulted	O	O	O
in	O	O	O
a	O	O	O
more	O	O	O
defective	O	O	B-T169
complex	O	O	O
I.	O	O	O
Furthermore	O	O	O
,	O	O	O
more	O	O	O
reductions	O	O	O
in	O	O	O
the	O	O	O
levels	O	O	O
of	O	O	O
mitochondrial	O	O	B-T026
ATP	O	O	B-T114
and	O	O	O
increasing	O	O	O
production	O	O	O
of	O	O	O
reactive	O	O	B-T123
oxygen	O	O	I-T123
species	O	O	I-T123
were	O	O	O
also	O	O	O
observed	O	O	O
in	O	O	O
mutant	O	O	B-T049
cells	O	O	B-T025
bearing	O	O	O
both	O	O	O
m.14502	O	O	O
T	O	O	O
>	O	O	O
C	O	O	O
and	O	O	O
m.11778	O	O	O
G	O	O	O
>	O	O	O
A	O	O	O
mutation	O	O	O
than	O	O	O
those	O	O	O
carrying	O	O	O
only	O	O	O
11778	O	O	B-T045
G	O	O	I-T045
>	O	O	I-T045
A	O	O	I-T045
mutation	O	O	I-T045
.	O	O	O

Our	O	O	O
findings	O	O	O
provided	O	O	O
new	O	O	O
insights	O	O	O
into	O	O	O
the	O	O	O
pathophysiology	O	O	B-T169
of	O	O	O
LHON	O	O	B-T047
that	O	O	O
were	O	O	O
manifested	O	O	B-T080
by	O	O	I-T080
interaction	O	O	O
between	O	O	O
primary	O	O	O
and	O	O	O
secondary	O	O	O
mtDNA	O	O	B-T114
mutations	O	O	B-T019
.	O	O	O

-DOCSTART- (27427881)

Improving	O	O	B-T080
Care	O	O	B-T058
Transitions	O	O	I-T058
Across	O	O	O
Healthcare	O	O	B-T058
Settings	O	O	B-T082
Through	O	O	O
a	O	O	O
Human	O	O	B-T033
Factors	O	O	I-T033
Approach	O	O	O

After	O	O	O
more	O	O	O
than	O	O	O
two	O	O	O
decades	O	O	B-T081
of	O	O	O
research	O	O	B-T062
focused	O	O	O
on	O	O	O
care	O	O	B-T058
transition	O	O	I-T058
improvement	O	O	B-T077
and	O	O	O
intervention	O	O	B-T061
development	O	O	B-T169
,	O	O	O
unfavorable	O	O	B-T033
outcome	O	O	I-T033
measures	O	O	B-T169
associated	O	O	B-T080
with	O	O	I-T080
care	O	O	B-T058
transitions	O	O	I-T058
across	O	O	O
healthcare	O	O	B-T058
settings	O	O	B-T082
persist	O	O	O
.	O	O	O

Readmissions	O	O	B-UnknownType
rates	O	O	B-T081
remain	O	O	O
an	O	O	O
important	O	O	O
outcome	O	O	B-T169
to	O	O	O
target	O	O	B-T169
for	O	O	O
intervention	O	O	B-T061
,	O	O	O
adverse	O	O	B-T046
events	O	O	I-T046
associated	O	O	B-T080
with	O	O	I-T080
care	O	O	B-T052
transitions	O	O	I-T058
continue	O	O	O
to	O	O	O
be	O	O	O
an	O	O	O
issue	O	O	B-T033
,	O	O	O
and	O	O	O
patients	O	O	B-T101
are	O	O	O
often	O	O	O
dissatisfied	O	O	B-T041
with	O	O	O
the	O	O	O
quality	O	O	B-T080
of	O	O	O
their	O	O	O
care	O	O	O
.	O	O	O

Currently	O	O	O
,	O	O	O
interventions	O	O	B-T061
to	O	O	O
improve	O	O	O
care	O	O	B-T058
transitions	O	O	I-T058
are	O	O	O
disease	O	O	B-T047
specific	O	O	B-T080
,	O	O	O
require	O	O	O
substantial	O	O	B-T080
financial	O	O	B-T058
investments	O	O	I-T058
in	O	O	O
training	O	O	B-T065
allied	O	O	B-T097
healthcare	O	O	I-T097
professionals	O	O	I-T097
,	O	O	O
or	O	O	O
focus	O	O	O
primarily	O	O	O
on	O	O	O
hospital-based	O	O	B-T058
discharge	O	O	I-T058
planning	O	O	I-T058
with	O	O	O
mixed	O	O	O
results	O	O	O
.	O	O	O

This	O	O	O
complex	O	O	B-T080
situation	O	O	I-T080
requires	O	O	O
a	O	O	O
method	O	O	B-T062
of	O	O	I-T062
evaluation	O	O	I-T062
that	O	O	O
can	O	O	O
provide	O	O	O
a	O	O	O
comprehensive	O	O	B-T080
,	O	O	O
in-depth	O	O	B-T082
,	O	O	O
and	O	O	O
context-driven	O	O	B-T078
investigation	O	O	B-T058
of	O	O	O
potential	O	O	B-T033
risks	O	O	I-T033
to	O	O	O
safe	O	O	O
care	O	O	B-T058
transitions	O	O	I-T058
across	O	O	O
healthcare	O	O	B-T058
settings	O	O	B-T082
,	O	O	O
which	O	O	O
can	O	O	O
lead	O	O	O
to	O	O	O
the	O	O	O
creation	O	O	B-T052
of	O	O	O
effective	O	O	B-T080
,	O	O	O
usable	O	O	B-T080
,	O	O	O
and	O	O	O
sustainable	O	O	B-T169
interventions	O	O	B-T061
.	O	O	O

A	O	O	O
systems	O	O	O
'	O	O	O
approach	O	O	O
known	O	O	O
as	O	O	O
Human	O	O	B-T090
Factors	O	O	I-T090
and	O	O	I-T090
Ergonomics	O	O	I-T090
(	O	O	O
HFE	O	O	B-T090
)	O	O	O
evaluates	O	O	B-T170
the	O	O	O
factors	O	O	B-T169
in	O	O	O
a	O	O	O
system	O	O	O
that	O	O	O
affect	O	O	O
human	O	O	B-T052
performance	O	O	I-T052
.	O	O	O

This	O	O	O
article	O	O	B-T170
describes	O	O	O
how	O	O	O
HFE	O	O	B-T090
can	O	O	O
complement	O	O	O
and	O	O	O
further	O	O	O
strengthen	O	O	O
efforts	O	O	O
to	O	O	O
improve	O	O	B-T080
care	O	O	B-T058
transitions	O	O	I-T058
.	O	O	O

-DOCSTART- (27430240)

Adenosine	O	O	B-T114
and	O	O	O
the	O	O	O
adenosine	O	O	B-T121
A2A	O	O	I-T121
receptor	O	O	I-T121
agonist	O	O	I-T121
,	O	O	O
CGS21680	O	O	B-T109
,	O	O	O
upregulate	O	O	B-T044
CD39	O	O	B-T129
and	O	O	O
CD73	O	O	B-T116
expression	O	O	B-T045
through	O	O	O
E2F-1	O	O	B-T116
and	O	O	O
CREB	O	O	B-T116
in	O	O	O
regulatory	O	O	B-T025
T	O	O	I-T025
cells	O	O	I-T025
isolated	O	O	B-T169
from	O	O	O
septic	O	O	B-T169
mice	O	O	O

The	O	O	O
number	O	O	O
of	O	O	O
regulatory	O	O	B-T025
T	O	O	I-T025
cells	O	O	I-T025
(	O	O	O
Treg	O	O	B-T025
cells	O	O	I-T025
)	O	O	O
and	O	O	O
the	O	O	O
expression	O	O	B-T045
of	O	O	O
ectonucleoside	O	O	B-T129
triphosphate	O	O	I-T129
diphosphohydrolase	O	O	I-T129
1	O	O	I-T129
(	O	O	O
ENTPD1	O	O	B-T129
;	O	O	O
also	O	O	O
known	O	O	O
as	O	O	O
CD39	O	O	B-T129
)	O	O	O
and	O	O	O
5'-ectonucleotidase	O	O	B-T116
(	O	O	O
NT5E	O	O	B-T116
;	O	O	O
also	O	O	O
known	O	O	O
as	O	O	O
CD73	O	O	B-T116
)	O	O	O
on	O	O	O
the	O	O	O
Treg	O	O	B-T025
cell	O	O	I-T025
surface	O	O	B-T082
are	O	O	O
increased	O	O	B-T081
during	O	O	O
sepsis	O	O	B-T047
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	O
,	O	O	O
to	O	O	O
determine	O	O	O
the	O	O	O
factors	O	O	B-T123
leading	O	O	O
to	O	O	O
the	O	O	O
high	O	O	B-T080
expression	O	O	B-T045
of	O	O	O
CD39	O	O	B-T129
and	O	O	O
CD73	O	O	B-T116
,	O	O	O
and	O	O	O
the	O	O	O
regulation	O	O	B-T038
of	O	O	I-T038
the	O	O	O
CD39	O	O	O
/	O	O	O
CD73	O	O	O
/	O	O	O
adenosine	O	O	B-T114
pathway	O	O	B-T077
in	O	O	O
Treg	O	O	B-T025
cells	O	O	I-T025
under	O	O	O
septic	O	O	B-T169
conditions	O	O	O
,	O	O	O
we	O	O	O
constructed	O	O	O
a	O	O	O
mouse	O	O	B-T050
model	O	O	I-T050
of	O	O	O
sepsis	O	O	B-T047
and	O	O	O
separated	O	O	O
the	O	O	O
Treg	O	O	O
cells	O	O	O
using	O	O	O
a	O	O	O
flow	O	O	B-T074
cytometer	O	O	I-T074
.	O	O	O

The	O	O	O
Treg	O	O	B-T025
cells	O	O	I-T025
isolated	O	O	B-T169
from	O	O	O
the	O	O	O
peritoneal	O	O	B-T058
lavage	O	O	I-T058
and	O	O	O
splenocytes	O	O	B-T025
of	O	O	O
the	O	O	O
mice	O	O	B-T015
were	O	O	O
treated	O	O	B-T061
with	O	O	I-T061
adenosine	O	O	B-T114
or	O	O	O
the	O	O	O
specific	O	O	O
adenosine	O	O	B-T121
A2A	O	O	I-T121
receptor	O	O	I-T121
agonist	O	O	I-T121
,	O	O	O
CGS21680	O	O	B-T109
,	O	O	O
and	O	O	O
were	O	O	O
transfected	O	O	B-T063
with	O	O	O
specific	O	O	O
siRNA	O	O	B-T114
targeting	O	O	B-T169
E2F	O	O	B-T116
transcription	O	O	I-T116
factor	O	O	I-T116
1	O	O	I-T116
(	O	O	O
E2F-1	O	O	B-T116
)	O	O	O
or	O	O	O
cyclic	O	O	B-T116
adenosine	O	O	I-T116
monophosphate	O	O	I-T116
(	O	O	I-T116
cAMP	O	O	I-T116
)	O	O	I-T116
response	O	O	I-T116
element-binding	O	O	I-T116
protein	O	O	I-T116
(	O	O	O
CREB	O	O	B-T116
)	O	O	O
,	O	O	O
which	O	O	O
are	O	O	O
predicted	O	O	O
transcription	O	O	B-T116
regulatory	O	O	I-T116
factors	O	O	I-T116
of	O	O	O
CD39	O	O	B-T129
or	O	O	O
CD73	O	O	B-T116
.	O	O	O

The	O	O	O
regulatory	O	O	B-T038
relationships	O	O	O
among	O	O	O
these	O	O	O
factors	O	O	B-T123
were	O	O	O
then	O	O	O
determined	O	O	O
by	O	O	O
western	O	O	B-T059
blot	O	O	I-T059
analysis	O	O	I-T059
and	O	O	O
dual-luciferase	O	O	B-T059
reporter	O	O	I-T059
assay	O	O	I-T059
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
changes	O	O	B-T169
in	O	O	O
adenosine	O	O	B-T044
metabolism	O	O	I-T044
were	O	O	O
measured	O	O	O
in	O	O	O
the	O	O	O
treated	O	O	B-T169
cells	O	O	B-T025
.	O	O	O

The	O	O	O
results	O	O	O
revealed	O	O	O
that	O	O	O
adenosine	O	O	B-T114
and	O	O	O
CGS21680	O	O	B-T109
significantly	O	O	O
upregulated	O	O	B-T044
CD39	O	O	B-T129
and	O	O	O
CD73	O	O	B-T116
expression	O	O	B-T045
(	O	O	O
P<0.01	O	O	O
)	O	O	O
.	O	O	O

E2F-1	O	O	B-T116
and	O	O	O
CREB	O	O	B-T116
induced	O	O	O
CD39	O	O	B-T129
and	O	O	O
CD73	O	O	B-T116
expression	O	O	B-T045
,	O	O	O
and	O	O	O
were	O	O	O
upregulated	O	O	B-T044
by	O	O	O
adenosine	O	O	B-T114
and	O	O	O
CGS21680	O	O	B-T109
.	O	O	O

Adenosine	O	O	B-T044
triphosphate	O	O	I-T044
(	O	O	I-T044
ATP	O	O	I-T044
)	O	O	I-T044
hydrolysis	O	O	I-T044
and	O	O	O
adenosine	O	O	B-T114
generation	O	O	B-T052
were	O	O	O
inhibited	O	O	B-T052
by	O	O	O
the	O	O	O
knockdown	O	O	B-T080
of	O	O	O
E2F-1	O	O	B-T116
or	O	O	O
CREB	O	O	B-T116
,	O	O	O
and	O	O	O
were	O	O	O
accelerated	O	O	B-T169
in	O	O	O
the	O	O	O
presence	O	O	O
of	O	O	O
CGS21680	O	O	B-T109
.	O	O	O

Based	O	O	O
on	O	O	O
these	O	O	O
results	O	O	O
,	O	O	O
it	O	O	O
can	O	O	O
be	O	O	O
inferred	O	O	O
that	O	O	O
adenosine	O	O	B-T114
,	O	O	O
the	O	O	O
adenosine	O	O	B-T121
A2A	O	O	I-T121
receptor	O	O	I-T121
agonist	O	O	I-T121
,	O	O	O
E2F-1	O	O	B-T116
and	O	O	O
CREB	O	O	B-T116
are	O	O	O
the	O	O	O
possible	O	O	O
factors	O	O	B-T123
contributing	O	O	O
to	O	O	O
the	O	O	O
high	O	O	B-T080
expression	O	O	B-T045
of	O	O	O
CD39	O	O	B-T129
and	O	O	O
CD73	O	O	B-T116
on	O	O	O
the	O	O	O
Treg	O	O	B-T025
cell	O	O	I-T025
surface	O	O	B-T082
during	O	O	O
sepsis	O	O	B-T047
.	O	O	O

Adenosine	O	O	B-T114
and	O	O	O
its	O	O	O
A2A	O	O	B-T121
receptor	O	O	I-T121
agonist	O	O	I-T121
served	O	O	O
as	O	O	O
the	O	O	O
signal	O	O	B-T044
transducer	O	O	I-T044
factors	O	O	B-T123
of	O	O	O
the	O	O	O
CD39	O	O	B-T129
/	O	O	O
CD73	O	O	B-T116
/	O	O	O
adenosine	O	O	B-T114
pathway	O	O	B-T077
,	O	O	O
accelerating	O	O	B-T169
adenosine	O	O	O
generation	O	O	B-T052
.	O	O	O

Our	O	O	O
study	O	O	O
may	O	O	O
benefit	O	O	O
further	O	O	O
research	O	O	B-T062
on	O	O	O
adenosine	O	O	B-T044
metabolism	O	O	I-T044
for	O	O	O
the	O	O	O
treatment	O	O	B-T061
of	O	O	O
sepsis	O	O	B-T047
.	O	O	O

-DOCSTART- (27430264)

Exploring	O	O	O
Consumer	O	O	B-T098
and	O	O	O
Patient	O	O	B-T101
Knowledge	O	O	B-T170
,	O	O	O
Behavior	O	O	B-T053
,	O	O	O
and	O	O	O
Attitude	O	O	B-T041
Toward	O	O	B-T078
Medicinal	O	O	B-T121
and	O	O	O
Lifestyle	O	O	B-T073
Products	O	O	I-T073
Purchased	O	O	B-T052
From	O	O	O
the	O	O	O
Internet	O	O	B-T073
:	O	O	O
A	O	O	O
Web	O	O	B-T073
-	O	O	O
Based	O	O	B-T169
Survey	O	O	O

In	O	O	O
recent	O	O	O
years	O	O	O
,	O	O	O
lifestyle	O	O	B-T073
products	O	O	I-T073
have	O	O	O
emerged	O	O	O
to	O	O	O
help	O	O	O
improve	O	O	B-T033
people	O	O	B-T098
's	O	O	I-T098
physical	O	O	B-T032
and	O	O	O
mental	O	O	B-T041
performance	O	O	B-T055
.	O	O	O

The	O	O	O
Internet	O	O	B-T073
plays	O	O	O
a	O	O	O
major	O	O	B-T080
role	O	O	B-T077
in	O	O	O
the	O	O	O
spread	O	O	B-T080
of	O	O	O
these	O	O	O
products	O	O	B-T071
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
literature	O	O	B-T170
has	O	O	O
reported	O	O	O
issues	O	O	O
regarding	O	O	O
the	O	O	O
authenticity	O	O	B-T080
of	O	O	O
medicines	O	O	B-T121
purchased	O	O	B-T052
from	O	O	O
the	O	O	O
Internet	O	O	B-T073
and	O	O	O
the	O	O	O
impact	O	O	B-T080
of	O	O	O
counterfeit	O	O	B-T131
medicines	O	O	I-T131
on	O	O	O
public	O	O	B-T092
health	O	O	B-T078
.	O	O	O

Little	O	O	O
or	O	O	O
no	O	O	B-T080
data	O	O	I-T080
are	O	O	I-T080
available	O	O	I-T080
on	O	O	O
the	O	O	O
authenticity	O	O	B-T080
of	O	O	O
lifestyle	O	O	B-T073
products	O	O	I-T073
and	O	O	O
actual	O	O	O
toxicity	O	O	B-T080
associated	O	O	B-T080
with	O	O	I-T080
their	O	O	O
use	O	O	B-T169
and	O	O	O
misuse	O	O	B-T033
.	O	O	O

Our	O	O	O
aim	O	O	O
was	O	O	O
to	O	O	O
investigate	O	O	B-T169
consumer	O	O	B-T080
and	O	O	O
patient	O	O	B-T041
attitudes	O	O	I-T041
toward	O	O	B-T078
the	O	O	O
purchase	O	O	B-T052
of	O	O	O
lifestyle	O	O	B-T073
products	O	O	I-T073
from	O	O	O
the	O	O	O
Internet	O	O	B-T073
,	O	O	O
their	O	O	O
knowledge	O	O	B-T170
of	O	O	O
product	O	O	B-T071
authenticity	O	O	B-T080
and	O	O	O
toxicity	O	O	B-T080
,	O	O	O
and	O	O	O
their	O	O	O
experiences	O	O	B-T041
with	O	O	O
counterfeit	O	O	B-T080
lifestyle	O	O	O
products	O	O	O
.	O	O	O

A	O	O	O
Web	O	O	B-T073
-	O	O	O
based	O	O	B-T169
study	O	O	B-T062
was	O	O	O
performed	O	O	B-T169
between	O	O	O
May	O	O	O
2014	O	O	O
and	O	O	O
May	O	O	O
2015	O	O	O
.	O	O	O

Uniform	O	O	B-T080
collection	O	O	B-T062
of	O	O	I-T062
data	O	O	I-T062
was	O	O	O
performed	O	O	B-T169
through	O	O	B-T169
an	O	O	O
anonymous	O	O	B-T080
online	O	O	B-T073
questionnaire	O	O	B-T170
.	O	O	O

Participants	O	O	B-T098
were	O	O	O
invited	O	O	O
worldwide	O	O	B-T082
via	O	O	O
email	O	O	B-T170
,	O	O	O
social	O	O	B-T170
media	O	O	I-T170
,	O	O	O
or	O	O	O
personal	O	O	B-T054
communication	O	O	I-T054
to	O	O	O
complete	O	O	B-T080
the	O	O	O
online	O	O	B-T073
questionnaire	O	O	B-T170
.	O	O	O

A	O	O	O
total	O	O	B-T080
of	O	O	O
320	O	O	O
participants	O	O	B-T098
completed	O	O	B-T080
the	O	O	O
questionnaire	O	O	B-T170
.	O	O	O

The	O	O	O
results	O	O	B-T169
of	O	O	O
the	O	O	O
questionnaire	O	O	B-T170
showed	O	O	O
that	O	O	O
208	O	O	O
(	O	O	O
65.0	O	O	O
%	O	O	O
)	O	O	O
participants	O	O	B-T098
purchased	O	O	B-T052
lifestyle	O	O	B-T073
products	O	O	I-T073
from	O	O	O
the	O	O	O
Internet	O	O	B-T073
mainly	O	O	B-T080
due	O	O	B-T169
to	O	O	I-T169
convenience	O	O	B-T080
and	O	O	O
reduced	O	O	B-T080
cost	O	O	B-T081
.	O	O	O

More	O	O	B-T081
than	O	O	I-T081
half	O	O	B-T081
(	O	O	O
55.6	O	O	O
%	O	O	O
,	O	O	O
178/320	O	O	O
)	O	O	O
of	O	O	O
participants	O	O	B-T098
purchased	O	O	B-T052
cosmetic	O	O	B-T073
products	O	O	I-T073
,	O	O	O
whereas	O	O	O
only	O	O	O
a	O	O	O
minority	O	O	B-T080
purchased	O	O	O
medicinal	O	O	B-T121
products	O	O	I-T121
.	O	O	O

Yet	O	O	O
,	O	O	O
62.8	O	O	O
%	O	O	O
(	O	O	O
201/320	O	O	O
)	O	O	O
of	O	O	O
participants	O	O	B-T098
were	O	O	O
aware	O	O	B-T041
of	O	O	O
the	O	O	O
presence	O	O	B-T033
of	O	O	O
counterfeit	O	O	B-T080
lifestyle	O	O	B-T073
products	O	O	B-T071
from	O	O	O
the	O	O	O
Internet	O	O	B-T073
,	O	O	O
and	O	O	O
11.9	O	O	O
%	O	O	O
(	O	O	O
38/320	O	O	O
)	O	O	O
experienced	O	O	B-T041
counterfeit	O	O	O
products	O	O	O
.	O	O	O

In	O	O	O
only	O	O	O
0.9	O	O	O
%	O	O	O
(	O	O	O
3/320	O	O	O
)	O	O	O
of	O	O	O
those	O	O	O
cases	O	O	B-T169
were	O	O	O
counterfeit	O	O	B-T080
lifestyle	O	O	B-T073
products	O	O	I-T073
reported	O	O	B-T058
to	O	O	O
authorities	O	O	B-T093
.	O	O	O

Moreover	O	O	O
,	O	O	O
7.2	O	O	O
%	O	O	O
(	O	O	O
23/320	O	O	O
)	O	O	O
of	O	O	O
the	O	O	O
participants	O	O	B-T098
experienced	O	O	B-T041
adverse	O	O	B-T046
effects	O	O	I-T046
due	O	O	O
to	O	O	O
counterfeit	O	O	B-T080
lifestyle	O	O	B-T073
products	O	O	I-T073
.	O	O	O

In	O	O	O
summary	O	O	O
,	O	O	O
patients	O	O	B-T101
experienced	O	O	B-T041
counterfeit	O	O	B-T080
lifestyle	O	O	B-T073
products	O	O	I-T073
that	O	O	O
resulted	O	O	B-T169
in	O	O	I-T169
adverse	O	O	B-T046
effects	O	O	I-T046
on	O	O	O
their	O	O	O
health	O	O	B-T078
.	O	O	O

Although	O	O	O
certain	O	O	O
adverse	O	O	B-T046
effects	O	O	I-T046
were	O	O	O
reported	O	O	B-T058
in	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
counterfeit	O	O	B-T080
products	O	O	B-T071
were	O	O	O
underreported	O	O	B-T058
to	O	O	O
authorities	O	O	B-T093
.	O	O	O

Further	O	O	O
public	O	O	B-UnknownType
awareness	O	O	I-UnknownType
campaigns	O	O	I-UnknownType
and	O	O	O
patient	O	O	B-T065
education	O	O	I-T065
are	O	O	O
needed	O	O	B-T080
.	O	O	O

-DOCSTART- (27433451)

It	O	O	O
's	O	O	O
not	O	O	O
All	O	O	O
Doom	O	O	O
and	O	O	O
Gloom	O	O	O
:	O	O	O
Prune	O	O	B-T047
Belly	O	O	I-T047
Syndrome	O	O	I-T047
Associated	O	O	O
with	O	O	O
VACTERL	O	O	O

Prune	O	O	B-T047
belly	O	O	I-T047
syndrome	O	O	I-T047
is	O	O	O
a	O	O	O
rare	O	O	B-T080
abnormality	O	O	B-T033
;	O	O	O
its	O	O	O
association	O	O	B-T019
with	O	O	I-T019
VACTERL	O	O	I-T019
is	O	O	O
even	O	O	O
rarer	O	O	B-T080
.	O	O	O

This	O	O	O
association	O	O	B-T019
has	O	O	O
been	O	O	O
reported	O	O	B-T058
in	O	O	O
literature	O	O	B-T170
a	O	O	O
few	O	O	O
times	O	O	O
since	O	O	O
first	O	O	O
reported	O	O	O
in	O	O	O
1993	O	O	O
and	O	O	O
so	O	O	O
far	O	O	O
the	O	O	O
majority	O	O	B-T054
have	O	O	O
either	O	O	O
been	O	O	O
stillbirths	O	O	B-T033
or	O	O	I-T033
died	O	O	I-T033
shortly	O	O	I-T033
after	O	O	I-T033
birth	O	O	I-T033
.	O	O	O

We	O	O	O
present	O	O	O
a	O	O	O
case	O	O	B-T077
of	O	O	O
Prune	O	O	B-T047
belly	O	O	I-T047
syndrome	O	O	I-T047
associated	O	O	B-T019
with	O	O	I-T019
VACTERL	O	O	I-T019
who	O	O	O
is	O	O	O
now	O	O	O
one	O	O	O
year	O	O	O
old	O	O	O
.	O	O	O

-DOCSTART- (27434049)

Changes	O	O	B-T169
in	O	O	O
Cardiovascular	O	O	B-T029
Health	O	O	B-T080
Status	O	O	I-T080
and	O	O	O
the	O	O	O
Risk	O	O	B-T078
of	O	O	I-T078
New-Onset	O	O	B-UnknownType
Hypertension	O	O	I-UnknownType
in	O	O	O
Kailuan	O	O	B-T098
Cohort	O	O	O
Study	O	O	O

American	O	O	B-T093
Heart	O	O	I-T093
Association	O	O	I-T093
cardiovascular	O	O	B-T029
health	O	O	B-T170
metrics	O	O	I-T170
are	O	O	O
intimately	O	O	O
related	O	O	O
to	O	O	O
cardiovascular	O	O	B-T047
diseases	O	O	I-T047
.	O	O	O

Acting	O	O	O
as	O	O	O
a	O	O	O
key	O	O	B-T080
independent	O	O	O
risk	O	O	B-T033
factor	O	O	I-T033
for	O	O	O
high	O	O	B-T080
morbidity	O	O	B-T081
and	O	O	O
mortality	O	O	B-T081
of	O	O	O
cardiovascular	O	O	B-T047
diseases	O	O	I-T047
,	O	O	O
hypertension	O	O	B-T047
and	O	O	O
its	O	O	O
relationship	O	O	B-T080
between	O	O	O
health	O	O	B-T080
status	O	O	I-T080
get	O	O	O
urgent	O	O	O
attention	O	O	B-T041
.	O	O	O

While	O	O	O
the	O	O	O
influence	O	O	B-T077
of	O	O	O
individual	O	O	B-T098
health	O	O	B-T080
status	O	O	I-T080
changes	O	O	B-T169
and	O	O	O
the	O	O	O
future	O	O	O
risk	O	O	B-T078
of	O	O	I-T078
new-onset	O	O	B-UnknownType
hypertension	O	O	B-T047
is	O	O	O
rarely	O	O	O
understood	O	O	O
,	O	O	O
the	O	O	O
present	O	O	O
study	O	O	O
applied	O	O	O
this	O	O	O
construct	O	O	O
to	O	O	O
assess	O	O	B-T058
the	O	O	O
changes	O	O	O
of	O	O	O
cardiovascular	O	O	B-T029
health	O	O	O
status	O	O	O
and	O	O	O
the	O	O	O
morbidity	O	O	B-T081
of	O	O	O
hypertension	O	O	O
in	O	O	O
Kailuan	O	O	B-T098
cohort	O	O	B-T081
study	O	O	I-T081
in	O	O	O
north	O	O	B-T082
China	O	O	B-T083
.	O	O	O

The	O	O	O
Cardiovascular	O	O	B-T029
Health	O	O	B-T081
Score	O	O	I-T081
(	O	O	O
CHS	O	O	B-T081
)	O	O	O
was	O	O	O
evaluated	O	O	B-T058
by	O	O	O
the	O	O	O
follow-ups	O	O	B-T058
of	O	O	O
2006	O	O	O
-	O	O	O
2007	O	O	O
,	O	O	O
2008	O	O	O
-	O	O	O
2009	O	O	O
,	O	O	O
2010	O	O	O
-	O	O	O
2011	O	O	O
and	O	O	O
2012	O	O	O
-	O	O	O
2013	O	O	O
.	O	O	O

The	O	O	O
study	O	O	B-T098
population	O	O	I-T098
(	O	O	O
n	O	O	O
=	O	O	O
19381	O	O	O
)	O	O	O
was	O	O	O
divided	O	O	B-T169
into	O	O	O
5	O	O	O
groups	O	O	B-T078
based	O	O	O
on	O	O	O
the	O	O	O
changes	O	O	B-T169
in	O	O	O
their	O	O	O
CHS	O	O	B-T081
score	O	O	I-T081
between	O	O	O
the	O	O	O
first	O	O	O
two	O	O	O
follow-ups	O	O	B-T058
(	O	O	O
â³	O	O	O
CHS	O	O	O
)	O	O	O
of	O	O	O
2006	O	O	O
-	O	O	O
2007	O	O	O
and	O	O	O
2008	O	O	O
-	O	O	O
2009	O	O	O
(	O	O	O
â¤-2	O	O	O
,	O	O	O
-1	O	O	O
,	O	O	O
0	O	O	O
,	O	O	O
1	O	O	O
,	O	O	O
â¥2	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
morbidity	O	O	B-T081
of	O	O	O
hypertension	O	O	B-T047
was	O	O	O
collected	O	O	B-T169
during	O	O	B-T079
2010	O	O	O
-	O	O	O
2011	O	O	O
and	O	O	O
2012	O	O	O
-	O	O	O
2013	O	O	O
follow-ups	O	O	B-T058
.	O	O	O

Data	O	O	B-T057
analysis	O	O	I-T057
showed	O	O	O
that	O	O	O
during	O	O	B-T079
a	O	O	O
median	O	O	B-T081
follow-up	O	O	B-T058
of	O	O	O
3.79Â±0.96	O	O	O
years	O	O	O
,	O	O	O
morbidity	O	O	B-T081
of	O	O	O
hypertension	O	O	B-T047
had	O	O	O
a	O	O	O
graded	O	O	O
relationship	O	O	B-T080
with	O	O	O
â³	O	O	O
CHS	O	O	O
.	O	O	O

As	O	O	O
â³	O	O	O
CHS	O	O	O
scored	O	O	O
from	O	O	O
low	O	O	O
to	O	O	O
high	O	O	O
,	O	O	O
the	O	O	O
standardized	O	O	B-T058
morbidity	O	O	B-T081
of	O	O	O
hypertension	O	O	B-T047
for	O	O	O
all	O	O	O
participants	O	O	B-T098
were	O	O	O
81.40	O	O	O
,	O	O	O
75.47	O	O	O
,	O	O	O
68.37	O	O	O
,	O	O	O
71.43	O	O	O
and	O	O	O
83.13	O	O	O
per	O	O	O
1000	O	O	O
person-year	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

An	O	O	O
increased	O	O	B-T081
â³	O	O	O
CHS	O	O	O
score	O	O	O
of	O	O	O
1	O	O	O
was	O	O	O
associated	O	O	O
with	O	O	O
a	O	O	O
10	O	O	O
%	O	O	O
decrease	O	O	B-T081
in	O	O	O
the	O	O	O
future	O	O	B-T079
risk	O	O	B-T078
of	O	O	I-T078
new-onset	O	O	B-UnknownType
hypertension	O	O	I-UnknownType
(	O	O	O
HR	O	O	O
:	O	O	O
0.90	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
:	O	O	O
0.88	O	O	O
-	O	O	O
0.92	O	O	O
)	O	O	O
.	O	O	O

In	O	O	O
conclusion	O	O	O
,	O	O	O
there	O	O	O
was	O	O	O
a	O	O	O
strong	O	O	O
inverse	O	O	O
relationship	O	O	B-T080
between	O	O	O
the	O	O	O
incidence	O	O	O
of	O	O	O
new-onset	O	O	B-UnknownType
hypertension	O	O	I-UnknownType
and	O	O	O
elevation	O	O	B-T080
of	O	O	O
cardiovascular	O	O	B-T029
health	O	O	B-T170
metrics	O	O	I-T170
.	O	O	O

Population	O	O	B-T098
-wide	O	O	O
prevention	O	O	B-T080
,	O	O	O
especially	O	O	O
the	O	O	O
promotion	O	O	B-T058
of	O	O	O
lifestyle	O	O	B-T054
improvements	O	O	B-T077
,	O	O	O
is	O	O	O
critical	O	O	B-T080
to	O	O	O
reducing	O	O	B-T080
the	O	O	O
morbidity	O	O	B-T081
of	O	O	O
new-onset	O	O	B-UnknownType
hypertension	O	O	I-UnknownType
.	O	O	O

-DOCSTART- (27435835)

An	O	O	O
HIV	O	O	B-T005
-	O	O	O
tailored	O	O	B-T058
quit	O	O	B-T052
-	O	O	O
smoking	O	O	B-T055
counselling	O	O	B-T058
pilot	O	O	B-T062
intervention	O	O	B-T061
targeting	O	O	B-T169
depressive	O	O	B-T184
symptoms	O	O	I-T184
plus	O	O	O
Nicotine	O	O	O
Replacement	O	O	O
Therapy	O	O	O

Cardiovascular	O	O	B-T047
disease	O	O	I-T047
(	O	O	O
CVD	O	O	B-T047
)	O	O	O
rates	O	O	B-T081
among	O	O	O
people	O	O	B-T098
living	O	O	B-T101
with	O	O	I-T101
HIV/AIDS	O	O	I-T101
(	O	O	O
PHAs	O	O	B-T101
)	O	O	O
are	O	O	O
high	O	O	B-T080
.	O	O	O

Rates	O	O	B-T081
of	O	O	O
cigarette	O	O	B-T055
smoking	O	O	I-T055
,	O	O	O
a	O	O	O
leading	O	O	B-T169
contributor	O	O	B-T052
to	O	O	O
CVD	O	O	B-T047
among	O	O	O
PHAs	O	O	B-T101
,	O	O	O
are	O	O	O
40	O	O	O
-	O	O	O
70	O	O	O
%	O	O	O
(	O	O	O
2	O	O	O
-	O	O	O
3	O	O	O
times	O	O	O
higher	O	O	B-T080
than	O	O	O
the	O	O	O
general	O	O	B-T098
population	O	O	I-T098
)	O	O	O
.	O	O	O

Furthermore	O	O	O
,	O	O	O
PHAs	O	O	B-T101
have	O	O	O
high	O	O	B-T080
rates	O	O	B-T081
of	O	O	O
depression	O	O	B-T048
(	O	O	O
40	O	O	O
-	O	O	O
60	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
a	O	O	O
risk	O	O	B-T033
factor	O	O	I-T033
for	O	O	O
smoking	O	O	B-T055
cessation	O	O	B-T052
relapse	O	O	B-T067
.	O	O	O

The	O	O	O
current	O	O	O
pilot	O	O	B-T062
study	O	O	I-T062
examined	O	O	B-T033
the	O	O	O
effectiveness	O	O	B-T080
of	O	O	O
a	O	O	O
specifically	O	O	O
tailored	O	O	B-T058
5-	O	O	O
session	O	O	B-T051
smoking	O	O	B-T055
cessation	O	O	B-T052
counselling	O	O	B-T058
programme	O	O	I-T058
for	O	O	O
PHAs	O	O	B-T101
,	O	O	O
which	O	O	O
addressed	O	O	O
depression	O	O	B-T048
,	O	O	O
in	O	O	O
combination	O	O	O
with	O	O	O
Nicotine	O	O	B-T061
Replacement	O	O	I-T061
Therapy	O	O	I-T061
(	O	O	O
NRT	O	O	B-T061
)	O	O	O
in	O	O	O
a	O	O	O
cohort	O	O	B-T098
of	O	O	O
PHA	O	O	B-T101
smokers	O	O	B-T033
(	O	O	O
n	O	O	O
=	O	O	O
50	O	O	O
)	O	O	O
.	O	O	O

At	O	O	O
6-	O	O	O
month	O	O	B-T079
follow-up	O	O	B-T058
,	O	O	O
28	O	O	O
%	O	O	O
of	O	O	O
participants	O	O	B-T098
demonstrated	O	O	O
biochemically	O	O	B-T169
verified	O	O	B-T169
abstinence	O	O	B-T061
from	O	O	O
smoking	O	O	B-T055
.	O	O	O

This	O	O	O
result	O	O	B-T033
compares	O	O	B-T052
favourably	O	O	O
to	O	O	O
other	O	O	O
quit	O	O	B-T052
-	O	O	O
smoking	O	O	B-T055
intervention	O	O	B-T061
studies	O	O	B-T062
,	O	O	O
particularly	O	O	O
given	O	O	O
the	O	O	O
high	O	O	B-T080
percentage	O	O	B-T081
of	O	O	O
HIV+	O	O	B-T034
smokers	O	O	B-T033
with	O	O	O
depression	O	O	B-T048
.	O	O	O

At	O	O	O
study	O	O	B-T062
baseline	O	O	B-T081
,	O	O	O
52	O	O	O
%	O	O	O
of	O	O	O
HIV+	O	O	B-T034
smokers	O	O	B-T033
scored	O	O	O
above	O	O	O
the	O	O	O
clinical	O	O	B-T080
cut-off	O	O	B-T169
for	O	O	O
depression	O	O	B-T048
on	O	O	O
the	O	O	O
Centre	O	O	B-T170
for	O	O	I-T170
Epidemiological	O	O	I-T170
Studies	O	O	I-T170
-	O	O	I-T170
Depression	O	O	I-T170
(	O	O	I-T170
CES-D	O	O	I-T170
)	O	O	I-T170
scale	O	O	I-T170
.	O	O	O

HIV+	O	O	B-T034
smokers	O	O	B-T033
with	O	O	O
depression	O	O	B-T048
at	O	O	O
study	O	O	B-T062
baseline	O	O	B-T081
demonstrated	O	O	O
quantitatively	O	O	B-T081
lower	O	O	B-T052
depression	O	O	O
at	O	O	O
6-	O	O	O
month	O	O	B-T079
follow-up	O	O	B-T058
with	O	O	O
a	O	O	O
large	O	O	B-T081
effect	O	O	B-T081
size	O	O	I-T081
(	O	O	O
d	O	O	O
=	O	O	O
1	O	O	O
)	O	O	O
,	O	O	O
though	O	O	O
it	O	O	O
did	O	O	O
not	O	O	O
reach	O	O	O
statistical	O	O	B-T081
significance	O	O	I-T081
(	O	O	O
p	O	O	O
=	O	O	O
.058	O	O	O
)	O	O	O
.	O	O	O

Furthermore	O	O	O
,	O	O	O
those	O	O	O
with	O	O	O
depression	O	O	B-T048
were	O	O	O
no	O	O	O
more	O	O	O
likely	O	O	O
to	O	O	O
relapse	O	O	B-T067
than	O	O	O
those	O	O	O
without	O	O	O
depression	O	O	O
(	O	O	O
p	O	O	O
=	O	O	O
.33	O	O	O
)	O	O	O
,	O	O	O
suggesting	O	O	O
that	O	O	O
our	O	O	O
counselling	O	O	B-T058
programme	O	O	I-T058
adequately	O	O	B-T080
addressed	O	O	O
this	O	O	O
significant	O	O	B-T078
barrier	O	O	B-T080
to	O	O	O
smoking	O	O	B-T055
cessation	O	O	B-T052
among	O	O	O
PHAs	O	O	B-T101
.	O	O	O

Our	O	O	O
pilot	O	O	B-T062
study	O	O	I-T062
indicates	O	O	O
the	O	O	O
importance	O	O	B-T080
of	O	O	O
tailored	O	O	B-T058
programmes	O	O	I-T058
to	O	O	O
help	O	O	O
PHAs	O	O	B-T101
quit	O	O	B-T052
smoking	O	O	B-T055
,	O	O	O
the	O	O	O
significance	O	O	B-T078
of	O	O	O
addressing	O	O	O
depressive	O	O	B-T184
symptoms	O	O	I-T184
,	O	O	O
and	O	O	O
the	O	O	O
need	O	O	O
for	O	O	O
tailored	O	O	B-T058
counselling	O	O	I-T058
programmes	O	O	I-T058
to	O	O	O
enhance	O	O	B-T052
quit	O	O	O
rates	O	O	B-T081
among	O	O	O
PHAs	O	O	O
.	O	O	O

-DOCSTART- (27436524)

Effects	O	O	B-T080
of	O	O	I-T080
complex	O	O	B-T080
life	O	O	B-T079
cycles	O	O	I-T079
on	O	O	O
genetic	O	O	B-T070
diversity	O	O	I-T070
:	O	O	O
cyclical	O	O	O
parthenogenesis	O	O	O

Neutral	O	O	O
patterns	O	O	O
of	O	O	O
population	O	O	B-T098
genetic	O	O	B-T070
diversity	O	O	I-T070
in	O	O	O
species	O	O	B-T185
with	O	O	O
complex	O	O	B-T080
life	O	O	B-T079
cycles	O	O	I-T079
are	O	O	O
difficult	O	O	O
to	O	O	O
anticipate	O	O	B-T078
.	O	O	O

Cyclical	O	O	B-T040
parthenogenesis	O	O	I-T040
(	O	O	O
CP	O	O	B-T040
)	O	O	O
,	O	O	O
in	O	O	O
which	O	O	O
organisms	O	O	B-T001
undergo	O	O	O
several	O	O	O
rounds	O	O	O
of	O	O	O
clonal	O	O	B-T024
reproduction	O	O	B-T040
followed	O	O	O
by	O	O	O
a	O	O	O
sexual	O	O	B-T053
event	O	O	I-T053
,	O	O	O
is	O	O	O
one	O	O	O
such	O	O	O
life	O	O	B-T079
cycle	O	O	I-T079
.	O	O	O

Many	O	O	O
species	O	O	B-T185
,	O	O	O
including	O	O	O
crop	O	O	B-T002
pests	O	O	B-T008
(	O	O	O
aphids	O	O	B-T204
)	O	O	O
,	O	O	O
human	O	O	B-T204
parasites	O	O	I-T204
(	O	O	O
trematodes	O	O	B-T204
)	O	O	O
or	O	O	O
models	O	O	B-T170
used	O	O	O
in	O	O	O
evolutionary	O	O	B-T091
science	O	O	I-T091
(	O	O	O
Daphnia	O	O	B-T204
)	O	O	O
,	O	O	O
are	O	O	O
cyclical	O	O	B-T001
parthenogens	O	O	I-T001
.	O	O	O

It	O	O	O
is	O	O	O
therefore	O	O	O
crucial	O	O	O
to	O	O	O
understand	O	O	O
the	O	O	O
impact	O	O	O
of	O	O	O
such	O	O	O
a	O	O	O
life	O	O	B-T079
cycle	O	O	I-T079
on	O	O	O
neutral	O	O	O
genetic	O	O	B-T070
diversity	O	O	I-T070
.	O	O	O

In	O	O	O
this	O	O	O
paper	O	O	O
,	O	O	O
we	O	O	O
describe	O	O	O
distributions	O	O	B-T169
of	O	O	O
genetic	O	O	B-T070
diversity	O	O	I-T070
under	O	O	O
conditions	O	O	B-T080
of	O	O	O
CP	O	O	B-T040
with	O	O	O
various	O	O	O
clonal	O	O	B-T024
phase	O	O	B-T079
lengths	O	O	B-T081
.	O	O	O

Using	O	O	O
a	O	O	O
Markov	O	O	B-T081
chain	O	O	I-T081
model	O	O	I-T081
of	O	O	O
CP	O	O	B-T040
for	O	O	O
a	O	O	O
single	O	O	B-T081
locus	O	O	B-T082
and	O	O	O
individual-based	O	O	O
simulations	O	O	B-T062
for	O	O	O
two	O	O	B-T081
loci	O	O	B-T082
,	O	O	O
our	O	O	O
analysis	O	O	O
first	O	O	O
demonstrates	O	O	O
that	O	O	O
strong	O	O	O
departures	O	O	B-T052
from	O	O	O
full	O	O	O
sexuality	O	O	B-T053
are	O	O	O
observed	O	O	O
after	O	O	O
only	O	O	O
a	O	O	O
few	O	O	O
generations	O	O	B-T079
of	O	O	O
clonality	O	O	B-T080
.	O	O	O

The	O	O	O
convergence	O	O	B-T052
towards	O	O	O
predictions	O	O	B-T078
made	O	O	O
under	O	O	O
conditions	O	O	O
of	O	O	O
full	O	O	O
clonality	O	O	B-T080
during	O	O	O
the	O	O	O
clonal	O	O	B-T024
phase	O	O	B-T079
depends	O	O	O
on	O	O	O
the	O	O	O
balance	O	O	O
between	O	O	O
mutations	O	O	B-T045
and	O	O	O
genetic	O	O	B-T045
drift	O	O	I-T045
.	O	O	O

Second	O	O	O
,	O	O	O
the	O	O	O
sexual	O	O	B-T053
event	O	O	I-T053
of	O	O	O
CP	O	O	B-T040
usually	O	O	O
resets	O	O	O
the	O	O	O
genetic	O	O	B-T070
diversity	O	O	I-T070
at	O	O	O
a	O	O	O
single	O	O	B-T081
locus	O	O	B-T082
towards	O	O	O
predictions	O	O	B-T078
made	O	O	O
under	O	O	O
full	O	O	O
sexuality	O	O	B-T053
.	O	O	O

However	O	O	O
,	O	O	O
this	O	O	O
single	O	O	O
recombination	O	O	B-T045
event	O	O	O
is	O	O	O
insufficient	O	O	O
to	O	O	O
reshuffle	O	O	O
gametic	O	O	B-T043
phases	O	O	I-T043
towards	O	O	O
full-sexuality	O	O	B-T053
predictions	O	O	B-T078
.	O	O	O

Finally	O	O	O
,	O	O	O
for	O	O	O
similar	O	O	O
levels	O	O	O
of	O	O	O
clonality	O	O	B-T080
,	O	O	O
CP	O	O	B-T040
and	O	O	O
acyclic	O	O	O
partial	O	O	B-T081
clonality	O	O	O
(	O	O	O
wherein	O	O	O
a	O	O	O
fixed	O	O	O
proportion	O	O	O
of	O	O	O
individuals	O	O	B-T098
are	O	O	O
clonally	O	O	B-T080
produced	O	O	O
within	O	O	O
each	O	O	O
generation	O	O	B-T079
)	O	O	O
differentially	O	O	O
affect	O	O	O
the	O	O	O
distribution	O	O	B-T169
of	O	O	O
genetic	O	O	B-T070
diversity	O	O	I-T070
.	O	O	O

Overall	O	O	O
,	O	O	O
this	O	O	O
work	O	O	O
provides	O	O	O
solid	O	O	O
predictions	O	O	B-T078
of	O	O	O
neutral	O	O	O
genetic	O	O	B-T070
diversity	O	O	I-T070
that	O	O	O
may	O	O	O
serve	O	O	O
as	O	O	O
a	O	O	O
null	O	O	B-T170
model	O	O	I-T170
in	O	O	O
detecting	O	O	O
the	O	O	O
action	O	O	O
of	O	O	O
common	O	O	O
evolutionary	O	O	B-T045
or	O	O	O
demographic	O	O	B-T090
processes	O	O	B-T067
in	O	O	O
cyclical	O	O	B-T001
parthenogens	O	O	I-T001
(	O	O	O
for	O	O	O
example	O	O	O
,	O	O	O
selection	O	O	O
or	O	O	O
bottlenecks	O	O	O
)	O	O	O
.	O	O	O

-DOCSTART- (27439116)

Recent	O	O	B-T079
advances	O	O	B-T078
in	O	O	O
chitosan	O	O	B-T109
-based	O	O	O
nanoparticulate	O	O	B-T073
pulmonary	O	O	B-T023
drug	O	O	O
delivery	O	O	O

The	O	O	O
advent	O	O	O
of	O	O	O
biodegradable	O	O	B-T109
polymer	O	O	I-T109
-	O	O	O
encapsulated	O	O	B-T080
drug	O	O	B-T121
nanoparticles	O	O	B-T073
has	O	O	O
made	O	O	O
the	O	O	O
pulmonary	O	O	B-T023
route	O	O	B-T169
of	O	O	I-T169
administration	O	O	I-T169
an	O	O	O
exciting	O	O	O
area	O	O	O
of	O	O	O
drug	O	O	B-T074
delivery	O	O	I-T074
research	O	O	B-T062
.	O	O	O

Chitosan	O	O	B-T109
,	O	O	O
a	O	O	O
natural	O	O	B-T169
biodegradable	O	O	B-T109
and	O	O	O
biocompatible	O	O	B-T122
polysaccharide	O	O	B-T109
has	O	O	O
received	O	O	B-T080
enormous	O	O	O
attention	O	O	O
as	O	O	O
a	O	O	O
carrier	O	O	B-T122
for	O	O	O
drug	O	O	B-T074
delivery	O	O	I-T074
.	O	O	O

Recently	O	O	O
,	O	O	O
nanoparticles	O	O	B-T073
of	O	O	O
chitosan	O	O	B-T109
(	O	O	O
CS	O	O	B-T109
)	O	O	O
and	O	O	O
its	O	O	O
synthetic	O	O	B-T109
derivatives	O	O	I-T109
have	O	O	O
been	O	O	O
investigated	O	O	B-T169
for	O	O	O
the	O	O	O
encapsulation	O	O	B-T067
and	O	O	O
delivery	O	O	B-T169
of	O	O	O
many	O	O	O
drugs	O	O	B-T121
with	O	O	O
improved	O	O	B-T033
targeting	O	O	B-T169
and	O	O	O
controlled	O	O	B-T079
release	O	O	I-T079
.	O	O	O

Herein	O	O	O
,	O	O	O
recent	O	O	B-T079
advances	O	O	B-T078
in	O	O	O
the	O	O	O
preparation	O	O	B-T052
and	O	O	O
use	O	O	B-T169
of	O	O	I-T169
micro-	O	O	B-T026
/	O	O	O
nanoparticles	O	O	B-T073
of	O	O	O
chitosan	O	O	B-T109
and	O	O	O
its	O	O	O
derivatives	O	O	B-T109
for	O	O	O
pulmonary	O	O	B-T023
delivery	O	O	B-T169
of	O	O	O
various	O	O	O
therapeutic	O	O	B-T073
agents	O	O	I-T073
(	O	O	O
drugs	O	O	B-T121
,	O	O	O
genes	O	O	B-T028
,	O	O	O
vaccines	O	O	B-T129
)	O	O	O
are	O	O	O
reviewed	O	O	B-T080
.	O	O	O

Although	O	O	O
chitosan	O	O	B-T109
has	O	O	O
wide	O	O	O
applications	O	O	B-T169
in	O	O	O
terms	O	O	O
of	O	O	O
formulations	O	O	B-T062
and	O	O	O
routes	O	O	B-T169
of	O	O	I-T169
drug	O	O	I-T169
delivery	O	O	I-T169
,	O	O	O
this	O	O	O
review	O	O	B-T170
is	O	O	O
focused	O	O	O
on	O	O	O
pulmonary	O	O	B-T023
delivery	O	O	B-T058
of	O	O	I-T058
drug-encapsulated	O	O	I-T058
nanoparticles	O	O	I-T058
of	O	O	O
chitosan	O	O	O
and	O	O	O
its	O	O	O
derivatives	O	O	B-T109
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
the	O	O	O
controversial	O	O	B-T078
toxicological	O	O	B-T037
effects	O	O	I-T037
of	O	O	O
chitosan	O	O	B-T109
nanoparticles	O	O	B-T073
for	O	O	O
lung	O	O	B-T023
delivery	O	O	B-T169
will	O	O	O
also	O	O	O
be	O	O	O
discussed	O	O	O
.	O	O	O

-DOCSTART- (27440255)

Form	O	O	B-T080
and	O	O	O
function	O	O	B-T169
in	O	O	O
gene	O	O	B-T044
regulatory	O	O	I-T044
networks	O	O	I-T044
:	O	O	O
the	O	O	O
structure	O	O	B-T082
of	O	O	O
network	O	O	B-T080
motifs	O	O	I-T080
determines	O	O	O
fundamental	O	O	B-T080
properties	O	O	I-T080
of	O	O	O
their	O	O	O
dynamical	O	O	O
state	O	O	O
space	O	O	O

Network	O	O	B-T080
motifs	O	O	B-T080
have	O	O	O
been	O	O	O
studied	O	O	O
extensively	O	O	O
over	O	O	O
the	O	O	O
past	O	O	O
decade	O	O	O
,	O	O	O
and	O	O	O
certain	O	O	O
motifs	O	O	O
,	O	O	O
such	O	O	O
as	O	O	O
the	O	O	O
feed-forward	O	O	B-T080
loop	O	O	I-T080
,	O	O	O
play	O	O	O
an	O	O	O
important	O	O	O
role	O	O	O
in	O	O	O
regulatory	O	O	B-T044
networks	O	O	I-T044
.	O	O	O

Recent	O	O	B-T079
studies	O	O	B-T062
have	O	O	O
used	O	O	O
Boolean	O	O	B-T170
network	O	O	B-T169
motifs	O	O	B-T080
to	O	O	O
explore	O	O	O
the	O	O	O
link	O	O	O
between	O	O	O
form	O	O	B-T080
and	O	O	O
function	O	O	B-T169
in	O	O	O
gene	O	O	B-T044
regulatory	O	O	I-T044
networks	O	O	I-T044
and	O	O	O
have	O	O	O
found	O	O	O
that	O	O	O
the	O	O	O
structure	O	O	B-T082
of	O	O	O
a	O	O	O
motif	O	O	B-T080
does	O	O	O
not	O	O	O
strongly	O	O	O
determine	O	O	O
its	O	O	O
function	O	O	O
,	O	O	O
if	O	O	O
this	O	O	O
is	O	O	O
defined	O	O	O
in	O	O	O
terms	O	O	O
of	O	O	O
the	O	O	O
gene	O	O	B-T045
expression	O	O	I-T045
patterns	O	O	B-T082
the	O	O	O
motif	O	O	O
can	O	O	O
produce	O	O	O
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
offer	O	O	O
a	O	O	O
different	O	O	O
,	O	O	O
higher	O	O	B-T080
-	O	O	O
level	O	O	B-T080
definition	O	O	B-T170
of	O	O	O
the	O	O	O
'	O	O	O
function	O	O	B-T169
'	O	O	O
of	O	O	O
a	O	O	O
motif	O	O	B-T080
,	O	O	O
in	O	O	O
terms	O	O	O
of	O	O	O
two	O	O	O
fundamental	O	O	B-T080
properties	O	O	I-T080
of	O	O	O
its	O	O	O
dynamical	O	O	B-T082
state	O	O	I-T082
space	O	O	I-T082
as	O	O	O
a	O	O	O
Boolean	O	O	B-T170
network	O	O	B-T169
.	O	O	O

One	O	O	O
is	O	O	O
the	O	O	O
basin	O	O	B-T081
entropy	O	O	I-T081
,	O	O	O
which	O	O	O
is	O	O	O
a	O	O	O
complexity	O	O	B-T169
measure	O	O	B-T081
of	O	O	O
the	O	O	O
dynamics	O	O	B-T070
of	O	O	O
Boolean	O	O	B-T170
networks	O	O	B-T169
.	O	O	O

The	O	O	O
other	O	O	O
is	O	O	O
the	O	O	O
diversity	O	O	B-T080
of	O	O	O
cyclic	O	O	B-T081
attractor	O	O	I-T081
lengths	O	O	I-T081
that	O	O	O
a	O	O	O
given	O	O	O
motif	O	O	B-T080
can	O	O	O
produce	O	O	O
.	O	O	O

Using	O	O	O
these	O	O	O
two	O	O	O
measures	O	O	B-T081
,	O	O	O
we	O	O	O
examine	O	O	O
all	O	O	O
104	O	O	O
topologically	O	O	O
distinct	O	O	O
three-node	O	O	B-T077
motifs	O	O	B-T080
and	O	O	O
show	O	O	O
that	O	O	O
the	O	O	O
structural	O	O	B-T082
properties	O	O	B-T080
of	O	O	O
a	O	O	O
motif	O	O	B-T080
,	O	O	O
such	O	O	O
as	O	O	O
the	O	O	O
presence	O	O	O
of	O	O	O
feedback	O	O	B-T080
loops	O	O	I-T080
and	O	O	O
feed-forward	O	O	B-T080
loops	O	O	I-T080
,	O	O	O
predict	O	O	O
fundamental	O	O	B-T080
characteristics	O	O	I-T080
of	O	O	O
its	O	O	O
dynamical	O	O	B-T082
state	O	O	I-T082
space	O	O	I-T082
,	O	O	O
which	O	O	O
in	O	O	O
turn	O	O	O
determine	O	O	O
aspects	O	O	O
of	O	O	O
its	O	O	O
functional	O	O	B-T169
versatility	O	O	I-T169
.	O	O	O

We	O	O	O
also	O	O	O
show	O	O	O
that	O	O	O
these	O	O	O
higher	O	O	B-T080
-	O	O	O
level	O	O	B-T080
properties	O	O	B-T080
have	O	O	O
a	O	O	O
direct	O	O	O
bearing	O	O	O
on	O	O	O
real	O	O	O
regulatory	O	O	B-T044
networks	O	O	I-T044
,	O	O	O
as	O	O	O
both	O	O	O
basin	O	O	B-T081
entropy	O	O	I-T081
and	O	O	O
cycle	O	O	B-T081
length	O	O	I-T081
diversity	O	O	B-T080
show	O	O	O
a	O	O	O
close	O	O	O
correspondence	O	O	O
with	O	O	O
the	O	O	O
prevalence	O	O	B-T081
,	O	O	O
in	O	O	O
neural	O	O	B-T040
and	O	O	O
genetic	O	O	B-T044
regulatory	O	O	I-T044
networks	O	O	I-T044
,	O	O	O
of	O	O	O
the	O	O	O
13	O	O	O
connected	O	O	O
motifs	O	O	B-T080
without	O	O	O
self-interactions	O	O	B-T169
that	O	O	O
have	O	O	O
been	O	O	O
studied	O	O	O
extensively	O	O	O
in	O	O	O
the	O	O	O
literature	O	O	B-T170
.	O	O	O

-DOCSTART- (27440725)

Jak1	O	O	B-T116
-	O	O	O
STAT3	O	O	B-T116
Signals	O	O	B-T043
Are	O	O	O
Essential	O	O	B-T080
Effectors	O	O	B-T116
of	O	O	O
the	O	O	O
USP6	O	O	B-T116
/	O	O	O
TRE17	O	O	B-T116
Oncogene	O	O	I-T116
in	O	O	O
Tumorigenesis	O	O	O

Bone	O	O	B-T191
and	O	O	O
soft	O	O	B-T191
tissue	O	O	I-T191
tumors	O	O	I-T191
(	O	O	O
BSTT	O	O	B-T191
)	O	O	O
are	O	O	O
relatively	O	O	O
poorly	O	O	O
understood	O	O	O
,	O	O	O
hampering	O	O	O
the	O	O	O
development	O	O	B-T169
of	O	O	O
effective	O	O	B-T080
therapies	O	O	B-T061
.	O	O	O

Here	O	O	O
we	O	O	O
report	O	O	B-T170
a	O	O	O
role	O	O	O
for	O	O	O
the	O	O	O
ubiquitin-specific	O	O	B-T116
protease	O	O	I-T116
6	O	O	I-T116
(USP6)/	O	O	O
TRE17	O	O	B-T116
oncogene	O	O	I-T116
,	O	O	O
which	O	O	O
is	O	O	O
overexpressed	O	O	B-T045
upon	O	O	O
chromosome	O	O	B-T049
translocation	O	O	I-T049
in	O	O	O
various	O	O	O
human	O	O	B-T016
tumors	O	O	B-T191
,	O	O	O
including	O	O	O
aneurysmal	O	O	B-T047
bone	O	O	I-T047
cyst	O	O	I-T047
(	O	O	O
ABC	O	O	B-T047
)	O	O	O
,	O	O	O
and	O	O	O
the	O	O	O
related	O	O	O
benign	O	O	B-T080
lesion	O	O	B-T033
nodular	O	O	B-T047
fasciitis	O	O	I-T047
.	O	O	O

Ectopic	O	O	B-T045
expression	O	O	I-T045
of	O	O	O
USP6	O	O	B-T116
is	O	O	O
known	O	O	O
to	O	O	O
drive	O	O	O
formation	O	O	B-T169
of	O	O	O
tumors	O	O	B-T191
,	O	O	O
which	O	O	O
recapitulate	O	O	O
key	O	O	B-T080
features	O	O	I-T080
of	O	O	O
ABC	O	O	B-T047
and	O	O	O
nodular	O	O	B-T047
fasciitis	O	O	I-T047
;	O	O	O
however	O	O	O
,	O	O	O
the	O	O	O
identity	O	O	B-T078
of	O	O	O
USP6	O	O	B-T116
's	O	O	I-T116
relevant	O	O	O
substrates	O	O	B-T120
has	O	O	O
been	O	O	O
obscure	O	O	O
.	O	O	O

Here	O	O	O
we	O	O	O
report	O	O	B-T170
that	O	O	O
the	O	O	O
Jak1	O	O	B-T116
-	O	O	O
STAT3	O	O	B-T116
signaling	O	O	B-T044
pathway	O	O	I-T044
serves	O	O	O
as	O	O	O
an	O	O	O
essential	O	O	B-T080
effector	O	O	B-T116
of	O	O	O
USP6	O	O	B-T116
in	O	O	O
BSTT	O	O	B-T191
formation	O	O	B-T169
.	O	O	O

We	O	O	O
found	O	O	O
that	O	O	O
USP6	O	O	B-T116
directly	O	O	O
deubiquitinated	O	O	B-T044
Jak1	O	O	B-T116
,	O	O	O
leading	O	O	B-T169
to	O	O	O
its	O	O	O
stabilization	O	O	B-T033
and	O	O	O
activation	O	O	B-T045
of	O	O	O
STAT3	O	O	B-T116
.	O	O	O

The	O	O	O
tumorigenic	O	O	B-T191
potential	O	O	B-T080
of	O	O	O
USP6	O	O	B-T116
was	O	O	O
attenuated	O	O	B-T080
significantly	O	O	I-T080
by	O	O	I-T080
CRISPR	O	O	B-T114
-mediated	O	O	O
deletion	O	O	B-T045
of	O	O	O
Jak1	O	O	B-T028
or	O	O	O
STAT3	O	O	B-T028
,	O	O	O
or	O	O	O
by	O	O	O
administration	O	O	B-T169
of	O	O	O
a	O	O	O
Jak	O	O	B-T116
family	O	O	I-T116
inhibitor	O	O	B-T080
.	O	O	O

Analysis	O	O	B-T062
of	O	O	O
primary	O	O	B-T077
clinical	O	O	I-T077
samples	O	O	I-T077
of	O	O	O
nodular	O	O	B-T047
fasciitis	O	O	I-T047
confirmed	O	O	B-T033
the	O	O	O
activation	O	O	B-T045
of	O	O	O
a	O	O	O
Jak1	O	O	B-T116
-	O	O	O
STAT3	O	O	B-T116
gene	O	O	B-T169
signature	O	O	I-T169
in	O	O	B-T062
vivo	O	O	I-T062
Together	O	O	O
,	O	O	O
our	O	O	O
studies	O	O	B-T059
highlight	O	O	O
Jak1	O	O	O
as	O	O	O
the	O	O	O
first	O	O	O
identified	O	O	O
substrate	O	O	B-T120
for	O	O	O
USP6	O	O	B-T116
,	O	O	O
and	O	O	O
they	O	O	O
offer	O	O	O
a	O	O	O
mechanistic	O	O	B-T078
rationale	O	O	I-T078
for	O	O	O
the	O	O	O
clinical	O	O	B-T058
investigation	O	O	I-T058
of	O	O	O
Jak	O	O	B-T116
and	O	O	O
STAT3	O	O	O
inhibitors	O	O	B-T080
as	O	O	O
therapeutics	O	O	B-T169
for	O	O	O
the	O	O	O
treatment	O	O	B-T061
of	O	O	O
bone	O	O	B-T191
and	O	O	O
soft	O	O	B-T191
tissue	O	O	I-T191
tumors	O	O	I-T191
along	O	O	O
with	O	O	O
other	O	O	O
neoplasms	O	O	B-T191
driven	O	O	O
by	O	O	O
USP6	O	O	O
overexpression	O	O	B-T045
.	O	O	O

Cancer	O	O	O
Res	O	O	O
;	O	O	O
76(18	O	O	O
)	O	O	O
;	O	O	O
5337	O	O	O
-	O	O	O
47	O	O	O
.	O	O	O

Â©	O	O	O
2016	O	O	O
AACR	O	O	O
.	O	O	O

-DOCSTART- (27441507)

The	O	O	O
Evidence	O	O	B-T078
Behind	O	O	O
Integrating	O	O	B-T052
Palliative	O	O	B-T091
Care	O	O	I-T091
Into	O	O	O
Oncology	O	O	B-T191
Practice	O	O	O

Palliative	O	O	B-T093
care	O	O	I-T093
services	O	O	I-T093
provided	O	O	B-T052
alongside	O	O	O
traditional	O	O	B-T169
oncology	O	O	B-T058
care	O	O	I-T058
have	O	O	O
been	O	O	O
shown	O	O	O
to	O	O	O
be	O	O	O
beneficial	O	O	B-T080
to	O	O	O
patients	O	O	B-T101
and	O	O	O
families	O	O	B-T099
.	O	O	O

This	O	O	O
article	O	O	B-T170
provides	O	O	O
a	O	O	O
brief	O	O	B-T079
history	O	O	B-T090
of	O	O	O
palliative	O	O	B-T091
care	O	O	I-T091
,	O	O	O
a	O	O	O
pathway	O	O	O
to	O	O	O
implementing	O	O	B-T052
these	O	O	O
services	O	O	B-T057
into	O	O	O
currently	O	O	B-T079
established	O	O	B-T080
oncology	O	O	B-T058
programs	O	O	I-T058
,	O	O	O
and	O	O	O
a	O	O	O
brief	O	O	O
discussion	O	O	B-T054
of	O	O	O
common	O	O	B-T080
barriers	O	O	I-T080
.	O	O	O

-DOCSTART- (27442214)

Secondary	O	O	B-T023
Ossification	O	O	I-T023
Center	O	O	I-T023
Appearance	O	O	B-T080
and	O	O	O
Closure	O	O	B-T061
in	O	O	I-T061
the	O	O	I-T061
Pelvis	O	O	I-T061
and	O	O	O
Proximal	O	O	O
Femur	O	O	O

Variable	O	O	O
ossification	O	O	B-T042
patterns	O	O	B-T082
of	O	O	O
the	O	O	O
pelvis	O	O	B-T023
in	O	O	O
skeletally	O	O	B-T022
immature	O	O	B-T080
patients	O	O	B-T101
can	O	O	O
make	O	O	O
the	O	O	O
interpretation	O	O	O
of	O	O	O
pelvic	O	O	B-T023
radiographs	O	O	B-T060
challenging	O	O	O
.	O	O	O

Inconsistencies	O	O	O
among	O	O	O
prior	O	O	O
studies	O	O	O
and	O	O	O
lack	O	O	O
of	O	O	O
sex	O	O	B-T032
comparisons	O	O	B-T052
underscore	O	O	O
the	O	O	O
need	O	O	O
for	O	O	O
a	O	O	O
more	O	O	O
comprehensive	O	O	O
characterization	O	O	O
of	O	O	O
the	O	O	O
secondary	O	O	B-T023
ossification	O	O	I-T023
centers	O	O	I-T023
.	O	O	O

This	O	O	O
study	O	O	O
evaluates	O	O	B-T058
the	O	O	O
chronology	O	O	B-T170
and	O	O	O
sex	O	O	B-T032
differences	O	O	I-T032
for	O	O	O
appearance	O	O	B-T080
and	O	O	O
closure	O	O	B-T061
of	O	O	I-T061
pelvic	O	O	I-T061
and	O	O	O
proximal	O	O	B-T029
femoral	O	O	I-T029
secondary	O	O	B-T023
ossification	O	O	I-T023
centers	O	O	I-T023
using	O	O	O
computed	O	O	B-T060
tomography	O	O	I-T060
(	O	O	O
CT	O	O	B-T060
)	O	O	O
.	O	O	O

Patients	O	O	B-T101
who	O	O	O
underwent	O	O	O
abdominal	O	O	B-T060
and	O	O	O
pelvic	O	O	B-T060
CT	O	O	I-T060
scans	O	O	I-T060
between	O	O	O
January	O	O	O
2009	O	O	O
and	O	O	O
December	O	O	O
2014	O	O	O
at	O	O	O
2	O	O	O
tertiary	O	O	O
level	O	O	O
1	O	O	O
trauma	O	O	B-T093
centers	O	O	I-T093
were	O	O	O
retrospectively	O	O	B-T080
reviewed	O	O	B-T080
.	O	O	O

Patients	O	O	B-T101
between	O	O	O
the	O	O	O
ages	O	O	B-T032
of	O	O	O
2	O	O	O
and	O	O	O
32	O	O	O
years	O	O	O
with	O	O	O
adequate	O	O	O
imaging	O	O	B-T060
of	O	O	O
the	O	O	O
pelvis	O	O	B-T023
and	O	O	O
proximal	O	O	B-T029
femurs	O	O	I-T029
were	O	O	O
included	O	O	O
.	O	O	O

Patients	O	O	B-T101
with	O	O	O
a	O	O	O
history	O	O	O
of	O	O	O
orthopaedic	O	O	B-T091
trauma	O	O	I-T091
or	O	O	O
pathology	O	O	B-T091
affecting	O	O	B-T169
ossification	O	O	B-T042
were	O	O	O
excluded	O	O	O
.	O	O	O

CT	O	O	B-T060
scans	O	O	I-T060
were	O	O	O
assessed	O	O	B-T052
for	O	O	O
the	O	O	O
appearance	O	O	B-T080
and	O	O	O
closure	O	O	B-T061
of	O	O	O
the	O	O	O
following	O	O	O
secondary	O	O	B-T023
ossification	O	O	I-T023
centers	O	O	I-T023
:	O	O	O
anterior	O	O	B-T023
inferior	O	O	I-T023
iliac	O	O	I-T023
spine	O	O	I-T023
(	O	O	O
AIIS	O	O	B-T023
)	O	O	O
,	O	O	O
anterior	O	O	B-T023
superior	O	O	I-T023
iliac	O	O	I-T023
spine	O	O	I-T023
(	O	O	O
ASIS	O	O	B-T023
)	O	O	O
,	O	O	O
femoral	O	O	B-T023
head	O	O	I-T023
(	O	O	O
FH	O	O	B-T023
)	O	O	O
,	O	O	O
greater	O	O	B-T023
trochanter	O	O	I-T023
(	O	O	O
GT	O	O	B-T023
)	O	O	O
,	O	O	O
iliac	O	O	B-T023
crest	O	O	I-T023
(	O	O	O
IC	O	O	B-T023
)	O	O	O
,	O	O	O
ischial	O	O	B-T023
tuberosity	O	O	I-T023
(	O	O	O
IT	O	O	B-T023
)	O	O	O
,	O	O	O
lesser	O	O	B-T023
trochanter	O	O	I-T023
(	O	O	O
LT	O	O	B-T023
)	O	O	O
,	O	O	O
posterior	O	O	B-T023
superior	O	O	I-T023
iliac	O	O	I-T023
spine	O	O	I-T023
(	O	O	O
PSIS	O	O	B-T023
)	O	O	O
,	O	O	O
symphysis	O	O	B-T030
pubis	O	O	I-T030
(	O	O	O
SP	O	O	B-T030
)	O	O	O
,	O	O	O
and	O	O	O
triradiate	O	O	B-T024
cartilage	O	O	I-T024
(	O	O	O
TRC	O	O	B-T024
)	O	O	O
.	O	O	O

Basic	O	O	O
descriptive	O	O	O
statistics	O	O	O
are	O	O	O
reported	O	O	O
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
496	O	O	O
CT	O	O	B-T060
scans	O	O	I-T060
met	O	O	O
inclusion	O	O	B-T080
criteria	O	O	I-T080
(	O	O	O
240	O	O	O
males	O	O	B-T032
and	O	O	O
256	O	O	O
females	O	O	B-T032
)	O	O	O
.	O	O	O

The	O	O	O
order	O	O	O
of	O	O	O
appearance	O	O	B-T080
of	O	O	O
the	O	O	O
secondary	O	O	B-T023
ossification	O	O	I-T023
centers	O	O	I-T023
was	O	O	O
:	O	O	O
(	O	O	O
male	O	O	B-T032
)	O	O	O
GT	O	O	B-T023
,	O	O	O
LT	O	O	B-T023
,	O	O	O
AIIS	O	O	B-T023
,	O	O	O
IT	O	O	B-T023
,	O	O	O
ASIS	O	O	B-T023
,	O	O	O
PSIS	O	O	B-T023
,	O	O	O
IC	O	O	B-T023
,	O	O	O
and	O	O	O
SP	O	O	B-T030
;	O	O	O
(	O	O	O
female	O	O	B-T032
)	O	O	O
GT	O	O	O
,	O	O	O
LT	O	O	O
,	O	O	O
IT	O	O	O
,	O	O	O
AIIS	O	O	O
,	O	O	O
PSIS	O	O	O
,	O	O	O
IC	O	O	O
,	O	O	O
ASIS	O	O	O
,	O	O	O
and	O	O	O
SP	O	O	O
.	O	O	O

The	O	O	O
order	O	O	O
of	O	O	O
closure	O	O	B-T061
was	O	O	O
similar	O	O	O
:	O	O	O
(	O	O	O
male	O	O	B-T032
)	O	O	O
TRC	O	O	B-T024
,	O	O	O
LT	O	O	B-T023
,	O	O	O
FH	O	O	B-T023
,	O	O	O
AIIS	O	O	B-T023
,	O	O	O
GT	O	O	B-T023
,	O	O	O
ASIS	O	O	B-T023
,	O	O	O
PSIS	O	O	B-T023
,	O	O	O
IT	O	O	B-T023
,	O	O	O
IC	O	O	B-T023
,	O	O	O
and	O	O	O
SP	O	O	B-T030
;	O	O	O
(	O	O	O
female	O	O	B-T032
)	O	O	O
LT	O	O	O
,	O	O	O
TRC	O	O	O
,	O	O	O
AIIS	O	O	O
,	O	O	O
FH	O	O	O
,	O	O	O
GT	O	O	O
,	O	O	O
ASIS	O	O	O
,	O	O	O
PSIS	O	O	O
,	O	O	O
IT	O	O	O
,	O	O	O
IC	O	O	O
,	O	O	O
and	O	O	O
SP	O	O	O
.	O	O	O

Female	O	O	B-T032
ossification	O	O	B-T023
centers	O	O	I-T023
appeared	O	O	O
~1	O	O	O
to	O	O	O
2	O	O	O
years	O	O	O
before	O	O	O
males	O	O	B-T032
in	O	O	O
all	O	O	O
locations	O	O	B-T029
.	O	O	O

Female	O	O	B-T032
ossification	O	O	B-T023
centers	O	O	I-T023
closed	O	O	O
~1	O	O	O
to	O	O	O
2	O	O	O
years	O	O	O
before	O	O	O
males	O	O	B-T032
in	O	O	O
all	O	O	O
locations	O	O	B-T029
except	O	O	O
TRC	O	O	B-T024
,	O	O	O
IC	O	O	B-T023
,	O	O	O
and	O	O	O
SP	O	O	B-T030
.	O	O	O

The	O	O	O
appearance	O	O	B-T080
and	O	O	O
closure	O	O	B-T061
of	O	O	I-T061
the	O	O	I-T061
pelvis	O	O	I-T061
and	O	O	O
proximal	O	O	B-T029
femur	O	O	I-T029
secondary	O	O	B-T023
ossification	O	O	I-T023
centers	O	O	I-T023
follow	O	O	O
a	O	O	O
predictable	O	O	O
pattern	O	O	O
of	O	O	O
development	O	O	O
,	O	O	O
occurring	O	O	O
slightly	O	O	O
earlier	O	O	O
in	O	O	O
females	O	O	B-T032
than	O	O	O
males	O	O	B-T032
.	O	O	O

Knowledge	O	O	O
of	O	O	O
more	O	O	O
precise	O	O	O
ages	O	O	B-T033
of	O	O	I-T033
developmen	O	O	I-T033
t	O	O	O
and	O	O	O
sex	O	O	B-T032
differences	O	O	I-T032
better	O	O	O
characterize	O	O	O
this	O	O	O
complex	O	O	O
skeletal	O	O	B-T040
development	O	O	I-T040
.	O	O	O

Future	O	O	O
studies	O	O	O
may	O	O	O
use	O	O	O
secondary	O	O	B-T023
ossification	O	O	I-T023
centers	O	O	I-T023
to	O	O	O
further	O	O	O
evaluate	O	O	B-T058
skeletal	O	O	B-T060
maturity	O	O	I-T060
,	O	O	O
assess	O	O	O
pediatric	O	O	B-T091
pathology	O	O	B-T091
,	O	O	O
and	O	O	O
aid	O	O	O
surgical	O	O	B-T058
management	O	O	I-T058
.	O	O	O

Level	O	O	O
III	O	O	O
.	O	O	O

-DOCSTART- (27442216)

Pediatric	O	O	B-T100
Orthopaedic	O	O	B-T022
Trauma	O	O	B-T037
and	O	O	O
Associated	O	O	B-T037
Injuries	O	O	I-T037
of	O	O	O
Snowmobile	O	O	B-T033
,	O	O	O
ATV	O	O	B-T067
,	O	O	O
and	O	O	O
Dirtbike	O	O	B-T067
Accidents	O	O	I-T067
:	O	O	O
A	O	O	O
19-Year	O	O	B-T079
Experience	O	O	O
at	O	O	O
a	O	O	O
Level	O	O	O
1	O	O	O
Pediatric	O	O	O
Trauma	O	O	O
Center	O	O	O

The	O	O	O
purpose	O	O	O
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
evaluate	O	O	O
the	O	O	O
type	O	O	B-T080
and	O	O	O
severity	O	O	B-T080
of	O	O	O
orthopaedic	O	O	B-T037
and	O	O	O
associated	O	O	B-UnknownType
injuries	O	O	I-UnknownType
for	O	O	O
snowmobile	O	O	B-T033
,	O	O	O
All-terrain	O	O	B-T067
vehicles	O	O	I-T067
(	O	O	O
ATV	O	O	B-T067
)	O	O	O
and	O	O	O
motorized	O	O	B-T067
dirtbike	O	O	I-T067
accidents	O	O	I-T067
in	O	O	O
a	O	O	O
pediatric	O	O	B-T100
patient	O	O	B-T101
population	O	O	I-T101
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
758	O	O	O
patients	O	O	B-T101
who	O	O	O
presented	O	O	O
following	O	O	O
either	O	O	O
snowmobile	O	O	B-T037
(	O	O	O
n=87	O	O	O
)	O	O	O
,	O	O	O
ATV-related	O	O	B-T037
(	O	O	O
n=308	O	O	O
)	O	O	O
or	O	O	O
dirtbike	O	O	B-T037
(n=363)-related	O	O	I-T037
trauma	O	O	I-T037
at	O	O	O
our	O	O	O
institution	O	O	B-T093
between	O	O	O
1996	O	O	O
and	O	O	O
2015	O	O	O
were	O	O	O
retrospectively	O	O	O
reviewed	O	O	B-T080
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
441	O	O	O
axial	O	O	B-T037
and	O	O	O
appendicular	O	O	B-T037
fractures	O	O	I-T037
occurred	O	O	O
requiring	O	O	O
533	O	O	O
procedures	O	O	B-T169
.	O	O	O

Snowmobile	O	O	B-T033
and	O	O	O
dirtbike	O	O	B-T067
accidents	O	O	I-T067
were	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
a	O	O	O
higher	O	O	O
rate	O	O	O
of	O	O	O
fractures	O	O	B-T037
(	O	O	O
63	O	O	O
%	O	O	O
,	O	O	O
64	O	O	O
%	O	O	O
)	O	O	O
than	O	O	O
the	O	O	O
ATV	O	O	B-T098
group	O	O	I-T098
(	O	O	O
50	O	O	O
%	O	O	O
)	O	O	O
(	O	O	O
P=0.0008	O	O	O
)	O	O	O
.	O	O	O

Snowmobile	O	O	B-UnknownType
injuries	O	O	I-UnknownType
had	O	O	O
the	O	O	O
highest	O	O	O
rate	O	O	O
of	O	O	O
spinal	O	O	B-T037
(	O	O	O
23	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
lower	O	O	B-T037
extremity	O	O	I-T037
fractures	O	O	I-T037
(	O	O	O
53	O	O	O
%	O	O	O
)	O	O	O
(	O	O	O
P=0.0004	O	O	O
)	O	O	O
.	O	O	O

Snowmobile	O	O	B-T098
and	O	O	O
dirtbike	O	O	B-T098
cohorts	O	O	I-T098
had	O	O	O
higher	O	O	O
rate	O	O	O
of	O	O	O
femur	O	O	B-T037
fractures	O	O	I-T037
(	O	O	O
22	O	O	O
%	O	O	O
,	O	O	O
17	O	O	O
%	O	O	O
,	O	O	O
P=0.001	O	O	O
)	O	O	O
whereas	O	O	O
the	O	O	O
ATV	O	O	B-T098
cohort	O	O	I-T098
had	O	O	O
higher	O	O	O
rates	O	O	O
of	O	O	O
upper	O	O	B-T023
extremity	O	O	I-T023
(	O	O	O
18	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
hand	O	O	B-T023
(	O	O	O
11	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
scapula	O	O	B-T023
(	O	O	O
4.6	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
open	O	O	B-T037
fractures	O	O	I-T037
(	O	O	O
28.6	O	O	O
%	O	O	O
)	O	O	O
(	O	O	O
P<0.01	O	O	O
)	O	O	O
.	O	O	O

Head	O	O	B-T037
trauma	O	O	I-T037
was	O	O	O
the	O	O	O
most	O	O	O
commonly	O	O	O
associated	O	O	B-UnknownType
injury	O	O	I-UnknownType
in	O	O	O
275	O	O	O
patients	O	O	B-T101
with	O	O	O
the	O	O	O
highest	O	O	O
rate	O	O	O
in	O	O	O
the	O	O	O
ATV	O	O	B-T098
group	O	O	I-T098
(	O	O	O
44	O	O	O
%	O	O	O
)	O	O	O
who	O	O	O
also	O	O	O
had	O	O	O
the	O	O	O
highest	O	O	O
rate	O	O	O
of	O	O	O
no	O	O	O
helmet	O	O	O
use	O	O	O
(	O	O	O
76	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

Snowmobile	O	O	B-T101
and	O	O	O
ATV	O	O	B-T101
patients	O	O	I-T101
had	O	O	O
higher	O	O	O
Injury	O	O	B-T170
Severity	O	O	I-T170
Score	O	O	I-T170
(	O	O	O
11.3	O	O	O
,	O	O	O
9.6	O	O	O
)	O	O	O
than	O	O	O
dirtbike	O	O	B-T101
patients	O	O	I-T101
(	O	O	O
7.8	O	O	O
)	O	O	O
(	O	O	O
P=0.001	O	O	O
)	O	O	O
.	O	O	O

ATV	O	O	B-T101
patients	O	O	I-T101
were	O	O	O
found	O	O	O
to	O	O	O
be	O	O	O
younger	O	O	B-T079
(	O	O	O
11.8	O	O	O
y	O	O	O
)	O	O	O
compared	O	O	O
with	O	O	O
snowmobile	O	O	B-T101
(	O	O	O
13.2	O	O	O
y	O	O	O
)	O	O	O
and	O	O	O
dirtbike	O	O	B-T101
(	O	O	O
13.5	O	O	O
y	O	O	O
)	O	O	O
(	O	O	O
P<0.01	O	O	O
)	O	O	O
.	O	O	O

Pediatric	O	O	B-T100
snowmobile	O	O	B-T033
,	O	O	O
ATV	O	O	B-T067
and	O	O	O
dirtbike	O	O	B-T067
accidents	O	O	I-T067
result	O	O	O
in	O	O	O
severe	O	O	B-T080
orthopaedic	O	O	B-T037
and	O	O	O
associated	O	O	B-UnknownType
injuries	O	O	I-UnknownType
with	O	O	O
each	O	O	O
vehicle	O	O	B-T073
demonstrating	O	O	O
significantly	O	O	O
different	O	O	O
injury	O	O	B-T037
patterns	O	O	B-T082
.	O	O	O

Injury	O	O	B-T061
prevention	O	O	I-T061
should	O	O	O
focus	O	O	O
on	O	O	O
improved	O	O	O
safety	O	O	B-T058
mechanisms	O	O	I-T058
,	O	O	O
protective	O	O	B-T073
gear	O	O	I-T073
,	O	O	O
safe	O	O	O
areas	O	O	O
for	O	O	O
off-road	O	O	B-T073
vehicle	O	O	I-T073
use	O	O	O
and	O	O	O
strict	O	O	B-T089
laws	O	O	I-T089
with	O	O	O
minimum	O	O	O
age	O	O	B-T032
requirements	O	O	O
LEVEL	O	O	O
OF	O	O	O
EVIDENCE	O	O	O
:	O	O	O
:	O	O	O
Level	O	O	O
IV	O	O	O
.	O	O	O

-DOCSTART- (27443131)

Hospitalist	O	O	B-T097
Co-management	O	O	B-T057
of	O	O	O
Pediatric	O	O	B-T080
Orthopaedic	O	O	B-T061
Surgical	O	O	B-T101
Patients	O	O	I-T101
at	O	O	O
a	O	O	O
Community	O	O	O
Hospital	O	O	O

The	O	O	O
benefits	O	O	O
of	O	O	O
hospitalist	O	O	B-T097
co-management	O	O	B-T057
of	O	O	O
pediatric	O	O	B-T080
surgical	O	O	B-T101
patients	O	O	B-T101
include	O	O	O
bettering	O	O	B-T080
patient	O	O	B-T058
safety	O	O	I-T058
,	O	O	O
decreasing	O	O	B-T033
negative	O	O	B-T080
patient	O	O	B-T078
outcomes	O	O	I-T078
,	O	O	O
providing	O	O	O
comprehensive	O	O	B-T058
medical	O	O	I-T058
care	O	O	I-T058
,	O	O	O
and	O	O	O
establishing	O	O	O
a	O	O	O
dedicated	O	O	B-T078
resource	O	O	I-T078
to	O	O	O
patients	O	O	O
for	O	O	O
postoperative	O	O	B-T058
care	O	O	I-T058
.	O	O	O

The	O	O	O
purpose	O	O	O
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
characterize	O	O	B-T052
the	O	O	O
nature	O	O	B-T078
of	O	O	O
patients	O	O	B-T101
co-managed	O	O	O
by	O	O	O
a	O	O	O
pediatric	O	O	B-T080
hospitalist	O	O	B-T097
.	O	O	O

The	O	O	O
authors	O	O	B-T097
hypothesize	O	O	B-T078
that	O	O	O
hospitalist	O	O	B-T097
co-management	O	O	B-T057
is	O	O	O
safe	O	O	B-T033
and	O	O	O
efficacious	O	O	B-T080
in	O	O	O
pediatric	O	O	B-T080
orthopaedic	O	O	B-T061
surgical	O	O	B-T101
patients	O	O	I-T101
who	O	O	O
are	O	O	O
admitted	O	O	B-T058
to	O	O	O
a	O	O	O
community	O	O	B-T093
hospital	O	O	I-T093
.	O	O	O

A	O	O	O
retrospective	O	O	B-T062
review	O	O	I-T062
was	O	O	O
performed	O	O	O
of	O	O	O
all	O	O	O
pediatric	O	O	B-T080
orthopaedic	O	O	B-T061
surgical	O	O	B-T101
patients	O	O	I-T101
admitted	O	O	B-T058
to	O	O	O
a	O	O	O
community	O	O	B-T093
hospital	O	O	I-T093
who	O	O	O
were	O	O	O
co-managed	O	O	O
by	O	O	O
a	O	O	O
pediatric	O	O	O
hospitalist	O	O	B-T097
.	O	O	O

Indications	O	O	O
for	O	O	O
hospitalization	O	O	B-T058
included	O	O	O
pain	O	O	B-T061
control	O	O	I-T061
,	O	O	O
antibiotic	O	O	B-T061
infusion	O	O	I-T061
,	O	O	O
and	O	O	O
need	O	O	O
for	O	O	O
neurovascular	O	O	B-T058
monitoring	O	O	I-T058
.	O	O	O

Parameters	O	O	B-T077
of	O	O	O
postoperative	O	O	B-T058
care	O	O	I-T058
and	O	O	O
co-management	O	O	B-T057
were	O	O	O
assessed	O	O	B-T052
,	O	O	O
including	O	O	O
presence	O	O	B-T033
of	O	O	O
complications	O	O	B-T078
,	O	O	O
medication	O	O	B-T061
introduction	O	O	I-T061
or	O	O	O
adjustment	O	O	O
by	O	O	O
the	O	O	O
hospitalist	O	O	B-T097
,	O	O	O
follow-up	O	O	B-T058
adherence	O	O	B-T169
,	O	O	O
and	O	O	O
readmission	O	O	B-T058
/	O	O	O
complication	O	O	B-T078
rates	O	O	B-T081
after	O	O	O
discharge	O	O	B-T058
.	O	O	O

Thirty-two	O	O	O
patients	O	O	B-T101
were	O	O	O
assessed	O	O	B-T052
with	O	O	O
an	O	O	O
average	O	O	B-T032
age	O	O	I-T032
of	O	O	O
8.8	O	O	O
years	O	O	B-T079
.	O	O	O

Twenty-five	O	O	O
percent	O	O	B-T081
of	O	O	O
patients	O	O	B-T101
had	O	O	O
an	O	O	O
associated	O	O	B-T078
comorbidity	O	O	I-T078
,	O	O	O
including	O	O	O
asthma	O	O	B-T047
,	O	O	O
attention	O	O	B-T048
deficit	O	O	I-T048
disorder	O	O	I-T048
,	O	O	O
and/or	O	O	O
autism	O	O	B-T048
.	O	O	O

The	O	O	O
pediatric	O	O	B-T080
hospitalist	O	O	B-T097
added	O	O	O
pain	O	O	B-T061
medication	O	O	I-T061
to	O	O	O
the	O	O	O
original	O	O	O
postoperative	O	O	B-T058
orders	O	O	I-T058
placed	O	O	O
by	O	O	O
the	O	O	O
orthopaedics	O	O	B-T097
team	O	O	I-T097
in	O	O	O
44	O	O	O
percent	O	O	B-T081
of	O	O	O
patients	O	O	B-T101
(	O	O	O
14	O	O	O
of	O	O	O
the	O	O	O
32	O	O	O
)	O	O	O
either	O	O	O
for	O	O	O
breakthrough	O	O	B-T184
pain	O	O	I-T184
or	O	O	O
better	O	O	O
long-term	O	O	O
coverage	O	O	O
.	O	O	O

Additionally	O	O	O
,	O	O	O
25	O	O	O
percent	O	O	B-T081
of	O	O	O
patients	O	O	B-T101
had	O	O	O
pain	O	O	B-T061
medication	O	O	I-T061
adjusted	O	O	O
from	O	O	O
the	O	O	O
original	O	O	O
dosing	O	O	B-T081
and	O	O	O
schedule	O	O	B-T058
.	O	O	O

The	O	O	O
hospitalist	O	O	B-T097
team	O	O	B-T096
contacted	O	O	O
the	O	O	O
surgeon	O	O	B-T097
about	O	O	O
the	O	O	O
four	O	O	O
patients	O	O	B-T101
(	O	O	O
12.5	O	O	O
percent	O	O	B-T081
)	O	O	O
.	O	O	O

In	O	O	O
three	O	O	O
of	O	O	O
the	O	O	O
cases	O	O	O
,	O	O	O
the	O	O	O
surgeon	O	O	B-T097
was	O	O	O
contacted	O	O	O
to	O	O	O
discuss	O	O	O
pain	O	O	B-T061
medication	O	O	I-T061
,	O	O	O
and	O	O	O
one	O	O	O
patient	O	O	B-T101
woke	O	O	O
up	O	O	O
agitated	O	O	O
from	O	O	O
anesthesia	O	O	B-T061
,	O	O	O
necessitating	O	O	O
a	O	O	O
visit	O	O	O
from	O	O	O
the	O	O	O
surgeon	O	O	O
on	O	O	O
the	O	O	O
pediatrics	O	O	O
floor	O	O	O
.	O	O	O

The	O	O	O
length	O	O	O
of	O	O	O
stay	O	O	O
was	O	O	O
one	O	O	O
day	O	O	O
for	O	O	O
all	O	O	O
patients	O	O	B-T101
.	O	O	O

The	O	O	O
hospitalists	O	O	B-T097
rounded	O	O	O
on	O	O	O
and	O	O	O
discharged	O	O	B-T058
patients	O	O	I-T058
the	O	O	O
subsequent	O	O	O
morning	O	O	O
.	O	O	O

All	O	O	O
patients	O	O	B-T101
were	O	O	O
given	O	O	O
a	O	O	O
follow-up	O	O	B-UnknownType
appointment	O	O	I-UnknownType
and	O	O	I-UnknownType
schedule	O	O	I-UnknownType
by	O	O	O
the	O	O	O
hospitalist	O	O	B-T097
team	O	O	O
,	O	O	O
and	O	O	O
every	O	O	B-T101
patient	O	O	I-T101
followed	O	O	B-T058
up	O	O	I-T058
accordingly	O	O	O
within	O	O	O
ten	O	O	O
days	O	O	B-T079
of	O	O	O
discharge	O	O	B-T058
.	O	O	O

No	O	O	O
complications	O	O	B-T078
or	O	O	O
hospital	O	O	B-T058
readmissions	O	O	I-T058
occurred	O	O	O
within	O	O	O
thirty	O	O	O
days	O	O	B-T079
of	O	O	O
discharge	O	O	B-T058
.	O	O	O

Hospitalist	O	O	B-T097
co-management	O	O	B-T057
of	O	O	O
pediatric	O	O	B-T080
orthopaedic	O	O	B-T061
surgical	O	O	B-T101
patients	O	O	B-T101
in	O	O	O
a	O	O	O
community	O	O	B-T093
hospital	O	O	I-T093
allows	O	O	O
for	O	O	O
better	O	O	O
medical	O	O	B-T078
comorbidity	O	O	I-T078
and	O	O	O
medication	O	O	B-T058
management	O	O	I-T058
.	O	O	O

Hospitalist	O	O	B-T097
s	O	O	O
can	O	O	O
provide	O	O	O
closer	O	O	O
observation	O	O	O
during	O	O	O
the	O	O	O
inpatient	O	O	B-T169
stay	O	O	I-T169
and	O	O	O
help	O	O	B-T080
streamline	O	O	B-T054
communication	O	O	I-T054
between	O	O	O
providers	O	O	B-T097
and	O	O	O
patients	O	O	B-T101
while	O	O	O
allowing	O	O	O
the	O	O	O
surgeon	O	O	B-T097
the	O	O	O
ability	O	O	O
to	O	O	O
be	O	O	O
more	O	O	O
mobile	O	O	O
.	O	O	O

Co-management	O	O	B-T057
is	O	O	O
safe	O	O	B-T033
and	O	O	O
efficacious	O	O	B-T080
in	O	O	O
pediatric	O	O	B-T080
orthopaedic	O	O	B-T061
surgical	O	O	B-T101
patients	O	O	B-T101
who	O	O	O
are	O	O	O
admitted	O	O	B-T058
to	O	O	O
a	O	O	O
community	O	O	B-T093
hospital	O	O	I-T093
.	O	O	O

-DOCSTART- (27444328)

Extra	O	O	O
carbohydrate	O	O	B-T116
binding	O	O	I-T116
module	O	O	I-T116
contributes	O	O	B-T052
to	O	O	O
the	O	O	O
processivity	O	O	B-T080
and	O	O	O
catalytic	O	O	B-T044
activity	O	O	I-T044
of	O	O	O
a	O	O	O
non-modular	O	O	B-T116
hydrolase	O	O	I-T116
family	O	O	O
5	O	O	B-T116
endoglucanase	O	O	I-T116
from	O	O	O
Fomitiporia	O	O	O
mediterranea	O	O	O
MF3/22	O	O	O

FmEG	O	O	B-T116
from	O	O	O
Fomitiporia	O	O	B-T004
mediterranea	O	O	I-T004
is	O	O	O
a	O	O	O
non-modular	O	O	B-T116
endoglucanase	O	O	I-T116
composed	O	O	O
of	O	O	O
a	O	O	O
24-amino	O	O	B-T116
acids	O	O	I-T116
extension	O	O	B-T169
and	O	O	O
13-amino	O	O	B-T116
acids	O	O	I-T116
linker-like	O	O	B-T116
peptide	O	O	I-T116
at	O	O	O
the	O	O	O
N-terminus	O	O	B-T087
and	O	O	O
a	O	O	O
312-amino	O	O	B-T116
acids	O	O	I-T116
GH5	O	O	B-T087
catalytic	O	O	I-T087
domain	O	O	I-T087
(	O	O	O
CD	O	O	B-T087
)	O	O	O
at	O	O	O
the	O	O	O
C-terminus	O	O	B-T087
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	O
,	O	O	O
six	O	O	O
FmEG	O	O	B-T116
derivatives	O	O	O
with	O	O	O
deletion	O	O	B-T052
of	O	O	O
N-terminal	O	O	B-T116
fragments	O	O	I-T116
or	O	O	O
fusion	O	O	B-T116
with	O	O	O
an	O	O	O
extra	O	O	O
family	O	O	B-T116
1	O	O	I-T116
carbohydrate-binding	O	O	I-T116
module	O	O	I-T116
(	O	O	O
CBM1	O	O	B-T116
)	O	O	O
was	O	O	O
constructed	O	O	O
in	O	O	O
order	O	O	O
to	O	O	O
evaluate	O	O	O
the	O	O	O
contribution	O	O	B-T052
of	O	O	O
CBM1	O	O	O
to	O	O	O
FmEG	O	O	O
processivity	O	O	B-T080
and	O	O	O
catalytic	O	O	B-T044
activity	O	O	I-T044
.	O	O	O

FmEG	O	O	B-T116
showed	O	O	O
a	O	O	O
weak	O	O	O
processivity	O	O	B-T080
and	O	O	O
released	O	O	O
cellobiose	O	O	B-T109
(	O	O	O
G2	O	O	B-T109
)	O	O	O
and	O	O	O
cellotriose	O	O	B-T109
(	O	O	O
G3	O	O	B-T109
)	O	O	O
as	O	O	O
main	O	O	B-T071
end	O	O	I-T071
products	O	O	I-T071
,	O	O	O
and	O	O	O
cellotriose	O	O	O
(	O	O	O
G4	O	O	B-T109
)	O	O	O
as	O	O	O
minor	O	O	B-T071
end	O	O	I-T071
product	O	O	I-T071
from	O	O	O
filter	O	O	B-T074
paper	O	O	I-T074
(	O	O	O
FP	O	O	B-T074
)	O	O	O
,	O	O	O
but	O	O	O
more	O	O	O
amount	O	O	O
of	O	O	O
G4	O	O	O
was	O	O	O
released	O	O	O
from	O	O	O
regenerated	O	O	B-T109
amorphous	O	O	I-T109
cellulose	O	O	I-T109
(	O	O	O
RAC	O	O	B-T109
)	O	O	O
.	O	O	O

All	O	O	O
derivatives	O	O	B-T109
had	O	O	O
similar	O	O	O
activity	O	O	O
on	O	O	O
carboxymethylcellulose	O	O	B-T109
(	O	O	O
CMC	O	O	B-T109
)	O	O	O
with	O	O	O
the	O	O	O
same	O	O	B-T080
optimal	O	O	I-T080
pH	O	O	B-T081
(	O	O	O
7.0	O	O	O
)	O	O	O
and	O	O	O
temperature	O	O	B-T081
(	O	O	O
50	O	O	O
Â°	O	O	O
C	O	O	O
)	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
fusing	O	O	O
an	O	O	O
extra	O	O	O
CBM1	O	O	B-T116
to	O	O	O
FmEG	O	O	B-T116
â³	O	O	I-T116
24	O	O	I-T116
or	O	O	O
FmEG	O	O	B-T116
â³	O	O	I-T116
37	O	O	I-T116
with	O	O	O
flexible	O	O	B-T116
peptide	O	O	I-T116
significantly	O	O	O
improved	O	O	O
its	O	O	O
processivity	O	O	B-T080
and	O	O	O
catalytic	O	O	B-T169
activity	O	O	I-T169
to	O	O	O
FP	O	O	B-T074
and	O	O	O
RAC	O	O	B-T109
.	O	O	O

Overall	O	O	O
,	O	O	O
1.79-	O	O	O
and	O	O	O
1.84-fold	O	O	O
increases	O	O	O
in	O	O	O
the	O	O	O
soluble	O	O	B-T080
/insoluble	O	O	O
product	O	O	O
ratio	O	O	B-T081
on	O	O	O
FP	O	O	B-T074
,	O	O	O
and	O	O	O
1.38-	O	O	O
and	O	O	O
1.39-fold	O	O	O
increases	O	O	O
on	O	O	O
RAC	O	O	B-T109
,	O	O	O
compared	O	O	O
to	O	O	O
FmEG	O	O	B-T116
â³	O	O	I-T116
24	O	O	I-T116
,	O	O	O
were	O	O	O
recorded	O	O	O
for	O	O	O
CBM1	O	O	B-T116
-	O	O	O
FmEG	O	O	O
â³	O	O	O
24	O	O	O
and	O	O	O
CBM1	O	O	O
-linker-	O	O	O
FmEG	O	O	O
â³	O	O	O
24	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

Meanwhile	O	O	O
,	O	O	O
they	O	O	O
displayed	O	O	O
2.64-	O	O	O
and	O	O	O
2.67-fold	O	O	B-T033
more	O	O	I-T033
activity	O	O	I-T033
on	O	O	O
RAC	O	O	B-T109
,	O	O	O
and	O	O	O
1.68-	O	O	O
and	O	O	O
1.77-fold	O	O	O
on	O	O	O
FP	O	O	B-T074
,	O	O	O
respectively	O	O	O
.	O	O	O

Similar	O	O	O
improvement	O	O	O
was	O	O	O
also	O	O	O
obtained	O	O	O
for	O	O	O
CBM1	O	O	B-T116
-linker-	O	O	O
FmEG	O	O	B-T116
â³	O	O	I-T116
37	O	O	I-T116
as	O	O	O
compared	O	O	O
with	O	O	O
FmEG	O	O	O
â³	O	O	O
37	O	O	O
.	O	O	O

Interestingly	O	O	O
,	O	O	O
fusion	O	O	O
of	O	O	O
an	O	O	O
extra	O	O	O
CBM1	O	O	B-T116
with	O	O	O
FmEG	O	O	B-T116
also	O	O	O
caused	O	O	O
an	O	O	O
alteration	O	O	B-T078
of	O	O	O
cleavage	O	O	B-T067
pattern	O	O	I-T067
on	O	O	O
insoluble	O	O	B-T109
celluloses	O	O	I-T109
.	O	O	O

Our	O	O	O
results	O	O	O
suggest	O	O	O
that	O	O	O
such	O	O	O
improvements	O	O	O
in	O	O	O
processivity	O	O	B-T080
and	O	O	O
catalytic	O	O	B-T169
activity	O	O	I-T169
may	O	O	O
arise	O	O	O
from	O	O	O
CBM1	O	O	B-T116
binding	O	O	B-T044
affinity	O	O	I-T044
.	O	O	O

The	O	O	O
N-terminal	O	O	B-T116
24-	O	O	I-T116
or	O	O	I-T116
37-amino	O	O	I-T116
acids	O	O	I-T116
may	O	O	O
serve	O	O	O
as	O	O	O
linker	O	O	O
for	O	O	O
sufficient	O	O	O
spatial	O	O	B-T082
separation	O	O	I-T082
of	O	O	O
the	O	O	O
two	O	O	B-T087
domains	O	O	I-T087
required	O	O	O
for	O	O	O
processivity	O	O	B-T080
and	O	O	O
catalytic	O	O	B-T169
activity	O	O	I-T169
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
deletion	O	O	B-T052
of	O	O	O
the	O	O	O
N-terminal	O	O	B-T116
24-	O	O	I-T116
or	O	O	I-T116
37-amino	O	O	I-T116
acids	O	O	I-T116
led	O	O	O
to	O	O	O
significant	O	O	B-T080
reduction	O	O	I-T080
in	O	O	O
thermostability	O	O	B-T070
but	O	O	O
not	O	O	O
the	O	O	O
enzymatic	O	O	B-T044
activity	O	O	I-T044
.	O	O	O

-DOCSTART- (27444636)

Overnight	O	O	B-T079
switching	O	O	B-T058
from	O	O	O
oxcarbazepine	O	O	B-T109
to	O	O	O
eslicarbazepine	O	O	B-T109
acetate	O	O	I-T109
:	O	O	O
an	O	O	O
observational	O	O	O
study	O	O	O

There	O	O	O
are	O	O	O
clinical	O	O	B-T067
situations	O	O	I-T067
where	O	O	O
it	O	O	O
might	O	O	O
be	O	O	O
appropriate	O	O	B-T080
to	O	O	O
switch	O	O	B-T058
patients	O	O	B-T101
from	O	O	O
immediate-release	O	O	B-T122
oxcarbazepine	O	O	B-T109
(	O	O	O
OXC	O	O	B-T109
)	O	O	O
to	O	O	O
eslicarbazepine	O	O	B-T109
acetate	O	O	I-T109
(	O	O	O
ESL	O	O	B-T109
)	O	O	O
.	O	O	O

We	O	O	O
investigated	O	O	B-T169
the	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
transitioning	O	O	O
patients	O	O	B-T101
overnight	O	O	B-T079
from	O	O	O
OXC	O	O	B-T109
to	O	O	O
ESL	O	O	B-T109
.	O	O	O

A	O	O	O
retrospective	O	O	B-T062
,	O	O	O
single-center	O	O	B-T062
study	O	O	I-T062
was	O	O	O
conducted	O	O	O
in	O	O	O
which	O	O	O
patients	O	O	B-T101
with	O	O	O
drug-resistant	O	O	B-T038
focal	O	O	B-T047
epilepsy	O	O	I-T047
on	O	O	O
a	O	O	O
stable	O	O	O
dose	O	O	B-T081
of	O	O	O
immediate-release	O	O	B-T122
OXC	O	O	B-T109
for	O	O	O
at	O	O	O
least	O	O	O
4	O	O	B-T079
weeks	O	O	I-T079
were	O	O	O
switched	O	O	B-T058
overnight	O	O	B-T079
to	O	O	O
ESL	O	O	B-T109
.	O	O	O

Patients	O	O	B-T101
were	O	O	O
switched	O	O	B-T058
because	O	O	O
they	O	O	O
experienced	O	O	O
persistent	O	O	B-T079
seizures	O	O	B-T184
with	O	O	O
OXC	O	O	B-T109
but	O	O	O
were	O	O	O
unable	O	O	B-T033
to	O	O	O
tolerate	O	O	B-T080
increased	O	O	O
OXC	O	O	O
dosing	O	O	B-T081
due	O	O	O
to	O	O	O
adverse	O	O	B-T046
events	O	O	I-T046
.	O	O	O

Tolerability	O	O	B-T080
was	O	O	O
assessed	O	O	B-T052
using	O	O	O
the	O	O	O
Adverse	O	O	B-T170
Events	O	O	I-T170
Profile	O	O	I-T170
(	O	O	O
AEP	O	O	B-T170
)	O	O	O
,	O	O	O
quality	O	O	B-T078
of	O	O	I-T078
life	O	O	I-T078
was	O	O	O
assessed	O	O	O
using	O	O	O
the	O	O	O
Quality	O	O	B-T170
of	O	O	I-T170
Life	O	O	I-T170
in	O	O	I-T170
Epilepsy	O	O	I-T170
Inventory	O	O	I-T170
10	O	O	I-T170
(	O	O	O
QOLIE-10	O	O	B-T170
)	O	O	O
,	O	O	O
and	O	O	O
alertness	O	O	B-T041
was	O	O	O
assessed	O	O	O
as	O	O	O
reaction	O	O	B-T079
time	O	O	I-T079
using	O	O	O
a	O	O	O
subtest	O	O	O
of	O	O	O
the	O	O	O
Test	O	O	B-T073
Battery	O	O	I-T073
for	O	O	I-T073
Attention	O	O	I-T073
Performance	O	O	I-T073
version	O	O	I-T073
2.3	O	O	I-T073
.	O	O	O

Assessments	O	O	B-T058
were	O	O	O
performed	O	O	B-T169
immediately	O	O	B-T079
prior	O	O	B-T079
to	O	O	I-T079
and	O	O	O
5	O	O	B-T079
days	O	O	B-T079
after	O	O	O
switching	O	O	B-T058
from	O	O	O
OXC	O	O	B-T109
to	O	O	O
ESL	O	O	B-T109
(	O	O	O
days	O	O	O
0	O	O	O
and	O	O	O
5	O	O	O
,	O	O	O
respectively	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
analysis	O	O	B-T062
included	O	O	O
21	O	O	O
patients	O	O	B-T101
(	O	O	O
12	O	O	O
women	O	O	B-T098
,	O	O	O
9	O	O	O
men	O	O	B-T098
;	O	O	O
mean	O	O	B-T033
age	O	O	I-T033
36	O	O	I-T033
years	O	O	I-T033
)	O	O	O
.	O	O	O

After	O	O	O
switching	O	O	B-T058
from	O	O	O
OXC	O	O	B-T109
to	O	O	O
ESL	O	O	B-T109
,	O	O	O
there	O	O	O
were	O	O	O
significant	O	O	O
improvements	O	O	B-T077
in	O	O	O
mean	O	O	B-T081
scores	O	O	I-T081
for	O	O	O
AEP	O	O	B-T170
(	O	O	O
P<.001	O	O	O
)	O	O	O
,	O	O	O
QOLIE-10	O	O	B-T170
(	O	O	O
P=.001	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
alertness	O	O	B-T041
(	O	O	O
P<.05	O	O	O
)	O	O	O
.	O	O	O

Adverse	O	O	B-T170
Events	O	O	I-T170
Profile	O	O	I-T170
total	O	O	B-T081
scores	O	O	B-T081
improved	O	O	B-T033
for	O	O	O
21/21	O	O	O
(	O	O	O
100.0	O	O	O
%	O	O	O
)	O	O	O
patients	O	O	B-T101
,	O	O	O
QOLIE-10	O	O	B-T170
total	O	O	O
scores	O	O	O
improved	O	O	O
for	O	O	O
17/21	O	O	O
(	O	O	O
81.0	O	O	O
%	O	O	O
)	O	O	O
patients	O	O	O
,	O	O	O
and	O	O	O
alertness	O	O	B-T041
scores	O	O	O
improved	O	O	O
for	O	O	O
16/21	O	O	O
(	O	O	O
76.2	O	O	O
%	O	O	O
)	O	O	O
patients	O	O	O
.	O	O	O

In	O	O	O
this	O	O	O
short-term	O	O	B-T079
,	O	O	O
single-center	O	O	B-T062
study	O	O	I-T062
,	O	O	O
an	O	O	O
overnight	O	O	B-T079
switch	O	O	B-T058
from	O	O	O
twice-daily	O	O	B-T079
OXC	O	O	B-T109
to	O	O	O
once-daily	O	O	B-T079
ESL	O	O	B-T109
in	O	O	O
patients	O	O	B-T101
with	O	O	O
drug-resistant	O	O	B-T038
focal	O	O	B-T047
epilepsies	O	O	I-T047
resulted	O	O	B-T033
in	O	O	O
improvements	O	O	B-T077
in	O	O	O
side	O	O	B-T046
effects	O	O	I-T046
,	O	O	O
quality	O	O	B-T078
of	O	O	I-T078
life	O	O	I-T078
,	O	O	O
and	O	O	O
alertness	O	O	B-T041
.	O	O	O

-DOCSTART- (27445383)

Complete	O	O	B-T080
Genome	O	O	B-T028
Sequences	O	O	B-T086
of	O	O	O
Three	O	O	O
Outbreak	O	O	B-T067
-Associated	O	O	O
Legionella	O	O	B-T007
pneumophila	O	O	I-T007
Isolates	O	O	O

We	O	O	O
report	O	O	O
here	O	O	O
the	O	O	O
complete	O	O	B-T080
genome	O	O	B-T028
sequences	O	O	B-T086
of	O	O	O
three	O	O	O
Legionella	O	O	B-T007
pneumophila	O	O	I-T007
isolates	O	O	B-T123
that	O	O	O
are	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
a	O	O	O
Legionnaires	O	O	B-T047
'	O	O	I-T047
disease	O	O	I-T047
outbreak	O	O	B-T067
in	O	O	O
New	O	O	B-T083
York	O	O	I-T083
in	O	O	O
2012	O	O	O
.	O	O	O

Two	O	O	O
clinical	O	O	B-T080
isolates	O	O	B-T123
(	O	O	O
D7630	O	O	B-T007
and	O	O	O
D7632	O	O	B-T007
)	O	O	O
and	O	O	O
one	O	O	O
environmental	O	O	B-T082
isolate	O	O	B-T123
(	O	O	O
D7631	O	O	B-T007
)	O	O	O
were	O	O	O
recovered	O	O	B-T080
from	O	O	O
this	O	O	O
outbreak	O	O	B-T067
.	O	O	O

A	O	O	O
single	O	O	O
isolate-specific	O	O	B-T123
virulence	O	O	B-T038
gene	O	O	B-T028
was	O	O	O
found	O	O	O
in	O	O	O
D7632	O	O	B-T007
.	O	O	O

These	O	O	O
isolates	O	O	B-T123
were	O	O	O
included	O	O	O
in	O	O	O
a	O	O	O
large	O	O	O
study	O	O	O
evaluating	O	O	B-T058
the	O	O	O
genomic	O	O	B-T028
resolution	O	O	B-T077
of	O	O	O
various	O	O	O
bioinformatics	O	O	B-T091
approaches	O	O	B-T169
for	O	O	O
L.	O	O	B-T007
pneumophila	O	O	I-T007
serogroup	O	O	B-T170
1	O	O	I-T170
isolates	O	O	O
.	O	O	O

-DOCSTART- (27445389)

Complete	O	O	O
Genome	O	O	B-T059
Sequence	O	O	I-T059
Analysis	O	O	I-T059
of	O	O	O
a	O	O	O
Naturally	O	O	O
Reassorted	O	O	O
Infectious	O	O	B-T005
Bursal	O	O	I-T005
Disease	O	O	I-T005
Virus	O	O	I-T005
from	O	O	O
India	O	O	O

The	O	O	O
novel	O	O	O
infectious	O	O	B-T005
bursal	O	O	I-T005
disease	O	O	I-T005
virus	O	O	I-T005
(	O	O	O
IBDV	O	O	B-T005
)	O	O	O
isolate	O	O	B-T123
BGE14/ABT1/MVC/India	O	O	B-T005
is	O	O	O
a	O	O	O
very	O	O	O
virulent	O	O	B-T080
IBDV	O	O	O
that	O	O	O
was	O	O	O
isolated	O	O	B-T123
from	O	O	O
broiler	O	O	B-T012
flocks	O	O	I-T012
in	O	O	O
southern	O	O	O
parts	O	O	O
of	O	O	O
India	O	O	B-T083
during	O	O	O
2014	O	O	O
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
report	O	O	O
,	O	O	O
for	O	O	O
the	O	O	O
first	O	O	O
time	O	O	O
in	O	O	O
India	O	O	B-T083
,	O	O	O
the	O	O	O
complete	O	O	O
genome	O	O	B-T028
sequence	O	O	I-T028
of	O	O	O
BGE14/ABT1/MVC/India	O	O	B-T005
,	O	O	O
a	O	O	O
reassortment	O	O	O
strain	O	O	B-T001
with	O	O	O
segments	O	O	B-T028
A	O	O	I-T028
and	O	O	I-T028
B	O	O	I-T028
derived	O	O	O
from	O	O	O
a	O	O	O
very	O	O	O
virulent	O	O	B-T080
IBDV	O	O	B-T005
strain	O	O	O
and	O	O	O
an	O	O	O
attenuated	O	O	B-T052
IBDV	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

The	O	O	O
findings	O	O	O
from	O	O	O
this	O	O	O
study	O	O	O
provide	O	O	O
additional	O	O	O
insight	O	O	O
into	O	O	O
the	O	O	O
genetic	O	O	B-T045
exchange	O	O	I-T045
between	O	O	O
attenuated	O	O	B-T052
and	O	O	O
very	O	O	O
virulent	O	O	B-T080
strains	O	O	B-T001
of	O	O	O
IBDV	O	O	B-T005
circulating	O	O	B-T169
in	O	O	B-T082
the	O	O	I-T082
field	O	O	I-T082
.	O	O	O

-DOCSTART- (27445450)

Patient	O	O	B-T080
Satisfaction	O	O	I-T080
With	O	O	O
Postpartum	O	O	B-T079
Teaching	O	O	B-T065
Methods	O	O	O

Postpartum	O	O	B-T079
discharge	O	O	B-T170
instructions	O	O	I-T170
are	O	O	O
a	O	O	O
crucial	O	O	O
part	O	O	O
of	O	O	O
a	O	O	O
mother	O	O	B-T099
's	O	O	I-T099
birth	O	O	B-T040
experience	O	O	B-T041
.	O	O	O

Finding	O	O	B-T033
the	O	O	O
method	O	O	B-T170
to	O	O	O
provide	O	O	O
those	O	O	O
discharge	O	O	B-T170
instructions	O	O	I-T170
in	O	O	O
a	O	O	O
manner	O	O	O
that	O	O	O
increases	O	O	B-T169
the	O	O	O
mother	O	O	B-T099
's	O	O	I-T099
satisfaction	O	O	B-T041
with	O	O	O
her	O	O	O
hospital	O	O	B-T093
experience	O	O	B-T041
is	O	O	O
important	O	O	O
.	O	O	O

This	O	O	O
quasi-experimental	O	O	B-T062
study	O	O	I-T062
examined	O	O	B-T033
the	O	O	O
relationship	O	O	B-T080
between	O	O	O
new	O	O	B-T080
mothers	O	O	B-T099
'	O	O	I-T099
interaction	O	O	B-T033
with	O	O	O
nurses	O	O	B-T097
providing	O	O	O
postpartum	O	O	B-T079
instructions	O	O	B-T170
by	O	O	O
the	O	O	O
traditional	O	O	B-T169
and	O	O	O
class	O	O	O
methods	O	O	B-T170
and	O	O	O
their	O	O	O
satisfaction	O	O	B-T041
with	O	O	O
discharge	O	O	B-T065
teaching	O	O	I-T065
.	O	O	O

The	O	O	O
results	O	O	O
indicated	O	O	O
new	O	O	B-T080
mothers	O	O	B-T099
were	O	O	O
satisfied	O	O	B-T041
with	O	O	O
both	O	O	O
methods	O	O	B-T170
of	O	O	O
discharge	O	O	B-T065
teaching	O	O	I-T065
;	O	O	O
however	O	O	O
,	O	O	O
they	O	O	O
were	O	O	O
more	O	O	O
likely	O	O	O
to	O	O	O
report	O	O	O
stronger	O	O	O
agreement	O	O	B-T054
with	O	O	O
overall	O	O	O
satisfaction	O	O	B-T041
with	O	O	O
the	O	O	O
traditional	O	O	B-T169
method	O	O	B-T170
of	O	O	O
discharge	O	O	O
teaching	O	O	O
than	O	O	O
with	O	O	O
attending	O	O	B-T169
the	O	O	O
discharge	O	O	B-T065
class	O	O	I-T065
.	O	O	O

-DOCSTART- (27446352)

Splicing	O	O	B-T045
variants	O	O	O
of	O	O	O
ADAR2	O	O	B-T116
and	O	O	O
ADAR2	O	O	O
-mediated	O	O	O
RNA	O	O	B-T045
editing	O	O	I-T045
in	O	O	O
glioma	O	O	O

The	O	O	O
roles	O	O	O
of	O	O	O
alternative	O	O	B-T045
splicing	O	O	I-T045
and	O	O	O
RNA	O	O	B-T045
editing	O	O	I-T045
in	O	O	O
gene	O	O	B-T045
regulation	O	O	I-T045
and	O	O	O
transcriptome	O	O	B-T086
diversity	O	O	O
are	O	O	O
well	O	O	O
documented	O	O	O
.	O	O	O

Adenosine	O	O	B-T116
deaminases	O	O	I-T116
acting	O	O	O
on	O	O	O
RNA	O	O	B-T114
(	O	O	O
ADARs	O	O	B-T116
)	O	O	O
are	O	O	O
responsible	O	O	O
for	O	O	O
adenosine-to-inosine	O	O	B-T045
(	O	O	I-T045
A-to-I	O	O	I-T045
)	O	O	I-T045
editing	O	O	I-T045
and	O	O	O
exemplify	O	O	O
the	O	O	O
complex	O	O	O
association	O	O	O
between	O	O	O
RNA	O	O	B-T045
editing	O	O	I-T045
and	O	O	O
alternative	O	O	B-T045
splicing	O	O	I-T045
.	O	O	O

The	O	O	O
self-editing	O	O	B-T045
activity	O	O	O
of	O	O	O
ADAR2	O	O	B-T116
,	O	O	O
which	O	O	O
acts	O	O	O
on	O	O	O
its	O	O	O
own	O	O	O
pre-mRNA	O	O	B-T114
,	O	O	O
leads	O	O	O
to	O	O	O
its	O	O	O
alternative	O	O	B-T045
splicing	O	O	I-T045
.	O	O	O

Alternative	O	O	B-T045
splicing	O	O	B-T045
occurs	O	O	O
independently	O	O	O
at	O	O	O
nine	O	O	O
splicing	O	O	O
sites	O	O	O
on	O	O	O
ADAR2	O	O	B-T116
pre-mRNA	O	O	B-T114
,	O	O	O
generating	O	O	O
numerous	O	O	O
alternative	O	O	B-T045
splicing	O	O	I-T045
variants	O	O	O
with	O	O	O
various	O	O	O
catalytic	O	O	B-T044
activities	O	O	I-T044
.	O	O	O

A-to-I	O	O	B-T045
RNA	O	O	I-T045
editing	O	O	I-T045
is	O	O	O
important	O	O	O
in	O	O	O
a	O	O	O
range	O	O	O
of	O	O	O
physiological	O	O	B-T039
processes	O	O	I-T039
in	O	O	O
humans	O	O	B-T016
and	O	O	O
is	O	O	O
associated	O	O	O
with	O	O	O
several	O	O	O
diseases	O	O	B-T047
,	O	O	O
including	O	O	O
amyotrophic	O	O	B-T047
lateral	O	O	I-T047
sclerosis	O	O	I-T047
,	O	O	O
mood	O	O	B-T048
disorders	O	O	I-T048
,	O	O	O
epilepsy	O	O	B-T047
and	O	O	O
glioma	O	O	B-T191
.	O	O	O

Reduced	O	O	O
editing	O	O	B-T045
at	O	O	O
the	O	O	O
glutamine	O	O	B-T116
/	O	O	O
arginine	O	O	B-T116
site	O	O	O
of	O	O	O
the	O	O	O
AMPA	O	O	B-T116
receptor	O	O	I-T116
subunit	O	O	I-T116
GluA2	O	O	I-T116
in	O	O	O
glioma	O	O	B-T191
,	O	O	O
without	O	O	O
any	O	O	O
alteration	O	O	O
in	O	O	O
ADAR2	O	O	B-T116
expression	O	O	B-T045
,	O	O	O
is	O	O	O
a	O	O	O
notable	O	O	O
phenomenon	O	O	O
.	O	O	O

Several	O	O	O
studies	O	O	O
have	O	O	O
tried	O	O	O
to	O	O	O
explain	O	O	O
this	O	O	O
alteration	O	O	B-T078
in	O	O	O
the	O	O	O
catalytic	O	O	B-T044
activity	O	O	I-T044
of	O	O	O
ADAR2	O	O	B-T116
;	O	O	O
however	O	O	O
,	O	O	O
the	O	O	O
underlying	O	O	O
mechanism	O	O	O
remains	O	O	O
unclear	O	O	O
.	O	O	O

The	O	O	O
present	O	O	O
review	O	O	B-T170
summarizes	O	O	O
the	O	O	O
relevant	O	O	O
literature	O	O	B-T170
and	O	O	O
shares	O	O	O
experimental	O	O	B-T033
results	O	O	I-T033
concerning	O	O	O
ADAR2	O	O	B-T116
alternative	O	O	B-T045
splicing	O	O	I-T045
.	O	O	O

In	O	O	O
particular	O	O	O
,	O	O	O
the	O	O	O
present	O	O	O
review	O	O	B-T170
demonstrates	O	O	O
that	O	O	O
shifts	O	O	O
in	O	O	O
the	O	O	O
relative	O	O	O
abundance	O	O	O
of	O	O	O
the	O	O	O
active	O	O	O
and	O	O	O
inactive	O	O	O
splicing	O	O	B-T045
variants	O	O	O
of	O	O	O
ADAR2	O	O	B-T116
may	O	O	O
reduce	O	O	O
the	O	O	O
ADAR2	O	O	O
editing	O	O	B-T045
activity	O	O	O
in	O	O	O
glioma	O	O	B-T191
.	O	O	O

Dominant	O	O	O
expression	O	O	B-T045
of	O	O	O
ADAR2	O	O	B-T116
splicing	O	O	B-T045
variant	O	O	O
with	O	O	O
low	O	O	O
enzyme	O	O	B-T044
activity	O	O	I-T044
causes	O	O	O
reduced	O	O	O
RNA	O	O	B-T045
editing	O	O	I-T045
of	O	O	O
GluA2	O	O	B-T116
subunit	O	O	I-T116
at	O	O	O
the	O	O	O
glutamine	O	O	B-T116
/	O	O	O
arginine	O	O	B-T116
site	O	O	O
in	O	O	O
glioma	O	O	B-T191
.	O	O	O

-DOCSTART- (27446550)

Heat-shock	O	O	B-T116
protein	O	O	I-T116
60	O	O	I-T116
of	O	O	O
Porphyromonas	O	O	B-T007
gingivalis	O	O	I-T007
may	O	O	O
induce	O	O	O
dysfunction	O	O	B-T077
of	O	O	O
human	O	O	B-T025
umbilical	O	O	I-T025
endothelial	O	O	I-T025
cells	O	O	I-T025
via	O	O	O
regulation	O	O	B-T038
of	O	O	O
endothelial-nitric	O	O	B-T116
oxide	O	O	I-T116
synthase	O	O	I-T116
and	O	O	O
vascular	O	O	O
endothelial-cadherin	O	O	O

Accumulating	O	O	O
evidence	O	O	O
has	O	O	O
established	O	O	O
that	O	O	O
periodontitis	O	O	B-T047
was	O	O	O
an	O	O	O
independent	O	O	O
risk	O	O	B-T033
factor	O	O	I-T033
for	O	O	O
coronary	O	O	B-T047
heart	O	O	I-T047
disease	O	O	I-T047
(	O	O	O
CAD	O	O	B-T047
)	O	O	O
.	O	O	O

Porphyromonus	O	O	B-T007
gingivalis	O	O	I-T007
(	O	O	O
P.	O	O	B-T007
gingivalis	O	O	I-T007
)	O	O	O
,	O	O	O
a	O	O	O
major	O	O	O
periodontal	O	O	B-T080
pathogen	O	O	B-T001
,	O	O	O
has	O	O	O
already	O	O	O
been	O	O	O
shown	O	O	O
to	O	O	O
have	O	O	O
a	O	O	O
significant	O	O	O
role	O	O	O
in	O	O	O
the	O	O	O
inflammatory	O	O	B-T046
response	O	O	I-T046
of	O	O	O
CAD	O	O	B-T047
in	O	O	B-T082
vivo	O	O	I-T082
.	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
the	O	O	O
present	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
identify	O	O	O
whether	O	O	O
P.	O	O	B-T007
gingivalis	O	O	I-T007
heat-shock	O	O	B-T116
protein	O	O	I-T116
60	O	O	I-T116
(	O	O	O
HSP60	O	O	B-T116
)	O	O	O
induced	O	O	O
the	O	O	O
dysfunction	O	O	B-T077
of	O	O	O
human	O	O	B-T025
umbilical	O	O	I-T025
vein	O	O	I-T025
endothelial	O	O	I-T025
cells	O	O	I-T025
(	O	O	O
HUVECs	O	O	B-T025
)	O	O	O
in	O	O	B-T080
vitro	O	O	I-T080
.	O	O	O

HUVECs	O	O	B-T025
were	O	O	O
stimulated	O	O	B-T070
with	O	O	O
a	O	O	O
range	O	O	O
of	O	O	O
P.	O	O	B-T007
gingivalis	O	O	I-T007
HSP60	O	O	B-T116
concentrations	O	O	B-T081
(	O	O	O
1	O	O	O
,	O	O	O
10	O	O	O
and	O	O	O
100	O	O	O
ng/l	O	O	O
)	O	O	O
at	O	O	O
different	O	O	O
time-points	O	O	B-T079
.	O	O	O

The	O	O	O
levels	O	O	B-T080
of	O	O	O
vascular	O	O	B-T116
endothelial	O	O	I-T116
(VE)-cadherin	O	O	I-T116
,	O	O	O
endothelial	O	O	B-T116
nitric	O	O	I-T116
oxide	O	O	I-T116
synthase	O	O	I-T116
(	O	O	O
eNOS	O	O	B-T116
)	O	O	O
and	O	O	O
cysteinyl	O	O	B-T116
aspartate-specific	O	O	I-T116
protease-3	O	O	I-T116
(	O	O	O
caspase-3	O	O	B-T116
)	O	O	O
were	O	O	O
measured	O	O	O
using	O	O	O
western	O	O	B-T059
blot	O	O	I-T059
analysis	O	O	B-T062
.	O	O	O

The	O	O	O
apoptotic	O	O	B-T043
rate	O	O	B-T081
of	O	O	O
HUVECs	O	O	B-T025
was	O	O	O
detected	O	O	O
using	O	O	O
flow	O	O	B-T059
cytometry	O	O	I-T059
.	O	O	O

P.	O	O	B-T007
gingivalis	O	O	I-T007
HSP60	O	O	B-T116
at	O	O	O
a	O	O	O
concentration	O	O	B-T081
of	O	O	O
10	O	O	O
ng/l	O	O	O
significantly	O	O	O
decreased	O	O	O
the	O	O	O
expression	O	O	B-T045
levels	O	O	B-T080
of	O	O	O
VE-cadherin	O	O	B-T116
and	O	O	O
eNOS	O	O	B-T116
protein	O	O	I-T116
at	O	O	O
24	O	O	O
h	O	O	B-T079
stimulation	O	O	B-T070
,	O	O	O
whereas	O	O	O
no	O	O	O
difference	O	O	O
in	O	O	O
these	O	O	O
proteins	O	O	B-T116
was	O	O	O
identified	O	O	O
following	O	O	O
a	O	O	O
low	O	O	B-T081
dose	O	O	I-T081
of	O	O	O
P.	O	O	O
gingivalis	O	O	O
HSP60	O	O	O
(	O	O	O
1	O	O	O
ng/l	O	O	O
)	O	O	O
.	O	O	O

P.	O	O	B-T007
gingivalis	O	O	I-T007
HSP60	O	O	B-T116
at	O	O	O
100	O	O	O
ng/l	O	O	O
significantly	O	O	O
downregulated	O	O	B-T044
the	O	O	O
expression	O	O	B-T045
levels	O	O	B-T080
of	O	O	O
VE-cadherin	O	O	B-T116
and	O	O	O
eNOS	O	O	B-T116
protein	O	O	I-T116
at	O	O	O
12	O	O	O
h	O	O	O
in	O	O	O
HUVECs	O	O	B-T025
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
cleavage	O	O	B-T067
of	O	O	O
caspase-3	O	O	B-T116
showed	O	O	O
an	O	O	O
opposing	O	O	O
change	O	O	O
at	O	O	O
different	O	O	O
concentrations	O	O	B-T081
.	O	O	O

Consistently	O	O	O
,	O	O	O
P.	O	O	B-T007
gingivalis	O	O	I-T007
HSP60	O	O	B-T116
induced	O	O	O
apoptosis	O	O	B-T043
of	O	O	O
HUVECs	O	O	B-T025
in	O	O	O
a	O	O	O
concentration	O	O	B-T081
-	O	O	O
dependent	O	O	B-T169
manner	O	O	O
.	O	O	O

These	O	O	O
results	O	O	B-T169
indicated	O	O	O
that	O	O	O
P.	O	O	B-T007
gingivalis	O	O	I-T007
HSP60	O	O	B-T116
may	O	O	O
induce	O	O	O
dysfunction	O	O	B-T077
and	O	O	O
apoptosis	O	O	B-T043
in	O	O	O
HUVECs	O	O	B-T025
via	O	O	O
downregulating	O	O	B-T044
the	O	O	O
expression	O	O	B-T045
levels	O	O	B-T080
of	O	O	O
VE-cadherin	O	O	B-T116
and	O	O	O
eNOS	O	O	B-T116
,	O	O	O
and	O	O	O
promoting	O	O	O
the	O	O	O
cleavage	O	O	B-T067
of	O	O	O
caspase-3	O	O	B-T116
.	O	O	O

-DOCSTART- (27449818)

Estradiol	O	O	B-T125
prodrugs	O	O	B-T120
(	O	O	O
EP	O	O	B-T120
)	O	O	O
for	O	O	O
efficient	O	O	O
oral	O	O	B-T061
estrogen	O	O	B-T125
treatment	O	O	I-T169
and	O	O	O
abolished	O	O	O
effects	O	O	O
on	O	O	O
estrogen	O	O	O
modulated	O	O	O
liver	O	O	O
functions	O	O	O

Oral	O	O	B-T061
compared	O	O	O
to	O	O	O
parenteral	O	O	B-T061
estrogen	O	O	B-T169
administration	O	O	I-T169
is	O	O	O
characterized	O	O	O
by	O	O	O
reduced	O	O	O
systemic	O	O	B-T169
but	O	O	O
prominent	O	O	O
hepatic	O	O	B-T029
estrogenic	O	O	B-T033
effects	O	O	I-T033
on	O	O	O
lipids	O	O	B-T109
,	O	O	O
hemostatic	O	O	B-T042
factors	O	O	I-T042
,	O	O	O
GH	O	O	B-T116
-/	O	O	O
IGF	O	O	B-T116
I	O	O	I-T116
axis	O	O	O
,	O	O	O
angiotensinogen	O	O	B-T116
.	O	O	O

In	O	O	O
order	O	O	O
to	O	O	O
avoid	O	O	O
such	O	O	O
adverse	O	O	O
metabolic	O	O	B-T039
effects	O	O	I-T039
of	O	O	O
oral	O	O	B-T061
treatment	O	O	I-T061
,	O	O	O
estradiol	O	O	B-T125
(	O	O	O
E2	O	O	B-T125
)	O	O	O
prodrugs	O	O	B-T120
(	O	O	O
EP	O	O	B-T120
)	O	O	O
were	O	O	O
designed	O	O	O
which	O	O	O
bypass	O	O	O
the	O	O	O
liver	O	O	B-T023
tissue	O	O	I-T023
as	O	O	O
inactive	O	O	O
molecules	O	O	O
.	O	O	O

Carbone17-OH	O	O	B-T104
sulfonamide	O	O	I-T104
[	O	O	I-T104
-O2-NH2	O	O	I-T104
]	O	O	I-T104
substituted	O	O	I-T104
esters	O	O	I-T104
of	O	O	O
E2	O	O	B-T125
(	O	O	O
EC508	O	O	B-T125
,	O	O	O
others	O	O	O
)	O	O	O
were	O	O	O
synthesized	O	O	O
and	O	O	O
tested	O	O	O
for	O	O	O
carbonic	O	O	B-T116
anhydrase	O	O	I-T116
II	O	O	I-T116
(	O	O	O
CA-II	O	O	B-T116
)	O	O	O
binding	O	O	B-T044
.	O	O	O

CA	O	O	B-T116
II	O	O	I-T116
in	O	O	O
erythrocytes	O	O	B-T025
is	O	O	O
thought	O	O	O
to	O	O	O
oppose	O	O	O
extraction	O	O	O
of	O	O	O
EP	O	O	B-T120
from	O	O	O
portal	O	O	B-T024
vein	O	O	I-T024
blood	O	O	I-T024
during	O	O	O
liver	O	O	B-T023
passage	O	O	B-T082
.	O	O	O

Ovariectomized	O	O	B-T033
(	O	O	O
OVX	O	O	B-T033
,	O	O	O
day	O	O	O
minus	O	O	O
14	O	O	O
)	O	O	O
rats	O	O	B-T015
were	O	O	O
orally	O	O	B-T061
treated	O	O	I-T061
once	O	O	O
daily	O	O	O
from	O	O	O
day	O	O	O
1	O	O	O
-	O	O	O
3	O	O	O
.	O	O	O

Sacrifice	O	O	O
day	O	O	O
4	O	O	O
.	O	O	O

Uteri	O	O	B-T023
were	O	O	O
dissected	O	O	B-T169
and	O	O	O
weighed	O	O	B-T059
.	O	O	O

Cholesterol	O	O	B-T059
fractions	O	O	I-T059
and	O	O	O
angiotensinogen	O	O	B-T059
were	O	O	O
determined	O	O	O
in	O	O	O
plasma	O	O	B-T031
.	O	O	O

Oral	O	O	B-T200
E2	O	O	I-T200
and	O	O	O
ethinyl	O	O	B-T125
estradiol	O	O	I-T125
(	O	O	O
EE	O	O	B-T125
)	O	O	O
generated	O	O	O
dose	O	O	O
related	O	O	O
uterine	O	O	B-T023
growth	O	O	B-T040
and	O	O	O
important	O	O	O
hepatic	O	O	B-T029
estrogenic	O	O	B-T033
effects	O	O	I-T033
.	O	O	O

EP	O	O	B-T120
induced	O	O	O
uterine	O	O	B-T042
growth	O	O	I-T042
at	O	O	O
about	O	O	O
hundred-fold	O	O	O
lower	O	O	O
doses	O	O	O
.	O	O	O

This	O	O	O
was	O	O	O
possible	O	O	O
with	O	O	O
almost	O	O	O
absent	O	O	O
effects	O	O	O
on	O	O	O
plasma	O	O	B-T031
cholesterol	O	O	B-T109
or	O	O	O
angiotensinogen	O	O	B-T116
.	O	O	O

Preliminary	O	O	O
pharmacokinetic	O	O	B-T062
studies	O	O	I-T062
with	O	O	O
EC508	O	O	B-T125
used	O	O	O
intravenous	O	O	B-T082
and	O	O	O
oral	O	O	B-T061
administration	O	O	I-T061
in	O	O	O
male	O	O	B-T032
rats	O	O	B-T015
.	O	O	O

Resulting	O	O	O
blood	O	O	O
levels	O	O	O
revealed	O	O	O
complete	O	O	O
oral	O	O	B-T061
bioavailability	O	O	B-T081
.	O	O	O

Further	O	O	O
high	O	O	O
blood	O	O	B-T031
-	O	O	O
but	O	O	O
low	O	O	O
plasma	O	O	B-T031
concentrations	O	O	O
indicated	O	O	O
erythrocyte	O	O	B-T025
binding	O	O	B-T052
of	O	O	O
EC508	O	O	B-T125
in	O	O	B-T082
vivo	O	O	I-T082
as	O	O	O
potential	O	O	O
mechanism	O	O	O
of	O	O	O
low	O	O	O
extraction	O	O	O
at	O	O	O
liver	O	O	B-T023
passage	O	O	B-T082
.	O	O	O

Very	O	O	O
high	O	O	O
systemic	O	O	B-T169
estrogenicity	O	O	B-T125
combined	O	O	O
with	O	O	O
markedly	O	O	O
lower	O	O	O
or	O	O	O
absent	O	O	O
adverse	O	O	O
hepatic	O	O	B-T029
estrogenic	O	O	B-T033
effects	O	O	I-T033
is	O	O	O
evidence	O	O	O
for	O	O	O
a	O	O	O
systemic	O	O	O
release	O	O	O
of	O	O	O
E2	O	O	B-T125
from	O	O	O
sulfonamide	O	O	B-T120
EP	O	O	I-T120
.	O	O	O

In	O	O	O
conclusion	O	O	O
,	O	O	O
tested	O	O	O
oral	O	O	B-T061
EP	O	O	B-T120
bypass	O	O	O
the	O	O	O
liver	O	O	B-T023
in	O	O	O
erythrocytes	O	O	B-T025
furnishing	O	O	O
systemic	O	O	B-T169
estradiol	O	O	B-T125
at	O	O	O
hydrolysis	O	O	B-T070
.	O	O	O

This	O	O	O
mechanism	O	O	O
avoids	O	O	O
the	O	O	O
hepatic	O	O	B-T029
estrogenic	O	O	B-UnknownType
impact	O	O	O
of	O	O	O
conventional	O	O	O
oral	O	O	B-T061
estrogen	O	O	B-T061
therapy	O	O	I-T061
.	O	O	O

-DOCSTART- (27450789)

Differences	O	O	B-T080
in	O	O	O
pain	O	O	B-T184
experience	O	O	B-T041
and	O	O	O
cooperation	O	O	B-T055
between	O	O	O
consecutive	O	O	B-T061
surgeries	O	O	I-T061
in	O	O	O
patients	O	O	B-T101
undergoing	O	O	O
phacoemulsification	O	O	O

The	O	O	O
purpose	O	O	O
of	O	O	O
this	O	O	O
study	O	O	B-T062
is	O	O	O
to	O	O	O
compare	O	O	O
pain	O	O	B-T184
experience	O	O	B-T041
and	O	O	O
cooperation	O	O	B-T055
between	O	O	O
consecutive	O	O	B-T061
surgeries	O	O	I-T061
in	O	O	O
patients	O	O	B-T101
undergoing	O	O	O
phacoemulsification	O	O	B-T061
in	O	O	O
both	O	O	O
eyes	O	O	B-T023
,	O	O	O
using	O	O	O
sub-Tenon	O	O	B-T061
's	O	O	I-T061
local	O	O	I-T061
anesthesia	O	O	I-T061
without	O	O	O
sedation	O	O	B-T061
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
268	O	O	O
patients	O	O	B-T101
with	O	O	O
bilateral	O	O	B-T047
senile	O	O	I-T047
cataracts	O	O	I-T047
were	O	O	O
recruited	O	O	O
.	O	O	O

All	O	O	O
operations	O	O	B-T061
were	O	O	O
performed	O	O	O
without	O	O	O
sedation	O	O	B-T061
,	O	O	O
using	O	O	O
a	O	O	O
clear	O	O	O
corneal	O	O	B-T023
phacoemulsification	O	O	B-T061
technique	O	O	I-T061
and	O	O	O
sub-Tenon	O	O	B-T061
's	O	O	I-T061
local	O	O	I-T061
anesthesia	O	O	I-T061
,	O	O	O
by	O	O	O
one	O	O	O
of	O	O	O
four	O	O	O
surgeons	O	O	B-T097
.	O	O	O

The	O	O	O
first	O	O	O
surgery	O	O	B-T061
was	O	O	O
performed	O	O	O
on	O	O	O
the	O	O	O
eye	O	O	B-T023
with	O	O	O
the	O	O	O
higher	O	O	O
grade	O	O	O
cataract	O	O	B-T020
.	O	O	O

The	O	O	O
other	O	O	O
eye	O	O	B-T023
was	O	O	O
operated	O	O	B-T052
on	O	O	O
within	O	O	O
3	O	O	B-T079
months	O	O	B-T079
by	O	O	O
the	O	O	O
same	O	O	O
surgeon	O	O	B-T097
(	O	O	O
mean	O	O	O
interval	O	O	O
1.9	O	O	O
Â±	O	O	O
1.1	O	O	O
months	O	O	O
)	O	O	O
.	O	O	O

All	O	O	O
patients	O	O	B-T101
were	O	O	O
asked	O	O	O
to	O	O	O
grade	O	O	O
their	O	O	O
pain	O	O	B-T184
experience	O	O	B-T041
during	O	O	O
induction	O	O	B-T061
and	O	O	O
maintenance	O	O	B-T052
of	O	O	O
anesthesia	O	O	B-T061
and	O	O	O
also	O	O	O
during	O	O	O
the	O	O	O
phacoemulsification	O	O	B-T061
surgery	O	O	B-T061
,	O	O	O
using	O	O	O
a	O	O	O
visual	O	O	B-T060
analogue	O	O	I-T060
scale	O	O	I-T060
(	O	O	O
VAS	O	O	B-T060
)	O	O	O
from	O	O	O
0	O	O	O
(	O	O	O
no	O	O	B-T033
pain	O	O	I-T033
)	O	O	O
to	O	O	O
10	O	O	O
(	O	O	O
unbearable	O	O	B-T184
pain	O	O	I-T184
)	O	O	O
administered	O	O	O
after	O	O	O
the	O	O	O
surgery	O	O	O
.	O	O	O

The	O	O	O
cooperation	O	O	B-T055
of	O	O	O
the	O	O	O
patient	O	O	B-T101
was	O	O	O
graded	O	O	O
from	O	O	O
0	O	O	O
(	O	O	O
no	O	O	O
event	O	O	O
)	O	O	O
to	O	O	O
3	O	O	O
(	O	O	O
markedeye	O	O	B-T039
and	O	O	O
head	O	O	B-T040
movement	O	O	I-T040
and	O	O	O
lid	O	O	B-T184
squeezing	O	O	I-T184
)	O	O	O
by	O	O	O
the	O	O	O
attending	O	O	O
surgeon	O	O	B-T097
.	O	O	O

The	O	O	O
VAS	O	O	B-T081
scores	O	O	B-T081
and	O	O	O
cooperation	O	O	B-T055
scores	O	O	O
of	O	O	O
the	O	O	O
patients	O	O	B-T101
were	O	O	O
the	O	O	O
outcome	O	O	B-T081
measurements	O	O	I-T081
.	O	O	O

The	O	O	O
mean	O	O	B-T033
pain	O	O	I-T033
score	O	O	I-T033
was	O	O	O
2.11	O	O	O
Â±	O	O	O
0.79	O	O	O
in	O	O	O
the	O	O	O
first	O	O	O
eye	O	O	B-T023
and	O	O	O
3.33	O	O	O
Â±	O	O	O
0.80	O	O	O
in	O	O	O
the	O	O	O
second	O	O	O
eye	O	O	O
during	O	O	O
the	O	O	O
administration	O	O	B-T061
of	O	O	O
sub-Tenon	O	O	B-T061
's	O	O	I-T061
anesthesia	O	O	I-T061
,	O	O	O
and	O	O	O
1.50	O	O	O
Â±	O	O	O
0.60	O	O	O
in	O	O	O
the	O	O	O
first	O	O	O
eye	O	O	O
and	O	O	O
2.10	O	O	O
Â±	O	O	O
0.57	O	O	O
in	O	O	O
the	O	O	O
second	O	O	O
eye	O	O	O
during	O	O	O
the	O	O	O
phacoemulsification	O	O	B-T061
surgery	O	O	I-T061
.	O	O	O

The	O	O	O
patient	O	O	B-T055
cooperation	O	O	I-T055
score	O	O	B-T081
was	O	O	O
1.60	O	O	O
Â±	O	O	O
0.75	O	O	O
in	O	O	O
the	O	O	O
first	O	O	O
surgery	O	O	B-T061
and	O	O	O
2.08	O	O	O
Â±	O	O	O
0.72	O	O	O
in	O	O	O
the	O	O	O
second	O	O	O
surgery	O	O	O
.	O	O	O

The	O	O	O
differences	O	O	B-T080
between	O	O	O
the	O	O	O
first	O	O	O
and	O	O	O
second	O	O	O
surgeries	O	O	B-T061
were	O	O	O
statistically	O	O	O
significant	O	O	O
for	O	O	O
all	O	O	O
outcome	O	O	B-T081
measures	O	O	I-T081
(	O	O	O
p	O	O	O
<	O	O	O
0.01	O	O	O
)	O	O	O
.	O	O	O

Patients	O	O	B-T101
who	O	O	O
previously	O	O	O
underwent	O	O	O
phaco	O	O	B-T061
surgery	O	O	I-T061
in	O	O	O
one	O	O	O
eye	O	O	B-T023
experienced	O	O	O
more	O	O	O
pain	O	O	B-T184
and	O	O	O
showed	O	O	O
worse	O	O	B-T033
cooperation	O	O	B-T055
during	O	O	O
the	O	O	O
phaco	O	O	O
surgery	O	O	O
in	O	O	O
the	O	O	O
second	O	O	O
eye	O	O	O
,	O	O	O
especially	O	O	O
if	O	O	O
there	O	O	O
was	O	O	O
a	O	O	O
short	O	O	O
time	O	O	O
between	O	O	O
the	O	O	O
surgeries	O	O	B-T061
,	O	O	O
viz	O	O	O
.	O	O	O
,	O	O	O
less	O	O	O
than	O	O	O
3	O	O	O
months	O	O	B-T079
.	O	O	O

Therefore	O	O	O
,	O	O	O
if	O	O	O
the	O	O	O
surgeon	O	O	B-T097
has	O	O	O
difficulty	O	O	B-T080
in	O	O	O
the	O	O	O
first	O	O	O
operation	O	O	B-T061
gaining	O	O	O
the	O	O	O
patient	O	O	B-T101
's	O	O	I-T101
cooperation	O	O	I-T055
,	O	O	O
the	O	O	O
surgeon	O	O	O
must	O	O	O
be	O	O	O
careful	O	O	O
:	O	O	O
if	O	O	O
contralateral	O	O	B-T061
eye	O	O	I-T061
surgery	O	O	B-T061
is	O	O	O
required	O	O	O
,	O	O	O
the	O	O	O
addition	O	O	O
of	O	O	O
sedation	O	O	B-T061
/	O	O	O
analgesia	O	O	B-T061
should	O	O	O
be	O	O	O
considered	O	O	O
or	O	O	O
the	O	O	O
surgery	O	O	O
postponed	O	O	O
for	O	O	O
a	O	O	O
while	O	O	O
to	O	O	O
abolish	O	O	O
the	O	O	O
influence	O	O	B-T077
of	O	O	O
recent	O	O	B-T041
memory	O	O	I-T041
on	O	O	O
the	O	O	O
patient	O	O	O
's	O	O	O
subsequent	O	O	O
pain	O	O	B-T184
experience	O	O	B-T041
.	O	O	O

-DOCSTART- (27454738)

Co-ChIP	O	O	B-T059
enables	O	O	O
genome-wide	O	O	B-T062
mapping	O	O	I-T062
of	O	O	O
histone	O	O	B-T087
mark	O	O	I-T087
co-occurrence	O	O	B-T079
at	O	O	O
single-molecule	O	O	O
resolution	O	O	O

Histone	O	O	B-T044
modifications	O	O	B-T044
play	O	O	O
an	O	O	O
important	O	O	B-T080
role	O	O	B-T077
in	O	O	O
chromatin	O	O	B-T045
organization	O	O	I-T045
and	O	O	O
transcriptional	O	O	B-T045
regulation	O	O	I-T045
,	O	O	O
but	O	O	O
despite	O	O	O
the	O	O	O
large	O	O	B-T081
amount	O	O	I-T081
of	O	O	O
genome-wide	O	O	B-T028
histone	O	O	B-T044
modification	O	O	I-T044
data	O	O	B-T078
collected	O	O	B-T078
in	O	O	O
different	O	O	B-T080
cells	O	O	B-T025
and	O	O	O
tissues	O	O	B-T024
,	O	O	O
little	O	O	O
is	O	O	O
known	O	O	O
about	O	O	O
co-occurrence	O	O	B-T079
of	O	O	O
modifications	O	O	O
on	O	O	O
the	O	O	O
same	O	O	O
nucleosome	O	O	B-T116
.	O	O	O

Here	O	O	O
we	O	O	O
present	O	O	B-T078
a	O	O	O
genome-wide	O	O	B-T062
quantitative	O	O	I-T062
method	O	O	I-T062
for	O	O	O
combinatorial	O	O	B-T170
indexed	O	O	I-T170
chromatin	O	O	B-T059
immunoprecipitation	O	O	I-T059
(	O	O	O
co-ChIP	O	O	B-T059
)	O	O	O
to	O	O	O
characterize	O	O	O
co-occurrence	O	O	B-T079
of	O	O	O
histone	O	O	B-T044
modifications	O	O	I-T044
on	O	O	O
nucleosomes	O	O	B-T116
.	O	O	O

Using	O	O	O
co-ChIP	O	O	B-T059
,	O	O	O
we	O	O	O
study	O	O	B-T062
the	O	O	O
genome-wide	O	O	B-T028
co-occurrence	O	O	B-T079
of	O	O	O
14	O	O	O
chromatin	O	O	B-T087
marks	O	O	I-T087
(	O	O	O
70	O	O	O
pairwise	O	O	B-T080
combinations	O	O	I-T080
)	O	O	O
,	O	O	O
and	O	O	O
find	O	O	O
previously	O	O	O
undescribed	O	O	O
co-occurrence	O	O	O
patterns	O	O	B-T082
,	O	O	O
including	O	O	O
the	O	O	O
co-occurrence	O	O	O
of	O	O	O
H3K9me1	O	O	B-T028
and	O	O	O
H3K27ac	O	O	B-T028
in	O	O	O
super-enhancers	O	O	B-T086
.	O	O	O

Finally	O	O	O
,	O	O	O
we	O	O	O
apply	O	O	B-T169
co-ChIP	O	O	B-T059
to	O	O	O
measure	O	O	B-T081
the	O	O	O
distribution	O	O	B-T169
of	O	O	O
the	O	O	O
bivalent	O	O	B-T081
H3K4me3	O	O	B-T028
-	O	O	O
H3K27me3	O	O	B-T028
domains	O	O	B-T087
in	O	O	O
two	O	O	O
distinct	O	O	O
mouse	O	O	B-T025
embryonic	O	O	I-T025
stem	O	O	I-T025
cell	O	O	I-T025
(	O	O	O
mESC	O	O	B-T025
)	O	O	O
states	O	O	O
and	O	O	O
in	O	O	O
four	O	O	O
adult	O	O	B-T024
tissues	O	O	I-T024
.	O	O	O

We	O	O	O
observe	O	O	B-T169
dynamic	O	O	B-T169
changes	O	O	B-T081
in	O	O	O
5,786	O	O	O
regions	O	O	O
and	O	O	O
discover	O	O	B-T052
both	O	O	O
loss	O	O	B-T081
and	O	O	O
de	O	O	B-T078
novo	O	O	I-T078
gain	O	O	B-T081
of	O	O	O
bivalency	O	O	B-T081
in	O	O	O
key	O	O	O
tissue-specific	O	O	B-T024
regulatory	O	O	B-T028
genes	O	O	I-T028
,	O	O	O
suggesting	O	O	B-T078
a	O	O	O
functional	O	O	B-T077
role	O	O	I-T077
for	O	O	O
bivalent	O	O	B-T081
domains	O	O	B-T087
during	O	O	O
different	O	O	O
stages	O	O	B-T079
of	O	O	O
development	O	O	B-T169
.	O	O	O

These	O	O	O
results	O	O	B-T033
show	O	O	O
that	O	O	O
co-ChIP	O	O	B-T059
can	O	O	O
reveal	O	O	B-T080
the	O	O	O
complex	O	O	B-T169
interactions	O	O	I-T169
between	O	O	O
histone	O	O	B-T044
modifications	O	O	I-T044
.	O	O	O

-DOCSTART- (27456018)

Hand-Assisted	O	O	B-T061
Laparoscopic	O	O	I-T061
Versus	O	O	O
Standard	O	O	B-T061
Laparoscopic	O	O	I-T061
Colectomy	O	O	I-T061
:	O	O	O
Are	O	O	O
Outcomes	O	O	B-T080
and	O	O	O
Operative	O	O	B-T079
Time	O	O	I-T079
Different	O	O	O
?	O	O	O

HAL	O	O	B-T061
colectomy	O	O	B-T061
is	O	O	O
a	O	O	O
technique	O	O	B-T169
perceived	O	O	O
to	O	O	O
provide	O	O	O
the	O	O	O
benefits	O	O	O
of	O	O	O
laparoscopic	O	O	B-T061
surgery	O	O	I-T061
while	O	O	O
improving	O	O	O
tactile	O	O	O
feedback	O	O	O
and	O	O	O
operative	O	O	B-T079
time	O	O	I-T079
.	O	O	O

Published	O	O	O
data	O	O	B-T078
are	O	O	O
largely	O	O	O
limited	O	O	O
to	O	O	O
small	O	O	O
,	O	O	O
single-institution	O	O	B-T062
studies	O	O	I-T062
.	O	O	O

The	O	O	O
2012	O	O	O
-	O	O	O
2013	O	O	O
National	O	O	B-T170
Surgical	O	O	I-T170
Quality	O	O	I-T170
Improvement	O	O	I-T170
Program	O	O	I-T170
Participant	O	O	I-T170
Data	O	O	I-T170
Use	O	O	I-T170
File	O	O	I-T170
was	O	O	O
queried	O	O	O
for	O	O	O
patients	O	O	B-T101
undergoing	O	O	O
elective	O	O	O
SL	O	O	B-T061
or	O	O	O
HAL	O	O	B-T061
colectomy	O	O	B-T061
.	O	O	O

Patients	O	O	B-T101
underwent	O	O	O
1:1	O	O	O
propensity	O	O	O
matching	O	O	O
and	O	O	O
had	O	O	O
outcomes	O	O	B-T080
compared	O	O	O
.	O	O	O

An	O	O	O
additional	O	O	O
subgroup	O	O	B-T062
analysis	O	O	I-T062
was	O	O	O
performed	O	O	O
for	O	O	O
patients	O	O	B-T101
undergoing	O	O	O
segmental	O	O	B-T082
resections	O	O	B-T061
only	O	O	O
.	O	O	O

13,949	O	O	O
patients	O	O	B-T101
were	O	O	O
identified	O	O	O
,	O	O	O
of	O	O	O
whom	O	O	O
6084	O	O	O
(	O	O	O
43.6	O	O	O
%	O	O	O
)	O	O	O
underwent	O	O	O
HAL	O	O	B-T061
colectomy	O	O	B-T061
.	O	O	O

Patients	O	O	B-T101
undergoing	O	O	O
HAL	O	O	B-T061
versus	O	O	O
SL	O	O	B-T061
colectomy	O	O	I-T061
had	O	O	O
higher	O	O	O
rates	O	O	B-T081
of	O	O	O
postoperative	O	O	B-T047
ileus	O	O	I-T047
(	O	O	O
8.7	O	O	O
vs.	O	O	O
6.3	O	O	O
%	O	O	O
,	O	O	O
p	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
,	O	O	O
wound	O	O	B-T037
complication	O	O	I-T037
(	O	O	O
8.8	O	O	O
vs.	O	O	O
6.8	O	O	O
%	O	O	O
,	O	O	O
p	O	O	O
=	O	O	O
0.006	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
30-	O	O	O
day	O	O	B-T079
readmission	O	O	B-T058
(	O	O	O
7.5	O	O	O
vs.	O	O	O
6.0	O	O	O
%	O	O	O
,	O	O	O
p	O	O	O
=	O	O	O
0.002	O	O	O
)	O	O	O
,	O	O	O
without	O	O	O
any	O	O	O
differences	O	O	O
in	O	O	O
operative	O	O	B-T079
time	O	O	I-T079
(	O	O	O
156	O	O	O
vs.	O	O	O
157	O	O	O
min	O	O	O
,	O	O	O
p	O	O	O
=	O	O	O
0.713	O	O	O
)	O	O	O
.	O	O	O

Amongst	O	O	O
segmental	O	O	B-T082
colectomies	O	O	B-T061
,	O	O	O
HAL	O	O	B-T061
remained	O	O	O
associated	O	O	O
with	O	O	O
higher	O	O	O
rates	O	O	B-T081
of	O	O	O
wound	O	O	B-T037
complications	O	O	I-T037
(	O	O	O
8.6	O	O	O
vs.	O	O	O
6.5	O	O	O
%	O	O	O
,	O	O	O
p	O	O	O
=	O	O	O
0.016	O	O	O
)	O	O	O
,	O	O	O
postoperative	O	O	B-T047
ileus	O	O	I-T047
(	O	O	O
8.9	O	O	O
vs.	O	O	O
6.3	O	O	O
%	O	O	O
,	O	O	O
p	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
30-	O	O	O
day	O	O	B-T079
readmission	O	O	B-T058
(	O	O	O
7.1	O	O	O
vs.	O	O	O
5.9	O	O	O
%	O	O	O
,	O	O	O
p	O	O	O
=	O	O	O
0.041	O	O	O
)	O	O	O
with	O	O	O
no	O	O	O
difference	O	O	O
in	O	O	O
operative	O	O	B-T079
time	O	O	I-T079
between	O	O	O
HAL	O	O	O
and	O	O	O
SL	O	O	O
(	O	O	O
145	O	O	O
vs.	O	O	O
145	O	O	O
min	O	O	O
,	O	O	O
p	O	O	O
=	O	O	O
0.334	O	O	O
)	O	O	O
.	O	O	O

Use	O	O	O
of	O	O	O
HAL	O	O	B-T061
colectomy	O	O	B-T061
is	O	O	O
associated	O	O	O
with	O	O	O
increased	O	O	O
risk	O	O	B-T058
of	O	O	O
wound	O	O	B-T037
complications	O	O	I-T037
,	O	O	O
postoperative	O	O	B-T047
ileus	O	O	I-T047
,	O	O	O
and	O	O	O
readmissions	O	O	B-T058
.	O	O	O

Importantly	O	O	O
,	O	O	O
this	O	O	O
technique	O	O	B-T169
is	O	O	O
not	O	O	O
associated	O	O	O
with	O	O	O
any	O	O	O
decrease	O	O	O
in	O	O	O
operative	O	O	B-T079
time	O	O	I-T079
.	O	O	O

-DOCSTART- (27457539)

Safety	O	O	B-T068
and	O	O	O
immunogenecity	O	O	B-T062
of	O	O	O
a	O	O	O
live	O	O	O
attenuated	O	O	B-T129
Rift	O	O	B-T129
Valley	O	O	I-T129
fever	O	O	I-T129
vaccine	O	O	I-T129
(	O	O	O
CL13	O	O	B-T129
T	O	O	I-T129
)	O	O	O
in	O	O	O
camels	O	O	O

Rift	O	O	B-T047
Valley	O	O	I-T047
fever	O	O	I-T047
is	O	O	O
an	O	O	O
emerging	O	O	O
zoonotic	O	O	B-T001
viral	O	O	B-T047
disease	O	O	I-T047
,	O	O	O
enzootic	O	O	B-T047
and	O	O	O
endemic	O	O	B-T047
in	O	O	O
Africa	O	O	B-T083
and	O	O	O
the	O	O	O
Arabian	O	O	B-T083
Peninsula	O	O	I-T083
,	O	O	O
which	O	O	O
poses	O	O	O
a	O	O	O
significant	O	O	B-T078
threat	O	O	B-T078
to	O	O	O
both	O	O	O
human	O	O	B-T016
and	O	O	O
animal	O	O	B-T008
health	O	O	B-T047
.	O	O	O

The	O	O	O
disease	O	O	B-T047
is	O	O	O
most	O	O	O
severe	O	O	B-T080
in	O	O	O
ruminants	O	O	B-T015
causing	O	O	B-T169
abortions	O	O	B-T046
in	O	O	O
pregnant	O	O	B-T040
animals	O	O	B-T008
,	O	O	O
especially	O	O	O
sheep	O	O	B-T015
animals	O	O	I-T015
and	O	O	O
high	O	O	O
mortality	O	O	B-T081
in	O	O	O
young	O	O	B-T079
populations	O	O	B-T098
.	O	O	O

High	O	O	O
mortality	O	O	B-T081
rates	O	O	I-T081
and	O	O	O
severe	O	O	B-T080
clinical	O	O	B-T080
manifestation	O	O	B-T080
have	O	O	O
also	O	O	O
been	O	O	O
reported	O	O	B-T170
among	O	O	O
camel	O	O	B-T015
populations	O	O	B-T098
in	O	O	O
Africa	O	O	B-T083
,	O	O	O
to	O	O	O
attend	O	O	O
however	O	O	O
none	O	O	O
of	O	O	O
the	O	O	O
currently	O	O	B-T079
available	O	O	B-T169
live	O	O	B-T129
vaccines	O	O	I-T129
against	O	O	O
RVF	O	O	B-T047
have	O	O	O
been	O	O	O
tested	O	O	B-T169
for	O	O	O
safety	O	O	B-T068
and	O	O	O
efficacy	O	O	B-T080
in	O	O	O
this	O	O	O
species	O	O	B-T185
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
the	O	O	O
safety	O	O	B-T068
and	O	O	O
efficacy	O	O	B-T080
(	O	O	O
through	O	O	O
a	O	O	O
neutralizing	O	O	B-T116
antibody	O	O	I-T116
response	O	O	B-T032
)	O	O	O
of	O	O	O
the	O	O	O
thermostable	O	O	B-T129
live	O	O	I-T129
attenuated	O	O	I-T129
RVF	O	O	B-T129
CL13	O	O	I-T129
T	O	O	I-T129
vaccine	O	O	I-T129
were	O	O	O
evaluated	O	O	B-T058
in	O	O	O
camels	O	O	B-T015
in	O	O	O
two	O	O	O
different	O	O	B-T080
preliminary	O	O	B-T079
experiments	O	O	B-T062
involving	O	O	O
16	O	O	O
camels	O	O	O
,	O	O	O
(	O	O	O
that	O	O	O
12	O	O	O
camels	O	O	O
and	O	O	O
4	O	O	O
pregnant	O	O	B-T040
camels	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
study	O	O	B-T062
revealed	O	O	B-T080
that	O	O	O
the	O	O	O
CL13	O	O	B-T129
T	O	O	I-T129
vaccine	O	O	I-T129
was	O	O	O
safe	O	O	B-T068
to	O	O	O
use	O	O	B-T169
in	O	O	O
camels	O	O	B-T015
and	O	O	O
no	O	O	O
abortions	O	O	B-T046
or	O	O	O
teratogenic	O	O	B-T046
effects	O	O	I-T046
were	O	O	O
observed	O	O	B-T169
.	O	O	O

The	O	O	O
single	O	O	O
dose	O	O	B-T081
of	O	O	O
the	O	O	O
vaccine	O	O	B-T129
stimulated	O	O	O
a	O	O	O
strong	O	O	B-T080
and	O	O	O
long-lasting	O	O	O
neutralizing	O	O	B-T116
antibody	O	O	I-T116
response	O	O	B-T032
for	O	O	O
up	O	O	O
to	O	O	O
12	O	O	O
months	O	O	B-T079
.	O	O	O

The	O	O	O
presence	O	O	B-T033
of	O	O	O
neutralization	O	O	B-T116
antibodies	O	O	I-T116
is	O	O	O
likely	O	O	O
to	O	O	O
correlate	O	O	B-T080
with	O	O	I-T080
protection	O	O	B-T033
;	O	O	O
however	O	O	O
protection	O	O	O
would	O	O	O
need	O	O	O
to	O	O	O
be	O	O	O
confirmed	O	O	B-T080
by	O	O	I-T080
challenge	O	O	O
experiments	O	O	B-T062
using	O	O	O
the	O	O	O
virulent	O	O	B-T080
RVF	O	O	B-T005
virus	O	O	I-T005
.	O	O	O

-DOCSTART- (27458601)

Autoantibodies	O	O	B-T116
to	O	O	O
MOG	O	O	B-T116
in	O	O	O
a	O	O	O
distinct	O	O	O
subgroup	O	O	B-T185
of	O	O	O
adult	O	O	B-T100
multiple	O	O	O
sclerosis	O	O	O

To	O	O	O
evaluate	O	O	B-T058
the	O	O	O
presence	O	O	O
of	O	O	O
antibodies	O	O	B-T116
to	O	O	O
conformation	O	O	B-T082
-intact	O	O	O
myelin	O	O	B-T116
oligodendrocyte	O	O	I-T116
glycoprotein	O	O	I-T116
(	O	O	O
MOG	O	O	B-T116
)	O	O	O
in	O	O	O
a	O	O	O
subgroup	O	O	B-T185
of	O	O	O
adult	O	O	B-T100
patients	O	O	B-T101
with	O	O	O
clinically	O	O	B-T080
definite	O	O	O
multiple	O	O	B-T047
sclerosis	O	O	I-T047
(	O	O	O
MS	O	O	B-T047
)	O	O	O
preselected	O	O	O
for	O	O	O
a	O	O	O
specific	O	O	O
clinical	O	O	B-T080
phenotype	O	O	B-T032
including	O	O	O
severe	O	O	B-T080
spinal	O	O	B-T023
cord	O	O	I-T023
,	O	O	O
optic	O	O	B-T023
nerve	O	O	I-T023
,	O	O	O
and	O	O	O
brainstem	O	O	B-T023
involvement	O	O	O
.	O	O	O

Antibodies	O	O	B-T116
to	O	O	O
MOG	O	O	B-T116
were	O	O	O
investigated	O	O	B-T169
using	O	O	O
a	O	O	O
cell-based	O	O	B-T059
assay	O	O	I-T059
in	O	O	O
3	O	O	O
groups	O	O	B-T098
of	O	O	O
patients	O	O	B-T101
:	O	O	O
104	O	O	O
preselected	O	O	O
patients	O	O	O
with	O	O	O
MS	O	O	B-T047
(	O	O	O
group	O	O	B-T098
1	O	O	I-T098
)	O	O	O
,	O	O	O
55	O	O	O
age	O	O	B-T032
-	O	O	O
and	O	O	O
sex	O	O	B-T032
-matched	O	O	O
,	O	O	O
otherwise	O	O	O
unselected	O	O	O
patients	O	O	O
with	O	O	O
MS	O	O	O
(	O	O	O
group	O	O	B-T098
2	O	O	I-T098
)	O	O	O
,	O	O	O
and	O	O	O
in	O	O	O
22	O	O	O
brain-biopsied	O	O	B-T060
patients	O	O	O
with	O	O	O
demyelinating	O	O	B-T047
diseases	O	O	I-T047
of	O	O	O
the	O	O	O
CNS	O	O	B-T022
(	O	O	O
n	O	O	O
=	O	O	O
19	O	O	O
with	O	O	O
MS	O	O	O
)	O	O	O
,	O	O	O
4	O	O	O
of	O	O	O
whom	O	O	O
classified	O	O	B-T185
as	O	O	O
MS	O	O	B-T047
type	O	O	I-T047
II	O	O	I-T047
(	O	O	O
group	O	O	B-T098
3	O	O	I-T098
)	O	O	O
.	O	O	O

Recognized	O	O	O
epitopes	O	O	B-T129
were	O	O	O
identified	O	O	O
with	O	O	O
mutated	O	O	B-T045
variants	O	O	B-T028
of	O	O	O
MOG	O	O	B-T028
.	O	O	O

Antibodies	O	O	B-T116
to	O	O	O
MOG	O	O	B-T116
were	O	O	O
found	O	O	O
in	O	O	O
about	O	O	O
5	O	O	O
%	O	O	O
(	O	O	O
5/104	O	O	O
)	O	O	O
of	O	O	O
preselected	O	O	O
adult	O	O	B-T100
patients	O	O	B-T101
with	O	O	O
MS	O	O	B-T047
.	O	O	O

In	O	O	O
contrast	O	O	O
,	O	O	O
in	O	O	O
groups	O	O	B-T098
2	O	O	I-T098
and	O	O	O
3	O	O	B-T098
,	O	O	O
none	O	O	O
of	O	O	O
the	O	O	O
patients	O	O	B-T101
tested	O	O	B-T169
positive	O	O	O
for	O	O	O
MOG	O	O	B-T116
antibodies	O	O	B-T116
.	O	O	O

Patients	O	O	B-T101
with	O	O	O
MS	O	O	B-T047
with	O	O	O
antibodies	O	O	B-T116
to	O	O	O
MOG	O	O	B-T116
predominantly	O	O	O
manifested	O	O	B-T169
with	O	O	O
concomitant	O	O	B-T079
severe	O	O	B-T080
brainstem	O	O	B-T023
and	O	O	O
spinal	O	O	B-T023
cord	O	O	I-T023
involvement	O	O	O
and	O	O	O
had	O	O	O
a	O	O	O
severe	O	O	O
disease	O	O	B-T046
course	O	O	I-T046
with	O	O	O
high	O	O	O
relapse	O	O	B-T067
rates	O	O	B-T081
and	O	O	O
failure	O	O	B-T033
to	O	O	O
several	O	O	O
disease-modifying	O	O	B-T061
therapies	O	O	I-T061
.	O	O	O

Three	O	O	O
of	O	O	O
them	O	O	O
had	O	O	O
been	O	O	O
treated	O	O	B-T061
with	O	O	I-T061
plasma	O	O	B-T061
exchange	O	O	I-T061
with	O	O	O
a	O	O	O
favorable	O	O	B-UnknownType
response	O	O	I-UnknownType
.	O	O	O

All	O	O	O
anti-MOG	O	O	B-T129
-positive	O	O	O
patients	O	O	B-T101
with	O	O	O
MS	O	O	B-T047
showed	O	O	O
typical	O	O	O
MS	O	O	O
lesions	O	O	B-T033
on	O	O	O
brain	O	O	B-T060
MRI	O	O	I-T060
.	O	O	O

Longitudinal	O	O	B-UnknownType
analysis	O	O	I-UnknownType
up	O	O	O
to	O	O	O
9	O	O	O
years	O	O	B-T079
revealed	O	O	O
fluctuations	O	O	B-T184
and	O	O	O
reappearance	O	O	O
of	O	O	O
anti-MOG	O	O	B-T044
reactivity	O	O	I-T044
.	O	O	O

Epitope	O	O	B-T059
mapping	O	O	I-T059
indicated	O	O	O
interindividual	O	O	B-T080
heterogeneity	O	O	I-T080
,	O	O	O
yet	O	O	O
intraindividual	O	O	B-T080
stability	O	O	I-T080
of	O	O	O
the	O	O	O
antibody	O	O	B-T038
response	O	O	I-T038
.	O	O	O

Antibodies	O	O	B-T116
to	O	O	O
MOG	O	O	B-T116
can	O	O	O
be	O	O	O
found	O	O	O
in	O	O	O
a	O	O	O
distinct	O	O	O
subgroup	O	O	B-T185
of	O	O	O
adult	O	O	B-T100
MS	O	O	B-T047
with	O	O	O
a	O	O	O
specific	O	O	O
clinical	O	O	B-T080
phenotype	O	O	B-T032
and	O	O	O
may	O	O	O
indicate	O	O	O
disease	O	O	B-T047
heterogeneity	O	O	B-T080
.	O	O	O

-DOCSTART- (27459610)

Acute	O	O	B-T191
Ph-negative	O	O	I-T191
lymphoblastic	O	O	I-T191
leukemias	O	O	I-T191
in	O	O	O
adults	O	O	B-T100
:	O	O	O
Risk	O	O	B-T033
factors	O	O	I-T033
in	O	O	O
the	O	O	O
use	O	O	O
of	O	O	O
the	O	O	O
ALL-2009	O	O	O
protocol	O	O	O

to	O	O	O
analyze	O	O	O
well-known	O	O	O
risk	O	O	B-T033
factors	O	O	I-T033
(	O	O	O
RFs	O	O	B-T033
)	O	O	O
,	O	O	O
such	O	O	O
as	O	O	O
age	O	O	B-T032
,	O	O	O
immunophenotype	O	O	B-T059
,	O	O	O
baseline	O	O	B-T081
leukocytosis	O	O	B-T046
,	O	O	O
enhanced	O	O	B-T052
lactate	O	O	B-T116
dehydrogenase	O	O	I-T116
(	O	O	O
LDH	O	O	B-T116
)	O	O	O
activity	O	O	B-T044
,	O	O	O
time	O	O	O
to	O	O	O
achieve	O	O	O
complete	O	O	O
remission	O	O	B-T033
,	O	O	O
a	O	O	O
risk	O	O	B-T098
group	O	O	I-T098
,	O	O	O
and	O	O	O
cytogenetic	O	O	B-T049
abnormalities	O	O	I-T049
)	O	O	O
in	O	O	O
patients	O	O	B-T101
with	O	O	O
acute	O	O	B-T191
lymphoblastic	O	O	I-T191
leukemia	O	O	I-T191
(	O	O	O
ALL	O	O	B-T191
)	O	O	O
in	O	O	O
the	O	O	O
use	O	O	O
of	O	O	O
the	O	O	O
ALL-2009	O	O	B-T170
protocol	O	O	I-T170
.	O	O	O

The	O	O	O
protocol	O	O	B-T170
covered	O	O	O
298	O	O	O
patients	O	O	B-T101
(	O	O	O
137	O	O	O
women	O	O	B-T098
(	O	O	O
including	O	O	B-T169
13	O	O	O
pregnant	O	O	B-T098
women	O	O	I-T098
)	O	O	O
and	O	O	O
161	O	O	O
men	O	O	B-T098
)	O	O	O
aged	O	O	O
15	O	O	O
to	O	O	O
55	O	O	O
years	O	O	O
(	O	O	O
median	O	O	O
age	O	O	O
28	O	O	O
years	O	O	O
)	O	O	O
with	O	O	O
Ph-negative	O	O	B-T191
ALL	O	O	I-T191
.	O	O	O

The	O	O	O
phenotype	O	O	B-T032
was	O	O	O
unknown	O	O	O
in	O	O	O
6	O	O	O
patients	O	O	B-T101
.	O	O	O

Three	O	O	O
(	O	O	O
1	O	O	O
%	O	O	O
)	O	O	O
were	O	O	O
ascertained	O	O	O
to	O	O	O
have	O	O	O
a	O	O	O
biphenotypic	O	O	O
variant	O	O	O
.	O	O	O

182	O	O	O
(	O	O	O
62.4	O	O	O
%	O	O	O
)	O	O	O
patients	O	O	B-T101
were	O	O	O
found	O	O	O
to	O	O	O
have	O	O	O
B-cell	O	O	B-T191
ALL	O	O	B-T191
(	O	O	O
early	O	O	O
pre-B	O	O	B-T191
ALL	O	O	I-T191
(	O	O	O
n=51	O	O	O
)	O	O	O
;	O	O	O
common	O	O	O
ALL	O	O	O
(	O	O	O
n=92	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
pre-B	O	O	O
ALL	O	O	O
(	O	O	O
n=39	O	O	O
)	O	O	O
;	O	O	O
107	O	O	O
(	O	O	O
36.6	O	O	O
%	O	O	O
)	O	O	O
patients	O	O	O
had	O	O	O
T-cell	O	O	B-T191
ALL	O	O	I-T191
(	O	O	O
early	O	O	O
T-ALL	O	O	B-T191
(	O	O	O
n=56	O	O	O
)	O	O	O
;	O	O	O
thymic	O	O	B-T023
T-ALL	O	O	O
(	O	O	O
n=41	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
mature	O	O	B-T079
T-ALL	O	O	O
(	O	O	O
n=10	O	O	O
)	O	O	O
.	O	O	O

According	O	O	O
to	O	O	O
the	O	O	O
baseline	O	O	B-T081
clinical	O	O	B-T080
and	O	O	O
laboratory	O	O	B-T093
parameters	O	O	B-T033
(	O	O	O
leukocytosis	O	O	B-T046
of	O	O	O
30Â·109/l	O	O	O
and	O	O	O
more	O	O	O
for	O	O	O
B-ALL	O	O	B-T191
;	O	O	O
and	O	O	O
that	O	O	O
of	O	O	O
100Â·109/l	O	O	O
and	O	O	O
more	O	O	O
for	O	O	O
T-ALL	O	O	B-T191
;	O	O	O
phenotype	O	O	B-T032
Ð-I	O	O	O
for	O	O	O
B-ALL	O	O	O
,	O	O	O
phenotype	O	O	O
Ð¢-I-II-IV	O	O	O
for	O	O	O
T-ALL	O	O	O
;	O	O	O
LDH	O	O	B-T116
activity	O	O	B-T044
was	O	O	O
more	O	O	O
than	O	O	O
twice	O	O	O
the	O	O	O
normal	O	O	O
values	O	O	O
;	O	O	O
the	O	O	O
presence	O	O	B-T033
of	O	O	O
translocation	O	O	B-T049
t(4;11	O	O	I-T049
)	O	O	I-T049
)	O	O	O
,	O	O	O
the	O	O	O
high-risk	O	O	B-T098
group	O	O	I-T098
included	O	O	B-T169
most	O	O	O
patients	O	O	B-T101
with	O	O	O
B-ALL	O	O	O
(	O	O	O
n=110	O	O	O
(	O	O	O
72.8	O	O	O
%	O	O	O
)	O	O	O
)	O	O	O
and	O	O	O
T-ALL	O	O	O
(	O	O	O
n=76	O	O	O
(	O	O	O
76	O	O	O
%	O	O	O
)	O	O	O
)	O	O	O
.	O	O	O

Thirty-five	O	O	O
patients	O	O	B-T101
with	O	O	O
T-ALL	O	O	B-T191
underwent	O	O	O
autologous	O	O	B-T061
bone	O	O	I-T061
marrow	O	O	I-T061
transplantation	O	O	I-T061
(	O	O	O
BMT	O	O	B-T061
)	O	O	O
.	O	O	O

Allogeneic	O	O	B-T061
BMT	O	O	I-T061
was	O	O	O
performed	O	O	B-T169
in	O	O	O
18	O	O	O
(	O	O	O
7	O	O	O
%	O	O	O
)	O	O	O
of	O	O	O
the	O	O	O
258	O	O	O
patients	O	O	B-T101
who	O	O	O
had	O	O	O
undergone	O	O	O
an	O	O	O
induction	O	O	B-T062
phase	O	O	I-T062
.	O	O	O

Five-year	O	O	O
overall	O	O	B-T081
survival	O	O	I-T081
for	O	O	O
all	O	O	O
the	O	O	O
patients	O	O	B-T101
included	O	O	B-T169
in	O	O	O
the	O	O	O
investigation	O	O	B-T058
was	O	O	O
59	O	O	O
%	O	O	O
;	O	O	O
relapse-free	O	O	B-T061
survival	O	O	O
was	O	O	O
65	O	O	O
%	O	O	O
,	O	O	O
which	O	O	O
was	O	O	O
significantly	O	O	O
different	O	O	O
in	O	O	O
the	O	O	O
patients	O	O	O
with	O	O	O
B-ALL	O	O	B-T191
and	O	O	O
in	O	O	O
those	O	O	O
with	O	O	O
T-ALL	O	O	B-T191
:	O	O	O
the	O	O	O
overall	O	O	B-T081
survival	O	O	I-T081
rates	O	O	I-T081
were	O	O	O
53.3	O	O	O
and	O	O	O
67.5	O	O	O
%	O	O	O
(	O	O	O
p=0.1	O	O	O
)	O	O	O
;	O	O	O
the	O	O	O
relapse-free	O	O	O
survival	O	O	O
was	O	O	O
56	O	O	O
and	O	O	O
79	O	O	O
%	O	O	O
(	O	O	O
p=0.005	O	O	O
)	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

Multivariate	O	O	B-T081
analysis	O	O	I-T081
including	O	O	B-T169
the	O	O	O
well-known	O	O	O
RFs	O	O	B-T033
demonstrated	O	O	O
that	O	O	O
the	O	O	O
latter	O	O	O
for	O	O	O
T-ALL	O	O	B-T191
were	O	O	O
of	O	O	O
no	O	O	O
independent	O	O	O
prognostic	O	O	O
value	O	O	O
and	O	O	O
only	O	O	O
the	O	O	O
patient	O	O	B-T101
's	O	O	I-T101
age	O	O	B-T032
was	O	O	O
identified	O	O	O
for	O	O	O
B-ALL	O	O	B-T191
(	O	O	O
p=0.013	O	O	O
)	O	O	O
.	O	O	O

A	O	O	O
lower	O	O	O
chemotherapeutic	O	O	B-T121
load	O	O	O
and	O	O	O
a	O	O	O
small	O	O	O
number	O	O	O
of	O	O	O
allogeneic	O	O	B-T061
BMTs	O	O	I-T061
did	O	O	O
not	O	O	O
affect	O	O	O
total	O	O	O
positive	O	O	O
treatment	O	O	B-T061
results	O	O	B-T034
in	O	O	O
adult	O	O	B-T100
patients	O	O	B-T101
with	O	O	O
ALL	O	O	B-T191
,	O	O	O
by	O	O	O
complying	O	O	O
with	O	O	O
the	O	O	O
principle	O	O	O
achieving	O	O	O
the	O	O	O
continuity	O	O	O
of	O	O	O
cytostatic	O	O	B-T121
effects	O	O	B-T080
and	O	O	O
by	O	O	O
preserving	O	O	B-T169
the	O	O	O
total	O	O	O
cytostatic	O	O	O
loading	O	O	B-T081
dose	O	O	I-T081
.	O	O	O

The	O	O	O
results	O	O	B-T034
of	O	O	O
the	O	O	O
Russian	O	O	B-T083
investigation	O	O	B-T058
casts	O	O	O
some	O	O	O
doubt	O	O	O
on	O	O	O
the	O	O	O
necessity	O	O	O
of	O	O	O
using	O	O	O
very	O	O	O
intensive	O	O	O
consolidation	O	O	O
cycles	O	O	O
and	O	O	O
performing	O	O	O
a	O	O	O
large	O	O	O
number	O	O	O
of	O	O	O
allogeneic	O	O	B-T061
BMTs	O	O	I-T061
in	O	O	O
adult	O	O	B-T100
patients	O	O	B-T101
with	O	O	O
ALL	O	O	B-T191
.	O	O	O

-DOCSTART- (27460285)

Multidetector	O	O	B-T060
CT	O	O	I-T060
of	O	O	O
expected	O	O	B-T170
findings	O	O	B-T033
and	O	O	O
complications	O	O	B-T046
after	O	O	O
contemporary	O	O	B-T079
inguinal	O	O	B-T061
hernia	O	O	I-T061
repair	O	O	I-T061
surgery	O	O	O

Inguinal	O	O	B-T061
hernia	O	O	I-T061
repair	O	O	I-T061
(	O	O	O
IHR	O	O	B-T061
)	O	O	O
with	O	O	O
prosthetic	O	O	B-T074
mesh	O	O	B-T074
implantation	O	O	B-T061
is	O	O	O
the	O	O	O
most	O	O	O
common	O	O	O
procedure	O	O	B-T061
in	O	O	O
general	O	O	B-T061
surgery	O	O	I-T061
,	O	O	O
and	O	O	O
may	O	O	O
be	O	O	O
performed	O	O	B-T169
using	O	O	O
either	O	O	O
an	O	O	O
open	O	O	B-T082
or	O	O	O
laparoscopic	O	O	B-T082
approach	O	O	I-T082
.	O	O	O

This	O	O	O
paper	O	O	B-T073
provides	O	O	O
an	O	O	O
overview	O	O	B-T170
of	O	O	O
contemporary	O	O	B-T079
tension-free	O	O	O
IHR	O	O	B-T061
techniques	O	O	B-T169
and	O	O	O
materials	O	O	B-T167
,	O	O	O
and	O	O	O
illustrates	O	O	O
the	O	O	O
expected	O	O	B-T170
postoperative	O	O	B-T033
imaging	O	O	B-T034
findings	O	O	I-T034
and	O	O	O
iatrogenic	O	O	B-T037
injuries	O	O	I-T037
.	O	O	O

Emphasis	O	O	O
is	O	O	O
placed	O	O	O
on	O	O	O
multidetector	O	O	B-T060
CT	O	O	I-T060
,	O	O	O
which	O	O	O
represents	O	O	O
the	O	O	O
ideal	O	O	B-T080
modality	O	O	B-T078
to	O	O	O
comprehensively	O	O	O
visualize	O	O	O
the	O	O	O
operated	O	O	B-T169
groin	O	O	B-T029
region	O	O	I-T029
and	O	O	O
deeper	O	O	B-T082
intra-abdominal	O	O	B-T023
structures	O	O	I-T023
.	O	O	O

CT	O	O	B-T060
consistently	O	O	O
depicts	O	O	O
seroma	O	O	B-T046
,	O	O	O
mesh	O	O	B-T046
infections	O	O	I-T046
,	O	O	O
hemorrhages	O	O	B-T046
,	O	O	O
bowel	O	O	B-T023
complications	O	O	B-T046
and	O	O	O
urinary	O	O	B-T023
bladder	O	O	I-T023
injuries	O	O	B-T037
,	O	O	O
and	O	O	O
thus	O	O	O
generally	O	O	O
provides	O	O	O
a	O	O	O
consistent	O	O	B-T078
basis	O	O	O
for	O	O	O
therapeutic	O	O	B-T169
choice	O	O	B-T052
.	O	O	O

Since	O	O	O
radiologists	O	O	B-T097
are	O	O	O
increasingly	O	O	B-T169
requested	O	O	O
to	O	O	O
investigate	O	O	B-T169
suspected	O	O	B-T078
iatrogenic	O	O	B-T080
complications	O	O	B-T046
,	O	O	O
this	O	O	O
paper	O	O	B-T073
aims	O	O	O
to	O	O	O
provide	O	O	O
an	O	O	O
increased	O	O	B-T081
familiarity	O	O	B-T041
with	O	O	O
early	O	O	B-T079
CT	O	O	B-T060
studies	O	O	B-T060
after	O	O	O
IHR	O	O	B-T061
,	O	O	O
including	O	O	O
complications	O	O	O
and	O	O	O
normal	O	O	B-T080
postoperative	O	O	B-T033
appearances	O	O	B-T080
such	O	O	O
as	O	O	O
focal	O	O	B-T082
pseudolesions	O	O	B-T046
,	O	O	O
in	O	O	O
order	O	O	O
to	O	O	O
avoid	O	O	B-T058
misinterpretation	O	O	I-T058
and	O	O	O
inappropriate	O	O	B-T080
management	O	O	B-T058
.	O	O	O

-DOCSTART- (27460657)

The	O	O	O
transcription	O	O	B-T116
factors	O	O	I-T116
MS188	O	O	B-T116
and	O	O	O
AMS	O	O	B-T116
form	O	O	O
a	O	O	O
complex	O	O	B-T080
to	O	O	O
activate	O	O	B-T169
the	O	O	O
expression	O	O	B-T045
of	O	O	O
CYP703A2	O	O	B-T116
for	O	O	O
sporopollenin	O	O	B-T044
biosynthesis	O	O	I-T044
in	O	O	O
Arabidopsis	O	O	O
thaliana	O	O	O

The	O	O	O
sexine	O	O	B-T026
layer	O	O	I-T026
of	O	O	O
pollen	O	O	B-T002
grain	O	O	I-T002
is	O	O	O
mainly	O	O	O
composed	O	O	O
of	O	O	O
sporopollenins	O	O	B-T109
.	O	O	O

The	O	O	O
sporophytic	O	O	B-T025
secretory	O	O	I-T025
tapetum	O	O	I-T025
is	O	O	O
required	O	O	B-T169
for	O	O	O
the	O	O	O
biosynthesis	O	O	B-T044
of	O	O	I-T044
sporopollenin	O	O	I-T044
.	O	O	O

Although	O	O	O
several	O	O	O
enzymes	O	O	B-T116
involved	O	O	B-T169
in	O	O	O
sporopollenin	O	O	B-T044
biosynthesis	O	O	I-T044
have	O	O	O
been	O	O	O
reported	O	O	O
,	O	O	O
the	O	O	O
regulatory	O	O	B-T044
mechanism	O	O	I-T044
of	O	O	O
these	O	O	O
enzymes	O	O	O
in	O	O	O
tapetal	O	O	B-T025
layer	O	O	I-T025
remains	O	O	O
elusive	O	O	O
.	O	O	O

ABORTED	O	O	B-T116
MICROSPORES	O	O	I-T116
(	O	O	O
AMS	O	O	B-T116
)	O	O	O
and	O	O	O
MALE	O	O	B-T116
STERILE	O	O	I-T116
188	O	O	I-T116
/	O	O	O
MYB103	O	O	B-T116
/	O	O	O
MYB80	O	O	B-T116
(	O	O	O
MS188	O	O	B-T116
/	O	O	O
MYB103	O	O	O
/	O	O	O
MYB80	O	O	O
)	O	O	O
are	O	O	O
two	O	O	O
tapetal	O	O	B-T025
cell	O	O	I-T025
-specific	O	O	O
transcription	O	O	B-T116
factors	O	O	I-T116
required	O	O	B-T169
for	O	O	O
pollen	O	O	B-T042
wall	O	O	I-T042
formation	O	O	I-T042
.	O	O	O

AMS	O	O	B-T116
functions	O	O	B-T169
upstream	O	O	B-T082
of	O	O	O
MS188	O	O	B-T116
.	O	O	O

Here	O	O	O
we	O	O	O
report	O	O	O
that	O	O	O
AMS	O	O	B-T116
and	O	O	O
MS188	O	O	B-T116
target	O	O	B-T169
the	O	O	O
CYP703A2	O	O	B-T028
gene	O	O	I-T028
,	O	O	O
which	O	O	O
is	O	O	O
involved	O	O	B-T169
in	O	O	O
sporopollenin	O	O	B-T044
biosynthesis	O	O	I-T044
.	O	O	O

We	O	O	O
found	O	O	O
that	O	O	O
AMS	O	O	B-T116
and	O	O	O
MS188	O	O	B-T116
were	O	O	O
localized	O	O	B-T082
in	O	O	O
tapetum	O	O	B-T025
while	O	O	O
CYP703A2	O	O	B-T116
was	O	O	O
localized	O	O	O
in	O	O	O
both	O	O	O
tapetum	O	O	O
and	O	O	O
locule	O	O	B-T002
.	O	O	O

Chromatin	O	O	B-T059
immunoprecipitation	O	O	I-T059
(	O	O	O
ChIP	O	O	B-T059
)	O	O	O
showed	O	O	O
that	O	O	O
MS188	O	O	B-T116
directly	O	O	O
bound	O	O	B-T052
to	O	O	O
the	O	O	O
promoter	O	O	B-T114
of	O	O	O
CYP703A2	O	O	B-T028
and	O	O	O
luciferase-inducible	O	O	B-T116
assay	O	O	B-T059
showed	O	O	O
that	O	O	O
MS188	O	O	O
activated	O	O	B-T052
the	O	O	O
expression	O	O	B-T045
of	O	O	O
CYP703A2	O	O	O
.	O	O	O

Yeast	O	O	B-T063
two-hybrid	O	O	I-T063
and	O	O	O
electrophoretic	O	O	B-T059
mobility	O	O	I-T059
shift	O	O	I-T059
assays	O	O	I-T059
(	O	O	O
EMSAs	O	O	B-T059
)	O	O	O
further	O	O	O
demonstrated	O	O	O
that	O	O	O
MS188	O	O	B-T116
complexed	O	O	B-T080
with	O	O	O
AMS	O	O	B-T116
.	O	O	O

The	O	O	O
expression	O	O	B-T045
of	O	O	O
CYP703A2	O	O	B-T028
could	O	O	O
be	O	O	O
partially	O	O	O
restored	O	O	O
by	O	O	O
the	O	O	O
elevated	O	O	B-T080
levels	O	O	I-T080
of	O	O	O
MS188	O	O	B-T116
in	O	O	O
the	O	O	O
ams	O	O	B-T116
mutant	O	O	B-T049
.	O	O	O

Therefore	O	O	O
,	O	O	O
our	O	O	O
data	O	O	B-T078
reveal	O	O	B-T080
that	O	O	O
MS188	O	O	B-T116
coordinates	O	O	B-T169
with	O	O	O
AMS	O	O	B-T116
to	O	O	O
activate	O	O	B-T169
CYP703A2	O	O	B-T116
in	O	O	O
sporopollenin	O	O	B-T044
biosynthesis	O	O	I-T044
of	O	O	O
plant	O	O	B-T002
tapetum	O	O	B-T025
.	O	O	O

-DOCSTART- (27461472)

Activation	O	O	B-T052
of	O	O	O
ephrinB-EphB	O	O	B-T169
receptor	O	O	I-T169
signalling	O	O	I-T169
in	O	O	O
rat	O	O	B-T023
spinal	O	O	I-T023
cord	O	O	I-T023
contributes	O	O	O
to	O	O	O
maintenance	O	O	B-T052
of	O	O	O
diabetic	O	O	B-T033
neuropathic	O	O	O
pain	O	O	O

Diabetic	O	O	B-T033
neuropathic	O	O	B-T033
pain	O	O	I-T033
(	O	O	O
DNP	O	O	B-T033
)	O	O	O
is	O	O	O
severe	O	O	B-T080
and	O	O	O
intractable	O	O	B-T169
in	O	O	O
clinic	O	O	B-T093
.	O	O	O

The	O	O	O
specific	O	O	B-T080
cellular	O	O	B-T043
and	O	O	O
molecular	O	O	B-T044
mechanisms	O	O	B-T169
underlying	O	O	O
DNP	O	O	B-T033
remain	O	O	O
elusive	O	O	O
and	O	O	O
its	O	O	O
treatment	O	O	B-T169
are	O	O	O
limited	O	O	B-T169
.	O	O	O

We	O	O	O
investigated	O	O	B-T169
roles	O	O	B-T077
of	O	O	O
EphB1	O	O	B-T116
receptor	O	O	I-T116
in	O	O	O
the	O	O	O
development	O	O	O
of	O	O	O
DNP	O	O	B-T033
.	O	O	O

Diabetic	O	O	B-T033
neuropathic	O	O	B-T033
pain	O	O	I-T033
was	O	O	O
produced	O	O	O
in	O	O	O
male	O	O	B-T032
,	O	O	O
adult	O	O	B-T100
,	O	O	O
Sprague-Dawley	O	O	B-T015
rats	O	O	I-T015
by	O	O	O
a	O	O	O
single	O	O	O
i.p	O	O	O
.	O	O	O

streptozotocin	O	O	B-T195
(	O	O	O
STZ	O	O	B-T195
)	O	O	O
or	O	O	O
alloxan	O	O	B-T109
.	O	O	O

Western	O	O	B-T059
blot	O	O	I-T059
analysis	O	O	I-T059
and	O	O	O
immunohistochemistry	O	O	B-T060
were	O	O	O
used	O	O	O
to	O	O	O
analyse	O	O	O
expression	O	O	B-T045
of	O	O	O
EphB1	O	O	B-T116
receptor	O	O	I-T116
as	O	O	O
well	O	O	O
as	O	O	O
the	O	O	O
activation	O	O	B-T052
of	O	O	O
the	O	O	O
glial	O	O	B-T025
cells	O	O	I-T025
and	O	O	O
the	O	O	O
pro-inflammatory	O	O	B-T116
cytokines	O	O	I-T116
in	O	O	O
the	O	O	O
spinal	O	O	B-T023
cord	O	O	I-T023
.	O	O	O

DNP	O	O	B-T033
manifested	O	O	B-T169
as	O	O	O
mechanical	O	O	B-T184
allodynia	O	O	I-T184
,	O	O	O
which	O	O	O
was	O	O	O
determined	O	O	O
by	O	O	O
measuring	O	O	B-T080
incidence	O	O	B-T081
of	O	O	O
foot	O	O	B-T023
withdrawal	O	O	B-T052
in	O	O	O
response	O	O	B-T032
to	O	O	O
mechanical	O	O	B-T082
indentation	O	O	I-T082
of	O	O	O
the	O	O	O
hind	O	O	B-T082
paw	O	O	B-T023
by	O	O	O
an	O	O	O
electro	O	O	B-T073
von	O	O	I-T073
Frey	O	O	I-T073
filament	O	O	I-T073
.	O	O	O

Diabetic	O	O	B-T033
neuropathic	O	O	B-T033
pain	O	O	I-T033
and	O	O	O
high	O	O	B-T033
blood	O	O	I-T033
glucose	O	O	I-T033
were	O	O	O
exhibited	O	O	O
simultaneously	O	O	B-T079
in	O	O	O
around	O	O	O
70	O	O	O
%	O	O	O
of	O	O	O
animals	O	O	B-T008
that	O	O	O
received	O	O	O
i.p	O	O	O
.	O	O	O

STZ	O	O	B-T195
or	O	O	O
alloxan	O	O	B-T109
.	O	O	O

Phosphorylation	O	O	B-T044
of	O	O	O
EphB1	O	O	B-T116
,	O	O	O
activation	O	O	B-T052
of	O	O	O
the	O	O	O
astrocytes	O	O	B-T025
and	O	O	O
microglial	O	O	B-T025
cells	O	O	I-T025
,	O	O	O
and	O	O	O
level	O	O	B-T080
of	O	O	O
tumour	O	O	B-T116
necrosis	O	O	I-T116
factor	O	O	I-T116
(TNF)-Î±	O	O	B-T116
and	O	O	O
interleukin	O	O	B-T116
(IL)-1Î²	O	O	I-T116
in	O	O	O
the	O	O	O
spinal	O	O	B-T023
cord	O	O	I-T023
were	O	O	O
significantly	O	O	O
increased	O	O	O
in	O	O	O
rats	O	O	B-T015
with	O	O	O
DNP	O	O	B-T033
.	O	O	O

Spinal	O	O	B-T082
blocking	O	O	B-T169
EphB1	O	O	B-T116
receptor	O	O	I-T116
activation	O	O	B-T052
in	O	O	O
the	O	O	O
late	O	O	O
phase	O	O	O
after	O	O	O
STZ	O	O	B-T195
injection	O	O	B-T061
significantly	O	O	O
suppressed	O	O	B-T169
the	O	O	O
established	O	O	O
mechanical	O	O	B-T184
allodynia	O	O	I-T184
as	O	O	O
well	O	O	O
as	O	O	O
activation	O	O	O
of	O	O	O
the	O	O	O
astrocytes	O	O	B-T025
and	O	O	O
microglial	O	O	B-T025
cells	O	O	I-T025
and	O	O	O
activity	O	O	B-T052
of	O	O	O
TNF-Î±	O	O	B-T116
and	O	O	O
IL-1Î²	O	O	B-T116
.	O	O	O

However	O	O	O
,	O	O	O
spinal	O	O	B-T082
treatment	O	O	B-T169
of	O	O	O
EphB1	O	O	B-T116
-	O	O	O
Fc	O	O	B-T116
in	O	O	O
the	O	O	O
early	O	O	B-UnknownType
phase	O	O	I-UnknownType
after	O	O	O
STZ	O	O	B-T195
injection	O	O	B-T061
did	O	O	O
not	O	O	O
prevent	O	O	O
the	O	O	O
induction	O	O	B-T169
of	O	O	O
DNP	O	O	B-T033
.	O	O	O

EphB1	O	O	B-T116
receptor	O	O	I-T116
activation	O	O	B-T052
in	O	O	O
the	O	O	O
spinal	O	O	B-T023
cord	O	O	I-T023
is	O	O	O
critical	O	O	B-T080
to	O	O	O
the	O	O	O
maintenance	O	O	B-T052
,	O	O	O
but	O	O	O
not	O	O	O
induction	O	O	B-T169
of	O	O	O
diabetic	O	O	B-T033
pain	O	O	B-T184
.	O	O	O

EphB1	O	O	B-T116
receptor	O	O	I-T116
may	O	O	O
be	O	O	O
a	O	O	O
potential	O	O	B-T080
target	O	O	B-T169
for	O	O	O
relieving	O	O	B-T061
the	O	O	O
established	O	O	O
diabetic	O	O	B-T033
pain	O	O	B-T184
.	O	O	O

Activation	O	O	B-T052
of	O	O	O
EphB1	O	O	B-T116
receptor	O	O	I-T116
in	O	O	O
the	O	O	O
spinal	O	O	B-T023
cord	O	O	I-T023
is	O	O	O
critical	O	O	B-T080
to	O	O	O
maintaining	O	O	B-T169
the	O	O	O
established	O	O	O
diabetic	O	O	B-T033
neuropathic	O	O	B-T033
pain	O	O	B-T184
,	O	O	O
but	O	O	O
not	O	O	O
to	O	O	O
diabetic	O	O	O
pain	O	O	O
induction	O	O	B-T169
.	O	O	O

Spinal	O	O	B-T082
blocking	O	O	B-T169
EphB1	O	O	B-T116
receptor	O	O	I-T116
activation	O	O	B-T052
suppresses	O	O	B-T169
ongoing	O	O	O
diabetic	O	O	B-T033
neuropathic	O	O	B-T033
pain	O	O	I-T033
.	O	O	O

-DOCSTART- (27463515)

Conservation	O	O	B-T080
of	O	O	O
the	O	O	O
Red	O	O	B-T012
Kite	O	O	I-T012
Milvus	O	O	B-T012
milvus	O	O	I-T012
(	O	O	O
Aves	O	O	B-T012
:	O	O	O
Accipitriformes	O	O	B-T012
)	O	O	O
Is	O	O	O
Not	O	O	O
Affected	O	O	B-T169
by	O	O	O
the	O	O	O
Establishment	O	O	O
of	O	O	O
a	O	O	O
Broad	O	O	O
Hybrid	O	O	B-T001
Zone	O	O	B-T082
with	O	O	O
the	O	O	O
Black	O	O	B-T012
Kite	O	O	I-T012
Milvus	O	O	B-T012
migrans	O	O	I-T012
migrans	O	O	I-T012
in	O	O	O
Central	O	O	O
Europe	O	O	O

Among	O	O	O
Accipitriformes	O	O	B-T012
sensu	O	O	O
stricto	O	O	O
,	O	O	O
only	O	O	O
a	O	O	O
few	O	O	O
species	O	O	B-T185
have	O	O	O
been	O	O	O
reported	O	O	B-T170
to	O	O	O
form	O	O	O
hybrid	O	O	B-T001
zones	O	O	B-T082
;	O	O	O
these	O	O	O
include	O	O	O
the	O	O	O
red	O	O	B-T012
kite	O	O	I-T012
Milvus	O	O	B-T012
milvus	O	O	I-T012
and	O	O	O
black	O	O	B-T012
kite	O	O	I-T012
Milvus	O	O	B-T012
migrans	O	O	I-T012
migrans	O	O	I-T012
.	O	O	O

M.	O	O	B-T012
milvus	O	O	I-T012
is	O	O	O
endemic	O	O	B-T169
to	O	O	O
the	O	O	O
western	O	O	B-UnknownType
Palearctic	O	O	I-UnknownType
and	O	O	O
has	O	O	O
an	O	O	O
estimated	O	O	O
total	O	O	O
population	O	O	B-T081
of	O	O	O
20	O	O	O
-	O	O	O
24,000	O	O	O
breeding	O	O	B-T040
pairs	O	O	B-T080
.	O	O	O

The	O	O	O
species	O	O	B-T185
was	O	O	O
in	O	O	O
decline	O	O	O
until	O	O	O
the	O	O	O
1970s	O	O	O
due	O	O	O
to	O	O	O
persecution	O	O	B-T054
and	O	O	O
has	O	O	O
declined	O	O	O
again	O	O	O
since	O	O	O
the	O	O	O
1990s	O	O	O
due	O	O	O
to	O	O	O
ingestion	O	O	B-T038
of	O	O	O
rodenticide-treated	O	O	B-T131
baits	O	O	I-T131
,	O	O	O
illegal	O	O	B-T078
poisoning	O	O	B-T037
and	O	O	O
changes	O	O	O
in	O	O	O
agricultural	O	O	B-T090
practices	O	O	I-T090
,	O	O	O
particularly	O	O	O
in	O	O	O
its	O	O	O
core	O	O	B-T082
range	O	O	B-T081
.	O	O	O

Whereas	O	O	O
F1	O	O	B-T099
M.	O	O	B-T012
milvus	O	O	I-T012
Ã	O	O	O
M.	O	O	O
migr	O	O	O
.	O	O	O

migrans	O	O	O
hybrid	O	O	B-T001
offspring	O	O	B-T099
have	O	O	O
been	O	O	O
found	O	O	O
,	O	O	O
F2	O	O	B-T099
and	O	O	O
F3	O	O	B-T099
hybrids	O	O	B-T001
have	O	O	O
only	O	O	O
rarely	O	O	O
been	O	O	O
reported	O	O	B-T170
,	O	O	O
with	O	O	O
low	O	O	O
nesting	O	O	B-T054
success	O	O	B-T054
rates	O	O	B-T081
of	O	O	O
F1	O	O	B-T099
hybrids	O	O	O
and	O	O	O
partial	O	O	B-T081
hybrid	O	O	O
sterility	O	O	O
likely	O	O	O
playing	O	O	O
a	O	O	O
role	O	O	O
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
analyzed	O	O	B-T062
the	O	O	O
mitochondrial	O	O	B-T026
(	O	O	O
CO1	O	O	B-T028
and	O	O	O
CytB	O	O	B-T028
)	O	O	O
and	O	O	O
nuclear	O	O	B-T026
(	O	O	O
Myc	O	O	B-T028
)	O	O	O
DNA	O	O	B-T114
loci	O	O	B-T082
of	O	O	O
184	O	O	O
M.	O	O	B-T012
milvus	O	O	I-T012
,	O	O	O
124	O	O	O
M.	O	O	O
migr	O	O	O
.	O	O	O

migrans	O	O	O
and	O	O	O
3	O	O	O
F1	O	O	B-T099
hybrid	O	O	B-T001
individuals	O	O	O
collected	O	O	O
across	O	O	O
central	O	O	B-T083
Europe	O	O	I-T083
.	O	O	O

In	O	O	O
agreement	O	O	B-T170
with	O	O	O
previous	O	O	O
studies	O	O	B-T062
,	O	O	O
we	O	O	O
found	O	O	O
low	O	O	O
heterozygosity	O	O	B-T032
in	O	O	O
M.	O	O	B-T012
milvus	O	O	I-T012
regardless	O	O	O
of	O	O	O
locus	O	O	B-T082
.	O	O	O

We	O	O	O
found	O	O	O
that	O	O	O
populations	O	O	B-T081
of	O	O	O
both	O	O	O
examined	O	O	B-T033
species	O	O	B-T185
were	O	O	O
characterized	O	O	B-T052
by	O	O	O
a	O	O	O
high	O	O	O
gene	O	O	B-T045
flow	O	O	I-T045
within	O	O	O
populations	O	O	O
,	O	O	O
with	O	O	O
all	O	O	O
of	O	O	O
the	O	O	O
major	O	O	O
haplotypes	O	O	B-T032
distributed	O	O	O
across	O	O	O
the	O	O	O
entire	O	O	O
examined	O	O	O
area	O	O	B-T083
.	O	O	O

Few	O	O	O
haplotypes	O	O	B-T032
displayed	O	O	O
statistically	O	O	B-T081
significant	O	O	I-T081
aggregation	O	O	B-T169
in	O	O	O
one	O	O	O
region	O	O	B-T083
over	O	O	O
another	O	O	O
.	O	O	O

We	O	O	O
did	O	O	O
not	O	O	O
find	O	O	O
mitochondrial	O	O	B-T114
DNA	O	O	I-T114
of	O	O	O
one	O	O	O
species	O	O	B-T185
in	O	O	O
individuals	O	O	O
with	O	O	O
the	O	O	O
plumage	O	O	B-T023
of	O	O	O
the	O	O	O
other	O	O	O
species	O	O	O
,	O	O	O
except	O	O	O
in	O	O	O
F1	O	O	B-T099
hybrids	O	O	B-T001
,	O	O	O
which	O	O	O
agrees	O	O	O
with	O	O	O
HaldaneÂ´s	O	O	B-T170
Rule	O	O	I-T170
.	O	O	O

It	O	O	O
remains	O	O	O
to	O	O	O
be	O	O	O
investigated	O	O	B-T169
by	O	O	O
genomic	O	O	B-T028
methods	O	O	B-T169
whether	O	O	O
occasional	O	O	O
gene	O	O	B-T045
flow	O	O	I-T045
occurs	O	O	O
through	O	O	O
the	O	O	O
paternal	O	O	B-T080
line	O	O	O
,	O	O	O
as	O	O	O
the	O	O	O
examined	O	O	B-T033
Myc	O	O	B-T028
gene	O	O	I-T028
displayed	O	O	O
only	O	O	O
marginal	O	O	O
divergence	O	O	B-T082
between	O	O	O
M.	O	O	B-T012
milvus	O	O	I-T012
and	O	O	O
M.	O	O	O
migr	O	O	O
.	O	O	O

migrans	O	O	O
.	O	O	O

The	O	O	O
central	O	O	B-T083
Europe	O	O	I-T083
an	O	O	O
population	O	O	B-T081
of	O	O	O
M.	O	O	B-T012
milvus	O	O	I-T012
is	O	O	O
clearly	O	O	O
subject	O	O	O
to	O	O	O
free	O	O	O
intraspecific	O	O	O
gene	O	O	B-T045
flow	O	O	I-T045
,	O	O	O
which	O	O	O
has	O	O	O
direct	O	O	O
implications	O	O	O
when	O	O	O
considering	O	O	O
the	O	O	O
origin	O	O	B-T079
of	O	O	O
individuals	O	O	O
in	O	O	O
M.	O	O	O
milvus	O	O	O
re-introduction	O	O	O
programs	O	O	O
.	O	O	O

-DOCSTART- (27464853)

Extracellular	O	O	B-T026
Potassium	O	O	B-T123
and	O	O	O
Seizures	O	O	B-T184
:	O	O	O
Excitation	O	O	B-T052
,	O	O	O
Inhibition	O	O	B-T052
and	O	O	O
the	O	O	O
Role	O	O	O
of	O	O	O
Ih	O	O	O

Seizure	O	O	B-T184
activity	O	O	I-T184
leads	O	O	O
to	O	O	O
increases	O	O	O
in	O	O	O
extracellular	O	O	B-T026
potassium	O	O	B-T123
concentration	O	O	B-T081
(	O	O	O
[	O	O	O
K	O	O	B-T121
[	O	O	O
Formula	O	O	O
:	O	O	O
see	O	O	O
text]]o	O	O	O
)	O	O	O
,	O	O	O
which	O	O	O
can	O	O	O
result	O	O	O
in	O	O	O
changes	O	O	O
in	O	O	O
neuronal	O	O	B-T025
passive	O	O	B-T080
and	O	O	O
active	O	O	B-T169
membrane	O	O	B-T026
properties	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
in	O	O	O
population	O	O	B-T098
activities	O	O	B-T052
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
we	O	O	O
examined	O	O	O
how	O	O	O
extracellular	O	O	B-T026
potassium	O	O	B-T123
modulates	O	O	O
seizure	O	O	B-T184
activities	O	O	I-T184
using	O	O	O
an	O	O	O
acute	O	O	O
4-AP	O	O	B-T109
induced	O	O	O
seizure	O	O	O
model	O	O	B-T170
in	O	O	O
the	O	O	O
neocortex	O	O	B-T023
,	O	O	O
both	O	O	O
in	O	O	B-T082
vivo	O	O	I-T082
and	O	O	O
in	O	O	B-T080
vitro	O	O	I-T080
.	O	O	O

Moderately	O	O	O
elevated	O	O	O
[	O	O	O
K	O	O	B-T121
[	O	O	O
Formula	O	O	O
:	O	O	O
see	O	O	O
text]]o	O	O	O
up	O	O	O
to	O	O	O
9[Formula	O	O	O
:	O	O	O
see	O	O	O
text]mM	O	O	O
prolonged	O	O	B-T079
seizure	O	O	B-T184
durations	O	O	B-T079
and	O	O	O
shortened	O	O	B-T079
interictal	O	O	I-T079
intervals	O	O	I-T079
as	O	O	O
well	O	O	O
as	O	O	O
depolarized	O	O	B-T046
the	O	O	O
neuronal	O	O	B-T025
resting	O	O	B-T043
membrane	O	O	I-T043
potential	O	O	I-T043
(	O	O	O
RMP	O	O	B-T043
)	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
when	O	O	O
[	O	O	O
K	O	O	B-T121
[	O	O	O
Formula	O	O	O
:	O	O	O
see	O	O	O
text]]o	O	O	O
reached	O	O	O
higher	O	O	O
than	O	O	O
9[Formula	O	O	O
:	O	O	O
see	O	O	O
text]mM	O	O	O
,	O	O	O
seizure	O	O	B-T184
like	O	O	I-T184
events	O	O	I-T184
(	O	O	O
SLEs	O	O	B-T184
)	O	O	O
were	O	O	O
blocked	O	O	B-T169
and	O	O	O
neurons	O	O	B-T025
went	O	O	O
into	O	O	O
a	O	O	O
depolarization	O	O	B-T046
-	O	O	O
blocked	O	O	O
state	O	O	O
.	O	O	O

Spreading	O	O	B-T080
depression	O	O	B-T048
was	O	O	O
never	O	O	O
observed	O	O	O
as	O	O	O
the	O	O	O
blockade	O	O	O
of	O	O	O
ictal	O	O	B-T184
events	O	O	I-T184
could	O	O	O
be	O	O	O
reversed	O	O	O
within	O	O	O
1	O	O	O
-	O	O	O
2[Formula	O	O	O
:	O	O	O
see	O	O	O
text]min	O	O	O
after	O	O	O
the	O	O	O
raised	O	O	O
[	O	O	O
K	O	O	B-T121
[	O	O	O
Formula	O	O	O
:	O	O	O
see	O	O	O
text]]o	O	O	O
was	O	O	O
changed	O	O	O
back	O	O	O
to	O	O	O
control	O	O	O
levels	O	O	O
.	O	O	O

This	O	O	O
concentration	O	O	B-T081
-dependent	O	O	O
dual	O	O	O
effect	O	O	O
of	O	O	O
[	O	O	O
K	O	O	B-T121
[	O	O	O
Formula	O	O	O
:	O	O	O
see	O	O	O
text]]o	O	O	O
was	O	O	O
observed	O	O	O
using	O	O	O
in	O	O	B-T082
vivo	O	O	I-T082
and	O	O	O
in	O	O	B-T080
vitro	O	O	I-T080
mouse	O	O	B-T024
brain	O	O	I-T024
preparations	O	O	I-T024
as	O	O	O
well	O	O	O
as	O	O	O
in	O	O	O
human	O	O	B-T016
neocortical	O	O	B-T023
tissue	O	O	B-T024
resected	O	O	O
during	O	O	O
epilepsy	O	O	B-T047
surgery	O	O	B-T061
.	O	O	O

Blocking	O	O	B-T169
the	O	O	O
Ih	O	O	O
current	O	O	O
,	O	O	O
mediated	O	O	O
by	O	O	O
hyperpolarization-activated	O	O	B-T116
cyclic	O	O	I-T116
nucleotide-gated	O	O	I-T116
(	O	O	I-T116
HCN	O	O	I-T116
)	O	O	I-T116
channels	O	O	I-T116
,	O	O	O
modulated	O	O	O
the	O	O	O
elevated	O	O	O
[	O	O	O
K	O	O	B-T121
[	O	O	O
Formula	O	O	O
:	O	O	O
see	O	O	O
text]]o	O	O	O
influence	O	O	B-T077
on	O	O	O
SLEs	O	O	B-T184
by	O	O	O
promoting	O	O	O
the	O	O	O
high	O	O	O
[	O	O	O
K	O	O	O
[	O	O	O
Formula	O	O	O
:	O	O	O
see	O	O	O
text]]o	O	O	O
inhibitory	O	O	B-T052
actions	O	O	I-T052
.	O	O	O

These	O	O	O
results	O	O	O
demonstrate	O	O	O
biphasic	O	O	O
actions	O	O	O
of	O	O	O
raised	O	O	O
[	O	O	O
K	O	O	B-T121
[	O	O	O
Formula	O	O	O
:	O	O	O
see	O	O	O
text]]o	O	O	O
on	O	O	O
neuronal	O	O	B-T025
excitability	O	O	B-T184
and	O	O	O
seizure	O	O	B-T184
activity	O	O	I-T184
.	O	O	O

-DOCSTART- (27465797)

Activation	O	O	B-T044
of	O	O	O
general	O	O	B-T116
control	O	O	I-T116
nonderepressible	O	O	I-T116
2	O	O	I-T116
kinase	O	O	I-T116
protects	O	O	B-T033
human	O	O	B-T016
glomerular	O	O	B-T025
endothelial	O	O	I-T025
cells	O	O	I-T025
from	O	O	O
harmful	O	O	O
high-glucose	O	O	B-T033
-	O	O	O
induced	O	O	B-T169
molecular	O	O	O
pathways	O	O	O

Considering	O	O	O
the	O	O	O
referred	O	O	O
beneficial	O	O	O
effects	O	O	O
of	O	O	O
protein	O	O	B-T116
restriction	O	O	B-T169
on	O	O	O
diabetic	O	O	B-T047
nephropathy	O	O	I-T047
(	O	O	O
DN	O	O	B-T047
)	O	O	O
and	O	O	O
the	O	O	O
role	O	O	O
of	O	O	O
renal	O	O	B-T023
endothelium	O	O	B-T024
in	O	O	O
its	O	O	O
pathogenesis	O	O	B-T046
,	O	O	O
we	O	O	O
evaluated	O	O	B-T058
the	O	O	O
effect	O	O	O
of	O	O	O
general	O	O	B-T116
control	O	O	I-T116
nonderepressible	O	O	I-T116
2	O	O	I-T116
(	O	O	I-T116
GCN2	O	O	I-T116
)	O	O	I-T116
kinase	O	O	I-T116
activation	O	O	B-T044
,	O	O	O
a	O	O	O
sensor	O	O	B-T075
of	O	O	O
amino	O	O	B-T116
acid	O	O	I-T116
deprivation	O	O	B-T080
,	O	O	O
on	O	O	O
known	O	O	O
detrimental	O	O	O
molecular	O	O	B-T044
pathways	O	O	I-T044
in	O	O	O
primary	O	O	O
human	O	O	B-T016
glomerular	O	O	B-T025
endothelial	O	O	I-T025
cells	O	O	I-T025
(	O	O	O
GEnC	O	O	B-T025
)	O	O	O
.	O	O	O

GEnC	O	O	B-T025
were	O	O	O
cultured	O	O	B-T059
under	O	O	O
normal	O	O	O
or	O	O	O
high	O	O	B-T047
-glucose	O	O	I-T047
conditions	O	O	I-T047
in	O	O	O
the	O	O	O
presence	O	O	O
or	O	O	O
not	O	O	O
of	O	O	O
the	O	O	O
GCN2	O	O	B-T116
kinase	O	O	I-T116
activator	O	O	B-T044
,	O	O	O
tryptophanol	O	O	B-T116
.	O	O	O

Glucose	O	O	B-T116
transporter	O	O	I-T116
1	O	O	I-T116
(	O	O	O
GLUT1	O	O	B-T116
)	O	O	O
expression	O	O	B-T045
was	O	O	O
assessed	O	O	B-T052
by	O	O	O
western	O	O	B-T059
blotting	O	O	I-T059
and	O	O	O
reactive	O	O	B-T123
oxygen	O	O	I-T123
species	O	O	I-T123
(	O	O	O
ROS	O	O	B-T123
)	O	O	O
using	O	O	O
a	O	O	O
fluorogenic	O	O	B-T130
probe	O	O	I-T130
.	O	O	O

Activities	O	O	B-T044
of	O	O	O
glyceraldehyde	O	O	B-T116
3-phosphate	O	O	I-T116
dehydrogenase	O	O	I-T116
(	O	O	O
GAPDH	O	O	B-T116
)	O	O	O
and	O	O	O
protein	O	O	B-T116
kinase	O	O	I-T116
C	O	O	I-T116
(	O	O	O
PKC	O	O	B-T116
)	O	O	O
were	O	O	O
assessed	O	O	B-T052
by	O	O	O
commercial	O	O	B-T059
activity	O	O	I-T059
assays	O	O	I-T059
,	O	O	O
sorbitol	O	O	B-T109
colorimetrically	O	O	B-T059
,	O	O	O
methylglyoxal	O	O	B-T109
by	O	O	O
ELISA	O	O	B-T059
and	O	O	O
O-linked	O	O	B-T116
Î²-N-acetyl	O	O	I-T116
glucosamine	O	O	I-T116
(O-GlcNAc)-modified	O	O	I-T116
proteins	O	O	I-T116
by	O	O	O
western	O	O	B-T059
blotting	O	O	I-T059
.	O	O	O

High	O	O	B-T033
glucose	O	O	I-T033
induced	O	O	B-T169
GLUT1	O	O	B-T116
expression	O	O	B-T045
,	O	O	O
increased	O	O	B-T081
ROS	O	O	B-T123
and	O	O	O
inhibited	O	O	B-T080
GAPDH	O	O	B-T116
.	O	O	O

Also	O	O	O
it	O	O	O
increased	O	O	B-T081
the	O	O	O
polyol	O	O	B-T109
pathway	O	O	B-T044
product	O	O	O
sorbitol	O	O	B-T109
,	O	O	O
PKC	O	O	B-T116
activity	O	O	B-T044
,	O	O	O
the	O	O	O
level	O	O	O
of	O	O	O
the	O	O	O
O-GlcNAc-modified	O	O	B-T116
proteins	O	O	I-T116
that	O	O	O
produced	O	O	O
by	O	O	O
the	O	O	O
hexosamine	O	O	B-T109
pathway	O	O	O
and	O	O	O
the	O	O	O
advanced	O	O	B-T109
glycation	O	O	I-T109
endproducts	O	O	I-T109
'	O	O	I-T109
precursor	O	O	B-T078
methylglyoxal	O	O	B-T109
.	O	O	O

Co-treatment	O	O	B-T058
of	O	O	O
GEnC	O	O	B-T025
with	O	O	O
tryptophanol	O	O	B-T116
restored	O	O	O
the	O	O	O
above	O	O	O
high-glucose	O	O	B-T033
-	O	O	O
induced	O	O	B-T169
alterations	O	O	O
.	O	O	O

Activation	O	O	B-T044
of	O	O	O
GCN2	O	O	B-T116
kinase	O	O	I-T116
protects	O	O	O
GEnC	O	O	B-T025
from	O	O	O
high-glucose	O	O	B-T033
-	O	O	O
induced	O	O	B-T169
harmful	O	O	O
molecular	O	O	B-T044
pathways	O	O	I-T044
.	O	O	O

By	O	O	O
inhibiting	O	O	O
concurrently	O	O	B-T079
many	O	O	O
pathways	O	O	B-T044
involved	O	O	O
in	O	O	O
DN	O	O	B-T047
pathogenesis	O	O	B-T046
,	O	O	O
GCN2	O	O	B-T116
kinase	O	O	I-T116
may	O	O	O
serve	O	O	O
as	O	O	O
a	O	O	O
pharmaceutical	O	O	B-T091
target	O	O	B-T169
for	O	O	O
the	O	O	O
treatment	O	O	B-T061
of	O	O	O
DN	O	O	O
.	O	O	O

-DOCSTART- (27467249)

Juicer	O	O	B-T170
Provides	O	O	B-T052
a	O	O	O
One-Click	O	O	O
System	O	O	O
for	O	O	O
Analyzing	O	O	B-T062
Loop-Resolution	O	O	O
Hi-C	O	O	O
Experiments	O	O	O

Hi-C	O	O	B-T059
experiments	O	O	I-T059
explore	O	O	O
the	O	O	O
3D	O	O	B-T082
structure	O	O	I-T082
of	O	O	O
the	O	O	O
genome	O	O	B-T028
,	O	O	O
generating	O	O	B-T052
terabases	O	O	B-T170
of	O	O	I-T170
data	O	O	I-T170
to	O	O	O
create	O	O	O
high-resolution	O	O	B-T059
contact	O	O	B-T170
maps	O	O	I-T170
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
introduce	O	O	O
Juicer	O	O	B-T170
,	O	O	O
an	O	O	O
open-source	O	O	B-T170
tool	O	O	I-T170
for	O	O	O
analyzing	O	O	O
terabase-scale	O	O	B-T081
Hi-C	O	O	B-T170
datasets	O	O	I-T170
.	O	O	O

Juicer	O	O	B-T170
allows	O	O	O
users	O	O	B-T098
without	O	O	B-T080
a	O	O	O
computational	O	O	B-T052
background	O	O	B-T077
to	O	O	O
transform	O	O	B-T062
raw	O	O	B-T170
sequence	O	O	I-T170
data	O	O	I-T170
into	O	O	O
normalized	O	O	O
contact	O	O	B-T170
maps	O	O	I-T170
with	O	O	O
one	O	O	O
click	O	O	O
.	O	O	O

Juicer	O	O	B-T170
produces	O	O	O
a	O	O	O
hic	O	O	B-T170
file	O	O	I-T170
containing	O	O	O
compressed	O	O	B-T169
contact	O	O	B-T082
matrices	O	O	I-T082
at	O	O	O
many	O	O	O
resolutions	O	O	B-T081
,	O	O	O
facilitating	O	O	O
visualization	O	O	B-T041
and	O	O	O
analysis	O	O	B-T062
at	O	O	O
multiple	O	O	B-T081
scales	O	O	I-T081
.	O	O	O

Structural	O	O	B-T082
features	O	O	I-T082
,	O	O	O
such	O	O	O
as	O	O	O
loops	O	O	B-T026
and	O	O	O
domains	O	O	B-T044
,	O	O	O
are	O	O	O
automatically	O	O	B-T066
annotated	O	O	B-T080
.	O	O	O

Juicer	O	O	B-T170
is	O	O	O
available	O	O	O
as	O	O	O
open	O	O	B-T080
source	O	O	B-T081
software	O	O	B-T073
at	O	O	O
http://aidenlab.org/juicer/.	O	O	O

-DOCSTART- (27467655)

BJN	O	O	B-T073
Awards	O	O	I-T073
2016	O	O	O
:	O	O	O
IV	O	O	O
therapy	O	O	O

Claire	O	O	O
Rickard	O	O	O
Professor	O	O	B-T097
of	O	O	O
Nursing	O	O	B-T097
,	O	O	O
National	O	O	O
Health	O	O	O
and	O	O	O
Medical	O	O	O
Research	O	O	O
Council	O	O	O
(	O	O	O
NHMRC	O	O	O
)	O	O	O
Centre	O	O	B-T097
of	O	O	I-T097
Research	O	O	I-T097
Excellence	O	O	I-T097
in	O	O	O
Nursing	O	O	O
,	O	O	O
Griffith	O	O	O
University	O	O	O
,	O	O	O
was	O	O	O
awarded	O	O	B-T073
second	O	O	O
place	O	O	O
in	O	O	O
the	O	O	O
BJN	O	O	B-T073
Awards	O	O	I-T073
2016	O	O	O
for	O	O	O
IV	O	O	B-T061
Therapy	O	O	I-T061
Nurse	O	O	B-T097
of	O	O	O
the	O	O	O
Year	O	O	B-T079
.	O	O	O

Here	O	O	O
she	O	O	O
talks	O	O	O
about	O	O	O
the	O	O	O
she	O	O	O
has	O	O	O
done	O	O	O
to	O	O	O
be	O	O	O
recognised	O	O	O
in	O	O	O
this	O	O	O
field	O	O	B-T058
.	O	O	O

-DOCSTART- (27470228)

Stressful	O	O	B-T169
life	O	O	B-T032
events	O	O	I-T032
and	O	O	O
leucocyte	O	O	B-T047
telomere	O	O	I-T047
length	O	O	I-T047
:	O	O	O
Do	O	O	O
lifestyle	O	O	B-T201
factors	O	O	I-T201
,	O	O	O
somatic	O	O	B-T080
and	O	O	O
mental	O	O	B-T041
health	O	O	I-T041
,	O	O	O
or	O	O	O
low	O	O	B-T046
grade	O	O	I-T046
inflammation	O	O	I-T046
mediate	O	O	O
this	O	O	O
relationship	O	O	B-T080
?	O	O	O
Results	O	O	O
from	O	O	O
a	O	O	O
cohort	O	O	B-T098
of	O	O	O
Danish	O	O	B-T098
men	O	O	I-T098
born	O	O	B-T040
in	O	O	O
1953	O	O	O

Results	O	O	O
from	O	O	O
a	O	O	O
cohort	O	O	B-T098
of	O	O	O
Danish	O	O	B-T098
men	O	O	I-T098
born	O	O	B-T040
in	O	O	O
1953	O	O	O
Exposure	O	O	B-T080
to	O	O	I-T080
psychosocial	O	O	B-T169
stress	O	O	B-T033
is	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
increased	O	O	O
risk	O	O	B-T078
of	O	O	O
a	O	O	O
number	O	O	O
of	O	O	O
somatic	O	O	B-T080
and	O	O	O
mental	O	O	B-T048
disorders	O	O	I-T048
with	O	O	O
relation	O	O	B-T080
to	O	O	O
immune	O	O	B-T022
system	O	O	I-T022
functioning	O	O	B-T169
.	O	O	O

We	O	O	O
aimed	O	O	O
to	O	O	O
explore	O	O	O
whether	O	O	O
stressful	O	O	B-T051
events	O	O	I-T051
in	O	O	O
early	O	O	O
and	O	O	O
recent	O	O	O
life	O	O	B-T078
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
leucocyte	O	O	B-T047
telomere	O	O	I-T047
length	O	O	I-T047
(	O	O	O
TL	O	O	B-T047
)	O	O	O
,	O	O	O
which	O	O	O
is	O	O	O
assumed	O	O	O
to	O	O	O
reflect	O	O	O
the	O	O	O
accumulated	O	O	B-T033
burden	O	O	O
of	O	O	O
inflammation	O	O	B-T046
and	O	O	O
oxidative	O	O	B-T049
stress	O	O	I-T049
occurring	O	O	O
during	O	O	O
the	O	O	O
life	O	O	B-T079
course	O	O	I-T079
.	O	O	O

We	O	O	O
specifically	O	O	O
aimed	O	O	O
to	O	O	O
address	O	O	B-T078
whether	O	O	O
childhood	O	O	B-T079
constitutes	O	O	O
a	O	O	O
sensitive	O	O	B-T079
period	O	O	I-T079
and	O	O	O
how	O	O	O
much	O	O	O
of	O	O	O
the	O	O	O
relation	O	O	B-T080
between	O	O	O
stressful	O	O	B-T169
life	O	O	O
events	O	O	O
and	O	O	O
TL	O	O	B-T047
is	O	O	O
mediated	O	O	O
through	O	O	O
somatic	O	O	B-T080
and	O	O	O
mental	O	O	B-T041
health	O	O	I-T041
,	O	O	O
lifestyle	O	O	B-T054
,	O	O	O
and	O	O	O
markers	O	O	B-T201
of	O	O	O
low-grade	O	O	B-T046
inflammation	O	O	I-T046
.	O	O	O

A	O	O	O
cohort	O	O	B-T098
of	O	O	O
Danish	O	O	B-T098
men	O	O	I-T098
born	O	O	B-T040
in	O	O	O
1953	O	O	O
has	O	O	O
been	O	O	O
followed	O	O	O
since	O	O	O
birth	O	O	B-T040
in	O	O	O
the	O	O	O
Metropolit	O	O	B-T098
Cohort	O	O	I-T098
.	O	O	O

These	O	O	O
men	O	O	B-T098
underwent	O	O	O
a	O	O	O
health	O	O	B-T058
examination	O	O	I-T058
including	O	O	O
blood	O	O	B-T060
sampling	O	O	I-T060
in	O	O	O
2010	O	O	O
and	O	O	O
a	O	O	O
subset	O	O	O
of	O	O	O
324	O	O	O
also	O	O	O
had	O	O	O
a	O	O	O
quantitative	O	O	B-T059
PCR-based	O	O	I-T059
measurement	O	O	I-T059
of	O	O	O
TL	O	O	B-T047
.	O	O	O

The	O	O	O
relation	O	O	B-T080
between	O	O	O
stressful	O	O	B-T169
life	O	O	B-T032
events	O	O	I-T032
and	O	O	O
TL	O	O	B-T047
was	O	O	O
analysed	O	O	O
using	O	O	O
structural	O	O	B-T062
equation	O	O	I-T062
modelling	O	O	I-T062
,	O	O	O
which	O	O	O
also	O	O	O
provided	O	O	O
an	O	O	O
estimate	O	O	B-T081
of	O	O	O
the	O	O	O
proportion	O	O	B-T081
of	O	O	O
the	O	O	O
total	O	O	O
effect	O	O	B-T080
mediated	O	O	O
by	O	O	O
somatic	O	O	B-T080
and	O	O	O
mental	O	O	B-T041
health	O	O	I-T041
(	O	O	O
cardiovascular	O	O	B-T047
disease	O	O	I-T047
,	O	O	O
body	O	O	B-T033
mass	O	O	I-T033
and	O	O	O
depressive	O	O	B-T033
mood	O	O	I-T033
)	O	O	O
,	O	O	O
lifestyle	O	O	B-T201
factors	O	O	I-T201
,	O	O	O
and	O	O	O
low	O	O	B-T046
grade	O	O	I-T046
inflammation	O	O	I-T046
(	O	O	O
C-reactive	O	O	B-T116
protein	O	O	I-T116
(	O	O	O
CRP	O	O	B-T116
)	O	O	O
,	O	O	O
interleukin	O	O	B-T116
(IL)-6	O	O	I-T116
and	O	O	O
IL-10	O	O	B-T116
)	O	O	O
.	O	O	O

Total	O	O	B-T081
number	O	O	I-T081
of	O	O	O
stressful	O	O	B-T051
events	O	O	I-T051
experienced	O	O	B-T067
during	O	O	B-T079
the	O	O	O
life	O	O	B-T079
course	O	O	I-T079
was	O	O	O
not	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
TL	O	O	B-T047
.	O	O	O

In	O	O	O
terms	O	O	O
of	O	O	O
sensitive	O	O	B-T079
periods	O	O	I-T079
,	O	O	O
we	O	O	O
found	O	O	O
that	O	O	O
number	O	O	B-T081
of	O	O	O
stressful	O	O	B-T051
events	O	O	I-T051
in	O	O	O
childhood	O	O	B-T079
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
shorter	O	O	B-T047
TL	O	O	I-T047
(	O	O	O
Î²per	O	O	O
number	O	O	O
stressful	O	O	O
events	O	O	O
in	O	O	O
childhood	O	O	O
=	O	O	O
-0.02(SE=-0.02	O	O	O
)	O	O	O
;	O	O	O
P=0.05	O	O	O
)	O	O	O
.	O	O	O

This	O	O	O
relation	O	O	B-T080
was	O	O	O
particularly	O	O	O
strong	O	O	O
for	O	O	O
being	O	O	O
placed	O	O	O
away	O	O	O
from	O	O	O
home	O	O	B-T082
(	O	O	O
Î²=-0.16	O	O	O
;	O	O	O
P<0.000	O	O	O
)	O	O	O
.	O	O	O

Thirty	O	O	O
percent	O	O	O
of	O	O	O
the	O	O	O
total	O	O	O
effect	O	O	B-T080
of	O	O	O
stressful	O	O	B-T051
events	O	O	I-T051
in	O	O	O
childhood	O	O	B-T079
on	O	O	O
TL	O	O	B-T047
was	O	O	O
mediated	O	O	O
by	O	O	O
the	O	O	O
included	O	O	O
variables	O	O	B-T081
,	O	O	O
with	O	O	O
the	O	O	O
largest	O	O	O
proportion	O	O	B-T081
being	O	O	O
mediated	O	O	O
through	O	O	O
depressive	O	O	B-T033
mood	O	O	I-T033
(	O	O	O
16	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
CRP	O	O	B-T116
(	O	O	O
9	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

This	O	O	O
study	O	O	O
suggests	O	O	O
that	O	O	O
stressful	O	O	B-T051
events	O	O	I-T051
in	O	O	O
childhood	O	O	B-T079
are	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
shorter	O	O	B-T047
TL	O	O	I-T047
in	O	O	O
middle-aged	O	O	B-T100
men	O	O	I-T100
and	O	O	O
that	O	O	O
part	O	O	O
of	O	O	O
this	O	O	O
relation	O	O	B-T080
is	O	O	O
explained	O	O	O
by	O	O	O
depressive	O	O	B-T048
mood	O	O	I-T048
and	O	O	O
low	O	O	B-T046
grade	O	O	I-T046
inflammation	O	O	I-T046
.	O	O	O

-DOCSTART- (27470589)

Description	O	O	B-T170
of	O	O	O
Ancylomarina	O	O	B-T007
subtilis	O	O	I-T007
gen.	O	O	I-T007
nov.	O	O	I-T007
,	O	O	I-T007
sp.	O	O	I-T007
nov.	O	O	I-T007
,	O	O	O
isolated	O	O	B-T169
from	O	O	O
coastal	O	O	B-T082
sediment	O	O	I-T082
,	O	O	O
proposal	O	O	B-T078
of	O	O	O
Marinilabiliales	O	O	B-T007
ord	O	O	I-T007
.	O	O	I-T007
nov.	O	O	I-T007
and	O	O	O
transfer	O	O	B-T078
of	O	O	O
Marinilabiliaceae	O	O	B-T007
,	O	O	O
Prolixibacteraceae	O	O	B-T007
and	O	O	O
Marinifilaceae	O	O	B-T007
to	O	O	O
the	O	O	O
order	O	O	B-T185
Marinilabiliales	O	O	O

nov.	O	O	O
and	O	O	O
transfer	O	O	B-T078
of	O	O	O
Marinilabiliaceae	O	O	B-T007
,	O	O	O
Prolixibacteraceae	O	O	B-T007
and	O	O	O
Marinifilaceae	O	O	B-T007
to	O	O	O
the	O	O	O
order	O	O	B-T185
Marinilabiliales	O	O	B-T007
A	O	O	O
Gram-stain-negative	O	O	B-T007
,	O	O	O
facultatively	O	O	B-T007
anaerobic	O	O	I-T007
,	O	O	O
moderately	O	O	B-T194
halophilic	O	O	I-T194
,	O	O	O
filamentous	O	O	B-T080
,	O	O	O
non-motile	O	O	B-T007
bacterium	O	O	I-T007
,	O	O	O
designated	O	O	B-T169
FA102	O	O	B-T007
T	O	O	I-T007
,	O	O	O
was	O	O	O
isolated	O	O	B-T169
from	O	O	O
marine	O	O	B-T070
sediment	O	O	I-T070
of	O	O	O
the	O	O	O
coast	O	O	B-T082
of	O	O	O
Weihai	O	O	B-T083
,	O	O	I-T083
China	O	O	I-T083
.	O	O	O

Phylogenetic	O	O	B-T062
analysis	O	O	I-T062
based	O	O	B-T169
on	O	O	O
16S	O	O	B-T114
rRNA	O	O	I-T114
gene	O	O	I-T114
sequences	O	O	I-T114
showed	O	O	B-T169
that	O	O	O
strain	O	O	B-T080
FA102	O	O	B-T007
T	O	O	I-T007
formed	O	O	O
a	O	O	O
distinct	O	O	B-T080
evolutionary	O	O	B-T045
lineage	O	O	B-T077
within	O	O	O
the	O	O	O
family	O	O	B-T077
Marinifilaceae	O	O	B-T007
and	O	O	O
its	O	O	O
closest	O	O	B-T033
relative	O	O	I-T033
was	O	O	O
Marinifilum	O	O	B-T007
fragile	O	O	I-T007
JCM	O	O	I-T007
15579	O	O	I-T007
T	O	O	I-T007
(	O	O	O
93.2	O	O	O
%	O	O	O
sequence	O	O	B-T081
similarity	O	O	I-T081
)	O	O	O
.	O	O	O

The	O	O	O
DNA	O	O	B-T114
G+C	O	O	B-T081
content	O	O	I-T081
of	O	O	O
the	O	O	O
novel	O	O	B-T080
strain	O	O	B-T080
was	O	O	O
36.5	O	O	O
mol%	O	O	O
.	O	O	O

The	O	O	O
predominant	O	O	B-T080
cellular	O	O	B-T025
fatty	O	O	B-T109
acids	O	O	I-T109
and	O	O	O
respiratory	O	O	B-T169
quinone	O	O	B-T109
were	O	O	O
iso-C15:0	O	O	B-T109
and	O	O	O
iso-C15:0	O	O	B-T116
3-OH	O	O	I-T116
,	O	O	O
and	O	O	O
MK-7	O	O	B-T127
,	O	O	O
respectively	O	O	B-T080
.	O	O	O

On	O	O	O
the	O	O	O
basis	O	O	B-T169
of	O	O	O
the	O	O	O
phylogenetic	O	O	B-UnknownType
,	O	O	O
phenotypic	O	O	B-T032
and	O	O	O
physiological	O	O	B-T169
data	O	O	B-T078
,	O	O	O
strain	O	O	B-T080
FA102	O	O	B-T007
T	O	O	I-T007
represents	O	O	B-T052
a	O	O	O
novel	O	O	B-T080
genus	O	O	B-T185
and	O	O	O
species	O	O	B-T185
,	O	O	O
for	O	O	O
which	O	O	O
the	O	O	O
name	O	O	O
Ancylomarina	O	O	B-T007
subtilis	O	O	I-T007
gen.	O	O	I-T007
nov.	O	O	I-T007
,	O	O	I-T007
sp.	O	O	I-T007
nov.	O	O	I-T007
is	O	O	O
proposed	O	O	B-T080
.	O	O	O

The	O	O	O
type	O	O	B-T080
strain	O	O	B-T080
of	O	O	O
Ancylomarina	O	O	B-T007
subtilis	O	O	I-T007
is	O	O	O
FA102	O	O	B-T007
T	O	O	I-T007
(=	O	O	O
KCTC	O	O	B-T007
42257	O	O	I-T007
T	O	O	I-T007
=	O	O	O
DSM	O	O	B-T007
28825	O	O	I-T007
T	O	O	I-T007
=	O	O	O
CICC	O	O	B-T007
10902	O	O	I-T007
T	O	O	I-T007
)	O	O	O
.	O	O	O

Furthermore	O	O	O
,	O	O	O
a	O	O	O
new	O	O	B-T080
order	O	O	B-T185
named	O	O	O
Marinilabiliales	O	O	B-T007
is	O	O	O
proposed	O	O	B-T080
to	O	O	O
accommodate	O	O	B-T033
three	O	O	O
families	O	O	B-T077
previously	O	O	B-T079
classified	O	O	B-T185
in	O	O	O
the	O	O	O
order	O	O	O
Bacteroidales	O	O	B-T007
.	O	O	O

Marinilabiliales	O	O	O
ord	O	O	O
.	O	O	O

nov.	O	O	O
encompasses	O	O	O
the	O	O	O
families	O	O	B-T077
Marinilabiliaceae	O	O	B-T007
,	O	O	O
Prolixibacteraceae	O	O	B-T007
and	O	O	O
Marinifilaceae	O	O	B-T007
.	O	O	O

-DOCSTART- (27470609)

Treatment	O	O	B-T061
for	O	O	O
Rheumatoid	O	O	B-T047
Arthritis	O	O	I-T047
and	O	O	O
Risk	O	O	B-T033
of	O	O	O
Alzheimer	O	O	B-T047
's	O	O	I-T047
Disease	O	O	I-T047
:	O	O	O
A	O	O	O
Nested	O	O	O
Case-Control	O	O	O
Analysis	O	O	O

It	O	O	O
is	O	O	O
increasingly	O	O	B-T169
becoming	O	O	O
accepted	O	O	B-T080
that	O	O	O
inflammation	O	O	B-T046
may	O	O	O
play	O	O	O
an	O	O	O
important	O	O	O
role	O	O	O
in	O	O	O
the	O	O	O
pathogenesis	O	O	B-T046
of	O	O	O
Alzheimer	O	O	B-T047
's	O	O	I-T047
disease	O	O	I-T047
(	O	O	O
AD	O	O	B-T047
)	O	O	O
,	O	O	O
as	O	O	O
several	O	O	B-T081
immune	O	O	B-T022
-related	O	O	O
genes	O	O	B-T028
have	O	O	O
been	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
AD	O	O	O
.	O	O	O

Among	O	O	O
these	O	O	O
is	O	O	O
tumor	O	O	B-T116
necrosis	O	O	I-T116
factor	O	O	I-T116
(TNF)-Î±	O	O	I-T116
,	O	O	O
a	O	O	O
proinflammatory	O	O	B-T116
cytokine	O	O	I-T116
known	O	O	O
to	O	O	O
play	O	O	O
an	O	O	O
important	O	O	O
role	O	O	O
in	O	O	O
autoimmune	O	O	B-T047
disorders	O	O	I-T047
,	O	O	O
including	O	O	O
rheumatoid	O	O	B-T047
arthritis	O	O	I-T047
(	O	O	O
RA	O	O	B-T047
)	O	O	O
.	O	O	O

Although	O	O	O
AD	O	O	B-T047
and	O	O	O
RA	O	O	B-T047
appear	O	O	O
to	O	O	O
involve	O	O	O
similar	O	O	B-T080
pathological	O	O	B-T046
mechanisms	O	O	I-T046
through	O	O	O
the	O	O	O
production	O	O	B-T038
of	O	O	O
TNF-Î±	O	O	B-T116
,	O	O	I-T116
the	O	O	O
relationship	O	O	B-T080
between	O	O	O
AD	O	O	O
and	O	O	O
RA	O	O	O
remains	O	O	O
unknown	O	O	B-T080
.	O	O	O

To	O	O	O
determine	O	O	O
the	O	O	O
relative	O	O	B-T081
risk	O	O	B-T033
of	O	O	O
AD	O	O	B-T047
among	O	O	O
RA	O	O	B-T047
patients	O	O	B-T101
and	O	O	O
non-	O	O	O
RA	O	O	O
patients	O	O	O
,	O	O	O
and	O	O	O
whether	O	O	O
anti-TNF	O	O	B-T061
therapy	O	O	I-T061
for	O	O	O
RA	O	O	O
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
a	O	O	O
lower	O	O	B-T080
risk	O	O	O
of	O	O	O
AD	O	O	O
in	O	O	O
RA	O	O	O
patients	O	O	O
.	O	O	O

We	O	O	O
performed	O	O	O
a	O	O	O
nested	O	O	B-T062
case-control	O	O	I-T062
study	O	O	I-T062
of	O	O	O
more	O	O	O
than	O	O	O
8.5	O	O	O
million	O	O	O
commercially	O	O	O
insured	O	O	B-T170
adults	O	O	B-T100
(	O	O	O
aged	O	O	O
â¥18	O	O	O
years	O	O	O
)	O	O	O
in	O	O	O
all	O	O	O
50	O	O	O
US	O	O	B-T083
states	O	O	I-T083
,	O	O	O
Puerto	O	O	B-T083
Rico	O	O	I-T083
,	O	O	O
and	O	O	O
US	O	O	B-T083
Virgin	O	O	I-T083
Islands	O	O	I-T083
in	O	O	O
the	O	O	O
Verisk	O	O	B-T170
Health	O	O	I-T170
claims	O	O	I-T170
database	O	O	I-T170
.	O	O	O

We	O	O	O
derived	O	O	O
a	O	O	O
sub-cohort	O	O	B-T098
of	O	O	O
subjects	O	O	O
with	O	O	O
a	O	O	O
diagnosis	O	O	B-T033
of	O	O	O
RA	O	O	B-T047
(	O	O	O
controls	O	O	B-T096
)	O	O	O
,	O	O	O
or	O	O	O
RA	O	O	O
and	O	O	O
AD	O	O	B-T047
(	O	O	O
cases	O	O	B-T077
)	O	O	O
,	O	O	O
matching	O	O	B-T062
cases	O	O	O
and	O	O	O
controls	O	O	O
based	O	O	O
on	O	O	O
age	O	O	B-T032
,	O	O	O
sex	O	O	B-T032
,	O	O	O
exposure	O	O	B-T058
assessment	O	O	I-T058
period	O	O	I-T058
,	O	O	O
and	O	O	O
methotrexate	O	O	B-T061
treatment	O	O	I-T061
.	O	O	O

We	O	O	O
also	O	O	O
assessed	O	O	B-T058
relative	O	O	I-T058
risk	O	O	I-T058
of	O	O	O
AD	O	O	B-T047
following	O	O	O
exposure	O	O	B-T080
to	O	O	I-T080
standard	O	O	B-T080
RA	O	O	B-T047
therapies	O	O	B-T061
,	O	O	O
including	O	O	O
anti-TNF	O	O	B-T121
agents	O	O	I-T121
(	O	O	O
infliximab	O	O	B-T116
,	O	O	O
adalimumab	O	O	B-T116
,	O	O	O
etanercept	O	O	B-T116
)	O	O	O
,	O	O	O
methotrexate	O	O	B-T109
,	O	O	O
prednisone	O	O	B-T125
,	O	O	O
sulfasalazine	O	O	B-T109
,	O	O	O
and	O	O	O
rituximab	O	O	B-T116
.	O	O	O

Odds	O	O	B-T081
ratios	O	O	I-T081
were	O	O	O
adjusted	O	O	O
for	O	O	O
comorbidities	O	O	B-T078
,	O	O	O
including	O	O	O
coronary	O	O	B-T047
artery	O	O	I-T047
disease	O	O	I-T047
,	O	O	O
diabetes	O	O	B-T047
mellitus	O	O	I-T047
,	O	O	O
and	O	O	O
peripheral	O	O	B-T047
vascular	O	O	I-T047
disease	O	O	I-T047
.	O	O	O

AD	O	O	B-T047
was	O	O	O
more	O	O	O
prevalent	O	O	B-T080
(	O	O	O
p	O	O	O
<	O	O	O
0.0001	O	O	O
)	O	O	O
among	O	O	O
RA	O	O	B-T047
patients	O	O	B-T101
(	O	O	O
0.79	O	O	O
%	O	O	O
)	O	O	O
than	O	O	O
among	O	O	O
those	O	O	O
without	O	O	B-T080
RA	O	O	O
(	O	O	O
0.11	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

Chronic	O	O	B-T033
conditions	O	O	I-T033
such	O	O	O
as	O	O	O
coronary	O	O	B-T047
artery	O	O	I-T047
disease	O	O	I-T047
(	O	O	O
odds	O	O	B-T081
ratio	O	O	I-T081
[	O	O	O
OR	O	O	B-T081
]	O	O	O
1.48	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
confidence	O	O	B-T081
interval	O	O	I-T081
[	O	O	O
CI	O	O	B-T081
]	O	O	O
1.04	O	O	O
-	O	O	O
2.05	O	O	O
;	O	O	O
p	O	O	O
=	O	O	O
0.03	O	O	O
)	O	O	O
,	O	O	O
diabetes	O	O	B-T047
(	O	O	O
OR	O	O	O
1.86	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
1.32	O	O	O
-	O	O	O
2.62	O	O	O
;	O	O	O
p	O	O	O
=	O	O	O
0.0004	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
peripheral	O	O	B-T047
vascular	O	O	I-T047
disease	O	O	I-T047
(	O	O	O
OR	O	O	O
1.61	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
1.06	O	O	O
-	O	O	O
2.43	O	O	O
;	O	O	O
p	O	O	O
=	O	O	O
0.02	O	O	O
)	O	O	O
significantly	O	O	O
increased	O	O	O
the	O	O	O
relative	O	O	B-T081
risk	O	O	I-T081
of	O	O	O
AD	O	O	B-T047
among	O	O	O
RA	O	O	B-T047
patients	O	O	B-T101
.	O	O	O

Exposure	O	O	B-T080
to	O	O	I-T080
anti-TNF	O	O	B-T121
agents	O	O	I-T121
as	O	O	O
a	O	O	O
class	O	O	B-T081
,	O	O	O
but	O	O	O
not	O	O	O
other	O	O	O
immunosuppressive	O	O	B-T129
drugs	O	O	I-T129
studied	O	O	O
,	O	O	O
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
lowered	O	O	B-T081
risk	O	O	B-T033
of	O	O	O
AD	O	O	B-T047
among	O	O	O
RA	O	O	B-T047
patients	O	O	B-T101
(	O	O	O
unadjusted	O	O	O
OR	O	O	B-T081
0.44	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
0.22	O	O	O
-	O	O	O
0.87	O	O	O
;	O	O	O
p	O	O	O
=	O	O	O
0.02	O	O	O
;	O	O	O
adjusted	O	O	O
OR	O	O	O
0.45	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
0.23	O	O	O
-	O	O	O
0.90	O	O	O
;	O	O	O
p	O	O	O
=	O	O	O
0.02	O	O	O
)	O	O	O
.	O	O	O

Sub-group	O	O	B-T081
analysis	O	O	I-T081
demonstrated	O	O	O
that	O	O	O
of	O	O	O
the	O	O	O
three	O	O	O
anti-TNF	O	O	B-T121
agents	O	O	I-T121
studied	O	O	O
,	O	O	O
only	O	O	O
etanercept	O	O	B-T116
(	O	O	O
unadjusted	O	O	O
OR	O	O	B-T081
,	O	O	O
0.33	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
0.08	O	O	O
-	O	O	O
0.94	O	O	O
;	O	O	O
p	O	O	O
=	O	O	O
0.03	O	O	O
;	O	O	O
adjusted	O	O	O
OR	O	O	O
0.30	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
0.08	O	O	O
-	O	O	O
0.89	O	O	O
;	O	O	O
p	O	O	O
=	O	O	O
0.02	O	O	O
)	O	O	O
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
a	O	O	O
decreased	O	O	B-T081
risk	O	O	B-T033
of	O	O	O
AD	O	O	B-T047
in	O	O	O
RA	O	O	B-T047
patients	O	O	B-T101
.	O	O	O

There	O	O	O
is	O	O	O
an	O	O	O
increased	O	O	B-T081
risk	O	O	B-T033
of	O	O	O
AD	O	O	B-T047
in	O	O	O
the	O	O	O
studied	O	O	O
RA	O	O	B-T047
population	O	O	B-T081
.	O	O	O

The	O	O	O
relative	O	O	B-T081
risk	O	O	I-T081
of	O	O	O
AD	O	O	B-T047
among	O	O	O
RA	O	O	B-T047
subjects	O	O	O
was	O	O	O
lowered	O	O	B-T081
in	O	O	O
those	O	O	O
exposed	O	O	B-T080
to	O	O	I-T080
etanercept	O	O	B-T116
.	O	O	O

Anti-TNF	O	O	B-T061
therapy	O	O	I-T061
with	O	O	O
etanercept	O	O	B-T116
shows	O	O	O
promise	O	O	B-T078
as	O	O	O
a	O	O	O
potential	O	O	B-T080
treatment	O	O	B-T061
for	O	O	O
AD	O	O	B-T047
.	O	O	O

-DOCSTART- (27472389)

Dimerization	O	O	B-T067
of	O	O	O
EGFR	O	O	B-T116
and	O	O	O
HER2	O	O	B-T116
induces	O	O	O
breast	O	O	B-T191
cancer	O	O	I-T191
cell	O	O	B-T040
motility	O	O	I-T040
through	O	O	O
STAT1	O	O	B-T116
-dependent	O	O	O
ACTA2	O	O	B-T116
induction	O	O	O

The	O	O	O
dimerization	O	O	B-T067
of	O	O	O
EGFR	O	O	B-T116
and	O	O	O
HER2	O	O	B-T116
is	O	O	O
associated	O	O	O
with	O	O	O
poor	O	O	O
prognosis	O	O	B-T058
such	O	O	O
as	O	O	O
induction	O	O	B-T169
of	O	O	O
tumor	O	O	B-T191
growth	O	O	I-T191
and	O	O	O
cell	O	O	B-T046
invasion	O	O	I-T046
compared	O	O	B-T052
to	O	O	O
when	O	O	O
EGFR	O	O	O
remains	O	O	O
as	O	O	O
a	O	O	O
homodimer	O	O	B-T104
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
mechanism	O	O	B-T169
for	O	O	O
events	O	O	O
after	O	O	O
dimerization	O	O	B-T067
in	O	O	O
breast	O	O	B-T191
cancer	O	O	I-T191
models	O	O	B-T075
is	O	O	O
not	O	O	O
clear	O	O	O
.	O	O	O

We	O	O	O
found	O	O	O
that	O	O	O
expressions	O	O	B-T045
of	O	O	O
alpha-smooth	O	O	B-T116
muscle	O	O	I-T116
actin	O	O	I-T116
(	O	O	O
ACTA2	O	O	B-T116
)	O	O	O
and	O	O	O
signal	O	O	B-T116
transducer	O	O	I-T116
and	O	O	I-T116
activator	O	O	I-T116
of	O	O	I-T116
transcription	O	O	I-T116
1	O	O	I-T116
(	O	O	O
STAT1	O	O	B-T116
)	O	O	O
significantly	O	O	O
increased	O	O	B-T081
with	O	O	O
transient	O	O	O
or	O	O	O
stable	O	O	O
overexpression	O	O	B-T045
of	O	O	O
HER2	O	O	B-T116
in	O	O	O
EGFR	O	O	B-T116
-	O	O	O
positive	O	O	B-T033
breast	O	O	B-T191
cancer	O	O	I-T191
cells	O	O	B-T025
.	O	O	O

ACTA2	O	O	B-T116
and	O	O	O
STAT1	O	O	B-T116
expression	O	O	B-T045
was	O	O	O
also	O	O	O
increased	O	O	B-T081
in	O	O	O
HER2	O	O	B-T116
-	O	O	O
positive	O	O	B-T033
breast	O	O	B-T191
cancer	O	O	I-T191
patients	O	O	B-T101
.	O	O	O

In	O	O	O
contrast	O	O	O
,	O	O	O
ACTA2	O	O	B-T116
expression	O	O	B-T045
was	O	O	O
decreased	O	O	B-T081
by	O	O	O
HER2	O	O	B-T114
siRNA	O	O	I-T114
.	O	O	O

Next	O	O	O
,	O	O	O
we	O	O	O
investigated	O	O	O
the	O	O	O
co-relation	O	O	O
between	O	O	O
STAT1	O	O	B-T116
and	O	O	O
ACTA2	O	O	B-T116
expression	O	O	B-T045
.	O	O	O

Basal	O	O	O
ACTA2	O	O	B-T116
expression	O	O	B-T045
was	O	O	O
significantly	O	O	O
decreased	O	O	B-T081
by	O	O	O
treatment	O	O	B-T061
with	O	O	O
the	O	O	O
STAT1	O	O	B-T121
inhibitor	O	O	I-T121
fludarabine	O	O	B-T114
or	O	O	O
the	O	O	O
JAK2	O	O	B-T121
inhibitor	O	O	I-T121
AG490	O	O	B-T109
.	O	O	O

In	O	O	O
contrast	O	O	O
,	O	O	O
ACTA2	O	O	B-T116
expression	O	O	B-T045
was	O	O	O
increased	O	O	B-T081
by	O	O	O
STAT1	O	O	B-T116
overexpression	O	O	B-T045
.	O	O	O

Levels	O	O	O
of	O	O	O
ACTA2	O	O	B-T116
,	O	O	O
STAT1	O	O	B-T116
,	O	O	O
and	O	O	O
HER2	O	O	B-T116
were	O	O	O
increased	O	O	B-T081
and	O	O	O
relapse	O	O	O
free	O	O	B-T081
survival	O	O	I-T081
was	O	O	O
decreased	O	O	B-T081
in	O	O	O
high-risk	O	O	B-T033
breast	O	O	B-T191
cancer	O	O	I-T191
patients	O	O	B-T101
.	O	O	O

We	O	O	O
also	O	O	O
investigated	O	O	B-T169
the	O	O	O
effect	O	O	O
of	O	O	O
ACTA2	O	O	B-T116
on	O	O	O
cell	O	O	B-T040
motility	O	O	I-T040
,	O	O	O
which	O	O	O
was	O	O	O
suppressed	O	O	B-T169
by	O	O	O
ACTA2	O	O	B-T114
shRNA	O	O	I-T114
overexpression	O	O	B-T045
in	O	O	O
MDA-MB231	O	O	B-T025
HER2	O	O	B-T116
and	O	O	O
4T1	O	O	B-T025
mammary	O	O	I-T025
carcinoma	O	O	I-T025
cells	O	O	I-T025
.	O	O	O

The	O	O	O
number	O	O	O
of	O	O	O
lung	O	O	B-T033
metastatic	O	O	I-T033
nodules	O	O	I-T033
was	O	O	O
significantly	O	O	O
decreased	O	O	B-T081
in	O	O	O
ACTA2	O	O	B-T116
knockdown	O	O	B-T015
mice	O	O	I-T015
.	O	O	O

Taken	O	O	O
together	O	O	O
,	O	O	O
these	O	O	O
results	O	O	O
demonstrated	O	O	O
that	O	O	O
induction	O	O	B-T169
of	O	O	O
ACTA2	O	O	B-T116
by	O	O	O
EGFR	O	O	B-T116
and	O	O	O
HER2	O	O	B-T116
dimerization	O	O	B-T067
was	O	O	O
regulated	O	O	O
through	O	O	O
a	O	O	O
JAK2	O	O	B-T116
/	O	O	O
STAT1	O	O	B-T116
signaling	O	O	B-T044
pathway	O	O	I-T044
,	O	O	O
and	O	O	O
aberrant	O	O	O
ACTA2	O	O	O
expression	O	O	B-T045
accelerated	O	O	O
the	O	O	O
invasiveness	O	O	B-T046
and	O	O	O
metastasis	O	O	B-T191
of	O	O	O
breast	O	O	B-T191
cancer	O	O	I-T191
cells	O	O	B-T025
.	O	O	O

-DOCSTART- (27473375)

Intensive	O	O	O
social	O	O	B-T169
cognitive	O	O	B-T061
treatment	O	O	B-T169
(	O	O	O
can	O	O	O
do	O	O	O
treatment	O	O	O
)	O	O	O
with	O	O	O
participation	O	O	B-T169
of	O	O	O
support	O	O	O
partners	O	O	B-T098
in	O	O	O
persons	O	O	B-T098
with	O	O	O
relapsing	O	O	B-T047
remitting	O	O	I-T047
multiple	O	O	I-T047
sclerosis	O	O	I-T047
:	O	O	O
observation	O	O	B-T058
of	O	O	O
improved	O	O	B-T033
self-efficacy	O	O	B-T041
,	O	O	O
quality	O	O	B-T078
of	O	O	I-T078
life	O	O	I-T078
,	O	O	O
anxiety	O	O	B-T033
and	O	O	O
depression	O	O	B-T048
1	O	O	O
year	O	O	B-T079
later	O	O	O

In	O	O	O
persons	O	O	B-T098
with	O	O	O
multiple	O	O	B-T047
sclerosis	O	O	I-T047
(	O	O	O
MS	O	O	B-T047
)	O	O	O
self-efficacy	O	O	B-T041
positively	O	O	B-T033
affects	O	O	O
health-related	O	O	B-T078
quality	O	O	I-T078
of	O	O	I-T078
life	O	O	I-T078
(	O	O	O
HRQoL	O	O	B-T078
)	O	O	O
and	O	O	O
physical	O	O	B-T056
activity	O	O	I-T056
.	O	O	O

In	O	O	O
a	O	O	O
previous	O	O	O
study	O	O	O
we	O	O	O
observed	O	O	B-T169
that	O	O	O
6	O	O	O
months	O	O	B-T079
after	O	O	O
an	O	O	O
intensive	O	O	O
3-	O	O	O
day	O	O	B-T079
social	O	O	B-T169
cognitive	O	O	B-T061
treatment	O	O	B-T169
(	O	O	O
Can	O	O	O
Do	O	O	O
treatment	O	O	O
)	O	O	O
with	O	O	O
the	O	O	O
participation	O	O	B-T169
of	O	O	O
support	O	O	O
partners	O	O	B-T098
,	O	O	O
self-efficacy	O	O	B-T041
and	O	O	O
HRQoL	O	O	B-T078
had	O	O	O
improved	O	O	B-T033
in	O	O	O
persons	O	O	B-T098
with	O	O	O
relapsing	O	O	B-T047
remitting	O	O	I-T047
MS	O	O	I-T047
(	O	O	O
RRMS	O	O	B-T047
)	O	O	O
.	O	O	O

Given	O	O	O
the	O	O	O
chronic	O	O	B-T079
nature	O	O	B-T080
of	O	O	I-T080
the	O	O	I-T080
disease	O	O	I-T080
,	O	O	O
it	O	O	O
is	O	O	O
important	O	O	O
to	O	O	O
know	O	O	O
whether	O	O	O
these	O	O	O
beneficial	O	O	B-T081
changes	O	O	B-T169
may	O	O	O
last	O	O	O
.	O	O	O

Can	O	O	O
Do	O	O	O
treatment	O	O	B-T169
was	O	O	O
given	O	O	O
to	O	O	O
60	O	O	O
persons	O	O	B-T098
with	O	O	O
MS	O	O	B-T047
and	O	O	O
their	O	O	O
support	O	O	O
partners	O	O	B-T098
.	O	O	O

At	O	O	O
baseline	O	O	B-T081
and	O	O	O
12	O	O	O
months	O	O	B-T079
after	O	O	O
treatment	O	O	B-T061
self-efficacy	O	O	B-T041
control	O	O	B-T169
,	O	O	O
self-efficacy	O	O	O
function	O	O	B-T169
,	O	O	O
physical	O	O	B-T169
and	O	O	O
mental	O	O	B-T041
HRQoL	O	O	B-T078
,	O	O	O
anxiety	O	O	B-T033
,	O	O	O
depression	O	O	B-T048
and	O	O	O
fatigue	O	O	B-T184
were	O	O	O
assessed	O	O	B-T052
via	O	O	O
self-report	O	O	B-T062
questionnaires	O	O	B-T170
.	O	O	O

Differences	O	O	B-T080
were	O	O	O
tested	O	O	B-T169
via	O	O	O
a	O	O	O
paired	O	O	B-T170
t	O	O	I-T170
test	O	O	I-T170
.	O	O	O

Of	O	O	O
the	O	O	O
57	O	O	O
persons	O	O	B-T098
with	O	O	O
MS	O	O	B-T047
that	O	O	O
completed	O	O	B-T080
the	O	O	O
baseline	O	O	B-T081
assessment	O	O	B-T052
and	O	O	O
the	O	O	O
3-	O	O	O
day	O	O	B-T079
treatment	O	O	B-T169
,	O	O	O
38	O	O	O
filled	O	O	O
in	O	O	O
the	O	O	O
12th	O	O	O
month	O	O	B-T079
questionnaires	O	O	B-T170
(	O	O	O
response	O	O	B-T033
rate	O	O	B-T081
66.7	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
22	O	O	O
with	O	O	O
RRMS	O	O	B-T047
and	O	O	O
14	O	O	O
with	O	O	O
progressive	O	O	B-T169
MS	O	O	O
.	O	O	O

In	O	O	O
the	O	O	O
RR	O	O	B-T047
group	O	O	B-T078
self-efficacy	O	O	B-T041
control	O	O	B-T169
had	O	O	O
increased	O	O	B-T081
by	O	O	O
20.2	O	O	O
%	O	O	O
and	O	O	O
physical	O	O	B-T169
HRQoL	O	O	B-T078
by	O	O	O
15.0	O	O	O
%	O	O	O
,	O	O	O
and	O	O	O
depression	O	O	B-T048
and	O	O	O
anxiety	O	O	B-T033
had	O	O	O
decreased	O	O	B-T081
by	O	O	O
29.8	O	O	O
and	O	O	O
25.9	O	O	O
%	O	O	O
,	O	O	O
respectively	O	O	O
(	O	O	O
all	O	O	O
P	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
;	O	O	O
the	O	O	O
changes	O	O	B-T169
in	O	O	O
mental	O	O	B-T041
HRQoL	O	O	O
(	O	O	O
+	O	O	O
17	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
fatigue	O	O	B-T184
(	O	O	O
-20	O	O	O
%	O	O	O
)	O	O	O
failed	O	O	B-T169
to	O	O	O
be	O	O	O
statistically	O	O	B-T081
significant	O	O	I-T081
(	O	O	O
P	O	O	O
=	O	O	O
0.087	O	O	O
,	O	O	O
P	O	O	O
=	O	O	O
0.080	O	O	O
,	O	O	O
respectively	O	O	O
)	O	O	O
.	O	O	O

In	O	O	O
the	O	O	O
progressive	O	O	B-T169
group	O	O	B-T078
no	O	O	O
changes	O	O	B-T169
suggestive	O	O	B-T169
of	O	O	I-T169
improvement	O	O	B-T077
were	O	O	O
seen	O	O	O
.	O	O	O

The	O	O	O
findings	O	O	B-T169
suggest	O	O	B-T078
that	O	O	O
a	O	O	O
3-	O	O	O
day	O	O	B-T079
intensive	O	O	O
social	O	O	B-T169
cognitive	O	O	B-T061
treatment	O	O	B-T169
(	O	O	O
Can	O	O	O
Do	O	O	O
treatment	O	O	O
)	O	O	O
with	O	O	O
the	O	O	O
participation	O	O	B-T169
of	O	O	O
support	O	O	O
partners	O	O	B-T098
may	O	O	O
have	O	O	O
long	O	O	B-T079
lasting	O	O	I-T079
beneficial	O	O	B-T081
effects	O	O	B-T080
on	O	O	O
the	O	O	O
self-efficacy	O	O	B-T041
and	O	O	O
HRQoL	O	O	B-T078
in	O	O	O
persons	O	O	B-T098
with	O	O	O
RRMS	O	O	B-T047
;	O	O	O
and	O	O	O
that	O	O	O
improvements	O	O	B-T077
in	O	O	O
anxiety	O	O	B-T033
and	O	O	O
depression	O	O	B-T048
,	O	O	O
not	O	O	O
seen	O	O	O
in	O	O	O
the	O	O	O
6-	O	O	O
month	O	O	B-T079
study	O	O	O
,	O	O	O
may	O	O	O
yet	O	O	O
develop	O	O	B-T169
at	O	O	O
12	O	O	O
months	O	O	B-T079
.	O	O	O

-DOCSTART- (27473380)

Perineal	O	O	B-T037
injuries	O	O	I-T037
and	O	O	O
birth	O	O	B-T033
positions	O	O	I-T033
among	O	O	O
2992	O	O	O
women	O	O	B-T098
with	O	O	O
a	O	O	O
low	O	O	B-T033
risk	O	O	I-T033
pregnancy	O	O	I-T033
who	O	O	O
opted	O	O	O
for	O	O	O
a	O	O	O
homebirth	O	O	O

Whether	O	O	O
certain	O	O	O
birth	O	O	B-T033
positions	O	O	I-T033
are	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
perineal	O	O	B-T037
injuries	O	O	I-T037
and	O	O	O
severe	O	O	B-UnknownType
perineal	O	O	I-UnknownType
trauma	O	O	I-UnknownType
(	O	O	O
SPT	O	O	B-UnknownType
)	O	O	O
is	O	O	O
still	O	O	O
unclear	O	O	B-T033
.	O	O	O

The	O	O	O
objective	O	O	B-T170
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
describe	O	O	O
the	O	O	O
prevalence	O	O	B-T081
of	O	O	O
perineal	O	O	B-T037
injuries	O	O	I-T037
of	O	O	O
different	O	O	O
severity	O	O	B-T080
in	O	O	O
a	O	O	O
low-risk	O	O	B-T081
population	O	O	B-T098
of	O	O	O
women	O	O	B-T098
who	O	O	O
planned	O	O	O
to	O	O	O
give	O	O	O
birth	O	O	B-T033
at	O	O	I-T033
home	O	O	I-T033
and	O	O	O
to	O	O	O
compare	O	O	O
the	O	O	O
prevalence	O	O	O
of	O	O	O
perineal	O	O	O
injuries	O	O	O
,	O	O	O
SPT	O	O	B-UnknownType
and	O	O	O
episiotomy	O	O	B-T061
in	O	O	O
different	O	O	O
birth	O	O	B-T033
positions	O	O	I-T033
in	O	O	O
four	O	O	O
Nordic	O	O	B-T083
countries	O	O	I-T083
.	O	O	O

A	O	O	O
population	O	O	B-T098
-based	O	O	O
prospective	O	O	B-T062
cohort	O	O	I-T062
study	O	O	I-T062
of	O	O	O
planned	O	O	O
home	O	O	B-T033
births	O	O	I-T033
in	O	O	O
four	O	O	O
Nordic	O	O	B-T083
countries	O	O	I-T083
.	O	O	O

To	O	O	O
assess	O	O	B-T057
medical	O	O	I-T057
outcomes	O	O	I-T057
a	O	O	O
questionnaire	O	O	B-T170
completed	O	O	O
after	O	O	O
birth	O	O	B-T040
by	O	O	O
the	O	O	O
attending	O	O	O
midwife	O	O	B-T097
was	O	O	O
used	O	O	O
.	O	O	O

Descriptive	O	O	B-T062
statistics	O	O	I-T062
,	O	O	O
bivariate	O	O	B-UnknownType
analysis	O	O	I-UnknownType
and	O	O	O
logistic	O	O	B-T062
regression	O	O	I-T062
were	O	O	O
used	O	O	O
to	O	O	O
analyze	O	O	O
the	O	O	O
data	O	O	B-T078
.	O	O	O

Two	O	O	O
thousand	O	O	O
nine	O	O	O
hundred	O	O	O
ninety-two	O	O	O
women	O	O	B-T098
with	O	O	O
planned	O	O	O
home	O	O	B-T082
births	O	O	I-T033
,	O	O	O
who	O	O	O
birthed	O	O	O
spontaneously	O	O	O
at	O	O	O
home	O	O	O
or	O	O	O
after	O	O	O
transfer	O	O	B-T058
to	O	O	I-T058
hospital	O	O	I-T058
,	O	O	O
between	O	O	O
2008	O	O	O
and	O	O	O
2013	O	O	O
were	O	O	O
included	O	O	O
.	O	O	O

The	O	O	O
prevalence	O	O	B-T081
of	O	O	O
SPT	O	O	B-UnknownType
was	O	O	O
0.7	O	O	O
%	O	O	O
and	O	O	O
the	O	O	O
prevalence	O	O	O
of	O	O	O
episiotomy	O	O	B-T061
was	O	O	O
1.0	O	O	O
%	O	O	O
.	O	O	O

There	O	O	O
were	O	O	O
differences	O	O	O
between	O	O	O
the	O	O	O
countries	O	O	O
regarding	O	O	O
all	O	O	O
maternal	O	O	B-T033
characteristics	O	O	B-T080
.	O	O	O

No	O	O	O
association	O	O	O
between	O	O	O
flexible	O	O	B-T080
sacrum	O	O	B-T029
positions	O	O	B-T082
and	O	O	O
sutured	O	O	B-T169
perineal	O	O	B-T037
injuries	O	O	I-T037
was	O	O	O
found	O	O	O
(	O	O	O
OR	O	O	B-T081
1.02	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
0.86	O	O	O
-	O	O	O
1.21	O	O	O
)	O	O	O
or	O	O	O
SPT	O	O	B-UnknownType
(	O	O	O
OR	O	O	O
0.68	O	O	O
;	O	O	O
CI	O	O	O
95	O	O	O
%	O	O	O
0.26	O	O	O
-	O	O	O
1.79	O	O	O
)	O	O	O
.	O	O	O

Flexible	O	O	B-T080
sacrum	O	O	B-T029
positions	O	O	B-T082
were	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
fewer	O	O	O
episiotomies	O	O	B-T061
(	O	O	O
OR	O	O	B-T081
0.20	O	O	O
;	O	O	O
CI	O	O	B-T081
95	O	O	O
%	O	O	O
0.10	O	O	O
-	O	O	O
0.54	O	O	O
)	O	O	O
.	O	O	O

A	O	O	O
low	O	O	O
prevalence	O	O	B-T081
of	O	O	O
SPT	O	O	B-UnknownType
and	O	O	O
episiotomy	O	O	B-T061
was	O	O	O
found	O	O	O
among	O	O	O
women	O	O	B-T098
opting	O	O	O
for	O	O	O
a	O	O	O
home	O	O	B-T033
birth	O	O	I-T033
in	O	O	O
four	O	O	O
Nordic	O	O	B-T083
countries	O	O	I-T083
.	O	O	O

Women	O	O	B-T098
used	O	O	O
a	O	O	O
variety	O	O	O
of	O	O	O
birth	O	O	B-T040
positions	O	O	B-T082
and	O	O	O
a	O	O	O
majority	O	O	O
gave	O	O	O
birth	O	O	O
in	O	O	O
flexible	O	O	B-T080
sacrum	O	O	B-T029
positions	O	O	O
.	O	O	O

No	O	O	O
associations	O	O	O
were	O	O	O
found	O	O	O
between	O	O	O
flexible	O	O	B-T080
sacrum	O	O	B-T029
positions	O	O	B-T082
and	O	O	O
SPT	O	O	B-UnknownType
.	O	O	O

Flexible	O	O	B-T080
sacrum	O	O	B-T029
positions	O	O	B-T082
were	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
fewer	O	O	O
episiotomies	O	O	B-T061
.	O	O	O

-DOCSTART- (27473429)

Parallel-processing	O	O	B-T066
continuous-flow	O	O	B-T074
device	O	O	I-T074
for	O	O	O
optimization	O	O	B-T052
-	O	O	O
free	O	O	B-T169
polymerase	O	O	O
chain	O	O	O
reaction	O	O	O

A	O	O	O
parallel-processing	O	O	B-T066
four-station	O	O	B-T063
polymerase	O	O	I-T063
chain	O	O	I-T063
reaction	O	O	I-T063
(	O	O	O
PCR	O	O	B-T063
)	O	O	O
device	O	O	B-T073
has	O	O	O
been	O	O	O
developed	O	O	O
,	O	O	O
which	O	O	O
performs	O	O	B-T169
continuous-flow	O	O	B-T070
PCR	O	O	O
without	O	O	O
optimization	O	O	B-T052
of	O	O	O
the	O	O	O
annealing	O	O	B-T045
temperature	O	O	B-T081
.	O	O	O

Since	O	O	O
the	O	O	O
annealing	O	O	B-T045
temperature	O	O	B-T081
of	O	O	O
each	O	O	O
station	O	O	B-T073
can	O	O	O
be	O	O	O
controlled	O	O	B-T169
independently	O	O	B-T169
,	O	O	O
the	O	O	O
device	O	O	B-T073
covers	O	O	B-T169
an	O	O	O
annealing	O	O	O
temperature	O	O	O
range	O	O	B-T081
of	O	O	O
50	O	O	O
-	O	O	O
68	O	O	O
Â°	O	O	O
C	O	O	O
,	O	O	O
which	O	O	O
is	O	O	O
wide	O	O	B-T082
enough	O	O	O
to	O	O	O
perform	O	O	B-T169
PCR	O	O	B-T063
for	O	O	O
any	O	O	O
DNA	O	O	B-UnknownType
fragment	O	O	I-UnknownType
regardless	O	O	O
of	O	O	O
its	O	O	O
optimum	O	O	B-T080
annealing	O	O	O
condition	O	O	B-T080
.	O	O	O

This	O	O	O
arrangement	O	O	B-T169
lets	O	O	O
us	O	O	O
continuously	O	O	B-T078
obtain	O	O	B-T169
an	O	O	O
amplified	O	O	B-T067
amount	O	O	B-T081
of	O	O	O
a	O	O	O
DNA	O	O	B-UnknownType
fragment	O	O	I-UnknownType
at	O	O	O
least	O	O	O
from	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
stations	O	O	B-T073
.	O	O	O

The	O	O	O
device	O	O	B-T073
consists	O	O	O
of	O	O	O
four	O	O	O
identical	O	O	B-T080
cylindrical	O	O	B-T082
stations	O	O	B-T073
(	O	O	O
diameter	O	O	B-T081
20	O	O	O
mm	O	O	O
,	O	O	O
height	O	O	B-T032
55	O	O	O
mm	O	O	O
)	O	O	O
.	O	O	O

A	O	O	O
polytetrafluoroethylene	O	O	B-T109
capillary	O	O	B-T074
reactor	O	O	I-T074
(	O	O	O
length	O	O	B-T081
2	O	O	O
m	O	O	O
,	O	O	O
I.D.	O	O	O
100	O	O	O
Î¼m	O	O	O
,	O	O	O
O.D.	O	O	O
400	O	O	O
Î¼m	O	O	O
)	O	O	O
is	O	O	O
wound	O	O	B-T082
helically	O	O	I-T082
up	O	O	B-T082
around	O	O	B-T078
each	O	O	O
station	O	O	B-T073
.	O	O	O

The	O	O	O
whole	O	O	O
assembly	O	O	B-T052
is	O	O	O
designed	O	O	B-T052
to	O	O	O
minimize	O	O	B-T080
the	O	O	O
number	O	O	B-T081
of	O	O	O
heating	O	O	B-T074
blocks	O	O	I-T074
(	O	O	O
for	O	O	O
providing	O	O	B-T052
temperatures	O	O	B-T081
of	O	O	O
denaturation	O	O	B-T044
,	O	O	O
annealing	O	O	B-T045
,	O	O	O
and	O	O	O
extension	O	O	B-T169
)	O	O	O
to	O	O	O
be	O	O	O
seven	O	O	O
and	O	O	O
to	O	O	O
shape	O	O	B-T082
a	O	O	O
compact	O	O	B-T033
cube	O	O	B-T082
(	O	O	O
height	O	O	B-T032
55	O	O	O
mm	O	O	O
,	O	O	O
base	O	O	B-T081
60	O	O	O
mm	O	O	O
Ã	O	O	O
60	O	O	O
mm	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
reproducibility	O	O	B-T080
for	O	O	O
continuous-flow	O	O	B-T070
PCR	O	O	B-T063
is	O	O	O
reasonably	O	O	O
high	O	O	B-T080
(	O	O	O
run	O	O	B-T169
-to-	O	O	O
run	O	O	O
and	O	O	O
station	O	O	B-T073
-to-	O	O	O
station	O	O	O
relative	O	O	O
standard	O	O	B-T081
deviation	O	O	I-T081
of	O	O	O
their	O	O	O
amplification	O	O	B-T045
is	O	O	O
lower	O	O	O
than	O	O	O
6	O	O	O
%	O	O	O
and	O	O	O
about	O	O	O
4	O	O	O
%	O	O	O
,	O	O	O
respectively	O	O	O
)	O	O	O
.	O	O	O

Performance	O	O	B-T052
on	O	O	O
the	O	O	O
optimization	O	O	B-T052
-	O	O	O
free	O	O	B-T169
DNA	O	O	B-T045
amplification	O	O	I-T045
has	O	O	O
been	O	O	O
evaluated	O	O	B-T058
with	O	O	O
four	O	O	O
DNA	O	O	B-T026
samples	O	O	I-T026
with	O	O	O
different	O	O	B-T080
annealing	O	O	B-T045
conditions	O	O	B-T080
and	O	O	O
product	O	O	B-T071
sizes	O	O	B-T082
(	O	O	O
323	O	O	O
,	O	O	O
608	O	O	O
,	O	O	O
828	O	O	O
,	O	O	O
and	O	O	O
1101	O	O	O
bp	O	O	O
)	O	O	O
,	O	O	O
which	O	O	O
has	O	O	O
demonstrated	O	O	B-T080
that	O	O	O
in	O	O	O
all	O	O	O
cases	O	O	B-T169
,	O	O	O
PCR	O	O	B-T063
is	O	O	O
successful	O	O	B-T080
at	O	O	O
least	O	O	O
on	O	O	O
one	O	O	O
station	O	O	B-T073
.	O	O	O

In	O	O	O
addition	O	O	B-T169
,	O	O	O
three	O	O	O
DNA	O	O	B-UnknownType
fragment	O	O	I-UnknownType
s	O	O	O
with	O	O	O
different	O	O	B-T080
lengths	O	O	B-T081
(	O	O	O
323	O	O	O
,	O	O	O
1101	O	O	O
,	O	O	O
and	O	O	O
2836	O	O	O
bp	O	O	O
)	O	O	O
have	O	O	O
been	O	O	O
successfully	O	O	B-T080
amplified	O	O	B-T067
in	O	O	O
a	O	O	O
segmented	O	O	B-T082
-	O	O	O
flow	O	O	B-T070
mode	O	O	B-T169
without	O	O	O
the	O	O	O
carry-over	O	O	O
contamination	O	O	B-T078
between	O	O	O
segments	O	O	B-T082
.	O	O	O

This	O	O	O
result	O	O	B-T169
suggests	O	O	O
that	O	O	O
this	O	O	O
device	O	O	B-T073
could	O	O	O
serve	O	O	O
as	O	O	O
the	O	O	O
PCR	O	O	B-T063
module	O	O	B-T077
of	O	O	O
a	O	O	O
continuous-flow	O	O	B-T070
high-throughput	O	O	B-T060
on-line	O	O	I-T060
total	O	O	I-T060
DNA	O	O	I-T060
analysis	O	O	B-T062
system	O	O	B-T169
integrating	O	O	B-T080
all	O	O	O
necessary	O	O	O
modules	O	O	B-T077
from	O	O	O
cell	O	O	B-T025
lysis	O	O	B-T046
/	O	O	O
DNA	O	O	B-T063
extraction	O	O	I-T063
to	O	O	O
PCR	O	O	O
product	O	O	B-T071
analysis	O	O	O
.	O	O	O

-DOCSTART- (27473951)

Assessing	O	O	B-T052
sex-differences	O	O	B-T032
and	O	O	O
the	O	O	O
effect	O	O	B-T080
of	O	O	O
timing	O	O	B-T079
of	O	O	O
vaccination	O	O	B-T061
on	O	O	O
immunogenicity	O	O	B-T038
,	O	O	O
reactogenicity	O	O	B-T033
and	O	O	O
efficacy	O	O	B-T033
of	O	O	I-T033
vaccines	O	O	I-T033
in	O	O	O
young	O	O	B-T079
children	O	O	B-T100
:	O	O	O
study	O	O	B-T170
protocol	O	O	I-T170
for	O	O	O
an	O	O	O
individual	O	O	B-T098
participant	O	O	B-T098
data	O	O	B-T078
meta-analysis	O	O	B-T062
of	O	O	O
randomised	O	O	O
controlled	O	O	O
trials	O	O	O

Disease	O	O	B-T047
incidence	O	O	B-T081
differs	O	O	O
between	O	O	O
males	O	O	B-T032
and	O	O	O
females	O	O	B-T032
for	O	O	O
some	O	O	O
infectious	O	O	B-T047
or	O	O	O
inflammatory	O	O	B-T047
diseases	O	O	I-T047
.	O	O	O

Sex-differences	O	O	B-T032
in	O	O	O
immune	O	O	B-T042
responses	O	O	I-T042
to	O	O	O
some	O	O	O
vaccines	O	O	B-T129
have	O	O	O
also	O	O	O
been	O	O	O
observed	O	O	O
,	O	O	O
mostly	O	O	O
to	O	O	O
viral	O	O	B-T129
vaccines	O	O	I-T129
in	O	O	O
adults	O	O	B-T100
.	O	O	O

Little	O	O	O
evidence	O	O	B-T078
is	O	O	O
available	O	O	B-T169
on	O	O	O
whether	O	O	O
sex-differences	O	O	B-T032
occur	O	O	O
in	O	O	O
response	O	O	B-T033
to	O	O	O
immunisation	O	O	B-T061
in	O	O	O
infancy	O	O	B-T079
even	O	O	O
though	O	O	O
this	O	O	O
is	O	O	O
the	O	O	O
age	O	O	B-T100
group	O	O	I-T100
in	O	O	O
which	O	O	O
most	O	O	O
vaccines	O	O	B-T129
are	O	O	O
administered	O	O	B-T169
.	O	O	O

Factors	O	O	B-T169
other	O	O	O
than	O	O	O
sex	O	O	B-T032
,	O	O	O
such	O	O	O
as	O	O	O
timing	O	O	B-T079
or	O	O	O
coadministration	O	O	B-T061
of	O	O	O
other	O	O	O
vaccines	O	O	B-T129
,	O	O	O
can	O	O	O
also	O	O	O
influence	O	O	B-T077
the	O	O	O
immune	O	O	B-T042
response	O	O	I-T042
to	O	O	O
vaccination	O	O	B-T061
.	O	O	O

Individual	O	O	B-T098
participant	O	O	B-T098
data	O	O	B-T078
meta-analysis	O	O	B-T062
of	O	O	O
randomised	O	O	B-T062
controlled	O	O	I-T062
trials	O	O	I-T062
of	O	O	O
vaccines	O	O	B-T129
in	O	O	O
healthy	O	O	O
infants	O	O	B-T100
and	O	O	O
young	O	O	B-T079
children	O	O	B-T100
will	O	O	O
be	O	O	O
conducted	O	O	O
.	O	O	O

Fully	O	O	O
anonymised	O	O	O
data	O	O	B-T078
from	O	O	O
â¼170	O	O	O
randomised	O	O	B-T062
controlled	O	O	I-T062
trials	O	O	I-T062
of	O	O	O
v	O	O	O
accines	O	O	B-T129
for	O	O	O
diphtheria	O	O	B-T047
,	O	O	O
tetanus	O	O	B-T047
,	O	O	O
Bordetella	O	O	B-T007
pertussis	O	O	I-T007
,	O	O	O
polio	O	O	B-T047
,	O	O	O
Haemophilus	O	O	B-T007
influenzae	O	O	I-T007
type	O	O	I-T007
B	O	O	I-T007
,	O	O	O
hepatitis	O	O	B-T047
B	O	O	I-T047
,	O	O	O
Streptococcus	O	O	B-T007
pneumoniae	O	O	I-T007
,	O	O	O
Neisseria	O	O	B-T007
meningitidis	O	O	I-T007
,	O	O	O
measles	O	O	B-T047
,	O	O	O
mumps	O	O	B-T047
,	O	O	O
rubella	O	O	B-T047
,	O	O	O
varicella	O	O	B-T047
and	O	O	O
rotavirus	O	O	B-T005
will	O	O	O
be	O	O	O
combined	O	O	O
for	O	O	O
analysis	O	O	B-T062
.	O	O	O

Outcomes	O	O	B-T169
include	O	O	O
measures	O	O	B-T169
of	O	O	O
immunogenicity	O	O	B-T038
(	O	O	O
immunoglobulins	O	O	B-T116
)	O	O	O
,	O	O	O
reactogenicity	O	O	B-T033
,	O	O	O
safety	O	O	B-T068
and	O	O	O
disease	O	O	B-T047
-specific	O	O	O
clinical	O	O	B-T080
efficacy	O	O	I-T080
.	O	O	O

Data	O	O	B-T078
from	O	O	O
trials	O	O	B-T062
of	O	O	O
vaccines	O	O	B-T129
containing	O	O	O
similar	O	O	O
components	O	O	B-T073
will	O	O	O
be	O	O	O
combined	O	O	O
in	O	O	O
hierarchical	O	O	B-T169
models	O	O	B-T170
and	O	O	O
the	O	O	O
effect	O	O	B-T080
of	O	O	O
sex	O	O	B-T032
and	O	O	O
timing	O	O	B-T079
of	O	O	O
vaccinations	O	O	B-T061
estimated	O	O	O
for	O	O	O
each	O	O	O
outcome	O	O	B-T169
separately	O	O	O
.	O	O	O

Systematic	O	O	B-T170
reviews	O	O	I-T170
of	O	O	O
published	O	O	B-T057
estimates	O	O	O
of	O	O	O
sex-differences	O	O	B-T032
can	O	O	O
not	O	O	O
adequately	O	O	O
answer	O	O	B-T061
questions	O	O	I-T061
in	O	O	O
this	O	O	O
field	O	O	B-T077
since	O	O	O
such	O	O	O
comparisons	O	O	B-T052
are	O	O	O
never	O	O	O
the	O	O	O
main	O	O	O
purpose	O	O	B-T169
of	O	O	O
a	O	O	O
clinical	O	O	B-T062
trial	O	O	I-T062
,	O	O	O
thus	O	O	O
a	O	O	O
large	O	O	B-T081
degree	O	O	B-T081
of	O	O	O
reporting	O	O	B-T058
bias	O	O	B-T078
exists	O	O	B-T077
in	O	O	O
the	O	O	O
published	O	O	O
literature	O	O	B-T170
.	O	O	O

Recent	O	O	O
improvements	O	O	B-T077
in	O	O	O
the	O	O	O
widespread	O	O	B-T082
availability	O	O	B-T169
of	O	O	I-T169
individual	O	O	B-T098
participant	O	O	B-T098
data	O	O	B-T078
from	O	O	O
randomised	O	O	B-T062
controlled	O	O	I-T062
trials	O	O	I-T062
makes	O	O	O
it	O	O	O
feasible	O	O	O
to	O	O	O
conduct	O	O	O
extensive	O	O	B-T080
individual	O	O	O
participant	O	O	O
data	O	O	O
meta-analyses	O	O	B-T062
which	O	O	O
were	O	O	O
previously	O	O	B-T079
impossible	O	O	B-T033
,	O	O	O
thereby	O	O	O
reducing	O	O	B-T080
the	O	O	O
effect	O	O	B-T080
of	O	O	O
publication	O	O	B-T073
or	O	O	O
reporting	O	O	B-T058
bias	O	O	B-T078
on	O	O	O
the	O	O	O
understanding	O	O	B-T041
of	O	O	O
the	O	O	O
infant	O	O	B-T100
immune	O	O	B-T042
response	O	O	I-T042
.	O	O	O

Preliminary	O	O	B-T078
results	O	O	B-T169
will	O	O	O
be	O	O	O
available	O	O	B-T169
in	O	O	O
2016	O	O	O
with	O	O	O
final	O	O	O
results	O	O	O
available	O	O	O
in	O	O	O
2019	O	O	O
.	O	O	O

No	O	O	B-T169
ethics	O	O	B-T078
review	O	O	B-T170
is	O	O	O
required	O	O	O
for	O	O	O
secondary	O	O	B-UnknownType
analyses	O	O	I-UnknownType
of	O	O	O
anonymised	O	O	O
data	O	O	B-T078
.	O	O	O

-DOCSTART- (27474969)

An	O	O	O
ultrasensitive	O	O	B-T169
electrochemiluminescence	O	O	B-T059
sensor	O	O	B-T073
based	O	O	O
on	O	O	O
reduced	O	O	B-T196
graphene	O	O	I-T196
oxide	O	O	I-T196
-	O	O	O
copper	O	O	B-T197
sulfide	O	O	I-T197
composite	O	O	B-T080
coupled	O	O	O
with	O	O	O
capillary	O	O	B-T059
electrophoresis	O	O	I-T059
for	O	O	O
determination	O	O	B-T059
of	O	O	O
amlodipine	O	O	B-T109
besylate	O	O	I-T109
in	O	O	O
mice	O	O	B-T015
plasma	O	O	O

A	O	O	O
new	O	O	O
electrochemiluminescence	O	O	B-T059
(	O	O	O
ECL	O	O	B-T059
)	O	O	O
sensor	O	O	B-T073
based	O	O	O
on	O	O	O
reduced	O	O	B-T196
graphene	O	O	I-T196
oxide	O	O	I-T196
-	O	O	O
copper	O	O	B-T197
sulfide	O	O	I-T197
(	O	O	O
rGO	O	O	B-T196
-	O	O	O
CuS	O	O	B-T197
)	O	O	O
composite	O	O	B-T080
coupled	O	O	O
with	O	O	O
capillary	O	O	B-T059
electrophoresis	O	O	I-T059
(	O	O	O
CE	O	O	B-T059
)	O	O	O
was	O	O	O
constructed	O	O	O
for	O	O	O
the	O	O	O
ultrasensitive	O	O	B-T169
detection	O	O	B-T061
of	O	O	O
amlodipine	O	O	B-T109
besylate	O	O	I-T109
(	O	O	O
AML	O	O	B-T109
)	O	O	O
for	O	O	O
the	O	O	O
first	O	O	O
time	O	O	O
.	O	O	O

In	O	O	O
this	O	O	O
work	O	O	O
,	O	O	O
rGO	O	O	B-T196
-	O	O	O
CuS	O	O	B-T197
composite	O	O	B-T080
was	O	O	O
synthesized	O	O	O
by	O	O	O
one-pot	O	O	O
hydrothermal	O	O	B-T169
method	O	O	I-T169
and	O	O	O
used	O	O	O
for	O	O	O
electrode	O	O	B-T074
modification	O	O	B-T033
.	O	O	O

The	O	O	O
electrochemical	O	O	B-T059
and	O	O	O
ECL	O	O	B-T059
behaviors	O	O	O
of	O	O	O
the	O	O	O
sensor	O	O	B-T073
were	O	O	O
investigated	O	O	B-T169
.	O	O	O

More	O	O	O
than	O	O	O
5-fold	O	O	O
enhance	O	O	B-T052
in	O	O	O
ECL	O	O	B-T059
intensity	O	O	B-T081
was	O	O	O
observed	O	O	B-T169
after	O	O	O
modified	O	O	O
with	O	O	O
rGO	O	O	B-T196
-	O	O	O
CuS	O	O	B-T197
composite	O	O	B-T080
.	O	O	O

The	O	O	O
results	O	O	B-T034
can	O	O	O
be	O	O	O
ascribed	O	O	O
to	O	O	O
the	O	O	O
presence	O	O	B-T080
of	O	O	O
rGO	O	O	B-T196
-	O	O	O
CuS	O	O	B-T197
composite	O	O	B-T080
on	O	O	O
the	O	O	O
electrode	O	O	B-T074
surface	O	O	B-T082
that	O	O	O
facilitates	O	O	O
the	O	O	O
electron	O	O	B-T081
transfer	O	O	I-T081
rate	O	O	I-T081
between	O	O	O
the	O	O	O
electroactive	O	O	B-T169
center	O	O	B-T082
of	O	O	O
Ru(bpy)3(2	O	O	B-T104
+	O	O	I-T104
)	O	O	I-T104
and	O	O	O
the	O	O	O
electrode	O	O	O
.	O	O	O

The	O	O	O
ECL	O	O	B-T059
sensor	O	O	B-T073
was	O	O	O
coupled	O	O	B-T169
with	O	O	O
CE	O	O	B-T059
to	O	O	O
improve	O	O	O
the	O	O	O
selectivity	O	O	B-T034
and	O	O	O
the	O	O	O
CE	O	O	O
-	O	O	O
ECL	O	O	O
parameters	O	O	B-T033
that	O	O	O
affect	O	O	O
separation	O	O	B-UnknownType
and	O	O	O
detection	O	O	B-T061
were	O	O	O
optimized	O	O	O
.	O	O	O

Under	O	O	O
the	O	O	O
optimum	O	O	B-T080
conditions	O	O	O
,	O	O	O
the	O	O	O
linear	O	O	B-T081
ranges	O	O	I-T081
for	O	O	O
AML	O	O	B-T109
was	O	O	O
0.008	O	O	O
-	O	O	O
5.0Î¼g/mL	O	O	O
with	O	O	O
a	O	O	O
detection	O	O	B-T081
limit	O	O	I-T081
of	O	O	O
2.8ng/mL	O	O	O
(	O	O	O
S/N=3	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
method	O	O	B-T059
displayed	O	O	O
the	O	O	O
advantages	O	O	O
of	O	O	O
high	O	O	B-T067
sensitivity	O	O	I-T067
,	O	O	O
good	O	O	B-T034
selectivity	O	O	I-T034
,	O	O	O
wide	O	O	O
linear	O	O	B-T081
range	O	O	I-T081
,	O	O	O
low	O	O	O
detection	O	O	B-T081
limit	O	O	I-T081
and	O	O	O
fine	O	O	B-T080
reproducibility	O	O	I-T080
,	O	O	O
and	O	O	O
was	O	O	O
used	O	O	O
to	O	O	O
analyze	O	O	O
AML	O	O	B-T109
in	O	O	O
mice	O	O	B-T015
plasma	O	O	B-T031
with	O	O	O
a	O	O	O
satisfactory	O	O	O
result	O	O	B-T034
,	O	O	O
which	O	O	O
holds	O	O	O
a	O	O	O
great	O	O	O
potential	O	O	B-T080
in	O	O	O
the	O	O	O
field	O	O	O
of	O	O	O
pharmaceutical	O	O	B-T062
analysis	O	O	I-T062
.	O	O	O

-DOCSTART- (27475696)

Estrogen	O	O	B-T125
and	O	O	O
Progesterone	O	O	B-T125
hormone	O	O	B-T125
receptor	O	O	B-T045
expression	O	O	I-T045
in	O	O	O
oral	O	O	O
cavity	O	O	O
cancer	O	O	O

Recent	O	O	O
studies	O	O	O
have	O	O	O
shown	O	O	O
an	O	O	O
increase	O	O	B-T169
in	O	O	O
the	O	O	O
incidence	O	O	B-T081
of	O	O	O
oral	O	O	B-T191
squamous	O	O	I-T191
cell	O	O	I-T191
carcinoma	O	O	I-T191
(	O	O	O
OSCC	O	O	B-T191
)	O	O	O
in	O	O	O
younger	O	O	B-T079
patients	O	O	B-T101
.	O	O	O

The	O	O	O
hypothesis	O	O	B-T078
that	O	O	O
tumors	O	O	B-T191
could	O	O	O
be	O	O	O
hormonally	O	O	B-T125
induced	O	O	B-T169
during	O	O	O
pregnancy	O	O	B-T040
or	O	O	O
in	O	O	O
young	O	O	B-T079
female	O	O	B-T032
patients	O	O	B-T101
without	O	O	O
the	O	O	O
well-known	O	O	O
risk	O	O	B-T033
factors	O	O	I-T033
alcohol	O	O	B-T048
or	O	O	O
tobacco	O	O	B-T048
abuse	O	O	I-T048
seems	O	O	O
to	O	O	O
be	O	O	O
plausible	O	O	O
.	O	O	O

Estrogen	O	O	B-T116
Receptor	O	O	I-T116
alpha	O	O	I-T116
(	O	O	O
ERÎ±	O	O	B-T116
)	O	O	O
and	O	O	O
Progesterone	O	O	B-T116
Receptor	O	O	I-T116
(	O	O	O
PR	O	O	B-T116
)	O	O	O
expression	O	O	B-T045
were	O	O	O
analyzed	O	O	B-T062
in	O	O	O
normal	O	O	O
oral	O	O	B-T023
mucosa	O	O	I-T023
(	O	O	O
n=5	O	O	O
)	O	O	O
,	O	O	O
oral	O	O	B-T033
precursor	O	O	I-T033
lesions	O	O	I-T033
(	O	O	O
simple	O	O	B-T047
hyperplasia	O	O	I-T047
,	O	O	O
n=11	O	O	O
;	O	O	O
squamous	O	O	B-T191
intraepithelial	O	O	I-T191
neoplasia	O	O	I-T191
,	O	O	O
SIN	O	O	B-T191
I-III	O	O	I-T191
,	O	O	O
n=35	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
OSCC	O	O	B-T191
specimen	O	O	B-T167
.	O	O	O

OSCCs	O	O	B-T191
were	O	O	O
stratified	O	O	B-T080
in	O	O	O
a	O	O	O
young	O	O	B-T079
female	O	O	B-T032
(	O	O	O
n=7	O	O	O
)	O	O	O
study	O	O	O
cohort	O	O	B-T098
and	O	O	O
older	O	O	B-T098
patients	O	O	B-T101
(	O	O	O
n=46	O	O	O
)	O	O	O
.	O	O	O

In	O	O	O
the	O	O	O
young	O	O	B-T079
female	O	O	B-T032
study	O	O	O
cohort	O	O	B-T098
three	O	O	O
patients	O	O	B-T101
(	O	O	O
n=3/7	O	O	O
)	O	O	O
developed	O	O	O
OSCC	O	O	B-T191
during	O	O	O
or	O	O	O
shortly	O	O	O
after	O	O	O
pregnancy	O	O	B-T040
.	O	O	O

Breast	O	O	B-T191
cancer	O	O	I-T191
tissues	O	O	B-T024
were	O	O	O
used	O	O	O
as	O	O	O
positive	O	O	B-T077
control	O	O	I-T077
for	O	O	O
ERÎ±	O	O	B-T116
and	O	O	O
PR	O	O	B-T116
expression	O	O	B-T045
.	O	O	O

ERÎ±	O	O	B-T116
expression	O	O	B-T045
was	O	O	O
found	O	O	O
in	O	O	O
four	O	O	O
oral	O	O	B-T033
precursor	O	O	I-T033
lesions	O	O	I-T033
(	O	O	O
squamous	O	O	B-T191
intraepithelial	O	O	I-T191
neoplasia	O	O	I-T191
,	O	O	O
SIN	O	O	B-T191
I-III	O	O	I-T191
,	O	O	O
n=4/35	O	O	O
,	O	O	O
11	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
in	O	O	O
five	O	O	O
OSCC	O	O	B-T191
specimen	O	O	B-T167
(	O	O	O
n=5/46	O	O	O
,	O	O	O
11	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
five	O	O	O
ERÎ±	O	O	B-T116
positive	O	O	B-T033
OSCC	O	O	B-T191
samples	O	O	B-T167
were	O	O	O
older	O	O	B-T098
male	O	O	B-T032
patients	O	O	B-T101
.	O	O	O

All	O	O	O
patients	O	O	B-T101
within	O	O	O
the	O	O	O
young	O	O	B-T079
female	O	O	B-T032
study	O	O	O
cohort	O	O	B-T098
were	O	O	O
negatively	O	O	B-T033
stained	O	O	O
for	O	O	O
both	O	O	O
ERÎ±	O	O	B-T116
and	O	O	O
PR	O	O	B-T116
.	O	O	O

ER	O	O	B-T116
expression	O	O	B-T045
could	O	O	O
be	O	O	O
regarded	O	O	O
as	O	O	O
a	O	O	O
seldom	O	O	B-T080
risk	O	O	B-T033
factor	O	O	I-T033
for	O	O	O
OSCC	O	O	B-T191
.	O	O	O

PR	O	O	B-T116
expression	O	O	B-T045
seems	O	O	O
to	O	O	O
be	O	O	O
not	O	O	O
relevant	O	O	B-T080
for	O	O	O
the	O	O	O
development	O	O	B-T169
of	O	O	O
OSCC	O	O	B-T191
.	O	O	O

-DOCSTART- (27476541)

Studying	O	O	B-T062
neuroprotective	O	O	B-T169
effect	O	O	I-T169
of	O	O	O
Atorvastatin	O	O	B-T109
as	O	O	O
a	O	O	O
small	O	O	B-T109
molecule	O	O	I-T109
drug	O	O	B-T121
on	O	O	O
high	O	O	B-T033
glucose	O	O	I-T033
-	O	O	O
induced	O	O	B-T169
neurotoxicity	O	O	B-T037
in	O	O	O
undifferentiated	O	O	B-T080
PC12	O	O	B-T025
cells	O	O	I-T025
:	O	O	O
role	O	O	B-T077
of	O	O	O
NADPH	O	O	O
oxidase	O	O	O

Overproduction	O	O	B-T080
of	O	O	O
reactive	O	O	B-T123
oxygen	O	O	I-T123
species	O	O	I-T123
(	O	O	O
ROS	O	O	B-T123
)	O	O	O
by	O	O	O
NADPH	O	O	B-T116
oxidase	O	O	I-T116
(	O	O	O
NOX	O	O	B-T116
)	O	O	O
activation	O	O	B-T044
has	O	O	O
been	O	O	O
considered	O	O	B-T078
the	O	O	O
essential	O	O	B-T080
mechanism	O	O	B-T169
induced	O	O	B-T169
by	O	O	O
hyperglycemia	O	O	B-T047
in	O	O	O
various	O	O	O
tissues	O	O	B-T024
.	O	O	O

However	O	O	O
,	O	O	O
there	O	O	O
is	O	O	O
no	O	O	B-T080
comprehensive	O	O	I-T080
study	O	O	B-T062
on	O	O	O
the	O	O	O
role	O	O	B-T077
of	O	O	O
NOXs	O	O	B-T116
in	O	O	O
high	O	O	B-T033
glucose	O	O	I-T033
(HG)-	O	O	O
induced	O	O	B-T169
toxic	O	O	B-T037
effect	O	O	I-T037
in	O	O	O
neural	O	O	B-T024
tissues	O	O	I-T024
.	O	O	O

Recently	O	O	O
,	O	O	O
a	O	O	O
therapeutic	O	O	B-T169
strategy	O	O	B-T041
in	O	O	O
oxidative	O	O	B-T169
related	O	O	B-T080
pathologies	O	O	B-T091
has	O	O	O
been	O	O	O
introduced	O	O	B-T169
by	O	O	O
blocking	O	O	B-T169
the	O	O	O
undesirable	O	O	B-T052
actions	O	O	I-T052
of	O	O	O
NOX	O	O	B-T116
enzymes	O	O	I-T116
by	O	O	O
small	O	O	B-T109
molecules	O	O	I-T109
.	O	O	O

The	O	O	O
protective	O	O	B-T033
roles	O	O	B-T077
of	O	O	O
Statins	O	O	B-T109
in	O	O	O
ameliorating	O	O	B-T080
oxidative	O	O	B-T049
stress	O	O	I-T049
by	O	O	O
NOX	O	O	B-T116
inhibition	O	O	B-T039
have	O	O	O
been	O	O	O
shown	O	O	O
in	O	O	O
some	O	O	O
tissues	O	O	B-T024
except	O	O	O
neural	O	O	B-T024
.	O	O	O

We	O	O	O
hypothesized	O	O	B-T078
then	O	O	O
,	O	O	O
that	O	O	O
different	O	O	B-T080
NOXs	O	O	B-T116
may	O	O	O
have	O	O	O
role	O	O	B-T077
in	O	O	O
HG	O	O	B-T033
-	O	O	O
induced	O	O	B-T169
neural	O	O	B-T049
cell	O	O	I-T049
injury	O	O	I-T049
.	O	O	O

Furthermore	O	O	O
,	O	O	O
we	O	O	O
postulate	O	O	B-T078
that	O	O	O
Atorvastatin	O	O	B-T109
as	O	O	O
a	O	O	O
small	O	O	B-T109
molecule	O	O	I-T109
may	O	O	O
modulate	O	O	B-T082
this	O	O	O
NOXs	O	O	B-T044
activity	O	O	I-T044
to	O	O	O
protect	O	O	B-T033
neural	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

Undifferentiated	O	O	B-T080
PC12	O	O	B-T025
cells	O	O	I-T025
were	O	O	O
treated	O	O	B-T061
with	O	O	I-T061
HG	O	O	B-T033
(	O	O	O
140	O	O	O
mM/	O	O	O
24	O	O	B-T079
h	O	O	I-T079
)	O	O	O
in	O	O	O
the	O	O	O
presence	O	O	B-T033
and	O	O	O
absence	O	O	B-T169
of	O	O	O
Atorvastatin	O	O	B-T109
(	O	O	O
1	O	O	O
Î¼M/	O	O	O
96	O	O	B-T079
h	O	O	I-T079
)	O	O	O
.	O	O	O

The	O	O	O
cell	O	O	B-T043
viability	O	O	I-T043
was	O	O	O
measured	O	O	B-T080
by	O	O	O
MTT	O	O	B-T062
assay	O	O	I-T062
and	O	O	O
the	O	O	O
gene	O	O	B-T081
and	O	O	O
protein	O	O	B-T034
expressions	O	O	I-T034
profile	O	O	I-T034
of	O	O	O
NOX	O	O	B-T116
(	O	O	O
1	O	O	O
-	O	O	O
4	O	O	O
)	O	O	O
were	O	O	O
determined	O	O	B-T080
by	O	O	I-T080
RT-PCR	O	O	B-T063
and	O	O	O
western	O	O	B-T059
blotting	O	O	I-T059
,	O	O	O
respectively	O	O	O
.	O	O	O

Levels	O	O	B-T080
of	O	O	O
ROS	O	O	B-T123
and	O	O	O
malondialdehyde	O	O	B-T109
(	O	O	O
MDA	O	O	B-T109
)	O	O	O
were	O	O	O
also	O	O	O
evaluated	O	O	B-T052
.	O	O	O

Gene	O	O	B-T045
and	O	O	O
protein	O	O	B-T045
expression	O	O	I-T045
levels	O	O	B-T080
of	O	O	O
NOX	O	O	B-T116
(	O	O	O
1	O	O	O
-	O	O	O
4	O	O	O
)	O	O	O
and	O	O	O
consequently	O	O	B-T033
ROS	O	O	B-T123
and	O	O	O
MDA	O	O	B-T109
levels	O	O	O
were	O	O	O
elevated	O	O	B-T080
in	O	O	O
HG	O	O	B-T033
-	O	O	O
treated	O	O	B-T169
PC12	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

Atorvastatin	O	O	B-T109
could	O	O	O
significantly	O	O	B-T078
decrease	O	O	B-T081
HG	O	O	B-T033
-	O	O	O
induced	O	O	B-T169
NOXs	O	O	B-T116
,	O	O	O
ROS	O	O	B-T123
and	O	O	O
MDA	O	O	B-T109
elevation	O	O	B-T082
and	O	O	O
improve	O	O	B-T033
impaired	O	O	B-T169
cell	O	O	B-T043
viability	O	O	I-T043
.	O	O	O

It	O	O	O
can	O	O	O
be	O	O	O
concluded	O	O	B-T078
that	O	O	O
HG	O	O	B-T033
could	O	O	O
elevate	O	O	B-T080
NOXs	O	O	B-T044
activity	O	O	I-T044
,	O	O	O
ROS	O	O	B-T123
and	O	O	O
MDA	O	O	B-T109
levels	O	O	B-T080
in	O	O	O
neural	O	O	B-T024
tissues	O	O	I-T024
and	O	O	O
Atorvastatin	O	O	B-T109
as	O	O	O
a	O	O	O
small	O	O	B-T109
molecule	O	O	I-T109
NOX	O	O	B-T121
inhibitor	O	O	I-T121
drug	O	O	I-T121
may	O	O	O
prevent	O	O	B-T080
and	O	O	O
delay	O	O	B-T079
diabetic	O	O	B-T047
complications	O	O	I-T047
,	O	O	O
particularly	O	O	O
neuropathy	O	O	B-T047
.	O	O	O

-DOCSTART- (27477569)

Intravascular	O	O	B-T082
Inflammation	O	O	B-T046
Triggers	O	O	B-T080
Intracerebral	O	O	B-T082
Activated	O	O	B-T052
Microglia	O	O	B-T025
and	O	O	O
Contributes	O	O	O
to	O	O	O
Secondary	O	O	B-T037
Brain	O	O	I-T037
Injury	O	O	I-T037
After	O	O	O
Experimental	O	O	B-T080
Subarachnoid	O	O	B-T047
Hemorrhage	O	O	I-T047
(	O	O	O
eSAH	O	O	B-T047
)	O	O	O

Activation	O	O	B-T052
of	O	O	O
innate	O	O	B-T032
immunity	O	O	I-T032
contributes	O	O	O
to	O	O	O
secondary	O	O	B-T037
brain	O	O	I-T037
injury	O	O	I-T037
after	O	O	O
experimental	O	O	B-T080
subarachnoid	O	O	B-T047
hemorrhage	O	O	I-T047
(	O	O	O
eSAH	O	O	B-T047
)	O	O	O
.	O	O	O

Microglia	O	O	B-T025
accumulation	O	O	B-T033
and	O	O	O
activation	O	O	B-T052
within	O	O	O
the	O	O	O
brain	O	O	B-T023
has	O	O	O
recently	O	O	O
been	O	O	O
shown	O	O	O
to	O	O	O
induce	O	O	O
neuronal	O	O	B-T043
cell	O	O	I-T043
death	O	O	I-T043
after	O	O	O
eSAH	O	O	B-T047
.	O	O	O

In	O	O	O
isolated	O	O	B-T169
mouse	O	O	B-T015
brain	O	O	B-T023
capillaries	O	O	B-T023
after	O	O	O
eSAH	O	O	B-T047
,	O	O	O
we	O	O	O
show	O	O	O
a	O	O	O
significantly	O	O	O
increased	O	O	O
gene	O	O	B-T045
expression	O	O	I-T045
for	O	O	O
intercellular	O	O	B-T028
adhesion	O	O	I-T028
molecule-1	O	O	I-T028
(	O	O	O
ICAM-1	O	O	B-T028
)	O	O	O
and	O	O	O
P-selectin	O	O	B-T028
.	O	O	O

Hence	O	O	O
,	O	O	O
we	O	O	O
hypothesized	O	O	B-T078
that	O	O	O
extracerebral	O	O	B-T082
intravascular	O	O	B-T082
inflammatory	O	O	B-T046
processes	O	O	I-T046
might	O	O	O
initiate	O	O	O
the	O	O	O
previously	O	O	O
reported	O	O	B-T058
microglia	O	O	B-T025
accumulation	O	O	B-T033
within	O	O	O
the	O	O	O
brain	O	O	B-T023
tissue	O	O	I-T023
.	O	O	O

We	O	O	O
therefore	O	O	O
induced	O	O	O
eSAH	O	O	B-T047
in	O	O	O
knockout	O	O	B-T015
mice	O	O	I-T015
for	O	O	O
ICAM-1	O	O	B-T028
(	O	O	O
ICAM-1(-/-	O	O	B-T028
)	O	O	I-T028
)	O	O	O
and	O	O	O
P-selectin	O	O	B-T028
glycoprotein	O	O	I-T028
ligand-1	O	O	I-T028
(	O	O	O
PSGL-1(-/-	O	O	B-T028
)	O	O	I-T028
)	O	O	O
to	O	O	O
find	O	O	O
a	O	O	O
significant	O	O	O
decrease	O	O	O
in	O	O	O
neutrophil	O	O	B-T025
-	O	O	O
endothelial	O	O	B-T025
interaction	O	O	B-T043
within	O	O	O
the	O	O	O
first	O	O	O
7	O	O	O
days	O	O	O
after	O	O	O
the	O	O	O
bleeding	O	O	B-T046
in	O	O	O
a	O	O	O
chronic	O	O	B-T079
cranial	O	O	B-T082
window	O	O	B-T075
model	O	O	I-T075
.	O	O	O

This	O	O	O
inhibition	O	O	B-T052
of	O	O	O
neutrophil	O	O	B-T039
recruitment	O	O	I-T039
to	O	O	O
the	O	O	O
endothelium	O	O	B-T025
results	O	O	O
in	O	O	O
significantly	O	O	O
ameliorated	O	O	B-T033
microglia	O	O	B-T025
accumulation	O	O	B-T033
and	O	O	O
neuronal	O	O	B-T043
cell	O	O	I-T043
death	O	O	I-T043
in	O	O	O
knockout	O	O	B-T008
animals	O	O	I-T008
in	O	O	O
comparison	O	O	O
to	O	O	O
controls	O	O	O
.	O	O	O

Our	O	O	O
results	O	O	O
suggest	O	O	O
an	O	O	O
outside-in	O	O	O
activation	O	O	B-T052
of	O	O	O
the	O	O	O
CNS	O	O	B-T022
innate	O	O	I-T022
immune	O	O	B-T022
system	O	O	I-T022
at	O	O	O
the	O	O	O
vessel	O	O	B-T029
/	O	O	O
brain	O	O	B-T023
interface	O	O	O
following	O	O	O
eSAH	O	O	B-T047
.	O	O	O

Microglia	O	O	B-T025
cells	O	O	B-T025
,	O	O	O
as	O	O	O
part	O	O	O
of	O	O	O
the	O	O	O
brain	O	O	B-T023
's	O	O	I-T023
innate	O	O	B-T032
immune	O	O	I-T032
system	O	O	I-T032
,	O	O	O
are	O	O	O
triggered	O	O	B-T080
by	O	O	O
an	O	O	O
inflammatory	O	O	B-T046
reaction	O	O	I-T046
in	O	O	O
the	O	O	O
microvasculature	O	O	B-T042
after	O	O	O
eSAH	O	O	B-T047
,	O	O	O
thus	O	O	O
contributing	O	O	O
to	O	O	O
neuronal	O	O	B-T043
cell	O	O	I-T043
death	O	O	I-T043
.	O	O	O

This	O	O	O
finding	O	O	O
offers	O	O	O
a	O	O	O
whole	O	O	O
range	O	O	O
of	O	O	O
new	O	O	O
research	O	O	B-T062
targets	O	O	B-T169
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
possible	O	O	O
therapy	O	O	B-T169
options	O	O	O
for	O	O	O
patients	O	O	B-T101
suffering	O	O	O
from	O	O	O
eSAH	O	O	B-T047
.	O	O	O

-DOCSTART- (27478387)

Amphetamine	O	O	B-T048
Withdrawal	O	O	I-T048
Differentially	O	O	O
Increases	O	O	O
the	O	O	O
Expression	O	O	B-T045
of	O	O	O
Organic	O	O	B-T116
Cation	O	O	I-T116
Transporter	O	O	I-T116
3	O	O	I-T116
and	O	O	O
Serotonin	O	O	B-T116
Transporter	O	O	I-T116
in	O	O	O
Limbic	O	O	B-T022
Brain	O	O	O
Regions	O	O	O

Amphetamine	O	O	B-T048
withdrawal	O	O	I-T048
increases	O	O	O
anxiety	O	O	B-T033
and	O	O	O
stress	O	O	B-T033
sensitivity	O	O	O
related	O	O	O
to	O	O	O
blunted	O	O	B-T080
ventral	O	O	B-T082
hippocampus	O	O	B-T023
(	O	O	O
vHipp	O	O	B-T023
)	O	O	O
and	O	O	O
enhances	O	O	O
the	O	O	O
central	O	O	B-T023
nucleus	O	O	I-T023
of	O	O	I-T023
the	O	O	I-T023
amygdala	O	O	I-T023
(	O	O	O
CeA	O	O	B-T023
)	O	O	O
serotonin	O	O	B-T109
responses	O	O	B-T032
.	O	O	O

Extracellular	O	O	B-T026
serotonin	O	O	B-T109
levels	O	O	B-T080
are	O	O	O
regulated	O	O	O
by	O	O	O
the	O	O	O
serotonin	O	O	B-T116
transporter	O	O	I-T116
(	O	O	O
SERT	O	O	B-T116
)	O	O	O
and	O	O	O
organic	O	O	B-T116
cation	O	O	I-T116
transporter	O	O	I-T116
3	O	O	I-T116
(	O	O	O
OCT3	O	O	B-T116
)	O	O	O
,	O	O	O
and	O	O	O
vHipp	O	O	B-T023
OCT3	O	O	O
expression	O	O	B-T045
is	O	O	O
enhanced	O	O	O
during	O	O	O
24	O	O	B-T079
hours	O	O	I-T079
of	O	O	O
amphetamine	O	O	B-T048
withdrawal	O	O	I-T048
,	O	O	O
while	O	O	O
SERT	O	O	O
expression	O	O	O
is	O	O	O
unaltered	O	O	O
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
tested	O	O	O
whether	O	O	O
OCT3	O	O	B-T116
and	O	O	O
SERT	O	O	B-T116
expression	O	O	B-T045
in	O	O	O
the	O	O	O
CeA	O	O	B-T023
is	O	O	O
also	O	O	O
affected	O	O	O
during	O	O	O
acute	O	O	O
withdrawal	O	O	B-T048
to	O	O	O
explain	O	O	O
opposing	O	O	O
regional	O	O	O
alterations	O	O	O
in	O	O	O
limbic	O	O	B-T022
serotonergic	O	O	B-T043
neurotransmission	O	O	I-T043
and	O	O	O
if	O	O	O
respective	O	O	O
changes	O	O	O
continued	O	O	O
with	O	O	O
two	O	O	B-T079
weeks	O	O	I-T079
of	O	O	O
withdrawal	O	O	O
.	O	O	O

We	O	O	O
also	O	O	O
determined	O	O	O
whether	O	O	O
changes	O	O	O
in	O	O	O
transporter	O	O	B-T116
expression	O	O	B-T045
were	O	O	O
confined	O	O	O
to	O	O	O
these	O	O	O
regions	O	O	O
.	O	O	O

Male	O	O	B-T032
rats	O	O	B-T015
received	O	O	O
amphetamine	O	O	B-T109
or	O	O	O
saline	O	O	B-T167
for	O	O	O
two	O	O	B-T079
weeks	O	O	I-T079
followed	O	O	O
by	O	O	O
24	O	O	B-T079
hours	O	O	I-T079
or	O	O	O
two	O	O	O
weeks	O	O	O
of	O	O	O
withdrawal	O	O	B-T048
,	O	O	O
with	O	O	O
transporter	O	O	B-T116
expression	O	O	B-T045
measured	O	O	O
using	O	O	O
Western	O	O	B-T059
immunoblot	O	O	I-T059
.	O	O	O

OCT3	O	O	B-T116
and	O	O	O
SERT	O	O	B-T116
expression	O	O	B-T045
increased	O	O	O
in	O	O	O
the	O	O	O
CeA	O	O	B-T023
at	O	O	O
both	O	O	O
withdrawal	O	O	B-T048
timepoints	O	O	O
.	O	O	O

In	O	O	O
the	O	O	O
vHipp	O	O	B-T023
,	O	O	O
OCT3	O	O	B-T116
expression	O	O	B-T045
increased	O	O	O
only	O	O	O
at	O	O	O
24	O	O	B-T079
hours	O	O	I-T079
of	O	O	O
withdrawal	O	O	B-T048
,	O	O	O
with	O	O	O
an	O	O	O
equivalent	O	O	O
pattern	O	O	O
seen	O	O	O
in	O	O	O
the	O	O	O
dorsomedial	O	O	B-T023
hypothalamus	O	O	I-T023
.	O	O	O

No	O	O	B-T033
changes	O	O	I-T033
were	O	O	O
evident	O	O	O
in	O	O	O
any	O	O	O
other	O	O	O
regions	O	O	B-T029
sampled	O	O	O
.	O	O	O

These	O	O	O
regionally	O	O	O
specific	O	O	O
changes	O	O	O
in	O	O	O
limbic	O	O	B-T022
OCT3	O	O	B-T116
and	O	O	O
SERT	O	O	B-T116
expression	O	O	B-T045
may	O	O	O
partially	O	O	O
contribute	O	O	O
to	O	O	O
the	O	O	O
serotonergic	O	O	B-T109
imbalance	O	O	B-T184
and	O	O	O
negative	O	O	B-T033
affect	O	O	I-T033
during	O	O	O
amphetamine	O	O	B-T048
withdrawal	O	O	I-T048
.	O	O	O

-DOCSTART- (27478553)

Nutritional	O	O	B-T169
aspects	O	O	I-T169
of	O	O	O
night	O	O	B-T079
eating	O	O	B-T040
and	O	O	O
its	O	O	O
association	O	O	B-T080
with	O	O	I-T080
weight	O	O	B-T032
status	O	O	B-T080
among	O	O	O
Korean	O	O	B-T098
adolescents	O	O	O

A	O	O	O
growing	O	O	B-T169
body	O	O	O
of	O	O	O
research	O	O	B-T062
has	O	O	O
indicated	O	O	O
that	O	O	O
night	O	O	B-T079
eating	O	O	B-T040
could	O	O	O
be	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
poor	O	O	B-T033
diet	O	O	I-T033
quality	O	O	B-T080
and	O	O	O
negative	O	O	B-T033
health	O	O	B-T170
outcomes	O	O	I-T170
.	O	O	O

This	O	O	O
study	O	O	B-T170
examined	O	O	O
the	O	O	O
nutritional	O	O	B-T169
aspects	O	O	I-T169
of	O	O	O
night	O	O	B-T079
eating	O	O	B-T040
,	O	O	O
its	O	O	O
related	O	O	O
factors	O	O	B-T169
,	O	O	O
and	O	O	O
the	O	O	O
association	O	O	B-T080
between	O	O	O
night	O	O	O
eating	O	O	O
and	O	O	O
body	O	O	B-T032
weight	O	O	I-T032
among	O	O	O
Korean	O	O	B-T098
adolescents	O	O	B-T100
.	O	O	O

This	O	O	O
study	O	O	B-T170
analysed	O	O	O
the	O	O	O
data	O	O	B-T078
from	O	O	O
a	O	O	O
one	O	O	O
day	O	O	B-T079
24-hour	O	O	O
dietary	O	O	B-T062
recall	O	O	I-T062
as	O	O	O
well	O	O	O
as	O	O	O
a	O	O	O
demographic	O	O	B-T062
survey	O	O	I-T062
of	O	O	O
1,738	O	O	O
Korean	O	O	B-T098
adolescents	O	O	B-T100
aged	O	O	O
12	O	O	O
to	O	O	O
18-	O	O	O
years	O	O	B-T079
-old	O	O	O
obtained	O	O	O
from	O	O	O
the	O	O	O
2010	O	O	O
-	O	O	O
2012	O	O	O
Korea	O	O	B-T083
National	O	O	B-T062
Health	O	O	I-T062
and	O	O	I-T062
Nutrition	O	O	I-T062
Examination	O	O	I-T062
Survey	O	O	I-T062
.	O	O	O
'	O	O	O
Night	O	O	B-T079
eating	O	O	B-T040
'	O	O	O
was	O	O	O
defined	O	O	O
as	O	O	O
consuming	O	O	O
25	O	O	O
%	O	O	O
or	O	O	O
more	O	O	O
of	O	O	O
one	O	O	O
's	O	O	O
daily	O	O	B-T081
energy	O	O	I-T081
intake	O	O	I-T081
between	O	O	O
21:00	O	O	O
and	O	O	O
06:00	O	O	O
.	O	O	O

Subjects	O	O	B-T098
complying	O	O	O
with	O	O	O
the	O	O	O
preceding	O	O	O
condition	O	O	B-T080
were	O	O	O
classified	O	O	O
as	O	O	O
'	O	O	O
night	O	O	B-T079
eaters	O	O	B-T098
'	O	O	O
,	O	O	O
whereas	O	O	O
the	O	O	O
rest	O	O	O
were	O	O	O
considered	O	O	O
'	O	O	O
non-night	O	O	B-T098
eaters	O	O	I-T098
'	O	O	O
.	O	O	O

Logistic	O	O	B-UnknownType
regression	O	O	I-UnknownType
analysis	O	O	I-UnknownType
examined	O	O	O
factors	O	O	B-T169
related	O	O	O
to	O	O	O
night	O	O	B-T079
eating	O	O	B-T040
.	O	O	O

Multiple	O	O	B-T081
linear	O	O	I-T081
regression	O	O	I-T081
analyses	O	O	I-T081
were	O	O	O
used	O	O	O
to	O	O	O
examine	O	O	O
the	O	O	O
relationship	O	O	B-T080
between	O	O	O
night	O	O	B-T079
eating	O	O	B-T040
and	O	O	O
BMI	O	O	B-T201
z-scores	O	O	B-T081
,	O	O	O
whereas	O	O	O
multinomial	O	O	B-UnknownType
logistic	O	O	I-UnknownType
regression	O	O	I-UnknownType
analysis	O	O	I-UnknownType
was	O	O	O
used	O	O	O
to	O	O	O
examine	O	O	O
the	O	O	O
relationship	O	O	O
between	O	O	O
night	O	O	O
eating	O	O	O
and	O	O	O
weight	O	O	B-T032
status	O	O	B-T080
.	O	O	O

About	O	O	O
21	O	O	O
%	O	O	O
of	O	O	O
Korean	O	O	B-T098
adolescents	O	O	B-T100
appeared	O	O	O
to	O	O	O
be	O	O	O
night	O	O	B-T079
eaters	O	O	B-T098
.	O	O	O

Night	O	O	B-T079
eaters	O	O	B-T098
showed	O	O	O
increased	O	O	B-T081
breakfast	O	O	B-T056
skipping	O	O	B-T033
(	O	O	O
P	O	O	O
=	O	O	O
0.001	O	O	O
)	O	O	O
,	O	O	O
higher	O	O	O
energy	O	O	B-T081
intake	O	O	I-T081
from	O	O	O
snacks	O	O	B-T168
(	O	O	O
P	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
,	O	O	O
greater	O	O	O
proportion	O	O	B-T081
of	O	O	I-T081
energy	O	O	I-T081
intake	O	O	I-T081
from	O	O	I-T081
fat	O	O	I-T081
(	O	O	O
P	O	O	O
=	O	O	O
0.029	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
lower	O	O	B-T081
Dietary	O	O	I-T081
Diversity	O	O	I-T081
Scores	O	O	I-T081
(	O	O	O
P	O	O	O
=	O	O	O
0.008	O	O	O
)	O	O	O
than	O	O	O
non-night	O	O	B-T098
eaters	O	O	I-T098
.	O	O	O

Male	O	O	B-T032
adolescents	O	O	B-T100
presented	O	O	O
1.9	O	O	O
times	O	O	B-T081
higher	O	O	O
odds	O	O	O
of	O	O	O
being	O	O	O
night	O	O	B-T079
eaters	O	O	B-T098
than	O	O	O
females	O	O	B-T032
.	O	O	O

Adolescents	O	O	B-T100
whose	O	O	O
both	O	O	O
parents	O	O	B-T099
were	O	O	O
night	O	O	B-T079
eaters	O	O	B-T098
were	O	O	O
4.4	O	O	O
times	O	O	B-T081
as	O	O	O
likely	O	O	O
to	O	O	O
be	O	O	O
night	O	O	O
eaters	O	O	O
as	O	O	O
those	O	O	O
whose	O	O	O
neither	O	O	O
parents	O	O	O
were	O	O	O
.	O	O	O

Female	O	O	B-T032
adolescents	O	O	B-T100
showed	O	O	O
a	O	O	O
significant	O	O	O
relationship	O	O	B-T080
between	O	O	O
night	O	O	B-T079
eating	O	O	B-T040
and	O	O	O
BMI	O	O	B-T201
z-scores	O	O	B-T081
(	O	O	O
Î²	O	O	O
=	O	O	O
0.28	O	O	O
,	O	O	O
P	O	O	O
=	O	O	O
0.004	O	O	O
)	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
night	O	O	B-T079
eating	O	O	B-T040
did	O	O	O
not	O	O	O
increase	O	O	B-T169
odds	O	O	O
of	O	O	O
being	O	O	O
overweight	O	O	B-T184
or	O	O	O
obese	O	O	B-T047
in	O	O	O
adolescents	O	O	B-T100
.	O	O	O

Night	O	O	B-T079
eating	O	O	B-T040
in	O	O	O
Korean	O	O	B-T098
adolescents	O	O	B-T100
was	O	O	O
related	O	O	O
to	O	O	O
undesirable	O	O	B-T033
dietary	O	O	I-T033
behaviours	O	O	I-T033
and	O	O	O
low	O	O	B-T033
diet	O	O	I-T033
quality	O	O	I-T033
in	O	O	O
general	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
higher	O	O	O
BMI	O	O	B-T201
z-scores	O	O	B-T081
in	O	O	O
females	O	O	B-T032
.	O	O	O

Male	O	O	B-T032
gender	O	O	B-T032
and	O	O	O
parental	O	O	B-T099
night	O	O	B-T079
eating	O	O	B-T040
appeared	O	O	O
to	O	O	O
be	O	O	O
the	O	O	O
factors	O	O	B-T169
that	O	O	O
significantly	O	O	O
increased	O	O	B-T081
odds	O	O	O
of	O	O	O
night	O	O	O
eating	O	O	O
.	O	O	O

These	O	O	O
results	O	O	O
suggest	O	O	O
that	O	O	O
night	O	O	B-T079
eating	O	O	B-T040
should	O	O	O
be	O	O	O
considered	O	O	O
when	O	O	O
designing	O	O	O
nutrition	O	O	B-T065
education	O	O	I-T065
or	O	O	O
intervention	O	O	B-T061
programs	O	O	I-T061
targeting	O	O	O
adolescents	O	O	B-T100
.	O	O	O

-DOCSTART- (27480410)

A	O	O	O
randomized	O	O	B-T062
trial	O	O	I-T062
of	O	O	O
Plasma-Lyte	O	O	B-T121
A	O	O	I-T121
and	O	O	O
0.9	O	O	B-T121
%	O	O	I-T121
sodium	O	O	I-T121
chloride	O	O	I-T121
in	O	O	O
acute	O	O	O
pediatric	O	O	O
gastroenteritis	O	O	O

Compare	O	O	O
the	O	O	O
efficacy	O	O	B-T080
and	O	O	O
safety	O	O	O
of	O	O	O
Plasma-Lyte	O	O	B-T121
A	O	O	I-T121
(	O	O	O
PLA	O	O	B-T121
)	O	O	O
versus	O	O	O
0.9	O	O	B-T121
%	O	O	I-T121
sodium	O	O	I-T121
chloride	O	O	I-T121
(	O	O	O
NaCl	O	O	B-T121
)	O	O	O
intravenous	O	O	B-T061
(	O	O	I-T061
IV	O	O	I-T061
)	O	O	I-T061
fluid	O	O	I-T061
replacement	O	O	I-T061
in	O	O	O
children	O	O	B-T100
with	O	O	O
moderate	O	O	O
to	O	O	O
severe	O	O	B-T047
dehydration	O	O	I-T047
secondary	O	O	O
to	O	O	O
acute	O	O	B-T047
gastroenteritis	O	O	I-T047
(	O	O	O
AGE	O	O	B-T047
)	O	O	O
.	O	O	O

Prospective	O	O	B-T062
,	O	O	O
randomized	O	O	B-T062
,	O	O	O
double-blind	O	O	B-T062
study	O	O	I-T062
conducted	O	O	O
at	O	O	O
eight	O	O	O
pediatric	O	O	B-T080
emergency	O	O	B-T093
departments	O	O	I-T093
(	O	O	O
EDs	O	O	B-T093
)	O	O	O
in	O	O	O
the	O	O	O
US	O	O	B-T083
and	O	O	O
Canada	O	O	B-T083
(	O	O	O
NCT#01234883	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
primary	O	O	B-T080
outcome	O	O	I-T080
measure	O	O	I-T080
was	O	O	O
serum	O	O	B-T034
bicarbonate	O	O	I-T034
level	O	O	I-T034
at	O	O	O
4	O	O	O
h.	O	O	O
Secondary	O	O	B-T080
outcomes	O	O	I-T080
included	O	O	O
safety	O	O	O
and	O	O	O
tolerability	O	O	B-T062
.	O	O	O

The	O	O	O
hypothesis	O	O	B-T078
was	O	O	O
that	O	O	O
PLA	O	O	B-T121
would	O	O	O
be	O	O	O
superior	O	O	O
to	O	O	O
0.9	O	O	B-T121
%	O	O	I-T121
NaCl	O	O	I-T121
in	O	O	O
improvement	O	O	B-T059
of	O	O	I-T059
4-h	O	O	I-T059
bicarbonate	O	O	I-T059
.	O	O	O

Patients	O	O	B-T101
(	O	O	O
n	O	O	O
=	O	O	O
100	O	O	O
)	O	O	O
aged	O	O	O
â¥6	O	O	O
months	O	O	O
to	O	O	O
<	O	O	O
11	O	O	O
years	O	O	O
with	O	O	O
AGE	O	O	B-T047
-induced	O	O	O
moderate-to-	O	O	O
severe	O	O	B-T047
dehydration	O	O	I-T047
were	O	O	O
enrolled	O	O	O
.	O	O	O

Patients	O	O	B-T101
with	O	O	O
a	O	O	O
baseline	O	O	B-T081
bicarbonate	O	O	B-T034
level	O	O	I-T034
â¤22	O	O	O
mEq/L	O	O	O
formed	O	O	B-T169
the	O	O	O
modified	O	O	B-T169
intent	O	O	B-T169
to	O	O	I-T169
treat	O	O	I-T169
(	O	O	O
mITT	O	O	B-T169
)	O	O	O
group	O	O	B-T098
.	O	O	O

At	O	O	O
baseline	O	O	B-T081
,	O	O	O
the	O	O	O
treatment	O	O	B-T061
groups	O	O	B-T098
were	O	O	O
comparable	O	O	O
except	O	O	O
that	O	O	O
the	O	O	O
PLA	O	O	B-T121
group	O	O	B-T098
was	O	O	O
older	O	O	O
.	O	O	O

At	O	O	O
hour	O	O	O
4	O	O	O
,	O	O	O
the	O	O	O
PLA	O	O	B-T121
group	O	O	B-T098
had	O	O	O
greater	O	O	O
increases	O	O	B-T033
in	O	O	I-T033
serum	O	O	I-T033
bicarbonate	O	O	I-T033
from	O	O	O
baseline	O	O	B-T081
than	O	O	O
did	O	O	O
the	O	O	O
0.9	O	O	B-T121
%	O	O	I-T121
NaCl	O	O	I-T121
group	O	O	O
(	O	O	O
mean	O	O	O
Â±	O	O	O
SD	O	O	O
at	O	O	O
4	O	O	O
h	O	O	O
:	O	O	O
18	O	O	O
Â±	O	O	O
3.74	O	O	O
vs	O	O	O
18.0	O	O	O
Â±	O	O	O
3.67	O	O	O
;	O	O	O
change	O	O	O
from	O	O	O
baseline	O	O	O
of	O	O	O
1.6	O	O	O
and	O	O	O
0.0	O	O	O
,	O	O	O
respectively	O	O	O
;	O	O	O
P	O	O	O
=	O	O	O
.004	O	O	O
)	O	O	O
.	O	O	O

Both	O	O	O
treatment	O	O	B-T061
groups	O	O	B-T098
received	O	O	O
similar	O	O	O
fluid	O	O	B-T081
volumes	O	O	I-T081
.	O	O	O

The	O	O	O
PLA	O	O	B-T121
group	O	O	B-T098
had	O	O	O
less	O	O	O
abdominal	O	O	B-T184
pain	O	O	I-T184
and	O	O	O
better	O	O	O
dehydration	O	O	B-T047
scores	O	O	O
at	O	O	O
hour	O	O	O
2	O	O	O
(	O	O	O
both	O	O	O
P	O	O	O
=	O	O	O
.03	O	O	O
)	O	O	O
but	O	O	O
not	O	O	O
at	O	O	O
hour	O	O	O
4	O	O	O
(	O	O	O
P	O	O	O
=	O	O	O
0.15	O	O	O
and	O	O	O
0.08	O	O	O
,	O	O	O
respectively	O	O	O
)	O	O	O
.	O	O	O

No	O	O	O
patient	O	O	B-T101
experienced	O	O	O
clinically	O	O	B-T078
relevant	O	O	I-T078
worsening	O	O	I-T078
of	O	O	O
laboratory	O	O	B-T034
findings	O	O	I-T034
or	O	O	O
physical	O	O	B-T058
examination	O	O	I-T058
,	O	O	O
and	O	O	O
hospital	O	O	B-T081
admission	O	O	I-T081
rates	O	O	I-T081
were	O	O	O
similar	O	O	B-T080
.	O	O	O

One	O	O	O
patient	O	O	B-T101
in	O	O	O
each	O	O	O
treatment	O	O	B-T061
group	O	O	B-T098
developed	O	O	O
hyponatremia	O	O	B-T047
.	O	O	O

Four	O	O	O
patients	O	O	B-T101
developed	O	O	O
hyperkalemia	O	O	B-T033
(	O	O	O
PLA	O	O	B-T121
:1	O	O	O
,	O	O	O
0.9	O	O	B-T121
%	O	O	I-T121
NaCl	O	O	I-T121
:3	O	O	O
)	O	O	O
.	O	O	O

In	O	O	O
comparison	O	O	B-T052
with	O	O	O
0.9	O	O	B-T121
%	O	O	I-T121
NaCl	O	O	I-T121
,	O	O	O
PLA	O	O	B-T121
for	O	O	O
rehydration	O	O	B-T061
in	O	O	O
children	O	O	B-T100
with	O	O	O
AGE	O	O	B-T047
was	O	O	O
well	O	O	O
tolerated	O	O	O
and	O	O	O
led	O	O	O
to	O	O	O
more	O	O	O
rapid	O	O	O
improvement	O	O	B-T059
in	O	O	I-T059
serum	O	O	I-T059
bicarbonate	O	O	I-T059
and	O	O	O
dehydration	O	O	B-T047
score	O	O	O
.	O	O	O

NCT#01234883	O	O	O
(	O	O	O
Registration	O	O	O
Date	O	O	O
:	O	O	O
November	O	O	O
3	O	O	O
,	O	O	O
2010	O	O	O
)	O	O	O
.	O	O	O

-DOCSTART- (27481539)

The	O	O	O
relationships	O	O	B-T080
between	O	O	O
symptoms	O	O	B-T184
and	O	O	O
quality	O	O	B-T078
of	O	O	I-T078
life	O	O	I-T078
over	O	O	O
the	O	O	O
course	O	O	B-T079
of	O	O	O
cognitive-behavioral	O	O	B-T061
therapy	O	O	I-T061
for	O	O	O
panic	O	O	B-T048
disorder	O	O	I-T048
in	O	O	O
Japan	O	O	O

This	O	O	O
study	O	O	B-T062
examined	O	O	B-T033
the	O	O	O
relationships	O	O	B-T080
between	O	O	O
changes	O	O	B-T169
in	O	O	O
symptoms	O	O	B-T184
and	O	O	O
changes	O	O	O
in	O	O	O
quality	O	O	B-T078
of	O	O	I-T078
life	O	O	I-T078
(	O	O	O
QOL	O	O	B-T078
)	O	O	O
during	O	O	O
cognitive-behavioral	O	O	B-T061
therapy	O	O	I-T061
(	O	O	O
CBT	O	O	B-T061
)	O	O	O
for	O	O	O
panic	O	O	B-T048
disorder	O	O	I-T048
(	O	O	O
PD	O	O	B-T048
)	O	O	O
.	O	O	O

We	O	O	O
treated	O	O	B-T169
198	O	O	O
PD	O	O	B-T048
patients	O	O	B-T101
with	O	O	O
group	O	O	O
CBT	O	O	B-T061
in	O	O	O
Japan	O	O	B-T083
.	O	O	O

Using	O	O	O
multiple	O	O	B-T170
regression	O	O	I-T170
analysis	O	O	I-T170
,	O	O	O
we	O	O	O
examined	O	O	B-T033
the	O	O	O
associations	O	O	B-T080
between	O	O	O
changes	O	O	B-T169
in	O	O	O
QOL	O	O	B-T078
and	O	O	O
changes	O	O	O
in	O	O	O
PD	O	O	B-T048
symptoms	O	O	B-T184
or	O	O	O
comorbid	O	O	B-T184
psychological	O	O	I-T184
symptoms	O	O	I-T184
during	O	O	O
CBT	O	O	B-T061
.	O	O	O

Changes	O	O	B-T169
in	O	O	O
anticipatory	O	O	B-T033
anxiety	O	O	I-T033
,	O	O	O
agoraphobic	O	O	B-T048
fear	O	O	I-T048
/	O	O	O
avoidance	O	O	B-T041
,	O	O	O
and	O	O	O
somatization	O	O	B-T048
were	O	O	O
significant	O	O	O
predictors	O	O	B-T078
of	O	O	O
changes	O	O	B-T169
in	O	O	O
some	O	O	O
aspects	O	O	O
of	O	O	O
QOL	O	O	B-T078
.	O	O	O

It	O	O	O
might	O	O	O
be	O	O	O
useful	O	O	O
to	O	O	O
decrease	O	O	O
somatization	O	O	B-T048
,	O	O	O
anticipatory	O	O	B-T033
anxiety	O	O	I-T033
,	O	O	O
and	O	O	O
agoraphobic	O	O	B-T048
fear	O	O	I-T048
to	O	O	O
improve	O	O	O
QOL	O	O	B-T078
in	O	O	O
CBT	O	O	B-T061
for	O	O	O
PD	O	O	B-T048
.	O	O	O

-DOCSTART- (27481714)

Coupling	O	O	B-T169
of	O	O	O
TRPV6	O	O	B-T116
and	O	O	O
TMEM16A	O	O	B-T116
in	O	O	O
epithelial	O	O	B-T025
principal	O	O	I-T025
cells	O	O	I-T025
of	O	O	O
the	O	O	O
rat	O	O	O
epididymis	O	O	O

The	O	O	O
epididymis	O	O	B-T023
establishes	O	O	O
a	O	O	O
congenial	O	O	B-T080
environment	O	O	B-T082
for	O	O	O
sperm	O	O	B-T042
maturation	O	O	I-T042
and	O	O	O
protection	O	O	B-T033
.	O	O	O

Its	O	O	O
fluid	O	O	B-T031
is	O	O	O
acidic	O	O	B-T081
,	O	O	O
and	O	O	O
the	O	O	O
calcium	O	O	B-T121
concentration	O	O	B-T081
is	O	O	O
low	O	O	B-T080
and	O	O	O
declines	O	O	O
along	O	O	O
the	O	O	O
length	O	O	B-T081
of	O	O	O
the	O	O	O
epididymal	O	O	B-T023
tubule	O	O	I-T023
.	O	O	O

However	O	O	O
,	O	O	O
our	O	O	O
knowledge	O	O	O
of	O	O	O
ionic	O	O	B-T043
currents	O	O	I-T043
and	O	O	O
mechanisms	O	O	B-T169
of	O	O	O
calcium	O	O	B-T043
homeostasis	O	O	I-T043
in	O	O	O
rat	O	O	B-T023
epididymal	O	O	I-T023
epithelial	O	O	B-T025
cells	O	O	I-T025
remains	O	O	O
enigmatic	O	O	O
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
to	O	O	O
better	O	O	O
understand	O	O	O
calcium	O	O	B-T043
regulation	O	O	I-T043
in	O	O	O
the	O	O	O
epididymis	O	O	B-T023
,	O	O	O
we	O	O	O
use	O	O	O
the	O	O	O
patch-clamp	O	O	B-T062
method	O	O	I-T062
to	O	O	O
record	O	O	O
from	O	O	O
single	O	O	O
rat	O	O	B-T015
cauda	O	O	B-T023
epididymal	O	O	I-T023
principal	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

We	O	O	O
detect	O	O	B-T033
a	O	O	O
constitutively	O	O	O
active	O	O	B-T169
Ca(2	O	O	B-T121
+	O	O	I-T121
)	O	O	I-T121
current	O	O	B-T043
with	O	O	O
characteristics	O	O	B-T080
that	O	O	O
match	O	O	O
the	O	O	O
epithelial	O	O	B-T024
calcium	O	O	B-T116
channel	O	O	I-T116
TRPV6	O	O	B-T116
.	O	O	O

Electrophysiological	O	O	B-T060
and	O	O	O
pharmacological	O	O	B-T060
data	O	O	I-T060
also	O	O	O
reveal	O	O	O
a	O	O	O
constitutively	O	O	O
active	O	O	B-T116
calcium-activated	O	O	I-T116
chloride	O	O	I-T116
conductance	O	O	I-T116
(	O	O	O
CaCC	O	O	B-T116
)	O	O	O
.	O	O	O

Removal	O	O	O
of	O	O	O
extracellular	O	O	B-T026
calcium	O	O	B-T121
attenuates	O	O	B-T052
not	O	O	O
only	O	O	O
the	O	O	O
TRPV6	O	O	B-T116
-like	O	O	O
conductance	O	O	B-UnknownType
,	O	O	O
but	O	O	O
also	O	O	O
the	O	O	O
CaCC	O	O	B-T116
.	O	O	O

Lanthanide	O	O	B-T196
block	O	O	B-T169
is	O	O	O
time	O	O	B-T079
dependent	O	O	B-T080
such	O	O	O
that	O	O	O
the	O	O	O
TRPV6	O	O	B-T116
-like	O	O	O
component	O	O	O
is	O	O	O
inhibited	O	O	B-T043
first	O	O	O
,	O	O	O
followed	O	O	O
by	O	O	O
the	O	O	O
CaCC	O	O	B-T116
.	O	O	O

The	O	O	O
putative	O	O	O
CaCC	O	O	B-T116
blocker	O	O	B-T121
niflumic	O	O	B-T109
acid	O	O	I-T109
partially	O	O	O
inhibits	O	O	B-T043
whole-cell	O	O	B-T025
currents	O	O	B-T043
,	O	O	O
whereas	O	O	O
La(3	O	O	B-T197
+	O	O	I-T197
)	O	O	I-T197
almost	O	O	O
abolishes	O	O	O
whole-cell	O	O	O
currents	O	O	O
in	O	O	O
principal	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

Membrane	O	O	B-T043
potential	O	O	I-T043
measurements	O	O	B-T169
reveal	O	O	O
an	O	O	O
interplay	O	O	O
between	O	O	O
La(3	O	O	B-T197
+	O	O	I-T197
)	O	O	I-T197
-	O	O	O
sensitive	O	O	B-T169
ion	O	O	I-T116
channels	O	O	I-T116
and	O	O	O
those	O	O	O
that	O	O	O
are	O	O	O
sensitive	O	O	O
to	O	O	O
the	O	O	O
specific	O	O	B-T170
TMEM16A	O	O	B-T116
inhibitor	O	O	B-T120
tannic	O	O	B-T109
acid	O	O	I-T109
.	O	O	O

In	O	O	B-T082
vivo	O	O	I-T082
perfusion	O	O	B-T061
of	O	O	O
the	O	O	O
cauda	O	O	B-T023
epididymal	O	O	I-T023
tubule	O	O	I-T023
shows	O	O	O
a	O	O	O
substantial	O	O	O
rate	O	O	O
of	O	O	O
Ca(2	O	O	B-T121
+	O	O	I-T121
)	O	O	I-T121
reabsorption	O	O	B-T039
from	O	O	O
the	O	O	O
luminal	O	O	B-T082
side	O	O	I-T082
,	O	O	O
which	O	O	O
is	O	O	O
dose-dependently	O	O	O
suppressed	O	O	B-T169
by	O	O	O
ruthenium	O	O	B-T130
red	O	O	I-T130
,	O	O	O
a	O	O	O
putative	O	O	O
blocker	O	O	B-T121
of	O	O	O
epithelial	O	O	B-T024
Ca(2	O	O	B-T116
+	O	O	I-T116
)	O	O	I-T116
channels	O	O	I-T116
and	O	O	O
CaCC	O	O	B-T116
.	O	O	O

Finally	O	O	O
,	O	O	O
we	O	O	O
discover	O	O	O
messenger	O	O	B-T114
RNA	O	O	I-T114
for	O	O	O
both	O	O	O
TRPV6	O	O	B-T116
and	O	O	O
TMEM16A	O	O	B-T116
in	O	O	O
the	O	O	O
rat	O	O	B-T023
epididymis	O	O	I-T023
and	O	O	O
show	O	O	O
that	O	O	O
their	O	O	O
proteins	O	O	B-T116
colocalize	O	O	B-T082
in	O	O	O
the	O	O	O
apical	O	O	B-T026
membrane	O	O	I-T026
of	O	O	O
principal	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

Collectively	O	O	O
,	O	O	O
these	O	O	O
data	O	O	B-T078
provide	O	O	O
evidence	O	O	B-T078
for	O	O	O
a	O	O	O
coupling	O	O	B-T169
mechanism	O	O	B-T169
between	O	O	O
TRPV6	O	O	B-T116
and	O	O	O
TMEM16A	O	O	B-T116
in	O	O	O
principal	O	O	B-T025
cells	O	O	I-T025
that	O	O	O
may	O	O	O
play	O	O	O
an	O	O	O
important	O	O	O
role	O	O	O
in	O	O	O
the	O	O	O
regulation	O	O	B-T043
of	O	O	I-T043
calcium	O	O	I-T043
homeostasis	O	O	I-T043
in	O	O	O
the	O	O	O
epididymis	O	O	B-T023
.	O	O	O

-DOCSTART- (27482869)

Voices	O	O	O
:	O	O	O
A	O	O	O
Conversation	O	O	B-T054
with	O	O	O
Allen	O	O	O
J.	O	O	O
Wilcox	O	O	O

Allen	O	O	B-T016
James	O	O	I-T016
Wilcox	O	O	I-T016
was	O	O	O
born	O	O	O
on	O	O	O
30	O	O	O
September	O	O	O
1946	O	O	O
in	O	O	O
Columbus	O	O	B-T083
,	O	O	I-T083
OH	O	O	I-T083
.	O	O	O

He	O	O	O
studied	O	O	O
medicine	O	O	B-T091
at	O	O	O
the	O	O	O
University	O	O	B-T073
of	O	O	I-T073
Michigan	O	O	I-T073
,	O	O	O
graduated	O	O	O
in	O	O	O
1973	O	O	O
,	O	O	O
and	O	O	O
after	O	O	O
a	O	O	O
rotating	O	O	O
internship	O	O	B-T065
,	O	O	O
he	O	O	O
completed	O	O	B-T033
a	O	O	I-T033
master	O	O	I-T033
's	O	O	I-T033
degree	O	O	I-T033
in	O	O	O
maternal	O	O	B-T091
and	O	O	I-T091
child	O	O	I-T091
health	O	O	I-T091
(	O	O	O
1976	O	O	O
)	O	O	O
and	O	O	O
a	O	O	O
PhD	O	O	B-T170
in	O	O	O
epidemiology	O	O	B-T091
(	O	O	O
1979	O	O	O
)	O	O	O
at	O	O	O
the	O	O	O
University	O	O	B-T073
of	O	O	I-T073
North	O	O	I-T073
Carolina	O	O	I-T073
in	O	O	O
Chapel	O	O	B-T083
Hill	O	O	I-T083
.	O	O	O

After	O	O	O
graduation	O	O	B-T065
,	O	O	O
he	O	O	O
went	O	O	O
to	O	O	O
work	O	O	B-T057
at	O	O	O
the	O	O	O
National	O	O	B-T093
Institute	O	O	I-T093
of	O	O	I-T093
Environmental	O	O	I-T093
Health	O	O	I-T093
Sciences	O	O	I-T093
(	O	O	O
NIEHS	O	O	B-T093
,	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
US	O	O	B-T093
National	O	O	I-T093
Institutes	O	O	I-T093
of	O	O	I-T093
Health	O	O	I-T093
)	O	O	O
in	O	O	O
Durham	O	O	B-T083
,	O	O	I-T083
NC	O	O	I-T083
,	O	O	O
where	O	O	O
he	O	O	O
has	O	O	O
spent	O	O	O
his	O	O	O
career	O	O	B-T057
.	O	O	O

He	O	O	O
developed	O	O	O
a	O	O	O
research	O	O	B-T062
program	O	O	I-T062
in	O	O	O
reproductive	O	O	O
and	O	O	O
perinatal	O	O	B-T091
epidemiology	O	O	I-T091
,	O	O	O
a	O	O	O
relatively	O	O	O
unexplored	O	O	O
area	O	O	O
at	O	O	O
the	O	O	O
time	O	O	O
.	O	O	O

His	O	O	O
studies	O	O	O
include	O	O	O
the	O	O	O
early	O	O	B-T047
pregnancy	O	O	I-T047
study	O	O	O
,	O	O	O
which	O	O	O
documented	O	O	B-T058
the	O	O	O
extent	O	O	O
of	O	O	O
subclinical	O	O	B-T080
pregnancy	O	O	B-T046
loss	O	O	I-T046
in	O	O	O
humans	O	O	B-T016
and	O	O	O
established	O	O	B-T080
the	O	O	O
fertile	O	O	B-T079
days	O	O	I-T079
of	O	O	O
a	O	O	O
woman	O	O	B-T098
's	O	O	I-T098
menstrual	O	O	B-T040
cycle	O	O	I-T040
.	O	O	O

He	O	O	O
served	O	O	O
as	O	O	O
the	O	O	O
Chief	O	O	B-T097
of	O	O	I-T097
the	O	O	O
Epidemiology	O	O	B-T091
Branch	O	O	B-T097
from	O	O	O
1991	O	O	O
to	O	O	O
2001	O	O	O
,	O	O	O
and	O	O	O
as	O	O	O
Editor-in-Chief	O	O	B-T097
of	O	O	O
the	O	O	O
journal	O	O	B-T073
EPIDEMIOLOGY	O	O	B-T091
from	O	O	O
2001	O	O	O
to	O	O	O
2014	O	O	O
.	O	O	O

His	O	O	O
textbook	O	O	B-T073
,	O	O	O
Fertility	O	O	B-T073
and	O	O	I-T073
Pregnancy-An	O	O	I-T073
Epidemiologic	O	O	I-T073
Perspective	O	O	I-T073
,	O	O	O
was	O	O	O
published	O	O	B-T057
by	O	O	O
Oxford	O	O	B-T170
University	O	O	I-T170
Press	O	O	I-T170
in	O	O	O
2010	O	O	O
.	O	O	O

He	O	O	O
was	O	O	O
elected	O	O	B-UnknownType
to	O	O	O
the	O	O	O
American	O	O	B-T093
Epidemiological	O	O	I-T093
Society	O	O	I-T093
in	O	O	O
1989	O	O	O
,	O	O	O
and	O	O	O
served	O	O	O
as	O	O	O
its	O	O	O
president	O	O	B-T090
in	O	O	O
2003	O	O	O
.	O	O	O

He	O	O	O
also	O	O	O
served	O	O	O
as	O	O	O
president	O	O	B-T090
of	O	O	O
the	O	O	O
Society	O	O	B-T093
of	O	O	I-T093
Pediatric	O	O	I-T093
and	O	O	I-T093
Perinatal	O	O	I-T093
Epidemiological	O	O	I-T093
Research	O	O	I-T093
(	O	O	O
1996	O	O	O
)	O	O	O
and	O	O	O
the	O	O	O
president	O	O	O
of	O	O	O
the	O	O	O
Society	O	O	B-T093
of	O	O	I-T093
Epidemiological	O	O	I-T093
Research	O	O	I-T093
(	O	O	O
1998	O	O	O
)	O	O	O
.	O	O	O

He	O	O	O
holds	O	O	O
adjunct	O	O	O
teaching	O	O	B-T065
appointments	O	O	B-T079
at	O	O	O
the	O	O	O
University	O	O	B-T073
of	O	O	I-T073
North	O	O	I-T073
Carolina	O	O	I-T073
,	O	O	O
Harvard	O	O	B-T073
University	O	O	I-T073
,	O	O	O
and	O	O	O
the	O	O	O
University	O	O	B-T073
of	O	O	I-T073
Bergen	O	O	I-T073
(	O	O	O
Norway	O	O	B-T083
)	O	O	O
,	O	O	O
which	O	O	O
awarded	O	O	B-T073
him	O	O	O
an	O	O	O
honorary	O	O	B-T080
doctoral	O	O	B-T170
degree	O	O	I-T170
in	O	O	O
2008	O	O	O
.	O	O	O

-DOCSTART- (27484604)

Evaluation	O	O	B-T058
of	O	O	O
Spontaneous	O	O	B-T169
Bone	O	O	B-T042
Regeneration	O	O	I-T042
after	O	O	O
Enucleation	O	O	B-T061
of	O	O	O
Large	O	O	B-T081
Cysts	O	O	B-T047
of	O	O	O
the	O	O	O
Jaws	O	O	B-T023
using	O	O	O
Radiographic	O	O	B-T070
Computed	O	O	B-T059
Software	O	O	O

Spontaneous	O	O	B-T169
regeneration	O	O	B-T042
of	O	O	I-T042
bone	O	O	I-T042
is	O	O	O
commonly	O	O	B-T081
seen	O	O	O
in	O	O	O
the	O	O	O
small	O	O	B-T081
surgical	O	O	B-T061
defects	O	O	B-T169
caused	O	O	O
by	O	O	O
enucleation	O	O	B-T061
of	O	O	O
cysts	O	O	B-T047
.	O	O	O

However	O	O	O
,	O	O	O
in	O	O	O
case	O	O	O
of	O	O	O
large	O	O	B-T081
surgical	O	O	B-T061
defects	O	O	B-T169
caused	O	O	O
by	O	O	O
the	O	O	O
enucleation	O	O	B-T061
,	O	O	O
spontaneous	O	O	B-T169
regeneration	O	O	B-T042
of	O	O	I-T042
bone	O	O	I-T042
is	O	O	O
a	O	O	O
rare	O	O	B-T080
phenomenon	O	O	B-T067
and	O	O	O
it	O	O	O
depends	O	O	B-T080
on	O	O	O
factors	O	O	B-T169
,	O	O	O
such	O	O	O
as	O	O	O
age	O	O	B-T032
of	O	O	O
the	O	O	O
patient	O	O	B-T101
,	O	O	O
intact	O	O	B-T080
periosteum	O	O	B-T024
,	O	O	O
and	O	O	O
proper	O	O	O
stabilization	O	O	B-T061
.	O	O	O

The	O	O	O
study	O	O	B-T062
included	O	O	B-T169
16	O	O	O
patients	O	O	B-T101
,	O	O	O
who	O	O	O
reported	O	O	B-T058
to	O	O	O
the	O	O	O
department	O	O	B-T093
of	O	O	I-T093
oral	O	O	I-T093
and	O	O	I-T093
maxillofacial	O	O	I-T093
surgery	O	O	I-T093
with	O	O	O
the	O	O	O
complaint	O	O	B-T047
of	O	O	O
pain	O	O	B-T184
and	O	O	O
swelling	O	O	B-T033
in	O	O	O
the	O	O	O
jaws	O	O	B-T023
diagnosed	O	O	B-T033
as	O	O	O
cyst	O	O	B-T047
.	O	O	O

The	O	O	O
sample	O	O	B-T077
included	O	O	B-T169
equal	O	O	O
numbers	O	O	B-T081
of	O	O	O
male	O	O	B-T032
and	O	O	O
female	O	O	B-T032
subjects	O	O	B-T096
aged	O	O	B-T032
between	O	O	O
15	O	O	O
and	O	O	O
40	O	O	O
years	O	O	O
.	O	O	O

Panoramic	O	O	B-T060
radiographs	O	O	I-T060
were	O	O	O
taken	O	O	O
pre-	O	O	B-T079
and	O	O	O
postoperatively	O	O	B-T079
on	O	O	O
day	O	O	O
2	O	O	O
of	O	O	O
the	O	O	O
enucleation	O	O	B-T061
.	O	O	O

The	O	O	O
dimensions	O	O	B-T081
of	O	O	O
the	O	O	O
cyst	O	O	B-T047
were	O	O	O
evaluated	O	O	B-T058
on	O	O	O
the	O	O	O
radiograph	O	O	B-T060
according	O	O	O
to	O	O	O
the	O	O	O
proforma	O	O	B-T169
.	O	O	O

Subsequent	O	O	B-T079
radiographs	O	O	B-T060
were	O	O	O
taken	O	O	O
at	O	O	O
regular	O	O	B-T080
intervals	O	O	B-T079
of	O	O	O
1.5	O	O	O
,	O	O	O
3	O	O	O
,	O	O	O
and	O	O	O
6	O	O	O
months	O	O	O
using	O	O	O
standard	O	O	B-T081
parameters	O	O	B-T077
and	O	O	O
were	O	O	O
analyzed	O	O	B-T062
using	O	O	O
MCID	O	O	B-T170
â¢	O	O	I-T170
analysis	O	O	I-T170
software	O	O	B-T073
of	O	O	O
imaging	O	O	B-T060
research	O	O	I-T060
.	O	O	O

Mean	O	O	B-T081
reduction	O	O	B-T061
was	O	O	O
seen	O	O	O
in	O	O	O
up	O	O	O
to	O	O	O
39	O	O	O
and	O	O	O
60	O	O	O
%	O	O	O
in	O	O	O
the	O	O	O
cystic	O	O	B-T080
cavity	O	O	B-T190
size	O	O	B-T082
and	O	O	O
increase	O	O	B-T169
in	O	O	O
the	O	O	O
mean	O	O	B-T081
density	O	O	B-T081
up	O	O	O
to	O	O	O
59	O	O	O
and	O	O	O
90.2	O	O	O
%	O	O	O
at	O	O	O
3	O	O	O
and	O	O	O
6	O	O	O
months	O	O	O
intervals	O	O	B-T079
respectively	O	O	O
.	O	O	O

Spontaneous	O	O	B-T169
bone	O	O	B-T042
regeneration	O	O	I-T042
was	O	O	O
seen	O	O	O
even	O	O	O
after	O	O	O
primary	O	O	B-T080
closure	O	O	B-T061
of	O	O	O
the	O	O	O
large	O	O	B-T081
cystic	O	O	B-T080
defect	O	O	B-T169
without	O	O	O
the	O	O	O
need	O	O	B-T080
for	O	O	O
placement	O	O	B-T058
of	O	O	O
foreign	O	O	B-T167
substances	O	O	I-T167
or	O	O	O
grafts	O	O	B-T122
and	O	O	O
it	O	O	O
also	O	O	O
eliminated	O	O	B-T080
the	O	O	O
complications	O	O	B-T046
resulting	O	O	B-T169
from	O	O	I-T169
placement	O	O	O
of	O	O	O
foreign	O	O	B-T167
substance	O	O	I-T167
.	O	O	O

Further	O	O	O
studies	O	O	B-T062
are	O	O	O
required	O	O	B-T169
in	O	O	O
a	O	O	O
larger	O	O	B-T081
sample	O	O	B-T077
with	O	O	O
longer	O	O	B-T080
follow-up	O	O	B-T058
durations	O	O	B-T079
to	O	O	O
confirm	O	O	B-T080
the	O	O	O
outcome	O	O	B-T080
of	O	O	I-T080
the	O	O	I-T080
present	O	O	I-T080
work	O	O	I-T080
for	O	O	O
the	O	O	O
benefit	O	O	B-T081
of	O	O	O
patients	O	O	B-T101
.	O	O	O

The	O	O	O
present	O	O	B-T079
study	O	O	B-T062
depicted	O	O	O
that	O	O	O
spontaneous	O	O	B-T169
bone	O	O	B-T042
regeneration	O	O	I-T042
can	O	O	O
occur	O	O	O
with	O	O	O
accepted	O	O	B-T080
results	O	O	B-T033
after	O	O	O
simple	O	O	B-T080
enucleation	O	O	B-T061
of	O	O	O
jaw	O	O	B-T023
cyst	O	O	B-T047
without	O	O	O
the	O	O	O
aid	O	O	B-T080
of	O	O	O
any	O	O	O
graft	O	O	B-T122
material	O	O	I-T122
.	O	O	O

Hence	O	O	O
,	O	O	O
simple	O	O	B-T080
enucleation	O	O	B-T061
may	O	O	O
be	O	O	O
considered	O	O	B-T078
as	O	O	O
a	O	O	O
first	O	O	B-T061
line	O	O	I-T061
of	O	O	I-T061
treatment	O	O	I-T061
modality	O	O	B-T078
for	O	O	O
cystic	O	O	B-T080
lesion	O	O	B-T033
of	O	O	O
the	O	O	O
jaws	O	O	B-T023
.	O	O	O

This	O	O	O
simplifies	O	O	O
the	O	O	O
surgical	O	O	B-T061
procedure	O	O	I-T061
,	O	O	O
decreases	O	O	B-T081
the	O	O	O
economic	O	O	B-T169
and	O	O	O
biologic	O	O	B-T080
costs	O	O	B-T081
,	O	O	O
and	O	O	O
reduces	O	O	B-T061
the	O	O	O
risk	O	O	B-T078
of	O	O	O
postoperative	O	O	B-T046
complications	O	O	I-T046
.	O	O	O

Follow-up	O	O	B-T058
is	O	O	O
necessary	O	O	O
along	O	O	O
with	O	O	O
patient	O	O	B-T101
's	O	O	I-T101
compliance	O	O	B-T055
for	O	O	O
the	O	O	O
success	O	O	B-T080
of	O	O	I-T080
treatment	O	O	I-T080
.	O	O	O

-DOCSTART- (27485340)

Membrane	O	O	B-T044
Protein	O	O	B-T116
Solubilization	O	O	I-T044
and	O	O	O
Composition	O	O	B-T070
of	O	O	O
Protein	O	O	O
Detergent	O	O	B-T120
Complexes	O	O	O

Membrane	O	O	B-T116
proteins	O	O	I-T116
are	O	O	O
typically	O	O	B-T045
expressed	O	O	I-T045
in	O	O	O
heterologous	O	O	B-T080
systems	O	O	B-T169
with	O	O	O
a	O	O	O
view	O	O	O
to	O	O	O
in	O	O	B-T062
vitro	O	O	I-T062
characterization	O	O	B-T052
.	O	O	O

A	O	O	O
critical	O	O	B-T077
step	O	O	I-T077
in	O	O	O
the	O	O	O
preparation	O	O	B-T052
of	O	O	O
membrane	O	O	B-T116
proteins	O	O	I-T116
after	O	O	O
expression	O	O	B-T045
in	O	O	O
any	O	O	O
system	O	O	B-T169
is	O	O	O
the	O	O	O
solubilization	O	O	B-T044
of	O	O	I-T044
the	O	O	I-T044
protein	O	O	B-T116
in	O	O	O
aqueous	O	O	B-T121
solution	O	O	I-T121
,	O	O	O
typically	O	O	O
using	O	O	O
detergents	O	O	B-T120
and	O	O	O
lipids	O	O	B-T109
,	O	O	O
to	O	O	O
obtain	O	O	O
the	O	O	O
protein	O	O	O
in	O	O	O
a	O	O	O
form	O	O	O
suitable	O	O	B-T080
for	O	O	O
purification	O	O	B-T169
,	O	O	O
structural	O	O	B-T061
or	O	O	O
functional	O	O	B-T169
analysis	O	O	B-T062
.	O	O	O

This	O	O	O
process	O	O	B-T067
is	O	O	O
particularly	O	O	O
difficult	O	O	O
as	O	O	O
the	O	O	O
objective	O	O	O
is	O	O	O
to	O	O	O
prepare	O	O	O
the	O	O	O
protein	O	O	B-T116
in	O	O	O
an	O	O	O
unnatural	O	O	B-T080
environment	O	O	B-T082
,	O	O	O
a	O	O	O
protein	O	O	O
detergent	O	O	B-T120
complex	O	O	B-T104
,	O	O	O
separating	O	O	O
it	O	O	O
from	O	O	O
its	O	O	O
natural	O	O	B-T169
lipid	O	O	B-T109
partners	O	O	O
while	O	O	O
causing	O	O	O
the	O	O	O
minimum	O	O	B-T080
destabilization	O	O	B-T043
or	O	O	O
modification	O	O	B-T033
of	O	O	O
the	O	O	O
structure	O	O	B-T082
.	O	O	O

Although	O	O	O
the	O	O	O
process	O	O	B-T067
is	O	O	O
difficult	O	O	B-T080
,	O	O	O
and	O	O	O
relatively	O	O	O
hard	O	O	O
to	O	O	O
master	O	O	O
,	O	O	O
an	O	O	O
increasing	O	O	B-T169
number	O	O	O
of	O	O	O
membrane	O	O	B-T116
proteins	O	O	I-T116
have	O	O	O
been	O	O	O
successfully	O	O	B-T169
isolated	O	O	I-T169
after	O	O	O
expression	O	O	B-T045
in	O	O	O
a	O	O	O
wide	O	O	O
variety	O	O	O
of	O	O	O
systems	O	O	B-T169
.	O	O	O

In	O	O	O
this	O	O	O
chapter	O	O	O
we	O	O	O
give	O	O	O
a	O	O	O
general	O	O	B-T170
protocol	O	O	I-T170
for	O	O	O
preparing	O	O	O
protein	O	O	B-T116
detergent	O	O	B-T120
complexes	O	O	B-T104
that	O	O	O
is	O	O	O
aimed	O	O	O
at	O	O	O
guiding	O	O	O
the	O	O	O
reader	O	O	O
through	O	O	O
the	O	O	O
different	O	O	O
critical	O	O	B-T077
steps	O	O	I-T077
.	O	O	O

In	O	O	O
the	O	O	O
second	O	O	O
part	O	O	O
of	O	O	O
the	O	O	O
chapter	O	O	O
we	O	O	O
illustrate	O	O	O
how	O	O	O
to	O	O	O
analyze	O	O	B-T062
the	O	O	O
composition	O	O	B-T070
of	O	O	O
protein	O	O	B-T116
detergent	O	O	B-T120
complexes	O	O	B-T104
;	O	O	O
this	O	O	O
analysis	O	O	B-T062
is	O	O	O
important	O	O	O
as	O	O	O
it	O	O	O
has	O	O	O
been	O	O	O
found	O	O	O
that	O	O	O
compositional	O	O	B-T070
variation	O	O	B-T080
often	O	O	O
causes	O	O	O
irreproducible	O	O	O
results	O	O	O
.	O	O	O

-DOCSTART- (27486419)

Can	O	O	O
We	O	O	O
Predict	O	O	B-T078
Burnout	O	O	B-T048
among	O	O	O
Student	O	O	B-T097
Nurses	O	O	I-T097
?	O	O	O
An	O	O	O
Exploration	O	O	O
of	O	O	O
the	O	O	O
ICWR-1	O	O	B-T170
Model	O	O	I-T170
of	O	O	O
Individual	O	O	B-T098
Psychological	O	O	O
Resilience	O	O	O

An	O	O	O
Exploration	O	O	O
of	O	O	O
the	O	O	O
ICWR-1	O	O	B-T170
Model	O	O	I-T170
of	O	O	O
Individual	O	O	B-T098
Psychological	O	O	B-T055
Resilience	O	O	I-T055
The	O	O	O
nature	O	O	O
of	O	O	O
nursing	O	O	B-T091
work	O	O	I-T091
is	O	O	O
demanding	O	O	B-T061
and	O	O	O
can	O	O	O
be	O	O	O
stressful	O	O	B-T169
.	O	O	O

Previous	O	O	O
studies	O	O	O
have	O	O	O
shown	O	O	O
a	O	O	O
high	O	O	B-T080
rate	O	O	B-T081
of	O	O	O
burnout	O	O	B-T048
among	O	O	O
employed	O	O	B-T033
nurses	O	O	B-T097
.	O	O	O

Recently	O	O	O
,	O	O	O
efforts	O	O	O
have	O	O	O
been	O	O	O
made	O	O	O
to	O	O	O
understand	O	O	O
the	O	O	O
role	O	O	O
of	O	O	O
resilience	O	O	B-T055
in	O	O	O
determining	O	O	O
the	O	O	O
psychological	O	O	B-T055
adjustment	O	O	I-T055
of	O	O	O
employed	O	O	B-T033
nurses	O	O	B-T097
.	O	O	O

A	O	O	O
theoretical	O	O	B-T170
model	O	O	I-T170
of	O	O	O
resilience	O	O	B-T055
was	O	O	O
proposed	O	O	O
recently	O	O	O
that	O	O	O
includes	O	O	B-T169
several	O	O	B-T081
constructs	O	O	B-T185
identified	O	O	O
in	O	O	O
the	O	O	O
literature	O	O	B-T170
related	O	O	O
to	O	O	O
resilience	O	O	O
and	O	O	O
to	O	O	O
psychological	O	O	B-T041
functioning	O	O	I-T041
.	O	O	O

As	O	O	O
nursing	O	O	B-T091
students	O	O	I-T097
are	O	O	O
the	O	O	O
future	O	O	B-T079
of	O	O	O
the	O	O	O
nursing	O	O	O
workforce	O	O	B-T097
it	O	O	O
is	O	O	O
important	O	O	B-T080
to	O	O	O
advance	O	O	B-T079
our	O	O	O
understanding	O	O	O
of	O	O	O
the	O	O	O
determinants	O	O	B-T169
of	O	O	O
resilience	O	O	B-T055
in	O	O	O
this	O	O	O
population	O	O	B-T098
.	O	O	O

Student	O	O	B-T097
nurses	O	O	I-T097
who	O	O	O
had	O	O	O
completed	O	O	B-T078
their	O	O	O
final	O	O	B-T079
practicum	O	O	B-T065
were	O	O	O
invited	O	O	O
to	O	O	O
participate	O	O	O
in	O	O	O
an	O	O	O
online	O	O	B-T170
survey	O	O	I-T170
measuring	O	O	B-T080
the	O	O	O
key	O	O	O
constructs	O	O	B-T185
of	O	O	O
the	O	O	O
ICWR-1	O	O	B-T170
model	O	O	I-T170
.	O	O	O

422	O	O	O
students	O	O	B-T097
from	O	O	O
across	O	O	O
Australia	O	O	B-T083
and	O	O	O
Canada	O	O	B-T083
completed	O	O	B-T078
the	O	O	O
survey	O	O	B-T170
between	O	O	O
July	O	O	O
2014	O	O	O
and	O	O	O
July	O	O	O
2015	O	O	O
.	O	O	O

As	O	O	O
well	O	O	O
as	O	O	O
several	O	O	B-T081
key	O	O	O
demographics	O	O	B-T078
,	O	O	O
trait	O	O	B-T033
negative	O	O	I-T033
affect	O	O	I-T033
,	O	O	O
mindfulness	O	O	B-T041
,	O	O	O
self-efficacy	O	O	B-T041
,	O	O	O
coping	O	O	B-T055
,	O	O	O
resilience	O	O	B-T055
,	O	O	O
and	O	O	O
burnout	O	O	B-T048
were	O	O	O
measured	O	O	B-T080
.	O	O	O

We	O	O	O
used	O	O	O
structural	O	O	B-T062
equation	O	O	I-T062
modeling	O	O	I-T062
and	O	O	O
found	O	O	O
support	O	O	O
for	O	O	O
the	O	O	O
major	O	O	B-T080
pathways	O	O	B-T077
of	O	O	O
the	O	O	O
model	O	O	B-T170
;	O	O	O
namely	O	O	O
that	O	O	O
resilience	O	O	B-T055
had	O	O	O
a	O	O	O
significant	O	O	B-T078
influence	O	O	B-T077
on	O	O	O
the	O	O	O
relationship	O	O	B-T080
between	O	O	O
mindfulness	O	O	B-T041
,	O	O	O
self-efficacy	O	O	B-T041
and	O	O	O
coping	O	O	B-T055
,	O	O	O
and	O	O	O
psychological	O	O	B-T055
adjustment	O	O	I-T055
(	O	O	O
burnout	O	O	B-T048
scores	O	O	B-T081
)	O	O	O
.	O	O	O

Furthermore	O	O	O
,	O	O	O
as	O	O	O
predicted	O	O	B-T078
,	O	O	O
Neuroticism	O	O	B-T048
moderated	O	O	O
the	O	O	O
relationship	O	O	B-T080
between	O	O	O
coping	O	O	B-T055
and	O	O	O
burnout	O	O	B-T048
.	O	O	O

Results	O	O	O
are	O	O	O
discussed	O	O	O
in	O	O	O
terms	O	O	O
of	O	O	O
potential	O	O	B-T080
approaches	O	O	B-T169
to	O	O	O
supporting	O	O	O
nursing	O	O	B-T097
students	O	O	I-T097
who	O	O	O
may	O	O	O
be	O	O	O
at	O	O	B-T080
risk	O	O	I-T080
of	O	O	O
burnout	O	O	B-T048
.	O	O	O

-DOCSTART- (27487357)

Medication	O	O	B-T061
Intervention	O	O	I-T061
for	O	O	O
Chronic	O	O	B-T047
Kidney	O	O	I-T047
Disease	O	O	I-T047
Patients	O	O	B-T101
Transitioning	O	O	B-T052
from	O	O	O
Hospital	O	O	B-T093
to	O	O	O
Home	O	O	B-T082
:	O	O	O
Study	O	O	B-T062
Design	O	O	I-T062
and	O	O	O
Baseline	O	O	B-T081
Characteristics	O	O	O

The	O	O	O
hospital	O	O	B-T058
readmission	O	O	I-T058
rate	O	O	B-T081
in	O	O	O
the	O	O	O
population	O	O	B-T098
with	O	O	O
chronic	O	O	B-T047
kidney	O	O	I-T047
disease	O	O	I-T047
(	O	O	O
CKD	O	O	B-T047
)	O	O	O
is	O	O	O
high	O	O	O
and	O	O	O
strategies	O	O	O
to	O	O	O
reduce	O	O	O
this	O	O	O
risk	O	O	B-T078
are	O	O	O
urgently	O	O	O
needed	O	O	B-T080
.	O	O	O

The	O	O	O
CKD	O	O	B-T047
-	O	O	O
Medication	O	O	B-T061
Intervention	O	O	I-T061
Trial	O	O	I-T061
(	O	O	O
CKD	O	O	O
-	O	O	O
MIT	O	O	B-T061
;	O	O	O
www.clinicaltrials.gov	O	O	B-T170
;	O	O	I-T170
NCTO1459770	O	O	I-T170
)	O	O	O
is	O	O	O
a	O	O	O
single-blind	O	O	B-T062
(	O	O	O
investigators	O	O	B-T097
)	O	O	O
,	O	O	O
randomized	O	O	B-T062
,	O	O	O
clinical	O	O	B-T062
trial	O	O	I-T062
conducted	O	O	O
at	O	O	O
Providence	O	O	B-T058
Health	O	O	I-T058
Care	O	O	I-T058
in	O	O	O
Spokane	O	O	B-T083
,	O	O	I-T083
Washington	O	O	I-T083
.	O	O	O

Study	O	O	B-T096
participants	O	O	I-T096
are	O	O	O
hospitalized	O	O	B-T101
patients	O	O	I-T101
with	O	O	O
CKD	O	O	B-T047
stages	O	O	B-T079
3	O	O	O
-	O	O	O
5	O	O	O
(	O	O	O
not	O	O	O
treated	O	O	B-T061
with	O	O	I-T061
kidney	O	O	B-T061
replacement	O	O	I-T061
therapy	O	O	I-T061
)	O	O	O
and	O	O	O
acute	O	O	B-T046
illness	O	O	I-T046
.	O	O	O

The	O	O	O
study	O	O	B-T170
intervention	O	O	B-T061
is	O	O	O
a	O	O	O
pharmacist-led	O	O	B-T097
,	O	O	O
home-based	O	O	B-T058
,	O	O	O
medication	O	O	B-T058
management	O	O	I-T058
intervention	O	O	O
delivered	O	O	B-T169
within	O	O	O
7	O	O	O
days	O	O	B-T079
after	O	O	O
hospital	O	O	B-T058
discharge	O	O	I-T058
.	O	O	O

The	O	O	O
primary	O	O	B-T169
outcome	O	O	I-T169
is	O	O	O
a	O	O	O
composite	O	O	O
of	O	O	O
hospital	O	O	B-T058
readmissions	O	O	I-T058
and	O	O	O
visits	O	O	O
to	O	O	O
emergency	O	O	B-T093
departments	O	O	I-T093
and	O	O	O
urgent	O	O	B-T093
care	O	O	I-T093
centers	O	O	I-T093
for	O	O	O
90	O	O	O
days	O	O	B-T079
following	O	O	O
hospital	O	O	B-T058
discharge	O	O	I-T058
.	O	O	O

Secondary	O	O	B-T169
outcomes	O	O	I-T169
are	O	O	O
achievements	O	O	B-UnknownType
of	O	O	O
guideline-based	O	O	B-T170
targets	O	O	B-T169
for	O	O	O
CKD	O	O	B-T047
risk	O	O	B-T033
factors	O	O	I-T033
and	O	O	O
complications	O	O	B-T046
.	O	O	O

Enrollment	O	O	B-T058
began	O	O	O
in	O	O	O
February	O	O	B-T080
2012	O	O	O
and	O	O	O
ended	O	O	O
in	O	O	O
May	O	O	B-T079
2015	O	O	O
.	O	O	O

At	O	O	O
baseline	O	O	B-T081
,	O	O	O
the	O	O	O
age	O	O	B-T032
of	O	O	O
participants	O	O	B-T098
was	O	O	O
69	O	O	O
Â±	O	O	O
11	O	O	O
years	O	O	B-T079
(	O	O	O
mean	O	O	O
Â±	O	O	O
SD	O	O	O
)	O	O	O
,	O	O	O
50	O	O	O
%	O	O	O
(	O	O	O
77	O	O	O
of	O	O	O
155	O	O	O
)	O	O	O
were	O	O	O
women	O	O	B-T098
,	O	O	O
83	O	O	O
%	O	O	O
(	O	O	O
117	O	O	O
of	O	O	O
141	O	O	O
)	O	O	O
had	O	O	O
hypertension	O	O	B-T047
and	O	O	O
56	O	O	O
%	O	O	O
(	O	O	O
79	O	O	O
of	O	O	O
141	O	O	O
)	O	O	O
had	O	O	O
diabetes	O	O	B-T047
.	O	O	O

At	O	O	O
baseline	O	O	B-T081
,	O	O	O
the	O	O	O
estimated	O	O	B-T059
glomerular	O	O	I-T059
filtration	O	O	I-T059
rate	O	O	B-T081
was	O	O	O
41	O	O	O
Â±	O	O	O
14	O	O	O
ml/min/1.73	O	O	O
m2	O	O	O
and	O	O	O
urine	O	O	B-T059
albumin-to-creatinine	O	O	I-T059
ratio	O	O	I-T059
was	O	O	O
43	O	O	O
mg/g	O	O	O
(	O	O	O
interquartile	O	O	B-T081
range	O	O	I-T081
8	O	O	O
-	O	O	O
528	O	O	O
mg/g	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
most	O	O	O
frequent	O	O	O
diagnosis	O	O	B-T185
category	O	O	I-T185
for	O	O	O
the	O	O	O
index	O	O	O
hospital	O	O	B-T058
admission	O	O	B-T058
was	O	O	O
cardiovascular	O	O	B-T047
diseases	O	O	I-T047
at	O	O	O
34	O	O	O
%	O	O	O
(	O	O	O
53	O	O	O
of	O	O	O
155	O	O	O
)	O	O	O
,	O	O	O
but	O	O	O
the	O	O	O
most	O	O	O
common	O	O	O
single	O	O	B-T033
diagnosis	O	O	I-T033
for	O	O	O
admission	O	O	O
was	O	O	O
community-acquired	O	O	B-T080
acute	O	O	B-T047
kidney	O	O	I-T047
injury	O	O	I-T047
at	O	O	O
10	O	O	O
%	O	O	O
(	O	O	O
16	O	O	O
of	O	O	O
155	O	O	O
)	O	O	O
.	O	O	O

Participants	O	O	B-T098
in	O	O	O
CKD	O	O	B-T047
-	O	O	O
MIT	O	O	B-T061
are	O	O	O
typical	O	O	O
of	O	O	O
acutely	O	O	B-T046
ill	O	O	I-T046
hospitalized	O	O	B-T101
patients	O	O	I-T101
with	O	O	O
CKD	O	O	O
.	O	O	O

A	O	O	O
medication	O	O	B-T058
management	O	O	B-T058
intervention	O	O	B-T061
after	O	O	O
hospital	O	O	B-T058
discharge	O	O	I-T058
is	O	O	O
under	O	O	O
study	O	O	B-T062
to	O	O	O
reduce	O	O	B-T080
post	O	O	B-T079
-	O	O	O
hospitalization	O	O	B-T058
acute	O	O	B-T058
care	O	O	I-T058
utilization	O	O	B-T169
and	O	O	O
to	O	O	O
improve	O	O	O
CKD	O	O	B-T047
management	O	O	O
.	O	O	O

-DOCSTART- (27488290)

Direct	O	O	B-T080
Repair	O	O	B-T058
of	O	O	O
Lumbar	O	O	B-T023
Pars	O	O	I-T023
Interarticularis	O	O	I-T023
Defects	O	O	B-T169
by	O	O	O
Utilizing	O	O	B-T169
Intraoperative	O	O	B-T074
O-Arm-Based	O	O	I-T074
Navigation	O	O	I-T074
and	O	O	O
Microendoscopic	O	O	O
Techniques	O	O	O

A	O	O	O
retrospective	O	O	B-T062
analysis	O	O	I-T062
of	O	O	O
the	O	O	O
clinical	O	O	B-T033
outcomes	O	O	I-T033
of	O	O	O
eight	O	O	O
patients	O	O	B-T101
with	O	O	O
the	O	O	O
lumbar	O	O	B-T023
pars	O	O	I-T023
interarticulars	O	O	I-T023
defects	O	O	B-T169
treated	O	O	B-T033
by	O	O	O
direct	O	O	B-T080
repair	O	O	B-T058
with	O	O	O
the	O	O	O
aid	O	O	B-T080
of	O	O	O
intraoperative	O	O	B-T074
O-arm	O	O	I-T074
based	O	O	I-T074
navigation	O	O	I-T074
and	O	O	O
microendoscopic	O	O	B-T060
techniques	O	O	I-T060
.	O	O	O

The	O	O	O
aim	O	O	B-T078
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
investigate	O	O	B-T169
the	O	O	O
efficacy	O	O	B-T080
and	O	O	O
safety	O	O	B-T068
of	O	O	O
direct	O	O	B-T080
screw	O	O	B-T074
repair	O	O	B-T058
by	O	O	O
using	O	O	B-T169
minimally	O	O	B-T061
invasive	O	O	I-T061
surgery	O	O	I-T061
for	O	O	O
the	O	O	O
lumbar	O	O	B-T023
pars	O	O	I-T023
interarticulars	O	O	I-T023
defects	O	O	B-T169
in	O	O	O
a	O	O	O
pilot	O	O	B-T062
study	O	O	I-T062
.	O	O	O

Direct	O	O	B-T080
repair	O	O	B-T058
of	O	O	O
pars	O	O	B-T023
interarticulars	O	O	I-T023
defects	O	O	B-T169
has	O	O	O
been	O	O	O
used	O	O	B-T169
to	O	O	O
treat	O	O	B-T061
young	O	O	B-T100
adult	O	O	I-T100
patients	O	O	B-T101
.	O	O	O

Reports	O	O	B-T170
concerning	O	O	B-T078
direct	O	O	B-T080
repair	O	O	B-T058
by	O	O	O
minimally	O	O	B-T061
invasive	O	O	I-T061
techniques	O	O	I-T061
for	O	O	O
pars	O	O	B-T023
interarticulars	O	O	I-T023
defects	O	O	B-T169
are	O	O	O
quite	O	O	O
rare	O	O	B-T080
.	O	O	O

Review	O	O	B-T078
of	O	O	O
medical	O	O	B-T170
records	O	O	I-T170
identified	O	O	B-T080
eight	O	O	O
consecutive	O	O	B-T080
patients	O	O	B-T101
treated	O	O	B-T033
with	O	O	O
intraoperative	O	O	B-T074
O-arm	O	O	I-T074
based	O	O	I-T074
navigation	O	O	I-T074
and	O	O	O
microendoscopic	O	O	B-T060
techniques	O	O	I-T060
.	O	O	O

Debridement	O	O	B-T061
and	O	O	O
autograft	O	O	B-T061
of	O	O	O
pars	O	O	B-T023
interarticularis	O	O	I-T023
defects	O	O	B-T169
was	O	O	O
performed	O	O	B-T169
under	O	O	O
microendoscopic	O	O	B-T060
procedure	O	O	I-T060
.	O	O	O

Then	O	O	O
,	O	O	O
percutaneous	O	O	B-T082
bilateral	O	O	B-T082
intralaminar	O	O	B-T082
screws	O	O	B-T074
were	O	O	O
inserted	O	O	B-T058
by	O	O	O
utilizing	O	O	B-T169
intraoperative	O	O	B-T074
navigation	O	O	I-T074
.	O	O	O

The	O	O	O
clinical	O	O	B-T170
and	O	O	O
radiological	O	O	B-T091
data	O	O	B-T078
were	O	O	O
collected	O	O	B-T078
and	O	O	O
analyzed	O	O	B-T062
retrospectively	O	O	B-T080
.	O	O	O

Eight	O	O	O
patients	O	O	B-T101
had	O	O	O
a	O	O	O
mean	O	O	B-T081
age	O	O	B-T032
of	O	O	O
28.4	O	O	O
years	O	O	O
,	O	O	O
and	O	O	O
five	O	O	O
were	O	O	O
30	O	O	O
years	O	O	O
or	O	O	O
younger	O	O	B-T079
at	O	O	O
the	O	O	O
time	O	O	B-T079
of	O	O	O
treatment	O	O	B-T061
.	O	O	O

Symptoms	O	O	B-T184
included	O	O	B-T052
axial	O	O	B-T082
back	O	O	B-T184
pain	O	O	I-T184
in	O	O	O
100	O	O	O
%	O	O	O
of	O	O	O
patients	O	O	B-T101
without	O	O	O
concomitant	O	O	B-T079
radiculopathy	O	O	B-T047
.	O	O	O

Autograft	O	O	B-T061
was	O	O	O
used	O	O	B-T169
in	O	O	O
all	O	O	O
cases	O	O	B-T077
.	O	O	O

The	O	O	O
average	O	O	B-T081
follow-up	O	O	B-T058
duration	O	O	B-T079
was	O	O	O
27.4	O	O	O
months	O	O	O
with	O	O	O
a	O	O	O
range	O	O	B-T081
of	O	O	O
20	O	O	O
to	O	O	O
33	O	O	O
months	O	O	O
.	O	O	O

Symptoms	O	O	B-T184
resolved	O	O	B-T033
completely	O	O	B-T080
or	O	O	O
partially	O	O	B-T081
in	O	O	O
all	O	O	O
patients	O	O	B-T101
.	O	O	O

Low	O	O	B-T184
back	O	O	I-T184
pain	O	O	I-T184
visual	O	O	B-T201
analog	O	O	I-T201
scores	O	O	I-T201
decrease	O	O	B-T081
from	O	O	O
preoperative	O	O	B-T079
6.8	O	O	O
to	O	O	O
postoperative	O	O	B-T079
1.4	O	O	O
of	O	O	O
eight	O	O	O
cases	O	O	B-T077
.	O	O	O

Of	O	O	O
16	O	O	O
pars	O	O	B-T023
defects	O	O	B-T169
,	O	O	O
healing	O	O	B-T040
was	O	O	O
observed	O	O	B-T169
in	O	O	O
13	O	O	O
(	O	O	O
81.3	O	O	O
%	O	O	O
)	O	O	O
at	O	O	O
last	O	O	O
radiological	O	O	B-T091
follow-up	O	O	B-T058
.	O	O	O

One	O	O	O
patient	O	O	B-T101
with	O	O	O
bilateral	O	O	B-T019
fusion	O	O	I-T019
failure	O	O	I-T019
refused	O	O	B-T052
revision	O	O	B-T061
surgery	O	O	I-T061
because	O	O	O
of	O	O	O
mild	O	O	B-T033
complaint	O	O	I-T033
.	O	O	O

No	O	O	B-T033
complications	O	O	I-T033
such	O	O	O
as	O	O	O
dural	O	O	B-T037
tear	O	O	I-T037
,	O	O	O
nerve	O	O	B-T037
root	O	O	I-T037
injury	O	O	I-T037
,	O	O	O
and	O	O	O
infection	O	O	B-T046
occurred	O	O	B-T052
.	O	O	O

Minimally	O	O	B-T061
invasive	O	O	I-T061
direct	O	O	B-T080
repair	O	O	B-T058
of	O	O	O
the	O	O	O
pars	O	O	B-T023
interarticularis	O	O	I-T023
defects	O	O	B-T169
with	O	O	O
intralaminar	O	O	B-T082
screws	O	O	B-T074
by	O	O	O
using	O	O	B-T169
microendoscopic	O	O	B-T060
system	O	O	I-T060
and	O	O	O
navigation	O	O	B-T074
procedure	O	O	I-T074
can	O	O	O
provide	O	O	B-T052
safe	O	O	O
and	O	O	O
effective	O	O	B-T080
treatment	O	O	B-T061
of	O	O	O
spondylolysis	O	O	B-T047
with	O	O	O
satisfactory	O	O	B-T080
clinical	O	O	B-T080
and	O	O	O
radiological	O	O	B-T091
outcomes	O	O	B-T169
,	O	O	O
which	O	O	O
need	O	O	B-T080
some	O	O	O
special	O	O	B-T074
tools	O	O	I-T074
with	O	O	O
steep	O	O	B-T080
learning	O	O	B-T041
curve	O	O	I-T041
.	O	O	O

4	O	O	O
.	O	O	O

-DOCSTART- (27488293)

Evidence	O	O	B-T078
-Based	O	O	O
Review	O	O	B-T170
and	O	O	O
Survey	O	O	B-T170
of	O	O	O
Expert	O	O	B-T077
Opinion	O	O	I-T077
of	O	O	O
Reconstruction	O	O	B-T061
of	O	O	O
Metastatic	O	O	O
Spine	O	O	O
Tumors	O	O	O

Systematic	O	O	B-T169
review	O	O	B-T170
and	O	O	O
consensus	O	O	B-T054
expert	O	O	B-T077
opinion	O	O	I-T077
.	O	O	O

To	O	O	O
provide	O	O	O
surgeons	O	O	B-T097
and	O	O	O
other	O	O	O
health	O	O	B-T097
care	O	O	I-T097
professionals	O	O	I-T097
with	O	O	O
guidelines	O	O	B-T170
for	O	O	O
surgical	O	O	B-T061
reconstruction	O	O	I-T061
of	O	O	O
metastatic	O	O	B-T191
spine	O	O	B-T047
disease	O	O	I-T047
based	O	O	O
on	O	O	O
evidence	O	O	B-T078
and	O	O	O
expert	O	O	B-T077
opinion	O	O	I-T077
.	O	O	O

The	O	O	O
surgical	O	O	B-T061
treatment	O	O	I-T061
of	O	O	O
spinal	O	O	B-T191
metastases	O	O	I-T191
is	O	O	O
controversial	O	O	O
.	O	O	O

Specifically	O	O	O
two	O	O	O
aspects	O	O	O
of	O	O	O
surgical	O	O	B-T061
reconstruction	O	O	B-T061
are	O	O	O
addressed	O	O	O
in	O	O	O
this	O	O	O
study	O	O	O
:	O	O	O
(	O	O	O
i	O	O	O
)	O	O	O
choice	O	O	O
of	O	O	O
bone	O	O	B-T061
graft	O	O	I-T061
used	O	O	O
during	O	O	B-T079
surgery	O	O	B-T061
for	O	O	O
metastatic	O	O	B-T191
spine	O	O	I-T191
tumors	O	O	I-T191
and	O	O	O
(	O	O	O
ii	O	O	O
)	O	O	O
the	O	O	O
design	O	O	B-T052
of	O	O	O
reconstruction	O	O	O
or	O	O	O
construct	O	O	B-T122
to	O	O	O
stabilize	O	O	B-T033
.	O	O	O

A	O	O	O
systematic	O	O	B-T169
review	O	O	B-T170
of	O	O	O
the	O	O	O
available	O	O	B-T169
medical	O	O	B-T169
literature	O	O	B-T170
from	O	O	O
1980	O	O	O
to	O	O	O
2015	O	O	O
was	O	O	O
conducted	O	O	O
,	O	O	O
and	O	O	O
combined	O	O	B-T080
with	O	O	O
consensus	O	O	B-T054
expert	O	O	B-T077
opinion	O	O	I-T077
from	O	O	O
a	O	O	O
recent	O	O	O
survey	O	O	B-T170
of	O	O	O
spine	O	O	B-T023
surgeons	O	O	B-T097
who	O	O	O
treat	O	O	B-T061
metastatic	O	O	B-T191
spine	O	O	I-T191
tumors	O	O	I-T191
.	O	O	O

There	O	O	O
is	O	O	O
very	O	O	O
little	O	O	O
evidence	O	O	B-T078
in	O	O	O
the	O	O	O
literature	O	O	B-T170
to	O	O	O
provide	O	O	O
guidance	O	O	B-T058
on	O	O	O
the	O	O	O
use	O	O	B-T169
of	O	O	I-T169
bone	O	O	B-T061
graft	O	O	I-T061
in	O	O	O
metastatic	O	O	B-T191
tumor	O	O	I-T191
reconstruction	O	O	B-T061
.	O	O	O

There	O	O	O
is	O	O	O
little	O	O	O
evidence	O	O	B-T078
in	O	O	O
the	O	O	O
literature	O	O	B-T170
to	O	O	O
support	O	O	O
the	O	O	O
preferential	O	O	O
use	O	O	B-T169
of	O	O	I-T169
one	O	O	O
graft	O	O	B-T170
type	O	O	I-T170
over	O	O	O
the	O	O	O
other	O	O	O
.	O	O	O

Approximately	O	O	O
,	O	O	O
41	O	O	O
%	O	O	O
of	O	O	O
respondents	O	O	B-T098
said	O	O	O
they	O	O	O
used	O	O	O
bone	O	O	B-T061
graft	O	O	I-T061
or	O	O	O
bone	O	O	O
graft	O	O	O
substitutes	O	O	B-T122
to	O	O	O
accomplish	O	O	O
fusion	O	O	B-T061
.	O	O	O

There	O	O	O
were	O	O	O
17	O	O	O
studies	O	O	B-T062
that	O	O	O
described	O	O	O
the	O	O	O
use	O	O	B-T169
of	O	O	I-T169
a	O	O	O
prefabricated	O	O	B-T074
prosthetic	O	O	I-T074
,	O	O	O
10	O	O	O
studies	O	O	O
describing	O	O	O
the	O	O	O
use	O	O	O
of	O	O	O
polymethyl	O	O	B-T109
methacrylate	O	O	I-T109
(	O	O	O
PMMA	O	O	B-T109
)	O	O	O
bone	O	O	B-T122
cement	O	O	I-T122
,	O	O	O
and	O	O	O
only	O	O	O
three	O	O	O
studies	O	O	O
describing	O	O	O
the	O	O	O
use	O	O	O
of	O	O	O
bone	O	O	B-T061
graft	O	O	I-T061
for	O	O	O
anterior	O	O	B-T082
column	O	O	B-T023
reconstruction	O	O	B-T061
.	O	O	O

The	O	O	O
use	O	O	B-T169
of	O	O	I-T169
structural	O	O	B-T061
allograft	O	O	I-T061
was	O	O	O
most	O	O	O
popular	O	O	O
among	O	O	O
the	O	O	O
experts	O	O	B-T097
for	O	O	O
anterior	O	O	B-T082
reconstruction	O	O	B-T061
,	O	O	O
followed	O	O	B-T079
by	O	O	I-T079
cage	O	O	B-T074
reconstruction	O	O	O
,	O	O	O
and	O	O	O
PMMA	O	O	B-T109
bone	O	O	B-T122
cement	O	O	I-T122
.	O	O	O

Achieving	O	O	O
bony	O	O	B-T030
union	O	O	I-T030
may	O	O	O
be	O	O	O
of	O	O	O
importance	O	O	B-T080
for	O	O	O
the	O	O	O
maintenance	O	O	B-T052
of	O	O	O
spinal	O	O	B-T023
stability	O	O	B-T080
in	O	O	O
the	O	O	O
long	O	O	B-T079
term	O	O	I-T079
after	O	O	O
reconstruction	O	O	B-T061
.	O	O	O

Whether	O	O	O
bony	O	O	B-T030
union	O	O	I-T030
is	O	O	O
required	O	O	B-T169
for	O	O	O
patients	O	O	B-T101
with	O	O	O
shorter	O	O	B-T081
life	O	O	B-T102
expectancies	O	O	I-T102
is	O	O	O
debatable	O	O	O
.	O	O	O

The	O	O	O
literature	O	O	B-T170
supports	O	O	O
the	O	O	O
use	O	O	B-T169
of	O	O	I-T169
anterior	O	O	B-T082
reconstruction	O	O	B-T061
with	O	O	O
either	O	O	O
a	O	O	O
prefabricated	O	O	B-T074
prosthetic	O	O	I-T074
or	O	O	O
PMMA	O	O	B-T109
bone	O	O	B-T122
cement	O	O	I-T122
.	O	O	O

It	O	O	O
also	O	O	O
supports	O	O	O
the	O	O	O
use	O	O	B-T169
of	O	O	I-T169
an	O	O	O
anterior	O	O	B-T082
construct	O	O	B-T122
reinforced	O	O	O
with	O	O	O
bilateral	O	O	B-T082
posterior	O	O	B-T082
instrumentation	O	O	B-T080
when	O	O	O
performing	O	O	B-T061
a	O	O	O
three-column	O	O	B-T061
reconstruction	O	O	I-T061
.	O	O	O

N/A.	O	O	O

-DOCSTART- (27488602)

The	O	O	O
value	O	O	O
of	O	O	O
transesophageal	O	O	B-T060
echocardiography	O	O	I-T060
for	O	O	O
embolic	O	O	O
strokes	O	O	O
of	O	O	O
undetermined	O	O	O
source	O	O	O

Our	O	O	O
aim	O	O	O
was	O	O	O
to	O	O	O
evaluate	O	O	O
the	O	O	O
diagnostic	O	O	B-T060
yield	O	O	I-T060
of	O	O	O
transesophageal	O	O	B-T060
echocardiography	O	O	I-T060
(	O	O	O
TEE	O	O	B-T060
)	O	O	O
in	O	O	O
consecutive	O	O	O
patients	O	O	B-T101
with	O	O	O
ischemic	O	O	B-T047
stroke	O	O	I-T047
(	O	O	O
IS	O	O	B-T047
)	O	O	O
fulfilling	O	O	O
the	O	O	O
diagnostic	O	O	B-T170
criteria	O	O	I-T170
of	O	O	O
embolic	O	O	B-T047
strokes	O	O	I-T047
of	O	O	I-T047
undetermined	O	O	I-T047
source	O	O	I-T047
(	O	O	O
ESUS	O	O	B-T047
)	O	O	O
.	O	O	O

We	O	O	O
prospectively	O	O	O
evaluated	O	O	O
consecutive	O	O	O
patients	O	O	B-T101
with	O	O	O
acute	O	O	O
IS	O	O	B-T047
satisfying	O	O	O
ESUS	O	O	B-T047
criteria	O	O	O
who	O	O	O
underwent	O	O	O
in-	O	O	O
hospital	O	O	B-T093
TEE	O	O	B-T060
examination	O	O	I-T060
in	O	O	O
3	O	O	O
tertiary	O	O	B-T093
care	O	O	I-T093
stroke	O	O	I-T093
centers	O	O	I-T093
during	O	O	B-T079
a	O	O	I-T079
12-month	O	O	I-T079
period	O	O	I-T079
.	O	O	O

We	O	O	O
also	O	O	O
performed	O	O	O
a	O	O	O
systematic	O	O	B-T170
review	O	O	I-T170
and	O	O	O
meta-analysis	O	O	B-T062
estimating	O	O	I-T062
the	O	O	O
cumulative	O	O	O
effect	O	O	O
of	O	O	O
TEE	O	O	B-T060
findings	O	O	B-T033
on	O	O	O
therapeutic	O	O	B-T169
management	O	O	I-T169
for	O	O	O
secondary	O	O	B-T061
stroke	O	O	I-T061
prevention	O	O	I-T061
among	O	O	O
different	O	O	O
IS	O	O	B-T047
subgroups	O	O	O
.	O	O	O

We	O	O	O
identified	O	O	O
61	O	O	O
patients	O	O	B-T101
with	O	O	O
ESUS	O	O	B-T047
who	O	O	O
underwent	O	O	B-T058
investigation	O	O	I-T058
with	O	O	O
TEE	O	O	B-T060
(	O	O	O
mean	O	O	O
age	O	O	O
44	O	O	O
Â±	O	O	O
12	O	O	O
years	O	O	O
,	O	O	O
49	O	O	O
%	O	O	O
men	O	O	B-T098
,	O	O	O
median	O	O	O
NIH	O	O	B-T170
Stroke	O	O	I-T170
Scale	O	O	I-T170
score	O	O	I-T170
=	O	O	O
5	O	O	O
points	O	O	O
[	O	O	O
interquartile	O	O	B-T081
range	O	O	I-T081
:	O	O	O
3	O	O	O
-	O	O	O
8	O	O	O
]	O	O	O
)	O	O	O
.	O	O	O

TEE	O	O	B-T060
revealed	O	O	O
additional	O	O	O
findings	O	O	B-T033
in	O	O	O
52	O	O	O
%	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
confidence	O	O	B-T081
interval	O	O	I-T081
[	O	O	O
CI	O	O	B-T081
]	O	O	O
:	O	O	O
40%-65	O	O	O
%	O	O	O
)	O	O	O
of	O	O	O
the	O	O	O
study	O	O	B-T098
population	O	O	I-T098
.	O	O	O

TEE	O	O	B-T060
findings	O	O	B-T033
changed	O	O	O
management	O	O	O
(	O	O	O
initiation	O	O	B-T169
of	O	O	O
anticoagulation	O	O	B-T061
therapy	O	O	I-T061
,	O	O	O
administration	O	O	B-T061
of	O	O	O
IV	O	O	B-T061
antibiotic	O	O	I-T061
therapy	O	O	I-T061
,	O	O	O
and	O	O	O
patent	O	O	B-T061
foramen	O	O	I-T061
ovale	O	O	I-T061
closure	O	O	I-T061
)	O	O	O
in	O	O	O
10	O	O	O
(	O	O	O
16	O	O	O
%	O	O	O
[	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
:	O	O	O
9%-28	O	O	O
%	O	O	O
]	O	O	O
)	O	O	O
patients	O	O	B-T101
.	O	O	O

The	O	O	O
pooled	O	O	B-T081
rate	O	O	I-T081
of	O	O	O
reported	O	O	O
anticoagulation	O	O	B-T061
therapy	O	O	I-T061
attributed	O	O	O
to	O	O	O
abnormal	O	O	B-T033
TEE	O	O	B-T060
findings	O	O	B-T033
among	O	O	O
3,562	O	O	O
acute	O	O	O
IS	O	O	B-T047
patients	O	O	B-T101
included	O	O	O
in	O	O	O
the	O	O	O
meta-analysis	O	O	B-T062
(	O	O	O
12	O	O	O
studies	O	O	O
)	O	O	O

was	O	O	O
8.7	O	O	O
%	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
:	O	O	O
7.3%-10.4	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

In	O	O	O
subgroup	O	O	B-T062
analysis	O	O	I-T062
,	O	O	O
the	O	O	O
rates	O	O	O
of	O	O	O
initiation	O	O	B-T169
of	O	O	O
anticoagulation	O	O	B-T061
therapy	O	O	I-T061
on	O	O	O
the	O	O	O
basis	O	O	O
of	O	O	O
TEE	O	O	B-T060
investigation	O	O	O
did	O	O	O
not	O	O	O
differ	O	O	O
(	O	O	O
p	O	O	O
=	O	O	O
0.315	O	O	O
)	O	O	O
among	O	O	O
patients	O	O	B-T101
with	O	O	O
cryptogenic	O	O	B-T169
stroke	O	O	I-T169
(	O	O	O
6.9	O	O	O
%	O	O	O
[	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
:	O	O	O
4.9%-9.6	O	O	O
%	O	O	O
]	O	O	O
)	O	O	O
,	O	O	O
ESUS	O	O	B-T047
(	O	O	O
8.1	O	O	O
%	O	O	O
[	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
:	O	O	O
3.4%-18.1	O	O	O
%	O	O	O
]	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
IS	O	O	B-T047
(	O	O	O
9.4	O	O	O
%	O	O	O
[	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
:	O	O	O
7.5%-11.8	O	O	O
%	O	O	O
]	O	O	O
)	O	O	O
.	O	O	O

Abnormal	O	O	O
TEE	O	O	B-T060
findings	O	O	B-T033
may	O	O	O
decisively	O	O	O
affect	O	O	O
the	O	O	O
selection	O	O	O
of	O	O	O
appropriate	O	O	B-T080
therapeutic	O	O	B-T061
strategy	O	O	I-T061
in	O	O	O
approximately	O	O	O
1	O	O	O
of	O	O	O
7	O	O	O
patients	O	O	B-T101
with	O	O	O
ESUS	O	O	B-T047
.	O	O	O

-DOCSTART- (27489603)

Simultaneous	O	O	B-T079
thrombosis	O	O	B-T046
of	O	O	O
multiple	O	O	B-T023
coronary	O	O	I-T023
arteries	O	O	I-T023
in	O	O	O
a	O	O	O
patient	O	O	B-T101
with	O	O	O
rheumatoid	O	O	O
arthritis	O	O	O

We	O	O	O
present	O	O	O
a	O	O	O
case	O	O	B-T169
of	O	O	O
simultaneous	O	O	B-T079
coronary	O	O	B-T047
thrombosis	O	O	I-T047
of	O	O	I-T047
the	O	O	I-T047
left	O	O	I-T047
main	O	O	I-T047
,	O	O	O
the	O	O	O
left	O	O	B-T023
anterior	O	O	I-T023
descending	O	O	I-T023
artery	O	O	I-T023
and	O	O	O
the	O	O	O
right	O	O	B-T023
coronary	O	O	I-T023
artery	O	O	I-T023
in	O	O	O
a	O	O	O
patient	O	O	B-T101
,	O	O	O
recently	O	O	O
diagnosed	O	O	B-T060
with	O	O	O
rheumatoid	O	O	B-T047
arthritis	O	O	I-T047
.	O	O	O

-DOCSTART- (27492869)

Unintentional	O	O	B-T037
Injuries	O	O	I-T037
in	O	O	O
Children	O	O	B-T100
Up	O	O	O
to	O	O	O
Six	O	O	O
Years	O	O	B-T079
of	O	O	O
Age	O	O	B-T032
and	O	O	O
Related	O	O	O
Parental	O	O	B-T099
Knowledge	O	O	B-T170
,	O	O	O
Attitudes	O	O	B-T041
,	O	O	O
and	O	O	O
Behaviors	O	O	B-T053
in	O	O	O
Italy	O	O	O

To	O	O	O
describe	O	O	O
risk	O	O	B-T033
factors	O	O	I-T033
associated	O	O	B-T080
with	O	O	I-T080
unintentional	O	O	B-T037
injuries	O	O	B-T037
among	O	O	O
children	O	O	B-T100
aged	O	O	O
<	O	O	O
6	O	O	O
years	O	O	B-T079
and	O	O	O
to	O	O	O
examine	O	O	O
parents	O	O	B-T099
'	O	O	O
level	O	O	O
of	O	O	O
knowledge	O	O	B-T170
,	O	O	O
attitudes	O	O	B-T041
,	O	O	O
and	O	O	O
behaviors	O	O	B-T053
about	O	O	O
pediatric	O	O	B-T080
injuries	O	O	O
and	O	O	O
related	O	O	O
preventive	O	O	B-UnknownType
measures	O	O	I-UnknownType
.	O	O	O

A	O	O	O
cross-sectional	O	O	B-T062
survey	O	O	I-T062
was	O	O	O
conducted	O	O	O
between	O	O	O
May	O	O	B-T079
and	O	O	O
July	O	O	B-T080
2015	O	O	O
on	O	O	O
a	O	O	O
random	O	O	B-T062
sample	O	O	I-T062
of	O	O	O
794	O	O	O
parents	O	O	B-T099
of	O	O	O
3-	O	O	O
to	O	O	O
6-year-old	O	O	O
children	O	O	B-T100
through	O	O	O
a	O	O	O
self-administered	O	O	B-T169
anonymous	O	O	B-T170
questionnaire	O	O	I-T170
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
409	O	O	O
parents	O	O	B-T099
participated	O	O	O
.	O	O	O

Two-thirds	O	O	O
of	O	O	O
the	O	O	O
children	O	O	B-T100
had	O	O	O
experienced	O	O	O
at	O	O	O
least	O	O	O
1	O	O	O
unintentional	O	O	B-T037
injury	O	O	I-T037
in	O	O	O
the	O	O	O
previous	O	O	O
12	O	O	O
months	O	O	B-T079
.	O	O	O

More	O	O	O
than	O	O	O
one-half	O	O	O
of	O	O	O
these	O	O	O
children	O	O	B-T100
were	O	O	O
boys	O	O	B-T100
.	O	O	O

The	O	O	O
leading	O	O	B-T033
cause	O	O	I-T033
was	O	O	O
falls	O	O	B-T037
;	O	O	O
the	O	O	O
injuries	O	O	B-T037
occurred	O	O	O
mainly	O	O	O
at	O	O	O
home	O	O	B-T082
,	O	O	O
and	O	O	O
only	O	O	O
9.2	O	O	O
%	O	O	O
were	O	O	O
brought	O	O	O
for	O	O	O
attention	O	O	O
to	O	O	O
an	O	O	O
emergency	O	O	B-T093
department	O	O	I-T093
.	O	O	O

Parents	O	O	B-T099
who	O	O	O
did	O	O	O
not	O	O	O
believe	O	O	O
that	O	O	O
it	O	O	O
is	O	O	O
possible	O	O	O
to	O	O	O
prevent	O	O	O
unintentional	O	O	B-T037
injuries	O	O	I-T037
were	O	O	O
more	O	O	O
likely	O	O	O
to	O	O	O
have	O	O	O
had	O	O	O
a	O	O	O
child	O	O	B-T100
injured	O	O	B-T169
.	O	O	O

Approximately	O	O	O
70	O	O	O
%	O	O	O
of	O	O	O
respondents	O	O	B-T098
were	O	O	O
aware	O	O	B-T041
of	O	O	O
security	O	O	B-T089
measures	O	O	I-T089
to	O	O	O
prevent	O	O	O
pediatric	O	O	B-T080
injuries	O	O	B-T037
,	O	O	O
and	O	O	O
this	O	O	O
knowledge	O	O	B-T170
was	O	O	O
more	O	O	O
prevalent	O	O	O
in	O	O	O
older	O	O	O
parents	O	O	B-T099
and	O	O	O
in	O	O	O
those	O	O	O
with	O	O	O
at	O	O	O
least	O	O	O
a	O	O	O
college	O	O	B-T065
level	O	O	I-T065
of	O	O	I-T065
education	O	O	I-T065
compared	O	O	O
with	O	O	O
those	O	O	O
with	O	O	O
a	O	O	O
middle	O	O	B-T065
school	O	O	I-T065
education	O	O	I-T065
.	O	O	O

The	O	O	O
perceived	O	O	B-T041
utility	O	O	O
of	O	O	O
education	O	O	B-T065
about	O	O	O
preventive	O	O	B-UnknownType
measures	O	O	I-UnknownType
of	O	O	O
pediatric	O	O	B-T080
injuries	O	O	B-T037
had	O	O	O
a	O	O	O
mean	O	O	B-T081
value	O	O	I-T081
of	O	O	O
8.9	O	O	O
on	O	O	O
a	O	O	O
Likert	O	O	B-T170
scale	O	O	I-T170
of	O	O	O
1	O	O	O
-	O	O	O
10	O	O	O
(	O	O	O
1	O	O	O
,	O	O	O
not	O	O	O
useful	O	O	O
,	O	O	O
to	O	O	O
10	O	O	O
,	O	O	O
very	O	O	O
useful	O	O	O
)	O	O	O
and	O	O	O
was	O	O	O
significantly	O	O	O
higher	O	O	O
in	O	O	O
mothers	O	O	B-T099
.	O	O	O

This	O	O	O
study	O	O	O
highlights	O	O	O
a	O	O	O
clear	O	O	O
need	O	O	O
for	O	O	O
public	O	O	B-T058
health	O	O	I-T058
educational	O	O	B-T065
programs	O	O	I-T065
for	O	O	O
parents	O	O	B-T099
regarding	O	O	O
prevention	O	O	B-UnknownType
of	O	O	O
unintentional	O	O	B-T037
injuries	O	O	B-T037
in	O	O	O
children	O	O	B-T100
as	O	O	O
a	O	O	O
valuable	O	O	O
tool	O	O	O
to	O	O	O
increase	O	O	O
safety	O	O	B-T068
and	O	O	O
injury	O	O	B-T061
prevention	O	O	I-T061
and	O	O	O
to	O	O	O
reduce	O	O	B-T081
risks	O	O	B-T078
,	O	O	O
because	O	O	O
the	O	O	O
majority	O	O	O
of	O	O	O
such	O	O	O
injuries	O	O	O
occur	O	O	O
at	O	O	O
home	O	O	B-T082
.	O	O	O

-DOCSTART- (27494135)

Truncated	O	O	B-T015
Bovine	O	O	I-T015
Integrin	O	O	B-T116
Alpha-v/Beta-6	O	O	I-T116
as	O	O	O
a	O	O	O
Universal	O	O	B-T044
Capture	O	O	I-T044
Ligand	O	O	I-T044
for	O	O	O
FMD	O	O	B-T047
Diagnosis	O	O	O

Foot-and-mouth	O	O	B-T047
disease	O	O	I-T047
(	O	O	O
FMD	O	O	B-T047
)	O	O	O
is	O	O	O
endemic	O	O	B-T047
in	O	O	O
many	O	O	O
regions	O	O	B-T082
of	O	O	O
the	O	O	O
world	O	O	B-T098
and	O	O	O
is	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
most	O	O	O
prevalent	O	O	O
epizootic	O	O	B-T067
animal	O	O	B-T047
diseases	O	O	I-T047
.	O	O	O

FMD	O	O	B-T047
affects	O	O	O
livestock	O	O	B-T008
,	O	O	O
such	O	O	O
as	O	O	O
cattle	O	O	B-T015
,	O	O	O
sheep	O	O	B-T015
,	O	O	O
goats	O	O	B-T015
and	O	O	O
pigs	O	O	B-T015
,	O	O	O
and	O	O	O
causes	O	O	O
enormous	O	O	B-T081
economic	O	O	I-T081
losses	O	O	I-T081
due	O	O	O
to	O	O	O
reduced	O	O	O
productivity	O	O	B-T081
and	O	O	O
trade	O	O	B-T169
restrictions	O	O	I-T169
.	O	O	O

Preparedness	O	O	B-T033
and	O	O	O
early	O	O	B-T060
diagnosis	O	O	I-T060
are	O	O	O
essential	O	O	B-T080
for	O	O	O
effective	O	O	B-T058
control	O	O	I-T058
of	O	O	O
FMD	O	O	B-T047
.	O	O	O

Many	O	O	O
diagnostic	O	O	B-T059
assays	O	O	I-T059
are	O	O	O
dependent	O	O	B-T080
on	O	O	O
raising	O	O	O
high-affinity	O	O	B-T080
,	O	O	O
anti-FMD	O	O	B-T005
virus	O	O	B-T005
(	O	O	O
FMDV	O	O	B-T005
)	O	O	O
serotype-specific	O	O	B-T116
antibodies	O	O	I-T116
in	O	O	O
small	O	O	O
animals	O	O	B-T008
(	O	O	O
rabbits	O	O	B-T015
and	O	O	O
guinea	O	O	B-T015
pigs	O	O	I-T015
)	O	O	O
that	O	O	O
give	O	O	O
broad	O	O	O
virus	O	O	O
coverage	O	O	O
.	O	O	O

Here	O	O	O
we	O	O	O
show	O	O	O
that	O	O	O
soluble	O	O	B-T080
,	O	O	O
truncated	O	O	B-T080
forms	O	O	I-T080
of	O	O	O
bovine	O	O	B-T015
Î±vÎ²6	O	O	B-T116
bind	O	O	B-T044
FMDV	O	O	B-T005
in	O	O	O
an	O	O	O
authentic	O	O	O
RGD	O	O	B-T116
and	O	O	O
divalent	O	O	B-T044
cation	O	O	I-T044
dependent	O	O	I-T044
interaction	O	O	I-T044
and	O	O	O
can	O	O	O
be	O	O	O
used	O	O	O
as	O	O	O
the	O	O	O
trapping	O	O	B-T130
reagent	O	O	I-T130
in	O	O	O
a	O	O	O
FMDV	O	O	O
sandwich	O	O	B-T059
ELISA	O	O	I-T059
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
inclusion	O	O	B-T080
of	O	O	O
FLAG	O	O	B-T116
or	O	O	O
His	O	O	B-T116
tags	O	O	I-T116
facilitates	O	O	O
simple	O	O	O
purification	O	O	B-T059
without	O	O	O
the	O	O	O
loss	O	O	B-T081
of	O	O	O
virus	O	O	B-T038
binding	O	O	I-T038
.	O	O	O

We	O	O	O
also	O	O	O
provide	O	O	O
evidence	O	O	B-T078
that	O	O	O
when	O	O	O
combined	O	O	B-T080
with	O	O	O
a	O	O	O
guinea	O	O	B-T015
pig	O	O	I-T015
polyclonal	O	O	B-T031
serum	O	O	I-T031
,	O	O	O
or	O	O	O
serotype-specific	O	O	B-T116
monoclonal	O	O	I-T116
antibodies	O	O	I-T116
,	O	O	O
the	O	O	O
integrin	O	O	B-T116
can	O	O	O
be	O	O	O
used	O	O	O
to	O	O	O
detect	O	O	B-T033
viruses	O	O	B-T005
representative	O	O	O
of	O	O	O
all	O	O	O
FMDV	O	O	B-T005
serotypes	O	O	I-T005
.	O	O	O

We	O	O	O
also	O	O	O
show	O	O	O
that	O	O	O
recombinant	O	O	B-T005
FMDV	O	O	I-T005
empty	O	O	B-T017
capsids	O	O	I-T017
,	O	O	O
with	O	O	O
stabilising	O	O	B-T070
disulphide	O	O	I-T070
bonds	O	O	I-T070
,	O	O	O
can	O	O	O
serve	O	O	O
as	O	O	O
an	O	O	O
antigen	O	O	B-T129
in	O	O	O
the	O	O	O
ELISA	O	O	B-T059
and	O	O	O
can	O	O	O
therefore	O	O	O
replace	O	O	O
inactivated	O	O	B-T129
virus	O	O	I-T129
antigen	O	O	I-T129
as	O	O	O
a	O	O	O
positive	O	O	B-T077
control	O	O	I-T077
for	O	O	O
the	O	O	O
assay	O	O	B-T059
.	O	O	O

Our	O	O	O
results	O	O	B-T034
demonstrate	O	O	O
the	O	O	O
potential	O	O	B-T080
use	O	O	O
of	O	O	O
bovine	O	O	B-T015
Î±vÎ²6	O	O	B-T116
and	O	O	O
FMDV	O	O	B-T005
empty	O	O	B-T017
capsids	O	O	I-T017
in	O	O	O
FMD	O	O	B-T047
diagnostic	O	O	B-T059
assays	O	O	I-T059
.	O	O	O

-DOCSTART- (27498180)

Stress	O	O	B-T048
and	O	O	O
binge	O	O	B-T055
drinking	O	O	I-T055
:	O	O	O
A	O	O	O
toxic	O	O	B-T037
combination	O	O	O
for	O	O	O
the	O	O	O
teenage	O	O	B-T079
brain	O	O	O

Young	O	O	B-T100
adult	O	O	I-T100
university	O	O	B-T080
students	O	O	I-T080
frequently	O	O	O
binge	O	O	B-T055
on	O	O	O
alcohol	O	O	B-T055
and	O	O	O
have	O	O	O
high	O	O	B-T080
stress	O	O	B-T033
levels	O	O	I-T033
.	O	O	O

Based	O	O	O
on	O	O	O
findings	O	O	O
in	O	O	O
rodents	O	O	B-T015
,	O	O	O
we	O	O	O
predicted	O	O	O
that	O	O	O
heavy	O	O	B-T033
current	O	O	I-T033
alcohol	O	O	I-T033
use	O	O	I-T033
and	O	O	O
elevated	O	O	B-T080
stress	O	O	B-T048
and	O	O	O
depression	O	O	B-T033
scores	O	O	I-T033
would	O	O	O
be	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
deficits	O	O	B-T080
on	O	O	O
high	O	O	B-T080
interference	O	O	B-T169
memory	O	O	B-T041
tasks	O	O	B-T057
,	O	O	O
while	O	O	O
early	O	O	B-T033
onset	O	O	I-T033
,	O	O	O
prolonged	O	O	O
binge	O	O	B-T055
patterns	O	O	B-T055
would	O	O	O
lead	O	O	O
to	O	O	O
broader	O	O	O
cognitive	O	O	B-T048
deficits	O	O	I-T048
on	O	O	O
tests	O	O	O
of	O	O	O
associative	O	O	B-T041
encoding	O	O	I-T041
and	O	O	O
executive	O	O	B-T041
functions	O	O	I-T041
.	O	O	O

We	O	O	O
developed	O	O	O
the	O	O	O
Concentration	O	O	B-T041
Memory	O	O	B-T041
Task	O	O	B-T057
,	O	O	O
a	O	O	O
novel	O	O	O
computerized	O	O	B-T066
version	O	O	I-T066
of	O	O	O
the	O	O	O
Concentration	O	O	O
card	O	O	B-T073
game	O	O	I-T073
with	O	O	O
a	O	O	O
high	O	O	B-T080
degree	O	O	O
of	O	O	O
interference	O	O	B-T169
.	O	O	O

We	O	O	O
found	O	O	O
that	O	O	O
young	O	O	B-T100
adults	O	O	I-T100
with	O	O	O
elevated	O	O	B-T080
stress	O	O	B-T033
,	O	O	O
depression	O	O	B-T033
,	O	O	O
and	O	O	O
alcohol	O	O	B-T081
consumption	O	O	I-T081
scores	O	O	I-T081
were	O	O	O
impaired	O	O	B-T169
in	O	O	O
the	O	O	O
Concentration	O	O	B-T041
Memory	O	O	B-T041
Task	O	O	B-T057
.	O	O	O

We	O	O	O
also	O	O	O
analyzed	O	O	B-T057
data	O	O	I-T057
from	O	O	O
a	O	O	O
previous	O	O	O
study	O	O	O
,	O	O	O
and	O	O	O
found	O	O	O
that	O	O	O
higher	O	O	B-T080
alcohol	O	O	B-T081
consumption	O	O	I-T081
scores	O	O	I-T081
were	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
impaired	O	O	B-T169
performance	O	O	B-T055
on	O	O	O
another	O	O	O
high	O	O	B-T080
interference	O	O	B-T169
memory	O	O	B-T041
task	O	O	B-T057
,	O	O	O
based	O	O	O
on	O	O	O
Kirwan	O	O	B-T170
and	O	O	I-T170
Stark	O	O	I-T170
's	O	O	I-T170
Mnemonic	O	O	I-T170
Similarity	O	O	I-T170
Test	O	O	I-T170
.	O	O	O

On	O	O	O
the	O	O	O
other	O	O	O
hand	O	O	O
,	O	O	O
adolescent	O	O	B-T100
onset	O	O	B-T081
of	O	O	O
binge	O	O	B-T055
drinking	O	O	I-T055
predicted	O	O	O
poorer	O	O	B-T080
performance	O	O	B-T055
on	O	O	O
broader	O	O	O
range	O	O	O
of	O	O	O
memory	O	O	B-T041
tests	O	O	B-T170
,	O	O	O
including	O	O	O
a	O	O	O
more	O	O	O
systematic	O	O	B-T170
test	O	O	I-T170
of	O	O	I-T170
spatial	O	O	I-T170
recognition	O	O	I-T170
memory	O	O	I-T170
,	O	O	O
and	O	O	O
an	O	O	O
associative	O	O	B-T041
learning	O	O	I-T041
task	O	O	B-T057
.	O	O	O

Our	O	O	O
results	O	O	B-T033
are	O	O	O
broadly	O	O	O
consistent	O	O	B-T078
with	O	O	I-T078
findings	O	O	O
in	O	O	O
rodents	O	O	B-T015
that	O	O	O
acute	O	O	B-T051
alcohol	O	O	I-T051
and	O	O	O
stress	O	O	B-T048
exposure	O	O	O
suppress	O	O	B-T169
neurogenesis	O	O	B-T040
in	O	O	O
the	O	O	O
adult	O	O	B-T100
hippocampus	O	O	B-T023
,	O	O	O
which	O	O	O
in	O	O	O
turn	O	O	O
impairs	O	O	B-T169
performance	O	O	B-T055
in	O	O	O
high	O	O	B-T080
interference	O	O	B-T169
memory	O	O	B-T041
tasks	O	O	B-T057
,	O	O	O
while	O	O	O
adolescent	O	O	B-T100
onset	O	O	B-T081
binge	O	O	B-T055
drinking	O	O	I-T055
causes	O	O	O
more	O	O	O
extensive	O	O	B-T080
brain	O	O	B-T037
damage	O	O	I-T037
and	O	O	O
cognitive	O	O	B-T048
deficits	O	O	I-T048
.	O	O	O

-DOCSTART- (27500205)

Of	O	O	O
Kindlins	O	O	B-T116
and	O	O	O
Cancer	O	O	O

Kindlins	O	O	B-T116
are	O	O	O
4.1-ezrin-ridixin-moesin	O	O	B-T087
(	O	O	I-T087
FERM	O	O	I-T087
)	O	O	I-T087
domain	O	O	I-T087
containing	O	O	O
proteins	O	O	B-T116
.	O	O	O

There	O	O	O
are	O	O	O
three	O	O	O
kindlins	O	O	B-T116
in	O	O	O
mammals	O	O	B-T015
,	O	O	O
which	O	O	O
share	O	O	O
high	O	O	B-T080
sequence	O	O	B-T087
identity	O	O	O
.	O	O	O

Kindlin-1	O	O	B-T116
is	O	O	O
expressed	O	O	B-T045
primarily	O	O	O
in	O	O	O
epithelial	O	O	B-T025
cells	O	O	I-T025
,	O	O	O
kindlin-2	O	O	B-T116
is	O	O	O
widely	O	O	O
distributed	O	O	B-T169
and	O	O	O
is	O	O	O
particularly	O	O	O
abundant	O	O	B-T080
in	O	O	O
adherent	O	O	B-T025
cells	O	O	I-T025
,	O	O	O
and	O	O	O
kindlin-3	O	O	B-T116
is	O	O	O
expressed	O	O	O
primarily	O	O	O
in	O	O	O
hematopoietic	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

These	O	O	O
distributions	O	O	B-T169
are	O	O	O
not	O	O	O
exclusive	O	O	B-T078
;	O	O	O
some	O	O	O
cells	O	O	B-T025
express	O	O	B-T045
multiple	O	O	B-T081
kindlins	O	O	B-T116
,	O	O	O
and	O	O	O
transformed	O	O	B-T025
cells	O	O	I-T025
often	O	O	B-T079
exhibit	O	O	O
aberrant	O	O	B-T080
expression	O	O	B-T045
,	O	O	O
both	O	O	O
in	O	O	O
the	O	O	O
isoforms	O	O	B-T116
and	O	O	O
the	O	O	O
levels	O	O	B-T080
of	O	O	O
kindlins	O	O	O
.	O	O	O

Great	O	O	O
interest	O	O	O
in	O	O	O
the	O	O	O
kindlins	O	O	B-T116
has	O	O	O
emerged	O	O	O
from	O	O	O
the	O	O	O
recognition	O	O	O
that	O	O	O
they	O	O	O
play	O	O	O
major	O	O	B-T080
roles	O	O	B-T077
in	O	O	O
controlling	O	O	B-T067
integrin	O	O	B-T116
function	O	O	B-T044
.	O	O	O

In	O	O	B-T062
vitro	O	O	I-T062
studies	O	O	B-T062
,	O	O	O
in	O	O	B-T062
vivo	O	O	I-T062
studies	O	O	I-T062
of	O	O	O
mice	O	O	B-T015
deficient	O	O	B-T169
in	O	O	O
kindlins	O	O	B-T116
,	O	O	O
and	O	O	O
studies	O	O	O
of	O	O	O
patients	O	O	B-T101
with	O	O	O
genetic	O	O	B-T169
deficiencies	O	O	B-T169
of	O	O	O
kindlins	O	O	O
have	O	O	O
clearly	O	O	O
established	O	O	B-T080
that	O	O	O
they	O	O	O
regulate	O	O	O
the	O	O	O
capacity	O	O	B-T081
of	O	O	O
integrins	O	O	B-T116
to	O	O	O
mediate	O	O	B-T080
their	O	O	O
functions	O	O	B-T169
.	O	O	O

Kindlins	O	O	B-T116
are	O	O	O
adaptor	O	O	B-T116
proteins	O	O	I-T116
;	O	O	O
their	O	O	O
function	O	O	B-T169
emanate	O	O	B-T080
from	O	O	O
their	O	O	O
interaction	O	O	B-T169
with	O	O	O
binding	O	O	B-T044
partners	O	O	O
,	O	O	O
including	O	O	O
the	O	O	O
cytoplasmic	O	O	B-T026
tails	O	O	I-T026
of	O	O	O
integrins	O	O	B-T116
and	O	O	O
components	O	O	O
of	O	O	O
the	O	O	O
actin	O	O	B-T026
cytoskeleton	O	O	I-T026
.	O	O	O

The	O	O	O
purpose	O	O	B-T169
of	O	O	O
this	O	O	O
review	O	O	B-T170
is	O	O	O
to	O	O	O
provide	O	O	O
a	O	O	O
brief	O	O	B-T079
overview	O	O	B-T170
of	O	O	O
kindlin	O	O	B-T116
structure	O	O	B-T116
and	O	O	O
function	O	O	B-T044
,	O	O	O
a	O	O	O
consideration	O	O	B-T033
of	O	O	O
their	O	O	O
binding	O	O	B-T044
partners	O	O	O
,	O	O	O
and	O	O	O
then	O	O	O
to	O	O	O
focus	O	O	O
on	O	O	O
the	O	O	O
relationship	O	O	B-T080
of	O	O	O
each	O	O	O
kindlin	O	O	O
family	O	O	B-T116
member	O	O	B-T096
with	O	O	O
cancer	O	O	B-T191
.	O	O	O

In	O	O	O
view	O	O	B-T082
of	O	O	O
many	O	O	O
correlations	O	O	B-T080
of	O	O	O
kindlin	O	O	B-T116
expression	O	O	B-T045
levels	O	O	B-T080
and	O	O	O
neoplasia	O	O	B-T191
and	O	O	O
the	O	O	O
known	O	O	O
association	O	O	B-T080
of	O	O	O
integrins	O	O	B-T116
with	O	O	O
tumor	O	O	B-T191
progression	O	O	I-T191
and	O	O	O
metastasis	O	O	B-T191
,	O	O	O
we	O	O	O
consider	O	O	B-T078
whether	O	O	O
regulation	O	O	O
of	O	O	O
kindlins	O	O	B-T116
or	O	O	O
their	O	O	O
function	O	O	B-T169
would	O	O	O
be	O	O	O
attractive	O	O	B-T080
targets	O	O	B-T169
for	O	O	O
treatment	O	O	B-T061
of	O	O	I-T061
cancer	O	O	I-T061
.	O	O	O

-DOCSTART- (27503306)

Preclinical	O	O	B-T080
fibrinolysis	O	O	B-T039
in	O	O	O
patients	O	O	B-T101
with	O	O	O
ST-segment	O	O	B-T047
elevation	O	O	I-T047
myocardial	O	O	I-T047
infarction	O	O	I-T047
in	O	O	O
a	O	O	O
rural	O	O	O
region	O	O	O

In	O	O	O
the	O	O	O
current	O	O	B-T170
guidelines	O	O	I-T170
for	O	O	O
the	O	O	O
treatment	O	O	B-T061
of	O	O	O
patients	O	O	B-T101
with	O	O	O
ST-segment	O	O	B-T047
elevation	O	O	I-T047
myocardial	O	O	I-T047
infarction	O	O	I-T047
(	O	O	O
STEMI	O	O	B-T047
)	O	O	O
,	O	O	O
the	O	O	O
European	O	O	O
Society	O	O	O
of	O	O	O
Cardiology	O	O	O
(	O	O	O
ESC	O	O	O
)	O	O	O
recommends	O	O	B-T078
preclinical	O	O	B-T080
fibrinolysis	O	O	B-T039
as	O	O	O
a	O	O	O
reperfusion	O	O	B-T061
therapy	O	O	I-T061
if	O	O	O
,	O	O	O
due	O	O	O
to	O	O	O
long	O	O	O
transportation	O	O	B-T078
times	O	O	B-T079
,	O	O	O
no	O	O	O
cardiac	O	O	B-T058
catheterisation	O	O	I-T058
is	O	O	O
available	O	O	B-T169
within	O	O	O
90	O	O	O
-	O	O	O
120	O	O	O
min	O	O	B-T079
.	O	O	O

However	O	O	O
,	O	O	O
there	O	O	O
is	O	O	O
little	O	O	O
remaining	O	O	B-T080
in-depth	O	O	O
expertise	O	O	B-T080
in	O	O	O
this	O	O	O
method	O	O	B-T169
because	O	O	O
fibrinolysis	O	O	B-T039
is	O	O	O
presently	O	O	B-T078
only	O	O	O
rarely	O	O	B-T080
indicated	O	O	B-T033
.	O	O	O

In	O	O	O
a	O	O	O
rural	O	O	B-T082
area	O	O	I-T082
in	O	O	O
southwestern	O	O	B-T082
Germany	O	O	B-T083
,	O	O	O
where	O	O	O
an	O	O	O
emergency	O	O	B-T067
primary	O	O	I-T061
percutaneous	O	O	I-T061
coronary	O	O	I-T061
intervention	O	O	I-T061
was	O	O	O
not	O	O	O
routinely	O	O	B-T080
available	O	O	B-T169
within	O	O	O
90	O	O	O
-	O	O	O
120	O	O	O
min	O	O	B-T079
,	O	O	O
156	O	O	O
STEMI	O	O	B-T047
patients	O	O	B-T101
underwent	O	O	O
fibrinolysis	O	O	B-T039
with	O	O	O
the	O	O	O
plasminogen	O	O	B-T116
activator	O	O	I-T116
reteplase	O	O	I-T116
,	O	O	O
performed	O	O	B-T080
by	O	O	I-T080
trained	O	O	O
emergency	O	O	O
physicians	O	O	B-T097
.	O	O	O

The	O	O	O
practicality	O	O	B-T080
of	O	O	O
the	O	O	O
treatment	O	O	B-T061
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
complications	O	O	B-T046
and	O	O	O
the	O	O	O
mortality	O	O	B-T081
of	O	O	O
the	O	O	O
patients	O	O	B-T101
in	O	O	O
the	O	O	O
preclinical	O	O	B-T080
phase	O	O	B-T079
until	O	O	O
arrival	O	O	B-T052
at	O	O	O
the	O	O	O
hospital	O	O	B-T093
,	O	O	O
were	O	O	O
retrospectively	O	O	B-T062
studied	O	O	I-T062
.	O	O	O

The	O	O	O
mean	O	O	B-T079
time	O	O	I-T079
from	O	O	O
onset	O	O	B-T080
of	O	O	I-T080
the	O	O	O
symptoms	O	O	B-T184
to	O	O	O
first	O	O	O
medical	O	O	B-T058
contact	O	O	I-T058
was	O	O	O
114	O	O	O
Â±	O	O	O
116	O	O	O
min	O	O	B-T079
.	O	O	O

The	O	O	O
mean	O	O	B-T079
interval	O	O	I-T079
to	O	O	O
the	O	O	O
start	O	O	B-T079
of	O	O	O
fibrinolysis	O	O	B-T039
of	O	O	O
13.5	O	O	O
Â±	O	O	O
6.4	O	O	O
min	O	O	B-T079
was	O	O	O
within	O	O	O
the	O	O	O
30	O	O	O
min	O	O	O
mandated	O	O	B-T089
by	O	O	O
the	O	O	O
ESC	O	O	O
.	O	O	O

Patients	O	O	B-T101
with	O	O	O
inferior	O	O	B-T047
STEMI	O	O	I-T047
represented	O	O	B-T052
the	O	O	O
largest	O	O	B-T081
subgroup	O	O	B-T185
.	O	O	O

Occurring	O	O	O
in	O	O	O
39	O	O	O
cases	O	O	B-T096
(	O	O	O
25	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
complications	O	O	B-T046
due	O	O	O
to	O	O	O
infarction	O	O	B-T046
were	O	O	O
relatively	O	O	O
common	O	O	B-T081
during	O	O	O
the	O	O	O
prehospital	O	O	B-T058
phase	O	O	B-T079
,	O	O	O
including	O	O	O
15	O	O	O
cases	O	O	O
(	O	O	O
9.6	O	O	O
%	O	O	O
)	O	O	O
of	O	O	O
cardiogenic	O	O	B-T046
shock	O	O	I-T046
,	O	O	O
but	O	O	O
in	O	O	O
all	O	O	O
cases	O	O	O
the	O	O	O
complications	O	O	O
were	O	O	O
manageable	O	O	B-T033
.	O	O	O

No	O	O	O
patient	O	O	B-T101
died	O	O	B-T033
before	O	O	O
arrival	O	O	B-T052
at	O	O	O
the	O	O	O
hospital	O	O	B-T093
.	O	O	O

As	O	O	O
lysis	O	O	B-T046
-	O	O	O
associated	O	O	B-T080
adverse	O	O	B-T046
effects	O	O	I-T046
,	O	O	O
merely	O	O	O
two	O	O	O
uncomplicated	O	O	B-T080
mucosal	O	O	B-T184
haemorrhages	O	O	I-T184
and	O	O	O
one	O	O	O
case	O	O	O
of	O	O	O
mild	O	O	B-T047
allergic	O	O	I-T047
skin	O	O	I-T047
reactions	O	O	I-T047
were	O	O	O
seen	O	O	B-T080
.	O	O	O

In	O	O	O
emergency	O	O	B-T067
situations	O	O	I-T067
with	O	O	O
long	O	O	O
transportation	O	O	B-T078
times	O	O	B-T079
to	O	O	O
the	O	O	O
nearest	O	O	O
suitable	O	O	B-T080
cardiac	O	O	B-T058
catheterisation	O	O	I-T058
laboratory	O	O	B-T093
,	O	O	O
preclinical	O	O	B-T080
fibrinolysis	O	O	B-T039
in	O	O	O
STEMI	O	O	B-T047
still	O	O	O
represents	O	O	O
a	O	O	O
workable	O	O	B-T169
method	O	O	I-T169
.	O	O	O

Success	O	O	B-T054
of	O	O	O
this	O	O	O
strategy	O	O	B-T041
requires	O	O	O
particularly	O	O	O
strong	O	O	B-T065
training	O	O	I-T065
of	O	O	O
the	O	O	O
emergency	O	O	B-T067
physicians	O	O	B-T097
in	O	O	O
ECG	O	O	B-T060
and	O	O	O
lysis	O	O	B-T046
therapy	O	O	B-T061
,	O	O	O
and	O	O	O
co-operation	O	O	B-T054
with	O	O	O
nearby	O	O	O
cardiac	O	O	B-T093
centres	O	O	I-T093
.	O	O	O

-DOCSTART- (27503899)

A	O	O	O
method	O	O	B-T169
of	O	O	O
providing	O	O	B-T052
engaging	O	O	O
formative	O	O	B-T057
feedback	O	O	I-T057
to	O	O	O
large	O	O	B-T081
cohort	O	O	B-T098
first-year	O	O	B-T079
physiology	O	O	B-T091
and	O	O	O
anatomy	O	O	B-T091
students	O	O	O

A	O	O	O
growing	O	O	O
body	O	O	O
of	O	O	O
evidence	O	O	B-T078
demonstrates	O	O	B-T052
a	O	O	O
critical	O	O	B-T080
role	O	O	O
for	O	O	O
effective	O	O	B-T080
,	O	O	O
meaningful	O	O	B-T080
feedback	O	O	B-T041
to	O	O	O
enhance	O	O	B-T052
student	O	O	B-T098
learning	O	O	B-T041
.	O	O	O

Effective	O	O	B-T080
feedback	O	O	B-T041
can	O	O	O
become	O	O	O
part	O	O	B-T082
of	O	O	I-T082
the	O	O	O
learning	O	O	B-T041
cycle	O	O	B-T079
that	O	O	O
is	O	O	O
not	O	O	O
only	O	O	O
a	O	O	O
learning	O	O	O
opportunity	O	O	B-T062
for	O	O	O
the	O	O	O
student	O	O	B-T098
but	O	O	O
can	O	O	O
also	O	O	O
be	O	O	O
used	O	O	O
to	O	O	O
inform	O	O	B-T057
the	O	O	O
teacher	O	O	B-T097
and	O	O	O
ongoing	O	O	B-T078
curriculum	O	O	B-T065
development	O	O	I-T065
.	O	O	O

Feedback	O	O	B-T041
is	O	O	O
considered	O	O	B-T078
particularly	O	O	O
important	O	O	B-T080
during	O	O	B-T079
the	O	O	O
first	O	O	B-T079
year	O	O	I-T079
of	O	O	O
university	O	O	B-T073
and	O	O	O
can	O	O	O
even	O	O	O
be	O	O	O
viewed	O	O	O
as	O	O	O
a	O	O	O
retention	O	O	B-T169
strategy	O	O	O
that	O	O	O
can	O	O	O
help	O	O	O
attenuate	O	O	B-T052
student	O	O	B-T098
performance	O	O	B-T048
anxieties	O	O	I-T048
and	O	O	O
solidify	O	O	B-T080
perceptions	O	O	B-T041
of	O	O	O
academic	O	O	B-T065
support	O	O	I-T065
.	O	O	O

Unfortunately	O	O	O
,	O	O	O
the	O	O	O
provision	O	O	O
of	O	O	O
individualized	O	O	B-T080
,	O	O	O
timely	O	O	B-T080
feedback	O	O	B-T041
can	O	O	O
be	O	O	O
particularly	O	O	O
challenging	O	O	O
in	O	O	O
first-year	O	O	B-T079
courses	O	O	B-UnknownType
as	O	O	O
they	O	O	O
tend	O	O	O
to	O	O	O
be	O	O	O
large	O	O	B-T081
and	O	O	O
diverse	O	O	B-T080
cohort	O	O	B-T098
classes	O	O	B-T170
that	O	O	O
pose	O	O	O
challenges	O	O	O
of	O	O	O
time	O	O	B-T079
and	O	O	O
logistics	O	O	B-T057
.	O	O	O

Various	O	O	O
forms	O	O	O
of	O	O	O
generic	O	O	O
feedback	O	O	B-T041
can	O	O	O
provide	O	O	B-T052
rapid	O	O	B-T080
and	O	O	O
cost-effect	O	O	B-T081
feedback	O	O	O
to	O	O	O
large	O	O	B-T081
cohorts	O	O	B-T098
but	O	O	O
may	O	O	O
be	O	O	O
of	O	O	O
limited	O	O	B-T169
benefit	O	O	B-T081
to	O	O	O
students	O	O	B-T098
other	O	O	O
than	O	O	O
signaling	O	O	O
weaknesses	O	O	B-T033
in	O	O	O
knowledge	O	O	B-T170
.	O	O	O

The	O	O	O
present	O	O	B-T033
study	O	O	B-T062
describes	O	O	B-T078
a	O	O	O
method	O	O	B-T169
that	O	O	O
was	O	O	O
used	O	O	O
to	O	O	O
provide	O	O	B-T052
formative	O	O	B-T057
task-related	O	O	I-T057
feedback	O	O	I-T057
to	O	O	O
a	O	O	O
large	O	O	B-T081
cohort	O	O	B-T098
of	O	O	O
first-year	O	O	B-T079
physiology	O	O	B-T091
and	O	O	O
anatomy	O	O	B-T091
students	O	O	B-T098
.	O	O	O

Based	O	O	O
on	O	O	O
student	O	O	B-T098
evaluations	O	O	B-T058
presented	O	O	B-T078
in	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
this	O	O	O
method	O	O	B-T169
provided	O	O	B-T052
feedback	O	O	B-T041
in	O	O	O
a	O	O	O
manner	O	O	O
that	O	O	O
engaged	O	O	O
students	O	O	B-T098
,	O	O	O
uncovered	O	O	B-T169
underlying	O	O	B-T033
misconceptions	O	O	I-T033
,	O	O	O
facilitated	O	O	O
peer	O	O	B-T098
discussion	O	O	B-T054
,	O	O	O
and	O	O	O
provided	O	O	O
opportunity	O	O	O
for	O	O	O
new	O	O	B-T080
instruction	O	O	B-T065
while	O	O	O
allowing	O	O	B-T054
the	O	O	O
lecturer	O	O	B-T097
to	O	O	O
recognize	O	O	B-T041
common	O	O	B-T081
gaps	O	O	B-T082
in	O	O	O
knowledge	O	O	B-T170
and	O	O	O
inform	O	O	O
ongoing	O	O	B-T078
curriculum	O	O	B-T065
development	O	O	I-T065
.	O	O	O

-DOCSTART- (27503926)

SIRT2	O	O	B-T116
Deacetylates	O	O	B-T044
and	O	O	O
Inhibits	O	O	B-T044
the	O	O	I-T044
Peroxidase	O	O	I-T044
Activity	O	O	I-T044
of	O	O	O
Peroxiredoxin-1	O	O	B-T116
to	O	O	O
Sensitize	O	O	B-T025
Breast	O	O	I-T025
Cancer	O	O	I-T025
Cells	O	O	I-T025
to	O	O	O
Oxidant	O	O	B-T049
Stress	O	O	I-T049
-	O	O	O
Inducing	O	O	B-T169
Agents	O	O	O

SIRT2	O	O	B-T116
is	O	O	O
a	O	O	O
protein	O	O	B-T044
deacetylase	O	O	I-T044
with	O	O	O
tumor	O	O	B-T043
suppressor	O	O	I-T043
activity	O	O	I-T043
in	O	O	O
breast	O	O	B-T191
and	O	O	O
liver	O	O	B-T191
tumors	O	O	I-T191
where	O	O	O
it	O	O	O
is	O	O	O
mutated	O	O	B-T049
;	O	O	O
however	O	O	O
,	O	O	O
the	O	O	O
critical	O	O	O
substrates	O	O	B-T167
mediating	O	O	O
its	O	O	O
antitumor	O	O	B-T033
activity	O	O	I-T033
are	O	O	O
not	O	O	O
fully	O	O	O
defined	O	O	O
.	O	O	O

Here	O	O	O
we	O	O	O
demonstrate	O	O	O
that	O	O	O
SIRT2	O	O	B-T116
binds	O	O	B-T044
,	O	O	O
deacetylates	O	O	B-T044
,	O	O	O
and	O	O	O
inhibits	O	O	B-T044
the	O	O	I-T044
peroxidase	O	O	I-T044
activity	O	O	I-T044
of	O	O	O
the	O	O	O
antioxidant	O	O	B-T116
protein	O	O	I-T116
peroxiredoxin	O	O	I-T116
(	O	O	O
Prdx-1	O	O	B-T116
)	O	O	O
in	O	O	O
breast	O	O	B-T025
cancer	O	O	I-T025
cells	O	O	I-T025
.	O	O	O

Ectopic	O	O	B-T082
overexpression	O	O	B-T045
of	O	O	O
SIRT2	O	O	B-T116
,	O	O	O
but	O	O	O
not	O	O	O
its	O	O	O
catalytically	O	O	B-T049
dead	O	O	I-T049
mutant	O	O	I-T049
,	O	O	O
increased	O	O	B-T081
intracellular	O	O	B-T082
levels	O	O	B-T080
of	O	O	O
reactive	O	O	B-T123
oxygen	O	O	I-T123
species	O	O	I-T123
(	O	O	O
ROS	O	O	B-T123
)	O	O	O
induced	O	O	B-T121
by	O	O	I-T121
hydrogen	O	O	I-T121
peroxide	O	O	I-T121
,	O	O	I-T121
which	O	O	O
led	O	O	O
to	O	O	O
increased	O	O	O
levels	O	O	O
of	O	O	O
an	O	O	O
overoxidized	O	O	B-T116
and	O	O	I-T116
multimeric	O	O	I-T116
form	O	O	I-T116
of	O	O	I-T116
Prdx-1	O	O	I-T116
with	O	O	O
activity	O	O	B-T116
as	O	O	I-T116
a	O	O	I-T116
molecular	O	O	I-T116
chaperone	O	O	I-T116
.	O	O	O

Elevated	O	O	B-T080
levels	O	O	B-T080
of	O	O	O
SIRT2	O	O	B-T028
sensitized	O	O	B-T025
breast	O	O	I-T025
cancer	O	O	I-T025
cells	O	O	I-T025
to	O	O	O
intracellular	O	O	B-T049
DNA	O	O	I-T049
damage	O	O	I-T049
and	O	O	O
cell	O	O	B-T043
death	O	O	I-T043
induced	O	O	I-T043
by	O	O	I-T043
oxidative	O	O	I-T043
stress	O	O	I-T043
,	O	O	O
as	O	O	O
associated	O	O	O
with	O	O	O
increased	O	O	B-T081
levels	O	O	O
of	O	O	O
nuclear	O	O	B-T116
FOXO3A	O	O	I-T116
and	O	O	O
the	O	O	O
proapoptotic	O	O	B-T116
BIM	O	O	I-T116
protein	O	O	I-T116
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
elevated	O	O	B-T080
levels	O	O	B-T080
of	O	O	O
SIRT2	O	O	B-T116
sensitized	O	O	B-T025
breast	O	O	I-T025
cancer	O	O	I-T025
cells	O	O	I-T025
to	O	O	O
arsenic	O	O	B-T121
trioxide	O	O	I-T121
,	O	O	O
an	O	O	O
approved	O	O	O
therapeutic	O	O	B-T073
agent	O	O	I-T073
,	O	O	O
along	O	O	O
with	O	O	O
other	O	O	O
intracellular	O	O	B-T123
ROS	O	O	I-T123
-	O	O	O
inducing	O	O	B-T121
agents	O	O	I-T121
.	O	O	O

Conversely	O	O	O
,	O	O	O
antisense	O	O	B-T114
RNA	O	O	I-T114
-	O	O	O
mediated	O	O	B-T052
attenuation	O	O	I-T052
of	O	O	O
SIRT2	O	O	B-T116
reversed	O	O	B-T169
ROS	O	O	B-T123
-	O	O	O
induced	O	O	B-T037
toxicity	O	O	I-T037
as	O	O	O
demonstrated	O	O	O
in	O	O	O
a	O	O	O
zebrafish	O	O	B-T013
embryo	O	O	B-T018
model	O	O	I-T018
system	O	O	I-T018
.	O	O	O

Collectively	O	O	O
,	O	O	O
our	O	O	O
findings	O	O	O
suggest	O	O	O
that	O	O	O
the	O	O	O
tumor	O	O	B-T043
suppressor	O	O	I-T043
activity	O	O	I-T043
of	O	O	O
SIRT2	O	O	B-T116
requires	O	O	O
its	O	O	O
ability	O	O	O
to	O	O	O
restrict	O	O	B-T169
the	O	O	O
antioxidant	O	O	B-T044
activity	O	O	I-T044
of	O	O	O
Prdx-1	O	O	B-T116
,	O	O	O
thereby	O	O	O
sensitizing	O	O	B-T025
breast	O	O	I-T025
cancer	O	O	I-T025
cells	O	O	I-T025
to	O	O	O
ROS	O	O	B-T123
-	O	O	O
induced	O	O	B-T049
DNA	O	O	I-T049
damage	O	O	I-T049
and	O	O	O
cell	O	O	B-T049
cytotoxicity	O	O	I-T049
.	O	O	O

Cancer	O	O	O
Res	O	O	O
;	O	O	O
76(18	O	O	O
)	O	O	O
;	O	O	O
5467	O	O	O
-	O	O	O
78	O	O	O
.	O	O	O

Â©	O	O	O
2016	O	O	O
AACR	O	O	O
.	O	O	O

-DOCSTART- (27506129)

On	O	O	O
the	O	O	O
development	O	O	B-T169
of	O	O	O
conjunctival	O	O	B-T047
hyperemia	O	O	I-T047
computer-assisted	O	O	B-T060
diagnosis	O	O	I-T060
tools	O	O	I-T060
:	O	O	O
Influence	O	O	O
of	O	O	O
feature	O	O	B-T080
selection	O	O	B-T052
and	O	O	O
class	O	O	B-T170
imbalance	O	O	I-T170
in	O	O	O
automatic	O	O	O
gradings	O	O	O

The	O	O	O
sudden	O	O	O
increase	O	O	O
of	O	O	O
blood	O	O	B-T039
flow	O	O	I-T039
in	O	O	O
the	O	O	O
bulbar	O	O	B-T023
conjunctiva	O	O	I-T023
,	O	O	O
known	O	O	O
as	O	O	O
hyperemia	O	O	B-T047
,	O	O	O
is	O	O	O
associated	O	O	O
to	O	O	O
a	O	O	O
red	O	O	B-T070
hue	O	O	I-T070
of	O	O	O
variable	O	O	B-T080
intensity	O	O	B-T080
.	O	O	O

Experts	O	O	O
measure	O	O	O
hyperemia	O	O	B-T047
using	O	O	O
levels	O	O	O
in	O	O	O
a	O	O	O
grading	O	O	B-T170
scale	O	O	I-T170
,	O	O	O
a	O	O	O
procedure	O	O	O
that	O	O	O
is	O	O	O
subjective	O	O	O
,	O	O	O
non-repeatable	O	O	O
and	O	O	O
time	O	O	B-T080
consuming	O	O	I-T080
,	O	O	O
thus	O	O	O
creating	O	O	O
a	O	O	O
need	O	O	O
for	O	O	O
its	O	O	O
automatisation	O	O	B-T066
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
task	O	O	O
is	O	O	O
far	O	O	O
from	O	O	O
straightforward	O	O	B-T080
due	O	O	O
to	O	O	O
data	O	O	O
issues	O	O	O
such	O	O	O
as	O	O	O
class	O	O	B-T170
imbalance	O	O	I-T170
or	O	O	O
correlated	O	O	B-T080
features	O	O	B-T080
.	O	O	O

In	O	O	O
this	O	O	O
paper	O	O	O
,	O	O	O
we	O	O	O
study	O	O	O
the	O	O	O
specific	O	O	O
features	O	O	B-T080
of	O	O	O
hyperemia	O	O	B-T047
and	O	O	O
propose	O	O	O
various	O	O	O
approaches	O	O	O
to	O	O	O
address	O	O	O
these	O	O	O
problems	O	O	O
in	O	O	O
the	O	O	O
context	O	O	O
of	O	O	O
an	O	O	O
automatic	O	O	B-T170
framework	O	O	I-T170
for	O	O	O
hyperemia	O	O	O
grading	O	O	B-T033
.	O	O	O

Oversampling	O	O	B-T170
,	O	O	O
undersampling	O	O	B-T170
and	O	O	O
SMOTE	O	O	B-T170
approaches	O	O	I-T170
were	O	O	O
applied	O	O	O
in	O	O	O
order	O	O	O
to	O	O	O
tackle	O	O	O
the	O	O	O
problem	O	O	O
of	O	O	O
class	O	O	B-T170
imbalance	O	O	I-T170
.	O	O	O

25	O	O	O
features	O	O	O
were	O	O	O
computed	O	O	O
for	O	O	O
each	O	O	O
image	O	O	O
and	O	O	O
regression	O	O	B-T170
methods	O	O	I-T170
were	O	O	O
then	O	O	O
used	O	O	O
to	O	O	O
transform	O	O	O
them	O	O	O
into	O	O	O
a	O	O	O
value	O	O	O
on	O	O	O
the	O	O	O
grading	O	O	B-T170
scale	O	O	I-T170
.	O	O	O

The	O	O	O
values	O	O	O
and	O	O	O
relationships	O	O	O
among	O	O	O
features	O	O	B-T080
and	O	O	O
experts	O	O	B-T033
'	O	O	I-T033
values	O	O	I-T033
were	O	O	O
analysed	O	O	O
,	O	O	O
and	O	O	O
five	O	O	O
feature	O	O	B-T080
selection	O	O	B-T052
techniques	O	O	O
were	O	O	O
subsequently	O	O	O
studied	O	O	O
.	O	O	O

The	O	O	O
lowest	O	O	B-T081
mean	O	O	I-T081
square	O	O	I-T081
error	O	O	I-T081
(	O	O	O
MSE	O	O	B-T081
)	O	O	O
for	O	O	O
the	O	O	O
regression	O	O	B-T170
systems	O	O	I-T170
trained	O	O	O
with	O	O	O
individual	O	O	O
features	O	O	O
is	O	O	O
below	O	O	O
0.1	O	O	O
for	O	O	O
both	O	O	O
scales	O	O	O
.	O	O	O

Multi-layer	O	O	B-T170
perceptron	O	O	I-T170
(	O	O	O
MLP	O	O	B-T170
)	O	O	O
obtains	O	O	O
the	O	O	O
best	O	O	O
values	O	O	O
,	O	O	O
but	O	O	O
is	O	O	O
less	O	O	O
consistent	O	O	O
than	O	O	O
the	O	O	O
random	O	O	B-T170
forest	O	O	I-T170
(	O	O	I-T170
RF	O	O	I-T170
)	O	O	I-T170
method	O	O	I-T170
.	O	O	O

When	O	O	O
all	O	O	O
features	O	O	O
are	O	O	O
combined	O	O	O
,	O	O	O
the	O	O	O
best	O	O	O
results	O	O	O
for	O	O	O
both	O	O	O
scales	O	O	O
are	O	O	O
achieved	O	O	O
with	O	O	O
MLP	O	O	B-T170
.	O	O	O

Correlation	O	O	B-T170
based	O	O	I-T170
feature	O	O	I-T170
selection	O	O	I-T170
(	O	O	O
CFS	O	O	B-T170
)	O	O	O
and	O	O	O
M5	O	O	O
provide	O	O	O
the	O	O	O
best	O	O	O
results	O	O	O
,	O	O	O
MSE	O	O	B-T081
=	O	O	O
0.108	O	O	O
and	O	O	O
MSE	O	O	O
=	O	O	O
0.061	O	O	O
respectively	O	O	O
.	O	O	O

Finally	O	O	O
,	O	O	O
the	O	O	O
class	O	O	B-T170
imbalance	O	O	I-T170
problem	O	O	I-T170
is	O	O	O
minimised	O	O	O
with	O	O	O
the	O	O	O
SMOTE	O	O	B-T170
approach	O	O	I-T170
for	O	O	O
both	O	O	O
scales	O	O	O
(	O	O	O
MSE	O	O	B-T081
<	O	O	O
0.006	O	O	O
)	O	O	O
.	O	O	O

Machine	O	O	B-T066
learning	O	O	I-T066
methods	O	O	O
are	O	O	O
able	O	O	O
to	O	O	O
perform	O	O	O
an	O	O	O
objective	O	O	O
assessment	O	O	O
of	O	O	O
hyperemia	O	O	B-T047
grading	O	O	B-T033
,	O	O	O
removing	O	O	O
both	O	O	O
intra-	O	O	B-T080
and	O	O	I-T080
inter-expert	O	O	I-T080
subjectivity	O	O	I-T080
while	O	O	O
providing	O	O	O
a	O	O	O
gain	O	O	O
in	O	O	O
computation	O	O	B-T052
time	O	O	B-T079
.	O	O	O

SMOTE	O	O	B-T170
and	O	O	O
oversampling	O	O	B-T170
approaches	O	O	I-T170
minimise	O	O	O
the	O	O	O
class	O	O	B-T170
imbalance	O	O	I-T170
problem	O	O	I-T170
,	O	O	O
while	O	O	O
feature	O	O	B-T080
selection	O	O	B-T052
reduces	O	O	O
the	O	O	O
number	O	O	O
of	O	O	O
features	O	O	B-T080
from	O	O	O
25	O	O	O
to	O	O	O
3	O	O	O
-	O	O	O
5	O	O	O
without	O	O	O
worsening	O	O	O
the	O	O	O
MSE	O	O	B-T081
.	O	O	O

As	O	O	O
the	O	O	O
differences	O	O	O
between	O	O	O
the	O	O	O
system	O	O	B-T073
and	O	O	O
a	O	O	O
human	O	O	B-T097
expert	O	O	B-T097
are	O	O	O
similar	O	O	O
to	O	O	O
the	O	O	O
differences	O	O	O
between	O	O	O
experts	O	O	B-T097
,	O	O	O
we	O	O	O
can	O	O	O
therefore	O	O	O
conclude	O	O	O
that	O	O	O
the	O	O	O
system	O	O	O
behaves	O	O	O
like	O	O	O
an	O	O	O
expert	O	O	O
.	O	O	O

-DOCSTART- (27506220)

Medication	O	O	B-T058
,	O	O	O
rehabilitation	O	O	B-T169
and	O	O	O
health	O	O	B-T055
care	O	O	I-T055
consumption	O	O	I-T055
in	O	O	O
adults	O	O	B-T100
with	O	O	O
cerebral	O	O	B-T047
palsy	O	O	I-T047
:	O	O	O
A	O	O	O
population	O	O	O
based	O	O	O
study	O	O	O

To	O	O	O
evaluate	O	O	O
medication	O	O	B-T058
,	O	O	O
rehabilitation	O	O	B-T169
and	O	O	O
healthcare	O	O	B-T055
consumption	O	O	I-T055
in	O	O	O
adults	O	O	B-T100
with	O	O	O
CP	O	O	B-T047
as	O	O	O
a	O	O	O
function	O	O	B-T169
of	O	O	O
Gross	O	O	B-T170
Motor	O	O	I-T170
Function	O	O	I-T170
Classification	O	O	I-T170
System	O	O	I-T170
(	O	O	O
GMFCS	O	O	B-T170
)	O	O	O
level	O	O	O
.	O	O	O

Questionnaire	O	O	B-T170
-based	O	O	O
cross-sectional	O	O	B-T062
study	O	O	I-T062
.	O	O	O

Brittany	O	O	B-T083
,	O	O	O
a	O	O	O
French	O	O	B-T083
county	O	O	I-T083
.	O	O	O

Adults	O	O	B-T100
with	O	O	O
cerebral	O	O	B-T047
palsy	O	O	I-T047
.	O	O	O

Questionnaires	O	O	B-T170
relating	O	O	O
to	O	O	O
drugs	O	O	B-T121
,	O	O	O
orthotic	O	O	B-T074
devices	O	O	I-T074
,	O	O	O
mobility	O	O	B-T074
aids	O	O	I-T074
,	O	O	O
rehabilitation	O	O	B-T169
and	O	O	O
medical	O	O	B-T033
input	O	O	I-T033
were	O	O	O
sent	O	O	B-T169
to	O	O	O
435	O	O	O
members	O	O	B-T098
of	O	O	O
a	O	O	O
unique	O	O	B-T080
regional	O	O	B-T083
French	O	O	I-T083
network	O	O	B-T169
dedicated	O	O	O
to	O	O	O
adults	O	O	B-T100
with	O	O	O
cerebral	O	O	B-T047
palsy	O	O	I-T047
.	O	O	O

The	O	O	O
questionnaire	O	O	B-T170
was	O	O	O
completed	O	O	B-T080
by	O	O	O
the	O	O	O
participant	O	O	B-T098
or	O	O	O
a	O	O	O
helper	O	O	B-UnknownType
if	O	O	O
necessary	O	O	O
.	O	O	O

Of	O	O	O
the	O	O	O
282	O	O	O
responders	O	O	B-T033
,	O	O	O
7.8	O	O	O
%	O	O	O
had	O	O	O
a	O	O	O
GMFCS	O	O	B-T170
level	O	O	I-T170
of	O	O	O
I	O	O	O
,	O	O	O
14.2	O	O	O
%	O	O	O
II	O	O	O
,	O	O	O
17.7	O	O	O
%	O	O	O
III	O	O	O
,	O	O	O
29.1	O	O	O
%	O	O	O
IV	O	O	O
and	O	O	O
31.2	O	O	O
%	O	O	O
V.	O	O	O
Participants	O	O	B-T098
consumed	O	O	O
a	O	O	O
large	O	O	B-T055
amount	O	O	I-T055
of	O	O	I-T055
healthcare	O	O	I-T055
.	O	O	O

Almost	O	O	B-T081
three-quarters	O	O	I-T081
took	O	O	O
orally	O	O	B-T121
administered	O	O	I-T121
drugs	O	O	I-T121
,	O	O	O
of	O	O	O
which	O	O	O
antispastic	O	O	B-T121
and	O	O	O
antiepileptic	O	O	B-T121
drugs	O	O	I-T121
were	O	O	O
among	O	O	O
the	O	O	O
most	O	O	B-T079
frequent	O	O	I-T079
.	O	O	O

Nearly	O	O	O
all	O	O	O
patients	O	O	B-T101
had	O	O	O
at	O	O	O
least	O	O	O
one	O	O	O
type	O	O	O
of	O	O	O
rehabilitation	O	O	B-T169
,	O	O	O
87.2	O	O	O
%	O	O	O
had	O	O	O
physiotherapy	O	O	B-T061
,	O	O	O
78	O	O	O
%	O	O	O
used	O	O	O
at	O	O	O
least	O	O	O
one	O	O	O
mobility	O	O	B-T074
aid	O	O	I-T074
and	O	O	O
69.5	O	O	O
%	O	O	O
used	O	O	O
at	O	O	O
least	O	O	O
one	O	O	O
orthotic	O	O	B-T074
device	O	O	I-T074
.	O	O	O

The	O	O	O
frequency	O	O	B-T079
of	O	O	O
numerous	O	O	O
inputs	O	O	O
increased	O	O	O
with	O	O	O
GMFCS	O	O	B-T170
level	O	O	I-T170
.	O	O	O

Specificities	O	O	B-T081
were	O	O	O
found	O	O	B-T033
for	O	O	O
each	O	O	O
GMFCS	O	O	B-T170
level	O	O	I-T170
,	O	O	O
e.g.	O	O	O
participants	O	O	B-T098
with	O	O	O
GMFCS	O	O	O
level	O	O	O
IV	O	O	O
and	O	O	O
V	O	O	O
had	O	O	O
a	O	O	O
high	O	O	B-T080
level	O	O	I-T080
of	O	O	O
medical	O	O	B-T033
input	O	O	I-T033
and	O	O	O
a	O	O	O
greater	O	O	B-T169
use	O	O	I-T169
of	O	O	I-T169
trunk-supporting	O	O	B-T074
devices	O	O	I-T074
,	O	O	O
antireflux	O	O	B-T061
and	O	O	O
laxative	O	O	B-T121
.	O	O	O

Profiles	O	O	B-T081
could	O	O	O
be	O	O	O
established	O	O	O
based	O	O	O
on	O	O	O
GMFCS	O	O	B-T170
levels	O	O	I-T170
.	O	O	O

Adults	O	O	B-T100
with	O	O	O
cerebral	O	O	B-T047
palsy	O	O	I-T047
use	O	O	O
a	O	O	O
large	O	O	B-T081
amount	O	O	I-T081
of	O	O	O
drugs	O	O	B-T121
,	O	O	O
mobility	O	O	B-T074
aids	O	O	I-T074
,	O	O	O
orthotic	O	O	B-T074
devices	O	O	I-T074
,	O	O	O
rehabilitation	O	O	B-T169
and	O	O	O
medical	O	O	B-T033
input	O	O	I-T033
.	O	O	O

Healthcare	O	O	B-T058
is	O	O	O
targeted	O	O	B-T169
at	O	O	O
cerebral	O	O	B-T033
palsy	O	O	I-T033
-related	O	O	I-T033
issues	O	O	I-T033
.	O	O	O

GMFCS	O	O	B-T170
is	O	O	O
a	O	O	O
determinant	O	O	B-T169
of	O	O	O
healthcare	O	O	B-T055
consumption	O	O	I-T055
and	O	O	O
thus	O	O	O
a	O	O	O
useful	O	O	O
tool	O	O	O
for	O	O	O
clinical	O	O	B-T057
practice	O	O	I-T057
to	O	O	O
target	O	O	B-T169
care	O	O	B-T052
appropriately	O	O	B-T080
.	O	O	O

-DOCSTART- (27507702)

Transcriptome	O	O	B-T059
sequencing	O	O	I-T059
and	O	O	O
de	O	O	B-T078
novo	O	O	I-T078
characterization	O	O	B-T052
of	O	O	O
Korean	O	O	B-T083
endemic	O	O	O
land	O	O	B-T204
snail	O	O	I-T204
,	O	O	O
Koreanohadra	O	O	B-T204
kurodana	O	O	I-T204
for	O	O	O
functional	O	O	O
transcripts	O	O	B-T114
and	O	O	O
SSR	O	O	B-T114
markers	O	O	O

The	O	O	O
Korean	O	O	B-T083
endemic	O	O	O
land	O	O	B-T204
snail	O	O	I-T204
Koreanohadra	O	O	B-T204
kurodana	O	O	I-T204
(	O	O	O
Gastropoda	O	O	B-T204
:	O	O	O
Bradybaenidae	O	O	B-T204
)	O	O	O
found	O	O	O
in	O	O	O
humid	O	O	B-T067
areas	O	O	I-T067
of	O	O	O
broadleaf	O	O	B-T070
forests	O	O	I-T070
and	O	O	O
shrubs	O	O	B-T002
have	O	O	O
been	O	O	O
considered	O	O	O
vulnerable	O	O	O
as	O	O	O
the	O	O	O
number	O	O	O
of	O	O	O
individuals	O	O	B-T098
are	O	O	O
declining	O	O	O
in	O	O	O
recent	O	O	O
years	O	O	B-T079
.	O	O	O

The	O	O	O
species	O	O	B-T204
is	O	O	O
poorly	O	O	O
characterized	O	O	O
at	O	O	O
the	O	O	O
genomic	O	O	B-T028
level	O	O	I-T028
that	O	O	O
limits	O	O	O
the	O	O	O
understanding	O	O	O
of	O	O	O
functions	O	O	B-T169
at	O	O	O
the	O	O	O
molecular	O	O	B-T080
and	O	O	O
genetics	O	O	B-T169
level	O	O	I-T169
.	O	O	O

In	O	O	O
the	O	O	O
present	O	O	O
study	O	O	B-T062
,	O	O	O
we	O	O	O
performed	O	O	O
de	O	O	B-T078
novo	O	O	I-T078
transcriptome	O	O	B-T059
sequencing	O	O	I-T059
to	O	O	O
produce	O	O	O
a	O	O	O
comprehensive	O	O	O
transcript	O	O	B-T114
dataset	O	O	B-T170
of	O	O	O
visceral	O	O	B-T024
mass	O	O	I-T024
tissue	O	O	I-T024
of	O	O	O
K.	O	O	B-T204
kurodana	O	O	I-T204
by	O	O	O
the	O	O	O
Illumina	O	O	B-T063
paired-end	O	O	I-T063
sequencing	O	O	I-T063
technology	O	O	I-T063
.	O	O	O

Over	O	O	O
234	O	O	O
million	O	O	O
quality	O	O	O
reads	O	O	O
were	O	O	O
assembled	O	O	O
to	O	O	O
a	O	O	O
total	O	O	O
of	O	O	O
315,924	O	O	O
contigs	O	O	B-T082
and	O	O	O
191,071	O	O	O
unigenes	O	O	B-T170
,	O	O	O
with	O	O	O
an	O	O	O
average	O	O	O
and	O	O	O
N50	O	O	B-T114
length	O	O	B-T081
of	O	O	O
585.6	O	O	O
and	O	O	O
715	O	O	O
bp	O	O	O
and	O	O	O
678	O	O	O
and	O	O	O
927	O	O	O
bp	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

Overall	O	O	O
,	O	O	O
36.32	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
unigenes	O	O	B-T170
found	O	O	O
matches	O	O	O
to	O	O	O
known	O	O	O
protein	O	O	B-T087
/	O	O	O
nucleotide	O	O	B-T086
sequences	O	O	I-T086
in	O	O	O
the	O	O	O
public	O	O	B-T170
databases	O	O	I-T170
.	O	O	O

The	O	O	O
direction	O	O	B-T082
of	O	O	O
the	O	O	O
unigenes	O	O	B-T170
to	O	O	O
functional	O	O	O
categories	O	O	O
was	O	O	O
determined	O	O	O
using	O	O	O
COG	O	O	B-T170
,	O	O	O
GO	O	O	B-T170
,	O	O	O
KEGG	O	O	B-T170
,	O	O	O
and	O	O	O
InterProScan	O	O	B-T170
protein	O	O	B-T087
domain	O	O	I-T087
search	O	O	B-T052
.	O	O	O

The	O	O	O
GO	O	O	B-T170
analysis	O	O	B-T062
search	O	O	O
resulted	O	O	O
in	O	O	O
22,967	O	O	O
unigenes	O	O	B-T170
(	O	O	O
12.02	O	O	O
%	O	O	O
)	O	O	O
being	O	O	O
categorized	O	O	O
into	O	O	O
40	O	O	O
functional	O	O	B-T120
groups	O	O	I-T120
.	O	O	O

The	O	O	O
KEGG	O	O	B-T170
annotation	O	O	I-T170
revealed	O	O	O
that	O	O	O
metabolism	O	O	B-T169
pathway	O	O	I-T169
genes	O	O	B-T028
were	O	O	O
enriched	O	O	O
.	O	O	O

The	O	O	O
most	O	O	O
prominent	O	O	O
protein	O	O	B-T087
motifs	O	O	I-T087
include	O	O	O
the	O	O	O
zinc	O	O	B-T087
finger	O	O	I-T087
,	O	O	O
ribonuclease	O	O	B-T116
H	O	O	I-T116
,	O	O	O
reverse	O	O	B-T116
transcriptase	O	O	I-T116
,	O	O	O
and	O	O	O
ankyrin	O	O	B-T044
repeat	O	O	I-T044
domains	O	O	I-T044
.	O	O	O

The	O	O	O
simple	O	O	B-T114
sequence	O	O	I-T114
repeats	O	O	I-T114
(	O	O	O
SSRs	O	O	B-T114
)	O	O	O
identified	O	O	O
from	O	O	O
>	O	O	O
1	O	O	O
kb	O	O	O
length	O	O	B-T081
of	O	O	O
unigenes	O	O	B-T170
show	O	O	O
a	O	O	O
dominancy	O	O	O
of	O	O	O
dinucleotide	O	O	B-T114
repeat	O	O	I-T114
motifs	O	O	I-T114
followed	O	O	O
with	O	O	O
tri-	O	O	B-T114
and	O	O	O
tetranucleotide	O	O	B-T114
motifs	O	O	I-T114
.	O	O	O

A	O	O	O
number	O	O	O
of	O	O	O
unigenes	O	O	B-T170
were	O	O	O
putatively	O	O	O
assessed	O	O	O
to	O	O	O
belong	O	O	O
to	O	O	O
adaptation	O	O	B-T038
and	O	O	O
defense	O	O	B-T041
mechanisms	O	O	I-T041
including	O	O	O
heat	O	O	B-T116
shock	O	O	I-T116
proteins	O	O	I-T116
70	O	O	I-T116
,	O	O	O
Toll-like	O	O	B-T116
receptor	O	O	I-T116
4	O	O	I-T116
,	O	O	O
AMP-activated	O	O	B-T116
protein	O	O	I-T116
kinase	O	O	I-T116
,	O	O	O
aquaporin-2	O	O	B-T116
,	O	O	O
etc	O	O	O
.	O	O	O

Our	O	O	O
data	O	O	O
provide	O	O	O
a	O	O	O
rich	O	O	O
source	O	O	O
for	O	O	O
the	O	O	O
identification	O	O	B-T080
and	O	O	O
functional	O	O	O
characterization	O	O	B-T052
of	O	O	O
new	O	O	O
genes	O	O	B-T028
and	O	O	O
candidate	O	O	O
polymorphic	O	O	B-T080
SSR	O	O	B-T114
markers	O	O	B-T045
in	O	O	O
K.	O	O	B-T204
kurodana	O	O	I-T204
.	O	O	O

The	O	O	O
availability	O	O	O
of	O	O	O
transcriptome	O	O	B-T086
information	O	O	O
(	O	O	O
http://bioinfo.sch.ac.kr/submission/	O	O	B-T170
)	O	O	O
would	O	O	O
promote	O	O	O
the	O	O	O
utilization	O	O	O
of	O	O	O
the	O	O	O
resources	O	O	O
for	O	O	O
phylogenetics	O	O	B-T062
study	O	O	I-T062
and	O	O	O
genetic	O	O	B-T070
diversity	O	O	I-T070
assessment	O	O	B-T052
.	O	O	O

-DOCSTART- (27509301)

Prediction	O	O	B-T078
of	O	O	O
Estrogenic	O	O	B-T125
Bioactivity	O	O	B-T052
of	O	O	O
Environmental	O	O	B-T103
Chemical	O	O	I-T103
Metabolites	O	O	O

The	O	O	O
US	O	O	B-T092
Environmental	O	O	I-T092
Protection	O	O	I-T092
Agency	O	O	I-T092
's	O	O	I-T092
(	O	O	O
EPA	O	O	B-T092
)	O	O	O
Endocrine	O	O	B-T058
Disruptor	O	O	I-T058
Screening	O	O	I-T058
Program	O	O	I-T058
(	O	O	O
EDSP	O	O	B-T058
)	O	O	O
is	O	O	O
using	O	O	O
in	O	O	B-T078
vitro	O	O	I-T078
data	O	O	I-T078
generated	O	O	O
from	O	O	O
ToxCast	O	O	B-T170
/	O	O	O
Tox21	O	O	B-T170
high-throughput	O	O	B-T059
screening	O	O	I-T059
assays	O	O	I-T059
to	O	O	O
assess	O	O	O
the	O	O	O
endocrine	O	O	B-T022
activity	O	O	B-T052
of	O	O	O
environmental	O	O	B-T103
chemicals	O	O	I-T103
.	O	O	O

Considering	O	O	O
that	O	O	O
in	O	O	B-T059
vitro	O	O	I-T059
assays	O	O	I-T059
may	O	O	O
have	O	O	O
limited	O	O	O
metabolic	O	O	B-T169
capacity	O	O	I-T169
,	O	O	O
inactive	O	O	B-T103
chemicals	O	O	I-T103
that	O	O	O
are	O	O	O
biotransformed	O	O	B-T040
into	O	O	O
metabolites	O	O	B-T123
with	O	O	O
endocrine	O	O	B-T022
bioactivity	O	O	B-T052
may	O	O	O
be	O	O	O
missed	O	O	O
for	O	O	O
further	O	O	O
screening	O	O	B-T169
and	O	O	O
testing	O	O	B-T169
.	O	O	O

Therefore	O	O	O
,	O	O	O
there	O	O	O
is	O	O	O
a	O	O	O
value	O	O	O
in	O	O	O
developing	O	O	O
novel	O	O	O
approaches	O	O	O
to	O	O	O
account	O	O	O
for	O	O	O
metabolism	O	O	B-T040
and	O	O	O
endocrine	O	O	B-T022
activity	O	O	B-T052
of	O	O	O
both	O	O	O
parent	O	O	B-T103
chemicals	O	O	I-T103
and	O	O	O
their	O	O	O
associated	O	O	O
metabolites	O	O	B-T123
.	O	O	O

We	O	O	O
used	O	O	O
commercially	O	O	O
available	O	O	O
software	O	O	B-T073
to	O	O	O
predict	O	O	O
metabolites	O	O	B-T123
of	O	O	O
50	O	O	O
parent	O	O	B-T103
compounds	O	O	B-T103
,	O	O	O
out	O	O	O
of	O	O	O
which	O	O	O
38	O	O	O
chemicals	O	O	B-T103
are	O	O	O
known	O	O	O
to	O	O	O
have	O	O	O
estrogenic	O	O	B-T125
metabolites	O	O	O
,	O	O	O
and	O	O	O
12	O	O	O
compounds	O	O	O
and	O	O	O
their	O	O	O
metabolites	O	O	O
are	O	O	O
negative	O	O	O
for	O	O	O
estrogenic	O	O	O
activity	O	O	B-T052
.	O	O	O

Three	O	O	O
ER	O	O	B-T116
QSAR	O	O	B-T081
models	O	O	B-T170
were	O	O	O
used	O	O	O
to	O	O	O
determine	O	O	O
potential	O	O	O
estrogen	O	O	B-T125
bioactivity	O	O	B-T052
of	O	O	O
the	O	O	O
parent	O	O	B-T103
compounds	O	O	I-T103
and	O	O	O
predicted	O	O	O
metabolites	O	O	B-T123
,	O	O	O
the	O	O	O
outputs	O	O	O
of	O	O	O
the	O	O	O
models	O	O	O
were	O	O	O
averaged	O	O	O
,	O	O	O
and	O	O	O
the	O	O	O
chemicals	O	O	B-T103
were	O	O	O
then	O	O	O
ranked	O	O	O
based	O	O	O
on	O	O	O
the	O	O	O
total	O	O	O
estrogenicity	O	O	B-T169
of	O	O	O
the	O	O	O
parent	O	O	B-T103
chemical	O	O	I-T103
and	O	O	O
metabolites	O	O	O
.	O	O	O

The	O	O	O
metabolite	O	O	B-T123
prediction	O	O	I-T073
software	O	O	I-T073
correctly	O	O	O
identified	O	O	O
known	O	O	O
estrogenic	O	O	B-T125
metabolites	O	O	B-T123
for	O	O	O
26	O	O	O
out	O	O	O
of	O	O	O
27	O	O	O
parent	O	O	B-T103
chemicals	O	O	I-T103
with	O	O	O
associated	O	O	O
metabolite	O	O	O
data	O	O	O
,	O	O	O
and	O	O	O
39	O	O	O
out	O	O	O
of	O	O	O
46	O	O	O
estrogenic	O	O	O
metabolites	O	O	O
were	O	O	O
predicted	O	O	O
as	O	O	O
potential	O	O	O
biotransformation	O	O	B-T040
products	O	O	B-T121
derived	O	O	O
from	O	O	O
the	O	O	O
parent	O	O	B-T103
chemical	O	O	I-T103
.	O	O	O

The	O	O	O
QSAR	O	O	B-T081
models	O	O	B-T170
estimated	O	O	O
stronger	O	O	O
estrogenic	O	O	B-T125
activity	O	O	B-T052
for	O	O	O
the	O	O	O
majority	O	O	O
of	O	O	O
the	O	O	O
known	O	O	O
estrogenic	O	O	O
metabolites	O	O	B-T123
compared	O	O	O
to	O	O	O
their	O	O	O
parent	O	O	B-T103
chemicals	O	O	I-T103
.	O	O	O

Finally	O	O	O
,	O	O	O
the	O	O	O
three	O	O	O
models	O	O	B-T170
identified	O	O	O
a	O	O	O
similar	O	O	O
set	O	O	O
of	O	O	O
parent	O	O	B-T103
compounds	O	O	I-T103
as	O	O	O
top	O	O	O
ranked	O	O	O
chemicals	O	O	B-T103
based	O	O	O
on	O	O	O
the	O	O	O
estrogenicity	O	O	B-T169
of	O	O	O
putative	O	O	O
metabolites	O	O	B-T123
.	O	O	O

This	O	O	O
proposed	O	O	O
in	O	O	B-T066
silico	O	O	I-T066
approach	O	O	O
is	O	O	O
an	O	O	O
inexpensive	O	O	O
and	O	O	O
rapid	O	O	O
strategy	O	O	O
for	O	O	O
the	O	O	O
detection	O	O	B-T033
of	O	O	O
chemicals	O	O	B-T103
with	O	O	O
estrogenic	O	O	B-T125
metabolites	O	O	B-T123
and	O	O	O
may	O	O	O
reduce	O	O	O
potential	O	O	O
false	O	O	B-T034
negative	O	O	I-T034
results	O	O	O
from	O	O	O
in	O	O	B-T059
vitro	O	O	I-T059
assays	O	O	I-T059
.	O	O	O

-DOCSTART- (27510000)

Effects	O	O	B-T080
of	O	O	I-T080
Application	O	O	B-T169
of	O	O	O
Social	O	O	B-T057
Marketing	O	O	I-T057
Theory	O	O	B-T078
and	O	O	O
the	O	O	O
Health	O	O	B-T058
Belief	O	O	I-T058
Model	O	O	I-T058
in	O	O	O
Promoting	O	O	B-T052
Cervical	O	O	B-T061
Cancer	O	O	I-T061
Screening	O	O	I-T061
among	O	O	O
Targeted	O	O	B-T169
Women	O	O	B-T098
in	O	O	O
Sisaket	O	O	B-T083
Province	O	O	I-T083
,	O	O	O
Thailand	O	O	O

Cervical	O	O	B-T191
cancer	O	O	I-T191
is	O	O	O
a	O	O	O
major	O	O	B-T080
public	O	O	B-T033
health	O	O	I-T033
problem	O	O	I-T033
in	O	O	O
Thailand	O	O	B-T083
,	O	O	O
being	O	O	O
ranked	O	O	B-T170
second	O	O	O
only	O	O	O
to	O	O	O
breast	O	O	B-T191
cancer	O	O	I-T191
.	O	O	O

Thai	O	O	B-T098
women	O	O	B-T098
have	O	O	O
been	O	O	O
reported	O	O	B-T058
to	O	O	O
have	O	O	O
a	O	O	O
low	O	O	B-T080
rate	O	O	B-T081
of	O	O	O
cervical	O	O	B-T061
cancer	O	O	I-T061
screening	O	O	I-T061
(	O	O	O
27.7	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
80	O	O	O
%	O	O	O
goal	O	O	B-T170
of	O	O	O
WHO	O	O	B-T093
)	O	O	O
.	O	O	O

We	O	O	O
therefore	O	O	O
aimed	O	O	B-T078
to	O	O	O
apply	O	O	B-T169
the	O	O	O
social	O	O	B-T057
marketing	O	O	I-T057
theory	O	O	B-T078
and	O	O	O
health	O	O	B-T058
belief	O	O	I-T058
model	O	O	I-T058
in	O	O	O
promoting	O	O	B-T052
cervical	O	O	B-T061
cancer	O	O	I-T061
screening	O	O	I-T061
in	O	O	O
Kanthararom	O	O	B-T083
District	O	O	I-T083
,	O	O	O
Sisaket	O	O	B-T083
Province	O	O	I-T083
.	O	O	O

A	O	O	O
total	O	O	B-T080
of	O	O	O
92	O	O	O
from	O	O	O
974	O	O	O
targeted	O	O	B-T169
women	O	O	B-T098
aged	O	O	B-T032
3060	O	O	O
years	O	O	B-T079
were	O	O	O
randomly	O	O	B-T062
divided	O	O	B-T169
into	O	O	O
two	O	O	O
groups	O	O	B-T078
.	O	O	O

The	O	O	O
experimental	O	O	B-T098
group	O	O	I-T098
underwent	O	O	O
application	O	O	B-T169
of	O	O	O
social	O	O	B-T057
marketing	O	O	I-T057
theory	O	O	B-T078
and	O	O	O
a	O	O	O
health	O	O	B-T058
belief	O	O	I-T058
model	O	O	I-T058
program	O	O	B-T169
promoting	O	O	B-T052
cervical	O	O	B-T061
cancer	O	O	I-T061
screening	O	O	I-T061
while	O	O	O
the	O	O	O
control	O	O	B-T096
group	O	O	I-T096
received	O	O	B-T080
normal	O	O	B-T058
services	O	O	I-T058
.	O	O	O

Two	O	O	O
research	O	O	B-T170
tools	O	O	I-T170
were	O	O	O
used	O	O	O
:	O	O	O
(	O	O	O
1	O	O	O
)	O	O	O
application	O	O	B-T169
of	O	O	O
social	O	O	B-T057
marketing	O	O	I-T057
theory	O	O	B-T078
and	O	O	O
health	O	O	B-T058
belief	O	O	I-T058
model	O	O	I-T058
program	O	O	B-T169
and	O	O	O
(	O	O	O
2	O	O	O
)	O	O	O
questionnaire	O	O	B-T170
used	O	O	O
to	O	O	O
evaluate	O	O	B-T052
perceptions	O	O	B-T041
of	O	O	O
cervical	O	O	B-T191
cancer	O	O	I-T191
.	O	O	O

Descriptive	O	O	B-T170
and	O	O	O
inferential	O	O	B-T081
statistics	O	O	I-T081
including	O	O	B-T169
paired	O	O	B-T080
sample	O	O	B-T170
ttest	O	O	B-T170
and	O	O	O
independent	O	O	B-T169
ttest	O	O	O
were	O	O	O
used	O	O	O
to	O	O	O
analyze	O	O	B-T057
the	O	O	I-T057
data	O	O	I-T057
.	O	O	O

After	O	O	O
the	O	O	O
program	O	O	B-T169
had	O	O	O
been	O	O	O
used	O	O	O
,	O	O	O
the	O	O	O
mean	O	O	B-T033
score	O	O	I-T033
of	O	O	O
perception	O	O	B-T041
of	O	O	O
cervical	O	O	B-T191
cancer	O	O	I-T191
of	O	O	O
experimental	O	O	B-T098
group	O	O	I-T098
was	O	O	O
at	O	O	O
a	O	O	O
higher	O	O	B-T080
level	O	O	B-T080
(	O	O	O
x=4.09	O	O	O
;	O	O	O
S.D.	O	O	B-T081
=	O	O	O
0.30	O	O	O
)	O	O	O
,	O	O	O
than	O	O	O
in	O	O	O
the	O	O	O
control	O	O	B-T096
group	O	O	I-T096
(	O	O	O
x=3.82	O	O	O
;	O	O	O
S.D.	O	O	O
=	O	O	O
0.20	O	O	O
)	O	O	O
with	O	O	O
statistical	O	O	B-T081
significance	O	O	I-T081
(	O	O	O
p<0.001	O	O	O
)	O	O	O
.	O	O	O

This	O	O	O
research	O	O	B-T062
demonstrated	O	O	O
an	O	O	O
appropriate	O	O	B-T080
communication	O	O	B-T054
process	O	O	B-T067
in	O	O	O
behavioral	O	O	B-T053
modification	O	O	B-T169
to	O	O	O
prevent	O	O	O
cervical	O	O	B-T191
cancer	O	O	I-T191
.	O	O	O

It	O	O	O
can	O	O	O
be	O	O	O
recommended	O	O	B-T078
that	O	O	O
this	O	O	O
program	O	O	B-T169
featuring	O	O	B-T080
social	O	O	B-T057
marketing	O	O	I-T057
and	O	O	O
the	O	O	O
health	O	O	B-T058
belief	O	O	I-T058
model	O	O	I-T058
be	O	O	O
used	O	O	O
to	O	O	O
promote	O	O	B-T052
cervical	O	O	B-T061
cancer	O	O	I-T061
screening	O	O	I-T061
in	O	O	O
targeted	O	O	B-T169
women	O	O	B-T098
and	O	O	O
it	O	O	O
can	O	O	O
be	O	O	O
promoted	O	O	B-T052
as	O	O	O
a	O	O	O
guideline	O	O	B-T170
for	O	O	O
other	O	O	O
health	O	O	B-T058
services	O	O	I-T058
,	O	O	O
especially	O	O	O
in	O	O	O
health	O	O	B-T058
promotion	O	O	I-T058
and	O	O	O
disease	O	O	B-T061
prevention	O	O	I-T061
.	O	O	O

-DOCSTART- (27510458)

Visualization	O	O	B-T060
of	O	O	O
the	O	O	O
Intimal	O	O	B-T023
Flap	O	O	I-T023
in	O	O	O
Intracranial	O	O	B-T190
Arterial	O	O	I-T190
Dissection	O	O	I-T190
Using	O	O	O
High-Resolution	O	O	B-T059
3	O	O	O
T	O	O	O
MRI	O	O	O

Presence	O	O	B-T033
of	O	O	O
an	O	O	O
intimal	O	O	B-T023
flap	O	O	I-T023
is	O	O	O
a	O	O	O
critical	O	O	B-T080
imaging	O	O	B-T034
finding	O	O	I-T034
in	O	O	O
diagnosing	O	O	B-T033
intracranial	O	O	B-T190
artery	O	O	I-T190
dissection	O	O	I-T190
(	O	O	O
ICAD	O	O	B-T190
)	O	O	O
.	O	O	O

Recent	O	O	O
reports	O	O	B-T170
showed	O	O	O
that	O	O	O
high-resolution	O	O	B-T059
magnetic	O	O	B-T060
resonance	O	O	I-T060
imaging	O	O	I-T060
(	O	O	O
MRI	O	O	B-T060
)	O	O	O
was	O	O	O
better	O	O	B-T080
at	O	O	O
identifying	O	O	O
intimal	O	O	B-T023
flaps	O	O	I-T023
as	O	O	O
compared	O	O	B-T052
with	O	O	O
routine	O	O	O
MRI	O	O	B-T060
techniques	O	O	I-T060
used	O	O	O
in	O	O	O
clinical	O	O	B-T082
settings	O	O	I-T082
.	O	O	O

However	O	O	O
,	O	O	O
no	O	O	O
current	O	O	O
standardized	O	O	O
sequence	O	O	B-T169
for	O	O	O
high-resolution	O	O	B-T059
MRI	O	O	B-T060
without	O	O	O
gadolinium	O	O	B-T130
enhancement	O	O	B-T052
produces	O	O	O
images	O	O	B-T078
of	O	O	O
satisfactory	O	O	O
quality	O	O	B-T080
with	O	O	O
clinically	O	O	O
tolerable	O	O	O
scanning	O	O	B-T060
times	O	O	B-T079
.	O	O	O

This	O	O	O
study	O	O	O
evaluated	O	O	B-T058
a	O	O	O
nonenhanced	O	O	B-T060
high-resolution	O	O	I-T060
fast	O	O	I-T060
spin	O	O	I-T060
echo	O	O	I-T060
(	O	O	I-T060
HR-FSE	O	O	I-T060
)	O	O	I-T060
MRI	O	O	I-T060
sequence	O	O	B-T169
for	O	O	O
visualizing	O	O	O
intimal	O	O	B-T023
flaps	O	O	I-T023
in	O	O	O
patients	O	O	B-T101
with	O	O	O
ICAD	O	O	B-T190
.	O	O	O

Three	O	O	O
patients	O	O	B-T101
with	O	O	O
ICAD	O	O	B-T190
underwent	O	O	O
plain	O	O	O
MRI	O	O	B-T060
examination	O	O	O
using	O	O	O
a	O	O	O
2-dimensional	O	O	B-T082
T2-weighted	O	O	B-T060
FSE	O	O	I-T060
imaging	O	O	I-T060
sequence	O	O	B-T169
optimized	O	O	O
for	O	O	O
our	O	O	O
3	O	O	B-T169
T	O	O	I-T169
system	O	O	I-T169
(	O	O	O
in-plane	O	O	O
pixel	O	O	O
size	O	O	O
,	O	O	O
.23	O	O	O
mm	O	O	O
Ã	O	O	O
.23	O	O	O
mm	O	O	O
;	O	O	O
slice	O	O	O
thickness	O	O	O
3	O	O	O
mm	O	O	O
with	O	O	O
no	O	O	O
interslice	O	O	O
gap	O	O	O
)	O	O	O
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
scanning	O	O	B-T060
with	O	O	O
conventional	O	O	B-T080
modalities	O	O	B-T078
,	O	O	O
including	O	O	O
CT	O	O	B-T060
angiography	O	O	I-T060
,	O	O	O
magnetic	O	O	B-T060
resonance	O	O	I-T060
angiography	O	O	I-T060
,	O	O	O
and	O	O	O
digital	O	O	B-T060
subtraction	O	O	I-T060
angiography	O	O	I-T060
.	O	O	O

We	O	O	O
assessed	O	O	B-T052
whether	O	O	O
these	O	O	O
imaging	O	O	B-T169
methods	O	O	I-T169
could	O	O	O
visualize	O	O	O
an	O	O	O
intimal	O	O	B-T023
flap	O	O	I-T023
and/or	O	O	O
double	O	O	B-T033
lumen	O	O	I-T033
sign	O	O	I-T033
in	O	O	O
the	O	O	O
participants	O	O	B-T098
and	O	O	O
compared	O	O	B-T052
the	O	O	O
results	O	O	B-T033
between	O	O	O
HR-FSE	O	O	B-T060
and	O	O	O
the	O	O	O
other	O	O	O
modalities	O	O	B-T078
.	O	O	O

HR-FSE	O	O	B-T060
images	O	O	B-T078
clearly	O	O	O
showed	O	O	O
intimal	O	O	B-T023
flaps	O	O	I-T023
and	O	O	O
double	O	O	B-T033
lumen	O	O	I-T033
signs	O	O	I-T033
in	O	O	O
all	O	O	O
3	O	O	O
patients	O	O	B-T101
,	O	O	O
whereas	O	O	O
the	O	O	O
conventional	O	O	B-T080
modalities	O	O	B-T078
identified	O	O	B-T080
a	O	O	O
double	O	O	B-T033
lumen	O	O	I-T033
sign	O	O	I-T033
in	O	O	O
only	O	O	O
2	O	O	O
of	O	O	O
the	O	O	O
3	O	O	O
patients	O	O	O
.	O	O	O

The	O	O	O
present	O	O	O
method	O	O	O
of	O	O	O
optimized	O	O	O
HR-FSE	O	O	B-T060
imaging	O	O	I-T060
with	O	O	O
a	O	O	O
3	O	O	B-T169
T	O	O	I-T169
system	O	O	I-T169
improved	O	O	B-T033
visualization	O	O	B-T060
of	O	O	O
intimal	O	O	B-T023
flaps	O	O	I-T023
and	O	O	O
should	O	O	O
thus	O	O	O
be	O	O	O
considered	O	O	O
for	O	O	O
assessing	O	O	B-T052
patients	O	O	B-T101
with	O	O	O
suspected	O	O	B-T078
ICAD	O	O	B-T190
that	O	O	O
can	O	O	O
not	O	O	O
be	O	O	O
definitively	O	O	O
diagnosed	O	O	B-T033
by	O	O	O
conventional	O	O	B-T080
imaging	O	O	B-T169
modalities	O	O	I-T169
.	O	O	O

-DOCSTART- (27511456)

Quantification	O	O	B-T081
of	O	O	O
intact	O	O	B-T080
plasma	O	O	B-T031
AGT	O	O	B-T116
consisting	O	O	O
of	O	O	O
oxidized	O	O	O
and	O	O	O
reduced	O	O	B-T082
conformations	O	O	I-T082
using	O	O	O
a	O	O	O
modified	O	O	O
ELISA	O	O	O

The	O	O	O
pleiotropic	O	O	B-T052
actions	O	O	I-T052
of	O	O	O
the	O	O	O
renin-angiotensin	O	O	B-T022
system	O	O	I-T022
(	O	O	O
RAS	O	O	B-T022
)	O	O	O
depend	O	O	O
on	O	O	O
the	O	O	O
availability	O	O	B-T169
of	O	O	I-T169
angiotensinogen	O	O	B-T116
(	O	O	O
AGT	O	O	B-T116
)	O	O	O
which	O	O	O
generates	O	O	B-T052
angiotensin	O	O	B-T116
I	O	O	I-T116
(	O	O	O
ANG	O	O	B-T116
I	O	O	I-T116
)	O	O	O
when	O	O	O
cleaved	O	O	B-T082
by	O	O	O
renin	O	O	B-T116
.	O	O	O

Thus	O	O	O
,	O	O	O
quantification	O	O	B-T081
of	O	O	O
the	O	O	O
intact	O	O	B-T080
AGT	O	O	B-T116
(	O	O	O
iAGT	O	O	B-T116
)	O	O	O
concentrations	O	O	B-T081
is	O	O	O
important	O	O	B-T080
to	O	O	O
evaluate	O	O	O
the	O	O	O
actual	O	O	B-T080
renin	O	O	B-T116
substrate	O	O	I-T116
available	O	O	B-T169
.	O	O	O

The	O	O	O
iAGT	O	O	B-T116
conformation	O	O	B-T082
exists	O	O	O
as	O	O	O
oxidized	O	O	B-T116
AGT	O	O	I-T116
(	O	O	O
oxi-AGT	O	O	B-T116
)	O	O	O
and	O	O	O
reduced	O	O	B-T116
AGT	O	O	I-T116
(	O	O	O
red-AGT	O	O	B-T116
)	O	O	O
in	O	O	O
a	O	O	O
disulfide	O	O	B-T087
bond	O	O	I-T087
,	O	O	O
and	O	O	O
oxi-AGT	O	O	O
has	O	O	O
a	O	O	O
higher	O	O	B-T080
affinity	O	O	B-T070
for	O	O	O
renin	O	O	B-T116
,	O	O	O
which	O	O	O
may	O	O	O
exacerbate	O	O	O
RAS	O	O	B-T022
-	O	O	O
associated	O	O	B-T046
diseases	O	O	I-T046
.	O	O	O

Accordingly	O	O	O
,	O	O	O
we	O	O	O
determined	O	O	B-T080
iAGT	O	O	B-T116
,	O	O	O
oxi-AGT	O	O	B-T116
,	O	O	O
and	O	O	O
red-AGT	O	O	B-T116
levels	O	O	B-T080
in	O	O	O
plasma	O	O	B-T031
from	O	O	O
rats	O	O	B-T015
and	O	O	O
mice	O	O	B-T015
.	O	O	O

Blood	O	O	B-T031
samples	O	O	I-T031
were	O	O	O
obtained	O	O	B-T169
by	O	O	O
cardiac	O	O	B-T059
puncture	O	O	I-T059
and	O	O	O
then	O	O	O
immediately	O	O	B-T079
mixed	O	O	B-T169
with	O	O	O
an	O	O	O
inhibitor	O	O	B-T120
solution	O	O	B-T167
containing	O	O	B-T169
a	O	O	O
renin	O	O	B-T121
inhibitor	O	O	I-T121
.	O	O	O

Total	O	O	B-T080
AGT	O	O	B-T116
(	O	O	O
tAGT	O	O	B-T116
)	O	O	O
levels	O	O	B-T080
were	O	O	O
measured	O	O	B-T080
by	O	O	O
tAGT	O	O	O
ELISA	O	O	B-T059
which	O	O	O
detects	O	O	B-T033
both	O	O	O
cleaved	O	O	B-T082
and	O	O	O
iAGT	O	O	B-T116
.	O	O	O

iAGT	O	O	B-T116
levels	O	O	B-T080
were	O	O	O
determined	O	O	B-T080
by	O	O	I-T080
iAGT	O	O	O
ELISA	O	O	B-T059
which	O	O	O
was	O	O	O
found	O	O	O
to	O	O	O
only	O	O	O
detect	O	O	B-T033
red-AGT	O	O	B-T116
.	O	O	O

Thus	O	O	O
,	O	O	O
it	O	O	O
was	O	O	O
necessary	O	O	O
to	O	O	O
treat	O	O	O
samples	O	O	B-T031
with	O	O	O
dithiothreitol	O	O	B-T109
,	O	O	O
a	O	O	O
reducing	O	O	B-T130
agent	O	O	I-T130
,	O	O	O
to	O	O	O
quantify	O	O	B-T081
total	O	O	B-T080
iAGT	O	O	B-T116
concentration	O	O	B-T081
.	O	O	O

tAGT	O	O	B-T116
levels	O	O	B-T080
in	O	O	O
rat	O	O	B-T015
and	O	O	O
mouse	O	O	B-T015
plasma	O	O	B-T031
were	O	O	O
1,839	O	O	O
Â±	O	O	O
139	O	O	O
and	O	O	O
1,082	O	O	O
Â±	O	O	O
77	O	O	O
ng/ml	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

iAGT	O	O	B-T116
levels	O	O	B-T080
were	O	O	O
53	O	O	O
%	O	O	O
of	O	O	O
tAGT	O	O	B-T116
in	O	O	O
rat	O	O	B-T015
plasma	O	O	B-T031
but	O	O	O
only	O	O	O
22	O	O	O
%	O	O	O
in	O	O	O
mouse	O	O	B-T015
plasma	O	O	O
,	O	O	O
probably	O	O	O
reflecting	O	O	O
the	O	O	O
greater	O	O	B-T081
plasma	O	O	O
renin	O	O	B-T116
activity	O	O	B-T044
in	O	O	O
mice	O	O	B-T015
.	O	O	O

The	O	O	O
ratios	O	O	B-T081
of	O	O	O
oxi-AGT	O	O	B-T116
and	O	O	O
red-AGT	O	O	B-T116
were	O	O	O
â¼4:1	O	O	O
(	O	O	O
rat	O	O	B-T015
)	O	O	O
and	O	O	O
16:1	O	O	O
(	O	O	O
mouse	O	O	B-T015
)	O	O	O
.	O	O	O

Plasma	O	O	B-T031
iAGT	O	O	B-T116
consists	O	O	O
of	O	O	O
oxi-AGT	O	O	B-T116
and	O	O	O
red-AGT	O	O	B-T116
,	O	O	O
suggesting	O	O	B-T078
that	O	O	O
oxidative	O	O	B-T049
stress	O	O	I-T049
can	O	O	O
influence	O	O	B-T077
ANG	O	O	B-T116
I	O	O	I-T116
generation	O	O	B-T052
by	O	O	O
the	O	O	O
AGT	O	O	B-T116
conformation	O	O	B-T082
switch	O	O	O
.	O	O	O

Furthermore	O	O	O
,	O	O	O
the	O	O	O
lower	O	O	B-T052
availability	O	O	B-T169
of	O	O	I-T169
plasma	O	O	B-T031
iAGT	O	O	B-T116
in	O	O	O
mice	O	O	B-T015
suggests	O	O	B-T078
that	O	O	O
it	O	O	O
may	O	O	O
serve	O	O	O
as	O	O	O
a	O	O	O
limiting	O	O	B-T169
factor	O	O	B-T169
in	O	O	O
ANG	O	O	B-T116
I	O	O	I-T116
formation	O	O	B-T169
in	O	O	O
this	O	O	O
species	O	O	B-T185
.	O	O	O

-DOCSTART- (27513357)

Carbon	O	O	B-T131
Monoxide	O	O	I-T131
Improves	O	O	B-T033
Efficacy	O	O	B-T080
of	O	O	O
Mesenchymal	O	O	B-T025
Stromal	O	O	I-T025
Cells	O	O	I-T025
During	O	O	B-T079
Sepsis	O	O	B-T047
by	O	O	O
Production	O	O	O
of	O	O	O
Specialized	O	O	B-T077
Proresolving	O	O	B-T033
Lipid	O	O	O
Mediators	O	O	O

Mesenchymal	O	O	B-T025
stromal	O	O	I-T025
cells	O	O	I-T025
are	O	O	O
being	O	O	O
investigated	O	O	B-T169
as	O	O	O
a	O	O	O
cell-based	O	O	B-T061
therapy	O	O	I-T061
for	O	O	O
a	O	O	O
number	O	O	O
of	O	O	O
disease	O	O	B-T046
processes	O	O	I-T046
,	O	O	O
with	O	O	O
promising	O	O	O
results	O	O	B-T033
in	O	O	O
animal	O	O	B-T008
models	O	O	I-T008
of	O	O	O
systemic	O	O	B-T047
inflammation	O	O	I-T047
and	O	O	O
sepsis	O	O	B-T047
.	O	O	O

Studies	O	O	B-T062
are	O	O	O
ongoing	O	O	O
to	O	O	O
determine	O	O	O
ways	O	O	O
to	O	O	O
further	O	O	O
improve	O	O	B-T033
the	O	O	O
therapeutic	O	O	B-T169
potential	O	O	B-T080
of	O	O	O
mesenchymal	O	O	B-T025
stromal	O	O	I-T025
cells	O	O	I-T025
.	O	O	O

A	O	O	O
gas	O	O	B-T104
molecule	O	O	B-T167
that	O	O	O
improves	O	O	B-T033
outcome	O	O	B-T169
in	O	O	O
experimental	O	O	B-T080
sepsis	O	O	B-T047
is	O	O	O
carbon	O	O	B-T131
monoxide	O	O	I-T131
.	O	O	O

We	O	O	O
hypothesized	O	O	O
that	O	O	O
preconditioning	O	O	B-T169
of	O	O	O
mesenchymal	O	O	B-T025
stromal	O	O	I-T025
cells	O	O	B-T025
with	O	O	O
carbon	O	O	B-T131
monoxide	O	O	I-T131
ex	O	O	B-T169
vivo	O	O	I-T169
would	O	O	O
promote	O	O	B-T052
further	O	O	O
therapeutic	O	O	B-T169
benefit	O	O	B-T081
when	O	O	O
cells	O	O	O
are	O	O	O
administered	O	O	B-T169
in	O	O	B-T082
vivo	O	O	I-T082
after	O	O	O
the	O	O	O
onset	O	O	B-T080
of	O	O	I-T080
polymicrobial	O	O	B-T047
sepsis	O	O	B-T047
in	O	O	O
mice	O	O	B-T015
.	O	O	O

Animal	O	O	B-T008
study	O	O	I-T008
and	O	O	O
primary	O	O	B-T059
cell	O	O	I-T059
culture	O	O	I-T059
.	O	O	O

Laboratory	O	O	B-T093
investigation	O	O	B-T058
.	O	O	O

BALB/c	O	O	B-T015
mice	O	O	I-T015
.	O	O	O

Polymicrobial	O	O	B-T047
sepsis	O	O	B-T047
was	O	O	O
induced	O	O	B-T169
by	O	O	O
cecal	O	O	B-T023
ligation	O	O	B-T061
and	O	O	O
puncture	O	O	B-T058
.	O	O	O

Mesenchymal	O	O	B-T025
stromal	O	O	I-T025
cells	O	O	I-T025
,	O	O	O
mesenchymal	O	O	B-T025
stromal	O	O	I-T025
cells	O	O	I-T025
-	O	O	O
conditioned	O	O	B-T080
with	O	O	O
carbon	O	O	B-T131
monoxide	O	O	I-T131
,	O	O	O
fibroblasts	O	O	B-T025
,	O	O	O
or	O	O	O
fibroblasts	O	O	O
-	O	O	O
conditioned	O	O	O
with	O	O	O
carbon	O	O	O
monoxide	O	O	O
were	O	O	O
delivered	O	O	B-T169
by	O	O	O
tail	O	O	B-T023
vein	O	O	I-T023
injections	O	O	B-T061
to	O	O	O
septic	O	O	B-T169
mice	O	O	B-T015
.	O	O	O

The	O	O	O
mice	O	O	B-T015
were	O	O	O
assessed	O	O	B-T052
for	O	O	O
survival	O	O	B-T052
,	O	O	O
bacterial	O	O	B-T080
clearance	O	O	B-T080
,	O	O	O
and	O	O	O
the	O	O	O
inflammatory	O	O	B-T046
response	O	O	I-T046
during	O	O	B-T079
sepsis	O	O	B-T047
in	O	O	O
each	O	O	O
of	O	O	O
the	O	O	O
groups	O	O	B-T078
.	O	O	O

Mesenchymal	O	O	B-T025
stromal	O	O	I-T025
cells	O	O	I-T025
were	O	O	O
also	O	O	O
assessed	O	O	B-T052
for	O	O	O
their	O	O	O
ability	O	O	B-T032
to	O	O	O
promote	O	O	B-T052
bacterial	O	O	B-T080
phagocytosis	O	O	B-T043
by	O	O	O
neutrophils	O	O	B-T025
,	O	O	O
the	O	O	O
production	O	O	O
of	O	O	O
specialized	O	O	B-T077
proresolving	O	O	B-T033
lipid	O	O	B-T123
mediators	O	O	I-T123
,	O	O	O
and	O	O	O
their	O	O	O
importance	O	O	O
for	O	O	O
mesenchymal	O	O	B-T025
stromal	O	O	I-T025
cells	O	O	I-T025
function	O	O	B-T039
using	O	O	O
gene	O	O	B-T045
silencing	O	O	I-T045
.	O	O	O

Ex	O	O	B-T169
vivo	O	O	I-T169
preconditioning	O	O	B-T169
with	O	O	O
carbon	O	O	B-T131
monoxide	O	O	I-T131
allowed	O	O	O
mesenchymal	O	O	B-T025
stromal	O	O	I-T025
cells	O	O	I-T025
to	O	O	O
be	O	O	O
administered	O	O	B-T169
later	O	O	O
after	O	O	O
the	O	O	O
onset	O	O	B-T080
of	O	O	I-T080
sepsis	O	O	B-T047
(	O	O	O
6	O	O	O
hr	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
yet	O	O	O
maintain	O	O	O
their	O	O	O
therapeutic	O	O	B-T201
effect	O	O	I-T201
with	O	O	O
increased	O	O	B-T081
survival	O	O	B-T052
.	O	O	O

Carbon	O	O	B-T131
monoxide	O	O	I-T131
preconditioned	O	O	B-T081
mesenchymal	O	O	B-T025
stromal	O	O	I-T025
cells	O	O	I-T025
were	O	O	O
also	O	O	O
able	O	O	O
to	O	O	O
alleviate	O	O	O
organ	O	O	B-T037
injury	O	O	I-T037
,	O	O	O
improve	O	O	B-T033
bacterial	O	O	B-T080
clearance	O	O	B-T080
,	O	O	O
and	O	O	O
promote	O	O	B-T052
the	O	O	O
resolution	O	O	B-T046
of	O	O	O
inflammation	O	O	B-T046
.	O	O	O

Mesenchymal	O	O	B-T025
stromal	O	O	I-T025
cells	O	O	I-T025
exposed	O	O	B-T080
to	O	O	I-T080
carbon	O	O	B-T131
monoxide	O	O	I-T131
,	O	O	O
with	O	O	O
docosahexaenoic	O	O	B-T109
acid	O	O	I-T109
substrate	O	O	B-T167
,	O	O	O
produced	O	O	O
specialized	O	O	B-T077
proresolving	O	O	B-T033
lipid	O	O	B-T123
mediators	O	O	I-T123
,	O	O	O
particularly	O	O	O
D-series	O	O	B-T080
resolvins	O	O	B-T109
,	O	O	O
which	O	O	O
promoted	O	O	B-T052
survival	O	O	B-T052
.	O	O	O

Silencing	O	O	B-T045
of	O	O	O
lipoxygenase	O	O	B-T044
pathways	O	O	I-T044
(	O	O	O
5-lipoxygenase	O	O	B-T044
and	O	O	O
12	O	O	B-T044
/	O	O	O
15-lipoxygenase	O	O	B-T044
)	O	O	O
,	O	O	O
which	O	O	O
are	O	O	O
important	O	O	B-T080
enzymes	O	O	B-T116
for	O	O	O
specialized	O	O	B-T077
proresolving	O	O	B-T033
lipid	O	O	B-T123
mediator	O	O	I-T123
biosynthesis	O	O	B-T169
,	O	O	O
resulted	O	O	B-T169
in	O	O	O
a	O	O	O
loss	O	O	O
of	O	O	O
therapeutic	O	O	B-T169
benefit	O	O	B-T081
bestowed	O	O	O
on	O	O	O
mesenchymal	O	O	B-T025
stromal	O	O	I-T025
cells	O	O	I-T025
by	O	O	O
carbon	O	O	B-T131
monoxide	O	O	I-T131
.	O	O	O

Taken	O	O	O
together	O	O	O
,	O	O	O
these	O	O	O
data	O	O	B-T078
suggest	O	O	O
that	O	O	O
production	O	O	O
of	O	O	O
specialized	O	O	B-T077
proresolving	O	O	B-T033
lipid	O	O	B-T123
mediators	O	O	I-T123
contribute	O	O	B-T052
to	O	O	O
improved	O	O	B-T033
mesenchymal	O	O	B-T025
stromal	O	O	I-T025
cell	O	O	I-T025
efficacy	O	O	B-T080
when	O	O	O
exposed	O	O	B-T080
to	O	O	I-T080
carbon	O	O	B-T131
monoxide	O	O	I-T131
,	O	O	O
resulting	O	O	O
in	O	O	O
an	O	O	O
improved	O	O	O
therapeutic	O	O	B-T201
response	O	O	I-T201
during	O	O	B-T079
sepsis	O	O	B-T047
.	O	O	O

-DOCSTART- (27515404)

Effect	O	O	B-T080
of	O	O	O
primary	O	O	B-T058
health	O	O	I-T058
care	O	O	I-T058
reforms	O	O	B-T077
in	O	O	O
Turkey	O	O	B-T083
on	O	O	O
health	O	O	B-T058
service	O	O	I-T058
utilization	O	O	I-T058
and	O	O	O
user	O	O	O
satisfaction	O	O	O

Strengthening	O	O	B-T080
primary	O	O	B-T058
health	O	O	I-T058
care	O	O	I-T058
(	O	O	O
PHC	O	O	B-T058
)	O	O	O
is	O	O	O
considered	O	O	O
a	O	O	O
priority	O	O	O
for	O	O	O
efficient	O	O	B-T080
and	O	O	O
responsive	O	O	B-T169
health	O	O	B-T093
systems	O	O	I-T093
,	O	O	O
but	O	O	O
empirical	O	O	B-T080
evidence	O	O	B-T078
from	O	O	O
low-	O	O	O
and	O	O	O
middle-	O	O	O
income	O	O	B-T081
countries	O	O	B-T083
is	O	O	O
limited	O	O	B-T169
.	O	O	O

The	O	O	O
stepwise	O	O	B-T061
introduction	O	O	I-T061
of	O	O	O
family	O	O	B-T091
medicine	O	O	I-T091
across	O	O	O
all	O	O	O
81	O	O	O
provinces	O	O	B-T083
of	O	O	O
Turkey	O	O	B-T083
(	O	O	O
a	O	O	O
middle-income	O	O	B-T080
country	O	O	B-T083
)	O	O	O
between	O	O	O
2005	O	O	O
and	O	O	O
2010	O	O	O
,	O	O	O
aimed	O	O	O
at	O	O	O
PHC	O	O	B-T058
strengthening	O	O	B-T080
,	O	O	O
presents	O	O	O
a	O	O	O
natural	O	O	B-T062
experiment	O	O	I-T062
for	O	O	O
assessing	O	O	B-T052
the	O	O	O
effect	O	O	B-T080
of	O	O	O
family	O	O	O
medicine	O	O	O
on	O	O	O
health	O	O	B-T058
service	O	O	I-T058
utilization	O	O	B-T169
and	O	O	O
user	O	O	B-T033
satisfaction	O	O	I-T033
.The	O	O	O
effect	O	O	O
of	O	O	O
health	O	O	B-T093
system	O	O	I-T093
reforms	O	O	B-T077
,	O	O	O
that	O	O	O
introduced	O	O	O
family	O	O	O
medicine	O	O	O
,	O	O	O
on	O	O	O
utilization	O	O	O
was	O	O	O
assessed	O	O	B-T052
using	O	O	O
longitudinal	O	O	B-T062
,	O	O	O
province-level	O	O	B-T062
data	O	O	I-T062
for	O	O	O
12	O	O	O
years	O	O	B-T079
and	O	O	O
multivariate	O	O	B-T075
regression	O	O	I-T075
models	O	O	I-T075
adjusting	O	O	O
for	O	O	O
supply-side	O	O	B-T080
variables	O	O	I-T080
,	O	O	O
demographics	O	O	B-UnknownType
,	O	O	O
socio-economic	O	O	B-T080
development	O	O	I-T080
and	O	O	O
underlying	O	O	O
yearly	O	O	B-T079
trends	O	O	B-T079
.	O	O	O

User	O	O	B-T033
satisfaction	O	O	I-T033
with	O	O	O
primary	O	O	B-T058
and	O	O	O
secondary	O	O	B-T058
care	O	O	I-T058
services	O	O	B-T058
was	O	O	O
explored	O	O	O
using	O	O	O
data	O	O	B-T078
from	O	O	O
annual	O	O	B-T170
Life	O	O	I-T170
Satisfaction	O	O	I-T170
Surveys	O	O	I-T170
.	O	O	O

Trends	O	O	B-T079
in	O	O	O
preferred	O	O	O
first	O	O	O
point	O	O	O
of	O	O	O
contact	O	O	B-T169
(	O	O	O
primary	O	O	B-T058
vs	O	O	O
secondary	O	O	B-T058
,	O	O	O
public	O	O	B-T093
vs.	O	O	O
private	O	O	B-T093
)	O	O	O
,	O	O	O
reason	O	O	B-T055
for	O	O	I-T055
choice	O	O	I-T055
and	O	O	O
health	O	O	B-T058
services	O	O	I-T058
issues	O	O	B-UnknownType
,	O	O	O
were	O	O	O
described	O	O	B-T078
and	O	O	O
stratified	O	O	B-T080
by	O	O	O
patient	O	O	B-T201
characteristics	O	O	I-T201
,	O	O	O
provider	O	O	B-T201
type	O	O	I-T201
,	O	O	O
and	O	O	O
rural/urban	O	O	B-T083
settings	O	O	I-T083
.Between	O	O	O
2002	O	O	O
and	O	O	O
2013	O	O	O
,	O	O	O
the	O	O	O
average	O	O	B-T081
number	O	O	I-T081
of	O	O	O
PHC	O	O	B-T058
consultations	O	O	B-T058
increased	O	O	B-T081
from	O	O	O
1.75	O	O	O
to	O	O	O
2.83	O	O	O
per	O	O	O
person	O	O	B-T098
per	O	O	O
year	O	O	B-T079
.	O	O	O

In	O	O	O
multivariate	O	O	B-T075
models	O	O	I-T075
,	O	O	O
family	O	O	B-T091
medicine	O	O	I-T091
introduction	O	O	B-T061
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
an	O	O	O
increase	O	O	B-T169
of	O	O	O
0.37	O	O	O
PHC	O	O	B-T058
consultations	O	O	B-T058
per	O	O	O
person	O	O	B-T098
(	O	O	O
P	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
slower	O	O	B-T080
annual	O	O	B-T067
growth	O	O	I-T067
in	O	O	O
PHC	O	O	O
and	O	O	O
secondary	O	O	B-T058
care	O	O	I-T058
consultations	O	O	O
.	O	O	O

Following	O	O	O
family	O	O	B-T091
medicine	O	O	I-T091
introduction	O	O	B-T061
,	O	O	O
the	O	O	O
growth	O	O	B-T067
of	O	O	O
PHC	O	O	B-T058
and	O	O	O
secondary	O	O	B-T058
care	O	O	I-T058
consultations	O	O	B-T058
per	O	O	O
person	O	O	B-T098
was	O	O	O
0.08	O	O	O
and	O	O	O
0.30	O	O	O
,	O	O	O
respectively	O	O	O
,	O	O	O
a	O	O	O
year	O	O	B-T079
.	O	O	O

PHC	O	O	B-T058
increased	O	O	B-T081
as	O	O	O
preferred	O	O	O
provider	O	O	B-T201
by	O	O	O
9.5	O	O	O
%	O	O	O
over	O	O	O
7	O	O	O
years	O	O	B-T079
with	O	O	O
the	O	O	O
reasons	O	O	O
of	O	O	O
proximity	O	O	B-T082
and	O	O	O
service	O	O	B-T033
satisfaction	O	O	I-T033
,	O	O	O
which	O	O	O
increased	O	O	O
by	O	O	O
14.9	O	O	O
%	O	O	O
and	O	O	O
11.8	O	O	O
%	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

Reporting	O	O	B-T058
of	O	O	O
poor	O	O	B-T080
facility	O	O	I-T033
hygiene	O	O	I-T033
,	O	O	O
difficulty	O	O	B-T033
getting	O	O	I-T033
an	O	O	I-T033
appointment	O	O	I-T033
,	O	O	O
poor	O	O	O
physician	O	O	B-T097
behaviour	O	O	B-T053
and	O	O	O
high	O	O	B-T080
costs	O	O	B-T081
of	O	O	I-T081
health	O	O	I-T081
care	O	O	I-T081
all	O	O	O
declined	O	O	B-T080
(	O	O	O
P	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
in	O	O	O
PHC	O	O	B-T058
settings	O	O	B-T083
,	O	O	O
but	O	O	O
remained	O	O	O
higher	O	O	B-T080
among	O	O	O
urban	O	O	B-T080
,	O	O	O
low-income	O	O	B-T033
and	O	O	O
working-age	O	O	B-T032
populations	O	O	B-T098
.	O	O	O

-DOCSTART- (27515772)

Laparoscopic	O	O	B-T060
radical	O	O	B-T061
lymph	O	O	I-T061
node	O	O	I-T061
dissection	O	O	I-T061
for	O	O	O
advanced	O	O	B-T191
colon	O	O	I-T191
cancer	O	O	I-T191
close	O	O	O
to	O	O	O
the	O	O	O
hepatic	O	O	O
flexure	O	O	O

Complete	O	O	B-T061
mesocolic	O	O	I-T061
excision	O	O	I-T061
is	O	O	O
currently	O	O	O
recognized	O	O	O
as	O	O	O
a	O	O	O
standard	O	O	B-T061
procedure	O	O	I-T061
for	O	O	O
colon	O	O	B-T191
cancer	O	O	I-T191
.	O	O	O

Gastroepiploic	O	O	B-T023
,	O	O	O
infrapyloric	O	O	B-T023
,	O	O	O
and	O	O	O
superficial	O	O	B-T023
pancreatic	O	O	I-T023
head	O	O	I-T023
lymph	O	O	I-T023
node	O	O	I-T023
metastases	O	O	B-T191
in	O	O	O
the	O	O	O
gastrocolic	O	O	B-T023
ligament	O	O	I-T023
have	O	O	O
been	O	O	O
reported	O	O	O
for	O	O	O
colon	O	O	B-T191
cancer	O	O	I-T191
close	O	O	O
to	O	O	O
the	O	O	O
hepatic	O	O	B-T029
flexure	O	O	I-T029
.	O	O	O

We	O	O	O
sought	O	O	O
to	O	O	O
investigate	O	O	O
metastases	O	O	B-T191
in	O	O	O
the	O	O	O
gastrocolic	O	O	B-T023
ligament	O	O	I-T023
in	O	O	O
colon	O	O	B-T191
cancer	O	O	I-T191
close	O	O	O
to	O	O	O
the	O	O	O
hepatic	O	O	B-T029
flexure	O	O	I-T029
.	O	O	O

This	O	O	O
was	O	O	O
a	O	O	O
single-center	O	O	B-T062
retrospective	O	O	I-T062
study	O	O	I-T062
.	O	O	O

All	O	O	O
patients	O	O	B-T101
with	O	O	O
T2	O	O	B-T033
or	O	O	O
deeper	O	O	O
invasive	O	O	B-T080
colon	O	O	B-T191
cancer	O	O	I-T191
in	O	O	O
the	O	O	O
relevant	O	O	O
tumor	O	O	B-T082
location	O	O	I-T082
who	O	O	O
underwent	O	O	O
laparoscopic	O	O	B-T061
right	O	O	I-T061
hemicolectomy	O	O	I-T061
or	O	O	O
extended	O	O	B-T061
right	O	O	I-T061
hemicolectomy	O	O	I-T061
at	O	O	O
our	O	O	O
institution	O	O	B-T093
between	O	O	O
1	O	O	O
April	O	O	B-T079
2011	O	O	O
and	O	O	O
31	O	O	O
March	O	O	B-T079
2015	O	O	O
were	O	O	O
included	O	O	O
.	O	O	O

Lymph	O	O	B-T061
node	O	O	I-T061
dissection	O	O	I-T061
in	O	O	O
the	O	O	O
gastrocolic	O	O	B-T023
ligament	O	O	I-T023
was	O	O	O
performed	O	O	O
in	O	O	O
35	O	O	O
cases	O	O	O
.	O	O	O

Complications	O	O	B-T046
occurred	O	O	O
in	O	O	O
11	O	O	O
patients	O	O	B-T101
(	O	O	O
31	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
were	O	O	O
grades	O	O	O
I	O	O	O
and	O	O	O
II	O	O	O
according	O	O	O
to	O	O	O
the	O	O	O
Clavien-Dindo	O	O	B-T185
classification	O	O	I-T185
.	O	O	O

Lymph	O	O	B-T191
node	O	O	I-T191
metastases	O	O	I-T191
in	O	O	O
the	O	O	O
gastrocolic	O	O	B-T023
ligament	O	O	I-T023
were	O	O	O
found	O	O	O
in	O	O	O
only	O	O	O
three	O	O	O
patients	O	O	B-T101
(	O	O	O
9	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

Each	O	O	O
metastasis	O	O	B-T191
was	O	O	O
larger	O	O	O
than	O	O	O
9	O	O	O
mm	O	O	B-T081
.	O	O	O

Metastases	O	O	B-T191
in	O	O	O
the	O	O	O
gastrocolic	O	O	B-T023
ligament	O	O	I-T023
occurred	O	O	O
in	O	O	O
9	O	O	O
%	O	O	O
of	O	O	O
patients	O	O	B-T101
with	O	O	O
T2	O	O	B-T033
or	O	O	O
deeper	O	O	O
invasive	O	O	B-T080
colon	O	O	B-T191
cancer	O	O	I-T191
close	O	O	O
to	O	O	O
the	O	O	O
hepatic	O	O	B-T029
flexure	O	O	I-T029
.	O	O	O

Laparoscopy	O	O	B-T061
was	O	O	O
feasible	O	O	O
and	O	O	O
useful	O	O	O
during	O	O	O
gastrocolic	O	O	B-T061
ligament	O	O	I-T061
resection	O	O	I-T061
.	O	O	O

This	O	O	O
study	O	O	B-T062
included	O	O	O
a	O	O	O
small	O	O	O
sample	O	O	B-T167
and	O	O	O
lacked	O	O	O
an	O	O	O
extended	O	O	B-T082
follow-up	O	O	B-T058
.	O	O	O

Further	O	O	O
studies	O	O	B-T062
are	O	O	O
needed	O	O	O
to	O	O	O
determine	O	O	O
the	O	O	O
clinical	O	O	B-T080
relevance	O	O	I-T080
of	O	O	O
this	O	O	O
finding	O	O	B-T033
,	O	O	O
particularly	O	O	O
in	O	O	O
terms	O	O	O
of	O	O	O
recurrence	O	O	B-T067
and	O	O	O
long-term	O	O	B-T079
survival	O	O	B-T052
.	O	O	O

-DOCSTART- (27516747)

Smartphone	O	O	B-T073
-Based	O	O	O
Psychotherapeutic	O	O	B-T061
Micro-Interventions	O	O	B-T061
to	O	O	O
Improve	O	O	O
Mood	O	O	B-T041
in	O	O	O
a	O	O	O
Real-World	O	O	O
Setting	O	O	O

Using	O	O	O
mobile	O	O	B-T073
communication	O	O	B-UnknownType
technology	O	O	I-UnknownType
as	O	O	O
new	O	O	O
personalized	O	O	O
approach	O	O	B-T082
to	O	O	O
treat	O	O	B-T061
mental	O	O	B-T048
disorders	O	O	I-T048
or	O	O	O
to	O	O	O
more	O	O	O
generally	O	O	O
improve	O	O	O
quality	O	O	B-T078
of	O	O	I-T078
life	O	O	I-T078
is	O	O	O
highly	O	O	O
promising	O	O	O
.	O	O	O

Knowledge	O	O	B-T170
about	O	O	O
intervention	O	O	B-T061
components	O	O	B-T073
that	O	O	O
target	O	O	O
key	O	O	O
psychopathological	O	O	B-T091
processes	O	O	B-T067
in	O	O	O
terms	O	O	O
of	O	O	O
transdiagnostic	O	O	O
psychotherapy	O	O	B-T061
approaches	O	O	B-T082
is	O	O	O
urgently	O	O	O
needed	O	O	O
.	O	O	O

We	O	O	O
explored	O	O	O
the	O	O	O
use	O	O	O
of	O	O	O
smartphone	O	O	B-T073
-based	O	O	O
micro-interventions	O	O	B-T061
based	O	O	O
on	O	O	O
psychotherapeutic	O	O	B-T170
techniques	O	O	I-T170
,	O	O	O
guided	O	O	O
by	O	O	O
short	O	O	O
video-clips	O	O	B-T170
,	O	O	O
to	O	O	O
elicit	O	O	O
mood	O	O	B-T048
changes	O	O	I-T048
.	O	O	O

As	O	O	O
part	O	O	O
of	O	O	O
a	O	O	O
larger	O	O	O
neurofeedback	O	O	B-T061
study	O	O	B-T062
,	O	O	O
all	O	O	O
subjects	O	O	B-T098
-after	O	O	O
being	O	O	O
randomly	O	O	O
assigned	O	O	O
to	O	O	O
an	O	O	O
experimental	O	O	O
or	O	O	O
control	O	O	O
neurofeedback	O	O	O
condition	O	O	B-T080
-underwent	O	O	O
daily	O	O	B-T079
smartphone	O	O	B-T073
-based	O	O	O
micro-interventions	O	O	B-T061
for	O	O	O
13	O	O	O
consecutive	O	O	O
days	O	O	B-T079
.	O	O	O

They	O	O	O
were	O	O	O
free	O	O	O
to	O	O	O
choose	O	O	O
out	O	O	O
of	O	O	O
provided	O	O	O
techniques	O	O	B-T169
,	O	O	O
including	O	O	O
viscerosensory	O	O	B-T080
attention	O	O	B-T041
,	O	O	O
emotional	O	O	B-T033
imagery	O	O	B-T041
,	O	O	O
facial	O	O	B-T033
expression	O	O	I-T033
,	O	O	O
and	O	O	O
contemplative	O	O	B-T080
repetition	O	O	B-T169
.	O	O	O

Changes	O	O	B-T169
in	O	O	O
mood	O	O	B-T041
were	O	O	O
assessed	O	O	O
in	O	O	O
real	O	O	O
world	O	O	O
using	O	O	O
the	O	O	O
Multidimensional	O	O	B-T170
Mood	O	O	I-T170
State	O	O	I-T170
Questionnaire	O	O	I-T170
(	O	O	O
scales	O	O	O
:	O	O	O
good	O	O	B-T080
-	O	O	O
bad	O	O	B-T080
,	O	O	O
GB	O	O	O
;	O	O	O
awake	O	O	B-T033
-	O	O	O
tired	O	O	B-T184
,	O	O	O
AT	O	O	O
;	O	O	O
and	O	O	O
calm	O	O	B-T041
-	O	O	O
nervous	O	O	B-T184
,	O	O	O
CN	O	O	O
)	O	O	O
.	O	O	O

Twenty-seven	O	O	O
men	O	O	B-T098
participated	O	O	O
on	O	O	O
at	O	O	O
least	O	O	O
11	O	O	O
days	O	O	B-T079
and	O	O	O
were	O	O	O
thus	O	O	O
included	O	O	O
in	O	O	O
the	O	O	O
analyses	O	O	B-T062
.	O	O	O

Altogether	O	O	O
,	O	O	O
they	O	O	O
underwent	O	O	O
335	O	O	O
,	O	O	O
generally	O	O	O
well-tolerated	O	O	O
,	O	O	O
micro-intervention	O	O	B-UnknownType
sessions	O	O	B-UnknownType
,	O	O	O
with	O	O	O
viscerosensory	O	O	B-T080
attention	O	O	B-T041
(	O	O	O
178	O	O	O
sessions	O	O	O
,	O	O	O
53.13	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
contemplative	O	O	B-T080
repetition	O	O	B-T169
(	O	O	O
68	O	O	O
sessions	O	O	O
,	O	O	O
20.30	O	O	O
%	O	O	O
)	O	O	O
being	O	O	O
the	O	O	O
most	O	O	O
frequently	O	O	O
applied	O	O	O
techniques	O	O	B-T169
.	O	O	O

Mixed	O	O	O
models	O	O	B-T170
indicated	O	O	O
that	O	O	O
subjects	O	O	B-T098
showed	O	O	O
better	O	O	O
mood	O	O	B-T041
[	O	O	O
GB	O	O	O
:	O	O	O
b	O	O	O
=	O	O	O
0.464	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
confidence	O	O	B-T081
interval	O	O	I-T081
(	O	O	O
CI	O	O	B-T081
)	O	O	O
[	O	O	O
0.068	O	O	O
,	O	O	O
0.860	O	O	O
]	O	O	O
,	O	O	O
t	O	O	O
(	O	O	O
613.3	O	O	O
)	O	O	O
=	O	O	O
2.298	O	O	O
,	O	O	O
p	O	O	O
=	O	O	O
0.022	O	O	O
]	O	O	O
and	O	O	O
became	O	O	O
more	O	O	O
awake	O	O	B-T033
[	O	O	O
AT	O	O	O
:	O	O	O
b	O	O	O
=	O	O	O
0.514	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
[	O	O	O
0.103	O	O	O
,	O	O	O
0.925	O	O	O
]	O	O	O
,	O	O	O
t	O	O	O
(	O	O	O
612.4	O	O	O
)	O	O	O
=	O	O	O
2.456	O	O	O
,	O	O	O
p	O	O	O
=	O	O	O
0.014	O	O	O
]	O	O	O
and	O	O	O
calmer	O	O	B-T041
[	O	O	O
CN	O	O	O
:	O	O	O
b	O	O	O
=	O	O	O
0.685	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
[	O	O	O
0.360	O	O	O
,	O	O	O
1.010	O	O	O
]	O	O	O
,	O	O	O
t	O	O	O
(	O	O	O
612.3	O	O	O
)	O	O	O
=	O	O	O
4.137	O	O	O
,	O	O	O
p	O	O	O
<	O	O	O
0.001	O	O	O
]	O	O	O
from	O	O	O
pre	O	O	B-T079
-	O	O	O
to	O	O	O
post-micro-intervention	O	O	B-T079
.	O	O	O

These	O	O	O
mood	O	O	B-T041
improvements	O	O	B-T077
from	O	O	O
pre	O	O	B-T079
-	O	O	O
to	O	O	O
post-micro-intervention	O	O	B-T079
were	O	O	O
associated	O	O	O
with	O	O	O
changes	O	O	B-T048
in	O	O	I-T048
mood	O	O	I-T048
from	O	O	O
the	O	O	O
1st	O	O	O
day	O	O	B-T079
until	O	O	O
the	O	O	O
last	O	O	O
day	O	O	O
with	O	O	O
regard	O	O	O
to	O	O	O
GB	O	O	B-T041
mood	O	O	I-T041
(	O	O	O
r	O	O	O
=	O	O	O
0.614	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
[	O	O	O
0.297	O	O	O
,	O	O	O
0.809	O	O	O
]	O	O	O
,	O	O	O
p	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
,	O	O	O
but	O	O	O
not	O	O	O
AT	O	O	B-T041
mood	O	O	I-T041
(	O	O	O
r	O	O	O
=	O	O	O
0.279	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
[	O	O	O
-0.122	O	O	O
,	O	O	O
0.602	O	O	O
]	O	O	O
,	O	O	O
p	O	O	O
=	O	O	O
0.167	O	O	O
)	O	O	O
and	O	O	O
CN	O	O	B-T041
mood	O	O	I-T041
(	O	O	O
r	O	O	O
=	O	O	O
0.277	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
[	O	O	O
0.124	O	O	O
,	O	O	O
0.601	O	O	O
]	O	O	O
,	O	O	O
p	O	O	O
=	O	O	O
0.170	O	O	O
)	O	O	O
.	O	O	O

Our	O	O	O
findings	O	O	B-T033
provide	O	O	O
evidence	O	O	O
for	O	O	O
the	O	O	O
applicability	O	O	O
of	O	O	O
smartphone	O	O	B-T073
-based	O	O	O
micro-interventions	O	O	B-T061
eliciting	O	O	O
short-term	O	O	B-T079
mood	O	O	B-T048
changes	O	O	I-T048
,	O	O	O
based	O	O	O
on	O	O	O
techniques	O	O	B-T169
used	O	O	O
in	O	O	O
psychotherapeutic	O	O	B-T061
approaches	O	O	B-T082
,	O	O	O
such	O	O	O
as	O	O	O
mindfulness	O	O	B-T041
-based	O	O	O
psychotherapy	O	O	B-T061
,	O	O	O
transcendental	O	O	B-T041
meditation	O	O	I-T041
,	O	O	O
and	O	O	O
other	O	O	O
contemplative	O	O	B-T080
therapies	O	O	B-T061
.	O	O	O

The	O	O	O
results	O	O	O
encourage	O	O	O
exploring	O	O	O
these	O	O	O
techniques	O	O	B-T169
'	O	O	O
capability	O	O	B-T080
to	O	O	O
improve	O	O	O
mood	O	O	B-T041
in	O	O	O
randomized	O	O	O
controlled	O	O	B-T062
studies	O	O	I-T062
and	O	O	O
patients	O	O	B-T101
.	O	O	O

Smartphone	O	O	B-T073
-based	O	O	O
micro-interventions	O	O	B-T061
are	O	O	O
promising	O	O	O
to	O	O	O
modify	O	O	O
mood	O	O	B-T041
in	O	O	O
real-world	O	O	B-T079
settings	O	O	I-T079
,	O	O	O
complementing	O	O	O
other	O	O	O
psychotherapeutic	O	O	B-T061
interventions	O	O	I-T061
,	O	O	O
in	O	O	O
line	O	O	O
with	O	O	O
the	O	O	O
precision	O	O	B-T079
medicine	O	O	B-UnknownType
approach	O	O	I-UnknownType
.	O	O	O

The	O	O	O
here	O	O	O
presented	O	O	O
data	O	O	B-T078
were	O	O	O
collected	O	O	O
within	O	O	O
a	O	O	O
randomized	O	O	B-T062
trial	O	O	I-T062
,	O	O	O
registered	O	O	O
at	O	O	O
ClinicalTrials.gov	O	O	O
(	O	O	O
Identifier	O	O	O
:	O	O	O
NCT01921088	O	O	O
)	O	O	O
https://clinicaltrials.gov/ct2/show/NCT01921088	O	O	O
.	O	O	O

-DOCSTART- (27518527)

Primary	O	O	B-T080
pituitary	O	O	B-T023
diffuse	O	O	B-T191
large	O	O	I-T191
B-cell	O	O	I-T191
lymphoma	O	O	I-T191
with	O	O	O
somatotroph	O	O	B-T190
hyperplasia	O	O	I-T190
and	O	O	O
acromegaly	O	O	B-T047
:	O	O	O
case	O	O	O
report	O	O	O

Diffuse	O	O	B-T191
large	O	O	I-T191
B-cell	O	O	I-T191
lymphoma	O	O	I-T191
(	O	O	O
DLBCL	O	O	B-T191
)	O	O	O
is	O	O	O
the	O	O	O
most	O	O	O
common	O	O	B-T081
type	O	O	B-T080
of	O	O	O
non-Hodgkin	O	O	B-T191
lymphoma	O	O	I-T191
and	O	O	O
comprises	O	O	O
approximately	O	O	O
30	O	O	O
%	O	O	O
of	O	O	O
all	O	O	O
lymphomas	O	O	B-T191
.	O	O	O

Patients	O	O	B-T101
typically	O	O	O
present	O	O	B-T033
with	O	O	O
a	O	O	O
nonpainful	O	O	B-T169
mass	O	O	B-T033
in	O	O	O
the	O	O	O
neck	O	O	B-T029
,	O	O	O
groin	O	O	B-T029
,	O	O	O
or	O	O	O
abdomen	O	O	B-T029
associated	O	O	B-T080
with	O	O	I-T080
constitutional	O	O	B-T184
symptoms	O	O	I-T184
.	O	O	O

In	O	O	O
this	O	O	O
report	O	O	B-T170
,	O	O	O
however	O	O	O
,	O	O	O
the	O	O	O
authors	O	O	B-T097
describe	O	O	O
a	O	O	O
rare	O	O	B-T080
case	O	O	B-T169
of	O	O	O
a	O	O	O
61-	O	O	O
year	O	O	B-T079
-old	O	O	O
woman	O	O	B-T098
with	O	O	O
hyperprolactinemia	O	O	B-T047
,	O	O	O
hypothyroidism	O	O	B-T047
,	O	O	O
and	O	O	O
acromegaly	O	O	B-T047
(	O	O	O
elevation	O	O	B-T080
of	O	O	O
insulin-like	O	O	B-T116
growth	O	O	I-T116
factor-1	O	O	I-T116
[	O	O	O
IGF-1	O	O	B-T116
]	O	O	O
)	O	O	O
with	O	O	O
elevated	O	O	B-T080
growth	O	O	B-T116
hormone-releasing	O	O	I-T116
hormone	O	O	I-T116
(	O	O	O
GHRH	O	O	B-T116
)	O	O	O
in	O	O	O
whom	O	O	O
an	O	O	O
MRI	O	O	B-T060
demonstrated	O	O	B-T080
diffuse	O	O	B-T184
enlargement	O	O	I-T184
of	O	O	I-T184
the	O	O	I-T184
pituitary	O	O	I-T184
gland	O	O	I-T184
.	O	O	O

Despite	O	O	O
medical	O	O	B-T061
treatment	O	O	I-T061
,	O	O	O
the	O	O	O
patient	O	O	B-T101
had	O	O	O
persistent	O	O	B-T079
elevation	O	O	B-T080
of	O	O	O
IGF-1	O	O	B-T116
.	O	O	O

She	O	O	O
underwent	O	O	O
a	O	O	O
transsphenoidal	O	O	B-T060
biopsy	O	O	I-T060
,	O	O	O
which	O	O	O
yielded	O	O	B-T052
a	O	O	O
diagnosis	O	O	B-T033
of	O	O	O
DLBCL	O	O	B-T191
with	O	O	O
an	O	O	O
activated	O	O	B-T052
B-cell	O	O	B-T025
immunophenotype	O	O	B-T059
with	O	O	O
somatotroph	O	O	B-T190
hyperplasia	O	O	I-T190
.	O	O	O

After	O	O	O
stereo-tactic	O	O	B-T061
radiation	O	O	I-T061
therapy	O	O	I-T061
in	O	O	O
combination	O	O	B-T080
with	O	O	O
chemotherapy	O	O	B-T061
,	O	O	O
she	O	O	O
is	O	O	O
currently	O	O	B-T079
in	O	O	O
remission	O	O	B-T191
from	O	O	O
her	O	O	O
lymphoma	O	O	B-T191
and	O	O	O
has	O	O	O
normalized	O	O	B-T062
IGF-1	O	O	B-T116
levels	O	O	B-T080
without	O	O	O
medical	O	O	B-T061
therapy	O	O	I-T061
,	O	O	O
8	O	O	O
months	O	O	B-T079
after	O	O	O
her	O	O	O
histopathological	O	O	B-T169
diagnosis	O	O	B-T033
.	O	O	O

This	O	O	O
is	O	O	O
the	O	O	O
only	O	O	O
reported	O	O	B-T170
case	O	O	B-T169
of	O	O	O
its	O	O	O
kind	O	O	O
and	O	O	O
displays	O	O	O
the	O	O	O
importance	O	O	O
of	O	O	O
a	O	O	O
broad	O	O	O
differential	O	O	B-T060
diagnosis	O	O	I-T060
,	O	O	O
multidisciplinary	O	O	B-T060
evaluation	O	O	I-T060
,	O	O	O
and	O	O	O
critical	O	O	B-T080
intraoperative	O	O	B-T079
decision-making	O	O	B-T041
when	O	O	O
treating	O	O	B-T169
atypical	O	O	O
sellar	O	O	B-T023
lesions	O	O	B-T033
.	O	O	O

-DOCSTART- (27524208)

Doctor	O	O	B-T097
Competence	O	O	B-T080
and	O	O	O
the	O	O	O
Demand	O	O	B-T061
for	O	O	O
Healthcare	O	O	B-T058
:	O	O	O
Evidence	O	O	B-T078
from	O	O	O
Rural	O	O	O
China	O	O	O

The	O	O	O
agency	O	O	B-T092
problem	O	O	B-T033
between	O	O	O
patients	O	O	B-T101
and	O	O	O
doctors	O	O	B-T097
has	O	O	O
long	O	O	O
been	O	O	O
emphasised	O	O	O
in	O	O	O
the	O	O	O
health	O	O	B-T170
economics	O	O	I-T170
literature	O	O	I-T170
,	O	O	O
but	O	O	O
the	O	O	O
empirical	O	O	B-T080
evidence	O	O	B-T078
on	O	O	O
whether	O	O	O
patients	O	O	O
can	O	O	O
evaluate	O	O	B-T052
and	O	O	O
respond	O	O	O
to	O	O	O
better	O	O	B-T080
quality	O	O	B-T058
care	O	O	I-T058
remains	O	O	O
mixed	O	O	B-T169
and	O	O	O
inconclusive	O	O	B-T080
.	O	O	O

Using	O	O	O
household	O	O	B-T099
data	O	O	B-T078
linked	O	O	O
to	O	O	O
an	O	O	O
assessment	O	O	B-T052
of	O	O	O
village	O	O	B-T083
doctors	O	O	B-T097
'	O	O	I-T097
clinical	O	O	B-T080
competence	O	O	B-T080
in	O	O	O
rural	O	O	B-T083
China	O	O	I-T083
,	O	O	O
we	O	O	O
show	O	O	O
that	O	O	O
there	O	O	O
is	O	O	O
no	O	O	B-T080
correlation	O	O	I-T080
between	O	O	O
doctor	O	O	B-T097
competence	O	O	O
and	O	O	O
patients	O	O	B-T101
'	O	O	I-T101
healthcare	O	O	B-T058
utilisation	O	O	B-T169
,	O	O	O
with	O	O	O
confidence	O	O	B-T081
intervals	O	O	I-T081
reasonably	O	O	O
tight	O	O	O
around	O	O	O
zero	O	O	O
.	O	O	O

Household	O	O	B-T099
perceptions	O	O	B-T041
of	O	O	O
quality	O	O	B-T080
are	O	O	O
an	O	O	O
important	O	O	B-T080
determinant	O	O	B-T169
of	O	O	O
care-seeking	O	O	B-T055
behaviour	O	O	I-T055
,	O	O	O
yet	O	O	O
patients	O	O	B-T101
appear	O	O	B-T080
unable	O	O	B-T033
to	O	O	O
recognise	O	O	B-T080
more	O	O	O
competent	O	O	B-T080
doctors	O	O	B-T097
-	O	O	O
there	O	O	O
is	O	O	O
no	O	O	O
relationship	O	O	B-T080
between	O	O	O
doctor	O	O	B-T097
competence	O	O	B-T080
and	O	O	O
perceptions	O	O	O
of	O	O	O
quality	O	O	O
.	O	O	O

Copyright	O	O	O
Â©	O	O	O
2016	O	O	O
John	O	O	O
Wiley	O	O	O
&	O	O	O
Sons	O	O	O
,	O	O	O
Ltd.	O	O	O
JOURNAL	O	O	O
ARTICLE	O	O	O

-DOCSTART- (27524790)

Unintentional	O	O	B-T169
insecticide	O	O	B-T037
poisoning	O	O	I-T037
by	O	O	O
age	O	O	B-T032
:	O	O	O
an	O	O	O
analysis	O	O	B-T062
of	O	O	O
Queensland	O	O	O
Poisons	O	O	O
Information	O	O	O
Centre	O	O	O
calls	O	O	O

Data	O	O	B-T078
from	O	O	O
the	O	O	O
Queensland	O	O	O
Poisons	O	O	O
Information	O	O	O
Centre	O	O	O
(	O	O	O
QPIC	O	O	O
)	O	O	O
was	O	O	O
assessed	O	O	B-T052
to	O	O	O
determine	O	O	B-T078
mechanisms	O	O	B-T169
of	O	O	O
acute	O	O	O
insecticide	O	O	B-T037
poisoning	O	O	I-T037
in	O	O	O
young	O	O	B-T100
children	O	O	I-T100
(	O	O	O
<	O	O	B-T079
5	O	O	I-T079
years	O	O	I-T079
)	O	O	O
and	O	O	O
whether	O	O	O
age	O	O	B-T032
affects	O	O	B-T041
insecticide-poisoning	O	O	B-T037
patterns	O	O	B-T082
.	O	O	O

Records	O	O	B-T170
of	O	O	O
all	O	O	O
insecticide-related	O	O	B-T058
calls	O	O	I-T058
placed	O	O	O
to	O	O	O
QPIC	O	O	O
in	O	O	O
2014	O	O	O
were	O	O	O
obtained	O	O	B-T169
.	O	O	O

A	O	O	O
stratified	O	O	B-T080
analysis	O	O	B-T062
of	O	O	O
call	O	O	B-T058
patterns	O	O	B-T082
by	O	O	O
age	O	O	B-T032
was	O	O	O
conducted	O	O	B-T169
.	O	O	O

Of	O	O	O
743	O	O	O
insecticide-related	O	O	B-T058
calls	O	O	I-T058
received	O	O	B-T080
by	O	O	I-T080
QPIC	O	O	O
364	O	O	O
(	O	O	O
49.0	O	O	O
%	O	O	O
)	O	O	O
were	O	O	O
for	O	O	O
young	O	O	B-T100
children	O	O	I-T100
.	O	O	O

The	O	O	O
number	O	O	O
of	O	O	O
calls	O	O	B-T058
peaked	O	O	B-T080
in	O	O	O
children	O	O	B-T100
aged	O	O	B-T079
one	O	O	I-T079
.	O	O	O

Ant	O	O	B-T204
and	O	O	O
cockroach	O	O	B-T204
baits	O	O	B-T131
accounted	O	O	B-T081
for	O	O	O
39.0	O	O	O
%	O	O	O
of	O	O	O
calls	O	O	B-T058
.	O	O	O

Sprays	O	O	B-T122
,	O	O	O
which	O	O	O
were	O	O	O
found	O	O	B-T033
to	O	O	O
contain	O	O	O
not	O	O	O
only	O	O	O
pyrethroids	O	O	B-T109
,	O	O	O
pyrethrins	O	O	B-T109
and/or	O	O	O
piperonly	O	O	B-T109
butoxide	O	O	I-T109
but	O	O	O
also	O	O	O
the	O	O	O
organophosphate	O	O	B-T109
diazinon	O	O	I-T109
,	O	O	O
accounted	O	O	B-T081
for	O	O	O
25.8	O	O	O
%	O	O	O
of	O	O	O
calls	O	O	B-T058
.	O	O	O

Mouthing	O	O	B-T040
or	O	O	O
ingesting	O	O	B-T038
a	O	O	O
pest-control	O	O	B-T131
product	O	O	I-T131
and	O	O	O
consuming	O	O	B-T052
an	O	O	O
item/insect	O	O	O
after	O	O	O
treatment	O	O	B-T169
were	O	O	O
common	O	O	O
mechanisms	O	O	B-T169
for	O	O	O
children	O	O	B-T100
under	O	O	O
the	O	O	O
age	O	O	B-T079
of	O	O	I-T079
two	O	O	I-T079
.	O	O	O

Topical	O	O	B-T082
exposure	O	O	B-T080
to	O	O	I-T080
sprays	O	O	B-T122
,	O	O	O
via	O	O	O
direct	O	O	B-T080
application	O	O	B-T169
,	O	O	O
typically	O	O	O
by	O	O	O
the	O	O	O
child	O	O	B-T100
or	O	O	O
an	O	O	O
older	O	O	B-T099
sibling	O	O	I-T099
,	O	O	O
peaked	O	O	B-T080
in	O	O	O
children	O	O	B-T100
aged	O	O	B-T079
two	O	O	I-T079
.	O	O	O

In	O	O	O
12.3	O	O	O
%	O	O	O
of	O	O	O
calls	O	O	B-T058
medical	O	O	B-T058
attention	O	O	I-T058
for	O	O	O
the	O	O	O
child	O	O	B-T100
was	O	O	O
already	O	O	O
sought	O	O	B-UnknownType
or	O	O	O
advised	O	O	B-T058
by	O	O	I-T058
QPIC	O	O	O
.	O	O	O

Normal	O	O	B-T053
behaviours	O	O	B-T053
associated	O	O	B-T080
with	O	O	I-T080
child	O	O	B-T040
development	O	O	I-T040
,	O	O	O
particularly	O	O	O
mouthing	O	O	B-T040
behaviours	O	O	O
,	O	O	O
explained	O	O	O
the	O	O	O
peak	O	O	B-T080
of	O	O	I-T080
exposure	O	O	I-T080
in	O	O	O
one-year	O	O	B-T079
-	O	O	O
olds	O	O	B-T100
.	O	O	O

This	O	O	O
finding	O	O	B-T033
should	O	O	O
guide	O	O	O
strategies	O	O	B-T041
to	O	O	O
minimise	O	O	B-T080
poisonings	O	O	B-T037
in	O	O	O
this	O	O	O
vulnerable	O	O	B-T098
population	O	O	I-T098
.	O	O	O

-DOCSTART- (27525173)

Investigating	O	O	O
Synthetic	O	O	B-T114
Oligonucleotide	O	O	B-T114
Targeting	O	O	O
of	O	O	O
Mir31	O	O	B-T114
in	O	O	O
Duchenne	O	O	O
Muscular	O	O	O
Dystrophy	O	O	O

Exon-skipping	O	O	B-T045
via	O	O	O
synthetic	O	O	B-T114
antisense	O	O	B-T114
oligonucleotides	O	O	I-T114
represents	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
most	O	O	O
promising	O	O	O
potential	O	O	O
therapies	O	O	B-T061
for	O	O	O
Duchenne	O	O	B-T047
muscular	O	O	I-T047
dystrophy	O	O	I-T047
(	O	O	O
DMD	O	O	B-T047
)	O	O	O
,	O	O	O
yet	O	O	O
this	O	O	O
approach	O	O	O
is	O	O	O
highly	O	O	O
sequence-specific	O	O	B-T045
and	O	O	O
thus	O	O	O
each	O	O	O
oligonucleotide	O	O	B-T114
is	O	O	O
of	O	O	O
benefit	O	O	O
to	O	O	O
only	O	O	O
a	O	O	O
subset	O	O	O
of	O	O	O
patients	O	O	B-T101
.	O	O	O

The	O	O	O
discovery	O	O	B-T052
that	O	O	O
dystrophin	O	O	B-T116
mRNA	O	O	B-T114
is	O	O	O
subject	O	O	O
to	O	O	O
translational	O	O	B-T045
suppression	O	O	I-T045
by	O	O	O
the	O	O	O
microRNA	O	O	B-T114
miR31	O	O	B-T114
,	O	O	O
and	O	O	O
that	O	O	O
miR31	O	O	O
is	O	O	O
elevated	O	O	O
in	O	O	O
the	O	O	O
muscle	O	O	B-T024
of	O	O	O
DMD	O	O	B-T047
patients	O	O	B-T101
,	O	O	O
raises	O	O	O
the	O	O	O
possibility	O	O	O
that	O	O	O
the	O	O	O
same	O	O	O
oligonucleotide	O	O	B-T114
chemistries	O	O	O
employed	O	O	O
for	O	O	O
exon	O	O	B-T045
skipping	O	O	I-T045
could	O	O	O
be	O	O	O
directed	O	O	O
toward	O	O	O
relieving	O	O	O
this	O	O	O
translational	O	O	B-T045
block	O	O	I-T045
.	O	O	O

This	O	O	O
approach	O	O	O
would	O	O	O
act	O	O	O
synergistically	O	O	B-T080
with	O	O	O
exon	O	O	B-T045
skipping	O	O	I-T045
where	O	O	O
possible	O	O	O
,	O	O	O
but	O	O	O
by	O	O	O
targeting	O	O	O
the	O	O	O
3'UTR	O	O	B-T086
it	O	O	O
would	O	O	O
further	O	O	O
be	O	O	O
of	O	O	O
benefit	O	O	O
to	O	O	O
the	O	O	O
many	O	O	O
DMD	O	O	B-T047
patients	O	O	B-T101
who	O	O	O
express	O	O	O
low	O	O	O
levels	O	O	O
of	O	O	O
in-frame	O	O	B-T086
transcript	O	O	B-T114
.	O	O	O

We	O	O	O
here	O	O	O
present	O	O	O
investigations	O	O	B-T058
into	O	O	O
the	O	O	O
feasibility	O	O	O
of	O	O	O
combining	O	O	O
exon	O	O	B-T045
skipping	O	O	I-T045
with	O	O	O
several	O	O	O
different	O	O	O
strategies	O	O	O
for	O	O	O
miR31	O	O	B-T114
-	O	O	O
modulation	O	O	B-UnknownType
,	O	O	O
using	O	O	O
both	O	O	O
in	O	O	B-T059
vitro	O	O	I-T059
models	O	O	B-T075
and	O	O	O
the	O	O	O
mdx	O	O	B-T015
mouse	O	O	I-T015
(	O	O	O
the	O	O	O
classical	O	O	O
animal	O	O	B-T008
model	O	O	I-T008
of	O	O	O
DMD	O	O	B-T047
)	O	O	O
,	O	O	O
and	O	O	O
monitoring	O	O	B-T058
effects	O	O	B-T080
on	O	O	O
dystrophin	O	O	B-T116
at	O	O	O
the	O	O	O
transcriptional	O	O	B-T045
and	O	O	O
translational	O	O	B-T045
level	O	O	O
.	O	O	O

We	O	O	O
show	O	O	O
that	O	O	O
despite	O	O	O
promising	O	O	O
results	O	O	O
from	O	O	O
our	O	O	O
cell	O	O	B-T059
culture	O	O	I-T059
model	O	O	B-T075
,	O	O	O
our	O	O	O
in	O	O	B-T082
vivo	O	O	I-T082
data	O	O	B-T078
failed	O	O	O
to	O	O	O
demonstrate	O	O	O
similarly	O	O	O
reproducible	O	O	O
enhancement	O	O	B-T052
of	O	O	O
dystrophin	O	O	B-T116
translation	O	O	B-T045
,	O	O	O
suggesting	O	O	O
that	O	O	O
miR31	O	O	B-T114
-	O	O	O
modulation	O	O	B-UnknownType
may	O	O	O
not	O	O	O
be	O	O	O
practical	O	O	O
under	O	O	O
current	O	O	O
oligonucleotide	O	O	B-T114
approaches	O	O	O
.	O	O	O

Possible	O	O	O
explanations	O	O	O
for	O	O	O
this	O	O	O
disappointing	O	O	O
outcome	O	O	B-T080
are	O	O	O
discussed	O	O	O
,	O	O	O
along	O	O	O
with	O	O	O
suggestions	O	O	O
for	O	O	O
future	O	O	O
investigations	O	O	B-T058
.	O	O	O

-DOCSTART- (27525549)

Undisclosed	O	O	B-T080
HIV	O	O	B-T047
infection	O	O	I-T047
and	O	O	O
art	O	O	B-T061
use	O	O	B-T169
in	O	O	O
the	O	O	O
kenya	O	O	B-T170
AIDS	O	O	I-T170
indicator	O	O	I-T170
survey	O	O	I-T170
2012	O	O	I-T170
:	O	O	O
relevance	O	O	B-T080
to	O	O	O
targets	O	O	B-T169
for	O	O	O
HIV	O	O	B-T060
diagnosis	O	O	I-T060
and	O	O	O
treatment	O	O	B-T061
in	O	O	O
kenya	O	O	O

To	O	O	O
assess	O	O	B-T058
the	O	O	O
impact	O	O	B-T080
of	O	O	O
undisclosed	O	O	B-T080
HIV	O	O	B-T047
infection	O	O	I-T047
and	O	O	O
antiretroviral	O	O	B-T061
(	O	O	I-T061
ARV	O	O	I-T061
)	O	O	I-T061
therapy	O	O	I-T061
(	O	O	O
ART	O	O	B-T061
)	O	O	O
on	O	O	O
national	O	O	B-T082
estimates	O	O	B-T081
of	O	O	O
diagnosed	O	O	B-T033
HIV	O	O	I-T033
and	O	O	O
ART	O	O	O
coverage	O	O	B-T169
in	O	O	O
Kenya	O	O	B-T083
.	O	O	O

HIV-positive	O	O	B-T033
dried	O	O	B-T031
blood	O	O	I-T031
spot	O	O	I-T031
samples	O	O	I-T031
from	O	O	O
Kenya	O	O	B-T170
's	O	O	I-T170
second	O	O	I-T170
AIDS	O	O	I-T170
Indicator	O	O	I-T170
Survey	O	O	I-T170
were	O	O	O
tested	O	O	B-T169
for	O	O	O
an	O	O	O
ARV	O	O	B-T121
biomarker	O	O	B-T201
by	O	O	O
liquid	O	O	B-T059
chromatography-tandem	O	O	I-T059
mass	O	O	I-T059
spectrometry	O	O	I-T059
.	O	O	O

Estimates	O	O	B-T081
of	O	O	O
diagnosed	O	O	B-T033
HIV	O	O	I-T033
and	O	O	O
ART	O	O	B-T061
use	O	O	B-T169
based	O	O	O
on	O	O	O
self-report	O	O	B-T062
were	O	O	O
compared	O	O	B-T052
with	O	O	O
those	O	O	O
corrected	O	O	O
for	O	O	O
undisclosed	O	O	B-T080
HIV	O	O	B-T047
infection	O	O	I-T047
and	O	O	O
ART	O	O	O
use	O	O	O
based	O	O	O
on	O	O	O
ARV	O	O	B-T121
testing	O	O	O
.	O	O	O

Multivariate	O	O	B-T081
analysis	O	O	I-T081
determined	O	O	B-T080
factors	O	O	B-T169
associated	O	O	B-T080
with	O	O	I-T080
undisclosed	O	O	B-T080
HIV	O	O	B-T047
infection	O	O	I-T047
and	O	O	O
ART	O	O	B-T061
use	O	O	B-T169
among	O	O	O
persons	O	O	B-T098
on	O	O	O
ART	O	O	O
.	O	O	O

Among	O	O	O
559	O	O	O
HIV-positive	O	O	B-T033
samples	O	O	B-T031
,	O	O	O
the	O	O	O
ARV	O	O	B-T121
biomarker	O	O	B-T201
was	O	O	O
detected	O	O	B-T033
in	O	O	O
42.5	O	O	O
%	O	O	O
(	O	O	O
CI	O	O	O
37.4	O	O	O
-	O	O	O
47.7	O	O	O
)	O	O	O
.	O	O	O

ARV	O	O	B-T121
drugs	O	O	I-T121
were	O	O	O
present	O	O	O
in	O	O	O
90.7	O	O	O
%	O	O	O
(	O	O	O
CI	O	O	O
86.1	O	O	O
-	O	O	O
95.2	O	O	O
)	O	O	O
reporting	O	O	B-T058
HIV-positive	O	O	I-T033
status	O	O	O
and	O	O	O
receiving	O	O	B-T080
ART	O	O	B-T061
,	O	O	O
66.7	O	O	O
%	O	O	O
(	O	O	O
CI	O	O	O
59.9	O	O	O
-	O	O	O
73.4	O	O	O
)	O	O	O
reporting	O	O	O
HIV-positive	O	O	O
status	O	O	O
irrespective	O	O	O
of	O	O	O
ART	O	O	O
use	O	O	B-T169
,	O	O	O
21.0	O	O	O
%	O	O	O
(	O	O	O
CI	O	O	O
13.4	O	O	O
-	O	O	O
28.6	O	O	O
)	O	O	O
reporting	O	O	O
HIV-negative	O	O	B-T034
status	O	O	I-T034
,	O	O	O
and	O	O	O
19.3	O	O	O
%	O	O	O
(	O	O	O
CI	O	O	O
9.0	O	O	O
-	O	O	O
29.5	O	O	O
)	O	O	O
reporting	O	O	O
no	O	O	B-T033
previous	O	O	B-T079
HIV	O	O	B-T059
test	O	O	I-T059
.	O	O	O

After	O	O	O
correcting	O	O	O
for	O	O	O
undisclosed	O	O	B-T080
HIV	O	O	B-T047
infection	O	O	I-T047
and	O	O	O
ART	O	O	B-T061
use	O	O	B-T169
,	O	O	O
diagnosed	O	O	B-T033
HIV	O	O	I-T033
increased	O	O	B-T081
from	O	O	O
46.9	O	O	O
%	O	O	O
to	O	O	O
57.2	O	O	O
%	O	O	O
and	O	O	O
ART	O	O	O
coverage	O	O	B-T169
increased	O	O	O
from	O	O	O
31.8	O	O	O
%	O	O	O
to	O	O	O
42.8	O	O	O
%	O	O	O
.	O	O	O

Undisclosed	O	O	B-T080
HIV	O	O	B-T047
infection	O	O	I-T047
on	O	O	O
ART	O	O	B-T061
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
being	O	O	O
aged	O	O	B-T098
25	O	O	O
-	O	O	O
39	O	O	O
years	O	O	O
and	O	O	O
not	O	O	O
visiting	O	O	O
a	O	O	O
health	O	O	B-T097
provider	O	O	I-T097
in	O	O	O
the	O	O	O
past	O	O	O
year	O	O	O
,	O	O	O
while	O	O	O
younger	O	O	B-T033
age	O	O	I-T033
and	O	O	O
higher	O	O	B-T080
wealth	O	O	I-T080
was	O	O	O
associated	O	O	O
with	O	O	O
undisclosed	O	O	B-T080
ART	O	O	O
use	O	O	B-T169
.	O	O	O

Substantial	O	O	B-T078
levels	O	O	B-T080
of	O	O	O
undisclosed	O	O	B-T080
HIV	O	O	B-T047
infection	O	O	I-T047
and	O	O	O
ART	O	O	B-T061
use	O	O	B-T169
while	O	O	O
on	O	O	O
ART	O	O	O
were	O	O	O
observed	O	O	B-T169
,	O	O	O
resulting	O	O	B-T169
in	O	O	I-T169
diagnosed	O	O	B-T033
HIV	O	O	I-T033
underestimated	O	O	O
by	O	O	O
112,000	O	O	O
persons	O	O	B-T098
and	O	O	O
ART	O	O	O
coverage	O	O	B-T169
by	O	O	O
131,000	O	O	O
persons	O	O	O
.	O	O	O

Supplementing	O	O	O
self-reported	O	O	B-T062
ART	O	O	B-T061
status	O	O	B-T080
with	O	O	O
objective	O	O	B-T170
measures	O	O	I-T170
of	O	O	O
ART	O	O	O
use	O	O	B-T169
in	O	O	O
national	O	O	B-T082
population	O	O	B-T098
-based	O	O	O
sero-surveys	O	O	B-T058
can	O	O	O
improve	O	O	B-T033
monitoring	O	O	B-T058
of	O	O	O
treatment	O	O	B-T061
targets	O	O	B-T169
in	O	O	O
countries	O	O	B-T083
.	O	O	O

-DOCSTART- (27526663)

Differential	O	O	O
control	O	O	B-T080
and	O	O	O
function	O	O	B-T169
of	O	O	O
Arabidopsis	O	O	B-T002
ProDH1	O	O	B-T028
and	O	O	O
ProDH2	O	O	B-T028
genes	O	O	I-T028
on	O	O	O
infection	O	O	B-T046
with	O	O	O
biotrophic	O	O	B-T033
and	O	O	O
necrotrophic	O	O	B-T033
pathogens	O	O	O

Arabidopsis	O	O	B-T002
contains	O	O	O
two	O	O	O
proline	O	O	B-T028
dehydrogenase	O	O	I-T028
(	O	O	I-T028
ProDH	O	O	I-T028
)	O	O	I-T028
genes	O	O	I-T028
,	O	O	O
ProDH1	O	O	B-T028
and	O	O	O
ProDH2	O	O	B-T028
,	O	O	O
encoding	O	O	B-T052
for	O	O	O
homologous	O	O	B-T116
and	O	O	O
functional	O	O	B-T169
isoenzymes	O	O	B-T116
.	O	O	O

Although	O	O	O
ProDH1	O	O	B-T028
has	O	O	O
been	O	O	O
studied	O	O	O
extensively	O	O	O
,	O	O	O
especially	O	O	O
under	O	O	O
abiotic	O	O	B-T046
stress	O	O	I-T046
,	O	O	O
ProDH2	O	O	B-T028
has	O	O	O
only	O	O	O
started	O	O	O
to	O	O	O
be	O	O	O
analysed	O	O	O
in	O	O	O
recent	O	O	O
years	O	O	B-T079
.	O	O	O

These	O	O	O
genes	O	O	B-T028
display	O	O	O
distinctive	O	O	O
expression	O	O	B-T045
patterns	O	O	B-T082
and	O	O	O
show	O	O	O
weak	O	O	B-T080
transcriptional	O	O	B-T045
co-regulation	O	O	I-T045
,	O	O	O
but	O	O	O
are	O	O	O
both	O	O	O
activated	O	O	B-T052
in	O	O	O
pathogen	O	O	B-T001
-	O	O	O
infected	O	O	B-T033
tissues	O	O	B-T024
.	O	O	O

We	O	O	O
have	O	O	O
demonstrated	O	O	O
previously	O	O	O
that	O	O	O
Arabidopsis	O	O	B-T002
plants	O	O	I-T002
with	O	O	O
silenced	O	O	B-T045
ProDH1	O	O	B-T028
/	O	O	O
2	O	O	B-T028
expression	O	O	B-T045
fail	O	O	B-T169
to	O	O	O
trigger	O	O	O
defences	O	O	B-T040
against	O	O	O
the	O	O	O
hemibiotrophic	O	O	B-T033
bacterial	O	O	B-T007
pathogen	O	O	B-T001
Pseudomonas	O	O	O
syringae	O	O	O
pv	O	O	O
.	O	O	O

tomato	O	O	O
AvrRpm1	O	O	O
(	O	O	O
Pst-AvrRpm1	O	O	B-T007
)	O	O	O
,	O	O	O
and	O	O	O
that	O	O	O
ProDH1	O	O	B-T028
and	O	O	O
ProDH2	O	O	B-T028
are	O	O	O
differentially	O	O	O
regulated	O	O	B-T064
by	O	O	O
salicylic	O	O	B-T109
acid	O	O	I-T109
(	O	O	O
SA	O	O	B-T109
)	O	O	O
.	O	O	O

In	O	O	O
the	O	O	O
current	O	O	O
work	O	O	O
,	O	O	O
we	O	O	O
used	O	O	O
prodh1	O	O	B-T002
and	O	O	O
prodh2	O	O	B-T002
single-	O	O	O
mutant	O	O	B-T049
plants	O	O	B-T002
to	O	O	O
assess	O	O	O
the	O	O	O
particular	O	O	O
contribution	O	O	O
of	O	O	O
each	O	O	O
gene	O	O	B-T028
to	O	O	O
resistance	O	O	B-T169
against	O	O	O
Pst-AvrRpm1	O	O	B-T007
and	O	O	O
the	O	O	O
necrotrophic	O	O	B-T033
fungal	O	O	B-T004
pathogen	O	O	I-T004
Botrytis	O	O	B-T004
cinerea	O	O	I-T004
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
we	O	O	O
studied	O	O	O
the	O	O	O
sensitivity	O	O	B-T169
of	O	O	O
ProDH1	O	O	B-T028
and	O	O	O
ProDH2	O	O	B-T028
to	O	O	O
the	O	O	O
jasmonic	O	O	B-T109
acid	O	O	I-T109
(	O	O	O
JA	O	O	B-T109
)	O	O	O
defence	O	O	B-T040
pathway	O	O	B-T044
.	O	O	O

We	O	O	O
found	O	O	O
that	O	O	O
ProDH1	O	O	B-T116
and	O	O	O
ProDH2	O	O	B-T116
are	O	O	O
both	O	O	O
necessary	O	O	O
to	O	O	O
achieve	O	O	O
maximum	O	O	O
resistance	O	O	B-T169
against	O	O	O
Pst-AvrRpm1	O	O	B-T007
and	O	O	O
B.	O	O	B-T004
cinerea	O	O	I-T004
.	O	O	O

However	O	O	O
,	O	O	O
ProDH2	O	O	B-T116
has	O	O	O
a	O	O	O
major	O	O	O
effect	O	O	O
on	O	O	O
early	O	O	O
restriction	O	O	B-T169
of	O	O	O
B.	O	O	B-T004
cinerea	O	O	I-T004
growth	O	O	B-T040
.	O	O	O

Interestingly	O	O	O
,	O	O	O
ProDH1	O	O	B-T028
is	O	O	O
up-regulated	O	O	B-T044
by	O	O	O
SA	O	O	B-T109
and	O	O	O
JA	O	O	B-T109
,	O	O	O
whereas	O	O	O
ProDH2	O	O	B-T028
is	O	O	O
only	O	O	O
activated	O	O	B-T052
by	O	O	O
JA	O	O	O
,	O	O	O
and	O	O	O
both	O	O	O
genes	O	O	B-T028
display	O	O	O
transcriptional	O	O	B-T045
inter-regulation	O	O	I-T045
at	O	O	O
basal	O	O	B-T082
and	O	O	O
infection	O	O	B-T046
conditions	O	O	B-T080
.	O	O	O

These	O	O	O
studies	O	O	O
provide	O	O	O
the	O	O	O
first	O	O	O
evidence	O	O	O
of	O	O	O
the	O	O	O
contribution	O	O	O
of	O	O	O
ProDH2	O	O	B-T028
to	O	O	O
disease	O	O	B-T040
resistance	O	O	I-T040
,	O	O	O
and	O	O	O
describe	O	O	O
the	O	O	O
differential	O	O	O
regulation	O	O	B-T064
and	O	O	O
non-redundant	O	O	O
but	O	O	O
complementary	O	O	B-T169
function	O	O	I-T169
of	O	O	O
both	O	O	O
enzyme	O	O	B-T116
isoforms	O	O	I-T116
in	O	O	O
infected	O	O	B-T033
tissues	O	O	B-T024
,	O	O	O
providing	O	O	O
support	O	O	O
for	O	O	O
a	O	O	O
fundamental	O	O	O
role	O	O	O
of	O	O	O
ProDH	O	O	B-T028
in	O	O	O
the	O	O	O
control	O	O	O
of	O	O	O
biotrophic	O	O	B-T033
and	O	O	O
necrotrophic	O	O	B-T033
pathogens	O	O	B-T001
.	O	O	O

-DOCSTART- (27529135)

Effect	O	O	B-T080
of	O	O	O
Protein	O	O	B-T116
Repetitiveness	O	O	B-T169
on	O	O	O
Protein-Protein	O	O	B-T044
Interaction	O	O	I-T044
Prediction	O	O	B-T078
Results	O	O	B-T169
Using	O	O	O
Support	O	O	O
Vector	O	O	O
Machines	O	O	O

There	O	O	O
are	O	O	O
many	O	O	O
computational	O	O	B-T062
approaches	O	O	I-T062
to	O	O	O
predict	O	O	O
the	O	O	O
protein-protein	O	O	B-T044
interactions	O	O	I-T044
using	O	O	O
support	O	O	B-T081
vector	O	O	I-T081
machines	O	O	I-T081
(	O	O	O
SVMs	O	O	B-T081
)	O	O	O
with	O	O	O
high	O	O	O
performance	O	O	O
.	O	O	O

In	O	O	O
fact	O	O	O
,	O	O	O
performance	O	O	O
of	O	O	O
currently	O	O	O
reported	O	O	O
methods	O	O	B-T170
are	O	O	O
significantly	O	O	O
over-estimated	O	O	O
and	O	O	O
affected	O	O	O
by	O	O	O
the	O	O	O
object	O	O	O
repetitiveness	O	O	B-T169
in	O	O	O
the	O	O	O
datasets	O	O	B-T170
used	O	O	O
.	O	O	O

To	O	O	O
study	O	O	B-T062
the	O	O	O
effect	O	O	O
of	O	O	O
object	O	O	O
repetitiveness	O	O	B-T169
of	O	O	O
datasets	O	O	B-T170
on	O	O	O
predicting	O	O	B-T078
results	O	O	B-T169
.	O	O	O

We	O	O	O
present	O	O	O
novel	O	O	O
methods	O	O	B-T170
to	O	O	O
construct	O	O	O
different	O	O	O
positive	O	O	B-T033
datasets	O	O	B-T170
with	O	O	O
or	O	O	O
without	O	O	O
repeating	O	O	O
proteins	O	O	B-T116
using	O	O	O
graph	O	O	B-T170
maximum	O	O	O
matching	O	O	O
in	O	O	O
the	O	O	O
protein-protein	O	O	B-T044
interaction	O	O	I-T044
datasets	O	O	O
and	O	O	O
corresponding	O	O	O
series	O	O	O
of	O	O	O
negative	O	O	B-T033
datasets	O	O	O
with	O	O	O
different	O	O	O
proteins	O	O	O
repetitiveness	O	O	B-T169
are	O	O	O
constructed	O	O	O
using	O	O	O
graph	O	O	O
adjacency	O	O	B-T082
matrix	O	O	I-T082
.	O	O	O

The	O	O	O
relationship	O	O	B-T080
between	O	O	O
the	O	O	O
SVM	O	O	B-T081
prediction	O	O	B-T078
results	O	O	B-T169
and	O	O	O
the	O	O	O
repeated	O	O	B-T169
proteins	O	O	B-T116
(	O	O	O
repeat	O	O	O
numbers	O	O	O
and	O	O	O
repeat	O	O	O
rates	O	O	O
)	O	O	O
and	O	O	O
the	O	O	O
distributions	O	O	B-T169
of	O	O	O
repeated	O	O	O
proteins	O	O	O
in	O	O	O
the	O	O	O
datasets	O	O	B-T170
are	O	O	O
analyzed	O	O	O
.	O	O	O

Protein	O	O	B-T116
repetitiveness	O	O	B-T169
of	O	O	O
positive	O	O	B-T033
and	O	O	O
negative	O	O	B-T033
datasets	O	O	B-T170
can	O	O	O
affect	O	O	O
the	O	O	O
prediction	O	O	B-T078
result	O	O	B-T169
:	O	O	O
high	O	O	O
protein	O	O	B-T116
repetitiveness	O	O	O
of	O	O	O
positive	O	O	O
or	O	O	O
negative	O	O	O
datasets	O	O	O
yield	O	O	O
high	O	O	O
performance	O	O	O
prediction	O	O	O
result	O	O	O
.	O	O	O

This	O	O	O
indicate	O	O	O
that	O	O	O
dealing	O	O	O
with	O	O	O
object	O	O	O
repetitiveness	O	O	B-T169
of	O	O	O
datasets	O	O	B-T170
is	O	O	O
a	O	O	O
key	O	O	O
issue	O	O	O
in	O	O	O
protein-protein	O	O	B-T044
interactions	O	O	I-T044
prediction	O	O	B-T078
using	O	O	O
SVMs	O	O	B-T081
since	O	O	O
real	O	O	O
world	O	O	O
data	O	O	B-T078
contain	O	O	O
certain	O	O	O
degrees	O	O	O
of	O	O	O
repeat	O	O	B-T169
proteins	O	O	B-T116
.	O	O	O

-DOCSTART- (27530053)

From	O	O	O
'	O	O	O
sense	O	O	B-T041
of	O	O	I-T041
number	O	O	I-T041
'	O	O	O
to	O	O	O
'	O	O	O
sense	O	O	O
of	O	O	O
magnitude	O	O	B-T081
'	O	O	O
-	O	O	O
The	O	O	O
role	O	O	O
of	O	O	O
continuous	O	O	B-T078
magnitudes	O	O	B-T081
in	O	O	O
numerical	O	O	B-T081
cognition	O	O	O

In	O	O	O
this	O	O	O
review	O	O	O
,	O	O	O
we	O	O	O
are	O	O	O
pitting	O	O	B-T169
two	O	O	O
theories	O	O	B-T078
against	O	O	O
each	O	O	O
other	O	O	O
:	O	O	O
the	O	O	O
more	O	O	O
accepted	O	O	O
theory	O	O	B-T078
-the	O	O	O
'	O	O	O
number	O	O	B-T041
sense	O	O	I-T041
'	O	O	O
theory	O	O	O
-suggesting	O	O	O
that	O	O	O
a	O	O	O
sense	O	O	B-T041
of	O	O	I-T041
number	O	O	I-T041
is	O	O	O
innate	O	O	B-T055
and	O	O	O
non-symbolic	O	O	B-T041
numerosity	O	O	I-T041
is	O	O	O
being	O	O	O
processed	O	O	O
independently	O	O	O
of	O	O	O
continuous	O	O	B-T078
magnitudes	O	O	B-T081
(	O	O	O
e.g.	O	O	O
,	O	O	O
size	O	O	B-T082
,	O	O	O
area	O	O	B-T082
,	O	O	O
density	O	O	B-T081
)	O	O	O
;	O	O	O
and	O	O	O
the	O	O	O
newly	O	O	O
emerging	O	O	O
theory	O	O	O
suggesting	O	O	O
that	O	O	O
(	O	O	O
1	O	O	O
)	O	O	O
both	O	O	O
numerosities	O	O	B-T041
and	O	O	O
continuous	O	O	O
magnitudes	O	O	O
are	O	O	O
processed	O	O	O
holistically	O	O	O
when	O	O	O
comparing	O	O	O
numerosities	O	O	O
,	O	O	O
and	O	O	O
(	O	O	O
2	O	O	O
)	O	O	O
a	O	O	O
sense	O	O	O
of	O	O	O
number	O	O	O
might	O	O	O
not	O	O	O
be	O	O	O
innate	O	O	O
.	O	O	O

In	O	O	O
the	O	O	O
first	O	O	O
part	O	O	O
of	O	O	O
this	O	O	O
review	O	O	O
,	O	O	O
we	O	O	O
discuss	O	O	O
the	O	O	O
'	O	O	O
number	O	O	B-T041
sense	O	O	I-T041
'	O	O	O
theory	O	O	B-T078
.	O	O	O

Against	O	O	O
this	O	O	O
background	O	O	O
,	O	O	O
we	O	O	O
demonstrate	O	O	O
how	O	O	O
the	O	O	O
natural	O	O	O
correlation	O	O	B-T080
between	O	O	O
numerosities	O	O	B-T041
and	O	O	O
continuous	O	O	B-T078
magnitudes	O	O	B-T081
makes	O	O	O
it	O	O	O
nearly	O	O	O
impossible	O	O	O
to	O	O	O
study	O	O	O
non-symbolic	O	O	B-T041
numerosity	O	O	I-T041
processing	O	O	I-T041
in	O	O	O
isolation	O	O	O
from	O	O	O
continuous	O	O	O
magnitudes	O	O	O
,	O	O	O
and	O	O	O
therefore	O	O	O
the	O	O	O
results	O	O	O
of	O	O	O
behavioral	O	O	B-T062
and	O	O	O
imaging	O	O	B-T060
studies	O	O	I-T060
with	O	O	O
infants	O	O	B-T100
,	O	O	O
adults	O	O	B-T100
and	O	O	O
animals	O	O	B-T008
can	O	O	O
be	O	O	O
explained	O	O	O
,	O	O	O
at	O	O	O
least	O	O	O
in	O	O	O
part	O	O	O
,	O	O	O
by	O	O	O
relying	O	O	O
on	O	O	O
continuous	O	O	O
magnitudes	O	O	O
.	O	O	O

In	O	O	O
the	O	O	O
second	O	O	O
part	O	O	O
,	O	O	O
we	O	O	O
explain	O	O	O
the	O	O	O
'	O	O	O
sense	O	O	B-T041
of	O	O	I-T041
magnitude	O	O	B-T081
'	O	O	O
theory	O	O	B-T078
and	O	O	O
review	O	O	O
studies	O	O	O
that	O	O	O
directly	O	O	O
demonstrate	O	O	O
that	O	O	O
continuous	O	O	B-T078
magnitudes	O	O	B-T081
are	O	O	O
more	O	O	O
automatic	O	O	O
and	O	O	O
basic	O	O	O
than	O	O	O
numerosities	O	O	B-T041
.	O	O	O

Finally	O	O	O
,	O	O	O
we	O	O	O
present	O	O	O
outstanding	O	O	O
questions	O	O	O
.	O	O	O

Our	O	O	O
conclusion	O	O	O
is	O	O	O
that	O	O	O
there	O	O	O
is	O	O	O
not	O	O	O
enough	O	O	O
convincing	O	O	O
evidence	O	O	O
to	O	O	O
support	O	O	O
the	O	O	O
number	O	O	B-T041
sense	O	O	I-T041
theory	O	O	B-T078
anymore	O	O	O
.	O	O	O

Therefore	O	O	O
,	O	O	O
we	O	O	O
encourage	O	O	O
researchers	O	O	O
not	O	O	O
to	O	O	O
assume	O	O	O
that	O	O	O
number	O	O	B-T041
sense	O	O	I-T041
is	O	O	O
simply	O	O	O
innate	O	O	B-T055
,	O	O	O
but	O	O	O
to	O	O	O
put	O	O	O
this	O	O	O
hypothesis	O	O	B-T078
to	O	O	O
the	O	O	O
test	O	O	O
,	O	O	O
and	O	O	O
to	O	O	O
consider	O	O	O
if	O	O	O
such	O	O	O
an	O	O	O
assumption	O	O	O
is	O	O	O
even	O	O	O
testable	O	O	O
in	O	O	O
light	O	O	O
of	O	O	O
the	O	O	O
correlation	O	O	B-T080
of	O	O	O
numerosity	O	O	B-T041
and	O	O	O
continuous	O	O	B-T078
magnitudes	O	O	B-T081
.	O	O	O

-DOCSTART- (27532007)

How	O	O	O
Integrated	O	O	B-T059
Management	O	O	I-T059
Strategies	O	O	I-T059
Promote	O	O	B-T052
Protein	O	O	B-T116
Quality	O	O	B-T080
of	O	O	O
Cotton	O	O	B-T002
Embryos	O	O	I-T002
:	O	O	O
High	O	O	B-T080
Levels	O	O	B-T080
of	O	O	O
Soil	O	O	B-T167
Available	O	O	B-T169
N	O	O	B-T123
,	O	O	O
N	O	O	O
Assimilation	O	O	B-T070
and	O	O	O
Protein	O	O	O
Accumulation	O	O	B-T033
Rate	O	O	O

Cottonseed	O	O	B-T002
is	O	O	O
widely	O	O	O
used	O	O	O
as	O	O	O
a	O	O	O
source	O	O	B-T033
of	O	O	O
ruminant	O	O	B-T015
feed	O	O	B-T168
and	O	O	O
for	O	O	O
industrial	O	O	B-T057
purposes	O	O	B-T169
.	O	O	O

Therefore	O	O	O
,	O	O	O
there	O	O	O
is	O	O	O
a	O	O	O
tremendous	O	O	O
need	O	O	O
to	O	O	O
improve	O	O	B-T033
the	O	O	O
nutritional	O	O	B-T080
value	O	O	I-T080
of	O	O	O
cotton	O	O	B-T002
embryos	O	O	I-T002
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
a	O	O	O
conventional	O	O	B-T059
management	O	O	I-T059
(	O	O	O
CM	O	O	B-T059
)	O	O	O
and	O	O	O
two	O	O	O
integrated	O	O	O
cotton	O	O	B-T002
management	O	O	B-T059
strategies	O	O	I-T059
(	O	O	O
IMS1	O	O	B-T059
,	O	O	O
IMS2	O	O	B-T059
)	O	O	O
were	O	O	O
performed	O	O	B-T169
at	O	O	O
two	O	O	O
soil	O	O	B-T167
fertility	O	O	B-T033
levels	O	O	B-T080
to	O	O	O
study	O	O	O
the	O	O	O
relationships	O	O	B-T080
among	O	O	O
soil	O	O	O
N	O	O	B-T123
,	O	O	O
N	O	O	O
assimilation	O	O	B-T070
,	O	O	O
embryonic	O	O	B-T002
protein	O	O	B-T116
accumulation	O	O	B-T033
and	O	O	O
protein	O	O	O
quality	O	O	B-T080
.	O	O	O

The	O	O	O
levels	O	O	B-T059
of	O	O	I-T059
proteins	O	O	I-T059
,	O	O	O
essential	O	O	B-T059
amino	O	O	I-T059
acids	O	O	I-T059
,	O	O	O
and	O	O	O
semi-essential	O	O	B-T059
amino	O	O	I-T059
acids	O	O	I-T059
,	O	O	O
especially	O	O	O
those	O	O	O
of	O	O	O
glutamate	O	O	B-T059
,	O	O	O
lysine	O	O	B-T059
,	O	O	O
and	O	O	O
methionine	O	O	B-T059
,	O	O	O
were	O	O	O
higher	O	O	B-T080
in	O	O	O
IMS1	O	O	B-T059
and	O	O	O
IMS2	O	O	B-T059
embryos	O	O	B-T002
than	O	O	O
in	O	O	O
CM	O	O	B-T059
embryos	O	O	O
.	O	O	O

These	O	O	O
changes	O	O	B-T169
were	O	O	O
significantly	O	O	O
positively	O	O	B-T033
correlated	O	O	B-T080
with	O	O	O
the	O	O	O
soil	O	O	B-T167
-	O	O	O
available	O	O	B-T169
N	O	O	B-T059
content	O	O	I-T059
,	O	O	O
glutamine	O	O	B-T044
synthetase	O	O	I-T044
activity	O	O	I-T044
and	O	O	O
peak	O	O	B-T080
value	O	O	O
of	O	O	O
protein	O	O	B-T116
accumulation	O	O	B-T033
rate	O	O	B-T081
and	O	O	O
were	O	O	O
negatively	O	O	B-T033
correlated	O	O	O
with	O	O	O
the	O	O	O
free	O	O	B-T080
amino	O	O	B-T059
acid	O	O	I-T059
level	O	O	I-T059
.	O	O	O

These	O	O	O
results	O	O	B-T033
illustrated	O	O	O
that	O	O	O
integrated	O	O	B-T059
management	O	O	I-T059
strategies	O	O	I-T059
,	O	O	O
especially	O	O	O
the	O	O	O
rates	O	O	B-T081
and	O	O	O
timing	O	O	B-T079
of	O	O	O
N	O	O	B-T123
application	O	O	B-T169
,	O	O	O
raise	O	O	B-T169
the	O	O	O
level	O	O	B-T080
of	O	O	O
soil	O	O	B-T167
available	O	O	B-T169
N	O	O	O
,	O	O	O
which	O	O	O
is	O	O	O
beneficial	O	O	O
for	O	O	O
N	O	O	O
assimilation	O	O	B-T070
in	O	O	O
developing	O	O	O
cotton	O	O	B-T002
embryos	O	O	I-T002
.	O	O	O

The	O	O	O
protein	O	O	B-T116
content	O	O	I-T059
was	O	O	O
limited	O	O	B-T169
by	O	O	O
the	O	O	O
rate	O	O	B-T081
of	O	O	O
protein	O	O	O
accumulation	O	O	B-T033
rather	O	O	O
than	O	O	O
by	O	O	O
the	O	O	O
free	O	O	B-T080
amino	O	O	B-T059
acid	O	O	I-T059
content	O	O	I-T059
.	O	O	O

The	O	O	O
combination	O	O	B-T080
of	O	O	O
target	O	O	B-T081
yield	O	O	I-T081
fertilization	O	O	B-T070
,	O	O	O
a	O	O	O
growth	O	O	B-T040
-driven	O	O	O
N	O	O	B-T123
application	O	O	B-T169
schedule	O	O	O
,	O	O	O
a	O	O	O
high	O	O	B-T080
plant	O	O	B-T002
density	O	O	B-T081
and	O	O	O
the	O	O	O
seedling	O	O	B-T002
raising	O	O	O
with	O	O	O
bio-organic	O	O	B-T167
fertilizer	O	O	I-T167
can	O	O	O
substantially	O	O	O
improve	O	O	B-T033
protein	O	O	B-T116
quality	O	O	B-T080
in	O	O	O
cotton	O	O	B-T002
embryos	O	O	I-T002
,	O	O	O
especially	O	O	O
at	O	O	O
a	O	O	O
soil	O	O	B-T167
with	O	O	O
low	O	O	O
soil	O	O	O
organic	O	O	B-T109
matter	O	O	I-T109
and	O	O	O
total	O	O	B-T080
nitrogen	O	O	B-T123
.	O	O	O

-DOCSTART- (27533401)

Help	O	O	O
end	O	O	O
the	O	O	O
HIV	O	O	B-T005
epidemic	O	O	O

After	O	O	O
many	O	O	O
delays	O	O	O
,	O	O	O
the	O	O	O
public	O	O	B-T061
consultation	O	O	I-T061
on	O	O	O
HIV	O	O	B-T061
prevention	O	O	I-T061
tool	O	O	B-T170
PrEP	O	O	B-T061
(	O	O	O
pre-exposure	O	O	B-T061
prophylaxis	O	O	I-T061
)	O	O	O
is	O	O	O
finally	O	O	O
here	O	O	O
.	O	O	O

Now	O	O	O
is	O	O	O
the	O	O	O
time	O	O	O
to	O	O	O
mobilise	O	O	O
-	O	O	O
help	O	O	O
end	O	O	O
the	O	O	O
HIV	O	O	B-T005
epidemic	O	O	B-T067
by	O	O	O
responding	O	O	O
to	O	O	O
this	O	O	O
NHS	O	O	B-T058
England	O	O	I-T058
consultation	O	O	I-T058
before	O	O	O
23	O	O	O
September	O	O	B-T079
.	O	O	O

-DOCSTART- (27534399)

Osseointegration	O	O	B-T042
behavior	O	O	O
of	O	O	O
novel	O	O	B-T080
Ti-Nb-Zr-Ta-Si	O	O	B-T122
alloy	O	O	I-T122
for	O	O	O
dental	O	O	B-T074
implants	O	O	I-T074
:	O	O	O
an	O	O	O
in	O	O	B-T082
vivo	O	O	I-T082
study	O	O	O

This	O	O	O
study	O	O	O
aimed	O	O	O
to	O	O	O
evaluate	O	O	B-T058
the	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
Ti-Nb-Zr-Ta-Si	O	O	B-T122
alloy	O	O	I-T122
implants	O	O	B-T074
on	O	O	O
mineral	O	O	B-T081
apposition	O	O	I-T081
rate	O	O	I-T081
and	O	O	O
new	O	O	O
BIC	O	O	B-T081
contact	O	O	I-T081
in	O	O	O
rabbits	O	O	B-T015
.	O	O	O

Twelve	O	O	O
Ti-Nb-Zr-Ta-Si	O	O	B-T122
alloy	O	O	I-T122
implants	O	O	B-T074
were	O	O	O
fabricated	O	O	B-T169
and	O	O	O
placed	O	O	B-T058
into	O	O	O
the	O	O	O
right	O	O	B-T082
femur	O	O	B-T023
sites	O	O	B-T029
in	O	O	O
six	O	O	O
rabbits	O	O	B-T015
,	O	O	O
and	O	O	O
commercially	O	O	O
pure	O	O	O
titanium	O	O	B-T196
implants	O	O	O
were	O	O	O
used	O	O	O
as	O	O	O
controls	O	O	B-T096
in	O	O	O
the	O	O	O
left	O	O	B-T082
femur	O	O	O
.	O	O	O

Tetracycline	O	O	B-T195
and	O	O	O
alizarin	O	O	B-T109
red	O	O	I-T109
were	O	O	O
administered	O	O	O
3	O	O	O
weeks	O	O	B-T079
and	O	O	O
1	O	O	O
week	O	O	B-T079
before	O	O	O
euthanization	O	O	B-T058
,	O	O	O
respectively	O	O	O
.	O	O	O

At	O	O	O
4	O	O	O
weeks	O	O	B-T079
and	O	O	O
8	O	O	O
weeks	O	O	O
after	O	O	O
implantation	O	O	B-T061
,	O	O	O
animals	O	O	B-T008
were	O	O	O
euthanized	O	O	B-T058
,	O	O	O
respectively	O	O	O
.	O	O	O

Surface	O	O	B-T082
characterization	O	O	B-T052
and	O	O	O
implant-bone	O	O	B-T081
contact	O	O	I-T081
surface	O	O	B-T082
analysis	O	O	B-T062
were	O	O	O
performed	O	O	B-T169
by	O	O	O
using	O	O	O
a	O	O	O
scanning	O	O	B-T074
electron	O	O	I-T074
microscope	O	O	I-T074
and	O	O	O
an	O	O	O
energy	O	O	B-T074
dispersive	O	O	I-T074
X-ray	O	O	I-T074
detector	O	O	I-T074
.	O	O	O

Mineral	O	O	B-T081
apposition	O	O	I-T081
rate	O	O	I-T081
was	O	O	O
evaluated	O	O	B-T058
using	O	O	O
a	O	O	O
confocal	O	O	B-T059
laser	O	O	I-T059
scanning	O	O	I-T059
microscope	O	O	I-T059
.	O	O	O

Toluidine	O	O	B-T059
blue	O	O	I-T059
staining	O	O	I-T059
was	O	O	O
performed	O	O	B-T169
on	O	O	O
undecalcified	O	O	B-T033
sections	O	O	B-T167
for	O	O	O
histology	O	O	B-T091
and	O	O	O
histomorphology	O	O	B-T080
evaluation	O	O	O
.	O	O	O

Scanning	O	O	B-T074
electron	O	O	I-T074
microscope	O	O	I-T074
and	O	O	O
histomorphology	O	O	B-T080
observation	O	O	B-T078
revealed	O	O	B-T080
a	O	O	O
direct	O	O	B-T169
contact	O	O	I-T169
between	O	O	O
implants	O	O	B-T074
and	O	O	O
bone	O	O	B-T023
of	O	O	O
all	O	O	O
groups	O	O	B-T078
.	O	O	O

After	O	O	O
a	O	O	O
healing	O	O	B-T040
period	O	O	B-T079
of	O	O	O
4	O	O	O
weeks	O	O	B-T079
,	O	O	O
Ti-Nb-Zr-Ta-Si	O	O	B-T122
alloy	O	O	I-T122
implants	O	O	B-T074
showed	O	O	O
significantly	O	O	O
higher	O	O	O
mineral	O	O	B-T081
apposition	O	O	I-T081
rate	O	O	I-T081
compared	O	O	O
to	O	O	O
commercially	O	O	O
pure	O	O	O
titanium	O	O	B-T196
implants	O	O	O
(	O	O	O
P	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
,	O	O	O
whereas	O	O	O
there	O	O	O
was	O	O	O
no	O	O	B-T033
significant	O	O	I-T033
difference	O	O	O
between	O	O	O
Ti-Nb-Zr-Ta-Si	O	O	O
alloy	O	O	O
implants	O	O	O
and	O	O	O
commercially	O	O	O
pure	O	O	O
titanium	O	O	O
implants	O	O	O
(	O	O	O
P	O	O	O
>	O	O	O
0.05	O	O	O
)	O	O	O
at	O	O	O
8	O	O	O
weeks	O	O	O
.	O	O	O

No	O	O	B-T033
significant	O	O	I-T033
difference	O	O	O
of	O	O	O
bone-to-implant	O	O	B-T081
contact	O	O	I-T081
was	O	O	O
observed	O	O	B-T169
between	O	O	O
Ti-Nb-Zr-Ta-Si	O	O	B-T122
alloy	O	O	I-T122
implants	O	O	B-T074
and	O	O	O
commercially	O	O	O
pure	O	O	O
titanium	O	O	B-T196
implants	O	O	O
implants	O	O	O
after	O	O	O
a	O	O	O
healing	O	O	B-T040
period	O	O	B-T079
of	O	O	O
4	O	O	O
weeks	O	O	B-T079
and	O	O	O
8	O	O	O
weeks	O	O	O
.	O	O	O

This	O	O	O
study	O	O	O
showed	O	O	O
that	O	O	O
Ti-Nb-Zr-Ta-Si	O	O	B-T122
alloy	O	O	I-T122
implants	O	O	B-T074
could	O	O	O
establish	O	O	O
a	O	O	O
close	O	O	B-T169
direct	O	O	I-T169
contact	O	O	I-T169
comparedto	O	O	O
commercially	O	O	O
pure	O	O	O
titanium	O	O	B-T196
implants	O	O	O
implants	O	O	O
,	O	O	O
improved	O	O	B-T033
mineral	O	O	B-T081
matrix	O	O	I-T081
apposition	O	O	I-T081
rate	O	O	I-T081
,	O	O	O
and	O	O	O
may	O	O	O
someday	O	O	O
be	O	O	O
an	O	O	O
alternative	O	O	B-T077
as	O	O	O
a	O	O	O
material	O	O	B-T167
for	O	O	O
dental	O	O	B-T074
implants	O	O	I-T074
.	O	O	O

-DOCSTART- (27534734)

Simultaneous	O	O	B-T079
edited	O	O	B-T077
MRS	O	O	B-T060
of	O	O	O
GABA	O	O	B-T116
and	O	O	O
glutathione	O	O	O

Edited	O	O	B-T077
MRS	O	O	B-T060
allows	O	O	O
the	O	O	O
detection	O	O	B-T061
of	O	O	O
low	O	O	B-T080
-	O	O	O
concentration	O	O	B-T081
metabolites	O	O	B-T123
,	O	O	O
whose	O	O	O
signals	O	O	B-T067
are	O	O	O
not	O	O	B-T169
resolved	O	O	B-T077
in	O	O	O
the	O	O	O
MR	O	O	B-T060
spectrum	O	O	I-T060
.	O	O	O

Tailored	O	O	B-T052
acquisitions	O	O	I-T052
can	O	O	O
be	O	O	O
designed	O	O	B-T090
to	O	O	O
detect	O	O	B-T061
,	O	O	O
for	O	O	O
example	O	O	B-T077
,	O	O	O
the	O	O	O
inhibitory	O	O	B-T052
neurotransmitter	O	O	B-T123
Î³-aminobutyric	O	O	B-T116
acid	O	O	I-T116
(	O	O	O
GABA	O	O	B-T116
)	O	O	O
,	O	O	O
or	O	O	O
the	O	O	O
reduction-oxidation	O	O	B-T044
(	O	O	O
redox	O	O	B-T044
)	O	O	O
compound	O	O	O
glutathione	O	O	B-T116
(	O	O	O
GSH	O	O	B-T116
)	O	O	O
,	O	O	O
and	O	O	O
single	O	O	B-T081
-	O	O	O
voxel	O	O	B-T077
edited	O	O	B-T077
experiments	O	O	B-T062
are	O	O	O
generally	O	O	O
acquired	O	O	O
at	O	O	O
a	O	O	O
rate	O	O	B-T081
of	O	O	O
one	O	O	B-T081
metabolite	O	O	B-T123
-	O	O	O
per-experiment	O	O	B-T062
.	O	O	O

We	O	O	O
demonstrate	O	O	O
that	O	O	O
simultaneous	O	O	B-T079
detection	O	O	B-T061
of	O	O	O
the	O	O	O
overlapping	O	O	B-T079
signals	O	O	B-T067
of	O	O	O
GABA	O	O	B-T116
and	O	O	O
GSH	O	O	B-T116
is	O	O	O
possible	O	O	O
using	O	O	B-T169
Hadamard	O	O	B-T059
Encoding	O	O	I-T059
and	O	O	I-T059
Reconstruction	O	O	I-T059
of	O	O	I-T059
Mega-Edited	O	O	I-T059
Spectroscopy	O	O	I-T059
(	O	O	O
HERMES	O	O	B-T059
)	O	O	O
.	O	O	O

HERMES	O	O	B-T059
applies	O	O	B-T169
orthogonal	O	O	B-T052
editing	O	O	I-T052
encoding	O	O	I-T052
(	O	O	O
following	O	O	B-T079
a	O	O	O
Hadamard	O	O	B-T170
scheme	O	O	I-T170
)	O	O	O
,	O	O	O
such	O	O	O
that	O	O	O
GSH-	O	O	B-T116
and	O	O	O
GABA	O	O	B-T116
-	O	O	O
edited	O	O	B-T077
difference	O	O	B-T080
spectra	O	O	B-T077
can	O	O	O
be	O	O	O
reconstructed	O	O	O
from	O	O	O
a	O	O	O
single	O	O	B-T062
multiplexed	O	O	I-T062
experiment	O	O	I-T062
.	O	O	O

At	O	O	O
a	O	O	O
TE	O	O	B-T079
of	O	O	O
80ms	O	O	O
,	O	O	O
20-ms	O	O	O
editing	O	O	B-T077
pulses	O	O	B-T067
are	O	O	O
applied	O	O	B-T169
at	O	O	O
4.56ppm	O	O	O
(	O	O	O
on	O	O	O
GSH),1.9ppm	O	O	O
(	O	O	O
on	O	O	O
GABA	O	O	B-T116
)	O	O	O
,	O	O	O
both	O	O	B-T080
offsets	O	O	B-T081
(	O	O	O
using	O	O	O
a	O	O	O
dual-lobe	O	O	B-T067
cosine-modulated	O	O	I-T067
pulse	O	O	I-T067
)	O	O	O
or	O	O	O
neither	O	O	O
.	O	O	O

Hadamard	O	O	B-T170
combinations	O	O	I-T170
of	O	O	O
the	O	O	O
four	O	O	O
sub-experiments	O	O	B-T062
yield	O	O	O
GABA	O	O	B-T116
and	O	O	O
GSH	O	O	B-T116
difference	O	O	B-T080
spectra	O	O	B-T077
.	O	O	O

It	O	O	O
is	O	O	O
shown	O	O	O
that	O	O	O
HERMES	O	O	B-T059
gives	O	O	O
excellent	O	O	B-T080
separation	O	O	B-T080
of	O	O	O
the	O	O	O
edited	O	O	B-T077
GABA	O	O	B-T116
and	O	O	O
GSH	O	O	B-T116
signals	O	O	B-T067
in	O	O	O
phantoms	O	O	B-T073
,	O	O	O
and	O	O	O
resulting	O	O	O
edited	O	O	O
lineshapes	O	O	B-T080
agree	O	O	B-T033
well	O	O	B-T080
with	O	O	O
separate	O	O	B-T080
Mescher-Garwood	O	O	B-T059
Point-resolved	O	O	I-T059
Spectroscopy	O	O	I-T059
(	O	O	O
MEGA-PRESS	O	O	B-T059
)	O	O	O
acquisitions	O	O	B-T052
.	O	O	O

In	O	O	B-T082
vivo	O	O	I-T082
,	O	O	O
the	O	O	O
quality	O	O	B-T080
and	O	O	O
signal-to-noise	O	O	B-T081
ratio	O	O	I-T081
(	O	O	O
SNR	O	O	B-T081
)	O	O	O
of	O	O	O
HERMES	O	O	B-T059
spectra	O	O	B-T077
are	O	O	O
similar	O	O	B-T080
to	O	O	O
those	O	O	O
of	O	O	O
sequentially	O	O	B-T080
acquired	O	O	B-T080
MEGA-PRESS	O	O	B-T059
spectra	O	O	O
,	O	O	O
with	O	O	O
the	O	O	O
benefit	O	O	B-T081
of	O	O	O
saving	O	O	O
half	O	O	O
the	O	O	O
acquisition	O	O	B-T052
time	O	O	B-T079
.	O	O	O

-DOCSTART- (27535586)

Chitosan	O	O	B-T109
-functionalised	O	O	O
poly(2-hydroxyethyl	O	O	B-T109
methacrylate	O	O	I-T109
)	O	O	I-T109
core-shell	O	O	B-T122
microgels	O	O	I-T122
as	O	O	O
drug	O	O	B-T074
delivery	O	O	I-T074
carriers	O	O	I-T074
:	O	O	O
salicylic	O	O	B-T109
acid	O	O	I-T109
loading	O	O	O
and	O	O	O
release	O	O	O

This	O	O	O
work	O	O	O
presents	O	O	O
the	O	O	O
evaluation	O	O	O
of	O	O	O
chitosan	O	O	B-T109
-functionalised	O	O	O
poly(2-hydroxyethyl	O	O	B-T109
methacrylate	O	O	I-T109
)	O	O	I-T109
(	O	O	O
CS	O	O	B-T109
/	O	O	O
PHEMA	O	O	B-T109
)	O	O	O
core-shell	O	O	B-T122
microgels	O	O	I-T122
as	O	O	O
drug	O	O	B-T074
delivery	O	O	I-T074
carriers	O	O	I-T074
.	O	O	O

CS	O	O	B-T109
/	O	O	O
PHEMA	O	O	B-T109
microgels	O	O	B-T122
were	O	O	O
prepared	O	O	O
by	O	O	O
emulsifier-free	O	O	B-T067
emulsion	O	O	I-T067
polymerisation	O	O	I-T067
with	O	O	O
N	O	O	B-T109
,	O	O	I-T109
N	O	O	I-T109
'	O	O	I-T109
-methylenebisacrylamide	O	O	I-T109
(	O	O	O
MBA	O	O	B-T109
)	O	O	O
as	O	O	O
a	O	O	O
crosslinker	O	O	B-T109
.	O	O	O

The	O	O	O
study	O	O	B-T062
on	O	O	I-T062
drug	O	O	I-T062
loading	O	O	I-T062
,	O	O	O
using	O	O	O
salicylic	O	O	B-T109
acid	O	O	I-T109
(	O	O	O
SA	O	O	B-T109
)	O	O	O
as	O	O	O
a	O	O	O
model	O	O	B-T121
drug	O	O	I-T121
,	O	O	O
was	O	O	O
performed	O	O	O
.	O	O	O

The	O	O	O
results	O	O	O
showed	O	O	O
that	O	O	O
the	O	O	O
encapsulation	O	O	B-T067
efficiency	O	O	I-T067
(	O	O	O
EE	O	O	B-T067
)	O	O	O
increased	O	O	O
as	O	O	O
drug	O	O	B-T121
-to-	O	O	O
microgel	O	O	O
ratio	O	O	B-T081
was	O	O	O
increased	O	O	O
.	O	O	O

Higher	O	O	O
EE	O	O	B-T067
can	O	O	O
be	O	O	O
achieved	O	O	O
with	O	O	O
the	O	O	O
increase	O	O	O
in	O	O	O
degree	O	O	O
of	O	O	O
crosslinking	O	O	B-T067
,	O	O	O
by	O	O	O
increasing	O	O	O
the	O	O	O
amount	O	O	O
of	O	O	O
MBA	O	O	B-T109
from	O	O	O
0.01	O	O	O
g	O	O	O
to	O	O	O
0.03	O	O	O
g.	O	O	O
In	O	O	O
addition	O	O	O
,	O	O	O
the	O	O	O
highest	O	O	O
EE	O	O	O
(	O	O	O
61.1	O	O	O
%	O	O	O
)	O	O	O
was	O	O	O
observed	O	O	O
at	O	O	O
pH	O	O	B-T081
3	O	O	O
.	O	O	O

The	O	O	O
highest	O	O	O
release	O	O	B-T070
of	O	O	I-T070
SA	O	O	I-T070
(	O	O	O
60	O	O	O
%	O	O	O
)	O	O	O
was	O	O	O
noticed	O	O	O
at	O	O	O
pH	O	O	B-T081
2.4	O	O	O
,	O	O	O
while	O	O	O
the	O	O	O
lowest	O	O	O
one	O	O	O
(	O	O	O
49.4	O	O	O
%	O	O	O
)	O	O	O
was	O	O	O
obtained	O	O	O
at	O	O	O
pH	O	O	O
7.4	O	O	O
.	O	O	O

Moreover	O	O	O
,	O	O	O
the	O	O	O
highest	O	O	O
release	O	O	B-T070
of	O	O	I-T070
SA	O	O	I-T070
was	O	O	O
enhanced	O	O	O
by	O	O	O
the	O	O	O
presence	O	O	O
of	O	O	O
0.2	O	O	O
M	O	O	O
NaCl	O	O	B-T121
.	O	O	O

The	O	O	O
pH	O	O	B-T081
-	O	O	O
and	O	O	O
ionic-sensitivity	O	O	B-T080
of	O	O	O
CS	O	O	B-T109
/	O	O	O
PHEMA	O	O	B-T109
could	O	O	O
be	O	O	O
useful	O	O	O
as	O	O	O
a	O	O	O
sustained	O	O	B-T121
release	O	O	I-T121
delivery	O	O	I-T121
device	O	O	I-T121
,	O	O	O
especially	O	O	O
for	O	O	O
oral	O	O	B-T074
delivery	O	O	I-T074
.	O	O	O

-DOCSTART- (27536475)

Breast	O	O	B-T061
Augmentation	O	O	I-T061
after	O	O	O
Conservation	O	O	B-T061
Surgery	O	O	I-T061
and	O	O	O
Radiation	O	O	O
Therapy	O	O	O

There	O	O	O
is	O	O	O
a	O	O	O
paucity	O	O	O
of	O	O	O
data	O	O	O
regarding	O	O	O
outcomes	O	O	O
for	O	O	O
patients	O	O	B-T101
undergoing	O	O	O
breast	O	O	B-T061
augmentation	O	O	I-T061
with	O	O	O
implants	O	O	B-T074
after	O	O	O
breast	O	O	B-T061
conservation	O	O	I-T061
surgery	O	O	I-T061
(	O	O	O
BCS	O	O	B-T061
)	O	O	O
and	O	O	O
radiotherapy	O	O	B-T061
.	O	O	O

This	O	O	O
retrospective	O	O	B-T062
study	O	O	I-T062
examined	O	O	O
outcomes	O	O	O
for	O	O	O
patients	O	O	B-T101
with	O	O	O
breast	O	O	B-T074
implant	O	O	I-T074
-only	O	O	O
augmentation	O	O	B-T061
after	O	O	O
BCS	O	O	B-T061
and	O	O	O
radiotherapy	O	O	B-T061
.	O	O	O

Between	O	O	O
June	O	O	O
1998	O	O	O
and	O	O	O
December	O	O	O
2010	O	O	O
,	O	O	O
671	O	O	O
women	O	O	B-T098
underwent	O	O	O
prosthetic	O	O	B-T074
breast	O	O	B-T061
reconstruction	O	O	I-T061
.	O	O	O

Nineteen	O	O	O
patients	O	O	B-T101
(	O	O	O
2.8	O	O	O
%	O	O	O
)	O	O	O
underwent	O	O	O
an	O	O	O
augmentation	O	O	B-T061
after	O	O	O
BCS	O	O	B-T061
and	O	O	O
radiotherapy	O	O	B-T061
.	O	O	O

The	O	O	O
mean	O	O	B-T081
age	O	O	B-T032
was	O	O	O
55.8	O	O	O
years	O	O	B-T079
(	O	O	O
range	O	O	B-T081
,	O	O	O
40	O	O	O
-	O	O	O
69	O	O	O
years	O	O	O
)	O	O	O
.	O	O	O

Sixteen	O	O	O
of	O	O	O
these	O	O	O
patients	O	O	B-T101
underwent	O	O	O
one-stage	O	O	B-T061
implant	O	O	I-T061
-only	O	O	O
breast	O	O	B-T061
augmentation	O	O	I-T061
,	O	O	O
whereas	O	O	O
3	O	O	O
patients	O	O	O
underwent	O	O	O
two-stage	O	O	B-T061
expander	O	O	I-T061
and	O	O	O
then	O	O	O
implant	O	O	B-T061
augmentation	O	O	I-T061
.	O	O	O

All	O	O	O
surgeries	O	O	B-T061
were	O	O	O
successful	O	O	O
.	O	O	O

The	O	O	O
average	O	O	O
size	O	O	O
of	O	O	O
breast	O	O	B-T074
implant	O	O	I-T074
used	O	O	O
was	O	O	O
258.7	O	O	O
ï¿½	O	O	O
â¬â°g	O	O	O
.	O	O	O

Seven	O	O	O
patients	O	O	B-T101
also	O	O	O
received	O	O	O
contralateral	O	O	B-T082
augmentation	O	O	B-T061
with	O	O	O
an	O	O	O
average	O	O	O
implant	O	O	O
size	O	O	O
of	O	O	O
232.2	O	O	O
ï¿½	O	O	O
â¬â°g	O	O	O
.	O	O	O

One	O	O	O
patient	O	O	B-T101
received	O	O	O
oral	O	O	B-T169
antibiotics	O	O	B-T195
for	O	O	O
minor	O	O	O
wound	O	O	B-T046
infection	O	O	I-T046
.	O	O	O

Patients	O	O	B-T101
were	O	O	O
judged	O	O	O
to	O	O	O
have	O	O	O
an	O	O	O
excellent	O	O	O
(	O	O	O
14/19	O	O	O
;	O	O	O
73.7	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
good	O	O	O
(	O	O	O
3/19	O	O	O
;	O	O	O
15.8	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
or	O	O	O
fair	O	O	O
(	O	O	O
2/19	O	O	O
;	O	O	O
10.5	O	O	O
%	O	O	O
)	O	O	O
cosmetic	O	O	B-T033
result	O	O	B-T169
.	O	O	O

The	O	O	O
breasts	O	O	B-T023
of	O	O	O
selected	O	O	O
patients	O	O	B-T101
with	O	O	O
breast	O	O	B-T191
cancer	O	O	I-T191
after	O	O	O
BCS	O	O	B-T061
and	O	O	O
radiotherapy	O	O	B-T061
.	O	O	O

with	O	O	O
asymmetry	O	O	O
can	O	O	O
be	O	O	O
adequately	O	O	O
augmented	O	O	B-T081
with	O	O	O
breast	O	O	B-T074
implants	O	O	I-T074
alone	O	O	O
.	O	O	O

-DOCSTART- (27538372)

Mitochondrial	O	O	B-T028
pyruvate	O	O	I-T028
dehydrogenase	O	O	I-T028
phosphatase	O	O	I-T028
1	O	O	I-T028
regulates	O	O	O
the	O	O	O
early	O	O	O
differentiation	O	O	B-T043
of	O	O	I-T043
cardiomyocytes	O	O	I-T043
from	O	O	O
mouse	O	O	O
embryonic	O	O	O
stem	O	O	O
cells	O	O	O

Mitochondria	O	O	B-T026
are	O	O	O
crucial	O	O	O
for	O	O	O
maintaining	O	O	O
the	O	O	O
properties	O	O	O
of	O	O	O
embryonic	O	O	B-T025
stem	O	O	I-T025
cells	O	O	I-T025
(	O	O	O
ESCs	O	O	B-T025
)	O	O	O
and	O	O	O
for	O	O	O
regulating	O	O	O
their	O	O	O
subsequent	O	O	O
differentiation	O	O	B-T043
into	O	O	O
diverse	O	O	O
cell	O	O	B-T078
lineages	O	O	I-T078
,	O	O	O
including	O	O	O
cardiomyocytes	O	O	B-T025
.	O	O	O

However	O	O	O
,	O	O	O
mitochondrial	O	O	B-T123
regulators	O	O	I-T123
that	O	O	O
manage	O	O	O
the	O	O	O
rate	O	O	B-T081
of	O	O	I-T081
differentiation	O	O	I-T081
or	O	O	O
cell	O	O	B-T043
fate	O	O	I-T043
have	O	O	O
been	O	O	O
rarely	O	O	O
identified	O	O	O
.	O	O	O

This	O	O	O
study	O	O	O
aimed	O	O	O
to	O	O	O
determine	O	O	O
the	O	O	O
potential	O	O	O
mitochondrial	O	O	B-T116
factor	O	O	I-T116
that	O	O	O
controls	O	O	O
the	O	O	O
differentiation	O	O	B-T043
of	O	O	I-T043
ESCs	O	O	I-T043
into	O	O	O
cardiac	O	O	B-T025
myocytes	O	O	I-T025
.	O	O	O

We	O	O	O
induced	O	O	O
cardiomyocyte	O	O	B-T043
differentiation	O	O	I-T043
from	O	O	O
mouse	O	O	B-T025
ESCs	O	O	I-T025
(	O	O	O
mESCs	O	O	B-T025
)	O	O	O
and	O	O	O
performed	O	O	O
microarray	O	O	B-T059
assays	O	O	I-T059
to	O	O	O
assess	O	O	O
messenger	O	O	B-T114
RNA	O	O	I-T114
(	O	O	O
mRNA	O	O	B-T114
)	O	O	O
expression	O	O	B-T045
changes	O	O	O
at	O	O	O
differentiation	O	O	B-T033
day	O	O	I-T033
8	O	O	I-T033
(	O	O	O
D8	O	O	B-T033
)	O	O	O
compared	O	O	O
with	O	O	O
undifferentiated	O	O	B-T080
mESCs	O	O	O
(	O	O	O
D0	O	O	O
)	O	O	O
.	O	O	O

Among	O	O	O
the	O	O	O
differentially	O	O	O
expressed	O	O	B-T028
genes	O	O	I-T028
,	O	O	O
Pdp1	O	O	B-T028
expression	O	O	B-T045
was	O	O	O
significantly	O	O	O
decreased	O	O	O
(	O	O	O
27-fold	O	O	O
)	O	O	O
on	O	O	O
D8	O	O	B-T033
compared	O	O	O
to	O	O	O
D0	O	O	B-T080
,	O	O	O
which	O	O	O
was	O	O	O
accompanied	O	O	O
by	O	O	O
suppressed	O	O	B-T169
mitochondrial	O	O	B-T026
indices	O	O	B-T170
,	O	O	O
including	O	O	O
ATP	O	O	B-T114
levels	O	O	O
,	O	O	O
membrane	O	O	B-T043
potential	O	O	I-T043
,	O	O	O
ROS	O	O	B-T044
and	O	O	O
mitochondrial	O	O	B-T043
Ca(2	O	O	I-T043
+	O	O	I-T043
)	O	O	I-T043
.	O	O	O

Notably	O	O	O
,	O	O	O
Pdp1	O	O	B-T028
overexpression	O	O	B-T045
significantly	O	O	O
enhanced	O	O	O
the	O	O	O
mitochondrial	O	O	B-T026
indices	O	O	B-T170
and	O	O	O
pyruvate	O	O	B-T044
dehydrogenase	O	O	I-T044
activity	O	O	I-T044
and	O	O	O
reduced	O	O	O
the	O	O	O
expression	O	O	B-T045
of	O	O	O
cardiac	O	O	B-T043
differentiation	O	O	I-T043
marker	O	O	B-T045
mRNA	O	O	I-T045
and	O	O	O
the	O	O	O
cardiac	O	O	O
differentiation	O	O	O
rate	O	O	B-T081
compared	O	O	O
to	O	O	O
a	O	O	O
mock	O	O	O
control	O	O	O
.	O	O	O

In	O	O	O
confirmation	O	O	O
of	O	O	O
this	O	O	O
,	O	O	O
a	O	O	O
knockdown	O	O	B-T063
of	O	O	O
the	O	O	O
Pdp1	O	O	B-T028
gene	O	O	I-T028
promoted	O	O	O
the	O	O	O
expression	O	O	B-T045
of	O	O	O
cardiac	O	O	B-T043
differentiation	O	O	I-T043
marker	O	O	B-T045
mRNA	O	O	I-T045
and	O	O	O
the	O	O	O
cardiac	O	O	O
differentiation	O	O	O
rate	O	O	B-T081
.	O	O	O

In	O	O	O
conclusion	O	O	O
,	O	O	O
our	O	O	O
results	O	O	O
suggest	O	O	O
that	O	O	O
mitochondrial	O	O	B-T028
PDP1	O	O	I-T028
is	O	O	O
a	O	O	O
potential	O	O	O
regulator	O	O	O
that	O	O	O
controls	O	O	O
cardiac	O	O	B-T043
differentiation	O	O	I-T043
at	O	O	O
an	O	O	O
early	O	O	O
differentiation	O	O	B-T079
stage	O	O	I-T079
in	O	O	O
ESCs	O	O	B-T025
.	O	O	O

-DOCSTART- (27539945)

Thermo-reversible	O	O	B-T067
capture	O	O	I-T067
and	O	O	I-T067
release	O	O	I-T067
of	O	O	O
DNA	O	O	B-T114
by	O	O	O
zwitterionic	O	O	O
surfactants	O	O	O

The	O	O	O
thermo-reversible	O	O	B-T067
capture	O	O	I-T067
and	O	O	I-T067
release	O	O	I-T067
of	O	O	O
DNA	O	O	B-T114
were	O	O	O
studied	O	O	O
by	O	O	O
the	O	O	O
protonation	O	O	B-T067
and	O	O	O
deprotonation	O	O	B-T067
of	O	O	O
alkyldimethylamine	O	O	B-T109
oxide	O	O	I-T109
(	O	O	O
CnDMAO	O	O	B-T109
,	O	O	O
n	O	O	O
=	O	O	O
10	O	O	O
,	O	O	O
12	O	O	O
and	O	O	O
14	O	O	O
)	O	O	O
in	O	O	O
Tris-HCl	O	O	B-T130
buffer	O	O	B-T130
solution	O	O	I-T130
.	O	O	O

DNA	O	O	B-T114
/	O	O	O
C14DMAO	O	O	B-T109
in	O	O	O
Tris-HCl	O	O	B-T130
buffer	O	O	B-T130
solution	O	O	I-T130
with	O	O	O
pH	O	O	B-T081
=	O	O	O
7.2	O	O	O
is	O	O	O
transparent	O	O	B-T080
at	O	O	O
25	O	O	O
Â°	O	O	O
C	O	O	O
,	O	O	O
indicating	O	O	O
that	O	O	O
DNA	O	O	O
molecules	O	O	B-T167
exist	O	O	O
mainly	O	O	O
in	O	O	O
individuals	O	O	B-T098
and	O	O	O
the	O	O	O
binding	O	O	B-T044
of	O	O	O
C14DMAO	O	O	O
is	O	O	O
weak	O	O	B-T080
.	O	O	O

With	O	O	O
the	O	O	O
increase	O	O	B-T169
of	O	O	O
temperature	O	O	B-T081
,	O	O	O
the	O	O	O
pH	O	O	B-T081
of	O	O	O
the	O	O	O
buffer	O	O	B-T130
solution	O	O	I-T130
continuously	O	O	O
decreases	O	O	B-T081
,	O	O	O
which	O	O	O
leads	O	O	O
to	O	O	O
protonation	O	O	B-T067
of	O	O	O
C14DMAO	O	O	B-T109
(	O	O	O
C14DMAO	O	O	O
+	O	O	O
H(+	O	O	B-T196
)	O	O	I-T196
â	O	O	O
C14DMAOH(+	O	O	B-T109
)	O	O	I-T109
)	O	O	O
and	O	O	O
an	O	O	O
obvious	O	O	O
increase	O	O	B-T033
of	O	O	I-T033
the	O	O	I-T033
turbidity	O	O	I-T033
of	O	O	O
the	O	O	O
samples	O	O	B-T167
.	O	O	O

This	O	O	O
indicates	O	O	O
a	O	O	O
stronger	O	O	O
binding	O	O	B-T044
of	O	O	O
the	O	O	O
protonated	O	O	B-T067
C14DMAOH(+	O	O	B-T109
)	O	O	I-T109
to	O	O	O
DNA	O	O	B-T114
.	O	O	O

Further	O	O	O
investigations	O	O	O
demonstrated	O	O	O
the	O	O	O
formation	O	O	B-T169
of	O	O	O
DNA	O	O	B-T114
/	O	O	O
C14DMAOH(+	O	O	B-T109
)	O	O	I-T109
complexes	O	O	B-T104
,	O	O	O
in	O	O	O
which	O	O	O
the	O	O	O
stretched	O	O	O
DNA	O	O	O
molecules	O	O	B-T167
are	O	O	O
effectively	O	O	O
compacted	O	O	B-T033
as	O	O	O
evidenced	O	O	O
from	O	O	O
UV-vis	O	O	B-T070
absorptions	O	O	O
,	O	O	O
circular	O	O	B-T059
dichroism	O	O	I-T059
(	O	O	O
CD	O	O	B-T059
)	O	O	O
measurements	O	O	B-T169
,	O	O	O
atomic	O	O	B-T059
force	O	O	I-T059
microscopy	O	O	I-T059
(	O	O	O
AFM	O	O	B-T059
)	O	O	O
observations	O	O	B-T062
,	O	O	O
dynamic	O	O	B-T059
light	O	O	I-T059
scattering	O	O	I-T059
(	O	O	O
DLS	O	O	B-T059
)	O	O	O
measurements	O	O	O
and	O	O	O
agarose	O	O	B-T059
gel	O	O	I-T059
electrophoresis	O	O	I-T059
(	O	O	O
AGE	O	O	B-T059
)	O	O	O
.	O	O	O

Interestingly	O	O	O
,	O	O	O
when	O	O	O
the	O	O	O
temperature	O	O	B-T081
is	O	O	O
turned	O	O	O
back	O	O	O
to	O	O	O
25	O	O	O
Â°	O	O	O
C	O	O	O
,	O	O	O
the	O	O	O
compacted	O	O	B-T033
DNA	O	O	B-T114
molecules	O	O	B-T167
can	O	O	O
fully	O	O	O
recover	O	O	O
to	O	O	O
the	O	O	O
stretched	O	O	O
conformation	O	O	O
.	O	O	O

This	O	O	O
cycle	O	O	B-T079
can	O	O	O
be	O	O	O
repeated	O	O	O
several	O	O	O
times	O	O	O
without	O	O	O
obvious	O	O	O
loss	O	O	B-T081
of	O	O	O
efficiency	O	O	B-T081
.	O	O	O

The	O	O	O
effect	O	O	B-T080
of	O	O	I-T080
the	O	O	O
chain	O	O	B-T081
length	O	O	I-T081
of	O	O	O
CnDMAO	O	O	B-T109
has	O	O	O
also	O	O	O
been	O	O	O
investigated	O	O	O
.	O	O	O

When	O	O	O
C14DMAO	O	O	B-T109
was	O	O	O
replaced	O	O	O
by	O	O	O
C12DMAO	O	O	B-T109
,	O	O	O
similar	O	O	O
phenomena	O	O	B-T067
can	O	O	O
be	O	O	O
observed	O	O	O
with	O	O	O
a	O	O	O
slightly	O	O	O
higher	O	O	B-T080
critical	O	O	B-T080
surfactant	O	O	B-T120
concentration	O	O	B-T081
for	O	O	O
DNA	O	O	B-T114
compaction	O	O	B-T033
and	O	O	O
a	O	O	O
slightly	O	O	O
lower	O	O	B-T080
pH	O	O	B-T081
of	O	O	O
Tris-HCl	O	O	B-T130
buffer	O	O	B-T130
solution	O	O	I-T130
with	O	O	O
pH	O	O	O
=	O	O	O
6.8	O	O	O
.	O	O	O

For	O	O	O
the	O	O	O
DNA	O	O	B-T114
/	O	O	O
C10DMAO	O	O	B-T109
system	O	O	O
,	O	O	O
however	O	O	O
,	O	O	O
no	O	O	O
DNA	O	O	O
compaction	O	O	B-T033
was	O	O	O
observed	O	O	O
even	O	O	O
in	O	O	O
Tris-HCl	O	O	B-T130
buffer	O	O	B-T130
solution	O	O	I-T130
with	O	O	O
a	O	O	O
much	O	O	O
lower	O	O	B-T080
pH	O	O	B-T081
and	O	O	O
a	O	O	O
much	O	O	O
higher	O	O	B-T080
C10DMAO	O	O	O
concentration	O	O	B-T081
.	O	O	O

The	O	O	O
negative	O	O	B-T080
charges	O	O	I-T080
of	O	O	O
DNA	O	O	B-T114
molecules	O	O	B-T167
can	O	O	O
easily	O	O	O
be	O	O	O
neutralized	O	O	O
by	O	O	O
positive	O	O	B-T080
charges	O	O	I-T080
of	O	O	O
cationic	O	O	B-T109
CnDMAOH(+	O	O	I-T109
)	O	O	I-T109
(	O	O	O
n	O	O	O
=	O	O	O
12	O	O	O
and	O	O	O
14	O	O	O
)	O	O	O
micelles	O	O	B-T109
.	O	O	O

DNA	O	O	B-T114
was	O	O	O
compacted	O	O	B-T033
and	O	O	O
then	O	O	O
insoluble	O	O	O
DNA	O	O	O
/	O	O	O
CnDMAOH(+	O	O	B-T109
)	O	O	I-T109
complexes	O	O	B-T104
were	O	O	O
formed	O	O	O
.	O	O	O

Because	O	O	O
of	O	O	O
the	O	O	O
much	O	O	O
higher	O	O	B-T080
critical	O	O	B-T080
micelle	O	O	B-T109
concentration	O	O	B-T081
(	O	O	O
cmc	O	O	B-T081
)	O	O	O
of	O	O	O
the	O	O	O
shorter	O	O	O
chain	O	O	B-T081
length	O	O	I-T081
C10DMAOH(+	O	O	B-T109
)	O	O	I-T109
,	O	O	O
cationic	O	O	B-T109
C10DMAOH(+	O	O	I-T109
)	O	O	I-T109
micelles	O	O	B-T109
can	O	O	O
not	O	O	O
form	O	O	O
under	O	O	O
the	O	O	O
studied	O	O	O
condition	O	O	O
to	O	O	O
compact	O	O	B-T033
DNA	O	O	B-T114
.	O	O	O

The	O	O	O
strategy	O	O	O
may	O	O	O
provide	O	O	O
an	O	O	O
efficient	O	O	B-T080
and	O	O	O
alternative	O	O	B-T061
approach	O	O	I-T061
for	O	O	O
stimuli-responsive	O	O	B-T061
gene	O	O	I-T061
therapy	O	O	I-T061
and	O	O	O
drug	O	O	B-T070
release	O	O	I-T070
.	O	O	O

-DOCSTART- (27540024)

Collaborating	O	O	B-T054
for	O	O	O
Systems	O	O	B-T169
Change	O	O	B-T169
:	O	O	O
A	O	O	O
Social	O	O	B-T170
Science	O	O	I-T170
Framework	O	O	I-T170
for	O	O	O
Academic	O	O	B-UnknownType
Roles	O	O	I-UnknownType
in	O	O	O
Community	O	O	O
Partnerships	O	O	O

Environmental	O	O	B-T091
health	O	O	I-T091
researchers	O	O	B-T097
,	O	O	O
government	O	O	B-T092
agencies	O	O	I-T092
,	O	O	O
and	O	O	O
community	O	O	B-T096
groups	O	O	I-UnknownType
have	O	O	O
endorsed	O	O	O
long-term	O	O	O
community	O	O	O
-	O	O	O
academic	O	O	B-UnknownType
partnerships	O	O	B-T092
as	O	O	O
an	O	O	O
effective	O	O	B-T041
strategy	O	O	I-T041
to	O	O	O
support	O	O	B-T077
science	O	O	B-T090
-based	O	O	O
improvements	O	O	B-T077
in	O	O	O
environmental	O	O	B-T091
health	O	O	I-T091
.	O	O	O

Social	O	O	B-T090
sciences	O	O	I-T090
concepts	O	O	B-T078
,	O	O	O
approaches	O	O	B-T078
,	O	O	O
and	O	O	O
methods	O	O	B-T170
are	O	O	O
fundamental	O	O	O
to	O	O	O
these	O	O	O
translational	O	O	B-T092
partnerships	O	O	I-T092
.	O	O	O

However	O	O	O
,	O	O	O
appropriate	O	O	B-T080
roles	O	O	B-T078
for	O	O	O
academic	O	O	B-UnknownType
partners	O	O	B-T098
vary	O	O	O
throughout	O	O	O
the	O	O	O
process	O	O	B-T067
of	O	O	O
changing	O	O	B-T169
systems	O	O	B-T169
(	O	O	O
policies	O	O	B-T170
,	O	O	O
practices	O	O	B-T057
,	O	O	O
programs	O	O	B-T169
,	O	O	O
etc	O	O	O
.	O	O	O
)	O	O	O
.	O	O	O

This	O	O	O
can	O	O	O
complicate	O	O	O
planning	O	O	B-T170
,	O	O	O
evaluating	O	O	B-T078
,	O	O	O
and	O	O	O
sustaining	O	O	B-T169
such	O	O	O
partnerships	O	O	B-T092
.	O	O	O

We	O	O	O
set	O	O	O
forth	O	O	O
a	O	O	O
conceptual	O	O	B-T078
framework	O	O	I-T078
for	O	O	O
academic	O	O	B-UnknownType
partners	O	O	B-T098
'	O	O	O
roles	O	O	O
at	O	O	O
different	O	O	B-T079
stages	O	O	I-T079
of	O	O	O
systems	O	O	B-T169
change	O	O	B-T169
.	O	O	O

We	O	O	O
apply	O	O	O
this	O	O	O
framework	O	O	B-T078
to	O	O	O
three	O	O	O
longstanding	O	O	O
academic	O	O	B-UnknownType
-	O	O	O
community	O	O	B-T096
partnerships	O	O	B-T092
involving	O	O	O
National	O	O	B-T093
Institute	O	O	I-T093
of	O	O	I-T093
Environmental	O	O	I-T093
Health	O	O	I-T093
Sciences	O	O	I-T093
Community	O	O	B-T097
Outreach	O	O	I-T097
and	O	O	I-T097
Engagement	O	O	I-T097
Cores	O	O	I-T097
.	O	O	O

We	O	O	O
conclude	O	O	O
by	O	O	O
discussing	O	O	O
how	O	O	O
the	O	O	O
framework	O	O	B-T078
can	O	O	O
help	O	O	O
academic	O	O	B-UnknownType
partners	O	O	B-T098
tap	O	O	O
appropriate	O	O	B-T080
expertise	O	O	B-T080
,	O	O	O
redefine	O	O	O
their	O	O	O
roles	O	O	O
,	O	O	O
and	O	O	O
evaluate	O	O	O
their	O	O	O
contributions	O	O	O
to	O	O	O
community	O	O	B-T096
efforts	O	O	O
to	O	O	O
improve	O	O	B-T033
environmental	O	O	B-T091
health	O	O	I-T091
.	O	O	O

-DOCSTART- (27540584)

A	O	O	O
novel	O	O	B-T080
mechanical	O	O	B-T074
simulator	O	O	I-T074
for	O	O	O
cannulation	O	O	B-T061
and	O	O	O
sphincterotomy	O	O	B-T061
after	O	O	O
Billroth	O	O	B-T061
II	O	O	I-T061
or	O	O	O
Roux-en-Y	O	O	O
reconstruction	O	O	O

In	O	O	O
patients	O	O	B-T101
with	O	O	O
Billroth	O	O	B-T061
II	O	O	I-T061
(	O	O	O
B	O	O	B-T061
II	O	O	I-T061
)	O	O	O
or	O	O	O
Roux-en-Y	O	O	B-T061
anatomy	O	O	B-T017
,	O	O	O
endoscopic	O	O	B-T060
retrograde	O	O	I-T060
cholangiopancreatography	O	O	I-T060
(	O	O	O
ERCP	O	O	B-T060
)	O	O	O
is	O	O	O
demanding	O	O	O
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
describe	O	O	O
a	O	O	O
novel	O	O	B-T080
simulator	O	O	B-T074
with	O	O	O
simulated	O	O	B-T062
fluoroscopy	O	O	B-T060
for	O	O	O
cannulation	O	O	B-T061
and	O	O	O
sphincterotomy	O	O	B-T061
training	O	O	B-T065
in	O	O	O
such	O	O	O
situations	O	O	O
.	O	O	O

A	O	O	O
custom-made	O	O	O
simulation	O	O	B-T074
system	O	O	I-T074
was	O	O	O
built	O	O	B-T052
based	O	O	O
upon	O	O	O
a	O	O	O
common	O	O	B-T081
chassis	O	O	B-T073
of	O	O	O
a	O	O	O
series	O	O	B-T081
of	O	O	O
previously	O	O	B-T079
described	O	O	O
ERCP	O	O	B-T060
simulators	O	O	B-T074
.	O	O	O

The	O	O	O
papilla	O	O	B-T023
is	O	O	O
made	O	O	O
out	O	O	O
of	O	O	O
organic	O	O	B-T080
material	O	O	B-T167
and	O	O	O
can	O	O	O
be	O	O	O
cut	O	O	B-T067
by	O	O	O
high	O	O	B-T079
frequency	O	O	I-T079
current	O	O	B-T070
.	O	O	O

The	O	O	O
advancement	O	O	B-T169
of	O	O	O
guidewires	O	O	B-T073
and	O	O	O
other	O	O	O
instruments	O	O	B-T074
within	O	O	O
transparent	O	O	B-T080
mock	O	O	O
bile	O	O	B-T023
ducts	O	O	I-T023
can	O	O	O
be	O	O	O
viewed	O	O	O
in	O	O	O
the	O	O	O
window	O	O	B-T073
of	O	O	O
the	O	O	O
simulator	O	O	B-T074
without	O	O	O
the	O	O	O
need	O	O	O
for	O	O	O
fluoroscopy	O	O	B-T060
.	O	O	O

The	O	O	O
ERCP	O	O	B-T060
B	O	O	B-T061
II	O	O	I-T061
/	O	O	O
Roux-en-Y	O	O	B-T061
simulation	O	O	B-T074
system	O	O	I-T074
was	O	O	O
first	O	O	O
evaluated	O	O	B-T058
during	O	O	O
an	O	O	O
ERCP	O	O	O
course	O	O	B-T079
.	O	O	O

There	O	O	O
were	O	O	O
no	O	O	O
technical	O	O	B-T067
problems	O	O	I-T067
related	O	O	O
to	O	O	O
the	O	O	O
novel	O	O	B-T080
simulator	O	O	B-T074
during	O	O	O
the	O	O	O
course	O	O	B-T079
.	O	O	O

After	O	O	O
sphincterotomy	O	O	B-T061
,	O	O	O
the	O	O	O
organic	O	O	B-T080
papillae	O	O	B-T023
could	O	O	O
easily	O	O	O
be	O	O	O
exchanged	O	O	B-T169
within	O	O	O
a	O	O	O
few	O	O	O
seconds	O	O	B-T079
.	O	O	O

Overall	O	O	O
,	O	O	O
the	O	O	O
novel	O	O	B-T080
B	O	O	B-T061
II	O	O	I-T061
/	O	O	O
Roux-en-Y	O	O	B-T061
simulator	O	O	B-T074
achieved	O	O	O
favorable	O	O	B-T080
results	O	O	B-T169
by	O	O	O
trainees	O	O	B-T097
and	O	O	O
expert	O	O	B-T097
endoscopists	O	O	B-T097
in	O	O	O
all	O	O	O
categories	O	O	B-T170
assessed	O	O	B-T052
.	O	O	O

The	O	O	O
new	O	O	O
B	O	O	B-T061
II	O	O	I-T061
/	O	O	O
Roux-en-Y	O	O	B-T061
mechanical	O	O	B-T074
simulator	O	O	I-T074
is	O	O	O
simple	O	O	B-T080
and	O	O	O
practicable	O	O	B-T080
.	O	O	O

A	O	O	O
first	O	O	O
evaluation	O	O	B-T058
during	O	O	O
an	O	O	O
ERCP	O	O	B-T060
course	O	O	B-T079
showed	O	O	O
promising	O	O	O
results	O	O	B-T169
.	O	O	O

-DOCSTART- (27542380)

A	O	O	O
thermophilic	O	O	B-T001
-like	O	O	O
ene-reductase	O	O	B-T116
originating	O	O	O
from	O	O	O
an	O	O	O
acidophilic	O	O	B-T169
iron	O	O	O
oxidizer	O	O	O

Ene-reductases	O	O	B-T116
originating	O	O	O
from	O	O	O
extremophiles	O	O	B-T001
are	O	O	O
gaining	O	O	O
importance	O	O	O
in	O	O	O
the	O	O	O
field	O	O	O
of	O	O	O
biocatalysis	O	O	B-T070
due	O	O	O
to	O	O	O
higher	O	O	B-T080
-	O	O	O
stability	O	O	B-T080
properties	O	O	B-T080
.	O	O	O

The	O	O	O
genome	O	O	B-T028
of	O	O	O
the	O	O	O
acidophilic	O	O	B-T169
iron-oxidizing	O	O	B-T007
bacterium	O	O	I-T007
"	O	O	O
Ferrovum	O	O	B-T007
"	O	O	I-T007
sp.	O	O	I-T007
JA12	O	O	I-T007
was	O	O	O
found	O	O	O
to	O	O	O
harbor	O	O	O
a	O	O	O
thermophilic	O	O	B-T001
-like	O	O	O
ene-reductase	O	O	B-T116
(	O	O	O
FOYE-1	O	O	B-T116
)	O	O	O
.	O	O	O

The	O	O	O
foye-1	O	O	B-T028
gene	O	O	I-T028
was	O	O	O
ligated	O	O	O
into	O	O	O
a	O	O	O
pET16bp	O	O	B-T114
expression	O	O	B-T045
vector	O	O	B-T114
system	O	O	I-T114
,	O	O	O
and	O	O	O
the	O	O	O
enzyme	O	O	B-T116
was	O	O	O
produced	O	O	O
in	O	O	O
Escherichia	O	O	B-T007
coli	O	O	I-T007
BL21	O	O	B-T025
(	O	O	I-T025
DE3	O	O	I-T025
;	O	O	I-T025
pLysS	O	O	I-T025
)	O	O	I-T025
cells	O	O	I-T025
in	O	O	O
yields	O	O	O
of	O	O	O
10	O	O	O
mg	O	O	O
L(-1	O	O	O
)	O	O	O
.	O	O	O

FOYE-1	O	O	B-T116
showed	O	O	O
remarkable	O	O	O
activity	O	O	B-T044
and	O	O	O
rates	O	O	B-T081
on	O	O	O
N-phenylmaleimide	O	O	B-T109
and	O	O	O
N-phenyl-2-methylmaleimide	O	O	B-T109
(	O	O	O
up	O	O	O
to	O	O	O
89	O	O	O
U	O	O	O
mg(-1	O	O	O
)	O	O	O
,	O	O	O
>	O	O	O
97	O	O	O
%	O	O	O
conversion	O	O	B-T169
,	O	O	O
95	O	O	O
%	O	O	O
(R)-selective	O	O	O
)	O	O	O
with	O	O	O
both	O	O	O
nicotinamide	O	O	B-T109
cofactors	O	O	I-T109
,	O	O	O
NADPH	O	O	B-T114
and	O	O	O
NADH	O	O	B-T114
.	O	O	O

The	O	O	O
catalytic	O	O	B-T070
efficiency	O	O	B-T081
with	O	O	O
NADPH	O	O	B-T114
was	O	O	O
27	O	O	O
times	O	O	O
higher	O	O	B-T080
compared	O	O	O
to	O	O	O
NADH	O	O	B-T114
.	O	O	O

At	O	O	O
the	O	O	O
temperature	O	O	B-T081
maximum	O	O	B-T081
(	O	O	O
50	O	O	O
Â°	O	O	O
C	O	O	O
)	O	O	O
and	O	O	O
pH	O	O	B-T081
optimum	O	O	I-T081
(	O	O	O
6.5	O	O	O
)	O	O	O
,	O	O	O
activity	O	O	B-T044
was	O	O	O
almost	O	O	O
doubled	O	O	B-T052
to	O	O	O
160	O	O	O
U	O	O	O
mg(-1	O	O	O
)	O	O	O
.	O	O	O

These	O	O	O
findings	O	O	B-T033
accomplish	O	O	O
FOYE-1	O	O	B-T116
for	O	O	O
a	O	O	O
valuable	O	O	O
biocatalyst	O	O	B-T067
in	O	O	O
the	O	O	O
synthesis	O	O	B-T052
of	O	O	O
succinimides	O	O	B-T109
.	O	O	O

The	O	O	O
appearance	O	O	O
of	O	O	O
a	O	O	O
thermophilic	O	O	B-T001
-like	O	O	O
ene-reductase	O	O	B-T116
in	O	O	O
an	O	O	O
acidic	O	O	B-T082
habitat	O	O	I-T082
is	O	O	O
discussed	O	O	O
with	O	O	O
respect	O	O	O
to	O	O	O
its	O	O	O
phylogenetic	O	O	O
placement	O	O	O
and	O	O	O
to	O	O	O
the	O	O	O
genomic	O	O	B-T028
neighborhood	O	O	B-T082
of	O	O	O
the	O	O	O
encoding	O	O	B-T052
gene	O	O	B-T028
,	O	O	O
awarding	O	O	O
FOYE-1	O	O	B-T116
a	O	O	O
putative	O	O	O
involvement	O	O	O
in	O	O	O
a	O	O	O
quorum-sensing	O	O	B-T043
process	O	O	O
.	O	O	O

-DOCSTART- (27545500)

A	O	O	O
tanshinone	O	O	B-T109
I	O	O	I-T109
derivative	O	O	B-T169
enhances	O	O	O
the	O	O	O
activities	O	O	B-T038
of	O	O	O
antibiotics	O	O	B-T195
against	O	O	O
Staphylococcus	O	O	B-T007
aureus	O	O	I-T007
in	O	O	B-T080
vitro	O	O	I-T080
and	O	O	O
in	O	O	O
vivo	O	O	O

Infections	O	O	B-T046
caused	O	O	O
by	O	O	O
Staphylococcus	O	O	B-T007
aureus	O	O	I-T007
are	O	O	O
prevalent	O	O	O
.	O	O	O

The	O	O	O
dramatically	O	O	O
reduced	O	O	O
discovery	O	O	B-T052
of	O	O	O
new	O	O	O
antibiotics	O	O	B-T195
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
the	O	O	O
persistent	O	O	O
emergence	O	O	O
of	O	O	O
resistant	O	O	B-T007
bacteria	O	O	I-T007
,	O	O	O
represents	O	O	O
a	O	O	O
major	O	O	O
health	O	O	B-T078
problem	O	O	B-T033
in	O	O	O
both	O	O	O
hospital	O	O	B-T093
and	O	O	O
community	O	O	B-T093
settings	O	O	I-T093
.	O	O	O

Using	O	O	O
antibiotic	O	O	B-T195
enhancers	O	O	O
to	O	O	O
rescue	O	O	O
existing	O	O	O
classes	O	O	O
of	O	O	O
antibiotics	O	O	B-T195
is	O	O	O
an	O	O	O
attractive	O	O	O
strategy	O	O	O
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
16-aldehyde	O	O	B-T121
tanshinone	O	O	I-T121
I	O	O	I-T121
(	O	O	O
ALT	O	O	B-T121
)	O	O	O
was	O	O	O
synthesized	O	O	B-T052
and	O	O	O
bacteriostatic	O	O	B-T038
activity	O	O	I-T038
was	O	O	O
explored	O	O	O
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
synergistic	O	O	B-T080
or	O	O	O
additive	O	O	B-T080
activity	O	O	B-T038
between	O	O	O
ALT	O	O	B-T121
and	O	O	O
aminoglycoside	O	O	B-T195
antibiotics	O	O	I-T195
or	O	O	O
Î²-lactam	O	O	B-T195
antibiotics	O	O	I-T195
in	O	O	B-T080
vitro	O	O	I-T080
was	O	O	O
identified	O	O	O
.	O	O	O

Moreover	O	O	O
,	O	O	O
ALT	O	O	B-T121
was	O	O	O
documented	O	O	O
to	O	O	O
augment	O	O	O
clearance	O	O	O
of	O	O	O
streptomycin	O	O	B-T195
(	O	O	O
STR	O	O	B-T195
)	O	O	O
and	O	O	O
ampicillin	O	O	B-T195
(	O	O	O
AMP	O	O	B-T195
)	O	O	O
against	O	O	O
S.	O	O	B-T007
aureus	O	O	I-T007
in	O	O	O
a	O	O	O
murine	O	O	B-T050
infection	O	O	I-T050
model	O	O	I-T050
.	O	O	O

Primary	O	O	O
mechanistic	O	O	B-T044
insight	O	O	I-T044
indicated	O	O	O
that	O	O	O
ALT	O	O	B-T121
could	O	O	O
damage	O	O	B-T169
the	O	O	O
bacterial	O	O	B-T007
cell	O	O	B-T026
membrane	O	O	I-T026
,	O	O	O
leading	O	O	O
to	O	O	O
accumulation	O	O	B-T033
of	O	O	O
antibiotics	O	O	B-T195
inside	O	O	O
bacterial	O	O	B-T007
cells	O	O	I-T007
.	O	O	O

This	O	O	O
finding	O	O	O
might	O	O	O
be	O	O	O
useful	O	O	O
for	O	O	O
treating	O	O	B-T169
infections	O	O	B-T046
caused	O	O	O
by	O	O	O
S.	O	O	B-T007
aureus	O	O	I-T007
and	O	O	O
expand	O	O	O
the	O	O	O
scope	O	O	O
of	O	O	O
application	O	O	B-T169
of	O	O	O
tanshinones	O	O	B-T109
.	O	O	O

-DOCSTART- (27546367)

Investigation	O	O	O
of	O	O	O
argyrophilic	O	O	B-T025
nucleolar	O	O	O
organizing	O	O	O
region	O	O	O

Ischemia/reperfusion	O	O	B-T037
(	O	O	I-T037
I/R	O	O	I-T037
)	O	O	I-T037
injury	O	O	I-T037
is	O	O	O
a	O	O	O
complex	O	O	B-T051
event	O	O	I-T051
frequently	O	O	O
observed	O	O	B-T169
in	O	O	O
vascular	O	O	B-T061
surgery	O	O	I-T061
and	O	O	O
can	O	O	O
cause	O	O	O
functional	O	O	B-T043
and	O	O	O
structural	O	O	B-T026
cell	O	O	B-T049
damage	O	O	I-T049
.	O	O	O

Nucleolar-organizing	O	O	B-T026
regions	O	O	I-T026
(	O	O	O
NORs	O	O	B-T026
)	O	O	O
are	O	O	O
sites	O	O	B-T082
of	O	O	O
the	O	O	O
ribosomal	O	O	B-T028
genes	O	O	I-T028
located	O	O	O
on	O	O	O
chromosomes	O	O	B-T026
and	O	O	O
can	O	O	O
be	O	O	O
stained	O	O	B-T059
with	O	O	O
silver	O	O	B-T196
when	O	O	O
they	O	O	O
are	O	O	O
active	O	O	B-T169
.	O	O	O

Thus	O	O	O
these	O	O	O
proteins	O	O	B-T116
are	O	O	O
named	O	O	O
as	O	O	O
argyrophilic-NOR	O	O	B-T116
(AgNOR)-associated	O	O	I-T116
proteins	O	O	I-T116
.	O	O	O

We	O	O	O
aimed	O	O	O
to	O	O	O
investigate	O	O	O
any	O	O	O
possible	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
renal	O	O	B-T023
I/R	O	O	B-T037
injury	O	O	I-T037
on	O	O	O
the	O	O	O
NOR	O	O	B-T116
protein	O	O	I-T116
synthesis	O	O	B-T044
and	O	O	O
association	O	O	O
between	O	O	O
the	O	O	O
AgNOR	O	O	B-T116
proteins	O	O	I-T116
amount	O	O	B-T081
and	O	O	O
histopathological	O	O	B-T033
injuring	O	O	I-T033
score	O	O	I-T033
.	O	O	O

Nine	O	O	O
female	O	O	B-T032
wistar-albino	O	O	B-T015
rats	O	O	I-T015
with	O	O	O
weight	O	O	O
of	O	O	O
200	O	O	O
-	O	O	O
250	O	O	O
g	O	O	O
were	O	O	O
included	O	O	O
into	O	O	O
the	O	O	O
study	O	O	O
.	O	O	O

The	O	O	O
animals	O	O	B-T008
were	O	O	O
randomly	O	O	B-T080
divided	O	O	B-T169
in	O	O	O
two	O	O	O
groups	O	O	B-T078
,	O	O	O
a	O	O	O
Control	O	O	B-T096
Group	O	O	B-T078
and	O	O	O
an	O	O	O
I/R	O	O	B-T037
Group	O	O	O
.	O	O	O

In	O	O	O
I/R	O	O	B-T037
group	O	O	B-T078
,	O	O	O
rats	O	O	B-T015
were	O	O	O
subjected	O	O	O
to	O	O	O
45	O	O	O
minutes	O	O	O
of	O	O	O
renal	O	O	B-T023
pedicle	O	O	I-T023
occlusion	O	O	B-T046
followed	O	O	O
by	O	O	O
24	O	O	O
hours	O	O	O
of	O	O	O
reperfusion	O	O	B-T038
.	O	O	O

In	O	O	O
the	O	O	O
control	O	O	B-T096
group	O	O	I-T096
no	O	O	O
drug	O	O	B-T061
injections	O	O	I-T061
or	O	O	O
ischemia	O	O	B-T037
reperfusion	O	O	I-T037
were	O	O	O
performed	O	O	B-T169
in	O	O	O
animals	O	O	B-T008
.	O	O	O

Then	O	O	O
histopathological	O	O	B-T033
injury	O	O	I-T033
score	O	O	I-T033
,	O	O	O
mean	O	O	B-T033
AgNOR	O	O	I-T033
number	O	O	I-T033
and	O	O	O
total	O	O	B-T033
AgNOR	O	O	I-T033
area	O	O	I-T033
/	O	O	O
nuclear	O	O	B-T033
area	O	O	I-T033
(	O	O	O
TAA	O	O	B-T033
/	O	O	O
NA	O	O	B-T033
)	O	O	O
were	O	O	O
detected	O	O	B-T033
for	O	O	O
each	O	O	O
rat	O	O	B-T015
.	O	O	O

The	O	O	O
differences	O	O	O
between	O	O	O
control	O	O	B-T096
and	O	O	O
I/R	O	O	B-T037
groups	O	O	B-T078
were	O	O	O
significant	O	O	B-T078
for	O	O	O
histopathological	O	O	B-T033
injury	O	O	I-T033
scores	O	O	I-T033
(	O	O	O
p	O	O	O
=	O	O	O
0.016	O	O	O
)	O	O	O
.	O	O	O

Also	O	O	O
the	O	O	O
differences	O	O	O
between	O	O	O
control	O	O	B-T096
group	O	O	B-T078
and	O	O	O
I/R	O	O	B-T037
group	O	O	O
were	O	O	O
significant	O	O	B-T078
for	O	O	O
mean	O	O	B-T033
AgNOR	O	O	I-T033
number	O	O	I-T033
(	O	O	O
p	O	O	O
=	O	O	O
0.000	O	O	O
)	O	O	O
and	O	O	O
TAA/NA	O	O	B-T081
ratio	O	O	I-T081
(	O	O	O
p	O	O	O
=	O	O	O
0.000	O	O	O
)	O	O	O
.	O	O	O

Additionally	O	O	O
,	O	O	O
there	O	O	O
was	O	O	O
a	O	O	O
positive	O	O	B-T080
correlation	O	O	I-T080
between	O	O	O
TAA/NA	O	O	B-T081
ratio	O	O	I-T081
and	O	O	O
histopathological	O	O	B-T033
injury	O	O	I-T033
score	O	O	I-T033
(	O	O	O
r	O	O	O
=	O	O	O
0.728	O	O	O
;	O	O	O
p	O	O	O
=	O	O	O
0.026	O	O	O
)	O	O	O
and	O	O	O
between	O	O	O
mean	O	O	B-T033
AgNOR	O	O	I-T033
number	O	O	I-T033
and	O	O	O
histopathological	O	O	O
injury	O	O	O
score	O	O	O
(	O	O	O
r	O	O	O
=	O	O	O
0.670	O	O	O
;	O	O	O
p	O	O	O
=	O	O	O
0.048	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
detection	O	O	B-T061
of	O	O	O
AgNOR	O	O	B-T116
proteins	O	O	I-T116
amount	O	O	B-T081
may	O	O	O
be	O	O	O
used	O	O	O
as	O	O	O
an	O	O	O
indicator	O	O	B-T169
to	O	O	O
obtain	O	O	O
information	O	O	B-T078
about	O	O	O
the	O	O	O
cellular	O	O	B-T043
behaviour	O	O	I-T043
(	O	O	O
self-protective	O	O	B-T039
mechanism	O	O	O
of	O	O	O
tubular	O	O	B-T025
epithelial	O	O	I-T025
cells	O	O	I-T025
)	O	O	O
against	O	O	O
I/R	O	O	B-T037
injury	O	O	I-T037
and	O	O	O
cellular	O	O	B-T049
damage	O	O	I-T049
levels	O	O	B-T080
(	O	O	O
Tab	O	O	O
.	O	O	O
2	O	O	O
,	O	O	O
Fig.	O	O	O
4	O	O	O
,	O	O	O
Ref	O	O	O
.	O	O	O
24	O	O	O
)	O	O	O
.	O	O	O

-DOCSTART- (27548715)

When	O	O	O
emotion	O	O	B-T041
and	O	O	O
expression	O	O	B-T033
diverge	O	O	O
:	O	O	O
The	O	O	O
social	O	O	B-UnknownType
costs	O	O	I-UnknownType
of	O	O	O
Parkinson	O	O	O
's	O	O	O
disease	O	O	O

Patients	O	O	B-T101
with	O	O	O
Parkinson	O	O	B-T047
's	O	O	I-T047
disease	O	O	I-T047
(	O	O	O
PD	O	O	B-T047
)	O	O	O
are	O	O	O
perceived	O	O	B-T041
more	O	O	O
negatively	O	O	B-T033
than	O	O	O
their	O	O	O
healthy	O	O	B-T080
peers	O	O	B-T098
,	O	O	O
yet	O	O	O
it	O	O	O
remains	O	O	O
unclear	O	O	O
what	O	O	O
factors	O	O	B-T169
contribute	O	O	B-T052
to	O	O	O
this	O	O	O
negative	O	O	B-T033
social	O	O	B-T041
perception	O	O	I-T041
.	O	O	O

Based	O	O	O
on	O	O	O
a	O	O	O
cohort	O	O	B-T098
of	O	O	O
17	O	O	O
PD	O	O	B-T047
patients	O	O	B-T101
and	O	O	O
20	O	O	O
healthy	O	O	B-T080
controls	O	O	I-T080
,	O	O	O
we	O	O	O
assessed	O	O	B-T052
how	O	O	O
naÃ¯ve	O	O	O
raters	O	O	O
judge	O	O	O
the	O	O	O
emotion	O	O	B-T041
and	O	O	O
emotional	O	O	B-T033
intensity	O	O	B-T080
displayed	O	O	B-T169
in	O	O	O
dynamic	O	O	B-T169
facial	O	O	B-T033
expressions	O	O	I-T033
as	O	O	O
adults	O	O	B-T100
with	O	O	O
and	O	O	O
without	O	O	O
PD	O	O	O
watched	O	O	B-T041
emotionally	O	O	B-T041
evocative	O	O	O
films	O	O	B-T170
(	O	O	O
Experiment	O	O	B-T062
1	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
how	O	O	O
age	O	O	B-T032
-matched	O	O	O
peers	O	O	B-T098
naÃ¯ve	O	O	O
to	O	O	O
patients	O	O	O
'	O	O	O
disease	O	O	B-T047
status	O	O	O
judge	O	O	O
their	O	O	O
social	O	O	B-T054
desirability	O	O	I-T054
along	O	O	O
various	O	O	O
dimensions	O	O	B-T081
from	O	O	O
audiovisual	O	O	B-T170
stimuli	O	O	B-T067
(	O	O	O
interview	O	O	B-T097
excerpts	O	O	I-T097
)	O	O	O
recorded	O	O	O
after	O	O	O
certain	O	O	O
films	O	O	O
(	O	O	O
Experiment	O	O	O
2	O	O	O
)	O	O	O
.	O	O	O

In	O	O	O
Experiment	O	O	B-T062
1	O	O	O
,	O	O	O
participants	O	O	B-T098
with	O	O	O
PD	O	O	B-T047
were	O	O	O
rated	O	O	B-T052
as	O	O	O
significantly	O	O	B-T081
more	O	O	I-T081
facially	O	O	B-T033
expressive	O	O	I-T033
than	O	O	O
healthy	O	O	B-T080
controls	O	O	B-T080
;	O	O	O
moreover	O	O	O
,	O	O	O
ratings	O	O	B-T052
demonstrated	O	O	O
that	O	O	O
PD	O	O	O
patients	O	O	B-T101
were	O	O	O
routinely	O	O	O
mistaken	O	O	O
for	O	O	O
experiencing	O	O	B-T041
a	O	O	O
negative	O	O	B-T033
emotion	O	O	B-T041
,	O	O	O
whereas	O	O	O
controls	O	O	O
were	O	O	O
rated	O	O	O
as	O	O	O
displaying	O	O	B-T169
a	O	O	O
more	O	O	O
positive	O	O	B-T033
emotion	O	O	O
than	O	O	O
they	O	O	O
reported	O	O	B-T058
feeling	O	O	B-T041
.	O	O	O

In	O	O	O
Experiment	O	O	B-T062
2	O	O	O
,	O	O	O
results	O	O	B-T034
showed	O	O	O
that	O	O	O
age-peers	O	O	B-T098
rated	O	O	B-T052
PD	O	O	B-T047
patients	O	O	B-T101
as	O	O	O
significantly	O	O	B-T081
less	O	O	I-T081
socially	O	O	B-T054
desirable	O	O	I-T054
than	O	O	O
control	O	O	B-T080
participants	O	O	B-T098
.	O	O	O

Specifically	O	O	O
,	O	O	O
PD	O	O	B-T047
patients	O	O	B-T101
were	O	O	O
rated	O	O	B-T052
as	O	O	O
less	O	O	O
involved	O	O	B-T169
,	O	O	O
interested	O	O	B-T041
,	O	O	O
friendly	O	O	B-T080
,	O	O	O
intelligent	O	O	O
,	O	O	O
optimistic	O	O	B-T033
,	O	O	O
attentive	O	O	O
,	O	O	O
and	O	O	O
physically	O	O	B-T080
attractive	O	O	I-T080
than	O	O	O
healthy	O	O	B-T080
controls	O	O	I-T080
.	O	O	O

Taken	O	O	O
together	O	O	O
,	O	O	O
our	O	O	O
results	O	O	B-T034
point	O	O	O
to	O	O	O
a	O	O	O
disconnect	O	O	O
between	O	O	O
how	O	O	O
PD	O	O	B-T047
patients	O	O	B-T101
report	O	O	B-T058
feeling	O	O	B-T041
and	O	O	O
attributions	O	O	B-T041
that	O	O	O
others	O	O	O
make	O	O	O
about	O	O	O
their	O	O	O
emotions	O	O	B-T041
and	O	O	O
social	O	O	B-T055
characteristics	O	O	I-T055
,	O	O	O
underlining	O	O	O
significant	O	O	B-T078
social	O	O	B-T080
challenges	O	O	I-T080
of	O	O	O
the	O	O	O
disease	O	O	B-T047
.	O	O	O

In	O	O	O
particular	O	O	O
,	O	O	O
changes	O	O	B-T169
in	O	O	O
the	O	O	O
ability	O	O	B-T032
to	O	O	O
modulate	O	O	B-T082
the	O	O	O
expression	O	O	B-T033
of	O	O	O
negative	O	O	B-T033
emotions	O	O	B-T041
may	O	O	O
contribute	O	O	B-T052
to	O	O	O
the	O	O	O
negative	O	O	O
social	O	O	B-T169
impressions	O	O	B-T055
that	O	O	O
many	O	O	O
PD	O	O	B-T047
patients	O	O	B-T101
face	O	O	O
.	O	O	O

-DOCSTART- (27549420)

Establishing	O	O	O
in-	O	O	O
hospital	O	O	B-T093
geriatrics	O	O	B-T091
services	O	O	I-T093
in	O	O	O
Africa	O	O	B-T083
:	O	O	O
Insights	O	O	O
from	O	O	O
the	O	O	O
University	O	O	B-T093
of	O	O	I-T093
Benin	O	O	I-T093
Teaching	O	O	I-T093
Hospital	O	O	I-T093
geriatrics	O	O	O
project	O	O	O

Unawareness	O	O	O
of	O	O	O
the	O	O	O
peculiar	O	O	O
healthcare	O	O	B-T058
needs	O	O	B-T080
of	O	O	O
the	O	O	O
elderly	O	O	B-T098
and	O	O	O
resource	O	O	B-T078
constraints	O	O	B-T169
may	O	O	O
be	O	O	O
some	O	O	O
reasons	O	O	O
why	O	O	O
until	O	O	O
recently	O	O	O
,	O	O	O
Nigerian	O	O	B-T083
hospitals	O	O	B-T093
have	O	O	O
not	O	O	O
been	O	O	O
equipped	O	O	O
with	O	O	O
the	O	O	O
human	O	O	B-T081
and	O	O	O
infrastructural	O	O	B-T081
resources	O	O	I-T081
required	O	O	O
to	O	O	O
meet	O	O	O
older	O	O	B-T098
adults	O	O	I-T098
'	O	O	O
special	O	O	O
healthcare	O	O	O
needs	O	O	O
.	O	O	O

There	O	O	O
is	O	O	O
paucity	O	O	O
of	O	O	O
specialized	O	O	O
health	O	O	B-T093
services	O	O	B-T058
for	O	O	O
the	O	O	O
elderly	O	O	B-T098
in	O	O	O
Africa	O	O	B-T083
.	O	O	O
Nigeria	O	O	B-T083
,	O	O	O
with	O	O	O
a	O	O	O
population	O	O	B-T098
of	O	O	O
over	O	O	O
170	O	O	O
million	O	O	O
,	O	O	O
did	O	O	O
not	O	O	O
have	O	O	O
any	O	O	O
healthcare	O	O	B-T093
facility	O	O	I-T093
with	O	O	O
dedicated	O	O	O
services	O	O	O
for	O	O	O
the	O	O	O
elderly	O	O	O
until	O	O	O
2012	O	O	O
.	O	O	O

The	O	O	O
University	O	O	B-T093
of	O	O	I-T093
Benin	O	O	I-T093
Teaching	O	O	I-T093
Hospital	O	O	I-T093
(	O	O	O
UBTH	O	O	B-T093
)	O	O	O
in	O	O	O
Nigeria	O	O	B-T083
was	O	O	O
established	O	O	O
in	O	O	O
1973	O	O	O
and	O	O	O
created	O	O	O
its	O	O	O
geriatrics	O	O	B-T091
unit	O	O	O
in	O	O	O
October	O	O	O
2013	O	O	O
.	O	O	O

A	O	O	O
prepared	O	O	O
environment	O	O	O
and	O	O	O
trained	O	O	B-T058
interdisciplinary	O	O	I-T058
teams	O	O	I-T058
are	O	O	O
pivotal	O	O	O
in	O	O	O
providing	O	O	O
effective	O	O	O
healthcare	O	O	B-T093
services	O	O	I-T093
for	O	O	O
the	O	O	O
elderly	O	O	B-T098
.	O	O	O

The	O	O	O
ongoing	O	O	O
UBTH	O	O	B-T093
geriatrics	O	O	B-T091
project	O	O	B-T077
aims	O	O	O
to	O	O	O
provide	O	O	O
specialized	O	O	O
interdisciplinary	O	O	B-T058
health	O	O	B-T058
services	O	O	I-T058
to	O	O	O
older	O	O	B-T098
adults	O	O	I-T098
and	O	O	O
to	O	O	O
provide	O	O	O
training	O	O	B-T065
and	O	O	O
continuing	O	O	O
professional	O	O	B-T057
development	O	O	I-T057
in	O	O	O
geriatrics	O	O	O
for	O	O	O
healthcare	O	O	B-T097
staff	O	O	I-T097
.	O	O	O

In	O	O	O
developing	O	O	O
our	O	O	O
inpatient	O	O	B-T101
services	O	O	B-T058
,	O	O	O
we	O	O	O
adopted	O	O	O
the	O	O	O
acute	O	O	B-T058
care	O	O	I-T058
for	O	O	I-T058
elders	O	O	I-T058
(	O	O	O
ACE	O	O	B-T058
)	O	O	O
model	O	O	B-T170
and	O	O	O
worked	O	O	O
in	O	O	O
tandem	O	O	O
with	O	O	O
the	O	O	O
"	O	O	O
ABCs	O	O	O
"	O	O	O
of	O	O	O
implementing	O	O	O
ACE	O	O	B-T170
units	O	O	I-T170
.	O	O	O

In	O	O	O
the	O	O	O
face	O	O	O
of	O	O	O
limited	O	O	O
resources	O	O	B-T078
,	O	O	O
it	O	O	O
was	O	O	O
possible	O	O	O
to	O	O	O
establish	O	O	O
a	O	O	O
functional	O	O	O
geriatrics	O	O	B-T091
unit	O	O	I-T091
with	O	O	O
a	O	O	O
trained	O	O	O
interdisciplinary	O	O	B-T058
team	O	O	I-T058
.	O	O	O

Family	O	O	B-T099
participation	O	O	B-T169
is	O	O	O
central	O	O	O
in	O	O	O
our	O	O	O
practice	O	O	B-T091
.	O	O	O

Since	O	O	O
October	O	O	O
2013	O	O	O
,	O	O	O
residents	O	O	B-T098
and	O	O	O
house	O	O	B-T097
officers	O	O	I-T097
in	O	O	O
internal	O	O	B-T121
medicine	O	O	I-T121
have	O	O	O
been	O	O	O
undertaking	O	O	O
4-	O	O	O
and	O	O	O
12-	O	O	O
weekly	O	O	B-T079
rotations	O	O	B-T169
,	O	O	O
respectively	O	O	O
.	O	O	O

There	O	O	O
is	O	O	O
also	O	O	O
a	O	O	O
robust	O	O	O
academic	O	O	B-T033
program	O	O	I-T033
,	O	O	O
which	O	O	O
includes	O	O	O
once-	O	O	O
weekly	O	O	B-T079
geriatric	O	O	B-T080
pharmacotherapy	O	O	B-T061
seminars	O	O	B-T058
,	O	O	O
once-	O	O	O
weekly	O	O	O
interdisciplinary	O	O	O
seminars	O	O	O
,	O	O	O
and	O	O	O
2-	O	O	O
weekly	O	O	O
journal	O	O	B-T052
club	O	O	I-T052
meetings	O	O	I-T052
alternating	O	O	O
with	O	O	O
seminars	O	O	O
on	O	O	O
geriatric	O	O	B-T170
assessment	O	O	I-T170
tools	O	O	I-T170
.	O	O	O

It	O	O	O
is	O	O	O
possible	O	O	O
to	O	O	O
establish	O	O	O
geriatric	O	O	B-T093
services	O	O	I-T093
and	O	O	O
achieve	O	O	O
best	O	O	O
practices	O	O	B-T091
in	O	O	O
resource-limited	O	O	O
settings	O	O	O
by	O	O	O
investing	O	O	O
on	O	O	O
improving	O	O	O
available	O	O	O
human	O	O	B-T081
resources	O	O	I-T081
and	O	O	O
infrastructure	O	O	B-T185
.	O	O	O

We	O	O	O
also	O	O	O
make	O	O	O
recommendations	O	O	O
for	O	O	O
setting	O	O	O
up	O	O	O
similar	O	O	O
services	O	O	B-T093
in	O	O	O
other	O	O	O
parts	O	O	O
of	O	O	O
Africa	O	O	B-T083
.	O	O	O

-DOCSTART- (27551992)

Engaging	O	O	B-T033
adolescent	O	O	B-T100
girls	O	O	I-T100
in	O	O	O
transactional	O	O	B-T054
sex	O	O	I-T054
through	O	O	B-T169
compensated	O	O	B-T080
dating	O	O	O

Transactional	O	O	B-T054
sex	O	O	I-T054
through	O	O	B-T169
so-called	O	O	O
compensated	O	O	B-T080
dating	O	O	B-T054
in	O	O	O
adolescent	O	O	B-T100
girls	O	O	I-T100
is	O	O	O
a	O	O	O
problem	O	O	B-T033
in	O	O	O
need	O	O	B-T080
of	O	O	O
public	O	O	B-T092
concern	O	O	B-T078
.	O	O	O

Compensated	O	O	B-T080
dating	O	O	B-T054
typically	O	O	O
involves	O	O	O
the	O	O	O
use	O	O	B-T169
of	O	O	I-T169
information	O	O	B-T170
communication	O	O	I-T170
technology	O	O	I-T170
to	O	O	O
advertise	O	O	B-T057
,	O	O	O
search	O	O	B-T052
,	O	O	O
bargain	O	O	B-T054
,	O	O	O
and	O	O	O
eventually	O	O	O
arrange	O	O	O
for	O	O	O
transactional	O	O	B-T054
sex	O	O	I-T054
.	O	O	O

The	O	O	O
technology	O	O	B-T170
enables	O	O	B-T041
the	O	O	O
sexual	O	O	B-T098
partners	O	O	I-T098
to	O	O	O
maintain	O	O	B-T052
privacy	O	O	B-T078
and	O	O	O
secrecy	O	O	B-T078
in	O	O	O
transactional	O	O	B-T054
sex	O	O	I-T054
.	O	O	O

Such	O	O	O
secrecy	O	O	B-T078
necessitates	O	O	B-T080
the	O	O	O
girls	O	O	B-T098
'	O	O	O
disclosure	O	O	B-T055
about	O	O	O
their	O	O	O
life	O	O	B-T067
experiences	O	O	I-T067
in	O	O	O
order	O	O	B-T080
to	O	O	O
address	O	O	O
the	O	O	O
concern	O	O	B-T078
.	O	O	O

The	O	O	O
disclosure	O	O	B-T055
is	O	O	O
the	O	O	O
focus	O	O	B-T169
of	O	O	O
the	O	O	O
present	O	O	O
qualitative	O	O	B-T062
study	O	O	I-T062
of	O	O	O
27	O	O	O
girls	O	O	B-T098
practicing	O	O	B-T041
the	O	O	O
dating	O	O	B-T054
in	O	O	O
Hong	O	O	B-T083
Kong	O	O	I-T083
,	O	O	O
China	O	O	B-T083
.	O	O	O

Based	O	O	B-T169
on	O	O	O
the	O	O	O
disclosure	O	O	B-T055
,	O	O	O
the	O	O	O
study	O	O	B-T062
presents	O	O	O
a	O	O	O
grounded	O	O	B-T170
theory	O	O	I-T170
that	O	O	O
epitomizes	O	O	O
engagement	O	O	B-T033
in	O	O	O
compensated	O	O	B-T080
dating	O	O	B-T054
by	O	O	O
referential	O	O	B-T055
choice	O	O	I-T055
.	O	O	O

Such	O	O	O
a	O	O	O
referential	O	O	B-T078
choice	O	O	B-T055
theory	O	O	I-T078
unravels	O	O	O
that	O	O	O
choice	O	O	O
with	O	O	O
reference	O	O	B-T169
to	O	O	O
the	O	O	O
family	O	O	B-T099
push	O	O	B-T067
and	O	O	O
social	O	O	B-T078
norms	O	O	I-T078
sustains	O	O	B-T169
the	O	O	O
engagement	O	O	B-T033
.	O	O	O

Meanwhile	O	O	O
,	O	O	O
the	O	O	O
choice	O	O	B-T055
rests	O	O	O
on	O	O	O
expectancy	O	O	B-T078
and	O	O	O
reinforcement	O	O	B-T169
from	O	O	O
experiential	O	O	B-T065
learning	O	O	I-T065
about	O	O	O
compensated	O	O	B-T080
dating	O	O	B-T054
.	O	O	O

The	O	O	O
theory	O	O	B-T078
thus	O	O	O
implies	O	O	O
ways	O	O	O
to	O	O	O
undercut	O	O	O
the	O	O	O
engagement	O	O	B-T033
through	O	O	B-T169
diverting	O	O	B-T080
the	O	O	O
referential	O	O	B-T055
choice	O	O	I-T055
of	O	O	O
the	O	O	O
dating	O	O	B-T054
.	O	O	O

-DOCSTART- (27552906)

Numerical	O	O	B-T062
simulation	O	O	I-T062
of	O	O	O
emitted	O	O	B-T104
particle	O	O	I-T104
characteristics	O	O	B-T080
and	O	O	O
airway	O	O	B-T023
deposition	O	O	B-T169
distribution	O	O	B-T039
of	O	O	O
Symbicort	O	O	B-T109
(	O	O	I-T109
Â®	O	O	I-T109
)	O	O	I-T109
Turbuhaler	O	O	I-T109
(	O	O	I-T109
Â®	O	O	I-T109
)	O	O	I-T109
dry	O	O	B-T122
powder	O	O	I-T122
fixed	O	O	O
combination	O	O	B-T121
aerosol	O	O	O
drug	O	O	O

One	O	O	O
of	O	O	O
the	O	O	O
most	O	O	O
widespread	O	O	O
dry	O	O	B-T122
powder	O	O	I-T122
fixed	O	O	O
combinations	O	O	B-T121
used	O	O	O
in	O	O	O
asthma	O	O	B-T047
and	O	O	O
chronic	O	O	B-T047
obstructive	O	O	I-T047
pulmonary	O	O	I-T047
disease	O	O	I-T047
(	O	O	O
COPD	O	O	B-T047
)	O	O	O
management	O	O	B-T058
is	O	O	O
Symbicort	O	O	B-T109
(	O	O	I-T109
Â®	O	O	I-T109
)	O	O	I-T109
Turbuhaler	O	O	I-T109
(	O	O	I-T109
Â®	O	O	I-T109
)	O	O	I-T109
.	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
simulate	O	O	B-T062
the	O	O	O
deposition	O	O	B-T169
distribution	O	O	B-T039
of	O	O	O
both	O	O	O
components	O	O	B-T185
of	O	O	O
this	O	O	O
drug	O	O	B-T121
within	O	O	O
the	O	O	O
airways	O	O	B-T023
based	O	O	O
on	O	O	O
realistic	O	O	O
airflow	O	O	B-T060
measurements	O	O	I-T060
.	O	O	O

Breathing	O	O	B-T040
parameters	O	O	B-T077
of	O	O	O
25	O	O	O
healthy	O	O	B-T033
adults	O	O	I-T033
(	O	O	O
11	O	O	O
females	O	O	B-T032
and	O	O	O
14	O	O	O
males	O	O	B-T032
)	O	O	O
were	O	O	O
acquired	O	O	B-T080
while	O	O	O
inhaling	O	O	B-T040
through	O	O	O
Turbuhaler	O	O	B-T074
(	O	O	I-T074
Â®	O	O	I-T074
)	O	O	I-T074
.	O	O	O

Individual	O	O	B-T098
specific	O	O	O
emitted	O	O	B-T081
doses	O	O	I-T081
and	O	O	O
particle	O	O	B-T081
size	O	O	I-T081
distributions	O	O	B-T039
of	O	O	O
Symbicort	O	O	B-T109
(	O	O	I-T109
Â®	O	O	I-T109
)	O	O	I-T109
Turbuhaler	O	O	I-T109
(	O	O	I-T109
Â®	O	O	I-T109
)	O	O	I-T109
were	O	O	O
determined	O	O	B-T080
.	O	O	O

A	O	O	O
self-developed	O	O	O
particle	O	O	B-T104
deposition	O	O	B-T169
model	O	O	B-T170
was	O	O	O
adapted	O	O	B-T169
and	O	O	O
validated	O	O	B-T169
to	O	O	O
simulate	O	O	B-T062
the	O	O	O
deposition	O	O	O
of	O	O	O
budesonide	O	O	B-T109
(	O	O	O
inhaled	O	O	B-T125
corticosteroid	O	O	I-T125
;	O	O	O
ICS	O	O	B-T125
)	O	O	O
and	O	O	O
formoterol	O	O	B-T109
(	O	O	O
long	O	O	B-T121
acting	O	O	I-T121
Î²2	O	O	I-T121
agonist	O	O	I-T121
;	O	O	O
LABA	O	O	B-T121
)	O	O	O
in	O	O	O
the	O	O	O
upper	O	O	B-T030
airways	O	O	I-T030
and	O	O	O
lungs	O	O	B-T023
of	O	O	O
the	O	O	O
healthy	O	O	B-T098
volunteers	O	O	I-T098
.	O	O	O

Based	O	O	O
on	O	O	O
current	O	O	B-T079
simulations	O	O	B-T062
the	O	O	O
emitted	O	O	B-T081
doses	O	O	I-T081
varied	O	O	O
between	O	O	O
50.4	O	O	O
%	O	O	O
and	O	O	O
92.5	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
metered	O	O	O
dose	O	O	B-T081
for	O	O	O
the	O	O	O
ICS	O	O	B-T125
,	O	O	O
and	O	O	O
between	O	O	O
38	O	O	O
%	O	O	O
and	O	O	O
96.1	O	O	O
%	O	O	O
in	O	O	O
case	O	O	O
of	O	O	O
LABA	O	O	B-T121
component	O	O	B-T185
depending	O	O	O
on	O	O	O
the	O	O	O
individual	O	O	B-T098
inhalation	O	O	B-T201
flow	O	O	I-T201
rate	O	O	I-T201
.	O	O	O

This	O	O	O
variability	O	O	B-T077
induced	O	O	B-T169
a	O	O	O
notable	O	O	O
inter-	O	O	O
individual	O	O	B-T098
spread	O	O	B-T080
of	O	O	O
the	O	O	O
deposited	O	O	B-T169
lung	O	O	B-T023
doses	O	O	B-T081
(	O	O	O
mean	O	O	O
:	O	O	O
33.6	O	O	O
%	O	O	O
,	O	O	O
range	O	O	B-T081
:	O	O	O
20.4%-48.8	O	O	O
%	O	O	O
for	O	O	O
budesonide	O	O	B-T109
and	O	O	O
mean	O	O	O
:	O	O	O
29.8	O	O	O
%	O	O	O
,	O	O	O
range	O	O	O
:	O	O	O
16.4%-42.9	O	O	O
%	O	O	O
for	O	O	O
formoterol	O	O	B-T109
)	O	O	O
.	O	O	O

Significant	O	O	B-T078
inter-gender	O	O	B-T032
differences	O	O	B-T080
were	O	O	O
also	O	O	O
observed	O	O	B-T169
.	O	O	O

Average	O	O	O
lung	O	O	B-T023
dose	O	O	B-T081
of	O	O	O
budesonide	O	O	B-T109
was	O	O	O
29.2	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
metered	O	O	O
dose	O	O	O
for	O	O	O
females	O	O	B-T032
and	O	O	O
37	O	O	O
%	O	O	O
for	O	O	O
males	O	O	B-T032
,	O	O	O
while	O	O	O
formoterol	O	O	B-T109
deposited	O	O	B-T169
with	O	O	O
26.4	O	O	O
%	O	O	O
efficiency	O	O	B-T081
for	O	O	O
females	O	O	O
and	O	O	O
32.5	O	O	O
%	O	O	O
for	O	O	O
males	O	O	O
.	O	O	O

Present	O	O	O
results	O	O	B-T169
also	O	O	O
highlighted	O	O	O
the	O	O	O
importance	O	O	B-T080
of	O	O	O
breath-holding	O	O	B-T033
after	O	O	O
inhalation	O	O	B-T040
of	O	O	O
the	O	O	O
drug	O	O	B-T121
.	O	O	O

About	O	O	O
a	O	O	O
half	O	O	O
of	O	O	O
the	O	O	O
total	O	O	O
lung	O	O	B-T023
deposition	O	O	B-T169
occurred	O	O	B-T052
during	O	O	O
breath-hold	O	O	B-T033
at	O	O	O
9.6s	O	O	O
average	O	O	O
breath-hold	O	O	O
time	O	O	B-T079
.	O	O	O

Calculated	O	O	O
depositions	O	O	B-T169
confirmed	O	O	B-T080
appropriate	O	O	B-T080
lung	O	O	B-T023
deposition	O	O	B-T169
of	O	O	O
Symbicort	O	O	B-T109
(	O	O	I-T109
Â®	O	O	I-T109
)	O	O	I-T109
Turbuhaler	O	O	I-T109
(	O	O	I-T109
Â®	O	O	I-T109
)	O	O	I-T109
for	O	O	O
both	O	O	O
genders	O	O	B-T032
,	O	O	O
however	O	O	O
more	O	O	O
effort	O	O	O
for	O	O	O
optimal	O	O	B-T061
inhalation	O	O	I-T061
technique	O	O	I-T061
is	O	O	O
advised	O	O	B-T078
for	O	O	O
persons	O	O	B-T098
with	O	O	O
low	O	O	B-T033
vital	O	O	I-T033
capacity	O	O	I-T033
.	O	O	O

This	O	O	O
study	O	O	B-T062
demonstrated	O	O	O
the	O	O	O
possibility	O	O	O
of	O	O	O
personalized	O	O	B-T080
prediction	O	O	B-T078
of	O	O	O
airway	O	O	B-T023
deposition	O	O	B-T169
of	O	O	O
aerosol	O	O	B-T122
drugs	O	O	I-T122
by	O	O	O
numerical	O	O	B-T062
simulations	O	O	I-T062
.	O	O	O

The	O	O	O
methodology	O	O	B-T078
developed	O	O	O
in	O	O	O
this	O	O	O
study	O	O	B-T062
will	O	O	O
be	O	O	O
applicable	O	O	B-T080
also	O	O	O
to	O	O	O
other	O	O	O
marketed	O	O	B-T080
drugs	O	O	B-T121
in	O	O	O
the	O	O	O
future	O	O	B-T079
.	O	O	O

-DOCSTART- (27553395)

Nutrient	O	O	B-T058
intake	O	O	I-T058
of	O	O	O
infants	O	O	B-T100
and	O	O	O
toddlers	O	O	B-T100
in	O	O	O
the	O	O	O
United	O	O	B-T083
Arab	O	O	I-T083
Emirates	O	O	I-T083
:	O	O	O
the	O	O	O
Feeding	O	O	O
Infants	O	O	B-T100
and	O	O	O
Toddlers	O	O	B-T100
Study	O	O	O

This	O	O	O
descriptive	O	O	O
study	O	O	O
evaluated	O	O	O
the	O	O	O
nutrient	O	O	B-T081
adequacy	O	O	I-T081
of	O	O	O
the	O	O	O
diet	O	O	B-T168
of	O	O	O
infants	O	O	B-T100
(	O	O	O
aged	O	O	O
6	O	O	O
-	O	O	O
11.9	O	O	O
months	O	O	O
)	O	O	O
and	O	O	O
toddlers	O	O	B-T100
(	O	O	O
aged	O	O	O
12	O	O	O
-	O	O	O
24	O	O	O
months	O	O	O
)	O	O	O
in	O	O	O
the	O	O	O
United	O	O	B-T083
Arab	O	O	I-T083
Emirates	O	O	I-T083
.	O	O	O

A	O	O	O
random	O	O	O
sample	O	O	O
of	O	O	O
1000	O	O	O
infants	O	O	B-T100
and	O	O	O
toddlers	O	O	B-T100
was	O	O	O
recruited	O	O	O
from	O	O	O
2	O	O	O
cities	O	O	O
(	O	O	O
Al	O	O	B-T083
Ain	O	O	I-T083
and	O	O	O
Dubai	O	O	B-T083
)	O	O	O
from	O	O	O
March	O	O	B-T079
2011	O	O	O
to	O	O	O
February	O	O	B-T080
2012	O	O	O
and	O	O	O
their	O	O	O
usual	O	O	O
nutrient	O	O	B-T058
intake	O	O	I-T058
was	O	O	O
determined	O	O	O
using	O	O	O
24-hour	O	O	O
recall	O	O	O
.	O	O	O

In	O	O	O
all	O	O	O
,	O	O	O
54.2	O	O	O
%	O	O	O
of	O	O	O
infants	O	O	B-T100
and	O	O	O
25.2	O	O	O
%	O	O	O
of	O	O	O
toddlers	O	O	B-T100
were	O	O	O
breastfeeding	O	O	B-T040
.	O	O	O

Mean	O	O	O
energy	O	O	B-T081
intake	O	O	I-T081
of	O	O	O
infant	O	O	B-T100
girls	O	O	I-T100
in	O	O	O
Al	O	O	B-T083
Ain	O	O	I-T083
and	O	O	O
Dubai	O	O	B-T083
was	O	O	O
747	O	O	O
(	O	O	O
SD	O	O	O
189	O	O	O
)	O	O	O
kcal	O	O	B-T081
and	O	O	O
773	O	O	O
(	O	O	O
SD	O	O	O
215	O	O	O
)	O	O	O
kcal	O	O	O
respectively	O	O	O
and	O	O	O
810.5	O	O	O
(	O	O	O
SD	O	O	O
232.2	O	O	O
)	O	O	O
kcal	O	O	O
and	O	O	O
821.9	O	O	O
(	O	O	O
SD	O	O	O
262	O	O	O
)	O	O	O
kcal	O	O	O
for	O	O	O
boys	O	O	B-T100
.	O	O	O

In	O	O	O
toddlers	O	O	B-T100
,	O	O	O
mean	O	O	O
energy	O	O	B-T081
intake	O	O	I-T081
for	O	O	O
girls	O	O	B-T100
in	O	O	O
Al	O	O	O
Ain	O	O	O
and	O	O	O
Dubai	O	O	O
was	O	O	O
1032.8	O	O	O
(	O	O	O
SD	O	O	O
252	O	O	O
)	O	O	O
kcal	O	O	B-T081
and	O	O	O
1013	O	O	O
(	O	O	O
SD	O	O	O
339.1	O	O	O
)	O	O	O
kcal	O	O	O
respectively	O	O	O
and	O	O	O
1057.2	O	O	O
(	O	O	O
SD	O	O	O
201.8	O	O	O
)	O	O	O
kcal	O	O	O
and	O	O	O
1030.3	O	O	O
(	O	O	O
SD	O	O	O
341.7	O	O	O
)	O	O	O
kcal	O	O	O
for	O	O	O
boys	O	O	B-T100
.	O	O	O

Iron	O	O	B-T033
intake	O	O	I-T033
was	O	O	O
low	O	O	B-T080
in	O	O	O
both	O	O	O
groups	O	O	O
.	O	O	O

Mean	O	O	O
body	O	O	B-T201
mass	O	O	I-T201
index	O	O	I-T201
and	O	O	O
body	O	O	B-T032
weight	O	O	I-T032
and	O	O	O
height	O	O	B-T032
were	O	O	O
similar	O	O	O
to	O	O	O
World	O	O	B-T093
Health	O	O	I-T093
Organization	O	O	I-T093
figures	O	O	O
but	O	O	O
significant	O	O	O
numbers	O	O	O
of	O	O	O
infants	O	O	B-T100
and	O	O	O
toddlers	O	O	B-T100
of	O	O	O
both	O	O	O
sexes	O	O	O
were	O	O	O
over	O	O	B-T184
-	O	O	O
or	O	O	O
underweight	O	O	B-T033
.	O	O	O

Although	O	O	O
mean	O	O	O
energy	O	O	O
and	O	O	O
macronutrient	O	O	B-T077
intakes	O	O	B-T058
were	O	O	O
comparable	O	O	O
to	O	O	O
the	O	O	O
RDA	O	O	B-T170
,	O	O	O
significant	O	O	O
numbers	O	O	O
were	O	O	O
over	O	O	B-T047
-	O	O	O
or	O	O	O
underfed	O	O	B-T047
.	O	O	O

-DOCSTART- (27553875)

Estimation	O	O	O
of	O	O	O
the	O	O	O
HIV-1	O	O	B-T005
backward	O	O	B-T082
mutation	O	O	B-T080
rate	O	O	I-T080
from	O	O	O
transmitted	O	O	B-T038
drug-resistant	O	O	I-T038
strains	O	O	O

One	O	O	O
of	O	O	O
the	O	O	O
serious	O	O	O
threats	O	O	B-T078
facing	O	O	O
the	O	O	O
administration	O	O	O
of	O	O	O
antiretroviral	O	O	B-T061
therapy	O	O	I-T061
to	O	O	O
human	O	O	B-T005
immunodeficiency	O	O	I-T005
virus	O	O	I-T005
(	O	O	O
HIV-1	O	O	B-T005
)	O	O	O
infected	O	O	B-T047
patients	O	O	B-T101
is	O	O	O
the	O	O	O
reported	O	O	O
increasing	O	O	B-T081
prevalence	O	O	I-T081
of	O	O	O
transmitted	O	O	B-T038
drug	O	O	I-T038
resistance	O	O	I-T038
.	O	O	O

However	O	O	O
,	O	O	O
given	O	O	O
that	O	O	O
HIV-1	O	O	B-T005
drug-resistant	O	O	B-T038
strains	O	O	B-T001
are	O	O	O
often	O	O	O
less	O	O	O
fit	O	O	O
than	O	O	O
the	O	O	O
wild-type	O	O	B-T028
strains	O	O	O
,	O	O	O
it	O	O	O
is	O	O	O
expected	O	O	O
that	O	O	O
drug-resistant	O	O	O
strains	O	O	O
that	O	O	O
are	O	O	O
present	O	O	O
during	O	O	O
the	O	O	O
primary	O	O	B-T080
phase	O	O	B-T079
of	O	O	O
the	O	O	O
HIV-1	O	O	B-T047
infection	O	O	I-T047
are	O	O	O
replaced	O	O	B-T169
by	O	O	O
the	O	O	O
fitter	O	O	O
wild-type	O	O	O
strains	O	O	O
.	O	O	O

This	O	O	O
replacement	O	O	B-T169
of	O	O	O
HIV-1	O	O	B-T033
resistant	O	O	I-T033
mutations	O	O	B-T045
involves	O	O	O
the	O	O	O
emergence	O	O	O
of	O	O	O
wild-type	O	O	B-T028
strains	O	O	B-T001
by	O	O	O
a	O	O	O
process	O	O	B-T067
of	O	O	O
backward	O	O	B-T082
mutation	O	O	B-T045
.	O	O	O

How	O	O	O
quickly	O	O	O
the	O	O	O
replacement	O	O	B-T169
happens	O	O	O
is	O	O	O
dependent	O	O	B-T169
on	O	O	O
the	O	O	O
class	O	O	O
of	O	O	O
HIV-1	O	O	B-T005
mutation	O	O	B-T045
group	O	O	B-T078
.	O	O	O

We	O	O	O
estimate	O	O	O
the	O	O	O
backward	O	O	B-T082
mutation	O	O	B-T080
rates	O	O	I-T080
and	O	O	O
relative	O	O	O
fitness	O	O	O
of	O	O	O
various	O	O	O
mutational	O	O	B-T045
groups	O	O	B-T078
known	O	O	O
to	O	O	O
confer	O	O	O
HIV-1	O	O	B-T005
drug	O	O	B-T038
resistance	O	O	I-T038
.	O	O	O

We	O	O	O
do	O	O	O
this	O	O	O
by	O	O	O
fitting	O	O	O
a	O	O	O
stochastic	O	O	B-T062
model	O	O	I-T062
to	O	O	O
data	O	O	B-T078
for	O	O	O
individuals	O	O	B-T098
who	O	O	O
were	O	O	O
originally	O	O	O
infected	O	O	B-T033
by	O	O	O
an	O	O	O
HIV-1	O	O	B-T005
strain	O	O	B-T001
carrying	O	O	O
any	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
known	O	O	O
drug	O	O	B-T038
resistance	O	O	I-T038
-conferring	O	O	O
mutations	O	O	B-T045
and	O	O	O
observed	O	O	O
over	O	O	O
a	O	O	O
period	O	O	B-T201
of	O	O	I-T201
time	O	O	I-T201
to	O	O	O
see	O	O	O
whether	O	O	O
the	O	O	O
resistant	O	O	B-T169
strain	O	O	O
is	O	O	O
replaced	O	O	B-T169
.	O	O	O

To	O	O	O
do	O	O	O
this	O	O	O
,	O	O	O
we	O	O	O
seek	O	O	O
a	O	O	O
distribution	O	O	B-T169
,	O	O	O
generated	O	O	O
from	O	O	O
simulations	O	O	B-T062
of	O	O	O
the	O	O	O
stochastic	O	O	B-T062
model	O	O	I-T062
,	O	O	O
that	O	O	O
best	O	O	O
describes	O	O	O
the	O	O	O
observed	O	O	B-T169
(	O	O	O
clinical	O	O	B-T170
data	O	O	I-T170
)	O	O	O
replacement	O	O	B-T169
times	O	O	B-T081
of	O	O	O
a	O	O	O
given	O	O	O
mutation	O	O	B-T045
.	O	O	O

We	O	O	O
found	O	O	O
that	O	O	O
Lamivudine/Emtricitabine	O	O	B-T195
-associated	O	O	O
mutations	O	O	B-T045
have	O	O	O
a	O	O	O
distinctly	O	O	O
higher	O	O	O
,	O	O	O
backward	O	O	B-T082
mutation	O	O	B-T080
rate	O	O	I-T080
and	O	O	O
low	O	O	O
relative	O	O	B-T080
fitness	O	O	B-T056
compared	O	O	O
to	O	O	O
the	O	O	O
other	O	O	O
classes	O	O	B-T170
(	O	O	O
as	O	O	O
has	O	O	O
been	O	O	O
reported	O	O	O
before	O	O	O
)	O	O	O
while	O	O	O
protease	O	O	B-T121
inhibitors	O	O	I-T121
-associated	O	O	O
mutations	O	O	O
have	O	O	O
a	O	O	O
slower	O	O	O
backward	O	O	O
mutation	O	O	O
rate	O	O	O
and	O	O	O
high	O	O	O
relative	O	O	O
fitness	O	O	O
.	O	O	O

For	O	O	O
the	O	O	O
other	O	O	O
mutation	O	O	B-T045
classes	O	O	B-T170
,	O	O	O
we	O	O	O
found	O	O	O
more	O	O	O
uncertainty	O	O	O
in	O	O	O
their	O	O	O
estimates	O	O	B-T081
.	O	O	O

-DOCSTART- (27555752)

Modeling	O	O	B-T062
the	O	O	O
hospital	O	O	B-T093
safety	O	O	B-T068
partnership	O	O	B-T058
preferences	O	O	B-T080
of	O	O	I-T080
patients	O	O	I-T080
and	O	O	O
their	O	O	O
families	O	O	B-T099
:	O	O	O
a	O	O	O
discrete	O	O	B-T080
choice	O	O	B-T055
conjoint	O	O	O
experiment	O	O	O

Patients	O	O	B-T101
and	O	O	O
their	O	O	O
families	O	O	B-T099
play	O	O	O
an	O	O	O
important	O	O	O
role	O	O	B-T077
in	O	O	O
efforts	O	O	O
to	O	O	O
improve	O	O	B-T077
health	O	O	B-T058
service	O	O	I-T058
safety	O	O	B-T068
.	O	O	O

The	O	O	O
objective	O	O	B-T170
of	O	O	O
this	O	O	O
study	O	O	B-T062
is	O	O	O
to	O	O	O
understand	O	O	O
the	O	O	O
safety	O	O	B-T068
partnership	O	O	B-T058
preferences	O	O	B-T080
of	O	O	I-T080
patients	O	O	I-T080
and	O	O	O
their	O	O	O
families	O	O	B-T099
.	O	O	O

We	O	O	O
used	O	O	O
a	O	O	O
discrete	O	O	B-T080
choice	O	O	B-T055
conjoint	O	O	B-T062
experiment	O	O	I-T062
to	O	O	O
model	O	O	O
the	O	O	O
safety	O	O	B-T068
partnership	O	O	B-T058
preferences	O	O	B-T080
of	O	O	O
1,084	O	O	O
patients	O	O	B-T101
or	O	O	O
those	O	O	O
such	O	O	O
as	O	O	O
parents	O	O	B-T099
acting	O	O	O
on	O	O	O
their	O	O	O
behalf	O	O	O
.	O	O	O

Participants	O	O	B-T098
made	O	O	O
choices	O	O	B-T055
between	O	O	O
hypothetical	O	O	O
safety	O	O	B-T068
partnerships	O	O	B-T058
composed	O	O	O
by	O	O	O
experimentally	O	O	O
varying	O	O	O
15	O	O	O
four-level	O	O	O
partnership	O	O	B-T058
design	O	O	B-T052
attributes	O	O	B-T055
.	O	O	O

Participants	O	O	B-T098
preferred	O	O	B-T078
an	O	O	O
approach	O	O	B-T082
to	O	O	O
safety	O	O	B-T068
based	O	O	O
on	O	O	O
partnerships	O	O	B-T058
between	O	O	O
patients	O	O	B-T101
and	O	O	O
staff	O	O	B-T097
rather	O	O	O
than	O	O	O
a	O	O	O
model	O	O	O
delegating	O	O	O
responsibility	O	O	B-T055
for	O	O	O
safety	O	O	O
to	O	O	O
hospital	O	O	B-T097
staff	O	O	I-T097
.	O	O	O

They	O	O	O
valued	O	O	O
the	O	O	O
opportunity	O	O	B-UnknownType
to	O	O	I-UnknownType
participate	O	O	I-UnknownType
in	O	O	O
point	O	O	O
of	O	O	O
service	O	O	O
safety	O	O	B-T068
partnerships	O	O	B-T058
,	O	O	O
such	O	O	O
as	O	O	O
identity	O	O	O
and	O	O	O
medication	O	O	B-T058
double	O	O	I-T058
checks	O	O	I-T058
,	O	O	O
that	O	O	O
might	O	O	O
afford	O	O	O
an	O	O	O
immediate	O	O	B-T079
risk	O	O	B-T055
reduction	O	O	I-T055
.	O	O	O

Latent	O	O	O
class	O	O	O
analysis	O	O	B-T062
yielded	O	O	O
two	O	O	O
segments	O	O	O
.	O	O	O

Actively	O	O	B-T098
engaged	O	O	I-T098
participants	O	O	I-T098
(	O	O	O
73.3	O	O	O
%	O	O	O
)	O	O	O
comprised	O	O	O
outpatients	O	O	B-T101
with	O	O	O
higher	O	O	B-T065
education	O	O	I-T065
,	O	O	O
who	O	O	O
anticipated	O	O	B-T033
more	O	O	O
benefits	O	O	B-T081
to	O	O	O
safety	O	O	B-T068
partnerships	O	O	B-T058
,	O	O	O
were	O	O	O
more	O	O	B-T033
confident	O	O	I-T033
in	O	O	O
their	O	O	O
ability	O	O	B-T032
to	O	O	O
contribute	O	O	B-T052
,	O	O	O
and	O	O	O
were	O	O	O
more	O	O	O
intent	O	O	B-T080
on	O	O	O
participating	O	O	B-T169
.	O	O	O

They	O	O	O
were	O	O	O
more	O	O	O
likely	O	O	O
to	O	O	O
prefer	O	O	B-T080
a	O	O	O
personal	O	O	O
engagement	O	O	B-T058
strategy	O	O	B-T041
,	O	O	O
valued	O	O	O
scientific	O	O	B-T078
evidence	O	O	I-T078
,	O	O	O
preferred	O	O	B-T078
a	O	O	O
more	O	O	O
active	O	O	O
approach	O	O	B-T082
to	O	O	O
safety	O	O	B-T065
education	O	O	I-T065
,	O	O	O
and	O	O	O
advocated	O	O	O
disclosure	O	O	B-T080
of	O	O	I-T080
errors	O	O	I-T080
.	O	O	O

The	O	O	O
passively	O	O	O
engaged	O	O	O
segment	O	O	O
(	O	O	O
26.7	O	O	O
%	O	O	O
)	O	O	O
anticipated	O	O	B-T033
fewer	O	O	B-T081
benefits	O	O	B-T081
,	O	O	O
were	O	O	O
less	O	O	O
confident	O	O	B-T055
in	O	O	O
their	O	O	O
ability	O	O	B-T032
to	O	O	O
contribute	O	O	B-T052
,	O	O	O
and	O	O	O
were	O	O	O
less	O	O	O
intent	O	O	O
on	O	O	O
participating	O	O	B-T169
.	O	O	O

They	O	O	O
were	O	O	O
more	O	O	O
likely	O	O	O
to	O	O	O
prefer	O	O	O
an	O	O	O
engagement	O	O	B-T058
strategy	O	O	B-T041
based	O	O	O
on	O	O	O
signage	O	O	B-T073
.	O	O	O

They	O	O	O
preferred	O	O	B-T078
that	O	O	O
staff	O	O	B-T097
explain	O	O	O
why	O	O	O
they	O	O	O
thought	O	O	O
patients	O	O	B-T101
should	O	O	O
help	O	O	O
make	O	O	O
care	O	O	B-T058
safer	O	O	O
and	O	O	O
decide	O	O	O
whether	O	O	O
errors	O	O	B-T080
were	O	O	O
disclosed	O	O	O
.	O	O	O

Inpatients	O	O	B-T101
,	O	O	O
those	O	O	O
with	O	O	O
immigrant	O	O	B-T033
backgrounds	O	O	I-T033
,	O	O	O
and	O	O	O
those	O	O	O
with	O	O	O
less	O	O	B-T033
education	O	O	I-T033
were	O	O	O
more	O	O	O
likely	O	O	O
to	O	O	O
be	O	O	O
in	O	O	O
this	O	O	O
segment	O	O	O
.	O	O	O

Health	O	O	B-T058
services	O	O	I-T058
need	O	O	O
to	O	O	O
communicate	O	O	O
information	O	O	B-T078
regarding	O	O	O
risks	O	O	B-T078
,	O	O	O
ask	O	O	O
about	O	O	O
partnership	O	O	B-T058
preferences	O	O	B-T080
,	O	O	O
create	O	O	O
opportunities	O	O	B-UnknownType
respecting	O	O	O
individual	O	O	B-T054
differences	O	O	I-T054
,	O	O	O
and	O	O	O
ensure	O	O	O
a	O	O	O
positive	O	O	B-T033
response	O	O	I-T033
when	O	O	O
patients	O	O	B-T101
raise	O	O	O
safety	O	O	B-T068
concerns	O	O	B-T078
.	O	O	O

-DOCSTART- (27555898)

Influence	O	O	O
of	O	O	O
ozone	O	O	B-T103
and	O	O	O
paracetic	O	O	B-T109
acid	O	O	I-T109
disinfection	O	O	B-T061
on	O	O	O
adhesion	O	O	B-T070
of	O	O	I-T070
resilient	O	O	B-T122
liners	O	O	I-T122
to	O	O	O
acrylic	O	O	O
resin	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
this	O	O	O
study	O	O	O
was	O	O	O
to	O	O	O
evaluate	O	O	O
the	O	O	O
effect	O	O	O
of	O	O	O
paracetic	O	O	B-T109
acid	O	O	I-T109
(	O	O	O
PAA	O	O	B-T109
)	O	O	O
and	O	O	O
ozone	O	O	B-T103
disinfection	O	O	B-T061
on	O	O	O
the	O	O	O
tensile	O	O	B-T081
bond	O	O	I-T081
strength	O	O	I-T081
(	O	O	O
TBS	O	O	B-T081
)	O	O	O
of	O	O	O
silicone-based	O	O	B-T109
resilient	O	O	B-T122
liners	O	O	I-T122
to	O	O	O
acrylic	O	O	B-T122
resins	O	O	I-T122
.	O	O	O

One	O	O	O
hundred	O	O	O
and	O	O	O
twenty	O	O	O
dumbbell	O	O	B-T082
shaped	O	O	I-T082
heat-polymerized	O	O	B-T067
acrylic	O	O	B-T122
resins	O	O	I-T122
were	O	O	O
prepared	O	O	O
.	O	O	O

From	O	O	O
the	O	O	O
mid	O	O	O
segment	O	O	O
of	O	O	O
the	O	O	O
specimens	O	O	B-T167
,	O	O	O
3	O	O	O
mm	O	O	O
of	O	O	O
acrylic	O	O	B-T122
were	O	O	O
grinded	O	O	O
off	O	O	O
and	O	O	O
separated	O	O	O
parts	O	O	O
were	O	O	O
reattached	O	O	O
by	O	O	O
resilient	O	O	B-T122
liners	O	O	I-T122
.	O	O	O

The	O	O	O
specimens	O	O	B-T167
were	O	O	O
divided	O	O	O
into	O	O	O
2	O	O	B-T167
control	O	O	I-T167
(	O	O	O
control1	O	O	B-T167
,	O	O	O
control7	O	O	B-T167
)	O	O	O
and	O	O	O
4	O	O	O
test	O	O	O
groups	O	O	O
of	O	O	O
PAA	O	O	B-T109
and	O	O	O
ozone	O	O	B-T103
disinfection	O	O	B-T061
(	O	O	O
PAA1	O	O	B-T109
,	O	O	O
PAA7	O	O	B-T109
,	O	O	O
ozone1	O	O	B-T103
and	O	O	O
ozone7	O	O	B-T103
;	O	O	O
n=10	O	O	O
)	O	O	O
.	O	O	O

While	O	O	O
control	O	O	O
groups	O	O	O
were	O	O	O
immersed	O	O	O
in	O	O	O
distilled	O	O	B-T121
water	O	O	B-T121
for	O	O	O
10	O	O	O
min	O	O	O
(	O	O	O
control1	O	O	B-T167
)	O	O	O
and	O	O	O
7	O	O	O
days	O	O	O
(	O	O	O
control7	O	O	B-T167
)	O	O	O
,	O	O	O
test	O	O	O
groups	O	O	O
were	O	O	O
subjected	O	O	O
to	O	O	O
PAA	O	O	B-T109
(	O	O	O
16	O	O	O
g/L	O	O	O
)	O	O	O
or	O	O	O
ozone	O	O	B-T103
rich	O	O	O
water	O	O	O
(	O	O	O
4	O	O	O
mg/L	O	O	O
)	O	O	O
for	O	O	O
1	O	O	O
cycle	O	O	O
(	O	O	O
10	O	O	O
min	O	O	O
for	O	O	O
PAA	O	O	O
and	O	O	O
60	O	O	O
min	O	O	O
for	O	O	O
ozone	O	O	O
)	O	O	O
per	O	O	O
day	O	O	O
for	O	O	O
7	O	O	O
days	O	O	O
prior	O	O	O
to	O	O	O
tensile	O	O	B-T081
tests	O	O	B-T059
.	O	O	O

Measurements	O	O	O
of	O	O	O
the	O	O	O
TBS	O	O	B-T081
were	O	O	O
analyzed	O	O	O
using	O	O	O
3-way	O	O	O
ANOVA	O	O	B-T081
and	O	O	O
Tukey	O	O	B-T059
's	O	O	I-T059
HSD	O	O	I-T059
test	O	O	I-T059
.	O	O	O

Adhesive	O	O	B-T073
strength	O	O	B-T078
of	O	O	O
Mollosil	O	O	B-T109
decreased	O	O	O
significantly	O	O	O
by	O	O	O
application	O	O	O
of	O	O	O
ozone	O	O	B-T103
disinfection	O	O	B-T061
.	O	O	O

PAA	O	O	B-T109
disinfection	O	O	B-T061
had	O	O	O
no	O	O	O
negative	O	O	O
effect	O	O	O
on	O	O	O
the	O	O	O
TBS	O	O	B-T081
values	O	O	O
of	O	O	O
Mollosil	O	O	B-T109
and	O	O	O
Molloplast	O	O	B-T109
B	O	O	I-T109
to	O	O	O
acrylic	O	O	B-T122
resin	O	O	I-T122
.	O	O	O

Single	O	O	O
application	O	O	O
of	O	O	O
ozone	O	O	B-T103
disinfection	O	O	B-T061
did	O	O	O
not	O	O	O
have	O	O	O
any	O	O	O
negative	O	O	O
effect	O	O	O
on	O	O	O
TBS	O	O	B-T081
values	O	O	O
of	O	O	O
Molloplast	O	O	B-T109
B	O	O	I-T109
,	O	O	O
but	O	O	O
prolonged	O	O	B-T079
exposure	O	O	B-T033
to	O	O	I-T033
ozone	O	O	I-T033
decreased	O	O	O
its	O	O	O
adhesive	O	O	B-T073
strength	O	O	B-T078
.	O	O	O

The	O	O	O
adhesion	O	O	B-T070
of	O	O	O
resilient	O	O	B-T122
liners	O	O	I-T122
to	O	O	O
acrylic	O	O	O
was	O	O	O
not	O	O	O
adversely	O	O	O
affected	O	O	O
by	O	O	O
PAA	O	O	B-T109
disinfection	O	O	B-T061
.	O	O	O

Immersion	O	O	O
in	O	O	O
ozonated	O	O	B-T052
water	O	O	B-T121
significantly	O	O	O
decreased	O	O	O
TBS	O	O	B-T081
of	O	O	O
Mollosil	O	O	B-T109
.	O	O	O

Prolonged	O	O	O
exposure	O	O	O
to	O	O	O
ozone	O	O	B-T103
negatively	O	O	O
affects	O	O	O
adhesion	O	O	B-T070
of	O	O	O
Molloplast	O	O	B-T109
B	O	O	I-T109
to	O	O	O
denture	O	O	B-T074
base	O	O	I-T074
materials	O	O	I-T074
.	O	O	O

-DOCSTART- (27563025)

The	O	O	O
construction	O	O	B-T052
of	O	O	O
three-dimensional	O	O	B-T082
composite	O	O	B-T122
fibrous	O	O	B-T080
macrostructures	O	O	B-T082
with	O	O	B-T080
nanotextures	O	O	I-T080
for	O	O	O
biomedical	O	O	B-T091
applications	O	O	O

The	O	O	O
development	O	O	O
of	O	O	O
modern	O	O	O
biomedical	O	O	B-T091
nanotechnology	O	O	B-T090
requires	O	O	O
three-dimensional	O	O	B-T082
macrostructures	O	O	B-T082
with	O	O	B-T080
nanotextures	O	O	I-T080
to	O	O	O
meet	O	O	O
the	O	O	O
requirements	O	O	O
for	O	O	O
practical	O	O	O
applications	O	O	B-T169
in	O	O	O
intricate	O	O	O
biological	O	O	B-T022
systems	O	O	I-T022
.	O	O	O

Additionally	O	O	O
,	O	O	O
the	O	O	O
restoration	O	O	B-UnknownType
and	O	O	O
regeneration	O	O	B-T040
of	O	O	O
some	O	O	O
specific	O	O	O
body	O	O	B-T024
tissues	O	O	I-T024
and	O	O	O
organs	O	O	B-T023
rely	O	O	O
on	O	O	O
the	O	O	O
function	O	O	O
of	O	O	O
conductive	O	O	B-T122
polymers	O	O	I-T122
,	O	O	O
which	O	O	O
can	O	O	O
provide	O	O	O
electrical	O	O	B-T169
cues	O	O	B-T078
for	O	O	O
cells	O	O	B-T025
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	O
,	O	O	O
we	O	O	O
fabricated	O	O	O
three-dimensional	O	O	B-T082
composite	O	O	B-T122
nanofibre	O	O	B-T073
macrostructures	O	O	B-T082
of	O	O	O
polycaprolactone	O	O	B-T109
(	O	O	O
PCL	O	O	B-T109
)	O	O	O
with	O	O	O
different	O	O	O
concentrations	O	O	B-T081
of	O	O	O
polyaniline	O	O	B-T109
(	O	O	O
PANi	O	O	B-T109
)	O	O	O
by	O	O	O
employing	O	O	O
an	O	O	O
improved	O	O	O
electrospinning	O	O	B-T169
technology	O	O	I-T169
with	O	O	O
a	O	O	O
specially	O	O	O
designed	O	O	O
collector	O	O	O
.	O	O	O

The	O	O	O
3D	O	O	B-T082
structures	O	O	B-T082
possessed	O	O	O
cap-like	O	O	B-T082
macrostructures	O	O	I-T082
with	O	O	O
centimetre-scale	O	O	B-T081
thickness	O	O	B-T080
and	O	O	O
interconnected	O	O	O
pore	O	O	B-T080
nanotextures	O	O	I-T080
with	O	O	O
nanometre-scale	O	O	B-T081
nanofibres	O	O	B-T073
.	O	O	O

To	O	O	O
estimate	O	O	O
the	O	O	O
biocompatibility	O	O	B-T044
of	O	O	O
the	O	O	O
3D	O	O	B-T082
PCL	O	O	B-T109
/	O	O	O
PANi	O	O	B-T109
composite	O	O	B-T122
nanofibre	O	O	B-T073
macrostructures	O	O	B-T082
,	O	O	O
mouse	O	O	B-T015
myoblasts	O	O	B-T025
(	O	O	O
C2C12	O	O	B-T025
cells	O	O	B-T025
)	O	O	O
were	O	O	O
cultured	O	O	O
as	O	O	O
model	O	O	B-T050
cells	O	O	O
.	O	O	O

The	O	O	O
initial	O	O	O
responses	O	O	O
of	O	O	O
C2C12	O	O	B-T025
cells	O	O	B-T025
to	O	O	O
the	O	O	O
3D	O	O	B-T082
PCL	O	O	B-T109
/	O	O	O
PANi	O	O	B-T109
composite	O	O	B-T122
macrostructures	O	O	B-T082
were	O	O	O
significantly	O	O	O
superior	O	O	O
to	O	O	O
those	O	O	O
to	O	O	O
pure	O	O	O
PCL	O	O	O
,	O	O	O
that	O	O	O
is	O	O	O
,	O	O	O
the	O	O	O
cells	O	O	O
exhibited	O	O	O
typical	O	O	O
myoblast-like	O	O	B-T080
morphologies	O	O	I-T080
with	O	O	O
obvious	O	O	O
pseudopodia	O	O	B-T026
and	O	O	O
the	O	O	O
moderate	O	O	O
incorporation	O	O	O
(	O	O	O
less	O	O	O
than	O	O	O
2.0	O	O	O
wt%	O	O	O
)	O	O	O
of	O	O	O
conductive	O	O	O
PANi	O	O	O
facilitated	O	O	O
cell	O	O	B-T043
proliferation	O	O	I-T043
,	O	O	O
which	O	O	O
indicated	O	O	O
that	O	O	O
PANi	O	O	O
has	O	O	O
appreciable	O	O	O
cell	O	O	B-T038
affinity	O	O	I-T038
.	O	O	O

Moreover	O	O	O
,	O	O	O
the	O	O	O
addition	O	O	O
of	O	O	O
conductive	O	O	B-T080
PANi	O	O	B-T109
to	O	O	O
the	O	O	O
3D	O	O	B-T082
composite	O	O	B-T122
nanofibre	O	O	B-T073
macrostructures	O	O	B-T082
considerably	O	O	O
enhanced	O	O	O
myoblast	O	O	B-T043
differentiation	O	O	I-T043
and	O	O	O
myotube	O	O	B-T043
maturation	O	O	I-T043
.	O	O	O

These	O	O	O
results	O	O	O
suggest	O	O	O
that	O	O	O
electrospun	O	O	B-T080
3D	O	O	B-T082
PCL	O	O	B-T109
/	O	O	O
PANi	O	O	B-T109
composite	O	O	B-T122
nanofibre	O	O	B-T073
macrostructures	O	O	B-T082
would	O	O	O
have	O	O	O
promising	O	O	O
applications	O	O	B-T169
in	O	O	O
tissue	O	O	B-T061
engineering	O	O	I-T061
.	O	O	O

-DOCSTART- (27569827)

Mechanisms	O	O	B-T169
of	O	O	O
replacement	O	O	B-T169
of	O	O	O
circulating	O	O	B-T169
viruses	O	O	B-T005
by	O	O	O
seasonal	O	O	B-T047
and	O	O	O
pandemic	O	O	O
influenza	O	O	O
A	O	O	O
viruses	O	O	O

Seasonal	O	O	B-T047
influenza	O	O	I-T047
causes	O	O	O
annual	O	O	O
epidemics	O	O	B-T067
by	O	O	O
the	O	O	O
accumulation	O	O	B-T033
of	O	O	O
antigenic	O	O	B-T044
changes	O	O	I-T044
.	O	O	O

Pandemic	O	O	B-T047
influenza	O	O	I-T047
occurs	O	O	O
through	O	O	O
a	O	O	O
major	O	O	O
antigenic	O	O	B-T044
change	O	O	I-T044
of	O	O	O
the	O	O	O
influenza	O	O	B-T005
A	O	O	I-T005
virus	O	O	I-T005
,	O	O	O
which	O	O	O
can	O	O	O
originate	O	O	B-T079
from	O	O	O
other	O	O	O
hosts	O	O	B-T001
.	O	O	O

Although	O	O	O
new	O	O	O
antigenic	O	O	B-T044
variants	O	O	I-T044
of	O	O	O
the	O	O	O
influenza	O	O	B-T005
A	O	O	I-T005
virus	O	O	I-T005
replace	O	O	O
formerly	O	O	O
circulating	O	O	B-T169
seasonal	O	O	B-T005
and	O	O	O
pandemic	O	O	B-T005
viruses	O	O	I-T005
,	O	O	O
replacement	O	O	B-T169
mechanisms	O	O	B-T169
remain	O	O	O
poorly	O	O	O
understood	O	O	O
.	O	O	O

A	O	O	O
stochastic	O	O	B-T170
individual-based	O	O	I-T170
SEIR	O	O	I-T170
(	O	O	I-T170
susceptible-exposed-infectious-recovered	O	O	I-T170
)	O	O	I-T170
model	O	O	I-T170
with	O	O	O
two	O	O	O
viral	O	O	B-T001
strains	O	O	I-T001
(	O	O	O
formerly	O	O	O
circulating	O	O	B-T169
old	O	O	B-T001
strain	O	O	I-T001
and	O	O	O
newly	O	O	B-T001
emerged	O	O	I-T001
strain	O	O	I-T001
)	O	O	O
was	O	O	O
developed	O	O	O
for	O	O	O
simulations	O	O	B-T062
to	O	O	O
elucidate	O	O	O
the	O	O	O
replacement	O	O	B-T169
mechanisms	O	O	B-T169
.	O	O	O

Factors	O	O	B-T169
and	O	O	O
conditions	O	O	B-T080
of	O	O	O
virus	O	O	B-T005
and	O	O	O
host	O	O	B-T001
populations	O	O	O
affecting	O	O	O
the	O	O	O
replacement	O	O	B-T169
were	O	O	O
identified	O	O	O
.	O	O	O

Replacement	O	O	O
is	O	O	O
more	O	O	O
likely	O	O	O
to	O	O	O
occur	O	O	O
in	O	O	O
tropical	O	O	B-T083
regions	O	O	I-T083
than	O	O	O
temperate	O	O	B-T083
regions	O	O	I-T083
.	O	O	O

The	O	O	O
magnitude	O	O	B-T081
of	O	O	O
the	O	O	O
ongoing	O	O	O
epidemic	O	O	B-T067
by	O	O	O
the	O	O	O
old	O	O	B-T001
strain	O	O	I-T001
,	O	O	O
herd	O	O	B-T039
immunity	O	O	I-T039
against	O	O	O
the	O	O	O
old	O	O	O
strain	O	O	O
,	O	O	O
and	O	O	O
timing	O	O	B-T079
of	O	O	O
appearance	O	O	B-T080
of	O	O	O
the	O	O	O
new	O	O	B-T001
strain	O	O	I-T001
are	O	O	O
not	O	O	O
that	O	O	O
important	O	O	O
for	O	O	O
replacement	O	O	B-T169
.	O	O	O

It	O	O	O
is	O	O	O
probable	O	O	O
that	O	O	O
the	O	O	O
frequency	O	O	O
of	O	O	O
replacement	O	O	B-T169
by	O	O	O
a	O	O	O
pandemic	O	O	B-T005
virus	O	O	I-T005
is	O	O	O
higher	O	O	O
than	O	O	O
a	O	O	O
seasonal	O	O	B-T005
virus	O	O	I-T005
because	O	O	O
of	O	O	O
the	O	O	O
high	O	O	O
initial	O	O	O
susceptibility	O	O	B-T169
and	O	O	O
high	O	O	O
basic	O	O	O
reproductive	O	O	B-T040
number	O	O	O
of	O	O	O
the	O	O	O
pandemic	O	O	O
virus	O	O	O
.	O	O	O

The	O	O	O
findings	O	O	O
of	O	O	O
this	O	O	O
study	O	O	O
on	O	O	O
replacement	O	O	B-T169
mechanisms	O	O	B-T169
could	O	O	O
lead	O	O	O
to	O	O	O
a	O	O	O
better	O	O	O
understanding	O	O	O
of	O	O	O
virus	O	O	B-T043
transmission	O	O	I-T043
dynamics	O	O	B-T070
and	O	O	O
may	O	O	O
possibly	O	O	O
be	O	O	O
helpful	O	O	O
in	O	O	O
establishing	O	O	O
an	O	O	O
effective	O	O	B-T080
strategy	O	O	O
to	O	O	O
mitigate	O	O	B-T067
the	O	O	O
impact	O	O	O
of	O	O	O
seasonal	O	O	B-T047
and	O	O	O
pandemic	O	O	B-T047
influenza	O	O	I-T047
.	O	O	O

-DOCSTART- (27570140)

Request	O	O	B-T052
and	O	O	O
fulfillment	O	O	B-T169
of	O	O	O
postpartum	O	O	B-T079
tubal	O	O	B-T061
ligation	O	O	I-T061
in	O	O	O
patients	O	O	B-T101
after	O	O	O
high-risk	O	O	O
pregnancy	O	O	O

Female	O	O	B-T061
sterilization	O	O	I-T061
is	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
most	O	O	O
prevalent	O	O	O
methods	O	O	B-T170
of	O	O	O
contraception	O	O	B-T061
in	O	O	O
the	O	O	O
United	O	O	B-T083
States	O	O	I-T083
.	O	O	O

Prior	O	O	O
studies	O	O	B-T062
have	O	O	O
shown	O	O	O
that	O	O	O
nearly	O	O	O
half	O	O	O
of	O	O	O
postpartum	O	O	B-T079
tubal	O	O	B-T061
ligation	O	O	I-T061
(	O	O	O
PPTL	O	O	B-T061
)	O	O	O
requests	O	O	B-T052
go	O	O	O
unfulfilled	O	O	B-T169
.	O	O	O

This	O	O	O
study	O	O	B-T062
seeks	O	O	O
to	O	O	O
establish	O	O	O
whether	O	O	O
obstetric	O	O	B-T169
or	O	O	O
medical	O	O	B-T078
risk	O	O	I-T078
status	O	O	B-T080
influences	O	O	O
patients	O	O	B-T101
'	O	O	O
request	O	O	B-T052
for	O	O	O
or	O	O	O
subsequent	O	O	O
completion	O	O	B-T080
of	O	O	O
PPTL	O	O	B-T061
.	O	O	O

This	O	O	O
study	O	O	B-T062
was	O	O	O
a	O	O	O
retrospective	O	O	B-T062
cohort	O	O	I-T062
study	O	O	I-T062
of	O	O	O
women	O	O	B-T098
delivering	O	O	B-T040
at	O	O	O
a	O	O	O
university	O	O	B-T093
hospital	O	O	I-T093
in	O	O	O
2009	O	O	O
-	O	O	O
2010	O	O	O
who	O	O	O
received	O	O	O
prenatal	O	O	B-T058
care	O	O	I-T058
in	O	O	O
the	O	O	O
faculty	O	O	B-T097
and	O	O	O
resident	O	O	B-T093
clinics	O	O	I-T093
.	O	O	O

High-risk	O	O	B-T033
status	O	O	B-T080
was	O	O	O
defined	O	O	O
by	O	O	O
Society	O	O	B-T170
for	O	O	I-T170
Maternal-Fetal	O	O	I-T170
Medicine	O	O	I-T170
guidelines	O	O	I-T170
.	O	O	O

Documentation	O	O	B-T170
of	O	O	O
contraceptive	O	O	B-T170
plan	O	O	I-T170
and	O	O	O
administration	O	O	B-T061
of	O	O	O
contraceptive	O	O	B-T061
methods	O	O	I-T061
was	O	O	O
abstracted	O	O	B-T079
from	O	O	O
patient	O	O	B-T170
records	O	O	I-T170
.	O	O	O

Subsequent	O	O	O
pregnancies	O	O	B-T040
through	O	O	O
March	O	O	O
1	O	O	O
,	O	O	O
2013	O	O	O
,	O	O	O
were	O	O	O
abstracted	O	O	B-T079
.	O	O	O

Of	O	O	O
3063	O	O	O
participants	O	O	B-T098
(	O	O	O
2048	O	O	O
low	O	O	B-T081
risk	O	O	I-T081
and	O	O	O
1015	O	O	O
high	O	O	B-T033
risk	O	O	I-T033
)	O	O	O
,	O	O	O
231	O	O	O
requested	O	O	B-T052
PPTL	O	O	B-T061
(	O	O	O
7.5	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

This	O	O	O
was	O	O	O
more	O	O	O
likely	O	O	O
among	O	O	O
high-risk	O	O	B-T033
patients	O	O	B-T101
than	O	O	O
low-risk	O	O	B-T081
patients	O	O	O
(	O	O	O
10.0	O	O	O
%	O	O	O
vs.	O	O	O
6.3	O	O	O
%	O	O	O
,	O	O	O
p<.001	O	O	O
)	O	O	O
,	O	O	O
those	O	O	O
with	O	O	O
public	O	O	B-T078
insurance	O	O	I-T078
(	O	O	O
13.8	O	O	O
%	O	O	O
vs.	O	O	O
3.2	O	O	O
%	O	O	O
,	O	O	O
p<.001	O	O	O
)	O	O	O
and	O	O	O
those	O	O	O
with	O	O	O
an	O	O	O
unintended	O	O	B-T033
index	O	O	I-T033
pregnancy	O	O	I-T033
(	O	O	O
13.8	O	O	O
%	O	O	O
vs.	O	O	O
4.1	O	O	O
%	O	O	O
,	O	O	O
p<.001	O	O	O
)	O	O	O
.	O	O	O

Of	O	O	O
the	O	O	O
patients	O	O	B-T101
requesting	O	O	B-T052
PPTL	O	O	B-T061
,	O	O	O
118	O	O	O
(	O	O	O
51.1	O	O	O
%	O	O	O
)	O	O	O
underwent	O	O	O
the	O	O	O
procedure	O	O	B-T061
immediately	O	O	O
postpartum	O	O	B-T079
.	O	O	O

Completion	O	O	B-T080
was	O	O	O
not	O	O	O
associated	O	O	O
with	O	O	O
high-risk	O	O	B-T033
status	O	O	B-T080
(	O	O	O
54.0	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
or	O	O	O
with	O	O	O
race	O	O	B-T098
,	O	O	O
insurance	O	O	B-T078
status	O	O	I-T078
or	O	O	O
parity	O	O	B-T033
.	O	O	O

Among	O	O	O
113	O	O	O
women	O	O	B-T098
with	O	O	O
an	O	O	O
unfulfilled	O	O	B-T169
PPTL	O	O	B-T061
request	O	O	B-T052
,	O	O	O
there	O	O	O
were	O	O	O
17	O	O	O
subsequent	O	O	O
pregnancies	O	O	B-T040
(	O	O	O
15.0	O	O	O
%	O	O	O
)	O	O	O
during	O	O	O
the	O	O	O
27	O	O	O
months	O	O	B-T079
of	O	O	O
follow-up	O	O	B-T058
.	O	O	O

Though	O	O	O
women	O	O	B-T098
with	O	O	O
high-risk	O	O	B-T046
pregnancies	O	O	I-T046
were	O	O	O
more	O	O	O
likely	O	O	O
to	O	O	O
request	O	O	B-T052
PPTL	O	O	B-T061
,	O	O	O
they	O	O	O
were	O	O	O
not	O	O	O
more	O	O	O
likely	O	O	O
to	O	O	O
complete	O	O	B-T080
the	O	O	O
procedure	O	O	B-T061
.	O	O	O

Over	O	O	O
one	O	O	O
third	O	O	O
of	O	O	O
high-risk	O	O	B-T033
patients	O	O	B-T101
'	O	O	O
requests	O	O	B-T052
were	O	O	O
unfulfilled	O	O	B-T169
,	O	O	O
indicating	O	O	O
that	O	O	O
significant	O	O	O
barriers	O	O	O
may	O	O	O
remain	O	O	O
.	O	O	O

Though	O	O	O
women	O	O	B-T098
with	O	O	O
high-risk	O	O	B-T046
pregnancies	O	O	I-T046
were	O	O	O
more	O	O	O
likely	O	O	O
to	O	O	O
request	O	O	B-T052
PPTL	O	O	B-T061
,	O	O	O
they	O	O	O
were	O	O	O
not	O	O	O
more	O	O	O
likely	O	O	O
to	O	O	O
complete	O	O	B-T080
the	O	O	O
procedure	O	O	B-T061
.	O	O	O

Providers	O	O	O
should	O	O	O
consider	O	O	O
these	O	O	O
procedures	O	O	B-T061
urgent	O	O	B-T079
,	O	O	O
especially	O	O	O
in	O	O	O
high-risk	O	O	B-T033
women	O	O	B-T098
,	O	O	O
and	O	O	O
advocate	O	O	O
for	O	O	O
their	O	O	O
patients	O	O	B-T101
'	O	O	O
access	O	O	O
to	O	O	O
this	O	O	O
procedure	O	O	B-T061
.	O	O	O

-DOCSTART- (27572277)

Gut	O	O	B-T001
microbiota	O	O	I-T001
after	O	O	O
Roux-en-Y	O	O	B-T061
gastric	O	O	I-T061
bypass	O	O	I-T061
and	O	O	O
sleeve	O	O	B-T061
gastrectomy	O	O	I-T061
in	O	O	O
a	O	O	O
diabetic	O	O	B-T047
rat	O	O	B-T015
model	O	O	B-T050
:	O	O	O
Increased	O	O	O
diversity	O	O	B-T080
and	O	O	O
associations	O	O	O
of	O	O	O
discriminant	O	O	B-T080
genera	O	O	B-T185
with	O	O	O
metabolic	O	O	B-T040
changes	O	O	O

Recent	O	O	O
work	O	O	O
with	O	O	O
gut	O	O	B-T001
microbiota	O	O	I-T001
after	O	O	O
bariatric	O	O	B-T061
surgery	O	O	I-T061
is	O	O	O
limited	O	O	O
,	O	O	O
and	O	O	O
the	O	O	O
results	O	O	O
have	O	O	O
not	O	O	O
been	O	O	O
in	O	O	O
agreement	O	O	O
.	O	O	O

Given	O	O	O
the	O	O	O
role	O	O	O
of	O	O	O
the	O	O	O
gut	O	O	B-T001
microbiota	O	O	I-T001
in	O	O	O
regulating	O	O	O
host	O	O	B-T001
metabolism	O	O	B-T040
,	O	O	O
we	O	O	O
explored	O	O	O
the	O	O	O
effect	O	O	O
of	O	O	O
Roux-en-Y	O	O	B-T061
gastric	O	O	I-T061
bypass	O	O	I-T061
(	O	O	O
RYGB	O	O	B-T061
)	O	O	O
and	O	O	O
sleeve	O	O	B-T061
gastrectomy	O	O	I-T061
(	O	O	O
SG	O	O	B-T061
)	O	O	O
on	O	O	O
the	O	O	O
modifications	O	O	O
of	O	O	O
gut	O	O	O
microbiota	O	O	O
with	O	O	O
regard	O	O	O
to	O	O	O
the	O	O	O
potential	O	O	O
influence	O	O	O
of	O	O	O
food	O	O	B-T168
intake	O	O	B-T169
and/or	O	O	O
weight	O	O	B-T032
loss	O	O	B-T081
and	O	O	O
examined	O	O	O
their	O	O	O
links	O	O	O
with	O	O	O
host	O	O	O
metabolism	O	O	O
.	O	O	O

Zucker	O	O	O
diabetic	O	O	B-T047
fatty	O	O	B-T015
rats	O	O	I-T015
were	O	O	O
divided	O	O	O
into	O	O	O
the	O	O	O
following	O	O	O
groups	O	O	B-T078
:	O	O	O
RYGB	O	O	B-T061
;	O	O	O
sham-operated	O	O	B-T061
with	O	O	O
pair-fed	O	O	O
as	O	O	O
RYGB	O	O	O
;	O	O	O
sham-operated	O	O	O
fed	O	O	O
ad	O	O	O
libitum	O	O	O
;	O	O	O
and	O	O	O
SG	O	O	B-T061
.	O	O	O

The	O	O	O
metabolic	O	O	B-T039
effects	O	O	I-T039
and	O	O	O
gut	O	O	B-T001
microbiota	O	O	I-T001
profile	O	O	B-T169
were	O	O	O
analyzed	O	O	B-T062
10	O	O	O
weeks	O	O	B-T079
postoperatively	O	O	O
.	O	O	O

Associations	O	O	O
between	O	O	O
discriminating	O	O	B-T080
genera	O	O	B-T185
and	O	O	O
metabolic	O	O	B-T123
markers	O	O	I-T123
after	O	O	O
RYGB	O	O	B-T061
were	O	O	O
explored	O	O	O
.	O	O	O

The	O	O	O
2	O	O	O
procedures	O	O	B-T061
induced	O	O	O
similar	O	O	O
glucose	O	O	B-T109
improvement	O	O	B-T077
and	O	O	O
increased	O	O	O
flora	O	O	B-T001
diversity	O	O	B-T080
after	O	O	O
10	O	O	O
weeks	O	O	B-T079
compared	O	O	B-T052
with	O	O	O
sham-operated	O	O	B-T061
groups	O	O	O
.	O	O	O

RYGB	O	O	B-T061
induced	O	O	O
a	O	O	O
marked	O	O	O
higher	O	O	O
relative	O	O	O
abundance	O	O	O
of	O	O	O
Proteobacteria	O	O	B-T007
/	O	O	O
Gammaproteobacteria	O	O	B-T007
and	O	O	O
Betaproteobacteria	O	O	B-T007
and	O	O	O
increased	O	O	O
emergence	O	O	O
of	O	O	O
Fusobacteria	O	O	B-T007
and	O	O	O
Clostridium	O	O	B-T007
,	O	O	O
whereas	O	O	O
SG	O	O	B-T061
resulted	O	O	O
in	O	O	O
more	O	O	O
abundant	O	O	O
Actinobacteria	O	O	B-T007
compared	O	O	B-T052
with	O	O	O
other	O	O	O
groups	O	O	O
.	O	O	O

Most	O	O	O
of	O	O	O
the	O	O	O
12	O	O	O
discriminant	O	O	B-T080
genera	O	O	B-T185
correlated	O	O	B-T080
with	O	O	O
changes	O	O	B-T169
in	O	O	O
metabolic	O	O	B-T040
phenotype	O	O	B-T032
,	O	O	O
but	O	O	O
only	O	O	O
28.6	O	O	O
%	O	O	O
of	O	O	O
these	O	O	O
correlations	O	O	B-T080
were	O	O	O
independent	O	O	O
of	O	O	O
weight	O	O	B-T032
,	O	O	O
and	O	O	O
4	O	O	O
discriminant	O	O	O
genera	O	O	O
still	O	O	O
negatively	O	O	O
correlated	O	O	O
with	O	O	O
serum	O	O	B-T034
insulin	O	O	I-T034
level	O	O	I-T034
independent	O	O	O
of	O	O	O
food	O	O	B-T168
intake	O	O	B-T169
and	O	O	O
weight	O	O	O
loss	O	O	B-T081
after	O	O	O
RYGB	O	O	B-T061
.	O	O	O

These	O	O	O
data	O	O	B-T078
demonstrate	O	O	O
that	O	O	O
RYGB	O	O	B-T061
and	O	O	O
SG	O	O	B-T061
surgery	O	O	B-T169
produced	O	O	O
similar	O	O	O
diversity	O	O	B-T080
but	O	O	O
different	O	O	O
microbiota	O	O	B-T001
compositions	O	O	O
changes	O	O	O
in	O	O	O
Zucker	O	O	O
diabetic	O	O	B-T047
fatty	O	O	B-T015
rats	O	O	I-T015
.	O	O	O

These	O	O	O
findings	O	O	O
stimulate	O	O	O
deeper	O	O	O
explorations	O	O	O
of	O	O	O
functions	O	O	B-T040
of	O	O	O
the	O	O	O
discriminate	O	O	B-T080
microbiota	O	O	B-T001
and	O	O	O
the	O	O	O
mechanisms	O	O	B-T169
linking	O	O	O
postsurgical	O	O	B-T079
modulation	O	O	B-T082
of	O	O	O
gut	O	O	B-T001
microbiota	O	O	I-T001
and	O	O	O
improvements	O	O	B-T077
in	O	O	O
insulin	O	O	B-T046
resistance	O	O	I-T046
.	O	O	O

-DOCSTART- (27576608)

Ocular	O	O	B-T037
toxicity	O	O	I-T037
of	O	O	O
AUY922	O	O	B-T109
in	O	O	O
pigmented	O	O	B-T015
and	O	O	O
albino	O	O	O
rats	O	O	O

AUY922	O	O	B-T109
,	O	O	O
a	O	O	O
heat	O	O	B-T116
shock	O	O	I-T116
protein	O	O	I-T116
90	O	O	I-T116
inhibitor	O	O	B-T080
is	O	O	O
associated	O	O	O
with	O	O	O
ocular	O	O	B-T023
adverse	O	O	B-T046
events	O	O	I-T046
(	O	O	O
AEs	O	O	B-T046
)	O	O	O
.	O	O	O

To	O	O	O
provide	O	O	O
a	O	O	O
better	O	O	O
understanding	O	O	O
of	O	O	O
ocular	O	O	B-T023
AEs	O	O	B-T046
in	O	O	O
patients	O	O	B-T101
,	O	O	O
4	O	O	O
investigative	O	O	B-T062
studies	O	O	I-T062
were	O	O	O
performed	O	O	O
in	O	O	O
a	O	O	O
step-wise	O	O	B-T082
approach	O	O	I-T082
to	O	O	O
assess	O	O	O
retinal	O	O	B-T023
structure	O	O	I-T023
and	O	O	O
function	O	O	O
in	O	O	O
pigmented	O	O	B-T015
(	O	O	O
Brown	O	O	B-T015
Norway	O	O	I-T015
)	O	O	O
and	O	O	O
albino	O	O	B-T015
(	O	O	I-T015
Wistar	O	O	B-T015
)	O	O	I-T015
rats	O	O	I-T015
.	O	O	O

In	O	O	O
rats	O	O	B-T015
administered	O	O	B-T169
30mg/kg	O	O	O
of	O	O	O
AUY922	O	O	B-T109
,	O	O	O
the	O	O	O
AUC	O	O	B-T081
0	O	O	O
-	O	O	O
24	O	O	O
h	O	O	B-T079
and	O	O	O
Cmax	O	O	B-T081
are	O	O	O
comparable	O	O	O
to	O	O	O
that	O	O	O
in	O	O	O
patients	O	O	B-T101
at	O	O	O
70mg/m(2	O	O	O
)	O	O	O
.	O	O	O

AUY922	O	O	B-T109
at	O	O	O
â¥30mg/kg	O	O	O
was	O	O	O
poorly	O	O	O
tolerated	O	O	O
by	O	O	O
rats	O	O	B-T015
with	O	O	O
morbidity	O	O	B-T081
or	O	O	O
mortality	O	O	B-T081
generally	O	O	O
after	O	O	O
the	O	O	O
third	O	O	O
weekly	O	O	B-T079
treatment	O	O	B-T061
.	O	O	O

Electroretinography	O	O	B-T060
(	O	O	O
ERG	O	O	B-T060
)	O	O	O
changes	O	O	B-T169
were	O	O	O
observed	O	O	O
at	O	O	O
doses	O	O	B-T081
â¥30mg/kg	O	O	O
.	O	O	O

The	O	O	O
ERG	O	O	B-T060
changes	O	O	B-T169
were	O	O	O
dose	O	O	B-T081
dependent	O	O	I-T081
,	O	O	O
consistent	O	O	B-T078
with	O	O	O
an	O	O	O
effect	O	O	O
on	O	O	O
the	O	O	O
photoreceptors	O	O	B-T025
,	O	O	O
and	O	O	O
fully	O	O	O
reversible	O	O	B-T169
.	O	O	O

The	O	O	O
ERG	O	O	B-T060
effects	O	O	O
could	O	O	O
not	O	O	O
be	O	O	O
minimized	O	O	O
by	O	O	O
decreasing	O	O	O
the	O	O	O
Cmax	O	O	B-T081
while	O	O	O
maintaining	O	O	O
AUC	O	O	B-T081
.	O	O	O

Histopathological	O	O	B-T169
changes	O	O	B-T169
were	O	O	O
seen	O	O	O
mainly	O	O	O
when	O	O	O
rats	O	O	B-T015
were	O	O	O
administered	O	O	B-T169
AUY922	O	O	B-T109
at	O	O	O
100mg/kg	O	O	O
.	O	O	O

The	O	O	O
2-	O	O	O
hour	O	O	B-T079
infusion	O	O	B-T061
of	O	O	O
AUY922	O	O	B-T109
at	O	O	O
100mg/kg	O	O	O
caused	O	O	O
disorganization	O	O	B-T033
of	O	O	O
the	O	O	O
outer	O	O	B-T026
segment	O	O	I-T026
photoreceptor	O	O	I-T026
morphology	O	O	B-T080
in	O	O	O
male	O	O	B-T032
Brown	O	O	B-T015
Norway	O	O	I-T015
rats	O	O	I-T015
;	O	O	O
the	O	O	O
severity	O	O	O
of	O	O	O
the	O	O	O
disorganization	O	O	O
increased	O	O	O
with	O	O	O
the	O	O	O
number	O	O	O
of	O	O	O
administrations	O	O	B-T061
,	O	O	O
but	O	O	O
was	O	O	O
reversible	O	O	B-T169
during	O	O	O
a	O	O	O
4-	O	O	O
week	O	O	B-T079
posttreatment	O	O	B-T079
period	O	O	I-T079
.	O	O	O

There	O	O	O
was	O	O	O
no	O	O	O
major	O	O	O
difference	O	O	O
in	O	O	O
ocular	O	O	B-T023
response	O	O	B-T032
between	O	O	O
Brown	O	O	B-T015
Norway	O	O	I-T015
and	O	O	O
Wistar	O	O	B-T015
rats	O	O	I-T015
.	O	O	O

No	O	O	O
changes	O	O	O
in	O	O	O
serum	O	O	B-T034
iron	O	O	I-T034
levels	O	O	I-T034
,	O	O	O
and	O	O	O
no	O	O	O
changes	O	O	O
in	O	O	O
rhodopsin	O	O	B-T116
,	O	O	O
PDE6Î±	O	O	B-T116
,	O	O	O
Î²-transducin	O	O	B-T116
concentrations	O	O	B-T081
,	O	O	O
or	O	O	O
retinal	O	O	B-T116
pigment	O	O	I-T116
epithelium-specific	O	O	I-T116
protein	O	O	I-T116
RPE65	O	O	I-T116
expression	O	O	B-T045
were	O	O	O
observed	O	O	O
after	O	O	O
single	O	O	O
and	O	O	O
multiple	O	O	O
infusions	O	O	B-T061
of	O	O	O
AUY922	O	O	B-T109
at	O	O	O
100mg/kg	O	O	O
compared	O	O	O
to	O	O	O
vehicle-treated	O	O	B-T096
controls	O	O	I-T096
.	O	O	O

AUY922	O	O	B-T109
retinal	O	O	B-T190
toxicity	O	O	I-T190
in	O	O	O
rats	O	O	B-T015
recapitulates	O	O	O
and	O	O	O
further	O	O	O
characterizes	O	O	O
that	O	O	O
reported	O	O	O
in	O	O	O
patients	O	O	B-T101
and	O	O	O
is	O	O	O
shown	O	O	O
to	O	O	O
be	O	O	O
reversible	O	O	B-T169
,	O	O	O
while	O	O	O
a	O	O	O
precise	O	O	O
molecular	O	O	B-T044
mechanism	O	O	I-T044
for	O	O	O
the	O	O	O
effect	O	O	O
was	O	O	O
not	O	O	O
determined	O	O	O
.	O	O	O

-DOCSTART- (27580517)

Assessment	O	O	B-T058
of	O	O	O
cerebral	O	O	B-T023
blood	O	O	B-T042
perfusion	O	O	I-T042
reserve	O	O	O
with	O	O	O
acetazolamide	O	O	B-T109
using	O	O	O
3D	O	O	B-T060
spiral	O	O	I-T060
ASL	O	O	I-T060
MRI	O	O	I-T060
:	O	O	O
Preliminary	O	O	O
experience	O	O	O
in	O	O	O
pediatric	O	O	B-T080
patients	O	O	O

To	O	O	O
demonstrate	O	O	O
the	O	O	O
clinical	O	O	B-T062
feasibility	O	O	I-T062
of	O	O	O
a	O	O	O
new	O	O	O
non-Cartesian	O	O	B-T060
cylindrically-distributed	O	O	I-T060
spiral	O	O	I-T060
3D	O	O	I-T060
pseudo-continuous	O	O	I-T060
arterial	O	O	I-T060
spin	O	O	I-T060
labeling	O	O	I-T060
(	O	O	I-T060
pCASL	O	O	I-T060
)	O	O	I-T060
magnetic	O	O	I-T060
resonance	O	O	I-T060
imaging	O	O	I-T060
(	O	O	I-T060
MRI	O	O	I-T060
)	O	O	I-T060
pulse	O	O	B-T082
sequence	O	O	I-T082
in	O	O	O
pediatric	O	O	B-T080
patients	O	O	B-T101
in	O	O	O
quantifying	O	O	B-T081
cerebral	O	O	B-T033
blood	O	O	I-T033
flow	O	O	I-T033
(	O	O	O
CBF	O	O	B-T033
)	O	O	O
response	O	O	O
to	O	O	O
an	O	O	O
acetazolamide	O	O	B-T121
(	O	O	I-T121
ACZ	O	O	I-T121
)	O	O	I-T121
vasodilator	O	O	I-T121
challenge	O	O	O
.	O	O	O

MRI	O	O	B-T060
exams	O	O	I-T060
were	O	O	O
performed	O	O	O
on	O	O	O
two	O	O	O
3	O	O	B-T073
Tesla	O	O	I-T073
Philips	O	O	I-T073
Ingenia	O	O	I-T073
systems	O	O	I-T073
using	O	O	I-T073
32	O	O	I-T073
channel	O	O	I-T073
head	O	O	I-T073
coil	O	O	I-T073
arrays	O	O	I-T073
.	O	O	O

After	O	O	O
local	O	O	O
institutional	O	O	B-T170
review	O	O	I-T170
board	O	O	I-T170
approval	O	O	I-T170
,	O	O	O
the	O	O	O
3D	O	O	B-T060
spiral-based	O	O	I-T060
pCASL	O	O	I-T060
technique	O	O	I-T060
was	O	O	O
added	O	O	O
to	O	O	O
a	O	O	O
standard	O	O	O
brain	O	O	B-T060
MRI	O	O	I-T060
exam	O	O	I-T060
and	O	O	O
evaluated	O	O	O
in	O	O	O
13	O	O	O
pediatric	O	O	B-T080
patients	O	O	B-T101
(	O	O	O
average	O	O	O
age	O	O	O
:	O	O	O
11.7Â±6.4years	O	O	O
,	O	O	O
range	O	O	O
:	O	O	O
1.4	O	O	O
-	O	O	O
22.2years	O	O	O
)	O	O	O
.	O	O	O

All	O	O	O
patients	O	O	B-T101
were	O	O	O
administered	O	O	B-T058
ACZ	O	O	B-T109
for	O	O	O
clinically	O	O	B-T033
indicated	O	O	I-T033
reasons	O	O	O
.	O	O	O

Quantitative	O	O	O
whole-brain	O	O	B-T060
CBF	O	O	I-T060
measurements	O	O	I-T060
were	O	O	O
computed	O	O	O
pre	O	O	B-T079
-	O	O	O
and	O	O	O
post	O	O	B-T079
-	O	O	O
ACZ	O	O	B-T109
to	O	O	O
assess	O	O	O
cerebrovascular	O	O	B-T042
reserve	O	O	I-T042
.	O	O	O

3D	O	O	B-T060
spiral	O	O	I-T060
pCASL	O	O	I-T060
data	O	O	B-T078
were	O	O	O
successfully	O	O	O
reconstructed	O	O	O
in	O	O	O
all	O	O	O
13	O	O	O
cases	O	O	B-T062
.	O	O	O

In	O	O	O
11	O	O	O
patients	O	O	B-T101
,	O	O	O
CBF	O	O	B-T033
increased	O	O	O
2.8	O	O	O
%	O	O	O
to	O	O	O
93.2	O	O	O
%	O	O	O
after	O	O	O
administration	O	O	B-T058
of	O	O	I-T058
ACZ	O	O	B-T109
.	O	O	O

In	O	O	O
the	O	O	O
two	O	O	O
remaining	O	O	O
patients	O	O	B-T101
,	O	O	O
CBF	O	O	B-T033
decreased	O	O	O
by	O	O	O
2.4	O	O	O
to	O	O	O
6.0	O	O	O
%	O	O	O
after	O	O	O
ACZ	O	O	B-T109
.	O	O	O

The	O	O	O
group	O	O	O
average	O	O	O
change	O	O	O
in	O	O	O
CBF	O	O	B-T033
due	O	O	O
to	O	O	O
ACZ	O	O	B-T109
was	O	O	O
approximately	O	O	O
25.0	O	O	O
%	O	O	O
and	O	O	O
individual	O	O	O
changes	O	O	O
were	O	O	O
statistically	O	O	B-T081
significant	O	O	I-T081
(	O	O	O
p<0.01	O	O	O
)	O	O	O
in	O	O	O
all	O	O	O
patients	O	O	B-T101
using	O	O	O
a	O	O	O
paired	O	O	O
t-test	O	O	B-T170
analysis	O	O	I-T170
.	O	O	O

CBF	O	O	B-T033
perfusion	O	O	B-T042
data	O	O	O
were	O	O	O
diagnostically	O	O	O
useful	O	O	O
in	O	O	O
supporting	O	O	O
conventional	O	O	O
MR	O	O	B-T060
angiography	O	O	I-T060
and	O	O	O
clinical	O	O	B-T170
findings	O	O	I-T170
.	O	O	O

3D	O	O	B-T060
cylindrically-distributed	O	O	I-T060
spiral	O	O	I-T060
pCASL	O	O	I-T060
MRI	O	O	I-T060
provides	O	O	O
a	O	O	O
robust	O	O	O
approach	O	O	O
to	O	O	O
assess	O	O	B-T058
cerebral	O	O	B-T033
blood	O	O	I-T033
flow	O	O	I-T033
and	O	O	O
reserve	O	O	O
in	O	O	O
pediatric	O	O	B-T080
patients	O	O	B-T101
.	O	O	O

-DOCSTART- (27580908)

Assessing	O	O	B-T058
the	O	O	O
learning	O	O	B-T041
potential	O	O	B-T080
of	O	O	O
an	O	O	O
interactive	O	O	B-T065
digital	O	O	B-T073
game	O	O	I-T073
versus	O	O	O
an	O	O	O
interactive-style	O	O	B-T065
didactic	O	O	B-T080
lecture	O	O	B-T170
:	O	O	O
the	O	O	O
continued	O	O	O
importance	O	O	O
of	O	O	O
didactic	O	O	O
teaching	O	O	B-T065
in	O	O	O
medical	O	O	B-T097
student	O	O	I-T097
education	O	O	O

Games	O	O	B-T056
with	O	O	O
educational	O	O	B-T065
intent	O	O	O
offer	O	O	O
a	O	O	O
possible	O	O	B-T033
advantage	O	O	O
of	O	O	O
being	O	O	O
more	O	O	O
interactive	O	O	B-T065
and	O	O	O
increasing	O	O	B-T081
learner	O	O	B-T098
satisfaction	O	O	B-T041
.	O	O	O

We	O	O	O
conducted	O	O	O
a	O	O	O
two-armed	O	O	B-T062
experiment	O	O	I-T062
to	O	O	O
evaluate	O	O	B-T058
student	O	O	B-T098
satisfaction	O	O	B-T041
and	O	O	O
content	O	O	B-T077
mastery	O	O	B-T041
for	O	O	O
an	O	O	O
introductory	O	O	O
pediatric	O	O	B-T091
radiology	O	O	I-T091
topic	O	O	B-T170
,	O	O	O
taught	O	O	B-T080
by	O	O	O
either	O	O	O
an	O	O	O
interactive	O	O	B-T065
digital	O	O	B-T073
game	O	O	I-T073
or	O	O	O
with	O	O	O
a	O	O	O
traditional	O	O	B-T169
didactic	O	O	B-T080
lecture	O	O	B-T170
.	O	O	O

Medical	O	O	B-T097
students	O	O	I-T097
participating	O	O	B-T169
in	O	O	O
a	O	O	O
fourth-year	O	O	O
radiology	O	O	B-T091
elective	O	O	B-T079
were	O	O	O
invited	O	O	O
to	O	O	O
participate	O	O	B-T169
.	O	O	O

Student	O	O	B-T098
cohorts	O	O	B-T098
were	O	O	O
alternatively	O	O	B-T077
given	O	O	O
a	O	O	O
faculty	O	O	B-T097
-	O	O	O
supervised	O	O	B-T065
1h	O	O	O
session	O	O	B-T077
playing	O	O	B-T056
a	O	O	O
simple	O	O	O
interactive	O	O	B-T065
digital	O	O	B-T080
Tic-tac-toe	O	O	B-T056
quiz	O	O	B-T077
module	O	O	I-T077
on	O	O	O
pediatric	O	O	B-T060
gastrointestinal	O	O	I-T060
radiology	O	O	I-T060
or	O	O	O
a	O	O	O
1h	O	O	O
didactic	O	O	B-T080
introductory	O	O	O
lecture	O	O	B-T170
on	O	O	O
the	O	O	O
same	O	O	O
topic	O	O	B-T170
.	O	O	O

Survey	O	O	B-T170
questions	O	O	B-T170
assessed	O	O	B-T052
the	O	O	O
learners	O	O	B-T098
'	O	O	I-T098
perceived	O	O	B-T041
ability	O	O	B-T201
to	O	O	I-T201
recall	O	O	I-T201
the	O	O	O
material	O	O	B-T167
as	O	O	O
well	O	O	O
as	O	O	O
their	O	O	O
satisfaction	O	O	B-T041
with	O	O	O
the	O	O	O
educational	O	O	B-T065
experience	O	O	B-T041
.	O	O	O

Results	O	O	O
of	O	O	O
an	O	O	O
end-of-rotation	O	O	B-T079
exam	O	O	B-T169
were	O	O	O
reviewed	O	O	B-T080
to	O	O	O
evaluate	O	O	B-T058
a	O	O	O
quantitative	O	O	B-T081
measure	O	O	I-T081
of	O	O	O
learning	O	O	B-T041
between	O	O	O
groups	O	O	B-T078
.	O	O	O

Survey	O	O	B-T170
responses	O	O	B-T041
were	O	O	O
analyzed	O	O	B-T062
with	O	O	O
a	O	O	O
chi-squared	O	O	B-T170
test	O	O	I-T170
.	O	O	O

Exam	O	O	B-T169
results	O	O	O
for	O	O	O
both	O	O	O
groups	O	O	B-T078
were	O	O	O
analyzed	O	O	B-T062
with	O	O	O
a	O	O	O
paired	O	O	O
Student	O	O	B-T081
's	O	O	I-T081
t-test	O	O	I-T081
.	O	O	O

Students	O	O	B-T098
in	O	O	O
the	O	O	O
lecture	O	O	B-T170
group	O	O	B-T078
had	O	O	O
higher	O	O	B-T080
test	O	O	B-T080
scores	O	O	I-T080
compared	O	O	B-T052
to	O	O	O
students	O	O	B-T098
in	O	O	O
the	O	O	O
game	O	O	B-T056
group	O	O	O
(	O	O	O
4.0/5	O	O	O
versus	O	O	O
3.6/5	O	O	O
,	O	O	O
P	O	O	O
=	O	O	O
0.045	O	O	O
)	O	O	O
.	O	O	O

Students	O	O	B-T098
in	O	O	O
the	O	O	O
lecture	O	O	B-T170
group	O	O	B-T078
reported	O	O	B-T058
greater	O	O	B-T081
understanding	O	O	B-T041
and	O	O	O
recall	O	O	B-T041
of	O	O	O
the	O	O	O
material	O	O	B-T167
than	O	O	O
students	O	O	B-T098
in	O	O	O
the	O	O	O
game	O	O	B-T056
group	O	O	O
(	O	O	O
P	O	O	O
<	O	O	O
0.001	O	O	O
and	O	O	O
P	O	O	O
=	O	O	O
0.004	O	O	O
,	O	O	O
respectively	O	O	O
)	O	O	O
.	O	O	O

Students	O	O	B-T098
in	O	O	O
the	O	O	O
lecture	O	O	B-T170
group	O	O	B-T078
perceived	O	O	B-T041
the	O	O	O
lecture	O	O	O
to	O	O	O
be	O	O	O
more	O	O	O
enjoyable	O	O	B-T033
and	O	O	O
a	O	O	O
better	O	O	O
use	O	O	O
of	O	O	O
their	O	O	O
time	O	O	B-T079
compared	O	O	B-T052
to	O	O	O
those	O	O	O
in	O	O	O
the	O	O	O
game	O	O	B-T056
group	O	O	O
(	O	O	O
P	O	O	O
=	O	O	O
0.04	O	O	O
and	O	O	O
P	O	O	O
<	O	O	O
0.001	O	O	O
,	O	O	O
respectively	O	O	O
)	O	O	O
.	O	O	O

There	O	O	O
was	O	O	O
no	O	O	O
statistically	O	O	B-T081
significant	O	O	I-T081
difference	O	O	B-T033
between	O	O	O
the	O	O	O
lecture	O	O	B-T170
and	O	O	O
game	O	O	B-T056
group	O	O	B-T078
in	O	O	O
ability	O	O	B-T032
to	O	O	O
maintain	O	O	O
interest	O	O	B-T054
(	O	O	O
P	O	O	O
=	O	O	O
0.187	O	O	O
)	O	O	O
.	O	O	O

In	O	O	O
comparison	O	O	O
to	O	O	O
pre-survey	O	O	B-T079
results	O	O	O
,	O	O	O
there	O	O	O
was	O	O	O
a	O	O	O
statistically	O	O	B-T081
significant	O	O	I-T081
decrease	O	O	B-T081
in	O	O	O
interest	O	O	B-T054
for	O	O	O
further	O	O	O
digital	O	O	B-T080
interactive	O	O	B-T065
materials	O	O	B-T167
reported	O	O	B-T058
by	O	O	O
students	O	O	B-T098
in	O	O	O
the	O	O	O
game	O	O	B-T056
group	O	O	B-T078
(	O	O	O
P	O	O	O
=	O	O	O
0.146	O	O	O
)	O	O	O
.	O	O	O

Our	O	O	O
experience	O	O	B-T041
supported	O	O	O
the	O	O	O
use	O	O	O
of	O	O	O
a	O	O	O
traditional	O	O	B-T169
lecture	O	O	B-T170
over	O	O	O
a	O	O	O
digital	O	O	B-T073
game	O	O	I-T073
module	O	O	O
.	O	O	O

While	O	O	O
these	O	O	O
results	O	O	O
might	O	O	O
be	O	O	O
affected	O	O	B-T169
by	O	O	O
the	O	O	O
specific	O	O	B-T080
lecture	O	O	B-T170
and	O	O	O
digital	O	O	B-T080
content	O	O	B-T077
in	O	O	O
any	O	O	O
given	O	O	O
comparison	O	O	B-T052
,	O	O	O
a	O	O	O
digital	O	O	O
module	O	O	B-T077
is	O	O	O
not	O	O	O
always	O	O	O
the	O	O	O
superior	O	O	O
option	O	O	O
.	O	O	O

-DOCSTART- (27583176)

Predictors	O	O	B-T078
of	O	O	O
30-	O	O	O
day	O	O	B-T079
mortality	O	O	B-T081
in	O	O	O
patients	O	O	B-T101
with	O	O	O
spontaneous	O	O	B-T169
primary	O	O	B-T080
intracerebral	O	O	O
hemorrhage	O	O	O

Intracerebral	O	O	B-T033
hemorrhage	O	O	I-T033
(	O	O	O
ICH	O	O	B-T033
)	O	O	O
is	O	O	O
a	O	O	O
life	O	O	B-T033
threatening	O	O	I-T033
entity	O	O	O
,	O	O	O
and	O	O	O
an	O	O	O
early	O	O	B-T058
outcome	O	O	I-T058
assessment	O	O	I-T058
is	O	O	O
mandatory	O	O	O
for	O	O	O
optimizing	O	O	O
therapeutic	O	O	B-T061
efforts	O	O	I-T061
.	O	O	O

We	O	O	O
retrospectively	O	O	B-T080
analyzed	O	O	B-T062
data	O	O	B-T078
from	O	O	O
342	O	O	O
patients	O	O	B-T101
with	O	O	O
spontaneous	O	O	B-T169
primary	O	O	B-T080
ICH	O	O	B-T033
to	O	O	O
evaluate	O	O	O
possible	O	O	O
predictors	O	O	B-T078
of	O	O	O
30-	O	O	O
day	O	O	B-T079
mortality	O	O	B-T081
considering	O	O	O
clinical	O	O	B-T080
,	O	O	O
radiological	O	O	B-T169
,	O	O	O
and	O	O	O
therapeutical	O	O	B-T169
parameters	O	O	B-T077
.	O	O	O

We	O	O	O
also	O	O	O
applied	O	O	O
three	O	O	O
widely	O	O	O
accepted	O	O	O
outcome	O	O	B-T170
grading	O	O	I-T170
scoring	O	O	I-T170
systems	O	O	I-T170
[	O	O	O
(	O	O	O
ICH	O	O	B-T081
score	O	O	I-T081
,	O	O	O
FUNC	O	O	B-T081
score	O	O	I-T081
and	O	O	O
intracerebral	O	O	B-T170
hemorrhage	O	O	I-T170
grading	O	O	I-T170
scale	O	O	I-T170
(	O	O	O
ICH-GS	O	O	B-T170
)	O	O	O
]	O	O	O
on	O	O	O
our	O	O	O
population	O	O	B-T098
to	O	O	O
evaluate	O	O	O
the	O	O	O
correlation	O	O	B-T080
of	O	O	O
these	O	O	O
scores	O	O	B-T081
with	O	O	O
the	O	O	O
30-	O	O	O
day	O	O	B-T079
mortality	O	O	B-T081
in	O	O	O
our	O	O	O
study	O	O	B-T062
.	O	O	O

We	O	O	O
also	O	O	O
applied	O	O	O
three	O	O	O
widely	O	O	O
accepted	O	O	O
outcome	O	O	B-T170
grading	O	O	I-T170
scoring	O	O	I-T170
systems	O	O	I-T170
[	O	O	O
(	O	O	O
ICH	O	O	B-T081
score	O	O	I-T081
,	O	O	O
FUNC	O	O	B-T081
score	O	O	I-T081
and	O	O	O
intracerebral	O	O	B-T170
hemorrhage	O	O	I-T170
grading	O	O	I-T170
scale	O	O	I-T170
(	O	O	O
ICH-GS	O	O	B-T170
)	O	O	O
]	O	O	O
on	O	O	O
our	O	O	O
population	O	O	B-T098
to	O	O	O
evaluate	O	O	O
the	O	O	O
correlation	O	O	B-T080
of	O	O	O
these	O	O	O
scores	O	O	B-T081
with	O	O	O
the	O	O	O
30-	O	O	O
day	O	O	B-T079
mortality	O	O	B-T081
in	O	O	O
our	O	O	O
study	O	O	B-T062
.	O	O	O

From	O	O	O
342	O	O	O
patients	O	O	B-T101
(	O	O	O
mean	O	O	O
age	O	O	B-T032
:	O	O	O
67	O	O	O
years	O	O	B-T079
,	O	O	O
mean	O	O	O
Glasgow	O	O	B-T170
Coma	O	O	I-T170
Scale	O	O	I-T170
[	O	O	O
GCS	O	O	B-T170
]	O	O	O
on	O	O	O
admission	O	O	B-T058
:	O	O	O
9	O	O	O
,	O	O	O
mean	O	O	O
ICH	O	O	B-T033
volume	O	O	B-T081
:	O	O	O
62.19	O	O	O
ml	O	O	O
,	O	O	O
most	O	O	O
common	O	O	O
hematoma	O	O	B-T046
location	O	O	B-T029
:	O	O	O
basal	O	O	B-T023
ganglia	O	O	I-T023
[	O	O	O
43.9	O	O	O
%	O	O	O
]	O	O	O
)	O	O	O
,	O	O	O
102	O	O	O
received	O	O	O
surgical	O	O	B-T061
and	O	O	O
240	O	O	O
conservative	O	O	B-T061
treatment	O	O	I-T061
.	O	O	O

The	O	O	O
30-	O	O	O
day	O	O	B-T079
mortality	O	O	B-T081
was	O	O	O
25.15	O	O	O
%	O	O	O
.	O	O	O

In	O	O	O
a	O	O	O
multivariate	O	O	B-T081
analysis	O	O	I-T081
,	O	O	O
GCS	O	O	B-T170
(	O	O	O
Odds	O	O	B-T081
ratio	O	O	I-T081
[	O	O	O
OR	O	O	B-T081
]	O	O	O
=	O	O	O
0.726	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
confidence	O	O	B-T081
interval	O	O	I-T081
[	O	O	O
CI	O	O	B-T081
]	O	O	O
=	O	O	O
0.661	O	O	O
-	O	O	O
0.796	O	O	O
,	O	O	O
P	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
,	O	O	O
bleeding	O	O	B-T046
volume	O	O	B-T081
(	O	O	O
OR	O	O	O
=	O	O	O
1.012	O	O	O
per	O	O	O
ml	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
=	O	O	O
1.007	O	O	O
-	O	O	O
1.017	O	O	O
,	O	O	O
P	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
infratentorial	O	O	B-T082
hematoma	O	O	B-T046
location	O	O	B-T029
(	O	O	O
OR	O	O	O
=	O	O	O
5.381	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
=	O	O	O
2.166	O	O	O
-	O	O	O
13.356	O	O	O
,	O	O	O
P	O	O	O
=	O	O	O
0.009	O	O	O
)	O	O	O
were	O	O	O
significant	O	O	O
predictors	O	O	B-T078
for	O	O	O
the	O	O	O
30-	O	O	O
day	O	O	B-T079
mortality	O	O	B-T081
.	O	O	O

After	O	O	O
receiver	O	O	B-T081
operating	O	O	I-T081
characteristics	O	O	I-T081
analysis	O	O	B-T062
,	O	O	O
we	O	O	O
defined	O	O	O
a	O	O	O
"	O	O	O
high-risk	O	O	B-T098
group	O	O	I-T098
"	O	O	O
for	O	O	O
an	O	O	O
unfavorable	O	O	O
short-term	O	O	B-T079
outcome	O	O	B-T169
with	O	O	O
GCS	O	O	B-T170
<	O	O	O
11	O	O	O
and	O	O	O
ICH	O	O	B-T033
volume	O	O	B-T081
>	O	O	O
32	O	O	O
ml	O	O	O
supratentorially	O	O	B-T082
or	O	O	O
21	O	O	O
ml	O	O	O
infratentorially	O	O	B-T082
.	O	O	O

Using	O	O	O
Pearson	O	O	B-T170
correlation	O	O	B-T080
,	O	O	O
we	O	O	O
found	O	O	O
a	O	O	O
correlation	O	O	O
of	O	O	O
0.986	O	O	O
between	O	O	O
ICH	O	O	B-T081
score	O	O	I-T081
and	O	O	O
30-	O	O	O
day	O	O	B-T079
mortality	O	O	B-T081
(	O	O	O
P	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
,	O	O	O
0.853	O	O	O
between	O	O	O
FUNC	O	O	B-T081
score	O	O	I-T081
and	O	O	O
30-	O	O	O
day	O	O	O
mortality	O	O	O
(	O	O	O
P	O	O	O
=	O	O	O
0.001	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
0.924	O	O	O
between	O	O	O
ICH-GS	O	O	B-T170
and	O	O	O
30-	O	O	O
day	O	O	O
mortality	O	O	O
(	O	O	O
P	O	O	O
=	O	O	O
0.001	O	O	O
)	O	O	O
.	O	O	O

GCS	O	O	B-T170
score	O	O	B-T081
on	O	O	O
admission	O	O	B-T058
together	O	O	O
with	O	O	O
the	O	O	O
baseline	O	O	B-T081
volume	O	O	B-T081
and	O	O	O
localization	O	O	B-T169
of	O	O	O
the	O	O	O
hemorrhage	O	O	B-T046
are	O	O	O
strong	O	O	O
predictors	O	O	B-T078
for	O	O	O
30-	O	O	O
day	O	O	B-T079
mortality	O	O	B-T081
in	O	O	O
patients	O	O	B-T101
with	O	O	O
spontaneous	O	O	B-T169
primary	O	O	B-T080
intracerebral	O	O	B-T033
hemorrhage	O	O	I-T033
,	O	O	O
and	O	O	O
by	O	O	O
relying	O	O	O
on	O	O	O
them	O	O	O
it	O	O	O
is	O	O	O
possible	O	O	O
to	O	O	O
identify	O	O	O
high-risk	O	O	B-T033
patients	O	O	O
with	O	O	O
poor	O	O	O
short-term	O	O	B-T079
outcome	O	O	B-T169
.	O	O	O

The	O	O	O
ICH	O	O	B-T081
score	O	O	I-T081
and	O	O	O
the	O	O	O
ICH-GS	O	O	B-T170
accurately	O	O	B-T080
predict	O	O	B-T078
the	O	O	O
30-	O	O	O
day	O	O	B-T079
mortality	O	O	B-T081
.	O	O	O

-DOCSTART- (27587730)

Gga-miR-21	O	O	B-T114
inhibits	O	O	B-T080
chicken	O	O	B-T012
pre-adipocyte	O	O	B-T025
proliferation	O	O	B-T043
in	O	O	O
part	O	O	O
by	O	O	O
down-regulating	O	O	B-T044
Kruppel-like	O	O	O
factor	O	O	O
5	O	O	O

Gga-miR-21	O	O	B-T114
is	O	O	O
abundantly	O	O	O
expressed	O	O	B-T045
in	O	O	O
chicken	O	O	B-T012
pre-adipocytes	O	O	B-T025
,	O	O	O
but	O	O	O
its	O	O	O
role	O	O	O
is	O	O	O
unclear	O	O	O
.	O	O	O

The	O	O	O
present	O	O	O
study	O	O	O
investigated	O	O	B-T169
the	O	O	O
role	O	O	O
of	O	O	O
gga-miR-21	O	O	B-T114
in	O	O	O
chicken	O	O	B-T012
pre-adipocyte	O	O	B-T025
proliferation	O	O	B-T043
.	O	O	O

Cell	O	O	B-T062
proliferation	O	O	B-T043
assay	O	O	I-T062
and	O	O	O
gene	O	O	B-T063
expression	O	O	I-T063
analysis	O	O	I-T063
of	O	O	O
proliferating	O	O	B-T028
cell	O	O	I-T028
nuclear	O	O	I-T028
antigen	O	O	I-T028
(	O	O	O
PCNA	O	O	B-T028
)	O	O	O
showed	O	O	O
that	O	O	O
the	O	O	O
gga-miR-21	O	O	B-T114
mimic	O	O	B-T052
inhibited	O	O	B-T080
pre-adipocyte	O	O	B-T025
proliferation	O	O	O
.	O	O	O

In	O	O	O
contrast	O	O	O
,	O	O	O
the	O	O	O
gga-miR-21	O	O	B-T114
inhibitor	O	O	B-T080
enhanced	O	O	B-T052
pre-adipocyte	O	O	B-T025
proliferation	O	O	B-T043
.	O	O	O

The	O	O	O
subsequent	O	O	O
investigation	O	O	B-T169
identified	O	O	O
Kruppel-like	O	O	B-T028
factor	O	O	I-T028
5	O	O	I-T028
(	O	O	O
KLF5	O	O	B-T028
)	O	O	O
mRNA	O	O	B-T114
as	O	O	O
a	O	O	O
target	O	O	B-T169
of	O	O	O
gga-miR-21	O	O	B-T114
.	O	O	O

The	O	O	O
gga-miR-21	O	O	B-T114
mimic	O	O	B-T052
inhibited	O	O	B-T080
KLF5	O	O	B-T028
3(')UTR	O	O	B-T086
reporter	O	O	B-T028
activity	O	O	B-T052
and	O	O	O
decreased	O	O	B-T081
endogenous	O	O	B-T169
KLF5	O	O	O
expression	O	O	B-T045
in	O	O	O
primary	O	O	B-T080
pre-adipocytes	O	O	B-T025
.	O	O	O

KLF5	O	O	B-T028
knockdown	O	O	B-T063
using	O	O	O
RNAi	O	O	B-T045
had	O	O	O
a	O	O	O
similar	O	O	O
effect	O	O	B-T080
to	O	O	O
that	O	O	O
of	O	O	O
the	O	O	O
gga-miR-21	O	O	B-T114
mimic	O	O	B-T052
on	O	O	O
cell	O	O	B-T043
proliferation	O	O	I-T043
.	O	O	O

The	O	O	O
promoting	O	O	B-T052
effect	O	O	B-T080
of	O	O	O
the	O	O	O
gga-miR-21	O	O	B-T114
inhibitor	O	O	B-T080
on	O	O	O
pre-adipocyte	O	O	B-T025
proliferation	O	O	B-T043
was	O	O	O
partially	O	O	O
attenuated	O	O	B-T080
by	O	O	O
KLF5	O	O	B-T028
knockdown	O	O	B-T063
.	O	O	O

Taken	O	O	O
together	O	O	O
,	O	O	O
our	O	O	O
results	O	O	O
demonstrated	O	O	O
that	O	O	O
miR-21	O	O	B-T114
inhibits	O	O	O
chicken	O	O	B-T012
pre-adipocyte	O	O	B-T025
proliferation	O	O	B-T043
,	O	O	O
at	O	O	O
least	O	O	O
in	O	O	O
part	O	O	O
,	O	O	O
by	O	O	O
targeting	O	O	B-T063
KLF5	O	O	B-T028
.	O	O	O

-DOCSTART- (27590047)

The	O	O	O
application	O	O	B-T169
of	O	O	O
heterogeneous	O	O	B-T081
cluster	O	O	I-T081
grouping	O	O	I-T081
to	O	O	O
reflective	O	O	B-T090
writing	O	O	I-T090
for	O	O	O
medical	O	O	B-T090
humanities	O	O	I-T090
literature	O	O	B-T062
study	O	O	I-T062
to	O	O	O
enhance	O	O	B-T052
students	O	O	B-T098
'	O	O	I-T098
empathy	O	O	B-T055
,	O	O	O
critical	O	O	B-T041
thinking	O	O	I-T041
,	O	O	O
and	O	O	O
reflective	O	O	O
writing	O	O	O

To	O	O	O
facilitate	O	O	O
interdisciplinary	O	O	B-T058
collaboration	O	O	I-T058
and	O	O	O
to	O	O	O
make	O	O	O
connections	O	O	B-T082
between	O	O	O
patients	O	O	B-T101
'	O	O	I-T101
diseases	O	O	B-T047
and	O	O	O
their	O	O	O
social	O	O	B-T169
/	O	O	O
cultural	O	O	B-T169
contexts	O	O	I-T169
,	O	O	O
the	O	O	O
study	O	O	B-T062
examined	O	O	B-T033
whether	O	O	O
the	O	O	O
use	O	O	O
of	O	O	O
heterogeneous	O	O	B-T081
cluster	O	O	I-T081
grouping	O	O	I-T081
in	O	O	O
reflective	O	O	B-T090
writing	O	O	I-T090
for	O	O	O
medical	O	O	B-T090
humanities	O	O	I-T090
literature	O	O	O
acquisition	O	O	B-T052
could	O	O	O
have	O	O	O
positive	O	O	B-T080
effects	O	O	I-T080
on	O	O	O
medical	O	O	B-T093
university	O	O	I-T093
students	O	O	B-T098
in	O	O	O
terms	O	O	O
of	O	O	O
empathy	O	O	B-T055
,	O	O	O
critical	O	O	B-T041
thinking	O	O	I-T041
,	O	O	O
and	O	O	O
reflective	O	O	O
writing	O	O	O
.	O	O	O

A	O	O	O
15-week	O	O	B-T079
quasi-experimental	O	O	B-UnknownType
design	O	O	I-UnknownType
was	O	O	O
conducted	O	O	O
to	O	O	O
investigate	O	O	B-T169
the	O	O	O
learning	O	O	B-T169
outcomes	O	O	I-T169
.	O	O	O

After	O	O	O
conducting	O	O	O
cluster	O	O	B-T170
algorithms	O	O	I-T170
,	O	O	O
heterogeneous	O	O	B-T081
learning	O	O	I-T081
clusters	O	O	I-T081
(	O	O	O
experimental	O	O	B-UnknownType
group	O	O	I-UnknownType
;	O	O	O
n	O	O	O
=	O	O	O
43	O	O	O
)	O	O	O
and	O	O	O
non-heterogeneous	O	O	B-T081
learning	O	O	I-T081
clusters	O	O	I-T081
(	O	O	O
control	O	O	B-T096
group	O	O	I-T096
;	O	O	O
n	O	O	O
=	O	O	O
43	O	O	O
)	O	O	O
were	O	O	O
derived	O	O	O
for	O	O	O
a	O	O	O
medical	O	O	B-T090
humanities	O	O	I-T090
literature	O	O	B-T062
study	O	O	I-T062
.	O	O	O

Before	O	O	O
and	O	O	O
after	O	O	O
the	O	O	O
intervention	O	O	B-T061
,	O	O	O
an	O	O	O
Empathy	O	O	B-T170
Scale	O	O	I-T170
in	O	O	O
Patient	O	O	B-T058
Care	O	O	I-T058
(	O	O	O
ES	O	O	B-T170
-	O	O	O
PC	O	O	B-T058
)	O	O	O
,	O	O	O
a	O	O	O
critical	O	O	B-T058
thinking	O	O	I-T058
disposition	O	O	I-T058
assessment	O	O	I-T058
(	O	O	O
CTDA-R	O	O	B-T058
)	O	O	O
,	O	O	O
and	O	O	O
a	O	O	O
reflective	O	O	B-T058
writing	O	O	I-T058
test	O	O	I-T058
were	O	O	O
administered	O	O	B-T169
to	O	O	O
both	O	O	O
groups	O	O	B-T078
.	O	O	O

The	O	O	O
findings	O	O	O
showed	O	O	O
that	O	O	O
on	O	O	O
the	O	O	O
empathy	O	O	B-T170
scale	O	O	I-T170
,	O	O	O
significant	O	O	O
differences	O	O	O
in	O	O	O
the	O	O	O
"	O	O	O
behavioral	O	O	B-T055
empathy	O	O	I-T055
,	O	O	O
"	O	O	O
"	O	O	O
affective	O	O	B-T055
empathy	O	O	I-T055
,	O	O	O
"	O	O	O
and	O	O	O
overall	O	O	O
sections	O	O	O
existed	O	O	O
between	O	O	O
the	O	O	O
post-test	O	O	B-T033
mean	O	O	I-T033
scores	O	O	I-T033
of	O	O	O
the	O	O	O
experimental	O	O	B-UnknownType
group	O	O	I-UnknownType
and	O	O	O
those	O	O	O
of	O	O	O
the	O	O	O
control	O	O	B-T096
group	O	O	I-T096
,	O	O	O
but	O	O	O
such	O	O	O
differences	O	O	O
did	O	O	O
not	O	O	O
exist	O	O	O
in	O	O	O
"	O	O	O
intelligent	O	O	B-T055
empathy	O	O	I-T055
.	O	O	O
"	O	O	O
Regarding	O	O	O
critical	O	O	B-T041
thinking	O	O	I-T041
,	O	O	O
there	O	O	O
were	O	O	O
significant	O	O	O
differences	O	O	O
in	O	O	O
"	O	O	O
systematicity	O	O	B-T169
and	O	O	O
analyticity	O	O	B-T062
,	O	O	O
"	O	O	O
"	O	O	O
skepticism	O	O	B-T041
and	O	O	O
well-informed	O	O	B-T058
,	O	O	O
"	O	O	O
"	O	O	O
maturity	O	O	B-T080
and	O	O	O
skepticism	O	O	O
,	O	O	O
"	O	O	O
and	O	O	O
overall	O	O	O
sections	O	O	O
.	O	O	O

As	O	O	O
for	O	O	O
reflective	O	O	B-T090
writing	O	O	I-T090
,	O	O	O
significant	O	O	O
differences	O	O	O
existed	O	O	O
in	O	O	O
"	O	O	O
ideas	O	O	B-T078
,	O	O	O
"	O	O	O
"	O	O	O
voice	O	O	B-T040
and	O	O	O
point	O	O	B-T078
of	O	O	I-T078
view	O	O	I-T078
,	O	O	O
"	O	O	O
"	O	O	O
critical	O	O	B-T041
thinking	O	O	I-T041
and	O	O	O
representation	O	O	B-T052
,	O	O	O
"	O	O	O
"	O	O	O
depth	O	O	B-T041
of	O	O	I-T041
reflection	O	O	I-T041
on	O	O	O
personal	O	O	B-T055
growth	O	O	I-T055
,	O	O	O
"	O	O	O
and	O	O	O
overall	O	O	O
sections	O	O	O
,	O	O	O
but	O	O	O
not	O	O	O
in	O	O	O
"	O	O	O
focus	O	O	B-T169
and	O	O	O
context	O	O	B-T078
structure	O	O	I-T078
"	O	O	O
and	O	O	O
"	O	O	O
language	O	O	B-T171
and	O	O	O
conventions	O	O	B-T068
.	O	O	O
"	O	O	O
This	O	O	O
study	O	O	B-T062
outlined	O	O	O
an	O	O	O
alternative	O	O	O
for	O	O	O
using	O	O	O
heterogeneous	O	O	B-T081
cluster	O	O	I-T081
grouping	O	O	I-T081
in	O	O	O
reflective	O	O	O
writing	O	O	O
about	O	O	O
medical	O	O	B-T090
humanities	O	O	I-T090
literature	O	O	O
to	O	O	O
facilitate	O	O	O
interdisciplinary	O	O	B-T054
cooperation	O	O	I-T054
to	O	O	O
provide	O	O	O
more	O	O	O
humanizing	O	O	O
medical	O	O	B-T033
care	O	O	I-T033
.	O	O	O

-DOCSTART- (27593786)

The	O	O	O
Usefulness	O	O	O
of	O	O	O
Employing	O	O	B-T033
an	O	O	O
Electronic	O	O	B-T074
Traction	O	O	I-T074
Table	O	O	I-T074
to	O	O	O
Determine	O	O	O
Flexibility	O	O	B-T080
in	O	O	O
Adolescent	O	O	O
Idiopathic	O	O	O
Scoliosis	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
the	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
develop	O	O	B-T169
new	O	O	O
equipment	O	O	B-T073
for	O	O	O
the	O	O	O
assessment	O	O	B-T058
of	O	O	O
the	O	O	O
flexibility	O	O	B-T080
of	O	O	O
the	O	O	O
spine	O	O	B-T023
with	O	O	O
different	O	O	O
forces	O	O	B-T067
.	O	O	O

This	O	O	O
new	O	O	O
system	O	O	B-T169
should	O	O	O
provide	O	O	O
a	O	O	O
different	O	O	O
perspective	O	O	O
to	O	O	O
adolescent	O	O	B-T190
idiopathic	O	O	I-T190
scoliosis	O	O	I-T190
(	O	O	O
AIS	O	O	B-T190
)	O	O	O
for	O	O	O
the	O	O	O
selection	O	O	B-T052
of	O	O	O
fusion	O	O	B-T080
levels	O	O	I-T080
and	O	O	O
surgical	O	O	B-T061
success	O	O	B-T080
.	O	O	O

Eighteen	O	O	O
patients	O	O	B-T101
suffering	O	O	O
from	O	O	O
AIS	O	O	B-T190
who	O	O	O
were	O	O	O
scheduled	O	O	O
to	O	O	O
undergo	O	O	O
posterior	O	O	B-T082
instrumented	O	O	B-T061
spinal	O	O	I-T061
fusion	O	O	I-T061
in	O	O	O
our	O	O	O
clinic	O	O	B-T093
were	O	O	O
recruited	O	O	O
in	O	O	O
this	O	O	O
study	O	O	B-T062
.	O	O	O

The	O	O	O
Electronic	O	O	B-T074
Traction	O	O	I-T074
Table	O	O	I-T074
(	O	O	O
ETT	O	O	B-T074
)	O	O	O
that	O	O	O
was	O	O	O
designed	O	O	O
in	O	O	O
our	O	O	O
clinic	O	O	B-T093
was	O	O	O
used	O	O	O
to	O	O	O
evaluate	O	O	O
the	O	O	O
radiogical	O	O	B-T077
and	O	O	O
clinical	O	O	B-T080
parameters	O	O	B-T077
of	O	O	O
the	O	O	O
spine	O	O	B-T023
.	O	O	O

The	O	O	O
significant	O	O	O
prescriptive	O	O	B-T080
angle	O	O	I-T080
of	O	O	O
major	O	O	O
Cobb	O	O	B-T033
angles	O	O	I-T033
between	O	O	O
postoperative	O	O	B-T080
angles	O	O	I-T080
were	O	O	O
longitudinal	O	O	B-T082
traction	O	O	B-T061
and	O	O	O
lateral	O	O	B-T033
pushing	O	O	I-T033
Cobb	O	O	I-T033
angles	O	O	I-T033
.	O	O	O

Longitudinal	O	O	B-T082
traction	O	O	B-T061
and	O	O	O
lateral	O	O	B-T033
pushing	O	O	I-T033
angles	O	O	I-T033
were	O	O	O
more	O	O	O
correlated	O	O	O
with	O	O	O
correction	O	O	B-T081
ratios	O	O	I-T081
.	O	O	O

There	O	O	O
was	O	O	O
a	O	O	O
significant	O	O	B-T078
difference	O	O	O
between	O	O	O
longitudinal	O	O	B-T082
traction	O	O	B-T061
minor	O	O	O
Cobb	O	O	B-T033
angle	O	O	I-T033
,	O	O	O
longitudinal	O	O	O
traction	O	O	O
lateral	O	O	B-T033
pushing	O	O	I-T033
minor	O	O	I-T033
Cobb	O	O	I-T033
angle	O	O	I-T033
and	O	O	O
postoperative	O	O	B-T033
minor	O	O	I-T033
Cobb	O	O	I-T033
angles	O	O	I-T033
.	O	O	O

The	O	O	O
deformity	O	O	B-T190
is	O	O	O
needed	O	O	O
to	O	O	O
balance	O	O	O
both	O	O	O
tractional	O	O	B-T061
and	O	O	O
rotational	O	O	B-T169
forces	O	O	O
and	O	O	O
useful	O	O	O
technique	O	O	B-T169
to	O	O	O
evaluate	O	O	O
curve	O	O	O
flexibility	O	O	B-T080
before	O	O	O
the	O	O	O
operation	O	O	B-T061
.	O	O	O

Electronic	O	O	B-T074
traction	O	O	B-T061
table	O	O	I-T074
is	O	O	O
a	O	O	O
new	O	O	O
device	O	O	B-T074
for	O	O	O
determining	O	O	O
preoperative	O	O	B-T080
flexibility	O	O	I-T080
with	O	O	O
longitudinal	O	O	B-T082
traction	O	O	O
and	O	O	O
lateral	O	O	B-T060
pushing	O	O	I-T060
radiographs	O	O	I-T060
.	O	O	O

It	O	O	O
can	O	O	O
be	O	O	O
useful	O	O	O
for	O	O	O
choosing	O	O	B-T052
selective	O	O	O
fusion	O	O	B-T080
levels	O	O	I-T080
at	O	O	O
the	O	O	O
proximal	O	O	B-T082
and	O	O	O
distal	O	O	B-T082
end	O	O	O
of	O	O	O
the	O	O	O
vertebral	O	O	B-T023
column	O	O	I-T023
.	O	O	O

-DOCSTART- (27595710)

The	O	O	O
MEssaging	O	O	B-T058
for	O	O	I-T058
Diabetes	O	O	I-T058
Intervention	O	O	B-T061
Reduced	O	O	O
Barriers	O	O	B-T080
to	O	O	O
Medication	O	O	B-T033
Adherence	O	O	I-T033
Among	O	O	O
Low-Income	O	O	B-T033
,	O	O	O
Diverse	O	O	O
Adults	O	O	B-T100
With	O	O	O
Type	O	O	O
2	O	O	O

Nonadherence	O	O	B-T033
to	O	O	O
diabetes	O	O	B-T047
medication	O	O	B-T058
is	O	O	O
prevalent	O	O	O
and	O	O	O
costly	O	O	O
.	O	O	O

MEssaging	O	O	B-T058
for	O	O	I-T058
Diabetes	O	O	I-T058
(	O	O	O
MED	O	O	B-T058
)	O	O	O
,	O	O	O
a	O	O	O
mobile	O	O	B-T058
health	O	O	I-T058
(	O	O	O
mHealth	O	O	B-T058
)	O	O	O
intervention	O	O	B-T061
,	O	O	O
identified	O	O	O
and	O	O	O
addressed	O	O	O
user	O	O	B-T098
-specific	O	O	O
barriers	O	O	B-T080
to	O	O	O
medication	O	O	B-T033
adherence	O	O	I-T033
.	O	O	O

We	O	O	O
assessed	O	O	O
whether	O	O	O
MED	O	O	B-T058
reduced	O	O	O
users	O	O	B-T098
'	O	O	O
targeted	O	O	O
barriers	O	O	B-T080
and	O	O	O
if	O	O	O
barrier	O	O	B-T080
reductions	O	O	O
were	O	O	O
associated	O	O	O
with	O	O	O
within-participant	O	O	B-T098
improvements	O	O	O
in	O	O	O
adherence	O	O	B-T169
or	O	O	O
glycemic	O	O	B-T080
control	O	O	I-T080
(	O	O	O
HbA1c	O	O	B-T116
)	O	O	O
.	O	O	O

Adults	O	O	B-T100
(	O	O	O
N	O	O	O
=	O	O	O
80	O	O	O
)	O	O	O
with	O	O	O
type	O	O	B-T047
2	O	O	I-T047
diabetes	O	O	I-T047
completed	O	O	O
self-report	O	O	O
measures	O	O	O
identifying	O	O	O
barriers	O	O	B-T080
to	O	O	O
adherence	O	O	B-T169
at	O	O	O
baseline	O	O	O
and	O	O	O
monthly	O	O	B-T079
for	O	O	O
3	O	O	O
months	O	O	B-T079
.	O	O	O

At	O	O	O
each	O	O	O
assessment	O	O	B-T058
,	O	O	O
17	O	O	O
barriers	O	O	B-T080
were	O	O	O
assessed	O	O	O
and	O	O	O
ranked	O	O	O
for	O	O	O
each	O	O	O
user	O	O	B-T098
.	O	O	O

Each	O	O	O
subsequent	O	O	O
month	O	O	B-T079
,	O	O	O
users	O	O	B-T098
received	O	O	O
daily	O	O	O
text	O	O	B-T170
messages	O	O	I-T170
addressing	O	O	O
their	O	O	O
3	O	O	O
highest	O	O	O
ranked	O	O	O
barriers	O	O	B-T080
.	O	O	O

Targeted	O	O	O
barriers	O	O	B-T080
were	O	O	O
different	O	O	O
for	O	O	O
each	O	O	O
participant	O	O	B-T098
and	O	O	O
could	O	O	O
change	O	O	O
monthly	O	O	B-T079
.	O	O	O

Paired	O	O	O
t-tests	O	O	B-T170
assessed	O	O	O
within-participant	O	O	B-T098
improvement	O	O	O
in	O	O	O
targeted	O	O	O
barriers	O	O	B-T080
each	O	O	O
month	O	O	B-T079
,	O	O	O
and	O	O	O
nested	O	O	O
regression	O	O	B-T170
models	O	O	I-T170
assessed	O	O	O
if	O	O	O
changes	O	O	O
in	O	O	O
a	O	O	O
participant	O	O	B-T098
's	O	O	I-T098
barrier	O	O	O
scores	O	O	O
were	O	O	O
associated	O	O	O
with	O	O	O
improvements	O	O	O
in	O	O	O
adherence	O	O	B-T169
and	O	O	O
HbA1c	O	O	B-T116
.	O	O	O

Participants	O	O	B-T098
were	O	O	O
69	O	O	O
%	O	O	O
non-white	O	O	O
and	O	O	O
82	O	O	O
%	O	O	O
had	O	O	O
incomes	O	O	O
<	O	O	O
$	O	O	O
25	O	O	O
K	O	O	O
.	O	O	O

Average	O	O	O
HbA1c	O	O	B-T116
was	O	O	O
8.2	O	O	O
Â±	O	O	O
2.0	O	O	O
%	O	O	O
.	O	O	O

Assessment	O	O	O
completion	O	O	O
rates	O	O	O
were	O	O	O
100	O	O	O
%	O	O	O
at	O	O	O
baseline	O	O	O
,	O	O	O
59	O	O	O
%	O	O	O
at	O	O	O
1	O	O	O
month	O	O	B-T079
,	O	O	O
30	O	O	O
%	O	O	O
at	O	O	O
2	O	O	O
months	O	O	B-T079
,	O	O	O
and	O	O	O
65	O	O	O
%	O	O	O
at	O	O	O
3	O	O	O
months	O	O	O
.	O	O	O

The	O	O	O
most	O	O	O
commonly	O	O	O
reported	O	O	O
barriers	O	O	B-T080
were	O	O	O
the	O	O	O
cost	O	O	B-T081
of	O	O	O
medications	O	O	B-T058
(	O	O	O
76	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
believing	O	O	O
medications	O	O	O
are	O	O	O
harmful	O	O	O
(	O	O	O
58	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
lacking	O	O	O
information	O	O	O
about	O	O	O
medications	O	O	O
(	O	O	O
53	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

Participants	O	O	B-T098
'	O	O	O
barrier	O	O	B-T080
scores	O	O	O
improved	O	O	O
each	O	O	O
month	O	O	B-T079
and	O	O	O
barrier	O	O	O
improvement	O	O	O
predicted	O	O	O
adherence	O	O	B-T169
assessed	O	O	O
via	O	O	O
nightly	O	O	O
adherence	O	O	O
assessment	O	O	O
text	O	O	B-T170
messages	O	O	I-T170
(	O	O	O
P	O	O	O
<	O	O	O
.001	O	O	O
)	O	O	O
.	O	O	O

Among	O	O	O
participants	O	O	B-T098
who	O	O	O
completed	O	O	O
assessments	O	O	O
each	O	O	O
month	O	O	B-T079
,	O	O	O
barrier	O	O	B-T080
improvement	O	O	O
in	O	O	O
months	O	O	B-T079
2	O	O	O
and	O	O	O
3	O	O	O
(	O	O	O
P	O	O	O
<	O	O	O
.05	O	O	O
)	O	O	O
predicted	O	O	O
HbA1c	O	O	B-T116
improvement	O	O	O
.	O	O	O

Iterative	O	O	O
,	O	O	O
individual	O	O	O
tailoring	O	O	O
may	O	O	O
overcome	O	O	O
users	O	O	B-T098
'	O	O	O
barriers	O	O	B-T080
to	O	O	O
adherence	O	O	B-T169
.	O	O	O

Attrition	O	O	O
is	O	O	O
a	O	O	O
challenge	O	O	O
for	O	O	O
mHealth	O	O	B-T058
interventions	O	O	B-T061
among	O	O	O
low-income	O	O	B-T033
patients	O	O	B-T101
.	O	O	O

-DOCSTART- (27598262)

Macular	O	O	B-T082
Ganglion	O	O	B-T025
Cell	O	O	I-T025
-	O	O	O
Inner	O	O	B-T023
Plexiform	O	O	I-T023
Layer	O	O	I-T023
Thickness	O	O	B-T080
Is	O	O	O
Associated	O	O	B-T080
with	O	O	I-T080
Clinical	O	O	B-T046
Progression	O	O	I-T046
in	O	O	O
Mild	O	O	B-T047
Cognitive	O	O	I-T047
Impairment	O	O	I-T047
and	O	O	O
Alzheimers	O	O	O
Disease	O	O	O

We	O	O	O
investigated	O	O	O
the	O	O	O
association	O	O	O
of	O	O	O
the	O	O	O
macular	O	O	B-T082
ganglion	O	O	B-T025
cell	O	O	I-T025
-	O	O	O
inner	O	O	B-T023
plexiform	O	O	I-T023
layer	O	O	I-T023
(	O	O	O
GCIPL	O	O	B-T023
)	O	O	O
and	O	O	O
peripapillary	O	O	B-T023
retinal	O	O	I-T023
nerve	O	O	I-T023
fiber	O	O	I-T023
layer	O	O	I-T023
(	O	O	O
RNFL	O	O	B-T023
)	O	O	O
thicknesses	O	O	B-T080
with	O	O	O
disease	O	O	B-T046
progression	O	O	I-T046
in	O	O	O
mild	O	O	B-T047
cognitive	O	O	I-T047
impairment	O	O	I-T047
(	O	O	O
MCI	O	O	B-T047
)	O	O	O
and	O	O	O
Alzheimer	O	O	B-T047
's	O	O	I-T047
disease	O	O	I-T047
(	O	O	O
AD	O	O	B-T047
)	O	O	O
.	O	O	O

We	O	O	O
recruited	O	O	O
42	O	O	O
patients	O	O	B-T101
with	O	O	O
AD	O	O	B-T047
,	O	O	O
26	O	O	O
with	O	O	O
MCI	O	O	B-T047
,	O	O	O
and	O	O	O
66	O	O	O
normal	O	O	O
elderly	O	O	B-T096
controls	O	O	I-T096
.	O	O	O

The	O	O	O
thicknesses	O	O	B-T080
of	O	O	O
the	O	O	O
RNFL	O	O	B-T023
and	O	O	O
GCIPL	O	O	B-T023
were	O	O	O
measured	O	O	O
via	O	O	O
spectral-domain	O	O	B-T074
optic	O	O	I-T074
coherent	O	O	I-T074
tomography	O	O	I-T074
in	O	O	O
all	O	O	O
participants	O	O	B-T098
at	O	O	O
baseline	O	O	B-T081
.	O	O	O

The	O	O	O
patients	O	O	B-T101
with	O	O	O
MCI	O	O	B-T047
or	O	O	O
AD	O	O	B-T047
underwent	O	O	O
clinical	O	O	B-T080
and	O	O	O
neuropsychological	O	O	B-T060
tests	O	O	I-T060
at	O	O	O
baseline	O	O	B-T081
and	O	O	O
once	O	O	B-T079
every	O	O	I-T079
year	O	O	I-T079
thereafter	O	O	I-T079
for	O	O	I-T079
2	O	O	I-T079
years	O	O	I-T079
.	O	O	O

The	O	O	O
Clinical	O	O	B-T170
Dementia	O	O	I-T170
Rating	O	O	I-T170
scale-Sum	O	O	I-T170
of	O	O	I-T170
Boxes	O	O	I-T170
(	O	O	O
CDR-SB	O	O	B-T170
)	O	O	O
score	O	O	B-T081
exhibited	O	O	O
significant	O	O	O
negative	O	O	B-T033
relationships	O	O	B-T080
with	O	O	O
the	O	O	O
average	O	O	B-T023
GCIPL	O	O	B-T023
thickness	O	O	B-T080
(	O	O	O
Î²	O	O	O
=	O	O	O
-0.15	O	O	O
,	O	O	O
p	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
and	O	O	O
the	O	O	O
GCIPL	O	O	O
thickness	O	O	O
in	O	O	O
the	O	O	O
superotemporal	O	O	B-T029
,	O	O	O
superonasal	O	O	B-T029
,	O	O	O
and	O	O	O
inferonasal	O	O	B-T029
sectors	O	O	I-T029
.	O	O	O

The	O	O	O
composite	O	O	B-T081
memory	O	O	I-T081
score	O	O	I-T081
exhibited	O	O	O
significant	O	O	O
positive	O	O	B-T033
associations	O	O	B-T080
with	O	O	O
the	O	O	O
average	O	O	B-T023
GCIPL	O	O	B-T023
thickness	O	O	B-T080
and	O	O	O
the	O	O	O
GCIPL	O	O	O
thickness	O	O	O
in	O	O	O
the	O	O	O
superotemporal	O	O	B-T029
,	O	O	O
inferonasal	O	O	B-T029
,	O	O	O
and	O	O	O
inferotemporal	O	O	B-T029
sectors	O	O	I-T029
.	O	O	O

The	O	O	O
temporal	O	O	B-T023
RNFL	O	O	I-T023
thickness	O	O	B-T080
,	O	O	O
the	O	O	O
average	O	O	O
and	O	O	O
minimum	O	O	O
GCIPL	O	O	B-T023
thicknesses	O	O	B-T080
,	O	O	O
and	O	O	O
the	O	O	O
GCIPL	O	O	O
thickness	O	O	O
in	O	O	O
the	O	O	O
inferonasal	O	O	B-T029
,	O	O	O
inferior	O	O	B-T029
,	O	O	O
and	O	O	O
inferotemporal	O	O	B-T029
sectors	O	O	I-T029
at	O	O	O
baseline	O	O	B-T081
were	O	O	O
significantly	O	O	O
reduced	O	O	B-T080
in	O	O	O
MCI	O	O	B-T047
patients	O	O	B-T101
who	O	O	O
were	O	O	O
converted	O	O	O
to	O	O	O
AD	O	O	B-T047
compared	O	O	O
to	O	O	O
stable	O	O	O
MCI	O	O	O
patients	O	O	O
.	O	O	O

The	O	O	O
change	O	O	O
of	O	O	O
CDR-SB	O	O	B-T170
from	O	O	O
baseline	O	O	B-T081
to	O	O	O
2	O	O	O
years	O	O	B-T079
exhibited	O	O	O
significant	O	O	O
negative	O	O	B-T033
associations	O	O	B-T080
with	O	O	O
the	O	O	O
average	O	O	O
(	O	O	O
Î²	O	O	O
=	O	O	O
-0.150	O	O	O
,	O	O	O
p	O	O	O
=	O	O	O
0.006	O	O	O
)	O	O	O
and	O	O	O
minimum	O	O	B-T023
GCIPL	O	O	B-T023
thicknesses	O	O	B-T080
as	O	O	O
well	O	O	O
as	O	O	O
GCIPL	O	O	O
thickness	O	O	B-T080
in	O	O	O
the	O	O	O
superotemporal	O	O	B-T029
,	O	O	O
superior	O	O	B-T029
,	O	O	O
superonasal	O	O	B-T029
,	O	O	O
and	O	O	O
inferonasal	O	O	B-T029
sectors	O	O	I-T029
at	O	O	O
baseline	O	O	O
.	O	O	O

Our	O	O	O
data	O	O	O
suggest	O	O	O
that	O	O	O
macular	O	O	O
GCIPL	O	O	B-T023
thickness	O	O	B-T080
represents	O	O	O
a	O	O	O
promising	O	O	O
biomarker	O	O	B-T201
for	O	O	O
monitoring	O	O	O
the	O	O	O
progression	O	O	B-T046
of	O	O	O
MCI	O	O	B-T047
and	O	O	O
AD	O	O	B-T047
.	O	O	O

-DOCSTART- (27598388)

Green	O	O	B-T057
and	O	O	O
rapid	O	O	B-T080
synthesis	O	O	B-T052
of	O	O	O
silver	O	O	B-T196
nanoparticles	O	O	B-T073
using	O	O	O
Borago	O	O	B-T002
officinalis	O	O	I-T002
leaf	O	O	B-T002
extract	O	O	B-T123
:	O	O	O
anticancer	O	O	B-T033
and	O	O	O
antibacterial	O	O	O
activities	O	O	O

This	O	O	O
study	O	O	O
highlights	O	O	O
the	O	O	O
facile	O	O	O
,	O	O	O
reliable	O	O	O
,	O	O	O
cost	O	O	B-T081
effective	O	O	B-T080
,	O	O	O
and	O	O	O
ecofriendly	O	O	B-T057
synthesis	O	O	B-T052
of	O	O	O
silver	O	O	B-T196
nanoparticles	O	O	B-T073
(	O	O	O
AgNPs	O	O	B-T073
)	O	O	O
using	O	O	O
Borago	O	O	B-T002
officinalis	O	O	I-T002
leaves	O	O	B-T002
extract	O	O	B-T123
efficiently	O	O	B-T080
.	O	O	O

The	O	O	O
biosynthesis	O	O	B-T052
of	O	O	O
AgNPs	O	O	B-T073
was	O	O	O
verified	O	O	B-T078
by	O	O	O
UV-Vis	O	O	B-T070
spectrum	O	O	I-T070
which	O	O	O
showed	O	O	O
the	O	O	O
surface	O	O	B-T063
plasmon	O	O	I-T063
resonance	O	O	I-T063
(	O	O	O
SPR	O	O	B-T063
)	O	O	O
band	O	O	O
at	O	O	O
422	O	O	O
nm	O	O	O
.	O	O	O

Transmission	O	O	B-T059
electron	O	O	I-T059
microscope	O	O	I-T059
(	O	O	I-T059
TEM	O	O	I-T059
)	O	O	I-T059
analysis	O	O	I-T059
revealed	O	O	O
that	O	O	O
the	O	O	O
particles	O	O	B-T073
were	O	O	O
spherical	O	O	B-T082
,	O	O	O
hexagonal	O	O	B-T082
,	O	O	O
and	O	O	O
irregular	O	O	B-T080
in	O	O	O
shape	O	O	B-T082
and	O	O	O
had	O	O	O
size	O	O	B-T081
ranging	O	O	B-T081
from	O	O	O
30	O	O	O
to	O	O	O
80	O	O	O
nm	O	O	O
.	O	O	O

The	O	O	O
energy	O	O	B-T059
dispersive	O	O	I-T059
X-ray	O	O	I-T059
spectroscopy	O	O	I-T059
(	O	O	O
EDX	O	O	B-T059
)	O	O	O
and	O	O	O
elemental	O	O	B-T059
mapping	O	O	I-T059
have	O	O	O
displayed	O	O	O
the	O	O	O
purity	O	O	B-T081
and	O	O	O
maximum	O	O	B-T081
distribution	O	O	B-T169
of	O	O	O
silver	O	O	B-T196
in	O	O	O
the	O	O	O
AgNPs	O	O	B-T196
.	O	O	O

The	O	O	O
crystalline	O	O	B-T104
nature	O	O	O
of	O	O	O
AgNPs	O	O	B-T196
had	O	O	O
been	O	O	O
identified	O	O	B-T080
using	O	O	O
X-ray	O	O	B-T059
diffraction	O	O	I-T059
(	O	O	O
XRD	O	O	B-T059
)	O	O	O
and	O	O	O
selected	O	O	B-T059
area	O	O	I-T059
diffraction	O	O	I-T059
pattern	O	O	I-T059
(	O	O	O
SAED	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
particle	O	O	B-T081
size	O	O	I-T081
analysis	O	O	B-T169
revealed	O	O	O
that	O	O	O
the	O	O	O
Z-average	O	O	B-T081
diameter	O	O	B-T081
of	O	O	O
the	O	O	O
AgNPs	O	O	B-T196
was	O	O	O
50.86	O	O	O
nm	O	O	O
with	O	O	O
polydispersity	O	O	B-T077
index	O	O	I-T077
(	O	O	O
PDI	O	O	B-T077
)	O	O	O
0.136	O	O	O
.	O	O	O

Zeta	O	O	B-T067
potential	O	O	I-T067
analysis	O	O	B-T169
displayed	O	O	O
the	O	O	O
colloidal	O	O	B-T080
stability	O	O	I-T080
of	O	O	O
AgNPs	O	O	B-T196
.	O	O	O

This	O	O	O
work	O	O	O
also	O	O	O
showed	O	O	O
the	O	O	O
efficacy	O	O	B-T080
of	O	O	O
AgNPs	O	O	B-T073
against	O	O	O
lung	O	O	B-T023
cancer	O	O	B-T025
cell	O	O	I-T025
lines	O	O	I-T025
(	O	O	O
A549	O	O	B-T025
)	O	O	O
and	O	O	O
cervical	O	O	B-T023
cancer	O	O	B-T025
cell	O	O	I-T025
line	O	O	I-T025
(	O	O	O
HeLa	O	O	B-T025
)	O	O	O
,	O	O	O
in	O	O	B-T080
vitro	O	O	I-T080
.	O	O	O

The	O	O	O
AgNPs	O	O	B-T073
showed	O	O	O
cytotoxicity	O	O	B-T049
to	O	O	O
the	O	O	O
A549	O	O	B-T025
and	O	O	O
HeLa	O	O	B-T025
cancer	O	O	B-T025
cell	O	O	I-T025
line	O	O	I-T025
at	O	O	O
the	O	O	O
concentrations	O	O	B-T081
5	O	O	O
and	O	O	O
2	O	O	O
Î¼g/ml	O	O	O
.	O	O	O

The	O	O	O
AgNPs	O	O	B-T196
were	O	O	O
also	O	O	O
explored	O	O	O
for	O	O	O
the	O	O	O
antibacterial	O	O	B-T033
activity	O	O	I-T033
including	O	O	O
biofilm	O	O	B-T007
inhibition	O	O	B-T052
against	O	O	O
pathogenic	O	O	B-T033
bacteria	O	O	B-T007
.	O	O	O

The	O	O	O
B.	O	O	B-T002
officinalis	O	O	I-T002
leaves	O	O	B-T002
extract	O	O	B-T123
can	O	O	O
be	O	O	O
used	O	O	O
efficiently	O	O	B-T080
for	O	O	O
green	O	O	O
synthesis	O	O	B-T052
AgNPs	O	O	B-T196
.	O	O	O

The	O	O	O
biosynthesized	O	O	O
AgNPs	O	O	B-T196
demonstrated	O	O	O
potentials	O	O	B-T080
as	O	O	O
anticancer	O	O	B-T109
and	O	O	O
antibacterial	O	O	B-T195
agents	O	O	I-T195
.	O	O	O

This	O	O	O
work	O	O	O
provides	O	O	O
helpful	O	O	O
insight	O	O	O
into	O	O	O
the	O	O	O
development	O	O	B-T169
of	O	O	O
new	O	O	O
anticancer	O	O	B-T109
and	O	O	O
antimicrobial	O	O	B-T121
agents	O	O	I-T121
.	O	O	O

-DOCSTART- (27599942)

Genotyping	O	O	B-T059
of	O	O	O
Staphylococcus	O	O	B-T007
aureus	O	O	I-T007
in	O	O	O
bovine	O	O	B-T047
mastitis	O	O	I-T047
and	O	O	O
correlation	O	O	O
to	O	O	O
phenotypic	O	O	B-T032
characteristics	O	O	O

Reducing	O	O	O
the	O	O	O
prevalence	O	O	O
of	O	O	O
mastitis	O	O	B-T047
caused	O	O	O
by	O	O	O
Staphylococcus	O	O	B-T007
aureus	O	O	I-T007
(	O	O	O
S.	O	O	B-T007
aureus	O	O	I-T007
)	O	O	O
is	O	O	O
essential	O	O	O
to	O	O	O
improve	O	O	O
animal	O	O	B-T008
health	O	O	B-T078
and	O	O	O
reduce	O	O	O
economic	O	O	O
losses	O	O	O
for	O	O	O
farmers	O	O	B-T097
.	O	O	O

The	O	O	O
clinical	O	O	O
outcome	O	O	O
of	O	O	O
acute	O	O	B-T047
mastitis	O	O	B-T047
and	O	O	O
risk	O	O	B-T078
of	O	O	O
progression	O	O	O
to	O	O	O
persistent	O	O	B-T079
mastitis	O	O	O
can	O	O	O
,	O	O	O
at	O	O	O
least	O	O	O
to	O	O	O
some	O	O	O
extent	O	O	O
,	O	O	O
be	O	O	O
related	O	O	O
to	O	O	O
genetic	O	O	B-T028
variants	O	O	I-T028
of	O	O	O
the	O	O	O
strain	O	O	B-T001
causing	O	O	O
the	O	O	O
infection	O	O	B-T046
.	O	O	O

In	O	O	O
the	O	O	O
present	O	O	O
study	O	O	B-T062
we	O	O	O
have	O	O	O
used	O	O	O
microarrays	O	O	B-T073
to	O	O	O
investigate	O	O	O
the	O	O	O
presence	O	O	O
of	O	O	O
virulence	O	O	B-T038
genes	O	O	B-T028
in	O	O	O
S.	O	O	B-T007
aureus	O	O	I-T007
isolates	O	O	O
from	O	O	O
dairy	O	O	B-T015
cows	O	O	I-T015
with	O	O	O
acute	O	O	B-T047
clinical	O	O	I-T047
mastitis	O	O	I-T047
(	O	O	O
n=70	O	O	O
)	O	O	O
and	O	O	O
correlated	O	O	O
the	O	O	O
findings	O	O	B-T033
to	O	O	O
other	O	O	O
genotypic	O	O	B-T032
and	O	O	O
phenotypic	O	O	B-T032
characteristics	O	O	B-T080
.	O	O	O

Among	O	O	O
the	O	O	O
most	O	O	O
commonly	O	O	O
found	O	O	O
virulence	O	O	B-T109
factors	O	O	I-T109
were	O	O	O
genes	O	O	B-T028
encoding	O	O	B-T052
several	O	O	O
hemolysin	O	O	B-T123
types	O	O	B-T080
,	O	O	O
leukocidins	O	O	B-T116
D	O	O	I-T116
and	O	O	O
lukM	O	O	B-T116
/	O	O	O
lukF-P83	O	O	B-T116
,	O	O	O
clumping	O	O	B-T116
factors	O	O	I-T116
A	O	O	I-T116
and	O	O	O
B	O	O	B-T116
,	O	O	O
fibrinogen	O	O	B-T116
binding	O	O	I-T116
protein	O	O	I-T116
and	O	O	O
fibronectin-binding	O	O	O
protein	O	O	O
A.	O	O	O
Some	O	O	O
virulence	O	O	O
factors	O	O	O
e.g.	O	O	O
fibronectin-binding	O	O	B-T116
protein	O	O	I-T116
B	O	O	I-T116
and	O	O	O
Staphylococcus	O	O	B-T007
aureus	O	O	I-T007
surface	O	O	B-T116
protein	O	O	I-T116
G	O	O	I-T116
were	O	O	O
less	O	O	O
common	O	O	O
.	O	O	O

Genes	O	O	B-T028
coding	O	O	O
for	O	O	O
several	O	O	O
staphylococcal	O	O	B-T123
enterotoxins	O	O	I-T123
and	O	O	O
toxic	O	O	B-T116
shock	O	O	I-T116
syndrome	O	O	I-T116
toxin-1	O	O	I-T116
(	O	O	O
TSST-1	O	O	B-T116
)	O	O	O
were	O	O	O
commonly	O	O	O
found	O	O	O
,	O	O	O
especially	O	O	O
in	O	O	O
one	O	O	O
major	O	O	O
pulsotype	O	O	B-T001
.	O	O	O

No	O	O	B-T033
beta-lactamase	O	O	B-T028
genes	O	O	I-T028
were	O	O	O
found	O	O	O
in	O	O	O
any	O	O	O
common	O	O	O
pulsotype	O	O	B-T001
,	O	O	O
while	O	O	O
present	O	O	O
in	O	O	O
some	O	O	O
rare	O	O	O
pulsotypes	O	O	B-T001
,	O	O	O
indicated	O	O	O
to	O	O	O
be	O	O	O
of	O	O	O
human	O	O	B-T077
origin	O	O	I-T077
.	O	O	O

Production	O	O	O
of	O	O	O
TSST-1	O	O	B-T116
,	O	O	O
enterotoxins	O	O	B-T116
,	O	O	O
hemolysins	O	O	B-T123
and	O	O	O
beta-lactamase	O	O	B-T116
could	O	O	O
all	O	O	O
be	O	O	O
positively	O	O	O
correlated	O	O	O
to	O	O	O
presence	O	O	O
of	O	O	O
the	O	O	O
corresponding	O	O	O
genes	O	O	B-T028
.	O	O	O

This	O	O	O
study	O	O	B-T062
reveals	O	O	O
a	O	O	O
number	O	O	O
of	O	O	O
genotypic	O	O	B-T032
differences	O	O	B-T080
and	O	O	O
similarities	O	O	B-T080
among	O	O	O
common	O	O	O
and	O	O	O
rare	O	O	O
pulsotypes	O	O	B-T001
of	O	O	O
S.	O	O	B-T007
aureus	O	O	I-T007
from	O	O	O
cases	O	O	O
of	O	O	O
mastitis	O	O	B-T047
in	O	O	O
Sweden	O	O	B-T083
.	O	O	O

The	O	O	O
results	O	O	O
could	O	O	O
help	O	O	O
the	O	O	O
design	O	O	O
of	O	O	O
diagnostic	O	O	B-T063
tools	O	O	I-T063
to	O	O	O
guide	O	O	O
on-farm	O	O	O
interventions	O	O	O
according	O	O	O
to	O	O	O
the	O	O	O
expected	O	O	O
impact	O	O	O
on	O	O	O
udder	O	O	B-T023
health	O	O	B-T078
from	O	O	O
a	O	O	O
specific	O	O	O
S.	O	O	B-T007
aureus	O	O	I-T007
genotype	O	O	B-T032
.	O	O	O

-DOCSTART- (27600888)

Uveitis	O	O	B-T047
in	O	O	O
spondyloarthritis	O	O	B-T047
patients	O	O	B-T101
and	O	O	O
its	O	O	O
association	O	O	B-T080
with	O	O	I-T080
HLA-B27	O	O	B-T116
histocompatibility	O	O	I-T116
antigen	O	O	I-T116
:	O	O	O
prospective	O	O	O
study	O	O	O

T	O	O	O
o	O	O	O
perform	O	O	O
a	O	O	O
prospective	O	O	B-T062
study	O	O	I-T062
of	O	O	O
clinical	O	O	B-T170
presentation	O	O	I-T170
and	O	O	O
course	O	O	B-T079
of	O	O	O
uveitis	O	O	B-T047
in	O	O	O
spondyloarthritis	O	O	B-T047
(	O	O	O
SpA	O	O	B-T047
)	O	O	O
patients	O	O	B-T101
as	O	O	O
well	O	O	O
as	O	O	O
its	O	O	O
association	O	O	B-T080
with	O	O	I-T080
the	O	O	O
HLA-B27	O	O	B-T116
histocompatibility	O	O	I-T116
antigen	O	O	I-T116
.	O	O	O

The	O	O	O
study	O	O	B-T062
included	O	O	O
219	O	O	O
patients	O	O	B-T101
with	O	O	O
uveitis	O	O	B-T047
,	O	O	O
all	O	O	O
tested	O	O	B-T169
for	O	O	O
HLA-B27	O	O	B-T116
antigen	O	O	I-T116
and	O	O	O
various	O	O	O
infections	O	O	B-T046
(	O	O	O
viral	O	O	B-T047
,	O	O	O
bacterial	O	O	B-T047
,	O	O	O
and	O	O	O
parasitic	O	O	B-T047
)	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
examined	O	O	B-T033
for	O	O	O
locomotive	O	O	B-T022
system	O	O	I-T022
involvement	O	O	B-T169
.	O	O	O

The	O	O	O
presence	O	O	B-T033
of	O	O	O
the	O	O	O
HLA-B27	O	O	B-T116
antigen	O	O	I-T116
was	O	O	O
determined	O	O	B-T080
in	O	O	O
142	O	O	O
(	O	O	O
64.8	O	O	O
%	O	O	O
)	O	O	O
out	O	O	O
of	O	O	O
219	O	O	O
patients	O	O	B-T101
,	O	O	O
of	O	O	O
them	O	O	O
87	O	O	O
were	O	O	O
diagnosed	O	O	B-T033
with	O	O	O
an	O	O	O
entity	O	O	B-T071
of	O	O	O
the	O	O	O
SpA	O	O	B-T047
group	O	O	B-T078
.	O	O	O

The	O	O	O
remaining	O	O	B-T080
77	O	O	O
(	O	O	O
35.2	O	O	O
%	O	O	O
)	O	O	O
patients	O	O	B-T101
appeared	O	O	O
to	O	O	O
be	O	O	O
HLA-B27	O	O	B-T116
-	O	O	O
negative	O	O	B-T033
,	O	O	O
but	O	O	O
13	O	O	O
were	O	O	O
still	O	O	O
diagnosed	O	O	B-T033
with	O	O	O
an	O	O	O
entity	O	O	B-T071
of	O	O	O
the	O	O	O
SpA	O	O	B-T047
group	O	O	B-T078
.	O	O	O

There	O	O	O
were	O	O	O
10	O	O	O
(	O	O	O
4.6	O	O	O
%	O	O	O
)	O	O	O
patients	O	O	B-T101
with	O	O	O
2	O	O	O
or	O	O	O
more	O	O	O
diseases	O	O	B-T047
from	O	O	O
the	O	O	O
SpA	O	O	B-T047
group	O	O	B-T078
(	O	O	O
Â«	O	O	O
clinical	O	O	O
decussation	O	O	O
Â»	O	O	O
)	O	O	O
.	O	O	O

When	O	O	O
comparing	O	O	B-T052
the	O	O	O
two	O	O	O
groups	O	O	B-T078
of	O	O	O
HLA-B27-positive	O	O	B-T034
and	O	O	O
negative	O	O	B-T033
patients	O	O	B-T101
having	O	O	O
both	O	O	O
SpA	O	O	B-T047
and	O	O	O
uveitis	O	O	B-T047
,	O	O	O
no	O	O	O
statistically	O	O	B-T081
significant	O	O	I-T081
difference	O	O	B-T080
was	O	O	O
found	O	O	O
as	O	O	O
to	O	O	O
the	O	O	O
age	O	O	B-T081
of	O	O	I-T081
onset	O	O	I-T081
,	O	O	O
site	O	O	B-T029
,	O	O	O
frequency	O	O	B-T079
of	O	O	I-T079
attacks	O	O	I-T079
,	O	O	O
and	O	O	O
uni	O	O	B-T082
-	O	O	O
or	O	O	O
bilateral	O	O	B-T082
involvement	O	O	B-T169
(	O	O	O
p>0.05	O	O	O
)	O	O	O
.	O	O	O

We	O	O	O
also	O	O	O
performed	O	O	B-T169
a	O	O	O
comparison	O	O	B-T052
of	O	O	O
HLA-B27-positive	O	O	B-T034
and	O	O	O
negative	O	O	B-T033
patients	O	O	B-T101
with	O	O	O
no	O	O	O
account	O	O	O
to	O	O	O
their	O	O	O
SpA	O	O	B-T047
status	O	O	B-T080
and	O	O	O
revealed	O	O	B-T080
a	O	O	O
higher	O	O	B-T080
complication	O	O	B-T046
rate	O	O	B-T081
in	O	O	O
those	O	O	O
that	O	O	O
were	O	O	O
Â«	O	O	O
negative	O	O	O
Â»	O	O	O
(	O	O	O
p<0.0001	O	O	O
)	O	O	O
,	O	O	O
which	O	O	O
can	O	O	O
be	O	O	O
explained	O	O	O
by	O	O	O
the	O	O	O
fact	O	O	O
that	O	O	O
HLA-B27	O	O	B-T116
-	O	O	O
negative	O	O	O
patients	O	O	O
often	O	O	O
have	O	O	O
autoimmune	O	O	B-T047
or	O	O	O
infectious	O	O	B-T047
uveitis	O	O	I-T047
of	O	O	O
different	O	O	B-T080
origin	O	O	O
notable	O	O	O
for	O	O	O
long	O	O	B-T080
attacks	O	O	O
and	O	O	O
short	O	O	B-T081
remissions	O	O	B-T033
.	O	O	O

Assessing	O	O	B-T058
the	O	O	O
site	O	O	B-T029
and	O	O	O
course	O	O	B-T079
of	O	O	O
uveitis	O	O	B-T047
as	O	O	O
well	O	O	O
as	O	O	O
HLA-B27	O	O	B-T116
testing	O	O	B-T169
of	O	O	O
uveitis	O	O	O
patients	O	O	B-T101
has	O	O	O
proved	O	O	O
important	O	O	B-T080
for	O	O	O
etiological	O	O	B-T169
diagnosis	O	O	B-T033
.	O	O	O

Diseases	O	O	B-T047
of	O	O	O
the	O	O	O
SpA	O	O	B-T047
group	O	O	B-T078
have	O	O	O
been	O	O	O
shown	O	O	O
to	O	O	O
be	O	O	O
6.7	O	O	O
times	O	O	B-T081
more	O	O	O
common	O	O	O
in	O	O	O
HLA-B27-positive	O	O	B-T034
patients	O	O	B-T101
as	O	O	O
compared	O	O	B-T052
to	O	O	O
HLA-B27	O	O	B-T116
-	O	O	O
negative	O	O	B-T033
ones	O	O	O
.	O	O	O

Clinical	O	O	B-T170
presentation	O	O	I-T170
of	O	O	O
uveitis	O	O	B-T047
in	O	O	O
the	O	O	O
presence	O	O	B-T033
of	O	O	O
SpA	O	O	B-T047
in	O	O	O
both	O	O	O
HLA-B27-positive	O	O	B-T034
and	O	O	O
negative	O	O	B-T033
patients	O	O	B-T101
resembles	O	O	O
that	O	O	O
of	O	O	O
idiopathic	O	O	B-T047
uveitis	O	O	I-T047
-	O	O	O
an	O	O	O
independent	O	O	O
HLA-B27	O	O	B-T116
-	O	O	O
associated	O	O	B-T080
syndrome	O	O	B-T047
(	O	O	O
Ñ>0.05	O	O	O
)	O	O	O
.	O	O	O

Cases	O	O	O
of	O	O	O
Â«	O	O	O
decussation	O	O	O
Â»	O	O	O
between	O	O	O
entities	O	O	B-T071
of	O	O	O
the	O	O	O
SpA	O	O	B-T047
group	O	O	B-T078
are	O	O	O
usually	O	O	O
more	O	O	O
severe	O	O	B-T080
in	O	O	O
terms	O	O	O
of	O	O	O
clinical	O	O	B-T170
presentation	O	O	I-T170
and	O	O	O
course	O	O	B-T079
of	O	O	O
uveitis	O	O	B-T047
and	O	O	O
are	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
a	O	O	O
worse	O	O	B-T033
prognosis	O	O	I-T033
.	O	O	O

Complications	O	O	B-T046
of	O	O	O
uveitis	O	O	B-T047
are	O	O	O
more	O	O	O
likely	O	O	O
to	O	O	O
be	O	O	O
found	O	O	O
in	O	O	O
non-SpA	O	O	B-T033
HLA-B27	O	O	B-T116
-	O	O	O
negative	O	O	B-T033
patients	O	O	B-T101
(	O	O	O
Ñ<0.0001	O	O	O
)	O	O	O
.	O	O	O

-DOCSTART- (27601111)

Human	O	O	B-T016
brucellosis	O	O	B-T047
in	O	O	O
South	O	O	B-T083
Africa	O	O	I-T083
:	O	O	O
Public	O	O	B-T170
health	O	O	I-T170
and	O	O	O
diagnostic	O	O	O
pitfalls	O	O	O

Human	O	O	B-T016
brucellosis	O	O	B-T047
in	O	O	O
South	O	O	B-T083
Africa	O	O	I-T083
(	O	O	O
SA	O	O	B-T083
)	O	O	O
is	O	O	O
under-diagnosed	O	O	B-UnknownType
and	O	O	O
under-reported	O	O	B-T033
.	O	O	O

This	O	O	O
is	O	O	O
because	O	O	O
many	O	O	O
clinicians	O	O	B-T097
have	O	O	O
little	O	O	O
or	O	O	O
no	O	O	O
experience	O	O	O
in	O	O	O
managing	O	O	O
affected	O	O	B-T080
patients	O	O	I-T080
,	O	O	O
and	O	O	O
in	O	O	O
part	O	O	O
because	O	O	O
of	O	O	O
the	O	O	O
nonspecific	O	O	B-T078
and	O	O	O
insidious	O	O	B-T080
nature	O	O	B-T080
of	O	O	I-T080
the	O	O	I-T080
disease	O	O	I-T080
.	O	O	O

A	O	O	O
case	O	O	B-T169
of	O	O	O
human	O	O	B-T016
brucellosis	O	O	B-T047
caused	O	O	O
by	O	O	O
Brucella	O	O	B-T007
melitensis	O	O	I-T007
in	O	O	O
a	O	O	O
patient	O	O	B-T101
from	O	O	O
the	O	O	O
Western	O	O	B-UnknownType
Cape	O	O	I-UnknownType
Province	O	O	I-UnknownType
of	O	O	O
SA	O	O	B-T083
is	O	O	O
described	O	O	B-T078
,	O	O	O
and	O	O	O
the	O	O	O
resulting	O	O	B-T169
exposure	O	O	O
of	O	O	O
staff	O	O	B-T097
members	O	O	I-T097
at	O	O	O
two	O	O	O
medical	O	O	B-T093
microbiology	O	O	I-T093
laboratories	O	O	I-T093
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
the	O	O	O
public	O	O	B-T058
health	O	O	I-T058
investigation	O	O	I-T058
that	O	O	O
was	O	O	O
conducted	O	O	O
,	O	O	O
are	O	O	O
discussed	O	O	O
.	O	O	O

This	O	O	O
article	O	O	B-T170
aims	O	O	B-T078
to	O	O	O
highlight	O	O	O
the	O	O	O
need	O	O	O
for	O	O	O
strengthening	O	O	O
integration	O	O	B-T169
between	O	O	O
public	O	O	B-T170
health	O	O	I-T170
,	O	O	O
medical	O	O	B-T058
and	O	O	O
veterinary	O	O	B-T091
services	O	O	B-T057
and	O	O	O
exposing	O	O	B-T169
deficiencies	O	O	I-T169
in	O	O	O
public	O	O	O
health	O	O	O
,	O	O	O
veterinary	O	O	O
and	O	O	O
laboratory	O	O	B-T093
practices	O	O	O
.	O	O	O

-DOCSTART- (27601238)

Survey	O	O	B-T170
of	O	O	O
Trichinella	O	O	B-T047
infection	O	O	I-T047
from	O	O	O
domestic	O	O	B-T015
pigs	O	O	I-T015
in	O	O	O
the	O	O	O
historical	O	O	B-T033
endemic	O	O	B-T082
areas	O	O	I-T082
of	O	O	O
Henan	O	O	B-T083
province	O	O	I-T083
,	O	O	O
central	O	O	O
China	O	O	O

The	O	O	O
aim	O	O	B-T078
of	O	O	O
this	O	O	O
work	O	O	B-T057
was	O	O	O
to	O	O	O
investigate	O	O	B-T169
the	O	O	O
current	O	O	B-T033
situation	O	O	I-T033
of	O	O	O
Trichinella	O	O	B-T047
infection	O	O	I-T047
from	O	O	O
domestic	O	O	B-T015
pigs	O	O	I-T015
in	O	O	O
the	O	O	O
historical	O	O	B-T033
endemic	O	O	B-T082
areas	O	O	I-T082
of	O	O	O
Henan	O	O	B-T083
province	O	O	I-T083
,	O	O	O
central	O	O	B-T083
China	O	O	I-T083
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
823	O	O	O
diaphragm	O	O	B-T031
samples	O	O	I-T031
from	O	O	O
the	O	O	O
indoor-raised	O	O	B-T015
pigs	O	O	I-T015
were	O	O	O
collected	O	O	B-T169
in	O	O	O
five	O	O	B-T081
cities	O	O	B-T083
of	O	O	O
Henan	O	O	B-T083
during	O	O	O
2014	O	O	O
-	O	O	O
2015	O	O	O
and	O	O	O
examined	O	O	B-T033
by	O	O	O
artificial	O	O	B-T169
digestion	O	O	I-T169
method	O	O	I-T169
.	O	O	O

The	O	O	O
overall	O	O	B-T081
prevalence	O	O	I-T081
of	O	O	O
Trichinella	O	O	B-T047
infection	O	O	I-T047
in	O	O	O
pigs	O	O	B-T015
was	O	O	O
0.61	O	O	O
%	O	O	O
(	O	O	O
5/823	O	O	O
)	O	O	O
.	O	O	O

Trichinella	O	O	B-T204
larvae	O	O	I-T204
were	O	O	O
detected	O	O	B-T033
in	O	O	O
0.91	O	O	O
%	O	O	O
(	O	O	O
5/550	O	O	O
)	O	O	O
of	O	O	O
pigs	O	O	B-T015
from	O	O	O
Nanyang	O	O	B-T083
city	O	O	I-T083
of	O	O	O
Henan	O	O	B-T083
.	O	O	O

The	O	O	O
larval	O	O	B-T204
burden	O	O	B-T078
in	O	O	O
infected	O	O	B-T033
animals	O	O	I-T033
was	O	O	O
0.03	O	O	O
larvae	O	O	B-T204
per	O	O	O
gram	O	O	O
(	O	O	O
lpg	O	O	O
)	O	O	O
of	O	O	O
muscles	O	O	B-T024
with	O	O	O
a	O	O	O
range	O	O	B-T081
from	O	O	O
0.02	O	O	O
to	O	O	O
0.05	O	O	O
lpg	O	O	O
.	O	O	O

The	O	O	O
larvae	O	O	B-T204
were	O	O	O
identified	O	O	B-T080
as	O	O	O
Trichinella	O	O	B-T204
spiralis	O	O	I-T204
by	O	O	O
multiple	O	O	B-T063
PCR	O	O	I-T063
.	O	O	O

Our	O	O	O
study	O	O	B-T062
confirms	O	O	B-T080
the	O	O	O
existence	O	O	B-T077
of	O	O	O
swine	O	O	B-T015
trichinellosis	O	O	B-T047
in	O	O	O
Henan	O	O	B-T083
,	O	O	O
but	O	O	O
the	O	O	O
infection	O	O	B-T046
level	O	O	B-T080
was	O	O	O
under	O	O	O
the	O	O	O
minimum	O	O	B-T080
level	O	O	I-T080
for	O	O	O
defining	O	O	O
infectious	O	O	B-T001
sources	O	O	I-T001
for	O	O	O
humans	O	O	B-T016
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
prevalence	O	O	B-T081
of	O	O	O
swine	O	O	B-T015
Trichinella	O	O	B-T047
infection	O	O	I-T047
in	O	O	O
Henan	O	O	B-T083
need	O	O	O
to	O	O	O
be	O	O	O
further	O	O	O
evaluated	O	O	B-T058
with	O	O	O
a	O	O	O
large	O	O	B-T081
scale	O	O	I-T081
of	O	O	O
pork	O	O	B-T167
samples	O	O	I-T167
for	O	O	O
ensuring	O	O	O
meat	O	O	B-T168
food	O	O	B-T057
safety	O	O	I-T057
.	O	O	O

-DOCSTART- (27601292)

Voriconazole	O	O	B-T109
metabolism	O	O	B-T044
is	O	O	O
influenced	O	O	B-T077
by	O	O	O
severe	O	O	B-T080
inflammation	O	O	B-T046
:	O	O	O
a	O	O	O
prospective	O	O	O
study	O	O	O

During	O	O	O
an	O	O	O
infection	O	O	B-T046
or	O	O	O
inflammation	O	O	B-T046
,	O	O	O
several	O	O	B-T081
drug	O	O	B-T121
-	O	O	O
metabolizing	O	O	B-T044
enzymes	O	O	B-T116
in	O	O	O
the	O	O	O
liver	O	O	B-T023
are	O	O	O
down-regulated	O	O	B-T044
,	O	O	O
including	O	O	O
cytochrome	O	O	B-T116
P450	O	O	I-T116
iso-enzymes	O	O	I-T116
.	O	O	O

Since	O	O	O
voriconazole	O	O	B-T109
is	O	O	O
extensively	O	O	B-T080
metabolized	O	O	B-T044
by	O	O	O
cytochrome	O	O	B-T116
P450	O	O	I-T116
iso-enzymes	O	O	I-T116
,	O	O	O
the	O	O	O
metabolism	O	O	B-T044
of	O	O	O
voriconazole	O	O	O
can	O	O	O
be	O	O	O
influenced	O	O	B-T077
during	O	O	O
inflammation	O	O	B-T046
via	O	O	O
reduced	O	O	B-T080
clearance	O	O	B-T039
of	O	O	I-T039
the	O	O	I-T039
drug	O	O	I-T039
,	O	O	O
resulting	O	O	O
in	O	O	O
higher	O	O	B-T080
voriconazole	O	O	O
trough	O	O	B-T081
concentrations	O	O	I-T081
.	O	O	O

To	O	O	O
investigate	O	O	O
prospectively	O	O	O
the	O	O	O
influence	O	O	B-T077
of	O	O	O
inflammation	O	O	B-T046
on	O	O	O
voriconazole	O	O	B-T109
metabolism	O	O	B-T044
and	O	O	O
voriconazole	O	O	O
trough	O	O	B-T081
concent	O	O	I-T081
ratio	O	O	B-T081
ns	O	O	I-T081
.	O	O	O

A	O	O	O
prospective	O	O	B-T062
observational	O	O	I-T062
study	O	O	I-T062
was	O	O	O
performed	O	O	O
at	O	O	O
the	O	O	O
University	O	O	B-T093
Medical	O	O	I-T093
Center	O	O	I-T093
Groningen	O	O	B-T083
.	O	O	O

Patients	O	O	B-T101
were	O	O	O
eligible	O	O	B-T080
for	O	O	O
inclusion	O	O	B-T080
if	O	O	O
they	O	O	O
were	O	O	O
â¥18	O	O	O
years	O	O	O
old	O	O	O
and	O	O	O
treated	O	O	B-T061
with	O	O	I-T061
voriconazole	O	O	B-T109
.	O	O	O

Voriconazole	O	O	B-T109
and	O	O	O
voriconazole-N-oxide	O	O	B-T109
concentrations	O	O	B-T081
were	O	O	O
determined	O	O	O
in	O	O	O
discarded	O	O	O
blood	O	O	B-T031
samples	O	O	I-T031
.	O	O	O

To	O	O	O
determine	O	O	O
the	O	O	O
degree	O	O	B-T081
of	O	O	O
inflammation	O	O	B-T046
,	O	O	O
C-reactive	O	O	B-T059
protein	O	O	I-T059
(	O	O	I-T059
CRP	O	O	I-T059
)	O	O	I-T059
concentrations	O	O	I-T059
were	O	O	O
used	O	O	O
.	O	O	O

Subsequently	O	O	O
,	O	O	O
a	O	O	O
longitudinal	O	O	B-T062
data	O	O	I-T062
analysis	O	O	I-T062
was	O	O	O
performed	O	O	O
to	O	O	O
assess	O	O	B-T058
the	O	O	O
effect	O	O	B-T080
of	O	O	O
inflammation	O	O	B-T046
on	O	O	O
the	O	O	O
metabolic	O	O	B-T044
ratio	O	O	B-T081
and	O	O	O
voriconazole	O	O	B-T109
trough	O	O	B-T081
concentration	O	O	I-T081
.	O	O	O

Thirty-four	O	O	O
patients	O	O	B-T101
were	O	O	O
included	O	O	O
.	O	O	O

In	O	O	O
total	O	O	O
489	O	O	O
voriconazole	O	O	B-T109
trough	O	O	B-T081
concentrations	O	O	I-T081
were	O	O	O
included	O	O	O
in	O	O	O
the	O	O	O
longitudinal	O	O	B-T062
data	O	O	I-T062
analysis	O	O	I-T062
.	O	O	O

This	O	O	O
analysis	O	O	B-T062
showed	O	O	O
that	O	O	O
inflammation	O	O	B-T046
,	O	O	O
reflected	O	O	O
by	O	O	O
CRP	O	O	B-T059
concentrations	O	O	I-T059
,	O	O	O
significantly	O	O	O
influence	O	O	B-T077
d	O	O	O
the	O	O	O
metabolic	O	O	B-T044
ratio	O	O	B-T081
,	O	O	O
voriconazole	O	O	B-T109
trough	O	O	B-T081
concentration	O	O	B-T081
and	O	O	O
voriconazole-N-oxide	O	O	B-T109
concentration	O	O	O
(	O	O	O
all	O	O	O
P	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
,	O	O	O
when	O	O	O
corrected	O	O	O
for	O	O	O
other	O	O	O
factors	O	O	B-T169
that	O	O	O
could	O	O	O
influence	O	O	O
voriconazole	O	O	O
metabolism	O	O	B-T044
.	O	O	O

The	O	O	O
metabolic	O	O	B-T044
ratio	O	O	B-T081
was	O	O	O
decreased	O	O	B-T081
by	O	O	O
0.99229(N	O	O	O
)	O	O	O
and	O	O	O
the	O	O	O
voriconazole-N-oxide	O	O	B-T109
concentration	O	O	B-T081
by	O	O	O
0.99775(N	O	O	O
)	O	O	O
,	O	O	O
while	O	O	O
the	O	O	O
voriconazole	O	O	B-T109
trough	O	O	B-T081
concentration	O	O	I-T081
was	O	O	O
increased	O	O	B-T081
by	O	O	O
1.005321(N	O	O	O
)	O	O	O
,	O	O	O
where	O	O	O
N	O	O	O
is	O	O	O
the	O	O	O
difference	O	O	O
in	O	O	O
CRP	O	O	B-T116
units	O	O	O
(	O	O	O
in	O	O	O
mg/L	O	O	O
)	O	O	O
.	O	O	O

This	O	O	O
study	O	O	O
shows	O	O	O
that	O	O	O
voriconazole	O	O	B-T109
metabolism	O	O	B-T044
is	O	O	O
decreased	O	O	B-T081
during	O	O	O
inflammation	O	O	B-T046
,	O	O	O
resulting	O	O	O
in	O	O	O
higher	O	O	B-T080
voriconazole	O	O	O
trough	O	O	B-T081
concentration	O	O	I-T081
s.	O	O	O
Therefore	O	O	O
,	O	O	O
frequent	O	O	B-T079
monitoring	O	O	B-T058
of	O	O	O
voriconazole	O	O	O
serum	O	O	B-T081
concentrations	O	O	I-T081
is	O	O	O
recommended	O	O	O
during	O	O	O
and	O	O	O
following	O	O	O
severe	O	O	B-T080
inflammation	O	O	O
.	O	O	O

-DOCSTART- (27601594)

Neoadjuvant	O	O	B-T061
Chemotherapy	O	O	I-T061
of	O	O	O
Ovarian	O	O	B-T191
Cancer	O	O	I-T191
Results	O	O	O
in	O	O	O
Three	O	O	O
Patterns	O	O	O
of	O	O	O
Tumor-Infiltrating	O	O	B-T025
Lymphocyte	O	O	I-T025
Response	O	O	B-T039
with	O	O	O
Distinct	O	O	O
Implications	O	O	O
for	O	O	O
Immunotherapy	O	O	O

Purpose	O	O	O
:	O	O	O
Some	O	O	O
forms	O	O	O
of	O	O	O
chemotherapy	O	O	B-T061
can	O	O	O
enhance	O	O	O
antitumor	O	O	B-T080
immunity	O	O	B-T039
through	O	O	O
immunogenic	O	O	B-T169
cell	O	O	B-T043
death	O	O	I-T043
,	O	O	O
resulting	O	O	O
in	O	O	O
increased	O	O	O
T-cell	O	O	B-T043
activation	O	O	I-T043
and	O	O	O
tumor	O	O	B-T191
infiltration	O	O	I-T191
.	O	O	O

Such	O	O	O
effects	O	O	O
could	O	O	O
potentially	O	O	O
sensitize	O	O	O
tumors	O	O	B-T191
to	O	O	O
immunotherapies	O	O	B-T061
,	O	O	O
including	O	O	O
checkpoint	O	O	B-T043
blockade	O	O	I-T043
.	O	O	O

We	O	O	O
investigated	O	O	O
whether	O	O	O
platinum	O	O	B-T196
-	O	O	O
and	O	O	O
taxane	O	O	B-T109
-based	O	O	O
chemotherapy	O	O	B-T061
for	O	O	O
ovarian	O	O	B-T191
cancer	O	O	I-T191
induces	O	O	O
immunologic	O	O	B-T169
changes	O	O	O
consistent	O	O	O
with	O	O	O
this	O	O	O
possibility	O	O	O
.	O	O	O

Experimental	O	O	B-T062
Design	O	O	I-T062
:	O	O	O
Matched	O	O	O
pre	O	O	B-T079
-	O	O	O
and	O	O	O
post	O	O	B-T079
-	O	O	O
neoadjuvant	O	O	B-T061
chemotherapy	O	O	I-T061
tumor	O	O	B-T024
samples	O	O	I-T024
from	O	O	O
26	O	O	O
high-grade	O	O	B-T191
serous	O	O	I-T191
carcinoma	O	O	I-T191
(	O	O	O
HGSC	O	O	B-T191
)	O	O	O
patients	O	O	O
were	O	O	O
analyzed	O	O	O
by	O	O	O
immunohistochemistry	O	O	B-T060
(	O	O	O
IHC	O	O	B-T060
)	O	O	O
for	O	O	O
a	O	O	O
large	O	O	O
panel	O	O	O
of	O	O	O
immune	O	O	B-T025
cells	O	O	I-T025
and	O	O	O
associated	O	O	O
factors	O	O	O
.	O	O	O

The	O	O	O
prognostic	O	O	O
significance	O	O	O
of	O	O	O
post	O	O	B-T079
-	O	O	O
chemotherapy	O	O	B-T061
TIL	O	O	B-T025
patterns	O	O	O
was	O	O	O
assessed	O	O	O
in	O	O	O
an	O	O	O
expanded	O	O	O
cohort	O	O	B-T098
(	O	O	O
n	O	O	O
=	O	O	O
90).Results	O	O	O
:	O	O	O
Neoadjuvant	O	O	B-T061
chemotherapy	O	O	I-T061
was	O	O	O
associated	O	O	O
with	O	O	O
increased	O	O	O
densities	O	O	O
of	O	O	O
CD3	O	O	B-T116
(	O	O	O
+	O	O	O
)	O	O	O
,	O	O	O
CD8	O	O	B-T129
(	O	O	O
+	O	O	O
)	O	O	O
,	O	O	O
CD8	O	O	O
(	O	O	O
+	O	O	O
)	O	O	O
TIA-1	O	O	B-T116
(	O	O	O
+	O	O	O
)	O	O	O
,	O	O	O
PD-1	O	O	B-T116
(	O	O	O
+	O	O	O
)	O	O	O
and	O	O	O
CD20	O	O	B-T116
(	O	O	O
+	O	O	O
)	O	O	O
TIL	O	O	O
.	O	O	O

Other	O	O	O
immune	O	O	O
subsets	O	O	O
and	O	O	O
factors	O	O	O
were	O	O	O
unchanged	O	O	O
,	O	O	O
including	O	O	O
CD79a	O	O	B-T116
(	O	O	O
+	O	O	O
)	O	O	O
CD138	O	O	B-T116
(	O	O	O
+	O	O	O
)	O	O	O
plasma	O	O	B-T025
cells	O	O	I-T025
,	O	O	O
CD68	O	O	B-T116
(	O	O	O
+	O	O	O
)	O	O	O
macrophages	O	O	B-T025
,	O	O	O
and	O	O	O
MHC	O	O	B-T116
class	O	O	I-T116
I	O	O	I-T116
on	O	O	O
tumor	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

Immunosuppressive	O	O	B-T047
cell	O	O	B-T025
types	O	O	O
were	O	O	O
also	O	O	O
unchanged	O	O	O
,	O	O	O
including	O	O	O
FoxP3	O	O	B-T116
(	O	O	O
+	O	O	O
)	O	O	O
PD-1	O	O	B-T116
(	O	O	O
+	O	O	O
)	O	O	O
cells	O	O	B-T025
(	O	O	O
putative	O	O	O
regulatory	O	O	B-T025
T	O	O	I-T025
cells	O	O	I-T025
)	O	O	O
,	O	O	O
IDO-1	O	O	B-T116
(	O	O	O
+	O	O	O
)	O	O	O
cells	O	O	O
,	O	O	O
and	O	O	O
PD-L1	O	O	B-T129
(	O	O	O
+	O	O	O
)	O	O	O
cells	O	O	O
(	O	O	O
both	O	O	O
macrophages	O	O	B-T025
and	O	O	O
tumor	O	O	B-T025
cells	O	O	I-T025
)	O	O	O
.	O	O	O

Hierarchical	O	O	B-T062
clustering	O	O	I-T062
revealed	O	O	O
three	O	O	O
response	O	O	O
patterns	O	O	O
:	O	O	O
(	O	O	O
i	O	O	O
)	O	O	O
TIL	O	O	B-T025
(	O	O	O
high	O	O	O
)	O	O	O
tumors	O	O	B-T191
showed	O	O	O
increases	O	O	O
in	O	O	O
multiple	O	O	O
immune	O	O	B-T080
markers	O	O	I-T080
after	O	O	O
chemotherapy	O	O	B-T061
;	O	O	O
(	O	O	O
ii	O	O	O
)	O	O	O
TIL	O	O	O
(	O	O	O
low	O	O	O
)	O	O	O
tumors	O	O	O
underwent	O	O	O
similar	O	O	O
increases	O	O	O
,	O	O	O
achieving	O	O	O
patterns	O	O	O
indistinguishable	O	O	O
from	O	O	O
the	O	O	O
first	O	O	O
group	O	O	O
;	O	O	O
and	O	O	O
(	O	O	O
iii	O	O	O
)	O	O	O
TIL	O	O	O
(	O	O	O
negative	O	O	B-T033
)	O	O	O
cases	O	O	O
generally	O	O	O
remained	O	O	O
negative	O	O	O
.	O	O	O

Despite	O	O	O
the	O	O	O
dramatic	O	O	O
increases	O	O	O
seen	O	O	O
in	O	O	O
the	O	O	O
first	O	O	O
two	O	O	O
patterns	O	O	O
,	O	O	O
post-	O	O	O
chemotherapy	O	O	B-T061
TIL	O	O	B-T025
showed	O	O	O
limited	O	O	O
prognostic	O	O	O
significance	O	O	O
.	O	O	O

Conclusions	O	O	O
:	O	O	O
Chemotherapy	O	O	B-T061
augments	O	O	O
pre-existing	O	O	O
TIL	O	O	B-T025
responses	O	O	B-T039
but	O	O	O
fails	O	O	O
to	O	O	O
relieve	O	O	O
major	O	O	O
immune-suppressive	O	O	B-T047
mechanisms	O	O	I-T047
or	O	O	O
confer	O	O	O
significant	O	O	O
prognostic	O	O	O
benefit	O	O	O
.	O	O	O

Our	O	O	O
findings	O	O	O
provide	O	O	O
rationale	O	O	O
for	O	O	O
multipronged	O	O	O
approaches	O	O	O
to	O	O	O
immunotherapy	O	O	B-T061
tailored	O	O	O
to	O	O	O
the	O	O	O
baseline	O	O	O
features	O	O	O
of	O	O	O
the	O	O	O
tumor	O	O	B-T070
microenvironment	O	O	I-T070
.	O	O	O

Clin	O	O	O
Cancer	O	O	O
Res	O	O	O
;	O	O	O
23(4	O	O	O
)	O	O	O
;	O	O	O
925	O	O	O
-	O	O	O
34	O	O	O
.	O	O	O

Â©	O	O	O
2016	O	O	O
AACR	O	O	O
.	O	O	O

-DOCSTART- (27602300)

The	O	O	O
adder	O	O	B-T014
(	O	O	O
Vipera	O	O	B-T014
berus	O	O	I-T014
)	O	O	O
in	O	O	O
Southern	O	O	B-T083
Altay	O	O	I-T083
Mountains	O	O	I-T083
:	O	O	O
population	O	O	B-T102
characteristics	O	O	I-T102
,	O	O	O
distribution	O	O	B-T082
,	O	O	O
morphology	O	O	B-T080
and	O	O	O
phylogenetic	O	O	O
position	O	O	O

As	O	O	O
the	O	O	O
most	O	O	O
widely	O	O	O
distributed	O	O	B-T082
snake	O	O	B-T014
in	O	O	O
Eurasia	O	O	B-T083
,	O	O	O
the	O	O	O
adder	O	O	B-T014
(	O	O	O
Vipera	O	O	B-T014
berus	O	O	I-T014
)	O	O	O
has	O	O	O
been	O	O	O
extensively	O	O	B-T080
investigated	O	O	B-T169
in	O	O	O
Europe	O	O	B-T083
but	O	O	O
poorly	O	O	O
understood	O	O	O
in	O	O	O
Asia	O	O	B-T083
.	O	O	O

The	O	O	O
Southern	O	O	B-T083
Altay	O	O	I-T083
Mountains	O	O	I-T083
represent	O	O	O
the	O	O	O
adder	O	O	B-T014
's	O	O	I-T014
southern	O	O	B-T082
distribution	O	O	B-T082
limit	O	O	B-T169
in	O	O	O
Central	O	O	B-T083
Asia	O	O	I-T083
,	O	O	O
whereas	O	O	O
its	O	O	O
population	O	O	B-T081
status	O	O	I-T081
has	O	O	O
never	O	O	O
been	O	O	O
assessed	O	O	B-T052
.	O	O	O

We	O	O	O
conducted	O	O	O
,	O	O	O
for	O	O	O
the	O	O	O
first	O	O	O
time	O	O	O
,	O	O	O
field	O	O	B-T062
surveys	O	O	I-T062
for	O	O	O
the	O	O	O
adder	O	O	B-T014
at	O	O	O
two	O	O	O
areas	O	O	B-T082
of	O	O	O
Southern	O	O	B-T083
Altay	O	O	I-T083
Mountains	O	O	I-T083
using	O	O	O
a	O	O	O
combination	O	O	B-T080
of	O	O	O
line	O	O	B-T062
transects	O	O	I-T062
and	O	O	O
random	O	O	B-T080
searches	O	O	B-T052
.	O	O	O

We	O	O	O
also	O	O	O
described	O	O	O
the	O	O	O
morphological	O	O	B-T080
characteristics	O	O	I-T080
of	O	O	O
the	O	O	O
collected	O	O	B-T059
specimens	O	O	I-T059
and	O	O	O
conducted	O	O	O
analyses	O	O	B-T062
of	O	O	O
external	O	O	B-T082
morphology	O	O	B-T080
and	O	O	O
molecular	O	O	B-T078
phylogeny	O	O	I-T078
.	O	O	O

The	O	O	O
results	O	O	B-T033
showed	O	O	O
that	O	O	O
the	O	O	O
adder	O	O	B-T014
distributed	O	O	B-T082
in	O	O	O
both	O	O	O
survey	O	O	B-T062
sites	O	O	B-T082
and	O	O	O
we	O	O	O
recorded	O	O	B-T170
a	O	O	O
total	O	O	O
of	O	O	O
34	O	O	O
sightings	O	O	B-T053
.	O	O	O

In	O	O	O
Kanas	O	O	B-T082
river	O	O	I-T082
valley	O	O	I-T082
,	O	O	O
the	O	O	O
estimated	O	O	B-T081
encounter	O	O	B-T053
rate	O	O	B-T081
over	O	O	O
a	O	O	O
total	O	O	O
of	O	O	O
137	O	O	O
km	O	O	O
transects	O	O	B-T062
was	O	O	O
0.15	O	O	O
Â±	O	O	O
0.05	O	O	O
sightings	O	O	B-T053
/km	O	O	O
.	O	O	O

The	O	O	O
occurrence	O	O	B-T079
of	O	O	O
melanism	O	O	B-T047
was	O	O	O
only	O	O	O
17	O	O	O
%	O	O	O
.	O	O	O

The	O	O	O
small	O	O	B-T033
size	O	O	I-T033
was	O	O	O
typical	O	O	B-T080
for	O	O	O
the	O	O	O
adders	O	O	B-T014
in	O	O	O
Southern	O	O	B-T083
Altay	O	O	I-T083
Mountains	O	O	I-T083
in	O	O	O
contrast	O	O	O
to	O	O	O
other	O	O	O
geographic	O	O	B-T081
populations	O	O	I-T081
of	O	O	O
the	O	O	O
nominate	O	O	B-T052
subspecies	O	O	B-T185
.	O	O	O

A	O	O	O
phylogenetic	O	O	B-T080
tree	O	O	I-T080
obtained	O	O	B-T169
by	O	O	O
Bayesian	O	O	B-T081
Inference	O	O	I-T081
based	O	O	O
on	O	O	O
DNA	O	O	B-T086
sequences	O	O	I-T086
of	O	O	O
the	O	O	O
mitochondrial	O	O	B-T116
cytochrome	O	O	I-T116
b	O	O	I-T116
(	O	O	O
1,023	O	O	O
bp	O	O	O
)	O	O	O
grouped	O	O	B-T082
them	O	O	O
within	O	O	O
the	O	O	O
Northern	O	O	B-T081
clade	O	O	I-T081
of	O	O	O
the	O	O	O
species	O	O	B-T185
but	O	O	O
failed	O	O	O
to	O	O	O
separate	O	O	B-T080
them	O	O	O
from	O	O	O
the	O	O	O
subspecies	O	O	B-T185
V.	O	O	B-T014
b.	O	O	I-T014
sachalinensis	O	O	I-T014
.	O	O	O

Our	O	O	O
discovery	O	O	B-T052
extends	O	O	O
the	O	O	O
distribution	O	O	B-T082
range	O	O	B-T081
of	O	O	O
V.	O	O	B-T014
berus	O	O	I-T014
and	O	O	O
provides	O	O	O
a	O	O	O
basis	O	O	B-T169
for	O	O	O
further	O	O	O
researches	O	O	B-T062
.	O	O	O

We	O	O	O
discuss	O	O	O
the	O	O	O
hypothesis	O	O	B-T078
that	O	O	O
the	O	O	O
adder	O	O	B-T014
expands	O	O	B-T082
its	O	O	O
distribution	O	O	B-T082
border	O	O	B-T185
to	O	O	O
the	O	O	O
southwest	O	O	B-T082
along	O	O	O
the	O	O	O
mountains	O	O	B-T083
'	O	O	O
elevation	O	O	B-T082
gradient	O	O	B-T081
,	O	O	O
but	O	O	O
the	O	O	O
population	O	O	B-T098
abundance	O	O	B-T080
declines	O	O	B-T081
gradually	O	O	B-T080
due	O	O	O
to	O	O	O
a	O	O	O
drying	O	O	B-T070
climate	O	O	I-T070
.	O	O	O

-DOCSTART- (27603112)

Binding	O	O	B-T052
of	O	O	O
Pollutants	O	O	B-T131
to	O	O	O
Biomolecules	O	O	B-T123
:	O	O	O
A	O	O	O
Simulation	O	O	O
Study	O	O	O

A	O	O	O
number	O	O	O
of	O	O	O
cases	O	O	B-T169
around	O	O	O
the	O	O	O
world	O	O	B-T098
have	O	O	O
been	O	O	O
reported	O	O	O
where	O	O	O
animals	O	O	B-T008
were	O	O	O
found	O	O	B-T033
dead	O	O	I-T033
or	O	O	O
dying	O	O	B-T040
with	O	O	O
symptoms	O	O	B-T184
resembling	O	O	O
a	O	O	O
thiamine	O	O	B-T047
(	O	O	B-T047
vitamin	O	O	I-T047
B	O	O	I-T047
)	O	O	I-T047
deficiency	O	O	I-T047
,	O	O	O
and	O	O	O
for	O	O	O
some	O	O	O
of	O	O	O
these	O	O	O
,	O	O	O
a	O	O	O
link	O	O	O
to	O	O	O
pollutants	O	O	B-T131
has	O	O	O
been	O	O	O
suggested	O	O	O
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
investigate	O	O	B-T058
whether	O	O	O
biomolecules	O	O	B-T123
involved	O	O	O
in	O	O	O
thiamin	O	O	B-T044
binding	O	O	I-T044
and	O	O	O
transport	O	O	B-T043
could	O	O	O
be	O	O	O
blocked	O	O	B-T169
by	O	O	O
a	O	O	O
range	O	O	O
of	O	O	O
different	O	O	O
pollutants	O	O	B-T131
.	O	O	O

We	O	O	O
used	O	O	O
in	O	O	B-T066
silico	O	O	I-T066
docking	O	O	B-T044
of	O	O	O
five	O	O	O
compound	O	O	B-T123
classes	O	O	B-T170
(	O	O	O
25	O	O	O
compounds	O	O	B-T123
in	O	O	O
total	O	O	O
)	O	O	O
to	O	O	O
each	O	O	O
of	O	O	O
five	O	O	O
targets	O	O	O
(	O	O	O
prion	O	O	B-T116
protein	O	O	I-T116
,	O	O	O
ECF-type	O	O	B-T026
ABC	O	O	I-T026
transporter	O	O	I-T026
,	O	O	O
thi-box	O	O	B-T114
riboswitch	O	O	I-T114
receptor	O	O	I-T114
,	O	O	O
thiamin	O	O	B-T116
pyrophosphokinase	O	O	I-T116
,	O	O	O
and	O	O	O
YKoF	O	O	B-T116
protein	O	O	I-T116
)	O	O	O
and	O	O	O
subsequently	O	O	O
performed	O	O	O
molecular	O	O	B-T066
dynamics	O	O	I-T066
(	O	O	I-T066
MD	O	O	I-T066
)	O	O	I-T066
simulations	O	O	I-T066
to	O	O	O
assess	O	O	O
the	O	O	O
stability	O	O	B-T080
of	O	O	O
the	O	O	O
complexes	O	O	B-T104
.	O	O	O

The	O	O	O
compound	O	O	B-T123
classes	O	O	B-T170
were	O	O	O
thiamin	O	O	B-T127
analogues	O	O	B-T104
(	O	O	O
control	O	O	B-T167
)	O	O	O
,	O	O	O
pesticides	O	O	B-T131
,	O	O	O
veterinary	O	O	B-T080
medicines	O	O	B-T121
,	O	O	O
polychlorinated	O	O	B-T109
biphenyls	O	O	I-T109
,	O	O	O
and	O	O	O
dioxins	O	O	B-T109
,	O	O	O
all	O	O	O
of	O	O	O
which	O	O	O
are	O	O	O
prevalent	O	O	B-T081
in	O	O	O
the	O	O	O
environment	O	O	B-T082
to	O	O	O
some	O	O	O
extent	O	O	O
.	O	O	O

A	O	O	O
few	O	O	O
anthropogenic	O	O	O
compounds	O	O	B-T123
were	O	O	O
found	O	O	O
to	O	O	O
bind	O	O	B-T044
the	O	O	O
ECF-type	O	O	B-T026
ABC	O	O	I-T026
transporter	O	O	I-T026
,	O	O	O
but	O	O	O
none	O	O	B-T033
binds	O	O	I-T033
stably	O	O	I-T033
to	O	O	O
prion	O	O	B-T116
protein	O	O	I-T116
.	O	O	O

For	O	O	O
the	O	O	O
riboswitch	O	O	B-T114
,	O	O	O
most	O	O	O
compounds	O	O	B-T123
remained	O	O	O
in	O	O	O
their	O	O	O
binding	O	O	B-T120
pockets	O	O	I-T120
during	O	O	O
50	O	O	O
ns	O	O	O
of	O	O	O
MD	O	O	B-T066
simulation	O	O	I-T066
,	O	O	O
indicating	O	O	O
that	O	O	O
RNA	O	O	B-T114
provides	O	O	O
a	O	O	O
promiscuous	O	O	O
binding	O	O	B-T192
site	O	O	I-T192
.	O	O	O

In	O	O	O
both	O	O	O
YKoF	O	O	B-T116
and	O	O	O
thiamin	O	O	B-T116
pyrophosphokinase	O	O	I-T116
(	O	O	O
TPK	O	O	B-T116
)	O	O	O
,	O	O	O
most	O	O	O
compounds	O	O	B-T123
remain	O	O	O
tightly	O	O	B-T052
bound	O	O	I-T052
.	O	O	O

However	O	O	O
,	O	O	O
TPK	O	O	B-T116
biomolecules	O	O	B-T123
undergo	O	O	O
pollutant	O	O	B-T131
-	O	O	O
induced	O	O	B-T169
conformational	O	O	B-T044
changes	O	O	I-T044
.	O	O	O

Although	O	O	O
most	O	O	O
compounds	O	O	B-T123
are	O	O	O
found	O	O	O
to	O	O	O
bind	O	O	O
to	O	O	O
some	O	O	O
of	O	O	O
these	O	O	O
targets	O	O	O
,	O	O	O
a	O	O	O
larger	O	O	O
data	O	O	O
set	O	O	O
is	O	O	O
needed	O	O	O
along	O	O	O
with	O	O	O
more	O	O	O
quantitative	O	O	B-T062
methods	O	O	I-T062
like	O	O	O
free	O	O	B-UnknownType
energy	O	O	I-UnknownType
perturbation	O	O	I-UnknownType
calculations	O	O	B-T052
before	O	O	O
firm	O	O	O
conclusions	O	O	B-T078
can	O	O	O
be	O	O	O
drawn	O	O	O
.	O	O	O

This	O	O	O
study	O	O	B-T062
is	O	O	O
in	O	O	O
part	O	O	O
a	O	O	O
test	O	O	O
bed	O	O	O
for	O	O	O
large-scale	O	O	O
quantitative	O	O	B-T081
computational	O	O	B-T059
screening	O	O	I-T059
of	O	O	O
interactions	O	O	B-T169
between	O	O	O
biological	O	O	B-T123
entities	O	O	I-T123
and	O	O	O
pollutant	O	O	B-T131
molecules	O	O	I-T131
.	O	O	O

-DOCSTART- (27604152)

Characterisation	O	O	B-T052
of	O	O	O
methicillin-resistant	O	O	B-T007
Staphylococcus	O	O	I-T007
aureus	O	O	I-T007
clinical	O	O	B-T080
isolates	O	O	B-T123
from	O	O	O
animals	O	O	B-T008
in	O	O	O
New	O	O	B-T083
Zealand	O	O	I-T083
,	O	O	O
2012	O	O	O
-	O	O	O
2013	O	O	O
,	O	O	O
and	O	O	O
subclinical	O	O	B-T080
colonisation	O	O	B-T033
in	O	O	O
dogs	O	O	B-T015
and	O	O	O
cats	O	O	B-T015
in	O	O	O
Auckland	O	O	O

To	O	O	O
characterise	O	O	B-T052
methicillin-resistant	O	O	B-T007
Staphylococcus	O	O	I-T007
aureus	O	O	I-T007
(	O	O	O
MRSA	O	O	B-T007
)	O	O	O
isolates	O	O	B-T123
from	O	O	O
infection	O	O	B-T047
sites	O	O	I-T047
in	O	O	O
animals	O	O	B-T008
in	O	O	O
New	O	O	B-T083
Zealand	O	O	I-T083
and	O	O	O
assess	O	O	O
the	O	O	O
prevalence	O	O	B-T081
of	O	O	O
subclinical	O	O	B-T080
MRSA	O	O	B-T033
colonisation	O	O	I-T033
in	O	O	O
dogs	O	O	B-T015
and	O	O	O
cats	O	O	B-T015
attending	O	O	O
veterinary	O	O	B-T093
clinics	O	O	I-T093
in	O	O	O
Auckland	O	O	B-UnknownType
.	O	O	O

MRSA	O	O	B-T007
isolates	O	O	B-T123
from	O	O	O
clinical	O	O	B-T080
specimens	O	O	B-T167
obtained	O	O	O
by	O	O	O
the	O	O	O
main	O	O	O
New	O	O	B-T083
Zealand	O	O	I-T083
veterinary	O	O	B-T093
diagnostic	O	O	I-T093
laboratories	O	O	I-T093
between	O	O	O
June	O	O	B-T079
2012	O	O	O
and	O	O	O
June	O	O	O
2013	O	O	O
,	O	O	O
were	O	O	O
genotypically	O	O	B-T052
characterised	O	O	I-T052
by	O	O	O
DNA	O	O	B-T063
microarray	O	O	I-T063
hybridisation	O	O	I-T063
analysis	O	O	I-T063
and	O	O	O
spa	O	O	B-T116
typing	O	O	B-T059
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
nasal	O	O	B-T023
or	O	O	O
perineal	O	O	B-T023
skin	O	O	I-T023
swabs	O	O	B-T167
collected	O	O	O
from	O	O	O
a	O	O	O
cross-sectional	O	O	B-T167
sample	O	O	I-T167
of	O	O	O
dogs	O	O	B-T015
(	O	O	O
n=361	O	O	O
)	O	O	O
and	O	O	O
cats	O	O	B-T015
(	O	O	O
n=225	O	O	O
)	O	O	O
attending	O	O	O
29	O	O	O
veterinary	O	O	B-T093
clinics	O	O	I-T093
in	O	O	O
Auckland	O	O	B-UnknownType
during	O	O	O
the	O	O	O
same	O	O	O
period	O	O	B-T079
were	O	O	O
analysed	O	O	B-T062
for	O	O	O
MRSA	O	O	B-T007
by	O	O	O
culture	O	O	B-T059
.	O	O	O

Eight	O	O	O
MRSA	O	O	B-T007
clinical	O	O	B-T080
isolates	O	O	B-T123
were	O	O	O
submitted	O	O	O
for	O	O	O
characterisation	O	O	B-T052
by	O	O	O
the	O	O	O
participating	O	O	O
laboratories	O	O	B-T093
.	O	O	O

The	O	O	O
isolates	O	O	B-T123
originated	O	O	O
from	O	O	O
five	O	O	O
dogs	O	O	B-T015
,	O	O	O
including	O	O	O
two	O	O	O
isolates	O	O	O
from	O	O	O
the	O	O	O
same	O	O	O
dog	O	O	B-T015
,	O	O	O
one	O	O	O
foal	O	O	B-T015
,	O	O	O
and	O	O	O
one	O	O	O
isolate	O	O	B-T123
had	O	O	O
no	O	O	O
identification	O	O	O
of	O	O	O
the	O	O	O
source	O	O	B-T033
.	O	O	O

The	O	O	O
strain	O	O	B-T001
-	O	O	O
types	O	O	B-T080
identified	O	O	B-T080
were	O	O	O
AK3	O	O	B-T007
(	O	O	I-T007
ST-5	O	O	I-T007
SCCmecIV	O	O	I-T007
t045	O	O	O
;	O	O	O
n=1	O	O	O
)	O	O	O
,	O	O	O
USA500	O	O	B-T007
(	O	O	I-T007
ST8	O	O	I-T007
SCCmecIV	O	O	I-T007
t064	O	O	O
;	O	O	O
n=1	O	O	O
)	O	O	O
,	O	O	O
WSPP	O	O	B-T007
(	O	O	I-T007
ST30	O	O	I-T007
SCCmecIV	O	O	I-T007
t019	O	O	O
;	O	O	O
n=1	O	O	O
)	O	O	O
,	O	O	O
Rhine	O	O	B-T007
Hesse	O	O	I-T007
(	O	O	I-T007
ST5	O	O	I-T007
SCCmecII	O	O	I-T007
t002	O	O	O
;	O	O	O
n=2	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
EMRSA-15	O	O	B-T007
(	O	O	I-T007
ST22	O	O	I-T007
SCCmecIV	O	O	I-T007
t032	O	O	O
;	O	O	O
n=3	O	O	O
)	O	O	O
.	O	O	O

No	O	O	O
MRSA	O	O	B-T007
were	O	O	O
isolated	O	O	B-T169
from	O	O	O
586	O	O	O
cultured	O	O	B-T167
swabs	O	O	I-T167
.	O	O	O

Methicillin-susceptible	O	O	B-T007
S.	O	O	I-T007
aureus	O	O	I-T007
were	O	O	O
detected	O	O	B-T033
in	O	O	O
9/257	O	O	O
(	O	O	O
3.5	O	O	O
%	O	O	O
)	O	O	O
swabs	O	O	B-T167
and	O	O	O
non-aureus	O	O	B-T007
staphylococci	O	O	I-T007
in	O	O	O
22/257	O	O	O
(	O	O	O
8.5	O	O	O
%	O	O	O
)	O	O	O
swabs	O	O	O
.	O	O	O

The	O	O	O
estimated	O	O	O
true	O	O	O
MRSA	O	O	B-T007
subclinical	O	O	B-T080
colonisation	O	O	B-T033
prevalence	O	O	B-T081
was	O	O	O
0	O	O	O
%	O	O	O
,	O	O	O
with	O	O	O
an	O	O	O
upper	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
boundary	O	O	O
of	O	O	O
1.9	O	O	O
%	O	O	O
for	O	O	O
cats	O	O	B-T015
and	O	O	O
1.4	O	O	O
%	O	O	O
for	O	O	O
dogs	O	O	B-T015
.	O	O	O

The	O	O	O
modest	O	O	B-T081
number	O	O	I-T081
of	O	O	O
MRSA	O	O	B-T007
isolates	O	O	B-T123
submitted	O	O	O
for	O	O	O
this	O	O	O
study	O	O	B-T170
by	O	O	O
the	O	O	O
participating	O	O	O
laboratories	O	O	B-T093
suggests	O	O	O
clinical	O	O	B-T080
MRSA	O	O	B-T047
infection	O	O	I-T047
in	O	O	O
animals	O	O	B-T008
in	O	O	O
New	O	O	B-T083
Zealand	O	O	I-T083
continues	O	O	O
to	O	O	O
be	O	O	O
sporadic	O	O	B-T079
.	O	O	O

The	O	O	O
wide	O	O	O
variety	O	O	O
of	O	O	O
strain	O	O	B-T001
-	O	O	O
types	O	O	B-T080
found	O	O	O
mirrored	O	O	O
the	O	O	O
evolving	O	O	O
strain	O	O	O
-	O	O	O
type	O	O	B-T080
diversity	O	O	B-T080
observed	O	O	O
in	O	O	O
humans	O	O	B-T016
.	O	O	O

We	O	O	O
can	O	O	O
not	O	O	O
rule	O	O	O
out	O	O	O
bias	O	O	B-T078
due	O	O	O
to	O	O	O
the	O	O	O
non-random	O	O	B-T062
sampling	O	O	I-T062
of	O	O	O
dogs	O	O	B-T015
and	O	O	O
cats	O	O	B-T015
,	O	O	O
but	O	O	O
the	O	O	O
apparent	O	O	O
colonisation	O	O	B-T033
prevalence	O	O	B-T081
of	O	O	O
0	O	O	O
%	O	O	O
was	O	O	O
consistent	O	O	B-T078
with	O	O	I-T078
the	O	O	O
low	O	O	O
prevalence	O	O	O
of	O	O	O
subclinical	O	O	B-T080
colonisation	O	O	O
in	O	O	O
humans	O	O	B-T016
in	O	O	O
New	O	O	B-T083
Zealand	O	O	I-T083
.	O	O	O

These	O	O	O
similarities	O	O	B-T080
indicate	O	O	O
the	O	O	O
epidemiology	O	O	B-T091
of	O	O	O
animal	O	O	B-T008
and	O	O	O
human	O	O	B-T016
MRSA	O	O	B-T047
infections	O	O	I-T047
are	O	O	O
linked	O	O	O
.	O	O	O

In	O	O	O
the	O	O	O
last	O	O	O
decade	O	O	B-T081
,	O	O	O
the	O	O	O
prevalence	O	O	B-T081
of	O	O	O
human	O	O	B-T016
MRSA	O	O	B-T047
infections	O	O	I-T047
in	O	O	O
New	O	O	B-T083
Zealand	O	O	I-T083
has	O	O	O
steadily	O	O	O
increased	O	O	B-T081
.	O	O	O

This	O	O	O
is	O	O	O
the	O	O	O
second	O	O	O
published	O	O	O
study	O	O	B-T170
of	O	O	O
MRSA	O	O	B-T007
in	O	O	O
animals	O	O	B-T008
in	O	O	O
New	O	O	B-T083
Zealand	O	O	I-T083
.	O	O	O

The	O	O	O
results	O	O	O
indicate	O	O	O
clinical	O	O	B-T080
MRSA	O	O	B-T047
infection	O	O	I-T047
in	O	O	O
animals	O	O	B-T008
remains	O	O	O
sporadic	O	O	B-T079
,	O	O	O
but	O	O	O
the	O	O	O
diversification	O	O	B-T057
of	O	O	O
the	O	O	O
strain	O	O	B-T001
-	O	O	O
types	O	O	B-T080
may	O	O	O
pose	O	O	O
new	O	O	O
therapeutic	O	O	B-T169
challenges	O	O	O
to	O	O	O
veterinarians	O	O	B-T097
,	O	O	O
due	O	O	O
to	O	O	O
their	O	O	O
diverse	O	O	O
resistome	O	O	B-T028
.	O	O	O

-DOCSTART- (27606547)

Cloud-based	O	O	B-T170
MOTIFSIM	O	O	I-T170
:	O	O	O
Detecting	O	O	B-T033
Similarity	O	O	B-T080
in	O	O	O
Large	O	O	O
DNA	O	O	B-T086
Motif	O	O	I-T086
Data	O	O	O
Sets	O	O	O

We	O	O	O
developed	O	O	O
the	O	O	O
cloud-based	O	O	B-T170
MOTIFSIM	O	O	I-T170
on	O	O	O
Amazon	O	O	B-T066
Web	O	O	I-T066
Services	O	O	I-T066
(	O	O	O
AWS	O	O	B-T066
)	O	O	O
cloud	O	O	B-T066
.	O	O	O

The	O	O	O
tool	O	O	B-T170
is	O	O	O
an	O	O	O
extended	O	O	O
version	O	O	B-T170
from	O	O	O
our	O	O	O
web-based	O	O	B-T170
tool	O	O	I-T170
version	O	O	I-T170
2.0	O	O	I-T170
,	O	O	O
which	O	O	O
was	O	O	O
developed	O	O	O
based	O	O	O
on	O	O	O
a	O	O	O
novel	O	O	O
algorithm	O	O	B-T170
for	O	O	O
detecting	O	O	B-T033
similarity	O	O	B-T080
in	O	O	O
multiple	O	O	O
DNA	O	O	B-T086
motif	O	O	I-T086
data	O	O	B-T170
sets	O	O	I-T170
.	O	O	O

This	O	O	O
cloud	O	O	B-T066
-based	O	O	O
version	O	O	B-T170
further	O	O	O
allows	O	O	O
researchers	O	O	B-T097
to	O	O	O
exploit	O	O	O
the	O	O	O
computing	O	O	B-T078
resources	O	O	I-T078
available	O	O	O
from	O	O	O
AWS	O	O	B-T066
to	O	O	O
detect	O	O	B-T033
similarity	O	O	B-T080
in	O	O	O
multiple	O	O	O
large-scale	O	O	O
DNA	O	O	B-T086
motif	O	O	I-T086
data	O	O	B-T170
sets	O	O	I-T170
resulting	O	O	O
from	O	O	O
the	O	O	O
next-generation	O	O	B-T063
sequencing	O	O	I-T063
technology	O	O	I-T063
.	O	O	O

The	O	O	O
tool	O	O	B-T170
is	O	O	O
highly	O	O	O
scalable	O	O	O
with	O	O	O
expandable	O	O	O
AWS	O	O	B-T066
.	O	O	O

-DOCSTART- (27607871)

Utilization	O	O	B-T169
and	O	O	O
Outcomes	O	O	B-T062
of	O	O	O
Sentinel	O	O	B-T060
Lymph	O	O	I-T060
Node	O	O	I-T060
Biopsy	O	O	I-T060
for	O	O	O
Vulvar	O	O	O
Cancer	O	O	O

To	O	O	O
examine	O	O	O
the	O	O	O
use	O	O	O
and	O	O	O
predictors	O	O	O
of	O	O	O
sentinel	O	O	B-T060
node	O	O	I-T060
biopsy	O	O	I-T060
in	O	O	O
women	O	O	B-T098
with	O	O	O
vulvar	O	O	B-T191
cancer	O	O	I-T191
.	O	O	O

The	O	O	O
Perspective	O	O	B-T170
database	O	O	I-T170
,	O	O	O
an	O	O	O
all-payer	O	O	B-T170
database	O	O	I-T170
that	O	O	O
collects	O	O	B-T062
data	O	O	I-T062
from	O	O	O
more	O	O	O
than	O	O	O
500	O	O	O
hospitals	O	O	B-T093
,	O	O	O
was	O	O	O
used	O	O	O
to	O	O	O
perform	O	O	O
a	O	O	O
retrospective	O	O	B-T062
cohort	O	O	I-T062
study	O	O	I-T062
of	O	O	O
women	O	O	B-T098
with	O	O	O
vulvar	O	O	B-T191
cancer	O	O	I-T191
who	O	O	O
underwent	O	O	O
vulvectomy	O	O	B-T061
and	O	O	O
lymph	O	O	B-T060
node	O	O	I-T060
assessment	O	O	I-T060
from	O	O	O
2006	O	O	O
to	O	O	O
2015	O	O	O
.	O	O	O

Multivariable	O	O	B-T075
models	O	O	I-T075
were	O	O	O
used	O	O	O
to	O	O	O
determine	O	O	O
factors	O	O	B-T169
associated	O	O	O
with	O	O	O
sentinel	O	O	B-T060
node	O	O	I-T060
biopsy	O	O	I-T060
.	O	O	O

Length	O	O	B-T079
of	O	O	I-T079
stay	O	O	I-T079
and	O	O	O
cost	O	O	B-T081
were	O	O	O
compared	O	O	O
between	O	O	O
women	O	O	B-T098
who	O	O	O
underwent	O	O	O
sentinel	O	O	B-T060
node	O	O	I-T060
biopsy	O	O	I-T060
and	O	O	O
lymphadenectomy	O	O	B-T061
.	O	O	O

Among	O	O	O
2,273	O	O	O
women	O	O	B-T098
,	O	O	O
sentinel	O	O	B-T060
node	O	O	I-T060
biopsy	O	O	I-T060
was	O	O	O
utilized	O	O	O
in	O	O	O
618	O	O	O
(	O	O	O
27.2	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
1,655	O	O	O
(	O	O	O
72.8	O	O	O
%	O	O	O
)	O	O	O
underwent	O	O	O
inguinofemoral	O	O	B-T061
lymphadenectomy	O	O	I-T061
.	O	O	O

Performance	O	O	O
of	O	O	O
sentinel	O	O	B-T060
node	O	O	I-T060
biopsy	O	O	I-T060
increased	O	O	O
from	O	O	O
17.0	O	O	O
%	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
confidence	O	O	B-T081
interval	O	O	I-T081
[	O	O	O
CI	O	O	B-T081
]	O	O	O
12.0	O	O	O
-	O	O	O
22.0	O	O	O
%	O	O	O
)	O	O	O
in	O	O	O
2006	O	O	O
to	O	O	O
39.1	O	O	O
%	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
27.1	O	O	O
-	O	O	O
51.0	O	O	O
%	O	O	O
)	O	O	O
in	O	O	O
2015	O	O	O
.	O	O	O

In	O	O	O
a	O	O	O
multivariable	O	O	B-T075
model	O	O	I-T075
,	O	O	O
women	O	O	B-T098
treated	O	O	B-T169
more	O	O	O
recently	O	O	O
were	O	O	O
more	O	O	O
likely	O	O	O
to	O	O	O
have	O	O	O
undergone	O	O	O
sentinel	O	O	B-T060
node	O	O	I-T060
biopsy	O	O	I-T060
,	O	O	O
whereas	O	O	O
women	O	O	O
with	O	O	O
more	O	O	O
comorbidities	O	O	B-T078
and	O	O	O
those	O	O	O
treated	O	O	O
at	O	O	O
rural	O	O	B-T093
hospitals	O	O	I-T093
were	O	O	O
less	O	O	O
likely	O	O	O
to	O	O	O
have	O	O	O
undergone	O	O	O
the	O	O	O
procedure	O	O	B-T060
.	O	O	O

The	O	O	O
median	O	O	B-T082
length	O	O	B-T079
of	O	O	I-T079
stay	O	O	I-T079
was	O	O	O
shorter	O	O	O
for	O	O	O
those	O	O	O
undergoing	O	O	O
sentinel	O	O	B-T060
node	O	O	I-T060
biopsy	O	O	I-T060
(	O	O	O
median	O	O	O
2	O	O	O
days	O	O	O
,	O	O	O
interquartile	O	O	B-T081
range	O	O	I-T081
1	O	O	O
-	O	O	O
3	O	O	O
)	O	O	O
compared	O	O	O
with	O	O	O
women	O	O	B-T098
who	O	O	O
underwent	O	O	O
inguinofemoral	O	O	B-T061
lymphadenectomy	O	O	I-T061
(	O	O	O
median	O	O	O
3	O	O	O
days	O	O	O
,	O	O	O
interquartile	O	O	O
range	O	O	O
2	O	O	O
-	O	O	O
4	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
cost	O	O	O
of	O	O	O
sentinel	O	O	B-T060
node	O	O	I-T060
biopsy	O	O	I-T060
was	O	O	O
$	O	O	O
7,599	O	O	O
(	O	O	O
interquartile	O	O	B-T081
range	O	O	I-T081
$	O	O	O
5,739	O	O	O
-	O	O	O
9,922	O	O	O
)	O	O	O
compared	O	O	O
with	O	O	O
$	O	O	O
8,095	O	O	O
(	O	O	O
interquartile	O	O	O
range	O	O	O
$	O	O	O
5,917	O	O	O
-	O	O	O
11,281	O	O	O
)	O	O	O
for	O	O	O
lymphadenectomy	O	O	B-T061
.	O	O	O

The	O	O	O
use	O	O	O
of	O	O	O
sentinel	O	O	B-T060
node	O	O	I-T060
biopsy	O	O	I-T060
for	O	O	O
vulvar	O	O	B-T191
cancer	O	O	I-T191
has	O	O	O
more	O	O	O
than	O	O	O
doubled	O	O	O
since	O	O	O
2006	O	O	O
.	O	O	O

Sentinel	O	O	B-T060
lymph	O	O	I-T060
node	O	O	I-T060
biopsy	O	O	I-T060
is	O	O	O
associated	O	O	O
with	O	O	O
a	O	O	O
shorter	O	O	B-T079
hospital	O	O	I-T079
stay	O	O	I-T079
and	O	O	O
decreased	O	O	B-T081
cost	O	O	I-T081
compared	O	O	O
with	O	O	O
inguinofemoral	O	O	B-T061
lymphadenectomy	O	O	I-T061
.	O	O	O

-DOCSTART- (27608421)

Condition	O	O	B-T080
-	O	O	O
dependent	O	O	B-T080
co-regulation	O	O	B-T038
of	O	O	O
genomic	O	O	B-T028
clusters	O	O	I-T028
of	O	O	O
virulence	O	O	B-T109
factors	O	O	I-T109
in	O	O	O
the	O	O	O
grapevine	O	O	B-T047
trunk	O	O	I-T047
pathogen	O	O	B-T001
Neofusicoccum	O	O	O
parvum	O	O	O

The	O	O	O
ascomycete	O	O	B-T004
Neofusicoccum	O	O	B-T004
parvum	O	O	I-T004
,	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
causal	O	O	B-T033
agents	O	O	I-T033
of	O	O	O
Botryosphaeria	O	O	B-T004
dieback	O	O	I-T004
,	O	O	O
is	O	O	O
a	O	O	O
destructive	O	O	O
wood	O	O	B-T167
-	O	O	O
infecting	O	O	B-T033
fungus	O	O	B-T004
and	O	O	O
a	O	O	O
serious	O	O	O
threat	O	O	B-T078
to	O	O	O
grape	O	O	B-T168
production	O	O	O
worldwide	O	O	B-T098
.	O	O	O

The	O	O	O
capability	O	O	B-T080
of	O	O	O
colonizing	O	O	B-T033
woody	O	O	B-T025
tissue	O	O	I-T025
combined	O	O	B-T080
with	O	O	O
the	O	O	O
secretion	O	O	B-T038
of	O	O	O
phytotoxic	O	O	B-T080
compounds	O	O	B-T103
is	O	O	O
thought	O	O	O
to	O	O	O
underlie	O	O	O
its	O	O	O
pathogenicity	O	O	B-T032
and	O	O	O
virulence	O	O	B-T038
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
describe	O	O	O
the	O	O	O
repertoire	O	O	O
of	O	O	O
virulence	O	O	B-T109
factors	O	O	I-T109
and	O	O	O
their	O	O	O
transcriptional	O	O	B-T045
dynamics	O	O	B-T070
as	O	O	O
the	O	O	O
fungus	O	O	B-T004
feeds	O	O	B-T168
on	O	O	O
different	O	O	O
substrates	O	O	B-T167
and	O	O	O
colonizes	O	O	B-T033
the	O	O	O
woody	O	O	B-T002
stem	O	O	I-T002
.	O	O	O

We	O	O	O
assembled	O	O	B-T052
and	O	O	O
annotated	O	O	B-T080
a	O	O	O
highly	O	O	B-T080
contiguous	O	O	B-T082
genome	O	O	B-T028
using	O	O	O
single	O	O	B-UnknownType
molecule	O	O	I-UnknownType
real-time	O	O	I-UnknownType
DNA	O	O	I-UnknownType
sequencing	O	O	I-UnknownType
.	O	O	O

Transcriptome	O	O	B-T059
profiling	O	O	I-T059
by	O	O	O
RNA-sequencing	O	O	B-T059
determined	O	O	O
the	O	O	O
genome	O	O	B-T028
-wide	O	O	O
patterns	O	O	B-T082
of	O	O	O
expression	O	O	B-T045
of	O	O	O
virulence	O	O	B-T109
factors	O	O	I-T109
both	O	O	O
in	O	O	B-T062
vitro	O	O	I-T062
(	O	O	O
potato	O	O	B-T168
dextrose	O	O	B-T130
agar	O	O	I-T130
or	O	O	O
medium	O	O	B-T130
amended	O	O	B-T080
with	O	O	O
grape	O	O	B-T168
wood	O	O	B-T167
as	O	O	O
substrate	O	O	B-T167
)	O	O	O
and	O	O	O
in	O	O	O
planta	O	O	B-T002
.	O	O	O

Pairwise	O	O	B-T170
statistical	O	O	I-T170
testing	O	O	I-T170
of	O	O	O
differential	O	O	B-T080
expression	O	O	B-T045
followed	O	O	O
by	O	O	O
co-expression	O	O	B-T063
network	O	O	I-T063
analysis	O	O	I-T063
revealed	O	O	O
that	O	O	O
physically	O	O	B-T169
clustered	O	O	B-T028
genes	O	O	I-T028
coding	O	O	B-T085
for	O	O	O
putative	O	O	O
virulence	O	O	B-T038
functions	O	O	B-T169
were	O	O	O
induced	O	O	O
depending	O	O	O
on	O	O	O
substrate	O	O	B-T167
or	O	O	O
stage	O	O	B-T079
of	O	O	O
plant	O	O	B-T002
infection	O	O	B-T046
.	O	O	O

Co-expressed	O	O	B-T045
gene	O	O	B-T028
clusters	O	O	I-T028
were	O	O	O
significantly	O	O	O
enriched	O	O	O
not	O	O	O
only	O	O	O
in	O	O	O
genes	O	O	B-T028
associated	O	O	B-T080
with	O	O	I-T080
secondary	O	O	B-T044
metabolism	O	O	I-T044
,	O	O	O
but	O	O	O
also	O	O	O
with	O	O	O
cell	O	O	B-T043
wall	O	O	I-T043
degradation	O	O	I-T043
,	O	O	O
suggesting	O	O	O
that	O	O	O
dynamic	O	O	B-T169
co-regulation	O	O	B-T038
of	O	O	O
transcriptional	O	O	B-T044
networks	O	O	I-T044
contribute	O	O	O
to	O	O	O
multiple	O	O	O
aspects	O	O	O
of	O	O	O
N.	O	O	B-T004
parvum	O	O	I-T004
virulence	O	O	B-T038
.	O	O	O

In	O	O	O
most	O	O	O
of	O	O	O
the	O	O	O
co-expressed	O	O	B-T045
clusters	O	O	B-T028
,	O	O	O
all	O	O	O
genes	O	O	B-T028
shared	O	O	O
at	O	O	O
least	O	O	O
a	O	O	O
common	O	O	O
motif	O	O	O
in	O	O	O
their	O	O	O
promoter	O	O	B-T114
region	O	O	I-T114
indicative	O	O	O
of	O	O	O
co-regulation	O	O	B-T038
by	O	O	O
the	O	O	O
same	O	O	O
transcription	O	O	B-T116
factor	O	O	I-T116
.	O	O	O

Co-expression	O	O	B-T063
analysis	O	O	I-T063
also	O	O	O
identified	O	O	O
chromatin	O	O	B-T116
regulators	O	O	B-T077
with	O	O	O
correlated	O	O	B-T080
expression	O	O	B-T045
with	O	O	O
inducible	O	O	B-T169
clusters	O	O	B-T028
of	O	O	O
virulence	O	O	B-T038
factors	O	O	I-T109
,	O	O	O
suggesting	O	O	O
a	O	O	O
complex	O	O	O
,	O	O	O
multi-layered	O	O	O
regulation	O	O	B-T038
of	O	O	O
the	O	O	O
virulence	O	O	O
repertoire	O	O	O
of	O	O	O
N.	O	O	B-T004
parvum	O	O	I-T004
.	O	O	O

This	O	O	O
article	O	O	O
is	O	O	O
protected	O	O	O
by	O	O	O
copyright	O	O	O
.	O	O	O

All	O	O	O
rights	O	O	O
reserved	O	O	O
.	O	O	O

-DOCSTART- (27608968)

Congenital	O	O	B-T019
anomalies	O	O	I-T019
following	O	O	O
use	O	O	O
of	O	O	O
isotretinoin	O	O	B-T109
:	O	O	O
Emphasis	O	O	O
on	O	O	O
its	O	O	O
legal	O	O	O
aspects	O	O	O

We	O	O	O
described	O	O	O
a	O	O	O
neonate	O	O	B-T100
with	O	O	O
severe	O	O	B-T080
and	O	O	O
multiple	O	O	B-T019
abnormalities	O	O	I-T019
following	O	O	O
use	O	O	O
of	O	O	O
isotretinoin	O	O	B-T109
,	O	O	O
in	O	O	O
spite	O	O	O
of	O	O	O
the	O	O	O
mother	O	O	B-T099
's	O	O	O
previous	O	O	O
knowledge	O	O	B-T170
of	O	O	O
drug	O	O	B-T046
complications	O	O	I-T046
.	O	O	O

Initial	O	O	O
physical	O	O	B-T058
examination	O	O	I-T058
after	O	O	O
delivery	O	O	B-T061
showed	O	O	O
congenital	O	O	B-T019
absence	O	O	I-T019
of	O	O	O
both	O	O	B-T023
eyes	O	O	I-T023
and	O	O	O
both	O	O	O
auricles	O	O	B-T023
as	O	O	O
well	O	O	O
as	O	O	O
anal	O	O	B-T019
atresia	O	O	I-T019
and	O	O	O
a	O	O	O
cleft	O	O	B-T019
palate	O	O	I-T019
.	O	O	O

Due	O	O	O
to	O	O	O
severe	O	O	B-T080
respiratory	O	O	B-T184
distress	O	O	I-T184
and	O	O	O
atresia	O	O	B-T019
of	O	O	O
the	O	O	O
anus	O	O	B-T023
,	O	O	O
the	O	O	O
neonate	O	O	B-T100
was	O	O	O
admitted	O	O	O
to	O	O	O
a	O	O	O
neonatal	O	O	B-T100
intensive	O	O	B-T093
care	O	O	I-T093
unit	O	O	I-T093
and	O	O	O
underwent	O	O	O
reconstructive	O	O	B-T061
surgery	O	O	I-T061
.	O	O	O

The	O	O	O
drug	O	O	B-T121
should	O	O	O
not	O	O	O
have	O	O	O
been	O	O	O
used	O	O	O
during	O	O	O
pregnancy	O	O	B-T040
.	O	O	O

Using	O	O	O
this	O	O	O
drug	O	O	B-T121
within	O	O	O
pregnancy	O	O	B-T040
with	O	O	O
awareness	O	O	O
of	O	O	O
its	O	O	O
side	O	O	B-T046
effects	O	O	I-T046
may	O	O	O
have	O	O	O
legal	O	O	B-T169
consequences	O	O	B-T169
.	O	O	O

-DOCSTART- (27609556)

Functional	O	O	B-T038
adaptation	O	O	I-T038
of	O	O	O
crustacean	O	O	B-T204
exoskeletal	O	O	B-T023
elements	O	O	B-T196
through	O	O	O
structural	O	O	B-T082
and	O	O	O
compositional	O	O	B-T032
diversity	O	O	B-T080
:	O	O	O
a	O	O	O
combined	O	O	B-T080
experimental	O	O	B-T062
and	O	O	O
theoretical	O	O	O
study	O	O	O

The	O	O	O
crustacean	O	O	B-T204
cuticle	O	O	B-T002
is	O	O	O
a	O	O	O
composite	O	O	B-T080
material	O	O	B-T167
that	O	O	O
covers	O	O	O
the	O	O	O
whole	O	O	O
animal	O	O	B-T008
and	O	O	O
forms	O	O	O
the	O	O	O
continuous	O	O	B-T023
exoskeleton	O	O	I-T023
.	O	O	O

Nano-fibers	O	O	B-T073
composed	O	O	O
of	O	O	O
chitin	O	O	B-T109
and	O	O	O
protein	O	O	B-T116
molecules	O	O	I-T116
form	O	O	O
most	O	O	O
of	O	O	O
the	O	O	O
organic	O	O	B-T080
matrix	O	O	B-T109
of	O	O	O
the	O	O	O
cuticle	O	O	B-T002
that	O	O	O
,	O	O	O
at	O	O	O
the	O	O	O
macroscale	O	O	B-T081
,	O	O	O
is	O	O	O
organized	O	O	O
in	O	O	O
up	O	O	O
to	O	O	O
eight	O	O	O
hierarchical	O	O	B-T169
levels	O	O	B-T080
.	O	O	O

At	O	O	O
least	O	O	O
two	O	O	O
of	O	O	O
them	O	O	O
,	O	O	O
the	O	O	O
exo-	O	O	B-T002
and	O	O	O
endocuticle	O	O	B-T002
,	O	O	O
contain	O	O	O
a	O	O	O
mineral	O	O	B-T197
phase	O	O	I-T197
of	O	O	O
mainly	O	O	O
Mg	O	O	B-T123
-	O	O	O
calcite	O	O	B-T197
,	O	O	O
amorphous	O	O	B-T080
calcium	O	O	B-T121
carbonate	O	O	I-T121
and	O	O	O
phosphate	O	O	B-T121
.	O	O	O

The	O	O	O
high	O	O	O
number	O	O	O
of	O	O	O
hierarchical	O	O	B-T169
levels	O	O	B-T080
and	O	O	O
the	O	O	O
compositional	O	O	B-T032
diversity	O	O	B-T080
provide	O	O	O
a	O	O	O
high	O	O	O
degree	O	O	B-T080
of	O	O	I-T080
freedom	O	O	I-T080
for	O	O	O
varying	O	O	B-T169
the	O	O	O
physical	O	O	B-T201
,	O	O	O
in	O	O	O
particular	O	O	O
mechanical	O	O	B-T169
,	O	O	O
properties	O	O	B-T080
of	O	O	O
the	O	O	O
material	O	O	B-T167
.	O	O	O

This	O	O	O
makes	O	O	O
the	O	O	O
cuticle	O	O	B-T002
a	O	O	O
versatile	O	O	B-T167
material	O	O	I-T167
ideally	O	O	O
suited	O	O	O
to	O	O	O
form	O	O	O
a	O	O	O
variety	O	O	O
of	O	O	O
skeletal	O	O	B-T082
elements	O	O	B-T196
that	O	O	O
are	O	O	O
adapted	O	O	B-T038
to	O	O	O
different	O	O	O
functions	O	O	B-T169
and	O	O	O
the	O	O	O
eco-physiological	O	O	B-T001
strains	O	O	I-T001
of	O	O	O
individual	O	O	B-T185
species	O	O	I-T185
.	O	O	O

This	O	O	O
review	O	O	B-T170
presents	O	O	O
our	O	O	O
recent	O	O	O
analytical	O	O	B-T170
,	O	O	O
experimental	O	O	B-T062
and	O	O	O
theoretical	O	O	B-T062
studies	O	O	I-T062
on	O	O	O
the	O	O	O
cuticle	O	O	B-T002
,	O	O	O
summarising	O	O	O
at	O	O	O
which	O	O	O
hierarchical	O	O	B-T169
levels	O	O	B-T080
structure	O	O	B-T082
and	O	O	O
composition	O	O	B-T032
are	O	O	O
modified	O	O	O
to	O	O	O
achieve	O	O	O
the	O	O	O
required	O	O	O
physical	O	O	B-T201
properties	O	O	I-T201
.	O	O	O

We	O	O	O
describe	O	O	O
our	O	O	O
multi-scale	O	O	B-T075
hierarchical	O	O	I-T075
modeling	O	O	I-T075
approach	O	O	I-T075
based	O	O	O
on	O	O	O
the	O	O	O
results	O	O	B-T169
from	O	O	O
these	O	O	O
studies	O	O	B-T062
,	O	O	O
aiming	O	O	O
at	O	O	O
systematically	O	O	B-T169
predicting	O	O	B-T078
the	O	O	O
structure	O	O	B-T082
-	O	O	O
composition	O	O	B-T032
-	O	O	O
property	O	O	B-T080
relations	O	O	B-T080
of	O	O	O
cuticle	O	O	B-T002
composites	O	O	B-T080
from	O	O	O
the	O	O	O
molecular	O	O	B-T080
level	O	O	B-T080
to	O	O	O
the	O	O	O
macro-scale	O	O	B-T081
.	O	O	O

This	O	O	O
modeling	O	O	B-T075
approach	O	O	I-T075
provides	O	O	O
a	O	O	O
tool	O	O	O
to	O	O	O
facilitate	O	O	O
the	O	O	O
development	O	O	B-T169
of	O	O	O
optimized	O	O	O
biomimetic	O	O	B-T073
materials	O	O	I-T073
within	O	O	O
a	O	O	O
knowledge-based	O	O	B-T075
design	O	O	I-T075
approach	O	O	I-T075
.	O	O	O

-DOCSTART- (27609916)

Draft	O	O	B-T085
Genome	O	O	I-T085
Sequences	O	O	I-T085
of	O	O	O
15	O	O	O
Isolates	O	O	B-T123
of	O	O	O
Listeria	O	O	B-T007
monocytogenes	O	O	I-T007
Serotype	O	O	I-T007
1/2a	O	O	I-T007
,	O	O	O
Subgroup	O	O	B-T185
ST204	O	O	O

Listeria	O	O	B-T007
monocytogenes	O	O	I-T007
sequence	O	O	B-T001
type	O	O	I-T001
204	O	O	I-T001
(	O	O	I-T001
ST204	O	O	I-T001
)	O	O	I-T001
strains	O	O	I-T001
have	O	O	O
been	O	O	O
isolated	O	O	B-T169
from	O	O	O
a	O	O	O
range	O	O	B-T168
of	O	O	I-T168
food	O	O	I-T168
,	O	O	O
environmental	O	O	B-T082
,	O	O	O
and	O	O	O
clinical	O	O	B-T080
sources	O	O	B-T033
in	O	O	O
Australia	O	O	B-T083
.	O	O	O

This	O	O	O
study	O	O	O
describes	O	O	O
the	O	O	O
draft	O	O	B-T085
genome	O	O	I-T085
sequences	O	O	I-T085
of	O	O	O
15	O	O	O
isolates	O	O	O
collected	O	O	O
from	O	O	O
meat	O	O	B-T168
and	O	O	O
dairy	O	O	B-T168
associated	O	O	I-T168
sources	O	O	I-T168
.	O	O	O

-DOCSTART- (27611704)

High	O	O	O
Transferability	O	O	B-T080
of	O	O	O
Homoeolog-Specific	O	O	B-T045
Markers	O	O	I-T045
between	O	O	O
Bread	O	O	B-T168
Wheat	O	O	B-T168
and	O	O	O
Newly	O	O	O
Synthesized	O	O	B-T052
Hexaploid	O	O	O
Wheat	O	O	O
Lines	O	O	O

Bread	O	O	B-T168
wheat	O	O	B-T168
(	O	O	O
Triticum	O	O	B-T002
aestivum	O	O	I-T002
,	O	O	O
2n	O	O	O
=	O	O	O
6x	O	O	O
=	O	O	O
42	O	O	O
,	O	O	O
AABBDD	O	O	O
)	O	O	O
has	O	O	O
a	O	O	O
complex	O	O	O
allohexaploid	O	O	B-T028
genome	O	O	I-T028
,	O	O	O
which	O	O	O
makes	O	O	O
it	O	O	O
difficult	O	O	O
to	O	O	O
differentiate	O	O	B-T169
between	O	O	O
the	O	O	O
homoeologous	O	O	B-T085
sequences	O	O	I-T085
and	O	O	O
assign	O	O	O
them	O	O	O
to	O	O	O
the	O	O	O
chromosome	O	O	B-T026
A	O	O	I-T026
,	O	O	O
B	O	O	B-T026
,	O	O	O
or	O	O	O
D	O	O	B-T026
subgenomes	O	O	B-T028
.	O	O	O

The	O	O	O
chromosome	O	O	B-T026
-based	O	O	O
draft	O	O	O
genome	O	O	B-T028
sequence	O	O	B-T086
of	O	O	O
the	O	O	O
'	O	O	O
Chinese	O	O	B-T168
Spring	O	O	I-T168
'	O	O	O
common	O	O	O
wheat	O	O	B-T168
cultivar	O	O	I-T168
enables	O	O	O
the	O	O	O
large-scale	O	O	O
development	O	O	B-T169
of	O	O	O
polymerase	O	O	B-T063
chain	O	O	I-T063
reaction	O	O	I-T063
(PCR)-based	O	O	O
markers	O	O	B-T045
specific	O	O	O
for	O	O	O
homoeologs	O	O	O
.	O	O	O

Based	O	O	O
on	O	O	O
high-confidence	O	O	O
'	O	O	O
Chinese	O	O	B-T168
Spring	O	O	I-T168
'	O	O	O
genes	O	O	B-T028
with	O	O	O
known	O	O	O
functions	O	O	O
,	O	O	O
we	O	O	O
developed	O	O	O
183	O	O	O
putative	O	O	O
homoeolog-specific	O	O	B-T045
markers	O	O	I-T045
for	O	O	O
chromosomes	O	O	B-T026
4B	O	O	I-T026
and	O	O	O
7B	O	O	B-T026
.	O	O	O

These	O	O	O
markers	O	O	B-T045
were	O	O	O
used	O	O	O
in	O	O	O
PCR	O	O	B-T063
assays	O	O	I-T063
for	O	O	O
the	O	O	O
4B	O	O	B-T026
and	O	O	O
7B	O	O	B-T026
nullisomes	O	O	O
and	O	O	O
their	O	O	O
euploid	O	O	O
synthetic	O	O	B-T168
hexaploid	O	O	I-T168
wheat	O	O	I-T168
(	O	O	I-T168
SHW	O	O	I-T168
)	O	O	I-T168
line	O	O	I-T168
that	O	O	O
was	O	O	O
newly	O	O	O
generated	O	O	O
from	O	O	O
a	O	O	O
hybridization	O	O	B-T070
between	O	O	O
Triticum	O	O	B-T002
turgidum	O	O	I-T002
(	O	O	O
AABB	O	O	O
)	O	O	O
and	O	O	O
the	O	O	O
wild	O	O	O
diploid	O	O	B-T025
species	O	O	I-T025
Aegilops	O	O	B-T002
tauschii	O	O	I-T002
(	O	O	O
DD	O	O	O
)	O	O	O
.	O	O	O

Up	O	O	O
to	O	O	O
64	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
markers	O	O	B-T045
for	O	O	O
chromosomes	O	O	B-T026
4B	O	O	I-T026
or	O	O	O
7B	O	O	B-T026
in	O	O	O
the	O	O	O
SHW	O	O	B-T168
background	O	O	O
were	O	O	O
confirmed	O	O	O
to	O	O	O
be	O	O	O
homoeolog-specific	O	O	O
.	O	O	O

Thus	O	O	O
,	O	O	O
these	O	O	O
markers	O	O	B-T045
were	O	O	O
highly	O	O	O
transferable	O	O	O
between	O	O	O
the	O	O	O
'	O	O	O
Chinese	O	O	B-T168
Spring	O	O	I-T168
'	O	O	O
bread	O	O	B-T168
wheat	O	O	B-T168
and	O	O	O
SHW	O	O	B-T168
lines	O	O	I-T168
.	O	O	O

Homoeolog-specific	O	O	B-T045
markers	O	O	I-T045
designed	O	O	O
using	O	O	O
genes	O	O	B-T028
with	O	O	O
known	O	O	O
functions	O	O	O
may	O	O	O
be	O	O	O
useful	O	O	O
for	O	O	O
genetic	O	O	B-T059
investigations	O	O	I-T059
involving	O	O	O
homoeologous	O	O	O
chromosome	O	O	B-T026
tracking	O	O	O
and	O	O	O
homoeolog	O	O	O
expression	O	O	B-T045
and	O	O	O
interaction	O	O	O
analyses	O	O	O
.	O	O	O

-DOCSTART- (27612561)

Participation	O	O	B-T169
in	O	O	O
and	O	O	O
adherence	O	O	B-T169
to	O	O	O
physical	O	O	B-T056
exercise	O	O	I-T056
after	O	O	O
completion	O	O	B-T080
of	O	O	O
primary	O	O	B-T191
cancer	O	O	I-T191
treatment	O	O	O

The	O	O	O
purpose	O	O	B-T169
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
identify	O	O	B-T041
demographic	O	O	B-T078
,	O	O	O
clinical	O	O	B-T080
,	O	O	O
psychosocial	O	O	B-T169
,	O	O	O
physical	O	O	B-T169
and	O	O	O
environmental	O	O	B-T082
factors	O	O	B-T169
that	O	O	O
are	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
participation	O	O	B-T169
in	O	O	O
and	O	O	O
adherence	O	O	B-T169
to	O	O	O
a	O	O	O
combined	O	O	B-T080
resistance	O	O	B-T169
and	O	O	O
endurance	O	O	B-T061
exercise	O	O	I-T061
program	O	O	B-T169
among	O	O	O
cancer	O	O	B-T101
survivors	O	O	I-T101
,	O	O	O
shortly	O	O	O
after	O	O	O
completion	O	O	B-T080
of	O	O	O
primary	O	O	B-T191
cancer	O	O	I-T191
treatment	O	O	B-T061
.	O	O	O

Data	O	O	B-T078
from	O	O	O
the	O	O	O
randomized	O	O	B-T033
controlled	O	O	B-T169
Resistance	O	O	B-T170
and	O	O	I-T170
Endurance	O	O	I-T170
exercise	O	O	I-T170
After	O	O	I-T170
ChemoTherapy	O	O	I-T170
(	O	O	O
REACT	O	O	B-T170
)	O	O	O
study	O	O	B-T062
were	O	O	O
used	O	O	O
for	O	O	O
this	O	O	O
study	O	O	O
.	O	O	O

The	O	O	O
participants	O	O	B-T098
of	O	O	O
the	O	O	O
REACT	O	O	B-T170
study	O	O	B-T062
were	O	O	O
randomly	O	O	B-T080
allocated	O	O	B-T052
to	O	O	O
either	O	O	O
a	O	O	O
high	O	O	B-T185
intensity	O	O	I-T185
(	O	O	O
HI	O	O	B-T185
)	O	O	O
or	O	O	O
low	O	O	B-T080
-to-	O	O	O
moderate	O	O	B-T185
intensity	O	O	I-T185
(	O	O	O
LMI	O	O	B-T080
)	O	O	O
exercise	O	O	B-T056
program	O	O	B-T169
.	O	O	O

Patients	O	O	B-T101
'	O	O	O
participation	O	O	B-T169
rate	O	O	B-T081
was	O	O	O
defined	O	O	O
as	O	O	O
the	O	O	O
cancer	O	O	B-T101
survivors	O	O	I-T101
'	O	O	O
decision	O	O	O
to	O	O	O
participate	O	O	B-T169
in	O	O	O
the	O	O	O
REACT	O	O	B-T170
study	O	O	B-T062
.	O	O	O

Exercise	O	O	B-T056
adherence	O	O	B-T169
reflected	O	O	B-T041
participants	O	O	B-T098
'	O	O	O
attendance	O	O	B-T052
to	O	O	O
the	O	O	O
scheduled	O	O	B-T080
exercise	O	O	B-T056
sessions	O	O	B-T051
and	O	O	O
their	O	O	O
compliance	O	O	B-T055
to	O	O	O
the	O	O	O
prescribed	O	O	B-T058
exercises	O	O	B-T056
.	O	O	O

High	O	O	B-T080
session	O	O	B-T051
attendance	O	O	B-T052
rates	O	O	B-T081
were	O	O	O
defined	O	O	O
as	O	O	O
attending	O	O	B-T169
at	O	O	O
least	O	O	O
80	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
sessions	O	O	B-T051
.	O	O	O

High	O	O	B-T080
compliance	O	O	B-T055
rates	O	O	B-T081
were	O	O	O
defined	O	O	O
as	O	O	O
performing	O	O	B-T169
at	O	O	O
least	O	O	O
of	O	O	O
90	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
prescribed	O	O	B-T058
exercise	O	O	B-T056
across	O	O	O
all	O	O	O
sessions	O	O	B-T051
.	O	O	O

Correlates	O	O	B-T080
of	O	O	O
exercise	O	O	B-T056
adherence	O	O	B-T169
were	O	O	O
studied	O	O	B-T062
separately	O	O	B-T080
for	O	O	O
HI	O	O	B-T185
and	O	O	O
LMI	O	O	B-T080
exercise	O	O	O
.	O	O	O

Demographic	O	O	B-T078
,	O	O	O
clinical	O	O	B-T080
,	O	O	O
and	O	O	O
physical	O	O	B-T169
factors	O	O	B-T169
were	O	O	O
assessed	O	O	B-T052
using	O	O	O
self-reported	O	O	B-T062
questionnaires	O	O	B-T170
.	O	O	O

Relevant	O	O	B-T080
clinical	O	O	B-T170
information	O	O	I-T170
was	O	O	O
extracted	O	O	B-T169
from	O	O	O
medical	O	O	B-T170
records	O	O	I-T170
.	O	O	O

Multivariable	O	O	B-UnknownType
logistic	O	O	I-UnknownType
regression	O	O	I-UnknownType
analyses	O	O	I-UnknownType
were	O	O	O
applied	O	O	B-T169
to	O	O	O
identify	O	O	B-T041
correlates	O	O	B-T080
that	O	O	O
were	O	O	O
significantly	O	O	B-T078
associated	O	O	B-T080
with	O	O	I-T080
participation	O	O	B-T169
,	O	O	O
high	O	O	B-T080
session	O	O	B-T051
attendance	O	O	B-T052
,	O	O	O
high	O	O	O
compliance	O	O	B-T055
with	O	O	O
resistance	O	O	B-T169
and	O	O	O
high	O	O	O
compliance	O	O	O
with	O	O	O
endurance	O	O	B-T061
exercises	O	O	I-T061
.	O	O	O

Participants	O	O	B-T098
were	O	O	O
more	O	O	B-T081
likely	O	O	I-T033
to	O	O	O
have	O	O	O
higher	O	O	B-T080
education	O	O	I-T170
,	O	O	O
be	O	O	O
non-smokers	O	O	B-T033
,	O	O	O
have	O	O	O
lower	O	O	B-T080
psychological	O	O	B-T048
distress	O	O	I-T048
,	O	O	O
higher	O	O	O
outcome	O	O	B-T080
expectations	O	O	B-T078
,	O	O	O
and	O	O	O
perceive	O	O	B-T041
more	O	O	O
exercise	O	O	B-T056
barriers	O	O	B-T080
than	O	O	O
non-participants	O	O	B-T098
.	O	O	O

In	O	O	O
HI	O	O	B-T185
exercise	O	O	B-T056
,	O	O	O
higher	O	O	B-T080
self-efficacy	O	O	B-T041
was	O	O	O
significantly	O	O	B-T078
associated	O	O	B-T080
with	O	O	I-T080
high	O	O	B-T080
session	O	O	B-T051
attendance	O	O	B-T052
and	O	O	O
high	O	O	O
compliance	O	O	B-T055
with	O	O	O
endurance	O	O	B-T061
exercises	O	O	B-T056
,	O	O	O
and	O	O	O
lower	O	O	B-T080
psychological	O	O	B-T048
distress	O	O	I-T048
was	O	O	O
significantly	O	O	O
associated	O	O	O
with	O	O	O
high	O	O	O
compliance	O	O	O
with	O	O	O
resistance	O	O	B-T169
exercise	O	O	O
s.	O	O	O
In	O	O	O
LMI	O	O	B-T080
exercise	O	O	O
,	O	O	O
being	O	O	O
a	O	O	O
non-smoker	O	O	B-T033
was	O	O	O
significantly	O	O	O
associated	O	O	O
with	O	O	O
high	O	O	O
compliance	O	O	O
with	O	O	O
resistance	O	O	O
exercises	O	O	O
and	O	O	O
higher	O	O	O
BMI	O	O	B-T201
was	O	O	O
significantly	O	O	O
associated	O	O	O
with	O	O	O
high	O	O	O
compliance	O	O	O
with	O	O	O
resistance	O	O	O
and	O	O	O
endurance	O	O	O
exercises	O	O	O
.	O	O	O

Furthermore	O	O	O
,	O	O	O
breast	O	O	B-T101
cancer	O	O	B-T191
survivors	O	O	B-T101
were	O	O	O
less	O	O	B-T081
likely	O	O	B-T078
to	O	O	O
report	O	O	B-T058
high	O	O	B-T080
compliance	O	O	B-T055
with	O	O	O
resistance	O	O	B-T169
and	O	O	O
endurance	O	O	B-T061
exercises	O	O	I-T061
in	O	O	O
LMI	O	O	B-T080
exercise	O	O	B-T056
compared	O	O	B-T052
to	O	O	O
survivors	O	O	O
of	O	O	O
other	O	O	O
types	O	O	O
of	O	O	O
cancer	O	O	O
.	O	O	O

The	O	O	O
discriminative	O	O	B-T041
ability	O	O	B-T032
of	O	O	O
the	O	O	O
multivariable	O	O	B-T080
models	O	O	B-T170
ranged	O	O	B-T081
from	O	O	O
0.62	O	O	O
to	O	O	O
0.75	O	O	O
.	O	O	O

Several	O	O	O
demographic	O	O	B-T078
,	O	O	O
clinical	O	O	B-T080
and	O	O	O
psychosocial	O	O	B-T169
factors	O	O	B-T169
were	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
participation	O	O	B-T169
in	O	O	O
and	O	O	O
adherence	O	O	B-T169
to	O	O	O
exercise	O	O	B-T056
among	O	O	O
cancer	O	O	B-T101
survivors	O	O	I-T101
.	O	O	O

Psychosocial	O	O	B-T169
factors	O	O	B-T169
were	O	O	O
more	O	O	B-T081
strongly	O	O	B-T080
associated	O	O	B-T080
with	O	O	I-T080
adherence	O	O	B-T169
in	O	O	O
HI	O	O	B-T185
than	O	O	O
LMI	O	O	B-T080
exercise	O	O	B-T056
.	O	O	O

This	O	O	O
study	O	O	B-T062
was	O	O	O
registered	O	O	B-T170
at	O	O	O
the	O	O	O
Netherlands	O	O	B-T170
Trial	O	O	I-T170
Register	O	O	I-T170
[	O	O	O
NTR2153	O	O	B-T170
]	O	O	O
on	O	O	O
the	O	O	O
5(th	O	O	O
)	O	O	O
of	O	O	O
January	O	O	O
2010	O	O	O
.	O	O	O

-DOCSTART- (27614652)

In	O	O	B-T082
situ	O	O	I-T082
stabilization	O	O	B-T080
of	O	O	O
heavy	O	O	B-T196
metals	O	O	I-T196
in	O	O	O
multiple-	O	O	O
metal	O	O	B-T197
contaminated	O	O	B-T169
paddy	O	O	B-T002
soil	O	O	B-T167
using	O	O	O
different	O	O	O
steel	O	O	B-T122
slag	O	O	B-T197
-based	O	O	O
silicon	O	O	B-T196
fertilizer	O	O	O

Steel	O	O	B-T122
slag	O	O	B-T197
has	O	O	O
been	O	O	O
widely	O	O	O
used	O	O	O
as	O	O	O
amendment	O	O	O
and	O	O	O
silicon	O	O	B-T196
fertilizer	O	O	B-T131
to	O	O	O
alleviate	O	O	O
the	O	O	O
mobility	O	O	B-T033
and	O	O	O
bioavailability	O	O	B-T081
of	O	O	O
heavy	O	O	B-T196
metals	O	O	I-T196
in	O	O	O
soil	O	O	B-T167
.	O	O	O

The	O	O	O
objective	O	O	B-T170
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
evaluate	O	O	B-T058
the	O	O	O
influence	O	O	B-T077
of	O	O	O
particle	O	O	B-T081
size	O	O	I-T081
,	O	O	O
composition	O	O	B-T070
,	O	O	O
and	O	O	O
application	O	O	O
rate	O	O	O
of	O	O	O
slag	O	O	B-T197
on	O	O	O
metal	O	O	B-T197
immobilization	O	O	B-T169
in	O	O	O
acidic	O	O	B-T103
soil	O	O	B-T167
,	O	O	O
metals	O	O	B-T197
uptake	O	O	B-T039
by	O	O	O
rice	O	O	B-T002
and	O	O	O
rice	O	O	O
growth	O	O	B-T039
.	O	O	O

The	O	O	O
results	O	O	O
indicated	O	O	O
that	O	O	O
application	O	O	O
of	O	O	O
slag	O	O	B-T197
increased	O	O	O
soil	O	O	B-T167
pH	O	O	B-T081
,	O	O	O
plant	O	O	B-T002
-available	O	O	O
silicon	O	O	B-T196
concentrations	O	O	B-T081
in	O	O	O
soil	O	O	O
,	O	O	O
and	O	O	O
decreased	O	O	B-T081
the	O	O	O
bioavailability	O	O	B-T081
of	O	O	O
metals	O	O	B-T197
compared	O	O	O
with	O	O	O
control	O	O	B-T080
treatment	O	O	I-T080
,	O	O	O
whereas	O	O	O
pulverous	O	O	B-T197
slag	O	O	I-T197
(	O	O	O
S1	O	O	B-T197
)	O	O	O
was	O	O	O
more	O	O	B-T080
effective	O	O	I-T080
than	O	O	O
granular	O	O	B-T080
slag	O	O	O
(	O	O	O
S2	O	O	O
and	O	O	O
S3	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
acid	O	O	B-T103
-	O	O	O
extractable	O	O	B-T081
fraction	O	O	I-T081
of	O	O	I-T081
Cd	O	O	B-T131
in	O	O	O
the	O	O	O
spiked	O	O	O
soil	O	O	B-T167
was	O	O	O
significantly	O	O	O
decreased	O	O	B-T081
with	O	O	O
application	O	O	O
of	O	O	O
S1	O	O	B-T197
at	O	O	O
rates	O	O	O
of	O	O	O
1	O	O	O
and	O	O	O
3	O	O	O
%	O	O	O
,	O	O	O
acid-extractable	O	O	O
fractions	O	O	O
of	O	O	O
Cu	O	O	B-T121
and	O	O	O
Zn	O	O	B-T121
were	O	O	O
decreased	O	O	O
when	O	O	O
treated	O	O	B-T169
at	O	O	O
3	O	O	O
%	O	O	O
.	O	O	O

Use	O	O	O
of	O	O	O
S1	O	O	B-T197
at	O	O	O
both	O	O	O
rates	O	O	O
resulted	O	O	O
in	O	O	O
significantly	O	O	B-T081
lower	O	O	I-T081
Cd	O	O	B-T131
,	O	O	O
Cu	O	O	B-T121
,	O	O	O
and	O	O	O
Zn	O	O	B-T121
concentrations	O	O	B-T081
in	O	O	O
rice	O	O	B-T002
tissues	O	O	B-T025
than	O	O	O
in	O	O	O
controls	O	O	B-T096
by	O	O	O
82.6	O	O	O
-	O	O	O
92.9	O	O	O
,	O	O	O
88.4	O	O	O
-	O	O	O
95.6	O	O	O
,	O	O	O
and	O	O	O
67.4	O	O	O
-	O	O	O
81.4	O	O	O
%	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
use	O	O	O
of	O	O	O
pulverous	O	O	B-T197
slag	O	O	I-T197
at	O	O	O
1	O	O	O
%	O	O	O
significantly	O	O	O
promotes	O	O	B-T052
rice	O	O	B-T002
growth	O	O	B-T039
,	O	O	O
restricted	O	O	O
rice	O	O	O
growth	O	O	O
when	O	O	O
treated	O	O	B-T169
at	O	O	O
3	O	O	O
%	O	O	O
.	O	O	O

Thus	O	O	O
,	O	O	O
the	O	O	O
results	O	O	O
explained	O	O	O
that	O	O	O
reduced	O	O	B-T080
particle	O	O	B-T081
size	O	O	I-T081
and	O	O	O
suitable	O	O	O
application	O	O	O
rate	O	O	O
of	O	O	O
slag	O	O	B-T197
could	O	O	O
be	O	O	O
beneficial	O	O	O
to	O	O	O
rice	O	O	B-T002
growth	O	O	B-T039
and	O	O	O
metals	O	O	B-T197
stabilization	O	O	B-T080
.	O	O	O

-DOCSTART- (27616047)

Plasmodium	O	O	B-T204
falciparum	O	O	I-T204
Choline	O	O	B-T116
Kinase	O	O	I-T116
Inhibition	O	O	B-T052
Leads	O	O	O
to	O	O	O
a	O	O	O
Major	O	O	O
Decrease	O	O	B-T081
in	O	O	O
Phosphatidylethanolamine	O	O	B-T109
Causing	O	O	O
Parasite	O	O	B-T204
Death	O	O	O

Malaria	O	O	B-T047
is	O	O	O
a	O	O	O
life-threatening	O	O	B-T033
disease	O	O	B-T047
caused	O	O	O
by	O	O	O
different	O	O	O
species	O	O	B-T185
of	O	O	O
the	O	O	O
protozoan	O	O	B-T204
parasite	O	O	I-T204
Plasmodium	O	O	B-T204
,	O	O	O
with	O	O	O
P.	O	O	B-T204
falciparum	O	O	I-T204
being	O	O	O
the	O	O	O
deadliest	O	O	O
.	O	O	O

Increasing	O	O	B-T169
parasitic	O	O	B-T169
resistance	O	O	B-T169
to	O	O	O
existing	O	O	O
antimalarials	O	O	B-T121
makes	O	O	O
the	O	O	O
necessity	O	O	O
of	O	O	O
novel	O	O	B-T080
avenues	O	O	O
to	O	O	O
treat	O	O	B-T061
this	O	O	O
disease	O	O	B-T047
an	O	O	O
urgent	O	O	O
priority	O	O	O
.	O	O	O

The	O	O	O
enzymes	O	O	B-T116
responsible	O	O	O
for	O	O	O
the	O	O	O
synthesis	O	O	B-T052
of	O	O	O
phosphatidylcholine	O	O	B-T109
and	O	O	O
phosphatidylethanolamine	O	O	B-T109
are	O	O	O
attractive	O	O	O
drug	O	O	B-T169
targets	O	O	I-T169
to	O	O	O
treat	O	O	B-T061
malaria	O	O	B-T047
as	O	O	O
their	O	O	O
selective	O	O	O
inhibition	O	O	B-T052
leads	O	O	O
to	O	O	O
an	O	O	O
arrest	O	O	O
of	O	O	O
the	O	O	O
parasite	O	O	B-T204
's	O	O	I-T204
growth	O	O	B-T040
and	O	O	O
cures	O	O	B-T033
malaria	O	O	O
in	O	O	O
a	O	O	O
mouse	O	O	B-T050
model	O	O	I-T050
.	O	O	O

We	O	O	O
present	O	O	O
here	O	O	O
a	O	O	O
detailed	O	O	O
study	O	O	B-T062
that	O	O	O
reveals	O	O	O
a	O	O	O
mode	O	O	B-T169
of	O	O	I-T169
action	O	O	I-T169
for	O	O	O
two	O	O	O
P.	O	O	B-T204
falciparum	O	O	I-T204
choline	O	O	B-T116
kinase	O	O	I-T116
inhibitors	O	O	B-T120
both	O	O	O
in	O	O	B-T080
vitro	O	O	I-T080
and	O	O	O
in	O	O	B-T082
vivo	O	O	I-T082
.	O	O	O

The	O	O	O
compounds	O	O	B-T080
present	O	O	O
distinct	O	O	O
binding	O	O	B-T044
modes	O	O	O
to	O	O	O
the	O	O	O
choline	O	O	B-T109
/	O	O	O
ethanolamine	O	O	B-T109
-	O	O	O
binding	O	O	B-T192
site	O	O	I-T192
of	O	O	O
P.	O	O	B-T204
falciparum	O	O	I-T204
choline	O	O	B-T116
kinase	O	O	I-T116
,	O	O	O
reflecting	O	O	O
different	O	O	O
types	O	O	O
of	O	O	O
inhibition	O	O	B-T052
.	O	O	O

Strikingly	O	O	O
,	O	O	O
these	O	O	O
compounds	O	O	B-T080
primarily	O	O	O
inhibit	O	O	O
the	O	O	O
ethanolamine	O	O	B-T044
kinase	O	O	I-T044
activity	O	O	I-T044
of	O	O	O
the	O	O	O
P.	O	O	B-T204
falciparum	O	O	I-T204
choline	O	O	B-T116
kinase	O	O	I-T116
,	O	O	O
leading	O	O	O
to	O	O	O
a	O	O	O
severe	O	O	O
decrease	O	O	B-T081
in	O	O	O
the	O	O	O
phosphatidylethanolamine	O	O	B-T109
levels	O	O	B-T080
within	O	O	O
P.	O	O	O
falciparum	O	O	O
,	O	O	O
which	O	O	O
explains	O	O	O
the	O	O	O
resulting	O	O	O
growth	O	O	B-T032
phenotype	O	O	I-T032
and	O	O	O
the	O	O	O
parasites	O	O	B-T204
death	O	O	B-T040
.	O	O	O

These	O	O	O
studies	O	O	O
provide	O	O	O
an	O	O	O
understanding	O	O	O
of	O	O	O
the	O	O	O
mode	O	O	B-T169
of	O	O	I-T169
action	O	O	I-T169
,	O	O	O
and	O	O	O
act	O	O	O
as	O	O	O
a	O	O	O
springboard	O	O	O
for	O	O	O
continued	O	O	O
antimalarial	O	O	B-T039
development	O	O	I-T039
efforts	O	O	O
selectively	O	O	O
targeting	O	O	O
P.	O	O	B-T204
falciparum	O	O	I-T204
choline	O	O	B-T116
kinase	O	O	I-T116
.	O	O	O

-DOCSTART- (27616751)

Anti-CD45RB	O	O	B-T116
and	O	O	O
donor-specific	O	O	B-T169
spleen	O	O	I-T169
cells	O	O	I-T169
transfusion	O	O	I-T169
inhibition	O	O	B-T052
allograft	O	O	B-T046
skin	O	O	I-T046
rejection	O	O	I-T046
mediated	O	O	O
by	O	O	O
memory	O	O	O
T	O	O	O
cells	O	O	O

Donor-reactive	O	O	O
memory	O	O	B-T025
T	O	O	I-T025
(Tm)cells	O	O	I-T025
mediate	O	O	O
accelerated	O	O	O
rejection	O	O	B-T042
,	O	O	O
which	O	O	O
is	O	O	O
known	O	O	O
as	O	O	O
a	O	O	O
barrier	O	O	O
to	O	O	O
the	O	O	O
survival	O	O	O
of	O	O	O
transplanted	O	O	B-T023
organs	O	O	I-T023
.	O	O	O

Selective	O	O	O
interference	O	O	O
with	O	O	O
the	O	O	O
anti-CD45RB	O	O	B-T116
monoclonal	O	O	I-T116
antibody	O	O	I-T116
(	O	O	I-T116
Î±-CD45RB	O	O	I-T116
)	O	O	I-T116
reliably	O	O	O
induces	O	O	O
donor	O	O	B-T098
-	O	O	O
specific	O	O	B-T080
tolerance	O	O	B-T040
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
pre-sensitization	O	O	B-T079
to	O	O	O
female	O	O	B-T032
C57BL/6	O	O	B-T015
mice	O	O	I-T015
with	O	O	O
the	O	O	O
skin	O	O	B-T022
of	O	O	O
female	O	O	O
BLAB/c	O	O	B-T015
mice	O	O	I-T015
generated	O	O	O
a	O	O	O
large	O	O	O
number	O	O	O
of	O	O	O
Tm	O	O	B-T025
cells	O	O	I-T025
and	O	O	O
resulted	O	O	O
in	O	O	O
rapid	O	O	O
rejection	O	O	B-T042
of	O	O	O
the	O	O	O
secondly	O	O	B-T081
transplanted	O	O	B-T169
allografts	O	O	B-T122
.	O	O	O

Î±-CD45RB	O	O	B-T116
did	O	O	O
induce	O	O	O
the	O	O	O
tolerance	O	O	B-T040
to	O	O	O
skin	O	O	B-T122
allograft	O	O	I-T122
primarily	O	O	B-T080
transplanted	O	O	B-T169
but	O	O	O
failed	O	O	O
to	O	O	O
induce	O	O	O
tolerance	O	O	O
in	O	O	O
the	O	O	O
pre-sensitized	O	O	B-T015
mice	O	O	I-T015
.	O	O	O

Donor-specific	O	O	B-T169
spleen	O	O	I-T169
cell	O	O	I-T169
transfusion	O	O	I-T169
(	O	O	O
DST	O	O	B-T169
)	O	O	O
alone	O	O	O
also	O	O	O
failed	O	O	O
to	O	O	O
induce	O	O	O
the	O	O	O
tolerance	O	O	B-T040
in	O	O	O
the	O	O	O
pre-sensitized	O	O	B-T079
recipients	O	O	B-T101
.	O	O	O

Interestingly	O	O	O
,	O	O	O
combination	O	O	O
of	O	O	O
Î±-CD45RB	O	O	B-T116
with	O	O	O
DST	O	O	B-T169
inhibited	O	O	O
the	O	O	O
rejection	O	O	B-T042
induced	O	O	O
by	O	O	O
memory	O	O	B-T025
T	O	O	I-T025
cells	O	O	I-T025
in	O	O	O
the	O	O	O
pre-sensitized	O	O	B-T015
mice	O	O	I-T015
.	O	O	O

CD25	O	O	B-T025
+	O	O	I-T025
T-cell	O	O	I-T025
depletion	O	O	B-T061
in	O	O	O
Î±-CD45RB	O	O	B-T116
combined	O	O	O
with	O	O	O
DST	O	O	B-T169
therapy	O	O	B-T061
recipients	O	O	B-T101
could	O	O	O
prevent	O	O	O
skin	O	O	B-T122
allograft	O	O	I-T122
tolerance	O	O	B-T040
from	O	O	O
establishing	O	O	O
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
adoptive	O	O	B-T061
transfer	O	O	I-T061
of	O	O	O
donor	O	O	B-T098
-primed	O	O	O
memory	O	O	B-T025
T	O	O	I-T025
cells	O	O	I-T025
into	O	O	O
the	O	O	O
tolerant	O	O	B-T040
recipients	O	O	B-T101
markedly	O	O	O
broke	O	O	O
the	O	O	O
established	O	O	O
tolerance	O	O	B-T040
.	O	O	O

Our	O	O	O
findings	O	O	B-T033
indicate	O	O	O
that	O	O	O
Î±-CD45RB	O	O	B-T116
and	O	O	O
DST	O	O	B-T169
can	O	O	O
synergistically	O	O	O
inhibit	O	O	O
the	O	O	O
accelerated	O	O	O
rejection	O	O	B-T042
mediated	O	O	O
by	O	O	O
memory	O	O	B-T025
T	O	O	I-T025
cells	O	O	I-T025
and	O	O	O
induce	O	O	O
long-term	O	O	O
skin	O	O	B-T122
allograft	O	O	I-T122
acceptance	O	O	B-T039
in	O	O	O
mice	O	O	B-T015
.	O	O	O

-DOCSTART- (27617108)

Recruitment	O	O	B-T052
of	O	O	O
Minority	O	O	B-T098
Adolescents	O	O	B-T100
and	O	O	O
Young	O	O	B-T100
Adults	O	O	I-T100
into	O	O	O
Randomised	O	O	B-T062
Clinical	O	O	I-T062
Trials	O	O	I-T062
:	O	O	O
Testing	O	O	B-T169
the	O	O	O
Design	O	O	B-T052
of	O	O	O
the	O	O	O
Technology	O	O	B-T058
Enhanced	O	O	I-T058
Community	O	O	I-T058
Health	O	O	I-T058
Nursing	O	O	I-T058
(	O	O	O
TECH-N	O	O	B-T058
)	O	O	O
Pelvic	O	O	B-T047
Inflammatory	O	O	I-T047
Disease	O	O	I-T047
Trial	O	O	O

Pelvic	O	O	B-T047
inflammatory	O	O	I-T047
disease	O	O	I-T047
(	O	O	O
PID	O	O	B-T047
)	O	O	O
disproportionately	O	O	B-T080
affects	O	O	O
adolescent	O	O	B-T100
and	O	O	O
young	O	O	B-T100
adult	O	O	I-T100
(	O	O	O
AYA	O	O	B-T100
)	O	O	O
women	O	O	B-T098
and	O	O	O
can	O	O	O
negatively	O	O	O
influence	O	O	B-T077
reproductive	O	O	B-T091
health	O	O	I-T091
trajectories	O	O	O
.	O	O	O

Few	O	O	O
randomized	O	O	B-T062
controlled	O	O	I-T062
trials	O	O	I-T062
(	O	O	O
RCTs	O	O	B-T062
)	O	O	O
have	O	O	O
focused	O	O	O
on	O	O	O
strategies	O	O	O
to	O	O	O
improve	O	O	B-T033
outpatient	O	O	B-T101
adherence	O	O	B-T169
or	O	O	O
to	O	O	O
reduce	O	O	B-T080
reproductive	O	O	B-T040
morbidity	O	O	B-T081
in	O	O	O
this	O	O	O
population	O	O	B-T098
.	O	O	O

This	O	O	O
paper	O	O	O
describes	O	O	O
the	O	O	O
research	O	O	B-T062
methods	O	O	I-T062
and	O	O	O
preliminary	O	O	B-T079
effectiveness	O	O	B-T080
of	O	O	O
recruitment	O	O	B-T052
,	O	O	O
retention	O	O	B-UnknownType
,	O	O	O
and	O	O	O
intervention	O	O	B-T058
strategies	O	O	O
employed	O	O	O
in	O	O	O
a	O	O	O
novel	O	O	O
RCT	O	O	B-T062
designed	O	O	O
to	O	O	O
test	O	O	O
a	O	O	O
technology-enhanced	O	O	B-T058
community-health	O	O	I-T058
nursing	O	O	I-T058
(	O	O	O
TECH-N	O	O	B-T058
)	O	O	O
intervention	O	O	O
among	O	O	O
urban	O	O	O
AYA	O	O	B-T100
with	O	O	O
PID	O	O	B-T047
.	O	O	O

AYA	O	O	B-T100
women	O	O	B-T098
aged	O	O	B-T032
13	O	O	O
-	O	O	O
25	O	O	O
years	O	O	B-T079
were	O	O	O
recruited	O	O	B-T052
during	O	O	O
acute	O	O	B-T047
PID	O	O	I-T047
visits	O	O	B-T058
in	O	O	O
outpatient	O	O	B-T093
clinics	O	O	I-T093
and	O	O	O
emergency	O	O	B-T093
departments	O	O	I-T093
(	O	O	O
ED	O	O	B-T093
)	O	O	O
to	O	O	O
participate	O	O	B-T058
in	O	O	O
this	O	O	O
IRB-approved	O	O	B-T170
trial	O	O	O
.	O	O	O

Participants	O	O	B-T098
completed	O	O	B-T080
an	O	O	O
audio-computerized	O	O	B-T052
self-interview	O	O	I-T052
(	O	O	O
ACASI	O	O	B-T052
)	O	O	O
,	O	O	O
provided	O	O	O
vaginal	O	O	B-T024
specimens	O	O	I-T024
,	O	O	O
and	O	O	O
were	O	O	O
randomized	O	O	B-T062
to	O	O	O
standard	O	O	B-T080
treatment	O	O	B-T061
or	O	O	O
the	O	O	O
intervention	O	O	B-T058
.	O	O	O

Intervention	O	O	B-T058
participants	O	O	B-T098
received	O	O	B-T080
text-messaging	O	O	B-T052
support	O	O	B-T077
for	O	O	O
30	O	O	O
days	O	O	B-T079
and	O	O	O
a	O	O	O
community	O	O	B-T097
health	O	O	I-T097
nurse	O	O	I-T097
(	O	O	I-T097
CHN	O	O	I-T097
)	O	O	I-T097
interventionist	O	O	I-T097
performed	O	O	B-T169
a	O	O	O
home	O	O	B-T058
visit	O	O	I-T058
with	O	O	I-T058
clinical	O	O	I-T058
assessment	O	O	I-T058
within	O	O	O
5	O	O	O
days	O	O	O
after	O	O	O
enrollment	O	O	B-T058
.	O	O	O

All	O	O	O
patients	O	O	B-T101
received	O	O	O
a	O	O	O
full	O	O	O
course	O	O	B-T079
of	O	O	O
medications	O	O	B-T058
and	O	O	O
completed	O	O	B-T080
research	O	O	O
visits	O	O	B-T058
at	O	O	O
14-	O	O	O
days	O	O	B-T079
(	O	O	O
adherence	O	O	B-T169
)	O	O	O
,	O	O	O
30	O	O	O
days	O	O	O
and	O	O	O
90	O	O	O
days	O	O	O
with	O	O	O
by	O	O	O
an	O	O	O
outreach	O	O	B-T097
worker	O	O	I-T097
.	O	O	O

STI	O	O	B-T047
testing	O	O	B-T169
performed	O	O	B-T169
at	O	O	O
the	O	O	O
30-and	O	O	O
90-	O	O	O
day	O	O	B-T079
visits	O	O	B-T058
.	O	O	O

Exploratory	O	O	B-T062
analyses	O	O	I-T062
using	O	O	O
descriptive	O	O	B-T062
statistics	O	O	I-T062
were	O	O	O
conducted	O	O	O
to	O	O	O
examine	O	O	O
recruitment	O	O	B-T052
,	O	O	O
retention	O	O	B-UnknownType
,	O	O	O
and	O	O	O
follow-up	O	O	B-T058
data	O	O	B-T078
to	O	O	O
test	O	O	O
the	O	O	O
overall	O	O	O
design	O	O	B-T052
of	O	O	O
the	O	O	O
intervention	O	O	B-T058
.	O	O	O

In	O	O	O
the	O	O	O
first	O	O	O
48	O	O	O
months	O	O	B-T079
,	O	O	O
64	O	O	O
%	O	O	O
of	O	O	O
463	O	O	O
patients	O	O	B-T101
were	O	O	O
eligible	O	O	B-T080
for	O	O	O
the	O	O	O
study	O	O	O
and	O	O	O
81.2	O	O	O
%	O	O	O
of	O	O	O
293	O	O	O
eligible	O	O	O
patients	O	O	O
were	O	O	O
recruited	O	O	B-T052
for	O	O	O
the	O	O	O
study	O	O	O
(	O	O	O
63.3	O	O	O
%	O	O	O
)	O	O	O
;	O	O	O
238	O	O	O
(	O	O	O
81.2	O	O	O
%	O	O	O
)	O	O	O
of	O	O	O
eligible	O	O	O
patients	O	O	O
were	O	O	O
enrolled	O	O	B-T058
.	O	O	O

Most	O	O	O
participants	O	O	B-T098
were	O	O	O
African	O	O	B-T098
American	O	O	I-T098
(	O	O	O
95.6	O	O	O
%	O	O	O
)	O	O	O
with	O	O	O
a	O	O	O
mean	O	O	B-T081
age	O	O	B-T032
of	O	O	O
18.6	O	O	O
(	O	O	O
2.3	O	O	O
)	O	O	O
.	O	O	O

Ninety-four	O	O	O
percent	O	O	O
of	O	O	O
individuals	O	O	B-T098
assigned	O	O	O
to	O	O	O
the	O	O	O
TECH-N	O	O	B-T058
intervention	O	O	I-T058
completed	O	O	B-T080
the	O	O	O
nursing	O	O	B-T058
visits	O	O	I-T058
.	O	O	O

All	O	O	O
completed	O	O	B-T080
visits	O	O	B-T058
have	O	O	O
been	O	O	O
within	O	O	O
the	O	O	O
5-	O	O	O
day	O	O	B-T079
window	O	O	B-T079
and	O	O	O
over	O	O	O
90	O	O	O
%	O	O	O
of	O	O	O
patients	O	O	B-T101
in	O	O	O
both	O	O	O
arms	O	O	O
have	O	O	O
been	O	O	O
retained	O	O	B-T169
over	O	O	O
the	O	O	O
3-	O	O	O
month	O	O	B-T079
follow-up	O	O	B-T058
period	O	O	B-T079
.	O	O	O

Biological	O	O	B-T080
data	O	O	B-T078
suggests	O	O	O
a	O	O	O
shift	O	O	B-T070
in	O	O	I-T070
the	O	O	I-T070
biological	O	O	I-T070
milieu	O	O	I-T070
with	O	O	O
the	O	O	O
predominance	O	O	O
of	O	O	O
Chlamydia	O	O	B-T047
trachomatis	O	O	I-T047
,	O	O	O
Mycoplasma	O	O	B-T047
genitalium	O	O	I-T047
,	O	O	O
and	O	O	O
Trichomonas	O	O	B-T047
vaginalis	O	O	I-T047
infections	O	O	I-T047
.	O	O	O

Preliminary	O	O	B-T079
data	O	O	B-T078
from	O	O	O
the	O	O	O
TECH-N	O	O	B-T058
study	O	O	O
demonstrated	O	O	O
that	O	O	O
urban	O	O	B-T083
,	O	O	O
low-income	O	O	B-T033
,	O	O	O
minority	O	O	B-T098
AYA	O	O	B-T100
with	O	O	O
PID	O	O	B-T047
can	O	O	O
effectively	O	O	O
be	O	O	O
recruited	O	O	B-T052
and	O	O	O
retained	O	O	B-T169
to	O	O	O
participate	O	O	B-T058
in	O	O	O
sexual	O	O	B-T032
and	O	O	O
reproductive	O	O	B-T091
health	O	O	I-T091
RCTs	O	O	B-T062
with	O	O	O
sufficient	O	O	B-T080
investment	O	O	B-T073
in	O	O	O
the	O	O	O
design	O	O	B-T052
and	O	O	O
infrastructure	O	O	B-T185
of	O	O	I-T185
the	O	O	I-T185
study	O	O	I-T185
.	O	O	O

Community	O	O	B-T096
-based	O	O	O
sexual	O	O	B-T032
health	O	O	I-T032
interventions	O	O	B-T061
appear	O	O	O
to	O	O	O
be	O	O	O
both	O	O	O
feasible	O	O	B-T080
and	O	O	O
acceptable	O	O	B-T080
in	O	O	O
this	O	O	O
population	O	O	B-T098
.	O	O	O

-DOCSTART- (27617315)

Extended	O	O	O
use	O	O	O
of	O	O	O
Prostate	O	O	B-T059
Health	O	O	I-T059
Index	O	O	I-T059
and	O	O	O
percentage	O	O	O
of	O	O	O
[-2]pro-prostate-specific	O	O	B-T116
antigen	O	O	I-T116
in	O	O	O
Chinese	O	O	B-T098
men	O	O	B-T098
with	O	O	O
prostate	O	O	B-T116
specific	O	O	I-T116
antigen	O	O	I-T116
10	O	O	O
-	O	O	O
20	O	O	O
ng/mL	O	O	O
and	O	O	O
normal	O	O	B-T080
digital	O	O	O
rectal	O	O	O
examination	O	O	O

We	O	O	O
investigated	O	O	O
the	O	O	O
extended	O	O	O
use	O	O	O
of	O	O	O
Prostate	O	O	B-T059
Health	O	O	I-T059
Index	O	O	I-T059
(	O	O	O
PHI	O	O	B-T059
)	O	O	O
and	O	O	O
percentage	O	O	O
of	O	O	O
[-2]pro-prostate-specific	O	O	B-T116
antigen	O	O	I-T116
(	O	O	O
%	O	O	B-T116
p2PSA	O	O	I-T116
)	O	O	O
in	O	O	O
Chinese	O	O	B-T098
men	O	O	B-T098
with	O	O	O
prostate-specific	O	O	B-T116
antigen	O	O	I-T116
(	O	O	O
PSA	O	O	B-T116
)	O	O	O
10	O	O	O
-	O	O	O
20	O	O	O
ng/mL	O	O	O
and	O	O	O
normal	O	O	B-T080
digital	O	O	B-T060
rectal	O	O	I-T060
examination	O	O	I-T060
(	O	O	O
DRE	O	O	B-T060
)	O	O	O
.	O	O	O

All	O	O	O
consecutive	O	O	O
Chinese	O	O	B-T098
men	O	O	B-T098
with	O	O	O
PSA	O	O	B-T116
10	O	O	O
-	O	O	O
20	O	O	O
ng/mL	O	O	O
and	O	O	O
normal	O	O	B-T080
DRE	O	O	B-T060
who	O	O	O
agreed	O	O	O
for	O	O	O
transrectal	O	O	B-T060
ultrasound	O	O	I-T060
(TRUS)-guided	O	O	O
10-core	O	O	O
prostate	O	O	B-T060
biopsy	O	O	I-T060
were	O	O	O
recruited	O	O	O
.	O	O	O

Blood	O	O	B-T031
samples	O	O	I-T031
were	O	O	O
taken	O	O	O
immediately	O	O	O
before	O	O	O
TRUS	O	O	B-T060
-guided	O	O	O
prostate	O	O	B-T060
biopsy	O	O	I-T060
.	O	O	O

The	O	O	O
performances	O	O	O
of	O	O	O
total	O	O	B-T059
PSA	O	O	I-T059
(	O	O	O
tPSA	O	O	B-T059
)	O	O	O
,	O	O	O
%	O	O	O
free-to-total	O	O	B-T059
PSA	O	O	I-T059
(	O	O	O
%	O	O	O
fPSA	O	O	B-T059
)	O	O	O
,	O	O	O
%	O	O	B-T116
p2PSA	O	O	I-T116
,	O	O	O
and	O	O	O
PHI	O	O	B-T059
were	O	O	O
compared	O	O	O
using	O	O	O
logistic	O	O	B-T062
regression	O	O	I-T062
,	O	O	O
receiver	O	O	B-T081
operating	O	O	I-T081
characteristic	O	O	I-T081
,	O	O	O
and	O	O	O
decision	O	O	B-T062
curve	O	O	I-T062
analyses	O	O	I-T062
(	O	O	O
DCA	O	O	B-T062
)	O	O	O
.	O	O	O

From	O	O	O
2008	O	O	O
to	O	O	O
2015	O	O	O
,	O	O	O
312	O	O	O
consecutive	O	O	O
Chinese	O	O	B-T098
men	O	O	B-T098
were	O	O	O
included	O	O	O
.	O	O	O

Among	O	O	O
them	O	O	O
,	O	O	O
53	O	O	O
out	O	O	O
of	O	O	O
312	O	O	O
(	O	O	O
17.0	O	O	O
%	O	O	O
)	O	O	O
men	O	O	B-T098
were	O	O	O
diagnosed	O	O	B-T033
to	O	O	O
have	O	O	O
prostate	O	O	B-T191
cancer	O	O	I-T191
on	O	O	O
biopsy	O	O	B-T060
.	O	O	O

The	O	O	O
proportions	O	O	O
of	O	O	O
men	O	O	B-T098
with	O	O	O
positive	O	O	B-T033
biopsies	O	O	B-T060
were	O	O	O
6.7	O	O	O
%	O	O	O
in	O	O	O
PHI	O	O	B-T059
<	O	O	O
35	O	O	O
,	O	O	O
22.8	O	O	O
%	O	O	O
in	O	O	O
PHI	O	O	O
35	O	O	O
-	O	O	O
55	O	O	O
,	O	O	O
and	O	O	O
54.5	O	O	O
%	O	O	O
in	O	O	O
PHI	O	O	O
>	O	O	O
55	O	O	O
(	O	O	O
chi-square	O	O	B-T170
test	O	O	I-T170
,	O	O	O
p<0.001	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
area	O	O	B-T081
under	O	O	I-T081
curves	O	O	I-T081
(	O	O	O
AUC	O	O	B-T081
)	O	O	O
of	O	O	O
the	O	O	O
base	O	O	B-T170
model	O	O	I-T170
including	O	O	O
age	O	O	B-T032
,	O	O	O
tPSA	O	O	B-T059
and	O	O	O
status	O	O	O
of	O	O	O
initial/repeated	O	O	O
biopsy	O	O	B-T060
was	O	O	O
0.64	O	O	O
.	O	O	O

Adding	O	O	O
%	O	O	B-T116
p2PSA	O	O	I-T116
and	O	O	O
PHI	O	O	B-T059
to	O	O	O
the	O	O	O
base	O	O	B-T170
model	O	O	I-T170
improved	O	O	B-T033
the	O	O	O
AUC	O	O	B-T081
to	O	O	O
0.79	O	O	O
(	O	O	O
p<0.001	O	O	O
)	O	O	O
and	O	O	O
0.78	O	O	O
(	O	O	O
p<0.001	O	O	O
)	O	O	O
,	O	O	O
respectively	O	O	O
,	O	O	O
and	O	O	O
provided	O	O	O
net	O	O	O
clinical	O	O	O
benefit	O	O	O
in	O	O	O
DCA	O	O	B-T062
.	O	O	O

The	O	O	O
positive	O	O	B-T033
biopsy	O	O	B-T060
rates	O	O	O
of	O	O	O
Gleason	O	O	B-T185
7	O	O	I-T185
or	O	O	I-T185
above	O	O	I-T185
prostate	O	O	B-T191
cancers	O	O	I-T191
were	O	O	O
2.2	O	O	O
%	O	O	O
for	O	O	O
PHI	O	O	B-T059
<	O	O	O
35	O	O	O
,	O	O	O
7.9	O	O	O
%	O	O	O
for	O	O	O
PHI	O	O	O
35	O	O	O
-	O	O	O
55	O	O	O
,	O	O	O
and	O	O	O
36.4	O	O	O
%	O	O	O
for	O	O	O
PHI	O	O	O
>	O	O	O
55	O	O	O
(	O	O	O
chi-square	O	O	B-T170
test	O	O	I-T170
,	O	O	O
p<0.001	O	O	O
)	O	O	O
.	O	O	O

By	O	O	O
utilizing	O	O	O
the	O	O	O
PHI	O	O	B-T059
cutoff	O	O	O
of	O	O	O
35	O	O	O
to	O	O	O
men	O	O	B-T098
with	O	O	O
PSA	O	O	B-T116
10	O	O	O
-	O	O	O
20	O	O	O
ng/mL	O	O	O
and	O	O	O
normal	O	O	B-T080
DRE	O	O	B-T060
,	O	O	O
57.1	O	O	O
%	O	O	O
(	O	O	O
178	O	O	O
of	O	O	O
312	O	O	O
)	O	O	O
biopsies	O	O	B-T060
could	O	O	O
be	O	O	O
avoided	O	O	B-T078
.	O	O	O

Both	O	O	O
PHI	O	O	B-T059
and	O	O	O
%	O	O	B-T116
p2PSA	O	O	I-T116
performed	O	O	O
well	O	O	O
in	O	O	O
predicting	O	O	O
prostate	O	O	B-T191
cancer	O	O	I-T191
and	O	O	O
high	O	O	B-T191
grade	O	O	I-T191
prostate	O	O	I-T191
cancer	O	O	I-T191
.	O	O	O

The	O	O	O
use	O	O	O
of	O	O	O
PHI	O	O	B-T059
and	O	O	O
%	O	O	B-T116
p2PSA	O	O	I-T116
should	O	O	O
be	O	O	O
extended	O	O	O
to	O	O	O
Chinese	O	O	B-T098
men	O	O	B-T098
with	O	O	O
PSA	O	O	O
10	O	O	O
-	O	O	O
20	O	O	O
ng/mL	O	O	O
and	O	O	O
normal	O	O	B-T080
DRE	O	O	B-T060
.	O	O	O

-DOCSTART- (27621200)

A	O	O	O
pilot	O	O	B-T062
study	O	O	I-T062
exploring	O	O	O
the	O	O	O
relationship	O	O	B-T080
between	O	O	O
self	O	O	B-T078
-	O	O	O
compassion	O	O	B-T054
,	O	O	O
self	O	O	O
-	O	O	O
judgement	O	O	B-T041
,	O	O	O
self	O	O	O
-	O	O	O
kindness	O	O	B-T041
,	O	O	O
compassion	O	O	O
,	O	O	O
professional	O	O	B-T078
quality	O	O	I-T078
of	O	O	I-T078
life	O	O	I-T078
and	O	O	O
wellbeing	O	O	B-T033
among	O	O	O
UK	O	O	B-T083
community	O	O	O
nurses	O	O	O

Compassion	O	O	B-T048
fatigue	O	O	I-T048
and	O	O	O
burnout	O	O	B-T048
can	O	O	O
impact	O	O	B-T080
on	O	O	O
performance	O	O	B-T052
of	O	O	O
nurses	O	O	B-T097
.	O	O	O

This	O	O	O
paper	O	O	O
explores	O	O	O
the	O	O	O
relationship	O	O	B-T080
between	O	O	O
self	O	O	B-T078
-	O	O	O
compassion	O	O	B-T054
,	O	O	O
self	O	O	O
-	O	O	O
judgement	O	O	B-T041
,	O	O	O
self	O	O	O
-	O	O	O
kindness	O	O	B-T041
,	O	O	O
compassion	O	O	O
,	O	O	O
professional	O	O	B-T078
quality	O	O	I-T078
of	O	O	I-T078
life	O	O	I-T078
,	O	O	O
and	O	O	O
wellbeing	O	O	B-T033
among	O	O	O
community	O	O	B-T097
nurses	O	O	I-T097
.	O	O	O

To	O	O	O
measure	O	O	B-T081
associations	O	O	B-T080
between	O	O	O
self	O	O	B-T078
-	O	O	O
compassion	O	O	B-T054
,	O	O	O
compassion	O	O	B-T048
fatigue	O	O	I-T048
,	O	O	O
wellbeing	O	O	B-T033
,	O	O	O
and	O	O	O
burnout	O	O	B-T048
in	O	O	O
community	O	O	B-T097
nurses	O	O	I-T097
.	O	O	O

Quantitative	O	O	B-T081
data	O	O	B-T078
were	O	O	O
collected	O	O	B-T169
using	O	O	O
standardised	O	O	B-T080
psychometric	O	O	B-T170
questionnaires	O	O	I-T170
:	O	O	O
(	O	O	O
1	O	O	O
)	O	O	O
Professional	O	O	B-T170
Quality	O	O	I-T170
of	O	O	I-T170
Life	O	O	I-T170
Scale	O	O	I-T170
;	O	O	O
(	O	O	O
2	O	O	O
)	O	O	O
Self-Compassion	O	O	B-T081
Scale	O	O	I-T081
;	O	O	O
(	O	O	O
3	O	O	O
)	O	O	O
short	O	O	B-T170
Warwick	O	O	I-T170
Edinburgh	O	O	I-T170
Mental	O	O	I-T170
Wellbeing	O	O	I-T170
Scale	O	O	I-T170
;	O	O	O
(	O	O	O
4	O	O	O
)	O	O	O
Compassion	O	O	B-T081
For	O	O	I-T081
Others	O	O	I-T081
Scale	O	O	I-T081
,	O	O	O
used	O	O	O
to	O	O	O
measure	O	O	B-T081
relationships	O	O	B-T080
between	O	O	O
self	O	O	B-T078
-	O	O	O
compassion	O	O	B-T054
,	O	O	O
compassion	O	O	B-T048
fatigue	O	O	I-T048
,	O	O	O
wellbeing	O	O	B-T033
,	O	O	O
and	O	O	O
burnout	O	O	B-T048
.	O	O	O

A	O	O	O
cross	O	O	B-T062
sectional	O	O	I-T062
sample	O	O	O
of	O	O	O
registered	O	O	B-T097
community	O	O	I-T097
nurses	O	O	I-T097
(	O	O	O
n=37	O	O	O
)	O	O	O
studying	O	O	O
for	O	O	O
a	O	O	O
postgraduate	O	O	B-T077
diploma	O	O	B-T033
at	O	O	O
a	O	O	O
University	O	O	B-T073
in	O	O	O
the	O	O	O
North	O	O	B-T083
of	O	O	I-T083
England	O	O	I-T083
took	O	O	O
part	O	O	O
in	O	O	O
this	O	O	O
study	O	O	B-T062
.	O	O	O

Results	O	O	B-T169
show	O	O	O
that	O	O	O
community	O	O	B-T097
nurses	O	O	I-T097
who	O	O	O
score	O	O	B-T081
high	O	O	B-T080
on	O	O	O
measures	O	O	B-T081
of	O	O	O
self	O	O	B-T078
-	O	O	O
compassion	O	O	B-T054
and	O	O	O
wellbeing	O	O	B-T033
,	O	O	O
also	O	O	O
report	O	O	O
less	O	O	B-T080
burnout	O	O	B-T048
.	O	O	O

Greater	O	O	B-T081
compassion	O	O	B-T054
satisfaction	O	O	B-T041
was	O	O	O
also	O	O	O
positively	O	O	B-T033
associated	O	O	B-T080
with	O	O	I-T080
compassion	O	O	O
for	O	O	O
others	O	O	O
,	O	O	O
and	O	O	O
wellbeing	O	O	B-T033
,	O	O	O
whilst	O	O	O
also	O	O	O
being	O	O	O
negatively	O	O	B-T033
correlated	O	O	B-T080
with	O	O	O
burnout	O	O	B-T048
.	O	O	O

High	O	O	B-T080
levels	O	O	B-T080
of	O	O	O
self	O	O	B-T078
-	O	O	O
compassion	O	O	B-T054
were	O	O	O
linked	O	O	O
with	O	O	O
lower	O	O	B-T052
levels	O	O	O
of	O	O	O
burnout	O	O	B-T048
.	O	O	O

Furthermore	O	O	O
when	O	O	O
community	O	O	B-T097
nurses	O	O	I-T097
have	O	O	O
greater	O	O	B-T081
compassion	O	O	B-T054
satisfaction	O	O	B-T041
they	O	O	O
also	O	O	O
report	O	O	O
more	O	O	O
compassion	O	O	O
for	O	O	O
others	O	O	O
,	O	O	O
increased	O	O	B-T081
wellbeing	O	O	B-T033
,	O	O	O
and	O	O	O
less	O	O	B-T080
burnout	O	O	B-T048
.	O	O	O

The	O	O	O
implications	O	O	B-T169
of	O	O	O
this	O	O	O
are	O	O	O
discussed	O	O	O
alongside	O	O	O
suggestions	O	O	B-T078
for	O	O	O
the	O	O	O
promotion	O	O	B-T052
of	O	O	O
greater	O	O	B-T081
compassion	O	O	O

-DOCSTART- (27622027)

CD169	O	O	B-T116
identifies	O	O	B-T033
an	O	O	O
activated	O	O	B-T025
CD8(+	O	O	B-T025
)	O	O	I-T025
T	O	O	I-T025
cell	O	O	I-T025
subset	O	O	B-T185
in	O	O	O
regional	O	O	B-T023
lymph	O	O	I-T023
nodes	O	O	I-T023
that	O	O	O
predicts	O	O	B-T078
favorable	O	O	B-T080
prognosis	O	O	B-T058
in	O	O	O
colorectal	O	O	B-T191
cancer	O	O	I-T191
patients	O	O	O

CD169	O	O	B-T116
was	O	O	O
first	O	O	O
identified	O	O	O
on	O	O	O
macrophages	O	O	B-T025
(	O	O	O
MÏ	O	O	B-T025
)	O	O	O
and	O	O	O
linked	O	O	O
to	O	O	O
antigen	O	O	B-T043
presentation	O	O	I-T043
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
showed	O	O	O
CD169	O	O	B-T045
expression	O	O	I-T045
on	O	O	O
some	O	O	O
CD8(+	O	O	B-T025
)	O	O	I-T025
T	O	O	I-T025
lymphocytes	O	O	I-T025
in	O	O	O
regional	O	O	B-T023
lymph	O	O	I-T023
nodes	O	O	I-T023
(	O	O	O
LNs	O	O	B-T023
)	O	O	O
and	O	O	O
investigated	O	O	B-T169
the	O	O	O
function	O	O	B-T039
and	O	O	O
clinical	O	O	B-T033
relevance	O	O	I-T033
of	O	O	O
CD169(+)CD8(+	O	O	B-T025
)	O	O	I-T025
T	O	O	I-T025
cells	O	O	I-T025
in	O	O	O
tumor-draining	O	O	B-T023
LNs	O	O	I-T023
of	O	O	O
colorectal	O	O	B-T191
cancer	O	O	I-T191
(	O	O	O
CRC	O	O	B-T191
)	O	O	O
patients	O	O	B-T101
.	O	O	O

Fresh	O	O	B-T024
tumor-draining	O	O	I-T024
LN	O	O	I-T024
tissues	O	O	I-T024
from	O	O	O
39	O	O	O
randomly	O	O	B-T080
enrolled	O	O	B-T033
patients	O	O	I-T033
were	O	O	O
assessed	O	O	B-T052
by	O	O	O
flow	O	O	B-T059
cytometry	O	O	I-T059
for	O	O	O
activation	O	O	B-T025
and	O	O	O
differentiation	O	O	B-T043
of	O	O	O
CD169(+)CD8(+	O	O	B-T025
)	O	O	I-T025
T	O	O	I-T025
cells	O	O	I-T025
and	O	O	O
T	O	O	B-T043
cell-mediated	O	O	I-T043
killing	O	O	I-T043
of	O	O	I-T043
tumor	O	O	I-T043
cells	O	O	I-T043
.	O	O	O

In	O	O	O
total	O	O	O
,	O	O	O
114	O	O	O
tumor-draining	O	O	B-T023
LN	O	O	I-T023
paraffin	O	O	O
sections	O	O	O
from	O	O	O
CRC	O	O	B-T191
patients	O	O	B-T101
were	O	O	O
analyzed	O	O	O
by	O	O	O
multiple-color	O	O	B-T059
immunofluorescence	O	O	I-T059
for	O	O	O
CD169(+)CD8(+	O	O	B-T025
)	O	O	I-T025
T	O	O	I-T025
cell	O	O	I-T025
distribution	O	O	B-T169
and	O	O	O
clinical	O	O	O
values	O	O	O
.	O	O	O

The	O	O	O
prognostic	O	O	B-T170
significance	O	O	B-T080
of	O	O	O
CD169(+)CD8(+	O	O	B-T025
)	O	O	I-T025
T	O	O	I-T025
cells	O	O	I-T025
was	O	O	O
evaluated	O	O	B-T058
by	O	O	O
Kaplan-Meier	O	O	B-T081
analysis	O	O	I-T081
.	O	O	O

A	O	O	O
fraction	O	O	B-T081
of	O	O	I-T081
CD8(+	O	O	B-T025
)	O	O	I-T025
T	O	O	I-T025
cells	O	O	I-T025
in	O	O	O
regional	O	O	B-T023
LNs	O	O	I-T023
,	O	O	O
but	O	O	O
not	O	O	O
peripheral	O	O	B-T031
blood	O	O	I-T031
,	O	O	O
tonsils	O	O	B-T023
,	O	O	O
or	O	O	O
tumors	O	O	B-T191
,	O	O	O
expressed	O	O	B-T116
surface	O	O	I-T116
CD169	O	O	I-T116
.	O	O	O

In	O	O	B-T082
situ	O	O	I-T082
detection	O	O	B-T061
of	O	O	O
draining	O	O	B-T023
LNs	O	O	B-T023
revealed	O	O	B-T080
preferential	O	O	O
localization	O	O	B-T169
of	O	O	O
CD169(+)CD8(+	O	O	B-T025
)	O	O	I-T025
T	O	O	I-T025
cells	O	O	I-T025
to	O	O	O
subcapsular	O	O	B-T024
sinus	O	O	I-T024
and	O	O	O
interfollicular	O	O	B-T029
regions	O	O	I-T029
,	O	O	O
closely	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
CD169(+	O	O	O
)	O	O	O
MÏ.	O	O	O
CD169(+)CD8(+	O	O	B-T025
)	O	O	I-T025
T	O	O	I-T025
cell	O	O	I-T025
ratios	O	O	B-T081
were	O	O	O
significantly	O	O	O
lower	O	O	O
in	O	O	O
peri-tumor	O	O	B-T082
LNs	O	O	O
than	O	O	O
distant-tumor	O	O	B-T082
LNs	O	O	O
.	O	O	O

CD169(+)CD8(+	O	O	B-T025
)	O	O	I-T025
T	O	O	I-T025
cells	O	O	I-T025
predominantly	O	O	B-T080
expressed	O	O	O
activation	O	O	B-T201
markers	O	O	I-T201
(	O	O	O
CD69	O	O	B-T116
,	O	O	O
HLA-DR	O	O	B-T116
,	O	O	O
PD-1	O	O	B-T116
)	O	O	O
with	O	O	O
slightly	O	O	O
lower	O	O	O
CD45RA	O	O	B-T116
and	O	O	O
CD62L	O	O	B-T116
levels	O	O	B-T080
.	O	O	O

They	O	O	O
produced	O	O	O
high	O	O	B-T080
granzyme	O	O	B-T116
B	O	O	I-T116
,	O	O	O
perforin	O	O	B-T116
,	O	O	O
TNF-Î±	O	O	B-T116
,	O	O	O
and	O	O	O
IFNÎ³	O	O	B-T116
levels	O	O	B-T080
,	O	O	O
and	O	O	O
promoted	O	O	O
tumor-killing	O	O	B-T061
efficiency	O	O	I-T061
ex	O	O	B-T082
vitro	O	O	I-T082
.	O	O	O

Moreover	O	O	O
,	O	O	O
CD169(+)CD8(+	O	O	B-T025
)	O	O	I-T025
T	O	O	I-T025
cells	O	O	I-T025
infiltrating	O	O	B-T046
tumor-draining	O	O	B-T023
LNs	O	O	I-T023
decreased	O	O	B-T081
with	O	O	O
disease	O	O	B-T046
progression	O	O	I-T046
and	O	O	O
were	O	O	O
strongly	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
CRC	O	O	B-T191
patient	O	O	B-T101
survival	O	O	B-T052
.	O	O	O

We	O	O	O
identified	O	O	B-T080
novel	O	O	O
activated	O	O	B-T025
/	O	O	O
cytolytic	O	O	B-T025
CD169(+)CD8(+	O	O	I-T025
)	O	O	I-T025
T	O	O	I-T025
cells	O	O	I-T025
selectively	O	O	O
present	O	O	O
in	O	O	O
regional	O	O	B-T023
LNs	O	O	I-T023
,	O	O	O
potentially	O	O	O
serving	O	O	O
as	O	O	O
a	O	O	O
powerful	O	O	O
prognostic	O	O	B-T201
factor	O	O	I-T201
and	O	O	O
indicator	O	O	B-T169
for	O	O	O
selecting	O	O	B-T052
patients	O	O	B-T101
for	O	O	O
immunotherapy	O	O	B-T061
.	O	O	O

-DOCSTART- (27622771)

Appearance	O	O	B-T080
Differences	O	O	B-T080
Between	O	O	O
Lots	O	O	B-T170
and	O	O	O
Brands	O	O	B-T170
of	O	O	O
Similar	O	O	O
Shade	O	O	B-T080
Designations	O	O	B-T170
of	O	O	O
Dental	O	O	O
Composite	O	O	O
Resins	O	O	O

The	O	O	O
purposes	O	O	B-T169
of	O	O	O
this	O	O	O
study	O	O	B-T062
were	O	O	O
to	O	O	O
investigate	O	O	B-T169
differences	O	O	B-T080
in	O	O	O
two	O	O	O
inherent	O	O	B-T080
appearance	O	O	B-T080
characteristics	O	O	B-T080
between	O	O	O
lots	O	O	B-T170
of	O	O	O
an	O	O	O
enamel	O	O	B-T109
dental	O	O	I-T109
composite	O	O	I-T109
resin	O	O	I-T109
of	O	O	O
the	O	O	O
same	O	O	O
shade	O	O	B-T080
and	O	O	O
brand	O	O	B-T170
,	O	O	O
and	O	O	O
to	O	O	O
further	O	O	O
compare	O	O	B-T052
these	O	O	O
differences	O	O	O
to	O	O	O
those	O	O	O
of	O	O	O
similar	O	O	O
shade	O	O	O
designation	O	O	B-T170
of	O	O	O
a	O	O	O
different	O	O	B-T080
brand	O	O	O
of	O	O	O
dental	O	O	B-T109
composite	O	O	I-T109
resins	O	O	I-T109
.	O	O	O

Appearance	O	O	B-T080
analyses	O	O	B-T062
proceeded	O	O	B-T079
for	O	O	O
three	O	O	O
different	O	O	O
lots	O	O	B-T170
of	O	O	O
shades	O	O	B-T080
A1	O	O	B-T185
,	O	O	O
B2	O	O	B-T185
,	O	O	O
and	O	O	O
D3	O	O	B-T185
manufactured	O	O	B-T057
by	O	O	O
one	O	O	O
company	O	O	B-T073
and	O	O	O
for	O	O	O
one	O	O	O
lot	O	O	B-T170
of	O	O	O
shade	O	O	B-T080
EA1	O	O	B-T185
manufactured	O	O	O
by	O	O	O
another	O	O	O
.	O	O	O

Samples	O	O	B-T167
were	O	O	O
measured	O	O	B-T080
on	O	O	O
black	O	O	B-T080
,	O	O	O
white	O	O	B-T080
,	O	O	O
and	O	O	O
gray	O	O	B-T080
backings	O	O	B-T077
using	O	O	O
spectroradiometry	O	O	B-T059
.	O	O	O

Kubelka-Munk	O	O	B-T078
theory	O	O	I-T078
was	O	O	O
used	O	O	O
to	O	O	O
determine	O	O	O
reflectivity	O	O	B-T081
of	O	O	O
each	O	O	O
lot	O	O	B-T170
studied	O	O	B-T062
.	O	O	O

CIELAB	O	O	B-T080
values	O	O	I-T080
and	O	O	O
color	O	O	B-T080
differences	O	O	B-T080
between	O	O	O
shades	O	O	B-T080
and	O	O	O
lots	O	O	B-T170
were	O	O	O
analyzed	O	O	B-T062
.	O	O	O

Translucency	O	O	B-T080
indicators	O	O	B-T130
were	O	O	O
compared	O	O	B-T052
between	O	O	O
lots	O	O	B-T170
over	O	O	O
thicknesses	O	O	B-T080
from	O	O	O
0.5	O	O	O
to	O	O	O
3.0	O	O	O
mm	O	O	O
.	O	O	O

Differences	O	O	B-T080
in	O	O	O
inherent	O	O	B-T080
color	O	O	B-T080
between	O	O	O
some	O	O	O
lots	O	O	B-T170
of	O	O	O
same	O	O	O
shade	O	O	B-T080
designations	O	O	B-T170
within	O	O	O
a	O	O	O
brand	O	O	B-T170
were	O	O	O
found	O	O	O
to	O	O	O
be	O	O	O
above	O	O	O
the	O	O	O
acceptability	O	O	B-T080
threshold	O	O	B-T080
.	O	O	O

Color	O	O	B-T080
difference	O	O	B-T080
between	O	O	O
an	O	O	O
enamel	O	O	B-T109
composite	O	O	B-T109
resin	O	O	I-T109
of	O	O	O
shade	O	O	B-T080
A1	O	O	B-T185
and	O	O	O
a	O	O	O
composite	O	O	O
resin	O	O	O
of	O	O	O
shade	O	O	O
EA1	O	O	B-T185
was	O	O	O
also	O	O	O
above	O	O	O
the	O	O	O
acceptability	O	O	B-T080
threshold	O	O	B-T080
.	O	O	O

Statistically	O	O	B-T081
significant	O	O	I-T081
differences	O	O	B-T080
in	O	O	O
the	O	O	O
translucency	O	O	B-T080
were	O	O	O
found	O	O	O
between	O	O	O
some	O	O	O
lots	O	O	B-T170
of	O	O	O
one	O	O	O
shade	O	O	B-T080
over	O	O	O
the	O	O	O
entire	O	O	O
range	O	O	B-T081
of	O	O	O
thicknesses	O	O	B-T080
studied	O	O	B-T062
.	O	O	O

Appearance	O	O	B-T080
analyses	O	O	B-T062
indicate	O	O	B-T078
substantial	O	O	O
variation	O	O	B-T080
between	O	O	O
lots	O	O	B-T170
of	O	O	O
same	O	O	O
shade	O	O	B-T080
designations	O	O	B-T170
as	O	O	O
well	O	O	O
as	O	O	O
between	O	O	O
brands	O	O	B-T170
of	O	O	O
similar	O	O	O
shade	O	O	O
designations	O	O	O
.	O	O	O

Optical	O	O	B-T090
principles	O	O	O
applied	O	O	B-T169
to	O	O	O
important	O	O	B-T080
clinical	O	O	B-T080
appearance	O	O	B-T080
attributes	O	O	O
are	O	O	O
described	O	O	O
which	O	O	O
characterize	O	O	B-T052
inherent	O	O	B-T080
appearance	O	O	O
attributes	O	O	O
and	O	O	O
provide	O	O	O
aid	O	O	B-T080
in	O	O	O
the	O	O	O
appearance	O	O	O
matching	O	O	B-T080
process	O	O	B-T067
for	O	O	O
dental	O	O	B-T109
composite	O	O	I-T109
resins	O	O	I-T109
used	O	O	O
in	O	O	O
restorative	O	O	B-T061
and	O	O	O
operative	O	O	B-T061
dental	O	O	I-T061
procedures	O	O	I-T061
.	O	O	O

(	O	O	O
J	O	O	O
Esthet	O	O	O
Restor	O	O	O
Dent	O	O	O
29:E6-E14	O	O	O
,	O	O	O
2017	O	O	O
)	O	O	O
.	O	O	O

-DOCSTART- (27623277)

Patient	O	O	B-T080
Preferences	O	O	I-T080
in	O	O	O
Treatment	O	O	B-T061
Choices	O	O	B-T052
for	O	O	O
Early-Stage	O	O	B-T079
Lung	O	O	O
Cancer	O	O	O

Decision-making	O	O	B-T041
for	O	O	O
lung	O	O	B-T191
cancer	O	O	I-T191
treatment	O	O	B-T061
can	O	O	O
be	O	O	O
complex	O	O	B-T080
because	O	O	O
it	O	O	O
involves	O	O	O
both	O	O	O
provider	O	O	B-T097
recommendations	O	O	B-T078
based	O	O	O
on	O	O	O
the	O	O	O
patient	O	O	B-T101
's	O	O	I-T101
clinical	O	O	B-T080
condition	O	O	B-T080
and	O	O	O
patient	O	O	B-T080
preferences	O	O	I-T080
.	O	O	O

This	O	O	O
study	O	O	B-T062
describes	O	O	O
the	O	O	O
relative	O	O	O
importance	O	O	O
of	O	O	O
several	O	O	O
considerations	O	O	B-T033
in	O	O	O
lung	O	O	B-T191
cancer	O	O	I-T191
treatment	O	O	B-T061
from	O	O	O
the	O	O	O
patient	O	O	B-T101
's	O	O	I-T101
perspective	O	O	B-T041
.	O	O	O

A	O	O	O
conjoint	O	O	B-T062
preference	O	O	I-T062
experiment	O	O	I-T062
began	O	O	O
by	O	O	O
asking	O	O	O
respondents	O	O	B-T098
to	O	O	O
imagine	O	O	O
that	O	O	O
they	O	O	O
had	O	O	O
just	O	O	O
been	O	O	O
diagnosed	O	O	B-T033
with	O	O	O
lung	O	O	B-T191
cancer	O	O	I-T191
.	O	O	O

Respondents	O	O	B-T098
then	O	O	O
chose	O	O	B-T052
among	O	O	O
procedures	O	O	B-T061
that	O	O	O
differed	O	O	O
regarding	O	O	O
treatment	O	O	B-T061
modalities	O	O	B-T077
,	O	O	O
the	O	O	O
potential	O	O	O
for	O	O	O
treatment	O	O	O
-related	O	O	O
complications	O	O	B-T046
,	O	O	O
the	O	O	O
likelihood	O	O	B-T081
of	O	O	O
recurrence	O	O	B-T067
,	O	O	O
provider	O	O	B-T097
case	O	O	B-T169
volume	O	O	B-T081
,	O	O	O
and	O	O	O
distance	O	O	B-T081
needed	O	O	B-T169
to	O	O	O
travel	O	O	B-T056
for	O	O	O
treatment	O	O	O
.	O	O	O

Conjoint	O	O	B-T062
analysis	O	O	I-T062
derived	O	O	O
relative	O	O	O
weights	O	O	O
for	O	O	O
these	O	O	O
attributes	O	O	B-T080
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
225	O	O	O
responses	O	O	B-T170
were	O	O	O
analyzed	O	O	B-T062
.	O	O	O

Respondents	O	O	B-T098
were	O	O	O
most	O	O	O
willing	O	O	O
to	O	O	O
accept	O	O	O
minimally	O	O	B-T080
invasive	O	O	B-T061
operations	O	O	I-T061
for	O	O	O
treatment	O	O	B-T061
of	O	O	O
their	O	O	O
hypothetical	O	O	O
lung	O	O	B-T191
cancer	O	O	I-T191
,	O	O	O
followed	O	O	O
by	O	O	O
stereotactic	O	O	B-T061
body	O	O	I-T061
radiation	O	O	I-T061
therapy	O	O	I-T061
(	O	O	O
SBRT	O	O	B-T061
)	O	O	O
;	O	O	O
they	O	O	O
were	O	O	O
least	O	O	O
willing	O	O	O
to	O	O	O
accept	O	O	O
thoracotomy	O	O	B-T061
.	O	O	O

Treatment	O	O	B-T061
type	O	O	O
and	O	O	O
risk	O	O	B-T078
of	O	O	I-T081
recurrence	O	O	I-T081
were	O	O	O
the	O	O	O
most	O	O	O
important	O	O	O
attributes	O	O	B-T080
from	O	O	O
the	O	O	O
conjoint	O	O	B-T062
experiment	O	O	I-T062
(	O	O	O
each	O	O	O
with	O	O	O
a	O	O	O
relative	O	O	O
weight	O	O	O
of	O	O	O
0.23	O	O	O
)	O	O	O
,	O	O	O
followed	O	O	O
by	O	O	O
provider	O	O	B-T097
volume	O	O	B-T081
(	O	O	O
relative	O	O	O
weight	O	O	O
of	O	O	O
0.21	O	O	O
)	O	O	O
,	O	O	O
risk	O	O	O
of	O	O	O
major	O	O	O
complications	O	O	B-T046
(	O	O	O
relative	O	O	O
weight	O	O	O
of	O	O	O
0.18	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
distance	O	O	B-T081
needed	O	O	B-T169
to	O	O	O
travel	O	O	B-T056
for	O	O	O
treatment	O	O	B-T061
(	O	O	O
relative	O	O	O
weight	O	O	O
of	O	O	O
0.15	O	O	O
)	O	O	O
.	O	O	O

Procedural	O	O	B-T061
and	O	O	O
treatment	O	O	B-T061
preferences	O	O	B-T078
did	O	O	O
not	O	O	O
vary	O	O	O
with	O	O	O
demographics	O	O	B-T080
,	O	O	O
self-reported	O	O	B-T062
health	O	O	B-T080
status	O	O	I-T080
,	O	O	O
or	O	O	O
familiarity	O	O	B-T041
with	O	O	O
the	O	O	O
procedures	O	O	B-T061
.	O	O	O

Survey	O	O	B-T170
respondents	O	O	B-T098
preferred	O	O	O
minimally	O	O	B-T080
invasive	O	O	B-T061
operations	O	O	I-T061
over	O	O	O
SBRT	O	O	B-T061
or	O	O	O
thoracotomy	O	O	B-T061
for	O	O	O
treatment	O	O	B-T061
of	O	O	O
early-stage	O	O	B-T079
non-small	O	O	B-T191
cell	O	O	I-T191
lung	O	O	I-T191
cancer	O	O	I-T191
.	O	O	O

Treatment	O	O	B-T061
modality	O	O	B-T077
and	O	O	O
risk	O	O	B-T078
of	O	O	O
cancer	O	O	B-T191
recurrence	O	O	I-T191
were	O	O	O
the	O	O	O
most	O	O	O
important	O	O	O
factors	O	O	O
associated	O	O	O
with	O	O	O
treatment	O	O	B-T061
preferences	O	O	B-T078
.	O	O	O

Provider	O	O	B-T097
experience	O	O	B-T041
outweighed	O	O	O
the	O	O	O
potential	O	O	O
need	O	O	B-T169
to	O	O	O
travel	O	O	B-T056
for	O	O	O
lung	O	O	B-T191
cancer	O	O	I-T191
treatment	O	O	B-T061
.	O	O	O

-DOCSTART- (27629431)

Suppressed	O	O	B-T169
translation	O	O	B-T044
and	O	O	O
ULK1	O	O	B-T116
degradation	O	O	B-T044
as	O	O	O
potential	O	O	B-T080
mechanisms	O	O	B-T169
of	O	O	O
autophagy	O	O	B-T043
limitation	O	O	O
under	O	O	O
prolonged	O	O	B-T079
starvation	O	O	O

Macroautophagy	O	O	B-T043
/	O	O	O
autophagy	O	O	B-T043
is	O	O	O
a	O	O	O
well-organized	O	O	O
process	O	O	O
of	O	O	O
intracellular	O	O	B-T043
degradation	O	O	I-T043
,	O	O	O
which	O	O	O
is	O	O	O
rapidly	O	O	O
activated	O	O	B-T052
under	O	O	O
starvation	O	O	B-T033
conditions	O	O	O
.	O	O	O

Recent	O	O	O
data	O	O	B-T078
demonstrate	O	O	O
a	O	O	O
transcriptional	O	O	B-T045
upregulation	O	O	B-T044
of	O	O	O
several	O	O	O
autophagy	O	O	B-T043
genes	O	O	B-T028
as	O	O	O
a	O	O	O
mechanism	O	O	B-T169
that	O	O	O
controls	O	O	B-T169
autophagy	O	O	O
in	O	O	O
response	O	O	O
to	O	O	O
starvation	O	O	B-T033
.	O	O	O

Here	O	O	O
we	O	O	O
report	O	O	O
that	O	O	O
despite	O	O	O
the	O	O	O
significant	O	O	O
upregulation	O	O	B-T044
of	O	O	O
mRNA	O	O	B-T114
of	O	O	O
the	O	O	O
essential	O	O	O
autophagy	O	O	B-T043
initiation	O	O	B-T028
gene	O	O	I-T028
ULK1	O	O	B-T028
,	O	O	O
its	O	O	O
protein	O	O	B-T116
level	O	O	B-T080
is	O	O	O
rapidly	O	O	O
reduced	O	O	B-T080
under	O	O	O
starvation	O	O	B-T033
.	O	O	O

Although	O	O	O
both	O	O	O
autophagic	O	O	B-T043
and	O	O	O
proteasomal	O	O	B-T116
systems	O	O	I-T116
contribute	O	O	O
to	O	O	O
the	O	O	O
degradation	O	O	B-T044
of	O	O	O
ULK1	O	O	B-T116
,	O	O	O
under	O	O	O
prolonged	O	O	B-T079
nitrogen	O	O	B-T123
deprivation	O	O	B-T080
,	O	O	O
its	O	O	O
level	O	O	B-T080
was	O	O	O
still	O	O	O
reduced	O	O	B-T080
in	O	O	O
ATG7	O	O	B-T028
knockout	O	O	B-T025
cells	O	O	B-T025
,	O	O	O
and	O	O	O
only	O	O	O
initially	O	O	O
stabilized	O	O	O
in	O	O	O
cells	O	O	O
treated	O	O	B-T169
with	O	O	O
the	O	O	O
lysosomal	O	O	B-T026
or	O	O	O
proteasomal	O	O	B-T121
inhibitors	O	O	I-T121
.	O	O	O

We	O	O	O
demonstrate	O	O	O
that	O	O	O
under	O	O	O
starvation	O	O	B-T033
,	O	O	O
protein	O	O	B-T044
translation	O	O	I-T044
is	O	O	O
rapidly	O	O	O
diminished	O	O	B-T081
and	O	O	O
,	O	O	O
similar	O	O	O
to	O	O	O
treatments	O	O	B-T061
with	O	O	O
the	O	O	O
proteosynthesis	O	O	B-T121
inhibitors	O	O	I-T121
cycloheximide	O	O	B-T195
or	O	O	O
anisomycin	O	O	B-T195
,	O	O	O
is	O	O	O
associated	O	O	O
with	O	O	O
a	O	O	O
significant	O	O	O
reduction	O	O	B-T080
of	O	O	O
ULK1	O	O	B-T116
.	O	O	O

Furthermore	O	O	O
,	O	O	O
it	O	O	O
was	O	O	O
found	O	O	O
that	O	O	O
inhibition	O	O	B-T052
of	O	O	O
the	O	O	O
mitochondrial	O	O	B-T026
respiratory	O	O	B-T026
complexes	O	O	I-T026
or	O	O	O
the	O	O	O
mitochondrial	O	O	O
ATP	O	O	B-T044
synthase	O	O	I-T044
function	O	O	I-T044
that	O	O	O
could	O	O	O
also	O	O	O
take	O	O	O
place	O	O	O
in	O	O	O
the	O	O	O
absence	O	O	B-T169
of	O	O	O
substrates	O	O	B-T167
,	O	O	O
promote	O	O	O
upregulation	O	O	B-T044
of	O	O	O
ULK1	O	O	B-T114
mRNA	O	O	I-T114
and	O	O	O
protein	O	O	B-T045
expression	O	O	I-T045
in	O	O	O
an	O	O	O
AMPK	O	O	B-T116
-	O	O	O
dependent	O	O	B-T169
manner	O	O	O
in	O	O	O
U1810	O	O	B-T025
lung	O	O	I-T025
cancer	O	O	I-T025
cells	O	O	I-T025
growing	O	O	O
in	O	O	O
complete	O	O	O
culture	O	O	B-T130
medium	O	O	I-T130
.	O	O	O

These	O	O	O
inhibitors	O	O	B-T080
could	O	O	O
also	O	O	O
drastically	O	O	O
increase	O	O	B-T169
the	O	O	O
ULK1	O	O	B-T116
protein	O	O	I-T116
in	O	O	O
U1810	O	O	B-T025
cells	O	O	I-T025
with	O	O	O
knockout	O	O	O
of	O	O	O
ATG13	O	O	B-T028
,	O	O	O
where	O	O	O
the	O	O	O
ULK1	O	O	O
expression	O	O	B-T045
is	O	O	O
significantly	O	O	O
diminished	O	O	B-T081
.	O	O	O

However	O	O	O
,	O	O	O
such	O	O	O
upregulation	O	O	B-T044
of	O	O	O
ULK1	O	O	B-T116
protein	O	O	I-T116
is	O	O	O
negligible	O	O	O
under	O	O	O
starvation	O	O	B-T033
conditions	O	O	O
,	O	O	O
further	O	O	O
signifying	O	O	O
the	O	O	O
contribution	O	O	O
of	O	O	O
translation	O	O	B-T044
and	O	O	O
suggesting	O	O	O
that	O	O	O
transcriptional	O	O	B-T045
upregulation	O	O	O
of	O	O	O
ULK1	O	O	O
protein	O	O	O
will	O	O	O
be	O	O	O
diminished	O	O	B-T081
under	O	O	O
such	O	O	O
conditions	O	O	O
.	O	O	O

Thus	O	O	O
,	O	O	O
we	O	O	O
propose	O	O	O
a	O	O	O
model	O	O	B-T075
where	O	O	O
inhibition	O	O	B-T052
of	O	O	O
protein	O	O	B-T044
translation	O	O	I-T044
,	O	O	O
together	O	O	O
with	O	O	O
the	O	O	O
degradation	O	O	B-T044
systems	O	O	O
,	O	O	O
limit	O	O	O
autophagy	O	O	B-T043
during	O	O	O
starvation	O	O	B-T033
.	O	O	O

-DOCSTART- (27631550)

Neuroprotective	O	O	B-T169
Role	O	O	I-T169
of	O	O	O
MicroRNA-22	O	O	B-T028
in	O	O	O
a	O	O	O
6-Hydroxydopamine	O	O	B-T109
-	O	O	O
Induced	O	O	B-T169
Cell	O	O	B-T025
Model	O	O	B-T050
of	O	O	O
Parkinson	O	O	B-T047
's	O	O	I-T047
Disease	O	O	I-T047
via	O	O	O
Regulation	O	O	B-T045
of	O	O	O
Its	O	O	O
Target	O	O	B-T169
Gene	O	O	B-T028
TRPM7	O	O	O

Parkinson	O	O	B-T047
's	O	O	I-T047
disease	O	O	I-T047
(	O	O	O
PD	O	O	B-T047
)	O	O	O
,	O	O	O
the	O	O	O
second	O	O	O
most	O	O	O
prevalent	O	O	B-T082
neurodegenerative	O	O	B-T047
disorder	O	O	I-T047
with	O	O	O
only	O	O	O
symptomatic	O	O	B-T169
treatment	O	O	B-T061
available	O	O	B-T169
,	O	O	O
is	O	O	O
characterized	O	O	B-T052
by	O	O	O
a	O	O	O
progressive	O	O	B-T169
loss	O	O	B-T081
of	O	O	O
dopaminergic	O	O	B-T025
neurons	O	O	I-T025
in	O	O	O
the	O	O	O
midbrain	O	O	B-T023
.	O	O	O

Ample	O	O	O
evidence	O	O	O
indicated	O	O	O
that	O	O	O
microRNAs	O	O	B-T114
(	O	O	O
miRs	O	O	B-T114
)	O	O	O
could	O	O	O
regulate	O	O	B-T045
post-transcriptional	O	O	I-T045
gene	O	O	B-T045
expression	O	O	I-T045
and	O	O	O
neuronal	O	O	B-T047
disease	O	O	I-T047
.	O	O	O

In	O	O	O
the	O	O	O
present	O	O	O
study	O	O	B-T062
,	O	O	O
we	O	O	O
have	O	O	O
evaluated	O	O	O
the	O	O	O
effects	O	O	B-T080
and	O	O	O
mechanism	O	O	B-T169
of	O	O	O
miR-22	O	O	B-T028
in	O	O	O
PC12	O	O	B-T025
pheochromocytoma	O	O	I-T025
cells	O	O	I-T025
treated	O	O	B-T169
with	O	O	O
6-hydroxydopamine	O	O	B-T109
(	O	O	O
6-OHDA	O	O	B-T109
)	O	O	O
to	O	O	O
mimic	O	O	O
PD	O	O	B-T047
.	O	O	O

RT-PCR	O	O	B-T063
results	O	O	B-T169
showed	O	O	O
that	O	O	O
the	O	O	O
expression	O	O	B-T045
of	O	O	O
miR-22	O	O	B-T028
is	O	O	O
downregulated	O	O	B-T044
in	O	O	O
6-OHDA	O	O	B-T109
-	O	O	O
treated	O	O	B-T169
PC12	O	O	B-T025
cells	O	O	I-T025
,	O	O	O
and	O	O	O
the	O	O	O
overexpression	O	O	B-T045
of	O	O	O
miR-22	O	O	O
significantly	O	O	O
promoted	O	O	B-T052
the	O	O	O
survival	O	O	B-T043
and	O	O	O
proliferation	O	O	B-T043
of	O	O	O
6-OHDA	O	O	O
-	O	O	O
induced	O	O	B-T169
PC12	O	O	O
cells	O	O	O
,	O	O	O
whereas	O	O	O
miR-22	O	O	O
inhibitor	O	O	B-T080
reversed	O	O	B-T169
these	O	O	O
effects	O	O	B-T080
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
PC12	O	O	B-T025
cells	O	O	I-T025
were	O	O	O
treated	O	O	B-T169
with	O	O	O
miR-22	O	O	B-T028
mimics	O	O	I-T028
or	O	O	O
inhibitor	O	O	B-T080
following	O	O	B-T079
6-OHDA	O	O	B-T109
administration	O	O	B-T061
,	O	O	O
which	O	O	O
medicated	O	O	O
ROS	O	O	B-T123
production	O	O	B-T044
and	O	O	O
upregulation	O	O	B-T044
or	O	O	O
downregulation	O	O	B-T044
of	O	O	O
caspase-3	O	O	B-T044
activity	O	O	I-T044
,	O	O	O
respectively	O	O	O
.	O	O	O

A	O	O	O
luciferase	O	O	B-T116
reporter	O	O	O
assay	O	O	B-T059
revealed	O	O	B-T080
that	O	O	O
transient	O	O	B-T028
receptor	O	O	I-T028
potential	O	O	I-T028
melastatin	O	O	I-T028
7	O	O	I-T028
(	O	O	O
TRPM7	O	O	B-T028
)	O	O	O
is	O	O	O
a	O	O	O
direct	O	O	B-T080
target	O	O	B-T169
gene	O	O	B-T028
of	O	O	O
miR-22	O	O	B-T028
,	O	O	O
and	O	O	O
miR-22	O	O	O
overexpression	O	O	B-T045
markedly	O	O	O
downregulated	O	O	B-T044
the	O	O	O
level	O	O	B-T080
of	O	O	O
TRPM7	O	O	O
.	O	O	O

Strikingly	O	O	O
,	O	O	O
further	O	O	O
analysis	O	O	B-T062
showed	O	O	O
that	O	O	O
miR-22	O	O	B-T028
mediated	O	O	O
6-OHDA	O	O	B-T109
-	O	O	O
induced	O	O	B-T169
PC12	O	O	B-T025
cell	O	O	B-T043
survival	O	O	I-T043
and	O	O	O
proliferation	O	O	B-T043
by	O	O	O
targeting	O	O	B-T169
TRPM7	O	O	B-T028
.	O	O	O

Taken	O	O	O
together	O	O	O
,	O	O	O
the	O	O	O
present	O	O	O
study	O	O	B-T062
showed	O	O	O
that	O	O	O
miR-22	O	O	B-T028
overexpression	O	O	B-T045
exhibited	O	O	O
neuroprotective	O	O	B-T169
and	O	O	O
reversal	O	O	B-T169
effects	O	O	B-T080
on	O	O	O
the	O	O	O
6-OHDA	O	O	B-T109
-	O	O	O
induced	O	O	B-T169
PC12	O	O	B-T025
cell	O	O	B-T043
growth	O	O	I-T043
and	O	O	O
apoptosis	O	O	B-T043
by	O	O	O
targeting	O	O	B-T169
TRPM7	O	O	B-T028
.	O	O	O

-DOCSTART- (27633344)

Obstacle	O	O	B-T056
course	O	O	I-T056
runs	O	O	I-T056
:	O	O	O
review	O	O	B-T170
of	O	O	O
acquired	O	O	O
injuries	O	O	B-T037
and	O	O	O
illnesses	O	O	B-T184
at	O	O	O
a	O	O	O
series	O	O	B-T081
of	O	O	O
Canadian	O	O	B-T033
events	O	O	B-T051
(	O	O	O
RACE	O	O	B-T056
)	O	O	O

The	O	O	O
growing	O	O	O
popularity	O	O	O
of	O	O	O
obstacle	O	O	B-T056
course	O	O	I-T056
runs	O	O	I-T056
(	O	O	O
OCRs	O	O	B-T056
)	O	O	O
has	O	O	O
led	O	O	O
to	O	O	O
significant	O	O	B-T078
concerns	O	O	B-T078
regarding	O	O	O
their	O	O	O
safety	O	O	B-T068
.	O	O	O

The	O	O	O
influx	O	O	O
of	O	O	O
injuries	O	O	B-T037
and	O	O	O
illnesses	O	O	B-T184
in	O	O	O
rural	O	O	B-T082
areas	O	O	I-T082
where	O	O	O
OCRs	O	O	B-T056
are	O	O	O
often	O	O	O
held	O	O	O
can	O	O	O
impose	O	O	O
a	O	O	O
large	O	O	O
burden	O	O	O
on	O	O	O
emergency	O	O	B-T058
medical	O	O	I-T058
services	O	O	I-T058
(	O	O	O
EMS	O	O	B-T058
)	O	O	O
and	O	O	O
local	O	O	O
EDs	O	O	O
.	O	O	O

Literature	O	O	B-T170
concerning	O	O	B-T078
the	O	O	O
safety	O	O	B-T068
of	O	O	O
these	O	O	O
events	O	O	B-T051
is	O	O	O
minimal	O	O	B-T080
and	O	O	O
mostly	O	O	O
consists	O	O	O
of	O	O	O
media	O	O	B-T170
reports	O	O	B-T170
.	O	O	O

We	O	O	O
sought	O	O	O
to	O	O	O
characterise	O	O	B-T052
the	O	O	O
injury	O	O	B-T037
and	O	O	O
illness	O	O	B-T184
profile	O	O	O
of	O	O	O
OCRs	O	O	B-T056
and	O	O	O
the	O	O	O
level	O	O	B-T080
of	O	O	O
medical	O	O	B-T061
care	O	O	I-T061
required	O	O	O
.	O	O	O

This	O	O	O
study	O	O	B-T062
analysed	O	O	B-T062
OCR	O	O	B-T056
events	O	O	B-T051
occurring	O	O	O
in	O	O	O
eight	O	O	O
locations	O	O	O
across	O	O	O
Canada	O	O	B-T083
from	O	O	O
May	O	O	O
to	O	O	O
August	O	O	O
2015	O	O	O
(	O	O	O
total	O	O	O
45	O	O	O
285	O	O	O
participants	O	O	B-T098
)	O	O	O
.	O	O	O

Data	O	O	B-T078
were	O	O	O
extracted	O	O	B-UnknownType
from	O	O	O
event	O	O	B-T051
medical	O	O	B-T074
charts	O	O	I-T074
of	O	O	O
patients	O	O	B-T101
presenting	O	O	O
to	O	O	O
the	O	O	O
onsite	O	O	B-T082
medical	O	O	B-T058
team	O	O	I-T058
,	O	O	O
including	O	O	O
injury	O	O	B-T037
or	O	O	O
illness	O	O	B-T184
type	O	O	O
,	O	O	O
onsite	O	O	O
treatment	O	O	B-T061
and	O	O	O
disposition	O	O	B-T078
.	O	O	O

There	O	O	O
were	O	O	O
557	O	O	O
race	O	O	B-T098
participants	O	O	B-T098
treated	O	O	B-T169
at	O	O	O
eight	O	O	O
OCR	O	O	B-T056
events	O	O	B-T051
(	O	O	O
1.2	O	O	O
%	O	O	O
of	O	O	O
all	O	O	O
participants	O	O	O
)	O	O	O
.	O	O	O

There	O	O	O
were	O	O	O
609	O	O	O
medical	O	O	B-T170
complaints	O	O	I-T170
in	O	O	O
total	O	O	O
.	O	O	O

Three	O	O	O
quarters	O	O	O
of	O	O	O
injuries	O	O	B-T037
were	O	O	O
musculoskeletal	O	O	B-T169
in	O	O	O
nature	O	O	O
.	O	O	O

Eighty-nine	O	O	O
per	O	O	O
cent	O	O	O
returned	O	O	O
to	O	O	O
the	O	O	O
event	O	O	B-T051
with	O	O	O
no	O	O	O
need	O	O	O
for	O	O	O
further	O	O	O
medical	O	O	B-T061
care	O	O	I-T061
.	O	O	O

The	O	O	O
majority	O	O	O
of	O	O	O
treatments	O	O	B-T061
were	O	O	O
completed	O	O	O
with	O	O	O
first	O	O	B-T061
aid	O	O	I-T061
and	O	O	O
basic	O	O	O
medical	O	O	B-T074
equipment	O	O	I-T074
.	O	O	O

Eleven	O	O	O
patients	O	O	B-T101
(	O	O	O
2	O	O	O
%	O	O	O
of	O	O	O
patients	O	O	O
)	O	O	O
required	O	O	O
transfer	O	O	O
to	O	O	O
hospital	O	O	B-T093
by	O	O	O
EMS	O	O	B-T058
for	O	O	O
presentations	O	O	O
including	O	O	O
fracture	O	O	B-T037
,	O	O	O
dislocation	O	O	B-T037
,	O	O	O
head	O	O	B-T037
injury	O	O	I-T037
,	O	O	O
chest	O	O	B-T184
pain	O	O	I-T184
,	O	O	O
fall	O	O	B-T067
from	O	O	I-T067
height	O	O	I-T067
,	O	O	O
and	O	O	O
abdominal	O	O	B-T184
pain	O	O	I-T184
.	O	O	O

We	O	O	O
found	O	O	O
that	O	O	O
1.2	O	O	O
%	O	O	O
of	O	O	O
race	O	O	B-T098
participants	O	O	I-T098
presented	O	O	O
to	O	O	O
onsite	O	O	O
medical	O	O	B-T058
services	O	O	I-T058
.	O	O	O

The	O	O	O
majority	O	O	O
of	O	O	O
complaints	O	O	O
were	O	O	O
minor	O	O	B-T037
and	O	O	O
musculoskeletal	O	O	B-T037
in	O	O	O
nature	O	O	O
.	O	O	O

Only	O	O	O
2	O	O	O
%	O	O	O
of	O	O	O
those	O	O	O
treated	O	O	B-T169
were	O	O	O
transferred	O	O	O
to	O	O	O
hospital	O	O	B-T093
through	O	O	O
EMS	O	O	B-T058
.	O	O	O

This	O	O	O
is	O	O	O
consistent	O	O	B-T078
with	O	O	I-T078
other	O	O	O
types	O	O	O
of	O	O	O
mass	O	O	B-T033
gathering	O	O	I-T033
events	O	O	B-T051
.	O	O	O

-DOCSTART- (27634305)

Is	O	O	O
Modern	O	O	B-T079
Medical	O	O	B-T058
Management	O	O	I-T058
Changing	O	O	B-T169
Ultimate	O	O	O
Patient	O	O	B-T078
Outcomes	O	O	I-T078
in	O	O	O
Inflammatory	O	O	B-T047
Bowel	O	O	I-T047
Disease	O	O	I-T047
?	O	O	O

The	O	O	O
impact	O	O	B-T080
of	O	O	O
modern	O	O	B-T079
medical	O	O	B-T058
management	O	O	I-T058
of	O	O	O
inflammatory	O	O	B-T047
bowel	O	O	I-T047
disease	O	O	I-T047
(	O	O	O
IBD	O	O	B-T047
)	O	O	O
on	O	O	O
surgical	O	O	B-T058
necessity	O	O	I-T058
and	O	O	O
outcomes	O	O	B-T169
remains	O	O	O
unclear	O	O	B-T033
.	O	O	O

We	O	O	O
hypothesized	O	O	O
that	O	O	O
surgery	O	O	B-T061
rates	O	O	B-T081
have	O	O	O
decreased	O	O	B-T081
while	O	O	O
outcomes	O	O	B-T169
have	O	O	O
worsened	O	O	B-T033
due	O	O	O
to	O	O	O
operating	O	O	B-T061
on	O	O	O
"	O	O	O
sicker	O	O	B-T184
"	O	O	O
patients	O	O	B-T101
since	O	O	O
the	O	O	O
introduction	O	O	B-T169
of	O	O	O
biologic	O	O	B-T061
medications	O	O	I-T061
.	O	O	O

The	O	O	O
Nationwide	O	O	O
Inpatient	O	O	B-T101
Sample	O	O	B-T167
and	O	O	O
ICD-9-CM	O	O	B-T170
codes	O	O	I-T170
were	O	O	O
used	O	O	O
to	O	O	O
identify	O	O	O
inpatient	O	O	B-T101
admissions	O	O	B-T058
for	O	O	O
Crohn	O	O	B-T047
's	O	O	I-T047
disease	O	O	I-T047
and	O	O	O
ulcerative	O	O	B-T047
colitis	O	O	I-T047
.	O	O	O

Trends	O	O	B-T079
in	O	O	O
IBD	O	O	B-T047
nutrition	O	O	B-T033
,	O	O	O
surgeries	O	O	B-T061
,	O	O	O
and	O	O	O
postoperative	O	O	B-T046
complications	O	O	I-T046
were	O	O	O
determined	O	O	O
.	O	O	O

There	O	O	O
were	O	O	O
191,743	O	O	O
admissions	O	O	B-T058
for	O	O	O
IBD	O	O	B-T047
during	O	O	O
the	O	O	O
study	O	O	B-T062
period	O	O	B-T079
.	O	O	O

Surgery	O	O	B-T061
rates	O	O	B-T081
were	O	O	O
largely	O	O	O
unchanged	O	O	B-T033
over	O	O	O
the	O	O	O
study	O	O	B-T062
period	O	O	B-T079
,	O	O	O
ranging	O	O	O
from	O	O	O
9	O	O	O
to	O	O	O
12	O	O	O
%	O	O	O
of	O	O	O
admissions	O	O	B-T058
in	O	O	O
both	O	O	O
Crohn	O	O	B-T047
's	O	O	I-T047
disease	O	O	I-T047
and	O	O	O
ulcerative	O	O	B-T047
colitis	O	O	I-T047
.	O	O	O

The	O	O	O
rate	O	O	B-T081
of	O	O	O
poor	O	O	B-T047
nutrition	O	O	I-T047
increased	O	O	B-T081
by	O	O	O
67	O	O	O
%	O	O	O
in	O	O	O
ulcerative	O	O	B-T047
colitis	O	O	I-T047
and	O	O	O
by	O	O	O
83	O	O	O
%	O	O	O
in	O	O	O
Crohn	O	O	B-T047
's	O	O	I-T047
disease	O	O	I-T047
.	O	O	O

Rates	O	O	B-T081
of	O	O	O
postoperative	O	O	B-T079
anastomotic	O	O	B-T046
leak	O	O	I-T046
(	O	O	O
10.2	O	O	O
-	O	O	O
13.9	O	O	O
%	O	O	O
)	O	O	O
were	O	O	O
unchanged	O	O	B-T033
over	O	O	O
the	O	O	O
years	O	O	O
.	O	O	O

Postoperative	O	O	B-T046
infection	O	O	I-T046
rates	O	O	B-T081
decreased	O	O	B-T081
by	O	O	O
17	O	O	O
%	O	O	O
in	O	O	O
Crohn	O	O	B-T047
's	O	O	I-T047
disease	O	O	I-T047
(	O	O	O
18	O	O	O
%	O	O	O
in	O	O	O
2003	O	O	O
to	O	O	O
15	O	O	O
%	O	O	O
in	O	O	O
2012	O	O	O
;	O	O	O
P	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
but	O	O	O
did	O	O	O
not	O	O	O
show	O	O	O
a	O	O	O
trend	O	O	B-T033
in	O	O	O
any	O	O	O
direction	O	O	O
in	O	O	O
ulcerative	O	O	B-T047
colitis	O	O	I-T047
.	O	O	O

Rates	O	O	B-T081
of	O	O	O
IBD	O	O	B-T047
surgery	O	O	B-T091
have	O	O	O
remained	O	O	O
stable	O	O	B-T080
while	O	O	O
postoperative	O	O	B-T046
infectious	O	O	I-T046
complications	O	O	I-T046
have	O	O	O
remained	O	O	O
stable	O	O	O
or	O	O	O
decreased	O	O	B-T081
since	O	O	O
the	O	O	O
implementation	O	O	B-T058
of	O	O	O
biologic	O	O	B-T061
therapies	O	O	I-T061
.	O	O	O

We	O	O	O
identified	O	O	O
an	O	O	O
increase	O	O	B-T169
in	O	O	O
poor	O	O	B-T047
nutrition	O	O	I-T047
in	O	O	O
surgical	O	O	B-T101
patients	O	O	I-T101
.	O	O	O

-DOCSTART- (27635073)

Clinical	O	O	B-T080
Experience	O	O	B-T067
With	O	O	O
the	O	O	O
Subcutaneous	O	O	B-T074
Implantable	O	O	I-T074
Cardioverter-Defibrillator	O	O	I-T074
in	O	O	O
Adults	O	O	B-T100
With	O	O	O
Congenital	O	O	O
Heart	O	O	O
Disease	O	O	O

Sudden	O	O	B-T046
cardiac	O	O	I-T046
death	O	O	I-T046
is	O	O	O
a	O	O	O
major	O	O	O
contributor	O	O	O
to	O	O	O
mortality	O	O	B-T081
for	O	O	O
adults	O	O	B-T100
with	O	O	O
congenital	O	O	B-T019
heart	O	O	I-T019
disease	O	O	I-T019
.	O	O	O

The	O	O	O
subcutaneous	O	O	B-T082
implantable	O	O	B-T074
cardioverter-defibrillator	O	O	I-T074
(	O	O	O
ICD	O	O	B-T074
)	O	O	O
has	O	O	O
emerged	O	O	O
as	O	O	O
a	O	O	O
novel	O	O	B-T080
tool	O	O	B-T073
for	O	O	O
prevention	O	O	B-T080
of	O	O	O
sudden	O	O	B-T046
cardiac	O	O	I-T046
death	O	O	I-T046
,	O	O	O
but	O	O	O
clinical	O	O	B-T033
performance	O	O	I-T033
data	O	O	B-T078
for	O	O	O
adults	O	O	B-T100
with	O	O	O
congenital	O	O	B-T019
heart	O	O	I-T019
disease	O	O	I-T019
are	O	O	O
limited	O	O	O
.	O	O	O

A	O	O	O
retrospective	O	O	B-T062
study	O	O	I-T062
involving	O	O	O
7	O	O	O
centers	O	O	O
over	O	O	O
a	O	O	O
5-	O	O	O
year	O	O	B-T079
period	O	O	B-T079
beginning	O	O	O
in	O	O	O
2011	O	O	O
was	O	O	O
performed	O	O	B-T169
.	O	O	O

Twenty-one	O	O	O
patients	O	O	B-T101
(	O	O	O
median	O	O	B-T081
33.9	O	O	O
years	O	O	B-T079
)	O	O	O
were	O	O	O
identified	O	O	O
.	O	O	O

The	O	O	O
most	O	O	O
common	O	O	O
diagnosis	O	O	B-T033
was	O	O	O
single	O	O	B-T019
ventricle	O	O	I-T019
physiology	O	O	B-T039
(	O	O	O
52	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
9	O	O	O
palliated	O	O	B-T061
by	O	O	O
Fontan	O	O	B-T061
operation	O	O	I-T061
and	O	O	O
2	O	O	O
by	O	O	O
aortopulmonary	O	O	B-T061
shunts	O	O	I-T061
:	O	O	O
d-transposition	O	O	B-T047
of	O	O	I-T047
the	O	O	I-T047
great	O	O	I-T047
arteries	O	O	I-T047
after	O	O	O
Mustard	O	O	B-T061
/	O	O	O
Senning	O	O	B-T061
(	O	O	O
n=2	O	O	O
)	O	O	O
,	O	O	O
tetralogy	O	O	B-T019
of	O	O	I-T019
Fallot	O	O	I-T019
(	O	O	O
n=2	O	O	O
)	O	O	O
,	O	O	O
aortic	O	O	B-T047
valve	O	O	I-T047
disease	O	O	I-T047
(	O	O	O
n=2	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
other	O	O	O
biventricular	O	O	B-T082
surgery	O	O	B-T061
(	O	O	O
n=4	O	O	O
)	O	O	O
.	O	O	O

A	O	O	O
prior	O	O	O
cardiac	O	O	B-T074
device	O	O	I-T074
had	O	O	O
been	O	O	O
implanted	O	O	B-T061
in	O	O	O
7	O	O	O
(	O	O	O
33	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
ICD	O	O	B-T074
indication	O	O	B-T078
was	O	O	O
primary	O	O	B-T061
prevention	O	O	I-T061
in	O	O	O
67	O	O	O
%	O	O	O
and	O	O	O
secondary	O	O	B-T061
in	O	O	O
33	O	O	O
%	O	O	O
patient	O	O	O
s.	O	O	O
The	O	O	O
most	O	O	O
common	O	O	O
reason	O	O	O
for	O	O	O
subcutaneous	O	O	B-T082
ICD	O	O	O
placement	O	O	B-T058
was	O	O	O
limited	O	O	O
transvenous	O	O	B-T082
access	O	O	I-T082
for	O	O	O
ventricular	O	O	B-T074
lead	O	O	I-T074
placement	O	O	O
(	O	O	O
n=10	O	O	O
)	O	O	O
followed	O	O	O
by	O	O	O
intracardiac	O	O	B-T033
right-to-left	O	O	I-T033
shunt	O	O	I-T033
(	O	O	O
n=5	O	O	O
)	O	O	O
.	O	O	O

Ventricular	O	O	B-T047
arrhythmia	O	O	I-T047
was	O	O	O
induced	O	O	B-T169
in	O	O	O
17	O	O	O
(	O	O	O
81	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
was	O	O	O
converted	O	O	O
with	O	O	O
â¤80	O	O	O
Joules	O	O	B-T081
in	O	O	O
all	O	O	O
.	O	O	O

There	O	O	O
was	O	O	O
one	O	O	O
implant	O	O	B-T046
complication	O	O	I-T046
related	O	O	I-T046
to	O	O	I-T046
infection	O	O	I-T046
,	O	O	O
not	O	O	B-T080
requiring	O	O	O
device	O	O	B-T061
removal	O	O	I-T061
.	O	O	O

Over	O	O	O
a	O	O	O
median	O	O	B-T081
follow-up	O	O	B-T058
of	O	O	O
14	O	O	O
months	O	O	B-T079
,	O	O	O
4	O	O	O
patients	O	O	B-T101
(	O	O	O
21	O	O	O
%	O	O	O
)	O	O	O
received	O	O	O
inappropriate	O	O	B-T047
and	O	O	O
1	O	O	O
(	O	O	O
5	O	O	O
%	O	O	O
)	O	O	O
patient	O	O	B-T101
received	O	O	O
appropriate	O	O	B-T046
shocks	O	O	I-T046
.	O	O	O

There	O	O	O
was	O	O	O
one	O	O	O
arrhythmic	O	O	B-T033
death	O	O	I-T033
related	O	O	O
to	O	O	O
asystole	O	O	B-T047
in	O	O	O
a	O	O	O
single	O	O	B-T019
ventricle	O	O	I-T019
patient	O	O	B-T101
.	O	O	O

Subcutaneous	O	O	B-T082
ICD	O	O	B-T074
implantation	O	O	B-T061
is	O	O	O
feasible	O	O	O
for	O	O	O
adults	O	O	B-T100
with	O	O	O
congenital	O	O	B-T019
heart	O	O	I-T019
disease	O	O	I-T019
patients	O	O	B-T101
.	O	O	O

Most	O	O	O
candidates	O	O	B-T101
have	O	O	O
single	O	O	B-T019
ventricle	O	O	I-T019
heart	O	O	B-T047
disease	O	O	I-T047
and	O	O	O
limited	O	O	O
transvenous	O	O	B-T082
options	O	O	I-T082
for	O	O	O
ICD	O	O	B-T074
placement	O	O	B-T058
.	O	O	O

Despite	O	O	O
variable	O	O	B-T080
anatomy	O	O	B-T080
,	O	O	O
this	O	O	O
study	O	O	B-T062
demonstrates	O	O	O
successful	O	O	B-T080
conversion	O	O	B-T169
of	O	O	O
induced	O	O	B-T169
ventricular	O	O	B-T047
arrhythmia	O	O	I-T047
and	O	O	O
reasonable	O	O	B-T033
rhythm	O	O	B-T042
discrimination	O	O	B-T042
during	O	O	O
follow-up	O	O	B-T058
.	O	O	O

-DOCSTART- (27636509)

Interaction	O	O	B-T169
of	O	O	O
multiple	O	O	B-T081
gene	O	O	B-T028
variants	O	O	I-T028
and	O	O	O
their	O	O	O
effects	O	O	B-T080
on	O	O	O
schizophrenia	O	O	B-T048
phenotypes	O	O	O

Schizophrenia	O	O	B-T048
is	O	O	O
a	O	O	O
clinically	O	O	B-T080
heterogeneous	O	O	B-T033
disorder	O	O	I-T033
and	O	O	O
may	O	O	O
be	O	O	O
explained	O	O	O
by	O	O	O
its	O	O	O
complex	O	O	O
genetic	O	O	B-T169
architecture	O	O	I-T169
.	O	O	O

Many	O	O	O
schizophrenia	O	O	B-T048
susceptibility	O	O	B-T201
genes	O	O	B-T028
were	O	O	O
identified	O	O	B-T080
but	O	O	O
the	O	O	O
picture	O	O	O
remains	O	O	O
unclear	O	O	O
due	O	O	O
to	O	O	O
inconsistent	O	O	B-T080
or	O	O	O
contradictory	O	O	B-T080
genetic	O	O	B-T063
association	O	O	I-T063
studies	O	O	I-T063
.	O	O	O

This	O	O	O
confusion	O	O	O
may	O	O	O
,	O	O	O
in	O	O	O
part	O	O	O
,	O	O	O
be	O	O	O
because	O	O	O
symptoms	O	O	B-T184
result	O	O	O
from	O	O	O
the	O	O	O
combined	O	O	O
interaction	O	O	B-T169
of	O	O	O
many	O	O	O
genes	O	O	B-T028
and	O	O	O
these	O	O	O
interacting	O	O	B-T169
genes	O	O	O
are	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
specific	O	O	B-T080
sub-phenotypes	O	O	B-T032
of	O	O	O
schizophrenia	O	O	B-T048
rather	O	O	O
than	O	O	O
schizophrenia	O	O	O
as	O	O	O
a	O	O	O
whole	O	O	O
.	O	O	O

This	O	O	O
study	O	O	O
investigates	O	O	B-T169
the	O	O	O
relationship	O	O	B-T080
between	O	O	O
schizophrenia	O	O	B-T048
susceptibility	O	O	B-T201
genes	O	O	B-T028
and	O	O	O
schizophrenia	O	O	O
sub-phenotypes	O	O	B-T032
by	O	O	O
identifying	O	O	B-T080
multiple	O	O	B-T081
gene	O	O	B-T028
variant	O	O	I-T028
interactions	O	O	B-T169
.	O	O	O

Fifty	O	O	O
SNPs	O	O	B-T086
from	O	O	O
21	O	O	O
genes	O	O	B-T028
were	O	O	O
genotyped	O	O	B-T059
in	O	O	O
235	O	O	O
Australian	O	O	B-T098
participants	O	O	B-T098
with	O	O	O
schizophrenia	O	O	B-T048
screened	O	O	B-T058
for	O	O	O
various	O	O	O
phenotypes	O	O	B-T032
.	O	O	O

Schizophrenia	O	O	B-T048
participants	O	O	B-T098
were	O	O	O
grouped	O	O	O
into	O	O	O
relevant	O	O	B-T080
phenotype	O	O	B-T032
clusters	O	O	B-T081
using	O	O	O
cluster	O	O	B-T081
analysis	O	O	I-T062
and	O	O	O
normalized	O	O	B-T062
phenotype	O	O	O
cluster	O	O	O
scores	O	O	B-T081
were	O	O	O
calculated	O	O	O
for	O	O	O
each	O	O	O
patient	O	O	B-T101
.	O	O	O

The	O	O	O
relationship	O	O	B-T080
between	O	O	O
genotypes	O	O	B-T032
and	O	O	O
normalized	O	O	B-T062
phenotype	O	O	B-T032
cluster	O	O	B-T081
scores	O	O	B-T081
were	O	O	O
analyzed	O	O	O
by	O	O	O
linear	O	O	B-T170
regression	O	O	I-T170
analysis	O	O	I-T170
.	O	O	O

Three	O	O	O
phenotype	O	O	B-T032
clusters	O	O	B-T081
were	O	O	O
identified	O	O	B-T080
.	O	O	O

There	O	O	O
was	O	O	O
some	O	O	O
overlap	O	O	O
in	O	O	O
symptoms	O	O	B-T184
between	O	O	O
phenotype	O	O	B-T032
clusters	O	O	B-T081
,	O	O	O
particularly	O	O	O
for	O	O	O
depression	O	O	B-T048
.	O	O	O

However	O	O	O
,	O	O	O
cluster	O	O	B-T081
1	O	O	I-T081
appears	O	O	O
to	O	O	O
be	O	O	O
characterized	O	O	O
by	O	O	O
speech	O	O	B-T047
disorder	O	O	I-T047
and	O	O	O
affective	O	O	O
behavior	O	O	B-T184
symptoms	O	O	I-T184
,	O	O	O
cluster	O	O	O
2	O	O	O

has	O	O	O
predominantly	O	O	O
hallucination	O	O	B-T048
symptoms	O	O	B-T184
and	O	O	O
cluster	O	O	B-T081
3	O	O	I-T081
has	O	O	O
mainly	O	O	O
delusion	O	O	B-T048
symptoms	O	O	O
.	O	O	O

Interaction	O	O	B-T169
of	O	O	O
five	O	O	O
SNPs	O	O	B-T086
was	O	O	O
found	O	O	O
to	O	O	O
have	O	O	O
an	O	O	O
effect	O	O	O
on	O	O	O
cluster	O	O	B-T081
1	O	O	I-T081
symptoms	O	O	B-T184
;	O	O	O
ten	O	O	O
SNPs	O	O	O
on	O	O	O
cluster	O	O	B-T081
2	O	O	I-T081
symptoms	O	O	O
;	O	O	O
and	O	O	O
eight	O	O	O
SNPs	O	O	O
on	O	O	O
cluster	O	O	B-T081
3	O	O	I-T081
symptoms	O	O	O
.	O	O	O

The	O	O	O
interaction	O	O	B-T169
of	O	O	O
specific	O	O	B-T080
susceptibility	O	O	B-T201
genes	O	O	B-T028
is	O	O	O
likely	O	O	O
to	O	O	O
lead	O	O	O
to	O	O	O
specific	O	O	O
clinical	O	O	B-T080
sub-phenotypes	O	O	B-T032
of	O	O	O
schizophrenia	O	O	B-T048
.	O	O	O

Larger	O	O	O
patient	O	O	B-T101
cohorts	O	O	B-T098
with	O	O	O
more	O	O	O
extensive	O	O	O
clinical	O	O	B-T080
data	O	O	B-T078
will	O	O	O
improve	O	O	O
the	O	O	O
detection	O	O	B-T033
of	O	O	O
gene	O	O	B-T045
interactions	O	O	I-T045
and	O	O	O
the	O	O	O
resultant	O	O	O
schizophrenia	O	O	B-T048
clinical	O	O	O
phenotypes	O	O	B-T032
.	O	O	O

-DOCSTART- (27637577)

Evaluation	O	O	O
of	O	O	O
DNMT1	O	O	B-T028
gene	O	O	B-T081
expression	O	O	I-T081
profile	O	O	I-T081
and	O	O	O
methylation	O	O	B-T044
of	O	O	O
its	O	O	O
promoter	O	O	B-T114
region	O	O	I-T114
in	O	O	O
patients	O	O	B-T101
with	O	O	O
ankylosing	O	O	O
spondylitis	O	O	O

Ankylosing	O	O	B-T047
spondylitis	O	O	I-T047
(	O	O	O
AS	O	O	B-T047
)	O	O	O
is	O	O	O
an	O	O	O
autoimmune	O	O	B-T047
disease	O	O	I-T047
with	O	O	O
a	O	O	O
chronic	O	O	B-T047
inflammatory	O	O	I-T047
arthritis	O	O	I-T047
.	O	O	O

The	O	O	O
critical	O	O	O
role	O	O	O
of	O	O	O
methylation	O	O	B-T044
in	O	O	O
the	O	O	O
biology	O	O	B-T091
of	O	O	O
immunocytes	O	O	B-T025
has	O	O	O
increasingly	O	O	O
been	O	O	O
surveyed	O	O	B-T170
to	O	O	O
discover	O	O	O
disease	O	O	B-T047
etiology	O	O	B-T169
.	O	O	O

DNA	O	O	B-T116
methyltransferase	O	O	I-T116
1	O	O	I-T116
(	O	O	O
DNMT1	O	O	B-T116
)	O	O	O
is	O	O	O
an	O	O	O
enzyme	O	O	B-T116
,	O	O	O
which	O	O	O
establishes	O	O	O
and	O	O	O
regulates	O	O	B-T038
patterns	O	O	B-T082
of	O	O	O
methylated	O	O	B-T109
cytosine	O	O	I-T109
residues	O	O	O
.	O	O	O

The	O	O	O
aim	O	O	B-T078
of	O	O	O
the	O	O	O
current	O	O	O
investigation	O	O	B-T058
was	O	O	O
to	O	O	O
unveil	O	O	O
if	O	O	O
methylation	O	O	B-T044
circumstances	O	O	O
of	O	O	O
CpG	O	O	B-T114
sites	O	O	B-T082
in	O	O	O
DNMT1	O	O	B-T028
promoter	O	O	B-T114
could	O	O	O
affect	O	O	O
the	O	O	O
mRNA	O	O	B-T045
expression	O	O	I-T045
level	O	O	B-T080
of	O	O	O
this	O	O	O
gene	O	O	B-T028
in	O	O	O
peripheral	O	O	B-T025
blood	O	O	I-T025
mononuclear	O	O	I-T025
cells	O	O	I-T025
(	O	O	O
PBMCs	O	O	B-T025
)	O	O	O
from	O	O	O
AS	O	O	B-T047
patients	O	O	B-T101
.	O	O	O

PBMCs	O	O	B-T025
were	O	O	O
isolated	O	O	O
from	O	O	O
whole	O	O	B-T031
blood	O	O	I-T031
of	O	O	O
40	O	O	O
AS	O	O	B-T047
patients	O	O	B-T101
and	O	O	O
40	O	O	O
healthy	O	O	B-T080
individuals	O	O	B-T098
.	O	O	O

Total	O	O	O
RNA	O	O	B-T114
and	O	O	O
DNA	O	O	B-T114
contents	O	O	O
of	O	O	O
leukocytes	O	O	B-T025
were	O	O	O
extracted	O	O	B-T061
.	O	O	O

Afterward	O	O	O
,	O	O	O
quantitative	O	O	B-T081
analysis	O	O	I-T081
was	O	O	O
carried	O	O	O
out	O	O	O
by	O	O	O
real-time	O	O	B-T063
PCR	O	O	I-T063
using	O	O	O
the	O	O	O
SYBR	O	O	B-T170
Green	O	O	I-T170
PCR	O	O	I-T170
Master	O	O	I-T170
Mix	O	O	I-T170
.	O	O	O

Finally	O	O	O
,	O	O	O
to	O	O	O
determine	O	O	O
the	O	O	O
methylation	O	O	B-T044
level	O	O	B-T080
,	O	O	O
PCR	O	O	B-T063
products	O	O	B-T114
of	O	O	O
bisulfite-treated	O	O	B-T114
DNA	O	O	I-T114
from	O	O	O
patients	O	O	B-T101
and	O	O	O
controls	O	O	B-T096
were	O	O	O
sequenced	O	O	B-T059
.	O	O	O

Compared	O	O	O
with	O	O	O
healthy	O	O	B-T080
controls	O	O	B-T096
,	O	O	O
expression	O	O	B-T045
level	O	O	I-T045
of	O	O	O
DNMT1	O	O	B-T028
in	O	O	O
AS	O	O	B-T047
patients	O	O	B-T101
was	O	O	O
significantly	O	O	O
downregulated	O	O	B-T044
.	O	O	O

Methylation	O	O	B-T044
of	O	O	O
DNMT1	O	O	B-T028
promoter	O	O	B-T114
was	O	O	O
significantly	O	O	O
higher	O	O	O
in	O	O	O
AS	O	O	B-T047
patients	O	O	B-T101
in	O	O	O
comparison	O	O	O
to	O	O	O
controls	O	O	B-T096
.	O	O	O

While	O	O	O
a	O	O	O
negative	O	O	B-T033
correlation	O	O	B-T080
between	O	O	O
methylation	O	O	B-T044
and	O	O	O
expression	O	O	B-T045
level	O	O	I-T045
of	O	O	O
DNMT1	O	O	B-T028
was	O	O	O
observed	O	O	O
in	O	O	O
AS	O	O	B-T047
patients	O	O	B-T101
,	O	O	O
both	O	O	O
methylation	O	O	O
and	O	O	O
expression	O	O	O
level	O	O	O
of	O	O	O
DNMT1	O	O	O
did	O	O	O
not	O	O	O
correlate	O	O	B-T080
with	O	O	O
clinical	O	O	B-T080
manifestations	O	O	B-T169
.	O	O	O

Considering	O	O	O
the	O	O	O
observation	O	O	O
that	O	O	O
decreased	O	O	B-T081
expression	O	O	B-T045
level	O	O	B-T080
of	O	O	O
DNMT1	O	O	B-T028
was	O	O	O
associated	O	O	O
with	O	O	O
hypermethylation	O	O	B-T045
of	O	O	O
DNMT1	O	O	O
promoter	O	O	B-T114
in	O	O	O
PBMCs	O	O	B-T025
from	O	O	O
AS	O	O	B-T047
patients	O	O	B-T101
,	O	O	O
this	O	O	O
survey	O	O	B-T170
suggests	O	O	O
that	O	O	O
dysregulation	O	O	O
of	O	O	O
DNMT1	O	O	O
expression	O	O	O
through	O	O	O
altered	O	O	B-T169
methylation	O	O	B-T044
level	O	O	O
of	O	O	O
other	O	O	O
target	O	O	B-T169
genes	O	O	B-T028
would	O	O	O
probably	O	O	O
contribute	O	O	O
to	O	O	O
AS	O	O	O
development	O	O	O
.	O	O	O

-DOCSTART- (27642330)

Antibacterial	O	O	B-T195
Activity	O	O	B-T052
of	O	O	O
Polyaniline	O	O	B-T109
Coated	O	O	B-T080
Silver	O	O	B-T196
Nanoparticles	O	O	B-T073
Synthesized	O	O	B-T052
from	O	O	O
Piper	O	O	O
Betle	O	O	O
Leaves	O	O	O
Extract	O	O	O

Plants	O	O	B-T002
or	O	O	O
natural	O	O	B-T078
resources	O	O	I-T078
have	O	O	O
been	O	O	O
found	O	O	O
to	O	O	O
be	O	O	O
a	O	O	O
good	O	O	O
alternative	O	O	B-T077
method	O	O	B-T169
for	O	O	O
nanoparticles	O	O	B-T073
synthesis	O	O	B-T052
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
polyaniline	O	O	B-T109
coated	O	O	B-T080
silver	O	O	B-T196
nanoparticles	O	O	B-T073
(	O	O	O
AgNPs	O	O	B-T073
)	O	O	O
synthesized	O	O	B-T052
from	O	O	O
Piper	O	O	B-T109
betle	O	O	I-T109
leaves	O	O	I-T109
extract	O	O	I-T109
were	O	O	O
investigated	O	O	O
for	O	O	O
their	O	O	O
antibacterial	O	O	B-T195
activity	O	O	B-T052
.	O	O	O

Silver	O	O	B-T196
nanoparticles	O	O	B-T073
were	O	O	O
prepared	O	O	O
from	O	O	O
the	O	O	O
reduction	O	O	B-T080
of	O	O	O
silver	O	O	B-T121
nitrate	O	O	I-T121
and	O	O	O
NaBH4	O	O	B-T130
was	O	O	O
used	O	O	O
as	O	O	O
reducing	O	O	B-T130
agent	O	O	I-T130
.	O	O	O

Silver	O	O	B-T196
nanoparticles	O	O	B-T073
and	O	O	O
extracts	O	O	B-T123
were	O	O	O
mixed	O	O	O
thoroughly	O	O	O
and	O	O	O
then	O	O	O
coated	O	O	B-T080
by	O	O	O
polyaniline	O	O	B-T109
.	O	O	O

Prepared	O	O	O
nanoparticles	O	O	B-T073
were	O	O	O
characterized	O	O	B-T052
by	O	O	O
Visual	O	O	B-T169
inspection	O	O	I-T169
,	O	O	O
Ultraviolet-visible	O	O	B-T059
spectroscopy	O	O	I-T059
(	O	O	O
UV	O	O	B-T059
)	O	O	O
,	O	O	O
Fourier	O	O	B-T062
transform	O	O	I-T062
infrared	O	O	I-T062
Spectroscopy	O	O	I-T062
(	O	O	O
FT-IR	O	O	B-T062
)	O	O	O
,	O	O	O
Transmission	O	O	B-T059
Electron	O	O	I-T059
Microscopy	O	O	I-T059
(	O	O	I-T059
TEM	O	O	I-T059
)	O	O	I-T059
techniques	O	O	I-T059
.	O	O	O

Antibacterial	O	O	B-T195
activities	O	O	B-T052
of	O	O	O
the	O	O	O
synthesized	O	O	B-T052
silver	O	O	B-T196
nanoparticles	O	O	B-T073
were	O	O	O
tested	O	O	B-T169
against	O	O	O
Staphylococcus	O	O	B-T007
aureus	O	O	I-T007
ATCC	O	O	I-T007
25923	O	O	I-T007
,	O	O	O
Salmonella	O	O	B-T007
typhi	O	O	I-T007
ATCC	O	O	I-T007
14028	O	O	I-T007
,	O	O	O
Escherichia	O	O	B-T007
coli	O	O	I-T007
ATCC	O	O	I-T007
25922	O	O	I-T007
and	O	O	O
Pseudomonas	O	O	B-T007
aeruginosa	O	O	I-T007
ATCC	O	O	I-T007
27853	O	O	I-T007
.	O	O	O

UV-Vis	O	O	B-T059
spectrum	O	O	I-T059
of	O	O	O
reaction	O	O	B-T167
mixture	O	O	I-T167
showed	O	O	O
strong	O	O	B-T080
absorption	O	O	I-T080
peak	O	O	I-T080
with	O	O	O
centering	O	O	O
at	O	O	O
400	O	O	O
nm	O	O	O
.	O	O	O

The	O	O	O
FT-IR	O	O	B-T062
results	O	O	B-T034
imply	O	O	O
that	O	O	O
Ag-NPs	O	O	B-T073
were	O	O	O
successfully	O	O	O
synthesized	O	O	B-T052
and	O	O	O
capped	O	O	B-T080
with	O	O	I-T080
bio-compounds	O	O	I-T080
present	O	O	O
in	O	O	O
P.	O	O	B-T109
betle	O	O	I-T109
.	O	O	O

TEM	O	O	B-T059
image	O	O	O
showed	O	O	O
that	O	O	O
Ag-NPs	O	O	B-T073
formed	O	O	O
were	O	O	O
well	O	O	O
dispersed	O	O	B-T082
with	O	O	O
a	O	O	O
spherical	O	O	B-T082
structures	O	O	I-T082
and	O	O	O
particle	O	O	B-T081
size	O	O	I-T081
ranging	O	O	O
from	O	O	O
10	O	O	O
to	O	O	O
30	O	O	O
nm	O	O	O
.	O	O	O

The	O	O	O
result	O	O	B-T169
revealed	O	O	B-T080
that	O	O	O
Ag-Extract	O	O	B-T073
NPs	O	O	I-T073
showed	O	O	O
32.78Â±0.64	O	O	O
mm	O	O	O
zone	O	O	O
of	O	O	O
inhibition	O	O	B-T052
against	O	O	O
S.	O	O	B-T007
aureus	O	O	I-T007
,	O	O	O
whereas	O	O	O
norfloxacin	O	O	B-T195
(	O	O	O
positive	O	O	B-T077
control	O	O	I-T077
)	O	O	O
showed	O	O	O
maximum	O	O	O
32.15Â±0.40	O	O	O
mm	O	O	O
zone	O	O	O
of	O	O	O
inhibition	O	O	O
for	O	O	O
S.	O	O	O
aureus	O	O	O
.	O	O	O

Again	O	O	O
,	O	O	O
maximum	O	O	B-T082
zone	O	O	I-T082
of	O	O	O
inhibition	O	O	B-T052
29.55Â±0.45	O	O	O
mm	O	O	O
was	O	O	O
found	O	O	O
for	O	O	O
S.	O	O	B-T007
typhi	O	O	I-T007
,	O	O	O
27.12Â±0.38	O	O	O
mm	O	O	O
for	O	O	O
E.	O	O	B-T007
coli	O	O	I-T007
and	O	O	O
21.95Â±0.45	O	O	O
mm	O	O	O
for	O	O	O
P.	O	O	B-T007
aeruginosa	O	O	I-T007
.	O	O	O

The	O	O	O
results	O	O	B-T169
obtained	O	O	O
by	O	O	O
this	O	O	O
study	O	O	B-T062
ca	O	O	O
n't	O	O	O
be	O	O	O
directly	O	O	O
extrapolated	O	O	B-T081
to	O	O	O
human	O	O	B-T016
;	O	O	O
so	O	O	O
further	O	O	B-T062
studies	O	O	I-T062
should	O	O	O
be	O	O	O
undertaken	O	O	O
to	O	O	O
established	O	O	O
the	O	O	O
strong	O	O	O
antimicrobial	O	O	B-T121
activity	O	O	B-T052
of	O	O	O
Ag-Extract	O	O	B-T073
NPs	O	O	I-T073
for	O	O	O
drug	O	O	B-T091
development	O	O	I-T091
program	O	O	I-T091
.	O	O	O

-DOCSTART- (27643901)

Clinical	O	O	B-T170
Pearls	O	O	I-T170
in	O	O	O
Tremor	O	O	B-T184
and	O	O	O
Other	O	O	O
Hyperkinetic	O	O	B-T048
Movement	O	O	I-T048
Disorders	O	O	O

Hyperkinetic	O	O	B-T048
movements	O	O	I-T048
,	O	O	O
such	O	O	O
as	O	O	O
tremor	O	O	B-T184
,	O	O	O
myoclonus	O	O	B-T184
,	O	O	O
chorea	O	O	B-T047
,	O	O	O
and	O	O	O
dystonia	O	O	B-T184
,	O	O	O
occur	O	O	O
in	O	O	O
many	O	O	O
neurologic	O	O	B-T047
and	O	O	O
medical	O	O	B-T047
conditions	O	O	I-T047
.	O	O	O

Accurate	O	O	O
clinical	O	O	B-T058
evaluation	O	O	I-T058
is	O	O	O
the	O	O	O
important	O	O	O
first	O	O	O
step	O	O	O
for	O	O	O
the	O	O	O
proper	O	O	O
diagnosis	O	O	B-T062
and	O	O	O
treatment	O	O	B-T061
of	O	O	O
patients	O	O	B-T101
with	O	O	O
abnormal	O	O	B-T047
movements	O	O	I-T047
.	O	O	O

-DOCSTART- (27645371)

Tracking	O	O	O
children	O	O	B-T100
with	O	O	O
acute	O	O	B-T191
lymphoblastic	O	O	I-T191
leukemia	O	O	I-T191
who	O	O	O
abandoned	O	O	B-T080
therapy	O	O	B-T061
:	O	O	O
Experience	O	O	B-T041
,	O	O	O
challenges	O	O	B-T058
,	O	O	O
parental	O	O	B-T099
perspectives	O	O	B-T082
,	O	O	O
and	O	O	O
impact	O	O	O
of	O	O	O
treatment	O	O	B-T061
subsidies	O	O	B-T058
and	O	O	O
intensified	O	O	O
counseling	O	O	O

Refusal	O	O	B-T055
for	O	O	I-T055
treatment	O	O	I-T055
and	O	O	O
therapy	O	O	B-T061
abandonment	O	O	B-T033
are	O	O	O
important	O	O	O
reasons	O	O	O
for	O	O	O
unfavorable	O	O	O
outcome	O	O	O
of	O	O	O
childhood	O	O	B-T079
acute	O	O	B-T191
lymphoblastic	O	O	I-T191
leukemia	O	O	I-T191
(	O	O	O
ALL	O	O	B-T191
)	O	O	O
in	O	O	O
resource	O	O	B-T078
-poor	O	O	O
countries	O	O	B-T083
.	O	O	O

The	O	O	O
present	O	O	O
study	O	O	B-T062
,	O	O	O
conducted	O	O	O
on	O	O	O
children	O	O	B-T100
with	O	O	O
ALL	O	O	B-T191
whose	O	O	O
treatment	O	O	B-T061
was	O	O	O
abandoned	O	O	B-T080
,	O	O	O
attempted	O	O	O
to	O	O	O
track	O	O	O
all	O	O	O
these	O	O	O
children	O	O	O
to	O	O	O
ascertain	O	O	O
the	O	O	O
causes	O	O	O
and	O	O	O
outcome	O	O	B-T169
of	O	O	O
therapy	O	O	B-T061
abandonment	O	O	B-T033
/	O	O	O
refusal	O	O	B-T055
.	O	O	O

In	O	O	O
order	O	O	O
to	O	O	O
improve	O	O	O
outcome	O	O	B-T169
of	O	O	O
ALL	O	O	B-T191
,	O	O	O
measures	O	O	O
to	O	O	O
prevent	O	O	O
abandonment	O	O	B-T033
were	O	O	O
introduced	O	O	O
in	O	O	O
the	O	O	O
form	O	O	O
of	O	O	O
treatment	O	O	B-T061
subsidies	O	O	B-T058
and	O	O	O
intensified	O	O	B-T058
multistage	O	O	I-T058
counseling	O	O	I-T058
.	O	O	O

Of	O	O	O
the	O	O	O
77	O	O	O
(	O	O	O
of	O	O	O
418	O	O	O
)	O	O	O
children	O	O	B-T100
abandoning	O	O	O
therapy	O	O	B-T061
,	O	O	O
17	O	O	O
(	O	O	O
22	O	O	O
%	O	O	O
)	O	O	O
refused	O	O	B-T052
upfront	O	O	I-T052
,	O	O	O
whereas	O	O	O
the	O	O	O
rest	O	O	O
abandoned	O	O	B-T080
during	O	O	O
various	O	O	O
phases	O	O	O
of	O	O	O
chemotherapy	O	O	B-T061
.	O	O	O

Only	O	O	O
39	O	O	O
(	O	O	O
50.6	O	O	O
%	O	O	O
)	O	O	O
of	O	O	O
these	O	O	O
77	O	O	O
families	O	O	B-T099
could	O	O	O
be	O	O	O
subsequently	O	O	O
contacted	O	O	O
.	O	O	O

Financial	O	O	B-T033
problems	O	O	I-T033
,	O	O	O
too	O	O	O
many	O	O	O
dependents	O	O	B-T098
at	O	O	O
home	O	O	B-T082
,	O	O	O
and	O	O	O
wrong	O	O	O
perceptions	O	O	B-T041
about	O	O	O
cancer	O	O	B-T191
led	O	O	O
to	O	O	O
abandonment	O	O	B-T033
in	O	O	O
majority	O	O	O
.	O	O	O

Children	O	O	B-T033
abandoning	O	O	I-T033
treatment	O	O	I-T033
before	O	O	O
completion	O	O	O
of	O	O	O
induction	O	O	B-T061
had	O	O	O
a	O	O	O
significantly	O	O	O
shorter	O	O	O
survival	O	O	B-T052
than	O	O	O
who	O	O	O
abandoned	O	O	B-T080
post	O	O	B-T079
induction	O	O	I-T079
(	O	O	O
P	O	O	O
<	O	O	O
.0001	O	O	O
)	O	O	O
.	O	O	O

Intensified	O	O	B-T058
preabandonment	O	O	I-T058
counseling	O	O	I-T058
and	O	O	O
subsidized	O	O	O
treatment	O	O	B-T061
led	O	O	O
to	O	O	O
significant	O	O	O
reduction	O	O	B-T080
in	O	O	O
abandonment	O	O	B-T081
rates	O	O	I-T081
(	O	O	O
P	O	O	O
<	O	O	O
.0001	O	O	O
)	O	O	O
.	O	O	O

-DOCSTART- (27645763)

Effect	O	O	B-T080
of	O	O	O
New-Onset	O	O	B-T033
Left	O	O	B-T047
Bundle	O	O	I-T047
Branch	O	O	I-T047
Block	O	O	I-T047
After	O	O	O
Transcatheter	O	O	B-T061
Aortic	O	O	I-T061
Valve	O	O	I-T061
Implantation	O	O	I-T061
(	O	O	O
CoreValve	O	O	B-T074
)	O	O	O
on	O	O	O
Mortality	O	O	B-T081
,	O	O	O
Frequency	O	O	B-T079
of	O	O	O
Re-Hospitalization	O	O	B-T058
,	O	O	O
and	O	O	O
Need	O	O	O
for	O	O	O
Pacemaker	O	O	O

New-onset	O	O	B-T033
conduction	O	O	B-T046
disturbances	O	O	I-T046
are	O	O	O
common	O	O	O
after	O	O	O
transcatheter	O	O	B-T061
aortic	O	O	I-T061
valve	O	O	I-T061
implantation	O	O	I-T061
(	O	O	O
TAVI	O	O	B-T061
)	O	O	O
.	O	O	O

The	O	O	O
most	O	O	O
common	O	O	O
complication	O	O	B-T046
is	O	O	O
left	O	O	B-T047
bundle	O	O	I-T047
branch	O	O	I-T047
block	O	O	I-T047
(	O	O	O
LBBB	O	O	B-T047
)	O	O	O
.	O	O	O

The	O	O	O
clinical	O	O	B-T080
impact	O	O	B-T080
of	O	O	O
new-onset	O	O	B-T033
LBBB	O	O	B-T047
after	O	O	O
TAVI	O	O	B-T061
remains	O	O	O
controversial	O	O	B-T054
.	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
this	O	O	O
study	O	O	O
was	O	O	O
to	O	O	O
analyze	O	O	O
the	O	O	O
clinical	O	O	B-T080
impact	O	O	B-T080
of	O	O	O
new-onset	O	O	B-T033
LBBB	O	O	B-T047
in	O	O	O
terms	O	O	O
of	O	O	O
mortality	O	O	B-T081
and	O	O	O
morbidity	O	O	B-T081
(	O	O	O
need	O	O	O
for	O	O	O
pacemakers	O	O	B-T074
and	O	O	O
admissions	O	O	B-T058
for	O	O	O
heart	O	O	B-T047
failure	O	O	I-T047
)	O	O	O
at	O	O	O
long-term	O	O	B-T058
follow-up	O	O	I-T058
.	O	O	O

From	O	O	O
April	O	O	O
2008	O	O	O
to	O	O	O
December	O	O	O
2014	O	O	O
,	O	O	O
220	O	O	O
patients	O	O	B-T101
who	O	O	O
had	O	O	O
severe	O	O	O
aortic	O	O	B-T047
stenosis	O	O	I-T047
were	O	O	O
treated	O	O	B-T061
with	O	O	I-T061
the	O	O	O
implantation	O	O	B-T061
of	O	O	O
a	O	O	O
CoreValve	O	O	B-T074
prosthesis	O	O	I-T074
.	O	O	O

Sixty-seven	O	O	O
of	O	O	O
these	O	O	O
patients	O	O	B-T101
were	O	O	O
excluded	O	O	O
from	O	O	O
the	O	O	O
analysis	O	O	B-T062
,	O	O	O
including	O	O	O
22	O	O	O
patients	O	O	O
with	O	O	O
pre-existing	O	O	B-T080
LBBB	O	O	B-T047
and	O	O	O
45	O	O	O
with	O	O	O
a	O	O	O
permanent	O	O	B-T074
pacemaker	O	O	I-T074
,	O	O	O
implanted	O	O	B-T074
previously	O	O	O
or	O	O	O
within	O	O	O
72	O	O	O
hours	O	O	B-T079
of	O	O	O
implantation	O	O	B-T061
.	O	O	O

The	O	O	O
remaining	O	O	O
153	O	O	O
patients	O	O	B-T101
were	O	O	O
divided	O	O	O
into	O	O	O
2	O	O	O
groups	O	O	B-T078
:	O	O	O
group	O	O	B-T078
1	O	O	O
(	O	O	O
n	O	O	O
=	O	O	O
80	O	O	O
)	O	O	O
,	O	O	O
those	O	O	O
with	O	O	O
persistent	O	O	B-T079
new-onset	O	O	B-T033
LBBB	O	O	B-T047
,	O	O	O
and	O	O	O
group	O	O	O
2	O	O	O
(	O	O	O
n	O	O	O
=	O	O	O
73	O	O	O
)	O	O	O
,	O	O	O
those	O	O	O
without	O	O	O
conduction	O	O	B-T046
disturbances	O	O	I-T046
after	O	O	O
treatment	O	O	B-T061
.	O	O	O

Both	O	O	O
groups	O	O	B-T078
were	O	O	O
followed	O	O	B-T058
up	O	O	I-T058
at	O	O	O
1	O	O	O
month	O	O	B-T079
,	O	O	O
6	O	O	O
months	O	O	B-T079
,	O	O	O
12	O	O	O
months	O	O	O
,	O	O	O
and	O	O	O
yearly	O	O	B-T079
thereafter	O	O	O
.	O	O	O

Persistent	O	O	B-T079
new-onset	O	O	B-T033
LBBB	O	O	B-T047
occurred	O	O	O
in	O	O	O
80	O	O	O
patients	O	O	B-T101
(	O	O	O
36	O	O	O
%	O	O	O
)	O	O	O
immediately	O	O	O
after	O	O	O
TAVI	O	O	B-T061
;	O	O	O
73	O	O	O
patients	O	O	O
(	O	O	O
33	O	O	O
%	O	O	O
)	O	O	O
did	O	O	O
not	O	O	O
develop	O	O	O
conduction	O	O	B-T046
disturbances	O	O	I-T046
.	O	O	O

The	O	O	O
mean	O	O	O
follow-up	O	O	B-T058
time	O	O	B-T079
of	O	O	O
both	O	O	O
groups	O	O	B-T078
was	O	O	O
32	O	O	O
Â±	O	O	O
22	O	O	O
months	O	O	B-T079
(	O	O	O
range	O	O	O
3	O	O	O
to	O	O	O
82	O	O	O
months	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
there	O	O	O
were	O	O	O
no	O	O	O
differences	O	O	O
in	O	O	O
time	O	O	O
between	O	O	O
the	O	O	O
groups	O	O	O
.	O	O	O

There	O	O	O
were	O	O	O
no	O	O	O
differences	O	O	O
in	O	O	O
mortality	O	O	B-T081
between	O	O	O
the	O	O	O
groups	O	O	B-T078
(	O	O	O
39	O	O	O
%	O	O	O
vs	O	O	O
48	O	O	O
%	O	O	O
,	O	O	O
p	O	O	O
=	O	O	O
0.58	O	O	O
)	O	O	O
.	O	O	O

No	O	O	O
differences	O	O	O
were	O	O	O
observed	O	O	O
between	O	O	O
the	O	O	O
groups	O	O	B-T078
in	O	O	O
re-hospitalizations	O	O	B-T058
for	O	O	O
heart	O	O	B-T047
failure	O	O	I-T047
(	O	O	O
11	O	O	O
%	O	O	O
vs	O	O	O
16	O	O	O
%	O	O	O
,	O	O	O
p	O	O	O
=	O	O	O
0.55	O	O	O
)	O	O	O
.	O	O	O

Group	O	O	B-T078
1	O	O	O
did	O	O	O
not	O	O	O
require	O	O	O
pacemaker	O	O	B-T061
implantation	O	O	I-T061
more	O	O	O
often	O	O	O
at	O	O	O
follow-up	O	O	B-T058
(	O	O	O
10	O	O	O
%	O	O	O
vs	O	O	O
13	O	O	O
%	O	O	O
,	O	O	O
p	O	O	O
=	O	O	O
0.38	O	O	O
)	O	O	O
than	O	O	O
group	O	O	B-T078
2	O	O	O
.	O	O	O

In	O	O	O
conclusion	O	O	O
,	O	O	O
new-onset	O	O	B-T033
LBBB	O	O	B-T047
was	O	O	O
not	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
a	O	O	O
higher	O	O	B-T080
incidence	O	O	B-T081
of	O	O	O
late	O	O	O
need	O	O	O
for	O	O	O
a	O	O	O
permanent	O	O	B-T074
pacemaker	O	O	I-T074
after	O	O	O
CoreValve	O	O	B-T074
implantation	O	O	B-T061
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
it	O	O	O
was	O	O	O
not	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
a	O	O	O
higher	O	O	O
risk	O	O	O
of	O	O	O
late	O	O	O
mortality	O	O	B-T081
or	O	O	O
re-hospitalization	O	O	B-T058
.	O	O	O

-DOCSTART- (27647760)

The	O	O	O
relationship	O	O	B-T080
between	O	O	O
polymorphisms	O	O	B-T045
of	O	O	O
BDNFOS	O	O	B-T028
and	O	O	O
BDNF	O	O	B-T028
genes	O	O	I-T028
and	O	O	O
heroin	O	O	B-T048
addiction	O	O	I-T048
in	O	O	O
the	O	O	O
Han	O	O	O
Chinese	O	O	O
population	O	O	O

The	O	O	O
number	O	O	O
of	O	O	O
heroin	O	O	B-T109
addicts	O	O	B-T101
is	O	O	O
increasing	O	O	B-T169
in	O	O	O
the	O	O	O
world	O	O	B-T098
.	O	O	O

Both	O	O	O
environmental	O	O	B-T080
and	O	O	O
genetic	O	O	B-T080
factors	O	O	I-T080
both	O	O	O
play	O	O	O
critical	O	O	B-T080
roles	O	O	O
in	O	O	O
the	O	O	O
process	O	O	B-T067
of	O	O	O
heroin	O	O	B-T048
addiction	O	O	I-T048
.	O	O	O

We	O	O	O
aimed	O	O	B-T078
to	O	O	O
investigate	O	O	B-T169
the	O	O	O
associations	O	O	B-T080
between	O	O	O
single	O	O	B-T086
nucleotide	O	O	I-T086
polymorphisms	O	O	I-T086
(	O	O	O
SNPs	O	O	B-T086
)	O	O	O
in	O	O	O
LIN7C	O	O	B-T028
,	O	O	O
BDNFOS	O	O	B-T028
and	O	O	O
BDNF	O	O	B-T028
genes	O	O	I-T028
and	O	O	O
drug	O	O	B-T048
addiction	O	O	I-T048
in	O	O	O
the	O	O	O
Han	O	O	B-UnknownType
Chinese	O	O	I-UnknownType
population	O	O	I-UnknownType
.	O	O	O

We	O	O	O
conducted	O	O	O
a	O	O	O
case-control	O	O	B-T062
study	O	O	I-T062
among	O	O	O
692	O	O	O
cases	O	O	B-T169
and	O	O	O
700	O	O	O
healthy	O	O	B-T080
controls	O	O	I-T080
from	O	O	O
Xi'an	O	O	B-UnknownType
,	O	O	O
China	O	O	B-T083
.	O	O	O

Eight	O	O	O
SNPs	O	O	B-T086
were	O	O	O
selected	O	O	B-T052
and	O	O	O
genotyped	O	O	B-T059
using	O	O	O
MassARRAY	O	O	B-T170
technology	O	O	I-T170
(	O	O	O
Sequenom	O	O	B-T073
,	O	O	O
San	O	O	B-T083
Diego	O	O	I-T083
,	O	O	I-T083
CA	O	O	I-T083
,	O	O	O
USA	O	O	B-T083
)	O	O	O
.	O	O	O

Odds	O	O	B-T081
ratios	O	O	I-T081
(	O	O	O
OR	O	O	B-T081
)	O	O	O
and	O	O	O
95	O	O	O
%	O	O	O
confidence	O	O	B-T081
intervals	O	O	I-T081
(	O	O	O
CIs	O	O	B-T081
)	O	O	O
were	O	O	O
calculated	O	O	B-T052
by	O	O	O
unconditional	O	O	B-T062
logistic	O	O	I-T062
regression	O	O	I-T062
adjusting	O	O	O
for	O	O	O
age	O	O	B-T032
and	O	O	O
sex	O	O	B-T032
.	O	O	O

Using	O	O	O
the	O	O	O
chi-squared	O	O	B-T170
test	O	O	I-T170
,	O	O	O
we	O	O	O
found	O	O	O
that	O	O	O
rs7481311	O	O	B-T028
(	O	O	O
OR	O	O	B-T081
=	O	O	O
1.275	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
=	O	O	O
1.087	O	O	O
-	O	O	O
1.497	O	O	O
,	O	O	O
p	O	O	O
=	O	O	O
0.009	O	O	O
)	O	O	O
and	O	O	O
rs11030096	O	O	B-T028
(	O	O	O
OR	O	O	O
=	O	O	O
1.227	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
=	O	O	O
1.049	O	O	O
-	O	O	O
1.436	O	O	O
,	O	O	O
p	O	O	O
=	O	O	O
0.011	O	O	O
)	O	O	O
in	O	O	O
the	O	O	O
BNDFOS	O	O	B-T028
were	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
an	O	O	O
increased	O	O	B-T081
risk	O	O	B-T078
of	O	O	O
heroin	O	O	B-T048
addiction	O	O	I-T048
.	O	O	O

By	O	O	O
contrast	O	O	O
,	O	O	O
rs988712	O	O	B-T028
located	O	O	O
in	O	O	O
BDNFOS	O	O	B-T028
showed	O	O	O
a	O	O	O
decreased	O	O	B-T081
risk	O	O	B-T078
of	O	O	O
heroin	O	O	B-T048
addiction	O	O	I-T048
(	O	O	O
OR	O	O	B-T081
=	O	O	O
0.734	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
=	O	O	O
0.582	O	O	O
-	O	O	O
0.925	O	O	O
,	O	O	O
p	O	O	O
=	O	O	O
0.003	O	O	O
)	O	O	O
.	O	O	O

By	O	O	O
genetic	O	O	B-T170
model	O	O	I-T170
analysis	O	O	B-T062
,	O	O	O
we	O	O	O
found	O	O	O
that	O	O	O
the	O	O	O
'	O	O	B-T028
T	O	O	I-T028
'	O	O	I-T028
allele	O	O	I-T028
of	O	O	O
rs988712	O	O	B-T028
in	O	O	O
BDNFOS	O	O	B-T028
had	O	O	O
a	O	O	O
protective	O	O	O
role	O	O	O
for	O	O	O
heroin	O	O	B-T048
addiction	O	O	I-T048
in	O	O	O
the	O	O	O
additive	O	O	B-T170
model	O	O	I-T170
and	O	O	O
dominant	O	O	B-T170
model	O	O	I-T170
(	O	O	O
p	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
.	O	O	O

By	O	O	O
contrast	O	O	O
,	O	O	O
the	O	O	O
allele	O	O	B-T028
'	O	O	I-T028
T	O	O	I-T028
'	O	O	I-T028
of	O	O	O
rs7481311	O	O	B-T028
in	O	O	O
BDNFOS	O	O	B-T028
significantly	O	O	O
elevated	O	O	B-T080
the	O	O	O
risk	O	O	B-T078
of	O	O	O
heroin	O	O	B-T048
addiction	O	O	I-T048
in	O	O	O
the	O	O	O
additive	O	O	B-T170
model	O	O	I-T170
,	O	O	O
recessive	O	O	B-T170
model	O	O	I-T170
and	O	O	O
dominant	O	O	B-T170
model	O	O	I-T170
(	O	O	O
p	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
.	O	O	O

We	O	O	O
also	O	O	O
found	O	O	O
that	O	O	O
allele	O	O	B-T028
'	O	O	I-T028
C	O	O	I-T028
'	O	O	O
of	O	O	O
rs11030096	O	O	B-T028
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
an	O	O	O
increased	O	O	B-T081
risk	O	O	B-T078
of	O	O	O
addiction	O	O	B-T048
in	O	O	O
the	O	O	O
dominant	O	O	B-T170
model	O	O	I-T170
and	O	O	O
additive	O	O	B-T170
model	O	O	I-T170
(	O	O	O
p	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
.	O	O	O

Additionally	O	O	O
,	O	O	O
we	O	O	O
found	O	O	O
that	O	O	O
rs6265	O	O	B-T028
,	O	O	O
rs11030104	O	O	B-T028
and	O	O	O
rs10767664	O	O	B-T028
in	O	O	O
BDNF	O	O	B-T028
were	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
a	O	O	O
decreased	O	O	B-T081
risk	O	O	B-T078
of	O	O	O
heroin	O	O	B-T048
addiction	O	O	I-T048
(	O	O	O
p	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
only	O	O	O
rs7481311	O	O	B-T028
in	O	O	O
BDNFOS	O	O	B-T028
remained	O	O	O
significant	O	O	B-T078
after	O	O	O
Bonferroni	O	O	B-T081
correction	O	O	I-T081
(	O	O	O
p	O	O	O
<	O	O	O
0.00625	O	O	O
)	O	O	O
.	O	O	O

These	O	O	O
results	O	O	B-T033
suggest	O	O	O
that	O	O	O
polymorphisms	O	O	B-T045
of	O	O	O
BDNFOS	O	O	B-T028
play	O	O	O
an	O	O	O
important	O	O	B-T080
role	O	O	O
in	O	O	O
heroin	O	O	B-T048
addiction	O	O	I-T048
susceptibility	O	O	B-T169
in	O	O	O
the	O	O	O
Chinese	O	O	B-UnknownType
Han	O	O	I-UnknownType
population	O	O	I-UnknownType
.	O	O	O

-DOCSTART- (27648525)

Risk	O	O	B-T201
and	O	O	I-T201
protective	O	O	I-T201
factors	O	O	I-T201
associated	O	O	B-T080
with	O	O	I-T080
adolescent	O	O	B-T100
girls	O	O	I-T100
'	O	O	I-T100
substance	O	O	B-T048
use	O	O	I-T048
:	O	O	O
Data	O	O	B-T078
from	O	O	O
a	O	O	O
nationwide	O	O	O
Facebook	O	O	B-T170
sample	O	O	O

Despite	O	O	O
overall	O	O	O
reductions	O	O	B-T081
in	O	O	O
teenage	O	O	B-T079
substance	O	O	B-T048
use	O	O	I-T048
,	O	O	O
adolescent	O	O	B-T100
girls	O	O	I-T100
'	O	O	O
rates	O	O	B-T081
of	O	O	O
substance	O	O	O
use	O	O	O
remain	O	O	O
unacceptably	O	O	B-T080
high	O	O	I-T080
.	O	O	O

This	O	O	O
article	O	O	B-T170
examines	O	O	O
whether	O	O	O
girls	O	O	B-T098
'	O	O	O
substance	O	O	B-T048
use	O	O	I-T048
is	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
general	O	O	O
risk	O	O	B-T201
and	O	O	I-T201
protective	O	O	I-T201
factors	O	O	I-T201
(	O	O	O
goal	O	O	B-T041
setting	O	O	I-T041
,	O	O	O
problem	O	O	B-T041
solving	O	O	I-T041
,	O	O	O
refusal	O	O	B-T055
skills	O	O	I-T055
,	O	O	O
peer	O	O	B-T054
use	O	O	I-T054
,	O	O	O
and	O	O	O
self-efficacy	O	O	B-T041
)	O	O	O
and	O	O	O
gender	O	O	B-T032
-	O	O	O
specific	O	O	B-T080
risk	O	O	O
and	O	O	O
protective	O	O	O
factors	O	O	O
(	O	O	O
communication	O	O	B-T054
style	O	O	I-T054
,	O	O	O
coping	O	O	B-T055
skills	O	O	I-T055
,	O	O	O
self-esteem	O	O	B-T041
,	O	O	O
body	O	O	B-T041
image	O	O	I-T041
,	O	O	O
perceived	O	O	B-T048
stress	O	O	I-T048
,	O	O	O
anxiety	O	O	B-T048
,	O	O	O
and	O	O	O
depression	O	O	B-T048
)	O	O	O
.	O	O	O

Cross-sectional	O	O	B-T062
data	O	O	I-T062
were	O	O	O
collected	O	O	O
in	O	O	O
2013	O	O	O
via	O	O	O
online	O	O	B-T062
surveys	O	O	I-T062
from	O	O	O
a	O	O	O
nationwide	O	O	O
sample	O	O	O
of	O	O	O
adolescent	O	O	B-T100
girls	O	O	I-T100
(	O	O	O
N	O	O	O
=	O	O	O
788	O	O	O
)	O	O	O
,	O	O	O
aged	O	O	O
13	O	O	O
and	O	O	O
14	O	O	O
years	O	O	O
,	O	O	O
who	O	O	O
were	O	O	O
recruited	O	O	O
through	O	O	O
Facebook	O	O	B-T170
.	O	O	O

In	O	O	O
multivariate	O	O	B-T081
analyses	O	O	I-T081
,	O	O	O
controlling	O	O	O
for	O	O	O
correlates	O	O	B-T041
of	O	O	O
adolescent	O	O	B-T100
substance	O	O	B-T048
use	O	O	I-T048
,	O	O	O
11	O	O	O
of	O	O	O
the	O	O	O
13	O	O	O
general	O	O	O
and	O	O	O
gender	O	O	B-T032
-	O	O	O
specific	O	O	B-T080
risk	O	O	B-T201
and	O	O	I-T201
protective	O	O	I-T201
factors	O	O	B-T169
were	O	O	O
consistently	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
past-month	O	O	O
alcohol	O	O	B-T055
,	O	O	O
cigarette	O	O	B-T055
,	O	O	O
and	O	O	O
other	O	O	O
drug	O	O	B-T048
use	O	O	I-T048
in	O	O	O
the	O	O	O
expected	O	O	O
direction	O	O	O
;	O	O	O
past-month	O	O	B-T048
marijuana	O	O	I-T048
use	O	O	I-T048
was	O	O	O
associated	O	O	O
with	O	O	O
8	O	O	O
of	O	O	O
the	O	O	O
13	O	O	O
factors	O	O	O
.	O	O	O

Refusal	O	O	B-T055
skill	O	O	I-T055
s	O	O	O
,	O	O	O
peer	O	O	B-T054
use	O	O	I-T054
,	O	O	O
coping	O	O	B-T055
,	O	O	O
and	O	O	O
depressive	O	O	B-T033
mood	O	O	I-T033
were	O	O	O
most	O	O	O
consistently	O	O	O
and	O	O	O
strongly	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
substance	O	O	B-T048
use	O	O	I-T048
.	O	O	O

Substance	O	O	B-T058
abuse	O	O	I-T058
prevention	O	O	I-T058
programs	O	O	B-T058
targeting	O	O	O
adolescent	O	O	B-T100
girls	O	O	I-T100
should	O	O	O
focus	O	O	O
on	O	O	O
such	O	O	O
general	O	O	O
risk	O	O	B-T201
and	O	O	I-T201
protective	O	O	I-T201
factors	O	O	I-T201
as	O	O	O
problem	O	O	B-T041
solving	O	O	I-T041
,	O	O	O
refusal	O	O	B-T055
skill	O	O	I-T055
s	O	O	O
,	O	O	O
peer	O	O	B-T054
influences	O	O	I-T054
,	O	O	O
and	O	O	O
self-efficacy	O	O	B-T041
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
such	O	O	O
gender	O	O	B-T032
-	O	O	O
specific	O	O	B-T080
risk	O	O	O
and	O	O	O
protective	O	O	O
factors	O	O	O
as	O	O	O
communication	O	O	B-T054
style	O	O	I-T054
,	O	O	O
coping	O	O	B-T055
,	O	O	O
self-esteem	O	O	B-T041
,	O	O	O
body	O	O	B-T041
image	O	O	I-T041
,	O	O	O
perceived	O	O	B-T048
stress	O	O	I-T048
,	O	O	O
and	O	O	O
mood	O	O	B-T061
management	O	O	I-T061
.	O	O	O

-DOCSTART- (27649824)

Ethics	O	O	B-T078
Hype	O	O	B-T080
?	O	O	O

There	O	O	O
has	O	O	O
been	O	O	O
growing	O	O	O
concern	O	O	B-T078
about	O	O	O
the	O	O	O
phenomenon	O	O	B-T067
of	O	O	O
science	O	O	B-T090
hype	O	O	B-T080
,	O	O	O
the	O	O	O
tendency	O	O	O
to	O	O	O
exaggerate	O	O	B-T080
the	O	O	O
value	O	O	O
or	O	O	O
near	O	O	B-T080
-	O	O	O
future	O	O	B-T079
application	O	O	B-T169
of	O	O	O
research	O	O	B-T033
results	O	O	I-T033
.	O	O	O

Although	O	O	O
this	O	O	O
is	O	O	O
a	O	O	O
problem	O	O	B-T033
that	O	O	O
touches	O	O	O
every	O	O	O
area	O	O	B-T091
of	O	O	I-T091
biomedicine	O	O	I-T091
,	O	O	O
the	O	O	O
topic	O	O	B-T170
of	O	O	O
genetics	O	O	B-T091
seems	O	O	O
to	O	O	O
be	O	O	O
particularly	O	O	O
prone	O	O	O
to	O	O	O
enthusiastic	O	O	B-T041
predictions	O	O	B-T078
.	O	O	O

The	O	O	O
world	O	O	B-T098
has	O	O	O
been	O	O	O
told	O	O	O
for	O	O	O
over	O	O	O
two	O	O	O
decades	O	O	B-T079
-by	O	O	O
the	O	O	O
media	O	O	B-T170
,	O	O	O
researchers	O	O	B-T097
,	O	O	O
politicians	O	O	B-T097
,	O	O	O
and	O	O	O
the	O	O	O
biotech	O	O	B-T091
industry	O	O	B-T057
-that	O	O	O
a	O	O	O
genome	O	O	B-T028
-driven	O	O	O
health	O	O	B-T058
care	O	O	I-T058
revolution	O	O	B-T068
is	O	O	O
just	O	O	O
around	O	O	O
the	O	O	O
corner	O	O	O
.	O	O	O
And	O	O	O
while	O	O	O
the	O	O	O
revolution	O	O	O
never	O	O	O
seems	O	O	O
to	O	O	O
arrive	O	O	O
,	O	O	O
the	O	O	O
hopeful	O	O	O
rhetoric	O	O	B-T169
continues	O	O	O
.	O	O	O

It	O	O	O
has	O	O	O
been	O	O	O
suggested	O	O	O
that	O	O	O
this	O	O	O
unrelenting	O	O	O
"	O	O	O
genohype	O	O	B-T080
"	O	O	O
is	O	O	O
having	O	O	O
a	O	O	O
range	O	O	O
of	O	O	O
adverse	O	O	B-T033
social	O	O	B-T054
consequences	O	O	I-T054
,	O	O	O
including	O	O	O
misleading	O	O	O
the	O	O	O
public	O	O	B-T098
and	O	O	O
hurting	O	O	B-T184
the	O	O	O
long-term	O	O	B-T079
legitimacy	O	O	B-T089
of	O	O	O
the	O	O	O
field	O	O	B-T077
.	O	O	O

While	O	O	O
we	O	O	O
need	O	O	O
more	O	O	O
good	O	O	O
data	O	O	B-T078
on	O	O	O
the	O	O	O
nature	O	O	B-T078
and	O	O	O
magnitude	O	O	B-T081
of	O	O	O
these	O	O	O
possible	O	O	O
harms	O	O	B-UnknownType
,	O	O	O
few	O	O	O
would	O	O	O
argue	O	O	O
with	O	O	O
the	O	O	O
proposition	O	O	B-T170
that	O	O	O
sustained	O	O	B-T169
science	O	O	B-T090
hype	O	O	B-T080
is	O	O	O
a	O	O	O
bad	O	O	O
thing	O	O	O
.	O	O	O

We	O	O	O
all	O	O	O
benefit	O	O	B-T081
from	O	O	O
robust	O	O	B-T080
science	O	O	B-T090
and	O	O	O
accurate	O	O	B-T080
public	O	O	B-T098
representations	O	O	B-T052
of	O	O	O
biomedical	O	O	B-T062
research	O	O	I-T062
.	O	O	O

But	O	O	O
,	O	O	O
to	O	O	O
date	O	O	O
,	O	O	O
there	O	O	O
has	O	O	O
been	O	O	O
very	O	O	O
little	O	O	O
consideration	O	O	B-T033
of	O	O	O
the	O	O	O
degree	O	O	B-T081
to	O	O	O
which	O	O	O
the	O	O	O
scholarship	O	O	B-T078
on	O	O	O
the	O	O	O
related	O	O	O
ethical	O	O	B-T078
,	O	O	O
legal	O	O	B-T089
,	O	O	O
and	O	O	O
social	O	O	B-T054
issues	O	O	I-T054
has	O	O	O
been	O	O	O
hyped	O	O	O
.	O	O	O

Are	O	O	O
the	O	O	O
conclusions	O	O	B-T078
from	O	O	O
ELSI	O	O	B-T078
scholarship	O	O	I-T078
also	O	O	O
exaggerated	O	O	B-T080
?	O	O	O

-DOCSTART- (27650225)

Lubiprostone	O	O	B-T109
Accelerates	O	O	B-T169
Intestinal	O	O	B-T042
Transit	O	O	I-T042
and	O	O	O
Alleviates	O	O	B-T169
Small	O	O	B-T047
Intestinal	O	O	I-T047
Bacterial	O	O	I-T047
Overgrowth	O	O	I-T047
in	O	O	O
Patients	O	O	B-T101
With	O	O	O
Chronic	O	O	O
Constipation	O	O	O

Lubiprostone	O	O	B-T109
is	O	O	O
an	O	O	O
effective	O	O	B-T080
treatment	O	O	B-T169
for	O	O	O
chronic	O	O	B-T184
constipation	O	O	I-T184
(	O	O	O
CC	O	O	B-T184
)	O	O	O
.	O	O	O

The	O	O	O
mechanism	O	O	B-T169
of	O	O	I-T169
action	O	O	I-T169
of	O	O	O
lubiprostone	O	O	B-T109
is	O	O	O
through	O	O	O
increasing	O	O	B-T169
fluid	O	O	B-T043
secretion	O	O	I-T043
and	O	O	O
lubrication	O	O	B-T067
of	O	O	O
the	O	O	O
intestinal	O	O	B-T030
lumen	O	O	I-T030
.	O	O	O

The	O	O	O
effects	O	O	B-T080
of	O	O	O
lubiprostone	O	O	B-T109
on	O	O	O
gastrointestinal	O	O	B-T042
transit	O	O	I-T042
and	O	O	O
small	O	O	B-T047
intestinal	O	O	I-T047
bacterial	O	O	I-T047
overgrowth	O	O	I-T047
(	O	O	O
SIBO	O	O	B-T047
)	O	O	O
have	O	O	O
not	O	O	O
been	O	O	O
adequately	O	O	O
explored	O	O	O
.	O	O	O

The	O	O	O
current	O	O	O
study	O	O	B-T062
was	O	O	O
designed	O	O	O
to	O	O	O
investigate	O	O	B-T169
whether	O	O	O
lubiprostone	O	O	B-T109
(	O	O	O
1	O	O	O
)	O	O	O
alters	O	O	O
gastrointestinal	O	O	B-T042
transit	O	O	I-T042
and	O	O	O
(	O	O	O
2	O	O	O
)	O	O	O
affects	O	O	O
SIBO	O	O	B-T047
in	O	O	O
patients	O	O	B-T101
with	O	O	O
constipation	O	O	B-T184
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
29	O	O	O
female	O	O	B-T032
patients	O	O	I-T032
(	O	O	O
mean	O	O	B-T032
age	O	O	I-T032
=	O	O	O
39	O	O	O
years	O	O	B-T079
;	O	O	O
range	O	O	B-T081
:	O	O	O
19	O	O	O
-	O	O	O
64	O	O	O
)	O	O	O
with	O	O	O
CC	O	O	B-T184
received	O	O	B-T080
2	O	O	O
weeks	O	O	B-T079
of	O	O	O
lubiprostone	O	O	B-T109
(	O	O	O
24mcg	O	O	O
b.i.d	O	O	O
.	O	O	O
,	O	O	O
P.O.	O	O	O
)	O	O	O
.	O	O	O

Stool	O	O	B-T033
consistency	O	O	I-T033
based	O	O	O
on	O	O	O
Bristol	O	O	B-T170
stool	O	O	I-T170
scale	O	O	I-T170
and	O	O	O
the	O	O	O
frequency	O	O	B-T033
of	O	O	I-T033
bowel	O	O	I-T033
movements	O	O	I-T033
(	O	O	O
BMs	O	O	B-T040
)	O	O	O
were	O	O	O
recorded	O	O	O
.	O	O	O

Gastric	O	O	B-T079
emptying	O	O	I-T079
time	O	O	I-T079
,	O	O	O
small	O	O	B-T042
bowel	O	O	I-T042
transit	O	O	B-T042
time	O	O	I-T042
,	O	O	O
colon	O	O	B-T023
transit	O	O	O
time	O	O	O
(	O	O	O
CTT	O	O	B-T042
)	O	O	O
,	O	O	O
combined	O	O	O
small	O	O	B-T042
and	O	O	I-T042
large	O	O	I-T042
bowel	O	O	I-T042
transit	O	O	I-T042
time	O	O	I-T042
(	O	O	O
SLBTT	O	O	B-T042
)	O	O	O
and	O	O	O
whole	O	O	O
gut	O	O	B-T023
transit	O	O	O
time	O	O	O
were	O	O	O
measured	O	O	B-T080
using	O	O	O
wireless	O	O	B-T060
motility	O	O	I-T060
capsule	O	O	I-T060
.	O	O	O

The	O	O	O
SIBO	O	O	B-T047
status	O	O	B-T080
was	O	O	O
assessed	O	O	O
by	O	O	O
the	O	O	O
lactulose	O	O	B-T060
breath	O	O	I-T060
test	O	O	I-T060
.	O	O	O

Data	O	O	B-T078
were	O	O	O
analyzed	O	O	B-T062
using	O	O	O
Wilcoxon	O	O	B-T081
rank	O	O	I-T081
,	O	O	O
Mann-Whitney	O	O	B-T081
U	O	O	I-T081
,	O	O	O
Spearman×³s	O	O	B-T081
rank	O	O	I-T081
correlation	O	O	I-T081
and	O	O	O
Chi-square	O	O	B-T170
tests	O	O	I-T170
.	O	O	O

Lubiprostone	O	O	B-T109
significantly	O	O	O
softened	O	O	B-T067
the	O	O	O
stool	O	O	B-T031
and	O	O	O
increased	O	O	B-T081
the	O	O	O
frequency	O	O	B-T033
of	O	O	I-T033
BM	O	O	I-T033
from	O	O	O
median	O	O	B-T081
of	O	O	O
2	O	O	O
to	O	O	O
4	O	O	O
times	O	O	B-T081
per	O	O	O
week	O	O	B-T079
.	O	O	O

The	O	O	O
CTT	O	O	B-T042
and	O	O	O
SLBTT	O	O	B-T042
were	O	O	O
significantly	O	O	O
shorter	O	O	B-T080
in	O	O	O
responders	O	O	B-T098
to	O	O	O
lubiprostone	O	O	B-T109
(	O	O	O
i.e.	O	O	O
,	O	O	O
those	O	O	O
with	O	O	O
â¥	O	O	O
2	O	O	O
times	O	O	B-T081
increase	O	O	B-T169
in	O	O	O
the	O	O	O
number	O	O	B-T081
of	O	O	O
their	O	O	O
weekly	O	O	B-T079
BM	O	O	B-T040
)	O	O	O
compared	O	O	B-T052
with	O	O	O
nonresponders	O	O	B-T098
.	O	O	O

The	O	O	O
higher	O	O	B-T080
frequency	O	O	B-T033
of	O	O	I-T033
BM	O	O	I-T033
after	O	O	O
treatment	O	O	B-T169
was	O	O	O
significantly	O	O	O
correlated	O	O	B-T080
with	O	O	O
the	O	O	O
acceleration	O	O	B-T067
of	O	O	O
CTT	O	O	B-T042
,	O	O	O
SLBTT	O	O	B-T042
and	O	O	O
whole	O	O	O
gut	O	O	B-T023
transit	O	O	B-T042
time	O	O	I-T042
.	O	O	O

In	O	O	O
all	O	O	O
,	O	O	O
17	O	O	O
out	O	O	O
of	O	O	O
25	O	O	O
(	O	O	O
68	O	O	O
%	O	O	O
)	O	O	O
patients	O	O	B-T101
,	O	O	O
who	O	O	O
were	O	O	O
tested	O	O	B-T169
for	O	O	O
SIBO	O	O	B-T047
at	O	O	O
baseline	O	O	B-T081
,	O	O	O
were	O	O	O
positive	O	O	B-T033
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
7	O	O	O
out	O	O	O
of	O	O	O
17	O	O	O
(	O	O	O
41	O	O	O
%	O	O	O
)	O	O	O
SIBO	O	O	B-T047
-	O	O	O
positive	O	O	B-T033
patients	O	O	B-T101
became	O	O	O
SIBO	O	O	O
-	O	O	O
negative	O	O	B-T033
after	O	O	O
lubiprostone	O	O	B-T109
treatment	O	O	B-T169
(	O	O	O
P	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
.	O	O	O

In	O	O	O
CC	O	O	B-T184
,	O	O	O
lubiprostone	O	O	B-T109
improves	O	O	O
the	O	O	O
frequency	O	O	B-T033
of	O	O	I-T033
BMs	O	O	I-T033
,	O	O	O
softens	O	O	B-T067
the	O	O	O
stool	O	O	B-T031
,	O	O	O
accelerates	O	O	B-T169
intestinal	O	O	B-T042
transit	O	O	I-T042
and	O	O	O
decreases	O	O	B-T081
accompanying	O	O	O
SIBO	O	O	B-T047
.	O	O	O

The	O	O	O
improvement	O	O	B-T077
of	O	O	O
SIBO	O	O	B-T047
could	O	O	O
be	O	O	O
explained	O	O	O
by	O	O	O
the	O	O	O
cleansing	O	O	B-T052
effect	O	O	B-T080
of	O	O	O
increased	O	O	B-T081
intestinal	O	O	B-T042
fluid	O	O	I-T042
and	O	O	O
mucus	O	O	B-T031
combined	O	O	O
with	O	O	O
enhanced	O	O	B-T052
intestinal	O	O	B-T042
motility	O	O	I-T042
with	O	O	O
lubiprostone	O	O	B-T109
.	O	O	O

-DOCSTART- (27650462)

Minimally	O	O	B-T061
invasive	O	O	I-T061
treatment	O	O	I-T061
of	O	O	O
difficult	O	O	O
bleeding	O	O	B-T046
lesions	O	O	B-T033
of	O	O	O
the	O	O	O
small	O	O	O
bowel	O	O	O

Bleeding	O	O	B-T046
lesions	O	O	B-T033
of	O	O	O
the	O	O	O
small	O	O	B-T023
bowel	O	O	I-T023
are	O	O	O
often	O	O	O
difficult	O	O	O
to	O	O	O
identify	O	O	B-T080
due	O	O	O
to	O	O	O
the	O	O	O
obscure	O	O	B-T033
symptomatology	O	O	B-T184
.	O	O	O

Localizing	O	O	B-T082
these	O	O	O
lesions	O	O	B-T033
requires	O	O	O
specific	O	O	B-T080
techniques	O	O	B-T169
.	O	O	O

The	O	O	O
Double-balloon	O	O	B-T060
enteroscopy	O	O	I-T060
(	O	O	O
DBE	O	O	B-T060
)	O	O	O
could	O	O	O
be	O	O	O
used	O	O	O
to	O	O	O
precisely	O	O	O
localize	O	O	B-T082
and	O	O	O
mark	O	O	O
lesions	O	O	B-T033
,	O	O	O
so	O	O	O
that	O	O	O
a	O	O	O
minimally	O	O	B-T061
invasive	O	O	I-T061
surgical	O	O	I-T061
treatment	O	O	I-T061
could	O	O	O
be	O	O	O
performed	O	O	O
.	O	O	O

Twenty	O	O	O
robot	O	O	B-T073
-	O	O	O
assisted	O	O	B-T080
small	O	O	B-T061
bowel	O	O	I-T061
procedures	O	O	I-T061
are	O	O	O
presented	O	O	O
using	O	O	O
a	O	O	O
combination	O	O	B-T080
of	O	O	O
DBE	O	O	B-T060
for	O	O	O
localization	O	O	B-T082
and	O	O	O
robotic	O	O	B-T061
resection	O	O	I-T061
.	O	O	O

There	O	O	O
were	O	O	O
10	O	O	O
jejunal	O	O	B-T061
resections	O	O	I-T061
and	O	O	O
10	O	O	O
ileal	O	O	B-T061
resections	O	O	I-T061
.	O	O	O

Mean	O	O	O
age	O	O	B-T032
was	O	O	O
58.7	O	O	O
years	O	O	B-T079
.	O	O	O

Mean	O	O	O
operative	O	O	B-T079
time	O	O	I-T079
was	O	O	O
153.4	O	O	O
minutes	O	O	B-T079
,	O	O	O
mean	O	O	O
blood	O	O	B-T033
loss	O	O	I-T033
of	O	O	O
46	O	O	O
mL.	O	O	O
No	O	O	O
conversion-to-open	O	O	B-T061
and	O	O	O
there	O	O	O
were	O	O	O
4	O	O	O
post-operative	O	O	B-T079
complications	O	O	B-T046
.	O	O	O

The	O	O	O
90-	O	O	O
day	O	O	B-T079
mortality	O	O	B-T081
was	O	O	O
nil	O	O	O
and	O	O	O
the	O	O	O
median	O	O	O
length	O	O	B-T079
of	O	O	I-T079
stay	O	O	I-T079
was	O	O	O
4.1	O	O	O
days	O	O	B-T079
.	O	O	O

Final	O	O	O
pathology	O	O	B-T170
was	O	O	O
consistent	O	O	B-T078
with	O	O	I-T078
malignancy	O	O	B-T191
in	O	O	O
10	O	O	O
cases	O	O	B-T169
.	O	O	O

The	O	O	O
combination	O	O	B-T080
of	O	O	O
double-balloon	O	O	B-T060
enteroscopy	O	O	I-T060
and	O	O	O
robotic	O	O	B-T061
technology	O	O	I-T061
allows	O	O	O
accurate	O	O	B-T080
identification	O	O	B-T080
and	O	O	O
selective	O	O	O
treatment	O	O	B-T169
of	O	O	O
lesions	O	O	B-T033
that	O	O	O
could	O	O	O
be	O	O	O
otherwise	O	O	O
difficult	O	O	O
to	O	O	O
treat	O	O	B-T169
in	O	O	O
a	O	O	O
minimally	O	O	B-T061
invasive	O	O	I-T061
fashion	O	O	I-T061
.	O	O	O

-DOCSTART- (27651955)

Kinematic	O	O	B-T091
and	O	O	O
EMG	O	O	B-T060
Responses	O	O	B-T032
to	O	O	O
Pelvis	O	O	B-T023
and	O	O	O
Leg	O	O	B-T023
Assistance	O	O	B-T077
Force	O	O	B-T070
during	O	O	O
Treadmill	O	O	B-T056
Walking	O	O	I-T056
in	O	O	O
Children	O	O	B-T100
with	O	O	O
Cerebral	O	O	O
Palsy	O	O	O

Treadmill	O	O	B-T061
training	O	O	I-T061
has	O	O	O
been	O	O	O
used	O	O	O
for	O	O	O
improving	O	O	O
locomotor	O	O	B-T040
function	O	O	I-T040
in	O	O	O
children	O	O	B-T100
with	O	O	O
cerebral	O	O	B-T047
palsy	O	O	I-T047
(	O	O	O
CP	O	O	B-T047
)	O	O	O
,	O	O	O
but	O	O	O
the	O	O	O
functional	O	O	O
gains	O	O	O
are	O	O	O
relatively	O	O	O
small	O	O	O
,	O	O	O
suggesting	O	O	O
a	O	O	O
need	O	O	O
to	O	O	O
improve	O	O	O
current	O	O	O
paradigms	O	O	B-T062
.	O	O	O

The	O	O	O
understanding	O	O	O
of	O	O	O
the	O	O	O
kinematic	O	O	B-T091
and	O	O	O
EMG	O	O	B-T060
responses	O	O	B-T032
to	O	O	O
force	O	O	B-T070
s	O	O	O
applied	O	O	O
to	O	O	O
the	O	O	O
body	O	O	B-T017
of	O	O	O
subjects	O	O	O
during	O	O	O
treadmill	O	O	B-T056
walking	O	O	I-T056
is	O	O	O
crucial	O	O	O
for	O	O	O
improving	O	O	O
current	O	O	O
paradigms	O	O	B-T062
.	O	O	O

The	O	O	O
objective	O	O	B-T170
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
determine	O	O	O
the	O	O	O
kinematic	O	O	B-T091
s	O	O	O
and	O	O	O
EMG	O	O	B-T060
responses	O	O	B-T032
to	O	O	O
the	O	O	O
pelvis	O	O	B-T023
and/or	O	O	O
leg	O	O	B-T023
assistance	O	O	B-T077
force	O	O	B-T070
.	O	O	O

Ten	O	O	O
children	O	O	B-T100
with	O	O	O
spastic	O	O	B-T047
CP	O	O	I-T047
were	O	O	O
recruited	O	O	O
to	O	O	O
participate	O	O	B-T058
in	O	O	O
this	O	O	O
study	O	O	B-T062
.	O	O	O

A	O	O	O
controlled	O	O	O
assistance	O	O	B-T077
force	O	O	B-T070
was	O	O	O
applied	O	O	O
to	O	O	O
the	O	O	O
pelvis	O	O	B-T023
and/or	O	O	O
legs	O	O	B-T023
during	O	O	O
stance	O	O	B-T033
and	O	O	O
swing	O	O	B-T033
phase	O	O	I-T033
of	O	O	I-T033
gait	O	O	I-T033
through	O	O	O
a	O	O	O
custom	O	O	O
designed	O	O	O
robotic	O	O	B-T170
system	O	O	I-T170
during	O	O	O
walking	O	O	B-T056
.	O	O	O

Muscle	O	O	B-T024
activities	O	O	B-T052
and	O	O	O
spatial	O	O	B-T082
-	O	O	O
temporal	O	O	B-T079
gait	O	O	B-T033
parameters	O	O	I-T033
were	O	O	O
measured	O	O	O
at	O	O	O
different	O	O	O
loading	O	O	B-T032
conditions	O	O	I-T032
during	O	O	O
walking	O	O	B-T056
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
the	O	O	O
spatial-temporal	O	O	B-T033
gait	O	O	I-T033
parameters	O	O	I-T033
during	O	O	O
overground	O	O	O
walking	O	O	B-T056
before	O	O	O
and	O	O	O
after	O	O	O
treadmill	O	O	B-T061
training	O	O	I-T061
were	O	O	O
also	O	O	O
collected	O	O	O
.	O	O	O

Applying	O	O	O
pelvis	O	O	B-T023
assistance	O	O	B-T077
improved	O	O	B-T033
step	O	O	B-T033
height	O	O	I-T033
and	O	O	O
applying	O	O	O
leg	O	O	B-T023
assistance	O	O	O
improved	O	O	O
step	O	O	B-T033
length	O	O	I-T033
during	O	O	O
walking	O	O	B-T056
,	O	O	O
but	O	O	O
applying	O	O	O
leg	O	O	O
assistance	O	O	O
also	O	O	O
reduced	O	O	B-T080
muscle	O	O	B-T024
activation	O	O	B-T052
of	O	O	O
ankle	O	O	B-T023
flexor	O	O	I-T023
during	O	O	O
the	O	O	O
swing	O	O	B-T033
phase	O	O	I-T033
of	O	O	I-T033
gait	O	O	I-T033
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
step	O	O	B-T033
length	O	O	I-T033
and	O	O	O
self-selected	O	O	O
walking	O	O	B-T032
speed	O	O	I-T032
significantly	O	O	O
improved	O	O	B-T033
after	O	O	O
one	O	O	O
session	O	O	B-T051
of	O	O	O
treadmill	O	O	B-T061
training	O	O	I-T061
with	O	O	O
combined	O	O	O
pelvis	O	O	B-T023
and	O	O	O
leg	O	O	B-T023
assistance	O	O	B-T077
.	O	O	O

-DOCSTART- (27651975)

Outlining	O	O	O
a	O	O	O
Population	O	O	B-T098
"	O	O	I-T098
at	O	O	I-T098
Risk	O	O	I-T098
"	O	O	I-T098
of	O	O	O
Parkinson	O	O	B-T047
's	O	O	I-T047
Disease	O	O	I-T047
:	O	O	O
Evidence	O	O	B-T078
from	O	O	O
a	O	O	O
Case-Control	O	O	O
Study	O	O	O

The	O	O	O
multifactorial	O	O	B-T046
pathogenesis	O	O	I-T046
of	O	O	O
Parkinson	O	O	B-T047
's	O	O	I-T047
Disease	O	O	I-T047
(	O	O	O
PD	O	O	B-T047
)	O	O	O
requires	O	O	O
a	O	O	O
careful	O	O	O
identification	O	O	O
of	O	O	O
populations	O	O	B-T098
"	O	O	I-T098
at	O	O	I-T098
risk	O	O	I-T098
"	O	O	I-T098
of	O	O	O
developing	O	O	O
the	O	O	O
disease	O	O	B-T047
.	O	O	O

In	O	O	O
this	O	O	O
case-control	O	O	B-T062
study	O	O	I-T062
we	O	O	O
analyzed	O	O	B-T062
a	O	O	O
large	O	O	O
Italian	O	O	B-T083
population	O	O	B-T098
,	O	O	O
in	O	O	O
an	O	O	O
attempt	O	O	O
to	O	O	O
outline	O	O	O
general	O	O	B-T078
criteria	O	O	I-T078
to	O	O	O
define	O	O	O
a	O	O	O
population	O	O	B-T098
"	O	O	I-T098
at	O	O	I-T098
risk	O	O	I-T098
"	O	O	I-T098
of	O	O	O
PD	O	O	B-T047
.	O	O	O

We	O	O	O
enrolled	O	O	O
300	O	O	O
PD	O	O	B-T047
patients	O	O	B-T101
and	O	O	O
300	O	O	O
controls	O	O	B-T096
,	O	O	O
gender	O	O	B-T032
and	O	O	O
age	O	O	B-T032
matched	O	O	B-T096
,	O	O	O
from	O	O	O
the	O	O	O
same	O	O	O
urban	O	O	B-T080
geographical	O	O	B-UnknownType
area	O	O	I-UnknownType
.	O	O	O

All	O	O	O
subjects	O	O	B-T098
were	O	O	O
interviewed	O	O	B-T052
on	O	O	O
demographics	O	O	B-T090
,	O	O	O
family	O	O	B-T033
history	O	O	I-T033
of	O	O	O
PD	O	O	B-T047
,	O	O	O
occupational	O	O	B-T033
and	O	O	I-T033
environmental	O	O	I-T033
toxicants	O	O	I-T033
exposure	O	O	I-T033
,	O	O	O
smoking	O	O	B-T201
status	O	O	I-T201
,	O	O	O
and	O	O	O
alcohol	O	O	B-T055
consumption	O	O	I-T055
.	O	O	O

A	O	O	O
sample	O	O	O
of	O	O	O
65	O	O	O
patients	O	O	B-T101
and	O	O	O
65	O	O	O
controls	O	O	B-T096
also	O	O	O
underwent	O	O	O
serum	O	O	B-T031
dosing	O	O	B-T081
of	O	O	O
iron	O	O	B-T059
,	O	O	O
copper	O	O	B-T059
,	O	O	O
mercury	O	O	B-T059
,	O	O	O
and	O	O	O
manganese	O	O	B-T059
by	O	O	O
means	O	O	O
of	O	O	O
Inductively	O	O	B-T059
Coupled-Plasma-Mass-Spectrometry	O	O	I-T059
(	O	O	O
ICP-MS	O	O	B-T059
)	O	O	O
.	O	O	O

Positive	O	O	B-T033
family	O	O	B-T033
history	O	O	I-T033
,	O	O	O
toxicants	O	O	B-T033
exposure	O	O	I-T033
,	O	O	O
non-current-smoker	O	O	B-T033
,	O	O	O
and	O	O	O
alcohol	O	O	B-T033
nonconsumer	O	O	I-T033
status	O	O	I-T033
occurred	O	O	O
as	O	O	O
significant	O	O	O
risk	O	O	B-T033
factors	O	O	I-T033
in	O	O	O
our	O	O	O
population	O	O	B-T098
.	O	O	O

The	O	O	O
number	O	O	O
of	O	O	O
concurring	O	O	B-T033
risk	O	O	I-T033
factors	O	O	I-T033
overlapping	O	O	B-T079
in	O	O	O
the	O	O	O
same	O	O	B-T098
subject	O	O	I-T098
impressively	O	O	O
increased	O	O	B-T081
the	O	O	O
overall	O	O	B-T080
risk	O	O	I-T080
.	O	O	O

No	O	O	B-T033
significant	O	O	I-T033
differences	O	O	I-T033
were	O	O	O
measured	O	O	B-T080
in	O	O	O
the	O	O	O
metal	O	O	B-T197
serum	O	O	B-T031
levels	O	O	B-T080
.	O	O	O

Our	O	O	O
findings	O	O	B-T033
indicate	O	O	O
that	O	O	O
combination	O	O	O
of	O	O	O
three	O	O	O
to	O	O	O
four	O	O	O
concurrent	O	O	B-T079
PD	O	O	B-T047
-	O	O	O
risk	O	O	B-T033
factors	O	O	I-T033
defines	O	O	O
a	O	O	O
condition	O	O	O
"	O	O	O
at	O	O	B-T080
risk	O	O	I-T080
"	O	O	O
of	O	O	O
PD	O	O	O
.	O	O	O

A	O	O	O
simple	O	O	O
stratification	O	O	B-T062
,	O	O	O
based	O	O	O
on	O	O	O
these	O	O	O
questionnaires	O	O	B-T170
,	O	O	O
might	O	O	O
be	O	O	O
of	O	O	O
help	O	O	O
in	O	O	O
identifying	O	O	B-T062
subjects	O	O	I-T062
suitable	O	O	O
for	O	O	O
neuroprotective	O	O	B-T041
strategies	O	O	I-T041
.	O	O	O

-DOCSTART- (27652926)

Work	O	O	B-T057
process	O	O	B-T067
,	O	O	O
performance	O	O	B-T033
and	O	O	O
professional	O	O	B-T097
profile	O	O	I-T097
of	O	O	O
a	O	O	O
Hearing	O	O	B-T058
Health	O	O	I-T058
Network	O	O	I-T058
:	O	O	O
reference	O	O	B-T170
for	O	O	O
satisfaction	O	O	O

To	O	O	O
analyze	O	O	B-T062
the	O	O	O
correlation	O	O	B-T080
between	O	O	O
the	O	O	O
satisfaction	O	O	B-T041
of	O	O	O
professionals	O	O	B-T097
from	O	O	O
the	O	O	O
Hearing	O	O	B-T058
Health	O	O	I-T058
Care	O	O	I-T058
network	O	O	I-T058
in	O	O	O
two	O	O	O
micro	O	O	B-T077
-	O	O	O
regions	O	O	B-T082
of	O	O	O
Minas	O	O	B-UnknownType
Gerais	O	O	I-UnknownType
state	O	O	I-UnknownType
and	O	O	O
the	O	O	O
sociodemographic	O	O	B-T169
profile	O	O	I-T169
,	O	O	O
work	O	O	B-T057
process	O	O	B-T067
,	O	O	O
and	O	O	O
work	O	O	B-T033
performance	O	O	I-T033
in	O	O	O
the	O	O	O
health	O	O	B-T058
service	O	O	I-T058
.	O	O	O

This	O	O	O
is	O	O	O
a	O	O	O
cross-sectional	O	O	B-T062
,	O	O	O
observational	O	O	B-T062
,	O	O	O
analytic	O	O	B-T081
study	O	O	I-T081
with	O	O	O
a	O	O	O
non-probabilistic	O	O	B-T062
sample	O	O	I-T062
including	O	O	O
34	O	O	O
professionals	O	O	B-T097
from	O	O	O
the	O	O	O
Hearing	O	O	B-T058
Health	O	O	I-T058
Care	O	O	I-T058
services	O	O	I-T058
.	O	O	O

Data	O	O	B-T062
collection	O	O	I-T062
occurred	O	O	O
through	O	O	O
individual	O	O	B-T098
interviews	O	O	B-T052
in	O	O	O
the	O	O	O
municipality	O	O	B-T083
of	O	O	O
professional	O	O	B-T057
practice	O	O	I-T057
.	O	O	O

Associations	O	O	B-T080
between	O	O	O
the	O	O	O
Professional	O	O	B-T041
Satisfaction	O	O	I-T041
variable	O	O	B-T080
and	O	O	O
the	O	O	O
explanatory	O	O	B-T170
variables	O	O	B-T080
Sociodemographic	O	O	B-T078
Data	O	O	I-T078
,	O	O	O
Work	O	O	B-T080
Routine	O	O	I-T080
,	O	O	O
and	O	O	O
Developed	O	O	B-T169
Actions	O	O	B-T052
were	O	O	O
conducted	O	O	O
.	O	O	O

Professionals	O	O	B-T097
with	O	O	O
graduate	O	O	B-T065
studies	O	O	I-T065
were	O	O	O
more	O	O	O
satisfied	O	O	B-T170
with	O	O	O
the	O	O	O
human	O	O	B-T170
resources	O	O	I-T170
policy	O	O	B-T170
and	O	O	O
the	O	O	O
activities	O	O	B-T052
developed	O	O	B-T169
,	O	O	O
whereas	O	O	O
health	O	O	B-T058
civil	O	O	B-T097
servants	O	O	I-T097
showed	O	O	O
more	O	O	O
satisfaction	O	O	B-T041
with	O	O	O
the	O	O	O
wage	O	O	B-T081
policy	O	O	O
and	O	O	O
the	O	O	O
work	O	O	B-T079
schedule	O	O	I-T079
.	O	O	O

The	O	O	O
correlation	O	O	B-T080
analysis	O	O	I-T062
between	O	O	O
work	O	O	B-T057
process	O	O	B-T067
and	O	O	O
satisfaction	O	O	B-T041
revealed	O	O	B-T080
a	O	O	O
moderate	O	O	B-T081
positive	O	O	B-T033
correlation	O	O	O
between	O	O	O
items	O	O	O
such	O	O	O
as	O	O	O
Health	O	O	B-T058
Promotion	O	O	I-T058
Actions	O	O	B-T052
,	O	O	O
Satisfaction	O	O	B-T041
with	O	O	O
Diagnostic	O	O	B-T074
Equipment	O	O	I-T074
,	O	O	O
and	O	O	O
Satisfaction	O	O	O
with	O	O	O
Maintenance	O	O	B-T033
Equipment	O	O	I-T033
.	O	O	O

The	O	O	O
present	O	O	O
study	O	O	B-T062
revealed	O	O	O
a	O	O	O
higher	O	O	B-T080
level	O	O	B-T080
of	O	O	O
satisfaction	O	O	B-T041
among	O	O	O
professionals	O	O	B-T090
with	O	O	O
graduate	O	O	B-T065
studies	O	O	I-T065
(	O	O	O
human	O	O	B-T170
resources	O	O	I-T170
policy	O	O	B-T170
and	O	O	O
activities	O	O	B-T052
developed	O	O	B-T169
)	O	O	O
and	O	O	O
civil	O	O	B-T097
servants	O	O	I-T097
(	O	O	O
wage	O	O	B-T081
policy	O	O	O
and	O	O	O
work	O	O	B-T079
schedule	O	O	I-T079
)	O	O	O
.	O	O	O

The	O	O	O
relevance	O	O	B-T080
of	O	O	O
this	O	O	O
study	O	O	B-T062
lies	O	O	O
on	O	O	O
the	O	O	O
important	O	O	O
role	O	O	O
that	O	O	O
health	O	O	B-T097
professionals	O	O	I-T097
play	O	O	O
on	O	O	O
the	O	O	O
Health	O	O	B-T058
Care	O	O	I-T058
Network	O	O	I-T058
.	O	O	O

Additionally	O	O	O
,	O	O	O
the	O	O	O
study	O	O	B-T062
of	O	O	O
satisfaction	O	O	B-T041
level	O	O	B-T080
can	O	O	O
provide	O	O	O
a	O	O	O
search	O	O	O
for	O	O	O
improvements	O	O	B-T077
,	O	O	O
considering	O	O	O
that	O	O	O
satisfied	O	O	B-T170
professionals	O	O	B-T090
not	O	O	O
only	O	O	O
improve	O	O	B-T033
service	O	O	B-T080
quality	O	O	I-T080
,	O	O	O
but	O	O	O
also	O	O	O
show	O	O	B-T033
greater	O	O	I-T033
creativity	O	O	I-T033
,	O	O	O
commitment	O	O	B-T041
,	O	O	O
and	O	O	O
performance	O	O	B-T033
.	O	O	O

-DOCSTART- (27653010)

Application	O	O	B-T058
of	O	O	O
Laparoscopic	O	O	B-T060
Lumbar	O	O	B-T061
Discectomy	O	O	I-T061
and	O	O	O
Artificial	O	O	B-T061
Disc	O	O	I-T061
Replacement	O	O	I-T061
:	O	O	O
At	O	O	O
Least	O	O	O
Two	O	O	O
Years	O	O	O
of	O	O	O
Follow-Up	O	O	O

This	O	O	O
prospective	O	O	B-T062
observational	O	O	B-T062
study	O	O	I-T062
included	O	O	O
22	O	O	O
patients	O	O	B-T101
who	O	O	O
were	O	O	O
diagnosed	O	O	B-T033
with	O	O	O
symptomatic	O	O	B-T169
degenerative	O	O	B-T047
disc	O	O	I-T047
disease	O	O	I-T047
treated	O	O	O
via	O	O	O
artificial	O	O	B-T061
disc	O	O	I-T061
replacement	O	O	I-T061
(	O	O	O
ADR	O	O	B-T061
)	O	O	O
with	O	O	O
a	O	O	O
laparoscopic	O	O	B-T060
technique	O	O	B-T169
.	O	O	O

The	O	O	O
current	O	O	O
study	O	O	B-T062
aimed	O	O	B-T078
to	O	O	O
assess	O	O	B-T052
the	O	O	O
safety	O	O	B-T068
and	O	O	O
efficacy	O	O	B-T080
of	O	O	O
ADR	O	O	B-T061
using	O	O	O
a	O	O	O
laparoscopic	O	O	B-T060
technique	O	O	B-T169
for	O	O	O
lumbar	O	O	B-T020
disc	O	O	I-T020
herniation	O	O	I-T020
.	O	O	O

Symptomatic	O	O	B-T169
degenerative	O	O	B-T047
disc	O	O	I-T047
disease	O	O	I-T047
is	O	O	O
the	O	O	O
major	O	O	O
cause	O	O	O
of	O	O	O
low	O	O	B-T184
back	O	O	I-T184
pain	O	O	I-T184
with	O	O	O
lumbar	O	O	B-T029
segmental	O	O	B-T082
instability	O	O	B-T033
.	O	O	O

ADR	O	O	B-T061
has	O	O	O
increased	O	O	B-T081
in	O	O	O
popularity	O	O	B-T054
as	O	O	O
an	O	O	O
alternative	O	O	B-UnknownType
treatment	O	O	I-UnknownType
for	O	O	O
lumbar	O	O	B-T020
disc	O	O	I-T020
herniation	O	O	I-T020
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
traditional	O	O	B-T169
approach	O	O	B-T082
to	O	O	O
spinal	O	O	B-T061
surgery	O	O	I-T061
carries	O	O	O
the	O	O	O
risk	O	O	B-T078
of	O	O	O
catastrophic	O	O	B-T047
bleeding	O	O	B-T046
from	O	O	O
injury	O	O	B-T037
to	O	O	O
major	O	O	O
vessels	O	O	B-T023
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
iatrogenic	O	O	B-T080
injury	O	O	O
to	O	O	O
the	O	O	O
viscera	O	O	B-T023
and	O	O	O
associated	O	O	B-T023
structures	O	O	I-T023
.	O	O	O

Therefore	O	O	O
,	O	O	O
laparoscopic	O	O	B-T060
lumbar	O	O	B-T061
discectomy	O	O	I-T061
and	O	O	O
ADR	O	O	B-T061
may	O	O	O
represent	O	O	B-T052
a	O	O	O
useful	O	O	O
alternative	O	O	B-T077
.	O	O	O

Twenty-two	O	O	O
patients	O	O	B-T101
(	O	O	O
8	O	O	O
males	O	O	B-T032
and	O	O	O
14	O	O	O
females	O	O	B-T032
)	O	O	O
who	O	O	O
were	O	O	O
diagnosed	O	O	B-T033
with	O	O	O
symptomatic	O	O	B-T169
degenerative	O	O	B-T047
disc	O	O	I-T047
disease	O	O	I-T047
were	O	O	O
included	O	O	O
in	O	O	O
this	O	O	O
study	O	O	B-T062
.	O	O	O

Seven	O	O	O
cases	O	O	B-T169
involved	O	O	O
the	O	O	O
L4/5	O	O	O
level	O	O	O
,	O	O	O
and	O	O	O
15	O	O	O
cases	O	O	O
involved	O	O	O
the	O	O	O
L5/S1	O	O	O
level	O	O	O
.	O	O	O

All	O	O	O
patients	O	O	B-T101
were	O	O	O
ineffective	O	O	B-T078
after	O	O	O
at	O	O	O
least	O	O	O
6	O	O	O
months	O	O	O
of	O	O	O
conservative	O	O	B-T061
treatments	O	O	I-T061
;	O	O	O
all	O	O	O
patients	O	O	O
were	O	O	O
informed	O	O	O
of	O	O	O
the	O	O	O
surgery	O	O	B-T061
before	O	O	O
the	O	O	O
operation	O	O	B-T061
and	O	O	O
provided	O	O	O
consent	O	O	B-T169
.	O	O	O

Three-dimensional	O	O	B-T082
computed	O	O	B-T060
tomographic	O	O	I-T060
angiography	O	O	I-T060
(	O	O	O
3D	O	O	B-T082
-	O	O	O
CTA	O	O	B-T060
)	O	O	O
of	O	O	O
the	O	O	O
iliac	O	O	B-T023
great	O	O	O
blood	O	O	B-T023
vessels	O	O	I-T023
was	O	O	O
completed	O	O	B-T080
before	O	O	O
the	O	O	O
surgery	O	O	B-T061
.	O	O	O

All	O	O	O
surgical	O	O	B-T061
procedures	O	O	I-T061
were	O	O	O
performed	O	O	O
under	O	O	O
a	O	O	O
laparoscope	O	O	B-T074
.	O	O	O

All	O	O	O
patients	O	O	B-T101
were	O	O	O
followed	O	O	B-T058
up	O	O	I-T058
.	O	O	O

All	O	O	O
surgeries	O	O	B-T061
were	O	O	O
successfully	O	O	B-T080
completed	O	O	B-T080
.	O	O	O

The	O	O	O
average	O	O	B-T081
operation	O	O	B-T061
time	O	O	B-T079
was	O	O	O
120	O	O	O
minutes	O	O	O
(	O	O	O
range	O	O	B-T081
110	O	O	O
-	O	O	O
150	O	O	O
min	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
the	O	O	O
average	O	O	O
hemorrhage	O	O	B-T046
was	O	O	O
145	O	O	O
mL	O	O	O
(	O	O	O
range	O	O	O
80	O	O	O
-	O	O	O
360	O	O	O
mL	O	O	O
)	O	O	O
.	O	O	O

All	O	O	O
cases	O	O	B-T169
underwent	O	O	O
X-rays	O	O	B-T060
at	O	O	O
3	O	O	O
days	O	O	O
,	O	O	O
3	O	O	O
months	O	O	O
,	O	O	O
6	O	O	O
months	O	O	O
,	O	O	O
1	O	O	O
year	O	O	O
,	O	O	O
and	O	O	O
the	O	O	O
final	O	O	O
postoperative	O	O	B-T058
follow-up	O	O	B-T058
.	O	O	O

The	O	O	O
outcome	O	O	B-T169
indicated	O	O	O
that	O	O	O
there	O	O	O
was	O	O	O
no	O	O	O
mobilization	O	O	B-T169
,	O	O	O
displacement	O	O	B-T067
,	O	O	O
or	O	O	O
subsidence	O	O	B-T067
in	O	O	O
all	O	O	O
patients	O	O	B-T101
with	O	O	O
the	O	O	O
exception	O	O	B-T077
of	O	O	O
one	O	O	O
case	O	O	B-T169
with	O	O	O
prosthesis	O	O	B-T067
migration	O	O	I-T067
.	O	O	O

The	O	O	O
follow-up	O	O	B-T058
time	O	O	O
was	O	O	O
43.8	O	O	O
months	O	O	O
(	O	O	O
range	O	O	B-T081
24	O	O	O
-	O	O	O
64	O	O	O
months	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
mean	O	O	B-T081
visual	O	O	B-T201
analog	O	O	I-T201
scale	O	O	I-T201
(	O	O	O
VAS	O	O	B-T201
)	O	O	O
and	O	O	O
Oswestry	O	O	B-T033
scores	O	O	I-T033
were	O	O	O
decreased	O	O	B-T081
postoperatively	O	O	B-T079
.	O	O	O

The	O	O	O
mean	O	O	B-T081
improvement	O	O	B-T077
rate	O	O	B-T081
of	O	O	O
the	O	O	O
VAS	O	O	B-T201
score	O	O	I-T201
was	O	O	O
73.5	O	O	O
%	O	O	O
.	O	O	O

Lumbar	O	O	B-T029
ADR	O	O	B-T061
using	O	O	O
a	O	O	O
laparoscope	O	O	B-T074
represents	O	O	O
a	O	O	O
novel	O	O	O
,	O	O	O
minimally	O	O	B-T169
invasive	O	O	I-T169
treatment	O	O	B-T169
for	O	O	O
symptomatic	O	O	B-T169
degenerative	O	O	B-T047
disc	O	O	I-T047
disease	O	O	I-T047
and	O	O	O
severe	O	O	B-T080
lumbar	O	O	B-T047
discogenic	O	O	I-T047
pain	O	O	I-T047
.	O	O	O

-DOCSTART- (27655308)

Low	O	O	B-T033
literacy	O	O	I-T033
and	O	O	O
written	O	O	B-T170
drug	O	O	I-T170
information	O	O	I-T170
:	O	O	O
information-seeking	O	O	B-T033
,	O	O	O
leaflet	O	O	B-T170
evaluation	O	O	B-T078
and	O	O	O
preferences	O	O	B-T078
,	O	O	O
and	O	O	O
roles	O	O	O
for	O	O	O
images	O	O	O

Background	O	O	O
Low-literate	O	O	B-T098
patients	O	O	B-T101
are	O	O	O
at	O	O	O
risk	O	O	B-T078
to	O	O	O
misinterpret	O	O	O
written	O	O	B-T170
drug	O	O	I-T170
information	O	O	I-T170
.	O	O	O

For	O	O	O
the	O	O	O
(	O	O	O
co-	O	O	O
)	O	O	O
design	O	O	O
of	O	O	O
targeted	O	O	O
patient	O	O	B-T170
information	O	O	B-T078
,	O	O	O
it	O	O	O
is	O	O	O
key	O	O	O
to	O	O	O
involve	O	O	O
this	O	O	O
group	O	O	B-T098
in	O	O	O
determining	O	O	O
their	O	O	O
communication	O	O	B-T078
barriers	O	O	I-T078
and	O	O	O
information	O	O	O
needs	O	O	O
.	O	O	O

Objective	O	O	O
To	O	O	O
gain	O	O	O
insight	O	O	O
into	O	O	O
how	O	O	O
people	O	O	B-T098
with	O	O	O
low	O	O	B-T033
literacy	O	O	I-T033
use	O	O	O
and	O	O	O
evaluate	O	O	O
written	O	O	B-T170
drug	O	O	I-T170
information	O	O	I-T170
,	O	O	O
and	O	O	O
to	O	O	O
identify	O	O	O
ways	O	O	O
in	O	O	O
which	O	O	O
they	O	O	O
feel	O	O	O
the	O	O	O
patient	O	O	B-T101
leaflet	O	O	B-T170
can	O	O	O
be	O	O	O
improved	O	O	O
,	O	O	O
and	O	O	O
in	O	O	O
particular	O	O	O
how	O	O	O
images	O	O	B-T170
could	O	O	O
be	O	O	O
used	O	O	O
.	O	O	O

Setting	O	O	O
Food	O	O	B-T092
banks	O	O	I-T092
and	O	O	O
an	O	O	O
education	O	O	B-T073
institution	O	O	I-T073
for	O	O	O
Dutch	O	O	B-T171
language	O	O	I-T171
training	O	O	B-T065
in	O	O	O
the	O	O	O
Netherlands	O	O	B-T083
.	O	O	O

Method	O	O	O
Semi-structured	O	O	O
focus	O	O	B-T096
groups	O	O	I-T096
and	O	O	O
individual	O	O	B-T098
interviews	O	O	B-T052
were	O	O	O
held	O	O	O
with	O	O	O
low-literate	O	O	B-T098
participants	O	O	I-T098
(	O	O	O
n	O	O	O
=	O	O	O
45	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
thematic	O	O	B-T077
framework	O	O	I-T077
approach	O	O	I-T077
was	O	O	O
used	O	O	O
for	O	O	O
analysis	O	O	O
to	O	O	O
identify	O	O	O
themes	O	O	O
in	O	O	O
the	O	O	O
data	O	O	B-T078
.	O	O	O

Main	O	O	O
outcome	O	O	B-T169
measure	O	O	O
Low-literate	O	O	B-T098
people	O	O	I-T098
's	O	O	I-T098
experience	O	O	B-T078
with	O	O	O
patient	O	O	B-T170
information	O	O	I-T170
leaflets	O	O	B-T170
,	O	O	O
ideas	O	O	B-T078
for	O	O	O
improvements	O	O	B-T077
,	O	O	O
and	O	O	O
perceptions	O	O	B-T041
on	O	O	O
possible	O	O	O
uses	O	O	O
for	O	O	O
visuals	O	O	B-T169
.	O	O	O

Results	O	O	O
Patient	O	O	B-T170
information	O	O	B-T078
leaflets	O	O	B-T170
were	O	O	O
considered	O	O	O
discouraging	O	O	O
to	O	O	O
use	O	O	O
,	O	O	O
and	O	O	O
information	O	O	O
difficult	O	O	O
to	O	O	O
find	O	O	O
and	O	O	O
understand	O	O	B-T041
.	O	O	O

Many	O	O	O
rely	O	O	O
on	O	O	O
alternative	O	O	O
information	O	O	B-T033
sources	O	O	I-T033
.	O	O	O

The	O	O	O
leaflet	O	O	B-T170
should	O	O	O
be	O	O	O
shorter	O	O	O
,	O	O	O
and	O	O	O
improved	O	O	O
in	O	O	O
terms	O	O	O
of	O	O	O
organisation	O	O	B-T169
,	O	O	O
legibility	O	O	B-T033
and	O	O	O
readability	O	O	B-T080
.	O	O	O

Participants	O	O	B-T098
thought	O	O	O
images	O	O	B-T170
could	O	O	O
increase	O	O	O
the	O	O	O
leaflet	O	O	B-T170
's	O	O	I-T170
appeal	O	O	O
,	O	O	O
help	O	O	O
ask	O	O	O
questions	O	O	B-T170
,	O	O	O
provide	O	O	O
an	O	O	O
overview	O	O	B-T170
,	O	O	O
help	O	O	O
understand	O	O	O
textual	O	O	B-T170
information	O	O	B-T078
,	O	O	O
aid	O	O	O
recall	O	O	B-T041
,	O	O	O
reassure	O	O	O
,	O	O	O
and	O	O	O
even	O	O	O
lead	O	O	O
to	O	O	O
increased	O	O	O
confidence	O	O	B-T041
,	O	O	O
empowerment	O	O	B-T054
and	O	O	O
feeling	O	O	O
of	O	O	O
safety	O	O	B-T068
.	O	O	O

Conclusion	O	O	O
Already	O	O	O
at	O	O	O
the	O	O	O
stages	O	O	O
of	O	O	O
paying	O	O	O
attention	O	O	O
to	O	O	O
the	O	O	O
leaflet	O	O	B-T170
and	O	O	O
maintaining	O	O	O
interest	O	O	O
in	O	O	O
the	O	O	O
message	O	O	O
,	O	O	O
low-literate	O	O	B-T098
patients	O	O	I-T098
experience	O	O	B-T041
barriers	O	O	B-T078
in	O	O	I-T078
the	O	O	I-T078
communication	O	O	I-T078
process	O	O	O
through	O	O	O
written	O	O	B-T170
drug	O	O	I-T170
information	O	O	I-T170
.	O	O	O

Short	O	O	O
,	O	O	O
structured	O	O	O
,	O	O	O
visual	O	O	B-T169
/	O	O	O
textual	O	O	B-T170
explanations	O	O	B-T170
can	O	O	O
lower	O	O	O
the	O	O	O
motivational	O	O	O
threshold	O	O	O
to	O	O	O
use	O	O	O
the	O	O	O
leaflet	O	O	B-T170
,	O	O	O
improve	O	O	B-T033
understanding	O	O	B-T041
,	O	O	O
and	O	O	O
empower	O	O	O
the	O	O	O
low-literate	O	O	B-T098
target	O	O	I-T098
group	O	O	I-T098
.	O	O	O

-DOCSTART- (27655319)

Establishment	O	O	O
and	O	O	O
application	O	O	O
of	O	O	O
a	O	O	O
flow	O	O	B-T059
cytometry	O	O	I-T059
-based	O	O	O
method	O	O	B-T170
for	O	O	O
detecting	O	O	B-T033
histone	O	O	B-T044
acetylation	O	O	I-T044
levels	O	O	O

Histone	O	O	B-T116
deacetylase	O	O	I-T116
inhibitors	O	O	I-T116
,	O	O	O
which	O	O	O
have	O	O	O
also	O	O	O
received	O	O	O
attention	O	O	O
in	O	O	O
AIDS	O	O	B-T047
and	O	O	O
other	O	O	O
diseases	O	O	B-T047
,	O	O	O
are	O	O	O
a	O	O	O
new	O	O	O
class	O	O	O
of	O	O	O
anticancer	O	O	B-T109
drugs	O	O	I-T109
developed	O	O	O
in	O	O	O
recent	O	O	O
years	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
there	O	O	O
is	O	O	O
still	O	O	O
a	O	O	O
lack	O	O	B-T080
of	O	O	O
a	O	O	O
unified	O	O	B-T080
and	O	O	O
reliable	O	O	B-T170
method	O	O	B-T170
for	O	O	O
detecting	O	O	B-T033
histone	O	O	B-T044
acetylation	O	O	I-T044
levels	O	O	B-T080
in	O	O	O
basic	O	O	B-T062
and	O	O	O
clinical	O	O	B-T062
research	O	O	I-T062
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
we	O	O	O
developed	O	O	O
a	O	O	O
flow	O	O	B-T059
cytometry	O	O	I-T059
-based	O	O	O
method	O	O	B-T170
to	O	O	O
detect	O	O	B-T061
histone	O	O	B-T044
acetylation	O	O	I-T044
levels	O	O	B-T080
by	O	O	O
comparing	O	O	B-T052
different	O	O	O
sample	O	O	B-T167
processing	O	O	B-T052
temperature	O	O	B-T081
(	O	O	O
on	O	O	O
ice	O	O	B-T197
vs.	O	O	O
room	O	O	B-T033
temperature	O	O	I-T033
)	O	O	O
,	O	O	O
permeabilization	O	O	B-T043
method	O	O	O
(	O	O	O
intracellular	O	O	B-T026
vs.	O	O	O
nuclear	O	O	B-T026
)	O	O	O
,	O	O	O
antibody	O	O	B-T116
dose	O	O	B-T081
(	O	O	O
antibody	O	O	B-T059
titration	O	O	I-T059
)	O	O	O
and	O	O	O
antibody	O	O	O
incubation	O	O	B-T079
time	O	O	I-T079
(	O	O	O
time	O	O	B-T081
gradient	O	O	I-T081
)	O	O	O
using	O	O	O
whole	O	O	B-T031
blood	O	O	I-T031
and	O	O	O
peripheral	O	O	B-T025
blood	O	O	I-T025
mononuclear	O	O	I-T025
cells	O	O	I-T025
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
we	O	O	O
applied	O	O	O
this	O	O	O
optimized	O	O	B-T052
method	O	O	B-T170
in	O	O	O
in	O	O	B-T080
vitro	O	O	I-T080
experiment	O	O	B-T062
and	O	O	O
clinical	O	O	B-T062
trial	O	O	I-T062
of	O	O	O
Chidamide	O	O	B-T109
(	O	O	O
the	O	O	O
only	O	O	O
China	O	O	B-T083
FDA	O	O	B-T170
approved	O	O	I-T170
HDACi	O	O	I-T170
)	O	O	O
,	O	O	O
the	O	O	O
result	O	O	B-T169
of	O	O	O
which	O	O	O
confirmed	O	O	B-T033
that	O	O	O
the	O	O	O
flow	O	O	B-T059
cytometry	O	O	I-T059
-based	O	O	O
method	O	O	O
for	O	O	O
detecting	O	O	B-T033
histone	O	O	B-T044
acetylation	O	O	I-T044
levels	O	O	B-T080
is	O	O	O
a	O	O	O
reliable	O	O	B-T170
,	O	O	O
fast	O	O	B-T080
and	O	O	O
convenient	O	O	B-T080
method	O	O	O
which	O	O	O
can	O	O	O
be	O	O	O
used	O	O	O
in	O	O	O
basic	O	O	B-T062
and	O	O	O
clinical	O	O	B-T062
research	O	O	I-T062
.	O	O	O

-DOCSTART- (27659183)

Performance	O	O	B-T052
and	O	O	O
safety	O	O	B-T080
of	O	O	O
collagenated	O	O	B-T122
xenogeneic	O	O	I-T122
bone	O	O	I-T122
block	O	O	I-T122
for	O	O	O
lateral	O	O	B-T061
alveolar	O	O	I-T061
ridge	O	O	I-T061
augmentation	O	O	I-T061
and	O	O	O
staged	O	O	B-T061
implant	O	O	I-T061
placement	O	O	I-T061
.	O	O	O
A	O	O	O
monocenter	O	O	O
,	O	O	O
prospective	O	O	O
single-arm	O	O	O
clinical	O	O	O
study	O	O	O

A	O	O	O
monocenter	O	O	B-T062
,	O	O	I-T062
prospective	O	O	I-T062
single-arm	O	O	I-T062
clinical	O	O	I-T062
study	O	O	I-T062
To	O	O	O
assess	O	O	B-T058
the	O	O	O
clinical	O	O	B-T080
safety	O	O	I-T080
and	O	O	O
performance	O	O	B-T052
of	O	O	O
collagenated	O	O	B-T122
xenogeneic	O	O	I-T122
bone	O	O	I-T122
block	O	O	I-T122
(	O	O	O
CXBB	O	O	B-T122
)	O	O	O
for	O	O	O
lateral	O	O	B-T061
alveolar	O	O	I-T061
ridge	O	O	I-T061
augmentation	O	O	I-T061
and	O	O	O
two-stage	O	O	B-T079
implant	O	O	B-T061
placement	O	O	I-T061
.	O	O	O

In	O	O	O
ten	O	O	O
patients	O	O	B-T101
exhibiting	O	O	B-T078
a	O	O	O
single	O	O	B-T081
-	O	O	O
tooth	O	O	B-T023
gap	O	O	B-T082
,	O	O	O
the	O	O	O
surgical	O	O	B-T061
procedure	O	O	I-T061
included	O	O	B-T052
the	O	O	O
preparation	O	O	B-T052
of	O	O	O
mucoperiosteal	O	O	B-T017
flaps	O	O	I-T017
,	O	O	O
a	O	O	O
rigid	O	O	B-T061
fixation	O	O	I-T061
of	O	O	O
CXBB	O	O	B-T122
(	O	O	O
Geistlich	O	O	B-T170
Bio-Graft	O	O	I-T170
(	O	O	I-T170
Â®	O	O	I-T170
)	O	O	I-T170
)	O	O	O
using	O	O	O
an	O	O	O
osteosynthesis	O	O	B-T074
screw	O	O	I-T074
,	O	O	O
and	O	O	O
contour	O	O	B-T082
augmentation	O	O	B-T061
.	O	O	O

After	O	O	O
24	O	O	O
weeks	O	O	O
of	O	O	O
submerged	O	O	B-T040
healing	O	O	I-T040
,	O	O	O
the	O	O	O
primary	O	O	B-T130
endpoint	O	O	I-T130
was	O	O	O
defined	O	O	O
as	O	O	O
the	O	O	O
final	O	O	B-T079
ridge	O	O	B-T029
width	O	O	B-T081
sufficient	O	O	B-T080
to	O	O	O
place	O	O	O
an	O	O	O
adequately	O	O	B-T080
dimensioned	O	O	B-T081
titanium	O	O	B-T061
implant	O	O	I-T061
at	O	O	O
the	O	O	O
respective	O	O	O
sites	O	O	B-T082
.	O	O	O

Secondary	O	O	B-T080
outcomes	O	O	I-T080
included	O	O	B-T052
,	O	O	O
for	O	O	O
example	O	O	O
,	O	O	O
the	O	O	O
gain	O	O	B-T081
in	O	O	O
ridge	O	O	B-T029
width	O	O	B-T081
(	O	O	O
mm	O	O	O
)	O	O	O
.	O	O	O

Clinical	O	O	B-T062
parameters	O	O	I-T062
(	O	O	O
e.g.	O	O	O
,	O	O	O
bleeding	O	O	B-T033
on	O	O	I-T033
probing	O	O	I-T033
-	O	O	O
BOP	O	O	B-T033
,	O	O	O
probing	O	O	B-T081
depth	O	O	I-T081
-	O	O	O
PD	O	O	B-T081
,	O	O	O
mucosal	O	O	B-T190
recession	O	O	I-T190
-	O	O	O
MR	O	O	B-T190
)	O	O	O
were	O	O	O
assessed	O	O	B-T052
immediately	O	O	O
after	O	O	O
the	O	O	O
cementation	O	O	B-T061
of	O	O	I-T061
the	O	O	I-T061
crown	O	O	I-T061
and	O	O	O
at	O	O	O
the	O	O	O
final	O	O	B-T061
visit	O	O	I-T061
.	O	O	O

At	O	O	O
24	O	O	O
weeks	O	O	O
,	O	O	O
implant	O	O	B-T061
placement	O	O	I-T061
could	O	O	O
be	O	O	O
achieved	O	O	B-T052
in	O	O	O
8	O	O	O
of	O	O	O
10	O	O	O
patients	O	O	B-T101
exhibiting	O	O	B-T078
a	O	O	O
mean	O	O	B-T081
gain	O	O	B-T081
in	O	O	O
ridge	O	O	B-T029
width	O	O	B-T081
(	O	O	O
mean	O	O	O
Â±	O	O	O
SD	O	O	B-T081
)	O	O	O
of	O	O	O
3.88	O	O	O
Â±	O	O	O
1.75	O	O	O
mm	O	O	O
.	O	O	O

Histological	O	O	B-T080
analysis	O	O	B-T062
has	O	O	O
pointed	O	O	O
to	O	O	O
a	O	O	O
homogeneous	O	O	B-T082
osseous	O	O	B-T023
organization	O	O	B-T169
of	O	O	O
CXBB	O	O	B-T122
.	O	O	O

The	O	O	O
changes	O	O	B-T169
of	O	O	O
mean	O	O	B-T081
BOP	O	O	B-T033
,	O	O	O
PD	O	O	B-T081
,	O	O	O
and	O	O	O
MR	O	O	B-T190
values	O	O	B-T081
at	O	O	O
the	O	O	O
final	O	O	B-T061
visit	O	O	I-T061
amounted	O	O	B-T081
to	O	O	O
16.62	O	O	O
Â±	O	O	O
32.02	O	O	O
%	O	O	O
,	O	O	O
0.04	O	O	O
Â±	O	O	O
0.21	O	O	O
mm	O	O	O
,	O	O	O
and	O	O	O
-0.04	O	O	O
Â±	O	O	O
0.12	O	O	O
mm	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

CXBB	O	O	B-T122
may	O	O	O
be	O	O	O
successfully	O	O	B-T080
used	O	O	O
to	O	O	O
support	O	O	B-T077
lateral	O	O	B-T061
alveolar	O	O	I-T061
ridge	O	O	I-T061
augmentation	O	O	I-T061
and	O	O	O
two-stage	O	O	B-T079
implant	O	O	B-T061
placement	O	O	I-T061
.	O	O	O

-DOCSTART- (27659547)

The	O	O	O
link	O	O	O
between	O	O	O
self-perceptions	O	O	B-T041
of	O	O	O
aging	O	O	B-T040
,	O	O	O
cancer	O	O	B-T191
view	O	O	O
and	O	O	O
physical	O	O	B-T169
and	O	O	O
mental	O	O	B-T041
health	O	O	I-T041
of	O	O	O
older	O	O	B-T098
people	O	O	I-T098
with	O	O	O
cancer	O	O	O
:	O	O	O
A	O	O	O
cross-sectional	O	O	O
study	O	O	O

Older	O	O	B-T098
people	O	O	I-T098
may	O	O	O
suffer	O	O	O
from	O	O	O
stigmas	O	O	B-T048
linked	O	O	O
to	O	O	O
cancer	O	O	B-T191
and	O	O	O
aging	O	O	B-T040
.	O	O	O

Although	O	O	O
some	O	O	O
studies	O	O	B-T062
suggested	O	O	O
that	O	O	O
a	O	O	O
negative	O	O	B-T033
view	O	O	B-T082
of	O	O	O
cancer	O	O	B-T191
may	O	O	O
increase	O	O	O
the	O	O	O
level	O	O	B-T033
of	O	O	I-T033
depression	O	O	I-T033
,	O	O	O
such	O	O	O
an	O	O	O
association	O	O	O
has	O	O	O
never	O	O	O
been	O	O	O
studied	O	O	B-T062
in	O	O	O
the	O	O	O
elderly	O	O	B-T098
population	O	O	I-T098
.	O	O	O

Similarly	O	O	O
,	O	O	O
even	O	O	O
though	O	O	O
it	O	O	O
is	O	O	O
established	O	O	O
that	O	O	O
a	O	O	O
negative	O	O	B-T033
self-perception	O	O	B-T041
of	O	O	O
aging	O	O	B-T040
has	O	O	O
deleterious	O	O	O
consequences	O	O	B-T169
on	O	O	O
mental	O	O	B-T041
and	O	O	O
physical	O	O	B-T033
health	O	O	I-T033
in	O	O	O
normal	O	O	O
aging	O	O	O
,	O	O	O
the	O	O	O
influence	O	O	O
in	O	O	O
pathological	O	O	B-T169
contexts	O	O	B-T078
,	O	O	O
such	O	O	O
as	O	O	O
oncology	O	O	B-T191
,	O	O	O
has	O	O	O
not	O	O	O
been	O	O	O
studied	O	O	O
.	O	O	O

The	O	O	O
main	O	O	O
aim	O	O	O
of	O	O	O
this	O	O	O
study	O	O	O
is	O	O	O
thus	O	O	O
to	O	O	O
analyze	O	O	B-T062
the	O	O	O
effect	O	O	O
of	O	O	O
these	O	O	O
two	O	O	O
stigmas	O	O	B-T048
on	O	O	O
the	O	O	O
health	O	O	B-T078
of	O	O	O
elderly	O	O	B-T098
oncology	O	O	B-T191
patients	O	O	B-T101
.	O	O	O

101	O	O	O
patients	O	O	B-T101
suffering	O	O	O
from	O	O	O
a	O	O	O
cancer	O	O	B-T191
(	O	O	O
breast	O	O	B-T191
,	O	O	O
gynecological	O	O	B-T047
,	O	O	O
lung	O	O	B-T191
or	O	O	O
hematological	O	O	B-T047
)	O	O	O
were	O	O	O
seen	O	O	O
as	O	O	O
soon	O	O	O
as	O	O	O
possible	O	O	O
after	O	O	O
their	O	O	O
diagnosis	O	O	B-T033
.	O	O	O

Their	O	O	O
self-perception	O	O	B-T041
of	O	O	O
age	O	O	B-T032
,	O	O	O
cancer	O	O	B-T191
view	O	O	O
and	O	O	O
health	O	O	B-T078
(	O	O	O
physical	O	O	B-T033
and	O	O	O
mental	O	O	B-T041
)	O	O	O
was	O	O	O
assessed	O	O	O
.	O	O	O

Multiple	O	O	O
regressions	O	O	B-T041
showed	O	O	O
that	O	O	O
patients	O	O	B-T101
with	O	O	O
a	O	O	O
more	O	O	O
negative	O	O	B-T033
self-perception	O	O	B-T041
of	O	O	O
aging	O	O	B-T040
and/or	O	O	O
more	O	O	O
negative	O	O	O
cancer	O	O	B-T191
view	O	O	O
reported	O	O	O
poorer	O	O	B-T080
global	O	O	B-T091
health	O	O	I-T091
.	O	O	O

We	O	O	O
also	O	O	O
observed	O	O	O
that	O	O	O
negative	O	O	B-T033
self-perception	O	O	B-T041
of	O	O	O
aging	O	O	B-T040
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
worse	O	O	O
physical	O	O	B-T033
and	O	O	O
mental	O	O	B-T041
health	O	O	I-T041
,	O	O	O
whereas	O	O	O
negative	O	O	O
cancer	O	O	B-T191
views	O	O	O
were	O	O	O
only	O	O	O
linked	O	O	O
to	O	O	O
worse	O	O	O
mental	O	O	O
health	O	O	O
.	O	O	O

No	O	O	O
interaction	O	O	O
was	O	O	O
observed	O	O	O
between	O	O	O
these	O	O	O
two	O	O	O
stigmas	O	O	B-T048
,	O	O	O
suggesting	O	O	O
that	O	O	O
their	O	O	O
action	O	O	O
is	O	O	O
independent	O	O	B-T078
.	O	O	O

Older	O	O	O
patients	O	O	B-T101
with	O	O	O
cancer	O	O	B-T191
face	O	O	O
double	O	O	O
stigmatization	O	O	B-T078
,	O	O	O
due	O	O	O
to	O	O	O
negative	O	O	B-T033
self-perception	O	O	B-T041
of	O	O	O
aging	O	O	B-T040
and	O	O	O
cancer	O	O	O
,	O	O	O
and	O	O	O
these	O	O	O
stigmas	O	O	B-T048
have	O	O	O
impacts	O	O	O
on	O	O	O
global	O	O	O
and	O	O	O
mental	O	O	B-T041
health	O	O	I-T041
.	O	O	O

Self-perception	O	O	B-T041
of	O	O	O
aging	O	O	B-T040
is	O	O	O
also	O	O	O
linked	O	O	O
to	O	O	O
physical	O	O	B-T033
health	O	O	I-T033
.	O	O	O

Longitudinal	O	O	B-T062
studies	O	O	I-T062
will	O	O	O
be	O	O	O
necessary	O	O	O
to	O	O	O
analyze	O	O	B-T062
the	O	O	O
direction	O	O	O
of	O	O	O
the	O	O	O
association	O	O	O
between	O	O	O
this	O	O	O
double	O	O	O
stigmatization	O	O	B-T078
and	O	O	O
health	O	O	B-T078
.	O	O	O

-DOCSTART- (27659602)

The	O	O	O
Aortic	O	O	B-T029
Root	O	O	I-T029
:	O	O	O
Natural	O	O	B-T090
History	O	O	I-T090
After	O	O	O
Root-Sparing	O	O	B-T061
Ascending	O	O	I-T061
Replacement	O	O	I-T061
in	O	O	O
Nonsyndromic	O	O	B-T033
Aneurysmal	O	O	O
Patients	O	O	O

Leaving	O	O	O
native	O	O	B-T169
aortic	O	O	B-T024
tissue	O	O	I-T024
in	O	O	B-T082
situ	O	O	I-T082
in	O	O	O
root-sparing	O	O	B-T061
ascending	O	O	I-T061
aortic	O	O	I-T061
replacement	O	O	I-T061
raises	O	O	O
concern	O	O	B-T078
regarding	O	O	O
potential	O	O	B-T080
later	O	O	B-T079
need	O	O	B-T080
for	O	O	O
root	O	O	B-T029
reoperation	O	O	B-T061
or	O	O	O
for	O	O	O
the	O	O	O
potential	O	O	O
occurrence	O	O	B-T079
of	O	O	O
localized	O	O	B-T082
dissections	O	O	B-T047
or	O	O	O
rupture	O	O	B-T037
in	O	O	O
the	O	O	O
residual	O	O	B-T080
root	O	O	O
.	O	O	O

The	O	O	O
purpose	O	O	B-UnknownType
of	O	O	I-UnknownType
this	O	O	I-UnknownType
study	O	O	I-UnknownType
was	O	O	O
to	O	O	O
evaluate	O	O	B-T058
the	O	O	O
natural	O	O	B-T040
growth	O	O	I-T040
of	O	O	O
the	O	O	O
aortic	O	O	B-T029
root	O	O	I-T029
after	O	O	O
root-sparing	O	O	B-T061
aortic	O	O	I-T061
replacement	O	O	I-T061
.	O	O	O

In	O	O	O
all	O	O	O
,	O	O	O
102	O	O	O
consecutive	O	O	B-T080
patients	O	O	B-T101
(	O	O	O
mean	O	O	B-T081
age	O	O	B-T032
61.8	O	O	O
Â±	O	O	O
12.5	O	O	O
years	O	O	B-T079
;	O	O	O
60	O	O	O
%	O	O	O
male	O	O	B-T098
)	O	O	O
who	O	O	O
had	O	O	O
undergone	O	O	O
root-sparing	O	O	B-T061
aortic	O	O	I-T061
replacement	O	O	I-T061
had	O	O	O
sufficient	O	O	B-T080
retrievable	O	O	B-T078
information	O	O	I-T078
regarding	O	O	O
their	O	O	O
aortic	O	O	B-T029
root	O	O	I-T029
diameter	O	O	B-T081
at	O	O	O
postoperative	O	O	B-T079
baseline	O	O	B-T081
and	O	O	O
follow-up	O	O	B-T058
imaging	O	O	B-T060
by	O	O	O
computed	O	O	B-T060
tomography	O	O	I-T060
or	O	O	O
echocardiography	O	O	B-T060
.	O	O	O

The	O	O	O
annual	O	O	B-T079
growth	O	O	B-T079
rate	O	O	I-T079
was	O	O	O
evaluated	O	O	B-T052
and	O	O	O
also	O	O	O
compared	O	O	B-T052
according	O	O	O
to	O	O	O
the	O	O	O
influence	O	O	B-T077
of	O	O	O
valve	O	O	B-T080
morphology	O	O	I-T080
and	O	O	O
concomitant	O	O	B-T079
aortic	O	O	B-T061
valve	O	O	I-T061
replacement	O	O	I-T061
.	O	O	O

Furthermore	O	O	O
,	O	O	O
the	O	O	O
years	O	O	B-T079
of	O	O	O
natural	O	O	B-T090
history	O	O	I-T090
that	O	O	O
would	O	O	O
require	O	O	B-T169
for	O	O	O
root	O	O	B-T029
enlargement	O	O	B-T190
to	O	O	O
meet	O	O	O
a	O	O	O
50	O	O	O
mm	O	O	B-T081
threshold	O	O	B-T080
of	O	O	O
the	O	O	O
root	O	O	O
diameter	O	O	B-T081
were	O	O	O
calculated	O	O	B-T052
.	O	O	O

The	O	O	O
estimated	O	O	B-T081
growth	O	O	B-T079
rate	O	O	I-T079
of	O	O	O
the	O	O	O
aortic	O	O	B-T029
root	O	O	I-T029
after	O	O	O
root-sparing	O	O	B-T061
aortic	O	O	I-T061
replacement	O	O	I-T061
is	O	O	O
between	O	O	O
0.27	O	O	O
and	O	O	O
0.51	O	O	O
mm	O	O	B-T081
per	O	O	B-T079
year	O	O	I-T079
(	O	O	O
mean	O	O	B-T081
0.41	O	O	O
mm	O	O	O
,	O	O	O
varying	O	O	O
according	O	O	O
to	O	O	O
the	O	O	O
underlying	O	O	B-T081
diameter	O	O	I-T081
)	O	O	O
and	O	O	O
therefore	O	O	O
fivefold	O	O	O
less	O	O	B-T081
than	O	O	I-T081
other	O	O	O
aortic	O	O	B-T029
regions	O	O	I-T029
.	O	O	O

Accordingly	O	O	O
,	O	O	O
a	O	O	O
root	O	O	B-T047
aneurysm	O	O	I-T047
indicating	O	O	O
reoperation	O	O	B-T061
would	O	O	O
not	O	O	O
be	O	O	O
expected	O	O	B-T170
for	O	O	O
29.1	O	O	O
years	O	O	B-T079
on	O	O	O
average	O	O	B-T081
.	O	O	O

Only	O	O	O
patients	O	O	B-T101
with	O	O	O
a	O	O	O
diameter	O	O	B-T081
of	O	O	O
45	O	O	O
mm	O	O	B-T081
or	O	O	O
more	O	O	O
are	O	O	O
at	O	O	B-T080
risk	O	O	I-T080
for	O	O	O
reoperation	O	O	B-T061
,	O	O	O
and	O	O	O
not	O	O	O
until	O	O	B-T170
at	O	O	O
least	O	O	O
after	O	O	B-T079
10.4	O	O	O
years	O	O	B-T079
have	O	O	B-T033
passed	O	O	I-T033
.	O	O	O

Neither	O	O	B-T080
the	O	O	O
valve	O	O	B-T080
morphology	O	O	I-T080
(	O	O	O
p	O	O	O
=	O	O	O
0.62	O	O	O
)	O	O	O
nor	O	O	O
concomitant	O	O	B-T079
aortic	O	O	B-T061
valve	O	O	I-T061
replacement	O	O	I-T061
(	O	O	O
p	O	O	O
=	O	O	O
0.86	O	O	O
)	O	O	O
influenced	O	O	B-T077
rate	O	O	B-T081
of	O	O	O
root	O	O	B-T047
dilation	O	O	I-T047
.	O	O	O

In	O	O	O
nonsyndromic	O	O	B-T033
patients	O	O	B-T101
,	O	O	O
the	O	O	O
aortic	O	O	B-T029
root	O	O	I-T029
is	O	O	O
the	O	O	O
slowest	O	O	B-T080
growing	O	O	B-T040
portion	O	O	B-T082
of	O	O	O
the	O	O	O
thoracic	O	O	B-T023
aorta	O	O	I-T023
.	O	O	O

Leaving	O	O	O
the	O	O	O
native	O	O	B-T169
root	O	O	B-T029
,	O	O	O
as	O	O	O
in	O	O	O
root-sparing	O	O	B-T061
ascending	O	O	I-T061
aortic	O	O	I-T061
replacement	O	O	I-T061
,	O	O	O
is	O	O	O
a	O	O	O
safe	O	O	B-T082
approach	O	O	I-T082
regarding	O	O	O
secondary	O	O	B-T029
root	O	O	I-T029
intervention	O	O	B-T061
for	O	O	O
aortic	O	O	B-T029
root	O	O	I-T029
diameters	O	O	B-T081
of	O	O	O
45	O	O	O
mm	O	O	B-T081
or	O	O	O
less	O	O	O
.	O	O	O

-DOCSTART- (27660194)

Physical	O	O	B-T056
Exercise	O	O	I-T056
for	O	O	O
Late-Life	O	O	B-T079
Depression	O	O	B-T048
:	O	O	O
Effects	O	O	B-T080
on	O	O	O
Heart	O	O	B-T201
Rate	O	O	I-T201
Variability	O	O	O

Late-life	O	O	B-T079
major	O	O	B-T048
depression	O	O	I-T048
is	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
increased	O	O	B-T081
cardiovascular	O	O	B-T033
risk	O	O	I-T033
and	O	O	O
impaired	O	O	B-T047
autonomic	O	O	I-T047
control	O	O	I-T047
of	O	O	I-T047
the	O	O	I-T047
heart	O	O	I-T047
,	O	O	O
as	O	O	O
evident	O	O	O
from	O	O	O
reduced	O	O	B-T080
heart	O	O	B-T201
rate	O	O	I-T201
variability	O	O	B-T077
(	O	O	O
HRV	O	O	B-T077
)	O	O	O
.	O	O	O

Moreover	O	O	O
,	O	O	O
antidepressant	O	O	B-T121
drug	O	O	I-T121
therapy	O	O	B-T061
also	O	O	O
might	O	O	O
be	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
further	O	O	O
reductions	O	O	B-T080
of	O	O	O
HRV	O	O	B-T077
.	O	O	O

In	O	O	O
the	O	O	O
SEEDS	O	O	B-T062
study	O	O	I-T062
,	O	O	O
we	O	O	O
investigated	O	O	O
whether	O	O	O
sertraline	O	O	B-T109
associated	O	O	B-T080
with	O	O	I-T080
physical	O	O	B-T056
exercise	O	O	I-T056
protocols	O	O	O
led	O	O	O
to	O	O	O
improvements	O	O	B-T077
of	O	O	O
HRV	O	O	B-T077
,	O	O	O
compared	O	O	O
with	O	O	O
antidepressant	O	O	B-T121
drug	O	O	I-T121
therapy	O	O	B-T061
alone	O	O	O
.	O	O	O

Single-blind	O	O	B-T062
randomized	O	O	B-T062
controlled	O	O	I-T062
trial	O	O	I-T062
.	O	O	O

Psychiatric	O	O	B-T073
consultation	O	O	I-T073
-liaison	O	O	O
program	O	O	O
for	O	O	O
primary	O	O	B-T058
care	O	O	I-T058
.	O	O	O

Patients	O	O	B-T101
aged	O	O	O
65	O	O	O
-	O	O	O
85	O	O	O
years	O	O	O
with	O	O	O
major	O	O	B-T048
depression	O	O	I-T048
,	O	O	O
recruited	O	O	O
from	O	O	O
primary	O	O	B-T058
care	O	O	I-T058
.	O	O	O

Sertraline	O	O	B-T109
plus	O	O	O
structured	O	O	O
,	O	O	O
tailored	O	O	B-UnknownType
group	O	O	I-UnknownType
physical	O	O	B-T056
exercise	O	O	I-T056
(	O	O	O
S	O	O	B-UnknownType
+	O	O	I-UnknownType
EX	O	O	I-UnknownType
)	O	O	O
versus	O	O	O
sertraline	O	O	B-T109
alone	O	O	O
(	O	O	O
S	O	O	O
)	O	O	O
for	O	O	O
24	O	O	O
weeks	O	O	B-T079
.	O	O	O

HRV	O	O	B-T077
indices	O	O	B-T170
(	O	O	O
RR	O	O	O
,	O	O	O
percentage	O	O	B-T081
of	O	O	I-T081
NN	O	O	I-T081
intervals	O	O	I-T081
greater	O	O	I-T081
than	O	O	I-T081
50	O	O	I-T081
msec	O	O	I-T081
[	O	O	O
pNN50	O	O	B-T081
]	O	O	O
,	O	O	O
square	O	O	B-T081
root	O	O	I-T081
of	O	O	I-T081
the	O	O	I-T081
mean	O	O	I-T081
squared	O	O	I-T081
differences	O	O	I-T081
of	O	O	I-T081
successive	O	O	I-T081
NN	O	O	I-T081
intervals	O	O	I-T081
[	O	O	O
RMSSD	O	O	B-T081
]	O	O	O
,	O	O	O
standard	O	O	B-T081
deviation	O	O	I-T081
of	O	O	O
heart	O	O	B-T201
rate	O	O	I-T201
[	O	O	O
SDHR	O	O	B-T081
]	O	O	O
,	O	O	O
standard	O	O	B-T081
deviation	O	O	I-T081
of	O	O	I-T081
the	O	O	I-T081
NN	O	O	I-T081
interval	O	O	I-T081
[	O	O	O
SDNN	O	O	B-T081
]	O	O	O
,	O	O	O
high-frequency	O	O	B-T081
band	O	O	I-T081
[	O	O	O
HF	O	O	B-T081
]	O	O	O
,	O	O	O
low-frequency	O	O	B-T081
band	O	O	I-T081
[	O	O	O
LF	O	O	B-T081
]	O	O	O
,	O	O	O
and	O	O	O
their	O	O	O
ratio	O	O	B-T081
[	O	O	O
LF/HF	O	O	B-T081
]	O	O	O
)	O	O	O
were	O	O	O
measured	O	O	B-T080
at	O	O	O
baseline	O	O	B-T081
,	O	O	O
week	O	O	B-T079
12	O	O	O
,	O	O	O
and	O	O	O
week	O	O	O
24	O	O	O
.	O	O	O

Psychiatric	O	O	B-T060
and	O	O	O
medical	O	O	B-T058
assessments	O	O	I-T058
.	O	O	O

Participants	O	O	B-T098
displayed	O	O	O
significant	O	O	O
improvements	O	O	B-T077
of	O	O	O
most	O	O	O
HRV	O	O	B-T077
indices	O	O	B-T170
over	O	O	O
time	O	O	O
,	O	O	O
irrespective	O	O	O
of	O	O	O
the	O	O	O
group	O	O	O
assignment	O	O	O
(	O	O	O
pNN50	O	O	B-T081
,	O	O	O
RMSSD	O	O	B-T081
,	O	O	O
SDHR	O	O	B-T081
,	O	O	O
SDNN	O	O	B-T081
,	O	O	O
HF	O	O	B-T081
,	O	O	O
LF	O	O	B-T081
,	O	O	O
and	O	O	O
LF/HF	O	O	B-T081
)	O	O	O
.	O	O	O

Moreover	O	O	O
,	O	O	O
patients	O	O	B-T101
in	O	O	O
the	O	O	O
S	O	O	B-UnknownType
+	O	O	I-UnknownType
EX	O	O	I-UnknownType
group	O	O	I-UnknownType
displayed	O	O	O
greater	O	O	O
increases	O	O	B-T169
of	O	O	O
different	O	O	O
HRV	O	O	B-T077
indices	O	O	B-T170
(	O	O	O
RR	O	O	B-T081
,	O	O	O
pNN50	O	O	B-T081
,	O	O	O
RMSSD	O	O	B-T081
,	O	O	O
SDHR	O	O	B-T081
,	O	O	O
SDNN	O	O	B-T081
,	O	O	O
HF	O	O	B-T081
,	O	O	O
and	O	O	O
LF	O	O	B-T081
)	O	O	O
compared	O	O	O
with	O	O	O
those	O	O	O
in	O	O	O
the	O	O	O
S	O	O	B-UnknownType
group	O	O	I-UnknownType
.	O	O	O

The	O	O	O
combination	O	O	B-T080
of	O	O	O
structured	O	O	O
physical	O	O	B-T056
exercise	O	O	I-T056
and	O	O	O
sertraline	O	O	B-T109
might	O	O	O
exert	O	O	O
positive	O	O	B-T033
effects	O	O	B-T080
on	O	O	O
the	O	O	O
autonomic	O	O	B-T042
control	O	O	I-T042
of	O	O	I-T042
the	O	O	I-T042
heart	O	O	I-T042
among	O	O	O
older	O	O	O
patients	O	O	B-T101
with	O	O	O
major	O	O	B-T048
depression	O	O	I-T048
.	O	O	O

-DOCSTART- (27660632)

Genome-Wide	O	O	B-T059
SNP	O	O	I-T059
Linkage	O	O	I-T059
Mapping	O	O	I-T059
and	O	O	O
QTL	O	O	B-T028
Analysis	O	O	B-T059
for	O	O	O
Fiber	O	O	B-T002
Quality	O	O	B-T080
and	O	O	O
Yield	O	O	B-T081
Traits	O	O	B-T032
in	O	O	O
the	O	O	O
Upland	O	O	B-T002
Cotton	O	O	I-T002
Recombinant	O	O	B-T008
Inbred	O	O	I-T008
Lines	O	O	I-T008
Population	O	O	O

It	O	O	O
is	O	O	O
of	O	O	O
significance	O	O	O
to	O	O	O
discover	O	O	O
genes	O	O	B-T028
related	O	O	O
to	O	O	O
fiber	O	O	B-T002
quality	O	O	B-T080
and	O	O	O
yield	O	O	B-T081
traits	O	O	B-T032
and	O	O	O
tightly	O	O	O
linked	O	O	O
markers	O	O	B-T045
for	O	O	O
marker-assisted	O	O	B-T062
selection	O	O	I-T062
(	O	O	O
MAS	O	O	B-T062
)	O	O	O
in	O	O	O
cotton	O	O	B-T002
breeding	O	O	B-T040
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	O
,	O	O	O
188	O	O	B-T002
F8	O	O	I-T002
recombinant	O	O	B-T008
inbred	O	O	I-T008
lines	O	O	I-T008
(	O	O	O
RILs	O	O	B-T008
)	O	O	O
,	O	O	O
derived	O	O	O
from	O	O	O
a	O	O	O
intraspecific	O	O	B-T080
cross	O	O	B-T040
between	O	O	O
HS46	O	O	B-T002
and	O	O	O
MARCABUCAG8US-1	O	O	B-T002
-	O	O	I-T002
88	O	O	I-T002
were	O	O	O
genotyped	O	O	B-T032
by	O	O	O
the	O	O	O
cotton	O	O	B-T002
63	O	O	O
K	O	O	O
single	O	O	B-T059
nucleotide	O	O	I-T059
polymorphism	O	O	I-T059
(	O	O	I-T059
SNP	O	O	I-T059
)	O	O	I-T059
assay	O	O	I-T059
.	O	O	O

Field	O	O	B-T062
trials	O	O	I-T062
were	O	O	O
conducted	O	O	O
in	O	O	O
Sanya	O	O	B-UnknownType
,	O	O	I-UnknownType
Hainan	O	O	I-UnknownType
Province	O	O	I-UnknownType
,	O	O	O
during	O	O	O
the	O	O	O
2014	O	O	O
-	O	O	O
2015	O	O	O
cropping	O	O	B-T090
seasons	O	O	B-T079
under	O	O	O
standard	O	O	B-T080
conditions	O	O	B-T080
.	O	O	O

Results	O	O	O
revealed	O	O	O
significant	O	O	B-T081
differences	O	O	B-T080
(	O	O	O
P	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
among	O	O	O
RILs	O	O	B-T008
,	O	O	O
environments	O	O	B-T082
and	O	O	O
replications	O	O	B-T080
for	O	O	O
fiber	O	O	B-T002
quality	O	O	B-T080
and	O	O	O
yield	O	O	B-T081
traits	O	O	B-T032
.	O	O	O

Broad-sense	O	O	O
heritabilities	O	O	B-T169
of	O	O	O
all	O	O	O
traits	O	O	B-T032
including	O	O	O
fiber	O	O	B-T002
length	O	O	B-T081
,	O	O	O
fiber	O	O	O
uniformity	O	O	B-T080
,	O	O	O
micronaire	O	O	B-T080
,	O	O	O
fiber	O	O	O
elongation	O	O	B-T040
,	O	O	O
fiber	O	O	O
strength	O	O	B-T081
,	O	O	O
boll	O	O	B-T002
weight	O	O	B-T081
,	O	O	O
and	O	O	O
lint	O	O	B-T167
percentage	O	O	B-T081
ranged	O	O	O
from	O	O	O
0.26	O	O	O
to	O	O	O
0.66	O	O	O
.	O	O	O

A	O	O	O
1784.28	O	O	O
cM	O	O	B-T081
(	O	O	O
centimorgans	O	O	B-T081
)	O	O	O
linkage	O	O	B-T059
map	O	O	I-T059
,	O	O	O
harboring	O	O	O
2618	O	O	O
polymorphic	O	O	B-T080
SNP	O	O	B-T086
markers	O	O	B-T045
,	O	O	O
was	O	O	O
constructed	O	O	O
,	O	O	O
which	O	O	O
had	O	O	O
0.68	O	O	O
cM	O	O	O
per	O	O	O
marker	O	O	B-T045
density	O	O	O
.	O	O	O

Seventy-one	O	O	O
quantitative	O	O	B-T028
trait	O	O	I-T028
locus	O	O	I-T028
(	O	O	O
QTLs	O	O	B-T028
)	O	O	O
for	O	O	O
fiber	O	O	B-T002
quality	O	O	B-T080
and	O	O	O
yield	O	O	B-T081
traits	O	O	B-T032
were	O	O	O
detected	O	O	O
on	O	O	O
21	O	O	O
chromosomes	O	O	B-T026
,	O	O	O
explaining	O	O	O
4.70~32.28	O	O	O
%	O	O	O
phenotypic	O	O	B-T032
variance	O	O	B-T080
,	O	O	O
in	O	O	O
which	O	O	O
16	O	O	O
were	O	O	O
identified	O	O	O
as	O	O	O
stable	O	O	B-T080
QTLs	O	O	O
across	O	O	O
two	O	O	O
environments	O	O	B-T082
.	O	O	O

Meanwhile	O	O	O
,	O	O	O
12	O	O	O
certain	O	O	O
regions	O	O	B-T026
were	O	O	O
investigated	O	O	O
to	O	O	O
be	O	O	O
involved	O	O	O
in	O	O	O
the	O	O	O
control	O	O	O
of	O	O	O
one	O	O	O
(	O	O	O
hotspot	O	O	B-T086
)	O	O	O
or	O	O	O
more	O	O	O
(	O	O	O
cluster	O	O	B-T028
)	O	O	O
traits	O	O	B-T032
,	O	O	O
mainly	O	O	O
focused	O	O	O
on	O	O	O
Chr05	O	O	B-T026
,	O	O	O
Chr09	O	O	B-T026
,	O	O	O
Chr10	O	O	B-T026
,	O	O	O
Chr14	O	O	B-T026
,	O	O	O
Chr19	O	O	B-T026
,	O	O	O
and	O	O	O
Chr20	O	O	B-T026
.	O	O	O

Nineteen	O	O	O
pairs	O	O	O
of	O	O	O
epistatic	O	O	B-T028
QTLs	O	O	B-T028
(	O	O	O
e-QTLs	O	O	B-T028
)	O	O	O
were	O	O	O
identified	O	O	O
,	O	O	O
of	O	O	O
which	O	O	O
two	O	O	O
pairs	O	O	O
involved	O	O	O
in	O	O	O
two	O	O	O
additive	O	O	B-T080
QTLs	O	O	O
.	O	O	O

These	O	O	O
additive	O	O	B-T080
QTLs	O	O	B-T028
,	O	O	O
e-QTLs	O	O	B-T028
,	O	O	O
and	O	O	O
QTL	O	O	B-T028
clusters	O	O	B-T028
were	O	O	O
tightly	O	O	O
linked	O	O	O
to	O	O	O
SNP	O	O	B-T086
markers	O	O	B-T045
,	O	O	O
which	O	O	O
may	O	O	O
serve	O	O	O
as	O	O	O
target	O	O	B-T169
regions	O	O	B-T026
for	O	O	O
map-based	O	O	B-T059
cloning	O	O	I-T059
,	O	O	O
gene	O	O	B-T063
discovery	O	O	I-T063
,	O	O	O
and	O	O	O
MAS	O	O	B-T062
in	O	O	O
cotton	O	O	B-T002
breeding	O	O	B-T040
.	O	O	O

-DOCSTART- (27667559)

Effects	O	O	B-T080
of	O	O	O
an	O	O	O
early	O	O	O
intervention	O	O	B-T061
using	O	O	O
human	O	O	B-T016
amniotic	O	O	B-T018
epithelial	O	O	B-T025
cells	O	O	I-T025
in	O	O	O
a	O	O	O
COPD	O	O	B-T047
rat	O	O	B-T015
model	O	O	O

The	O	O	O
study	O	O	B-T062
aimed	O	O	O
to	O	O	O
investigate	O	O	B-T169
the	O	O	O
effect	O	O	B-T080
of	O	O	O
an	O	O	O
early	O	O	O
intervention	O	O	B-T061
using	O	O	O
human	O	O	B-T016
amniotic	O	O	B-T018
epithelial	O	O	B-T025
cell	O	O	I-T025
(	O	O	O
hAEC	O	O	B-T025
)	O	O	O
in	O	O	O
a	O	O	O
rat	O	O	B-T015
model	O	O	B-T075
of	O	O	O
chronic	O	O	B-T047
obstructive	O	O	I-T047
pulmonary	O	O	I-T047
disease	O	O	I-T047
(	O	O	O
COPD	O	O	B-T047
)	O	O	O
.	O	O	O

Twenty-four	O	O	O
specific	O	O	B-T001
pathogen-free	O	O	I-T001
Wistar	O	O	B-T015
rats	O	O	I-T015
were	O	O	O
randomized	O	O	B-T062
to	O	O	O
the	O	O	O
control	O	O	B-T096
,	O	O	O
COPD	O	O	B-T047
,	O	O	O
and	O	O	O
COPD	O	O	O
+	O	O	O
hAEC	O	O	B-T025
groups	O	O	B-T078
.	O	O	O

COPD	O	O	B-T047
was	O	O	O
established	O	O	O
by	O	O	O
intratracheal	O	O	B-T169
LPS	O	O	B-T109
injection	O	O	O
combined	O	O	O
with	O	O	O
smoke	O	O	B-T131
fumigation	O	O	B-T068
over	O	O	O
30	O	O	O
days	O	O	B-T079
.	O	O	O

On	O	O	O
the	O	O	O
first	O	O	O
day	O	O	B-T079
of	O	O	O
model	O	O	B-T075
establishment	O	O	O
rats	O	O	B-T015
in	O	O	O
the	O	O	O
AEC	O	O	B-T025
group	O	O	B-T078
also	O	O	O
received	O	O	O
intratracheal	O	O	B-T169
instillation	O	O	I-T169
of	O	O	O
500,000	O	O	O
hAECs	O	O	B-T025
isolated	O	O	O
from	O	O	O
the	O	O	O
placenta	O	O	B-T018
of	O	O	O
healthy	O	O	B-T080
donors	O	O	B-T098
.	O	O	O

The	O	O	O
mean	O	O	B-T081
linear	O	O	I-T081
intercept	O	O	I-T081
(	O	O	O
MLI	O	O	B-T081
)	O	O	O
and	O	O	O
mean	O	O	B-T081
alveolar	O	O	I-T081
number	O	O	I-T081
(	O	O	O
MAN	O	O	B-T081
)	O	O	O
were	O	O	O
used	O	O	O
to	O	O	O
assess	O	O	O
the	O	O	O
degree	O	O	O
of	O	O	O
lung	O	O	B-T047
emphysema	O	O	I-T047
.	O	O	O

IL-8	O	O	B-T116
was	O	O	O
measured	O	O	O
using	O	O	O
a	O	O	O
radioimmunoassay	O	O	B-T059
,	O	O	O
surfactant	O	O	B-T116
protein	O	O	I-T116
D	O	O	I-T116
(	O	O	O
SP-D	O	O	B-T116
)	O	O	O
was	O	O	O
measured	O	O	O
by	O	O	O
ELISA	O	O	B-T059
,	O	O	O
and	O	O	O
matrix	O	O	B-T116
metalloproteinase	O	O	I-T116
(MMP)2	O	O	I-T116
and	O	O	O
MMP8	O	O	B-T116
expression	O	O	B-T045
was	O	O	O
assessed	O	O	O
by	O	O	O
PCR	O	O	B-T063
.	O	O	O

Smoke	O	O	B-T131
fumigation	O	O	B-T068
combined	O	O	O
to	O	O	O
LPS	O	O	B-T109
injection	O	O	O
successfully	O	O	O
established	O	O	O
a	O	O	O
COPD	O	O	B-T047
rat	O	O	B-T015
model	O	O	B-T075
with	O	O	O
significant	O	O	O
emphysema	O	O	B-T047
and	O	O	O
airway	O	O	B-T046
inflammation	O	O	I-T046
,	O	O	O
elevated	O	O	B-T080
MLI	O	O	B-T081
and	O	O	O
MAN	O	O	B-T081
,	O	O	O
elevated	O	O	O
systemic	O	O	B-T169
and	O	O	O
lung	O	O	B-T023
tissue	O	O	B-T024
levels	O	O	B-T080
of	O	O	O
IL-8	O	O	B-T116
and	O	O	O
SP-D	O	O	B-T116
(	O	O	O
P<0.05	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
high	O	O	O
expression	O	O	B-T045
of	O	O	O
MMP2	O	O	B-T116
and	O	O	O
MMP8	O	O	B-T116
.	O	O	O

Rats	O	O	B-T015
in	O	O	O
the	O	O	O
COPD	O	O	B-T047
+	O	O	O
hAEC	O	O	B-T025
group	O	O	B-T078
exhibited	O	O	O
alleviated	O	O	B-T080
lung	O	O	B-T023
damage	O	O	B-T037
,	O	O	O
MLI	O	O	B-T081
and	O	O	O
MAN	O	O	B-T081
(	O	O	O
P<0.05	O	O	O
)	O	O	O
,	O	O	O
reduced	O	O	B-T080
systemic	O	O	B-T169
and	O	O	O
lung	O	O	O
tissue	O	O	B-T024
levels	O	O	B-T080
of	O	O	O
IL-8	O	O	B-T116
and	O	O	O
SP-D	O	O	B-T116
(	O	O	O
P<0.05	O	O	O
)	O	O	O
and	O	O	O
MMP2	O	O	B-T116
and	O	O	O
MMP8	O	O	B-T116
expression	O	O	B-T045
(	O	O	O
P<0.05	O	O	O
)	O	O	O
.	O	O	O

Early	O	O	O
intervention	O	O	B-T061
using	O	O	O
hAECs	O	O	B-T025
could	O	O	O
delay	O	O	O
disease	O	O	B-T046
progression	O	O	I-T046
in	O	O	O
rats	O	O	B-T015
with	O	O	O
COPD	O	O	B-T047
.	O	O	O

-DOCSTART- (27667560)

Systematic	O	O	B-T169
Identification	O	O	B-T041
of	O	O	O
Pharmacological	O	O	B-T038
Targets	O	O	B-T169
from	O	O	O
Small-Molecule	O	O	B-T109
Phenotypic	O	O	O
Screens	O	O	O

Phenotypic	O	O	B-T032
drug	O	O	B-T062
discovery	O	O	I-T062
offers	O	O	O
some	O	O	O
advantages	O	O	B-UnknownType
over	O	O	O
target	O	O	B-T169
-	O	O	O
based	O	O	B-T169
methods	O	O	B-T170
,	O	O	O
mainly	O	O	O
because	O	O	O
it	O	O	O
allows	O	O	O
drug	O	O	B-T121
leads	O	O	I-T121
to	O	O	O
be	O	O	O
tested	O	O	B-T169
in	O	O	O
systems	O	O	B-T169
that	O	O	O
more	O	O	B-T081
closely	O	O	B-T033
model	O	O	B-T075
distinct	O	O	B-T080
disease	O	O	B-T033
states	O	O	I-T033
.	O	O	O

However	O	O	O
,	O	O	O
a	O	O	O
potential	O	O	B-T080
disadvantage	O	O	B-T080
is	O	O	O
the	O	O	O
difficulty	O	O	B-T080
of	O	O	O
linking	O	O	B-T052
the	O	O	O
observed	O	O	B-T169
phenotype	O	O	B-T032
to	O	O	O
a	O	O	O
specific	O	O	B-T080
cellular	O	O	B-T025
target	O	O	B-T169
.	O	O	O

To	O	O	O
address	O	O	O
this	O	O	O
problem	O	O	B-T033
,	O	O	O
we	O	O	O
developed	O	O	B-T169
DePick	O	O	B-T170
,	O	O	O
a	O	O	O
computational	O	O	B-T052
target	O	O	O
de-convolution	O	O	B-T066
tool	O	O	B-T073
to	O	O	O
determine	O	O	B-T059
targets	O	O	B-T169
specifically	O	O	B-T080
linked	O	O	B-T052
to	O	O	O
small-molecule	O	O	B-T109
phenotypic	O	O	B-T059
screens	O	O	I-T059
.	O	O	O

We	O	O	O
applied	O	O	B-T169
DePick	O	O	B-T170
to	O	O	O
eight	O	O	O
publicly	O	O	B-T092
available	O	O	O
screens	O	O	B-T074
and	O	O	O
predicted	O	O	B-T078
59	O	O	O
drug	O	O	B-T121
target	O	O	B-T169
-	O	O	O
phenotype	O	O	B-T032
associations	O	O	B-T080
.	O	O	O

In	O	O	O
addition	O	O	O
to	O	O	O
literature	O	O	B-T170
-	O	O	O
based	O	O	B-T169
evidence	O	O	B-T078
for	O	O	O
our	O	O	O
predictions	O	O	B-T078
,	O	O	O
we	O	O	O
provide	O	O	B-T052
experimental	O	O	B-T080
support	O	O	B-T077
for	O	O	O
seven	O	O	O
predicted	O	O	B-T078
associations	O	O	B-T080
.	O	O	O

Interestingly	O	O	B-T041
,	O	O	O
our	O	O	O
analysis	O	O	B-T062
led	O	O	O
to	O	O	O
the	O	O	O
discovery	O	O	B-T052
of	O	O	O
a	O	O	O
previously	O	O	B-T079
unrecognized	O	O	B-T080
connection	O	O	B-T082
between	O	O	O
the	O	O	O
Wnt	O	O	B-T044
signaling	O	O	I-T044
pathway	O	O	I-T044
and	O	O	O
an	O	O	O
aromatase	O	O	B-T116
,	O	O	O
CYP19A1	O	O	B-T116
.	O	O	O

These	O	O	O
results	O	O	B-T033
demonstrate	O	O	B-T080
that	O	O	O
the	O	O	O
DePick	O	O	B-T170
approach	O	O	O
can	O	O	O
not	O	O	O
only	O	O	O
accelerate	O	O	B-T169
target	O	O	B-T169
de-convolution	O	O	B-T066
but	O	O	O
also	O	O	O
aid	O	O	B-T080
in	O	O	O
discovery	O	O	B-T052
of	O	O	O
new	O	O	O
functionally	O	O	B-T169
relevant	O	O	B-T080
biological	O	O	B-T080
relationships	O	O	B-T080
.	O	O	O

-DOCSTART- (27667643)

'	O	O	O
Yarn	O	O	B-T058
with	O	O	O
me	O	O	O
'	O	O	O
:	O	O	O
applying	O	O	O
clinical	O	O	B-T058
yarning	O	O	I-T058
to	O	O	O
improve	O	O	O
clinician	O	O	B-T097
-	O	O	O
patient	O	O	B-T101
communication	O	O	B-T054
in	O	O	O
Aboriginal	O	O	B-T098
health	O	O	O
care	O	O	O

Although	O	O	O
successful	O	O	O
communication	O	O	B-T054
is	O	O	O
at	O	O	O
the	O	O	O
heart	O	O	O
of	O	O	O
the	O	O	O
clinical	O	O	B-T058
consultation	O	O	I-T058
,	O	O	O
communication	O	O	O
between	O	O	O
Aboriginal	O	O	B-T098
patients	O	O	B-T101
and	O	O	O
practitioners	O	O	B-T097
such	O	O	O
as	O	O	O
doctors	O	O	B-T097
,	O	O	O
nurses	O	O	B-T097
and	O	O	O
allied	O	O	B-T097
health	O	O	I-T097
professionals	O	O	I-T097
,	O	O	O
continues	O	O	O
to	O	O	O
be	O	O	O
problematic	O	O	B-T033
and	O	O	O
is	O	O	O
arguably	O	O	O
the	O	O	O
biggest	O	O	O
barrier	O	O	O
to	O	O	O
the	O	O	O
delivery	O	O	O
of	O	O	O
successful	O	O	O
health	O	O	B-T058
care	O	O	I-T058
to	O	O	O
Aboriginal	O	O	B-T098
people	O	O	I-T098
.	O	O	O

This	O	O	O
paper	O	O	O
presents	O	O	O
an	O	O	O
overarching	O	O	B-T170
framework	O	O	I-T170
for	O	O	O
practitioners	O	O	B-T097
to	O	O	O
help	O	O	O
them	O	O	O
reorientate	O	O	O
their	O	O	O
communication	O	O	B-T054
with	O	O	O
Aboriginal	O	O	B-T098
patients	O	O	B-T101
using	O	O	O
'	O	O	O
clinical	O	O	B-T058
yarning	O	O	I-T058
'	O	O	O
.	O	O	O

Clinical	O	O	B-T058
yarning	O	O	I-T058
is	O	O	O
a	O	O	O
patient	O	O	B-T101
-centred	O	O	O
approach	O	O	O
that	O	O	O
marries	O	O	O
Aboriginal	O	O	B-T098
cultural	O	O	B-T054
communication	O	O	I-T054
preferences	O	O	O
with	O	O	O
biomedical	O	O	B-T091
understandings	O	O	O
of	O	O	O
health	O	O	B-T070
and	O	O	I-T070
disease	O	O	I-T070
.	O	O	O

Clinical	O	O	B-T058
yarning	O	O	I-T058
consists	O	O	O
of	O	O	O
three	O	O	O
interrelated	O	O	O
areas	O	O	O
:	O	O	O
the	O	O	O
social	O	O	B-T169
yarn	O	O	B-T058
,	O	O	O
in	O	O	O
which	O	O	O
the	O	O	O
practitioner	O	O	B-T097
aims	O	O	O
to	O	O	O
find	O	O	O
common	O	O	O
ground	O	O	O
and	O	O	O
develop	O	O	O
the	O	O	O
interpersonal	O	O	B-T054
relationship	O	O	I-T054
;	O	O	O
the	O	O	O
diagnostic	O	O	B-T169
yarn	O	O	O
,	O	O	O
in	O	O	O
which	O	O	O
the	O	O	O
practitioner	O	O	O
facilitates	O	O	O
the	O	O	O
patient	O	O	B-T101
's	O	O	I-T101
health	O	O	B-T078
story	O	O	I-T078
while	O	O	O
interpreting	O	O	O
it	O	O	O
through	O	O	O
a	O	O	O
biomedical	O	O	B-T091
or	O	O	O
scientific	O	O	B-T059
lens	O	O	I-T059
;	O	O	O
and	O	O	O
the	O	O	O
management	O	O	O
yarn	O	O	O
,	O	O	O
that	O	O	O
employs	O	O	B-T078
stories	O	O	I-T078
and	O	O	O
metaphors	O	O	B-T078
as	O	O	O
tools	O	O	O
for	O	O	O
patients	O	O	B-T101
to	O	O	O
help	O	O	O
them	O	O	O
understand	O	O	O
a	O	O	O
health	O	O	B-T033
issue	O	O	I-T033
so	O	O	O
a	O	O	O
collaborative	O	O	B-T062
management	O	O	I-T062
approach	O	O	I-T062
can	O	O	O
be	O	O	O
adopted	O	O	O
.	O	O	O

There	O	O	O
is	O	O	O
cultural	O	O	B-T169
and	O	O	O
research	O	O	B-T062
evidence	O	O	B-T078
that	O	O	O
supports	O	O	O
this	O	O	O
approach	O	O	O
.	O	O	O

Clinical	O	O	B-T058
yarning	O	O	I-T058
has	O	O	O
the	O	O	O
potential	O	O	O
to	O	O	O
improve	O	O	O
outcomes	O	O	B-T169
for	O	O	O
patients	O	O	B-T101
and	O	O	O
practitioners	O	O	B-T097
.	O	O	O

-DOCSTART- (27668722)

Effect	O	O	O
of	O	O	O
single-dose	O	O	B-T201
carbapenem	O	O	B-T195
exposure	O	O	B-T033
on	O	O	O
transcriptional	O	O	B-T045
expression	O	O	I-T045
of	O	O	O
blaNDM-1	O	O	B-T028
and	O	O	O
mexA	O	O	B-T028
in	O	O	O
Pseudomonas	O	O	O
aeruginosa	O	O	O

The	O	O	O
therapeutic	O	O	B-T169
option	O	O	I-T169
of	O	O	O
a	O	O	O
carbapenem	O	O	B-T195
antibiotic	O	O	I-T195
is	O	O	O
compromised	O	O	O
in	O	O	O
Pseudomonas	O	O	B-T007
aeruginosa	O	O	I-T007
owing	O	O	O
both	O	O	O
to	O	O	O
acquired	O	O	B-T040
and	O	O	O
intrinsic	O	O	B-T032
resistance	O	O	I-T032
mechanisms	O	O	O
.	O	O	O

In	O	O	O
recent	O	O	O
years	O	O	O
,	O	O	O
New	O	O	B-T116
Delhi	O	O	I-T116
metallo-Î²-lactamase	O	O	I-T116
has	O	O	O
been	O	O	O
the	O	O	O
focus	O	O	O
as	O	O	O
a	O	O	O
predominant	O	O	O
carbapenem	O	O	B-T032
resistance	O	O	I-T032
determinant	O	O	I-T032
.	O	O	O

However	O	O	O
,	O	O	O
it	O	O	O
is	O	O	O
unclear	O	O	O
which	O	O	O
of	O	O	O
the	O	O	O
mechanisms	O	O	O
might	O	O	O
be	O	O	O
adopted	O	O	O
by	O	O	O
a	O	O	O
P.	O	O	B-T007
aeruginosa	O	O	I-T007
strain	O	O	B-T001
possessing	O	O	O
both	O	O	O
blaNDM-1	O	O	B-T028
and	O	O	O
an	O	O	O
overexpressed	O	O	B-T045
MexAB-OprM	O	O	B-T028
system	O	O	O
during	O	O	O
carbapenem	O	O	B-T195
therapy	O	O	B-T061
.	O	O	O

This	O	O	O
study	O	O	O
investigated	O	O	O
the	O	O	O
interplay	O	O	O
of	O	O	O
both	O	O	O
mechanisms	O	O	O
in	O	O	O
clinical	O	O	B-T123
isolates	O	O	I-T123
of	O	O	O
P.	O	O	B-T007
aeruginosa	O	O	I-T007
when	O	O	O
exposed	O	O	O
to	O	O	O
meropenem	O	O	B-T195
.	O	O	O

Five	O	O	O
strains	O	O	B-T001
were	O	O	O
used	O	O	O
:	O	O	O
(	O	O	O
i	O	O	O
)	O	O	O
strain	O	O	B-T001
overexpressing	O	O	B-T045
MexAB-OprM	O	O	B-T028
but	O	O	O
with	O	O	O
no	O	O	B-T169
blaNDM-1	O	O	B-T028
;	O	O	O
(	O	O	O
ii	O	O	O
)	O	O	O
strain	O	O	O
harbouring	O	O	O
blaNDM-1	O	O	O
but	O	O	O
expressing	O	O	B-T045
MexAB-OprM	O	O	O
at	O	O	O
basal	O	O	O
level	O	O	O
;	O	O	O
(	O	O	O
iii	O	O	O
)	O	O	O
strain	O	O	O
possessing	O	O	O
blaNDM-1	O	O	O
and	O	O	O
overexpressing	O	O	O
MexAB-OprM	O	O	O
;	O	O	O
(	O	O	O
iv	O	O	O
)	O	O	O
P.	O	O	B-T007
aeruginosa	O	O	I-T007
PAO1	O	O	I-T007
;	O	O	O
and	O	O	O
(	O	O	O
v	O	O	O
)	O	O	O
P.	O	O	B-T007
aeruginosa	O	O	I-T007
K2733-PAO1	O	O	I-T007
(	O	O	O
ÎMexAB-OprM	O	O	B-T028
ÎMexCD-OprJ	O	O	B-T028
ÎMexEF-OprN	O	O	B-T028
ÎMexXY-OprM	O	O	B-T028
)	O	O	O
into	O	O	O
which	O	O	O
blaNDM-1	O	O	O
was	O	O	O
cloned	O	O	B-T059
.	O	O	O

Strains	O	O	B-T001
were	O	O	O
incubated	O	O	O
in	O	O	O
Luria-Bertani	O	O	B-T130
broth	O	O	I-T130
with	O	O	O
and	O	O	O
without	O	O	O
1Î¼g/mL	O	O	O
meropenem	O	O	B-T195
.	O	O	O

Total	O	O	B-T059
RNA	O	O	I-T059
was	O	O	O
isolated	O	O	O
at	O	O	O
45-min	O	O	O
intervals	O	O	O
and	O	O	O
was	O	O	O
immediately	O	O	O
reverse	O	O	B-T045
transcribed	O	O	I-T045
to	O	O	O
cDNA	O	O	B-T114
.	O	O	O

This	O	O	O
was	O	O	O
repeated	O	O	O
for	O	O	O
6h	O	O	O
.	O	O	O

Quantitative	O	O	B-T063
real-time	O	O	I-T063
PCR	O	O	I-T063
was	O	O	O
performed	O	O	O
for	O	O	O
both	O	O	O
resistance	O	O	B-T062
mechanisms	O	O	I-T062
.	O	O	O

Meropenem	O	O	B-T195
exposure	O	O	B-T033
did	O	O	O
not	O	O	O
significantly	O	O	O
elevate	O	O	B-T045
transcription	O	O	I-T045
of	O	O	O
either	O	O	O
the	O	O	O
blaNDM-1	O	O	B-T028
or	O	O	O
mexA	O	O	B-T028
gene	O	O	I-T028
.	O	O	O

However	O	O	O
,	O	O	O
an	O	O	O
interesting	O	O	O
finding	O	O	O
was	O	O	O
that	O	O	O
upon	O	O	O
single-dose	O	O	B-T201
exposure	O	O	B-T033
to	O	O	I-T033
carbapenem	O	O	I-T033
,	O	O	O
the	O	O	O
efflux	O	O	B-T024
pump	O	O	I-T024
system	O	O	I-T024
played	O	O	O
a	O	O	O
major	O	O	O
role	O	O	B-T169
in	O	O	I-T169
bacterial	O	O	I-T169
survival	O	O	I-T169
compared	O	O	O
with	O	O	O
NDM-1	O	O	B-T116
.	O	O	O

This	O	O	O
study	O	O	O
gives	O	O	O
an	O	O	O
insight	O	O	O
into	O	O	O
the	O	O	O
bacterial	O	O	B-T040
response	O	O	I-T040
to	O	O	I-T040
carbapenem	O	O	I-T040
antibiotic	O	O	I-T040
when	O	O	O
two	O	O	O
different	O	O	O
resistance	O	O	B-T062
mechanisms	O	O	I-T062
coexist	O	O	O
.	O	O	O

This	O	O	O
type	O	O	O
of	O	O	O
study	O	O	O
would	O	O	O
be	O	O	O
helpful	O	O	O
in	O	O	O
designing	O	O	O
future	O	O	O
antimicrobials	O	O	B-T121
.	O	O	O

-DOCSTART- (27669217)

Inducible	O	O	B-T169
Expression	O	O	B-T045
of	O	O	O
both	O	O	O
ermB	O	O	B-T028
and	O	O	O
ermT	O	O	B-T028
Conferred	O	O	O
High	O	O	B-T080
Macrolide	O	O	B-T033
Resistance	O	O	I-T033
in	O	O	O
Streptococcus	O	O	B-T007
gallolyticus	O	O	I-T007
subsp	O	O	I-T007
.	O	O	I-T007
pasteurianus	O	O	I-T007
Isolates	O	O	B-T001
in	O	O	O
China	O	O	O

pasteurianus	O	O	O
Isolates	O	O	B-T001
in	O	O	O
China	O	O	B-T083
Streptococcus	O	O	O
gallolyticus	O	O	O
subsp	O	O	O
.	O	O	O

pasteurianus	O	O	O
is	O	O	O
an	O	O	O
under-recognized	O	O	O
pathogen	O	O	B-T001
and	O	O	O
zoonotic	O	O	B-T007
agent	O	O	I-T007
causing	O	O	O
opportunistic	O	O	B-T047
infections	O	O	I-T047
in	O	O	O
humans	O	O	B-T016
.	O	O	O

Despite	O	O	O
increasing	O	O	O
recognition	O	O	B-T080
of	O	O	O
this	O	O	O
subspecies	O	O	B-T007
as	O	O	O
a	O	O	O
cause	O	O	O
for	O	O	O
human	O	O	B-T016
infectious	O	O	B-T047
diseases	O	O	I-T047
,	O	O	O
limited	O	O	O
information	O	O	O
is	O	O	O
known	O	O	O
about	O	O	O
its	O	O	O
antibiotic	O	O	B-T032
resistance	O	O	I-T032
mechanism	O	O	B-T169
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
we	O	O	O
aim	O	O	O
to	O	O	O
identify	O	O	O
the	O	O	O
molecular	O	O	B-T044
mechanism	O	O	I-T044
underlying	O	O	O
the	O	O	O
high	O	O	O
macrolide	O	O	B-T033
resistance	O	O	I-T033
of	O	O	O
six	O	O	O
S.	O	O	O
gallolyticus	O	O	O
subsp	O	O	O
.	O	O	O

pasteurianus	O	O	O
isolates	O	O	B-T001
from	O	O	O
dead	O	O	B-T033
ducklings	O	O	B-T012
collected	O	O	O
in	O	O	O
several	O	O	O
natural	O	O	O
outbreaks	O	O	O
in	O	O	O
China	O	O	B-T083
during	O	O	O
2010	O	O	O
-	O	O	O
2013	O	O	O
.	O	O	O

All	O	O	O
isolates	O	O	B-T001
exhibited	O	O	O
multi-drug	O	O	B-T032
resistance	O	O	I-T032
including	O	O	O
high	O	O	O
macrolide	O	O	B-T033
resistance	O	O	I-T033
(	O	O	O
MIC	O	O	B-T034
â¥	O	O	O
1024	O	O	O
mg/L	O	O	O
for	O	O	O
erythromycin	O	O	B-T195
,	O	O	O
and	O	O	O
512	O	O	O
mg/L	O	O	O
for	O	O	O
clarithromycin	O	O	B-T195
)	O	O	O
.	O	O	O

Efflux-encoding	O	O	B-T028
mefA	O	O	I-T028
and	O	O	O
mefE	O	O	B-T028
genes	O	O	I-T028
were	O	O	O
not	O	O	O
detectable	O	O	O
in	O	O	O
these	O	O	O
isolates	O	O	B-T001
.	O	O	O

The	O	O	O
presence	O	O	O
of	O	O	O
23S	O	O	B-T114
rRNA	O	O	I-T114
mutations	O	O	B-T045
in	O	O	O
specific	O	O	O
isolates	O	O	B-T001
did	O	O	O
not	O	O	O
significantly	O	O	O
change	O	O	O
macrolide	O	O	B-T109
MIC	O	O	B-T034
s.	O	O	O
No	O	O	O
nucleotide	O	O	B-T114
substitutions	O	O	B-T052
were	O	O	O
found	O	O	O
in	O	O	O
genes	O	O	B-T028
encoding	O	O	O
ribosomal	O	O	B-T116
proteins	O	O	I-T116
L4	O	O	I-T116
or	O	O	O
L22	O	O	B-T116
.	O	O	O

The	O	O	O
ermB	O	O	B-T028
and	O	O	O
ermT	O	O	B-T028
genes	O	O	I-T028
were	O	O	O
found	O	O	O
in	O	O	O
the	O	O	O
genomes	O	O	B-T028
of	O	O	O
all	O	O	O
isolates	O	O	B-T001
.	O	O	O

These	O	O	O
two	O	O	O
genes	O	O	B-T028
were	O	O	O
acquired	O	O	O
independently	O	O	B-T169
in	O	O	O
one	O	O	O
highly	O	O	O
virulent	O	O	B-T001
isolate	O	O	I-T001
AL101002	O	O	I-T001
,	O	O	O
and	O	O	O
clustered	O	O	O
with	O	O	O
Tn916	O	O	B-T001
and	O	O	O
IS1216	O	O	B-T001
,	O	O	O
respectively	O	O	O
.	O	O	O

The	O	O	O
expression	O	O	B-T045
of	O	O	O
both	O	O	O
ermB	O	O	B-T028
and	O	O	O
ermT	O	O	B-T028
in	O	O	O
all	O	O	O
isolates	O	O	B-T001
was	O	O	O
erythromycin	O	O	B-T195
inducible	O	O	B-T169
and	O	O	O
yielded	O	O	O
comparable	O	O	O
macrolide	O	O	B-T109
MICs	O	O	B-T034
in	O	O	O
all	O	O	O
six	O	O	O
isolates	O	O	O
.	O	O	O

Taken	O	O	O
together	O	O	O
,	O	O	O
inducible	O	O	B-T169
expression	O	O	B-T045
of	O	O	O
both	O	O	O
ermB	O	O	B-T028
and	O	O	O
ermT	O	O	B-T028
conferred	O	O	O
high	O	O	O
macrolide	O	O	B-T033
resistance	O	O	I-T033
in	O	O	O
these	O	O	O
S.	O	O	O
gallolyticus	O	O	O
subsp	O	O	O
.	O	O	O

pasterianus	O	O	O
isolates	O	O	B-T001
.	O	O	O

Our	O	O	O
findings	O	O	B-T033
reveal	O	O	O
new	O	O	O
macrolide	O	O	B-T033
resistance	O	O	I-T033
features	O	O	O
in	O	O	O
S.	O	O	O
gallolyticus	O	O	O
subsp	O	O	O
.	O	O	O

pasteurianus	O	O	O
by	O	O	O
both	O	O	O
ermB	O	O	B-T028
and	O	O	O
ermT.	O	O	O

-DOCSTART- (27669669)

Bilateral	O	O	B-T082
C1	O	O	B-T074
laminar	O	O	I-T074
hooks	O	O	I-T074
combined	O	O	O
with	O	O	O
C2	O	O	B-T074
pedicle	O	O	I-T074
screw	O	O	I-T074
fixation	O	O	B-T061
in	O	O	O
the	O	O	O
treatment	O	O	B-T061
of	O	O	O
atlantoaxial	O	O	B-T037
subluxation	O	O	I-T037
after	O	O	O
Grisel	O	O	O
syndrome	O	O	O

Many	O	O	O
etiologies	O	O	B-T169
can	O	O	O
lead	O	O	O
to	O	O	O
atlantoaxial	O	O	B-T037
subluxaion	O	O	I-T037
.	O	O	O

In	O	O	O
Grisel	O	O	B-T047
syndrome	O	O	I-T047
(	O	O	O
GS	O	O	B-T047
)	O	O	O
,	O	O	O
this	O	O	O
subluxation	O	O	B-T037
occurs	O	O	O
spontaneously	O	O	B-T169
after	O	O	O
inflammatory	O	O	B-T169
processes	O	O	B-T067
of	O	O	O
the	O	O	O
head	O	O	B-T029
and	O	O	O
neck	O	O	B-T029
.	O	O	O

Diagnosis	O	O	B-T033
is	O	O	O
typically	O	O	O
based	O	O	O
on	O	O	O
clinical	O	O	B-T033
history	O	O	I-T033
and	O	O	O
a	O	O	O
strong	O	O	O
suspicion	O	O	B-T041
of	O	O	O
this	O	O	O
syndrome	O	O	B-T047
.	O	O	O

Nonsurgical	O	O	B-T061
treatment	O	O	I-T061
most	O	O	O
often	O	O	O
resolves	O	O	B-T077
the	O	O	O
symptoms	O	O	B-T184
;	O	O	O
however	O	O	O
,	O	O	O
in	O	O	O
some	O	O	O
cases	O	O	B-T169
surgical	O	O	B-T061
treatment	O	O	I-T061
is	O	O	O
necessary	O	O	O
to	O	O	O
repair	O	O	B-T061
the	O	O	O
subluxation	O	O	B-T037
.	O	O	O

Various	O	O	O
surgical	O	O	B-T060
techniques	O	O	I-T060
and	O	O	O
instrumentation	O	O	B-T074
systems	O	O	I-T074
have	O	O	O
been	O	O	O
used	O	O	O
to	O	O	O
treat	O	O	B-T061
atlantoaxial	O	O	B-T037
subluxation	O	O	I-T037
,	O	O	O
although	O	O	O
there	O	O	O
is	O	O	O
no	O	O	O
consensus	O	O	B-T054
regarding	O	O	O
the	O	O	O
best	O	O	O
treatment	O	O	B-T061
method	O	O	I-T061
for	O	O	O
the	O	O	O
pediatric	O	O	B-T080
population	O	O	B-T098
.	O	O	O

To	O	O	O
describe	O	O	O
a	O	O	O
case	O	O	B-T169
of	O	O	O
atlantoaxial	O	O	B-T037
subluxation	O	O	I-T037
in	O	O	O
a	O	O	O
child	O	O	B-T100
with	O	O	O
GS	O	O	B-T047
treated	O	O	B-T033
surgically	O	O	B-T061
with	O	O	O
an	O	O	O
alternative	O	O	B-T077
construct	O	O	B-T074
.	O	O	O

This	O	O	O
is	O	O	O
a	O	O	O
case	O	O	B-T170
report	O	O	I-T170
and	O	O	O
literature	O	O	B-T170
review	O	O	I-T170
.	O	O	O

Our	O	O	O
case	O	O	B-T170
study	O	O	I-T170
involves	O	O	O
a	O	O	O
5-	O	O	O
year	O	O	B-T079
-old	O	O	O
girl	O	O	B-T100
with	O	O	O
a	O	O	O
6-	O	O	O
month	O	O	B-T079
history	O	O	B-T033
of	O	O	O
unresolved	O	O	B-T080
Fielding	O	O	B-T037
type	O	O	I-T037
II	O	O	I-T037
atlantoaxial	O	O	I-T037
subluxation	O	O	I-T037
caused	O	O	O
by	O	O	O
GS	O	O	B-T047
.	O	O	O

Despite	O	O	O
conservative	O	O	B-T061
treatment	O	O	I-T061
,	O	O	O
the	O	O	O
patient	O	O	B-T101
's	O	O	I-T101
symptoms	O	O	B-T184
continued	O	O	B-T078
to	O	O	O
progress	O	O	B-T169
.	O	O	O

After	O	O	O
two	O	O	O
failed	O	O	B-T169
closed	O	O	B-T061
reduction	O	O	I-T061
attempts	O	O	B-T051
,	O	O	O
open	O	O	B-T061
reduction	O	O	I-T061
and	O	O	O
C1-C2	O	O	B-T061
fusion	O	O	I-T061
were	O	O	O
performed	O	O	B-T169
with	O	O	O
atlas	O	O	B-T074
laminar	O	O	I-T074
hook	O	O	I-T074
and	O	O	O
axis	O	O	B-T074
pedicle	O	O	I-T074
polyaxial	O	O	I-T074
screws	O	O	I-T074
.	O	O	O

A	O	O	O
literature	O	O	B-T170
review	O	O	I-T170
of	O	O	O
the	O	O	O
surgical	O	O	B-T061
treatment	O	O	I-T061
of	O	O	O
GS	O	O	B-T047
was	O	O	O
also	O	O	O
performed	O	O	B-T169
.	O	O	O

After	O	O	O
surgery	O	O	B-T169
,	O	O	O
the	O	O	O
patient	O	O	B-T101
exhibited	O	O	O
full	O	O	O
clinical	O	O	B-T080
and	O	O	O
functional	O	O	B-T184
recovery	O	O	I-T184
with	O	O	O
complete	O	O	B-T077
resolution	O	O	I-T077
of	O	O	O
symptoms	O	O	B-T184
.	O	O	O

At	O	O	O
the	O	O	O
36-	O	O	O
month	O	O	B-T079
follow-up	O	O	B-T058
examination	O	O	B-T058
,	O	O	O
there	O	O	O
was	O	O	O
continual	O	O	B-T079
evidence	O	O	B-T078
of	O	O	O
satisfactory	O	O	B-T033
reduction	O	O	B-T061
and	O	O	O
fusion	O	O	B-T061
.	O	O	O

No	O	O	O
complications	O	O	B-T046
were	O	O	O
observed	O	O	B-T169
.	O	O	O

Upon	O	O	O
completion	O	O	B-T080
of	O	O	O
the	O	O	O
literature	O	O	B-T170
review	O	O	I-T170
,	O	O	O
eight	O	O	O
GS	O	O	B-T047
cases	O	O	B-T169
were	O	O	O
found	O	O	O
to	O	O	O
have	O	O	O
been	O	O	O
treated	O	O	B-T169
surgically	O	O	B-T061
with	O	O	O
the	O	O	O
minimum	O	O	O
patient	O	O	B-T101
age	O	O	B-T032
being	O	O	O
9	O	O	O
years	O	O	B-T079
.	O	O	O

Conservative	O	O	B-T061
management	O	O	I-T061
of	O	O	O
GS	O	O	B-T047
is	O	O	O
the	O	O	O
most	O	O	O
common	O	O	B-T081
and	O	O	O
effective	O	O	B-T080
treatment	O	O	B-T061
;	O	O	O
however	O	O	O
,	O	O	O
a	O	O	O
few	O	O	O
surgical	O	O	B-T169
cases	O	O	I-T169
have	O	O	O
been	O	O	O
reported	O	O	B-T058
in	O	O	O
the	O	O	O
literature	O	O	B-T170
with	O	O	O
good	O	O	O
results	O	O	B-T169
.	O	O	O

Satisfactory	O	O	B-T033
clinical	O	O	B-T033
results	O	O	I-T033
and	O	O	O
fusion	O	O	B-T061
at	O	O	O
36	O	O	O
months	O	O	B-T079
post	O	O	B-T033
surgery	O	O	I-T033
were	O	O	O
seen	O	O	O
in	O	O	O
a	O	O	O
pediatric	O	O	B-T080
patient	O	O	B-T101
with	O	O	O
atlantoaxial	O	O	B-T037
subluxation	O	O	I-T037
and	O	O	O
instability	O	O	B-T033
using	O	O	O
atlas	O	O	B-T074
laminar	O	O	I-T074
hook	O	O	I-T074
and	O	O	O
axis	O	O	B-T074
pedicle	O	O	I-T074
polyaxial	O	O	I-T074
screws	O	O	I-T074
.	O	O	O

-DOCSTART- (27671177)

Caries	O	O	B-T047
with	O	O	O
Dental	O	O	B-T047
Fluorosis	O	O	I-T047
and	O	O	O
Oral	O	O	B-T201
Health	O	O	I-T201
Behaviour	O	O	I-T201
Among	O	O	O
12-Year	O	O	B-T079
School	O	O	B-T100
Children	O	O	I-T100
in	O	O	O
Moderate-Fluoride	O	O	B-T096
Drinking	O	O	I-T096
Water	O	O	I-T096
Community	O	O	I-T096
in	O	O	O
Quetta	O	O	B-T083
,	O	O	O
Pakistan	O	O	O

To	O	O	O
determine	O	O	O
the	O	O	O
prevalence	O	O	B-T081
of	O	O	O
dental	O	O	B-T047
caries	O	O	I-T047
and	O	O	O
its	O	O	O
relationship	O	O	B-T080
with	O	O	O
dental	O	O	B-T047
fluorosis	O	O	I-T047
,	O	O	O
oral	O	O	B-T201
health	O	O	I-T201
behaviour	O	O	I-T201
and	O	O	O
dietary	O	O	B-T033
behaviour	O	O	I-T033
among	O	O	O
12-year	O	O	B-T079
school	O	O	B-T100
children	O	O	I-T100
in	O	O	O
moderate-fluoride	O	O	B-T096
drinking	O	O	I-T096
water	O	O	I-T096
community	O	O	I-T096
in	O	O	O
Quetta	O	O	B-T083
,	O	O	O
Pakistan	O	O	B-T083
.	O	O	O

Cross-sectional	O	O	B-T062
study	O	O	I-T062
.	O	O	O

Government	O	O	B-T073
and	O	O	O
private	O	O	B-T073
schools	O	O	I-T073
of	O	O	O
Quetta	O	O	B-T083
,	O	O	O
from	O	O	O
November	O	O	B-T079
2012	O	O	O
to	O	O	O
February	O	O	B-T080
2013	O	O	O
.	O	O	O

Atotal	O	O	O
of	O	O	O
349	O	O	O
children	O	O	B-T100
aged	O	O	O
12-year	O	O	B-T079
from	O	O	O
14	O	O	O
randomly	O	O	O
selected	O	O	O
schools	O	O	B-T073
were	O	O	O
included	O	O	O
.	O	O	O

The	O	O	O
data	O	O	B-T062
collection	O	O	I-T062
was	O	O	O
done	O	O	O
on	O	O	O
questionnaire	O	O	B-T170
designed	O	O	O
for	O	O	O
children	O	O	B-T100
.	O	O	O

Dental	O	O	B-T047
caries	O	O	I-T047
status	O	O	B-T080
was	O	O	O
examined	O	O	B-T033
by	O	O	O
using	O	O	O
WHO	O	O	B-T093
criteria	O	O	O
.	O	O	O

Dental	O	O	B-T047
caries	O	O	I-T047
was	O	O	O
found	O	O	O
in	O	O	O
81	O	O	O
children	O	O	B-T100
(	O	O	O
23.2	O	O	O
%	O	O	O
)	O	O	O
with	O	O	O
mean	O	O	O
DMFT	O	O	B-T081
0.61	O	O	O
.	O	O	O

Boys	O	O	B-T100
had	O	O	O
1.6	O	O	O
times	O	O	O
more	O	O	O
chance	O	O	O
to	O	O	O
have	O	O	O
dental	O	O	B-T047
caries	O	O	I-T047
than	O	O	O
girls	O	O	B-T100
.	O	O	O

Dental	O	O	B-T047
fluorosis	O	O	I-T047
was	O	O	O
found	O	O	O
in	O	O	O
63.6	O	O	O
%	O	O	O
of	O	O	O
children	O	O	B-T100
with	O	O	O
majority	O	O	O
of	O	O	O
moderate	O	O	B-T080
degree	O	O	O
(	O	O	O
50.5	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

Dental	O	O	B-T047
fluorosis	O	O	I-T047
status	O	O	B-T080
was	O	O	O
found	O	O	O
significantly	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
dental	O	O	B-T047
caries	O	O	I-T047
status	O	O	O
in	O	O	O
children	O	O	B-T100
.	O	O	O

The	O	O	O
children	O	O	B-T100
who	O	O	O
had	O	O	O
mild	O	O	B-T080
,	O	O	O
moderate	O	O	B-T080
and	O	O	O
severe	O	O	B-T080
fluorosis	O	O	B-T047
,	O	O	O
had	O	O	O
4	O	O	O
times	O	O	O
more	O	O	O
chances	O	O	O
to	O	O	O
develop	O	O	B-T169
caries	O	O	B-T047
than	O	O	O
those	O	O	O
who	O	O	O
did	O	O	O
not	O	O	O
have	O	O	O
fluorosis	O	O	O
.	O	O	O

There	O	O	O
was	O	O	O
no	O	O	O
significant	O	O	O
association	O	O	B-T080
between	O	O	O
children	O	O	B-T100
's	O	O	I-T100
caries	O	O	B-T047
status	O	O	B-T080
and	O	O	O
use	O	O	O
of	O	O	O
paste	O	O	B-T122
,	O	O	O
brushing	O	O	B-T061
habit	O	O	I-T061
,	O	O	O
miswak	O	O	B-T122
,	O	O	O
and	O	O	O
visit	O	O	B-T053
to	O	O	O
the	O	O	O
dentist	O	O	B-T097
.	O	O	O

The	O	O	O
use	O	O	O
of	O	O	O
pastries	O	O	B-T168
and	O	O	O
juices	O	O	B-T168
had	O	O	O
a	O	O	O
direct	O	O	O
relation	O	O	O
with	O	O	O
the	O	O	O
children	O	O	B-T100
's	O	O	I-T100
dental	O	O	B-T047
caries	O	O	I-T047
status	O	O	B-T080
.	O	O	O

Dental	O	O	B-T047
caries	O	O	I-T047
in	O	O	O
children	O	O	B-T100
of	O	O	O
Quetta	O	O	B-T083
is	O	O	O
not	O	O	O
so	O	O	O
much	O	O	O
frequent	O	O	O
as	O	O	O
compared	O	O	O
to	O	O	O
the	O	O	O
fluoride	O	O	B-T121
deficient	O	O	B-T169
countries	O	O	B-T083
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
high	O	O	O
prevalence	O	O	B-T081
of	O	O	O
moderate	O	O	O
dental	O	O	B-T047
fluorosis	O	O	I-T047
and	O	O	O
consumption	O	O	B-T052
of	O	O	O
pastries	O	O	B-T168
and	O	O	O
juices	O	O	B-T168
resulted	O	O	O
in	O	O	O
dental	O	O	B-T047
caries	O	O	I-T047
.	O	O	O

-DOCSTART- (27671789)

Proteomics	O	O	B-T116
analysis	O	O	B-T059
of	O	O	O
the	O	O	O
endogenous	O	O	B-T169
,	O	O	O
constitutive	O	O	O
,	O	O	O
leaf	O	O	B-T002
SUMOylome	O	O	O

SUMOylation	O	O	B-T044
is	O	O	O
a	O	O	O
post-translational	O	O	B-T044
modification	O	O	I-T044
which	O	O	O
regulates	O	O	B-T038
a	O	O	O
number	O	O	O
of	O	O	O
critical	O	O	B-T080
biological	O	O	B-T038
processes	O	O	I-T038
in	O	O	O
,	O	O	O
for	O	O	O
example	O	O	O
mammals	O	O	B-T015
,	O	O	O
yeast	O	O	B-T004
and	O	O	O
plants	O	O	B-T002
.	O	O	O

In	O	O	O
order	O	O	O
to	O	O	O
fully	O	O	O
understand	O	O	B-T041
the	O	O	O
functional	O	O	B-T033
effects	O	O	I-T033
of	O	O	O
SUMOylation	O	O	B-T044
an	O	O	O
essential	O	O	B-T080
first	O	O	O
step	O	O	O
is	O	O	O
the	O	O	O
identification	O	O	B-T041
of	O	O	O
endogenous	O	O	B-T169
targets	O	O	B-T169
for	O	O	O
SUMOylation	O	O	O
.	O	O	O

Here	O	O	O
we	O	O	O
report	O	O	B-T170
the	O	O	O
results	O	O	B-T169
of	O	O	O
using	O	O	O
a	O	O	O
recently	O	O	O
developed	O	O	O
proteomic	O	O	B-T091
approach	O	O	I-T091
based	O	O	O
on	O	O	O
the	O	O	O
use	O	O	O
of	O	O	O
3D	O	O	B-T082
gels	O	O	B-T122
to	O	O	O
identify	O	O	O
the	O	O	O
endogenous	O	O	B-T169
SUMO	O	O	B-T116
targets	O	O	B-T169
in	O	O	O
leaves	O	O	B-T002
of	O	O	O
Solanum	O	O	B-T002
tuberosum	O	O	I-T002
.	O	O	O

By	O	O	O
using	O	O	O
3D	O	O	B-T082
gels	O	O	B-T122
we	O	O	O
avoid	O	O	O
the	O	O	O
problem	O	O	O
of	O	O	O
co-migration	O	O	B-T067
of	O	O	O
proteins	O	O	B-T116
,	O	O	O
which	O	O	O
is	O	O	O
a	O	O	O
major	O	O	B-T080
limitation	O	O	B-T169
of	O	O	O
2D	O	O	B-T082
gels	O	O	O
,	O	O	O
and	O	O	O
we	O	O	O
enable	O	O	O
the	O	O	O
use	O	O	O
of	O	O	O
the	O	O	O
highly	O	O	B-T080
sensitive	O	O	I-T080
CyDye	O	O	B-T130
DIGE	O	O	I-T130
fluor	O	O	I-T130
saturation	O	O	I-T130
dyes	O	O	I-T130
.	O	O	O

Using	O	O	O
this	O	O	O
new	O	O	O
method	O	O	O
we	O	O	O
have	O	O	O
identified	O	O	B-T080
39	O	O	O
individual	O	O	B-T116
proteins	O	O	I-T116
as	O	O	O
probable	O	O	B-T081
SUMO	O	O	B-T116
targets	O	O	B-T169
in	O	O	O
leaves	O	O	B-T002
of	O	O	O
Solanum	O	O	B-T002
tuberosum	O	O	I-T002
.	O	O	O

The	O	O	O
advantages	O	O	O
of	O	O	O
this	O	O	O
method	O	O	B-T059
compared	O	O	O
with	O	O	O
other	O	O	O
approaches	O	O	B-T169
are	O	O	O
discussed	O	O	O
,	O	O	O
and	O	O	O
possible	O	O	B-T033
future	O	O	B-T079
developments	O	O	B-T169
are	O	O	O
outlined	O	O	O
.	O	O	O

The	O	O	O
authors	O	O	B-T097
have	O	O	O
no	O	O	O
conflicts	O	O	B-T078
of	O	O	I-T078
interest	O	O	I-T078
to	O	O	O
declare	O	O	O
.	O	O	O

All	O	O	O
authors	O	O	B-T097
have	O	O	O
approved	O	O	B-T080
the	O	O	O
manuscript	O	O	B-T073
and	O	O	O
agree	O	O	B-T033
with	O	O	O
submission	O	O	B-T169
to	O	O	O
Journal	O	O	B-T073
of	O	O	I-T073
Proteomics	O	O	I-T073
.	O	O	O

-DOCSTART- (27676724)

Antenatal	O	O	B-T079
consultation	O	O	B-T058
following	O	O	B-T079
limb	O	O	B-T019
malformation	O	O	I-T019
discovery	O	O	B-T052
using	O	O	O
ultrasound	O	O	O
scan	O	O	O

Our	O	O	O
unit	O	O	B-T093
has	O	O	O
been	O	O	O
providing	O	O	B-T052
antenatal	O	O	B-T079
consultations	O	O	B-T058
for	O	O	O
30	O	O	O
years	O	O	O
following	O	O	B-T079
the	O	O	O
discovery	O	O	B-T052
of	O	O	O
limb	O	O	B-T019
malformation	O	O	I-T019
with	O	O	O
the	O	O	O
fetus	O	O	B-T018
.	O	O	O

Each	O	O	O
of	O	O	O
these	O	O	O
consultations	O	O	B-T058
is	O	O	O
specific	O	O	B-T080
and	O	O	O
carried	O	O	B-T058
out	O	O	I-T058
by	O	O	O
a	O	O	O
multi-professional	O	O	B-T058
team	O	O	I-T058
.	O	O	O

It	O	O	O
requires	O	O	B-T169
a	O	O	O
physical	O	O	O
and	O	O	O
rehabilitation	O	O	B-T091
doctor	O	O	B-T097
,	O	O	O
an	O	O	O
orthopedic	O	O	B-T097
surgeon	O	O	I-T097
,	O	O	O
an	O	O	O
occupational	O	O	B-T097
therapist	O	O	I-T097
for	O	O	O
upper	O	O	B-T019
limb	O	O	I-T019
malformation	O	O	I-T019
,	O	O	O
a	O	O	O
physiotherapist	O	O	B-T097
for	O	O	O
lower	O	O	B-T019
malformation	O	O	I-T019
and	O	O	O
a	O	O	O
psychologist	O	O	B-T097
.	O	O	O

This	O	O	O
multidisciplinary	O	O	B-T057
consultation	O	O	B-T058
is	O	O	O
unique	O	O	B-T080
because	O	O	O
of	O	O	O
each	O	O	O
pregnancy	O	O	B-T040
story	O	O	O
,	O	O	O
because	O	O	O
of	O	O	O
each	O	O	O
patient	O	O	B-T101
life	O	O	B-T170
story	O	O	I-T170
but	O	O	O
also	O	O	O
because	O	O	O
of	O	O	O
the	O	O	O
words	O	O	O
used	O	O	O
by	O	O	O
the	O	O	O
sonologist	O	O	B-T097
when	O	O	O
announcing	O	O	O
the	O	O	O
diagnosis	O	O	B-T033
.	O	O	O

We	O	O	O
deal	O	O	O
with	O	O	O
couples	O	O	B-T099
shocked	O	O	B-T033
by	O	O	O
the	O	O	O
prenatal	O	O	B-T060
diagnosis	O	O	I-T060
.	O	O	O

We	O	O	O
help	O	O	O
them	O	O	O
get	O	O	O
acceptance	O	O	B-T055
of	O	O	O
the	O	O	O
child	O	O	B-T100
to	O	O	O
be	O	O	O
born	O	O	O
and	O	O	O
to	O	O	O
forget	O	O	O
about	O	O	O
their	O	O	O
imaginary	O	O	B-T041
child	O	O	O
.	O	O	O

Medical	O	O	B-T058
information	O	O	B-T078
is	O	O	O
often	O	O	O
perceived	O	O	B-T041
as	O	O	O
being	O	O	O
"	O	O	O
a	O	O	O
surfeit	O	O	B-T080
of	O	O	O
information	O	O	O
"	O	O	O
difficult	O	O	B-T080
to	O	O	O
handle	O	O	O
by	O	O	O
the	O	O	O
couple	O	O	B-T099
stunned	O	O	B-T033
by	O	O	O
the	O	O	O
overwhelming	O	O	B-T080
diagnosis	O	O	B-T033
.	O	O	O

We	O	O	O
must	O	O	O
stress	O	O	O
that	O	O	O
it	O	O	O
is	O	O	O
critical	O	O	B-T080
to	O	O	O
not	O	O	O
only	O	O	O
have	O	O	O
a	O	O	O
good	O	O	O
medical	O	O	B-T033
description	O	O	I-T033
of	O	O	O
the	O	O	O
malformations	O	O	B-T019
and	O	O	O
potential	O	O	B-T061
treatments	O	O	I-T061
but	O	O	O
also	O	O	O
a	O	O	O
good	O	O	O
psychological	O	O	B-T058
support	O	O	I-T058
(	O	O	O
parents	O	O	B-T099
personal	O	O	B-T032
life	O	O	B-T170
story	O	O	I-T170
,	O	O	O
self-defense	O	O	B-T041
mechanism	O	O	I-T041
,	O	O	O
guilt	O	O	B-T041
feeling	O	O	I-T041
)	O	O	O
.	O	O	O

The	O	O	O
ethical	O	O	B-T078
aspect	O	O	I-T078
of	O	O	O
this	O	O	O
consultation	O	O	B-T058
is	O	O	O
also	O	O	O
important	O	O	B-T080
.	O	O	O

Team	O	O	B-T058
members	O	O	B-T098
must	O	O	O
be	O	O	O
as	O	O	O
neutral	O	O	B-T170
as	O	O	O
possible	O	O	B-T033
in	O	O	O
their	O	O	O
assessments	O	O	B-T058
in	O	O	O
order	O	O	O
to	O	O	O
let	O	O	O
the	O	O	O
couple	O	O	B-T099
take	O	O	O
the	O	O	O
final	O	O	O
decision	O	O	B-T041
:	O	O	O
the	O	O	O
continuation	O	O	B-T033
of	O	O	O
the	O	O	O
pregnancy	O	O	B-T040
or	O	O	O
a	O	O	O
request	O	O	B-T052
of	O	O	O
voluntary	O	O	B-T055
termination	O	O	B-T061
of	O	O	I-T061
pregnancy	O	O	I-T061
.	O	O	O

These	O	O	O
prenatal	O	O	B-T100
consultations	O	O	B-T058
highlight	O	O	O
the	O	O	O
importance	O	O	B-T080
of	O	O	O
the	O	O	O
multidisciplinary	O	O	B-T080
global	O	O	B-T080
care	O	O	B-T058
.	O	O	O

-DOCSTART- (27678020)

Bending	O	O	B-T170
rules	O	O	I-T170
:	O	O	O
the	O	O	O
shape	O	O	B-T082
of	O	O	O
the	O	O	O
perceptual	O	O	B-T041
generalisation	O	O	B-T041
gradient	O	O	B-T081
is	O	O	O
sensitive	O	O	B-T169
to	O	O	O
inference	O	O	O
rules	O	O	O

Generalising	O	O	B-T041
what	O	O	O
is	O	O	O
learned	O	O	B-T041
about	O	O	O
one	O	O	O
stimulus	O	O	B-T067
to	O	O	O
other	O	O	O
but	O	O	O
perceptually	O	O	B-T041
related	O	O	O
stimuli	O	O	B-T067
is	O	O	O
a	O	O	O
basic	O	O	O
behavioural	O	O	B-T053
phenomenon	O	O	B-T067
.	O	O	O

We	O	O	O
evaluated	O	O	B-T058
whether	O	O	O
a	O	O	O
rule	O	O	B-T170
learning	O	O	B-T041
mechanism	O	O	B-T169
may	O	O	O
serve	O	O	O
to	O	O	O
explain	O	O	O
such	O	O	O
generalisation	O	O	B-T041
.	O	O	O

To	O	O	O
this	O	O	O
end	O	O	O
,	O	O	O
we	O	O	O
assessed	O	O	B-T052
whether	O	O	O
inference	O	O	B-T170
rules	O	O	I-T170
communicated	O	O	B-T033
through	O	O	O
verbal	O	O	B-T058
instructions	O	O	I-T058
affect	O	O	O
generalisation	O	O	B-T041
.	O	O	O

Expectancy	O	O	B-T078
ratings	O	O	B-T052
,	O	O	O
but	O	O	O
not	O	O	O
valence	O	O	O
ratings	O	O	O
,	O	O	O
proved	O	O	O
sensitive	O	O	B-T169
to	O	O	O
this	O	O	O
manipulation	O	O	B-T053
.	O	O	O

In	O	O	O
addition	O	O	O
to	O	O	O
revealing	O	O	O
a	O	O	O
role	O	O	B-T170
for	O	O	O
inference	O	O	B-T170
rules	O	O	I-T170
in	O	O	O
generalisation	O	O	B-T041
,	O	O	O
our	O	O	O
study	O	O	B-T062
has	O	O	O
clinical	O	O	B-T080
implications	O	O	B-T169
as	O	O	O
well	O	O	O
.	O	O	O

More	O	O	O
specifically	O	O	O
,	O	O	O
we	O	O	O
argue	O	O	O
that	O	O	O
targeting	O	O	B-T169
inference	O	O	B-T170
rules	O	O	I-T170
might	O	O	O
prove	O	O	O
to	O	O	O
be	O	O	O
an	O	O	O
effective	O	O	O
strategy	O	O	B-T041
to	O	O	O
affect	O	O	O
the	O	O	O
excessive	O	O	B-T080
generalisation	O	O	B-T041
that	O	O	O
is	O	O	O
often	O	O	O
observed	O	O	O
in	O	O	O
psychopathology	O	O	B-T091
.	O	O	O

-DOCSTART- (27678044)

Neuroticism	O	O	B-T048
and	O	O	O
Fatigue	O	O	B-T184
3	O	O	B-T079
Months	O	O	I-T079
After	O	O	O
Ischemic	O	O	B-T047
Stroke	O	O	I-T047
:	O	O	O
A	O	O	O
Cross-Sectional	O	O	O
Study	O	O	O

To	O	O	O
examine	O	O	B-T033
the	O	O	O
relation	O	O	O
between	O	O	O
neuroticism	O	O	B-T048
and	O	O	O
fatigue	O	O	B-T184
in	O	O	O
Chinese	O	O	B-T083
patients	O	O	B-T101
with	O	O	O
stroke	O	O	B-T047
.	O	O	O

Cross-sectional	O	O	B-T062
study	O	O	I-T062
.	O	O	O

Acute	O	O	B-T079
stroke	O	O	B-T093
unit	O	O	I-T093
.	O	O	O

Survivors	O	O	B-T101
of	O	O	O
ischemic	O	O	B-T047
stroke	O	O	I-T047
(	O	O	O
N=191	O	O	O
)	O	O	O
recruited	O	O	O
from	O	O	O
the	O	O	O
acute	O	O	B-T079
stroke	O	O	B-T093
unit	O	O	I-T093
between	O	O	O
May	O	O	O
1	O	O	O
,	O	O	O
2010	O	O	O
,	O	O	O
and	O	O	O
September	O	O	O
1	O	O	O
,	O	O	O
2011	O	O	O
.	O	O	O

Not	O	O	O
applicable	O	O	O
.	O	O	O

The	O	O	O
personality	O	O	B-T033
trait	O	O	I-T033
of	O	O	O
neuroticism	O	O	B-T048
was	O	O	O
measured	O	O	B-T080
with	O	O	O
the	O	O	O
neuroticism	O	O	O
subscale	O	O	B-T081
of	O	O	O
the	O	O	O
Chinese	O	O	B-T083
version	O	O	B-T170
of	O	O	O
the	O	O	O
NEO	O	O	B-T060
Five-Factor	O	O	I-T060
Inventory	O	O	I-T060
.	O	O	O

The	O	O	O
level	O	O	B-T080
of	O	O	O
fatigue	O	O	B-T184
was	O	O	O
measured	O	O	B-T080
with	O	O	O
the	O	O	O
Fatigue	O	O	B-T170
Assessment	O	O	I-T170
Scale	O	O	I-T170
.	O	O	O

The	O	O	O
National	O	O	B-T170
Institutes	O	O	I-T170
of	O	O	I-T170
Health	O	O	I-T170
Stroke	O	O	I-T170
Scale	O	O	I-T170
,	O	O	O
Geriatric	O	O	B-T170
Depression	O	O	I-T170
Scale	O	O	I-T170
,	O	O	O
Barthel	O	O	B-T170
Index	O	O	I-T170
,	O	O	O
and	O	O	O
Mini-Mental	O	O	B-T060
State	O	O	I-T060
Examination	O	O	I-T060
were	O	O	O
administered	O	O	B-T169
to	O	O	O
obtain	O	O	O
demographic	O	O	B-T090
and	O	O	O
clinical	O	O	B-T170
information	O	O	I-T170
.	O	O	O

Fatigue	O	O	B-T170
severity	O	O	I-T170
3	O	O	B-T079
months	O	O	I-T079
after	O	O	O
stroke	O	O	B-T047
positively	O	O	O
correlated	O	O	B-T080
with	O	O	O
Geriatric	O	O	B-T170
Depression	O	O	I-T170
Scale	O	O	I-T170
and	O	O	O
NEO	O	O	B-T060
Five-Factor	O	O	I-T060
Inventory	O	O	I-T060
neuroticism	O	O	B-T048
scores	O	O	B-T081
and	O	O	O
negatively	O	O	B-T033
correlated	O	O	O
with	O	O	O
the	O	O	O
Barthel	O	O	B-T081
Index	O	O	I-T081
score	O	O	I-T081
.	O	O	O

Neuroticism	O	O	B-T048
,	O	O	O
independent	O	O	B-T033
of	O	O	O
depressive	O	O	B-T184
symptoms	O	O	I-T184
,	O	O	O
is	O	O	O
a	O	O	O
predictor	O	O	O
of	O	O	O
fatigue	O	O	B-T170
severity	O	O	I-T170
3	O	O	B-T079
months	O	O	I-T079
after	O	O	O
stroke	O	O	B-T047
.	O	O	O

Interventions	O	O	O
such	O	O	O
as	O	O	O
psychological	O	O	B-T169
screening	O	O	B-T169
programs	O	O	I-T169
are	O	O	O
warranted	O	O	O
for	O	O	O
early	O	O	O
detection	O	O	B-T061
of	O	O	O
patients	O	O	B-T101
at	O	O	O
high	O	O	B-T033
risk	O	O	I-T033
of	O	O	I-T033
poststroke	O	O	B-T047
depression	O	O	I-T047
.	O	O	O

-DOCSTART- (27680006)

Hematological	O	O	B-T033
,	O	O	O
biochemical	O	O	B-T033
,	O	O	O
and	O	O	O
toxicopathic	O	O	B-T033
effects	O	O	I-T033
of	O	O	O
subchronic	O	O	B-T080
acetamiprid	O	O	B-T109
toxicity	O	O	B-T037
in	O	O	O
Wistar	O	O	O
rats	O	O	O

Acetamiprid	O	O	B-T109
is	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
most	O	O	O
widely	O	O	O
used	O	O	O
neonicotinoids	O	O	B-T131
.	O	O	O

This	O	O	O
study	O	O	O
investigates	O	O	B-T169
toxic	O	O	B-T037
effects	O	O	I-T037
of	O	O	O
repeated	O	O	O
oral	O	O	B-T169
administration	O	O	I-T169
of	O	O	O
three	O	O	O
doses	O	O	B-T081
of	O	O	O
acetamiprid	O	O	B-T109
(	O	O	O
1/20	O	O	O
,	O	O	O
1/10	O	O	O
,	O	O	O
and	O	O	O
1/5	O	O	O
of	O	O	O
LD50	O	O	B-T081
)	O	O	O
during	O	O	O
60	O	O	O
days	O	O	B-T079
.	O	O	O

For	O	O	O
this	O	O	O
,	O	O	O
male	O	O	B-T032
Wistar	O	O	B-T015
rats	O	O	I-T015
were	O	O	O
divided	O	O	O
into	O	O	O
four	O	O	O
different	O	O	O
groups	O	O	B-T078
.	O	O	O

Hematological	O	O	B-T033
,	O	O	O
biochemical	O	O	B-T033
,	O	O	O
and	O	O	O
toxicopathic	O	O	B-T033
effects	O	O	I-T033
of	O	O	O
acetamiprid	O	O	B-T109
were	O	O	O
evaluated	O	O	B-T058
.	O	O	O

According	O	O	O
to	O	O	O
the	O	O	O
results	O	O	O
,	O	O	O
a	O	O	O
significant	O	O	O
decrease	O	O	B-T081
in	O	O	O
the	O	O	O
body	O	O	B-T033
weight	O	O	I-T033
gain	O	O	I-T033
at	O	O	O
the	O	O	O
highest	O	O	O
dose	O	O	B-T081
1/5	O	O	O
of	O	O	O
LD50	O	O	B-T081
of	O	O	O
acetamiprid	O	O	B-T109
was	O	O	O
noticed	O	O	O
.	O	O	O

An	O	O	O
increase	O	O	B-T169
in	O	O	O
the	O	O	O
relative	O	O	O
liver	O	O	B-T023
weight	O	O	B-T081
was	O	O	O
also	O	O	O
observed	O	O	O
at	O	O	O
this	O	O	O
dose	O	O	B-T081
level	O	O	B-T080
.	O	O	O

The	O	O	O
hematological	O	O	B-T167
constituents	O	O	I-T167
were	O	O	O
affected	O	O	O
.	O	O	O

A	O	O	O
significant	O	O	O
decrease	O	O	B-T081
in	O	O	O
RBC	O	O	B-T025
,	O	O	O
HGB	O	O	B-T116
,	O	O	O
and	O	O	O
HCT	O	O	B-T033
in	O	O	O
rats	O	O	B-T015
treated	O	O	B-T169
with	O	O	O
higher	O	O	O
doses	O	O	B-T081
of	O	O	O
acetamiprid	O	O	B-T109
(	O	O	O
1/10	O	O	O
and	O	O	O
1/5	O	O	O
of	O	O	O
LD50	O	O	B-T081
)	O	O	O
was	O	O	O
noted	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
a	O	O	O
significant	O	O	O
increase	O	O	B-T169
in	O	O	O
WBC	O	O	B-T025
and	O	O	O
PLT	O	O	B-T025
were	O	O	O
observed	O	O	O
at	O	O	O
the	O	O	O
same	O	O	O
doses	O	O	B-T081
.	O	O	O

Furthermore	O	O	O
,	O	O	O
acetamiprid	O	O	B-T109
induced	O	O	B-T047
liver	O	O	I-T047
toxicity	O	O	I-T047
measured	O	O	O
by	O	O	O
the	O	O	O
increased	O	O	B-T081
activities	O	O	B-T044
of	O	O	O
aspartate	O	O	B-T116
aminotransferase	O	O	I-T116
(	O	O	O
AST	O	O	B-T116
)	O	O	O
,	O	O	O
alanine	O	O	B-T116
aminotransferase	O	O	I-T116
(	O	O	O
ALT	O	O	B-T116
)	O	O	O
,	O	O	O
alkaline	O	O	B-T116
phosphates	O	O	I-T116
(	O	O	O
ALPs	O	O	B-T116
)	O	O	O
,	O	O	O
and	O	O	O
lactate	O	O	B-T116
dehydrogenase	O	O	I-T116
(	O	O	O
LDH	O	O	B-T116
)	O	O	O
which	O	O	O
may	O	O	O
be	O	O	O
due	O	O	O
to	O	O	O
the	O	O	O
loss	O	O	B-T081
of	O	O	O
hepatic	O	O	B-T026
membrane	O	O	I-T026
architecture	O	O	I-T026
and	O	O	O
hepatocellular	O	O	B-T046
damage	O	O	I-T046
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
exposure	O	O	B-T080
to	O	O	I-T080
acetamiprid	O	O	B-T109
resulted	O	O	O
in	O	O	O
a	O	O	O
significant	O	O	O
decrease	O	O	B-T081
in	O	O	O
the	O	O	O
levels	O	O	B-T080
of	O	O	O
superoxide	O	O	B-T116
dismutase	O	O	I-T116
and	O	O	O
catalase	O	O	B-T116
activities	O	O	B-T044
(	O	O	O
p	O	O	O
â¤	O	O	O
0.01	O	O	O
)	O	O	O
with	O	O	O
concomitant	O	O	B-T079
increase	O	O	B-T169
in	O	O	O
lipid	O	O	B-T044
peroxidation	O	O	I-T044
in	O	O	O
rat	O	O	B-T015
liver	O	O	B-T023
.	O	O	O

These	O	O	O
findings	O	O	B-T033
highlight	O	O	O
the	O	O	O
subchronic	O	O	B-T080
hepatotoxicity	O	O	B-T037
of	O	O	O
acetamiprid	O	O	B-T109
.	O	O	O

-DOCSTART- (27680598)

Sustained	O	O	B-T122
delivery	O	O	I-T122
of	O	O	O
vincristine	O	O	B-T109
inside	O	O	O
an	O	O	O
orthotopic	O	O	B-T082
mouse	O	O	B-T191
sarcoma	O	O	I-T191
model	O	O	O
decreases	O	O	B-T081
tumor	O	O	O
growth	O	O	O

Sarcoma	O	O	B-T191
accounts	O	O	O
for	O	O	O
20	O	O	O
%	O	O	O
of	O	O	O
solid	O	O	B-T191
tumors	O	O	I-T191
in	O	O	O
children	O	O	B-T100
.	O	O	O

Surgery	O	O	B-T061
has	O	O	O
significant	O	O	O
morbidity	O	O	B-T081
.	O	O	O

We	O	O	O
hypothesized	O	O	O
that	O	O	O
delivering	O	O	O
chemotherapy	O	O	B-T061
directly	O	O	O
into	O	O	O
tumors	O	O	B-T191
through	O	O	O
sustained	O	O	B-T122
release	O	O	I-T122
silk	O	O	B-T116
systems	O	O	O
could	O	O	O
slow	O	O	O
tumor	O	O	B-T191
growth	O	O	I-T191
.	O	O	O

Human	O	O	B-T016
Ewing	O	O	B-T191
sarcoma	O	O	I-T191
cells	O	O	B-T025
A673	O	O	I-T025
were	O	O	O
cultured	O	O	B-T059
with	O	O	O
vincristine	O	O	B-T109
and	O	O	O
doxorubicin	O	O	B-T195
to	O	O	O
determine	O	O	O
half	O	O	B-T081
maximal	O	O	I-T081
inhibitory	O	O	I-T081
concentration	O	O	I-T081
(	O	O	O
IC50	O	O	B-T081
)	O	O	O
.	O	O	O

Cells	O	O	B-T025
were	O	O	O
injected	O	O	O
into	O	O	O
mouse	O	O	B-T015
hind	O	O	B-T023
leg	O	O	I-T023
to	O	O	O
create	O	O	O
orthotopic	O	O	B-T082
tumors	O	O	B-T191
.	O	O	O

Tumor	O	O	B-T081
volumes	O	O	I-T081
were	O	O	O
measured	O	O	O
using	O	O	O
ultrasound	O	O	B-T060
.	O	O	O

When	O	O	O
volume	O	O	O
reached	O	O	O
>	O	O	O
250mm(3	O	O	O
,	O	O	O
)	O	O	O
interventions	O	O	B-T061
included	O	O	O
:	O	O	O
implantation	O	O	B-T061
of	O	O	O
drug-free	O	O	B-UnknownType
silk	O	O	B-T116
foam	O	O	O
(	O	O	O
Control	O	O	B-T096
-F	O	O	O
)	O	O	O
,	O	O	O
doxorubicin	O	O	B-T195
400Î¼g	O	O	O
foam	O	O	O
(	O	O	B-T195
Dox400	O	O	I-T195
-F	O	O	O
)	O	O	O
,	O	O	O
vincristine	O	O	B-T109
50Î¼g	O	O	O
foam	O	O	O
(	O	O	O
Vin50	O	O	B-T109
-F	O	O	O
)	O	O	O
,	O	O	O
drug-free	O	O	O
silk	O	O	O
gel	O	O	B-T167
(	O	O	O
Control	O	O	O
-G	O	O	O
)	O	O	O
,	O	O	O
vincristine	O	O	O
50Î¼g	O	O	O
gel	O	O	O
(	O	O	O
Vin50	O	O	O
-G	O	O	O
)	O	O	O
,	O	O	O
or	O	O	O
single	O	O	O
dose	O	O	O
intravenous	O	O	B-T082
vincristine	O	O	O
50Î¼g	O	O	O
(	O	O	O
Vin50	O	O	O
-IV	O	O	O
)	O	O	O
.	O	O	O

End-point	O	O	B-T080
was	O	O	O
volume>1000mm(3	O	O	O
)	O	O	O
.	O	O	O

Kaplan	O	O	B-T081
Meier	O	O	I-T081
and	O	O	O
ANOVA	O	O	B-T081
were	O	O	O
used	O	O	O
.	O	O	O

IC50	O	O	B-T081
for	O	O	O
vincristine	O	O	B-T109
and	O	O	O
doxorubicin	O	O	B-T195
was	O	O	O
0.5ng/mL	O	O	O
and	O	O	O
200ng/mL	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

There	O	O	O
was	O	O	O
no	O	O	O
difference	O	O	O
between	O	O	O
Dox400	O	O	B-T195
-F	O	O	O
[	O	O	O
6Â±	O	O	O
1days	O	O	B-T079
to	O	O	O
end	O	O	B-T080
point	O	O	I-T080
(	O	O	O
DTEP	O	O	B-T080
)	O	O	O
]	O	O	O
and	O	O	O
Control	O	O	B-T096
-F	O	O	O
(	O	O	O
5Â±1.3	O	O	O
DTEP	O	O	O
)	O	O	O
.	O	O	O

Vin50	O	O	B-T109
-F	O	O	O
(	O	O	O
12.4Â±3.5	O	O	O
DTEP	O	O	B-T080
)	O	O	O
had	O	O	O
slower	O	O	B-T033
growth	O	O	I-T033
compared	O	O	O
to	O	O	O
Control	O	O	B-T096
-F	O	O	O
(	O	O	O
p<0.001	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
there	O	O	O
was	O	O	O
no	O	O	O
difference	O	O	O
between	O	O	O
Vin50	O	O	O
-F	O	O	O
and	O	O	O
Vin50	O	O	O
-IV	O	O	O
(	O	O	O
14Â±0	O	O	O
DTEP	O	O	O
)	O	O	O
.	O	O	O

Growth	O	O	B-T033
was	O	O	I-T033
slowest	O	O	I-T033
with	O	O	O
Vin50	O	O	B-T109
-G	O	O	O
,	O	O	O
28Â±10.3	O	O	O
DTEP	O	O	B-T080
compared	O	O	O
to	O	O	O
all	O	O	O
other	O	O	O
treatment	O	O	O
groups	O	O	O
(	O	O	O
p<0.05	O	O	O
)	O	O	O
.	O	O	O

Sustained	O	O	B-T122
delivery	O	O	I-T122
of	O	O	O
vincristine	O	O	B-T109
inside	O	O	O
the	O	O	O
sarcoma	O	O	B-T191
tumor	O	O	B-T191
with	O	O	O
silk	O	O	B-T116
gel	O	O	B-T167
decreased	O	O	B-T081
tumor	O	O	B-T191
growth	O	O	I-T191
.	O	O	O

Applying	O	O	O
this	O	O	O
intratumoral	O	O	B-T061
treatment	O	O	I-T061
strategy	O	O	O
may	O	O	O
potentially	O	O	O
decrease	O	O	B-T081
the	O	O	O
extent	O	O	O
of	O	O	O
surgical	O	O	B-T061
excision	O	O	I-T061
.	O	O	O

-DOCSTART- (27681567)

Spinal	O	O	B-T023
load	O	O	B-T032
in	O	O	O
nurses	O	O	B-T097
during	O	O	O
emergency	O	O	B-T067
lifting	O	O	B-T052
of	O	O	O
obese	O	O	B-T047
patients	O	O	B-T101
:	O	O	O
preliminary	O	O	O
results	O	O	O

Nurses	O	O	B-T097
are	O	O	O
exposed	O	O	O
to	O	O	O
the	O	O	O
risk	O	O	B-T078
of	O	O	O
injury	O	O	B-T037
while	O	O	O
handling	O	O	B-T033
patients	O	O	B-T101
.	O	O	O

This	O	O	O
is	O	O	O
particularly	O	O	O
true	O	O	O
for	O	O	O
obese	O	O	B-T047
patients	O	O	B-T101
.	O	O	O

The	O	O	O
goal	O	O	B-T170
of	O	O	O
this	O	O	O
paper	O	O	O
is	O	O	O
to	O	O	O
estimate	O	O	B-T081
the	O	O	O
spinal	O	O	B-T023
loads	O	O	B-T032
and	O	O	O
the	O	O	O
related	O	O	O
risk	O	O	B-T078
of	O	O	O
injury	O	O	B-T037
to	O	O	O
nurses	O	O	B-T097
while	O	O	O
lifting	O	O	B-T052
obese	O	O	B-T047
patients	O	O	B-T101
from	O	O	O
the	O	O	O
floor	O	O	B-T073
with	O	O	O
a	O	O	O
bariatric	O	O	B-T074
sheet	O	O	I-T074
during	O	O	O
a	O	O	O
hospital	O	O	B-T093
emergency	O	O	B-T067
.	O	O	O

Six	O	O	O
male	O	O	B-T032
nurses	O	O	B-T097
participated	O	O	O
in	O	O	O
this	O	O	O
study	O	O	B-T062
.	O	O	O

The	O	O	O
biomechanical	O	O	B-T060
analysis	O	O	I-T060
focused	O	O	O
on	O	O	O
the	O	O	O
lifting	O	O	B-T052
strategy	O	O	O
.	O	O	O

Thirty	O	O	O
obese	O	O	B-T047
in-patients	O	O	B-T101
were	O	O	O
enrolled	O	O	O
to	O	O	O
take	O	O	O
part	O	O	O
in	O	O	O
the	O	O	O
experimental	O	O	B-T062
study	O	O	I-T062
and	O	O	O
divided	O	O	O
into	O	O	O
three	O	O	O
groups	O	O	B-T078
according	O	O	O
to	O	O	O
their	O	O	O
Body	O	O	B-T201
Mass	O	O	I-T201
Index	O	O	I-T201
(	O	O	O
BMI	O	O	B-T201
)	O	O	O
.	O	O	O

Three-dimensional	O	O	B-T060
motion	O	O	I-T060
analysis	O	O	I-T060
was	O	O	O
conducted	O	O	O
using	O	O	O
an	O	O	O
optoelectronic	O	O	B-T074
system	O	O	I-T074
.	O	O	O

The	O	O	O
trunk	O	O	B-T029
kinematics	O	O	B-T091
and	O	O	O
the	O	O	O
loading	O	O	B-T032
on	O	O	O
the	O	O	O
spines	O	O	B-T023
of	O	O	O
the	O	O	O
operating	O	O	O
nurses	O	O	B-T097
were	O	O	O
computed	O	O	B-T059
.	O	O	O

Our	O	O	O
data	O	O	B-T078
showed	O	O	O
that	O	O	O
when	O	O	O
the	O	O	O
nurse	O	O	B-T097
was	O	O	O
operating	O	O	O
from	O	O	O
the	O	O	O
central	O	O	O
handle	O	O	O
,	O	O	O
his	O	O	O
trunk	O	O	B-T029
was	O	O	O
more	O	O	O
flexed	O	O	B-T042
at	O	O	O
the	O	O	O
end	O	O	O
of	O	O	O
the	O	O	O
lift	O	O	B-T052
with	O	O	O
a	O	O	O
reduced	O	O	B-T080
range	O	O	B-T201
of	O	O	I-T201
motion	O	O	I-T201
.	O	O	O

The	O	O	O
values	O	O	B-T081
were	O	O	O
higher	O	O	B-T080
when	O	O	O
the	O	O	O
nurse	O	O	B-T097
lifted	O	O	O
patients	O	O	B-T101
with	O	O	O
higher	O	O	O
BMIs	O	O	B-T201
.	O	O	O

All	O	O	O
kinetic	O	O	B-T081
parameters	O	O	I-T081
and	O	O	O
tension	O	O	B-T042
in	O	O	O
the	O	O	O
lumbar	O	O	B-T023
muscles	O	O	I-T023
at	O	O	O
the	O	O	O
end	O	O	O
of	O	O	O
the	O	O	O
movement	O	O	B-T040
were	O	O	O
characterised	O	O	O
by	O	O	O
lower	O	O	B-T080
values	O	O	B-T081
for	O	O	O
the	O	O	O
nurse	O	O	B-T097
placed	O	O	O
beside	O	O	O
the	O	O	O
patient	O	O	B-T101
's	O	O	I-T101
head	O	O	B-T029
or	O	O	O
feet	O	O	B-T023
if	O	O	O
compared	O	O	O
to	O	O	O
the	O	O	O
operator	O	O	O
positioned	O	O	O
beside	O	O	O
the	O	O	O
central	O	O	O
handle	O	O	O
in	O	O	O
all	O	O	O
patient	O	O	B-T101
groups	O	O	I-T101
.	O	O	O

Our	O	O	O
preliminary	O	O	O
data	O	O	B-T078
suggest	O	O	O
that	O	O	O
only	O	O	O
the	O	O	O
reaction	O	O	O
load	O	O	B-T032
on	O	O	O
the	O	O	O
spine	O	O	B-T023
of	O	O	O
the	O	O	O
nurse	O	O	B-T097
holding	O	O	O
the	O	O	O
central	O	O	O
handle	O	O	O
,	O	O	O
closest	O	O	O
to	O	O	O
the	O	O	O
patient	O	O	B-T101
's	O	O	I-T101
centre	O	O	O
of	O	O	O
mass	O	O	O
,	O	O	O
seems	O	O	O
to	O	O	O
exceed	O	O	O
the	O	O	O
recommended	O	O	B-T078
safety	O	O	B-T068
limits	O	O	B-T169
.	O	O	O

-DOCSTART- (27685187)

Expectations	O	O	B-T078
for	O	O	O
the	O	O	O
methodology	O	O	B-T078
and	O	O	O
translation	O	O	B-T062
of	O	O	O
animal	O	O	B-T008
research	O	O	I-T062
:	O	O	O
a	O	O	O
survey	O	O	B-T170
of	O	O	O
the	O	O	O
general	O	O	B-T098
public	O	O	I-T098
,	O	O	O
medical	O	O	B-T097
students	O	O	I-T097
and	O	O	O
animal	O	O	O
researchers	O	O	B-T097
in	O	O	O
North	O	O	O
America	O	O	O

To	O	O	O
determine	O	O	O
what	O	O	O
are	O	O	O
considered	O	O	O
acceptable	O	O	B-T080
standards	O	O	B-T170
for	O	O	O
animal	O	O	B-T062
research	O	O	I-T062
(	O	O	O
AR	O	O	B-T062
)	O	O	O
methodology	O	O	B-T078
and	O	O	O
translation	O	O	B-T081
rate	O	O	I-T081
to	O	O	O
humans	O	O	B-T016
,	O	O	O
a	O	O	O
validated	O	O	O
survey	O	O	B-T170
was	O	O	O
sent	O	O	O
to	O	O	O
:	O	O	O
a	O	O	O
)	O	O	O
a	O	O	O
sample	O	O	O
of	O	O	O
the	O	O	O
general	O	O	B-T098
public	O	O	I-T098
,	O	O	O
via	O	O	O
Sampling	O	O	B-T170
Survey	O	O	I-T170
International	O	O	I-T170
(	O	O	O
SSI	O	O	B-T170
;	O	O	O
Canada	O	O	B-T083
)	O	O	O
,	O	O	O
Amazon	O	O	B-T170
Mechanical	O	O	I-T170
Turk	O	O	I-T170
(	O	O	O
AMT	O	O	B-T170
;	O	O	O
USA	O	O	B-T083
)	O	O	O
,	O	O	O
a	O	O	O
Canadian	O	O	B-T083
city	O	O	I-T083
festival	O	O	B-T052
(	O	O	O
CF	O	O	B-T052
)	O	O	O
and	O	O	O
a	O	O	O
Canadian	O	O	O
children	O	O	B-T093
's	O	O	I-T093
hospital	O	O	I-T093
(	O	O	O
CH	O	O	B-T093
)	O	O	O
;	O	O	O
b	O	O	O
)	O	O	O
a	O	O	O
sample	O	O	O
of	O	O	O
medical	O	O	B-T097
students	O	O	I-T097
(	O	O	O
two	O	O	O
first-year	O	O	O
classes	O	O	O
)	O	O	O
;	O	O	O
and	O	O	O
c	O	O	O
)	O	O	O
a	O	O	O
sample	O	O	O
of	O	O	O
scientists	O	O	B-T097
(	O	O	O
corresponding	O	O	O
authors	O	O	B-T097
and	O	O	O
academic	O	O	B-T092
paediatricians	O	O	B-T097
)	O	O	O
.	O	O	O

There	O	O	O
were	O	O	O
1379	O	O	O
responses	O	O	B-T032
from	O	O	O
the	O	O	O
general	O	O	B-T098
public	O	O	I-T098
sample	O	O	O
(	O	O	O
SSI	O	O	B-T170
,	O	O	O
n	O	O	O
=	O	O	O
557	O	O	O
;	O	O	O
AMT	O	O	B-T170
,	O	O	O
n	O	O	O
=	O	O	O
590	O	O	O
;	O	O	O
CF	O	O	B-T052
,	O	O	O
n	O	O	O
=	O	O	O
195	O	O	O
;	O	O	O
CH	O	O	B-T093
,	O	O	O
n	O	O	O
=	O	O	O
102	O	O	O
)	O	O	O
,	O	O	O
205/330	O	O	O
(	O	O	O
62	O	O	O
%	O	O	O
)	O	O	O
medical	O	O	B-T097
student	O	O	I-T097
responses	O	O	O
,	O	O	O
and	O	O	O
23/323	O	O	O
(	O	O	O
7	O	O	O
%	O	O	O
,	O	O	O
too	O	O	O
few	O	O	O
to	O	O	O
report	O	O	O
)	O	O	O
scientist	O	O	B-T097
responses	O	O	O
.	O	O	O

Asked	O	O	O
about	O	O	O
methodological	O	O	B-UnknownType
quality	O	O	I-UnknownType
,	O	O	O
most	O	O	O
of	O	O	O
the	O	O	O
general	O	O	B-T098
public	O	O	I-T098
and	O	O	O
medical	O	O	B-T097
student	O	O	I-T097
respondents	O	O	B-T098
expect	O	O	O
that	O	O	O
:	O	O	O
AR	O	O	B-T062
is	O	O	O
of	O	O	O
high	O	O	B-T080
quality	O	O	I-T080
(	O	O	O
e.g.	O	O	O
anaesthesia	O	O	B-T061
and	O	O	O
analgesia	O	O	B-T061
are	O	O	O
monitored	O	O	O
,	O	O	O
even	O	O	O
overnight	O	O	O
,	O	O	O
and	O	O	O
'	O	O	O
humane	O	O	O
'	O	O	O
euthanasia	O	O	B-T058
,	O	O	O
optimal	O	O	B-T080
statistical	O	O	B-UnknownType
design	O	O	I-UnknownType
,	O	O	O
comprehensive	O	O	B-T080
literature	O	O	B-T170
review	O	O	I-T170
,	O	O	O
randomisation	O	O	B-T062
and	O	O	O
blinding	O	O	B-T062
,	O	O	O
are	O	O	O
performed	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
costs	O	O	B-T081
and	O	O	O
difficulty	O	O	O
are	O	O	O
not	O	O	O
acceptable	O	O	B-T080
justifications	O	O	B-T078
for	O	O	O
lower	O	O	B-T080
quality	O	O	I-T080
(	O	O	O
e.g.	O	O	O
costs	O	O	O
of	O	O	O
expert	O	O	O
consultation	O	O	B-T058
,	O	O	O
or	O	O	O
more	O	O	O
laboratory	O	O	B-T097
staff	O	O	I-T097
)	O	O	O
.	O	O	O

Asked	O	O	O
about	O	O	O
their	O	O	O
expectations	O	O	B-T078
of	O	O	O
translation	O	O	B-T062
to	O	O	O
humans	O	O	B-T016
(	O	O	O
of	O	O	O
toxicity	O	O	B-T037
,	O	O	O
carcinogenicity	O	O	B-T191
,	O	O	O
teratogenicity	O	O	B-T046
and	O	O	O
treatment	O	O	B-T169
findings	O	O	B-T169
)	O	O	O
,	O	O	O
most	O	O	O
expect	O	O	O
translation	O	O	O
more	O	O	O
than	O	O	O
60	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
time	O	O	O
.	O	O	O

If	O	O	O
translation	O	O	B-T062
occurred	O	O	O
less	O	O	O
than	O	O	O
20	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
time	O	O	O
,	O	O	O
a	O	O	O
minority	O	O	B-T098
disagreed	O	O	O
that	O	O	O
this	O	O	O
would	O	O	O
"	O	O	O
significantly	O	O	O
reduce	O	O	O
your	O	O	O
support	O	O	O
for	O	O	O
AR	O	O	B-T062
"	O	O	O
.	O	O	O

Medical	O	O	B-T097
students	O	O	I-T097
were	O	O	O
more	O	O	O
supportive	O	O	B-T077
of	O	O	O
AR	O	O	B-T062
,	O	O	O
even	O	O	O
if	O	O	O
translation	O	O	B-T062
occurred	O	O	O
less	O	O	O
than	O	O	O
20	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
time	O	O	O
.	O	O	O

Expectations	O	O	B-T078
for	O	O	O
AR	O	O	B-T062
are	O	O	O
much	O	O	O
higher	O	O	O
than	O	O	O
empirical	O	O	B-T078
data	O	O	I-T078
show	O	O	O
to	O	O	O
have	O	O	O
been	O	O	O
achieved	O	O	O
.	O	O	O

-DOCSTART- (27686952)

Predicting	O	O	B-T078
violence	O	O	B-T048
and	O	O	O
recidivism	O	O	B-T055
in	O	O	O
a	O	O	O
large	O	O	O
sample	O	O	O
of	O	O	O
males	O	O	B-T032
on	O	O	O
probation	O	O	B-T089
or	O	O	O
parole	O	O	O

This	O	O	O
study	O	O	B-T062
evaluated	O	O	B-T078
the	O	O	O
utility	O	O	O
of	O	O	O
items	O	O	O
and	O	O	O
scales	O	O	O
from	O	O	O
the	O	O	O
Iowa	O	O	B-T083
Violence	O	O	B-T048
and	O	O	O
Victimization	O	O	B-T068
Instrument	O	O	B-T170
in	O	O	O
a	O	O	O
sample	O	O	O
of	O	O	O
1961	O	O	O
males	O	O	B-T032
from	O	O	O
the	O	O	O
state	O	O	O
of	O	O	O
Iowa	O	O	O
who	O	O	O
were	O	O	O
on	O	O	O
probation	O	O	B-T089
or	O	O	O
released	O	O	B-T033
from	O	O	I-T033
prison	O	O	I-T033
to	O	O	O
parole	O	O	B-T089
supervision	O	O	B-T057
.	O	O	O

This	O	O	O
is	O	O	O
the	O	O	O
first	O	O	O
study	O	O	B-T062
to	O	O	O
examine	O	O	O
the	O	O	O
potential	O	O	B-T080
of	O	O	O
the	O	O	O
Iowa	O	O	B-T083
Violence	O	O	B-T048
and	O	O	O
Victimization	O	O	B-T068
Instrument	O	O	B-T170
to	O	O	O
predict	O	O	B-T078
criminal	O	O	B-UnknownType
offenses	O	O	I-UnknownType
.	O	O	O

The	O	O	O
males	O	O	B-T032
were	O	O	O
followed	O	O	O
for	O	O	O
30	O	O	O
months	O	O	B-T079
immediately	O	O	O
following	O	O	O
their	O	O	O
admission	O	O	B-T079
to	O	O	O
probation	O	O	B-T089
or	O	O	O
parole	O	O	B-T089
.	O	O	O

AUC	O	O	B-T081
analyses	O	O	B-T062
indicated	O	O	O
fair	O	O	O
to	O	O	O
good	O	O	O
predictive	O	O	B-T080
power	O	O	O
for	O	O	O
the	O	O	O
Iowa	O	O	B-T083
Violence	O	O	B-T048
and	O	O	O
Victimization	O	O	B-T068
Instrument	O	O	B-T170
for	O	O	O
charges	O	O	O
of	O	O	O
violence	O	O	B-T048
and	O	O	O
victimization	O	O	B-T068
,	O	O	O
but	O	O	O
chance	O	O	O
predictive	O	O	O
power	O	O	O
for	O	O	O
drug	O	O	B-UnknownType
offenses	O	O	I-UnknownType
.	O	O	O

Notably	O	O	O
,	O	O	O
both	O	O	O
scales	O	O	O
of	O	O	O
the	O	O	O
instrument	O	O	B-T170
performed	O	O	O
equally	O	O	O
well	O	O	O
at	O	O	O
the	O	O	O
30-	O	O	O
month	O	O	B-T079
follow-up	O	O	B-T058
.	O	O	O

Items	O	O	O
on	O	O	O
the	O	O	O
Iowa	O	O	B-T083
Violence	O	O	B-T048
and	O	O	O
Victimization	O	O	B-T068
Instrument	O	O	B-T170
not	O	O	O
only	O	O	O
predicted	O	O	B-T078
violence	O	O	B-T048
,	O	O	O
but	O	O	O
are	O	O	O
straightforward	O	O	O
to	O	O	O
score	O	O	O
.	O	O	O

Violence	O	O	B-T048
management	O	O	O
strategies	O	O	O
are	O	O	O
discussed	O	O	O
as	O	O	O
they	O	O	O
relate	O	O	O
to	O	O	O
the	O	O	O
current	O	O	B-T079
findings	O	O	B-T169
,	O	O	O
including	O	O	O
the	O	O	O
potential	O	O	B-T080
to	O	O	O
expand	O	O	B-T082
the	O	O	O
measure	O	O	O
to	O	O	O
other	O	O	O
jurisdictions	O	O	B-T170
and	O	O	O
populations	O	O	B-T098
.	O	O	O

-DOCSTART- (27688111)

Prognostic	O	O	B-T201
significance	O	O	I-T201
of	O	O	O
non-HPV16	O	O	B-T032
genotypes	O	O	I-T032
in	O	O	O
oropharyngeal	O	O	O
squamous	O	O	O
cell	O	O	O
carcinoma	O	O	O

Recent	O	O	O
studies	O	O	O
have	O	O	O
found	O	O	O
that	O	O	O
cases	O	O	O
with	O	O	O
oropharyngeal	O	O	B-T191
squamous	O	O	I-T191
cell	O	O	I-T191
carcinoma	O	O	I-T191
(	O	O	O
OPSCC	O	O	B-T191
)	O	O	O
positive	O	O	B-T034
for	O	O	O
HPV16	O	O	B-T114
genotype	O	O	I-T114
have	O	O	O
better	O	O	B-T080
overall	O	O	B-T081
survival	O	O	I-T081
compared	O	O	B-T052
with	O	O	O
cases	O	O	O
positive	O	O	O
for	O	O	O
other	O	O	O
HPV	O	O	B-T114
genotypes	O	O	I-T114
.	O	O	O

We	O	O	O
sought	O	O	O
to	O	O	O
further	O	O	O
replicate	O	O	B-T080
these	O	O	O
studies	O	O	O
and	O	O	O
determine	O	O	O
if	O	O	O
this	O	O	O
relationship	O	O	O
is	O	O	O
modified	O	O	B-T080
by	O	O	I-T080
expression	O	O	B-T045
of	O	O	O
p16	O	O	B-T116
tumor	O	O	I-T116
suppressor	O	O	I-T116
protein	O	O	I-T116
.	O	O	O

We	O	O	O
identified	O	O	O
238	O	O	O
OPSCC	O	O	B-T191
cases	O	O	O
from	O	O	O
the	O	O	O
Carolina	O	O	B-T062
Head	O	O	I-T062
and	O	O	I-T062
Neck	O	O	I-T062
Cancer	O	O	I-T062
Study	O	O	I-T062
(	O	O	O
CHANCE	O	O	B-T062
)	O	O	O
study	O	O	O
,	O	O	O
a	O	O	O
population	O	O	B-T062
based	O	O	I-T062
case-control	O	O	I-T062
study	O	O	I-T062
.	O	O	O

Tumors	O	O	B-T191
that	O	O	O
tested	O	O	O
positive	O	O	B-T034
solely	O	O	I-T034
for	O	O	O
HPV16	O	O	B-T114
genotype	O	O	I-T114
and	O	O	O
no	O	O	O
other	O	O	O
genotypes	O	O	B-T032
with	O	O	O
PCR	O	O	B-T063
were	O	O	O
classified	O	O	B-T185
as	O	O	O
HPV16-positive	O	O	B-T034
.	O	O	O

Tumors	O	O	B-T191
positive	O	O	B-T034
for	O	O	I-T034
any	O	O	O
other	O	O	O
high-risk	O	O	B-T033
HPV	O	O	B-T114
genotype	O	O	I-T114
were	O	O	O
classified	O	O	B-T185
as	O	O	O
non-HPV16-positive	O	O	B-T034
.	O	O	O

Expression	O	O	B-T045
of	O	O	O
p16	O	O	B-T116
in	O	O	O
the	O	O	O
tumor	O	O	B-T191
was	O	O	O
determined	O	O	B-T080
with	O	O	O
immunohistochemistry	O	O	B-T060
.	O	O	O

Follow-up	O	O	O
time	O	O	O
was	O	O	O
calculated	O	O	O
from	O	O	O
the	O	O	O
date	O	O	B-T079
of	O	O	I-T079
diagnosis	O	O	I-T079
to	O	O	O
date	O	O	B-T079
of	O	O	I-T079
death	O	O	I-T079
or	O	O	O
December	O	O	O
31	O	O	O
,	O	O	O
2013	O	O	O
.	O	O	O

Overall	O	O	B-T081
survival	O	O	I-T081
was	O	O	O
compared	O	O	O
with	O	O	O
the	O	O	O
Kaplan-Meier	O	O	B-T081
curves	O	O	I-T081
and	O	O	O
log-rank	O	O	B-T081
test	O	O	I-T081
.	O	O	O

Hazard	O	O	B-T081
ratios	O	O	I-T081
(	O	O	O
HR	O	O	B-T081
)	O	O	O
adjusted	O	O	O
for	O	O	O
smoking	O	O	B-T055
,	O	O	O
alcohol	O	O	B-T055
use	O	O	I-T055
,	O	O	O
sex	O	O	B-T032
,	O	O	O
race	O	O	B-T098
,	O	O	O
and	O	O	O
age	O	O	B-T032
was	O	O	O
calculated	O	O	O
with	O	O	O
the	O	O	O
Cox	O	O	B-T081
proportional	O	O	I-T081
hazard	O	O	I-T081
regression	O	O	I-T081
.	O	O	O

Cases	O	O	O
with	O	O	O
HPV16-positive	O	O	B-T034
OPSCC	O	O	B-T191
had	O	O	O
better	O	O	B-T080
overall	O	O	B-T081
survival	O	O	I-T081
than	O	O	O
cases	O	O	O
with	O	O	O
non-HPV16-positive	O	O	B-T034
OPSCC	O	O	O
(	O	O	O
log-rank	O	O	O
p-value	O	O	O
:	O	O	O
0.010	O	O	O
)	O	O	O
.	O	O	O

When	O	O	O
restricted	O	O	O
to	O	O	O
OPSCC	O	O	B-T191
cases	O	O	O
positive	O	O	B-T033
for	O	O	O
p16	O	O	B-T045
expression	O	O	I-T045
,	O	O	O
the	O	O	O
same	O	O	O
trend	O	O	B-T079
continued	O	O	O
(	O	O	O
log-rank	O	O	O
p-value	O	O	O
:	O	O	O
0.002	O	O	O
)	O	O	O
.	O	O	O

In	O	O	O
the	O	O	O
adjusted	O	O	O
model	O	O	O
,	O	O	O
cases	O	O	O
with	O	O	O
non-HPV16-positive	O	O	B-T034
OPSCC	O	O	B-T191
had	O	O	O
greater	O	O	B-T033
risk	O	O	I-T033
of	O	O	I-T033
death	O	O	B-T033
compared	O	O	O
to	O	O	O
cases	O	O	O
with	O	O	O
HPV16-positive	O	O	B-T034
tumors	O	O	B-T191
(	O	O	O
HR	O	O	B-T081
:	O	O	O
1.92	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
:	O	O	O
1.03	O	O	O
,	O	O	O
3.60	O	O	O
)	O	O	O
.	O	O	O

This	O	O	O
finding	O	O	B-T033
indicates	O	O	B-T033
that	O	O	O
HPV	O	O	B-T005
genotyping	O	O	B-T059
carries	O	O	O
valuable	O	O	B-T201
prognostic	O	O	I-T201
significance	O	O	I-T201
in	O	O	O
addition	O	O	O
to	O	O	O
p16	O	O	B-T116
status	O	O	B-T080
and	O	O	O
future	O	O	O
survival	O	O	O
studies	O	O	O
of	O	O	O
OPSCC	O	O	B-T191
should	O	O	O
take	O	O	O
into	O	O	O
account	O	O	O
differing	O	O	O
HPV	O	O	B-T114
genotypes	O	O	I-T114
.	O	O	O

-DOCSTART- (27689491)

Randomized	O	O	B-T062
Trials	O	O	I-T062
of	O	O	O
the	O	O	O
Teen	O	O	B-T100
Outreach	O	O	B-T095
Program	O	O	I-T095
in	O	O	O
Louisiana	O	O	B-T083
and	O	O	O
Rochester	O	O	B-T083
,	O	O	O
New	O	O	O
York	O	O	O

To	O	O	O
evaluate	O	O	B-T058
the	O	O	O
Teen	O	O	B-T100
Outreach	O	O	B-T095
Program	O	O	I-T095
,	O	O	O
a	O	O	O
pregnancy	O	O	B-T061
prevention	O	O	I-T061
program	O	O	B-T170
,	O	O	O
in	O	O	O
2	O	O	O
community	O	O	B-T096
-based	O	O	O
settings	O	O	O
.	O	O	O

We	O	O	O
evaluated	O	O	B-T058
the	O	O	O
Teen	O	O	B-T100
Outreach	O	O	B-T095
Program	O	O	I-T095
,	O	O	O
a	O	O	O
9-month	O	O	O
positive	O	O	B-T077
youth	O	O	I-T077
development	O	O	I-T077
program	O	O	I-T077
,	O	O	O
in	O	O	O
3	O	O	O
cohorts	O	O	B-T098
of	O	O	O
youths	O	O	B-T100
from	O	O	O
2012	O	O	O
to	O	O	O
2015	O	O	O
in	O	O	O
2	O	O	O
states	O	O	B-T083
.	O	O	O

In	O	O	O
Louisiana	O	O	B-T083
,	O	O	O
7	O	O	O
agencies	O	O	B-T092
participated	O	O	O
in	O	O	O
an	O	O	O
individualized	O	O	B-T080
randomized	O	O	B-T062
controlled	O	O	I-T062
trial	O	O	I-T062
,	O	O	O
with	O	O	O
youths	O	O	B-T100
randomly	O	O	O
assigned	O	O	O
to	O	O	O
a	O	O	O
treatment	O	O	B-T061
or	O	O	O
control	O	O	B-T096
condition	O	O	I-T096
.	O	O	O

Fourteen	O	O	O
agencies	O	O	B-T092
in	O	O	O
Rochester	O	O	B-T083
,	O	O	O
New	O	O	B-T083
York	O	O	I-T083
,	O	O	O
participated	O	O	O
in	O	O	O
a	O	O	O
cluster	O	O	B-T081
randomized	O	O	B-T062
controlled	O	O	I-T062
trial	O	O	I-T062
.	O	O	O

We	O	O	O
found	O	O	O
no	O	O	B-T033
differences	O	O	I-T033
between	O	O	O
the	O	O	O
intervention	O	O	B-T061
and	O	O	O
control	O	O	B-T096
youths	O	O	I-T096
on	O	O	O
delay	O	O	B-T079
of	O	O	O
sexual	O	O	B-T053
onset	O	O	B-T080
in	O	O	O
Louisiana	O	O	B-T083
(	O	O	O
adjusted	O	O	B-T081
odds	O	O	I-T081
ratio	O	O	I-T081
[	O	O	O
AOR	O	O	B-T081
]	O	O	O
=	O	O	O
0.80	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
confidence	O	O	B-T081
interval	O	O	I-T081
[	O	O	O
CI	O	O	B-T081
]	O	O	O
=	O	O	O
0.62	O	O	O
,	O	O	O
1.03	O	O	O
)	O	O	O
or	O	O	O
in	O	O	O
Rochester	O	O	B-T083
,	O	O	O
New	O	O	B-T083
York	O	O	I-T083
(	O	O	O
AOR	O	O	O
=	O	O	O
0.89	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
=	O	O	O
0.45	O	O	O
,	O	O	O
1.77	O	O	O
)	O	O	O
,	O	O	O
or	O	O	O
for	O	O	O
sex	O	O	B-T040
with	O	O	O
no	O	O	O
effective	O	O	O
means	O	O	O
of	O	O	O
birth	O	O	B-T121
control	O	O	I-T121
(	O	O	O
Louisiana	O	O	O
,	O	O	O
AOR	O	O	O
=	O	O	O
1.18	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
=	O	O	O
0.78	O	O	O
,	O	O	O
1.78	O	O	O
;	O	O	O
Rochester	O	O	O
,	O	O	O
AOR	O	O	O
=	O	O	O
0.41	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
=	O	O	O
0.13	O	O	O
,	O	O	O
1.27	O	O	O
)	O	O	O
after	O	O	O
controlling	O	O	B-T067
for	O	O	O
relevant	O	O	O
covariates	O	O	B-T081
.	O	O	O

We	O	O	O
found	O	O	O
no	O	O	B-T033
short-term	O	O	B-T079
effects	O	O	B-T080
for	O	O	O
the	O	O	O
offer	O	O	O
of	O	O	O
the	O	O	O
intervention	O	O	B-T061
.	O	O	O

Research	O	O	B-T062
might	O	O	O
be	O	O	O
needed	O	O	O
for	O	O	O
the	O	O	O
long-term	O	O	B-T067
and	O	O	O
intermediate	O	O	B-T080
impacts	O	O	I-T080
of	O	O	O
youth	O	O	B-T077
development	O	O	I-T077
programs	O	O	I-T077
on	O	O	O
these	O	O	O
and	O	O	O
other	O	O	O
adolescent	O	O	B-T100
risk	O	O	B-T055
behaviors	O	O	I-T055
.	O	O	O

-DOCSTART- (27690568)

A	O	O	O
single	O	O	B-T051
session	O	O	I-T051
of	O	O	O
exhaustive	O	O	B-T056
exercise	O	O	I-T056
markedly	O	O	O
decreases	O	O	B-T081
circulating	O	O	B-T169
levels	O	O	O
of	O	O	O
guanidinoacetic	O	O	B-T109
acid	O	O	I-T109
in	O	O	O
healthy	O	O	B-T080
men	O	O	B-T098
and	O	O	O
women	O	O	O

We	O	O	O
evaluated	O	O	B-T058
the	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
exercise	O	O	B-T056
on	O	O	O
circulating	O	O	B-T169
concentrations	O	O	B-T081
of	O	O	O
guanidinoacetic	O	O	B-T109
acid	O	O	I-T109
(	O	O	O
GAA	O	O	B-T109
)	O	O	O
and	O	O	O
creatine	O	O	B-T116
in	O	O	O
23	O	O	O
healthy	O	O	B-T098
volunteers	O	O	I-T098
subjected	O	O	O
to	O	O	O
running	O	O	B-T056
to	O	O	O
exhaustion	O	O	B-T184
and	O	O	O
free-weight	O	O	B-T056
bench-press	O	O	I-T056
to	O	O	O
volitional	O	O	B-T056
failure	O	O	I-T056
.	O	O	O

Blood	O	O	B-T031
was	O	O	O
taken	O	O	O
before	O	O	O
and	O	O	O
following	O	O	O
each	O	O	O
exercise	O	O	B-T056
session	O	O	B-T051
.	O	O	O

Running	O	O	B-T056
induced	O	O	B-T169
a	O	O	O
significant	O	O	O
decrease	O	O	B-T081
in	O	O	O
serum	O	O	B-T031
GAA	O	O	B-T109
by	O	O	O
20.1	O	O	O
%	O	O	O
(	O	O	O
P	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
,	O	O	O
while	O	O	O
free-weight	O	O	B-T056
exercise	O	O	I-T056
reduced	O	O	B-T080
GAA	O	O	O
by	O	O	O
11.7	O	O	O
%	O	O	O
(	O	O	O
P	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
,	O	O	O
suggesting	O	O	O
the	O	O	O
possible	O	O	O
use	O	O	O
of	O	O	O
serum	O	O	O
GAA	O	O	O
as	O	O	O
a	O	O	O
novel	O	O	O
biomarker	O	O	B-T201
of	O	O	O
exhaustion	O	O	B-T184
.	O	O	O

-DOCSTART- (27692319)

Anti-helminthic	O	O	B-T121
activity	O	O	B-T169
of	O	O	O
Momordica	O	O	O
charantia	O	O	O
L.	O	O	O
against	O	O	O
Fasciola	O	O	B-T204
hepatica	O	O	I-T204
eggs	O	O	I-T204
after	O	O	O
twelve	O	O	O
days	O	O	B-T079
of	O	O	O
incubation	O	O	B-T059
in	O	O	O
vitro	O	O	O

Fasciolosis	O	O	B-T047
,	O	O	O
a	O	O	O
parasitic	O	O	B-T047
disease	O	O	I-T047
caused	O	O	O
by	O	O	O
the	O	O	O
trematode	O	O	B-T204
Fasciola	O	O	B-T204
hepatica	O	O	I-T204
underreported	O	O	O
is	O	O	O
expanding	O	O	O
both	O	O	O
in	O	O	O
human	O	O	B-T016
and	O	O	O
animal	O	O	B-T008
population	O	O	I-T008
,	O	O	O
throughout	O	O	O
the	O	O	O
world	O	O	B-T098
.	O	O	O

The	O	O	O
constant	O	O	O
use	O	O	O
of	O	O	O
synthetic	O	O	B-T121
drugs	O	O	I-T121
to	O	O	O
treat	O	O	B-T061
this	O	O	O
condition	O	O	B-T047
has	O	O	O
led	O	O	O
to	O	O	O
the	O	O	O
natural	O	O	B-T070
selection	O	O	I-T070
of	O	O	O
resistant	O	O	B-T169
strains	O	O	B-T001
of	O	O	O
the	O	O	O
parasite	O	O	B-T204
.	O	O	O

Hence	O	O	O
,	O	O	O
there	O	O	O
is	O	O	O
a	O	O	O
growing	O	O	O
focus	O	O	O
on	O	O	O
the	O	O	O
potential	O	O	O
anti-helminthic	O	O	B-T121
properties	O	O	B-T169
of	O	O	O
medicinal	O	O	B-T002
plants	O	O	I-T002
and	O	O	O
phytopharmaceuticals	O	O	B-T109
.	O	O	O

The	O	O	O
current	O	O	O
study	O	O	B-T062
assessed	O	O	O
the	O	O	O
potential	O	O	O
anti-fasciolicide	O	O	B-T169
action	O	O	B-T052
of	O	O	O
Momordica	O	O	B-T002
charantia	O	O	I-T002
leaf	O	O	B-T002
extracts	O	O	B-T123
and	O	O	O
fractions	O	O	B-T081
on	O	O	O
the	O	O	O
eggs	O	O	B-T204
of	O	O	I-T204
F.	O	O	I-T204
hepatica	O	O	I-T204
parasites	O	O	I-T204
.	O	O	O

The	O	O	O
lyophilized	O	O	B-T080
crude	O	O	B-T103
extract	O	O	I-T103
(	O	O	O
CE	O	O	B-T103
)	O	O	O
of	O	O	O
M.	O	O	B-T002
charantia	O	O	I-T002
leaves	O	O	I-T002
and	O	O	O
its	O	O	O
sub-fractions	O	O	B-T081
,	O	O	O
obtained	O	O	O
from	O	O	O
liquid-liquid	O	O	B-T059
partitioning	O	O	I-T059
with	O	O	O
organic	O	O	B-T109
solvents	O	O	I-T109
,	O	O	O
were	O	O	O
analysed	O	O	B-T062
by	O	O	O
High	O	O	B-T059
Performance	O	O	I-T059
Liquid	O	O	I-T059
Chromatography	O	O	I-T059
(	O	O	O
HPLC	O	O	B-T059
)	O	O	O
,	O	O	O
suspended	O	O	B-T078
in	O	O	O
1	O	O	O
%	O	O	O
DMSO	O	O	B-T109
and	O	O	O
used	O	O	O
in	O	O	O
in	O	O	B-T080
vitro	O	O	I-T080
tests	O	O	B-T059
.	O	O	O

Quadruplicates	O	O	B-T081
of	O	O	O
50	O	O	O
F.	O	O	B-T204
hepatica	O	O	I-T204
eggs	O	O	I-T204
were	O	O	O
incubated	O	O	B-T059
at	O	O	O
23	O	O	O
Â°	O	O	O
C	O	O	O
with	O	O	O
M.	O	O	B-T002
charantia	O	O	I-T002
leaf	O	O	B-T002
CE	O	O	B-T103
in	O	O	O
different	O	O	O
concentrations	O	O	B-T081
.	O	O	O

After	O	O	O
12	O	O	O
days	O	O	B-T079
no	O	O	O
larvae	O	O	B-T204
were	O	O	O
formed	O	O	O
in	O	O	O
eggs	O	O	B-T204
incubated	O	O	B-T059
with	O	O	O
CE	O	O	B-T103
concentrations	O	O	B-T081
above	O	O	O
12.5mg/mL.	O	O	O
Eggs	O	O	B-T204
incubated	O	O	O
with	O	O	O
CE	O	O	O
sub-fractions	O	O	B-T081
at	O	O	O
concentrations	O	O	O
of	O	O	O
1000	O	O	O
,	O	O	O
100	O	O	O
,	O	O	O
10	O	O	O
,	O	O	O
1	O	O	O
,	O	O	O
0.1	O	O	O
,	O	O	O
0.01Î¼g/mL	O	O	O
affected	O	O	B-T169
embryonic	O	O	B-T042
development	O	O	I-T042
,	O	O	O
with	O	O	O
n-butanol	O	O	B-T109
presenting	O	O	O
the	O	O	O
strongest	O	O	O
inhibition	O	O	B-T052
of	O	O	O
miracidia	O	O	B-T204
formation	O	O	B-T169
.	O	O	O

In	O	O	O
contrast	O	O	O
,	O	O	O
on	O	O	O
the	O	O	O
12th	O	O	O
day	O	O	O
,	O	O	O
90	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
miracidia	O	O	B-T204
hatched	O	O	B-T040
in	O	O	O
the	O	O	O
control	O	O	B-T096
experiments	O	O	I-T096
using	O	O	O
0.03	O	O	O
%	O	O	O
DMSO	O	O	B-T109
whereas	O	O	O
embryogenesis	O	O	B-T042
was	O	O	O
completely	O	O	O
abolished	O	O	B-T079
with	O	O	O
any	O	O	O
concentration	O	O	B-T081
of	O	O	O
albendazole	O	O	B-T109
sulphoxide	O	O	I-T109
ABZ(SO	O	O	B-T109
)	O	O	I-T109
.	O	O	O

Chemical	O	O	B-T059
analysis	O	O	I-T059
of	O	O	O
the	O	O	O
CE	O	O	B-T103
and	O	O	O
sub-fractions	O	O	B-T081
revealed	O	O	O
a	O	O	O
prominent	O	O	O
presence	O	O	O
of	O	O	O
flavonoids	O	O	B-T109
.	O	O	O

HPLC-MS	O	O	B-T059
confirmed	O	O	O
Quercetin	O	O	B-T127
to	O	O	O
be	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
main	O	O	O
flavonoids	O	O	B-T109
present	O	O	O
in	O	O	O
the	O	O	O
CE	O	O	B-T103
and	O	O	O
the	O	O	O
n-butanol	O	O	B-T109
subfraction	O	O	B-T081
.	O	O	O

This	O	O	O
is	O	O	O
the	O	O	O
first	O	O	O
study	O	O	B-T062
to	O	O	O
analyse	O	O	B-T062
the	O	O	O
potential	O	O	O
anti-fasciolicide	O	O	B-T169
action	O	O	B-T052
of	O	O	O
M.	O	O	B-T002
charantia	O	O	I-T002
leaf	O	O	B-T002
CE	O	O	B-T103
and	O	O	O
subfractions	O	O	B-T081
.	O	O	O

-DOCSTART- (27694780)

Dabigatran	O	O	B-T109
:	O	O	O
A	O	O	O
new	O	O	O
oral	O	O	B-T109
anticoagulant	O	O	I-T109
.	O	O	O
Guidelines	O	O	B-T170
to	O	O	O
follow	O	O	O
in	O	O	O
oral	O	O	B-T061
surgery	O	O	I-T061
procedures	O	O	I-T061
.	O	O	O
A	O	O	O
systematic	O	O	O
review	O	O	O
of	O	O	O
the	O	O	O
literature	O	O	O

Guidelines	O	O	B-T170
to	O	O	O
follow	O	O	O
in	O	O	O
oral	O	O	B-T061
surgery	O	O	I-T061
procedures	O	O	I-T061
.	O	O	O

A	O	O	O
systematic	O	O	O
review	O	O	B-T170
of	O	O	I-T170
the	O	O	I-T170
literature	O	O	I-T170
Dabigatran	O	O	B-T109
is	O	O	O
a	O	O	O
newly	O	O	O
commercialized	O	O	O
drug	O	O	B-T121
that	O	O	O
is	O	O	O
replacing	O	O	O
other	O	O	O
anticoagulants	O	O	B-T121
in	O	O	O
the	O	O	O
prevention	O	O	O
of	O	O	O
venous	O	O	B-T047
thromboembolism	O	O	I-T047
,	O	O	O
stroke	O	O	B-T047
and	O	O	O
systemic	O	O	B-UnknownType
arterial	O	O	I-UnknownType
valve	O	O	I-UnknownType
embolism	O	O	I-UnknownType
.	O	O	O

It	O	O	O
acts	O	O	O
directly	O	O	O
on	O	O	O
thrombin	O	O	B-T116
presenting	O	O	O
in	O	O	O
a	O	O	O
dynamic	O	O	O
and	O	O	O
predictable	O	O	O
way	O	O	O
,	O	O	O
which	O	O	O
does	O	O	O
not	O	O	O
require	O	O	O
monitoring	O	O	O
these	O	O	O
patients	O	O	B-T101
.	O	O	O

Therefore	O	O	O
,	O	O	O
we	O	O	O
consider	O	O	O
the	O	O	O
need	O	O	O
to	O	O	O
assess	O	O	O
whether	O	O	O
their	O	O	O
use	O	O	O
increases	O	O	B-T169
the	O	O	O
risk	O	O	B-T033
of	O	O	I-T033
bleeding	O	O	I-T033
involved	O	O	O
before	O	O	O
any	O	O	O
dental	O	O	B-T061
treatment	O	O	I-T061
.	O	O	O

We	O	O	O
performed	O	O	O
a	O	O	O
systematic	O	O	O
review	O	O	O
with	O	O	O
a	O	O	O
bibliographic	O	O	B-UnknownType
search	O	O	I-UnknownType
in	O	O	O
PubMed	O	O	B-T170
/	O	O	O
Medline	O	O	B-T170
along	O	O	O
with	O	O	O
the	O	O	O
Cochrane	O	O	B-T093
Library	O	O	I-T093
.	O	O	O

We	O	O	O
excluded	O	O	O
articles	O	O	O
dealing	O	O	O
with	O	O	O
all	O	O	O
anticoagulants	O	O	B-T121
other	O	O	O
than	O	O	O
dabigatran	O	O	B-T109
,	O	O	O
and	O	O	O
works	O	O	O
about	O	O	O
surgical	O	O	B-T061
treatments	O	O	I-T061
in	O	O	O
anatomical	O	O	B-T029
locations	O	O	I-T029
other	O	O	O
than	O	O	O
the	O	O	O
oral	O	O	B-T030
cavity	O	O	I-T030
.	O	O	O

We	O	O	O
included	O	O	O
a	O	O	O
total	O	O	O
of	O	O	O
13	O	O	O
papers	O	O	O
of	O	O	O
which	O	O	O
1	O	O	O
was	O	O	O
a	O	O	O
randomized	O	O	B-T062
clinical	O	O	I-T062
trial	O	O	I-T062
,	O	O	O
9	O	O	O
narrative	O	O	B-UnknownType
literature	O	O	I-UnknownType
reviews	O	O	I-UnknownType
,	O	O	O
1	O	O	O
case	O	O	B-T062
series	O	O	I-T062
,	O	O	O
2	O	O	O
clinical	O	O	B-T077
cases	O	O	I-T077
and	O	O	O
1	O	O	O
expert	O	O	B-T077
opinion	O	O	I-T077
.	O	O	O

Because	O	O	O
we	O	O	O
did	O	O	O
not	O	O	O
obtain	O	O	O
any	O	O	O
properly	O	O	O
designed	O	O	O
clinical	O	O	B-T062
trials	O	O	I-T062
,	O	O	O
we	O	O	O
were	O	O	O
unable	O	O	O
to	O	O	O
conduct	O	O	O
a	O	O	O
meta-analysis	O	O	B-T062
.	O	O	O

Currently	O	O	O
,	O	O	O
there	O	O	O
is	O	O	O
no	O	O	O
consensus	O	O	B-T054
on	O	O	O
the	O	O	O
procedure	O	O	B-T061
to	O	O	O
be	O	O	O
followed	O	O	O
in	O	O	O
patients	O	O	B-T101
taking	O	O	O
dabigatran	O	O	B-T109
.	O	O	O

However	O	O	O
,	O	O	O
all	O	O	O
authors	O	O	O
agree	O	O	O
to	O	O	O
treat	O	O	O
each	O	O	O
case	O	O	O
individually	O	O	O
in	O	O	O
accordance	O	O	O
to	O	O	O
the	O	O	O
risk	O	O	B-T078
of	O	O	O
embolism	O	O	B-T046
,	O	O	O
postoperative	O	O	B-T046
bleeding	O	O	I-T046
and	O	O	O
renal	O	O	B-T042
function	O	O	I-T042
.	O	O	O

Also	O	O	O
,	O	O	O
it	O	O	O
is	O	O	O
necessary	O	O	O
to	O	O	O
perform	O	O	O
minimally	O	O	O
invasive	O	O	B-T061
interventions	O	O	I-T061
,	O	O	O
and	O	O	O
take	O	O	O
the	O	O	O
appropriate	O	O	O
local	O	O	O
anti-hemolytic	O	O	B-T061
measures	O	O	I-T061
.	O	O	O

-DOCSTART- (27695680)

Did	O	O	O
FIDELIS	O	O	B-T170
projects	O	O	B-T077
contribute	O	O	B-T052
to	O	O	O
the	O	O	O
detection	O	O	B-T033
of	O	O	O
new	O	O	O
smear	O	O	B-T059
-	O	O	O
positive	O	O	B-T033
pulmonary	O	O	B-T047
tuberculosis	O	O	I-T047
cases	O	O	O
in	O	O	O
China	O	O	B-T083
?	O	O	O

Setting	O	O	O
:	O	O	O
The	O	O	O
first	O	O	B-T170
phase	O	O	I-T170
of	O	O	I-T170
the	O	O	I-T170
Fund	O	O	I-T170
for	O	O	I-T170
Innovative	O	O	I-T170
DOTS	O	O	I-T170
Expansion	O	O	I-T170
through	O	O	I-T170
Local	O	O	I-T170
Initiatives	O	O	I-T170
to	O	O	I-T170
Stop	O	O	I-T170
TB	O	O	I-T170
(	O	O	O
FIDELIS	O	O	B-T170
)	O	O	O
projects	O	O	B-T077
in	O	O	O
China	O	O	B-T083
started	O	O	O
in	O	O	O
2003	O	O	O
.	O	O	O

Objective	O	O	O
:	O	O	O
To	O	O	O
determine	O	O	O
whether	O	O	O
the	O	O	O
FIDELIS	O	O	B-T170
projects	O	O	B-T077
contribute	O	O	B-T052
d	O	O	O
to	O	O	O
the	O	O	O
increased	O	O	B-T081
case	O	O	B-T169
detection	O	O	B-T033
rate	O	O	B-T081
for	O	O	O
new	O	O	O
smear	O	O	B-T059
-	O	O	O
positive	O	O	B-T033
pulmonary	O	O	B-T047
tuberculosis	O	O	I-T047
(	O	O	O
PTB	O	O	B-T047
)	O	O	O
in	O	O	O
China	O	O	B-T083
.	O	O	O

Methods	O	O	O
:	O	O	O
We	O	O	O
compared	O	O	B-T052
the	O	O	O
case	O	O	B-T081
notification	O	O	I-T081
rates	O	O	I-T081
(	O	O	O
CNRs	O	O	B-T081
)	O	O	O
in	O	O	O
the	O	O	O
intervention	O	O	B-T079
year	O	O	B-T079
with	O	O	O
those	O	O	O
of	O	O	O
the	O	O	O
previous	O	O	B-T079
year	O	O	O
in	O	O	O
the	O	O	O
FIDELIS	O	O	B-T170
areas	O	O	B-T083
,	O	O	O
then	O	O	O
compared	O	O	O
the	O	O	O
difference	O	O	B-T080
between	O	O	O
the	O	O	O
CNRs	O	O	O
of	O	O	O
the	O	O	O
intervention	O	O	O
year	O	O	O
and	O	O	O
the	O	O	O
previous	O	O	O
year	O	O	O
in	O	O	O
the	O	O	O
FIDELIS	O	O	O
areas	O	O	O
with	O	O	O
those	O	O	O
in	O	O	O
the	O	O	O
non-FI-DELIS	O	O	B-T033
areas	O	O	O
within	O	O	O
the	O	O	O
province	O	O	B-T083
.	O	O	O

Results	O	O	O
:	O	O	O
There	O	O	O
was	O	O	O
an	O	O	O
increase	O	O	B-T169
in	O	O	O
the	O	O	O
CNR	O	O	B-T081
in	O	O	O
the	O	O	O
intervention	O	O	B-T079
year	O	O	B-T079
compared	O	O	B-T052
with	O	O	O
the	O	O	O
previous	O	O	B-T079
year	O	O	O
for	O	O	O
all	O	O	O
the	O	O	O
project	O	O	B-T077
sites	O	O	O
.	O	O	O

The	O	O	O
differences	O	O	B-T080
between	O	O	O
the	O	O	O
CNR	O	O	B-T081
in	O	O	O
the	O	O	O
intervention	O	O	B-T079
year	O	O	B-T079
and	O	O	O
the	O	O	O
previous	O	O	B-T079
year	O	O	O
ranged	O	O	B-T081
from	O	O	O
6.4	O	O	O
to	O	O	O
31.1	O	O	O
per	O	O	O
100	O	O	O
000	O	O	O
population	O	O	B-T098
in	O	O	O
the	O	O	O
FIDELIS	O	O	B-T170
areas	O	O	B-T083
and	O	O	O
from	O	O	O
2.9	O	O	O
to	O	O	O
20.4/100	O	O	O
000	O	O	O
in	O	O	O
the	O	O	O
non-FIDELIS	O	O	B-T033
areas	O	O	O
.	O	O	O

Differences	O	O	B-T080
-in-	O	O	O
differences	O	O	B-T080
analysis	O	O	B-T062
shows	O	O	O
that	O	O	O
the	O	O	O
differences	O	O	O
in	O	O	O
the	O	O	O
CNRs	O	O	B-T081
in	O	O	O
the	O	O	O
FIDELIS	O	O	B-T170
areas	O	O	B-T083
were	O	O	O
not	O	O	O
statistically	O	O	B-T081
significantly	O	O	I-T081
different	O	O	B-T080
from	O	O	O
those	O	O	O
in	O	O	O
the	O	O	O
non-	O	O	O
FIDELIS	O	O	O
areas	O	O	O
(	O	O	O
P	O	O	O
=	O	O	O
0.393	O	O	O
)	O	O	O
.	O	O	O

Conclusion	O	O	O
:	O	O	O
The	O	O	O
FIDELIS	O	O	B-T170
projects	O	O	B-T077
may	O	O	O
have	O	O	O
contributed	O	O	B-T052
to	O	O	O
the	O	O	O
increase	O	O	B-T169
in	O	O	O
case	O	O	B-T169
detection	O	O	B-T033
of	O	O	O
new	O	O	O
smear	O	O	B-T059
-	O	O	O
positive	O	O	B-T033
PTB	O	O	B-T047
in	O	O	O
China	O	O	B-T083
,	O	O	O
but	O	O	O
the	O	O	O
level	O	O	B-T080
of	O	O	O
evidence	O	O	B-T078
is	O	O	O
low	O	O	B-T080
.	O	O	O

-DOCSTART- (27697757)

Liver	O	O	B-T116
Fatty	O	O	I-T116
Acid	O	O	I-T116
Binding	O	O	I-T116
Protein	O	O	I-T116
Deficiency	O	O	B-T169
Provokes	O	O	O
Oxidative	O	O	B-T049
Stress	O	O	I-T049
,	O	O	O
Inflammation	O	O	B-T046
,	O	O	O
and	O	O	O
Apoptosis	O	O	B-T043
-Mediated	O	O	O
Hepatotoxicity	O	O	B-T037
Induced	O	O	B-T169
by	O	O	O
Pyrazinamide	O	O	B-T109
in	O	O	O
Zebrafish	O	O	B-T013
Larvae	O	O	O

Pyrazinamide	O	O	B-T109
(	O	O	O
PZA	O	O	B-T109
)	O	O	O
is	O	O	O
an	O	O	O
essential	O	O	B-T080
antitubercular	O	O	B-T121
drug	O	O	I-T121
,	O	O	O
but	O	O	O
little	O	O	O
is	O	O	O
still	O	O	O
known	O	O	O
about	O	O	O
its	O	O	O
hepatotoxicity	O	O	B-T037
potential	O	O	B-T080
.	O	O	O

This	O	O	O
study	O	O	O
examined	O	O	O
the	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
PZA	O	O	B-T109
exposure	O	O	B-T080
on	O	O	O
zebrafish	O	O	B-T013
(	O	O	O
Danio	O	O	B-T013
rerio	O	O	I-T013
)	O	O	O
larvae	O	O	B-T204
and	O	O	O
the	O	O	O
mechanisms	O	O	O
underlying	O	O	O
its	O	O	O
hepatotoxicity	O	O	B-T037
.	O	O	O

A	O	O	O
transgenic	O	O	B-T028
line	O	O	I-T028
of	O	O	O
zebrafish	O	O	B-T013
larvae	O	O	B-T204
that	O	O	O
expressed	O	O	B-T045
enhanced	O	O	B-T116
green	O	O	I-T116
fluorescent	O	O	I-T116
protein	O	O	I-T116
(	O	O	O
EGFP	O	O	B-T116
)	O	O	O
in	O	O	O
the	O	O	O
liver	O	O	B-T023
was	O	O	O
incubated	O	O	B-T059
with	O	O	O
1	O	O	O
,	O	O	O
2.5	O	O	O
,	O	O	O
and	O	O	O
5	O	O	O
mM	O	O	O
PZA	O	O	B-T109
from	O	O	O
72	O	O	O
h	O	O	O
postfertilization	O	O	B-T040
(	O	O	O
hpf	O	O	O
)	O	O	O
.	O	O	O

Different	O	O	O
endpoints	O	O	B-T080
such	O	O	O
as	O	O	O
mortality	O	O	B-T081
,	O	O	O
morphology	O	O	B-T033
changes	O	O	B-T169
in	O	O	O
the	O	O	O
size	O	O	B-T032
and	O	O	O
shape	O	O	B-T082
of	O	O	O
the	O	O	O
liver	O	O	B-T023
,	O	O	O
histological	O	O	B-T091
changes	O	O	O
,	O	O	O
transaminase	O	O	B-T059
analysis	O	O	I-T059
and	O	O	O
apoptosis	O	O	B-T043
,	O	O	O
markers	O	O	B-T201
of	O	O	O
oxidative	O	O	B-T049
and	O	O	O
genetic	O	O	B-T049
damage	O	O	I-T049
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
the	O	O	O
expression	O	O	B-T045
of	O	O	O
certain	O	O	O
genes	O	O	B-T028
were	O	O	O
selected	O	O	O
to	O	O	O
evaluate	O	O	B-T058
PZA	O	O	B-T109
-	O	O	O
induced	O	O	B-T169
hepatotoxicity	O	O	B-T037
.	O	O	O

Our	O	O	O
results	O	O	O
confirm	O	O	B-T033
the	O	O	O
manner	O	O	O
of	O	O	O
PZA	O	O	B-T109
dose-dependent	O	O	B-T081
hepatotoxicity	O	O	B-T037
.	O	O	O

PZA	O	O	B-T109
was	O	O	O
found	O	O	O
to	O	O	O
induce	O	O	B-T169
marked	O	O	B-T080
injury	O	O	B-T037
in	O	O	O
zebrafish	O	O	B-T013
larvae	O	O	B-T204
,	O	O	O
such	O	O	O
as	O	O	O
liver	O	O	B-T047
atrophy	O	O	I-T047
,	O	O	O
elevations	O	O	B-T033
of	O	O	I-T033
transaminase	O	O	I-T033
levels	O	O	I-T033
,	O	O	O
oxidative	O	O	B-T049
stress	O	O	I-T049
,	O	O	O
and	O	O	O
hepatocyte	O	O	B-T043
apoptosis	O	O	I-T043
.	O	O	O

To	O	O	O
further	O	O	O
understand	O	O	O
the	O	O	O
mechanism	O	O	O
behind	O	O	O
PZA	O	O	B-T109
-	O	O	O
induced	O	O	B-T169
hepatotoxicity	O	O	B-T037
,	O	O	O
changes	O	O	B-T169
in	O	O	O
gene	O	O	B-T081
expression	O	O	I-T081
levels	O	O	I-T081
in	O	O	O
zebrafish	O	O	B-T013
larvae	O	O	B-T204
exposed	O	O	B-T080
to	O	O	I-T080
PZA	O	O	O
for	O	O	O
72	O	O	O
h	O	O	O
postexposure	O	O	B-T080
(	O	O	O
hpe	O	O	O
)	O	O	O
were	O	O	O
determined	O	O	O
.	O	O	O

The	O	O	O
results	O	O	O
of	O	O	O
this	O	O	O
study	O	O	O
demonstrated	O	O	O
that	O	O	O
PZA	O	O	B-T109
decreased	O	O	B-T081
the	O	O	O
expression	O	O	B-T081
levels	O	O	I-T081
of	O	O	O
liver	O	O	B-T116
fatty	O	O	I-T116
acid	O	O	I-T116
binding	O	O	I-T116
protein	O	O	I-T116
(	O	O	O
L-FABP	O	O	B-T116
)	O	O	O
and	O	O	O
its	O	O	O
target	O	O	B-T028
gene	O	O	I-T028
,	O	O	O
peroxisome	O	O	B-T116
proliferator-activated	O	O	I-T116
receptor	O	O	I-T116
Î±	O	O	I-T116
(	O	O	O
PPAR-Î±	O	O	B-T116
)	O	O	O
,	O	O	O
and	O	O	O
provoked	O	O	O
more	O	O	O
severe	O	O	B-T080
oxidative	O	O	B-T049
stress	O	O	I-T049
and	O	O	O
hepatitis	O	O	B-T047
via	O	O	O
the	O	O	O
upregulation	O	O	B-T044
of	O	O	O
inflammatory	O	O	B-T043
cytokines	O	O	I-T043
such	O	O	O
as	O	O	O
tumor	O	O	B-T116
necrosis	O	O	I-T116
factor	O	O	I-T116
alpha	O	O	I-T116
(	O	O	O
TNF-Î±	O	O	B-T116
)	O	O	O
and	O	O	O
transforming	O	O	B-T116
growth	O	O	I-T116
factor	O	O	I-T116
Î²	O	O	I-T116
(	O	O	O
TGF-Î²	O	O	B-T116
)	O	O	O
.	O	O	O

These	O	O	O
findings	O	O	O
suggest	O	O	O
that	O	O	O
L-FABP	O	O	B-T116
-mediated	O	O	O
PPAR-Î±	O	O	B-T116
downregulation	O	O	B-T044
appears	O	O	O
to	O	O	O
be	O	O	O
a	O	O	O
hepatotoxic	O	O	B-T043
response	O	O	I-T043
resulting	O	O	O
from	O	O	O
zebrafish	O	O	B-T013
larva	O	O	B-T204
liver	O	O	B-T025
cell	O	O	I-T025
apoptosis	O	O	B-T043
,	O	O	O
and	O	O	O
L-FABP	O	O	O
can	O	O	O
be	O	O	O
used	O	O	O
as	O	O	O
a	O	O	O
biomarker	O	O	B-T201
for	O	O	O
the	O	O	O
early	O	O	B-T060
detection	O	O	I-T060
of	O	O	O
PZA	O	O	B-T109
-	O	O	O
induced	O	O	B-T169
liver	O	O	B-T046
damage	O	O	I-T046
in	O	O	O
zebrafish	O	O	O
larvae	O	O	B-T204
.	O	O	O

-DOCSTART- (27699206)

Smooth	O	O	B-T080
versus	O	O	O
Textured	O	O	B-T080
Surfaces	O	O	B-T082
:	O	O	O
Feature	O	O	B-T080
-Based	O	O	O
Category	O	O	B-T170
Selectivity	O	O	B-T052
in	O	O	O
Human	O	O	B-T016
Visual	O	O	O
Cortex	O	O	O

In	O	O	O
fMRI	O	O	B-T060
studies	O	O	I-T060
,	O	O	O
human	O	O	B-T016
lateral	O	O	B-T023
occipital	O	O	I-T023
(	O	O	I-T023
LO	O	O	I-T023
)	O	O	I-T023
cortex	O	O	I-T023
is	O	O	O
thought	O	O	O
to	O	O	O
respond	O	O	O
selectively	O	O	O
to	O	O	O
images	O	O	B-T170
of	O	O	O
objects	O	O	B-T072
,	O	O	O
compared	O	O	B-T052
with	O	O	O
nonobjects	O	O	B-T071
.	O	O	O

However	O	O	O
,	O	O	O
it	O	O	O
remains	O	O	O
unresolved	O	O	B-T080
whether	O	O	O
all	O	O	O
objects	O	O	B-T072
evoke	O	O	O
equivalent	O	O	B-T080
levels	O	O	B-T080
of	O	O	O
activity	O	O	B-T052
in	O	O	O
LO	O	O	B-T023
,	O	O	O
and	O	O	O
,	O	O	O
if	O	O	O
not	O	O	O
,	O	O	O
which	O	O	O
image	O	O	B-T080
features	O	O	I-T080
produce	O	O	O
stronger	O	O	B-T080
activation	O	O	B-T052
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
used	O	O	O
an	O	O	O
unbiased	O	O	B-T170
parametric	O	O	I-T170
texture	O	O	I-T170
model	O	O	I-T170
to	O	O	O
predict	O	O	B-T078
preferred	O	O	B-T067
versus	O	O	O
nonpreferred	O	O	B-T067
stimuli	O	O	I-T067
in	O	O	O
LO	O	O	B-T023
.	O	O	O

Observation	O	O	B-T062
and	O	O	O
psychophysical	O	O	B-T169
results	O	O	I-T169
showed	O	O	O
that	O	O	O
predicted	O	O	B-T078
preferred	O	O	B-T078
stimuli	O	O	B-T067
(	O	O	O
both	O	O	O
objects	O	O	B-T072
and	O	O	O
nonobjects	O	O	B-T071
)	O	O	O
had	O	O	O
smooth	O	O	B-T080
(	O	O	O
rather	O	O	O
than	O	O	O
textured	O	O	B-T080
)	O	O	O
surfaces	O	O	B-T082
.	O	O	O

These	O	O	O
predictions	O	O	B-T078
were	O	O	O
confirmed	O	O	B-T080
using	O	O	O
fMRI	O	O	B-T060
,	O	O	O
for	O	O	O
objects	O	O	B-T072
and	O	O	O
nonobjects	O	O	B-T071
.	O	O	O

Similar	O	O	O
preferences	O	O	B-T078
were	O	O	O
also	O	O	O
found	O	O	O
in	O	O	O
the	O	O	O
fusiform	O	O	B-T022
face	O	O	I-T022
area	O	O	I-T022
(	O	O	O
FFA	O	O	B-T022
)	O	O	O
.	O	O	O

Consistent	O	O	B-T078
with	O	O	I-T078
this	O	O	O
:	O	O	O
(	O	O	O
1	O	O	O
)	O	O	O
FFA	O	O	B-T022
and	O	O	O
LO	O	O	B-T023
responded	O	O	O
more	O	O	O
strongly	O	O	O
to	O	O	O
nonfreckled	O	O	B-T080
(	O	O	O
smooth	O	O	B-T080
)	O	O	O
faces	O	O	B-T082
,	O	O	O
compared	O	O	B-T052
with	O	O	O
otherwise	O	O	O
identical	O	O	O
freckled	O	O	B-T033
(	O	O	O
textured	O	O	B-T080
)	O	O	O
faces	O	O	O
;	O	O	O
and	O	O	O
(	O	O	O
2	O	O	O
)	O	O	O
strong	O	O	O
functional	O	O	B-T169
connections	O	O	B-T082
were	O	O	O
found	O	O	O
between	O	O	O
LO	O	O	O
and	O	O	O
FFA	O	O	O
.	O	O	O

Thus	O	O	O
,	O	O	O
LO	O	O	B-T023
and	O	O	O
FFA	O	O	B-T022
may	O	O	O
be	O	O	O
part	O	O	O
of	O	O	O
an	O	O	O
information	O	O	B-T078
-	O	O	O
processing	O	O	B-T052
stream	O	O	O
distinguished	O	O	O
by	O	O	O
feature	O	O	B-T080
-based	O	O	O
category	O	O	B-T170
selectivity	O	O	B-T052
(	O	O	O
smooth	O	O	B-T080
>	O	O	O
textured	O	O	B-T080
)	O	O	O
.	O	O	O

-DOCSTART- (27699590)

High-fructose	O	O	B-T061
diet	O	O	I-T061
is	O	O	O
as	O	O	O
detrimental	O	O	O
as	O	O	O
high-fat	O	O	B-T061
diet	O	O	I-T061
in	O	O	O
the	O	O	O
induction	O	O	B-T061
of	O	O	O
insulin	O	O	B-T046
resistance	O	O	I-T046
and	O	O	O
diabetes	O	O	B-T047
mediated	O	O	O
by	O	O	O
hepatic	O	O	B-T029
/	O	O	O
pancreatic	O	O	B-T023
endoplasmic	O	O	O
reticulum	O	O	O
(	O	O	O
ER	O	O	O
)	O	O	O
stress	O	O	O

In	O	O	O
the	O	O	O
context	O	O	B-T078
of	O	O	O
high	O	O	B-T080
human	O	O	B-T016
consumption	O	O	B-T169
of	O	O	O
fructose	O	O	B-T109
diets	O	O	B-T168
,	O	O	O
there	O	O	O
is	O	O	O
an	O	O	O
imperative	O	O	O
need	O	O	B-T080
to	O	O	O
understand	O	O	B-T041
how	O	O	O
dietary	O	O	B-T169
fructose	O	O	B-T033
intake	O	O	I-T033
influence	O	O	B-T077
cellular	O	O	B-T025
and	O	O	O
molecular	O	O	B-T080
mechanisms	O	O	B-T169
and	O	O	O
thereby	O	O	O
affect	O	O	B-T080
Î²-cell	O	O	B-T033
dysfunction	O	O	I-T033
and	O	O	O
insulin	O	O	B-T046
resistance	O	O	I-T046
.	O	O	O

While	O	O	O
evidence	O	O	B-T078
exists	O	O	B-T077
for	O	O	O
a	O	O	O
relationship	O	O	B-T080
between	O	O	O
high	O	O	B-T080
-	O	O	O
fat	O	O	B-T109
-	O	O	O
induced	O	O	B-T169
insulin	O	O	B-T046
resistance	O	O	I-T046
and	O	O	O
metabolic	O	O	B-T047
disorders	O	O	I-T047
,	O	O	O
there	O	O	O
is	O	O	O
lack	O	O	B-T080
of	O	O	I-T080
studies	O	O	B-T062
in	O	O	O
relation	O	O	O
to	O	O	O
high-fructose	O	O	B-T061
diet	O	O	I-T061
.	O	O	O

Therefore	O	O	O
,	O	O	O
we	O	O	O
attempted	O	O	O
to	O	O	O
study	O	O	B-T062
the	O	O	O
effect	O	O	B-T080
of	O	O	O
different	O	O	B-T080
diets	O	O	B-T168
viz	O	O	O
.	O	O	O
,	O	O	O
high-fat	O	O	B-T061
diet	O	O	B-T168
(	O	O	O
HFD	O	O	B-T061
)	O	O	O
,	O	O	O
high-fructose	O	O	B-T061
diet	O	O	I-T061
(	O	O	O
HFS	O	O	B-T061
)	O	O	O
,	O	O	O
and	O	O	O
a	O	O	O
combination	O	O	B-T080
(	O	O	O
HFS	O	O	O
+	O	O	O
HFD	O	O	O
)	O	O	O
diet	O	O	O
on	O	O	O
glucose	O	O	B-T039
homeostasis	O	O	I-T039
and	O	O	O
insulin	O	O	B-T046
sensitivity	O	O	I-T046
in	O	O	O
male	O	O	B-T032
Wistar	O	O	B-T015
rats	O	O	I-T015
compared	O	O	B-T052
to	O	O	O
control	O	O	B-T008
animals	O	O	I-T008
fed	O	O	B-T052
with	O	O	O
normal	O	O	B-T080
pellet	O	O	B-T081
diet	O	O	O
.	O	O	O

Investigations	O	O	B-T169
include	O	O	O
oral	O	O	B-T060
glucose	O	O	I-T060
tolerance	O	O	I-T060
test	O	O	I-T060
,	O	O	O
insulin	O	O	B-T059
tolerance	O	O	I-T059
test	O	O	I-T059
,	O	O	O
histopathology	O	O	B-T059
by	O	O	O
H&E	O	O	B-T059
and	O	O	O
Masson	O	O	B-T059
's	O	O	I-T059
trichrome	O	O	I-T059
staining	O	O	I-T059
,	O	O	O
mRNA	O	O	B-T045
expression	O	O	I-T045
by	O	O	O
real-time	O	O	B-T063
PCR	O	O	I-T063
,	O	O	O
protein	O	O	B-T059
expression	O	O	I-T059
by	O	O	O
Western	O	O	B-T059
blot	O	O	I-T059
,	O	O	O
and	O	O	O
caspase-3	O	O	B-T044
activity	O	O	I-T044
by	O	O	O
colorimetry	O	O	B-T059
.	O	O	O

Rats	O	O	B-T015
subjected	O	O	O
to	O	O	O
high-fat	O	O	B-T061
/	O	O	O
fructose	O	O	B-T061
diets	O	O	I-T061
became	O	O	O
glucose	O	O	B-T109
intolerant	O	O	B-T169
,	O	O	O
insulin-resistant	O	O	B-T046
,	O	O	O
and	O	O	O
dyslipidemic	O	O	B-T033
.	O	O	O

Compared	O	O	B-T052
to	O	O	O
control	O	O	B-T008
animals	O	O	I-T008
,	O	O	O
rats	O	O	B-T015
subjected	O	O	O
to	O	O	O
different	O	O	B-T080
combination	O	O	B-T080
of	O	O	O
fat	O	O	B-T061
/	O	O	O
fructose	O	O	B-T061
diets	O	O	I-T061
showed	O	O	O
increased	O	O	B-T081
mRNA	O	O	B-T045
and	O	O	O
protein	O	O	B-T045
expression	O	O	I-T045
of	O	O	O
a	O	O	O
battery	O	O	O
of	O	O	O
ER	O	O	B-T049
stress	O	O	I-T049
markers	O	O	B-T080
both	O	O	O
in	O	O	O
pancreas	O	O	B-T023
and	O	O	O
liver	O	O	B-T023
.	O	O	O

Transcription	O	O	B-T116
factors	O	O	I-T116
of	O	O	O
Î²-cell	O	O	B-T043
function	O	O	I-T043
(	O	O	O
INSIG1	O	O	B-T116
,	O	O	O
SREBP1c	O	O	B-T116
and	O	O	O
PDX1	O	O	B-T116
)	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
hepatic	O	O	B-T029
gluconeogenesis	O	O	B-T044
(	O	O	O
FOXO1	O	O	B-T116
and	O	O	O
PEPCK	O	O	B-T116
)	O	O	O
were	O	O	O
adversely	O	O	B-T046
affected	O	O	I-T046
in	O	O	O
diet	O	O	B-T168
-	O	O	O
induced	O	O	B-T169
insulin-resistant	O	O	B-T046
rats	O	O	B-T015
.	O	O	O

The	O	O	O
convergence	O	O	B-T052
of	O	O	O
chronic	O	O	B-T079
ER	O	O	B-T049
stress	O	O	I-T049
towards	O	O	O
apoptosis	O	O	B-T043
in	O	O	O
pancreas	O	O	B-T023
/	O	O	O
liver	O	O	B-T023
was	O	O	O
also	O	O	O
indicated	O	O	B-T033
by	O	O	O
increased	O	O	B-T081
levels	O	O	B-T080
of	O	O	O
CHOP	O	O	B-T114
mRNA	O	O	I-T114
&	O	O	O
increased	O	O	O
activity	O	O	O
of	O	O	O
both	O	O	O
JNK	O	O	B-T044
and	O	O	O
Caspase-3	O	O	B-T044
in	O	O	O
rats	O	O	B-T015
subjected	O	O	O
to	O	O	O
high-fat	O	O	B-T061
/	O	O	O
fructose	O	O	B-T061
diets	O	O	I-T061
.	O	O	O

Our	O	O	O
study	O	O	B-T062
exposes	O	O	O
the	O	O	O
experimental	O	O	B-T080
support	O	O	B-T077
in	O	O	O
that	O	O	O
high-fructose	O	O	B-T061
diet	O	O	I-T061
is	O	O	O
equally	O	O	B-T080
detrimental	O	O	O
in	O	O	O
causing	O	O	B-T169
metabolic	O	O	B-T047
disorders	O	O	I-T047
.	O	O	O

-DOCSTART- (27701287)

Immature	O	O	B-T080
stages	O	O	B-T079
and	O	O	O
larval	O	O	B-T204
chaetotaxy	O	O	B-T090
of	O	O	O
Notofairchildia	O	O	B-T204
stenygros	O	O	I-T204
(	O	O	O
Quate	O	O	O
&	O	O	O
Alexander	O	O	O
)	O	O	O
(	O	O	O
Diptera	O	O	B-T204
:	O	O	O
Psychodidae	O	O	B-T204
:	O	O	O
Bruchomyiinae	O	O	B-T204
)	O	O	O

Some	O	O	O
authors	O	O	O
have	O	O	O
hypothesized	O	O	O
that	O	O	O
Bruchomyiinae	O	O	B-T204
is	O	O	O
"	O	O	O
the	O	O	O
most	O	O	O
plesiomorphic	O	O	B-T185
subfamily	O	O	I-T185
of	O	O	O
Psychodidae	O	O	B-T204
"	O	O	O
and	O	O	O
its	O	O	O
members	O	O	B-T071
"	O	O	O
are	O	O	O
among	O	O	O
the	O	O	O
most	O	O	O
primitive	O	O	B-T080
living	O	O	B-T078
Diptera	O	O	B-T204
"	O	O	O
.	O	O	O

Although	O	O	O
Bruchomyiinae	O	O	B-T204
is	O	O	O
of	O	O	O
no	O	O	B-T033
medical	O	O	B-T169
importance	O	O	B-T080
,	O	O	O
it	O	O	O
is	O	O	O
of	O	O	O
great	O	O	O
evolutionary	O	O	B-T045
significance	O	O	B-T078
,	O	O	O
having	O	O	O
long	O	O	O
been	O	O	O
placed	O	O	O
as	O	O	O
the	O	O	O
sister	O	O	B-T169
group	O	O	I-T169
of	O	O	O
Phlebotominae	O	O	B-T204
.	O	O	O

In	O	O	O
general	O	O	O
,	O	O	O
species	O	O	B-T185
of	O	O	O
this	O	O	O
subfamily	O	O	B-T185
are	O	O	O
rarely	O	O	O
collected	O	O	O
in	O	O	O
their	O	O	O
natural	O	O	B-T082
environment	O	O	I-T082
;	O	O	O
therefore	O	O	O
,	O	O	O
adults	O	O	B-T204
and	O	O	O
,	O	O	O
even	O	O	O
more	O	O	O
so	O	O	O
,	O	O	O
the	O	O	O
immature	O	O	B-T080
stages	O	O	B-T079
of	O	O	O
these	O	O	O
flies	O	O	B-T204
are	O	O	O
poorly	O	O	O
known	O	O	O
.	O	O	O

We	O	O	O
describe	O	O	O
the	O	O	O
egg	O	O	B-T204
,	O	O	O
larvae	O	O	B-T204
and	O	O	O
pupae	O	O	B-T204
of	O	O	O
Notofairchildia	O	O	B-T204
stenygros	O	O	I-T204
and	O	O	O
provide	O	O	O
nomenclatural	O	O	B-T170
notes	O	O	I-T170
on	O	O	O
larval	O	O	B-T204
chaetotaxy	O	O	B-T090
based	O	O	O
on	O	O	O
analyses	O	O	O
using	O	O	O
scanning	O	O	B-T059
electron	O	O	I-T059
microscopy	O	O	I-T059
(	O	O	O
SEM	O	O	B-T059
)	O	O	O
and	O	O	O
optic	O	O	B-T059
microscopy	O	O	I-T059
.	O	O	O

The	O	O	O
morphology	O	O	B-T080
of	O	O	O
immature	O	O	B-T080
Nt	O	O	O
.	O	O	O

stenygros	O	O	O
is	O	O	O
compared	O	O	O
with	O	O	O
other	O	O	O
Bruchomyiinae	O	O	B-T204
and	O	O	O
Psychodidae	O	O	B-T204
species	O	O	B-T185
,	O	O	O
especially	O	O	O
with	O	O	O
species	O	O	O
of	O	O	O
Phlebotominae	O	O	B-T204
that	O	O	O
are	O	O	O
superficially	O	O	O
similar	O	O	B-T080
to	O	O	O
Bruchomyiinae	O	O	O
.	O	O	O

Results	O	O	B-T033
of	O	O	O
this	O	O	O
study	O	O	B-T062
revealed	O	O	O
striking	O	O	O
morphological	O	O	B-T082
differences	O	O	B-T080
between	O	O	O
the	O	O	O
immature	O	O	B-T080
stages	O	O	B-T079
of	O	O	O
Bruchomyiinae	O	O	B-T204
and	O	O	O
Phlebotominae	O	O	B-T204
;	O	O	O
the	O	O	O
former	O	O	O
are	O	O	O
lacking	O	O	O
abdominal	O	O	B-T029
pseudopods	O	O	B-T026
and	O	O	O
microtrichia	O	O	B-T023
on	O	O	O
the	O	O	O
cephalic	O	O	B-T082
integument	O	O	B-T022
,	O	O	O
both	O	O	O
of	O	O	O
which	O	O	O
are	O	O	O
present	O	O	O
in	O	O	O
the	O	O	O
larvae	O	O	B-T204
of	O	O	O
Phlebotominae	O	O	O
.	O	O	O

These	O	O	O
morphological	O	O	B-T082
differences	O	O	B-T080
observed	O	O	O
in	O	O	O
the	O	O	O
immature	O	O	B-T080
stages	O	O	B-T079
between	O	O	O
members	O	O	B-T071
of	O	O	O
the	O	O	O
two	O	O	O
subfamilies	O	O	B-T185
support	O	O	O
the	O	O	O
findings	O	O	B-T033
of	O	O	O
recent	O	O	O
molecular	O	O	B-T059
studies	O	O	I-T059
indicating	O	O	O
that	O	O	O
Bruchomyiinae	O	O	B-T204
and	O	O	O
Phlebtominae	O	O	B-T204
are	O	O	O
evolutionarily	O	O	B-T045
not	O	O	B-T078
closely	O	O	I-T078
related	O	O	I-T078
.	O	O	O

Notofairchildia	O	O	B-T204
stenygros	O	O	I-T204
is	O	O	O
now	O	O	O
the	O	O	O
fourth	O	O	B-T081
species	O	O	B-T185
of	O	O	O
Bruchomyiinae	O	O	B-T204
for	O	O	O
which	O	O	O
the	O	O	O
immature	O	O	B-T080
stages	O	O	B-T079
are	O	O	O
described	O	O	O
.	O	O	O

-DOCSTART- (27702870)

Initial	O	O	O
clinical	O	O	B-T034
results	O	O	I-T034
with	O	O	O
the	O	O	O
ThermoCool	O	O	O
Â®	O	O	O
SmartTouch	O	O	O
Â®	O	O	O
Surround	O	O	O
Flow	O	O	O
catheter	O	O	O

The	O	O	O
Biosense	O	O	B-T074
Webster	O	O	I-T074
ThermoCool	O	O	I-T074
(	O	O	I-T074
Â®	O	O	I-T074
)	O	O	I-T074
SmartTouch	O	O	I-T074
(	O	O	I-T074
Â®	O	O	I-T074
)	O	O	I-T074
Surround	O	O	B-T042
Flow	O	O	I-T042
(	O	O	I-T074
STSF	O	O	I-T074
)	O	O	I-T074
catheter	O	O	B-T074
is	O	O	O
a	O	O	O
recently	O	O	O
developed	O	O	O
ablation	O	O	B-T061
catheter	O	O	O
incorporating	O	O	O
Surround	O	O	O
Flow	O	O	O
(	O	O	O
SF	O	O	B-T042
)	O	O	O
technology	O	O	B-T090
to	O	O	O
ensure	O	O	O
efficient	O	O	O
cooling	O	O	O
and	O	O	O
force	O	O	O
sensing	O	O	O
to	O	O	O
quantify	O	O	B-T081
tissue	O	O	B-T024
contact	O	O	B-T169
.	O	O	O

In	O	O	O
our	O	O	O
unit	O	O	O
,	O	O	O
it	O	O	O
superseded	O	O	O
the	O	O	O
ThermoCool	O	O	B-T074
(	O	O	I-T074
Â®	O	O	I-T074
)	O	O	I-T074
SF	O	O	I-T074
catheter	O	O	I-T074
from	O	O	O
the	O	O	O
time	O	O	O
of	O	O	O
its	O	O	O
introduction	O	O	O
in	O	O	O
May	O	O	O
2015	O	O	O
.	O	O	O

Procedure	O	O	B-T061
-related	O	O	O
data	O	O	B-T078
were	O	O	O
collected	O	O	O
prospectively	O	O	O
for	O	O	O
the	O	O	O
first	O	O	O
100	O	O	O
ablation	O	O	B-T061
procedures	O	O	I-T061
performed	O	O	O
in	O	O	O
our	O	O	O
department	O	O	O
using	O	O	O
the	O	O	O
STSF	O	O	B-T074
catheter	O	O	I-T074
.	O	O	O

From	O	O	O
a	O	O	O
database	O	O	B-T170
of	O	O	O
654	O	O	O
procedures	O	O	B-T061
performed	O	O	O
in	O	O	O
our	O	O	O
unit	O	O	O
using	O	O	O
the	O	O	O
SF	O	O	B-T074
catheter	O	O	I-T074
,	O	O	O
we	O	O	O
selected	O	O	O
one	O	O	O
to	O	O	O
match	O	O	O
each	O	O	O
STSF	O	O	B-T061
procedure	O	O	I-T061
,	O	O	O
matching	O	O	O
for	O	O	O
procedure	O	O	B-T185
type	O	O	I-T185
,	O	O	O
operator	O	O	B-T098
experience	O	O	B-T041
,	O	O	O
patient	O	O	B-T032
age	O	O	I-T032
,	O	O	O
and	O	O	O
gender	O	O	B-T032
.	O	O	O

The	O	O	O
groups	O	O	B-UnknownType
were	O	O	O
well	O	O	O
matched	O	O	O
for	O	O	O
patient	O	O	B-T032
age	O	O	I-T032
,	O	O	O
gender	O	O	B-T032
,	O	O	O
and	O	O	O
procedure	O	O	B-T185
type	O	O	I-T185
.	O	O	O

Procedure	O	O	B-T079
duration	O	O	I-T079
was	O	O	O
similar	O	O	O
in	O	O	O
both	O	O	O
groups	O	O	B-UnknownType
(	O	O	O
mean	O	O	O
225.5	O	O	O
vs.	O	O	O
221.4	O	O	O
min	O	O	O
,	O	O	O
IQR	O	O	B-T081
106.5	O	O	O
vs.	O	O	O
91.5	O	O	O
,	O	O	O
P	O	O	O
=	O	O	O
0.55	O	O	O
)	O	O	O
,	O	O	O
but	O	O	O
fluoroscopy	O	O	B-T079
duration	O	O	I-T079
was	O	O	O
shorter	O	O	B-T081
in	O	O	O
the	O	O	O
STSF	O	O	B-UnknownType
group	O	O	I-UnknownType
(	O	O	O
mean	O	O	O
25.8	O	O	O
vs.	O	O	O
30.0	O	O	O
,	O	O	O
IQR	O	O	O
19.6	O	O	O
vs.	O	O	O
18.5	O	O	O
,	O	O	O
P	O	O	O
=	O	O	O
0.03	O	O	O
)	O	O	O
.	O	O	O

No	O	O	B-T033
complication	O	O	I-T033
occurred	O	O	O
in	O	O	O
the	O	O	O
STSF	O	O	B-UnknownType
group	O	O	I-UnknownType
.	O	O	O

Complications	O	O	B-T046
occurred	O	O	O
in	O	O	O
two	O	O	O
cases	O	O	B-T077
in	O	O	O
the	O	O	O
SF	O	O	B-UnknownType
group	O	O	I-UnknownType
(	O	O	O
one	O	O	O
pericardial	O	O	B-T047
effusion	O	O	I-T047
requiring	O	O	O
drainage	O	O	B-T061
and	O	O	O
one	O	O	O
need	O	O	O
for	O	O	O
permanent	O	O	B-T079
pacing	O	O	B-T061
)	O	O	O
.	O	O	O

Complete	O	O	B-T033
procedural	O	O	I-T033
success	O	O	I-T033
was	O	O	O
achieved	O	O	O
in	O	O	O
98	O	O	O
cases	O	O	B-T077
in	O	O	O
the	O	O	O
STSF	O	O	B-UnknownType
group	O	O	I-UnknownType
and	O	O	O
94	O	O	O
cases	O	O	O
in	O	O	O
the	O	O	O
SF	O	O	B-UnknownType
group	O	O	I-UnknownType
(	O	O	O
P	O	O	O
=	O	O	O
0.15	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
composite	O	O	O
endpoint	O	O	O
of	O	O	O
procedure	O	O	O
failure	O	O	B-T066
or	O	O	O
acute	O	O	B-T079
complication	O	O	B-T046
was	O	O	O
less	O	O	O
common	O	O	O
in	O	O	O
the	O	O	O
STSF	O	O	B-UnknownType
group	O	O	I-UnknownType
(	O	O	O
2	O	O	O
vs.	O	O	O
8	O	O	O
,	O	O	O
P	O	O	O
=	O	O	O
0.05	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
STSF	O	O	B-T074
catheter	O	O	I-T074
is	O	O	O
safe	O	O	O
and	O	O	O
effective	O	O	B-T080
in	O	O	O
treating	O	O	B-T169
a	O	O	O
range	O	O	O
of	O	O	O
arrhythmias	O	O	B-T033
.	O	O	O

Compared	O	O	O
with	O	O	O
the	O	O	O
SF	O	O	B-T074
catheter	O	O	I-T074
,	O	O	O
it	O	O	O
shows	O	O	O
a	O	O	O
trend	O	O	O
towards	O	O	O
improved	O	O	O
safety	O	O	B-T068
-	O	O	O
efficacy	O	O	B-T080
balance	O	O	O
.	O	O	O

-DOCSTART- (27703752)

Low	O	O	B-T033
birth	O	O	I-T033
weight	O	O	I-T033
and	O	O	O
features	O	O	B-T080
of	O	O	O
neuroticism	O	O	B-T048
and	O	O	O
mood	O	O	B-T048
disorder	O	O	I-T048
in	O	O	O
83	O	O	O
545	O	O	O
participants	O	O	B-T098
of	O	O	O
the	O	O	O
UK	O	O	B-T083
Biobank	O	O	B-T093
cohort	O	O	O

Low	O	O	B-T033
birth	O	O	I-T033
weight	O	O	I-T033
has	O	O	O
been	O	O	O
inconsistently	O	O	O
associated	O	O	O
with	O	O	O
risk	O	O	B-T078
of	O	O	O
developing	O	O	O
affective	O	O	B-T048
disorders	O	O	I-T048
,	O	O	O
including	O	O	O
major	O	O	B-T048
depressive	O	O	I-T048
disorder	O	O	I-T048
(	O	O	O
MDD	O	O	B-T048
)	O	O	O
.	O	O	O

To	O	O	O
date	O	O	O
,	O	O	O
studies	O	O	B-T062
investigating	O	O	B-T169
possible	O	O	O
associations	O	O	B-T080
between	O	O	O
birth	O	O	B-T032
weight	O	O	I-T032
and	O	O	O
bipolar	O	O	B-T048
disorder	O	O	I-T048
(	O	O	O
BD	O	O	B-T048
)	O	O	O
,	O	O	O
or	O	O	O
personality	O	O	B-T033
traits	O	O	I-T033
known	O	O	O
to	O	O	O
predispose	O	O	B-T032
to	O	O	O
affective	O	O	B-T048
disorders	O	O	I-T048
such	O	O	O
as	O	O	O
neuroticism	O	O	B-T048
,	O	O	O
have	O	O	O
not	O	O	O
been	O	O	O
conducted	O	O	O
in	O	O	O
large	O	O	O
cohorts	O	O	B-T098
.	O	O	O

To	O	O	O
assess	O	O	B-T052
whether	O	O	O
very	O	O	B-T184
low	O	O	B-T033
birth	O	O	I-T033
weight	O	O	I-T033
(	O	O	O
<	O	O	O
1500	O	O	O
g	O	O	O
)	O	O	O
and	O	O	O
low	O	O	O
birth	O	O	O
weight	O	O	O
(	O	O	O
1500	O	O	O
-	O	O	O
2490	O	O	O
g	O	O	O
)	O	O	O
were	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
higher	O	O	B-T033
neuroticism	O	O	I-T033
scores	O	O	B-T081
assessed	O	O	B-T052
in	O	O	O
middle	O	O	B-T079
age	O	O	I-T079
,	O	O	O
and	O	O	O
lifetime	O	O	B-T032
history	O	O	I-T032
of	O	O	O
either	O	O	O
MDD	O	O	B-T048
or	O	O	O
BD	O	O	B-T048
.	O	O	O

We	O	O	O
controlled	O	O	O
for	O	O	O
possible	O	O	O
confounding	O	O	B-T169
factors	O	O	I-T169
.	O	O	O

Retrospective	O	O	B-T080
cohort	O	O	B-T081
study	O	O	I-T081
using	O	O	O
baseline	O	O	B-T081
data	O	O	B-T078
on	O	O	O
the	O	O	O
83	O	O	O
545	O	O	O
UK	O	O	B-T083
Biobank	O	O	B-T093
participants	O	O	B-T098
with	O	O	O
detailed	O	O	O
mental	O	O	B-T041
health	O	O	I-T041
and	O	O	O
birth	O	O	B-T032
weight	O	O	I-T032
data	O	O	O
.	O	O	O

Main	O	O	O
outcomes	O	O	B-T169
were	O	O	O
prevalent	O	O	O
MDD	O	O	B-T048
and	O	O	O
BD	O	O	B-T048
,	O	O	O
and	O	O	O
neuroticism	O	O	B-T048
assessed	O	O	B-T052
using	O	O	O
the	O	O	O
Eysenck	O	O	B-T170
Personality	O	O	I-T170
Inventory	O	O	I-T170
Neuroticism	O	O	I-T170
scale	O	O	I-T170
-	O	O	I-T170
Revised	O	O	I-T170
(	O	O	O
EPIN-R	O	O	B-T170
)	O	O	O
.	O	O	O

Referent	O	O	O
to	O	O	O
normal	O	O	B-T033
birth	O	O	I-T033
weight	O	O	I-T033
,	O	O	O
very	O	O	B-T184
low	O	O	I-T184
/	O	O	O
low	O	O	B-T033
birth	O	O	I-T033
weight	O	O	I-T033
were	O	O	O
associated	O	O	O
with	O	O	O
higher	O	O	B-T033
neuroticism	O	O	I-T033
scores	O	O	B-T081
,	O	O	O
increased	O	O	B-T081
MDD	O	O	B-T048
and	O	O	O
BD	O	O	B-T048
.	O	O	O

The	O	O	O
associations	O	O	B-T080
between	O	O	O
birth	O	O	B-T032
weight	O	O	I-T032
category	O	O	B-T170
and	O	O	O
MDD	O	O	B-T048
were	O	O	O
partially	O	O	O
mediated	O	O	O
by	O	O	O
higher	O	O	B-T033
neuroticism	O	O	I-T033
.	O	O	O

These	O	O	O
findings	O	O	B-T033
suggest	O	O	O
that	O	O	O
intrauterine	O	O	B-T029
programming	O	O	B-T038
may	O	O	O
play	O	O	O
a	O	O	O
role	O	O	B-T077
in	O	O	O
lifetime	O	O	B-T079
vulnerability	O	O	B-T033
to	O	O	O
affective	O	O	B-T048
disorders	O	O	I-T048
.	O	O	O

None	O	O	O
.	O	O	O

Â©	O	O	O
The	O	O	O
Royal	O	O	O
College	O	O	O
of	O	O	O
Psychiatrists	O	O	O
2016	O	O	O
.	O	O	O

This	O	O	O
is	O	O	O
an	O	O	O
open	O	O	O
access	O	O	O
article	O	O	O
distributed	O	O	O
under	O	O	O
the	O	O	O
terms	O	O	O
of	O	O	O
the	O	O	O
Creative	O	O	O
Commons	O	O	O
Non-Commercial	O	O	O
,	O	O	O
No	O	O	O
Derivatives	O	O	O
(	O	O	O
CC	O	O	O
BY-NC-ND	O	O	O
)	O	O	O
licence	O	O	O
.	O	O	O

-DOCSTART- (27708411)

DNA	O	O	B-T045
annealing	O	O	I-T045
by	O	O	O
RedÎ²	O	O	B-T116
is	O	O	O
insufficient	O	O	O
for	O	O	O
homologous	O	O	B-T045
recombination	O	O	I-T045
and	O	O	O
the	O	O	O
additional	O	O	O
requirements	O	O	O
involve	O	O	O
intra-	O	O	O
and	O	O	O
inter-molecular	O	O	O
interactions	O	O	O

Single	O	O	B-T116
strand	O	O	I-T116
annealing	O	O	I-T116
proteins	O	O	I-T116
(	O	O	O
SSAPs	O	O	B-T116
)	O	O	O
like	O	O	O
RedÎ²	O	O	B-T116
initiate	O	O	O
homologous	O	O	B-T045
recombination	O	O	I-T045
by	O	O	O
annealing	O	O	B-T114
complementary	O	O	I-T114
DNA	O	O	I-T114
strands	O	O	I-T114
.	O	O	O

We	O	O	O
show	O	O	O
that	O	O	O
C-terminally	O	O	B-T044
truncated	O	O	I-T044
RedÎ²	O	O	B-T116
,	O	O	O
whilst	O	O	O
still	O	O	O
able	O	O	O
to	O	O	O
promote	O	O	O
annealing	O	O	B-T045
and	O	O	O
nucleoprotein	O	O	B-T045
filament	O	O	I-T045
formation	O	O	I-T045
,	O	O	O
is	O	O	O
unable	O	O	O
to	O	O	O
mediate	O	O	O
homologous	O	O	B-T045
recombination	O	O	I-T045
.	O	O	O

Mutations	O	O	B-T045
of	O	O	O
the	O	O	O
C-terminal	O	O	B-T087
domain	O	O	I-T087
were	O	O	O
evaluated	O	O	O
using	O	O	O
both	O	O	O
single	O	O	B-T114
-	O	O	O
and	O	O	O
double	O	O	B-T114
stranded	O	O	I-T114
(	O	O	O
ss	O	O	B-T114
and	O	O	O
ds	O	O	B-T114
)	O	O	O
substrates	O	O	O
in	O	O	O
recombination	O	O	B-T045
assays	O	O	B-T059
.	O	O	O

Mutations	O	O	B-T059
of	O	O	O
critical	O	O	B-T116
amino	O	O	I-T116
acids	O	O	I-T116
affected	O	O	O
either	O	O	O
dsDNA	O	O	B-T114
recombination	O	O	B-T043
or	O	O	O
both	O	O	O
ssDNA	O	O	B-T114
and	O	O	O
dsDNA	O	O	B-T043
recombination	O	O	I-T043
indicating	O	O	O
two	O	O	O
separable	O	O	O
functions	O	O	O
,	O	O	O
one	O	O	O
of	O	O	O
which	O	O	O
is	O	O	O
critical	O	O	O
for	O	O	O
dsDNA	O	O	O
recombination	O	O	O
and	O	O	O
the	O	O	O
second	O	O	O
for	O	O	O
recombination	O	O	O
per	O	O	O
se	O	O	O
.	O	O	O

As	O	O	O
evaluated	O	O	O
by	O	O	O
co-immunoprecipitation	O	O	B-T059
experiments	O	O	I-T059
,	O	O	O
the	O	O	O
dsDNA	O	O	B-T043
recombination	O	O	I-T043
function	O	O	I-T043
relates	O	O	O
to	O	O	O
the	O	O	O
RedÎ±	O	O	B-T116
-	O	O	O
RedÎ²	O	O	B-T116
protein-protein	O	O	B-T044
interaction	O	O	I-T044
,	O	O	O
which	O	O	O
requires	O	O	O
not	O	O	O
only	O	O	O
contacts	O	O	O
in	O	O	O
the	O	O	O
C-terminal	O	O	B-T087
domain	O	O	I-T087
but	O	O	O
also	O	O	O
a	O	O	O
region	O	O	O
near	O	O	O
the	O	O	O
N-terminus	O	O	B-T087
.	O	O	O

Because	O	O	O
the	O	O	O
nucleoprotein	O	O	B-T045
filament	O	O	I-T045
formed	O	O	I-T045
with	O	O	O
C-terminally	O	O	B-T044
truncated	O	O	I-T044
RedÎ²	O	O	B-T116
has	O	O	O
altered	O	O	O
properties	O	O	O
,	O	O	O
the	O	O	O
second	O	O	O
C-terminal	O	O	B-T044
function	O	O	I-T044
could	O	O	O
be	O	O	O
due	O	O	O
to	O	O	O
an	O	O	O
interaction	O	O	B-T045
required	O	O	O
for	O	O	O
functional	O	O	B-T169
filaments	O	O	B-T026
.	O	O	O

Alternatively	O	O	O
the	O	O	O
second	O	O	O
C-terminal	O	O	B-T044
function	O	O	I-T044
could	O	O	O
indicate	O	O	O
a	O	O	O
requirement	O	O	O
for	O	O	O
a	O	O	O
RedÎ²	O	O	B-T116
-	O	O	O
host	O	O	B-T043
factor	O	O	I-T043
interaction	O	O	I-T043
.	O	O	O

These	O	O	O
data	O	O	O
further	O	O	O
advance	O	O	O
the	O	O	O
model	O	O	O
for	O	O	O
Red	O	O	B-T045
recombination	O	O	I-T045
and	O	O	O
the	O	O	O
proposition	O	O	O
that	O	O	O
RedÎ²	O	O	B-T116
and	O	O	O
RAD52	O	O	B-T116
SSAPs	O	O	B-T116
share	O	O	O
ancestral	O	O	O
and	O	O	O
mechanistic	O	O	O
roots	O	O	O
.	O	O	O

-DOCSTART- (27709647)

Multi-drug-resistant	O	O	B-T032
Acinetobacter	O	O	B-T007
calcoaceticus-Acinetobacter	O	O	I-T007
baumannii	O	O	I-T007
complex	O	O	I-T007
infection	O	O	B-T046
outbreak	O	O	B-T067
in	O	O	O
dogs	O	O	B-T015
and	O	O	O
cats	O	O	B-T015
in	O	O	O
a	O	O	O
veterinary	O	O	O
hospital	O	O	O

Members	O	O	O
of	O	O	O
the	O	O	O
Acinetobacter	O	O	B-T007
calcoaceticus-Acinetobacter	O	O	I-T007
baumannii	O	O	I-T007
complex	O	O	I-T007
cause	O	O	O
severe	O	O	B-T080
outbreaks	O	O	B-T067
in	O	O	O
humans	O	O	B-T016
,	O	O	O
and	O	O	O
are	O	O	O
increasingly	O	O	B-T169
reported	O	O	B-T058
in	O	O	O
animals	O	O	B-T008
.	O	O	O

A	O	O	O
retrospective	O	O	B-T062
study	O	O	I-T062
,	O	O	O
describing	O	O	O
a	O	O	O
severe	O	O	B-T080
outbreak	O	O	B-T067
in	O	O	O
dogs	O	O	B-T015
and	O	O	O
cats	O	O	B-T015
caused	O	O	O
by	O	O	O
a	O	O	O
multidrug	O	O	B-T007
resistant	O	O	I-T007
member	O	O	I-T007
of	O	O	O
the	O	O	O
Acinetobacter	O	O	B-T007
calcoaceticus-Acinetobacter	O	O	I-T007
baumannii	O	O	I-T007
complex	O	O	I-T007
in	O	O	O
a	O	O	O
veterinary	O	O	B-T093
hospital	O	O	I-T093
,	O	O	O
between	O	O	O
July	O	O	O
2010	O	O	O
and	O	O	O
November	O	O	O
2012	O	O	O
.	O	O	O

The	O	O	O
study	O	O	B-T062
included	O	O	B-T169
19	O	O	O
dogs	O	O	B-T015
and	O	O	O
4	O	O	O
cats	O	O	B-T015
.	O	O	O

Acinetobacter	O	O	B-T007
calcoaceticus-Acinetobacter	O	O	I-T007
baumannii	O	O	I-T007
complex	O	O	I-T007
bacteria	O	O	I-T007
were	O	O	O
isolated	O	O	B-T169
from	O	O	O
urine	O	O	B-T031
(	O	O	O
9	O	O	O
animals	O	O	B-T008
)	O	O	O
,	O	O	O
respiratory	O	O	B-T022
tract	O	O	I-T022
(	O	O	O
11	O	O	O
)	O	O	O
,	O	O	O
tissues	O	O	B-T024
(	O	O	O
3	O	O	O
)	O	O	O
and	O	O	O
blood	O	O	B-T031
(	O	O	O
1	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
most	O	O	B-T081
common	O	O	B-T081
infection	O	O	B-T046
-	O	O	O
associated	O	O	B-T033
findings	O	O	I-T033
included	O	O	B-T169
fever	O	O	B-T184
,	O	O	O
purulent	O	O	B-T184
discharge	O	O	I-T184
from	O	O	O
endotracheal	O	O	B-T074
tubes	O	O	I-T074
,	O	O	O
hypotension	O	O	B-T033
,	O	O	O
and	O	O	O
neutropaenia	O	O	B-T047
.	O	O	O

Infection	O	O	B-T046
s	O	O	O
led	O	O	O
to	O	O	O
pneumonia	O	O	B-T047
,	O	O	O
urinary	O	O	B-T047
tract	O	O	I-T047
infection	O	O	I-T047
,	O	O	O
cellulitis	O	O	B-T046
and	O	O	O
sepsis	O	O	B-T047
.	O	O	O

Infection	O	O	B-T046
was	O	O	O
transmitted	O	O	B-T046
in	O	O	O
the	O	O	O
intensive	O	O	B-T093
care	O	O	I-T093
unit	O	O	I-T093
,	O	O	O
where	O	O	O
22	O	O	O
of	O	O	O
23	O	O	O
animals	O	O	B-T008
were	O	O	O
initially	O	O	B-T079
hospitalised	O	O	B-T058
.	O	O	O

The	O	O	O
mortality	O	O	B-T081
rate	O	O	I-T081
was	O	O	O
70	O	O	O
%	O	O	O
(	O	O	O
16	O	O	O
of	O	O	O
23	O	O	O
animals	O	O	B-T008
)	O	O	O
,	O	O	O
and	O	O	O
was	O	O	O
higher	O	O	B-T080
in	O	O	O
cases	O	O	O
of	O	O	O
respiratory	O	O	B-T047
infection	O	O	I-T047
compared	O	O	B-T052
to	O	O	O
other	O	O	O
infections	O	O	B-T046
.	O	O	O

Aggressive	O	O	O
environmental	O	O	B-T082
cleaning	O	O	B-T052
and	O	O	O
disinfection	O	O	B-T061
,	O	O	O
with	O	O	O
staff	O	O	B-T065
education	O	O	I-T065
for	O	O	O
personal	O	O	B-T056
hygiene	O	O	I-T056
and	O	O	O
antisepsis	O	O	B-T061
,	O	O	O
sharply	O	O	O
decreased	O	O	B-T081
the	O	O	O
infection	O	O	B-T046
incidence	O	O	B-T081
.	O	O	O

Health	O	O	B-T078
care	O	O	I-T078
-	O	O	O
associated	O	O	B-T080
outbreaks	O	O	B-T067
with	O	O	O
multidrug	O	O	B-T032
resistant	O	O	I-T032
Acinetobacter	O	O	B-T007
calcoaceticus-Acinetobacter	O	O	I-T007
baumannii	O	O	I-T007
complex	O	O	I-T007
in	O	O	O
dogs	O	O	B-T015
and	O	O	O
cats	O	O	B-T015
are	O	O	O
potentially	O	O	O
highly	O	O	B-T080
fatal	O	O	B-T080
and	O	O	O
difficult	O	O	B-T080
to	O	O	O
eradicate	O	O	B-T061
,	O	O	O
warranting	O	O	O
monitoring	O	O	B-T058
,	O	O	O
antiseptic	O	O	B-T121
techniques	O	O	B-T169
and	O	O	O
judicious	O	O	O
antibiotic	O	O	B-T195
use	O	O	B-T169
.	O	O	O

-DOCSTART- (27710934)

Manipulation	O	O	O
of	O	O	O
an	O	O	O
existing	O	O	O
crystal	O	O	B-T104
form	O	O	I-T104
unexpectedly	O	O	B-T033
results	O	O	I-T033
in	O	O	O
interwoven	O	O	B-T116
packing	O	O	I-T116
networks	O	O	I-T116
with	O	O	O
pseudo-translational	O	O	O
symmetry	O	O	O

Nonribosomal	O	O	B-T116
peptide	O	O	I-T116
synthetases	O	O	I-T116
(	O	O	O
NRPSs	O	O	B-T116
)	O	O	O
are	O	O	O
multimodular	O	O	B-T116
enzymes	O	O	I-T116
that	O	O	O
synthesize	O	O	B-T052
a	O	O	O
myriad	O	O	B-T081
of	O	O	O
diverse	O	O	B-T167
molecules	O	O	I-T167
.	O	O	O

Tailoring	O	O	B-T087
domains	O	O	I-T087
have	O	O	O
been	O	O	O
co-opted	O	O	O
into	O	O	O
NRPSs	O	O	B-T116
to	O	O	O
introduce	O	O	O
further	O	O	O
variety	O	O	O
into	O	O	O
nonribosomal	O	O	B-T116
peptide	O	O	I-T116
products	O	O	I-T116
.	O	O	O

Linear	O	O	B-T116
gramicidin	O	O	I-T116
synthetase	O	O	I-T116
contains	O	O	B-T052
a	O	O	O
unique	O	O	O
formylation	O	O	B-T044
-	O	O	O
tailoring	O	O	B-T087
domain	O	O	I-T087
in	O	O	O
its	O	O	O
initiation	O	O	B-T077
module	O	O	I-T077
(	O	O	O
F-A	O	O	B-T044
-	O	O	O
PCP	O	O	B-T087
)	O	O	O
.	O	O	O

The	O	O	O
structure	O	O	O
of	O	O	O
the	O	O	O
F-A	O	O	B-T044
di-domain	O	O	B-T087
has	O	O	O
previously	O	O	O
been	O	O	O
determined	O	O	O
in	O	O	O
a	O	O	O
crystal	O	O	B-T104
form	O	O	I-T104
which	O	O	O
had	O	O	O
large	O	O	O
solvent	O	O	B-T130
channels	O	O	B-T082
and	O	O	O
no	O	O	B-T081
density	O	O	I-T081
for	O	O	O
the	O	O	O
minor	O	O	O
Asub	O	O	B-T087
subdomain	O	O	I-T087
.	O	O	O

An	O	O	O
attempt	O	O	O
was	O	O	O
made	O	O	O
to	O	O	O
take	O	O	O
advantage	O	O	O
of	O	O	O
this	O	O	O
packing	O	O	B-T052
by	O	O	O
removing	O	O	B-T052
the	O	O	O
Asub	O	O	B-T087
subdomain	O	O	I-T087
from	O	O	O
the	O	O	O
construct	O	O	O
(	O	O	O
F-A	O	O	B-T044
Î	O	O	O
sub	O	O	B-T087
)	O	O	O
in	O	O	O
order	O	O	O
to	O	O	O
produce	O	O	O
a	O	O	O
crystal	O	O	B-T104
that	O	O	O
could	O	O	O
accommodate	O	O	O
the	O	O	O
PCP	O	O	B-T087
domain	O	O	I-T087
.	O	O	O

In	O	O	O
the	O	O	O
resulting	O	O	O
crystal	O	O	B-T104
the	O	O	O
original	O	O	B-T116
packing	O	O	B-T052
network	O	O	I-T116
was	O	O	O
still	O	O	O
present	O	O	O
,	O	O	O
but	O	O	O
a	O	O	O
second	O	O	B-T116
network	O	O	I-T116
with	O	O	O
the	O	O	O
same	O	O	O
packing	O	O	O
and	O	O	O
almost	O	O	O
no	O	O	O
contact	O	O	O
with	O	O	O
the	O	O	O
original	O	O	B-T116
network	O	O	I-T116
took	O	O	O
the	O	O	O
place	O	O	O
of	O	O	O
the	O	O	O
solvent	O	O	B-T130
channels	O	O	B-T082
and	O	O	O
changed	O	O	O
the	O	O	O
space	O	O	B-T104
group	O	O	I-T104
of	O	O	I-T104
the	O	O	I-T104
crystal	O	O	I-T104
.	O	O	O

-DOCSTART- (27714135)

Folate	O	O	B-T127
-based	O	O	O
single	O	O	B-T059
cell	O	O	I-T059
screening	O	O	I-T059
using	O	O	O
surface	O	O	O
enhanced	O	O	O
Raman	O	O	O
microimaging	O	O	O

Recent	O	O	O
progress	O	O	O
in	O	O	O
nanotechnology	O	O	B-T090
and	O	O	O
its	O	O	O
application	O	O	O
to	O	O	O
biomedical	O	O	B-T062
settings	O	O	I-T062
have	O	O	O
generated	O	O	O
great	O	O	O
advantages	O	O	O
in	O	O	O
dealing	O	O	O
with	O	O	O
early	O	O	B-T060
cancer	O	O	I-T060
diagnosis	O	O	I-T060
.	O	O	O

The	O	O	O
identification	O	O	O
of	O	O	O
the	O	O	O
specific	O	O	O
properties	O	O	O
of	O	O	O
cancer	O	O	B-T025
cells	O	O	I-T025
,	O	O	O
such	O	O	O
as	O	O	O
the	O	O	O
expression	O	O	B-T045
of	O	O	O
particular	O	O	O
plasma	O	O	B-T026
membrane	O	O	I-T026
molecular	O	O	B-T091
receptors	O	O	I-T091
,	O	O	O
has	O	O	O
become	O	O	O
crucial	O	O	O
in	O	O	O
revealing	O	O	O
the	O	O	O
presence	O	O	O
and	O	O	O
in	O	O	O
assessing	O	O	B-T058
the	O	O	I-T058
stage	O	O	I-T058
of	O	O	I-T058
development	O	O	I-T058
of	O	O	I-T058
the	O	O	I-T058
disease	O	O	I-T058
.	O	O	O

Here	O	O	O
we	O	O	O
report	O	O	O
a	O	O	O
single	O	O	B-T059
cell	O	O	I-T059
screening	O	O	I-T059
approach	O	O	O
based	O	O	O
on	O	O	O
Surface	O	O	B-T059
Enhanced	O	O	I-T059
Raman	O	O	I-T059
Scattering	O	O	I-T059
(	O	O	I-T059
SERS	O	O	B-T059
)	O	O	I-T059
microimaging	O	O	I-T059
.	O	O	O

We	O	O	O
fabricated	O	O	O
a	O	O	O
SERS-labelled	O	O	B-T059
nanovector	O	O	B-T090
based	O	O	O
on	O	O	O
the	O	O	O
biofunctionalization	O	O	B-T078
of	O	O	O
gold	O	O	B-T073
nanoparticles	O	O	I-T073
with	O	O	O
folic	O	O	B-T127
acid	O	O	I-T127
.	O	O	O

After	O	O	O
treating	O	O	B-T025
the	O	O	I-T025
cells	O	O	I-T025
with	O	O	O
the	O	O	O
nanovector	O	O	B-T090
,	O	O	O
we	O	O	O
were	O	O	O
able	O	O	O
to	O	O	O
distinguish	O	O	B-T059
three	O	O	I-T059
different	O	O	I-T059
cell	O	O	I-T059
populations	O	O	I-T059
from	O	O	O
different	O	O	B-T025
cell	O	O	I-T025
lines	O	O	I-T025
(	O	O	O
cancer	O	O	B-T025
HeLa	O	O	I-T025
and	O	O	O
PC-3	O	O	B-T050
,	O	O	O
and	O	O	O
normal	O	O	B-T025
HaCaT	O	O	I-T025
lines	O	O	I-T025
)	O	O	O
,	O	O	O
suitably	O	O	O
chosen	O	O	O
for	O	O	O
their	O	O	O
different	O	O	O
expressions	O	O	B-T045
of	O	O	O
folate	O	O	B-T116
binding	O	O	I-T116
proteins	O	O	I-T116
.	O	O	O

The	O	O	O
nanovector	O	O	B-T090
,	O	O	O
indeed	O	O	O
,	O	O	O
binds	O	O	B-T052
much	O	O	I-T052
more	O	O	I-T052
efficiently	O	O	I-T052
on	O	O	O
cancer	O	O	B-T025
cell	O	O	I-T025
lines	O	O	I-T025
than	O	O	O
on	O	O	O
normal	O	O	O
ones	O	O	O
,	O	O	O
resulting	O	O	O
in	O	O	O
a	O	O	O
higher	O	O	O
SERS	O	O	B-T059
signal	O	O	O
measured	O	O	O
on	O	O	O
cancer	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

These	O	O	O
results	O	O	O
pave	O	O	O
the	O	O	O
way	O	O	O
for	O	O	O
applications	O	O	O
in	O	O	O
single	O	O	B-T059
cell	O	O	I-T059
diagnostics	O	O	I-T059
and	O	O	O
,	O	O	O
potentially	O	O	B-T080
,	O	O	O
in	O	O	O
theranostics	O	O	B-T091
.	O	O	O

-DOCSTART- (27715500)

Self-reported	O	O	B-T062
occupational	O	O	B-T037
injuries	O	O	I-T037
among	O	O	O
industrial	O	O	B-T057
beef	O	O	B-T015
slaughterhouse	O	O	B-T073
workers	O	O	B-T098
in	O	O	O
the	O	O	O
Midwestern	O	O	O
United	O	O	O
States	O	O	O

Although	O	O	O
workers	O	O	B-T098
in	O	O	O
meatpacking	O	O	B-T092
facilities	O	O	I-T092
in	O	O	O
the	O	O	O
United	O	O	B-T083
States	O	O	I-T083
experience	O	O	O
high	O	O	B-T081
rates	O	O	I-T081
of	O	O	O
occupational	O	O	B-T037
injury	O	O	B-T037
,	O	O	O
their	O	O	O
injury	O	O	O
experiences	O	O	O
have	O	O	O
received	O	O	O
limited	O	O	O
research	O	O	B-T062
attention	O	O	O
.	O	O	O

Prior	O	O	O
research	O	O	B-T062
indicates	O	O	I-T062
underreporting	O	O	B-T058
in	O	O	O
injury	O	O	B-T033
rates	O	O	I-T033
in	O	O	O
this	O	O	O
industry	O	O	B-T057
as	O	O	O
well	O	O	O
significant	O	O	O
variation	O	O	O
in	O	O	O
injury	O	O	O
rates	O	O	O
among	O	O	O
facilities	O	O	O
.	O	O	O

To	O	O	O
add	O	O	O
detail	O	O	O
to	O	O	O
the	O	O	O
rates	O	O	O
and	O	O	O
circumstances	O	O	O
surrounding	O	O	O
occupational	O	O	B-T037
injury	O	O	B-T037
among	O	O	O
meatpacking	O	O	B-T092
workers	O	O	B-T098
,	O	O	O
we	O	O	O
conducted	O	O	O
a	O	O	O
cross-sectional	O	O	B-T062
study	O	O	I-T062
of	O	O	O
workers	O	O	O
employed	O	O	O
at	O	O	O
an	O	O	O
industrial	O	O	B-T092
beefpacking	O	O	I-T092
plant	O	O	I-T092
in	O	O	O
Nebraska	O	O	B-T083
,	O	O	O
United	O	O	B-T083
States	O	O	I-T083
(	O	O	O
n	O	O	O
=	O	O	O
137	O	O	O
)	O	O	O
and	O	O	O
interviewed	O	O	O
workers	O	O	O
about	O	O	O
recent	O	O	O
injury	O	O	O
experiences	O	O	O
.	O	O	O

We	O	O	O
assessed	O	O	O
frequency	O	O	O
,	O	O	O
cause	O	O	O
and	O	O	O
nature	O	O	O
of	O	O	O
self-reported	O	O	B-T062
injury	O	O	B-T037
.	O	O	O

We	O	O	O
estimated	O	O	O
annual	O	O	B-T081
incidence	O	O	I-T081
rates	O	O	I-T081
of	O	O	O
self-reported	O	O	B-T062
injuries	O	O	B-T037
using	O	O	O
the	O	O	O
OSHA	O	O	B-T093
formula	O	O	B-T170
and	O	O	O
compared	O	O	O
these	O	O	O
rates	O	O	O
to	O	O	O
industry-wide	O	O	B-T078
data	O	O	I-T078
.	O	O	O

We	O	O	O
also	O	O	O
evaluated	O	O	O
psychological	O	O	B-T048
distress	O	O	B-T033
in	O	O	O
this	O	O	O
workforce	O	O	O
as	O	O	O
measured	O	O	O
by	O	O	O
the	O	O	O
Kessler-6	O	O	B-T170
scale	O	O	I-T170
to	O	O	O
assess	O	O	O
whether	O	O	O
distress	O	O	O
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
recent	O	O	O
occupational	O	O	B-T037
injury	O	O	B-T037
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	O
,	O	O	O
15.1	O	O	O
%	O	O	O
of	O	O	O
workers	O	O	B-T098
experienced	O	O	O
occupational	O	O	B-T037
injuries	O	O	I-T037
that	O	O	O
required	O	O	O
time	O	O	O
off	O	O	O
work	O	O	O
,	O	O	O
job	O	O	B-UnknownType
transfer	O	O	I-UnknownType
,	O	O	O
or	O	O	O
restriction	O	O	B-T079
during	O	O	I-T079
the	O	O	O
past	O	O	O
three	O	O	O
months	O	O	O
.	O	O	O

The	O	O	O
estimated	O	O	O
annual	O	O	B-T081
incidence	O	O	I-T081
rate	O	O	I-T081
was	O	O	O
15.2	O	O	O
injuries	O	O	B-T037
per	O	O	O
100	O	O	O
full-time	O	O	O
workers	O	O	B-T098
for	O	O	O
these	O	O	O
injuries	O	O	O
at	O	O	O
this	O	O	O
plant	O	O	B-T073
.	O	O	O

Rushing	O	O	O
was	O	O	O
identified	O	O	O
as	O	O	O
the	O	O	O
cause	O	O	O
of	O	O	O
nearly	O	O	O
50	O	O	O
%	O	O	O
of	O	O	O
injuries	O	O	B-T037
,	O	O	O
and	O	O	O
repetitive	O	O	O
work	O	O	O
as	O	O	O
the	O	O	O
cause	O	O	O
of	O	O	O
an	O	O	O
additional	O	O	O
20	O	O	O
%	O	O	O
of	O	O	O
injuries	O	O	O
.	O	O	O

Use	O	O	O
of	O	O	O
metal	O	O	B-T074
mesh	O	O	I-T074
sleeves	O	O	B-T074
(	O	O	O
POR	O	O	O
:	O	O	O
0.10	O	O	O
(	O	O	O
p	O	O	O
=	O	O	O
0.008	O	O	O
)	O	O	O
)	O	O	O
and	O	O	O
metal	O	O	O
mesh	O	O	O
gloves	O	O	B-T073
(	O	O	O
POR	O	O	O
:	O	O	O
0.41	O	O	O
(	O	O	O
p	O	O	O
=	O	O	O
0.05	O	O	O
)	O	O	O
were	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
reduced	O	O	O
risk	O	O	O
of	O	O	O
injury	O	O	B-T037
.	O	O	O

Use	O	O	O
of	O	O	O
a	O	O	O
carbon	O	O	B-T196
steel	O	O	B-T122
for	O	O	O
knife	O	O	B-T073
sharpening	O	O	O
(	O	O	O
POR	O	O	O
:	O	O	O
5.2	O	O	O
(	O	O	O
p	O	O	O
=	O	O	O
0.02	O	O	O
)	O	O	O
)	O	O	O
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
elevated	O	O	O
risk	O	O	O
of	O	O	O
moderate	O	O	B-T080
and	O	O	I-T080
severe	O	O	I-T080
injury	O	O	B-T037
.	O	O	O

There	O	O	O
were	O	O	O
no	O	O	O
associations	O	O	O
between	O	O	O
self-reported	O	O	B-T062
occupational	O	O	B-T037
injury	O	O	I-T037
and	O	O	O
overall	O	O	O
measures	O	O	O
of	O	O	O
psychological	O	O	B-T048
distress	O	O	I-T048
.	O	O	O

Self-reported	O	O	B-T062
incidence	O	O	B-T081
rate	O	O	I-T081
of	O	O	O
severe	O	O	B-T080
injury	O	O	B-T037
in	O	O	O
this	O	O	O
plant	O	O	O
was	O	O	O
more	O	O	O
than	O	O	O
twice	O	O	O
official	O	O	O
industry	O	O	B-T081
estimates	O	O	I-T081
.	O	O	O

Worker	O	O	O
self-reports	O	O	B-T062
may	O	O	O
illustrate	O	O	O
key	O	O	O
areas	O	O	O
for	O	O	O
injury	O	O	B-T061
prevention	O	O	I-T061
.	O	O	O

-DOCSTART- (27717775)

The	O	O	O
Effect	O	O	B-T080
of	O	O	O
l-Arginine	O	O	B-T116
on	O	O	O
Dural	O	O	B-T023
Healing	O	O	I-T040
After	O	O	O
Experimentally	O	O	O
Induced	O	O	B-T169
Dural	O	O	O
Defect	O	O	B-T169
in	O	O	O
a	O	O	O
Rat	O	O	B-T015
Model	O	O	O

Incomplete	O	O	B-T080
repair	O	O	B-T040
of	O	O	O
the	O	O	O
dura	O	O	B-T023
mater	O	O	I-T023
may	O	O	O
result	O	O	B-T169
in	O	O	O
numerous	O	O	B-T081
complications	O	O	B-T046
such	O	O	O
as	O	O	O
cerebrospinal	O	O	B-T047
fluid	O	O	I-T047
leakage	O	O	I-T047
and	O	O	O
meningitis	O	O	B-T047
.	O	O	O

For	O	O	O
this	O	O	O
reason	O	O	O
,	O	O	O
accurate	O	O	B-T080
repair	O	O	B-T040
of	O	O	O
the	O	O	O
dura	O	O	B-T023
mater	O	O	I-T023
is	O	O	O
essential	O	O	B-T080
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	O
,	O	O	O
the	O	O	O
effect	O	O	B-T080
of	O	O	O
systemic	O	O	B-T169
and	O	O	O
local	O	O	B-T082
supplementation	O	O	B-T169
of	O	O	O
l-arginine	O	O	B-T116
on	O	O	O
dural	O	O	B-T040
healing	O	O	I-T040
was	O	O	O
evaluated	O	O	O
.	O	O	O

Thirty	O	O	O
male	O	O	B-T032
Wistar	O	O	B-T015
rats	O	O	B-T015
were	O	O	O
used	O	O	O
and	O	O	O
divided	O	O	B-T169
into	O	O	O
control	O	O	B-T096
,	O	O	O
local	O	O	B-T082
,	O	O	O
and	O	O	O
systemic	O	O	B-T169
l-arginine	O	O	B-T116
groups	O	O	B-T078
,	O	O	O
with	O	O	O
10	O	O	O
rats	O	O	O
in	O	O	O
each	O	O	O
.	O	O	O

In	O	O	O
each	O	O	O
group	O	O	B-T078
,	O	O	O
a	O	O	O
5-mm	O	O	O
experimental	O	O	B-T061
incision	O	O	I-T061
was	O	O	O
made	O	O	O
at	O	O	O
the	O	O	O
lumbar	O	O	B-T029
segment	O	O	I-T029
of	O	O	I-T029
the	O	O	I-T029
dura	O	O	I-T029
mater	O	O	I-T029
and	O	O	O
cerebrospinal	O	O	B-T047
fluid	O	O	I-T047
leakage	O	O	I-T047
was	O	O	O
induced	O	O	B-T169
.	O	O	O

Each	O	O	O
group	O	O	B-T078
was	O	O	O
divided	O	O	B-T169
into	O	O	O
2	O	O	O
subgroups	O	O	B-T185
and	O	O	O
at	O	O	O
the	O	O	O
end	O	O	O
of	O	O	O
the	O	O	O
first	O	O	O
and	O	O	O
sixth	O	O	O
weeks	O	O	B-T079
,	O	O	O
the	O	O	O
rats	O	O	B-T015
were	O	O	O
killed	O	O	B-T058
and	O	O	O
the	O	O	O
damaged	O	O	B-T169
segments	O	O	B-T082
of	O	O	O
the	O	O	O
dura	O	O	B-T023
were	O	O	O
separated	O	O	B-T080
,	O	O	O
histologically	O	O	B-T169
evaluated	O	O	O
and	O	O	O
the	O	O	O
dural	O	O	B-T040
healing	O	O	I-T040
indicators	O	O	B-T169
including	O	O	O
cell	O	O	B-T025
types	O	O	I-T025
,	O	O	O
granulation	O	O	B-T024
tissue	O	O	I-T024
formation	O	O	B-T169
,	O	O	O
collagen	O	O	B-T116
deposit	O	O	B-T169
,	O	O	O
and	O	O	O
vascularization	O	O	B-T169
were	O	O	O
compared	O	O	B-T052
between	O	O	O
groups	O	O	B-T078
.	O	O	O

The	O	O	O
systematic	O	O	B-T169
supplementation	O	O	B-T169
of	O	O	O
l-arginine	O	O	B-T116
showed	O	O	O
a	O	O	O
significant	O	O	B-T078
effect	O	O	B-T080
in	O	O	O
dural	O	O	B-T040
healing	O	O	I-T040
compared	O	O	B-T052
with	O	O	O
the	O	O	O
control	O	O	B-T096
group	O	O	I-T096
.	O	O	O

After	O	O	O
the	O	O	O
first	O	O	O
week	O	O	B-T079
,	O	O	O
granulation	O	O	B-T024
formation	O	O	B-T169
increased	O	O	B-T081
considerably	O	O	O
(	O	O	O
P	O	O	O
<	O	O	O
0.031	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
after	O	O	O
6	O	O	O
weeks	O	O	B-T079
,	O	O	O
collagen	O	O	B-T116
deposition	O	O	B-T169
and	O	O	O
neovascularization	O	O	B-T046
were	O	O	O
significantly	O	O	O
different	O	O	B-T080
compared	O	O	B-T052
with	O	O	O
the	O	O	O
control	O	O	B-T096
group	O	O	I-T096
(	O	O	O
P	O	O	O
<	O	O	O
0.030	O	O	O
;	O	O	O
P	O	O	O
<	O	O	O
0.009	O	O	O
)	O	O	O
.	O	O	O

In	O	O	O
comparison	O	O	B-T052
between	O	O	O
different	O	O	B-T080
groups	O	O	B-T078
at	O	O	O
the	O	O	O
end	O	O	O
of	O	O	O
the	O	O	O
first	O	O	O
and	O	O	O
sixth	O	O	O
weeks	O	O	B-T079
,	O	O	O
maximum	O	O	B-T081
changes	O	O	B-T169
in	O	O	O
healing	O	O	B-T040
indicators	O	O	B-T169
were	O	O	O
observed	O	O	B-T169
in	O	O	O
the	O	O	O
systemic	O	O	B-T169
group	O	O	B-T078
and	O	O	O
the	O	O	O
least	O	O	O
variations	O	O	B-T080
were	O	O	O
related	O	O	O
to	O	O	O
the	O	O	O
control	O	O	B-T096
group	O	O	I-T096
.	O	O	O

The	O	O	O
systemic	O	O	B-T169
supplementation	O	O	B-T169
of	O	O	O
l-arginine	O	O	B-T116
may	O	O	O
accelerate	O	O	B-T169
dural	O	O	B-T040
healing	O	O	I-T040
by	O	O	O
increasing	O	O	B-T169
the	O	O	O
level	O	O	B-T080
of	O	O	O
granulation	O	O	B-T024
tissue	O	O	I-T024
formation	O	O	B-T169
,	O	O	O
collagen	O	O	B-T116
deposition	O	O	B-T169
,	O	O	O
and	O	O	O
vascularization	O	O	B-T169
.	O	O	O

-DOCSTART- (27722201)

Birth	O	O	B-T058
Preparedness	O	O	I-T058
and	O	O	I-T058
Complication	O	O	I-T058
Readiness	O	O	I-T058
Practice	O	O	I-T058
and	O	O	O
Associated	O	O	B-T080
Factors	O	O	B-T169
among	O	O	O
Pregnant	O	O	B-T098
Women	O	O	I-T098
,	O	O	O
Northwest	O	O	O
Ethiopia	O	O	O

Background	O	O	O
.	O	O	O

Little	O	O	O
is	O	O	O
known	O	O	O
about	O	O	O
birth	O	O	B-T058
preparedness	O	O	I-T058
and	O	O	I-T058
complication	O	O	I-T058
readiness	O	O	I-T058
(	O	O	O
BPCR	O	O	B-T058
)	O	O	O
plan	O	O	B-T169
in	O	O	O
resource	O	O	O
limited	O	O	O
settings	O	O	O
to	O	O	O
decrease	O	O	O
maternal	O	O	B-T081
mortality	O	O	I-T081
.	O	O	O

Therefore	O	O	O
,	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
done	O	O	O
to	O	O	O
assess	O	O	B-T058
the	O	O	O
status	O	O	B-T080
of	O	O	O
BPCR	O	O	B-T058
and	O	O	O
associated	O	O	B-T080
factors	O	O	B-T169
among	O	O	O
pregnant	O	O	B-T098
women	O	O	I-T098
in	O	O	O
South	O	O	B-T083
Wollo	O	O	I-T083
,	O	O	O
Northwest	O	O	B-T083
Ethiopia	O	O	I-T083
,	O	O	O
by	O	O	O
involving	O	O	O
819	O	O	O
pregnant	O	O	O
women	O	O	O
from	O	O	O
March	O	O	O
to	O	O	O
April	O	O	O
,	O	O	O
2014	O	O	O
.	O	O	O

Data	O	O	B-T078
were	O	O	O
collected	O	O	O
by	O	O	O
using	O	O	O
pretested	O	O	O
interviewer	O	O	B-T097
administered	O	O	B-T170
questionnaire	O	O	I-T170
and	O	O	O
analyzed	O	O	B-T062
using	O	O	O
a	O	O	O
computer	O	O	B-T073
program	O	O	I-T073
of	O	O	O
SPSS	O	O	B-T170
version	O	O	I-T170
20.00	O	O	I-T170
.	O	O	O

Results	O	O	B-T169
.	O	O	O

Pregnant	O	O	B-T098
women	O	O	I-T098
who	O	O	O
were	O	O	O
prepared	O	O	B-T033
for	O	O	O
at	O	O	O
least	O	O	O
three	O	O	O
elements	O	O	B-T077
of	O	O	O
BPCR	O	O	B-T058
were	O	O	O
24.1	O	O	O
%	O	O	O
.	O	O	O

Pregnant	O	O	B-T098
women	O	O	I-T098
knowing	O	O	O
at	O	O	O
least	O	O	O
three	O	O	O
key	O	O	O
danger	O	O	B-T184
signs	O	O	I-T184
during	O	O	O
pregnancy	O	O	B-T040
,	O	O	O
delivery	O	O	B-T040
,	O	O	O
and	O	O	O
postnatal	O	O	B-T079
period	O	O	I-T079
were	O	O	O
23.2	O	O	O
%	O	O	O
,	O	O	O
22.6	O	O	O
%	O	O	O
,	O	O	O
and	O	O	O
9.6	O	O	O
%	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

Women	O	O	B-T098
having	O	O	O
secondary	O	O	B-T170
education	O	O	I-T170
and	O	O	O
higher	O	O	O
were	O	O	O
6.20	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
=	O	O	O
[	O	O	O
1.36	O	O	O
,	O	O	O
28.120	O	O	O
]	O	O	O
)	O	O	O
times	O	O	O
more	O	O	O
likely	O	O	O
to	O	O	O
be	O	O	O
prepared	O	O	B-T033
than	O	O	O
illiterates	O	O	B-T033
.	O	O	O

Women	O	O	B-T098
having	O	O	O
a	O	O	O
lifetime	O	O	B-T032
history	O	O	I-T032
of	O	O	O
stillbirth	O	O	B-T033
[	O	O	O
5.80	O	O	O
(	O	O	O
1.13	O	O	O
,	O	O	O
29.63	O	O	O
)	O	O	O
]	O	O	O
,	O	O	O
attending	O	O	B-T169
ANC	O	O	B-T058
for	O	O	O
last	O	O	O
child	O	O	B-T100
pregnancy	O	O	B-T040
[	O	O	O
5.44	O	O	O
(	O	O	O
2.07	O	O	O
,	O	O	O
14.27	O	O	O
)	O	O	O
]	O	O	O
,	O	O	O
participating	O	O	B-T169
in	O	O	O
community	O	O	B-T096
BPCR	O	O	B-T058
group	O	O	B-T054
discussion	O	O	I-T054
[	O	O	O
4.36	O	O	O
(	O	O	O
1.17	O	O	O
,	O	O	O
16.26	O	O	O
)	O	O	O
]	O	O	O
,	O	O	O
and	O	O	O
having	O	O	O
their	O	O	O
male	O	O	B-T032
partner	O	O	B-T099
involved	O	O	O
in	O	O	O
BPCR	O	O	O
counseling	O	O	B-T058
during	O	O	O
ANC	O	O	O
follow-up	O	O	B-T058
[	O	O	O
4.45	O	O	O
(	O	O	O
1.95	O	O	O
,	O	O	O
10.16	O	O	O
)	O	O	O
]	O	O	O
were	O	O	O
more	O	O	O
likely	O	O	O
to	O	O	O
be	O	O	O
prepared	O	O	B-T033
.	O	O	O

Conclusions	O	O	B-T078
.	O	O	O

BPCR	O	O	B-T058
was	O	O	O
very	O	O	O
low	O	O	O
and	O	O	O
should	O	O	O
be	O	O	O
strengthened	O	O	O
through	O	O	O
health	O	O	B-T058
communication	O	O	I-T058
by	O	O	O
involving	O	O	O
partner	O	O	B-T099
in	O	O	O
BPCR	O	O	O
counseling	O	O	B-T058
.	O	O	O

-DOCSTART- (27722881)

Fluoranthene	O	O	B-T109
degradation	O	O	B-T070
and	O	O	O
binding	O	O	B-T044
mechanism	O	O	B-T169
study	O	O	B-T062
based	O	O	O
on	O	O	O
the	O	O	O
active-site	O	O	B-T169
structure	O	O	B-T082
of	O	O	O
ring-hydroxylating	O	O	B-T116
dioxygenase	O	O	I-T116
in	O	O	O
Microbacterium	O	O	O
paraoxydans	O	O	O
JPM1	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
a	O	O	O
gram-positive	O	O	B-T007
fluoranthene-degrading	O	O	I-T007
bacterial	O	O	I-T007
strain	O	O	B-T001
was	O	O	O
isolated	O	O	B-T169
from	O	O	O
crude	O	O	B-T109
oil	O	O	I-T109
in	O	O	O
Dagang	O	O	B-T070
Oilfield	O	O	I-T070
and	O	O	O
identified	O	O	B-T080
as	O	O	O
Microbacterium	O	O	B-T007
paraoxydans	O	O	I-T007
JPM1	O	O	I-T007
by	O	O	O
the	O	O	O
analysis	O	O	B-T062
of	O	O	O
16S	O	O	B-T114
rDNA	O	O	I-T114
sequence	O	O	B-T086
.	O	O	O

After	O	O	O
25	O	O	O
days	O	O	B-T079
of	O	O	O
incubation	O	O	B-T059
,	O	O	O
the	O	O	O
strain	O	O	B-T001
JPM1	O	O	B-T007
could	O	O	O
degrade	O	O	O
91.78	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
initial	O	O	B-T079
amount	O	O	B-T081
of	O	O	O
fluoranthene	O	O	B-T109
.	O	O	O

Moreover	O	O	O
,	O	O	O
four	O	O	O
metabolites	O	O	B-T123
9-fluorenone-1-carboxylic	O	O	B-T123
acid	O	O	I-T123
,	O	O	O
9-fluorenone	O	O	B-T109
,	O	O	O
phthalic	O	O	B-T109
acid	O	O	I-T109
,	O	O	O
and	O	O	O
benzoic	O	O	B-T109
acid	O	O	I-T109
were	O	O	O
detected	O	O	O
in	O	O	O
the	O	O	O
culture	O	O	B-T130
solution	O	O	I-T130
.	O	O	O

The	O	O	O
gene	O	O	B-T086
sequence	O	O	I-T086
encoding	O	O	B-T052
the	O	O	O
aromatic-ring-hydroxylating	O	O	B-T116
dioxygenase	O	O	I-T116
was	O	O	O
amplified	O	O	B-T045
in	O	O	O
the	O	O	O
strain	O	O	B-T001
JPM1	O	O	B-T007
by	O	O	O
PCR	O	O	B-T063
.	O	O	O

Based	O	O	O
on	O	O	O
the	O	O	O
translated	O	O	O
protein	O	O	B-T087
sequence	O	O	I-T087
,	O	O	O
a	O	O	O
homology	O	O	B-T063
modeling	O	O	I-T063
method	O	O	I-T063
was	O	O	O
applied	O	O	O
to	O	O	O
build	O	O	O
the	O	O	O
crystal	O	O	B-T104
structure	O	O	I-T104
of	O	O	O
dioxygenase	O	O	B-T116
.	O	O	O

Subsequently	O	O	O
,	O	O	O
the	O	O	O
interaction	O	O	B-T169
mechanism	O	O	B-T169
between	O	O	O
fluoranthene	O	O	B-T109
and	O	O	O
the	O	O	O
active	O	O	B-T169
site	O	O	I-T169
of	O	O	O
dioxygenase	O	O	B-T116
was	O	O	O
simulated	O	O	B-T062
and	O	O	O
analyzed	O	O	B-T062
by	O	O	O
molecular	O	O	B-T063
docking	O	O	I-T063
.	O	O	O

Consequently	O	O	O
,	O	O	O
a	O	O	O
feasible	O	O	O
degrading	O	O	B-T070
pathway	O	O	B-T044
of	O	O	O
fluoranthene	O	O	B-T109
in	O	O	O
the	O	O	O
strain	O	O	B-T001
JPM1	O	O	B-T007
was	O	O	O
proposed	O	O	O
based	O	O	O
on	O	O	O
the	O	O	O
metabolites	O	O	B-T123
and	O	O	O
the	O	O	O
interaction	O	O	B-T081
analyses	O	O	I-T081
.	O	O	O

Additionally	O	O	O
,	O	O	O
the	O	O	O
thermodynamic	O	O	B-T062
analysis	O	O	I-T062
showed	O	O	O
that	O	O	O
the	O	O	O
strain	O	O	B-T001
JPM1	O	O	B-T007
had	O	O	O
high	O	O	B-T080
tolerance	O	O	B-T080
for	O	O	O
fluoranthene	O	O	B-T109
,	O	O	O
and	O	O	O
the	O	O	O
influence	O	O	B-T077
of	O	O	O
fluoranthene	O	O	O
for	O	O	O
the	O	O	O
bacterial	O	O	B-T007
growth	O	O	B-T040
activity	O	O	O
was	O	O	O
negligible	O	O	B-T080
under	O	O	O
100	O	O	O
to	O	O	O
400	O	O	O
mg	O	O	O
L(-1	O	O	O
)	O	O	O
concentrations	O	O	B-T081
.	O	O	O

Taken	O	O	O
together	O	O	O
,	O	O	O
this	O	O	O
study	O	O	B-T062
indicates	O	O	O
that	O	O	O
the	O	O	O
strain	O	O	B-T001
JPM1	O	O	B-T007
has	O	O	O
high	O	O	O
potential	O	O	B-T080
for	O	O	O
further	O	O	O
study	O	O	O
in	O	O	O
bioremediation	O	O	B-T069
of	O	O	O
polycyclic	O	O	B-T109
aromatic	O	O	I-T109
hydrocarbon	O	O	I-T109
(PAH)-	O	O	O
contaminated	O	O	B-T169
sites	O	O	B-T082
.	O	O	O

-DOCSTART- (27723907)

Ultrasonography	O	O	B-T060
for	O	O	O
acute	O	O	B-T047
appendicitis	O	O	I-T047
-	O	O	O
the	O	O	O
way	O	O	O
it	O	O	O
looks	O	O	O
today	O	O	O

Despite	O	O	O
sophisticated	O	O	O
physical	O	O	B-T058
examination	O	O	I-T058
and	O	O	O
laboratory	O	O	B-T059
support	O	O	I-T059
,	O	O	O
diagnosis	O	O	B-T033
of	O	O	O
acute	O	O	B-T047
appendicitis	O	O	I-T047
remained	O	O	O
challenging	O	O	O
in	O	O	O
clinical	O	O	B-T057
practice	O	O	I-T057
with	O	O	O
a	O	O	O
negative	O	O	B-T061
appendectomy	O	O	I-T061
rate	O	O	B-T081
of	O	O	O
15	O	O	O
-	O	O	O
30	O	O	O
%	O	O	O
.	O	O	O

As	O	O	O
a	O	O	O
remarkable	O	O	O
clue	O	O	O
and	O	O	O
as	O	O	O
early	O	O	O
as	O	O	O
1986	O	O	O
,	O	O	O
ultrasonography	O	O	B-T060
(	O	O	O
US	O	O	B-T060
)	O	O	O
has	O	O	O
been	O	O	O
proven	O	O	O
a	O	O	O
reliable	O	O	B-T170
diagnostic	O	O	B-T060
method	O	O	I-T060
that	O	O	O
is	O	O	O
also	O	O	O
explicitly	O	O	O
helpful	O	O	O
in	O	O	O
difficult	O	O	O
cases	O	O	O
with	O	O	O
atypical	O	O	B-T080
presentation	O	O	B-T078
and	O	O	O
enables	O	O	O
to	O	O	O
rule	O	O	B-T169
out	O	O	I-T169
many	O	O	O
differential	O	O	B-T060
diagnoses	O	O	I-T060
.Recent	O	O	O
publications	O	O	B-T073
emphasized	O	O	O
the	O	O	O
role	O	O	O
of	O	O	O
multidetector	O	O	B-T060
computed	O	O	I-T060
tomography	O	O	I-T060
(	O	O	O
CT	O	O	B-T060
)	O	O	O
resulting	O	O	O
in	O	O	O
a	O	O	O
significant	O	O	O
reduction	O	O	O
of	O	O	O
false	O	O	B-T034
negative	O	O	I-T034
findings	O	O	I-T034
at	O	O	O
operation	O	O	B-T061
.	O	O	O

Extensive	O	O	B-T080
as	O	O	O
well	O	O	O
as	O	O	O
uncritical	O	O	B-T061
application	O	O	I-T061
of	O	O	O
this	O	O	O
method	O	O	O
even	O	O	O
in	O	O	O
children	O	O	B-T100
inevitably	O	O	O
causes	O	O	O
substantial	O	O	O
radiation	O	O	B-T037
exposure	O	O	I-T037
,	O	O	O
a	O	O	O
sequel	O	O	O
to	O	O	O
either	O	O	O
pure	O	O	O
ignorance	O	O	O
or	O	O	O
unqualified/	O	O	O
inadequate	O	O	B-T080
performance	O	O	B-T052
of	O	O	O
US	O	O	B-T060
in	O	O	O
this	O	O	O
particular	O	O	O
situation	O	O	O
,	O	O	O
which	O	O	O
in	O	O	O
turn	O	O	O
can	O	O	O
be	O	O	O
considered	O	O	O
sequel	O	O	O
to	O	O	O
either	O	O	O
egocentric	O	O	B-T033
or	O	O	O
economic	O	O	B-T169
preponderance	O	O	B-T081
.Recent	O	O	O
data	O	O	O
shed	O	O	O
new	O	O	O
light	O	O	O
on	O	O	O
the	O	O	O
role	O	O	O
of	O	O	O
US	O	O	O
(	O	O	O
and	O	O	O
CT	O	O	B-T060
)	O	O	O
in	O	O	O
acute	O	O	B-T047
appendicitis	O	O	I-T047
.	O	O	O

Therefore	O	O	O
,	O	O	O
1	O	O	O
generation	O	O	O
after	O	O	O
US	O	O	B-T060
with	O	O	I-T060
graded	O	O	I-T060
compression	O	O	I-T060
was	O	O	O
etched	O	O	O
in	O	O	O
stone	O	O	O
as	O	O	O
the	O	O	O
method	O	O	O
of	O	O	O
choice	O	O	O
for	O	O	O
diagnosing	O	O	B-T033
acute	O	O	B-T047
appendicitis	O	O	I-T047
(	O	O	O
Puylaert	O	O	O
)	O	O	O
,	O	O	O
a	O	O	O
visual	O	O	B-T169
arousal	O	O	B-T041
fostering	O	O	B-T056
its	O	O	O
role	O	O	O
and	O	O	O
performance	O	O	O
in	O	O	O
clinical	O	O	B-T091
medicine	O	O	I-T091
appears	O	O	O
justified	O	O	O
.	O	O	O

-DOCSTART- (27724977)

Mesenchymal	O	O	B-T025
stem	O	O	B-T025
cells	O	O	I-T025
enhance	O	O	B-T052
the	O	O	O
oncolytic	O	O	B-T080
effect	O	O	B-T080
of	O	O	O
Newcastle	O	O	B-T005
disease	O	O	I-T005
virus	O	O	I-T005
in	O	O	O
glioma	O	O	B-T191
cells	O	O	O
and	O	O	O
glioma	O	O	O
stem	O	O	O
cells	O	O	O
via	O	O	O
the	O	O	O
secretion	O	O	B-T038
of	O	O	O
TRAIL	O	O	O

Newcastle	O	O	B-T005
disease	O	O	I-T005
virus	O	O	I-T005
(	O	O	O
NDV	O	O	B-T005
)	O	O	O
is	O	O	O
an	O	O	O
avian	O	O	B-T005
paramyxovirus	O	O	I-T005
,	O	O	O
which	O	O	O
selectively	O	O	O
exerts	O	O	B-T040
oncolytic	O	O	B-T080
effects	O	O	B-T080
in	O	O	O
cancer	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

Mesenchymal	O	O	B-T025
stem	O	O	I-T025
cells	O	O	I-T025
(	O	O	O
MSCs	O	O	B-T025
)	O	O	O
have	O	O	O
been	O	O	O
reported	O	O	O
to	O	O	O
affect	O	O	O
tumor	O	O	B-T191
growth	O	O	I-T191
and	O	O	O
deliver	O	O	B-T169
anti-tumor	O	O	B-T109
agents	O	O	I-T109
to	O	O	O
experimental	O	O	B-T080
glioblastoma	O	O	B-T191
(	O	O	O
GBM	O	O	B-T191
)	O	O	O
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
explored	O	O	O
the	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
NDV	O	O	B-T005
-	O	O	O
infected	O	O	B-T033
MSCs	O	O	B-T025
derived	O	O	O
from	O	O	O
different	O	O	O
sources	O	O	B-T033
,	O	O	O
on	O	O	O
glioma	O	O	B-T191
cells	O	O	B-T025
and	O	O	O
glioma	O	O	O
stem	O	O	B-T025
cells	O	O	I-T025
(	O	O	O
GSCs	O	O	B-T025
)	O	O	O
and	O	O	O
the	O	O	O
mechanisms	O	O	B-T169
involved	O	O	O
in	O	O	O
their	O	O	O
effects	O	O	O
.	O	O	O

The	O	O	O
glioma	O	O	B-T191
cell	O	O	B-T025
lines	O	O	I-T025
(	O	O	O
A172	O	O	B-T025
and	O	O	O
U87	O	O	B-T025
)	O	O	O
and	O	O	O
primary	O	O	B-T080
GSCs	O	O	B-T025
that	O	O	O
were	O	O	O
generated	O	O	B-T052
from	O	O	O
GBM	O	O	B-T191
tumors	O	O	B-T191
were	O	O	O
used	O	O	O
in	O	O	O
this	O	O	O
study	O	O	B-T062
.	O	O	O

MSCs	O	O	B-T025
derived	O	O	B-T080
from	O	O	O
bone	O	O	B-T024
marrow	O	O	I-T024
,	O	O	O
adipose	O	O	B-T024
tissue	O	O	I-T024
or	O	O	O
umbilical	O	O	B-T018
cord	O	O	I-T018
were	O	O	O
infected	O	O	B-T033
with	O	O	O
NDV	O	O	B-T005
(	O	O	O
MTH-68/H	O	O	B-T061
)	O	O	O
.	O	O	O

The	O	O	O
ability	O	O	B-T032
of	O	O	O
these	O	O	O
cells	O	O	B-T025
to	O	O	O
deliver	O	O	B-T169
the	O	O	O
virus	O	O	B-T005
to	O	O	O
glioma	O	O	B-T191
cell	O	O	B-T025
lines	O	O	I-T025
and	O	O	O
GSCs	O	O	B-T025
and	O	O	O
the	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
NDV	O	O	B-T005
-	O	O	O
infected	O	O	B-T033
MSCs	O	O	B-T025
on	O	O	O
cell	O	O	B-T043
death	O	O	I-T043
and	O	O	O
on	O	O	O
the	O	O	O
stemness	O	O	B-T080
and	O	O	O
self-renewal	O	O	B-T043
of	O	O	O
GSCs	O	O	O
were	O	O	O
examined	O	O	B-T033
.	O	O	O

The	O	O	O
mechanisms	O	O	B-T169
involved	O	O	B-T169
in	O	O	O
the	O	O	O
cytotoxic	O	O	B-T169
effects	O	O	B-T080
of	O	O	I-T080
the	O	O	O
NDV	O	O	B-T005
-	O	O	O
infected	O	O	B-T033
MSCs	O	O	B-T025
and	O	O	O
their	O	O	O
influence	O	O	B-T077
on	O	O	O
the	O	O	O
radiation	O	O	B-T032
sensitivity	O	O	I-T032
of	O	O	O
GSCs	O	O	B-T025
were	O	O	O
examined	O	O	B-T033
as	O	O	O
well	O	O	O
.	O	O	O

NDV	O	O	B-T005
induced	O	O	B-T169
a	O	O	O
dose-dependent	O	O	B-T081
cell	O	O	B-T043
death	O	O	I-T043
in	O	O	O
glioma	O	O	B-T191
cells	O	O	B-T025
and	O	O	O
a	O	O	O
low	O	O	B-T080
level	O	O	B-T080
of	O	O	O
apoptosis	O	O	B-T043
and	O	O	O
inhibition	O	O	B-T052
of	O	O	O
self-renewal	O	O	B-T043
in	O	O	O
GSCs	O	O	B-T025
.	O	O	O

MSCs	O	O	B-T025
derived	O	O	B-T080
from	O	O	O
bone	O	O	B-T024
marrow	O	O	I-T024
,	O	O	O
adipose	O	O	B-T024
and	O	O	O
umbilical	O	O	B-T018
cord	O	O	I-T018
that	O	O	O
were	O	O	O
infected	O	O	B-T033
with	O	O	O
NDV	O	O	B-T005
delivered	O	O	B-T169
the	O	O	O
virus	O	O	B-T005
to	O	O	O
co-cultured	O	O	B-T059
glioma	O	O	B-T191
cells	O	O	B-T025
and	O	O	O
GSCs	O	O	B-T025
.	O	O	O

Conditioned	O	O	B-T130
medium	O	O	I-T130
of	O	O	O
NDV	O	O	B-T005
-	O	O	O
infected	O	O	B-T033
MSCs	O	O	B-T025
induced	O	O	B-T169
higher	O	O	B-T080
level	O	O	B-T080
of	O	O	O
apoptosis	O	O	B-T043
in	O	O	O
the	O	O	O
tumor	O	O	B-T025
cells	O	O	I-T025
compared	O	O	B-T052
with	O	O	O
the	O	O	O
apoptosis	O	O	O
induced	O	O	O
by	O	O	O
their	O	O	O
direct	O	O	B-T047
infection	O	O	I-T047
with	O	O	O
similar	O	O	B-T080
virus	O	O	B-T081
titers	O	O	I-T081
.	O	O	O

These	O	O	O
results	O	O	B-T033
suggest	O	O	B-T078
that	O	O	O
factor(s	O	O	B-T169
)	O	O	I-T169
secreted	O	O	B-T043
by	O	O	O
the	O	O	O
infected	O	O	B-T033
MSCs	O	O	B-T025
sensitized	O	O	B-T025
the	O	O	O
glioma	O	O	B-T191
cells	O	O	B-T025
to	O	O	O
the	O	O	O
cytotoxic	O	O	B-T169
effects	O	O	B-T080
of	O	O	I-T080
NDV	O	O	B-T005
.	O	O	O

We	O	O	O
identified	O	O	B-T080
TRAIL	O	O	B-T116
as	O	O	O
a	O	O	O
mediator	O	O	B-T080
of	O	O	O
the	O	O	O
cytotoxic	O	O	B-T169
effects	O	O	B-T080
of	O	O	I-T080
the	O	O	O
infected	O	O	B-T033
MSCs	O	O	B-T025
and	O	O	O
demonstrated	O	O	B-T080
that	O	O	O
TRAIL	O	O	O
synergized	O	O	O
with	O	O	O
NDV	O	O	B-T005
in	O	O	O
the	O	O	O
induction	O	O	B-T169
of	O	O	O
cell	O	O	B-T043
death	O	O	I-T043
in	O	O	O
glioma	O	O	B-T191
cells	O	O	B-T025
and	O	O	O
GSCs	O	O	B-T025
.	O	O	O

Moreover	O	O	O
,	O	O	O
conditioned	O	O	B-T080
medium	O	O	B-T081
of	O	O	O
infected	O	O	B-T033
MSCs	O	O	B-T025
enhanced	O	O	B-T052
the	O	O	O
sensitivity	O	O	O
of	O	O	O
GSCs	O	O	B-T025
to	O	O	O
Î³-radiation	O	O	B-T070
.	O	O	O

NDV	O	O	B-T005
-	O	O	O
infected	O	O	B-T033
umbilical	O	O	B-T018
cord	O	O	I-T018
-	O	O	O
derived	O	O	B-T080
MSCs	O	O	B-T025
may	O	O	O
provide	O	O	O
a	O	O	O
novel	O	O	B-T080
effective	O	O	B-T080
therapeutic	O	O	B-T169
approach	O	O	B-T082
for	O	O	O
targeting	O	O	B-T169
GSCs	O	O	B-T025
and	O	O	O
GBM	O	O	B-T191
and	O	O	O
for	O	O	O
sensitizing	O	O	O
these	O	O	O
tumors	O	O	B-T191
to	O	O	O
Î³-radiation	O	O	B-T070
.	O	O	O

-DOCSTART- (27727312)

Importance	O	O	B-T080
of	O	O	O
Ecological	O	O	B-T077
Factors	O	O	I-T077
and	O	O	O
Colony	O	O	B-T078
Handling	O	O	B-T033
for	O	O	O
Optimizing	O	O	B-T052
Health	O	O	B-T080
Status	O	O	I-T080
of	O	O	O
Apiaries	O	O	B-T073
in	O	O	O
Mediterranean	O	O	B-T098
Ecosystems	O	O	O

We	O	O	O
analyzed	O	O	B-T062
six	O	O	O
apiaries	O	O	B-T073
in	O	O	O
several	O	O	O
natural	O	O	B-T082
environments	O	O	I-T082
with	O	O	O
a	O	O	O
Mediterranean	O	O	B-T098
ecosystem	O	O	B-T070
in	O	O	O
Madrid	O	O	B-T083
,	O	O	O
central	O	O	B-T083
Spain	O	O	I-T083
,	O	O	O
in	O	O	O
order	O	O	O
to	O	O	O
understand	O	O	B-T041
how	O	O	O
landscape	O	O	B-T082
and	O	O	O
management	O	O	B-T170
characteristics	O	O	B-T080
may	O	O	O
influence	O	O	B-T077
apiary	O	O	B-T073
health	O	O	B-T078
and	O	O	O
bee	O	O	B-T204
production	O	O	O
in	O	O	O
the	O	O	O
long	O	O	B-T079
term	O	O	I-T079
.	O	O	O

We	O	O	O
focused	O	O	B-T169
on	O	O	O
five	O	O	O
criteria	O	O	B-T078
(	O	O	O
habitat	O	O	B-T082
quality	O	O	B-T080
,	O	O	O
landscape	O	O	B-T082
heterogeneity	O	O	B-T080
,	O	O	O
climate	O	O	B-T070
,	O	O	O
management	O	O	B-T170
and	O	O	O
health	O	O	B-T078
)	O	O	O
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
30	O	O	O
subcriteria	O	O	B-T078
,	O	O	O
and	O	O	O
we	O	O	O
used	O	O	O
the	O	O	O
analytic	O	O	B-T062
hierarchy	O	O	I-T062
process	O	O	I-T062
(	O	O	O
AHP	O	O	B-T062
)	O	O	O
to	O	O	O
rank	O	O	B-T170
them	O	O	O
according	O	O	O
to	O	O	O
relevance	O	O	B-T080
.	O	O	O

Habitat	O	O	B-T082
quality	O	O	B-T080
proved	O	O	O
to	O	O	O
have	O	O	O
the	O	O	O
highest	O	O	O
relevance	O	O	B-T080
,	O	O	O
followed	O	O	O
by	O	O	O
beehive	O	O	B-T073
management	O	O	B-T170
.	O	O	O

Within	O	O	O
habitat	O	O	B-T082
quality	O	O	B-T080
,	O	O	O
the	O	O	O
following	O	O	O
subcriteria	O	O	B-T078
proved	O	O	O
to	O	O	O
be	O	O	O
most	O	O	O
relevant	O	O	B-T080
:	O	O	O
orographic	O	O	B-T080
diversity	O	O	I-T080
,	O	O	O
elevation	O	O	B-T082
range	O	O	B-T081
and	O	O	O
important	O	O	B-T080
plant	O	O	B-T002
species	O	O	B-T185
located	O	O	B-T082
1.5	O	O	O
km	O	O	O
from	O	O	O
the	O	O	O
apiary	O	O	B-T073
.	O	O	O

The	O	O	O
most	O	O	O
important	O	O	B-T080
subcriteria	O	O	B-T078
under	O	O	O
beehive	O	O	B-T073
management	O	O	B-T170
were	O	O	O
honey	O	O	B-T168
production	O	O	B-T057
,	O	O	O
movement	O	O	O
of	O	O	O
the	O	O	O
apiary	O	O	B-T073
to	O	O	O
a	O	O	O
location	O	O	B-T082
with	O	O	O
a	O	O	O
higher	O	O	O
altitude	O	O	B-T081
and	O	O	O
wax	O	O	B-T122
renewal	O	O	B-T169
.	O	O	O

Temperature	O	O	B-T081
was	O	O	O
the	O	O	O
most	O	O	O
important	O	O	O
subcriterion	O	O	B-T078
under	O	O	O
climate	O	O	B-T070
,	O	O	O
while	O	O	O
pathogen	O	O	B-T001
and	O	O	O
Varroa	O	O	B-T204
loads	O	O	B-T033
were	O	O	O
the	O	O	O
most	O	O	O
significant	O	O	B-T078
under	O	O	O
health	O	O	B-T078
.	O	O	O

Two	O	O	O
of	O	O	O
the	O	O	O
six	O	O	O
apiaries	O	O	B-T073
showed	O	O	O
the	O	O	O
best	O	O	B-T081
values	O	O	I-T081
in	O	O	O
the	O	O	O
AHP	O	O	B-T062
analysis	O	O	B-T062
and	O	O	O
showed	O	O	O
annual	O	O	B-T079
honey	O	O	B-T168
production	O	O	B-T057
of	O	O	O
70	O	O	O
and	O	O	O
28	O	O	O
kg/	O	O	O
colony	O	O	B-T078
.	O	O	O

This	O	O	O
high	O	O	O
productivity	O	O	B-T081
was	O	O	O
due	O	O	O
primarily	O	O	O
to	O	O	O
high	O	O	O
elevation	O	O	B-T082
range	O	O	B-T081
and	O	O	O
high	O	O	O
orographic	O	O	B-T080
diversity	O	O	I-T080
,	O	O	O
which	O	O	O
favored	O	O	O
high	O	O	O
habitat	O	O	B-T082
quality	O	O	B-T080
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
one	O	O	O
of	O	O	O
these	O	O	O
apiaries	O	O	B-T073
showed	O	O	O
the	O	O	O
best	O	O	B-T081
value	O	O	I-T081
for	O	O	O
beehive	O	O	B-T073
management	O	O	B-T170
,	O	O	O
while	O	O	O
the	O	O	O
other	O	O	O
showed	O	O	O
the	O	O	O
best	O	O	O
value	O	O	O
for	O	O	O
health	O	O	B-T078
,	O	O	O
reflected	O	O	O
in	O	O	O
the	O	O	O
low	O	O	B-T080
pathogen	O	O	B-T001
load	O	O	B-T033
and	O	O	O
low	O	O	O
average	O	O	B-T081
number	O	O	B-T081
of	O	O	O
viruses	O	O	B-T005
.	O	O	O

These	O	O	O
results	O	O	B-T169
highlight	O	O	O
the	O	O	O
importance	O	O	B-T080
of	O	O	O
environmental	O	O	B-T077
factors	O	O	I-T077
and	O	O	O
good	O	O	O
sanitary	O	O	B-T169
practices	O	O	I-T169
to	O	O	O
maximize	O	O	O
apiary	O	O	B-T073
health	O	O	B-T078
and	O	O	O
honey	O	O	B-T168
productivity	O	O	B-T081
.	O	O	O

-DOCSTART- (27729085)

Chordoma	O	O	B-T191
dedifferentiation	O	O	I-T191
after	O	O	O
proton	O	O	B-T061
beam	O	O	I-T061
therapy	O	O	I-T061
:	O	O	O
a	O	O	O
case	O	O	B-T170
report	O	O	I-T170
and	O	O	O
review	O	O	O
of	O	O	O
the	O	O	O
literature	O	O	O

Chordoma	O	O	B-T191
is	O	O	O
a	O	O	O
rare	O	O	B-T080
invasive	O	O	B-T080
bone	O	O	B-T191
tumor	O	O	I-T191
that	O	O	O
may	O	O	O
occur	O	O	O
anywhere	O	O	O
along	O	O	O
the	O	O	O
neuraxis	O	O	B-T082
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
three	O	O	O
primary	O	O	B-T080
histological	O	O	B-T191
varieties	O	O	I-T191
have	O	O	O
been	O	O	O
identified	O	O	B-T080
:	O	O	O
conventional	O	O	B-T191
,	O	O	O
chondroid	O	O	B-T191
,	O	O	O
and	O	O	O
dedifferentiated	O	O	B-T191
.	O	O	O

We	O	O	O
report	O	O	B-T170
a	O	O	O
case	O	O	B-T077
of	O	O	O
an	O	O	O
8-year-old	O	O	O
white	O	O	B-T098
girl	O	O	B-T100
who	O	O	O
presented	O	O	O
with	O	O	O
conventional	O	O	B-T191
chordoma	O	O	I-T191
,	O	O	O
was	O	O	O
treated	O	O	B-T033
with	O	O	O
surgical	O	O	B-T061
resection	O	O	I-T061
and	O	O	O
mixed	O	O	B-T169
proton	O	O	B-T070
and	O	O	O
photon	O	O	B-T061
beam	O	O	I-T061
therapy	O	O	I-T061
,	O	O	O
and	O	O	O
had	O	O	O
a	O	O	O
recurrence	O	O	B-T067
in	O	O	O
the	O	O	O
resection	O	O	B-T020
cavity	O	O	I-T020
2.5	O	O	O
years	O	O	O
later	O	O	O
with	O	O	O
dedifferentiated	O	O	B-T191
morphology	O	O	I-T191
.	O	O	O

The	O	O	O
recurrent	O	O	B-T191
tumor	O	O	I-T191
did	O	O	O
not	O	O	O
express	O	O	B-T045
brachyury	O	O	B-T116
,	O	O	O
a	O	O	O
recently	O	O	B-T079
identified	O	O	B-T080
protein	O	O	B-T116
specific	O	O	B-T080
to	O	O	O
tissue	O	O	B-T024
of	O	O	O
notochordal	O	O	B-T018
origin	O	O	B-T079
.	O	O	O

The	O	O	O
short	O	O	B-T081
time	O	O	B-T079
period	O	O	I-T079
between	O	O	O
radiation	O	O	B-T061
therapy	O	O	I-T061
and	O	O	O
dedifferentiation	O	O	B-T043
,	O	O	O
low	O	O	B-T081
dose	O	O	I-T081
of	O	O	O
photons	O	O	B-T167
,	O	O	O
and	O	O	O
rarity	O	O	B-T080
of	O	O	O
dedifferentiated	O	O	B-T191
skull	O	O	I-T191
base	O	O	I-T191
chordomas	O	O	I-T191
in	O	O	O
pediatric	O	O	B-T080
patients	O	O	B-T101
should	O	O	O
alert	O	O	B-T169
clinicians	O	O	B-T097
to	O	O	O
the	O	O	O
possibility	O	O	B-T033
of	O	O	O
chordoma	O	O	B-T191
dedifferentiation	O	O	I-T191
after	O	O	O
proton	O	O	B-T061
beam	O	O	I-T061
therapy	O	O	I-T061
.	O	O	O

-DOCSTART- (27732552)

Volumetric	O	O	B-T060
absorptive	O	O	I-T060
microsampling	O	O	I-T060
at	O	O	O
home	O	O	B-T082
as	O	O	O
an	O	O	O
alternative	O	O	B-T077
tool	O	O	B-T073
for	O	O	O
the	O	O	O
monitoring	O	O	B-T058
of	O	O	O
HbA1c	O	O	B-T116
in	O	O	O
diabetes	O	O	B-T047
patients	O	O	O

Microsampling	O	O	B-T169
techniques	O	O	I-T169
have	O	O	O
several	O	O	O
advantages	O	O	O
over	O	O	O
traditional	O	O	O
blood	O	O	B-T060
collection	O	O	I-T060
.	O	O	O

Dried	O	O	B-T059
blood	O	O	I-T059
spot	O	O	I-T059
(	O	O	I-T059
DBS	O	O	I-T059
)	O	O	I-T059
sampling	O	O	I-T059
and	O	O	O
blood	O	O	B-T060
collection	O	O	I-T060
with	O	O	O
heparinized	O	O	B-T074
capillaries	O	O	I-T074
are	O	O	O
the	O	O	O
standard	O	O	B-T080
techniques	O	O	B-T059
.	O	O	O

Volumetric	O	O	B-T060
absorptive	O	O	I-T060
microsampling	O	O	I-T060
(	O	O	O
VAMS	O	O	B-T060
)	O	O	O
is	O	O	O
a	O	O	O
novel	O	O	O
technique	O	O	B-T059
that	O	O	O
collects	O	O	O
a	O	O	O
fixed	O	O	O
volume	O	O	B-T081
of	O	O	O
blood	O	O	B-T031
by	O	O	O
applying	O	O	O
an	O	O	O
absorbent	O	O	O
tip	O	O	B-T080
to	O	O	O
a	O	O	O
blood	O	O	B-T031
drop	O	O	I-T031
.	O	O	O

In	O	O	O
the	O	O	O
present	O	O	O
study	O	O	B-T062
we	O	O	O
explored	O	O	O
the	O	O	O
feasibility	O	O	O
of	O	O	O
HbA1c	O	O	B-T116
monitoring	O	O	B-T058
with	O	O	O
VAMS	O	O	B-T060
sampling	O	O	I-T060
at	O	O	O
home	O	O	B-T082
and	O	O	O
analysis	O	O	B-T062
in	O	O	O
the	O	O	O
laboratory	O	O	B-T093
.	O	O	O

Diabetic	O	O	B-T047
patients	O	O	B-T101
were	O	O	O
enrolled	O	O	O
in	O	O	O
this	O	O	O
study	O	O	B-T062
during	O	O	O
consultation	O	O	B-T058
with	O	O	O
the	O	O	O
endocrinologist	O	O	B-T097
.	O	O	O

A	O	O	O
venous	O	O	B-T031
(	O	O	O
adults	O	O	B-T100
)	O	O	O
or	O	O	O
capillary	O	O	B-T031
(	O	O	I-T031
children	O	O	I-T031
)	O	O	I-T031
sample	O	O	I-T031
was	O	O	O
taken	O	O	O
for	O	O	O
immediate	O	O	O
HbA1c	O	O	B-T116
analysis	O	O	B-T062
.	O	O	O

DBS	O	O	B-T059
(	O	O	O
n=1	O	O	O
)	O	O	O
and	O	O	O
dried	O	O	B-T060
VAMS	O	O	I-T060
(	O	O	O
n=2	O	O	O
)	O	O	O
were	O	O	O
collected	O	O	O
at	O	O	O
home	O	O	B-T082
and	O	O	O
sent	O	O	O
to	O	O	O
the	O	O	O
laboratory	O	O	B-T093
.	O	O	O

For	O	O	O
25	O	O	O
pediatric	O	O	B-T080
patients	O	O	B-T101
one	O	O	O
VAMS	O	O	B-T060
was	O	O	O
collected	O	O	O
during	O	O	O
consultation	O	O	B-T058
for	O	O	O
immediate	O	O	O
analysis	O	O	B-T062
(	O	O	O
without	O	O	O
drying	O	O	O
)	O	O	O
,	O	O	O
referred	O	O	O
to	O	O	O
as	O	O	O
"	O	O	O
wet	O	O	B-T060
VAMS	O	O	I-T060
"	O	O	O
.	O	O	O

HbA1c	O	O	B-T116
analyses	O	O	B-T062
were	O	O	O
performed	O	O	O
on	O	O	O
a	O	O	O
Tosoh	O	O	B-T074
HLC-723	O	O	I-T074
G8	O	O	I-T074
high-performance	O	O	I-T074
liquid	O	O	I-T074
chromatography	O	O	I-T074
(	O	O	I-T074
HPLC	O	O	I-T074
)	O	O	I-T074
analyzer	O	O	I-T074
.	O	O	O

The	O	O	O
median	O	O	O
time	O	O	O
between	O	O	O
sampling	O	O	B-T060
at	O	O	O
home	O	O	B-T082
and	O	O	O
analysis	O	O	B-T062
was	O	O	O
3	O	O	O
days	O	O	B-T079
.	O	O	O

Results	O	O	B-T169
of	O	O	O
HbA1c	O	O	B-T116
in	O	O	O
dried	O	O	O
VAMS	O	O	B-T060
showed	O	O	O
a	O	O	O
poor	O	O	O
agreement	O	O	O
with	O	O	O
venous	O	O	B-T031
/	O	O	O
capillary	O	O	B-T031
blood	O	O	I-T031
collected	O	O	O
in	O	O	O
hospital	O	O	B-T093
(	O	O	O
concordance	O	O	B-T081
correlation	O	O	I-T081
coefficient	O	O	I-T081
CCC	O	O	B-T081
=	O	O	O
0.72	O	O	O
)	O	O	O
.	O	O	O

Similar	O	O	O
observations	O	O	O
were	O	O	O
found	O	O	O
with	O	O	O
standard	O	O	B-T080
DBS	O	O	B-T059
.	O	O	O

An	O	O	O
excellent	O	O	O
agreement	O	O	O
was	O	O	O
obtained	O	O	O
between	O	O	O
HbA1c	O	O	B-T116
results	O	O	B-T169
on	O	O	O
wet	O	O	B-T060
VAMS	O	O	I-T060
(	O	O	O
CCC	O	O	B-T081
=	O	O	O
0.996	O	O	O
)	O	O	O
and	O	O	O
standard	O	O	B-T080
blood	O	O	B-T031
samples	O	O	I-T031
.	O	O	O

Patients	O	O	B-T101
experienced	O	O	O
VAMS	O	O	B-T060
and	O	O	O
DBS	O	O	B-T059
as	O	O	O
easy	O	O	B-T033
and	O	O	O
convenient	O	O	B-T080
to	O	O	O
use	O	O	B-T169
.	O	O	O

Utilizing	O	O	O
equipment	O	O	B-T073
standard	O	O	B-T080
available	O	O	O
in	O	O	O
the	O	O	O
clinical	O	O	B-T080
laboratory	O	O	B-T093
,	O	O	O
the	O	O	O
use	O	O	O
of	O	O	O
home	O	O	B-T082
-sampled	O	O	O
dried	O	O	B-T060
VAMS	O	O	I-T060
and	O	O	O
DBS	O	O	B-T059
is	O	O	O
not	O	O	O
a	O	O	O
reliable	O	O	O
tool	O	O	O
for	O	O	O
the	O	O	O
monitoring	O	O	B-T058
of	O	O	O
HbA1c	O	O	B-T116
.	O	O	O

However	O	O	O
,	O	O	O
perfect	O	O	O
agreement	O	O	O
between	O	O	O
HbA1c	O	O	B-T116
measured	O	O	O
on	O	O	O
wet	O	O	B-T060
VAMS	O	O	I-T060
and	O	O	O
capillary	O	O	B-T031
microsamples	O	O	I-T031
was	O	O	O
obtained	O	O	O
.	O	O	O

-DOCSTART- (27732647)

Are	O	O	O
Eyes	O	O	B-T023
a	O	O	O
Mirror	O	O	B-T070
of	O	O	O
the	O	O	O
Soul	O	O	B-T078
?	O	O	O
What	O	O	O
Eye	O	O	B-T023
Wrinkles	O	O	B-T190
Reveal	O	O	B-T080
about	O	O	O
a	O	O	O
Horse	O	O	B-T015
's	O	O	I-T015
Emotional	O	O	O
State	O	O	O

Finding	O	O	O
valid	O	O	B-T080
indicators	O	O	B-T169
of	O	O	O
emotional	O	O	B-T041
states	O	O	I-T041
is	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
biggest	O	O	O
challenges	O	O	O
in	O	O	O
animal	O	O	B-T052
welfare	O	O	I-T052
science	O	O	I-T052
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
investigated	O	O	B-T169
in	O	O	O
horses	O	O	B-T015
whether	O	O	O
variation	O	O	B-T080
in	O	O	O
the	O	O	O
expression	O	O	B-T080
of	O	O	O
eye	O	O	B-T023
wrinkles	O	O	B-T190
caused	O	O	O
by	O	O	O
contraction	O	O	B-T046
of	O	O	O
the	O	O	O
inner	O	O	B-T023
eyebrow	O	O	I-T023
raiser	O	O	O
reflects	O	O	B-T041
emotional	O	O	B-T033
valence	O	O	I-T033
.	O	O	O

By	O	O	O
confronting	O	O	O
horses	O	O	B-T015
with	O	O	O
positive	O	O	B-T033
and	O	O	O
negative	O	O	B-T033
conditions	O	O	B-T080
,	O	O	O
we	O	O	O
aimed	O	O	O
to	O	O	O
induce	O	O	B-T169
positive	O	O	O
and	O	O	O
negative	O	O	O
emotional	O	O	B-T041
states	O	O	I-T041
,	O	O	O
hypothesising	O	O	B-T078
that	O	O	O
positive	O	O	O
emotions	O	O	B-T041
would	O	O	O
reduce	O	O	B-T080
whereas	O	O	O
negative	O	O	O
emotions	O	O	O
would	O	O	O
increase	O	O	B-T169
eye	O	O	B-T023
wrinkle	O	O	B-T190
expression	O	O	B-T080
.	O	O	O

Sixteen	O	O	O
horses	O	O	B-T015
were	O	O	O
individually	O	O	O
exposed	O	O	B-T080
in	O	O	O
a	O	O	O
balanced	O	O	B-T169
order	O	O	O
to	O	O	O
two	O	O	O
positive	O	O	B-T033
(	O	O	O
grooming	O	O	B-T055
,	O	O	O
food	O	O	B-T168
anticipation	O	O	I-T041
)	O	O	O
and	O	O	O
two	O	O	O
negative	O	O	B-T033
condition	O	O	B-T080
s	O	O	O
(	O	O	O
food	O	O	O
competition	O	O	B-T054
,	O	O	O
waving	O	O	B-T052
a	O	O	O
plastic	O	O	B-T073
bag	O	O	I-T073
)	O	O	O
.	O	O	O

Each	O	O	O
condition	O	O	B-T080
lasted	O	O	O
for	O	O	O
60	O	O	O
seconds	O	O	B-T079
and	O	O	O
was	O	O	O
preceded	O	O	O
by	O	O	O
a	O	O	O
60	O	O	O
second	O	O	B-T079
control	O	O	B-T079
phase	O	O	I-T079
.	O	O	O

Throughout	O	O	O
both	O	O	O
phases	O	O	B-T079
,	O	O	O
pictures	O	O	B-T073
of	O	O	O
the	O	O	O
eyes	O	O	B-T023
were	O	O	O
taken	O	O	O
,	O	O	O
and	O	O	O
for	O	O	O
each	O	O	O
horse	O	O	B-T015
four	O	O	O
pictures	O	O	O
per	O	O	O
condition	O	O	B-T080
and	O	O	O
phase	O	O	B-T079
were	O	O	O
randomly	O	O	B-T052
selected	O	O	I-T052
.	O	O	O

Pictures	O	O	B-T073
were	O	O	O
scored	O	O	O
in	O	O	O
random	O	O	B-T080
order	O	O	I-T080
and	O	O	O
by	O	O	O
two	O	O	O
experimenters	O	O	B-T097
blind	O	O	B-T062
to	O	O	O
condition	O	O	B-T080
and	O	O	O
phase	O	O	B-T079
for	O	O	O
six	O	O	O
outcome	O	O	B-T081
measures	O	O	I-T081
:	O	O	O
qualitative	O	O	B-T080
impression	O	O	B-T080
,	O	O	O
eyelid	O	O	B-T023
shape	O	O	B-T082
,	O	O	O
markedness	O	O	B-T080
of	O	O	O
the	O	O	O
wrinkles	O	O	B-T190
,	O	O	O
presence	O	O	B-T033
of	O	O	O
eye	O	O	B-T023
white	O	O	I-T023
,	O	O	O
number	O	O	B-T081
of	O	O	O
wrinkles	O	O	O
,	O	O	O
and	O	O	O
the	O	O	O
angle	O	O	B-T082
between	O	O	O
the	O	O	O
line	O	O	O
through	O	O	O
the	O	O	O
eyeball	O	O	B-T023
and	O	O	O
the	O	O	O
highest	O	O	B-T080
wrinkle	O	O	B-T190
.	O	O	O

The	O	O	O
angle	O	O	B-T082
decreased	O	O	B-T081
during	O	O	O
grooming	O	O	B-T055
and	O	O	O
increased	O	O	B-T081
during	O	O	O
food	O	O	B-T168
competition	O	O	B-T054
compared	O	O	B-T052
to	O	O	O
control	O	O	B-T079
phase	O	O	I-T079
s	O	O	O
,	O	O	O
whereas	O	O	O
the	O	O	O
two	O	O	O
phases	O	O	B-T079
did	O	O	O
not	O	O	O
differ	O	O	O
during	O	O	O
food	O	O	B-T041
anticipation	O	O	I-T041
and	O	O	O
the	O	O	O
plastic	O	O	B-T073
bag	O	O	I-T073
condition	O	O	B-T080
.	O	O	O

No	O	O	B-T080
effects	O	O	I-T080
on	O	O	O
the	O	O	O
other	O	O	O
outcome	O	O	B-T081
measures	O	O	I-T081
were	O	O	O
detected	O	O	B-T033
.	O	O	O

Taken	O	O	O
together	O	O	O
,	O	O	O
we	O	O	O
have	O	O	O
defined	O	O	O
a	O	O	O
set	O	O	O
of	O	O	O
measures	O	O	B-T081
to	O	O	O
assess	O	O	B-T052
eye	O	O	B-T023
wrinkle	O	O	B-T190
expression	O	O	B-T080
reliably	O	O	O
,	O	O	O
of	O	O	O
which	O	O	O
one	O	O	O
measure	O	O	B-T081
was	O	O	O
affected	O	O	B-T169
by	O	O	O
the	O	O	O
conditions	O	O	B-T080
the	O	O	O
horses	O	O	B-T015
were	O	O	O
exposed	O	O	B-T080
to	O	O	I-T080
.	O	O	O

Variation	O	O	B-T080
in	O	O	O
eye	O	O	B-T023
wrinkle	O	O	B-T190
expression	O	O	B-T080
might	O	O	O
provide	O	O	B-T168
valuable	O	O	O
information	O	O	B-T078
on	O	O	O
horse	O	O	B-T015
welfare	O	O	B-T052
but	O	O	O
further	O	O	O
validation	O	O	B-T062
of	O	O	O
specific	O	O	B-T080
measures	O	O	B-T081
across	O	O	O
different	O	O	B-T080
conditions	O	O	B-T080
is	O	O	O
needed	O	O	O
.	O	O	O

-DOCSTART- (27732923)

Effective	O	O	B-T080
mercury(II	O	O	B-T131
)	O	O	I-T131
bioremoval	O	O	B-T052
from	O	O	O
aqueous	O	O	B-T121
solution	O	O	I-T121
,	O	O	O
and	O	O	O
its	O	O	O
electrochemical	O	O	O
determination	O	O	O

This	O	O	O
work	O	O	O
proposed	O	O	O
mercury	O	O	B-T131
elimination	O	O	B-T052
using	O	O	O
agricultural	O	O	B-T090
waste	O	O	B-T167
(	O	O	O
Allium	O	O	B-T002
Cepa	O	O	I-T002
L	O	O	I-T002
.	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
biomass	O	O	B-T081
removed	O	O	B-T080
99.4	O	O	O
%	O	O	O
of	O	O	O
mercury	O	O	B-T131
,	O	O	O
following	O	O	O
a	O	O	O
pseudo-second	O	O	B-T070
order	O	O	I-T070
kinetics	O	O	I-T070
(	O	O	O
r(2	O	O	O
)	O	O	O
=	O	O	O
0.9999	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
Langmuir	O	O	B-T170
model	O	O	I-T170
was	O	O	O
adequately	O	O	B-T080
fitted	O	O	O
to	O	O	O
the	O	O	O
adsorption	O	O	B-T059
isotherm	O	O	I-T067
,	O	O	O
thereby	O	O	O
obtaining	O	O	O
the	O	O	O
maximum	O	O	B-T081
mercury	O	O	B-T131
adsorption	O	O	O
capacity	O	O	B-T081
of	O	O	O
111.1	O	O	O
Â±	O	O	O
0.3	O	O	O
mg	O	O	O
g(-1	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
biomass	O	O	B-T081
showed	O	O	O
high	O	O	B-T080
density	O	O	B-T081
of	O	O	O
strong	O	O	B-T080
mercury	O	O	B-T131
chelating	O	O	B-T121
groups	O	O	I-T121
,	O	O	O
thus	O	O	O
making	O	O	O
it	O	O	O
economically	O	O	B-T169
attractive	O	O	B-T080
.	O	O	O

Also	O	O	O
,	O	O	O
the	O	O	O
implementation	O	O	B-T052
of	O	O	O
a	O	O	O
mercury	O	O	B-T131
-	O	O	O
selective	O	O	B-T059
electrode	O	O	B-T073
for	O	O	O
continuous	O	O	B-T078
determination	O	O	B-T059
in	O	O	O
real	O	O	B-T079
time	O	O	I-T079
is	O	O	O
proposed	O	O	B-T080
;	O	O	O
this	O	O	O
electrode	O	O	O
replaces	O	O	B-T078
techniques	O	O	B-T169
like	O	O	O
atomic	O	O	B-T059
absorption	O	O	I-T059
spectroscopy	O	O	I-T059
,	O	O	O
thus	O	O	O
it	O	O	O
can	O	O	O
be	O	O	O
applied	O	O	O
to	O	O	O
real	O	O	O
time	O	O	O
studies	O	O	B-T062
.	O	O	O

This	O	O	O
work	O	O	O
therefore	O	O	O
presents	O	O	O
a	O	O	O
new	O	O	O
perspective	O	O	B-T169
for	O	O	O
removing	O	O	B-T052
mercury(II	O	O	B-T131
)	O	O	I-T131
from	O	O	O
contaminated	O	O	B-T069
water	O	O	I-T069
for	O	O	O
environmental	O	O	B-T069
remediation	O	O	I-T069
.	O	O	O

-DOCSTART- (27742350)

Modeling	O	O	B-T062
nurse-patient	O	O	B-T057
assignments	O	O	I-T057
considering	O	O	O
patient	O	O	B-T080
acuity	O	O	I-T080
and	O	O	O
travel	O	O	B-T056
distance	O	O	B-T081
metrics	O	O	O

Balancing	O	O	B-T169
workload	O	O	B-T081
among	O	O	O
nurses	O	O	B-T097
on	O	O	O
a	O	O	O
hospital	O	O	B-T093
unit	O	O	I-T093
is	O	O	O
important	O	O	O
for	O	O	O
the	O	O	O
satisfaction	O	O	B-T041
and	O	O	O
safety	O	O	B-T068
of	O	O	O
nurses	O	O	O
and	O	O	O
patients	O	O	B-T101
.	O	O	O

To	O	O	O
balance	O	O	B-T169
nurse	O	O	B-T097
workloads	O	O	B-T081
,	O	O	O
direct	O	O	B-T080
patient	O	O	B-T058
care	O	O	I-T058
activities	O	O	I-T058
,	O	O	O
indirect	O	O	B-T080
patient	O	O	O
care	O	O	O
activities	O	O	O
,	O	O	O
and	O	O	O
non-patient	O	O	B-T058
care	O	O	I-T058
activities	O	O	I-T058
that	O	O	O
occur	O	O	O
throughout	O	O	O
a	O	O	O
shift	O	O	B-T169
must	O	O	O
be	O	O	O
considered	O	O	O
.	O	O	O

The	O	O	O
layout	O	O	O
of	O	O	O
a	O	O	O
hospital	O	O	B-T093
unit	O	O	B-T093
and	O	O	O
the	O	O	O
location	O	O	B-T082
of	O	O	O
a	O	O	O
nurse	O	O	B-T097
's	O	O	I-T097
assigned	O	O	B-T169
patients	O	O	B-T101
relative	O	O	B-T080
to	O	O	O
other	O	O	O
resources	O	O	B-T078
on	O	O	O
the	O	O	O
unit	O	O	O
are	O	O	O
also	O	O	O
important	O	O	B-T169
factors	O	O	I-T169
in	O	O	O
achieving	O	O	B-T033
workload	O	O	B-T081
balance	O	O	B-T169
.	O	O	O

In	O	O	O
most	O	O	O
hospitals	O	O	B-T093
,	O	O	O
a	O	O	O
unit	O	O	O
charge	O	O	O
nurse	O	O	B-T097
is	O	O	O
responsible	O	O	B-T033
for	O	O	O
the	O	O	O
shift	O	O	B-T169
assignment	O	O	B-T169
of	O	O	O
patients	O	O	B-T101
to	O	O	O
nurses	O	O	B-T097
based	O	O	O
on	O	O	O
experience	O	O	B-T041
and	O	O	O
past	O	O	B-T041
practices	O	O	I-T041
.	O	O	O

The	O	O	O
nurse-patient	O	O	B-T057
assignment	O	O	I-T057
process	O	O	B-T067
is	O	O	O
also	O	O	O
often	O	O	O
a	O	O	O
manual	O	O	B-T067
process	O	O	I-T067
in	O	O	O
which	O	O	O
the	O	O	O
charge	O	O	O
nurse	O	O	B-T097
must	O	O	O
sort	O	O	B-T052
through	O	O	O
multiple	O	O	B-T078
decision	O	O	I-T078
criteria	O	O	I-T078
in	O	O	O
a	O	O	O
limited	O	O	O
amount	O	O	O
of	O	O	O
time	O	O	B-T079
.	O	O	O

In	O	O	O
this	O	O	O
paper	O	O	O
,	O	O	O
a	O	O	O
methodology	O	O	B-T078
for	O	O	O
the	O	O	O
construction	O	O	O
of	O	O	O
balanced	O	O	B-T169
nurse-patient	O	O	B-T057
workload	O	O	I-T057
assignments	O	O	I-T057
is	O	O	O
proposed	O	O	B-T080
.	O	O	O

Through	O	O	O
the	O	O	O
illustration	O	O	O
of	O	O	O
this	O	O	O
methodology	O	O	B-T078
new	O	O	O
scoring	O	O	B-T081
metrics	O	O	B-T169
are	O	O	O
developed	O	O	B-T169
using	O	O	O
measures	O	O	B-T081
currently	O	O	O
available	O	O	B-T169
on	O	O	O
,	O	O	O
or	O	O	O
from	O	O	O
,	O	O	O
the	O	O	O
hospital	O	O	B-T093
unit	O	O	I-T093
.	O	O	O

It	O	O	O
was	O	O	O
demonstrated	O	O	B-T169
that	O	O	O
the	O	O	O
complex	O	O	B-T080
scheduling	O	O	I-T080
problem	O	O	B-T033
can	O	O	O
be	O	O	O
captured	O	O	O
.	O	O	O

While	O	O	O
the	O	O	O
methodology	O	O	B-T078
was	O	O	O
illustrated	O	O	O
for	O	O	O
a	O	O	O
scheduling	O	O	B-T080
problem	O	O	B-T033
commonly	O	O	O
encountered	O	O	O
on	O	O	O
a	O	O	O
hospital	O	O	B-T093
unit	O	O	I-T093
,	O	O	O
the	O	O	O
approach	O	O	B-T082
can	O	O	O
be	O	O	O
adapted	O	O	O
to	O	O	O
other	O	O	O
workforce	O	O	B-T169
scheduling	O	O	O
problems	O	O	B-T033
in	O	O	O
which	O	O	O
measures	O	O	B-T081
of	O	O	O
workload	O	O	B-T081
are	O	O	O
required	O	O	B-T169
and	O	O	O
composed	O	O	O
of	O	O	O
elements	O	O	B-T077
imposed	O	O	O
by	O	O	O
the	O	O	O
work	O	O	B-T082
environment	O	O	I-T082
,	O	O	O
variability	O	O	B-T077
within	O	O	O
the	O	O	O
required	O	O	O
tasks	O	O	B-T057
,	O	O	O
and	O	O	O
a	O	O	O
measurable	O	O	B-T169
perception	O	O	B-T041
of	O	O	O
the	O	O	O
relative	O	O	B-T080
intensity	O	O	B-T080
of	O	O	O
the	O	O	O
work	O	O	B-T077
elements	O	O	I-T077
.	O	O	O

-DOCSTART- (27743686)

Effect	O	O	B-T080
of	O	O	I-T080
alpha	O	O	B-T127
lipoic	O	O	I-T127
acid	O	O	I-T127
on	O	O	O
in	O	O	B-T080
vitro	O	O	I-T080
development	O	O	B-T040
of	O	O	O
bovine	O	O	B-T015
secondary	O	O	O
preantral	O	O	O
follicles	O	O	O

The	O	O	O
present	O	O	O
study	O	O	B-T062
aimed	O	O	O
to	O	O	O
evaluate	O	O	B-T058
the	O	O	O
in	O	O	B-T080
vitro	O	O	I-T080
effect	O	O	B-T080
of	O	O	I-T080
alpha	O	O	B-T127
lipoic	O	O	I-T127
acid	O	O	I-T127
(	O	O	O
ALA	O	O	B-T127
)	O	O	O
addition	O	O	O
to	O	O	O
the	O	O	O
culture	O	O	B-T130
medium	O	O	I-T130
on	O	O	O
the	O	O	O
development	O	O	B-T040
of	O	O	O
the	O	O	O
bovine	O	O	B-T015
secondary	O	O	B-T023
preantral	O	O	I-T023
follicles	O	O	I-T023
.	O	O	O

Bovine	O	O	B-T015
secondary	O	O	B-T023
preantral	O	O	I-T023
follicles	O	O	I-T023
were	O	O	O
collected	O	O	B-T169
and	O	O	O
divided	O	O	B-T169
into	O	O	O
two	O	O	O
groups	O	O	B-T078
depending	O	O	O
on	O	O	O
their	O	O	O
size	O	O	B-T082
(	O	O	O
80	O	O	O
-	O	O	O
100	O	O	O
Î¼m	O	O	O
and	O	O	O
100	O	O	O
-	O	O	O
110	O	O	O
Î¼m	O	O	O
)	O	O	O
.	O	O	O

They	O	O	O
were	O	O	O
cultured	O	O	O
in	O	O	B-T080
vitro	O	O	I-T080
for	O	O	O
15	O	O	O
days	O	O	O
(	O	O	O
D	O	O	O
)	O	O	O
using	O	O	O
different	O	O	O
media	O	O	B-T130
including	O	O	O
at	O	O	O
three	O	O	O
different	O	O	O
doses	O	O	B-T081
of	O	O	O
ALA	O	O	B-T127
.	O	O	O

The	O	O	O
genes	O	O	B-T045
expression	O	O	I-T045
levels	O	O	B-T080
of	O	O	O
follicle-stimulating	O	O	B-T028
hormone	O	O	I-T028
beta-subunit	O	O	I-T028
(	O	O	O
FSHR	O	O	B-T028
)	O	O	O
,	O	O	O
insulin-like	O	O	B-T028
growth	O	O	I-T028
factor	O	O	I-T028
(	O	O	O
IGF-1	O	O	B-T028
)	O	O	O
,	O	O	O
Activin	O	O	B-T028
,	O	O	O
luteinizing	O	O	B-T028
hormone/choriogonadotropin	O	O	I-T028
receptor	O	O	I-T028
,	O	O	O
bone	O	O	B-T028
morphogenetic	O	O	I-T028
protein	O	O	I-T028
receptor	O	O	I-T028
type	O	O	I-T028
IA	O	O	I-T028
,	O	O	O
transforming	O	O	B-T028
growth	O	O	I-T028
factor	O	O	I-T028
beta	O	O	I-T028
receptor	O	O	I-T028
1	O	O	I-T028
,	O	O	O
growth	O	O	B-T028
differentiation	O	O	I-T028
factor	O	O	I-T028
9	O	O	I-T028
,	O	O	O
BCL2-associated	O	O	B-T028
X	O	O	I-T028
protein	O	O	I-T028
(	O	O	O
BAX	O	O	B-T028
)	O	O	O
,	O	O	O
and	O	O	O
C-Myc	O	O	B-T028
were	O	O	O
studied	O	O	O
using	O	O	O
real-time	O	O	B-T063
polymerase	O	O	I-T063
chain	O	O	I-T063
reaction	O	O	I-T063
.	O	O	O

The	O	O	O
protein	O	O	B-T045
expression	O	O	I-T045
levels	O	O	B-T080
of	O	O	O
FSHR	O	O	B-T116
,	O	O	O
IGF-1	O	O	B-T116
,	O	O	O
and	O	O	O
BAX	O	O	B-T116
were	O	O	O
measured	O	O	O
using	O	O	O
Western	O	O	B-T059
blot	O	O	I-T059
analysis	O	O	I-T059
.	O	O	O

The	O	O	O
results	O	O	B-T034
of	O	O	O
the	O	O	O
present	O	O	O
work	O	O	O
revealed	O	O	O
that	O	O	O
in	O	O	B-T080
vitro	O	O	I-T080
addition	O	O	O
of	O	O	O
ALA	O	O	B-T127
-	O	O	O
induced	O	O	B-T169
significant	O	O	B-T078
increase	O	O	B-T042
in	O	O	I-T042
the	O	O	I-T042
growth	O	O	I-T042
and	O	O	O
development	O	O	B-T040
of	O	O	O
secondary	O	O	B-T023
preantral	O	O	I-T023
follicles	O	O	I-T023
throughout	O	O	O
the	O	O	O
culture	O	O	B-T059
period	O	O	B-T079
as	O	O	O
compared	O	O	B-T052
to	O	O	O
control	O	O	B-T096
.	O	O	O

The	O	O	O
FSHR	O	O	B-T028
,	O	O	O
IGF-1	O	O	B-T028
,	O	O	O
luteinizing	O	O	B-T028
hormone/choriogonadotropin	O	O	I-T028
receptor	O	O	I-T028
,	O	O	O
bone	O	O	B-T028
morphogenetic	O	O	I-T028
protein	O	O	I-T028
receptor	O	O	I-T028
type	O	O	I-T028
IA	O	O	I-T028
,	O	O	O
transforming	O	O	B-T028
growth	O	O	I-T028
factor	O	O	I-T028
beta	O	O	I-T028
receptor	O	O	I-T028
1	O	O	I-T028
,	O	O	O
growth	O	O	B-T028
differentiation	O	O	I-T028
factor	O	O	I-T028
9	O	O	I-T028
,	O	O	O
and	O	O	O
Activin	O	O	B-T028
A	O	O	I-T028
genes	O	O	I-T028
were	O	O	O
upregulated	O	O	B-T044
in	O	O	O
ALA	O	O	B-T127
-	O	O	O
treated	O	O	B-T169
follicles	O	O	B-T023
as	O	O	O
compared	O	O	B-T052
to	O	O	O
the	O	O	O
control	O	O	B-T096
.	O	O	O

On	O	O	O
contrary	O	O	O
,	O	O	O
preapoptotic	O	O	B-T028
genes	O	O	I-T028
BAX	O	O	B-T028
and	O	O	O
C-Myc	O	O	B-T028
were	O	O	O
downregulated	O	O	B-T044
in	O	O	O
treated	O	O	B-T169
follicles	O	O	B-T023
compared	O	O	B-T052
to	O	O	O
control	O	O	B-T096
ones	O	O	O
.	O	O	O

The	O	O	O
protein	O	O	B-T034
levels	O	O	I-T034
of	O	O	O
FSHR	O	O	B-T116
and	O	O	O
IGF-1	O	O	B-T116
were	O	O	O
highly	O	O	O
expressed	O	O	B-T045
in	O	O	O
treated	O	O	B-T169
follicles	O	O	B-T023
compared	O	O	B-T052
to	O	O	O
control	O	O	B-T096
;	O	O	O
however	O	O	O
,	O	O	O
BAX	O	O	B-T116
protein	O	O	I-T116
was	O	O	O
downregulated	O	O	B-T044
in	O	O	O
the	O	O	O
treated	O	O	O
follicles	O	O	O
groups	O	O	B-T078
.	O	O	O

The	O	O	O
addition	O	O	O
of	O	O	O
ALA	O	O	B-T127
to	O	O	O
the	O	O	O
culture	O	O	B-T130
medium	O	O	I-T130
enhances	O	O	B-T052
secondary	O	O	B-T023
preantral	O	O	I-T023
follicles	O	O	I-T023
development	O	O	B-T040
and	O	O	O
growth	O	O	B-T042
.	O	O	O

-DOCSTART- (27745564)

How	O	O	O
should	O	O	O
proxies	O	O	B-T169
of	O	O	O
cognitive	O	O	B-T041
reserve	O	O	I-T041
be	O	O	O
evaluated	O	O	B-T058
in	O	O	O
a	O	O	O
population	O	O	B-T098
of	O	O	O
healthy	O	O	B-T080
older	O	O	B-T098
adults	O	O	I-T098
?	O	O	O

While	O	O	O
some	O	O	O
tools	O	O	B-T170
have	O	O	O
been	O	O	O
developed	O	O	O
to	O	O	O
estimate	O	O	B-T081
an	O	O	O
individual	O	O	B-T098
's	O	O	I-T098
cognitive	O	O	B-T041
reserve	O	O	I-T041
(	O	O	O
CR	O	O	B-T041
)	O	O	O
,	O	O	O
no	O	O	O
study	O	O	O
has	O	O	O
assessed	O	O	B-T052
the	O	O	O
adequacy	O	O	B-T080
of	O	O	O
the	O	O	O
method	O	O	O
used	O	O	O
for	O	O	O
assessing	O	O	O
these	O	O	O
CR	O	O	O
proxy	O	O	B-T169
indicators	O	O	O
.	O	O	O

Therefore	O	O	O
,	O	O	O
we	O	O	O
aimed	O	O	O
to	O	O	O
determine	O	O	O
the	O	O	O
most	O	O	O
appropriate	O	O	B-T080
method	O	O	O
to	O	O	O
estimate	O	O	B-T081
CR	O	O	B-T041
by	O	O	O
comparing	O	O	O
two	O	O	O
approaches	O	O	O
:	O	O	O
(	O	O	O
1	O	O	O
)	O	O	O
the	O	O	O
common	O	O	B-T081
assessment	O	O	B-T058
of	O	O	O
CR	O	O	O
proxies	O	O	B-T169
in	O	O	O
the	O	O	O
literature	O	O	B-T170
(	O	O	O
e.g.	O	O	O
years	O	O	B-T081
of	O	O	I-T081
education	O	O	I-T081
)	O	O	O
and	O	O	O
(	O	O	O
2	O	O	O
)	O	O	O
the	O	O	O
calculation	O	O	B-T052
of	O	O	O
a	O	O	O
comprehensive	O	O	B-T080
index	O	O	B-T170
based	O	O	O
on	O	O	O
most	O	O	B-T080
significant	O	O	I-T080
parameters	O	O	B-T033
used	O	O	O
in	O	O	O
the	O	O	O
estimation	O	O	B-T041
of	O	O	O
CR	O	O	O
.	O	O	O

Data	O	O	O
on	O	O	O
CR	O	O	B-T041
proxies	O	O	B-T169
(	O	O	O
i.e.	O	O	O
education	O	O	B-T065
,	O	O	O
occupation	O	O	B-T090
,	O	O	O
and	O	O	O
leisure	O	O	B-T056
activities	O	O	I-T056
)	O	O	O
were	O	O	O
obtained	O	O	O
in	O	O	O
a	O	O	O
sample	O	O	O
of	O	O	O
204	O	O	O
older	O	O	B-T098
adults	O	O	I-T098
.	O	O	O

Regression	O	O	B-T170
analyses	O	O	I-T170
were	O	O	O
used	O	O	O
to	O	O	O
develop	O	O	O
the	O	O	O
two	O	O	O
indices	O	O	B-T170
of	O	O	O
CR	O	O	B-T041
(	O	O	O
i.e.	O	O	O
ICR-standard	O	O	B-T170
and	O	O	O
ICR-detailed	O	O	B-T170
)	O	O	O
and	O	O	O
to	O	O	O
determine	O	O	O
which	O	O	O
index	O	O	B-T170
best	O	O	O
represented	O	O	O
the	O	O	O
level	O	O	O
of	O	O	O
one	O	O	O
's	O	O	O
CR	O	O	O
.	O	O	O

The	O	O	O
ICR-standard	O	O	B-T170
was	O	O	O
calculated	O	O	B-T052
using	O	O	O
a	O	O	O
combination	O	O	B-T080
of	O	O	O
the	O	O	O
three	O	O	O
most	O	O	O
common	O	O	B-T081
measures	O	O	B-T081
of	O	O	O
reserve	O	O	B-T041
in	O	O	O
the	O	O	O
literature	O	O	B-T170
:	O	O	O
number	O	O	B-T081
of	O	O	I-T081
schooling	O	O	I-T081
years	O	O	I-T081
,	O	O	O
complexity	O	O	B-T080
of	O	O	O
the	O	O	O
primary	O	O	O
occupation	O	O	B-T090
,	O	O	O
and	O	O	O
amount	O	O	O
of	O	O	O
current	O	O	B-T079
participation	O	O	B-T169
in	O	O	O
stimulating	O	O	B-T070
activities	O	O	B-T052
.	O	O	O

The	O	O	O
ICR-detailed	O	O	B-T170
was	O	O	O
calculated	O	O	B-T052
using	O	O	O
the	O	O	O
most	O	O	B-T080
significant	O	O	I-T080
parameters	O	O	B-T033
(	O	O	O
established	O	O	O
in	O	O	O
initial	O	O	B-T079
analyses	O	O	B-T062
)	O	O	O
of	O	O	O
CR	O	O	B-T041
:	O	O	O
highest	O	O	B-T033
level	O	O	I-T033
of	O	O	I-T033
education	O	O	I-T033
combined	O	O	B-T080
with	O	O	O
the	O	O	O
number	O	O	O
of	O	O	O
training	O	O	B-T065
courses	O	O	I-T065
,	O	O	O
last	O	O	B-T080
occupation	O	O	B-T090
,	O	O	O
and	O	O	O
amount	O	O	B-T081
of	O	O	O
current	O	O	O
participation	O	O	B-T169
in	O	O	O
social	O	O	B-T054
and	O	O	O
intellectual	O	O	B-T065
activities	O	O	I-T065
.	O	O	O

The	O	O	O
comparison	O	O	B-T052
of	O	O	O
both	O	O	O
indices	O	O	B-T170
showed	O	O	O
that	O	O	O
higher	O	O	O
levels	O	O	O
of	O	O	O
ICR-standard	O	O	B-T170
and	O	O	O
ICR-detailed	O	O	B-T170
were	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
a	O	O	O
greater	O	O	B-T081
minimization	O	O	B-T080
of	O	O	O
the	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
age	O	O	B-T032
on	O	O	O
cognition	O	O	B-T041
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
ICR-detailed	O	O	B-T170
was	O	O	O
more	O	O	O
strongly	O	O	O
associated	O	O	B-T080
to	O	O	O
this	O	O	O
minimization	O	O	B-T080
than	O	O	O
the	O	O	O
ICR-standard	O	O	B-T170
,	O	O	O
suggesting	O	O	O
that	O	O	O
the	O	O	O
ICR-detailed	O	O	O
best	O	O	O
reflect	O	O	O
one	O	O	O
's	O	O	O
CR	O	O	B-T041
.	O	O	O

This	O	O	O
study	O	O	O
is	O	O	O
the	O	O	O
first	O	O	O
to	O	O	O
show	O	O	O
that	O	O	O
it	O	O	O
is	O	O	O
of	O	O	O
great	O	O	B-T081
importance	O	O	B-T080
to	O	O	O
question	O	O	O
methods	O	O	O
measuring	O	O	B-T080
CR	O	O	B-T041
proxies	O	O	B-T169
in	O	O	O
order	O	O	O
to	O	O	O
develop	O	O	O
a	O	O	O
clinical	O	O	B-T170
tool	O	O	I-T170
allowing	O	O	O
a	O	O	O
comprehensive	O	O	B-T080
and	O	O	O
accurate	O	O	B-T080
estimation	O	O	B-T041
of	O	O	O
CR	O	O	O
.	O	O	O

-DOCSTART- (27750105)

Discordance	O	O	B-T077
in	O	O	O
pathology	O	O	B-T170
report	O	O	I-T170
after	O	O	O
central	O	O	B-T060
pathology	O	O	I-T060
review	O	O	I-T060
:	O	O	O
Implications	O	O	O
for	O	O	O
breast	O	O	B-T191
cancer	O	O	I-T191
adjuvant	O	O	O
treatment	O	O	O

Pathological	O	O	B-T169
predictive	O	O	B-T170
factors	O	O	I-T170
are	O	O	O
the	O	O	O
most	O	O	O
important	O	O	O
markers	O	O	B-T201
when	O	O	O
selecting	O	O	O
early	O	O	O
breast	O	O	B-T191
cancer	O	O	I-T191
adjuvant	O	O	B-T061
therapy	O	O	I-T061
.	O	O	O

In	O	O	O
randomized	O	O	B-T062
clinical	O	O	I-T062
trials	O	O	I-T062
the	O	O	O
variability	O	O	B-T077
in	O	O	O
pathology	O	O	B-T170
report	O	O	I-T170
after	O	O	O
central	O	O	B-T060
pathology	O	O	I-T060
review	O	O	I-T060
is	O	O	O
noteworthy	O	O	O
.	O	O	O

We	O	O	O
evaluated	O	O	O
the	O	O	O
discordance	O	O	B-T077
rate	O	O	B-T081
(	O	O	O
DR	O	O	B-T081
)	O	O	O
and	O	O	O
inter-rater	O	O	B-T081
agreement	O	O	I-T081
between	O	O	O
local	O	O	B-T082
and	O	O	O
central	O	O	B-T082
histopathological	O	O	B-T170
report	O	O	I-T170
and	O	O	O
the	O	O	O
clinical	O	O	B-T080
implication	O	O	O
on	O	O	O
treatment	O	O	B-T033
decision	O	O	I-T033
.	O	O	O

A	O	O	O
retrospective	O	O	B-T062
analysis	O	O	I-T062
was	O	O	O
conducted	O	O	O
in	O	O	O
a	O	O	O
series	O	O	O
of	O	O	O
consecutive	O	O	O
early	O	O	O
breast	O	O	B-T191
cancer	O	O	I-T191
tumors	O	O	I-T191
diagnosed	O	O	O
by	O	O	O
local	O	O	B-T097
pathologists	O	O	I-T097
and	O	O	O
subsequently	O	O	O
reviewed	O	O	B-T080
at	O	O	O
the	O	O	O
Pathology	O	O	B-T093
Division	O	O	I-T093
of	O	O	O
European	O	O	B-T093
Institute	O	O	I-T093
of	O	O	I-T093
Oncology	O	O	I-T093
.	O	O	O

The	O	O	O
inter-rater	O	O	B-T081
agreement	O	O	I-T081
(	O	O	O
k	O	O	O
)	O	O	O
between	O	O	O
local	O	O	O
and	O	O	O
central	O	O	B-T091
pathology	O	O	I-T091
was	O	O	O
calculated	O	O	O
for	O	O	O
Ki-67	O	O	B-T116
,	O	O	O
grading	O	O	B-T170
,	O	O	O
hormone	O	O	B-T116
receptors	O	O	I-T116
(	O	O	O
ER	O	O	B-T116
/	O	O	O
PgR	O	O	B-T116
)	O	O	O
and	O	O	O
HER2/neu	O	O	B-T201
.	O	O	O

The	O	O	O
Bland-Altman	O	O	B-T062
plots	O	O	I-T062
were	O	O	O
derived	O	O	O
to	O	O	O
determine	O	O	O
discrepancies	O	O	O
in	O	O	O
Ki-67	O	O	B-T116
,	O	O	O
ER	O	O	B-T116
and	O	O	O
PgR.	O	O	O
DR	O	O	B-T081
was	O	O	O
calculated	O	O	O
for	O	O	O
ER	O	O	O
/	O	O	O
PgR	O	O	B-T116
and	O	O	O
HER2	O	O	B-T116
.	O	O	O

From	O	O	O
2007	O	O	O
to	O	O	O
2013	O	O	O
,	O	O	O
187	O	O	O
pathology	O	O	B-T031
specimens	O	O	I-T031
from	O	O	O
10	O	O	O
Cancer	O	O	B-T093
Centers	O	O	I-T093
were	O	O	O
reviewed	O	O	B-T080
.	O	O	O

Substantial	O	O	O
agreement	O	O	O
was	O	O	O
observed	O	O	O
for	O	O	O
ER	O	O	B-T116
(	O	O	O
k0.612	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
,	O	O	O
0538	O	O	O
-	O	O	O
0.686	O	O	O
)	O	O	O
,	O	O	O
PgR	O	O	B-T116
(	O	O	O
k0.659	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
,	O	O	O
0580	O	O	O
-	O	O	O
0.737	O	O	O
)	O	O	O
,	O	O	O
Ki-67	O	O	B-T116
(	O	O	O
k0.609	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
,	O	O	O
0.534	O	O	O
-	O	O	O
0.684	O	O	O
)	O	O	O
and	O	O	O
grading	O	O	B-T170
(	O	O	O
k0.669	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
,	O	O	O
0.569	O	O	O
-	O	O	O
0.769	O	O	O
)	O	O	O
.	O	O	O

Moderate	O	O	O
agreement	O	O	O
was	O	O	O
found	O	O	O
for	O	O	O
HER2	O	O	B-T116
(	O	O	O
k0.546	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
,	O	O	O
0444	O	O	O
-	O	O	O
0.649	O	O	O
)	O	O	O
.	O	O	O

DR	O	O	B-T081
was	O	O	O
9.5	O	O	O
%	O	O	O
(	O	O	O
negativity	O	O	O
to	O	O	O
positivity	O	O	O
)	O	O	O
and	O	O	O
31.7	O	O	O
%	O	O	O
(	O	O	O
positivity	O	O	O
to	O	O	O
negativity	O	O	O
)	O	O	O
for	O	O	O
HER2	O	O	B-T116
and	O	O	O
26.2	O	O	O
%	O	O	O
(	O	O	O
negativity	O	O	O
to	O	O	O
positivity	O	O	O
)	O	O	O
and	O	O	O
12.5	O	O	O
%	O	O	O
(	O	O	O
positivity	O	O	O
to	O	O	O
negativity	O	O	O
)	O	O	O
for	O	O	O
ER	O	O	B-T116
/	O	O	O
PgR.	O	O	O
According	O	O	O
to	O	O	O
changes	O	O	O
in	O	O	O
Her2	O	O	B-T116
and	O	O	O
ER	O	O	O
/	O	O	O
PgR	O	O	B-T116
status	O	O	O
,	O	O	O
23	O	O	O
(	O	O	O
12.2	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
33	O	O	O
(	O	O	O
17.6	O	O	O
%	O	O	O
)	O	O	O
systemic	O	O	B-T169
prescription	O	O	B-T058
were	O	O	O
respectively	O	O	O
modified	O	O	O
.	O	O	O

In	O	O	O
our	O	O	O
retrospective	O	O	B-T062
analysis	O	O	I-T062
,	O	O	O
central	O	O	B-T060
pathological	O	O	I-T060
review	O	O	I-T060
has	O	O	O
a	O	O	O
significant	O	O	O
impact	O	O	O
in	O	O	O
the	O	O	O
decision-making	O	O	B-T058
process	O	O	I-T058
in	O	O	O
early	O	O	O
breast	O	O	B-T191
cancer	O	O	I-T191
,	O	O	O
as	O	O	O
shown	O	O	O
in	O	O	O
clinical	O	O	B-T062
trials	O	O	I-T062
.	O	O	O

Further	O	O	O
studies	O	O	O
are	O	O	O
warranted	O	O	O
to	O	O	O
confirm	O	O	O
these	O	O	O
provocative	O	O	O
results	O	O	O
.	O	O	O

-DOCSTART- (27753022)

Implementing	O	O	B-T052
Non-Invasive	O	O	B-T169
Prenatal	O	O	B-T060
Diagnosis	O	O	I-T060
(	O	O	O
NIPD	O	O	B-T060
)	O	O	O
in	O	O	O
a	O	O	O
National	O	O	B-T093
Health	O	O	I-T093
Service	O	O	I-T093
Laboratory	O	O	I-T093
;	O	O	O
From	O	O	O
Dominant	O	O	B-T169
to	O	O	O
Recessive	O	O	B-T045
Disorders	O	O	O

Our	O	O	O
UK	O	O	B-T093
National	O	O	I-T093
Health	O	O	I-T093
Service	O	O	I-T093
regional	O	O	I-T093
genetics	O	O	I-T093
laboratory	O	O	I-T093
offers	O	O	O
NIPD	O	O	B-T060
for	O	O	O
autosomal	O	O	B-T045
dominant	O	O	I-T045
and	O	O	O
de	O	O	B-T078
novo	O	O	I-T078
conditions	O	O	B-T080
(	O	O	O
achondroplasia	O	O	B-T019
,	O	O	O
thanataphoric	O	O	B-T019
dysplasia	O	O	I-T019
,	O	O	O
Apert	O	O	B-T019
syndrome	O	O	I-T019
)	O	O	O
,	O	O	O
paternal	O	O	B-T080
mutation	O	O	B-T045
exclusion	O	O	B-T169
for	O	O	O
cystic	O	O	B-T047
fibrosis	O	O	I-T047
and	O	O	O
a	O	O	O
range	O	O	O
of	O	O	O
bespoke	O	O	B-T060
tests	O	O	I-T060
.	O	O	O

NIPD	O	O	B-T060
avoids	O	O	O
the	O	O	O
risks	O	O	B-T033
associated	O	O	B-T080
with	O	O	I-T080
invasive	O	O	B-T060
testing	O	O	I-T060
,	O	O	O
making	O	O	O
prenatal	O	O	B-T060
diagnosis	O	O	I-T060
more	O	O	B-T081
accessible	O	O	O
to	O	O	O
families	O	O	B-T099
at	O	O	O
high	O	O	B-T080
genetic	O	O	B-T081
risk	O	O	I-T081
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
challenge	O	O	O
remains	O	O	O
in	O	O	O
offering	O	O	O
definitive	O	O	B-T079
diagnosis	O	O	B-T033
for	O	O	O
autosomal	O	O	B-T047
recessive	O	O	I-T047
diseases	O	O	I-T047
,	O	O	O
which	O	O	O
is	O	O	O
complicated	O	O	B-T169
by	O	O	O
the	O	O	O
predominance	O	O	B-T080
of	O	O	O
the	O	O	O
maternal	O	O	B-T099
mutant	O	O	B-T049
allele	O	O	B-T028
in	O	O	O
the	O	O	O
cell-free	O	O	B-T114
DNA	O	O	I-T114
sample	O	O	B-T077
and	O	O	O
thus	O	O	O
requires	O	O	O
a	O	O	O
variety	O	O	B-T077
of	O	O	O
different	O	O	B-T080
approaches	O	O	B-T082
.	O	O	O

Validation	O	O	B-T062
and	O	O	O
diagnostic	O	O	B-T169
implementation	O	O	B-T052
for	O	O	O
NIPD	O	O	B-T060
of	O	O	O
congenital	O	O	B-T047
adrenal	O	O	I-T047
hyperplasia	O	O	I-T047
(	O	O	O
CAH	O	O	B-T047
)	O	O	O
is	O	O	O
further	O	O	O
complicated	O	O	B-T169
by	O	O	O
presence	O	O	B-T033
of	O	O	O
a	O	O	O
pseudogene	O	O	B-T028
that	O	O	O
requires	O	O	O
a	O	O	O
different	O	O	B-T080
approach	O	O	B-T082
.	O	O	O

We	O	O	O
have	O	O	O
used	O	O	O
an	O	O	O
assay	O	O	B-T059
targeting	O	O	B-T169
approximately	O	O	B-T080
6700	O	O	O
heterozygous	O	O	B-T032
SNPs	O	O	B-T086
around	O	O	O
the	O	O	O
CAH	O	O	B-T028
gene	O	O	I-T028
(	O	O	O
CYP21A2	O	O	B-T028
)	O	O	O
to	O	O	O
construct	O	O	O
the	O	O	O
high-risk	O	O	B-T033
parental	O	O	B-T099
haplotypes	O	O	B-T032
and	O	O	O
tested	O	O	O
this	O	O	O
approach	O	O	B-T082
in	O	O	O
five	O	O	O
cases	O	O	O
,	O	O	O
showing	O	O	O
that	O	O	O
inheritance	O	O	B-T081
of	O	O	O
the	O	O	O
parental	O	O	O
alleles	O	O	B-T028
can	O	O	O
be	O	O	O
correctly	O	O	O
identified	O	O	B-T080
using	O	O	O
NIPD	O	O	B-T060
.	O	O	O

We	O	O	O
are	O	O	O
evaluating	O	O	O
various	O	O	O
measures	O	O	B-T081
of	O	O	O
the	O	O	O
fetal	O	O	B-T018
fraction	O	O	O
to	O	O	O
help	O	O	O
determine	O	O	O
inheritance	O	O	B-T081
of	O	O	O
parental	O	O	B-T099
mutations	O	O	B-T045
.	O	O	O

We	O	O	O
are	O	O	O
currently	O	O	O
exploring	O	O	O
the	O	O	O
utility	O	O	B-T080
of	O	O	O
an	O	O	O
NIPD	O	O	B-T060
multi-disorder	O	O	B-T059
panel	O	O	I-T059
for	O	O	O
autosomal	O	O	B-T047
recessive	O	O	I-T047
disease	O	O	I-T047
,	O	O	O
to	O	O	O
make	O	O	O
testing	O	O	B-T169
more	O	O	O
widely	O	O	O
applicable	O	O	B-T080
to	O	O	O
families	O	O	B-T099
with	O	O	O
a	O	O	O
variety	O	O	O
of	O	O	O
serious	O	O	B-T080
genetic	O	O	B-T047
conditions	O	O	I-T047
.	O	O	O

-DOCSTART- (27756117)

Silk	O	O	B-T121
fibroin	O	O	I-T121
based	O	O	O
carrier	O	O	B-T122
system	O	O	I-T122
for	O	O	O
delivery	O	O	B-T169
of	O	O	O
fibrinogen	O	O	B-T116
and	O	O	O
thrombin	O	O	B-T116
as	O	O	O
coagulant	O	O	B-T121
supplements	O	O	O

The	O	O	O
control	O	O	B-T169
of	O	O	O
bleeding	O	O	B-T046
is	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
most	O	O	O
important	O	O	O
interventions	O	O	B-T061
after	O	O	O
a	O	O	O
traumatic	O	O	B-T037
injury	O	O	I-T037
.	O	O	O

Hemostatic	O	O	B-T121
devices	O	O	I-T121
delivering	O	O	B-UnknownType
blood	O	O	B-T046
clotting	O	O	I-T046
accelerating	O	O	O
agents	O	O	B-T121
such	O	O	O
as	O	O	O
fibrinogen	O	O	B-T116
are	O	O	O
increasingly	O	O	B-T169
used	O	O	O
due	O	O	O
to	O	O	O
their	O	O	O
efficacy	O	O	B-T080
and	O	O	O
their	O	O	O
ease	O	O	O
of	O	O	O
application	O	O	B-T058
.	O	O	O

In	O	O	O
the	O	O	O
present	O	O	O
study	O	O	O
,	O	O	O
we	O	O	O
describe	O	O	O
a	O	O	O
method	O	O	B-T170
to	O	O	O
incorporate	O	O	B-T169
the	O	O	O
coagulant	O	O	B-T121
supplements	O	O	B-T169
fibrinogen	O	O	B-T116
and	O	O	O
thrombin	O	O	B-T116
in	O	O	O
silk	O	O	B-T116
protein	O	O	I-T121
sponges	O	O	B-T074
by	O	O	O
mixing	O	O	O
the	O	O	O
coagulants	O	O	B-T121
with	O	O	O
an	O	O	O
aqueous	O	O	B-T121
silk	O	O	O
solution	O	O	O
,	O	O	O
followed	O	O	O
by	O	O	O
molding	O	O	B-T059
,	O	O	O
freeze-drying	O	O	B-T059
and	O	O	O
water	O	O	B-T059
annealing	O	O	I-T059
.	O	O	O

In	O	O	O
this	O	O	O
combination	O	O	B-T080
system	O	O	B-T169
we	O	O	O
demonstrate	O	O	O
the	O	O	O
delivery	O	O	B-T169
of	O	O	O
fibrinogen	O	O	B-T116
while	O	O	O
maintaining	O	O	O
its	O	O	O
hemostatic	O	O	B-T042
potential	O	O	I-T042
.	O	O	O

Concentration	O	O	B-T081
ratios	O	O	I-T081
of	O	O	O
silk	O	O	B-T116
to	O	O	O
fibrinogen	O	O	B-T116
of	O	O	O
1.0%/2.8	O	O	O
%	O	O	O
,	O	O	O
2.3%/1.5	O	O	O
%	O	O	O
and	O	O	O
3.0%/0.8	O	O	O
%	O	O	O
were	O	O	O
used	O	O	O
.	O	O	O

The	O	O	O
thrombin	O	O	B-T116
-induced	O	O	O
fibrin	O	O	B-T116
polymeric	O	O	B-T122
network	O	O	B-T169
filled	O	O	O
the	O	O	O
space	O	O	O
in	O	O	O
and	O	O	O
next	O	O	O
to	O	O	O
the	O	O	O
silk	O	O	B-T116
spongy	O	O	B-T082
structure	O	O	I-T082
but	O	O	O
also	O	O	O
remained	O	O	O
interconnected	O	O	B-UnknownType
to	O	O	O
the	O	O	O
silk	O	O	O
,	O	O	O
providing	O	O	O
an	O	O	O
intact	O	O	B-T080
network	O	O	O
.	O	O	O

The	O	O	O
mechanical	O	O	B-T052
characterization	O	O	I-T052
of	O	O	O
the	O	O	O
fibrinogen-releasing	O	O	B-T169
silk	O	O	B-T116
sponges	O	O	B-T074
before	O	O	O
and	O	O	O
after	O	O	O
the	O	O	O
induction	O	O	B-T169
of	O	O	O
the	O	O	O
fibrinogen	O	O	B-T116
polymerization	O	O	B-T067
demonstrated	O	O	O
that	O	O	O
the	O	O	O
fibrin	O	O	B-T116
network	O	O	B-T169
resulted	O	O	O
in	O	O	O
reduced	O	O	B-T080
permanent	O	O	B-T079
deformation	O	O	B-T169
from	O	O	O
21.1	O	O	O
%	O	O	O
to	O	O	O
6.5	O	O	O
%	O	O	O
,	O	O	O
19.6	O	O	O
%	O	O	O
to	O	O	O
5.7	O	O	O
%	O	O	O
and	O	O	O
12.7	O	O	O
%	O	O	O
to	O	O	O
9.4	O	O	O
%	O	O	O
for	O	O	O
the	O	O	O
2.8	O	O	O
%	O	O	O
,	O	O	O
1.5	O	O	O
%	O	O	O
and	O	O	O
0.8	O	O	O
%	O	O	O
fibrinogen	O	O	O
-containing	O	O	O
silk	O	O	O
sponges	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

Moreover	O	O	O
,	O	O	O
the	O	O	O
fibrin	O	O	B-T116
formation	O	O	B-T169
lead	O	O	O
to	O	O	O
a	O	O	O
more	O	O	O
linear	O	O	B-T082
elastic	O	O	B-T070
behavior	O	O	I-T070
over	O	O	O
longer	O	O	O
strain	O	O	O
ranges	O	O	O
.	O	O	O

In	O	O	O
combination	O	O	O
,	O	O	O
the	O	O	O
Calcein-AM	O	O	B-T109
/	O	O	O
PI	O	O	B-T109
stainings	O	O	B-T130
and	O	O	O
MTT	O	O	B-T062
assay	O	O	I-T062
results	O	O	O
indicate	O	O	O
uniform	O	O	B-T080
cell	O	O	B-T043
adhesion	O	O	I-T043
on	O	O	O
the	O	O	O
surface	O	O	B-T082
and	O	O	O
cytocompatibility	O	O	B-T080
of	O	O	O
the	O	O	O
silk	O	O	B-T116
/	O	O	O
fibrin	O	O	B-T116
sponges	O	O	B-T074
,	O	O	O
respectively	O	O	O
.	O	O	O

Moreover	O	O	O
,	O	O	O
the	O	O	O
co-delivery	O	O	B-T169
of	O	O	O
thrombin	O	O	B-T116
with	O	O	O
fibrinogen	O	O	B-T116
via	O	O	O
silk	O	O	B-T116
as	O	O	O
carrier	O	O	B-T122
material	O	O	I-T122
is	O	O	O
described	O	O	O
,	O	O	O
offering	O	O	O
a	O	O	O
more	O	O	O
mechanically	O	O	B-T169
robust	O	O	B-T080
and	O	O	O
durable	O	O	B-T080
system	O	O	I-T080
while	O	O	O
preserving	O	O	B-T169
hemostatic	O	O	B-T042
features	O	O	I-T042
of	O	O	O
the	O	O	O
coagulant	O	O	B-T121
substances	O	O	I-T121
for	O	O	O
the	O	O	O
generation	O	O	B-T052
of	O	O	O
hemostatic	O	O	B-T121
devices	O	O	I-T121
.	O	O	O

This	O	O	O
article	O	O	O
is	O	O	O
protected	O	O	O
by	O	O	O
copyright	O	O	O
.	O	O	O

All	O	O	O
rights	O	O	O
reserved	O	O	O
.	O	O	O

-DOCSTART- (27757318)

Adoptively	O	O	O
transferred	O	O	O
natural	O	O	B-T025
killer	O	O	I-T025
cells	O	O	I-T025
maintain	O	O	O
long-term	O	O	O
antitumor	O	O	B-T033
activity	O	O	I-T033
by	O	O	O
epigenetic	O	O	B-T045
imprinting	O	O	I-T045
and	O	O	O
CD4(+	O	O	B-T025
)	O	O	I-T025
T	O	O	I-T025
cell	O	O	I-T025
help	O	O	O

Natural	O	O	B-T025
killer	O	O	I-T025
(	O	O	I-T025
NK	O	O	I-T025
)	O	O	I-T025
cell	O	O	I-T025
infusions	O	O	B-T061
can	O	O	O
induce	O	O	O
remissions	O	O	O
in	O	O	O
subsets	O	O	O
of	O	O	O
patients	O	O	B-T101
with	O	O	O
different	O	O	O
types	O	O	O
of	O	O	O
cancer	O	O	B-T191
.	O	O	O

The	O	O	O
optimal	O	O	O
strategies	O	O	O
for	O	O	O
NK	O	O	B-T025
cell	O	O	I-T025
activation	O	O	B-T043
prior	O	O	O
to	O	O	O
infusion	O	O	B-T061
are	O	O	O
still	O	O	O
under	O	O	O
debate	O	O	O
.	O	O	O

There	O	O	O
is	O	O	O
recent	O	O	O
evidence	O	O	O
that	O	O	O
NK	O	O	B-T025
cells	O	O	I-T025
can	O	O	O
acquire	O	O	O
long-term	O	O	O
functional	O	O	O
competence	O	O	O
by	O	O	O
preactivation	O	O	O
with	O	O	O
the	O	O	O
cytokines	O	O	B-T116
IL-12	O	O	B-T116
/	O	O	O
15	O	O	B-T116
/	O	O	O
18	O	O	B-T116
.	O	O	O

The	O	O	O
mechanisms	O	O	O
supporting	O	O	O
the	O	O	O
maintenance	O	O	O
of	O	O	O
long-term	O	O	O
NK	O	O	B-T025
cell	O	O	I-T025
antitumor	O	O	B-T033
activity	O	O	I-T033
are	O	O	O
incompletely	O	O	O
under-stood	O	O	O
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
show	O	O	O
that	O	O	O
NK	O	O	B-T025
cells	O	O	I-T025
preactivated	O	O	O
in	O	O	B-T059
vitro	O	O	I-T059
with	O	O	O
IL-12	O	O	B-T116
/	O	O	O
15	O	O	B-T116
/	O	O	O
18	O	O	B-T116
,	O	O	O
but	O	O	O
not	O	O	O
with	O	O	O
IL-15	O	O	B-T116
alone	O	O	O
,	O	O	O
maintained	O	O	O
high	O	O	O
antitumor	O	O	B-T033
activity	O	O	I-T033
even	O	O	O
1	O	O	B-T079
mo	O	O	I-T079
after	O	O	O
transfer	O	O	O
into	O	O	O
lymphopenic	O	O	B-T047
RAG-2(-/-	O	O	B-T028
)	O	O	I-T028
Î³c(-/-	O	O	O
)	O	O	O
mice	O	O	B-T015
.	O	O	O

The	O	O	O
NK	O	O	B-T025
cell	O	O	I-T025
intrinsic	O	O	O
ability	O	O	O
for	O	O	O
IFNÎ³	O	O	B-T116
production	O	O	O
coincided	O	O	O
with	O	O	O
demethylation	O	O	O
of	O	O	O
the	O	O	O
conserved	O	O	O
non-coding	O	O	B-T114
sequence	O	O	I-T114
(	O	O	O
CNS	O	O	B-T114
)	O	O	O
1	O	O	O
in	O	O	O
the	O	O	O
Ifng	O	O	B-T028
locus	O	O	B-T082
,	O	O	O
previously	O	O	O
shown	O	O	O
to	O	O	O
enhance	O	O	O
transcription	O	O	B-T045
of	O	O	O
Ifng	O	O	O
.	O	O	O

In	O	O	O
a	O	O	O
xenograft	O	O	B-T050
melanoma	O	O	I-T050
mouse	O	O	I-T050
model	O	O	I-T050
,	O	O	O
human	O	O	B-T016
IL-12	O	O	B-T116
/	O	O	O
15	O	O	B-T116
/	O	O	O
18	O	O	B-T116
-preactivated	O	O	O
NK	O	O	B-T025
cells	O	O	I-T025
rejected	O	O	O
tumors	O	O	B-T191
more	O	O	O
efficiently	O	O	O
.	O	O	O

In	O	O	O
RAG-2(-/-	O	O	B-T028
)	O	O	I-T028
Î³c(-/-	O	O	O
)	O	O	O
mice	O	O	B-T015
,	O	O	O
co-transfer	O	O	O
of	O	O	O
CD4(+	O	O	B-T025
)	O	O	I-T025
T	O	O	I-T025
cells	O	O	I-T025
further	O	O	O
improved	O	O	O
the	O	O	O
long-term	O	O	O
competence	O	O	O
of	O	O	O
NK	O	O	B-T025
cells	O	O	I-T025
for	O	O	O
IFNÎ³	O	O	B-T116
production	O	O	O
that	O	O	O
was	O	O	O
dependent	O	O	O
on	O	O	O
IL-2	O	O	B-T116
.	O	O	O

CD4(+	O	O	B-T025
)	O	O	I-T025
T	O	O	I-T025
cell	O	O	I-T025
activation	O	O	B-T043
during	O	O	O
homeostatic	O	O	B-T043
proliferation	O	O	I-T043
required	O	O	O
macrophages	O	O	B-T025
and	O	O	O
further	O	O	O
promoted	O	O	O
the	O	O	O
long-term	O	O	O
NK	O	O	B-T025
cell	O	O	I-T025
antitumor	O	O	B-T033
activity	O	O	I-T033
.	O	O	O

Thus	O	O	O
,	O	O	O
NK	O	O	B-T025
cells	O	O	I-T025
can	O	O	O
"	O	O	O
remember	O	O	O
"	O	O	O
a	O	O	O
previous	O	O	O
exposure	O	O	O
to	O	O	O
cytokines	O	O	B-T116
by	O	O	O
epigenetic	O	O	B-T045
imprinting	O	O	I-T045
resulting	O	O	O
in	O	O	O
a	O	O	O
remarkable	O	O	O
stability	O	O	O
of	O	O	O
the	O	O	O
IFNÎ³	O	O	B-T116
-producing	O	O	O
phenotype	O	O	B-T032
after	O	O	O
adoptive	O	O	O
transfer	O	O	O
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
our	O	O	O
results	O	O	O
support	O	O	O
combination	O	O	O
of	O	O	O
cytokine	O	O	B-T116
-preactivated	O	O	O
NK	O	O	B-T025
cells	O	O	I-T025
with	O	O	O
CD4(+	O	O	B-T025
)	O	O	I-T025
T	O	O	I-T025
cell	O	O	I-T025
activation	O	O	B-T043
upon	O	O	O
lymphopenic	O	O	B-T047
conditioning	O	O	O
to	O	O	O
achieve	O	O	O
long-term	O	O	O
NK	O	O	B-T025
cell	O	O	I-T025
effector	O	O	O
function	O	O	O
for	O	O	O
cancer	O	O	B-T061
immunotherapy	O	O	I-T061
.	O	O	O

-DOCSTART- (27759568)

Survey	O	O	B-T062
of	O	O	O
Neonatal	O	O	B-T093
Intensive	O	O	I-T093
Care	O	O	I-T093
Unit	O	O	I-T093
Nurse	O	O	B-T097
Attitudes	O	O	B-T041
Toward	O	O	O
Therapeutic	O	O	O
Hypothermia	O	O	O
Treatment	O	O	O

The	O	O	O
traumatic	O	O	B-T169
experiences	O	O	O
of	O	O	O
parent	O	O	B-T099
s	O	O	O
of	O	O	O
babies	O	O	B-T100
treated	O	O	B-T061
with	O	O	I-T061
therapeutic	O	O	B-T061
hypothermia	O	O	I-T061
(	O	O	O
TH	O	O	B-T061
)	O	O	O
have	O	O	O
been	O	O	O
described	O	O	O
.	O	O	O

No	O	O	O
research	O	O	B-T062
has	O	O	O
assessed	O	O	B-T052
neonatal	O	O	B-T093
intensive	O	O	I-T093
care	O	O	I-T093
unit	O	O	I-T093
(	O	O	O
NICU	O	O	B-T093
)	O	O	O
nurse	O	O	B-T097
experience	O	O	O
in	O	O	O
providing	O	O	O
care	O	O	O
to	O	O	O
hypothermic	O	O	B-T033
babies	O	O	B-T100
and	O	O	O
emotional	O	O	O
support	O	O	O
to	O	O	O
their	O	O	O
parents	O	O	B-T099
.	O	O	O

To	O	O	O
assess	O	O	O
NICU	O	O	B-T093
nurse	O	O	B-T097
attitudes	O	O	B-T041
to	O	O	O
the	O	O	O
provision	O	O	O
of	O	O	O
TH	O	O	B-T061
with	O	O	O
respect	O	O	O
to	O	O	O
perceptions	O	O	B-T041
about	O	O	O
baby	O	O	B-T100
pain	O	O	B-T184
/	O	O	O
sedation	O	O	B-T061
,	O	O	O
need	O	O	O
for	O	O	O
nurse	O	O	O
and	O	O	O
parent	O	O	B-T099
education	O	O	B-T065
,	O	O	O
decision	O	O	B-T041
making	O	O	I-T041
about	O	O	O
initiation	O	O	B-T169
of	O	O	O
TH	O	O	O
,	O	O	O
and	O	O	O
barriers	O	O	O
to	O	O	O
best	O	O	O
care	O	O	O
.	O	O	O

A	O	O	O
survey	O	O	B-T062
was	O	O	O
electronically	O	O	O
sent	O	O	O
to	O	O	O
219	O	O	O
nurses	O	O	B-T097
at	O	O	O
2	O	O	O
affiliated	O	O	O
academic	O	O	O
level	O	O	O
III	O	O	O
NICUs	O	O	B-T093
:	O	O	O
1	O	O	O
rural	O	O	O
and	O	O	O
1	O	O	O
urban	O	O	O
location	O	O	O
.	O	O	O

There	O	O	O
were	O	O	O
17	O	O	O
questions	O	O	O
where	O	O	O
responses	O	O	B-T170
were	O	O	O
selected	O	O	O
from	O	O	O
a	O	O	O
preset	O	O	O
list	O	O	O
and	O	O	O
7	O	O	O
opportunities	O	O	O
for	O	O	O
nurses	O	O	B-T097
to	O	O	O
provide	O	O	O
free	O	O	O
text	O	O	O
responses	O	O	O
.	O	O	O

The	O	O	O
response	O	O	B-T170
rate	O	O	O
was	O	O	O
38	O	O	O
%	O	O	O
(	O	O	O
N	O	O	O
=	O	O	O
83	O	O	O
)	O	O	O
.	O	O	O

Overwhelming	O	O	B-T080
similarities	O	O	O
between	O	O	O
the	O	O	O
urban	O	O	B-T093
and	O	O	O
rural	O	O	B-T093
institutions	O	O	I-T093
were	O	O	O
found	O	O	O
with	O	O	O
NICU	O	O	B-T093
nurses	O	O	B-T097
expressing	O	O	O
understanding	O	O	O
of	O	O	O
the	O	O	O
indications	O	O	O
for	O	O	O
initiating	O	O	O
TH	O	O	B-T061
,	O	O	O
agreement	O	O	O
that	O	O	O
TH	O	O	O
improves	O	O	O
long-term	O	O	B-T079
outcomes	O	O	B-T080
and	O	O	O
that	O	O	O
the	O	O	O
benefits	O	O	O
of	O	O	O
TH	O	O	O
outweigh	O	O	O
the	O	O	O
risks	O	O	O
.	O	O	O

Nurses	O	O	B-T097
at	O	O	O
the	O	O	O
urban	O	O	B-T093
institution	O	O	I-T093
more	O	O	O
frequently	O	O	O
expressed	O	O	O
concerns	O	O	O
surrounding	O	O	O
inadequate	O	O	O
treatment	O	O	B-T061
of	O	O	O
baby	O	O	B-T100
pain	O	O	B-T184
/	O	O	O
sedation	O	O	B-T061
,	O	O	O
and	O	O	O
nurses	O	O	B-T097
at	O	O	O
both	O	O	O
institutions	O	O	B-UnknownType
strongly	O	O	O
emphasized	O	O	O
the	O	O	O
need	O	O	O
for	O	O	O
more	O	O	O
nurse	O	O	B-T097
and	O	O	O
parent	O	O	B-T099
education	O	O	B-T065
about	O	O	O
TH	O	O	B-T061
and	O	O	O
improved	O	O	O
timeliness	O	O	O
of	O	O	O
decision	O	O	B-T041
making	O	O	I-T041
for	O	O	O
initiation	O	O	B-T169
of	O	O	O
TH	O	O	O
.	O	O	O

NICU	O	O	B-T093
nurses	O	O	B-T097
specifically	O	O	O
want	O	O	O
to	O	O	O
learn	O	O	O
more	O	O	O
about	O	O	O
outcomes	O	O	B-T080
of	O	O	O
babies	O	O	B-T100
after	O	O	O
treatment	O	O	B-T061
with	O	O	O
TH	O	O	B-T061
and	O	O	O
feel	O	O	O
that	O	O	O
parents	O	O	B-T099
need	O	O	O
more	O	O	O
education	O	O	B-T065
about	O	O	O
TH	O	O	O
.	O	O	O

Research	O	O	B-T062
is	O	O	O
urgently	O	O	O
needed	O	O	O
to	O	O	O
better	O	O	O
understand	O	O	O
the	O	O	O
implications	O	O	O
of	O	O	O
TH	O	O	B-T061
treatment	O	O	I-T061
for	O	O	O
parent	O	O	B-T099
-	O	O	O
baby	O	O	B-T100
bonding	O	O	O
.	O	O	O

-DOCSTART- (27759877)

Pharmacological	O	O	B-T061
Venous	O	O	I-T061
Thromboembolism	O	O	I-T061
Prophylaxis	O	O	I-T061
in	O	O	O
Meningioma	O	O	B-T191
Patients	O	O	B-T101
:	O	O	O
Should	O	O	O
It	O	O	O
Be	O	O	O
Earlier	O	O	O
Than	O	O	O
Clinical	O	O	B-T061
Practice	O	O	I-T061
?	O	O	O

We	O	O	O
read	O	O	O
the	O	O	O
report	O	O	B-T170
by	O	O	O
ÃeltikÃ§i	O	O	O
et	O	O	O
al	O	O	O
in	O	O	O
the	O	O	O
Turkish	O	O	B-T093
Neurosurgery	O	O	I-T093
with	O	O	O
great	O	O	O
interest	O	O	O
.	O	O	O

In	O	O	O
this	O	O	O
single-center	O	O	O
retrospective	O	O	B-T062
study	O	O	I-T062
,	O	O	O
they	O	O	O
analysed	O	O	O
449	O	O	O
intracranial	O	O	B-T191
meningioma	O	O	I-T191
patients	O	O	B-T101
underwent	O	O	O
open	O	O	B-T061
surgery	O	O	I-T061
.	O	O	O

They	O	O	O
stated	O	O	O
that	O	O	O
venous	O	O	B-T047
thromboembolism	O	O	I-T047
(	O	O	O
VTE	O	O	B-T047
)	O	O	O
had	O	O	O
been	O	O	O
seen	O	O	O
in	O	O	O
21	O	O	O
(	O	O	O
4.6	O	O	O
%	O	O	O
)	O	O	O
of	O	O	O
their	O	O	O
patients	O	O	B-T101
.	O	O	O

This	O	O	O
is	O	O	O
an	O	O	O
important	O	O	O
issue	O	O	O
because	O	O	O
VTE	O	O	B-T047
,	O	O	O
including	O	O	O
deep	O	O	B-T047
vein	O	O	I-T047
thrombosis	O	O	I-T047
(	O	O	O
DVT	O	O	B-T047
)	O	O	O
and	O	O	O
pulmonary	O	O	B-T047
embolism	O	O	I-T047
(	O	O	O
PE	O	O	B-T047
)	O	O	O
,	O	O	O
is	O	O	O
the	O	O	O
most	O	O	O
common	O	O	O
overall	O	O	O
complication	O	O	B-T046
in	O	O	O
meningioma	O	O	B-T061
surgery	O	O	I-T061
and	O	O	O
is	O	O	O
fatal	O	O	O
in	O	O	O
up	O	O	O
to	O	O	O
one	O	O	O
third	O	O	O
of	O	O	O
patients	O	O	B-T101
(	O	O	O
2	O	O	O
)	O	O	O
.	O	O	O

We	O	O	O
suppose	O	O	O
that	O	O	O
prophylaxis	O	O	B-T061
of	O	O	O
VTE	O	O	B-T047
is	O	O	O
most	O	O	O
effective	O	O	O
when	O	O	O
mechanical	O	O	O
and	O	O	O
pharmacological	O	O	B-T061
prophylaxis	O	O	I-T061
are	O	O	O
combined	O	O	O
.	O	O	O

We	O	O	O
consider	O	O	O
that	O	O	O
there	O	O	O
key	O	O	O
some	O	O	O
practical	O	O	O
questions	O	O	O
to	O	O	O
be	O	O	O
answered	O	O	O
for	O	O	O
a	O	O	O
proper	O	O	O
clinical	O	O	B-T169
extrapolation	O	O	I-T169
.	O	O	O

-DOCSTART- (27760149)

BEST	O	O	B-T170
:	O	O	O
Next-Generation	O	O	B-T079
Biomedical	O	O	B-T170
Entity	O	O	I-T170
Search	O	O	I-T170
Tool	O	O	I-T170
for	O	O	O
Knowledge	O	O	B-T170
Discovery	O	O	B-T052
from	O	O	O
Biomedical	O	O	O
Literature	O	O	O

As	O	O	O
the	O	O	O
volume	O	O	B-T080
of	O	O	O
publications	O	O	B-T073
rapidly	O	O	B-T080
increases	O	O	B-T081
,	O	O	O
searching	O	O	B-T052
for	O	O	O
relevant	O	O	B-T080
information	O	O	B-T078
from	O	O	O
the	O	O	O
literature	O	O	B-T170
becomes	O	O	O
more	O	O	O
challenging	O	O	B-T033
.	O	O	O

To	O	O	O
complement	O	O	O
standard	O	O	B-T080
search	O	O	B-T170
engines	O	O	I-T170
such	O	O	O
as	O	O	O
PubMed	O	O	B-T170
,	O	O	O
it	O	O	O
is	O	O	O
desirable	O	O	B-T080
to	O	O	O
have	O	O	O
an	O	O	O
advanced	O	O	B-T170
search	O	O	I-T170
tool	O	O	I-T170
that	O	O	O
directly	O	O	B-T080
returns	O	O	B-T080
relevant	O	O	B-T080
biomedical	O	O	B-T080
entities	O	O	B-T071
such	O	O	O
as	O	O	O
targets	O	O	B-T074
,	O	O	O
drugs	O	O	B-T121
,	O	O	O
and	O	O	O
mutations	O	O	B-T045
rather	O	O	O
than	O	O	O
a	O	O	O
long	O	O	O
list	O	O	O
of	O	O	O
articles	O	O	O
.	O	O	O

Some	O	O	O
existing	O	O	B-T033
tools	O	O	B-T170
submit	O	O	B-T169
a	O	O	O
query	O	O	B-T170
to	O	O	O
PubMed	O	O	B-T170
and	O	O	O
process	O	O	B-T067
retrieved	O	O	O
abstracts	O	O	B-T170
to	O	O	O
extract	O	O	O
information	O	O	B-T078
at	O	O	O
query	O	O	O
time	O	O	B-T079
,	O	O	O
resulting	O	O	B-T169
in	O	O	O
a	O	O	O
slow	O	O	B-T080
response	O	O	O
time	O	O	O
and	O	O	O
limited	O	O	B-T169
coverage	O	O	B-T169
of	O	O	O
only	O	O	O
a	O	O	O
fraction	O	O	B-T081
of	O	O	I-T081
the	O	O	O
PubMed	O	O	B-T170
corpus	O	O	I-T170
.	O	O	O

Other	O	O	O
tools	O	O	B-T170
preprocess	O	O	B-T066
the	O	O	O
PubMed	O	O	B-T170
corpus	O	O	I-T170
to	O	O	O
speed	O	O	O
up	O	O	O
the	O	O	O
response	O	O	O
time	O	O	B-T079
;	O	O	O
however	O	O	O
,	O	O	O
they	O	O	O
are	O	O	O
not	O	O	O
constantly	O	O	B-T080
updated	O	O	B-T079
,	O	O	O
and	O	O	O
thus	O	O	O
produce	O	O	B-T169
outdated	O	O	B-T170
results	O	O	B-T169
.	O	O	O

Further	O	O	O
,	O	O	O
most	O	O	O
existing	O	O	O
tools	O	O	B-T170
can	O	O	O
not	O	O	O
process	O	O	B-T067
sophisticated	O	O	B-T080
queries	O	O	B-T170
such	O	O	O
as	O	O	O
searches	O	O	B-T052
for	O	O	O
mutations	O	O	B-T045
that	O	O	O
co-occur	O	O	B-T052
with	O	O	O
query	O	O	B-T170
terms	O	O	O
in	O	O	O
the	O	O	O
literature	O	O	B-T170
.	O	O	O

To	O	O	O
address	O	O	O
these	O	O	O
problems	O	O	B-T033
,	O	O	O
we	O	O	O
introduce	O	O	B-T169
BEST	O	O	B-T170
,	O	O	O
a	O	O	O
biomedical	O	O	B-T170
entity	O	O	I-T170
search	O	O	I-T170
tool	O	O	I-T170
.	O	O	O

BEST	O	O	B-T170
returns	O	O	B-T080
,	O	O	O
as	O	O	O
a	O	O	O
result	O	O	B-T169
,	O	O	O
a	O	O	O
list	O	O	O
of	O	O	O
10	O	O	O
different	O	O	B-T080
types	O	O	O
of	O	O	O
biomedical	O	O	B-T080
entities	O	O	B-T071
including	O	O	B-T169
genes	O	O	B-T028
,	O	O	O
diseases	O	O	B-T047
,	O	O	O
drugs	O	O	B-T121
,	O	O	O
targets	O	O	B-T074
,	O	O	O
transcription	O	O	B-T116
factors	O	O	I-T116
,	O	O	O
miRNAs	O	O	B-T114
,	O	O	O
and	O	O	O
mutations	O	O	B-T045
that	O	O	O
are	O	O	O
relevant	O	O	B-T080
to	O	O	O
a	O	O	O
user	O	O	O
's	O	O	O
query	O	O	B-T170
.	O	O	O

To	O	O	O
the	O	O	O
best	O	O	O
of	O	O	O
our	O	O	O
knowledge	O	O	B-T170
,	O	O	O
BEST	O	O	B-T170
is	O	O	O
the	O	O	O
only	O	O	O
system	O	O	B-T169
that	O	O	O
processes	O	O	B-T067
free	O	O	O
text	O	O	B-T170
queries	O	O	B-T170
and	O	O	O
returns	O	O	B-T080
up-to-date	O	O	B-T033
results	O	O	B-T169
in	O	O	O
real	O	O	B-T079
time	O	O	I-T079
including	O	O	B-T169
mutation	O	O	B-T045
information	O	O	B-T078
in	O	O	O
the	O	O	O
results	O	O	O
.	O	O	O

BEST	O	O	B-T170
is	O	O	O
freely	O	O	O
accessible	O	O	O
at	O	O	O
http://best.korea.ac.kr	O	O	O
.	O	O	O

-DOCSTART- (27761213)

Alanine	O	O	B-T116
to	O	O	O
Serine	O	O	B-T116
Variant	O	O	B-T080
at	O	O	O
Position	O	O	O
986	O	O	O
of	O	O	O
Calcium	O	O	B-T116
Sensing	O	O	I-T116
Receptor	O	O	I-T116
and	O	O	O
Colorectal	O	O	B-T191
Cancer	O	O	I-T191
Risk	O	O	O

With	O	O	O
regard	O	O	O
to	O	O	O
the	O	O	O
effect	O	O	B-T080
of	O	O	O
calcium	O	O	B-T121
against	O	O	O
colorectal	O	O	B-T191
cancer	O	O	I-T191
(	O	O	O
CRC	O	O	B-T191
)	O	O	O
and	O	O	O
considering	O	O	O
the	O	O	O
key	O	O	O
role	O	O	B-T077
of	O	O	O
calcium	O	O	B-T116
sensing	O	O	I-T116
receptor	O	O	I-T116
(	O	O	O
CaSR	O	O	B-T116
)	O	O	O
in	O	O	O
calcium	O	O	B-T121
homeostasis	O	O	I-T121
,	O	O	O
this	O	O	O
study	O	O	O
investigated	O	O	B-T169
whether	O	O	O
CaSR	O	O	B-T028
gene	O	O	I-T028
rs1801725	O	O	B-T028
or	O	O	O
A986S	O	O	B-T028
variant	O	O	I-T028
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
susceptibility	O	O	B-T169
to	O	O	O
CRC	O	O	O
risk	O	O	B-T078
.	O	O	O

This	O	O	O
study	O	O	O
was	O	O	O
conducted	O	O	O
as	O	O	O
a	O	O	O
case-control	O	O	B-T062
study	O	O	I-T062
and	O	O	O
303	O	O	O
cases	O	O	B-T169
with	O	O	O
CRC	O	O	B-T191
and	O	O	O
354	O	O	O
controls	O	O	B-T096
were	O	O	O
enrolled	O	O	O
.	O	O	O

All	O	O	O
657	O	O	O
subjects	O	O	B-T096
were	O	O	O
genotyped	O	O	B-T032
for	O	O	O
CaSR	O	O	B-T028
gene	O	O	I-T028
A986S	O	O	B-T028
variant	O	O	I-T028
using	O	O	O
PCR	O	O	B-T063
-	O	O	O
RFLP	O	O	B-T059
method	O	O	I-T059
.	O	O	O

No	O	O	B-T033
significant	O	O	I-T033
difference	O	O	B-T080
was	O	O	O
observed	O	O	B-T169
for	O	O	O
the	O	O	O
A986S	O	O	B-T028
variant	O	O	I-T028
of	O	O	O
CaSR	O	O	B-T028
gene	O	O	I-T028
in	O	O	O
either	O	O	O
genotype	O	O	B-T032
or	O	O	O
allele	O	O	B-T081
frequencies	O	O	I-T081
between	O	O	O
the	O	O	O
cases	O	O	B-T169
and	O	O	O
the	O	O	O
controls	O	O	B-T096
and	O	O	O
this	O	O	O
lack	O	O	B-T080
of	O	O	O
difference	O	O	O
remained	O	O	O
non-significant	O	O	O
even	O	O	O
after	O	O	O
adjustment	O	O	B-T169
for	O	O	O
age	O	O	B-T032
,	O	O	O
BMI	O	O	B-T201
,	O	O	O
sex	O	O	B-T032
,	O	O	O
smoking	O	O	B-T201
status	O	O	I-T201
,	O	O	O
and	O	O	O
family	O	O	B-T033
history	O	O	I-T033
of	O	O	O
CRC	O	O	B-T191
.	O	O	O

No	O	O	B-T080
evidence	O	O	I-T080
for	O	O	O
the	O	O	O
effect	O	O	B-T080
modification	O	O	B-T033
of	O	O	O
the	O	O	O
association	O	O	B-T080
A986S	O	O	B-T028
variant	O	O	I-T028
and	O	O	O
CRC	O	O	B-T191
by	O	O	O
BMI	O	O	B-T201
,	O	O	O
sex	O	O	B-T032
,	O	O	O
or	O	O	O
tumor	O	O	B-T082
site	O	O	I-T082
was	O	O	O
also	O	O	O
observed	O	O	B-T169
.	O	O	O

Furthermore	O	O	O
,	O	O	O
the	O	O	O
risk	O	O	B-T078
of	O	O	O
obesity	O	O	B-T047
in	O	O	O
relation	O	O	B-T080
to	O	O	O
the	O	O	O
A986S	O	O	B-T028
variant	O	O	I-T028
in	O	O	O
the	O	O	O
controls	O	O	B-T096
and	O	O	O
the	O	O	O
cases	O	O	B-T169
was	O	O	O
separately	O	O	O
analyzed	O	O	B-T062
and	O	O	O
we	O	O	O
observed	O	O	O
no	O	O	B-T033
significant	O	O	I-T033
difference	O	O	I-T033
between	O	O	O
normal	O	O	B-T033
weight	O	O	I-T033
(	O	O	O
BMI	O	O	B-T201
<	O	O	O
25kg/m(2	O	O	O
)	O	O	O
)	O	O	O
and	O	O	O
overweight	O	O	B-T184
/	O	O	O
obese	O	O	B-T047
(	O	O	O
BMI	O	O	O
â¥	O	O	O
25kg/m(2	O	O	O
)	O	O	O
)	O	O	O
subjects	O	O	B-T096
.	O	O	O

Our	O	O	O
findings	O	O	B-T033
do	O	O	O
not	O	O	O
support	O	O	O
a	O	O	O
role	O	O	B-T077
for	O	O	O
effect	O	O	B-T080
of	O	O	O
the	O	O	O
CaSR	O	O	B-T028
gene	O	O	I-T028
A986S	O	O	B-T028
variant	O	O	I-T028
on	O	O	O
CRC	O	O	B-T191
risk	O	O	B-T078
;	O	O	O
nevertheless	O	O	O
,	O	O	O
this	O	O	O
finding	O	O	B-T033
requires	O	O	O
confirmation	O	O	B-T033
and	O	O	O
the	O	O	O
role	O	O	O
of	O	O	O
the	O	O	O
gene	O	O	B-T028
variant	O	O	I-T028
in	O	O	O
carcinogenesis	O	O	B-T191
needs	O	O	O
to	O	O	O
be	O	O	O
further	O	O	O
investigated	O	O	B-T169
.	O	O	O

-DOCSTART- (27762482)

Treatment	O	O	B-T061
of	O	O	O
erythematotelangiectatic	O	O	B-T047
rosacea	O	O	I-T047
with	O	O	O
the	O	O	O
fractionation	O	O	B-T061
of	O	O	O
high-fluence	O	O	B-T079
,	O	O	O
long-pulsed	O	O	O
595-nm	O	O	O
pulsed	O	O	O
dye	O	O	O
laser	O	O	O

Various	O	O	O
lasers	O	O	B-T073
have	O	O	O
been	O	O	O
used	O	O	O
for	O	O	O
the	O	O	O
treatment	O	O	B-T061
of	O	O	O
erythematotelangiectatic	O	O	B-T047
rosacea	O	O	I-T047
(	O	O	O
ETR	O	O	B-T047
)	O	O	O
that	O	O	O
does	O	O	O
not	O	O	O
respond	O	O	O
to	O	O	O
systemic	O	O	B-T061
or	O	O	O
topical	O	O	B-T061
therapy	O	O	I-T061
.	O	O	O

The	O	O	O
pulsed	O	O	B-T074
dye	O	O	I-T074
lasers	O	O	I-T074
(	O	O	O
PDLs	O	O	B-T074
)	O	O	O
are	O	O	O
an	O	O	O
effective	O	O	O
option	O	O	O
for	O	O	O
ETR	O	O	B-T047
,	O	O	O
and	O	O	O
the	O	O	O
purpuragenic	O	O	B-T047
fluence	O	O	B-T079
proved	O	O	O
to	O	O	O
be	O	O	O
superior	O	O	O
until	O	O	O
now	O	O	O
.	O	O	O

Given	O	O	O
that	O	O	O
purpura	O	O	B-T047
and	O	O	O
subsequent	O	O	O
possible	O	O	O
postinflammatory	O	O	B-T046
hyperpigmentation	O	O	I-T046
(	O	O	O
PIH	O	O	B-T046
)	O	O	O
are	O	O	O
occasionally	O	O	O
unbearable	O	O	O
in	O	O	O
some	O	O	O
patients	O	O	B-T101
,	O	O	O
and	O	O	O
several	O	O	O
studies	O	O	O
using	O	O	O
the	O	O	O
low	O	O	O
nonpurpuragenic	O	O	B-T033
fluence	O	O	B-T079
were	O	O	O
reported	O	O	O
.	O	O	O

To	O	O	O
deliver	O	O	O
the	O	O	O
sufficient	O	O	O
high	O	O	B-T079
fluence	O	O	I-T079
of	O	O	O
a	O	O	O
PDL	O	O	B-T074
without	O	O	O
generating	O	O	O
purpura	O	O	B-T047
,	O	O	O
we	O	O	O
designed	O	O	O
the	O	O	O
fractionation	O	O	B-T061
of	O	O	O
high	O	O	O
fluence	O	O	O
using	O	O	O
five	O	O	O
passes	O	O	O
and	O	O	O
longer	O	O	O
pulse	O	O	O
duration	O	O	O
(	O	O	O
6	O	O	O
milliseconds	O	O	O
)	O	O	O
of	O	O	O
a	O	O	O
PDL	O	O	O
in	O	O	O
succession	O	O	O
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
eight	O	O	O
patients	O	O	B-T101
with	O	O	O
ETR	O	O	B-T047
were	O	O	O
enrolled	O	O	O
in	O	O	O
this	O	O	O
study	O	O	O
;	O	O	O
all	O	O	O
patients	O	O	O
were	O	O	O
treated	O	O	O
with	O	O	O
PDL	O	O	B-T074
10	O	O	O
times	O	O	O
at	O	O	O
2-week	O	O	O
intervals	O	O	O
.	O	O	O

Erythema	O	O	B-T047
and	O	O	O
telangiectasia	O	O	B-T047
scores	O	O	O
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
improvement	O	O	O
,	O	O	O
were	O	O	O
assessed	O	O	O
by	O	O	O
two	O	O	O
physicians	O	O	B-T097
using	O	O	O
the	O	O	O
digital	O	O	B-T170
photographs	O	O	I-T170
.	O	O	O

Moderate-to-marked	O	O	O
improvement	O	O	O
was	O	O	O
achieved	O	O	O
in	O	O	O
most	O	O	O
of	O	O	O
the	O	O	O
patients	O	O	B-T101
,	O	O	O
and	O	O	O
erythema	O	O	B-T047
and	O	O	O
telangiectasia	O	O	B-T047
scores	O	O	O
were	O	O	O
significantly	O	O	O
decreased	O	O	O
.	O	O	O

Purpura	O	O	B-T047
and	O	O	O
PIH	O	O	B-T046
were	O	O	O
not	O	O	O
reported	O	O	O
in	O	O	O
all	O	O	O
patients	O	O	B-T101
.	O	O	O

The	O	O	O
fractionation	O	O	B-T061
of	O	O	O
high-fluence	O	O	B-T079
,	O	O	O
long-pulsed	O	O	O
595	O	O	O
nm	O	O	O
PDL	O	O	B-T074
is	O	O	O
a	O	O	O
very	O	O	O
safe	O	O	O
and	O	O	O
effective	O	O	O
treatment	O	O	B-T061
for	O	O	O
ETR	O	O	B-T047
.	O	O	O

-DOCSTART- (27764714)

Propulsion	O	O	B-T041
strategy	O	O	I-T041
in	O	O	O
the	O	O	O
gait	O	O	B-T033
of	O	O	O
primary	O	O	B-T073
school	O	O	I-T073
children	O	O	B-T100
;	O	O	O
the	O	O	O
effect	O	O	B-T080
of	O	O	O
age	O	O	B-T032
and	O	O	O
speed	O	O	O

The	O	O	O
strategy	O	O	B-T041
used	O	O	O
to	O	O	O
generate	O	O	B-T052
power	O	O	B-T081
for	O	O	O
forward	O	O	O
propulsion	O	O	B-T040
in	O	O	O
walking	O	O	B-T056
and	O	O	O
running	O	O	B-T056
has	O	O	O
recently	O	O	O
been	O	O	O
highlighted	O	O	O
as	O	O	O
a	O	O	O
marker	O	O	B-T201
of	O	O	O
gait	O	O	B-T033
maturation	O	O	B-T040
and	O	O	O
elastic	O	O	B-T081
energy	O	O	I-T081
recycling	O	O	B-T169
.	O	O	O

This	O	O	O
study	O	O	B-T062
investigated	O	O	B-T058
ankle	O	O	B-T029
and	O	O	O
hip	O	O	B-T023
power	O	O	B-T081
generation	O	O	B-T052
as	O	O	O
a	O	O	O
propulsion	O	O	B-T041
strategy	O	O	I-T041
(	O	O	O
PS	O	O	B-T041
)	O	O	O
during	O	O	O
the	O	O	O
late	O	O	B-T033
stance	O	O	I-T033
/	O	O	O
early	O	O	B-T033
swing	O	O	I-T033
phases	O	O	I-T033
of	O	O	O
walking	O	O	B-T056
and	O	O	O
running	O	O	B-T056
in	O	O	O
typically	O	O	B-T067
developing	O	O	I-T067
(	O	O	O
TD	O	O	B-T067
)	O	O	O
children	O	O	B-T100
(	O	O	O
15	O	O	O
:	O	O	O
six	O	O	O
to	O	O	O
nine	O	O	O
years	O	O	B-T079
;	O	O	O
17	O	O	O
:	O	O	O
nine	O	O	O
to	O	O	O
13	O	O	O
years	O	O	O
)	O	O	O
using	O	O	O
three-dimensional	O	O	B-T082
gait	O	O	B-T060
analysis	O	O	I-T060
.	O	O	O

Peak	O	O	B-T080
ankle	O	O	B-T029
power	O	O	B-T081
generation	O	O	B-T052
at	O	O	O
push-off	O	O	B-T080
(	O	O	O
peakA2	O	O	B-T080
)	O	O	O
,	O	O	O
peak	O	O	B-T080
hip	O	O	B-T023
power	O	O	O
generation	O	O	O
in	O	O	O
early	O	O	B-T033
swing	O	O	I-T033
(	O	O	O
peakH3	O	O	B-T080
)	O	O	O
and	O	O	O
propulsion	O	O	B-T040
strategy	O	O	I-T041
(	O	O	B-T041
PS	O	O	I-T041
)	O	O	I-T041
[	O	O	O
peakA2	O	O	O
/	O	O	O
(	O	O	B-T080
peakA2+peakH3	O	O	I-T080
)	O	O	O
]	O	O	O
were	O	O	O
calculated	O	O	B-T169
to	O	O	O
provide	O	O	O
the	O	O	O
relative	O	O	O
contribution	O	O	O
of	O	O	O
ankle	O	O	O
power	O	O	O
to	O	O	O
total	O	O	O
propulsion	O	O	O
.	O	O	O

Mean	O	O	B-T081
PS	O	O	B-T041
values	O	O	B-T080
decreased	O	O	B-T081
as	O	O	O
speed	O	O	B-T081
increased	O	O	B-T081
for	O	O	O
comfortable	O	O	B-T056
walking	O	O	B-T056
(	O	O	O
p<0.001	O	O	O
)	O	O	O
,	O	O	O
fast	O	O	B-T080
walking	O	O	O
(	O	O	O
p<0.001	O	O	O
)	O	O	O
and	O	O	O
fast	O	O	O
running	O	O	B-T056
(	O	O	O
p<0.001	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
less	O	O	O
consistently	O	O	O
during	O	O	O
jogging	O	O	B-T056
(	O	O	O
p=0.054	O	O	O
)	O	O	O
.	O	O	O

PS	O	O	B-T041
varied	O	O	O
with	O	O	O
age	O	O	B-T032
(	O	O	O
p<0.001	O	O	O
)	O	O	O
only	O	O	O
during	O	O	O
fast	O	O	B-T080
walking	O	O	B-T056
.	O	O	O

At	O	O	O
any	O	O	O
speed	O	O	B-T081
of	O	O	O
fast	O	O	B-T080
walking	O	O	B-T056
,	O	O	O
older	O	O	B-T100
children	O	O	I-T100
generated	O	O	B-T052
more	O	O	O
peakA2	O	O	B-T080
(	O	O	O
p=0.001	O	O	O
)	O	O	O
and	O	O	O
less	O	O	O
peakH3	O	O	B-T080
(	O	O	O
p=0.001	O	O	O
)	O	O	O
than	O	O	O
younger	O	O	B-T100
children	O	O	I-T100
.	O	O	O

While	O	O	O
the	O	O	O
kinetics	O	O	B-T070
of	O	O	O
running	O	O	B-T056
propulsion	O	O	B-T040
appear	O	O	O
to	O	O	O
be	O	O	O
developed	O	O	O
by	O	O	O
age	O	O	B-T032
six	O	O	O
years	O	O	B-T079
,	O	O	O
the	O	O	O
skills	O	O	B-T055
of	O	O	O
fast	O	O	B-T080
walking	O	O	B-T056
appeared	O	O	O
to	O	O	O
require	O	O	O
additional	O	O	O
neuromuscular	O	O	B-T080
maturity	O	O	B-UnknownType
.	O	O	O

These	O	O	O
findings	O	O	B-T033
support	O	O	O
the	O	O	O
concept	O	O	O
that	O	O	O
running	O	O	B-T056
is	O	O	O
a	O	O	O
skill	O	O	B-T055
that	O	O	O
matures	O	O	B-T040
early	O	O	B-T079
for	O	O	O
TD	O	O	B-T067
children	O	O	B-T100
.	O	O	O

-DOCSTART- (27764968)

The	O	O	O
relationship	O	O	B-T080
between	O	O	O
anthropometry	O	O	B-T062
and	O	O	O
body	O	O	B-T032
composition	O	O	I-T032
from	O	O	O
computed	O	O	B-T060
tomography	O	O	I-T060
:	O	O	O
The	O	O	O
Mediators	O	O	O
of	O	O	O
Atherosclerosis	O	O	B-T047
in	O	O	O
South	O	O	B-T098
Asians	O	O	I-T098
Living	O	O	B-T078
in	O	O	O
America	O	O	B-T083
Study	O	O	O

Few	O	O	O
studies	O	O	O
examine	O	O	O
the	O	O	O
relationships	O	O	B-T080
between	O	O	O
anthropometry	O	O	B-T062
and	O	O	O
the	O	O	O
body	O	O	B-T032
composition	O	O	I-T032
measures	O	O	O
they	O	O	O
approximate	O	O	O
,	O	O	O
or	O	O	O
whether	O	O	O
they	O	O	O
differ	O	O	O
by	O	O	O
sex	O	O	B-T032
,	O	O	O
and	O	O	O
no	O	O	O
studies	O	O	O
have	O	O	O
examined	O	O	O
these	O	O	O
relationships	O	O	O
in	O	O	O
South	O	O	B-T098
Asians	O	O	I-T098
living	O	O	O
in	O	O	O
the	O	O	O
US	O	O	B-T083
.	O	O	O

We	O	O	O
conducted	O	O	O
a	O	O	O
cross-sectional	O	O	B-T062
study	O	O	I-T062
of	O	O	O
871	O	O	O
participants	O	O	B-T098
in	O	O	O
the	O	O	O
Mediators	O	O	O
of	O	O	O
Atherosclerosis	O	O	B-T047
in	O	O	O
South	O	O	B-T098
Asians	O	O	I-T098
Living	O	O	B-T078
in	O	O	O
America	O	O	B-T083
(	O	O	B-T062
MASALA	O	O	I-T062
)	O	O	I-T062
Study	O	O	I-T062
who	O	O	O
had	O	O	O
BMI	O	O	B-T201
<	O	O	O
40	O	O	O
kg/m(2	O	O	O
)	O	O	O
and	O	O	O
underwent	O	O	O
abdominal	O	O	B-T060
CT	O	O	I-T060
scans	O	O	I-T060
for	O	O	O
measurement	O	O	B-T169
of	O	O	O
visceral	O	O	B-T024
and	O	O	O
subcutaneous	O	O	B-T024
fat	O	O	I-T024
.	O	O	O

Linear	O	O	B-T081
regression	O	O	I-T081
was	O	O	O
used	O	O	O
to	O	O	O
model	O	O	B-T170
the	O	O	O
associations	O	O	O
between	O	O	O
anthropometric	O	O	B-T170
measures	O	O	I-T170
and	O	O	O
naturally	O	O	O
log-transformed	O	O	O
body	O	O	B-T032
composition	O	O	I-T032
measures	O	O	O
.	O	O	O

All	O	O	O
measures	O	O	O
of	O	O	O
anthropometry	O	O	B-T062
,	O	O	O
except	O	O	O
height	O	O	B-T032
,	O	O	O
were	O	O	O
significantly	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
visceral	O	O	B-T024
fat	O	O	I-T024
and	O	O	O
had	O	O	O
a	O	O	O
significant	O	O	B-T078
non-linear	O	O	O
component	O	O	O
(	O	O	O
p	O	O	O
<	O	O	O
.05	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
only	O	O	O
associations	O	O	O
for	O	O	O
visceral	O	O	B-T024
fat	O	O	I-T024
that	O	O	O
exhibited	O	O	O
significant	O	O	B-T078
heterogeneity	O	O	B-T080
by	O	O	O
sex	O	O	B-T032
were	O	O	O
waist	O	O	B-T201
circumference	O	O	I-T201
(	O	O	O
%	O	O	O
difference	O	O	O
in	O	O	O
visceral	O	O	O
fat	O	O	O
slope	O	O	O
:	O	O	O
women	O	O	B-T098
1.92	O	O	O
,	O	O	O
men	O	O	B-T098
2.74	O	O	O
,	O	O	O
p	O	O	O
=	O	O	O
.007	O	O	O
for	O	O	O
interaction	O	O	O
)	O	O	O
and	O	O	O
waist-to-hip	O	O	B-T032
ratio	O	O	I-T032
(	O	O	O
women	O	O	O
25.9	O	O	O
,	O	O	O
men	O	O	O
717.4	O	O	O
,	O	O	O
p	O	O	O
<	O	O	O
.001	O	O	O
)	O	O	O
.	O	O	O

Except	O	O	O
for	O	O	O
height	O	O	B-T032
,	O	O	O
all	O	O	O
measures	O	O	O
of	O	O	O
anthropometry	O	O	B-T062
were	O	O	O
significantly	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
subcutaneous	O	O	B-T024
fat	O	O	I-T024
,	O	O	O
had	O	O	O
a	O	O	O
significant	O	O	B-T078
quadratic	O	O	O
component	O	O	O
,	O	O	O
and	O	O	O
significant	O	O	O
heterogeneity	O	O	B-T080
by	O	O	O
sex	O	O	B-T032
(	O	O	O
weight	O	O	B-T032
(	O	O	O
kg	O	O	O
):	O	O	O
2.74	O	O	O
for	O	O	O
women	O	O	B-T098
,	O	O	O
4.08	O	O	O
for	O	O	O
men	O	O	B-T098
;	O	O	O
BMI	O	O	B-T201
(	O	O	O
kg/m(2	O	O	O
)	O	O	O
):	O	O	O
10.3	O	O	O
,	O	O	O
14.0	O	O	O
;	O	O	O
waist	O	O	B-T201
circumference	O	O	I-T201
(	O	O	O
cm	O	O	O
):	O	O	O
1.51	O	O	O
,	O	O	O
3.36	O	O	O
;	O	O	O
hip	O	O	B-T201
circumference	O	O	I-T201
(	O	O	O
cm	O	O	O
):	O	O	O
2.53	O	O	O
,	O	O	O
4.50	O	O	O
)	O	O	O
with	O	O	O
p	O	O	O
<	O	O	O
.001	O	O	O
for	O	O	O
each	O	O	O
.	O	O	O

In	O	O	O
MASALA	O	O	O
participants	O	O	B-T098
,	O	O	O
the	O	O	O
relationships	O	O	B-T080
of	O	O	O
anthropometric	O	O	B-T170
measures	O	O	I-T170
with	O	O	O
visceral	O	O	B-T024
and	O	O	O
subcutaneous	O	O	B-T024
fat	O	O	I-T024
appear	O	O	O
similar	O	O	O
to	O	O	O
other	O	O	O
race	O	O	B-T098
/	O	O	O
ethnic	O	O	B-T098
groups	O	O	I-T098
,	O	O	O
but	O	O	O
with	O	O	O
weaker	O	O	B-T080
non-linearity	O	O	O
and	O	O	O
heterogeneity	O	O	B-T080
by	O	O	O
sex	O	O	B-T032
.	O	O	O

Given	O	O	O
these	O	O	O
results	O	O	O
,	O	O	O
researchers	O	O	B-T097
should	O	O	O
consider	O	O	O
separate	O	O	O
models	O	O	O
by	O	O	O
sex	O	O	B-T032
for	O	O	O
US	O	O	O
South	O	O	B-T098
Asians	O	O	I-T098
when	O	O	O
approximating	O	O	O
subcutaneous	O	O	B-T024
fat	O	O	I-T024
or	O	O	O
when	O	O	O
using	O	O	O
waist	O	O	B-T201
circumference	O	O	I-T201
to	O	O	O
approximate	O	O	O
visceral	O	O	B-T024
fat	O	O	I-T024
.	O	O	O

-DOCSTART- (27765873)

Active	O	O	B-T169
packaging	O	O	B-T068
of	O	O	O
chicken	O	O	B-T168
meats	O	O	I-T168
with	O	O	O
modified	O	O	B-T169
atmosphere	O	O	B-T070
including	O	O	O
oxygen	O	O	B-T121
scavengers	O	O	O

The	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
modified	O	O	B-T169
atmosphere	O	O	B-T070
packaging	O	O	B-T068
(	O	O	O
MAP	O	O	B-T070
-70	O	O	O
%	O	O	O
CO2	O	O	B-T123
/30	O	O	O
%	O	O	O
N2	O	O	B-T123
)	O	O	O
and	O	O	O
iron	O	O	B-T121
-based	O	O	O
oxygen	O	O	B-T121
scavengers	O	O	B-T120
(	O	O	O
OS	O	O	B-T120
)	O	O	O
with	O	O	O
various	O	O	O
absorption	O	O	O
capacities	O	O	O
(	O	O	O
Ageless	O	O	O
(	O	O	O
Â®	O	O	O
)	O	O	O
ss100	O	O	O
,	O	O	O
ss300	O	O	O
,	O	O	O
and	O	O	O
ss500	O	O	O
)	O	O	O
as	O	O	O
an	O	O	O
active	O	O	O
packaging	O	O	B-T073
system	O	O	I-T073
on	O	O	O
microbiological	O	O	B-T170
and	O	O	O
oxidative	O	O	B-T169
changes	O	O	B-T169
in	O	O	O
chicken	O	O	B-T168
thigh	O	O	I-T168
meats	O	O	I-T168
were	O	O	O
evaluated	O	O	O
during	O	O	O
refrigerated	O	O	B-T169
storage	O	O	I-T169
(	O	O	O
4	O	O	O
Â°	O	O	O
C	O	O	O
)	O	O	O
for	O	O	O
19	O	O	O
d	O	O	O
at	O	O	O
3-	O	O	O
day	O	O	B-T079
intervals	O	O	B-T079
.	O	O	O

Total	O	O	B-T081
aerobic	O	O	I-T081
mesophilic	O	O	I-T081
bacteria	O	O	I-T081
counts	O	O	I-T081
exceeded	O	O	O
the	O	O	O
acceptability	O	O	B-T081
limit	O	O	I-T081
at	O	O	O
d	O	O	O
7	O	O	O
in	O	O	O
the	O	O	O
control	O	O	B-T096
group	O	O	I-T096
without	O	O	O
MAP	O	O	B-T070
(	O	O	O
AIR	O	O	B-T167
)	O	O	O
,	O	O	O
and	O	O	O
at	O	O	O
d	O	O	O
19	O	O	O
in	O	O	O
MAP	O	O	O
and	O	O	O
OS	O	O	B-T120
containing	O	O	O
samples	O	O	B-T167
.	O	O	O

OS	O	O	B-T120
utilization	O	O	B-T169
resulted	O	O	O
in	O	O	O
around	O	O	O
1.5	O	O	O
and	O	O	O
1.0	O	O	O
log	O	O	O
unit	O	O	O
reductions	O	O	B-T080
in	O	O	O
Pseudomonas	O	O	O
spp	O	O	O
.	O	O	O

counts	O	O	B-T081
at	O	O	O
d	O	O	O
7	O	O	O
and	O	O	O
d	O	O	O
10	O	O	O
of	O	O	O
storage	O	O	B-T169
,	O	O	O
respectively	O	O	O
,	O	O	O
as	O	O	O
compared	O	O	O
with	O	O	O
AIR	O	O	B-T167
and	O	O	O
MAP	O	O	B-T070
groups	O	O	B-T078
(	O	O	O
P	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
.	O	O	O

MAP	O	O	B-T070
and	O	O	O
OS	O	O	B-T120
groups	O	O	B-T078
had	O	O	O
fewer	O	O	O
(	O	O	O
P	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
coliform	O	O	B-T081
counts	O	O	I-T081
than	O	O	O
did	O	O	O
the	O	O	O
AIR	O	O	B-T167
group	O	O	B-T078
,	O	O	O
with	O	O	O
an	O	O	O
approximately	O	O	O
1.0	O	O	O
log	O	O	O
reduction	O	O	B-T080
observed	O	O	O
at	O	O	O
d	O	O	O
10	O	O	O
.	O	O	O

Although	O	O	O
in	O	O	O
some	O	O	O
cases	O	O	B-T169
OS	O	O	B-T120
utilization	O	O	B-T169
resulted	O	O	O
in	O	O	O
lower	O	O	O
TBARS	O	O	B-T109
values	O	O	B-T081
and	O	O	O
carbonyl	O	O	B-T077
and	O	O	O
sulphydryl	O	O	B-T077
contents	O	O	I-T077
,	O	O	O
particularly	O	O	O
during	O	O	O
later	O	O	O
stages	O	O	B-T079
of	O	O	O
refrigerated	O	O	B-T169
storage	O	O	I-T169
as	O	O	O
compared	O	O	O
to	O	O	O
AIR	O	O	B-T167
and	O	O	O
MAP	O	O	B-T070
groups	O	O	B-T078
,	O	O	O
in	O	O	O
general	O	O	O
,	O	O	O
these	O	O	O
effects	O	O	B-T080
were	O	O	O
not	O	O	O
always	O	O	O
apparent	O	O	O
.	O	O	O

The	O	O	O
results	O	O	O
of	O	O	O
this	O	O	O
study	O	O	O
suggested	O	O	O
that	O	O	O
MAP	O	O	B-T070
suppressed	O	O	B-T169
microbiological	O	O	B-T067
growth	O	O	I-T067
and	O	O	O
retarded	O	O	O
lipid	O	O	B-T044
and	O	O	O
protein	O	O	B-T044
oxidation	O	O	I-T044
in	O	O	O
chicken	O	O	B-T168
thigh	O	O	I-T168
meats	O	O	I-T168
,	O	O	O
with	O	O	O
a	O	O	O
9-	O	O	O
day	O	O	B-T079
shelf-life	O	O	B-T070
extention	O	O	O
with	O	O	O
insignificant	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
OS	O	O	B-T120
.	O	O	O

-DOCSTART- (27766173)

Multidrug	O	O	B-T032
Resistance	O	O	I-T032
of	O	O	O
Acinetobacter	O	O	B-T007
Baumannii	O	O	I-T007
in	O	O	O
Ladoke	O	O	B-T093
Akintola	O	O	I-T093
University	O	O	I-T093
Teaching	O	O	I-T093
Hospital	O	O	I-T093
,	O	O	O
Osogbo	O	O	O
,	O	O	O
Nigeria	O	O	O

Acinetobacter	O	O	B-T007
baumannii	O	O	I-T007
is	O	O	O
a	O	O	O
ubiquitous	O	O	O
pathogen	O	O	B-T001
that	O	O	O
has	O	O	O
emerged	O	O	O
as	O	O	O
a	O	O	O
major	O	O	O
cause	O	O	O
of	O	O	O
healthcare-associated	O	O	B-T046
infections	O	O	I-T046
at	O	O	O
Ladoke	O	O	B-T093
Akintola	O	O	I-T093
University	O	O	I-T093
Teaching	O	O	I-T093
Hospital	O	O	I-T093
.	O	O	O

Isolates	O	O	B-T123
were	O	O	O
assayed	O	O	B-T059
according	O	O	O
to	O	O	O
standard	O	O	B-T170
protocol	O	O	I-T170
.	O	O	O

The	O	O	O
isolates	O	O	B-T123
were	O	O	O
subjected	O	O	O
to	O	O	O
molecular	O	O	B-T063
techniques	O	O	I-T063
to	O	O	O
detect	O	O	O
blaOXA	O	O	B-T028
,	O	O	I-T028
blaTEM	O	O	I-T028
,	O	O	I-T028
blaCTX-M	O	O	I-T028
,	O	O	I-T028
and	O	O	I-T028
blaSHV	O	O	I-T028
genes	O	O	I-T028
in	O	O	O
strains	O	O	B-T007
of	O	O	O
the	O	O	O
A.	O	O	B-T007
baumannii	O	O	I-T007
isolates	O	O	O
.	O	O	O

The	O	O	O
prevalence	O	O	O
of	O	O	O
A.	O	O	B-T007
baumannii	O	O	I-T007
was	O	O	O
8.5	O	O	O
%	O	O	O
and	O	O	O
was	O	O	O
most	O	O	O
prevalent	O	O	O
among	O	O	O
patients	O	O	B-T101
in	O	O	O
the	O	O	O
age	O	O	B-T100
group	O	O	I-T100
51	O	O	O
-	O	O	O
60	O	O	O
(	O	O	O
36	O	O	O
%	O	O	O
)	O	O	O
;	O	O	O
the	O	O	O
male	O	O	B-T032
patients	O	O	O
(	O	O	O
63.6	O	O	O
%	O	O	O
)	O	O	O
were	O	O	O
more	O	O	O
infected	O	O	B-T033
than	O	O	O
their	O	O	O
female	O	O	B-T032
counterparts	O	O	O
.	O	O	O

Patients	O	O	B-T101
(	O	O	O
72.7	O	O	O
%	O	O	O
)	O	O	O
in	O	O	O
the	O	O	O
intensive	O	O	B-T093
care	O	O	I-T093
unit	O	O	I-T093
(	O	O	O
ICU	O	O	B-T093
)	O	O	O
were	O	O	O
most	O	O	O
infected	O	O	B-T033
with	O	O	O
this	O	O	O
organism	O	O	B-T001
.	O	O	O

The	O	O	O
isolates	O	O	B-T123
showed	O	O	O
100	O	O	O
%	O	O	O
resistance	O	O	B-T169
to	O	O	O
both	O	O	O
amikacin	O	O	B-T195
and	O	O	O
ciprofloxacin	O	O	B-T109
and	O	O	O
90.9	O	O	O
%	O	O	O
to	O	O	O
both	O	O	O
ceftriaxone	O	O	B-T195
and	O	O	O
ceftazidime	O	O	B-T195
,	O	O	O
while	O	O	O
resistance	O	O	O
to	O	O	O
the	O	O	O
other	O	O	O
antibiotics	O	O	B-T195
used	O	O	O
in	O	O	O
this	O	O	O
study	O	O	B-T062
were	O	O	O
:	O	O	O
piperacillin	O	O	B-T195
(	O	O	O
81.8	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
imipenem	O	O	B-T195
(	O	O	O
72.7	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
gentamycin	O	O	B-T195
(	O	O	O
72.2	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
meropenem	O	O	B-T195
(	O	O	O
63.6	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

None	O	O	O
of	O	O	O
the	O	O	O
isolates	O	O	B-T123
was	O	O	O
,	O	O	O
however	O	O	O
,	O	O	O
resistant	O	O	B-T169
to	O	O	O
colistin	O	O	B-T195
.	O	O	O

PCR	O	O	B-T063
results	O	O	B-T034
showed	O	O	O
that	O	O	O
blaOXA	O	O	B-T028
,	O	O	I-T028
blaTEM	O	O	I-T028
,	O	O	I-T028
and	O	O	I-T028
blaCTX-M	O	O	I-T028
genes	O	O	I-T028
were	O	O	O
positive	O	O	B-T033
in	O	O	O
some	O	O	O
isolates	O	O	B-T123
,	O	O	O
while	O	O	O
blaSHV	O	O	B-T028
was	O	O	O
not	O	O	B-T033
detected	O	O	I-T033
in	O	O	O
any	O	O	O
of	O	O	O
the	O	O	O
isolates	O	O	O
.	O	O	O

This	O	O	O
study	O	O	B-T062
has	O	O	O
revealed	O	O	B-T080
that	O	O	O
the	O	O	O
strains	O	O	B-T007
of	O	O	O
A.	O	O	B-T007
baumannii	O	O	I-T007
isolated	O	O	B-T169
are	O	O	O
multiple	O	O	B-T032
drug	O	O	I-T032
resistant	O	O	I-T032
.	O	O	O

Regular	O	O	O
monitoring	O	O	B-T058
,	O	O	O
judicious	O	O	O
prescription	O	O	B-T058
,	O	O	O
and	O	O	O
early	O	O	O
detection	O	O	B-T061
of	O	O	O
resistance	O	O	B-T169
to	O	O	O
these	O	O	O
antibiotics	O	O	B-T195
are	O	O	O
,	O	O	O
therefore	O	O	O
,	O	O	O
necessary	O	O	O
to	O	O	O
check	O	O	O
further	O	O	O
dissemination	O	O	O
of	O	O	O
the	O	O	O
organism	O	O	B-T001
.	O	O	O

-DOCSTART- (27766286)

Dataset	O	O	B-T170
of	O	O	O
the	O	O	O
molecular	O	O	B-T066
dynamics	O	O	I-T066
simulations	O	O	I-T066
of	O	O	O
bilayers	O	O	B-T080
consisting	O	O	O
of	O	O	O
short	O	O	O
amyloidogenic	O	O	B-T116
peptide	O	O	I-T116
VDSWNVLVAG	O	O	B-T087
from	O	O	O
Bgl2p-glucantransferase	O	O	B-T116
of	O	O	O
S.	O	O	B-T004
cerevisiae	O	O	I-T004
cell	O	O	O
wall	O	O	O

The	O	O	O
amyloidogenic	O	O	B-T116
peptide	O	O	I-T116
VDSWNVLVAG	O	O	B-T087
from	O	O	O
Bgl2p-glucantransferase	O	O	B-T116
of	O	O	O
Saccharomyces	O	O	B-T004
cerevisiae	O	O	I-T004
cell	O	O	B-T026
wall	O	O	I-T026
and	O	O	O
its	O	O	O
modifying	O	O	O
analog	O	O	B-T104
VESWNVLVAG	O	O	B-T087
were	O	O	O
taken	O	O	O
for	O	O	O
the	O	O	O
construction	O	O	O
of	O	O	O
four	O	O	B-T081
types	O	O	O
of	O	O	O
bilayers	O	O	B-T080
which	O	O	O
differ	O	O	O
by	O	O	O
orientation	O	O	B-T082
of	O	O	O
the	O	O	O
peptides	O	O	B-T116
in	O	O	O
the	O	O	O
layers	O	O	B-T080
and	O	O	O
of	O	O	O
the	O	O	O
layers	O	O	O
relative	O	O	O
to	O	O	O
each	O	O	O
other	O	O	O
.	O	O	O

These	O	O	O
bilayers	O	O	B-T080
were	O	O	O
used	O	O	O
as	O	O	O
starting	O	O	O
models	O	O	B-T170
for	O	O	O
the	O	O	O
molecular	O	O	B-T044
dynamics	O	O	I-T044
(	O	O	O
MD	O	O	B-T044
)	O	O	O
at	O	O	O
three	O	O	O
charge	O	O	O
states	O	O	O
(	O	O	O
neutral	O	O	O
,	O	O	O
pH3	O	O	O
,	O	O	O
and	O	O	O
pH5	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
changes	O	O	B-T169
of	O	O	O
the	O	O	O
fraction	O	O	O
of	O	O	O
secondary	O	O	B-T082
structure	O	O	I-T082
during	O	O	O
1	O	O	O
ns	O	O	O
simulations	O	O	B-T062
were	O	O	O
received	O	O	O
for	O	O	O
96	O	O	O
MD	O	O	O
trajectories	O	O	O
.	O	O	O

The	O	O	O
data	O	O	B-T078
article	O	O	B-T170
contains	O	O	O
the	O	O	O
necessary	O	O	O
information	O	O	B-T078
for	O	O	O
the	O	O	O
construction	O	O	O
of	O	O	O
models	O	O	B-T170
of	O	O	O
Î²-strands	O	O	B-T082
organization	O	O	B-T169
in	O	O	O
the	O	O	O
oligomer	O	O	B-T087
structure	O	O	B-T082
.	O	O	O

These	O	O	O
results	O	O	B-T169
were	O	O	O
used	O	O	O
in	O	O	O
the	O	O	O
associated	O	O	O
research	O	O	B-T170
article	O	O	I-T170
"	O	O	O
Structural	O	O	B-T073
model	O	O	I-T073
of	O	O	O
amyloid	O	O	B-T116
fibrils	O	O	I-T116
for	O	O	O
amyloidogenic	O	O	B-T116
peptide	O	O	I-T116
from	O	O	O
Bgl2p-glucantransferase	O	O	B-T116
of	O	O	O
S.	O	O	B-T004
cerevisiae	O	O	I-T004
cell	O	O	B-T026
wall	O	O	I-T026
and	O	O	O
its	O	O	O
modifying	O	O	O
analog	O	O	B-T104
.	O	O	O

New	O	O	O
morphology	O	O	B-T080
of	O	O	O
amyloid	O	O	B-T116
fibrils	O	O	I-T116
"	O	O	O
(	O	O	O
Selivanova	O	O	O
et	O	O	O
al.	O	O	O
,	O	O	O
2016	O	O	O
)	O	O	O
[	O	O	O
1	O	O	O
]	O	O	O
.	O	O	O

-DOCSTART- (27768206)

Straight	O	O	B-T023
configuration	O	O	I-T023
saphenous	O	O	I-T023
vein	O	O	I-T023
transposition	O	O	B-T061
to	O	O	O
popliteal	O	O	B-T023
artery	O	O	I-T023
for	O	O	O
vascular	O	O	O
access	O	O	O

The	O	O	O
saphenous	O	O	B-T023
vein	O	O	I-T023
is	O	O	O
commonly	O	O	O
used	O	O	O
as	O	O	O
a	O	O	O
vascular	O	O	B-T023
graft	O	O	I-T023
in	O	O	O
peripheral	O	O	B-T023
artery	O	O	I-T023
surgery	O	O	B-T061
but	O	O	O
rarely	O	O	B-T080
used	O	O	O
for	O	O	O
vascular	O	O	B-T074
access	O	O	I-T074
.	O	O	O

The	O	O	O
literature	O	O	B-T170
on	O	O	O
straight	O	O	B-T023
configuration	O	O	I-T023
saphenous	O	O	I-T023
vein	O	O	I-T023
transposition	O	O	B-T061
to	O	O	O
the	O	O	O
popliteal	O	O	B-T023
artery	O	O	I-T023
is	O	O	O
scarce	O	O	B-T080
.	O	O	O

Here	O	O	O
we	O	O	O
present	O	O	O
two	O	O	O
cases	O	O	O
of	O	O	O
straight	O	O	B-T023
configuration	O	O	I-T023
saphenous	O	O	I-T023
vein	O	O	I-T023
transposition	O	O	B-T061
to	O	O	O
the	O	O	O
popliteal	O	O	B-T023
artery	O	O	I-T023
for	O	O	O
vascular	O	O	B-T074
access	O	O	I-T074
,	O	O	O
the	O	O	O
surgical	O	O	B-T060
technique	O	O	I-T060
and	O	O	O
respective	O	O	O
follow-up	O	O	B-T058
.	O	O	O

Two	O	O	O
young	O	O	B-T100
men	O	O	B-T098
,	O	O	O
aged	O	O	O
29	O	O	O
and	O	O	O
36	O	O	O
years	O	O	B-T079
,	O	O	O
were	O	O	O
chosen	O	O	O
for	O	O	O
lower-limb	O	O	B-T061
vascular	O	O	I-T061
access	O	O	I-T061
for	O	O	O
hemodialysis	O	O	B-T061
.	O	O	O

The	O	O	O
first	O	O	O
patient	O	O	B-T101
was	O	O	O
paraplegic	O	O	B-T047
since	O	O	O
birth	O	O	O
.	O	O	O

He	O	O	O
used	O	O	O
his	O	O	O
arms	O	O	O
to	O	O	O
move	O	O	O
so	O	O	O
upper	O	O	B-UnknownType
extremity	O	O	I-UnknownType
vascular	O	O	I-UnknownType
access	O	O	I-UnknownType
was	O	O	O
avoided	O	O	O
.	O	O	O

The	O	O	O
second	O	O	O
patient	O	O	B-T101
presented	O	O	O
with	O	O	O
an	O	O	O
infected	O	O	B-T033
upper	O	O	B-UnknownType
extremity	O	O	I-UnknownType
arteriovenous	O	O	I-UnknownType
graft	O	O	I-UnknownType
(	O	O	B-UnknownType
AVG	O	O	I-UnknownType
)	O	O	O
and	O	O	O
after	O	O	O
multiple	O	O	O
closed	O	O	B-T169
AVFs	O	O	B-T190
he	O	O	O
had	O	O	O
no	O	O	O
more	O	O	O
available	O	O	O
arm	O	O	B-T023
veins	O	O	I-T023
.	O	O	O

Both	O	O	O
patients	O	O	B-T101
received	O	O	B-T080
autologous	O	O	B-T080
lower	O	O	B-T023
extremity	O	O	I-T023
straight	O	O	B-T023
configuration	O	O	I-T023
saphenous	O	O	I-T023
vein	O	O	I-T023
transpositions	O	O	B-T061
to	O	O	O
the	O	O	O
popliteal	O	O	B-T023
artery	O	O	I-T023
under	O	O	O
spinal	O	O	B-T061
anesthesia	O	O	I-T061
in	O	O	O
May	O	O	O
and	O	O	O
October	O	O	O
2012	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

Cannulation	O	O	B-T061
of	O	O	O
the	O	O	O
fistula	O	O	B-T190
was	O	O	O
allowed	O	O	O
after	O	O	O
one	O	O	O
month	O	O	B-T079
.	O	O	O

There	O	O	O
were	O	O	O
no	O	O	B-T184
early	O	O	I-T184
complications	O	O	I-T184
.	O	O	O

Slight	O	O	B-T033
swelling	O	O	I-T033
on	O	O	O
the	O	O	O
leg	O	O	B-T023
appeared	O	O	B-T080
in	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
patients	O	O	B-T101
.	O	O	O

Both	O	O	O
fistulas	O	O	B-T190
were	O	O	O
still	O	O	O
functional	O	O	B-T169
after	O	O	O
36	O	O	O
and	O	O	O
32	O	O	O
months	O	O	B-T079
,	O	O	O
respectively	O	O	O
.	O	O	O

The	O	O	O
straight	O	O	B-T023
configuration	O	O	I-T023
saphenous	O	O	I-T023
vein	O	O	I-T023
transposition	O	O	B-T061
to	O	O	O
popliteal	O	O	B-T023
artery	O	O	I-T023
is	O	O	O
simple	O	O	O
to	O	O	O
perform	O	O	O
,	O	O	O
offers	O	O	O
a	O	O	O
long	O	O	B-T082
and	O	O	I-T082
straight	O	O	I-T082
segment	O	O	I-T082
for	O	O	O
cannulation	O	O	B-T061
and	O	O	O
may	O	O	O
be	O	O	O
a	O	O	O
suitable	O	O	O
autologous	O	O	B-T080
vascular	O	O	B-T074
access	O	O	I-T074
in	O	O	O
selected	O	O	O
patients	O	O	B-T101
.	O	O	O

-DOCSTART- (27768380)

Inhibited	O	O	B-T080
Temperament	O	O	B-T041
and	O	O	O
Hippocampal	O	O	B-T023
Volume	O	O	B-T081
in	O	O	O
Offspring	O	O	B-T099
of	O	O	O
Parents	O	O	B-T099
with	O	O	O
Bipolar	O	O	O
Disorder	O	O	O

Prior	O	O	O
studies	O	O	O
have	O	O	O
suggested	O	O	B-T078
that	O	O	O
inhibited	O	O	B-T080
temperament	O	O	B-T041
may	O	O	O
be	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
an	O	O	O
increased	O	O	B-T081
risk	O	O	B-T078
for	O	O	O
developing	O	O	O
anxiety	O	O	B-T048
or	O	O	O
mood	O	O	B-T048
disorder	O	O	I-T048
,	O	O	O
including	O	O	O
bipolar	O	O	B-T048
disorder	O	O	I-T048
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
neurobiological	O	O	O
basis	O	O	O
for	O	O	O
this	O	O	O
increased	O	O	B-T081
risk	O	O	B-T078
is	O	O	O
unknown	O	O	B-T080
.	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
this	O	O	O
study	O	O	O
was	O	O	O
to	O	O	O
examine	O	O	B-T033
temperament	O	O	B-T041
in	O	O	O
symptomatic	O	O	B-T169
and	O	O	O
asymptomatic	O	O	B-T033
child	O	O	B-T100
offspring	O	O	B-T099
of	O	O	O
parents	O	O	B-T099
with	O	O	O
bipolar	O	O	B-T048
disorder	O	O	I-T048
(	O	O	O
OBD	O	O	B-T048
)	O	O	O
and	O	O	O
to	O	O	O
investigate	O	O	B-T169
whether	O	O	O
inhibited	O	O	B-T080
temperament	O	O	O
is	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
aberrant	O	O	B-T080
hippocampal	O	O	B-T023
volumes	O	O	B-T081
compared	O	O	B-T052
with	O	O	O
healthy	O	O	B-T080
control	O	O	I-T080
(	O	O	O
HC	O	O	B-T080
)	O	O	O
youth	O	O	B-T100
.	O	O	O

The	O	O	O
OBD	O	O	B-T048
group	O	O	B-UnknownType
consisted	O	O	O
of	O	O	O
45	O	O	O
youth	O	O	B-T100
,	O	O	O
24	O	O	O
of	O	O	O
whom	O	O	O
had	O	O	O
current	O	O	B-T079
psychiatric	O	O	B-T184
symptoms	O	O	I-T184
(	O	O	B-T048
OBD(+)s	O	O	I-T048
)	O	O	I-T048
and	O	O	O
21	O	O	O
without	O	O	B-T080
any	O	O	O
psychiatric	O	O	O
symptoms	O	O	O
(	O	O	O
OBD(-)s	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
were	O	O	O
compared	O	O	B-T052
with	O	O	O
24	O	O	O
HC	O	O	B-T080
youth	O	O	O
.	O	O	O

Temperament	O	O	B-T041
characteristics	O	O	B-T080
were	O	O	O
measured	O	O	B-T080
by	O	O	O
using	O	O	O
the	O	O	O
Revised	O	O	B-T060
Dimensions	O	O	I-T060
of	O	O	I-T060
Temperament	O	O	I-T060
Survey	O	O	I-T060
.	O	O	O

Magnetic	O	O	B-T060
resonance	O	O	I-T060
imaging	O	O	I-T060
was	O	O	O
used	O	O	O
to	O	O	O
measure	O	O	B-T081
hippocampal	O	O	B-T023
volumes	O	O	B-T081
.	O	O	O

The	O	O	O
association	O	O	B-T080
between	O	O	O
temperament	O	O	B-T041
and	O	O	O
hippocampal	O	O	B-T023
volumes	O	O	B-T081
was	O	O	O
tested	O	O	B-T169
by	O	O	O
using	O	O	O
multiple	O	O	B-T080
regression	O	O	I-T080
analysis	O	O	I-T080
.	O	O	O

Compared	O	O	B-T052
with	O	O	O
the	O	O	O
OBD(-)s	O	O	B-UnknownType
group	O	O	B-UnknownType
,	O	O	O
the	O	O	O
OBD(+)s	O	O	B-T048
group	O	O	O
had	O	O	O
significantly	O	O	B-T081
more	O	O	B-T081
inhibited	O	O	B-T080
temperament	O	O	B-T041
traits	O	O	B-T032
,	O	O	O
less	O	O	B-T080
flexibility	O	O	B-T080
,	O	O	O
more	O	O	O
negative	O	O	B-T033
mood	O	O	B-T041
,	O	O	O
and	O	O	O
less	O	O	O
regular	O	O	B-T080
rhythm	O	O	B-T033
in	O	O	O
their	O	O	O
daily	O	O	B-T079
routines	O	O	B-T080
.	O	O	O

In	O	O	O
contrast	O	O	O
,	O	O	O
the	O	O	O
OBD(-)s	O	O	B-UnknownType
group	O	O	I-UnknownType
was	O	O	O
more	O	O	O
likely	O	O	O
to	O	O	O
approach	O	O	O
novel	O	O	B-T080
situations	O	O	B-T080
compared	O	O	B-T052
with	O	O	O
OBD(+)s	O	O	B-T048
or	O	O	O
HC	O	O	B-T080
groups	O	O	B-UnknownType
.	O	O	O

Within	O	O	O
the	O	O	O
OBD(+)s	O	O	B-T048
group	O	O	B-UnknownType
,	O	O	O
a	O	O	O
more	O	O	O
inhibited	O	O	B-T080
temperament	O	O	B-T041
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
smaller	O	O	O
right	O	O	B-T082
hippocampal	O	O	B-T023
volumes	O	O	B-T081
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	O
,	O	O	O
symptomatic	O	O	B-T169
OBD	O	O	B-T048
were	O	O	O
characterized	O	O	B-T052
by	O	O	O
an	O	O	O
inhibited	O	O	B-T080
temperament	O	O	B-T041
that	O	O	O
was	O	O	O
inversely	O	O	B-T080
correlated	O	O	B-T080
with	O	O	O
hippocampal	O	O	B-T023
volume	O	O	B-T081
.	O	O	O

Additional	O	O	O
longitudinal	O	O	B-T062
studies	O	O	I-T062
are	O	O	O
needed	O	O	B-T080
to	O	O	O
determine	O	O	O
whether	O	O	O
inverse	O	O	B-T080
correlations	O	O	B-T080
between	O	O	O
hippocampal	O	O	B-T023
volume	O	O	B-T081
and	O	O	O
inhibited	O	O	B-T080
temperament	O	O	B-T041
represent	O	O	O
early	O	O	O
markers	O	O	B-T201
of	O	O	O
risk	O	O	B-T078
for	O	O	O
later	O	O	O
developing	O	O	O
bipolar	O	O	B-T048
disorder	O	O	I-T048
.	O	O	O

-DOCSTART- (27771331)

Dynamic	O	O	B-T169
disorder	O	O	B-T080
can	O	O	O
explain	O	O	O
non-exponential	O	O	B-T081
kinetics	O	O	B-T070
of	O	O	O
fast	O	O	O
protein	O	O	O
mechanical	O	O	O
unfolding	O	O	O

Protein	O	O	B-T043
unfolding	O	O	I-T043
often	O	O	O
does	O	O	O
not	O	O	O
obey	O	O	O
a	O	O	O
simple	O	O	O
two-state	O	O	O
behavior	O	O	O
.	O	O	O

Previous	O	O	O
single	O	O	B-T059
molecule	O	O	I-T059
force	O	O	I-T059
spectroscopy	O	O	I-T059
studies	O	O	B-T059
demonstrated	O	O	O
stretched	O	O	B-T080
exponential	O	O	I-T080
kinetics	O	O	B-T070
of	O	O	O
protein	O	O	B-T043
unfolding	O	O	I-T043
under	O	O	O
a	O	O	O
constant	O	O	B-T067
pulling	O	O	I-T067
force	O	O	I-T067
,	O	O	O
the	O	O	O
molecular	O	O	B-T080
origin	O	O	B-T079
of	O	O	O
which	O	O	O
remains	O	O	O
subject	O	O	O
to	O	O	O
debate	O	O	O
.	O	O	O

We	O	O	O
here	O	O	O
set	O	O	O
out	O	O	O
to	O	O	O
extensively	O	O	O
sample	O	O	O
the	O	O	O
mechanical	O	O	B-T043
unfolding	O	O	I-T043
of	O	O	O
ubiquitin	O	O	B-T116
and	O	O	O
NuG2	O	O	B-T116
by	O	O	O
Molecular	O	O	B-T066
Dynamics	O	O	I-T066
(	O	O	I-T066
MD	O	O	I-T066
)	O	O	I-T066
simulations	O	O	I-T066
.	O	O	O

Both	O	O	O
proteins	O	O	B-T116
show	O	O	O
kinetics	O	O	B-T070
best	O	O	O
fit	O	O	O
by	O	O	O
stretched	O	O	B-T080
exponentials	O	O	I-T080
,	O	O	O
with	O	O	O
stretching	O	O	B-T081
exponents	O	O	I-T081
similar	O	O	O
to	O	O	O
those	O	O	O
found	O	O	O
in	O	O	O
experiments	O	O	B-T062
,	O	O	O
even	O	O	O
though	O	O	O
static	O	O	O
disorder	O	O	O
is	O	O	O
absent	O	O	B-T169
in	O	O	O
our	O	O	O
short	O	O	O
MD	O	O	B-T066
simulations	O	O	I-T066
.	O	O	O

Instead	O	O	O
,	O	O	O
we	O	O	O
can	O	O	O
ascribe	O	O	O
non-exponential	O	O	B-T081
kinetics	O	O	B-T070
to	O	O	O
dynamic	O	O	B-T169
disorder	O	O	B-T080
,	O	O	O
due	O	O	O
to	O	O	O
conformational	O	O	B-T082
fluctuations	O	O	B-T079
on	O	O	O
the	O	O	O
nanosecond	O	O	B-T079
timescale	O	O	I-T079
.	O	O	O

Our	O	O	O
study	O	O	B-T062
highlights	O	O	O
the	O	O	O
general	O	O	O
role	O	O	O
of	O	O	O
dynamic	O	O	B-T169
disorder	O	O	B-T080
in	O	O	O
protein	O	O	B-T070
kinetics	O	O	I-T070
on	O	O	O
a	O	O	O
broad	O	O	O
range	O	O	O
of	O	O	O
time	O	O	B-T079
scales	O	O	I-T079
even	O	O	O
including	O	O	O
those	O	O	O
probed	O	O	O
in	O	O	O
MD	O	O	B-T066
simulations	O	O	I-T066
.	O	O	O

-DOCSTART- (27771746)

Identification	O	O	O
and	O	O	O
functional	O	O	O
analysis	O	O	O
of	O	O	O
the	O	O	O
GTPV	O	O	B-T005
bidirectional	O	O	B-T080
promoter	O	O	O
region	O	O	O

The	O	O	O
goat	O	O	B-T005
pox	O	O	I-T005
chick	O	O	I-T005
embryo-attenuated	O	O	I-T005
virus	O	O	I-T005
(	O	O	O
GTPV	O	O	B-T005
)	O	O	O
has	O	O	O
been	O	O	O
developed	O	O	O
as	O	O	O
an	O	O	O
effective	O	O	O
vaccine	O	O	B-T129
that	O	O	O
can	O	O	O
elicit	O	O	O
protective	O	O	O
immune	O	O	B-T042
responses	O	O	I-T042
.	O	O	O

It	O	O	O
possesses	O	O	O
a	O	O	O
large	O	O	O
genome	O	O	B-T028
and	O	O	O
a	O	O	O
robust	O	O	O
ability	O	O	O
to	O	O	O
express	O	O	B-T045
exogenous	O	O	B-T169
genes	O	O	B-T028
.	O	O	O

Thus	O	O	O
,	O	O	O
this	O	O	O
virus	O	O	B-T005
is	O	O	O
an	O	O	O
ideal	O	O	B-T080
vector	O	O	B-T114
for	O	O	O
recombinant	O	O	B-T116
live	O	O	I-T116
vaccines	O	O	I-T116
for	O	O	O
infectious	O	O	B-T047
diseases	O	O	I-T047
in	O	O	O
ruminant	O	O	B-T015
animals	O	O	I-T015
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	O
,	O	O	O
we	O	O	O
identified	O	O	O
a	O	O	O
novel	O	O	O
bidirectional	O	O	B-T080
promoter	O	O	B-T114
region	O	O	I-T114
of	O	O	O
GTPV	O	O	B-T005
through	O	O	O
screening	O	O	O
named	O	O	O
PbVV(Â±	O	O	B-T114
)	O	O	I-T114
.	O	O	O

PbVV(Â±	O	O	B-T114
)	O	O	I-T114
is	O	O	O
located	O	O	O
between	O	O	O
ETF-l	O	O	B-T116
and	O	O	O
VITF-3	O	O	B-T116
,	O	O	O
which	O	O	O
are	O	O	O
transcribed	O	O	B-T045
in	O	O	O
opposite	O	O	B-T082
directions	O	O	B-T082
.	O	O	O

A	O	O	O
new	O	O	O
recombinant	O	O	B-T005
goat	O	O	I-T005
pox	O	O	I-T005
virus	O	O	I-T005
(	O	O	O
rGTPV	O	O	B-T005
)	O	O	O
was	O	O	O
constructed	O	O	O
,	O	O	O
in	O	O	O
which	O	O	O
duplicate	O	O	O
PbVV(+	O	O	B-T114
)	O	O	I-T114
was	O	O	O
used	O	O	O
as	O	O	O
a	O	O	O
promoter	O	O	B-T114
element	O	O	O
to	O	O	O
enhance	O	O	B-T052
Brucella	O	O	B-T116
OMP31	O	O	I-T116
expression	O	O	B-T045
,	O	O	O
and	O	O	O
duplicate	O	O	O
PbVV	O	O	B-T114
(	O	O	O
-	O	O	O
)	O	O	O
was	O	O	O
used	O	O	O
as	O	O	O
a	O	O	O
promoter	O	O	B-T114
element	O	O	I-T114
to	O	O	O
regulate	O	O	O
enhanced	O	O	B-T116
green	O	O	I-T116
fluorescent	O	O	I-T116
protein	O	O	I-T116
(	O	O	O
EGFP	O	O	B-T116
)	O	O	O
at	O	O	O
the	O	O	O
same	O	O	O
time	O	O	O
as	O	O	O
the	O	O	O
selection	O	O	O
marker	O	O	O
.	O	O	O

PbVV(-	O	O	B-T114
)	O	O	I-T114
promoter	O	O	I-T114
activity	O	O	O
was	O	O	O
compared	O	O	O
to	O	O	O
that	O	O	O
of	O	O	O
the	O	O	O
P7.5	O	O	B-T114
promoter	O	O	I-T114
of	O	O	O
vaccinia	O	O	B-T005
virus	O	O	I-T005
,	O	O	O
as	O	O	O
measured	O	O	O
by	O	O	O
EGFP	O	O	B-T116
expression	O	O	B-T045
;	O	O	O
the	O	O	O
fluorescence	O	O	B-T059
intensity	O	O	I-T059
of	O	O	O
EGFP	O	O	O
expressed	O	O	B-T045
in	O	O	O
cells	O	O	B-T025
was	O	O	O
confirmed	O	O	O
by	O	O	O
fluorescence	O	O	B-T059
microscopy	O	O	I-T059
and	O	O	O
flow	O	O	B-T059
cytometry	O	O	I-T059
.	O	O	O

PbVV(+	O	O	B-T114
)	O	O	I-T114
promoter	O	O	I-T114
activity	O	O	O
was	O	O	O
measured	O	O	O
by	O	O	O
Brucella	O	O	B-T116
OMP31	O	O	I-T116
expression	O	O	B-T045
.	O	O	O

Interaction	O	O	O
with	O	O	O
the	O	O	O
anti-Brucella-OMP31	O	O	B-T116
monoclonal	O	O	I-T116
antibody	O	O	I-T116
was	O	O	O
confirmed	O	O	O
by	O	O	O
western	O	O	B-T059
blotting	O	O	I-T059
,	O	O	O
and	O	O	O
OMP31	O	O	B-T116
mRNA	O	O	B-T045
expression	O	O	I-T045
was	O	O	O
assessed	O	O	O
by	O	O	O
qRT-PCR	O	O	B-T063
.	O	O	O

The	O	O	O
results	O	O	O
of	O	O	O
this	O	O	O
study	O	O	O
will	O	O	O
be	O	O	O
useful	O	O	O
for	O	O	O
the	O	O	O
further	O	O	O
study	O	O	O
of	O	O	O
effective	O	O	B-T080
multivalent	O	O	B-T129
vaccines	O	O	I-T129
based	O	O	O
on	O	O	O
rGTPV	O	O	B-T005
.	O	O	O

This	O	O	O
study	O	O	O
also	O	O	O
provides	O	O	O
a	O	O	O
theoretical	O	O	O
basis	O	O	O
for	O	O	O
overcoming	O	O	O
the	O	O	O
problem	O	O	O
of	O	O	O
low	O	O	O
expression	O	O	B-T045
of	O	O	O
exogenous	O	O	B-T169
genes	O	O	B-T028
.	O	O	O

-DOCSTART- (27772556)

Psychometric	O	O	B-T060
analysis	O	O	I-T060
of	O	O	O
the	O	O	O
Patient	O	O	B-T170
Health	O	O	I-T170
Questionnaire	O	O	I-T170
in	O	O	O
Danish	O	O	B-T083
patients	O	O	B-T101
with	O	O	O
an	O	O	O
implantable	O	O	B-T074
cardioverter	O	O	I-T074
defibrillator	O	O	I-T074
(	O	O	O
The	O	O	O
DEFIB-WOMEN	O	O	B-T062
study	O	O	I-T062
)	O	O	O

To	O	O	O
assess	O	O	O
the	O	O	O
psychometric	O	O	B-T060
properties	O	O	I-T060
of	O	O	O
the	O	O	O
Patient	O	O	B-T170
Health	O	O	I-T170
Questionnaire	O	O	I-T170
(	O	O	O
PHQ-9	O	O	B-T170
)	O	O	O
,	O	O	O
a	O	O	O
measure	O	O	B-T081
of	O	O	O
depressive	O	O	B-T184
symptoms	O	O	I-T184
,	O	O	O
in	O	O	O
a	O	O	O
large	O	O	B-T081
Danish	O	O	B-T083
national	O	O	B-T098
cohort	O	O	I-T098
of	O	O	O
patients	O	O	B-T101
with	O	O	O
heart	O	O	B-T047
disease	O	O	I-T047
,	O	O	O
implanted	O	O	B-T061
with	O	O	O
an	O	O	O
implantable	O	O	B-T074
cardioverter	O	O	I-T074
defibrillator	O	O	I-T074
(	O	O	O
ICD	O	O	B-T074
)	O	O	O
,	O	O	O
using	O	O	O
item	O	O	B-T062
response	O	O	I-T062
theory	O	O	I-T062
.	O	O	O

A	O	O	O
prospective	O	O	B-T098
cohort	O	O	I-T098
of	O	O	O
patients	O	O	B-T101
implanted	O	O	B-T061
with	O	O	O
an	O	O	O
ICD	O	O	B-T074
(	O	O	O
n=1531	O	O	O
;	O	O	O
80.4	O	O	O
%	O	O	O
men	O	O	B-T098
)	O	O	O
completed	O	O	O
the	O	O	O
PHQ-9	O	O	B-T170
at	O	O	O
the	O	O	O
time	O	O	O
of	O	O	O
implant	O	O	B-T061
.	O	O	O

Data	O	O	B-T078
were	O	O	O
analyzed	O	O	B-T062
using	O	O	O
two	O	O	O
item	O	O	B-T062
response	O	O	I-T062
theory	O	O	I-T062
models	O	O	I-T062
,	O	O	O
the	O	O	O
partial	O	O	B-T081
credit	O	O	I-T081
model	O	O	I-T081
and	O	O	O
the	O	O	O
generalized	O	O	B-T081
partial	O	O	I-T081
credit	O	O	I-T081
model	O	O	I-T081
.	O	O	O

The	O	O	O
analysis	O	O	B-T062
showed	O	O	O
disordered	O	O	B-T170
response	O	O	B-T170
thresholds	O	O	B-T080
in	O	O	O
eight	O	O	O
of	O	O	O
nine	O	O	O
items	O	O	B-T080
for	O	O	O
the	O	O	O
partial	O	O	B-T081
credit	O	O	I-T081
model	O	O	I-T081
and	O	O	O
five	O	O	O
of	O	O	O
nine	O	O	O
items	O	O	O
for	O	O	O
the	O	O	O
generalized	O	O	B-T081
partial	O	O	I-T081
credit	O	O	I-T081
model	O	O	I-T081
,	O	O	O
indicating	O	O	O
that	O	O	O
respondents	O	O	B-T098
have	O	O	O
difficulty	O	O	B-T080
discriminating	O	O	B-T041
between	O	O	O
response	O	O	O
options	O	O	O
.	O	O	O

When	O	O	O
collapsing	O	O	O
response	O	O	B-T170
options	O	O	B-T169
2	O	O	O
and	O	O	O
3	O	O	O
,	O	O	O
the	O	O	O
rescored	O	O	B-T081
PHQ-9	O	O	B-T170
had	O	O	O
a	O	O	O
better	O	O	O
fit	O	O	O
to	O	O	O
both	O	O	O
models	O	O	B-T081
.	O	O	O

The	O	O	O
unidimensionality	O	O	B-T080
and	O	O	O
the	O	O	O
precision	O	O	B-T080
of	O	O	O
the	O	O	O
rescored	O	O	B-T081
PHQ-9	O	O	B-T170
were	O	O	O
confirmed	O	O	O
.	O	O	O

Items	O	O	B-T062
did	O	O	O
not	O	O	O
have	O	O	O
any	O	O	O
differential	O	O	B-T169
functioning	O	O	I-T169
(	O	O	O
DIF	O	O	B-T169
)	O	O	O
across	O	O	O
educational	O	O	B-T033
level	O	O	I-T033
,	O	O	O
age	O	O	B-T032
,	O	O	O
indication	O	O	B-T078
for	O	O	O
ICD	O	O	B-T074
implantation	O	O	B-T061
,	O	O	O
and	O	O	O
severity	O	O	B-T080
of	O	O	O
heart	O	O	B-T047
failure	O	O	I-T047
that	O	O	O
influence	O	O	B-T077
depression	O	O	B-T048
outcomes	O	O	B-T169
in	O	O	O
patients	O	O	B-T101
with	O	O	O
an	O	O	O
ICD	O	O	O
.	O	O	O

One	O	O	O
item	O	O	O
exhibited	O	O	O
DIF	O	O	B-T169
by	O	O	O
gender	O	O	B-T032
.	O	O	O

Three	O	O	O
items	O	O	B-T062
did	O	O	O
not	O	O	O
fit	O	O	O
the	O	O	O
partial	O	O	B-T081
credit	O	O	I-T081
model	O	O	I-T081
,	O	O	O
but	O	O	O
the	O	O	O
generalized	O	O	B-T081
partial	O	O	I-T081
credit	O	O	I-T081
model	O	O	I-T081
could	O	O	O
be	O	O	O
fitted	O	O	O
to	O	O	O
the	O	O	O
full	O	O	O
item	O	O	B-T062
set	O	O	I-T062
.	O	O	O

The	O	O	O
unidimensionality	O	O	B-T080
and	O	O	O
reliability	O	O	B-T081
of	O	O	O
the	O	O	O
Danish	O	O	B-T171
version	O	O	I-T171
of	O	O	O
the	O	O	O
PHQ-9	O	O	B-T170
were	O	O	O
confirmed	O	O	B-T033
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
associated	O	O	B-T080
consequences	O	O	B-T169
of	O	O	O
the	O	O	O
number	O	O	O
of	O	O	O
response	O	O	B-T170
options	O	O	B-T169
(	O	O	O
3-point	O	O	O
versus	O	O	O
4-point	O	O	O
Likert	O	O	B-T170
scale	O	O	I-T170
)	O	O	O
need	O	O	O
to	O	O	O
be	O	O	O
further	O	O	O
examined	O	O	B-T033
for	O	O	O
the	O	O	O
PHQ-9	O	O	B-T170
both	O	O	O
as	O	O	O
a	O	O	O
screening	O	O	B-T058
tool	O	O	B-T170
and	O	O	O
outcome	O	O	B-T081
measure	O	O	I-T081
.	O	O	O

-DOCSTART- (27773614)

Geographical	O	O	B-T033
variations	O	O	I-T033
in	O	O	O
incidence	O	O	B-T081
,	O	O	O
management	O	O	B-T058
and	O	O	O
survival	O	O	B-T081
of	O	O	O
hepatocellular	O	O	B-T191
carcinoma	O	O	I-T191
in	O	O	O
a	O	O	O
Western	O	O	O
country	O	O	O

Information	O	O	B-T078
on	O	O	O
the	O	O	O
incidence	O	O	B-T081
,	O	O	O
management	O	O	B-T058
,	O	O	O
and	O	O	O
prognosis	O	O	B-T058
of	O	O	O
hepatocellular	O	O	B-T191
carcinoma	O	O	I-T191
(	O	O	O
HCC	O	O	B-T191
)	O	O	O
is	O	O	O
derived	O	O	O
from	O	O	O
population	O	O	B-T098
samples	O	O	I-T098
,	O	O	O
regional	O	O	B-T082
data	O	O	B-T078
,	O	O	O
or	O	O	O
registries	O	O	B-T170
.	O	O	O

Comprehensive	O	O	B-T080
national	O	O	B-T092
evaluations	O	O	B-T058
within	O	O	O
a	O	O	O
given	O	O	O
country	O	O	B-T083
are	O	O	O
lacking	O	O	B-T080
.	O	O	O

This	O	O	O
study	O	O	B-T062
aimed	O	O	O
to	O	O	O
investigate	O	O	B-T169
regional	O	O	B-T082
variations	O	O	B-T080
in	O	O	O
HCC	O	O	B-T191
care	O	O	B-T052
within	O	O	O
France	O	O	B-T083
.	O	O	O

This	O	O	O
observational	O	O	B-T062
study	O	O	I-T062
analysed	O	O	O
data	O	O	B-T078
from	O	O	O
French	O	O	B-T098
administrative	O	O	B-T170
databases	O	O	I-T170
for	O	O	O
more	O	O	O
than	O	O	O
30,000	O	O	O
patients	O	O	B-T101
with	O	O	O
HCC	O	O	B-T191
diagnosed	O	O	B-T033
between	O	O	O
2009	O	O	O
and	O	O	O
2012	O	O	O
,	O	O	O
and	O	O	O
followed-up	O	O	O
until	O	O	O
2013	O	O	O
.	O	O	O

The	O	O	O
incidence	O	O	B-T081
of	O	O	O
HCC	O	O	B-T191
,	O	O	O
access	O	O	B-T082
to	O	O	O
surgery	O	O	B-T061
,	O	O	O
and	O	O	O
survival	O	O	B-T081
,	O	O	O
at	O	O	O
both	O	O	O
the	O	O	O
national	O	O	B-T082
level	O	O	I-T082
and	O	O	O
two	O	O	O
geographical	O	O	B-UnknownType
levels	O	O	I-UnknownType
(	O	O	O
the	O	O	O
21	O	O	O
French	O	O	B-T098
regions	O	O	I-T083
and	O	O	O
95	O	O	O
French	O	O	O
departments	O	O	B-T092
into	O	O	O
which	O	O	O
France	O	O	B-T083
is	O	O	O
divided	O	O	B-T092
administratively	O	O	I-T092
)	O	O	O
,	O	O	O
were	O	O	O
determined	O	O	O
.	O	O	O

The	O	O	O
influence	O	O	B-T077
on	O	O	O
outcome	O	O	B-T169
of	O	O	O
the	O	O	O
structure	O	O	O
of	O	O	O
the	O	O	O
hospital	O	O	B-T093
where	O	O	O
HCC	O	O	B-T191
was	O	O	O
first	O	O	O
managed	O	O	B-T057
was	O	O	O
assessed	O	O	B-T052
.	O	O	O

At	O	O	O
the	O	O	O
national	O	O	B-T082
level	O	O	I-T082
,	O	O	O
the	O	O	O
median	O	O	B-T079
survival	O	O	I-T079
was	O	O	O
9.4	O	O	O
months	O	O	B-T079
and	O	O	O
only	O	O	O
22.8	O	O	O
%	O	O	O
of	O	O	O
patients	O	O	B-T101
had	O	O	O
curative	O	O	B-T033
treatment	O	O	I-T033
.	O	O	O

There	O	O	O
were	O	O	O
marked	O	O	O
variations	O	O	O
between	O	O	O
regions	O	O	B-T083
and	O	O	O
departments	O	O	B-T092
in	O	O	O
incidence	O	O	B-T081
,	O	O	O
access	O	O	B-T082
to	O	O	O
curative	O	O	B-T033
treatment	O	O	I-T033
(	O	O	O
range	O	O	B-T081
1.3	O	O	O
-	O	O	O
28.8	O	O	O
%	O	O	O
and	O	O	O
8.1	O	O	O
-	O	O	O
32.3	O	O	O
%	O	O	O
respectively	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
in	O	O	O
median	O	O	B-T079
survival	O	O	I-T079
(	O	O	O
range	O	O	O
5.7	O	O	O
-	O	O	O
12.1	O	O	O
and	O	O	O
4.3	O	O	O
-	O	O	O
16.5	O	O	O
months	O	O	B-T079
respectively	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
administrative	O	O	B-T057
type	O	O	I-T057
and	O	O	O
annual	O	O	B-T079
HCC	O	O	B-T191
-	O	O	O
caseload	O	O	B-T081
of	O	O	O
the	O	O	O
hospital	O	O	B-T093
where	O	O	O
patients	O	O	B-T101
were	O	O	O
first	O	O	O
admitted	O	O	B-T058
also	O	O	O
had	O	O	O
an	O	O	O
independent	O	O	B-T078
influence	O	O	B-T077
on	O	O	O
treatment	O	O	B-T061
and	O	O	O
survival	O	O	B-T081
.	O	O	O

Despite	O	O	O
full	O	O	O
insurance	O	O	B-T078
coverage	O	O	I-T078
for	O	O	O
all	O	O	O
citizens	O	O	B-T098
,	O	O	O
national	O	O	B-T092
measures	O	O	B-T081
to	O	O	O
reduce	O	O	B-T080
inequities	O	O	I-T080
in	O	O	O
the	O	O	O
management	O	O	B-T058
of	O	O	O
cancer	O	O	B-T101
patients	O	O	B-T101
,	O	O	O
standardised	O	O	O
recommendations	O	O	B-T078
for	O	O	O
HCC	O	O	B-T191
surveillance	O	O	B-T061
and	O	O	O
management	O	O	O
,	O	O	O
the	O	O	O
percentage	O	O	B-T081
of	O	O	O
patients	O	O	O
undergoing	O	O	O
curative	O	O	B-T033
treatment	O	O	I-T033
and	O	O	O
their	O	O	O
survival	O	O	B-T081
may	O	O	O
vary	O	O	O
four-fold	O	O	O
depending	O	O	O
on	O	O	O
their	O	O	O
postcode	O	O	B-T033
.	O	O	O

The	O	O	O
hospital	O	O	B-T093
in	O	O	O
which	O	O	O
patients	O	O	B-T101
are	O	O	O
first	O	O	O
managed	O	O	B-T057
has	O	O	O
a	O	O	O
clear	O	O	O
influence	O	O	B-T077
on	O	O	O
accessibility	O	O	B-T080
to	O	O	O
both	O	O	O
good	O	O	B-T052
care	O	O	I-T052
and	O	O	O
survival	O	O	B-T081
.	O	O	O

Population-based	O	O	B-T062
studies	O	O	I-T062
have	O	O	O
highlighted	O	O	O
large	O	O	O
and	O	O	O
sometimes	O	O	O
unexpected	O	O	O
differences	O	O	O
between	O	O	O
countries	O	O	B-T083
in	O	O	O
the	O	O	O
survival	O	O	B-T081
of	O	O	O
patients	O	O	B-T101
with	O	O	O
malignancy	O	O	B-T191
.	O	O	O

As	O	O	O
these	O	O	O
differences	O	O	O
are	O	O	O
considered	O	O	O
to	O	O	O
indicate	O	O	O
the	O	O	O
overall	O	O	O
effectiveness	O	O	B-T080
of	O	O	O
health	O	O	B-T064
systems	O	O	I-T064
,	O	O	O
in	O	O	O
addition	O	O	O
to	O	O	O
the	O	O	O
incidence	O	O	B-T081
of	O	O	O
the	O	O	O
cancer	O	O	B-T191
or	O	O	O
quality	O	O	B-T080
of	O	O	O
registration	O	O	B-T058
,	O	O	O
variations	O	O	O
within	O	O	O
a	O	O	O
given	O	O	O
country	O	O	B-T083
should	O	O	O
be	O	O	O
minimal	O	O	B-T080
.	O	O	O

However	O	O	O
,	O	O	O
similar	O	O	O
to	O	O	O
between	O	O	O
countries	O	O	B-T083
differences	O	O	O
,	O	O	O
this	O	O	O
study	O	O	B-T062
shows	O	O	O
differences	O	O	O
within	O	O	O
the	O	O	O
same	O	O	O
country	O	O	B-T083
in	O	O	O
the	O	O	O
incidence	O	O	B-T081
,	O	O	O
curative	O	O	B-T033
treatment	O	O	I-T033
rate	O	O	B-T081
,	O	O	O
and	O	O	O
survival	O	O	B-T081
of	O	O	O
patients	O	O	B-T101
with	O	O	O
HCC	O	O	B-T191
.	O	O	O

Evidence	O	O	B-T078
that	O	O	O
access	O	O	O
to	O	O	O
care	O	O	B-T052
and	O	O	O
survival	O	O	B-T081
varies	O	O	O
within	O	O	O
a	O	O	O
country	O	O	B-T083
can	O	O	O
strengthen	O	O	B-T080
the	O	O	I-T080
impetus	O	O	I-T080
for	O	O	O
government	O	O	B-T092
and	O	O	O
clinicians	O	O	B-T097
to	O	O	O
address	O	O	O
these	O	O	O
disparities	O	O	B-T080
.	O	O	O

-DOCSTART- (27778231)

Identification	O	O	B-T080
of	O	O	O
potential	O	O	O
predictive	O	O	B-T080
markers	O	O	B-T080
of	O	O	O
dexamethasone	O	O	B-T109
resistance	O	O	B-T038
in	O	O	O
childhood	O	O	B-T079
acute	O	O	O
lymphoblastic	O	O	O
leukemia	O	O	O

Response	O	O	B-T040
to	O	O	O
dexamethasone	O	O	B-T109
(	O	O	O
DEXA	O	O	B-T109
)	O	O	O
,	O	O	O
as	O	O	O
a	O	O	O
hallmark	O	O	B-T121
drug	O	O	I-T121
in	O	O	O
the	O	O	O
treatment	O	O	B-T169
of	O	O	O
childhood	O	O	B-T079
acute	O	O	B-T191
lymphoblastic	O	O	I-T191
leukemia	O	O	I-T191
(	O	O	O
ALL	O	O	B-T191
)	O	O	O
,	O	O	O
is	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
pivotal	O	O	O
prognostic	O	O	B-T201
factors	O	O	I-T201
in	O	O	O
the	O	O	O
prediction	O	O	B-T058
of	O	O	I-T058
outcome	O	O	I-T058
in	O	O	O
ALL	O	O	O
.	O	O	O

Identification	O	O	B-T080
of	O	O	O
predictive	O	O	B-T080
markers	O	O	B-T080
of	O	O	O
chemoresistance	O	O	B-T038
is	O	O	O
beneficial	O	O	O
to	O	O	O
selecting	O	O	O
of	O	O	O
the	O	O	O
best	O	O	O
therapeutic	O	O	B-T061
protocol	O	O	I-T061
with	O	O	O
the	O	O	O
lowest	O	O	O
effect	O	O	B-T046
adverse	O	O	I-T046
.	O	O	O

Hence	O	O	O
,	O	O	O
we	O	O	O
aimed	O	O	O
to	O	O	O
find	O	O	O
drug	O	O	B-T074
targets	O	O	I-T074
using	O	O	O
the	O	O	O
2DE	O	O	B-T059
/	O	O	O
MS	O	O	B-T059
proteomics	O	O	B-T059
study	O	O	I-T059
of	O	O	O
a	O	O	O
DEXA	O	O	B-T109
-	O	O	O
resistant	O	O	B-T025
cell	O	O	I-T025
line	O	O	I-T025
(	O	O	O
REH	O	O	B-T025
)	O	O	O
as	O	O	O
a	O	O	O
model	O	O	B-T075
for	O	O	O
poor	O	O	O
DEXA	O	O	O
responding	O	O	O
patients	O	O	B-T101
before	O	O	O
and	O	O	O
after	O	O	O
drug	O	O	B-T061
treatment	O	O	I-T061
.	O	O	O

Using	O	O	O
the	O	O	O
proteomic	O	O	B-T059
methods	O	O	I-T059
,	O	O	O
three	O	O	O
differentially	O	O	O
expressed	O	O	B-T045
proteins	O	O	B-T116
were	O	O	O
detected	O	O	B-T033
,	O	O	O
including	O	O	O
voltage	O	O	B-T116
dependent	O	O	I-T116
anion	O	O	I-T116
channel	O	O	I-T116
1	O	O	I-T116
(	O	O	O
VDAC1	O	O	B-T116
)	O	O	O
,	O	O	O
sorting	O	O	B-T116
Nexin	O	O	I-T116
3	O	O	I-T116
(	O	O	O
SNX3	O	O	B-T116
)	O	O	O
,	O	O	O
and	O	O	O
prefoldin	O	O	B-T116
subunit	O	O	I-T116
6	O	O	I-T116
(	O	O	O
PFDN6	O	O	B-T116
)	O	O	O
.	O	O	O

We	O	O	O
observed	O	O	O
low	O	O	O
expression	O	O	B-T045
of	O	O	O
three	O	O	O
proteins	O	O	B-T116
after	O	O	O
DEXA	O	O	B-T109
treatment	O	O	B-T169
in	O	O	O
REH	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

We	O	O	O
subsequently	O	O	O
verified	O	O	O
low	O	O	O
expression	O	O	B-T045
of	O	O	O
resulted	O	O	O
proteins	O	O	B-T116
at	O	O	O
the	O	O	O
mRNA	O	O	B-T114
level	O	O	B-T080
using	O	O	O
the	O	O	O
quantitative	O	O	B-T059
PCR	O	O	I-T059
method	O	O	I-T059
.	O	O	O

These	O	O	O
proteins	O	O	B-T116
are	O	O	O
promising	O	O	O
proteins	O	O	O
because	O	O	O
of	O	O	O
their	O	O	O
important	O	O	O
roles	O	O	B-T077
in	O	O	O
drug	O	O	B-T038
resistance	O	O	I-T038
and	O	O	O
regulation	O	O	B-T043
of	O	O	I-T043
apoptosis	O	O	I-T043
(	O	O	O
VDAC1	O	O	B-T116
)	O	O	O
,	O	O	O
protein	O	O	B-T043
trafficking	O	O	I-T043
(	O	O	O
SNX3	O	O	B-T116
)	O	O	O
,	O	O	O
and	O	O	O
protein	O	O	B-T044
folding	O	O	I-T044
(	O	O	O
PFDN6	O	O	B-T116
)	O	O	O
.	O	O	O

Additionally	O	O	O
,	O	O	O
mRNA	O	O	B-T114
expression	O	O	B-T081
level	O	O	I-T081
of	O	O	O
these	O	O	O
proteins	O	O	B-T116
was	O	O	O
assessed	O	O	B-T052
in	O	O	O
17	O	O	O
bone	O	O	B-T031
marrow	O	O	I-T031
samples	O	O	I-T031
from	O	O	O
children	O	O	B-T100
with	O	O	O
newly	O	O	B-T080
diagnosed	O	O	I-T080
ALL	O	O	B-T191
and	O	O	O
7	O	O	O
non-cancerous	O	O	B-T167
samples	O	O	I-T167
as	O	O	O
controls	O	O	B-T096
.	O	O	O

The	O	O	O
results	O	O	O
indicated	O	O	O
that	O	O	O
independent	O	O	O
of	O	O	O
the	O	O	O
molecular	O	O	B-T185
subtypes	O	O	I-T185
of	O	O	O
leukemia	O	O	B-T191
,	O	O	O
mRNA	O	O	B-T114
expression	O	O	B-T045
of	O	O	O
VDAC1	O	O	B-T116
,	O	O	O
SNX3	O	O	B-T116
,	O	O	O
and	O	O	O
PFDN6	O	O	B-T116
decreased	O	O	O
in	O	O	O
ALL	O	O	B-T191
samples	O	O	B-T167
compared	O	O	O
with	O	O	O
non-cancerous	O	O	B-T167
samples	O	O	I-T167
particularly	O	O	O
in	O	O	O
VDAC1	O	O	O
(	O	O	O
p	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
.	O	O	O

Additionally	O	O	O
,	O	O	O
mRNA	O	O	B-T114
expression	O	O	B-T045
of	O	O	O
three	O	O	O
proteins	O	O	B-T116
was	O	O	O
also	O	O	O
declined	O	O	O
in	O	O	O
high-risk	O	O	B-T033
samples	O	O	B-T167
compared	O	O	O
with	O	O	O
standard	O	O	B-T080
risk	O	O	B-T078
cases	O	O	B-T169
.	O	O	O

These	O	O	O
results	O	O	O
demonstrated	O	O	O
diagnostic	O	O	B-T169
and	O	O	O
prognostic	O	O	B-T170
value	O	O	B-T080
of	O	O	O
these	O	O	O
proteins	O	O	B-T116
in	O	O	O
childhood	O	O	B-T079
ALL	O	O	B-T191
.	O	O	O

Furthermore	O	O	O
,	O	O	O
investigation	O	O	B-T058
of	O	O	O
protein-protein	O	O	B-T044
interaction	O	O	I-T044
using	O	O	O
STRING	O	O	B-T170
database	O	O	B-T170
indicated	O	O	O
that	O	O	O

these	O	O	O
proteins	O	O	B-T116
involved	O	O	O
in	O	O	O
the	O	O	O
signaling	O	O	B-T044
pathway	O	O	I-T044
of	O	O	O
NR3C1	O	O	B-T116
as	O	O	O
dexamethasone	O	O	B-T109
target	O	O	B-T033
.	O	O	O

In	O	O	O
conclusion	O	O	O
,	O	O	O
our	O	O	O
proteomic	O	O	B-T059
study	O	O	I-T059
in	O	O	O
DEXA	O	O	B-T109
resistant	O	O	B-T038
leukemic	O	O	B-T025
cells	O	O	I-T025
revealed	O	O	O
VDAC1	O	O	B-T116
,	O	O	O
SNX3	O	O	B-T116
,	O	O	O
and	O	O	O
PFDN6	O	O	B-T116
are	O	O	O
promising	O	O	O
proteins	O	O	B-T116
that	O	O	O
might	O	O	O
serve	O	O	O
as	O	O	O
potential	O	O	O
biomarkers	O	O	B-T201
of	O	O	O
prognosis	O	O	B-T058
and	O	O	O
chemotherapy	O	O	B-T061
in	O	O	O
childhood	O	O	B-T079
ALL	O	O	B-T191
.	O	O	O

-DOCSTART- (27779321)

Benthic	O	O	B-T170
injury	O	O	I-T170
dose-response	O	O	I-T170
models	O	O	I-T170
for	O	O	O
polychlorinated	O	O	B-T109
biphenyl	O	O	I-T109
-	O	O	O
contaminated	O	O	B-T169
sediment	O	O	B-T167
using	O	O	O
equilibrium	O	O	O
partitioning	O	O	O

The	O	O	O
study	O	O	B-T062
goal	O	O	O
was	O	O	O
to	O	O	O
develop	O	O	O
a	O	O	O
sediment	O	O	B-T167
polychlorinated	O	O	B-T109
biphenyl	O	O	I-T109
(	O	O	O
PCB	O	O	B-T109
)	O	O	O
dose-response	O	O	B-T170
model	O	O	I-T170
based	O	O	O
on	O	O	O
benthic	O	O	B-T001
invertebrate	O	O	I-T001
effects	O	O	O
to	O	O	O
PCBs	O	O	B-T109
.	O	O	O

The	O	O	O
authors	O	O	O
used	O	O	O
an	O	O	O
equilibrium	O	O	B-T170
partitioning	O	O	I-T170
(	O	O	I-T170
EqP	O	O	I-T170
)	O	O	I-T170
approach	O	O	I-T170
to	O	O	O
generate	O	O	O
predicted	O	O	O
PCB	O	O	B-T109
sediment	O	O	B-T167
effect	O	O	O
concentrations	O	O	B-T081
(	O	O	O
largely	O	O	O
Aroclor	O	O	B-T109
1254	O	O	I-T109
)	O	O	O
associated	O	O	O
with	O	O	O
a	O	O	O
gradient	O	O	B-T081
of	O	O	O
toxic	O	O	B-T037
effects	O	O	I-T037
in	O	O	O
benthic	O	O	B-T001
organisms	O	O	I-T001
from	O	O	O
effects	O	O	O
observed	O	O	O
in	O	O	O
aquatic	O	O	B-T067
toxicity	O	O	B-T037
studies	O	O	B-T062
.	O	O	O

The	O	O	O
present	O	O	O
study	O	O	B-T062
differs	O	O	O
from	O	O	O
all	O	O	O
other	O	O	O
EqP	O	O	B-T170
collective	O	O	O
sediment	O	O	B-T167
investigations	O	O	O
in	O	O	O
that	O	O	O
the	O	O	O
authors	O	O	O
examined	O	O	O
a	O	O	O
common	O	O	O
dose-response	O	O	B-T038
gradient	O	O	B-T081
of	O	O	O
effects	O	O	O
for	O	O	O
PCBs	O	O	B-T109
rather	O	O	O
than	O	O	O
a	O	O	O
single	O	O	O
,	O	O	O
protective	O	O	O
value	O	O	O
.	O	O	O

The	O	O	O
authors	O	O	O
reviewed	O	O	O
the	O	O	O
chronic	O	O	B-T079
aquatic	O	O	B-T067
toxicity	O	O	B-T037
literature	O	O	B-T170
to	O	O	O
identify	O	O	O
measured	O	O	O
aqueous	O	O	B-T080
PCB	O	O	B-T109
concentrations	O	O	B-T081
and	O	O	O
associated	O	O	O
benthic	O	O	B-T001
invertebrate	O	O	I-T001
effects	O	O	O
.	O	O	O

The	O	O	O
authors	O	O	O
control-normalized	O	O	O
the	O	O	O
aquatic	O	O	B-T067
toxic	O	O	B-T037
effect	O	O	I-T037
data	O	O	B-T078
and	O	O	O
expressed	O	O	O
results	O	O	O
from	O	O	O
various	O	O	O
studies	O	O	B-T062
as	O	O	O
a	O	O	O
common	O	O	B-T081
metric	O	O	I-T081
,	O	O	O
percent	O	O	B-T081
injury	O	O	I-T081
.	O	O	O

Then	O	O	O
,	O	O	O
they	O	O	O
calculated	O	O	O
organic	O	O	B-T109
carbon	O	O	I-T109
-normalized	O	O	O
sediment	O	O	B-T167
PCB	O	O	B-T109
concentrations	O	O	B-T081
(	O	O	O
mg/kg	O	O	O
organic	O	O	O
carbon	O	O	O
)	O	O	O
from	O	O	O
the	O	O	O
aqueous	O	O	B-T080
PCB	O	O	O
toxicity	O	O	B-T037
data	O	O	B-T170
set	O	O	I-T170
using	O	O	O
EqP	O	O	B-T170
theory	O	O	O
based	O	O	O
on	O	O	O
the	O	O	O
US	O	O	B-T092
Environmental	O	O	I-T092
Protection	O	O	I-T092
Agency	O	O	I-T092
's	O	O	I-T092
(	O	O	O
EPIWEB	O	O	B-T073
4.1	O	O	I-T073
)	O	O	O
derivation	O	O	O
of	O	O	O
the	O	O	O
water-organic	O	O	B-T081
carbon	O	O	I-T081
partition	O	O	I-T081
coefficient	O	O	I-T081
(	O	O	O
KOC	O	O	B-T081
)	O	O	O
.	O	O	O

Lastly	O	O	O
,	O	O	O
the	O	O	O
authors	O	O	O
constructed	O	O	O
a	O	O	O
nonlinear	O	O	O
dose-response	O	O	B-T170
numerical	O	O	I-T170
model	O	O	I-T170
for	O	O	O
these	O	O	O
synoptic	O	O	O
sediment	O	O	B-T167
PCB	O	O	B-T109
concentrations	O	O	B-T081
and	O	O	O
biological	O	O	B-T070
effects	O	O	I-T070
:	O	O	O
Y	O	O	O
=	O	O	O
100/1	O	O	O
+	O	O	O
10(([logEC50-logX	O	O	O
]	O	O	O
Ã	O	O	O
[	O	O	O
Hill	O	O	O
slope	O	O	O
]	O	O	O
)	O	O	O
)	O	O	O
(	O	O	O
EC50	O	O	O
=	O	O	O
median	O	O	B-T081
effective	O	O	I-T081
concentration	O	O	I-T081
)	O	O	O
.	O	O	O

These	O	O	O
models	O	O	B-T170
were	O	O	O
used	O	O	O
to	O	O	O
generate	O	O	O
"	O	O	O
look-up	O	O	O
"	O	O	O
tables	O	O	B-T170
reporting	O	O	O
percent	O	O	B-T081
injury	O	O	I-T081
in	O	O	O
benthic	O	O	B-T070
biota	O	O	I-T070
for	O	O	O
a	O	O	O
range	O	O	O
of	O	O	O
Aroclor	O	O	B-T109
-specific	O	O	O
sediment	O	O	B-T167
concentrations	O	O	B-T081
.	O	O	O

For	O	O	O
example	O	O	O
,	O	O	O
the	O	O	O
model	O	O	B-T170
using	O	O	O
the	O	O	O
EPIWEB	O	O	B-T073
KOC	O	O	B-T081
estimate	O	O	O
predicts	O	O	O
mean	O	O	B-T081
benthic	O	O	I-T081
injury	O	O	I-T081
of	O	O	O
23.3	O	O	O
%	O	O	O
,	O	O	O
46.0	O	O	O
%	O	O	O
,	O	O	O
70.6	O	O	O
%	O	O	O
,	O	O	O
87.1	O	O	O
%	O	O	O
,	O	O	O
and	O	O	O
95	O	O	O
%	O	O	O
for	O	O	O
hypothetical	O	O	O
sediment	O	O	B-T167
concentrations	O	O	B-T081
of	O	O	O
1	O	O	O
mg/kg	O	O	O
,	O	O	O
2	O	O	O
mg/kg	O	O	O
,	O	O	O
4	O	O	O
mg/kg	O	O	O
,	O	O	O
8	O	O	O
mg/kg	O	O	O
,	O	O	O
and	O	O	O
16	O	O	O
mg/kg	O	O	O
dry	O	O	O
weight	O	O	O
of	O	O	O
Aroclor	O	O	B-T109
1254	O	O	I-T109
,	O	O	O
respectively	O	O	O
(	O	O	O
at	O	O	O
1	O	O	O
%	O	O	O
organic	O	O	B-T109
carbon	O	O	I-T109
)	O	O	O
.	O	O	O

The	O	O	O
authors	O	O	O
recommend	O	O	O
the	O	O	O
model	O	O	B-T170
presented	O	O	O
for	O	O	O
screening	O	O	O
but	O	O	O
suggest	O	O	O
,	O	O	O
when	O	O	O
possible	O	O	O
,	O	O	O
determining	O	O	O
a	O	O	O
site-specific	O	O	B-T082
KOC	O	O	B-T081
that	O	O	O
,	O	O	O
along	O	O	O
with	O	O	O
the	O	O	O
tables	O	O	B-T170
and	O	O	O
equations	O	O	B-T077
,	O	O	O
allows	O	O	O
users	O	O	O
to	O	O	O
create	O	O	O
their	O	O	O
own	O	O	O
protective	O	O	O
dose-response	O	O	B-T038
sediment	O	O	B-T167
concentration	O	O	B-T081
.	O	O	O

Environ	O	O	O
Toxicol	O	O	O
Chem	O	O	O
2017;36:1311	O	O	O
-	O	O	O
1329	O	O	O
.	O	O	O

Â©	O	O	O
2016	O	O	O
SETAC	O	O	O
.	O	O	O

-DOCSTART- (27779702)

Extract	O	O	B-T123
of	O	O	I-T123
Caulis	O	O	B-T002
Spatholobi	O	O	I-T002
,	O	O	O
a	O	O	O
novel	O	O	O
blocker	O	O	B-T121
targeting	O	O	O
tumor	O	O	B-T043
cell	O	O	I-T043
âinduced	O	O	I-T043
platelet	O	O	I-T043
aggregation	O	O	I-T043
,	O	O	O
inhibits	O	O	O
breast	O	O	B-T191
cancer	O	O	I-T191
metastasis	O	O	O

Metastasis	O	O	B-T191
of	O	O	O
breast	O	O	B-T191
cancer	O	O	I-T191
is	O	O	O
the	O	O	O
vital	O	O	O
step	O	O	O
for	O	O	O
malignant	O	O	B-T191
progression	O	O	I-T191
.	O	O	O

During	O	O	O
such	O	O	O
a	O	O	O
process	O	O	O
,	O	O	O
hematogenous	O	O	B-T191
metastasis	O	O	I-T191
is	O	O	O
an	O	O	O
indispensable	O	O	O
approach	O	O	O
for	O	O	O
the	O	O	O
dissemination	O	O	O
of	O	O	O
cancer	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

A	O	O	O
platelet	O	O	B-T025
,	O	O	O
contributes	O	O	O
to	O	O	O
hypercoagulable	O	O	B-T047
state	O	O	I-T047
,	O	O	O
and	O	O	O
is	O	O	O
also	O	O	O
identified	O	O	O
the	O	O	O
crucial	O	O	O
factor	O	O	B-T169
in	O	O	O
the	O	O	O
coagulation	O	O	B-T042
system	O	O	B-T169
for	O	O	O
supporting	O	O	O
metastasis	O	O	B-T191
.	O	O	O

Therefore	O	O	O
,	O	O	O
the	O	O	O
relationship	O	O	O
of	O	O	O
a	O	O	O
platelet	O	O	B-T025
and	O	O	O
a	O	O	O
tumor	O	O	B-T025
cell	O	O	I-T025
plays	O	O	O
a	O	O	O
critical	O	O	O
role	O	O	O
in	O	O	O
tumor	O	O	O
cell	O	O	O
metastasis	O	O	B-T191
.	O	O	O

Consequently	O	O	O
,	O	O	O
inhibiting	O	O	O
tumor	O	O	B-T043
cell	O	O	I-T043
âinduced	O	O	I-T043
platelet	O	O	I-T043
aggregation	O	O	I-T043
(	O	O	O
TCIPA	O	O	B-T043
)	O	O	O
is	O	O	O
recongnized	O	O	O
as	O	O	O
a	O	O	O
crucial	O	O	O
target	O	O	O
on	O	O	O
suppression	O	O	B-T044
of	O	O	O
tumor	O	O	B-T191
metastasis	O	O	I-T191
such	O	O	O
as	O	O	O
aspirin	O	O	B-T109
(	O	O	O
ASA	O	O	B-T109
)	O	O	O
.	O	O	O

Under	O	O	O
such	O	O	O
circumstance	O	O	O
,	O	O	O
here	O	O	O
we	O	O	O
report	O	O	O
that	O	O	O
,	O	O	O
through	O	O	O
dissociating	O	O	O
the	O	O	O
tumorâplatelet	O	O	B-T026
(	O	O	I-T026
TâP	O	O	I-T026
)	O	O	I-T026
complex	O	O	I-T026
,	O	O	I-T026
80	O	O	O
%	O	O	O
ethanol	O	O	B-T109
extracts	O	O	B-T123
of	O	O	I-T123
Caulis	O	O	B-T002
Spatholobi	O	O	I-T002
(	O	O	O
SET	O	O	B-T123
)	O	O	O
successfully	O	O	O
alleviated	O	O	O
the	O	O	O
hypercoagulation	O	O	B-T047
state	O	O	I-T047
,	O	O	O
thereby	O	O	O
reducing	O	O	O
tumor	O	O	B-T191
metastasis	O	O	I-T191
and	O	O	O
improving	O	O	O
the	O	O	O
prospects	O	O	O
of	O	O	O
survival	O	O	B-T052
in	O	O	O
breast	O	O	B-T023
cancer	O	O	B-T025
cell	O	O	I-T025
model	O	O	B-T075
.	O	O	O

Through	O	O	O
MTT	O	O	B-T059
and	O	O	O
antiâaggregation	O	O	B-T059
assay	O	O	I-T059
stimulated	O	O	I-T059
by	O	O	I-T059
ADP	O	O	I-T059
,	O	O	O
we	O	O	O
detected	O	O	O
the	O	O	O
optimum	O	O	B-T079
treatment	O	O	I-T079
time	O	O	I-T079
and	O	O	O
the	O	O	O
optimum	O	O	B-T081
dose	O	O	I-T081
of	O	O	O
SET	O	O	B-T123
.	O	O	O

By	O	O	O
using	O	O	O
confocal	O	O	B-T059
microscopy	O	O	I-T059
,	O	O	O
we	O	O	O
observed	O	O	O
that	O	O	O
SET	O	O	B-T123
can	O	O	O
strongly	O	O	O
block	O	O	O
the	O	O	O
formation	O	O	B-T169
of	O	O	O
TâP	O	O	B-T026
complex	O	O	I-T026
i	O	O	O
n	O	O	B-T080
vitro	O	O	I-T080
.	O	O	O

The	O	O	O
result	O	O	O
was	O	O	O
further	O	O	O
quantified	O	O	O
and	O	O	O
confirmed	O	O	O
by	O	O	O
the	O	O	O
FACS	O	O	B-T059
analysis	O	O	I-T059
.	O	O	O

The	O	O	O
fluorescent	O	O	B-T081
value	O	O	I-T081
of	O	O	O
TâP	O	O	B-T026
complex	O	O	I-T026
was	O	O	O
obviously	O	O	O
decreased	O	O	O
in	O	O	O
the	O	O	O
drugâtreated	O	O	O
groups	O	O	O
.	O	O	O

In	O	O	B-T082
vivo	O	O	I-T082
,	O	O	O
4T1	O	O	B-T025
cells	O	O	I-T025
were	O	O	O
injected	O	O	B-T061
through	O	O	O
the	O	O	O
mouse	O	O	B-T015
tail	O	O	B-T023
vein	O	O	I-T023
for	O	O	O
dynamic	O	O	B-T060
visualization	O	O	I-T060
by	O	O	O
small	O	O	B-T073
animal	O	O	I-T073
imaging	O	O	I-T073
system	O	O	I-T073
.	O	O	O

The	O	O	O
metastatic	O	O	B-T081
intensity	O	O	I-T081
was	O	O	O
quantified	O	O	O
and	O	O	O
the	O	O	O
survival	O	O	B-T081
curve	O	O	I-T081
was	O	O	O
analyzed	O	O	B-T062
.	O	O	O

Additionally	O	O	O
,	O	O	O
general	O	O	O
observation	O	O	O
and	O	O	O
hematoxylin	O	O	B-T059
and	O	O	I-T059
eosin	O	O	I-T059
(	O	O	I-T059
H&E	O	O	I-T059
)	O	O	I-T059
staining	O	O	I-T059
of	O	O	O
lung	O	O	B-T023
tissue	O	O	B-T024
was	O	O	O
performed	O	O	O
.	O	O	O

SET	O	O	B-T123
exerted	O	O	O
an	O	O	O
obvious	O	O	O
effect	O	O	O
on	O	O	O
the	O	O	O
inhibition	O	O	B-T052
of	O	O	O
metastasis	O	O	B-T191
and	O	O	O
increasing	O	O	O
the	O	O	O
survival	O	O	B-T081
rate	O	O	I-T081
of	O	O	O
mice	O	O	B-T015
.	O	O	O

For	O	O	O
the	O	O	O
molecular	O	O	B-T044
mechanism	O	O	I-T044
study	O	O	B-T062
of	O	O	O
antiâTCIPA	O	O	B-T059
,	O	O	O
zymography	O	O	B-T062
and	O	O	O
R	O	O	O
TâPCR	O	O	B-T063
assay	O	O	I-T063
preliminarily	O	O	O
revealed	O	O	O
the	O	O	O
molecular	O	O	O
mechanism	O	O	O
of	O	O	O
SET	O	O	B-T123
in	O	O	O
the	O	O	O
regulation	O	O	O
of	O	O	O
P	O	O	O
âT	O	O	B-T043
interaction	O	O	I-T043
.	O	O	O

Collectively	O	O	O
,	O	O	O
through	O	O	O
drug	O	O	B-T080
efficacy	O	O	I-T080
identification	O	O	O
and	O	O	O
pharmacological	O	O	B-T169
revealing	O	O	O
,	O	O	O
we	O	O	O
have	O	O	O
obtained	O	O	O
a	O	O	O
promising	O	O	O
candidate	O	O	O
for	O	O	O
the	O	O	O
interference	O	O	O
of	O	O	O
breast	O	O	B-T023
metastasis	O	O	B-T191
by	O	O	O
suppressing	O	O	O
TCIPA	O	O	B-T043
,	O	O	O
which	O	O	O
will	O	O	O
be	O	O	O
beneficial	O	O	O
for	O	O	O
clinical	O	O	B-T080
cancer	O	O	B-T061
treatment	O	O	I-T061
.	O	O	O

-DOCSTART- (27781034)

Generalized	O	O	B-T047
Epilepsy	O	O	I-T047
and	O	O	O
Myoclonic	O	O	B-T047
Seizures	O	O	I-T047
in	O	O	O
22q11.2	O	O	O
Deletion	O	O	O
Syndrome	O	O	O

Prompted	O	O	O
by	O	O	O
the	O	O	O
observations	O	O	O
of	O	O	O
juvenile	O	O	B-T047
myoclonic	O	O	I-T047
epilepsy	O	O	I-T047
(	O	O	O
JME	O	O	B-T047
)	O	O	O
in	O	O	O
22q11.2	O	O	B-T047
deletion	O	O	I-T047
syndrome	O	O	I-T047
(	O	O	O
22q11DS	O	O	B-T047
)	O	O	O
and	O	O	O
recurrent	O	O	B-T086
copy	O	O	I-T086
number	O	O	I-T086
variants	O	O	I-T086
in	O	O	O
genetic	O	O	B-T169
generalized	O	O	B-T047
epilepsy	O	O	I-T047
(	O	O	O
GGE	O	O	B-T047
)	O	O	O
,	O	O	O
we	O	O	O
searched	O	O	O
for	O	O	O
further	O	O	O
evidence	O	O	O
supporting	O	O	O
a	O	O	O
possible	O	O	O
correlation	O	O	B-T080
of	O	O	O
22q11DS	O	O	O
with	O	O	O
GGE	O	O	O
and	O	O	O
with	O	O	O
myoclonic	O	O	B-T047
seizures	O	O	I-T047
.	O	O	O

Through	O	O	O
routine	O	O	B-T060
diagnostics	O	O	I-T060
,	O	O	O
we	O	O	O
identified	O	O	O
3	O	O	O
novel	O	O	O
individuals	O	O	B-T098
with	O	O	O
the	O	O	O
seemingly	O	O	O
uncommon	O	O	B-T080
combination	O	O	B-T080
of	O	O	O
22q11DS	O	O	B-T047
and	O	O	O
JME	O	O	B-T047
.	O	O	O

We	O	O	O
subsequently	O	O	O
screened	O	O	B-T058
the	O	O	O
literature	O	O	B-T170
for	O	O	O
reports	O	O	B-T170
focussing	O	O	O
on	O	O	O
the	O	O	O
epilepsy	O	O	B-T032
phenotype	O	O	I-T032
in	O	O	O
22q11DS	O	O	B-T047
.	O	O	O

We	O	O	O
additionally	O	O	O
screened	O	O	B-T058
a	O	O	O
database	O	O	B-T170
of	O	O	O
173	O	O	O
22q11DS	O	O	B-T047
patients	O	O	B-T101
and	O	O	O
identified	O	O	O
a	O	O	O
fourth	O	O	O
individual	O	O	B-T098
with	O	O	O
JME	O	O	B-T047
as	O	O	O
well	O	O	O
as	O	O	O
2	O	O	O
additional	O	O	O
cases	O	O	B-T169
with	O	O	O
GGE	O	O	B-T047
.	O	O	O

We	O	O	O
describe	O	O	O
6	O	O	O
novel	O	O	B-T080
and	O	O	O
22	O	O	O
published	O	O	B-T057
cases	O	O	B-T169
with	O	O	O
co-occurrence	O	O	B-T033
of	O	O	O
22q11DS	O	O	B-T047
and	O	O	O
GGE	O	O	B-T047
.	O	O	O

In	O	O	O
many	O	O	O
patients	O	O	B-T101
,	O	O	O
GGE	O	O	B-T047
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
myoclonic	O	O	B-T047
seizures	O	O	I-T047
allowing	O	O	O
for	O	O	O
a	O	O	O
diagnosis	O	O	B-T033
of	O	O	O
JME	O	O	B-T047
in	O	O	O
at	O	O	O
least	O	O	O
6	O	O	O
individuals	O	O	B-T098
.	O	O	O

Seventeen	O	O	O
of	O	O	O
the	O	O	O
173	O	O	O
22q11DS	O	O	B-T047
cases	O	O	B-T169
(	O	O	O
10	O	O	O
%	O	O	O
)	O	O	O
had	O	O	O
a	O	O	O
diagnosis	O	O	B-T033
of	O	O	O
either	O	O	O
focal	O	O	B-T047
or	O	O	O
generalized	O	O	B-T047
epilepsy	O	O	I-T047
.	O	O	O

In	O	O	O
these	O	O	O
cases	O	O	B-T169
,	O	O	O
focal	O	O	B-T047
epilepsy	O	O	I-T047
could	O	O	O
often	O	O	O
be	O	O	O
attributed	O	O	O
to	O	O	O
syndrome-associated	O	O	B-T047
hypocalcaemia	O	O	I-T047
,	O	O	O
cerebral	O	O	B-T033
bleeds	O	O	I-T033
,	O	O	O
or	O	O	O
structural	O	O	B-T033
brain	O	O	I-T033
anomalies	O	O	I-T033
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
cause	O	O	O
of	O	O	O
GGE	O	O	B-T047
remained	O	O	O
unclear	O	O	O
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
we	O	O	O
describe	O	O	O
and	O	O	O
review	O	O	O
28	O	O	O
individuals	O	O	B-T098
with	O	O	O
22q11DS	O	O	B-T047
and	O	O	O
GGE	O	O	B-T047
(	O	O	O
especially	O	O	O
JME	O	O	B-T047
)	O	O	O
,	O	O	O
showing	O	O	O
that	O	O	O
both	O	O	O
disorders	O	O	B-T047
frequently	O	O	B-T033
co-occur	O	O	I-T033
.	O	O	O

Compared	O	O	O
to	O	O	O
the	O	O	O
reported	O	O	B-T081
prevalence	O	O	I-T081
of	O	O	O
15	O	O	O
-	O	O	O
21	O	O	O
%	O	O	O
,	O	O	O
in	O	O	O
our	O	O	O
case	O	O	B-T062
series	O	O	I-T062
only	O	O	O
10	O	O	O
%	O	O	O
of	O	O	O
22q11DS	O	O	B-T047
individuals	O	O	B-T098
were	O	O	O
found	O	O	O
to	O	O	O
have	O	O	O
epilepsy	O	O	B-T047
,	O	O	O
often	O	O	O
GGE	O	O	B-T047
.	O	O	O

Since	O	O	O
22q11.2	O	O	B-T026
does	O	O	O
not	O	O	O
contain	O	O	O
convincing	O	O	O
GGE	O	O	B-T047
candidate	O	O	B-T028
genes	O	O	I-T028
,	O	O	O
we	O	O	O
discuss	O	O	O
the	O	O	O
possibility	O	O	O
of	O	O	O
an	O	O	O
aetiological	O	O	B-T169
correlation	O	O	B-T080
through	O	O	O
a	O	O	O
possibly	O	O	O
disturbed	O	O	O
interaction	O	O	O
with	O	O	O
the	O	O	O
GABAB	O	O	B-T116
receptor	O	O	I-T116
.	O	O	O

-DOCSTART- (27782044)

Normal	O	O	B-T080
Levels	O	O	B-T059
of	O	O	O
Urinary	O	O	B-T031
CC16	O	O	B-T116
Protein	O	O	I-T116
.	O	O	O
Comments	O	O	B-T170
on	O	O	I-T170
Beamer	O	O	I-T170
et	O	O	I-T170
al.	O	O	I-T170
Association	O	O	I-T170
of	O	O	O
Children	O	O	B-T100
's	O	O	I-T100
Urinary	O	O	O
CC16	O	O	O
Levels	O	O	O
with	O	O	O
Arsenic	O	O	B-T059
Concentrations	O	O	I-T059
in	O	O	O
Multiple	O	O	B-T077
Environmental	O	O	I-T077
Media	O	O	I-T077
.	O	O	O
Int	O	O	O
.	O	O	O
J.	O	O	O
Environ	O	O	O
.	O	O	O
Res	O	O	O
.	O	O	O
Public	O	O	O
Health	O	O	O
2016	O	O	O
,	O	O	O
13	O	O	O
,	O	O	O
521	O	O	O

Comments	O	O	B-T170
on	O	O	I-T170
Beamer	O	O	I-T170
et	O	O	I-T170
al.	O	O	I-T170
Association	O	O	I-T170
of	O	O	O
Children	O	O	B-T100
's	O	O	I-T100
Urinary	O	O	B-T031
CC16	O	O	B-T116
Levels	O	O	B-T059
with	O	O	O
Arsenic	O	O	B-T059
Concentrations	O	O	I-T059
in	O	O	O
Multiple	O	O	B-T077
Environmental	O	O	I-T077
Media	O	O	I-T077
.	O	O	O

Int	O	O	O
.	O	O	O

J.	O	O	O
Environ	O	O	O
.	O	O	O

Res	O	O	O
.	O	O	O

Public	O	O	O
Health	O	O	O
2016	O	O	O
,	O	O	O
13	O	O	O
,	O	O	O
521	O	O	O
In	O	O	O
1937	O	O	O
,	O	O	O
Max	O	O	B-T016
Clara	O	O	I-T016
described	O	O	O
a	O	O	O
new	O	O	O
type	O	O	O
of	O	O	O
cell	O	O	B-T025
in	O	O	O
the	O	O	O
human	O	O	B-T016
lung	O	O	B-T023
,	O	O	O
which	O	O	O
was	O	O	O
later	O	O	O
determined	O	O	O
to	O	O	O
be	O	O	O
an	O	O	O
exocrine	O	O	B-T026
secretory	O	O	I-T026
cell	O	O	I-T026
type	O	O	I-T026
containing	O	O	I-T026
granules	O	O	I-T026
composed	O	O	O
of	O	O	O
proteins	O	O	B-T116
[	O	O	O
1	O	O	O
]	O	O	O
.	O	O	O
[	O	O	O
...	O	O	O
]	O	O	O
.	O	O	O

-DOCSTART- (27782129)

Diverse	O	O	O
Colletotrichum	O	O	B-T004
species	O	O	I-T004
cause	O	O	O
anthracnose	O	O	B-T047
of	O	O	O
tea	O	O	B-T002
plants	O	O	I-T002
(	O	O	O
Camellia	O	O	B-T002
sinensis	O	O	I-T002
(	O	O	I-T002
L.	O	O	I-T002
)	O	O	I-T002
O.	O	O	I-T002
Kuntze	O	O	I-T002
)	O	O	O
in	O	O	O
China	O	O	O

Anthracnose	O	O	B-T047
caused	O	O	O
by	O	O	O
Colletotrichum	O	O	B-T004
is	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
most	O	O	O
severe	O	O	O
diseases	O	O	B-T047
that	O	O	O
can	O	O	O
afflict	O	O	O
Camellia	O	O	B-T002
sinensis	O	O	I-T002
.	O	O	O

However	O	O	O
,	O	O	O
research	O	O	B-T062
on	O	O	O
the	O	O	O
diversity	O	O	B-T080
and	O	O	O
geographical	O	O	B-T079
distribution	O	O	I-T079
of	O	O	O
Colletotrichum	O	O	B-T004
in	O	O	O
China	O	O	B-T083
remain	O	O	O
limited	O	O	O
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
106	O	O	O
Colletotrichum	O	O	B-T004
isolates	O	O	B-T123
were	O	O	O
collected	O	O	B-T169
from	O	O	O
diseased	O	O	B-T047
leaves	O	O	B-T002
of	O	O	O
Ca	O	O	O
.	O	O	O

sinensis	O	O	O
cultivated	O	O	O
in	O	O	O
the	O	O	O
15	O	O	O
main	O	O	O
tea	O	O	B-T090
production	O	O	I-T090
provinces	O	O	B-T083
in	O	O	O
China	O	O	B-T083
.	O	O	O

Multi-locus	O	O	B-T062
phylogenetic	O	O	I-T062
analysis	O	O	I-T062
coupled	O	O	O
with	O	O	O
morphological	O	O	B-T059
identification	O	O	I-T059
showed	O	O	O
that	O	O	O
the	O	O	O
collected	O	O	B-T169
isolates	O	O	B-T123
belonged	O	O	O
to	O	O	O
11	O	O	O
species	O	O	B-T185
,	O	O	O
including	O	O	O
6	O	O	O
known	O	O	O
species	O	O	O
(	O	O	O
C.	O	O	B-T004
camelliae	O	O	I-T004
,	O	O	O
C.	O	O	B-T004
cliviae	O	O	I-T004
,	O	O	O
C.	O	O	B-T004
fioriniae	O	O	I-T004
,	O	O	O
C.	O	O	B-T004
fructicola	O	O	I-T004
,	O	O	O
C.	O	O	B-T004
karstii	O	O	I-T004
,	O	O	O
and	O	O	O
C.	O	O	B-T004
siamense	O	O	I-T004
)	O	O	O
,	O	O	O
3	O	O	O
new	O	O	O
record	O	O	B-T185
species	O	O	I-T185
(	O	O	O
C.	O	O	B-T004
aenigma	O	O	I-T004
,	O	O	O
C.	O	O	B-T004
endophytica	O	O	I-T004
,	O	O	O
and	O	O	O
C.	O	O	B-T004
truncatum	O	O	I-T004
)	O	O	O
,	O	O	O
1	O	O	O
novel	O	O	O
species	O	O	O
(	O	O	O
C.	O	O	B-T004
wuxiense	O	O	I-T004
)	O	O	O
,	O	O	O
and	O	O	O
1	O	O	O
indistinguishable	O	O	O
strain	O	O	B-T001
,	O	O	O
herein	O	O	O
described	O	O	O
as	O	O	O
Colletotrichum	O	O	B-T004
sp.	O	O	I-T004
Of	O	O	O
these	O	O	O
species	O	O	O
,	O	O	O
C.	O	O	O
camelliae	O	O	O
and	O	O	O
C.	O	O	O
fructicola	O	O	O
were	O	O	O
the	O	O	O
dominant	O	O	O
species	O	O	O
causing	O	O	O
anthracnose	O	O	B-T047
in	O	O	O
Ca	O	O	O
.	O	O	O

sinensis	O	O	O
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
our	O	O	O
study	O	O	B-T062
provided	O	O	O
further	O	O	O
evidence	O	O	B-T078
that	O	O	O
phylogenetic	O	O	B-T062
analysis	O	O	I-T062
using	O	O	O
a	O	O	O
combination	O	O	O
of	O	O	O
ApMat	O	O	B-T086
and	O	O	I-T086
GS	O	O	I-T086
sequences	O	O	I-T086
can	O	O	O
be	O	O	O
used	O	O	O
to	O	O	O
effectively	O	O	O
resolve	O	O	O
the	O	O	O
taxonomic	O	O	B-T169
relationships	O	O	B-T080
within	O	O	O
the	O	O	O
C.	O	O	B-T004
gloeosporioides	O	O	I-T004
species	O	O	B-T185
complex	O	O	I-T185
.	O	O	O

Finally	O	O	O
,	O	O	O
pathogenicity	O	O	B-T032
tests	O	O	B-T059
suggested	O	O	O
that	O	O	O
C.	O	O	B-T004
camelliae	O	O	I-T004
,	O	O	O
C.	O	O	B-T004
aenigma	O	O	I-T004
,	O	O	O
and	O	O	O
C.	O	O	B-T004
endophytica	O	O	I-T004
are	O	O	O
more	O	O	O
invasive	O	O	B-T080
than	O	O	O
other	O	O	O
species	O	O	B-T185
after	O	O	O
the	O	O	O
inoculation	O	O	B-T061
of	O	O	O
the	O	O	O
leaves	O	O	B-T002
of	O	O	O
Ca	O	O	O
.	O	O	O

sinensis	O	O	O
.	O	O	O

-DOCSTART- (27784873)

ATP	O	O	B-T114
release	O	O	B-T169
from	O	O	O
bladder	O	O	B-T024
urothelium	O	O	I-T024
and	O	O	O
serosa	O	O	B-T024
in	O	O	O
a	O	O	O
rat	O	O	O
model	O	O	B-T050
of	O	O	O
partial	O	O	O
bladder	O	O	O
outlet	O	O	O
obstruction	O	O	O

Overactive	O	O	B-T047
bladder	O	O	I-T047
is	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
major	O	O	O
health	O	O	B-T033
problem	O	O	I-T033
especially	O	O	O
in	O	O	O
elderly	O	O	B-T098
people	O	O	I-T098
.	O	O	O

Adenosine	O	O	B-T114
triphosphate	O	O	I-T114
(	O	O	O
ATP	O	O	B-T114
)	O	O	O
is	O	O	O
released	O	O	B-T169
from	O	O	O
urinary	O	O	B-T025
bladder	O	O	I-T025
cells	O	O	I-T025
and	O	O	O
acts	O	O	O
as	O	O	O
a	O	O	O
smooth	O	O	B-T042
muscle	O	O	I-T042
contraction	O	O	I-T042
and	O	O	O
sensory	O	O	B-T041
signal	O	O	I-T041
in	O	O	O
micturition	O	O	B-T040
but	O	O	O
little	O	O	O
is	O	O	O
known	O	O	O
about	O	O	O
the	O	O	O
role	O	O	O
of	O	O	O
ATP	O	O	O
release	O	O	O
in	O	O	O
the	O	O	O
pathophysiology	O	O	B-T046
of	O	O	O
overactive	O	O	B-T047
bladder	O	O	I-T047
.	O	O	O

To	O	O	O
assess	O	O	O
the	O	O	O
relationship	O	O	O
between	O	O	O
ATP	O	O	B-T114
and	O	O	O
overactive	O	O	B-T047
bladder	O	O	I-T047
,	O	O	O
we	O	O	O
used	O	O	O
a	O	O	O
partial	O	O	B-T047
bladder	O	O	I-T047
outlet	O	O	I-T047
obstruction	O	O	I-T047
(	O	O	O
pBOO	O	O	B-T047
)	O	O	O
model	O	O	B-T050
in	O	O	O
rats	O	O	B-T015
.	O	O	O

The	O	O	O
bladder	O	O	B-T023
caused	O	O	O
several	O	O	O
changes	O	O	O
by	O	O	O
pBOO	O	O	B-T047
:	O	O	O
An	O	O	O
increase	O	O	B-T169
in	O	O	O
bladder	O	O	O
weight	O	O	B-T081
,	O	O	O
hypertrophy	O	O	B-T046
of	O	O	O
sub-urothelium	O	O	B-T024
and	O	O	O
sub-serosal	O	O	B-T024
area	O	O	I-T024
,	O	O	O
and	O	O	O
frequent	O	O	O
non	O	O	B-T169
-	O	O	O
voiding	O	O	B-T042
bladder	O	O	I-T042
contraction	O	O	I-T042
during	O	O	O
urine	O	O	B-T031
storage	O	O	O
.	O	O	O

Basal	O	O	B-T082
ATP	O	O	B-T114
release	O	O	O
from	O	O	O
urothelium	O	O	B-T024
and	O	O	O
serosa	O	O	B-T024
of	O	O	O
pBOO	O	O	B-T047
rats	O	O	B-T015
was	O	O	O
significantly	O	O	O
higher	O	O	O
than	O	O	O
that	O	O	O
of	O	O	O
normal	O	O	O
rats	O	O	O
.	O	O	O

Distention	O	O	B-T033
induced	O	O	O
ATP	O	O	B-T114
release	O	O	B-T169
from	O	O	O
urothelium	O	O	B-T024
of	O	O	O
normal	O	O	O
and	O	O	O
pBOO	O	O	B-T047
rats	O	O	B-T015
had	O	O	O
no	O	O	O
significant	O	O	O
change	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
distention	O	O	B-T033
-	O	O	O
induced	O	O	B-T169
ATP	O	O	B-T114
release	O	O	B-T169
from	O	O	O
serosa	O	O	B-T024
of	O	O	O
pBOO	O	O	B-T047
rats	O	O	B-T015
was	O	O	O
higher	O	O	O
than	O	O	O
that	O	O	O
of	O	O	O
normal	O	O	O
.	O	O	O

These	O	O	O
findings	O	O	O
may	O	O	O
identify	O	O	O
ATP	O	O	B-T114
especially	O	O	O
released	O	O	B-T169
from	O	O	O
serosa	O	O	B-T024
as	O	O	O
one	O	O	O
of	O	O	O
causes	O	O	O
of	O	O	O
non	O	O	B-T169
-	O	O	O
voiding	O	O	B-T042
contractions	O	O	I-T042
and	O	O	O
overactive	O	O	B-T047
bladder	O	O	I-T047
symptoms	O	O	B-T184
.	O	O	O

-DOCSTART- (27786249)

Determining	O	O	O
putative	O	O	B-T008
vectors	O	O	I-T008
of	O	O	O
the	O	O	O
Bogia	O	O	B-T047
Coconut	O	O	I-T047
Syndrome	O	O	I-T047
phytoplasma	O	O	B-T007
using	O	O	O
loop-mediated	O	O	B-T059
isothermal	O	O	I-T059
amplification	O	O	I-T059
of	O	O	O
single-insect	O	O	O
feeding	O	O	O
media	O	O	O

Phytoplasmas	O	O	B-T007
are	O	O	O
insect	O	O	B-T007
vectored	O	O	I-T007
mollicutes	O	O	I-T007
responsible	O	O	O
for	O	O	O
disease	O	O	B-T047
in	O	O	O
many	O	O	O
economically	O	O	O
important	O	O	O
crops	O	O	B-T002
.	O	O	O

Determining	O	O	O
which	O	O	O
insect	O	O	B-T204
species	O	O	I-T204
are	O	O	O
vectors	O	O	B-T008
of	O	O	O
a	O	O	O
given	O	O	O
phytoplasma	O	O	B-T007
is	O	O	O
important	O	O	O
for	O	O	O
managing	O	O	O
disease	O	O	B-T047
but	O	O	O
is	O	O	O
methodologically	O	O	O
challenging	O	O	O
because	O	O	O
disease-free	O	O	B-T002
plants	O	O	I-T002
need	O	O	O
to	O	O	O
be	O	O	O
exposed	O	O	O
to	O	O	O
large	O	O	O
numbers	O	O	O
of	O	O	O
insects	O	O	B-T204
,	O	O	O
often	O	O	O
over	O	O	O
many	O	O	O
months	O	O	B-T079
.	O	O	O

A	O	O	O
relatively	O	O	O
new	O	O	O
method	O	O	O
to	O	O	O
detect	O	O	O
likely	O	O	O
transmission	O	O	B-T070
involves	O	O	O
molecular	O	O	B-T059
testing	O	O	I-T059
for	O	O	O
phytoplasma	O	O	B-T007
DNA	O	O	B-T114
in	O	O	O
sucrose	O	O	B-T109
solution	O	O	B-T167
that	O	O	O
insects	O	O	B-T204
have	O	O	O
fed	O	O	B-T052
upon	O	O	O
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
we	O	O	O
combined	O	O	O
this	O	O	O
feeding	O	O	B-T059
medium	O	O	I-T059
method	O	O	I-T059
with	O	O	O
a	O	O	O
loop-mediated	O	O	B-T059
isothermal	O	O	I-T059
amplification	O	O	I-T059
(	O	O	I-T059
LAMP	O	O	I-T059
)	O	O	I-T059
assay	O	O	I-T059
to	O	O	O
study	O	O	O
627	O	O	O
insect	O	O	B-T204
specimens	O	O	B-T077
of	O	O	O
11	O	O	O
Hemiptera	O	O	B-T204
taxa	O	O	I-T204
sampled	O	O	O
from	O	O	O
sites	O	O	O
in	O	O	O
Papua	O	O	B-T083
New	O	O	I-T083
Guinea	O	O	I-T083
affected	O	O	O
by	O	O	O
Bogia	O	O	B-T047
coconut	O	O	I-T047
syndrome	O	O	I-T047
(	O	O	O
BCS	O	O	B-T047
)	O	O	O
.	O	O	O

The	O	O	O
LAMP	O	O	B-T059
assay	O	O	I-T059
detected	O	O	O
phytoplasma	O	O	B-T007
DNA	O	O	B-T114
from	O	O	O
the	O	O	O
feeding	O	O	B-T168
solution	O	O	I-T168
and	O	O	O
head	O	O	B-T029
tissue	O	O	B-T024
of	O	O	O
insects	O	O	B-T204
from	O	O	O
six	O	O	O
taxa	O	O	B-T077
belonging	O	O	O
to	O	O	O
four	O	O	O
families	O	O	O
:	O	O	O
Derbidae	O	O	B-T204
,	O	O	O
Lophopidae	O	O	B-T204
,	O	O	O
Flatidae	O	O	B-T204
and	O	O	O
Ricaniidae	O	O	B-T204
.	O	O	O

Two	O	O	O
other	O	O	O
taxa	O	O	B-T077
yielded	O	O	O
positives	O	O	O
only	O	O	O
from	O	O	O
the	O	O	O
heads	O	O	B-T029
and	O	O	O
the	O	O	O
remainder	O	O	O
tested	O	O	O
negative	O	O	O
.	O	O	O

These	O	O	O
results	O	O	O
demonstrate	O	O	O
the	O	O	O
utility	O	O	O
of	O	O	O
combining	O	O	O
single-insect	O	O	B-T059
feeding	O	O	I-T059
medium	O	O	I-T059
tests	O	O	B-T169
with	O	O	O
LAMP	O	O	B-T059
assays	O	O	I-T059
to	O	O	O
identify	O	O	O
putative	O	O	B-T008
vectors	O	O	I-T008
that	O	O	O
can	O	O	O
be	O	O	O
the	O	O	O
subject	O	O	O
of	O	O	O
transmission	O	O	B-T070
tests	O	O	O
and	O	O	O
to	O	O	O
better	O	O	O
understand	O	O	O
phytoplasma	O	O	B-T007
pathosystems	O	O	B-T091
.	O	O	O

-DOCSTART- (27786291)

Non-toxigenic	O	O	B-T169
environmental	O	O	B-T082
Vibrio	O	O	B-T007
cholerae	O	O	I-T007
O1	O	O	I-T007
strain	O	O	B-T001
from	O	O	O
Haiti	O	O	B-T083
provides	O	O	B-T052
evidence	O	O	B-T078
of	O	O	O
pre-pandemic	O	O	B-T067
cholera	O	O	B-T047
in	O	O	O
Hispaniola	O	O	O

Vibrio	O	O	B-T007
cholerae	O	O	I-T007
is	O	O	O
ubiquitous	O	O	B-T080
in	O	O	O
aquatic	O	O	B-T067
environments	O	O	I-T067
,	O	O	O
with	O	O	O
environmental	O	O	B-T082
toxigenic	O	O	B-T170
V.	O	O	B-T007
cholerae	O	O	I-T007
O1	O	O	I-T007
strains	O	O	B-T001
serving	O	O	B-T081
as	O	O	O
a	O	O	O
source	O	O	B-T033
for	O	O	O
recurrent	O	O	B-T079
cholera	O	O	B-T047
epidemics	O	O	I-T047
and	O	O	O
pandemic	O	O	B-T067
disease	O	O	B-T047
.	O	O	O

However	O	O	O
,	O	O	O
a	O	O	O
number	O	O	O
of	O	O	O
questions	O	O	O
remain	O	O	O
about	O	O	O
long-term	O	O	B-T079
survival	O	O	B-T169
and	O	O	O
evolution	O	O	O
of	O	O	O
V.	O	O	B-T007
cholerae	O	O	I-T007
strains	O	O	B-T001
within	O	O	O
these	O	O	O
aquatic	O	O	B-T067
environmental	O	O	I-T067
reservoirs	O	O	B-T083
.	O	O	O

Through	O	O	O
monitoring	O	O	B-T057
of	O	O	O
the	O	O	O
Haitian	O	O	B-T083
aquatic	O	O	B-T067
environment	O	O	I-T067
following	O	O	O
the	O	O	O
2010	O	O	O
cholera	O	O	B-T047
epidemic	O	O	I-T047
,	O	O	O
we	O	O	O
isolated	O	O	B-T169
two	O	O	B-T081
novel	O	O	B-T080
non-toxigenic	O	O	B-T169
(	O	O	O
ctxA/B	O	O	B-T028
-	O	O	O
negative	O	O	B-T033
)	O	O	O
Vibrio	O	O	B-T007
cholerae	O	O	I-T007
O1	O	O	I-T007
.	O	O	O

These	O	O	O
two	O	O	B-T081
isolates	O	O	B-T123
underwent	O	O	O
whole-genome	O	O	B-T063
sequencing	O	O	I-T063
and	O	O	O
were	O	O	O
investigated	O	O	B-T169
through	O	O	B-T169
comparative	O	O	B-T052
genomics	O	O	B-T091
and	O	O	O
Bayesian	O	O	B-T081
coalescent	O	O	I-T081
analysis	O	O	I-T081
.	O	O	O

These	O	O	O
isolates	O	O	B-T123
cluster	O	O	O
in	O	O	O
the	O	O	O
evolutionary	O	O	O
tree	O	O	B-T002
with	O	O	O
strains	O	O	B-T001
responsible	O	O	O
for	O	O	O
clinical	O	O	B-T080
cholera	O	O	B-T047
,	O	O	O
possessing	O	O	B-T078
genomic	O	O	B-T028
components	O	O	I-T028
of	O	O	O
6(th	O	O	O
)	O	O	O
and	O	O	O
7(th	O	O	O
)	O	O	O
pandemic	O	O	B-T067
lineages	O	O	B-T077
,	O	O	O
and	O	O	O
diverge	O	O	B-T080
from	O	O	O
"	O	O	O
modern	O	O	B-T079
"	O	O	O
cholera	O	O	O
strains	O	O	O
around	O	O	O
1548	O	O	O
C.E.	O	O	O
[	O	O	O
95	O	O	O
%	O	O	O
HPD	O	O	O
:	O	O	O
1532	O	O	O
-	O	O	O
1555	O	O	O
]	O	O	O
.	O	O	O

Vibrio	O	O	B-T028
Pathogenicity	O	O	I-T028
Island	O	O	I-T028
(VPI)-1	O	O	B-T028
was	O	O	O
present	O	O	B-T033
;	O	O	O
however	O	O	O
,	O	O	O
SXT/R391-family	O	O	B-T028
ICE	O	O	I-T028
and	O	O	O
VPI-2	O	O	B-T028
were	O	O	O
absent	O	O	B-T169
.	O	O	O

Rugose	O	O	B-T032
phenotype	O	O	I-T032
conversion	O	O	B-T169
and	O	O	O
vibriophage	O	O	B-T005
resistance	O	O	B-T169
evidenced	O	O	B-T169
adaption	O	O	O
for	O	O	O
persistence	O	O	B-T041
in	O	O	O
aquatic	O	O	B-T067
environments	O	O	I-T067
.	O	O	O

The	O	O	O
identification	O	O	B-T080
of	O	O	O
V.	O	O	B-T007
cholerae	O	O	I-T007
O1	O	O	I-T007
strains	O	O	B-T001
in	O	O	O
the	O	O	O
Haitian	O	O	B-T083
environment	O	O	B-T067
,	O	O	O
which	O	O	O
predate	O	O	O
the	O	O	O
first	O	O	O
reported	O	O	B-T062
cholera	O	O	B-T047
pandemic	O	O	B-T067
in	O	O	O
1817	O	O	O
,	O	O	O
broadens	O	O	O
our	O	O	O
understanding	O	O	B-T041
of	O	O	O
the	O	O	O
history	O	O	B-T169
of	O	O	O
pandemics	O	O	B-T067
.	O	O	O

It	O	O	O
also	O	O	O
raises	O	O	O
the	O	O	O
possibility	O	O	O
that	O	O	O
these	O	O	O
and	O	O	O
similar	O	O	B-T080
environmental	O	O	B-T067
strains	O	O	B-T001
could	O	O	O
acquire	O	O	B-T052
virulence	O	O	B-T080
genes	O	O	B-T028
from	O	O	O
the	O	O	O
2010	O	O	O
Haitian	O	O	B-T083
epidemic	O	O	B-T067
clone	O	O	B-T024
,	O	O	O
including	O	O	O
the	O	O	O
cholera	O	O	B-T116
toxin	O	O	I-T116
producing	O	O	B-T169
CTXÏ.	O	O	O

-DOCSTART- (27788142)

The	O	O	O
Pre-Eclampsia	O	O	B-T046
Ontology	O	O	B-T077
:	O	O	O
A	O	O	O
Disease	O	O	B-T077
Ontology	O	O	I-T077
Representing	O	O	O
the	O	O	O
Domain	O	O	O
Knowledge	O	O	O
Specific	O	O	O
to	O	O	O
Pre-Eclampsia	O	O	O

Pre-eclampsia	O	O	B-T046
(	O	O	O
PE	O	O	B-T046
)	O	O	O
is	O	O	O
a	O	O	O
clinical	O	O	B-T185
syndrome	O	O	I-T185
characterized	O	O	O
by	O	O	O
new-onset	O	O	B-UnknownType
hypertension	O	O	I-UnknownType
and	O	O	O
proteinuria	O	O	B-T033
at	O	O	O
â¥20	O	O	B-T033
weeks	O	O	I-T033
of	O	O	I-T033
gestation	O	O	I-T033
,	O	O	O
and	O	O	O
is	O	O	O
a	O	O	O
leading	O	O	O
cause	O	O	B-T169
of	O	O	O
maternal	O	O	B-T033
and	O	O	O
perinatal	O	O	B-T046
morbidity	O	O	I-T046
and	O	O	O
mortality	O	O	B-T081
.	O	O	O

Previous	O	O	O
studies	O	O	O
have	O	O	O
gathered	O	O	O
abundant	O	O	B-T080
data	O	O	B-T078
about	O	O	O
PE	O	O	B-T046
such	O	O	O
as	O	O	O
risk	O	O	B-T033
factors	O	O	I-T033
and	O	O	O
pathological	O	O	B-T169
findings	O	O	I-T169
.	O	O	O

However	O	O	O
,	O	O	O
most	O	O	O
of	O	O	O
these	O	O	O
data	O	O	B-T078
are	O	O	O
not	O	O	O
semantically	O	O	O
structured	O	O	O
.	O	O	O

Clinical	O	O	B-T170
data	O	O	I-T170
on	O	O	O
PE	O	O	B-T046
patients	O	O	B-T101
are	O	O	O
often	O	O	O
generated	O	O	O
with	O	O	O
semantic	O	O	B-T078
heterogeneity	O	O	B-T080
such	O	O	O
as	O	O	O
using	O	O	O
disparate	O	O	B-T170
terminology	O	O	I-T170
to	O	O	O
describe	O	O	O
the	O	O	O
same	O	O	O
phenomena	O	O	B-T067
.	O	O	O

In	O	O	O
clinical	O	O	B-T062
studies	O	O	I-T062
,	O	O	O
interoperability	O	O	O
of	O	O	O
heterogenic	O	O	B-T078
clinical	O	O	B-T170
data	O	O	I-T170
is	O	O	O
required	O	O	O
in	O	O	O
various	O	O	O
situations	O	O	B-T169
.	O	O	O

In	O	O	O
such	O	O	O
a	O	O	O
situation	O	O	B-T169
,	O	O	O
it	O	O	O
is	O	O	O
necessary	O	O	O
to	O	O	O
develop	O	O	O
an	O	O	O
interoperable	O	O	O
and	O	O	O
standardized	O	O	O
semantic	O	O	B-T078
framework	O	O	B-T077
to	O	O	O
research	O	O	B-T062
the	O	O	O
pathology	O	O	B-T169
of	O	O	O
PE	O	O	B-T046
more	O	O	O
comprehensively	O	O	O
and	O	O	O
to	O	O	O
achieve	O	O	O
interoperability	O	O	O
of	O	O	O
heterogenic	O	O	B-T078
clinical	O	O	B-T170
data	O	O	I-T170
of	O	O	O
PE	O	O	O
patients	O	O	B-T101
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	O
,	O	O	O
we	O	O	O
developed	O	O	O
an	O	O	O
ontology	O	O	B-T077
representing	O	O	O
clinical	O	O	B-T201
features	O	O	I-T201
,	O	O	O
treatments	O	O	B-T061
,	O	O	O
genetic	O	O	B-T080
factors	O	O	I-T080
,	O	O	O
environmental	O	O	B-T080
factors	O	O	I-T080
,	O	O	O
and	O	O	O
other	O	O	O
aspects	O	O	B-T080
of	O	O	O
the	O	O	O
current	O	O	O
knowledge	O	O	O
in	O	O	O
the	O	O	O
domain	O	O	O
of	O	O	O
PE	O	O	B-T046
.	O	O	O

We	O	O	O
call	O	O	O
this	O	O	O
pre-eclampsia	O	O	B-T046
ontology	O	O	B-T077
"	O	O	O
PEO	O	O	B-T077
"	O	O	O
.	O	O	O

To	O	O	O
achieve	O	O	O
interoperability	O	O	O
with	O	O	O
other	O	O	O
ontologies	O	O	B-T077
,	O	O	O
the	O	O	O
core	O	O	O
structure	O	O	O
of	O	O	O
PEO	O	O	B-T077
was	O	O	O
compliant	O	O	O
with	O	O	O
the	O	O	O
hierarchy	O	O	O
of	O	O	O
the	O	O	O
Basic	O	O	B-T090
Formal	O	O	I-T090
Ontology	O	O	I-T090
(	O	O	O
BFO	O	O	B-T090
)	O	O	O
.	O	O	O

The	O	O	O
PEO	O	O	B-T077
incorporates	O	O	O
a	O	O	O
wide	O	O	O
range	O	O	O
of	O	O	O
key	O	O	O
concepts	O	O	B-T078
and	O	O	O
terms	O	O	B-T079
of	O	O	O
PE	O	O	B-T046
from	O	O	O
clinical	O	O	B-T062
and	O	O	O
biomedical	O	O	B-T062
research	O	O	I-T062
in	O	O	O
structuring	O	O	O
the	O	O	O
knowledge	O	O	O
base	O	O	O
that	O	O	O
is	O	O	O
specific	O	O	O
to	O	O	O
PE	O	O	O
;	O	O	O
therefore	O	O	O
,	O	O	O
PEO	O	O	O
is	O	O	O
expected	O	O	O
to	O	O	O
enhance	O	O	B-T052
PE	O	O	O
-specific	O	O	O
information	O	O	B-T057
retrieval	O	O	I-T057
and	O	O	O
knowledge	O	O	O
discovery	O	O	O
in	O	O	O
both	O	O	O
clinical	O	O	O
and	O	O	O
biomedical	O	O	O
research	O	O	O
fields	O	O	B-UnknownType
.	O	O	O

-DOCSTART- (27790175)

Predictors	O	O	B-T078
and	O	O	O
Moderators	O	O	B-T080
of	O	O	O
Spontaneous	O	O	B-T169
Pretend	O	O	B-T041
Play	O	O	I-T041
in	O	O	O
Children	O	O	B-T100
with	O	O	O
and	O	O	O
without	O	O	O
Autism	O	O	O
Spectrum	O	O	O
Disorder	O	O	O

Although	O	O	O
pretend	O	O	B-T041
play	O	O	I-T041
has	O	O	O
long	O	O	O
been	O	O	O
linked	O	O	O
to	O	O	O
children	O	O	B-T100
's	O	O	I-T100
normative	O	O	B-T080
cognitive	O	O	B-T041
development	O	O	I-T041
,	O	O	O
inconsistent	O	O	B-T080
findings	O	O	B-T033
call	O	O	O
for	O	O	O
greater	O	O	O
rigor	O	O	O
in	O	O	O
examining	O	O	B-T169
this	O	O	O
relation	O	O	B-T080
(	O	O	O
Lillard	O	O	O
et	O	O	O
al.	O	O	O
,	O	O	O
2013	O	O	O
)	O	O	O
.	O	O	O

Spontaneous	O	O	B-T169
pretend	O	O	B-T041
play	O	O	I-T041
is	O	O	O
often	O	O	O
impacted	O	O	O
in	O	O	O
atypical	O	O	B-T080
development	O	O	B-T039
,	O	O	O
notably	O	O	O
in	O	O	O
autism	O	O	B-T048
spectrum	O	O	I-T048
disorder	O	O	I-T048
(	O	O	O
ASD	O	O	B-T048
)	O	O	O
.	O	O	O

Since	O	O	O
ASD	O	O	B-T048
traits	O	O	B-T032
exist	O	O	O
along	O	O	O
a	O	O	O
continuum	O	O	B-T082
in	O	O	O
the	O	O	O
general	O	O	B-T098
population	O	O	I-T098
,	O	O	O
investigating	O	O	B-T169
how	O	O	O
pretend	O	O	B-T041
play	O	O	I-T041
varies	O	O	O
across	O	O	O
the	O	O	O
range	O	O	O
of	O	O	O
ASD	O	O	O
symptoms	O	O	B-T184
by	O	O	O
indexing	O	O	O
variations	O	O	B-T080
in	O	O	O
ASD	O	O	O
traits	O	O	O
in	O	O	O
both	O	O	O
typically	O	O	O
developing	O	O	O
and	O	O	O
ASD	O	O	O
populations	O	O	B-T098
may	O	O	O
provide	O	O	O
insight	O	O	O
into	O	O	O
how	O	O	O
ASD	O	O	O
symptoms	O	O	O
may	O	O	O
influence	O	O	O
the	O	O	O
relation	O	O	B-T080
between	O	O	O
pretend	O	O	O
play	O	O	O
and	O	O	O
associated	O	O	O
processes	O	O	O
in	O	O	O
cognitive	O	O	B-T041
development	O	O	I-T041
.	O	O	O

This	O	O	O
study	O	O	B-T062
used	O	O	O
rigorous	O	O	B-T062
observational	O	O	I-T062
methods	O	O	I-T062
to	O	O	O
assess	O	O	O
spontaneous	O	O	B-T169
pretend	O	O	B-T041
play	O	O	I-T041
.	O	O	O

Specifically	O	O	O
,	O	O	O
5-	O	O	O
min	O	O	B-T079
free-play	O	O	B-T058
sessions	O	O	I-T058
with	O	O	O
two	O	O	O
discrete	O	O	B-T080
toy	O	O	B-T073
sets	O	O	O
were	O	O	O
double-coded	O	O	O
by	O	O	O
blinded	O	O	B-T073
coders	O	O	I-T073
(	O	O	O
coder	O	O	O
assignment	O	O	O
counterbalanced	O	O	O
)	O	O	O
.	O	O	O

Key	O	O	O
facets	O	O	O
of	O	O	O
pretense	O	O	B-T041
development	O	O	I-T041
[	O	O	O
attribution	O	O	B-T080
of	O	O	I-T080
pretend	O	O	I-T080
properties	O	O	I-T080
(	O	O	O
APP	O	O	B-T080
)	O	O	O
,	O	O	O
object	O	O	B-T052
substitution	O	O	I-T052
(	O	O	O
OS	O	O	B-T052
)	O	O	O
,	O	O	O
imaginary	O	O	B-T041
objects	O	O	I-T041
]	O	O	O
were	O	O	O
examined	O	O	B-T169
.	O	O	O

These	O	O	O
facets	O	O	O
of	O	O	O
pretend	O	O	B-T041
play	O	O	I-T041
production	O	O	B-T041
were	O	O	O
then	O	O	O
analyzed	O	O	B-T062
in	O	O	O
relation	O	O	B-T080
to	O	O	O
ASD	O	O	B-T048
symptoms	O	O	B-T184
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
plausible	O	O	O
,	O	O	O
long-theorized	O	O	O
correlates	O	O	O
[	O	O	O
theory	O	O	B-T078
of	O	O	I-T078
mind	O	O	I-T078
(	O	O	O
ToM	O	O	B-T078
)	O	O	O
,	O	O	O
verbal	O	O	B-T041
ability	O	O	I-T041
,	O	O	O
familiarity	O	O	B-T041
,	O	O	O
and	O	O	O
interest	O	O	B-T041
in	O	O	O
specific	O	O	B-T080
toys	O	O	B-T073
]	O	O	O
.	O	O	O

Forty	O	O	O
children	O	O	B-T100
(	O	O	O
Mage	O	O	O
=	O	O	O
6;5	O	O	O
,	O	O	O
SDage	O	O	O
=	O	O	O
1.45	O	O	O
;	O	O	O
29	O	O	O
males	O	O	B-T032
)	O	O	O
,	O	O	O
six	O	O	O
of	O	O	O
whom	O	O	O
met	O	O	O
the	O	O	O
threshold	O	O	B-T080
for	O	O	O
ASD	O	O	B-T048
diagnosis	O	O	B-T033
via	O	O	O
parent	O	O	B-T099
-reported	O	O	O
ASD	O	O	O
symptoms	O	O	B-T184
,	O	O	O
participated	O	O	O
in	O	O	O
play	O	O	B-T058
sessions	O	O	I-T058
and	O	O	O
completed	O	O	O
measures	O	O	B-T081
of	O	O	O
verbal	O	O	B-T032
IQ	O	O	I-T032
and	O	O	O
ToM.	O	O	O
Besides	O	O	O
the	O	O	O
measure	O	O	B-T081
of	O	O	O
child	O	O	B-T100
ASD	O	O	O
symptoms	O	O	O
,	O	O	O
parents	O	O	B-T099
completed	O	O	O
a	O	O	O
survey	O	O	B-T170
of	O	O	O
their	O	O	O
child	O	O	B-T100
's	O	O	I-T100
interest	O	O	B-T041
in	O	O	O
and	O	O	O
familiarity	O	O	B-T041
with	O	O	O
the	O	O	O
play	O	O	B-T058
session	O	O	I-T058
toys	O	O	B-T073
.	O	O	O

Overall	O	O	O
,	O	O	O
greater	O	O	O
ToM	O	O	B-T078
predicted	O	O	B-T078
more	O	O	O
APP	O	O	B-T080
,	O	O	O
and	O	O	O
more	O	O	O
interest	O	O	B-T041
in	O	O	O
the	O	O	O
toys	O	O	B-T073
presented	O	O	O
predicted	O	O	O
more	O	O	O
OS	O	O	B-T052
.	O	O	O

In	O	O	O
terms	O	O	O
of	O	O	O
overall	O	O	O
pretend	O	O	B-T041
play	O	O	I-T041
production	O	O	B-T041
,	O	O	O
two	O	O	O
results	O	O	O
were	O	O	O
counterintuitive	O	O	O
.	O	O	O

First	O	O	O
,	O	O	O
among	O	O	O
children	O	O	B-T100
with	O	O	O
more	O	O	O
ASD	O	O	B-T048
symptoms	O	O	B-T184
,	O	O	O
verbal	O	O	B-T041
ability	O	O	I-T041
marginally	O	O	O
negatively	O	O	O
predicted	O	O	B-T078
pretend	O	O	B-T041
play	O	O	I-T041
production	O	O	B-T041
.	O	O	O

Second	O	O	O
,	O	O	O
among	O	O	O
children	O	O	B-T100
with	O	O	O
fewer	O	O	O
ASD	O	O	B-T048
symptoms	O	O	B-T184
,	O	O	O
ToM	O	O	B-T078
negatively	O	O	O
predicted	O	O	B-T078
pretend	O	O	B-T041
play	O	O	I-T041
production	O	O	B-T041
.	O	O	O

Further	O	O	O
probing	O	O	O
revealed	O	O	O
that	O	O	O
the	O	O	O
negative	O	O	O
effect	O	O	O
of	O	O	O
ASD	O	O	B-T048
symptoms	O	O	B-T184
on	O	O	O
pretend	O	O	B-T041
play	O	O	I-T041
was	O	O	O
simultaneously	O	O	O
moderated	O	O	O
by	O	O	O
both	O	O	O
variables	O	O	O
:	O	O	O
low	O	O	O
ToM	O	O	B-T078
and	O	O	O
high	O	O	O
verbal	O	O	B-T041
ability	O	O	I-T041
both	O	O	O
related	O	O	O
to	O	O	O
less	O	O	O
pretend	O	O	O
play	O	O	O
production	O	O	O
among	O	O	O
children	O	O	B-T100
with	O	O	O
more	O	O	O
ASD	O	O	O
symptoms	O	O	O
.	O	O	O

Implications	O	O	O
for	O	O	O
assessment	O	O	O
and	O	O	O
subsequent	O	O	O
treatment	O	O	B-T061
for	O	O	O
pretend	O	O	B-T032
ability	O	O	I-T032
among	O	O	O
children	O	O	B-T100
with	O	O	O
varying	O	O	O
degrees	O	O	O
of	O	O	O
ASD	O	O	B-T048
symptoms	O	O	B-T184
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
for	O	O	O
future	O	O	O
research	O	O	O
,	O	O	O
are	O	O	O
discussed	O	O	O
.	O	O	O

-DOCSTART- (27791169)

Allelic	O	O	B-T028
diversity	O	O	B-T080
in	O	O	O
an	O	O	O
NLR	O	O	B-T028
gene	O	O	I-T028
BPH9	O	O	B-T028
enables	O	O	O
rice	O	O	B-T002
to	O	O	O
combat	O	O	O
planthopper	O	O	B-T204
variation	O	O	O

Brown	O	O	B-T204
planthopper	O	O	I-T204
(	O	O	O
BPH	O	O	B-T204
)	O	O	O
,	O	O	O
Nilaparvata	O	O	B-T204
lugens	O	O	I-T204
StÃ¥l	O	O	I-T204
,	O	O	O
is	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
most	O	O	O
devastating	O	O	O
insect	O	O	B-T204
pests	O	O	B-T008
of	O	O	O
rice	O	O	B-T002
(	O	O	O
Oryza	O	O	B-T002
sativa	O	O	I-T002
L.	O	O	I-T002
)	O	O	O
.	O	O	O

Currently	O	O	O
,	O	O	O
30	O	O	O
BPH	O	O	B-T204
-	O	O	O
resistance	O	O	B-T028
genes	O	O	I-T028
have	O	O	O
been	O	O	O
genetically	O	O	O
defined	O	O	O
,	O	O	O
most	O	O	O
of	O	O	O
which	O	O	O
are	O	O	O
clustered	O	O	O
on	O	O	O
specific	O	O	O
chromosome	O	O	B-T026
regions	O	O	I-T026
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
describe	O	O	O
molecular	O	O	B-T059
cloning	O	O	I-T059
and	O	O	O
characterization	O	O	B-T052
of	O	O	O
a	O	O	O
BPH	O	O	B-T204
-	O	O	O
resistance	O	O	B-T028
gene	O	O	I-T028
,	O	O	O
BPH9	O	O	B-T028
,	O	O	O
mapped	O	O	O
on	O	O	O
the	O	O	O
long	O	O	B-T026
arm	O	O	I-T026
of	O	O	I-T026
rice	O	O	I-T026
chromosome	O	O	I-T026
12	O	O	I-T026
(	O	O	O
12L	O	O	O
)	O	O	O
.	O	O	O

BPH9	O	O	B-T028
encodes	O	O	O
a	O	O	O
rare	O	O	O
type	O	O	O
of	O	O	O
nucleotide-binding	O	O	B-T044
and	O	O	O
leucine-rich	O	O	B-T087
repeat	O	O	I-T087
(NLR)-containing	O	O	O
protein	O	O	B-T116
that	O	O	O
localizes	O	O	O
to	O	O	O
the	O	O	O
endomembrane	O	O	B-T026
system	O	O	I-T026
and	O	O	O
causes	O	O	O
a	O	O	O
cell	O	O	B-T043
death	O	O	I-T043
phenotype	O	O	B-T032
.	O	O	O

BPH9	O	O	B-T028
activates	O	O	O
salicylic	O	O	B-T109
acid	O	O	I-T109
-	O	O	O
and	O	O	O
jasmonic	O	O	B-T109
acid	O	O	I-T109
-	O	O	O
signaling	O	O	B-T044
pathways	O	O	I-T044
in	O	O	O
rice	O	O	B-T002
plants	O	O	B-T002
and	O	O	O
confers	O	O	O
both	O	O	O
antixenosis	O	O	B-T070
and	O	O	O
antibiosis	O	O	B-T070
to	O	O	O
BPH	O	O	B-T204
.	O	O	O

We	O	O	O
further	O	O	O
demonstrated	O	O	O
that	O	O	O
the	O	O	O
eight	O	O	O
BPH	O	O	B-T204
-	O	O	O
resistance	O	O	B-T028
genes	O	O	I-T028
that	O	O	O
are	O	O	O
clustered	O	O	O
on	O	O	O
chromosome	O	O	B-T026
12L	O	O	I-T026
,	O	O	O
including	O	O	O
the	O	O	O
widely	O	O	O
used	O	O	O
BPH1	O	O	B-T028
,	O	O	O
are	O	O	O
allelic	O	O	O
with	O	O	O
each	O	O	O
other	O	O	O
.	O	O	O

To	O	O	O
honor	O	O	O
the	O	O	O
priority	O	O	O
in	O	O	O
the	O	O	O
literature	O	O	B-T170
,	O	O	O
we	O	O	O
thus	O	O	O
designated	O	O	O
this	O	O	O
locus	O	O	B-T082
as	O	O	O
BPH1/9	O	O	B-T028
These	O	O	O
eight	O	O	O
genes	O	O	B-T028
can	O	O	O
be	O	O	O
classified	O	O	O
into	O	O	O
four	O	O	O
allelotypes	O	O	B-T028
,	O	O	O
BPH1/9	O	O	B-T028
-	O	O	I-T028
1	O	O	I-T028
,	O	O	O
-2	O	O	B-T028
,	O	O	O
-7	O	O	B-T028
,	O	O	O
and	O	O	O
-9	O	O	B-T028
These	O	O	O
allelotypes	O	O	O
confer	O	O	O
varying	O	O	O
levels	O	O	B-T080
of	O	O	O
resistance	O	O	B-T039
to	O	O	O
different	O	O	O
biotypes	O	O	B-T170
of	O	O	O
BPH	O	O	B-T204
.	O	O	O

The	O	O	O
coding	O	O	B-T028
region	O	O	I-T028
of	O	O	O
BPH1/9	O	O	B-T028
shows	O	O	O
a	O	O	O
high	O	O	O
level	O	O	O
of	O	O	O
diversity	O	O	B-T080
in	O	O	O
rice	O	O	B-T002
germplasm	O	O	I-T002
.	O	O	O

Homologous	O	O	O
fragments	O	O	O
of	O	O	O
the	O	O	O
nucleotide-binding	O	O	B-T044
(	O	O	O
NB	O	O	B-T044
)	O	O	O
and	O	O	O
leucine-rich	O	O	B-T087
repeat	O	O	I-T087
(	O	O	O
LRR	O	O	B-T087
)	O	O	O
domains	O	O	B-T087
exist	O	O	O
,	O	O	O
which	O	O	O
might	O	O	O
have	O	O	O
served	O	O	O
as	O	O	O
a	O	O	O
repository	O	O	B-T073
for	O	O	O
generating	O	O	O
allele	O	O	B-T028
diversity	O	O	B-T080
.	O	O	O

Our	O	O	O
findings	O	O	O
reveal	O	O	O
a	O	O	O
rice	O	O	B-T002
plant	O	O	B-T002
strategy	O	O	O
for	O	O	O
modifying	O	O	O
the	O	O	O
genetic	O	O	B-T169
information	O	O	I-T169
to	O	O	O
gain	O	O	O
the	O	O	O
upper	O	O	O
hand	O	O	O
in	O	O	O
the	O	O	O
struggle	O	O	O
against	O	O	O
insect	O	O	B-T204
herbivores	O	O	B-T008
.	O	O	O

Further	O	O	O
exploration	O	O	O
of	O	O	O
natural	O	O	O
allelic	O	O	B-T070
variation	O	O	I-T070
and	O	O	O
artificial	O	O	B-T062
shuffling	O	O	I-T062
within	O	O	O
this	O	O	O
gene	O	O	B-T028
may	O	O	O
allow	O	O	O
breeding	O	O	B-T040
to	O	O	O
be	O	O	O
tailored	O	O	O
to	O	O	O
control	O	O	O
emerging	O	O	O
biotypes	O	O	B-T170
of	O	O	O
BPH	O	O	B-T204
.	O	O	O

-DOCSTART- (27791362)

Nontoxic	O	O	B-T080
Formulations	O	O	B-T167
of	O	O	O
Scintillation	O	O	B-T070
Nanocrystals	O	O	B-T073
for	O	O	O
Use	O	O	O
as	O	O	O
X-ray	O	O	B-T060
Computed	O	O	I-T060
Tomography	O	O	I-T060
Contrast	O	O	O
Agents	O	O	O

X-ray	O	O	B-T060
computed	O	O	I-T060
tomography	O	O	I-T060
(	O	O	O
CT	O	O	B-T060
)	O	O	O
is	O	O	O
currently	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
most	O	O	O
powerful	O	O	O
,	O	O	O
noninvasive	O	O	B-T185
,	O	O	O
clinical	O	O	B-T080
in	O	O	B-T082
vivo	O	O	I-T082
imaging	O	O	B-T060
techniques	O	O	I-T060
,	O	O	O
which	O	O	O
has	O	O	O
resulted	O	O	O
from	O	O	O
advances	O	O	O
in	O	O	O
both	O	O	O
X-ray	O	O	B-T074
device	O	O	I-T074
and	O	O	O
contrast	O	O	B-T080
enhancement	O	O	B-T061
technologies	O	O	I-T061
.	O	O	O

The	O	O	O
present	O	O	O
study	O	O	B-T062
demonstrates	O	O	O
,	O	O	O
for	O	O	O
the	O	O	O
first	O	O	O
time	O	O	O
,	O	O	O
that	O	O	O
metal	O	O	B-T130
tungstates	O	O	I-T130
(	O	O	O
such	O	O	O
as	O	O	O
CaWO4	O	O	B-T130
)	O	O	O
are	O	O	O
promising	O	O	O
contrast	O	O	B-T130
agents	O	O	I-T130
for	O	O	O
X-ray	O	O	B-T060
,	O	O	O
radiation	O	O	B-T070
,	O	O	O
and	O	O	O
CT	O	O	B-T060
imaging	O	O	I-T060
,	O	O	O
because	O	O	O
of	O	O	O
the	O	O	O
high	O	O	O
X-ray	O	O	O
mass	O	O	B-T052
attenuation	O	O	I-T052
of	O	O	O
tungsten	O	O	B-T196
(	O	O	O
W	O	O	B-T196
)	O	O	O
.	O	O	O

We	O	O	O
have	O	O	O
developed	O	O	O
a	O	O	O
method	O	O	O
of	O	O	O
formulation	O	O	B-T167
,	O	O	O
in	O	O	O
which	O	O	O
CaWO4	O	O	B-T130
(	O	O	O
CWO	O	O	B-T130
)	O	O	O
nanoparticles	O	O	B-T073
(	O	O	O
NPs	O	O	B-T073
)	O	O	O
are	O	O	O
encapsulated	O	O	B-T080
within	O	O	O
a	O	O	O
biocompatible	O	O	O
poly(ethylene	O	O	B-T109
glycol-b-d	O	O	I-T109
,	O	O	I-T109
l-lactic	O	O	I-T109
acid	O	O	I-T109
)	O	O	I-T109
(	O	O	I-T109
PEG-PLA	O	O	I-T109
)	O	O	I-T109
block	O	O	I-T109
copolymer	O	O	I-T109
(	O	O	I-T109
BCP	O	O	I-T109
)	O	O	I-T109
capsule	O	O	I-T109
.	O	O	O

We	O	O	O
show	O	O	O
that	O	O	O
these	O	O	O
PEG-PLA	O	O	B-T109
-	O	O	O
encapsulated	O	O	B-T080
CWO	O	O	B-T073
NPs	O	O	I-T073
(	O	O	O
170	O	O	O
Â±	O	O	O
10	O	O	O
nm	O	O	O
hydrodynamic	O	O	O
diameter	O	O	O
)	O	O	O
produce	O	O	O
a	O	O	O
higher	O	O	O
CT	O	O	B-T060
contrast	O	O	B-T080
(	O	O	O
by	O	O	O
a	O	O	O
factor	O	O	O
of	O	O	O
about	O	O	O
2	O	O	O
)	O	O	O
than	O	O	O
commercial	O	O	O
iodine	O	O	B-T121
-based	O	O	O
radiocontrast	O	O	B-T130
agents	O	O	I-T130
(	O	O	O
e.g.	O	O	O
,	O	O	O
Iohexol	O	O	B-T109
)	O	O	O
at	O	O	O
identical	O	O	O
molar	O	O	O
concentrations	O	O	O
of	O	O	O
W	O	O	B-T196
or	O	O	O
I	O	O	B-T121
atoms	O	O	B-T196
.	O	O	O

PEG-PLA	O	O	B-T109
-	O	O	O
coated	O	O	B-T080
CWO	O	O	B-T073
NPs	O	O	I-T073
are	O	O	O
chemically	O	O	O
stable	O	O	O
and	O	O	O
completely	O	O	O
nontoxic	O	O	B-T080
.	O	O	O

It	O	O	O
was	O	O	O
confirmed	O	O	O
that	O	O	O
the	O	O	O
maximum	O	O	B-T081
tolerated	O	O	I-T081
dose	O	O	B-T081
(	O	O	O
MTD	O	O	B-T081
)	O	O	O
of	O	O	O
this	O	O	O
material	O	O	B-T167
in	O	O	O
mice	O	O	B-T015
is	O	O	O
significantly	O	O	O
higher	O	O	O
(	O	O	O
250	O	O	O
Â±	O	O	O
50	O	O	O
mg	O	O	O
per	O	O	O
kg	O	O	O
body	O	O	B-T032
weight	O	O	I-T032
following	O	O	O
a	O	O	O
single	O	O	O
intravenous	O	O	B-T082
(	O	O	I-T082
IV	O	O	I-T082
)	O	O	I-T082
administration	O	O	I-T082
)	O	O	O
than	O	O	O
,	O	O	O
for	O	O	O
instance	O	O	O
,	O	O	O
commercially	O	O	O
available	O	O	O
dextran	O	O	B-T109
-	O	O	O
coated	O	O	B-T080
iron	O	O	B-T121
oxide	O	O	I-T121
nanoparticles	O	O	B-T073
that	O	O	O
are	O	O	O
currently	O	O	O
used	O	O	O
clinically	O	O	B-T080
as	O	O	O
MRI	O	O	B-T060
contrast	O	O	B-T130
agents	O	O	I-T130
(	O	O	O
MTD	O	O	O
in	O	O	O
mice	O	O	O
â	O	O	O
168	O	O	O
mg/kg	O	O	O
per	O	O	O
dose	O	O	O
IV	O	O	O
)	O	O	O
.	O	O	O

IV-	O	O	O
injected	O	O	B-T169
PEG-PLA	O	O	B-T109
/	O	O	O
CWO	O	O	B-T073
NPs	O	O	I-T073
caused	O	O	O
no	O	O	B-T033
histopathologic	O	O	B-T091
damage	O	O	B-T169
in	O	O	O
major	O	O	O
excretory	O	O	B-T023
organs	O	O	I-T023
(	O	O	O
heart	O	O	B-T023
,	O	O	O
liver	O	O	B-T023
,	O	O	O
lungs	O	O	B-T023
,	O	O	O
spleen	O	O	B-T023
,	O	O	O
and	O	O	O
kidney	O	O	B-T023
)	O	O	O
.	O	O	O

When	O	O	O
an	O	O	O
IV	O	O	O
dose	O	O	B-T081
of	O	O	O
100	O	O	O
mg/kg	O	O	O
was	O	O	O
given	O	O	O
to	O	O	O
mice	O	O	B-T015
,	O	O	O
the	O	O	O
blood	O	O	B-T039
circulation	O	O	I-T039
half-life	O	O	B-T079
was	O	O	O
measured	O	O	O
to	O	O	O
be	O	O	O
about	O	O	O
4	O	O	O
h	O	O	O
,	O	O	O
and	O	O	O
more	O	O	O
than	O	O	O
90	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
NPs	O	O	B-T073
were	O	O	O
cleared	O	O	O
from	O	O	O
the	O	O	O
mice	O	O	O
within	O	O	O
24	O	O	O
h	O	O	O
via	O	O	O
the	O	O	O
renal	O	O	B-T023
and	O	O	O
hepatobiliary	O	O	B-T022
systems	O	O	I-T022
.	O	O	O

When	O	O	O
intratumorally	O	O	B-T169
administered	O	O	I-T169
,	O	O	O
PEG-PLA	O	O	B-T109
-	O	O	O
coated	O	O	B-T080
CWO	O	O	B-T073
NPs	O	O	I-T073
showed	O	O	O
complete	O	O	O
retention	O	O	O
in	O	O	O
a	O	O	O
tumor-bearing	O	O	B-T050
mouse	O	O	I-T050
model	O	O	I-T050
(	O	O	O
measurements	O	O	O
were	O	O	O
made	O	O	O
up	O	O	O
to	O	O	O
1	O	O	O
week	O	O	B-T079
)	O	O	O
.	O	O	O

These	O	O	O
results	O	O	O
suggest	O	O	O
that	O	O	O
PEG-PLA	O	O	B-T109
-	O	O	O
coated	O	O	B-T080
CWO	O	O	B-T073
NPs	O	O	I-T073
are	O	O	O
promising	O	O	O
materials	O	O	B-T167
for	O	O	O
use	O	O	O
in	O	O	O
CT	O	O	B-T060
contrast	O	O	B-T080
.	O	O	O

-DOCSTART- (27791364)

Albumin	O	O	B-T116
-Bioinspired	O	O	O
Gd	O	O	B-T130
:	O	O	O
CuS	O	O	B-T197
Nanotheranostic	O	O	B-T073
Agent	O	O	I-T073
for	O	O	O
In	O	O	B-T082
Vivo	O	O	I-T082
Photoacoustic	O	O	B-T060
/	O	O	O
Magnetic	O	O	B-T060
Resonance	O	O	I-T060
Imaging	O	O	I-T060
-Guided	O	O	O
Tumor	O	O	B-T191
-Targeted	O	O	O
Photothermal	O	O	O
Therapy	O	O	O

Photothermal	O	O	B-T061
therapy	O	O	I-T061
(	O	O	O
PTT	O	O	B-T061
)	O	O	O
is	O	O	O
attracting	O	O	O
increasing	O	O	O
interest	O	O	O
and	O	O	O
becoming	O	O	O
more	O	O	O
widely	O	O	O
used	O	O	O
for	O	O	O
skin	O	O	B-T061
cancer	O	O	I-T061
therapy	O	O	I-T061
in	O	O	O
the	O	O	O
clinic	O	O	B-T093
,	O	O	O
as	O	O	O
a	O	O	O
result	O	O	O
of	O	O	O
its	O	O	O
noninvasiveness	O	O	B-T080
and	O	O	O
low	O	O	B-T046
systemic	O	O	I-T046
adverse	O	O	I-T046
effects	O	O	I-T046
.	O	O	O

However	O	O	O
,	O	O	O
there	O	O	O
is	O	O	O
an	O	O	O
urgent	O	O	O
need	O	O	O
to	O	O	O
develop	O	O	O
biocompatible	O	O	B-T073
PTT	O	O	I-T073
agents	O	O	I-T073
,	O	O	O
which	O	O	O
enable	O	O	O
accurate	O	O	B-T080
imaging	O	O	B-T060
,	O	O	O
monitoring	O	O	B-T058
,	O	O	O
and	O	O	O
diagnosis	O	O	B-T033
.	O	O	O

Herein	O	O	O
,	O	O	O
a	O	O	O
biocompatible	O	O	B-T073
Gd	O	O	B-T130
-integrated	O	O	I-T073
CuS	O	O	B-T197
nanotheranostic	O	O	I-T073
agent	O	O	I-T073
(	O	O	O
Gd	O	O	O
:	O	O	O
CuS	O	O	O
@	O	O	O
BSA	O	O	B-T116
)	O	O	O
was	O	O	O
synthesized	O	O	B-T052
via	O	O	O
a	O	O	O
facile	O	O	O
and	O	O	O
environmentally	O	O	O
friendly	O	O	O
biomimetic	O	O	B-T041
strategy	O	O	I-T041
,	O	O	O
using	O	O	O
bovine	O	O	B-T116
serum	O	O	I-T116
albumin	O	O	I-T116
(	O	O	O
BSA	O	O	O
)	O	O	O
as	O	O	O
a	O	O	O
biotemplate	O	O	B-T078
at	O	O	O
physiological	O	O	B-T081
temperature	O	O	I-T081
.	O	O	O

The	O	O	O
as-prepared	O	O	O
Gd	O	O	B-T130
:	O	O	O
CuS	O	O	B-T197
@	O	O	O
BSA	O	O	B-T116
nanoparticles	O	O	B-T073
(	O	O	O
NPs	O	O	B-T073
)	O	O	O
with	O	O	O
ultrasmall	O	O	B-T033
sizes	O	O	I-T033
(	O	O	O
ca	O	O	O
.	O	O	O

9	O	O	O
nm	O	O	O
)	O	O	O
exhibited	O	O	O
high	O	O	O
photothermal	O	O	B-T033
conversion	O	O	I-T033
efficiency	O	O	I-T033
and	O	O	O
good	O	O	O
photostability	O	O	B-T033
under	O	O	O
near-infrared	O	O	B-T070
(	O	O	I-T070
NIR	O	O	I-T070
)	O	O	I-T070
laser	O	O	I-T070
irradiation	O	O	B-T070
.	O	O	O

With	O	O	O
doped	O	O	B-T130
Gd	O	O	B-T130
species	O	O	I-T130
and	O	O	O
strong	O	O	O
tunable	O	O	B-T080
NIR	O	O	I-T080
absorbance	O	O	I-T080
,	O	O	O
Gd	O	O	O
:	O	O	O
CuS	O	O	B-T197
@	O	O	O
BSA	O	O	B-T116
NPs	O	O	B-T073
demonstrate	O	O	O
prominent	O	O	O
tumor-contrasted	O	O	B-T060
imaging	O	O	I-T060
performance	O	O	O
both	O	O	O
on	O	O	O
the	O	O	O
photoacoustic	O	O	B-T169
and	O	O	I-T169
magnetic	O	O	B-T060
resonance	O	O	I-T060
imaging	O	O	I-T060
modalities	O	O	I-T169
.	O	O	O

The	O	O	O
subsequent	O	O	O
Gd	O	O	B-T061
:	O	O	I-T061
CuS	O	O	B-T197
@	O	O	I-T061
BSA	O	O	B-T116
-mediated	O	O	I-T061
PTT	O	O	I-T061
result	O	O	O
shows	O	O	O
high	O	O	O
therapy	O	O	B-T033
efficacy	O	O	I-T033
as	O	O	O
a	O	O	O
result	O	O	O
of	O	O	O
their	O	O	O
potent	O	O	O
NIR	O	O	B-T033
absorption	O	O	I-T033
and	O	O	O
high	O	O	O
photothermal	O	O	B-T033
conversion	O	O	I-T033
efficiency	O	O	I-T033
.	O	O	O

The	O	O	O
immune	O	O	B-T042
response	O	O	I-T042
triggered	O	O	B-T080
by	O	O	I-T080
Gd	O	O	B-T061
:	O	O	I-T061
CuS	O	O	B-T197
@	O	O	I-T061
BSA	O	O	B-T116
-mediated	O	O	I-T061
PTT	O	O	I-T061
is	O	O	O
preliminarily	O	O	O
explored	O	O	O
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
toxicity	O	O	B-T060
studies	O	O	I-T060
in	O	O	B-T080
vitro	O	O	I-T080
and	O	O	O
in	O	O	B-T082
vivo	O	O	I-T082
verify	O	O	O
that	O	O	O
Gd	O	O	B-T130
:	O	O	O
CuS	O	O	B-T197
@	O	O	O
BSA	O	O	B-T116
NPs	O	O	B-T073
qualify	O	O	O
as	O	O	O
biocompatible	O	O	B-T073
agents	O	O	I-T073
.	O	O	O

A	O	O	O
biodistribution	O	O	B-T062
study	O	O	I-T062
demonstrated	O	O	O
that	O	O	O
the	O	O	O
NPs	O	O	B-T073
can	O	O	O
undergo	O	O	O
hepatic	O	O	B-UnknownType
clearance	O	O	I-UnknownType
from	O	O	O
the	O	O	O
body	O	O	B-T016
.	O	O	O

This	O	O	O
study	O	O	O
highlights	O	O	O
the	O	O	O
practicality	O	O	B-T080
and	O	O	O
versatility	O	O	B-T080
of	O	O	O
albumin	O	O	B-T067
-mediated	O	O	I-T067
biomimetic	O	O	I-T067
mineralization	O	O	I-T067
of	O	O	O
a	O	O	O
nanotheranostic	O	O	B-T073
agent	O	O	I-T073
and	O	O	O
also	O	O	O
suggests	O	O	O
that	O	O	O
bioinspired	O	O	O
Gd	O	O	B-T130
:	O	O	O
CuS	O	O	B-T197
@	O	O	O
BSA	O	O	B-T116
NPs	O	O	B-T073
possess	O	O	O
promising	O	O	O
imaging	O	O	B-T061
guidance	O	O	I-T061
and	O	O	O
effective	O	O	O
tumor	O	O	B-T061
ablation	O	O	I-T061
properties	O	O	I-T061
,	O	O	O
with	O	O	O
high	O	O	O
spatial	O	O	B-T080
resolution	O	O	I-T080
and	O	O	O
deep	O	O	B-T080
tissue	O	O	B-T024
penetration	O	O	I-T080
.	O	O	O

-DOCSTART- (27793144)

Family	O	O	B-T099
and	O	O	O
healthcare	O	O	B-T097
professionals	O	O	I-T097
'	O	O	O
perceptions	O	O	B-T041
of	O	O	O
a	O	O	O
pilot	O	O	O
hospice	O	O	B-T058
at	O	O	O
home	O	O	B-T082
programme	O	O	B-T058
for	O	O	O
children	O	O	B-T100
:	O	O	O
a	O	O	O
qualitative	O	O	O
study	O	O	O

Parents	O	O	B-T099
commonly	O	O	O
report	O	O	O
a	O	O	O
significant	O	O	O
improvement	O	O	B-T077
in	O	O	O
quality	O	O	B-T078
of	O	O	I-T078
life	O	O	I-T078
following	O	O	O
the	O	O	O
provision	O	O	B-T058
of	O	O	O
hospice	O	O	B-T058
and	O	O	O
supportive	O	O	B-T061
care	O	O	I-T061
and	O	O	O
have	O	O	O
identified	O	O	O
a	O	O	O
need	O	O	O
for	O	O	O
such	O	O	O
a	O	O	O
service	O	O	B-T058
in	O	O	O
the	O	O	O
home	O	O	B-T082
.	O	O	O

The	O	O	O
purpose	O	O	O
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
understand	O	O	O
the	O	O	O
experiences	O	O	B-T041
of	O	O	O
families	O	O	B-T099
receiving	O	O	O
a	O	O	O
nurse	O	O	B-T097
led	O	O	O
pilot	O	O	O
hospice	O	O	B-T058
at	O	O	O
home	O	O	B-T082
programme	O	O	B-T058
and	O	O	O
the	O	O	O
experiences	O	O	O
of	O	O	O
healthcare	O	O	B-T097
professionals	O	O	I-T097
delivering	O	O	O
and	O	O	O
engaging	O	O	O
with	O	O	O
the	O	O	O
programme	O	O	O
.	O	O	O

An	O	O	O
exploratory	O	O	O
,	O	O	O
qualitative	O	O	O
study	O	O	B-T062
was	O	O	O
conducted	O	O	O
,	O	O	O
including	O	O	O
telephone	O	O	B-T062
interviews	O	O	B-T052
with	O	O	O
parents	O	O	B-T099
and	O	O	O
focus	O	O	B-T096
groups	O	O	I-T096
and	O	O	O
individual	O	O	B-T098
interviews	O	O	O
with	O	O	O
healthcare	O	O	B-T097
professionals	O	O	I-T097
.	O	O	O

All	O	O	O
parents	O	O	B-T099
of	O	O	O
families	O	O	B-T099
who	O	O	O
received	O	O	O
the	O	O	O
programme	O	O	B-T058
of	O	O	O
care	O	O	B-T058
between	O	O	O
June	O	O	O
2014	O	O	O
and	O	O	O
September	O	O	O
2015	O	O	O
and	O	O	O
healthcare	O	O	B-T097
professionals	O	O	I-T097
delivering	O	O	O
and	O	O	O
engaging	O	O	O
with	O	O	O
the	O	O	O
programme	O	O	O
were	O	O	O
invited	O	O	O
to	O	O	O
participate	O	O	O
.	O	O	O

Seven	O	O	O
parents	O	O	B-T099
participated	O	O	O
in	O	O	O
telephone	O	O	B-T062
interviews	O	O	I-T062
.	O	O	O

Four	O	O	O
focus	O	O	B-T096
groups	O	O	I-T096
took	O	O	O
place	O	O	O
,	O	O	O
two	O	O	O
with	O	O	O
external	O	O	B-T098
stakeholders	O	O	I-T098
(	O	O	O
18	O	O	O
participants	O	O	B-T098
in	O	O	O
total	O	O	O
)	O	O	O
,	O	O	O
one	O	O	O
with	O	O	O
in-patient	O	O	B-T101
hospice	O	O	B-T058
staff	O	O	I-T097
(	O	O	O
13	O	O	O
participants	O	O	O
)	O	O	O
and	O	O	O
one	O	O	O
with	O	O	O
the	O	O	O
hospice	O	O	O
at	O	O	O
home	O	O	O
team	O	O	O
(	O	O	O
8	O	O	O
participants	O	O	O
)	O	O	O
.	O	O	O

Two	O	O	O
additional	O	O	O
interviews	O	O	B-T052
took	O	O	O
place	O	O	O
with	O	O	O
individual	O	O	B-T098
stakeholders	O	O	B-T098
who	O	O	O
were	O	O	O
unable	O	O	O
to	O	O	O
attend	O	O	O
a	O	O	O
scheduled	O	O	O
focus	O	O	B-T096
group	O	O	I-T096
.	O	O	O

Themes	O	O	O
from	O	O	O
interviews	O	O	B-T052
with	O	O	O
parents	O	O	B-T099
focused	O	O	O
on	O	O	O
the	O	O	O
value	O	O	O
of	O	O	O
having	O	O	O
consistent	O	O	O
and	O	O	O
expert	O	O	O
care	O	O	B-T058
.	O	O	O

The	O	O	O
findings	O	O	O
from	O	O	O
healthcare	O	O	B-T097
professionals	O	O	I-T097
centred	O	O	O
on	O	O	O
communication	O	O	B-T054
within	O	O	O
and	O	O	O
across	O	O	O
services	O	O	B-T058
,	O	O	O
education	O	O	B-T065
and	O	O	I-T065
training	O	O	I-T065
and	O	O	O
lone	O	O	B-T057
working	O	O	I-T057
.	O	O	O

The	O	O	O
pilot	O	O	O
hospice	O	O	B-T058
at	O	O	O
home	O	O	B-T082
programme	O	O	B-T058
was	O	O	O
welcomed	O	O	O
by	O	O	O
all	O	O	O
those	O	O	O
who	O	O	O
took	O	O	O
part	O	O	O
in	O	O	O
the	O	O	O
study	O	O	B-T062
.	O	O	O

The	O	O	O
programme	O	O	B-T058
may	O	O	O
be	O	O	O
improved	O	O	O
by	O	O	O
enhanced	O	O	O
clarification	O	O	B-T052
of	O	O	O
roles	O	O	O
,	O	O	O
enhanced	O	O	O
access	O	O	O
to	O	O	O
multi-disciplinary	O	O	O
services	O	O	B-T058
,	O	O	O
greater	O	O	O
communication	O	O	B-T054
across	O	O	O
services	O	O	O
and	O	O	O
improved	O	O	O
information	O	O	O
provision	O	O	O
to	O	O	O
families	O	O	B-T099
.	O	O	O

-DOCSTART- (27793568)

Functional	O	O	B-T169
1,3a,6a-triazapentalene	O	O	B-T109
scaffold	O	O	B-T104
:	O	O	O
Design	O	O	B-T052
of	O	O	O
fluorescent	O	O	B-T130
probes	O	O	I-T130
for	O	O	O
kinesin	O	O	B-T116
spindle	O	O	I-T116
protein	O	O	I-T116
(	O	O	O
KSP	O	O	B-T116
)	O	O	O

1,3a,6a-Triazapentalene	O	O	B-T109
is	O	O	O
a	O	O	O
compact	O	O	O
fluorescent	O	O	B-T130
chromophore	O	O	B-T120
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
triazapentalene	O	O	B-T109
was	O	O	O
used	O	O	O
to	O	O	O
modify	O	O	O
a	O	O	O
series	O	O	O
of	O	O	O
biphenyl-type	O	O	B-T109
inhibitors	O	O	B-T121
of	O	O	O
kinesin	O	O	B-T116
spindle	O	O	I-T116
protein	O	O	B-T116
(	O	O	O
KSP	O	O	B-T116
)	O	O	O
to	O	O	O
develop	O	O	O
fluorescent	O	O	B-T130
probes	O	O	I-T130
for	O	O	O
the	O	O	O
intracellular	O	O	B-T082
visualization	O	O	B-T169
of	O	O	O
this	O	O	O
protein	O	O	O
.	O	O	O

Microscopic	O	O	B-T080
studies	O	O	B-T062
demonstrated	O	O	O
that	O	O	O
these	O	O	O
novel	O	O	B-T080
triazapentalene	O	O	B-T109
-	O	O	O
labeled	O	O	B-T080
compounds	O	O	B-T103
exhibited	O	O	O
inhibitory	O	O	B-T052
activity	O	O	B-T169
towards	O	O	O
KSP	O	O	B-T116
in	O	O	O
cultured	O	O	B-T025
cells	O	O	I-T025
and	O	O	O
provided	O	O	O
important	O	O	O
information	O	O	B-T078
concerning	O	O	O
the	O	O	O
intracellular	O	O	B-T082
distribution	O	O	B-T169
.	O	O	O

-DOCSTART- (27794068)

C4b	O	O	B-T116
binding	O	O	I-T116
protein	O	O	I-T116
negatively	O	O	B-T044
regulates	O	O	I-T044
TLR1	O	O	B-T116
/	O	O	O
2	O	O	B-T116
response	O	O	O

TLR2	O	O	B-T116
associates	O	O	B-T080
with	O	O	I-T080
TLR1	O	O	B-T116
and	O	O	O
recognizes	O	O	O
microbial	O	O	B-T001
lipoproteins	O	O	B-T116
.	O	O	O

Pam3CSK4	O	O	B-T116
,	O	O	O
a	O	O	O
triacylated	O	O	B-T116
lipoprotein	O	O	I-T116
,	O	O	O
is	O	O	O
anchored	O	O	B-T044
to	O	O	O
the	O	O	O
extracellular	O	O	B-T082
domain	O	O	I-T082
of	O	O	O
TLR1	O	O	B-T116
and	O	O	O
TLR2	O	O	B-T116
and	O	O	O
induces	O	O	B-T169
pro-inflammatory	O	O	B-T046
signals	O	O	B-T038
.	O	O	O

Here	O	O	O
we	O	O	O
show	O	O	O
that	O	O	O
C4b	O	O	B-T116
binding	O	O	I-T116
protein	O	O	I-T116
(	O	O	O
C4BP	O	O	B-T116
)	O	O	O
,	O	O	O
which	O	O	O
is	O	O	O
a	O	O	O
complement	O	O	B-T044
pathway	O	O	I-T044
inhibitor	O	O	B-T080
,	O	O	O
is	O	O	O
a	O	O	O
TLR2	O	O	B-T116
-associated	O	O	O
molecule	O	O	O
.	O	O	O

Immunoprecipitation	O	O	B-T059
assay	O	O	I-T059
using	O	O	O
anti-TLR2	O	O	B-T129
mAb	O	O	I-T129
shows	O	O	O
that	O	O	O
C4BP	O	O	B-T116
binds	O	O	B-T044
to	O	O	I-T044
TLR2	O	O	B-T116
.	O	O	O

In	O	O	O
C4BP-deficient	O	O	B-T028
mice	O	O	B-T015
,	O	O	O
Pam3CSK4	O	O	B-T116
-	O	O	O
induced	O	O	B-T169
IL-6	O	O	B-T116
levels	O	O	B-T080
were	O	O	O
increased	O	O	B-T081
compared	O	O	B-T052
with	O	O	O
wild	O	O	B-T015
type	O	O	I-T015
mice	O	O	I-T015
.	O	O	O

In	O	O	O
C4BP	O	O	B-T116
-	O	O	O
expressing	O	O	B-T045
cells	O	O	B-T025
,	O	O	O
Pam3CSK4	O	O	B-T116
-	O	O	O
induced	O	O	B-T169
IL-8	O	O	B-T040
production	O	O	I-T040
was	O	O	O
reduced	O	O	B-T080
depending	O	O	O
on	O	O	O
the	O	O	O
C4BP	O	O	O
expression	O	O	B-T081
levels	O	O	I-T081
.	O	O	O

These	O	O	O
results	O	O	O
reveal	O	O	B-T080
the	O	O	O
important	O	O	O
role	O	O	O
of	O	O	O
C4BP	O	O	B-T116
in	O	O	O
negative	O	O	B-T044
regulation	O	O	I-T044
of	O	O	O
TLR1	O	O	B-T116
/	O	O	O
2	O	O	B-T116
-	O	O	O
dependent	O	O	B-T116
pro-inflammatory	O	O	B-T046
cytokine	O	O	B-T040
production	O	O	I-T040
.	O	O	O

Furthermore	O	O	O
,	O	O	O
using	O	O	O
a	O	O	O
fluorescent	O	O	B-T130
conjugated	O	O	I-T130
Pam3CSK4	O	O	B-T116
,	O	O	O
we	O	O	O
show	O	O	O
that	O	O	O
C4BP	O	O	B-T116
blocks	O	O	B-T169
the	O	O	O
binding	O	O	B-T044
of	O	O	I-T044
Pam3CSK4	O	O	O
to	O	O	O
TLR1	O	O	B-T116
/	O	O	O
2	O	O	B-T116
.	O	O	O

Finally	O	O	O
,	O	O	O
we	O	O	O
show	O	O	O
that	O	O	O
exogenous	O	O	B-T169
C4BP	O	O	B-T116
also	O	O	O
inhibits	O	O	B-T052
Pam3CSK4	O	O	B-T116
-	O	O	O
induced	O	O	B-T044
signaling	O	O	I-T044
leading	O	O	O
to	O	O	O
IL-8	O	O	B-T040
production	O	O	I-T040
.	O	O	O

Our	O	O	O
results	O	O	O
indicate	O	O	O
C4BP	O	O	B-T116
binding	O	O	B-T044
to	O	O	I-T044
TLR2	O	O	B-T116
and	O	O	O
consequent	O	O	B-T033
neutralization	O	O	B-T169
of	O	O	O
its	O	O	O
activity	O	O	B-T044
otherwise	O	O	O
inducing	O	O	O
pro-inflammatory	O	O	B-T046
cytokine	O	O	B-T040
production	O	O	I-T040
.	O	O	O

C4BP	O	O	B-T116
is	O	O	O
a	O	O	O
negative	O	O	B-T044
regulator	O	O	I-T044
of	O	O	O
TLR1	O	O	B-T116
/	O	O	O
2	O	O	B-T116
activity	O	O	B-T044
.	O	O	O

-DOCSTART- (27794381)

Effect	O	O	B-T080
of	O	O	O
emodin	O	O	B-T109
on	O	O	O
mobility	O	O	B-T043
signal	O	O	I-T043
transduction	O	O	I-T043
system	O	O	I-T043
of	O	O	O
gallbladder	O	O	B-T023
smooth	O	O	B-T024
muscle	O	O	I-T024
in	O	O	O
Guinea	O	O	B-T015
pig	O	O	I-T015
with	O	O	O
cholelithiasis	O	O	O

To	O	O	O
study	O	O	B-T062
the	O	O	O
effect	O	O	B-T080
of	O	O	O
emodin	O	O	B-T109
on	O	O	O
protein	O	O	B-T045
and	O	O	O
gene	O	O	B-T045
expressions	O	O	I-T045
of	O	O	O
the	O	O	O
massagers	O	O	B-UnknownType
in	O	O	O
mobility	O	O	B-T043
signal	O	O	I-T043
transduction	O	O	I-T043
system	O	O	I-T043
of	O	O	O
cholecyst	O	O	B-T023
smooth	O	O	B-T025
muscle	O	O	I-T025
cells	O	O	I-T025
in	O	O	O
guinea	O	O	B-T015
pig	O	O	I-T015
with	O	O	O
cholesterol	O	O	B-T031
calculus	O	O	I-T031
.	O	O	O

The	O	O	O
guinea	O	O	B-T015
pigs	O	O	I-T015
were	O	O	O
randomly	O	O	O
divided	O	O	O
into	O	O	O
4	O	O	O
groups	O	O	B-T078
,	O	O	O
such	O	O	O
as	O	O	O
control	O	O	B-T096
group	O	O	B-T078
,	O	O	O
gall-stone	O	O	B-T047
(	O	O	O
GS	O	O	B-T047
)	O	O	O
group	O	O	O
,	O	O	O
emodin	O	O	B-T109
group	O	O	O
and	O	O	O
ursodeoxycholic	O	O	B-T109
acid	O	O	I-T109
(	O	O	O
UA	O	O	B-T109
)	O	O	O
group	O	O	O
.	O	O	O

Cholesterol	O	O	B-T031
calculus	O	O	I-T031
models	O	O	B-T075
were	O	O	O
induced	O	O	O
in	O	O	O
guinea	O	O	B-T015
pigs	O	O	I-T015
of	O	O	O
GS	O	O	B-T047
,	O	O	O
emodin	O	O	B-T109
and	O	O	O
UA	O	O	B-T109
groups	O	O	B-T078
by	O	O	O
lithogenic	O	O	B-T168
diet	O	O	I-T168
,	O	O	O
while	O	O	O
emodin	O	O	O
or	O	O	O
UA	O	O	O
were	O	O	O
given	O	O	O
to	O	O	O
the	O	O	O
corresponding	O	O	O
group	O	O	B-T078
for	O	O	O
7	O	O	O
weeks	O	O	B-T079
.	O	O	O

The	O	O	O
histomorphological	O	O	B-T080
and	O	O	O
ultrastructure	O	O	B-T078
change	O	O	B-T169
of	O	O	O
gallbladder	O	O	B-T023
were	O	O	O
detected	O	O	B-T033
by	O	O	O
microscope	O	O	B-T074
and	O	O	O
electron	O	O	B-T074
microscope	O	O	I-T074
,	O	O	O
the	O	O	O
content	O	O	O
of	O	O	O
plasma	O	O	B-T031
cholecystokinin	O	O	B-T116
(	O	O	O
CCK	O	O	B-T116
)	O	O	O
and	O	O	O
[Ca(2+)]i	O	O	B-T121
were	O	O	O
analyzed	O	O	B-T062
successively	O	O	O
by	O	O	O
radioimmunoassay	O	O	B-T059
and	O	O	O
flow	O	O	B-T059
cytometry	O	O	I-T059
.	O	O	O

The	O	O	O
protein	O	O	B-T116
and	O	O	O
mRNA	O	O	B-T114
of	O	O	O
GsÎ±	O	O	B-T116
,	O	O	O
GiÎ±	O	O	B-T116
and	O	O	O
Cap	O	O	B-T116
in	O	O	O
cholecyst	O	O	B-T023
cells	O	O	B-T025
were	O	O	O
determined	O	O	B-T080
by	O	O	I-T080
western	O	O	B-T059
blotting	O	O	I-T059
and	O	O	O
real	O	O	B-T063
time	O	O	I-T063
polymerase	O	O	I-T063
chain	O	O	I-T063
reaction	O	O	I-T063
(	O	O	O
RT-PCR	O	O	B-T063
)	O	O	O
.	O	O	O

Emodin	O	O	B-T109
or	O	O	O
UA	O	O	B-T109
can	O	O	O
relieve	O	O	O
pathogenic	O	O	B-T033
changes	O	O	B-T169
in	O	O	O
epithelial	O	O	B-T025
cells	O	O	I-T025
and	O	O	O
muscle	O	O	B-T025
cells	O	O	I-T025
in	O	O	O
gallbladder	O	O	B-T023
of	O	O	O
guinea	O	O	B-T015
pig	O	O	I-T015
with	O	O	O
cholesterol	O	O	B-T031
calculus	O	O	I-T031
by	O	O	O
microscope	O	O	B-T074
and	O	O	O
transmission	O	O	B-T074
electron	O	O	I-T074
microscope	O	O	I-T074
.	O	O	O

In	O	O	O
the	O	O	O
cholecyst	O	O	B-T023
cells	O	O	B-T025
of	O	O	O
GS	O	O	B-T047
group	O	O	B-T078
,	O	O	O
CCK	O	O	B-T116
levels	O	O	B-T080
in	O	O	O
plasma	O	O	B-T031
and	O	O	O
[Ca(2+)]i	O	O	B-T121
decreased	O	O	B-T081
,	O	O	O
the	O	O	O
protein	O	O	B-T116
and	O	O	O
mRNA	O	O	B-T114
of	O	O	O
GS	O	O	O
were	O	O	O
down-regulated	O	O	B-T044
,	O	O	O
the	O	O	O
protein	O	O	O
and	O	O	O
mRNA	O	O	O
of	O	O	O
Gi	O	O	B-T116
and	O	O	O
Cap	O	O	B-T116
were	O	O	O
up-regulated	O	O	B-T044
.	O	O	O

Emodin	O	O	B-T109
significantly	O	O	B-T078
decreased	O	O	B-T081
the	O	O	O
formative	O	O	B-T169
rate	O	O	B-T081
of	O	O	O
gallstone	O	O	B-T047
,	O	O	O
improved	O	O	O
the	O	O	O
pathogenic	O	O	B-T033
change	O	O	B-T169
in	O	O	O
epithelial	O	O	B-T025
cells	O	O	B-T025
and	O	O	O
muscle	O	O	B-T025
cells	O	O	I-T025
,	O	O	O
increased	O	O	O
CCK	O	O	B-T116
levels	O	O	B-T080
in	O	O	O
plasma	O	O	B-T031
and	O	O	O
[Ca(2+)]i	O	O	B-T121
in	O	O	O
cholecyst	O	O	B-T023
cells	O	O	O
,	O	O	O
enhanced	O	O	O
the	O	O	O
protein	O	O	B-T116
and	O	O	O
mRNA	O	O	B-T114
of	O	O	O
Gs	O	O	B-T116
in	O	O	O
cholecyst	O	O	O
cells	O	O	O
,	O	O	O
reduced	O	O	B-T080
the	O	O	O
protein	O	O	O
and	O	O	O
mRNA	O	O	O
of	O	O	O
Gi	O	O	B-T116
and	O	O	O
Cap	O	O	B-T116
in	O	O	O
cholecyst	O	O	O
cells	O	O	O
in	O	O	O
guinea	O	O	B-T015
pig	O	O	I-T015
with	O	O	O
cholesterol	O	O	B-T031
calculus	O	O	I-T031
.	O	O	O

The	O	O	O
dysfunction	O	O	B-T077
of	O	O	O
gallbladder	O	O	B-T042
contraction	O	O	I-T042
gives	O	O	O
rise	O	O	O
to	O	O	O
the	O	O	O
disorders	O	O	B-T047
of	O	O	O
mobility	O	O	B-T043
signal	O	O	I-T043
transduction	O	O	I-T043
system	O	O	I-T043
in	O	O	O
cholecyst	O	O	B-T023
smooth	O	O	B-T025
muscle	O	O	I-T025
cells	O	O	B-T025
,	O	O	O
including	O	O	B-T169
low	O	O	O
content	O	O	O
of	O	O	O
plasma	O	O	B-T031
CCK	O	O	B-T116
and	O	O	O
[Ca(2+)]i	O	O	B-T121
in	O	O	O
cholecyst	O	O	O
cells	O	O	O
,	O	O	O
abnormal	O	O	B-T116
protein	O	O	I-T116
and	O	O	O
mRNA	O	O	B-T114
of	O	O	O
Gs	O	O	B-T116
,	O	O	O
Gi	O	O	B-T116
and	O	O	O
Cap	O	O	B-T116
.	O	O	O

Emodin	O	O	B-T109
can	O	O	O
enhance	O	O	B-T052
the	O	O	O
contractibility	O	O	B-T042
of	O	O	I-T042
gallbladder	O	O	I-T042
and	O	O	O
alleviate	O	O	B-T081
cholestasis	O	O	B-T047
by	O	O	O
regulating	O	O	B-T038
plasma	O	O	B-T031
CCK	O	O	B-T116
levels	O	O	B-T080
,	O	O	O
[Ca(2+)]i	O	O	B-T121
in	O	O	O
cholecyst	O	O	B-T023
cells	O	O	B-T025
and	O	O	O
the	O	O	O
protein	O	O	B-T116
and	O	O	O
mRNA	O	O	B-T114
of	O	O	O
Gs	O	O	B-T116
,	O	O	O
Gi	O	O	B-T116
and	O	O	O
Cap	O	O	B-T116
.	O	O	O

-DOCSTART- (27796450)

Quantification	O	O	B-T081
of	O	O	O
urinary	O	O	B-T080
mono-hydroxylated	O	O	B-T123
metabolites	O	O	I-T123
of	O	O	O
polycyclic	O	O	B-T109
aromatic	O	O	I-T109
hydrocarbons	O	O	I-T109
by	O	O	O
on-line	O	O	B-T059
solid	O	O	I-T059
phase	O	O	I-T059
extraction	O	O	I-T059
-	O	O	O
high	O	O	O
performance	O	O	O
liquid	O	O	O
chromatography-tandem	O	O	O
mass	O	O	O
spectrometry	O	O	O

Human	O	O	B-T016
exposure	O	O	B-T080
to	O	O	I-T080
polycyclic	O	O	B-T109
aromatic	O	O	I-T109
hydrocarbons	O	O	I-T109
(	O	O	O
PAHs	O	O	B-T109
)	O	O	O
can	O	O	O
be	O	O	O
assessed	O	O	B-T052
through	O	O	O
monitoring	O	O	B-T058
of	O	O	O
urinary	O	O	B-T080
mono-hydroxylated	O	O	B-T109
PAHs	O	O	I-T109
(	O	O	O
OH-PAHs	O	O	B-T109
)	O	O	O
.	O	O	O

Gas	O	O	B-T059
chromatography	O	O	I-T059
(	O	O	O
GC	O	O	B-T059
)	O	O	O
has	O	O	O
been	O	O	O
widely	O	O	O
used	O	O	O
to	O	O	O
separate	O	O	B-T080
OH-PAHs	O	O	B-T109
before	O	O	O
quantification	O	O	B-T081
by	O	O	O
mass	O	O	B-T059
spectrometry	O	O	I-T059
in	O	O	O
biomonitoring	O	O	B-T057
studies	O	O	B-T062
.	O	O	O

However	O	O	O
,	O	O	O
because	O	O	O
GC	O	O	B-T059
requires	O	O	O
derivatization	O	O	B-T169
,	O	O	O
it	O	O	O
can	O	O	O
be	O	O	O
time	O	O	B-T080
consuming	O	O	I-T080
.	O	O	O

We	O	O	O
developed	O	O	B-T169
an	O	O	O
on-line	O	O	B-T059
solid	O	O	I-T059
phase	O	O	I-T059
extraction	O	O	I-T059
coupled	O	O	B-T169
to	O	O	O
isotope	O	O	B-T196
dilution	O	O	B-T169
-	O	O	O
high	O	O	B-T059
performance	O	O	I-T059
liquid	O	O	I-T059
chromatography-tandem	O	O	I-T059
mass	O	O	I-T059
spectrometry	O	O	I-T059
(	O	O	O
on-line-SPE	O	O	B-T059
-	O	O	O
HPLC-MS	O	O	B-T059
/	O	O	O
MS	O	O	B-T059
)	O	O	O
method	O	O	B-T170
for	O	O	O
the	O	O	O
quantification	O	O	B-T081
in	O	O	O
urine	O	O	B-T031
of	O	O	O
1-OH-naphthalene	O	O	B-T109
,	O	O	O
2-OH-naphthalene	O	O	B-T109
,	O	O	O
2-OH-fluorene	O	O	B-T109
,	O	O	O
3-OH-fluorene	O	O	B-T109
,	O	O	O
1-OH-phenanthrene	O	O	B-T109
,	O	O	O
the	O	O	O
sum	O	O	O
of	O	O	O
2-OH	O	O	B-T109
and	O	O	O
3-OH-phenanthrene	O	O	B-T109
,	O	O	O
4-OH-phenanthrene	O	O	B-T109
,	O	O	O
and	O	O	O
1-OH-pyrene	O	O	B-T109
.	O	O	O

The	O	O	O
method	O	O	B-T170
,	O	O	O
which	O	O	O
employed	O	O	B-T033
a	O	O	O
96-	O	O	O
well	O	O	B-T082
plate	O	O	I-T082
platform	O	O	I-T082
and	O	O	O
on-line	O	O	B-T059
SPE	O	O	I-T059
,	O	O	O
showed	O	O	O
good	O	O	B-T067
sensitivity	O	O	I-T067
(	O	O	O
i.e.	O	O	O
,	O	O	O
limits	O	O	B-T169
of	O	O	O
detection	O	O	B-T061
ranged	O	O	B-T081
from	O	O	O
0.007	O	O	O
to	O	O	O
0.09	O	O	O
ng/mL	O	O	O
)	O	O	O
and	O	O	O
used	O	O	O
only	O	O	O
100	O	O	O
Î¼L	O	O	O
of	O	O	O
urine	O	O	B-T031
.	O	O	O

Accuracy	O	O	B-T080
,	O	O	O
calculated	O	O	B-T059
from	O	O	O
the	O	O	O
recovery	O	O	B-T052
percentage	O	O	B-T081
at	O	O	O
three	O	O	O
spiking	O	O	B-T082
levels	O	O	B-T080
,	O	O	O
varied	O	O	B-T080
from	O	O	O
94	O	O	O
to	O	O	O
113	O	O	O
%	O	O	O
,	O	O	O
depending	O	O	B-T080
on	O	O	O
the	O	O	O
analyte	O	O	B-T167
.	O	O	O

The	O	O	O
inter	O	O	B-T079
-	O	O	O
and	O	O	O
intra	O	O	B-T079
-	O	O	O
day	O	O	B-T078
precision	O	O	I-T078
,	O	O	O
calculated	O	O	B-T059
from	O	O	O
20	O	O	O
repeated	O	O	B-T169
measurements	O	O	B-T169
of	O	O	O
two	O	O	O
quality	O	O	B-T169
control	O	O	I-T169
materials	O	O	B-T167
,	O	O	O
varied	O	O	B-T080
from	O	O	O
5.2	O	O	O
to	O	O	O
16.7	O	O	O
%	O	O	O
.	O	O	O

Adequate	O	O	B-T080
method	O	O	B-T170
performance	O	O	B-T052
was	O	O	O
also	O	O	O
confirmed	O	O	B-T080
by	O	O	I-T080
acceptable	O	O	B-T080
recovery	O	O	B-T052
(	O	O	O
83	O	O	O
-	O	O	O
102	O	O	O
%	O	O	O
)	O	O	O
of	O	O	O
two	O	O	O
NIST	O	O	B-T092
standard	O	O	B-T081
reference	O	O	I-T081
materials	O	O	B-T167
(	O	O	O
3672	O	O	O
and	O	O	O
3673	O	O	O
)	O	O	O
.	O	O	O

This	O	O	O
high-throughput	O	O	B-T170
on-line-SPE	O	O	B-T059
-	O	O	O
HPLC-MS	O	O	B-T059
/	O	O	O
MS	O	O	B-T059
method	O	O	B-T170
can	O	O	O
be	O	O	O
applied	O	O	O
in	O	O	O
large	O	O	B-T081
-	O	O	O
scale	O	O	B-T077
epidemiological	O	O	B-T062
studies	O	O	I-T062
.	O	O	O

Graphical	O	O	B-T170
abstract	O	O	I-T170
Example	O	O	O
LC-MS	O	O	B-T169
chromatogram	O	O	I-T169
of	O	O	O
urinary	O	O	B-T080
mono-hydroxylated	O	O	B-T109
PAH	O	O	I-T109
metabolites	O	O	B-T123
.	O	O	O

-DOCSTART- (27796510)

Utility	O	O	B-T169
and	O	O	O
applicability	O	O	B-T169
of	O	O	O
the	O	O	O
"	O	O	B-T170
Childhood	O	O	I-T170
Obesity	O	O	I-T170
Risk	O	O	I-T170
Evaluation	O	O	I-T170
"	O	O	I-T170
(CORE)-index	O	O	I-T170
in	O	O	O
predicting	O	O	O
obesity	O	O	B-T047
in	O	O	O
childhood	O	O	B-T079
and	O	O	O
adolescence	O	O	B-T079
in	O	O	O
Greece	O	O	B-T083
from	O	O	O
early	O	O	B-T079
life	O	O	B-T078
:	O	O	O
the	O	O	O
"	O	O	O
National	O	O	O
Action	O	O	O
Plan	O	O	O
for	O	O	O
Public	O	O	O
Health	O	O	O
"	O	O	O

Early	O	O	B-T079
identification	O	O	B-T058
of	O	O	O
infants	O	O	B-T100
being	O	O	O
at	O	O	O
high	O	O	B-T033
risk	O	O	I-T033
to	O	O	O
become	O	O	O
obese	O	O	B-T047
at	O	O	O
their	O	O	O
later	O	O	B-T079
childhood	O	O	B-T079
or	O	O	O
adolescence	O	O	B-T079
can	O	O	O
be	O	O	O
of	O	O	O
vital	O	O	O
importance	O	O	O
in	O	O	O
any	O	O	O
obesity	O	O	B-T047
prevention	O	O	B-T080
initiative	O	O	B-T033
.	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
the	O	O	O
present	O	O	O
study	O	O	O
was	O	O	O
to	O	O	O
examine	O	O	O
the	O	O	O
utility	O	O	B-T169
and	O	O	O
applicability	O	O	B-T169
of	O	O	O
the	O	O	O
"	O	O	B-T170
Childhood	O	O	I-T170
Obesity	O	O	I-T170
Risk	O	O	I-T170
Evaluation	O	O	I-T170
(	O	O	I-T170
CORE	O	O	I-T170
)	O	O	I-T170
"	O	O	I-T170
index	O	O	I-T170
as	O	O	O
a	O	O	O
screening	O	O	B-T058
tool	O	O	B-T073
for	O	O	O
the	O	O	O
early	O	O	B-T079
prediction	O	O	B-T078
of	O	O	O
obesity	O	O	B-T047
in	O	O	O
childhood	O	O	B-T079
and	O	O	O
adolescence	O	O	B-T079
.	O	O	O

Anthropometric	O	O	B-T078
,	O	O	O
socio-demographic	O	O	B-T078
data	O	O	I-T078
were	O	O	O
collected	O	O	B-T078
cross-sectionally	O	O	B-T080
and	O	O	O
retrospectively	O	O	B-T080
from	O	O	O
a	O	O	O
representative	O	O	O
sample	O	O	B-T167
of	O	O	O
5946	O	O	O
children	O	O	B-T100
,	O	O	O
and	O	O	O
adolescents	O	O	B-T100
and	O	O	O
were	O	O	O
combined	O	O	O
for	O	O	O
calculating	O	O	B-T052
the	O	O	O
CORE-index	O	O	B-T170
score	O	O	I-T170
.	O	O	O

Logistic	O	O	B-UnknownType
regression	O	O	I-UnknownType
analyses	O	O	I-UnknownType
were	O	O	O
performed	O	O	O
to	O	O	O
examine	O	O	O
the	O	O	O
associations	O	O	B-T080
of	O	O	O
the	O	O	O
CORE-index	O	O	B-T170
score	O	O	I-T170
with	O	O	O
obesity	O	O	B-T047
by	O	O	O
gender	O	O	B-T032
and	O	O	O
age	O	O	B-T100
group	O	O	I-T100
,	O	O	O
and	O	O	O
cut-off	O	O	B-T062
point	O	O	I-T062
analysis	O	O	I-T062
was	O	O	O
also	O	O	O
applied	O	O	O
to	O	O	O
identify	O	O	O
the	O	O	O
optimal	O	O	B-T080
value	O	O	B-T081
of	O	O	O
the	O	O	O
CORE-index	O	O	O
score	O	O	O
that	O	O	O
differentiates	O	O	B-T080
obese	O	O	B-T047
from	O	O	O
non-obese	O	O	B-T100
children	O	O	I-T100
.	O	O	O

Mean	O	O	B-T170
CORE-index	O	O	I-T170
score	O	O	I-T170
in	O	O	O
the	O	O	O
total	O	O	B-T080
sample	O	O	B-T167
was	O	O	O
3.06	O	O	O
(	O	O	O
sd	O	O	B-T081
1.92	O	O	O
)	O	O	O
units	O	O	O
(	O	O	O
range	O	O	O
0	O	O	O
-	O	O	O
11	O	O	O
units	O	O	O
)	O	O	O
.	O	O	O

Each	O	O	O
unit	O	O	O
increase	O	O	B-T169
in	O	O	O
the	O	O	O
CORE-index	O	O	B-T170
score	O	O	I-T170
was	O	O	O
found	O	O	O
to	O	O	O
be	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
a	O	O	O
30	O	O	O
%	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
C.I.	O	O	B-T081
1.24	O	O	O
-	O	O	O
1.36	O	O	O
)	O	O	O
increased	O	O	B-T081
likelihood	O	O	B-T081
for	O	O	O
obesity	O	O	B-T047
in	O	O	O
childhood	O	O	B-T079
or	O	O	O
adolescence	O	O	B-T079
,	O	O	O
while	O	O	O
the	O	O	O
optimal	O	O	B-T080
cut-off	O	O	B-T081
value	O	O	I-T081
of	O	O	O
the	O	O	O
CORE-index	O	O	O
score	O	O	O
that	O	O	O
predicted	O	O	B-T078
obesity	O	O	O
with	O	O	O
the	O	O	O
highest	O	O	B-T080
possible	O	O	O
sensitivity	O	O	B-T081
and	O	O	I-T081
specificity	O	O	I-T081
was	O	O	O
found	O	O	O
to	O	O	O
be	O	O	O
3.5	O	O	O
.	O	O	O

The	O	O	O
present	O	O	O
study	O	O	O
supports	O	O	O
the	O	O	O
utility	O	O	B-T169
and	O	O	O
applicability	O	O	B-T169
of	O	O	O
the	O	O	O
CORE-index	O	O	B-T170
as	O	O	O
a	O	O	O
screening	O	O	B-T058
tool	O	O	B-T073
for	O	O	O
the	O	O	O
early	O	O	B-T079
identification	O	O	B-T058
of	O	O	O
infants	O	O	B-T100
that	O	O	O
are	O	O	O
potentially	O	O	O
at	O	O	O
a	O	O	O
higher	O	O	B-T033
risk	O	O	I-T033
for	O	O	O
becoming	O	O	O
obese	O	O	B-T047
at	O	O	O
their	O	O	O
childhood	O	O	B-T079
and	O	O	O
adolescence	O	O	B-T079
.	O	O	O

This	O	O	O
tool	O	O	B-T073
could	O	O	O
be	O	O	O
routinely	O	O	O
used	O	O	O
by	O	O	O
health	O	O	B-T097
professionals	O	O	I-T097
to	O	O	O
identify	O	O	O
infants	O	O	B-T100
at	O	O	O
high	O	O	B-T033
risk	O	O	I-T033
and	O	O	O
provide	O	O	O
appropriate	O	O	O
counselling	O	O	B-T058
to	O	O	O
their	O	O	O
parents	O	O	B-T099
and	O	O	O
caregivers	O	O	B-T097
so	O	O	O
as	O	O	O
to	O	O	O
maximize	O	O	O
the	O	O	O
effectiveness	O	O	B-T080
of	O	O	O
early	O	O	B-T079
obesity	O	O	B-T047
prevention	O	O	B-T080
initiatives	O	O	B-T033
.	O	O	O

What	O	O	O
is	O	O	O
known	O	O	O
?	O	O	O

â¢	O	O	O
Childhood	O	O	B-T079
obesity	O	O	B-T047
has	O	O	O
reached	O	O	O
epidemic	O	O	B-T081
proportions	O	O	I-T081
worldwide	O	O	O
.	O	O	O

â¢	O	O	O
Certain	O	O	O
perinatal	O	O	B-T033
and	O	O	O
socio-demographic	O	O	B-T033
indices	O	O	I-T033
that	O	O	O
were	O	O	O
previously	O	O	O
identified	O	O	B-T080
as	O	O	O
correlates	O	O	O
of	O	O	O
childhood	O	O	B-T079
obesity	O	O	B-T047
in	O	O	O
children	O	O	B-T100
were	O	O	O
combined	O	O	O
to	O	O	O
develop	O	O	O
the	O	O	O
CORE-index	O	O	B-T170
,	O	O	O
a	O	O	O
screening	O	O	B-T058
tool	O	O	B-T073
that	O	O	O
estimates	O	O	O
obesity	O	O	O
risk	O	O	B-T078
in	O	O	O
9	O	O	O
-	O	O	O
13	O	O	O
year-old	O	O	B-T079
children	O	O	O
.	O	O	O

What	O	O	O
is	O	O	O
new	O	O	O
?	O	O	O

â¢	O	O	O
The	O	O	O
utility	O	O	B-T169
and	O	O	O
applicability	O	O	B-T169
of	O	O	O
the	O	O	O
CORE-index	O	O	B-T170
as	O	O	O
screening	O	O	B-T058
tool	O	O	B-T073
can	O	O	O
be	O	O	O
extended	O	O	O
to	O	O	O
the	O	O	O
age	O	O	B-T032
range	O	O	O
of	O	O	O
6	O	O	O
-	O	O	O
15	O	O	O
years	O	O	B-T079
.	O	O	O

â¢	O	O	O
The	O	O	O
CORE-index	O	O	B-T170
is	O	O	O
a	O	O	O
cost-effective	O	O	B-T080
screening	O	O	B-T058
tool	O	O	B-T073
that	O	O	O
can	O	O	O
assist	O	O	O
health	O	O	B-T097
professionals	O	O	I-T097
in	O	O	O
initiating	O	O	O
obesity	O	O	B-T047
preventive	O	O	B-T170
measures	O	O	I-T170
from	O	O	O
early	O	O	B-T079
life	O	O	B-T078
.	O	O	O

-DOCSTART- (27796974)

Methodology	O	O	B-T078
development	O	O	B-T169
on	O	O	O
aquatic	O	O	B-T067
environmental	O	O	I-T067
assessment	O	O	O

The	O	O	O
Water	O	O	B-T170
Framework	O	O	I-T170
Directive	O	O	I-T170
aims	O	O	B-T078
at	O	O	O
reaching	O	O	O
the	O	O	O
good	O	O	O
ecological	O	O	B-T070
status	O	O	B-T080
of	O	O	O
the	O	O	O
surface	O	O	B-T082
and	O	O	O
ground	O	O	B-T082
water	O	O	I-T082
bodies	O	O	I-T082
(	O	O	O
LÃ¡szlÃ³	O	O	O
et	O	O	O
al.	O	O	O
Microchem	O	O	O
J	O	O	O
85(1):65	O	O	O
-	O	O	O
71	O	O	O
,	O	O	O
2007	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
paper	O	O	O
deals	O	O	O
with	O	O	O
quality	O	O	B-T080
evaluation	O	O	B-T058
of	O	O	O
waters	O	O	B-T121
with	O	O	O
special	O	O	B-T080
focus	O	O	O
on	O	O	O
the	O	O	O
water	O	O	B-T121
chemistry	O	O	B-T169
parameters	O	O	B-T077
as	O	O	O
defined	O	O	O
in	O	O	O
the	O	O	O
Water	O	O	B-T170
Framework	O	O	I-T170
Directive	O	O	I-T170
and	O	O	O
pertaining	O	O	O
legal	O	O	B-T089
regulations	O	O	I-T089
.	O	O	O

The	O	O	O
purpose	O	O	B-T169
of	O	O	O
this	O	O	O
paper	O	O	O
is	O	O	O
to	O	O	O
devise	O	O	O
a	O	O	O
quantitative	O	O	B-T081
type	O	O	O
of	O	O	O
water	O	O	B-T121
quality	O	O	B-T080
assessment	O	O	B-T058
method	O	O	B-T170
which	O	O	O
could	O	O	O
provide	O	O	B-T052
rapid	O	O	B-T080
,	O	O	O
accurate	O	O	B-T080
,	O	O	O
and	O	O	O
reliable	O	O	B-T170
information	O	O	B-T078
on	O	O	O
the	O	O	O
quality	O	O	O
of	O	O	O
the	O	O	O
surface	O	O	B-T082
waters	O	O	B-T121
by	O	O	O
using	O	O	O
water	O	O	O
chemistry	O	O	B-T169
parameters	O	O	B-T077
.	O	O	O

Quality	O	O	B-T080
classes	O	O	B-T170
have	O	O	O
been	O	O	O
defined	O	O	B-T080
for	O	O	O
every	O	O	O
water	O	O	B-T121
chemistry	O	O	B-T169
parameter	O	O	B-T077
in	O	O	O
light	O	O	O
of	O	O	O
the	O	O	O
legal	O	O	B-T089
limit	O	O	I-T089
values	O	O	I-T089
of	O	O	O
the	O	O	O
water	O	O	O
parameters	O	O	B-T077
.	O	O	O

In	O	O	O
addition	O	O	O
to	O	O	O
this	O	O	O
,	O	O	O
weight	O	O	B-T081
indices	O	O	I-T081
were	O	O	O
calculated	O	O	B-T059
on	O	O	O
the	O	O	O
basis	O	O	O
of	O	O	O
the	O	O	O
outcome	O	O	B-T169
of	O	O	O
the	O	O	O
paired	O	O	B-T081
comparison	O	O	I-T081
of	O	O	O
water	O	O	B-T121
chemistry	O	O	B-T169
parameters	O	O	B-T077
and	O	O	O
normalized	O	O	B-T062
matrix	O	O	B-T082
.	O	O	O

This	O	O	O
was	O	O	O
followed	O	O	O
by	O	O	O
the	O	O	O
parametric	O	O	B-UnknownType
level	O	O	I-UnknownType
analysis	O	O	I-UnknownType
of	O	O	O
the	O	O	O
water	O	O	B-T121
chemistry	O	O	B-T169
parameters	O	O	B-T077
,	O	O	O
and	O	O	O
finally	O	O	O
,	O	O	O
the	O	O	O
aquatic	O	O	B-T170
environment	O	O	I-T170
index	O	O	I-T170
(	O	O	O
AEI	O	O	B-T170
)	O	O	O
was	O	O	O
calculated	O	O	B-T059
,	O	O	O
which	O	O	O
provided	O	O	B-T052
general	O	O	B-T185
information	O	O	I-T185
on	O	O	O
the	O	O	O
quality	O	O	B-T080
of	O	O	O
water	O	O	O
regarding	O	O	O
the	O	O	O
water	O	O	O
chemistry	O	O	O
parameters	O	O	O
.	O	O	O

The	O	O	O
method	O	O	B-T170
was	O	O	O
illustrated	O	O	O
on	O	O	O
Lake	O	O	B-T083
Balaton	O	O	B-T083
,	O	O	O
Hungary	O	O	B-T083
in	O	O	O
which	O	O	O
case	O	O	O
water	O	O	B-T121
samples	O	O	B-T167
taken	O	O	O
from	O	O	O
BalatonfÃ¼red	O	O	B-T083
City	O	O	I-T083
lake	O	O	B-T083
area	O	O	B-T083
were	O	O	O
analyzed	O	O	B-T062
and	O	O	O
evaluated	O	O	B-T058
with	O	O	O
the	O	O	O
method	O	O	O
devised	O	O	O
.	O	O	O

-DOCSTART- (27797717)

WDR26	O	O	B-T116
promotes	O	O	B-T052
mitophagy	O	O	B-T043
of	O	O	O
cardiomyocytes	O	O	B-T025
induced	O	O	B-T169
by	O	O	O
hypoxia	O	O	B-T046
through	O	O	O
Parkin	O	O	B-T116
translocation	O	O	O

Myocardial	O	O	B-T047
ischemia	O	O	I-T047
is	O	O	O
a	O	O	O
heart	O	O	B-T023
condition	O	O	B-T080
caused	O	O	O
by	O	O	O
reduction	O	O	B-T080
of	O	O	O
blood	O	O	B-T039
flow	O	O	I-T039
to	O	O	O
the	O	O	O
heart	O	O	O
,	O	O	O
preventing	O	O	O
heart	O	O	O
from	O	O	O
receiving	O	O	B-T080
enough	O	O	O
oxygen	O	O	B-T121
.	O	O	O

Myocardial	O	O	B-T047
ischemia	O	O	I-T047
is	O	O	O
the	O	O	O
most	O	O	O
common	O	O	O
cause	O	O	B-T033
of	O	O	I-T033
death	O	O	I-T033
globally	O	O	B-T082
.	O	O	O

Heart	O	O	B-T023
ischemic	O	O	B-T061
preconditioning	O	O	I-T061
(	O	O	O
IPC	O	O	B-T061
)	O	O	O
has	O	O	O
a	O	O	O
protective	O	O	B-T080
effect	O	O	I-T080
against	O	O	O
myocardial	O	O	B-T025
cell	O	O	I-T025
death	O	O	B-T043
induced	O	O	B-T169
by	O	O	O
ischemia	O	O	B-T046
and	O	O	O
ischemia-reperfusion	O	O	B-T037
injury	O	O	I-T037
.	O	O	O

WDR26	O	O	B-T116
has	O	O	O
recently	O	O	O
been	O	O	O
identified	O	O	B-T080
as	O	O	O
a	O	O	O
protein	O	O	B-T116
that	O	O	O
is	O	O	O
increased	O	O	B-T081
following	O	O	O
rat	O	O	B-T015
cardiac	O	O	B-T023
IPC	O	O	B-T061
.	O	O	O

WDR26	O	O	B-T116
can	O	O	O
promote	O	O	B-T052
the	O	O	O
proliferation	O	O	B-T043
of	O	O	O
H9c2	O	O	B-T025
cells	O	O	I-T025
and	O	O	O
protect	O	O	O
cardiomyocytes	O	O	B-T025
against	O	O	O
oxidative	O	O	B-T049
stress	O	O	I-T049
through	O	O	O
inhibiting	O	O	B-T052
apoptosis	O	O	B-T043
.	O	O	O

However	O	O	O
,	O	O	O
its	O	O	O
role	O	O	B-T077
in	O	O	O
myocardial	O	O	B-T047
ischemia	O	O	I-T047
is	O	O	O
unclear	O	O	O
.	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
explore	O	O	O
the	O	O	O
role	O	O	O
of	O	O	O
WDR26	O	O	B-T116
in	O	O	O
myocardial	O	O	B-T047
ischemia	O	O	I-T047
and	O	O	O
H9c2	O	O	B-T025
cell	O	O	I-T025
hypoxia	O	O	B-T046
.	O	O	O

Our	O	O	O
results	O	O	B-T169
showed	O	O	O
that	O	O	O
WDR26	O	O	B-T116
is	O	O	O
induced	O	O	B-T169
by	O	O	O
myocardial	O	O	B-T047
ischemia	O	O	I-T047
and	O	O	O
H9c2	O	O	B-T025
cell	O	O	I-T025
hypoxia	O	O	B-T046
.	O	O	O

WDR26	O	O	B-T116
protects	O	O	O
H9c2	O	O	B-T025
cells	O	O	I-T025
against	O	O	O
hypoxia	O	O	B-T046
injury	O	O	B-T037
through	O	O	O
inhibiting	O	O	B-T052
LDH	O	O	B-T116
release	O	O	O
and	O	O	O
increasing	O	O	O
cell	O	O	B-T043
viability	O	O	I-T043
.	O	O	O

WDR26	O	O	B-T116
promotes	O	O	B-T052
hypoxia	O	O	B-T046
-	O	O	O
induced	O	O	B-T169
autophagy	O	O	B-T043
in	O	O	O
hypoxia	O	O	O
of	O	O	O
H9c2	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

We	O	O	O
further	O	O	O
demonstrated	O	O	O
that	O	O	O
in	O	O	O
H9c2	O	O	B-T025
cell	O	O	I-T025
hypoxia	O	O	B-T046
,	O	O	O
WDR26	O	O	B-T116
increases	O	O	B-T169
mitochondrial	O	O	B-T043
membrane	O	O	I-T043
potential	O	O	I-T043
,	O	O	O
thereby	O	O	O
increases	O	O	O
Parkin	O	O	B-T116
translocation	O	O	B-T043
of	O	O	O
mitochondria	O	O	B-T026
.	O	O	O

After	O	O	O
Parkin	O	O	B-T116
is	O	O	O
translocated	O	O	B-T043
at	O	O	O
mitochondria	O	O	B-T026
,	O	O	O
WDR26	O	O	B-T116
can	O	O	O
increase	O	O	B-T169
mitochondria	O	O	O
l	O	O	O
protein	O	O	B-T044
ubiquitination	O	O	I-T044
in	O	O	O
hypoxia	O	O	B-T046
of	O	O	O
H9c2	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

WDR26	O	O	B-T116
is	O	O	O
a	O	O	O
mediator	O	O	O
of	O	O	O
response	O	O	O
to	O	O	O
hypoxia	O	O	B-T046
,	O	O	O
and	O	O	O
WDR26	O	O	O
plays	O	O	O
an	O	O	O
important	O	O	O
role	O	O	O
in	O	O	O
hypoxia	O	O	O
-mediated	O	O	O
autophagy	O	O	B-T043
and	O	O	O
mitophagy	O	O	B-T043
.	O	O	O

This	O	O	O
study	O	O	B-T062
provides	O	O	O
novel	O	O	B-T080
insights	O	O	O
into	O	O	O
the	O	O	O
protective	O	O	O
role	O	O	O
of	O	O	O
WDR26	O	O	B-T116
in	O	O	O
cardiomyocyte	O	O	B-T025
injury	O	O	B-T037
during	O	O	O
hypoxia	O	O	B-T046
.	O	O	O

WDR26	O	O	B-T116
may	O	O	O
serve	O	O	O
as	O	O	O
a	O	O	O
potential	O	O	O
target	O	O	B-T169
for	O	O	O
the	O	O	O
treatment	O	O	B-T061
of	O	O	O
myocardial	O	O	B-T047
ischemia	O	O	I-T047
.	O	O	O

-DOCSTART- (27798219)

Impact	O	O	B-T080
of	O	O	O
antibiotic	O	O	B-T195
de-escalation	O	O	B-T061
on	O	O	O
clinical	O	O	B-T169
outcomes	O	O	I-T169
in	O	O	O
community-acquired	O	O	B-T080
pneumococcal	O	O	O
pneumonia	O	O	O

Although	O	O	O
antibiotic	O	O	B-T195
de-escalation	O	O	B-T061
is	O	O	O
regarded	O	O	O
as	O	O	O
a	O	O	O
measure	O	O	O
that	O	O	O
reduces	O	O	B-T080
selection	O	O	O
pressure	O	O	O
,	O	O	O
adverse	O	O	B-T046
drug	O	O	I-T046
effects	O	O	I-T046
and	O	O	O
costs	O	O	B-T081
,	O	O	O
evidence	O	O	B-T078
supporting	O	O	O
this	O	O	O
practice	O	O	O
in	O	O	O
community-acquired	O	O	B-T047
pneumococcal	O	O	I-T047
pneumonia	O	O	I-T047
(	O	O	O
CAPP	O	O	B-T047
)	O	O	O
is	O	O	O
lacking	O	O	B-T080
.	O	O	O

We	O	O	O
carried	O	O	O
out	O	O	O
a	O	O	O
retrospective	O	O	B-T080
analysis	O	O	B-T062
of	O	O	O
prospectively	O	O	O
collected	O	O	O
data	O	O	B-T078
of	O	O	O
a	O	O	O
cohort	O	O	B-T098
of	O	O	O
hospitalized	O	O	B-T101
adults	O	O	I-T101
with	O	O	O
CAPP	O	O	B-T047
.	O	O	O

Pneumococcal	O	O	B-T047
aetiology	O	O	B-T169
was	O	O	O
established	O	O	B-T080
in	O	O	O
patients	O	O	B-T101
with	O	O	O
one	O	O	O
or	O	O	O
more	O	O	O
positive	O	O	B-T033
cultures	O	O	I-T033
for	O	O	O
Streptococcus	O	O	B-T007
pneumoniae	O	O	I-T007
obtained	O	O	O
from	O	O	O
blood	O	O	B-T031
,	O	O	O
sterile	O	O	B-T031
fluids	O	O	I-T031
or	O	O	O
sputum	O	O	B-T031
,	O	O	O
and/or	O	O	O
a	O	O	O
positive	O	O	O
urinary	O	O	B-T059
antigen	O	O	I-T059
test	O	O	I-T059
.	O	O	O

De-escalation	O	O	B-T061
therapy	O	O	I-T061
was	O	O	O
considered	O	O	O
when	O	O	O
the	O	O	O
initial	O	O	O
antibiotic	O	O	B-T061
therapy	O	O	I-T061
was	O	O	O
narrowed	O	O	O
to	O	O	O
penicillin	O	O	B-T195
,	O	O	O
amoxicillin	O	O	B-T195
or	O	O	O
amoxicillin/clavulanate	O	O	B-T121
within	O	O	O
the	O	O	O
first	O	O	O
72	O	O	O
h	O	O	O
after	O	O	O
admission	O	O	B-T058
.	O	O	O

The	O	O	O
primary	O	O	O
outcomes	O	O	B-T169
were	O	O	O
30	O	O	O
day	O	O	B-T079
mortality	O	O	B-T081
and	O	O	O
length	O	O	B-T079
of	O	O	I-T079
hospital	O	O	I-T079
stay	O	O	I-T079
(	O	O	O
LOS	O	O	B-T079
)	O	O	O
.	O	O	O

Adjustment	O	O	B-T169
for	O	O	O
confounders	O	O	O
was	O	O	O
performed	O	O	B-T169
with	O	O	O
multivariate	O	O	B-T081
and	O	O	O
propensity	O	O	B-T081
score	O	O	I-T081
analyses	O	O	B-T062
.	O	O	O

Of	O	O	O
1410	O	O	O
episodes	O	O	O
of	O	O	O
CAPP	O	O	B-T047
,	O	O	O
antibiotic	O	O	B-T195
de-escalation	O	O	B-T061
within	O	O	O
the	O	O	O
first	O	O	O
72	O	O	O
h	O	O	O
after	O	O	O
admission	O	O	B-T058
was	O	O	O
performed	O	O	B-T169
in	O	O	O
166	O	O	O
cases	O	O	B-T169
.	O	O	O

After	O	O	O
adjustment	O	O	B-T169
,	O	O	O
antibiotic	O	O	B-T195
de-escalation	O	O	B-T061
was	O	O	O
not	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
a	O	O	O
higher	O	O	O
risk	O	O	B-T078
of	O	O	O
mortality	O	O	B-T081
(	O	O	O
OR	O	O	B-T081
=	O	O	O
0.83	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
=	O	O	O
0.24	O	O	O
-	O	O	O
2.81	O	O	O
)	O	O	O
,	O	O	O
but	O	O	O
it	O	O	O
was	O	O	O
found	O	O	O
to	O	O	O
be	O	O	O
a	O	O	O
protective	O	O	B-T055
factor	O	O	I-T055
for	O	O	O
prolonged	O	O	B-T079
LOS	O	O	B-T079
(	O	O	O
above	O	O	O
the	O	O	O
median	O	O	B-T081
)	O	O	O
(	O	O	O
OR	O	O	O
=	O	O	O
0.46	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
=	O	O	O
0.30	O	O	O
-	O	O	O
0.70	O	O	O
)	O	O	O
.	O	O	O

Similar	O	O	O
results	O	O	B-T169
were	O	O	O
found	O	O	O
in	O	O	O
patients	O	O	B-T101
classified	O	O	O
into	O	O	O
high-risk	O	O	B-T033
pneumonia	O	O	B-T047
severity	O	O	O
index	O	O	O
classes	O	O	O
(	O	O	O
IV-V	O	O	O
)	O	O	O
,	O	O	O
those	O	O	O
with	O	O	O
clinical	O	O	B-T033
instability	O	O	I-T033
and	O	O	O
those	O	O	O
with	O	O	O
bacteraemia	O	O	B-T047
.	O	O	O

No	O	O	B-T033
significant	O	O	I-T033
differences	O	O	I-T033
were	O	O	O
documented	O	O	B-T058
in	O	O	O
adverse	O	O	B-T046
drug	O	O	I-T046
reactions	O	O	I-T046
or	O	O	O
readmission	O	O	B-T058
(	O	O	O
<	O	O	O
30	O	O	O
days	O	O	B-T079
)	O	O	O
.	O	O	O

Antibiotic	O	O	B-T195
de-escalation	O	O	B-T061
seems	O	O	O
to	O	O	O
be	O	O	O
safe	O	O	O
and	O	O	O
effective	O	O	B-T080
in	O	O	O
reducing	O	O	B-T080
the	O	O	O
duration	O	O	B-T079
of	O	O	O
LOS	O	O	B-T079
,	O	O	O
and	O	O	O
did	O	O	O
not	O	O	O
adversely	O	O	B-T046
affect	O	O	I-T046
outcomes	O	O	B-T169
of	O	O	O
patients	O	O	B-T101
with	O	O	O
CAPP	O	O	B-T047
,	O	O	O
even	O	O	O
those	O	O	O
with	O	O	O
bacteraemia	O	O	B-T047
and	O	O	O
severe	O	O	B-T047
disease	O	O	I-T047
,	O	O	O
and	O	O	O
those	O	O	O
who	O	O	O
were	O	O	O
clinically	O	O	B-T033
unstable	O	O	I-T033
.	O	O	O

-DOCSTART- (27798906)

Radiation	O	O	B-T070
-	O	O	O
induced	O	O	B-T169
Parotid	O	O	B-T046
Gland	O	O	I-T046
Atrophy	O	O	I-T046
in	O	O	O
Patients	O	O	B-T101
with	O	O	O
Head	O	O	B-T191
and	O	O	I-T191
Neck	O	O	I-T191
Cancer	O	O	I-T191
After	O	O	O
Carbon-ion	O	O	O
Radiotherapy	O	O	O

This	O	O	O
study	O	O	B-T062
aimed	O	O	O
to	O	O	O
clarify	O	O	B-T052
the	O	O	O
relationship	O	O	B-T080
between	O	O	O
dosimetric	O	O	B-T059
factors	O	O	B-T169
and	O	O	O
parotid	O	O	B-T046
gland	O	O	I-T046
(	O	O	I-T046
PG	O	O	I-T046
)	O	O	I-T046
atrophy	O	O	I-T046
after	O	O	O
carbon	O	O	B-T061
ion	O	O	I-T061
radiotherapy	O	O	I-T061
(	O	O	O
C-ion	O	O	B-T061
RT	O	O	I-T061
)	O	O	O
.	O	O	O

Fifty-four	O	O	O
patients	O	O	B-T101
with	O	O	O
head	O	O	B-T191
and	O	O	I-T191
neck	O	O	I-T191
tumours	O	O	I-T191
were	O	O	O
enrolled	O	O	O
and	O	O	O
93	O	O	O
irradiated	O	O	O
PGs	O	O	B-T023
were	O	O	O
analyzed	O	O	O
.	O	O	O

Thirty	O	O	O
and	O	O	O
24	O	O	O
patients	O	O	B-T101
were	O	O	O
treated	O	O	B-T061
with	O	O	I-T061
total	O	O	B-T081
doses	O	O	I-T081
[	O	O	O
relative	O	O	B-T081
biological	O	O	I-T081
effectiveness	O	O	I-T081
(	O	O	O
RBE	O	O	B-T081
)	O	O	O
]	O	O	O
of	O	O	O
57.6	O	O	O
Gy	O	O	O
and	O	O	O
64.0	O	O	O
Gy	O	O	O
,	O	O	O
respectively	O	O	O
,	O	O	O
in	O	O	O
16	O	O	O
fractions	O	O	O
.	O	O	O

PG	O	O	B-T023
volumes	O	O	B-T081
were	O	O	O
measured	O	O	B-T059
using	O	O	O
computed	O	O	B-T078
tomographic	O	O	I-T078
images	O	O	I-T078
obtained	O	O	O
before	O	O	O
C-ion	O	O	B-T061
RT	O	O	I-T061
and	O	O	O
every	O	O	O
3	O	O	O
-	O	O	O
6	O	O	O
months	O	O	B-T079
thereafter	O	O	O
.	O	O	O

The	O	O	O
median	O	O	B-T081
follow-up	O	O	B-T058
period	O	O	B-T079
was	O	O	O
46.4	O	O	O
months	O	O	B-T079
(	O	O	O
range	O	O	B-T081
=	O	O	O
24.0	O	O	O
-	O	O	O
123.0	O	O	O
months	O	O	O
)	O	O	O
.	O	O	O

Univariate	O	O	B-T062
analysis	O	O	I-T062
showed	O	O	O
that	O	O	O
PG	O	O	B-T023
volumes	O	O	B-T081
receiving	O	O	O
more	O	O	O
than	O	O	O
5	O	O	O
,	O	O	O
10	O	O	O
,	O	O	O
15	O	O	O
,	O	O	O
and	O	O	O
20	O	O	O
Gy	O	O	O
RBE	O	O	B-T081
(	O	O	O
V5	O	O	B-T081
,	O	O	O
V10	O	O	B-T081
,	O	O	O
V15	O	O	B-T081
and	O	O	O
V20	O	O	B-T081
,	O	O	O
respectively	O	O	O
)	O	O	O
,	O	O	O
mean	O	O	B-T081
dose	O	O	B-T081
,	O	O	O
and	O	O	O
maximum	O	O	B-T081
dose	O	O	O
were	O	O	O
significantly	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
PG	O	O	B-T046
atrophy	O	O	I-T046
.	O	O	O

Multivariate	O	O	B-T081
analysis	O	O	I-T081
indicated	O	O	O
that	O	O	O
only	O	O	O
V5	O	O	B-T081
was	O	O	O
significantly	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
atrophy	O	O	B-T046
.	O	O	O

Increasing	O	O	B-T169
V5	O	O	B-T081
was	O	O	O
a	O	O	O
significant	O	O	O
risk	O	O	B-T033
factor	O	O	I-T033
for	O	O	O
PG	O	O	B-T046
atrophy	O	O	I-T046
after	O	O	O
C-ion	O	O	B-T061
RT	O	O	I-T061
.	O	O	O

-DOCSTART- (27799314)

IL-27	O	O	B-T116
Is	O	O	O
Essential	O	O	O
for	O	O	O
Suppression	O	O	B-T061
of	O	O	O
Experimental	O	O	B-T080
Allergic	O	O	B-T047
Asthma	O	O	I-T047
by	O	O	O
the	O	O	O
TLR7	O	O	B-T116
/	O	O	O
8	O	O	B-T116
Agonist	O	O	B-T121
R848	O	O	B-T109
(	O	O	O
Resiquimod	O	O	B-T109
)	O	O	O

Different	O	O	O
models	O	O	B-T050
of	O	O	I-T050
experimental	O	O	I-T050
allergic	O	O	B-T047
asthma	O	O	I-T047
have	O	O	O
shown	O	O	O
that	O	O	O
the	O	O	O
TLR7	O	O	B-T116
/	O	O	O
8	O	O	B-T116
agonist	O	O	B-T121
resiquimod	O	O	B-T109
(	O	O	O
R848	O	O	B-T109
)	O	O	O
is	O	O	O
a	O	O	O
potential	O	O	O
inhibitor	O	O	B-T080
of	O	O	O
type	O	O	B-T025
2	O	O	I-T025
helper	O	O	I-T025
cell	O	O	I-T025
-driven	O	O	O
inflammatory	O	O	B-T046
responses	O	O	I-T046
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
mechanisms	O	O	O
mediating	O	O	O
its	O	O	O
therapeutic	O	O	B-T201
effects	O	O	I-T201
are	O	O	O
not	O	O	O
fully	O	O	O
understood	O	O	O
.	O	O	O

Using	O	O	O
a	O	O	O
model	O	O	B-T050
of	O	O	I-T050
experimental	O	O	I-T050
allergic	O	O	B-T047
asthma	O	O	I-T047
,	O	O	O
we	O	O	O
show	O	O	O
that	O	O	O
induction	O	O	B-T061
of	O	O	O
IL-27	O	O	B-T116
by	O	O	O
R848	O	O	B-T109
is	O	O	O
critical	O	O	O
for	O	O	O
the	O	O	O
observed	O	O	O
ameliorative	O	O	B-T080
effects	O	O	O
.	O	O	O

R848	O	O	B-T109
significantly	O	O	O
inhibited	O	O	B-T080
all	O	O	O
hallmarks	O	O	B-T025
of	O	O	O
experimental	O	O	B-T080
allergic	O	O	B-T047
asthma	O	O	I-T047
,	O	O	O
including	O	O	O
airway	O	O	B-T023
hyperreactivity	O	O	I-T047
,	O	O	O
eosinophilic	O	O	B-T169
airway	O	O	O
inflammation	O	O	B-T046
,	O	O	O
mucus	O	O	B-T047
hypersecretion	O	O	I-T047
,	O	O	O
and	O	O	O
Ag	O	O	B-T129
-	O	O	O
specific	O	O	B-T116
Ig	O	O	I-T116
production	O	O	B-T038
.	O	O	O

Whereas	O	O	O
R848	O	O	B-T109
significantly	O	O	O
reduced	O	O	O
IL-5	O	O	B-T116
,	O	O	O
IL-13	O	O	B-T116
,	O	O	O
and	O	O	O
IL-17	O	O	B-T116
,	O	O	O
it	O	O	O
induced	O	O	O
IFN-Î³	O	O	B-T116
and	O	O	O
IL-27	O	O	B-T116
.	O	O	O

Neutralization	O	O	B-T169
of	O	O	O
IL-27	O	O	B-T116
completely	O	O	O
reversed	O	O	O
the	O	O	O
therapeutic	O	O	B-T201
effect	O	O	I-T201
of	O	O	O
R848	O	O	B-T109
in	O	O	O
the	O	O	O
experimental	O	O	B-T080
asthma	O	O	B-T047
model	O	O	B-T050
,	O	O	O
demonstrating	O	O	O
dependence	O	O	O
of	O	O	O
R848	O	O	O
-mediated	O	O	O
suppression	O	O	B-T061
on	O	O	O
IL-27	O	O	O
.	O	O	O

In	O	O	B-T080
vitro	O	O	I-T080
,	O	O	O
R848	O	O	B-T109
induced	O	O	B-T061
production	O	O	O
of	O	O	O
IL-27	O	O	B-T116
by	O	O	O
murine	O	O	B-T015
alveolar	O	O	B-T025
macrophages	O	O	I-T025
and	O	O	O
dendritic	O	O	B-T025
cells	O	O	I-T025
and	O	O	O
enhanced	O	O	B-T052
expression	O	O	B-T045
of	O	O	O
programmed	O	O	B-T129
death-ligand	O	O	I-T129
1	O	O	I-T129
,	O	O	O
whose	O	O	O
expression	O	O	O
on	O	O	O
monocytes	O	O	B-T025
and	O	O	O
dendritic	O	O	O
cells	O	O	O
has	O	O	O
been	O	O	O
shown	O	O	O
to	O	O	O
regulate	O	O	B-T038
peripheral	O	O	B-T042
tolerance	O	O	I-T042
in	O	O	O
both	O	O	O
murine	O	O	O
and	O	O	O
human	O	O	B-T016
studies	O	O	O
.	O	O	O

Moreover	O	O	O
,	O	O	O
in	O	O	B-T080
vitro	O	O	I-T080
IL-27	O	O	B-T116
enhanced	O	O	B-T052
secretion	O	O	B-T043
of	O	O	O
IFN-Î³	O	O	B-T116
whereas	O	O	O
it	O	O	O
inhibited	O	O	B-T080
IL-5	O	O	B-T116
and	O	O	O
IL-13	O	O	B-T116
,	O	O	O
demonstrating	O	O	O
its	O	O	O
direct	O	O	O
effect	O	O	O
on	O	O	O
attenuating	O	O	O
Th2	O	O	B-T025
responses	O	O	O
.	O	O	O

Taken	O	O	O
together	O	O	O
,	O	O	O
our	O	O	O
study	O	O	O
proves	O	O	O
that	O	O	O
R848	O	O	B-T109
-mediated	O	O	O
suppression	O	O	B-T061
of	O	O	O
experimental	O	O	B-T080
asthma	O	O	B-T047
is	O	O	O
dependent	O	O	O
on	O	O	O
IL-27	O	O	B-T116
.	O	O	O

These	O	O	O
data	O	O	O
provide	O	O	O
evidence	O	O	O
of	O	O	O
a	O	O	O
central	O	O	O
role	O	O	O
of	O	O	O
IL-27	O	O	B-T116
for	O	O	O
the	O	O	O
control	O	O	O
of	O	O	O
Th2	O	O	B-T025
-mediated	O	O	O
allergic	O	O	B-T047
diseases	O	O	I-T047
.	O	O	O

-DOCSTART- (27799834)

A	O	O	O
comparison	O	O	O
of	O	O	O
functional	O	O	B-T169
outcomes	O	O	O
in	O	O	O
patients	O	O	B-T101
undergoing	O	O	O
revision	O	O	B-T061
arthroscopic	O	O	B-T082
repair	O	O	I-T061
of	O	O	O
massive	O	O	O
rotator	O	O	B-T047
cuff	O	O	I-T047
tears	O	O	I-T047
with	O	O	O
and	O	O	O
without	O	O	B-T080
arthroscopic	O	O	O
suprascapular	O	O	O
nerve	O	O	O
release	O	O	O

This	O	O	O
study	O	O	O
was	O	O	O
designed	O	O	O
to	O	O	O
compare	O	O	O
functional	O	O	B-T169
outcomes	O	O	O
in	O	O	O
patients	O	O	B-T101
undergoing	O	O	O
revision	O	O	B-T061
repair	O	O	I-T061
of	O	O	O
massive	O	O	O
rotator	O	O	B-T047
cuff	O	O	I-T047
tears	O	O	I-T047
(	O	O	O
retracted	O	O	B-T082
medial	O	O	I-T082
to	O	O	O
the	O	O	O
glenoid	O	O	B-T030
)	O	O	O
with	O	O	O
Goutallier	O	O	B-T046
Grade	O	O	I-T046
4	O	O	I-T046
atrophy	O	O	I-T046
and	O	O	O
concomitant	O	O	O
release	O	O	B-T061
of	O	O	I-T061
the	O	O	I-T061
suprascapular	O	O	I-T061
nerve	O	O	I-T061
to	O	O	O
a	O	O	O
similar	O	O	O
group	O	O	O
of	O	O	O
patients	O	O	O
with	O	O	O
Grade	O	O	B-T046
3	O	O	I-T046
atrophy	O	O	I-T046
undergoing	O	O	O
revision	O	O	B-T061
rotator	O	O	I-T061
cuff	O	O	I-T061
repair	O	O	I-T061
(	O	O	O
RTCR	O	O	B-T061
)	O	O	O
without	O	O	O
nerve	O	O	B-T061
release	O	O	I-T061
.	O	O	O

We	O	O	O
hypothesized	O	O	O
that	O	O	O
patients	O	O	B-T101
undergoing	O	O	O
nerve	O	O	B-T061
release	O	O	I-T061
would	O	O	O
have	O	O	O
more	O	O	O
favorable	O	O	O
functional	O	O	B-T169
outcomes	O	O	O
as	O	O	O
measured	O	O	O
by	O	O	O
the	O	O	O
Modified	O	O	O
University	O	O	B-T092
of	O	O	I-T092
California	O	O	I-T092
at	O	O	O
Los	O	O	B-T083
Angeles	O	O	I-T083
shoulder	O	O	B-T081
rating	O	O	I-T081
scale	O	O	I-T081
(	O	O	O
UCLA	O	O	B-T081
)	O	O	O
.	O	O	O

Twenty-two	O	O	O
patients	O	O	B-T101
underwent	O	O	O
revision	O	O	B-T061
repair	O	O	I-T061
of	O	O	O
massive	O	O	O
rotator	O	O	B-T047
cuff	O	O	I-T047
tears	O	O	I-T047
with	O	O	O
release	O	O	B-T061
of	O	O	I-T061
the	O	O	I-T061
suprascapular	O	O	I-T061
nerve	O	O	I-T061
at	O	O	O
the	O	O	O
suprascapular	O	O	B-T029
notch	O	O	I-T029
.	O	O	O

We	O	O	O
compared	O	O	O
total	O	O	O
preoperative	O	O	B-T079
,	O	O	O
postoperative	O	O	B-T079
,	O	O	O
and	O	O	O
change	O	O	O
in	O	O	O
UCLA	O	O	B-T080
score	O	O	I-T080
in	O	O	O
these	O	O	O
patients	O	O	B-T101
to	O	O	O
a	O	O	O
similar	O	O	O
group	O	O	B-T098
of	O	O	O
22	O	O	O
patients	O	O	O
undergoing	O	O	O
revision	O	O	B-T061
RTCR	O	O	I-T061
without	O	O	B-T080
suprascapular	O	O	B-T061
nerve	O	O	I-T061
release	O	O	I-T061
.	O	O	O

Additionally	O	O	O
,	O	O	O
UCLA	O	O	O
subscores	O	O	O
between	O	O	O
the	O	O	O
two	O	O	O
groups	O	O	B-T098
were	O	O	O
compared	O	O	O
preoperatively	O	O	B-T079
and	O	O	O
at	O	O	O
final	O	O	O
follow-up	O	O	B-T058
.	O	O	O

The	O	O	O
average	O	O	O
preoperative	O	O	B-T079
UCLA	O	O	B-T080
score	O	O	I-T080
in	O	O	O
the	O	O	O
nerve-release	O	O	B-T098
group	O	O	I-T098
was	O	O	O
7.91	O	O	O
,	O	O	O
and	O	O	O
final	O	O	O
follow-up	O	O	B-T058
average	O	O	O
was	O	O	O
27.86	O	O	O
;	O	O	O
average	O	O	O
3.05	O	O	O
grades	O	O	O
of	O	O	O
strength	O	O	O
were	O	O	O
recovered	O	O	O
.	O	O	O

In	O	O	O
the	O	O	O
comparison	O	O	O
group	O	O	B-T098
,	O	O	O
average	O	O	O
preoperative	O	O	B-T079
UCLA	O	O	B-T080
score	O	O	I-T080
was	O	O	O
11.77	O	O	O
,	O	O	O
and	O	O	O
final	O	O	O
follow-up	O	O	B-T058
average	O	O	O
was	O	O	O
29.09	O	O	O
;	O	O	O
average	O	O	O
1.32	O	O	O
grades	O	O	O
of	O	O	O
strength	O	O	O
were	O	O	O
recovered	O	O	O
.	O	O	O

The	O	O	O
average	O	O	O
preoperative	O	O	B-T079
UCLA	O	O	B-T080
score	O	O	I-T080
was	O	O	O
significantly	O	O	O
worse	O	O	O
in	O	O	O
the	O	O	O
nerve-release	O	O	B-T098
group	O	O	I-T098
(	O	O	O
P=0.007	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
average	O	O	O
postoperative	O	O	B-T079
UCLA	O	O	B-T080
score	O	O	I-T080
was	O	O	O
not	O	O	O
significantly	O	O	O
different	O	O	O
(	O	O	O
P=0.590	O	O	O
)	O	O	O
between	O	O	O
the	O	O	O
groups	O	O	B-T098
,	O	O	O
indicating	O	O	O
a	O	O	O
better	O	O	O
improvement	O	O	O
in	O	O	O
the	O	O	O
nerve-release	O	O	B-T098
group	O	O	I-T098
with	O	O	O
significantly	O	O	O
greater	O	O	O
improvement	O	O	O
in	O	O	O
active	O	O	O
forward	O	O	O
flexion	O	O	B-T042
,	O	O	O
strength	O	O	B-T042
,	O	O	O
and	O	O	O
pain	O	O	B-T061
relief	O	O	I-T061
.	O	O	O

Patients	O	O	B-T101
who	O	O	O
underwent	O	O	O
concomitant	O	O	O
release	O	O	B-T061
of	O	O	I-T061
the	O	O	I-T061
suprascapular	O	O	I-T061
nerve	O	O	I-T061
during	O	O	O
revision	O	O	B-T061
RTCR	O	O	I-T061
had	O	O	O
greater	O	O	O
overall	O	O	O
improvement	O	O	O
as	O	O	O
noted	O	O	O
in	O	O	O
pain	O	O	B-T061
relief	O	O	I-T061
,	O	O	O
active	O	O	B-T042
forward	O	O	I-T042
flexion	O	O	I-T042
,	O	O	O
and	O	O	O
strength	O	O	B-T042
,	O	O	O
than	O	O	O
a	O	O	O
comparable	O	O	O
group	O	O	B-T098
without	O	O	B-T080
nerve	O	O	B-T061
release	O	O	I-T061
.	O	O	O

-DOCSTART- (27801735)

Fading	O	O	B-T081
With	O	O	B-T079
Time	O	O	I-T079
of	O	O	O
PD-L1	O	O	B-T129
Immunoreactivity	O	O	B-T044
in	O	O	O
Non-Small	O	O	B-T191
Cells	O	O	I-T191
Lung	O	O	I-T191
Cancer	O	O	I-T191
Tissues	O	O	B-T024
:	O	O	O
A	O	O	O
Methodological	O	O	O
Study	O	O	O

Blockade	O	O	B-T169
of	O	O	O
inhibitory	O	O	B-T043
immune	O	O	I-T043
checkpoints	O	O	I-T043
is	O	O	O
currently	O	O	O
arising	O	O	O
as	O	O	O
a	O	O	O
potential	O	O	O
immunologic	O	O	B-T169
option	O	O	B-T169
for	O	O	O
tumor	O	O	B-T061
therapy	O	O	I-T061
.	O	O	O

Inhibition	O	O	B-T052
of	O	O	O
programmed	O	O	B-T116
cell	O	O	I-T116
death	O	O	I-T116
protein	O	O	I-T116
1	O	O	I-T116
and/or	O	O	O
its	O	O	O
specific	O	O	O
ligand	O	O	B-T103
programmed	O	O	B-T129
death-ligand	O	O	I-T129
1	O	O	I-T129
(	O	O	O
PD-L1	O	O	B-T129
)	O	O	O
was	O	O	O
effective	O	O	O
in	O	O	O
clinical	O	O	B-T062
trials	O	O	I-T062
in	O	O	O
advanced	O	O	B-T080
melanoma	O	O	B-T191
,	O	O	O
non-small	O	O	B-T191
cell	O	O	I-T191
lung	O	O	I-T191
cancer	O	O	I-T191
(	O	O	O
NSCLC	O	O	B-T191
)	O	O	O
bladder	O	O	B-T191
and	O	O	O
kidney	O	O	B-T191
cancer	O	O	I-T191
.	O	O	O

The	O	O	O
predictive	O	O	O
role	O	O	O
of	O	O	O
the	O	O	O
immunohistochemical	O	O	B-T059
(	O	O	O
IHC	O	O	B-T059
)	O	O	O
expression	O	O	B-T045
of	O	O	O
PD-L1	O	O	B-T129
is	O	O	O
highly	O	O	O
debated	O	O	O
.	O	O	O

Different	O	O	O
reagents	O	O	B-T130
,	O	O	O
clones	O	O	B-T024
,	O	O	O
cutoffs	O	O	O
of	O	O	O
cell	O	O	B-T025
expression	O	O	B-T045
and	O	O	O
subjective	O	O	B-T080
interpretation	O	O	B-T033
of	O	O	O
PD-L1	O	O	B-T129
immunoreactivity	O	O	B-T044
in	O	O	O
epithelial	O	O	B-T025
cells	O	O	I-T025
and	O	O	O
lymphocytes	O	O	B-T025
are	O	O	O
the	O	O	O
main	O	O	O
issue	O	O	B-T033
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	O
we	O	O	O
selected	O	O	O
58	O	O	O
consecutive	O	O	O
NSCLC	O	O	B-T191
surgical	O	O	B-T024
specimens	O	O	I-T024
that	O	O	O
underwent	O	O	O
pathologic	O	O	B-T060
examination	O	O	I-T060
from	O	O	O
January	O	O	B-T080
2014	O	O	O
to	O	O	O
July	O	O	B-T080
2015	O	O	O
.	O	O	O

Using	O	O	O
a	O	O	O
tissue	O	O	O
microarray	O	O	B-T059
approach	O	O	I-T059
we	O	O	O
evaluated	O	O	O
the	O	O	O
IHC	O	O	B-T059
expression	O	O	I-T059
of	O	O	O
PD-L1	O	O	B-T129
in	O	O	O
tumor-infiltrating	O	O	B-T025
lymphocytes	O	O	I-T025
and	O	O	O
tumor	O	O	B-T025
cells	O	O	I-T025
(	O	O	O
TCs	O	O	B-T025
)	O	O	O
and	O	O	O
compared	O	O	O
the	O	O	O
ICH	O	O	B-T059
staining	O	O	I-T059
with	O	O	O
tumor	O	O	B-T091
histology	O	O	I-T091
,	O	O	O
grade	O	O	B-T185
and	O	O	O
the	O	O	O
age	O	O	O
of	O	O	O
the	O	O	O
tissue	O	O	B-T024
blocks	O	O	I-T024
.	O	O	O

The	O	O	O
main	O	O	O
new	O	O	O
finding	O	O	B-T033
was	O	O	O
the	O	O	O
fading	O	O	B-T081
of	O	O	O
PD-L1	O	O	B-T129
IHC	O	O	B-T059
expression	O	O	I-T059
in	O	O	O
TCs	O	O	B-T025
in	O	O	O
tissues	O	O	B-T024
processed	O	O	O
in	O	O	O
2014	O	O	O
compared	O	O	O
with	O	O	O
2015	O	O	O
.	O	O	O

PD-L1	O	O	B-T129
expression	O	O	B-T045
in	O	O	O
tumor-infiltrating	O	O	B-T025
lymphocytes	O	O	I-T025
in	O	O	O
the	O	O	O
2	O	O	O
years	O	O	B-T079
was	O	O	O
similar	O	O	B-T080
.	O	O	O

We	O	O	O
also	O	O	O
found	O	O	O
a	O	O	O
significant	O	O	B-T080
higher	O	O	I-T080
immunoreactivity	O	O	B-T044
of	O	O	O
TCs	O	O	B-T025
in	O	O	O
high	O	O	B-T080
grade	O	O	I-T080
NSCLC	O	O	B-T191
and	O	O	O
in	O	O	O
the	O	O	O
squamous	O	O	B-T191
carcinoma	O	O	I-T191
histotype	O	O	B-T201
compared	O	O	O
with	O	O	O
low	O	O	B-T080
grade	O	O	I-T080
tumors	O	O	B-T091
and	O	O	O
the	O	O	O
adenocarcinoma	O	O	B-T191
histology	O	O	B-T091
(	O	O	O
P=0.013	O	O	O
)	O	O	O
.	O	O	O

We	O	O	O
demonstrated	O	O	O
that	O	O	O
the	O	O	O
IHC	O	O	B-T059
evaluation	O	O	I-T059
of	O	O	O
PD-L1	O	O	B-T129
in	O	O	O
NSCLC	O	O	B-T191
archival	O	O	B-T024
tissues	O	O	I-T024
is	O	O	O
feasible	O	O	O
and	O	O	O
can	O	O	O
be	O	O	O
implemented	O	O	O
in	O	O	O
a	O	O	O
routine	O	O	O
pathology	O	O	B-T091
setting	O	O	I-T091
,	O	O	O
but	O	O	O
it	O	O	O
should	O	O	O
be	O	O	O
carefully	O	O	O
assessed	O	O	O
in	O	O	O
tissue	O	O	B-T024
blocks	O	O	I-T024
older	O	O	O
than	O	O	O
1	O	O	O
year	O	O	B-T079
.	O	O	O

-DOCSTART- (27801889)

Differential	O	O	B-T080
transcriptome	O	O	B-T086
expression	O	O	B-T045
in	O	O	O
human	O	O	B-T016
nucleus	O	O	B-T023
accumbens	O	O	I-T023
as	O	O	O
a	O	O	O
function	O	O	O
of	O	O	O
loneliness	O	O	O

Loneliness	O	O	B-T033
is	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
impaired	O	O	B-T046
mental	O	O	B-T041
and	O	O	O
physical	O	O	B-T078
health	O	O	I-T078
.	O	O	O

Studies	O	O	O
of	O	O	O
lonely	O	O	B-T098
individuals	O	O	I-T098
reported	O	O	O
differential	O	O	B-T045
expression	O	O	I-T045
of	O	O	O
inflammatory	O	O	B-T169
genes	O	O	B-T028
in	O	O	O
peripheral	O	O	B-T082
leukocytes	O	O	B-T025
and	O	O	O
diminished	O	O	B-T081
activation	O	O	B-T045
in	O	O	O
brain	O	O	B-T023
reward	O	O	B-T029
regions	O	O	I-T029
such	O	O	O
as	O	O	O
nucleus	O	O	B-T023
accumbens	O	O	I-T023
,	O	O	O
but	O	O	O
could	O	O	O
not	O	O	O
address	O	O	O
gene	O	O	B-T045
expression	O	O	I-T045
in	O	O	O
the	O	O	O
human	O	O	B-T016
brain	O	O	O
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
examined	O	O	O
genome-wide	O	O	B-T045
RNA	O	O	I-T045
expression	O	O	I-T045
in	O	O	O
post-mortem	O	O	B-T060
nucleus	O	O	B-T023
accumbens	O	O	I-T023
from	O	O	O
donors	O	O	B-T098
(	O	O	O
N=26	O	O	O
)	O	O	O
with	O	O	O
known	O	O	O
loneliness	O	O	B-T033
measures	O	O	B-T081
.	O	O	O

Loneliness	O	O	B-T033
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
1710	O	O	O
differentially	O	O	B-T114
expressed	O	O	I-T114
transcripts	O	O	I-T114
and	O	O	O
genes	O	O	B-T028
from	O	O	O
1599	O	O	O
genes	O	O	O
(	O	O	O
DEGs	O	O	B-T028
;	O	O	O
false	O	O	B-T081
discovery	O	O	I-T081
rate	O	O	I-T081
P<0.05	O	O	O
,	O	O	O
fold	O	O	O
change	O	O	O
â©¾|2|	O	O	O
,	O	O	O
controlling	O	O	O
for	O	O	O
confounds	O	O	O
)	O	O	O
previously	O	O	O
associated	O	O	O
with	O	O	O
behavioral	O	O	B-T053
processes	O	O	I-T053
,	O	O	O
neurological	O	O	B-T047
disease	O	O	I-T047
,	O	O	O
psychological	O	O	B-T048
disorders	O	O	I-T048
,	O	O	O
cancer	O	O	B-T191
,	O	O	O
organismal	O	O	B-T001
injury	O	O	B-T037
and	O	O	O
skeletal	O	O	B-T047
and	O	O	O
muscular	O	O	B-T047
disorders	O	O	I-T047
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
networks	O	O	B-T169
of	O	O	O
upstream	O	O	B-T082
RNA	O	O	B-T028
regulators	O	O	I-T028
.	O	O	O

Furthermore	O	O	O
,	O	O	O
a	O	O	O
number	O	O	O
of	O	O	O
DEGs	O	O	B-T028
were	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
Alzheimer	O	O	B-T047
's	O	O	I-T047
disease	O	O	I-T047
(	O	O	O
AD	O	O	B-T047
)	O	O	O
genes	O	O	B-T028
(	O	O	O
that	O	O	O
was	O	O	O
correlated	O	O	B-T080
with	O	O	O
loneliness	O	O	B-T033
in	O	O	O
this	O	O	O
sample	O	O	B-T167
,	O	O	O
although	O	O	O
gene	O	O	B-T063
expression	O	O	I-T063
analyses	O	O	I-T063
controlled	O	O	O
for	O	O	O
AD	O	O	O
diagnosis	O	O	B-T033
)	O	O	O
.	O	O	O

These	O	O	O
results	O	O	O
identify	O	O	O
novel	O	O	O
targets	O	O	B-T169
for	O	O	O
future	O	O	O
mechanistic	O	O	B-T062
studies	O	O	I-T062
of	O	O	O
gene	O	O	B-T028
networks	O	O	O
in	O	O	O
nucleus	O	O	B-T023
accumbens	O	O	I-T023
and	O	O	O
gene	O	O	B-T045
regulatory	O	O	I-T045
mechanisms	O	O	I-T045
across	O	O	O
a	O	O	O
variety	O	O	O
of	O	O	O
diseases	O	O	B-T047
exacerbated	O	O	O
by	O	O	O
loneliness	O	O	B-T033
.	O	O	O

Molecular	O	O	B-T073
Psychiatry	O	O	I-T073
advance	O	O	I-T073
online	O	O	I-T073
publication	O	O	I-T073
,	O	O	O
1	O	O	O
November	O	O	B-T079
2016	O	O	O
;	O	O	O
doi:10.1038/mp.2016.186	O	O	O
.	O	O	O

-DOCSTART- (27802570)

Overall	O	O	O
Quality	O	O	B-T080
Properties	O	O	I-T080
of	O	O	O
Kiwifruit	O	O	B-T168
Treated	O	O	B-T061
by	O	O	I-T061
Cinnamaldehyde	O	O	B-T109
and	O	O	O
Citral	O	O	B-T109
:	O	O	O
Microbial	O	O	B-T001
,	O	O	O
Antioxidant	O	O	B-T044
Capacity	O	O	I-T044
during	O	O	O
Cold	O	O	O
Storage	O	O	O

This	O	O	O
work	O	O	O
was	O	O	O
undertaken	O	O	O
to	O	O	O
evaluate	O	O	B-T058
the	O	O	O
microbiological	O	O	B-T170
characteristics	O	O	B-T080
and	O	O	O
antioxidant	O	O	B-T044
and	O	O	O
physiological	O	O	B-T039
activities	O	O	I-T039
in	O	O	O
kiwifruits	O	O	B-T168
(	O	O	O
Actinida	O	O	B-T002
deliciosa	O	O	I-T002
var	O	O	O
.	O	O	O

Qinmei	O	O	O
)	O	O	O
with/without	O	O	O
cinnamaldehyde	O	O	B-T109
(	O	O	O
C1	O	O	O
)	O	O	O
and	O	O	O
citral	O	O	B-T109
(	O	O	O
C2	O	O	O
)	O	O	O
fumigation	O	O	B-T068
treatments	O	O	B-T169
(	O	O	O
5	O	O	O
Î¼L/L	O	O	O
)	O	O	O
during	O	O	O
0	O	O	O
,	O	O	O
3	O	O	O
,	O	O	O
6	O	O	O
,	O	O	O
9	O	O	O
,	O	O	O
and	O	O	O
12	O	O	O
d	O	O	O
of	O	O	O
storage	O	O	B-T169
at	O	O	O
4	O	O	O
Â°	O	O	O
C	O	O	O
.	O	O	O

Essential	O	O	B-T109
oils	O	O	I-T109
(	O	O	O
EOs	O	O	B-T109
)	O	O	O
treatment	O	O	B-T169
lowered	O	O	O
the	O	O	O
total	O	O	O
viable	O	O	B-T081
counts	O	O	I-T081
,	O	O	O
yeast	O	O	B-T004
,	O	O	O
and	O	O	O
mold	O	O	B-T004
to	O	O	O
1.54	O	O	O
,	O	O	O
2.36	O	O	O
,	O	O	O
and	O	O	O
2.05	O	O	O
log	O	O	O
CFU/g	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

Moreover	O	O	O
,	O	O	O
EOs	O	O	B-T109
improved	O	O	O
the	O	O	O
antioxidant	O	O	B-T044
activities	O	O	I-T044
of	O	O	O
kiwifruit	O	O	B-T168
.	O	O	O

They	O	O	O
enhanced	O	O	B-T052
phenolics	O	O	B-T109
and	O	O	O
flavonoids	O	O	B-T109
content	O	O	O
in	O	O	O
fruit	O	O	B-T168
tissue	O	O	B-T025
by	O	O	O
49.48	O	O	O
%	O	O	O
at	O	O	O
day	O	O	O
3	O	O	O
and	O	O	O
56.93	O	O	O
%	O	O	O
at	O	O	O
day	O	O	O
6	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
ascorbic	O	O	B-T127
acid	O	O	I-T127
in	O	O	O
treated	O	O	B-T169
groups	O	O	B-T078
had	O	O	O
the	O	O	O
lower	O	O	O
losing	O	O	O
rate	O	O	B-T081
.	O	O	O

Similarly	O	O	O
,	O	O	O
MDA	O	O	B-T109
(	O	O	O
malondialdehyde	O	O	B-T109
)	O	O	O
,	O	O	O
H2	O	O	B-T121
O2	O	O	I-T121
(	O	O	O
hydrogen	O	O	B-T121
peroxide	O	O	I-T121
)	O	O	O
,	O	O	O
and	O	O	O
(	O	O	O
â¢	O	O	O
)	O	O	O
O2(-	O	O	B-T196
)	O	O	I-T196
(	O	O	O
superoxide	O	O	B-T196
anion	O	O	I-T196
)	O	O	O
production	O	O	O
were	O	O	O
effectively	O	O	B-T080
decreased	O	O	B-T081
in	O	O	O
the	O	O	O
range	O	O	O
of	O	O	O
27.27	O	O	O
%	O	O	O
to	O	O	O
54.38	O	O	O
%	O	O	O
.	O	O	O

Physicochemical	O	O	B-T080
characteristics	O	O	I-T080
showed	O	O	O
that	O	O	O
kiwifruits	O	O	B-T168
from	O	O	O
treated	O	O	B-T169
group	O	O	B-T078
maintained	O	O	O
higher	O	O	O
levels	O	O	O
of	O	O	O
flesh	O	O	B-T080
luminosity	O	O	I-T080
and	O	O	O
firmness	O	O	B-T080
.	O	O	O

EOs	O	O	B-T109
also	O	O	O
decreased	O	O	B-T081
the	O	O	O
levels	O	O	O
of	O	O	O
reducing	O	O	B-T109
sugar	O	O	I-T109
by	O	O	O
45.97	O	O	O
%	O	O	O
at	O	O	O
day	O	O	O
3	O	O	O
,	O	O	O
and	O	O	O
increased	O	O	B-T081
the	O	O	O
content	O	O	O
of	O	O	O
soluble	O	O	B-T116
protein	O	O	I-T116
and	O	O	O
hydrolyzed	O	O	O
amino	O	O	B-T116
acid	O	O	I-T116
.	O	O	O

Therefore	O	O	O
,	O	O	O
postharvest	O	O	O
EOs	O	O	B-T109
treatment	O	O	B-T169
has	O	O	O
positive	O	O	B-T080
effects	O	O	I-T080
on	O	O	O
delaying	O	O	O
senescence	O	O	B-T038
and	O	O	O
enhancing	O	O	B-T052
antioxidant	O	O	B-T044
capacities	O	O	I-T044
in	O	O	O
kiwifruit	O	O	B-T168
.	O	O	O

-DOCSTART- (27803787)

Anti-inflammatory	O	O	B-T080
effect	O	O	I-T080
of	O	O	O
Yu-Ping-Feng-San	O	O	B-T109
via	O	O	O
TGF-Î²1	O	O	B-T116
signaling	O	O	B-T038
suppression	O	O	I-T038
in	O	O	O
rat	O	O	B-T015
model	O	O	B-T050
of	O	O	O
COPD	O	O	O

Yu-Ping-Feng-San	O	O	B-T109
(	O	O	O
YPFS	O	O	B-T109
)	O	O	O
is	O	O	O
a	O	O	O
classical	O	O	O
traditional	O	O	O
Chinese	O	O	B-T121
medicine	O	O	I-T121
that	O	O	O
is	O	O	O
widely	O	O	O
used	O	O	O
for	O	O	O
treatment	O	O	B-T169
of	O	O	O
the	O	O	O
diseases	O	O	B-T047
in	O	O	O
respiratory	O	O	B-T022
systems	O	O	I-T022
,	O	O	O
including	O	O	O
chronic	O	O	B-T047
obstructive	O	O	I-T047
pulmonary	O	O	I-T047
disease	O	O	I-T047
(	O	O	O
COPD	O	O	B-T047
)	O	O	O
recognized	O	O	O
as	O	O	O
chronic	O	O	B-T047
inflammatory	O	O	I-T047
disease	O	O	I-T047
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
molecular	O	O	B-T044
mechanism	O	O	I-T044
remains	O	O	O
unclear	O	O	O
.	O	O	O

Here	O	O	O
we	O	O	O
detected	O	O	O
the	O	O	O
factors	O	O	O
involved	O	O	O
in	O	O	O
transforming	O	O	B-T116
growth	O	O	I-T116
factor	O	O	I-T116
beta	O	O	I-T116
1	O	O	I-T116
(TGF-Î²1)/	O	O	O
Smad2	O	O	B-T116
signaling	O	O	B-T038
pathway	O	O	I-T044
and	O	O	O
inflammatory	O	O	B-T116
cytokines	O	O	I-T116
,	O	O	O
to	O	O	O
clarify	O	O	O
whether	O	O	O
YPFS	O	O	B-T109
could	O	O	O
attenuate	O	O	B-T052
inflammatory	O	O	B-T046
response	O	O	I-T046
dependent	O	O	O
on	O	O	O
TGF-Î²1	O	O	B-T116
/	O	O	O
Smad2	O	O	O
signaling	O	O	O
in	O	O	O
COPD	O	O	B-T047
rats	O	O	B-T015
or	O	O	O
cigarette	O	O	B-T131
smoke	O	O	I-T131
extract	O	O	I-T131
(CSE)-	O	O	O
treated	O	O	B-T169
human	O	O	B-T016
bronchial	O	O	B-T025
epithelial	O	O	I-T025
(	O	O	I-T025
Beas-2B	O	O	I-T025
)	O	O	I-T025
cells	O	O	I-T025
.	O	O	O

The	O	O	O
COPD	O	O	B-T047
rat	O	O	B-T015
model	O	O	B-T050
was	O	O	O
established	O	O	O
by	O	O	O
exposure	O	O	B-T080
to	O	O	O
cigarette	O	O	B-T131
smoke	O	O	I-T131
and	O	O	O
intratracheal	O	O	B-T169
instillation	O	O	I-T169
of	O	O	O
lipopolysaccharide	O	O	B-T109
,	O	O	O
YPFS	O	O	B-T109
was	O	O	O
administered	O	O	O
to	O	O	O
the	O	O	O
animals	O	O	B-T008
.	O	O	O

The	O	O	O
efficacy	O	O	B-T080
of	O	O	O
YPFS	O	O	B-T109
was	O	O	O
evaluated	O	O	O
by	O	O	O
comparing	O	O	O
the	O	O	O
severity	O	O	B-T080
of	O	O	O
pulmonary	O	O	B-T046
pathological	O	O	I-T046
damage	O	O	I-T046
,	O	O	O
pro-inflammation	O	O	B-T116
cytokines	O	O	I-T116
,	O	O	O
collagen	O	O	B-T028
related	O	O	I-T028
genes	O	O	I-T028
and	O	O	O
the	O	O	O
activation	O	O	B-T052
of	O	O	O
TGF-Î²1	O	O	B-T116
/	O	O	O
Smad2	O	O	B-T116
signaling	O	O	B-T044
pathway	O	O	I-T044
.	O	O	O

Furthermore	O	O	O
,	O	O	O
CSE	O	O	B-T131
-	O	O	O
treated	O	O	B-T169
cells	O	O	B-T025
were	O	O	O
employed	O	O	O
to	O	O	O
confirm	O	O	O
whether	O	O	O
the	O	O	O
effect	O	O	B-T080
of	O	O	O
YPFS	O	O	B-T109
was	O	O	O
dependent	O	O	O
on	O	O	O
the	O	O	O
TGF-Î²1	O	O	B-T116
/	O	O	O
Smad2	O	O	B-T116
signaling	O	O	B-T038
via	O	O	O
knockdown	O	O	B-T063
Smad2	O	O	O
(	O	O	O
Si-RNA	O	O	B-T114
)	O	O	O
,	O	O	O
or	O	O	O
pretreatment	O	O	B-T052
with	O	O	O
the	O	O	O
inhibitor	O	O	B-T080
of	O	O	O
TGF-Î²1	O	O	O
.	O	O	O

Administration	O	O	O
of	O	O	O
YPFS	O	O	B-T109
effectively	O	O	O
alleviated	O	O	O
injury	O	O	B-T037
of	O	O	I-T037
lung	O	O	I-T037
,	O	O	O
suppressed	O	O	B-T169
releasing	O	O	O
of	O	O	O
pro-inflammatory	O	O	B-T116
cytokines	O	O	I-T116
and	O	O	O
collagen	O	O	B-T046
deposition	O	O	I-T046
in	O	O	O
COPD	O	O	B-T047
animals	O	O	B-T008
(	O	O	O
P<0.05	O	O	O
)	O	O	O
,	O	O	O
whereas	O	O	O
exogenous	O	O	B-T116
TGF-Î²1	O	O	I-T116
promoted	O	O	O
releasing	O	O	O
of	O	O	O
IL-1Î²	O	O	B-T116
,	O	O	O
IL-6	O	O	B-T116
,	O	O	O
TNFÎ±	O	O	B-T116
(	O	O	O
P<0.05	O	O	O
)	O	O	O
.	O	O	O

Administration	O	O	O
YPFS	O	O	B-T109
reduced	O	O	O
inflammatory	O	O	B-T046
response	O	O	I-T046
significantly	O	O	O
,	O	O	O
also	O	O	O
down-regulated	O	O	B-T044
TGF-Î²1	O	O	B-T116
/	O	O	O
Smad2	O	O	B-T116
signaling	O	O	B-T038
in	O	O	B-T082
vivo	O	O	I-T082
and	O	O	O
in	O	O	B-T080
vitro	O	O	I-T080
.	O	O	O

Unexpectedly	O	O	O
,	O	O	O
knockdown	O	O	B-T063
Smad2	O	O	B-T028
or	O	O	O
inhibition	O	O	B-T052
of	O	O	O
TGF-Î²1	O	O	B-T116
abolished	O	O	O
anti-inflammatory	O	O	B-T080
effect	O	O	I-T080
of	O	O	O
YPFS	O	O	B-T109
in	O	O	O
CSE	O	O	B-T131
-	O	O	O
treated	O	O	B-T169
cells	O	O	B-T025
.	O	O	O

YPFS	O	O	B-T109
accomplished	O	O	O
anti-inflammatory	O	O	B-T080
effects	O	O	I-T080
mainly	O	O	O
by	O	O	O
suppressing	O	O	B-T169
phosphorylation	O	O	B-T044
of	O	O	O
Smad2	O	O	B-T116
,	O	O	O
TGF-Î²1	O	O	B-T116
/	O	O	O
Smad2	O	O	O
signaling	O	O	B-T044
pathway	O	O	I-T044
was	O	O	O
required	O	O	O
for	O	O	O
YPFS	O	O	O
-mediated	O	O	O
anti-inflammation	O	O	B-T080
in	O	O	O
COPD	O	O	B-T047
rats	O	O	B-T015
or	O	O	O
CSE	O	O	B-T131
-	O	O	O
treated	O	O	B-T169
Beas-2B	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

-DOCSTART- (27806658)

The	O	O	O
association	O	O	B-T080
between	O	O	O
maternal	O	O	B-T033
hydronephrosis	O	O	B-T047
and	O	O	O
acute	O	O	B-T079
flank	O	O	B-T184
pain	O	O	I-T184
during	O	O	O
pregnancy	O	O	B-T040
:	O	O	O
a	O	O	O
prospective	O	O	B-T062
pilot-study	O	O	O

Maternal	O	O	B-T033
hydronephrosis	O	O	B-T047
may	O	O	O
cause	O	O	O
flank	O	O	B-T184
pain	O	O	I-T184
during	O	O	O
pregnancy	O	O	B-T040
.	O	O	O

We	O	O	O
aimed	O	O	B-T078
to	O	O	O
investigate	O	O	B-T169
the	O	O	O
association	O	O	O
between	O	O	O
maternal	O	O	B-T033
hydronephrosis	O	O	B-T047
and	O	O	O
flank	O	O	B-T184
pain	O	O	I-T184
intensity	O	O	B-T201
.	O	O	O

From	O	O	O
2014	O	O	O
to	O	O	O
2015	O	O	O
,	O	O	O
all	O	O	O
consecutive	O	O	B-T080
women	O	O	B-T098
with	O	O	O
singleton	O	O	B-T040
pregnancies	O	O	I-T040
,	O	O	O
who	O	O	O
presented	O	O	O
at	O	O	O
our	O	O	O
tertiary	O	O	O
center	O	O	O
due	O	O	O
to	O	O	O
acute	O	O	B-T079
flank	O	O	B-T184
pain	O	O	B-T184
,	O	O	O
were	O	O	O
prospectively	O	O	B-T062
evaluated	O	O	B-T058
by	O	O	O
renal	O	O	B-T023
ultrasonography	O	O	B-T060
and	O	O	O
pain	O	O	O
questionnaires	O	O	B-T170
.	O	O	O

A	O	O	O
visual	O	O	B-T060
analogue	O	O	I-T060
scale	O	O	I-T060
was	O	O	O
used	O	O	O
to	O	O	O
assess	O	O	O
pain	O	O	B-T201
intensity	O	O	I-T201
.	O	O	O

The	O	O	O
study	O	O	B-T062
had	O	O	O
90	O	O	O
%	O	O	O
power	O	O	O
to	O	O	O
detect	O	O	O
a	O	O	O
significant	O	O	B-T078
correlation	O	O	B-T080
between	O	O	O
hydronephrosis	O	O	B-T047
and	O	O	O
flank	O	O	B-T184
pain	O	O	I-T184
(	O	O	O
Spearman	O	O	B-T170
's	O	O	I-T170
test	O	O	I-T170
)	O	O	O
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
51	O	O	O
consecutive	O	O	B-T080
women	O	O	B-T098
with	O	O	O
left-sided	O	O	B-T082
(	O	O	O
13.7	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
right-sided	O	O	B-T082
(	O	O	O
64.7	O	O	O
%	O	O	O
)	O	O	O
or	O	O	O
bilateral	O	O	B-T082
(	O	O	O
21.6	O	O	O
%	O	O	O
)	O	O	O
pain	O	O	B-T184
were	O	O	O
enrolled	O	O	O
.	O	O	O

The	O	O	O
mean	O	O	B-T081
gestational	O	O	B-T032
age	O	O	I-T032
of	O	O	O
these	O	O	O
women	O	O	B-T098
,	O	O	O
who	O	O	O
presented	O	O	O
due	O	O	O
to	O	O	O
their	O	O	O
pain	O	O	B-T184
,	O	O	O
was	O	O	O
27.5	O	O	O
Â±	O	O	O
6.8	O	O	O
weeks	O	O	B-T079
at	O	O	O
the	O	O	O
time	O	O	O
of	O	O	O
consultation	O	O	B-T058
.	O	O	O

The	O	O	O
mean	O	O	B-T081
VAS	O	O	B-T201
score	O	O	I-T201
was	O	O	O
7.6	O	O	O
Â±	O	O	O
2.2	O	O	O
.	O	O	O

In	O	O	O
43/51	O	O	O
(	O	O	O
84.3	O	O	O
%	O	O	O
)	O	O	O
women	O	O	B-T098
,	O	O	O
hydronephrosis	O	O	B-T047
was	O	O	O
found	O	O	O
on	O	O	O
renal	O	O	B-T023
sonograms	O	O	O
.	O	O	O

No	O	O	O
correlation	O	O	B-T080
was	O	O	O
found	O	O	O
between	O	O	O
the	O	O	O
grade	O	O	O
of	O	O	O
hydronephrosis	O	O	B-T047
and	O	O	O
pain	O	O	B-T201
intensity	O	O	I-T201
(	O	O	O
p	O	O	O
=	O	O	O
0.466	O	O	O
;	O	O	O
r=	O	O	O
-0.28	O	O	O
)	O	O	O
.	O	O	O

Women	O	O	B-T098
delivered	O	O	O
at	O	O	O
a	O	O	O
mean	O	O	B-T081
gestational	O	O	B-T032
age	O	O	I-T032
of	O	O	O
38.1	O	O	O
Â±	O	O	O
2.4	O	O	O
weeks	O	O	B-T079
and	O	O	O
their	O	O	O
infants	O	O	B-T100
had	O	O	O
a	O	O	O
mean	O	O	O
birthweight	O	O	B-T032
of	O	O	O
3138	O	O	O
Â±	O	O	O
677	O	O	O
g.	O	O	O
Hydronephrosis	O	O	B-T047
is	O	O	O
a	O	O	O
common	O	O	O
finding	O	O	B-T033
among	O	O	O
pregnant	O	O	B-T098
women	O	O	I-T098
with	O	O	O
acute	O	O	B-T079
flank	O	O	B-T184
pain	O	O	I-T184
.	O	O	O

The	O	O	O
grade	O	O	O
of	O	O	O
hydronephrosis	O	O	B-T047
does	O	O	O
not	O	O	O
affect	O	O	O
pain	O	O	B-T201
intensity	O	O	I-T201
.	O	O	O

This	O	O	O
study	O	O	B-T062
suggests	O	O	O
normal	O	O	B-T033
pregnancy	O	O	I-T033
outcomes	O	O	B-T033
in	O	O	O
these	O	O	O
women	O	O	B-T098
.	O	O	O

-DOCSTART- (27806921)

Simulating	O	O	B-T062
the	O	O	O
potential	O	O	B-T080
role	O	O	B-T077
of	O	O	O
media	O	O	B-T057
coverage	O	O	I-T057
and	O	O	O
infected	O	O	B-T033
bats	O	O	B-T015
in	O	O	O
the	O	O	O
2014	O	O	O
Ebola	O	O	B-T047
outbreak	O	O	O

Multiple	O	O	O
epidemiological	O	O	B-T169
models	O	O	B-T075
have	O	O	O
been	O	O	O
developed	O	O	B-T169
to	O	O	O
model	O	O	O
the	O	O	O
transmission	O	O	B-T078
dynamics	O	O	I-T078
of	O	O	O
Ebola	O	O	B-T047
virus	O	O	I-T047
(	O	O	I-T047
EBOV	O	O	I-T047
)	O	O	I-T047
disease	O	O	I-T047
in	O	O	O
West	O	O	B-T083
Africa	O	O	I-T083
in	O	O	O
2014	O	O	O
because	O	O	O
the	O	O	O
severity	O	O	B-T080
of	O	O	O
the	O	O	O
epidemic	O	O	B-T067
is	O	O	O
commonly	O	O	O
overestimated	O	O	O
.	O	O	O

A	O	O	O
compartmental	O	O	B-T170
model	O	O	I-T170
that	O	O	O
incorporates	O	O	O
the	O	O	O
media	O	O	B-T080
impact	O	O	I-T080
and	O	O	O
the	O	O	O
effect	O	O	B-T080
of	O	O	O
infected	O	O	B-T033
bats	O	O	B-T015
was	O	O	O
constructed	O	O	O
and	O	O	O
calibrated	O	O	B-T081
using	O	O	O
data	O	O	B-T078
reported	O	O	O
until	O	O	O
the	O	O	O
end	O	O	O
of	O	O	O
2014	O	O	O
.	O	O	O

The	O	O	O
final	O	O	O
cumulative	O	O	B-T080
number	O	O	B-T081
of	O	O	I-T081
deaths	O	O	I-T081
and	O	O	O
confirmed	O	O	B-T033
cases	O	O	B-T077
were	O	O	O
estimated	O	O	B-T081
to	O	O	O
be	O	O	O
1.0921	O	O	O
Ã	O	O	O
10(4	O	O	O
)	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
9.7706	O	O	O
Ã	O	O	O
10(3)-1.2072	O	O	O
Ã	O	O	O
10(4	O	O	O
)	O	O	O
)	O	O	O
and	O	O	O
1.5193	O	O	O
Ã	O	O	O
10(4	O	O	O
)	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
1.3593	O	O	O
Ã	O	O	O
10(4)-1.6795	O	O	O
Ã	O	O	O
10(4	O	O	O
)	O	O	O
)	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

The	O	O	O
epidemic	O	O	B-T067
was	O	O	O
estimated	O	O	B-T081
to	O	O	O
end	O	O	O
on	O	O	O
June	O	O	O
2015	O	O	O
,	O	O	O
which	O	O	O
was	O	O	O
similar	O	O	B-T080
to	O	O	O
the	O	O	O
data	O	O	B-T078
reported	O	O	B-T058
by	O	O	O
the	O	O	O
World	O	O	B-T093
Health	O	O	I-T093
Organization	O	O	I-T093
.	O	O	O

A	O	O	O
sensitivity	O	O	B-T062
analysis	O	O	I-T062
indicated	O	O	B-T033
that	O	O	O
an	O	O	O
increase	O	O	B-T169
of	O	O	O
either	O	O	O
the	O	O	O
media	O	O	B-T080
impact	O	O	I-T080
or	O	O	O
the	O	O	O
number	O	O	B-T081
of	O	O	O
infectious	O	O	B-T080
bats	O	O	B-T015
that	O	O	O
are	O	O	O
captured	O	O	O
daily	O	O	B-T079
can	O	O	O
increase	O	O	O
the	O	O	O
cumulative	O	O	B-T080
number	O	O	O
of	O	O	O
confirmed	O	O	B-T033
cases	O	O	B-T077
/	O	O	O
deaths	O	O	B-T081
.	O	O	O

Of	O	O	O
the	O	O	O
considered	O	O	O
epidemiological	O	O	B-T169
parameters	O	O	I-T169
,	O	O	O
only	O	O	O
the	O	O	O
media	O	O	B-T057
coverage	O	O	I-T057
can	O	O	O
significantly	O	O	O
reduce	O	O	O
both	O	O	O
the	O	O	O
peak	O	O	B-T033
time	O	O	I-T033
and	O	O	O
the	O	O	O
value	O	O	B-T081
of	O	O	O
the	O	O	O
cumulative	O	O	B-T080
confirmed	O	O	B-T033
cases	O	O	B-T077
/	O	O	O
deaths	O	O	B-T081
.	O	O	O

Thus	O	O	O
,	O	O	O
we	O	O	O
propose	O	O	O
'	O	O	O
the	O	O	O
cumulative	O	O	B-T080
confirmed	O	O	B-T033
cases	O	O	B-T077
and	O	O	O
deaths	O	O	B-T081
'	O	O	O
as	O	O	O
another	O	O	O
media	O	O	B-T170
mechanism	O	O	B-T169
.	O	O	O

In	O	O	O
conclusion	O	O	O
,	O	O	O
the	O	O	O
media	O	O	B-T080
impact	O	O	I-T080
contributed	O	O	O
to	O	O	O
the	O	O	O
control	O	O	B-T080
of	O	O	O
the	O	O	O
2014	O	O	O
Ebola	O	O	B-T047
outbreak	O	O	B-T067
,	O	O	O
and	O	O	O
infectious	O	O	B-T080
bats	O	O	B-T015
may	O	O	O
be	O	O	O
a	O	O	O
potential	O	O	B-T080
source	O	O	B-T033
of	O	O	O
the	O	O	O
epidemic	O	O	B-T067
.	O	O	O

-DOCSTART- (27810802)

Body	O	O	B-T016
Diffusion	O	O	B-T060
Weighted	O	O	I-T060
Imaging	O	O	I-T060
Using	O	O	O
Non-CPMG	O	O	O
Fast	O	O	O
Spin	O	O	O
Echo	O	O	O

SS-FSE	O	O	B-T060
is	O	O	O
a	O	O	O
fast	O	O	B-T080
technique	O	O	B-T060
that	O	O	O
does	O	O	O
not	O	O	O
suffer	O	O	O
from	O	O	O
off-resonance	O	O	B-T033
distortions	O	O	B-T080
to	O	O	O
the	O	O	O
degree	O	O	O
that	O	O	O
EPI	O	O	B-T060
does	O	O	O
.	O	O	O

Unlike	O	O	O
EPI	O	O	B-T060
,	O	O	O
SS-FSE	O	O	B-T060
is	O	O	O
ill-suited	O	O	O
to	O	O	O
diffusion	O	O	B-T060
weighted	O	O	I-T060
imaging	O	O	I-T060
(	O	O	O
DWI	O	O	B-T060
)	O	O	O
due	O	O	O
to	O	O	O
the	O	O	O
Carr-Purcell-Meiboom-Geill	O	O	B-T033
(	O	O	I-T033
CPMG	O	O	I-T033
)	O	O	I-T033
condition	O	O	I-T033
.	O	O	O

Non-CPMG	O	O	B-T033
phase	O	O	B-T079
cycling	O	O	B-T079
does	O	O	O
accommodate	O	O	O
SS-FSE	O	O	B-T060
and	O	O	O
DWI	O	O	B-T060
but	O	O	O
places	O	O	B-T082
constraints	O	O	B-T169
on	O	O	O
reconstruction	O	O	B-T169
,	O	O	O
which	O	O	O
are	O	O	O
resolved	O	O	B-T033
here	O	O	O
through	O	O	O
parallel	O	O	B-T060
imaging	O	O	I-T060
.	O	O	O

Additionally	O	O	O
,	O	O	O
improved	O	O	B-T033
echo	O	O	B-T080
stability	O	O	I-T080
can	O	O	O
be	O	O	O
achieved	O	O	O
by	O	O	O
using	O	O	O
short	O	O	B-T080
duration	O	O	I-T080
and	O	O	O
highly	O	O	O
selective	O	O	O
DIVERSE	O	O	B-T080
radiofrequency	O	O	B-T070
pulses	O	O	B-T067
.	O	O	O

Here	O	O	O
,	O	O	O
signal-to-noise	O	O	B-T081
ratio	O	O	I-T081
(	O	O	O
SNR	O	O	B-T081
)	O	O	O
comparisons	O	O	O
between	O	O	O
EPI	O	O	B-T060
and	O	O	O
nCPMG	O	O	B-T033
SS-FSE	O	O	B-T060
acquisitions	O	O	B-T066
and	O	O	O
reconstruction	O	O	B-T169
techniques	O	O	I-T169
give	O	O	O
similar	O	O	B-T080
values	O	O	B-T080
.	O	O	O

Diffusion	O	O	B-T060
imaging	O	O	I-T060
with	O	O	O
nCPMG	O	O	B-T033
SS-FSE	O	O	B-T060
gives	O	O	O
similar	O	O	B-T080
SNR	O	O	B-T081
to	O	O	O
an	O	O	O
EPI	O	O	B-T060
acquisition	O	O	B-T066
,	O	O	O
though	O	O	O
apparent	O	O	B-T077
diffusion	O	O	I-T077
coefficient	O	O	I-T077
values	O	O	B-T080
are	O	O	O
higher	O	O	B-T080
than	O	O	O
seen	O	O	O
with	O	O	O
EPI	O	O	O
.	O	O	O

In	O	O	B-T082
vivo	O	O	I-T082
images	O	O	B-T170
have	O	O	O
good	O	O	O
image	O	O	B-T080
quality	O	O	I-T080
with	O	O	O
little	O	O	O
distortion	O	O	B-T080
.	O	O	O

This	O	O	O
method	O	O	O
has	O	O	O
the	O	O	O
ability	O	O	O
to	O	O	O
capture	O	O	O
distortion	O	O	B-T080
-	O	O	O
free	O	O	B-T169
DWI	O	O	B-T060
images	O	O	B-T170
near	O	O	O
areas	O	O	B-T082
of	O	O	O
significant	O	O	B-T078
off-resonance	O	O	B-T033
as	O	O	O
well	O	O	O
as	O	O	O
preserve	O	O	O
adequate	O	O	O
SNR	O	O	B-T081
.	O	O	O

Parallel	O	O	B-T060
imaging	O	O	I-T060
and	O	O	O
DIVERSE	O	O	B-T080
refocusing	O	O	O
RF	O	O	B-T070
pulses	O	O	B-T066
allow	O	O	O
shorter	O	O	B-T079
ETL	O	O	I-T079
compared	O	O	O
to	O	O	O
previous	O	O	O
implementations	O	O	B-T052
and	O	O	O
thus	O	O	O
reduces	O	O	B-T080
phase	O	O	B-T079
encode	O	O	B-T052
direction	O	O	B-T082
blur	O	O	B-T080
and	O	O	O
SAR	O	O	B-T040
accumulation	O	O	B-T033
.	O	O	O

-DOCSTART- (27812530)

Modification	O	O	B-T169
of	O	O	O
Mechanical	O	O	B-T080
Properties	O	O	I-T080
,	O	O	O
Polymerization	O	O	B-T067
Temperature	O	O	B-T081
,	O	O	O
and	O	O	O
Handling	O	O	B-T079
Time	O	O	I-T079
of	O	O	O
Polymethylmethacrylate	O	O	B-T109
Cement	O	O	B-T122
for	O	O	O
Enhancing	O	O	O
Applicability	O	O	B-T169
in	O	O	O
Vertebroplasty	O	O	O

Polymethylmethacrylate	O	O	B-T109
(	O	O	O
PMMA	O	O	B-T109
)	O	O	O
bone	O	O	B-T023
cement	O	O	I-T122
is	O	O	O
a	O	O	O
popular	O	O	O
bone	O	O	O
void	O	O	B-T030
filler	O	O	B-T122
for	O	O	O
vertebroplasty	O	O	B-T061
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
use	O	O	O
of	O	O	O
PMMA	O	O	B-T109
has	O	O	O
some	O	O	O
drawbacks	O	O	O
,	O	O	O
including	O	O	O
the	O	O	O
material	O	O	B-T122
's	O	O	I-T122
excessive	O	O	O
stiffness	O	O	B-T080
,	O	O	O
exothermic	O	O	B-T067
polymerization	O	O	I-T067
,	O	O	O
and	O	O	O
short	O	O	B-T081
handling	O	O	B-T079
time	O	O	I-T079
.	O	O	O

This	O	O	O
study	O	O	B-T062
aimed	O	O	O
to	O	O	O
create	O	O	O
an	O	O	O
ideal	O	O	O
modified	O	O	B-T169
bone	O	O	B-T122
cement	O	O	I-T122
to	O	O	O
solve	O	O	O
the	O	O	O
above-mentioned	O	O	O
problems	O	O	B-T033
.	O	O	O

Modified	O	O	B-T169
bone	O	O	B-T122
cements	O	O	I-T122
were	O	O	O
prepared	O	O	B-T052
by	O	O	O
combining	O	O	O
PMMA	O	O	B-T109
with	O	O	O
three	O	O	O
different	O	O	O
volume	O	O	B-T081
fractions	O	O	I-T081
of	O	O	O
castor	O	O	B-T109
oil	O	O	I-T109
(	O	O	O
5	O	O	O
%	O	O	O
,	O	O	O
10	O	O	O
%	O	O	O
,	O	O	O
and	O	O	O
15	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
peak	O	O	B-T080
polymerization	O	O	B-T067
temperatures	O	O	B-T081
,	O	O	O
times	O	O	O
to	O	O	O
achieve	O	O	O
the	O	O	O
peak	O	O	O
polymerization	O	O	O
temperature	O	O	B-T081
,	O	O	O
porosities	O	O	B-T080
,	O	O	O
densities	O	O	B-T081
,	O	O	O
modulus	O	O	B-T081
and	O	O	O
maximum	O	O	B-T081
compression	O	O	B-T081
strengths	O	O	I-T081
of	O	O	O
standard	O	O	B-T080
(	O	O	O
without	O	O	O
castor	O	O	B-T109
oil	O	O	I-T109
)	O	O	O
,	O	O	O
and	O	O	O
modified	O	O	B-T169
cements	O	O	B-T122
were	O	O	O
investigated	O	O	B-T169
following	O	O	O
storage	O	O	O
at	O	O	O
ambient	O	O	B-T070
temperature	O	O	I-T070
(	O	O	O
22	O	O	O
Â°	O	O	O
C	O	O	O
)	O	O	O
or	O	O	O
under	O	O	O
precooling	O	O	B-T070
conditions	O	O	B-T080
(	O	O	O
3	O	O	O
Â°	O	O	O
C	O	O	O
)	O	O	O
.	O	O	O

Six	O	O	O
specimens	O	O	B-T167
were	O	O	O
tested	O	O	O
in	O	O	O
each	O	O	O
group	O	O	O
of	O	O	O
the	O	O	O
aforementioned	O	O	O
parameters	O	O	B-T077
.	O	O	O

Increasing	O	O	B-T081
castor	O	O	B-T109
oil	O	O	I-T109
content	O	O	O
and	O	O	O
precooling	O	O	B-T070
treatment	O	O	B-T169
effectively	O	O	O
decreased	O	O	B-T081
the	O	O	O
peak	O	O	B-T080
polymerization	O	O	B-T067
temperatures	O	O	B-T081
and	O	O	O
increased	O	O	B-T081
the	O	O	O
duration	O	O	B-T079
to	O	O	O
achieve	O	O	O
the	O	O	O
peak	O	O	O
polymerization	O	O	O
temperature	O	O	B-T081
(	O	O	O
P	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
.	O	O	O

Furthermore	O	O	O
,	O	O	O
the	O	O	O
mechanical	O	O	B-T080
properties	O	O	I-T080
of	O	O	O
the	O	O	O
material	O	O	B-T122
,	O	O	O
including	O	O	O
density	O	O	B-T081
,	O	O	O
modulus	O	O	B-T081
,	O	O	O
and	O	O	O
maximum	O	O	B-T081
compression	O	O	B-T081
strength	O	O	I-T081
,	O	O	O
decreased	O	O	B-T081
with	O	O	O
increasing	O	O	B-T081
castor	O	O	B-T109
oil	O	O	I-T109
content	O	O	B-T077
.	O	O	O

However	O	O	O
,	O	O	O
preparation	O	O	B-T052
temperature	O	O	B-T081
(	O	O	O
room	O	O	B-T070
temperature	O	O	I-T070
versus	O	O	O
precooling	O	O	B-T070
)	O	O	O
had	O	O	O
no	O	O	O
significant	O	O	O
effect	O	O	O
(	O	O	O
P	O	O	O
>	O	O	O
0.05	O	O	O
)	O	O	O
on	O	O	O
these	O	O	O
mechanical	O	O	B-T080
properties	O	O	I-T080
.	O	O	O

In	O	O	O
conclusion	O	O	O
,	O	O	O
the	O	O	O
addition	O	O	O
of	O	O	O
castor	O	O	B-T109
oil	O	O	I-T109
to	O	O	O
PMMA	O	O	B-T109
followed	O	O	O
by	O	O	O
precooling	O	O	B-T070
created	O	O	O
an	O	O	O
ideal	O	O	O
modified	O	O	B-T169
bone	O	O	B-T122
cement	O	O	I-T122
with	O	O	O
a	O	O	O
low	O	O	O
modulus	O	O	B-T081
,	O	O	O
low	O	O	O
polymerization	O	O	B-T067
temperature	O	O	B-T081
,	O	O	O
and	O	O	O
long	O	O	O
handling	O	O	B-T079
time	O	O	I-T079
,	O	O	O
enhancing	O	O	O
its	O	O	O
applicability	O	O	B-T169
and	O	O	O
safety	O	O	B-T068
for	O	O	O
vertebroplasty	O	O	B-T061
.	O	O	O

-DOCSTART- (27813022)

A	O	O	O
case	O	O	B-T169
of	O	O	O
retrograde	O	O	B-T020
intussusception	O	O	I-T020
at	O	O	O
Roux-en-Y	O	O	B-T061
anastomosis	O	O	I-T061
10	O	O	O
years	O	O	O
after	O	O	O
total	O	O	B-T061
gastrectomy	O	O	I-T061
:	O	O	O
review	O	O	O
of	O	O	O
the	O	O	O
literature	O	O	O

A	O	O	O
63-year-	O	O	O
old	O	O	B-T032
man	O	O	I-T032
,	O	O	O
who	O	O	O
had	O	O	O
undergone	O	O	O
total	O	O	B-T061
gastrectomy	O	O	I-T061
and	O	O	O
Roux-en-Y	O	O	B-T061
reconstruction	O	O	I-T061
for	O	O	O
gastric	O	O	B-T191
cancer	O	O	I-T191
10	O	O	O
years	O	O	O
previously	O	O	O
,	O	O	O
was	O	O	O
admitted	O	O	B-T058
to	O	O	O
our	O	O	O
hospital	O	O	B-T093
with	O	O	O
complaints	O	O	B-T184
of	O	O	O
abdominal	O	O	B-T184
pain	O	O	I-T184
,	O	O	O
palpable	O	O	B-T080
abdominal	O	O	B-T191
tumor	O	O	I-T191
,	O	O	O
and	O	O	O
hematemesis	O	O	B-T033
.	O	O	O

On	O	O	B-T058
admission	O	O	I-T058
,	O	O	O
the	O	O	O
abdominal	O	O	B-T184
tenderness	O	O	I-T184
was	O	O	O
improving	O	O	B-T080
and	O	O	O
no	O	O	O
abdominal	O	O	B-T191
tumor	O	O	I-T191
was	O	O	O
palpable	O	O	B-T080
.	O	O	O

Mild	O	O	B-T046
inflammatory	O	O	I-T046
changes	O	O	O
and	O	O	O
anemia	O	O	B-T047
were	O	O	O
noted	O	O	O
on	O	O	O
blood	O	O	B-T059
examination	O	O	I-T059
.	O	O	O

Abdominal	O	O	B-T029
computed	O	O	B-T060
tomography	O	O	I-T060
revealed	O	O	O
a	O	O	O
tumor	O	O	B-T191
with	O	O	O
a	O	O	O
layered	O	O	B-T080
structure	O	O	I-T080
in	O	O	O
the	O	O	O
left	O	O	B-T029
abdomen	O	O	I-T029
.	O	O	O

The	O	O	O
patient	O	O	B-T101
was	O	O	O
diagnosed	O	O	B-T033
with	O	O	O
intestinal	O	O	B-T047
obstruction	O	O	I-T047
secondary	O	O	O
to	O	O	O
intussusception	O	O	B-T047
,	O	O	O
and	O	O	O
surgery	O	O	B-T061
was	O	O	O
performed	O	O	B-T169
.	O	O	O

Retrograde	O	O	B-T020
intussusception	O	O	I-T020
was	O	O	O
found	O	O	O
at	O	O	O
the	O	O	O
site	O	O	O
of	O	O	O
the	O	O	O
Y	O	O	B-T061
anastomosis	O	O	I-T061
.	O	O	O

We	O	O	O
conducted	O	O	O
manual	O	O	B-T061
reduction	O	O	I-T061
using	O	O	O
the	O	O	O
Hutchinson	O	O	B-T061
procedure	O	O	I-T061
.	O	O	O

The	O	O	O
intestinal	O	O	B-T023
color	O	O	B-T080
after	O	O	O
the	O	O	O
reduction	O	O	B-T061
was	O	O	O
good	O	O	O
,	O	O	O
and	O	O	O
no	O	O	O
intestinal	O	O	B-T061
resection	O	O	I-T061
was	O	O	O
required	O	O	B-T169
.	O	O	O

Postoperative	O	O	B-T033
recovery	O	O	I-T033
was	O	O	O
uneventful	O	O	O
,	O	O	O
and	O	O	O
the	O	O	O
patient	O	O	B-T101
was	O	O	O
discharged	O	O	B-T058
12	O	O	O
days	O	O	O
after	O	O	O
surgery	O	O	B-T061
.	O	O	O

Reports	O	O	B-T170
of	O	O	O
jejunal	O	O	B-T023
intussusception	O	O	B-T047
after	O	O	O
total	O	O	B-T061
gastrectomy	O	O	I-T061
with	O	O	O
Roux-en-Y	O	O	B-T061
reconstruction	O	O	I-T061
are	O	O	O
relatively	O	O	O
rare	O	O	O
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
report	O	O	O
a	O	O	O
case	O	O	O
of	O	O	O
jejunal	O	O	B-T023
intussusception	O	O	B-T047
after	O	O	O
total	O	O	B-T061
gastrectomy	O	O	I-T061
with	O	O	O
Roux-en-Y	O	O	B-T061
reconstruction	O	O	I-T061
.	O	O	O

-DOCSTART- (27815033)

Brassinosteroid	O	O	B-T109
-	O	O	O
induced	O	O	B-T169
changes	O	O	B-T169
of	O	O	O
lipid	O	O	B-T109
composition	O	O	B-T070
in	O	O	O
leaves	O	O	B-T002
of	O	O	O
Pisum	O	O	B-T002
sativum	O	O	I-T002
L.	O	O	I-T002
during	O	O	O
senescence	O	O	O

The	O	O	O
effect	O	O	B-T080
of	O	O	I-T080
steroid	O	O	B-T109
phytohormone	O	O	B-T116
24-epibrassinolide	O	O	B-T109
(	O	O	O
EBR	O	O	B-T109
)	O	O	O
on	O	O	O
the	O	O	O
composition	O	O	B-T070
of	O	O	O
some	O	O	O
lipid	O	O	B-T109
classes	O	O	B-T170
(	O	O	O
free	O	O	B-T109
fatty	O	O	I-T109
acids	O	O	I-T109
,	O	O	O
triacylglycerols	O	O	B-T109
and	O	O	O
galactolipids	O	O	B-T109
)	O	O	O
in	O	O	O
detached	O	O	B-T169
pea	O	O	B-T002
leaves	O	O	B-T002
was	O	O	O
studied	O	O	O
for	O	O	O
the	O	O	O
first	O	O	O
time	O	O	O
.	O	O	O

EBR	O	O	B-T109
(	O	O	O
0.1Î¼M	O	O	O
)	O	O	O
promoted	O	O	O
senescence	O	O	B-T040
and	O	O	O
increased	O	O	B-T081
the	O	O	O
content	O	O	B-T077
of	O	O	O
14:0	O	O	O
,	O	O	O
16:0	O	O	O
and	O	O	O
18:1	O	O	O
free	O	O	B-T109
fatty	O	O	I-T109
acids	O	O	I-T109
as	O	O	O
well	O	O	O
as	O	O	O
18:2	O	O	O
and	O	O	O
18:3	O	O	O
bound	O	O	O
to	O	O	O
triacylglycerols	O	O	B-T109
in	O	O	O
the	O	O	O
detached	O	O	B-T169
leaves	O	O	B-T002
in	O	O	O
contrast	O	O	O
to	O	O	O
mock-treated	O	O	B-T002
leaves	O	O	I-T002
.	O	O	O

The	O	O	O
content	O	O	B-T077
of	O	O	O
all	O	O	O
identified	O	O	B-T080
fatty	O	O	B-T109
acids	O	O	I-T109
bound	O	O	O
to	O	O	O
galactolipids	O	O	B-T109
decreased	O	O	B-T081
in	O	O	O
the	O	O	O
detached	O	O	B-T169
leaves	O	O	B-T002
treated	O	O	B-T169
with	O	O	O
EBR	O	O	B-T109
compared	O	O	O
to	O	O	O
that	O	O	O
in	O	O	O
mock-treated	O	O	B-T002
leaves	O	O	I-T002
.	O	O	O

These	O	O	O
findings	O	O	B-T169
suggest	O	O	O
that	O	O	O
free	O	O	B-T109
fatty	O	O	I-T109
acids	O	O	I-T109
are	O	O	O
liberated	O	O	O
from	O	O	O
polar	O	O	B-T081
lipids	O	O	B-T109
and	O	O	O
then	O	O	O
undergo	O	O	O
esterification	O	O	B-T044
to	O	O	O
neutral	O	O	B-T109
lipids	O	O	I-T109
in	O	O	O
the	O	O	O
detached	O	O	B-T169
leaves	O	O	B-T002
upon	O	O	O
EBR	O	O	B-T109
treatment	O	O	B-T169
.	O	O	O

We	O	O	O
propose	O	O	O
that	O	O	O
steroid	O	O	B-T109
phytohormones	O	O	B-T116
may	O	O	O
be	O	O	O
involved	O	O	O
into	O	O	O
regulation	O	O	B-T038
of	O	O	O
leaf	O	O	B-T002
senescence	O	O	B-T040
via	O	O	O
alteration	O	O	B-T078
of	O	O	O
cell	O	O	B-T025
lipid	O	O	B-T109
composition	O	O	B-T070
.	O	O	O

-DOCSTART- (27818984)

Posterior	O	O	B-T037
dislocation	O	O	I-T037
of	O	O	O
the	O	O	O
sternoclavicular	O	O	B-T030
joint	O	O	I-T030
:	O	O	O
report	O	O	B-T170
of	O	O	O
two	O	O	O
cases	O	O	O

The	O	O	O
authors	O	O	O
report	O	O	B-T170
the	O	O	O
cases	O	O	B-T169
of	O	O	O
two	O	O	O
young	O	O	B-T079
patients	O	O	B-T101
who	O	O	O
had	O	O	O
suffered	O	O	O
a	O	O	O
sporting	O	O	B-T037
accident	O	O	I-T037
with	O	O	O
posterior	O	O	B-T037
traumatic	O	O	I-T037
dislocation	O	O	I-T037
of	O	O	O
sternoclavicular	O	O	B-T030
joint	O	O	I-T030
.	O	O	O

In	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
patients	O	O	B-T101
closed	O	O	B-T061
reduction	O	O	I-T061
was	O	O	O
accomplished	O	O	O
by	O	O	O
keeping	O	O	O
the	O	O	O
limb	O	O	B-T023
in	O	O	O
a	O	O	O
sling	O	O	B-T074
.	O	O	O

The	O	O	O
second	O	O	O
patient	O	O	B-T101
,	O	O	O
after	O	O	O
reduction	O	O	B-T061
was	O	O	O
done	O	O	O
,	O	O	O
presented	O	O	O
recurrence	O	O	B-T067
of	O	O	O
the	O	O	O
dislocation	O	O	B-T037
,	O	O	O
thus	O	O	O
requiring	O	O	O
surgical	O	O	B-T061
treatment	O	O	I-T061
.	O	O	O

It	O	O	O
is	O	O	O
important	O	O	O
to	O	O	O
observe	O	O	O
the	O	O	O
relevance	O	O	B-T080
of	O	O	O
computed	O	O	B-T060
tomography	O	O	I-T060
to	O	O	O
help	O	O	O
diagnosing	O	O	B-T062
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
monitoring	O	O	O
the	O	O	O
reduction	O	O	B-T061
procedure	O	O	I-T061
.	O	O	O

The	O	O	O
objective	O	O	O
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
demonstrate	O	O	O
two	O	O	O
different	O	O	O
types	O	O	O
of	O	O	O
treatment	O	O	B-T061
in	O	O	O
a	O	O	O
rare	O	O	B-T080
injury	O	O	B-T037
such	O	O	O
as	O	O	O
the	O	O	O
posterior	O	O	B-T037
dislocation	O	O	I-T037
of	O	O	O
sternoclavicular	O	O	B-T030
joint	O	O	I-T030
.	O	O	O

-DOCSTART- (27820159)

Using	O	O	O
a	O	O	O
graphical	O	O	B-T058
risk	O	O	I-T058
tool	O	O	I-T058
to	O	O	O
examine	O	O	O
willingness	O	O	B-T033
to	O	O	I-T033
take	O	O	I-T033
migraine	O	O	B-T047
prophylactic	O	O	B-T061
medications	O	O	O

Many	O	O	O
migraine	O	O	B-T047
sufferers	O	O	B-T101
use	O	O	O
daily	O	O	B-T079
prophylactic	O	O	B-T061
therapy	O	O	I-T061
to	O	O	O
reduce	O	O	O
the	O	O	O
frequency	O	O	B-T079
of	O	O	O
their	O	O	O
headache	O	O	B-T184
attacks	O	O	O
.	O	O	O

The	O	O	O
Food	O	O	B-T093
and	O	O	I-T093
Drug	O	O	I-T093
Administration	O	O	I-T093
has	O	O	O
approved	O	O	B-T080
several	O	O	B-T081
different	O	O	O
medications	O	O	B-T121
for	O	O	O
migraine	O	O	B-T047
prophylaxis	O	O	B-T061
,	O	O	O
but	O	O	O
it	O	O	O
is	O	O	O
not	O	O	O
clear	O	O	O
whether	O	O	O
sufferers	O	O	B-T101
perceive	O	O	O
these	O	O	O
treatments	O	O	B-T061
to	O	O	O
provide	O	O	O
clinically	O	O	B-T078
significant	O	O	I-T078
benefits	O	O	B-T081
given	O	O	O
their	O	O	O
side	O	O	B-T046
effect	O	O	I-T046
profiles	O	O	B-T059
.	O	O	O

Three	O	O	O
hundred	O	O	O
headache	O	O	B-T184
sufferers	O	O	B-T101
were	O	O	O
recruited	O	O	O
from	O	O	O
the	O	O	O
community	O	O	B-T096
and	O	O	O
local	O	O	B-T082
headache	O	O	O
clinics	O	O	B-T093
using	O	O	O
print	O	O	B-T057
and	O	O	O
television	O	O	B-T073
advertising	O	O	B-T057
.	O	O	O

Participants	O	O	B-T098
reported	O	O	O
experiencing	O	O	O
problematic	O	O	O
headache	O	O	B-T184
attacks	O	O	O
with	O	O	O
a	O	O	O
median	O	O	B-T081
(	O	O	O
IQR	O	O	O
)	O	O	O
frequency	O	O	B-T079
of	O	O	O
7.0	O	O	O
(	O	O	O
4	O	O	O
-	O	O	O
13	O	O	O
)	O	O	O
headache	O	O	O
days	O	O	B-T079
per	O	O	I-T079
month	O	O	I-T079
.	O	O	O

These	O	O	O
sufferers	O	O	B-T101
participated	O	O	O
in	O	O	O
a	O	O	O
cross-sectional	O	O	B-T062
,	O	O	I-T062
single-site	O	O	I-T062
,	O	O	I-T062
study	O	O	I-T062
that	O	O	O
used	O	O	O
a	O	O	O
specially	O	O	O
designed	O	O	O
computer	O	O	O
assessment	O	O	O
task	O	O	O
.	O	O	O

Participants	O	O	B-T098
were	O	O	O
instructed	O	O	O
on	O	O	O
the	O	O	O
probability	O	O	B-T081
of	O	O	O
experiencing	O	O	O
the	O	O	O
3	O	O	O
most	O	O	O
commonly	O	O	O
experienced	O	O	O
side	O	O	B-T046
effects	O	O	I-T046
for	O	O	O
several	O	O	B-T081
blinded	O	O	B-T062
medication	O	O	B-T121
profiles	O	O	B-T059
:	O	O	O
divalproex	O	O	B-T109
sodium	O	O	I-T109
,	O	O	O
venlafaxine	O	O	B-T109
,	O	O	O
gabapentin	O	O	B-T109
,	O	O	O
propranolol	O	O	B-T109
,	O	O	O
and	O	O	O
topiramate	O	O	B-T109
.	O	O	O

After	O	O	O
learning	O	O	O
the	O	O	O
likelihood	O	O	B-T081
of	O	O	O
experiencing	O	O	O
side	O	O	B-T046
effect	O	O	I-T046
profiles	O	O	B-T059
of	O	O	O
each	O	O	O
medication	O	O	B-T121
,	O	O	O
participants	O	O	B-T098
were	O	O	O
asked	O	O	O
whether	O	O	O
they	O	O	O
would	O	O	O
be	O	O	O
willing	O	O	B-T033
to	O	O	I-T033
take	O	O	I-T033
the	O	O	O
medication	O	O	O
for	O	O	O
a	O	O	O
given	O	O	O
headache	O	O	B-T184
reduction	O	O	B-T080
level	O	O	B-T080
,	O	O	O
which	O	O	O
ranged	O	O	O
from	O	O	O
0	O	O	O
to	O	O	O
7	O	O	O
days	O	O	B-T079
per	O	O	I-T079
month	O	O	I-T079
.	O	O	O

The	O	O	O
side	O	O	B-T046
effect	O	O	I-T046
profile	O	O	B-T059
for	O	O	O
divalproex	O	O	B-T109
sodium	O	O	I-T109
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
the	O	O	O
smallest	O	O	B-T033
willingness	O	O	I-T033
to	O	O	I-T033
take	O	O	I-T033
,	O	O	O
with	O	O	O
gabapentin	O	O	B-T109
,	O	O	O
propranolol	O	O	B-T109
,	O	O	O
and	O	O	O
topiramate	O	O	B-T109
perceived	O	O	O
to	O	O	O
be	O	O	O
much	O	O	O
more	O	O	O
agreeable	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
<	O	O	O
60	O	O	O
%	O	O	O
of	O	O	O
participants	O	O	B-T098
reported	O	O	O
willingness	O	O	B-T033
to	O	O	I-T033
take	O	O	I-T033
any	O	O	O
of	O	O	O
these	O	O	O
medications	O	O	B-T121
even	O	O	O
if	O	O	O
they	O	O	O
provided	O	O	O
a	O	O	O
50	O	O	O
%	O	O	O
reduction	O	O	B-T080
in	O	O	O
headache	O	O	B-T184
frequency	O	O	B-T079
.	O	O	O

Several	O	O	B-T081
general	O	O	O
predictors	O	O	B-T078
of	O	O	O
willingness	O	O	B-T033
to	O	O	I-T033
take	O	O	I-T033
were	O	O	O
observed	O	O	O
including	O	O	O
high	O	O	B-T080
headache	O	O	B-T184
-related	O	O	O
disability	O	O	B-T033
,	O	O	O
depressive	O	O	B-T184
symptoms	O	O	I-T184
,	O	O	O
and	O	O	O
pain	O	O	B-T109
medication	O	O	I-T109
concerns	O	O	B-T078
including	O	O	O
fear	O	O	B-T041
of	O	O	O
tolerance	O	O	B-T041
.	O	O	O

These	O	O	O
findings	O	O	B-T033
suggest	O	O	O
that	O	O	O
if	O	O	O
properly	O	O	O
informed	O	O	B-T080
of	O	O	O
the	O	O	O
side	O	O	B-T046
effect	O	O	I-T046
profiles	O	O	B-T059
of	O	O	O
these	O	O	O
medications	O	O	B-T121
,	O	O	O
many	O	O	O
patients	O	O	B-T101
might	O	O	O
opt	O	O	O
for	O	O	O
other	O	O	O
treatments	O	O	B-T061
.	O	O	O

-DOCSTART- (27820849)

Genome-Wide	O	O	B-T063
Detection	O	O	I-T063
of	O	O	O
Selective	O	O	B-T045
Signatures	O	O	I-T045
in	O	O	O
Chicken	O	O	B-T012
through	O	O	O
High	O	O	O
Density	O	O	O
SNPs	O	O	O

Chicken	O	O	B-T012
is	O	O	O
recognized	O	O	O
as	O	O	O
an	O	O	O
excellent	O	O	O
model	O	O	B-T075
for	O	O	O
studies	O	O	O
of	O	O	O
genetic	O	O	B-T169
mechanism	O	O	B-T169
of	O	O	O
phenotypic	O	O	B-T032
and	O	O	O
genomic	O	O	B-T028
evolution	O	O	B-T045
,	O	O	O
with	O	O	O
large	O	O	O
effective	O	O	O
population	O	O	B-T081
size	O	O	I-T081
and	O	O	O
strong	O	O	O
human	O	O	B-T016
-driven	O	O	O
selection	O	O	B-T052
.	O	O	O

In	O	O	O
the	O	O	O
present	O	O	O
study	O	O	O
,	O	O	O
we	O	O	O
performed	O	O	O
Extended	O	O	B-UnknownType
Haplotype	O	O	I-UnknownType
Homozygosity	O	O	I-UnknownType
(	O	O	O
EHH	O	O	B-UnknownType
)	O	O	O
tests	O	O	O
to	O	O	O
identify	O	O	O
significant	O	O	O
core	O	O	B-T086
regions	O	O	I-T086
employing	O	O	O
600	O	O	O
K	O	O	O
SNP	O	O	B-T086
Chicken	O	O	B-T012
chip	O	O	B-T063
in	O	O	O
an	O	O	O
F2	O	O	B-T078
population	O	O	I-T078
of	O	O	O
1,534	O	O	O
hens	O	O	B-T012
,	O	O	O
which	O	O	O
was	O	O	O
derived	O	O	O
from	O	O	O
reciprocal	O	O	B-T059
crosses	O	O	I-T059
between	O	O	O
White	O	O	B-T012
Leghorn	O	O	I-T012
and	O	O	O
Dongxiang	O	O	B-T012
chicken	O	O	I-T012
.	O	O	O

Results	O	O	O
indicated	O	O	O
that	O	O	O
a	O	O	O
total	O	O	O
of	O	O	O
49,151	O	O	O
core	O	O	B-T086
regions	O	O	I-T086
with	O	O	O
an	O	O	O
average	O	O	O
length	O	O	B-T081
of	O	O	O
9.79	O	O	O
Kb	O	O	O
were	O	O	O
identified	O	O	B-T080
,	O	O	O
which	O	O	O
occupied	O	O	O
approximately	O	O	O
52.15	O	O	O
%	O	O	O
of	O	O	O
genome	O	O	B-T028
across	O	O	O
all	O	O	O
autosomes	O	O	B-T026
,	O	O	O
and	O	O	O
806	O	O	O
significant	O	O	O
core	O	O	O
regions	O	O	O
attracted	O	O	O
us	O	O	O
mostly	O	O	O
.	O	O	O

Genes	O	O	B-T028
in	O	O	O
candidate	O	O	B-T086
regions	O	O	I-T086
may	O	O	O
experience	O	O	O
positive	O	O	B-T059
selection	O	O	I-T059
and	O	O	O
were	O	O	O
considered	O	O	O
to	O	O	O
have	O	O	O
possible	O	O	O
influence	O	O	O
on	O	O	O
beneficial	O	O	O
economic	O	O	B-T080
traits	O	O	I-T080
.	O	O	O

A	O	O	O
panel	O	O	B-T078
of	O	O	O
genes	O	O	B-T028
including	O	O	O
AASDHPPT	O	O	B-T028
,	O	O	O
GDPD5	O	O	B-T028
,	O	O	O
PAR3	O	O	B-T028
,	O	O	O
SOX6	O	O	B-T028
,	O	O	O
GPC1	O	O	B-T028
and	O	O	O
a	O	O	O
signal	O	O	B-T044
pathway	O	O	I-T044
of	O	O	O
AKT1	O	O	B-T028
were	O	O	O
detected	O	O	B-T033
with	O	O	O
the	O	O	O
most	O	O	O
extreme	O	O	O
P-values	O	O	B-T081
.	O	O	O

Further	O	O	O
enrichment	O	O	B-T062
analyses	O	O	I-T062
indicated	O	O	O
that	O	O	O
these	O	O	O
genes	O	O	B-T028
were	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
immune	O	O	B-T042
function	O	O	I-T042
,	O	O	O
sensory	O	O	B-T042
organ	O	O	I-T042
development	O	O	I-T042
and	O	O	O
neurogenesis	O	O	B-T040
,	O	O	O
and	O	O	O
may	O	O	O
have	O	O	O
experienced	O	O	O
positive	O	O	B-T059
selection	O	O	I-T059
in	O	O	O
chicken	O	O	B-T012
.	O	O	O

Moreover	O	O	O
,	O	O	O
some	O	O	O
of	O	O	O
core	O	O	B-T086
regions	O	O	I-T086
exactly	O	O	O
overlapped	O	O	O
with	O	O	O
genes	O	O	B-T028
excavated	O	O	O
in	O	O	O
our	O	O	O
previous	O	O	O
GWAS	O	O	B-T063
,	O	O	O
suggesting	O	O	O
that	O	O	O
these	O	O	O
genes	O	O	O
have	O	O	O
undergone	O	O	O
positive	O	O	B-T059
selection	O	O	I-T059
may	O	O	O
affect	O	O	O
egg	O	O	B-T168
production	O	O	B-T052
.	O	O	O

Findings	O	O	B-T169
in	O	O	O
our	O	O	O
study	O	O	O
could	O	O	O
draw	O	O	O
a	O	O	O
comparatively	O	O	O
integrate	O	O	O
genome-wide	O	O	B-T062
map	O	O	I-T062
of	O	O	O
selection	O	O	B-T045
signature	O	O	I-T045
in	O	O	O
the	O	O	O
chicken	O	O	B-T012
genome	O	O	B-T028
,	O	O	O
and	O	O	O
would	O	O	O
be	O	O	O
worthy	O	O	O
for	O	O	O
explicating	O	O	O
the	O	O	O
genetic	O	O	B-T169
mechanisms	O	O	B-T169
of	O	O	O
phenotypic	O	O	B-T032
diversity	O	O	B-T080
in	O	O	O
poultry	O	O	B-T012
breeding	O	O	B-T040
.	O	O	O

-DOCSTART- (27822855)

High-Throughput	O	O	O
Genotyping	O	O	B-T059
with	O	O	O
TaqMan	O	O	B-T059
Allelic	O	O	I-T059
Discrimination	O	O	I-T059
and	O	O	O
Allele-Specific	O	O	O
Genotyping	O	O	O
Assays	O	O	O

Real-time	O	O	B-T063
PCR	O	O	I-T063
-based	O	O	O
genotyping	O	O	B-T059
methods	O	O	I-T059
,	O	O	O
such	O	O	O
as	O	O	O
TaqMan	O	O	B-T059
allelic	O	O	I-T059
discrimination	O	O	I-T059
assays	O	O	I-T059
and	O	O	O
allele-specific	O	O	B-T059
genotyping	O	O	I-T059
,	O	O	O
are	O	O	O
particularly	O	O	O
useful	O	O	B-T080
when	O	O	O
screening	O	O	B-T060
a	O	O	O
handful	O	O	O
of	O	O	O
single	O	O	B-T086
nucleotide	O	O	I-T086
polymorphisms	O	O	I-T086
in	O	O	O
hundreds	O	O	O
of	O	O	O
samples	O	O	B-T167
;	O	O	O
either	O	O	O
derived	O	O	O
from	O	O	O
different	O	O	B-T080
individuals	O	O	B-T098
,	O	O	O
tissues	O	O	B-T024
,	O	O	O
or	O	O	O
pre	O	O	B-T079
-	O	O	O
amplified	O	O	B-T045
DNA	O	O	I-T045
.	O	O	O

Although	O	O	O
real-time	O	O	B-T063
PCR	O	O	I-T063
-	O	O	O
based	O	O	B-T169
methods	O	O	B-T170
such	O	O	O
as	O	O	O
TaqMan	O	O	B-T059
are	O	O	O
well-established	O	O	B-T080
,	O	O	O
alternative	O	O	B-T077
methods	O	O	O
,	O	O	O
like	O	O	O
allele-specific	O	O	B-T059
genotyping	O	O	B-T059
,	O	O	O
are	O	O	O
powerful	O	O	O
alternatives	O	O	B-T077
,	O	O	O
especially	O	O	O
for	O	O	O
genotyping	O	O	O
short	O	O	B-T114
tandem	O	O	I-T114
repeat	O	O	I-T114
(	O	O	B-T114
STR	O	O	I-T114
)	O	O	I-T114
length	O	O	B-T081
polymorphisms	O	O	B-T045
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
describe	O	O	O
all	O	O	O
relevant	O	O	B-T080
aspects	O	O	B-T080
when	O	O	O
developing	O	O	B-T169
an	O	O	O
assay	O	O	B-T059
for	O	O	O
a	O	O	O
new	O	O	O
SNP	O	O	B-T086
or	O	O	O
STR	O	O	B-T114
using	O	O	O
either	O	O	O
TaqMan	O	O	B-T059
or	O	O	O
allele-specific	O	O	B-T059
genotyping	O	O	I-T059
,	O	O	O
respectively	O	O	O
,	O	O	O
such	O	O	O
as	O	O	O
primer	O	O	B-T114
and	O	O	O
probe	O	O	B-T114
design	O	O	O
,	O	O	O
optimization	O	O	B-T052
of	O	O	O
reaction	O	O	B-T169
conditions	O	O	B-T080
,	O	O	O
the	O	O	O
experimental	O	O	B-T059
procedure	O	O	I-T059
for	O	O	I-T059
typing	O	O	I-T059
hundreds	O	O	O
of	O	O	O
samples	O	O	B-T167
,	O	O	O
and	O	O	O
finally	O	O	O
the	O	O	O
data	O	O	B-T078
evaluation	O	O	B-T058
.	O	O	O

Our	O	O	O
goal	O	O	B-T170
is	O	O	O
to	O	O	O
provide	O	O	B-T052
a	O	O	O
guideline	O	O	B-T170
for	O	O	O
developing	O	O	B-T169
genotyping	O	O	B-T059
assays	O	O	I-T059
using	O	O	O
these	O	O	O
two	O	O	O
approaches	O	O	B-T169
that	O	O	O
render	O	O	O
reliable	O	O	O
and	O	O	O
reproducible	O	O	B-T080
genotype	O	O	B-T059
calls	O	O	I-T059
involving	O	O	B-T169
minimal	O	O	B-T080
optimization	O	O	B-T052
.	O	O	O

-DOCSTART- (27824163)

The	O	O	O
role	O	O	O
of	O	O	O
P2X7	O	O	B-T116
receptors	O	O	I-T116
in	O	O	O
a	O	O	O
rodent	O	O	B-T015
PCP	O	O	B-T109
-	O	O	O
induced	O	O	B-T169
schizophrenia	O	O	B-T048
model	O	O	O

P2X7	O	O	B-T116
receptors	O	O	I-T116
(	O	O	O
P2X7Rs	O	O	B-T116
)	O	O	O
are	O	O	O
ligand-gated	O	O	B-T116
ion	O	O	I-T116
channels	O	O	I-T116
sensitive	O	O	B-T169
to	O	O	O
extracellular	O	O	B-T026
ATP	O	O	B-T114
.	O	O	O

Here	O	O	O
we	O	O	O
examined	O	O	B-T033
for	O	O	O
the	O	O	O
first	O	O	O
time	O	O	O
the	O	O	O
role	O	O	O
of	O	O	O
P2X7R	O	O	B-T116
in	O	O	O
an	O	O	O
animal	O	O	B-T008
model	O	O	I-T008
of	O	O	O
schizophrenia	O	O	B-T048
.	O	O	O

Using	O	O	O
the	O	O	O
PCP	O	O	B-T109
induced	O	O	B-T169
schizophrenia	O	O	B-T048
model	O	O	B-T050
we	O	O	O
show	O	O	O
that	O	O	O
both	O	O	O
genetic	O	O	B-T045
deletion	O	O	I-T045
and	O	O	O
pharmacological	O	O	B-T169
inhibition	O	O	B-T052
of	O	O	O
P2X7Rs	O	O	B-T116
alleviate	O	O	B-T169
schizophrenia-like	O	O	B-T033
behavioral	O	O	B-T053
alterations	O	O	B-T078
.	O	O	O

In	O	O	O
P2rx7+/+	O	O	B-T028
mice	O	O	B-T015
,	O	O	O
PCP	O	O	B-T109
induced	O	O	B-T169
hyperlocomotion	O	O	B-T033
,	O	O	O
stereotype	O	O	B-T048
behavior	O	O	I-T048
,	O	O	O
ataxia	O	O	B-T184
and	O	O	O
social	O	O	B-T033
withdrawal	O	O	I-T033
.	O	O	O

In	O	O	O
P2X7	O	O	B-T028
receptor	O	O	I-T028
deficient	O	O	B-T169
mice	O	O	B-T015
(	O	O	O
P2rx7-/-	O	O	B-T028
)	O	O	O
,	O	O	O
the	O	O	O
social	O	O	B-T033
interactions	O	O	I-T033
were	O	O	O
increased	O	O	B-T081
,	O	O	O
whereas	O	O	O
the	O	O	O
PCP	O	O	B-T109
induced	O	O	B-T169
hyperlocomotion	O	O	B-T033
and	O	O	O
stereotype	O	O	B-T048
behavior	O	O	I-T048
were	O	O	O
alleviated	O	O	B-T169
.	O	O	O

The	O	O	O
selective	O	O	O
P2X7	O	O	B-T121
receptor	O	O	I-T121
antagonist	O	O	I-T121
JNJ-47965567	O	O	B-T121
partly	O	O	O
replicated	O	O	O
the	O	O	O
effect	O	O	B-T080
of	O	O	I-T080
gene	O	O	B-T045
deficiency	O	O	I-T045
on	O	O	O
PCP	O	O	B-T109
-	O	O	O
induced	O	O	B-T169
behavioral	O	O	B-T055
changes	O	O	I-T055
and	O	O	O
counteracted	O	O	O
PCP	O	O	O
-	O	O	O
induced	O	O	O
social	O	O	B-T033
withdrawal	O	O	I-T033
.	O	O	O

We	O	O	O
also	O	O	O
show	O	O	O
that	O	O	O
PCP	O	O	B-T109
treatment	O	O	B-T169
upregulates	O	O	B-T044
and	O	O	O
increases	O	O	B-T169
the	O	O	O
functional	O	O	B-T169
responsiveness	O	O	B-T169
of	O	O	O
P2X7Rs	O	O	B-T116
in	O	O	O
the	O	O	O
prefrontal	O	O	B-T023
cortex	O	O	I-T023
of	O	O	O
young	O	O	B-T100
adult	O	O	I-T100
animals	O	O	B-T008
.	O	O	O

The	O	O	O
amplitude	O	O	B-UnknownType
of	O	O	O
NMDA	O	O	B-T116
evoked	O	O	B-T080
currents	O	O	B-T070
recorded	O	O	O
from	O	O	O
layer	O	O	B-T025
V	O	O	I-T025
pyramidal	O	O	I-T025
neurons	O	O	I-T025
of	O	O	O
cortical	O	O	B-T023
slices	O	O	O
were	O	O	O
slightly	O	O	O
decreased	O	O	B-T081
by	O	O	O
both	O	O	O
genetic	O	O	B-T045
deletion	O	O	I-T045
of	O	O	O
P2rx7	O	O	B-T028
and	O	O	O
by	O	O	O
JNJ-47965567	O	O	B-T121
.	O	O	O

PCP	O	O	B-T109
induced	O	O	B-T169
alterations	O	O	B-T078
in	O	O	O
mRNA	O	O	B-T045
expression	O	O	I-T045
encoding	O	O	O
schizophrenia-related	O	O	B-T048
genes	O	O	B-T028
,	O	O	O
such	O	O	O
as	O	O	O
NR2A	O	O	B-T028
,	O	O	O
NR2B	O	O	B-T028
,	O	O	O
neuregulin	O	O	B-T116
1	O	O	I-T116
,	O	O	O
NR1	O	O	B-T192
and	O	O	O
GABA	O	O	B-T116
Î±1	O	O	I-T116
subunit	O	O	O
were	O	O	O
absent	O	O	B-T169
in	O	O	O
the	O	O	O
PFC	O	O	O
of	O	O	O
young	O	O	B-T100
adult	O	O	I-T100
P2rx7-/-	O	O	B-T028
animals	O	O	B-T050
.	O	O	O

Our	O	O	O
findings	O	O	B-T033
point	O	O	O
to	O	O	O
P2X7R	O	O	B-T116
as	O	O	O
a	O	O	O
potential	O	O	B-T080
therapeutic	O	O	B-T169
target	O	O	B-T169
in	O	O	O
schizophrenia	O	O	B-T048
.	O	O	O

-DOCSTART- (27826436)

The	O	O	O
flavor	O	O	B-T168
and	O	O	O
nutritional	O	O	B-T080
characteristic	O	O	B-T080
of	O	O	O
four	O	O	O
strawberry	O	O	B-T168
varieties	O	O	B-T077
cultured	O	O	B-T090
in	O	O	O
soilless	O	O	O
system	O	O	O

Strawberry	O	O	B-T168
fruits	O	O	I-T168
(	O	O	O
cv	O	O	O
.	O	O	O

Benihoppe	O	O	O
,	O	O	O
Tochiotome	O	O	B-T168
,	O	O	O
Sachinoka	O	O	B-T168
,	O	O	O
and	O	O	O
Guimeiren	O	O	B-T168
)	O	O	O
were	O	O	O
harvested	O	O	O
and	O	O	O
evaluated	O	O	O
the	O	O	O
flavor	O	O	B-T168
and	O	O	O
nutritional	O	O	B-T080
parameters	O	O	B-T077
.	O	O	O

By	O	O	O
principal	O	O	B-T081
component	O	O	I-T081
analysis	O	O	I-T081
and	O	O	O
hierarchical	O	O	B-T062
clustering	O	O	I-T062
analysis	O	O	I-T062
,	O	O	O
differences	O	O	O
were	O	O	O
observed	O	O	O
based	O	O	O
on	O	O	O
the	O	O	O
volatile	O	O	B-T109
compounds	O	O	I-T109
composition	O	O	B-T070
,	O	O	O
sugar	O	O	B-T109
and	O	O	O
acid	O	O	B-T109
concentration	O	O	B-T081
,	O	O	O
sweetness	O	O	B-T080
,	O	O	O
and	O	O	O
total	O	O	B-T109
soluble	O	O	I-T109
sugars	O	O	I-T109
/	O	O	O
total	O	O	B-T109
organic	O	O	I-T109
acids	O	O	I-T109
of	O	O	O
the	O	O	O
four	O	O	O
varieties	O	O	B-T077
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
37	O	O	O
,	O	O	O
48	O	O	O
,	O	O	O
65	O	O	O
,	O	O	O
and	O	O	O
74	O	O	O
volatile	O	O	B-T109
compounds	O	O	I-T109
were	O	O	O
identified	O	O	B-T080
and	O	O	O
determined	O	O	B-T080
in	O	O	O
cv	O	O	O
.	O	O	O

Benihoppe	O	O	O
,	O	O	O
Tochiotome	O	O	B-T168
,	O	O	O
Sachinoka	O	O	B-T168
,	O	O	O
and	O	O	O
Guimeiren	O	O	B-T168
strawberry	O	O	I-T168
fruits	O	O	I-T168
extracted	O	O	B-T061
by	O	O	O
head-space	O	O	B-T059
solid-phase	O	O	I-T059
microextraction	O	O	I-T059
(	O	O	O
HS-SPME	O	O	B-T059
)	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

Esters	O	O	B-T109
significantly	O	O	O
dominated	O	O	O
the	O	O	O
chemical	O	O	B-T070
composition	O	O	I-T070
of	O	O	O
the	O	O	O
four	O	O	O
varieties	O	O	B-T077
.	O	O	O

Furaneol	O	O	B-T109
was	O	O	O
detected	O	O	O
in	O	O	O
cultivars	O	O	B-T002
of	O	O	O
Sachinoka	O	O	B-T168
and	O	O	O
Guimeiren	O	O	B-T168
,	O	O	O
but	O	O	O
mesifuran	O	O	B-T168
was	O	O	O
only	O	O	O
found	O	O	O
in	O	O	O
cv	O	O	O
.	O	O	O

Tochiotome	O	O	O
.	O	O	O

Tochiotome	O	O	B-T168
and	O	O	O
Sachinoka	O	O	B-T168
showed	O	O	O
higher	O	O	O
content	O	O	B-T081
of	O	O	O
linalool	O	O	B-T109
and	O	O	O
(E)-nerolidol	O	O	B-T109
.	O	O	O

Sachinoka	O	O	B-T168
showed	O	O	O
the	O	O	O
highest	O	O	B-T080
content	O	O	B-T081
of	O	O	O
total	O	O	B-T109
sugars	O	O	I-T109
and	O	O	O
total	O	O	B-T109
acids	O	O	I-T109
.	O	O	O

Guimeiren	O	O	B-T168
showed	O	O	O
higher	O	O	O
sweetness	O	O	B-T080
index	O	O	B-T170
than	O	O	O
the	O	O	O
other	O	O	O
three	O	O	O
cultivars	O	O	B-T002
.	O	O	O

Firmness	O	O	B-T080
of	O	O	O
Tochiotome	O	O	B-T168
was	O	O	O
highest	O	O	B-T080
among	O	O	O
all	O	O	O
the	O	O	O
varieties	O	O	B-T077
.	O	O	O

The	O	O	O
highest	O	O	B-T080
total	O	O	B-T081
soluble	O	O	I-T081
solids	O	O	I-T081
TSS	O	O	I-T081
value	O	O	I-T081
was	O	O	O
found	O	O	O
in	O	O	O
cv	O	O	O
.	O	O	O

Sachinoka	O	O	O
,	O	O	O
followed	O	O	O
by	O	O	O
the	O	O	O
Guimeiren	O	O	B-T168
and	O	O	O
Tochiotome	O	O	B-T168
varieties	O	O	B-T077
.	O	O	O

Sachinoka	O	O	B-T168
had	O	O	O
the	O	O	O
highest	O	O	B-T080
titratable	O	O	B-T034
acidity	O	O	I-T034
TA	O	O	I-T034
value	O	O	I-T034
.	O	O	O

The	O	O	O
content	O	O	B-T081
of	O	O	O
ascorbic	O	O	B-T127
acid	O	O	I-T127
(	O	O	O
AsA	O	O	B-T127
)	O	O	O
of	O	O	O
cv	O	O	O
.	O	O	O

Tochiotome	O	O	B-T168
was	O	O	O
higher	O	O	B-T080
than	O	O	O
the	O	O	O
others	O	O	O
,	O	O	O
but	O	O	O
there	O	O	O
was	O	O	O
no	O	O	B-T033
significant	O	O	I-T033
difference	O	O	B-T081
in	O	O	O
cultivars	O	O	B-T002
of	O	O	O
Benihoppe	O	O	B-T168
,	O	O	O
Tochiotome	O	O	O
,	O	O	O
and	O	O	O
Sachinoka	O	O	B-T168
.	O	O	O

Fructose	O	O	B-T109
and	O	O	O
glucose	O	O	B-T109
were	O	O	O
the	O	O	O
major	O	O	O
sugars	O	O	B-T109
in	O	O	O
all	O	O	O
cultivars	O	O	B-T002
.	O	O	O

Citric	O	O	B-T109
acid	O	O	I-T109
was	O	O	O
the	O	O	O
major	O	O	O
organic	O	O	B-T109
acid	O	O	I-T109
in	O	O	O
cv	O	O	O
.	O	O	O

Tochiotome	O	O	O
,	O	O	O
cv	O	O	O
.	O	O	O

Sachinoka	O	O	O
,	O	O	O
and	O	O	O
cv	O	O	O
.	O	O	O

Guimeiren	O	O	O
.	O	O	O
Tochiotome	O	O	B-T168
had	O	O	O
higher	O	O	B-T080
ratios	O	O	B-T081
of	O	O	O
TSS	O	O	B-T109
/	O	O	O
TA	O	O	B-T034
and	O	O	O
total	O	O	B-T109
sugars	O	O	I-T109
/	O	O	O
total	O	O	B-T109
organic	O	O	I-T109
acids	O	O	I-T109
than	O	O	O
others	O	O	O
,	O	O	O
arising	O	O	O
from	O	O	O
its	O	O	O
lower	O	O	O
acid	O	O	B-T109
content	O	O	B-T081
.	O	O	O

The	O	O	O
order	O	O	O
of	O	O	O
the	O	O	O
comprehensive	O	O	B-T081
evaluation	O	O	I-T081
score	O	O	I-T081
was	O	O	O
Sachinoka	O	O	B-T168
>	O	O	O
Guimeiren	O	O	B-T168
>	O	O	O
Tochiotome	O	O	B-T168
>	O	O	O
Benihoppe	O	O	B-T168
.	O	O	O

-DOCSTART- (27828852)

Prognostic	O	O	B-T081
value	O	O	I-T081
of	O	O	O
GLUT-1	O	O	B-T116
expression	O	O	B-T045
in	O	O	O
oral	O	O	B-T191
squamous	O	O	I-T191
cell	O	O	I-T191
carcinoma	O	O	I-T191
:	O	O	O
A	O	O	O
prisma-compliant	O	O	O
meta-analysis	O	O	O

A	O	O	O
variety	O	O	O
of	O	O	O
studies	O	O	B-T062
have	O	O	O
evaluated	O	O	B-T058
the	O	O	O
correlation	O	O	B-T080
between	O	O	O
glucose	O	O	B-T116
transporter-1	O	O	I-T116
(	O	O	O
GLUT-1	O	O	B-T116
)	O	O	O
expression	O	O	B-T045
and	O	O	O
prognosis	O	O	B-T058
of	O	O	O
oral	O	O	B-T191
squamous	O	O	I-T191
cell	O	O	I-T191
carcinoma	O	O	I-T191
(	O	O	O
OSCC	O	O	B-T191
)	O	O	O
;	O	O	O
however	O	O	O
,	O	O	O
the	O	O	O
results	O	O	B-T169
were	O	O	O
inconsistent	O	O	B-T080
and	O	O	O
inconclusive	O	O	B-T080
.	O	O	O

A	O	O	O
meta-analysis	O	O	B-T062
was	O	O	O
performed	O	O	O
to	O	O	O
assess	O	O	B-T058
the	O	O	O
prognostic	O	O	B-T170
significance	O	O	B-T078
of	O	O	O
GLUT-1	O	O	B-T116
in	O	O	O
OSCC	O	O	B-T191
.	O	O	O

Electronic	O	O	B-T170
databases	O	O	I-T170
of	O	O	O
PubMed	O	O	B-T170
,	O	O	O
Embase	O	O	B-T170
,	O	O	O
and	O	O	O
Web	O	O	B-T170
of	O	O	I-T170
Science	O	O	I-T170
were	O	O	O
searched	O	O	O
for	O	O	O
relevant	O	O	B-T062
studies	O	O	I-T062
.	O	O	O

The	O	O	O
last	O	O	O
search	O	O	O
was	O	O	O
updated	O	O	O
on	O	O	O
July	O	O	B-T080
2016	O	O	O
.	O	O	O

Odds	O	O	B-T081
ratio	O	O	I-T081
(	O	O	O
OR	O	O	B-T081
)	O	O	O
and	O	O	O
95	O	O	O
%	O	O	O
confidence	O	O	B-T081
interval	O	O	I-T081
(	O	O	O
CI	O	O	B-T081
)	O	O	O
were	O	O	O
pooled	O	O	O
to	O	O	O
evaluate	O	O	B-T058
the	O	O	O
relationship	O	O	B-T078
between	O	O	O
GLUT-1	O	O	B-T116
and	O	O	O
clinical	O	O	B-T033
features	O	O	I-T033
and	O	O	O
hazard	O	O	B-T081
ratio	O	O	I-T081
(	O	O	O
HR	O	O	B-T081
)	O	O	O
and	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
were	O	O	O
combined	O	O	O
to	O	O	O
measure	O	O	B-T081
the	O	O	O
effect	O	O	B-T080
of	O	O	O
GLUT-1	O	O	O
on	O	O	O
overall	O	O	B-T081
survival	O	O	I-T081
(	O	O	O
OS	O	O	B-T081
)	O	O	O
.	O	O	O

P	O	O	O
value	O	O	O
<	O	O	O
0.05	O	O	O
was	O	O	O
considered	O	O	O
as	O	O	O
statistically	O	O	B-T081
significant	O	O	I-T081
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
13	O	O	O
studies	O	O	B-T062
with	O	O	O
1301	O	O	O
subjects	O	O	B-T098
were	O	O	O
included	O	O	O
for	O	O	O
meta-analysis	O	O	B-T062
.	O	O	O

The	O	O	O
pooled	O	O	B-T078
data	O	O	I-T078
showed	O	O	O
that	O	O	O
high	O	O	O
GLUT-1	O	O	B-T116
expression	O	O	B-T045
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
advanced	O	O	B-T201
tumor	O	O	I-T201
stages	O	O	I-T201
(	O	O	O
n	O	O	O
=	O	O	O
7	O	O	O
,	O	O	O
OR	O	O	B-T081
=	O	O	O
2.99	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
:	O	O	O
2.01	O	O	O
-	O	O	O
4.46	O	O	O
,	O	O	O
P	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
,	O	O	O
higher	O	O	B-T185
tumor	O	O	I-T185
grade	O	O	I-T185
(	O	O	O
n	O	O	O
=	O	O	O
5	O	O	O
,	O	O	O
OR	O	O	O
=	O	O	O
3.34	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
:	O	O	O
1.12	O	O	O
-	O	O	O
9.94	O	O	O
,	O	O	O
P	O	O	O
=	O	O	O
0.031	O	O	O
)	O	O	O
,	O	O	O
tumor	O	O	B-T082
size	O	O	I-T082
(	O	O	O
n	O	O	O
=	O	O	O
5	O	O	O
,	O	O	O
OR	O	O	O
=	O	O	O
3.36	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
:	O	O	O
2.04	O	O	O
-	O	O	O
5.51	O	O	O
,	O	O	O
P	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
,	O	O	O
lymph	O	O	B-T033
node	O	O	I-T033
metastasis	O	O	I-T033
(	O	O	O
n	O	O	O
=	O	O	O
5	O	O	O
,	O	O	O
OR	O	O	O
=	O	O	O
3.15	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
:	O	O	O
1.89	O	O	O
-	O	O	O
5.25	O	O	O
,	O	O	O
P	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
,	O	O	O
tobacco	O	O	B-T055
use	O	O	I-T055
(	O	O	O
n	O	O	O
=	O	O	O
3	O	O	O
,	O	O	O
OR	O	O	O
=	O	O	O
2.18	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
:	O	O	O
1.18	O	O	O
-	O	O	O
4.01	O	O	O
,	O	O	O
P	O	O	O
=	O	O	O
0.013	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
distant	O	O	B-T201
metastasis	O	O	I-T201
(	O	O	O
n	O	O	O
=	O	O	O
2	O	O	O
,	O	O	O
OR	O	O	O
=	O	O	O
3.06	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
:	O	O	O
1.19	O	O	O
-	O	O	O
7.9	O	O	O
,	O	O	O
P	O	O	O
=	O	O	O
0.02	O	O	O
)	O	O	O
.	O	O	O

Furthermore	O	O	O
,	O	O	O
increased	O	O	B-T081
GLUT-1	O	O	B-T116
expression	O	O	B-T045
was	O	O	O
also	O	O	O
correlated	O	O	B-T080
with	O	O	O
shorter	O	O	B-T081
OS	O	O	I-T081
(	O	O	O
n	O	O	O
=	O	O	O
8	O	O	O
,	O	O	O
HR	O	O	B-T081
=	O	O	O
1.88	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
:	O	O	O
1.51	O	O	O
-	O	O	O
2.33	O	O	O
,	O	O	O
P	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
.	O	O	O

No	O	O	O
significant	O	O	B-T080
publication	O	O	I-T080
bias	O	O	I-T080
was	O	O	O
detected	O	O	B-T033
in	O	O	O
this	O	O	O
meta-analysis	O	O	B-T062
.	O	O	O

GLUT-1	O	O	B-T116
overexpression	O	O	B-T045
was	O	O	O
in	O	O	O
connection	O	O	O
with	O	O	O
aggressive	O	O	B-T033
clinical	O	O	I-T033
features	O	O	I-T033
and	O	O	O
worse	O	O	B-T081
OS	O	O	I-T081
in	O	O	O
OSCC	O	O	B-T191
.	O	O	O

However	O	O	O
,	O	O	O
further	O	O	O
studies	O	O	B-T062
are	O	O	O
still	O	O	O
needed	O	O	O
to	O	O	O
verify	O	O	O
whether	O	O	O
GLUT-1	O	O	B-T116
could	O	O	O
serve	O	O	O
as	O	O	O
a	O	O	O
prognostic	O	O	B-T170
biomarker	O	O	B-T201
for	O	O	O
OSCC	O	O	B-T191
.	O	O	O

-DOCSTART- (27828996)

Biogeography	O	O	B-T090
and	O	O	O
Character	O	O	O
Evolution	O	O	B-T038
of	O	O	O
the	O	O	O
Ciliate	O	O	B-T204
Genus	O	O	B-T185
Euplotes	O	O	B-T204
(	O	O	O
Spirotrichea	O	O	B-T204
,	O	O	O
Euplotia	O	O	B-T204
)	O	O	O
,	O	O	O
with	O	O	O
Description	O	O	B-T170
of	O	O	O
Euplotes	O	O	O
curdsi	O	O	O
sp.	O	O	O
nov	O	O	O

Ciliates	O	O	B-T204
comprise	O	O	O
a	O	O	O
diverse	O	O	B-T080
and	O	O	O
ecologically	O	O	B-T077
important	O	O	B-T080
phylum	O	O	B-T185
of	O	O	O
unicellular	O	O	B-T001
protists	O	O	I-T001
.	O	O	O

One	O	O	O
of	O	O	O
the	O	O	O
most	O	O	O
specious	O	O	O
and	O	O	O
best-defined	O	O	O
genera	O	O	B-T185
is	O	O	O
Euplotes	O	O	B-T204
,	O	O	O
which	O	O	O
constitutes	O	O	O
more	O	O	O
than	O	O	O
70	O	O	O
morphospecies	O	O	B-T185
,	O	O	O
many	O	O	O
of	O	O	O
which	O	O	O
have	O	O	O
never	O	O	O
been	O	O	O
molecularly	O	O	B-T169
tested	O	O	I-T169
.	O	O	O

The	O	O	O
increasing	O	O	O
number	O	O	O
of	O	O	O
described	O	O	O
Euplotes	O	O	B-T204
taxa	O	O	B-T077
emphasizes	O	O	O
the	O	O	O
importance	O	O	O
for	O	O	O
detailed	O	O	O
characterizations	O	O	B-T052
of	O	O	O
new	O	O	O
ones	O	O	O
,	O	O	O
requiring	O	O	O
standardized	O	O	O
morphological	O	O	B-T082
observations	O	O	B-T062
,	O	O	O
sequencing	O	O	B-T169
of	O	O	O
molecular	O	O	B-T201
markers	O	O	I-T201
and	O	O	O
careful	O	O	O
comparison	O	O	B-T052
with	O	O	O
previous	O	O	O
literature	O	O	B-T170
.	O	O	O

Here	O	O	O
we	O	O	O
describe	O	O	O
Euplotes	O	O	B-T204
curdsi	O	O	I-T204
sp.	O	O	I-T204
nov	O	O	I-T204
.	O	O	O
,	O	O	O
distinguishable	O	O	B-T080
by	O	O	O
the	O	O	O
combination	O	O	B-T080
of	O	O	O
the	O	O	O
following	O	O	O
features	O	O	B-T080
:	O	O	O
45	O	O	O
-	O	O	O
65	O	O	O
Î¼m	O	O	O
length	O	O	B-T081
,	O	O	O
oval	O	O	B-T080
or	O	O	I-T080
elongated	O	O	I-T080
shape	O	O	I-T080
with	O	O	O
both	O	O	O
ends	O	O	O
rounded	O	O	O
,	O	O	O
narrow	O	O	B-T080
peristome	O	O	I-T080
with	O	O	O
25	O	O	O
-	O	O	O
34	O	O	O
adoral	O	O	B-T080
membranelles	O	O	I-T080
,	O	O	O
conspicuous	O	O	B-T026
paroral	O	O	I-T026
membrane	O	O	I-T026
,	O	O	O
double-eurystomus	O	O	B-T080
dorsal	O	O	I-T080
argyrome	O	O	I-T080
type	O	O	I-T080
,	O	O	O
6	O	O	O
-	O	O	O
7	O	O	O
dorsolateral	O	O	B-T080
kineties	O	O	I-T080
and	O	O	O
10	O	O	O
frontoventral	O	O	B-T080
cirri	O	O	I-T080
.	O	O	O

Three	O	O	O
populations	O	O	B-T081
of	O	O	O
the	O	O	O
novel	O	O	O
species	O	O	B-T185
have	O	O	O
been	O	O	O
found	O	O	O
in	O	O	O
brackish	O	O	B-T131
and	O	O	O
marine	O	O	B-T083
samples	O	O	I-T083
in	O	O	O
the	O	O	O
Mediterranean	O	O	B-T083
and	O	O	O
the	O	O	O
White	O	O	B-T083
Sea	O	O	I-T083
.	O	O	O

We	O	O	O
provide	O	O	O
the	O	O	O
SSU	O	O	B-T028
rRNA	O	O	I-T028
gene	O	O	I-T028
sequences	O	O	B-T028
of	O	O	O
these	O	O	O
populations	O	O	B-T081
,	O	O	O
and	O	O	O
an	O	O	O
updated	O	O	O
phylogeny	O	O	B-T078
of	O	O	O
the	O	O	O
genus	O	O	B-T185
Euplotes	O	O	B-T204
.	O	O	O

Using	O	O	O
the	O	O	O
molecular	O	O	B-T080
phylogenetic	O	O	B-T080
tree	O	O	I-T080
,	O	O	O
we	O	O	O
inferred	O	O	O
aspects	O	O	B-T080
of	O	O	O
the	O	O	O
biogeographical	O	O	B-T169
history	O	O	I-T169
of	O	O	O
the	O	O	O
genus	O	O	B-T185
and	O	O	O
the	O	O	O
evolution	O	O	B-T038
of	O	O	O
its	O	O	O
most	O	O	O
important	O	O	O
taxonomic	O	O	B-T169
characters	O	O	B-T080
in	O	O	O
order	O	O	O
to	O	O	O
provide	O	O	O
a	O	O	O
frame	O	O	O
for	O	O	O
future	O	O	O
descriptions	O	O	B-T170
.	O	O	O

Ultimately	O	O	O
,	O	O	O
these	O	O	O
data	O	O	B-T078
reveal	O	O	O
recurrent	O	O	B-T079
trends	O	O	B-T079
of	O	O	O
freshwater	O	O	B-T167
invasion	O	O	O
and	O	O	O
highlight	O	O	O
the	O	O	O
dynamic	O	O	O
,	O	O	O
yet	O	O	O
convergent	O	O	O
,	O	O	O
morphological	O	O	B-T082
evolution	O	O	B-T038
of	O	O	O
Euplotes	O	O	B-T204
.	O	O	O

-DOCSTART- (27831982)

Comparative	O	O	B-T062
Effectiveness	O	O	I-T062
of	O	O	O
Treatments	O	O	B-T061
for	O	O	O
Chronic	O	O	B-T047
Low	O	O	I-T047
Back	O	O	I-T047
Pain	O	O	I-T047
:	O	O	O
A	O	O	O
Multiple	O	O	O
Treatment	O	O	O
Comparison	O	O	O
Analysis	O	O	O

A	O	O	O
systematic	O	O	B-T170
review	O	O	I-T170
and	O	O	O
network	O	O	B-T062
meta-analysis	O	O	I-T062
.	O	O	O

To	O	O	O
determine	O	O	O
current	O	O	B-T061
treatment	O	O	I-T061
options	O	O	I-T061
of	O	O	O
chronic	O	O	B-T047
low	O	O	I-T047
back	O	O	I-T047
pain	O	O	I-T047
(	O	O	O
LBP	O	O	B-T047
)	O	O	O
as	O	O	O
defined	O	O	O
by	O	O	O
randomized	O	O	B-T062
controlled	O	O	I-T062
trials	O	O	I-T062
(	O	O	O
RCTs	O	O	B-T062
)	O	O	O
and	O	O	O
to	O	O	O
compare	O	O	B-T052
effectiveness	O	O	B-T080
of	O	O	O
those	O	O	O
treatments	O	O	B-T061
using	O	O	O
a	O	O	O
mixed-treatment	O	O	B-T062
comparison	O	O	I-T062
(	O	O	O
MTC	O	O	B-T062
)	O	O	O
.	O	O	O

It	O	O	O
is	O	O	O
important	O	O	O
to	O	O	O
provide	O	O	O
an	O	O	O
evidence-based	O	O	B-T078
assessment	O	O	B-T058
of	O	O	O
the	O	O	O
treatment	O	O	B-T061
options	O	O	I-T061
that	O	O	O
exist	O	O	O
for	O	O	O
LBP	O	O	B-T047
.	O	O	O

A	O	O	O
systematic	O	O	B-T062
search	O	O	I-T062
of	O	O	O
RCTs	O	O	B-T062
was	O	O	O
conducted	O	O	O
in	O	O	O
MEDLINE	O	O	B-T170
and	O	O	O
the	O	O	O
Cochrane	O	O	B-T073
Collaboration	O	O	I-T073
Library	O	O	I-T073
from	O	O	O
1990	O	O	O
to	O	O	O
2014	O	O	O
.	O	O	O

From	O	O	O
the	O	O	O
selected	O	O	B-T062
studies	O	O	I-T062
,	O	O	O
we	O	O	O
extracted	O	O	O
preoperative	O	O	B-T079
and	O	O	O
postoperative	O	O	B-T079
ODI	O	O	B-T033
and	O	O	O
VAS	O	O	B-T081
back	O	O	I-T081
pain	O	O	I-T081
scores	O	O	I-T081
,	O	O	O
additional	O	O	B-T058
surgeries	O	O	I-T058
,	O	O	O
and	O	O	O
complications	O	O	B-T046
.	O	O	O

Standard	O	O	B-T062
and	O	O	I-T062
network	O	O	I-T062
meta-analytic	O	O	I-T062
techniques	O	O	I-T062
were	O	O	O
used	O	O	O
.	O	O	O

Twelve	O	O	O
RCTs	O	O	B-T062
were	O	O	O
included	O	O	O
in	O	O	O
the	O	O	O
analysis	O	O	B-T062
:	O	O	O
5	O	O	O
total	O	O	B-T061
disk	O	O	I-T061
replacement	O	O	I-T061
(	O	O	O
TDR	O	O	B-T061
)	O	O	O
versus	O	O	O
fusion	O	O	B-T061
;	O	O	O
1	O	O	O
TDR	O	O	O
versus	O	O	O
exercise	O	O	B-T061
and	O	O	O
cognitive	O	O	B-T061
behavioral	O	O	I-T061
therapy	O	O	I-T061
(	O	O	O
CBT	O	O	B-T061
)	O	O	O
;	O	O	O
5	O	O	O
fusion	O	O	O
versus	O	O	O
exercise	O	O	O
and	O	O	O
CBT	O	O	O
;	O	O	O
and	O	O	O
1	O	O	O
fusion	O	O	O
versus	O	O	O
physical	O	O	B-T061
therapy	O	O	I-T061
(	O	O	O
PT	O	O	B-T061
)	O	O	O
.	O	O	O

On	O	O	O
the	O	O	O
basis	O	O	O
of	O	O	O
MTC	O	O	B-T062
,	O	O	O
with	O	O	O
respect	O	O	O
to	O	O	O
ODI	O	O	B-T033
change	O	O	I-T033
scores	O	O	I-T033
,	O	O	O
the	O	O	O
pooled	O	O	B-T081
mean	O	O	I-T081
difference	O	O	I-T081
favoring	O	O	O
fusion	O	O	B-T061
over	O	O	O
exercise	O	O	B-T061
and	O	O	O
CBT	O	O	B-T061
was	O	O	O
2.0	O	O	O
points	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
,	O	O	O
-1.2	O	O	O
to	O	O	O
4.8	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
pooled	O	O	B-T081
mean	O	O	I-T081
difference	O	O	I-T081
favoring	O	O	O
TDR	O	O	B-T061
over	O	O	O
exercise	O	O	B-T061
and	O	O	O
CBT	O	O	B-T061
was	O	O	O
6.4	O	O	O
points	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
,	O	O	O
3.2	O	O	O
-	O	O	O
9.3	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
pooled	O	O	B-T081
mean	O	O	I-T081
difference	O	O	I-T081
favoring	O	O	O
fusion	O	O	B-T061
over	O	O	O
PT	O	O	B-T061
was	O	O	O
8.8	O	O	O
points	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
,	O	O	O
4.1	O	O	O
-	O	O	O
13.6	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
pooled	O	O	B-T081
mean	O	O	I-T081
differences	O	O	I-T081
favoring	O	O	O
TDR	O	O	B-T061
over	O	O	O
fusion	O	O	B-T061
was	O	O	O
4.4	O	O	O
points	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
,	O	O	O
2.37	O	O	O
-	O	O	O
6.63	O	O	O
)	O	O	O
.	O	O	O

For	O	O	O
PT	O	O	B-T061
versus	O	O	O
structured	O	O	B-T061
exercise	O	O	B-T061
with	O	O	O
CBT	O	O	B-T061
,	O	O	O
the	O	O	O
pooled	O	O	B-T081
mean	O	O	I-T081
difference	O	O	I-T081
favoring	O	O	O
exercise	O	O	O
with	O	O	O
CBT	O	O	O
over	O	O	O
PT	O	O	O
was	O	O	O
6.8	O	O	O
points	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
,	O	O	O
1.5	O	O	O
-	O	O	O
12.8	O	O	O
)	O	O	O
.	O	O	O

For	O	O	O
TDR	O	O	B-T061
versus	O	O	O
PT	O	O	B-T061
,	O	O	O
the	O	O	O
pooled	O	O	B-T081
mean	O	O	I-T081
difference	O	O	I-T081
favoring	O	O	O
TDR	O	O	O
over	O	O	O
PT	O	O	O
was	O	O	O
13.2	O	O	O
points	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
,	O	O	O
8.0	O	O	O
-	O	O	O
18.4	O	O	O
)	O	O	O
.	O	O	O

Additional	O	O	O
surgery	O	O	B-T081
rates	O	O	I-T081
were	O	O	O
similar	O	O	O
between	O	O	O
treatment	O	O	B-T061
options	O	O	I-T061
.	O	O	O

All	O	O	O
4	O	O	O
treatments	O	O	B-T061
provided	O	O	O
some	O	O	O
benefit	O	O	B-T081
to	O	O	O
patients	O	O	B-T101
with	O	O	O
chronic	O	O	B-T047
LBP	O	O	I-T047
.	O	O	O

According	O	O	O
to	O	O	O
the	O	O	O
MTC	O	O	B-T062
analysis	O	O	I-T062
,	O	O	O
TDR	O	O	B-T061
may	O	O	O
be	O	O	O
the	O	O	O
most	O	O	B-T080
effective	O	O	I-T080
treatment	O	O	B-T061
and	O	O	O
PT	O	O	B-T061
the	O	O	O
least	O	O	B-T080
effective	O	O	I-T080
treatment	O	O	O
for	O	O	O
chronic	O	O	B-T047
LBP	O	O	I-T047
.	O	O	O

This	O	O	O
review	O	O	B-T170
is	O	O	O
based	O	O	O
on	O	O	O
a	O	O	O
limited	O	O	B-T081
number	O	O	I-T081
of	O	O	O
RCT	O	O	B-T062
studies	O	O	I-T062
and	O	O	O
does	O	O	O
not	O	O	O
support	O	O	O
any	O	O	O
1	O	O	O
treatment	O	O	B-T061
modality	O	O	B-T078
for	O	O	O
all	O	O	O
patients	O	O	B-T101
.	O	O	O

-DOCSTART- (27832159)

A	O	O	O
Novel	O	O	O
Selective	O	O	O
Inhibitor	O	O	B-T121
of	O	O	O
Delta-5	O	O	B-T116
Desaturase	O	O	I-T116
Lowers	O	O	O
Insulin	O	O	B-T046
Resistance	O	O	I-T046
and	O	O	O
Reduces	O	O	B-T033
Body	O	O	I-T033
Weight	O	O	I-T033
in	O	O	O
Diet	O	O	B-T168
-Induced	O	O	O
Obese	O	O	B-T047
C57BL/6J	O	O	O
Mice	O	O	O

Obesity	O	O	B-T047
is	O	O	O
now	O	O	O
recognized	O	O	O
as	O	O	O
a	O	O	O
state	O	O	O
of	O	O	O
chronic	O	O	O
low-grade	O	O	O
inflammation	O	O	B-T046
and	O	O	O
is	O	O	O
called	O	O	O
as	O	O	O
metabolic	O	O	B-T169
inflammation	O	O	O
.	O	O	O

Delta-5	O	O	B-T116
desaturase	O	O	I-T116
(	O	O	O
D5D	O	O	B-T116
)	O	O	O
is	O	O	O
an	O	O	O
enzyme	O	O	B-T116
that	O	O	O
metabolizes	O	O	O
dihomo-Î³-linolenic	O	O	B-T109
acid	O	O	I-T109
(	O	O	O
DGLA	O	O	B-T109
)	O	O	O
to	O	O	O
arachidonic	O	O	B-T109
acid	O	O	I-T109
(	O	O	O
AA	O	O	B-T109
)	O	O	O
.	O	O	O

Thus	O	O	O
,	O	O	O
D5D	O	O	B-T116
inhibition	O	O	B-T039
increases	O	O	O
DGLA	O	O	B-T109
(	O	O	O
precursor	O	O	O
to	O	O	O
anti-inflammatory	O	O	B-T080
eicosanoids	O	O	B-T109
)	O	O	O
while	O	O	O
decreasing	O	O	O
AA	O	O	B-T109
(	O	O	O
precursor	O	O	O
to	O	O	O
pro-inflammatory	O	O	O
eicosanoids	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
could	O	O	O
result	O	O	O
in	O	O	O
synergistic	O	O	B-T080
improvement	O	O	B-T077
in	O	O	O
the	O	O	O
low-grade	O	O	O
inflammatory	O	O	O
state	O	O	O
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
demonstrate	O	O	O
reduced	O	O	B-T080
insulin	O	O	B-T046
resistance	O	O	I-T046
and	O	O	O
the	O	O	O
anti-obesity	O	O	B-T121
effect	O	O	O
of	O	O	O
a	O	O	O
D5D	O	O	B-T116
selective	O	O	O
inhibitor	O	O	O
(	O	O	O
compound-326	O	O	B-T121
)	O	O	O
,	O	O	O
an	O	O	O
orally	O	O	B-T082
active	O	O	O
small-molecule	O	O	B-T109
,	O	O	O
in	O	O	O
a	O	O	O
high-fat	O	O	B-T168
diet	O	O	I-T168
-induced	O	O	O
obese	O	O	B-T015
(	O	O	I-T015
DIO	O	O	I-T015
)	O	O	I-T015
mouse	O	O	I-T015
model	O	O	B-T050
.	O	O	O

In	O	O	O
vivo	O	O	O
D5D	O	O	B-T116
inhibition	O	O	B-T039
was	O	O	O
confirmed	O	O	O
by	O	O	O
determining	O	O	O
changes	O	O	O
in	O	O	O
blood	O	O	B-T031
AA	O	O	B-T109
/	O	O	O
DGLA	O	O	B-T109
profiles	O	O	B-T059
.	O	O	O

In	O	O	O
DIO	O	O	B-T015
mice	O	O	I-T015
,	O	O	O
chronic	O	O	O
treatment	O	O	O
with	O	O	O
compound-326	O	O	B-T121
lowered	O	O	O
insulin	O	O	B-T046
resistance	O	O	I-T046
and	O	O	O
caused	O	O	O
body	O	O	B-T033
weight	O	O	I-T033
loss	O	O	I-T033
without	O	O	O
significant	O	O	O
impact	O	O	O
on	O	O	O
cumulative	O	O	O
calorie	O	O	B-T081
intake	O	O	I-T081
.	O	O	O

Decreased	O	O	O
macrophage	O	O	B-T033
infiltration	O	O	I-T033
into	O	O	I-T033
adipose	O	O	I-T033
tissue	O	O	I-T033
was	O	O	O
expected	O	O	O
from	O	O	O
mRNA	O	O	B-T059
analysis	O	O	I-T059
.	O	O	O

Increased	O	O	O
daily	O	O	O
energy	O	O	B-T039
expenditure	O	O	I-T039
was	O	O	O
also	O	O	O
observed	O	O	O
following	O	O	O
administration	O	O	B-T061
of	O	O	O
compound-326	O	O	B-T121
,	O	O	O
in	O	O	O
line	O	O	O
with	O	O	O
sustained	O	O	O
body	O	O	B-T033
weight	O	O	I-T033
loss	O	O	I-T033
.	O	O	O

These	O	O	O
data	O	O	O
indicate	O	O	O
that	O	O	O
the	O	O	O
novel	O	O	O
D5D	O	O	B-T116
selective	O	O	O
inhibitor	O	O	B-T121
,	O	O	O
compound-326	O	O	B-T121
,	O	O	O
will	O	O	O
be	O	O	O
a	O	O	O
new	O	O	O
class	O	O	O
of	O	O	O
drug	O	O	O
for	O	O	O
the	O	O	O
treatment	O	O	O
of	O	O	O
obese	O	O	B-T047
and	O	O	O
diabetic	O	O	B-T047
patients	O	O	B-T101
.	O	O	O

-DOCSTART- (27832181)

Blood	O	O	B-T074
Collection	O	O	I-T074
Tubes	O	O	I-T074
and	O	O	O
Storage	O	O	B-T080
Temperature	O	O	I-T080
Should	O	O	O
Be	O	O	O
Evaluated	O	O	O
when	O	O	O
Using	O	O	O
the	O	O	O
Siemens	O	O	B-T073
ADVIA	O	O	I-T073
Centaur	O	O	I-T073
XP	O	O	I-T073
for	O	O	O
Measuring	O	O	O
25-Hydroxyvitamin	O	O	O
D	O	O	O

A	O	O	O
significant	O	O	O
bias	O	O	O
was	O	O	O
found	O	O	O
when	O	O	O
using	O	O	O
the	O	O	O
Siemens	O	O	B-T073
ADVIA	O	O	I-T073
Centaur	O	O	I-T073
XP	O	O	I-T073
system	O	O	O
for	O	O	O
measurement	O	O	B-T059
of	O	O	I-T059
25-hydroxyvitamin	O	O	I-T059
D	O	O	I-T059
(	O	O	O
25OHD	O	O	B-T127
)	O	O	O
with	O	O	O
VACUETTE	O	O	B-T074
Â®	O	O	I-T074
tubes	O	O	I-T074
with	O	O	I-T074
Serum	O	O	I-T074
Clot	O	O	I-T074
Activator	O	O	I-T074
and	O	O	I-T074
Gel	O	O	I-T074
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
examined	O	O	O
whether	O	O	O
other	O	O	O
commonly	O	O	O
used	O	O	O
tubes	O	O	B-T074
or	O	O	O
temperatures	O	O	B-T081
affected	O	O	O
25OHD	O	O	B-T059
results	O	O	I-T059
obtained	O	O	O
with	O	O	O
the	O	O	O
Siemens	O	O	B-T073
ADVIA	O	O	I-T073
Centaur	O	O	I-T073
XP	O	O	I-T073
system	O	O	O
.	O	O	O

Serum	O	O	B-T031
was	O	O	O
collected	O	O	O
into	O	O	O
five	O	O	O
types	O	O	O
of	O	O	O
vacuum	O	O	B-T074
blood	O	O	I-T074
collection	O	O	I-T074
tubes	O	O	I-T074
from	O	O	O
three	O	O	O
manufacturers	O	O	O
,	O	O	O
and	O	O	O
25OHD	O	O	B-T059
was	O	O	I-T059
analyzed	O	O	I-T059
using	O	O	O
the	O	O	O
Siemens	O	O	B-T073
ADVIA	O	O	I-T073
Centaur	O	O	I-T073
XP	O	O	I-T073
system	O	O	O
and	O	O	O
liquid	O	O	B-T059
chromatography	O	O	I-T059
tandem	O	O	I-T059
mass	O	O	I-T059
spectrometry	O	O	I-T059
(	O	O	O
LC-MS/MS	O	O	B-T059
)	O	O	O
immediately	O	O	O
or	O	O	O
after	O	O	O
storage	O	O	O
at	O	O	O
4	O	O	O
Â°	O	O	O
C	O	O	O
or	O	O	O
-80	O	O	O
Â°	O	O	O
C	O	O	O
for	O	O	O
48	O	O	O
h.	O	O	O
Significantly	O	O	B-T081
higher	O	O	I-T081
25OHD	O	O	B-T059
values	O	O	I-T059
were	O	O	O
found	O	O	O
when	O	O	O
using	O	O	O
the	O	O	O
Siemens	O	O	O
ADVIA	O	O	O
Centaur	O	O	O
XP	O	O	O
system	O	O	O
with	O	O	O
VACUETTE	O	O	B-T074
Â®	O	O	I-T074
tubes	O	O	I-T074
with	O	O	I-T074
serum	O	O	I-T074
clot	O	O	I-T074
activator	O	O	I-T074
and	O	O	I-T074
gel	O	O	I-T074
and	O	O	O
VACUETTE	O	O	B-T074
Â®	O	O	I-T074
tubes	O	O	I-T074
with	O	O	I-T074
clot	O	O	I-T074
activator	O	O	I-T074
but	O	O	O
no	O	O	O
gel	O	O	O
compared	O	O	O
with	O	O	O
VACUETTE	O	O	O
Â®	O	O	O
tubes	O	O	O
with	O	O	O
no	O	O	O
additives	O	O	O
.	O	O	O

The	O	O	O
25OHD	O	O	B-T059
values	O	O	I-T059
in	O	O	O
all	O	O	O
of	O	O	O
these	O	O	O
tubes	O	O	O
were	O	O	O
not	O	O	O
significantly	O	O	O
different	O	O	O
from	O	O	O
those	O	O	O
obtained	O	O	O
by	O	O	O
LC-MS/MS	O	O	B-T059
.	O	O	O

Moreover	O	O	O
,	O	O	O
after	O	O	O
storage	O	O	O
at	O	O	O
-80	O	O	O
Â°	O	O	O
C	O	O	O
for	O	O	O
48	O	O	O
h	O	O	O
,	O	O	O
the	O	O	O
values	O	O	O
obtained	O	O	O
in	O	O	O
IMPROVEVACUTER	O	O	B-T074
Â®	O	O	I-T074
tubes	O	O	I-T074
with	O	O	I-T074
serum	O	O	I-T074
clot	O	O	I-T074
activator	O	O	I-T074
and	O	O	I-T074
ge	O	O	I-T074
l	O	O	O
significantly	O	O	B-T081
increased	O	O	I-T081
,	O	O	O
with	O	O	O
a	O	O	O
mean	O	O	O
bias	O	O	O
of	O	O	O
74.6	O	O	O
%	O	O	O
compared	O	O	O
with	O	O	O
the	O	O	O
values	O	O	O
before	O	O	O
storage	O	O	O
,	O	O	O
on	O	O	O
analysis	O	O	O
with	O	O	O
the	O	O	O
Siemens	O	O	B-T073
ADVIA	O	O	I-T073
Centaur	O	O	I-T073
XP	O	O	I-T073
system	O	O	O
.	O	O	O

VACUETTE	O	O	B-T074
Â®	O	O	I-T074
tubes	O	O	I-T074
containing	O	O	O
additives	O	O	O
significantly	O	O	O
affect	O	O	O
the	O	O	O
accuracy	O	O	O
of	O	O	O
25OHD	O	O	B-T059
results	O	O	I-T059
obtained	O	O	O
using	O	O	O
the	O	O	O
Siemens	O	O	B-T073
ADVIA	O	O	I-T073
Centaur	O	O	I-T073
XP	O	O	I-T073
system	O	O	O
.	O	O	O

Additionally	O	O	O
,	O	O	O
the	O	O	O
composition	O	O	O
of	O	O	O
serum	O	O	B-T031
collected	O	O	O
in	O	O	O
IMPROVEVACUTER	O	O	B-T074
Â®	O	O	I-T074
tubes	O	O	I-T074
was	O	O	O
affected	O	O	O
by	O	O	O
freezing	O	O	B-T070
,	O	O	O
resulting	O	O	O
in	O	O	O
different	O	O	O
measurements	O	O	O
when	O	O	O
using	O	O	O
the	O	O	O
Siemens	O	O	O
25OHD	O	O	B-T127
assay	O	O	B-T073
platform	O	O	I-T073
.	O	O	O

-DOCSTART- (27832198)

Evolution	O	O	B-T045
of	O	O	O
Fitness	O	O	B-T045
Cost-Neutral	O	O	B-T033
Mutant	O	O	B-T049
PfCRT	O	O	B-T116
Conferring	O	O	O
P.	O	O	B-T204
falciparum	O	O	I-T204
4-Aminoquinoline	O	O	B-T109
Drug	O	O	B-T038
Resistance	O	O	I-T038
Is	O	O	O
Accompanied	O	O	O
by	O	O	O
Altered	O	O	B-T169
Parasite	O	O	B-T204
Metabolism	O	O	B-T040
and	O	O	O
Digestive	O	O	B-T026
Vacuole	O	O	I-T026
Physiology	O	O	O

Southeast	O	O	B-T083
Asia	O	O	I-T083
is	O	O	O
an	O	O	O
epicenter	O	O	O
of	O	O	O
multidrug-resistant	O	O	B-T032
Plasmodium	O	O	B-T204
falciparum	O	O	I-T204
strains	O	O	I-T204
.	O	O	O

Selective	O	O	O
pressures	O	O	O
on	O	O	O
the	O	O	O
subcontinent	O	O	O
have	O	O	O
recurrently	O	O	O
produced	O	O	O
several	O	O	O
allelic	O	O	B-T028
variants	O	O	B-T028
of	O	O	O
parasite	O	O	B-T204
drug	O	O	B-T038
resistance	O	O	I-T038
genes	O	O	B-T028
,	O	O	O
including	O	O	O
the	O	O	O
P.	O	O	B-T028
falciparum	O	O	I-T028
chloroquine	O	O	I-T028
resistance	O	O	I-T028
transporter	O	O	I-T028
(	O	O	O
pfcrt	O	O	B-T028
)	O	O	O
.	O	O	O

Despite	O	O	O
significant	O	O	O
reductions	O	O	B-T061
in	O	O	O
the	O	O	O
deployment	O	O	B-T052
of	O	O	O
the	O	O	O
4-aminoquinoline	O	O	B-T109
drug	O	O	B-T121
chloroquine	O	O	B-T109
(	O	O	O
CQ	O	O	B-T109
)	O	O	O
,	O	O	O
which	O	O	O
selected	O	O	O
for	O	O	O
the	O	O	O
mutant	O	O	B-T028
pfcrt	O	O	B-T028
alleles	O	O	B-T028
that	O	O	O
halted	O	O	O
CQ	O	O	O
efficacy	O	O	B-T080
decades	O	O	O
ago	O	O	O
,	O	O	O
the	O	O	O
parasite	O	O	B-T204
pfcrt	O	O	O
locus	O	O	B-T082
is	O	O	O
continuously	O	O	O
evolving	O	O	O
.	O	O	O

This	O	O	O
is	O	O	O
highlighted	O	O	O
by	O	O	O
the	O	O	O
presence	O	O	O
of	O	O	O
a	O	O	O
highly	O	O	B-T080
mutated	O	O	B-T045
allele	O	O	B-T028
,	O	O	O
Cam734	O	O	B-T028
pfcrt	O	O	I-T028
,	O	O	O
which	O	O	O
has	O	O	O
acquired	O	O	O
the	O	O	O
singular	O	O	O
ability	O	O	O
to	O	O	O
confer	O	O	O
parasite	O	O	B-T204
CQ	O	O	B-T109
resistance	O	O	B-T038
without	O	O	O
an	O	O	O
associated	O	O	O
fitness	O	O	B-T045
cost	O	O	B-T080
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
used	O	O	O
pfcrt	O	O	B-T028
-specific	O	O	O
zinc-finger	O	O	B-T116
nucleases	O	O	I-T116
to	O	O	O
genetically	O	O	B-T169
dissect	O	O	I-T169
this	O	O	O
allele	O	O	B-T028
in	O	O	O
the	O	O	O
pathogenic	O	O	B-T033
setting	O	O	O
of	O	O	O
asexual	O	O	B-T046
blood-stage	O	O	I-T046
infection	O	O	I-T046
.	O	O	O

Comparative	O	O	B-T062
analysis	O	O	I-T062
of	O	O	O
drug	O	O	B-T038
resistance	O	O	I-T038
and	O	O	O
growth	O	O	B-T040
profiles	O	O	O
of	O	O	O
recombinant	O	O	B-T204
parasites	O	O	I-T204
that	O	O	O
express	O	O	B-T045
Cam734	O	O	B-T028
or	O	O	O
variants	O	O	B-T028
thereof	O	O	O
,	O	O	O
Dd2	O	O	B-T028
(	O	O	O
the	O	O	O
most	O	O	O
common	O	O	O
Southeast	O	O	B-T083
Asian	O	O	I-T083
variant	O	O	B-T028
)	O	O	O
,	O	O	O
or	O	O	O
wild-type	O	O	B-T028
pfcrt	O	O	B-T028
,	O	O	O
revealed	O	O	O
previously	O	O	O
unknown	O	O	O
roles	O	O	O
for	O	O	O
PfCRT	O	O	B-T116
mutations	O	O	B-T045
in	O	O	O
modulating	O	O	O
parasite	O	O	B-T204
susceptibility	O	O	O
to	O	O	O
multiple	O	O	O
antimalarial	O	O	B-T121
agents	O	O	I-T121
.	O	O	O

These	O	O	O
results	O	O	O
were	O	O	O
generated	O	O	O
in	O	O	O
the	O	O	O
GC03	O	O	B-T028
strain	O	O	B-T001
,	O	O	O
used	O	O	O
in	O	O	O
multiple	O	O	O
earlier	O	O	O
pfcrt	O	O	B-T028
studies	O	O	B-T062
,	O	O	O
and	O	O	O
might	O	O	O
differ	O	O	O
in	O	O	O
natural	O	O	O
isolates	O	O	O
harboring	O	O	O
this	O	O	O
allele	O	O	B-T028
.	O	O	O

Results	O	O	O
presented	O	O	O
herein	O	O	O
show	O	O	O
that	O	O	O
Cam734	O	O	B-T028
-mediated	O	O	O
CQ	O	O	B-T109
resistance	O	O	B-T038
is	O	O	O
dependent	O	O	O
on	O	O	O
the	O	O	O
rare	O	O	O
A144F	O	O	B-T045
mutation	O	O	B-T045
that	O	O	O
has	O	O	O
not	O	O	O
been	O	O	O
observed	O	O	O
beyond	O	O	O
Southeast	O	O	B-T083
Asia	O	O	I-T083
,	O	O	O
and	O	O	O
reveal	O	O	O
distinct	O	O	O
impacts	O	O	B-T080
of	O	O	O
this	O	O	O
and	O	O	O
other	O	O	O
Cam734	O	O	O
-specific	O	O	O
mutations	O	O	B-T045
on	O	O	O
CQ	O	O	O
resistance	O	O	O
and	O	O	O
parasite	O	O	B-T204
growth	O	O	B-T079
rates	O	O	I-T079
.	O	O	O

Biochemical	O	O	B-T059
assays	O	O	I-T059
revealed	O	O	O
a	O	O	O
broad	O	O	O
impact	O	O	B-T080
of	O	O	O
mutant	O	O	B-T049
PfCRT	O	O	B-T116
isoforms	O	O	B-T116
on	O	O	O
parasite	O	O	B-T204
metabolism	O	O	B-T040
,	O	O	O
including	O	O	O
nucleoside	O	O	B-T114
triphosphate	O	O	I-T114
levels	O	O	B-T080
,	O	O	O
hemoglobin	O	O	B-T044
catabolism	O	O	I-T044
and	O	O	O
disposition	O	O	O
of	O	O	O
heme	O	O	B-T109
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
digestive	O	O	B-T026
vacuole	O	O	I-T026
volume	O	O	B-T081
and	O	O	O
pH.	O	O	O
Results	O	O	O
from	O	O	O
our	O	O	O
study	O	O	O
provide	O	O	O
new	O	O	O
insights	O	O	O
into	O	O	O
the	O	O	O
complex	O	O	B-T170
molecular	O	O	I-T170
basis	O	O	I-T170
and	O	O	O
physiological	O	O	B-T169
impact	O	O	O
of	O	O	O
PfCRT	O	O	O
-mediated	O	O	O
antimalarial	O	O	B-T121
drug	O	O	B-T038
resistance	O	O	I-T038
,	O	O	O
and	O	O	O
inform	O	O	O
ongoing	O	O	O
efforts	O	O	O
to	O	O	O
characterize	O	O	O
novel	O	O	O
pfcrt	O	O	B-T028
alleles	O	O	B-T028
that	O	O	O
can	O	O	O
undermine	O	O	O
the	O	O	O
efficacy	O	O	B-T080
of	O	O	O
first-line	O	O	O
antimalarial	O	O	B-T121
drug	O	O	I-T121
regimens	O	O	B-T061
.	O	O	O

-DOCSTART- (27832581)

Effect	O	O	B-T080
of	O	O	O
nutritionally	O	O	B-T033
induced	O	O	I-T033
hyperlipidaemia	O	O	B-T047
on	O	O	O
in	O	O	B-T080
vitro	O	O	I-T080
bovine	O	O	B-T015
embryo	O	O	B-T018
quality	O	O	O
depends	O	O	O
on	O	O	O
the	O	O	O
type	O	O	O
of	O	O	O
major	O	O	O
fatty	O	O	B-T109
acid	O	O	I-T109
in	O	O	O
the	O	O	O
diet	O	O	O

The	O	O	O
present	O	O	O
study	O	O	B-T062
examined	O	O	B-T033
whether	O	O	O
the	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
dietary	O	O	B-T168
-induced	O	O	O
hyperlipidaemia	O	O	B-T047
on	O	O	O
preimplantation	O	O	B-T039
embryo	O	O	I-T039
development	O	O	I-T039
depend	O	O	O
on	O	O	O
the	O	O	O
predominant	O	O	O
fatty	O	O	B-T109
acid	O	O	I-T109
(	O	O	O
FA	O	O	B-T109
)	O	O	O
type	O	O	O
in	O	O	O
the	O	O	O
diet	O	O	B-T168
.	O	O	O

In	O	O	O
a	O	O	O
combined	O	O	O
in	O	O	B-T082
vivo	O	O	I-T082
-	O	O	O
in	O	O	B-T080
vitro	O	O	I-T080
bovine	O	O	B-T015
model	O	O	B-T008
,	O	O	O
two	O	O	O
groups	O	O	O
of	O	O	O
cows	O	O	B-T015
(	O	O	O
n=3	O	O	O
in	O	O	O
each	O	O	O
group	O	O	O
)	O	O	O
were	O	O	O
fed	O	O	B-T052
with	O	O	O
three	O	O	O
diets	O	O	B-T168
consecutively	O	O	O
(	O	O	O
4	O	O	O
weeks	O	O	O
feeding	O	O	B-T052
for	O	O	O
each	O	O	O
):	O	O	O
(	O	O	O
1	O	O	O
)	O	O	O
a	O	O	O
maintenance	O	O	B-T168
control	O	O	I-T168
diet	O	O	B-T168
(	O	O	O
CONT	O	O	B-T168
)	O	O	O
;	O	O	O
(	O	O	O
2	O	O	O
)	O	O	O
a	O	O	O
high	O	O	B-T080
-	O	O	O
starch	O	O	B-T168
diet	O	O	O
rich	O	O	O
in	O	O	O
saturated	O	O	B-T168
fat	O	O	I-T168
(	O	O	O
SAT	O	O	B-T168
)	O	O	O
;	O	O	O
and	O	O	O
(	O	O	O
3	O	O	O
)	O	O	O
a	O	O	O
high	O	O	O
-	O	O	O
starch	O	O	O
diet	O	O	O
rich	O	O	O
in	O	O	O
omega-3	O	O	B-T109
unsaturated	O	O	B-T109
fat	O	O	I-T109
(	O	O	O
UNSAT	O	O	B-T109
)	O	O	O
.	O	O	O

Two	O	O	O
feeding	O	O	B-T052
sequences	O	O	B-T169
were	O	O	O
used	O	O	O
to	O	O	O
test	O	O	O
for	O	O	O
carry-over	O	O	O
effects	O	O	O
:	O	O	O
Group	O	O	O
A	O	O	O
was	O	O	O
fed	O	O	B-T052
CONT	O	O	B-T168
,	O	O	O
SAT1	O	O	B-T168
and	O	O	O
then	O	O	O
UNSAT2	O	O	B-T109
,	O	O	O
whereas	O	O	O
Group	O	O	O
B	O	O	O
was	O	O	O
fed	O	O	O
CONT	O	O	O
,	O	O	O
UNSAT1	O	O	B-T109
and	O	O	O
then	O	O	O
SAT2	O	O	B-T168
.	O	O	O

Serum	O	O	B-T031
was	O	O	O
collected	O	O	O
after	O	O	O
each	O	O	O
dietary	O	O	B-T168
period	O	O	B-T079
,	O	O	O
analysed	O	O	B-T062
and	O	O	O
tested	O	O	B-T169
in	O	O	O
bovine	O	O	B-T015
in	O	O	B-T080
vitro	O	O	I-T080
embryo	O	O	B-T059
culture	O	O	I-T059
.	O	O	O

Introducing	O	O	O
SAT	O	O	B-T168
and	O	O	O
UNSAT	O	O	B-T109
diets	O	O	B-T168
induced	O	O	O
hyperlipidaemia	O	O	B-T047
(	O	O	O
specifically	O	O	O
hypercholesterolaemia	O	O	B-T047
and	O	O	O
elevated	O	O	O
free	O	O	B-T109
FAs	O	O	I-T109
)	O	O	O
and	O	O	O
reduced	O	O	O
insulin	O	O	B-T046
sensitivity	O	O	I-T046
.	O	O	O

Carry-over	O	O	O
effects	O	O	O
in	O	O	O
serum	O	O	B-T031
metabolites	O	O	B-T123
and	O	O	O
FA	O	O	B-T059
profile	O	O	I-T059
were	O	O	O
dependent	O	O	O
on	O	O	O
the	O	O	O
diet	O	O	B-T168
and	O	O	O
feeding	O	O	B-T052
sequence	O	O	B-T169
.	O	O	O

SAT1	O	O	B-T168
and	O	O	O
SAT2	O	O	B-T168
serum	O	O	B-T031
decreased	O	O	O
blastocyst	O	O	B-T018
rates	O	O	O
and	O	O	O
altered	O	O	O
blastocyst	O	O	O
mRNA	O	O	B-T045
expression	O	O	I-T045
related	O	O	O
to	O	O	O
apoptosis	O	O	B-T043
and	O	O	O
oxidative	O	O	B-T049
stress	O	O	I-T049
.	O	O	O

UNSAT1	O	O	B-T109
and	O	O	O
UNSAT2	O	O	B-T109
serum	O	O	B-T031
resulted	O	O	O
in	O	O	O
normal	O	O	O
embryo	O	O	B-T018
development	O	O	O
and	O	O	O
quality	O	O	B-T080
.	O	O	O

Other	O	O	O
in	O	O	B-T080
vitro	O	O	I-T080
effects	O	O	O
depended	O	O	O
on	O	O	O
the	O	O	O
sequence	O	O	B-T169
of	O	O	O
feeding	O	O	B-T052
.	O	O	O

In	O	O	O
conclusion	O	O	O
,	O	O	O
substitution	O	O	B-T052
of	O	O	O
saturated	O	O	B-T168
fat	O	O	I-T168
with	O	O	O
omega-3	O	O	B-T109
fat	O	O	I-T109
in	O	O	O
a	O	O	O
high-caloric	O	O	B-T061
diet	O	O	I-T061
induced	O	O	O
hyperlipidaemia	O	O	B-T047
with	O	O	O
an	O	O	O
FA	O	O	B-T059
profile	O	O	I-T059
yielding	O	O	O
similar	O	O	O
rates	O	O	O
and	O	O	O
quality	O	O	O
of	O	O	O
blastocysts	O	O	B-T018
compared	O	O	O
with	O	O	O
normolipidaemic	O	O	B-T096
controls	O	O	I-T096
.	O	O	O

-DOCSTART- (27834716)

Draft	O	O	B-T085
Genome	O	O	I-T085
Sequence	O	O	I-T085
of	O	O	O
the	O	O	O
Soil	O	O	B-T167
Isolate	O	O	B-T123
Lysinibacillus	O	O	B-T007
fusiformis	O	O	I-T007
M5	O	O	I-T007
,	O	O	O
a	O	O	O
Potential	O	O	B-T080
Hypoxanthine	O	O	B-T109
Producer	O	O	O

Lysinibacillus	O	O	B-T007
fusiformis	O	O	I-T007
strain	O	O	I-T007
M5	O	O	I-T007
is	O	O	O
a	O	O	O
potential	O	O	B-T080
hypoxanthine	O	O	B-T109
producer	O	O	O
that	O	O	O
was	O	O	O
isolated	O	O	B-T123
from	O	O	O
clay	O	O	B-T197
soil	O	O	B-T167
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
present	O	O	O
the	O	O	O
draft	O	O	B-T085
genome	O	O	I-T085
sequence	O	O	I-T085
that	O	O	O
was	O	O	O
annotated	O	O	B-T063
in	O	O	O
order	O	O	O
to	O	O	O
facilitate	O	O	O
future	O	O	O
studies	O	O	B-T062
of	O	O	O
L.	O	O	O
fusiformis	O	O	O
M5	O	O	O
.	O	O	O

-DOCSTART- (27834754)

Impact	O	O	B-T080
of	O	O	O
Clinical	O	O	B-T062
Trial	O	O	I-T062
Results	O	O	B-T034
on	O	O	O
the	O	O	O
Temporal	O	O	B-T079
Trends	O	O	B-T079
of	O	O	O
Carotid	O	O	B-T061
Endarterectomy	O	O	I-T061
and	O	O	O
Stenting	O	O	B-T061
From	O	O	O
2002	O	O	O
to	O	O	O
2014	O	O	O

Randomized	O	O	B-T062
trials	O	O	I-T062
provide	O	O	O
conflicting	O	O	B-T080
data	O	O	B-T078
for	O	O	O
the	O	O	O
efficacy	O	O	B-T080
of	O	O	O
carotid-artery	O	O	B-T061
stenting	O	O	I-T061
compared	O	O	O
with	O	O	O
endarterectomy	O	O	B-T061
.	O	O	O

The	O	O	O
purpose	O	O	O
of	O	O	O
this	O	O	O
study	O	O	O
was	O	O	O
to	O	O	O
examine	O	O	O
the	O	O	O
impact	O	O	B-T080
of	O	O	O
conflicting	O	O	B-T080
clinical	O	O	B-T170
trial	O	O	I-T170
publications	O	O	I-T170
on	O	O	O
the	O	O	O
utilization	O	O	B-UnknownType
rates	O	O	O
of	O	O	O
carotid	O	O	B-T061
revascularization	O	O	I-T061
procedures	O	O	I-T061
.	O	O	O

We	O	O	O
conducted	O	O	O
a	O	O	O
population-level	O	O	B-T062
time-series	O	O	I-T062
analysis	O	O	I-T062
of	O	O	O
all	O	O	O
individuals	O	O	B-T098
who	O	O	O
underwent	O	O	O
carotid	O	O	B-T061
endarterectomy	O	O	I-T061
and	O	O	O
stenting	O	O	B-T061
in	O	O	O
Ontario	O	O	B-T083
,	O	O	O
Canada	O	O	B-T083
(	O	O	O
2002	O	O	O
-	O	O	O
2014	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
primary	O	O	B-T062
analysis	O	O	I-T062
examined	O	O	O
temporal	O	O	B-T079
changes	O	O	B-T081
in	O	O	O
the	O	O	O
rates	O	O	B-T081
of	O	O	O
carotid	O	O	B-T061
revascularization	O	O	I-T061
procedures	O	O	I-T061
after	O	O	O
publications	O	O	B-T073
of	O	O	O
major	O	O	O
randomized	O	O	B-T062
trials	O	O	I-T062
.	O	O	O

Secondary	O	O	B-UnknownType
analyses	O	O	I-UnknownType
examined	O	O	O
changes	O	O	B-T081
in	O	O	O
overall	O	O	B-T080
and	O	O	O
age	O	O	B-T032
,	O	O	O
sex	O	O	B-T032
,	O	O	O
carotid-artery	O	O	B-T184
symptom	O	O	I-T184
,	O	O	O
and	O	O	O
operator	O	O	B-T081
specialty-specific	O	O	I-T081
procedure	O	O	I-T081
rates	O	O	I-T081
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
16	O	O	O
772	O	O	O
patients	O	O	B-T101
were	O	O	O
studied	O	O	O
(	O	O	O
14	O	O	O
394	O	O	O
endarterectomy	O	O	B-T061
[	O	O	O
86	O	O	O
%	O	O	O
]	O	O	O
;	O	O	O
2378	O	O	O
stenting	O	O	B-T061
[	O	O	O
14	O	O	O
%	O	O	O
]	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
overall	O	O	O
rate	O	O	O
of	O	O	O
carotid	O	O	B-T061
revascularization	O	O	I-T061
decreased	O	O	O
from	O	O	O
6.0	O	O	O
procedures	O	O	B-T061
per	O	O	O
100	O	O	O
000	O	O	O
individuals	O	O	B-T098
â¥40	O	O	O
years	O	O	O
old	O	O	O
in	O	O	O
April	O	O	O
2002	O	O	O
to	O	O	O
4.3	O	O	O
procedures	O	O	O
in	O	O	O
the	O	O	O
first	O	O	O
quarter	O	O	O
of	O	O	O
2014	O	O	O
(	O	O	O
29	O	O	O
%	O	O	O
decrease	O	O	O
;	O	O	O
P<0.001	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
rate	O	O	B-T081
of	O	O	O
endarterectomy	O	O	B-T061
decreased	O	O	B-T081
by	O	O	O
36	O	O	O
%	O	O	O
(	O	O	O
P<0.001	O	O	O
)	O	O	O
,	O	O	O
whereas	O	O	O
the	O	O	O
rate	O	O	O
of	O	O	O
carotid-artery	O	O	B-T061
stenting	O	O	I-T061
increased	O	O	B-T081
by	O	O	O
72	O	O	O
%	O	O	O
(	O	O	O
P=0.006	O	O	O
)	O	O	O
.	O	O	O

We	O	O	O
observed	O	O	O
a	O	O	O
marked	O	O	B-T169
increase	O	O	I-T169
(	O	O	O
P=0.01	O	O	O
)	O	O	O
in	O	O	O
stenting	O	O	B-T061
after	O	O	O
publication	O	O	B-T073
of	O	O	O
the	O	O	O
SAPPHIRE	O	O	B-T062
trial	O	O	I-T062
(	O	O	O
Stenting	O	O	B-T062
and	O	O	I-T062
Angioplasty	O	O	I-T062
With	O	O	I-T062
Protection	O	O	I-T062
in	O	O	I-T062
Patients	O	O	I-T062
at	O	O	I-T062
High	O	O	I-T062
Risk	O	O	I-T062
for	O	O	I-T062
Endarterectomy	O	O	I-T062
)	O	O	O
in	O	O	O
2004	O	O	O
,	O	O	O
whereas	O	O	O
stenting	O	O	O
remained	O	O	O
relatively	O	O	O
unchanged	O	O	B-T033
after	O	O	O
subsequent	O	O	O
randomized	O	O	B-T062
trials	O	O	I-T062
published	O	O	O
in	O	O	O
2006	O	O	O
(	O	O	O
P=0.11	O	O	O
)	O	O	O
and	O	O	O
2010	O	O	O
(	O	O	O
P=0.34	O	O	O
)	O	O	O
.	O	O	O

In	O	O	O
contrast	O	O	O
,	O	O	O
endarterectomy	O	O	B-T061
decreased	O	O	B-T081
after	O	O	O
trials	O	O	B-T062
published	O	O	O
in	O	O	O
2006	O	O	O
(	O	O	O
P=0.04	O	O	O
)	O	O	O
and	O	O	O
2010	O	O	O
(	O	O	O
P=0.005	O	O	O
)	O	O	O
.	O	O	O

Although	O	O	O
the	O	O	O
overall	O	O	B-T081
rates	O	O	I-T081
of	O	O	O
carotid	O	O	B-T061
revascularization	O	O	I-T061
and	O	O	O
endarterectomy	O	O	B-T061
have	O	O	O
fallen	O	O	O
since	O	O	O
2002	O	O	O
,	O	O	O
the	O	O	O
rate	O	O	B-T081
of	O	O	O
carotid-artery	O	O	B-T061
stenting	O	O	B-T061
has	O	O	O
risen	O	O	B-T081
since	O	O	O
the	O	O	O
publication	O	O	B-T073
of	O	O	O
stenting	O	O	O
-favorable	O	O	O
SAPPHIRE	O	O	B-T062
trial	O	O	I-T062
.	O	O	O

Subsequent	O	O	O
conflicting	O	O	B-T080
randomized	O	O	B-T062
trials	O	O	I-T062
were	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
a	O	O	O
decreasing	O	O	B-T033
rate	O	O	I-T033
of	O	O	O
carotid	O	O	B-T061
endarterectomy	O	O	I-T061
.	O	O	O

-DOCSTART- (27837821)

Electronic	O	O	B-T073
tongues	O	O	I-T073
to	O	O	O
assess	O	O	O
wine	O	O	B-T168
sensory	O	O	B-T080
descriptors	O	O	O

This	O	O	O
work	O	O	B-T057
reports	O	O	B-T170
the	O	O	O
application	O	O	B-T169
of	O	O	O
an	O	O	O
electronic	O	O	B-T073
tongue	O	O	I-T073
as	O	O	O
a	O	O	O
tool	O	O	B-T073
towards	O	O	O
the	O	O	O
analysis	O	O	B-T062
of	O	O	O
wine	O	O	B-T168
in	O	O	O
tasks	O	O	O
such	O	O	O
as	O	O	O
its	O	O	O
discrimination	O	O	B-T078
based	O	O	O
on	O	O	O
the	O	O	O
maturing	O	O	B-T079
in	O	O	O
barrels	O	O	B-T073
or	O	O	O
the	O	O	O
prediction	O	O	B-T078
of	O	O	O
the	O	O	O
global	O	O	B-T080
scores	O	O	B-T081
assigned	O	O	O
by	O	O	O
a	O	O	O
sensory	O	O	B-T097
panel	O	O	I-T097
.	O	O	O

To	O	O	O
this	O	O	O
aim	O	O	O
,	O	O	O
red	O	O	B-T168
wine	O	O	I-T168
samples	O	O	B-T167
were	O	O	O
first	O	O	O
analysed	O	O	B-T062
with	O	O	O
the	O	O	O
voltammetric	O	O	B-T073
sensor	O	O	I-T073
array	O	O	I-T073
,	O	O	O
without	O	O	O
performing	O	O	O
any	O	O	O
sample	O	O	B-T167
pretreatment	O	O	B-T052
.	O	O	O

Afterwards	O	O	O
,	O	O	O
obtained	O	O	O
responses	O	O	B-T169
were	O	O	O
preprocessed	O	O	B-T067
employing	O	O	O
fast	O	O	B-T170
Fourier	O	O	I-T170
transform	O	O	I-T170
(	O	O	O
FFT	O	O	B-T170
)	O	O	O
for	O	O	O
the	O	O	O
compression	O	O	B-T070
and	O	O	O
reduction	O	O	B-T080
of	O	O	O
signal	O	O	B-T067
complexity	O	O	B-T080
,	O	O	O
and	O	O	O
obtained	O	O	O
coefficients	O	O	B-T081
were	O	O	O
then	O	O	O
used	O	O	O
as	O	O	O
inputs	O	O	B-T077
to	O	O	O
build	O	O	O
the	O	O	O
qualitative	O	O	B-T080
and	O	O	O
quantitative	O	O	B-T081
models	O	O	B-T075
employing	O	O	O
either	O	O	O
linear	O	O	B-T062
discriminant	O	O	I-T062
analysis	O	O	I-T062
(	O	O	O
LDA	O	O	B-T062
)	O	O	O
or	O	O	O
partial	O	O	B-T170
least	O	O	I-T170
squares	O	O	I-T170
regression	O	O	I-T170
(	O	O	O
PLS	O	O	B-T170
)	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

Satisfactory	O	O	O
results	O	O	B-T033
were	O	O	O
obtained	O	O	O
overall	O	O	O
,	O	O	O
with	O	O	O
a	O	O	O
classification	O	O	B-T185
rate	O	O	B-T081
of	O	O	O
100	O	O	O
%	O	O	O
in	O	O	O
the	O	O	O
discrimination	O	O	B-T078
of	O	O	O
the	O	O	O
type	O	O	O
of	O	O	O
barrel	O	O	B-T073
used	O	O	O
during	O	O	O
wine	O	O	B-T168
maturing	O	O	B-T079
,	O	O	O
a	O	O	O
normalized	O	O	B-T081
NRMSE	O	O	I-T081
of	O	O	O
0.077	O	O	O
in	O	O	O
the	O	O	O
estimation	O	O	O
of	O	O	O
ageing	O	O	B-T040
time	O	O	B-T079
(	O	O	O
months	O	O	B-T079
)	O	O	O
or	O	O	O
0.11	O	O	O
in	O	O	O
the	O	O	O
prediction	O	O	B-T078
of	O	O	O
the	O	O	O
scores	O	O	B-T081
(	O	O	O
0	O	O	O
-	O	O	O
10	O	O	O
)	O	O	O
from	O	O	O
a	O	O	O
trained	O	O	B-T097
sensory	O	O	I-T097
panel	O	O	I-T097
(	O	O	O
all	O	O	O
for	O	O	O
the	O	O	O
external	O	O	O
test	O	O	B-T169
subset	O	O	B-T185
)	O	O	O
.	O	O	O

-DOCSTART- (27837915)

Toward	O	O	O
optimizing	O	O	B-T052
dental	O	O	B-T074
implant	O	O	I-T074
performance	O	O	O
:	O	O	O
Surface	O	O	B-T082
characterization	O	O	B-T052
of	O	O	O
Ti	O	O	B-T196
and	O	O	O
TiZr	O	O	B-T197
implant	O	O	O
materials	O	O	O

Targeting	O	O	B-T169
understanding	O	O	O
enhanced	O	O	B-T052
osseointegration	O	O	B-T042
kinetics	O	O	B-T070
,	O	O	O
the	O	O	O
goal	O	O	B-T170
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
characterize	O	O	B-T052
the	O	O	O
surface	O	O	B-T082
morphology	O	O	B-T080
and	O	O	O
composition	O	O	B-T201
of	O	O	O
Ti	O	O	B-T196
and	O	O	O
TiZr	O	O	B-T197
dental	O	O	B-T074
implant	O	O	I-T074
substrates	O	O	B-T167
subjected	O	O	O
to	O	O	O
one	O	O	O
of	O	O	O
two	O	O	O
surface	O	O	O
treatments	O	O	B-T169
developed	O	O	O
by	O	O	O
Straumann	O	O	O
.	O	O	O

These	O	O	O
two	O	O	O
treatments	O	O	B-T169
are	O	O	O
typically	O	O	O
known	O	O	O
as	O	O	O
SLA	O	O	B-T074
and	O	O	O
SLActive	O	O	B-T074
,	O	O	O
with	O	O	O
the	O	O	O
latter	O	O	O
resulting	O	O	O
in	O	O	O
more	O	O	O
rapid	O	O	B-T080
osseointegration	O	O	B-T042
.	O	O	O

A	O	O	O
range	O	O	O
of	O	O	O
techniques	O	O	B-T169
was	O	O	O
applied	O	O	B-T169
to	O	O	O
characterize	O	O	B-T052
four	O	O	O
different	O	O	B-T080
substrate	O	O	B-T082
/	O	O	O
surface	O	O	B-T082
treatment	O	O	B-T169
combinations	O	O	B-T080
(	O	O	O
TiSLA	O	O	B-T074
,	O	O	O
TiSLActive	O	O	B-T074
,	O	O	O
TiZrSLA	O	O	B-T074
,	O	O	O
and	O	O	O
TiZrSLActive	O	O	B-T074
)	O	O	O
.	O	O	O

Contact	O	O	B-T169
angle	O	O	B-T082
measurements	O	O	B-T169
establish	O	O	O
establish	O	O	O
their	O	O	O
hydrophilic	O	O	B-T080
/	O	O	O
hydrophobic	O	O	B-T080
nature	O	O	O
.	O	O	O

Surface	O	O	B-T082
morphology	O	O	B-T080
was	O	O	O
probed	O	O	O
with	O	O	O
scanning	O	O	B-T059
electron	O	O	I-T059
microscopy	O	O	I-T059
.	O	O	O

X-ray	O	O	B-T059
diffraction	O	O	I-T059
,	O	O	O
Raman	O	O	B-T059
Î¼-spectroscopy	O	O	I-T059
,	O	O	O
and	O	O	O
X-ray	O	O	B-T059
photoelectron	O	O	I-T059
spectroscopy	O	O	I-T059
were	O	O	O
used	O	O	O
to	O	O	O
elucidate	O	O	O
the	O	O	O
composition	O	O	B-T201
of	O	O	O
the	O	O	O
near-	O	O	O
surface	O	O	B-T082
region	O	O	O
.	O	O	O

Consistent	O	O	B-T078
with	O	O	I-T078
previous	O	O	B-T079
work	O	O	O
,	O	O	O
surface	O	O	B-T082
morphology	O	O	B-T080
was	O	O	O
found	O	O	O
to	O	O	O
differ	O	O	B-T080
only	O	O	O
at	O	O	O
the	O	O	O
nanoscale	O	O	B-T081
,	O	O	O
with	O	O	O
both	O	O	O
SLActive	O	O	B-T074
substrates	O	O	B-T167
displaying	O	O	B-T169
nano	O	O	B-T081
-	O	O	O
protrusions	O	O	B-T190
.	O	O	O

Spectroscopic	O	O	B-T059
data	O	O	B-T078
indicate	O	O	O
that	O	O	O
all	O	O	O
substrates	O	O	B-T167
exhibit	O	O	O
surface	O	O	B-T082
films	O	O	B-T080
of	O	O	O
titanium	O	O	B-T121
oxide	O	O	I-T121
displaying	O	O	O
near	O	O	O
TiO2	O	O	B-T121
stoichiometry	O	O	B-T081
.	O	O	O

Raman	O	O	B-T059
Î¼-spectroscopy	O	O	I-T059
reveals	O	O	B-T080
that	O	O	O
amorphous	O	O	B-T080
TiO2	O	O	B-T121
is	O	O	O
most	O	O	O
likely	O	O	O
the	O	O	O
only	O	O	O
phase	O	O	B-T079
present	O	O	B-T033
on	O	O	O
TiSLA	O	O	B-T074
,	O	O	O
whilst	O	O	O
rutile	O	O	B-T121
-	O	O	O
TiO2	O	O	O
is	O	O	O
also	O	O	O
evidenced	O	O	B-T078
on	O	O	O
TiSLActive	O	O	B-T074
,	O	O	O
TiZrSLA	O	O	B-T074
,	O	O	O
and	O	O	O
TiZrSLActive	O	O	B-T074
.	O	O	O

For	O	O	O
TiZr	O	O	B-T197
alloy	O	O	B-T122
substrates	O	O	B-T167
,	O	O	O
there	O	O	O
is	O	O	O
no	O	O	O
evidence	O	O	B-T078
of	O	O	O
discrete	O	O	B-T080
phases	O	O	B-T079
of	O	O	O
oxidized	O	O	B-T044
Zr	O	O	B-T196
.	O	O	O

X-ray	O	O	B-T059
photoelectron	O	O	I-T059
spectra	O	O	I-T059
demonstrate	O	O	O
that	O	O	O
all	O	O	O
samples	O	O	B-T167
are	O	O	O
terminated	O	O	B-T078
by	O	O	O
adventitious	O	O	B-T080
carbon	O	O	B-T196
,	O	O	O
with	O	O	O
it	O	O	O
being	O	O	O
somewhat	O	O	O
thicker	O	O	B-T080
(	O	O	O
â¼1	O	O	O
nm	O	O	O
)	O	O	O
on	O	O	O
TiSLA	O	O	B-T074
and	O	O	O
TiZrSLA	O	O	B-T074
.	O	O	O

Given	O	O	O
previous	O	O	B-T079
in	O	O	B-T062
vivo	O	O	I-T062
studies	O	O	I-T062
,	O	O	O
acquired	O	O	B-T080
data	O	O	B-T078
suggest	O	O	O
that	O	O	O
both	O	O	O
nanoscale	O	O	B-T081
protrusions	O	O	B-T190
,	O	O	O
and	O	O	O
a	O	O	O
thinner	O	O	B-T080
layer	O	O	B-T080
of	O	O	O
adventitious	O	O	B-T080
carbon	O	O	B-T196
contribute	O	O	B-T052
to	O	O	O
the	O	O	O
more	O	O	O
rapid	O	O	B-T080
osseointegration	O	O	B-T042
of	O	O	O
SLActive	O	O	B-T074
dental	O	O	B-T074
implants	O	O	I-T074
.	O	O	O

Composition	O	O	B-T201
of	O	O	O
the	O	O	O
surface	O	O	B-T082
oxide	O	O	B-T197
layer	O	O	B-T080
is	O	O	O
apparently	O	O	O
less	O	O	B-T080
important	O	O	B-T080
in	O	O	O
determining	O	O	O
osseointegration	O	O	B-T042
kinetics	O	O	B-T070
.	O	O	O

-DOCSTART- (27837917)

Cocaine	O	O	B-T109
Use	O	O	B-T169
Reverses	O	O	B-T169
Striatal	O	O	B-T042
Plasticity	O	O	I-T042
Produced	O	O	B-T169
During	O	O	B-T079
Cocaine	O	O	O
Seeking	O	O	O

Relapse	O	O	B-T067
is	O	O	O
a	O	O	O
two	O	O	B-T081
-	O	O	O
component	O	O	B-T077
process	O	O	B-T067
consisting	O	O	O
of	O	O	O
a	O	O	O
highly	O	O	B-T080
motivated	O	O	B-T041
drug-seeking	O	O	O
phase	O	O	B-T079
that	O	O	O
,	O	O	O
if	O	O	O
successful	O	O	O
,	O	O	O
is	O	O	O
followed	O	O	B-T079
by	O	O	I-T079
a	O	O	O
drug-using	O	O	B-T048
phase	O	O	O
resulting	O	O	B-T169
in	O	O	I-T169
temporary	O	O	B-T079
satiation	O	O	B-T041
.	O	O	O

In	O	O	O
rodents	O	O	B-T015
,	O	O	O
cue-induced	O	O	O
drug	O	O	O
seeking	O	O	O
requires	O	O	B-T169
transient	O	O	B-T042
synaptic	O	O	I-T042
potentiation	O	O	I-T042
(	O	O	O
t-SP	O	O	B-T042
)	O	O	O
of	O	O	O
cortical	O	O	B-T030
glutamatergic	O	O	I-T030
synapses	O	O	I-T030
on	O	O	O
nucleus	O	O	B-T023
accumbens	O	O	I-T023
core	O	O	B-T082
medium	O	O	B-T025
spiny	O	O	I-T025
neurons	O	O	I-T025
,	O	O	O
but	O	O	O
it	O	O	O
is	O	O	O
unknown	O	O	B-T080
how	O	O	O
achieving	O	O	O
drug	O	O	B-T048
use	O	O	I-T048
affects	O	O	B-T041
this	O	O	O
plasticity	O	O	B-T042
.	O	O	O

We	O	O	O
modeled	O	O	B-T077
the	O	O	O
two	O	O	O
phases	O	O	B-T079
of	O	O	O
relapse	O	O	B-T067
after	O	O	O
extinction	O	O	B-T041
from	O	O	O
cocaine	O	O	B-T109
self-administration	O	O	B-T061
to	O	O	O
assess	O	O	B-T052
how	O	O	O
cocaine	O	O	O
use	O	O	O
affects	O	O	B-T041
t-SP	O	O	B-T042
associated	O	O	B-T080
with	O	O	I-T080
cue-induced	O	O	O
drug	O	O	O
seeking	O	O	O
.	O	O	O

Rats	O	O	B-T015
were	O	O	O
trained	O	O	O
to	O	O	O
self-administer	O	O	B-T061
cocaine	O	O	B-T109
(	O	O	O
n	O	O	O
=	O	O	O
96	O	O	O
)	O	O	O
or	O	O	O
were	O	O	O
used	O	O	O
as	O	O	O
yoked	O	O	B-T073
-	O	O	O
saline	O	O	B-T167
control	O	O	B-T008
animals	O	O	I-T008
(	O	O	O
n	O	O	O
=	O	O	O
21	O	O	O
)	O	O	O
.	O	O	O

After	O	O	O
extinction	O	O	B-T041
,	O	O	O
reinstatement	O	O	B-T079
was	O	O	O
initiated	O	O	B-T169
by	O	O	O
10	O	O	O
minutes	O	O	B-T079
of	O	O	O
cue-induced	O	O	O
drug	O	O	O
seeking	O	O	O
,	O	O	O
followed	O	O	B-T079
by	O	O	I-T079
45	O	O	O
minutes	O	O	O
with	O	O	O
contingent	O	O	B-T080
cocaine	O	O	B-T109
access	O	O	B-T169
,	O	O	O
after	O	O	O
which	O	O	O
cocaine	O	O	O
was	O	O	O
discontinued	O	O	B-T033
and	O	O	O
unreinforced	O	O	B-T033
lever	O	O	I-T033
pressing	O	O	I-T033
ensued	O	O	I-T033
.	O	O	O

Three	O	O	B-T081
measures	O	O	B-T081
of	O	O	O
t-SP	O	O	B-T042
were	O	O	O
assayed	O	O	B-T059
during	O	O	B-T079
reinstatement	O	O	B-T079
:	O	O	O
dendritic	O	O	B-T026
spine	O	O	I-T026
morphology	O	O	B-T080
,	O	O	O
alpha-amino-3-hydroxy-5-methyl-4-isoxazole	O	O	B-T109
propionic	O	O	I-T109
acid	O	O	I-T109
(	O	O	O
AMPA	O	O	B-T109
)	O	O	O
to	O	O	O
N-methyl-D-aspartate	O	O	B-T116
(	O	O	O
NMDA	O	O	B-T116
)	O	O	O
ratios	O	O	B-T081
,	O	O	O
and	O	O	O
matrix	O	O	B-T116
metalloproteinase	O	O	I-T116
activity	O	O	B-T044
.	O	O	O

We	O	O	O
found	O	O	B-T033
that	O	O	O
cocaine	O	O	B-T109
use	O	O	O
for	O	O	O
10	O	O	O
minutes	O	O	B-T079
collapsed	O	O	B-T169
all	O	O	O
three	O	O	B-T081
measures	O	O	B-T081
of	O	O	O
cue-potentiated	O	O	O
t-SP	O	O	B-T042
back	O	O	O
to	O	O	O
baseline	O	O	B-T081
.	O	O	O

Moreover	O	O	O
,	O	O	O
when	O	O	O
cocaine	O	O	B-T109
use	O	O	O
was	O	O	O
discontinued	O	O	B-T033
45	O	O	O
minutes	O	O	B-T079
later	O	O	O
,	O	O	O
dendritic	O	O	B-T026
spine	O	O	I-T026
morphology	O	O	B-T080
and	O	O	O
AMPA	O	O	B-T109
to	O	O	O
NMDA	O	O	B-T116
ratios	O	O	B-T081
were	O	O	O
restored	O	O	O
as	O	O	O
animals	O	O	B-T008
became	O	O	O
motivated	O	O	B-T041
to	O	O	O
engage	O	O	O
unrewarded	O	O	O
lever	O	O	B-T033
pressing	O	O	I-T033
.	O	O	O

Nonreinforced	O	O	O
drug	O	O	O
seeking	O	O	O
was	O	O	O
positively	O	O	B-T033
correlated	O	O	B-T080
with	O	O	O
changes	O	O	B-T169
in	O	O	O
spine	O	O	B-T026
morphology	O	O	B-T080
,	O	O	O
and	O	O	O
cocaine	O	O	B-T109
access	O	O	B-T169
reversed	O	O	B-T169
this	O	O	O
relationship	O	O	B-T080
.	O	O	O

Using	O	O	O
a	O	O	O
novel	O	O	B-T080
modification	O	O	B-T169
of	O	O	O
the	O	O	O
reinstatement	O	O	B-T079
paradigm	O	O	B-T062
,	O	O	O
we	O	O	O
show	O	O	O
that	O	O	O
achieving	O	O	O
cocaine	O	O	B-T109
use	O	O	O
reversed	O	O	B-T169
the	O	O	O
synaptic	O	O	B-T042
plasticity	O	O	I-T042
underpinning	O	O	O
the	O	O	O
motivation	O	O	B-T041
to	O	O	O
seek	O	O	O
the	O	O	O
drug	O	O	B-T121
.	O	O	O

-DOCSTART- (27838742)

Delicaflavone	O	O	B-T121
induces	O	O	B-T169
autophagic	O	O	B-T043
cell	O	O	I-T043
death	O	O	I-T043
in	O	O	O
lung	O	O	B-T191
cancer	O	O	I-T191
via	O	O	O
Akt	O	O	B-T044
/	O	O	O
mTOR	O	O	B-T044
/	O	O	O
p70S6	O	O	B-T116
K	O	O	I-T116
signaling	O	O	O
pathway	O	O	O

Searching	O	O	O
for	O	O	O
potential	O	O	B-T080
anticancer	O	O	B-T109
agents	O	O	I-T109
from	O	O	O
natural	O	O	B-T033
sources	O	O	I-T033
is	O	O	O
an	O	O	O
effective	O	O	B-T080
strategy	O	O	O
for	O	O	O
developing	O	O	O
novel	O	O	B-T080
chemotherapeutic	O	O	B-T121
agents	O	O	I-T121
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
data	O	O	B-T078
supporting	O	O	O
the	O	O	O
in	O	O	B-T080
vitro	O	O	I-T080
and	O	O	O
in	O	O	B-T082
vivo	O	O	I-T082
anticancer	O	O	B-T033
effects	O	O	I-T033
of	O	O	O
delicaflavone	O	O	B-T121
,	O	O	O
a	O	O	O
rarely	O	O	O
occurring	O	O	O
biflavonoid	O	O	B-T109
from	O	O	O
Selaginella	O	O	B-T002
doederleinii	O	O	I-T002
,	O	O	O
were	O	O	O
reported	O	O	O
.	O	O	O

Delicaflavone	O	O	B-T121
exhibited	O	O	O
favorable	O	O	B-T080
anticancer	O	O	B-T033
properties	O	O	B-T070
,	O	O	O
as	O	O	O
shown	O	O	O
by	O	O	O
the	O	O	O
MTT	O	O	B-T062
assay	O	O	I-T062
and	O	O	O
xenograft	O	O	B-T050
model	O	O	I-T050
of	O	O	O
human	O	O	B-T016
non-small	O	O	B-T191
cell	O	O	I-T191
lung	O	O	I-T191
cancer	O	O	I-T191
in	O	O	O
male	O	O	B-T032
BALB/c	O	O	B-T015
nude	O	O	I-T015
mice	O	O	I-T015
without	O	O	O
observable	O	O	O
adverse	O	O	B-T046
effect	O	O	I-T046
.	O	O	O

By	O	O	O
transmission	O	O	B-T059
electron	O	O	I-T059
microscopy	O	O	I-T059
with	O	O	O
acridine	O	O	B-T109
orange	O	O	I-T109
and	O	O	O
Cyto-ID	O	O	B-T043
Â®	O	O	I-T043
Autophagy	O	O	I-T043
detection	O	O	O
dyes	O	O	B-T130
,	O	O	O
Western	O	O	B-T059
blot	O	O	I-T059
analysis	O	O	B-T062
,	O	O	O
and	O	O	O
RT-PCR	O	O	B-T063
assay	O	O	I-T063
,	O	O	O
we	O	O	O
confirmed	O	O	O
that	O	O	O
delicaflavone	O	O	B-T121
induces	O	O	B-T169
autophagic	O	O	B-T043
cell	O	O	I-T043
death	O	O	I-T043
by	O	O	O
increasing	O	O	B-T169
the	O	O	O
ratio	O	O	O
of	O	O	O
LC3-II	O	O	B-T116
to	O	O	O
LC3-I	O	O	B-T116
,	O	O	O
which	O	O	O
are	O	O	O
autophagy-related	O	O	B-T116
proteins	O	O	I-T116
,	O	O	O
and	O	O	O
promoting	O	O	B-T052
the	O	O	O
generation	O	O	B-T052
of	O	O	O
acidic	O	O	B-T026
vesicular	O	O	I-T026
organelles	O	O	I-T026
and	O	O	O
autolysosomes	O	O	B-T026
in	O	O	O
the	O	O	O
cytoplasm	O	O	B-T026
of	O	O	O
human	O	O	O
lung	O	O	B-T191
cancer	O	O	I-T191
A549	O	O	B-T025
and	O	O	O
PC-9	O	O	B-T025
cells	O	O	I-T025
in	O	O	O
a	O	O	O
time	O	O	B-T079
-	O	O	O
and	O	O	O
dose-dependent	O	O	B-T081
manner	O	O	O
.	O	O	O

Delicaflavone	O	O	B-T121
downregulated	O	O	B-T044
the	O	O	O
expression	O	O	B-T033
of	O	O	I-T033
phospho-Akt	O	O	I-T033
,	O	O	O
phospho-mTOR	O	O	B-T116
,	O	O	O
and	O	O	O
phospho-p70S6	O	O	B-T116
K	O	O	I-T116
in	O	O	O
a	O	O	O
time	O	O	B-T079
-	O	O	O
and	O	O	O
dose-dependent	O	O	B-T081
manner	O	O	O
,	O	O	O
suggesting	O	O	B-T078
that	O	O	O
it	O	O	O
induced	O	O	B-T169
autophagy	O	O	B-T043
by	O	O	O
inhibiting	O	O	B-T052
the	O	O	O
Akt	O	O	B-T044
/	O	O	O
mTOR	O	O	B-T044
/	O	O	O
p70S6	O	O	B-T116
K	O	O	I-T116
pathway	O	O	B-T044
in	O	O	O
A549	O	O	B-T025
and	O	O	O
PC-9	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

Delicaflavone	O	O	B-T121
is	O	O	O
a	O	O	O
potential	O	O	B-T080
anticancer	O	O	B-T109
agent	O	O	I-T109
that	O	O	O
can	O	O	O
induce	O	O	B-T169
autophagic	O	O	B-T043
cell	O	O	I-T043
death	O	O	I-T043
in	O	O	O
human	O	O	B-T016
non-small	O	O	B-T191
cell	O	O	I-T191
lung	O	O	I-T191
cancer	O	O	I-T191
via	O	O	O
the	O	O	O
Akt	O	O	B-T044
/	O	O	O
mTOR	O	O	B-T044
/	O	O	O
p70S6	O	O	B-T116
K	O	O	I-T116
signaling	O	O	B-T044
pathway	O	O	I-T044
.	O	O	O

Delicaflavone	O	O	B-T121
showed	O	O	O
anti-lung	O	O	B-T033
cancer	O	O	I-T033
effects	O	O	I-T033
in	O	O	B-T080
vitro	O	O	I-T080
and	O	O	O
in	O	O	B-T082
vivo	O	O	I-T082
.	O	O	O

Delicaflavone	O	O	B-T121
induced	O	O	B-T169
autophagic	O	O	B-T043
cell	O	O	I-T043
death	O	O	I-T043
via	O	O	O
Akt	O	O	B-T044
/	O	O	O
mTOR	O	O	B-T044
/	O	O	O
p70S6	O	O	B-T116
K	O	O	I-T116
signaling	O	O	B-T044
pathway	O	O	I-T044
.	O	O	O

Delicaflavone	O	O	B-T121
did	O	O	O
not	O	O	O
show	O	O	O
observable	O	O	O
side	O	O	B-T046
effects	O	O	I-T046
in	O	O	O
a	O	O	O
xenograft	O	O	B-T050
mouse	O	O	I-T050
model	O	O	I-T050
.	O	O	O

Delicaflavone	O	O	B-T121
may	O	O	O
represent	O	O	O
a	O	O	O
potential	O	O	B-T080
therapeutic	O	O	B-T073
agent	O	O	I-T073
for	O	O	O
lung	O	O	B-T191
cancer	O	O	I-T191
.	O	O	O

Delicaflavone	O	O	B-T121
showed	O	O	O
anti-lung	O	O	B-T033
cancer	O	O	I-T033
effects	O	O	I-T033
in	O	O	B-T080
vitro	O	O	I-T080
and	O	O	O
in	O	O	B-T082
vivo	O	O	I-T082
.	O	O	O

Delicaflavone	O	O	B-T121
induced	O	O	O
autophagic	O	O	B-T043
cell	O	O	I-T043
death	O	O	I-T043
via	O	O	O
Akt	O	O	B-T044
/	O	O	O
mTOR	O	O	B-T044
/	O	O	O
p70S6	O	O	B-T116
K	O	O	I-T116
signaling	O	O	B-T044
pathway	O	O	I-T044
.	O	O	O

Delicaflavone	O	O	B-T121
did	O	O	O
not	O	O	O
show	O	O	O
observable	O	O	O
side	O	O	B-T046
effects	O	O	I-T046
in	O	O	O
a	O	O	O
xenograft	O	O	B-T050
mouse	O	O	I-T050
model	O	O	I-T050
.	O	O	O

Delicaflavone	O	O	B-T121
may	O	O	O
represent	O	O	O
a	O	O	O
potential	O	O	B-T080
therapeutic	O	O	B-T073
agent	O	O	I-T073
for	O	O	O
lung	O	O	B-T191
cancer	O	O	I-T191
.	O	O	O

-DOCSTART- (27840131)

Determinants	O	O	B-T169
of	O	O	O
On-Road	O	O	B-T073
Driving	O	O	B-T056
in	O	O	O
Multiple	O	O	O
Sclerosis	O	O	O

To	O	O	O
investigate	O	O	B-T169
the	O	O	O
cognitive	O	O	B-T169
,	O	O	O
visual	O	O	B-T169
,	O	O	O
and	O	O	O
motor	O	O	B-T033
deficits	O	O	I-T033
underlying	O	O	O
poor	O	O	O
performance	O	O	O
on	O	O	O
different	O	O	O
dimensions	O	O	B-T033
of	O	O	O
on-road	O	O	B-T073
driving	O	O	B-T056
in	O	O	O
individuals	O	O	B-T098
with	O	O	O
multiple	O	O	B-T047
sclerosis	O	O	I-T047
(	O	O	O
MS	O	O	B-T047
)	O	O	O
.	O	O	O

Prospective	O	O	O
cross-sectional	O	O	B-T062
study	O	O	I-T062
.	O	O	O

MS	O	O	B-T093
clinic	O	O	I-T093
and	O	O	O
driving	O	O	B-T056
simulator	O	O	B-T062
lab	O	O	B-T093
.	O	O	O

Active	O	O	B-T098
drivers	O	O	I-T098
(	O	O	O
N=102	O	O	O
)	O	O	O
with	O	O	O
various	O	O	O
types	O	O	O
of	O	O	O
MS	O	O	B-T047
.	O	O	O

Not	O	O	O
applicable	O	O	O
.	O	O	O

Off-road	O	O	B-T073
cognitive	O	O	B-T169
,	O	O	O
visual	O	O	B-T169
,	O	O	O
and	O	O	O
motor	O	O	B-T038
functions	O	O	I-T038
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
13	O	O	O
specific	O	O	B-T080
driving	O	O	B-UnknownType
skills	O	O	I-UnknownType
.	O	O	O

These	O	O	O
skills	O	O	B-UnknownType
were	O	O	O
categorized	O	O	B-T052
into	O	O	O
hierarchic	O	O	B-T062
clusters	O	O	I-T062
of	O	O	O
operational	O	O	B-T052
,	O	O	O
tactical	O	O	B-UnknownType
,	O	O	O
visuo-integrative	O	O	B-T169
,	O	O	O
and	O	O	O
mixed	O	O	B-UnknownType
driving	O	O	I-UnknownType
.	O	O	O

Stepwise	O	O	B-T170
regression	O	O	I-T170
analysis	O	O	I-T170
was	O	O	O
used	O	O	O
to	O	O	O
determine	O	O	O
the	O	O	O
off-road	O	O	B-T073
functions	O	O	O
influencing	O	O	O
performance	O	O	O
on	O	O	O
the	O	O	O
on-road	O	O	B-T073
test	O	O	B-T169
and	O	O	O
each	O	O	O
cluster	O	O	B-T081
.	O	O	O

Visuospatial	O	O	B-T041
function	O	O	I-T041
(	O	O	O
P=.002	O	O	O
)	O	O	O
,	O	O	O
inhibition	O	O	B-T041
(	O	O	O
P=.008	O	O	O
)	O	O	O
,	O	O	O
binocular	O	O	B-T033
acuity	O	O	I-T033
(	O	O	O
P=.04	O	O	O
)	O	O	O
,	O	O	O
vertical	O	O	B-T060
visual	O	O	I-T060
field	O	O	I-T060
(	O	O	O
P=.02	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
stereopsis	O	O	B-T041
(	O	O	O
P=.03	O	O	O
)	O	O	O
best	O	O	O
determined	O	O	O
variance	O	O	B-T080
in	O	O	O
total	O	O	O
on-road	O	O	B-T073
score	O	O	B-T081
(	O	O	O
unadjusted	O	O	O
R(2)=.37	O	O	O
)	O	O	O
.	O	O	O

Attentional	O	O	B-T033
shift	O	O	I-T033
(	O	O	O
P=.0004	O	O	O
)	O	O	O
,	O	O	O
stereopsis	O	O	B-T041
(	O	O	O
P=.007	O	O	O
)	O	O	O
,	O	O	O
glare	O	O	B-T060
recovery	O	O	I-T060
(	O	O	O
P=.047	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
use	O	O	O
of	O	O	O
assistive	O	O	B-T074
devices	O	O	I-T074
(	O	O	O
P=.03	O	O	O
)	O	O	O
best	O	O	O
predicted	O	O	O
the	O	O	O
operational	O	O	B-T062
cluster	O	O	I-T062
(	O	O	O
unadjusted	O	O	O
R(2)=.28	O	O	O
)	O	O	O
.	O	O	O

Visuospatial	O	O	B-T041
function	O	O	I-T041
(	O	O	O
P=.002	O	O	O
)	O	O	O
,	O	O	O
inhibition	O	O	B-T041
(	O	O	O
P=.002	O	O	O
)	O	O	O
,	O	O	O
reasoning	O	O	B-T041
(	O	O	O
P=.003	O	O	O
)	O	O	O
,	O	O	O
binocular	O	O	B-T033
acuity	O	O	I-T033
(	O	O	O
P=.04	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
stereopsis	O	O	B-T041
(	O	O	O
P=.005	O	O	O
)	O	O	O
best	O	O	O
determined	O	O	O
the	O	O	O
tactical	O	O	B-T062
cluster	O	O	I-T062
(	O	O	O
unadjusted	O	O	O
R(2)=.41	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
visuo-integrative	O	O	B-T170
mode	O	O	I-T170
l	O	O	O
(	O	O	O
unadjusted	O	O	O
R(2)=.12	O	O	O
)	O	O	O
comprised	O	O	O
binocular	O	O	B-T033
acuity	O	O	I-T033
(	O	O	O
P=.007	O	O	O
)	O	O	O
and	O	O	O
stereopsis	O	O	B-T041
(	O	O	O
P=.045	O	O	O
)	O	O	O
.	O	O	O

Inhibition	O	O	B-T041
(	O	O	O
P=.0001	O	O	O
)	O	O	O
and	O	O	O
binocular	O	O	B-T033
acuity	O	O	I-T033
(	O	O	O
P=.001	O	O	O
)	O	O	O
provided	O	O	O
the	O	O	O
best	O	O	O
model	O	O	B-T081
of	O	O	O
the	O	O	O
mixed	O	O	B-T062
cluster	O	O	I-T062
(	O	O	O
unadjusted	O	O	O
R(2)=.25	O	O	O
)	O	O	O
.	O	O	O

Our	O	O	O
results	O	O	O
provide	O	O	O
more	O	O	O
insights	O	O	O
into	O	O	O
the	O	O	O
specific	O	O	O
impairments	O	O	B-T169
that	O	O	O
influence	O	O	O
different	O	O	O
dimensions	O	O	O
of	O	O	O
on-road	O	O	B-T073
driving	O	O	B-T056
and	O	O	O
may	O	O	O
be	O	O	O
used	O	O	O
as	O	O	O
a	O	O	O
framework	O	O	O
for	O	O	O
targeted	O	O	B-T169
driving	O	O	O
intervention	O	O	B-T061
programs	O	O	I-T061
in	O	O	O
MS	O	O	B-T047
.	O	O	O

-DOCSTART- (27842161)

Netarsudil	O	O	B-T121
Increases	O	O	B-T169
Outflow	O	O	B-T060
Facility	O	O	I-T060
in	O	O	O
Human	O	O	B-T016
Eyes	O	O	B-T023
Through	O	O	O
Multiple	O	O	B-T081
Mechanisms	O	O	O

Netarsudil	O	O	B-T121
is	O	O	O
a	O	O	O
Rho	O	O	B-T121
kinase/norepinephrine	O	O	I-T121
transporter	O	O	I-T121
inhibitor	O	O	I-T121
currently	O	O	O
in	O	O	O
phase	O	O	B-T062
3	O	O	I-T062
clinical	O	O	I-T062
development	O	O	I-T062
for	O	O	O
glaucoma	O	O	B-T047
treatment	O	O	B-T061
.	O	O	O

We	O	O	O
investigated	O	O	O
the	O	O	O
effects	O	O	O
of	O	O	O
its	O	O	O
active	O	O	O
metabolite	O	O	B-T123
,	O	O	O
netarsudil-M1	O	O	B-T121
,	O	O	O
on	O	O	O
outflow	O	O	B-T039
facility	O	O	I-T060
(	O	O	O
C	O	O	B-T060
)	O	O	O
,	O	O	O
outflow	O	O	O
hydrodynamics	O	O	B-T070
,	O	O	O
and	O	O	O
morphology	O	O	B-T080
of	O	O	O
the	O	O	O
conventional	O	O	B-T080
outflow	O	O	B-T077
pathway	O	O	I-T077
in	O	O	O
enucleated	O	O	B-T037
human	O	O	I-T037
eyes	O	O	I-T037
.	O	O	O

Paired	O	O	B-T080
human	O	O	B-T016
eyes	O	O	B-T023
(	O	O	O
n	O	O	O
=	O	O	O
5	O	O	O
)	O	O	O
were	O	O	O
perfused	O	O	B-T061
with	O	O	O
either	O	O	O
0.3	O	O	O
Î¼M	O	O	O
netarsudil-M1	O	O	B-T121
or	O	O	O
vehicle	O	O	B-T122
solution	O	O	I-T122
at	O	O	O
constant	O	O	B-T067
pressure	O	O	I-T067
(	O	O	O
15	O	O	O
mm	O	O	O
Hg	O	O	O
)	O	O	O
.	O	O	O

After	O	O	O
3	O	O	O
hours	O	O	B-T079
,	O	O	O
fluorescent	O	O	B-T074
microspheres	O	O	I-T074
were	O	O	O
added	O	O	O
to	O	O	O
perfusion	O	O	B-T061
media	O	O	B-T130
to	O	O	O
trace	O	O	B-T081
the	O	O	O
outflow	O	O	B-T039
patterns	O	O	I-T039
before	O	O	O
perfusion	O	O	O
-	O	O	O
fixation	O	O	B-T061
.	O	O	O

The	O	O	O
percentage	O	O	B-T081
effective	O	O	I-T081
filtration	O	O	I-T081
length	O	O	I-T081
(	O	O	O
PEFL	O	O	B-T081
)	O	O	O
was	O	O	O
calculated	O	O	O
from	O	O	O
the	O	O	O
measured	O	O	B-T080
lengths	O	O	B-T081
of	O	O	O
tracer	O	O	B-T130
distribution	O	O	B-T169
in	O	O	O
the	O	O	O
trabecular	O	O	B-T023
meshwork	O	O	I-T023
(	O	O	O
TM	O	O	B-T023
)	O	O	O
,	O	O	O
episcleral	O	O	B-T023
veins	O	O	I-T023
(	O	O	O
ESVs	O	O	B-T023
)	O	O	O
,	O	O	O
and	O	O	O
along	O	O	O
the	O	O	O
inner	O	O	B-T082
wall	O	O	I-T082
(	O	O	O
IW	O	O	B-T082
)	O	O	O
of	O	O	O
Schlemm	O	O	B-T030
's	O	O	I-T030
canal	O	O	I-T030
after	O	O	O
global	O	O	B-T080
and	O	O	O
confocal	O	O	B-T059
imaging	O	O	I-T059
.	O	O	O

Morphologic	O	O	B-T190
changes	O	O	I-T190
along	O	O	O
the	O	O	O
trabecular	O	O	B-T023
outflow	O	O	B-T077
pathway	O	O	I-T077
were	O	O	O
investigated	O	O	O
by	O	O	O
confocal	O	O	B-T059
,	O	O	O
light	O	O	B-T059
,	O	O	O
and	O	O	O
electron	O	O	B-T059
microscopy	O	O	I-T059
.	O	O	O

Perfusion	O	O	B-T061
with	O	O	O
netarsudil-M1	O	O	B-T121
significantly	O	O	B-T078
increased	O	O	B-T081
C	O	O	B-T060
when	O	O	O
compared	O	O	O
to	O	O	O
baseline	O	O	O
(	O	O	O
51	O	O	O
%	O	O	O
,	O	O	O
P	O	O	O
<	O	O	O
0.01	O	O	O
)	O	O	O
and	O	O	O
to	O	O	O
paired	O	O	B-T080
controls	O	O	O
(	O	O	O
102	O	O	O
%	O	O	O
,	O	O	O
P	O	O	O
<	O	O	O
0.01	O	O	O
)	O	O	O
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
significantly	O	O	O
increased	O	O	O
PEFL	O	O	B-T081
in	O	O	O
both	O	O	O
IW	O	O	B-T082
(	O	O	O
P	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
and	O	O	O
ESVs	O	O	B-T023
(	O	O	O
P	O	O	O
<	O	O	O
0.01	O	O	O
)	O	O	O
.	O	O	O

In	O	O	O
treated	O	O	O
eyes	O	O	B-T023
,	O	O	O
PEFL	O	O	B-T081
was	O	O	O
significantly	O	O	B-T078
higher	O	O	O
in	O	O	O
ESVs	O	O	B-T023
than	O	O	O
in	O	O	O
the	O	O	O
IW	O	O	B-T082
(	O	O	O
P	O	O	O
<	O	O	O
0.01	O	O	O
)	O	O	O
and	O	O	O
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
increased	O	O	B-T081
cross-sectional	O	O	B-T082
area	O	O	I-T082
of	O	O	O
ESVs	O	O	O
(	O	O	O
P	O	O	O
<	O	O	O
0.01	O	O	O
)	O	O	O
.	O	O	O

Percentage	O	O	B-T081
effective	O	O	I-T081
filtration	O	O	I-T081
length	O	O	I-T081
in	O	O	O
ESVs	O	O	B-T023
positively	O	O	O
correlated	O	O	O
with	O	O	O
the	O	O	O
percentage	O	O	O
change	O	O	O
in	O	O	O
C	O	O	B-T060
(	O	O	O
R2	O	O	O
=	O	O	O
0.58	O	O	O
,	O	O	O
P	O	O	O
=	O	O	O
0.01	O	O	O
)	O	O	O
.	O	O	O

A	O	O	O
significant	O	O	B-T078
increase	O	O	B-T169
in	O	O	O
juxtacanalicular	O	O	B-T024
connective	O	O	I-T024
tissue	O	O	I-T024
(	O	O	O
JCT	O	O	B-T024
)	O	O	O
thickness	O	O	B-T080
(	O	O	O
P	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
was	O	O	O
found	O	O	O
in	O	O	O
treated	O	O	O
eyes	O	O	B-T023
compared	O	O	O
to	O	O	O
controls	O	O	O
.	O	O	O

Netarsudil	O	O	B-T121
acutely	O	O	B-T079
increased	O	O	B-T081
C	O	O	B-T060
by	O	O	O
expansion	O	O	O
of	O	O	O
the	O	O	O
JCT	O	O	B-T024
and	O	O	O
dilating	O	O	O
the	O	O	O
ESVs	O	O	B-T023
,	O	O	O
which	O	O	O
led	O	O	O
to	O	O	O
redistribution	O	O	B-T169
of	O	O	O
aqueous	O	O	O
outflow	O	O	B-T039
through	O	O	O
a	O	O	O
larger	O	O	B-T082
area	O	O	I-T082
of	O	O	O
the	O	O	O
IW	O	O	B-T082
and	O	O	O
ESVs	O	O	O
.	O	O	O

-DOCSTART- (27842329)

Geographical	O	O	B-UnknownType
Factors	O	O	B-T169
Associated	O	O	B-T080
With	O	O	I-T080
Health	O	O	B-T033
Disparities	O	O	I-T033
in	O	O	O
Prostate	O	O	O
Cancer	O	O	O

Treatment	O	O	B-T061
variation	O	O	B-T080
in	O	O	O
prostate	O	O	B-T191
cancer	O	O	I-T191
is	O	O	O
common	O	O	O
,	O	O	O
and	O	O	O
it	O	O	O
is	O	O	O
driven	O	O	O
by	O	O	O
clinical	O	O	B-T080
and	O	O	O
clinician	O	O	B-T097
factors	O	O	B-T169
,	O	O	O
patient	O	O	B-T080
preferences	O	O	I-T080
,	O	O	O
availability	O	O	B-T169
of	O	O	I-T169
resources	O	O	B-T078
,	O	O	O
and	O	O	O
access	O	O	B-T082
to	O	O	O
physicians	O	O	B-T097
and	O	O	O
treating	O	O	B-T093
facilities	O	O	I-T093
.	O	O	O

Most	O	O	O
research	O	O	B-T062
on	O	O	O
treatment	O	O	B-T061
disparities	O	O	B-T080
in	O	O	O
men	O	O	B-T098
with	O	O	O
prostate	O	O	B-T191
cancer	O	O	I-T191
has	O	O	O
focused	O	O	O
on	O	O	O
race	O	O	B-T098
and	O	O	O
socioeconomic	O	O	B-T102
factors	O	O	I-T102
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
geography	O	O	B-T077
of	O	O	O
disparities	O	O	B-T080
-	O	O	O
capturing	O	O	O
racial	O	O	B-T033
and	O	O	O
socioeconomic	O	O	B-T033
differences	O	O	I-T033
based	O	O	O
on	O	O	O
where	O	O	O
patients	O	O	B-T080
live	O	O	B-T052
-	O	O	O
can	O	O	O
provide	O	O	O
insight	O	O	O
into	O	O	O
barriers	O	O	B-T080
to	O	O	O
care	O	O	B-T058
and	O	O	O
help	O	O	O
identify	O	O	O
outlier	O	O	O
areas	O	O	B-UnknownType
in	O	O	O
which	O	O	O
access	O	O	B-T082
to	O	O	O
care	O	O	O
,	O	O	O
health	O	O	B-T078
resources	O	O	I-T078
,	O	O	O
or	O	O	O
both	O	O	O
are	O	O	O
more	O	O	O
pronounced	O	O	O
.	O	O	O

Research	O	O	B-T062
regarding	O	O	O
treatment	O	O	B-T061
patterns	O	O	B-T082
and	O	O	O
disparities	O	O	B-T080
in	O	O	O
prostate	O	O	B-T191
cancer	O	O	I-T191
using	O	O	O
the	O	O	O
Geographical	O	O	B-T170
Information	O	O	I-T170
System	O	O	I-T170
(	O	O	O
GIS	O	O	B-T170
)	O	O	O
was	O	O	O
searched	O	O	B-T052
.	O	O	O

Studies	O	O	B-T062
were	O	O	O
limited	O	O	O
to	O	O	O
English-language	O	O	B-T171
articles	O	O	B-T170
and	O	O	O
research	O	O	B-T062
focused	O	O	O
on	O	O	O
US	O	O	B-T083
populations	O	O	B-T098
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
43	O	O	O
articles	O	O	B-T170
were	O	O	O
found	O	O	O
;	O	O	O
of	O	O	O
those	O	O	O
,	O	O	O
30	O	O	O
provided	O	O	O
information	O	O	B-T078
about	O	O	O
or	O	O	O
used	O	O	O
spatial	O	O	B-T082
or	O	O	O
geographical	O	O	B-UnknownType
analyses	O	O	B-T062
to	O	O	O
assess	O	O	B-T052
and	O	O	O
describe	O	O	O
differences	O	O	B-T080
or	O	O	O
disparities	O	O	B-T080
in	O	O	O
prostate	O	O	B-T191
cancer	O	O	I-T191
and	O	O	O
its	O	O	O
treatment	O	O	B-T061
.	O	O	O

Two	O	O	O
additional	O	O	O
GIS	O	O	B-T170
resources	O	O	O
were	O	O	O
included	O	O	O
.	O	O	O

The	O	O	O
research	O	O	B-T062
on	O	O	O
geographical	O	O	B-UnknownType
and	O	O	O
spatial	O	O	B-T169
determinants	O	O	I-T169
of	O	O	O
prostate	O	O	B-T191
cancer	O	O	I-T191
disparities	O	O	B-T080
was	O	O	O
reviewed	O	O	B-T080
.	O	O	O

We	O	O	O
also	O	O	O
examined	O	O	O
geographical	O	O	B-UnknownType
analyses	O	O	B-T062
at	O	O	O
the	O	O	O
state	O	O	B-UnknownType
level	O	O	I-UnknownType
,	O	O	O
focusing	O	O	O
on	O	O	O
Florida	O	O	B-T083
.	O	O	O

Overall	O	O	O
,	O	O	O
we	O	O	O
described	O	O	O
a	O	O	O
geographical	O	O	B-UnknownType
framework	O	O	O
to	O	O	O
disparities	O	O	B-T080
that	O	O	O
affect	O	O	O
men	O	O	B-T098
with	O	O	O
prostate	O	O	B-T191
cancer	O	O	I-T191
and	O	O	O
reviewed	O	O	B-T080
existing	O	O	O
published	O	O	O
evidence	O	O	B-T078
supporting	O	O	O
the	O	O	O
interplay	O	O	O
of	O	O	O
geographical	O	O	O
factors	O	O	B-T169
and	O	O	O
disparities	O	O	O
in	O	O	O
prostate	O	O	O
cancer	O	O	O
.	O	O	O

Disparities	O	O	B-T080
in	O	O	O
prostate	O	O	B-T191
cancer	O	O	I-T191
are	O	O	O
common	O	O	B-T081
and	O	O	O
persistent	O	O	B-T079
,	O	O	O
and	O	O	O
notable	O	O	O
differences	O	O	O
in	O	O	O
treatment	O	O	B-T061
are	O	O	O
observable	O	O	O
across	O	O	O
racial	O	O	O
and	O	O	O
socioeconomic	O	O	O
strata	O	O	O
.	O	O	O

Geographical	O	O	B-UnknownType
analysis	O	O	B-T062
provides	O	O	O
additional	O	O	O
information	O	O	B-T078
about	O	O	O
where	O	O	O
disparate	O	O	B-T080
groups	O	O	B-T098
live	O	O	B-T052
and	O	O	O
also	O	O	O
helps	O	O	O
to	O	O	O
map	O	O	B-T073
access	O	O	B-T082
to	O	O	O
care	O	O	B-T058
.	O	O	O

This	O	O	O
information	O	O	B-T078
can	O	O	O
be	O	O	O
used	O	O	O
by	O	O	O
public	O	O	B-T097
health	O	O	I-T097
officials	O	O	I-T097
,	O	O	O
health-systems	O	O	B-T097
administrators	O	O	I-T097
,	O	O	O
clinicians	O	O	B-T097
,	O	O	O
and	O	O	O
policymakers	O	O	B-T097
to	O	O	O
better	O	O	O
understand	O	O	O
and	O	O	O
respond	O	O	O
to	O	O	O
geographical	O	O	B-UnknownType
barriers	O	O	B-T080
that	O	O	O
contribute	O	O	O
to	O	O	O
disparities	O	O	B-T080
in	O	O	I-T080
care	O	O	I-T080
.	O	O	O

-DOCSTART- (27845771)

The	O	O	O
Novel	O	O	O
miR-9600	O	O	B-T114
Suppresses	O	O	B-T169
Tumor	O	O	B-T191
Progression	O	O	I-T191
and	O	O	O
Promotes	O	O	O
Paclitaxel	O	O	B-T109
Sensitivity	O	O	B-T080
in	O	O	O
Non-small-cell	O	O	B-T191
Lung	O	O	I-T191
Cancer	O	O	I-T191
Through	O	O	O
Altering	O	O	B-T078
STAT3	O	O	B-T028
Expression	O	O	O

MicroRNAs	O	O	B-T114
have	O	O	O
been	O	O	O
identified	O	O	B-T080
to	O	O	O
be	O	O	O
involved	O	O	O
in	O	O	O
center	O	O	B-T201
stage	O	O	I-T201
of	O	O	O
cancer	O	O	B-T091
biology	O	O	I-T091
.	O	O	O

They	O	O	O
accommodate	O	O	O
cell	O	O	B-T043
proliferation	O	O	I-T043
and	O	O	O
migration	O	O	B-T043
by	O	O	O
negatively	O	O	B-T033
regulate	O	O	B-T045
gene	O	O	I-T045
expression	O	O	I-T045
either	O	O	O
by	O	O	O
hampering	O	O	O
the	O	O	O
translation	O	O	B-UnknownType
of	O	O	O
targeted	O	O	B-T114
mRNAs	O	O	I-T114
or	O	O	O
by	O	O	O
promoting	O	O	O
their	O	O	O
degradation	O	O	B-T169
.	O	O	O

We	O	O	O
characterized	O	O	B-T052
and	O	O	O
identified	O	O	B-T080
the	O	O	O
novel	O	O	O
miR-9600	O	O	B-T114
and	O	O	O
its	O	O	O
target	O	O	B-T169
in	O	O	O
human	O	O	B-T016
non-small-cell	O	O	B-T191
lung	O	O	I-T191
cancer	O	O	I-T191
(	O	O	O
NSCLC	O	O	B-T191
)	O	O	O
.	O	O	O

Our	O	O	O
results	O	O	O
demonstrated	O	O	O
that	O	O	O
the	O	O	O
miR-9600	O	O	B-T114
were	O	O	O
downregulated	O	O	B-T044
in	O	O	O
NSCLC	O	O	B-T191
tissues	O	O	B-T024
and	O	O	O
cells	O	O	B-T025
.	O	O	O

It	O	O	O
is	O	O	O
confirmed	O	O	O
that	O	O	O
signal	O	O	B-T028
transducer	O	O	I-T028
and	O	O	I-T028
activator	O	O	I-T028
of	O	O	I-T028
transcription	O	O	I-T028
3	O	O	I-T028
(	O	O	O
STAT3	O	O	B-T028
)	O	O	O
,	O	O	O
a	O	O	O
putative	O	O	B-T028
target	O	O	I-T028
gene	O	O	I-T028
,	O	O	O
is	O	O	O
directly	O	O	O
inhibited	O	O	B-T080
by	O	O	O
miR-9600	O	O	B-T114
.	O	O	O

The	O	O	O
miR-9600	O	O	B-T114
markedly	O	O	O
suppressed	O	O	B-T169
the	O	O	O
protein	O	O	B-T045
expression	O	O	I-T045
of	O	O	O
STAT3	O	O	B-T028
,	O	O	O
but	O	O	O
with	O	O	O
no	O	O	B-T033
significant	O	O	I-T033
influence	O	O	B-T077
in	O	O	O
corresponding	O	O	O
mRNA	O	O	B-T114
levels	O	O	B-T080
,	O	O	O
and	O	O	O
the	O	O	O
direct	O	O	O
combination	O	O	O
of	O	O	O
miR-9600	O	O	O
and	O	O	O
STAT3	O	O	O
was	O	O	O
confirmed	O	O	O
by	O	O	O
a	O	O	O
luciferase	O	O	O
reporter	O	O	O
assay	O	O	O
.	O	O	O

miR-9600	O	O	B-T114
inhibited	O	O	B-T080
cell	O	O	B-T043
growth	O	O	I-T043
,	O	O	O
hampered	O	O	O
expression	O	O	B-T045
of	O	O	O
cell	O	O	B-T043
cycle	O	O	I-T043
-related	O	O	O
proteins	O	O	B-T116
and	O	O	O
inhibited	O	O	O
cell	O	O	B-T043
migration	O	O	I-T043
and	O	O	O
invasion	O	O	B-T046
in	O	O	O
human	O	O	B-T016
NSCLC	O	O	B-T191
cell	O	O	B-T025
lines	O	O	I-T025
.	O	O	O

Further	O	O	O
,	O	O	O
miR-9600	O	O	B-T114
significantly	O	O	O
suppressed	O	O	B-T169
tumor	O	O	B-T191
growth	O	O	I-T191
in	O	O	O
nude	O	O	B-T015
mice	O	O	I-T015
.	O	O	O

Similarly	O	O	O
,	O	O	O
miR-9600	O	O	B-T114
impeded	O	O	O
tumorigenesis	O	O	B-T191
and	O	O	O
metastasis	O	O	B-T046
through	O	O	O
directly	O	O	O
targeting	O	O	B-T044
STAT3	O	O	B-T028
.	O	O	O

Furthermore	O	O	O
,	O	O	O
we	O	O	O
identified	O	O	B-T080
that	O	O	O
miR-9600	O	O	B-T114
augmented	O	O	O
paclitaxel	O	O	B-T109
and	O	O	O
cisplatin	O	O	B-T121
sensitivity	O	O	B-T080
by	O	O	O
downregulating	O	O	B-T044
STAT3	O	O	B-T028
and	O	O	O
promoting	O	O	O
chemotherapy	O	O	B-T061
-	O	O	O
induced	O	O	B-T169
apoptosis	O	O	B-T043
.	O	O	O

These	O	O	O
data	O	O	O
demonstrate	O	O	O
that	O	O	O
miR-9600	O	O	B-T114
might	O	O	O
be	O	O	O
a	O	O	O
useful	O	O	O
and	O	O	O
novel	O	O	O
therapeutic	O	O	B-T169
target	O	O	B-T169
for	O	O	O
NSCLC	O	O	B-T191
.	O	O	O

-DOCSTART- (27846748)

Beneficial	O	O	B-UnknownType
effects	O	O	I-UnknownType
of	O	O	O
natural	O	O	B-T109
eggshell	O	O	I-T109
membrane	O	O	I-T109
(	O	O	O
NEM	O	O	B-T109
)	O	O	O
on	O	O	O
multiple	O	O	O
indices	O	O	O
of	O	O	O
arthritis	O	O	B-T047
in	O	O	O
collagen-induced	O	O	B-T050
arthritic	O	O	I-T050
rats	O	O	O

This	O	O	O
study	O	O	B-T062
was	O	O	O
performed	O	O	O
to	O	O	O
evaluate	O	O	B-T058
the	O	O	O
potential	O	O	B-T080
efficacy	O	O	I-T080
of	O	O	O
natural	O	O	B-T109
eggshell	O	O	I-T109
membrane	O	O	I-T109
(	O	O	O
NEM	O	O	B-T109
)	O	O	O
in	O	O	O
collagen-induced	O	O	B-T050
arthritic	O	O	I-T050
rats	O	O	B-T015
,	O	O	O
a	O	O	O
well-established	O	O	O
rodent	O	O	B-T050
model	O	O	I-T050
of	O	O	I-T050
inflammation	O	O	I-T050
and	O	O	O
rheumatoid	O	O	B-T047
arthritis	O	O	I-T047
.	O	O	O

Rats	O	O	B-T015
with	O	O	O
developing	O	O	O
type	O	O	B-T050
II	O	O	I-T050
collagen-induced	O	O	I-T050
arthritis	O	O	I-T050
(	O	O	O
CIA	O	O	B-T050
)	O	O	O
were	O	O	O
treated	O	O	O
once	O	O	O
daily	O	O	B-T079
by	O	O	O
oral	O	O	B-T169
gavage	O	O	I-T169
on	O	O	O
study	O	O	B-T079
days	O	O	I-T079
-14	O	O	O
to	O	O	O
17	O	O	O
with	O	O	O
vehicle	O	O	B-T122
or	O	O	O
NEM	O	O	B-T109
(	O	O	O
52	O	O	O
mg/kg	O	O	O
body	O	O	B-T032
weight	O	O	I-T032
)	O	O	O
.	O	O	O

Rats	O	O	B-T015
were	O	O	O
euthanized	O	O	B-T062
on	O	O	O
study	O	O	B-T079
day	O	O	I-T079
17	O	O	O
.	O	O	O

Efficacy	O	O	B-T080
was	O	O	O
assessed	O	O	B-T052
by	O	O	O
daily	O	O	B-T079
ankle	O	O	B-T029
caliper	O	O	B-T074
measurements	O	O	B-T169
,	O	O	O
ankle	O	O	O
diameter	O	O	B-T081
expressed	O	O	O
as	O	O	O
area	O	O	B-T081
under	O	O	I-T081
the	O	O	I-T081
curve	O	O	I-T081
(	O	O	O
AUCd0	O	O	B-T081
-	O	O	I-T081
17	O	O	I-T081
)	O	O	O
,	O	O	O
and	O	O	O
histopathologic	O	O	B-T091
evaluation	O	O	I-T091
of	O	O	O
ankles	O	O	B-T029
and	O	O	O
knees	O	O	B-T023
.	O	O	O

Serum	O	O	B-T031
biomarkers	O	O	B-T201
of	O	O	O
cartilage	O	O	B-T042
function	O	O	I-T042
and	O	O	O
inflammation	O	O	B-T046
[	O	O	O
collagen	O	O	B-T059
type	O	O	I-T059
II	O	O	I-T059
C-telopeptide	O	O	I-T059
(	O	O	O
CTXII	O	O	B-T059
)	O	O	O
,	O	O	O
cartilage	O	O	B-T059
oligomeric	O	O	I-T059
matrix	O	O	I-T059
protein	O	O	I-T059
(	O	O	O
COMP	O	O	B-T059
)	O	O	O
,	O	O	O
and	O	O	O
alpha-2-macroglobulin	O	O	B-T059
(	O	O	O
A2	O	O	B-T059
M	O	O	I-T059
)	O	O	O
]	O	O	O
were	O	O	O
measured	O	O	B-T080
by	O	O	O
ELISA	O	O	B-T059
.	O	O	O

Treatment	O	O	B-T169
with	O	O	O
NEM	O	O	B-T109
resulted	O	O	O
in	O	O	O
significant	O	O	B-UnknownType
beneficial	O	O	I-UnknownType
effects	O	O	I-UnknownType
on	O	O	O
the	O	O	O
daily	O	O	B-T079
ankle	O	O	B-T029
diameter	O	O	B-T081
measurements	O	O	B-T169
and	O	O	O
ankle	O	O	O
diameter	O	O	O
AUC	O	O	B-T081
.	O	O	O

Ankle	O	O	B-T029
and	O	O	O
knee	O	O	B-T023
histopathology	O	O	B-T034
scores	O	O	I-T034
were	O	O	O
significantly	O	O	B-T080
reduced	O	O	I-T080
(	O	O	O
36	O	O	O
%	O	O	O
and	O	O	O
43	O	O	O
%	O	O	O
reduction	O	O	B-T080
of	O	O	O
summed	O	O	O
individual	O	O	O
histopathology	O	O	O
scores	O	O	O
for	O	O	O
ankle	O	O	B-T029
and	O	O	O
knee	O	O	O
,	O	O	O
respectively	O	O	O
;	O	O	O
p	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
toward	O	O	O
normal	O	O	O
for	O	O	O
rats	O	O	B-T015
given	O	O	O
NEM	O	O	B-T109
compared	O	O	O
to	O	O	O
vehicle	O	O	O
controls	O	O	O
.	O	O	O

The	O	O	O
percent	O	O	O
reduction	O	O	O
of	O	O	O
serum	O	O	B-T031
CTXII	O	O	B-T059
,	O	O	O
COMP	O	O	B-T059
,	O	O	O
and	O	O	O
A2	O	O	B-T059
M	O	O	I-T059
in	O	O	O
NEM	O	O	B-T109
-	O	O	O
treated	O	O	B-T169
rats	O	O	B-T015
ranged	O	O	O
from	O	O	O
30	O	O	O
%	O	O	O
to	O	O	O
72	O	O	O
%	O	O	O
(	O	O	O
p	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
.	O	O	O

NEM	O	O	B-T109
significantly	O	O	O
improved	O	O	O
multiple	O	O	O
aspects	O	O	O
of	O	O	O
inflammatory	O	O	B-T047
arthritis	O	O	I-T047
including	O	O	O
inflammation	O	O	B-T046
,	O	O	O
pannus	O	O	B-T046
,	O	O	O
cartilage	O	O	B-T037
damage	O	O	I-T037
,	O	O	O
bone	O	O	B-T042
resorption	O	O	I-T042
,	O	O	O
and	O	O	O
periosteal	O	O	B-T042
bone	O	O	I-T042
formation	O	O	I-T042
.	O	O	O

This	O	O	O
study	O	O	B-T062
provides	O	O	O
further	O	O	O
support	O	O	O
for	O	O	O
the	O	O	O
use	O	O	O
of	O	O	O
CTXII	O	O	B-T116
,	O	O	O
COMP	O	O	B-T116
,	O	O	O
and	O	O	O
A2	O	O	B-T116
M	O	O	I-T116
as	O	O	O
relevant	O	O	O
biomarkers	O	O	B-T201
that	O	O	O
were	O	O	O
responsive	O	O	O
to	O	O	O
NEM	O	O	B-T109
.	O	O	O

-DOCSTART- (27853255)

Mimicking	O	O	O
the	O	O	O
cell	O	O	B-T026
membrane	O	O	I-T026
:	O	O	O
bio-inspired	O	O	B-T090
simultaneous	O	O	B-T079
functions	O	O	O
with	O	O	O
monovalent	O	O	B-UnknownType
anion	O	O	B-T196
selectivity	O	O	B-T052
and	O	O	O
antifouling	O	O	B-T070
properties	O	O	I-T070
of	O	O	O
anion	O	O	O
exchange	O	O	O
membrane	O	O	O

A	O	O	O
new	O	O	O
bio-inspired	O	O	B-T090
method	O	O	I-T090
was	O	O	O
applied	O	O	O
in	O	O	O
this	O	O	O
study	O	O	O
to	O	O	O
simultaneously	O	O	B-T079
improve	O	O	O
the	O	O	O
monovalent	O	O	B-UnknownType
anion	O	O	B-T196
selectivity	O	O	B-T052
and	O	O	O
antifouling	O	O	B-T070
properties	O	O	I-T070
of	O	O	O
anion	O	O	O
exchange	O	O	O
membranes	O	O	B-T074
(	O	O	O
AEMs	O	O	O
)	O	O	O
.	O	O	O

Three-layer	O	O	O
architecture	O	O	O
was	O	O	O
developed	O	O	O
by	O	O	O
deposition	O	O	O
of	O	O	O
polydopamine	O	O	B-T109
(	O	O	O
PDA	O	O	B-T109
)	O	O	O
and	O	O	O
electro-deposition	O	O	O
of	O	O	O
N-O-sulfonic	O	O	B-T109
acid	O	O	I-T109
benzyl	O	O	I-T109
chitosan	O	O	I-T109
(	O	O	O
NSBC	O	O	B-T109
)	O	O	O
.	O	O	O

The	O	O	O
innermost	O	O	B-T082
and	O	O	O
outermost	O	O	B-T082
layers	O	O	B-T167
were	O	O	O
PDA	O	O	B-T109
with	O	O	O
different	O	O	O
deposition	O	O	O
time	O	O	O
.	O	O	O

The	O	O	O
middle	O	O	B-T082
layer	O	O	B-T167
was	O	O	O
prepared	O	O	O
by	O	O	O
NSBC	O	O	B-T109
.	O	O	O

Fourier	O	O	B-T062
transform	O	O	I-T062
infrared	O	O	I-T062
spectroscopy	O	O	I-T062
and	O	O	O
scanning	O	O	B-T059
electron	O	O	I-T059
microscopy	O	O	I-T059
confirmed	O	O	O
that	O	O	O
PDA	O	O	B-T109
and	O	O	O
NSBC	O	O	B-T109
were	O	O	O
successfully	O	O	O
modified	O	O	O
on	O	O	O
the	O	O	O
surfaces	O	O	O
of	O	O	O
AEMs	O	O	O
.	O	O	O

The	O	O	O
contact	O	O	O
angle	O	O	O
of	O	O	O
the	O	O	O
membranes	O	O	B-T074
indicated	O	O	O
an	O	O	O
improved	O	O	O
hydrophilicity	O	O	B-T080
of	O	O	O
the	O	O	O
modified	O	O	O
membranes	O	O	O
.	O	O	O

A	O	O	O
series	O	O	O
of	O	O	O
electrodialysis	O	O	B-UnknownType
experiments	O	O	I-UnknownType
in	O	O	O
which	O	O	O
Cl(-	O	O	B-T196
)	O	O	I-T196
/	O	O	O
SO4(2-	O	O	B-T196
)	O	O	I-T196
separation	O	O	O
was	O	O	O
studied	O	O	O
,	O	O	O
demonstrating	O	O	O
the	O	O	O
monovalent	O	O	B-UnknownType
anion	O	O	B-T196
selectivity	O	O	B-T052
of	O	O	O
the	O	O	O
samples	O	O	O
.	O	O	O

The	O	O	O
Cl(-	O	O	B-T196
)	O	O	I-T196
/	O	O	O
SO4(2-	O	O	B-T196
)	O	O	I-T196
permselectivity	O	O	B-T070
of	O	O	O
the	O	O	O
modified	O	O	O
membranes	O	O	B-T074
can	O	O	O
reach	O	O	O
up	O	O	O
to	O	O	O
2.20	O	O	O
,	O	O	O
higher	O	O	O
than	O	O	O
that	O	O	O
of	O	O	O
the	O	O	O
commercial	O	O	B-T074
membrane	O	O	I-T074
(	O	O	O
only	O	O	O
0.78	O	O	O
)	O	O	O
during	O	O	O
90	O	O	O
minutes	O	O	O
in	O	O	O
electrodialysis	O	O	B-UnknownType
(	O	O	O
ED	O	O	B-UnknownType
)	O	O	O
.	O	O	O

The	O	O	O
increase	O	O	O
value	O	O	O
of	O	O	O
the	O	O	O
resistance	O	O	O
of	O	O	O
the	O	O	O
membranes	O	O	B-T074
was	O	O	O
also	O	O	O
measured	O	O	O
to	O	O	O
evaluate	O	O	O
the	O	O	O
antifouling	O	O	B-T070
properties	O	O	I-T070
.	O	O	O

Sodium	O	O	B-T109
dodecyl	O	O	I-T109
benzene	O	O	I-T109
sulfonate	O	O	I-T109
(	O	O	O
SDBS	O	O	B-T109
)	O	O	O
was	O	O	O
used	O	O	O
as	O	O	O
the	O	O	O
fouling	O	O	B-T070
material	O	O	O
in	O	O	O
the	O	O	O
ED	O	O	B-UnknownType
process	O	O	O
and	O	O	O
the	O	O	O
membrane	O	O	B-T074
area	O	O	O
resistance	O	O	O
of	O	O	O
modified	O	O	B-T074
membrane	O	O	I-T074
increase	O	O	O
value	O	O	O
of	O	O	O
was	O	O	O
only	O	O	O
0.08	O	O	O
Î©cm(2	O	O	O
)	O	O	O
30	O	O	O
minutes	O	O	O
later	O	O	O
.	O	O	O

-DOCSTART- (27855073)

The	O	O	O
Loop	O	O	B-T087
2	O	O	I-T087
Region	O	O	I-T087
of	O	O	O
Ribosomal	O	O	B-T116
Protein	O	O	I-T116
uS5	O	O	I-T116
Influences	O	O	O
Spectinomycin	O	O	B-T195
Sensitivity	O	O	B-T033
,	O	O	O
Translational	O	O	B-T044
Fidelity	O	O	I-T044
,	O	O	O
and	O	O	O
Ribosome	O	O	O
Biogenesis	O	O	O

Ribosomal	O	O	B-T116
protein	O	O	I-T116
uS5	O	O	I-T116
is	O	O	O
an	O	O	O
essential	O	O	B-T077
component	O	O	I-T077
of	O	O	O
the	O	O	O
small	O	O	B-T026
ribosomal	O	O	I-T026
subunit	O	O	I-T026
that	O	O	O
is	O	O	O
involved	O	O	O
in	O	O	O
subunit	O	O	B-T043
assembly	O	O	I-T043
,	O	O	O
maintenance	O	O	B-T044
of	O	O	I-T044
translational	O	O	I-T044
fidelity	O	O	I-T044
,	O	O	O
and	O	O	O
the	O	O	O
ribosome	O	O	B-T026
's	O	O	I-T026
response	O	O	B-T032
to	O	O	O
the	O	O	O
antibiotic	O	O	B-T195
spectinomycin	O	O	I-T195
.	O	O	O

While	O	O	O
many	O	O	O
of	O	O	O
the	O	O	O
characterized	O	O	O
uS5	O	O	B-T045
mutations	O	O	I-T045
that	O	O	O
affect	O	O	O
decoding	O	O	B-T044
map	O	O	O
to	O	O	O
its	O	O	O
interface	O	O	B-T044
with	O	O	O
uS4	O	O	B-T116
,	O	O	O
more	O	O	O
recent	O	O	O
work	O	O	O
has	O	O	O
shown	O	O	O
that	O	O	O
residues	O	O	B-T077
distant	O	O	O
from	O	O	O
the	O	O	O
uS4-uS5	O	O	B-T044
interface	O	O	I-T044
can	O	O	O
also	O	O	O
affect	O	O	O
the	O	O	O
decoding	O	O	B-T067
process	O	O	I-T067
.	O	O	O

We	O	O	O
targeted	O	O	O
one	O	O	O
such	O	O	O
interface-remote	O	O	B-T082
area	O	O	I-T082
,	O	O	O
the	O	O	O
loop	O	O	B-T087
2	O	O	I-T087
region	O	O	I-T087
(	O	O	O
residues	O	O	B-T077
20	O	O	O
to	O	O	O
31	O	O	O
)	O	O	O
,	O	O	O
for	O	O	O
mutagenesis	O	O	B-T044
in	O	O	O
Escherichia	O	O	O
.	O	O	O

coli	O	O	O
and	O	O	O
generated	O	O	O
21	O	O	O
unique	O	O	B-T049
mutants	O	O	I-T049
.	O	O	O

A	O	O	O
majority	O	O	O
of	O	O	O
the	O	O	O
loop	O	O	B-T087
2	O	O	I-T087
alterations	O	O	O
confer	O	O	O
resistance	O	O	B-T169
to	O	O	O
spectinomycin	O	O	B-T195
and	O	O	O
affect	O	O	O
the	O	O	O
fidelity	O	O	B-T044
of	O	O	I-T044
translation	O	O	I-T044
.	O	O	O

However	O	O	O
,	O	O	O
only	O	O	O
a	O	O	O
minority	O	O	O
show	O	O	O
altered	O	O	O
rRNA	O	O	B-T114
processing	O	O	O
or	O	O	O
ribosome	O	O	B-T043
biogenesis	O	O	I-T043
defects	O	O	B-T169
.	O	O	O

-DOCSTART- (27856752)

Multiplex	O	O	B-T080
social	O	O	B-T169
ecological	O	O	B-T082
network	O	O	B-T062
analysis	O	O	I-T062
reveals	O	O	B-T080
how	O	O	O
social	O	O	B-T054
changes	O	O	I-T054
affect	O	O	B-T169
community	O	O	B-T096
robustness	O	O	B-T080
more	O	O	O
than	O	O	O
resource	O	O	B-T081
depletion	O	O	O

Network	O	O	B-T062
analysis	O	O	I-T062
provides	O	O	B-T052
a	O	O	O
powerful	O	O	O
tool	O	O	O
to	O	O	O
analyze	O	O	O
complex	O	O	B-T080
influences	O	O	B-T077
of	O	O	O
social	O	O	B-T102
and	O	O	O
ecological	O	O	B-T082
structures	O	O	I-T082
on	O	O	O
community	O	O	B-T096
and	O	O	O
household	O	O	B-T099
dynamics	O	O	O
.	O	O	O

Most	O	O	O
network	O	O	B-T062
studies	O	O	I-T062
of	O	O	O
social	O	O	B-T169
-	O	O	O
ecological	O	O	B-T070
systems	O	O	I-T070
use	O	O	O
simple	O	O	B-T080
,	O	O	O
undirected	O	O	O
,	O	O	O
unweighted	O	O	B-T169
networks	O	O	I-T169
.	O	O	O

We	O	O	O
analyze	O	O	O
multiplex	O	O	B-T080
,	O	O	O
directed	O	O	B-T082
,	O	O	O
and	O	O	O
weighted	O	O	B-T169
networks	O	O	I-T169
of	O	O	O
subsistence	O	O	B-T052
food	O	O	B-T168
flows	O	O	O
collected	O	O	B-T078
in	O	O	O
three	O	O	O
small	O	O	O
indigenous	O	O	B-T102
communities	O	O	B-T096
in	O	O	O
Arctic	O	O	B-T083
Alaska	O	O	B-T083
potentially	O	O	O
facing	O	O	O
substantial	O	O	O
economic	O	O	B-T169
and	O	O	O
ecological	O	O	B-T082
changes	O	O	B-T169
.	O	O	O

Our	O	O	O
analysis	O	O	O
of	O	O	O
plausible	O	O	O
future	O	O	B-T079
scenarios	O	O	B-T169
suggests	O	O	O
that	O	O	O
changes	O	O	B-T169
to	O	O	O
social	O	O	B-T169
relations	O	O	B-T080
and	O	O	O
key	O	O	O
households	O	O	B-T099
have	O	O	O
greater	O	O	O
effects	O	O	B-T080
on	O	O	O
community	O	O	B-T096
robustness	O	O	B-T080
than	O	O	O
changes	O	O	O
to	O	O	O
specific	O	O	B-T080
wild	O	O	B-T081
food	O	O	I-T081
resources	O	O	I-T081
.	O	O	O

-DOCSTART- (27857693)

Heavy	O	O	B-T061
Resistance	O	O	I-T061
Training	O	O	I-T061
in	O	O	O
Hypoxia	O	O	B-T046
Enhances	O	O	B-T052
1RM	O	O	B-T081
Squat	O	O	B-T033
Performance	O	O	O

Purpose	O	O	O
:	O	O	O
To	O	O	O
determine	O	O	O
if	O	O	O
heavy	O	O	B-T061
resistance	O	O	I-T061
training	O	O	B-T080
in	O	O	O
hypoxia	O	O	B-T046
(	O	O	O
IHRT	O	O	B-T061
)	O	O	O
is	O	O	O
more	O	O	O
effective	O	O	B-T080
at	O	O	O
improving	O	O	B-T080
strength	O	O	B-T081
,	O	O	O
power	O	O	B-T033
,	O	O	O
and	O	O	O
increasing	O	O	B-T169
lean	O	O	B-T201
mass	O	O	I-T201
than	O	O	O
the	O	O	O
same	O	O	O
training	O	O	O
in	O	O	O
normoxia	O	O	O
.	O	O	O

Methods	O	O	O
:	O	O	O
A	O	O	O
pair-matched	O	O	B-T080
,	O	O	O
placebo-controlled	O	O	B-T062
study	O	O	I-T062
design	O	O	B-T052
included	O	O	O
20	O	O	O
resistance-trained	O	O	B-T061
participants	O	O	B-T098
assigned	O	O	O
to	O	O	O
IHRT	O	O	B-T061
(	O	O	O
FIO2	O	O	B-T061
0.143	O	O	O
)	O	O	O
or	O	O	O
placebo	O	O	B-T096
(	O	O	O
FIO2	O	O	O
0.20	O	O	O
)	O	O	O
,	O	O	O
(	O	O	O
n	O	O	O
=	O	O	O
10	O	O	O
per	O	O	O
group	O	O	B-UnknownType
)	O	O	O
.	O	O	O

Participants	O	O	B-T098
were	O	O	O
matched	O	O	B-T080
for	O	O	O
strength	O	O	B-T081
and	O	O	O
training	O	O	B-T061
.	O	O	O

Both	O	O	B-T080
groups	O	O	B-UnknownType
performed	O	O	B-T169
20	O	O	O
sessions	O	O	B-T051
over	O	O	O
7	O	O	O
weeks	O	O	B-T079
either	O	O	O
with	O	O	O
IHRT	O	O	B-T061
or	O	O	O
placebo	O	O	B-T096
.	O	O	O

All	O	O	O
participants	O	O	B-T098
were	O	O	O
tested	O	O	B-T169
for	O	O	O
1RM	O	O	B-T081
,	O	O	O
20-m	O	O	B-T081
sprint	O	O	B-T061
,	O	O	O
body	O	O	B-T032
composition	O	O	I-T032
,	O	O	O
and	O	O	O
countermovement	O	O	B-T056
jump	O	O	I-T056
pre	O	O	B-T079
-	O	O	O
,	O	O	O
mid	O	O	B-T079
-	O	O	O
,	O	O	O
and	O	O	O
post	O	O	B-T079
-	O	O	O
training	O	O	B-T061
and	O	O	O
compared	O	O	B-T052
via	O	O	O
magnitude	O	O	B-T081
-	O	O	O
based	O	O	B-T169
inferences	O	O	B-T041
.	O	O	O

Presentation	O	O	O
of	O	O	O
Results	O	O	O
:	O	O	O
Groups	O	O	B-UnknownType
were	O	O	O
not	O	O	B-T033
clearly	O	O	I-T033
different	O	O	B-T080
for	O	O	O
any	O	O	O
test	O	O	B-T169
at	O	O	O
baseline	O	O	B-T081
.	O	O	O

Training	O	O	B-T061
improved	O	O	B-T033
both	O	O	B-T080
absolute	O	O	B-T080
(	O	O	O
IHRT	O	O	B-T061
:	O	O	O
13.1	O	O	O
Â±	O	O	O
3.9	O	O	O
%	O	O	O
,	O	O	O
effect	O	O	B-T081
size	O	O	I-T081
(	O	O	O
ES	O	O	B-T081
)	O	O	O
0.60	O	O	O
,	O	O	O
placebo	O	O	B-T096
9.8	O	O	O
Â±	O	O	O
4.7	O	O	O
%	O	O	O
,	O	O	O
ES	O	O	O
0.31	O	O	O
)	O	O	O
and	O	O	O
relative	O	O	B-T080
1RM	O	O	B-T081
(	O	O	O
IHRT	O	O	O
:	O	O	O
13.4	O	O	O
Â±	O	O	O
5.1	O	O	O
%	O	O	O
,	O	O	O
ES	O	O	O
0.76	O	O	O
,	O	O	O
placebo	O	O	O
9.7	O	O	O
Â±	O	O	O
5.3	O	O	O
%	O	O	O
,	O	O	O
ES	O	O	O
0.48	O	O	O
)	O	O	O
at	O	O	O
mid	O	O	O
.	O	O	O

Similarly	O	O	O
,	O	O	O
at	O	O	O
post	O	O	B-T079
both	O	O	B-T080
groups	O	O	B-UnknownType
increased	O	O	B-T081
absolute	O	O	B-T080
(	O	O	O
IHRT	O	O	B-T061
:	O	O	O
20.7	O	O	O
Â±	O	O	O
7.6	O	O	O
%	O	O	O
,	O	O	O
ES	O	O	B-T081
0.74	O	O	O
,	O	O	O
placebo	O	O	B-T096
14.1	O	O	O
Â±	O	O	O
6.0	O	O	O
%	O	O	O
,	O	O	O
ES	O	O	O
0.58	O	O	O
)	O	O	O
and	O	O	O
relative	O	O	B-T080
1RM	O	O	B-T081
(	O	O	O
IHRT	O	O	O
:	O	O	O
21.6	O	O	O
Â±	O	O	O
8.5	O	O	O
%	O	O	O
,	O	O	O
ES	O	O	O
1.08	O	O	O
,	O	O	O
placebo	O	O	O
13.2	O	O	O
Â±	O	O	O
6.4	O	O	O
%	O	O	O
,	O	O	O
ES	O	O	O
0.78	O	O	O
)	O	O	O
.	O	O	O

Importantly	O	O	O
,	O	O	O
the	O	O	O
change	O	O	B-T169
in	O	O	O
IHRT	O	O	B-T061
was	O	O	O
greater	O	O	B-T081
than	O	O	O
placebo	O	O	B-T096
at	O	O	O
mid	O	O	O
for	O	O	O
both	O	O	B-T080
absolute	O	O	B-T080
[	O	O	O
4.4	O	O	O
%	O	O	O
greater	O	O	O
change	O	O	O
,	O	O	O
90	O	O	O
%	O	O	O
Confidence	O	O	B-T081
Interval	O	O	I-T081
(	O	O	O
CI	O	O	B-T081
)	O	O	O
1.0:8.0	O	O	O
%	O	O	O
,	O	O	O
ES	O	O	B-T081
0.21	O	O	O
,	O	O	O
and	O	O	O
relative	O	O	B-T080
strength	O	O	B-T081
(	O	O	O
5.6	O	O	O
%	O	O	O
greater	O	O	O
change	O	O	O
,	O	O	O
90	O	O	O
%	O	O	O
CI	O	O	O
1.0:9.4	O	O	O
%	O	O	O
,	O	O	O
ES	O	O	O
0.31	O	O	O
(	O	O	O
relative	O	O	O
)	O	O	O
]	O	O	O
.	O	O	O

There	O	O	O
was	O	O	O
also	O	O	O
a	O	O	O
greater	O	O	B-T081
change	O	O	B-T169
for	O	O	O
IHRT	O	O	B-T061
at	O	O	O
post	O	O	O
for	O	O	O
both	O	O	B-T080
absolute	O	O	B-T080
(	O	O	O
7.0	O	O	O
%	O	O	O
greater	O	O	O
change	O	O	O
,	O	O	O
90	O	O	O
%	O	O	O
CI	O	O	B-T081
1.3:13	O	O	O
%	O	O	O
,	O	O	O
ES	O	O	B-T081
0.33	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
relative	O	O	B-T080
1RM	O	O	B-T081
(	O	O	O
9.2	O	O	O
%	O	O	O
greater	O	O	O
change	O	O	O
,	O	O	O
90	O	O	O
%	O	O	O
CI	O	O	O
1.6:14.9	O	O	O
%	O	O	O
,	O	O	O
ES	O	O	O
0.49	O	O	O
)	O	O	O
.	O	O	O

Only	O	O	O
IHRT	O	O	B-T061
increased	O	O	B-T081
countermovement	O	O	B-T056
jump	O	O	I-T056
peak	O	O	B-T080
power	O	O	B-T033
at	O	O	O
Post	O	O	B-T079
(	O	O	O
4.9	O	O	O
%	O	O	O
,	O	O	O
ES	O	O	B-T081
0.35	O	O	O
)	O	O	O
,	O	O	O
however	O	O	O
the	O	O	O
difference	O	O	B-T080
between	O	O	O
IHRT	O	O	O
and	O	O	O
placebo	O	O	B-T096
was	O	O	O
unclear	O	O	B-T033
(	O	O	O
2.7	O	O	O
,	O	O	O
90	O	O	O
%	O	O	O
CI	O	O	B-T081
-2.0:7.6	O	O	O
%	O	O	O
,	O	O	O
ES	O	O	O
0.20	O	O	O
)	O	O	O
with	O	O	O
no	O	O	B-T033
clear	O	O	I-T033
differences	O	O	B-T080
in	O	O	O
speed	O	O	B-T081
or	O	O	O
body	O	O	B-T032
composition	O	O	I-T032
throughout	O	O	O
.	O	O	O

Conclusion	O	O	O
:	O	O	O
Heavy	O	O	B-T061
resistance	O	O	I-T061
training	O	O	I-T061
in	O	O	O
hypoxia	O	O	B-T046
is	O	O	O
more	O	O	O
effective	O	O	B-T080
than	O	O	O
placebo	O	O	B-T096
for	O	O	O
improving	O	O	B-T080
absolute	O	O	B-T080
and	O	O	O
relative	O	O	B-T080
strength	O	O	B-T081
.	O	O	O

-DOCSTART- (27857788)

Ultrasonography	O	O	B-T060
and	O	O	O
magnetic	O	O	B-T060
resonance	O	O	I-T060
imaging	O	O	I-T060
evaluation	O	O	B-T058
of	O	O	O
pediatric	O	O	B-T080
spinal	O	O	O
anomalies	O	O	O

Spinal	O	O	B-T019
dysraphisms	O	O	I-T019
are	O	O	O
congenital	O	O	B-T019
abnormalities	O	O	I-T019
of	O	O	O
the	O	O	O
spine	O	O	B-T023
due	O	O	O
to	O	O	O
imperfect	O	O	O
fusion	O	O	B-T169
of	O	O	O
midline	O	O	B-T082
mesenchymal	O	O	B-T080
,	O	O	O
bony	O	O	B-T169
and	O	O	O
neural	O	O	B-T169
structures	O	O	B-T082
.	O	O	O

Imaging	O	O	B-T060
plays	O	O	O
a	O	O	O
vital	O	O	O
role	O	O	O
in	O	O	O
their	O	O	O
evaluation	O	O	B-T058
as	O	O	O
significant	O	O	O
portion	O	O	O
of	O	O	O
patients	O	O	B-T101
may	O	O	O
present	O	O	O
with	O	O	O
concurrent	O	O	B-T079
anomalies	O	O	B-T019
that	O	O	O
need	O	O	O
to	O	O	O
be	O	O	O
corrected	O	O	B-T080
simultaneously	O	O	B-T079
to	O	O	O
avoid	O	O	O
repeat	O	O	B-T061
surgeries	O	O	I-T061
.	O	O	O

The	O	O	O
aims	O	O	O
of	O	O	O
the	O	O	O
study	O	O	B-T062
were	O	O	O
to	O	O	O
evaluate	O	O	B-T058
Spinal	O	O	B-T019
dysraphisms	O	O	I-T019
using	O	O	O
USG	O	O	B-T060
and	O	O	O
MRI	O	O	B-T060
and	O	O	O
to	O	O	O
correlate	O	O	B-T080
imaging	O	O	B-T060
findings	O	O	B-T169
with	O	O	O
operative	O	O	B-T079
findings	O	O	O
in	O	O	O
patients	O	O	B-T101
undergoing	O	O	O
surgery	O	O	B-T061
.	O	O	O

Hospital	O	O	B-T093
based	O	O	O
observational	O	O	B-T062
study	O	O	I-T062
conducted	O	O	O
over	O	O	O
a	O	O	O
period	O	O	B-T079
of	O	O	O
year	O	O	B-T079
.	O	O	O

38	O	O	O
cases	O	O	B-T077
of	O	O	O
both	O	O	O
sexes	O	O	B-T032
and	O	O	O
below	O	O	O
12	O	O	O
years	O	O	B-T079
of	O	O	O
age	O	O	B-T032
with	O	O	O
spinal	O	O	B-T019
dysraphism	O	O	I-T019
were	O	O	O
studied	O	O	O
.	O	O	O

USG	O	O	B-T060
was	O	O	O
performed	O	O	O
in	O	O	O
29	O	O	O
cases	O	O	B-T077
where	O	O	O
acoustic	O	O	B-T082
window	O	O	I-T082
was	O	O	O
available	O	O	O
for	O	O	O
proper	O	O	O
evaluation	O	O	B-T058
.	O	O	O

MRI	O	O	B-T060
was	O	O	O
performed	O	O	O
in	O	O	O
all	O	O	O
cases	O	O	B-T077
.	O	O	O

USG	O	O	B-T060
findings	O	O	B-T169
were	O	O	O
compared	O	O	O
with	O	O	O
MRI	O	O	B-T060
findings	O	O	O
and	O	O	O
operative	O	O	B-T079
follow	O	O	B-T058
up	O	O	I-T058
was	O	O	O
taken	O	O	O
in	O	O	O
23	O	O	O
cases	O	O	B-T077
who	O	O	O
underwent	O	O	O
operative	O	O	B-T058
management	O	O	I-T058
.	O	O	O

Results	O	O	O
were	O	O	O
analysed	O	O	B-T062
using	O	O	O
percentage	O	O	B-T081
and	O	O	O
arithmetic	O	O	B-T081
mean	O	O	I-T081
.	O	O	O

39.47	O	O	O
%	O	O	O
cases	O	O	B-T077
were	O	O	O
male	O	O	B-T032
and	O	O	O
60.53	O	O	O
%	O	O	O
cases	O	O	O
were	O	O	O
female	O	O	B-T032
.	O	O	O

Neonatal	O	O	B-T079
period	O	O	I-T079
was	O	O	O
the	O	O	O
most	O	O	O
common	O	O	O
presenting	O	O	O
age	O	O	B-T100
group	O	O	I-T100
.	O	O	O

Closed	O	O	B-T169
spinal	O	O	B-T019
dysraphism	O	O	I-T019
(	O	O	O
63.16	O	O	O
%	O	O	O
)	O	O	O
was	O	O	O
more	O	O	O
common	O	O	O
than	O	O	O
open	O	O	B-T082
(	O	O	O
36.84	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

79.31	O	O	O
%	O	O	O
cases	O	O	B-T077
showed	O	O	O
full	O	O	O
agreement	O	O	O
between	O	O	O
spinal	O	O	B-T082
USG	O	O	B-T060
and	O	O	O
MRI	O	O	B-T060
examinations	O	O	B-T058
and	O	O	O
6	O	O	O
out	O	O	O
of	O	O	O
20.69	O	O	O
%	O	O	O
showed	O	O	O
partial	O	O	O
agreement	O	O	O
.	O	O	O

On	O	O	O
operative	O	O	B-T079
correlation	O	O	B-T080
,	O	O	O
USG	O	O	B-T060
findings	O	O	B-T169
were	O	O	O
confirmatory	O	O	B-T033
in	O	O	O
91.30	O	O	O
%	O	O	O
cases	O	O	B-T077
and	O	O	O
MRI	O	O	B-T060
findings	O	O	O
were	O	O	O
confirmatory	O	O	O
in	O	O	O
100	O	O	O
%	O	O	O
cases	O	O	O
.	O	O	O

USG	O	O	B-T060
can	O	O	O
be	O	O	O
used	O	O	O
as	O	O	O
the	O	O	O
initial	O	O	O
modality	O	O	B-T169
for	O	O	O
evaluation	O	O	B-T058
of	O	O	O
spinal	O	O	B-T019
dysraphism	O	O	I-T019
as	O	O	O
well	O	O	O
as	O	O	O
for	O	O	O
screening	O	O	B-T058
of	O	O	O
suspected	O	O	B-T078
cases	O	O	B-T077
.	O	O	O

MRI	O	O	B-T060
is	O	O	O
indicated	O	O	O
to	O	O	O
confirm	O	O	O
abnormal	O	O	B-T033
USG	O	O	B-T060
findings	O	O	B-T169
,	O	O	O
which	O	O	O
shows	O	O	O
all	O	O	O
concurrent	O	O	B-T079
abnormalities	O	O	B-T019
and	O	O	O
also	O	O	O
provides	O	O	O
additional	O	O	O
anatomical	O	O	B-T080
details	O	O	B-T080
relevant	O	O	O
to	O	O	O
surgical	O	O	B-T170
planning	O	O	I-T170
.	O	O	O

-DOCSTART- (27857970)

BORA	O	O	B-T028
-dependent	O	O	O
PLK1	O	O	B-T116
regulation	O	O	B-T043
:	O	O	O
A	O	O	O
new	O	O	O
weapon	O	O	O
for	O	O	O
cancer	O	O	B-T061
therapy	O	O	I-T061
?	O	O	O

The	O	O	O
mitotic	O	O	B-T116
kinase	O	O	I-T116
polo	O	O	I-T116
like	O	O	I-T116
kinase	O	O	I-T116
1	O	O	I-T116
(	O	O	O
PLK1	O	O	B-T116
)	O	O	O
is	O	O	O
overexpressed	O	O	B-T045
in	O	O	O
many	O	O	O
cancers	O	O	B-T043
and	O	O	I-T043
its	O	O	I-T043
inhibition	O	O	I-T043
slows	O	O	B-T043
down	O	O	I-T043
proliferation	O	O	I-T043
and	O	O	O
increases	O	O	B-T043
apoptosis	O	O	I-T043
in	O	O	O
cancer	O	O	B-T025
cell	O	O	I-T025
lines	O	O	I-T025
.	O	O	O

Understanding	O	O	O
how	O	O	O
PLK1	O	O	B-T043
is	O	O	I-T043
activated	O	O	I-T043
is	O	O	O
therefore	O	O	O
crucial	O	O	O
for	O	O	O
the	O	O	O
development	O	O	O
of	O	O	O
novel	O	O	O
PLK1	O	O	B-T116
inhibitors	O	O	I-T116
with	O	O	O
anticancer	O	O	B-T109
properties	O	O	I-T109
.	O	O	O

We	O	O	O
recently	O	O	O
identified	O	O	O
a	O	O	O
conserved	O	O	O
regulatory	O	O	B-UnknownType
loop	O	O	I-UnknownType
leading	O	O	O
to	O	O	O
PLK1	O	O	B-T043
activation	O	O	I-T043
that	O	O	O
involves	O	O	O
cyclin-dependent	O	O	B-T116
kinase	O	O	I-T116
1	O	O	I-T116
(	O	O	O
CDK1	O	O	B-T116
)	O	O	O
.	O	O	O

-DOCSTART- (27858508)

Activation	O	O	B-T045
of	O	O	I-T045
transcription	O	O	I-T045
enforces	O	O	O
the	O	O	O
formation	O	O	O
of	O	O	O
distinct	O	O	O
nuclear	O	O	B-T026
bodies	O	O	I-T026
in	O	O	O
zebrafish	O	O	B-T013
embryos	O	O	O

Nuclear	O	O	B-T026
bodies	O	O	I-T026
are	O	O	O
cellular	O	O	B-T030
compartments	O	O	I-T030
that	O	O	O
lack	O	O	B-T080
lipid	O	O	B-T026
bilayers	O	O	I-T026
and	O	O	O
harbor	O	O	O
specific	O	O	B-T080
RNAs	O	O	B-T114
and	O	O	O
proteins	O	O	B-T116
.	O	O	O

Recent	O	O	O
proposals	O	O	O
that	O	O	O
nuclear	O	O	B-T026
bodies	O	O	I-T026
form	O	O	O
through	O	O	O
liquid-liquid	O	O	O
phase	O	O	O
separation	O	O	O
leave	O	O	O
the	O	O	O
question	O	O	O
of	O	O	O
how	O	O	O
different	O	O	O
nuclear	O	O	O
bodies	O	O	O
maintain	O	O	O
their	O	O	O
distinct	O	O	O
identities	O	O	O
unanswered	O	O	O
.	O	O	O

Here	O	O	O
we	O	O	O
investigate	O	O	B-T169
Cajal	O	O	B-T026
bodies	O	O	I-T026
(	O	O	O
CBs	O	O	B-T026
)	O	O	O
,	O	O	O
histone	O	O	B-T026
locus	O	O	I-T026
bodies	O	O	I-T026
(	O	O	O
HLBs	O	O	B-T026
)	O	O	O
and	O	O	O
nucleoli	O	O	B-T026
-	O	O	O
involved	O	O	O
in	O	O	O
assembly	O	O	O
of	O	O	O
the	O	O	O
splicing	O	O	B-T045
machinery	O	O	I-T045
,	O	O	O
histone	O	O	B-T045
mRNA	O	O	I-T045
3	O	O	I-T045
'	O	O	I-T045
end	O	O	I-T045
processing	O	O	I-T045
,	O	O	O
and	O	O	O
rRNA	O	O	B-T045
processing	O	O	I-T045
,	O	O	O
respectively	O	O	O
-	O	O	O
in	O	O	O
the	O	O	O
embryos	O	O	B-T018
of	O	O	O
the	O	O	O
zebrafish	O	O	B-T013
,	O	O	O
Danio	O	O	B-T013
rerio	O	O	I-T013
.	O	O	O

We	O	O	O
take	O	O	O
advantage	O	O	O
of	O	O	O
the	O	O	O
transcriptional	O	O	O
silence	O	O	O
of	O	O	O
the	O	O	O
1-cell	O	O	O
embryo	O	O	B-T018
and	O	O	O
follow	O	O	O
nuclear	O	O	B-T026
body	O	O	I-T026
appearance	O	O	O
as	O	O	O
zygotic	O	O	B-T018
transcription	O	O	B-T045
becomes	O	O	O
activated	O	O	B-T052
.	O	O	O

CBs	O	O	B-T026
are	O	O	O
present	O	O	O
from	O	O	O
fertilization	O	O	B-T040
onwards	O	O	O
,	O	O	O
while	O	O	O
HLB	O	O	B-T026
and	O	O	O
nucleolar	O	O	B-T026
components	O	O	B-T026
formed	O	O	O
foci	O	O	B-T082
several	O	O	O
hours	O	O	O
later	O	O	O
when	O	O	O
histone	O	O	B-T116
genes	O	O	B-T028
and	O	O	O
rDNA	O	O	B-T114
became	O	O	O
active	O	O	B-T169
.	O	O	O

HLB	O	O	B-T026
formation	O	O	O
was	O	O	O
blocked	O	O	B-T169
by	O	O	O
transcription	O	O	B-T045
inhibition	O	O	I-T045
,	O	O	O
suggesting	O	O	O
nascent	O	O	B-T114
histone	O	O	I-T114
transcripts	O	O	I-T114
recruit	O	O	O
HLB	O	O	O
components	O	O	B-T026
like	O	O	O
U7	O	O	B-T114
snRNP	O	O	I-T114
.	O	O	O

Surprisingly	O	O	O
,	O	O	O
we	O	O	O
found	O	O	O
that	O	O	O
U7	O	O	O
base-pairing	O	O	B-T044
with	O	O	O
nascent	O	O	B-T114
histone	O	O	I-T114
transcripts	O	O	I-T114
was	O	O	O
not	O	O	O
required	O	O	O
for	O	O	O
localization	O	O	B-T043
to	O	O	O
HLBs	O	O	B-T026
.	O	O	O

Rather	O	O	O
,	O	O	O
the	O	O	O
type	O	O	O
of	O	O	O
Sm	O	O	O
ring	O	O	O
assembled	O	O	O
on	O	O	O
U7	O	O	O
determined	O	O	O
its	O	O	O
targeting	O	O	O
to	O	O	O
HLBs	O	O	B-T026
or	O	O	O
CBs	O	O	B-T026
;	O	O	O
the	O	O	O
spliceosomal	O	O	O
Sm	O	O	O
ring	O	O	O
targeted	O	O	O
snRNAs	O	O	B-T114
to	O	O	O
CBs	O	O	O
while	O	O	O
the	O	O	O
specialized	O	O	O
U7	O	O	O
Sm-ring	O	O	O
localized	O	O	O
to	O	O	O
HLBs	O	O	O
,	O	O	O
demonstrating	O	O	O
the	O	O	O
contribution	O	O	B-T052
of	O	O	O
protein	O	O	B-T116
constituents	O	O	B-T167
to	O	O	O
the	O	O	O
distinction	O	O	O
among	O	O	O
nuclear	O	O	B-T026
bodies	O	O	I-T026
.	O	O	O

Thus	O	O	O
,	O	O	O
nucleolar	O	O	B-T026
,	O	O	O
HLB	O	O	B-T026
,	O	O	O
and	O	O	O
CB	O	O	B-T026
components	O	O	B-T026
can	O	O	O
mix	O	O	O
in	O	O	O
early	O	O	B-T079
embryogenesis	O	O	B-T042
when	O	O	O
transcription	O	O	B-T045
is	O	O	O
naturally	O	O	O
or	O	O	O
artificially	O	O	O
silenced	O	O	O
.	O	O	O

These	O	O	O
data	O	O	O
support	O	O	O
a	O	O	O
model	O	O	O
in	O	O	O
which	O	O	O
transcription	O	O	B-T045
of	O	O	O
specific	O	O	B-T080
gene	O	O	B-T082
loci	O	O	I-T082
nucleates	O	O	O
nuclear	O	O	B-T026
body	O	O	I-T026
components	O	O	B-T026
with	O	O	O
high	O	O	O
specificity	O	O	B-T081
and	O	O	O
fidelity	O	O	O
to	O	O	O
perform	O	O	O
distinct	O	O	O
regulatory	O	O	B-T077
functions	O	O	B-T039
.	O	O	O

-DOCSTART- (27859167)

Variation	O	O	B-T100
in	O	O	I-T100
the	O	O	I-T100
age	O	O	I-T100
of	O	O	O
first	O	O	B-T040
reproduction	O	O	I-T040
:	O	O	O
different	O	O	B-T080
strategies	O	O	I-T080
or	O	O	O
individual	O	O	B-T080
quality	O	O	I-T080
?	O	O	O

Although	O	O	O
age	O	O	B-T032
at	O	O	O
first	O	O	B-T040
reproduction	O	O	I-T040
is	O	O	O
a	O	O	O
key	O	O	O
demographic	O	O	B-T078
parameter	O	O	I-T078
that	O	O	O
is	O	O	O
probably	O	O	O
under	O	O	O
high	O	O	B-T033
selective	O	O	I-T033
pressure	O	O	I-T033
,	O	O	O
it	O	O	O
is	O	O	O
highly	O	O	O
variable	O	O	B-T080
and	O	O	O
the	O	O	O
cause	O	O	O
of	O	O	O
this	O	O	O
variability	O	O	B-T077
is	O	O	O
not	O	O	O
well	O	O	O
understood	O	O	O
.	O	O	O

Two	O	O	O
non-exclusive	O	O	O
hypotheses	O	O	B-T078
may	O	O	O
explain	O	O	O
such	O	O	O
variability	O	O	B-T077
.	O	O	O

It	O	O	O
could	O	O	O
be	O	O	O
the	O	O	O
expression	O	O	B-T055
of	O	O	O
different	O	O	O
individual	O	O	B-T080
strategies	O	O	I-T080
,	O	O	O
i.e.	O	O	O
,	O	O	O
different	O	O	O
allocation	O	O	B-T052
strategies	O	O	I-T052
in	O	O	O
fitness	O	O	B-T078
components	O	O	I-T078
,	O	O	O
or	O	O	O
the	O	O	O
consequences	O	O	O
of	O	O	O
individual	O	O	B-T054
difference	O	O	I-T054
in	O	O	O
intrinsic	O	O	B-T082
quality	O	O	I-T082
,	O	O	O
i.e.	O	O	O
,	O	O	O
some	O	O	O
individuals	O	O	B-T098
always	O	O	O
doing	O	O	O
better	O	O	O
than	O	O	O
others	O	O	O
in	O	O	O
all	O	O	O
fitness	O	O	O
components	O	O	O
.	O	O	O

We	O	O	O
tested	O	O	B-T169
these	O	O	O
hypotheses	O	O	B-T078
in	O	O	O
the	O	O	O
Wandering	O	O	B-T012
Albatross	O	O	I-T012
investigating	O	O	O
relationships	O	O	B-T080
between	O	O	O
the	O	O	O
age	O	O	B-T032
at	O	O	O
first	O	O	B-T040
reproduction	O	O	I-T040
and	O	O	O
subsequent	O	O	O
adult	O	O	B-T100
demographic	O	O	B-T090
traits	O	O	B-T032
.	O	O	O

Using	O	O	O
finite	O	O	B-T062
mixture	O	O	I-T062
capture	O	O	I-T062
recapture	O	O	I-T062
modeling	O	O	I-T062
,	O	O	O
we	O	O	O
demonstrate	O	O	O
that	O	O	O
the	O	O	O
age	O	O	B-T032
at	O	O	O
first	O	O	B-T040
reproduction	O	O	I-T040
is	O	O	O
negatively	O	O	B-T033
related	O	O	O
to	O	O	O
both	O	O	O
reproductive	O	O	B-T040
performances	O	O	B-T055
and	O	O	O
adult	O	O	B-T100
survival	O	O	B-T052
,	O	O	O
suggesting	O	O	O
that	O	O	O
individual	O	O	B-T080
quality	O	O	I-T080
was	O	O	O
an	O	O	O
important	O	O	O
factor	O	O	O
explaining	O	O	O
variation	O	O	B-T077
in	O	O	O
the	O	O	O
age	O	O	O
at	O	O	O
first	O	O	O
reproduction	O	O	O
.	O	O	O

Our	O	O	O
results	O	O	O
suggest	O	O	O
that	O	O	O
age	O	O	B-T032
at	O	O	O
first	O	O	B-T040
breeding	O	O	I-T040
is	O	O	O
a	O	O	O
good	O	O	O
predictor	O	O	B-T078
of	O	O	O
quality	O	O	B-T080
in	O	O	O
this	O	O	O
long-lived	O	O	O
seabird	O	O	B-T012
species	O	O	I-T012
.	O	O	O

-DOCSTART- (27859268)

Heterogeneity	O	O	B-T080
of	O	O	O
colorectal	O	O	B-T191
cancer	O	O	I-T191
risk	O	O	B-T078
by	O	O	O
tumour	O	O	B-T191
characteristics	O	O	B-T080
:	O	O	O
Large	O	O	O
prospective	O	O	B-T062
study	O	O	I-T062
of	O	O	O
UK	O	O	B-T083
women	O	O	O

Associations	O	O	B-T080
between	O	O	O
behavioural	O	O	B-T053
and	O	O	O
other	O	O	O
personal	O	O	B-T032
factors	O	O	B-T169
and	O	O	O
colorectal	O	O	B-T191
cancer	O	O	I-T191
risk	O	O	B-T078
have	O	O	O
been	O	O	O
reported	O	O	O
to	O	O	O
vary	O	O	O
by	O	O	O
tumour	O	O	B-T191
characteristics	O	O	B-T080
,	O	O	O
but	O	O	O
evidence	O	O	O
is	O	O	O
inconsistent	O	O	O
.	O	O	O

In	O	O	O
a	O	O	O
large	O	O	O
UK	O	O	B-T083
-based	O	O	O
prospective	O	O	B-T062
study	O	O	I-T062
we	O	O	O
examined	O	O	O
associations	O	O	O
of	O	O	O
14	O	O	O
postulated	O	O	O
risk	O	O	B-T078
factors	O	O	I-T033
with	O	O	O
colorectal	O	O	B-T191
cancer	O	O	I-T191
risk	O	O	O
overall	O	O	O
,	O	O	O
and	O	O	O
across	O	O	O
three	O	O	O
anatomical	O	O	B-T029
sites	O	O	I-T029
and	O	O	O
four	O	O	O
morphological	O	O	B-T082
subtypes	O	O	B-T185
.	O	O	O

Among	O	O	O
1.3	O	O	O
million	O	O	O
women	O	O	B-T098
,	O	O	O
18,518	O	O	O
incident	O	O	O
colorectal	O	O	B-T191
cancers	O	O	I-T191
were	O	O	O
identified	O	O	O
during	O	O	O
13.8	O	O	O
(	O	O	O
SD	O	O	O
3.4	O	O	O
)	O	O	O
years	O	O	O
follow-up	O	O	B-T058
via	O	O	O
record	O	O	O
linkage	O	O	O
to	O	O	O
national	O	O	B-T170
cancer	O	O	I-T170
registry	O	O	I-T170
data	O	O	B-T078
.	O	O	O

Cox	O	O	B-T081
regression	O	O	I-T081
yielded	O	O	O
adjusted	O	O	O
relative	O	O	B-T081
risks	O	O	I-T081
.	O	O	O

Statistical	O	O	B-T081
significance	O	O	I-T081
was	O	O	O
assessed	O	O	O
using	O	O	O
correction	O	O	O
for	O	O	O
multiple	O	O	O
testing	O	O	O
.	O	O	O

Overall	O	O	O
,	O	O	O
colorectal	O	O	B-T191
cancer	O	O	I-T191
risk	O	O	B-T078
was	O	O	O
significantly	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
height	O	O	B-T032
,	O	O	O
body	O	O	B-T201
mass	O	O	I-T201
index	O	O	I-T201
(	O	O	O
BMI	O	O	B-T201
)	O	O	O
,	O	O	O
smoking	O	O	B-T055
,	O	O	O
alcohol	O	O	B-T055
intake	O	O	I-T055
,	O	O	O
physical	O	O	B-T056
activity	O	O	I-T056
,	O	O	O
parity	O	O	B-T033
and	O	O	O
menopausal	O	O	B-T061
hormone	O	O	I-T061
therapy	O	O	I-T061
use	O	O	O
.	O	O	O

For	O	O	O
smoking	O	O	B-T055
there	O	O	O
was	O	O	O
substantial	O	O	O
heterogeneity	O	O	B-T080
across	O	O	O
morphological	O	O	B-T082
types	O	O	B-T080
;	O	O	O
relative	O	O	B-T081
risks	O	O	I-T081
around	O	O	O
two	O	O	O
or	O	O	O
greater	O	O	O
were	O	O	O
seen	O	O	O
in	O	O	O
current	O	O	O
smokers	O	O	B-T033
both	O	O	O
for	O	O	O
signet	O	O	B-T025
ring	O	O	I-T025
cell	O	O	I-T025
and	O	O	O
for	O	O	O
neuroendocrine	O	O	B-T191
tumours	O	O	I-T191
.	O	O	O

Obese	O	O	B-T047
women	O	O	B-T098
were	O	O	O
also	O	O	O
at	O	O	B-T033
higher	O	O	I-T033
risk	O	O	I-T033
for	O	O	O
signet	O	O	B-T025
ring	O	O	I-T025
cell	O	O	I-T025
tumours	O	O	B-T191
.	O	O	O

For	O	O	O
adenocarcinomas	O	O	B-T191
,	O	O	O
the	O	O	O
large	O	O	O
majority	O	O	O
of	O	O	O
colorectal	O	O	B-T191
cancers	O	O	I-T191
in	O	O	O
the	O	O	O
cohort	O	O	B-T098
,	O	O	O
all	O	O	O
risk	O	O	B-T033
factor	O	O	I-T033
associations	O	O	B-T080
were	O	O	O
weak	O	O	O
.	O	O	O

There	O	O	O
was	O	O	O
little	O	O	O
or	O	O	O
no	O	O	O
heterogeneity	O	O	B-T080
in	O	O	O
risk	O	O	B-T078
between	O	O	O
tumours	O	O	B-T191
of	O	O	O
the	O	O	O
right	O	O	B-T023
colon	O	O	I-T023
,	O	O	O
left	O	O	B-T023
colon	O	O	I-T023
and	O	O	O
rectum	O	O	B-T023
for	O	O	O
any	O	O	O
of	O	O	O
the	O	O	O
14	O	O	O
factors	O	O	B-T033
examined	O	O	O
.	O	O	O

These	O	O	O
epidemiological	O	O	B-T091
findings	O	O	B-T033
complement	O	O	O
an	O	O	O
emerging	O	O	O
picture	O	O	O
from	O	O	O
molecular	O	O	B-T063
studies	O	O	I-T063
of	O	O	O
possible	O	O	O
different	O	O	O
developmental	O	O	B-T080
pathways	O	O	B-T077
for	O	O	O
different	O	O	O
tumour	O	O	B-T191
types	O	O	B-T080
.	O	O	O

-DOCSTART- (27859998)

Impact	O	O	B-T080
of	O	O	O
alcohol	O	O	B-T055
use	O	O	I-T055
on	O	O	O
EEG	O	O	B-T060
dynamics	O	O	I-T060
of	O	O	O
response	O	O	B-T041
inhibition	O	O	I-T041
:	O	O	O
a	O	O	O
cotwin	O	O	O
control	O	O	O
analysis	O	O	O

Research	O	O	O
indicates	O	O	O
that	O	O	O
alcohol	O	O	B-UnknownType
misuse	O	O	I-UnknownType
is	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
behavioral	O	O	B-T048
disinhibition	O	O	I-T048
,	O	O	O
but	O	O	O
the	O	O	O
neurophysiological	O	O	B-T040
mechanisms	O	O	I-T040
governing	O	O	O
this	O	O	O
relationship	O	O	B-T080
remain	O	O	O
largely	O	O	O
unknown	O	O	O
.	O	O	O

Recent	O	O	O
work	O	O	O
suggests	O	O	O
that	O	O	O
successful	O	O	O
inhibition	O	O	B-T041
and	O	O	O
cognitive	O	O	B-T041
control	O	O	I-T041
involve	O	O	O
electrophysiological	O	O	B-T060
theta-band	O	O	I-T060
dynamics	O	O	I-T060
,	O	O	O
including	O	O	O
medial	O	O	B-T024
frontal	O	O	I-T024
cortex	O	O	I-T024
(	O	O	O
MFC	O	O	B-T024
)	O	O	O
power	O	O	B-T042
enhancement	O	O	I-T042
and	O	O	O
functional	O	O	B-T042
connectivity	O	O	I-T042
between	O	O	O
the	O	O	O
MFC	O	O	O
and	O	O	O
dorsal	O	O	B-T023
prefrontal	O	O	I-T023
cortex	O	O	I-T023
(	O	O	O
dPFC	O	O	B-T023
)	O	O	O
regions	O	O	O
,	O	O	O
which	O	O	O
may	O	O	O
be	O	O	O
disrupted	O	O	O
by	O	O	O
alcohol	O	O	B-UnknownType
misuse	O	O	I-UnknownType
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
research	O	O	O
suggests	O	O	O
that	O	O	O
,	O	O	O
compared	O	O	O
to	O	O	O
men	O	O	B-T098
,	O	O	O
women	O	O	B-T098
are	O	O	O
at	O	O	O
heightened	O	O	O
risk	O	O	B-T078
of	O	O	O
experiencing	O	O	O
the	O	O	O
negative	O	O	O
physical	O	O	B-T039
and	O	O	O
neurocognitive	O	O	B-T041
correlates	O	O	I-T041
of	O	O	O
drinking	O	O	B-T055
.	O	O	O

The	O	O	O
present	O	O	O
study	O	O	B-T062
tested	O	O	O
the	O	O	O
hypothesis	O	O	O
that	O	O	O
alcohol	O	O	B-UnknownType
misuse	O	O	I-UnknownType
has	O	O	O
a	O	O	O
deleterious	O	O	B-T046
effect	O	O	I-T046
on	O	O	O
theta-band	O	O	B-T061
response	O	O	B-T041
inhibition	O	O	I-T041
EEG	O	O	B-T060
dynamics	O	O	I-T060
in	O	O	O
a	O	O	O
sample	O	O	B-T098
of	O	O	O
300	O	O	O
24-year-old	O	O	O
same-sex	O	O	O
twins	O	O	B-T099
.	O	O	O

A	O	O	O
cotwin	O	O	B-T062
control	O	O	I-T062
(	O	O	I-T062
CTC	O	O	I-T062
)	O	O	I-T062
design	O	O	I-T062
was	O	O	O
used	O	O	O
to	O	O	O
disentangle	O	O	O
premorbid	O	O	O
risk	O	O	B-T078
for	O	O	O
alcohol	O	O	B-T055
use	O	O	I-T055
from	O	O	O
the	O	O	O
causal	O	O	B-T080
effects	O	O	I-T080
of	O	O	O
alcohol	O	O	B-T051
exposure	O	O	I-T051
.	O	O	O

Drinking	O	O	B-T055
was	O	O	O
negatively	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
theta-band	O	O	B-T061
MFC	O	O	B-T024
power	O	O	I-T042
and	O	O	O
MFC	O	O	O
-	O	O	O
dPFC	O	O	B-T023
connectivity	O	O	B-T030
during	O	O	O
response	O	O	B-T041
inhibition	O	O	I-T041
,	O	O	O
and	O	O	O
this	O	O	O
effect	O	O	B-T080
was	O	O	O
stronger	O	O	O
among	O	O	O
women	O	O	B-T098
.	O	O	O

The	O	O	O
CTC	O	O	B-T062
analysis	O	O	I-T062
suggested	O	O	O
that	O	O	O
,	O	O	O
for	O	O	O
women	O	O	B-T098
,	O	O	O
reduced	O	O	O
nogo-related	O	O	O
theta-band	O	O	B-T061
MFC	O	O	B-T024
power	O	O	I-T042
and	O	O	O
MFC	O	O	O
-	O	O	O
dPFC	O	O	B-T023
connectivity	O	O	B-T030
were	O	O	O
both	O	O	O
consistent	O	O	O
with	O	O	O
the	O	O	O
potential	O	O	O
deleterious	O	O	B-T046
causal	O	O	I-T046
effects	O	O	I-T046
of	O	O	O
alcohol	O	O	B-T051
exposure	O	O	I-T051
.	O	O	O

These	O	O	O
findings	O	O	O
suggest	O	O	O
that	O	O	O
diminished	O	O	B-T081
theta-band	O	O	B-T061
MFC	O	O	B-T024
power	O	O	I-T042
and	O	O	O
MFC	O	O	O
-	O	O	O
dPFC	O	O	B-T023
connectivity	O	O	B-T030
may	O	O	O
be	O	O	O
neurophysiological	O	O	B-T040
mechanisms	O	O	I-T040
underlying	O	O	O
alcohol-related	O	O	B-T048
disinhibition	O	O	I-T048
.	O	O	O

Although	O	O	O
preliminary	O	O	O
,	O	O	O
these	O	O	O
results	O	O	O
suggest	O	O	O
that	O	O	O
normative	O	O	B-T033
levels	O	O	I-T033
of	O	O	O
alcohol	O	O	B-T055
use	O	O	I-T055
during	O	O	O
emerging	O	O	O
adulthood	O	O	B-T079
have	O	O	O
potential	O	O	O
sex-specific	O	O	O
causal	O	O	B-T080
effects	O	O	I-T080
on	O	O	O
response	O	O	B-T041
inhibition	O	O	I-T041
EEG	O	O	B-T060
dynamics	O	O	I-T060
,	O	O	O
and	O	O	O
thus	O	O	O
have	O	O	O
potentially	O	O	O
significant	O	O	O
public	O	O	O
health	O	O	O
implications	O	O	O
.	O	O	O

-DOCSTART- (27861593)

Neutrophil	O	O	B-T025
and	O	O	O
Monocyte	O	O	B-T025
Function	O	O	B-T043
in	O	O	O
Patients	O	O	B-T101
with	O	O	O
Chronic	O	O	B-T047
Hepatitis	O	O	I-T047
C	O	O	I-T047
Undergoing	O	O	O
Antiviral	O	O	B-T061
Therapy	O	O	I-T061
with	O	O	O
Regimens	O	O	B-T061
Containing	O	O	O
Protease	O	O	B-T121
Inhibitors	O	O	I-T121
with	O	O	O
and	O	O	O
without	O	O	O
Interferon	O	O	O

Real-life	O	O	B-T078
data	O	O	I-T078
showed	O	O	O
an	O	O	O
increased	O	O	B-T081
incidence	O	O	B-T081
of	O	O	O
bacterial	O	O	B-T047
infections	O	O	I-T047
in	O	O	O
patients	O	O	B-T101
with	O	O	O
advanced	O	O	O
liver	O	O	B-T047
disease	O	O	I-T047
receiving	O	O	B-T080
a	O	O	O
protease	O	O	B-T121
inhibitor	O	O	I-T121
(PI)-containing	O	O	O
antiviral	O	O	B-T061
regimen	O	O	I-T061
against	O	O	O
hepatitis	O	O	B-T005
C	O	O	I-T005
(	O	O	O
HCV	O	O	B-T005
)	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
causes	O	O	O
of	O	O	O
this	O	O	O
event	O	O	O
are	O	O	O
unknown	O	O	O
.	O	O	O

We	O	O	O
hypothesized	O	O	O
that	O	O	O
PIs	O	O	B-T121
might	O	O	O
impair	O	O	O
innate	O	O	B-T032
immune	O	O	I-T032
responses	O	O	I-T032
through	O	O	O
the	O	O	O
inhibition	O	O	B-T039
of	O	O	I-T039
proteases	O	O	I-T039
participating	O	O	O
in	O	O	O
the	O	O	O
anti-bacterial	O	O	B-T039
functions	O	O	I-T039
of	O	O	O
neutrophils	O	O	B-T025
and	O	O	O
monocytes	O	O	B-T025
.	O	O	O

The	O	O	O
aims	O	O	O
of	O	O	O
the	O	O	O
study	O	O	B-T077
were	O	O	O
to	O	O	O
assess	O	O	B-T058
phagocytic	O	O	B-T043
and	O	O	I-T043
oxidative	O	O	I-T043
burst	O	O	I-T043
capacity	O	O	B-T081
in	O	O	O
neutrophils	O	O	B-T025
and	O	O	O
monocytes	O	O	B-T025
obtained	O	O	O
from	O	O	O
patients	O	O	B-T101
receiving	O	O	B-T080
a	O	O	O
PI	O	O	B-T121
containing-	O	O	O
antiviral	O	O	B-T061
regimen	O	O	I-T061
,	O	O	O
and	O	O	O
to	O	O	O
determine	O	O	O
cytokine	O	O	B-T043
secretion	O	O	I-T043
after	O	O	O
neutrophil	O	O	B-T025
stimulation	O	O	B-T043
with	O	O	O
flagellin	O	O	B-T116
.	O	O	O

Forty	O	O	O
patients	O	O	B-T101
with	O	O	O
chronic	O	O	B-T047
HCV	O	O	I-T047
(	O	O	O
80	O	O	O
%	O	O	O
with	O	O	O
cirrhosis	O	O	B-T047
)	O	O	O
were	O	O	O
enrolled	O	O	O
in	O	O	O
the	O	O	O
study	O	O	B-T077
,	O	O	O
28	O	O	O
received	O	O	B-T080
triple	O	O	B-T061
therapy	O	O	I-T061
(	O	O	O
Group	O	O	B-T185
A	O	O	I-T185
)	O	O	O
with	O	O	O
pegylated-interferon	O	O	B-T116
and	O	O	O
ribavirin	O	O	B-T114
for	O	O	O
4	O	O	O
weeks	O	O	B-T079
followed	O	O	O
by	O	O	O
the	O	O	O
addition	O	O	O
of	O	O	O
a	O	O	O
PI	O	O	B-T121
(	O	O	O
telaprevir	O	O	B-T116
,	O	O	O
boceprevir	O	O	B-T116
or	O	O	O
simeprevir	O	O	B-T109
)	O	O	O
,	O	O	O
and	O	O	O
12	O	O	O
patients	O	O	O
received	O	O	O
an	O	O	O
interferon	O	O	B-T061
-free	O	O	I-T061
regimen	O	O	I-T061
(	O	O	O
Group	O	O	B-T185
B	O	O	I-T185
)	O	O	O
with	O	O	O
simeprevir	O	O	O
and	O	O	O
sofosbuvir	O	O	B-T114
.	O	O	O

Phagocytosis	O	O	B-T043
and	O	O	I-T043
oxidative	O	O	I-T043
burst	O	O	I-T043
capacity	O	O	B-T081
were	O	O	O
analyzed	O	O	O
by	O	O	O
flow	O	O	B-T059
cytometry	O	O	I-T059
at	O	O	O
baseline	O	O	B-T081
,	O	O	O
week	O	O	B-T079
4	O	O	O
,	O	O	O
and	O	O	O
week	O	O	O
8	O	O	O
of	O	O	O
therapy	O	O	B-T061
.	O	O	O

In	O	O	O
neutrophils	O	O	B-T025
from	O	O	O
Group	O	O	B-T185
A	O	O	I-T185
patients	O	O	B-T101
,	O	O	O
oxidative	O	O	B-T169
burst	O	O	I-T043
rate	O	O	B-T081
and	O	O	O
oxidative	O	O	O
enzymatic	O	O	B-T044
activity	O	O	I-T044
per	O	O	I-T044
cell	O	O	I-T044
significantly	O	O	O
decreased	O	O	B-T081
throughout	O	O	O
the	O	O	O
study	O	O	B-T079
period	O	O	I-T079
(	O	O	O
p	O	O	O
=	O	O	O
0.014	O	O	O
and	O	O	O
p	O	O	O
=	O	O	O
0.010	O	O	O
,	O	O	O
respectively	O	O	O
)	O	O	O
.	O	O	O

Pairwise	O	O	B-T081
comparisons	O	O	I-T081
showed	O	O	O
a	O	O	O
decrease	O	O	B-T081
between	O	O	O
baseline	O	O	B-T081
and	O	O	O
week	O	O	B-T079
4	O	O	O
and	O	O	O
8	O	O	O
of	O	O	O
therapy	O	O	B-T061
.	O	O	O

No	O	O	O
differences	O	O	O
were	O	O	O
observed	O	O	O
after	O	O	O
the	O	O	O
introduction	O	O	B-T061
of	O	O	O
the	O	O	O
PI	O	O	B-T121
.	O	O	O

The	O	O	O
oxidative	O	O	B-T169
enzymatic	O	O	B-T044
activity	O	O	I-T044
per	O	O	I-T044
cell	O	O	I-T044
in	O	O	O
monocytes	O	O	B-T025
significantly	O	O	O
decrease	O	O	B-T081
during	O	O	O
the	O	O	O
study	O	O	B-T079
period	O	O	I-T079
(	O	O	O
p	O	O	O
=	O	O	O
0.042	O	O	O
)	O	O	O
due	O	O	O
to	O	O	O
a	O	O	O
decrease	O	O	O
from	O	O	O
baseline	O	O	B-T081
to	O	O	O
week	O	O	B-T079
8	O	O	O
of	O	O	O
therapy	O	O	B-T061
(	O	O	O
p	O	O	O
=	O	O	O
0.037	O	O	O
)	O	O	O
in	O	O	O
patients	O	O	B-T101
from	O	O	O
Group	O	O	O
A.	O	O	O
None	O	O	O
of	O	O	O
these	O	O	O
findings	O	O	B-T169
were	O	O	O
observed	O	O	O
in	O	O	O
Group	O	O	B-T185
B	O	O	I-T185
patients	O	O	O
.	O	O	O

Cytokine	O	O	B-T043
secretion	O	O	I-T043
did	O	O	O
not	O	O	O
significantly	O	O	O
change	O	O	O
during	O	O	O
the	O	O	O
study	O	O	B-T077
in	O	O	O
both	O	O	O
groups	O	O	B-T078
.	O	O	O

In	O	O	O
conclusion	O	O	O
,	O	O	O
our	O	O	O
data	O	O	B-T078
suggest	O	O	O
that	O	O	O
the	O	O	O
use	O	O	O
interferon	O	O	B-T116
(	O	O	O
rather	O	O	O
than	O	O	O
the	O	O	O
PI	O	O	B-T121
)	O	O	O
has	O	O	O
a	O	O	O
deleterious	O	O	B-T080
effect	O	O	I-T080
on	O	O	O
neutrophil	O	O	B-T025
and	O	O	O
monocyte	O	O	B-T025
phagocytic	O	O	B-T043
and	O	O	I-T043
oxidative	O	O	I-T043
burst	O	O	I-T043
capacity	O	O	B-T081
in	O	O	O
this	O	O	O
cohort	O	O	B-T098
of	O	O	O
patients	O	O	B-T101
with	O	O	O
HCV	O	O	B-T005
-related	O	O	O
advanced	O	O	B-T047
liver	O	O	I-T047
fibrosis	O	O	I-T047
.	O	O	O

-DOCSTART- (27863934)

Child	O	O	B-T033
death	O	O	I-T033
and	O	O	O
maternal	O	O	B-T033
psychosis-like	O	O	B-T048
experiences	O	O	I-T048
in	O	O	O
44	O	O	O
low-	O	O	B-T098
and	O	O	O
middle-income	O	O	B-T080
countries	O	O	B-T083
:	O	O	O
The	O	O	O
role	O	O	O
of	O	O	O
depression	O	O	O

Studies	O	O	O
on	O	O	O
the	O	O	O
effect	O	O	O
of	O	O	O
child	O	O	B-T033
death	O	O	I-T033
on	O	O	O
the	O	O	O
mental	O	O	B-T041
wellbeing	O	O	I-T041
of	O	O	O
women	O	O	B-T098
in	O	O	O
low-	O	O	B-T098
and	O	O	O
middle-income	O	O	B-T080
countries	O	O	B-T083
(	O	O	O
LMICs	O	O	B-T083
)	O	O	O
are	O	O	O
scarce	O	O	O
despite	O	O	O
the	O	O	O
high	O	O	O
child	O	O	B-T081
mortality	O	O	I-T081
rates	O	O	O
.	O	O	O

Thus	O	O	O
,	O	O	O
the	O	O	O
aim	O	O	O
of	O	O	O
the	O	O	O
current	O	O	O
study	O	O	O
was	O	O	O
to	O	O	O
assess	O	O	O
the	O	O	O
association	O	O	B-T080
between	O	O	O
child	O	O	B-T033
death	O	O	I-T033
and	O	O	O
psychosis-like	O	O	B-T048
experiences	O	O	I-T048
(	O	O	O
PLEs	O	O	B-T048
)	O	O	O
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
the	O	O	O
role	O	O	O
of	O	O	O
depression	O	O	B-T048
in	O	O	O
this	O	O	O
association	O	O	O
.	O	O	O

Data	O	O	B-T081
from	O	O	O
44	O	O	O
LMICs	O	O	B-T083
which	O	O	O
participated	O	O	O
in	O	O	O
the	O	O	O
World	O	O	B-T062
Health	O	O	I-T062
Survey	O	O	I-T062
(	O	O	O
WHS	O	O	B-T062
)	O	O	O
were	O	O	O
analyzed	O	O	O
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
59,444	O	O	O
women	O	O	B-T098
who	O	O	O
ever	O	O	O
gave	O	O	O
birth	O	O	B-T040
,	O	O	O
aged	O	O	O
18	O	O	O
-	O	O	O
49	O	O	O
years	O	O	B-T079
,	O	O	O
without	O	O	O
a	O	O	O
self-reported	O	O	B-T062
lifetime	O	O	B-T079
psychosis	O	O	B-T060
diagnosis	O	O	I-T060
,	O	O	O
were	O	O	O
included	O	O	O
in	O	O	O
the	O	O	O
analysis	O	O	O
.	O	O	O

The	O	O	O
World	O	O	B-T170
Mental	O	O	I-T170
Health	O	O	I-T170
Survey	O	O	I-T170
version	O	O	O
of	O	O	O
the	O	O	O
Composite	O	O	B-T170
International	O	O	I-T170
Diagnostic	O	O	I-T170
Interview	O	O	I-T170
(	O	O	O
CIDI	O	O	B-T170
)	O	O	O
was	O	O	O
used	O	O	O
to	O	O	O
establish	O	O	O
the	O	O	O
diagnosis	O	O	B-T062
of	O	O	O
past	O	O	O
12-	O	O	O
month	O	O	B-T079
DSM-IV	O	O	B-T170
depression	O	O	B-T048
,	O	O	O
and	O	O	O
assess	O	O	O
four	O	O	O
positive	O	O	B-T184
psychotic	O	O	I-T184
symptoms	O	O	I-T184
.	O	O	O

Depression	O	O	B-T048
was	O	O	O
defined	O	O	O
as	O	O	O
self-reported	O	O	B-T062
lifetime	O	O	B-T079
depression	O	O	B-T048
diagnosis	O	O	I-T060
and/or	O	O	O
past	O	O	O
12-	O	O	O
month	O	O	B-T079
depression	O	O	O
.	O	O	O

Multivariable	O	O	O
logistic	O	O	B-UnknownType
regression	O	O	I-UnknownType
analyses	O	O	I-UnknownType
were	O	O	O
performed	O	O	O
.	O	O	O

After	O	O	O
adjustment	O	O	O
for	O	O	O
potential	O	O	B-T169
confounders	O	O	I-T169
,	O	O	O
women	O	O	B-T098
who	O	O	O
experienced	O	O	O
child	O	O	B-T033
death	O	O	I-T033
had	O	O	O
higher	O	O	O
odds	O	O	O
for	O	O	O
all	O	O	O
types	O	O	O
of	O	O	O
PLEs	O	O	B-T048
(	O	O	O
when	O	O	O
unadjusted	O	O	O
for	O	O	O
depression	O	O	B-T048
)	O	O	O
(	O	O	O
OR	O	O	B-T081
1.20	O	O	O
-	O	O	O
1.71	O	O	O
;	O	O	O
p<0.05	O	O	O
)	O	O	O
and	O	O	O
depression	O	O	O
(	O	O	O
OR	O	O	O
=	O	O	O
1.64	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
=	O	O	O
1.39	O	O	O
-	O	O	O
1.93	O	O	O
)	O	O	O
.	O	O	O

When	O	O	O
adjusted	O	O	O
for	O	O	O
depression	O	O	B-T048
,	O	O	O
only	O	O	O
delusion	O	O	B-T048
of	O	O	I-T048
control	O	O	I-T048
was	O	O	O
strongly	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
child	O	O	B-T033
death	O	O	I-T033
(	O	O	O
OR	O	O	B-T081
=	O	O	O
1.54	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
=	O	O	O
1.20	O	O	O
-	O	O	O
1.97	O	O	O
)	O	O	O
.	O	O	O

Child	O	O	B-T033
death	O	O	I-T033
may	O	O	O
be	O	O	O
an	O	O	O
important	O	O	O
determinant	O	O	O
of	O	O	O
mental	O	O	B-T041
wellbeing	O	O	I-T041
among	O	O	O
women	O	O	B-T098
in	O	O	O
LMICs	O	O	B-T083
.	O	O	O

Given	O	O	O
the	O	O	O
known	O	O	O
adverse	O	O	B-T057
health	O	O	I-T057
outcomes	O	O	I-T057
associated	O	O	B-T080
with	O	O	I-T080
PLEs	O	O	B-T048
and	O	O	O
depression	O	O	B-T048
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
the	O	O	O
co-occurrence	O	O	O
of	O	O	O
these	O	O	O
symptoms	O	O	B-T184
,	O	O	O
mental	O	O	B-T061
health	O	O	I-T061
care	O	O	I-T061
may	O	O	O
be	O	O	O
particularly	O	O	O
important	O	O	O
for	O	O	O
mothers	O	O	B-T099
who	O	O	O
have	O	O	O
experienced	O	O	O
child	O	O	B-T033
loss	O	O	I-T033
in	O	O	O
LMICs	O	O	B-T083
.	O	O	O

-DOCSTART- (27864317)

Prednisolone	O	O	B-T109
is	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
a	O	O	O
worse	O	O	B-T033
lipid	O	O	I-T033
profile	O	O	I-T033
than	O	O	O
hydrocortisone	O	O	B-T125
in	O	O	O
patients	O	O	B-T101
with	O	O	O
adrenal	O	O	O
insufficiency	O	O	O

Prednisolone	O	O	B-T109
is	O	O	O
used	O	O	O
as	O	O	O
glucocorticoid	O	O	B-T125
replacement	O	O	B-T061
therapy	O	O	I-T061
for	O	O	O
adrenal	O	O	B-T047
insufficiency	O	O	I-T047
(	O	O	O
AI	O	O	B-T047
)	O	O	O
.	O	O	O

Recent	O	O	O
data	O	O	B-T078
indicate	O	O	O
that	O	O	O
its	O	O	O
use	O	O	O
in	O	O	O
AI	O	O	B-T047
is	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
low	O	O	O
bone	O	O	B-T201
mineral	O	O	I-T201
density	O	O	I-T201
.	O	O	O

Data	O	O	B-T078
on	O	O	O
risk	O	O	B-T033
factors	O	O	I-T033
for	O	O	O
cardiovascular	O	O	B-T047
disease	O	O	I-T047
in	O	O	O
patients	O	O	B-T101
with	O	O	O
AI	O	O	B-T047
treated	O	O	B-T169
with	O	O	O
prednisolone	O	O	B-T109
are	O	O	O
scarce	O	O	O
,	O	O	O
despite	O	O	O
this	O	O	O
condition	O	O	O
being	O	O	O
the	O	O	O
predominant	O	O	O
cause	O	O	B-T033
of	O	O	O
excess	O	O	O
mortality	O	O	B-T081
.	O	O	O

We	O	O	O
aimed	O	O	O
to	O	O	O
address	O	O	O
this	O	O	O
question	O	O	O
using	O	O	O
real-world	O	O	O
data	O	O	B-T078
from	O	O	O
the	O	O	O
European	O	O	B-T170
Adrenal	O	O	I-T170
Insufficiency	O	O	I-T170
Registry	O	O	I-T170
(	O	O	O
EU-AIR	O	O	B-T170
)	O	O	O
.	O	O	O

EU-AIR	O	O	B-T170
,	O	O	O
comprising	O	O	O
of	O	O	O
19	O	O	O
centres	O	O	B-T093
across	O	O	O
Germany	O	O	B-T083
,	O	O	O
the	O	O	O
Netherlands	O	O	B-T083
,	O	O	O
Sweden	O	O	B-T083
and	O	O	O
the	O	O	O
UK	O	O	B-T083
,	O	O	O
commenced	O	O	O
enrolling	O	O	O
patients	O	O	B-T101
with	O	O	O
AI	O	O	B-T047
in	O	O	O
August	O	O	O
2012	O	O	O
.	O	O	O

Patients	O	O	B-T101
receiving	O	O	O
prednisolone	O	O	B-T109
(	O	O	O
3	O	O	O
-	O	O	O
6	O	O	O
mg/day	O	O	O
,	O	O	O
n	O	O	O
=	O	O	O
50	O	O	O
)	O	O	O
or	O	O	O
hydrocortisone	O	O	B-T125
(	O	O	O
15	O	O	O
-	O	O	O
30	O	O	O
mg/day	O	O	O
,	O	O	O
n	O	O	O
=	O	O	O
909	O	O	O
)	O	O	O
were	O	O	O
identified	O	O	B-T080
and	O	O	O
grouped	O	O	B-T082
at	O	O	O
a	O	O	O
ratio	O	O	O
of	O	O	O
1:3	O	O	O
(	O	O	O
prednisolone	O	O	O
:	O	O	O
hydrocortisone	O	O	O
)	O	O	O
by	O	O	O
matching	O	O	O
for	O	O	O
gender	O	O	B-T032
,	O	O	O
age	O	O	B-T032
,	O	O	O
duration	O	O	B-T079
and	O	O	O
type	O	O	B-T170
of	O	O	I-T170
disease	O	O	I-T170
.	O	O	O

Data	O	O	B-T078
from	O	O	O
baseline	O	O	B-T081
and	O	O	O
follow-up	O	O	B-T058
visits	O	O	B-T058
were	O	O	O
analysed	O	O	O
.	O	O	O

Data	O	O	B-T078
from	O	O	O
patients	O	O	B-T101
with	O	O	O
congenital	O	O	B-T047
adrenal	O	O	I-T047
hyperplasia	O	O	I-T047
were	O	O	O
excluded	O	O	B-T052
.	O	O	O

Significantly	O	O	O
higher	O	O	O
mean	O	O	B-T081
Â±	O	O	I-T081
s.d	O	O	I-T081
.	O	O	I-T081
total	O	O	I-T081
(	O	O	O
6.3	O	O	O
Â±	O	O	O
1.6	O	O	O
vs	O	O	O
5.4	O	O	O
Â±	O	O	O
1.1	O	O	O
mmol/L	O	O	O
;	O	O	O
P	O	O	O
=	O	O	O
0.003	O	O	O
)	O	O	O
and	O	O	O
low-density	O	O	B-T109
lipoprotein	O	O	I-T109
(	O	O	I-T109
LDL	O	O	B-T109
)	O	O	I-T109
cholesterol	O	O	I-T109
levels	O	O	B-T080
(	O	O	O
3.9	O	O	O
Â±	O	O	O
1.4	O	O	O
vs	O	O	O
3.2	O	O	O
Â±	O	O	O
1.0	O	O	O
mmol/L	O	O	O
;	O	O	O
P	O	O	O
=	O	O	O
0.013	O	O	O
)	O	O	O
were	O	O	O
identified	O	O	B-T080
in	O	O	O
47	O	O	O
patients	O	O	B-T101
on	O	O	O
prednisolone	O	O	B-T109
vs	O	O	O
141	O	O	O
receiving	O	O	O
hydrocortisone	O	O	B-T125
at	O	O	O
baseline	O	O	B-T081
and	O	O	O
at	O	O	O
follow-up	O	O	B-T058
(	O	O	O
P	O	O	O
=	O	O	O
0.005	O	O	O
and	O	O	O
P	O	O	O
=	O	O	O
0.006	O	O	O
,	O	O	O
respectively	O	O	O
)	O	O	O
.	O	O	O

HbA1c	O	O	B-T116
,	O	O	O
high-density	O	O	B-T116
lipoprotein	O	O	I-T116
and	O	O	O
triglyceride	O	O	B-T034
levels	O	O	I-T034
,	O	O	O
body	O	O	B-T201
mass	O	O	I-T201
index	O	O	I-T201
,	O	O	O
systolic	O	O	B-T047
and	O	O	O
diastolic	O	O	B-T047
blood	O	O	I-T047
pressure	O	O	I-T047
and	O	O	O
waist	O	O	B-T201
circumference	O	O	I-T201
were	O	O	O
not	O	O	O
significantly	O	O	O
different	O	O	O
.	O	O	O

This	O	O	O
is	O	O	O
the	O	O	O
first	O	O	O
matched	O	O	B-T080
analysis	O	O	B-T062
of	O	O	O
its	O	O	O
kind	O	O	O
.	O	O	O

Significantly	O	O	O
higher	O	O	O
LDL	O	O	B-T034
levels	O	O	I-T034
in	O	O	O
patients	O	O	B-T101
receiving	O	O	O
prednisolone	O	O	B-T109
relative	O	O	O
to	O	O	O
hydrocortisone	O	O	B-T125
could	O	O	O
predict	O	O	O
a	O	O	O
higher	O	O	O
relative	O	O	O
risk	O	O	B-T078
of	O	O	O
cardiovascular	O	O	B-T047
disease	O	O	I-T047
in	O	O	O
the	O	O	O
former	O	O	O
group	O	O	B-T078
.	O	O	O

-DOCSTART- (27866504)

Oxytocin	O	O	B-T116
Reduces	O	O	B-T080
Face	O	O	B-T029
Processing	O	O	B-T052
Time	O	O	B-T079
but	O	O	O
Leaves	O	O	B-T080
Recognition	O	O	B-T041
Accuracy	O	O	B-T080
and	O	O	O
Eye	O	O	B-T023
-	O	O	O
Gaze	O	O	B-T033
Unaffected	O	O	O

Previous	O	O	B-T079
studies	O	O	B-T062
have	O	O	O
found	O	O	O
that	O	O	O
oxytocin	O	O	B-T116
(	O	O	O
OXT	O	O	B-T116
)	O	O	O
can	O	O	O
improve	O	O	B-T033
the	O	O	O
recognition	O	O	B-T041
of	O	O	O
emotional	O	O	B-T033
facial	O	O	B-T033
expressions	O	O	I-T033
;	O	O	O
it	O	O	O
has	O	O	O
been	O	O	O
proposed	O	O	B-T080
that	O	O	O
this	O	O	O
effect	O	O	B-T080
is	O	O	O
mediated	O	O	B-T054
by	O	O	O
an	O	O	O
increase	O	O	B-T169
in	O	O	O
attention	O	O	B-T041
to	O	O	O
the	O	O	O
eye-region	O	O	B-T029
of	O	O	O
faces	O	O	B-T029
.	O	O	O

Nevertheless	O	O	O
,	O	O	O
evidence	O	O	B-T078
in	O	O	O
support	O	O	O
of	O	O	O
this	O	O	O
claim	O	O	O
is	O	O	O
inconsistent	O	O	B-T080
,	O	O	O
and	O	O	O
few	O	O	B-T081
studies	O	O	B-T062
have	O	O	O
directly	O	O	B-T080
tested	O	O	B-T169
the	O	O	O
effect	O	O	B-T080
of	O	O	O
oxytocin	O	O	B-T116
on	O	O	O
emotion	O	O	B-T041
recognition	O	O	B-T041
via	O	O	O
altered	O	O	B-T169
eye	O	O	B-T023
-	O	O	O
gaze	O	O	B-T033
Methods	O	O	B-T170
:	O	O	O
In	O	O	O
a	O	O	O
double-blind	O	O	B-T062
,	O	O	O
within	O	O	B-T082
-	O	O	O
subjects	O	O	B-T098
,	O	O	O
randomized	O	O	B-T062
control	O	O	I-T062
experiment	O	O	I-T062
,	O	O	O
40	O	O	O
healthy	O	O	B-T080
male	O	O	B-T098
participants	O	O	I-T098
received	O	O	B-T080
24	O	O	O
IU	O	O	B-T081
intranasal	O	O	B-T061
OXT	O	O	B-T116
and	O	O	O
placebo	O	O	B-T122
in	O	O	O
two	O	O	O
identical	O	O	B-T080
experimental	O	O	B-T080
sessions	O	O	B-T051
separated	O	O	B-T080
by	O	O	O
a	O	O	O
2-	O	O	O
week	O	O	B-T079
interval	O	O	B-T079
.	O	O	O

Visual	O	O	B-T041
attention	O	O	I-T041
to	O	O	O
the	O	O	O
eye-region	O	O	B-T029
was	O	O	O
assessed	O	O	B-T052
on	O	O	O
both	O	O	O
occasions	O	O	O
while	O	O	O
participants	O	O	B-T098
completed	O	O	B-T080
a	O	O	O
static	O	O	B-T080
facial	O	O	B-T029
emotion	O	O	B-T041
recognition	O	O	B-T041
task	O	O	B-T057
using	O	O	O
medium	O	O	B-T080
intensity	O	O	I-T080
facial	O	O	B-T033
expressions	O	O	I-T033
.	O	O	O

Although	O	O	O
OXT	O	O	B-T116
had	O	O	O
no	O	O	B-T080
effect	O	O	I-T080
on	O	O	O
emotion	O	O	B-T041
recognition	O	O	B-T041
accuracy	O	O	B-T080
,	O	O	O
recognition	O	O	O
performance	O	O	B-T052
was	O	O	O
improved	O	O	B-T033
because	O	O	O
face	O	O	B-T029
processing	O	O	B-T052
was	O	O	O
faster	O	O	B-T080
across	O	O	O
emotions	O	O	B-T041
under	O	O	O
the	O	O	O
influence	O	O	B-T077
of	O	O	O
OXT	O	O	O
.	O	O	O

This	O	O	O
effect	O	O	B-T080
was	O	O	O
marginally	O	O	B-T080
significant	O	O	B-T078
(	O	O	O
p<.06	O	O	O
)	O	O	O
.	O	O	O

Consistent	O	O	B-T078
with	O	O	I-T078
a	O	O	O
previous	O	O	B-T079
study	O	O	B-T062
using	O	O	O
dynamic	O	O	B-T067
stimuli	O	O	I-T067
,	O	O	O
OXT	O	O	B-T116
had	O	O	O
no	O	O	B-T080
effect	O	O	I-T080
on	O	O	O
eye	O	O	B-T023
-	O	O	O
gaze	O	O	B-T033
patterns	O	O	B-T082
when	O	O	O
viewing	O	O	B-T082
static	O	O	B-T080
emotional	O	O	B-T033
faces	O	O	B-T029
and	O	O	O
this	O	O	O
was	O	O	O
not	O	O	O
related	O	O	O
to	O	O	O
recognition	O	O	B-T041
accuracy	O	O	B-T080
or	O	O	O
face	O	O	B-T029
processing	O	O	B-T052
time	O	O	B-T079
.	O	O	O

These	O	O	O
findings	O	O	B-T033
suggest	O	O	B-T078
that	O	O	O
OXT	O	O	B-T116
-	O	O	O
induced	O	O	B-T169
enhanced	O	O	B-T052
facial	O	O	B-T029
emotion	O	O	B-T041
recognition	O	O	B-T041
is	O	O	O
not	O	O	O
necessarily	O	O	O
mediated	O	O	B-T054
by	O	O	O
an	O	O	O
increase	O	O	B-T169
in	O	O	O
attention	O	O	B-T041
to	O	O	O
the	O	O	O
eye-region	O	O	B-T029
of	O	O	O
faces	O	O	B-T029
,	O	O	O
as	O	O	O
previously	O	O	B-T079
assumed	O	O	B-T170
.	O	O	O

We	O	O	O
discuss	O	O	O
several	O	O	B-T081
methodological	O	O	B-T078
issues	O	O	B-T033
which	O	O	O
may	O	O	O
explain	O	O	O
discrepant	O	O	B-T033
findings	O	O	I-T033
and	O	O	O
suggest	O	O	B-T078
the	O	O	O
effect	O	O	B-T080
of	O	O	O
OXT	O	O	B-T116
on	O	O	O
visual	O	O	B-T041
attention	O	O	I-T041
may	O	O	O
differ	O	O	O
depending	O	O	O
on	O	O	O
task	O	O	B-T057
requirements	O	O	B-T169
.	O	O	O

(	O	O	O
JINS	O	O	O
,	O	O	O
2017	O	O	O
,	O	O	O
23	O	O	O
,	O	O	O
23	O	O	O
-	O	O	O
33	O	O	O
)	O	O	O
.	O	O	O

-DOCSTART- (27866508)

New	O	O	O
directions	O	O	O
for	O	O	O
psychiatric	O	O	B-T061
rehabilitation	O	O	I-T061
in	O	O	O
the	O	O	O
USA	O	O	O

American	O	O	B-T098
researchers	O	O	B-T097
have	O	O	O
led	O	O	O
the	O	O	O
world	O	O	B-T098
in	O	O	O
developing	O	O	B-T169
,	O	O	O
evaluating	O	O	B-T058
,	O	O	O
and	O	O	O
disseminating	O	O	B-T082
evidence	O	O	B-T078
-based	O	O	O
psychiatric	O	O	B-T061
rehabilitation	O	O	I-T061
practices	O	O	B-T169
for	O	O	O
people	O	O	B-T098
with	O	O	O
serious	O	O	B-T080
mental	O	O	B-T048
illness	O	O	I-T048
.	O	O	O

Paradoxically	O	O	O
,	O	O	O
however	O	O	O
,	O	O	O
the	O	O	O
USA	O	O	B-T083
lags	O	O	O
behind	O	O	O
most	O	O	O
industrialized	O	O	B-T080
nations	O	O	I-T080
in	O	O	O
providing	O	O	O
access	O	O	B-T080
to	O	O	O
high-quality	O	O	B-T058
mental	O	O	B-T058
health	O	O	I-T058
and	O	O	O
psychiatric	O	O	B-T058
services	O	O	I-T058
.	O	O	O

This	O	O	O
essay	O	O	B-T170
examines	O	O	O
several	O	O	O
evidence-based	O	O	B-T169
practices	O	O	B-T058
developed	O	O	O
in	O	O	O
the	O	O	O
USA	O	O	B-T083
,	O	O	O
the	O	O	O
spread	O	O	O
of	O	O	O
these	O	O	O
practices	O	O	O
,	O	O	O
the	O	O	O
barriers	O	O	B-T033
to	O	O	O
ensuring	O	O	O
availability	O	O	B-T080
to	O	O	O
people	O	O	B-T098
who	O	O	O
could	O	O	O
benefit	O	O	B-T081
from	O	O	O
these	O	O	O
services	O	O	B-T058
,	O	O	O
and	O	O	O
some	O	O	O
promising	O	O	O
directions	O	O	O
for	O	O	O
overcoming	O	O	B-T052
the	O	O	O
barriers	O	O	O
.	O	O	O

Factors	O	O	B-T169
influencing	O	O	O
the	O	O	O
growth	O	O	O
and	O	O	O
sustainment	O	O	B-T052
of	O	O	O
effective	O	O	B-T080
client	O	O	B-T096
-centred	O	O	O
practices	O	O	B-T058
include	O	O	O
the	O	O	O
availability	O	O	B-T169
of	O	O	O
adequate	O	O	B-T081
and	O	O	I-T081
stable	O	O	I-T081
funding	O	O	I-T081
,	O	O	O
committed	O	O	B-T054
leadership	O	O	I-T054
,	O	O	O
and	O	O	O
the	O	O	O
influence	O	O	B-T077
of	O	O	O
vested	O	O	O
interests	O	O	O
.	O	O	O

Two	O	O	O
strategies	O	O	O
for	O	O	O
promoting	O	O	B-T052
the	O	O	O
spread	O	O	B-T080
and	O	O	O
sustainment	O	O	B-T052
of	O	O	O
well-implemented	O	O	B-T169
evidence-based	O	O	I-T169
practices	O	O	I-T169
are	O	O	O
the	O	O	O
adoption	O	O	B-T052
of	O	O	O
fidelity	O	O	B-T054
scales	O	O	I-T054
and	O	O	O
learning	O	O	B-T041
communities	O	O	B-T096
.	O	O	O

-DOCSTART- (27866595)

Modifiable	O	O	B-T169
Healthy	O	O	B-T055
Lifestyle	O	O	I-T055
Behaviors	O	O	I-T055
:	O	O	O
10-Year	O	O	O
Health	O	O	B-T170
Outcomes	O	O	I-T170
From	O	O	O
a	O	O	O
Health	O	O	O
Promotion	O	O	O
Program	O	O	O

Previous	O	O	O
studies	O	O	O
have	O	O	O
examined	O	O	O
the	O	O	O
impact	O	O	B-T080
of	O	O	I-T080
healthy	O	O	B-T055
lifestyle	O	O	I-T055
choices	O	O	I-T055
on	O	O	O
health-related	O	O	B-T170
outcomes	O	O	B-T170
;	O	O	O
however	O	O	O
,	O	O	O
given	O	O	O
their	O	O	O
fragmented	O	O	B-T080
,	O	O	O
often	O	O	O
cross-sectional	O	O	B-T062
nature	O	O	I-T062
,	O	O	O
assessing	O	O	B-T058
the	O	O	I-T058
relative	O	O	I-T058
impact	O	O	I-T058
of	O	O	O
daily	O	O	O
modifiable	O	O	B-T169
behaviors	O	O	B-T053
on	O	O	O
overall	O	O	O
long-term	O	O	B-T079
outcomes	O	O	O
,	O	O	O
particularly	O	O	O
for	O	O	O
a	O	O	O
diverse	O	O	O
working	O	O	B-T098
adult	O	O	I-T098
population	O	O	I-T098
,	O	O	O
remains	O	O	B-T080
challenging	O	O	I-T080
.	O	O	O

Relationships	O	O	O
between	O	O	O
ten	O	O	O
self-reported	O	O	B-T062
healthy	O	O	B-T055
lifestyle	O	O	I-T055
behaviors	O	O	I-T055
and	O	O	O
health	O	O	B-T170
outcomes	O	O	I-T170
during	O	O	O
the	O	O	O
subsequent	O	O	O
9	O	O	O
years	O	O	O
in	O	O	O
a	O	O	O
cohort	O	O	B-T098
of	O	O	O
10,248	O	O	O
participants	O	O	B-T098
enrolled	O	O	O
during	O	O	O
2003	O	O	O
in	O	O	O
a	O	O	O
voluntary	O	O	B-T055
workplace	O	O	B-T082
wellness	O	O	B-T058
program	O	O	I-T058
were	O	O	O
assessed	O	O	O
.	O	O	O

Cox	O	O	B-T081
proportional-hazards	O	O	I-T081
models	O	O	I-T081
computed	O	O	B-T081
hazard	O	O	I-T081
ratios	O	O	I-T081
(	O	O	O
HRs	O	O	B-T081
)	O	O	O
for	O	O	O
lifestyle	O	O	B-T054
characteristics	O	O	I-T054
associated	O	O	O
with	O	O	O
time	O	O	B-T079
to	O	O	O
one	O	O	O
of	O	O	O
seven	O	O	O
self-reported	O	O	B-T062
chronic	O	O	B-T047
diseases	O	O	I-T047
or	O	O	O
death	O	O	B-T040
.	O	O	O

Data	O	O	B-T033
were	O	O	I-T033
collected	O	O	I-T033
between	O	O	O
2003	O	O	O
and	O	O	O
2012	O	O	O
and	O	O	O
analyzed	O	O	O
between	O	O	O
2014	O	O	O
and	O	O	O
2016	O	O	O
.	O	O	O

Behaviors	O	O	B-T053
that	O	O	O
most	O	O	O
significantly	O	O	O
affected	O	O	O
future	O	O	B-T081
outcomes	O	O	I-T081
were	O	O	O
low-fat	O	O	B-T061
diet	O	O	I-T061
,	O	O	O
aerobic	O	O	B-T061
exercise	O	O	I-T061
,	O	O	O
nonsmoking	O	O	B-T058
,	O	O	O
and	O	O	O
adequate	O	O	B-T033
sleep	O	O	I-T033
.	O	O	O

A	O	O	O
dose-response	O	O	B-T062
effect	O	O	I-T062
was	O	O	O
seen	O	O	O
between	O	O	O
dietary	O	O	B-T033
fat	O	O	I-T033
intake	O	O	I-T033
and	O	O	O
hypertension	O	O	B-T047
,	O	O	O
obesity	O	O	B-T047
,	O	O	O
diabetes	O	O	B-T047
,	O	O	O
heart	O	O	B-T047
disease	O	O	I-T047
,	O	O	O
and	O	O	O
hypercholesterolemia	O	O	B-T047
.	O	O	O

After	O	O	O
dietary	O	O	B-T033
fat	O	O	I-T033
intake	O	O	I-T033
,	O	O	O
aerobic	O	O	B-T061
exercise	O	O	I-T061
was	O	O	O
the	O	O	O
next	O	O	O
most	O	O	O
significant	O	O	O
behavior	O	O	B-T053
associated	O	O	O
with	O	O	O
development	O	O	B-T062
of	O	O	I-T062
outcomes	O	O	I-T062
.	O	O	O

Compared	O	O	O
with	O	O	O
sedentary	O	O	B-T080
participants	O	O	B-T098
,	O	O	O
those	O	O	O
who	O	O	O
exercised	O	O	B-T056
4	O	O	O
days	O	O	O
per	O	O	O
week	O	O	O
were	O	O	O
less	O	O	O
likely	O	O	O
to	O	O	O
develop	O	O	O
new-onset	O	O	B-UnknownType
diabetes	O	O	I-UnknownType
(	O	O	O
HR	O	O	B-T081
=	O	O	O
0.31	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
=	O	O	O
0.20	O	O	O
,	O	O	O
0.48	O	O	O
)	O	O	O
;	O	O	O
heart	O	O	B-T047
disease	O	O	I-T047
(	O	O	O
HR	O	O	O
=	O	O	O
0.46	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
=	O	O	O
0.27	O	O	O
,	O	O	O
0.80	O	O	O
)	O	O	O
;	O	O	O
and	O	O	O
hypercholesterolemia	O	O	B-T047
(	O	O	O
HR	O	O	O
=	O	O	O
0.61	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
=	O	O	O
0.50	O	O	O
,	O	O	O
0.74	O	O	O
)	O	O	O
.	O	O	O

Low-fat	O	O	B-T061
diet	O	O	I-T061
and	O	O	O
adequate	O	O	B-T033
sleep	O	O	I-T033
were	O	O	O
more	O	O	O
significant	O	O	O
than	O	O	O
commonly	O	O	O
promoted	O	O	O
healthy	O	O	B-T055
behaviors	O	O	I-T055
,	O	O	O
such	O	O	O
as	O	O	O
eating	O	O	B-T055
a	O	O	I-T055
daily	O	O	I-T055
breakfast	O	O	I-T055
.	O	O	O

Modifiable	O	O	B-T169
lifestyle	O	O	B-T054
behaviors	O	O	I-T054
targeted	O	O	O
in	O	O	O
health	O	O	B-T058
promotion	O	O	I-T058
programs	O	O	I-T058
should	O	O	O
be	O	O	O
prioritized	O	O	O
in	O	O	O
an	O	O	O
evidence-based	O	O	B-T169
manner	O	O	I-T169
.	O	O	O

Top	O	O	O
priorities	O	O	O
for	O	O	O
workplace	O	O	B-T082
health	O	O	B-T058
promotion	O	O	I-T058
should	O	O	O
include	O	O	O
low-fat	O	O	B-T061
diet	O	O	I-T061
,	O	O	O
aerobic	O	O	B-T061
exercise	O	O	I-T061
,	O	O	O
nonsmoking	O	O	B-T058
,	O	O	O
and	O	O	O
adequate	O	O	B-T033
sleep	O	O	I-T033
.	O	O	O

-DOCSTART- (27867086)

Diazoxide	O	O	B-T109
prevents	O	O	B-T169
reactive	O	O	B-T123
oxygen	O	O	I-T123
species	O	O	I-T123
and	O	O	O
mitochondrial	O	O	B-T046
damage	O	O	I-T046
,	O	O	O
leading	O	O	O
to	O	O	O
anti-hypertrophic	O	O	O
effects	O	O	O

Pathological	O	O	B-T169
cardiac	O	O	B-T046
hypertrophy	O	O	I-T046
is	O	O	O
characterized	O	O	B-T052
by	O	O	O
wall	O	O	B-T023
thickening	O	O	B-T033
or	O	O	O
chamber	O	O	B-T023
enlargement	O	O	B-T046
of	O	O	O
the	O	O	O
heart	O	O	B-T023
in	O	O	O
response	O	O	O
to	O	O	O
pressure	O	O	B-T081
or	O	O	O
volume	O	O	B-T081
overload	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

This	O	O	O
condition	O	O	B-T080
will	O	O	O
,	O	O	O
initially	O	O	O
,	O	O	O
improve	O	O	B-T033
the	O	O	O
organ	O	O	B-T023
contractile	O	O	B-T042
function	O	O	I-T042
,	O	O	O
but	O	O	O
if	O	O	O
sustained	O	O	B-T169
will	O	O	O
render	O	O	O
dysfunctional	O	O	B-T077
mitochondria	O	O	B-T026
and	O	O	O
oxidative	O	O	B-T049
stress	O	O	I-T049
.	O	O	O

Mitochondrial	O	O	B-T116
ATP-sensitive	O	O	I-T116
K(+	O	O	I-T116
)	O	O	I-T116
channels	O	O	I-T116
(	O	O	O
mitoKATP	O	O	B-T116
)	O	O	O
modulate	O	O	B-T082
the	O	O	O
redox	O	O	B-T044
status	O	O	I-T044
of	O	O	O
the	O	O	O
cell	O	O	B-T025
and	O	O	O
protect	O	O	B-T033
against	O	O	O
several	O	O	O
cardiac	O	O	B-T023
insults	O	O	B-T169
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
tested	O	O	O
the	O	O	O
hypothesis	O	O	B-T078
that	O	O	O
mitoKATP	O	O	B-T116
opening	O	O	B-T082
(	O	O	O
using	O	O	O
diazoxide	O	O	B-T109
)	O	O	O
will	O	O	O
avoid	O	O	O
isoproterenol	O	O	B-T109
-	O	O	O
induced	O	O	B-T169
cardiac	O	O	B-T046
hypertrophy	O	O	I-T046
in	O	O	B-T082
vivo	O	O	I-T082
by	O	O	O
decreasing	O	O	O
reactive	O	O	B-T123
oxygen	O	O	I-T123
species	O	O	I-T123
(	O	O	B-T123
ROS	O	O	I-T123
)	O	O	O
production	O	O	O
and	O	O	O
mitochondrial	O	O	B-T026
Ca(2	O	O	B-T121
+	O	O	I-T121
)	O	O	I-T121
-	O	O	O
induced	O	O	O
swelling	O	O	B-T033
.	O	O	O

To	O	O	O
induce	O	O	B-T169
cardiac	O	O	B-T046
hypertrophy	O	O	I-T046
,	O	O	O
Swiss	O	O	B-T015
mice	O	O	I-T015
were	O	O	O
treated	O	O	B-T169
intraperitoneally	O	O	B-T082
with	O	O	O
isoproterenol	O	O	B-T109
(	O	O	O
30	O	O	O
mg/kg/	O	O	O
day	O	O	B-T079
)	O	O	O
for	O	O	O
8	O	O	O
days	O	O	B-T079
.	O	O	O

Diazoxide	O	O	B-T109
(	O	O	O
5	O	O	O
mg/kg/	O	O	O
day	O	O	B-T079
)	O	O	O
was	O	O	O
used	O	O	O
to	O	O	O
open	O	O	O
mitoKATP	O	O	B-T116
and	O	O	O
5-hydroxydecanoate	O	O	B-T109
(	O	O	O
5	O	O	O
mg/kg/	O	O	O
day	O	O	O
)	O	O	O
was	O	O	O
administrated	O	O	O
as	O	O	O
a	O	O	O
mitoKATP	O	O	O
blocker	O	O	B-T121
.	O	O	O

Isoproterenol	O	O	B-T109
-	O	O	O
treated	O	O	B-T169
mice	O	O	B-T015
had	O	O	O
elevated	O	O	B-T080
heart	O	O	B-T023
weight	O	O	B-T081
/	O	O	O
tibia	O	O	B-T023
length	O	O	B-T081
ratios	O	O	B-T081
and	O	O	O
increased	O	O	B-T081
myocyte	O	O	B-T025
cross-sectional	O	O	B-T033
areas	O	O	I-T033
.	O	O	O

Additionally	O	O	O
,	O	O	O
hypertrophic	O	O	B-T169
hearts	O	O	B-T023
produced	O	O	O
higher	O	O	B-T080
levels	O	O	B-T080
of	O	O	O
H2O2	O	O	B-T121
and	O	O	O
had	O	O	O
lower	O	O	O
glutathione	O	O	B-T044
peroxidase	O	O	I-T044
activity	O	O	I-T044
.	O	O	O

In	O	O	O
contrast	O	O	O
,	O	O	O
mitoKATP	O	O	B-T116
opening	O	O	B-T082
with	O	O	O
diazoxide	O	O	B-T109
blocked	O	O	B-T169
all	O	O	O
isoproterenol	O	O	B-T109
effects	O	O	B-T080
in	O	O	O
a	O	O	O
manner	O	O	O
reversed	O	O	B-T169
by	O	O	O
5-hydroxydecanoate	O	O	B-T109
.	O	O	O

Isolated	O	O	B-T169
mitochondria	O	O	B-T026
from	O	O	O
Isoproterenol	O	O	B-T109
-	O	O	O
induced	O	O	B-T169
hypertrophic	O	O	B-T169
hearts	O	O	B-T023
had	O	O	O
increased	O	O	B-T081
susceptibility	O	O	B-T169
to	O	O	O
Ca(2	O	O	B-T121
+	O	O	I-T121
)	O	O	I-T121
-	O	O	O
induced	O	O	O
swelling	O	O	B-T033
secondary	O	O	O
to	O	O	O
mitochondrial	O	O	B-T116
permeability	O	O	I-T116
transition	O	O	I-T116
pore	O	O	I-T116
opening	O	O	B-T082
.	O	O	O

MitokATP	O	O	B-T116
opening	O	O	B-T082
was	O	O	O
accompanied	O	O	O
by	O	O	O
lower	O	O	O
Ca(2	O	O	B-T121
+	O	O	I-T121
)	O	O	I-T121
-	O	O	O
induced	O	O	B-T169
mitochondrial	O	O	B-T049
swelling	O	O	I-T049
,	O	O	O
an	O	O	O
effect	O	O	B-T080
blocked	O	O	B-T169
by	O	O	O
5-hydroxydecanoate	O	O	B-T109
.	O	O	O

Our	O	O	O
results	O	O	O
suggest	O	O	O
that	O	O	O
mitoKATP	O	O	B-T116
opening	O	O	B-T082
negatively	O	O	B-T033
regulates	O	O	B-T038
cardiac	O	O	B-T046
hypertrophy	O	O	I-T046
by	O	O	O
avoiding	O	O	O
oxidative	O	O	B-T169
impairment	O	O	B-T169
and	O	O	O
mitochondrial	O	O	B-T046
damage	O	O	I-T046
.	O	O	O

-DOCSTART- (27871510)

Anticholinergic	O	O	B-T121
premedication	O	O	B-T061
to	O	O	O
prevent	O	O	O
bradycardia	O	O	B-T046
in	O	O	O
combined	O	O	O
spinal	O	O	B-T061
anesthesia	O	O	I-T061
and	O	O	O
dexmedetomidine	O	O	B-T109
sedation	O	O	B-T061
:	O	O	O
a	O	O	O
randomized	O	O	B-T062
,	O	O	O
double-blind	O	O	B-T062
,	O	O	O
placebo-controlled	O	O	O
study	O	O	O

When	O	O	O
dexmedetomidine	O	O	B-T109
is	O	O	O
used	O	O	O
in	O	O	O
patients	O	O	B-T101
undergoing	O	O	O
spinal	O	O	B-T061
anesthesia	O	O	I-T061
,	O	O	O
high	O	O	O
incidence	O	O	B-T169
of	O	O	O
bradycardia	O	O	B-T046
in	O	O	O
response	O	O	O
to	O	O	O
parasympathetic	O	O	B-T022
activation	O	O	B-T052
is	O	O	O
reported	O	O	O
.	O	O	O

Therefore	O	O	O
,	O	O	O
we	O	O	O
aimed	O	O	O
to	O	O	O
evaluate	O	O	O
the	O	O	O
effectiveness	O	O	B-T080
of	O	O	O
atropine	O	O	B-T109
premedication	O	O	B-T061
for	O	O	O
preventing	O	O	B-T169
the	O	O	O
incidence	O	O	B-T169
of	O	O	O
bradycardia	O	O	B-T046
and	O	O	O
the	O	O	O
hemodynamic	O	O	B-T042
effect	O	O	I-T042
on	O	O	O
patients	O	O	B-T101
undergoing	O	O	O
spinal	O	O	B-T061
anesthesia	O	O	I-T061
with	O	O	O
sedation	O	O	B-T061
by	O	O	O
dexmedetomidine	O	O	B-T109
.	O	O	O

Randomized	O	O	B-T062
,	O	O	O
double-blind	O	O	B-T062
,	O	O	O
placebo-controlled	O	O	B-T062
study	O	O	I-T062
.	O	O	O

Operating	O	O	B-T093
room	O	O	I-T093
.	O	O	O

One	O	O	O
hundred	O	O	O
fourteen	O	O	O
patients	O	O	B-T109
(	O	O	O
age	O	O	O
range	O	O	O
,	O	O	O
2	O	O	O
-	O	O	O
65	O	O	O
years	O	O	B-T079
;	O	O	O
American	O	O	B-T094
Society	O	O	I-T094
of	O	O	I-T094
Anesthesiology	O	O	I-T094
class	O	O	I-T094
I-II	O	O	I-T094
)	O	O	O
participated	O	O	O
in	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
willing	O	O	O
to	O	O	O
be	O	O	O
sedated	O	O	O
and	O	O	O
to	O	O	O
undergo	O	O	O
spinal	O	O	B-T061
anesthesia	O	O	I-T061
.	O	O	O

The	O	O	O
patients	O	O	B-T109
were	O	O	O
divided	O	O	O
into	O	O	O
2	O	O	O
groups	O	O	B-UnknownType
:	O	O	O
group	O	O	B-UnknownType
A	O	O	I-UnknownType
and	O	O	O
group	O	O	O
C.	O	O	O
After	O	O	O
performing	O	O	O
spinal	O	O	B-T061
anesthesia	O	O	I-T061
,	O	O	O
dexmedetomidine	O	O	B-T109
was	O	O	O
infused	O	O	B-T061
at	O	O	O
a	O	O	O
loading	O	O	B-UnknownType
dose	O	O	I-UnknownType
of	O	O	O
0.6	O	O	O
Î¼g/kg	O	O	O
for	O	O	O
10	O	O	O
minutes	O	O	B-T079
,	O	O	O
followed	O	O	O
by	O	O	O
an	O	O	O
infusion	O	O	B-T061
at	O	O	O
0.25	O	O	O
Î¼g/(kg	O	O	O
h	O	O	O
)	O	O	O
.	O	O	O

Simultaneously	O	O	O
with	O	O	O
the	O	O	O
loading	O	O	B-UnknownType
dose	O	O	I-UnknownType
of	O	O	O
dexmedetomidine	O	O	B-T109
,	O	O	O
patients	O	O	B-T109
in	O	O	O
group	O	O	B-UnknownType
A	O	O	I-UnknownType
received	O	O	O
an	O	O	O
intravenous	O	O	B-T169
bolus	O	O	B-T061
of	O	O	O
0.5	O	O	O
mg	O	O	O
atropine	O	O	B-T109
,	O	O	O
whereas	O	O	O
patients	O	O	O
in	O	O	O
group	O	O	B-UnknownType
C	O	O	I-UnknownType
received	O	O	O
an	O	O	O
intravenous	O	O	B-T061
normal	O	O	I-T061
saline	O	O	I-T061
bolus	O	O	O
.	O	O	O

Data	O	O	B-T078
on	O	O	O
administration	O	O	B-T061
of	O	O	O
atropine	O	O	B-T109
and	O	O	O
ephedrine	O	O	B-T109
were	O	O	O
collected	O	O	O
.	O	O	O

Hemodynamic	O	O	B-T059
data	O	O	B-T078
including	O	O	O
heart	O	O	B-T201
rate	O	O	I-T201
,	O	O	O
systolic	O	O	B-T201
blood	O	O	I-T201
pressure	O	O	I-T201
,	O	O	O
diastolic	O	O	B-T201
blood	O	O	I-T201
pressure	O	O	I-T201
(	O	O	O
DBP	O	O	B-T201
)	O	O	O
,	O	O	O
and	O	O	O
mean	O	O	B-T033
blood	O	O	I-T033
pressure	O	O	I-T033
(	O	O	O
MBP	O	O	B-T033
)	O	O	O
were	O	O	O
also	O	O	O
recorded	O	O	O
.	O	O	O

The	O	O	O
incidence	O	O	B-T169
of	O	O	O
bradycardia	O	O	B-T046
requiring	O	O	O
atropine	O	O	B-T109
treatment	O	O	B-T061
was	O	O	O
significantly	O	O	B-T081
higher	O	O	I-T081
in	O	O	O
group	O	O	B-UnknownType
C	O	O	I-UnknownType
than	O	O	O
group	O	O	B-UnknownType
A	O	O	I-UnknownType
(	O	O	O
P=.035	O	O	O
)	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
incidence	O	O	B-T169
of	O	O	O
hypotension	O	O	B-T033
needing	O	O	O
ephedrine	O	O	B-T109
treatment	O	O	B-T061
showed	O	O	O
no	O	O	B-T033
significant	O	O	I-T033
difference	O	O	I-T033
between	O	O	O
the	O	O	O
2	O	O	O
groups	O	O	B-UnknownType
(	O	O	O
P=.7	O	O	O
)	O	O	O
.	O	O	O

Systolic	O	O	B-T201
blood	O	O	I-T201
pressure	O	O	I-T201
and	O	O	O
heart	O	O	B-T201
rate	O	O	I-T201
showed	O	O	O
no	O	O	B-T033
significant	O	O	I-T033
differences	O	O	I-T033
between	O	O	O
the	O	O	O
2	O	O	O
groups	O	O	B-UnknownType
(	O	O	O
P=.138	O	O	O
and	O	O	O
.464	O	O	O
,	O	O	O
respectively	O	O	O
)	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
group	O	O	B-UnknownType
A	O	O	I-UnknownType
showed	O	O	O
significant	O	O	O
increases	O	O	B-T081
in	O	O	O
DBP	O	O	B-T201
and	O	O	O
MBP	O	O	B-T033
,	O	O	O
and	O	O	O
group	O	O	B-UnknownType
C	O	O	I-UnknownType
did	O	O	O
not	O	O	O
(	O	O	O
P=.014	O	O	O
and	O	O	O
.008	O	O	O
,	O	O	O
respectively	O	O	O
)	O	O	O
.	O	O	O

Prophylactic	O	O	B-T061
atropine	O	O	B-T109
reduces	O	O	O
the	O	O	O
incidence	O	O	B-T169
of	O	O	O
bradycardia	O	O	B-T046
in	O	O	O
patients	O	O	B-T109
undergoing	O	O	O
spinal	O	O	B-T061
anesthesia	O	O	I-T061
with	O	O	O
dexmedetomidine	O	O	B-T109
sedation	O	O	B-T061
.	O	O	O

However	O	O	O
,	O	O	O
DBP	O	O	B-T201
and	O	O	O
MBP	O	O	B-T033
showed	O	O	O
significant	O	O	O
increases	O	O	B-T081
in	O	O	O
patients	O	O	B-T109
when	O	O	O
prophylactic	O	O	B-T061
atropine	O	O	B-T109
was	O	O	O
administrated	O	O	B-T061
.	O	O	O

Therefore	O	O	O
,	O	O	O
atropine	O	O	B-T109
premedication	O	O	B-T061
should	O	O	O
be	O	O	O
administered	O	O	B-T061
cautiously	O	O	O
.	O	O	O

-DOCSTART- (27872234)

Downregulation	O	O	B-T044
of	O	O	O
Endothelial	O	O	B-T116
Transient	O	O	I-T116
Receptor	O	O	I-T116
Potential	O	O	I-T116
Vanilloid	O	O	I-T116
Type	O	O	I-T116
4	O	O	I-T116
Channel	O	O	I-T116
and	O	O	O
Small-Conductance	O	O	B-T116
of	O	O	I-T116
Ca2	O	O	I-T116
+	O	O	I-T116
-Activated	O	O	I-T116
K+	O	O	I-T116
Channels	O	O	I-T116
Underpins	O	O	O
Impaired	O	O	B-T169
Endothelium-Dependent	O	O	B-T123
Hyperpolarization	O	O	I-T123
in	O	O	O
Hypertension	O	O	O

Endothelium-dependent	O	O	B-T123
hyperpolarization	O	O	I-T123
(EDH)-mediated	O	O	O
responses	O	O	B-T033
are	O	O	O
impaired	O	O	B-T169
in	O	O	O
hypertension	O	O	B-T047
,	O	O	O
but	O	O	O
the	O	O	O
underlying	O	O	O
mechanisms	O	O	B-T169
have	O	O	O
not	O	O	O
yet	O	O	O
been	O	O	O
determined	O	O	O
.	O	O	O

The	O	O	O
activation	O	O	B-T052
of	O	O	O
small-	O	O	B-T116
and	O	O	O
intermediate-conductance	O	O	B-T116
of	O	O	I-T116
Ca(2+)-activated	O	O	I-T116
K(+	O	O	I-T116
)	O	O	I-T116
channels	O	O	I-T116
(	O	O	O
SKCa	O	O	B-T116
and	O	O	O
IKCa	O	O	B-T116
)	O	O	O
underpins	O	O	O
EDH	O	O	B-T123
-mediated	O	O	O
responses	O	O	B-T033
.	O	O	O

It	O	O	O
was	O	O	O
recently	O	O	O
reported	O	O	B-T170
that	O	O	O
Ca(2	O	O	B-T043
+	O	O	I-T043
)	O	O	I-T043
influx	O	O	I-T043
through	O	O	O
endothelial	O	O	B-T116
transient	O	O	I-T116
receptor	O	O	I-T116
potential	O	O	I-T116
vanilloid	O	O	I-T116
type	O	O	I-T116
4	O	O	I-T116
channel	O	O	I-T116
(	O	O	O
TRPV4	O	O	B-T116
)	O	O	O
is	O	O	O
a	O	O	O
prerequisite	O	O	B-T078
for	O	O	O
the	O	O	O
activation	O	O	B-T052
of	O	O	O
SKCa	O	O	B-T116
/	O	O	O
IKCa	O	O	B-T116
in	O	O	O
endothelial	O	O	B-T025
cells	O	O	I-T025
in	O	O	O
specific	O	O	O
beds	O	O	O
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
attempted	O	O	B-T051
to	O	O	O
determine	O	O	O
whether	O	O	O
the	O	O	O
impairment	O	O	B-T169
of	O	O	O
EDH	O	O	B-T123
in	O	O	O
hypertension	O	O	B-T047
is	O	O	O
attributable	O	O	O
to	O	O	O
the	O	O	O
dysfunction	O	O	B-T077
of	O	O	O
TRPV4	O	O	B-T116
and	O	O	O
S	O	O	B-T116
/	O	O	O
IKCa	O	O	B-T116
,	O	O	O
using	O	O	O
isolated	O	O	O
superior	O	O	B-T023
mesenteric	O	O	I-T023
arteries	O	O	I-T023
of	O	O	O
20-week-old	O	O	O
stroke-prone	O	O	B-T015
spontaneously	O	O	I-T015
hypertensive	O	O	I-T015
rats	O	O	I-T015
(	O	O	O
SHRSP	O	O	B-T015
)	O	O	O
and	O	O	O
age-matched	O	O	O
Wistar-Kyoto	O	O	B-T015
(	O	O	I-T015
WKY	O	O	I-T015
)	O	O	I-T015
rats	O	O	I-T015
.	O	O	O

In	O	O	O
the	O	O	O
WKY	O	O	B-T015
arteries	O	O	B-T023
,	O	O	O
EDH	O	O	B-T123
-mediated	O	O	O
responses	O	O	B-T033
were	O	O	O
reduced	O	O	B-T080
by	O	O	O
a	O	O	O
combination	O	O	B-T080
of	O	O	O
SKCa	O	O	B-T116
/	O	O	O
IKCa	O	O	B-T116
blockers	O	O	B-T121
(	O	O	O
apamin	O	O	B-T116
plus	O	O	O
TRAM-34	O	O	B-T109
;	O	O	O
1-[(2-chlorophenyl)diphenylmethl]-1H-pyrazole	O	O	B-T109
)	O	O	O
and	O	O	O
by	O	O	O
the	O	O	O
blockade	O	O	B-T169
of	O	O	O
TRPV4	O	O	B-T116
with	O	O	O
the	O	O	O
selective	O	O	O
antagonist	O	O	B-T120
RN-1734	O	O	B-T109
or	O	O	O
HC-067047	O	O	B-T109
.	O	O	O

In	O	O	O
the	O	O	O
SHRSP	O	O	B-T015
arteries	O	O	B-T023
,	O	O	O
EDH-mediated	O	O	B-T123
hyperpolarization	O	O	I-T123
and	O	O	O
relaxation	O	O	B-T052
were	O	O	O
significantly	O	O	B-T078
impaired	O	O	B-T169
when	O	O	O
compared	O	O	O
with	O	O	O
WKY	O	O	B-T015
.	O	O	O

GSK1016790A	O	O	B-T109
,	O	O	O
a	O	O	O
selective	O	O	O
TRPV4	O	O	B-T116
activator	O	O	B-T121
,	O	O	O
evoked	O	O	O
robust	O	O	O
hyperpolarization	O	O	B-T043
and	O	O	O
relaxation	O	O	B-T052
in	O	O	O
WKY	O	O	B-T015
arteries	O	O	B-T023
.	O	O	O

In	O	O	O
contrast	O	O	O
,	O	O	O
in	O	O	O
SHRSP	O	O	B-T015
arteries	O	O	B-T023
,	O	O	O
the	O	O	O
GSK1016790A	O	O	B-T109
-evoked	O	O	O
hyperpolarization	O	O	B-T043
was	O	O	O
small	O	O	O
and	O	O	O
relaxation	O	O	B-T052
was	O	O	O
absent	O	O	B-T169
.	O	O	O

Hyperpolarization	O	O	B-T043
and	O	O	O
relaxation	O	O	B-T052
to	O	O	O
cyclohexyl-[2-(3,5-dimethyl-pyrazol-1-yl)-6-methyl-pyrimidin-4-yl]-amine	O	O	B-T109
,	O	O	O
a	O	O	O
selective	O	O	O
SKCa	O	O	B-T116
activator	O	O	B-T121
,	O	O	O
were	O	O	O
marginally	O	O	B-T080
decreased	O	O	B-T081
in	O	O	O
SHRSP	O	O	B-T015
arteries	O	O	B-T023
compared	O	O	O
with	O	O	O
WKY	O	O	B-T015
arteries	O	O	O
.	O	O	O

The	O	O	O
expression	O	O	B-T045
of	O	O	O
endothelial	O	O	B-T116
TRPV4	O	O	I-T116
and	O	O	O
SKCa	O	O	B-T116
protein	O	O	O
was	O	O	O
significantly	O	O	B-T081
decreased	O	O	I-T081
in	O	O	O
the	O	O	O
SHRSP	O	O	B-T015
mesenteric	O	O	B-T023
arteries	O	O	B-T023
compared	O	O	O
with	O	O	O
those	O	O	O
of	O	O	O
WKY	O	O	B-T015
,	O	O	O
whereas	O	O	O
function	O	O	B-T169
and	O	O	O
expression	O	O	O
of	O	O	O
IKCa	O	O	B-T116
were	O	O	O
preserved	O	O	O
in	O	O	O
SHRSP	O	O	O
arteries	O	O	O
.	O	O	O

These	O	O	O
findings	O	O	B-T033
suggest	O	O	O
that	O	O	O
EDH	O	O	B-T123
-mediated	O	O	O
responses	O	O	B-T033
are	O	O	O
impaired	O	O	B-T169
in	O	O	O
superior	O	O	B-T023
mesenteric	O	O	I-T023
arteries	O	O	I-T023
of	O	O	O
SHRSP	O	O	B-T015
because	O	O	O
of	O	O	O
a	O	O	O
reduction	O	O	B-T061
in	O	O	O
both	O	O	O
TRPV4	O	O	B-T116
and	O	O	O
SKCa	O	O	B-T116
input	O	O	B-T077
to	O	O	O
EDH	O	O	O
.	O	O	O

-DOCSTART- (27873109)

Bioavailability	O	O	B-T062
and	O	O	O
health	O	O	B-T061
risk	O	O	I-T061
assessment	O	O	I-T061
of	O	O	O
potentially	O	O	B-T080
toxic	O	O	B-T131
elements	O	O	I-T131
in	O	O	O
Thriasio	O	O	B-T083
Plain	O	O	I-T083
,	O	O	I-T083
near	O	O	I-T083
Athens	O	O	I-T083
,	O	O	O
Greece	O	O	O

Elevated	O	O	O
concentrations	O	O	B-T081
of	O	O	O
potentially	O	O	B-T080
toxic	O	O	B-T131
elements	O	O	I-T131
(	O	O	O
PTEs	O	O	B-T131
)	O	O	O
are	O	O	O
usually	O	O	O
found	O	O	O
in	O	O	O
areas	O	O	B-T033
of	O	O	I-T033
intense	O	O	I-T033
industrial	O	O	I-T033
activity	O	O	I-T033
.	O	O	O

Thriasio	O	O	B-T083
Plain	O	O	I-T083
is	O	O	O
a	O	O	O
plain	O	O	B-T083
near	O	O	I-T083
Athens	O	O	I-T083
,	O	O	O
Greece	O	O	B-T083
,	O	O	O
where	O	O	O
most	O	O	O
of	O	O	O
the	O	O	O
heavy	O	O	B-T090
industry	O	O	I-T090
of	O	O	O
the	O	O	O
country	O	O	O
has	O	O	O
been	O	O	O
situated	O	O	O
for	O	O	O
decades	O	O	O
,	O	O	O
but	O	O	O
it	O	O	O
also	O	O	O
is	O	O	O
a	O	O	O
residential	O	O	B-T082
and	O	O	O
horticultural	O	O	B-UnknownType
area	O	O	B-T082
.	O	O	O

We	O	O	O
aimed	O	O	O
at	O	O	O
measuring	O	O	O
the	O	O	O
levels	O	O	O
of	O	O	O
PTEs	O	O	B-T131
in	O	O	O
soils	O	O	B-T167
and	O	O	O
indigenous	O	O	B-T169
plant	O	O	B-T002
species	O	O	I-T002
and	O	O	O
assessing	O	O	B-T061
the	O	O	I-T061
health	O	O	I-T061
risk	O	O	I-T061
associated	O	O	B-T080
with	O	O	I-T080
direct	O	O	O
soil	O	O	B-T167
ingestion	O	O	B-T038
.	O	O	O

Samples	O	O	B-T167
of	O	O	I-T167
soils	O	O	I-T167
at	O	O	O
roadsides	O	O	B-T073
and	O	O	O
growing	O	O	O
plants	O	O	B-T002
were	O	O	O
collected	O	O	O
from	O	O	O
31	O	O	O
sites	O	O	O
of	O	O	O
that	O	O	O
area	O	O	B-T082
.	O	O	O

Concentrations	O	O	B-T081
of	O	O	O
Al	O	O	B-T196
,	O	O	O
As	O	O	B-T121
,	O	O	O
Cd	O	O	B-T131
,	O	O	O
Co	O	O	B-T123
,	O	O	O
Cr	O	O	B-T131
,	O	O	O
Cu	O	O	B-T121
,	O	O	O
Fe	O	O	B-T121
,	O	O	O
Mn	O	O	B-T123
,	O	O	O
Mo	O	O	B-T123
,	O	O	O
Ni	O	O	B-T123
,	O	O	O
Pb	O	O	B-T131
,	O	O	O
V	O	O	B-T131
and	O	O	O
Zn	O	O	B-T121
were	O	O	O
measured	O	O	O
in	O	O	O
both	O	O	O
soils	O	O	B-T167
(	O	O	O
as	O	O	O
pseudo-total	O	O	O
)	O	O	O
and	O	O	O
aerial	O	O	O
plant	O	O	B-T025
tissues	O	O	I-T025
.	O	O	O

We	O	O	O
found	O	O	O
that	O	O	O
As	O	O	B-T121
,	O	O	O
Cd	O	O	B-T131
,	O	O	O
Cr	O	O	B-T131
,	O	O	O
Cu	O	O	B-T121
,	O	O	O
Ni	O	O	B-T123
,	O	O	O
Pb	O	O	B-T131
and	O	O	O
Zn	O	O	B-T121
were	O	O	O
higher	O	O	O
than	O	O	O
maximum	O	O	O
regulatory	O	O	B-T089
limits	O	O	B-T078
.	O	O	O

Element	O	O	B-T196
concentrations	O	O	B-T081
in	O	O	O
plants	O	O	B-T002
were	O	O	O
rather	O	O	O
lower	O	O	O
than	O	O	O
expected	O	O	O
,	O	O	O
probably	O	O	O
because	O	O	O
indigenous	O	O	B-T169
plants	O	O	O
have	O	O	O
developed	O	O	O
excluder	O	O	B-T169
behaviour	O	O	O
over	O	O	O
time	O	O	O
.	O	O	O

Copper	O	O	B-T121
and	O	O	O
Zn	O	O	B-T121
soil	O	O	B-T167
-to-	O	O	O
plant	O	O	B-T002
coefficients	O	O	B-T081
were	O	O	O
highest	O	O	O
among	O	O	O
the	O	O	O
other	O	O	O
elements	O	O	B-T196
;	O	O	O
for	O	O	O
Cu	O	O	B-T121
this	O	O	O
was	O	O	O
unexpected	O	O	O
,	O	O	O
and	O	O	O
probably	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
recent	O	O	O
Cu	O	O	O
-	O	O	O
releasing	O	O	B-T169
industrial	O	O	B-T057
activity	O	O	B-T052
.	O	O	O

Risk	O	O	B-T058
assessment	O	O	I-T058
analysis	O	O	I-T058
indicated	O	O	O
that	O	O	O
As	O	O	B-T121
was	O	O	O
the	O	O	O
element	O	O	B-T196
contributing	O	O	O
more	O	O	O
than	O	O	O
50	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
health	O	O	B-T078
risk	O	O	B-T078
related	O	O	O
to	O	O	O
direct	O	O	O
soil	O	O	B-T167
ingestion	O	O	B-T038
,	O	O	O
followed	O	O	O
by	O	O	O
Cr	O	O	B-T131
,	O	O	O
Pb	O	O	B-T131
,	O	O	O
and	O	O	O
,	O	O	O
surprisingly	O	O	O
,	O	O	O
Mn	O	O	B-T123
.	O	O	O

We	O	O	O
concluded	O	O	O
that	O	O	O
in	O	O	O
a	O	O	O
multi	O	O	B-T081
-	O	O	O
element	O	O	B-T196
contamination	O	O	B-T068
situation	O	O	O
,	O	O	O
elevated	O	O	O
risk	O	O	O
of	O	O	O
PTEs	O	O	B-T131
(	O	O	O
such	O	O	O
as	O	O	O
As	O	O	B-T121
,	O	O	O
Cr	O	O	B-T131
and	O	O	O
Pb	O	O	B-T131
)	O	O	O
may	O	O	O
reduce	O	O	O
the	O	O	O
tolerance	O	O	B-T080
limits	O	O	B-T169
of	O	O	O
exposure	O	O	B-T080
to	O	O	I-T080
less-	O	O	O
toxic	O	O	B-T131
elements	O	O	I-T131
(	O	O	O
here	O	O	O
,	O	O	O
Mn	O	O	B-T123
)	O	O	O
.	O	O	O

-DOCSTART- (27875010)

Nutrients	O	O	B-T168
influence	O	O	O
the	O	O	O
thermal	O	O	B-T039
ecophysiology	O	O	I-T039
of	O	O	O
an	O	O	O
intertidal	O	O	B-T082
macroalga	O	O	B-T204
:	O	O	O
multiple	O	O	B-T078
stressors	O	O	I-T078
or	O	O	O
multiple	O	O	B-T078
drivers	O	O	I-T078
?	O	O	O

Urbanization	O	O	B-T068
of	O	O	O
coastlines	O	O	B-UnknownType
is	O	O	O
leading	O	O	O
to	O	O	O
increased	O	O	O
introduction	O	O	O
of	O	O	O
nutrients	O	O	B-T168
from	O	O	O
the	O	O	O
terrestrial	O	O	B-T082
environment	O	O	I-T082
to	O	O	O
nearshore	O	O	B-T082
habitats	O	O	I-T082
.	O	O	O

While	O	O	O
such	O	O	O
nutrient	O	O	B-T168
influxes	O	O	O
can	O	O	O
be	O	O	O
detrimental	O	O	O
to	O	O	O
coastal	O	O	B-UnknownType
marine	O	O	B-T001
organisms	O	O	I-T001
due	O	O	O
to	O	O	O
increased	O	O	O
eutrophication	O	O	B-T067
and	O	O	O
subsequent	O	O	O
reduced	O	O	B-T080
oxygen	O	O	B-T121
,	O	O	O
they	O	O	O
could	O	O	O
also	O	O	O
have	O	O	O
positive	O	O	B-T080
effects	O	O	I-T080
(	O	O	O
i.e.	O	O	O
,	O	O	O
increased	O	O	O
food	O	O	B-T168
availability	O	O	B-T169
)	O	O	O
on	O	O	O
species	O	O	B-T185
that	O	O	O
are	O	O	O
nitrogen-limited	O	O	B-T123
such	O	O	O
as	O	O	O
macroalgae	O	O	B-T204
.	O	O	O

Nutrient	O	O	B-T168
enrichment	O	O	B-T067
in	O	O	O
this	O	O	O
environment	O	O	B-T082
thus	O	O	O
has	O	O	O
the	O	O	O
potential	O	O	B-T080
to	O	O	O
counteract	O	O	O
some	O	O	O
of	O	O	O
the	O	O	O
negative	O	O	B-T080
impacts	O	O	I-T080
of	O	O	O
increasing	O	O	B-T169
temperatures	O	O	B-T081
,	O	O	O
at	O	O	O
least	O	O	O
for	O	O	O
some	O	O	O
species	O	O	B-T185
.	O	O	O

Characterizing	O	O	O
the	O	O	O
physiological	O	O	B-T039
response	O	O	I-T039
of	O	O	O
organisms	O	O	B-T001
to	O	O	O
simultaneous	O	O	B-T079
changes	O	O	B-T169
in	O	O	O
multiple	O	O	B-T078
drivers	O	O	I-T078
such	O	O	O
as	O	O	O
these	O	O	O
is	O	O	O
an	O	O	O
important	O	O	O
first	O	O	O
step	O	O	O
in	O	O	O
predicting	O	O	O
how	O	O	O
global	O	O	B-T080
climate	O	O	B-T070
change	O	O	I-T070
may	O	O	O
lead	O	O	O
to	O	O	O
ecological	O	O	B-T070
responses	O	O	B-T032
at	O	O	O
more	O	O	O
local	O	O	B-UnknownType
levels	O	O	I-UnknownType
.	O	O	O

We	O	O	O
evaluated	O	O	O
how	O	O	O
nutrient	O	O	B-T168
enrichment	O	O	B-T067
(	O	O	O
i.e.	O	O	O
,	O	O	O
nitrogen	O	O	B-T123
availability	O	O	B-T169
)	O	O	O
affected	O	O	O
the	O	O	O
growth	O	O	B-T040
of	O	O	O
Fucus	O	O	B-T002
vesiculosus	O	O	I-T002
,	O	O	O
a	O	O	O
foundational	O	O	O
macroalgal	O	O	B-T204
species	O	O	B-T204
in	O	O	O
the	O	O	O
North	O	O	B-T083
Atlantic	O	O	I-T083
rocky	O	O	I-T083
intertidal	O	O	I-T083
zone	O	O	I-T083
,	O	O	O
and	O	O	O
found	O	O	O
that	O	O	O
nutrient	O	O	O
-enriched	O	O	O
algal	O	O	B-T185
blades	O	O	I-T185
showed	O	O	O
a	O	O	O
significant	O	O	O
increase	O	O	O
in	O	O	O
tissue	O	O	B-T042
growth	O	O	I-T042
compared	O	O	O
to	O	O	O
individuals	O	O	B-T078
grown	O	O	O
under	O	O	O
ambient	O	O	B-T080
conditions	O	O	O
.	O	O	O

We	O	O	O
further	O	O	O
quantified	O	O	O
net	O	O	O
photosynthesis	O	O	B-T070
by	O	O	O
ambient	O	O	O
and	O	O	O
nutrient	O	O	B-T168
-enriched	O	O	O
tissues	O	O	B-T025
at	O	O	O
saturating	O	O	B-T070
irradiance	O	O	I-T070
over	O	O	O
a	O	O	O
range	O	O	O
of	O	O	O
temperature	O	O	B-T081
conditions	O	O	O
(	O	O	O
6	O	O	O
-	O	O	O
30	O	O	O
Â°	O	O	O
C	O	O	O
)	O	O	O
.	O	O	O

Respiration	O	O	B-T039
was	O	O	O
unaffected	O	O	O
by	O	O	O
nutrient	O	O	B-T168
treatment	O	O	B-T169
;	O	O	O
however	O	O	O
,	O	O	O
there	O	O	O
was	O	O	O
a	O	O	O
significant	O	O	O
increase	O	O	O
in	O	O	O
photosynthetic	O	O	B-T070
oxygen	O	O	B-T121
production	O	O	O
for	O	O	O
nutrient	O	O	O
-enriched	O	O	O
tissue	O	O	B-T025
compared	O	O	O
to	O	O	O
ambient	O	O	B-T080
,	O	O	O
but	O	O	O
only	O	O	O
at	O	O	O
elevated	O	O	B-T080
(	O	O	O
â¥18	O	O	O
Â°	O	O	O
C	O	O	O
)	O	O	O
temperatures	O	O	B-T081
.	O	O	O

This	O	O	O
study	O	O	B-T062
contributes	O	O	O
to	O	O	O
a	O	O	O
growing	O	O	O
body	O	O	O
of	O	O	O
literature	O	O	B-T170
showing	O	O	O
the	O	O	O
complexity	O	O	O
of	O	O	O
responses	O	O	B-T032
to	O	O	I-T032
changes	O	O	I-T032
in	O	O	O
multiple	O	O	B-T078
drivers	O	O	I-T078
,	O	O	O
and	O	O	O
highlights	O	O	O
the	O	O	O
importance	O	O	O
of	O	O	O
studying	O	O	B-T062
the	O	O	O
impacts	O	O	B-T067
of	O	O	O
global	O	O	B-T080
climate	O	O	B-T070
change	O	O	I-T070
within	O	O	O
the	O	O	O
context	O	O	O
of	O	O	O
more	O	O	O
local	O	O	O
environmental	O	O	B-T082
conditions	O	O	B-T080
.	O	O	O

-DOCSTART- (27876084)

A	O	O	O
trial	O	O	B-T062
to	O	O	O
determine	O	O	O
whether	O	O	O
septic	O	O	B-T046
shock	O	O	I-T046
-	O	O	O
reversal	O	O	B-T169
is	O	O	O
quicker	O	O	B-T080
in	O	O	O
pediatric	O	O	B-T080
patients	O	O	B-T101
randomized	O	O	B-T062
to	O	O	O
an	O	O	O
early	O	O	B-T079
goal-directed	O	O	B-T061
fluid-sparing	O	O	I-T061
strategy	O	O	I-T061
versus	O	O	O
usual	O	O	B-T058
care	O	O	I-T058
(	O	O	O
SQUEEZE	O	O	B-T062
):	O	O	O
study	O	O	B-T170
protocol	O	O	I-T170
for	O	O	O
a	O	O	O
pilot	O	O	O
randomized	O	O	O
controlled	O	O	O
trial	O	O	O

Current	O	O	B-T079
pediatric	O	O	B-T080
septic	O	O	B-T046
shock	O	O	I-T046
resuscitation	O	O	B-T061
guidelines	O	O	B-T170
from	O	O	O
the	O	O	O
American	O	O	B-T093
College	O	O	I-T093
of	O	O	I-T093
Critical	O	O	I-T093
Care	O	O	I-T093
Medicine	O	O	I-T093
focus	O	O	O
on	O	O	O
the	O	O	O
early	O	O	B-T079
and	O	O	O
goal-directed	O	O	B-T061
administration	O	O	I-T061
of	O	O	O
intravascular	O	O	B-T082
fluid	O	O	B-T031
followed	O	O	O
by	O	O	O
vasoactive	O	O	B-T080
medication	O	O	B-T121
infusions	O	O	B-T061
for	O	O	O
persistent	O	O	B-T079
and	O	O	O
fluid-refractory	O	O	B-T047
shock	O	O	I-T047
.	O	O	O

However	O	O	O
,	O	O	O
accumulating	O	O	B-T033
adult	O	O	B-T100
and	O	O	O
pediatric	O	O	B-T080
data	O	O	B-T078
suggest	O	O	O
that	O	O	O
excessive	O	O	B-T080
fluid	O	O	B-T061
administration	O	O	I-T061
is	O	O	O
associated	O	O	O
with	O	O	O
worse	O	O	B-T033
patient	O	O	B-T101
outcomes	O	O	B-T169
and	O	O	O
even	O	O	O
increased	O	O	B-T033
risk	O	O	I-T033
of	O	O	I-T033
death	O	O	I-T033
.	O	O	O

The	O	O	O
optimal	O	O	B-T081
amount	O	O	I-T081
of	O	O	O
intravascular	O	O	B-T082
fluid	O	O	B-T031
required	O	O	O
in	O	O	O
early	O	O	B-T079
pediatric	O	O	B-T080
septic	O	O	B-T046
shock	O	O	I-T046
resuscitation	O	O	B-T061
prior	O	O	O
to	O	O	O
the	O	O	O
initiation	O	O	B-T169
of	O	O	O
vasoactive	O	O	B-T080
support	O	O	I-T080
remains	O	O	O
unanswered	O	O	O
.	O	O	O

The	O	O	O
SQUEEZE	O	O	B-T062
Pilot	O	O	I-T062
Trial	O	O	I-T062
is	O	O	O
a	O	O	O
pragmatic	O	O	B-T054
,	O	O	O
two-arm	O	O	B-T062
,	O	O	O
parallel-group	O	O	B-T062
,	O	O	O
open-label	O	O	B-T062
,	O	O	O
prospective	O	O	B-T062
pilot	O	O	I-T062
randomized	O	O	I-T062
controlled	O	O	I-T062
trial	O	O	I-T062
.	O	O	O

Participants	O	O	B-T098
are	O	O	O
children	O	O	B-T100
aged	O	O	B-T032
29	O	O	O
days	O	O	B-T079
to	O	O	O
under	O	O	O
18	O	O	O
years	O	O	B-T079
with	O	O	O
suspected	O	O	B-T078
or	O	O	O
confirmed	O	O	B-T033
septic	O	O	B-T046
shock	O	O	I-T046
and	O	O	O
a	O	O	O
need	O	O	O
for	O	O	O
ongoing	O	O	O
resuscitation	O	O	B-T061
.	O	O	O

Eligible	O	O	O
participants	O	O	B-T098
are	O	O	O
enrolled	O	O	B-T058
under	O	O	O
an	O	O	O
exception	O	O	B-T077
to	O	O	O
consent	O	O	B-T169
process	O	O	B-T067
and	O	O	O
randomly	O	O	B-T080
assigned	O	O	B-T169
via	O	O	O
concealed	O	O	B-T080
allocation	O	O	B-T052
to	O	O	O
either	O	O	O
the	O	O	O
Usual	O	O	B-T058
Care	O	O	I-T058
(	O	O	O
control	O	O	B-T096
)	O	O	O
or	O	O	O
Fluid	O	O	B-T061
Sparing	O	O	I-T061
(	O	O	I-T061
intervention	O	O	I-T061
)	O	O	I-T061
resuscitation	O	O	I-T061
strategy	O	O	I-T061
.	O	O	O

The	O	O	O
primary	O	O	B-T080
objective	O	O	B-T170
of	O	O	O
this	O	O	O
pilot	O	O	B-T062
trial	O	O	I-T062
is	O	O	O
to	O	O	O
determine	O	O	O
feasibility	O	O	B-T062
,	O	O	O
based	O	O	O
on	O	O	O
the	O	O	O
ability	O	O	O
to	O	O	O
enroll	O	O	B-T058
participants	O	O	B-T098
and	O	O	O
to	O	O	O
adhere	O	O	O
to	O	O	O
the	O	O	O
study	O	O	B-T170
protocol	O	O	I-T170
.	O	O	O

The	O	O	O
primary	O	O	B-T080
outcome	O	O	I-T080
measure	O	O	I-T080
by	O	O	O
which	O	O	O
success	O	O	B-T080
will	O	O	O
be	O	O	O
determined	O	O	O
is	O	O	O
participant	O	O	B-T098
enrollment	O	O	B-T058
rate	O	O	B-T081
(	O	O	O
"	O	O	O
pass	O	O	O
"	O	O	O
defined	O	O	O
as	O	O	O
at	O	O	O
least	O	O	O
two	O	O	O
participants	O	O	B-T098
/	O	O	O
site	O	O	B-T082
/	O	O	O
month	O	O	B-T079
,	O	O	O
recognizing	O	O	O
that	O	O	O
enrollment	O	O	O
may	O	O	O
be	O	O	O
slower	O	O	O
during	O	O	O
the	O	O	O
run-in	O	O	O
phase	O	O	O
)	O	O	O
.	O	O	O

Secondary	O	O	O
objectives	O	O	B-T170
include	O	O	O
assessing	O	O	O
(	O	O	O
1	O	O	O
)	O	O	O
appropriateness	O	O	B-T080
of	O	O	O
eligibility	O	O	B-T080
criteria	O	O	I-T080
,	O	O	O
and	O	O	O
(	O	O	O
2	O	O	O
)	O	O	O
completeness	O	O	B-T080
of	O	O	O
clinical	O	O	B-T169
outcomes	O	O	I-T169
to	O	O	O
inform	O	O	O
the	O	O	O
endpoints	O	O	B-T080
for	O	O	O
the	O	O	O
planned	O	O	B-T169
multisite	O	O	B-T062
trial	O	O	I-T062
.	O	O	O

To	O	O	O
support	O	O	O
the	O	O	O
nested	O	O	B-T062
translational	O	O	I-T062
study	O	O	I-T062
,	O	O	O
SQUEEZE-D	O	O	B-T062
,	O	O	O
we	O	O	O
will	O	O	O
also	O	O	O
evaluate	O	O	O
the	O	O	O
feasibility	O	O	B-T062
of	O	O	O
describing	O	O	O
cell-free	O	O	B-T114
DNA	O	O	I-T114
(	O	O	O
a	O	O	O
procoagulant	O	O	B-T116
molecule	O	O	I-T116
with	O	O	O
prognostic	O	O	B-T170
utility	O	O	I-T170
)	O	O	O
in	O	O	O
blood	O	O	B-T031
samples	O	O	I-T031
obtained	O	O	O
from	O	O	O
children	O	O	B-T100
enrolled	O	O	B-T058
into	O	O	O
the	O	O	O
SQUEEZE	O	O	B-T062
Pilot	O	O	I-T062
Trial	O	O	I-T062
at	O	O	O
baseline	O	O	B-T081
and	O	O	O
at	O	O	O
24	O	O	O
h.	O	O	O
The	O	O	O
optimal	O	O	O
degree	O	O	B-T081
of	O	O	O
fluid	O	O	B-T031
resuscitation	O	O	B-T061
and	O	O	O
the	O	O	O
timing	O	O	B-T079
of	O	O	O
initiation	O	O	B-T169
of	O	O	O
vasoactive	O	O	B-T080
support	O	O	I-T080
in	O	O	O
order	O	O	O
to	O	O	O
achieve	O	O	O
recommended	O	O	O
therapeutic	O	O	B-T169
targets	O	O	B-T169
in	O	O	O
children	O	O	O
with	O	O	O
septic	O	O	B-T046
shock	O	O	I-T046
remains	O	O	O
unanswered	O	O	O
.	O	O	O

No	O	O	O
prospective	O	O	B-T062
study	O	O	I-T062
to	O	O	O
date	O	O	B-T079
has	O	O	O
examined	O	O	O
this	O	O	O
important	O	O	O
question	O	O	B-T170
for	O	O	O
children	O	O	B-T100
in	O	O	O
developed	O	O	B-T080
countries	O	O	I-T080
including	O	O	O
Canada	O	O	B-T083
.	O	O	O

Recruitment	O	O	B-T052
for	O	O	O
the	O	O	O
SQUEEZE	O	O	B-T062
Pilot	O	O	I-T062
Trial	O	O	I-T062
opened	O	O	B-T033
on	O	O	O
6	O	O	O
January	O	O	O
2014	O	O	O
.	O	O	O

Findings	O	O	B-T033
will	O	O	O
inform	O	O	O
the	O	O	O
feasibility	O	O	B-T062
of	O	O	O
the	O	O	O
planned	O	O	B-T169
multicenter	O	O	B-T062
trial	O	O	I-T062
to	O	O	O
answer	O	O	O
our	O	O	O
overall	O	O	B-T080
research	O	O	B-T078
question	O	O	I-T078
.	O	O	O

ClinicalTrials.gov	O	O	O
Identifier	O	O	O
NCT01973907	O	O	O
,	O	O	O
registered	O	O	O
on	O	O	O
23	O	O	O
October	O	O	O
2013	O	O	O
.	O	O	O

-DOCSTART- (27876145)

Entropy-driven	O	O	B-T169
reactions	O	O	I-T169
in	O	O	O
living	O	O	B-T078
cells	O	O	B-T025
for	O	O	O
assay	O	O	B-T059
let-7a	O	O	O
microRNA	O	O	O

Imaging	O	O	B-T060
of	O	O	O
microRNA	O	O	B-T114
(	O	O	O
miRNA	O	O	B-T114
)	O	O	O
in	O	O	O
living	O	O	B-T078
cells	O	O	B-T025
could	O	O	O
facilitate	O	O	O
the	O	O	O
monitoring	O	O	B-T057
of	O	O	O
the	O	O	O
expression	O	O	B-T045
and	O	O	O
distribution	O	O	B-T169
of	O	O	O
miRNA	O	O	O
and	O	O	O
research	O	O	B-T062
on	O	O	O
miRNA	O	O	O
-related	O	O	O
diseases	O	O	B-T047
.	O	O	O

Given	O	O	O
the	O	O	O
low	O	O	O
expression	O	O	B-T081
levels	O	O	I-T081
and	O	O	O
even	O	O	O
down-regulation	O	O	B-T044
of	O	O	O
cellular	O	O	B-T025
miRNA	O	O	B-T114
that	O	O	O
is	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
some	O	O	O
diseases	O	O	B-T047
,	O	O	O
enzyme	O	O	B-T116
-	O	O	O
free	O	O	B-T169
amplification	O	O	B-T063
strategies	O	O	I-T063
are	O	O	O
imperative	O	O	O
for	O	O	O
intracellular	O	O	B-T082
miRNA	O	O	O
assay	O	O	B-T059
.	O	O	O

In	O	O	O
this	O	O	O
work	O	O	O
,	O	O	O
we	O	O	O
report	O	O	O
an	O	O	O
entropy-driven	O	O	B-T169
reaction	O	O	I-T169
for	O	O	O
amplification	O	O	B-T063
assay	O	O	B-T059
miRNA	O	O	B-T114
with	O	O	O
a	O	O	O
detection	O	O	B-T081
limit	O	O	I-T081
of	O	O	O
0.27	O	O	O
pM.	O	O	O
The	O	O	O
resulting	O	O	O
signal	O	O	B-T067
amplification	O	O	O
provides	O	O	O
excellent	O	O	O
recognition	O	O	O
and	O	O	O
signal	O	O	O
enhancement	O	O	B-T052
of	O	O	O
specific	O	O	B-T080
miRNA	O	O	O
s	O	O	O
in	O	O	O
living	O	O	B-T078
cells	O	O	B-T025
.	O	O	O

This	O	O	O
method	O	O	O
supplies	O	O	O
accurate	O	O	B-T080
information	O	O	B-T078
regarding	O	O	O
cellular	O	O	B-T025
miRNA	O	O	B-T114
-related	O	O	O
biological	O	O	B-T038
events	O	O	I-T038
and	O	O	O
provides	O	O	O
a	O	O	O
new	O	O	O
tool	O	O	O
for	O	O	O
highly	O	O	B-T080
sensitive	O	O	I-T080
and	O	O	O
simultaneous	O	O	B-T079
imaging	O	O	B-T060
of	O	O	O
multiple	O	O	B-T081
low-level	O	O	O
biomarkers	O	O	B-T201
,	O	O	O
thereby	O	O	O
improving	O	O	O
the	O	O	O
accuracy	O	O	B-T080
of	O	O	O
early	O	O	B-T060
disease	O	O	I-T060
diagnosis	O	O	I-T060
.	O	O	O

-DOCSTART- (27878205)

Iterative	O	O	B-T033
Development	O	O	B-T169
and	O	O	O
Evaluation	O	O	B-T058
of	O	O	O
a	O	O	O
Pharmacogenomic	O	O	B-T091
-Guided	O	O	O
Clinical	O	O	B-T170
Decision	O	O	I-T170
Support	O	O	I-T170
System	O	O	I-T170
for	O	O	O
Warfarin	O	O	O
Dosing	O	O	O

Pharmacogenomic	O	O	B-T091
-guided	O	O	O
dosing	O	O	B-T081
has	O	O	O
the	O	O	O
potential	O	O	O
to	O	O	O
improve	O	O	O
patient	O	O	B-T101
outcomes	O	O	O
but	O	O	O
its	O	O	O
implementation	O	O	B-T052
has	O	O	O
been	O	O	O
met	O	O	O
with	O	O	O
clinical	O	O	B-T080
challenges	O	O	B-T058
.	O	O	O

Our	O	O	O
objective	O	O	O
was	O	O	O
to	O	O	O
develop	O	O	O
and	O	O	O
evaluate	O	O	B-T058
a	O	O	O
clinical	O	O	B-T170
decision	O	O	I-T170
support	O	O	I-T170
system	O	O	I-T170
(	O	O	O
CDSS	O	O	B-T170
)	O	O	O
for	O	O	O
pharmacogenomic	O	O	B-T091
-guided	O	O	O
warfarin	O	O	B-T081
dosing	O	O	I-T081
designed	O	O	B-T052
for	O	O	O
physicians	O	O	B-T097
and	O	O	O
pharmacists	O	O	B-T097
.	O	O	O

Twelve	O	O	O
physicians	O	O	B-T097
and	O	O	O
pharmacists	O	O	B-T097
completed	O	O	O
6	O	O	O
prescribing	O	O	B-T058
tasks	O	O	B-T057
using	O	O	O
simulated	O	O	B-T065
patient	O	O	I-T065
scenarios	O	O	B-T169
in	O	O	O
two	O	O	O
iterations	O	O	B-T033
(	O	O	O
development	O	O	B-T169
and	O	O	O
validation	O	O	B-T062
phases	O	O	B-T079
)	O	O	O
of	O	O	O
a	O	O	O
newly	O	O	O
developed	O	O	O
pharmacogenomic	O	O	B-T091
-driven	O	O	O
CDSS	O	O	B-T170
prototype	O	O	B-T080
.	O	O	O

For	O	O	O
each	O	O	O
scenario	O	O	B-T169
,	O	O	O
usability	O	O	B-T170
was	O	O	O
measured	O	O	B-T080
via	O	O	O
efficiency	O	O	B-T081
,	O	O	O
recorded	O	O	B-T170
as	O	O	O
time	O	O	B-T201
to	O	O	I-T201
task	O	O	I-T201
completion	O	O	I-T201
,	O	O	O
and	O	O	O
participants	O	O	B-T098
'	O	O	O
perceived	O	O	B-T041
satisfaction	O	O	B-T041
which	O	O	O
were	O	O	O
compared	O	O	O
using	O	O	O
Kruskal-Wallis	O	O	B-T170
and	O	O	I-T170
Mann	O	O	I-T170
Whitney	O	O	I-T170
U	O	O	I-T170
tests	O	O	I-T170
,	O	O	O
respectively	O	O	O
.	O	O	O

Debrief	O	O	O
interviews	O	O	O
were	O	O	O
conducted	O	O	O
and	O	O	O
qualitatively	O	O	B-T059
analyzed	O	O	I-T059
.	O	O	O

Usability	O	O	B-T170
findings	O	O	O
from	O	O	O
the	O	O	O
first	O	O	O
(	O	O	O
i.e.	O	O	O
development	O	O	B-T169
)	O	O	O
iteration	O	O	B-T033
were	O	O	O
incorporated	O	O	O
into	O	O	O
the	O	O	O
CDSS	O	O	B-T170
design	O	O	B-T052
for	O	O	O
the	O	O	O
second	O	O	B-T079
(	O	O	O
i.e.	O	O	O
validation	O	O	B-T062
)	O	O	O
iteration	O	O	O
.	O	O	O

During	O	O	O
the	O	O	O
CDSS	O	O	B-T170
validation	O	O	B-T062
iteration	O	O	B-T033
,	O	O	O
participants	O	O	B-T098
took	O	O	O
more	O	O	O
time	O	O	B-T201
to	O	O	I-T201
complete	O	O	I-T201
tasks	O	O	I-T201
with	O	O	O
a	O	O	O
median	O	O	B-T082
(	O	O	O
IQR	O	O	O
)	O	O	O
of	O	O	O
183	O	O	O
(	O	O	O
124	O	O	O
-	O	O	O
247	O	O	O
)	O	O	O
seconds	O	O	B-T079
versus	O	O	O
101	O	O	O
(	O	O	O
73.5	O	O	O
-	O	O	O
197	O	O	O
)	O	O	O
seconds	O	O	O
in	O	O	O
the	O	O	O
development	O	O	B-T169
iteration	O	O	O
(	O	O	O
p=0.01	O	O	O
)	O	O	O
.	O	O	O

This	O	O	O
increase	O	O	B-T169
in	O	O	O
time	O	O	B-T079
on	O	O	I-T079
task	O	O	I-T079
was	O	O	O
due	O	O	O
to	O	O	O
the	O	O	O
increase	O	O	O
in	O	O	O
time	O	O	O
spent	O	O	O
in	O	O	O
the	O	O	O
CDSS	O	O	B-T170
corresponding	O	O	O
to	O	O	O
several	O	O	O
design	O	O	B-T052
changes	O	O	O
.	O	O	O

Efficiency	O	O	B-T081
differences	O	O	O
that	O	O	O
were	O	O	O
observed	O	O	O
between	O	O	O
pharmacists	O	O	B-T097
and	O	O	O
physicians	O	O	B-T097
in	O	O	O
the	O	O	O
development	O	O	B-T169
iteration	O	O	B-T033
were	O	O	O
eliminated	O	O	O
in	O	O	O
the	O	O	O
validation	O	O	B-T062
iteration	O	O	O
.	O	O	O

The	O	O	O
increased	O	O	B-T081
use	O	O	O
of	O	O	O
the	O	O	O
CDSS	O	O	B-T170
corresponded	O	O	O
to	O	O	O
a	O	O	O
greater	O	O	O
acceptance	O	O	O
of	O	O	O
CDSS	O	O	O
recommended	O	O	O
doses	O	O	B-T081
in	O	O	O
the	O	O	O
validation	O	O	B-T062
iteration	O	O	B-T033
(	O	O	O
4	O	O	O
%	O	O	O
in	O	O	O
the	O	O	O
first	O	O	O
iteration	O	O	O
vs.	O	O	O
37.5	O	O	O
%	O	O	O
in	O	O	O
the	O	O	O
second	O	O	B-T079
iteration	O	O	O
,	O	O	O
p<0.001	O	O	O
)	O	O	O
.	O	O	O

Overall	O	O	O
satisfaction	O	O	B-T041
did	O	O	O
not	O	O	O
change	O	O	O
statistically	O	O	O
between	O	O	O
the	O	O	O
iterations	O	O	B-T033
but	O	O	O
the	O	O	O
qualitative	O	O	B-T059
analysis	O	O	I-T059
revealed	O	O	O
greater	O	O	O
trust	O	O	O
in	O	O	O
the	O	O	O
second	O	O	B-T079
prototype	O	O	B-T080
.	O	O	O

A	O	O	O
pharmacogenomic	O	O	B-T091
-guided	O	O	O
CDSS	O	O	B-T170
has	O	O	O
been	O	O	O
developed	O	O	O
using	O	O	O
warfarin	O	O	B-T109
as	O	O	O
the	O	O	O
test	O	O	O
drug	O	O	B-T121
.	O	O	O

The	O	O	O
final	O	O	O
CDSS	O	O	B-T170
prototype	O	O	B-T080
was	O	O	O
trusted	O	O	O
by	O	O	O
prescribers	O	O	O
and	O	O	O
significantly	O	O	O
increased	O	O	B-T081
the	O	O	O
time	O	O	B-T079
using	O	O	O
the	O	O	O
tool	O	O	B-T033
and	O	O	O
acceptance	O	O	O
of	O	O	O
the	O	O	O
recommended	O	O	O
doses	O	O	B-T081
.	O	O	O

This	O	O	O
study	O	O	O
is	O	O	O
an	O	O	O
important	O	O	O
step	O	O	O
toward	O	O	O
incorporating	O	O	O
pharmacogenomics	O	O	B-T091
into	O	O	O
CDSS	O	O	B-T170
design	O	O	B-T052
for	O	O	O
clinical	O	O	B-T062
testing	O	O	I-T062
.	O	O	O

-DOCSTART- (27879507)

Pedicle	O	O	B-T074
Screw	O	O	I-T074
Combined	O	O	B-T080
With	O	O	O
Lateral	O	O	B-T074
Mass	O	O	I-T074
Screw	O	O	I-T074
Fixation	O	O	B-T061
in	O	O	O
the	O	O	O
Treatment	O	O	B-T061
of	O	O	O
Basilar	O	O	B-T019
Invagination	O	O	I-T019
and	O	O	O
Congenital	O	O	O
C2-C3	O	O	O
Fusion	O	O	O

Clinical	O	O	B-T058
evaluation	O	O	I-T058
of	O	O	O
a	O	O	O
surgical	O	O	B-T061
fixation	O	O	B-T061
technique	O	O	B-T169
featuring	O	O	O
combined	O	O	B-T080
use	O	O	O
of	O	O	O
pedicle	O	O	B-T074
screw	O	O	I-T074
and	O	O	O
lateral	O	O	B-T074
mass	O	O	I-T074
screw	O	O	I-T074
(	O	O	O
LMS	O	O	B-T074
)	O	O	O
.	O	O	O

Introduction	O	O	O
of	O	O	O
a	O	O	O
novel	O	O	O
technique	O	O	B-T169
for	O	O	O
the	O	O	O
treatment	O	O	B-T061
of	O	O	O
congenital	O	O	B-T019
C2-C3	O	O	I-T019
fusion	O	O	I-T019
and	O	O	O
basilar	O	O	B-T019
invagination	O	O	I-T019
(	O	O	O
BI	O	O	B-T019
)	O	O	O
.	O	O	O

Posterior	O	O	B-T082
occipitocervical	O	O	B-T029
fixation	O	O	B-T061
using	O	O	O
C2	O	O	B-T074
pedicle	O	O	I-T074
screw	O	O	I-T074
was	O	O	O
widely	O	O	O
used	O	O	O
for	O	O	O
BI	O	O	B-T019
.	O	O	O

However	O	O	O
,	O	O	O
in	O	O	O
cases	O	O	B-T169
where	O	O	O
BI	O	O	B-T019
is	O	O	O
concurrent	O	O	B-T079
with	O	O	O
congenital	O	O	B-T019
C2-C3	O	O	I-T019
fusion	O	O	I-T019
,	O	O	O
the	O	O	O
C2	O	O	B-T023
pedicles	O	O	I-T023
tend	O	O	O
to	O	O	O
be	O	O	O
thinner	O	O	B-T080
than	O	O	O
that	O	O	O
in	O	O	O
normal	O	O	B-T080
population	O	O	B-T098
and	O	O	O
hence	O	O	O
more	O	O	O
likely	O	O	O
to	O	O	O
fail	O	O	B-T169
.	O	O	O

We	O	O	O
prompted	O	O	O
to	O	O	O
tackle	O	O	O
the	O	O	O
issue	O	O	B-T033
by	O	O	O
combining	O	O	B-T080
the	O	O	O
pedicle	O	O	B-T074
screw	O	O	I-T074
with	O	O	O
the	O	O	O
additional	O	O	O
use	O	O	O
of	O	O	O
LMS	O	O	B-T074
in	O	O	O
attempt	O	O	O
to	O	O	O
strengthen	O	O	B-T078
the	O	O	O
fixation	O	O	B-T061
.	O	O	O

Twenty-five	O	O	O
patients	O	O	B-T101
who	O	O	O
underwent	O	O	O
combined	O	O	B-T080
pedicle	O	O	B-T074
screw	O	O	I-T074
with	O	O	O
LMS	O	O	B-T074
fixation	O	O	B-T061
were	O	O	O
retrospectively	O	O	B-T062
studied	O	O	I-T062
.	O	O	O

The	O	O	O
instrument	O	O	B-T074
position	O	O	B-T082
,	O	O	O
fusion	O	O	B-T169
status	O	O	B-T080
,	O	O	O
and	O	O	O
complications	O	O	B-T046
were	O	O	O
analyzed	O	O	B-T062
.	O	O	O

None	O	O	O
had	O	O	O
spinal	O	O	B-T037
cord	O	O	I-T037
or	O	O	O
vertebral	O	O	B-T037
artery	O	O	I-T037
injury	O	O	I-T037
.	O	O	O

The	O	O	O
average	O	O	O
follow-up	O	O	B-T058
time	O	O	B-T079
was	O	O	O
20	O	O	O
months	O	O	B-T079
.	O	O	O

Solid	O	O	O
fusion	O	O	B-T169
was	O	O	O
achieved	O	O	O
in	O	O	O
23	O	O	O
patients	O	O	B-T101
(	O	O	O
92	O	O	O
%	O	O	O
)	O	O	O
as	O	O	O
detected	O	O	O
radiologically	O	O	B-T060
.	O	O	O

Two	O	O	O
cases	O	O	B-T169
suffered	O	O	O
from	O	O	O
recurred	O	O	B-T067
BI	O	O	B-T019
and	O	O	O
instrument	O	O	B-T074
failure	O	O	B-T033
but	O	O	O
eventually	O	O	O
achieved	O	O	O
solid	O	O	O
fusion	O	O	B-T169
between	O	O	O
the	O	O	O
occiput	O	O	B-T029
and	O	O	O
C2	O	O	B-T023
was	O	O	O
after	O	O	O
revision	O	O	B-T061
.	O	O	O

Among	O	O	O
all	O	O	O
25	O	O	O
patients	O	O	B-T101
,	O	O	O
4	O	O	O
suffered	O	O	O
from	O	O	O
complications	O	O	B-T046
including	O	O	O
instrument	O	O	B-T074
s	O	O	O
failure	O	O	B-T033
,	O	O	O
cerebrospinal	O	O	B-T047
fluid	O	O	I-T047
leakage	O	O	I-T047
,	O	O	O
and	O	O	O
intracranial	O	O	B-T029
infection	O	O	B-T046
.	O	O	O

The	O	O	O
clinical	O	O	B-T080
outcome	O	O	B-T169
indicates	O	O	O
that	O	O	O
the	O	O	O
technique	O	O	B-T169
is	O	O	O
reliable	O	O	O
for	O	O	O
the	O	O	O
treatment	O	O	B-T061
of	O	O	O
BI	O	O	B-T019
with	O	O	O
congenital	O	O	B-T019
C2-C3	O	O	I-T019
fusion	O	O	I-T019
.	O	O	O

-DOCSTART- (27881529)

Co-occurrence	O	O	B-T079
and	O	O	O
clustering	O	O	B-T081
of	O	O	O
health	O	O	B-T078
conditions	O	O	B-T080
at	O	O	O
age	O	O	B-T032
11	O	O	O
:	O	O	O
cross-sectional	O	O	B-T062
findings	O	O	B-T169
from	O	O	O
the	O	O	O
Millennium	O	O	O
Cohort	O	O	O
Study	O	O	O

To	O	O	O
identify	O	O	O
patterns	O	O	O
of	O	O	O
co-occurrence	O	O	B-T079
and	O	O	O
clustering	O	O	B-T081
of	O	O	O
6	O	O	O
common	O	O	O
adverse	O	O	B-T046
health	O	O	B-T078
conditions	O	O	B-T080
in	O	O	O
11-	O	O	O
year	O	O	B-T079
-old	O	O	O
children	O	O	B-T100
and	O	O	O
explore	O	O	O
differences	O	O	B-T080
by	O	O	O
sociodemographic	O	O	B-T078
factors	O	O	I-T078
.	O	O	O

Nationally	O	O	O
representative	O	O	O
prospective	O	O	B-T062
cohort	O	O	I-T062
study	O	O	I-T062
.	O	O	O

Children	O	O	B-T100
born	O	O	O
in	O	O	O
the	O	O	O
UK	O	O	B-T083
between	O	O	O
2000	O	O	O
and	O	O	O
2002	O	O	O
.	O	O	O

11	O	O	O
399	O	O	O
11-	O	O	O
year	O	O	B-T079
-old	O	O	O
singleton	O	O	B-T099
children	O	O	B-T100
for	O	O	O
whom	O	O	O
data	O	O	B-T078
on	O	O	O
all	O	O	O
6	O	O	O
health	O	O	B-T078
conditions	O	O	B-T080
and	O	O	O
sociodemographic	O	O	B-T078
information	O	O	I-T078
were	O	O	O
available	O	O	O
(	O	O	O
complete	O	O	B-T080
cases	O	O	B-T169
)	O	O	O
.	O	O	O

Prevalence	O	O	B-T081
,	O	O	O
co-occurrence	O	O	B-T079
and	O	O	O
clustering	O	O	B-T081
of	O	O	O
6	O	O	O
common	O	O	O
health	O	O	B-T078
conditions	O	O	B-T080
:	O	O	O
wheeze	O	O	B-T184
;	O	O	O
eczema	O	O	B-T047
;	O	O	O
long-standing	O	O	B-T184
illness	O	O	I-T184
(	O	O	O
excluding	O	O	O
wheeze	O	O	O
and	O	O	O
eczema	O	O	O
)	O	O	O
;	O	O	O
injury	O	O	B-T037
;	O	O	O
socioemotional	O	O	B-T048
difficulties	O	O	I-T048
(	O	O	O
measured	O	O	O
using	O	O	O
Strengths	O	O	B-T170
and	O	O	I-T170
Difficulties	O	O	I-T170
Questionnaire	O	O	I-T170
)	O	O	O
and	O	O	O
unfavourable	O	O	B-T032
weight	O	O	I-T032
(	O	O	O
thin	O	O	B-T033
/	O	O	O
overweight	O	O	B-T184
/	O	O	O
obese	O	O	B-T047
vs	O	O	O
normal	O	O	B-T032
)	O	O	O
.	O	O	O

42.4	O	O	O
%	O	O	O
of	O	O	O
children	O	O	B-T100
had	O	O	O
2	O	O	O
or	O	O	O
more	O	O	O
adverse	O	O	B-T046
health	O	O	B-T078
conditions	O	O	B-T080
(	O	O	O
co-occurrence	O	O	B-T079
)	O	O	O
.	O	O	O

Co-occurrence	O	O	B-T079
was	O	O	O
more	O	O	O
common	O	O	O
in	O	O	O
boys	O	O	B-T100
and	O	O	O
children	O	O	B-T100
from	O	O	O
lower	O	O	O
income	O	O	B-T081
households	O	O	B-T099
.	O	O	O

Latent	O	O	B-T062
class	O	O	I-T062
analysis	O	O	I-T062
identified	O	O	O
6	O	O	O
classes	O	O	B-T170
:	O	O	O
'	O	O	O
normative	O	O	B-T080
'	O	O	O
(	O	O	O
57.4	O	O	O
%	O	O	O
):	O	O	O
'	O	O	O
atopic	O	O	B-T046
burdened	O	O	B-T078
'	O	O	O
(	O	O	O
14.0	O	O	O
%	O	O	O
)	O	O	O
;	O	O	O
'	O	O	O
socioemotional	O	O	B-T048
burdened	O	O	I-T048
'	O	O	O
(	O	O	O
11.0	O	O	O
%	O	O	O
)	O	O	O
;	O	O	O
'	O	O	O
unfavourable	O	O	B-T032
weight	O	O	I-T032
/	O	O	O
injury	O	O	B-T037
'	O	O	O
(	O	O	O
7.7	O	O	O
%	O	O	O
)	O	O	O
;	O	O	O
'	O	O	O
eczema	O	O	B-T047
/	O	O	O
injury	O	O	O
'	O	O	O
(	O	O	O
6.0	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
'	O	O	O
eczema	O	O	O
/	O	O	O
unfavourable	O	O	O
weight	O	O	O
'	O	O	O
(	O	O	O
3.9	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

As	O	O	O
with	O	O	O
co-occurrence	O	O	B-T079
,	O	O	O
class	O	O	B-T170
membership	O	O	B-T055
differed	O	O	O
by	O	O	O
sociodemographic	O	O	B-T078
factors	O	O	I-T078
:	O	O	O
boys	O	O	B-T100
,	O	O	O
children	O	O	B-T100
of	O	O	O
mothers	O	O	B-T099
with	O	O	O
lower	O	O	O
educational	O	O	B-T033
attainment	O	O	I-T033
and	O	O	O
children	O	O	O
from	O	O	O
lower	O	O	O
income	O	O	B-T081
households	O	O	B-T099
were	O	O	O
more	O	O	O
likely	O	O	O
to	O	O	O
be	O	O	O
in	O	O	O
the	O	O	O
'	O	O	O
socioemotional	O	O	B-T048
burdened	O	O	I-T048
'	O	O	O
class	O	O	O
.	O	O	O

Children	O	O	B-T100
of	O	O	O
mothers	O	O	B-T099
with	O	O	O
higher	O	O	O
educational	O	O	B-T033
attainment	O	O	I-T033
were	O	O	O
more	O	O	O
likely	O	O	O
to	O	O	O
be	O	O	O
in	O	O	O
the	O	O	O
'	O	O	O
normative	O	O	B-T080
'	O	O	O
and	O	O	O
'	O	O	O
eczema	O	O	B-T047
/	O	O	O
unfavourable	O	O	B-T032
weight	O	O	I-T032
'	O	O	O
classes	O	O	B-T170
.	O	O	O

Co-occurrence	O	O	B-T079
of	O	O	O
adverse	O	O	B-T046
health	O	O	B-T078
conditions	O	O	B-T080
at	O	O	O
age	O	O	B-T032
11	O	O	O
is	O	O	O
common	O	O	O
and	O	O	O
is	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
adverse	O	O	O
socioeconomic	O	O	B-T077
circumstances	O	O	B-T077
.	O	O	O

Holistic	O	O	B-T078
,	O	O	O
child	O	O	B-T100
focused	O	O	O
care	O	O	B-T052
,	O	O	O
particularly	O	O	O
in	O	O	O
boys	O	O	B-T100
and	O	O	O
those	O	O	O
in	O	O	O
lower	O	O	O
income	O	O	B-T081
groups	O	O	B-T078
,	O	O	O
may	O	O	O
help	O	O	O
to	O	O	O
prevent	O	O	B-T080
and	O	O	O
reduce	O	O	B-T080
co-occurrence	O	O	B-T079
in	O	O	O
later	O	O	B-T079
childhood	O	O	B-T079
and	O	O	O
adolescence	O	O	B-T079
.	O	O	O

-DOCSTART- (27882444)

Genomic	O	O	B-T028
characterization	O	O	B-T052
of	O	O	O
a	O	O	O
wild-bird	O	O	B-T012
-	O	O	O
origin	O	O	B-T033
pigeon	O	O	B-T012
paramyxovirus	O	O	B-T005
type	O	O	I-T005
1	O	O	I-T005
(	O	O	O
PPMV-1	O	O	B-T005
)	O	O	O
first	O	O	O
isolated	O	O	B-T169
in	O	O	O
the	O	O	O
northwest	O	O	O
region	O	O	O
of	O	O	O
China	O	O	O

Pigeon	O	O	B-T012
paramyxovirus	O	O	B-T005
type-1	O	O	I-T005
(	O	O	O
PPMV-1	O	O	B-T005
)	O	O	O
is	O	O	O
an	O	O	O
enzootic	O	O	B-T169
in	O	O	O
pigeon	O	O	B-T012
flocks	O	O	B-T096
and	O	O	O
causes	O	O	O
severe	O	O	B-T080
economic	O	O	B-T081
losses	O	O	I-T081
in	O	O	O
the	O	O	O
poultry	O	O	B-T012
industry	O	O	B-T057
in	O	O	O
many	O	O	O
countries	O	O	B-T083
.	O	O	O

A	O	O	O
PPMV-1	O	O	B-T005
isolate	O	O	B-T123
,	O	O	O
abbreviated	O	O	O
as	O	O	O
PPMV-1/QL-01/CH/15	O	O	B-T005
,	O	O	O
was	O	O	O
isolated	O	O	B-T169
from	O	O	O
a	O	O	O
great	O	O	O
spotted	O	O	O
woodpecker	O	O	B-T012
in	O	O	O
the	O	O	O
northwest	O	O	B-T083
region	O	O	I-T083
of	O	O	I-T083
China	O	O	I-T083
in	O	O	O
2015	O	O	O
.	O	O	O

The	O	O	O
complete	O	O	O
genome	O	O	B-T028
was	O	O	O
sequenced	O	O	B-T059
,	O	O	O
and	O	O	O
the	O	O	O
results	O	O	B-T169
showed	O	O	O
that	O	O	O
the	O	O	O
virus	O	O	B-T005
genome	O	O	O
was	O	O	O
15,192	O	O	O
nt	O	O	O
in	O	O	O
length	O	O	B-T081
,	O	O	O
in	O	O	O
the	O	O	O
gene	O	O	B-T044
arrangement	O	O	I-T044
3'-NP-P-M-F-HN-L-5	O	O	I-T044
'	O	O	I-T044
.	O	O	O

Several	O	O	O
amino	O	O	B-T116
acid	O	O	I-T116
mutations	O	O	B-T045
were	O	O	O
identified	O	O	B-T080
in	O	O	O
the	O	O	O
functional	O	O	B-T087
domains	O	O	I-T087
of	O	O	O
the	O	O	O
F	O	O	B-T116
and	O	O	O
HN	O	O	B-T116
proteins	O	O	I-T116
.	O	O	O

The	O	O	O
pathogenicity	O	O	B-T032
index	O	O	I-T032
of	O	O	O
the	O	O	O
isolate	O	O	B-T123
was	O	O	O
evaluated	O	O	B-T058
,	O	O	O
and	O	O	O
the	O	O	O
mean	O	O	B-T079
death	O	O	I-T079
time	O	O	I-T079
(	O	O	O
MDT	O	O	B-T079
)	O	O	O
was	O	O	O
72	O	O	O
h	O	O	O
and	O	O	O
the	O	O	O
intracerebral	O	O	B-T032
pathogenicity	O	O	I-T032
index	O	O	I-T032
(	O	O	O
ICPI	O	O	B-T032
)	O	O	O
was	O	O	O
0.925	O	O	O
,	O	O	O
indicating	O	O	O
that	O	O	O
this	O	O	O
isolate	O	O	O
was	O	O	O
mesogenic	O	O	B-T080
.	O	O	O

Sequencing	O	O	B-T059
results	O	O	B-T169
showed	O	O	O
that	O	O	O
it	O	O	O
had	O	O	O
a	O	O	O
virulent	O	O	B-T080
Newcastle	O	O	B-T005
disease	O	O	I-T005
virus	O	O	I-T005
cleavage	O	O	B-T087
motif	O	O	I-T087
(112)R-R-Q-K-R-F(117	O	O	I-T087
)	O	O	I-T087
at	O	O	O
the	O	O	O
fusion	O	O	B-T116
protein	O	O	I-T116
cleavage	O	O	B-T087
site	O	O	I-T087
.	O	O	O

Morbidity	O	O	B-T081
and	O	O	O
mortality	O	O	B-T081
were	O	O	O
70	O	O	O
%	O	O	O
and	O	O	O
50	O	O	O
%	O	O	O
,	O	O	O
after	O	O	O
inoculation	O	O	B-T061
of	O	O	O
pigeons	O	O	B-T012
,	O	O	O
whereas	O	O	O
this	O	O	O
virus	O	O	B-T005
was	O	O	O
nonpathogenic	O	O	B-T033
in	O	O	O
chickens	O	O	B-T012
.	O	O	O

Different	O	O	O
immune	O	O	B-T042
responses	O	O	I-T042
of	O	O	O
pigeons	O	O	B-T012
and	O	O	O
chickens	O	O	B-T012
were	O	O	O
induced	O	O	B-T169
in	O	O	B-T082
vivo	O	O	I-T082
,	O	O	O
which	O	O	O
led	O	O	O
to	O	O	O
different	O	O	O
HI	O	O	B-T059
serum	O	O	I-T059
antibody	O	O	I-T059
titers	O	O	I-T059
.	O	O	O

The	O	O	O
results	O	O	B-T169
of	O	O	O
phylogenetic	O	O	B-T062
and	O	O	O
evolutionary	O	O	B-T062
distance	O	O	I-T062
analysis	O	O	I-T062
showed	O	O	O
that	O	O	O
this	O	O	O
PPMV-1	O	O	B-T005
strain	O	O	B-T001
belonged	O	O	O
to	O	O	O
sub-genotype	O	O	B-T170
VIa	O	O	I-T170
in	O	O	O
class	O	O	B-T170
II	O	O	I-T170
.	O	O	O

To	O	O	O
our	O	O	O
knowledge	O	O	O
,	O	O	O
this	O	O	O
is	O	O	O
the	O	O	O
first	O	O	O
identification	O	O	B-T059
and	O	O	O
analysis	O	O	B-T062
of	O	O	O
PPMV-1	O	O	B-T005
co-circulation	O	O	B-T033
among	O	O	O
wild	O	O	B-T012
birds	O	O	I-T012
and	O	O	O
domestic	O	O	B-T012
pigeon	O	O	I-T012
flocks	O	O	B-T096
in	O	O	O
China	O	O	B-T083
.	O	O	O

The	O	O	O
data	O	O	B-T078
from	O	O	O
this	O	O	O
study	O	O	B-T062
highlight	O	O	O
the	O	O	O
important	O	O	O
role	O	O	O
of	O	O	O
wild	O	O	B-T012
birds	O	O	I-T012
in	O	O	O
the	O	O	O
dissemination	O	O	B-T082
of	O	O	O
PPMV-1	O	O	B-T005
and	O	O	O
provide	O	O	O
useful	O	O	O
references	O	O	B-T170
for	O	O	O
improving	O	O	B-T080
our	O	O	O
understanding	O	O	O
of	O	O	O
the	O	O	O
distribution	O	O	B-T082
and	O	O	O
evolution	O	O	B-T045
of	O	O	O
PPMV-1	O	O	O
in	O	O	O
China	O	O	B-T083
.	O	O	O

-DOCSTART- (27882455)

Memory	O	O	B-T041
consolidation	O	O	I-T041
effects	O	O	B-T080
on	O	O	O
memory	O	O	B-T041
stabilization	O	O	I-T041
and	O	O	O
item	O	O	B-T041
integration	O	O	I-T041
in	O	O	O
older	O	O	O
adults	O	O	O

This	O	O	O
study	O	O	B-T062
examined	O	O	O
the	O	O	O
differential	O	O	B-T169
effects	O	O	I-T169
of	O	O	O
aging	O	O	B-T040
on	O	O	O
consolidation	O	O	B-T041
processes	O	O	I-T041
that	O	O	O
strengthen	O	O	O
newly	O	O	O
acquired	O	O	O
memory	O	O	B-T041
traces	O	O	I-T041
in	O	O	O
veridical	O	O	O
form	O	O	O
(	O	O	O
memory	O	O	B-T041
stabilization	O	O	I-T041
)	O	O	O
versus	O	O	O
consolidation	O	O	O
processes	O	O	O
that	O	O	O
are	O	O	O
responsible	O	O	O
for	O	O	O
integrating	O	O	B-T041
these	O	O	O
memory	O	O	O
traces	O	O	O
into	O	O	O
an	O	O	O
existing	O	O	O
body	O	O	O
of	O	O	O
knowledge	O	O	B-T170
(	O	O	O
item	O	O	B-T041
integration	O	O	I-T041
)	O	O	O
.	O	O	O

Older	O	O	B-T098
adults	O	O	I-T098
learned	O	O	B-T041
13	O	O	O
nonwords	O	O	B-T170
and	O	O	O
were	O	O	O
tested	O	O	O
on	O	O	O
their	O	O	O
memory	O	O	B-T041
for	O	O	O
the	O	O	O
nonwords	O	O	O
,	O	O	O
and	O	O	O
on	O	O	O
whether	O	O	O
these	O	O	O
nonwords	O	O	O
impacted	O	O	O
upon	O	O	O
processing	O	O	O
of	O	O	O
similar-sounding	O	O	O
English	O	O	B-T171
words	O	O	B-T170
immediately	O	O	O
and	O	O	O
24	O	O	O
hours	O	O	B-T079
later	O	O	O
.	O	O	O

Participants	O	O	B-T098
accurately	O	O	O
recognized	O	O	O
the	O	O	O
nonwords	O	O	B-T170
immediately	O	O	O
,	O	O	O
but	O	O	O
showed	O	O	O
significant	O	O	O
decreases	O	O	O
in	O	O	O
delayed	O	O	O
recognition	O	O	B-T041
and	O	O	O
recall	O	O	B-T041
.	O	O	O

In	O	O	O
comparison	O	O	O
,	O	O	O
the	O	O	O
nonwords	O	O	B-T170
impacted	O	O	O
upon	O	O	O
processing	O	O	B-T052
of	O	O	O
similar-sounding	O	O	B-T170
words	O	O	I-T170
only	O	O	O
in	O	O	O
the	O	O	O
delayed	O	O	B-T170
test	O	O	I-T170
.	O	O	O

Together	O	O	O
,	O	O	O
these	O	O	O
findings	O	O	O
suggest	O	O	O
that	O	O	O
memory	O	O	B-T041
consolidation	O	O	I-T041
processes	O	O	I-T041
may	O	O	O
be	O	O	O
more	O	O	O
evident	O	O	O
in	O	O	O
item	O	O	B-T041
integration	O	O	I-T041
than	O	O	O
memory	O	O	B-T041
stabilization	O	O	I-T041
processes	O	O	I-T041
for	O	O	O
new	O	O	O
declarative	O	O	O
memories	O	O	B-T041
in	O	O	O
older	O	O	B-T098
adults	O	O	I-T098
.	O	O	O

-DOCSTART- (27883264)

Mucosa	O	O	B-T031
-	O	O	O
associated	O	O	B-T080
biohydrogenating	O	O	B-T001
microbes	O	O	I-T001
protect	O	O	O
the	O	O	O
simulated	O	O	O
colon	O	O	B-T204
microbiome	O	O	B-T001
from	O	O	O
stress	O	O	B-T033
associated	O	O	B-T080
with	O	O	I-T080
high	O	O	B-T081
concentrations	O	O	I-T081
of	O	O	O
poly-unsaturated	O	O	O
fat	O	O	O

Polyunsaturated	O	O	B-T109
fatty	O	O	I-T109
acids	O	O	I-T109
(	O	O	O
PUFAs	O	O	B-T109
)	O	O	O
may	O	O	O
affect	O	O	O
colon	O	O	B-T204
microbiome	O	O	B-T001
homeostasis	O	O	B-T038
by	O	O	O
exerting	O	O	B-T040
(	O	O	O
specific	O	O	B-T080
)	O	O	O
antimicrobial	O	O	B-T195
effects	O	O	B-T080
and/or	O	O	O
interfering	O	O	O
with	O	O	O
mucosal	O	O	B-T031
biofilm	O	O	B-T167
formation	O	O	B-T169
at	O	O	O
the	O	O	O
gut	O	O	B-T023
mucosal	O	O	I-T023
interface	O	O	I-T023
.	O	O	O

We	O	O	O
used	O	O	O
standardized	O	O	B-T059
batch	O	O	I-T059
incubations	O	O	I-T059
and	O	O	O
the	O	O	O
Mucosal-Simulator	O	O	B-T170
of	O	O	I-T170
the	O	O	I-T170
Human	O	O	I-T170
Microbial	O	O	I-T170
Intestinal	O	O	I-T170
Ecosystem	O	O	I-T170
(	O	O	O
M-SHIME	O	O	B-T170
)	O	O	O
to	O	O	O
show	O	O	O
the	O	O	O
in	O	O	B-T080
vitro	O	O	I-T080
luminal	O	O	B-T030
and	O	O	O
mucosal	O	O	B-T031
effects	O	O	B-T080
of	O	O	I-T080
the	O	O	O
main	O	O	O
PUFA	O	O	B-T109
in	O	O	O
the	O	O	O
Western	O	O	B-T061
diet	O	O	I-T061
,	O	O	O
linoleic	O	O	B-T109
acid	O	O	I-T109
(	O	O	O
LA	O	O	B-T109
)	O	O	O
.	O	O	O

High	O	O	B-T081
concentrations	O	O	I-T081
of	O	O	O
LA	O	O	B-T109
were	O	O	O
found	O	O	O
to	O	O	O
decrease	O	O	B-T081
butyrate	O	O	B-T109
production	O	O	B-T169
and	O	O	O
Faecalibacterium	O	O	B-T007
prausnitzii	O	O	I-T007
numbers	O	O	O
dependent	O	O	O
on	O	O	O
LA	O	O	O
biohydrogenation	O	O	B-T070
to	O	O	O
vaccenic	O	O	B-T109
acid	O	O	I-T109
(	O	O	O
VA	O	O	B-T109
)	O	O	O
and	O	O	O
stearic	O	O	B-T109
acid	O	O	I-T109
(	O	O	O
SA	O	O	B-T109
)	O	O	O
.	O	O	O

In	O	O	O
faecal	O	O	B-T031
batch	O	O	B-T059
incubations	O	O	I-T059
,	O	O	O
LA	O	O	B-T109
biohydrogenation	O	O	B-T070
and	O	O	O
butyrate	O	O	B-T109
production	O	O	B-T169
were	O	O	O
positively	O	O	B-T080
correlated	O	O	I-T080
and	O	O	O
SA	O	O	B-T109
did	O	O	O
not	O	O	O
inhibit	O	O	B-T052
butyrate	O	O	O
production	O	O	O
.	O	O	O

In	O	O	O
the	O	O	O
M-SHIME	O	O	B-T170
,	O	O	O
addition	O	O	O
of	O	O	O
a	O	O	O
mucosal	O	O	B-T031
environment	O	O	B-T082
stimulated	O	O	B-T070
biohydrogenation	O	O	B-T070
to	O	O	O
SA	O	O	B-T109
and	O	O	O
protected	O	O	O
F.	O	O	B-T007
prausnitzii	O	O	I-T007
from	O	O	O
inhibition	O	O	B-T052
by	O	O	O
LA	O	O	B-T109
.	O	O	O

This	O	O	O
was	O	O	O
probably	O	O	O
due	O	O	O
to	O	O	O
the	O	O	O
preference	O	O	B-T078
of	O	O	O
two	O	O	O
biohydrogenating	O	O	B-T070
genera	O	O	B-T185
Roseburia	O	O	B-T007
and	O	O	O
Pseudobutyrivibrio	O	O	B-T007
for	O	O	O
the	O	O	O
mucosal	O	O	B-T031
niche	O	O	O
.	O	O	O

Co-culture	O	O	B-T059
batch	O	O	B-T059
incubations	O	O	I-T059
using	O	O	O
Roseburia	O	O	B-T007
hominis	O	O	I-T007
and	O	O	O
F.	O	O	B-T007
prausnitzii	O	O	I-T007
validated	O	O	B-T062
these	O	O	O
observations	O	O	B-T062
.	O	O	O

Correlations	O	O	B-T080
networks	O	O	B-T169
further	O	O	O
uncovered	O	O	O
the	O	O	O
central	O	O	O
role	O	O	O
of	O	O	O
Roseburia	O	O	B-T007
and	O	O	O
Pseudobutyrivibrio	O	O	B-T007
in	O	O	O
protecting	O	O	O
luminal	O	O	B-T030
and	O	O	O
mucosal	O	O	B-T059
SHIME	O	O	I-T059
microbiota	O	O	I-T059
from	O	O	O
LA	O	O	B-T109
-	O	O	O
induced	O	O	B-T033
stress	O	O	I-T033
.	O	O	O

Our	O	O	O
results	O	O	B-T169
confirm	O	O	O
how	O	O	O
cross-shielding	O	O	B-T169
interactions	O	O	I-T169
provide	O	O	O
resilience	O	O	O
to	O	O	O
the	O	O	O
microbiome	O	O	B-T001
and	O	O	O
demonstrate	O	O	O
the	O	O	O
importance	O	O	B-T080
of	O	O	O
biohydrogenating	O	O	B-T070
,	O	O	O
mucosal	O	O	B-T031
bacteria	O	O	B-T007
for	O	O	O
recovery	O	O	B-T052
from	O	O	O
LA	O	O	B-T109
stress	O	O	B-T033
.	O	O	O

-DOCSTART- (27884439)

Genetic	O	O	B-T169
parameters	O	O	B-T033
for	O	O	O
tick	O	O	B-T081
count	O	O	I-T081
and	O	O	O
udder	O	O	B-T023
health	O	O	B-T078
in	O	O	O
commercial	O	O	B-T170
and	O	O	O
indigenous	O	O	B-T102
ewes	O	O	B-UnknownType
in	O	O	O
South	O	O	O
Africa	O	O	O

The	O	O	O
genetics	O	O	B-T169
of	O	O	O
tick	O	O	B-T047
infestation	O	O	I-T047
in	O	O	O
sheep	O	O	B-T015
need	O	O	O
study	O	O	O
,	O	O	O
as	O	O	O
host	O	O	B-T169
resistance	O	O	I-T169
often	O	O	O
forms	O	O	O
part	O	O	O
of	O	O	O
integrated	O	O	O
pest	O	O	B-T057
control	O	O	I-T057
programs	O	O	I-T057
.	O	O	O

Repeated	O	O	O
udder	O	O	B-T023
health	O	O	B-T170
scores	O	O	I-T170
,	O	O	O
site-specific	O	O	B-T082
tick	O	O	B-T081
count	O	O	I-T081
,	O	O	O
mating	O	O	B-T040
weight	O	O	B-T081
and	O	O	O
reproduction	O	O	B-T040
records	O	O	B-T170
(	O	O	O
N=879	O	O	O
-	O	O	O
1204	O	O	O
)	O	O	O
were	O	O	O
recorded	O	O	O
annually	O	O	O
from	O	O	O
2010	O	O	O
to	O	O	O
2015	O	O	O
on	O	O	O
ewes	O	O	B-UnknownType
of	O	O	O
the	O	O	O
indigenous	O	O	B-T102
Namaqua	O	O	B-T015
Afrikaner	O	O	I-T015
(	O	O	O
NA	O	O	B-T015
)	O	O	O
fat-tailed	O	O	B-T185
breed	O	O	I-T185
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
the	O	O	O
commercial	O	O	B-T170
Dorper	O	O	B-T015
and	O	O	O
SA	O	O	B-T015
Mutton	O	O	I-T015
Merino	O	O	I-T015
(	O	O	I-T015
SAMM	O	O	I-T015
)	O	O	I-T015
breeds	O	O	I-T015
.	O	O	O

Udder	O	O	B-T023
s	O	O	O
were	O	O	O
scored	O	O	B-T081
subjectively	O	O	O
on	O	O	O
a	O	O	O
1	O	O	O
-	O	O	O
5	O	O	O
scale	O	O	O
(	O	O	O
1	O	O	O
-	O	O	O
udder	O	O	B-T023
intact	O	O	B-T080
and	O	O	O
5	O	O	O
-	O	O	O
udder	O	O	O
damaged	O	O	B-T037
severely	O	O	I-T037
)	O	O	O
and	O	O	O
ticks	O	O	B-T047
were	O	O	O
counted	O	O	B-T081
on	O	O	O
three	O	O	B-T029
locations	O	O	I-T029
.	O	O	O

The	O	O	O
body	O	O	B-T029
sites	O	O	I-T029
counted	O	O	B-T081
were	O	O	O
the	O	O	O
head	O	O	B-T023
and	O	O	I-T023
thoracic	O	O	I-T023
limb	O	O	I-T023
(	O	O	O
HTLTC	O	O	B-T023
)	O	O	O
,	O	O	O
udder-pelvic	O	O	B-T023
limb	O	O	I-T023
(	O	O	O
UPLTC	O	O	B-T023
)	O	O	O
and	O	O	O
perineum-breech-tail	O	O	B-T023
(	O	O	O
PBTTC	O	O	B-T023
)	O	O	O
.	O	O	O

These	O	O	O
counts	O	O	B-T081
were	O	O	O
also	O	O	O
totaled	O	O	O
for	O	O	O
a	O	O	O
total	O	O	B-T081
tick	O	O	I-T081
count	O	O	I-T081
(	O	O	O
TTC	O	O	B-T081
)	O	O	O
.	O	O	O

Reproduction	O	O	B-T040
traits	O	O	B-T032
were	O	O	O
number	O	O	O
of	O	O	O
lambs	O	O	B-T015
weaned	O	O	B-T033
per	O	O	O
ewe	O	O	B-T033
lambed	O	O	I-T033
and	O	O	O
total	O	O	O
weight	O	O	O
of	O	O	O
lamb	O	O	B-T033
weaned	O	O	I-T033
per	O	O	O
ewe	O	O	O
lambed	O	O	O
.	O	O	O

Udder	O	O	B-T023
health	O	O	B-T170
scores	O	O	I-T170
of	O	O	O
NA	O	O	B-T015
ewes	O	O	B-UnknownType
were	O	O	O
lower	O	O	O
than	O	O	O
those	O	O	O
of	O	O	O
Dorpers	O	O	B-T015
,	O	O	O
which	O	O	O
in	O	O	O
turn	O	O	O
had	O	O	O
lower	O	O	O
scores	O	O	O
than	O	O	O
SAMM	O	O	B-T015
ewes	O	O	O
.	O	O	O

NA	O	O	B-T015
ewes	O	O	B-UnknownType
had	O	O	O
lower	O	O	O
values	O	O	O
for	O	O	O
HTLTC	O	O	B-T023
,	O	O	O
UPLTC	O	O	B-T023
and	O	O	O
TTC	O	O	B-T081
than	O	O	O
the	O	O	O
commercial	O	O	B-T170
breeds	O	O	B-T185
,	O	O	O
but	O	O	O
higher	O	O	O
values	O	O	O
for	O	O	O
PBTTC	O	O	B-T023
than	O	O	O
Dorpers	O	O	B-T015
.	O	O	O

Heritability	O	O	B-T033
estimates	O	O	B-T081
amounted	O	O	O
to	O	O	O
0.26Â±0.04	O	O	O
for	O	O	O
HTLTC	O	O	B-T023
,	O	O	O
0.53Â±0.04	O	O	O
for	O	O	O
UPLTC	O	O	B-T023
,	O	O	O
0.07Â±0.06	O	O	O
for	O	O	O
PBTTC	O	O	B-T023
,	O	O	O
0.44Â±0.06	O	O	O
for	O	O	O
TTC	O	O	B-T081
and	O	O	O
0.61Â±0.03	O	O	O
for	O	O	O
udder	O	O	B-T023
health	O	O	B-T170
score	O	O	I-T170
.	O	O	O

Animal	O	O	B-T082
permanent	O	O	I-T082
environment	O	O	I-T082
also	O	O	O
affected	O	O	O
PBTTC	O	O	B-T023
(	O	O	O
0.14Â±0.07	O	O	O
)	O	O	O
.	O	O	O

Significant	O	O	B-UnknownType
genetic	O	O	I-UnknownType
correlations	O	O	I-UnknownType
were	O	O	O
found	O	O	O
between	O	O	O
the	O	O	O
HTLTC	O	O	B-T023
and	O	O	O
UPLTC	O	O	B-T023
(	O	O	O
0.47Â±0.10	O	O	O
)	O	O	O
,	O	O	O
UPLTC	O	O	O
and	O	O	O
udder	O	O	B-T023
health	O	O	B-T170
score	O	O	I-T170
(	O	O	O
0.52Â±0.07	O	O	O
)	O	O	O
,	O	O	O
HTLTC	O	O	O
and	O	O	O
UPLTC	O	O	O
(	O	O	O
0.24Â±0.11	O	O	O
)	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
UPLTC	O	O	O
and	O	O	O
PBTTC	O	O	B-T023
(	O	O	O
-0.44Â±0.11	O	O	O
)	O	O	O
.	O	O	O

Heavier	O	O	O
ewes	O	O	B-UnknownType
had	O	O	O
higher	O	O	O
UPLTC	O	O	B-T023
(	O	O	O
0.38Â±0.09	O	O	O
)	O	O	O
,	O	O	O
TTC	O	O	B-T081
(	O	O	O
0.33Â±0.09	O	O	O
)	O	O	O
and	O	O	O
impaired	O	O	B-T169
udder	O	O	B-T023
health	O	O	B-T078
(	O	O	O
0.21Â±0.08	O	O	O
)	O	O	O
.	O	O	O

Udder	O	O	B-T023
health	O	O	B-T170
score	O	O	I-T170
s	O	O	O
and	O	O	O
tick	O	O	B-T081
counts	O	O	I-T081
at	O	O	O
all	O	O	O
sites	O	O	O
were	O	O	O
not	O	O	O
related	O	O	O
to	O	O	O
reproduction	O	O	B-T040
traits	O	O	B-T032
.	O	O	O

The	O	O	O
indigenous	O	O	B-T102
NA	O	O	B-T015
breed	O	O	B-T185
outperformed	O	O	O
the	O	O	O
commercial	O	O	B-T170
breeds	O	O	B-T185
with	O	O	O
lower	O	O	O
values	O	O	O
for	O	O	O
HTLTC	O	O	B-T023
,	O	O	O
UPLTC	O	O	B-T023
,	O	O	O
TTC	O	O	B-T081
and	O	O	O
a	O	O	O
better	O	O	O
udder	O	O	B-T023
health	O	O	B-T170
score	O	O	I-T170
.	O	O	O

Mechanisms	O	O	O
contributing	O	O	O
to	O	O	O
the	O	O	O
better	O	O	O
performance	O	O	O
of	O	O	O
the	O	O	O
NA	O	O	B-T015
breed	O	O	B-T185
under	O	O	O
pastoral	O	O	B-T058
conditions	O	O	I-T058
and	O	O	O
the	O	O	O
scope	O	O	O
for	O	O	O
selection	O	O	O
for	O	O	O
tick	O	O	B-T047
tolerance	O	O	B-T080
within	O	O	O
breeds	O	O	B-T185
should	O	O	O
be	O	O	O
studied	O	O	O
further	O	O	O
.	O	O	O

-DOCSTART- (27886280)

Starvation	O	O	B-T033
-	O	O	O
and	O	O	O
antibiotics	O	O	B-T195
-induced	O	O	O
formation	O	O	B-T043
of	O	O	O
persister	O	O	B-T007
cells	O	O	I-T007
in	O	O	O
Pseudomonas	O	O	O
aeruginosa	O	O	O

Planktonic	O	O	B-T007
stationary	O	O	B-T059
and	O	O	I-T059
exponential	O	O	I-T059
cultures	O	O	I-T059
of	O	O	O
Pseudomonas	O	O	B-T007
aeruginosa	O	O	I-T007
are	O	O	O
highly	O	O	B-T169
resistant	O	O	I-T169
to	O	O	O
killing	O	O	B-T033
by	O	O	O
bactericidal	O	O	B-T195
antimicrobials	O	O	I-T195
because	O	O	O
of	O	O	O
the	O	O	O
presence	O	O	O
of	O	O	O
persisters	O	O	B-T007
,	O	O	O
cells	O	O	B-T007
that	O	O	O
are	O	O	O
multidrug	O	O	B-T033
tolerant	O	O	I-T033
and	O	O	O
play	O	O	O
a	O	O	O
key	O	O	O
role	O	O	O
in	O	O	O
the	O	O	O
recalcitrance	O	O	B-T169
of	O	O	O
biofilm	O	O	B-T007
infections	O	O	B-T046
.	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
this	O	O	O
study	O	O	B-T170
was	O	O	O
to	O	O	O
investigate	O	O	B-T169
the	O	O	O
formation	O	O	B-T043
of	O	O	O
persister	O	O	B-T007
cells	O	O	I-T007
in	O	O	O
P.	O	O	B-T007
aeruginosa	O	O	I-T007
stationary	O	O	B-T059
vs.	O	O	O
exponential	O	O	B-T059
cultures	O	O	I-T059
using	O	O	O
different	O	O	B-T080
class	O	O	B-T170
antimicrobials	O	O	B-T195
.	O	O	O

The	O	O	O
susceptibilities	O	O	B-T169
of	O	O	O
P.	O	O	B-T007
aeruginosa	O	O	I-T007
PAO1	O	O	I-T007
wild-type	O	O	I-T007
and	O	O	O
mutant	O	O	B-T001
strains	O	O	I-T001
to	O	O	O
antimicrobials	O	O	B-T195
were	O	O	O
determined	O	O	O
by	O	O	O
standard	O	O	B-T059
microtiter	O	O	I-T059
broth	O	O	I-T059
dilution	O	O	I-T059
method	O	O	I-T059
.	O	O	O

In	O	O	O
order	O	O	O
to	O	O	O
determine	O	O	O
persister	O	O	B-T007
formation	O	O	B-T043
,	O	O	O
dose	O	O	B-T081
-	O	O	O
and	O	O	O
time	O	O	B-T079
-dependent	O	O	O
killing	O	O	B-T059
experiments	O	O	I-T059
were	O	O	O
performed	O	O	B-T169
with	O	O	O
antibiotics	O	O	B-T195
.	O	O	O

Ceftazidime	O	O	B-T195
(	O	O	O
Cephalosporin	O	O	B-T195
)	O	O	O
showed	O	O	O
little	O	O	O
efficacy	O	O	B-T080
against	O	O	O
either	O	O	O
culture	O	O	B-T059
.	O	O	O

Stationary-phase	O	O	B-T007
cells	O	O	I-T007
were	O	O	O
more	O	O	O
tolerant	O	O	B-T033
to	O	O	O
imipenem	O	O	B-T195
(	O	O	O
Carbapenem	O	O	B-T195
)	O	O	O
than	O	O	O
exponential	O	O	B-T007
cells	O	O	I-T007
,	O	O	O
leaving	O	O	O
a	O	O	O
small	O	O	O
fraction	O	O	B-T081
of	O	O	I-T081
persisters	O	O	B-T007
at	O	O	O
high	O	O	B-T080
imipenem	O	O	O
concentration	O	O	B-T081
in	O	O	O
both	O	O	O
populations	O	O	B-T098
.	O	O	O

Polymyxin	O	O	B-T116
B	O	O	I-T116
(	O	O	O
Polymyxin	O	O	O
)	O	O	O
appeared	O	O	O
to	O	O	O
be	O	O	O
ineffective	O	O	O
at	O	O	O
low	O	O	B-T081
concentrations	O	O	I-T081
against	O	O	O
both	O	O	O
cell	O	O	B-T098
populations	O	O	I-T098
.	O	O	O

Very	O	O	O
high	O	O	O
polymyxin	O	O	B-T116
B	O	O	I-T116
concentration	O	O	B-T081
completely	O	O	O
eradicated	O	O	O
exponential	O	O	B-T007
cells	O	O	I-T007
and	O	O	O
regrowth	O	O	B-T169
was	O	O	O
seen	O	O	O
in	O	O	O
a	O	O	O
stationary	O	O	B-T098
population	O	O	I-T098
.	O	O	O

Stationary	O	O	B-T007
cells	O	O	I-T007
were	O	O	O
more	O	O	O
tolerant	O	O	B-T033
to	O	O	O
tobramycin	O	O	B-T195
(	O	O	O
Aminoglycoside	O	O	B-T109
)	O	O	O
than	O	O	O
exponential	O	O	B-T007
cells	O	O	I-T007
but	O	O	O
a	O	O	O
higher	O	O	B-T081
concentration	O	O	I-T081
of	O	O	O
tobramycin	O	O	O
completely	O	O	O
eliminated	O	O	B-T080
survivors	O	O	B-T078
.	O	O	O

Ciprofloxacin	O	O	B-T109
(	O	O	O
Fluoroquinolone	O	O	B-T109
)	O	O	O
at	O	O	O
a	O	O	O
low	O	O	B-T081
concentration	O	O	I-T081
resulted	O	O	O
in	O	O	O
killing	O	O	B-T033
of	O	O	O
both	O	O	O
cultures	O	O	B-T059
of	O	O	O
P.	O	O	B-T007
aeruginosa	O	O	I-T007
,	O	O	O
producing	O	O	O
persisters	O	O	B-T007
that	O	O	O
were	O	O	O
invulnerable	O	O	O
to	O	O	O
killing	O	O	O
.	O	O	O

Stationary	O	O	B-T007
cells	O	O	I-T007
appear	O	O	O
to	O	O	O
be	O	O	O
somewhat	O	O	O
more	O	O	O
tolerant	O	O	B-T033
than	O	O	O
exponential	O	O	B-T007
cells	O	O	I-T007
in	O	O	O
all	O	O	O
of	O	O	O
these	O	O	O
assays	O	O	B-T059
.	O	O	O

We	O	O	O
also	O	O	O
showed	O	O	O
that	O	O	O
nutrient	O	O	B-T168
deprivation	O	O	B-T080
(	O	O	O
serine	O	O	B-T116
starvation	O	O	B-T033
)	O	O	O
regulated	O	O	O
by	O	O	O
stringent	O	O	B-T039
and	O	O	I-T039
general	O	O	I-T039
stress	O	O	I-T039
response	O	O	I-T039
,	O	O	O
contribute	O	O	O
to	O	O	O
the	O	O	O
increased	O	O	B-T033
tolerance	O	O	I-T033
of	O	O	O
P.	O	O	B-T007
aeruginosa	O	O	I-T007
exponential	O	O	B-T007
and	O	O	I-T007
stationary	O	O	I-T007
planktonic	O	O	I-T007
cells	O	O	I-T007
via	O	O	O
production	O	O	B-T043
of	O	O	O
persisters	O	O	B-T007
.	O	O	O

-DOCSTART- (27887026)

Chaetomium	O	O	B-T004
thermophilum	O	O	I-T004
formate	O	O	B-T116
dehydrogenase	O	O	I-T116
has	O	O	O
high	O	O	O
activity	O	O	O
in	O	O	O
the	O	O	O
reduction	O	O	B-T070
of	O	O	O
hydrogen	O	O	B-T197
carbonate	O	O	I-T197
(	O	O	O
HCO3	O	O	B-T197
-	O	O	I-T197
)	O	O	O
to	O	O	O
formate	O	O	O

While	O	O	O
formate	O	O	B-T109
dehydrogenases	O	O	I-T116
(	O	O	O
FDHs	O	O	B-T116
)	O	O	O
have	O	O	O
been	O	O	O
used	O	O	O
for	O	O	O
cofactor	O	O	B-T123
recycling	O	O	B-T068
in	O	O	O
chemoenzymatic	O	O	B-T044
synthesis	O	O	I-T044
,	O	O	O
the	O	O	O
ability	O	O	O
of	O	O	O
FDH	O	O	B-T116
to	O	O	O
reduce	O	O	O
CO2	O	O	B-T123
could	O	O	O
also	O	O	O
be	O	O	O
utilized	O	O	O
in	O	O	O
the	O	O	O
conversion	O	O	B-T169
of	O	O	O
CO2	O	O	O
to	O	O	O
useful	O	O	O
products	O	O	B-T071
via	O	O	O
formate	O	O	O
(	O	O	O
HCOO(-	O	O	B-T109
)	O	O	I-T109
)	O	O	O
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	O
,	O	O	O
we	O	O	O
investigated	O	O	B-T169
the	O	O	O
reduction	O	O	B-T070
of	O	O	O
CO2	O	O	B-T123
in	O	O	O
the	O	O	O
form	O	O	O
of	O	O	O
hydrogen	O	O	B-T197
carbonate	O	O	I-T197
(	O	O	O
HCO3(-	O	O	B-T197
)	O	O	I-T197
)	O	O	O
to	O	O	O
formate	O	O	B-T109
by	O	O	O
FDHs	O	O	B-T116
from	O	O	O
Candida	O	O	B-T004
methylica	O	O	I-T004
(	O	O	O
CmFDH	O	O	B-T116
)	O	O	O
and	O	O	O
Chaetomium	O	O	B-T004
thermophilum	O	O	I-T004
(	O	O	O
CtFDH	O	O	B-T116
)	O	O	O
in	O	O	O
a	O	O	O
NADH	O	O	B-T114
-dependent	O	O	O
reaction	O	O	B-T169
.	O	O	O

The	O	O	O
catalytic	O	O	B-T044
performance	O	O	I-T044
with	O	O	O
HCO3(-	O	O	B-T197
)	O	O	I-T197
as	O	O	O
a	O	O	O
substrate	O	O	B-T167
was	O	O	O
evaluated	O	O	O
by	O	O	O
measuring	O	O	B-T080
the	O	O	O
kinetic	O	O	B-T079
rates	O	O	I-T079
and	O	O	O
conducting	O	O	O
productivity	O	O	B-T059
assays	O	O	I-T059
.	O	O	O

CtFDH	O	O	B-T116
showed	O	O	O
a	O	O	O
higher	O	O	O
efficiency	O	O	B-T081
in	O	O	O
converting	O	O	B-T169
HCO3(-	O	O	B-T197
)	O	O	I-T197
to	O	O	O
formate	O	O	B-T109
than	O	O	O
CmFDH	O	O	B-T116
,	O	O	O
whereas	O	O	O
CmFDH	O	O	O
was	O	O	O
better	O	O	O
in	O	O	O
the	O	O	O
oxidation	O	O	B-T044
of	O	O	O
formate	O	O	O
.	O	O	O

The	O	O	O
pH	O	O	B-T081
optimum	O	O	O
of	O	O	O
the	O	O	O
reduction	O	O	B-T070
was	O	O	O
at	O	O	O
pH	O	O	O
7	O	O	O
-	O	O	O
8	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
high	O	O	B-T081
concentrations	O	O	I-T081
of	O	O	O
HCO3(-	O	O	B-T197
)	O	O	I-T197
reduced	O	O	O
the	O	O	O
reaction	O	O	B-T079
rate	O	O	I-T079
.	O	O	O

CtFDH	O	O	B-T116
was	O	O	O
modeled	O	O	O
in	O	O	O
the	O	O	O
presence	O	O	O
of	O	O	O
HCO3(-	O	O	B-T197
)	O	O	I-T197
showing	O	O	O
that	O	O	O
it	O	O	O
fits	O	O	O
to	O	O	O
the	O	O	O
active	O	O	B-T169
site	O	O	I-T169
.	O	O	O

The	O	O	O
active	O	O	B-T169
site	O	O	I-T169
setting	O	O	O
for	O	O	O
hydride	O	O	B-T044
transfer	O	O	I-T044
in	O	O	O
CO2	O	O	B-T123
reduction	O	O	B-T070
was	O	O	O
modeled	O	O	O
.	O	O	O

The	O	O	O
hydride	O	O	B-T044
donated	O	O	I-T044
by	O	O	O
NADH	O	O	B-T114
would	O	O	O
form	O	O	O
a	O	O	O
favorable	O	O	O
contact	O	O	O
to	O	O	O
the	O	O	O
carbon	O	O	B-T196
atom	O	O	I-T196
of	O	O	O
HCO3(-	O	O	B-T197
)	O	O	I-T197
,	O	O	O
resulting	O	O	O
in	O	O	O
a	O	O	O
surplus	O	O	O
of	O	O	O
electrons	O	O	B-T196
within	O	O	O
the	O	O	O
molecule	O	O	B-T167
.	O	O	O

This	O	O	O
would	O	O	O
cause	O	O	O
the	O	O	O
complex	O	O	O
formed	O	O	O
by	O	O	O
hydrogen	O	O	B-T197
carbonate	O	O	I-T197
and	O	O	O
the	O	O	O
hydride	O	O	B-T196
to	O	O	O
break	O	O	O
into	O	O	O
formate	O	O	B-T109
and	O	O	O
hydroxide	O	O	B-T196
ions	O	O	I-T196
.	O	O	O

-DOCSTART- (27887578)

Evaluation	O	O	B-T170
of	O	O	O
an	O	O	O
international	O	O	B-T078
educational	O	O	B-T065
programme	O	O	I-T065
for	O	O	O
health	O	O	B-T097
care	O	O	I-T097
professionals	O	O	I-T097
on	O	O	O
best	O	O	O
practice	O	O	O
in	O	O	O
the	O	O	O
management	O	O	B-T057
of	O	O	O
a	O	O	O
perinatal	O	O	B-T079
death	O	O	B-T040
:	O	O	O
IMproving	O	O	B-T065
Perinatal	O	O	I-T065
mortality	O	O	I-T065
Review	O	O	I-T065
and	O	O	I-T065
Outcomes	O	O	I-T065
Via	O	O	I-T065
Education	O	O	I-T065
(	O	O	O
IMPROVE	O	O	B-T065
)	O	O	O

Stillbirths	O	O	B-T033
and	O	O	O
neonatal	O	O	B-T033
deaths	O	O	I-T033
are	O	O	O
devastating	O	O	B-T051
events	O	O	I-T051
for	O	O	O
both	O	O	O
parents	O	O	B-T099
and	O	O	O
clinicians	O	O	B-T080
and	O	O	O
are	O	O	O
global	O	O	B-T091
public	O	O	I-T091
health	O	O	I-T091
concerns	O	O	B-T078
.	O	O	O

Careful	O	O	O
clinical	O	O	B-T058
management	O	O	I-T058
after	O	O	O
these	O	O	O
deaths	O	O	B-T040
is	O	O	O
required	O	O	O
,	O	O	O
including	O	O	O
appropriate	O	O	O
investigation	O	O	B-T058
and	O	O	O
assessment	O	O	B-T058
to	O	O	O
determine	O	O	O
cause	O	O	O
(	O	O	O
s	O	O	O
)	O	O	O
to	O	O	O
prevent	O	O	O
future	O	O	O
losses	O	O	O
,	O	O	O
and	O	O	O
to	O	O	O
improve	O	O	O
bereavement	O	O	B-T058
care	O	O	I-T058
for	O	O	O
families	O	O	B-T099
.	O	O	O

An	O	O	O
educational	O	O	B-T065
programme	O	O	I-T065
for	O	O	O
health	O	O	B-T097
care	O	O	I-T097
professionals	O	O	I-T097
working	O	O	O
in	O	O	O
maternal	O	O	B-T033
and	O	O	O
child	O	O	B-T058
health	O	O	I-T058
has	O	O	O
been	O	O	O
designed	O	O	O
to	O	O	O
address	O	O	O
these	O	O	O
needs	O	O	O
according	O	O	O
to	O	O	O
the	O	O	O
Perinatal	O	O	B-T170
Society	O	O	I-T170
of	O	O	I-T170
Australia	O	O	I-T170
and	O	O	I-T170
New	O	O	I-T170
Zealand	O	O	I-T170
Guideline	O	O	I-T170
for	O	O	I-T170
Perinatal	O	O	I-T170
Mortality	O	O	I-T170
:	O	O	O
IMproving	O	O	B-T065
Perinatal	O	O	I-T065
mortality	O	O	I-T065
Review	O	O	I-T065
and	O	O	I-T065
Outcomes	O	O	I-T065
Via	O	O	I-T065
Education	O	O	I-T065
(	O	O	O
IMPROVE	O	O	B-T065
)	O	O	O
.	O	O	O

The	O	O	O
programme	O	O	B-T065
has	O	O	O
a	O	O	O
major	O	O	O
focus	O	O	O
on	O	O	O
stillbirth	O	O	B-T033
and	O	O	O
is	O	O	O
delivered	O	O	O
as	O	O	O
six	O	O	O
interactive	O	O	B-T065
skills	O	O	I-T065
-based	O	O	O
stations	O	O	B-T073
.	O	O	O

We	O	O	O
aimed	O	O	O
to	O	O	O
determine	O	O	O
participants	O	O	B-T098
'	O	O	O
pre-	O	O	B-T065
and	O	O	O
post-programme	O	O	B-T065
knowledge	O	O	B-T170
of	O	O	O
and	O	O	O
confidence	O	O	B-T041
in	O	O	O
the	O	O	O
management	O	O	B-T057
of	O	O	O
perinatal	O	O	B-T079
deaths	O	O	B-T040
,	O	O	O
along	O	O	O
with	O	O	O
satisfaction	O	O	B-T041
with	O	O	O
the	O	O	O
programme	O	O	B-T065
.	O	O	O

We	O	O	O
also	O	O	O
aimed	O	O	O
to	O	O	O
determine	O	O	O
suitability	O	O	O
for	O	O	O
international	O	O	B-T078
use	O	O	O
.	O	O	O

The	O	O	O
IMPROVE	O	O	B-T065
programme	O	O	I-T065
was	O	O	O
delivered	O	O	O
to	O	O	O
health	O	O	B-T097
professionals	O	O	I-T097
in	O	O	O
maternity	O	O	B-T093
hospitals	O	O	I-T093
in	O	O	O
all	O	O	O
seven	O	O	O
Australian	O	O	B-T083
states	O	O	B-T083
and	O	O	O
territories	O	O	B-UnknownType
and	O	O	O
modified	O	O	O
for	O	O	O
use	O	O	O
internationally	O	O	B-T078
with	O	O	O
piloting	O	O	O
in	O	O	O
Vietnam	O	O	B-T083
,	O	O	O
Fiji	O	O	B-T083
,	O	O	O
and	O	O	O
the	O	O	O
Netherlands	O	O	B-T083
(	O	O	O
with	O	O	O
the	O	O	O
assistance	O	O	B-T058
of	O	O	O
the	O	O	O
International	O	O	B-T093
Stillbirth	O	O	I-T093
Alliance	O	O	I-T093
,	O	O	O
ISA	O	O	B-T093
)	O	O	O
.	O	O	O

Modifications	O	O	O
were	O	O	O
made	O	O	O
to	O	O	O
programme	O	O	B-T170
materials	O	O	I-T170
in	O	O	O
consultation	O	O	B-T058
with	O	O	O
local	O	O	O
teams	O	O	O
and	O	O	O
included	O	O	O
translation	O	O	B-T170
for	O	O	O
the	O	O	O
Vietnam	O	O	B-T065
programme	O	O	I-T065
.	O	O	O

Participants	O	O	B-T098
completed	O	O	O
pre-	O	O	B-T065
and	O	O	O
post-programme	O	O	B-T065
evaluation	O	O	B-T170
questionnaires	O	O	B-T170
on	O	O	O
knowledge	O	O	B-T170
and	O	O	O
confidence	O	O	B-T041
on	O	O	O
six	O	O	O
key	O	O	O
components	O	O	O
of	O	O	O
perinatal	O	O	B-T079
death	O	O	B-T040
management	O	O	B-T057
as	O	O	O
well	O	O	O
as	O	O	O
a	O	O	O
satisfaction	O	O	B-T170
questionnaire	O	O	I-T170
.	O	O	O

Over	O	O	O
the	O	O	O
period	O	O	O
May	O	O	O
2012	O	O	O
to	O	O	O
May	O	O	O
2015	O	O	O
,	O	O	O
30	O	O	O
IMPROVE	O	O	B-T065
workshops	O	O	B-T065
were	O	O	O
conducted	O	O	O
,	O	O	O
including	O	O	O
26	O	O	O
with	O	O	O
758	O	O	O
participants	O	O	B-T098
in	O	O	O
Australia	O	O	B-T083
and	O	O	O
four	O	O	O
with	O	O	O
136	O	O	O
participants	O	O	O
internationally	O	O	B-T078
.	O	O	O

Evaluations	O	O	B-T170
showed	O	O	O
a	O	O	O
significant	O	O	B-T078
improvement	O	O	B-T057
between	O	O	O
pre-	O	O	B-T065
and	O	O	O
post-programme	O	O	B-T065
knowledge	O	O	B-T170
and	O	O	O
confidence	O	O	B-T041
in	O	O	O
all	O	O	O
six	O	O	O
stations	O	O	B-T073
and	O	O	O
overall	O	O	O
,	O	O	O
and	O	O	O
a	O	O	O
high	O	O	O
degree	O	O	O
of	O	O	O
satisfaction	O	O	B-T041
in	O	O	O
all	O	O	O
settings	O	O	B-T082
.	O	O	O

The	O	O	O
IMPROVE	O	O	B-T065
programme	O	O	I-T065
has	O	O	O
been	O	O	O
well	O	O	O
received	O	O	O
in	O	O	O
Australia	O	O	B-T083
and	O	O	O
in	O	O	O
three	O	O	O
different	O	O	O
international	O	O	B-T078
settings	O	O	B-T082
and	O	O	O
is	O	O	O
now	O	O	O
being	O	O	O
made	O	O	O
available	O	O	O
through	O	O	O
ISA	O	O	B-T093
.	O	O	O

Future	O	O	O
research	O	O	B-T062
is	O	O	O
required	O	O	O
to	O	O	O
determine	O	O	O
whether	O	O	O
the	O	O	O
immediate	O	O	O
improvements	O	O	B-T057
in	O	O	O
knowledge	O	O	B-T170
are	O	O	O
sustained	O	O	B-T169
with	O	O	O
less	O	O	O
causes	O	O	O
of	O	O	O
death	O	O	B-T040
being	O	O	O
classified	O	O	O
as	O	O	O
unknown	O	O	O
,	O	O	O
changes	O	O	B-T057
in	O	O	I-T057
clinical	O	O	I-T057
practice	O	O	I-T057
and	O	O	O
improvement	O	O	B-T057
in	O	O	O
parents	O	O	B-T099
'	O	O	I-T099
experiences	O	O	O
with	O	O	O
care	O	O	B-T052
.	O	O	O

The	O	O	O
suitability	O	O	O
for	O	O	O
this	O	O	O
programme	O	O	B-T065
in	O	O	O
low-income	O	O	B-T033
countries	O	O	B-T083
also	O	O	O
needs	O	O	O
to	O	O	O
be	O	O	O
established	O	O	O
.	O	O	O

-DOCSTART- (27887587)

Experiences	O	O	O
of	O	O	O
support	O	O	O
in	O	O	O
working	O	O	O
toward	O	O	O
personal	O	O	B-T032
recovery	O	O	B-T040
goals	O	O	B-T170
:	O	O	O
a	O	O	O
collaborative	O	O	B-T062
,	O	O	O
qualitative	O	O	O
study	O	O	O

Recovery	O	O	B-T040
can	O	O	O
be	O	O	O
understood	O	O	O
as	O	O	O
a	O	O	O
subjective	O	O	B-T067
process	O	O	I-T067
guided	O	O	O
by	O	O	O
personal	O	O	B-T032
expectations	O	O	B-T078
,	O	O	O
goals	O	O	B-T170
and	O	O	O
hopes	O	O	B-T041
.	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
the	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
explore	O	O	O
how	O	O	O
persons	O	O	B-T098
using	O	O	O
a	O	O	O
Community	O	O	B-T093
Mental	O	O	I-T093
Health	O	O	I-T093
Centre	O	O	I-T093
(	O	O	O
CMHC	O	O	B-T093
)	O	O	O
experienced	O	O	O
that	O	O	O
their	O	O	O
expectations	O	O	B-T078
for	O	O	O
treatment	O	O	B-T061
,	O	O	O
and	O	O	O
goals	O	O	B-T170
and	O	O	O
hopes	O	O	B-T041
for	O	O	O
recovery	O	O	B-T040
were	O	O	O
supported	O	O	O
by	O	O	O
the	O	O	O
health	O	O	B-T097
professionals	O	O	I-T097
during	O	O	O
treatment	O	O	O
.	O	O	O

Employing	O	O	O
a	O	O	O
hermeneutic	O	O	B-T078
-phenomenological	O	O	O
approach	O	O	O
,	O	O	O
eight	O	O	O
service	O	O	B-T101
users	O	O	I-T101
were	O	O	O
interviewed	O	O	O
about	O	O	O
their	O	O	O
expectations	O	O	B-T078
for	O	O	O
treatment	O	O	B-T061
and	O	O	O
their	O	O	O
goals	O	O	B-T170
and	O	O	O
hopes	O	O	B-T041
for	O	O	O
recovery	O	O	B-T040
at	O	O	O
the	O	O	O
start	O	O	O
of	O	O	O
their	O	O	O
contact	O	O	O
with	O	O	O
health	O	O	B-T097
professionals	O	O	I-T097
at	O	O	O
a	O	O	O
CMHC	O	O	B-T093
.	O	O	O

Two	O	O	O
years	O	O	B-T079
later	O	O	O
,	O	O	O
they	O	O	O
were	O	O	O
re-interviewed	O	O	O
about	O	O	O
their	O	O	O
experiences	O	O	O
of	O	O	O
treatment	O	O	B-T061
and	O	O	O
support	O	O	O
from	O	O	O
the	O	O	O
health	O	O	B-T097
professionals	O	O	I-T097
in	O	O	O
their	O	O	O
work	O	O	O
towards	O	O	O
these	O	O	O
goals	O	O	B-T170
and	O	O	O
hopes	O	O	B-T041
.	O	O	O

A	O	O	O
collaborative	O	O	B-T054
approach	O	O	I-T054
was	O	O	O
adopted	O	O	O
.	O	O	O

A	O	O	O
co-researcher	O	O	B-T097
with	O	O	O
lived	O	O	O
experience	O	O	O
took	O	O	O
part	O	O	O
in	O	O	O
all	O	O	O
stages	O	O	O
of	O	O	O
the	O	O	O
study	O	O	B-T062
.	O	O	O

Data	O	O	B-T078
were	O	O	O
analysed	O	O	O
by	O	O	O
means	O	O	O
of	O	O	O
a	O	O	O
data	O	O	B-T078
-driven	O	O	O
stepwise	O	O	O
approach	O	O	O
in	O	O	O
line	O	O	O
with	O	O	O
thematic	O	O	B-T062
analysis	O	O	I-T062
.	O	O	O

Five	O	O	O
themes	O	O	O
reflecting	O	O	O
how	O	O	O
participants	O	O	B-T098
experienced	O	O	O
support	O	O	O
from	O	O	O
health	O	O	B-T097
professionals	O	O	I-T097
at	O	O	O
the	O	O	O
CMHC	O	O	B-T093
in	O	O	O
their	O	O	O
work	O	O	O
towards	O	O	O
their	O	O	O
recovery	O	O	B-T040
goals	O	O	B-T170
were	O	O	O
elicited	O	O	O
,	O	O	O
as	O	O	O
follows	O	O	O
:	O	O	O
developing	O	O	B-T080
an	O	O	I-T080
understanding	O	O	I-T080
of	O	O	I-T080
oneself	O	O	I-T080
and	O	O	O
one	O	O	O
's	O	O	O
mental	O	O	B-T033
health	O	O	I-T033
problems	O	O	I-T033
;	O	O	O
learning	O	O	O
how	O	O	O
to	O	O	O
change	O	O	O
feelings	O	O	B-T041
and	O	O	O
behaviours	O	O	B-T053
;	O	O	O
being	O	O	B-T033
'	O	O	I-T033
pushed	O	O	I-T033
'	O	O	I-T033
into	O	O	I-T033
social	O	O	I-T033
arenas	O	O	I-T033
;	O	O	O
finding	O	O	B-T033
helpful	O	O	I-T033
medication	O	O	I-T033
;	O	O	O
and	O	O	O
counselling	O	O	B-T058
in	O	O	O
family	O	O	B-T033
,	O	O	O
practical	O	O	B-T033
and	O	O	O
financial	O	O	B-T033
issues	O	O	I-T033
.	O	O	O

The	O	O	O
participants	O	O	B-T098
'	O	O	O
expectations	O	O	B-T078
about	O	O	O
counselling	O	O	B-T058
with	O	O	O
regard	O	O	O
to	O	O	O
longer-term	O	O	O
family	O	O	B-T033
,	O	O	O
practical	O	O	B-T033
,	O	O	O
and	O	O	O
financial	O	O	B-T033
challenges	O	O	I-T033
were	O	O	O
insufficiently	O	O	O
met	O	O	O
by	O	O	O
the	O	O	O
CMHC	O	O	B-T093
.	O	O	O

In	O	O	O
the	O	O	O
experience	O	O	O
of	O	O	O
the	O	O	O
service	O	O	B-T101
users	O	O	I-T101
,	O	O	O
recovery	O	O	B-T040
occurred	O	O	O
within	O	O	O
the	O	O	O
context	O	O	O
of	O	O	O
their	O	O	O
everyday	O	O	B-T078
life	O	O	I-T078
with	O	O	O
or	O	O	O
without	O	O	O
the	O	O	O
support	O	O	O
of	O	O	O
their	O	O	O
professional	O	O	B-T097
helpers	O	O	B-T097
.	O	O	O

To	O	O	O
facilitate	O	O	O
recovery	O	O	B-T040
,	O	O	O
health	O	O	B-T097
professionals	O	O	I-T097
should	O	O	O
acknowledge	O	O	O
the	O	O	O
service	O	O	B-T101
user	O	O	I-T101
's	O	O	I-T101
personal	O	O	B-T032
goals	O	O	B-T170
and	O	O	O
hopes	O	O	B-T041
and	O	O	O
take	O	O	O
a	O	O	O
more	O	O	O
comprehensive	O	O	O
and	O	O	O
longer-term	O	O	O
approach	O	O	O
to	O	O	O
his	O	O	O
or	O	O	O
her	O	O	O
needs	O	O	B-T080
and	O	O	O
desires	O	O	B-T041
.	O	O	O

Acknowledging	O	O	O
and	O	O	O
facilitating	O	O	O
recovery	O	O	B-T040
goals	O	O	B-T170
by	O	O	O
offering	O	O	O
counselling	O	O	B-T058
with	O	O	O
regard	O	O	O
to	O	O	O
family	O	O	B-T033
,	O	O	O
practical	O	O	B-T033
and	O	O	O
financial	O	O	B-T033
issues	O	O	I-T033
seems	O	O	O
particularly	O	O	O
important	O	O	O
.	O	O	O

-DOCSTART- (27888348)

Pathogenesis	O	O	B-T046
of	O	O	O
COPD	O	O	B-T047
and	O	O	O
Asthma	O	O	O

Asthma	O	O	B-T047
and	O	O	O
COPD	O	O	B-T047
remain	O	O	O
two	O	O	O
diseases	O	O	B-T047
of	O	O	I-T047
the	O	O	I-T047
respiratory	O	O	I-T047
tract	O	O	I-T047
with	O	O	O
unmet	O	O	B-T052
medical	O	O	B-T169
needs	O	O	B-T080
.	O	O	O

This	O	O	O
review	O	O	B-T170
considers	O	O	O
the	O	O	O
current	O	O	O
state	O	O	O
of	O	O	O
play	O	O	O
with	O	O	O
respect	O	O	O
to	O	O	O
what	O	O	O
is	O	O	O
known	O	O	O
about	O	O	O
the	O	O	O
underlying	O	O	O
pathogenesis	O	O	B-T046
of	O	O	O
these	O	O	O
two	O	O	O
chronic	O	O	B-T047
inflammatory	O	O	I-T047
diseases	O	O	I-T047
of	O	O	O
the	O	O	O
lung	O	O	B-T023
.	O	O	O

The	O	O	O
review	O	O	B-T170
highlights	O	O	O
why	O	O	O
they	O	O	O
are	O	O	O
different	O	O	O
conditions	O	O	B-T080
requiring	O	O	O
different	O	O	O
approaches	O	O	O
to	O	O	O
treatment	O	O	B-T061
and	O	O	O
provides	O	O	O
a	O	O	O
backdrop	O	O	O
for	O	O	O
the	O	O	O
subsequent	O	O	O
chapters	O	O	O
in	O	O	O
this	O	O	O
volume	O	O	O
discussing	O	O	O
recent	O	O	O
advances	O	O	O
in	O	O	O
the	O	O	O
pharmacology	O	O	B-T091
and	O	O	O
treatment	O	O	O
of	O	O	O
asthma	O	O	B-T047
and	O	O	O
COPD	O	O	B-T047
.	O	O	O

-DOCSTART- (27891581)

Antigen	O	O	B-T044
specificity	O	O	I-T044
determines	O	O	O
anti-red	O	O	B-T116
blood	O	O	I-T116
cell	O	O	I-T116
IgG-Fc	O	O	I-T116
alloantibody	O	O	I-T116
glycosylation	O	O	B-T070
and	O	O	O
thereby	O	O	O
severity	O	O	B-T080
of	O	O	O
haemolytic	O	O	O
disease	O	O	O
of	O	O	O
the	O	O	O
fetus	O	O	O
and	O	O	O
newborn	O	O	O

Haemolytic	O	O	B-T047
disease	O	O	B-T047
of	O	O	I-T047
the	O	O	I-T047
fetus	O	O	I-T047
and	O	O	I-T047
newborn	O	O	I-T047
(	O	O	O
HDFN	O	O	B-T047
)	O	O	O
is	O	O	O
a	O	O	O
severe	O	O	O
disease	O	O	O
in	O	O	O
which	O	O	O
fetal	O	O	B-T018
red	O	O	B-T025
blood	O	O	I-T025
cells	O	O	I-T025
(	O	O	O
RBC	O	O	B-T025
)	O	O	O
are	O	O	O
destroyed	O	O	B-T052
by	O	O	O
maternal	O	O	B-T116
anti-RBC	O	O	I-T116
IgG	O	O	I-T116
alloantibodies	O	O	I-T116
.	O	O	O

HDFN	O	O	B-T047
is	O	O	O
most	O	O	O
often	O	O	O
caused	O	O	O
by	O	O	O
anti-D	O	O	B-T116
but	O	O	O
may	O	O	O
also	O	O	O
occur	O	O	O
due	O	O	B-T169
to	O	O	I-T169
anti-K	O	O	B-T116
,	O	O	O
-c	O	O	B-T116
-	O	O	O
or	O	O	O
-E.	O	O	O
We	O	O	O
recently	O	O	O
found	O	O	O
N-linked	O	O	B-T044
glycosylation	O	O	I-T044
of	O	O	O
anti-D	O	O	O
to	O	O	O
be	O	O	O
skewed	O	O	O
towards	O	O	O
low	O	O	B-T080
fucosylation	O	O	B-T044
,	O	O	O
thereby	O	O	O
increasing	O	O	B-T169
the	O	O	O
affinity	O	O	B-T044
to	O	O	O
IgG-Fc	O	O	B-T116
receptor	O	O	I-T116
IIIa	O	O	I-T116
and	O	O	O
IIIb	O	O	B-T116
,	O	O	O
which	O	O	O
correlated	O	O	B-T080
with	O	O	O
HDFN	O	O	O
disease	O	O	B-T047
severity	O	O	B-T080
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
analysed	O	O	O
230	O	O	O
pregnant	O	O	B-T098
women	O	O	I-T098
with	O	O	O
anti-c	O	O	B-T116
,	O	O	O
-E	O	O	B-T116
or	O	O	O
-K	O	O	B-T116
alloantibodies	O	O	B-T129
from	O	O	O
a	O	O	O
prospective	O	O	O
screening	O	O	B-T058
cohort	O	O	I-T058
and	O	O	O
investigated	O	O	B-T169
the	O	O	O
type	O	O	O
of	O	O	O
Fc-tail	O	O	B-T044
glycosylation	O	O	I-T044
of	O	O	O
these	O	O	O
antibodies	O	O	B-T116
in	O	O	O
relation	O	O	O
to	O	O	O
the	O	O	O
trigger	O	O	B-T080
of	O	O	O
immunisation	O	O	B-T061
and	O	O	O
pregnancy	O	O	B-T033
outcome	O	O	I-T033
.	O	O	O

Anti-c	O	O	B-T116
,	O	O	O
-E	O	O	B-T116
and	O	O	O
-K	O	O	B-T116
show	O	O	O
-	O	O	O
independent	O	O	B-T169
of	O	O	I-T169
the	O	O	O
event	O	O	B-T051
that	O	O	O
had	O	O	O
led	O	O	O
to	O	O	O
immunisation	O	O	B-T061
-	O	O	O
a	O	O	O
different	O	O	B-T080
kind	O	O	O
of	O	O	O
Fc-glycosylation	O	O	B-T044
compared	O	O	O
to	O	O	O
that	O	O	O
of	O	O	O
the	O	O	O
total	O	O	O
IgG	O	O	B-T116
fraction	O	O	O
,	O	O	O
but	O	O	O
with	O	O	O
less	O	O	O
pronounced	O	O	O
differences	O	O	O
compared	O	O	O
to	O	O	O
anti-D.	O	O	O
High	O	O	O
Fc-galactosylation	O	O	B-T044
and	O	O	O
sialylation	O	O	B-T043
of	O	O	O
anti-c	O	O	B-T116
correlated	O	O	B-T080
with	O	O	O
HDFN	O	O	B-T047
disease	O	O	B-T047
severity	O	O	B-T080
,	O	O	O
while	O	O	O
low	O	O	O
anti-K	O	O	B-T116
Fc-fucosylation	O	O	B-T044
correlated	O	O	O
with	O	O	O
severe	O	O	B-T080
fetal	O	O	B-T047
anaemia	O	O	I-T047
.	O	O	O

IgG-Fc	O	O	B-T044
glycosylation	O	O	I-T044
of	O	O	O
anti-RBC	O	O	B-T116
antibodies	O	O	I-T116
is	O	O	O
shaped	O	O	O
depending	O	O	O
on	O	O	O
the	O	O	O
antigen	O	O	B-T129
.	O	O	O

These	O	O	O
features	O	O	B-T080
influence	O	O	O
their	O	O	O
clinical	O	O	B-T080
potency	O	O	I-T080
and	O	O	O
may	O	O	O
therefore	O	O	O
be	O	O	O
used	O	O	O
to	O	O	O
predict	O	O	B-T078
severity	O	O	B-T080
and	O	O	O
identify	O	O	O
those	O	O	O
needing	O	O	O
treatment	O	O	B-T169
.	O	O	O

-DOCSTART- (27892235)

Shout	O	O	O
louder	O	O	O
about	O	O	O
poor	O	O	O
pay	O	O	O

It	O	O	O
seems	O	O	O
increasingly	O	O	O
clear	O	O	O
to	O	O	O
me	O	O	O
that	O	O	O
the	O	O	O
NHS	O	O	B-T058
pay	O	O	B-T081
campaign	O	O	B-UnknownType
is	O	O	O
not	O	O	O
making	O	O	O
waves	O	O	O
either	O	O	O
in	O	O	O
the	O	O	O
NHS	O	O	O
or	O	O	O
with	O	O	O
the	O	O	O
public	O	O	B-T098
.	O	O	O

-DOCSTART- (27892522)

SARS	O	O	B-T047
-	O	O	O
CoV	O	O	B-T005
fusion	O	O	O
peptides	O	O	B-T116
induce	O	O	O
membrane	O	O	B-T026
surface	O	O	B-T082
ordering	O	O	B-T082
and	O	O	O
curvature	O	O	O

Viral	O	O	B-T038
membrane	O	O	I-T038
fusion	O	O	I-T038
is	O	O	O
an	O	O	O
orchestrated	O	O	O
process	O	O	O
triggered	O	O	O
by	O	O	O
membrane-anchored	O	O	B-T026
viral	O	O	B-T116
fusion	O	O	I-T116
glycoproteins	O	O	I-T116
.	O	O	O

The	O	O	O
S2	O	O	B-T116
subunit	O	O	B-T116
of	O	O	O
the	O	O	O
spike	O	O	B-T116
glycoprotein	O	O	I-T116
from	O	O	O
severe	O	O	B-T047
acute	O	O	I-T047
respiratory	O	O	I-T047
syndrome	O	O	I-T047
(	O	O	O
SARS	O	O	B-T047
)	O	O	O
coronavirus	O	O	B-T005
(	O	O	O
CoV	O	O	B-T005
)	O	O	O
contains	O	O	O
internal	O	O	B-T087
domains	O	O	I-T087
called	O	O	O
fusion	O	O	B-T116
peptides	O	O	I-T116
(	O	O	O
FP	O	O	B-T116
)	O	O	O
that	O	O	O
play	O	O	O
essential	O	O	O
roles	O	O	O
in	O	O	O
virus	O	O	B-T038
entry	O	O	I-T038
.	O	O	O

Although	O	O	O
membrane	O	O	B-T026
fusion	O	O	I-T044
has	O	O	O
been	O	O	O
broadly	O	O	O
studied	O	O	B-T062
,	O	O	O
there	O	O	O
are	O	O	O
still	O	O	O
major	O	O	O
gaps	O	O	O
in	O	O	O
the	O	O	O
molecular	O	O	B-T080
details	O	O	O
of	O	O	O
lipid	O	O	B-T109
rearrangements	O	O	B-T067
in	O	O	O
the	O	O	O
bilayer	O	O	B-T026
during	O	O	O
fusion	O	O	B-T116
peptide	O	O	I-T116
-	O	O	O
membrane	O	O	O
interactions	O	O	B-T169
.	O	O	O

Here	O	O	O
we	O	O	O
employed	O	O	O
differential	O	O	B-T059
scanning	O	O	I-T059
calorimetry	O	O	I-T059
(	O	O	O
DSC	O	O	B-T059
)	O	O	O
and	O	O	O
electron	O	O	B-T059
spin	O	O	I-T059
resonance	O	O	I-T059
(	O	O	O
ESR	O	O	B-T059
)	O	O	O
to	O	O	O
gather	O	O	O
information	O	O	O
on	O	O	O
the	O	O	O
membrane	O	O	B-T044
fusion	O	O	I-T044
mechanism	O	O	B-T169
promoted	O	O	B-T052
by	O	O	O
two	O	O	O
putative	O	O	O
SARS	O	O	B-T047
FPs	O	O	B-T116
.	O	O	O

DSC	O	O	B-T059
data	O	O	B-T078
showed	O	O	O
the	O	O	O
peptides	O	O	B-T116
strongly	O	O	O
perturb	O	O	O
the	O	O	O
structural	O	O	B-T082
integrity	O	O	B-T080
of	O	O	O
anionic	O	O	B-T026
vesicles	O	O	I-T026
and	O	O	O
support	O	O	O
the	O	O	O
hypothesis	O	O	B-T078
that	O	O	O
the	O	O	O
peptides	O	O	O
generate	O	O	O
opposing	O	O	O
curvature	O	O	B-T082
stresses	O	O	O
on	O	O	O
phosphatidylethanolamine	O	O	B-T109
membranes	O	O	B-T026
.	O	O	O

ESR	O	O	B-T059
showed	O	O	O
that	O	O	O
both	O	O	O
FPs	O	O	B-T116
increase	O	O	O
lipid	O	O	B-T109
packing	O	O	B-T052
and	O	O	O
head	O	O	O
group	O	O	O
ordering	O	O	B-T082
as	O	O	O
well	O	O	O
as	O	O	O
reduce	O	O	O
the	O	O	O
intramembrane	O	O	B-T026
water	O	O	B-T081
content	O	O	I-T081
for	O	O	O
anionic	O	O	B-T026
membranes	O	O	I-T026
.	O	O	O

Therefore	O	O	O
,	O	O	O
bending	O	O	O
moment	O	O	O
in	O	O	O
the	O	O	O
bilayer	O	O	B-T026
could	O	O	O
be	O	O	O
generated	O	O	O
,	O	O	O
promoting	O	O	O
negative	O	O	O
curvature	O	O	B-T082
.	O	O	O

The	O	O	O
significance	O	O	B-T078
of	O	O	O
the	O	O	O
ordering	O	O	B-T080
effect	O	O	I-T080
,	O	O	O
membrane	O	O	B-T026
dehydration	O	O	B-T033
,	O	O	O
changes	O	O	O
in	O	O	O
the	O	O	O
curvature	O	O	B-T082
properties	O	O	O
and	O	O	O
the	O	O	O
possible	O	O	O
role	O	O	O
of	O	O	O
negatively	O	O	O
charged	O	O	O
phospholipids	O	O	B-T109
in	O	O	O
helping	O	O	O
to	O	O	O
overcome	O	O	O
the	O	O	O
high	O	O	O
kinetic	O	O	O
barrier	O	O	O
involved	O	O	O
in	O	O	O
the	O	O	O
different	O	O	O
stages	O	O	O
of	O	O	O
the	O	O	O
SARS	O	O	B-T047
-	O	O	O
CoV	O	O	B-T005
-mediated	O	O	O
membrane	O	O	B-T044
fusion	O	O	I-T044
are	O	O	O
discussed	O	O	O
.	O	O	O

-DOCSTART- (27894019)

Elucidating	O	O	O
a	O	O	O
chemical	O	O	O
defense	O	O	B-T040
mechanism	O	O	I-T040
of	O	O	O
Antarctic	O	O	B-T083
sponges	O	O	B-T204
:	O	O	O
A	O	O	O
computational	O	O	O
study	O	O	O

In	O	O	O
2000	O	O	O
,	O	O	O
a	O	O	O
novel	O	O	O
secondary	O	O	B-T123
metabolite	O	O	I-T123
(	O	O	O
erebusinone	O	O	B-T123
,	O	O	O
Ereb	O	O	B-T123
)	O	O	O
was	O	O	O
isolated	O	O	O
from	O	O	O
the	O	O	O
Antarctic	O	O	B-T083
sea	O	O	B-T204
sponge	O	O	I-T204
,	O	O	O
Isodictya	O	O	B-T204
erinacea	O	O	I-T204
.	O	O	O

The	O	O	O
bioactivity	O	O	B-T070
of	O	O	O
Ereb	O	O	B-T123
was	O	O	O
investigated	O	O	O
,	O	O	O
and	O	O	O
it	O	O	O
was	O	O	O
found	O	O	O
to	O	O	O
inhibit	O	O	B-T052
molting	O	O	B-T040
when	O	O	O
fed	O	O	O
to	O	O	O
the	O	O	O
arthropod	O	O	B-T204
species	O	O	I-T204
Orchomene	O	O	B-T204
plebs	O	O	I-T204
.	O	O	O

Xanthurenic	O	O	B-T109
acid	O	O	I-T109
(	O	O	O
XA	O	O	B-T109
)	O	O	O
is	O	O	O
a	O	O	O
known	O	O	O
endogenous	O	O	B-T169
molt	O	O	B-T077
regulator	O	O	I-T077
present	O	O	O
in	O	O	O
arthropods	O	O	B-T204
.	O	O	O

Experimental	O	O	O
studies	O	O	O
have	O	O	O
confirmed	O	O	O
that	O	O	O
XA	O	O	B-T109
inhibits	O	O	B-T052
molting	O	O	B-T040
by	O	O	O
binding	O	O	B-T044
to	O	O	O
either	O	O	O
(	O	O	O
or	O	O	O
both	O	O	O
)	O	O	O
of	O	O	O
two	O	O	O
P450	O	O	B-T116
enzymes	O	O	I-T116
(	O	O	O
CYP315a1	O	O	B-T116
or	O	O	O
CYP314a1	O	O	B-T116
)	O	O	O
that	O	O	O
are	O	O	O
responsible	O	O	O
for	O	O	O
the	O	O	O
final	O	O	O
two	O	O	O
hydroxylations	O	O	B-T070
in	O	O	O
the	O	O	O
production	O	O	O
of	O	O	O
the	O	O	O
molt-inducing	O	O	B-T125
hormone	O	O	I-T125
,	O	O	O
20-hydroxyecdysone	O	O	B-T125
(	O	O	O
20E	O	O	B-T125
)	O	O	O
.	O	O	O

The	O	O	O
lack	O	O	O
of	O	O	O
crystal	O	O	B-T104
structures	O	O	I-T104
and	O	O	O
biochemical	O	O	B-T059
assays	O	O	I-T059
for	O	O	O
CYP315a1	O	O	B-T116
or	O	O	O
CYP314a1	O	O	B-T116
,	O	O	O
has	O	O	O
prevented	O	O	O
further	O	O	O
experimental	O	O	O
exploration	O	O	B-T062
of	O	O	O
XA	O	O	B-T109
and	O	O	O
Ereb	O	O	B-T123
's	O	O	I-T123
molt	O	O	B-T040
inhibition	O	O	B-T052
mechanisms	O	O	B-T169
.	O	O	O

Herein	O	O	O
,	O	O	O
a	O	O	O
wide	O	O	O
array	O	O	O
of	O	O	O
computational	O	O	B-T062
techniques	O	O	I-T062
-	O	O	O
homology	O	O	B-T063
modeling	O	O	I-T063
,	O	O	O
molecular	O	O	B-T066
dynamics	O	O	I-T066
simulations	O	O	I-T066
,	O	O	O
binding	O	O	B-T044
site	O	O	I-T044
bioinformatics	O	O	B-T091
,	O	O	O
flexible	O	O	B-T044
receptor-flexible	O	O	I-T044
ligand	O	O	I-T044
docking	O	O	I-T044
,	O	O	O
and	O	O	O
molecular	O	O	O
mechanics-generalized	O	O	O
Born	O	O	B-T170
surface	O	O	I-T170
area	O	O	I-T170
calculations	O	O	I-T170
-	O	O	O
have	O	O	O
been	O	O	O
employed	O	O	O
to	O	O	O
elucidate	O	O	O
the	O	O	O
structure-function	O	O	B-T080
relationships	O	O	I-T080
between	O	O	O
the	O	O	O
aforementioned	O	O	O
P450s	O	O	B-T116
and	O	O	O
the	O	O	O
two	O	O	O
described	O	O	O
small	O	O	O
molecule	O	O	O
inhibitors	O	O	B-T120
(	O	O	O
Ereb	O	O	B-T123
and	O	O	O
XA	O	O	B-T109
)	O	O	O
.	O	O	O

Results	O	O	O
indicate	O	O	O
that	O	O	O
Ereb	O	O	B-T123
likely	O	O	O
targets	O	O	O
CYP315a1	O	O	B-T116
by	O	O	O
interacting	O	O	O
with	O	O	O
a	O	O	O
network	O	O	O
of	O	O	O
aromatic	O	O	B-T104
residues	O	O	I-T104
in	O	O	O
the	O	O	O
binding	O	O	B-T044
site	O	O	I-T044
,	O	O	O
while	O	O	O
XA	O	O	B-T109
may	O	O	O
inhibit	O	O	O
both	O	O	O
CYP315a1	O	O	O
and	O	O	O
CYP314a1	O	O	B-T116
because	O	O	O
of	O	O	O
its	O	O	O
aromatic	O	O	O
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
charged	O	O	B-T196
nature	O	O	I-T196
.	O	O	O

-DOCSTART- (27894020)

The	O	O	O
anatomical	O	O	B-T015
mummies	O	O	I-T015
of	O	O	O
Mombello	O	O	B-UnknownType
:	O	O	O
detection	O	O	B-T033
of	O	O	O
cocaine	O	O	B-T109
,	O	O	O
nicotine	O	O	B-T109
,	O	O	O
and	O	O	O
caffeine	O	O	B-T109
in	O	O	O
the	O	O	O
hair	O	O	B-T023
of	O	O	O
psychiatric	O	O	B-T101
patients	O	O	I-T101
of	O	O	O
the	O	O	O
early	O	O	O
20th	O	O	O
century	O	O	O

The	O	O	O
Mombello	O	O	B-T093
Psychiatric	O	O	B-T093
Hospital	O	O	I-T093
in	O	O	O
Limbiate	O	O	B-UnknownType
,	O	O	O
near	O	O	O
Milan	O	O	B-UnknownType
,	O	O	O
replaced	O	O	O
the	O	O	O
old	O	O	O
Senavra	O	O	B-T093
Hospital	O	O	I-T093
as	O	O	O
the	O	O	O
Psychiatric	O	O	O
Hospital	O	O	O
for	O	O	O
the	O	O	O
Province	O	O	B-UnknownType
of	O	O	I-UnknownType
Milan	O	O	I-UnknownType
in	O	O	O
the	O	O	O
19th	O	O	O
century	O	O	O
.	O	O	O

During	O	O	O
the	O	O	O
early	O	O	O
20th	O	O	O
century	O	O	O
,	O	O	O
bodies	O	O	B-T016
of	O	O	O
several	O	O	O
Mombello	O	O	B-T101
patients	O	O	I-T101
were	O	O	O
dissected	O	O	B-T169
and	O	O	O
preserved	O	O	B-T059
by	O	O	O
Giuseppe	O	O	B-T016
Paravicini	O	O	I-T016
,	O	O	O
an	O	O	O
anatomist	O	O	B-T097
who	O	O	O
operated	O	O	O
within	O	O	O
the	O	O	O
asylum	O	O	B-T093
.	O	O	O

The	O	O	O
aim	O	O	B-T078
of	O	O	O
the	O	O	O
present	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
examine	O	O	O
and	O	O	O
memorialize	O	O	O
this	O	O	O
important	O	O	O
assemblage	O	O	B-T062
.	O	O	O

To	O	O	O
this	O	O	O
end	O	O	O
,	O	O	O
we	O	O	O
were	O	O	O
allowed	O	O	O
to	O	O	O
sample	O	O	B-T077
the	O	O	O
head	O	O	B-T023
hair	O	O	I-T023
of	O	O	O
six	O	O	O
such	O	O	O
preparations	O	O	B-T052
for	O	O	O
toxicological	O	O	B-T169
analysis	O	O	B-T062
.	O	O	O

By	O	O	O
means	O	O	O
of	O	O	O
high	O	O	B-T059
performance	O	O	I-T059
liquid	O	O	I-T059
chromatography	O	O	I-T059
,	O	O	O
cocaine	O	O	B-T109
and	O	O	O
its	O	O	O
main	O	O	O
metabolite	O	O	B-T123
,	O	O	O
benzoylecgonine	O	O	B-T109
,	O	O	O
were	O	O	O
detected	O	O	B-T033
in	O	O	O
two	O	O	O
out	O	O	O
of	O	O	O
six	O	O	O
hair	O	O	B-T077
samples	O	O	I-T077
.	O	O	O

The	O	O	O
concentrations	O	O	B-T081
for	O	O	O
cocaine	O	O	B-T109
were	O	O	O
0.151	O	O	O
and	O	O	O
0.09ng/mg	O	O	O
and	O	O	O
for	O	O	O
benzoylecgonine	O	O	B-T109
0.103	O	O	O
and	O	O	O
0.147ng/mg	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

Given	O	O	O
that	O	O	O
cocaine	O	O	B-T109
was	O	O	O
a	O	O	O
commonly	O	O	O
used	O	O	O
medicine	O	O	B-T121
,	O	O	O
beginning	O	O	O
in	O	O	O
the	O	O	O
mid-19th	O	O	O
century	O	O	O
and	O	O	O
persisting	O	O	O
into	O	O	O
the	O	O	O
20th	O	O	O
century	O	O	O
,	O	O	O
it	O	O	O
is	O	O	O
not	O	O	O
surprising	O	O	O
that	O	O	O
some	O	O	O
patients	O	O	B-T093
may	O	O	O
have	O	O	O
ingested	O	O	B-T038
this	O	O	O
drug	O	O	B-T121
.	O	O	O

In	O	O	O
addition	O	O	O
to	O	O	O
the	O	O	O
detection	O	O	B-T033
of	O	O	O
cocaine	O	O	B-T109
,	O	O	O
these	O	O	O
analyses	O	O	B-T062
also	O	O	O
provided	O	O	O
evidence	O	O	O
of	O	O	O
nicotine	O	O	B-T109
and	O	O	O
caffeine	O	O	B-T109
intake	O	O	B-T169
.	O	O	O

-DOCSTART- (27895988)

Terahertz	O	O	B-T059
identification	O	O	I-T059
and	O	O	O
quantification	O	O	B-T081
of	O	O	O
neurotransmitter	O	O	B-T123
and	O	O	O
neurotrophy	O	O	O
mixture	O	O	O

Terahertz	O	O	B-T059
spectroscopy	O	O	I-T059
has	O	O	O
been	O	O	O
widely	O	O	O
used	O	O	O
for	O	O	O
investigating	O	O	B-T169
the	O	O	O
fingerprint	O	O	B-T059
spectrum	O	O	I-T059
of	O	O	O
different	O	O	O
substances	O	O	B-T167
.	O	O	O

For	O	O	O
cancerous	O	O	B-T191
tissues	O	O	B-T024
,	O	O	O
the	O	O	O
greatest	O	O	O
difficulty	O	O	O
is	O	O	O
the	O	O	O
absorption	O	O	B-T067
peaks	O	O	O
of	O	O	O
various	O	O	O
substances	O	O	B-T167
contained	O	O	O
in	O	O	O
tissues	O	O	O
overlap	O	O	B-T079
with	O	O	O
each	O	O	O
other	O	O	O
,	O	O	O
which	O	O	O
are	O	O	O
hard	O	O	O
to	O	O	O
identify	O	O	O
and	O	O	O
quantitative	O	O	B-T081
analyze	O	O	B-T062
.	O	O	O

As	O	O	O
a	O	O	O
result	O	O	O
,	O	O	O
it	O	O	O
is	O	O	O
very	O	O	O
hard	O	O	O
to	O	O	O
measure	O	O	O
the	O	O	O
presence	O	O	O
of	O	O	O
cancer	O	O	B-T025
cell	O	O	I-T025
and	O	O	O
then	O	O	O
to	O	O	O
diagnose	O	O	B-T033
accurately	O	O	B-T080
.	O	O	O

In	O	O	O
this	O	O	O
paper	O	O	O
,	O	O	O
we	O	O	O
select	O	O	O
three	O	O	O
typical	O	O	O
neurotransmitters	O	O	B-T123
(	O	O	O
Î³-aminobutyric	O	O	B-T116
acid	O	O	I-T116
,	O	O	O
L-glutamic	O	O	B-T116
acid	O	O	I-T116
,	O	O	O
dopamine	O	O	B-T109
hydrochloride	O	O	I-T109
)	O	O	O
and	O	O	O
two	O	O	O
typical	O	O	O
metabolites	O	O	B-T123
(	O	O	O
inositol	O	O	B-T127
and	O	O	O
creatine	O	O	B-T116
)	O	O	O
in	O	O	O
neurons	O	O	B-T025
to	O	O	O
measure	O	O	O
their	O	O	O
terahertz	O	O	B-T059
spectra	O	O	I-T059
with	O	O	O
different	O	O	O
mixture	O	O	B-T081
ratios	O	O	I-T081
.	O	O	O

By	O	O	O
choosing	O	O	O
characteristic	O	O	B-T080
absorption	O	O	B-T067
peaks	O	O	O
,	O	O	O
removing	O	O	O
baseline	O	O	B-T081
and	O	O	O
using	O	O	O
the	O	O	O
least	O	O	B-T081
square	O	O	I-T081
method	O	O	I-T081
,	O	O	O
we	O	O	O
can	O	O	O
identify	O	O	O
the	O	O	O
components	O	O	O
and	O	O	O
proportions	O	O	B-T081
of	O	O	O
each	O	O	O
mixture	O	O	O
,	O	O	O
where	O	O	O
the	O	O	O
goodness	O	O	B-T080
of	O	O	I-T080
fit	O	O	I-T080
to	O	O	O
practical	O	O	O
situation	O	O	O
is	O	O	O
up	O	O	O
to	O	O	O
94	O	O	O
%	O	O	O
.	O	O	O

These	O	O	O
results	O	O	O
provide	O	O	O
important	O	O	O
evidences	O	O	O
for	O	O	O
identifying	O	O	O
nerve	O	O	B-T123
substances	O	O	I-T123
and	O	O	O
obtaining	O	O	O
exact	O	O	O
quantitative	O	O	B-T081
analysis	O	O	B-T062
.	O	O	O

-DOCSTART- (27896576)

Comparing	O	O	O
the	O	O	O
bulking	O	O	O
effect	O	O	O
of	O	O	O
calcium	O	O	B-T121
hydroxyapatite	O	O	I-T121
and	O	O	O
Deflux	O	O	B-T109
injection	O	O	B-T061
into	O	O	O
the	O	O	O
bladder	O	O	B-T023
neck	O	O	I-T023
for	O	O	O
improvement	O	O	B-T077
of	O	O	O
urinary	O	O	B-T046
incontinence	O	O	I-T046
in	O	O	O
bladder	O	O	O
exstrophy-epispadias	O	O	O
complex	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
evaluate	O	O	O
the	O	O	O
efficacy	O	O	B-T080
of	O	O	O
the	O	O	O
endoscopic	O	O	B-T061
injection	O	O	I-T061
of	O	O	O
calcium	O	O	B-T121
hydroxyapatite	O	O	I-T121
(	O	O	O
CaHA	O	O	B-T121
)	O	O	O
into	O	O	O
the	O	O	O
bladder	O	O	B-T023
neck	O	O	I-T023
(	O	O	O
BN	O	O	B-T023
)	O	O	O
region	O	O	O
of	O	O	O
patients	O	O	B-T101
with	O	O	O
urinary	O	O	B-T046
incontinence	O	O	I-T046
and	O	O	O
bladder	O	O	B-T047
exstrophy-epispadias	O	O	I-T047
complex	O	O	I-T047
(	O	O	O
BEEC	O	O	B-T047
)	O	O	O
.	O	O	O

We	O	O	O
designed	O	O	O
a	O	O	O
retrospective	O	O	B-T062
cohort	O	O	I-T062
study	O	O	I-T062
in	O	O	O
which	O	O	O
we	O	O	O
retrospectively	O	O	B-T062
studied	O	O	I-T062
medical	O	O	B-UnknownType
charts	O	O	I-UnknownType
of	O	O	O
female	O	O	B-T032
and	O	O	O
male	O	O	B-T032
patients	O	O	B-T101
of	O	O	O
BEEC	O	O	B-T047
who	O	O	O
had	O	O	O
undergone	O	O	O
CaHA	O	O	B-T121
or	O	O	O
Deflux	O	O	B-T109
injection	O	O	B-T061
for	O	O	O
continence	O	O	B-T061
improvement	O	O	I-T061
between	O	O	O
2009	O	O	O
and	O	O	O
2014	O	O	O
.	O	O	O

Sixteen	O	O	O
incontinent	O	O	B-T047
patients	O	O	B-T101
with	O	O	O
a	O	O	O
mean	O	O	O
Â±	O	O	O
SD	O	O	O
age	O	O	O
of	O	O	O
8.09	O	O	O
Â±	O	O	O
3.5	O	O	O
years	O	O	O
received	O	O	O
an	O	O	O
endoscopic	O	O	B-T061
submucosal	O	O	I-T061
injection	O	O	I-T061
of	O	O	O
5.4	O	O	O
ml	O	O	O
of	O	O	O
pure	O	O	O
CaHA	O	O	B-T121
powder	O	O	O
with	O	O	O
autologous	O	O	B-T080
plasma	O	O	B-T031
(	O	O	O
group	O	O	O
A	O	O	O
)	O	O	O
.	O	O	O

Patients	O	O	B-T101
in	O	O	O
group	O	O	O
B	O	O	O
(	O	O	O
N	O	O	O
=	O	O	O
21	O	O	O
)	O	O	O
,	O	O	O
control	O	O	B-T096
group	O	O	I-T096
,	O	O	O
with	O	O	O
a	O	O	O
mean	O	O	O
Â±	O	O	O
SD	O	O	O
age	O	O	O
of	O	O	O
7.51	O	O	O
Â±	O	O	O
2.8	O	O	O
years	O	O	O
received	O	O	O
Deflux	O	O	B-T109
injection	O	O	B-T061
(	O	O	O
5.1	O	O	O
ml	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
mean	O	O	O
follow-up	O	O	B-T058
after	O	O	O
injection	O	O	B-T061
was	O	O	O
38	O	O	O
Â±	O	O	O
5.2	O	O	O
and	O	O	O
33	O	O	O
Â±	O	O	O
4.1	O	O	O
months	O	O	O
in	O	O	O
groups	O	O	O
A	O	O	O
and	O	O	O
B	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

No	O	O	O
post-injection	O	O	B-T046
complication	O	O	I-T046
was	O	O	O
detected	O	O	B-T033
in	O	O	O
none	O	O	O
of	O	O	O
the	O	O	O
patients	O	O	B-T101
during	O	O	O
the	O	O	O
follow-up	O	O	B-T058
.	O	O	O

Eleven	O	O	O
patients	O	O	B-T101
(	O	O	O
68.75	O	O	O
%	O	O	O
)	O	O	O
in	O	O	O
group	O	O	O
A	O	O	O
became	O	O	O
socially	O	O	O
dry	O	O	B-T080
following	O	O	O
1	O	O	O
-	O	O	O
2	O	O	O
injections	O	O	B-T061
,	O	O	O
the	O	O	O
degree	O	O	O
of	O	O	O
incontinence	O	O	B-T047
was	O	O	O
improved	O	O	O
in	O	O	O
4	O	O	O
patients	O	O	O
(	O	O	O
25	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
there	O	O	O
was	O	O	O
no	O	O	B-T033
change	O	O	I-T033
in	O	O	O
one	O	O	O
patient	O	O	B-T101
(	O	O	O
6.25	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
Deflux	O	O	B-T109
injection	O	O	B-T061
resulted	O	O	O
in	O	O	O
complete	O	O	B-T080
dryness	O	O	I-T080
in	O	O	O
14	O	O	O
(	O	O	O
66.66	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
improvement	O	O	B-T077
in	O	O	O
the	O	O	O
degree	O	O	O
of	O	O	O
incontinence	O	O	B-T047
in	O	O	O
5	O	O	O
(	O	O	O
23.81	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
no	O	O	B-T033
change	O	O	I-T033
in	O	O	O
2	O	O	O
patients	O	O	B-T101
(	O	O	O
9.52	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
leading	O	O	O
to	O	O	O
no	O	O	B-T033
significant	O	O	I-T033
difference	O	O	I-T033
in	O	O	O
continence	O	O	B-T061
achievement	O	O	I-T061
between	O	O	O
CaHA	O	O	B-T121
and	O	O	O
Deflux	O	O	O
groups	O	O	O
(	O	O	O
p	O	O	O
=	O	O	O
0.9	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
statistical	O	O	B-T062
analysis	O	O	I-T062
was	O	O	O
not	O	O	B-T033
significantly	O	O	I-T033
different	O	O	I-T033
in	O	O	O
terms	O	O	O
of	O	O	O
bladder	O	O	B-T033
capacity	O	O	I-T033
(	O	O	O
p	O	O	O
=	O	O	O
0.7	O	O	O
)	O	O	O
or	O	O	O
Q	O	O	O
max	O	O	O
(	O	O	O
p	O	O	O
=	O	O	O
0.8	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
preliminary	O	O	B-T078
results	O	O	I-T078
of	O	O	O
this	O	O	O
study	O	O	B-T062
revealed	O	O	B-T080
that	O	O	O
CaHA	O	O	B-T121
may	O	O	O
be	O	O	O
applied	O	O	O
as	O	O	O
an	O	O	O
affordable	O	O	O
bulking	O	O	B-T121
agent	O	O	I-T121
in	O	O	O
treatment	O	O	B-T061
of	O	O	O
urinary	O	O	B-T046
incontinence	O	O	I-T046
in	O	O	O
BEEC	O	O	B-T047
.	O	O	O

-DOCSTART- (27898905)

Opportunities	O	O	B-T062
for	O	O	O
genomic	O	O	B-T028
prediction	O	O	B-T078
for	O	O	O
fertility	O	O	B-T040
using	O	O	O
endocrine	O	O	B-T022
and	O	O	O
classical	O	O	B-T169
fertility	O	O	O
traits	O	O	B-T032
in	O	O	O
dairy	O	O	O
cattle	O	O	O

Endocrine	O	O	B-T022
fertility	O	O	B-T040
traits	O	O	B-T032
,	O	O	O
defined	O	O	O
from	O	O	O
progesterone	O	O	B-T125
concentration	O	O	B-T081
levels	O	O	B-T080
in	O	O	O
milk	O	O	B-T031
,	O	O	O
have	O	O	O
been	O	O	O
suggested	O	O	O
as	O	O	O
alternative	O	O	B-T077
indicators	O	O	B-T169
for	O	O	O
fertility	O	O	O
in	O	O	O
dairy	O	O	B-T015
cows	O	O	I-T015
because	O	O	O
they	O	O	O
are	O	O	O
less	O	O	O
biased	O	O	O
by	O	O	O
farm	O	O	B-T082
management	O	O	B-T057
decisions	O	O	B-T041
and	O	O	O
more	O	O	O
directly	O	O	O
reflect	O	O	O
a	O	O	O
cow	O	O	B-T015
's	O	O	O
reproductive	O	O	B-T040
physiology	O	O	B-T039
than	O	O	O
classical	O	O	B-T169
traits	O	O	O
derived	O	O	O
from	O	O	O
insemination	O	O	B-T042
and	O	O	O
calving	O	O	O
data	O	O	B-T078
.	O	O	O

To	O	O	O
determine	O	O	O
the	O	O	O
potential	O	O	O
use	O	O	B-T169
of	O	O	I-T169
endocrine	O	O	B-T022
fertility	O	O	B-T040
traits	O	O	B-T032
in	O	O	O
genomic	O	O	B-T028
evaluations	O	O	B-T062
,	O	O	O
the	O	O	O
improvement	O	O	B-T077
in	O	O	O
accuracy	O	O	B-T080
from	O	O	O
using	O	O	O
endocrine	O	O	O
fertility	O	O	O
traits	O	O	O
concurrent	O	O	B-T079
with	O	O	O
classical	O	O	B-T169
traits	O	O	O
in	O	O	O
the	O	O	O
genomic	O	O	O
prediction	O	O	B-T078
of	O	O	O
fertility	O	O	O
was	O	O	O
quantified	O	O	B-T081
.	O	O	O

The	O	O	O
impact	O	O	B-T080
of	O	O	O
recording	O	O	O
all	O	O	O
traits	O	O	B-T032
on	O	O	O
all	O	O	O
training	O	O	O
animals	O	O	B-T008
was	O	O	O
also	O	O	O
investigated	O	O	B-T169
.	O	O	O

Endocrine	O	O	B-T022
and	O	O	O
classical	O	O	B-T169
fertility	O	O	B-T040
records	O	O	O
were	O	O	O
available	O	O	O
on	O	O	O
5,339	O	O	O
lactations	O	O	B-T042
from	O	O	O
2,447	O	O	O
Holstein	O	O	B-T015
cows	O	O	I-T015
in	O	O	O
Ireland	O	O	B-T083
,	O	O	O
the	O	O	O
Netherlands	O	O	B-T083
,	O	O	O
Sweden	O	O	B-T083
,	O	O	O
and	O	O	O
the	O	O	O
United	O	O	B-T083
Kingdom	O	O	I-T083
.	O	O	O

The	O	O	O
endocrine	O	O	B-T022
traits	O	O	B-T032
were	O	O	O
commencement	O	O	B-T042
of	O	O	I-T042
luteal	O	O	B-T042
activity	O	O	I-T042
(	O	O	O
C-LA	O	O	B-T042
)	O	O	O
and	O	O	O
proportion	O	O	B-T081
of	O	O	O
samples	O	O	B-T167
with	O	O	O
luteal	O	O	O
activity	O	O	O
(	O	O	O
PLA	O	O	B-T167
)	O	O	O
;	O	O	O
the	O	O	O
classical	O	O	B-T169
trait	O	O	B-T032
was	O	O	O
the	O	O	O
interval	O	O	B-T079
from	O	O	O
calving	O	O	O
to	O	O	O
first	O	O	O
service	O	O	O
(	O	O	O
CFS	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
interval	O	O	B-T079
from	O	O	O
C-LA	O	O	B-T042
to	O	O	O
first	O	O	O
service	O	O	O
(	O	O	O
C-LAFS	O	O	O
)	O	O	O
,	O	O	O
which	O	O	O
is	O	O	O
a	O	O	O
combination	O	O	O
of	O	O	O
an	O	O	O
endocrine	O	O	B-T022
trait	O	O	B-T032
and	O	O	O
a	O	O	O
classical	O	O	B-T169
trait	O	O	O
,	O	O	O
was	O	O	O
also	O	O	O
investigated	O	O	B-T169
.	O	O	O

The	O	O	O
target	O	O	B-T169
(	O	O	O
breeding	O	O	B-T169
goal	O	O	I-T169
)	O	O	O
trait	O	O	B-T032
for	O	O	O
fertility	O	O	B-T040
was	O	O	O
CFS	O	O	O
or	O	O	O
C-LAFS	O	O	O
,	O	O	O
whereas	O	O	O
C-LA	O	O	B-T042
and	O	O	O
PLA	O	O	B-T167
served	O	O	O
as	O	O	O
predictor	O	O	B-T078
traits	O	O	B-T032
.	O	O	O

Genomic	O	O	B-T028
EBV	O	O	I-T028
(	O	O	O
GEBV	O	O	B-T028
)	O	O	O
for	O	O	O
fertility	O	O	B-T040
were	O	O	O
derived	O	O	O
using	O	O	O
genomic	O	O	B-T062
BLUP	O	O	I-T062
in	O	O	O
bivariate	O	O	B-T075
models	O	O	I-T075
with	O	O	O
85,485	O	O	O
SNP	O	O	B-T086
.	O	O	O

Genomic	O	O	O
EBV	O	O	O
for	O	O	O
the	O	O	O
separate	O	O	O
fertility	O	O	B-T040
traits	O	O	B-T032
were	O	O	O
also	O	O	O
computed	O	O	O
,	O	O	O
in	O	O	O
univariate	O	O	B-T075
models	O	O	I-T075
.	O	O	O

The	O	O	O
accuracy	O	O	B-T080
of	O	O	O
GEBV	O	O	B-T028
was	O	O	O
evaluated	O	O	O
by	O	O	O
5-fold	O	O	O
cross-validation	O	O	B-T062
.	O	O	O

The	O	O	O
highest	O	O	O
accuracy	O	O	B-T080
of	O	O	O
GEBV	O	O	B-T028
was	O	O	O
achieved	O	O	O
using	O	O	O
bivariate	O	O	B-UnknownType
predictions	O	O	B-T078
,	O	O	O
where	O	O	O
both	O	O	O
an	O	O	O
endocrine	O	O	B-T022
fertility	O	O	B-T040
trait	O	O	B-T032
and	O	O	O
the	O	O	O
classical	O	O	B-T169
fertility	O	O	O
trait	O	O	O
were	O	O	O
used	O	O	O
.	O	O	O

Accuracy	O	O	B-T080
of	O	O	O
GEBV	O	O	B-T028
for	O	O	O
predicting	O	O	B-T078
adjusted	O	O	O
phenotypes	O	O	B-T032
for	O	O	O
CFS	O	O	O
in	O	O	O
the	O	O	O
univariate	O	O	B-T075
model	O	O	I-T075
was	O	O	O
0.04	O	O	O
,	O	O	O
but	O	O	O
when	O	O	O
predicting	O	O	O
CFS	O	O	O
using	O	O	O
a	O	O	O
bivariate	O	O	B-T075
model	O	O	I-T075
with	O	O	O
C-LA	O	O	B-T042
,	O	O	O
the	O	O	O
accuracy	O	O	B-T080
increased	O	O	B-T081
to	O	O	O
0.14	O	O	O
when	O	O	O
all	O	O	O
training	O	O	B-T008
animals	O	O	I-T008
were	O	O	O
phenotyped	O	O	B-T032
for	O	O	O
C-LA	O	O	O
and	O	O	O
(	O	O	O
or	O	O	O
not	O	O	O
)	O	O	O
for	O	O	O
CFS	O	O	O
.	O	O	O

On	O	O	O
phenotyping	O	O	B-T032
all	O	O	O
training	O	O	B-T008
animals	O	O	B-T008
for	O	O	O
both	O	O	O
C-LA	O	O	B-T042
and	O	O	O
CFS	O	O	O
,	O	O	O
accuracy	O	O	B-T080
for	O	O	O
CFS	O	O	O
increased	O	O	B-T081
to	O	O	O
0.18	O	O	O
;	O	O	O
however	O	O	O
,	O	O	O
when	O	O	O
validation	O	O	B-T062
animals	O	O	O
were	O	O	O
also	O	O	O
phenotyped	O	O	B-T032
for	O	O	O
C-LA	O	O	O
,	O	O	O
there	O	O	O
was	O	O	O
no	O	O	B-T033
substantial	O	O	B-T169
increase	O	O	I-T169
in	O	O	O
accuracy	O	O	O
.	O	O	O

When	O	O	O
predicting	O	O	B-T078
CFS	O	O	O
in	O	O	O
bivariate	O	O	B-UnknownType
analysis	O	O	I-UnknownType
with	O	O	O
PLA	O	O	B-T167
,	O	O	O
accuracy	O	O	B-T080
ranged	O	O	O
from	O	O	O
0.07	O	O	O
to	O	O	O
0.14	O	O	O
.	O	O	O

This	O	O	O
first	O	O	O
study	O	O	B-T062
on	O	O	O
genomic	O	O	B-T028
predictions	O	O	B-T078
for	O	O	O
fertility	O	O	B-T040
using	O	O	O
endocrine	O	O	B-T022
traits	O	O	B-T032
suggests	O	O	O
some	O	O	O
improvement	O	O	B-T077
in	O	O	O
the	O	O	O
accuracy	O	O	B-T080
of	O	O	O
prediction	O	O	B-T078
over	O	O	O
using	O	O	O
only	O	O	O
the	O	O	O
classical	O	O	B-T169
traits	O	O	O
.	O	O	O

Further	O	O	O
studies	O	O	B-T062
with	O	O	O
larger	O	O	B-T081
training	O	O	B-T098
populations	O	O	I-T098
may	O	O	O
show	O	O	O
greater	O	O	B-T081
improvements	O	O	B-T077
.	O	O	O

-DOCSTART- (27901092)

A	O	O	O
Microfluidic	O	O	B-T090
Platform	O	O	O
to	O	O	O
design	O	O	B-T052
crosslinked	O	O	B-T073
Hyaluronic	O	O	I-T073
Acid	O	O	I-T073
Nanoparticles	O	O	I-T073
(	O	O	O
cHANPs	O	O	B-T073
)	O	O	O
for	O	O	O
enhanced	O	O	O
MRI	O	O	O

Recent	O	O	B-T079
advancements	O	O	B-T079
in	O	O	O
imaging	O	O	B-T060
diagnostics	O	O	I-T060
have	O	O	O
focused	O	O	O
on	O	O	O
the	O	O	O
use	O	O	O
of	O	O	O
nanostructures	O	O	B-T073
that	O	O	O
entrap	O	O	O
Magnetic	O	O	B-T060
Resonance	O	O	I-T060
Imaging	O	O	I-T060
(	O	O	O
MRI	O	O	B-T060
)	O	O	O
Contrast	O	O	B-T130
Agents	O	O	I-T130
(	O	O	O
CAs	O	O	B-T130
)	O	O	O
,	O	O	O
without	O	O	O
the	O	O	O
need	O	O	O
to	O	O	O
chemically	O	O	B-T103
modify	O	O	B-T169
the	O	O	O
clinically	O	O	B-T080
approved	O	O	B-T080
compounds	O	O	B-T103
.	O	O	O

Nevertheless	O	O	O
,	O	O	O
the	O	O	O
exploitation	O	O	O
of	O	O	O
microfluidic	O	O	B-T090
platforms	O	O	I-T090
for	O	O	O
their	O	O	O
controlled	O	O	B-T169
and	O	O	O
continuous	O	O	B-T078
production	O	O	B-T052
is	O	O	O
still	O	O	O
missing	O	O	O
.	O	O	O

Here	O	O	O
,	O	O	O
a	O	O	O
microfluidic	O	O	B-T090
platform	O	O	I-T090
is	O	O	O
used	O	O	O
to	O	O	O
synthesize	O	O	B-T052
crosslinked	O	O	B-T073
Hyaluronic	O	O	I-T073
Acid	O	O	I-T073
NanoParticles	O	O	I-T073
(	O	O	O
cHANPs	O	O	B-T073
)	O	O	O
in	O	O	O
which	O	O	O
a	O	O	O
clinically	O	O	B-T080
relevant	O	O	B-T080
MRI	O	O	B-T060
-	O	O	O
CAs	O	O	B-T130
,	O	O	O
gadolinium	O	O	B-T109
diethylenetriamine	O	O	I-T109
penta-acetic	O	O	I-T109
acid	O	O	I-T109
(	O	O	O
Gd-DTPA	O	O	B-T109
)	O	O	O
,	O	O	O
is	O	O	O
entrapped	O	O	O
.	O	O	O

This	O	O	O
microfluidic	O	O	B-T090
process	O	O	B-T067
facilitates	O	O	O
a	O	O	O
high	O	O	O
degree	O	O	B-T080
of	O	O	O
control	O	O	B-T169
over	O	O	O
particle	O	O	B-T073
synthesis	O	O	B-T052
,	O	O	O
enabling	O	O	O
the	O	O	O
production	O	O	B-T052
of	O	O	O
monodisperse	O	O	B-T073
particles	O	O	I-T073
as	O	O	O
small	O	O	O
as	O	O	O
35	O	O	O
nm	O	O	O
.	O	O	O

Furthermore	O	O	O
,	O	O	O
the	O	O	O
interference	O	O	B-T169
of	O	O	O
Gd-DTPA	O	O	B-T109
during	O	O	O
polymer	O	O	B-T122
precipitation	O	O	B-T070
is	O	O	O
overcome	O	O	O
by	O	O	O
finely	O	O	O
tuning	O	O	O
process	O	O	B-T067
parameters	O	O	B-T077
and	O	O	O
leveraging	O	O	O
the	O	O	O
use	O	O	O
of	O	O	O
hydrophilic-lipophilic	O	O	B-T081
balance	O	O	I-T081
(	O	O	O
HLB	O	O	B-T081
)	O	O	O
of	O	O	O
surfactants	O	O	B-T120
and	O	O	O
pH	O	O	B-T081
conditions	O	O	B-T080
.	O	O	O

For	O	O	O
both	O	O	O
production	O	O	B-T052
strategies	O	O	O
proposed	O	O	O
to	O	O	O
design	O	O	B-T052
Gd	O	O	B-T109
-loaded	O	O	O
cHANPs	O	O	B-T073
,	O	O	O
a	O	O	O
boosting	O	O	O
of	O	O	O
the	O	O	O
relaxation	O	O	B-T081
rate	O	O	I-T081
T1	O	O	B-T081
is	O	O	O
observed	O	O	O
since	O	O	O
a	O	O	O
T1	O	O	O
of	O	O	O
1562	O	O	O
is	O	O	O
achieved	O	O	O
with	O	O	O
a	O	O	O
10	O	O	O
Î¼M	O	O	O
of	O	O	O
Gd	O	O	O
-loaded	O	O	O
cHANPs	O	O	O
while	O	O	O
a	O	O	O
similar	O	O	O
value	O	O	B-T081
is	O	O	O
reached	O	O	O
with	O	O	O
100	O	O	O
Î¼M	O	O	O
of	O	O	O
the	O	O	O
relevant	O	O	B-T080
clinical	O	O	B-T080
Gd-DTPA	O	O	B-T109
in	O	O	O
solution	O	O	B-T167
.	O	O	O

The	O	O	O
advanced	O	O	O
microfluidic	O	O	B-T090
platform	O	O	O
to	O	O	O
synthesize	O	O	O
intravascularly	O	O	B-T082
-	O	O	O
injectable	O	O	B-T122
and	O	O	O
completely	O	O	O
biocompatible	O	O	B-T109
hydrogel	O	O	I-T109
nanoparticles	O	O	B-T073
entrapping	O	O	O
clinically	O	O	B-T080
approved	O	O	B-T080
CAs	O	O	B-T130
enables	O	O	O
the	O	O	O
implementation	O	O	B-T052
of	O	O	O
straightforward	O	O	O
and	O	O	O
scalable	O	O	O
strategies	O	O	O
in	O	O	O
diagnostics	O	O	B-T080
and	O	O	O
therapy	O	O	B-T061
applications	O	O	B-T169
.	O	O	O

-DOCSTART- (27902303)

Arthrobacter	O	O	B-T007
ginkgonis	O	O	I-T007
sp.	O	O	I-T007
nov.	O	O	I-T007
,	O	O	O
an	O	O	O
actinomycete	O	O	B-T007
isolated	O	O	B-T169
from	O	O	O
rhizosphere	O	O	B-T070
of	O	O	O
Ginkgo	O	O	O
biloba	O	O	O
L	O	O	O

A	O	O	O
Gram-stain-positive	O	O	B-T034
,	O	O	O
aerobic	O	O	B-T080
actinobacterial	O	O	B-T007
strain	O	O	I-T007
(	O	O	O
designated	O	O	O
SYP-A7299	O	O	B-T007
T	O	O	I-T007
)	O	O	O
,	O	O	O
which	O	O	O
displayed	O	O	O
a	O	O	O
rod-coccus	O	O	B-T007
growth	O	O	I-T007
lifecycle	O	O	I-T007
,	O	O	O
was	O	O	O
isolated	O	O	B-T169
from	O	O	O
the	O	O	O
rhizosphere	O	O	B-T070
of	O	O	O
Ginkgo	O	O	O
biloba	O	O	O
L.	O	O	O
Phylogenetic	O	O	B-T062
analyses	O	O	I-T062
based	O	O	O
on	O	O	O
16S	O	O	B-T028
rRNA	O	O	I-T028
gene	O	O	I-T028
sequences	O	O	I-T028
indicated	O	O	O
that	O	O	O
strain	O	O	B-T007
SYP-A7299	O	O	I-T007
T	O	O	I-T007
belongs	O	O	O
to	O	O	O
the	O	O	O
genus	O	O	B-T185
Arthrobacter	O	O	B-T007
and	O	O	O
is	O	O	O
most	O	O	O
closely	O	O	O
related	O	O	O
to	O	O	O
Arthrobacter	O	O	B-T007
halodurans	O	O	I-T007
JSM	O	O	I-T007
078085	O	O	I-T007
T	O	O	I-T007
(	O	O	O
97.4	O	O	O
%	O	O	O
16S	O	O	B-T028
rRNA	O	O	I-T028
gene	O	O	I-T028
sequence	O	O	I-T028
similarity	O	O	B-T080
)	O	O	O
.	O	O	O

The	O	O	O
DNA	O	O	B-T114
-	O	O	O
DNA	O	O	O
relatedness	O	O	B-T081
value	O	O	I-T081
between	O	O	O
strain	O	O	B-T007
SYP-A7299	O	O	I-T007
T	O	O	I-T007
and	O	O	O
A.	O	O	B-T007
halodurans	O	O	I-T007
JSM	O	O	I-T007
078085	O	O	I-T007
T	O	O	I-T007
was	O	O	O
37	O	O	O
%	O	O	O
Â±2.9	O	O	O
.	O	O	O

The	O	O	O
cell-wall	O	O	B-T026
peptidoglycan	O	O	B-T109
was	O	O	O
A4Î±	O	O	B-T109
,	O	O	O
and	O	O	O
glucose	O	O	B-T109
and	O	O	O
galactose	O	O	B-T109
were	O	O	O
whole-cell	O	O	B-T109
sugars	O	O	I-T109
.	O	O	O

The	O	O	O
polar	O	O	B-T109
lipids	O	O	I-T109
consisted	O	O	O
of	O	O	O
diphosphatidylglycerol	O	O	B-T123
,	O	O	O
phosphatidylglycerol	O	O	B-T109
,	O	O	O
phosphatidylinositol	O	O	B-T109
,	O	O	O
two	O	O	O
glycolipids	O	O	B-T109
and	O	O	O
an	O	O	O
unknown	O	O	O
polar	O	O	B-T109
lipid	O	O	I-T109
.	O	O	O

The	O	O	O
major	O	O	O
menaquinone	O	O	B-T127
were	O	O	O
MK-8(H2	O	O	B-T127
)	O	O	I-T127
(	O	O	O
72	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
MK-9(H2	O	O	B-T127
)	O	O	I-T127
(	O	O	O
28	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
the	O	O	O
predominant	O	O	O
cellular	O	O	B-T109
fatty	O	O	I-T109
acids	O	O	I-T109
were	O	O	O
anteiso-C15	O	O	B-T109
:	O	O	I-T109
0	O	O	I-T109
,	O	O	O
iso-C15	O	O	B-T109
:	O	O	I-T109
0	O	O	I-T109
and	O	O	O
anteiso-C17	O	O	B-T109
:	O	O	I-T109
0	O	O	I-T109
.	O	O	O

The	O	O	O
DNA	O	O	B-T114
G+C	O	O	B-T081
content	O	O	I-T081
was	O	O	O
68.9	O	O	O
mol%	O	O	O
.	O	O	O

Based	O	O	O
on	O	O	O
the	O	O	O
morphological	O	O	B-T082
,	O	O	O
physiological	O	O	B-T169
,	O	O	O
biochemical	O	O	B-T169
and	O	O	O
chemotaxonomic	O	O	B-T169
characters	O	O	I-T169
presented	O	O	O
in	O	O	O
this	O	O	O
study	O	O	O
,	O	O	O
strain	O	O	B-T007
SYP-A7299	O	O	I-T007
T	O	O	I-T007
represents	O	O	O
a	O	O	O
novel	O	O	O
species	O	O	B-T185
of	O	O	O
the	O	O	O
genus	O	O	B-T185
Arthrobacter	O	O	B-T007
,	O	O	O
for	O	O	O
which	O	O	O
the	O	O	O
name	O	O	O
Arthrobacter	O	O	B-T007
ginkgonis	O	O	I-T007
sp.	O	O	I-T007
nov.	O	O	I-T007
is	O	O	O
proposed	O	O	O
.	O	O	O

The	O	O	O
type	O	O	B-T001
strain	O	O	I-T001
is	O	O	O
SYP-A7299	O	O	B-T007
T	O	O	I-T007
(=	O	O	O
DSM	O	O	O
100491T	O	O	O
=	O	O	O
KCTC	O	O	O
39	O	O	O
592	O	O	O
T	O	O	O
)	O	O	O
.	O	O	O

-DOCSTART- (27902690)

Decoding	O	O	B-T041
the	O	O	O
Interactions	O	O	B-T043
Regulating	O	O	B-T080
the	O	O	O
Active	O	O	B-T033
State	O	O	I-T033
Mechanics	O	O	B-T070
of	O	O	O
Eukaryotic	O	O	B-T204
Protein	O	O	O
Kinases	O	O	O

Eukaryotic	O	O	B-T204
protein	O	O	B-T116
kinases	O	O	I-T116
regulate	O	O	B-T080
most	O	O	O
cellular	O	O	B-T043
functions	O	O	I-T043
by	O	O	O
phosphorylating	O	O	B-T044
targeted	O	O	B-T169
protein	O	O	O
substrates	O	O	B-T167
through	O	O	B-T169
a	O	O	O
highly	O	O	B-T080
conserved	O	O	B-T169
catalytic	O	O	B-T026
core	O	O	I-T026
.	O	O	O

In	O	O	O
the	O	O	O
active	O	O	B-T033
state	O	O	I-T033
,	O	O	O
the	O	O	O
catalytic	O	O	B-T026
core	O	O	I-T026
oscillates	O	O	B-T061
between	O	O	O
open	O	O	B-T082
,	O	O	O
intermediate	O	O	B-T082
,	O	O	O
and	O	O	O
closed	O	O	B-T082
conformations	O	O	B-T082
.	O	O	O

Currently	O	O	B-T079
,	O	O	O
the	O	O	O
intramolecular	O	O	B-T043
interactions	O	O	I-T043
that	O	O	O
regulate	O	O	B-T080
the	O	O	O
active	O	O	B-T033
state	O	O	I-T033
mechanics	O	O	B-T070
are	O	O	O
not	O	O	B-T080
well	O	O	I-T080
understood	O	O	I-T080
.	O	O	O

Here	O	O	O
,	O	O	O
using	O	O	O
cAMP-dependent	O	O	B-T116
protein	O	O	I-T116
kinase	O	O	I-T116
as	O	O	O
a	O	O	O
representative	O	O	B-T052
model	O	O	B-T075
coupled	O	O	B-T169
with	O	O	O
biochemical	O	O	B-T169
,	O	O	O
biophysical	O	O	B-T038
,	O	O	O
and	O	O	O
computational	O	O	B-T062
techniques	O	O	I-T062
,	O	O	O
we	O	O	O
define	O	O	O
a	O	O	O
set	O	O	O
of	O	O	O
highly	O	O	B-T080
conserved	O	O	B-T080
electrostatic	O	O	B-UnknownType
and	O	O	O
hydrophobic	O	O	B-T044
interactions	O	O	I-T044
working	O	O	O
harmoniously	O	O	B-T054
to	O	O	O
regulate	O	O	B-T080
these	O	O	O
mechanics	O	O	B-T070
.	O	O	O

These	O	O	O
include	O	O	B-T169
the	O	O	O
previously	O	O	B-T079
identified	O	O	B-T080
salt	O	O	B-T044
bridge	O	O	I-T044
between	O	O	O
a	O	O	O
lysine	O	O	B-T116
from	O	O	O
the	O	O	O
Î²3-strand	O	O	B-T082
and	O	O	O
a	O	O	O
glutamate	O	O	B-T116
from	O	O	O
the	O	O	O
Î±C-helix	O	O	B-T082
as	O	O	O
well	O	O	O
as	O	O	O
an	O	O	O
electrostatic	O	O	B-UnknownType
interaction	O	O	I-UnknownType
between	O	O	O
the	O	O	O
phosphorylated	O	O	B-T044
activation	O	O	B-T052
loop	O	O	B-T082
and	O	O	O
Î±C-helix	O	O	O
and	O	O	O
an	O	O	O
ensemble	O	O	B-T081
of	O	O	O
hydrophobic	O	O	B-T080
residues	O	O	B-T077
of	O	O	O
the	O	O	O
Regulatory	O	O	O
spine	O	O	O
and	O	O	O
Shell	O	O	O
.	O	O	O

Moreover	O	O	O
,	O	O	O
for	O	O	O
over	O	O	O
three	O	O	O
decades	O	O	B-T081
it	O	O	O
was	O	O	O
thought	O	O	O
that	O	O	O
the	O	O	O
highly	O	O	B-T080
conserved	O	O	B-T169
Î²3	O	O	B-T082
-lysine	O	O	O
was	O	O	O
essential	O	O	B-T080
for	O	O	O
phosphoryl	O	O	B-T044
transfer	O	O	I-T044
,	O	O	O
but	O	O	O
our	O	O	O
findings	O	O	B-T169
show	O	O	O
that	O	O	O
the	O	O	O
Î²3	O	O	B-T116
-lysine	O	O	I-T116
is	O	O	O
not	O	O	O
required	O	O	O
for	O	O	O
phosphoryl	O	O	O
transfer	O	O	O
but	O	O	O
is	O	O	O
essential	O	O	O
for	O	O	O
the	O	O	O
active	O	O	B-T033
state	O	O	I-T033
mechanics	O	O	B-T070
.	O	O	O

-DOCSTART- (27903185)

Acute	O	O	B-T079
clinical	O	O	B-T080
adverse	O	O	B-T037
radiation	O	O	I-T037
effects	O	O	I-T037
after	O	O	O
Gamma	O	O	B-T061
Knife	O	O	I-T061
surgery	O	O	I-T061
for	O	O	O
vestibular	O	O	O
schwannomas	O	O	O

OBJECTIVE	O	O	O
Vestibular	O	O	B-T191
schwannomas	O	O	I-T191
(	O	O	O
VSs	O	O	B-T191
)	O	O	O
represent	O	O	O
a	O	O	O
common	O	O	O
indication	O	O	O
of	O	O	O
Gamma	O	O	B-T061
Knife	O	O	I-T061
surgery	O	O	I-T061
(	O	O	O
GKS	O	O	B-T061
)	O	O	O
.	O	O	O

While	O	O	O
most	O	O	O
studies	O	O	B-T062
focus	O	O	O
on	O	O	O
the	O	O	O
long-term	O	O	B-T079
morbidity	O	O	B-T081
and	O	O	O
adverse	O	O	B-T037
radiation	O	O	I-T037
effects	O	O	I-T037
(	O	O	O
AREs	O	O	B-T037
)	O	O	O
,	O	O	O
none	O	O	O
describe	O	O	O
the	O	O	O
acute	O	O	B-T079
clinical	O	O	B-T080
AREs	O	O	O
that	O	O	O
might	O	O	O
appear	O	O	O
on	O	O	O
a	O	O	O
short-term	O	O	B-T079
basis	O	O	O
.	O	O	O

These	O	O	O
types	O	O	O
of	O	O	O
events	O	O	O
are	O	O	O
investigated	O	O	B-T169
,	O	O	O
and	O	O	O
their	O	O	O
incidence	O	O	B-T081
,	O	O	O
type	O	O	B-T080
,	O	O	O
and	O	O	O
outcomes	O	O	B-T062
are	O	O	O
reported	O	O	B-T170
in	O	O	O
the	O	O	O
present	O	O	O
paper	O	O	O
.	O	O	O

METHODS	O	O	O
The	O	O	O
included	O	O	O
patients	O	O	B-T101
were	O	O	O
treated	O	O	B-T169
between	O	O	O
July	O	O	O
2010	O	O	O
and	O	O	O
March	O	O	O
2016	O	O	O
,	O	O	O
underwent	O	O	O
at	O	O	O
least	O	O	O
6	O	O	O
months	O	O	B-T079
of	O	O	O
follow-up	O	O	B-T058
,	O	O	O
and	O	O	O
presented	O	O	O
with	O	O	O
a	O	O	O
disabling	O	O	B-T047
symptom	O	O	B-T184
during	O	O	O
the	O	O	O
first	O	O	O
6	O	O	O
months	O	O	O
after	O	O	O
GKS	O	O	B-T061
that	O	O	O
affected	O	O	B-T169
their	O	O	O
quality	O	O	B-T078
of	O	O	I-T078
life	O	O	I-T078
.	O	O	O

The	O	O	O
timing	O	O	O
of	O	O	O
appearance	O	O	O
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
the	O	O	O
type	O	O	O
of	O	O	O
main	O	O	O
symptom	O	O	B-T184
and	O	O	O
outcome	O	O	B-T062
,	O	O	O
were	O	O	O
noted	O	O	O
.	O	O	O

The	O	O	O
prescribed	O	O	B-T058
dose	O	O	B-T081
was	O	O	O
12	O	O	O
Gy	O	O	O
at	O	O	O
the	O	O	O
margin	O	O	O
.	O	O	O

RESULTS	O	O	O
Thirty-five	O	O	O
(	O	O	O
22	O	O	O
%	O	O	O
)	O	O	O
of	O	O	O
159	O	O	O
patients	O	O	B-T101
who	O	O	O
fulfilled	O	O	O
the	O	O	O
inclusion	O	O	B-T080
criteria	O	O	O
had	O	O	O
acute	O	O	B-T079
clinical	O	O	B-T080
AREs	O	O	B-T037
.	O	O	O

The	O	O	O
mean	O	O	B-T081
followup	O	O	B-T058
period	O	O	O
was	O	O	O
30	O	O	O
months	O	O	B-T079
(	O	O	O
range	O	O	B-T081
6	O	O	O
-	O	O	O
49.2	O	O	O
months	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
mean	O	O	B-T081
time	O	O	O
of	O	O	O
appearance	O	O	O
was	O	O	O
37.9	O	O	O
days	O	O	B-T079
(	O	O	O
median	O	O	B-T081
31	O	O	O
days	O	O	O
;	O	O	O
range	O	O	B-T081
3	O	O	O
-	O	O	O
110	O	O	O
days	O	O	O
)	O	O	O
.	O	O	O

In	O	O	O
patients	O	O	B-T101
with	O	O	O
de	O	O	B-T078
novo	O	O	I-T078
symptoms	O	O	B-T184
,	O	O	O
the	O	O	O
more	O	O	O
frequent	O	O	O
symptoms	O	O	O
were	O	O	O
vertigo	O	O	B-T184
(	O	O	O
n	O	O	O
=	O	O	O
4	O	O	O
;	O	O	O
11.4	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
gait	O	O	B-T033
disturbance	O	O	I-T033
(	O	O	O
n	O	O	O
=	O	O	O
3	O	O	O
;	O	O	O
8.6	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
exacerbation	O	O	B-T033
of	O	O	O
a	O	O	O
preexisting	O	O	O
symptom	O	O	B-T184
was	O	O	O
more	O	O	O
frequently	O	O	O
related	O	O	O
to	O	O	O
hearing	O	O	B-T033
loss	O	O	I-T033
(	O	O	O
n	O	O	O
=	O	O	O
10	O	O	O
;	O	O	O
28.6	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
followed	O	O	O
by	O	O	O
gait	O	O	B-T033
disturbance	O	O	I-T033
(	O	O	O
n	O	O	O
=	O	O	O
7	O	O	O
;	O	O	O
20	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
vertigo	O	O	B-T184
(	O	O	O
n	O	O	O
=	O	O	O
3	O	O	O
,	O	O	O
8.6	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

In	O	O	O
the	O	O	O
univariate	O	O	B-T062
logistic	O	O	B-UnknownType
regression	O	O	I-UnknownType
analysis	O	O	I-UnknownType
,	O	O	O
the	O	O	O
following	O	O	O
factors	O	O	B-T169
were	O	O	O
statistically	O	O	B-T081
significant	O	O	I-T081
:	O	O	O
age	O	O	B-T032
(	O	O	O
p	O	O	O
=	O	O	O
0.002	O	O	O
;	O	O	O
odds	O	O	B-T081
ratio	O	O	I-T081
[	O	O	O
OR	O	O	B-T081
]	O	O	O
0.96	O	O	O
)	O	O	O
,	O	O	O
hearing	O	O	O
at	O	O	O
baseline	O	O	B-T081
by	O	O	O
Gardner-Robertson	O	O	B-T170
(	O	O	O
GR	O	O	B-T170
)	O	O	O
class	O	O	O
(	O	O	O
p	O	O	O
=	O	O	O
0.006	O	O	O
;	O	O	O
OR	O	O	O
0.21	O	O	O
)	O	O	O
,	O	O	O
pure	O	O	B-T081
tone	O	O	I-T081
average	O	O	I-T081
at	O	O	O
baseline	O	O	O
(	O	O	O
p	O	O	O
=	O	O	O
0.006	O	O	O
;	O	O	O
OR	O	O	O
0.97	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
Koos	O	O	B-T170
grade	O	O	I-T170
at	O	O	O
baseline	O	O	O
(	O	O	O
with	O	O	O
Koos	O	O	B-T170
Grade	O	O	I-T170
I	O	O	I-T170
used	O	O	O
as	O	O	O
a	O	O	O
reference	O	O	O
)	O	O	O
(	O	O	O
for	O	O	O
Koos	O	O	B-T170
Grade	O	O	I-T170
II	O	O	I-T170
,	O	O	O
OR	O	O	O
0.17	O	O	O
and	O	O	O
p	O	O	O
=	O	O	O
0.002	O	O	O
;	O	O	O
for	O	O	O
Koos	O	O	B-T170
Grade	O	O	I-T170
III	O	O	I-T170
,	O	O	O
OR	O	O	O
0.42	O	O	O
and	O	O	O
p	O	O	O
=	O	O	O
0.05	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
following	O	O	O
were	O	O	O
not	O	O	O
statistically	O	O	B-T081
significant	O	O	I-T081
but	O	O	O
showed	O	O	O
a	O	O	O
tendency	O	O	O
toward	O	O	O
significance	O	O	O
:	O	O	O
the	O	O	O
number	O	O	O
of	O	O	O
isocenters	O	O	B-T082
(	O	O	O
p	O	O	O
=	O	O	O
0.06	O	O	O
;	O	O	O
OR	O	O	B-T081
0.94	O	O	O
)	O	O	O
and	O	O	O
the	O	O	O
maximal	O	O	B-T081
dose	O	O	B-T081
received	O	O	O
by	O	O	O
the	O	O	O
cochlea	O	O	B-T047
(	O	O	O
p	O	O	O
=	O	O	O
0.07	O	O	O
;	O	O	O
OR	O	O	O
0.74	O	O	O
)	O	O	O
.	O	O	O

Fractional	O	O	B-T170
polynomial	O	O	I-T170
regression	O	O	I-T170
analysis	O	O	B-T062
showed	O	O	O
a	O	O	O
nonlinear	O	O	O
relationship	O	O	O
between	O	O	O
the	O	O	O
outcome	O	O	B-T062
and	O	O	O
the	O	O	O
radiation	O	O	B-T081
dose	O	O	B-T081
rate	O	O	I-T081
(	O	O	O
minimum	O	O	O
reached	O	O	O
at	O	O	O
a	O	O	O
cutoff	O	O	O
of	O	O	O
2.5	O	O	O
Gy/minute	O	O	O
)	O	O	O
and	O	O	O
the	O	O	O
maximal	O	O	B-T081
vestibular	O	O	B-T030
dose	O	O	O
(	O	O	O
maximum	O	O	O
reached	O	O	O
at	O	O	O
a	O	O	O
cutoff	O	O	O
of	O	O	O
8	O	O	O
Gy	O	O	O
)	O	O	O
,	O	O	O
but	O	O	O
the	O	O	O
small	O	O	O
sample	O	O	B-T081
size	O	O	I-T081
precludes	O	O	B-T169
a	O	O	O
detailed	O	O	O
analysis	O	O	O
of	O	O	O
the	O	O	O
former	O	O	O
.	O	O	O

The	O	O	O
clinical	O	O	B-T080
acute	O	O	B-T079
AREs	O	O	B-T037
disappeared	O	O	O
in	O	O	O
32	O	O	O
(	O	O	O
91.4	O	O	O
%	O	O	O
)	O	O	O
patients	O	O	B-T101
during	O	O	O
the	O	O	O
first	O	O	O
6	O	O	O
months	O	O	B-T079
after	O	O	O
appearance	O	O	O
.	O	O	O

Permanent	O	O	O
and	O	O	O
somewhat	O	O	O
disabling	O	O	B-T047
morbidity	O	O	B-T081
was	O	O	O
found	O	O	O
in	O	O	O
3	O	O	O
cases	O	O	B-T077
(	O	O	O
1.9	O	O	O
%	O	O	O
from	O	O	O
the	O	O	O
whole	O	O	O
series	O	O	O
):	O	O	O
1	O	O	O
each	O	O	O
with	O	O	O
complete	O	O	B-T033
hearing	O	O	I-T033
loss	O	O	I-T033
(	O	O	O
GR	O	O	B-T170
Class	O	O	I-T170
I	O	O	I-T170
before	O	O	O
and	O	O	O
V	O	O	B-T170
after	O	O	O
)	O	O	O
,	O	O	O
hemifacial	O	O	B-T033
spasm	O	O	I-T033
(	O	O	O
persistent	O	O	B-T079
but	O	O	O
alleviated	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
dysgeusia	O	O	B-T033
.	O	O	O

CONCLUSIONS	O	O	O
Acute	O	O	B-T079
effects	O	O	B-T080
after	O	O	O
radiosurgery	O	O	B-T061
for	O	O	O
VS	O	O	B-T191
are	O	O	O
not	O	O	O
rare	O	O	O
.	O	O	O

They	O	O	O
concern	O	O	O
predominantly	O	O	O
de	O	O	B-T078
novo	O	O	I-T078
vertigo	O	O	B-T184
and	O	O	O
gait	O	O	B-T033
disturbance	O	O	I-T033
and	O	O	O
the	O	O	O
exacerbation	O	O	B-T033
of	O	O	O
preexistent	O	O	O
hearing	O	O	B-T033
loss	O	O	I-T033
.	O	O	O

In	O	O	O
de	O	O	B-T078
novo	O	O	I-T078
vestibular	O	O	B-T030
symptom	O	O	B-T184
s	O	O	O
,	O	O	O
a	O	O	O
vestibular	O	O	O
dose	O	O	B-T081
of	O	O	O
more	O	O	O
than	O	O	O
8	O	O	O
Gy	O	O	O
is	O	O	O
thought	O	O	O
to	O	O	O
play	O	O	O
a	O	O	O
role	O	O	O
.	O	O	O

In	O	O	O
most	O	O	O
cases	O	O	B-T077
,	O	O	O
none	O	O	O
of	O	O	O
these	O	O	O
effects	O	O	B-T080
are	O	O	O
permanent	O	O	O
,	O	O	O
and	O	O	O
they	O	O	O
will	O	O	O
ultimately	O	O	O
improve	O	O	O
or	O	O	O
disappear	O	O	O
with	O	O	O
steroid	O	O	B-T061
therapy	O	O	I-T061
.	O	O	O

Permanent	O	O	O
AREs	O	O	B-T037
remain	O	O	O
very	O	O	O
rare	O	O	B-T080
.	O	O	O

-DOCSTART- (27903410)

Long-chain	O	O	B-T109
n-3	O	O	I-T109
PUFA	O	O	I-T109
supplied	O	O	B-T052
by	O	O	O
the	O	O	O
usual	O	O	B-T080
diet	O	O	B-T168
decrease	O	O	B-T081
plasma	O	O	B-T116
stearoyl-CoA	O	O	I-T116
desaturase	O	O	I-T116
index	O	O	B-T170
in	O	O	O
non-hypertriglyceridemic	O	O	B-T033
older	O	O	B-T098
adults	O	O	I-T098
at	O	O	O
high	O	O	O
vascular	O	O	B-T023
risk	O	O	O

The	O	O	O
activity	O	O	B-T044
of	O	O	O
stearoyl-CoA	O	O	B-T116
desaturase-1	O	O	I-T116
(	O	O	O
SCD1	O	O	B-T116
)	O	O	O
,	O	O	O
the	O	O	O
central	O	O	B-T116
enzyme	O	O	I-T116
in	O	O	O
the	O	O	O
synthesis	O	O	B-T052
of	O	O	O
monounsaturated	O	O	B-T109
fatty	O	O	I-T109
acids	O	O	I-T109
(	O	O	O
MUFA	O	O	B-T109
)	O	O	O
,	O	O	O
has	O	O	O
been	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
de	O	O	B-T078
novo	O	O	I-T078
lipogenesis	O	O	B-T040
.	O	O	O

In	O	O	O
experimental	O	O	B-T170
models	O	O	I-T170
SCD1	O	O	B-T116
is	O	O	O
down-regulated	O	O	B-T044
by	O	O	O
polyunsaturated	O	O	B-T109
fatty	O	O	I-T109
acids	O	O	I-T109
(	O	O	O
PUFA	O	O	B-T109
)	O	O	O
,	O	O	O
but	O	O	O
clinical	O	O	B-T062
studies	O	O	I-T062
are	O	O	O
scarce	O	O	O
.	O	O	O

The	O	O	O
effect	O	O	B-T080
of	O	O	O
long-chain	O	O	B-T109
n-3	O	O	I-T109
PUFA	O	O	I-T109
(	O	O	O
LCn-3PUFA	O	O	B-T109
)	O	O	O
supplied	O	O	B-T052
by	O	O	O
the	O	O	O
regular	O	O	B-T168
diet	O	O	I-T168
,	O	O	O
in	O	O	O
the	O	O	O
absence	O	O	B-T169
of	O	O	O
fatty	O	O	B-T168
fish	O	O	I-T168
or	O	O	O
fish	O	O	B-T168
oil	O	O	I-T168
supplementation	O	O	B-T168
,	O	O	I-T168
remains	O	O	O
to	O	O	O
be	O	O	O
explored	O	O	O
.	O	O	O

We	O	O	O
related	O	O	B-T080
1-y	O	O	O
changes	O	O	B-T169
in	O	O	O
plasma	O	O	B-T116
SCD1	O	O	I-T116
index	O	O	B-T170
,	O	O	O
as	O	O	O
assessed	O	O	B-T052
by	O	O	O
the	O	O	O
C16:1n-7	O	O	B-T109
/	O	O	O
C16:0	O	O	B-T109
ratio	O	O	B-T081
,	O	O	O
to	O	O	O
both	O	O	O
adiposity	O	O	B-T032
traits	O	O	B-T032
and	O	O	O
nutrient	O	O	B-T033
intake	O	O	I-T033
changes	O	O	O
in	O	O	O
a	O	O	O
sub-cohort	O	O	B-T098
(	O	O	O
n	O	O	O
=	O	O	O
243	O	O	O
)	O	O	O
of	O	O	O
non-hypertriglyceridemic	O	O	B-T033
subjects	O	O	B-T098
of	O	O	O
the	O	O	O
PREDIMED	O	O	B-T062
(	O	O	I-T062
PREvenciÃ³n	O	O	I-T062
con	O	O	I-T062
DIeta	O	O	I-T062
MEDiterranea	O	O	I-T062
)	O	O	I-T062
trial	O	O	I-T062
.	O	O	O

After	O	O	O
adjustment	O	O	O
for	O	O	O
confounders	O	O	O
,	O	O	O
including	O	O	O
changes	O	O	B-T169
in	O	O	O
fasting	O	O	B-T033
triglycerides	O	O	B-T109
,	O	O	O
plasma	O	O	B-T116
SCD1	O	O	I-T116
index	O	O	B-T170
increased	O	O	B-T081
in	O	O	O
parallel	O	O	O
with	O	O	O
body	O	O	B-T032
weight	O	O	I-T032
(	O	O	O
0.221	O	O	O
[	O	O	O
95	O	O	O
%	O	O	O
confidence	O	O	B-T081
interval	O	O	I-T081
,	O	O	O
0.021	O	O	O
to	O	O	O
0.422	O	O	O
]	O	O	O
,	O	O	O
P	O	O	O
=	O	O	O
0.031	O	O	O
)	O	O	O
and	O	O	O
BMI	O	O	B-T201
(	O	O	O
0.115	O	O	O
[	O	O	O
0.027	O	O	O
to	O	O	O
0.202	O	O	O
]	O	O	O
,	O	O	O
P	O	O	O
=	O	O	O
0.011	O	O	O
)	O	O	O
.	O	O	O

Additionally	O	O	O
,	O	O	O
dietary	O	O	B-T168
LCn-3PUFA	O	O	B-T109
(	O	O	O
but	O	O	O
not	O	O	O
MUFA	O	O	B-T109
or	O	O	O
plant-derived	O	O	B-T109
PUFA	O	O	I-T109
)	O	O	O
were	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
decreased	O	O	B-T081
plasma	O	O	B-T116
SCD1	O	O	I-T116
index	O	O	B-T170
(	O	O	O
-0.544	O	O	O
[	O	O	O
-1.044	O	O	O
to	O	O	O
-0.043	O	O	O
]	O	O	O
,	O	O	O
P	O	O	O
=	O	O	O
0.033	O	O	O
,	O	O	O
for	O	O	O
each	O	O	O
1	O	O	O
g/d-	O	O	O
increase	O	O	B-T169
in	O	O	O
LCn-3PUFA	O	O	O
)	O	O	O
.	O	O	O

No	O	O	O
associations	O	O	B-T080
were	O	O	O
found	O	O	O
for	O	O	O
other	O	O	O
food	O	O	B-T168
groups	O	O	B-T078
,	O	O	O
but	O	O	O
there	O	O	O
was	O	O	O
a	O	O	O
trend	O	O	O
for	O	O	O
fatty	O	O	B-T168
fish	O	O	I-T168
intake	O	O	B-T169
(	O	O	O
-0.083	O	O	O
[	O	O	O
-0.177	O	O	O
to	O	O	O
0.012	O	O	O
]	O	O	O
,	O	O	O
P	O	O	O
=	O	O	O
0.085	O	O	O
,	O	O	O
for	O	O	O
each	O	O	O
10	O	O	O
g/d-	O	O	O
increase	O	O	B-T169
)	O	O	O
.	O	O	O

Our	O	O	O
data	O	O	B-T078
add	O	O	O
clinical	O	O	B-T080
evidence	O	O	B-T078
on	O	O	O
the	O	O	O
down-regulation	O	O	B-T044
of	O	O	O
plasma	O	O	B-T116
SCD1	O	O	I-T116
index	O	O	B-T170
by	O	O	O
LCn-3PUFA	O	O	B-T109
in	O	O	O
the	O	O	O
context	O	O	B-T078
of	O	O	O
realistic	O	O	O
changes	O	O	B-T169
in	O	O	O
fish	O	O	B-T013
consumption	O	O	B-T052
in	O	O	O
the	O	O	O
customary	O	O	B-T080
,	O	O	O
non-supplemented	O	O	B-T033
diet	O	O	B-T168
.	O	O	O

http://www	O	O	O
.	O	O	O

Controlled-trials.com/ISRCTN35739639	O	O	O
.	O	O	O

-DOCSTART- (27905023)

Distinct	O	O	B-T025
cortical	O	O	I-T025
and	O	O	I-T025
sub-cortical	O	O	I-T025
neurogenic	O	O	I-T025
domains	O	O	I-T025
for	O	O	O
GABAergic	O	O	B-T043
interneuron	O	O	B-T025
precursor	O	O	B-T078
transcription	O	O	B-T116
factors	O	O	I-T116
NKX2.1	O	O	B-T116
,	O	O	O
OLIG2	O	O	B-T116
and	O	O	O
COUP-TFII	O	O	B-T116
in	O	O	O
early	O	O	O
fetal	O	O	B-T169
human	O	O	B-T016
telencephalon	O	O	O

The	O	O	O
extent	O	O	O
of	O	O	O
similarities	O	O	B-T080
and	O	O	O
differences	O	O	B-T080
between	O	O	O
cortical	O	O	B-T043
GABAergic	O	O	I-T043
interneuron	O	O	I-T043
generation	O	O	I-T043
in	O	O	O
rodent	O	O	B-T015
and	O	O	O
primate	O	O	B-T015
telencephalon	O	O	B-T018
remains	O	O	O
contentious	O	O	O
.	O	O	O

We	O	O	O
examined	O	O	O
expression	O	O	B-T045
of	O	O	O
three	O	O	O
interneuron	O	O	B-T025
precursor	O	O	B-T078
transcription	O	O	B-T116
factors	O	O	I-T116
,	O	O	O
alongside	O	O	O
other	O	O	O
markers	O	O	B-T201
,	O	O	O
using	O	O	O
immunohistochemistry	O	O	B-T060
on	O	O	O
8	O	O	O
-	O	O	O
12	O	O	O
post-conceptional	O	O	B-T032
weeks	O	O	I-T032
(	O	O	O
PCW	O	O	B-T032
)	O	O	O
human	O	O	B-T016
telencephalon	O	O	B-T018
sections	O	O	O
.	O	O	O

NKX2.1	O	O	B-T116
,	O	O	O
OLIG2	O	O	B-T116
,	O	O	O
and	O	O	O
COUP-TFII	O	O	B-T116
expression	O	O	B-T045
occupied	O	O	O
distinct	O	O	O
(	O	O	O
although	O	O	O
overlapping	O	O	O
)	O	O	O
neurogenic	O	O	B-T025
domains	O	O	I-T025
which	O	O	O
extended	O	O	O
into	O	O	O
the	O	O	O
cortex	O	O	B-T023
and	O	O	O
revealed	O	O	O
three	O	O	O
CGE	O	O	B-T018
compartments	O	O	I-T018
:	O	O	O
lateral	O	O	B-T082
,	O	O	O
medial	O	O	B-T082
,	O	O	O
and	O	O	O
ventral	O	O	B-T082
.	O	O	O

NKX2.1	O	O	B-T116
expression	O	O	B-T045
was	O	O	O
very	O	O	O
largely	O	O	O
confined	O	O	O
to	O	O	O
the	O	O	O
MGE	O	O	B-T018
,	O	O	O
medial	O	O	B-T082
CGE	O	O	B-T018
,	O	O	O
and	O	O	O
ventral	O	O	B-T082
septum	O	O	B-T023
confirming	O	O	O
that	O	O	O
,	O	O	O
at	O	O	O
this	O	O	O
developmental	O	O	B-T079
stage	O	O	I-T079
,	O	O	O
interneuron	O	O	B-T025
generation	O	O	O
from	O	O	O
NKX2.1	O	O	O
+	O	O	O
precursor	O	O	B-T078
s	O	O	O
closely	O	O	O
resembles	O	O	O
the	O	O	O
process	O	O	O
observed	O	O	O
in	O	O	O
rodents	O	O	B-T015
.	O	O	O

OLIG2	O	O	B-T116
immunoreactivity	O	O	B-T044
was	O	O	O
observed	O	O	O
in	O	O	O
GABAergic	O	O	B-T025
cells	O	O	I-T025
of	O	O	O
the	O	O	O
proliferative	O	O	B-T043
zones	O	O	B-T082
of	O	O	O
the	O	O	O
MGE	O	O	B-T018
and	O	O	O
septum	O	O	B-T023
,	O	O	O
but	O	O	O
not	O	O	O
necessarily	O	O	O
co-expressed	O	O	O
with	O	O	O
NKX2.1	O	O	B-T116
,	O	O	O
and	O	O	O
OLIG2	O	O	O
expression	O	O	B-T045
was	O	O	O
also	O	O	O
extensively	O	O	O
seen	O	O	O
in	O	O	O
the	O	O	O
LGE	O	O	B-T018
,	O	O	O
CGE	O	O	B-T018
,	O	O	O
and	O	O	O
cortex	O	O	B-T023
.	O	O	O

At	O	O	O
8	O	O	O
PCW	O	O	B-T032
,	O	O	O
OLIG2	O	O	B-T116
+	O	O	O
cells	O	O	B-T025
were	O	O	O
only	O	O	O
present	O	O	O
in	O	O	O
the	O	O	O
medial	O	O	B-T082
and	O	O	O
anterior	O	O	B-T082
cortical	O	O	B-T023
wall	O	O	I-T023
suggesting	O	O	O
a	O	O	O
migratory	O	O	B-T169
pathway	O	O	B-T077
for	O	O	O
interneuron	O	O	B-T025
precursor	O	O	B-T078
s	O	O	O
via	O	O	O
the	O	O	O
septum	O	O	B-T023
into	O	O	O
the	O	O	O
medial	O	O	O
cortex	O	O	B-T023
.	O	O	O

By	O	O	O
12	O	O	O
PCW	O	O	B-T032
,	O	O	O
OLIG2	O	O	B-T116
+	O	O	O
cells	O	O	B-T025
were	O	O	O
present	O	O	O
throughout	O	O	O
the	O	O	O
cortex	O	O	B-T023
and	O	O	O
many	O	O	O
were	O	O	O
actively	O	O	O
dividing	O	O	B-T169
but	O	O	O
without	O	O	O
co-expressing	O	O	O
cortical	O	O	B-T023
progenitor	O	O	B-T025
markers	O	O	B-T201
.	O	O	O

Dividing	O	O	O
COUP-TFII	O	O	B-T116
+	O	O	O
progenitor	O	O	B-T025
cells	O	O	I-T025
were	O	O	O
localized	O	O	B-T082
to	O	O	O
ventral	O	O	B-T082
CGE	O	O	B-T018
as	O	O	O
previously	O	O	O
described	O	O	O
but	O	O	O
were	O	O	O
also	O	O	O
numerous	O	O	O
in	O	O	O
adjacent	O	O	O
ventral	O	O	O
cortex	O	O	B-T023
;	O	O	O
in	O	O	O
both	O	O	O
the	O	O	O
cases	O	O	O
,	O	O	O
COUP-TFII	O	O	O
was	O	O	O
co-expressed	O	O	O
with	O	O	O
PAX6	O	O	B-T116
in	O	O	O
proliferative	O	O	B-T043
zones	O	O	B-T082
and	O	O	O
TBR1	O	O	B-T116
or	O	O	O
calretinin	O	O	B-T116
in	O	O	O
post-	O	O	O
mitotic	O	O	B-T080
cortical	O	O	B-T025
neurons	O	O	I-T025
.	O	O	O

Thus	O	O	O
COUP-TFII	O	O	B-T116
+	O	O	O
progenitors	O	O	B-T025
gave	O	O	O
rise	O	O	O
to	O	O	O
pyramidal	O	O	B-T025
cells	O	O	I-T025
,	O	O	O
but	O	O	O
also	O	O	O
interneurons	O	O	B-T025
which	O	O	O
not	O	O	O
only	O	O	O
migrated	O	O	B-T169
posteriorly	O	O	O
into	O	O	O
the	O	O	O
cortex	O	O	B-T023
from	O	O	O
ventral	O	O	B-T082
CGE	O	O	B-T018
but	O	O	O
also	O	O	O
anteriorly	O	O	B-T082
via	O	O	O
the	O	O	O
LGE	O	O	B-T018
.	O	O	O

-DOCSTART- (27905324)

Primary	O	O	B-T191
neuroendocrine	O	O	I-T191
carcinoma	O	O	I-T191
of	O	O	O
the	O	O	O
breast	O	O	B-T023
A	O	O	O
single	O	O	B-T041
Center	O	O	I-T041
experience	O	O	I-T041
and	O	O	O
review	O	O	O
of	O	O	O
the	O	O	O
literature	O	O	O

Neuroendocrine	O	O	B-T191
carcinoma	O	O	I-T191
of	O	O	O
the	O	O	O
breast	O	O	B-T023
is	O	O	O
an	O	O	O
extremely	O	O	B-T080
rare	O	O	B-T080
tumor	O	O	B-T191
.	O	O	O

A	O	O	O
standard	O	O	B-T080
treatment	O	O	B-T061
has	O	O	O
yet	O	O	O
to	O	O	O
be	O	O	O
established	O	O	B-T080
because	O	O	O
only	O	O	O
a	O	O	O
few	O	O	O
cases	O	O	B-T077
have	O	O	O
been	O	O	O
reported	O	O	O
in	O	O	O
literature	O	O	B-T170
.	O	O	O

The	O	O	O
authors	O	O	B-T097
report	O	O	O
five	O	O	O
cases	O	O	B-T077
observed	O	O	O
from	O	O	O
January	O	O	B-T080
2007	O	O	O
to	O	O	O
December	O	O	B-T080
2014	O	O	O
and	O	O	O
a	O	O	O
review	O	O	B-T170
of	O	O	I-T170
literature	O	O	I-T170
.	O	O	O

Four	O	O	O
patients	O	O	B-T101
underwent	O	O	O
quadrantectomy	O	O	B-T061
and	O	O	O
in	O	O	O
two	O	O	O
cases	O	O	B-T077
axillary	O	O	B-T061
nodal	O	O	I-T061
dissection	O	O	I-T061
and	O	O	O
only	O	O	O
one	O	O	O
to	O	O	O
mastectomy	O	O	B-T061
with	O	O	O
axillary	O	O	O
nodal	O	O	O
dissection	O	O	O
.	O	O	O

Tumor	O	O	B-T082
size	O	O	I-T082
was	O	O	O
from	O	O	O
T1	O	O	B-T033
to	O	O	O
T2	O	O	B-T033
with	O	O	O
N0	O	O	B-T033
to	O	O	O
N1	O	O	B-T033
,	O	O	O
according	O	O	O
TNM	O	O	B-T185
classification	O	O	I-T185
.	O	O	O

Pathological	O	O	B-T031
specimens	O	O	I-T031
were	O	O	O
stained	O	O	B-T080
with	O	O	O
hematoxylin	O	O	B-T109
and	O	O	O
eosin	O	O	B-T130
and	O	O	O
an	O	O	O
immunohistochemical	O	O	B-T059
panel	O	O	B-T078
of	O	O	O
antibodies	O	O	B-T130
(	O	O	O
Neuron-specific	O	O	B-T129
enolase	O	O	I-T129
,	O	O	O
Chromogranin	O	O	B-T116
,	O	O	O
Synaptophysin	O	O	B-T116
,	O	O	O
Estrogen	O	O	B-T116
and	O	O	O
Progesterone	O	O	B-T116
receptors	O	O	I-T116
,	O	O	O
c-erb	O	O	B-T129
and	O	O	O
Ki-67	O	O	B-T116
)	O	O	O
.	O	O	O

All	O	O	O
cases	O	O	B-T077
showed	O	O	O
markers	O	O	B-T080
positivity	O	O	O
to	O	O	O
Neuron-specific	O	O	B-T129
enolase	O	O	I-T129
,	O	O	O
Chromogranin	O	O	B-T116
,	O	O	O
Synaptophysin	O	O	B-T116
and	O	O	O
Estrogen	O	O	B-T116
and	O	O	O
Progesterone	O	O	B-T116
receptors	O	O	I-T116
were	O	O	O
found	O	O	O
.	O	O	O

Ki-67	O	O	B-T116
was	O	O	O
higher	O	O	O
than	O	O	O
40	O	O	O
%	O	O	O
in	O	O	O
four	O	O	O
patients	O	O	B-T101
.	O	O	O

Adjuvant	O	O	B-T061
chemotherapy	O	O	I-T061
was	O	O	O
administrated	O	O	B-T061
in	O	O	O
patients	O	O	B-T101
with	O	O	O
Ki-67	O	O	B-T116
>	O	O	O
10	O	O	O
%	O	O	O
;	O	O	O
every	O	O	O
patients	O	O	O
were	O	O	O
treated	O	O	B-T169
with	O	O	O
radiotherapy	O	O	B-T061
and	O	O	O
with	O	O	O
hormonal	O	O	B-T061
therapy	O	O	I-T061
too	O	O	O
.	O	O	O

Although	O	O	O
Neuroendocrine	O	O	B-T191
breast	O	O	I-T191
tumor	O	O	I-T191
is	O	O	O
considered	O	O	O
a	O	O	O
distinct	O	O	O
entity	O	O	B-T071
,	O	O	O
the	O	O	O
best	O	O	O
treatment	O	O	B-T061
seems	O	O	O
to	O	O	O
be	O	O	O
correlate	O	O	B-T080
to	O	O	O
the	O	O	O
size	O	O	B-T082
of	O	O	I-T082
tumor	O	O	I-T082
and	O	O	O
to	O	O	O
the	O	O	O
lymph	O	O	B-T023
node	O	O	I-T023
status	O	O	B-T080
and	O	O	O
to	O	O	O
Ki-67	O	O	B-T116
index	O	O	B-T170
like	O	O	O
the	O	O	O
common	O	O	O
breast	O	O	B-T191
cancer	O	O	I-T191
.	O	O	O

Diagnosis	O	O	B-T033
,	O	O	O
Neuroendocrine	O	O	B-T191
breast	O	O	I-T191
carcinoma	O	O	I-T191
.	O	O	O

-DOCSTART- (27905972)

A	O	O	O
new	O	O	O
parametric	O	O	B-T170
model	O	O	I-T170
to	O	O	O
assess	O	O	B-T052
delay	O	O	B-T079
and	O	O	O
compression	O	O	B-T080
of	O	O	O
mortality	O	O	O

A	O	O	O
decrease	O	O	B-T081
in	O	O	O
mortality	O	O	B-T081
across	O	O	O
all	O	O	O
ages	O	O	B-T032
causes	O	O	O
a	O	O	O
shift	O	O	O
of	O	O	O
the	O	O	O
age	O	O	B-T032
pattern	O	O	B-T082
of	O	O	O
mortality	O	O	O
,	O	O	O
or	O	O	O
mortality	O	O	O
delay	O	O	B-T079
,	O	O	O
while	O	O	O
differences	O	O	B-T080
in	O	O	O
the	O	O	O
rate	O	O	B-T081
of	O	O	O
decrease	O	O	O
across	O	O	O
ages	O	O	O
cause	O	O	O
a	O	O	O
change	O	O	O
in	O	O	O
the	O	O	O
shape	O	O	B-T082
of	O	O	O
the	O	O	O
age-at-death	O	O	B-T033
distribution	O	O	B-T169
,	O	O	O
mortality	O	O	O
compression	O	O	B-T080
or	O	O	O
expansion	O	O	B-T169
.	O	O	O

Evidence	O	O	B-T078
exists	O	O	O
for	O	O	O
both	O	O	O
compression	O	O	B-T080
and	O	O	O
delay	O	O	B-T079
of	O	O	O
mortality	O	O	B-T081
.	O	O	O

Existing	O	O	O
parametric	O	O	B-T170
models	O	O	I-T170
to	O	O	O
describe	O	O	O
the	O	O	O
full	O	O	O
age	O	O	B-T032
pattern	O	O	B-T082
of	O	O	O
mortality	O	O	B-T081
are	O	O	O
not	O	O	O
able	O	O	O
to	O	O	O
capture	O	O	O
mortality	O	O	O
delay	O	O	B-T079
versus	O	O	O
mortality	O	O	O
compression	O	O	B-T080
.	O	O	O

More	O	O	O
recent	O	O	O
models	O	O	B-T170
that	O	O	O
assess	O	O	O
delay	O	O	B-T079
versus	O	O	O
compression	O	O	B-T080
mostly	O	O	O
focused	O	O	O
on	O	O	O
the	O	O	O
adult	O	O	B-T100
or	O	O	O
old	O	O	B-T098
ages	O	O	I-T098
alone	O	O	O
and	O	O	O
did	O	O	O
not	O	O	O
distinguish	O	O	O
mortality	O	O	B-T081
compression	O	O	O
below	O	O	O
and	O	O	O
above	O	O	O
the	O	O	O
modal	O	O	B-T032
age	O	O	I-T032
at	O	O	O
death	O	O	B-T033
,	O	O	O
although	O	O	O
they	O	O	O
represent	O	O	O
different	O	O	B-T080
mechanisms	O	O	B-T169
.	O	O	O

This	O	O	O
paper	O	O	B-T170
presents	O	O	O
a	O	O	O
new	O	O	O
parametric	O	O	B-T170
model	O	O	I-T170
that	O	O	O
describes	O	O	O
the	O	O	O
full	O	O	O
age	O	O	B-T032
pattern	O	O	B-T082
of	O	O	O
mortality	O	O	B-T081
and	O	O	O
assesses	O	O	O
compression	O	O	B-T080
-	O	O	O
at	O	O	O
different	O	O	B-T080
stages	O	O	B-T079
of	O	O	I-T079
life	O	O	I-T079
-	O	O	O
and	O	O	O
delay	O	O	B-T079
of	O	O	O
mortality	O	O	O
:	O	O	O
the	O	O	O
CoDe	O	O	B-T170
model	O	O	I-T170
.	O	O	O

The	O	O	O
model	O	O	B-T170
includes	O	O	O
10	O	O	O
parameters	O	O	B-T077
,	O	O	O
of	O	O	O
which	O	O	O
five	O	O	O
are	O	O	O
constant	O	O	B-T080
over	O	O	O
time	O	O	B-T079
.	O	O	O

The	O	O	O
five	O	O	O
time	O	O	B-T079
-varying	O	O	O
parameters	O	O	B-T077
reflect	O	O	O
delay	O	O	B-T079
of	O	O	O
mortality	O	O	B-T081
and	O	O	O
compression	O	O	B-T080
of	O	O	O
mortality	O	O	O
in	O	O	O
infancy	O	O	B-T079
,	O	O	O
adolescence	O	O	B-T079
,	O	O	O
young	O	O	B-T100
adulthood	O	O	I-T100
,	O	O	O
late	O	O	B-T079
adulthood	O	O	I-T079
,	O	O	O
and	O	O	O
old	O	O	B-T098
age	O	O	I-T098
.	O	O	O

The	O	O	O
model	O	O	B-T170
describes	O	O	O
infant	O	O	B-T100
and	O	O	O
background	O	O	O
mortality	O	O	B-T081
by	O	O	O
two	O	O	O
simple	O	O	O
functions	O	O	B-T169
,	O	O	O
uses	O	O	O
a	O	O	O
mixed	O	O	B-T081
logistic	O	O	I-T081
model	O	O	I-T081
with	O	O	O
different	O	O	B-T080
slopes	O	O	B-T081
in	O	O	O
adult	O	O	B-T100
,	O	O	O
middle	O	O	B-T079
,	O	O	O
and	O	O	O
old	O	O	B-T098
age	O	O	I-T098
,	O	O	O
and	O	O	O
includes	O	O	O
the	O	O	O
modal	O	O	B-T032
age	O	O	I-T032
at	O	O	O
death	O	O	B-T033
as	O	O	O
a	O	O	O
parameter	O	O	B-T077
to	O	O	O
account	O	O	O
for	O	O	O
the	O	O	O
delay	O	O	B-T079
in	O	O	O
mortality	O	O	O
.	O	O	O

Applying	O	O	O
the	O	O	O
CoDe	O	O	B-T170
model	O	O	I-T170
to	O	O	O
age	O	O	B-T032
-	O	O	O
specific	O	O	B-T080
probabilities	O	O	B-T081
of	O	O	O
death	O	O	B-T033
for	O	O	O
Japanese	O	O	B-T098
,	O	O	O
French	O	O	B-T098
,	O	O	O
American	O	O	B-T098
,	O	O	O
and	O	O	O
Danish	O	O	B-T098
men	O	O	B-T098
and	O	O	O
women	O	O	B-T098
between	O	O	O
1950	O	O	O
and	O	O	O
2010	O	O	O
showed	O	O	O
a	O	O	O
very	O	O	O
good	O	O	O
fit	O	O	O
of	O	O	O
the	O	O	O
full	O	O	O
age	O	O	O
pattern	O	O	B-T082
of	O	O	O
mortality	O	O	B-T081
.	O	O	O

Delay	O	O	B-T079
of	O	O	O
mortality	O	O	B-T081
explained	O	O	O
about	O	O	O
two-thirds	O	O	O
of	O	O	O
the	O	O	O
increase	O	O	B-T169
in	O	O	O
life	O	O	B-T102
expectancy	O	O	I-T102
at	O	O	O
birth	O	O	B-T040
,	O	O	O
whereas	O	O	O
compression	O	O	B-T080
of	O	O	O
mortality	O	O	O
due	O	O	O
to	O	O	O
mortality	O	O	B-T081
declines	O	O	I-T081
in	O	O	O
young	O	O	B-T033
age	O	O	I-T033
explained	O	O	O
about	O	O	O
one-third	O	O	O
.	O	O	O

No	O	O	O
strong	O	O	O
compression	O	O	B-T080
of	O	O	O
mortality	O	O	B-T081
in	O	O	O
late	O	O	B-T079
adulthood	O	O	I-T079
age	O	O	I-T079
was	O	O	O
observed	O	O	O
.	O	O	O

Mortality	O	O	B-T081
compression	O	O	B-T080
in	O	O	O
old	O	O	B-T098
age	O	O	I-T098
has	O	O	O
had	O	O	O
a	O	O	O
small	O	O	O
negative	O	O	O
impact	O	O	O
on	O	O	O
life	O	O	B-T102
expectancy	O	O	I-T102
.	O	O	O

The	O	O	O
CoDe	O	O	B-T170
model	O	O	I-T170
proved	O	O	O
a	O	O	O
valid	O	O	O
instrument	O	O	O
for	O	O	O
describing	O	O	O
the	O	O	O
full	O	O	O
age	O	O	B-T032
pattern	O	O	B-T082
of	O	O	O
mortality	O	O	B-T081
and	O	O	O
for	O	O	O
disentangling	O	O	O
the	O	O	O
effects	O	O	O
of	O	O	O
mortality	O	O	O
delay	O	O	B-T079
and	O	O	O
compression	O	O	B-T080
-	O	O	O
at	O	O	O
different	O	O	B-T080
stages	O	O	B-T079
of	O	O	I-T079
life	O	O	I-T079
-	O	O	O
on	O	O	O
the	O	O	O
increase	O	O	B-T169
in	O	O	O
life	O	O	B-T102
expectancy	O	O	I-T102
.	O	O	O

-DOCSTART- (27906155)

Prevalence	O	O	B-T081
of	O	O	O
Hypothyroidism	O	O	B-T047
in	O	O	O
Andalusia	O	O	B-T083
,	O	O	I-T083
Spain	O	O	I-T083
,	O	O	I-T083
Determined	O	O	O
by	O	O	O
Thyroid	O	O	B-T116
Hormone	O	O	I-T116
Comsumption	O	O	O

Hypothyroidism	O	O	B-T047
is	O	O	O
the	O	O	O
most	O	O	O
common	O	O	O
condition	O	O	O
linked	O	O	O
to	O	O	O
a	O	O	O
hormone	O	O	B-T047
deficiency	O	O	I-T047
,	O	O	O
nevertheless	O	O	O
data	O	O	O
on	O	O	O
its	O	O	O
prevalence	O	O	B-T081
are	O	O	O
scarce	O	O	O
in	O	O	O
Spain	O	O	B-T083
.	O	O	O

For	O	O	O
that	O	O	O
reason	O	O	O
,	O	O	O
we	O	O	O
have	O	O	O
estimated	O	O	O
its	O	O	O
prevalence	O	O	B-T081
through	O	O	O
the	O	O	O
registration	O	O	B-T058
of	O	O	O
patients	O	O	B-T101
who	O	O	O
had	O	O	O
used	O	O	O
thyroid	O	O	B-T116
hormones	O	O	I-T116
in	O	O	O
Andalusia	O	O	B-T083
(	O	O	I-T083
South	O	O	I-T083
Spain	O	O	I-T083
)	O	O	I-T083
.	O	O	O

Data	O	O	O
of	O	O	O
patients	O	O	B-T101
who	O	O	O
had	O	O	O
withdrawn	O	O	O
levothyroxine	O	O	B-T109
under	O	O	O
the	O	O	O
public	O	O	O
system	O	O	O
during	O	O	O
2014	O	O	O
from	O	O	O
the	O	O	O
base	O	O	O
of	O	O	O
the	O	O	O
Andalusian	O	O	B-T058
Health	O	O	I-T058
Service	O	O	I-T058
were	O	O	O
considered	O	O	O
.	O	O	O

Prevalence	O	O	B-T081
were	O	O	O
calculated	O	O	O
with	O	O	O
confidence	O	O	B-T081
intervals	O	O	I-T081
of	O	O	O
95	O	O	O
%	O	O	O
for	O	O	O
each	O	O	O
management	O	O	B-UnknownType
area	O	O	I-UnknownType
,	O	O	O
stratified	O	O	O
by	O	O	O
sex	O	O	B-T032
and	O	O	O
age	O	O	B-T100
groups	O	O	I-T100
,	O	O	O
and	O	O	O
differences	O	O	O
between	O	O	O
them	O	O	O
were	O	O	O
evaluated	O	O	B-T058
.	O	O	O

321,368	O	O	O
people	O	O	B-T098
(	O	O	O
98	O	O	O
%	O	O	O
older	O	O	O
than	O	O	O
18	O	O	O
years	O	O	O
and	O	O	O
83	O	O	O
%	O	O	O
female	O	O	B-T032
)	O	O	O
were	O	O	O
identified	O	O	O
as	O	O	O
levothyroxine	O	O	B-T109
users	O	O	O
and	O	O	O
a	O	O	O
prevalence	O	O	B-T081
of	O	O	O
hypothyroidism	O	O	B-T047
of	O	O	O
3.95	O	O	O
%	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
:	O	O	O
3.94	O	O	O
-	O	O	O
3.96	O	O	O
)	O	O	O
was	O	O	O
estimated	O	O	O
for	O	O	O
the	O	O	O
general	O	O	O
population	O	O	B-T098
.	O	O	O

The	O	O	O
condition	O	O	O
was	O	O	O
more	O	O	O
common	O	O	O
in	O	O	O
females	O	O	B-T032
,	O	O	O
in	O	O	O
the	O	O	O
older	O	O	O
18	O	O	O
years	O	O	O
7.81	O	O	O
%	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
:	O	O	O
7.80	O	O	O
to	O	O	O
7.82	O	O	O
)	O	O	O
compared	O	O	O
to	O	O	O
males	O	O	B-T032
1.75	O	O	O
%	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
:	O	O	O
1.73	O	O	O
-	O	O	O
1.77	O	O	O
)	O	O	O
with	O	O	O
a	O	O	O
ratio	O	O	O
of	O	O	O
4.5-fold	O	O	B-T079
.	O	O	O

It	O	O	O
increases	O	O	O
in	O	O	O
the	O	O	O
population	O	O	B-T098
of	O	O	O
women	O	O	B-T098
older	O	O	O
than	O	O	O
45	O	O	O
years	O	O	O
,	O	O	O
10.32	O	O	O
%	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
:	O	O	O
10.30	O	O	O
-	O	O	O
0.32	O	O	O
)	O	O	O
and	O	O	O
in	O	O	O
the	O	O	O
over	O	O	O
60	O	O	O
years	O	O	O
11.37	O	O	O
%	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
:	O	O	O
11.35	O	O	O
-	O	O	O
11.40	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
prevalence	O	O	B-T081
in	O	O	O
adult	O	O	B-T100
women	O	O	B-T098
in	O	O	O
the	O	O	O
western	O	O	B-T083
provinces	O	O	I-T083
is	O	O	O
7.38	O	O	O
%	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
:	O	O	O
7.36	O	O	O
-	O	O	O
7.40	O	O	O
)	O	O	O
,	O	O	O
in	O	O	O
the	O	O	O
eastern	O	O	B-T083
provinces	O	O	I-T083
8.59	O	O	O
%	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
:	O	O	O
8.57	O	O	O
-	O	O	O
8.62	O	O	O
)	O	O	O
and	O	O	O
in	O	O	O
coastal	O	O	B-T083
areas	O	O	I-T083
6.70	O	O	O
%	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
:	O	O	O
6.68	O	O	O
-	O	O	O
6.72	O	O	O
)	O	O	O
compared	O	O	O
to	O	O	O
the	O	O	O
mountainous	O	O	B-T098
ones	O	O	I-T098
,	O	O	O
which	O	O	O
is	O	O	O
8.91	O	O	O
%	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
:	O	O	O
8.88	O	O	O
-	O	O	O
8.94	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
results	O	O	O
denote	O	O	O
a	O	O	O
high	O	O	B-T081
prevalence	O	O	I-T081
of	O	O	O
hypothyroidism	O	O	B-T047
in	O	O	O
the	O	O	O
adult	O	O	B-T100
population	O	O	B-T098
of	O	O	O
Andalusia	O	O	B-T083
compared	O	O	O
to	O	O	O
the	O	O	O
nearby	O	O	O
countries	O	O	B-T083
,	O	O	O
with	O	O	O
a	O	O	O
clear	O	O	O
increased	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
females	O	O	B-T032
and	O	O	O
age	O	O	B-T032
.	O	O	O

Furthermore	O	O	O
,	O	O	O
the	O	O	O
prevalence	O	O	B-T081
of	O	O	O
the	O	O	O
illness	O	O	B-T184
presents	O	O	O
also	O	O	O
a	O	O	O
geographically-related	O	O	B-UnknownType
variability	O	O	B-T077
.	O	O	O

-DOCSTART- (27909142)

Disease	O	O	B-T047
Activity	O	O	I-T047
and	O	O	O
Increased	O	O	B-T033
Risk	O	O	I-T033
of	O	O	I-T033
Cardiovascular	O	O	B-T046
Death	O	O	I-T046
among	O	O	O
Patients	O	O	B-T101
with	O	O	O
Psoriatic	O	O	O
Arthritis	O	O	O

Recent	O	O	O
studies	O	O	O
indicate	O	O	O
increased	O	O	O
cardiovascular	O	O	B-T047
(	O	O	I-T047
CV	O	O	I-T047
)	O	O	I-T047
morbidity	O	O	I-T047
and	O	O	O
mortality	O	O	B-T046
in	O	O	O
patients	O	O	B-T101
with	O	O	O
psoriatic	O	O	B-T047
arthritis	O	O	I-T047
(	O	O	O
PsA	O	O	B-T047
)	O	O	O
,	O	O	O
but	O	O	O
results	O	O	O
are	O	O	O
inconsistent	O	O	O
.	O	O	O

This	O	O	O
prompted	O	O	O
our	O	O	O
investigation	O	O	O
of	O	O	O
the	O	O	O
mortality	O	O	B-T081
rate	O	O	I-T081
,	O	O	O
cause	O	O	B-T033
of	O	O	I-T033
death	O	O	I-T033
,	O	O	O
and	O	O	O
incidence	O	O	O
of	O	O	O
acute	O	O	O
CV	O	O	B-T033
events	O	O	I-T033
in	O	O	O
patients	O	O	B-T101
from	O	O	O
northern	O	O	B-T082
Sweden	O	O	B-T083
with	O	O	O
PsA.	O	O	O
Patients	O	O	B-T101
with	O	O	O
established	O	O	O
PsA	O	O	B-T047
(	O	O	O
464	O	O	O
)	O	O	O
were	O	O	O
included	O	O	O
.	O	O	O

To	O	O	O
calculate	O	O	O
standardized	O	O	B-T081
mortality	O	O	I-T081
ratio	O	O	I-T081
(	O	O	O
SMR	O	O	B-T081
)	O	O	O
and	O	O	O
standardized	O	O	B-T081
incidence	O	O	I-T081
ratio	O	O	I-T081
(	O	O	O
SIR	O	O	B-T081
)	O	O	O
for	O	O	O
CV	O	O	B-T033
events	O	O	I-T033
,	O	O	O
data	O	O	O
were	O	O	O
extracted	O	O	O
from	O	O	O
the	O	O	O
National	O	O	B-T170
Causes	O	O	I-T170
of	O	O	I-T170
Death	O	O	I-T170
Register	O	O	I-T170
and	O	O	O
the	O	O	O
National	O	O	B-T170
Inpatient	O	O	I-T170
Care	O	O	I-T170
Register	O	O	I-T170
in	O	O	O
Sweden	O	O	B-T083
,	O	O	O
and	O	O	O
compared	O	O	O
with	O	O	O
the	O	O	O
general	O	O	B-T098
population	O	O	I-T098
.	O	O	O

The	O	O	O
study	O	O	O
period	O	O	O
was	O	O	O
1995	O	O	O
-	O	O	O
2011	O	O	O
.	O	O	O

To	O	O	O
study	O	O	O
the	O	O	O
effect	O	O	O
of	O	O	O
inflammatory	O	O	B-T169
activity	O	O	O
,	O	O	O
a	O	O	O
composite	O	O	O
disease	O	O	B-T060
activity	O	O	I-T060
index	O	O	I-T060
(	O	O	O
DAI	O	O	B-T060
)	O	O	O
was	O	O	O
used	O	O	O
.	O	O	O

The	O	O	O
SMR	O	O	B-T081
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
)	O	O	O
for	O	O	O
overall	O	O	B-T081
mortality	O	O	I-T081
and	O	O	O
diseases	O	O	B-T047
of	O	O	I-T047
the	O	O	I-T047
circulatory	O	O	I-T047
system	O	O	I-T047
(	O	O	O
International	O	O	B-T170
Classification	O	O	I-T170
of	O	O	I-T170
Diseases	O	O	I-T170
,	O	O	O
10th	O	O	O
edition	O	O	O
;	O	O	O
I00-I99	O	O	O
)	O	O	O
was	O	O	O
1.22	O	O	O
(	O	O	O
0.89	O	O	O
-	O	O	O
1.63	O	O	O
)	O	O	O
and	O	O	O
1.64	O	O	O
(	O	O	O
1.02	O	O	O
-	O	O	O
2.52	O	O	O
)	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

In	O	O	O
regression	O	O	B-T170
analysis	O	O	I-T170
,	O	O	O
DAI	O	O	B-T060
was	O	O	O
significantly	O	O	O
associated	O	O	O
with	O	O	O
death	O	O	B-T033
(	O	O	O
OR	O	O	O
1.99	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
1.41	O	O	O
-	O	O	O
2.80	O	O	O
)	O	O	O
when	O	O	O
adjusted	O	O	O
for	O	O	O
age	O	O	O
and	O	O	O
sex	O	O	O
(	O	O	O
p	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
remained	O	O	O
significant	O	O	O
after	O	O	O
stratifying	O	O	B-T080
patients	O	O	B-T101
into	O	O	O
the	O	O	O
2	O	O	O
major	O	O	O
causes	O	O	B-T033
of	O	O	I-T033
death	O	O	I-T033
:	O	O	O
diseases	O	O	B-T047
of	O	O	I-T047
the	O	O	I-T047
circulatory	O	O	I-T047
system	O	O	I-T047
and	O	O	O
malignant	O	O	B-T191
neoplasms	O	O	I-T191
.	O	O	O

Peripheral	O	O	B-T047
and	O	O	O
axial	O	O	B-T033
disease	O	O	I-T033
was	O	O	O
associated	O	O	O
with	O	O	O
death	O	O	B-T033
(	O	O	O
OR	O	O	O
4.02	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
1.84	O	O	O
-	O	O	O
8.84	O	O	O
,	O	O	O
p	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
compared	O	O	O
with	O	O	O
peripheral	O	O	B-T047
disease	O	O	I-T047
only	O	O	O
.	O	O	O

The	O	O	O
SIR	O	O	B-T081
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
)	O	O	O
for	O	O	O
a	O	O	O
CV	O	O	B-T033
event	O	O	I-T033
(	O	O	O
myocardial	O	O	B-T047
infarction	O	O	I-T047
or	O	O	O
stroke	O	O	B-T037
)	O	O	O
was	O	O	O
0.597	O	O	O
(	O	O	O
0.40	O	O	O
-	O	O	O
0.86	O	O	O
)	O	O	O
;	O	O	O
this	O	O	O
association	O	O	O
was	O	O	O
only	O	O	O
significant	O	O	O
in	O	O	O
men	O	O	B-T098
.	O	O	O

Patients	O	O	B-T101
with	O	O	O
PsA	O	O	B-T047
had	O	O	O
a	O	O	O
small	O	O	O
but	O	O	O
significant	O	O	O
increase	O	O	O
in	O	O	O
SMR	O	O	B-T081
for	O	O	O
death	O	O	B-T033
due	O	O	O
to	O	O	O
diseases	O	O	B-T047
of	O	O	I-T047
the	O	O	I-T047
circulatory	O	O	I-T047
system	O	O	I-T047
compared	O	O	O
with	O	O	O
the	O	O	O
general	O	O	B-T098
population	O	O	I-T098
.	O	O	O

Among	O	O	O
patients	O	O	B-T101
,	O	O	O
death	O	O	B-T033
was	O	O	O
associated	O	O	O
with	O	O	O
DAI	O	O	B-T060
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
axial	O	O	B-T033
involvement	O	O	I-T033
in	O	O	O
combination	O	O	O
with	O	O	O
peripheral	O	O	B-T047
disease	O	O	I-T047
,	O	O	O
indicating	O	O	O
more	O	O	O
aggressive	O	O	O
disease	O	O	B-T032
phenotypes	O	O	I-T032
.	O	O	O

-DOCSTART- (27910818)

Histomorphometric	O	O	B-T059
and	O	O	O
transcriptome	O	O	B-T086
evaluation	O	O	B-T058
of	O	O	O
early	O	O	O
healing	O	O	B-T033
bone	O	O	I-T033
treated	O	O	B-T061
with	O	O	I-T061
a	O	O	O
novel	O	O	B-T080
human	O	O	B-T031
particulate	O	O	I-T031
dentin	O	O	I-T031
powder	O	O	O

Human	O	O	B-T031
particulate	O	O	I-T031
dentin	O	O	I-T031
(	O	O	O
HPD	O	O	B-T031
)	O	O	O
shows	O	O	O
potential	O	O	B-T080
as	O	O	O
an	O	O	O
alternative	O	O	B-T077
bone	O	O	B-T061
grafting	O	O	I-T061
material	O	O	B-T122
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
mechanism	O	O	B-T169
of	O	O	O
bone	O	O	B-T033
healing	O	O	I-T033
at	O	O	O
the	O	O	O
molecular	O	O	B-T080
level	O	O	B-T080
after	O	O	O
grafting	O	O	B-T061
with	O	O	O
HPD	O	O	B-T031
is	O	O	O
unclear	O	O	O
.	O	O	O

This	O	O	O
study	O	O	B-T062
assessed	O	O	B-T052
the	O	O	O
histological	O	O	B-T169
and	O	O	O
global	O	O	B-T080
gene	O	O	B-T045
expression	O	O	I-T045
of	O	O	O
bone	O	O	B-T024
tissues	O	O	I-T024
grafted	O	O	B-T169
with	O	O	O
HPD	O	O	B-T031
.	O	O	O

The	O	O	O
HPD	O	O	B-T031
was	O	O	O
prepared	O	O	B-T033
to	O	O	O
250	O	O	O
-	O	O	O
500	O	O	O
Âµm	O	O	O
in	O	O	O
size	O	O	O
.	O	O	O

X-ray	O	O	B-T059
diffraction	O	O	I-T059
(	O	O	O
XRD	O	O	B-T059
)	O	O	O
and	O	O	O
energy	O	O	B-T059
dispersive	O	O	I-T059
x-ray	O	O	I-T059
spectroscopy	O	O	I-T059
(	O	O	O
EDX	O	O	B-T059
)	O	O	O
were	O	O	O
performed	O	O	B-T169
to	O	O	O
confirm	O	O	B-T080
the	O	O	O
crystal	O	O	B-T104
structure	O	O	I-T104
,	O	O	O
organic	O	O	B-T109
compound	O	O	I-T109
residues	O	O	B-T077
,	O	O	O
and	O	O	O
surface	O	O	B-T080
morphology	O	O	I-T080
,	O	O	O
respectively	O	O	O
.	O	O	O

Bony	O	O	B-T169
defects	O	O	B-T169
were	O	O	O
created	O	O	B-T052
on	O	O	O
the	O	O	O
heads	O	O	B-T029
of	O	O	O
24	O	O	O
New	O	O	B-T015
Zealand	O	O	I-T015
White	O	O	I-T015
rabbits	O	O	I-T015
.	O	O	O

Sterilized	O	O	B-T080
HPD	O	O	B-T031
was	O	O	O
used	O	O	O
as	O	O	O
the	O	O	O
grafting	O	O	B-T122
material	O	O	I-T122
.	O	O	O

The	O	O	O
quality	O	O	B-T080
and	O	O	O
quantity	O	O	B-T081
of	O	O	O
new	O	O	B-T042
bone	O	O	I-T042
formation	O	O	I-T042
was	O	O	O
evaluated	O	O	B-T058
using	O	O	O
micro-CT	O	O	B-T060
and	O	O	O
histologic	O	O	B-T169
analyses	O	O	B-T062
during	O	O	B-T079
the	O	O	O
8	O	O	O
week	O	O	O
experimental	O	O	B-T080
periods	O	O	B-T079
.	O	O	O

For	O	O	O
microarray	O	O	B-T059
assay	O	O	I-T059
,	O	O	O
bone	O	O	B-T024
tissue	O	O	I-T024
and	O	O	O
blood	O	O	B-T031
samples	O	O	I-T031
were	O	O	O
taken	O	O	O
at	O	O	O
3	O	O	O
,	O	O	O
5	O	O	O
and	O	O	O
7	O	O	O
d	O	O	O
post-implantation	O	O	B-T079
.	O	O	O

The	O	O	O
results	O	O	B-T034
of	O	O	O
XRD	O	O	B-T059
and	O	O	O
EDX	O	O	B-T059
showed	O	O	O
that	O	O	O
HPD	O	O	B-T031
exhibited	O	O	O
physical	O	O	B-T070
and	O	O	O
chemical	O	O	B-T070
properties	O	O	I-T070
similar	O	O	B-T080
to	O	O	O
natural	O	O	B-T169
hydroxyapatite	O	O	B-T197
.	O	O	O

New	O	O	B-T042
bone	O	O	I-T042
formation	O	O	I-T042
was	O	O	O
observed	O	O	B-T169
after	O	O	O
HPD	O	O	B-T031
implantation	O	O	B-T061
compared	O	O	B-T052
to	O	O	O
the	O	O	O
controls	O	O	B-T096
,	O	O	O
as	O	O	O
shown	O	O	O
on	O	O	O
hematoxylin	O	O	B-T059
and	O	O	I-T059
eosin	O	O	I-T059
staining	O	O	I-T059
and	O	O	O
micro-CT	O	O	B-T060
.	O	O	O

The	O	O	O
bone	O	O	B-T032
volume	O	O	I-T032
of	O	O	O
HPD	O	O	B-T031
treated	O	O	B-T169
animals	O	O	B-T008
was	O	O	O
higher	O	O	B-T080
than	O	O	O
that	O	O	O
of	O	O	O
the	O	O	O
control	O	O	B-T096
group	O	O	I-T096
at	O	O	O
all	O	O	O
observation	O	O	B-T062
times	O	O	B-T081
.	O	O	O

Microarray	O	O	B-T059
analysis	O	O	I-T059
showed	O	O	O
that	O	O	O
vascular	O	O	B-T042
development	O	O	I-T042
coupled	O	O	O
with	O	O	O
immune	O	O	B-T169
and	O	O	O
inflammatory	O	O	B-T169
related	O	O	O
genes	O	O	B-T028
were	O	O	O
expressed	O	O	B-T045
in	O	O	O
the	O	O	O
early	O	O	B-T079
healing	O	O	B-T040
stage	O	O	B-T079
.	O	O	O

The	O	O	O
gene	O	O	B-T028
coding	O	O	I-T028
for	O	O	O
the	O	O	O
IL-1	O	O	B-T121
antagonist	O	O	I-T121
,	O	O	O
IL1RN	O	O	B-T028
,	O	O	O
was	O	O	O
expressed	O	O	B-T045
to	O	O	O
inhibit	O	O	B-T044
the	O	O	O
inflammatory	O	O	B-T046
response	O	O	I-T046
,	O	O	O
and	O	O	O
at	O	O	O
the	O	O	O
same	O	O	O
time	O	O	O
,	O	O	O
the	O	O	O
CCL2	O	O	B-T028
gene	O	O	I-T028
was	O	O	O
activated	O	O	B-T052
to	O	O	O
2.3	O	O	O
times	O	O	O
the	O	O	O
normal	O	O	B-T080
level	O	O	B-T080
.	O	O	O

BMP2	O	O	B-T028
,	O	O	O
RUNX2	O	O	B-T028
,	O	O	O
COL1A	O	O	B-T028
,	O	O	O
and	O	O	O
OPN	O	O	B-T028
expression	O	O	B-T045
were	O	O	O
also	O	O	O
up-regulated	O	O	B-T044
.	O	O	O

CCL2	O	O	B-T028
predominated	O	O	B-T080
in	O	O	O
osteoblastogenesis	O	O	B-T043
of	O	O	O
the	O	O	O
HPD	O	O	B-T031
-	O	O	O
treated	O	O	B-T169
bony	O	O	B-T169
defect	O	O	B-T169
in	O	O	O
the	O	O	O
early	O	O	B-T079
stage	O	O	I-T079
of	O	O	O
healing	O	O	B-T040
.	O	O	O

HPD	O	O	B-T031
accelerated	O	O	B-T169
bone	O	O	B-T042
regeneration	O	O	I-T042
and	O	O	O
augmentation	O	O	B-T033
.	O	O	O

These	O	O	O
results	O	O	B-T034
suggested	O	O	B-T078
that	O	O	O
HPD	O	O	B-T031
provided	O	O	B-T052
potential	O	O	B-T080
as	O	O	O
a	O	O	O
bone	O	O	B-T023
graft	O	O	I-T061
resource	O	O	B-T078
during	O	O	B-T079
the	O	O	O
bone	O	O	O
healing	O	O	B-T040
process	O	O	I-T040
.	O	O	O

-DOCSTART- (27913563)

'	O	O	O
You	O	O	O
ca	O	O	O
n't	O	O	O
be	O	O	O
a	O	O	O
person	O	O	B-T098
and	O	O	O
a	O	O	O
docto	O	O	B-T097
r	O	O	O
'	O	O	O
:	O	O	O
the	O	O	O
work-life	O	O	B-T056
balance	O	O	I-T056
of	O	O	O
doctors	O	O	B-T097
in	O	O	O
training	O	O	B-T065
-a	O	O	O
qualitative	O	O	O
study	O	O	O

Investigate	O	O	B-T169
the	O	O	O
work-life	O	O	B-T056
balance	O	O	I-T056
of	O	O	O
doctors	O	O	B-T097
in	O	O	O
training	O	O	B-T065
in	O	O	O
the	O	O	O
UK	O	O	B-T083
from	O	O	O
the	O	O	O
perspectives	O	O	O
of	O	O	O
trainers	O	O	B-T073
and	O	O	O
trainees	O	O	O
.	O	O	O

Qualitative	O	O	B-T080
semistructured	O	O	O
focus	O	O	O
groups	O	O	O
and	O	O	O
interviews	O	O	B-T052
with	O	O	O
trainees	O	O	O
and	O	O	O
trainers	O	O	B-T073
.	O	O	O

Postgraduate	O	O	B-T065
medical	O	O	I-T065
training	O	O	I-T065
in	O	O	O
London	O	O	B-T083
,	O	O	O
Yorkshire	O	O	B-T083
and	O	O	O
Humber	O	O	B-T083
,	O	O	O
Kent	O	O	B-T083
,	O	O	O
Surrey	O	O	B-T083
and	O	O	O
Sussex	O	O	B-T083
,	O	O	O
and	O	O	O
Wales	O	O	B-T083
during	O	O	O
the	O	O	O
junior	O	O	B-T097
doctor	O	O	I-T097
contract	O	O	B-T170
dispute	O	O	B-T054
at	O	O	O
the	O	O	O
end	O	O	O
of	O	O	O
2015	O	O	O
.	O	O	O

Part	O	O	O
of	O	O	O
a	O	O	O
larger	O	O	O
General	O	O	B-T092
Medical	O	O	I-T092
Council	O	O	I-T092
study	O	O	B-T062
about	O	O	O
the	O	O	O
fairness	O	O	O
of	O	O	O
postgraduate	O	O	B-T065
medical	O	O	I-T065
training	O	O	I-T065
.	O	O	O

96	O	O	O
trainees	O	O	O
and	O	O	O
41	O	O	O
trainers	O	O	B-T073
.	O	O	O

Trainees	O	O	O
comprised	O	O	O
UK	O	O	B-T083
graduates	O	O	B-T098
and	O	O	O
International	O	O	B-T097
Medical	O	O	I-T097
Graduates	O	O	I-T097
,	O	O	O
across	O	O	O
all	O	O	O
stages	O	O	O
of	O	O	O
training	O	O	B-T065
in	O	O	O
6	O	O	O
specialties	O	O	B-T091
(	O	O	O
General	O	O	B-T091
Practice	O	O	I-T091
,	O	O	O
Medicine	O	O	B-T091
,	O	O	O
Obstetrics	O	O	B-T091
and	O	O	I-T091
Gynaecology	O	O	I-T091
,	O	O	O
Psychiatry	O	O	B-T091
,	O	O	O
Radiology	O	O	B-T091
,	O	O	O
Surgery	O	O	B-T091
)	O	O	O
and	O	O	O
Foundation	O	O	B-T092
.	O	O	O
Postgraduate	O	O	B-T065
training	O	O	I-T065
was	O	O	O
characterised	O	O	O
by	O	O	O
work-life	O	O	B-T056
imbalance	O	O	I-T056
.	O	O	O

Long	O	O	B-T080
hours	O	O	B-T079
at	O	O	O
work	O	O	B-T057
were	O	O	O
typically	O	O	O
supplemented	O	O	O
with	O	O	O
revision	O	O	B-T079
and	O	O	O
completion	O	O	B-T080
of	O	O	O
the	O	O	O
e-portfolio	O	O	B-T080
.	O	O	O

Trainees	O	O	O
regularly	O	O	O
moved	O	O	O
workplaces	O	O	B-T082
which	O	O	O
could	O	O	O
disrupt	O	O	B-T080
their	O	O	O
personal	O	O	B-UnknownType
lives	O	O	I-UnknownType
and	O	O	O
sometimes	O	O	O
led	O	O	O
to	O	O	O
separation	O	O	B-T068
from	O	O	O
friends	O	O	B-T098
and	O	O	O
family	O	O	B-T099
.	O	O	O

This	O	O	O
made	O	O	O
it	O	O	O
challenging	O	O	O
to	O	O	O
cope	O	O	B-T055
with	O	O	O
personal	O	O	O
pressures	O	O	O
,	O	O	O
the	O	O	O
stresses	O	O	B-T048
of	O	O	O
which	O	O	O
could	O	O	O
then	O	O	O
impinge	O	O	O
on	O	O	O
learning	O	O	B-T041
and	O	O	O
training	O	O	B-T065
,	O	O	O
while	O	O	O
also	O	O	O
leaving	O	O	B-T052
trainees	O	O	O
with	O	O	O
a	O	O	O
lack	O	O	B-T080
of	O	O	O
social	O	O	B-T054
support	O	O	I-T054
outside	O	O	O
work	O	O	O
to	O	O	O
buffer	O	O	O
against	O	O	O
the	O	O	O
considerable	O	O	O
stresses	O	O	O
of	O	O	O
training	O	O	O
.	O	O	O

Low	O	O	B-T080
morale	O	O	B-T033
and	O	O	O
harm	O	O	B-T033
to	O	O	O
well-being	O	O	B-T033
resulted	O	O	O
in	O	O	O
some	O	O	O
trainees	O	O	O
feeling	O	O	B-T041
dehumanised	O	O	B-T054
.	O	O	O

Work-life	O	O	B-T056
imbalance	O	O	I-T056
was	O	O	O
particularly	O	O	O
severe	O	O	B-T080
for	O	O	O
those	O	O	O
with	O	O	O
children	O	O	B-T100
and	O	O	O
especially	O	O	O
women	O	O	B-T098
who	O	O	O
faced	O	O	O
a	O	O	O
lack	O	O	B-T080
of	O	O	O
less-than	O	O	B-T081
-	O	O	O
full-time	O	O	B-T056
positions	O	O	I-T056
and	O	O	O
discriminatory	O	O	B-T041
attitudes	O	O	B-T041
.	O	O	O

Female	O	O	B-T032
trainees	O	O	O
frequently	O	O	O
talked	O	O	B-T056
about	O	O	O
having	O	O	O
to	O	O	O
choose	O	O	B-T052
a	O	O	O
specialty	O	O	B-T091
they	O	O	O
felt	O	O	O
was	O	O	O
more	O	O	O
conducive	O	O	O
to	O	O	O
a	O	O	O
work-life	O	O	B-T056
balance	O	O	I-T056
such	O	O	O
as	O	O	O
General	O	O	B-T091
Practice	O	O	I-T091
.	O	O	O

The	O	O	O
proposed	O	O	O
junior	O	O	B-T097
doctor	O	O	I-T097
contract	O	O	B-T170
was	O	O	O
felt	O	O	O
to	O	O	O
exacerbate	O	O	B-T033
existing	O	O	B-T080
problems	O	O	B-T033
.	O	O	O

A	O	O	O
lack	O	O	B-T080
of	O	O	O
work-life	O	O	B-T056
balance	O	O	I-T056
in	O	O	O
postgraduate	O	O	B-T065
medical	O	O	I-T065
training	O	O	I-T065
negatively	O	O	B-T080
impacted	O	O	B-T169
on	O	O	O
trainees	O	O	O
'	O	O	O
learning	O	O	B-T041
and	O	O	O
well-being	O	O	B-T033
.	O	O	O

Women	O	O	B-T098
with	O	O	O
children	O	O	B-T100
were	O	O	O
particularly	O	O	O
affected	O	O	B-T169
,	O	O	O
suggesting	O	O	O
this	O	O	O
group	O	O	B-T078
would	O	O	O
benefit	O	O	B-T081
the	O	O	O
greatest	O	O	B-T081
from	O	O	O
changes	O	O	B-T169
to	O	O	O
improve	O	O	B-T033
the	O	O	O
work-life	O	O	B-T056
balance	O	O	I-T056
of	O	O	O
trainees	O	O	O
.	O	O	O

-DOCSTART- (27920749)

Reappraisal	O	O	B-T058
Modulates	O	O	O
Attentional	O	O	B-T041
Bias	O	O	I-T041
to	O	O	O
Angry	O	O	B-T041
Faces	O	O	O

Heightened	O	O	O
attentional	O	O	B-T041
bias	O	O	I-T041
to	O	O	O
emotional	O	O	B-T033
information	O	O	B-T078
is	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
main	O	O	O
characteristics	O	O	O
of	O	O	O
disorders	O	O	B-T047
related	O	O	O
to	O	O	O
emotion	O	O	B-T041
dysregulation	O	O	B-T048
such	O	O	O
as	O	O	O
anxiety	O	O	B-T048
,	O	O	O
depression	O	O	B-T048
,	O	O	O
and	O	O	O
substance	O	O	B-T048
abuse	O	O	I-T048
.	O	O	O

Although	O	O	O
reappraisal	O	O	B-T058
,	O	O	O
an	O	O	O
emotion	O	O	B-T041
regulation	O	O	I-T041
strategy	O	O	B-T041
,	O	O	O
is	O	O	O
known	O	O	O
to	O	O	O
effectively	O	O	O
modulate	O	O	O
subjective	O	O	B-T041
experience	O	O	I-T041
of	O	O	O
emotions	O	O	B-T041
,	O	O	O
it	O	O	O
remains	O	O	O
unknown	O	O	O
whether	O	O	O
reappraisal	O	O	O
can	O	O	O
alter	O	O	O
attentional	O	O	B-T041
biases	O	O	I-T041
to	O	O	O
emotional	O	O	B-T033
information	O	O	B-T078
.	O	O	O

In	O	O	O
the	O	O	O
current	O	O	O
research	O	O	B-T062
,	O	O	O
we	O	O	O
investigated	O	O	B-T169
the	O	O	O
influence	O	O	O
of	O	O	O
instruction-induced	O	O	B-T058
state	O	O	I-T058
reappraisal	O	O	I-T058
(	O	O	O
Study	O	O	B-T062
1	O	O	I-T062
)	O	O	O
and	O	O	O
trait	O	O	B-T058
reappraisal	O	O	I-T058
(	O	O	O
Study	O	O	B-T062
2	O	O	I-T062
)	O	O	O
on	O	O	O
attentional	O	O	B-T041
biases	O	O	I-T041
to	O	O	O
happy	O	O	B-T033
and	O	O	O
angry	O	O	B-T041
faces	O	O	O
.	O	O	O

In	O	O	O
Study	O	O	B-T062
1	O	O	I-T062
,	O	O	O
healthy	O	O	B-T080
young	O	O	B-T098
women	O	O	I-T098
were	O	O	O
recruited	O	O	O
and	O	O	O
randomly	O	O	O
assigned	O	O	O
to	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
three	O	O	O
groups	O	O	B-T078
:	O	O	O
up	O	O	B-T078
-	O	O	O
,	O	O	O
down	O	O	B-T078
-	O	O	O
,	O	O	O
and	O	O	O
no-regulation	O	O	B-T078
.	O	O	O

Participants	O	O	B-T098
were	O	O	O
instructed	O	O	O
to	O	O	O
reappraise	O	O	B-T058
their	O	O	O
emotions	O	O	B-T041
to	O	O	O
increase	O	O	O
and	O	O	O
decrease	O	O	O
emotional	O	O	B-T033
experience	O	O	B-T041
while	O	O	O
viewing	O	O	O
an	O	O	O
emotionally	O	O	B-T170
negative	O	O	I-T170
film	O	O	I-T170
clip	O	O	I-T170
.	O	O	O

Attentional	O	O	B-T041
bias	O	O	I-T041
was	O	O	O
assessed	O	O	O
with	O	O	O
a	O	O	O
dot-probe	O	O	B-T061
task	O	O	I-T061
with	O	O	O
pictures	O	O	B-T073
of	O	O	O
angry	O	O	B-T041
and	O	O	O
happy	O	O	B-T041
facial	O	O	B-T033
expressions	O	O	I-T033
.	O	O	O

In	O	O	O
Study	O	O	B-T062
2	O	O	I-T062
,	O	O	O
a	O	O	O
separate	O	O	O
group	O	O	B-T078
of	O	O	O
healthy	O	O	B-T080
young	O	O	B-T098
men	O	O	I-T098
and	O	O	O
women	O	O	B-T098
participated	O	O	O
.	O	O	O

Participants	O	O	B-T098
'	O	O	O
trait	O	O	B-T058
reappraisal	O	O	I-T058
and	O	O	O
suppression	O	O	B-T041
as	O	O	O
well	O	O	O
as	O	O	O
state	O	O	B-T048
and	O	O	O
trait	O	O	B-T033
anxiety	O	O	I-T033
were	O	O	O
assessed	O	O	O
.	O	O	O

A	O	O	O
dot-probe	O	O	B-T061
task	O	O	I-T061
was	O	O	O
completed	O	O	O
by	O	O	O
all	O	O	O
participants	O	O	B-T098
.	O	O	O

Statistical	O	O	B-T170
tests	O	O	I-T170
in	O	O	O
Study	O	O	B-T062
1	O	O	I-T062
revealed	O	O	O
that	O	O	O
participants	O	O	B-T098
who	O	O	O
reappraised	O	O	B-T058
to	O	O	O
decrease	O	O	O
negative	O	O	B-T041
emotions	O	O	I-T041
while	O	O	O
viewing	O	O	O
an	O	O	O
emotionally	O	O	B-T170
negative	O	O	I-T170
film	O	O	I-T170
clip	O	O	I-T170
had	O	O	O
reduced	O	O	O
attentional	O	O	B-T041
bias	O	O	I-T041
to	O	O	O
subsequently	O	O	O
presented	O	O	O
angry	O	O	B-T041
faces	O	O	O
compared	O	O	B-T052
to	O	O	O
participants	O	O	O
who	O	O	O
reappraised	O	O	O
to	O	O	O
increase	O	O	O
negative	O	O	O
emotions	O	O	O
.	O	O	O

Multiple	O	O	B-T170
regression	O	O	I-T170
analyses	O	O	I-T170
in	O	O	O
Study	O	O	B-T062
2	O	O	I-T062
revealed	O	O	O
that	O	O	O
trait	O	O	B-T058
reappraisal	O	O	I-T058
predicted	O	O	O
slower	O	O	O
orienting	O	O	O
toward	O	O	O
angry	O	O	B-T041
faces	O	O	O
,	O	O	O
whereas	O	O	O
state	O	O	B-T048
anxiety	O	O	I-T048
predicted	O	O	O
slower	O	O	O
disengagement	O	O	B-T052
from	O	O	O
angry	O	O	B-T033
faces	O	O	I-T033
.	O	O	O

Interestingly	O	O	O
,	O	O	O
trait	O	O	B-T041
suppression	O	O	I-T041
predicted	O	O	O
slower	O	O	O
disengagement	O	O	B-T052
from	O	O	O
happy	O	O	B-T033
faces	O	O	I-T033
.	O	O	O

Taken	O	O	O
together	O	O	O
,	O	O	O
these	O	O	O
results	O	O	O
suggest	O	O	O
that	O	O	O
both	O	O	O
instruction-induced	O	O	B-T058
state	O	O	I-T058
reappraisal	O	O	I-T058
and	O	O	O
trait	O	O	B-T058
reappraisal	O	O	I-T058
are	O	O	O
linked	O	O	O
to	O	O	O
reduced	O	O	O
attentional	O	O	B-T041
bias	O	O	I-T041
to	O	O	O
negative	O	O	B-T033
information	O	O	B-T078
and	O	O	O
contribute	O	O	O
to	O	O	O
better	O	O	O
understanding	O	O	O
of	O	O	O
how	O	O	O
everyday	O	O	O
emotion	O	O	B-T041
regulation	O	O	I-T041
styles	O	O	O
contribute	O	O	O
to	O	O	O
attentional	O	O	O
processing	O	O	O
of	O	O	O
emotional	O	O	B-T033
information	O	O	O
.	O	O	O

-DOCSTART- (27921269)

Graded	O	O	B-T185
Structure	O	O	I-T185
in	O	O	O
Sexual	O	O	B-T053
Definitions	O	O	B-T170
:	O	O	O
Categorizations	O	O	B-T185
of	O	O	O
Having	O	O	O
"	O	O	O
Had	O	O	B-T033
Sex	O	O	I-T033
"	O	O	O
and	O	O	O
Virginity	O	O	B-T055
Loss	O	O	B-T169
Among	O	O	O
Homosexual	O	O	B-T098
and	O	O	O
Heterosexual	O	O	B-T098
Men	O	O	B-T098
and	O	O	O
Women	O	O	O

Definitions	O	O	B-T170
of	O	O	O
sexual	O	O	B-T053
behavior	O	O	I-T053
display	O	O	O
a	O	O	O
robust	O	O	O
hierarchy	O	O	B-T080
of	O	O	O
agreement	O	O	O
regarding	O	O	O
whether	O	O	O
or	O	O	O
not	O	O	O
acts	O	O	B-T052
should	O	O	O
be	O	O	O
classed	O	O	O
as	O	O	O
,	O	O	O
for	O	O	O
example	O	O	O
,	O	O	O
sex	O	O	B-T040
or	O	O	O
virginity	O	O	B-T055
loss	O	O	B-T169
.	O	O	O

The	O	O	O
current	O	O	O
research	O	O	B-T062
offers	O	O	O
a	O	O	O
theoretical	O	O	B-T078
explanation	O	O	B-T170
for	O	O	O
this	O	O	O
hierarchy	O	O	B-T080
,	O	O	O
proposing	O	O	O
that	O	O	O
sexual	O	O	B-T053
definitions	O	O	B-T170
display	O	O	O
graded	O	O	B-T185
categorical	O	O	I-T185
structure	O	O	I-T185
,	O	O	O
arising	O	O	O
from	O	O	O
goodness	O	O	O
of	O	O	O
membership	O	O	B-T055
judgments	O	O	B-T041
.	O	O	O

Moderation	O	O	B-T080
of	O	O	O
this	O	O	O
graded	O	O	B-T185
structure	O	O	I-T185
is	O	O	O
also	O	O	O
predicted	O	O	O
,	O	O	O
with	O	O	O
the	O	O	O
focus	O	O	O
here	O	O	O
on	O	O	O
how	O	O	O
sexual	O	O	B-T053
orientation	O	O	I-T032
identity	O	O	B-T041
affects	O	O	O
sexual	O	O	O
definitions	O	O	B-T170
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
300	O	O	O
18-	O	O	O
to	O	O	O
30-	O	O	O
year	O	O	B-T079
-old	O	O	O
participants	O	O	B-T098
completed	O	O	O
an	O	O	O
online	O	O	B-T170
survey	O	O	I-T170
,	O	O	O
rating	O	O	B-T052
18	O	O	O
behaviors	O	O	B-T053
for	O	O	O
how	O	O	O
far	O	O	O
each	O	O	O
constitutes	O	O	O
having	O	O	O
"	O	O	O
had	O	O	B-T033
sex	O	O	I-T033
"	O	O	O
and	O	O	O
virginity	O	O	B-T055
loss	O	O	B-T169
.	O	O	O

Participants	O	O	B-T098
fell	O	O	O
into	O	O	O
one	O	O	O
of	O	O	O
four	O	O	O
groups	O	O	B-UnknownType
:	O	O	O
heterosexual	O	O	B-T098
male	O	O	B-T098
or	O	O	O
female	O	O	B-T098
,	O	O	O
gay	O	O	B-T098
male	O	O	I-T098
or	O	O	O
lesbian	O	O	B-T098
.	O	O	O

The	O	O	O
predicted	O	O	O
ratings	O	O	B-T052
hierarchy	O	O	B-T080
emerged	O	O	O
,	O	O	O
in	O	O	O
which	O	O	O
bidirectional	O	O	B-T053
genital	O	O	I-T053
acts	O	O	B-T052
were	O	O	O
rated	O	O	B-T052
significantly	O	O	O
higher	O	O	B-T080
than	O	O	O
unidirectional	O	O	B-T053
or	O	O	O
nonpenetrative	O	O	B-T033
contact	O	O	I-T033
,	O	O	O
which	O	O	O
was	O	O	O
in	O	O	O
turn	O	O	O
rated	O	O	O
significantly	O	O	O
higher	O	O	O
than	O	O	O
acts	O	O	O
involving	O	O	O
no	O	O	B-T033
genital	O	O	I-T033
contact	O	O	I-T033
.	O	O	O

Moderation	O	O	B-T080
of	O	O	O
graded	O	O	B-T185
structure	O	O	I-T185
was	O	O	O
also	O	O	O
in	O	O	O
line	O	O	O
with	O	O	O
predictions	O	O	B-T078
.	O	O	O

Compared	O	O	O
to	O	O	O
the	O	O	O
other	O	O	O
groups	O	O	B-UnknownType
,	O	O	O
the	O	O	O
lesbian	O	O	B-UnknownType
group	O	O	I-UnknownType
significantly	O	O	O
upgraded	O	O	O
ratings	O	O	B-T052
of	O	O	O
genital	O	O	B-T053
contact	O	O	I-T053
that	O	O	O
was	O	O	O
either	O	O	O
unidirectional	O	O	B-T053
or	O	O	O
nonpenetrative	O	O	B-T033
.	O	O	O

There	O	O	O
was	O	O	O
also	O	O	O
evidence	O	O	B-T078
of	O	O	O
upgrading	O	O	O
by	O	O	O
the	O	O	O
gay	O	O	B-T098
male	O	O	I-T098
sample	O	O	O
of	O	O	O
anal	O	O	B-T054
intercourse	O	O	I-T054
ratings	O	O	B-T052
.	O	O	O

These	O	O	O
effects	O	O	B-T080
are	O	O	O
theorized	O	O	O
to	O	O	O
reflect	O	O	O
group	O	O	B-UnknownType
-level	O	O	O
variation	O	O	B-T080
in	O	O	O
experience	O	O	B-T041
,	O	O	O
contextual	O	O	B-T041
perspective	O	O	I-T041
,	O	O	O
and	O	O	O
identity	O	O	B-T041
-management	O	O	O
.	O	O	O

The	O	O	O
implications	O	O	B-T078
of	O	O	O
the	O	O	O
findings	O	O	B-T033
in	O	O	O
relation	O	O	O
to	O	O	O
previous	O	O	O
research	O	O	B-T062
are	O	O	O
discussed	O	O	O
.	O	O	O

It	O	O	O
is	O	O	O
suggested	O	O	O
that	O	O	O
a	O	O	O
graded	O	O	B-T185
structure	O	O	I-T185
approach	O	O	O
can	O	O	O
greatly	O	O	O
benefit	O	O	B-T081
future	O	O	O
research	O	O	B-T062
into	O	O	O
sexual	O	O	B-T053
definitions	O	O	B-T170
,	O	O	O
by	O	O	O
permitting	O	O	O
variable	O	O	O
definitions	O	O	O
to	O	O	O
be	O	O	O
predicted	O	O	O
and	O	O	O
explained	O	O	O
,	O	O	O
rather	O	O	O
than	O	O	O
merely	O	O	O
identified	O	O	O
.	O	O	O

-DOCSTART- (27921401)

Effects	O	O	O
of	O	O	O
soybean	O	O	B-T109
isoflavone	O	O	I-T109
on	O	O	O
intestinal	O	O	B-T023
antioxidant	O	O	B-T044
capacity	O	O	I-T044
and	O	O	O
cytokines	O	O	B-T116
in	O	O	O
young	O	O	O
piglets	O	O	B-T015
fed	O	O	B-T052
oxidized	O	O	B-T044
fish	O	O	O
oil	O	O	O

To	O	O	O
investigate	O	O	O
the	O	O	O
effect	O	O	O
of	O	O	O
glycitein	O	O	B-T109
,	O	O	O
a	O	O	O
synthetic	O	O	B-T052
soybean	O	O	B-T109
isoflavone	O	O	I-T109
(	O	O	O
ISF	O	O	B-T109
)	O	O	O
,	O	O	O
on	O	O	O
the	O	O	O
intestinal	O	O	B-T023
antioxidant	O	O	B-T044
capacity	O	O	I-T044
,	O	O	O
morphology	O	O	B-T080
,	O	O	O
and	O	O	O
cytokine	O	O	B-T116
content	O	O	O
in	O	O	O
young	O	O	O
piglets	O	O	B-T015
fed	O	O	B-T052
oxidized	O	O	B-T044
fish	O	O	B-T109
oil	O	O	I-T109
,	O	O	O
72	O	O	O
4-d-old	O	O	O
male	O	O	O
piglets	O	O	O
were	O	O	O
assigned	O	O	O
to	O	O	O
three	O	O	O
treatments	O	O	B-T061
.	O	O	O

The	O	O	O
control	O	O	B-T096
group	O	O	I-T096
was	O	O	O
fed	O	O	B-T052
a	O	O	O
basal	O	O	B-T168
diet	O	O	I-T168
containing	O	O	O
fresh	O	O	B-T080
fish	O	O	B-T109
oil	O	O	I-T109
,	O	O	O
and	O	O	O
the	O	O	O
other	O	O	O
two	O	O	O
groups	O	O	O
received	O	O	O
the	O	O	O
same	O	O	O
diet	O	O	O
except	O	O	O
for	O	O	O
the	O	O	O
substitution	O	O	O
with	O	O	O
the	O	O	O
same	O	O	O
dosage	O	O	B-T081
of	O	O	O
oxidized	O	O	B-T044
fish	O	O	O
oil	O	O	O
alone	O	O	O
or	O	O	O
with	O	O	O
ISF	O	O	B-T109
(	O	O	O
oxidized	O	O	O
fish	O	O	O
oil	O	O	O
plus	O	O	O
ISF	O	O	O
)	O	O	O
.	O	O	O

After	O	O	O
21	O	O	O
d	O	O	O
of	O	O	O
feeding	O	O	B-T052
,	O	O	O
supplementation	O	O	B-T061
of	O	O	O
oxidized	O	O	B-T044
fish	O	O	B-T109
oil	O	O	B-T109
increased	O	O	O
the	O	O	O
levels	O	O	O
of	O	O	O
malondialdehyde	O	O	B-T109
(	O	O	O
MDA	O	O	B-T109
)	O	O	O
,	O	O	O
oxidized	O	O	B-T116
glutathione	O	O	I-T116
(	O	O	O
GSSG	O	O	B-T116
)	O	O	O
,	O	O	O
interleukin-1Î²	O	O	B-T116
(	O	O	O
IL-1Î²	O	O	B-T116
)	O	O	O
,	O	O	O
tumor	O	O	B-T116
necrosis	O	O	I-T116
factor-Î±	O	O	I-T116
(	O	O	O
TNF-Î±	O	O	B-T116
)	O	O	O
,	O	O	O
interleukin-2	O	O	B-T116
(	O	O	O
IL-2	O	O	B-T116
)	O	O	O
,	O	O	O
nuclear	O	O	B-T116
factor	O	O	I-T116
Îº	O	O	I-T116
B	O	O	I-T116
(	O	O	B-T116
NF-ÎºB	O	O	I-T116
)	O	O	O
,	O	O	O
inducible	O	O	B-T116
nitric	O	O	I-T116
oxide	O	O	I-T116
synthase	O	O	I-T116
(	O	O	O
iNOS	O	O	B-T116
)	O	O	O
,	O	O	O
NO	O	O	B-T121
,	O	O	O
and	O	O	O
Caspase-3	O	O	B-T116
in	O	O	O
jejunal	O	O	B-T023
mucosa	O	O	I-T023
,	O	O	O
and	O	O	O
decreased	O	O	O
the	O	O	O
villous	O	O	B-T023
height	O	O	B-T032
in	O	O	O
duodenum	O	O	B-T023
and	O	O	O
the	O	O	O
levels	O	O	O
of	O	O	O
secretory	O	O	B-T116
immunoglobulin	O	O	I-T116
A	O	O	I-T116
(	O	O	B-T116
sIgA	O	O	I-T116
)	O	O	O
and	O	O	O
IL-4	O	O	B-T116
in	O	O	O
the	O	O	O
jejunal	O	O	O
mucosa	O	O	O
compared	O	O	O
with	O	O	O
supplementation	O	O	O
with	O	O	O
fresh	O	O	B-T080
oil	O	O	O
.	O	O	O

The	O	O	O
addition	O	O	O
of	O	O	O
oxidized	O	O	B-T044
fish	O	O	B-T109
oil	O	O	I-T109
plus	O	O	O
ISF	O	O	B-T109
partially	O	O	O
alleviated	O	O	O
this	O	O	O
negative	O	O	O
effect	O	O	O
.	O	O	O

The	O	O	O
addition	O	O	O
of	O	O	O
oxidized	O	O	B-T044
fish	O	O	B-T109
oil	O	O	I-T109
plus	O	O	O
ISF	O	O	B-T109
increased	O	O	O
the	O	O	O
villous	O	O	B-T023
height	O	O	B-T032
and	O	O	O
levels	O	O	O
of	O	O	O
sIgA	O	O	B-T116
and	O	O	O
IL-4	O	O	B-T116
in	O	O	O
jejunal	O	O	B-T023
mucosa	O	O	I-T023
,	O	O	O
but	O	O	O
decreased	O	O	O
the	O	O	O
levels	O	O	O
of	O	O	O
IL-1Î²	O	O	B-T116
and	O	O	O
IL-2	O	O	B-T116
in	O	O	O
jejunal	O	O	O
mucosa	O	O	O
(	O	O	O
P<0.05	O	O	O
)	O	O	O
compared	O	O	O
with	O	O	O
oxidized	O	O	O
fish	O	O	O
oil	O	O	O
.	O	O	O

Collectively	O	O	O
,	O	O	O
these	O	O	O
results	O	O	O
show	O	O	O
that	O	O	O
dietary	O	O	B-T061
supplementation	O	O	I-T061
of	O	O	O
ISF	O	O	B-T109
could	O	O	O
partly	O	O	O
alleviate	O	O	O
the	O	O	O
negative	O	O	O
effect	O	O	O
of	O	O	O
oxidized	O	O	B-T044
fish	O	O	B-T109
oil	O	O	I-T109
by	O	O	O
improving	O	O	O
the	O	O	O
intestinal	O	O	B-T023
morphology	O	O	I-T023
as	O	O	O
well	O	O	O
as	O	O	O
the	O	O	O
antioxidant	O	O	B-T044
capacity	O	O	I-T044
and	O	O	O
immune	O	O	B-T042
function	O	O	I-T042
in	O	O	O
young	O	O	O
piglets	O	O	B-T015
.	O	O	O

-DOCSTART- (27923134)

Evolution	O	O	B-T045
:	O	O	O
Enhanced	O	O	B-T052
Footing	O	O	B-T169
for	O	O	O
Snake	O	O	B-T014
Limb	O	O	O
Development	O	O	O

Two	O	O	O
groups	O	O	O
have	O	O	O
studied	O	O	O
the	O	O	O
loss	O	O	B-T081
of	O	O	O
limbs	O	O	B-T023
in	O	O	O
snake	O	O	B-T014
evolution	O	O	B-T045
by	O	O	O
focusing	O	O	O
on	O	O	O
a	O	O	O
long-distance	O	O	B-T033
cis-acting	O	O	B-T086
enhancer	O	O	I-T086
of	O	O	O
Sonic	O	O	B-T028
Hedgehog	O	O	I-T028
.	O	O	O

They	O	O	O
find	O	O	O
a	O	O	O
progressive	O	O	B-T169
degeneration	O	O	B-T169
of	O	O	O
binding	O	O	B-T087
sites	O	O	I-T087
for	O	O	O
key	O	O	O
transcription	O	O	B-T116
factors	O	O	I-T116
,	O	O	O
mirroring	O	O	O
the	O	O	O
progressive	O	O	O
limblessness	O	O	B-T080
occurring	O	O	B-T052
in	O	O	O
these	O	O	O
reptiles	O	O	B-T014
.	O	O	O

-DOCSTART- (27923790)

Dynamin-related	O	O	B-T116
protein	O	O	I-T116
1	O	O	I-T116
mediates	O	O	B-T169
low	O	O	B-T109
glucose	O	O	I-T109
-	O	O	O
induced	O	O	B-T169
endothelial	O	O	B-T047
dysfunction	O	O	I-T047
in	O	O	O
human	O	O	B-T016
arterioles	O	O	O

Intensive	O	O	O
glycemic	O	O	B-T038
regulation	O	O	I-T038
has	O	O	O
resulted	O	O	O
in	O	O	O
an	O	O	O
increased	O	O	B-T081
incidence	O	O	B-T081
of	O	O	O
hypoglycemia	O	O	B-T047
.	O	O	O

Hypoglycemic	O	O	B-T047
burden	O	O	B-T078
correlates	O	O	O
with	O	O	O
adverse	O	O	B-T169
cardiovascular	O	O	B-T046
complications	O	O	I-T046
and	O	O	O
contributes	O	O	O
acutely	O	O	B-T079
and	O	O	O
chronically	O	O	B-T079
to	O	O	O
endothelial	O	O	B-T047
dysfunction	O	O	I-T047
.	O	O	O

Prior	O	O	O
data	O	O	B-T078
indicate	O	O	O
that	O	O	O
mitochondrial	O	O	B-T033
dysfunction	O	O	I-T033
contributes	O	O	O
to	O	O	O
hypoglycemia	O	O	B-T047
-	O	O	O
induced	O	O	B-T169
endothelial	O	O	B-T047
dysfunction	O	O	I-T047
,	O	O	O
but	O	O	O
the	O	O	O
mechanisms	O	O	B-T169
behind	O	O	O
this	O	O	O
linkage	O	O	B-T169
remain	O	O	O
unknown	O	O	B-T080
.	O	O	O

We	O	O	O
attempt	O	O	O
to	O	O	O
determine	O	O	O
whether	O	O	O
clinically	O	O	B-T080
relevant	O	O	B-T080
low-glucose	O	O	B-T109
(	O	O	O
LG	O	O	B-T109
)	O	O	O
exposures	O	O	B-T080
acutely	O	O	B-T079
induce	O	O	B-T169
endothelial	O	O	B-T047
dysfunction	O	O	I-T047
through	O	O	O
activation	O	O	B-T052
of	O	O	O
the	O	O	O
mitochondrial	O	O	B-T043
fission	O	O	I-T043
process	O	O	I-T043
.	O	O	O

Characterization	O	O	B-T052
of	O	O	O
mitochondrial	O	O	B-T033
morphology	O	O	I-T033
was	O	O	O
carried	O	O	O
out	O	O	O
in	O	O	O
cultured	O	O	B-T169
endothelial	O	O	B-T025
cells	O	O	I-T025
by	O	O	O
using	O	O	O
confocal	O	O	B-T059
microscopy	O	O	I-T059
.	O	O	O

Isolated	O	O	B-T169
human	O	O	B-T016
arterioles	O	O	B-T023
were	O	O	O
used	O	O	O
to	O	O	O
explore	O	O	O
the	O	O	O
effect	O	O	B-T080
LG	O	O	B-T109
-	O	O	O
induced	O	O	B-T169
mitochondrial	O	O	B-T043
fission	O	O	I-T043
has	O	O	O
on	O	O	O
the	O	O	O
formation	O	O	B-T169
of	O	O	O
detrimental	O	O	B-T123
reactive	O	O	I-T123
oxygen	O	O	I-T123
species	O	O	I-T123
(	O	O	O
ROS	O	O	B-T123
)	O	O	O
,	O	O	O
bioavailability	O	O	B-T081
of	O	O	O
nitric	O	O	B-T121
oxide	O	O	I-T121
(	O	O	O
NO	O	O	B-T121
)	O	O	O
,	O	O	O
and	O	O	O
endothelial-dependent	O	O	B-T042
vascular	O	O	I-T042
relaxation	O	O	I-T042
.	O	O	O

Fluorescence	O	O	B-T059
microscopy	O	O	I-T059
was	O	O	O
employed	O	O	O
to	O	O	O
visualize	O	O	O
changes	O	O	B-T169
in	O	O	O
mitochondrial	O	O	B-T026
ROS	O	O	B-T123
and	O	O	O
NO	O	O	B-T121
levels	O	O	B-T080
and	O	O	O
videomicroscopy	O	O	B-T059
applied	O	O	O
to	O	O	O
measure	O	O	B-T081
vasodilation	O	O	B-T042
response	O	O	B-T169
.	O	O	O

Pharmacological	O	O	B-T169
disruption	O	O	B-T169
of	O	O	O
the	O	O	O
profission	O	O	B-T116
protein	O	O	I-T116
Drp1	O	O	B-T116
with	O	O	O
Mdivi-1	O	O	B-T109
during	O	O	O
LG	O	O	B-T109
exposure	O	O	B-T080
reduced	O	O	B-T080
mitochondrial	O	O	B-T043
fragmentation	O	O	I-T043
among	O	O	O
vascular	O	O	B-T023
endothelial	O	O	I-T025
cells	O	O	I-T025
(	O	O	O
LG	O	O	O
:	O	O	O
0.469	O	O	O
;	O	O	O
LG	O	O	O
+	O	O	O
Mdivi-1	O	O	O
:	O	O	O
0.276	O	O	O
;	O	O	O
P	O	O	O
=	O	O	O
0.003	O	O	O
)	O	O	O
,	O	O	O
prevented	O	O	B-T169
formation	O	O	B-T169
of	O	O	O
vascular	O	O	O
ROS	O	O	B-T123
(	O	O	O
LG	O	O	O
:	O	O	O
2.036	O	O	O
;	O	O	O
LG	O	O	O
+	O	O	O
Mdivi-1	O	O	O
:	O	O	O
1.774	O	O	O
;	O	O	O
P	O	O	O
=	O	O	O
0.005	O	O	O
)	O	O	O
,	O	O	O
increased	O	O	B-T081
the	O	O	O
presence	O	O	B-T033
of	O	O	O
NO	O	O	B-T121
(	O	O	O
LG	O	O	O
:	O	O	O
1.352	O	O	O
;	O	O	O
LG	O	O	O
+	O	O	O
Mdivi-1	O	O	O
:	O	O	O
1.502	O	O	O
;	O	O	O
P	O	O	O
=	O	O	O
0.048	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
improved	O	O	B-T033
vascular	O	O	B-T042
dilation	O	O	I-T042
response	O	O	B-T169
to	O	O	O
acetylcholine	O	O	B-T109
(	O	O	O
LG	O	O	O
:	O	O	O
31.6	O	O	O
%	O	O	O
;	O	O	O
LG	O	O	O
+	O	O	O
Mdivi-1	O	O	O
;	O	O	O
78.5	O	O	O
%	O	O	O
at	O	O	O
maximum	O	O	B-T081
dose	O	O	B-T081
;	O	O	O
P	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
.	O	O	O

Additionally	O	O	O
,	O	O	O
decreased	O	O	B-T081
expression	O	O	B-T045
of	O	O	O
Drp1	O	O	B-T116
via	O	O	O
siRNA	O	O	B-T114
knockdown	O	O	B-T063
during	O	O	O
LG	O	O	B-T109
conditions	O	O	B-T080
also	O	O	O
improved	O	O	B-T033
vascular	O	O	B-T042
relaxation	O	O	I-T042
.	O	O	O

Exposure	O	O	B-T080
to	O	O	I-T080
LG	O	O	B-T109
imparts	O	O	O
endothelial	O	O	B-T047
dysfunction	O	O	I-T047
coupled	O	O	B-T169
with	O	O	O
altered	O	O	B-T169
mitochondrial	O	O	B-T026
phenotypes	O	O	B-T032
among	O	O	O
isolated	O	O	B-T169
human	O	O	B-T016
arterioles	O	O	B-T023
.	O	O	O

Disruption	O	O	B-T169
of	O	O	O
Drp1	O	O	B-T116
and	O	O	O
subsequent	O	O	B-T079
mitochondrial	O	O	B-T026
fragmentation	O	O	I-T043
events	O	O	O
prevents	O	O	B-T169
impaired	O	O	B-T169
vascular	O	O	B-T042
dilation	O	O	I-T042
,	O	O	O
restores	O	O	B-T169
mitochondrial	O	O	O
phenotype	O	O	B-T032
,	O	O	O
and	O	O	O
implicates	O	O	O
mitochondrial	O	O	B-T043
fission	O	O	I-T043
as	O	O	O
a	O	O	O
primary	O	O	B-T080
mediator	O	O	B-T080
of	O	O	O
LG	O	O	B-T109
-	O	O	O
induced	O	O	B-T169
endothelial	O	O	B-T025
dysfunction	O	O	I-T047
.NEW	O	O	O
&	O	O	O
NOTEWORTHY	O	O	O
Acute	O	O	B-T079
low-glucose	O	O	B-T109
exposure	O	O	B-T080
induces	O	O	B-T169
mitochondrial	O	O	B-T043
fragmentation	O	O	I-T043
in	O	O	O
endothelial	O	O	B-T025
cells	O	O	I-T025
via	O	O	O
Drp1	O	O	O
and	O	O	O
is	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
impaired	O	O	O
endothelial	O	O	O
function	O	O	B-T043
in	O	O	O
human	O	O	B-T016
arterioles	O	O	B-T023
.	O	O	O

Targeting	O	O	B-T043
of	O	O	O
Drp1	O	O	B-T116
prevents	O	O	B-T169
fragmentation	O	O	B-T043
,	O	O	O
improves	O	O	O
vasofunction	O	O	B-T042
,	O	O	O
and	O	O	O
may	O	O	O
provide	O	O	O
a	O	O	O
therapeutic	O	O	B-T169
target	O	O	B-T169
for	O	O	O
improving	O	O	O
cardiovascular	O	O	B-T046
complications	O	O	I-T046
among	O	O	O
diabetics	O	O	B-T033
.Listen	O	O	O
to	O	O	O
this	O	O	O
article	O	O	O
's	O	O	O
corresponding	O	O	O
podcast	O	O	O
@	O	O	O
http://ajpheart.podbean.com/e/mitochondrial-dynamics-impact-endothelial-function/.	O	O	O

-DOCSTART- (27925180)

A	O	O	O
16	O	O	O
Yin	O	O	B-T028
Yang	O	O	I-T028
gene	O	O	B-T045
expression	O	O	I-T045
ratio	O	O	B-T081
signature	O	O	B-T169
for	O	O	O
ER+	O	O	B-T191
/	O	O	O
node-	O	O	O
breast	O	O	O
cancer	O	O	O

Breast	O	O	B-T191
cancer	O	O	B-T191
is	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
leading	O	O	O
causes	O	O	B-T169
of	O	O	O
cancer	O	O	O
death	O	O	B-T040
in	O	O	O
women	O	O	B-T098
.	O	O	O

It	O	O	O
is	O	O	O
a	O	O	O
complex	O	O	B-T080
and	O	O	O
heterogeneous	O	O	B-T080
disease	O	O	B-T047
with	O	O	O
different	O	O	O
clinical	O	O	B-T080
outcomes	O	O	B-T080
.	O	O	O

Stratifying	O	O	B-T080
patients	O	O	B-T101
into	O	O	O
subgroups	O	O	B-T185
with	O	O	O
different	O	O	O
outcomes	O	O	B-T080
could	O	O	O
help	O	O	O
guide	O	O	O
clinical	O	O	B-T060
decision	O	O	I-T060
making	O	O	I-T060
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
we	O	O	O
used	O	O	O
two	O	O	O
opposing	O	O	O
groups	O	O	B-T078
of	O	O	O
genes	O	O	B-T028
,	O	O	O
Yin	O	O	B-T028
and	O	O	I-T028
Yang	O	O	I-T028
,	O	O	O
to	O	O	O
develop	O	O	O
a	O	O	O
prognostic	O	O	B-T201
expression	O	O	B-T045
ratio	O	O	B-T081
signature	O	O	B-T169
.	O	O	O

Using	O	O	O
the	O	O	O
METABRIC	O	O	B-T170
cohort	O	O	B-T062
we	O	O	O
identified	O	O	O
a16-	O	O	O
gene	O	O	B-T169
signature	O	O	I-T169
capable	O	O	O
of	O	O	O
stratifying	O	O	B-T080
breast	O	O	B-T191
cancer	O	O	I-T191
patients	O	O	B-T101
into	O	O	O
four	O	O	O
risk	O	O	B-T080
levels	O	O	I-T080
with	O	O	O
intention	O	O	O
that	O	O	O
low-risk	O	O	B-T081
patients	O	O	O
would	O	O	O
not	O	O	O
undergo	O	O	O
adjuvant	O	O	B-T169
systemic	O	O	B-T061
therapy	O	O	I-T061
,	O	O	O
intermediate	O	O	B-T082
-	O	O	O
low-risk	O	O	O
patients	O	O	O
will	O	O	O
be	O	O	O
treated	O	O	B-T061
with	O	O	I-T061
hormonal	O	O	B-T061
therapy	O	O	I-T061
only	O	O	O
,	O	O	O
and	O	O	O
intermediate	O	O	O
-high-	O	O	O
and	O	O	O
high-risk	O	O	B-T098
groups	O	O	I-T098
will	O	O	O
be	O	O	O
treated	O	O	O
by	O	O	O
chemotherapy	O	O	B-T061
in	O	O	O
addition	O	O	O
to	O	O	O
the	O	O	O
hormonal	O	O	O
therapy	O	O	O
.	O	O	O

The	O	O	O
16-	O	O	O
gene	O	O	B-T169
signature	O	O	I-T169
for	O	O	O
four	O	O	O
risk	O	O	B-T080
level	O	O	I-T080
stratifications	O	O	B-T185
of	O	O	O
breast	O	O	B-T191
cancer	O	O	I-T191
patients	O	O	B-T101
has	O	O	O
been	O	O	O
validated	O	O	B-T062
using	O	O	O
14	O	O	O
independent	O	O	O
datasets	O	O	B-T170
.	O	O	O

Notably	O	O	O
,	O	O	O
the	O	O	O
low-risk	O	O	B-T081
group	O	O	B-T098
(	O	O	O
n	O	O	O
=	O	O	O
51	O	O	O
)	O	O	O
of	O	O	O
205	O	O	O
estrogen	O	O	B-T191
receptor-positive	O	O	I-T191
and	O	O	O
node	O	O	B-T191
negative	O	O	I-T191
(	O	O	O
ER+	O	O	B-T191
/	O	O	O
node-	O	O	B-T191
)	O	O	O
patients	O	O	B-T101
from	O	O	O
three	O	O	O
different	O	O	O
datasets	O	O	B-T170
who	O	O	O
had	O	O	O
not	O	O	O
had	O	O	O
any	O	O	O
systemic	O	O	O
adjuvant	O	O	B-T061
therapy	O	O	I-T061
had	O	O	O
100	O	O	O
%	O	O	O
15-	O	O	O
year	O	O	B-T079
disease-specific	O	O	B-T081
survival	O	O	I-T081
rate	O	O	I-T081
.	O	O	O

The	O	O	O
Concordance	O	O	B-T170
Index	O	O	I-T170
of	O	O	O
YMR	O	O	B-T060
for	O	O	O
ER+	O	O	B-T191
/	O	O	O
node	O	O	B-T191
negative	O	O	I-T191
patients	O	O	B-T101
is	O	O	O
close	O	O	O
to	O	O	O
the	O	O	O
commercially	O	O	B-T170
available	O	O	O
signatures	O	O	B-T169
.	O	O	O

However	O	O	O
,	O	O	O
YMR	O	O	B-T060
showed	O	O	O
more	O	O	O
significance	O	O	B-T078
(	O	O	O
HR	O	O	B-T081
=	O	O	O
3.7	O	O	O
,	O	O	O
p	O	O	O
=	O	O	O
8.7e-12	O	O	O
)	O	O	O
in	O	O	O
stratifying	O	O	B-T080
ER+	O	O	B-T191
/	O	O	O
node-	O	O	B-T191
subgroup	O	O	B-T185
than	O	O	O
OncotypeDx	O	O	B-T060
(	O	O	O
HR	O	O	O
=	O	O	O
2.7	O	O	O
,	O	O	O
p	O	O	O
=	O	O	O
1.3e-7	O	O	O
)	O	O	O
,	O	O	O
MammaPrint	O	O	B-T059
(	O	O	O
HR	O	O	O
=	O	O	O
2.5	O	O	O
,	O	O	O
p	O	O	O
=	O	O	O
5.8e-7	O	O	O
)	O	O	O
,	O	O	O
rorS	O	O	B-T060
(	O	O	O
HR	O	O	O
=	O	O	O
2.4	O	O	O
,	O	O	O
p	O	O	O
=	O	O	O
1.4e-6	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
NPI	O	O	B-T060
(	O	O	O
HR	O	O	O
=	O	O	O
2.6	O	O	O
,	O	O	O
p	O	O	O
=	O	O	O
1.2e-6	O	O	O
)	O	O	O
.	O	O	O

YMR	O	O	B-T060
signature	O	O	B-T169
may	O	O	O
be	O	O	O
developed	O	O	O
as	O	O	O
a	O	O	O
clinical	O	O	B-T080
tool	O	O	B-T170
to	O	O	O
select	O	O	O
a	O	O	O
subgroup	O	O	B-T185
of	O	O	O
low-risk	O	O	B-T081
ER+	O	O	B-T191
/	O	O	O
node-	O	O	B-T191
patients	O	O	B-T101
who	O	O	O
do	O	O	O
not	O	O	O
require	O	O	O
any	O	O	O
adjuvant	O	O	B-T169
hormonal	O	O	B-T061
therapy	O	O	I-T061
(	O	O	O
AHT	O	O	B-T061
)	O	O	O
.	O	O	O

-DOCSTART- (27925484)

Risk	O	O	B-T033
Factors	O	O	I-T033
Associated	O	O	B-T080
With	O	O	I-T080
Repeated	O	O	B-T169
HIV	O	O	B-T059
Testing	O	O	I-T059
Among	O	O	O
Internet	O	O	B-T073
-Using	O	O	O
Men	O	O	O
Who	O	O	O
Have	O	O	O
Sex	O	O	O
With	O	O	O
Men	O	O	O

Men	O	O	B-T098
who	O	O	I-T098
have	O	O	I-T098
sex	O	O	I-T098
with	O	O	I-T098
men	O	O	I-T098
(	O	O	O
MSM	O	O	B-T098
)	O	O	O
represent	O	O	B-T052
a	O	O	O
disproportionately	O	O	B-T080
impacted	O	O	B-T169
risk	O	O	B-T098
group	O	O	I-T098
for	O	O	O
HIV	O	O	B-T005
incidence	O	O	B-T081
among	O	O	O
at-risk	O	O	B-T080
U.S.	O	O	O
Few	O	O	O
studies	O	O	B-T062
have	O	O	O
identified	O	O	B-T080
risk	O	O	B-T033
factors	O	O	I-T033
associated	O	O	B-T080
with	O	O	I-T080
HIV	O	O	B-T059
testing	O	O	I-T059
frequency	O	O	B-T081
both	O	O	O
within	O	O	B-T082
and	O	O	O
outside	O	O	B-T082
of	O	O	O
traditional	O	O	O
health	O	O	B-T058
care	O	O	I-T058
settings	O	O	I-T058
.	O	O	O

MSM	O	O	B-T098
enrolled	O	O	O
in	O	O	O
a	O	O	O
prospective	O	O	B-T062
cohort	O	O	I-T062
were	O	O	O
mailed	O	O	B-T073
at-home	O	O	B-T074
specimen	O	O	I-T074
collection	O	O	I-T074
kits	O	O	I-T074
and	O	O	O
followed	O	O	B-T079
for	O	O	O
a	O	O	O
year	O	O	B-T079
.	O	O	O

Incidence	O	O	B-T081
density	O	O	I-T081
rate	O	O	I-T081
ratios	O	O	I-T081
(	O	O	O
IDRR	O	O	B-T081
)	O	O	O
of	O	O	O
testing	O	O	B-T169
were	O	O	O
calculated	O	O	B-T052
,	O	O	O
and	O	O	O
generalized	O	O	B-T082
estimating	O	O	B-T081
equations	O	O	B-T077
were	O	O	O
used	O	O	O
to	O	O	O
analyze	O	O	O
the	O	O	O
association	O	O	B-T080
between	O	O	O
HIV	O	O	B-T059
testing	O	O	I-T059
and	O	O	O
behavioral	O	O	B-T053
factors	O	O	B-T169
.	O	O	O

The	O	O	O
incidence	O	O	B-T081
rate	O	O	I-T081
of	O	O	O
testing	O	O	B-T169
was	O	O	O
higher	O	O	B-T080
among	O	O	O
Black	O	O	B-T098
MSM	O	O	B-T098
than	O	O	O
White	O	O	B-T098
MSM	O	O	O
(	O	O	O
IDRR	O	O	B-T081
:	O	O	O
1.3	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
confidence	O	O	B-T081
interval	O	O	I-T081
CI	O	O	B-T081
[	O	O	O
1.1	O	O	O
,	O	O	O
1.5	O	O	O
]	O	O	O
)	O	O	O
and	O	O	O
higher	O	O	O
among	O	O	O
MSM	O	O	O
who	O	O	O
reported	O	O	O
3	O	O	O
+	O	O	O
condomless	O	O	B-T098
anal	O	O	B-T023
intercourse	O	O	I-T098
partners	O	O	I-T098
(	O	O	O
CAI	O	O	B-T098
)	O	O	O
than	O	O	O
MSM	O	O	O
who	O	O	O
reported	O	O	O
no	O	O	B-T033
CAI	O	O	O
(	O	O	O
IDRR	O	O	O
:	O	O	O
1.6	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
[	O	O	O
1.3	O	O	O
,	O	O	O
2.0	O	O	O
]	O	O	O
)	O	O	O
.	O	O	O

Increasing	O	O	B-T169
availability	O	O	B-T169
of	O	O	I-T169
HIV	O	O	B-T059
testing	O	O	I-T059
outside	O	O	B-T082
traditional	O	O	O
health	O	O	B-T058
care	O	O	I-T058
settings	O	O	I-T058
,	O	O	O
including	O	O	O
at-home	O	O	B-T074
testing	O	O	I-T074
kits	O	O	I-T074
,	O	O	O
in	O	O	O
conjunction	O	O	B-T078
with	O	O	O
targeted	O	O	B-T169
behavioral	O	O	B-T053
interventions	O	O	B-T169
and	O	O	O
biomedical	O	O	B-T091
treatment	O	O	B-T061
preventions	O	O	I-T061
is	O	O	O
needed	O	O	O
.	O	O	O

-DOCSTART- (27925527)

nursingstandard.com	O	O	O

1	O	O	O
Nurse	O	O	B-T097
Donna	O	O	O
Wood	O	O	O
has	O	O	O
been	O	O	O
suspended	O	O	B-T169
for	O	O	O
2	O	O	O
months	O	O	B-T079
by	O	O	O
the	O	O	O
Nursing	O	O	B-T094
and	O	O	I-T094
Midwifery	O	O	I-T094
Council	O	O	I-T094
(	O	O	O
NMC	O	O	B-T094
)	O	O	O
for	O	O	O
concealing	O	O	B-T080
the	O	O	O
high	O	O	B-T184
temperature	O	O	I-T184
of	O	O	O
colleague	O	O	B-T097
Pauline	O	O	O
Cafferkey	O	O	O
,	O	O	O
who	O	O	O
later	O	O	O
developed	O	O	O
Ebola	O	O	B-T047
.	O	O	O

Read	O	O	O
more	O	O	O
:	O	O	O
rcni.com/donna-wood	O	O	B-T170
.	O	O	O

-DOCSTART- (27928244)

Theory	O	O	B-T078
of	O	O	I-T078
Mind	O	O	I-T078
in	O	O	O
Adolescents	O	O	B-T100
with	O	O	O
Bipolar	O	O	B-T048
Disorder	O	O	I-T048
in	O	O	O
Euthymic	O	O	B-T048
Phase	O	O	I-T048
:	O	O	O
âUsing	O	O	O
the	O	O	O
Strange	O	O	O
Stories	O	O	O
Test	O	O	O

Objective	O	O	O
:	O	O	O
This	O	O	O
study	O	O	O
evaluated	O	O	B-T058
the	O	O	O
theory	O	O	B-T078
of	O	O	I-T078
mind	O	O	I-T078
(	O	O	O
ToM	O	O	B-T078
)	O	O	O
in	O	O	O
adolescents	O	O	B-T100
diagnosed	O	O	B-T033
with	O	O	O
bipolar	O	O	B-T048
disorder	O	O	I-T048
ââ(BD	O	O	O
)	O	O	O
during	O	O	O
their	O	O	O
euthymic	O	O	B-T048
period	O	O	I-T048
compared	O	O	O
to	O	O	O
a	O	O	O
typically	O	O	B-T078
developing	O	O	I-T078
(	O	O	I-T078
TD	O	O	I-T078
)	O	O	I-T078
group	O	O	B-T078
.â	O	O	O
Method	O	O	O
:	O	O	O
The	O	O	O
BD	O	O	B-T048
group	O	O	O
consisted	O	O	O
of	O	O	O
thirty	O	O	O
11	O	O	O
-	O	O	O
18	O	O	O
year	O	O	O
old	O	O	O
inpatients	O	O	B-T101
in	O	O	O
euthymic	O	O	B-T048
phase	O	O	I-T048
.	O	O	O

The	O	O	O
TD	O	O	B-T078
âgroup	O	O	I-T078
included	O	O	O
30	O	O	O
age	O	O	B-T032
,	O	O	O
gender	O	O	B-T032
,	O	O	O
and	O	O	O
IQ	O	O	B-T032
matched	O	O	O
volunteer	O	O	O
students	O	O	B-T098
.	O	O	O

To	O	O	O
assess	O	O	O
the	O	O	O
diagnosis	O	O	B-T033
and	O	O	O
âcomorbid	O	O	B-T047
disorders	O	O	I-T047
,	O	O	O
we	O	O	O
performed	O	O	O
the	O	O	O
semi-structured	O	O	B-UnknownType
interview	O	O	I-UnknownType
of	O	O	O
the	O	O	O
Kiddie	O	O	B-UnknownType
Schedule	O	O	I-UnknownType
for	O	O	I-UnknownType
Affective	O	O	I-UnknownType
Disorders	O	O	I-UnknownType
âand	O	O	I-UnknownType
Schizophrenia-Present	O	O	I-UnknownType
and	O	O	I-UnknownType
Lifetime	O	O	I-UnknownType
Version	O	O	I-UnknownType
(	O	O	O
K-SADS-PL	O	O	B-UnknownType
)	O	O	O
for	O	O	O
the	O	O	O
BD	O	O	B-T048
adolescents	O	O	B-T100
.	O	O	O

To	O	O	O
âevaluate	O	O	B-T058
the	O	O	O
severity	O	O	O
of	O	O	O
attention	O	O	B-T048
deficit	O	O	I-T048
hyperactivity	O	O	I-T048
disorder	O	O	I-T048
(	O	O	O
ADHD	O	O	B-T048
)	O	O	O
and	O	O	O
mania	O	O	B-T048
,	O	O	O
Conner	O	O	B-T081
's	O	O	I-T081
âParent	O	O	I-T081
Rating	O	O	I-T081
Scale-Revised	O	O	I-T081
version	O	O	I-T081
(	O	O	I-T081
CPRS-R	O	O	I-T081
)	O	O	I-T081
,	O	O	O
and	O	O	O
Young	O	O	B-T170
Mania	O	O	I-T170
Rating	O	O	I-T170
Scale	O	O	I-T170
(	O	O	O
YMRS	O	O	B-T170
)	O	O	O
were	O	O	O
âused	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

Ravens	O	O	B-T170
Progressive	O	O	I-T170
Matrices	O	O	I-T170
was	O	O	O
conducted	O	O	O
to	O	O	O
evaluate	O	O	B-T058
intellectual	O	O	B-T033
ability	O	O	I-T033
in	O	O	O
âthe	O	O	O
both	O	O	O
groups	O	O	B-T078
.	O	O	O

Happe	O	O	B-T170
Strange	O	O	I-T170
Stories	O	O	I-T170
test	O	O	I-T170
was	O	O	O
performed	O	O	O
to	O	O	O
assess	O	O	O
ToM	O	O	B-T078
in	O	O	O
the	O	O	O
participants	O	O	B-T098
.	O	O	O

Data	O	O	B-T078
were	O	O	O
âanalyzed	O	O	O
using	O	O	O
the	O	O	O
independent	O	O	O
t-test	O	O	B-T170
,	O	O	O
analysis	O	O	B-T081
of	O	O	I-T081
covariance	O	O	I-T081
,	O	O	O
and	O	O	O
Pearson	O	O	B-T062
Correlation	O	O	I-T062
analysis	O	O	I-T062
.â	O	O	O
Results	O	O	O
:	O	O	O
The	O	O	O
two	O	O	O
groups	O	O	B-T078
did	O	O	O
not	O	O	O
show	O	O	O
any	O	O	O
differences	O	O	O
in	O	O	O
comprehending	O	O	O
the	O	O	O
stories	O	O	O
;	O	O	O
however	O	O	O
,	O	O	O
the	O	O	O
BD	O	O	B-T048
â	O	O	O
group	O	O	B-T078
's	O	O	I-T078
mentalizing	O	O	B-T053
scores	O	O	I-T053
were	O	O	O
significantly	O	O	O
weaker	O	O	O
than	O	O	O
the	O	O	O
TD	O	O	B-T078
group	O	O	I-T078
(p<0.05).ââ	O	O	O
Conclusion	O	O	O
:	O	O	O
The	O	O	O
ToM	O	O	B-T078
impairments	O	O	B-T169
in	O	O	O
adolescents	O	O	B-T100
with	O	O	O
BD	O	O	O
may	O	O	O
be	O	O	O
explained	O	O	O
as	O	O	O
a	O	O	O
trait	O	O	B-T045
marker	O	O	I-T045
which	O	O	O
may	O	O	O
lead	O	O	O
âto	O	O	O
continuation	O	O	O
of	O	O	O
social	O	O	B-T033
problems	O	O	I-T033
even	O	O	O
during	O	O	O
remissionâ	O	O	B-T046
.â.	O	O	O

-DOCSTART- (27932585)

Structural	O	O	O
and	O	O	O
functional	O	O	O
characterization	O	O	O
of	O	O	O
the	O	O	O
TYW3	O	O	B-T116
/	O	O	O
Taw3	O	O	B-T116
class	O	O	O
of	O	O	O
SAM-dependent	O	O	O
methyltransferases	O	O	O

S-adenosylmethionine	O	O	B-T116
(SAM)-dependent	O	O	I-T116
methyltransferases	O	O	I-T116
regulate	O	O	B-T038
a	O	O	O
wide	O	O	O
range	O	O	O
of	O	O	O
biological	O	O	B-T038
processes	O	O	I-T038
through	O	O	O
the	O	O	O
modification	O	O	B-T044
of	O	O	O
proteins	O	O	B-T116
,	O	O	O
nucleic	O	O	B-T114
acids	O	O	I-T114
,	O	O	O
polysaccharides	O	O	B-T109
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
various	O	O	O
metabolites	O	O	B-T123
.	O	O	O

TYW3	O	O	B-T116
/	O	O	O
Taw3	O	O	B-T116
is	O	O	O
a	O	O	O
SAM-dependent	O	O	B-T116
methyltransferase	O	O	I-T116
responsible	O	O	O
for	O	O	O
the	O	O	O
formation	O	O	O
of	O	O	O
a	O	O	O
tRNA	O	O	B-T045
modification	O	O	I-T045
known	O	O	O
as	O	O	O
wybutosine	O	O	B-T114
and	O	O	O
its	O	O	O
derivatives	O	O	O
that	O	O	O
are	O	O	O
required	O	O	O
for	O	O	O
accurate	O	O	O
decoding	O	O	B-T045
in	O	O	O
protein	O	O	B-T044
synthesis	O	O	I-T044
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
report	O	O	O
the	O	O	O
crystal	O	O	B-T026
structure	O	O	I-T026
of	O	O	O
Taw3	O	O	B-T116
,	O	O	O
a	O	O	O
homolog	O	O	O
of	O	O	O
TYW3	O	O	B-T116
from	O	O	O
Sulfolobus	O	O	B-T194
solfataricus	O	O	I-T194
,	O	O	O
which	O	O	O
revealed	O	O	O
a	O	O	O
novel	O	O	O
Î±/Î²	O	O	B-T044
fold	O	O	I-T044
.	O	O	O

The	O	O	O
sequence	O	O	O
motif	O	O	O
(S/T)xSSCxGR	O	O	O
and	O	O	O
invariant	O	O	O
aspartate	O	O	B-T116
and	O	O	O
histidine	O	O	B-T116
,	O	O	O
conserved	O	O	O
in	O	O	O
TYW3	O	O	B-T116
/	O	O	O
Taw3	O	O	B-T116
,	O	O	O
cluster	O	O	B-T081
to	O	O	O
form	O	O	O
the	O	O	O
catalytic	O	O	B-T067
center	O	O	O
.	O	O	O

These	O	O	O
structural	O	O	B-T116
and	O	O	O
sequence	O	O	B-T087
features	O	O	O
indicate	O	O	O
that	O	O	O
TYW3	O	O	B-T116
/	O	O	O
Taw3	O	O	B-T116
proteins	O	O	O
constitute	O	O	O
a	O	O	O
distinct	O	O	O
class	O	O	O
of	O	O	O
SAM-dependent	O	O	B-T116
methyltransferases	O	O	I-T116
.	O	O	O

Using	O	O	O
site-directed	O	O	B-T045
mutagenesis	O	O	I-T045
along	O	O	O
with	O	O	O
in	O	O	B-T059
vivo	O	O	I-T059
complementation	O	O	I-T059
assays	O	O	B-T059
combined	O	O	O
with	O	O	O
mass	O	O	B-T059
spectrometry	O	O	I-T059
as	O	O	O
well	O	O	O
as	O	O	O
ligand	O	O	B-T044
docking	O	O	I-T044
and	O	O	O
cofactor	O	O	B-T044
binding	O	O	I-T044
assays	O	O	O
,	O	O	O
we	O	O	O
have	O	O	O
identified	O	O	O
the	O	O	O
active	O	O	B-T169
site	O	O	I-T169
of	O	O	O
TYW3	O	O	B-T116
and	O	O	O
residues	O	O	O
essential	O	O	O
for	O	O	O
cofactor	O	O	O
binding	O	O	O
and	O	O	O
methyltransferase	O	O	B-T044
activity	O	O	I-T044
.	O	O	O

-DOCSTART- (27933285)

Developmental	O	O	B-T080
Profile	O	O	B-T059
and	O	O	O
Diagnoses	O	O	B-T062
in	O	O	O
Children	O	O	B-T100
Presenting	O	O	O
with	O	O	O
Motor	O	O	O
Stereotypies	O	O	O

Motor	O	O	B-T033
stereotypies	O	O	I-T033
represent	O	O	O
a	O	O	O
typical	O	O	O
example	O	O	O
of	O	O	O
the	O	O	O
difficulty	O	O	B-T080
in	O	O	O
distinguishing	O	O	O
non-clinical	O	O	B-T053
behaviors	O	O	I-T053
(	O	O	O
physiological	O	O	B-T039
and	O	O	O
transient	O	O	B-T079
)	O	O	O
from	O	O	O
symptoms	O	O	B-T184
or	O	O	O
among	O	O	O
different	O	O	O
disorders	O	O	B-T047
[	O	O	O
"	O	O	O
primary	O	O	B-T048
stereotypies	O	O	I-T048
,	O	O	O
"	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
autistic	O	O	B-T048
spectrum	O	O	I-T048
disorder	O	O	I-T048
(	O	O	O
ASD	O	O	B-T048
)	O	O	O
,	O	O	O
intellectual	O	O	B-T048
disabilities	O	O	I-T048
,	O	O	O
genetic	O	O	B-T047
syndromes	O	O	I-T047
,	O	O	O
and	O	O	O
sensory	O	O	B-T033
impairment	O	O	I-T033
]	O	O	O
.	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
obtain	O	O	B-T169
an	O	O	O
accurate	O	O	O
assessment	O	O	B-T058
on	O	O	O
the	O	O	O
relationship	O	O	B-T080
between	O	O	O
stereotypies	O	O	B-T048
and	O	O	O
neurodevelopmental	O	O	B-T048
disorders	O	O	I-T048
.	O	O	O

We	O	O	O
studied	O	O	B-T062
23	O	O	O
children	O	O	B-T100
(	O	O	O
3	O	O	O
girls	O	O	B-T100
)	O	O	O
,	O	O	O
aged	O	O	B-T032
36	O	O	O
-	O	O	O
95	O	O	O
months	O	O	B-T079
,	O	O	O
who	O	O	O
requested	O	O	O
a	O	O	O
consultation	O	O	B-T058
due	O	O	O
to	O	O	O
the	O	O	O
persistence	O	O	B-T033
or	O	O	O
increased	O	O	B-T081
severity	O	O	B-T080
of	O	O	O
motor	O	O	B-T033
stereotypies	O	O	I-T033
.	O	O	O

None	O	O	O
of	O	O	O
the	O	O	O
patients	O	O	B-T101
had	O	O	O
a	O	O	O
previous	O	O	O
diagnosis	O	O	B-T062
of	O	O	O
ASD	O	O	B-T048
.	O	O	O

The	O	O	O
assessment	O	O	B-T058
included	O	O	O
the	O	O	O
Motor	O	O	B-T170
Severity	O	O	I-T170
Stereotypy	O	O	I-T170
Scale	O	O	I-T170
(	O	O	O
MSSS	O	O	B-T170
)	O	O	O
,	O	O	O
the	O	O	O
Repetitive	O	O	B-T170
Behavior	O	O	I-T170
Scale-Revised	O	O	I-T170
(	O	O	O
RBS-R	O	O	B-T170
)	O	O	O
,	O	O	O
the	O	O	O
Raven	O	O	B-T033
's	O	O	I-T033
Colored	O	O	I-T033
Progressive	O	O	I-T033
Matrices	O	O	I-T033
,	O	O	O
the	O	O	O
Child	O	O	B-T060
Behavior	O	O	I-T060
CheckList	O	O	I-T060
for	O	O	O
ages	O	O	B-T032
1Â½-5	O	O	O
or	O	O	O
4	O	O	O
-	O	O	O
18	O	O	O
(	O	O	O
CBCL	O	O	B-T060
)	O	O	O
,	O	O	O
the	O	O	O
Social	O	O	B-T170
Responsiveness	O	O	I-T170
Scale	O	O	I-T170
(	O	O	B-T170
SRS	O	O	I-T170
)	O	O	I-T170
,	O	O	O
and	O	O	O
the	O	O	O
Autism	O	O	B-T170
Diagnostic	O	O	I-T170
Observation	O	O	I-T170
Schedule-second	O	O	I-T170
edition	O	O	I-T170
(	O	O	O
ADOS	O	O	B-T170
2	O	O	I-T170
)	O	O	O
.	O	O	O

All	O	O	O
patients	O	O	B-T101
were	O	O	O
showing	O	O	O
motor	O	O	B-T033
stereotypies	O	O	I-T033
for	O	O	O
periods	O	O	B-T079
of	O	O	I-T079
time	O	O	I-T079
varying	O	O	O
from	O	O	O
6	O	O	O
to	O	O	O
77	O	O	O
months	O	O	B-T079
.	O	O	O

The	O	O	O
MSSS	O	O	B-T170
showed	O	O	O
that	O	O	O
each	O	O	O
child	O	O	B-T100
had	O	O	O
a	O	O	O
limited	O	O	B-T169
number	O	O	B-T081
of	O	O	O
stereotypies	O	O	B-T048
;	O	O	O
their	O	O	O
frequency	O	O	B-T081
and	O	O	O
intensity	O	O	B-T080
were	O	O	O
mild	O	O	B-T080
.	O	O	O

The	O	O	O
interference	O	O	B-T169
of	O	O	O
stereotypies	O	O	B-T048
was	O	O	O
variable	O	O	B-T080
;	O	O	O
the	O	O	O
impairment	O	O	B-T169
in	O	O	O
daily	O	O	O
life	O	O	B-T078
was	O	O	O
mild	O	O	B-T080
.	O	O	O

The	O	O	O
RBS-R	O	O	B-T170
scores	O	O	B-T081
were	O	O	O
positive	O	O	O
for	O	O	O
the	O	O	O
subscale	O	O	O
of	O	O	O
"	O	O	O
stereotypic	O	O	B-T048
behaviors	O	O	I-T048
"	O	O	O
in	O	O	O
all	O	O	O
children	O	O	B-T100
.	O	O	O

Moreover	O	O	O
,	O	O	O
several	O	O	O
children	O	O	B-T100
presented	O	O	O
other	O	O	O
repetitive	O	O	B-T033
behaviors	O	O	I-T033
,	O	O	O
mainly	O	O	O
"	O	O	O
ritualistic	O	O	B-T184
behavior	O	O	I-T184
"	O	O	O
and	O	O	O
"	O	O	O
sameness	O	O	B-T033
behavior	O	O	I-T033
.	O	O	O
"	O	O	O
All	O	O	O
patients	O	O	B-T101
showed	O	O	O
a	O	O	O
normal	O	O	B-T033
cognitive	O	O	I-T033
level	O	O	I-T033
.	O	O	O

The	O	O	O
CBCL	O	O	B-T060
evidenced	O	O	B-T078
behavioral	O	O	B-T048
problems	O	O	I-T048
in	O	O	O
22	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
children	O	O	B-T100
:	O	O	O
internalizing	O	O	B-T184
problems	O	O	I-T184
,	O	O	O
attention	O	O	B-T041
,	O	O	O
and	O	O	O
withdrawn	O	O	B-T048
were	O	O	O
the	O	O	O
main	O	O	O
complaints	O	O	O
.	O	O	O

On	O	O	O
the	O	O	O
SRS	O	O	B-T170
,	O	O	O
all	O	O	O
but	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
tested	O	O	B-T169
patients	O	O	B-T101
obtained	O	O	B-T169
clinical	O	O	B-T080
scores	O	O	I-T033
in	O	O	O
the	O	O	O
clinical	O	O	O
range	O	O	B-T081
for	O	O	O
at	O	O	O
least	O	O	O
one	O	O	O
area	O	O	O
.	O	O	O

On	O	O	O
the	O	O	O
ADOS	O	O	B-T170
2	O	O	I-T170
,	O	O	O
4	O	O	O
patients	O	O	B-T101
obtained	O	O	B-T169
scores	O	O	B-T081
indicating	O	O	O
a	O	O	O
moderate	O	O	B-T080
level	O	O	B-T080
of	O	O	O
ASD	O	O	B-T048
symptoms	O	O	B-T184
,	O	O	O
4	O	O	O
had	O	O	O
a	O	O	O
mild	O	O	B-T080
level	O	O	O
,	O	O	O
and	O	O	O
15	O	O	O
showed	O	O	O
no	O	O	O
or	O	O	O
minimal	O	O	O
signs	O	O	B-T184
of	O	O	O
ASD	O	O	O
.	O	O	O

Motor	O	O	B-T033
stereotypies	O	O	I-T033
in	O	O	O
children	O	O	B-T100
with	O	O	O
normal	O	O	B-T033
cognitive	O	O	I-T033
level	O	O	I-T033
represent	O	O	O
a	O	O	O
challenging	O	O	O
diagnostic	O	O	B-T169
issue	O	O	B-T033
for	O	O	O
which	O	O	O
a	O	O	O
finely	O	O	O
tailored	O	O	B-T170
assessment	O	O	B-T058
is	O	O	O
mandatory	O	O	O
in	O	O	O
order	O	O	O
to	O	O	O
define	O	O	O
a	O	O	O
precise	O	O	O
developmental	O	O	B-T080
profile	O	O	B-T169
.	O	O	O

Thus	O	O	O
,	O	O	O
careful	O	O	O
and	O	O	O
cautious	O	O	O
use	O	O	O
of	O	O	O
standardized	O	O	B-T170
tests	O	O	I-T170
is	O	O	O
warranted	O	O	O
to	O	O	O
avoid	O	O	O
misdiagnosis	O	O	B-T033
.	O	O	O

Furthermore	O	O	O
,	O	O	O
it	O	O	O
is	O	O	O
hard	O	O	O
to	O	O	O
consider	O	O	O
motor	O	O	B-T033
stereotypies	O	O	I-T033
,	O	O	O
even	O	O	O
the	O	O	O
primary	O	O	O
ones	O	O	O
,	O	O	O
exclusively	O	O	O
as	O	O	O
a	O	O	O
movement	O	O	B-T047
disorder	O	O	I-T047
.	O	O	O

-DOCSTART- (27933664)

Left	O	O	B-T023
ventricular	O	O	I-T023
rotational	O	O	B-T082
mechanics	O	O	B-T070
in	O	O	O
infants	O	O	B-T100
with	O	O	O
hypoxic	O	O	B-T047
ischemic	O	O	I-T047
encephalopathy	O	O	I-T047
and	O	O	O
preterm	O	O	B-T100
infants	O	O	I-T100
at	O	O	O
36	O	O	O
weeks	O	O	B-T079
postmenstrual	O	O	B-T032
age	O	O	I-T032
:	O	O	O
A	O	O	O
comparison	O	O	B-T052
with	O	O	O
healthy	O	O	B-T080
term	O	O	O
controls	O	O	O

There	O	O	O
is	O	O	O
a	O	O	O
paucity	O	O	O
of	O	O	O
data	O	O	B-T078
on	O	O	O
left	O	O	B-T023
ventricle	O	O	I-T023
(	O	O	O
LV	O	O	B-T023
)	O	O	O
rotational	O	O	B-T091
physiology	O	O	I-T091
in	O	O	O
neonates	O	O	B-T100
.	O	O	O

We	O	O	O
aimed	O	O	O
to	O	O	O
assess	O	O	O
rotational	O	O	B-T082
mechanics	O	O	B-T070
in	O	O	O
infants	O	O	B-T100
with	O	O	O
hypoxic	O	O	B-T047
ischemic	O	O	I-T047
encephalopathy	O	O	I-T047
(	O	O	O
HIE	O	O	B-T047
)	O	O	O
and	O	O	O
premature	O	O	B-T100
infants	O	O	I-T100
(	O	O	O
<	O	O	O
32	O	O	O
weeks	O	O	B-T079
)	O	O	O
at	O	O	O
36	O	O	O
weeks	O	O	O
postmenstrual	O	O	B-T032
age	O	O	I-T032
(	O	O	O
PMA	O	O	B-T032
)	O	O	O
(	O	O	O
preterm	O	O	B-T098
group	O	O	I-T098
)	O	O	O
and	O	O	O
compare	O	O	B-T052
them	O	O	O
with	O	O	O
healthy	O	O	B-T080
term	O	O	B-T096
controls	O	O	I-T096
(	O	O	O
term	O	O	O
controls	O	O	O
)	O	O	O
.	O	O	O

We	O	O	O
also	O	O	O
compared	O	O	B-T052
the	O	O	O
parameters	O	O	B-T077
in	O	O	O
preterm	O	O	B-T100
infants	O	O	I-T100
with	O	O	O
and	O	O	O
without	O	O	O
chronic	O	O	B-T047
lung	O	O	I-T047
disease	O	O	I-T047
(	O	O	O
CLD	O	O	B-T047
)	O	O	O
.	O	O	O

Echocardiography	O	O	B-T060
was	O	O	O
performed	O	O	O
within	O	O	O
48	O	O	O
hours	O	O	B-T079
of	O	O	O
birth	O	O	B-T040
or	O	O	O
at	O	O	O
36	O	O	O
weeks	O	O	B-T079
PMA	O	O	B-T032
.	O	O	O

LV	O	O	B-T023
basal	O	O	B-T082
and	O	O	O
apical	O	O	O
rotation	O	O	B-T169
,	O	O	O
twist	O	O	B-T082
(	O	O	O
and	O	O	O
torsion	O	O	O
=	O	O	O
twist	O	O	O
/	O	O	O
LV	O	O	B-T081
length	O	O	I-T081
)	O	O	O
,	O	O	O
twist	O	O	B-T081
rate	O	O	I-T081
(	O	O	O
LVTR	O	O	B-T081
)	O	O	O
,	O	O	O
and	O	O	O
untwist	O	O	B-T081
rate	O	O	I-T081
(	O	O	O
LVUTR	O	O	B-T081
)	O	O	O
were	O	O	O
measured	O	O	O
.	O	O	O

One-way	O	O	B-T081
ANOVA	O	O	I-T081
was	O	O	O
used	O	O	O
to	O	O	O
compare	O	O	B-T052
values	O	O	B-T080
.	O	O	O

There	O	O	O
was	O	O	O
no	O	O	O
difference	O	O	O
in	O	O	O
gestation	O	O	B-T040
(	O	O	O
40.0	O	O	O
[	O	O	O
39.1	O	O	O
-	O	O	O
40.3	O	O	O
]	O	O	O
vs	O	O	O
39.9	O	O	O
[	O	O	O
39.0	O	O	O
-	O	O	O
40.9	O	O	O
]	O	O	O
,	O	O	O
P>.05	O	O	O
)	O	O	O
or	O	O	O
birthweight	O	O	B-T032
(	O	O	O
3.7	O	O	O
[	O	O	O
3.4	O	O	O
-	O	O	O
4.1	O	O	O
]	O	O	O
vs	O	O	O
3.5	O	O	O
[	O	O	O
3.2	O	O	O
-	O	O	O
3.9	O	O	O
]	O	O	O
,	O	O	O
P>.05	O	O	O
)	O	O	O
between	O	O	O
the	O	O	O
HIE	O	O	B-T047
group	O	O	B-T098
(	O	O	O
n=16	O	O	O
)	O	O	O
and	O	O	O
term	O	O	B-T096
controls	O	O	I-T096
(	O	O	O
n=30	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
preterm	O	O	B-T098
group	O	O	I-T098
(	O	O	O
n=35	O	O	O
)	O	O	O
had	O	O	O
a	O	O	O
gestation	O	O	B-T040
and	O	O	O
weight	O	O	B-T081
of	O	O	O
36.0	O	O	O
[	O	O	O
34.6	O	O	O
-	O	O	O
36.3	O	O	O
]	O	O	O
weeks	O	O	B-T079
and	O	O	O
2.3	O	O	O
[	O	O	O
2.0	O	O	O
-	O	O	O
2.4	O	O	O
]	O	O	O
kg	O	O	O
.	O	O	O

The	O	O	O
HIE	O	O	B-T047
group	O	O	O
had	O	O	O
lower	O	O	O
twist	O	O	B-T082
,	O	O	O
torsion	O	O	O
,	O	O	O
LVTR	O	O	B-T081
,	O	O	O
and	O	O	O
LVUTR	O	O	B-T081
than	O	O	O
the	O	O	O
other	O	O	O
two	O	O	O
groups	O	O	O
.	O	O	O

The	O	O	O
preterm	O	O	B-T098
group	O	O	I-T098
had	O	O	O
a	O	O	O
more	O	O	O
negative	O	O	O
(	O	O	O
clockwise	O	O	B-T169
)	O	O	O
basal	O	O	B-T082
rotation	O	O	B-T169
while	O	O	O
the	O	O	O
term	O	O	B-T098
group	O	O	I-T098
had	O	O	O
a	O	O	O
more	O	O	O
positive	O	O	O
(	O	O	O
counterclockwise	O	O	B-T169
)	O	O	O
apical	O	O	B-T082
rotation	O	O	O
.	O	O	O

Preterm	O	O	B-T100
infants	O	O	B-T100
with	O	O	O
CLD	O	O	B-T047
had	O	O	O
higher	O	O	O
apical	O	O	B-T082
rotation	O	O	B-T169
,	O	O	O
twist	O	O	B-T082
,	O	O	O
and	O	O	O
torsion	O	O	O
when	O	O	O
compared	O	O	B-T052
to	O	O	O
infants	O	O	O
without	O	O	O
CLD	O	O	O
.	O	O	O

Infants	O	O	B-T100
with	O	O	O
HIE	O	O	B-T047
have	O	O	O
reduced	O	O	O
rotational	O	O	B-T082
mechanics	O	O	B-T070
.	O	O	O

Preterm	O	O	B-T100
infants	O	O	I-T100
at	O	O	O
36	O	O	O
weeks	O	O	B-T079
PMA	O	O	B-T032
have	O	O	O
comparable	O	O	B-T052
measurements	O	O	B-T169
of	O	O	O
twist	O	O	B-T082
to	O	O	O
term	O	O	B-T100
infants	O	O	I-T100
.	O	O	O

This	O	O	O
is	O	O	O
achieved	O	O	O
by	O	O	O
predominant	O	O	O
basal	O	O	B-T082
rather	O	O	O
than	O	O	O
apical	O	O	B-T082
rotation	O	O	B-T169
.	O	O	O

Infants	O	O	B-T100
with	O	O	O
CLD	O	O	B-T047
have	O	O	O
increased	O	O	O
apical	O	O	B-T082
rotation	O	O	B-T169
.	O	O	O

-DOCSTART- (27938365)

Comparing	O	O	B-T052
the	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
different	O	O	B-T080
dynamic	O	O	B-T061
sitting	O	O	I-T061
strategies	O	O	I-T061
in	O	O	O
wheelchair	O	O	B-T074
seating	O	O	I-T074
on	O	O	O
lumbar-pelvic	O	O	O
angle	O	O	O

Prolonged	O	O	B-T079
static	O	O	B-T033
sitting	O	O	I-T033
in	O	O	O
a	O	O	O
wheelchair	O	O	B-T074
is	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
an	O	O	O
increased	O	O	B-T081
risk	O	O	B-T078
of	O	O	O
lower	O	O	B-T184
back	O	O	I-T184
pain	O	O	I-T184
.	O	O	O

The	O	O	O
wheelchair	O	O	B-T074
seating	O	O	I-T074
system	O	O	I-T074
is	O	O	O
a	O	O	O
key	O	O	B-T169
factor	O	O	I-T169
of	O	O	O
this	O	O	O
risk	O	O	B-T078
because	O	O	O
it	O	O	O
affects	O	O	O
spinal	O	O	B-T082
loading	O	O	B-T169
in	O	O	O
the	O	O	O
sitting	O	O	B-T033
position	O	O	I-T033
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
7	O	O	O
dynamic	O	O	B-T061
sitting	O	O	I-T061
strategies	O	O	I-T061
(	O	O	O
DSSs	O	O	B-T061
)	O	O	O
are	O	O	O
examined	O	O	B-T033
:	O	O	O
lumbar	O	O	B-T061
prominent	O	O	I-T061
dynamic	O	O	I-T061
sitting	O	O	I-T061
(	O	O	O
LPDS	O	O	B-T061
)	O	O	O
,	O	O	O
back	O	O	B-T061
reclined	O	O	I-T061
dynamic	O	O	I-T061
sitting	O	O	I-T061
(	O	O	O
BRDS	O	O	B-T061
)	O	O	O
,	O	O	O
femur	O	O	B-T061
upward	O	O	I-T061
dynamic	O	O	I-T061
sitting	O	O	I-T061
(	O	O	O
FUDS	O	O	B-T061
)	O	O	O
,	O	O	O
lumbar	O	O	B-T061
prominent	O	O	I-T061
with	O	O	I-T061
back	O	O	I-T061
reclined	O	O	I-T061
dynamic	O	O	I-T061
sitting	O	O	I-T061
(	O	O	O
LBDS	O	O	B-T061
)	O	O	O
,	O	O	O
lumbar	O	O	B-T061
prominent	O	O	I-T061
with	O	O	I-T061
femur	O	O	I-T061
upward	O	O	I-T061
dynamic	O	O	I-T061
sitting	O	O	I-T061
(	O	O	O
LFDS	O	O	B-T061
)	O	O	O
,	O	O	O
back	O	O	B-T061
reclined	O	O	I-T061
with	O	O	I-T061
femur	O	O	I-T061
upward	O	O	I-T061
dynamic	O	O	I-T061
sitting	O	O	I-T061
(	O	O	O
BFDS	O	O	B-T061
)	O	O	O
,	O	O	O
and	O	O	O
lumbar	O	O	B-T061
prominent	O	O	I-T061
with	O	O	I-T061
back	O	O	I-T061
reclined	O	O	I-T061
with	O	O	I-T061
femur	O	O	I-T061
upward	O	O	I-T061
dynamic	O	O	I-T061
sitting	O	O	I-T061
(	O	O	O
LBFDS	O	O	B-T061
)	O	O	O
.	O	O	O

The	O	O	O
objective	O	O	B-T170
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
analyze	O	O	B-T062
the	O	O	O
biomechanical	O	O	B-T070
effects	O	O	B-T080
of	O	O	I-T080
these	O	O	O
sitting	O	O	B-T061
strategies	O	O	I-T061
on	O	O	O
lumbar-pelvic	O	O	B-T029
angles	O	O	I-T029
.	O	O	O

Twenty	O	O	O
able-bodied	O	O	B-T033
participants	O	O	B-T098
were	O	O	O
recruited	O	O	B-T169
for	O	O	O
the	O	O	O
study	O	O	B-T062
.	O	O	O

All	O	O	O
participants	O	O	B-T098
performed	O	O	B-T169
LPDS	O	O	B-T061
,	O	O	O
BRDS	O	O	B-T061
,	O	O	O
FUDS	O	O	B-T061
,	O	O	O
LBDS	O	O	B-T061
,	O	O	O
LFDS	O	O	B-T061
,	O	O	O
BFDS	O	O	B-T061
,	O	O	O
and	O	O	O
LBFDS	O	O	B-T061
in	O	O	O
a	O	O	O
random	O	O	B-T080
order	O	O	B-T080
.	O	O	O

All	O	O	O
lumbar-pelvic	O	O	B-T029
angle	O	O	I-T029
parameters	O	O	B-T077
,	O	O	O
including	O	O	O
the	O	O	O
static	O	O	B-T080
lumbar	O	O	B-T029
angle	O	O	I-T029
,	O	O	O
static	O	O	O
pelvic	O	O	B-T023
angle	O	O	I-T023
,	O	O	O
lumbar	O	O	B-T033
range	O	O	I-T033
of	O	O	I-T033
motion	O	O	I-T033
,	O	O	O
and	O	O	O
pelvic	O	O	B-T033
range	O	O	I-T033
of	O	O	I-T033
motion	O	O	I-T033
were	O	O	O
measured	O	O	B-T080
and	O	O	O
compared	O	O	B-T052
.	O	O	O

Results	O	O	B-T169
show	O	O	O
that	O	O	O
LBDS	O	O	B-T061
and	O	O	O
LBFDS	O	O	B-T061
enabled	O	O	B-T041
the	O	O	O
most	O	O	O
beneficial	O	O	B-T080
lumbar	O	O	B-T201
movements	O	O	I-T201
,	O	O	O
although	O	O	O
the	O	O	O
difference	O	O	B-T080
between	O	O	O
the	O	O	O
2	O	O	O
strategies	O	O	B-T041
was	O	O	O
nonsignificant	O	O	B-T033
.	O	O	O

BRDS	O	O	B-T061
and	O	O	O
BFDS	O	O	B-T061
enabled	O	O	B-T041
the	O	O	O
most	O	O	O
beneficial	O	O	B-T080
pelvic	O	O	B-T061
movements	O	O	I-T061
,	O	O	O
although	O	O	O
the	O	O	O
difference	O	O	B-T080
between	O	O	O
the	O	O	O
2	O	O	O
strategies	O	O	B-T041
was	O	O	O
nonsignificant	O	O	B-T033
.	O	O	O

Among	O	O	O
all	O	O	O
the	O	O	O
upright	O	O	O
DSSs	O	O	B-T061
,	O	O	O
LPDS	O	O	B-T061
and	O	O	O
LFDS	O	O	B-T061
enabled	O	O	B-T041
the	O	O	O
most	O	O	O
beneficial	O	O	B-T080
lumbar	O	O	B-T201
and	O	O	O
pelvic	O	O	B-T061
movements	O	O	I-T061
,	O	O	O
although	O	O	O
no	O	O	B-T033
significant	O	O	I-T033
difference	O	O	B-T080
was	O	O	O
observed	O	O	B-T169
between	O	O	O
these	O	O	O
2	O	O	O
strategies	O	O	B-T041
.	O	O	O

We	O	O	O
identified	O	O	B-T080
the	O	O	O
effects	O	O	B-T080
and	O	O	O
differences	O	O	B-T080
among	O	O	O
7	O	O	O
DSSs	O	O	B-T061
on	O	O	O
lumbar-pelvic	O	O	B-T029
angles	O	O	I-T029
.	O	O	O

Wheelchair	O	O	B-T101
users	O	O	I-T101
can	O	O	O
choose	O	O	B-T052
the	O	O	O
most	O	O	O
suitable	O	O	B-T080
DSS	O	O	B-T061
that	O	O	O
meets	O	O	B-T067
their	O	O	O
needs	O	O	B-T080
.	O	O	O

These	O	O	O
findings	O	O	B-T033
may	O	O	O
serve	O	O	O
as	O	O	O
a	O	O	O
reference	O	O	B-T077
for	O	O	O
practicing	O	O	B-T097
physicians	O	O	I-T097
or	O	O	O
wheelchair	O	O	B-T101
users	O	O	I-T101
to	O	O	O
choose	O	O	B-T052
an	O	O	O
appropriate	O	O	B-T080
dynamic	O	O	O
wheelchair	O	O	B-T074
seating	O	O	I-T074
system	O	O	O
.	O	O	O

ISRCTN12389808	O	O	O
,	O	O	O
18th	O	O	O
November	O	O	O
2016	O	O	O
,	O	O	O
retrospectively	O	O	O
registered	O	O	O
.	O	O	O

-DOCSTART- (27939207)

Source	O	O	O
apportionment	O	O	O
and	O	O	O
heavy	O	O	B-T196
metal	O	O	I-T196
health	O	O	B-T061
risk	O	O	I-T061
(	O	O	O
HMHR	O	O	B-T061
)	O	O	O
quantification	O	O	B-T081
from	O	O	O
sources	O	O	B-T033
in	O	O	O
a	O	O	O
southern	O	O	B-T082
city	O	O	B-T083
in	O	O	O
China	O	O	B-T083
,	O	O	O
using	O	O	O
an	O	O	O
ME2	O	O	B-T073
-	O	O	O
HMHR	O	O	O
model	O	O	O

Heavy	O	O	B-T196
metals	O	O	I-T196
(	O	O	O
Cr	O	O	B-T131
,	O	O	O
Co	O	O	B-T123
,	O	O	O
Ni	O	O	B-T123
,	O	O	O
As	O	O	B-T121
,	O	O	O
Cd	O	O	B-T131
,	O	O	O
and	O	O	O
Pb	O	O	B-T131
)	O	O	O
can	O	O	O
be	O	O	O
bound	O	O	O
to	O	O	O
PM	O	O	B-T167
adversely	O	O	B-T046
affecting	O	O	I-T046
human	O	O	B-T016
health	O	O	B-T078
.	O	O	O

Quantifying	O	O	O
the	O	O	O
source	O	O	B-T033
impacts	O	O	O
on	O	O	O
heavy	O	O	B-T196
metals	O	O	I-T196
can	O	O	O
provide	O	O	O
source	O	O	O
-	O	O	O
specific	O	O	B-T080
estimates	O	O	O
of	O	O	O
the	O	O	O
heavy	O	O	B-T196
metal	O	O	I-T196
health	O	O	B-T061
risk	O	O	I-T061
(	O	O	O
HMHR	O	O	B-T061
)	O	O	O
to	O	O	O
guide	O	O	O
effective	O	O	B-T080
development	O	O	O
of	O	O	O
strategies	O	O	O
to	O	O	O
reduce	O	O	O
such	O	O	O
risks	O	O	B-T078
from	O	O	O
exposure	O	O	B-T080
to	O	O	I-T080
heavy	O	O	O
metals	O	O	O
in	O	O	O
PM2.5	O	O	B-T167
(	O	O	O
particulate	O	O	B-T167
matter	O	O	I-T167
(	O	O	O
PM	O	O	B-T167
)	O	O	O
with	O	O	O
aerodynamic	O	O	B-T081
diameter	O	O	I-T081
less	O	O	O
than	O	O	O
or	O	O	O
equal	O	O	O
to	O	O	O
2.5	O	O	O
Î¼m	O	O	O
)	O	O	O
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	O
,	O	O	O
a	O	O	O
method	O	O	O
combining	O	O	O
Multilinear	O	O	B-T073
Engine	O	O	I-T073
2	O	O	I-T073
(	O	O	O
ME2	O	O	B-T073
)	O	O	O
and	O	O	O
a	O	O	O
risk	O	O	B-T058
assessment	O	O	I-T058
model	O	O	B-T170
is	O	O	O
developed	O	O	O
to	O	O	O
more	O	O	O
effectively	O	O	O
quantify	O	O	B-T081
source	O	O	B-T033
contributions	O	O	B-T052
to	O	O	O
HMHR	O	O	B-T061
,	O	O	O
including	O	O	O
heavy	O	O	B-T196
metal	O	O	I-T196
non-cancer	O	O	B-T033
risk	O	O	I-T033
(	O	O	O
non-HMCR	O	O	B-T033
)	O	O	O
and	O	O	O
cancer	O	O	B-T081
risk	O	O	I-T081
(	O	O	O
HMCR	O	O	B-T081
)	O	O	O
.	O	O	O

The	O	O	O
combined	O	O	O
model	O	O	B-T170
(	O	O	O
called	O	O	O
ME2-HMHR	O	O	B-T170
)	O	O	O
has	O	O	O
two	O	O	O
steps	O	O	O
:	O	O	O
step1	O	O	O
,	O	O	O
source	O	O	B-T033
contributions	O	O	B-T052
to	O	O	O
heavy	O	O	B-T196
metals	O	O	I-T196
are	O	O	O
estimated	O	O	O
by	O	O	O
employing	O	O	O
the	O	O	O
ME2	O	O	B-T073
model	O	O	O
;	O	O	O
step2	O	O	O
,	O	O	O
the	O	O	O
source	O	O	O
contributions	O	O	O
in	O	O	O
step	O	O	O
1	O	O	O
are	O	O	O
introduced	O	O	O
into	O	O	O
the	O	O	O
risk	O	O	B-T058
assessment	O	O	I-T058
model	O	O	O
to	O	O	O
calculate	O	O	O
the	O	O	O
source	O	O	O
contributions	O	O	O
to	O	O	O
HMHR	O	O	B-T061
.	O	O	O

The	O	O	O
approach	O	O	O
was	O	O	O
applied	O	O	O
to	O	O	O
Huzou	O	O	B-T083
,	O	O	O
China	O	O	B-T083
and	O	O	O
five	O	O	O
significant	O	O	O
sources	O	O	B-T033
were	O	O	O
identified	O	O	O
.	O	O	O

Soil	O	O	B-T167
dust	O	O	B-T167
is	O	O	O
the	O	O	O
largest	O	O	O
source	O	O	B-T033
of	O	O	O
non-HMCR	O	O	B-T033
.	O	O	O

For	O	O	O
HMCR	O	O	B-T081
,	O	O	O
the	O	O	O
source	O	O	B-T033
contributions	O	O	B-T052
of	O	O	O
soil	O	O	B-T167
dust	O	O	B-T167
,	O	O	O
coal	O	O	B-T109
combustion	O	O	B-T073
,	O	O	O
cement	O	O	B-T033
dust	O	O	I-T033
,	O	O	O
vehicle	O	O	B-T131
,	O	O	O
and	O	O	O
secondary	O	O	O
sources	O	O	B-T033
are	O	O	O
1.0	O	O	O
Ã	O	O	O
10(-4	O	O	O
)	O	O	O
,	O	O	O
3.7	O	O	O
Ã	O	O	O
10(-5	O	O	O
)	O	O	O
,	O	O	O
2.7	O	O	O
Ã	O	O	O
10(-6	O	O	O
)	O	O	O
,	O	O	O
1.6	O	O	O
Ã	O	O	O
10(-6	O	O	O
)	O	O	O
and	O	O	O
1.9	O	O	O
Ã	O	O	O
10(-9	O	O	O
)	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

The	O	O	O
soil	O	O	B-T167
dust	O	O	B-T167
is	O	O	O
the	O	O	O
largest	O	O	O
contributor	O	O	B-T052
to	O	O	O
HMCR	O	O	B-T081
,	O	O	O
being	O	O	O
driven	O	O	O
by	O	O	O
the	O	O	O
high	O	O	O
impact	O	O	B-T080
of	O	O	O
soil	O	O	O
dust	O	O	O
on	O	O	O
PM2.5	O	O	B-T167
and	O	O	O
the	O	O	O
abundance	O	O	B-T080
of	O	O	O
heavy	O	O	B-T196
metals	O	O	I-T196
in	O	O	O
soil	O	O	O
dust	O	O	O
.	O	O	O

-DOCSTART- (27940576)

Aspirin	O	O	B-T109
Suppresses	O	O	B-T169
Growth	O	O	B-T040
in	O	O	O
PI3	O	O	B-T028
K	O	O	I-T028
-	O	O	O
Mutant	O	O	B-T028
Breast	O	O	B-T191
Cancer	O	O	I-T191
by	O	O	O
Activating	O	O	B-T045
AMPK	O	O	B-T116
and	O	O	O
Inhibiting	O	O	B-T052
mTORC1	O	O	B-T116
Signaling	O	O	O

Despite	O	O	O
the	O	O	O
high	O	O	O
incidence	O	O	B-T081
of	O	O	O
oncogenic	O	O	B-T028
mutations	O	O	B-T045
in	O	O	O
PIK3CA	O	O	B-T028
,	O	O	O
the	O	O	O
gene	O	O	B-T028
encoding	O	O	I-T028
the	O	O	O
catalytic	O	O	B-T087
subunit	O	O	I-T087
of	O	O	O
PI3	O	O	B-T116
K	O	O	I-T116
,	O	O	O
PI3	O	O	O
K	O	O	O
inhibitors	O	O	B-T121
have	O	O	O
yielded	O	O	O
little	O	O	O
clinical	O	O	B-T033
benefit	O	O	I-T033
for	O	O	O
breast	O	O	B-T191
cancer	O	O	I-T191
patients	O	O	B-T101
.	O	O	O

Recent	O	O	B-T079
epidemiologic	O	O	B-T062
studies	O	O	I-T062
have	O	O	O
suggested	O	O	B-T078
a	O	O	O
therapeutic	O	O	B-T169
benefit	O	O	B-T081
from	O	O	O
aspirin	O	O	B-T109
intake	O	O	O
in	O	O	O
cancers	O	O	B-T191
harboring	O	O	O
oncogenic	O	O	B-T116
PIK3CA	O	O	B-T116
Here	O	O	O
,	O	O	O
we	O	O	O
show	O	O	O
that	O	O	O
mutant	O	O	B-T028
PIK3CA	O	O	O
-	O	O	O
expressing	O	O	B-T045
breast	O	O	B-T025
cancer	O	O	I-T025
cells	O	O	I-T025
have	O	O	O
greater	O	O	O
sensitivity	O	O	B-T169
to	O	O	O
aspirin	O	O	O
-mediated	O	O	O
growth	O	O	B-T043
suppression	O	O	B-T043
than	O	O	O
their	O	O	O
wild-type	O	O	B-T028
counterparts	O	O	O
.	O	O	O

Aspirin	O	O	B-T109
decreased	O	O	B-T081
viability	O	O	B-T043
and	O	O	O
anchorage-independent	O	O	B-T059
growth	O	O	I-T059
of	O	O	O
mutant	O	O	B-T028
PIK3CA	O	O	B-T116
breast	O	O	B-T025
cancer	O	O	I-T025
cells	O	O	I-T025
independently	O	O	B-T033
of	O	O	O
its	O	O	O
effects	O	O	B-T080
on	O	O	O
COX-2	O	O	B-T116
and	O	O	O
NF-ÎºB.	O	O	O
We	O	O	O
ascribed	O	O	O
the	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
aspirin	O	O	B-T109
to	O	O	O
AMP-activated	O	O	B-T116
protein	O	O	I-T116
kinase	O	O	I-T116
(	O	O	O
AMPK	O	O	B-T116
)	O	O	O
activation	O	O	B-T045
,	O	O	O
mTORC1	O	O	B-T116
inhibition	O	O	B-T043
,	O	O	O
and	O	O	O
autophagy	O	O	B-T043
induction	O	O	O
.	O	O	O

In	O	O	O
vivo	O	O	O
,	O	O	O
oncogenic	O	O	B-T028
PIK3CA	O	O	B-T116
-driven	O	O	O
mouse	O	O	B-T015
mammary	O	O	B-T191
tumors	O	O	I-T191
treated	O	O	B-T169
daily	O	O	O
with	O	O	O
aspirin	O	O	B-T109
resulted	O	O	O
in	O	O	O
decreased	O	O	B-T081
tumor	O	O	B-T191
growth	O	O	I-T191
kinetics	O	O	B-T070
,	O	O	O
whereas	O	O	O
combination	O	O	B-T080
therapy	O	O	B-T061
of	O	O	O
aspirin	O	O	O
and	O	O	O
a	O	O	O
PI3	O	O	B-T116
K	O	O	I-T116
inhibitor	O	O	B-T080
further	O	O	O
attenuated	O	O	B-T052
tumor	O	O	O
growth	O	O	O
.	O	O	O

Our	O	O	O
study	O	O	O
supports	O	O	O
the	O	O	O
evaluation	O	O	B-T058
of	O	O	O
aspirin	O	O	B-T109
and	O	O	O
PI3	O	O	B-T116
K	O	O	I-T116
pathway	O	O	O
inhibitors	O	O	B-T121
as	O	O	O
a	O	O	O
combination	O	O	B-T080
therapy	O	O	B-T061
for	O	O	O
targeting	O	O	B-T169
breast	O	O	B-T191
cancer	O	O	I-T191
.	O	O	O

Cancer	O	O	O
Res	O	O	O
;	O	O	O
77(3	O	O	O
)	O	O	O
;	O	O	O
790	O	O	O
-	O	O	O
801	O	O	O
.	O	O	O

Â©	O	O	O
2016	O	O	O
AACR	O	O	O
.	O	O	O

-DOCSTART- (27941728)

Prevalence	O	O	B-T081
of	O	O	O
Psychiatric	O	O	B-T048
Disorders	O	O	I-T048
among	O	O	O
Female	O	O	B-T032
Juvenile	O	O	O
Offenders	O	O	O

Inmates	O	O	B-T098
of	O	O	O
Juvenile	O	O	B-T093
Developmental	O	O	I-T093
Centers	O	O	I-T093
are	O	O	O
the	O	O	O
special	O	O	B-T080
group	O	O	B-T098
of	O	O	O
youth	O	O	B-T100
population	O	O	B-T098
who	O	O	O
are	O	O	O
in	O	O	O
conflict	O	O	B-T055
with	O	O	O
law	O	O	B-T089
.	O	O	O

They	O	O	O
are	O	O	O
vulnerable	O	O	B-T169
to	O	O	O
psychiatric	O	O	B-T048
illness	O	O	I-T048
.	O	O	O

The	O	O	O
objective	O	O	B-T170
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
see	O	O	O
the	O	O	O
prevalence	O	O	B-T081
and	O	O	O
type	O	O	B-T080
of	O	O	O
psychiatric	O	O	B-T048
disorders	O	O	I-T048
in	O	O	O
institutionalized	O	O	B-T033
female	O	O	B-T032
juvenile	O	O	B-T098
offenders	O	O	I-T098
and	O	O	O
non-offenders	O	O	B-T098
of	O	O	O
same	O	O	B-T080
age	O	O	B-T032
,	O	O	O
sex	O	O	B-T032
and	O	O	O
socioeconomic	O	O	B-T080
group	O	O	I-T080
in	O	O	O
the	O	O	O
community	O	O	B-T096
.	O	O	O

The	O	O	O
association	O	O	B-T041
of	O	O	O
mental	O	O	B-T048
disorders	O	O	I-T048
was	O	O	O
examined	O	O	B-T033
in	O	O	O
43	O	O	O
female	O	O	B-T032
inmates	O	O	B-T098
of	O	O	O
Juvenile	O	O	B-T093
Development	O	O	I-T093
Centers	O	O	I-T093
and	O	O	O
43	O	O	O
randomly	O	O	B-T080
selected	O	O	B-T052
comparison	O	O	B-T052
subjects	O	O	B-T096
in	O	O	O
community	O	O	B-T096
.	O	O	O

One	O	O	B-T058
stage-structured	O	O	I-T058
assessment	O	O	I-T058
of	O	O	O
psychopathology	O	O	B-T091
was	O	O	O
carried	O	O	O
out	O	O	O
by	O	O	O
using	O	O	O
a	O	O	O
structured	O	O	B-T169
and	O	O	O
valid	O	O	B-T080
Bangla	O	O	B-T171
version	O	O	B-T170
of	O	O	O
the	O	O	O
Development	O	O	B-T058
and	O	O	I-T058
Well-Being	O	O	I-T058
Assessment	O	O	I-T058
(	O	O	O
DAWBA	O	O	B-T058
)	O	O	O
.	O	O	O

Development	O	O	B-T058
and	O	O	I-T058
Well-Being	O	O	I-T058
Assessment	O	O	I-T058
generated	O	O	O
psychiatric	O	O	B-T169
diagnosis	O	O	B-T033
was	O	O	O
assigned	O	O	O
based	O	O	O
on	O	O	O
ICD-10	O	O	B-T170
diagnostic	O	O	B-T170
criteria	O	O	I-T170
for	O	O	O
research	O	O	B-T062
.	O	O	O

The	O	O	O
result	O	O	B-T033
revealed	O	O	B-T080
that	O	O	O
,	O	O	O
of	O	O	O
those	O	O	O
who	O	O	O
were	O	O	O
in	O	O	O
conflict	O	O	B-T055
with	O	O	O
law	O	O	B-T089
,	O	O	O
93	O	O	O
%	O	O	O
had	O	O	O
mental	O	O	B-T048
disorder	O	O	I-T048
,	O	O	O
whereas	O	O	O
14	O	O	O
%	O	O	O
of	O	O	O
non-offenders	O	O	B-T098
had	O	O	O
psychiatric	O	O	B-T048
disorder	O	O	I-T048
.	O	O	O

Among	O	O	O
the	O	O	O
offenders	O	O	B-T098
with	O	O	O
psychiatric	O	O	B-T048
disorders	O	O	I-T048
,	O	O	O
most	O	O	O
of	O	O	O
them	O	O	O
(	O	O	O
32.6	O	O	O
%	O	O	O
)	O	O	O
suffered	O	O	O
from	O	O	O
Major	O	O	B-T048
Depressive	O	O	I-T048
Disorder	O	O	I-T048
(	O	O	O
MDD	O	O	B-T048
)	O	O	O
,	O	O	O
followed	O	O	O
by	O	O	O
combined	O	O	B-T080
MDD	O	O	O
&	O	O	O
Post	O	O	B-T048
Traumatic	O	O	I-T048
Stress	O	O	I-T048
Disorder	O	O	I-T048
(	O	O	O
PTSD	O	O	B-T048
)	O	O	O
.	O	O	O

On	O	O	O
the	O	O	O
other	O	O	O
hand	O	O	O
,	O	O	O
among	O	O	O
the	O	O	O
non-offenders	O	O	B-T098
with	O	O	O
psychiatric	O	O	B-T048
disorder	O	O	I-T048
9.3	O	O	O
%	O	O	O
suffered	O	O	O
from	O	O	O
MDD	O	O	B-T048
.	O	O	O

It	O	O	O
can	O	O	O
be	O	O	O
concluded	O	O	B-T078
that	O	O	O
considerable	O	O	B-T080
psychiatric	O	O	B-T048
disorders	O	O	I-T048
are	O	O	O
prevalent	O	O	B-T081
among	O	O	O
the	O	O	O
female	O	O	B-T032
juvenile	O	O	B-T098
offenders	O	O	I-T098
with	O	O	O
comparison	O	O	B-T052
to	O	O	O
non-offenders	O	O	B-T098
.	O	O	O

Broad	O	O	B-T082
-based	O	O	O
replication	O	O	B-UnknownType
study	O	O	I-UnknownType
could	O	O	O
confirm	O	O	B-T080
these	O	O	O
findings	O	O	B-T033
.	O	O	O

-DOCSTART- (27941815)

Association	O	O	B-T080
between	O	O	O
neutrophil	O	O	B-T025
-to-	O	O	O
lymphocyte	O	O	B-T025
ratio	O	O	B-T081
and	O	O	O
differentiated	O	O	B-T191
thyroid	O	O	I-T191
cancer	O	O	I-T191
:	O	O	O
a	O	O	O
meta-analysis	O	O	O

The	O	O	O
association	O	O	B-T080
between	O	O	O
neutrophil	O	O	B-T025
-to-	O	O	O
lymphocyte	O	O	B-T025
ratio	O	O	B-T081
(	O	O	O
NLR	O	O	B-T081
)	O	O	O
and	O	O	O
differentiated	O	O	B-T191
thyroid	O	O	I-T191
cancer	O	O	I-T191
(	O	O	O
DTC	O	O	B-T191
)	O	O	O
is	O	O	O
undecided	O	O	O
.	O	O	O

To	O	O	O
rectify	O	O	O
this	O	O	O
question	O	O	O
,	O	O	O
we	O	O	O
conducted	O	O	B-T169
a	O	O	O
systematic	O	O	B-T169
meta-analysis	O	O	B-T062
based	O	O	O
on	O	O	O
7	O	O	O
prospective	O	O	B-T062
cohort	O	O	I-T062
studies	O	O	I-T062
published	O	O	B-T170
between	O	O	O
2013	O	O	O
and	O	O	O
2015	O	O	O
,	O	O	O
comprising	O	O	O
7349	O	O	O
patients	O	O	B-T101
.	O	O	O

Six	O	O	O
of	O	O	O
these	O	O	O
cohorts	O	O	B-T098
included	O	O	O
pretreatment	O	O	B-T052
(	O	O	O
baseline	O	O	B-T081
)	O	O	O
NLR	O	O	B-T081
data	O	O	B-T078
for	O	O	O
patients	O	O	B-T101
with	O	O	O
thyroid	O	O	B-T191
nodules	O	O	I-T191
.	O	O	O

The	O	O	O
meta-analysis	O	O	B-T062
of	O	O	O
these	O	O	O
6	O	O	O
cohorts	O	O	B-T098
showed	O	O	O
that	O	O	O
the	O	O	O
NLR	O	O	B-T081
of	O	O	O
patients	O	O	B-T101
with	O	O	O
DTC	O	O	B-T191
(	O	O	O
4617	O	O	O
cases	O	O	B-T077
)	O	O	O
was	O	O	O
statistically	O	O	B-T081
similar	O	O	O
to	O	O	O
patients	O	O	O
with	O	O	O
benign	O	O	B-T191
nodules	O	O	I-T191
only	O	O	O
(	O	O	O
1666	O	O	O
cases	O	O	O
)	O	O	O
,	O	O	O
with	O	O	O
a	O	O	O
mean	O	O	O
difference	O	O	O
(	O	O	O
MD	O	O	O
)	O	O	O
of	O	O	O
0.19	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
:	O	O	O
-0.09	O	O	O
to	O	O	O
0.46	O	O	O
;	O	O	O
I(2	O	O	O
)	O	O	O
=	O	O	O
93	O	O	O
%	O	O	O
;	O	O	O
P	O	O	B-T081
<	O	O	O
0.001	O	O	O
)	O	O	O
.	O	O	O

No	O	O	O
significant	O	O	O
difference	O	O	O
in	O	O	O
NLR	O	O	B-T081
was	O	O	O
found	O	O	O
between	O	O	O
patients	O	O	B-T101
with	O	O	O
DTC	O	O	B-T191
and	O	O	O
patients	O	O	O
with	O	O	O
benign	O	O	B-T191
nodules	O	O	I-T191
.	O	O	O

Two	O	O	O
studies	O	O	B-T059
addressed	O	O	O
an	O	O	O
association	O	O	B-T080
between	O	O	O
NLR	O	O	B-T081
and	O	O	O
papillary	O	O	B-T191
thyroid	O	O	I-T191
carcinoma	O	O	I-T191
in	O	O	O
patients	O	O	B-T101
stratified	O	O	B-T080
by	O	O	O
age	O	O	B-T032
<	O	O	O
45	O	O	O
and	O	O	O
â¥45	O	O	O
years	O	O	B-T079
(	O	O	O
496	O	O	O
and	O	O	O
891	O	O	O
cases	O	O	B-T077
,	O	O	O
respectively	O	O	O
)	O	O	O
;	O	O	O
the	O	O	O
pooled	O	O	O
MD	O	O	O
was	O	O	O
0.09	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
:	O	O	O
-0.37	O	O	O
to	O	O	O
0.55	O	O	O
;	O	O	O
I(2	O	O	O
)	O	O	O
=	O	O	O
92.2	O	O	O
%	O	O	O
,	O	O	O
P	O	O	B-T081
<	O	O	O
0.001	O	O	O
)	O	O	O
.	O	O	O

An	O	O	O
elevated	O	O	B-T080
NLR	O	O	B-T081
seems	O	O	O
not	O	O	O
a	O	O	O
reliable	O	O	B-T170
indicator	O	O	B-T169
of	O	O	O
progressing	O	O	B-T169
DTC	O	O	B-T191
in	O	O	O
patients	O	O	B-T101
with	O	O	O
goiters	O	O	B-T046
,	O	O	O
and	O	O	O
there	O	O	O
was	O	O	O
no	O	O	O
difference	O	O	O
in	O	O	O
NLR	O	O	O
between	O	O	O
patients	O	O	O
aged	O	O	B-T032
<	O	O	O
45	O	O	O
years	O	O	B-T079
and	O	O	O
those	O	O	O
aged	O	O	O
â¥45	O	O	O
years	O	O	O
.	O	O	O

Well-designed	O	O	O
and	O	O	O
large-scale	O	O	O
investigations	O	O	B-T058
are	O	O	O
warranted	O	O	O
to	O	O	O
understand	O	O	O
the	O	O	O
value	O	O	O
of	O	O	O
NLR	O	O	B-T081
in	O	O	O
the	O	O	O
prognosis	O	O	B-T033
of	O	O	O
DTC	O	O	B-T191
.	O	O	O

-DOCSTART- (27941943)

Transcriptomic	O	O	B-T086
insights	O	O	O
into	O	O	O
the	O	O	O
allelopathic	O	O	B-T070
effects	O	O	B-T080
of	O	O	I-T080
the	O	O	O
garlic	O	O	B-T168
allelochemical	O	O	B-T103
diallyl	O	O	B-T109
disulfide	O	O	I-T109
on	O	O	O
tomato	O	O	B-T168
roots	O	O	O

Garlic	O	O	B-T168
is	O	O	O
an	O	O	O
allelopathic	O	O	B-T070
crop	O	O	B-T002
that	O	O	O
can	O	O	O
alleviate	O	O	O
the	O	O	O
obstacles	O	O	O
to	O	O	O
continuous	O	O	B-T078
cropping	O	O	B-T090
of	O	O	O
vegetable	O	O	B-T002
crops	O	O	I-T002
.	O	O	O

Diallyl	O	O	B-T109
disulfide	O	O	I-T109
(	O	O	O
DADS	O	O	B-T109
)	O	O	O
,	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
most	O	O	O
important	O	O	O
allelochemicals	O	O	B-T103
in	O	O	O
garlic	O	O	B-T168
,	O	O	O
promotes	O	O	B-T052
tomato	O	O	B-T168
root	O	O	B-T040
growth	O	O	I-T040
.	O	O	O

Therefore	O	O	O
,	O	O	O
the	O	O	O
global	O	O	B-T080
transcriptome	O	O	B-T086
profiles	O	O	B-T081
of	O	O	O
DADS	O	O	B-T109
-	O	O	O
treated	O	O	B-T169
tomato	O	O	B-T168
roots	O	O	B-T002
over	O	O	O
time	O	O	O
were	O	O	O
investigated	O	O	B-T169
to	O	O	O
reveal	O	O	O
the	O	O	O
potential	O	O	B-T080
growth-promoting	O	O	B-UnknownType
mechanisms	O	O	I-UnknownType
.	O	O	O

We	O	O	O
detected	O	O	B-T033
1828	O	O	O
,	O	O	O
1296	O	O	O
and	O	O	O
1190	O	O	O
differentially	O	O	B-T045
expressed	O	O	I-T045
genes	O	O	B-T028
(	O	O	O
DEGs	O	O	B-T028
)	O	O	O
in	O	O	O
the	O	O	O
4	O	O	O
,	O	O	O
24	O	O	O
and	O	O	O
48	O	O	O
h	O	O	O
samples	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

Most	O	O	O
DEGs	O	O	B-T028
involved	O	O	O
in	O	O	O
assimilatory	O	O	B-T044
sulfate	O	O	I-T044
reduction	O	O	I-T044
and	O	O	O
glutathione	O	O	B-T044
metabolism	O	O	I-T044
were	O	O	O
up-regulated	O	O	B-T044
after	O	O	O
short-term	O	O	B-T079
(	O	O	O
4	O	O	O
h	O	O	O
)	O	O	O
DADS	O	O	B-T109
treatment	O	O	B-T169
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
increased	O	O	B-T033
activity	O	O	I-T033
of	O	O	I-T033
defensive	O	O	I-T033
enzymes	O	O	I-T033
and	O	O	O
up-regulation	O	O	B-T044
of	O	O	O
six	O	O	O
peroxidase	O	O	B-T028
genes	O	O	I-T028
were	O	O	O
observed	O	O	B-T169
,	O	O	O
suggesting	O	O	O
that	O	O	O
DADS	O	O	B-T109
could	O	O	O
induce	O	O	B-T169
tomato	O	O	B-T168
resistance	O	O	B-T169
.	O	O	O

In	O	O	O
plant-pathogen	O	O	B-T040
interactions	O	O	I-T040
,	O	O	O
DEGs	O	O	B-T028
related	O	O	O
to	O	O	O
calcium	O	O	B-T043
signaling	O	O	I-T043
were	O	O	O
primarily	O	O	O
inhibited	O	O	B-T080
,	O	O	O
while	O	O	O
those	O	O	O
encoding	O	O	B-T052
pathogenesis-related	O	O	B-T116
proteins	O	O	I-T116
were	O	O	O
primarily	O	O	O
up-regulated	O	O	B-T044
.	O	O	O

Although	O	O	O
plant	O	O	B-T002
hormone	O	O	B-T044
synthesis	O	O	I-T044
and	O	O	O
signal	O	O	B-T043
transduction	O	O	I-T043
were	O	O	O
both	O	O	O
significantly	O	O	B-T169
affected	O	O	I-T169
by	O	O	O
DADS	O	O	B-T109
,	O	O	O
the	O	O	O
expression	O	O	B-T045
trends	O	O	B-T079
of	O	O	O
the	O	O	O
genes	O	O	B-T028
in	O	O	O
these	O	O	O
two	O	O	O
pathways	O	O	B-T044
were	O	O	O
conflicting	O	O	O
.	O	O	O

This	O	O	O
research	O	O	B-T062
provides	O	O	O
comprehensive	O	O	B-T080
information	O	O	B-T078
concerning	O	O	O
the	O	O	O
changes	O	O	B-T169
in	O	O	O
the	O	O	O
tomato	O	O	B-T168
root	O	O	B-T002
transcriptome	O	O	B-T086
affected	O	O	B-T169
by	O	O	O
DADS	O	O	B-T109
and	O	O	O
may	O	O	O
help	O	O	O
direct	O	O	O
further	O	O	O
studies	O	O	B-T062
on	O	O	O
DADS	O	O	O
-	O	O	O
responsive	O	O	B-T169
genes	O	O	B-T028
to	O	O	O
enhance	O	O	B-T052
the	O	O	O
current	O	O	B-T079
understanding	O	O	O
of	O	O	O
the	O	O	O
mechanisms	O	O	B-T044
by	O	O	O
which	O	O	O
DADS	O	O	O
alleviates	O	O	O
the	O	O	O
obstacles	O	O	O
to	O	O	O
continuous	O	O	B-T078
cropping	O	O	B-T090
.	O	O	O

-DOCSTART- (27965426)

Mitotic	O	O	B-T080
phosphotyrosine	O	O	B-T116
network	O	O	B-T170
analysis	O	O	I-T170
reveals	O	O	O
that	O	O	O
tyrosine	O	O	B-T044
phosphorylation	O	O	I-T044
regulates	O	O	O
Polo-like	O	O	B-T116
kinase	O	O	I-T116
1	O	O	I-T116
(	O	O	O
PLK1	O	O	B-T116
)	O	O	O

Tyrosine	O	O	B-T044
phosphorylation	O	O	I-T044
is	O	O	O
closely	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
cell	O	O	B-T043
proliferation	O	O	I-T043
.	O	O	O

During	O	O	O
the	O	O	O
cell	O	O	B-T043
cycle	O	O	I-T043
,	O	O	O
serine	O	O	B-T044
and	O	O	I-T044
threonine	O	O	I-T044
phosphorylation	O	O	B-T044
plays	O	O	O
the	O	O	O
leading	O	O	O
role	O	O	O
,	O	O	O
and	O	O	O
such	O	O	O
phosphorylation	O	O	O
events	O	O	O
are	O	O	O
most	O	O	O
dynamic	O	O	B-T169
during	O	O	O
the	O	O	O
mitotic	O	O	B-T043
phase	O	O	I-T043
of	O	O	O
the	O	O	O
cell	O	O	O
cycle	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
mitotic	O	O	B-T080
phosphotyrosine	O	O	B-T116
is	O	O	O
not	O	O	O
well	O	O	O
characterized	O	O	O
.	O	O	O

Although	O	O	O
a	O	O	O
few	O	O	O
functionally	O	O	B-T169
-	O	O	O
relevant	O	O	B-T080
mitotic	O	O	B-T080
phosphotyrosine	O	O	B-T116
sites	O	O	B-T082
have	O	O	O
been	O	O	O
characterized	O	O	B-T052
,	O	O	O
evidence	O	O	O
suggests	O	O	O
that	O	O	O
this	O	O	O
modification	O	O	B-T169
may	O	O	O
be	O	O	O
more	O	O	O
prevalent	O	O	B-T081
than	O	O	O
previously	O	O	O
appreciated	O	O	O
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
examined	O	O	B-T033
tyrosine	O	O	B-T044
phosphorylation	O	O	I-T044
in	O	O	O
mitotic	O	O	B-T025
human	O	O	I-T025
cells	O	O	I-T025
including	O	O	O
those	O	O	O
on	O	O	O
spindle-associated	O	O	B-T116
proteins	O	O	I-T116
.	O	O	O

?	O	O	O

Database	O	O	B-T066
mining	O	O	I-T066
confirmed	O	O	O
~2000	O	O	O
mitotic	O	O	B-T080
phosphotyrosine	O	O	B-T116
sites	O	O	B-T082
,	O	O	O
and	O	O	O
network	O	O	B-T170
analysis	O	O	I-T170
revealed	O	O	O
a	O	O	O
number	O	O	O
of	O	O	O
subnetworks	O	O	O
that	O	O	O
were	O	O	O
enriched	O	O	O
in	O	O	O
tyrosine-phosphorylated	O	O	B-T116
proteins	O	O	I-T116
,	O	O	O
including	O	O	O
components	O	O	O
of	O	O	O
the	O	O	O
kinetochore	O	O	B-T026
or	O	O	O
spindle	O	O	B-T026
and	O	O	O
SRC	O	O	B-T116
family	O	O	I-T116
kinases	O	O	I-T116
.	O	O	O

We	O	O	O
identified	O	O	O
Polo-like	O	O	B-T116
kinase	O	O	I-T116
1	O	O	I-T116
(	O	O	O
PLK1	O	O	B-T116
)	O	O	O
,	O	O	O
a	O	O	O
major	O	O	O
signaling	O	O	B-T038
hub	O	O	O
in	O	O	O
the	O	O	O
spindle	O	O	B-T026
subnetwork	O	O	B-T169
,	O	O	O
as	O	O	O
phosphorylated	O	O	B-T116
at	O	O	O
the	O	O	O
conserved	O	O	O
Tyr(217	O	O	B-T116
)	O	O	I-T116
in	O	O	O
the	O	O	O
kinase	O	O	B-T087
domain	O	O	I-T087
.	O	O	O

Substitution	O	O	B-T045
of	O	O	O
Tyr(217	O	O	B-T116
)	O	O	I-T116
with	O	O	O
a	O	O	O
phosphomimetic	O	O	B-T104
residue	O	O	I-T104
eliminated	O	O	O
PLK1	O	O	B-T116
activity	O	O	B-T044
in	O	O	B-T080
vitro	O	O	I-T080
and	O	O	O
in	O	O	O
cells	O	O	B-T025
.	O	O	O

Further	O	O	O
analysis	O	O	B-T062
showed	O	O	O
that	O	O	O
Tyr(217	O	O	B-T116
)	O	O	I-T116
phosphorylation	O	O	B-T044
reduced	O	O	O
the	O	O	O
phosphorylation	O	O	B-T044
of	O	O	I-T044
Thr(210	O	O	I-T044
)	O	O	I-T044
in	O	O	O
the	O	O	O
activation	O	O	B-T082
loop	O	O	I-T082
,	O	O	O
a	O	O	O
phosphorylation	O	O	O
event	O	O	O
necessary	O	O	O
for	O	O	O
PLK1	O	O	B-T116
activity	O	O	B-T044
.	O	O	O

Our	O	O	O
data	O	O	O
indicate	O	O	O
that	O	O	O
mitotic	O	O	B-T080
tyrosine	O	O	B-T044
phosphorylation	O	O	I-T044
regulated	O	O	O
a	O	O	O
key	O	O	O
serine/threonine	O	O	B-T116
kinase	O	O	I-T116
hub	O	O	O
in	O	O	O
mitotic	O	O	B-T025
cells	O	O	I-T025
and	O	O	O
suggested	O	O	O
that	O	O	O
spatially	O	O	O
separating	O	O	O
tyrosine	O	O	O
phosphorylation	O	O	O
events	O	O	O
can	O	O	O
reveal	O	O	O
previously	O	O	O
unrecognized	O	O	B-T080
regulatory	O	O	B-T169
events	O	O	I-T169
and	O	O	O
complexes	O	O	B-T080
associated	O	O	O
with	O	O	O
specific	O	O	O
structures	O	O	B-T026
of	O	O	O
the	O	O	O
cell	O	O	B-T043
cycle	O	O	I-T043
.	O	O	O

-DOCSTART- (27975020)

Divided	O	O	B-T169
and	O	O	O
Sliding	O	O	B-T169
Superficial	O	O	B-T023
Temporal	O	O	I-T023
Artery	O	O	I-T023
Flap	O	O	B-T023
for	O	O	O
Primary	O	O	B-T080
Donor-site	O	O	B-T029
Closure	O	O	O

Superficial	O	O	B-T023
temporal	O	O	I-T023
artery	O	O	I-T023
(	O	O	O
STA	O	O	B-T023
)	O	O	O
flaps	O	O	B-T023
are	O	O	O
often	O	O	O
used	O	O	O
for	O	O	O
reconstruction	O	O	B-T061
of	O	O	O
hair-bearing	O	O	B-T029
areas	O	O	I-T029
.	O	O	O

However	O	O	O
,	O	O	O
primary	O	O	B-T061
closure	O	O	I-T061
of	O	O	O
the	O	O	O
donor	O	O	B-T029
site	O	O	I-T029
is	O	O	O
not	O	O	O
easy	O	O	O
when	O	O	O
the	O	O	O
size	O	O	B-T082
of	O	O	O
the	O	O	O
necessary	O	O	O
skin	O	O	B-T022
island	O	O	I-T022
is	O	O	O
relatively	O	O	O
large	O	O	B-T081
.	O	O	O

In	O	O	O
such	O	O	O
cases	O	O	O
,	O	O	O
skin	O	O	B-T023
grafts	O	O	I-T023
are	O	O	O
needed	O	O	O
at	O	O	O
the	O	O	O
donor	O	O	B-T029
site	O	O	I-T029
,	O	O	O
resulting	O	O	O
in	O	O	O
baldness	O	O	B-T047
.	O	O	O

We	O	O	O
have	O	O	O
solved	O	O	O
this	O	O	O
issue	O	O	O
by	O	O	O
applying	O	O	O
the	O	O	O
divided	O	O	B-T169
and	O	O	O
sliding	O	O	B-T169
flap	O	O	B-T023
technique	O	O	B-T169
,	O	O	O
which	O	O	O
was	O	O	O
first	O	O	O
reported	O	O	O
for	O	O	O
primary	O	O	B-T061
donor-site	O	O	I-T061
closure	O	O	I-T061
of	O	O	O
a	O	O	O
latissimus	O	O	B-T023
dorsi	O	O	I-T023
musculocutaneous	O	O	I-T023
flap	O	O	O
.	O	O	O

We	O	O	O
applied	O	O	O
this	O	O	O
technique	O	O	B-T169
to	O	O	O
the	O	O	O
hair-bearing	O	O	B-T023
STA	O	O	I-T023
flap	O	O	B-T023
,	O	O	O
where	O	O	O
primary	O	O	B-T061
donor-site	O	O	I-T061
closure	O	O	I-T061
is	O	O	O
extremely	O	O	O
beneficial	O	O	O
for	O	O	O
preventing	O	O	B-T080
baldness	O	O	B-T047
consequent	O	O	O
to	O	O	O
skin	O	O	B-T061
grafting	O	O	I-T061
.	O	O	O

The	O	O	O
STA	O	O	B-T023
flap	O	O	B-T023
was	O	O	O
divided	O	O	B-T169
into	O	O	O
3	O	O	O
,	O	O	O
and	O	O	O
creation	O	O	B-T052
of	O	O	O
large	O	O	O
flap	O	O	O
was	O	O	O
possible	O	O	O
.	O	O	O

Therefore	O	O	O
,	O	O	O
we	O	O	O
concluded	O	O	O
that	O	O	O
the	O	O	O
divided	O	O	B-T169
and	O	O	O
sliding	O	O	B-T169
STA	O	O	B-T023
flap	O	O	B-T023
could	O	O	O
at	O	O	O
least	O	O	O
partially	O	O	O
solve	O	O	O
the	O	O	O
donor-site	O	O	B-T029
problem	O	O	B-T033
.	O	O	O

Although	O	O	O
further	O	O	O
investigation	O	O	B-T058
is	O	O	O
necessary	O	O	O
to	O	O	O
validate	O	O	B-T062
the	O	O	O
maximum	O	O	B-T081
possible	O	O	B-T033
flap	O	O	B-T023
size	O	O	B-T082
,	O	O	O
this	O	O	O
technique	O	O	B-T169
may	O	O	O
be	O	O	O
applicable	O	O	O
to	O	O	O
at	O	O	O
least	O	O	O
small	O	O	B-T081
defects	O	O	B-T169
that	O	O	O
are	O	O	O
common	O	O	O
after	O	O	O
skin	O	O	B-T191
cancer	O	O	I-T191
ablation	O	O	B-T061
or	O	O	O
trauma	O	O	B-T037
.	O	O	O

-DOCSTART- (27975061)

Influence	O	O	B-T077
of	O	O	O
Surface	O	O	B-T070
Properties	O	O	I-T070
on	O	O	O
Adhesion	O	O	B-T067
Forces	O	O	I-T067
and	O	O	O
Attachment	O	O	B-T052
of	O	O	O
Streptococcus	O	O	B-T007
mutans	O	O	I-T007
to	O	O	O
Zirconia	O	O	B-T121
In	O	O	O
Vitro	O	O	O

Zirconia	O	O	B-T121
is	O	O	O
becoming	O	O	O
a	O	O	O
prevalent	O	O	B-T167
material	O	O	I-T167
in	O	O	O
dentistry	O	O	B-T091
.	O	O	O

However	O	O	O
,	O	O	O
any	O	O	O
foreign	O	O	B-T037
bodies	O	O	I-T037
inserted	O	O	B-T058
may	O	O	O
provide	O	O	O
new	O	O	O
niches	O	O	O
for	O	O	O
the	O	O	O
bacteria	O	O	B-T007
in	O	O	O
oral	O	O	B-T030
cavity	O	O	I-T030
.	O	O	O

The	O	O	O
object	O	O	O
of	O	O	O
this	O	O	O
study	O	O	O
was	O	O	O
to	O	O	O
explore	O	O	O
the	O	O	O
effect	O	O	B-T080
of	O	O	O
surface	O	O	B-T070
properties	O	O	I-T070
including	O	O	O
surface	O	O	B-T033
roughness	O	O	I-T033
and	O	O	O
hydrophobicity	O	O	B-T080
on	O	O	O
the	O	O	O
adhesion	O	O	B-T070
and	O	O	O
biofilm	O	O	B-T043
formation	O	O	I-T043
of	O	O	O
Streptococcus	O	O	B-T007
mutans	O	O	I-T007
(	O	O	O
S.	O	O	B-T007
mutans	O	O	I-T007
)	O	O	O
to	O	O	O
zirconia	O	O	B-T121
.	O	O	O

Atomic	O	O	B-T059
force	O	O	I-T059
microscopy	O	O	I-T059
was	O	O	O
employed	O	O	O
to	O	O	O
determine	O	O	O
the	O	O	O
zirconia	O	O	B-T121
surface	O	O	B-T082
morphology	O	O	B-T080
and	O	O	O
the	O	O	O
adhesion	O	O	B-T067
forces	O	O	I-T067
between	O	O	O
the	O	O	O
S.	O	O	B-T007
mutans	O	O	I-T007
and	O	O	O
zirconia	O	O	O
.	O	O	O

The	O	O	O
results	O	O	B-T169
showed	O	O	O
that	O	O	O
the	O	O	O
surface	O	O	B-T033
roughness	O	O	I-T033
was	O	O	O
nanoscale	O	O	B-T081
and	O	O	O
significantly	O	O	O
different	O	O	B-T080
among	O	O	O
tested	O	O	B-T078
groups	O	O	I-T078
(	O	O	O
P	O	O	O
<	O	O	O
0.05	O	O	O
):	O	O	O
Coarse	O	O	B-T080
(	O	O	O
23.94	O	O	O
Â±	O	O	O
2.52	O	O	O
nm	O	O	O
)	O	O	O
>	O	O	O
Medium	O	O	B-T081
(	O	O	O
17.00	O	O	O
Â±	O	O	O
3.81	O	O	O
nm	O	O	O
)	O	O	O
>	O	O	O
Fine	O	O	B-T080
(	O	O	O
11.89	O	O	O
Â±	O	O	O
1.68	O	O	O
nm	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
contact	O	O	B-T082
angles	O	O	I-T082
of	O	O	O
the	O	O	O
Coarse	O	O	B-T078
group	O	O	I-T078
were	O	O	O
the	O	O	O
highest	O	O	O
,	O	O	O
followed	O	O	O
by	O	O	O
the	O	O	O
Medium	O	O	B-T081
and	O	O	O
the	O	O	O
Fine	O	O	B-T078
groups	O	O	I-T078
.	O	O	O

Increasing	O	O	O
the	O	O	O
surface	O	O	B-T033
roughness	O	O	I-T033
and	O	O	O
hydrophobicity	O	O	B-T080
resulted	O	O	O
in	O	O	O
an	O	O	O
increase	O	O	O
of	O	O	O
adhesion	O	O	B-T067
forces	O	O	I-T067
and	O	O	O
early	O	O	O
attachment	O	O	B-T052
(	O	O	O
2	O	O	O
h	O	O	O
and	O	O	O
4	O	O	O
h	O	O	O
)	O	O	O
of	O	O	O
S.	O	O	B-T007
mutans	O	O	I-T007
on	O	O	O
the	O	O	O
zirconia	O	O	B-T121
but	O	O	O
no	O	O	O
influence	O	O	B-T077
on	O	O	O
the	O	O	O
further	O	O	O
development	O	O	B-T169
of	O	O	O
biofilm	O	O	B-T007
(	O	O	O
6	O	O	O
h~24	O	O	O
h	O	O	O
)	O	O	O
.	O	O	O

Our	O	O	O
findings	O	O	O
suggest	O	O	O
that	O	O	O
the	O	O	O
surface	O	O	B-T033
roughness	O	O	I-T033
in	O	O	O
nanoscale	O	O	B-T081
and	O	O	O
hydrophobicity	O	O	B-T080
of	O	O	O
zirconia	O	O	B-T121
had	O	O	O
influence	O	O	B-T077
on	O	O	O
the	O	O	O
S.	O	O	B-T007
mutans	O	O	I-T007
initial	O	O	O
adhesion	O	O	B-T067
force	O	O	I-T067
and	O	O	O
early	O	O	O
attachment	O	O	B-T052
instead	O	O	O
of	O	O	O
whole	O	O	O
stages	O	O	O
of	O	O	O
biofilm	O	O	B-T043
formation	O	O	I-T043
.	O	O	O

-DOCSTART- (27977319)

The	O	O	O
relationship	O	O	O
between	O	O	O
thiamine	O	O	B-T127
and	O	O	O
two	O	O	O
symbioses	O	O	B-T070
:	O	O	O
Root	O	O	B-T002
nodule	O	O	I-T002
symbiosis	O	O	B-T070
and	O	O	O
arbuscular	O	O	O
mycorrhiza	O	O	O

Lotus	O	O	B-T002
japonicus	O	O	I-T002
THIC	O	O	B-T028
is	O	O	O
expressed	O	O	B-T045
in	O	O	O
all	O	O	O
organs	O	O	B-T002
,	O	O	O
and	O	O	O
the	O	O	O
encoded	O	O	B-T116
protein	O	O	I-T116
catalyzes	O	O	B-T070
thiamine	O	O	B-T044
biosynthesis	O	O	I-T044
.	O	O	O

Loss	O	O	B-T033
of	O	O	I-T033
function	O	O	I-T033
produces	O	O	O
chlorosis	O	O	B-T047
,	O	O	O
a	O	O	O
typical	O	O	O
thiamine	O	O	B-T127
-deficiency	O	O	O
phenotype	O	O	B-T032
,	O	O	O
and	O	O	O
mortality	O	O	B-T081
.	O	O	O

To	O	O	O
investigate	O	O	O
thiamine	O	O	B-T127
's	O	O	I-T127
role	O	O	O
in	O	O	O
symbiosis	O	O	B-T070
,	O	O	O
we	O	O	O
focused	O	O	O
on	O	O	O
THI1	O	O	B-T028
,	O	O	O
a	O	O	O
thiamine-biosynthesis	O	O	B-T028
gene	O	O	I-T028
expressed	O	O	B-T045
in	O	O	O
roots	O	O	B-T002
,	O	O	O
nodules	O	O	B-T002
,	O	O	O
and	O	O	O
seeds	O	O	B-T002
.	O	O	O

The	O	O	O
thi1	O	O	B-T028
mutant	O	O	I-T028
had	O	O	O
green	O	O	B-T002
leaves	O	O	I-T002
,	O	O	O
but	O	O	O
formed	O	O	O
small	O	O	B-T081
nodules	O	O	B-T002
and	O	O	O
immature	O	O	B-T080
seeds	O	O	B-T002
.	O	O	O

These	O	O	O
phenotypes	O	O	B-T032
were	O	O	O
rescued	O	O	O
by	O	O	O
THI1	O	O	B-T028
complementation	O	O	B-T045
and	O	O	O
by	O	O	O
exogenous	O	O	B-T169
thiamine	O	O	B-T127
.	O	O	O

Thus	O	O	O
,	O	O	O
THI1	O	O	B-T028
is	O	O	O
required	O	O	O
for	O	O	O
nodule	O	O	B-T002
enlargement	O	O	B-T169
and	O	O	O
seed	O	O	B-T039
maturation	O	O	I-T039
.	O	O	O

On	O	O	O
the	O	O	O
other	O	O	O
hand	O	O	O
,	O	O	O
colonization	O	O	B-T033
by	O	O	O
arbuscular	O	O	B-T004
mycorrhiza	O	O	I-T004
(	O	O	O
AM	O	O	B-T004
)	O	O	O
fungus	O	O	B-T004
Rhizophagus	O	O	B-T004
irregularis	O	O	I-T004
was	O	O	O
not	O	O	O
affected	O	O	O
in	O	O	O
the	O	O	O
thi1	O	O	B-T028
mutant	O	O	I-T028
or	O	O	O
by	O	O	O
exogenous	O	O	B-T169
thiamine	O	O	B-T127
.	O	O	O

However	O	O	O
,	O	O	O
spores	O	O	B-T004
of	O	O	O
R.	O	O	B-T004
irregularis	O	O	I-T004
stored	O	O	O
more	O	O	O
thiamine	O	O	B-T127
than	O	O	O
the	O	O	O
source	O	O	O
(	O	O	O
host	O	O	B-UnknownType
plants	O	O	I-UnknownType
)	O	O	O
,	O	O	O
despite	O	O	O
lacking	O	O	O
thiamine	O	O	B-T028
biosynthesis	O	O	I-T028
genes	O	O	I-T028
.	O	O	O

Therefore	O	O	O
,	O	O	O
disturbance	O	O	O
of	O	O	O
the	O	O	O
thiamine	O	O	B-T127
supply	O	O	O
would	O	O	O
affect	O	O	O
progeny	O	O	B-T099
phenotypes	O	O	B-T032
such	O	O	O
as	O	O	O
spore	O	O	B-T043
formation	O	O	I-T043
and	O	O	O
hyphal	O	O	B-T043
growth	O	O	I-T043
.	O	O	O

Further	O	O	O
investigation	O	O	O
will	O	O	O
be	O	O	O
required	O	O	O
to	O	O	O
elucidate	O	O	O
thiamine	O	O	B-T127
's	O	O	I-T127
effect	O	O	O
on	O	O	O
AM	O	O	B-T004
.	O	O	O

-DOCSTART- (27977439)

Bilateral	O	O	B-T082
sternal	O	O	B-T023
infusion	O	O	B-T061
of	O	O	O
ropivacaine	O	O	B-T109
and	O	O	O
length	O	O	B-T079
of	O	O	I-T079
stay	O	O	I-T079
in	O	O	O
ICU	O	O	B-T093
after	O	O	O
cardiac	O	O	B-T061
surgery	O	O	I-T061
with	O	O	O
increased	O	O	B-T081
respiratory	O	O	B-UnknownType
risk	O	O	I-UnknownType
:	O	O	O
A	O	O	O
randomised	O	O	O
controlled	O	O	O
trial	O	O	O

The	O	O	O
continuous	O	O	O
bilateral	O	O	B-T082
infusion	O	O	B-T061
of	O	O	O
a	O	O	O
local	O	O	B-T109
anaesthetic	O	O	I-T109
solution	O	O	B-T122
around	O	O	O
the	O	O	O
sternotomy	O	O	B-T061
wound	O	O	B-T037
(	O	O	O
bilateral	O	O	O
sternal	O	O	B-T023
)	O	O	O
is	O	O	O
an	O	O	O
innovative	O	O	O
technique	O	O	B-T169
for	O	O	O
reducing	O	O	B-T080
pain	O	O	B-T184
after	O	O	O
sternotomy	O	O	O
.	O	O	O

To	O	O	O
assess	O	O	O
the	O	O	O
effects	O	O	B-T080
of	O	O	O
the	O	O	O
technique	O	O	B-T169
on	O	O	O
the	O	O	O
need	O	O	O
for	O	O	O
intensive	O	O	B-T058
care	O	O	I-T058
in	O	O	O
cardiac	O	O	B-T101
patients	O	O	I-T101
at	O	O	O
increased	O	O	B-T081
risk	O	O	B-T078
of	O	O	O
respiratory	O	O	B-T046
complications	O	O	I-T046
.	O	O	O

Randomised	O	O	B-T062
,	O	O	I-T062
observer-blind	O	O	I-T062
controlled	O	O	I-T062
trial	O	O	I-T062
.	O	O	O

Single	O	O	O
centre	O	O	O
,	O	O	O
French	O	O	B-T093
University	O	O	I-T093
Hospital	O	O	I-T093
.	O	O	O

In	O	O	O
total	O	O	O
,	O	O	O
120	O	O	O
adults	O	O	B-T100
scheduled	O	O	O
for	O	O	O
open-heart	O	O	B-T061
surgery	O	O	I-T061
,	O	O	O
with	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
following	O	O	O
conditions	O	O	O
:	O	O	O
age	O	O	B-T032
more	O	O	O
than	O	O	O
75	O	O	O
years	O	O	B-T079
,	O	O	O
BMI	O	O	B-T201
>	O	O	O
30	O	O	O
kg	O	O	O
m	O	O	O
,	O	O	O
chronic	O	O	B-T047
obstructive	O	O	I-T047
pulmonary	O	O	I-T047
disease	O	O	I-T047
,	O	O	O
active	O	O	B-T169
smoking	O	O	I-T169
habit	O	O	I-T169
.	O	O	O

Either	O	O	O
a	O	O	O
bilateral	O	O	B-T082
sternal	O	O	B-T023
infusion	O	O	B-T061
of	O	O	O
0.2	O	O	O
%	O	O	O
ropivacaine	O	O	B-T109
(	O	O	O
3	O	O	O
ml	O	O	O
h	O	O	O
through	O	O	O
each	O	O	O
catheter	O	O	B-T074
;	O	O	O
'	O	O	B-T098
intervention	O	O	I-T098
'	O	O	I-T098
group	O	O	I-T098
)	O	O	O
,	O	O	O
or	O	O	O
standardised	O	O	B-T052
care	O	O	I-T052
only	O	O	O
(	O	O	O
'	O	O	B-T096
control	O	O	I-T096
'	O	O	I-T096
group	O	O	I-T096
)	O	O	O
.	O	O	O

Analgesia	O	O	B-T061
was	O	O	O
provided	O	O	O
with	O	O	O
paracetamol	O	O	B-T109
and	O	O	O
self-administered	O	O	B-T169
intravenous	O	O	B-T169
morphine	O	O	B-T109
.	O	O	O

The	O	O	O
length	O	O	B-T079
of	O	O	I-T079
time	O	O	I-T079
to	O	O	O
readiness	O	O	B-T033
for	O	O	O
discharge	O	O	B-T058
from	O	O	O
ICU	O	O	B-T093
,	O	O	O
blindly	O	O	O
assessed	O	O	B-T052
by	O	O	O
a	O	O	O
committee	O	O	B-T096
of	O	O	O
experts	O	O	B-T097
.	O	O	O

No	O	O	B-T080
effect	O	O	I-T080
was	O	O	O
found	O	O	O
between	O	O	O
groups	O	O	B-T078
for	O	O	O
the	O	O	O
primary	O	O	B-T080
outcome	O	O	I-T080
(	O	O	O
P	O	O	O
=	O	O	O
0.680	O	O	O
,	O	O	O
intention	O	O	B-T062
to	O	O	I-T062
treat	O	O	I-T062
)	O	O	O
;	O	O	O
the	O	O	O
median	O	O	B-T080
values	O	O	I-T080
were	O	O	O
42.4	O	O	O
and	O	O	O
37.7	O	O	O
h	O	O	O
,	O	O	O
respectively	O	O	O
for	O	O	O
the	O	O	O
control	O	O	B-T096
and	O	O	O
intervention	O	O	B-T098
groups	O	O	I-T098
(	O	O	O
P	O	O	O
=	O	O	O
0.873	O	O	O
)	O	O	O
.	O	O	O

Similar	O	O	O
nonsignificant	O	O	O
trends	O	O	O
were	O	O	O
noted	O	O	O
for	O	O	O
other	O	O	O
postoperative	O	O	B-T033
delays	O	O	B-T079
.	O	O	O

Significant	O	O	O
effects	O	O	B-T080
favouring	O	O	O
the	O	O	O
intervention	O	O	B-T061
were	O	O	O
noted	O	O	O
for	O	O	O
dynamic	O	O	B-T184
pain	O	O	I-T184
,	O	O	O
patient	O	O	B-T080
satisfaction	O	O	I-T080
,	O	O	O
occurrence	O	O	B-T079
of	O	O	I-T184
nausea	O	O	I-T184
and	O	O	O
vomiting	O	O	B-T184
,	O	O	O
occurrence	O	O	O
of	O	O	O
delirium	O	O	B-T048
or	O	O	O
mental	O	O	B-T048
confusion	O	O	I-T048
and	O	O	O
occurrence	O	O	O
of	O	O	O
pulmonary	O	O	B-T046
complications	O	O	I-T046
.	O	O	O

In	O	O	O
12	O	O	O
patients	O	O	B-T101
,	O	O	O
although	O	O	O
no	O	O	O
symptoms	O	O	B-T184
actually	O	O	O
occurred	O	O	O
,	O	O	O
the	O	O	O
total	O	O	O
ropivacaine	O	O	O
plasma	O	O	O
level	O	O	O
exceeded	O	O	O
the	O	O	O
lowest	O	O	O
value	O	O	O
for	O	O	O
which	O	O	O
neurological	O	O	B-T184
symptoms	O	O	I-T184
have	O	O	O
been	O	O	O
observed	O	O	O
in	O	O	O
healthy	O	O	B-T098
volunteers	O	O	I-T098
.	O	O	O

Because	O	O	O
of	O	O	O
a	O	O	O
small	O	O	B-T081
size	O	O	I-T081
effect	O	O	I-T081
,	O	O	O
and	O	O	O
despite	O	O	O
significant	O	O	O
analgesic	O	O	B-T033
effects	O	O	I-T033
,	O	O	O
this	O	O	O
strategy	O	O	O
failed	O	O	O
to	O	O	O
reduce	O	O	O
the	O	O	O
time	O	O	B-T079
spent	O	O	O
in	O	O	O
ICU	O	O	B-T093
.	O	O	O

EudraCT	O	O	B-T077
(	O	O	O
N	O	O	O
Â°	O	O	O
:	O	O	O
2012	O	O	O
-	O	O	O
005225	O	O	O
-	O	O	O
69	O	O	O
)	O	O	O
;	O	O	O
ClinicalTrials.gov	O	O	B-T170
(	O	O	O
NCT01828788	O	O	O
)	O	O	O
.	O	O	O

-DOCSTART- (27977762)

Pupil	O	O	B-T201
Sizes	O	O	I-T201
Scale	O	O	B-T170
with	O	O	O
Attentional	O	O	B-T170
Load	O	O	I-T170
and	O	O	O
Task	O	O	B-T057
Experience	O	O	B-T041
in	O	O	O
a	O	O	O
Multiple	O	O	B-T081
Object	O	O	B-T072
Tracking	O	O	B-T082
Task	O	O	O

Previous	O	O	O
studies	O	O	O
have	O	O	O
related	O	O	O
changes	O	O	B-T169
in	O	O	O
attentional	O	O	B-T170
load	O	O	I-T170
to	O	O	O
pupil	O	O	B-T201
size	O	O	I-T201
modulations	O	O	B-T082
.	O	O	O

However	O	O	O
,	O	O	O
studies	O	O	O
relating	O	O	O
changes	O	O	B-T169
in	O	O	O
attentional	O	O	B-T170
load	O	O	I-T170
and	O	O	O
task	O	O	B-T057
experience	O	O	B-T041
on	O	O	O
a	O	O	O
finer	O	O	O
scale	O	O	B-T170
to	O	O	O
pupil	O	O	B-T201
size	O	O	I-T201
modulations	O	O	B-T082
are	O	O	O
scarce	O	O	O
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
investigated	O	O	B-T169
how	O	O	O
these	O	O	O
changes	O	O	B-T169
affect	O	O	B-T041
pupil	O	O	B-T201
sizes	O	O	I-T201
.	O	O	O

To	O	O	O
manipulate	O	O	B-T053
attentional	O	O	B-T170
load	O	O	I-T170
,	O	O	O
participants	O	O	B-T098
covertly	O	O	O
tracked	O	O	B-T082
between	O	O	O
zero	O	O	B-T081
and	O	O	O
five	O	O	B-T081
objects	O	O	B-T072
among	O	O	O
several	O	O	O
randomly	O	O	B-T080
moving	O	O	O
objects	O	O	O
on	O	O	O
a	O	O	O
computer	O	O	B-T073
screen	O	O	B-T073
.	O	O	O

To	O	O	O
investigate	O	O	B-T169
effects	O	O	B-T080
of	O	O	I-T080
task	O	O	B-T057
experience	O	O	B-T041
,	O	O	O
the	O	O	O
experiment	O	O	O
was	O	O	O
conducted	O	O	O
on	O	O	O
three	O	O	B-T081
consecutive	O	O	B-T080
days	O	O	B-T079
.	O	O	O

We	O	O	O
found	O	O	O
that	O	O	O
pupil	O	O	B-T201
sizes	O	O	I-T201
increased	O	O	O
with	O	O	O
each	O	O	O
increment	O	O	B-T081
in	O	O	O
attentional	O	O	B-T170
load	O	O	I-T170
.	O	O	O

Across	O	O	O
days	O	O	B-T079
,	O	O	O
we	O	O	O
found	O	O	O
systematic	O	O	B-T169
pupil	O	O	B-T201
size	O	O	I-T201
reductions	O	O	B-T080
.	O	O	O

We	O	O	O
compared	O	O	O
the	O	O	O
model	O	O	B-T080
fit	O	O	I-T080
for	O	O	O
predicting	O	O	O
pupil	O	O	B-T201
size	O	O	I-T201
modulations	O	O	B-T082
using	O	O	O
attentional	O	O	B-T170
load	O	O	I-T170
,	O	O	O
task	O	O	B-T057
experience	O	O	B-T041
,	O	O	O
and	O	O	O
task	O	O	B-T061
performance	O	O	I-T061
as	O	O	O
predictors	O	O	B-T078
.	O	O	O

We	O	O	O
found	O	O	O
that	O	O	O
a	O	O	O
model	O	O	B-T170
which	O	O	O
included	O	O	O
attentional	O	O	B-T170
load	O	O	I-T170
and	O	O	O
task	O	O	B-T057
experience	O	O	B-T041
as	O	O	O
predictors	O	O	B-T078
had	O	O	O
the	O	O	O
best	O	O	O
model	O	O	B-T080
fit	O	O	I-T080
while	O	O	O
adding	O	O	O
performance	O	O	B-T061
as	O	O	O
a	O	O	O
predictor	O	O	B-T078
to	O	O	O
this	O	O	O
model	O	O	O
reduced	O	O	O
the	O	O	O
overall	O	O	O
model	O	O	O
fit	O	O	O
.	O	O	O

Overall	O	O	O
,	O	O	O
results	O	O	B-T169
suggest	O	O	O
that	O	O	O
pupillometry	O	O	B-T060
provides	O	O	O
a	O	O	O
viable	O	O	B-T080
metric	O	O	B-T081
for	O	O	O
precisely	O	O	O
assessing	O	O	O
attentional	O	O	B-T170
load	O	O	I-T170
and	O	O	O
task	O	O	B-T057
experience	O	O	B-T041
in	O	O	O
visuospatial	O	O	B-T041
tasks	O	O	B-T057
.	O	O	O

-DOCSTART- (27984742)

Back	O	O	O
to	O	O	O
the	O	O	O
Roots	O	O	O
:	O	O	O
Deep	O	O	O
View	O	O	O
into	O	O	O
the	O	O	O
Evolutionary	O	O	B-T038
History	O	O	B-T169
of	O	O	O
ADP-Ribosylation	O	O	B-T067
Opened	O	O	O
by	O	O	O
the	O	O	O
DNA	O	O	B-T114
-	O	O	O
Targeting	O	O	B-T169
Toxin	O	O	B-T123
-	O	O	O
Antitoxin	O	O	B-T129
Module	O	O	O
DarTG	O	O	O

In	O	O	O
this	O	O	O
issue	O	O	O
of	O	O	O
Molecular	O	O	B-T091
Cell	O	O	I-T091
,	O	O	O
Jankevicius	O	O	O
et	O	O	O
al.	O	O	O
(	O	O	O
2016	O	O	O
)	O	O	O
characterize	O	O	O
the	O	O	O
DarTG	O	O	B-T077
toxin	O	O	B-T123
-	O	O	O
antitoxin	O	O	B-T129
module	O	O	B-T077
in	O	O	O
which	O	O	O
the	O	O	O
DarT	O	O	B-T116
toxin	O	O	O
ADP-ribosylates	O	O	B-T067
single-stranded	O	O	B-T114
DNA	O	O	I-T114
and	O	O	O
the	O	O	O
DarG	O	O	B-T116
antitoxin	O	O	O
counteracts	O	O	B-T169
DarT	O	O	O
by	O	O	O
direct	O	O	O
binding	O	O	B-T044
and	O	O	O
by	O	O	O
enzymatic	O	O	B-T116
remova	O	O	B-T052
l	O	O	O
of	O	O	O
the	O	O	O
ADP-ribosylation	O	O	B-T067
.	O	O	O

-DOCSTART- (27986797)

Growth	O	O	B-T116
differentiation	O	O	I-T116
factor	O	O	I-T116
15	O	O	I-T116
is	O	O	O
a	O	O	O
myomitokine	O	O	B-T123
governing	O	O	O
systemic	O	O	O
energy	O	O	O
homeostasis	O	O	O

Reduced	O	O	B-T080
mitochondrial	O	O	B-T026
electron	O	O	I-T026
transport	O	O	I-T026
chain	O	O	I-T026
activity	O	O	B-T052
promotes	O	O	B-T052
longevity	O	O	B-T079
and	O	O	O
improves	O	O	B-T033
energy	O	O	B-T038
homeostasis	O	O	I-T038
via	O	O	O
cell-autonomous	O	O	B-T043
and	O	O	O
-	O	O	O
non-autonomous	O	O	B-T043
factors	O	O	I-T043
in	O	O	O
multiple	O	O	B-T075
model	O	O	I-T075
systems	O	O	I-T075
.	O	O	O

This	O	O	O
mitohormetic	O	O	B-T040
effect	O	O	B-T080
is	O	O	O
thought	O	O	O
to	O	O	O
involve	O	O	O
the	O	O	O
mitochondrial	O	O	B-T026
unfolded	O	O	I-T044
protein	O	O	I-T044
response	O	O	I-T044
(	O	O	O
UPR(mt	O	O	B-T044
)	O	O	I-T044
)	O	O	O
,	O	O	O
an	O	O	O
adaptive	O	O	B-T039
stress-response	O	O	I-T039
pathway	O	O	B-T077
activated	O	O	B-T052
by	O	O	O
mitochondrial	O	O	O
proteotoxic	O	O	B-T046
stress	O	O	I-T046
.	O	O	O

Using	O	O	O
mice	O	O	B-T015
with	O	O	O
skeletal	O	O	B-T024
muscle-specific	O	O	B-T024
deficiency	O	O	B-T169
of	O	O	O
Crif1	O	O	B-T116
(	O	O	O
muscle-specific	O	O	O
knockout	O	O	B-T015
[	O	O	O
MKO	O	O	B-T015
]	O	O	O
)	O	O	O
,	O	O	O
an	O	O	O
integral	O	O	B-T116
protein	O	O	I-T116
of	O	O	O
the	O	O	O
large	O	O	B-T026
mitoribosomal	O	O	I-T026
subunit	O	O	I-T026
(	O	O	O
39S	O	O	B-T026
)	O	O	O
,	O	O	O
we	O	O	O
identified	O	O	O
growth	O	O	B-T116
differentiation	O	O	I-T116
factor	O	O	I-T116
15	O	O	I-T116
(	O	O	O
GDF15	O	O	B-T116
)	O	O	O
as	O	O	O
a	O	O	O
UPR(mt	O	O	B-T044
)	O	O	I-T044
-associated	O	O	O
cell-non-autonomous	O	O	B-T043
myomitokine	O	O	B-T123
that	O	O	O
regulates	O	O	B-T039
systemic	O	O	I-T039
energy	O	O	I-T039
homeostasis	O	O	I-T039
.	O	O	O

MKO	O	O	B-T015
mice	O	O	I-T015
were	O	O	O
protected	O	O	B-T033
against	O	O	O
obesity	O	O	B-T047
and	O	O	O
sensitized	O	O	B-T040
to	O	O	O
insulin	O	O	B-T116
,	O	O	O
an	O	O	O
effect	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
elevated	O	O	B-T080
GDF15	O	O	B-T116
secretion	O	O	B-T043
after	O	O	O
UPR(mt	O	O	B-T044
)	O	O	I-T044
activation	O	O	B-T052
.	O	O	O

In	O	O	O
ob/ob	O	O	B-T015
mice	O	O	I-T015
,	O	O	O
administration	O	O	O
of	O	O	O
recombinant	O	O	B-T116
GDF15	O	O	B-T116
decreased	O	O	B-T081
body	O	O	B-T032
weight	O	O	I-T032
and	O	O	O
improved	O	O	B-T033
insulin	O	O	B-T046
sensitivity	O	O	I-T046
,	O	O	O
which	O	O	O
was	O	O	O
attributed	O	O	O
to	O	O	O
elevated	O	O	B-T080
oxidative	O	O	B-T043
metabolism	O	O	I-T043
and	O	O	O
lipid	O	O	B-T042
mobilization	O	O	I-T042
in	O	O	O
the	O	O	O
liver	O	O	B-T023
,	O	O	O
muscle	O	O	B-T024
,	O	O	O
and	O	O	O
adipose	O	O	B-T024
tissue	O	O	I-T024
.	O	O	O

Thus	O	O	O
,	O	O	O
GDF15	O	O	B-T116
is	O	O	O
a	O	O	O
potent	O	O	B-T080
mitohormetic	O	O	B-T040
signal	O	O	B-T038
that	O	O	O
safeguards	O	O	O
against	O	O	O
the	O	O	O
onset	O	O	B-T033
of	O	O	I-T033
obesity	O	O	I-T033
and	O	O	O
insulin	O	O	B-T046
resistance	O	O	I-T046
.	O	O	O

-DOCSTART- (27987927)

Synthesis	O	O	B-T052
and	O	O	O
characterization	O	O	B-T052
of	O	O	O
acetylated	O	O	B-T109
amylose	O	O	I-T109
and	O	O	O
development	O	O	B-T169
of	O	O	O
inclusion	O	O	B-T104
complexes	O	O	I-T104
with	O	O	O
rifampicin	O	O	O

Amylose	O	O	B-T109
(	O	O	O
AM	O	O	B-T109
)	O	O	O
tends	O	O	O
to	O	O	O
form	O	O	O
single	O	O	O
helical	O	O	O
inclusion	O	O	B-T104
complexes	O	O	I-T104
with	O	O	O
suitable	O	O	O
agents	O	O	B-T120
.	O	O	O

These	O	O	O
complexes	O	O	B-T104
are	O	O	O
considered	O	O	B-T078
promising	O	O	O
biomaterial	O	O	B-T122
carrier	O	O	O
since	O	O	O
the	O	O	O
guest	O	O	B-T167
molecules	O	O	I-T167
can	O	O	O
be	O	O	O
released	O	O	B-T169
later	O	O	B-T079
,	O	O	O
leading	O	O	O
to	O	O	O
many	O	O	O
applications	O	O	B-T169
,	O	O	O
especially	O	O	O
in	O	O	O
the	O	O	O
pharmaceutical	O	O	B-T093
industry	O	O	I-T093
.	O	O	O

Rifampicin	O	O	B-T195
(	O	O	O
RIF	O	O	B-T195
)	O	O	O
has	O	O	O
long	O	O	O
been	O	O	O
recognized	O	O	O
as	O	O	O
an	O	O	O
active	O	O	B-T169
drug	O	O	B-T121
against	O	O	O
Mycobacterium	O	O	B-T007
tuberculosis	O	O	I-T007
,	O	O	O
however	O	O	O
,	O	O	O
the	O	O	O
administration	O	O	B-T061
of	O	O	O
RIF	O	O	O
in	O	O	O
high	O	O	O
dosages	O	O	B-T081
can	O	O	O
originate	O	O	O
unwanted	O	O	O
side-effects	O	O	B-T169
.	O	O	O

Due	O	O	O
to	O	O	O
the	O	O	O
fact	O	O	O
that	O	O	O
the	O	O	O
use	O	O	O
of	O	O	O
native	O	O	B-T169
amylose	O	O	B-T109
(	O	O	O
AM	O	O	B-T109
)	O	O	O
in	O	O	O
the	O	O	O
formation	O	O	B-T169
of	O	O	O
complexes	O	O	B-T104
is	O	O	O
limited	O	O	O
by	O	O	O
their	O	O	O
low	O	O	O
water	O	O	B-T121
solubility	O	O	B-T080
,	O	O	O
it	O	O	O
was	O	O	O
acetylated	O	O	O
with	O	O	O
a	O	O	O
medium	O	O	O
degree	O	O	B-T081
of	O	O	O
substitution	O	O	B-T052
(	O	O	O
DS	O	O	B-T052
)	O	O	O
,	O	O	O
allowing	O	O	O
solubilizing	O	O	B-T080
(	O	O	O
0.5gL(-1	O	O	O
)	O	O	O
)	O	O	O
acetylated	O	O	B-T109
amylose	O	O	I-T109
(	O	O	O
AMA	O	O	B-T109
)	O	O	O
in	O	O	O
water	O	O	O
at	O	O	O
neutral	O	O	B-T080
pH	O	O	I-T080
,	O	O	O
in	O	O	O
opposition	O	O	O
to	O	O	O
that	O	O	O
observed	O	O	B-T169
with	O	O	O
native	O	O	O
amylose	O	O	O
(	O	O	O
trace	O	O	B-T081
solubility	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
resulting	O	O	O
acetylated	O	O	B-T109
amylose	O	O	I-T109
was	O	O	O
characterized	O	O	B-T052
by	O	O	O
means	O	O	O
of	O	O	O
Fourier	O	O	B-T062
Transform	O	O	I-T062
Infrared	O	O	I-T062
(	O	O	I-T062
FT-IR	O	O	I-T062
)	O	O	I-T062
spectroscopy	O	O	I-T062
and	O	O	O
Scanning	O	O	B-T059
Electron	O	O	I-T059
Microscopy	O	O	I-T059
(	O	O	O
SEM	O	O	B-T059
)	O	O	O
.	O	O	O

FT-IR	O	O	B-T062
results	O	O	B-T169
indicated	O	O	B-T033
that	O	O	O
the	O	O	O
acetylation	O	O	B-T044
of	O	O	O
anhydroglucose	O	O	B-T109
units	O	O	B-T081
of	O	O	O
amylose	O	O	B-T109
corresponds	O	O	O
to	O	O	O
a	O	O	O
low	O	O	B-T080
DS	O	O	B-T052
,	O	O	O
whereas	O	O	O
SEM	O	O	B-T059
results	O	O	O
suggested	O	O	O
that	O	O	O
the	O	O	O
smooth	O	O	B-T082
surfaces	O	O	B-T082
of	O	O	O
amylose	O	O	O
granules	O	O	B-T167
were	O	O	O
changed	O	O	B-T169
into	O	O	O
rougher	O	O	O
surfaces	O	O	O
after	O	O	O
acetylation	O	O	O
.	O	O	O

Ultraviolet	O	O	B-T059
absorption	O	O	I-T059
spectroscopy	O	O	I-T059
(	O	O	O
UV-vis	O	O	B-T059
)	O	O	O
analysis	O	O	B-T062
confirmed	O	O	B-T080
the	O	O	O
formation	O	O	B-T169
and	O	O	O
allowed	O	O	O
the	O	O	O
quantification	O	O	B-T081
of	O	O	O
both	O	O	O
native	O	O	B-T169
(	O	O	O
AM	O	O	B-T109
-	O	O	O
RIF	O	O	B-T195
)	O	O	O
and	O	O	O
acetylated	O	O	O
(	O	O	O
AMA	O	O	B-T109
-	O	O	O
RIF	O	O	O
)	O	O	O
amylose	O	O	B-T109
inclusion	O	O	B-T104
complexes	O	O	I-T104
.	O	O	O

Their	O	O	O
characterization	O	O	B-T052
in	O	O	O
solution	O	O	B-T167
was	O	O	O
performed	O	O	B-T169
by	O	O	O
dynamic	O	O	B-T059
light	O	O	I-T059
scattering	O	O	I-T059
(	O	O	O
DLS	O	O	B-T059
)	O	O	O
and	O	O	O
zeta	O	O	B-T067
potential	O	O	I-T067
(	O	O	O
ZP	O	O	B-T067
)	O	O	O
measurements	O	O	B-T169
.	O	O	O

The	O	O	O
average	O	O	B-T082
size	O	O	I-T082
of	O	O	O
inclusion	O	O	B-T104
complexes	O	O	I-T104
as	O	O	O
determined	O	O	B-T080
by	O	O	I-T080
DLS	O	O	B-T059
,	O	O	O
ranged	O	O	B-T081
between	O	O	O
70	O	O	O
and	O	O	O
100	O	O	O
nm	O	O	O
.	O	O	O

Besides	O	O	O
,	O	O	O
ZP	O	O	B-T067
analysis	O	O	B-T062
showed	O	O	O
that	O	O	O
both	O	O	O
complexes	O	O	B-T104
are	O	O	O
more	O	O	O
stable	O	O	B-T080
in	O	O	O
the	O	O	O
presence	O	O	B-T033
of	O	O	O
RIF	O	O	B-T195
.	O	O	O

This	O	O	O
study	O	O	O
may	O	O	O
lead	O	O	O
to	O	O	O
the	O	O	O
development	O	O	B-T169
of	O	O	O
an	O	O	O
effective	O	O	B-T080
method	O	O	O
for	O	O	O
the	O	O	O
preparation	O	O	B-T052
of	O	O	O
amylose	O	O	B-T109
inclusion	O	O	B-T104
complexes	O	O	I-T104
,	O	O	O
which	O	O	O
is	O	O	O
beneficial	O	O	O
to	O	O	O
their	O	O	O
further	O	O	B-T082
application	O	O	B-T169
in	O	O	O
drug	O	O	B-T074
delivery	O	O	I-T074
systems	O	O	I-T074
.	O	O	O

-DOCSTART- (27990563)

Selective	O	O	B-T052
reaching	O	O	B-T040
in	O	O	O
macaques	O	O	B-T015
:	O	O	O
evidence	O	O	B-T078
for	O	O	O
action	O	O	B-T052
-centred	O	O	O
attention	O	O	O

When	O	O	O
a	O	O	O
monkey	O	O	B-T015
selects	O	O	B-T052
a	O	O	O
piece	O	O	O
of	O	O	O
food	O	O	B-T168
lying	O	O	O
on	O	O	O
the	O	O	O
ground	O	O	O
from	O	O	O
among	O	O	O
other	O	O	B-T080
viable	O	O	B-T080
objects	O	O	B-T072
in	O	O	O
the	O	O	O
near	O	O	B-T080
vicinity	O	O	B-T082
,	O	O	O
only	O	O	O
the	O	O	O
desired	O	O	B-T041
item	O	O	B-T168
governs	O	O	B-T080
the	O	O	O
particular	O	O	O
pattern	O	O	B-T082
and	O	O	O
direction	O	O	B-T082
of	O	O	O
the	O	O	O
animal	O	O	B-T008
's	O	O	I-T008
reaching	O	O	B-T040
action	O	O	B-T052
.	O	O	O

It	O	O	O
would	O	O	O
seem	O	O	O
then	O	O	O
that	O	O	O
selection	O	O	B-T052
is	O	O	O
an	O	O	O
important	O	O	B-T080
component	O	O	B-T078
controlling	O	O	B-T169
the	O	O	O
animal	O	O	B-T008
's	O	O	I-T008
action	O	O	B-T052
.	O	O	O

But	O	O	O
,	O	O	O
we	O	O	O
may	O	O	O
ask	O	O	O
,	O	O	O
is	O	O	O
the	O	O	O
selection	O	O	B-T052
process	O	O	B-T067
in	O	O	O
such	O	O	O
cases	O	O	B-T169
impervious	O	O	O
to	O	O	O
the	O	O	O
presence	O	O	B-T080
of	O	O	O
other	O	O	B-T080
objects	O	O	B-T072
that	O	O	O
could	O	O	O
constitute	O	O	B-T169
potential	O	O	B-T080
obstacles	O	O	B-T072
to	O	O	O
or	O	O	O
constraints	O	O	B-T169
on	O	O	O
movement	O	O	B-T040
execution	O	O	B-T052
?	O	O	O
And	O	O	O
if	O	O	O
it	O	O	O
is	O	O	O
,	O	O	O
in	O	O	O
fact	O	O	O
,	O	O	O
pervious	O	O	B-T169
to	O	O	O
other	O	O	O
objects	O	O	O
,	O	O	O
do	O	O	O
they	O	O	O
have	O	O	O
a	O	O	O
direct	O	O	B-T080
influence	O	O	B-T077
on	O	O	O
the	O	O	O
organization	O	O	B-T039
of	O	O	O
the	O	O	O
response	O	O	B-T032
?	O	O	O

The	O	O	O
kinematics	O	O	B-T091
of	O	O	O
macaques	O	O	B-T015
'	O	O	O
reaching	O	O	B-T040
movements	O	O	B-T040
were	O	O	O
examined	O	O	B-T033
by	O	O	O
the	O	O	O
current	O	O	B-T079
study	O	O	B-T062
that	O	O	O
analysed	O	O	B-T062
some	O	O	O
exemplars	O	O	O
as	O	O	O
they	O	O	O
selectively	O	O	B-T052
reached	O	O	B-T040
to	O	O	O
grasp	O	O	B-T040
a	O	O	O
food	O	O	B-T168
item	O	O	I-T168
in	O	O	O
the	O	O	O
absence	O	O	B-T169
as	O	O	O
well	O	O	O
as	O	O	O
in	O	O	O
the	O	O	O
presence	O	O	B-T080
of	O	O	O
potential	O	O	B-T080
obstacles	O	O	B-T072
(	O	O	O
i.e.	O	O	O
,	O	O	O
stones	O	O	B-T072
)	O	O	O
that	O	O	O
could	O	O	O
affect	O	O	B-T041
the	O	O	O
arm	O	O	B-T029
trajectory	O	O	B-T082
.	O	O	O

Changes	O	O	B-T169
in	O	O	O
movement	O	O	B-T040
parameterization	O	O	B-UnknownType
were	O	O	O
noted	O	O	B-T080
in	O	O	O
temporal	O	O	B-T079
measures	O	O	B-T081
,	O	O	O
such	O	O	O
as	O	O	O
movement	O	O	O
time	O	O	B-T079
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
in	O	O	O
spatial	O	O	B-T082
ones	O	O	I-T082
,	O	O	O
such	O	O	O
as	O	O	O
paths	O	O	O
of	O	O	O
trajectory	O	O	B-T082
.	O	O	O

Generally	O	O	O
speaking	O	O	O
,	O	O	O
the	O	O	O
presence	O	O	B-T080
of	O	O	O
stones	O	O	B-T072
in	O	O	O
the	O	O	O
vicinity	O	O	B-T082
of	O	O	O
the	O	O	O
acting	O	O	B-T055
hand	O	O	B-T023
stalled	O	O	B-T052
the	O	O	O
reaching	O	O	B-T040
movement	O	O	B-T040
and	O	O	O
affected	O	O	B-T041
the	O	O	O
arm	O	O	B-T029
trajectory	O	O	B-T082
as	O	O	O
the	O	O	O
hand	O	O	O
veered	O	O	B-T033
away	O	O	I-T033
from	O	O	O
the	O	O	O
stone	O	O	B-T072
even	O	O	O
when	O	O	O
it	O	O	O
was	O	O	O
not	O	O	B-T169
a	O	O	O
physical	O	O	B-T169
obstacle	O	O	B-T072
.	O	O	O

We	O	O	O
concluded	O	O	O
that	O	O	O
nearby	O	O	B-T080
objects	O	O	B-T072
evoke	O	O	O
a	O	O	O
motor	O	O	B-T201
response	O	O	I-T201
in	O	O	O
macaques	O	O	B-T015
,	O	O	O
and	O	O	O
the	O	O	O
attentional	O	O	B-T041
mechanisms	O	O	B-T169
that	O	O	O
allow	O	O	O
for	O	O	O
a	O	O	O
successful	O	O	B-T080
action	O	O	B-T052
selection	O	O	B-T052
are	O	O	O
revealed	O	O	B-T080
in	O	O	O
the	O	O	O
reaching	O	O	B-T040
path	O	O	B-T082
.	O	O	O

The	O	O	O
data	O	O	B-T078
outlined	O	O	O
here	O	O	O
concur	O	O	O
with	O	O	O
human	O	O	B-T016
studies	O	O	B-T062
indicating	O	O	B-T078
that	O	O	O
potential	O	O	B-T080
obstacles	O	O	B-T072
are	O	O	O
internally	O	O	B-T082
represented	O	O	B-T052
,	O	O	O
a	O	O	O
finding	O	O	B-T033
implying	O	O	O
basic	O	O	B-T169
cognitive	O	O	B-T169
operations	O	O	B-T052
allowing	O	O	O
for	O	O	O
action	O	O	B-T052
selection	O	O	B-T052
in	O	O	O
macaques	O	O	B-T015
.	O	O	O

-DOCSTART- (27991454)

A	O	O	O
novel	O	O	B-T080
method	O	O	B-T170
for	O	O	O
interactive	O	O	B-T169
multi-objective	O	O	B-T080
dose-guided	O	O	O
patient	O	O	O
positioning	O	O	O

In	O	O	O
intensity-modulated	O	O	B-T061
radiation	O	O	I-T061
therapy	O	O	I-T061
(	O	O	O
IMRT	O	O	B-T061
)	O	O	O
,	O	O	O
3D	O	O	O
in-room	O	O	O
imaging	O	O	B-T060
data	O	O	B-T078
is	O	O	O
typically	O	O	O
utilized	O	O	O
for	O	O	O
accurate	O	O	B-T080
patient	O	O	B-UnknownType
alignment	O	O	I-UnknownType
on	O	O	O
the	O	O	O
basis	O	O	O
of	O	O	O
anatomical	O	O	B-T029
landmarks	O	O	I-T029
.	O	O	O

In	O	O	O
the	O	O	O
presence	O	O	O
of	O	O	O
non-rigid	O	O	O
anatomical	O	O	B-T169
changes	O	O	I-T169
,	O	O	O
it	O	O	O
is	O	O	O
often	O	O	O
not	O	O	O
obvious	O	O	O
which	O	O	O
patient	O	O	B-T033
position	O	O	I-T033
is	O	O	O
most	O	O	O
suitable	O	O	O
.	O	O	O

Thus	O	O	O
,	O	O	O
dose	O	O	B-T081
-guided	O	O	O
patient	O	O	B-UnknownType
alignment	O	O	I-UnknownType
is	O	O	O
an	O	O	O
interesting	O	O	O
approach	O	O	O
to	O	O	O
use	O	O	O
available	O	O	O
in-room	O	O	O
imaging	O	O	B-T060
data	O	O	B-T078
for	O	O	O
up-to-date	O	O	O
dose	O	O	O
calculation	O	O	B-T052
,	O	O	O
aimed	O	O	O
at	O	O	O
finding	O	O	B-T033
the	O	O	O
position	O	O	O
that	O	O	O
yields	O	O	O
the	O	O	O
optimal	O	O	B-T080
dose	O	O	O
distribution	O	O	B-T169
.	O	O	O

This	O	O	O
contribution	O	O	O
presents	O	O	O
the	O	O	O
first	O	O	O
implementation	O	O	O
of	O	O	O
dose	O	O	B-T081
-guided	O	O	O
patient	O	O	B-UnknownType
alignment	O	O	I-UnknownType
as	O	O	O
multi-criteria	O	O	O
optimization	O	O	O
problem	O	O	O
.	O	O	O

User-defined	O	O	O
clinical	O	O	B-T080
objectives	O	O	B-T170
are	O	O	O
employed	O	O	O
for	O	O	O
setting	O	O	O
up	O	O	O
a	O	O	O
multi-objective	O	O	B-T080
problem	O	O	O
.	O	O	O

Using	O	O	O
pre-calculated	O	O	O
dose	O	O	B-T081
distributions	O	O	B-T169
at	O	O	O
a	O	O	O
limited	O	O	O
number	O	O	O
of	O	O	O
patient	O	O	B-T058
shifts	O	O	I-T058
and	O	O	O
dose	O	O	O
interpolation	O	O	B-T062
,	O	O	O
a	O	O	O
continuous	O	O	O
space	O	O	O
of	O	O	O
Pareto-efficient	O	O	B-T058
patient	O	O	I-T058
shifts	O	O	I-T058
becomes	O	O	O
accessible	O	O	O
.	O	O	O

Pareto	O	O	O
sliders	O	O	O
facilitate	O	O	O
interactive	O	O	B-T169
browsing	O	O	O
of	O	O	O
the	O	O	O
possible	O	O	O
shifts	O	O	O
with	O	O	O
real-time	O	O	O
dose	O	O	B-T081
display	O	O	O
to	O	O	O
the	O	O	O
user	O	O	O
.	O	O	O

Dose	O	O	B-T081
interpolation	O	O	B-T062
accuracy	O	O	B-T080
is	O	O	O
validated	O	O	O
and	O	O	O
the	O	O	O
potential	O	O	O
of	O	O	O
multi-objective	O	O	B-T080
dose-guided	O	O	B-T058
positioning	O	O	I-T058
demonstrated	O	O	O
for	O	O	O
three	O	O	O
head	O	O	B-T191
and	O	O	I-T191
neck	O	O	I-T191
(	O	O	O
H&N	O	O	B-T191
)	O	O	O
and	O	O	O
three	O	O	O
prostate	O	O	B-T191
cancer	O	O	I-T191
patients	O	O	B-T101
.	O	O	O

Dose-guided	O	O	B-T058
positioning	O	O	I-T058
is	O	O	O
compared	O	O	B-T052
to	O	O	O
replanning	O	O	O
for	O	O	O
all	O	O	O
cases	O	O	O
.	O	O	O

A	O	O	O
delineated	O	O	O
replanning	O	O	O
CT	O	O	B-T060
served	O	O	O
as	O	O	O
surrogate	O	O	O
for	O	O	O
in-room	O	O	O
imaging	O	O	B-T060
data	O	O	B-T078
.	O	O	O

Dose	O	O	B-T081
interpolation	O	O	B-T062
accuracy	O	O	B-T080
was	O	O	O
high	O	O	B-T080
.	O	O	O

Using	O	O	O
a	O	O	O
[	O	O	O
Formula	O	O	O
:	O	O	O
see	O	O	O
text	O	O	O
]	O	O	O
dose	O	O	B-T081
difference	O	O	O
criterion	O	O	O
,	O	O	O
a	O	O	O
median	O	O	O
pass-rate	O	O	O
of	O	O	O
95.7	O	O	O
%	O	O	O
for	O	O	O
H&N	O	O	B-T191
and	O	O	O
99.6	O	O	O
%	O	O	O
for	O	O	O
prostate	O	O	B-T191
cases	O	O	I-T191
was	O	O	O
determined	O	O	O
in	O	O	O
a	O	O	O
comparison	O	O	B-T052
to	O	O	O
exact	O	O	O
dose	O	O	O
calculations	O	O	B-T052
.	O	O	O

For	O	O	O
all	O	O	O
patients	O	O	B-T101
,	O	O	O
dose-guided	O	O	B-T058
positioning	O	O	I-T058
allowed	O	O	O
to	O	O	O
find	O	O	O
a	O	O	O
clinically	O	O	O
preferable	O	O	O
dose	O	O	B-T081
distribution	O	O	B-T169
compared	O	O	B-T052
to	O	O	O
bony	O	O	B-T081
anatomy	O	O	I-T081
based	O	O	I-T081
alignment	O	O	I-T081
.	O	O	O

For	O	O	O
all	O	O	O
H&N	O	O	B-T191
cases	O	O	O
,	O	O	O
mean	O	O	O
dose	O	O	B-T081
to	O	O	O
the	O	O	O
spared	O	O	O
parotid	O	O	B-T023
glands	O	O	I-T023
was	O	O	O
below	O	O	O
[	O	O	O
Formula	O	O	O
:	O	O	O
see	O	O	O
text	O	O	O
]	O	O	O
(	O	O	O
up	O	O	O
to	O	O	O
[	O	O	O
Formula	O	O	O
:	O	O	O
see	O	O	O
text	O	O	O
]	O	O	O
with	O	O	O
bony	O	O	B-T081
alignment	O	O	I-T081
)	O	O	O
and	O	O	O
clinical	O	O	B-T081
target	O	O	I-T081
volume	O	O	I-T081
(	O	O	O
CTV	O	O	B-T081
)	O	O	O
[	O	O	O
Formula	O	O	O
:	O	O	O
see	O	O	O
text	O	O	O
]	O	O	O
above	O	O	O
99.1	O	O	O
%	O	O	O
(	O	O	O
compared	O	O	B-T052
to	O	O	O
95.1	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

For	O	O	O
all	O	O	O
prostate	O	O	B-T191
patients	O	O	B-T101
,	O	O	O
CTV	O	O	B-T081
[	O	O	O
Formula	O	O	O
:	O	O	O
see	O	O	O
text	O	O	O
]	O	O	O
was	O	O	O
above	O	O	O
98.9	O	O	O
%	O	O	O
(	O	O	O
compared	O	O	B-T052
to	O	O	O
88.5	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
[	O	O	O
Formula	O	O	O
:	O	O	O
see	O	O	O
text	O	O	O
]	O	O	O
to	O	O	O
the	O	O	O
rectum	O	O	O
below	O	O	O
[	O	O	O
Formula	O	O	O
:	O	O	O
see	O	O	O
text	O	O	O
]	O	O	O
(	O	O	O
compared	O	O	O
to	O	O	O
56.1	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

Replanning	O	O	O
yielded	O	O	O
improved	O	O	O
results	O	O	O
for	O	O	O
the	O	O	O
H&N	O	O	B-T191
cases	O	O	O
.	O	O	O

For	O	O	O
the	O	O	O
prostate	O	O	B-T191
cases	O	O	I-T191
,	O	O	O
differences	O	O	O
to	O	O	O
dose-guided	O	O	B-T058
positioning	O	O	I-T058
were	O	O	O
minor	O	O	O
.	O	O	O

-DOCSTART- (27994448)

Clinical	O	O	B-T033
and	O	O	O
radiological	O	O	B-T060
outcome	O	O	B-T169
following	O	O	O
pneumothorax	O	O	B-T047
after	O	O	O
endoscopic	O	O	B-T061
lung	O	O	I-T061
volume	O	O	I-T061
reduction	O	O	I-T061
with	O	O	O
valves	O	O	O

Valve	O	O	B-T074
implantation	O	O	B-T061
has	O	O	O
evolved	O	O	O
as	O	O	O
a	O	O	O
therapy	O	O	B-T061
for	O	O	O
patients	O	O	B-T101
with	O	O	O
advanced	O	O	B-T080
emphysema	O	O	B-T047
.	O	O	O

Although	O	O	O
it	O	O	O
is	O	O	O
a	O	O	O
minimally	O	O	B-T061
invasive	O	O	I-T061
treatmen	O	O	I-T061
t	O	O	O
,	O	O	O
it	O	O	O
is	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
complications	O	O	B-T046
,	O	O	O
the	O	O	O
most	O	O	O
common	O	O	B-T081
being	O	O	O
pneumothorax	O	O	B-T047
.	O	O	O

Pneumothorax	O	O	B-T047
occurs	O	O	O
due	O	O	O
to	O	O	O
the	O	O	O
rapid	O	O	B-T080
target	O	O	B-T169
lobe	O	O	B-T023
volume	O	O	B-T061
reduction	O	O	I-T061
and	O	O	O
may	O	O	O
be	O	O	O
a	O	O	O
predictor	O	O	B-T078
of	O	O	O
clinical	O	O	B-T080
benefit	O	O	B-T081
despite	O	O	O
this	O	O	O
complication	O	O	B-T046
.	O	O	O

The	O	O	O
objective	O	O	B-T170
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
conduct	O	O	O
an	O	O	O
exploratory	O	O	B-T080
data	O	O	I-T080
analysis	O	O	I-T080
of	O	O	O
patients	O	O	B-T101
who	O	O	O
developed	O	O	O
a	O	O	O
pneumothorax	O	O	B-T047
following	O	O	O
endoscopic	O	O	B-T061
valve	O	O	I-T061
therapy	O	O	I-T061
for	O	O	O
emphysema	O	O	B-T047
.	O	O	O

This	O	O	O
study	O	O	B-T062
performed	O	O	B-T169
a	O	O	O
retrospective	O	O	B-T062
evaluation	O	O	I-T062
of	O	O	O
pneumothorax	O	O	B-T047
management	O	O	B-T058
and	O	O	O
the	O	O	O
impact	O	O	B-T080
of	O	O	O
pneumothorax	O	O	O
on	O	O	O
clinical	O	O	B-T033
outcomes	O	O	I-T033
in	O	O	O
70	O	O	O
patients	O	O	B-T101
following	O	O	O
valve	O	O	B-T061
therapy	O	O	I-T061
in	O	O	O
381	O	O	O
consecutive	O	O	B-T080
patients	O	O	O
.	O	O	O

Pneumothorax	O	O	B-T047
rate	O	O	B-T081
following	O	O	O
valve	O	O	B-T061
therapy	O	O	I-T061
was	O	O	O
18	O	O	O
%	O	O	O
.	O	O	O

Pneumothorax	O	O	B-T047
management	O	O	B-T058
consisted	O	O	O
of	O	O	O
chest	O	O	B-T061
tube	O	O	I-T061
insertion	O	O	I-T061
,	O	O	O
valve	O	O	B-T074
removal	O	O	B-T061
,	O	O	O
and	O	O	O
surgical	O	O	B-T033
intervention	O	O	I-T033
in	O	O	O
87	O	O	O
%	O	O	O
(	O	O	O
61/70	O	O	O
)	O	O	O
,	O	O	O
44	O	O	O
%	O	O	O
(	O	O	O
31/70	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
19	O	O	O
%	O	O	O
(	O	O	O
13/70	O	O	O
)	O	O	O
of	O	O	O
the	O	O	O
patients	O	O	B-T101
,	O	O	O
respectively	O	O	O
.	O	O	O

Despite	O	O	O
pneumothorax	O	O	B-T047
,	O	O	O
patients	O	O	B-T101
experienced	O	O	O
modest	O	O	B-T080
but	O	O	O
significant	O	O	B-T078
improvements	O	O	B-T077
in	O	O	O
lung	O	O	B-T042
function	O	O	I-T042
parameters	O	O	B-T077
(	O	O	O
forced	O	O	B-T042
expiratory	O	O	I-T042
volume	O	O	I-T042
in	O	O	O
1	O	O	O
second	O	O	O
:	O	O	O
55Â±148	O	O	O
mL	O	O	O
,	O	O	O
residual	O	O	B-T201
volume	O	O	I-T201
:	O	O	O
-390Â±964	O	O	O
mL	O	O	O
,	O	O	O
total	O	O	B-T033
lung	O	O	I-T033
capacity	O	O	I-T033
:	O	O	O
-348Â±876	O	O	O
;	O	O	O
all	O	O	O
P<0.05	O	O	O
)	O	O	O
.	O	O	O

Persistent	O	O	B-T079
lobar	O	O	B-T046
atelectasis	O	O	I-T046
3	O	O	O
months	O	O	O
after	O	O	O
recovering	O	O	B-T077
from	O	O	O
pneumothorax	O	O	B-T047
,	O	O	O
which	O	O	O
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
relevant	O	O	B-T080
clinical	O	O	B-T080
improvement	O	O	B-T077
,	O	O	O
was	O	O	O
observed	O	O	B-T169
in	O	O	O
only	O	O	O
21	O	O	O
%	O	O	O
(	O	O	O
15/70	O	O	O
)	O	O	O
of	O	O	O
the	O	O	O
patients	O	O	B-T101
.	O	O	O

Pneumothorax	O	O	B-T047
is	O	O	O
a	O	O	O
frequent	O	O	B-T079
severe	O	O	B-T080
complication	O	O	B-T046
following	O	O	O
valve	O	O	B-T061
therapy	O	O	I-T061
that	O	O	O
requires	O	O	O
further	O	O	O
intervention	O	O	B-T061
.	O	O	O

Nevertheless	O	O	O
,	O	O	O
the	O	O	O
pneumothorax	O	O	B-T047
does	O	O	O
not	O	O	O
impair	O	O	B-T169
the	O	O	O
clinical	O	O	B-T080
status	O	O	I-T080
in	O	O	O
the	O	O	O
majority	O	O	O
of	O	O	O
patients	O	O	B-T101
.	O	O	O

Patients	O	O	B-T101
with	O	O	O
lobar	O	O	B-T046
atelectasis	O	O	I-T046
benefit	O	O	B-T081
after	O	O	O
recovering	O	O	B-T077
from	O	O	O
pneumothorax	O	O	B-T047
in	O	O	O
terms	O	O	O
of	O	O	O
lung	O	O	B-T042
function	O	O	I-T042
parameters	O	O	B-T077
.	O	O	O

-DOCSTART- (27994535)

3Mo	O	O	B-T075
:	O	O	O
A	O	O	O
Model	O	O	B-T075
for	O	O	O
Music	O	O	B-T170
-	O	O	O
Based	O	O	B-T169
Biofeedback	O	O	O

In	O	O	O
the	O	O	O
domain	O	O	B-T169
of	O	O	O
sports	O	O	B-T056
and	O	O	O
motor	O	O	B-T038
rehabilitation	O	O	B-T169
,	O	O	O
it	O	O	O
is	O	O	O
of	O	O	O
major	O	O	B-T080
importance	O	O	B-T080
to	O	O	O
regulate	O	O	B-T038
and	O	O	O
control	O	O	B-T169
physiological	O	O	B-T039
processes	O	O	I-T039
and	O	O	O
physical	O	O	B-T070
motion	O	O	I-T070
in	O	O	O
most	O	O	B-T081
optimal	O	O	B-T080
ways	O	O	O
.	O	O	O

For	O	O	O
that	O	O	O
purpose	O	O	B-T169
,	O	O	O
real-time	O	O	B-T079
auditory	O	O	B-T041
feedback	O	O	I-T041
of	O	O	O
physiological	O	O	B-T169
and	O	O	O
physical	O	O	B-T169
information	O	O	B-T078
based	O	O	B-T169
on	O	O	O
sound	O	O	B-T070
signals	O	O	I-T070
,	O	O	O
often	O	O	O
termed	O	O	O
"	O	O	O
sonification	O	O	B-T169
,	O	O	O
"	O	O	O
has	O	O	O
been	O	O	O
proven	O	O	B-T080
particularly	O	O	O
useful	O	O	B-T080
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
use	O	O	B-T169
of	O	O	O
music	O	O	B-T170
in	O	O	O
biofeedback	O	O	B-T061
systems	O	O	B-T169
has	O	O	O
been	O	O	O
much	O	O	O
less	O	O	B-T081
explored	O	O	B-T061
.	O	O	O

In	O	O	O
the	O	O	O
current	O	O	B-T079
article	O	O	B-T170
,	O	O	O
we	O	O	O
assert	O	O	O
that	O	O	O
the	O	O	O
use	O	O	B-T169
of	O	O	O
music	O	O	B-T170
,	O	O	O
and	O	O	O
musical	O	O	B-T170
principles	O	O	B-T078
,	O	O	O
can	O	O	O
have	O	O	O
a	O	O	O
major	O	O	B-T080
added	O	O	O
value	O	O	B-T170
,	O	O	O
on	O	O	O
top	O	O	O
of	O	O	O
mere	O	O	B-T080
sound	O	O	B-T070
signals	O	O	I-T070
,	O	O	O
to	O	O	O
the	O	O	O
benefit	O	O	B-T081
of	O	O	O
psychological	O	O	B-T169
and	O	O	O
physical	O	O	B-T169
optimization	O	O	B-T052
of	O	O	O
sports	O	O	B-T056
and	O	O	O
motor	O	O	B-T038
rehabilitation	O	O	B-T169
tasks	O	O	B-T057
.	O	O	O

In	O	O	O
this	O	O	O
article	O	O	B-T170
,	O	O	O
we	O	O	O
present	O	O	B-T078
the	O	O	O
3Mo	O	O	B-T075
model	O	O	I-T075
to	O	O	O
describe	O	O	O
three	O	O	O
main	O	O	B-T080
functions	O	O	B-T169
of	O	O	O
music	O	O	B-T170
that	O	O	O
contribute	O	O	B-T052
to	O	O	O
these	O	O	O
benefits	O	O	B-T081
.	O	O	O

These	O	O	O
functions	O	O	B-T169
relate	O	O	O
the	O	O	O
power	O	O	B-T078
of	O	O	O
music	O	O	B-T170
to	O	O	O
Motivate	O	O	B-T041
,	O	O	O
and	O	O	O
to	O	O	O
Monitor	O	O	B-T058
and	O	O	O
Modify	O	O	B-T169
physiological	O	O	B-T169
and	O	O	O
physical	O	O	B-T169
processes	O	O	B-T067
.	O	O	O

The	O	O	O
model	O	O	B-T075
brings	O	O	O
together	O	O	O
concepts	O	O	B-T078
and	O	O	O
theories	O	O	B-T078
related	O	O	O
to	O	O	O
human	O	O	B-T016
sensorimotor	O	O	B-T040
interaction	O	O	I-T040
with	O	O	O
music	O	O	B-T170
,	O	O	O
and	O	O	O
specifies	O	O	B-T080
the	O	O	O
underlying	O	O	O
psychological	O	O	B-T169
and	O	O	O
physiological	O	O	B-T169
principles	O	O	B-T078
.	O	O	O

This	O	O	O
3Mo	O	O	B-T075
model	O	O	I-T075
is	O	O	O
intended	O	O	B-T080
to	O	O	O
provide	O	O	B-T052
a	O	O	O
conceptual	O	O	B-T077
framework	O	O	I-T077
that	O	O	O
guides	O	O	B-T170
future	O	O	B-T079
research	O	O	B-T062
on	O	O	O
musical	O	O	B-T170
biofeedback	O	O	B-T061
systems	O	O	B-T169
in	O	O	O
the	O	O	O
domain	O	O	B-T169
of	O	O	O
sports	O	O	B-T056
and	O	O	O
motor	O	O	B-T038
rehabilitation	O	O	B-T169
.	O	O	O

Journal	O	O	O

-DOCSTART- (27994640)

Analysis	O	O	B-T059
of	O	O	O
tilianin	O	O	B-T109
and	O	O	O
acacetin	O	O	B-T109
in	O	O	O
Agastache	O	O	B-T002
rugosa	O	O	I-T002
by	O	O	O
high-performance	O	O	B-T059
liquid	O	O	I-T059
chromatography	O	O	I-T059
with	O	O	O
ionic	O	O	B-T103
liquids	O	O	I-T103
-	O	O	O
ultrasound	O	O	B-T169
based	O	O	O
extraction	O	O	O

Ionic	O	O	B-T103
liquid	O	O	I-T103
1-butyl-3-methylimidazolium	O	O	B-T109
bromide	O	O	I-T109
-	O	O	O
methanol	O	O	B-T109
-based	O	O	O
ultrasonic	O	O	B-T169
-assisted	O	O	O
extraction	O	O	B-T059
(	O	O	O
ILUAE	O	O	B-T059
)	O	O	O
was	O	O	O
used	O	O	O
to	O	O	O
extract	O	O	B-T059
tilianin	O	O	B-T109
and	O	O	O
acacetin	O	O	B-T109
from	O	O	O
the	O	O	O
aerial	O	O	B-T002
parts	O	O	I-T002
of	O	O	O
Agastache	O	O	B-T002
rugose	O	O	I-T002
(	O	O	O
A.	O	O	B-T002
rugose	O	O	I-T002
)	O	O	O
,	O	O	O
and	O	O	O
simultaneously	O	O	O
determined	O	O	O
by	O	O	O
reversed	O	O	B-T059
phase	O	O	I-T059
high	O	O	I-T059
performance	O	O	I-T059
liquid	O	O	I-T059
chromatographic	O	O	I-T059
(	O	O	O
RP-HPLC	O	O	B-T059
)	O	O	O
method	O	O	O
with	O	O	O
ultraviolet	O	O	B-T170
detection	O	O	I-T170
(	O	O	O
RP-HPLC-UV	O	O	B-T170
)	O	O	I-T170
.	O	O	O

An	O	O	O
InertSustain	O	O	B-T075
RP-C18	O	O	I-T075
column	O	O	I-T075
was	O	O	O
used	O	O	O
with	O	O	O
the	O	O	O
mobile	O	O	B-T130
phase	O	O	I-T130
consisting	O	O	O
of	O	O	O
methanol	O	O	B-T109
and	O	O	O
0.2	O	O	O
%	O	O	O
acetic	O	O	B-T109
acid	O	O	I-T109
as	O	O	O
gradient	O	O	B-T081
elution	O	O	B-T059
at	O	O	O
the	O	O	O
detection	O	O	B-T081
wavelength	O	O	I-T081
of	O	O	O
332	O	O	O
nm	O	O	O
.	O	O	O

The	O	O	O
flow	O	O	B-T081
rate	O	O	I-T081
was	O	O	O
0.8	O	O	O
mL/min	O	O	O
,	O	O	O
and	O	O	O
the	O	O	O
column	O	O	B-T075
temperature	O	O	B-T081
was	O	O	O
30	O	O	O
Â°	O	O	O
C	O	O	O
.	O	O	O

Under	O	O	O
the	O	O	O
optimized	O	O	B-T052
conditions	O	O	B-T080
,	O	O	O
tilianin	O	O	B-T109
and	O	O	O
acacetin	O	O	B-T109
displayed	O	O	O
good	O	O	O
linearity	O	O	O
in	O	O	O
the	O	O	O
ranges	O	O	O
of	O	O	O
0.0595	O	O	O
-	O	O	O
4.76	O	O	O
and	O	O	O
0.0585	O	O	O
-	O	O	O
4.68	O	O	O
Î¼g/mL	O	O	O
,	O	O	O
respectively	O	O	O
,	O	O	O
with	O	O	O
the	O	O	O
average	O	O	O
recoveries	O	O	O
being	O	O	O
96.93	O	O	O
and	O	O	O
97.88	O	O	O
%	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

The	O	O	O
method	O	O	B-T169
of	O	O	O
ILUAE	O	O	B-T059
was	O	O	O
compared	O	O	O
with	O	O	O
the	O	O	O
traditional	O	O	B-T169
methods	O	O	I-T169
,	O	O	O
it	O	O	O
exhibited	O	O	O
higher	O	O	B-T080
efficiency	O	O	B-T081
,	O	O	O
higher	O	O	O
reproducibility	O	O	B-T080
and	O	O	O
environmental	O	O	B-T082
friendly	O	O	I-T082
in	O	O	O
analyzing	O	O	O
the	O	O	O
active	O	O	B-T169
compounds	O	O	B-T103
in	O	O	O
traditional	O	O	B-T091
Chinese	O	O	I-T091
medicines	O	O	I-T091
(	O	O	O
TCMs	O	O	B-T091
)	O	O	O
.	O	O	O

-DOCSTART- (27994913)

Evaluation	O	O	B-T058
of	O	O	O
MIF	O	O	B-T028
-173	O	O	I-T028
G/C	O	O	I-T028
Polymorphism	O	O	B-T045
in	O	O	O
Turkish	O	O	B-T098
Patients	O	O	B-T101
with	O	O	O
Ankylosing	O	O	O
Spondylitis	O	O	O

Ankylosing	O	O	B-T047
spondylitis	O	O	I-T047
(	O	O	O
AS	O	O	B-T047
)	O	O	O
is	O	O	O
a	O	O	O
chronic	O	O	B-T047
inflammatory	O	O	I-T047
disease	O	O	I-T047
mainly	O	O	O
affecting	O	O	O
the	O	O	O
spine	O	O	B-T023
and	O	O	O
sacroiliac	O	O	B-T030
joints	O	O	I-T030
.	O	O	O

Macrophage	O	O	B-T116
migration	O	O	I-T116
inhibitory	O	O	I-T116
(	O	O	I-T116
MIF	O	O	I-T116
)	O	O	I-T116
factor	O	O	I-T116
is	O	O	O
a	O	O	O
regulatory	O	O	B-T077
cytokine	O	O	B-T116
that	O	O	O
inhibits	O	O	B-T052
random	O	O	O
immune	O	O	B-T043
cell	O	O	I-T043
migration	O	O	I-T043
.	O	O	O

MIF	O	O	B-T028
gene	O	O	I-T028
promoter	O	O	B-T028
polymorphisms	O	O	B-T045
play	O	O	O
a	O	O	O
role	O	O	O
in	O	O	O
the	O	O	O
progression	O	O	B-T046
of	O	O	O
several	O	O	O
inflammatory	O	O	B-T047
disorders	O	O	I-T047
.	O	O	O

To	O	O	O
investigate	O	O	B-T169
the	O	O	O
relationship	O	O	O
between	O	O	O
the	O	O	O
MIF	O	O	B-T028
gene	O	O	I-T028
-173	O	O	I-T028
G/C	O	O	I-T028
single-nucleotide	O	O	B-T086
polymorphism	O	O	I-T086
(	O	O	O
SNP	O	O	B-T086
)	O	O	O
and	O	O	O
AS	O	O	B-T047
.	O	O	O

Cross-sectional	O	O	B-T062
study	O	O	I-T062
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
a	O	O	O
total	O	O	O
of	O	O	O
161	O	O	O
AS	O	O	B-T047
and	O	O	O
194	O	O	O
normal	O	O	B-T080
controls	O	O	B-T096
were	O	O	O
recruited	O	O	O
.	O	O	O

The	O	O	O
MIF	O	O	B-T028
gene	O	O	I-T028
-173	O	O	I-T028
G/C	O	O	I-T028
SNP	O	O	B-T086
was	O	O	O
analyzed	O	O	B-T062
by	O	O	O
polymerase	O	O	B-T063
chain	O	O	I-T063
reaction	O	O	I-T063
using	O	O	O
the	O	O	O
restriction	O	O	B-T059
fragment	O	O	I-T059
length	O	O	I-T059
polymorphism	O	O	I-T059
method	O	O	I-T059
.	O	O	O

There	O	O	O
was	O	O	O
no	O	O	O
significant	O	O	B-T078
difference	O	O	O
between	O	O	O
groups	O	O	B-T098
in	O	O	O
terms	O	O	O
of	O	O	O
genotype	O	O	B-T032
distribution	O	O	O
(	O	O	O
p>0.05	O	O	O
)	O	O	O
.	O	O	O

When	O	O	O
wild-type	O	O	B-T028
G/G	O	O	B-T032
and	O	O	O
G/C+C/C	O	O	B-T032
genotypes	O	O	I-T032
are	O	O	O
compared	O	O	O
in	O	O	O
terms	O	O	O
of	O	O	O
clinical	O	O	B-T201
characteristics	O	O	I-T201
,	O	O	O
there	O	O	O
is	O	O	O
a	O	O	O
significant	O	O	B-T078
difference	O	O	O
between	O	O	O
the	O	O	O
average	O	O	O
age	O	O	B-T032
and	O	O	O
the	O	O	O
duration	O	O	B-T079
of	O	O	I-T079
disease	O	O	I-T079
in	O	O	O
AS	O	O	B-T047
patients	O	O	B-T101
(	O	O	O
p<0.05	O	O	O
)	O	O	O
.	O	O	O

No	O	O	O
significant	O	O	B-T078
relationship	O	O	O
between	O	O	O
AS	O	O	B-T047
disease	O	O	B-T047
and	O	O	O
MIF	O	O	B-T028
-173	O	O	I-T028
G/C	O	O	I-T028
polymorphism	O	O	B-T045
was	O	O	O
found	O	O	O
.	O	O	O

MIF	O	O	B-T028
-173	O	O	I-T028
G/C	O	O	I-T028
polymorphism	O	O	B-T045
(	O	O	O
C	O	O	B-T028
allele	O	O	I-T028
)	O	O	O
may	O	O	O
affect	O	O	O
the	O	O	O
time	O	O	O
of	O	O	O
onset	O	O	O
and	O	O	O
the	O	O	O
duration	O	O	B-T079
of	O	O	I-T079
disease	O	O	I-T079
in	O	O	O
AS	O	O	B-T047
patients	O	O	B-T101
.	O	O	O

-DOCSTART- (27995510)

Mechanisms	O	O	O
of	O	O	O
Global	O	O	B-T080
Cerebral	O	O	B-T046
Edema	O	O	I-T046
Formation	O	O	O
in	O	O	O
Aneurysmal	O	O	O
Subarachnoid	O	O	O
Hemorrhage	O	O	O

A	O	O	O
growing	O	O	O
body	O	O	O
of	O	O	O
clinical	O	O	B-T080
literature	O	O	B-T170
emphasizes	O	O	O
the	O	O	O
impact	O	O	O
of	O	O	O
cerebral	O	O	B-T046
edema	O	O	I-T046
in	O	O	O
early	O	O	B-T037
brain	O	O	I-T037
injury	O	O	I-T037
following	O	O	O
aneurysmal	O	O	B-T046
subarachnoid	O	O	I-T046
hemorrhage	O	O	I-T046
(	O	O	O
aSAH	O	O	B-T046
)	O	O	O
.	O	O	O

Aneurysm	O	O	B-T047
rupture	O	O	I-T047
itself	O	O	O
initiates	O	O	O
global	O	O	B-T080
cerebral	O	O	B-T046
edema	O	O	I-T046
in	O	O	O
up	O	O	O
to	O	O	O
two	O	O	O
thirds	O	O	O
of	O	O	O
cases	O	O	O
.	O	O	O

Although	O	O	O
cerebral	O	O	B-T046
edema	O	O	I-T046
is	O	O	O
not	O	O	O
a	O	O	O
universal	O	O	O
feature	O	O	O
of	O	O	O
aSAH	O	O	B-T046
,	O	O	O
it	O	O	O
portends	O	O	O
a	O	O	O
poor	O	O	O
clinical	O	O	B-T079
course	O	O	I-T079
,	O	O	O
with	O	O	O
quantitative	O	O	B-T081
analysis	O	O	I-T081
revealing	O	O	O
a	O	O	O
direct	O	O	O
correlation	O	O	O
between	O	O	O
cerebral	O	O	O
edema	O	O	O
and	O	O	O
poor	O	O	B-T033
outcome	O	O	I-T033
,	O	O	O
including	O	O	O
mortality	O	O	O
and	O	O	O
cognitive	O	O	O
deficits	O	O	O
.	O	O	O

Mechanistically	O	O	O
,	O	O	O
global	O	O	B-T080
cerebral	O	O	B-T046
edema	O	O	I-T046
has	O	O	O
been	O	O	O
linked	O	O	O
to	O	O	O
global	O	O	O
ischemia	O	O	B-T046
at	O	O	O
the	O	O	O
time	O	O	O
of	O	O	O
aneurysm	O	O	B-T047
rupture	O	O	I-T047
,	O	O	O
dysfunction	O	O	B-T077
of	O	O	O
autoregulation	O	O	B-T038
,	O	O	O
blood	O	O	B-T043
breakdown	O	O	I-T043
products	O	O	B-T071
,	O	O	O
neuroinflammation	O	O	B-T046
,	O	O	O
and	O	O	O
hyponatremia	O	O	B-T047
/	O	O	O
endocrine	O	O	B-T190
abnormalities	O	O	I-T190
.	O	O	O

At	O	O	O
a	O	O	O
molecular	O	O	B-T080
level	O	O	B-T080
,	O	O	O
several	O	O	O
culprits	O	O	O
have	O	O	O
been	O	O	O
identified	O	O	O
,	O	O	O
including	O	O	O
aquaporin-4	O	O	B-T116
,	O	O	O
matrix	O	O	B-T116
metalloproteinase-9	O	O	I-T116
,	O	O	O
SUR1	O	O	B-T116
-	O	O	O
TRPM4	O	O	B-T116
cation	O	O	I-T116
channels	O	O	I-T116
,	O	O	O
vascular	O	O	B-T116
endothelial	O	O	I-T116
growth	O	O	I-T116
factor	O	O	I-T116
,	O	O	O
bradykinin	O	O	B-T116
,	O	O	O
and	O	O	O
others	O	O	O
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
review	O	O	O
these	O	O	O
cellular	O	O	B-T025
and	O	O	O
molecular	O	O	B-T080
mechanisms	O	O	O
of	O	O	O
global	O	O	B-T080
cerebral	O	O	B-T046
edema	O	O	I-T046
formation	O	O	O
in	O	O	O
aSAH	O	O	B-T046
.	O	O	O

Given	O	O	O
the	O	O	O
importance	O	O	O
of	O	O	O
edema	O	O	B-T184
to	O	O	O
the	O	O	O
outcome	O	O	O
of	O	O	O
patients	O	O	B-T101
with	O	O	O
aSAH	O	O	B-T046
and	O	O	O
its	O	O	O
status	O	O	B-T080
as	O	O	O
a	O	O	O
highly	O	O	O
modifiable	O	O	O
pathological	O	O	B-T046
process	O	O	I-T046
,	O	O	O
a	O	O	O
better	O	O	O
understanding	O	O	O
of	O	O	O
cerebral	O	O	B-T046
edema	O	O	I-T046
in	O	O	O
aSAH	O	O	O
promises	O	O	O
to	O	O	O
hasten	O	O	O
the	O	O	O
development	O	O	O
of	O	O	O
medical	O	O	B-T061
therapies	O	O	I-T061
to	O	O	O
improve	O	O	O
outcomes	O	O	O
in	O	O	O
this	O	O	O
frequently	O	O	O
devastating	O	O	B-T169
disease	O	O	B-T047
.	O	O	O

-DOCSTART- (27995969)

Biliary	O	O	B-T023
Phospholipids	O	O	B-T109
Sustain	O	O	B-T169
Enterocyte	O	O	B-T025
Proliferation	O	O	B-T043
and	O	O	O
Intestinal	O	O	B-T191
Tumor	O	O	I-T191
Progression	O	O	B-T191
via	O	O	O
Nuclear	O	O	B-T116
Receptor	O	O	I-T116
Lrh1	O	O	B-T116
in	O	O	O
mice	O	O	O

The	O	O	O
proliferative-	O	O	O
crypt	O	O	B-T023
compartment	O	O	I-T023
of	O	O	O
the	O	O	O
intestinal	O	O	B-T024
epithelium	O	O	I-T024
is	O	O	O
enriched	O	O	O
in	O	O	O
phospholipids	O	O	B-T109
and	O	O	O
accumulation	O	O	B-T033
of	O	O	O
phospholipids	O	O	O
has	O	O	O
been	O	O	O
described	O	O	O
in	O	O	O
colorectal	O	O	B-T191
tumors	O	O	I-T191
.	O	O	O

Here	O	O	O
we	O	O	O
hypothesize	O	O	O
that	O	O	O
biliary	O	O	B-T023
phospholipid	O	O	B-T109
flow	O	O	B-T070
could	O	O	O
directly	O	O	O
contribute	O	O	O
to	O	O	O
the	O	O	O
proliferative	O	O	B-T169
power	O	O	I-T169
of	O	O	O
normal	O	O	B-T025
and	O	O	O
dysplastic	O	O	B-T025
enterocytes	O	O	I-T025
.	O	O	O

We	O	O	O
used	O	O	O
Abcb4	O	O	B-T028
(	O	O	O
-/-	O	O	O
)	O	O	O
mice	O	O	B-T015
which	O	O	O
lack	O	O	O
biliary	O	O	B-T023
phospholipid	O	O	B-T109
secretion	O	O	B-T038
.	O	O	O

We	O	O	O
first	O	O	O
show	O	O	O
that	O	O	O
Abcb4	O	O	B-T028
(	O	O	O
-/-	O	O	O
)	O	O	O
mice	O	O	B-T015
are	O	O	O
protected	O	O	B-T033
against	O	O	O
intestinal	O	O	B-T023
tumorigenesis	O	O	B-T191
.	O	O	O

At	O	O	O
the	O	O	O
molecular	O	O	B-T080
level	O	O	B-T080
,	O	O	O
the	O	O	O
transcriptional	O	O	B-T045
activity	O	O	I-T045
of	O	O	O
the	O	O	O
nuclear	O	O	B-T116
receptor	O	O	I-T116
Liver	O	O	B-T116
Receptor	O	O	I-T116
Homolog-1	O	O	I-T116
(	O	O	O
Lrh1	O	O	B-T116
)	O	O	O
is	O	O	O
reduced	O	O	B-T080
in	O	O	O
Abcb4	O	O	B-T028
(	O	O	O
-/-	O	O	O
)	O	O	O
mice	O	O	B-T015
and	O	O	O
its	O	O	O
re-activation	O	O	B-T052
re-establishes	O	O	O
a	O	O	O
tumor	O	O	B-T191
burden	O	O	B-T078
comparable	O	O	O
to	O	O	O
control	O	O	B-T096
mice	O	O	O
.	O	O	O

Feeding	O	O	B-T052
Abcb4	O	O	B-T028
(	O	O	O
-/-	O	O	O
)	O	O	O
mice	O	O	B-T015
a	O	O	O
diet	O	O	B-T168
supplemented	O	O	I-T168
with	O	O	O
phospholipids	O	O	B-T109
completely	O	O	O
overcomes	O	O	B-T052
the	O	O	O
intestinal	O	O	B-T191
tumor	O	O	I-T191
protective	O	O	O
phenotype	O	O	B-T032
,	O	O	O
thus	O	O	O
corroborating	O	O	O
the	O	O	O
hypothesis	O	O	O
that	O	O	O
the	O	O	O
absence	O	O	B-T169
of	O	O	O
biliary	O	O	B-T023
phospholipids	O	O	O
and	O	O	O
not	O	O	O
lack	O	O	O
of	O	O	O
Abcb4	O	O	B-T028
gene	O	O	I-T028
per	O	O	O
se	O	O	O
is	O	O	O
responsible	O	O	O
for	O	O	O
the	O	O	O
protection	O	O	B-T033
.	O	O	O

In	O	O	O
turn	O	O	O
,	O	O	O
phospholipids	O	O	B-T109
can	O	O	O
not	O	O	O
re-establish	O	O	O
intestinal	O	O	B-T023
tumorigenesis	O	O	B-T191
in	O	O	O
Abcb4	O	O	B-T028
(	O	O	O
-/-	O	O	O
)	O	O	O
mice	O	O	B-T015
crossed	O	O	O
with	O	O	O
mice	O	O	O
with	O	O	O
intestinal	O	O	O
specific	O	O	B-T080
ablation	O	O	B-T061
of	O	O	O
Lrh1	O	O	B-T116
,	O	O	O
a	O	O	O
nuclear	O	O	B-T116
hormone	O	O	I-T116
receptor	O	O	I-T116
that	O	O	O
is	O	O	O
activates	O	O	B-T052
by	O	O	O
phospholipids	O	O	O
.	O	O	O

Our	O	O	O
data	O	O	B-T078
identify	O	O	O
the	O	O	O
key	O	O	O
role	O	O	O
of	O	O	O
biliary	O	O	B-T023
phospholipids	O	O	B-T109
in	O	O	O
sustaining	O	O	O
intestinal	O	O	B-T024
mucosa	O	O	I-T024
proliferation	O	O	B-T169
and	O	O	O
tumor	O	O	B-T191
progression	O	O	I-T191
through	O	O	O
the	O	O	O
activation	O	O	B-T052
of	O	O	O
nuclear	O	O	B-T116
receptor	O	O	I-T116
Lrh1	O	O	B-T116
.	O	O	O

-DOCSTART- (27999200)

Metalloproteinase	O	O	B-T116
meprin	O	O	B-T116
Î±	O	O	I-T116
regulates	O	O	O
migration	O	O	B-T043
and	O	O	O
invasion	O	O	B-T033
of	O	O	O
human	O	O	B-T016
hepatocarcinoma	O	O	B-T191
cells	O	O	B-T025
and	O	O	O
is	O	O	O
a	O	O	O
mediator	O	O	O
of	O	O	O
the	O	O	O
oncoprotein	O	O	B-T116
Reptin	O	O	O

Hepatocellular	O	O	B-T191
carcinoma	O	O	I-T191
is	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
a	O	O	O
high	O	O	B-T080
rate	O	O	B-T081
of	O	O	O
intra-hepatic	O	O	B-T029
invasion	O	O	B-T033
that	O	O	O
carries	O	O	O
a	O	O	O
poor	O	O	B-T033
prognosis	O	O	I-T033
.	O	O	O

Meprin	O	O	B-T116
alpha	O	O	I-T116
(	O	O	O
Mep1A	O	O	B-T116
)	O	O	O
is	O	O	O
a	O	O	O
secreted	O	O	B-T043
metalloproteinase	O	O	B-T116
with	O	O	O
many	O	O	O
substrates	O	O	O
relevant	O	O	O
to	O	O	O
cancer	O	O	B-T033
invasion	O	O	I-T033
.	O	O	O

We	O	O	O
found	O	O	O
that	O	O	O
Mep1A	O	O	B-T116
was	O	O	O
a	O	O	O
target	O	O	B-T169
of	O	O	O
Reptin	O	O	B-T116
,	O	O	O
a	O	O	O
protein	O	O	B-T116
that	O	O	I-T116
is	O	O	I-T116
oncogenic	O	O	I-T116
in	O	O	O
HCC	O	O	B-T191
.	O	O	O

We	O	O	O
studied	O	O	O
Mep1A	O	O	B-T116
regulation	O	O	B-T038
by	O	O	O
Reptin	O	O	B-T116
,	O	O	O
its	O	O	O
role	O	O	O
in	O	O	O
HCC	O	O	B-T191
,	O	O	O
and	O	O	O
whether	O	O	O
it	O	O	O
mediates	O	O	O
Reptin	O	O	O
oncogenic	O	O	B-T131
effects	O	O	B-T080
.	O	O	O

MepA	O	O	B-T116
and	O	O	O
Reptin	O	O	B-T116
expression	O	O	B-T045
was	O	O	O
measured	O	O	O
in	O	O	O
human	O	O	B-T016
HCC	O	O	B-T191
by	O	O	O
qRT-PCR	O	O	B-T063
and	O	O	O
in	O	O	O
cultured	O	O	B-T025
cells	O	O	I-T025
by	O	O	O
PCR	O	O	B-T063
,	O	O	O
western	O	O	B-T059
blot	O	O	I-T059
and	O	O	O
enzymatic	O	O	B-T062
activity	O	O	I-T062
measurements	O	O	I-T062
.	O	O	O

Cell	O	O	B-T043
growth	O	O	I-T043
was	O	O	O
assessed	O	O	B-T052
by	O	O	O
counting	O	O	B-T059
and	O	O	O
MTS	O	O	B-T062
assay	O	O	I-T062
.	O	O	O

Cell	O	O	B-T043
migration	O	O	I-T043
was	O	O	O
measured	O	O	O
in	O	O	O
Boyden	O	O	B-T074
chambers	O	O	I-T074
and	O	O	O
wound	O	O	B-T040
healing	O	O	I-T040
assays	O	O	B-T059
,	O	O	O
and	O	O	O
cell	O	O	B-T033
invasion	O	O	I-T033
in	O	O	O
Boyden	O	O	O
chambers	O	O	O
.	O	O	O

Silencing	O	O	B-T045
Reptin	O	O	B-T028
decreased	O	O	B-T081
Mep1A	O	O	B-T116
expression	O	O	B-T045
and	O	O	O
activity	O	O	B-T052
,	O	O	O
without	O	O	O
affecting	O	O	O
meprin	O	O	B-T116
Î²	O	O	I-T116
.	O	O	O

Mep1A	O	O	B-T116
,	O	O	O
but	O	O	O
not	O	O	O
meprin	O	O	B-T116
Î²	O	O	I-T116
,	O	O	O
was	O	O	O
overexpressed	O	O	B-T045
in	O	O	O
a	O	O	O
series	O	O	O
of	O	O	O
242	O	O	O
human	O	O	B-T016
HCC	O	O	B-T191
(	O	O	O
2.04	O	O	O
fold	O	O	O
,	O	O	O
p	O	O	O
<	O	O	O
0.0001	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
a	O	O	O
high	O	O	B-T080
expression	O	O	B-T045
correlated	O	O	B-T080
with	O	O	O
a	O	O	O
poor	O	O	B-T033
prognosis	O	O	I-T033
.	O	O	O

Mep1A	O	O	B-T116
and	O	O	O
Reptin	O	O	B-T116
expressions	O	O	B-T045
were	O	O	O
positively	O	O	O
correlated	O	O	B-T080
(	O	O	O
r	O	O	O
=	O	O	O
0.39	O	O	O
,	O	O	O
p	O	O	O
<	O	O	O
0.0001	O	O	O
)	O	O	O
.	O	O	O

Silencing	O	O	B-T045
Mep1A	O	O	B-T028
had	O	O	O
little	O	O	O
effect	O	O	O
on	O	O	O
cell	O	O	B-T043
proliferation	O	O	I-T043
,	O	O	O
but	O	O	O
decreased	O	O	B-T081
cell	O	O	B-T043
migration	O	O	I-T043
and	O	O	O
invasion	O	O	B-T033
of	O	O	O
HuH7	O	O	B-T025
and	O	O	O
Hep3B	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

Conversely	O	O	O
,	O	O	O
overexpression	O	O	B-T045
of	O	O	O
Mep1A	O	O	B-T116
or	O	O	O
addition	O	O	O
of	O	O	O
recombinant	O	O	B-T001
Mep1A	O	O	O
increased	O	O	B-T081
migration	O	O	B-T043
and	O	O	O
invasion	O	O	B-T033
.	O	O	O

Finally	O	O	O
,	O	O	O
overexpression	O	O	B-T045
of	O	O	O
Mep1A	O	O	B-T116
restored	O	O	O
a	O	O	O
normal	O	O	B-T080
cell	O	O	B-T043
migration	O	O	I-T043
in	O	O	O
cells	O	O	B-T025
where	O	O	O
Reptin	O	O	B-T116
was	O	O	O
depleted	O	O	B-T169
.	O	O	O

Mep1A	O	O	B-T116
is	O	O	O
overexpressed	O	O	B-T045
in	O	O	O
most	O	O	O
HCC	O	O	B-T191
and	O	O	O
induces	O	O	B-T169
HCC	O	O	O
cell	O	O	B-T043
migration	O	O	I-T043
and	O	O	O
invasion	O	O	B-T033
.	O	O	O

Mep1A	O	O	B-T116
expression	O	O	B-T045
is	O	O	O
regulated	O	O	O
by	O	O	O
Reptin	O	O	B-T116
,	O	O	O
and	O	O	O
Mep1A	O	O	O
mediates	O	O	O
Reptin	O	O	O
-	O	O	O
induced	O	O	B-T169
migration	O	O	B-T043
.	O	O	O

Overall	O	O	O
,	O	O	O
we	O	O	O
suggest	O	O	O
that	O	O	O
Mep1A	O	O	B-T116
may	O	O	O
be	O	O	O
a	O	O	O
useful	O	O	O
target	O	O	B-T169
in	O	O	O
HCC	O	O	B-T191
.	O	O	O

-DOCSTART- (28000391)

Psychosocial	O	O	B-T080
impact	O	O	I-T080
on	O	O	O
families	O	O	B-T099
with	O	O	O
an	O	O	O
infant	O	O	B-T100
with	O	O	O
a	O	O	O
hypoplastic	O	O	B-T047
left	O	O	I-T047
heart	O	O	I-T047
syndrome	O	O	I-T047
during	O	O	B-T079
and	O	O	I-T079
after	O	O	I-T079
the	O	O	I-T079
interstage	O	O	I-T079
monitoring	O	O	I-T079
period	O	O	I-T079
-	O	O	O
a	O	O	O
prospective	O	O	O
mixed-method	O	O	O
study	O	O	O

To	O	O	O
investigate	O	O	O
parents	O	O	B-T041
'	O	O	I-T041
experiences	O	O	I-T041
,	O	O	O
coping	O	O	B-T055
ability	O	O	I-T055
and	O	O	O
quality	O	O	B-T078
of	O	O	I-T078
life	O	O	I-T078
while	O	O	O
monitoring	O	O	B-T058
their	O	O	O
sick	O	O	B-T101
child	O	O	I-T101
with	O	O	O
hypoplastic	O	O	B-T047
left	O	O	I-T047
heart	O	O	I-T047
syndrome	O	O	I-T047
at	O	O	O
home	O	O	B-T082
.	O	O	O

Interstage	O	O	B-T058
home	O	O	I-T058
monitoring	O	O	I-T058
for	O	O	O
children	O	O	B-T100
with	O	O	O
hypoplastic	O	O	B-T047
left	O	O	I-T047
heart	O	O	I-T047
syndrome	O	O	I-T047
reduces	O	O	O
interstage	O	O	O
mortality	O	O	B-T081
between	O	O	O
Norwood	O	O	B-T061
stages	O	O	I-T061
I	O	O	I-T061
and	O	O	I-T061
II	O	O	I-T061
.	O	O	O

Little	O	O	O
is	O	O	O
known	O	O	O
about	O	O	O
the	O	O	O
psychosocial	O	O	B-T080
impact	O	O	I-T080
of	O	O	O
interstage	O	O	B-T058
home	O	O	I-T058
monitoring	O	O	I-T058
.	O	O	O

Prospective	O	O	B-T062
mixed-method	O	O	I-T062
study	O	O	I-T062
.	O	O	O

This	O	O	O
study	O	O	O
assessed	O	O	O
the	O	O	O
psychosocial	O	O	B-T080
impact	O	O	I-T080
on	O	O	O
parents	O	O	B-T099
during	O	O	O
interstage	O	O	B-T058
home	O	O	I-T058
monitoring	O	O	I-T058
.	O	O	O

This	O	O	O
contains	O	O	O
for	O	O	O
quantitative	O	O	B-T081
assessment	O	O	I-T081
the	O	O	O
Short	O	O	B-T170
Form	O	O	I-T170
Health	O	O	I-T170
Survey	O	O	I-T170
questionnaire	O	O	I-T170
and	O	O	O
the	O	O	O
Impact	O	O	O
of	O	O	O
Family	O	O	B-T033
Scale	O	O	I-T033
administered	O	O	I-T033
one	O	O	O
and	O	O	O
five	O	O	O
weeks	O	O	O
following	O	O	O
discharge	O	O	B-T058
before	O	O	B-T079
and	O	O	I-T079
after	O	O	I-T079
stage	O	O	I-T079
II	O	O	I-T079
.	O	O	O

For	O	O	O
qualitative	O	O	B-T080
assessment	O	O	I-T080
,	O	O	O
semi-structured	O	O	B-UnknownType
interviews	O	O	I-UnknownType
focussing	O	O	O
on	O	O	O
the	O	O	O
postdischarge	O	O	B-T033
coping	O	O	B-T061
strategies	O	O	I-T061
were	O	O	O
conducted	O	O	O
twice	O	O	O
,	O	O	O
five	O	O	O
weeks	O	O	O
after	O	O	B-T033
hospital	O	O	I-T033
discharge	O	O	I-T033
before	O	O	B-T079
and	O	O	I-T079
after	O	O	I-T079
stage	O	O	I-T079
II	O	O	I-T079
.	O	O	O

Ten	O	O	O
infants	O	O	B-T100
(	O	O	O
eight	O	O	O
males	O	O	B-T032
)	O	O	O
with	O	O	O
hypoplastic	O	O	B-T047
left	O	O	I-T047
heart	O	O	I-T047
syndrome	O	O	I-T047
(	O	O	O
n	O	O	O
=	O	O	O
7	O	O	O
)	O	O	O
or	O	O	O
other	O	O	O
types	O	O	O
of	O	O	O
univentricular	O	O	B-T019
heart	O	O	I-T019
malformations	O	O	I-T019
(	O	O	O
n	O	O	O
=	O	O	O
3	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
their	O	O	O
parents	O	O	B-T099
(	O	O	O
nine	O	O	O
mother/father	O	O	B-T099
two-	O	O	O
parent	O	O	B-T099
households	O	O	B-T099
,	O	O	O
one	O	O	O
single	O	O	B-T099
mother	O	O	I-T099
)	O	O	O
were	O	O	O
included	O	O	O
.	O	O	O

There	O	O	O
were	O	O	O
no	O	O	B-T033
interstage	O	O	I-T033
deaths	O	O	I-T033
.	O	O	O

Mental	O	O	B-T041
Health	O	O	I-T041
Composite	O	O	B-T081
Summary	O	O	I-T081
scores	O	O	I-T081
were	O	O	O
low	O	O	O
in	O	O	O
both	O	O	O
parents	O	O	B-T099
(	O	O	O
mothers	O	O	B-T099
:	O	O	O
40Â·45	O	O	O
Â±	O	O	O
9Â·07	O	O	O
;	O	O	O
fathers	O	O	B-T099
:	O	O	O
40Â·58	O	O	O
Â±	O	O	O
9Â·69	O	O	O
)	O	O	O
and	O	O	O
lowest	O	O	O
for	O	O	O
the	O	O	O
item	O	O	O
'	O	O	O
vitality	O	O	B-T033
'	O	O	O
(	O	O	O
mothers	O	O	O
:	O	O	O
37Â·0	O	O	O
Â±	O	O	O
19Â·46	O	O	O
;	O	O	O
fathers	O	O	O
:	O	O	O
43Â·12	O	O	O
Â±	O	O	O
25Â·9	O	O	O
)	O	O	O
before	O	O	B-T079
and	O	O	I-T079
after	O	O	I-T079
stage	O	O	I-T079
II	O	O	I-T079
.	O	O	O

Impact	O	O	O
of	O	O	O
Family	O	O	B-T033
Scale	O	O	I-T033
values	O	O	I-T033
showed	O	O	O
higher	O	O	O
daily	O	O	O
and	O	O	O
social	O	O	B-T078
burdens	O	O	I-T078
for	O	O	O
mothers	O	O	B-T099
.	O	O	O
'	O	O	O
Becoming	O	O	O
a	O	O	O
family	O	O	O
'	O	O	O
was	O	O	O
the	O	O	O
most	O	O	O
important	O	O	O
task	O	O	O
as	O	O	O
coping	O	O	B-T061
strategy	O	O	I-T061
to	O	O	O
equilibrate	O	O	O
the	O	O	O
fragile	O	O	B-T048
emotional	O	O	I-T048
balance	O	O	I-T048
.	O	O	O

The	O	O	O
parents	O	O	B-T099
judged	O	O	O
interstage	O	O	B-T058
home	O	O	I-T058
monitoring	O	O	I-T058
as	O	O	O
a	O	O	O
protective	O	O	B-T061
intervention	O	O	I-T061
.	O	O	O

Although	O	O	O
psychosocial	O	O	B-T080
burden	O	O	I-T080
before	O	O	B-T079
and	O	O	I-T079
after	O	O	I-T079
stage	O	O	I-T079
II	O	O	I-T079
remains	O	O	O
high	O	O	O
,	O	O	O
becoming	O	O	O
a	O	O	O
family	O	O	B-T099
is	O	O	O
an	O	O	O
essential	O	O	O
experience	O	O	O
for	O	O	O
parents	O	O	B-T099
and	O	O	O
confirms	O	O	O
their	O	O	O
parenthood	O	O	B-T054
.	O	O	O

Healthcare	O	O	B-T097
professionals	O	O	I-T097
must	O	O	O
be	O	O	O
aware	O	O	O
of	O	O	O
parents	O	O	B-T099
'	O	O	O
needs	O	O	O
during	O	O	O
this	O	O	O
vulnerable	O	O	B-T079
interstage	O	O	I-T079
period	O	O	I-T079
and	O	O	O
to	O	O	O
provide	O	O	O
psychosocial	O	O	B-T169
and	O	O	O
nursing	O	O	B-T061
support	O	O	I-T061
.	O	O	O

-DOCSTART- (28002085)

Rates	O	O	B-T081
and	O	O	O
predictors	O	O	B-T078
of	O	O	O
injury	O	O	B-T037
in	O	O	O
a	O	O	O
population	O	O	B-T081
-	O	O	O
based	O	O	B-T169
cohort	O	O	B-T098
of	O	O	O
people	O	O	B-T098
living	O	O	B-T078
with	O	O	O
HIV	O	O	O

Injuries	O	O	B-T037
are	O	O	O
responsible	O	O	O
for	O	O	O
10	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
global	O	O	B-T080
burden	O	O	B-T078
of	O	O	O
disease	O	O	B-T047
;	O	O	O
however	O	O	O
,	O	O	O
the	O	O	O
epidemiology	O	O	B-T169
of	O	O	O
injury	O	O	B-T037
among	O	O	O
people	O	O	B-T047
living	O	O	I-T047
with	O	O	I-T047
HIV	O	O	I-T047
(	O	O	O
PLHIV	O	O	B-T047
)	O	O	O
has	O	O	O
not	O	O	B-T033
been	O	O	I-T033
well	O	O	I-T033
elucidated	O	O	B-T052
.	O	O	O

This	O	O	O
study	O	O	B-T062
seeks	O	O	O
to	O	O	O
characterize	O	O	B-T052
rates	O	O	B-T081
and	O	O	O
predictors	O	O	B-T078
of	O	O	O
injury	O	O	B-T037
among	O	O	O
PLHIV	O	O	B-T047
compared	O	O	B-T052
to	O	O	O
the	O	O	O
general	O	O	B-T098
population	O	O	I-T098
in	O	O	O
British	O	O	B-T083
Columbia	O	O	I-T083
(	O	O	O
BC	O	O	B-T083
)	O	O	O
,	O	O	O
Canada	O	O	B-T083
.	O	O	O

A	O	O	O
population	O	O	B-T081
-	O	O	O
based	O	O	B-T169
dataset	O	O	B-T170
was	O	O	O
created	O	O	B-T080
via	O	O	O
linkage	O	O	B-T062
between	O	O	B-T082
the	O	O	O
BC	O	O	B-T093
Centre	O	O	I-T093
for	O	O	I-T093
Excellence	O	O	I-T093
in	O	O	I-T093
HIV/AIDS	O	O	I-T093
and	O	O	O
PopulationDataBC	O	O	B-T078
.	O	O	O

PLHIV	O	O	B-T047
aged	O	O	B-T032
20	O	O	B-T079
years	O	O	I-T079
and	O	O	O
older	O	O	B-T079
were	O	O	O
compared	O	O	B-T052
to	O	O	O
a	O	O	O
random	O	O	B-T080
10	O	O	O
%	O	O	O
sample	O	O	B-T167
of	O	O	O
the	O	O	O
adult	O	O	B-T100
general	O	O	B-T098
population	O	O	I-T098
.	O	O	O

The	O	O	O
International	O	O	B-T078
Classification	O	O	B-T185
of	O	O	O
Diseases	O	O	B-T047
9	O	O	O
and	O	O	O
10	O	O	O
codes	O	O	O
were	O	O	O
used	O	O	B-T169
to	O	O	O
classify	O	O	B-T185
unintentional	O	O	B-T037
and	O	O	O
intentional	O	O	B-T037
injuries	O	O	I-T037
based	O	O	B-T169
on	O	O	O
the	O	O	O
external	O	O	B-T033
cause	O	O	I-T033
of	O	O	O
the	O	O	O
injury	O	O	B-T037
from	O	O	O
1996	O	O	O
to	O	O	O
2013	O	O	O
.	O	O	O

Generalized	O	O	B-T081
estimating	O	O	I-T081
equation	O	O	I-T081
(	O	O	O
GEE	O	O	B-T081
)	O	O	O
Poisson	O	O	B-T081
regression	O	O	I-T081
models	O	O	I-T081
were	O	O	O
fit	O	O	O
to	O	O	O
estimate	O	O	B-T081
the	O	O	O
effect	O	O	B-T080
of	O	O	O
HIV	O	O	B-T047
status	O	O	B-T080
on	O	O	O
rates	O	O	B-T081
of	O	O	O
unintentional	O	O	B-T037
and	O	O	O
intentional	O	O	B-T037
injury	O	O	B-T037
,	O	O	O
and	O	O	O
to	O	O	O
identify	O	O	B-T080
correlates	O	O	B-T080
of	O	O	O
injury	O	O	O
among	O	O	O
PLHIV	O	O	B-T047
.	O	O	O

The	O	O	O
crude	O	O	O
incidence	O	O	B-T081
rate	O	O	I-T081
of	O	O	O
unintentional	O	O	B-T037
injury	O	O	I-T037
was	O	O	O
18.56/1000	O	O	O
person	O	O	B-T098
-	O	O	O
years	O	O	B-T079
[	O	O	O
95	O	O	O
%	O	O	O
confidence	O	O	B-T081
interval	O	O	I-T081
(	O	O	O
CI	O	O	B-T081
)	O	O	O
17.77	O	O	O
-	O	O	O
19.39	O	O	O
]	O	O	O
among	O	O	O
PLHIV	O	O	B-T047
and	O	O	O
8.51/1000	O	O	O
person	O	O	O
-	O	O	O
years	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
8.42	O	O	O
-	O	O	O
8.59	O	O	O
)	O	O	O
in	O	O	O
the	O	O	O
general	O	O	B-T098
population	O	O	I-T098
.	O	O	O

Among	O	O	O
PLHIV	O	O	B-T047
,	O	O	O
13.45	O	O	O
%	O	O	O
of	O	O	O
deaths	O	O	B-T033
were	O	O	O
due	O	O	B-T169
to	O	O	I-T169
injury	O	O	B-T037
,	O	O	O
compared	O	O	B-T052
to	O	O	O
5.52	O	O	O
%	O	O	O
of	O	O	O
deaths	O	O	O
in	O	O	O
the	O	O	O
general	O	O	B-T098
population	O	O	I-T098
.	O	O	O

In	O	O	O
adjusted	O	O	O
models	O	O	B-T081
,	O	O	O
PLHIV	O	O	B-T047
were	O	O	O
more	O	O	O
likely	O	O	O
to	O	O	O
report	O	O	B-T058
unintentional	O	O	B-T037
(	O	O	O
incidence	O	O	B-T081
rate	O	O	I-T081
ratio	O	O	B-T081
1.42	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
1.32	O	O	O
-	O	O	O
1.52	O	O	O
)	O	O	O
and	O	O	O
intentional	O	O	B-T037
injury	O	O	I-T037
(	O	O	O
incidence	O	O	O
rate	O	O	O
ratio	O	O	O
1.93	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
1.70	O	O	O
-	O	O	O
2.18	O	O	O
)	O	O	O
compared	O	O	B-T052
to	O	O	O
the	O	O	O
general	O	O	B-T098
population	O	O	I-T098
.	O	O	O

We	O	O	O
identified	O	O	B-T080
elevated	O	O	B-T080
rates	O	O	B-T081
of	O	O	O
intentional	O	O	B-T037
and	O	O	O
unintentional	O	O	B-T037
injury	O	O	I-T037
among	O	O	O
PLHIV	O	O	B-T047
.	O	O	O

Injuries	O	O	B-T037
are	O	O	O
largely	O	O	B-T081
preventable	O	O	B-T170
;	O	O	O
as	O	O	O
such	O	O	O
,	O	O	O
targeted	O	O	B-T169
efforts	O	O	O
are	O	O	O
needed	O	O	B-T080
to	O	O	O
decrease	O	O	B-T081
the	O	O	O
burden	O	O	B-T078
of	O	O	O
injury	O	O	B-T037
-	O	O	O
related	O	O	B-T080
disability	O	O	B-T033
and	O	O	O
death	O	O	B-T033
among	O	O	O
PLHIV	O	O	B-T047
.	O	O	O

-DOCSTART- (28005193)

TREK-1	O	O	B-T116
(	O	O	I-T116
K2P2.1	O	O	I-T116
)	O	O	I-T116
K(+	O	O	I-T116
)	O	O	I-T116
channels	O	O	I-T116
are	O	O	O
suppressed	O	O	B-T169
in	O	O	O
patients	O	O	B-T101
with	O	O	O
atrial	O	O	B-T047
fibrillation	O	O	I-T047
and	O	O	O
heart	O	O	B-T047
failure	O	O	I-T047
and	O	O	O
provide	O	O	B-T052
therapeutic	O	O	B-T169
targets	O	O	I-T169
for	O	O	O
rhythm	O	O	O
control	O	O	O

Atrial	O	O	B-T047
fibrillation	O	O	I-T047
(	O	O	O
AF	O	O	B-T047
)	O	O	O
is	O	O	O
the	O	O	O
most	O	O	O
common	O	O	O
cardiac	O	O	B-T033
arrhythmia	O	O	I-T033
.	O	O	O

Concomitant	O	O	B-T047
heart	O	O	I-T047
failure	O	O	I-T047
(	O	O	O
HF	O	O	B-T047
)	O	O	O
poses	O	O	O
a	O	O	O
particular	O	O	O
therapeutic	O	O	B-T169
challenge	O	O	B-T059
and	O	O	O
is	O	O	O
associated	O	O	O
with	O	O	O
prolonged	O	O	B-T079
atrial	O	O	B-T040
electrical	O	O	I-T040
refractoriness	O	O	I-T040
compared	O	O	O
with	O	O	O
non-failing	O	O	B-T023
hearts	O	O	I-T023
.	O	O	O

We	O	O	O
hypothesized	O	O	O
that	O	O	O
downregulation	O	O	B-T044
of	O	O	O
atrial	O	O	B-T042
repolarizing	O	O	I-T042
TREK-1	O	O	B-T116
(	O	O	I-T116
K2P2.1	O	O	I-T116
)	O	O	I-T116
K(+	O	O	I-T116
)	O	O	I-T116
channels	O	O	I-T116
contributes	O	O	B-T052
to	O	O	O
electrical	O	O	B-T046
remodeling	O	O	I-T046
during	O	O	O
AF	O	O	B-T047
with	O	O	O
HF	O	O	B-T047
,	O	O	O
and	O	O	O
that	O	O	O
TREK-1	O	O	B-T063
gene	O	O	I-T063
transfer	O	O	I-T063
would	O	O	O
provide	O	O	O
rhythm	O	O	B-T080
control	O	O	I-T080
via	O	O	O
normalization	O	O	B-T062
of	O	O	O
atrial	O	O	B-T033
effective	O	O	I-T033
refractory	O	O	I-T033
periods	O	O	I-T033
in	O	O	O
this	O	O	O
AF	O	O	O
subset	O	O	B-T062
.	O	O	O

In	O	O	O
patients	O	O	B-T101
with	O	O	O
chronic	O	O	B-T047
AF	O	O	I-T047
and	O	O	O
HF	O	O	B-T047
,	O	O	O
atrial	O	O	B-T116
TREK-1	O	O	I-T116
mRNA	O	O	B-T114
levels	O	O	B-T080
were	O	O	O
reduced	O	O	O
by	O	O	O
82	O	O	O
%	O	O	O
(	O	O	O
left	O	O	B-T023
atrium	O	O	I-T023
)	O	O	O
and	O	O	O
81	O	O	O
%	O	O	O
(	O	O	O
right	O	O	B-T023
atrium	O	O	I-T023
)	O	O	O
compared	O	O	O
with	O	O	O
sinus	O	O	B-T033
rhythm	O	O	I-T033
(	O	O	O
SR	O	O	B-T033
)	O	O	O
subjects	O	O	B-T098
.	O	O	O

Human	O	O	B-T016
findings	O	O	B-T033
were	O	O	O
recapitulated	O	O	O
in	O	O	O
a	O	O	O
porcine	O	O	B-T075
model	O	O	I-T075
of	O	O	O
atrial	O	O	B-T047
tachypacing-induced	O	O	I-T047
AF	O	O	I-T047
and	O	O	O
reduced	O	O	B-T080
left	O	O	B-T042
ventricular	O	O	I-T042
function	O	O	I-T042
.	O	O	O

TREK-1	O	O	B-T116
mRNA	O	O	B-T114
(	O	O	O
-66	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
protein	O	O	B-T116
(	O	O	O
-61	O	O	O
%	O	O	O
)	O	O	O
was	O	O	O
suppressed	O	O	B-T169
in	O	O	O
AF	O	O	B-T047
animals	O	O	B-T008
at	O	O	O
14-day	O	O	O
follow-up	O	O	O
compared	O	O	B-T052
with	O	O	O
SR	O	O	B-T033
controls	O	O	O
.	O	O	O

Downregulation	O	O	B-T044
of	O	O	O
repolarizing	O	O	B-T042
TREK-1	O	O	B-T116
channels	O	O	I-T116
was	O	O	O
associated	O	O	O
with	O	O	O
prolongation	O	O	B-T079
of	O	O	O
atrial	O	O	B-T033
effective	O	O	I-T033
refractory	O	O	I-T033
periods	O	O	I-T033
versus	O	O	O
baseline	O	O	B-T081
conditions	O	O	O
,	O	O	O
consistent	O	O	B-T078
with	O	O	I-T078
prior	O	O	B-T079
observations	O	O	B-T062
in	O	O	O
humans	O	O	B-T016
with	O	O	O
HF	O	O	B-T047
.	O	O	O

In	O	O	O
a	O	O	O
preclinical	O	O	B-T080
therapeutic	O	O	B-T169
approach	O	O	I-T169
,	O	O	O
pigs	O	O	B-T015
were	O	O	O
randomized	O	O	B-T062
to	O	O	O
either	O	O	O
atrial	O	O	B-T061
Ad-TREK-1	O	O	I-T061
gene	O	O	I-T061
therapy	O	O	I-T061
or	O	O	O
sham	O	O	B-T061
treatment	O	O	I-T061
.	O	O	O

Gene	O	O	B-T063
transfer	O	O	I-T063
effectively	O	O	B-T080
increased	O	O	B-T081
TREK-1	O	O	B-T116
protein	O	O	I-T116
levels	O	O	B-T080
and	O	O	O
attenuated	O	O	B-T052
atrial	O	O	B-T033
effective	O	O	I-T033
refractory	O	O	I-T033
period	O	O	I-T033
prolongation	O	O	B-T079
in	O	O	O
the	O	O	O
porcine	O	O	B-T075
AF	O	O	I-T075
model	O	O	I-T075
.	O	O	O

Ad-TREK-1	O	O	B-T116
increased	O	O	O
the	O	O	O
SR	O	O	B-T033
prevalence	O	O	B-T081
to	O	O	O
62	O	O	O
%	O	O	O
during	O	O	O
follow-up	O	O	O
in	O	O	O
AF	O	O	B-T047
animals	O	O	B-T008
,	O	O	O
compared	O	O	B-T052
to	O	O	O
35	O	O	O
%	O	O	O
in	O	O	O
the	O	O	O
untreated	O	O	O
AF	O	O	O
group	O	O	O
.	O	O	O

In	O	O	O
conclusion	O	O	B-T078
,	O	O	O
TREK-1	O	O	B-T116
downregulation	O	O	B-T044
and	O	O	O
rhythm	O	O	B-T080
control	O	O	I-T080
by	O	O	O
Ad-TREK-1	O	O	B-T063
transfer	O	O	I-T063
suggest	O	O	B-T078
mechanistic	O	O	B-T061
and	O	O	I-T061
potential	O	O	I-T061
therapeutic	O	O	I-T061
significance	O	O	B-T078
of	O	O	O
TREK-1	O	O	B-T116
channels	O	O	I-T116
in	O	O	O
a	O	O	O
subgroup	O	O	B-T185
of	O	O	O
AF	O	O	B-T047
patients	O	O	B-T101
with	O	O	O
HF	O	O	B-T047
and	O	O	O
prolonged	O	O	B-T079
atrial	O	O	B-T033
effective	O	O	I-T033
refractory	O	O	I-T033
periods	O	O	I-T033
.	O	O	O

Functional	O	O	B-T169
correction	O	O	I-T169
of	O	O	O
ionic	O	O	O
remodeling	O	O	O
through	O	O	O
TREK-1	O	O	B-T061
gene	O	O	I-T061
therapy	O	O	I-T061
represents	O	O	O
a	O	O	O
novel	O	O	B-T080
paradigm	O	O	B-T062
to	O	O	O
optimize	O	O	O
and	O	O	O
specify	O	O	O
AF	O	O	B-T047
management	O	O	O
.	O	O	O

-DOCSTART- (28009593)

A	O	O	O
Rasch	O	O	B-T062
Rating	O	O	I-T062
Scale	O	O	B-T081
Analysis	O	O	B-T062
of	O	O	O
the	O	O	O
Presence	O	O	B-T033
of	O	O	O
Nursing	O	O	B-T091
Scale	O	O	O
-	O	O	O
RN	O	O	O

The	O	O	O
phenomenon	O	O	B-T067
of	O	O	O
nursing	O	O	B-T091
presence	O	O	B-T033
encompasses	O	O	O
the	O	O	O
emotional	O	O	B-T033
connection	O	O	B-T082
between	O	O	O
nurse	O	O	B-T097
and	O	O	O
patient	O	O	B-T101
,	O	O	O
and	O	O	O
technical	O	O	B-T169
skills	O	O	I-T169
performed	O	O	B-T169
by	O	O	O
the	O	O	O
nurse	O	O	O
.	O	O	O

The	O	O	O
Presence	O	O	B-T033
of	O	O	O
Nursing	O	O	B-T091
Scale	O	O	B-T081
-	O	O	O
RN	O	O	B-T097
version	O	O	B-T170
(	O	O	O
PONS	O	O	B-T081
-	O	O	O
RN	O	O	O
)	O	O	O
was	O	O	O
developed	O	O	B-T169
to	O	O	O
measure	O	O	B-T081
nurses	O	O	B-T097
'	O	O	I-T097
perceptions	O	O	B-T041
of	O	O	O
their	O	O	O
ability	O	O	B-T032
to	O	O	O
be	O	O	O
present	O	O	B-T033
to	O	O	O
their	O	O	O
patients	O	O	B-T101
.	O	O	O

This	O	O	O
study	O	O	B-T062
summarizes	O	O	B-T170
the	O	O	O
process	O	O	B-T067
of	O	O	O
re-evaluation	O	O	B-T062
of	O	O	O
the	O	O	O
psychometric	O	O	B-T060
properties	O	O	I-T060
of	O	O	O
the	O	O	O
PONS	O	O	B-T081
-	O	O	O
RN	O	O	B-T097
instrument	O	O	O
.	O	O	O

A	O	O	O
sample	O	O	B-T098
of	O	O	O
76	O	O	O
registered	O	O	B-T097
nurses	O	O	I-T097
providing	O	O	B-T052
direct	O	O	B-T080
patient	O	O	B-T058
care	O	O	I-T058
responded	O	O	B-T041
to	O	O	O
the	O	O	O
31-	O	O	O
item	O	O	B-T071
questionnaire	O	O	B-T170
.	O	O	O

The	O	O	O
Rasch	O	O	B-T062
rating	O	O	I-T062
scale	O	O	I-T062
model	O	O	I-T062
was	O	O	O
used	O	O	O
for	O	O	O
assessing	O	O	B-T058
construct	O	O	B-T080
validity	O	O	I-T080
of	O	O	O
PONS	O	O	B-T081
-	O	O	O
RN	O	O	B-T097
data	O	O	B-T078
.	O	O	O

A	O	O	O
principal	O	O	B-T081
component	O	O	I-T081
analysis	O	O	I-T081
(	O	O	O
PCA	O	O	B-T081
)	O	O	O
of	O	O	O
residuals	O	O	B-T080
supported	O	O	B-T077
appropriateness	O	O	B-T080
of	O	O	O
the	O	O	O
subscales	O	O	B-T081
defined	O	O	O
by	O	O	O
a	O	O	O
2-dimensional	O	O	B-T082
structure	O	O	B-T082
.	O	O	O

The	O	O	O
results	O	O	B-T033
of	O	O	O
item	O	O	B-T071
and	O	O	O
person	O	O	B-T098
fit	O	O	B-T052
analysis	O	O	B-T062
,	O	O	O
rating	O	O	B-T081
scale	O	O	I-T081
functioning	O	O	B-T169
analysis	O	O	O
and	O	O	O
reliability	O	O	B-UnknownType
analysis	O	O	I-UnknownType
have	O	O	O
demonstrated	O	O	B-T080
that	O	O	O
the	O	O	O
thirty-one	O	O	O
item	O	O	O
Presence	O	O	B-T033
of	O	O	O
Nursing	O	O	B-T091
Scale	O	O	B-T081
-	O	O	O
RN	O	O	B-T097
instrument	O	O	O
yielded	O	O	O
measures	O	O	B-T081
with	O	O	O
high	O	O	B-T080
validity	O	O	B-UnknownType
and	O	O	I-UnknownType
reliability	O	O	I-UnknownType
as	O	O	O
two	O	O	O
sub-scales	O	O	B-T081
.	O	O	O

Jou	O	O	O
rn	O	O	O

-DOCSTART- (28009695)

Elastin	O	O	B-T116
Is	O	O	O
Differentially	O	O	B-T045
Regulated	O	O	I-T045
by	O	O	O
Pressure	O	O	B-T061
Therapy	O	O	I-T061
in	O	O	O
a	O	O	O
Porcine	O	O	B-T015
Model	O	O	B-T008
of	O	O	O
Hypertrophic	O	O	O
Scar	O	O	O

Beneficial	O	O	B-T080
effects	O	O	I-T080
of	O	O	O
pressure	O	O	B-T061
therapy	O	O	I-T061
for	O	O	O
hypertrophic	O	O	B-T020
scars	O	O	I-T020
have	O	O	O
been	O	O	O
reported	O	O	O
,	O	O	O
but	O	O	O
the	O	O	O
mechanisms	O	O	B-T169
of	O	O	O
action	O	O	O
are	O	O	O
not	O	O	O
fully	O	O	O
understood	O	O	O
.	O	O	O

This	O	O	O
study	O	O	B-T062
evaluated	O	O	O
elastin	O	O	B-T116
and	O	O	O
its	O	O	O
contribution	O	O	O
to	O	O	O
scar	O	O	B-T020
pliability	O	O	B-T080
.	O	O	O

The	O	O	O
relationship	O	O	B-T080
between	O	O	O
changes	O	O	O
in	O	O	O
Vancouver	O	O	B-T170
Scar	O	O	I-T170
Scale	O	O	I-T170
(	O	O	O
VSS	O	O	B-T170
)	O	O	O
scores	O	O	B-T081
of	O	O	O
pressure-treated	O	O	B-T061
scars	O	O	B-T020
and	O	O	O
differential	O	O	O
regulation	O	O	O
of	O	O	O
elastin	O	O	B-T116
was	O	O	O
assessed	O	O	O
.	O	O	O

Hypertrophic	O	O	B-T020
scars	O	O	I-T020
were	O	O	O
created	O	O	O
and	O	O	O
assessed	O	O	O
weekly	O	O	B-T079
using	O	O	O
VSS	O	O	B-T170
and	O	O	O
biopsy	O	O	B-T060
procurement	O	O	B-T033
.	O	O	O

Pressure	O	O	B-T061
treatment	O	O	I-T061
began	O	O	O
on	O	O	O
day	O	O	B-T079
70	O	O	O
postinjury	O	O	B-T079
.	O	O	O

Treated	O	O	B-T061
scars	O	O	B-T020
were	O	O	O
compared	O	O	B-T052
with	O	O	O
untreated	O	O	O
shams	O	O	B-T061
.	O	O	O

Treatment	O	O	B-T061
lasted	O	O	O
2	O	O	O
weeks	O	O	B-T079
,	O	O	O
through	O	O	O
day	O	O	B-T079
84	O	O	O
,	O	O	O
and	O	O	O
scars	O	O	B-T020
were	O	O	O
assessed	O	O	O
weekly	O	O	B-T079
through	O	O	O
day	O	O	O
126	O	O	O
.	O	O	O

Transcript	O	O	B-T114
and	O	O	O
protein	O	O	B-T034
levels	O	O	I-T034
of	O	O	O
elastin	O	O	B-T116
were	O	O	O
quantified	O	O	B-T081
.	O	O	O

Pressure	O	O	B-T061
treatment	O	O	I-T061
resulted	O	O	O
in	O	O	O
lower	O	O	O
VSS	O	O	B-T170
scores	O	O	B-T081
compared	O	O	B-T052
with	O	O	O
sham-treated	O	O	B-T061
scars	O	O	B-T020
.	O	O	O

Pliability	O	O	B-T080
(	O	O	O
VSSP	O	O	B-T080
)	O	O	O
was	O	O	O
a	O	O	O
key	O	O	O
contributor	O	O	O
to	O	O	O
this	O	O	O
difference	O	O	O
.	O	O	O

At	O	O	O
day	O	O	B-T079
70	O	O	O
pretreatment	O	O	B-T052
,	O	O	O
VSSP	O	O	B-T080
=	O	O	O
2	O	O	O
.	O	O	O

Without	O	O	B-T061
treatment	O	O	I-T061
,	O	O	O
sham-treated	O	O	B-T061
scars	O	O	B-T020
became	O	O	O
less	O	O	O
pliable	O	O	B-T080
,	O	O	O
while	O	O	O
pressure-treated	O	O	B-T061
scars	O	O	O
became	O	O	O
more	O	O	O
pliable	O	O	O
.	O	O	O

The	O	O	O
percentage	O	O	O
of	O	O	O
elastin	O	O	B-T116
in	O	O	O
scars	O	O	B-T020
at	O	O	O
day	O	O	B-T079
70	O	O	O
was	O	O	O
higher	O	O	O
than	O	O	O
in	O	O	O
uninjured	O	O	B-T022
skin	O	O	I-T022
.	O	O	O

Following	O	O	O
treatment	O	O	B-T061
,	O	O	O
the	O	O	O
percentage	O	O	O
of	O	O	O
elastin	O	O	B-T116
increased	O	O	B-T081
and	O	O	O
continued	O	O	O
to	O	O	O
increase	O	O	B-T169
through	O	O	O
day	O	O	B-T079
126	O	O	O
.	O	O	O

Untreated	O	O	O
sham	O	O	B-T061
scars	O	O	B-T020
did	O	O	O
not	O	O	O
show	O	O	O
a	O	O	O
similar	O	O	O
increase	O	O	B-T169
.	O	O	O

Quantification	O	O	B-T081
of	O	O	O
Verhoeff-Van	O	O	B-T059
Gieson	O	O	I-T059
staining	O	O	I-T059
corroborated	O	O	O
the	O	O	O
findings	O	O	B-T033
and	O	O	O
immunofluorescence	O	O	B-T059
revealed	O	O	O
the	O	O	O
alignment	O	O	B-T081
of	O	O	O
elastin	O	O	B-T116
fibers	O	O	I-T116
.	O	O	O

Pressure	O	O	B-T061
treatment	O	O	I-T061
results	O	O	O
in	O	O	O
increased	O	O	B-T081
protein	O	O	B-T045
level	O	O	I-T045
expression	O	O	I-T045
of	O	O	O
elastin	O	O	B-T116
compared	O	O	B-T052
with	O	O	O
sham	O	O	B-T061
-untreated	O	O	O
scars	O	O	B-T020
.	O	O	O

These	O	O	O
findings	O	O	B-T033
further	O	O	O
characterize	O	O	O
the	O	O	O
extracellular	O	O	B-T024
matrix	O	O	I-T024
's	O	O	I-T024
response	O	O	O
to	O	O	O
the	O	O	O
application	O	O	O
of	O	O	O
pressure	O	O	B-T067
as	O	O	O
a	O	O	O
scar	O	O	B-T020
treatment	O	O	B-T061
,	O	O	O
which	O	O	O
will	O	O	O
contribute	O	O	O
to	O	O	O
the	O	O	O
refinement	O	O	O
of	O	O	O
rehabilitation	O	O	B-T169
practices	O	O	O
and	O	O	O
ultimately	O	O	O
improvements	O	O	B-T077
in	O	O	O
functional	O	O	B-T169
and	O	O	O
psychosocial	O	O	B-T169
outcomes	O	O	B-T169
for	O	O	O
patients	O	O	B-T101
.	O	O	O

-DOCSTART- (28011059)

Epigenome-wide	O	O	B-T063
analysis	O	O	I-T063
links	O	O	O
SMAD3	O	O	B-T028
methylation	O	O	B-T044
at	O	O	O
birth	O	O	B-T040
to	O	O	O
asthma	O	O	B-T047
in	O	O	I-T047
children	O	O	I-T047
of	O	O	O
asthmatic	O	O	B-T047
mothers	O	O	O

The	O	O	O
timing	O	O	O
and	O	O	O
mechanisms	O	O	B-T169
of	O	O	O
asthma	O	O	B-T047
inception	O	O	B-T169
remain	O	O	O
imprecisely	O	O	O
defined	O	O	O
.	O	O	O

Although	O	O	O
epigenetic	O	O	B-T045
mechanisms	O	O	B-T169
likely	O	O	O
contribute	O	O	O
to	O	O	O
asthma	O	O	B-T047
pathogenesis	O	O	B-T046
,	O	O	O
little	O	O	O
is	O	O	O
known	O	O	O
about	O	O	O
their	O	O	O
role	O	O	O
in	O	O	O
asthma	O	O	O
inception	O	O	B-T169
.	O	O	O

We	O	O	O
sought	O	O	O
to	O	O	O
assess	O	O	B-T058
whether	O	O	O
the	O	O	O
trajectory	O	O	O
to	O	O	O
asthma	O	O	B-T047
begins	O	O	O
already	O	O	O
at	O	O	O
birth	O	O	B-T040
and	O	O	O
whether	O	O	O
epigenetic	O	O	B-T045
mechanisms	O	O	B-T169
,	O	O	O
specifically	O	O	O
DNA	O	O	B-T044
methylation	O	O	I-T044
,	O	O	O
contribute	O	O	O
to	O	O	O
asthma	O	O	O
inception	O	O	B-T169
.	O	O	O

We	O	O	O
used	O	O	O
the	O	O	O
Methylated	O	O	B-T059
CpG	O	O	I-T059
Island	O	O	I-T059
Recovery	O	O	I-T059
Assay	O	O	I-T059
chip	O	O	I-T059
to	O	O	O
survey	O	O	B-T170
DNA	O	O	B-T044
methylation	O	O	I-T044
in	O	O	O
cord	O	O	B-T031
blood	O	O	I-T031
mononuclear	O	O	B-T025
cells	O	O	I-T025
from	O	O	O
36	O	O	O
children	O	O	B-T100
(	O	O	O
18	O	O	O
nonasthmatic	O	O	B-T098
and	O	O	O
18	O	O	O
asthmatic	O	O	B-T047
subjects	O	O	B-T098
by	O	O	O
age	O	O	B-T032
9	O	O	O
years	O	O	B-T079
)	O	O	O
from	O	O	O
the	O	O	O
Infant	O	O	B-T100
Immune	O	O	B-T169
Study	O	O	B-T062
(	O	O	O
IIS	O	O	B-T062
)	O	O	O
,	O	O	O
an	O	O	O
unselected	O	O	O
birth	O	O	B-T040
cohort	O	O	B-T098
closely	O	O	O
monitored	O	O	O
for	O	O	O
asthma	O	O	B-T047
for	O	O	O
a	O	O	O
decade	O	O	O
.	O	O	O

SMAD3	O	O	B-T028
methylation	O	O	B-T044
in	O	O	O
IIS	O	O	B-T062
(	O	O	O
n	O	O	O
=	O	O	O
60	O	O	O
)	O	O	O
and	O	O	O
in	O	O	O
2	O	O	O
replication	O	O	B-T045
cohorts	O	O	B-T098
(	O	O	O
the	O	O	O
Manchester	O	O	B-UnknownType
Asthma	O	O	B-T047
and	O	O	O
Allergy	O	O	B-T059
Study	O	O	B-T062
[	O	O	O
n	O	O	O
=	O	O	O
30	O	O	O
]	O	O	O
and	O	O	O
the	O	O	O
Childhood	O	O	B-T047
Origins	O	O	I-T047
of	O	O	I-T047
Asthma	O	O	I-T047
Study	O	O	O
[	O	O	O
n	O	O	O
=	O	O	O
28	O	O	O
]	O	O	O
)	O	O	O
was	O	O	O
analyzed	O	O	B-T062
by	O	O	O
using	O	O	O
bisulfite	O	O	B-T063
sequencing	O	O	I-T063
or	O	O	O
Illumina	O	O	B-T059
450	O	O	I-T059
K	O	O	I-T059
arrays	O	O	I-T059
.	O	O	O

Cord	O	O	B-T031
blood	O	O	I-T031
mononuclear	O	O	B-T025
cell	O	O	I-T025
-derived	O	O	O
IL-1Î²	O	O	B-T116
levels	O	O	B-T080
were	O	O	O
measured	O	O	B-T080
by	O	O	O
means	O	O	O
of	O	O	O
ELISA	O	O	B-T059
.	O	O	O

Neonatal	O	O	B-T100
immune	O	O	B-T169
cells	O	O	B-T025
harbored	O	O	O
589	O	O	O
differentially	O	O	O
methylated	O	O	B-T086
regions	O	O	I-T086
that	O	O	O
distinguished	O	O	O
IIS	O	O	B-T062
children	O	O	B-T098
who	O	O	O
did	O	O	O
and	O	O	O
did	O	O	O
not	O	O	O
have	O	O	O
asthma	O	O	B-T047
by	O	O	O
age	O	O	B-T032
9	O	O	O
years	O	O	B-T079
.	O	O	O

In	O	O	O
all	O	O	O
3	O	O	O
cohorts	O	O	B-T098
methylation	O	O	B-T044
in	O	O	O
SMAD3	O	O	B-T028
,	O	O	O
the	O	O	O
most	O	O	O
connected	O	O	O
node	O	O	O
within	O	O	O
the	O	O	O
network	O	O	O
of	O	O	O
asthma	O	O	B-T047
-	O	O	O
associated	O	O	B-T080
,	O	O	O
differentially	O	O	O
methylated	O	O	B-T086
regions	O	O	I-T086
,	O	O	O
was	O	O	O
selectively	O	O	O
increased	O	O	B-T081
in	O	O	O
asthmatic	O	O	B-T047
children	O	O	B-T100
of	O	O	O
asthmatic	O	O	O
mothers	O	O	B-T099
and	O	O	O
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
childhood	O	O	B-T047
asthma	O	O	I-T047
risk	O	O	B-T078
.	O	O	O

Moreover	O	O	O
,	O	O	O
SMAD3	O	O	B-T028
methylation	O	O	B-T044
in	O	O	O
IIS	O	O	B-T062
neonates	O	O	B-T100
with	O	O	O
maternal	O	O	B-T099
asthma	O	O	B-T047
was	O	O	O
strongly	O	O	O
and	O	O	O
positively	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
neonatal	O	O	B-T100
production	O	O	O
of	O	O	O
IL-1Î²	O	O	B-T116
,	O	O	O
an	O	O	O
innate	O	O	B-T121
inflammatory	O	O	I-T121
mediator	O	O	I-T121
.	O	O	O

The	O	O	O
trajectory	O	O	O
to	O	O	O
childhood	O	O	B-T047
asthma	O	O	I-T047
begins	O	O	O
at	O	O	O
birth	O	O	B-T040
and	O	O	O
involves	O	O	O
epigenetic	O	O	B-T045
modifications	O	O	B-T169
in	O	O	O
immunoregulatory	O	O	B-T040
and	O	O	O
proinflammatory	O	O	B-T169
pathways	O	O	B-T044
.	O	O	O

Maternal	O	O	B-T099
asthma	O	O	B-T047
influences	O	O	O
epigenetic	O	O	B-T045
mechanisms	O	O	B-T169
that	O	O	O
contribute	O	O	O
to	O	O	O
the	O	O	O
inception	O	O	B-T169
of	O	O	O
this	O	O	O
trajectory	O	O	O
.	O	O	O

-DOCSTART- (28013205)

Clinical	O	O	B-T080
correlates	O	O	B-T080
of	O	O	O
faecal	O	O	B-T047
incontinence	O	O	I-T047
in	O	O	O
systemic	O	O	B-T047
sclerosis	O	O	I-T047
:	O	O	O
identifying	O	O	O
therapeutic	O	O	O
avenues	O	O	O

The	O	O	O
aim	O	O	O
was	O	O	O
to	O	O	O
establish	O	O	O
the	O	O	O
prevalence	O	O	B-T081
and	O	O	O
severity	O	O	B-T080
of	O	O	O
faecal	O	O	B-T047
incontinence	O	O	I-T047
(	O	O	O
FI	O	O	B-T047
)	O	O	O
in	O	O	O
SSc	O	O	B-T047
,	O	O	O
its	O	O	O
association	O	O	B-T080
with	O	O	O
other	O	O	O
intestinal	O	O	B-T023
manifestations	O	O	B-T169
and	O	O	O
potential	O	O	B-T080
predictors	O	O	B-T078
of	O	O	O
FI	O	O	O
,	O	O	O
and	O	O	O
its	O	O	O
impact	O	O	B-T080
on	O	O	O
quality	O	O	B-T078
of	O	O	I-T078
life	O	O	I-T078
.	O	O	O

A	O	O	O
multicentre	O	O	O
,	O	O	O
cross-sectional	O	O	B-T062
study	O	O	I-T062
of	O	O	O
298	O	O	O
SSc	O	O	B-T047
subjects	O	O	B-T101
followed	O	O	O
in	O	O	O
the	O	O	O
Canadian	O	O	B-T093
Scleroderma	O	O	I-T093
Research	O	O	I-T093
Group	O	O	I-T093
cohort	O	O	B-T098
was	O	O	O
performed	O	O	O
using	O	O	O
validated	O	O	O
questionnaires	O	O	B-T170
:	O	O	O
Jorge-Wexner	O	O	B-T170
score	O	O	I-T170
(	O	O	O
an	O	O	O
FI	O	O	B-T047
severity	O	O	B-T170
scale	O	O	I-T170
)	O	O	O
,	O	O	O
Bristol	O	O	B-T170
stool	O	O	I-T170
scale	O	O	I-T170
(	O	O	O
a	O	O	O
visual	O	O	O
scale	O	O	O
of	O	O	O
stool	O	O	B-T033
consistency	O	O	I-T033
)	O	O	O
and	O	O	O
FI	O	O	O
Quality-of-Life	O	O	B-T170
scale	O	O	I-T170
.	O	O	O

Constipation	O	O	B-T184
was	O	O	O
defined	O	O	O
by	O	O	O
the	O	O	O
Rome	O	O	B-T170
III	O	O	I-T170
criteria	O	O	I-T170
.	O	O	O

Associations	O	O	B-T080
between	O	O	O
the	O	O	O
Jorge-Wexner	O	O	B-T170
score	O	O	I-T170
and	O	O	O
other	O	O	O
clinical	O	O	B-T033
variables	O	O	I-T033
were	O	O	O
determined	O	O	O
using	O	O	O
multivariate	O	O	B-T170
regression	O	O	I-T170
analyses	O	O	I-T170
.	O	O	O

Eighty-one	O	O	O
(	O	O	O
27.2	O	O	O
%	O	O	O
)	O	O	O
subjects	O	O	B-T101
had	O	O	O
FI	O	O	B-T047
,	O	O	O
which	O	O	O
was	O	O	O
mild	O	O	B-T080
in	O	O	O
37	O	O	O
(	O	O	O
12.4	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
moderate	O	O	B-T080
to	O	O	I-T080
severe	O	O	I-T080
in	O	O	O
44	O	O	O
(	O	O	O
14.8	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

Most	O	O	O
patients	O	O	B-T101
had	O	O	O
well-formed	O	O	O
stools	O	O	B-T031
,	O	O	O
111	O	O	O
(	O	O	O
38.8	O	O	O
%	O	O	O
)	O	O	O
reported	O	O	O
constipation	O	O	B-T184
and	O	O	O
38	O	O	O
(	O	O	O
13.4	O	O	O
%	O	O	O
)	O	O	O
had	O	O	O
been	O	O	O
previously	O	O	B-T079
treated	O	O	B-T169
for	O	O	O
small	O	O	B-T047
intestinal	O	O	I-T047
bacterial	O	O	I-T047
overgrowth	O	O	I-T047
(	O	O	O
SIBO	O	O	B-T047
)	O	O	O
.	O	O	O

Variables	O	O	B-T080
independently	O	O	B-T078
associated	O	O	B-T080
with	O	O	I-T080
FI	O	O	B-T047
were	O	O	O
:	O	O	O
loose	O	O	B-T184
vs	O	O	O
well-formed	O	O	O
stools	O	O	B-T031
[	O	O	O
odds	O	O	B-T081
ratio	O	O	I-T081
(	O	O	O
OR	O	O	B-T081
)	O	O	O
=	O	O	O
7.01	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
:	O	O	O
2.09	O	O	O
,	O	O	O
23.51	O	O	O
)	O	O	O
]	O	O	O
,	O	O	O
constipation	O	O	B-T184
(	O	O	O
OR	O	O	O
=	O	O	O
3.64	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
:	O	O	O
1.61	O	O	O
,	O	O	O
8.27	O	O	O
,	O	O	O
P	O	O	B-T081
=	O	O	O
0.002	O	O	O
)	O	O	O
,	O	O	O
history	O	O	B-T033
of	O	O	O
SIBO	O	O	B-T047
(	O	O	O
OR	O	O	O
=	O	O	O
2.97	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
:	O	O	O
1.06	O	O	O
,	O	O	O
8.27	O	O	O
)	O	O	O
and	O	O	O
urinary	O	O	B-T046
incontinence	O	O	I-T046
(	O	O	O
OR	O	O	O
=	O	O	O
2.45	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
:	O	O	O
1.14	O	O	O
,	O	O	O
5.27	O	O	O
)	O	O	O
.	O	O	O

Quality	O	O	B-T078
of	O	O	I-T078
life	O	O	I-T078
measured	O	O	B-T080
with	O	O	O
the	O	O	O
FI	O	O	B-T047
Quality-of-Life	O	O	B-T170
scale	O	O	I-T170
was	O	O	O
inversely	O	O	B-T080
correlated	O	O	B-T080
with	O	O	O
FI	O	O	O
severity	O	O	B-T080
(	O	O	O
correlation	O	O	B-T080
coefficients	O	O	B-T081
between	O	O	O
-0.602	O	O	O
and	O	O	O
-0.702	O	O	O
,	O	O	O
P	O	O	B-T081
<	O	O	O
0.001	O	O	O
)	O	O	O
.	O	O	O

FI	O	O	B-T047
was	O	O	O
common	O	O	B-T081
and	O	O	O
often	O	O	O
severe	O	O	B-T080
in	O	O	O
SSc	O	O	B-T047
.	O	O	O

Loose	O	O	B-T184
stools	O	O	I-T184
,	O	O	O
SIBO	O	O	B-T047
,	O	O	O
constipation	O	O	B-T184
and	O	O	O
urinary	O	O	B-T046
incontinence	O	O	I-T046
were	O	O	O
strongly	O	O	B-T080
associated	O	O	B-T080
with	O	O	I-T080
FI	O	O	B-T047
.	O	O	O

Other	O	O	O
than	O	O	O
targeting	O	O	B-T169
anorectal	O	O	B-T030
dysfunction	O	O	B-T046
,	O	O	O
concomitant	O	O	B-T079
treatment	O	O	B-T061
of	O	O	O
clinical	O	O	B-T080
correlates	O	O	B-T080
could	O	O	O
lead	O	O	O
to	O	O	O
improvement	O	O	B-T077
in	O	O	O
FI	O	O	B-T047
and	O	O	O
quality	O	O	B-T078
of	O	O	I-T078
life	O	O	I-T078
in	O	O	O
SSc	O	O	B-T047
.	O	O	O

-DOCSTART- (28013256)

From	O	O	O
training	O	O	B-T065
to	O	O	O
practice	O	O	B-T057
:	O	O	O
the	O	O	O
impact	O	O	B-T080
of	O	O	O
ENGAGE	O	O	B-T093
,	O	O	O
Ireland	O	O	B-T083
's	O	O	I-T083
national	O	O	O
men	O	O	O
's	O	O	O
health	O	O	O
training	O	O	O
programme	O	O	O

Ireland	O	O	B-T083
's	O	O	I-T083
National	O	O	B-T170
Men	O	O	I-T170
's	O	O	I-T170
Health	O	O	I-T170
Policy	O	O	I-T170
recommended	O	O	B-T078
developing	O	O	O
training	O	O	B-T065
programmes	O	O	I-T065
tailored	O	O	B-T058
to	O	O	O
the	O	O	O
needs	O	O	B-T080
of	O	O	O
those	O	O	O
working	O	O	B-T057
in	O	O	O
health	O	O	B-T097
and	O	O	O
allied	O	O	B-T097
health	O	O	I-T097
professionals	O	O	I-T097
and	O	O	O
ENGAGE	O	O	B-T093
was	O	O	O
developed	O	O	O
to	O	O	O
meet	O	O	O
that	O	O	O
recommendation	O	O	B-T078
.	O	O	O

This	O	O	O
study	O	O	B-T062
evaluated	O	O	B-T058
the	O	O	O
impact	O	O	B-T080
of	O	O	O
ENGAGE	O	O	B-T093
on	O	O	O
frontline	O	O	B-T058
service	O	O	I-T058
providers	O	O	I-T058
'	O	O	I-T058
self-reported	O	O	B-T033
knowledge	O	O	I-T033
,	O	O	O
skills	O	O	B-T055
,	O	O	O
capacity	O	O	B-T081
and	O	O	O
practice	O	O	B-T057
up	O	O	O
to	O	O	O
5-months	O	O	O
post	O	O	B-T079
training	O	O	B-T065
.	O	O	O

Between	O	O	O
2012	O	O	O
and	O	O	O
2015	O	O	O
,	O	O	O
ENGAGE	O	O	B-T093
Trainers	O	O	B-T073
(	O	O	O
n	O	O	O
=	O	O	O
57	O	O	O
)	O	O	O
delivered	O	O	O
62	O	O	O
1-day	O	O	O
training	O	O	B-T065
programmes	O	O	I-T065
to	O	O	O
810	O	O	O
participants	O	O	B-T098
.	O	O	O

This	O	O	O
study	O	O	B-T062
was	O	O	O
conducted	O	O	O
on	O	O	O
a	O	O	O
subset	O	O	B-T185
of	O	O	O
those	O	O	O
training	O	O	B-T065
days	O	O	O
(	O	O	O
n	O	O	O
=	O	O	O
26	O	O	O
)	O	O	O
and	O	O	O
participants	O	O	B-T098
.	O	O	O

Quantitative	O	O	B-T081
methodologies	O	O	B-T062
were	O	O	O
used	O	O	O
to	O	O	O
collect	O	O	O
pre	O	O	O
(	O	O	O
n	O	O	O
=	O	O	O
295	O	O	O
)	O	O	O
,	O	O	O
post	O	O	B-T079
(	O	O	O
n	O	O	O
=	O	O	O
295	O	O	O
)	O	O	O
and	O	O	O
5-month	O	O	O
post	O	O	O
(	O	O	O
n	O	O	O
=	O	O	O
128	O	O	O
)	O	O	O
training	O	O	B-T065
questionnaire	O	O	B-T170
data	O	O	O
.	O	O	O

Overall	O	O	B-T080
,	O	O	O
participants	O	O	B-T098
were	O	O	O
highly	O	O	O
satisfied	O	O	B-T170
with	O	O	O
the	O	O	O
training	O	O	B-T065
immediately	O	O	B-T079
post	O	O	B-T079
training	O	O	O
(	O	O	O
8.60	O	O	O
Â±	O	O	O
1.60	O	O	O
out	O	O	O
of	O	O	O
10	O	O	O
)	O	O	O
and	O	O	O
at	O	O	O
5-month	O	O	O
follow	O	O	B-T033
up	O	O	I-T033
(	O	O	O
8.06	O	O	O
Â±	O	O	O
1.43	O	O	O
out	O	O	O
of	O	O	O
10	O	O	O
)	O	O	O
.	O	O	O

Participants	O	O	B-T098
'	O	O	I-T098
self-reported	O	O	B-T033
level	O	O	I-T033
of	O	O	I-T033
knowledge	O	O	I-T033
,	O	O	O
skill	O	O	B-T055
and	O	O	O
capacity	O	O	B-T081
in	O	O	O
identifying	O	O	O
priorities	O	O	B-T079
,	O	O	O
engaging	O	O	O
men	O	O	B-T098
and	O	O	O
influencing	O	O	B-T077
practice	O	O	B-T057
beyond	O	O	O
their	O	O	O
own	O	O	O
organisation	O	O	B-T057
increased	O	O	B-T081
immediately	O	O	B-T079
following	O	O	O
training	O	O	B-T065
(	O	O	O
P	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
and	O	O	O
,	O	O	O
with	O	O	O
the	O	O	O
exception	O	O	B-T077
of	O	O	O
improving	O	O	B-T080
capacity	O	O	O
to	O	O	O
engage	O	O	O
men	O	O	O
and	O	O	O
influencing	O	O	O
practice	O	O	O
beyond	O	O	O
their	O	O	O
organisation	O	O	O
,	O	O	O
these	O	O	O
improvements	O	O	B-T057
were	O	O	O
sustained	O	O	B-T169
at	O	O	O
5-month	O	O	O
post	O	O	B-T079
training	O	O	O
(	O	O	O
P	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
vast	O	O	O
majority	O	O	B-T054
of	O	O	O
service	O	O	B-T058
providers	O	O	I-T058
(	O	O	O
93.4	O	O	O
%	O	O	O
)	O	O	O
reported	O	O	B-T058
that	O	O	O
ENGAGE	O	O	B-T093
had	O	O	O
impacted	O	O	B-T080
their	O	O	O
work	O	O	B-T057
practice	O	O	B-T057
up	O	O	O
to	O	O	O
5-month	O	O	O
post	O	O	B-T079
training	O	O	B-T065
.	O	O	O

The	O	O	O
findings	O	O	B-T033
suggest	O	O	B-T078
that	O	O	O
ENGAGE	O	O	B-T093
has	O	O	O
succeeded	O	O	B-T033
in	O	O	O
improving	O	O	B-T080
service	O	O	B-T058
providers	O	O	I-T058
'	O	O	I-T058
capacity	O	O	B-T081
to	O	O	O
engage	O	O	O
and	O	O	O
work	O	O	B-T057
with	O	O	O
men	O	O	B-T098
;	O	O	O
improving	O	O	O
gender	O	O	B-T032
competency	O	O	B-T080
in	O	O	O
the	O	O	O
delivery	O	O	O
of	O	O	O
health	O	O	B-T078
and	O	O	O
health	O	O	B-T058
related	O	O	I-T058
services	O	O	B-T058
may	O	O	O
increase	O	O	B-T081
the	O	O	O
utilisation	O	O	B-T058
of	O	O	O
such	O	O	O
services	O	O	O
by	O	O	O
men	O	O	O
and	O	O	O
thereby	O	O	O
improve	O	O	B-T033
health	O	O	B-T057
outcomes	O	O	I-T057
for	O	O	O
men	O	O	O
.	O	O	O

-DOCSTART- (28017476)

Double	O	O	B-T049
strand	O	O	I-T049
break	O	O	I-T049
induction	O	O	B-T169
and	O	O	O
kinetics	O	O	B-T070
indicate	O	O	O
preserved	O	O	O
hypersensitivity	O	O	B-T046
in	O	O	O
keratinocytes	O	O	B-T025
to	O	O	O
subtherapeutic	O	O	B-T169
doses	O	O	B-T081
for	O	O	O
7	O	O	O
weeks	O	O	B-T079
of	O	O	O
radiotherapy	O	O	O

Previously	O	O	O
we	O	O	O
reported	O	O	O
that	O	O	O
hyper-radiosensitivity	O	O	B-T032
(	O	O	O
HRS	O	O	B-T032
)	O	O	O
was	O	O	O
evidenced	O	O	O
by	O	O	O
quantifying	O	O	B-T081
DNA	O	O	B-T026
double	O	O	I-T026
strand	O	O	I-T026
break	O	O	I-T026
(	O	O	I-T026
DSB	O	O	I-T026
)	O	O	I-T026
foci	O	O	I-T026
in	O	O	O
epidermis	O	O	B-T024
biopsies	O	O	B-T060
collected	O	O	O
after	O	O	O
delivering	O	O	O
radiotherapeutic	O	O	B-T170
one	O	O	O
and	O	O	O
five	O	O	O
dose	O	O	B-T081
fractions	O	O	I-T081
.	O	O	O

The	O	O	O
aim	O	O	B-T078
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
determine	O	O	O
whether	O	O	O
HRS	O	O	B-T032
was	O	O	O
preserved	O	O	O
throughout	O	O	O
a	O	O	O
7-	O	O	O
week	O	O	B-T079
radiotherapy	O	O	B-T061
treatment	O	O	B-T061
,	O	O	O
and	O	O	O
also	O	O	O
to	O	O	O
examine	O	O	O
the	O	O	O
rate	O	O	O
of	O	O	O
foci	O	O	B-T026
decline	O	O	O
and	O	O	O
foci	O	O	O
persistence	O	O	O
between	O	O	O
dose	O	O	B-T081
fractions	O	O	I-T081
.	O	O	O

42	O	O	O
patients	O	O	B-T101
with	O	O	O
prostate	O	O	B-T191
cancer	O	O	I-T191
received	O	O	O
7-	O	O	O
week	O	O	B-T079
fractionated	O	O	O
radiotherapy	O	O	B-T061
treatment	O	O	I-T061
(	O	O	O
RT	O	O	B-T061
)	O	O	O
with	O	O	O
daily	O	O	O
dose	O	O	B-T081
fractions	O	O	I-T081
of	O	O	O
0.05	O	O	O
-	O	O	O
1.10Gy	O	O	O
to	O	O	O
the	O	O	O
skin	O	O	B-T022
.	O	O	O

Before	O	O	O
RT	O	O	B-T061
,	O	O	O
and	O	O	O
at	O	O	O
several	O	O	O
times	O	O	O
throughout	O	O	O
treatment	O	O	B-T061
,	O	O	O
skin	O	O	B-T060
biopsies	O	O	I-T060
(	O	O	O
n=452	O	O	O
)	O	O	O
were	O	O	O
collected	O	O	O
at	O	O	O
30min	O	O	O
,	O	O	O
and	O	O	O
2	O	O	O
,	O	O	O
3	O	O	O
,	O	O	O
24	O	O	O
,	O	O	O
and	O	O	O
72h	O	O	O
after	O	O	O
dose	O	O	B-T081
fractions	O	O	I-T081
.	O	O	O

DSB-foci	O	O	B-T026
markers	O	O	B-T086
,	O	O	O
Î³H2AX	O	O	B-T028
and	O	O	O
53BP1	O	O	B-T028
,	O	O	O
were	O	O	O
labelled	O	O	O
in	O	O	O
epidermal	O	O	B-T024
keratinocytes	O	O	B-T025
with	O	O	O
immunofluorescence	O	O	B-T059
and	O	O	O
immunohistochemical	O	O	B-T059
staining	O	O	I-T059
.	O	O	O

Foci	O	O	O
were	O	O	O
counted	O	O	O
both	O	O	O
with	O	O	O
digital	O	O	B-T060
image	O	O	I-T060
analysis	O	O	I-T060
and	O	O	O
manually	O	O	O
.	O	O	O

HRS	O	O	B-T032
in	O	O	O
keratinocytes	O	O	B-T025
was	O	O	O
evidenced	O	O	O
by	O	O	O
the	O	O	O
dose-response	O	O	B-T038
relationships	O	O	I-T038
of	O	O	O
DSB	O	O	B-T026
foci	O	O	I-T026
,	O	O	O
observed	O	O	O
throughout	O	O	O
the	O	O	O
treatment	O	O	B-T079
course	O	O	I-T079
,	O	O	O
independent	O	O	B-T169
of	O	O	I-T169
sampling	O	O	B-T060
time	O	O	B-T079
and	O	O	O
quantification	O	O	B-T081
method	O	O	B-T170
.	O	O	O

Foci	O	O	B-T026
observed	O	O	O
at	O	O	O
24h	O	O	O
after	O	O	O
dose	O	O	B-T081
fractions	O	O	I-T081
indicated	O	O	O
considerable	O	O	O
DSB	O	O	B-T049
persistence	O	O	O
.	O	O	O

Accordingly	O	O	O
,	O	O	O
foci	O	O	B-T026
significantly	O	O	O
accumulated	O	O	O
after	O	O	O
5	O	O	O
consecutive	O	O	O
dose	O	O	B-T081
fractions	O	O	I-T081
.	O	O	O

For	O	O	O
doses	O	O	B-T081
below	O	O	O
0.3Gy	O	O	O
,	O	O	O
persistent	O	O	O
foci	O	O	B-T026
could	O	O	O
be	O	O	O
observed	O	O	O
even	O	O	O
at	O	O	O
72h	O	O	O
after	O	O	O
damage	O	O	B-T049
induction	O	O	B-T169
.	O	O	O

A	O	O	O
comparison	O	O	B-T052
of	O	O	O
Î³H2AX	O	O	B-T028
and	O	O	O
53BP1	O	O	B-T028
quantifications	O	O	B-T081
in	O	O	O
double-staine	O	O	B-T080
d	O	O	O
biopsies	O	O	B-T060
showed	O	O	O
similar	O	O	O
HRS	O	O	B-T032
dose-response	O	O	B-T038
relationships	O	O	I-T038
.	O	O	O

These	O	O	O
results	O	O	O
represented	O	O	O
the	O	O	O
first	O	O	O
evidence	O	O	B-T078
of	O	O	O
preserved	O	O	O
HRS	O	O	B-T032
,	O	O	O
assessed	O	O	B-T052
by	O	O	O
Î³H2AX	O	O	B-T028
-	O	O	O
and	O	O	O
53BP1	O	O	B-T028
-labelled	O	O	O
DSB	O	O	B-T026
foci	O	O	I-T026
,	O	O	O
throughout	O	O	O
a	O	O	O
7-	O	O	O
week	O	O	B-T079
treatment	O	O	B-T079
course	O	O	I-T079
with	O	O	O
daily	O	O	B-T079
repeated	O	O	O
subtherapeutic	O	O	B-T169
dose	O	O	B-T081
fractions	O	O	I-T081
.	O	O	O

-DOCSTART- (28027760)

CT	O	O	B-T060
angiography	O	O	I-T060
for	O	O	O
planning	O	O	B-T169
transcatheter	O	O	B-T061
aortic	O	O	I-T061
valve	O	O	I-T061
replacement	O	O	I-T061
using	O	O	O
automated	O	O	B-T081
tube	O	O	I-T081
voltage	O	O	I-T081
selection	O	O	I-T081
:	O	O	O
Image	O	O	B-T080
quality	O	O	I-T080
and	O	O	O
radiation	O	O	B-T070
exposure	O	O	O

To	O	O	O
assess	O	O	B-T058
image	O	O	B-T080
quality	O	O	I-T080
and	O	O	O
accuracy	O	O	B-T080
of	O	O	O
CT	O	O	B-T060
angiography	O	O	I-T060
(	O	O	O
CTA	O	O	B-T060
)	O	O	O
for	O	O	O
transcatheter	O	O	B-T061
aortic	O	O	I-T061
valve	O	O	I-T061
replacement	O	O	I-T061
(	O	O	O
TAVR	O	O	B-T061
)	O	O	O
planning	O	O	B-T169
performed	O	O	O
with	O	O	O
3rd	O	O	B-T060
generation	O	O	I-T060
dual-source	O	O	I-T060
CT	O	O	I-T060
(	O	O	O
DSCT	O	O	B-T060
)	O	O	O
.	O	O	O

We	O	O	O
evaluated	O	O	O
125	O	O	O
patients	O	O	B-T101
who	O	O	O
underwent	O	O	O
TAVR	O	O	B-T061
-	O	O	O
planning	O	O	B-T169
CTA	O	O	B-T060
on	O	O	O
3rd	O	O	B-T060
generation	O	O	I-T060
DSCT	O	O	I-T060
.	O	O	O

A	O	O	O
two-part	O	O	B-T061
protocol	O	O	I-T061
was	O	O	O
performed	O	O	O
including	O	O	O
retrospectively	O	O	B-T080
ECG-gated	O	O	B-T060
coronary	O	O	I-T060
CTA	O	O	I-T060
(	O	O	O
CCTA	O	O	B-T060
)	O	O	O
and	O	O	O
prospectively	O	O	B-T080
ECG-triggered	O	O	B-T060
aortoiliac	O	O	I-T060
CTA	O	O	I-T060
using	O	O	O
60mL	O	O	O
of	O	O	O
contrast	O	O	B-T130
medium	O	O	I-T130
.	O	O	O

Automated	O	O	B-T081
tube	O	O	I-T081
voltage	O	O	I-T081
selection	O	O	I-T081
and	O	O	O
advanced	O	O	B-T060
iterative	O	O	I-T060
reconstruction	O	O	I-T060
were	O	O	O
applied	O	O	O
.	O	O	O

Effective	O	O	B-T081
dose	O	O	I-T081
(	O	O	O
ED	O	O	B-T081
)	O	O	O
,	O	O	O
signal-to-noise	O	O	B-T081
(	O	O	O
SNR	O	O	B-T081
)	O	O	O
and	O	O	O
contrast-to-noise	O	O	B-T081
ratios	O	O	I-T081
(	O	O	O
CNR	O	O	B-T081
)	O	O	O
were	O	O	O
calculated	O	O	O
.	O	O	O

Five-point	O	O	B-T170
scales	O	O	I-T170
were	O	O	O
used	O	O	O
for	O	O	O
subjective	O	O	B-T080
image	O	O	B-T060
quality	O	O	I-T060
analysis	O	O	I-T060
.	O	O	O

In	O	O	O
patients	O	O	B-T101
who	O	O	O
underwent	O	O	O
TAVR	O	O	B-T061
,	O	O	O
sizing	O	O	B-T033
parameters	O	O	I-T033
were	O	O	O
obtained	O	O	O
.	O	O	O

Image	O	O	B-T080
quality	O	O	I-T080
was	O	O	O
rated	O	O	O
good	O	O	O
to	O	O	O
excellent	O	O	O
in	O	O	O
97.6	O	O	O
%	O	O	O
of	O	O	O
CCTA	O	O	B-T060
and	O	O	O
100	O	O	O
%	O	O	O
of	O	O	O
aortoiliac	O	O	B-T060
CTAs	O	O	I-T060
.	O	O	O

CTA	O	O	B-T060
studies	O	O	B-T062
at	O	O	O
>	O	O	O
100kV	O	O	O
showed	O	O	O
decreased	O	O	B-T081
objective	O	O	B-T080
image	O	O	B-T080
quality	O	O	I-T080
compared	O	O	O
to	O	O	O
70	O	O	O
-	O	O	O
100kV	O	O	O
(	O	O	O
SNR	O	O	B-T081
,	O	O	O
all	O	O	O
pâ¤0.0459	O	O	O
;	O	O	O
CNR	O	O	B-T081
,	O	O	O
all	O	O	O
pâ¤0.0462	O	O	O
)	O	O	O
.	O	O	O

Mean	O	O	B-T081
ED	O	O	B-T081
increased	O	O	B-T081
continuously	O	O	O
from	O	O	O
70	O	O	O
to	O	O	O
>	O	O	O
100kV	O	O	O
(	O	O	O
CCTA	O	O	B-T060
:	O	O	O
4.5Â±1.7mSv-13.6Â±2.9mSv	O	O	O
,	O	O	O
all	O	O	O
pâ¤0.0233	O	O	O
;	O	O	O
aortoiliac	O	O	B-T060
CTA	O	O	I-T060
:	O	O	O
2.4Â±0.9mSv-6.8Â±2.7mSv	O	O	O
,	O	O	O
all	O	O	O
pâ¤0.0414	O	O	O
)	O	O	O
.	O	O	O

In	O	O	O
39	O	O	O
patients	O	O	B-T101
TAVR	O	O	B-T061
was	O	O	O
performed	O	O	O
and	O	O	O
annulus	O	O	B-T023
diameter	O	O	B-T081
was	O	O	O
within	O	O	O
the	O	O	O
recommended	O	O	O
range	O	O	O
in	O	O	O
all	O	O	O
patients	O	O	O
.	O	O	O

No	O	O	B-T033
severe	O	O	B-T080
cardiac	O	O	B-T046
or	O	O	O
vascular	O	O	B-T046
complications	O	O	I-T046
were	O	O	O
noted	O	O	O
.	O	O	O

3rd	O	O	B-T060
generation	O	O	I-T060
DSCT	O	O	I-T060
provides	O	O	O
diagnostic	O	O	B-T169
image	O	O	B-T080
quality	O	O	I-T080
in	O	O	O
TAVR	O	O	B-T061
-	O	O	O
planning	O	O	B-T169
CTA	O	O	B-T060
and	O	O	O
facilitates	O	O	O
reliable	O	O	O
assessment	O	O	B-T058
of	O	O	O
TAVR	O	O	O
device	O	O	B-T074
and	O	O	O
delivery	O	O	B-T169
option	O	O	O
while	O	O	O
reducing	O	O	B-T080
radiation	O	O	B-T081
dose	O	O	I-T081
.	O	O	O

-DOCSTART- (28033191)

A	O	O	O
Giant	O	O	B-T025
Aneurysmal	O	O	B-T047
Bone	O	O	I-T047
Cyst	O	O	I-T047
in	O	O	O
the	O	O	O
Mandibular	O	O	O
Condyle	O	O	O

Aneurysmal	O	O	B-T047
bone	O	O	I-T047
cyst	O	O	I-T047
(	O	O	O
ABC	O	O	B-T047
)	O	O	O
is	O	O	O
a	O	O	O
rare	O	O	B-T080
,	O	O	O
rapidly	O	O	B-T080
expanding	O	O	B-T082
,	O	O	O
locally	O	O	B-T082
destructive	O	O	B-T052
,	O	O	O
and	O	O	O
easily	O	O	B-T033
misdiagnosed	O	O	B-T033
lesion	O	O	B-T033
.	O	O	O

An	O	O	O
ABC	O	O	B-T047
of	O	O	O
the	O	O	O
condyle	O	O	B-T023
is	O	O	O
rare	O	O	B-T080
.	O	O	O

This	O	O	O
report	O	O	O
presents	O	O	O
a	O	O	O
25-	O	O	O
year	O	O	B-T079
-	O	O	O
old	O	O	B-T079
female	O	O	B-T032
with	O	O	O
a	O	O	O
giant	O	O	B-T025
ABC	O	O	B-T047
in	O	O	O
the	O	O	O
left	O	O	B-T082
mandibular	O	O	B-T023
condyle	O	O	I-T023
.	O	O	O

This	O	O	O
patient	O	O	B-T101
was	O	O	O
treated	O	O	B-T061
with	O	O	I-T061
surgical	O	O	B-T061
resection	O	O	I-T061
of	O	O	O
the	O	O	O
affected	O	O	B-T169
bone	O	O	B-T023
and	O	O	O
immediate	O	O	O
mandibular	O	O	B-T061
reconstruction	O	O	I-T061
using	O	O	O
autologous	O	O	B-T080
bone	O	O	O
.	O	O	O

Follow-up	O	O	B-T058
to	O	O	I-T058
date	O	O	I-T058
showed	O	O	O
no	O	O	O
signs	O	O	B-T033
of	O	O	O
recurrence	O	O	B-T067
.	O	O	O

The	O	O	O
clinical	O	O	B-T080
feature	O	O	B-T080
,	O	O	O
imaging	O	O	B-T034
finding	O	O	I-T034
,	O	O	O
pathogenesis	O	O	B-T046
,	O	O	O
and	O	O	O
treatment	O	O	B-T061
methods	O	O	I-T061
of	O	O	O
ABCs	O	O	B-T047
are	O	O	O
discussed	O	O	O
.	O	O	O

-DOCSTART- (28034730)

Association	O	O	B-T080
between	O	O	O
postpartum	O	O	B-T048
depression	O	O	I-T048
and	O	O	O
the	O	O	O
practice	O	O	B-T041
of	O	O	O
exclusive	O	O	B-T055
breastfeeding	O	O	I-T055
in	O	O	O
the	O	O	O
first	O	O	O
three	O	O	O
months	O	O	B-T079
of	O	O	O
life	O	O	O

To	O	O	O
investigate	O	O	B-T169
the	O	O	O
association	O	O	B-T080
between	O	O	O
postpartum	O	O	B-T048
depression	O	O	I-T048
and	O	O	O
the	O	O	O
occurrence	O	O	B-T079
of	O	O	O
exclusive	O	O	B-T055
breastfeeding	O	O	I-T055
.	O	O	O

This	O	O	O
is	O	O	O
a	O	O	O
cross-sectional	O	O	B-T062
study	O	O	I-T062
conducted	O	O	O
in	O	O	O
the	O	O	O
states	O	O	B-T083
of	O	O	O
the	O	O	O
Northeast	O	O	B-T083
region	O	O	I-T083
,	O	O	O
during	O	O	O
the	O	O	O
vaccination	O	O	B-T058
campaign	O	O	I-T058
in	O	O	O
2010	O	O	O
.	O	O	O

The	O	O	O
sample	O	O	O
consisted	O	O	O
of	O	O	O
2583	O	O	O
mother	O	O	B-T099
-	O	O	O
child	O	O	B-T100
pairs	O	O	B-T080
,	O	O	O
with	O	O	O
children	O	O	B-T100
aged	O	O	B-T032
from	O	O	O
15	O	O	O
days	O	O	B-T079
to	O	O	O
3	O	O	O
months	O	O	B-T079
.	O	O	O

The	O	O	O
Edinburgh	O	O	B-T170
Postnatal	O	O	I-T170
Depression	O	O	I-T170
Scale	O	O	I-T170
was	O	O	O
used	O	O	O
to	O	O	O
screen	O	O	B-T058
for	O	O	O
postpartum	O	O	B-T048
depression	O	O	I-T048
.	O	O	O

The	O	O	O
outcome	O	O	B-T169
was	O	O	O
lack	O	O	B-T080
of	O	O	O
exclusive	O	O	B-T055
breastfeeding	O	O	I-T055
,	O	O	O
defined	O	O	O
as	O	O	O
the	O	O	O
occurrence	O	O	B-T079
of	O	O	O
this	O	O	O
practice	O	O	B-T078
in	O	O	O
the	O	O	O
24h	O	O	O
preceding	O	O	B-T079
the	O	O	O
interview	O	O	B-T052
.	O	O	O

Postpartum	O	O	B-T048
depression	O	O	I-T048
was	O	O	O
the	O	O	O
explanatory	O	O	B-UnknownType
variable	O	O	I-UnknownType
of	O	O	O
interest	O	O	O
and	O	O	O
the	O	O	O
covariates	O	O	B-UnknownType
were	O	O	O
:	O	O	O
socioeconomic	O	O	B-T102
and	O	O	O
demographic	O	O	B-T078
conditions	O	O	I-T078
;	O	O	O
maternal	O	O	B-T058
health	O	O	I-T058
care	O	O	I-T058
;	O	O	O
prenatal	O	O	B-T058
,	O	O	O
delivery	O	O	B-T061
,	O	O	O
and	O	O	O
postnatal	O	O	B-T058
care	O	O	I-T058
;	O	O	O
and	O	O	O
the	O	O	O
child	O	O	B-T080
's	O	O	I-T080
biological	O	O	I-T080
factors	O	O	I-T080
.	O	O	O

Multivariate	O	O	B-T081
logistic	O	O	I-T081
regression	O	O	I-T081
analysis	O	O	I-T081
was	O	O	O
conducted	O	O	O
to	O	O	O
control	O	O	O
for	O	O	O
possible	O	O	O
confounding	O	O	B-T169
factors	O	O	I-T169
.	O	O	O

Exclusive	O	O	B-T055
breastfeeding	O	O	I-T055
was	O	O	O
observed	O	O	B-T169
in	O	O	O
50.8	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
infants	O	O	B-T100
and	O	O	O
11.8	O	O	O
%	O	O	O
of	O	O	O
women	O	O	B-T098
had	O	O	O
symptoms	O	O	B-T184
of	O	O	O
postpartum	O	O	B-T048
depression	O	O	I-T048
.	O	O	O

In	O	O	O
the	O	O	O
multivariate	O	O	B-T081
logistic	O	O	I-T081
regression	O	O	I-T081
analysis	O	O	I-T081
,	O	O	O
a	O	O	O
higher	O	O	O
chance	O	O	O
of	O	O	O
exclusive	O	O	B-T055
breastfeeding	O	O	I-T055
absence	O	O	B-T169
was	O	O	O
found	O	O	O
among	O	O	O
mothers	O	O	B-T099
with	O	O	O
symptoms	O	O	B-T184
of	O	O	O
postpartum	O	O	B-T048
depression	O	O	I-T048
(	O	O	O
OR=1.67	O	O	O
;	O	O	O
p<0.001	O	O	O
)	O	O	O
,	O	O	O
among	O	O	O
younger	O	O	B-T098
subjects	O	O	I-T098
(	O	O	O
OR=1.89	O	O	O
;	O	O	O
p<0.001	O	O	O
)	O	O	O
,	O	O	O
those	O	O	O
who	O	O	O
reported	O	O	O
receiving	O	O	O
benefits	O	O	B-T081
from	O	O	O
the	O	O	O
Bolsa	O	O	B-UnknownType
FamÃ­lia	O	O	I-UnknownType
Program	O	O	I-UnknownType
(	O	O	O
OR=1.25	O	O	O
;	O	O	O
p=0.016	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
those	O	O	O
started	O	O	O
antenatal	O	O	B-T058
care	O	O	I-T058
later	O	O	O
during	O	O	O
pregnancy	O	O	B-T040
(	O	O	O
OR=2.14	O	O	O
;	O	O	O
p=0.032	O	O	O
)	O	O	O
.	O	O	O

Postpartum	O	O	B-T048
depression	O	O	I-T048
contributed	O	O	O
to	O	O	O
reducing	O	O	B-T080
the	O	O	O
practice	O	O	B-T078
of	O	O	O
exclusive	O	O	B-T055
breastfeeding	O	O	I-T055
.	O	O	O

Therefore	O	O	O
,	O	O	O
this	O	O	O
disorder	O	O	B-T047
should	O	O	O
be	O	O	O
included	O	O	O
in	O	O	O
the	O	O	O
prenatal	O	O	B-T058
and	O	O	O
early	O	O	B-T079
postpartum	O	O	I-T079
support	O	O	B-T170
guidelines	O	O	I-T170
for	O	O	O
breastfeeding	O	O	B-T040
,	O	O	O
especially	O	O	O
in	O	O	O
low	O	O	B-T081
socioeconomic	O	O	I-T081
status	O	O	I-T081
women	O	O	B-T098
.	O	O	O

-DOCSTART- (28035661)

Evidence	O	O	B-T169
of	O	O	I-T169
toothpick	O	O	B-T073
groove	O	O	B-T030
formation	O	O	B-T169
in	O	O	O
Neandertal	O	O	B-T015
anterior	O	O	B-T082
and	O	O	O
posterior	O	O	B-T082
teeth	O	O	O

During	O	O	O
the	O	O	O
microscopic	O	O	B-T059
examination	O	O	I-T059
of	O	O	O
the	O	O	O
Neandertal	O	O	B-T015
dentitions	O	O	B-T023
from	O	O	O
El	O	O	B-T083
SidrÃ³n	O	O	I-T083
(	O	O	O
Spain	O	O	B-T083
)	O	O	O
and	O	O	O
Hortus	O	O	B-T083
(	O	O	O
France	O	O	B-T083
)	O	O	O
,	O	O	O
we	O	O	O
found	O	O	O
unusual	O	O	B-T080
fine	O	O	O
parallel	O	O	O
microstriations	O	O	B-T070
on	O	O	O
the	O	O	O
mesial	O	O	B-T029
and	O	O	O
distal	O	O	B-T082
sides	O	O	I-T082
of	O	O	O
all	O	O	O
tooth	O	O	B-T023
types	O	O	O
,	O	O	O
near	O	O	O
the	O	O	O
cervix	O	O	B-T029
.	O	O	O

As	O	O	O
its	O	O	O
appearance	O	O	O
was	O	O	O
similar	O	O	B-T080
to	O	O	O
toothpick	O	O	B-T073
grooves	O	O	B-T030
described	O	O	O
in	O	O	O
other	O	O	O
Homo	O	O	B-T015
species	O	O	I-T015
,	O	O	O
it	O	O	O
could	O	O	O
correspond	O	O	O
to	O	O	O
early	O	O	B-T079
stages	O	O	I-T079
on	O	O	O
its	O	O	O
formation	O	O	B-T169
.	O	O	O

To	O	O	O
test	O	O	O
this	O	O	O
hypothesis	O	O	O
we	O	O	O
developed	O	O	O
an	O	O	O
experimental	O	O	B-T062
replication	O	O	I-T062
of	O	O	O
a	O	O	O
groove	O	O	B-T030
using	O	O	O
grass	O	O	B-T002
stalks	O	O	B-T002
.	O	O	O

Comparisons	O	O	B-T052
between	O	O	O
204	O	O	O
isolated	O	O	B-T169
Neandertal	O	O	B-T015
teeth	O	O	B-T023
and	O	O	O
the	O	O	O
two	O	O	O
experimental	O	O	B-T080
dental	O	O	B-T080
specimens	O	O	B-T167
corroborate	O	O	O
that	O	O	O
the	O	O	O
marks	O	O	B-T184
correspond	O	O	O
to	O	O	O
initial	O	O	B-T079
stages	O	O	I-T079
of	O	O	O
toothpick	O	O	B-T073
groove	O	O	B-T030
formation	O	O	B-T169
,	O	O	O
and	O	O	O
we	O	O	O
propose	O	O	O
a	O	O	O
five-grade	O	O	B-T170
recording	O	O	I-T170
scale	O	O	I-T170
that	O	O	O
summarized	O	O	O
the	O	O	O
groove	O	O	O
formation	O	O	B-T169
process	O	O	I-T169
.	O	O	O

Using	O	O	O
this	O	O	O
new	O	O	O
recording	O	O	O
procedure	O	O	O
,	O	O	O
we	O	O	O
found	O	O	O
that	O	O	O
Hortus	O	O	B-T083
individuals	O	O	B-T098
have	O	O	O
higher	O	O	O
incidence	O	O	B-T081
of	O	O	O
this	O	O	O
trait	O	O	O
(	O	O	O
eight	O	O	O
individuals	O	O	O
out	O	O	O
of	O	O	O
nine	O	O	O
)	O	O	O
than	O	O	O
the	O	O	O
El	O	O	B-T083
SidrÃ³n	O	O	I-T083
individuals	O	O	O
(	O	O	O
nine	O	O	O
out	O	O	O
of	O	O	O
11	O	O	O
)	O	O	O
.	O	O	O

Toothpick	O	O	B-T073
grooves	O	O	B-T030
from	O	O	O
El	O	O	B-T083
SidrÃ³n	O	O	I-T083
show	O	O	O
the	O	O	O
earliest	O	O	B-T079
stages	O	O	I-T079
of	O	O	O
development	O	O	B-T169
,	O	O	O
whereas	O	O	O
the	O	O	O
grooves	O	O	O
found	O	O	O
on	O	O	O
Hortus	O	O	B-T083
Neandertals	O	O	B-T015
were	O	O	O
well-developed	O	O	B-T080
.	O	O	O

Toothpick	O	O	B-T073
grooves	O	O	B-T030
were	O	O	O
also	O	O	O
found	O	O	O
in	O	O	O
21	O	O	O
incisors	O	O	B-T023
and	O	O	O
canines	O	O	B-T023
.	O	O	O

These	O	O	O
differences	O	O	B-T080
could	O	O	O
be	O	O	O
due	O	O	O
to	O	O	O
the	O	O	O
more	O	O	O
advanced	O	O	O
occlusal	O	O	B-T029
dental	O	O	B-T037
wear	O	O	I-T037
in	O	O	O
Hortus	O	O	B-T083
individuals	O	O	B-T098
,	O	O	O
maybe	O	O	O
age	O	O	B-T032
-related	O	O	O
and	O	O	O
with	O	O	O
a	O	O	O
more	O	O	O
meat	O	O	B-T168
-based	O	O	O
diet	O	O	B-T168
maybe	O	O	O
favoring	O	O	O
the	O	O	O
inclusion	O	O	O
of	O	O	O
food	O	O	B-T168
debris	O	O	B-T167
and	O	O	O
thus	O	O	O
probing	O	O	B-T169
as	O	O	O
the	O	O	O
cleaning	O	O	B-T052
methodology	O	O	I-T052
.	O	O	O

Our	O	O	O
results	O	O	O
allow	O	O	O
the	O	O	O
identification	O	O	B-T080
and	O	O	O
characterization	O	O	B-T052
of	O	O	O
incipient	O	O	B-T079
toothpick	O	O	B-T073
grooves	O	O	B-T030
on	O	O	O
the	O	O	O
human	O	O	B-T016
fossil	O	O	B-T167
record	O	O	B-T170
and	O	O	O
contribute	O	O	B-T052
to	O	O	O
increase	O	O	B-T169
our	O	O	O
knowledge	O	O	B-T170
on	O	O	O
Neandertals	O	O	B-T015
behavioral	O	O	B-T055
and	O	O	O
oral	O	O	B-T033
care	O	O	I-T033
habits	O	O	I-T033
.	O	O	O

-DOCSTART- (28035718)

THSD7A	O	O	B-T116
expression	O	O	B-T045
in	O	O	O
human	O	O	B-T016
cancer	O	O	O

We	O	O	O
recently	O	O	O
described	O	O	O
a	O	O	O
case	O	O	O
of	O	O	O
a	O	O	O
Thrombospondin	O	O	B-T116
Type-1	O	O	I-T116
Domain	O	O	I-T116
containing	O	O	I-T116
7A	O	O	I-T116
(	O	O	O
THSD7A	O	O	B-T116
)	O	O	O
associated	O	O	O
membranous	O	O	B-T047
nephropathy	O	O	I-T047
in	O	O	O
a	O	O	O
female	O	O	B-T032
patient	O	O	I-T032
who	O	O	O
was	O	O	O
synchronously	O	O	B-T079
suffering	O	O	B-T184
from	O	O	O
a	O	O	O
THSD7A	O	O	O
-	O	O	O
positive	O	O	B-T033
malignancy	O	O	B-T080
.	O	O	O

We	O	O	O
here	O	O	O
investigated	O	O	O
the	O	O	O
role	O	O	O
of	O	O	O
THSD7A	O	O	B-T116
as	O	O	O
a	O	O	O
new	O	O	O
potential	O	O	O
tumor	O	O	B-T116
antigen	O	O	I-T116
by	O	O	O
evaluating	O	O	O
over	O	O	O
20	O	O	O
000	O	O	O
tissue	O	O	B-T024
spots	O	O	I-T024
in	O	O	O
more	O	O	O
than	O	O	O
70	O	O	O
different	O	O	O
tumor	O	O	B-T033
entities	O	O	I-T033
by	O	O	O
immunohistochemistry	O	O	B-T060
using	O	O	O
tissue	O	O	B-T075
microarrays	O	O	I-T075
.	O	O	O

THSD7A	O	O	B-T116
expression	O	O	B-T045
was	O	O	O
highly	O	O	O
variable	O	O	O
in	O	O	O
different	O	O	B-T191
neoplasias	O	O	I-T191
with	O	O	O
differing	O	O	O
staining	O	O	B-T082
patterns	O	O	I-T082
.	O	O	O

Both	O	O	O
gain	O	O	B-T033
and	O	O	I-T033
loss	O	O	I-T033
of	O	O	O
THSD7A	O	O	B-T116
expression	O	O	B-T045
compared	O	O	O
to	O	O	O
expression	O	O	B-T045
status	O	O	I-T045
in	O	O	O
non-tumor	O	O	B-T024
tissue	O	O	I-T024
were	O	O	O
linked	O	O	O
to	O	O	O
tumor-specific	O	O	B-T123
markers	O	O	I-T123
in	O	O	O
the	O	O	O
different	O	O	O
tumor	O	O	B-T033
entities	O	O	I-T033
and	O	O	O
were	O	O	O
of	O	O	O
prognostic	O	O	B-T081
value	O	O	I-T081
.	O	O	O

The	O	O	O
potential	O	O	O
role	O	O	O
of	O	O	O
THSD7A	O	O	B-T116
in	O	O	O
tumor	O	O	B-T033
development	O	O	I-T033
and	O	O	O
therapy	O	O	B-T061
needs	O	O	O
further	O	O	O
investigation	O	O	O
.	O	O	O

-DOCSTART- (28042065)

Civil	O	O	B-UnknownType
Society	O	O	I-UnknownType
-Driven	O	O	O
Drug	O	O	B-UnknownType
Policy	O	O	I-UnknownType
Reform	O	O	I-UnknownType
for	O	O	O
Health	O	O	B-T078
and	O	O	O
Human	O	O	B-T095
Welfare	O	O	I-T095
-	O	O	O
India	O	O	O

The	O	O	O
lack	O	O	B-T080
of	O	O	O
adequate	O	O	B-T080
access	O	O	O
to	O	O	O
opioids	O	O	B-T109
in	O	O	O
India	O	O	B-T083
as	O	O	O
analgesics	O	O	B-T109
and	O	O	O
for	O	O	O
agonist	O	O	B-T121
therapies	O	O	B-T061
,	O	O	O
forces	O	O	O
millions	O	O	O
to	O	O	O
live	O	O	O
with	O	O	O
severe	O	O	B-T080
unalleviated	O	O	B-T184
pain	O	O	I-T184
,	O	O	O
or	O	O	O
languish	O	O	B-T080
with	O	O	O
suffering	O	O	B-T048
associated	O	O	O
with	O	O	O
drug	O	O	B-T048
dependence	O	O	I-T048
.	O	O	O

Although	O	O	O
India	O	O	B-T083
is	O	O	O
a	O	O	O
major	O	O	O
opium	O	O	B-T109
exporter	O	O	B-T097
,	O	O	O
the	O	O	O
excessively	O	O	O
prohibitive	O	O	B-T054
1985	O	O	O
narcotics	O	O	B-T089
law	O	O	I-T089
formulated	O	O	O
to	O	O	O
control	O	O	B-T080
harmful	O	O	B-T048
use	O	O	I-T048
of	O	O	I-T048
drugs	O	O	I-T048
,	O	O	O
impeded	O	O	O
the	O	O	O
availability	O	O	B-T169
and	O	O	O
access	O	O	B-T082
to	O	O	O
opioids	O	O	B-T109
for	O	O	O
medical	O	O	B-UnknownType
and	O	O	O
scientific	O	O	B-T062
purposes	O	O	B-T169
.	O	O	O

Amendment	O	O	B-T170
of	O	O	O
this	O	O	O
law	O	O	B-T170
in	O	O	O
2014	O	O	O
established	O	O	O
a	O	O	O
new	O	O	O
national	O	O	B-T089
regulatory	O	O	I-T089
framework	O	O	I-T089
for	O	O	O
improved	O	O	O
access	O	O	B-T082
to	O	O	O
essential	O	O	B-T080
opioid	O	O	B-T109
analgesics	O	O	I-T109
.	O	O	O

This	O	O	O
article	O	O	O
reflects	O	O	O
on	O	O	O
key	O	O	O
elements	O	O	O
and	O	O	O
processes	O	O	O
that	O	O	O
led	O	O	O
to	O	O	O
this	O	O	O
landmark	O	O	O
achievement	O	O	B-T053
.	O	O	O

Unlike	O	O	O
quick	O	O	O
timelines	O	O	O
associated	O	O	O
with	O	O	O
effecting	O	O	O
policy	O	O	B-UnknownType
reforms	O	O	I-UnknownType
for	O	O	O
law	O	O	B-T064
enforcement	O	O	I-T064
,	O	O	O
realizing	O	O	O
the	O	O	O
2014	O	O	O
drug	O	O	B-UnknownType
policy	O	O	I-UnknownType
change	O	O	O
primarily	O	O	O
to	O	O	O
mitigate	O	O	B-T067
human	O	O	B-T048
suffering	O	O	I-T048
,	O	O	I-T048
was	O	O	O
a	O	O	O
22-year-long	O	O	O
process	O	O	O
.	O	O	O

The	O	O	O
most	O	O	O
exacting	O	O	O
challenges	O	O	O
included	O	O	O
recognizing	O	O	O
the	O	O	O
multilayered	O	O	B-T033
complexities	O	O	I-T033
of	O	O	O
the	O	O	O
prior	O	O	O
policy	O	O	B-T170
framework	O	O	I-T170
and	O	O	O
understanding	O	O	O
their	O	O	O
adverse	O	O	B-T080
impact	O	O	B-UnknownType
on	O	O	O
field	O	O	O
practices	O	O	O
to	O	O	O
chart	O	O	O
an	O	O	O
appropriate	O	O	O
and	O	O	O
viable	O	O	O
path	O	O	O
for	O	O	O
reform	O	O	B-T064
.	O	O	O

The	O	O	O
evolution	O	O	O
of	O	O	O
an	O	O	O
informal	O	O	O
civil	O	O	B-T054
society	O	O	I-T054
movement	O	O	I-T054
involving	O	O	O
health	O	O	B-T097
care	O	O	I-T097
professionals	O	O	I-T097
,	O	O	O
lawyers	O	O	B-T097
,	O	O	O
media	O	O	B-T097
,	O	O	O
policy	O	O	B-T097
analysts	O	O	I-T097
,	O	O	O
government	O	O	B-T097
officials	O	O	I-T097
,	O	O	O
and	O	O	O
the	O	O	O
public	O	O	B-T098
was	O	O	O
pivotal	O	O	O
in	O	O	O
addressing	O	O	O
these	O	O	O
challenges	O	O	B-T058
and	O	O	O
garnering	O	O	O
momentum	O	O	O
for	O	O	O
reform	O	O	B-UnknownType
.	O	O	O

The	O	O	O
success	O	O	B-T054
of	O	O	O
the	O	O	O
effort	O	O	O
for	O	O	O
improving	O	O	O
access	O	O	B-T080
to	O	O	O
opioid	O	O	B-T109
medications	O	O	B-T058
was	O	O	O
underpinned	O	O	O
by	O	O	O
a	O	O	O
three-pronged	O	O	O
strategy	O	O	O
of	O	O	O
1	O	O	O
)	O	O	O
persuading	O	O	O
the	O	O	O
executive	O	O	B-T097
arm	O	O	I-T097
of	O	O	I-T097
the	O	O	I-T097
government	O	O	I-T097
to	O	O	O
take	O	O	O
interim	O	O	B-T079
enabling	O	O	O
measures	O	O	B-T170
;	O	O	O
2	O	O	O
)	O	O	O
leveraging	O	O	O
judicial	O	O	B-T064
intervention	O	O	I-T064
through	O	O	O
public	O	O	B-T098
interest	O	O	B-T098
litigation	O	O	B-T068
;	O	O	O
and	O	O	O
3	O	O	O
)	O	O	O
crafting	O	O	B-T064
a	O	O	I-T064
viable	O	O	I-T064
policy	O	O	I-T064
document	O	O	I-T064
for	O	O	O
legislative	O	O	B-T064
approval	O	O	I-T064
and	O	O	O
implementation	O	O	B-T052
.	O	O	O

We	O	O	O
hope	O	O	O
our	O	O	O
findings	O	O	O
are	O	O	O
useful	O	O	O
for	O	O	O
realizing	O	O	O
drug	O	O	B-UnknownType
policy	O	O	B-T170
reforms	O	O	I-UnknownType
,	O	O	O
given	O	O	O
the	O	O	O
current	O	O	O
transformed	O	O	O
global	O	O	B-T080
policy	O	O	O
mandates	O	O	B-UnknownType
emphasizing	O	O	O
humanitarian	O	O	B-T095
,	O	O	O
healthcare	O	O	B-T058
,	O	O	O
and	O	O	O
quality-of-life	O	O	B-T078
considerations	O	O	B-T033
.	O	O	O

-DOCSTART- (28042600)

Efficacy	O	O	B-T080
of	O	O	O
Synbiotics	O	O	B-T168
for	O	O	O
Treatment	O	O	B-T061
of	O	O	O
Bacillary	O	O	B-T047
Dysentery	O	O	I-T047
in	O	O	O
Children	O	O	B-T100
:	O	O	O
A	O	O	O
Double-Blind	O	O	B-T062
,	O	O	O
Randomized	O	O	B-T062
,	O	O	O
Placebo-Controlled	O	O	O
Study	O	O	O

Bacillary	O	O	B-T047
dysentery	O	O	I-T047
is	O	O	O
a	O	O	O
major	O	O	O
cause	O	O	O
of	O	O	O
children	O	O	B-T100
's	O	O	I-T100
admission	O	O	B-T058
to	O	O	I-T058
hospitals	O	O	I-T058
.	O	O	O

To	O	O	O
assess	O	O	B-T058
the	O	O	O
probiotic	O	O	B-T007
and	O	O	O
prebiotic	O	O	B-T109
(	O	O	O
synbiotics	O	O	B-T168
)	O	O	O
effects	O	O	B-T080
in	O	O	O
children	O	O	B-T100
with	O	O	O
dysentery	O	O	B-T047
in	O	O	O
a	O	O	O
randomized	O	O	B-T062
clinical	O	O	I-T062
trial	O	O	I-T062
,	O	O	O
200	O	O	O
children	O	O	O
with	O	O	O
dysentery	O	O	O
were	O	O	O
studied	O	O	O
in	O	O	O
2	O	O	O
groups	O	O	B-T078
:	O	O	O
the	O	O	O
synbiotic	O	O	B-T168
group	O	O	B-T078
received	O	O	O
1	O	O	O
tablet	O	O	B-T122
/day	O	O	B-T079
of	O	O	O
synbiotic	O	O	O
for	O	O	O
3	O	O	O
-	O	O	O
5	O	O	O
days	O	O	B-T079
and	O	O	O
the	O	O	O
placebo	O	O	B-T122
group	O	O	O
received	O	O	O
placebo	O	O	O
tablets	O	O	B-T122
(	O	O	O
identical	O	O	O
tablet	O	O	O
form	O	O	O
like	O	O	O
probiotics	O	O	B-T007
)	O	O	O
.	O	O	O

The	O	O	O
standard	O	O	B-T080
treatment	O	O	B-T061
was	O	O	O
administered	O	O	B-T169
for	O	O	O
all	O	O	O
patients	O	O	B-T101
.	O	O	O

Duration	O	O	B-T079
of	O	O	O
hospitalization	O	O	B-T058
,	O	O	O
dysentery	O	O	B-T047
,	O	O	O
fever	O	O	B-T184
,	O	O	O
and	O	O	O
the	O	O	O
weight	O	O	B-T033
loss	O	O	I-T033
were	O	O	O
assessed	O	O	B-T052
in	O	O	O
each	O	O	O
group	O	O	B-T078
.	O	O	O

It	O	O	O
was	O	O	O
concluded	O	O	O
that	O	O	O
there	O	O	O
was	O	O	O
no	O	O	B-T033
significant	O	O	I-T033
difference	O	O	I-T033
in	O	O	O
both	O	O	O
groups	O	O	B-T078
in	O	O	O
the	O	O	O
baseline	O	O	B-T081
characteristics	O	O	B-T080
.	O	O	O

The	O	O	O
mean	O	O	B-T079
duration	O	O	I-T079
of	O	O	O
dysentery	O	O	B-T047
reduced	O	O	B-T080
(	O	O	O
P	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
mean	O	O	B-T079
duration	O	O	I-T079
of	O	O	O
fever	O	O	B-T184
has	O	O	O
been	O	O	O
significantly	O	O	O
reduced	O	O	B-T080
in	O	O	O
the	O	O	O
synbiotic	O	O	B-T168
group	O	O	B-T078
(	O	O	O
1.64	O	O	O
Â±	O	O	O
0.87	O	O	O
days	O	O	B-T079
)	O	O	O
in	O	O	O
comparison	O	O	B-T052
to	O	O	O
the	O	O	O
placebo	O	O	B-T122
group	O	O	O
(	O	O	O
2.13	O	O	O
Â±	O	O	O
0.94	O	O	O
days	O	O	O
)	O	O	O
(	O	O	O
P	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
.	O	O	O

Average	O	O	B-T081
amount	O	O	I-T081
of	O	O	O
weight	O	O	B-T033
loss	O	O	I-T033
was	O	O	O
significantly	O	O	O
lower	O	O	O
in	O	O	O
the	O	O	O
synbiotic	O	O	B-T168
group	O	O	B-T078
in	O	O	O
comparison	O	O	B-T052
to	O	O	O
that	O	O	O
in	O	O	O
the	O	O	O
placebo	O	O	B-T122
group	O	O	O
(	O	O	O
129.5	O	O	O
Â±	O	O	O
23.388	O	O	O
grams	O	O	O
and	O	O	O
278	O	O	O
Â±	O	O	O
28.385	O	O	O
grams	O	O	O
,	O	O	O
resp	O	O	O
.	O	O	O
;	O	O	O
P	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
.	O	O	O

There	O	O	O
was	O	O	O
no	O	O	B-T033
significant	O	O	I-T033
difference	O	O	I-T033
in	O	O	O
the	O	O	O
mean	O	O	B-T079
duration	O	O	I-T079
of	O	O	O
hospitalization	O	O	B-T058
in	O	O	O
both	O	O	O
groups	O	O	B-T078
(	O	O	O
P	O	O	O
>	O	O	O
0.05	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
use	O	O	O
of	O	O	O
synbiotics	O	O	B-T168
as	O	O	O
an	O	O	O
adjuvant	O	O	B-T061
therapy	O	O	I-T061
to	O	O	O
the	O	O	O
standard	O	O	B-T080
treatment	O	O	B-T061
of	O	O	O
dysentery	O	O	B-T047
significantly	O	O	O
reduces	O	O	B-T080
the	O	O	O
duration	O	O	B-T079
of	O	O	O
dysentery	O	O	O
,	O	O	O
fever	O	O	B-T184
,	O	O	O
and	O	O	O
rate	O	O	B-T033
of	O	O	I-T033
weight	O	O	I-T033
losses	O	O	I-T033
.	O	O	O

The	O	O	O
trial	O	O	B-T062
is	O	O	O
registered	O	O	B-T058
with	O	O	O
IRCT201109267647N1	O	O	O
.	O	O	O

-DOCSTART- (28042936)

Effect	O	O	B-T080
of	O	O	O
type	O	O	B-T047
2	O	O	I-T047
diabetes	O	O	I-T047
mellitus	O	O	I-T047
on	O	O	O
the	O	O	O
pharmacokinetics	O	O	B-T169
and	O	O	O
transplacental	O	O	B-UnknownType
transfer	O	O	I-UnknownType
of	O	O	O
nifedipine	O	O	B-T109
in	O	O	O
hypertensive	O	O	B-T047
pregnant	O	O	O
women	O	O	O

Diabetes	O	O	B-T047
mellitus	O	O	I-T047
can	O	O	O
inhibit	O	O	B-T052
cytochrome	O	O	B-T116
P450	O	O	I-T116
3A4	O	O	I-T116
,	O	O	O
an	O	O	O
enzyme	O	O	B-T116
responsible	O	O	O
for	O	O	O
the	O	O	O
metabolism	O	O	B-T044
of	O	O	O
nifedipine	O	O	B-T109
,	O	O	O
used	O	O	O
for	O	O	O
the	O	O	O
treatment	O	O	B-T061
of	O	O	O
hypertension	O	O	B-T047
in	O	O	O
pregnant	O	O	B-T098
women	O	O	I-T098
.	O	O	O

We	O	O	O
aimed	O	O	B-T078
to	O	O	O
assess	O	O	B-T058
the	O	O	O
effect	O	O	B-T080
of	O	O	O
type	O	O	B-T047
2	O	O	I-T047
diabetes	O	O	I-T047
mellitus	O	O	I-T047
(	O	O	O
T2DM	O	O	B-T047
)	O	O	O
on	O	O	O
the	O	O	O
pharmacokinetics	O	O	B-T169
,	O	O	O
placental	O	O	B-UnknownType
transfer	O	O	I-UnknownType
and	O	O	O
distribution	O	O	O
of	O	O	O
nifedipine	O	O	B-T109
in	O	O	O
amniotic	O	O	B-T031
fluid	O	O	I-T031
in	O	O	O
hypertensive	O	O	B-T047
pregnant	O	O	B-T098
women	O	O	I-T098
.	O	O	O

The	O	O	O
study	O	O	B-T062
was	O	O	O
conducted	O	O	O
in	O	O	O
12	O	O	O
hypertensive	O	O	B-T047
pregnant	O	O	B-T098
women	O	O	I-T098
[	O	O	O
control	O	O	B-T096
group	O	O	I-T096
(	O	O	O
CG	O	O	B-T096
)	O	O	O
]	O	O	O
and	O	O	O
10	O	O	O
hypertensive	O	O	O
pregnant	O	O	O
women	O	O	O
with	O	O	O
T2DM	O	O	B-T047
taking	O	O	O
slow-release	O	O	O
nifedipine	O	O	B-T109
(	O	O	O
20	O	O	O
mg	O	O	O
,	O	O	O
12/12	O	O	O
h	O	O	O
)	O	O	O
.	O	O	O

On	O	O	O
the	O	O	O
34th	O	O	O
week	O	O	B-T079
of	O	O	O
gestation	O	O	B-T040
,	O	O	O
serial	O	O	O
blood	O	O	B-T031
samples	O	O	I-T031
were	O	O	O
collected	O	O	O
(	O	O	O
0	O	O	O
-	O	O	O
12	O	O	O
h	O	O	O
)	O	O	O
after	O	O	O
administration	O	O	B-T061
of	O	O	O
the	O	O	O
medication	O	O	B-T121
.	O	O	O

At	O	O	B-T079
delivery	O	O	I-T079
,	O	O	O
samples	O	O	B-T031
of	O	O	O
maternal	O	O	B-T099
and	O	O	O
fetal	O	O	B-T031
blood	O	O	I-T031
and	O	O	O
amniotic	O	O	B-T031
fluid	O	O	I-T031
were	O	O	O
collected	O	O	O
for	O	O	O
determination	O	O	B-T059
of	O	O	O
nifedipine	O	O	B-T109
distribution	O	O	O
in	O	O	O
these	O	O	O
compartments	O	O	O
.	O	O	O

The	O	O	O
median	O	O	B-T081
pharmacokinetic	O	O	B-T169
parameters	O	O	B-T077
of	O	O	O
CG	O	O	B-T096
were	O	O	O
:	O	O	O
peak	O	O	B-T081
plasma	O	O	I-T081
concentration	O	O	I-T081
(	O	O	O
Cmax	O	O	B-T081
)	O	O	O
26.41	O	O	O
ng	O	O	O
ml(-1	O	O	O
)	O	O	O
,	O	O	O
time	O	O	B-T081
to	O	O	I-T081
reach	O	O	I-T081
Cmax	O	O	I-T081
(	O	O	O
tmax	O	O	B-T081
)	O	O	O
1.79	O	O	O
h	O	O	O
,	O	O	O
area	O	O	B-T081
under	O	O	I-T081
the	O	O	I-T081
plasma	O	O	I-T081
concentration	O	O	I-T081
vs.	O	O	O
time	O	O	B-T081
curve	O	O	I-T081
from	O	O	O
0	O	O	O
-	O	O	O
12	O	O	O
h	O	O	O
(	O	O	O
AUC	O	O	B-T081
0	O	O	O
-	O	O	O
12	O	O	O
)	O	O	O
235.99	O	O	O
ng.h	O	O	O
ml(-1	O	O	O
)	O	O	O
,	O	O	O
half-life	O	O	B-T079
(	O	O	O
tÂ½	O	O	O
)	O	O	O
4.34	O	O	O
h	O	O	O
,	O	O	O
volume	O	O	B-T081
of	O	O	I-T081
distribution	O	O	I-T081
divided	O	O	O
by	O	O	O
bioavailability	O	O	B-T081
(	O	O	O
Vd	O	O	B-T081
/	O	O	O
F	O	O	B-T081
)	O	O	O
560.96	O	O	O
l	O	O	O
,	O	O	O
and	O	O	O
ClT	O	O	B-UnknownType
/	O	O	O
F	O	O	O
84.77	O	O	O
l	O	O	O
h(-1	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
parameters	O	O	B-T077
for	O	O	O
T2DM	O	O	B-T047
group	O	O	B-T098
were	O	O	O
:	O	O	O
Cmax	O	O	B-T081
23.52	O	O	O
ng	O	O	O
ml(-1	O	O	O
)	O	O	O
,	O	O	O
tmax	O	O	B-T081
1.48	O	O	O
h	O	O	O
,	O	O	O
AUC	O	O	B-T081
0	O	O	O
-	O	O	O
12	O	O	O
202.23	O	O	O
ng.h	O	O	O
ml(-1	O	O	O
)	O	O	O
,	O	O	O
tÂ½	O	O	O
5.00	O	O	O
h	O	O	O
,	O	O	O
Vd	O	O	B-T081
/	O	O	O
F	O	O	B-T081
609.40	O	O	O
l	O	O	O
,	O	O	O
and	O	O	O
apparent	O	O	O
total	O	O	B-UnknownType
clearance	O	O	I-UnknownType
(	O	O	O
ClT	O	O	B-UnknownType
/	O	O	O
F	O	O	O
)	O	O	O
98.94	O	O	O
l	O	O	O
h(-1	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
ratios	O	O	B-T081
of	O	O	O
plasma	O	O	B-T031
concentrations	O	O	I-T081
of	O	O	O
nifedipine	O	O	B-T109
in	O	O	O
the	O	O	O
umbilical	O	O	B-T018
vein	O	O	I-T018
,	O	O	O
intervillous	O	O	B-T030
space	O	O	I-T030
and	O	O	O
amniotic	O	O	B-T031
fluid	O	O	I-T031
to	O	O	O
those	O	O	O
in	O	O	O
the	O	O	O
maternal	O	O	B-T099
vein	O	O	O
for	O	O	O
CG	O	O	B-T096
and	O	O	O
T2DM	O	O	B-T047
were	O	O	O
0.53	O	O	O
and	O	O	O
0.44	O	O	O
,	O	O	O
0.78	O	O	O
and	O	O	O
0.87	O	O	O
,	O	O	O
respectively	O	O	O
,	O	O	O
with	O	O	O
an	O	O	O
amniotic	O	O	O
fluid	O	O	O
/	O	O	O
maternal	O	O	O
plasma	O	O	O
ratio	O	O	B-T081
of	O	O	O
0.05	O	O	O
for	O	O	O
both	O	O	O
groups	O	O	B-T098
.	O	O	O

The	O	O	O
ratios	O	O	B-T081
of	O	O	O
plasma	O	O	B-T081
concentrations	O	O	I-T081
in	O	O	O
the	O	O	O
umbilical	O	O	B-T018
artery	O	O	I-T018
to	O	O	O
those	O	O	O
in	O	O	O
the	O	O	O
umbilical	O	O	B-T018
vein	O	O	I-T018
were	O	O	O
0.82	O	O	O
for	O	O	O
CG	O	O	B-T096
and	O	O	O
0.88	O	O	O
for	O	O	O
T2DM	O	O	B-T047
.	O	O	O

There	O	O	O
was	O	O	O
no	O	O	O
influence	O	O	B-T077
of	O	O	O
T2DM	O	O	B-T047
on	O	O	O
the	O	O	O
pharmacokinetics	O	O	B-T169
or	O	O	O
placental	O	O	B-UnknownType
transfer	O	O	I-UnknownType
of	O	O	O
nifedipine	O	O	B-T109
in	O	O	O
hypertensive	O	O	B-T047
women	O	O	B-T098
with	O	O	O
controlled	O	O	B-T033
diabetes	O	O	B-T047
.	O	O	O

-DOCSTART- (28050885)

Results	O	O	B-T169
of	O	O	O
an	O	O	O
International	O	O	B-T062
Postmarketing	O	O	I-T062
Surveillance	O	O	I-T062
Study	O	O	I-T062
of	O	O	O
pl-VEGF165	O	O	B-T121
Safety	O	O	B-T068
and	O	O	O
Efficacy	O	O	B-T080
in	O	O	O
210	O	O	O
Patients	O	O	B-T101
with	O	O	O
Peripheral	O	O	O
Arterial	O	O	O
Disease	O	O	O

The	O	O	O
effective	O	O	O
treatment	O	O	B-T061
of	O	O	O
chronic	O	O	B-T079
lower	O	O	B-T023
limb	O	O	I-T023
ischemia	O	O	B-T046
is	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
most	O	O	O
challenging	O	O	O
issues	O	O	O
confronting	O	O	O
vascular	O	O	B-T097
surgeons	O	O	I-T097
.	O	O	O

Current	O	O	O
pharmacological	O	O	B-T169
therapies	O	O	B-T061
play	O	O	O
an	O	O	O
auxiliary	O	O	O
role	O	O	O
and	O	O	O
can	O	O	O
not	O	O	O
prevent	O	O	O
disease	O	O	B-T046
progression	O	O	I-T046
,	O	O	O
and	O	O	O
new	O	O	O
treatment	O	O	B-T061
methods	O	O	I-T061
are	O	O	O
needed	O	O	O
.	O	O	O

pl-VEGF165	O	O	B-T121
,	O	O	O
a	O	O	O
gene	O	O	B-T061
therapy	O	O	I-T061
drug	O	O	B-T121
,	O	O	O
was	O	O	O
approved	O	O	O
in	O	O	O
Russia	O	O	B-T083
for	O	O	O
the	O	O	O
treatment	O	O	B-T061
of	O	O	O
atherosclerotic	O	O	B-T169
peripheral	O	O	B-T047
arterial	O	O	I-T047
disease	O	O	I-T047
(	O	O	O
PAD	O	O	B-T047
)	O	O	O
after	O	O	O
clinical	O	O	B-T062
studies	O	O	I-T062
in	O	O	O
2011	O	O	O
.	O	O	O

The	O	O	O
study	O	O	B-T062
drug	O	O	B-T121
is	O	O	O
an	O	O	O
original	O	O	O
gene	O	O	B-T114
construction	O	O	I-T114
in	O	O	O
which	O	O	O
pl-VEGF165	O	O	B-T121
1.2	O	O	O
mg	O	O	O
is	O	O	O
the	O	O	O
active	O	O	B-T123
substance	O	O	I-T123
.	O	O	O

This	O	O	O
postmarketing	O	O	B-T062
surveillance	O	O	I-T062
study	O	O	I-T062
was	O	O	O
undertaken	O	O	O
to	O	O	O
evaluate	O	O	O
the	O	O	O
safety	O	O	B-T068
(	O	O	O
identification	O	O	O
of	O	O	O
uncommon	O	O	O
side	O	O	B-T046
effects	O	O	I-T046
)	O	O	O
and	O	O	O
efficacy	O	O	B-T080
of	O	O	O
gene	O	O	B-T061
therapy	O	O	I-T061
in	O	O	O
patients	O	O	B-T101
in	O	O	O
routine	O	O	O
clinical	O	O	B-T057
practice	O	O	I-T057
.	O	O	O

In	O	O	O
total	O	O	O
,	O	O	O
210	O	O	O
patients	O	O	B-T101
with	O	O	O
stage	O	O	B-T079
II-III	O	O	I-T079
chronic	O	O	B-T079
limb	O	O	B-T023
ischemia	O	O	B-T046
(	O	O	O
according	O	O	O
to	O	O	O
the	O	O	O
Fontaine	O	O	B-T170
classification	O	O	I-T170
modified	O	O	O
by	O	O	O
AV	O	O	O
Pokrovsky	O	O	O
)	O	O	O
in	O	O	O
33	O	O	O
healthcare	O	O	B-T093
facilities	O	O	I-T093
in	O	O	O
Russia	O	O	B-T083
and	O	O	O
the	O	O	O
Ukraine	O	O	B-T083
were	O	O	O
enrolled	O	O	O
in	O	O	O
the	O	O	O
study	O	O	B-T062
.	O	O	O

The	O	O	O
control	O	O	B-T096
group	O	O	I-T096
(	O	O	O
n	O	O	O
=	O	O	O
60	O	O	O
)	O	O	O
received	O	O	O
conservative	O	O	B-T061
therapy	O	O	I-T061
without	O	O	O
prostaglandins	O	O	B-T125
and	O	O	O
prostacyclins	O	O	B-T109
,	O	O	O
and	O	O	O
the	O	O	O
treatment	O	O	B-T061
group	O	O	I-T098
(	O	O	O
n	O	O	O
=	O	O	O
150	O	O	O
)	O	O	O
received	O	O	O
treatment	O	O	O
with	O	O	O
pl-VEGF165	O	O	B-T121
as	O	O	O
two	O	O	O
intramuscular	O	O	B-T169
injections	O	O	I-T169
for	O	O	O
a	O	O	O
total	O	O	O
dose	O	O	B-T081
of	O	O	O
2.4	O	O	O
mg	O	O	O
.	O	O	O

Pain-free	O	O	B-T033
walking	O	O	I-T033
distance	O	O	I-T033
(	O	O	O
PWD	O	O	B-T033
)	O	O	O
(	O	O	O
the	O	O	O
primary	O	O	O
efficacy	O	O	B-T080
criterion	O	O	O
for	O	O	O
Fontaine	O	O	B-T170
stages	O	O	B-T079
II-III	O	O	I-T079
)	O	O	O
,	O	O	O
blood	O	O	B-T033
flow	O	O	I-T033
linear	O	O	I-T033
velocity	O	O	I-T033
(	O	O	O
BFLV	O	O	B-T033
)	O	O	O
,	O	O	O
and	O	O	O
ankle-brachial	O	O	B-T201
index	O	O	I-T201
(	O	O	O
ABI	O	O	B-T201
)	O	O	O
were	O	O	O
monitored	O	O	O
for	O	O	O
6	O	O	O
months	O	O	B-T079
.	O	O	O

The	O	O	O
safety	O	O	B-T068
of	O	O	O
pl-VEGF165	O	O	B-T121
gene	O	O	B-T063
transfer	O	O	I-T063
in	O	O	O
terms	O	O	O
of	O	O	O
the	O	O	O
trial	O	O	B-T062
protocol	O	O	I-T062
was	O	O	O
initially	O	O	O
evaluated	O	O	O
6	O	O	O
months	O	O	B-T079
after	O	O	O
the	O	O	O
start	O	O	O
of	O	O	O
the	O	O	O
study	O	O	O
;	O	O	O
adverse	O	O	B-T046
events	O	O	I-T046
(	O	O	O
AEs	O	O	B-T046
)	O	O	O
and	O	O	O
serious	O	O	B-T046
adverse	O	O	I-T046
events	O	O	I-T046
(	O	O	O
SAEs	O	O	B-T046
)	O	O	O
were	O	O	O
recorded	O	O	O
during	O	O	O
both	O	O	O
routine	O	O	O
visits	O	O	B-T058
and	O	O	O
unscheduled	O	O	O
requests	O	O	O
for	O	O	O
medical	O	O	B-T058
care	O	O	I-T058
.	O	O	O

Overall	O	O	O
,	O	O	O
PWD	O	O	B-T033
increased	O	O	O
by	O	O	O
177	O	O	O
%	O	O	O
,	O	O	O
from	O	O	O
100.3	O	O	O
Â±	O	O	O
6.9	O	O	O
to	O	O	O
277.1	O	O	O
Â±	O	O	O
16.2	O	O	O
m	O	O	O
(	O	O	O
p	O	O	O
=	O	O	O
0.0001	O	O	O
)	O	O	O
,	O	O	O
in	O	O	O
the	O	O	O
treatment	O	O	B-T098
group	O	O	I-T098
,	O	O	O
whereas	O	O	O
the	O	O	O
mean	O	O	B-T081
value	O	O	O
was	O	O	O
unchanged	O	O	O
in	O	O	O
the	O	O	O
control	O	O	B-T096
group	O	O	I-T096
(	O	O	O
p	O	O	O
=	O	O	O
0.218	O	O	O
)	O	O	O
.	O	O	O

Both	O	O	O
BFLV	O	O	B-T033
and	O	O	O
ABI	O	O	B-T201
values	O	O	I-T201
increased	O	O	O
by	O	O	O
24	O	O	O
%	O	O	O
(	O	O	O
p	O	O	O
=	O	O	O
0.0001	O	O	O
)	O	O	O
in	O	O	O
the	O	O	O
treatment	O	O	B-T098
group	O	O	I-T098
but	O	O	O
decreased	O	O	O
in	O	O	O
the	O	O	O
control	O	O	B-T096
group	O	O	I-T096
.	O	O	O

The	O	O	O
greatest	O	O	O
therapeutic	O	O	B-T201
effect	O	O	I-T201
was	O	O	O
observed	O	O	O
for	O	O	O
stage	O	O	B-T080
III	O	O	I-T080
disease	O	O	B-T047
:	O	O	O
PWD	O	O	B-T033
increased	O	O	O
by	O	O	O
683	O	O	O
%	O	O	O
(	O	O	O
p	O	O	O
=	O	O	O
0.0001	O	O	O
)	O	O	O
.	O	O	O

No	O	O	B-T033
angiogenic	O	O	B-T061
therapy	O	O	I-T061
-related	O	O	O
AEs	O	O	B-T046
or	O	O	O
side	O	O	B-T046
effects	O	O	I-T046
were	O	O	O
recorded	O	O	O
,	O	O	O
and	O	O	O
target	O	O	O
limb	O	O	B-T061
salvage	O	O	I-T061
was	O	O	O
96	O	O	O
and	O	O	O
97	O	O	O
%	O	O	O
in	O	O	O
the	O	O	O
treatment	O	O	B-T098
and	O	O	O
control	O	O	B-T096
groups	O	O	I-T096
,	O	O	O
respectively	O	O	O
.	O	O	O

The	O	O	O
results	O	O	B-T169
obtained	O	O	O
in	O	O	O
this	O	O	O
study	O	O	B-T062
are	O	O	O
not	O	O	O
significantly	O	O	O
different	O	O	O
from	O	O	O
those	O	O	O
observed	O	O	O
in	O	O	O
the	O	O	O
phase	O	O	B-T062
IIb	O	O	I-T062
/	O	O	O
III	O	O	B-T062
registration	O	O	O
clinical	O	O	B-T062
study	O	O	I-T062
completed	O	O	O
in	O	O	O
2011	O	O	O
.	O	O	O

pl-VEGF165	O	O	B-T121
intramuscular	O	O	B-T082
gene	O	O	B-T063
transfer	O	O	I-T063
is	O	O	O
an	O	O	O
effective	O	O	O
treatment	O	O	B-T061
for	O	O	O
moderate	O	O	O
to	O	O	O
severe	O	O	O
claudication	O	O	B-T047
due	O	O	O
to	O	O	O
chronic	O	O	B-T079
lower	O	O	B-T023
limb	O	O	I-T023
ischemia	O	O	B-T046
in	O	O	O
routine	O	O	O
clinical	O	O	B-T057
practice	O	O	I-T057
.	O	O	O

ClinicalTrials.gov	O	O	O
identifier	O	O	O
:	O	O	O
NCT02369809	O	O	O
.	O	O	O

-DOCSTART- (28051263)

Psychological	O	O	B-T041
factors	O	O	I-T041
associated	O	O	B-T080
with	O	O	I-T080
NAFLD	O	O	B-T047
/	O	O	O
NASH	O	O	B-T047
:	O	O	O
a	O	O	O
systematic	O	O	O
review	O	O	O

Nonalcoholic	O	O	B-T047
fatty	O	O	I-T047
liver	O	O	I-T047
disease	O	O	I-T047
(	O	O	O
NAFLD	O	O	B-T047
)	O	O	O
represents	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
most	O	O	O
common	O	O	O
chronic	O	O	B-T047
liver	O	O	I-T047
diseases	O	O	I-T047
worldwide	O	O	O
.	O	O	O

So	O	O	O
far	O	O	O
,	O	O	O
the	O	O	O
pathogenesis	O	O	B-T046
of	O	O	O
NAFLD	O	O	B-T047
and	O	O	O
its	O	O	O
more	O	O	O
severe	O	O	B-T080
variant	O	O	O
nonalcoholic	O	O	B-T047
steatohepatitis	O	O	I-T047
(	O	O	O
NASH	O	O	B-T047
)	O	O	O
is	O	O	O
yet	O	O	O
unclear	O	O	O
,	O	O	O
with	O	O	O
many	O	O	O
mechanisms	O	O	B-T169
being	O	O	O
proposed	O	O	O
as	O	O	O
possible	O	O	O
causes	O	O	O
.	O	O	O

This	O	O	O
article	O	O	O
aims	O	O	O
to	O	O	O
review	O	O	B-T078
the	O	O	O
psychological	O	O	B-T041
factors	O	O	I-T041
associated	O	O	B-T080
with	O	O	I-T080
NAFLD	O	O	B-T047
/	O	O	O
NASH	O	O	B-T047
.	O	O	O

Three	O	O	O
main	O	O	O
categories	O	O	O
of	O	O	O
factors	O	O	B-T169
have	O	O	O
been	O	O	O
investigated	O	O	B-T169
:	O	O	O
emotional	O	O	B-T033
,	O	O	O
cognitive	O	O	B-T169
and	O	O	O
behavioral	O	O	B-T053
.	O	O	O

Five	O	O	O
electronic	O	O	B-T170
databases	O	O	I-T170
were	O	O	O
searched	O	O	O
,	O	O	O
limited	O	O	O
to	O	O	O
studies	O	O	O
published	O	O	O
in	O	O	O
the	O	O	O
English	O	O	B-T171
language	O	O	I-T171
,	O	O	O
during	O	O	O
the	O	O	O
period	O	O	B-T079
2005	O	O	O
-	O	O	O
2015	O	O	O
:	O	O	O
PubMed	O	O	B-T170
,	O	O	O
Thomson	O	O	B-T170
ISI	O	O	I-T170
-	O	O	I-T170
Web	O	O	I-T170
of	O	O	I-T170
Science	O	O	I-T170
,	O	O	O
Scopus	O	O	B-T170
,	O	O	O
ProQuest	O	O	B-T170
,	O	O	O
and	O	O	O
ScienceDirect	O	O	B-T170
.	O	O	O

Results	O	O	O
indicated	O	O	O
the	O	O	O
most	O	O	O
relevant	O	O	O
emotional	O	O	B-T033
factors	O	O	B-T169
to	O	O	O
be	O	O	O
depression	O	O	B-T048
and	O	O	O
anxiety	O	O	B-T033
.	O	O	O

The	O	O	O
areas	O	O	O
of	O	O	O
investigation	O	O	B-T169
for	O	O	O
cognitive	O	O	B-T041
functioning	O	O	I-T041
concern	O	O	O
those	O	O	O
contents	O	O	B-T077
and	O	O	O
processes	O	O	B-T067
related	O	O	O
to	O	O	O
the	O	O	O
ability	O	O	O
to	O	O	O
initiate	O	O	B-T169
and	O	O	O
maintain	O	O	O
lifestyle	O	O	B-T054
changes	O	O	I-T054
.	O	O	O

The	O	O	O
most	O	O	O
important	O	O	O
behavioral	O	O	B-T053
factors	O	O	B-T169
identified	O	O	O
are	O	O	O
physical	O	O	B-T056
activity	O	O	I-T056
,	O	O	O
nutrition	O	O	B-T040
/	O	O	O
food	O	O	B-T040
intake	O	O	I-T040
and	O	O	O
substance	O	O	B-T167
consumption	O	O	B-T039
:	O	O	O
coffee	O	O	B-T168
,	O	O	O
alcohol	O	O	B-T168
,	O	O	O
cigarettes	O	O	B-T073
.	O	O	O

Some	O	O	O
of	O	O	O
the	O	O	O
factors	O	O	B-T169
identified	O	O	O
act	O	O	O
as	O	O	O
protective	O	O	B-T055
factors	O	O	I-T055
,	O	O	O
other	O	O	O
as	O	O	O
vulnerability	O	O	B-T033
factors	O	O	I-T033
.	O	O	O

NAFLD	O	O	B-T047
/	O	O	O
NASH	O	O	B-T047
may	O	O	O
be	O	O	O
considered	O	O	O
a	O	O	O
cognitive-behavioral	O	O	B-T048
disease	O	O	I-T048
,	O	O	O
the	O	O	O
most	O	O	O
effective	O	O	O
management	O	O	B-T058
being	O	O	O
lifestyle	O	O	B-T054
changes	O	O	I-T054
,	O	O	O
with	O	O	O
emphasis	O	O	O
on	O	O	O
diet	O	O	B-T168
and	O	O	O
exercise	O	O	B-T056
.	O	O	O

-DOCSTART- (28054422)

An	O	O	O
approach	O	O	O
to	O	O	O
functionally	O	O	O
relevant	O	O	O
clustering	O	O	B-T169
of	O	O	O
the	O	O	O
protein	O	O	B-T116
universe	O	O	I-T116
:	O	O	O
Active	O	O	B-T169
site	O	O	I-T169
profile-based	O	O	I-T169
clustering	O	O	I-T169
of	O	O	O
protein	O	O	B-T116
structures	O	O	I-T116
and	O	O	O
sequences	O	O	O

Protein	O	O	B-T044
function	O	O	I-T044
identification	O	O	O
remains	O	O	O
a	O	O	O
significant	O	O	O
problem	O	O	O
.	O	O	O

Solving	O	O	O
this	O	O	O
problem	O	O	O
at	O	O	O
the	O	O	O
molecular	O	O	B-T080
functional	O	O	I-T080
level	O	O	I-T080
would	O	O	O
allow	O	O	O
mechanistic	O	O	O
determinant	O	O	O
identification-	O	O	O
amino	O	O	B-T116
acids	O	O	I-T116
that	O	O	O
distinguish	O	O	O
details	O	O	O
between	O	O	O
functional	O	O	B-T078
families	O	O	I-T078
within	O	O	O
a	O	O	O
superfamily	O	O	B-T078
.	O	O	O

Active	O	O	B-T062
site	O	O	I-T062
profiling	O	O	I-T062
was	O	O	O
developed	O	O	O
to	O	O	O
identify	O	O	O
mechanistic	O	O	O
determinants	O	O	O
.	O	O	O

DASP	O	O	B-T170
and	O	O	O
DASP2	O	O	B-T170
were	O	O	O
developed	O	O	O
as	O	O	O
tools	O	O	O
to	O	O	O
search	O	O	O
sequence	O	O	B-T170
databases	O	O	I-T170
using	O	O	O
active	O	O	B-T062
site	O	O	I-T062
profiling	O	O	I-T062
.	O	O	O

Here	O	O	O
,	O	O	O
TuLIP	O	O	B-T170
(	O	O	O
Two-Level	O	O	B-T170
Iterative	O	O	I-T170
clustering	O	O	I-T170
Process	O	O	I-T170
)	O	O	O
is	O	O	O
introduced	O	O	O
as	O	O	O
an	O	O	O
iterative	O	O	O
,	O	O	O
divisive	O	O	O
clustering	O	O	B-T169
process	O	O	I-T169
that	O	O	O
utilizes	O	O	O
active	O	O	B-T062
site	O	O	I-T062
profiling	O	O	I-T062
to	O	O	O
separate	O	O	O
structurally	O	O	O
characterized	O	O	O
superfamily	O	O	B-T078
members	O	O	O
into	O	O	O
functionally	O	O	O
relevant	O	O	O
clusters	O	O	B-T081
.	O	O	O

Underlying	O	O	O
TuLIP	O	O	B-T170
is	O	O	O
the	O	O	O
observation	O	O	O
that	O	O	O
functionally	O	O	B-T078
relevant	O	O	I-T078
families	O	O	I-T078
(	O	O	O
curated	O	O	O
by	O	O	O
Structure-Function	O	O	B-T170
Linkage	O	O	I-T170
Database	O	O	I-T170
,	O	O	O
SFLD	O	O	B-T170
)	O	O	O
self-identify	O	O	O
in	O	O	O
DASP2	O	O	B-T170
searches	O	O	O
;	O	O	O
clusters	O	O	B-T081
containing	O	O	O
multiple	O	O	B-T078
functional	O	O	I-T078
families	O	O	I-T078
do	O	O	O
not	O	O	O
.	O	O	O

Each	O	O	O
TuLIP	O	O	B-T170
iteration	O	O	O
produces	O	O	O
candidate	O	O	O
clusters	O	O	B-T081
,	O	O	O
each	O	O	O
evaluated	O	O	O
to	O	O	O
determine	O	O	O
if	O	O	O
it	O	O	O
self-identifies	O	O	O
using	O	O	O
DASP2	O	O	B-T170
.	O	O	O

If	O	O	O
so	O	O	O
,	O	O	O
it	O	O	O
is	O	O	O
deemed	O	O	O
a	O	O	O
functionally	O	O	B-T078
relevant	O	O	I-T078
group	O	O	I-T078
.	O	O	O

Divisive	O	O	O
clustering	O	O	B-T169
continues	O	O	O
until	O	O	O
each	O	O	O
structure	O	O	O
is	O	O	O
either	O	O	O
a	O	O	O
functionally	O	O	B-T078
relevant	O	O	I-T078
group	O	O	I-T078
member	O	O	O
or	O	O	O
a	O	O	O
singlet	O	O	O
.	O	O	O

TuLIP	O	O	B-T170
is	O	O	O
validated	O	O	O
on	O	O	O
enolase	O	O	B-T116
and	O	O	O
glutathione	O	O	B-T116
transferase	O	O	I-T116
structures	O	O	B-T116
,	O	O	O
superfamilies	O	O	B-T078
well-curated	O	O	O
by	O	O	O
SFLD	O	O	B-T170
.	O	O	O

Correlation	O	O	B-T080
is	O	O	O
strong	O	O	O
;	O	O	O
small	O	O	O
numbers	O	O	O
of	O	O	O
structures	O	O	B-T082
prevent	O	O	O
statistically	O	O	B-T062
significant	O	O	I-T062
analysis	O	O	I-T062
.	O	O	O

TuLIP	O	O	B-T170
-identified	O	O	O
enolase	O	O	B-T116
clusters	O	O	B-T081
are	O	O	O
used	O	O	O
in	O	O	O
DASP2	O	O	B-T170
GenBank	O	O	I-T170
searches	O	O	O
to	O	O	O
identify	O	O	O
sequences	O	O	B-T087
sharing	O	O	O
functional	O	O	O
site	O	O	O
features	O	O	O
.	O	O	O

Analysis	O	O	O
shows	O	O	O
a	O	O	O
true	O	O	O
positive	O	O	O
rate	O	O	O
of	O	O	O
96	O	O	O
%	O	O	O
,	O	O	O
false	O	O	O
negative	O	O	O
rate	O	O	O
of	O	O	O
4	O	O	O
%	O	O	O
,	O	O	O
and	O	O	O
maximum	O	O	O
false	O	O	O
positive	O	O	O
rate	O	O	O
of	O	O	O
4	O	O	O
%	O	O	O
.	O	O	O

F-measure	O	O	B-T081
and	O	O	O
performance	O	O	B-T062
analysis	O	O	I-T062
on	O	O	O
the	O	O	O
enolase	O	O	B-T116
search	O	O	O
results	O	O	O
and	O	O	O
comparison	O	O	O
to	O	O	O
GEMMA	O	O	B-T170
and	O	O	O
SCI-PHY	O	O	B-T170
demonstrate	O	O	O
that	O	O	O
TuLIP	O	O	B-T170
avoids	O	O	O
the	O	O	O
over-division	O	O	O
problem	O	O	O
of	O	O	O
these	O	O	O
methods	O	O	O
.	O	O	O

Mechanistic	O	O	O
determinants	O	O	O
for	O	O	O
enolase	O	O	B-T116
families	O	O	I-T116
are	O	O	O
evaluated	O	O	O
and	O	O	O
shown	O	O	O
to	O	O	O
correlate	O	O	O
well	O	O	O
with	O	O	O
literature	O	O	B-T170
results	O	O	O
.	O	O	O

-DOCSTART- (28054712)

Early	O	O	B-T079
high	O	O	B-T065
school	O	O	I-T065
engagement	O	O	I-T065
in	O	O	O
students	O	O	B-T098
with	O	O	O
attention/deficit	O	O	O
hyperactivity	O	O	O
disorder	O	O	O

Students	O	O	B-T098
with	O	O	O
attention/deficit	O	O	B-T048
hyperactivity	O	O	I-T048
disorder	O	O	I-T048
(	O	O	O
ADHD	O	O	B-T048
)	O	O	O
continue	O	O	O
to	O	O	O
languish	O	O	O
behind	O	O	O
their	O	O	O
peers	O	O	B-T098
with	O	O	O
regard	O	O	O
to	O	O	O
academic	O	O	B-T055
achievement	O	O	I-T055
and	O	O	O
education	O	O	B-T033
attainment	O	O	I-T033
.	O	O	O

School	O	O	B-T065
engagement	O	O	B-T065
is	O	O	O
potentially	O	O	O
modifiable	O	O	O
,	O	O	O
and	O	O	O
targeting	O	O	O
engagement	O	O	O
may	O	O	O
be	O	O	O
a	O	O	O
means	O	O	O
to	O	O	O
improve	O	O	O
education	O	O	B-T065
outcomes	O	O	B-T169
.	O	O	O

To	O	O	O
investigate	O	O	O
school	O	O	B-T065
engagement	O	O	I-T065
for	O	O	O
students	O	O	B-T098
with	O	O	O
ADHD	O	O	B-T048
during	O	O	O
the	O	O	O
crucial	O	O	O
high	O	O	B-T078
school	O	O	I-T078
transition	O	O	I-T078
period	O	O	B-T079
and	O	O	O
to	O	O	O
identify	O	O	O
factors	O	O	O
associated	O	O	O
with	O	O	O
low	O	O	B-T033
school	O	O	I-T033
engagement	O	O	I-T033
.	O	O	O

Participants	O	O	B-T098
are	O	O	O
adolescents	O	O	B-T100
(	O	O	O
12	O	O	O
-	O	O	O
15	O	O	O
years	O	O	B-T079
)	O	O	O
in	O	O	O
the	O	O	O
first	O	O	O
and	O	O	O
third	O	O	O
year	O	O	B-T079
of	O	O	O
high	O	O	B-T073
school	O	O	I-T073
with	O	O	O
diagnosed	O	O	B-T062
ADHD	O	O	B-T048
(	O	O	O
n	O	O	O
=	O	O	O
130	O	O	O
)	O	O	O
.	O	O	O

Participants	O	O	B-T098
were	O	O	O
recruited	O	O	O
from	O	O	O
21	O	O	O
paediatric	O	O	B-T091
practices	O	O	B-T057
.	O	O	O

Cross-sectional	O	O	B-T062
study	O	O	I-T062
assessing	O	O	O
school	O	O	B-T065
engagement	O	O	I-T065
.	O	O	O

Data	O	O	B-T078
were	O	O	O
collected	O	O	O
through	O	O	O
direct	O	O	O
assessment	O	O	B-T058
and	O	O	O
child	O	O	B-T100
,	O	O	O
parent	O	O	B-T099
,	O	O	O
and	O	O	O
teacher	O	O	B-T097
surveys	O	O	B-T170
.	O	O	O

School	O	O	B-T065
engagement	O	O	I-T065
is	O	O	O
measured	O	O	O
as	O	O	O
student	O	O	B-T041
attitudes	O	O	I-T041
to	O	O	O
school	O	O	B-T073
(	O	O	O
cognitive	O	O	B-T041
and	O	O	O
emotional	O	O	B-T041
)	O	O	O
and	O	O	O
suspension	O	O	B-T033
rates	O	O	B-T081
(	O	O	O
behavioural	O	O	B-T053
)	O	O	O
.	O	O	O

Multivariable	O	O	B-T170
regression	O	O	I-T170
analyses	O	O	I-T170
examined	O	O	O
student	O	O	B-T098
,	O	O	O
family	O	O	B-T099
,	O	O	O
and	O	O	O
school	O	O	B-UnknownType
factors	O	O	I-UnknownType
affecting	O	O	O
engagement	O	O	B-T065
.	O	O	O

In	O	O	O
comparison	O	O	O
with	O	O	O
state	O	O	O
data	O	O	O
,	O	O	O
students	O	O	B-T098
with	O	O	O
ADHD	O	O	B-T048
in	O	O	O
the	O	O	O
first	O	O	O
year	O	O	B-T079
of	O	O	O
high	O	O	B-T073
school	O	O	I-T073
were	O	O	O
less	O	O	O
motivated	O	O	O
(	O	O	O
p	O	O	O
<	O	O	O
.01	O	O	O
)	O	O	O
and	O	O	O
less	O	O	O
connected	O	O	O
to	O	O	O
peers	O	O	B-T098
(	O	O	O
p	O	O	O
<	O	O	O
.01	O	O	O
)	O	O	O
.	O	O	O

Overall	O	O	O
,	O	O	O
there	O	O	O
was	O	O	O
no	O	O	O
discordance	O	O	O
in	O	O	O
third	O	O	O
year	O	O	B-T079
attitudes	O	O	B-T041
.	O	O	O

There	O	O	O
were	O	O	O
high	O	O	B-T033
rates	O	O	I-T033
of	O	O	I-T033
suspension	O	O	I-T033
in	O	O	O
both	O	O	O
years	O	O	B-T079
in	O	O	O
comparison	O	O	O
to	O	O	O
state-wide	O	O	O
suspensions	O	O	B-T033
(	O	O	O
21	O	O	O
%	O	O	O
vs.	O	O	O
6	O	O	O
%	O	O	O
,	O	O	O
p	O	O	O
<	O	O	O
.01	O	O	O
)	O	O	O
.	O	O	O

Explanatory	O	O	O
factors	O	O	O
for	O	O	O
poor	O	O	O
attitudes	O	O	B-T041
include	O	O	O
adolescent	O	O	B-T100
depression	O	O	B-T048
,	O	O	O
poor	O	O	O
adolescent	O	O	O
supervision	O	O	B-T061
,	O	O	O
and	O	O	O
devaluing	O	O	B-T041
education	O	O	B-T065
.	O	O	O

Conduct	O	O	B-UnknownType
problems	O	O	I-UnknownType
and	O	O	O
increased	O	O	O
hyperactivity	O	O	B-T048
were	O	O	O
related	O	O	O
to	O	O	O
increased	O	O	B-T033
likelihood	O	O	I-T033
of	O	O	I-T033
being	O	O	I-T033
suspended	O	O	I-T033
,	O	O	O
whilst	O	O	O
higher	O	O	O
cognitive	O	O	B-T041
ability	O	O	I-T041
,	O	O	O
family	O	O	B-T099
socio-economic	O	O	B-T080
status	O	O	I-T080
,	O	O	O
and	O	O	O
independent	O	O	O
schools	O	O	B-T073
reduced	O	O	O
risk	O	O	B-T078
.	O	O	O

Potentially	O	O	O
modifiable	O	O	O
individual	O	O	B-T098
and	O	O	O
family	O	O	B-T099
factors	O	O	B-T033
including	O	O	O
adolescent	O	O	B-T100
depression	O	O	B-T048
,	O	O	O
behavioural	O	O	B-T048
problems	O	O	I-T048
,	O	O	O
education	O	O	B-T065
values	O	O	B-T080
,	O	O	O
and	O	O	O
family	O	O	O
supervision	O	O	B-T061
could	O	O	O
be	O	O	O
targeted	O	O	O
to	O	O	O
better	O	O	O
manage	O	O	O
the	O	O	O
high	O	O	B-T078
school	O	O	I-T078
transition	O	O	I-T078
for	O	O	O
students	O	O	B-T098
with	O	O	O
ADHD	O	O	B-T048
.	O	O	O

-DOCSTART- (28058258)

Proliferation	O	O	B-T043
-Related	O	O	O
Activity	O	O	O
in	O	O	O
Endothelial	O	O	B-T025
Cells	O	O	I-T025
Is	O	O	O
Enhanced	O	O	B-T052
by	O	O	O
Micropower	O	O	O
Plasma	O	O	O

Nonthermal	O	O	B-T058
plasma	O	O	I-T058
has	O	O	O
received	O	O	O
a	O	O	O
lot	O	O	O
of	O	O	O
attention	O	O	O
as	O	O	O
a	O	O	O
medical	O	O	B-UnknownType
treatment	O	O	I-UnknownType
technique	O	O	I-UnknownType
in	O	O	O
recent	O	O	O
years	O	O	O
.	O	O	O

It	O	O	O
can	O	O	O
easily	O	O	O
create	O	O	O
various	O	O	O
reactive	O	O	B-T123
chemical	O	O	I-T123
species	O	O	I-T123
(	O	O	O
ROS	O	O	B-T123
)	O	O	O
and	O	O	O
is	O	O	O
harmless	O	O	O
to	O	O	O
living	O	O	B-T016
body	O	O	I-T016
.	O	O	O

Although	O	O	O
plasma	O	O	B-T104
at	O	O	O
gas	O	O	B-T104
-	O	O	O
liquid	O	O	B-T167
interface	O	O	B-T082
has	O	O	O
a	O	O	O
potential	O	O	O
for	O	O	O
a	O	O	O
biomedical	O	O	B-T058
application	O	O	I-T058
,	O	O	O
the	O	O	O
interactions	O	O	O
between	O	O	O
the	O	O	O
gas	O	O	O
-	O	O	O
liquid	O	O	O
plasma	O	O	O
and	O	O	O
living	O	O	B-T025
cells	O	O	I-T025
remain	O	O	O
unclear	O	O	O
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
show	O	O	O
characteristics	O	O	O
of	O	O	O
a	O	O	O
micropower	O	O	O
plasma	O	O	B-T104
with	O	O	O
0.018	O	O	O
W	O	O	O
of	O	O	O
the	O	O	O
power	O	O	O
input	O	O	O
,	O	O	O
generated	O	O	O
at	O	O	O
gas	O	O	B-T104
-	O	O	O
liquid	O	O	B-T167
interface	O	O	B-T082
.	O	O	O

We	O	O	O
also	O	O	O
provide	O	O	O
the	O	O	O
evidence	O	O	O
of	O	O	O
plasma	O	O	B-T104
-induced	O	O	O
enhancement	O	O	B-T052
in	O	O	O
proliferation	O	O	B-T043
activity	O	O	O
of	O	O	O
endothelial	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

The	O	O	O
plasma	O	O	B-T104
produced	O	O	O
H2O2	O	O	B-T121
,	O	O	O
HNO2	O	O	B-T197
,	O	O	O
and	O	O	O
HNO3	O	O	B-T131
in	O	O	O
phosphate	O	O	B-T121
buffered	O	O	I-T121
saline	O	O	B-T167
containing	O	O	O
Mg(++	O	O	B-T123
)	O	O	I-T123
and	O	O	O
Ca(++	O	O	B-T121
)	O	O	I-T121
(	O	O	O
PBS	O	O	B-T121
(	O	O	O
+	O	O	O
)	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
their	O	O	O
concentration	O	O	B-T081
increased	O	O	O
linearly	O	O	O
during	O	O	O
600-second	O	O	B-T079
discharge	O	O	I-T079
.	O	O	O

The	O	O	O
value	O	O	O
of	O	O	O
pH	O	O	B-T081
in	O	O	O
PBS	O	O	B-T121
(	O	O	O
+	O	O	O
)	O	O	O
against	O	O	O
the	O	O	O
plasma	O	O	B-T104
discharge	O	O	B-T079
time	O	O	I-T079
was	O	O	O
stable	O	O	O
at	O	O	O
about	O	O	O
7.0	O	O	O
.	O	O	O

Temperature	O	O	B-T081
in	O	O	O
PBS	O	O	B-T121
(	O	O	O
+	O	O	O
)	O	O	O
rose	O	O	O
monotonically	O	O	O
,	O	O	O
and	O	O	O
its	O	O	O
rise	O	O	O
was	O	O	O
up	O	O	O
to	O	O	O
0.8	O	O	O
Â°	O	O	O
C	O	O	O
at	O	O	O
the	O	O	O
bottom	O	O	O
of	O	O	O
a	O	O	O
cell-cultured	O	O	B-T025
dish	O	O	O
by	O	O	O
the	O	O	O
plasma	O	O	B-T104
discharge	O	O	O
for	O	O	O
600	O	O	O
s.	O	O	O
Short-time	O	O	O
treatment	O	O	B-T169
of	O	O	O
the	O	O	O
plasma	O	O	O
enhanced	O	O	B-T052
proliferation	O	O	B-T043
activity	O	O	O
of	O	O	O
endothelial	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

In	O	O	O
contrast	O	O	O
,	O	O	O
the	O	O	O
treatment	O	O	B-T169
of	O	O	O
H2O2	O	O	B-T121
does	O	O	O
not	O	O	O
enhance	O	O	O
the	O	O	O
cell	O	O	B-T043
proliferation	O	O	I-T043
.	O	O	O

Thus	O	O	O
,	O	O	O
the	O	O	O
ROS	O	O	B-T123
production	O	O	O
and	O	O	O
the	O	O	O
nuclear	O	O	O
factor-kappa	O	O	O
B	O	O	O
(	O	O	O
NF-ÎºB	O	O	O
)	O	O	O
activation	O	O	O
due	O	O	O
to	O	O	O
the	O	O	O
plasma	O	O	B-T104
treatment	O	O	B-T169
might	O	O	O
be	O	O	O
related	O	O	O
to	O	O	O
enhancement	O	O	B-T052
of	O	O	O
the	O	O	O
cell	O	O	B-T043
proliferation	O	O	I-T043
.	O	O	O

Our	O	O	O
results	O	O	O
may	O	O	O
potentially	O	O	O
provide	O	O	O
the	O	O	O
basis	O	O	O
for	O	O	O
developing	O	O	O
the	O	O	O
biomedical	O	O	B-T058
applications	O	O	I-T058
using	O	O	O
the	O	O	O
gas	O	O	B-T104
-	O	O	O
liquid	O	O	B-T167
plasma	O	O	B-T104
.	O	O	O

-DOCSTART- (28058834)

pH	O	O	B-T081
-Dependent	O	O	O
Transmembrane	O	O	B-T044
Activity	O	O	I-T044
of	O	O	O
Peptide	O	O	B-T116
-Functionalized	O	O	O
Gold	O	O	B-T121
Nanostars	O	O	I-T121
for	O	O	O
Computed	O	O	B-T060
Tomography	O	O	I-T060
/	O	O	O
Photoacoustic	O	O	B-T060
Imaging	O	O	I-T060
and	O	O	O
Photothermal	O	O	O
Therapy	O	O	O

Progress	O	O	B-T169
in	O	O	O
multifunctional	O	O	B-T073
nanomaterials	O	O	I-T073
for	O	O	O
tumor	O	O	B-T191
therapy	O	O	I-T061
mostly	O	O	O
depends	O	O	O
on	O	O	O
the	O	O	O
development	O	O	B-T169
of	O	O	O
tumor	O	O	O
-	O	O	O
targeting	O	O	B-T169
delivery	O	O	B-T061
strategies	O	O	I-T061
.	O	O	O

One	O	O	O
approach	O	O	B-T169
is	O	O	O
to	O	O	O
explore	O	O	O
a	O	O	O
pH	O	O	B-T081
-responsive	O	O	O
strategy	O	O	B-T169
to	O	O	O
target	O	O	B-T169
the	O	O	O
slightly	O	O	O
acidic	O	O	B-T070
solid	O	O	I-T070
tumor	O	O	I-T070
microenvironment	O	O	I-T070
.	O	O	O

A	O	O	O
novel	O	O	O
class	O	O	O
of	O	O	O
pH	O	O	B-T081
(	O	O	I-T116
low	O	O	I-T116
)	O	O	I-T116
insertion	O	O	I-T116
peptides	O	O	I-T116
(	O	O	O
pHLIPs	O	O	B-T116
)	O	O	O
with	O	O	O
pH	O	O	O
-dependent	O	O	O
transmembrane	O	O	B-T044
activity	O	O	I-T044
can	O	O	O
fold	O	O	B-T082
and	O	O	O
rapidly	O	O	O
insert	O	O	B-T169
into	O	O	O
the	O	O	O
lipid	O	O	B-T026
bilayer	O	O	I-T026
of	O	O	O
tumor	O	O	B-T025
cells	O	O	I-T025
triggered	O	O	O
by	O	O	O
acidity	O	O	B-T070
,	O	O	O
facilitating	O	O	O
the	O	O	O
cellular	O	O	B-T067
internalization	O	O	I-T067
of	O	O	O
nanomaterials	O	O	B-T073
synchronously	O	O	B-T079
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
innovatively	O	O	O
decorated	O	O	O
gold	O	O	B-T121
nanostars	O	O	I-T121
(	O	O	O
GNSs	O	O	B-T121
)	O	O	O
with	O	O	O
pHLIPs	O	O	B-T116
(	O	O	O
GNS	O	O	B-T121
-	O	O	O
pHLIP	O	O	B-T116
)	O	O	O
to	O	O	O
improve	O	O	O
their	O	O	O
targeting	O	O	B-T169
ability	O	O	O
and	O	O	O
photothermal	O	O	B-T061
therapeutic	O	O	I-T061
(	O	O	O
PTT	O	O	B-T061
)	O	O	O
efficiency	O	O	B-T081
.	O	O	O

The	O	O	O
obtained	O	O	O
GNS	O	O	B-T121
-	O	O	O
pHLIP	O	O	B-T116
exhibited	O	O	O
the	O	O	O
excellent	O	O	O
characteristics	O	O	B-T080
of	O	O	O
uniform	O	O	O
size	O	O	B-T082
and	O	O	O
good	O	O	O
biocompatibility	O	O	B-T044
.	O	O	O

As	O	O	O
compared	O	O	O
to	O	O	O
GNS	O	O	B-T121
-	O	O	O
mPEG	O	O	B-T109
,	O	O	O
the	O	O	O
cellular	O	O	B-T067
internalization	O	O	I-T067
of	O	O	O
GNS	O	O	O
-	O	O	O
pHLIP	O	O	B-T116
was	O	O	O
1-fold	O	O	O
higher	O	O	O
after	O	O	O
a	O	O	O
2	O	O	O
h	O	O	O
incubation	O	O	O
with	O	O	O
cells	O	O	B-T025
in	O	O	O
media	O	O	B-T167
at	O	O	O
pH	O	O	B-T081
6.4	O	O	O
than	O	O	O
at	O	O	O
pH	O	O	O
7.4	O	O	O
.	O	O	O

Moreover	O	O	O
,	O	O	O
the	O	O	O
tumor	O	O	B-T191
accumulation	O	O	B-T033
of	O	O	O
the	O	O	O
GNS	O	O	B-T121
-	O	O	O
pHLIP	O	O	B-T116
was	O	O	O
3-fold	O	O	O
higher	O	O	O
than	O	O	O
that	O	O	O
of	O	O	O
GNS	O	O	O
-	O	O	O
mPEG	O	O	B-T109
after	O	O	O
intravenous	O	O	B-T169
injection	O	O	I-T169
into	O	O	O
MCF-7	O	O	B-T025
breast	O	O	B-T191
tumor	O	O	I-T191
animal	O	O	B-T050
models	O	O	I-T050
for	O	O	O
24	O	O	O
h.	O	O	O
Furthermore	O	O	O
,	O	O	O
GNS	O	O	O
-	O	O	O
pHLIP	O	O	O
exhibited	O	O	O
stronger	O	O	O
signals	O	O	B-T067
than	O	O	O
the	O	O	O
GNS	O	O	O
-	O	O	O
mPEG	O	O	O
through	O	O	O
computed	O	O	B-T060
tomography	O	O	I-T060
(	O	O	O
CT	O	O	B-T060
)	O	O	O
and	O	O	O
photoacoustic	O	O	B-T060
(	O	O	I-T060
PA	O	O	I-T060
)	O	O	I-T060
imaging	O	O	I-T060
.	O	O	O

Simultaneously	O	O	O
,	O	O	O
the	O	O	O
desirable	O	O	O
targeting	O	O	B-T169
efficiency	O	O	B-T081
significantly	O	O	O
improved	O	O	O
the	O	O	O
PTT	O	O	B-T061
efficacy	O	O	B-T080
to	O	O	O
tumors	O	O	B-T191
,	O	O	O
with	O	O	O
low	O	O	O
side	O	O	B-T046
effects	O	O	I-T046
on	O	O	O
normal	O	O	O
tissues	O	O	B-T024
.	O	O	O

The	O	O	O
results	O	O	O
clearly	O	O	O
demonstrate	O	O	O
that	O	O	O
the	O	O	O
GNS	O	O	B-T121
-	O	O	O
pHLIP	O	O	B-T116
successfully	O	O	O
took	O	O	O
advantage	O	O	O
of	O	O	O
the	O	O	O
tumor	O	O	B-T191
-	O	O	O
targeting	O	O	B-T169
ability	O	O	O
of	O	O	O
pHLIPs	O	O	B-T116
and	O	O	O
the	O	O	O
good	O	O	O
characteristics	O	O	B-T080
of	O	O	O
GNS	O	O	B-T121
s	O	O	I-T121
,	O	O	O
which	O	O	O
may	O	O	O
contribute	O	O	O
to	O	O	O
the	O	O	O
study	O	O	O
of	O	O	O
tumor	O	O	O
imaging	O	O	B-T060
and	O	O	O
therapy	O	O	B-T061
.	O	O	O

-DOCSTART- (28059412)

Stepwise	O	O	O
cyclopropanation	O	O	B-T044
on	O	O	O
the	O	O	O
polycyclopropanated	O	O	B-T109
polyketide	O	O	I-T109
formation	O	O	O
in	O	O	O
jawsamycin	O	O	B-T195
biosynthesis	O	O	O

Jawsamycin	O	O	B-T195
is	O	O	O
a	O	O	O
polyketide	O	O	B-T109
-	O	O	O
nucleoside	O	O	B-T114
hybrid	O	O	O
with	O	O	O
a	O	O	O
unique	O	O	O
polycyclopropane	O	O	B-T109
moiety	O	O	O
on	O	O	O
a	O	O	O
single	O	O	O
polyketide	O	O	B-T109
chain	O	O	I-T109
.	O	O	O

The	O	O	O
unexpected	O	O	O
isolation	O	O	O
of	O	O	O
cyclopropane	O	O	B-T109
deficient	O	O	O
jawsamycin	O	O	B-T195
analogs	O	O	O
allowed	O	O	O
us	O	O	O
to	O	O	O
propose	O	O	O
a	O	O	O
stepwise	O	O	O
cyclopropanation	O	O	B-T044
mechanism	O	O	B-T169
for	O	O	O
the	O	O	O
enzymatic	O	O	B-T116
synthesis	O	O	B-T169
of	O	O	O
this	O	O	O
polyketide	O	O	B-T109
.	O	O	O

The	O	O	O
concise	O	O	O
timing	O	O	O
of	O	O	O
the	O	O	O
cyclopropanation	O	O	B-T044
could	O	O	O
be	O	O	O
regulated	O	O	O
by	O	O	O
a	O	O	O
delicate	O	O	O
balance	O	O	O
between	O	O	O
reaction	O	O	B-T079
rates	O	O	I-T079
of	O	O	O
the	O	O	O
condensation	O	O	B-T067
and	O	O	O
cyclopropanation	O	O	B-T044
reactions	O	O	I-T044
.	O	O	O

-DOCSTART- (28061895)

Initial	O	O	O
experience	O	O	O
with	O	O	O
laparoscopic	O	O	B-T061
radical	O	O	I-T061
antegrade	O	O	I-T061
modular	O	O	I-T061
pancreatosplenectomy	O	O	I-T061
for	O	O	O
left-sided	O	O	B-T191
pancreatic	O	O	I-T191
cancer	O	O	I-T191
in	O	O	O
a	O	O	O
single	O	O	O
institution	O	O	B-T093
:	O	O	O
technical	O	O	O
aspects	O	O	O
and	O	O	O
oncological	O	O	O
outcomes	O	O	O

Laparoscopic	O	O	B-T061
surgery	O	O	I-T061
has	O	O	O
been	O	O	O
performed	O	O	O
less	O	O	O
frequently	O	O	O
in	O	O	O
the	O	O	O
era	O	O	O
of	O	O	O
pancreatic	O	O	B-T191
cancer	O	O	I-T191
due	O	O	O
to	O	O	O
technical	O	O	B-T067
difficulties	O	O	I-T067
and	O	O	O
concerns	O	O	O
about	O	O	O
oncological	O	O	B-T191
safety	O	O	B-T068
.	O	O	O

Radical	O	O	B-T061
antegrade	O	O	I-T061
modular	O	O	I-T061
pancreatosplenectomy	O	O	I-T061
(	O	O	O
RAMPS	O	O	B-T061
)	O	O	O
is	O	O	O
expected	O	O	O
to	O	O	O
be	O	O	O
helpful	O	O	O
to	O	O	O
obtain	O	O	O
a	O	O	O
negative	O	O	B-T033
margin	O	O	I-T033
during	O	O	O
radical	O	O	B-T061
lymph	O	O	I-T061
node	O	O	I-T061
dissection	O	O	I-T061
.	O	O	O

We	O	O	O
hypothesized	O	O	O
that	O	O	O
it	O	O	O
would	O	O	O
also	O	O	O
be	O	O	O
favorable	O	O	B-T080
as	O	O	O
a	O	O	O
laparoscopic	O	O	B-T082
application	O	O	I-T082
due	O	O	O
to	O	O	O
unique	O	O	O
features	O	O	O
.	O	O	O

Fifteen	O	O	O
laparoscopic	O	O	B-T060
RAMPS	O	O	B-T061
for	O	O	O
well-selected	O	O	O
patients	O	O	B-T101
with	O	O	O
left-sided	O	O	B-T191
pancreatic	O	O	I-T191
cancer	O	O	I-T191
were	O	O	O
performed	O	O	O
from	O	O	O
July	O	O	O
2011	O	O	O
to	O	O	O
April	O	O	O
2016	O	O	O
.	O	O	O

Five	O	O	O
trocars	O	O	B-T074
were	O	O	O
usually	O	O	O
used	O	O	O
,	O	O	O
and	O	O	O
the	O	O	O
operative	O	O	B-T061
procedures	O	O	I-T061
and	O	O	O
range	O	O	B-T061
of	O	O	I-T061
dissection	O	O	I-T061
were	O	O	O
similar	O	O	O
to	O	O	O
or	O	O	O
the	O	O	O
same	O	O	O
as	O	O	O
those	O	O	O
of	O	O	O
open	O	O	O
RAMPS	O	O	B-T061
described	O	O	O
by	O	O	O
Strasberg	O	O	B-T170
.	O	O	O

All	O	O	O
medical	O	O	O
records	O	O	O
and	O	O	O
follow-up	O	O	B-T170
data	O	O	I-T170
were	O	O	O
reviewed	O	O	O
and	O	O	O
analyzed	O	O	O
.	O	O	O

All	O	O	O
patients	O	O	B-T101
had	O	O	O
pancreatic	O	O	B-T191
ductal	O	O	I-T191
adenocarcinoma	O	O	I-T191
.	O	O	O

Mean	O	O	O
operative	O	O	B-T079
time	O	O	I-T079
was	O	O	O
219.3	O	O	O
Â±	O	O	O
53.8	O	O	O
min	O	O	O
,	O	O	O
and	O	O	O
estimated	O	O	B-T033
blood	O	O	I-T033
loss	O	O	I-T033
was	O	O	O
250	O	O	O
Â±	O	O	O
70	O	O	O
ml	O	O	O
.	O	O	O

The	O	O	O
length	O	O	B-T079
of	O	O	I-T079
postoperative	O	O	B-T046
hospital	O	O	I-T079
stay	O	O	I-T079
was	O	O	O
6.1	O	O	O
Â±	O	O	O
1.2	O	O	O
days	O	O	O
,	O	O	O
and	O	O	O
postoperative	O	O	O
morbidities	O	O	B-T081
developed	O	O	O
in	O	O	O
two	O	O	O
patients	O	O	B-T101
(	O	O	O
13.3	O	O	O
%	O	O	O
)	O	O	O
with	O	O	O
urinary	O	O	B-T033
retention	O	O	I-T033
.	O	O	O

The	O	O	O
median	O	O	O
number	O	O	O
of	O	O	O
retrieved	O	O	O
lymph	O	O	B-T023
nodes	O	O	I-T023
was	O	O	O
18.1	O	O	O
Â±	O	O	O
6.2	O	O	O
and	O	O	O
all	O	O	O
had	O	O	O
negative	O	O	B-T033
margins	O	O	I-T033
.	O	O	O

Median	O	O	O
follow-up	O	O	B-T058
time	O	O	O
was	O	O	O
46.0	O	O	O
months	O	O	O
,	O	O	O
and	O	O	O
the	O	O	O
3-year	O	O	O
disease	O	O	B-T081
free	O	O	I-T081
survival	O	O	I-T081
and	O	O	O
overall	O	O	B-T081
survival	O	O	I-T081
rates	O	O	I-T081
were	O	O	O
56.3	O	O	O
%	O	O	O
and	O	O	O
74.1	O	O	O
%	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

Our	O	O	O
early	O	O	O
experience	O	O	O
with	O	O	O
laparoscopic	O	O	B-T060
RAMPS	O	O	B-T061
achieved	O	O	O
feasible	O	O	O
perioperative	O	O	B-T079
results	O	O	O
accompanied	O	O	O
by	O	O	O
acceptable	O	O	O
survival	O	O	B-T081
outcomes	O	O	I-T081
.	O	O	O

Laparoscopic	O	O	B-T060
RAMPS	O	O	B-T061
could	O	O	O
be	O	O	O
a	O	O	O
safe	O	O	O
and	O	O	O
oncologically	O	O	B-T191
feasible	O	O	B-T080
procedure	O	O	I-T080
in	O	O	O
well-selected	O	O	O
patients	O	O	B-T101
with	O	O	O
left-sided	O	O	B-T191
pancreatic	O	O	I-T191
cancer	O	O	I-T191
.	O	O	O

-DOCSTART- (28063131)

Individual	O	O	B-T098
classification	O	O	B-T185
of	O	O	O
strong	O	O	B-T080
risk	O	O	B-T078
attitudes	O	O	B-T041
:	O	O	O
An	O	O	O
application	O	O	O
across	O	O	O
lottery	O	O	B-T081
types	O	O	B-T080
and	O	O	O
age	O	O	O
groups	O	O	O

Empirical	O	O	B-T080
evaluations	O	O	B-T169
of	O	O	O
risk	O	O	B-T078
attitudes	O	O	B-T041
often	O	O	O
rely	O	O	O
on	O	O	O
a	O	O	O
weak	O	O	B-T080
definition	O	O	B-T170
of	O	O	O
risk	O	O	O
that	O	O	O
concerns	O	O	O
preferences	O	O	O
towards	O	O	O
risky	O	O	B-T078
and	O	O	O
riskless	O	O	B-T169
options	O	O	I-T169
(	O	O	O
e.g.	O	O	O
,	O	O	O
a	O	O	O
lottery	O	O	B-T081
vs.	O	O	O
a	O	O	O
sure	O	O	O
outcome	O	O	B-T169
)	O	O	O
.	O	O	O

A	O	O	O
large	O	O	O
body	O	O	O
of	O	O	O
work	O	O	O
has	O	O	O
shown	O	O	O
that	O	O	O
individuals	O	O	B-T098
tend	O	O	O
to	O	O	O
be	O	O	O
weak	O	O	B-T080
risk	O	O	B-T078
averse	O	O	O
in	O	O	O
choice	O	O	B-T052
contexts	O	O	B-T078
involving	O	O	O
risky	O	O	B-T078
and	O	O	O
riskless	O	O	B-T081
gains	O	O	I-T081
but	O	O	O
weak	O	O	O
risk	O	O	O
seeking	O	O	O
in	O	O	O
contexts	O	O	O
involving	O	O	O
losses	O	O	B-T081
,	O	O	O
a	O	O	O
phenomenon	O	O	B-T067
known	O	O	O
as	O	O	O
the	O	O	O
reflection	O	O	B-T067
effect	O	O	I-T067
.	O	O	O

Recent	O	O	O
attempts	O	O	O
to	O	O	O
evaluate	O	O	O
age	O	O	B-T100
differences	O	O	I-T100
in	O	O	O
risk	O	O	B-T078
attitudes	O	O	B-T041
have	O	O	O
relied	O	O	O
on	O	O	O
this	O	O	O
weak	O	O	B-T080
definition	O	O	B-T170
,	O	O	O
testing	O	O	O
whether	O	O	O
the	O	O	O
reflection	O	O	B-T067
effect	O	O	I-T067
increases	O	O	B-T169
or	O	O	O
diminishes	O	O	B-T081
as	O	O	O
we	O	O	O
grow	O	O	O
older	O	O	B-T079
.	O	O	O

The	O	O	O
present	O	O	O
work	O	O	O
argues	O	O	O
that	O	O	O
weak	O	O	B-T080
risk	O	O	B-T078
attitudes	O	O	B-T041
have	O	O	O
limited	O	O	O
generalizability	O	O	B-T080
and	O	O	O
proposes	O	O	O
the	O	O	O
use	O	O	B-T169
of	O	O	I-T169
a	O	O	O
strong	O	O	B-T080
definition	O	O	B-T170
of	O	O	O
risk	O	O	O
that	O	O	O
is	O	O	O
concerned	O	O	O
with	O	O	O
preferences	O	O	O
towards	O	O	O
options	O	O	B-T169
with	O	O	O
the	O	O	O
same	O	O	O
expected	O	O	O
value	O	O	B-T081
but	O	O	O
different	O	O	B-T080
degrees	O	O	B-T081
of	O	O	O
risk	O	O	O
(	O	O	O
i.e.	O	O	O
,	O	O	O
outcome	O	O	B-T169
variance	O	O	B-T080
)	O	O	O
.	O	O	O

A	O	O	O
reanalysis	O	O	B-T062
of	O	O	O
previously-published	O	O	O
data	O	O	B-T078
and	O	O	O
the	O	O	O
results	O	O	B-T169
from	O	O	O
a	O	O	O
new	O	O	O
study	O	O	O
show	O	O	O
that	O	O	O
only	O	O	O
a	O	O	O
minority	O	O	O
of	O	O	O
individuals	O	O	B-T098
manifests	O	O	B-T169
the	O	O	O
reflection	O	O	B-T067
effect	O	O	I-T067
under	O	O	O
a	O	O	O
strong	O	O	B-T080
definition	O	O	B-T170
of	O	O	O
risk	O	O	B-T078
,	O	O	O
and	O	O	O
that	O	O	O
,	O	O	O
when	O	O	O
facing	O	O	O
certain	O	O	O
lottery	O	O	B-T081
-	O	O	O
pair	O	O	B-T080
types	O	O	I-T080
,	O	O	O
older	O	O	B-T098
adults	O	O	B-T100
appear	O	O	O
to	O	O	O
be	O	O	O
more	O	O	O
risk	O	O	O
seeking	O	O	O
than	O	O	O
younger	O	O	B-T079
adults	O	O	O
.	O	O	O

-DOCSTART- (28064539)

Treating	O	O	B-T169
the	O	O	O
binge	O	O	B-T048
or	O	O	O
the	O	O	O
(	O	O	B-T023
fat	O	O	I-T023
)	O	O	I-T023
body	O	O	I-T023
?	O	O	O
Representations	O	O	B-T052
of	O	O	O
fatness	O	O	B-T033
in	O	O	O
a	O	O	O
gold	O	O	B-T080
standard	O	O	I-T080
psychological	O	O	B-T169
treatment	O	O	B-UnknownType
manual	O	O	I-UnknownType
for	O	O	O
binge	O	O	O
eating	O	O	O
disorder	O	O	O

Representations	O	O	B-T052
of	O	O	O
fatness	O	O	B-T033
in	O	O	O
a	O	O	O
gold	O	O	B-T080
standard	O	O	I-T080
psychological	O	O	B-T169
treatment	O	O	B-UnknownType
manual	O	O	I-UnknownType
for	O	O	O
binge	O	O	B-T048
eating	O	O	I-T048
disorder	O	O	I-T048
This	O	O	O
article	O	O	O
reports	O	O	B-T058
the	O	O	O
results	O	O	B-T034
of	O	O	O
a	O	O	O
Foucauldian	O	O	B-T016
-informed	O	O	O
discourse	O	O	B-T062
analysis	O	O	I-T062
exploring	O	O	O
representations	O	O	B-T052
of	O	O	O
fatness	O	O	O
embedded	O	O	O
within	O	O	O
an	O	O	O
empirically	O	O	B-T080
based	O	O	O
psychological	O	O	O
treatment	O	O	O
manual	O	O	O
for	O	O	O
binge	O	O	O
eating	O	O	O
disorder	O	O	O
,	O	O	O
a	O	O	O
condition	O	O	B-T080
characterized	O	O	B-T052
by	O	O	O
overvaluation	O	O	O
of	O	O	O
weight	O	O	B-T032
and	O	O	O
shape	O	O	B-T080
.	O	O	O

Analyses	O	O	B-T062
indicate	O	O	B-T033
that	O	O	O
the	O	O	O
manual	O	O	B-T073
prioritizes	O	O	O
weight	O	O	B-T033
loss	O	O	I-T033
with	O	O	O
relatively	O	O	B-T080
less	O	O	O
emphasis	O	O	O
placed	O	O	O
on	O	O	O
treating	O	O	B-T169
the	O	O	O
diagnostic	O	O	B-T169
symptoms	O	O	B-T184
and	O	O	O
underlying	O	O	O
mechanisms	O	O	B-T169
of	O	O	O
binge	O	O	B-T048
eating	O	O	I-T048
disorder	O	O	I-T048
.	O	O	O

We	O	O	O
raise	O	O	O
critical	O	O	B-T033
concerns	O	O	I-T033
about	O	O	O
these	O	O	O
observations	O	O	B-T062
and	O	O	O
link	O	O	O
our	O	O	O
findings	O	O	B-T033
to	O	O	O
mainstream	O	O	O
psychology	O	O	B-T091
's	O	O	I-T091
adoption	O	O	O
of	O	O	O
the	O	O	O
medical	O	O	B-T080
framing	O	O	I-T080
of	O	O	O
fatness	O	O	B-T033
as	O	O	O
obesity	O	O	B-T047
within	O	O	O
the	O	O	O
"	O	O	O
gold	O	O	B-T080
standard	O	O	I-T080
"	O	O	O
approach	O	O	O
to	O	O	O
intervention	O	O	B-T058
.	O	O	O

We	O	O	O
recommend	O	O	O
that	O	O	O
psychology	O	O	B-T091
as	O	O	O
a	O	O	O
discipline	O	O	B-T058
abandons	O	O	O
the	O	O	O
weight	O	O	B-T033
loss	O	O	I-T033
imperative	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
binge	O	O	B-T048
eating	O	O	I-T048
disorder	O	O	I-T048
and	O	O	O
fat	O	O	B-T023
bodies	O	O	I-T023
.	O	O	O

We	O	O	O
recommend	O	O	O
that	O	O	O
practitioners	O	O	B-T097
locate	O	O	O
the	O	O	O
problem	O	O	B-T033
of	O	O	O
fat	O	O	B-T041
shame	O	O	I-T041
in	O	O	O
society	O	O	B-T092
as	O	O	O
opposed	O	O	O
to	O	O	O
the	O	O	O
individual	O	O	B-T098
person	O	O	O
's	O	O	O
body	O	O	B-T016
and	O	O	O
provide	O	O	B-T052
individuals	O	O	B-T098
with	O	O	O
tools	O	O	O
to	O	O	O
identify	O	O	O
and	O	O	O
resist	O	O	O
fat	O	O	B-T033
stigma	O	O	I-T033
and	O	O	O
oppression	O	O	B-T054
,	O	O	O
rather	O	O	O
than	O	O	O
provide	O	O	O
them	O	O	O
with	O	O	O
tools	O	O	O
to	O	O	O
reshape	O	O	O
their	O	O	O
bodies	O	O	B-T016
.	O	O	O

-DOCSTART- (28066382)

High	O	O	O
Diversity	O	O	B-T080
of	O	O	O
Planctomycetes	O	O	B-T007
in	O	O	O
Soils	O	O	B-T167
of	O	O	O
Two	O	O	O
Lichen	O	O	B-T002
-Dominated	O	O	O
Sub-Arctic	O	O	B-T083
Ecosystems	O	O	B-T070
of	O	O	O
Northwestern	O	O	B-T082
Siberia	O	O	O

A	O	O	O
wide	O	O	O
variety	O	O	O
of	O	O	O
terrestrial	O	O	B-T082
ecosystems	O	O	B-T070
in	O	O	O
tundra	O	O	B-T083
have	O	O	O
a	O	O	O
ground	O	O	O
vegetation	O	O	O
cover	O	O	O
composed	O	O	O
of	O	O	O
reindeer	O	O	O
lichens	O	O	B-T002
(	O	O	O
genera	O	O	B-T185
Cladonia	O	O	B-T004
and	O	O	O
Cetraria	O	O	B-T004
)	O	O	O
.	O	O	O

The	O	O	O
microbial	O	O	B-T001
communities	O	O	O
of	O	O	O
two	O	O	O
lichen	O	O	B-T002
-dominated	O	O	O
ecosystems	O	O	B-T070
typical	O	O	O
of	O	O	O
the	O	O	O
sub-arctic	O	O	B-T083
zone	O	O	I-T083
of	O	O	O
northwestern	O	O	B-T082
Siberia	O	O	B-T083
,	O	O	O
that	O	O	O
is	O	O	O
a	O	O	O
forested	O	O	B-T070
tundra	O	O	B-T083
soil	O	O	B-T167
and	O	O	O
a	O	O	O
shallow	O	O	B-T083
acidic	O	O	I-T083
peatland	O	O	I-T083
,	O	O	O
were	O	O	O
examined	O	O	O
in	O	O	O
our	O	O	O
study	O	O	B-T062
.	O	O	O

As	O	O	O
revealed	O	O	O
by	O	O	O
molecular	O	O	O
analyses	O	O	O
,	O	O	O
soil	O	O	B-T167
and	O	O	O
peat	O	O	B-T167
layers	O	O	O
just	O	O	O
beneath	O	O	O
the	O	O	O
lichen	O	O	B-T002
cover	O	O	O
were	O	O	O
abundantly	O	O	O
colonized	O	O	B-T033
by	O	O	O
bacteria	O	O	B-T007
from	O	O	O
the	O	O	O
phylum	O	O	B-T185
Planctomycetes	O	O	B-T007
.	O	O	O

Highest	O	O	O
abundance	O	O	O
of	O	O	O
planctomycetes	O	O	B-T007
detected	O	O	O
by	O	O	O
fluorescence	O	O	B-T070
in	O	O	B-T063
situ	O	O	I-T063
hybridization	O	O	I-T063
was	O	O	O
in	O	O	O
the	O	O	O
range	O	O	O
2.2	O	O	O
-	O	O	O
2.7	O	O	O
Ã	O	O	O
10(7	O	O	O
)	O	O	O
cells	O	O	B-T081
per	O	O	I-T081
gram	O	O	I-T081
of	O	O	I-T081
wet	O	O	I-T081
weight	O	O	I-T081
.	O	O	O

16S	O	O	B-T114
rRNA	O	O	I-T114
gene	O	O	B-T028
fragments	O	O	I-T028
from	O	O	O
the	O	O	O
Planctomycetes	O	O	B-T007
comprised	O	O	O
8	O	O	O
-	O	O	O
13	O	O	O
%	O	O	O
of	O	O	O
total	O	O	O
16S	O	O	O
rRNA	O	O	O
gene	O	O	O
reads	O	O	O
retrieved	O	O	O
using	O	O	O
Illumina	O	O	B-T170
pair-end	O	O	I-T170
sequencing	O	O	I-T170
from	O	O	O
the	O	O	O
soil	O	O	B-T167
and	O	O	O
peat	O	O	B-T167
samples	O	O	I-T167
.	O	O	O

Lichen	O	O	B-T002
-associated	O	O	O
assemblages	O	O	O
of	O	O	O
planctomycetes	O	O	B-T007
displayed	O	O	O
unexpectedly	O	O	O
high	O	O	O
diversity	O	O	B-T080
,	O	O	O
with	O	O	O
a	O	O	O
total	O	O	O
of	O	O	O
89,662	O	O	O
reads	O	O	O
representing	O	O	O
1723	O	O	O
operational	O	O	B-T062
taxonomic	O	O	I-T062
units	O	O	I-T062
determined	O	O	O
at	O	O	O
97	O	O	O
%	O	O	O
sequence	O	O	B-T081
identity	O	O	I-T081
.	O	O	O

The	O	O	O
soil	O	O	B-T167
of	O	O	O
forested	O	O	O
tundra	O	O	B-T083
was	O	O	O
dominated	O	O	O
by	O	O	O
uncultivated	O	O	O
members	O	O	O
of	O	O	O
the	O	O	O
family	O	O	B-T077
Planctomycetaceae	O	O	B-T007
(	O	O	O
53	O	O	O
-	O	O	O
71	O	O	O
%	O	O	O
of	O	O	O
total	O	O	O
Planctomycetes	O	O	B-T007
-like	O	O	O
reads	O	O	O
)	O	O	O
,	O	O	O
while	O	O	O
sequences	O	O	B-T086
affiliated	O	O	O
with	O	O	O
the	O	O	O
Phycisphaera-related	O	O	B-T007
group	O	O	I-T007
WD2101	O	O	I-T007
(	O	O	O
recently	O	O	O
assigned	O	O	O
to	O	O	O
the	O	O	O
order	O	O	B-T185
Tepidisphaerales	O	O	B-T007
)	O	O	O
were	O	O	O
most	O	O	O
abundant	O	O	O
in	O	O	O
peat	O	O	B-T167
(	O	O	O
28	O	O	O
-	O	O	O
51	O	O	O
%	O	O	O
of	O	O	O
total	O	O	O
reads	O	O	O
)	O	O	O
.	O	O	O

Representatives	O	O	O
of	O	O	O
the	O	O	O
Isosphaera	O	O	B-T007
-	O	O	O
Singulisphaera	O	O	B-T007
group	O	O	I-T007
(	O	O	O
14	O	O	O
-	O	O	O
28	O	O	O
%	O	O	O
of	O	O	O
total	O	O	O
reads	O	O	O
)	O	O	O
and	O	O	O
the	O	O	O
lineages	O	O	B-T077
defined	O	O	O
by	O	O	O
the	O	O	O
genera	O	O	B-T185
Gemmata	O	O	B-T007
(	O	O	O
1	O	O	O
-	O	O	O
4	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
Planctopirus	O	O	B-T007
-	O	O	O
Rubinisphaera	O	O	B-T007
(	O	O	O
1	O	O	O
-	O	O	O
3	O	O	O
%	O	O	O
)	O	O	O
were	O	O	O
present	O	O	O
in	O	O	O
both	O	O	O
habitats	O	O	B-T082
.	O	O	O

Two	O	O	O
strains	O	O	O
of	O	O	O
Singulisphaera-like	O	O	B-T007
bacteria	O	O	I-T007
were	O	O	O
isolated	O	O	O
from	O	O	O
studied	O	O	O
soil	O	O	B-T167
and	O	O	O
peat	O	O	B-T167
samples	O	O	I-T167
.	O	O	O

These	O	O	O
planctomycetes	O	O	B-T007
displayed	O	O	O
good	O	O	O
tolerance	O	O	O
of	O	O	O
low	O	O	B-T070
temperatures	O	O	I-T070
(	O	O	O
4	O	O	O
-	O	O	O
15	O	O	O
Â°	O	O	O
C	O	O	O
)	O	O	O
and	O	O	O
were	O	O	O
capable	O	O	O
of	O	O	O
growth	O	O	B-T040
on	O	O	O
a	O	O	O
number	O	O	O
of	O	O	O
polysaccharides	O	O	B-T109
,	O	O	O
including	O	O	O
lichenan	O	O	B-T109
,	O	O	O
a	O	O	O
characteristic	O	O	O
component	O	O	O
of	O	O	O
lichen	O	O	B-T002
-derived	O	O	O
phytomass	O	O	B-T081
.	O	O	O

-DOCSTART- (28066591)

Relationship	O	O	B-T080
between	O	O	O
polycythemia	O	O	B-T047
and	O	O	O
in-hospital	O	O	B-T080
mortality	O	O	I-T080
in	O	O	O
chronic	O	O	B-T047
obstructive	O	O	I-T047
pulmonary	O	O	I-T047
disease	O	O	I-T047
patients	O	O	B-T101
with	O	O	O
low-risk	O	O	B-T081
pulmonary	O	O	O
embolism	O	O	O

Pulmonary	O	O	B-T047
embolism	O	O	I-T047
(	O	O	O
PE	O	O	B-T047
)	O	O	O
is	O	O	O
frequent	O	O	B-T079
in	O	O	O
subjects	O	O	B-T098
with	O	O	O
chronic	O	O	B-T047
obstructive	O	O	I-T047
pulmonary	O	O	I-T047
disease	O	O	I-T047
(	O	O	O
COPD	O	O	B-T047
)	O	O	O
and	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
high	O	O	O
mortality	O	O	B-T081
.	O	O	O

This	O	O	O
multi-center	O	O	B-T062
retrospective	O	O	I-T062
study	O	O	I-T062
was	O	O	O
performed	O	O	O
to	O	O	O
investigate	O	O	B-T169
if	O	O	O
secondary	O	O	O
polycythemia	O	O	B-T047
is	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
in-hospital	O	O	B-T080
mortality	O	O	I-T080
in	O	O	O
COPD	O	O	B-T047
patients	O	O	B-T101
with	O	O	O
low-risk	O	O	B-T081
PE	O	O	B-T047
.	O	O	O

We	O	O	O
identified	O	O	O
COPD	O	O	B-T047
patients	O	O	B-T101
with	O	O	O
proven	O	O	O
PE	O	O	B-T047
between	O	O	O
October	O	O	O
,	O	O	O
2005	O	O	O
and	O	O	O
October	O	O	O
,	O	O	O
2015	O	O	O
.	O	O	O

Patients	O	O	B-T101
in	O	O	O
risk	O	O	O
classes	O	O	O
III-V	O	O	O
on	O	O	O
the	O	O	O
basis	O	O	O
of	O	O	O
the	O	O	O
PESI	O	O	B-T033
score	O	O	I-T033
were	O	O	O
excluded	O	O	O
.	O	O	O

We	O	O	O
extracted	O	O	O
demographic	O	O	B-T090
,	O	O	O
clinical	O	O	B-T080
and	O	O	O
laboratory	O	O	B-UnknownType
information	O	O	I-UnknownType
at	O	O	O
the	O	O	O
time	O	O	B-T079
of	O	O	I-T079
admission	O	O	I-T079
from	O	O	O
medical	O	O	B-T170
records	O	O	I-T170
.	O	O	O

All	O	O	O
subjects	O	O	B-T098
were	O	O	O
followed	O	O	O
until	O	O	O
hospital	O	O	B-T058
discharge	O	O	I-T058
to	O	O	O
identify	O	O	O
all-cause	O	O	O
mortality	O	O	B-T081
.	O	O	O

We	O	O	O
enrolled	O	O	O
629	O	O	O
consecutive	O	O	O
patients	O	O	B-T101
with	O	O	O
COPD	O	O	B-T047
and	O	O	O
PE	O	O	B-T047
at	O	O	O
low	O	O	B-T081
risk	O	O	I-T081
:	O	O	O
132	O	O	O
of	O	O	O
them	O	O	O
(	O	O	O
21.0	O	O	O
%	O	O	O
)	O	O	O
with	O	O	O
and	O	O	O
497	O	O	O
(	O	O	O
79.0	O	O	O
%	O	O	O
)	O	O	O
without	O	O	O
secondary	O	O	O
polycythemia	O	O	B-T047
.	O	O	O

Compared	O	O	O
with	O	O	O
those	O	O	O
without	O	O	O
polycythemia	O	O	B-T047
,	O	O	O
the	O	O	O
polycythemia	O	O	O
group	O	O	O
had	O	O	O
significantly	O	O	B-T081
lower	O	O	I-T081
forced	O	O	B-T060
expiratory	O	O	I-T060
volume	O	O	I-T060
in	O	O	I-T060
one	O	O	I-T060
second	O	O	I-T060
(	O	O	I-T060
FEV1	O	O	I-T060
)	O	O	I-T060
level	O	O	I-T060
(	O	O	O
0.9Â±0.3	O	O	O
vs.	O	O	O
1.4Â±0.5	O	O	O
,	O	O	O
P=0.000	O	O	O
)	O	O	O
,	O	O	O
lower	O	O	B-T033
PaO2	O	O	I-T033
and	O	O	O
SpO2	O	O	B-T042
as	O	O	O
well	O	O	O
as	O	O	O
higher	O	O	B-T034
PaCO2	O	O	I-T034
(	O	O	O
P=0.03	O	O	O
,	O	O	O
P=0.03	O	O	O
and	O	O	O
P=0.000	O	O	O
,	O	O	O
respectively	O	O	O
)	O	O	O
.	O	O	O

COPD	O	O	B-T047
patients	O	O	B-T101
with	O	O	O
polycythemia	O	O	B-T047
had	O	O	O
a	O	O	O
higher	O	O	B-T080
proportion	O	O	B-T081
of	O	O	O
arrhythmia	O	O	B-T033
in	O	O	O
electrocardiogram	O	O	B-T033
(	O	O	O
ECG	O	O	B-T033
)	O	O	O
(	O	O	O
49.5	O	O	O
%	O	O	O
vs.	O	O	O
35.7	O	O	O
%	O	O	O
,	O	O	O
P=0.02	O	O	O
)	O	O	O
,	O	O	O
a	O	O	O
longer	O	O	O
hospital	O	O	B-T081
duration	O	O	I-T081
time	O	O	I-T081
(	O	O	O
15.3Â±10.1	O	O	O
vs.	O	O	O
9.7Â±9.1	O	O	O
,	O	O	O
P=0.001	O	O	O
)	O	O	O
,	O	O	O
a	O	O	O
higher	O	O	O
mechanical	O	O	B-T061
ventilation	O	O	I-T061
rate	O	O	I-T061
(	O	O	O
noninvasive	O	O	B-T185
and	O	O	O
invasive	O	O	B-T080
,	O	O	O
51.7	O	O	O
%	O	O	O
vs.	O	O	O
30.3	O	O	O
%	O	O	O
,	O	O	O
P=0.04	O	O	O
and	O	O	O
31.0	O	O	O
%	O	O	O
vs.	O	O	O
7.9	O	O	O
%	O	O	O
,	O	O	O
P=0.04	O	O	O
,	O	O	O
respectively	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
a	O	O	O
higher	O	O	O
in-hospital	O	O	B-T080
mortality	O	O	I-T080
(	O	O	O
12.1	O	O	O
%	O	O	O
vs.	O	O	O
6.6	O	O	O
%	O	O	O
,	O	O	O
P=0.04	O	O	O
)	O	O	O
.	O	O	O

Multivariate	O	O	B-UnknownType
logistic	O	O	I-UnknownType
regression	O	O	I-UnknownType
analysis	O	O	I-UnknownType
revealed	O	O	O
that	O	O	O
polycythemia	O	O	B-T047
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
mortality	O	O	B-T081
in	O	O	O
COPD	O	O	B-T047
patients	O	O	B-T101
with	O	O	O
low-risk	O	O	B-T081
PE	O	O	B-T047
(	O	O	O
adjusted	O	O	O
OR	O	O	O
1.11	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
,	O	O	O
1.04	O	O	O
-	O	O	O
1.66	O	O	O
)	O	O	O
.	O	O	O

Polycythemia	O	O	B-T047
is	O	O	O
an	O	O	O
independent	O	O	O
risk	O	O	B-T033
factor	O	O	I-T033
for	O	O	O
all-cause	O	O	O
in-hospital	O	O	B-T080
mortality	O	O	I-T080
in	O	O	O
COPD	O	O	B-T047
patients	O	O	B-T101
with	O	O	O
PE	O	O	B-T047
at	O	O	O
low	O	O	B-T081
risk	O	O	I-T081
.	O	O	O

-DOCSTART- (28069279)

Masitinib	O	O	B-T109
for	O	O	O
treatment	O	O	B-T061
of	O	O	O
severely	O	O	B-T080
symptomatic	O	O	B-T169
indolent	O	O	B-T047
systemic	O	O	I-T047
mastocytosis	O	O	I-T047
:	O	O	O
a	O	O	O
randomised	O	O	B-T062
,	O	O	O
placebo-controlled	O	O	B-T062
,	O	O	O
phase	O	O	O
3	O	O	O
study	O	O	O

Indolent	O	O	B-T047
systemic	O	O	I-T047
mastocytosis	O	O	I-T047
,	O	O	O
including	O	O	O
the	O	O	O
subvariant	O	O	B-T080
of	O	O	O
smouldering	O	O	B-T191
systemic	O	O	I-T191
mastocytosis	O	O	I-T191
,	O	O	O
is	O	O	O
a	O	O	O
lifelong	O	O	B-T079
condition	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
reduced	O	O	B-T033
quality	O	O	I-T033
of	O	O	I-T033
life	O	O	I-T033
.	O	O	O

Masitinib	O	O	B-T109
inhibits	O	O	B-T052
KIT	O	O	B-T116
and	O	O	O
LYN	O	O	B-T116
kinases	O	O	I-T116
that	O	O	O
are	O	O	O
involved	O	O	O
in	O	O	O
indolent	O	O	B-T047
systemic	O	O	I-T047
mastocytosis	O	O	I-T047
pathogenesis	O	O	B-T046
.	O	O	O

We	O	O	O
aimed	O	O	O
to	O	O	O
assess	O	O	O
safety	O	O	B-T062
and	O	O	O
efficacy	O	O	B-T062
of	O	O	O
masitinib	O	O	B-T109
versus	O	O	O
placebo	O	O	B-T122
in	O	O	O
severely	O	O	B-T033
symptomatic	O	O	B-T169
patients	O	O	B-T101
who	O	O	O
were	O	O	O
unresponsive	O	O	B-T169
to	O	O	O
optimal	O	O	B-T080
symptomatic	O	O	O
treatments	O	O	B-T061
.	O	O	O

In	O	O	O
this	O	O	O
randomised	O	O	B-T062
,	O	O	O
double-blind	O	O	B-T062
,	O	O	O
placebo-controlled	O	O	B-T062
,	O	O	O
phase	O	O	B-T062
3	O	O	I-T062
study	O	O	I-T062
,	O	O	O
we	O	O	O
enrolled	O	O	O
adults	O	O	B-T100
(	O	O	O
aged	O	O	B-T032
18	O	O	O
-	O	O	O
75	O	O	O
years	O	O	O
)	O	O	O
with	O	O	O
indolent	O	O	B-T047
or	O	O	O
smouldering	O	O	B-T191
systemic	O	O	I-T191
mastocytosis	O	O	B-T047
,	O	O	O
according	O	O	O
to	O	O	O
WHO	O	O	B-T093
classification	O	O	B-T185
or	O	O	O
documented	O	O	B-T170
mastocytosis	O	O	O
based	O	O	O
on	O	O	O
histological	O	O	B-T201
criteria	O	O	I-T201
,	O	O	O
at	O	O	O
50	O	O	O
centres	O	O	O
in	O	O	O
15	O	O	O
countries	O	O	B-T083
.	O	O	O

We	O	O	O
excluded	O	O	O
patients	O	O	B-T101
with	O	O	O
cutaneous	O	O	B-T082
or	O	O	O
non-severe	O	O	O
systemic	O	O	B-T047
mastocytosis	O	O	I-T047
after	O	O	O
a	O	O	O
protocol	O	O	B-T170
amendment	O	O	I-T170
.	O	O	O

Patients	O	O	B-T101
were	O	O	O
centrally	O	O	O
randomised	O	O	B-T062
(	O	O	O
1:1	O	O	O
)	O	O	O
to	O	O	O
receive	O	O	O
either	O	O	O
oral	O	O	B-T169
masitinib	O	O	B-T109
(	O	O	O
6	O	O	O
mg/kg	O	O	O
per	O	O	O
day	O	O	O
over	O	O	O
24	O	O	O
weeks	O	O	O
with	O	O	O
possible	O	O	O
extension	O	O	O
)	O	O	O
or	O	O	O
matched	O	O	O
placebo	O	O	B-T122
with	O	O	O
minimisation	O	O	O
according	O	O	O
to	O	O	O
severe	O	O	B-T033
symptoms	O	O	I-T033
.	O	O	O

The	O	O	O
primary	O	O	B-T130
endpoint	O	O	I-T130
was	O	O	O
cumulative	O	O	O
response	O	O	B-T201
(	O	O	O
â¥75	O	O	O
%	O	O	O
improvement	O	O	B-T077
from	O	O	O
baseline	O	O	B-T081
within	O	O	O
weeks	O	O	O
8	O	O	O
-	O	O	O
24	O	O	O
)	O	O	O
in	O	O	O
at	O	O	O
least	O	O	O
one	O	O	O
severe	O	O	B-T033
baseline	O	O	I-T033
symptom	O	O	I-T033
from	O	O	O
the	O	O	O
following	O	O	O
:	O	O	O
pruritus	O	O	B-T184
score	O	O	B-T081
of	O	O	O
9	O	O	O
or	O	O	O
more	O	O	O
,	O	O	O
eight	O	O	O
or	O	O	O
more	O	O	O
flushes	O	O	O
per	O	O	O
week	O	O	O
,	O	O	O
Hamilton	O	O	B-T170
Rating	O	O	I-T170
Scale	O	O	I-T170
for	O	O	I-T170
Depression	O	O	I-T170
of	O	O	O
19	O	O	O
or	O	O	O
more	O	O	O
,	O	O	O
or	O	O	O
Fatigue	O	O	B-T170
Impact	O	O	I-T170
Scale	O	O	I-T170
of	O	O	O
75	O	O	O
or	O	O	O
more	O	O	O
.	O	O	O

We	O	O	O
assessed	O	O	O
treatment	O	O	B-T061
effect	O	O	I-T080
using	O	O	O
repeated	O	O	O
measures	O	O	O
methodology	O	O	B-T062
for	O	O	O
rare	O	O	B-T047
diseases	O	O	I-T047
via	O	O	O
the	O	O	O
generalised	O	O	B-T170
estimating	O	O	I-T170
equation	O	O	I-T170
model	O	O	I-T170
in	O	O	O
a	O	O	O
modified	O	O	O
intention-to-treat	O	O	B-T062
population	O	O	B-T098
,	O	O	O
including	O	O	O
all	O	O	O
participants	O	O	B-T098
assigned	O	O	O
to	O	O	O
treatment	O	O	O
minus	O	O	O
those	O	O	O
who	O	O	O
withdrew	O	O	O
due	O	O	O
to	O	O	O
a	O	O	O
non-treatment-related	O	O	B-T033
cause	O	O	I-T033
.	O	O	O

We	O	O	O
assessed	O	O	O
safety	O	O	B-T062
in	O	O	O
all	O	O	O
patients	O	O	B-T101
who	O	O	O
received	O	O	O
at	O	O	O
least	O	O	O
one	O	O	O
dose	O	O	B-T081
of	O	O	O
study	O	O	B-T062
drug	O	O	I-T062
.	O	O	O

This	O	O	O
trial	O	O	B-T062
is	O	O	O
registered	O	O	O
with	O	O	O
ClinicalTrials.gov	O	O	B-T062
,	O	O	I-T062
number	O	O	I-T062
NCT00814073	O	O	I-T062
.	O	O	O

Between	O	O	O
Feb	O	O	B-T080
19	O	O	O
,	O	O	O
2009	O	O	O
,	O	O	O
and	O	O	O
July	O	O	B-T080
15	O	O	O
,	O	O	O
2015	O	O	O
,	O	O	O
135	O	O	O
patients	O	O	B-T101
were	O	O	O
randomly	O	O	B-UnknownType
assigned	O	O	I-UnknownType
to	O	O	O
masitinib	O	O	B-T109
(	O	O	O
n=71	O	O	O
)	O	O	O
or	O	O	O
placebo	O	O	B-T122
(	O	O	O
n=64	O	O	O
)	O	O	O
.	O	O	O

By	O	O	O
24	O	O	O
weeks	O	O	B-T079
,	O	O	O
masitinib	O	O	B-T109
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
a	O	O	O
cumulative	O	O	O
response	O	O	B-T201
of	O	O	O
18Â·7	O	O	O
%	O	O	O
in	O	O	O
the	O	O	O
primary	O	O	B-T130
endpoint	O	O	I-T130
(	O	O	O
122Â·6	O	O	O
responses	O	O	B-T201
of	O	O	O
656Â·5	O	O	O
possible	O	O	O
responses	O	O	O
[	O	O	O
weighted	O	O	B-T080
generalised	O	O	I-T080
estimating	O	O	I-T080
equation	O	O	I-T080
]	O	O	O
)	O	O	O
compared	O	O	O
with	O	O	O
7Â·4	O	O	O
%	O	O	O
for	O	O	O
placebo	O	O	B-T122
(	O	O	O
48Â·9	O	O	O
of	O	O	O
656Â·5	O	O	O
;	O	O	O
difference	O	O	O
11Â·3	O	O	O
%	O	O	O
;	O	O	O
odds	O	O	B-T081
ratio	O	O	I-T081
3Â·6	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
1Â·2	O	O	O
-	O	O	O
10Â·8	O	O	O
;	O	O	O
p=0Â·0076	O	O	O
)	O	O	O
.	O	O	O

Frequent	O	O	B-T079
severe	O	O	B-T033
adverse	O	O	I-T033
events	O	O	I-T033
(	O	O	O
>	O	O	O
4	O	O	O
%	O	O	O
difference	O	O	O
from	O	O	O
placebo	O	O	B-T122
)	O	O	O
were	O	O	O
diarrhoea	O	O	B-T184
(	O	O	O
eight	O	O	O
[	O	O	O
11	O	O	O
%	O	O	O
]	O	O	O
of	O	O	O
70	O	O	O
in	O	O	O
the	O	O	O
masitinib	O	O	B-T109
group	O	O	B-T078
vs	O	O	O
one	O	O	O
[	O	O	O
2	O	O	O
%	O	O	O
]	O	O	O
of	O	O	O
63	O	O	O
in	O	O	O
the	O	O	O
placebo	O	O	O
group	O	O	O
)	O	O	O
,	O	O	O
rash	O	O	O
(	O	O	O
four	O	O	O
[	O	O	O
6	O	O	O
%	O	O	O
]	O	O	O
vs	O	O	O
none	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
asthenia	O	O	B-T184
(	O	O	O
four	O	O	O
[	O	O	O
6	O	O	O
%	O	O	O
]	O	O	O
vs	O	O	O
one	O	O	O
[	O	O	O
2	O	O	O
%	O	O	O
]	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
most	O	O	O
frequent	O	O	B-T079
serious	O	O	B-T033
adverse	O	O	I-T033
events	O	O	I-T033
were	O	O	O
diarrhoea	O	O	B-T184
(	O	O	O
three	O	O	O
patients	O	O	B-T101
[	O	O	O
4	O	O	O
%	O	O	O
]	O	O	O
vs	O	O	O
one	O	O	O
[	O	O	O
2	O	O	O
%	O	O	O
]	O	O	O
)	O	O	O
and	O	O	O
urticaria	O	O	B-T047
(	O	O	O
two	O	O	O
[	O	O	O
3	O	O	O
%	O	O	O
]	O	O	O
vs	O	O	O
none	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
no	O	O	O
life-threatening	O	O	B-T033
toxicities	O	O	B-T037
occurred	O	O	O
.	O	O	O

One	O	O	O
patient	O	O	B-T101
in	O	O	O
the	O	O	O
placebo	O	O	B-T122
group	O	O	B-T078
died	O	O	B-T033
(	O	O	O
unrelated	O	O	B-T080
to	O	O	O
study	O	O	B-T062
treatment	O	O	I-T062
)	O	O	O
.	O	O	O

These	O	O	O
study	O	O	B-T033
findings	O	O	I-T033
indicate	O	O	O
that	O	O	O
masitinib	O	O	B-T109
is	O	O	O
an	O	O	O
effective	O	O	B-T080
and	O	O	O
well	O	O	O
tolerated	O	O	B-T121
agent	O	O	I-T121
for	O	O	O
the	O	O	O
treatment	O	O	B-T061
of	O	O	O
severely	O	O	B-T033
symptomatic	O	O	I-T033
indolent	O	O	B-T047
or	O	O	O
smouldering	O	O	B-T191
systemic	O	O	I-T191
mastocytosis	O	O	I-T191
.	O	O	O

AB	O	O	O
Science	O	O	O
(	O	O	O
Paris	O	O	O
,	O	O	O
France	O	O	O
)	O	O	O
.	O	O	O

-DOCSTART- (28069303)

Attributable	O	O	B-T080
risk	O	O	I-T080
of	O	O	O
ambient	O	O	B-T080
PM10	O	O	B-T167
on	O	O	O
daily	O	O	O
mortality	O	O	B-T081
and	O	O	O
years	O	O	B-T081
of	O	O	I-T081
life	O	O	I-T081
lost	O	O	I-T081
in	O	O	O
Chengdu	O	O	B-UnknownType
,	O	O	O
China	O	O	O

Attributable	O	O	B-T080
risk	O	O	I-T080
is	O	O	O
an	O	O	O
important	O	O	O
indicator	O	O	O
for	O	O	O
planning	O	O	B-T058
and	O	O	O
evaluating	O	O	B-T058
public	O	O	I-T058
health	O	O	I-T058
interventions	O	O	I-T058
.	O	O	O

However	O	O	O
,	O	O	O
most	O	O	O
current	O	O	O
measures	O	O	O
of	O	O	O
the	O	O	O
attributable	O	O	B-T080
risk	O	O	B-T078
of	O	O	O
air	O	O	B-T131
pollutants	O	O	I-T131
have	O	O	O
not	O	O	O
considered	O	O	O
temporal	O	O	B-T079
relationships	O	O	I-T079
between	O	O	O
exposure	O	O	B-T080
and	O	O	O
risk	O	O	O
.	O	O	O

More	O	O	O
importantly	O	O	O
,	O	O	O
limited	O	O	O
information	O	O	O
is	O	O	O
available	O	O	O
regarding	O	O	O
the	O	O	O
attributable	O	O	B-T080
risk	O	O	I-T080
due	O	O	O
to	O	O	O
ambient	O	O	B-T080
air	O	O	B-T131
pollutants	O	O	I-T131
in	O	O	O
basin	O	O	B-UnknownType
regions	O	O	I-UnknownType
like	O	O	O
the	O	O	O
Sichuan	O	O	B-UnknownType
Basin	O	O	I-UnknownType
,	O	O	O
China	O	O	B-T083
.	O	O	O

To	O	O	O
quantify	O	O	O
the	O	O	O
association	O	O	O
between	O	O	O
PM10	O	O	B-T167
and	O	O	O
deaths	O	O	B-T033
in	O	O	O
the	O	O	O
Basin	O	O	B-UnknownType
region	O	O	I-UnknownType
,	O	O	O
we	O	O	O
used	O	O	O
a	O	O	O
measure	O	O	O
proposed	O	O	O
recently	O	O	O
within	O	O	O
the	O	O	O
framework	O	O	O
of	O	O	O
the	O	O	O
distributed	O	O	B-T081
lag	O	O	I-T081
non-linear	O	O	I-T081
model	O	O	I-T081
to	O	O	O
estimate	O	O	O
the	O	O	O
attributable	O	O	B-T080
risk	O	O	I-T080
in	O	O	O
Chengdu	O	O	B-UnknownType
,	O	O	O
China	O	O	B-T083
.	O	O	O

Meanwhile	O	O	O
,	O	O	O
we	O	O	O
examined	O	O	O
the	O	O	O
association	O	O	B-T080
between	O	O	O
PM10	O	O	B-T167
and	O	O	O
years	O	O	B-T081
of	O	O	I-T081
life	O	O	I-T081
lost	O	O	I-T081
(	O	O	O
YLL	O	O	B-T081
)	O	O	O
.	O	O	O

Our	O	O	O
analysis	O	O	B-T062
showed	O	O	O
that	O	O	O
population-attributable	O	O	B-T081
fractions	O	O	I-T081
for	O	O	O
non-accidental	O	O	B-T169
,	O	O	O
respiratory	O	O	B-T169
,	O	O	O
and	O	O	O
cardiovascular	O	O	B-T081
mortality	O	O	I-T081
were	O	O	O
0.569	O	O	O
%	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
:	O	O	O
-3.474	O	O	O
%	O	O	O
,	O	O	O
4.374	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
0.695	O	O	O
%	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
:	O	O	O
-5.260	O	O	O
%	O	O	O
,	O	O	O
6.457	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
0.631	O	O	O
%	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
:	O	O	O
-6.973	O	O	O
%	O	O	O
,	O	O	O
7.390	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

On	O	O	O
average	O	O	O
,	O	O	O
a	O	O	O
1Î¼g/m(3	O	O	O
)	O	O	O
increase	O	O	O
in	O	O	O
PM10	O	O	B-T167
was	O	O	O
associated	O	O	O
with	O	O	O
cumulative	O	O	B-T169
increases	O	O	I-T169
of	O	O	O
0.26893	O	O	O
,	O	O	O
0.30437	O	O	O
,	O	O	O
and	O	O	O
0.21924	O	O	O
YLL	O	O	B-T081
for	O	O	O
non-accidental	O	O	B-T169
,	O	O	O
respiratory	O	O	B-T169
,	O	O	O
and	O	O	O
cardiovascular	O	O	B-T081
mortality	O	O	I-T081
,	O	O	O
respectively	O	O	O
,	O	O	O
referring	O	O	O
to	O	O	O
20Î¼g/m(3	O	O	O
)	O	O	O
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
we	O	O	O
found	O	O	O
an	O	O	O
inverse	O	O	B-T082
U-shaped	O	O	I-T082
pattern	O	O	I-T082
for	O	O	O
the	O	O	O
cumulative	O	O	B-T078
risk	O	O	I-T078
with	O	O	O
350Î¼g/m(3	O	O	O
)	O	O	O
as	O	O	O
the	O	O	O
reverse	O	O	O
point	O	O	O
.	O	O	O

With	O	O	O
a	O	O	O
1Î¼g/m(3	O	O	O
)	O	O	O
increase	O	O	O
in	O	O	O
PM10	O	O	B-T167
,	O	O	O
YLL	O	O	B-T081
changed	O	O	O
more	O	O	O
significantly	O	O	O
than	O	O	O
mortality	O	O	B-T081
.	O	O	O

Moreover	O	O	O
,	O	O	O
PM10	O	O	B-T167
demonstrated	O	O	O
remarkable	O	O	O
effects	O	O	B-T080
on	O	O	O
YLL	O	O	B-T081
among	O	O	O
men	O	O	B-T098
and	O	O	O
the	O	O	O
elderly	O	O	B-T098
.	O	O	O

-DOCSTART- (28071754)

Far-infrared	O	O	B-T070
protects	O	O	B-T033
vascular	O	O	B-T025
endothelial	O	O	I-T025
cells	O	O	I-T025
from	O	O	O
advanced	O	O	B-T109
glycation	O	O	I-T109
end	O	O	I-T109
products	O	O	I-T109
-	O	O	O
induced	O	O	B-T169
injury	O	O	B-T037
via	O	O	O
PLZF	O	O	B-T116
-mediated	O	O	O
autophagy	O	O	B-T043
in	O	O	O
diabetic	O	O	O
mice	O	O	O

The	O	O	O
accumulation	O	O	O
of	O	O	O
advanced	O	O	B-T109
glycation	O	O	I-T109
end	O	O	I-T109
products	O	O	I-T109
(	O	O	O
AGEs	O	O	B-T109
)	O	O	O
in	O	O	O
diabetic	O	O	B-T047
patients	O	O	B-T101
induces	O	O	B-T169
vascular	O	O	B-T024
endothelial	O	O	I-T024
injury	O	O	B-T037
.	O	O	O

Promyelocytic	O	O	B-T116
leukemia	O	O	I-T116
zinc	O	O	I-T116
finger	O	O	I-T116
protein	O	O	I-T116
(	O	O	O
PLZF	O	O	B-T116
)	O	O	O
is	O	O	O
a	O	O	O
transcription	O	O	B-T116
factor	O	O	I-T116
that	O	O	O
can	O	O	O
be	O	O	O
activated	O	O	B-T039
by	O	O	O
low-temperature	O	O	B-T070
far-infrared	O	O	B-T070
(	O	O	O
FIR	O	O	B-T070
)	O	O	O
irradiation	O	O	B-T070
to	O	O	O
exert	O	O	B-T038
beneficial	O	O	I-T038
effects	O	O	I-T038
on	O	O	O
the	O	O	O
vascular	O	O	B-T024
endothelium	O	O	I-T024
.	O	O	O

In	O	O	O
the	O	O	O
present	O	O	O
study	O	O	B-T062
,	O	O	O
we	O	O	O
investigated	O	O	B-T169
the	O	O	O
influence	O	O	B-T077
of	O	O	O
FIR	O	O	B-T070
-	O	O	O
induced	O	O	B-T169
PLZF	O	O	B-T116
activation	O	O	B-T039
on	O	O	O
AGE	O	O	B-T109
-	O	O	O
induced	O	O	O
endothelial	O	O	B-T024
injury	O	O	B-T037
both	O	O	B-T080
in	O	O	B-T062
vitro	O	O	I-T062
and	O	O	O
in	O	O	B-T062
vivo	O	O	I-T062
.	O	O	O

FIR	O	O	B-T070
irradiation	O	O	B-T070
inhibited	O	O	B-T080
AGE	O	O	B-T109
-	O	O	O
induced	O	O	B-T169
apoptosis	O	O	B-T043
in	O	O	O
human	O	O	B-T025
umbilical	O	O	I-T025
vein	O	O	I-T025
endothelial	O	O	I-T025
cells	O	O	I-T025
(	O	O	O
HUVECs	O	O	B-T025
)	O	O	O
.	O	O	O

PLZF	O	O	B-T116
activation	O	O	B-T039
increased	O	O	B-T081
the	O	O	O
expression	O	O	B-T045
of	O	O	O
phosphatidylinositol-3	O	O	B-T116
kinases	O	O	B-T116
(	O	O	O
PI3	O	O	B-T116
K	O	O	I-T116
)	O	O	O
,	O	O	O
which	O	O	O
are	O	O	O
important	O	O	B-T080
kinases	O	O	O
in	O	O	O
the	O	O	O
autophagic	O	O	B-T043
signaling	O	O	B-T044
pathway	O	O	I-T044
.	O	O	O

FIR	O	O	B-T070
-	O	O	O
induced	O	O	B-T169
PLZF	O	O	B-T116
activation	O	O	B-T039
led	O	O	O
to	O	O	O
autophagy	O	O	B-T043
in	O	O	O
HUVEC	O	O	B-T025
,	O	O	O
which	O	O	O
was	O	O	O
mediated	O	O	O
through	O	O	B-T169
the	O	O	O
upregulation	O	O	B-T044
of	O	O	O
PI3	O	O	B-T116
K	O	O	I-T116
.	O	O	O

Immunofluorescence	O	O	B-T059
staining	O	O	B-T059
showed	O	O	O
that	O	O	O
AGEs	O	O	B-T109
were	O	O	O
engulfed	O	O	O
by	O	O	O
HUVECs	O	O	B-T025
and	O	O	O
localized	O	O	B-T082
to	O	O	O
lysosomes	O	O	B-T026
.	O	O	O

FIR	O	O	B-T070
-	O	O	O
induced	O	O	B-T169
autophagy	O	O	B-T043
promoted	O	O	B-T052
AGEs	O	O	B-T109
degradation	O	O	B-T169
in	O	O	O
HUVECs	O	O	B-T025
.	O	O	O

In	O	O	O
nicotinamide	O	O	B-T127
/	O	O	O
streptozotocin	O	O	B-T195
-	O	O	O
induced	O	O	B-T169
diabetic	O	O	B-T015
mice	O	O	I-T015
,	O	O	O
FIR	O	O	B-T070
therapy	O	O	B-T061
reduced	O	O	B-T080
serum	O	O	B-T116
AGEs	O	O	B-T109
and	O	O	O
AGEs	O	O	O
deposition	O	O	B-T169
at	O	O	O
the	O	O	O
vascular	O	O	B-T024
endothelium	O	O	I-T024
.	O	O	O

FIR	O	O	B-T070
therapy	O	O	B-T061
also	O	O	O
reduced	O	O	B-T080
diabetes	O	O	B-T047
-	O	O	O
induced	O	O	B-T169
inflammatory	O	O	B-T033
markers	O	O	I-T033
in	O	O	O
the	O	O	O
vascular	O	O	B-T024
endothelium	O	O	I-T024
and	O	O	O
improved	O	O	B-T033
vascular	O	O	B-T024
endothelial	O	O	I-T024
function	O	O	B-T042
.	O	O	O

These	O	O	O
protective	O	O	B-T039
effects	O	O	I-T039
of	O	O	O
FIR	O	O	B-T070
therapy	O	O	B-T061
were	O	O	O
not	O	O	B-T033
found	O	O	I-T033
in	O	O	O
PLZF	O	O	B-T116
-	O	O	O
knockout	O	O	B-T015
mice	O	O	I-T015
.	O	O	O

Our	O	O	O
data	O	O	B-T078
suggest	O	O	B-T078
that	O	O	O
FIR	O	O	B-T070
-	O	O	O
induced	O	O	B-T169
PLZF	O	O	B-T116
activation	O	O	B-T039
in	O	O	O
vascular	O	O	B-T025
endothelial	O	O	I-T025
cells	O	O	I-T025
protects	O	O	O
the	O	O	O
vascular	O	O	B-T024
endothelium	O	O	I-T024
in	O	O	O
diabetic	O	O	B-T015
mice	O	O	I-T015
from	O	O	O
AGE	O	O	B-T109
-	O	O	O
induced	O	O	O
injury	O	O	B-T037
.	O	O	O

-DOCSTART- (28072576)

Ultrasonic	O	O	B-T060
computed	O	O	I-T060
tomography	O	O	I-T060
imaging	O	O	I-T060
of	O	O	O
iron	O	O	O
oxide	O	O	O
nanoparticles	O	O	O

Iron	O	O	B-T130
oxide	O	O	I-T130
nanoparticles	O	O	I-T130
(	O	O	O
IONPs	O	O	B-T130
)	O	O	O
are	O	O	O
becoming	O	O	O
increasingly	O	O	B-T169
used	O	O	O
and	O	O	O
intensively	O	O	B-T169
investigated	O	O	I-T169
in	O	O	O
the	O	O	O
field	O	O	B-T077
of	O	O	O
medical	O	O	B-T060
imaging	O	O	I-T060
.	O	O	O

They	O	O	O
are	O	O	O
currently	O	O	B-T079
FDA	O	O	B-T093
approved	O	O	B-T080
for	O	O	O
magnetic	O	O	B-T060
resonance	O	O	I-T060
imaging	O	O	I-T060
(	O	O	O
MRI	O	O	B-T060
)	O	O	O
,	O	O	O
and	O	O	O
it	O	O	O
would	O	O	O
be	O	O	O
highly	O	O	B-T080
desirable	O	O	O
to	O	O	O
visualize	O	O	B-T169
them	O	O	O
by	O	O	O
ultrasound	O	O	B-T070
as	O	O	O
well	O	O	O
.	O	O	O

Previous	O	O	B-T079
reports	O	O	B-T170
using	O	O	O
the	O	O	O
conventional	O	O	B-T080
ultrasound	O	O	B-T060
B-scan	O	O	I-T060
(	O	O	I-T060
pulse-echo	O	O	I-T060
)	O	O	I-T060
imaging	O	O	I-T060
technique	O	O	I-T060
have	O	O	O
shown	O	O	O
very	O	O	O
limited	O	O	B-T169
detectability	O	O	B-T201
of	O	O	O
these	O	O	O
particles	O	O	B-T104
.	O	O	O

The	O	O	O
aim	O	O	B-T078
of	O	O	O
this	O	O	O
study	O	O	B-T062
is	O	O	O
to	O	O	O
explore	O	O	O
the	O	O	O
feasibility	O	O	B-T080
of	O	O	O
imaging	O	O	B-T060
IONPs	O	O	B-T130
using	O	O	O
the	O	O	O
through-transmission	O	O	B-T078
ultrasound	O	O	I-T078
methodology	O	O	I-T078
and	O	O	O
demonstrate	O	O	O
their	O	O	O
detectability	O	O	O
using	O	O	O
ultrasonic	O	O	B-T060
computed	O	O	I-T060
tomography	O	O	I-T060
(	O	O	O
UCT	O	O	B-T060
)	O	O	O
.	O	O	O

Commercially	O	O	O
available	O	O	O
IONPs	O	O	B-T130
were	O	O	O
acoustically	O	O	B-T070
analysed	O	O	B-T062
to	O	O	O
quantify	O	O	B-T081
their	O	O	O
effect	O	O	B-T080
on	O	O	O
the	O	O	O
speed	O	O	B-T081
of	O	O	O
sound	O	O	B-T070
(	O	O	O
SOS	O	O	B-T070
)	O	O	O
and	O	O	O
acoustic	O	O	B-T070
attenuation	O	O	B-T052
as	O	O	O
a	O	O	O
function	O	O	B-T169
of	O	O	O
concentration	O	O	B-T081
.	O	O	O

Next	O	O	O
,	O	O	O
through-transmission	O	O	B-T060
projection	O	O	I-T060
and	O	O	O
UCT	O	O	B-T060
imaging	O	O	I-T060
were	O	O	O
performed	O	O	B-T169
on	O	O	O
a	O	O	O
breast	O	O	B-T170
mimicking	O	O	I-T170
phantom	O	O	I-T170
and	O	O	O
on	O	O	O
an	O	O	O
ex	O	O	B-T050
vivo	O	O	I-T050
tissue	O	O	I-T050
model	O	O	I-T050
,	O	O	O
to	O	O	O
which	O	O	O
IONPs	O	O	B-T130
were	O	O	O
injected	O	O	O
.	O	O	O

Finally	O	O	O
,	O	O	O
an	O	O	O
MRI	O	O	B-T060
scan	O	O	I-T060
was	O	O	O
performed	O	O	B-T169
to	O	O	O
verify	O	O	B-T169
that	O	O	O
the	O	O	O
same	O	O	O
particles	O	O	B-T104
examined	O	O	B-T033
in	O	O	O
the	O	O	O
ultrasound	O	O	B-T070
experiment	O	O	B-T062
can	O	O	O
be	O	O	O
imaged	O	O	B-T170
by	O	O	O
magnetic	O	O	B-T070
resonance	O	O	I-T070
,	O	O	O
using	O	O	O
the	O	O	O
same	O	O	O
clinically	O	O	B-T080
relevant	O	O	I-T080
concentrations	O	O	B-T081
.	O	O	O

The	O	O	O
results	O	O	B-T033
have	O	O	O
shown	O	O	O
a	O	O	O
consistent	O	O	B-T078
concentration	O	O	B-T081
dependent	O	O	B-T169
speed	O	O	B-T081
of	O	O	O
sound	O	O	B-T070
increase	O	O	B-T169
(	O	O	O
1.86	O	O	O
[	O	O	O
Formula	O	O	O
:	O	O	O
see	O	O	O
text	O	O	O
]	O	O	O
rise	O	O	O
per	O	O	O
100	O	O	O
Âµg	O	O	O
Â·	O	O	O
ml(-1	O	O	O
)	O	O	O
IONPs	O	O	B-T130
)	O	O	O
.	O	O	O

Imaging	O	O	B-T060
based	O	O	B-T169
on	O	O	O
this	O	O	O
property	O	O	B-T080
has	O	O	O
shown	O	O	O
a	O	O	O
substantial	O	O	B-T081
contrast-to-noise	O	O	I-T081
ratio	O	O	I-T081
improvement	O	O	B-T077
(	O	O	O
up	O	O	O
to	O	O	O
5	O	O	O
fold	O	O	O
,	O	O	O
p	O	O	O
<	O	O	O
0.01	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
SOS	O	O	B-T070
-related	O	O	O
effect	O	O	B-T080
generated	O	O	O
a	O	O	O
well	O	O	O
discernible	O	O	B-T080
image	O	O	B-T170
contrast	O	O	B-T080
and	O	O	O
allowed	O	O	O
the	O	O	O
detection	O	O	B-T033
of	O	O	O
the	O	O	O
particles	O	O	B-T104
existence	O	O	B-T081
and	O	O	O
location	O	O	B-T082
,	O	O	O
in	O	O	O
both	O	O	B-T080
raster-scan	O	O	B-T060
projection	O	O	I-T060
and	O	O	O
UCT	O	O	B-T060
imaging	O	O	I-T060
.	O	O	O

Conversely	O	O	O
,	O	O	O
no	O	O	O
significant	O	O	B-T078
change	O	O	B-T169
in	O	O	O
the	O	O	O
acoustic	O	O	B-T070
attenuation	O	O	B-T081
coefficient	O	O	I-T081
was	O	O	O
noted	O	O	B-T080
.	O	O	O

Based	O	O	B-T169
on	O	O	O
these	O	O	O
findings	O	O	B-T033
,	O	O	O
it	O	O	O
is	O	O	O
concluded	O	O	B-T078
that	O	O	O
IONPs	O	O	B-T130
can	O	O	O
be	O	O	O
used	O	O	O
as	O	O	O
an	O	O	O
effective	O	O	B-T080
SOS	O	O	B-T070
-	O	O	O
based	O	O	B-T169
contrast	O	O	B-T130
agent	O	O	I-T130
,	O	O	O
potentially	O	O	B-T080
useful	O	O	I-T080
for	O	O	O
ultrasonic	O	O	B-T070
breast	O	O	B-T023
imaging	O	O	B-T060
.	O	O	O

Furthermore	O	O	O
,	O	O	O
the	O	O	O
particle	O	O	B-T104
offers	O	O	O
the	O	O	O
capacity	O	O	B-T081
of	O	O	O
significantly	O	O	B-T052
enhancing	O	O	I-T052
diagnosis	O	O	B-T080
accuracy	O	O	I-T080
using	O	O	O
multimodal	O	O	B-T060
MRI	O	O	B-T060
-	O	O	O
ultrasound	O	O	B-T060
imaging	O	O	I-T060
capabilities	O	O	B-T080
.	O	O	O

-DOCSTART- (28073595)

Genetically	O	O	B-T169
encoded	O	O	B-T052
calcium	O	O	B-T121
indicators	O	O	I-T130
for	O	O	O
studying	O	O	O
long-term	O	O	B-T079
calcium	O	O	O
dynamics	O	O	B-T044
during	O	O	O
apoptosis	O	O	O

Intracellular	O	O	B-T044
calcium	O	O	I-T044
release	O	O	I-T044
is	O	O	O
essential	O	O	B-T080
for	O	O	O
regulating	O	O	B-T043
almost	O	O	O
all	O	O	O
cellular	O	O	B-T043
functions	O	O	I-T043
.	O	O	O

Specific	O	O	B-T080
spatio-temporal	O	O	B-T062
patterns	O	O	B-T082
of	O	O	O
cytosolic	O	O	B-T026
calcium	O	O	B-T121
elevations	O	O	B-T080
are	O	O	O
critical	O	O	B-T080
determinants	O	O	B-T169
of	O	O	O
cell	O	O	B-T043
fate	O	O	I-T043
in	O	O	O
response	O	O	O
to	O	O	O
pro-apoptotic	O	O	B-T080
cellular	O	O	B-T025
stressors	O	O	B-T078
.	O	O	O

As	O	O	O
the	O	O	O
apoptotic	O	O	B-T043
program	O	O	I-T043
can	O	O	O
take	O	O	O
hours	O	O	B-T079
or	O	O	O
days	O	O	B-T079
,	O	O	O
measurement	O	O	B-T169
of	O	O	O
long-term	O	O	B-T079
calcium	O	O	B-T121
dynamics	O	O	B-T044
are	O	O	O
essential	O	O	B-T080
for	O	O	O
understanding	O	O	B-T041
the	O	O	O
mechanistic	O	O	B-T169
role	O	O	B-T077
of	O	O	O
calcium	O	O	O
in	O	O	O
apoptotic	O	O	B-T043
cell	O	O	I-T043
death	O	O	I-T043
.	O	O	O

Due	O	O	O
to	O	O	O
the	O	O	O
technical	O	O	B-T169
limitations	O	O	B-T169
of	O	O	O
using	O	O	O
calcium	O	O	B-T121
-	O	O	O
sensitive	O	O	B-T169
dyes	O	O	B-T130
to	O	O	O
measure	O	O	B-T081
cytosolic	O	O	B-T026
calcium	O	O	O
little	O	O	O
is	O	O	O
known	O	O	O
about	O	O	O
long-term	O	O	B-T079
calcium	O	O	O
dynamics	O	O	B-T044
in	O	O	O
living	O	O	B-T025
cells	O	O	I-T025
after	O	O	O
treatment	O	O	B-T061
with	O	O	O
apoptosis	O	O	B-T043
-	O	O	O
inducing	O	O	B-T169
drugs	O	O	B-T121
.	O	O	O

Genetically	O	O	B-T169
encoded	O	O	B-T052
calcium	O	O	B-T121
indicators	O	O	I-T130
could	O	O	O
potentially	O	O	O
overcome	O	O	B-T052
some	O	O	O
of	O	O	O
the	O	O	O
limitations	O	O	B-T169
of	O	O	O
calcium	O	O	O
-	O	O	O
sensitive	O	O	B-T169
dyes	O	O	B-T130
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
compared	O	O	O
the	O	O	O
performance	O	O	B-T052
of	O	O	O
the	O	O	O
genetically	O	O	B-T169
encoded	O	O	B-T052
calcium	O	O	B-T121
indicators	O	O	B-T130
GCaMP6s	O	O	B-T130
and	O	O	O
GCaMP6f	O	O	B-T130
with	O	O	O
the	O	O	O
ratiometric	O	O	B-T130
dye	O	O	I-T130
Fura-2	O	O	B-T109
.	O	O	O

GCaMP6s	O	O	B-T130
performed	O	O	O
as	O	O	O
well	O	O	O
or	O	O	O
better	O	O	O
than	O	O	O
Fura-2	O	O	B-T109
in	O	O	O
detecting	O	O	O
agonist	O	O	B-T121
-	O	O	O
induced	O	O	B-T169
calcium	O	O	B-T121
transients	O	O	B-T079
.	O	O	O

We	O	O	O
then	O	O	O
examined	O	O	O
the	O	O	O
utility	O	O	B-T169
of	O	O	O
GCaMP6s	O	O	B-T130
for	O	O	O
continuously	O	O	B-T078
measuring	O	O	B-T080
apoptotic	O	O	B-T080
calcium	O	O	B-T059
release	O	O	I-T059
over	O	O	O
the	O	O	O
course	O	O	B-T079
of	O	O	O
ten	O	O	O
hours	O	O	B-T079
after	O	O	O
treatment	O	O	B-T061
with	O	O	O
staurosporine	O	O	B-T109
.	O	O	O

We	O	O	O
found	O	O	O
that	O	O	O
GCaMP6s	O	O	B-T130
was	O	O	O
suitable	O	O	O
for	O	O	O
measuring	O	O	B-T080
apoptotic	O	O	B-T080
calcium	O	O	B-T059
release	O	O	I-T059
over	O	O	O
long	O	O	O
time	O	O	O
courses	O	O	B-T079
and	O	O	O
revealed	O	O	O
significant	O	O	B-T078
heterogeneity	O	O	B-T080
in	O	O	O
calcium	O	O	O
release	O	O	O
dynamics	O	O	B-T044
in	O	O	O
individual	O	O	O
cells	O	O	B-T025
challenged	O	O	O
with	O	O	O
staurosporine	O	O	B-T109
.	O	O	O

Our	O	O	O
results	O	O	O
suggest	O	O	O
GCaMP6s	O	O	B-T130
is	O	O	O
an	O	O	O
excellent	O	O	B-T080
indicator	O	O	B-T130
for	O	O	O
monitoring	O	O	B-T058
long-term	O	O	B-T079
changes	O	O	B-T169
cytosolic	O	O	B-T026
calcium	O	O	B-T121
during	O	O	O
apoptosis	O	O	B-T043
.	O	O	O

-DOCSTART- (28075235)

Staphylococcus	O	O	B-T007
pseudintermedius	O	O	I-T007
Human	O	O	B-T016
Infection	O	O	B-T046
Cases	O	O	B-T169
in	O	O	O
Spain	O	O	B-T083
:	O	O	O
Dog	O	O	B-T015
-to-	O	O	O
Human	O	O	O
Transmission	O	O	O

Staphylococcus	O	O	B-T007
pseudintermedius	O	O	I-T007
is	O	O	O
an	O	O	O
opportunistic	O	O	B-T001
pathogen	O	O	I-T001
that	O	O	O
has	O	O	O
been	O	O	O
identified	O	O	B-T080
as	O	O	O
infectious	O	O	B-T001
agent	O	O	I-T001
or	O	O	O
colonizer	O	O	B-T033
mainly	O	O	O
in	O	O	O
dogs	O	O	B-T015
.	O	O	O

S.	O	O	B-T007
pseudintermedius	O	O	I-T007
has	O	O	O
been	O	O	O
also	O	O	O
detected	O	O	B-T033
in	O	O	O
humans	O	O	B-T016
and	O	O	O
more	O	O	O
specifically	O	O	O
in	O	O	O
people	O	O	B-T098
in	O	O	O
contact	O	O	B-T169
with	O	O	I-T169
dogs	O	O	B-T015
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
the	O	O	O
possible	O	O	B-T033
S.	O	O	B-T007
pseudintermedius	O	O	I-T007
pet	O	O	B-T008
-to-	O	O	O
human	O	O	B-T016
transmission	O	O	B-T046
was	O	O	O
analyzed	O	O	B-T062
in	O	O	O
four	O	O	O
clinical	O	O	B-T080
human	O	O	O
cases	O	O	B-T169
.	O	O	O

Two	O	O	O
patients	O	O	B-T101
were	O	O	O
dog	O	O	B-T015
owners	O	O	B-T098
and	O	O	O
S.	O	O	B-T007
pseudintermedius	O	O	I-T007
was	O	O	O
also	O	O	O
detected	O	O	B-T033
as	O	O	O
colonizer	O	O	B-T033
in	O	O	O
these	O	O	O
healthy	O	O	B-T080
animals	O	O	B-T008
.	O	O	O

S.	O	O	B-T007
pseudintermedius	O	O	I-T007
isolates	O	O	B-T123
from	O	O	O
patients	O	O	B-T101
and	O	O	O
dogs	O	O	B-T015
of	O	O	O
the	O	O	O
same	O	O	O
household	O	O	B-T099
showed	O	O	O
identical	O	O	B-T080
pulsed-field	O	O	B-T059
gel	O	O	I-T059
electrophoresis	O	O	I-T059
patterns	O	O	B-T082
,	O	O	O
sequence	O	O	B-T033
types	O	O	I-T033
(	O	O	O
STs	O	O	B-T033
)	O	O	O
,	O	O	O
and	O	O	O
antimicrobial	O	O	B-T201
resistance	O	O	I-T201
phenotypes	O	O	B-T032
and	O	O	I-T032
genotypes	O	O	I-T032
,	O	O	O
and	O	O	O
were	O	O	O
methicillin	O	O	B-T032
susceptible	O	O	I-T032
.	O	O	O

Resistance	O	O	B-T169
to	O	O	O
erythromycin	O	O	B-T195
,	O	O	O
clindamycin	O	O	B-T195
,	O	O	O
tetracycline	O	O	B-T195
,	O	O	O
trimetoprim-sulfamethoxazole	O	O	B-T121
,	O	O	O
and/or	O	O	O
ciprofloxacin	O	O	B-T109
was	O	O	O
identified	O	O	B-T080
among	O	O	O
S.	O	O	B-T007
pseudintermedius	O	O	I-T007
strains	O	O	B-T001
.	O	O	O

The	O	O	O
lineages	O	O	B-T077
ST241	O	O	B-T033
and	O	O	O
the	O	O	O
new	O	O	O
ST521	O	O	B-T033
were	O	O	O
detected	O	O	B-T033
in	O	O	O
the	O	O	O
strains	O	O	B-T001
of	O	O	O
the	O	O	O
two	O	O	O
dog	O	O	B-T015
-	O	O	O
owner	O	O	B-T098
patients	O	O	B-T101
,	O	O	O
respectively	O	O	O
.	O	O	O

The	O	O	O
strains	O	O	B-T001
from	O	O	O
the	O	O	O
other	O	O	B-T080
two	O	O	O
patients	O	O	B-T101
presented	O	O	B-T078
two	O	O	O
new	O	O	O
STs	O	O	B-T033
,	O	O	O
ST719	O	O	B-T033
and	O	O	O
ST720	O	O	B-T033
.	O	O	O

To	O	O	O
our	O	O	O
knowledge	O	O	B-T170
,	O	O	O
this	O	O	O
is	O	O	O
the	O	O	O
first	O	O	O
description	O	O	B-T170
of	O	O	O
human	O	O	B-T016
infections	O	O	B-T046
caused	O	O	O
by	O	O	O
S.	O	O	B-T007
pseudintermedius	O	O	I-T007
in	O	O	O
Spain	O	O	B-T083
.	O	O	O

-DOCSTART- (28075514)

TANGO	O	O	B-T170
-	O	O	O
a	O	O	O
screening	O	O	B-T058
tool	O	O	I-T058
to	O	O	O
identify	O	O	O
comorbidities	O	O	B-T078
on	O	O	O
the	O	O	O
causal	O	O	B-T170
pathway	O	O	I-T170
of	O	O	O
nocturia	O	O	O

To	O	O	O
develop	O	O	O
a	O	O	O
robust	O	O	B-T058
screening	O	O	I-T058
metric	O	O	I-T058
for	O	O	O
use	O	O	O
in	O	O	O
identifying	O	O	O
non-lower	O	O	O
urinary	O	O	B-T023
tract	O	O	I-T023
comorbidities	O	O	B-T078
pertinent	O	O	O
to	O	O	O
the	O	O	O
multidisciplinary	O	O	B-T060
assessment	O	O	I-T060
of	O	O	O
patients	O	O	B-T101
with	O	O	O
nocturia	O	O	B-T047
.	O	O	O

Variables	O	O	B-T080
having	O	O	O
a	O	O	O
significant	O	O	O
risk	O	O	O
association	O	O	B-T080
with	O	O	I-T080
nocturia	O	O	B-T047
of	O	O	O
greater	O	O	O
than	O	O	O
once	O	O	O
per	O	O	O
night	O	O	B-T079
were	O	O	O
identified	O	O	O
.	O	O	O

Discriminating	O	O	B-T080
items	O	O	O
from	O	O	O
validated	O	O	O
and	O	O	O
reliable	O	O	O
tools	O	O	B-T058
measuring	O	O	O
these	O	O	O
comorbidities	O	O	B-T078
were	O	O	O
identified	O	O	O
.	O	O	O

A	O	O	O
self-completed	O	O	O
57-item	O	O	O
questionnaire	O	O	B-T170
was	O	O	O
developed	O	O	O
and	O	O	O
a	O	O	O
medical	O	O	B-T169
checklist	O	O	B-T170
and	O	O	O
pertinent	O	O	O
clinical	O	O	B-T033
measures	O	O	I-T033
added	O	O	O
.	O	O	O

Pre-determined	O	O	O
criteria	O	O	O
were	O	O	O
applied	O	O	O
to	O	O	O
retain	O	O	O
or	O	O	O
remove	O	O	O
items	O	O	O
in	O	O	O
the	O	O	O
development	O	O	O
of	O	O	O
the	O	O	O
Short-Form	O	O	B-T170
(	O	O	O
SF	O	O	B-T170
)	O	O	O
screening	O	O	B-T058
tool	O	O	I-T058
.	O	O	O

The	O	O	O
tool	O	O	B-T058
was	O	O	O
administered	O	O	O
to	O	O	O
252	O	O	O
individuals	O	O	B-T098
with	O	O	O
nocturia	O	O	B-T047
who	O	O	O
were	O	O	O
attending	O	O	O
either	O	O	O
a	O	O	O
tertiary	O	O	O
level	O	O	O
Sleep	O	O	B-T040
,	O	O	O
Continence	O	O	B-T061
,	O	O	O
Falls	O	O	B-T033
or	O	O	O
Rehabilitation	O	O	B-T058
service	O	O	I-T058
for	O	O	O
routine	O	O	B-T058
care	O	O	I-T058
.	O	O	O

Data	O	O	B-T033
collected	O	O	I-T033
were	O	O	O
subjected	O	O	O
to	O	O	O
descriptive	O	O	B-T170
analysis	O	O	I-T170
;	O	O	O
criteria	O	O	O
were	O	O	O
applied	O	O	O
to	O	O	O
reduce	O	O	O
the	O	O	O
number	O	O	O
of	O	O	O
items	O	O	O
.	O	O	O

Using	O	O	O
pre-determined	O	O	O
domains	O	O	O
,	O	O	O
a	O	O	O
nocturia	O	O	B-T047
screening	O	O	B-T058
metric	O	O	I-T058
,	O	O	O
entitled	O	O	O
TANGO	O	O	B-T170
,	O	O	O
was	O	O	O
generated	O	O	O
.	O	O	O

The	O	O	O
acronym	O	O	O
TANGO	O	O	B-T170
stands	O	O	O
for	O	O	O
Targeting	O	O	B-T169
the	O	O	O
individual	O	O	B-T169
's	O	O	I-T169
Aetiology	O	O	I-T169
of	O	O	O
Nocturia	O	O	B-T047
to	O	O	O
Guide	O	O	O
Outcomes	O	O	O
.	O	O	O

The	O	O	O
demographic	O	O	B-T102
characteristics	O	O	I-T102
of	O	O	O
the	O	O	O
sample	O	O	O
are	O	O	O
described	O	O	O
,	O	O	O
along	O	O	O
with	O	O	O
item	O	O	O
endorsement	O	O	O
levels	O	O	O
.	O	O	O

The	O	O	O
statistical	O	O	B-T062
and	O	O	O
structural	O	O	B-T073
framework	O	O	I-T073
to	O	O	O
justify	O	O	O
deleting	O	O	O
or	O	O	O
retaining	O	O	O
of	O	O	O
items	O	O	O
from	O	O	O
the	O	O	O
TANGO	O	O	B-T170
Long-Form	O	O	O
to	O	O	O
the	O	O	O
SF	O	O	B-T170
is	O	O	O
presented	O	O	O
.	O	O	O

The	O	O	O
resultant	O	O	O
TANGO	O	O	B-T170
-	O	O	O
SF	O	O	B-T170
patient	O	O	B-T101
-completed	O	O	O
nocturia	O	O	B-T047
screening	O	O	B-T058
tool	O	O	I-T058
is	O	O	O
reported	O	O	O
.	O	O	O

A	O	O	O
novel	O	O	O
all-cause	O	O	O
diagnostic	O	O	B-T169
metric	O	O	O
for	O	O	O
identifying	O	O	O
co-existing	O	O	O
morbidities	O	O	B-T081
of	O	O	O
clinical	O	O	B-T201
relevance	O	O	I-T201
to	O	O	O
nocturia	O	O	B-T047
in	O	O	O
patients	O	O	B-T101
who	O	O	O
present	O	O	O
across	O	O	O
disciplines	O	O	B-T058
and	O	O	O
medical	O	O	B-T091
specialties	O	O	I-T091
has	O	O	O
been	O	O	O
developed	O	O	O
.	O	O	O

TANGO	O	O	B-T170
has	O	O	O
the	O	O	O
potential	O	O	O
to	O	O	O
improve	O	O	O
practice	O	O	O
and	O	O	O
smooth	O	O	B-T080
inequalities	O	O	I-T080
associated	O	O	B-T080
with	O	O	I-T080
a	O	O	O
siloed	O	O	O
approach	O	O	O
to	O	O	O
assessment	O	O	B-T058
and	O	O	O
subsequent	O	O	O
care	O	O	B-T052
of	O	O	O
patients	O	O	B-T101
with	O	O	O
nocturia	O	O	B-T047
.	O	O	O

-DOCSTART- (28077027)

Probabilistic	O	O	B-T081
acute	O	O	B-T079
risk	O	O	B-T058
assessment	O	O	I-T058
of	O	O	O
cumulative	O	O	B-T067
exposure	O	O	I-T067
to	O	O	O
organophosphorus	O	O	B-T109
and	O	O	O
carbamate	O	O	B-T109
pesticides	O	O	I-T109
from	O	O	O
dietary	O	O	B-T168
vegetables	O	O	I-T168
and	O	O	O
fruits	O	O	B-T168
in	O	O	O
Shanghai	O	O	B-UnknownType
populations	O	O	O

Organophosphorus	O	O	B-T109
pesticides	O	O	B-T131
(	O	O	O
OPs	O	O	B-T109
)	O	O	O
and	O	O	O
carbamate	O	O	B-T109
pesticides	O	O	I-T109
(	O	O	O
CPs	O	O	B-T109
)	O	O	O
are	O	O	O
among	O	O	O
the	O	O	O
most	O	O	O
widely	O	O	O
used	O	O	O
pesticides	O	O	O
in	O	O	O
China	O	O	B-T083
,	O	O	O
playing	O	O	O
a	O	O	O
major	O	O	O
role	O	O	O
in	O	O	O
protecting	O	O	B-T033
agricultural	O	O	B-T002
commodities	O	O	I-T002
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	O
,	O	O	O
we	O	O	O
determined	O	O	B-T080
the	O	O	O
cumulative	O	O	B-T067
acute	O	O	I-T067
exposure	O	O	I-T067
to	O	O	O
OPs	O	O	B-T109
and	O	O	O
CPs	O	O	B-T109
of	O	O	O
Shanghai	O	O	B-UnknownType
residents	O	O	B-T098
from	O	O	O
vegetables	O	O	B-T168
and	O	O	O
fruits	O	O	B-T168
(	O	O	O
VFs	O	O	B-T168
)	O	O	O
.	O	O	O

The	O	O	O
food	O	O	B-T052
consumption	O	O	I-T052
data	O	O	B-T078
were	O	O	O
obtained	O	O	B-T169
from	O	O	O
the	O	O	O
Shanghai	O	O	B-T170
Food	O	O	I-T170
Consumption	O	O	I-T170
Survey	O	O	I-T170
(	O	O	O
SHFCS	O	O	B-T170
)	O	O	O
of	O	O	O
2012	O	O	O
-	O	O	O
14	O	O	O
including	O	O	O
a	O	O	O
total	O	O	O
of	O	O	O
1973	O	O	O
participants	O	O	B-T098
aged	O	O	B-T032
2	O	O	O
-	O	O	O
90	O	O	O
years	O	O	B-T079
.	O	O	O

The	O	O	O
pesticide	O	O	B-T131
residue	O	O	I-T131
data	O	O	B-T078
were	O	O	O
obtained	O	O	B-T169
from	O	O	O
the	O	O	O
Shanghai	O	O	B-UnknownType
monitoring	O	O	B-T058
programme	O	O	B-T169
during	O	O	O
2008	O	O	O
-	O	O	O
11	O	O	O
with	O	O	O
34	O	O	O
organophosphates	O	O	B-T109
and	O	O	O
11	O	O	O
carbamates	O	O	B-T109
analysed	O	O	O
in	O	O	O
a	O	O	O
total	O	O	O
of	O	O	O
5335	O	O	O
samples	O	O	B-T167
of	O	O	O
VFs	O	O	B-T168
.	O	O	O

A	O	O	O
probabilistic	O	O	B-T081
approach	O	O	O
was	O	O	O
performed	O	O	B-T169
as	O	O	O
recommended	O	O	B-T078
by	O	O	O
the	O	O	O
EFSA	O	O	B-T170
,	O	O	O
using	O	O	O
the	O	O	O
optimistic	O	O	B-T170
model	O	O	I-T170
with	O	O	O
non-detects	O	O	O
set	O	O	O
as	O	O	O
zero	O	O	B-T081
and	O	O	O
with	O	O	O
processing	O	O	B-T057
factors	O	O	B-T169
(	O	O	O
PFs	O	O	B-T169
)	O	O	O
being	O	O	O
used	O	O	O
and	O	O	O
the	O	O	O
pessimistic	O	O	B-T170
model	O	O	I-T170
with	O	O	O
non-detects	O	O	O
replaced	O	O	B-T169
by	O	O	I-T169
limit	O	O	B-T081
of	O	O	I-T081
detection	O	O	I-T081
(	O	O	O
LOD	O	O	B-T081
)	O	O	O
and	O	O	O
without	O	O	B-T080
PFs	O	O	O
.	O	O	O

We	O	O	O
used	O	O	O
the	O	O	O
relative	O	O	B-T170
potency	O	O	I-T170
factor	O	O	I-T170
(	O	O	I-T170
RPF	O	O	I-T170
)	O	O	I-T170
method	O	O	I-T170
to	O	O	O
normalise	O	O	O
the	O	O	O
various	O	O	O
pesticides	O	O	B-T131
to	O	O	O
the	O	O	O
index	O	O	B-T103
compound	O	O	I-T103
(	O	O	O
IC	O	O	B-T103
)	O	O	O
of	O	O	O
methamidophos	O	O	B-T109
and	O	O	O
chlorpyrifos	O	O	B-T109
separately	O	O	B-T080
.	O	O	O

Only	O	O	O
in	O	O	O
the	O	O	O
pessimistic	O	O	B-T170
model	O	O	I-T170
using	O	O	O
methamidophos	O	O	B-T109
as	O	O	O
the	O	O	O
IC	O	O	B-T103
was	O	O	O
there	O	O	O
was	O	O	O
small	O	O	O
risk	O	O	B-T078
of	O	O	O
exposure	O	O	B-T080
exceeding	O	O	O
the	O	O	O
ARfD	O	O	B-T081
(	O	O	O
3	O	O	O
Âµg	O	O	O
kg(-)(1	O	O	O
)	O	O	O
bw	O	O	O
day	O	O	B-T079
(-)(1	O	O	O
)	O	O	O
)	O	O	O
in	O	O	O
the	O	O	O
populations	O	O	B-T098
of	O	O	O
preschool	O	O	B-T100
children	O	O	I-T100
(	O	O	O
0.029	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
school-age	O	O	B-T100
children	O	O	I-T100
(	O	O	O
0.022	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
adults	O	O	B-T100
(	O	O	O
0.002	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

There	O	O	O
were	O	O	O
no	O	O	B-T033
risk	O	O	I-T033
of	O	O	O
exposure	O	O	B-T080
exceeding	O	O	O
the	O	O	O
ARfD	O	O	B-T081
of	O	O	O
methamidophos	O	O	B-T109
in	O	O	O
the	O	O	O
optimistic	O	O	B-T033
model	O	O	I-T170
and	O	O	O
of	O	O	O
chlorpyrifos	O	O	B-T109
(	O	O	O
100	O	O	O
Âµg	O	O	O
kg(-)(1	O	O	O
)	O	O	O
bw	O	O	O
day	O	O	B-T079
(-)(1	O	O	O
)	O	O	O
)	O	O	O
in	O	O	O
both	O	O	O
optimistic	O	O	O
and	O	O	O
pessimistic	O	O	B-T170
models	O	O	I-T170
in	O	O	O
all	O	O	O
three	O	O	O
populations	O	O	B-T098
.	O	O	O

Considering	O	O	O
the	O	O	O
Chinese	O	O	B-T033
habits	O	O	I-T033
of	O	O	O
overwhelmingly	O	O	O
eating	O	O	B-T040
processed	O	O	B-T168
food	O	O	I-T168
(	O	O	O
vegetables	O	O	B-T168
being	O	O	O
cooked	O	O	B-T056
,	O	O	O
and	O	O	O
fruits	O	O	B-T168
being	O	O	O
washed	O	O	B-T078
or	O	O	O
peeled	O	O	B-T169
)	O	O	O
,	O	O	O
we	O	O	O
conclude	O	O	O
that	O	O	O
little	O	O	O
acute	O	O	B-T079
risk	O	O	B-T078
was	O	O	O
found	O	O	O
for	O	O	O
the	O	O	O
exposure	O	O	B-T080
to	O	O	I-T080
VF	O	O	B-T168
-	O	O	O
sourced	O	O	B-T033
OPs	O	O	B-T109
and	O	O	O
CPs	O	O	B-T109
in	O	O	O
Shanghai	O	O	B-UnknownType
.	O	O	O

-DOCSTART- (28077155)

MODEM	O	O	B-T062
:	O	O	O
A	O	O	O
comprehensive	O	O	B-T080
approach	O	O	B-T082
to	O	O	O
modelling	O	O	B-T062
outcome	O	O	B-T080
and	O	O	O
costs	O	O	B-T081
impacts	O	O	B-T080
of	O	O	O
interventions	O	O	B-T061
for	O	O	O
dementia	O	O	B-T048
.	O	O	O
Protocol	O	O	B-T170
paper	O	O	O

Protocol	O	O	B-T170
paper	O	O	B-T073
The	O	O	O
MODEM	O	O	B-T062
project	O	O	I-T062
(	O	O	O
A	O	O	O
comprehensive	O	O	B-T080
approach	O	O	B-T082
to	O	O	O
MODelling	O	O	B-T062
outcome	O	O	B-T080
and	O	O	O
costs	O	O	B-T081
impacts	O	O	B-T080
of	O	O	O
interventions	O	O	B-T061
for	O	O	O
DEMentia	O	O	B-T048
)	O	O	O
explores	O	O	O
how	O	O	O
changes	O	O	B-T169
in	O	O	O
arrangements	O	O	O
for	O	O	O
the	O	O	O
future	O	O	B-T079
treatment	O	O	B-T061
and	O	O	O
care	O	O	B-T052
of	O	O	O
people	O	O	B-T098
living	O	O	O
with	O	O	O
dementia	O	O	B-T048
,	O	O	O
and	O	O	O
support	O	O	B-T061
for	O	O	O
family	O	O	B-T099
and	O	O	O
other	O	O	O
unpaid	O	O	B-T033
carers	O	O	B-T097
,	O	O	O
could	O	O	O
result	O	O	B-T169
in	O	O	O
better	O	O	O
outcomes	O	O	B-T080
and	O	O	O
more	O	O	O
efficient	O	O	B-T080
use	O	O	B-T169
of	O	O	I-T169
resources	O	O	B-T078
.	O	O	O

MODEM	O	O	B-T062
starts	O	O	O
with	O	O	O
a	O	O	O
systematic	O	O	B-T169
mapping	O	O	B-T052
of	O	O	O
the	O	O	O
literature	O	O	B-T170
on	O	O	O
effective	O	O	B-T080
and	O	O	O
(	O	O	O
potentially	O	O	O
)	O	O	O
cost	O	O	B-T081
-	O	O	O
effective	O	O	O
interventions	O	O	B-T061
in	O	O	O
dementia	O	O	B-T048
care	O	O	B-T052
.	O	O	O

Those	O	O	O
findings	O	O	B-T169
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
data	O	O	B-T078
from	O	O	O
a	O	O	O
cohort	O	O	B-T098
,	O	O	O
will	O	O	O
then	O	O	O
be	O	O	O
used	O	O	O
to	O	O	O
model	O	O	B-T170
the	O	O	O
quality	O	O	B-T078
of	O	O	I-T078
life	O	O	I-T078
and	O	O	O
cost	O	O	B-T081
impacts	O	O	B-T080
of	O	O	O
making	O	O	O
these	O	O	O
evidence	O	O	B-T078
-based	O	O	O
interventions	O	O	B-T061
more	O	O	O
widely	O	O	O
available	O	O	B-T169
in	O	O	O
England	O	O	B-T083
over	O	O	O
the	O	O	O
period	O	O	B-T079
from	O	O	O
now	O	O	O
to	O	O	O
2040	O	O	O
.	O	O	O

Modelling	O	O	B-T062
will	O	O	O
use	O	O	O
a	O	O	O
suite	O	O	O
of	O	O	O
models	O	O	B-T170
,	O	O	O
combining	O	O	B-T080
microsimulation	O	O	B-UnknownType
and	O	O	O
macrosimulation	O	O	B-UnknownType
methods	O	O	I-UnknownType
,	O	O	O
modelling	O	O	B-T062
the	O	O	O
costs	O	O	B-T081
and	O	O	O
outcomes	O	O	B-T080
of	O	O	O
care	O	O	B-T052
,	O	O	O
both	O	O	O
for	O	O	O
an	O	O	O
individual	O	O	B-T098
over	O	O	O
the	O	O	O
life-course	O	O	B-T079
from	O	O	O
the	O	O	O
point	O	O	O
of	O	O	O
dementia	O	O	B-T048
diagnosis	O	O	I-T048
,	O	O	O
and	O	O	O
for	O	O	O
individuals	O	O	B-T098
and	O	O	O
England	O	O	B-T083
as	O	O	O
a	O	O	O
whole	O	O	B-T081
in	O	O	O
a	O	O	O
particular	O	O	O
year	O	O	O
.	O	O	O

Project	O	O	B-T062
outputs	O	O	O
will	O	O	O
include	O	O	O
an	O	O	O
online	O	O	B-UnknownType
Dementia	O	O	B-T170
Evidence	O	O	I-T170
Toolkit	O	O	I-T170
,	O	O	O
making	O	O	O
evidence	O	O	B-T078
summaries	O	O	B-T170
and	O	O	O
a	O	O	O
literature	O	O	B-T170
database	O	O	B-T170
available	O	O	B-T169
free	O	O	O
to	O	O	O
anyone	O	O	O
,	O	O	O
papers	O	O	B-T073
in	O	O	O
academic	O	O	B-T073
journals	O	O	I-T073
and	O	O	O
other	O	O	O
written	O	O	O
outputs	O	O	O
,	O	O	O
and	O	O	O
a	O	O	O
MODEM	O	O	B-T170
Legacy	O	O	I-T170
Model	O	O	I-T170
,	O	O	O
which	O	O	O
will	O	O	O
enable	O	O	O
local	O	O	B-T097
commissioners	O	O	I-T097
of	O	O	O
services	O	O	B-T057
to	O	O	O
apply	O	O	O
the	O	O	O
model	O	O	B-T170
to	O	O	O
their	O	O	O
own	O	O	O
populations	O	O	B-T098
.	O	O	O

Modelling	O	O	B-T062
the	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
evidence	O	O	B-T078
-based	O	O	O
cost	O	O	B-T081
-	O	O	O
effective	O	O	B-T080
interventions	O	O	B-T061
and	O	O	O
making	O	O	O
this	O	O	O
information	O	O	B-T078
widely	O	O	O
available	O	O	B-T169
has	O	O	O
the	O	O	O
potential	O	O	B-T080
to	O	O	O
improve	O	O	B-T033
the	O	O	O
health	O	O	B-T078
and	O	O	O
quality	O	O	B-T078
of	O	O	I-T078
life	O	O	I-T078
both	O	O	O
of	O	O	O
people	O	O	B-T098
with	O	O	O
dementia	O	O	B-T048
and	O	O	O
their	O	O	O
carers	O	O	B-T097
,	O	O	O
while	O	O	O
ensuring	O	O	O
that	O	O	O
resources	O	O	B-T078
are	O	O	O
used	O	O	O
efficiently	O	O	O
.	O	O	O

-DOCSTART- (28077286)

Assessment	O	O	B-T062
of	O	O	O
neuroanatomical	O	O	B-T080
and	O	O	O
behavioural	O	O	B-UnknownType
effects	O	O	I-UnknownType
of	O	O	O
in	O	O	B-T169
ovo	O	O	I-T169
methylmercury	O	O	B-T109
exposure	O	O	B-T080
in	O	O	O
zebra	O	O	B-T012
finches	O	O	I-T012
(	O	O	O
Taeniopygia	O	O	B-T012
guttata	O	O	I-T012
)	O	O	O

Methylmercury	O	O	B-T109
(	O	O	O
MeHg	O	O	B-T109
)	O	O	O
readily	O	O	O
crosses	O	O	B-T077
the	O	O	O
blood	O	O	B-T023
brain	O	O	I-T023
barrier	O	O	I-T023
and	O	O	O
is	O	O	O
a	O	O	O
known	O	O	B-T080
neuro	O	O	B-T080
-	O	O	O
toxicant	O	O	B-T131
.	O	O	O

MeHg	O	O	B-T109
accumulation	O	O	B-T033
in	O	O	O
the	O	O	O
brain	O	O	B-T023
causes	O	O	B-T169
histopathological	O	O	B-T169
alterations	O	O	B-T169
,	O	O	O
neurobehavioral	O	O	B-T080
changes	O	O	B-T169
,	O	O	O
and	O	O	O
impairments	O	O	B-T169
to	O	O	O
cognitive	O	O	B-T169
motor	O	O	B-T038
functions	O	O	I-T038
in	O	O	O
mammalian	O	O	B-T015
models	O	O	B-T050
.	O	O	O

However	O	O	O
,	O	O	O
in	O	O	O
birds	O	O	B-T012
the	O	O	O
neurotoxic	O	O	B-T037
effects	O	O	I-T037
of	O	O	O
MeHg	O	O	B-T109
on	O	O	O
the	O	O	O
developing	O	O	O
pre	O	O	B-T079
-	O	O	O
hatching	O	O	B-T040
brain	O	O	B-T023
and	O	O	O
consequent	O	O	B-T033
behavioral	O	O	B-T055
alterations	O	O	I-T055
in	O	O	O
adult	O	O	B-T100
birds	O	O	O
have	O	O	O
not	O	O	B-T169
received	O	O	B-T080
much	O	O	O
attention	O	O	B-T041
.	O	O	O

Moreover	O	O	O
,	O	O	O
passerine	O	O	B-T012
birds	O	O	I-T012
are	O	O	O
poorly	O	O	B-T080
represented	O	O	B-T052
in	O	O	O
MeHg	O	O	B-T109
neurotoxicology	O	O	B-T040
studies	O	O	B-T062
in	O	O	O
comparison	O	O	B-T052
to	O	O	O
other	O	O	O
avian	O	O	B-T012
orders	O	O	B-T185
.	O	O	O

Hence	O	O	O
in	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
we	O	O	O
used	O	O	B-T169
the	O	O	O
egg	O	O	B-T168
injection	O	O	B-T170
method	O	O	I-T170
to	O	O	O
investigate	O	O	B-T169
the	O	O	O
long	O	O	B-T067
term	O	O	I-T067
effects	O	O	I-T067
of	O	O	O
in	O	O	B-T169
ovo	O	O	I-T169
MeHg	O	O	B-T109
exposure	O	O	B-T080
on	O	O	O
brain	O	O	B-T023
histopathology	O	O	B-T169
and	O	O	O
courtship	O	O	B-T054
behavior	O	O	I-T054
in	O	O	O
a	O	O	O
model	O	O	B-T050
songbird	O	O	B-T012
species	O	O	B-T185
,	O	O	O
the	O	O	O
zebra	O	O	B-T012
finch	O	O	I-T012
(	O	O	O
Taeniopygia	O	O	B-T012
guttata	O	O	I-T012
)	O	O	O
.	O	O	O

Egg	O	O	B-T168
treatment	O	O	B-T169
groups	O	O	B-UnknownType
included	O	O	B-T169
:	O	O	O
a	O	O	O
low	O	O	B-T080
MeHg	O	O	B-T109
dose	O	O	B-T081
of	O	O	O
0.2Î¼g	O	O	O
Hg	O	O	B-T131
g(-1	O	O	O
)	O	O	O
egg	O	O	B-T168
,	O	O	O
a	O	O	O
high	O	O	B-T080
MeHg	O	O	O
dose	O	O	O
of	O	O	O
3.2Î¼g	O	O	O
Hg	O	O	O
g(-1	O	O	O
)	O	O	O
egg	O	O	O
,	O	O	O
and	O	O	O
a	O	O	O
vehicle	O	O	B-T122
control	O	O	I-T122
(	O	O	O
water	O	O	B-T121
)	O	O	O
.	O	O	O

No	O	O	B-T184
adverse	O	O	I-T184
effects	O	O	I-T184
of	O	O	O
in	O	O	B-T169
ovo	O	O	I-T169
MeHg	O	O	B-T109
treatment	O	O	B-T169
were	O	O	O
detected	O	O	B-T033
on	O	O	O
courtship	O	O	B-T080
song	O	O	I-T080
quality	O	O	I-T080
or	O	O	O
on	O	O	O
mating	O	O	B-T040
behavior	O	O	I-T040
in	O	O	O
experimental	O	O	B-T080
males	O	O	B-T032
at	O	O	O
sexually	O	O	B-T033
maturity	O	O	I-T033
which	O	O	O
would	O	O	O
suggest	O	O	B-T078
that	O	O	O
observable	O	O	B-T201
neurobehavioral	O	O	B-UnknownType
effects	O	O	I-UnknownType
of	O	O	O
MeHg	O	O	O
exposure	O	O	B-T080
may	O	O	O
depend	O	O	O
on	O	O	O
the	O	O	O
timing	O	O	B-T079
of	O	O	O
exposure	O	O	O
during	O	O	B-T079
offspring	O	O	B-T099
development	O	O	B-T039
.	O	O	O

However	O	O	O
,	O	O	O
neuroanatomical	O	O	B-T080
analysis	O	O	B-T062
indicated	O	O	B-T033
an	O	O	O
increase	O	O	B-T169
in	O	O	O
telencephalon	O	O	B-T023
volume	O	O	B-T081
with	O	O	O
increased	O	O	B-T081
MeHg	O	O	B-T109
concentrations	O	O	B-T081
which	O	O	O
may	O	O	O
suggest	O	O	B-T078
a	O	O	O
prolonged	O	O	B-T079
inflammatory	O	O	B-T046
response	O	O	I-T046
in	O	O	O
this	O	O	O
region	O	O	B-T029
of	O	O	I-T029
the	O	O	I-T029
brain	O	O	I-T029
.	O	O	O

-DOCSTART- (28081044)

Evaluation	O	O	B-T058
of	O	O	O
the	O	O	O
Condom	O	O	B-T170
Barriers	O	O	I-T170
Scale	O	O	I-T170
for	O	O	O
Young	O	O	B-T100
Black	O	O	B-T098
Men	O	O	I-T098
Who	O	O	I-T098
Have	O	O	I-T098
Sex	O	O	I-T098
With	O	O	I-T098
Men	O	O	I-T098
:	O	O	O
Reliability	O	O	B-T080
and	O	O	I-T080
Validity	O	O	I-T080
of	O	O	O
3	O	O	O
Subscales	O	O	O

Reliable	O	O	B-T080
and	O	O	O
valid	O	O	B-T080
scale	O	O	B-T170
measures	O	O	B-T081
of	O	O	O
barriers	O	O	B-T061
to	O	O	O
condom	O	O	B-T055
use	O	O	I-T055
are	O	O	O
not	O	O	O
available	O	O	O
for	O	O	O
young	O	O	B-T100
black	O	O	B-T098
men	O	O	I-T098
who	O	O	I-T098
have	O	O	I-T098
sex	O	O	I-T098
with	O	O	I-T098
men	O	O	I-T098
(	O	O	O
YBMSM	O	O	B-T098
)	O	O	O
.	O	O	O

The	O	O	O
purpose	O	O	O
of	O	O	O
this	O	O	O
study	O	O	O
was	O	O	O
to	O	O	O
evaluate	O	O	O
the	O	O	O
Condom	O	O	B-T170
Barriers	O	O	I-T170
Scales	O	O	I-T170
for	O	O	O
application	O	O	O
with	O	O	O
YBMSM	O	O	B-T098
.	O	O	O

A	O	O	O
clinic-based	O	O	B-T080
sample	O	O	B-T077
of	O	O	O
600	O	O	O
YBMSM	O	O	B-T098
completed	O	O	O
a	O	O	O
computer-assisted	O	O	B-T059
self-interview	O	O	B-T052
.	O	O	O

The	O	O	O
primary	O	O	O
measure	O	O	B-T081
was	O	O	O
a	O	O	O
14-item	O	O	O
abbreviated	O	O	B-T170
version	O	O	I-T170
of	O	O	O
the	O	O	O
Condom	O	O	B-T170
Barriers	O	O	I-T170
Scale	O	O	I-T170
.	O	O	O

Reliability	O	O	B-T080
and	O	O	O
criterion	O	O	B-T081
validity	O	O	I-T081
were	O	O	O
assessed	O	O	O
.	O	O	O

All	O	O	O
3	O	O	O
subscales	O	O	B-T170
were	O	O	O
reliable	O	O	B-T080
:	O	O	O
partner	O	O	B-T098
-related	O	O	O
barriers	O	O	B-T061
(	O	O	O
Cronbach	O	O	B-T081
Î±	O	O	I-T081
=	O	O	O
0.73	O	O	O
)	O	O	O
,	O	O	O
sensation	O	O	B-T042
-related	O	O	O
barriers	O	O	O
(	O	O	O
Î±=0.70	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
motivation	O	O	B-T041
-related	O	O	O
barriers	O	O	O
(	O	O	O
Î±	O	O	O
=	O	O	O
0.81	O	O	O
)	O	O	O
.	O	O	O

A	O	O	O
complete	O	O	B-T033
absence	O	O	I-T033
of	O	O	I-T033
barriers	O	O	I-T033
was	O	O	O
common	O	O	O
:	O	O	O
47.0	O	O	O
%	O	O	O
(	O	O	O
partner	O	O	B-T098
-related	O	O	O
)	O	O	O
,	O	O	O
30.7	O	O	O
%	O	O	O
(	O	O	O
sensation	O	O	B-T042
-related	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
46.5	O	O	O
%	O	O	O
(	O	O	O
motivation	O	O	B-T041
-related	O	O	O
)	O	O	O
.	O	O	O

Dichotomized	O	O	O
subscales	O	O	B-T170
were	O	O	O
significantly	O	O	B-T081
associated	O	O	B-T080
with	O	O	I-T080
reporting	O	O	O
any	O	O	O
condomless	O	O	B-T033
insertive	O	O	B-T054
anal	O	O	B-T055
sex	O	O	I-T055
(	O	O	O
all	O	O	O
Ps	O	O	B-T081
<	O	O	O
0.001	O	O	O
)	O	O	O
and	O	O	O
any	O	O	O
condomless	O	O	O
receptive	O	O	B-T042
anal	O	O	O
sex	O	O	O
(	O	O	O
all	O	O	O
Ps	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
subscales	O	O	B-T170
were	O	O	O
significantly	O	O	B-T081
associated	O	O	B-T080
with	O	O	I-T080
these	O	O	O
measures	O	O	B-T081
of	O	O	O
condomless	O	O	B-T033
sex	O	O	B-T040
preserved	O	O	O
at	O	O	O
a	O	O	O
continuous	O	O	B-T078
level	O	O	B-T080
(	O	O	O
all	O	O	O
Ps	O	O	B-T081
<	O	O	O
0.001	O	O	O
,	O	O	O
except	O	O	O
for	O	O	O
sensation	O	O	B-T042
barriers	O	O	B-T061
associated	O	O	O
with	O	O	O
condomless	O	O	O
receptive	O	O	O
anal	O	O	B-T055
sex	O	O	I-T055
=	O	O	O
0.03	O	O	O
)	O	O	O
.	O	O	O

Further	O	O	O
,	O	O	O
the	O	O	O
subscales	O	O	B-T170
were	O	O	O
significantly	O	O	B-T081
associated	O	O	B-T080
with	O	O	I-T080
reporting	O	O	O
any	O	O	O
condom	O	O	B-T055
use	O	O	I-T055
problems	O	O	B-T078
(	O	O	O
all	O	O	O
Ps	O	O	B-T081
<	O	O	O
0.001	O	O	O
)	O	O	O
and	O	O	O
a	O	O	O
measure	O	O	B-T081
of	O	O	O
condomless	O	O	B-T033
oral	O	O	B-T055
sex	O	O	I-T055
(	O	O	O
all	O	O	O
Ps	O	O	O
<	O	O	O
0.001	O	O	O
,	O	O	O
except	O	O	O
for	O	O	O
partner	O	O	B-T098
-related	O	O	O
barriers	O	O	B-T061
=	O	O	O
0.31	O	O	O
)	O	O	O
.	O	O	O

Finally	O	O	O
,	O	O	O
the	O	O	O
sensation	O	O	B-T042
-related	O	O	O
barriers	O	O	B-T061
subscale	O	O	B-T170
was	O	O	O
significantly	O	O	B-T081
associated	O	O	B-T080
with	O	O	I-T080
testing	O	O	O
positive	O	O	B-T033
for	O	O	O
Chlamydia	O	O	B-T007
and/or	O	O	O
gonorrhea	O	O	B-T047
(	O	O	O
P=0.049	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
3	O	O	O
identified	O	O	O
subscales	O	O	B-T170
yielded	O	O	O
adequate	O	O	O
reliability	O	O	B-T080
and	O	O	O
strong	O	O	O
evidence	O	O	O
of	O	O	O
validity	O	O	B-T080
,	O	O	O
thereby	O	O	O
suggesting	O	O	O
the	O	O	O
utility	O	O	O
of	O	O	O
these	O	O	O
brief	O	O	O
measures	O	O	B-T081
for	O	O	O
use	O	O	O
in	O	O	O
observational	O	O	B-T062
and	O	O	O
experimental	O	O	B-T062
research	O	O	I-T062
with	O	O	O
YBMSM	O	O	B-T098
.	O	O	O

-DOCSTART- (28082609)

Variation	O	O	B-T070
in	O	O	O
the	O	O	O
Intensity	O	O	B-T080
of	O	O	O
Selection	O	O	B-T045
on	O	O	O
Codon	O	O	B-T086
Bias	O	O	B-T078
over	O	O	O
Time	O	O	B-T079
Causes	O	O	O
Contrasting	O	O	B-T082
Patterns	O	O	I-T082
of	O	O	O
Base	O	O	B-T081
Composition	O	O	I-T081
Evolution	O	O	B-T045
in	O	O	O
Drosophila	O	O	O

Four-fold	O	O	O
degenerate	O	O	B-T169
coding	O	O	B-T028
sites	O	O	I-T028
form	O	O	O
a	O	O	O
major	O	O	O
component	O	O	O
of	O	O	O
the	O	O	O
genome	O	O	B-T028
,	O	O	O
and	O	O	O
are	O	O	O
often	O	O	O
used	O	O	O
to	O	O	O
make	O	O	O
inferences	O	O	O
about	O	O	O
selection	O	O	B-T045
and	O	O	O
demography	O	O	B-T078
,	O	O	O
so	O	O	O
that	O	O	O
understanding	O	O	O
their	O	O	O
evolution	O	O	B-T045
is	O	O	O
important	O	O	O
.	O	O	O

Despite	O	O	O
previous	O	O	O
efforts	O	O	O
,	O	O	O
many	O	O	O
questions	O	O	O
regarding	O	O	O
the	O	O	O
causes	O	O	O
of	O	O	O
base	O	O	B-T081
composition	O	O	I-T081
changes	O	O	B-T169
at	O	O	O
these	O	O	O
sites	O	O	B-T028
in	O	O	O
Drosophila	O	O	B-T204
remain	O	O	O
unanswered	O	O	O
.	O	O	O

To	O	O	O
shed	O	O	O
further	O	O	O
light	O	O	O
on	O	O	O
this	O	O	O
issue	O	O	B-T033
,	O	O	O
we	O	O	O
obtained	O	O	O
a	O	O	O
new	O	O	O
whole-genome	O	O	B-T170
polymorphism	O	O	I-T170
data	O	O	I-T170
set	O	O	I-T170
from	O	O	O
D.	O	O	B-T204
simulans	O	O	I-T204
.	O	O	O

We	O	O	O
analyzed	O	O	B-T062
samples	O	O	B-T026
from	O	O	O
the	O	O	O
putatively	O	O	O
ancestral	O	O	O
range	O	O	O
of	O	O	O
D.	O	O	B-T204
simulans	O	O	I-T204
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
an	O	O	O
existing	O	O	O
polymorphism	O	O	B-T170
data	O	O	I-T170
set	O	O	I-T170
from	O	O	O
an	O	O	O
African	O	O	O
population	O	O	O
of	O	O	O
D.	O	O	B-T204
melanogaster	O	O	I-T204
.	O	O	O

By	O	O	O
using	O	O	O
D.	O	O	B-T204
yakuba	O	O	I-T204
as	O	O	O
an	O	O	O
outgroup	O	O	B-T098
,	O	O	O
we	O	O	O
found	O	O	O
clear	O	O	O
evidence	O	O	B-T078
for	O	O	O
selection	O	O	B-T045
on	O	O	O
4-fold	O	O	O
sites	O	O	B-T028
along	O	O	O
both	O	O	O
lineages	O	O	B-T078
over	O	O	O
a	O	O	O
substantial	O	O	B-T079
period	O	O	I-T079
,	O	O	O
with	O	O	O
the	O	O	O
intensity	O	O	B-T080
of	O	O	O
selection	O	O	O
increasing	O	O	O
with	O	O	O
GC	O	O	B-T081
content	O	O	I-T081
.	O	O	O

Based	O	O	O
on	O	O	O
an	O	O	O
explicit	O	O	O
model	O	O	B-T075
of	O	O	O
base	O	O	B-T081
composition	O	O	I-T081
evolution	O	O	B-T045
,	O	O	O
we	O	O	O
suggest	O	O	O
that	O	O	O
the	O	O	O
observed	O	O	B-T169
AT-	O	O	O
biased	O	O	B-T078
substitution	O	O	B-T082
pattern	O	O	I-T082
in	O	O	O
both	O	O	O
lineages	O	O	B-T078
is	O	O	O
probably	O	O	O
due	O	O	O
to	O	O	O
an	O	O	O
ancestral	O	O	B-T080
reduction	O	O	I-T080
in	O	O	O
selection	O	O	B-T045
intensity	O	O	B-T080
,	O	O	O
and	O	O	O
is	O	O	O
unlikely	O	O	O
to	O	O	O
be	O	O	O
the	O	O	O
result	O	O	B-T034
of	O	O	O
an	O	O	O
increase	O	O	B-T169
in	O	O	O
mutational	O	O	B-T045
bias	O	O	B-T078
towards	O	O	O
AT	O	O	O
alone	O	O	O
.	O	O	O

By	O	O	O
using	O	O	O
two	O	O	O
polymorphism-based	O	O	B-T060
methods	O	O	I-T060
for	O	O	O
estimating	O	O	B-T081
selection	O	O	B-T045
coefficients	O	O	B-T081
over	O	O	O
different	O	O	O
timescales	O	O	O
,	O	O	O
we	O	O	O
show	O	O	O
that	O	O	O
the	O	O	O
selection	O	O	O
intensity	O	O	B-T080
on	O	O	O
codon	O	O	B-T086
usage	O	O	O
has	O	O	O
been	O	O	O
rather	O	O	O
stable	O	O	B-T080
in	O	O	O
D.	O	O	B-T204
simulans	O	O	I-T204
in	O	O	O
the	O	O	O
recent	O	O	O
past	O	O	O
,	O	O	O
but	O	O	O
the	O	O	O
long-term	O	O	B-T079
estimates	O	O	B-T081
in	O	O	O
D.	O	O	B-T204
melanogaster	O	O	I-T204
are	O	O	O
much	O	O	O
higher	O	O	B-T080
than	O	O	O
the	O	O	O
short-term	O	O	B-T079
ones	O	O	O
,	O	O	O
indicating	O	O	O
a	O	O	O
continuing	O	O	B-T078
decline	O	O	B-T081
in	O	O	O
selection	O	O	O
intensity	O	O	O
,	O	O	O
to	O	O	O
such	O	O	O
an	O	O	O
extent	O	O	B-T082
that	O	O	O
the	O	O	O
short-term	O	O	O
estimates	O	O	O
suggest	O	O	O
that	O	O	O
selection	O	O	O
is	O	O	O
only	O	O	O
active	O	O	B-T169
in	O	O	O
the	O	O	O
most	O	O	O
GC	O	O	B-T081
-rich	O	O	O
parts	O	O	O
of	O	O	O
the	O	O	O
genome	O	O	B-T028
.	O	O	O

Finally	O	O	O
,	O	O	O
we	O	O	O
provide	O	O	O
evidence	O	O	B-T078
for	O	O	O
complex	O	O	B-T080
evolutionary	O	O	B-T082
patterns	O	O	I-T082
in	O	O	O
the	O	O	O
putatively	O	O	O
neutral	O	O	B-T114
short	O	O	I-T114
introns	O	O	I-T114
,	O	O	O
which	O	O	O
can	O	O	O
not	O	O	O
be	O	O	O
explained	O	O	O
by	O	O	O
the	O	O	O
standard	O	O	B-T081
GC	O	O	B-T081
-	O	O	O
biased	O	O	B-T078
gene	O	O	B-T045
conversion	O	O	I-T045
model	O	O	B-T075
.	O	O	O

These	O	O	O
results	O	O	B-T034
reveal	O	O	O
a	O	O	O
dynamic	O	O	B-T169
picture	O	O	O
of	O	O	O
base	O	O	B-T081
composition	O	O	I-T081
evolution	O	O	B-T045
.	O	O	O

-DOCSTART- (28083459)

A	O	O	O
Case	O	O	B-T169
of	O	O	O
Koch	O	O	B-T047
's	O	O	I-T047
Spine	O	O	I-T047
Treated	O	O	B-T169
with	O	O	O
Modified	O	O	B-T169
Transpedicular	O	O	B-T061
Vertebral	O	O	I-T061
Curettage	O	O	I-T061
and	O	O	O
Posterior	O	O	B-T082
Fixation	O	O	B-T061
:	O	O	O
A	O	O	O
Novel	O	O	O
Technique	O	O	O

Tuberculosis	O	O	B-T047
(	O	O	O
TB	O	O	B-T047
)	O	O	O
is	O	O	O
a	O	O	O
chronic	O	O	B-T079
granulomatous	O	O	B-T047
infection	O	O	I-T047
caused	O	O	O
by	O	O	O
acid-fast	O	O	B-T007
mycobacterium	O	O	I-T007
tuberculosis	O	O	I-T007
bacilli	O	O	I-T007
.	O	O	O

Spinal	O	O	B-T029
involvement	O	O	I-T029
occurs	O	O	O
in	O	O	O
less	O	O	O
than	O	O	O
one	O	O	O
percent	O	O	O
of	O	O	O
TB	O	O	B-T047
.	O	O	O

Spinal	O	O	B-T047
TB	O	O	I-T047
(	O	O	O
Pott	O	O	B-T047
's	O	O	I-T047
disease	O	O	I-T047
)	O	O	O
accounts	O	O	O
for	O	O	O
50	O	O	O
%	O	O	O
of	O	O	O
skeletal	O	O	B-UnknownType
TB	O	O	I-UnknownType
.	O	O	O

Though	O	O	O
it	O	O	O
most	O	O	O
commonly	O	O	O
affects	O	O	O
the	O	O	O
thoracolumbar	O	O	B-T030
junction	O	O	I-T030
,	O	O	O
it	O	O	O
can	O	O	O
occur	O	O	O
at	O	O	O
any	O	O	O
level	O	O	B-T080
of	O	O	O
the	O	O	O
spine	O	O	B-T023
.	O	O	O

Early	O	O	O
diagnosis	O	O	B-T033
and	O	O	O
treatment	O	O	B-T061
is	O	O	O
mandatory	O	O	O
in	O	O	O
order	O	O	O
to	O	O	O
avoid	O	O	O
neurological	O	O	B-T046
complications	O	O	I-T046
and	O	O	O
spinal	O	O	B-T190
deformity	O	O	I-T190
.	O	O	O

We	O	O	O
report	O	O	B-T170
a	O	O	O
case	O	O	B-T169
of	O	O	O
a	O	O	O
young	O	O	B-T079
female	O	O	B-T032
with	O	O	O
tuberculosis	O	O	B-T047
of	O	O	O
D12-L1	O	O	B-T030
who	O	O	O
was	O	O	O
treated	O	O	B-T169
with	O	O	O
posterior	O	O	B-T082
decompression	O	O	B-T061
using	O	O	O
a	O	O	O
modified	O	O	B-T169
transpedicular	O	O	B-T061
approach	O	O	I-T061
and	O	O	O
posterior	O	O	O
instrumentation	O	O	B-T061
with	O	O	O
a	O	O	O
successful	O	O	O
outcome	O	O	B-T169
.	O	O	O

-DOCSTART- (28084061)

A	O	O	O
comparison	O	O	B-T052
of	O	O	O
two	O	O	O
comorbidity	O	O	B-T081
indices	O	O	I-T081
for	O	O	O
predicting	O	O	B-T078
inpatient	O	O	B-T101
rehabilitation	O	O	B-T061
outcomes	O	O	O

Comorbid	O	O	B-T033
conditions	O	O	I-T033
are	O	O	O
important	O	O	O
in	O	O	O
health	O	O	B-T058
care	O	O	I-T058
.	O	O	O

The	O	O	O
best	O	O	O
comorbidity	O	O	B-T081
index	O	O	I-T081
for	O	O	O
predicting	O	O	B-T078
the	O	O	O
impact	O	O	B-T080
of	O	O	O
comorbidities	O	O	B-T078
on	O	O	O
rehabilitation	O	O	B-T061
outcomes	O	O	B-T080
has	O	O	O
not	O	O	O
been	O	O	O
determined	O	O	B-T080
.	O	O	O

Compare	O	O	B-T052
the	O	O	O
associations	O	O	B-T080
of	O	O	O
comorbidity	O	O	B-T078
measured	O	O	B-T080
using	O	O	O
the	O	O	O
Charlson	O	O	B-T081
Comorbidity	O	O	I-T081
Index	O	O	I-T081
(	O	O	O
CCI	O	O	B-T081
)	O	O	O
and	O	O	O
the	O	O	O
Cumulative	O	O	B-T081
Index	O	O	I-T081
Rating	O	O	I-T081
Scale	O	O	I-T081
(	O	O	O
CIRS	O	O	B-T081
)	O	O	O
with	O	O	O
key	O	O	O
rehabilitation	O	O	B-T061
outcomes	O	O	B-T080
.	O	O	O

Aim	O	O	O
was	O	O	O
to	O	O	O
determine	O	O	B-T080
whether	O	O	O
either	O	O	O
of	O	O	O
these	O	O	O
comorbidity	O	O	B-T081
indices	O	O	I-T081
helped	O	O	O
explain	O	O	O
the	O	O	O
variation	O	O	B-T080
in	O	O	O
key	O	O	O
rehabilitation	O	O	B-T061
outcomes	O	O	B-T080
.	O	O	O

Prospective	O	O	B-T062
open-cohort	O	O	I-T062
study	O	O	I-T062
.	O	O	O

Inpatient	O	O	B-T101
rehabilitation	O	O	B-T061
ward	O	O	B-T093
,	O	O	O
Melbourne	O	O	B-T083
,	O	O	O
Australia	O	O	B-T083
.	O	O	O

Adults	O	O	B-T100
admitted	O	O	B-T058
for	O	O	O
inpatient	O	O	B-T101
rehabilitation	O	O	B-T061
(	O	O	O
n=280	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
main	O	O	O
outcomes	O	O	B-T080
were	O	O	O
demographic	O	O	B-T078
(	O	O	O
e.g.	O	O	O
age	O	O	B-T032
,	O	O	O
gender	O	O	B-T032
,	O	O	O
discharge	O	O	B-T058
destination	O	O	B-T082
)	O	O	O
and	O	O	O
clinical	O	O	B-T080
outcomes	O	O	O
(	O	O	O
reason	O	O	B-T033
for	O	O	O
rehabilitation	O	O	B-T061
,	O	O	O
length	O	O	B-T079
of	O	O	I-T079
stay	O	O	I-T079
,	O	O	O
Functional	O	O	B-T170
Independence	O	O	I-T170
Measure	O	O	I-T170
,	O	O	O
CCI	O	O	B-T081
and	O	O	O
CIRS	O	O	B-T081
)	O	O	O
.	O	O	O

A	O	O	O
series	O	O	O
of	O	O	O
regression	O	O	B-T170
analyses	O	O	I-T170
were	O	O	O
performed	O	O	B-T169
to	O	O	O
determine	O	O	B-T080
the	O	O	O
influence	O	O	B-T077
of	O	O	O
comorbidity	O	O	B-T078
on	O	O	O
three	O	O	O
dependent	O	O	B-T169
variables	O	O	I-T169
:	O	O	O
LOS	O	O	B-T079
in	O	O	O
rehabilitation	O	O	B-T061
;	O	O	O
2	O	O	O
)	O	O	O
the	O	O	O
change	O	O	B-T081
in	O	O	O
Functional	O	O	B-T170
Independence	O	O	I-T170
Measure-motor	O	O	I-T170
score	O	O	B-T081
between	O	O	O
rehabilitation	O	O	O
discharge	O	O	B-T058
and	O	O	O
admission	O	O	B-T058
;	O	O	O
and	O	O	O
3	O	O	O
)	O	O	O
the	O	O	O
discharge	O	O	O
destination	O	O	B-T082
(	O	O	O
home	O	O	B-T082
vs	O	O	O
other	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
mean	O	O	B-T081
age	O	O	B-T032
was	O	O	O
57.7	O	O	O
years	O	O	B-T079
,	O	O	O
there	O	O	O
were	O	O	O
slightly	O	O	O
more	O	O	O
females	O	O	B-T032
(	O	O	O
51	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
most	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
)	O	O	O
patients	O	O	B-T101
previously	O	O	B-T079
lived	O	O	B-T033
at	O	O	I-T033
home	O	O	I-T033
with	O	O	O
family	O	O	B-T099
or	O	O	O
other	O	O	O
relatives	O	O	B-T099
(	O	O	O
63	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
most	O	O	O
common	O	O	O
reason	O	O	B-T033
for	O	O	O
rehabilitation	O	O	B-T061
was	O	O	O
orthopaedic	O	O	B-T061
or	O	O	O
other	O	O	O
conditions	O	O	B-T080
(	O	O	O
52	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
most	O	O	O
(	O	O	O
80	O	O	O
%	O	O	O
)	O	O	O
people	O	O	B-T098
were	O	O	O
discharged	O	O	B-T058
home	O	O	B-T082
.	O	O	O

The	O	O	O
median	O	O	O
LOS	O	O	B-T079
was	O	O	O
27	O	O	O
days	O	O	B-T079
.	O	O	O

There	O	O	O
were	O	O	O
100	O	O	O
(	O	O	O
35.7	O	O	O
%	O	O	O
)	O	O	O
patients	O	O	B-T101
who	O	O	O
had	O	O	O
no	O	O	O
comorbidity	O	O	B-T078
recorded	O	O	B-T170
using	O	O	O
the	O	O	O
CCI	O	O	B-T081
,	O	O	O
112	O	O	O
(	O	O	O
40.0	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
26	O	O	O
(	O	O	O
9.3	O	O	O
%	O	O	O
)	O	O	O
who	O	O	O
three	O	O	O
or	O	O	O
more	O	O	O
.	O	O	O

All	O	O	O
patients	O	O	B-T101
had	O	O	O
at	O	O	O
least	O	O	O
one	O	O	O
comorbidity	O	O	B-T078
recorded	O	O	B-T170
with	O	O	O
the	O	O	O
CIRS	O	O	B-T081
,	O	O	O
and	O	O	O
264	O	O	O
(	O	O	O
94.3	O	O	O
%	O	O	O
)	O	O	O
had	O	O	O
3	O	O	O
or	O	O	O
more	O	O	O
comorbidities	O	O	B-T078
.	O	O	O

There	O	O	O
was	O	O	O
little	O	O	O
or	O	O	O
no	O	O	O
difference	O	O	B-T080
between	O	O	O
the	O	O	O
CCI	O	O	B-T081
or	O	O	O
CIRS	O	O	B-T081
in	O	O	O
terms	O	O	O
of	O	O	O
their	O	O	O
ability	O	O	B-T032
to	O	O	O
explain	O	O	O
the	O	O	O
variance	O	O	B-T080
in	O	O	O
LOS	O	O	B-T079
(	O	O	O
adjusted	O	O	O
R2	O	O	B-T081
=	O	O	O
0.38	O	O	O
with	O	O	O
and	O	O	O
without	O	O	O
comorbidities	O	O	B-T078
)	O	O	O
,	O	O	O
change	O	O	B-T081
in	O	O	O
disability	O	O	B-T033
during	O	O	O
rehabilitation	O	O	B-T061
(	O	O	O
adjusted	O	O	O
R2	O	O	O
=	O	O	O
0.31	O	O	O
-	O	O	O
0.33	O	O	O
with	O	O	O
and	O	O	O
without	O	O	O
comorbidities	O	O	O
)	O	O	O
or	O	O	O
the	O	O	O
discharge	O	O	B-T058
destination	O	O	B-T082
(	O	O	O
AUC=0.72	O	O	O
without	O	O	O
comorbidities	O	O	O
;	O	O	O
0.73	O	O	O
-	O	O	O
0.74	O	O	O
with	O	O	O
comorbidities	O	O	O
)	O	O	O
beyond	O	O	O
that	O	O	O
accounted	O	O	O
for	O	O	O
by	O	O	O
demographic	O	O	B-T078
and	O	O	O
clinical	O	O	B-T170
information	O	O	I-T170
.	O	O	O

Neither	O	O	O
the	O	O	O
CIRS	O	O	B-T081
nor	O	O	O
the	O	O	O
CCI	O	O	B-T081
in	O	O	O
our	O	O	O
patient	O	O	B-T101
sample	O	O	B-T167
provide	O	O	B-T052
additional	O	O	O
information	O	O	B-T078
that	O	O	O
explains	O	O	O
the	O	O	O
impact	O	O	B-T080
of	O	O	O
comorbidities	O	O	B-T078
on	O	O	O
key	O	O	O
rehabilitation	O	O	B-T061
outcomes	O	O	B-T080
.	O	O	O

Further	O	O	O
research	O	O	B-T062
is	O	O	O
needed	O	O	O
to	O	O	O
determine	O	O	B-T080
the	O	O	O
most	O	O	O
appropriate	O	O	B-T080
measure	O	O	B-T081
of	O	O	O
comorbidity	O	O	B-T078
of	O	O	O
relevance	O	O	B-T080
to	O	O	O
inpatient	O	O	B-T101
rehabilitation	O	O	B-T061
outcomes	O	O	B-T080
.	O	O	O

-DOCSTART- (28085490)

Internet	O	O	B-T056
Gaming	O	O	I-T056
Disorder	O	O	B-T048
Explains	O	O	O
Unique	O	O	B-T080
Variance	O	O	I-T080
in	O	O	O
Psychological	O	O	B-T048
Distress	O	O	I-T048
and	O	O	O
Disability	O	O	B-T033
After	O	O	O
Controlling	O	O	O
for	O	O	O
Comorbid	O	O	B-T033
Depression	O	O	B-T048
,	O	O	O
OCD	O	O	B-T048
,	O	O	O
ADHD	O	O	B-T048
,	O	O	O
and	O	O	O
Anxiety	O	O	O

This	O	O	O
study	O	O	B-T062
extends	O	O	O
knowledge	O	O	B-T170
about	O	O	O
the	O	O	O
relationship	O	O	B-T080
of	O	O	O
Internet	O	O	B-T048
Gaming	O	O	I-T048
Disorder	O	O	I-T048
(	O	O	O
IGD	O	O	B-T048
)	O	O	O
to	O	O	O
other	O	O	O
established	O	O	O
mental	O	O	B-T048
disorders	O	O	I-T048
by	O	O	O
exploring	O	O	O
comorbidities	O	O	B-T078
with	O	O	O
anxiety	O	O	B-T033
,	O	O	O
depression	O	O	B-T048
,	O	O	O
Attention	O	O	B-T048
Deficit	O	O	I-T048
Hyperactivity	O	O	I-T048
Disorder	O	O	I-T048
(	O	O	O
ADHD	O	O	B-T048
)	O	O	O
,	O	O	O
and	O	O	O
obsessive	O	O	B-T048
compulsive	O	O	I-T048
disorder	O	O	I-T048
(	O	O	O
OCD	O	O	B-T048
)	O	O	O
,	O	O	O
and	O	O	O
assessing	O	O	B-T058
whether	O	O	O
IGD	O	O	O
accounts	O	O	O
for	O	O	O
unique	O	O	B-T080
variance	O	O	I-T080
in	O	O	O
distress	O	O	B-T033
and	O	O	O
disability	O	O	B-T033
.	O	O	O

An	O	O	O
online	O	O	B-T170
survey	O	O	I-T170
was	O	O	O
completed	O	O	O
by	O	O	O
a	O	O	O
convenience	O	O	B-T062
sample	O	O	I-T062
that	O	O	O
engages	O	O	O
in	O	O	O
Internet	O	O	B-T056
gaming	O	O	I-T056
(	O	O	O
N	O	O	O
=	O	O	O
404	O	O	O
)	O	O	O
.	O	O	O

Participants	O	O	B-T098
meeting	O	O	B-T077
criteria	O	O	B-T078
for	O	O	O
IGD	O	O	B-T048
based	O	O	O
on	O	O	O
the	O	O	O
Personal	O	O	B-T062
Internet	O	O	I-T062
Gaming	O	O	I-T062
Disorder	O	O	I-T062
Evaluation-9	O	O	I-T062
(	O	O	O
PIE-9	O	O	B-T062
)	O	O	O
reported	O	O	O
higher	O	O	B-T078
comorbidity	O	O	I-T078
with	O	O	O
depression	O	O	B-T048
,	O	O	O
OCD	O	O	B-T048
,	O	O	O
ADHD	O	O	B-T048
,	O	O	O
and	O	O	O
anxiety	O	O	B-T033
compared	O	O	O
with	O	O	O
those	O	O	O
who	O	O	O
did	O	O	O
not	O	O	O
meet	O	O	O
the	O	O	O
IGD	O	O	O
criteria	O	O	O
.	O	O	O

IGD	O	O	B-T048
explained	O	O	O
a	O	O	O
small	O	O	O
proportion	O	O	B-T081
of	O	O	O
unique	O	O	B-T080
variance	O	O	I-T080
in	O	O	O
distress	O	O	B-T033
(	O	O	O
1	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
disability	O	O	B-T033
(	O	O	O
3	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

IGD	O	O	B-T048
accounted	O	O	O
for	O	O	O
a	O	O	O
larger	O	O	B-T081
proportion	O	O	B-T081
of	O	O	O
unique	O	O	B-T080
variance	O	O	I-T080
in	O	O	O
disability	O	O	B-T033
than	O	O	O
anxiety	O	O	B-T033
and	O	O	O
ADHD	O	O	B-T048
,	O	O	O
and	O	O	O
a	O	O	O
similar	O	O	O
proportion	O	O	O
to	O	O	O
depression	O	O	B-T048
.	O	O	O

Replications	O	O	B-T080
with	O	O	O
clinical	O	O	B-T098
samples	O	O	I-T098
using	O	O	O
longitudinal	O	O	B-T052
designs	O	O	I-T052
and	O	O	O
structured	O	O	B-UnknownType
diagnostic	O	O	I-UnknownType
interviews	O	O	I-UnknownType
are	O	O	O
required	O	O	O
.	O	O	O

-DOCSTART- (28087237)

What	O	O	O
Is	O	O	O
the	O	O	O
Real	O	O	B-T080
Impact	O	O	B-T080
of	O	O	O
Urinary	O	O	B-T046
Incontinence	O	O	I-T046
on	O	O	O
Female	O	O	B-T048
Sexual	O	O	I-T048
Dysfunction	O	O	I-T048
?	O	O	O
A	O	O	O
Case	O	O	O
Control	O	O	O
Study	O	O	O

A	O	O	O
Case	O	O	B-T062
Control	O	O	I-T062
Study	O	O	I-T062
Urinary	O	O	B-T046
incontinence	O	O	I-T046
(	O	O	O
UI	O	O	B-T046
)	O	O	O
has	O	O	O
been	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
negative	O	O	B-T033
effects	O	O	B-T080
on	O	O	O
women	O	O	B-T098
's	O	O	I-T098
sexuality	O	O	B-T053
.	O	O	O

Women	O	O	B-T098
's	O	O	I-T098
sexuality	O	O	B-T053
and	O	O	O
sexual	O	O	B-T040
function	O	O	I-T040
are	O	O	O
a	O	O	O
complex	O	O	B-T080
issue	O	O	B-T033
,	O	O	O
and	O	O	O
the	O	O	O
role	O	O	B-T077
of	O	O	O
UI	O	O	B-T046
is	O	O	O
not	O	O	B-T080
completely	O	O	I-T080
clear	O	O	O
.	O	O	O

To	O	O	O
assess	O	O	B-T052
the	O	O	O
impact	O	O	B-T080
of	O	O	O
UI	O	O	B-T046
on	O	O	O
female	O	O	B-T040
sexual	O	O	I-T040
function	O	O	I-T040
by	O	O	O
comparing	O	O	B-T052
this	O	O	O
population	O	O	B-T098
with	O	O	O
a	O	O	O
control	O	O	B-T096
group	O	O	I-T096
of	O	O	O
continent	O	O	B-T080
women	O	O	B-T098
.	O	O	O

We	O	O	O
performed	O	O	O
a	O	O	O
case-control	O	O	B-T062
study	O	O	I-T062
from	O	O	O
August	O	O	O
2012	O	O	O
to	O	O	O
September	O	O	O
2013	O	O	O
.	O	O	O

We	O	O	O
evaluated	O	O	B-T058
continent	O	O	B-T080
and	O	O	O
incontinent	O	O	B-T169
women	O	O	B-T098
(	O	O	O
age	O	O	B-T032
range	O	O	B-T081
=	O	O	O
30	O	O	O
-	O	O	O
70	O	O	O
years	O	O	O
)	O	O	O
for	O	O	O
their	O	O	O
sexuality	O	O	B-T053
.	O	O	O

All	O	O	O
patients	O	O	B-T101
were	O	O	O
evaluated	O	O	B-T058
by	O	O	O
anamnesis	O	O	B-T042
,	O	O	O
physical	O	O	B-T058
examination	O	O	I-T058
,	O	O	O
and	O	O	O
self-report	O	O	B-T062
quality-of-life	O	O	B-T170
questionnaires	O	O	I-T170
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
incontinent	O	O	B-T169
women	O	O	B-T098
underwent	O	O	O
a	O	O	O
1-hour	O	O	O
pad	O	O	B-T060
test	O	O	I-T060
.	O	O	O

Patients	O	O	B-T101
without	O	O	O
sexual	O	O	B-T053
activity	O	O	I-T053
were	O	O	O
evaluated	O	O	B-T058
for	O	O	O
the	O	O	O
role	O	O	B-T077
of	O	O	O
UI	O	O	B-T046
in	O	O	O
their	O	O	O
sexual	O	O	B-T055
abstinence	O	O	I-T055
.	O	O	O

Sexual	O	O	B-T055
abstinence	O	O	I-T055
was	O	O	O
defined	O	O	O
as	O	O	O
the	O	O	O
absence	O	O	B-T033
of	O	O	I-T033
sexual	O	O	I-T033
activity	O	O	I-T033
for	O	O	O
more	O	O	O
than	O	O	O
6	O	O	O
months	O	O	O
.	O	O	O

All	O	O	O
sexually	O	O	B-T033
active	O	O	I-T033
women	O	O	B-T098
completed	O	O	O
the	O	O	O
self-report	O	O	B-T062
Sexuality	O	O	B-T053
Quotient	O	O	B-T081
-	O	O	O
Female	O	O	B-T032
Version	O	O	B-T170
(	O	O	O
SQ-F	O	O	O
)	O	O	O
questionnaire	O	O	B-T170
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
356	O	O	O
women	O	O	B-T098
were	O	O	O
included	O	O	O
in	O	O	O
the	O	O	O
study	O	O	B-T062
(	O	O	O
incontinent	O	O	B-T169
,	O	O	O
n	O	O	O
=	O	O	O
243	O	O	O
;	O	O	O
continent	O	O	B-T080
,	O	O	O
n	O	O	O
=	O	O	O
113	O	O	O
)	O	O	O
.	O	O	O

Sexual	O	O	B-T055
abstinence	O	O	I-T055
was	O	O	O
found	O	O	O
in	O	O	O
162	O	O	O
women	O	O	B-T098
(	O	O	O
45	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

Incontinent	O	O	B-T169
women	O	O	B-T098
presented	O	O	O
a	O	O	O
higher	O	O	B-T081
prevalence	O	O	I-T081
(	O	O	O
P	O	O	O
<	O	O	O
.001	O	O	O
)	O	O	O
of	O	O	O
sexual	O	O	B-T055
abstinence	O	O	I-T055
than	O	O	O
their	O	O	O
counterparts	O	O	B-T099
(	O	O	O
129	O	O	O
[	O	O	O
53	O	O	O
%	O	O	O
]	O	O	O
and	O	O	O
33	O	O	O
[	O	O	O
29.2	O	O	O
%	O	O	O
]	O	O	O
,	O	O	O
respectively	O	O	O
)	O	O	O
.	O	O	O

Age	O	O	B-T032
,	O	O	O
marital	O	O	B-T102
status	O	O	I-T102
,	O	O	O
and	O	O	O
UI	O	O	B-T046
were	O	O	O
found	O	O	O
to	O	O	O
be	O	O	O
isolated	O	O	B-T169
predictive	O	O	B-T170
factors	O	O	I-T170
for	O	O	O
more	O	O	O
sexual	O	O	B-T055
abstinence	O	O	I-T055
in	O	O	O
incontinent	O	O	B-T169
women	O	O	B-T098
.	O	O	O

Sexually	O	O	B-T033
active	O	O	I-T033
women	O	O	B-T098
(	O	O	O
incontinent	O	O	B-T169
,	O	O	O
n	O	O	O
=	O	O	O
114	O	O	O
;	O	O	O
continent	O	O	B-T080
,	O	O	O
n	O	O	O
=	O	O	O
80	O	O	O
)	O	O	O
presented	O	O	O
similar	O	O	O
demographic	O	O	B-T090
data	O	O	B-T078
.	O	O	O

Despite	O	O	O
a	O	O	O
similar	O	O	O
frequency	O	O	B-T079
of	O	O	O
sexual	O	O	B-T053
activity	O	O	I-T053
,	O	O	O
incontinent	O	O	B-T169
women	O	O	B-T098
had	O	O	O
less	O	O	O
sexual	O	O	B-T048
desire	O	O	I-T048
,	O	O	O
foreplay	O	O	B-T033
,	O	O	O
harmony	O	O	B-T054
with	O	O	O
a	O	O	O
partner	O	O	B-T098
,	O	O	O
sexual	O	O	B-T041
comfort	O	O	I-T041
,	O	O	O
and	O	O	O
sexual	O	O	B-T041
satisfaction	O	O	I-T041
than	O	O	O
their	O	O	O
counterparts	O	O	O
.	O	O	O

Women	O	O	B-T098
with	O	O	O
greater	O	O	B-T081
urinary	O	O	B-T033
leakage	O	O	I-T033
during	O	O	O
the	O	O	O
1-hour	O	O	O
pad	O	O	B-T060
test	O	O	I-T060
(	O	O	O
weight	O	O	B-T081
>	O	O	O
11	O	O	O
g	O	O	O
)	O	O	O
had	O	O	O
the	O	O	O
worst	O	O	O
sexual	O	O	B-T040
function	O	O	I-T040
(	O	O	O
SQ-F	O	O	O
)	O	O	O
score	O	O	B-T081
.	O	O	O

Women	O	O	B-T098
with	O	O	O
UI	O	O	B-T046
were	O	O	O
more	O	O	O
likely	O	O	O
to	O	O	O
be	O	O	O
sexual	O	O	B-T055
abstinent	O	O	I-T055
than	O	O	O
continent	O	O	B-T080
women	O	O	B-T098
.	O	O	O

Furthermore	O	O	O
,	O	O	O
women	O	O	B-T098
with	O	O	O
UI	O	O	B-T046
showed	O	O	O
less	O	O	O
sexual	O	O	B-T048
desire	O	O	I-T048
,	O	O	O
sexual	O	O	B-T041
comfort	O	O	I-T041
,	O	O	O
and	O	O	O
sexual	O	O	B-T041
satisfaction	O	O	I-T041
than	O	O	O
their	O	O	O
counterparts	O	O	B-T099
despite	O	O	O
having	O	O	O
a	O	O	O
similar	O	O	O
frequency	O	O	B-T079
of	O	O	O
sexual	O	O	B-T053
activity	O	O	I-T053
.	O	O	O

-DOCSTART- (28087473)

Salvianolic	O	O	B-T109
Acids	O	O	I-T109
for	O	O	O
Injection	O	O	B-T122
(	O	O	O
SAFI	O	O	B-T122
)	O	O	O
suppresses	O	O	B-T169
inflammatory	O	O	B-T046
responses	O	O	I-T046
in	O	O	O
activated	O	O	B-T052
microglia	O	O	B-T025
to	O	O	O
attenuate	O	O	B-T052
brain	O	O	B-T037
damage	O	O	I-T037
in	O	O	O
focal	O	O	O
cerebral	O	O	O
ischemia	O	O	O

Inflammatory	O	O	B-T046
reactions	O	O	I-T046
induced	O	O	O
by	O	O	O
microglia	O	O	B-T025
in	O	O	O
the	O	O	O
brain	O	O	B-T023
play	O	O	O
crucial	O	O	O
roles	O	O	B-T077
in	O	O	O
ischemia	O	O	B-T047
/	O	O	O
reperfusion	O	O	B-T037
(	O	O	I-T037
I/R	O	O	I-T037
)	O	O	I-T037
cerebral	O	O	I-T037
injuries	O	O	I-T037
.	O	O	O

Microglia	O	O	B-T025
activation	O	O	B-T052
has	O	O	O
been	O	O	O
shown	O	O	O
to	O	O	O
be	O	O	O
closely	O	O	O
related	O	O	O
to	O	O	O
TLR4	O	O	B-T044
/	O	O	O
NF-ÎºB	O	O	B-T045
signal	O	O	I-T045
pathways	O	O	I-T045
.	O	O	O

Salvianolic	O	O	B-T109
acids	O	O	I-T109
for	O	O	O
injection	O	O	B-T122
(	O	O	O
SAFI	O	O	B-T122
)	O	O	O
have	O	O	O
been	O	O	O
used	O	O	O
in	O	O	O
clinical	O	O	B-T057
practice	O	O	I-T057
to	O	O	O
treat	O	O	B-T169
ischemic	O	O	B-T047
stroke	O	O	I-T047
with	O	O	O
reported	O	O	B-T058
neuroprotective	O	O	B-T169
effects	O	O	I-T169
;	O	O	O
however	O	O	O
,	O	O	O
the	O	O	O
underlying	O	O	O
mechanisms	O	O	B-T169
are	O	O	O
still	O	O	O
uncertain	O	O	O
.	O	O	O

First	O	O	O
,	O	O	O
we	O	O	O
studied	O	O	B-T062
the	O	O	O
effect	O	O	B-T080
of	O	O	O
SAFI	O	O	B-T122
on	O	O	O
inflammatory	O	O	B-T046
responses	O	O	I-T046
in	O	O	O
LPS	O	O	B-T109
-	O	O	O
stimulated	O	O	B-T070
BV-2	O	O	B-T007
microglia	O	O	B-T025
.	O	O	O

Then	O	O	O
,	O	O	O
to	O	O	O
discover	O	O	B-T052
whether	O	O	O
the	O	O	O
beneficial	O	O	B-T081
in	O	O	B-T062
vitro	O	O	I-T062
effects	O	O	B-T080
of	O	O	O
SAFI	O	O	B-T122
lead	O	O	O
to	O	O	O
in	O	O	B-T062
vivo	O	O	I-T062
therapeutic	O	O	B-T201
effect	O	O	I-T201
s	O	O	O
,	O	O	O
an	O	O	O
MCAO	O	O	B-T020
(	O	O	O
Middle	O	O	B-T020
cerebral	O	O	I-T020
artery	O	O	I-T020
occlusion	O	O	I-T020
)	O	O	O
rat	O	O	B-T015
model	O	O	B-T050
was	O	O	O
further	O	O	O
employed	O	O	B-T033
to	O	O	O
elucidate	O	O	O
the	O	O	O
probable	O	O	O
mechanism	O	O	B-T169
of	O	O	O
SAFI	O	O	O
in	O	O	O
treating	O	O	B-T169
ischemic	O	O	B-T047
stroke	O	O	I-T047
.	O	O	O

Rats	O	O	B-T015
in	O	O	O
the	O	O	O
SAFI	O	O	B-T122
group	O	O	B-T078
were	O	O	O
given	O	O	O
SAFI	O	O	O
(	O	O	O
23	O	O	O
or	O	O	O
46mg/kg	O	O	O
)	O	O	O
before	O	O	O
I	O	O	B-T047
/	O	O	O
R	O	O	B-T037
injury	O	O	I-T037
.	O	O	O

The	O	O	O
results	O	O	B-T169
showed	O	O	O
that	O	O	O
SAFI	O	O	B-T122
treatment	O	O	B-T169
significantly	O	O	B-T081
decreased	O	O	I-T081
neuroinflammation	O	O	B-T046
and	O	O	O
the	O	O	O
infarction	O	O	B-T046
volume	O	O	B-T081
compared	O	O	O
with	O	O	O
the	O	O	O
vehicle	O	O	B-T122
group	O	O	B-T078
.	O	O	O

Activation	O	O	B-T052
of	O	O	O
microglia	O	O	B-T025
cells	O	O	I-T025
was	O	O	O
reduced	O	O	B-T080
,	O	O	O
and	O	O	O
TLR4	O	O	B-T044
/	O	O	O
NF-ÎºB	O	O	B-T045
signals	O	O	I-T045
,	O	O	O
which	O	O	O
were	O	O	O
markedly	O	O	O
inhibited	O	O	B-T080
by	O	O	O
SAFI	O	O	B-T122
treatment	O	O	B-T169
in	O	O	O
ischemic	O	O	B-T169
hemisphere	O	O	B-T023
,	O	O	O
were	O	O	O
accompanied	O	O	O
by	O	O	O
reduced	O	O	O
expression	O	O	B-T045
and	O	O	O
release	O	O	B-T058
of	O	O	O
cytokines	O	O	B-T116
IL-1Î²	O	O	B-T116
and	O	O	O
IL-6	O	O	B-T116
.	O	O	O

This	O	O	O
study	O	O	B-T062
provides	O	O	O
evidence	O	O	B-T078
that	O	O	O
SAFI	O	O	B-T122
effectively	O	O	B-T080
protects	O	O	O
the	O	O	O
brain	O	O	B-T023
after	O	O	O
cerebral	O	O	B-T047
ischemia	O	O	I-T047
,	O	O	O
which	O	O	O
may	O	O	O
be	O	O	O
caused	O	O	O
by	O	O	O
attenuating	O	O	B-T052
inflammation	O	O	B-T046
in	O	O	O
microglia	O	O	B-T025
.	O	O	O

-DOCSTART- (28087491)

Dynamics	O	O	B-T070
of	O	O	O
bacterial	O	O	B-T080
class	O	O	B-T007
Bacilli	O	O	I-T007
in	O	O	O
the	O	O	O
deepest	O	O	B-T083
valley	O	O	I-T083
lake	O	O	I-T083
of	O	O	O
Kashmir	O	O	B-UnknownType
-the	O	O	O
Manasbal	O	O	O
Lake	O	O	O

In	O	O	O
recognition	O	O	O
of	O	O	O
the	O	O	O
importance	O	O	O
of	O	O	O
bacteria	O	O	B-T007
as	O	O	O
ecological	O	O	B-T130
indicators	O	O	I-T130
of	O	O	O
the	O	O	O
aquatic	O	O	B-T070
systems	O	O	I-T070
a	O	O	O
comprehensive	O	O	B-T062
and	O	O	I-T062
systematic	O	O	I-T062
analysis	O	O	I-T062
was	O	O	O
carried	O	O	O
out	O	O	O
on	O	O	O
Manasbal	O	O	B-T083
Lake	O	O	I-T083
,	O	O	O
the	O	O	O
deepest	O	O	B-T083
spring	O	O	I-T083
fed	O	O	I-T083
valley	O	O	I-T083
lake	O	O	I-T083
of	O	O	O
Kashmir	O	O	B-UnknownType
.	O	O	O

The	O	O	O
main	O	O	O
objective	O	O	O
envisaged	O	O	O
was	O	O	O
to	O	O	O
analyze	O	O	B-T062
bacterial	O	O	B-T080
community	O	O	I-T080
composition	O	O	I-T080
(	O	O	O
BCC	O	O	B-T080
)	O	O	O
and	O	O	O
for	O	O	O
this	O	O	O
purpose	O	O	O
systematic	O	O	B-T081
and	O	O	O
regular	O	O	B-T057
sampling	O	O	I-T057
of	O	O	I-T057
waters	O	O	B-T121
from	O	O	O
ten	O	O	O
different	O	O	O
sampling	O	O	B-T082
stations	O	O	I-T082
,	O	O	O
predetermined	O	O	O
in	O	O	O
the	O	O	O
Lake	O	O	B-T083
according	O	O	O
to	O	O	O
differences	O	O	O
in	O	O	O
degree	O	O	B-T080
of	O	O	I-T080
human	O	O	I-T080
interference	O	O	I-T080
and	O	O	O
also	O	O	O
as	O	O	O
zones	O	O	B-T082
of	O	O	O
special	O	O	O
ecological	O	O	B-T078
interests	O	O	I-T078
were	O	O	O
selected	O	O	O
.	O	O	O

The	O	O	O
isolated	O	O	B-T169
species	O	O	B-T185
were	O	O	O
identified	O	O	B-T080
according	O	O	O
to	O	O	O
Bergey	O	O	B-T170
's	O	O	I-T170
Manual	O	O	I-T170
specification	O	O	I-T170
by	O	O	O
examining	O	O	O
their	O	O	O
micro	O	O	B-T080
and	O	O	I-T080
macro	O	O	I-T080
morphological	O	O	I-T080
characteristics	O	O	I-T080
and	O	O	O
biochemical	O	O	B-T080
characteristics	O	O	I-T080
on	O	O	O
different	O	O	O
culture	O	O	B-T130
media	O	O	I-T130
.	O	O	O

Further	O	O	O
confirmation	O	O	B-T033
was	O	O	O
done	O	O	O
by	O	O	O
sequencing	O	O	B-T169
the	O	O	O
16s	O	O	B-T028
rRNA	O	O	I-T028
gene	O	O	I-T028
by	O	O	O
using	O	O	O
universal	O	O	B-T114
bacterial	O	O	I-T114
primers	O	O	I-T114
27F	O	O	B-T114
and	O	O	O
1429R	O	O	B-T114
.	O	O	O

From	O	O	O
all	O	O	O
the	O	O	O
sampling	O	O	B-T082
stations	O	O	I-T082
the	O	O	O
class	O	O	B-T007
Bacilli	O	O	I-T007
showed	O	O	O
a	O	O	O
maximum	O	O	B-T081
relative	O	O	B-T080
abundance	O	O	I-T080
with	O	O	O
a	O	O	O
contribution	O	O	B-T052
of	O	O	O
16	O	O	O
bacterial	O	O	B-T185
species	O	O	I-T185
.	O	O	O

The	O	O	O
whole	O	O	O
process	O	O	B-T067
resulted	O	O	O
in	O	O	O
the	O	O	O
identification	O	O	B-T080
of	O	O	O
Bacillus	O	O	B-T007
aerius	O	O	I-T007
,	O	O	O
Bacillus	O	O	B-T007
altitudinis	O	O	I-T007
,	O	O	O
Bacillus	O	O	B-T007
anthracis	O	O	I-T007
,	O	O	O
Bacillus	O	O	B-T007
cereus	O	O	I-T007
,	O	O	O
Bacillus	O	O	B-T007
ginsengisoli	O	O	I-T007
,	O	O	O
Bacillus	O	O	B-T007
pumilus	O	O	I-T007
,	O	O	O
Bacillus	O	O	B-T007
safensis	O	O	I-T007
,	O	O	O
Bacillus	O	O	B-T007
stratosphericus	O	O	I-T007
,	O	O	O
Bacillus	O	O	B-T007
subtilis	O	O	I-T007
,	O	O	O
Bacillus	O	O	B-T007
tequilensis	O	O	I-T007
,	O	O	O
Bacillus	O	O	B-T007
thermocopriae	O	O	I-T007
,	O	O	O
Bacillus	O	O	B-T007
thuringiensis	O	O	I-T007
,	O	O	O
Brevibacillus	O	O	B-T007
agri	O	O	I-T007
strain	O	O	I-T007
,	O	O	O
Lysinibacillus	O	O	B-T007
boronitolerans	O	O	I-T007
,	O	O	O
Lysinibacillus	O	O	B-T007
pakistanensis	O	O	I-T007
and	O	O	O
Lysinibacillus	O	O	B-T007
sphaericus	O	O	I-T007
.	O	O	O

-DOCSTART- (28093376)

A	O	O	O
new	O	O	O
angle	O	O	B-T082
and	O	O	O
its	O	O	O
relationship	O	O	O
with	O	O	O
early	O	O	O
fixation	O	O	B-T046
failure	O	O	I-T046
of	O	O	O
femoral	O	O	B-T037
neck	O	O	I-T037
fractures	O	O	I-T037
treated	O	O	O
with	O	O	O
three	O	O	O
cannulated	O	O	O
compression	O	O	O
screws	O	O	O

The	O	O	O
Pauwels	O	O	O
angle	O	O	B-T082
has	O	O	O
been	O	O	O
used	O	O	O
widely	O	O	O
,	O	O	O
however	O	O	O
an	O	O	O
accurate	O	O	O
evaluation	O	O	O
of	O	O	O
this	O	O	O
angle	O	O	O
is	O	O	O
difficult	O	O	O
because	O	O	O
of	O	O	O
deformity	O	O	B-T190
of	O	O	O
the	O	O	O
affected	O	O	B-T169
lower	O	O	B-T023
extremity	O	O	I-T023
.	O	O	O

Therefore	O	O	O
we	O	O	O
designed	O	O	O
a	O	O	O
new	O	O	O
measurement	O	O	B-T169
of	O	O	O
the	O	O	O
orientation	O	O	B-T082
of	O	O	O
femoral	O	O	B-T037
neck	O	O	I-T037
fracture	O	O	I-T037
and	O	O	O
applied	O	O	O
this	O	O	O
in	O	O	O
a	O	O	O
retrospective	O	O	B-T062
study	O	O	I-T062
to	O	O	O
assess	O	O	O
:	O	O	O
(	O	O	O
1	O	O	O
)	O	O	O
its	O	O	O
reproducibility	O	O	B-T080
,	O	O	O
(	O	O	O
2	O	O	O
)	O	O	O
its	O	O	O
advantages	O	O	O
compared	O	O	O
with	O	O	O
the	O	O	O
Pauwels	O	O	O
angle	O	O	O
,	O	O	O
(	O	O	O
3	O	O	O
)	O	O	O
its	O	O	O
relationship	O	O	O
with	O	O	O
the	O	O	O
short-term	O	O	B-T058
prognosis	O	O	I-T058
treated	O	O	B-T169
with	O	O	O
three	O	O	O
cannulated	O	O	B-T074
compression	O	O	I-T074
screws	O	O	I-T074
.	O	O	O

This	O	O	O
new	O	O	O
measurement	O	O	B-T169
is	O	O	O
reproducible	O	O	O
and	O	O	O
has	O	O	O
some	O	O	O
reference	O	O	O
meaning	O	O	O
for	O	O	O
the	O	O	O
treatment	O	O	B-T061
of	O	O	O
femoral	O	O	B-T037
neck	O	O	I-T037
fractures	O	O	I-T037
.	O	O	O

Two	O	O	O
hundred	O	O	O
and	O	O	O
twenty-eight	O	O	O
patients	O	O	B-T101
with	O	O	O
femoral	O	O	B-T037
neck	O	O	I-T037
fractures	O	O	I-T037
treated	O	O	O
with	O	O	O
three	O	O	O
cannulated	O	O	B-T074
compression	O	O	I-T074
screws	O	O	I-T074
were	O	O	O
retrospectively	O	O	B-T062
analyzed	O	O	I-T062
.	O	O	O

The	O	O	O
VN	O	O	O
angle	O	O	B-T082
,	O	O	O
which	O	O	O
was	O	O	O
the	O	O	O
angle	O	O	O
between	O	O	O
the	O	O	O
fracture	O	O	B-T082
line	O	O	I-T082
and	O	O	O
the	O	O	O
vertical	O	O	B-T082
of	O	O	O
the	O	O	O
neck	O	O	B-T082
axis	O	O	I-T082
,	O	O	O
and	O	O	O
the	O	O	O
Pauwels	O	O	O
angle	O	O	O
were	O	O	O
measured	O	O	O
respectively	O	O	O
.	O	O	O

The	O	O	O
method	O	O	O
of	O	O	O
ICC	O	O	B-T081
was	O	O	O
performed	O	O	O
to	O	O	O
assess	O	O	O
the	O	O	O
reproducibility	O	O	B-T080
of	O	O	O
the	O	O	O
two	O	O	O
angles	O	O	B-T082
,	O	O	O
and	O	O	O
the	O	O	O
absolute	O	O	O
value	O	O	O
of	O	O	O
difference	O	O	O
in	O	O	O
pre-operative	O	O	B-T079
and	O	O	O
post-operative	O	O	B-T079
radiographs	O	O	B-T060
was	O	O	O
used	O	O	O
to	O	O	O
evaluate	O	O	O
the	O	O	O
uniformity	O	O	O
of	O	O	O
the	O	O	O
two	O	O	O
angles	O	O	O
.	O	O	O

These	O	O	O
fractures	O	O	B-T037
were	O	O	O
divided	O	O	O
into	O	O	O
four	O	O	O
groups	O	O	B-T078
according	O	O	O
to	O	O	O
VN	O	O	O
angle	O	O	O
(	O	O	O
VN<0	O	O	O
Â°	O	O	O
(	O	O	O
n=92	O	O	O
)	O	O	O
,	O	O	O
0	O	O	O
Â°	O	O	O
â¤VN<10	O	O	O
Â°	O	O	O
(	O	O	O
n=82	O	O	O
)	O	O	O
,	O	O	O
10	O	O	O
Â°	O	O	O
â¤VN<15	O	O	O
Â°	O	O	O
(	O	O	O
n=26	O	O	O
)	O	O	O
,	O	O	O
VNâ¥15	O	O	O
Â°	O	O	O
(	O	O	O
n=28	O	O	O
)	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
the	O	O	O
short-term	O	O	O
(	O	O	O
within	O	O	O
6	O	O	O
months	O	O	B-T079
)	O	O	O
fixation	O	O	B-T061
results	O	O	O
of	O	O	O
radiographs	O	O	B-T060
in	O	O	O
these	O	O	O
fractures	O	O	O
were	O	O	O
evaluated	O	O	O
.	O	O	O

The	O	O	O
ICC	O	O	B-T081
of	O	O	O
the	O	O	O
VN	O	O	O
angle	O	O	O
and	O	O	O
the	O	O	O
Pauwels	O	O	O
angle	O	O	O
in	O	O	O
pre-operative	O	O	B-T079
radiographs	O	O	B-T060
were	O	O	O
0.937	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
confidence	O	O	B-T081
interval	O	O	I-T081
(	O	O	O
CI	O	O	B-T081
):	O	O	O
0.922	O	O	O
-	O	O	O
0.950	O	O	O
)	O	O	O
and	O	O	O
0.942	O	O	O
respectively	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
:	O	O	O
0.914	O	O	O
-	O	O	O
0.970	O	O	O
)	O	O	O
,	O	O	O
indicating	O	O	O
both	O	O	O
angles	O	O	B-T082
had	O	O	O
a	O	O	O
good	O	O	O
inter-rater	O	O	B-T080
reproducibility	O	O	I-T080
.	O	O	O

However	O	O	O
,	O	O	O
there	O	O	O
was	O	O	O
a	O	O	O
great	O	O	O
difference	O	O	O
between	O	O	O
the	O	O	O
Pauwels	O	O	O
angle	O	O	O
in	O	O	O
pre-operative	O	O	B-T079
and	O	O	O
post-operative	O	O	B-T079
radiographs	O	O	B-T060
(	O	O	O
P=0.037	O	O	O
)	O	O	O
,	O	O	O
the	O	O	O
absolute	O	O	O
difference	O	O	O
was	O	O	O
10.66Â±6.47	O	O	O
(	O	O	O
range	O	O	O
:	O	O	O
1.72	O	O	O
-	O	O	O
38.48	O	O	O
)	O	O	O
,	O	O	O
while	O	O	O
no	O	O	O
statistical	O	O	O
difference	O	O	O
for	O	O	O
the	O	O	O
VN	O	O	O
angle	O	O	O
(	O	O	O
P=0.084	O	O	O
)	O	O	O
and	O	O	O
the	O	O	O
absolute	O	O	O
difference	O	O	O
was	O	O	O
2.20Â±1.63	O	O	O
(	O	O	O
range	O	O	O
:	O	O	O
0.05	O	O	O
-	O	O	O
7.56	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
overall	O	O	O
fixation	O	O	B-T046
failure	O	O	I-T046
rate	O	O	B-T081
which	O	O	O
was	O	O	O
defined	O	O	O
as	O	O	O
screw	O	O	B-T046
loosening	O	O	I-T046
,	O	O	O
varus	O	O	O
collapse	O	O	O
,	O	O	O
obvious	O	O	O
fracture	O	O	B-T037
displacement	O	O	I-T037
or	O	O	O
femoral	O	O	B-T023
neck	O	O	I-T023
shortening	O	O	O
was	O	O	O
11.84	O	O	O
%	O	O	O
,	O	O	O
and	O	O	O
the	O	O	O
mean	O	O	O
failure	O	O	O
rates	O	O	O
according	O	O	O
to	O	O	O
VN	O	O	O
angles	O	O	O
were	O	O	O
respectively	O	O	O
0	O	O	O
%	O	O	O
,	O	O	O
3.24	O	O	O
%	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
:	O	O	O
1.64	O	O	O
-	O	O	O
4.84	O	O	O
)	O	O	O
,	O	O	O
22.69	O	O	O
%	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
:	O	O	O
16.43	O	O	O
-	O	O	O
28.96	O	O	O
)	O	O	O
,	O	O	O
65.45	O	O	O
%	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
:	O	O	O
59.36	O	O	O
-	O	O	O
71.53	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
mean	O	O	O
failure	O	O	B-T081
rates	O	O	I-T081
of	O	O	O
fractures	O	O	B-T037
according	O	O	O
to	O	O	O
post-operative	O	O	B-T079
Pauwels	O	O	O
angle	O	O	O
(	O	O	O
<	O	O	O
30	O	O	O
Â°	O	O	O
,	O	O	O
30	O	O	O
-	O	O	O
50	O	O	O
Â°	O	O	O
,	O	O	O
>	O	O	O
50	O	O	O
Â°	O	O	O
)	O	O	O
were	O	O	O
respectively	O	O	O
0	O	O	O
%	O	O	O
,	O	O	O
1.46	O	O	O
%	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
:	O	O	O
1.42	O	O	O
-	O	O	O
1.50	O	O	O
)	O	O	O
and	O	O	O
36.24	O	O	O
%	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
:	O	O	O
34.93	O	O	O
-	O	O	O
37.54	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
VN	O	O	O
angle	O	O	O
has	O	O	O
a	O	O	O
good	O	O	O
inter-rater	O	O	B-T080
reproducibility	O	O	I-T080
,	O	O	O
a	O	O	O
higher	O	O	O
reliability	O	O	O
than	O	O	O
the	O	O	O
Pauwels	O	O	O
angle	O	O	O
and	O	O	O
is	O	O	O
closely	O	O	O
related	O	O	O
to	O	O	O
the	O	O	O
short-term	O	O	B-T058
prognosis	O	O	I-T058
of	O	O	O
femoral	O	O	B-T037
neck	O	O	I-T037
fractures	O	O	I-T037
treated	O	O	O
with	O	O	O
cannulated	O	O	B-T074
compression	O	O	I-T074
screws	O	O	I-T074
.	O	O	O

Level	O	O	O
IV	O	O	O
,	O	O	O
retrospective	O	O	O
diagnostic	O	O	O
study	O	O	O
.	O	O	O

-DOCSTART- (28094646)

Retirement	O	O	B-T033
crisis	O	O	B-T033
warnings	O	O	B-T080
becoming	O	O	O
a	O	O	O
reality	O	O	O

The	O	O	O
figures	O	O	B-T081
are	O	O	O
startling	O	O	B-T033
:	O	O	O
the	O	O	O
number	O	O	O
of	O	O	O
NHS	O	O	B-T064
staff	O	O	B-T097
applying	O	O	O
to	O	O	O
retire	O	O	B-T033
has	O	O	O
surged	O	O	B-T169
by	O	O	O
a	O	O	O
quarter	O	O	O
since	O	O	O
2012	O	O	O
.	O	O	O

The	O	O	O
potential	O	O	O
consequences	O	O	B-T169
are	O	O	O
alarming	O	O	B-T080
;	O	O	O
a	O	O	O
serious	O	O	O
shortage	O	O	B-T081
of	O	O	O
nurses	O	O	B-T097
and	O	O	O
other	O	O	O
healthcare	O	O	B-T097
professionals	O	O	I-T097
now	O	O	O
seems	O	O	O
inevitable	O	O	B-T080
.	O	O	O

-DOCSTART- (28095477)

The	O	O	O
Burden	O	O	B-T081
of	O	O	O
Mental	O	O	B-T048
Disorders	O	O	I-T048
in	O	O	O
the	O	O	O
Eastern	O	O	B-T083
Mediterranean	O	O	I-T083
Region	O	O	I-T083
,	O	O	O
1990	O	O	O
-	O	O	O
2013	O	O	O

The	O	O	O
Eastern	O	O	B-T083
Mediterranean	O	O	I-T083
Region	O	O	I-T083
(	O	O	O
EMR	O	O	B-T083
)	O	O	O
is	O	O	O
witnessing	O	O	O
an	O	O	O
increase	O	O	B-T169
in	O	O	O
chronic	O	O	B-T047
disorders	O	O	I-T047
,	O	O	O
including	O	O	O
mental	O	O	B-T048
illness	O	O	I-T048
.	O	O	O

With	O	O	O
ongoing	O	O	O
unrest	O	O	O
,	O	O	O
this	O	O	O
is	O	O	O
expected	O	O	O
to	O	O	O
rise	O	O	O
.	O	O	O

This	O	O	O
is	O	O	O
the	O	O	O
first	O	O	O
study	O	O	B-T062
to	O	O	O
quantify	O	O	O
the	O	O	O
burden	O	O	B-T081
of	O	O	O
mental	O	O	B-T048
disorders	O	O	I-T048
in	O	O	O
the	O	O	O
EMR	O	O	B-T083
.	O	O	O

We	O	O	O
used	O	O	O
data	O	O	B-T078
from	O	O	O
the	O	O	O
Global	O	O	B-T170
Burden	O	O	I-T170
of	O	O	I-T170
Disease	O	O	I-T170
study	O	O	I-T170
(	O	O	O
GBD	O	O	B-T170
)	O	O	O
2013	O	O	O
.	O	O	O

DALYs	O	O	B-UnknownType
(	O	O	O
disability-adjusted	O	O	B-UnknownType
life	O	O	I-UnknownType
years	O	O	I-UnknownType
)	O	O	O
allow	O	O	O
assessment	O	O	B-T058
of	O	O	O
both	O	O	O
premature	O	O	B-T033
mortality	O	O	I-T033
(	O	O	O
years	O	O	B-T081
of	O	O	I-T081
life	O	O	I-T081
lost	O	O	I-T081
-	O	O	O
YLLs	O	O	B-T081
)	O	O	O
and	O	O	O
nonfatal	O	O	O
outcomes	O	O	O
(	O	O	O
years	O	O	B-T079
lived	O	O	I-T079
with	O	O	I-T079
disability	O	O	I-T079
-	O	O	O
YLDs	O	O	B-T079
)	O	O	O
.	O	O	O

DALYs	O	O	B-UnknownType
are	O	O	O
computed	O	O	O
by	O	O	O
adding	O	O	O
YLLs	O	O	B-T081
and	O	O	O
YLDs	O	O	B-T079
for	O	O	O
each	O	O	O
age-sex-country	O	O	O
group	O	O	O
.	O	O	O

In	O	O	O
2013	O	O	O
,	O	O	O
mental	O	O	B-T048
disorders	O	O	I-T048
contributed	O	O	O
to	O	O	O
5.6	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
total	O	O	B-T081
disease	O	O	I-T081
burden	O	O	I-T081
in	O	O	O
the	O	O	O
EMR	O	O	B-T083
(	O	O	O
1894	O	O	O
DALYS	O	O	B-UnknownType
/100,000	O	O	O
population	O	O	B-T098
):	O	O	O
2519	O	O	O
DALYS	O	O	O
/100,000	O	O	O
(	O	O	O
2590/100,000	O	O	O
males	O	O	B-T032
,	O	O	O
2426/100,000	O	O	O
females	O	O	B-T032
)	O	O	O
in	O	O	O
high-income	O	O	B-T033
countries	O	O	B-T083
,	O	O	O
1884	O	O	O
DALYS	O	O	O
/100,000	O	O	O
(	O	O	O
1618/100,000	O	O	O
males	O	O	O
,	O	O	O
2157/100,000	O	O	O
females	O	O	O
)	O	O	O
in	O	O	O
middle-income	O	O	B-T080
countries	O	O	O
,	O	O	O
1607	O	O	O
DALYS	O	O	O
/100,000	O	O	O
(	O	O	O
1500/100,000	O	O	O
males	O	O	O
,	O	O	O
1717/100,000	O	O	O
females	O	O	O
)	O	O	O
in	O	O	O
low-income	O	O	B-T033
countries	O	O	O
.	O	O	O

Females	O	O	B-T032
had	O	O	O
a	O	O	O
greater	O	O	O
proportion	O	O	O
of	O	O	O
burden	O	O	B-T081
due	O	O	O
to	O	O	O
mental	O	O	B-T048
disorders	O	O	I-T048
than	O	O	O
did	O	O	O
males	O	O	B-T032
of	O	O	O
equivalent	O	O	O
ages	O	O	B-T032
,	O	O	O
except	O	O	O
for	O	O	O
those	O	O	O
under	O	O	O
15	O	O	O
years	O	O	B-T079
of	O	O	I-T079
age	O	O	I-T079
.	O	O	O

The	O	O	O
highest	O	O	O
proportion	O	O	O
of	O	O	O
DALYs	O	O	B-UnknownType
occurred	O	O	O
in	O	O	O
the	O	O	O
25	O	O	O
-	O	O	O
49	O	O	O
age	O	O	B-T100
group	O	O	I-T100
,	O	O	O
with	O	O	O
a	O	O	O
peak	O	O	O
in	O	O	O
the	O	O	O
35	O	O	O
-	O	O	O
39	O	O	O
years	O	O	O
age	O	O	O
group	O	O	O
(	O	O	O
5344	O	O	O
DALYs	O	O	O
/100,000	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
burden	O	O	B-T081
of	O	O	O
mental	O	O	B-T048
disorders	O	O	I-T048
in	O	O	O
EMR	O	O	B-T083
increased	O	O	O
from	O	O	O
1726	O	O	O
DALYs	O	O	B-UnknownType
/100,000	O	O	O
in	O	O	O
1990	O	O	O
to	O	O	O
1912	O	O	O
DALYs	O	O	O
/100,000	O	O	O
in	O	O	O
2013	O	O	O
(	O	O	O
10.8	O	O	O
%	O	O	O
increase	O	O	O
)	O	O	O
.	O	O	O

Within	O	O	O
the	O	O	O
mental	O	O	B-T098
disorders	O	O	I-T098
group	O	O	I-T098
in	O	O	O
EMR	O	O	B-T083
,	O	O	O
depressive	O	O	B-T048
disorders	O	O	I-T048
accounted	O	O	O
for	O	O	O
most	O	O	O
DALYs	O	O	B-UnknownType
,	O	O	O
followed	O	O	O
by	O	O	O
anxiety	O	O	B-T048
disorders	O	O	I-T048
.	O	O	O

Among	O	O	O
EMR	O	O	B-T083
countries	O	O	O
,	O	O	O
Palestine	O	O	B-UnknownType
had	O	O	O
the	O	O	O
largest	O	O	O
burden	O	O	B-T081
of	O	O	I-T081
mental	O	O	B-T048
disorders	O	O	I-T048
.	O	O	O

Nearly	O	O	O
all	O	O	O
EMR	O	O	B-T083
countries	O	O	I-T083
had	O	O	O
a	O	O	O
higher	O	O	O
mental	O	O	B-T081
disorder	O	O	I-T081
burden	O	O	I-T081
compared	O	O	O
to	O	O	O
the	O	O	O
global	O	O	O
level	O	O	O
.	O	O	O

Our	O	O	O
findings	O	O	O
call	O	O	O
for	O	O	O
EMR	O	O	B-UnknownType
ministries	O	O	I-UnknownType
of	O	O	O
health	O	O	O
to	O	O	O
increase	O	O	O
provision	O	O	B-T033
of	O	O	O
mental	O	O	B-T058
health	O	O	I-T058
services	O	O	I-T058
and	O	O	O
to	O	O	O
address	O	O	O
the	O	O	O
stigma	O	O	B-T033
of	O	O	I-T033
mental	O	O	I-T033
illness	O	O	I-T033
.	O	O	O

Moreover	O	O	O
,	O	O	O
our	O	O	O
results	O	O	O
showing	O	O	O
the	O	O	O
accelerating	O	O	B-T169
burden	O	O	B-T081
of	O	O	I-T081
mental	O	O	I-T081
health	O	O	I-T081
are	O	O	O
alarming	O	O	O
as	O	O	O
the	O	O	O
region	O	O	O
is	O	O	O
seeing	O	O	O
an	O	O	O
increased	O	O	O
level	O	O	O
of	O	O	O
instability	O	O	B-T033
.	O	O	O

Indeed	O	O	O
,	O	O	O
mental	O	O	B-T033
health	O	O	I-T033
problems	O	O	I-T033
,	O	O	O
if	O	O	O
not	O	O	O
properly	O	O	O
addressed	O	O	O
,	O	O	O
will	O	O	O
lead	O	O	O
to	O	O	O
an	O	O	O
increased	O	O	B-T081
burden	O	O	B-T081
of	O	O	I-T081
diseases	O	O	I-T081
in	O	O	O
the	O	O	O
region	O	O	B-T083
.	O	O	O

-DOCSTART- (28096993)

Like	O	O	O
Father	O	O	B-T099
,	O	O	O
Like	O	O	O
Daughter	O	O	B-T099
-	O	O	O
inherited	O	O	B-T169
cutis	O	O	B-T019
aplasia	O	O	I-T019
occurring	O	O	O
in	O	O	O
a	O	O	O
family	O	O	B-T099
with	O	O	O
Marfan	O	O	B-T047
syndrome	O	O	I-T047
:	O	O	O
a	O	O	O
case	O	O	O
report	O	O	O

We	O	O	O
present	O	O	O
the	O	O	O
case	O	O	B-T169
of	O	O	O
a	O	O	O
newborn	O	O	B-T100
with	O	O	O
co-occurrence	O	O	B-T079
of	O	O	O
Marfan	O	O	B-T047
syndrome	O	O	I-T047
and	O	O	O
aplasia	O	O	B-T019
cutis	O	O	I-T019
congenita	O	O	I-T019
(	O	O	O
ACC	O	O	B-T019
)	O	O	O
and	O	O	O
a	O	O	O
family	O	O	B-T033
history	O	O	I-T033
significant	O	O	B-T078
for	O	O	O
Marfan	O	O	O
syndrome	O	O	O
and	O	O	O
ACC	O	O	O
in	O	O	O
the	O	O	O
father	O	O	B-T099
.	O	O	O

This	O	O	O
case	O	O	B-T169
details	O	O	B-T080
a	O	O	O
previously	O	O	O
unreported	O	O	O
mutation	O	O	B-T045
in	O	O	O
Marfan	O	O	B-T047
syndrome	O	O	I-T047
and	O	O	O
describes	O	O	O
a	O	O	O
novel	O	O	O
coinheritance	O	O	B-T169
of	O	O	O
Marfan	O	O	O
syndrome	O	O	O
and	O	O	O
ACC	O	O	B-T019
.	O	O	O

-DOCSTART- (28099123)

Hyperandrogenemia	O	O	B-T033
in	O	O	O
women	O	O	B-T098
with	O	O	O
polycystic	O	O	B-T047
ovary	O	O	I-T047
syndrome	O	O	I-T047
:	O	O	O
prevalence	O	O	B-T081
,	O	O	O
characteristics	O	O	B-T080
and	O	O	O
association	O	O	B-T080
with	O	O	I-T080
body	O	O	O
mass	O	O	O
index	O	O	O

Hyperandrogenemia	O	O	B-T033
is	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
major	O	O	O
diagnostic	O	O	B-T169
features	O	O	O
for	O	O	O
the	O	O	O
diagnosis	O	O	B-T033
of	O	O	O
polycystic	O	O	B-T047
ovary	O	O	I-T047
syndrome	O	O	I-T047
(	O	O	O
PCOS	O	O	B-T047
)	O	O	O
.	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
this	O	O	O
study	O	O	O
was	O	O	O
to	O	O	O
estimate	O	O	B-T081
the	O	O	O
prevalence	O	O	B-T081
and	O	O	O
the	O	O	O
characteristics	O	O	B-T080
of	O	O	O
hyperandrogenemia	O	O	B-T033
in	O	O	O
women	O	O	B-T098
with	O	O	O
PCOS	O	O	B-T047
and	O	O	O
to	O	O	O
investigate	O	O	B-T169
the	O	O	O
association	O	O	O
of	O	O	O
clinical	O	O	B-T080
and	O	O	O
biochemical	O	O	B-T169
characteristics	O	O	O
with	O	O	O
body	O	O	B-T201
mass	O	O	I-T201
index	O	O	I-T201
(	O	O	O
BMI	O	O	B-T201
)	O	O	O
according	O	O	O
to	O	O	O
the	O	O	O
presence	O	O	B-T033
of	O	O	O
hyperandrogenemia	O	O	O
.	O	O	O

We	O	O	O
studied	O	O	O
266	O	O	O
women	O	O	B-T098
diagnosed	O	O	B-T033
with	O	O	O
PCOS	O	O	B-T047
.	O	O	O

Hyperandrogenemia	O	O	B-T033
was	O	O	O
defined	O	O	O
by	O	O	O
testosterone	O	O	B-T125
(	O	O	O
T	O	O	B-T125
)	O	O	O
and/or	O	O	O
free	O	O	B-T125
testosterone	O	O	I-T125
(	O	O	O
FT	O	O	B-T125
)	O	O	O
and/or	O	O	O
â4	O	O	B-T125
androstenedione	O	O	I-T125
(	O	O	O
Î4-A	O	O	B-T125
)	O	O	O
higher	O	O	O
than	O	O	O
75	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
upper	O	O	O
limits	O	O	O
of	O	O	O
each	O	O	O
hormone	O	O	B-T125
.	O	O	O

Patients	O	O	B-T101
were	O	O	O
stratified	O	O	B-T080
in	O	O	O
two	O	O	O
groups	O	O	B-T098
according	O	O	O
to	O	O	O
a	O	O	O
BMI	O	O	B-T201
threshold	O	O	B-T080
of	O	O	O
25	O	O	O
kg/m2	O	O	O
.	O	O	O

Hyperandrogenemia	O	O	B-T033
was	O	O	O
present	O	O	B-T033
in	O	O	O
78.2	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
patients	O	O	B-T101
.	O	O	O

Elevated	O	O	B-T080
levels	O	O	O
of	O	O	O
T	O	O	B-T125
were	O	O	O
found	O	O	O
in	O	O	O
58.4	O	O	O
%	O	O	O
,	O	O	O
while	O	O	O
elevated	O	O	B-T080
levels	O	O	O
of	O	O	O
FT	O	O	B-T125
and	O	O	O
Î4-A	O	O	B-T125
were	O	O	O
found	O	O	O
in	O	O	O
42.5	O	O	O
%	O	O	O
and	O	O	O
34.1	O	O	O
%	O	O	O
of	O	O	O
patients	O	O	B-T101
.	O	O	O

In	O	O	O
normal	O	O	B-T033
weight	O	O	I-T033
women	O	O	B-T098
(	O	O	O
BMI	O	O	B-T201
â¤25	O	O	O
kg/m2	O	O	O
)	O	O	O
with	O	O	O
hyperandrogenemia	O	O	B-T033
lower	O	O	O
values	O	O	O
of	O	O	O
hip	O	O	B-T201
circumference	O	O	I-T201
and	O	O	O
HOMA-IR	O	O	B-T059
and	O	O	O
increased	O	O	B-T081
levels	O	O	O
of	O	O	O
T	O	O	B-T125
,	O	O	O
FT	O	O	B-T125
,	O	O	O
Î4-A	O	O	B-T125
,	O	O	O
17-hydroxyprogesterone	O	O	B-T125
(	O	O	O
17-OHP	O	O	B-T125
)	O	O	O
,	O	O	O
dehydroepiandrosterone	O	O	B-T109
sulfate	O	O	I-T109
(	O	O	O
DHEAS	O	O	B-T109
)	O	O	O
,	O	O	O
white	O	O	B-T025
blood	O	O	I-T025
cells	O	O	I-T025
(	O	O	O
WBC	O	O	B-T025
)	O	O	O
and	O	O	O
neutrophils	O	O	B-T025
were	O	O	O
observed	O	O	O
compared	O	O	O
to	O	O	O
women	O	O	O
without	O	O	O
hyperandrogenemia	O	O	O
.	O	O	O

Also	O	O	O
,	O	O	O
in	O	O	O
overweight	O	O	B-T184
women	O	O	B-T098
higher	O	O	O
levels	O	O	O
of	O	O	O
T	O	O	B-T125
,	O	O	O
FT	O	O	B-T125
,	O	O	O
Î4-A	O	O	B-T125
,	O	O	O
17-OHP	O	O	B-T125
,	O	O	O
DHEAS	O	O	B-T109
and	O	O	O
cortisol	O	O	B-T125
were	O	O	O
measured	O	O	B-T080
,	O	O	O
while	O	O	O
lower	O	O	O
thyroid-stimulating	O	O	B-T059
hormone	O	O	I-T059
(	O	O	I-T059
TSH	O	O	I-T059
)	O	O	I-T059
levels	O	O	I-T059
were	O	O	O
comparable	O	O	O
to	O	O	O
women	O	O	O
without	O	O	O
hyperandrogenemia	O	O	B-T033
.	O	O	O

This	O	O	O
study	O	O	O
showed	O	O	O
high	O	O	O
prevalence	O	O	B-T081
of	O	O	O
hyperandrogenemia	O	O	B-T033
in	O	O	O
PCOS	O	O	B-T047
women	O	O	B-T098
.	O	O	O

Women	O	O	B-T098
with	O	O	O
BMI	O	O	B-T201
â¤25	O	O	O
kg/m2	O	O	O
have	O	O	O
significant	O	O	B-T078
differences	O	O	O
in	O	O	O
androgens	O	O	B-T125
,	O	O	O
WBC	O	O	B-T025
,	O	O	O
neutrophils	O	O	B-T025
and	O	O	O
HOMA-IR	O	O	B-T059
and	O	O	O
women	O	O	B-T098
with	O	O	O
BMI	O	O	O
â¥25	O	O	O
kg/m2	O	O	O
in	O	O	O
androgens	O	O	O
,	O	O	O
TSH	O	O	B-T121
and	O	O	O
cortisol	O	O	B-T125
according	O	O	O
to	O	O	O
the	O	O	O
presence	O	O	B-T033
or	O	O	O
not	O	O	O
of	O	O	O
hyperandrogenemia	O	O	B-T033
.	O	O	O

-DOCSTART- (28099370)

A	O	O	O
Course	O	O	B-T079
-Based	O	O	O
Approach	O	O	B-T082
to	O	O	O
the	O	O	O
Doctor	O	O	B-T097
of	O	O	O
Nursing	O	O	B-T062
Practice	O	O	I-T062
Project	O	O	I-T062
:	O	O	O
Supporting	O	O	O
Student	O	O	B-T098
Growth	O	O	O
From	O	O	O
Concept	O	O	B-T078
to	O	O	O
Completion	O	O	O

We	O	O	O
describe	O	O	O
a	O	O	O
course	O	O	B-T079
-based	O	O	O
approach	O	O	B-T082
to	O	O	O
the	O	O	O
doctor	O	O	B-T097
of	O	O	O
nursing	O	O	B-T062
practice	O	O	I-T062
project	O	O	I-T062
in	O	O	O
which	O	O	O
students	O	O	B-T098
work	O	O	B-T057
in	O	O	O
groups	O	O	B-T078
of	O	O	O
8	O	O	O
to	O	O	O
12	O	O	O
with	O	O	O
a	O	O	O
faculty	O	O	B-T097
member	O	O	I-T097
to	O	O	O
complete	O	O	B-T080
individual	O	O	O
final	O	O	O
projects	O	O	B-T077
that	O	O	O
require	O	O	O
a	O	O	O
minimum	O	O	B-T080
of	O	O	O
360	O	O	O
practicum	O	O	B-T065
hours	O	O	B-T079
in	O	O	O
3-	O	O	O
semester	O	O	B-T079
-long	O	O	O
courses	O	O	B-T079
.	O	O	O

Project	O	O	B-T096
teams	O	O	I-T096
include	O	O	O
agency	O	O	B-T092
or	O	O	O
community	O	O	B-T096
-based	O	O	O
mentors	O	O	B-T098
.	O	O	O

Project	O	O	B-T033
findings	O	O	I-T033
are	O	O	O
disseminated	O	O	B-T082
through	O	O	O
written	O	O	B-T170
and	O	O	O
oral	O	O	B-T170
reports	O	O	I-T170
.	O	O	O

This	O	O	O
approach	O	O	B-T082
preserves	O	O	O
faculty	O	O	B-T097
resources	O	O	B-T169
and	O	O	O
provides	O	O	O
students	O	O	B-T098
with	O	O	O
mentoring	O	O	B-T065
,	O	O	O
opportunities	O	O	B-T078
for	O	O	O
reflection	O	O	B-T054
,	O	O	O
and	O	O	O
time	O	O	B-T079
for	O	O	O
project	O	O	B-T169
development	O	O	I-T169
.	O	O	O

-DOCSTART- (28105138)

Clinical	O	O	B-T080
and	O	O	O
angiographic	O	O	B-T060
correlation	O	O	B-T080
of	O	O	O
high-sensitivity	O	O	B-T116
C-reactive	O	O	I-T116
protein	O	O	I-T116
with	O	O	O
acute	O	O	O
ST	O	O	O
elevation	O	O	O
myocardial	O	O	O
infarction	O	O	O

Vascular	O	O	B-T047
inflammation	O	O	I-T047
and	O	O	O
associated	O	O	O
ongoing	O	O	O
inflammatory	O	O	B-T046
responses	O	O	I-T046
are	O	O	O
considered	O	O	O
as	O	O	O
the	O	O	O
critical	O	O	O
culprits	O	O	O
in	O	O	O
the	O	O	O
pathogenesis	O	O	B-T046
of	O	O	O
acute	O	O	B-T079
atherothrombotic	O	O	B-T020
events	O	O	B-T051
such	O	O	O
as	O	O	O
acute	O	O	B-T047
coronary	O	O	I-T047
syndrome	O	O	I-T047
(	O	O	O
ACS	O	O	B-T047
)	O	O	O
and	O	O	O
myocardial	O	O	B-T047
infarction	O	O	I-T047
(	O	O	O
MI	O	O	B-T047
)	O	O	O
.	O	O	O

ST	O	O	B-T047
segment	O	O	I-T047
elevation	O	O	I-T047
myocardial	O	O	I-T047
infarction	O	O	I-T047
(	O	O	O
STEMI	O	O	B-T047
)	O	O	O
is	O	O	O
considered	O	O	O
as	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
prominent	O	O	O
clinical	O	O	B-T080
forms	O	O	B-T080
of	O	O	O
ACS	O	O	B-T047
.	O	O	O

Moreover	O	O	O
,	O	O	O
C-reactive	O	O	B-T116
protein	O	O	I-T116
(	O	O	O
CRP	O	O	B-T116
)	O	O	O
is	O	O	O
an	O	O	O
important	O	O	O
acute	O	O	B-T116
phase	O	O	I-T116
prsotein	O	O	I-T116
,	O	O	O
which	O	O	O
may	O	O	O
be	O	O	O
estimated	O	O	O
using	O	O	O
high-sensitivity	O	O	B-T059
methods	O	O	I-T059
(	O	O	O
hs-CRP	O	O	B-T059
)	O	O	O
,	O	O	O
and	O	O	O
its	O	O	O
elevated	O	O	B-T080
level	O	O	B-T034
in	O	O	O
body	O	O	B-T031
fluids	O	O	I-T031
reflects	O	O	O
chronic	O	O	B-T046
inflammatory	O	O	I-T046
status	O	O	B-T080
.	O	O	O

The	O	O	O
circulating	O	O	O
hs-CRP	O	O	B-T059
level	O	O	B-T034
has	O	O	O
been	O	O	O
proposed	O	O	O
as	O	O	O
a	O	O	O
promising	O	O	O
inflammatory	O	O	B-T046
marker	O	O	B-T201
of	O	O	O
coronary	O	O	B-T047
artery	O	O	I-T047
disease	O	O	I-T047
(	O	O	O
CAD	O	O	B-T047
)	O	O	O
.	O	O	O

The	O	O	O
present	O	O	O
study	O	O	B-T062
investigated	O	O	B-T169
the	O	O	O
correlation	O	O	B-T080
of	O	O	O
hs-CRP	O	O	B-T059
level	O	O	B-T034
with	O	O	O
clinical	O	O	B-T080
and	O	O	O
angiographic	O	O	B-T060
features	O	O	B-T080
of	O	O	O
STEMI	O	O	B-T047
,	O	O	O
various	O	O	O
other	O	O	O
traditional	O	O	O
risk	O	O	B-T033
factors	O	O	I-T033
,	O	O	O
complications	O	O	B-T046
of	O	O	O
myocardial	O	O	B-T047
infarction	O	O	I-T047
and	O	O	O
angiographically	O	O	B-T078
significant	O	O	I-T078
CAD	O	O	B-T047
.	O	O	O

Out	O	O	O
of	O	O	O
190	O	O	O
patients	O	O	B-T101
with	O	O	O
STEMI	O	O	B-T047
that	O	O	O
were	O	O	O
analyzed	O	O	B-T062
,	O	O	O
the	O	O	O
interval	O	O	B-T079
between	O	O	O
symptom	O	O	B-T079
onset	O	O	I-T079
and	O	O	O
reperfusion	O	O	B-T061
therapy	O	O	I-T061
(	O	O	O
window	O	O	B-T079
period	O	O	I-T079
)	O	O	O
varied	O	O	O
from	O	O	O
0.5	O	O	O
to	O	O	O
24	O	O	O
h.	O	O	O
The	O	O	O
hs-CRP	O	O	B-T059
value	O	O	O
was	O	O	O
found	O	O	O
to	O	O	O
be	O	O	O
higher	O	O	O
in	O	O	O
non-diabetic	O	O	B-T101
patients	O	O	I-T101
(	O	O	O
0.61	O	O	O
mg/dl	O	O	O
)	O	O	O
compared	O	O	B-T052
with	O	O	O
diabetic	O	O	B-T047
patients	O	O	O
(	O	O	O
0.87	O	O	O
mg/dl	O	O	O
)	O	O	O
.	O	O	O

Moreover	O	O	O
,	O	O	O
a	O	O	O
significant	O	O	O
correlation	O	O	B-T080
between	O	O	O
hs-CRP	O	O	B-T059
and	O	O	O
hs-troponin	O	O	B-T059
T	O	O	I-T059
was	O	O	O
also	O	O	O
recorded	O	O	O
(	O	O	O
P<0.001	O	O	O
)	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
there	O	O	O
was	O	O	O
no	O	O	O
significant	O	O	O
difference	O	O	O
in	O	O	O
the	O	O	O
mean	O	O	O
hs-CRP	O	O	B-T059
values	O	O	B-T080
in	O	O	O
patients	O	O	B-T101
with	O	O	O
or	O	O	O
without	O	O	O
mortality	O	O	B-T081
.	O	O	O

It	O	O	O
is	O	O	O
considered	O	O	O
that	O	O	O
the	O	O	O
present	O	O	O
study	O	O	B-T062
will	O	O	O
increase	O	O	O
the	O	O	O
understanding	O	O	O
of	O	O	O
atherosclerosis	O	O	B-T047
in	O	O	O
general	O	O	O
and	O	O	O
may	O	O	O
also	O	O	O
have	O	O	O
clinical	O	O	B-T058
applications	O	O	I-T058
in	O	O	O
the	O	O	O
targeting	O	O	O
of	O	O	O
therapy	O	O	B-T061
for	O	O	O
this	O	O	O
harmful	O	O	O
disease	O	O	B-T047
.	O	O	O

-DOCSTART- (28105595)

Bioelectrochemical	O	O	B-T059
anaerobic	O	O	B-T080
sewage	O	O	B-T057
treatment	O	O	I-T057
technology	O	O	B-T090
for	O	O	O
Arctic	O	O	B-T083
communities	O	O	O

This	O	O	O
study	O	O	B-T062
describes	O	O	O
a	O	O	O
novel	O	O	O
wastewater	O	O	B-T083
treatment	O	O	B-T169
technology	O	O	B-T090
suitable	O	O	O
for	O	O	O
small	O	O	O
remote	O	O	B-T082
northern	O	O	B-T082
communities	O	O	B-T096
.	O	O	O

The	O	O	O
technology	O	O	B-T090
is	O	O	O
based	O	O	B-T169
on	O	O	O
an	O	O	O
enhanced	O	O	B-T052
biodegradation	O	O	B-T070
of	O	O	O
organic	O	O	B-T104
carbon	O	O	I-T104
through	O	O	O
a	O	O	O
combination	O	O	O
of	O	O	O
anaerobic	O	O	B-T080
methanogenic	O	O	B-T194
and	O	O	O
microbial	O	O	B-T001
electrochemical	O	O	B-T059
(	O	O	O
bioelectrochemical	O	O	B-T059
)	O	O	O
degradation	O	O	B-T169
processes	O	O	I-T169
leading	O	O	O
to	O	O	O
biomethane	O	O	B-T109
production	O	O	B-T169
.	O	O	O

The	O	O	O
microbial	O	O	B-T001
electrochemical	O	O	B-T059
degradation	O	O	B-T169
is	O	O	O
achieved	O	O	O
in	O	O	O
a	O	O	O
membraneless	O	O	B-T033
flow	O	O	I-T033
-through	O	O	O
bioanode	O	O	B-T073
-	O	O	O
biocathode	O	O	B-T073
setup	O	O	O
operating	O	O	B-T169
at	O	O	O
an	O	O	O
applied	O	O	B-T169
voltage	O	O	B-T081
below	O	O	O
the	O	O	O
water	O	O	B-T121
electrolysis	O	O	B-T061
threshold	O	O	B-T080
.	O	O	O

Laboratory	O	O	B-T093
wastewater	O	O	B-T083
treatment	O	O	B-T169
tests	O	O	B-T170
conducted	O	O	O
through	O	O	O
a	O	O	O
broad	O	O	B-T082
range	O	O	I-T082
of	O	O	O
mesophilic	O	O	B-T080
and	O	O	O
psychrophilic	O	O	B-T070
temperatures	O	O	I-T070
(	O	O	O
5	O	O	O
-	O	O	O
23	O	O	O
Â°	O	O	O
C	O	O	O
)	O	O	O
using	O	O	O
synthetic	O	O	B-T080
wastewater	O	O	O
showed	O	O	O
a	O	O	O
biochemical	O	O	B-T059
oxygen	O	O	I-T059
demand	O	O	I-T059
(	O	O	O
BOD5	O	O	B-T059
)	O	O	O
removal	O	O	B-T052
efficiency	O	O	B-T081
of	O	O	O
90	O	O	O
-	O	O	O
97	O	O	O
%	O	O	O
and	O	O	O
an	O	O	O
effluent	O	O	B-T170
BOD5	O	O	O
concentration	O	O	B-T081
as	O	O	O
low	O	O	O
as	O	O	O
7	O	O	O
mg	O	O	O
L(-1	O	O	O
)	O	O	O
.	O	O	O

An	O	O	O
electricity	O	O	B-T070
consumption	O	O	B-T169
of	O	O	O
0.6	O	O	O
kWh	O	O	O
kg(-1	O	O	O
)	O	O	O
of	O	O	O
chemical	O	O	B-T038
oxygen	O	O	I-T038
demand	O	O	I-T038
(	O	O	O
COD	O	O	B-T038
)	O	O	O
removed	O	O	B-T080
was	O	O	O
observed	O	O	B-T169
.	O	O	O

Low	O	O	B-T080
energy	O	O	B-T081
consumption	O	O	B-T169
coupled	O	O	O
with	O	O	O
enhanced	O	O	B-T052
methane	O	O	B-T109
production	O	O	B-T169
led	O	O	O
to	O	O	O
a	O	O	O
net	O	O	O
positive	O	O	B-T033
energy	O	O	O
balance	O	O	B-T169
in	O	O	O
the	O	O	O
bioelectrochemical	O	O	B-T059
treatment	O	O	B-T169
system	O	O	B-T169
.	O	O	O

-DOCSTART- (28106001)

Impact	O	O	B-T080
of	O	O	O
femoral	O	O	B-T023
artery	O	O	I-T023
puncture	O	O	B-T058
using	O	O	O
digital	O	O	B-T060
subtraction	O	O	I-T060
angiography	O	O	I-T060
and	O	O	O
road	O	O	B-T052
mapping	O	O	I-T052
on	O	O	O
vascular	O	O	B-T047
and	O	O	O
bleeding	O	O	B-T046
complications	O	O	B-T046
after	O	O	O
transfemoral	O	O	O
transcatheter	O	O	O
aortic	O	O	O
valve	O	O	O
implantation	O	O	O

The	O	O	O
use	O	O	O
of	O	O	O
large	O	O	B-T081
-	O	O	O
diameter	O	O	B-T081
sheaths	O	O	O
carries	O	O	O
the	O	O	O
risk	O	O	B-T078
of	O	O	O
significant	O	O	O
vascular	O	O	B-T047
and	O	O	O
bleeding	O	O	B-T046
complications	O	O	B-T046
after	O	O	O
transfemoral	O	O	O
transcatheter	O	O	B-T061
aortic	O	O	I-T061
valve	O	O	I-T061
implantation	O	O	I-T061
(	O	O	O
TAVI	O	O	B-T061
)	O	O	O
.	O	O	O

In	O	O	O
this	O	O	O
analysis	O	O	B-T062
,	O	O	O
we	O	O	O
sought	O	O	O
to	O	O	O
assess	O	O	B-T058
the	O	O	O
impact	O	O	B-T080
of	O	O	O
a	O	O	O
modified	O	O	O
femoral	O	O	B-T023
artery	O	O	I-T023
puncture	O	O	B-T058
technique	O	O	B-T169
using	O	O	O
digital	O	O	B-T060
subtraction	O	O	I-T060
angiography	O	O	I-T060
(	O	O	O
DSA	O	O	B-T060
)	O	O	O
and	O	O	O
road	O	O	B-T052
mapping	O	O	I-T052
during	O	O	O
transfemoral	O	O	O
TAVI	O	O	B-T061
on	O	O	O
periprocedural	O	O	B-T046
vascular	O	O	B-T023
and	O	O	O
bleeding	O	O	B-T046
events	O	O	O
.	O	O	O

This	O	O	O
is	O	O	O
a	O	O	O
retrospective	O	O	O
analysis	O	O	B-T062
of	O	O	O
transfemoral	O	O	O
TAVI	O	O	B-T061
patients	O	O	B-T101
included	O	O	O
in	O	O	O
a	O	O	O
prospective	O	O	B-T170
institutional	O	O	I-T170
database	O	O	I-T170
.	O	O	O

The	O	O	O
modified	O	O	O
femoral	O	O	B-T023
artery	O	O	I-T023
puncture	O	O	B-T058
technique	O	O	B-T169
using	O	O	O
DSA	O	O	B-T060
-derived	O	O	O
road	O	O	B-T052
mapping	O	O	I-T052
guidance	O	O	O
was	O	O	O
introduced	O	O	O
in	O	O	O
October	O	O	O
2012	O	O	O
.	O	O	O

Before	O	O	O
the	O	O	O
introduction	O	O	O
of	O	O	O
this	O	O	O
technique	O	O	B-T169
,	O	O	O
vascular	O	O	B-T023
puncture	O	O	B-T058
was	O	O	O
acquired	O	O	O
based	O	O	O
on	O	O	O
an	O	O	O
integration	O	O	O
of	O	O	O
angiographic	O	O	B-T060
data	O	O	B-T078
,	O	O	O
the	O	O	O
bony	O	O	B-T169
iliofemoral	O	O	B-T023
landmarks	O	O	B-T029
and	O	O	O
a	O	O	O
radiopaque	O	O	B-T074
object	O	O	I-T074
.	O	O	O

Consecutive	O	O	O
patients	O	O	B-T101
who	O	O	O
underwent	O	O	O
TAVI	O	O	B-T061
with	O	O	O
the	O	O	O
road	O	O	B-T052
mapping	O	O	I-T052
technique	O	O	B-T169
(	O	O	O
RM	O	O	B-T078
group	O	O	I-T078
,	O	O	O
n=160	O	O	O
)	O	O	O
were	O	O	O
compared	O	O	O
with	O	O	O
consecutive	O	O	O
patients	O	O	O
who	O	O	O
underwent	O	O	O
TAVI	O	O	O
without	O	O	O
road	O	O	O
mapping	O	O	O
(	O	O	O
control	O	O	B-T096
group	O	O	I-T096
,	O	O	O
n=160	O	O	O
)	O	O	O
prior	O	O	O
to	O	O	O
its	O	O	O
introduction	O	O	O
.	O	O	O

A	O	O	O
standardised	O	O	O
strategy	O	O	O
of	O	O	O
periprocedural	O	O	B-T061
anticoagulation	O	O	I-T061
was	O	O	O
adopted	O	O	O
in	O	O	O
both	O	O	O
groups	O	O	B-T078
as	O	O	O
well	O	O	O
as	O	O	O
the	O	O	O
use	O	O	O
of	O	O	O
a	O	O	O
single	O	O	B-T074
suture-based	O	O	I-T074
closure	O	O	I-T074
device	O	O	I-T074
.	O	O	O

All	O	O	O
endpoints	O	O	B-T080
were	O	O	O
defined	O	O	O
according	O	O	O
to	O	O	O
the	O	O	O
VARC-2	O	O	B-T170
criteria	O	O	I-T170
for	O	O	O
event	O	O	O
definition	O	O	O
.	O	O	O

The	O	O	O
mean	O	O	O
age	O	O	O
in	O	O	O
the	O	O	O
RM	O	O	B-T078
group	O	O	I-T078
was	O	O	O
80Â±7.7	O	O	O
years	O	O	B-T079
compared	O	O	O
to	O	O	O
81Â±5.9	O	O	O
years	O	O	O
in	O	O	O
the	O	O	O
control	O	O	B-T096
group	O	O	I-T096
(	O	O	O
p=0.19	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
females	O	O	B-T032
were	O	O	O
equally	O	O	O
distributed	O	O	O
between	O	O	O
both	O	O	O
groups	O	O	B-T078
(	O	O	O
63.1	O	O	O
%	O	O	O
vs.	O	O	O
58.1	O	O	O
%	O	O	O
,	O	O	O
p=0.36	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
baseline	O	O	B-T170
logistic	O	O	I-T170
EuroSCORE	O	O	I-T170
was	O	O	O
20.7Â±14.4	O	O	O
%	O	O	O
vs.	O	O	O
24.9Â±15.2	O	O	O
%	O	O	O
in	O	O	O
the	O	O	O
RM	O	O	B-T078
and	O	O	O
control	O	O	B-T096
group	O	O	I-T096
,	O	O	O
respectively	O	O	O
(	O	O	O
p=0.01	O	O	O
)	O	O	O
.	O	O	O

Notably	O	O	O
,	O	O	O
sheath	O	O	B-T082
size	O	O	I-T082
was	O	O	O
significantly	O	O	O
larger	O	O	O
in	O	O	O
the	O	O	O
RM	O	O	B-T078
compared	O	O	O
to	O	O	O
the	O	O	O
control	O	O	B-T096
group	O	O	I-T096
due	O	O	O
to	O	O	O
the	O	O	O
more	O	O	O
frequent	O	O	O
use	O	O	O
of	O	O	O
the	O	O	O
20	O	O	O
Fr	O	O	O
sheath	O	O	O
(	O	O	O
23.8	O	O	O
%	O	O	O
vs.	O	O	O
1.8	O	O	O
%	O	O	O
,	O	O	O
p<0.001	O	O	O
,	O	O	O
respectively	O	O	O
)	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
the	O	O	O
more	O	O	O
frequent	O	O	O
implantation	O	O	B-T061
of	O	O	O
the	O	O	O
29	O	O	O
mm	O	O	O
Edwards	O	O	O
SAPIEN	O	O	O
XT	O	O	O
valve	O	O	O
in	O	O	O
the	O	O	O
RM	O	O	B-T078
group	O	O	I-T078
(	O	O	O
43.8	O	O	O
%	O	O	O
vs.	O	O	O
7	O	O	O
%	O	O	O
,	O	O	O
respectively	O	O	O
,	O	O	O
p<0.001	O	O	O
)	O	O	O
.	O	O	O

Despite	O	O	O
the	O	O	O
latter	O	O	O
finding	O	O	O
,	O	O	O
both	O	O	O
major	O	O	O
vascular	O	O	B-T047
complications	O	O	I-T047
and	O	O	O
major	O	O	O
bleeding	O	O	B-T046
at	O	O	O
30	O	O	O
days	O	O	B-T079
were	O	O	O
significantly	O	O	O
lower	O	O	B-T080
in	O	O	O
the	O	O	O
RM	O	O	B-T078
group	O	O	I-T078
compared	O	O	O
to	O	O	O
the	O	O	O
control	O	O	B-T096
group	O	O	I-T096
(	O	O	O
4.3	O	O	O
%	O	O	O
vs.	O	O	O
11.8	O	O	O
%	O	O	O
,	O	O	O
p=0.01	O	O	O
,	O	O	O
and	O	O	O
14.4	O	O	O
%	O	O	O
vs.	O	O	O
25.6	O	O	O
%	O	O	O
,	O	O	O
p=0.01	O	O	O
)	O	O	O
.	O	O	O

An	O	O	O
analysis	O	O	B-T062
limited	O	O	O
to	O	O	O
access	O	O	O
site-related	O	O	O
complications	O	O	B-T046
also	O	O	O
revealed	O	O	O
lower	O	O	O
events	O	O	O
in	O	O	O
the	O	O	O
road	O	O	B-T078
map	O	O	I-T078
group	O	O	I-T078
but	O	O	O
did	O	O	O
not	O	O	O
reach	O	O	O
statistical	O	O	B-T081
significance	O	O	I-T081
(	O	O	O
8.1	O	O	O
%	O	O	O
vs.	O	O	O
13.8	O	O	O
%	O	O	O
,	O	O	O
p=0.1	O	O	O
)	O	O	O
.	O	O	O

Other	O	O	O
forms	O	O	O
of	O	O	O
vascular	O	O	B-T047
and	O	O	O
bleeding	O	O	B-T046
complications	O	O	B-T046
as	O	O	O
well	O	O	O
as	O	O	O
all-cause	O	O	B-T081
mortality	O	O	I-T081
were	O	O	O
comparable	O	O	O
in	O	O	O
both	O	O	O
groups	O	O	B-T078
.	O	O	O

A	O	O	O
modified	O	O	O
femoral	O	O	B-T023
artery	O	O	I-T023
puncture	O	O	B-T058
technique	O	O	B-T169
using	O	O	O
DSA	O	O	B-T060
and	O	O	O
road	O	O	B-T052
mapping	O	O	I-T052
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
a	O	O	O
reduction	O	O	O
in	O	O	O
major	O	O	O
vascular	O	O	B-T047
and	O	O	O
bleeding	O	O	B-T046
complications	O	O	B-T046
after	O	O	O
transfemoral	O	O	O
TAVI	O	O	B-T061
,	O	O	O
and	O	O	O
provides	O	O	O
a	O	O	O
simple	O	O	B-T080
and	O	O	O
effective	O	O	B-T080
strategy	O	O	O
for	O	O	O
potentially	O	O	O
improving	O	O	O
patient	O	O	B-T170
outcomes	O	O	I-T170
.	O	O	O

-DOCSTART- (28107521)

Differential	O	O	B-T080
Roles	O	O	B-T078
of	O	O	O
AXIN1	O	O	B-T116
and	O	O	O
AXIN2	O	O	B-T116
in	O	O	O
Tankyrase	O	O	B-T116
Inhibitor-Induced	O	O	B-T121
Formation	O	O	B-T169
of	O	O	O
Degradasomes	O	O	B-T116
and	O	O	O
Î²-Catenin	O	O	B-T116
Degradation	O	O	O

Inhibition	O	O	B-T039
of	O	O	O
the	O	O	O
tankyrase	O	O	B-T116
enzymes	O	O	I-T116
(	O	O	O
TNKS1	O	O	B-T116
and	O	O	O
TNKS2	O	O	B-T116
)	O	O	O
has	O	O	O
recently	O	O	O
been	O	O	O
shown	O	O	O
to	O	O	O
induce	O	O	O
highly	O	O	B-T080
dynamic	O	O	B-T169
assemblies	O	O	B-T044
of	O	O	O
Î²-catenin	O	O	B-T116
destruction	O	O	B-T104
complex	O	O	I-T104
components	O	O	B-T116
known	O	O	O
as	O	O	O
degradasomes	O	O	B-T116
,	O	O	O
which	O	O	O
promote	O	O	B-T052
degradation	O	O	B-T169
of	O	O	O
Î²-catenin	O	O	O
and	O	O	O
reduced	O	O	B-T080
Wnt	O	O	B-T044
signaling	O	O	I-T044
activity	O	O	B-T169
in	O	O	O
colorectal	O	O	B-T191
cancer	O	O	I-T191
cells	O	O	B-T025
.	O	O	O

AXIN1	O	O	B-T116
and	O	O	O
AXIN2	O	O	B-T116
/	O	O	O
Conductin	O	O	B-T116
,	O	O	O
the	O	O	O
rate-limiting	O	O	B-T169
factors	O	O	B-T169
for	O	O	O
the	O	O	O
stability	O	O	B-T080
and	O	O	O
function	O	O	B-T169
of	O	O	O
endogenous	O	O	B-T169
destruction	O	O	B-T104
complexes	O	O	I-T104
,	O	O	O
are	O	O	O
stabilized	O	O	B-T033
upon	O	O	O
TNKS	O	O	B-T116
inhibition	O	O	B-T039
due	O	O	O
to	O	O	O
abrogated	O	O	O
degradation	O	O	B-T169
of	O	O	O
AXIN	O	O	B-T116
by	O	O	O
the	O	O	O
proteasome	O	O	B-T116
.	O	O	O

Since	O	O	O
the	O	O	O
role	O	O	B-T078
of	O	O	O
AXIN1	O	O	B-T116
versus	O	O	O
AXIN2	O	O	B-T116
as	O	O	O
scaffolding	O	O	B-T116
proteins	O	O	I-T116
in	O	O	O
the	O	O	O
Wnt	O	O	B-T044
signaling	O	O	I-T044
pathway	O	O	I-T044
still	O	O	O
remains	O	O	B-T080
incompletely	O	O	B-T080
understood	O	O	B-T041
,	O	O	O
we	O	O	O
sought	O	O	O
to	O	O	O
elucidate	O	O	O
their	O	O	O
relative	O	O	B-T080
contribution	O	O	B-T052
in	O	O	O
the	O	O	O
formation	O	O	B-T169
of	O	O	O
degradasomes	O	O	B-T116
,	O	O	O
as	O	O	O
these	O	O	O
protein	O	O	B-T116
assemblies	O	O	B-T044
most	O	O	O
likely	O	O	O
represent	O	O	O
the	O	O	O
morphological	O	O	B-T082
and	O	O	O
functional	O	O	B-T169
correlates	O	O	B-T080
of	O	O	O
endogenous	O	O	B-T169
Î²-catenin	O	O	B-T116
destruction	O	O	B-T104
complexes	O	O	I-T104
.	O	O	O

In	O	O	O
SW480	O	O	B-T025
colorectal	O	O	B-T191
cancer	O	O	I-T191
cells	O	O	B-T025
treated	O	O	B-T169
with	O	O	O
the	O	O	O
tankyrase	O	O	B-T121
inhibitor	O	O	I-T121
(	O	O	O
TNKSi	O	O	B-T121
)	O	O	O
G007-LK	O	O	B-T109
we	O	O	O
found	O	O	B-T033
that	O	O	O
AXIN1	O	O	B-T116
was	O	O	O
not	O	O	O
required	O	O	O
for	O	O	O
degradasome	O	O	B-T116
formation	O	O	B-T169
.	O	O	O

In	O	O	O
contrast	O	O	O
,	O	O	O
the	O	O	O
formation	O	O	B-T169
of	O	O	O
degradasomes	O	O	B-T116
as	O	O	O
well	O	O	O
as	O	O	O
their	O	O	O
capacity	O	O	B-T081
to	O	O	O
degrade	O	O	B-T169
Î²-catenin	O	O	B-T116
were	O	O	O
considerably	O	O	B-T078
impaired	O	O	B-T169
in	O	O	O
G007-LK-treated	O	O	B-T109
cells	O	O	B-T025
depleted	O	O	O
of	O	O	O
AXIN2	O	O	B-T116
.	O	O	O

These	O	O	O
findings	O	O	B-T033
give	O	O	O
novel	O	O	B-T080
insights	O	O	B-T041
into	O	O	O
differential	O	O	B-T080
functional	O	O	B-T077
roles	O	O	I-T077
of	O	O	O
AXIN1	O	O	B-T116
versus	O	O	O
AXIN2	O	O	B-T116
in	O	O	O
the	O	O	O
Î²-catenin	O	O	B-T116
destruction	O	O	B-T104
complex	O	O	I-T104
.	O	O	O

-DOCSTART- (28107548)

MRI	O	O	B-T060
-based	O	O	O
prostate	O	O	B-T191
cancer	O	O	I-T191
detection	O	O	B-T033
with	O	O	O
high-level	O	O	B-UnknownType
representation	O	O	I-UnknownType
and	O	O	O
hierarchical	O	O	B-T169
classification	O	O	O

Extracting	O	O	O
the	O	O	O
high-level	O	O	B-UnknownType
feature	O	O	I-UnknownType
representation	O	O	I-UnknownType
by	O	O	O
using	O	O	O
deep	O	O	B-T170
neural	O	O	I-T170
networks	O	O	I-T170
for	O	O	O
detection	O	O	B-T033
of	O	O	O
prostate	O	O	B-T191
cancer	O	O	I-T191
,	O	O	O
and	O	O	O
then	O	O	O
based	O	O	O
on	O	O	O
high-level	O	O	O
feature	O	O	O
representation	O	O	O
constructing	O	O	O
hierarchical	O	O	B-T169
classification	O	O	B-T185
to	O	O	O
refine	O	O	O
the	O	O	O
detection	O	O	O
results	O	O	B-T169
.	O	O	O

High-level	O	O	B-UnknownType
feature	O	O	I-UnknownType
representation	O	O	I-UnknownType
is	O	O	O
first	O	O	O
learned	O	O	O
by	O	O	O
a	O	O	O
deep	O	O	B-T170
learning	O	O	I-T170
network	O	O	I-T170
,	O	O	O
where	O	O	O
multiparametric	O	O	B-T060
MR	O	O	I-T060
images	O	O	B-T170
are	O	O	O
used	O	O	O
as	O	O	O
the	O	O	O
input	O	O	O
data	O	O	B-T078
.	O	O	O

Then	O	O	O
,	O	O	O
based	O	O	O
on	O	O	O
the	O	O	O
learned	O	O	O
high-level	O	O	B-T080
features	O	O	I-T080
,	O	O	O
a	O	O	O
hierarchical	O	O	B-T169
classification	O	O	B-T185
method	O	O	B-T170
is	O	O	O
developed	O	O	O
,	O	O	O
where	O	O	O
multiple	O	O	B-T170
random	O	O	I-T170
forest	O	O	I-T170
classifiers	O	O	I-T170
are	O	O	O
iteratively	O	O	B-T052
constructed	O	O	I-T052
to	O	O	O
refine	O	O	O
the	O	O	O
detection	O	O	B-T033
results	O	O	B-T169
of	O	O	O
prostate	O	O	B-T191
cancer	O	O	I-T191
.	O	O	O

The	O	O	O
experiments	O	O	B-T062
were	O	O	O
carried	O	O	O
on	O	O	O
21	O	O	O
real	O	O	O
patient	O	O	B-T101
subjects	O	O	O
,	O	O	O
and	O	O	O
the	O	O	O
proposed	O	O	O
method	O	O	B-T170
achieves	O	O	O
an	O	O	O
averaged	O	O	O
section-based	O	O	B-T058
evaluation	O	O	I-T058
(	O	O	O
SBE	O	O	B-T058
)	O	O	O
of	O	O	O
89.90	O	O	O
%	O	O	O
,	O	O	O
an	O	O	O
averaged	O	O	O
sensitivity	O	O	B-T169
of	O	O	O
91.51	O	O	O
%	O	O	O
,	O	O	O
and	O	O	O
an	O	O	O
averaged	O	O	O
specificity	O	O	B-T081
of	O	O	O
88.47	O	O	O
%	O	O	O
.	O	O	O

The	O	O	O
high-level	O	O	B-T080
features	O	O	B-T080
learned	O	O	O
from	O	O	O
our	O	O	O
proposed	O	O	O
method	O	O	B-T170
can	O	O	O
achieve	O	O	O
better	O	O	O
performance	O	O	B-T052
than	O	O	O
the	O	O	O
conventional	O	O	B-T081
handcrafted	O	O	B-T080
features	O	O	I-T080
(	O	O	O
e.g.	O	O	O
,	O	O	O
LBP	O	O	B-T080
and	O	O	O
Haar-like	O	O	B-T080
features	O	O	I-T080
)	O	O	O
in	O	O	O
detecting	O	O	B-T033
prostate	O	O	B-T191
cancer	O	O	B-T191
regions	O	O	B-T029
,	O	O	O
also	O	O	O
the	O	O	O
context	O	O	B-T078
features	O	O	O
obtained	O	O	O
from	O	O	O
the	O	O	O
proposed	O	O	O
hierarchical	O	O	B-T169
classification	O	O	B-T185
approach	O	O	O
are	O	O	O
effective	O	O	B-T080
in	O	O	O
refining	O	O	O
cancer	O	O	O
detection	O	O	B-T033
result	O	O	B-T169
.	O	O	O

-DOCSTART- (28113841)

Quantitative	O	O	B-T060
Susceptibility	O	O	I-T060
Mapping	O	O	I-T060
using	O	O	O
Structural	O	O	B-T066
Feature	O	O	I-T066
based	O	O	I-T066
Collaborative	O	O	I-T066
Reconstruction	O	O	I-T066
(	O	O	O
SFCR	O	O	B-T066
)	O	O	O
in	O	O	O
the	O	O	O
Human	O	O	B-T016
Brain	O	O	O

The	O	O	O
reconstruction	O	O	B-T066
of	O	O	O
MR	O	O	B-T070
quantitative	O	O	B-T060
susceptibility	O	O	I-T060
mapping	O	O	I-T060
(	O	O	O
QSM	O	O	B-T060
)	O	O	O
from	O	O	O
local	O	O	B-T079
phase	O	O	I-T079
measurements	O	O	B-T169
is	O	O	O
an	O	O	O
ill	O	O	O
posed	O	O	O
inverse	O	O	O
problem	O	O	O
and	O	O	O
different	O	O	O
regularization	O	O	B-T169
strategies	O	O	I-T169
incorporating	O	O	O
a	O	O	O
priori	O	O	B-T079
information	O	O	B-T078
extracted	O	O	O
from	O	O	O
magnitude	O	O	B-T081
and	O	O	O
phase	O	O	B-T170
images	O	O	I-T170
have	O	O	O
been	O	O	O
proposed	O	O	B-T080
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
anatomy	O	O	B-T017
observed	O	O	O
in	O	O	O
magnitude	O	O	B-T081
and	O	O	O
phase	O	O	B-T170
images	O	O	I-T170
does	O	O	O
not	O	O	O
always	O	O	O
coincide	O	O	O
spatially	O	O	O
with	O	O	O
that	O	O	O
in	O	O	O
susceptibility	O	O	B-T073
maps	O	O	I-T073
,	O	O	O
which	O	O	O
could	O	O	O
give	O	O	O
erroneous	O	O	B-T078
estimation	O	O	B-T081
in	O	O	O
the	O	O	O
reconstructed	O	O	B-T073
susceptibility	O	O	I-T073
map	O	O	I-T073
.	O	O	O

In	O	O	O
this	O	O	O
paper	O	O	O
,	O	O	O
we	O	O	O
develop	O	O	O
a	O	O	O
structural	O	O	B-T066
feature	O	O	I-T066
based	O	O	I-T066
collaborative	O	O	I-T066
reconstruction	O	O	I-T066
(	O	O	O
SFCR	O	O	B-T066
)	O	O	O
method	O	O	O
for	O	O	O
QSM	O	O	B-T060
including	O	O	O
both	O	O	O
magnitude	O	O	B-T081
and	O	O	O
susceptibility	O	O	B-T081
based	O	O	O
information	O	O	B-T078
.	O	O	O

The	O	O	O
SFCR	O	O	B-T066
algorithm	O	O	B-T170
is	O	O	O
composed	O	O	O
of	O	O	O
two	O	O	O
consecutive	O	O	B-T077
steps	O	O	I-T077
corresponding	O	O	O
to	O	O	O
complementary	O	O	O
reconstruction	O	O	B-T170
models	O	O	I-T170
,	O	O	O
each	O	O	O
with	O	O	O
a	O	O	O
structural	O	O	B-T082
feature	O	O	I-T082
based	O	O	O
l1	O	O	O
norm	O	O	B-T169
constraint	O	O	I-T169
and	O	O	O
a	O	O	O
voxel	O	O	O
fidelity	O	O	O
based	O	O	O
l2	O	O	O
norm	O	O	O
constraint	O	O	O
,	O	O	O
which	O	O	O
allows	O	O	O
both	O	O	O
the	O	O	O
structure	O	O	B-T082
edges	O	O	O
and	O	O	O
tiny	O	O	O
features	O	O	B-T080
to	O	O	O
be	O	O	O
recovered	O	O	O
,	O	O	O
whereas	O	O	O
the	O	O	O
noise	O	O	B-T067
and	O	O	O
artifacts	O	O	B-T068
could	O	O	O
be	O	O	O
reduced	O	O	O
.	O	O	O

In	O	O	O
the	O	O	O
M-step	O	O	B-T077
,	O	O	O
the	O	O	O
initial	O	O	O
susceptibility	O	O	B-T073
map	O	O	I-T073
is	O	O	O
reconstructed	O	O	B-T066
by	O	O	O
employing	O	O	O
a	O	O	O
k-space	O	O	O
based	O	O	O
compressed	O	O	B-T170
sensing	O	O	I-T170
model	O	O	I-T170
incorporating	O	O	O
magnitude	O	O	B-T081
prior	O	O	O
.	O	O	O

In	O	O	O
the	O	O	O
S-step	O	O	B-T077
,	O	O	O
the	O	O	O
susceptibility	O	O	B-T073
map	O	O	I-T073
is	O	O	O
fitted	O	O	O
in	O	O	O
spatial	O	O	B-T082
domain	O	O	I-T082
using	O	O	O
weighted	O	O	O
constraints	O	O	B-T169
derived	O	O	O
from	O	O	O
the	O	O	O
initial	O	O	O
susceptibility	O	O	O
map	O	O	O
from	O	O	O
the	O	O	O
M-step	O	O	B-T077
.	O	O	O

Simulations	O	O	B-T062
and	O	O	O
in	O	O	B-T082
vivo	O	O	I-T082
human	O	O	B-T016
experiments	O	O	B-T062
at	O	O	O
7	O	O	O
T	O	O	O
MRI	O	O	B-T060
show	O	O	O
that	O	O	O
the	O	O	O
SFCR	O	O	B-T066
method	O	O	O
provides	O	O	O
high	O	O	O
quality	O	O	B-T080
susceptibility	O	O	B-T073
maps	O	O	I-T073
with	O	O	O
improved	O	O	O
RMSE	O	O	B-T081
and	O	O	O
MSSIM	O	O	B-T081
.	O	O	O

Finally	O	O	O
,	O	O	O
the	O	O	O
susceptibility	O	O	B-T081
values	O	O	O
of	O	O	O
deep	O	O	O
gray	O	O	B-T024
matter	O	O	I-T024
are	O	O	O
analyzed	O	O	O
in	O	O	O
multiple	O	O	B-T082
head	O	O	I-T082
positions	O	O	I-T082
,	O	O	O
with	O	O	O
the	O	O	O
supine	O	O	B-T082
position	O	O	I-T082
most	O	O	O
approximate	O	O	O
to	O	O	O
the	O	O	O
gold	O	O	O
standard	O	O	O
COSMOS	O	O	B-T169
result	O	O	B-T169
.	O	O	O

-DOCSTART- (28117535)

High	O	O	B-T080
HbA1c	O	O	B-T116
at	O	O	O
onset	O	O	B-T080
can	O	O	O
not	O	O	O
be	O	O	O
used	O	O	O
as	O	O	O
a	O	O	O
predictor	O	O	B-T078
for	O	O	O
future	O	O	O
metabolic	O	O	B-T044
control	O	O	I-T044
for	O	O	O
the	O	O	O
individual	O	O	B-T098
child	O	O	B-T100
with	O	O	O
type	O	O	O
1	O	O	O
diabetes	O	O	O
mellitus	O	O	O

To	O	O	O
study	O	O	O
how	O	O	O
metabolic	O	O	B-T044
control	O	O	I-T044
at	O	O	O
onset	O	O	B-T080
of	O	O	O
type	O	O	B-T047
1	O	O	I-T047
diabetes	O	O	I-T047
correlates	O	O	O
to	O	O	O
metabolic	O	O	O
control	O	O	O
and	O	O	O
clinical	O	O	B-T080
parameters	O	O	B-T033
during	O	O	O
childhood	O	O	B-T079
until	O	O	O
transition	O	O	B-T052
from	O	O	O
pediatric	O	O	B-T061
care	O	O	I-T061
to	O	O	O
adult	O	O	B-T100
diabetes	O	O	B-T061
care	O	O	I-T061
.	O	O	O

Data	O	O	B-T078
at	O	O	O
onset	O	O	B-T080
,	O	O	O
three	O	O	O
months	O	O	B-T079
,	O	O	O
one	O	O	O
,	O	O	O
three	O	O	O
,	O	O	O
and	O	O	O
five	O	O	O
years	O	O	B-T079
after	O	O	O
diagnosis	O	O	B-T033
and	O	O	O
at	O	O	O
transition	O	O	B-T052
,	O	O	O
on	O	O	O
HbA1c	O	O	B-T116
and	O	O	O
clinical	O	O	B-T080
parameters	O	O	B-T033
,	O	O	O
on	O	O	O
8084	O	O	O
patients	O	O	B-T101
in	O	O	O
the	O	O	O
Swedish	O	O	B-T170
pediatric	O	O	I-T170
quality	O	O	I-T170
registry	O	O	I-T170
,	O	O	I-T170
SWEDIABKIDS	O	O	I-T170
,	O	O	O
were	O	O	O
used	O	O	O
.	O	O	O

Of	O	O	O
these	O	O	O
patients	O	O	B-T101
,	O	O	O
26	O	O	O
%	O	O	O
had	O	O	O
been	O	O	O
referred	O	O	O
to	O	O	O
adult	O	O	B-T100
diabetes	O	O	B-T061
care	O	O	I-T061
by	O	O	O
2014	O	O	O
.	O	O	O

Children	O	O	B-T100
with	O	O	O
HbA1c	O	O	B-T116
<	O	O	O
72	O	O	O
mmol/mol	O	O	O
(	O	O	O
8.7	O	O	O
%	O	O	O
)	O	O	O
(	O	O	O
20	O	O	O
%	O	O	O
of	O	O	O
patients	O	O	B-T101
,	O	O	O
low	O	O	B-T080
group	O	O	B-T098
)	O	O	O
at	O	O	O
diagnosis	O	O	B-T033
continued	O	O	O
to	O	O	O
have	O	O	O
good	O	O	O
metabolic	O	O	B-T044
control	O	O	I-T044
during	O	O	O
childhood	O	O	B-T079
,	O	O	O
in	O	O	O
contrast	O	O	O
to	O	O	O
children	O	O	B-T100
with	O	O	O
HbA1c	O	O	O
>	O	O	O
114	O	O	O
mmol/mol	O	O	O
(	O	O	O
12.6	O	O	O
%	O	O	O
)	O	O	O
(	O	O	O
20	O	O	O
%	O	O	O
of	O	O	O
patients	O	O	O
,	O	O	O
high	O	O	B-T080
group	O	O	O
)	O	O	O
at	O	O	O
diagnosis	O	O	O
,	O	O	O
who	O	O	O
continued	O	O	O
to	O	O	O
have	O	O	O
high	O	O	O
HbA1c	O	O	O
at	O	O	O
follow-up	O	O	B-T058
.	O	O	O

For	O	O	O
the	O	O	O
individual	O	O	B-T098
,	O	O	O
there	O	O	O
was	O	O	O
no	O	O	B-T033
significant	O	O	I-T033
correlation	O	O	B-T080
between	O	O	O
high	O	O	B-T080
HbA1c	O	O	B-T116
at	O	O	O
onset	O	O	B-T080
and	O	O	O
during	O	O	O
follow-up	O	O	B-T058
.	O	O	O

During	O	O	O
follow-up	O	O	B-T058
,	O	O	O
children	O	O	B-T100
in	O	O	O
the	O	O	O
high	O	O	B-T080
group	O	O	B-T098
were	O	O	O
more	O	O	O
often	O	O	O
smokers	O	O	B-T033
,	O	O	O
less	O	O	O
physically	O	O	B-T033
active	O	O	I-T033
,	O	O	O
and	O	O	O
more	O	O	O
often	O	O	O
had	O	O	O
retinopathy	O	O	B-T047
than	O	O	O
children	O	O	O
in	O	O	O
the	O	O	O
low	O	O	B-T080
group	O	O	O
(	O	O	O
P	O	O	O
<	O	O	O
.01	O	O	O
,	O	O	O
.01	O	O	O
,	O	O	O
.03	O	O	O
respectively	O	O	O
)	O	O	O
.	O	O	O

High	O	O	B-T080
HbA1c	O	O	B-T116
at	O	O	O
onset	O	O	B-T080
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
high	O	O	B-T080
HbA1c	O	O	O
during	O	O	O
follow-up	O	O	B-T058
on	O	O	O
a	O	O	O
group	O	O	B-T098
level	O	O	O
,	O	O	O
but	O	O	O
it	O	O	O
can	O	O	O
not	O	O	O
be	O	O	O
used	O	O	O
as	O	O	O
a	O	O	O
predictor	O	O	B-T078
of	O	O	O
future	O	O	O
metabolic	O	O	B-T044
control	O	O	I-T044
on	O	O	O
an	O	O	O
individual	O	O	B-T098
level	O	O	O
.	O	O	O

These	O	O	O
results	O	O	O
emphasize	O	O	O
the	O	O	O
important	O	O	O
work	O	O	O
done	O	O	O
by	O	O	O
the	O	O	O
diabetes	O	O	B-T047
team	O	O	B-T096
in	O	O	O
the	O	O	O
first	O	O	O
years	O	O	O
after	O	O	O
diagnosis	O	O	B-T033
.	O	O	O

It	O	O	O
is	O	O	O
important	O	O	O
to	O	O	O
continuously	O	O	O
set	O	O	O
high	O	O	B-T080
goals	O	O	B-T170
for	O	O	O
the	O	O	O
achievement	O	O	B-T053
of	O	O	O
tight	O	O	O
metabolic	O	O	B-T044
control	O	O	I-T044
,	O	O	O
in	O	O	O
order	O	O	O
to	O	O	O
decrease	O	O	B-T081
the	O	O	O
risk	O	O	B-T078
of	O	O	O
microvascular	O	O	B-T047
complications	O	O	I-T047
.	O	O	O

-DOCSTART- (28117965)

Photosensitizer	O	O	B-T121
Decorated	O	O	B-T067
Red	O	O	B-T025
Blood	O	O	I-T025
Cells	O	O	I-T025
as	O	O	O
an	O	O	O
Ultra-Sensitive	O	O	O
Light-Responsive	O	O	O
Drug	O	O	O
Delivery	O	O	O
System	O	O	O

Red	O	O	B-T025
blood	O	O	B-T031
cells	O	O	B-T025
(	O	O	O
RBCs	O	O	B-T025
)	O	O	O
,	O	O	O
the	O	O	O
most	O	O	O
abundant	O	O	B-T080
type	O	O	O
of	O	O	O
cells	O	O	O
in	O	O	O
our	O	O	O
blood	O	O	O
,	O	O	O
have	O	O	O
shown	O	O	O
promises	O	O	O
as	O	O	O
a	O	O	O
natural	O	O	B-T070
drug	O	O	I-T070
delivery	O	O	I-T070
system	O	O	I-T070
(	O	O	O
DDS	O	O	B-T070
)	O	O	O
with	O	O	O
inherent	O	O	O
biocompatibility	O	O	B-T044
.	O	O	O

Herein	O	O	O
,	O	O	O
we	O	O	O
uncover	O	O	O
that	O	O	O
a	O	O	O
photosensitizer	O	O	B-T121
,	O	O	O
chlorin	O	O	B-T109
e6	O	O	I-T109
(	O	O	O
Ce6	O	O	B-T109
)	O	O	O
,	O	O	O
could	O	O	O
be	O	O	O
decorated	O	O	B-T067
into	O	O	O
the	O	O	O
membrane	O	O	B-T026
of	O	O	O
RBCs	O	O	B-T025
upon	O	O	O
simple	O	O	O
mixing	O	O	B-T080
,	O	O	O
without	O	O	O
affecting	O	O	O
the	O	O	O
membrane	O	O	O
integrity	O	O	B-T080
and	O	O	O
stability	O	O	B-T080
in	O	O	O
dark	O	O	O
.	O	O	O

Upon	O	O	O
light	O	O	B-T070
irradiation	O	O	B-T070
with	O	O	O
a	O	O	O
rather	O	O	O
low	O	O	O
power	O	O	O
density	O	O	B-T081
,	O	O	O
the	O	O	O
generated	O	O	B-T052
singlet	O	O	B-T123
oxygen	O	O	I-T123
by	O	O	O
Ce6	O	O	B-T109
as	O	O	O
the	O	O	O
result	O	O	B-UnknownType
of	O	O	I-UnknownType
photodynamic	O	O	I-UnknownType
effect	O	O	I-UnknownType
would	O	O	O
lead	O	O	O
to	O	O	O
rather	O	O	O
efficient	O	O	O
disruption	O	O	B-T169
of	O	O	O
RBC	O	O	B-T025
membrane	O	O	B-T026
.	O	O	O

With	O	O	O
doxorubicin	O	O	B-T195
(	O	O	O
DOX	O	O	B-T195
)	O	O	O
,	O	O	O
a	O	O	O
typical	O	O	O
chemotherapy	O	O	B-T061
drug	O	O	B-T121
,	O	O	O
as	O	O	O
the	O	O	O
model	O	O	B-T170
,	O	O	O
we	O	O	O
engineer	O	O	O
a	O	O	O
unique	O	O	O
type	O	O	O
of	O	O	O
light-responsive	O	O	B-T074
RBC-based	O	O	I-T074
DDS	O	O	I-T074
by	O	O	O
decorating	O	O	B-T067
Ce6	O	O	B-T109
on	O	O	O
the	O	O	O
cell	O	O	B-T026
membrane	O	O	I-T026
and	O	O	O
loading	O	O	O
DOX	O	O	O
inside	O	O	O
cells	O	O	B-T025
.	O	O	O

The	O	O	O
light	O	O	B-T070
triggered	O	O	B-T080
cell	O	O	B-T026
membrane	O	O	I-T026
break	O	O	O
down	O	O	O
would	O	O	O
thus	O	O	O
trigger	O	O	B-T080
instant	O	O	O
release	O	O	O
of	O	O	O
DOX	O	O	B-T195
,	O	O	O
enabling	O	O	O
light-controlled	O	O	B-T061
chemotherapy	O	O	I-T061
with	O	O	O
great	O	O	O
specificity	O	O	B-T081
.	O	O	O

Beyond	O	O	O
that	O	O	O
,	O	O	O
our	O	O	O
RBC	O	O	B-T025
system	O	O	O
could	O	O	O
also	O	O	O
be	O	O	O
utilized	O	O	O
for	O	O	O
loading	O	O	O
of	O	O	O
larger	O	O	O
biomolecules	O	O	B-T167
such	O	O	O
as	O	O	O
enzymes	O	O	B-T116
,	O	O	O
whose	O	O	O
release	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
catalytic	O	O	B-T070
function	O	O	B-T169
is	O	O	O
also	O	O	O
controlled	O	O	O
by	O	O	O
light	O	O	B-T070
.	O	O	O

Our	O	O	O
work	O	O	B-T057
thus	O	O	O
presents	O	O	O
a	O	O	O
unique	O	O	O
type	O	O	O
of	O	O	O
biocompatible	O	O	B-T074
cell-based	O	O	I-T074
DDS	O	O	I-T074
that	O	O	O
can	O	O	O
be	O	O	O
precisely	O	O	O
controlled	O	O	O
by	O	O	O
mild	O	O	O
external	O	O	O
stimuli	O	O	B-T067
,	O	O	O
promising	O	O	O
not	O	O	O
only	O	O	O
for	O	O	O
cancer	O	O	B-T061
therapy	O	O	I-T061
but	O	O	O
also	O	O	O
for	O	O	O
other	O	O	O
potential	O	O	O
applications	O	O	B-T169
in	O	O	O
biotechnologies	O	O	B-T091
.	O	O	O

-DOCSTART- (28119436)

Validation	O	O	B-T062
of	O	O	O
the	O	O	O
Neogen	O	O	B-T109
Â®	O	O	I-T109
Fentanyl	O	O	I-T109
ELISA	O	O	B-T059
Kit	O	O	O
for	O	O	O
Blood	O	O	B-T031
and	O	O	O
Urine	O	O	O

The	O	O	O
Neogen	O	O	B-T109
Â®	O	O	I-T109
Fentanyl	O	O	I-T109
ready-to-use	O	O	O
enzyme-linked	O	O	B-T059
immunosorbent	O	O	I-T059
assay	O	O	I-T059
kit	O	O	O
was	O	O	O
validated	O	O	O
following	O	O	O
the	O	O	O
Scientific	O	O	B-T098
Working	O	O	I-T098
Group	O	O	I-T098
for	O	O	O
Forensic	O	O	B-T090
Toxicology	O	O	I-T090
Standard	O	O	B-T091
Practices	O	O	I-T091
for	O	O	O
Method	O	O	O
Validation	O	O	B-T062
in	O	O	O
Forensic	O	O	O
Toxicology	O	O	O
Laboratory	O	O	O
Guidelines	O	O	O
.	O	O	O

Two	O	O	O
decision	O	O	O
points	O	O	O
,	O	O	O
0.5	O	O	O
and	O	O	O
1	O	O	O
ng/mL	O	O	O
,	O	O	O
were	O	O	O
successfully	O	O	O
validated	O	O	O
for	O	O	O
whole	O	O	B-T031
blood	O	O	I-T031
.	O	O	O

For	O	O	O
urine	O	O	B-T031
,	O	O	O
two	O	O	O
decision	O	O	O
points	O	O	O
,	O	O	O
1	O	O	O
and	O	O	O
5	O	O	O
ng/mL	O	O	O
,	O	O	O
were	O	O	O
also	O	O	O
successfully	O	O	O
validated	O	O	O
.	O	O	O

The	O	O	O
validation	O	O	B-T062
included	O	O	O
the	O	O	O
evaluation	O	O	B-T058
of	O	O	O
sensitivity	O	O	B-T081
,	O	O	O
precision	O	O	B-T080
,	O	O	O
specificity	O	O	B-T081
,	O	O	O
carryover	O	O	B-T080
,	O	O	O
plate	O	O	B-T080
drift	O	O	I-T080
,	O	O	O
ruggedness/robustness	O	O	O
and	O	O	O
a	O	O	O
case	O	O	O
sample	O	O	O
evaluation	O	O	O
.	O	O	O

The	O	O	O
empirically	O	O	O
determined	O	O	O
limit	O	O	B-T081
of	O	O	I-T081
detection	O	O	I-T081
was	O	O	O
0.25	O	O	O
ng/mL	O	O	O
for	O	O	O
blood	O	O	B-T031
and	O	O	O
0.5	O	O	O
ng/mL	O	O	O
for	O	O	O
urine	O	O	B-T031
.	O	O	O

Precision	O	O	B-T080
was	O	O	O
determined	O	O	O
at	O	O	O
five	O	O	O
different	O	O	O
concentrations	O	O	B-T081
ranging	O	O	O
from	O	O	O
0.25	O	O	O
to	O	O	O
1.5	O	O	O
ng/mL	O	O	O
with	O	O	O
15	O	O	O
replicates	O	O	B-T080
at	O	O	O
each	O	O	O
level	O	O	O
for	O	O	O
whole	O	O	B-T031
blood	O	O	I-T031
and	O	O	O
demonstrated	O	O	O
a	O	O	O
<	O	O	O
2.4	O	O	O
%	O	O	O
coefficient	O	O	B-T081
of	O	O	I-T081
variation	O	O	I-T081
(	O	O	O
CV	O	O	B-T081
)	O	O	O
.	O	O	O

In	O	O	O
urine	O	O	B-T031
,	O	O	O
the	O	O	O
CV	O	O	B-T081
was	O	O	O
<	O	O	O
5.6	O	O	O
%	O	O	O
at	O	O	O
six	O	O	O
different	O	O	O
concentrations	O	O	B-T081
from	O	O	O
0.5	O	O	O
to	O	O	O
7.5	O	O	O
ng/mL	O	O	O
with	O	O	O
15	O	O	O
replicates	O	O	B-T080
at	O	O	O
each	O	O	O
level	O	O	O
.	O	O	O

Cross-reactivity	O	O	B-T044
was	O	O	O
evaluated	O	O	B-T058
for	O	O	O
norfentanyl	O	O	B-T109
,	O	O	O
acetyl	O	O	B-T109
fentanyl	O	O	I-T109
,	O	O	O
4-anilino-N-phenethylpiperidine	O	O	B-T109
,	O	O	O
beta-hydroxythiofentanyl	O	O	B-T121
,	O	O	O
butyryl	O	O	B-T121
fentanyl	O	O	I-T121
and	O	O	O
furanyl	O	O	B-T109
fentanyl	O	O	I-T109
.	O	O	O

-DOCSTART- (28121744)

Everolimus	O	O	B-T109
for	O	O	O
Treatment	O	O	B-T061
of	O	O	O
Pseudomyogenic	O	O	O
Hemangioendothelioma	O	O	O

Pseudomyogenic	O	O	B-T191
hemangioendothelioma	O	O	I-T191
(	O	O	O
PMH	O	O	B-T191
)	O	O	O
is	O	O	O
a	O	O	O
recently	O	O	O
described	O	O	O
vascular	O	O	B-T191
neoplasm	O	O	I-T191
that	O	O	O
occurs	O	O	O
most	O	O	O
commonly	O	O	O
in	O	O	O
the	O	O	O
soft	O	O	B-T024
tissue	O	O	I-T024
of	O	O	O
the	O	O	O
distal	O	O	O
extremities	O	O	O
of	O	O	O
young	O	O	B-T100
adults	O	O	I-T100
.	O	O	O

Metastatic	O	O	B-T169
PMH	O	O	B-T191
can	O	O	O
be	O	O	O
fatal	O	O	B-T080
and	O	O	O
there	O	O	O
are	O	O	O
no	O	O	O
effective	O	O	B-T080
medications	O	O	B-T121
.	O	O	O

We	O	O	O
describe	O	O	O
a	O	O	O
case	O	O	B-T077
of	O	O	O
a	O	O	O
15-year-old	O	O	O
boy	O	O	B-T100
with	O	O	O
metastatic	O	O	B-T169
PMH	O	O	B-T191
,	O	O	O
who	O	O	O
responded	O	O	B-T201
to	O	O	I-T201
treatment	O	O	I-T201
with	O	O	O
everolimus	O	O	B-T109
,	O	O	O
a	O	O	O
mammalian	O	O	B-T121
target	O	O	I-T121
of	O	O	I-T121
rapamycin	O	O	I-T121
inhibitor	O	O	I-T121
.	O	O	O

Immunohistochemistry	O	O	B-T060
showed	O	O	O
that	O	O	O
mammalian	O	O	B-T116
target	O	O	I-T116
of	O	O	I-T116
rapamycin	O	O	I-T116
was	O	O	O
expressed	O	O	B-T045
in	O	O	O
PMH	O	O	B-T191
biopsy	O	O	B-T024
specimens	O	O	I-T024
,	O	O	O
which	O	O	O
may	O	O	O
explain	O	O	O
the	O	O	O
reduction	O	O	B-T080
in	O	O	O
PMH	O	O	O
tumor	O	O	B-T082
size	O	O	I-T082
following	O	O	O
treatment	O	O	B-T061
.	O	O	O

-DOCSTART- (28122243)

Opposing	O	O	O
Roles	O	O	B-T080
of	O	O	O
Acetylation	O	O	B-T044
and	O	O	O
Phosphorylation	O	O	B-T044
in	O	O	O
LIFR	O	O	B-T116
-	O	O	O
Dependent	O	O	B-T169
Self-Renewal	O	O	B-T043
Growth	O	O	B-T040
Signaling	O	O	B-T044
in	O	O	O
Mouse	O	O	O
Embryonic	O	O	O
Stem	O	O	O
Cells	O	O	O

LIF	O	O	B-T116
promotes	O	O	O
self-renewal	O	O	B-T043
of	O	O	O
mouse	O	O	B-T025
embryonic	O	O	I-T025
stem	O	O	I-T025
cells	O	O	B-T025
(	O	O	O
mESCs	O	O	B-T025
)	O	O	O
,	O	O	O
and	O	O	O
in	O	O	O
its	O	O	O
absence	O	O	B-T080
,	O	O	O
the	O	O	O
cells	O	O	O
differentiate	O	O	B-T169
.	O	O	O

LIF	O	O	B-T116
binds	O	O	O
to	O	O	O
the	O	O	O
LIF	O	O	B-T116
receptor	O	O	I-T116
(	O	O	O
LIFR	O	O	B-T116
)	O	O	O
and	O	O	O
activates	O	O	B-T052
the	O	O	O
JAK-STAT3	O	O	B-T044
pathway	O	O	I-T044
,	O	O	O
but	O	O	O
it	O	O	O
remains	O	O	B-T080
unknown	O	O	I-T080
how	O	O	O
the	O	O	O
receptor	O	O	B-T026
complex	O	O	I-T026
triggers	O	O	B-T080
differentiation	O	O	B-T169
or	O	O	O
self-renewal	O	O	B-T043
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
report	O	O	O
that	O	O	O
the	O	O	O
LIFR	O	O	B-T116
cytoplasmic	O	O	B-T026
domain	O	O	B-T169
contains	O	O	O
a	O	O	O
self-renewal	O	O	B-T043
domain	O	O	O
within	O	O	O
the	O	O	O
juxtamembrane	O	O	B-T026
region	O	O	I-T026
and	O	O	O
a	O	O	O
differentiation	O	O	B-T169
domain	O	O	O
within	O	O	O
the	O	O	O
C-terminal	O	O	B-T087
region	O	O	I-T087
.	O	O	O

The	O	O	O
differentiation	O	O	B-T169
domain	O	O	B-T169
contains	O	O	O
four	O	O	O
SPXX	O	O	B-T116
repeats	O	O	I-T116
that	O	O	O
are	O	O	O
phosphorylated	O	O	B-T044
by	O	O	O
MAPK	O	O	B-T116
to	O	O	O
restrict	O	O	B-T169
STAT3	O	O	B-T043
activation	O	O	I-T043
;	O	O	O
the	O	O	O
self-renewal	O	O	B-T043
domain	O	O	O
is	O	O	O
characterized	O	O	O
by	O	O	O
a	O	O	O
3	O	O	B-T116
K	O	O	I-T116
motif	O	O	I-T116
that	O	O	O
is	O	O	O
acetylated	O	O	B-T044
by	O	O	O
p300	O	O	O
.	O	O	O

In	O	O	O
mESCs	O	O	B-T025
,	O	O	O
acetyl-	O	O	O
LIFR	O	O	B-T116
undergoes	O	O	O
homodimerization	O	O	B-T044
,	O	O	O
leading	O	O	O
to	O	O	O
STAT3	O	O	B-T116
hypo-	O	O	B-T052
or	O	O	I-T052
hyper-activation	O	O	I-T052
depending	O	O	B-T169
on	O	O	O
the	O	O	O
presence	O	O	B-T033
or	O	O	O
absence	O	O	B-T169
of	O	O	O
gp130	O	O	B-T116
.	O	O	O

LIFR	O	O	B-T116
-	O	O	O
activated	O	O	B-T052
STAT3	O	O	B-T116
restricts	O	O	B-T169
differentiation	O	O	B-T169
via	O	O	O
cytokine	O	O	B-T116
induction	O	O	B-T169
.	O	O	O

Thus	O	O	O
,	O	O	O
LIFR	O	O	B-T116
acetylation	O	O	B-T044
and	O	O	O
serine	O	O	B-T044
phosphorylation	O	O	I-T044
differentially	O	O	B-T169
promote	O	O	O
stem	O	O	B-T025
cell	O	O	I-T025
self-renewal	O	O	B-T043
and	O	O	O
differentiation	O	O	B-T169
.	O	O	O

-DOCSTART- (28122925)

Interprofessional	O	O	B-T054
primary	O	O	B-T058
care	O	O	I-T058
team	O	O	B-T058
meetings	O	O	I-T058
:	O	O	O
a	O	O	O
qualitative	O	O	B-T080
approach	O	O	B-T082
comparing	O	O	O
observations	O	O	B-T062
with	O	O	O
personal	O	O	B-T032
opinions	O	O	O

The	O	O	O
number	O	O	O
of	O	O	O
people	O	O	B-T098
with	O	O	O
multiple	O	O	B-T047
chronic	O	O	I-T047
conditions	O	O	I-T047
requiring	O	O	O
primary	O	O	B-T058
care	O	O	I-T058
services	O	O	I-T058
increases	O	O	B-T169
.	O	O	O

Professionals	O	O	B-T097
from	O	O	O
different	O	O	O
disciplines	O	O	B-T057
collaborate	O	O	B-T054
and	O	O	O
coordinate	O	O	B-T169
care	O	O	B-T052
to	O	O	O
deal	O	O	O
with	O	O	O
the	O	O	O
complex	O	O	O
health	O	O	B-T058
care	O	O	I-T058
needs	O	O	I-T058
.	O	O	O

There	O	O	O
is	O	O	O
lack	O	O	B-T080
of	O	O	O
information	O	O	B-T078
on	O	O	O
current	O	O	O
practices	O	O	O
regarding	O	O	O
interprofessional	O	O	B-T054
team	O	O	B-T058
(	O	O	I-T058
IPT	O	O	I-T058
)	O	O	I-T058
meetings	O	O	I-T058
.	O	O	O

This	O	O	O
study	O	O	B-T062
aimed	O	O	O
to	O	O	O
improve	O	O	O
our	O	O	O
understanding	O	O	O
of	O	O	O
the	O	O	O
process	O	O	O
of	O	O	O
interprofessional	O	O	B-T054
collaboration	O	O	B-T054
in	O	O	O
primary	O	O	B-T058
care	O	O	I-T058
team	O	O	B-T058
meetings	O	O	I-T058
in	O	O	O
the	O	O	O
Netherlands	O	O	B-T083
by	O	O	O
observing	O	O	O
the	O	O	O
current	O	O	B-T057
practice	O	O	I-T057
and	O	O	O
exploring	O	O	O
personal	O	O	B-T032
opinions	O	O	B-UnknownType
.	O	O	O

Qualitative	O	O	B-T062
study	O	O	I-T062
involving	O	O	O
observations	O	O	B-T062
of	O	O	O
team	O	O	B-T058
meeting	O	O	I-T058
s	O	O	O
and	O	O	O
interviews	O	O	B-T058
with	O	O	O
participants	O	O	B-T098
.	O	O	O

Eight	O	O	O
different	O	O	O
IPT	O	O	B-T058
meetings	O	O	I-T058
(	O	O	O
n	O	O	O
=	O	O	O
8)	O	O	O
in	O	O	O
different	O	O	O
primary	O	O	B-T058
care	O	O	I-T058
practices	O	O	I-T058
were	O	O	O
observed	O	O	O
by	O	O	O
means	O	O	O
of	O	O	O
video	O	O	B-T073
recordings	O	O	I-T073
.	O	O	O

Experiences	O	O	B-T041
were	O	O	O
explored	O	O	O
by	O	O	O
conducting	O	O	O
individual	O	O	O
semi-structured	O	O	B-UnknownType
interviews	O	O	I-UnknownType
(	O	O	O
n	O	O	O
=	O	O	O
60	O	O	O
)	O	O	O
with	O	O	O
participants	O	O	B-T098
(	O	O	O
i.e.	O	O	O
health	O	O	B-T097
care	O	O	I-T097
professionals	O	O	I-T097
from	O	O	O
different	O	O	O
disciplines	O	O	B-T057
)	O	O	O
of	O	O	O
the	O	O	O
observed	O	O	O
team	O	O	B-T058
meetings	O	O	I-T058
.	O	O	O

The	O	O	O
data	O	O	B-T078
were	O	O	O
analysed	O	O	B-T062
by	O	O	O
means	O	O	O
of	O	O	O
content	O	O	B-T062
analysis	O	O	I-T062
.	O	O	O

Most	O	O	O
participants	O	O	B-T098
expressed	O	O	O
favourable	O	O	O
opinions	O	O	B-UnknownType
about	O	O	O
their	O	O	O
team	O	O	B-T058
meetings	O	O	I-T058
.	O	O	O

However	O	O	O
,	O	O	O
observations	O	O	B-T062
showed	O	O	O
that	O	O	O
team	O	O	B-T058
meetings	O	O	I-T058
were	O	O	O
more	O	O	O
or	O	O	O
less	O	O	O
hectic	O	O	O
,	O	O	O
and	O	O	O
lacked	O	O	B-T080
a	O	O	O
clear	O	O	O
structure	O	O	O
and	O	O	O
team	O	O	B-T097
coordinator	O	O	I-T097
or	O	O	O
leader	O	O	B-T097
.	O	O	O

There	O	O	O
appears	O	O	O
to	O	O	O
be	O	O	O
a	O	O	O
discrepancy	O	O	B-T033
between	O	O	O
findings	O	O	B-T033
from	O	O	O
observations	O	O	B-T062
and	O	O	O
interviews	O	O	B-T052
.	O	O	O

From	O	O	O
the	O	O	O
interviews	O	O	B-T052
,	O	O	O
four	O	O	O
main	O	O	O
themes	O	O	O
were	O	O	O
extracted	O	O	O
:	O	O	O
(	O	O	O
1	O	O	O
)	O	O	O
Team	O	O	B-T098
structure	O	O	I-T098
and	O	O	I-T098
composition	O	O	I-T098
,	O	O	O
(	O	O	O
2	O	O	O
)	O	O	O
Patient-centredness	O	O	B-T058
,	O	O	O
(	O	O	O
3	O	O	O
)	O	O	O
Interaction	O	O	B-T054
and	O	O	O
(	O	O	O
4	O	O	O
)	O	O	O
Attitude	O	O	B-T041
and	O	O	O
motivation	O	O	B-T041
.	O	O	O

IPT	O	O	B-T058
meetings	O	O	I-T058
could	O	O	O
benefit	O	O	O
from	O	O	O
improvements	O	O	B-T077
in	O	O	O
structure	O	O	O
,	O	O	O
patient-centredness	O	O	B-T058
and	O	O	O
leadership	O	O	B-T054
by	O	O	O
the	O	O	O
chairpersons	O	O	B-T097
.	O	O	O

Given	O	O	O
the	O	O	O
discrepancy	O	O	B-T033
between	O	O	O
observations	O	O	B-T062
and	O	O	O
interviews	O	O	B-T052
,	O	O	O
it	O	O	O
would	O	O	O
appear	O	O	O
useful	O	O	O
to	O	O	O
improve	O	O	B-T077
team	O	O	B-T096
members	O	O	I-T096
'	O	O	O
awareness	O	O	B-T041
of	O	O	O
aspects	O	O	B-T080
that	O	O	O
could	O	O	O
be	O	O	O
improved	O	O	B-T077
before	O	O	O
training	O	O	B-T065
them	O	O	O
in	O	O	O
dealing	O	O	O
with	O	O	O
specific	O	O	O
challenges	O	O	B-T058
.	O	O	O

-DOCSTART- (28123739)

Urachal	O	O	B-T047
carcinoma	O	O	I-T047
:	O	O	O
Report	O	O	B-T170
of	O	O	O
two	O	O	O
cases	O	O	B-T077
and	O	O	O
review	O	O	B-T169
of	O	O	I-T169
the	O	O	O
literature	O	O	O

Urachal	O	O	B-T047
carcinoma	O	O	I-T047
is	O	O	O
a	O	O	O
rare	O	O	B-T080
tumor	O	O	B-T191
that	O	O	O
most	O	O	O
commonly	O	O	O
occurs	O	O	O
in	O	O	O
ovaries	O	O	B-T023
and	O	O	O
less	O	O	B-T033
often	O	O	I-T033
in	O	O	O
the	O	O	O
adnexal	O	O	B-T023
region	O	O	B-T029
and	O	O	O
urinary	O	O	B-T022
system	O	O	I-T022
.	O	O	O

We	O	O	O
herein	O	O	O
present	O	O	B-T078
two	O	O	O
cases	O	O	B-T077
of	O	O	O
urachal	O	O	B-T047
carcinoma	O	O	I-T047
:	O	O	O
One	O	O	O
case	O	O	B-T077
was	O	O	O
a	O	O	O
32-year-old	O	O	O
male	O	O	B-T098
patient	O	O	B-T101
who	O	O	O
presented	O	O	B-T078
with	O	O	O
painless	O	O	B-T184
hematuria	O	O	I-T184
with	O	O	O
blood	O	O	B-T046
clots	O	O	I-T046
for	O	O	O
1	O	O	O
month	O	O	B-T079
,	O	O	O
whereas	O	O	O
the	O	O	O
other	O	O	O
case	O	O	O
was	O	O	O
a	O	O	O
50-year-old	O	O	O
woman	O	O	B-T098
who	O	O	O
presented	O	O	O
with	O	O	O
gross	O	O	B-T033
hematuria	O	O	I-T033
with	O	O	O
mild	O	O	B-T080
dysuria	O	O	B-T184
,	O	O	O
urgency	O	O	B-T047
and	O	O	I-T047
frequent	O	O	I-T047
urination	O	O	I-T047
for	O	O	O
1	O	O	O
year	O	O	B-T079
.	O	O	O

Following	O	O	O
surgical	O	O	B-T061
resection	O	O	I-T061
,	O	O	O
the	O	O	O
two	O	O	O
patients	O	O	B-T101
were	O	O	O
diagnosed	O	O	B-T033
with	O	O	O
urachal	O	O	B-T047
adenocarcinoma	O	O	I-T047
(	O	O	O
mixed	O	O	B-T169
type	O	O	B-T080
)	O	O	O
and	O	O	O
urachal	O	O	B-T047
mucinous	O	O	I-T047
adenocarcinoma	O	O	I-T047
,	O	O	O
respectively	O	O	O
,	O	O	O
based	O	O	O
on	O	O	O
the	O	O	O
histopathological	O	O	B-T169
examination	O	O	B-T058
.	O	O	O

A	O	O	O
review	O	O	B-T169
of	O	O	I-T169
previously	O	O	O
published	O	O	B-T057
cases	O	O	B-T077
and	O	O	O
relevant	O	O	B-T080
literature	O	O	B-T170
is	O	O	O
also	O	O	O
presented	O	O	B-T078
.	O	O	O

The	O	O	O
aim	O	O	B-T078
of	O	O	O
the	O	O	O
present	O	O	B-T033
study	O	O	B-T062
was	O	O	O
to	O	O	O
help	O	O	O
understand	O	O	B-T041
this	O	O	O
disease	O	O	B-T191
better	O	O	B-T080
,	O	O	O
in	O	O	O
order	O	O	O
to	O	O	O
reduce	O	O	B-T080
the	O	O	O
rate	O	O	B-T081
of	O	O	O
clinical	O	O	B-T080
and	O	O	O
pathological	O	O	B-T169
misdiagnosis	O	O	B-T033
.	O	O	O

-DOCSTART- (28125612)

A	O	O	O
Recombinant	O	O	B-T063
Human	O	O	B-T016
Anti-Platelet	O	O	B-T116
scFv	O	O	B-T129
Antibody	O	O	I-T116
Produced	O	O	O
in	O	O	O
Pichia	O	O	B-T004
pastoris	O	O	I-T004
for	O	O	O
Atheroma	O	O	B-T046
Targeting	O	O	O

Cells	O	O	B-T025
of	O	O	O
the	O	O	O
innate	O	O	O
and	O	O	O
adaptive	O	O	O
immune	O	O	B-T022
system	O	O	I-T022
are	O	O	O
key	O	O	O
factors	O	O	O
in	O	O	O
the	O	O	O
progression	O	O	B-T046
of	O	O	O
atherosclerotic	O	O	B-T031
plaque	O	O	B-T033
,	O	O	O
leading	O	O	O
to	O	O	O
plaque	O	O	O
instability	O	O	B-T033
and	O	O	O
rupture	O	O	B-T037
,	O	O	O
potentially	O	O	O
resulting	O	O	O
in	O	O	O
acute	O	O	B-T079
atherothrombotic	O	O	B-T020
events	O	O	O
such	O	O	O
as	O	O	O
coronary	O	O	B-T047
artery	O	O	I-T047
disease	O	O	I-T047
,	O	O	O
cerebrovascular	O	O	B-T047
disease	O	O	I-T047
and	O	O	O
peripheral	O	O	B-T047
arterial	O	O	I-T047
disease	O	O	I-T047
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
describe	O	O	O
the	O	O	O
cloning	O	O	B-T062
,	O	O	O
expression	O	O	B-T045
,	O	O	O
purification	O	O	B-T169
,	O	O	O
and	O	O	O
immunoreactivity	O	O	B-T044
assessment	O	O	B-T058
of	O	O	O
a	O	O	O
recombinant	O	O	B-T001
single-chain	O	O	B-T129
variable	O	O	I-T129
fragment	O	O	I-T129
(	O	O	O
scFv	O	O	B-T129
)	O	O	O
derived	O	O	O
from	O	O	O
a	O	O	O
human	O	O	B-T016
anti-Î±IIbÎ²3	O	O	B-T116
antibody	O	O	I-T116
(	O	O	O
HuAb	O	O	B-T116
)	O	O	O
selected	O	O	O
to	O	O	O
target	O	O	O
atheromatous	O	O	B-T046
lesions	O	O	B-T033
for	O	O	O
the	O	O	O
presence	O	O	B-T033
of	O	O	O
platelets	O	O	B-T025
.	O	O	O

Indeed	O	O	O
,	O	O	O
platelets	O	O	B-T025
within	O	O	O
atheroma	O	O	B-T031
plaques	O	O	I-T031
have	O	O	O
been	O	O	O
shown	O	O	O
to	O	O	O
play	O	O	O
a	O	O	O
role	O	O	O
in	O	O	O
inflammation	O	O	B-T046
,	O	O	O
in	O	O	O
platelet	O	O	B-T025
-	O	O	O
leucocyte	O	O	B-T025
aggregates	O	O	B-T080
and	O	O	O
in	O	O	O
thrombi	O	O	B-T046
formation	O	O	B-T169
and	O	O	O
might	O	O	O
thus	O	O	O
be	O	O	O
considered	O	O	O
relevant	O	O	B-T080
biomarkers	O	O	B-T201
of	O	O	O
atherosclerotic	O	O	B-T169
progression	O	O	B-T046
.	O	O	O

The	O	O	O
DNA	O	O	B-T086
sequence	O	O	I-T086
that	O	O	O
encodes	O	O	B-T052
the	O	O	O
anti-Î±IIbÎ²3	O	O	B-T129
TEG4	O	O	I-T129
scFv	O	O	I-T129
previously	O	O	O
obtained	O	O	O
from	O	O	O
a	O	O	O
phage-display	O	O	B-T063
selection	O	O	I-T063
on	O	O	O
activated	O	O	B-T052
platelets	O	O	B-T025
,	O	O	O
was	O	O	O
inserted	O	O	B-T045
into	O	O	O
the	O	O	O
eukaryote	O	O	B-T204
vector	O	O	B-T114
(	O	O	O
pPICZÎ±A	O	O	B-T114
)	O	O	O
in	O	O	O
fusion	O	O	O
with	O	O	O
a	O	O	O
tag	O	O	B-T086
sequence	O	O	I-T086
encoding	O	O	B-T052
2	O	O	O
cysteines	O	O	B-T116
useable	O	O	O
for	O	O	O
specific	O	O	B-T080
probes	O	O	O
grafting	O	O	B-T059
experiments	O	O	I-T059
.	O	O	O

The	O	O	O
recombinant	O	O	B-T116
protein	O	O	I-T116
was	O	O	O
expressed	O	O	B-T045
at	O	O	O
high	O	O	B-T080
yields	O	O	O
in	O	O	O
Pichia	O	O	B-T004
pastoris	O	O	I-T004
(	O	O	O
30	O	O	O
mg/L	O	O	O
culture	O	O	B-T130
)	O	O	O
.	O	O	O

The	O	O	O
advantage	O	O	O
of	O	O	O
P.	O	O	B-T004
pastoris	O	O	I-T004
as	O	O	O
an	O	O	O
expression	O	O	B-T045
system	O	O	B-T169
is	O	O	O
the	O	O	O
production	O	O	O
and	O	O	O
secretion	O	O	B-T038
of	O	O	O
recombinant	O	O	B-T116
proteins	O	O	I-T116
in	O	O	O
the	O	O	O
supernatant	O	O	B-T031
,	O	O	O
ruling	O	O	O
out	O	O	O
the	O	O	O
difficulties	O	O	O
encountered	O	O	O
when	O	O	O
scFv	O	O	B-T129
are	O	O	O
produced	O	O	O
in	O	O	O
the	O	O	O
cytoplasm	O	O	B-T026
of	O	O	O
bacteria	O	O	B-T007
(	O	O	O
low	O	O	B-T080
yield	O	O	B-T081
,	O	O	O
low	O	O	O
solubility	O	O	B-T080
and	O	O	O
reduced	O	O	B-T080
affinity	O	O	B-T044
)	O	O	O
.	O	O	O

The	O	O	O
improved	O	O	B-T033
conditions	O	O	O
allowed	O	O	O
for	O	O	O
the	O	O	O
recovery	O	O	B-T052
of	O	O	O
highly	O	O	B-T080
purified	O	O	B-T169
and	O	O	O
biologically	O	O	B-T123
active	O	O	I-T123
scFv	O	O	B-T129
fragments	O	O	I-T123
ready	O	O	O
to	O	O	O
be	O	O	O
grafted	O	O	B-T169
in	O	O	O
a	O	O	O
site	O	O	B-T082
-directed	O	O	O
way	O	O	O
to	O	O	O
nanoparticles	O	O	B-T073
for	O	O	O
the	O	O	O
imaging	O	O	B-T060
of	O	O	O
atherosclerotic	O	O	B-T031
plaques	O	O	I-T031
involving	O	O	O
inflammatory	O	O	B-T169
processes	O	O	B-T067
and	O	O	O
thus	O	O	O
at	O	O	O
high	O	O	B-T033
risk	O	O	I-T033
of	O	O	I-T033
instability	O	O	B-T033
.	O	O	O

-DOCSTART- (28125734)

Identification	O	O	B-T080
of	O	O	O
MiR-21	O	O	B-T114
-	O	O	I-T114
5p	O	O	I-T114
as	O	O	O
a	O	O	O
Functional	O	O	B-T028
Regulator	O	O	I-T028
of	O	O	O
Mesothelin	O	O	B-T028
Expression	O	O	B-T045
Using	O	O	O
MicroRNA	O	O	B-T114
Capture	O	O	O
Affinity	O	O	B-T070
Coupled	O	O	B-T169
with	O	O	O
Next	O	O	O
Generation	O	O	O
Sequencing	O	O	O

MicroRNAs	O	O	B-T114
(	O	O	O
miRNAs	O	O	B-T114
)	O	O	O
are	O	O	O
small	O	O	B-T114
non-coding	O	O	I-T114
RNAs	O	O	I-T114
that	O	O	O
regulate	O	O	B-T045
mRNA	O	O	B-T045
expression	O	O	I-T045
mainly	O	O	O
by	O	O	O
silencing	O	O	B-T045
target	O	O	B-T169
transcripts	O	O	B-T114
via	O	O	O
binding	O	O	B-T044
to	O	O	O
miRNA	O	O	B-T086
recognition	O	O	I-T086
elements	O	O	I-T086
(	O	O	I-T086
MREs	O	O	I-T086
)	O	O	I-T086
in	O	O	O
the	O	O	O
3'untranslated	O	O	B-T086
region	O	O	I-T086
(	O	O	O
3'UTR	O	O	B-T086
)	O	O	O
.	O	O	O

The	O	O	O
identification	O	O	B-T080
of	O	O	O
bona	O	O	B-T082
fide	O	O	I-T082
targets	O	O	B-T169
is	O	O	O
challenging	O	O	O
for	O	O	O
researchers	O	O	B-T033
working	O	O	I-T033
on	O	O	O
the	O	O	O
functional	O	O	B-T169
aspect	O	O	I-T169
of	O	O	O
miRNAs	O	O	B-T114
.	O	O	O

Recently	O	O	O
,	O	O	O
we	O	O	O
developed	O	O	O
a	O	O	O
method	O	O	B-T169
(	O	O	I-T169
miR-CATCH	O	O	I-T169
)	O	O	I-T169
based	O	O	O
on	O	O	O
biotinylated	O	O	B-T044
DNA	O	O	B-T114
antisense	O	O	B-T114
oligonucleotides	O	O	I-T114
that	O	O	O
capture	O	O	O
the	O	O	O
mRNA	O	O	B-T114
of	O	O	O
interest	O	O	O
and	O	O	O
facilitates	O	O	O
the	O	O	O
characterisation	O	O	O
of	O	O	O
miRNAs::mRNA	O	O	B-T045
interactions	O	O	I-T045
in	O	O	O
a	O	O	O
physiological	O	O	B-T043
cellular	O	O	I-T043
context	O	O	O
.	O	O	O

Here	O	O	O
,	O	O	O
the	O	O	O
miR-CATCH	O	O	B-T169
technique	O	O	I-T169
was	O	O	O
applied	O	O	O
to	O	O	O
the	O	O	O
mesothelin	O	O	B-T028
(	O	O	I-T028
MSLN	O	O	I-T028
)	O	O	I-T028
gene	O	O	I-T028
and	O	O	O
coupled	O	O	B-T169
with	O	O	O
next	O	O	B-T063
generation	O	O	I-T063
sequencing	O	O	I-T063
(	O	O	O
NGS	O	O	B-T063
)	O	O	O
,	O	O	O
to	O	O	O
identify	O	O	O
miRNAs	O	O	B-T114
that	O	O	O
regulate	O	O	B-T045
MSLN	O	O	B-T028
mRNA	O	O	I-T028
and	O	O	O
that	O	O	O
may	O	O	O
be	O	O	O
responsible	O	O	O
for	O	O	O
its	O	O	O
increased	O	O	O
protein	O	O	B-T034
levels	O	O	I-T034
found	O	O	O
in	O	O	O
malignant	O	O	B-T191
pleural	O	O	I-T191
mesothelioma	O	O	I-T191
(	O	O	O
MPM	O	O	B-T191
)	O	O	O
.	O	O	O

Biotinylated	O	O	B-T044
MSLN	O	O	B-T116
oligos	O	O	I-T028
were	O	O	O
employed	O	O	O
to	O	O	O
isolate	O	O	O
miRNA::MSLN	O	O	B-T114
mRNA	O	O	I-T114
complexes	O	O	I-T114
from	O	O	O
a	O	O	O
normal	O	O	O
cell	O	O	B-T025
line	O	O	I-T025
(	O	O	I-T025
Met-5A	O	O	I-T025
)	O	O	I-T025
which	O	O	O
expresses	O	O	B-T045
low	O	O	O
levels	O	O	O
of	O	O	O
MSLN	O	O	O
.	O	O	O

MiRNAs	O	O	B-T114
targeting	O	O	B-T169
the	O	O	O
MSLN	O	O	B-T028
mRNA	O	O	I-T028
were	O	O	O
identified	O	O	O
by	O	O	O
NGS	O	O	B-T063
and	O	O	O
miR-21	O	O	B-T114
-	O	O	I-T114
5p	O	O	I-T114
and	O	O	O
miR-100	O	O	B-T114
-	O	O	I-T114
5p	O	O	I-T114
were	O	O	O
selected	O	O	O
for	O	O	O
further	O	O	O
validation	O	O	B-T062
analyses	O	O	I-T062
.	O	O	O

MiR-21	O	O	B-T114
-	O	O	I-T114
5p	O	O	I-T114
was	O	O	O
shown	O	O	O
to	O	O	O
be	O	O	O
able	O	O	O
to	O	O	O
modulate	O	O	B-T082
MSLN	O	O	B-T028
expression	O	O	B-T045
in	O	O	O
miRNA	O	O	B-T114
mimic	O	O	B-T061
experiments	O	O	B-T062
in	O	O	O
a	O	O	O
panel	O	O	O
of	O	O	O
malignant	O	O	B-T025
and	O	O	O
non-malignant	O	O	O
cell	O	O	B-T025
lines	O	O	I-T025
.	O	O	O

Further	O	O	O
miRNA	O	O	B-T114
inhibitor	O	O	B-T080
experiments	O	O	B-T062
and	O	O	O
luciferase	O	O	B-T116
assays	O	O	B-T059
in	O	O	O
Mero-14	O	O	B-T025
cells	O	O	I-T025
validated	O	O	O
miR-21	O	O	B-T114
-	O	O	I-T114
5p	O	O	I-T114
as	O	O	O
a	O	O	O
true	O	O	O
regulator	O	O	B-T028
of	O	O	O
MSLN	O	O	B-T028
.	O	O	O

Moreover	O	O	O
,	O	O	O
in	O	O	B-T062
vitro	O	O	I-T062
experiments	O	O	I-T062
showed	O	O	O
that	O	O	O
treatment	O	O	B-T061
with	O	O	O
miR-21	O	O	B-T114
-	O	O	I-T114
5p	O	O	I-T114
mimic	O	O	B-T061
reduced	O	O	O
proliferation	O	O	B-T169
of	O	O	O
MPM	O	O	B-T191
cell	O	O	B-T025
lines	O	O	I-T025
.	O	O	O

Altogether	O	O	O
,	O	O	O
this	O	O	O
work	O	O	O
shows	O	O	O
that	O	O	O
the	O	O	O
miR-CATCH	O	O	B-T169
technique	O	O	I-T169
,	O	O	O
coupled	O	O	B-T169
with	O	O	O
NGS	O	O	B-T063
and	O	O	O
in	O	O	B-T080
vitro	O	O	I-T080
validation	O	O	B-T062
,	O	O	O
represents	O	O	O
a	O	O	O
reliable	O	O	O
method	O	O	B-T169
to	O	O	O
identify	O	O	O
native	O	O	O
miRNA::mRNA	O	O	B-T045
interactions	O	O	I-T045
.	O	O	O

MiR-21	O	O	B-T114
-	O	O	I-T114
5p	O	O	I-T114
is	O	O	O
suggested	O	O	O
as	O	O	O
novel	O	O	O
regulator	O	O	B-T028
of	O	O	O
MSLN	O	O	B-T028
with	O	O	O
a	O	O	O
possible	O	O	O
functional	O	O	B-T169
role	O	O	I-T169
in	O	O	O
cellular	O	O	B-T043
growth	O	O	I-T043
.	O	O	O

-DOCSTART- (28127340)

Zoonotic	O	O	B-T001
and	O	O	O
Non-zoonotic	O	O	B-T033
Parasites	O	O	B-T204
of	O	O	O
Wild	O	O	B-T170
Rodents	O	O	B-T015
in	O	O	O
Turkman	O	O	O
Sahra	O	O	O
,	O	O	O
Northeastern	O	O	O
Iran	O	O	O

This	O	O	O
study	O	O	B-T062
was	O	O	O
conducted	O	O	O
to	O	O	O
collect	O	O	B-T062
informative	O	O	I-T062
data	O	O	I-T062
on	O	O	O
the	O	O	O
parasitic	O	O	B-T047
infection	O	O	I-T047
of	O	O	O
wild	O	O	B-T170
rodents	O	O	B-T015
,	O	O	O
emphasizing	O	O	O
on	O	O	O
finding	O	O	B-T033
parasites	O	O	B-T204
,	O	O	O
which	O	O	O
have	O	O	O
medical	O	O	B-T169
importance	O	O	B-T080
to	O	O	O
human	O	O	B-T016
.	O	O	O

During	O	O	O
2012	O	O	O
-	O	O	O
2014	O	O	O
,	O	O	O
a	O	O	O
total	O	O	B-T081
number	O	O	I-T081
of	O	O	O
91	O	O	O
wild	O	O	B-T170
rodents	O	O	B-T015
were	O	O	O
captured	O	O	B-T169
from	O	O	O
rural	O	O	B-T082
areas	O	O	I-T082
of	O	O	O
Turkmen	O	O	B-T083
Sahra	O	O	I-T083
,	O	O	I-T083
Golestan	O	O	I-T083
Province	O	O	I-T083
,	O	O	O
using	O	O	O
handmade	O	O	B-T073
traps	O	O	I-T073
.	O	O	O

Animals	O	O	B-T008
were	O	O	O
anesthetized	O	O	B-T033
,	O	O	O
surveyed	O	O	B-T170
for	O	O	O
any	O	O	O
ectoparasite	O	O	B-T204
and	O	O	O
then	O	O	O
their	O	O	O
carcasses	O	O	B-T021
were	O	O	O
carefully	O	O	O
dissected	O	O	B-T169
for	O	O	O
examination	O	O	B-T033
of	O	O	O
endoparsites	O	O	B-T204
.	O	O	O

Four	O	O	O
species	O	O	B-T185
of	O	O	O
rodents	O	O	B-T015
including	O	O	B-T169
Mus	O	O	B-T015
musculus	O	O	I-T015
(	O	O	O
52.75	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
Rattus	O	O	B-T015
norvegicus	O	O	I-T015
(	O	O	O
38.46	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
Rhombomys	O	O	B-T015
opimus	O	O	I-T015
(	O	O	O
4.40	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
Meriones	O	O	B-T015
libycus	O	O	I-T015
(	O	O	O
4.40	O	O	O
%	O	O	O
)	O	O	O
were	O	O	O
captured	O	O	B-T169
.	O	O	O

Parasitic	O	O	B-T047
infestation	O	O	I-T047
was	O	O	O
detected	O	O	B-T033
in	O	O	O
38.5	O	O	O
%	O	O	O
of	O	O	O
sampled	O	O	B-T078
rodents	O	O	B-T015
.	O	O	O

Parasite	O	O	B-T047
infestation	O	O	I-T047
rates	O	O	B-T081
of	O	O	O
sampled	O	O	B-T078
rodents	O	O	B-T015
was	O	O	O
Hymenolepis	O	O	B-T204
diminuta	O	O	I-T204
=	O	O	O
7.7	O	O	O
%	O	O	O
,	O	O	O
Cryptosporidium	O	O	B-T204
spp	O	O	I-T204
=	O	O	O
6.6	O	O	O
%	O	O	O
,	O	O	O
Trichuris	O	O	B-T204
spp	O	O	I-T204
.=	O	O	O
5.5	O	O	O
%	O	O	O
,	O	O	O
Cysticercus	O	O	B-T204
fasciolaris	O	O	I-T204
=	O	O	O
2.20	O	O	O
%	O	O	O
,	O	O	O
Angiostrongylus	O	O	B-T204
spp	O	O	I-T204
.=	O	O	O
2.20	O	O	O
%	O	O	O
,	O	O	O
Capillaria	O	O	B-T204
sp	O	O	I-T204
.=	O	O	O
1.09	O	O	O
%	O	O	O
,	O	O	O
Rhipicephalus	O	O	B-T204
spp	O	O	I-T204
.	O	O	O

=	O	O	O
8.70	O	O	O
%	O	O	O
,	O	O	O
Nosopsyllus	O	O	B-T204
fasciatus	O	O	I-T204
=	O	O	O
1.09	O	O	O
%	O	O	O
,	O	O	O
and	O	O	O
Laelaps	O	O	B-T204
nuttalli	O	O	I-T204
=	O	O	O
3.29	O	O	O
%	O	O	O
.	O	O	O

Among	O	O	O
10	O	O	O
genera	O	O	B-T185
/	O	O	O
species	O	O	B-T185
of	O	O	O
identified	O	O	B-T080
parasites	O	O	B-T204
,	O	O	O
at	O	O	O
least	O	O	O
8	O	O	O
of	O	O	O
them	O	O	O
were	O	O	O
zoonotic	O	O	B-T001
with	O	O	O
public	O	O	B-T170
health	O	O	I-T170
importance	O	O	B-T080
.	O	O	O

L.	O	O	B-T204
nuttalli	O	O	I-T204
and	O	O	O
N.	O	O	B-T204
fasciatus	O	O	I-T204
were	O	O	O
the	O	O	O
only	O	O	O
two	O	O	O
non-zoonotic	O	O	B-T033
detected	O	O	B-T033
parasites	O	O	B-T204
in	O	O	O
this	O	O	O
survey	O	O	B-T170
.	O	O	O

Harboring	O	O	B-T169
a	O	O	O
wide	O	O	B-T082
variety	O	O	O
of	O	O	O
zoonotic	O	O	B-T001
parasites	O	O	B-T204
in	O	O	O
sampled	O	O	B-T078
wild	O	O	B-T170
rodents	O	O	B-T015
particularly	O	O	B-T080
when	O	O	O
they	O	O	O
live	O	O	O
nearby	O	O	B-T080
villages	O	O	B-T083
,	O	O	O
represents	O	O	O
a	O	O	O
potential	O	O	B-T080
risk	O	O	B-T078
to	O	O	O
native	O	O	B-T098
inhabitants	O	O	I-T098
.	O	O	O

Hence	O	O	O
,	O	O	O
controlling	O	O	B-T169
rodents	O	O	B-T015
'	O	O	O
population	O	O	B-T098
in	O	O	O
residential	O	O	B-T082
regions	O	O	I-T082
and	O	O	O
improving	O	O	B-T033
awareness	O	O	B-T041
of	O	O	O
local	O	O	B-T082
people	O	O	B-T098
about	O	O	O
the	O	O	O
risk	O	O	B-T078
of	O	O	O
disease	O	O	B-T046
transmission	O	O	I-T046
through	O	O	O
rodents	O	O	O
seems	O	O	O
to	O	O	O
be	O	O	O
entirely	O	O	O
necessary	O	O	B-T080
.	O	O	O

-DOCSTART- (28127853)

Creative	O	O	O
approach	O	O	O
for	O	O	O
successful	O	O	B-T080
aging	O	O	B-T040
:	O	O	O
A	O	O	O
pilot	O	O	B-T062
study	O	O	I-T062
of	O	O	O
an	O	O	O
intergenerational	O	O	B-T079
health	O	O	O
promotion	O	O	O
program	O	O	O

To	O	O	O
develop	O	O	O
and	O	O	O
evaluate	O	O	B-T058
the	O	O	O
effectiveness	O	O	B-T080
of	O	O	O
an	O	O	O
intergenerational	O	O	B-T079
health	O	O	B-T058
promotion	O	O	I-T058
program	O	O	I-T058
.	O	O	O

This	O	O	O
was	O	O	O
an	O	O	O
action	O	O	O
research	O	O	B-T062
project	O	O	I-T062
.	O	O	O

A	O	O	O
total	O	O	B-T080
of	O	O	O
34	O	O	O
participants	O	O	B-T098
attended	O	O	O
the	O	O	O
12-	O	O	O
week	O	O	B-T079
program	O	O	B-T058
and	O	O	O
completed	O	O	B-T080
the	O	O	O
pre-test	O	O	B-T170
and	O	O	I-T170
post-test	O	O	I-T170
.	O	O	O

There	O	O	O
were	O	O	O
16	O	O	O
middle-aged	O	O	B-T100
and	O	O	O
nine	O	O	O
older	O	O	B-T098
adults	O	O	I-T098
recruited	O	O	B-T052
from	O	O	O
a	O	O	O
district	O	O	O
of	O	O	O
Taipei	O	O	B-T083
,	O	O	O
and	O	O	O
nine	O	O	O
young	O	O	B-T100
adults	O	O	I-T100
recruited	O	O	O
from	O	O	O
the	O	O	O
principal	O	O	B-T097
investigator	O	O	I-T097
's	O	O	I-T097
university	O	O	B-T073
.	O	O	O

The	O	O	O
"	O	O	O
Attitudes	O	O	B-T170
toward	O	O	I-T170
Aging	O	O	I-T170
Scale	O	O	I-T170
"	O	O	O
and	O	O	O
the	O	O	O
"	O	O	O
Spiritual	O	O	B-T170
Health	O	O	I-T170
Scale	O	O	I-T170
"	O	O	O
were	O	O	O
two	O	O	O
assessment	O	O	B-T058
instruments	O	O	B-T170
used	O	O	O
in	O	O	O
the	O	O	O
study	O	O	B-T062
.	O	O	O

The	O	O	O
results	O	O	B-T033
showed	O	O	O
that	O	O	O
there	O	O	O
were	O	O	O
significant	O	O	B-T078
improvements	O	O	B-T077
in	O	O	O
the	O	O	O
Attitudes	O	O	B-T170
toward	O	O	I-T170
Aging	O	O	I-T170
Scale	O	O	I-T170
for	O	O	O
the	O	O	O
young	O	O	B-T100
adult	O	O	I-T100
group	O	O	B-T078
(	O	O	O
aged	O	O	B-T032
18	O	O	O
-	O	O	O
29	O	O	O
years	O	O	B-T079
)	O	O	O
and	O	O	O
in	O	O	O
the	O	O	O
Spiritual	O	O	B-T170
Health	O	O	I-T170
Scale	O	O	I-T170
for	O	O	O
the	O	O	O
older	O	O	B-T098
adult	O	O	I-T098
group	O	O	O
(	O	O	O
aged	O	O	O
65	O	O	O
-	O	O	O
80	O	O	O
years	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
evaluation	O	O	B-T058
showed	O	O	O
that	O	O	O
participants	O	O	B-T098
were	O	O	O
satisfied	O	O	B-T041
with	O	O	O
the	O	O	O
program	O	O	B-T058
.	O	O	O

The	O	O	O
results	O	O	B-T033
of	O	O	O
the	O	O	O
present	O	O	O
study	O	O	O
provide	O	O	O
future	O	O	O
directions	O	O	O
for	O	O	O
successful	O	O	B-T080
aging	O	O	B-T040
and	O	O	O
intergenerational	O	O	B-T079
learning	O	O	B-T065
.	O	O	O

Geriatr	O	O	O
Gerontol	O	O	O
Int	O	O	O
2017	O	O	O
;	O	O	O
â¢â¢	O	O	O
:	O	O	O
â¢â¢-â¢â¢.	O	O	O

-DOCSTART- (28127863)

Signs	O	O	B-T184
of	O	O	O
dysarthria	O	O	B-T048
in	O	O	O
adults	O	O	B-T100
with	O	O	O
22q11.2	O	O	O
deletion	O	O	O
syndrome	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
the	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
investigate	O	O	O
how	O	O	O
adults	O	O	B-T100
with	O	O	O
22q11.2	O	O	B-T047
deletion	O	O	I-T047
syndrome	O	O	I-T047
(	O	O	O
22q11DS	O	O	B-T047
)	O	O	O
performed	O	O	O
on	O	O	O
dysarthria	O	O	B-T048
and	O	O	O
intelligibility	O	O	B-T041
tests	O	O	B-T060
compared	O	O	B-T052
with	O	O	O
a	O	O	O
control	O	O	B-T096
group	O	O	I-T096
.	O	O	O

Ten	O	O	O
participants	O	O	B-T098
with	O	O	O
confirmed	O	O	O
22q11.2	O	O	B-T049
deletion	O	O	I-T049
,	O	O	O
five	O	O	O
males	O	O	B-T032
and	O	O	O
five	O	O	O
females	O	O	B-T032
with	O	O	O
a	O	O	O
mean	O	O	O
age	O	O	B-T032
of	O	O	O
31	O	O	O
years	O	O	B-T079
(	O	O	O
range	O	O	O
:	O	O	O
19	O	O	O
-	O	O	O
49	O	O	O
)	O	O	O
,	O	O	O
were	O	O	O
compared	O	O	B-T052
with	O	O	O
a	O	O	O
control	O	O	B-T096
group	O	O	I-T096
matched	O	O	O
for	O	O	O
gender	O	O	B-T032
and	O	O	O
age	O	O	O
(	O	O	O
five	O	O	O
males	O	O	O
and	O	O	O
five	O	O	O
females	O	O	O
,	O	O	O
mean	O	O	O
age	O	O	O
:	O	O	O
32	O	O	O
years	O	O	O
,	O	O	O
range	O	O	O
:	O	O	O
19	O	O	O
-	O	O	O
49	O	O	O
)	O	O	O
.	O	O	O

Assessment	O	O	B-T052
of	O	O	O
non-verbal	O	O	B-T060
and	O	O	I-T060
verbal	O	O	I-T060
tasks	O	O	I-T060
reflecting	O	O	O
respiration	O	O	B-T039
,	O	O	O
phonation	O	O	B-T042
,	O	O	O
oral	O	O	B-T042
motor	O	O	I-T042
function	O	O	I-T042
,	O	O	O
velopharyngeal	O	O	B-T059
function	O	O	I-T059
,	O	O	O
articulation	O	O	B-T042
,	O	O	O
and	O	O	O
prosody	O	O	B-T033
was	O	O	O
performed	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
the	O	O	O
Swedish	O	O	B-T170
Test	O	O	I-T170
of	O	O	I-T170
Intelligibility	O	O	I-T170
(	O	O	O
STI	O	O	B-T170
)	O	O	O
.	O	O	O

All	O	O	O
assessments	O	O	B-T052
were	O	O	O
made	O	O	O
by	O	O	O
two	O	O	O
raters	O	O	O
;	O	O	O
inter-rater	O	O	B-T081
and	O	O	O
intra-rater	O	O	B-T081
reliability	O	O	I-T081
was	O	O	O
acceptable	O	O	O
.	O	O	O

The	O	O	O
participants	O	O	B-T098
with	O	O	O
22q11DS	O	O	B-T047
had	O	O	O
significantly	O	O	O
more	O	O	O
problems	O	O	B-T033
than	O	O	O
the	O	O	O
control	O	O	B-T096
group	O	O	I-T096
on	O	O	O
all	O	O	O
investigated	O	O	O
dimensions	O	O	O
except	O	O	O
the	O	O	O
STI	O	O	B-T170
.	O	O	O

Overall	O	O	O
,	O	O	O
the	O	O	O
severity	O	O	O
of	O	O	O
their	O	O	O
speech	O	O	B-T033
deviation	O	O	I-T033
was	O	O	O
rated	O	O	B-T052
as	O	O	O
mild	O	O	O
to	O	O	O
moderate	O	O	O
.	O	O	O

The	O	O	O
largest	O	O	O
difficulties	O	O	O
were	O	O	O
found	O	O	O
regarding	O	O	O
speech	O	O	B-T040
respiration	O	O	B-T039
,	O	O	O
phonation	O	O	B-T042
,	O	O	O
oral	O	O	B-T042
motor	O	O	I-T042
function	O	O	I-T042
,	O	O	O
and	O	O	O
velopharyngeal	O	O	B-T059
function	O	O	I-T059
.	O	O	O

The	O	O	O
results	O	O	O
of	O	O	O
the	O	O	O
present	O	O	O
study	O	O	B-T062
suggest	O	O	O
that	O	O	O
a	O	O	O
neurological	O	O	B-T169
etiology	O	O	I-T169
could	O	O	O
be	O	O	O
added	O	O	O
to	O	O	O
the	O	O	O
previously	O	O	O
described	O	O	O
structural	O	O	B-T169
etiology	O	O	I-T169
explaining	O	O	O
the	O	O	O
speech	O	O	B-T033
difficulties	O	O	I-T033
found	O	O	O
in	O	O	O
22q11DS	O	O	B-T047
.	O	O	O

Signs	O	O	B-T184
of	O	O	O
difficulties	O	O	O
in	O	O	O
both	O	O	O
speech	O	O	B-T041
motor	O	O	I-T041
planning	O	O	I-T041
and	O	O	O
speech	O	O	B-T041
motor	O	O	I-T041
programming	O	O	I-T041
were	O	O	O
found	O	O	O
.	O	O	O

Further	O	O	O
studies	O	O	B-T062
are	O	O	O
needed	O	O	O
to	O	O	O
confirm	O	O	O
the	O	O	O
results	O	O	B-T169
,	O	O	O
as	O	O	O
are	O	O	O
studies	O	O	O
of	O	O	O
the	O	O	O
association	O	O	O
between	O	O	O
structural	O	O	B-T033
brain	O	O	I-T033
abnormalities	O	O	I-T033
and	O	O	O
neurological	O	O	B-T184
speech	O	O	I-T184
symptoms	O	O	I-T184
.	O	O	O

For	O	O	O
clinical	O	O	B-T169
purposes	O	O	I-T169
,	O	O	O
it	O	O	O
is	O	O	O
important	O	O	O
that	O	O	O
clinicians	O	O	B-T097
have	O	O	O
knowledge	O	O	O
about	O	O	O
the	O	O	O
variable	O	O	O
speech	O	O	B-T184
symptoms	O	O	I-T184
that	O	O	O
may	O	O	O
occur	O	O	O
in	O	O	O
individuals	O	O	B-T098
with	O	O	O
22q11DS	O	O	B-T047
and	O	O	O
that	O	O	O
they	O	O	O
be	O	O	O
aware	O	O	O
of	O	O	O
the	O	O	O
complexity	O	O	O
of	O	O	O
the	O	O	O
etiology	O	O	B-T169
of	O	O	O
such	O	O	O
speech	O	O	O
symptoms	O	O	O
.	O	O	O

Â©	O	O	O
2017	O	O	O
Wiley	O	O	O
Periodicals	O	O	O
,	O	O	O
Inc.	O	O	O

-DOCSTART- (28128937)

Sulfur	O	O	B-T121
and	O	O	O
Zinc	O	O	B-T121
Availability	O	O	B-T169
from	O	O	O
Co-granulated	O	O	B-T167
Zn	O	O	B-T121
-Enriched	O	O	O
Elemental	O	O	B-T121
Sulfur	O	O	I-T121
Fertilizers	O	O	O

Acidification	O	O	B-T067
by	O	O	O
oxidation	O	O	B-T044
of	O	O	O
elemental	O	O	B-T121
sulfur	O	O	B-T121
(	O	O	O
ES	O	O	B-T121
)	O	O	O
can	O	O	O
solubilize	O	O	O
ZnO	O	O	B-T121
,	O	O	O
providing	O	O	O
slow	O	O	B-T080
release	O	O	B-T169
of	O	O	O
both	O	O	O
sulfur	O	O	O
(	O	O	O
S	O	O	B-T121
)	O	O	O
and	O	O	O
zinc	O	O	B-T121
(	O	O	O
Zn	O	O	B-T121
)	O	O	O
in	O	O	O
soil	O	O	O
.	O	O	O

For	O	O	O
this	O	O	O
study	O	O	O
,	O	O	O
a	O	O	O
new	O	O	O
granular	O	O	B-T167
fertilizer	O	O	B-T131
with	O	O	O
ES	O	O	B-T121
and	O	O	O
ZnO	O	O	B-T121
was	O	O	O
produced	O	O	O
and	O	O	O
evaluated	O	O	B-T052
.	O	O	O

The	O	O	O
effect	O	O	B-T080
of	O	O	O
incorporating	O	O	O
microorganisms	O	O	B-T001
or	O	O	O
a	O	O	O
carbon	O	O	B-T196
source	O	O	B-T033
in	O	O	O
the	O	O	O
granule	O	O	B-T167
was	O	O	O
also	O	O	O
evaluated	O	O	B-T052
.	O	O	O

Four	O	O	O
granulated	O	O	B-T167
ES-Zn	O	O	B-T167
fertilizers	O	O	I-T167
with	O	O	O
and	O	O	O
without	O	O	B-T080
S-oxidizing	O	O	B-T001
microorganisms	O	O	I-T001
,	O	O	O
a	O	O	O
commercial	O	O	O
ES	O	O	O
pastille	O	O	O
,	O	O	O
ZnSO4	O	O	B-T121
,	O	O	O
and	O	O	O
ZnO	O	O	B-T121
were	O	O	O
applied	O	O	O
to	O	O	O
the	O	O	O
center	O	O	B-T082
of	O	O	O
Petri	O	O	B-T074
dishes	O	O	I-T074
containing	O	O	O
two	O	O	O
contrasting	O	O	B-T080
pH	O	O	B-T081
soils	O	O	B-T167
.	O	O	O

Soil	O	O	B-T167
pH	O	O	B-T081
,	O	O	O
CaCl2	O	O	B-T121
-extractable	O	O	O
S	O	O	B-T121
and	O	O	O
Zn	O	O	B-T121
,	O	O	O
and	O	O	O
remaining	O	O	O
ES	O	O	B-T121
were	O	O	O
evaluated	O	O	B-T052
at	O	O	O
30	O	O	O
and	O	O	O
60	O	O	O
days	O	O	O
in	O	O	O
two	O	O	O
soil	O	O	B-T167
sections	O	O	I-T167
(	O	O	O
0	O	O	O
-	O	O	O
5	O	O	O
and	O	O	O
5	O	O	O
-	O	O	O
9	O	O	O
mm	O	O	O
from	O	O	O
the	O	O	O
fertilizer	O	O	B-T131
application	O	O	B-T082
site	O	O	I-T082
)	O	O	O
.	O	O	O

A	O	O	O
visualization	O	O	B-T059
test	O	O	I-T059
was	O	O	O
performed	O	O	O
to	O	O	O
evaluate	O	O	O
Zn	O	O	B-T121
diffusion	O	O	B-T070
over	O	O	O
time	O	O	O
.	O	O	O

A	O	O	O
significant	O	O	B-T078
pH	O	O	B-T033
decrease	O	O	I-T033
was	O	O	O
observed	O	O	B-T169
in	O	O	O
the	O	O	O
acidic	O	O	B-T103
soil	O	O	B-T167
for	O	O	O
all	O	O	O
ES-Zn	O	O	B-T167
fertilizer	O	O	I-T167
treatments	O	O	B-T169
and	O	O	O
in	O	O	O
the	O	O	O
alkaline	O	O	B-T080
soil	O	O	O
for	O	O	O
the	O	O	O
Acidithiobacillus	O	O	B-T007
thiooxidans	O	O	I-T007
-	O	O	O
inoculated	O	O	B-T034
treatment	O	O	I-T034
only	O	O	O
.	O	O	O

In	O	O	O
agreement	O	O	O
with	O	O	O
Zn	O	O	B-T121
visualization	O	O	B-T059
tests	O	O	I-T059
,	O	O	O
extractable-	O	O	O
Zn	O	O	O
concentrations	O	O	B-T081
were	O	O	O
higher	O	O	B-T080
from	O	O	O
the	O	O	O
point	O	O	O
of	O	O	O
application	O	O	O
in	O	O	O
the	O	O	O
acidic	O	O	B-T103
(	O	O	O
62.9	O	O	O
mg	O	O	O
dm(-3	O	O	O
)	O	O	O
)	O	O	O
compared	O	O	O
to	O	O	O
the	O	O	O
alkaline	O	O	B-T080
soil	O	O	B-T167
(	O	O	O
5.5	O	O	O
mg	O	O	O
dm(-3	O	O	O
)	O	O	O
)	O	O	O
.	O	O	O

Elemental	O	O	B-T044
S	O	O	I-T044
oxidation	O	O	I-T044
was	O	O	O
greater	O	O	B-T081
in	O	O	O
the	O	O	O
acidic	O	O	B-T103
soil	O	O	B-T167
(	O	O	O
20.9	O	O	O
%	O	O	O
)	O	O	O
than	O	O	O
slightly	O	O	O
alkaline	O	O	B-T080
soil	O	O	O
(	O	O	O
12	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
ES-Zn	O	O	B-T167
granular	O	O	I-T167
fertilizers	O	O	I-T167
increased	O	O	B-T081
S	O	O	B-T121
and	O	O	O
Zn	O	O	B-T121
concentrations	O	O	B-T081
in	O	O	O
soil	O	O	B-T167
and	O	O	O
can	O	O	O
provide	O	O	O
a	O	O	O
strategically	O	O	O
slow	O	O	B-T080
release	O	O	B-T169
of	O	O	O
nutrients	O	O	B-T168
to	O	O	O
the	O	O	O
soil	O	O	O
.	O	O	O

-DOCSTART- (28129238)

Impact	O	O	B-T080
of	O	O	O
Blood	O	O	B-T061
Transfusions	O	O	I-T061
on	O	O	O
Survival	O	O	B-T052
of	O	O	O
Locally	O	O	B-T082
Advanced	O	O	B-T080
Cervical	O	O	B-T191
Cancer	O	O	I-T191
Patients	O	O	B-T101
Undergoing	O	O	O
Neoadjuvant	O	O	B-T061
Chemotherapy	O	O	I-T061
Plus	O	O	O
Radical	O	O	O
Surgery	O	O	O

Transfusions	O	O	B-T061
represent	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
main	O	O	O
progresses	O	O	B-T169
of	O	O	O
modern	O	O	B-T079
medicine	O	O	I-T079
.	O	O	O

However	O	O	O
,	O	O	O
accumulating	O	O	O
evidence	O	O	B-T078
supports	O	O	O
that	O	O	O
transfusions	O	O	B-T061
correlate	O	O	O
with	O	O	O
worse	O	O	O
survival	O	O	B-T052
outcomes	O	O	B-T080
in	O	O	O
patients	O	O	B-T101
affected	O	O	B-T169
by	O	O	O
solid	O	O	B-T191
cancers	O	O	I-T191
.	O	O	O

In	O	O	O
the	O	O	O
present	O	O	O
study	O	O	B-T062
,	O	O	O
we	O	O	O
aimed	O	O	B-T078
to	O	O	O
investigate	O	O	B-T169
the	O	O	O
effects	O	O	O
of	O	O	O
perioperative	O	O	B-T079
blood	O	O	B-T061
transfusion	O	O	I-T061
in	O	O	O
locally	O	O	B-T082
advanced	O	O	B-T080
cervical	O	O	B-T191
cancer	O	O	I-T191
.	O	O	O

Data	O	O	O
of	O	O	O
consecutive	O	O	O
patients	O	O	B-T101
affected	O	O	B-T169
by	O	O	O
locally	O	O	B-T082
advanced	O	O	B-T080
cervical	O	O	B-T191
cancer	O	O	I-T191
scheduled	O	O	O
to	O	O	O
undergo	O	O	O
neoadjuvant	O	O	B-T061
chemotherapy	O	O	I-T061
plus	O	O	O
radical	O	O	B-T061
surgery	O	O	I-T061
were	O	O	O
retrospectively	O	O	B-T062
searched	O	O	B-T052
to	O	O	O
test	O	O	B-T169
the	O	O	O
impact	O	O	B-T080
of	O	O	O
perioperative	O	O	B-T079
transfusions	O	O	B-T061
on	O	O	O
survival	O	O	B-T052
outcomes	O	O	B-T080
.	O	O	O

Five-	O	O	O
year	O	O	B-T079
survival	O	O	B-T052
outcomes	O	O	B-T080
were	O	O	O
evaluated	O	O	O
using	O	O	O
Kaplan-Meier	O	O	B-T062
and	O	O	O
Cox	O	O	B-T081
models	O	O	I-T081
.	O	O	O

The	O	O	O
study	O	O	B-T062
included	O	O	O
275	O	O	O
patients	O	O	B-T101
.	O	O	O

Overall	O	O	O
,	O	O	O
170	O	O	O
(	O	O	O
62	O	O	O
%	O	O	O
)	O	O	O
patients	O	O	B-T101
had	O	O	O
blood	O	O	B-T061
transfusion	O	O	I-T061
.	O	O	O

Via	O	O	O
univariate	O	O	B-T062
analysis	O	O	I-T062
,	O	O	O
we	O	O	O
observed	O	O	B-T169
that	O	O	O
transfusion	O	O	B-T061
correlated	O	O	O
with	O	O	O
an	O	O	O
increased	O	O	O
risk	O	O	B-T078
of	O	O	O
developing	O	O	B-T169
recurrence	O	O	B-T191
(	O	O	O
hazard	O	O	B-T081
ratio	O	O	I-T081
[	O	O	O
HR	O	O	B-T081
]	O	O	O
,	O	O	O
2.2	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
confidence	O	O	B-T081
interval	O	O	I-T081
[	O	O	O
CI	O	O	B-T081
]	O	O	O
,	O	O	O
1.09	O	O	O
-	O	O	O
4.40	O	O	O
;	O	O	O
P	O	O	B-T081
=	O	O	O
0.02	O	O	O
)	O	O	O
.	O	O	O

Other	O	O	O
factors	O	O	O
associated	O	O	O
with	O	O	O
5-	O	O	O
year	O	O	B-T079
disease-free	O	O	B-T081
survival	O	O	I-T081
were	O	O	O
noncomplete	O	O	B-T033
clinical	O	O	B-T033
response	O	O	B-T033
after	O	O	O
neoadjuvant	O	O	B-T061
chemotherapy	O	O	I-T061
(	O	O	O
HR	O	O	B-T081
,	O	O	O
2.99	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
,	O	O	O
0.92	O	O	O
-	O	O	O
9.63	O	O	O
;	O	O	O
P	O	O	B-T081
=	O	O	O
0.06	O	O	O
)	O	O	O
and	O	O	O
pathological	O	O	B-T033
(	O	O	O
P	O	O	O
=	O	O	O
0.03	O	O	O
)	O	O	O
response	O	O	O
at	O	O	O
neoadjuvant	O	O	O
chemotherapy	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
parametrial	O	O	B-T029
(	O	O	O
P	O	O	O
=	O	O	O
0.004	O	O	O
)	O	O	O
,	O	O	O
vaginal	O	O	B-T023
(	O	O	O
P	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
lymph	O	O	B-T023
node	O	O	I-T023
(	O	O	O
P	O	O	O
=	O	O	O
0.002	O	O	O
)	O	O	O
involvements	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
via	O	O	O
multivariate	O	O	B-T081
analysis	O	O	I-T081
,	O	O	O
only	O	O	O
vaginal	O	O	B-T023
(	O	O	O
HR	O	O	B-T081
,	O	O	O
3.07	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
,	O	O	O
1.20	O	O	O
-	O	O	O
7.85	O	O	O
;	O	O	O
P	O	O	B-T081
=	O	O	O
0.01	O	O	O
)	O	O	O
and	O	O	O
lymph	O	O	B-T023
node	O	O	I-T023
involvements	O	O	O
(	O	O	O
HR	O	O	O
,	O	O	O
2.4	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
,	O	O	O
1.00	O	O	O
-	O	O	O
6.06	O	O	O
;	O	O	O
P	O	O	O
=	O	O	O
0.05	O	O	O
)	O	O	O
correlate	O	O	O
with	O	O	O
worse	O	O	O
disease-free	O	O	B-T081
survival	O	O	I-T081
.	O	O	O

No	O	O	O
association	O	O	O
with	O	O	O
worse	O	O	O
outcomes	O	O	B-T080
was	O	O	O
observed	O	O	B-T169
for	O	O	O
patients	O	O	B-T101
undergoing	O	O	O
blood	O	O	B-T061
transfusion	O	O	I-T061
(	O	O	O
HR	O	O	B-T081
,	O	O	O
2.71	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
,	O	O	O
0.91	O	O	O
-	O	O	O
8.03	O	O	O
;	O	O	O
P	O	O	B-T081
=	O	O	O
0.07	O	O	O
)	O	O	O
.	O	O	O

Looking	O	O	O
at	O	O	O
factors	O	O	O
influencing	O	O	O
overall	O	O	B-T081
survival	O	O	B-T052
,	O	O	O
we	O	O	O
observed	O	O	B-T169
that	O	O	O
lymph	O	O	B-T023
node	O	O	I-T023
status	O	O	O
(	O	O	O
P	O	O	B-T081
=	O	O	O
0.01	O	O	O
)	O	O	O
and	O	O	O
vaginal	O	O	B-T023
involvement	O	O	O
(	O	O	O
P	O	O	O
=	O	O	O
0.06	O	O	O
)	O	O	O
were	O	O	O
independently	O	O	O
associated	O	O	O
with	O	O	O
survival	O	O	O
.	O	O	O

The	O	O	O
role	O	O	O
of	O	O	O
blood	O	O	B-T061
transfusions	O	O	I-T061
in	O	O	O
increasing	O	O	O
the	O	O	O
risk	O	O	B-T078
of	O	O	O
developing	O	O	B-T169
recurrence	O	O	B-T191
in	O	O	O
LAAC	O	O	B-T191
patients	O	O	B-T101
treated	O	O	B-T061
by	O	O	O
neoadjuvant	O	O	B-T061
chemotherapy	O	O	I-T061
plus	O	O	O
radical	O	O	B-T061
surgery	O	O	I-T061
remains	O	O	O
unclear	O	O	B-T033
;	O	O	O
further	O	O	O
prospective	O	O	B-T062
studies	O	O	I-T062
are	O	O	O
warranted	O	O	O
.	O	O	O

-DOCSTART- (28130404)

Tissue	O	O	B-T024
reservoirs	O	O	O
of	O	O	O
antiviral	O	O	B-T033
T	O	O	B-T040
cell	O	O	I-T040
immunity	O	O	I-T040
in	O	O	O
persistent	O	O	O
human	O	O	B-T016
CMV	O	O	O
infection	O	O	O

T	O	O	B-T025
cell	O	O	I-T025
responses	O	O	B-T042
to	O	O	O
viruses	O	O	B-T005
are	O	O	O
initiated	O	O	O
and	O	O	O
maintained	O	O	O
in	O	O	O
tissue	O	O	B-T024
sites	O	O	O
;	O	O	O
however	O	O	O
,	O	O	O
knowledge	O	O	O
of	O	O	O
human	O	O	B-T016
antiviral	O	O	B-T033
T	O	O	B-T025
cells	O	O	I-T025
is	O	O	O
largely	O	O	O
derived	O	O	O
from	O	O	O
blood	O	O	B-T031
.	O	O	O

Cytomegalovirus	O	O	B-T005
(	O	O	O
CMV	O	O	B-T005
)	O	O	O
persists	O	O	O
in	O	O	O
most	O	O	O
humans	O	O	B-T016
,	O	O	O
requires	O	O	O
T	O	O	B-T040
cell	O	O	I-T040
immunity	O	O	I-T040
to	O	O	O
control	O	O	O
,	O	O	O
yet	O	O	O
tissue	O	O	B-T024
immune	O	O	B-T042
responses	O	O	I-T042
remain	O	O	O
undefined	O	O	O
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
investigated	O	O	O
human	O	O	B-T016
CMV	O	O	B-T005
-specific	O	O	O
T	O	O	B-T025
cells	O	O	I-T025
,	O	O	O
virus	O	O	B-T005
persistence	O	O	B-T081
and	O	O	O
CMV	O	O	O
-associated	O	O	O
T	O	O	B-T025
cell	O	O	I-T025
homeostasis	O	O	B-T038
in	O	O	O
blood	O	O	B-T031
,	O	O	O
lymphoid	O	O	B-T024
,	O	O	O
mucosa	O	O	B-T024
l	O	O	O
and	O	O	O
secretory	O	O	B-T024
tissues	O	O	I-T024
of	O	O	O
44	O	O	O
CMV	O	O	O
seropositive	O	O	B-T080
and	O	O	O
28	O	O	O
seronegative	O	O	B-T034
donors	O	O	B-T098
.	O	O	O

CMV	O	O	B-T005
-specific	O	O	O
T	O	O	B-T025
cells	O	O	I-T025
were	O	O	O
maintained	O	O	O
in	O	O	O
distinct	O	O	O
distribution	O	O	B-T082
patterns	O	O	I-T082
,	O	O	O
highest	O	O	O
in	O	O	O
blood	O	O	B-T031
,	O	O	O
bone	O	O	B-T024
marrow	O	O	I-T024
(	O	O	O
BM	O	O	B-T024
)	O	O	O
,	O	O	O
or	O	O	O
lymph	O	O	B-T023
nodes	O	O	I-T023
(	O	O	O
LN	O	O	B-T023
)	O	O	O
,	O	O	O
with	O	O	O
the	O	O	O
frequency	O	O	B-T080
and	O	O	O
function	O	O	B-T169
in	O	O	O
blood	O	O	O
distinct	O	O	O
from	O	O	O
tissues	O	O	B-T024
.	O	O	O

CMV	O	O	B-T005
genomes	O	O	B-T028
were	O	O	O
detected	O	O	B-T033
predominantly	O	O	O
in	O	O	O
lung	O	O	B-T023
and	O	O	O
also	O	O	O
in	O	O	O
spleen	O	O	B-T023
,	O	O	O
BM	O	O	B-T024
,	O	O	O
blood	O	O	B-T031
and	O	O	O
LN	O	O	B-T023
.	O	O	O

High	O	O	O
frequencies	O	O	O
of	O	O	O
activated	O	O	O
CMV	O	O	B-T005
-specific	O	O	O
T	O	O	B-T025
cells	O	O	I-T025
were	O	O	O
found	O	O	O
in	O	O	O
blood	O	O	B-T031
and	O	O	O
BM	O	O	B-T024
samples	O	O	B-T167
with	O	O	O
low	O	O	O
virus	O	O	B-T005
detection	O	O	I-T043
,	O	O	O
whereas	O	O	O
in	O	O	O
lung	O	O	B-T023
,	O	O	O
CMV	O	O	O
-specific	O	O	O
T	O	O	O
cells	O	O	O
were	O	O	O
present	O	O	O
along	O	O	O
with	O	O	O
detectable	O	O	O
virus	O	O	O
.	O	O	O

In	O	O	O
LNs	O	O	B-T023
,	O	O	O
CMV	O	O	B-T005
-specific	O	O	O
T	O	O	B-T025
cells	O	O	I-T025
exhibited	O	O	O
quiescent	O	O	O
phenotypes	O	O	B-T032
independent	O	O	O
of	O	O	O
virus	O	O	B-T005
.	O	O	O

Overall	O	O	O
,	O	O	O
T	O	O	B-T025
cell	O	O	I-T025
differentiation	O	O	B-T043
was	O	O	O
enhanced	O	O	B-T052
in	O	O	O
sites	O	O	O
of	O	O	O
viral	O	O	B-T169
persistence	O	O	B-T081
with	O	O	O
age	O	O	O
.	O	O	O

Together	O	O	O
,	O	O	O
our	O	O	O
results	O	O	O
suggest	O	O	O
tissue	O	O	B-T024
T	O	O	B-T025
cell	O	O	I-T025
reservoirs	O	O	O
for	O	O	O
CMV	O	O	B-T005
control	O	O	B-T058
shaped	O	O	O
by	O	O	O
both	O	O	O
viral	O	O	B-T169
and	O	O	O
tissue	O	O	O
-	O	O	O
intrinsic	O	O	B-T116
factors	O	O	I-T116
,	O	O	O
with	O	O	O
global	O	O	O
effects	O	O	O
on	O	O	O
homeostasis	O	O	B-T038
of	O	O	O
tissue	O	O	O
T	O	O	B-T025
cells	O	O	I-T025
over	O	O	O
the	O	O	O
lifespan	O	O	B-T102
.	O	O	O

-DOCSTART- (28135040)

Lipid	O	O	B-T059
levels	O	O	I-T059
and	O	O	O
risk	O	O	B-T078
of	O	O	O
recurrent	O	O	B-T046
venous	O	O	I-T046
thrombosis	O	O	I-T046
:	O	O	O
results	O	O	B-T169
from	O	O	O
the	O	O	O
MEGA	O	O	O
follow-up	O	O	O
study	O	O	O

Essentials	O	O	O
The	O	O	O
role	O	O	O
of	O	O	O
lipid	O	O	B-T059
levels	O	O	I-T059
in	O	O	O
the	O	O	O
risk	O	O	B-T078
of	O	O	O
recurrent	O	O	B-T046
venous	O	O	I-T046
thrombosis	O	O	I-T046
is	O	O	O
unclear	O	O	B-T033
.	O	O	O

Lipids	O	O	B-T109
were	O	O	O
assessed	O	O	B-T052
in	O	O	O
patients	O	O	B-T101
with	O	O	O
a	O	O	O
first	O	O	O
venous	O	O	B-T046
thrombosis	O	O	I-T046
(	O	O	O
n	O	O	O
=	O	O	O
2106	O	O	O
)	O	O	O
followed	O	O	B-T079
for	O	O	O
6.9	O	O	O
years	O	O	B-T079
.	O	O	O

Lipids	O	O	B-T109
were	O	O	O
not	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
recurrence	O	O	B-T067
,	O	O	O
overall	O	O	O
or	O	O	O
in	O	O	O
patients	O	O	B-T101
with	O	O	O
unprovoked	O	O	O
first	O	O	O
events	O	O	B-T051
.	O	O	O

Testing	O	O	B-T059
lipid	O	O	I-T059
levels	O	O	I-T059
is	O	O	O
not	O	O	O
useful	O	O	B-T080
to	O	O	O
identify	O	O	B-T080
patients	O	O	B-T101
at	O	O	O
an	O	O	O
increased	O	O	B-T081
risk	O	O	B-T078
of	O	O	O
recurrence	O	O	B-T067
.	O	O	O

Background	O	O	O
Knowledge	O	O	O
of	O	O	O
risk	O	O	B-T033
factors	O	O	I-T033
for	O	O	O
recurrent	O	O	B-T046
venous	O	O	I-T046
thrombosis	O	O	I-T046
may	O	O	O
guide	O	O	O
decisions	O	O	O
on	O	O	O
duration	O	O	B-T079
of	O	O	O
anticoagulation	O	O	B-T061
.	O	O	O

The	O	O	O
association	O	O	B-T080
between	O	O	O
lipid	O	O	B-T059
levels	O	O	I-T059
and	O	O	O
first	O	O	O
venous	O	O	B-T046
thrombosis	O	O	I-T046
has	O	O	O
been	O	O	O
studied	O	O	O
extensively	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
data	O	O	B-T078
on	O	O	O
the	O	O	O
role	O	O	O
of	O	O	O
lipids	O	O	B-T109
in	O	O	O
the	O	O	O
risk	O	O	B-T078
of	O	O	O
recurrence	O	O	B-T067
are	O	O	O
scarce	O	O	O
.	O	O	O

Objective	O	O	O
To	O	O	O
assess	O	O	B-T052
the	O	O	O
association	O	O	B-T080
between	O	O	O
lipid	O	O	B-T059
levels	O	O	I-T059
and	O	O	O
recurrent	O	O	B-T046
venous	O	O	I-T046
thrombosis	O	O	I-T046
.	O	O	O

Patients	O	O	B-T101
/Methods	O	O	O
Patients	O	O	O
with	O	O	O
a	O	O	O
first	O	O	O
venous	O	O	B-T046
thrombosis	O	O	I-T046
from	O	O	O
the	O	O	O
MEGA	O	O	B-T062
study	O	O	I-T062
were	O	O	O
included	O	O	B-T169
.	O	O	O

Follow-up	O	O	B-T058
started	O	O	B-T080
at	O	O	O
the	O	O	O
date	O	O	B-T079
of	O	O	O
end	O	O	B-T082
of	O	O	O
anticoagulant	O	O	B-T061
treatment	O	O	I-T061
.	O	O	O

Percentile	O	O	B-T081
categories	O	O	B-T170
of	O	O	O
total	O	O	B-T109
/	O	O	O
low-density	O	O	B-T109
lipoprotein	O	O	I-T109
/	O	O	O
high-density	O	O	B-T109
lipoprotein	O	O	I-T109
cholesterol	O	O	I-T109
,	O	O	O
triglycerides	O	O	B-T109
and	O	O	O
apolipoproteins	O	O	B-T116
B	O	O	I-T116
and	O	O	O
A1	O	O	B-T116
were	O	O	O
established	O	O	B-T080
(	O	O	O
<	O	O	O
10th	O	O	O
,	O	O	O
10th-25th	O	O	O
,	O	O	O
25th-75th	O	O	O
[	O	O	O
reference	O	O	B-T081
]	O	O	O
,	O	O	O
75th-90th	O	O	O
,	O	O	O
>	O	O	O
90th	O	O	O
percentile	O	O	B-T081
)	O	O	O
.	O	O	O

Lipids	O	O	B-T109
were	O	O	O
measured	O	O	B-T080
at	O	O	O
least	O	O	O
3	O	O	O
months	O	O	B-T079
after	O	O	O
discontinuing	O	O	B-T033
anticoagulation	O	O	B-T061
.	O	O	O

Results	O	O	B-T169
Of	O	O	O
2106	O	O	O
patients	O	O	B-T101
followed	O	O	O
for	O	O	O
a	O	O	O
median	O	O	O
of	O	O	O
6.9	O	O	O
years	O	O	B-T079
,	O	O	O
326	O	O	O
developed	O	O	O
recurrence	O	O	B-T067
(	O	O	O
incidence	O	O	B-T081
rate	O	O	I-T081
,	O	O	O
2.7/100	O	O	O
patient	O	O	B-T101
-	O	O	O
years	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
confidence	O	O	B-T081
interval	O	O	I-T081
[	O	O	O
CI	O	O	B-T081
]	O	O	O
,	O	O	O
2.5	O	O	O
-	O	O	O
3.1	O	O	O
)	O	O	O
.	O	O	O

With	O	O	O
hazard	O	O	B-T081
ratios	O	O	I-T081
ranging	O	O	B-T081
from	O	O	O
0.88	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
,	O	O	O
0.55	O	O	O
-	O	O	O
1.42	O	O	O
)	O	O	O
to	O	O	O
1.33	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
,	O	O	O
0.86	O	O	O
-	O	O	O
2.04	O	O	O
)	O	O	O
in	O	O	O
the	O	O	O
highest	O	O	O
percentile	O	O	B-T081
category	O	O	B-T170
vs.	O	O	O
the	O	O	O
reference	O	O	B-T081
,	O	O	O
we	O	O	O
found	O	O	O
no	O	O	O
association	O	O	B-T080
across	O	O	O
percentile	O	O	O
categories	O	O	B-T170
between	O	O	O
recurrence	O	O	B-T067
and	O	O	O
lipid	O	O	B-T059
levels	O	O	I-T059
in	O	O	O
age-	O	O	B-T032
and	O	O	O
sex	O	O	B-T032
-adjusted	O	O	O
models	O	O	B-T075
,	O	O	O
nor	O	O	O
after	O	O	O
further	O	O	B-T082
adjustments	O	O	B-T169
for	O	O	O
body	O	O	B-T201
mass	O	O	I-T201
index	O	O	I-T201
,	O	O	O
diabetes	O	O	B-T047
,	O	O	O
estrogen	O	O	B-T125
and	O	O	O
statin	O	O	B-T109
use	O	O	B-T169
,	O	O	O
and	O	O	O
duration	O	O	B-T079
of	O	O	O
anticoagulation	O	O	B-T061
.	O	O	O

Subgroup	O	O	B-T185
analyses	O	O	B-T062
stratified	O	O	B-T080
by	O	O	O
unprovoked	O	O	O
or	O	O	O
provoked	O	O	B-T080
first	O	O	O
events	O	O	B-T051
,	O	O	O
location	O	O	B-T082
(	O	O	O
deep	O	O	B-T047
vein	O	O	I-T047
thrombosis	O	O	I-T047
or	O	O	O
pulmonary	O	O	B-T047
embolism	O	O	I-T047
)	O	O	O
and	O	O	O
sex	O	O	B-T032
also	O	O	O
did	O	O	O
not	O	O	O
reveal	O	O	B-T080
an	O	O	O
association	O	O	B-T080
with	O	O	O
any	O	O	O
of	O	O	O
the	O	O	O
lipid	O	O	B-T059
levels	O	O	I-T059
studied	O	O	O
.	O	O	O

Conclusions	O	O	O
Testing	O	O	B-T059
lipid	O	O	I-T059
levels	O	O	I-T059
did	O	O	O
not	O	O	O
identify	O	O	B-T080
patients	O	O	B-T101
at	O	O	O
an	O	O	O
increased	O	O	B-T081
risk	O	O	B-T078
of	O	O	O
recurrent	O	O	B-T046
venous	O	O	I-T046
thrombosis	O	O	I-T046
in	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
including	O	O	O
those	O	O	O
with	O	O	O
unprovoked	O	O	O
first	O	O	O
events	O	O	B-T051
,	O	O	O
and	O	O	O
these	O	O	O
should	O	O	O
not	O	O	O
influence	O	O	B-T077
decisions	O	O	O
on	O	O	O
duration	O	O	B-T079
of	O	O	O
anticoagulation	O	O	B-T061
.	O	O	O

-DOCSTART- (28143560)

Insecticidal	O	O	B-T038
effects	O	O	I-T038
of	O	O	O
deltamethrin	O	O	B-T109
in	O	O	O
laboratory	O	O	B-T093
and	O	O	O
field	O	O	B-T077
populations	O	O	B-T081
of	O	O	O
Culicoides	O	O	B-T204
species	O	O	I-T204
:	O	O	O
how	O	O	O
effective	O	O	O
are	O	O	O
host	O	O	B-T001
-	O	O	O
contact	O	O	B-T067
reduction	O	O	B-T080
methods	O	O	B-T062
in	O	O	O
India	O	O	B-T083
?	O	O	O

Bluetongue	O	O	B-T005
virus	O	O	I-T005
(	O	O	O
BTV	O	O	B-T005
)	O	O	O
is	O	O	O
transmitted	O	O	B-T046
by	O	O	O
Culicoides	O	O	B-T204
biting	O	O	B-T204
midges	O	O	I-T204
and	O	O	O
causes	O	O	O
bluetongue	O	O	B-T047
(	O	O	O
BT	O	O	B-T047
)	O	O	O
,	O	O	O
a	O	O	O
clinical	O	O	B-T047
disease	O	O	I-T047
observed	O	O	O
primarily	O	O	O
in	O	O	O
sheep	O	O	B-T015
.	O	O	O

BT	O	O	B-T047
has	O	O	O
a	O	O	O
detrimental	O	O	B-T046
effect	O	O	I-T046
on	O	O	O
subsistence	O	O	O
farmers	O	O	B-T097
in	O	O	O
India	O	O	B-T083
,	O	O	O
where	O	O	O
hyperendemic	O	O	B-T047
outbreaks	O	O	I-T047
impact	O	O	O
on	O	O	O
smallholdings	O	O	O
in	O	O	O
the	O	O	O
southern	O	O	B-T083
states	O	O	I-T083
of	O	O	O
the	O	O	O
country	O	O	B-T083
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	O
,	O	O	O
we	O	O	O
establish	O	O	O
a	O	O	O
reliable	O	O	O
method	O	O	B-T062
for	O	O	O
testing	O	O	O
the	O	O	O
toxic	O	O	B-T037
effects	O	O	I-T037
of	O	O	O
deltamethrin	O	O	B-T109
on	O	O	O
Culicoides	O	O	B-T204
and	O	O	O
then	O	O	O
compare	O	O	O
deltamethrin	O	O	O
with	O	O	O
traditional	O	O	B-T062
control	O	O	I-T062
methods	O	O	I-T062
used	O	O	O
by	O	O	O
farmers	O	O	B-T097
in	O	O	O
India	O	O	B-T083
.	O	O	O

Effects	O	O	O
of	O	O	O
deltamethrin	O	O	B-T109
were	O	O	O
initially	O	O	O
tested	O	O	O
using	O	O	O
a	O	O	O
colonised	O	O	B-T080
strain	O	O	I-T080
of	O	O	O
Culicoides	O	O	B-T204
nubeculosus	O	O	I-T204
Meigen	O	O	I-T204
and	O	O	O
a	O	O	O
modified	O	O	O
World	O	O	B-T093
Health	O	O	I-T093
Organisation	O	O	I-T093
exposure	O	O	B-T059
assay	O	O	I-T059
.	O	O	O

This	O	O	O
method	O	O	B-T062
was	O	O	O
then	O	O	O
applied	O	O	O
to	O	O	O
field	O	O	B-T077
populations	O	O	B-T081
of	O	O	O
Culicoides	O	O	O
spp	O	O	O
.	O	O	O

in	O	O	O
India	O	O	B-T083
.	O	O	O

The	O	O	O
field	O	O	B-T077
population	O	O	B-T081
of	O	O	O
C.	O	O	B-T204
oxystoma	O	O	I-T204
in	O	O	O
India	O	O	B-T083
had	O	O	O
a	O	O	O
greater	O	O	O
LC50	O	O	O
(	O	O	O
0.012	O	O	O
Â±	O	O	O
0.009	O	O	O
%	O	O	O
)	O	O	O
for	O	O	O
deltamethrin	O	O	B-T109
than	O	O	O
laboratory-reared	O	O	B-T059
C.nubeculosus	O	O	B-T204
(	O	O	O
0.0013	O	O	O
Â±	O	O	O
0.0002	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

Exposure	O	O	O
of	O	O	O
C.	O	O	B-T204
nubeculosus	O	O	I-T204
to	O	O	O
deltamethrin	O	O	B-T109
at	O	O	O
higher	O	O	O
ambient	O	O	B-T070
temperatures	O	O	I-T070
resulted	O	O	O
in	O	O	O
greater	O	O	O
rates	O	O	O
of	O	O	O
knockdown	O	O	O
but	O	O	O
a	O	O	O
lower	O	O	O
mortality	O	O	B-T081
rate	O	O	I-T081
at	O	O	O
24	O	O	O
h	O	O	O
post-exposure	O	O	O
.	O	O	O

Behavioural	O	O	B-T059
assays	O	O	I-T059
with	O	O	O
C.	O	O	B-T204
nubeculosus	O	O	I-T204
in	O	O	O
WHO	O	O	B-T093
tubes	O	O	B-T077
provided	O	O	O
evidence	O	O	O
for	O	O	O
contact	O	O	O
irritancy	O	O	O
and	O	O	O
spatial	O	O	O
repellence	O	O	O
caused	O	O	O
by	O	O	O
deltamethrin	O	O	B-T109
.	O	O	O

The	O	O	O
field	O	O	B-T077
experiments	O	O	B-T062
in	O	O	O
India	O	O	B-T083
,	O	O	O
however	O	O	O
,	O	O	O
provided	O	O	O
no	O	O	O
evidence	O	O	O
for	O	O	O
repellent	O	O	B-T131
or	O	O	O
toxic	O	O	B-T037
effects	O	O	I-T037
of	O	O	O
deltamethrin	O	O	B-T109
.	O	O	O

Traditional	O	O	B-T062
methods	O	O	I-T062
such	O	O	O
as	O	O	O
the	O	O	O
application	O	O	B-T169
of	O	O	O
neem	O	O	B-T002
oil	O	O	I-T109
and	O	O	O
burning	O	O	B-T067
of	O	O	O
neem	O	O	O
leaves	O	O	B-T002
also	O	O	O
provided	O	O	O
no	O	O	B-T033
protection	O	O	B-T033
.	O	O	O

Our	O	O	O
study	O	O	O
demonstrates	O	O	O
that	O	O	O
field	O	O	B-T077
-collected	O	O	O
Culicoides	O	O	B-T204
in	O	O	O
India	O	O	B-T083
are	O	O	O
less	O	O	O
susceptible	O	O	O
to	O	O	O
deltamethrin	O	O	B-T109
exposure	O	O	O
than	O	O	O
laboratory-bred	O	O	B-T059
C.	O	O	B-T204
nubeculosus	O	O	I-T204
and	O	O	O
traditional	O	O	B-T062
methods	O	O	I-T062
of	O	O	O
insect	O	O	B-T068
control	O	O	I-T068
do	O	O	O
not	O	O	O
provide	O	O	O
protection	O	O	B-T033
to	O	O	O
sheep	O	O	B-T015
.	O	O	O

These	O	O	O
low	O	O	O
levels	O	O	O
of	O	O	O
susceptibility	O	O	B-T038
to	O	O	O
deltamethrin	O	O	B-T109
have	O	O	O
not	O	O	O
been	O	O	O
recorded	O	O	O
before	O	O	O
in	O	O	O
field	O	O	B-T077
populations	O	O	B-T081
of	O	O	O
Culicoides	O	O	B-T204
and	O	O	O
suggest	O	O	O
resistance	O	O	B-T032
to	O	O	O
synthetic	O	O	B-T121
pyrethrioids	O	O	I-T121
.	O	O	O

Alternative	O	O	O
insect	O	O	B-T068
control	O	O	I-T068
methods	O	O	B-T062
,	O	O	O
in	O	O	O
addition	O	O	O
to	O	O	O
vaccination	O	O	B-T061
,	O	O	O
may	O	O	O
be	O	O	O
needed	O	O	O
to	O	O	O
protect	O	O	O
Indian	O	O	B-T083
livestock	O	O	B-T008
from	O	O	O
BTV	O	O	B-T005
transmission	O	O	B-T046
.	O	O	O

-DOCSTART- (28144189)

Correlation	O	O	B-T080
of	O	O	O
the	O	O	O
Lipid	O	O	B-T109
Profile	O	O	B-T059
,	O	O	O
BMI	O	O	B-T201
and	O	O	O
Bone	O	O	B-T201
Mineral	O	O	I-T201
Density	O	O	I-T201
in	O	O	O
Postmenopausal	O	O	B-T040
Women	O	O	O

To	O	O	O
the	O	O	O
reduction	O	O	B-T080
of	O	O	O
bone	O	O	B-T201
density	O	O	I-T201
and	O	O	O
osteoporosis	O	O	B-T047
in	O	O	O
postmenopausal	O	O	B-T040
women	O	O	B-T098
contribute	O	O	O
elevated	O	O	B-T080
lipid	O	O	B-T109
parameters	O	O	B-T033
and	O	O	O
Body	O	O	B-T201
Mass	O	O	I-T201
Index	O	O	I-T201
(	O	O	O
BMI	O	O	B-T201
)	O	O	O
.	O	O	O

The	O	O	O
goal	O	O	O
of	O	O	O
our	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
determine	O	O	O
the	O	O	O
correlation	O	O	B-T080
between	O	O	O
lipid	O	O	B-T109
parameters	O	O	B-T033
,	O	O	O
BMI	O	O	B-T201
and	O	O	O
osteoporosis	O	O	B-T047
in	O	O	O
postmenopausal	O	O	B-T040
women	O	O	B-T098
.	O	O	O

The	O	O	O
study	O	O	B-T062
was	O	O	O
carried	O	O	O
out	O	O	O
by	O	O	O
matched	O	O	B-T080
type	O	O	B-T080
between	O	O	O
experimental	O	O	B-T080
group	O	O	B-T078
and	O	O	O
controls	O	O	B-T096
.	O	O	O

The	O	O	O
experimental	O	O	B-T080
group	O	O	B-T078
consisted	O	O	O
of	O	O	O
100	O	O	O
females	O	O	B-T098
at	O	O	O
postmenopausal	O	O	B-T040
age	O	O	B-T032
,	O	O	O
in	O	O	O
which	O	O	O
by	O	O	O
the	O	O	O
DEXA	O	O	B-T060
method	O	O	I-T060
was	O	O	O
diagnosed	O	O	B-T033
osteoporosis	O	O	B-T047
at	O	O	O
the	O	O	O
Department	O	O	O
of	O	O	O
Endocrinology	O	O	O
,	O	O	O
Diabetes	O	O	O
and	O	O	O
Metabolic	O	O	O
Diseases	O	O	O
,	O	O	O
University	O	O	B-T093
Medical	O	O	I-T093
Center	O	O	I-T093
of	O	O	I-T093
RS	O	O	I-T093
during	O	O	O
2015	O	O	O
-	O	O	O
2016	O	O	O
,	O	O	O
while	O	O	O
the	O	O	O
control	O	O	B-T096
group	O	O	I-T096
consisted	O	O	O
of	O	O	O
100	O	O	O
females	O	O	O
in	O	O	O
a	O	O	O
postmenopausal	O	O	O
age	O	O	O
but	O	O	O
without	O	O	O
diagnosed	O	O	O
osteoporosis	O	O	O
.	O	O	O

The	O	O	O
groups	O	O	B-T078
were	O	O	O
matched	O	O	B-T080
by	O	O	O
age	O	O	B-T032
(	O	O	O
Â±	O	O	O
2	O	O	O
years	O	O	B-T079
)	O	O	O
.	O	O	O

To	O	O	O
all	O	O	O
participants	O	O	B-T098
of	O	O	O
the	O	O	O
study	O	O	B-T062
were	O	O	O
carried	O	O	O
out	O	O	O
biochemical	O	O	B-T059
analysis	O	O	B-T062
of	O	O	I-T059
blood	O	O	I-T059
,	O	O	O
or	O	O	O
the	O	O	O
analysis	O	O	O
of	O	O	O
the	O	O	O
lipid	O	O	B-T109
profile	O	O	B-T059
that	O	O	O
included	O	O	O
total	O	O	B-T109
cholesterol	O	O	I-T109
,	O	O	O
LDL	O	O	B-T109
cholesterol	O	O	I-T109
,	O	O	O
triglycerides	O	O	B-T109
(	O	O	O
TG	O	O	B-T109
)	O	O	O
and	O	O	O
HDL	O	O	B-T109
cholesterol	O	O	I-T109
,	O	O	O
and	O	O	O
was	O	O	O
determined	O	O	O
the	O	O	O
values	O	O	B-T080
of	O	O	O
BMI	O	O	B-T201
and	O	O	O
waist	O	O	B-T201
circumference	O	O	I-T201
(	O	O	O
WC	O	O	B-T201
)	O	O	O
.	O	O	O

Analysis	O	O	B-T062
of	O	O	O
the	O	O	O
data	O	O	B-T078
of	O	O	O
our	O	O	O
research	O	O	B-T062
shows	O	O	O
that	O	O	O
by	O	O	O
the	O	O	O
univariate	O	O	B-T062
logistic	O	O	I-T062
regression	O	O	I-T062
the	O	O	O
values	O	O	B-T080
of	O	O	O
lipid	O	O	B-T109
parameters	O	O	B-T033
total	O	O	B-T109
cholesterol	O	O	I-T109
(	O	O	O
p=0.000	O	O	O
)	O	O	O
,	O	O	O
LDL	O	O	B-T109
(	O	O	O
p=0.005	O	O	O
)	O	O	O
and	O	O	O
TG	O	O	B-T109
(	O	O	O
p=0.033	O	O	O
)	O	O	O
were	O	O	O
significantly	O	O	B-T078
associated	O	O	B-T080
with	O	O	I-T080
osteoporosis	O	O	B-T047
,	O	O	O
while	O	O	O
in	O	O	O
multivariate	O	O	B-T081
logistic	O	O	I-T081
model	O	O	I-T081
only	O	O	O
total	O	O	O
cholesterol	O	O	O
(	O	O	O
p=	O	O	O
0.018	O	O	O
)	O	O	O
was	O	O	O
found	O	O	O
as	O	O	O
an	O	O	O
independent	O	O	B-T078
risk	O	O	B-T033
factor	O	O	I-T033
for	O	O	O
osteoporosis	O	O	O
in	O	O	O
postmenopausal	O	O	B-T040
women	O	O	B-T098
.	O	O	O

BMI	O	O	B-T201
values	O	O	B-T080
were	O	O	O
not	O	O	B-T033
statistically	O	O	B-T081
significantly	O	O	I-T081
associated	O	O	B-T080
with	O	O	I-T080
osteoporosis	O	O	B-T047
(	O	O	O
p=0.727	O	O	O
)	O	O	O
.	O	O	O

On	O	O	O
the	O	O	O
decrease	O	O	B-T081
in	O	O	O
bone	O	O	B-T201
mineral	O	O	I-T201
density	O	O	I-T201
and	O	O	O
osteoporosis	O	O	B-T047
in	O	O	O
postmenopausal	O	O	B-T040
women	O	O	B-T098
influence	O	O	O
many	O	O	O
risk	O	O	B-T033
factors	O	O	I-T033
whose	O	O	O
identification	O	O	B-T080
has	O	O	O
the	O	O	O
aim	O	O	O
to	O	O	O
develop	O	O	O
more	O	O	O
effective	O	O	B-T080
prevention	O	O	B-T080
of	O	O	O
this	O	O	O
disease	O	O	B-T047
in	O	O	O
the	O	O	O
elderly	O	O	B-T098
.	O	O	O

-DOCSTART- (28144577)

Heterotopic	O	O	B-T046
ossification	O	O	I-T046
after	O	O	O
the	O	O	O
use	O	O	O
of	O	O	O
recombinant	O	O	O
human	O	O	O
bone	O	O	O
morphogenetic	O	O	O
protein-7	O	O	O

To	O	O	O
present	O	O	O
the	O	O	O
incidence	O	O	B-T081
of	O	O	O
heterotopic	O	O	B-T046
ossification	O	O	I-T046
after	O	O	O
the	O	O	O
use	O	O	O
of	O	O	O
recombinant	O	O	B-T116
human	O	O	I-T116
bone	O	O	I-T116
morphogenetic	O	O	I-T116
protein-7	O	O	I-T116
(	O	O	O
rhBMP-7	O	O	B-T116
)	O	O	O
for	O	O	O
the	O	O	O
treatment	O	O	B-T061
of	O	O	O
nonunions	O	O	B-T033
.	O	O	O

Bone	O	O	B-T116
morphogenetic	O	O	I-T116
proteins	O	O	I-T116
(	O	O	O
BMPs	O	O	B-T116
)	O	O	O
promote	O	O	O
bone	O	O	B-T042
formation	O	O	I-T042
by	O	O	O
auto-induction	O	O	B-T044
.	O	O	O

Recombinant	O	O	B-T116
human	O	O	I-T116
BMP-7	O	O	I-T116
in	O	O	O
combination	O	O	O
with	O	O	O
bone	O	O	B-T122
grafts	O	O	I-T122
was	O	O	O
used	O	O	O
in	O	O	O
84	O	O	O
patients	O	O	B-T101
for	O	O	O
the	O	O	O
treatment	O	O	B-T061
of	O	O	O
long	O	O	B-T033
bone	O	O	I-T033
nonunions	O	O	I-T033
.	O	O	O

All	O	O	O
patients	O	O	B-T101
were	O	O	O
evaluated	O	O	B-T058
radiographicaly	O	O	B-T060
for	O	O	O
the	O	O	O
development	O	O	B-T169
of	O	O	O
heterotopic	O	O	B-T046
ossification	O	O	I-T046
during	O	O	O
the	O	O	O
standard	O	O	B-T080
assessment	O	O	B-T058
for	O	O	O
the	O	O	O
nonunion	O	O	B-T033
healing	O	O	B-T040
.	O	O	O

In	O	O	O
all	O	O	O
patients	O	O	B-T101
(	O	O	O
80.9	O	O	O
%	O	O	O
)	O	O	O
with	O	O	O
radiographic	O	O	B-T070
signs	O	O	B-T184
of	O	O	O
heterotopic	O	O	B-T046
ossification	O	O	I-T046
,	O	O	O
a	O	O	O
CT	O	O	B-T060
scan	O	O	I-T060
was	O	O	O
performed	O	O	O
.	O	O	O

Nonunion	O	O	B-T033
site	O	O	B-T082
palpation	O	O	B-T060
and	O	O	O
ROM	O	O	B-T059
evaluation	O	O	I-T059
of	O	O	O
the	O	O	O
adjacent	O	O	B-T082
joints	O	O	B-T030
were	O	O	O
also	O	O	O
carried	O	O	O
out	O	O	O
.	O	O	O

Factors	O	O	B-T169
related	O	O	O
to	O	O	O
the	O	O	O
patient	O	O	B-T101
(	O	O	O
age	O	O	B-T032
,	O	O	O
gender	O	O	B-T032
)	O	O	O
,	O	O	O
the	O	O	O
nonunion	O	O	B-T033
(	O	O	O
location	O	O	B-T082
,	O	O	O
size	O	O	B-T082
,	O	O	O
chronicity	O	O	B-T079
,	O	O	O
number	O	O	B-T169
of	O	O	I-T169
previous	O	O	I-T169
procedures	O	O	I-T169
,	O	O	O
infection	O	O	B-T046
,	O	O	O
surrounding	O	O	B-T082
tissues	O	O	B-T024
condition	O	O	B-T080
)	O	O	O
and	O	O	O
the	O	O	O
surgical	O	O	B-T061
procedure	O	O	I-T061
(	O	O	O
graft	O	O	B-T122
and	O	O	O
fixation	O	O	B-T061
type	O	O	B-T080
,	O	O	O
amount	O	O	B-T081
of	O	O	O
rhBMP-7	O	O	B-T116
)	O	O	O
were	O	O	O
correlated	O	O	B-T080
with	O	O	O
the	O	O	O
development	O	O	B-T169
of	O	O	O
heterotopic	O	O	B-T046
ossification	O	O	I-T046
and	O	O	O
statistical	O	O	B-T062
analysis	O	O	I-T062
with	O	O	O
Pearsons	O	O	B-T170
Ï	O	O	I-T170
(	O	O	I-T170
2	O	O	I-T170
)	O	O	I-T170
test	O	O	I-T170
was	O	O	O
performed	O	O	O
.	O	O	O

Eighty	O	O	O
point	O	O	O
nine	O	O	O
percent	O	O	O
of	O	O	O
the	O	O	O
nonunions	O	O	B-T033
treated	O	O	B-T169
with	O	O	O
rhBMP-7	O	O	B-T116
,	O	O	O
healed	O	O	B-T169
with	O	O	O
no	O	O	O
need	O	O	O
for	O	O	O
further	O	O	O
procedures	O	O	B-T169
.	O	O	O

Heterotopic	O	O	B-T046
bone	O	O	I-T046
formation	O	O	I-T046
occurred	O	O	O
in	O	O	O
15	O	O	O
of	O	O	O
84	O	O	O
patients	O	O	B-T101
(	O	O	O
17.8	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
it	O	O	O
was	O	O	O
apparent	O	O	O
in	O	O	O
the	O	O	O
routine	O	O	O
radiological	O	O	B-T058
evaluation	O	O	I-T058
of	O	O	O
the	O	O	O
nonunion	O	O	B-T033
site	O	O	O
,	O	O	O
in	O	O	O
a	O	O	O
mean	O	O	B-T079
time	O	O	I-T079
of	O	O	O
5.5	O	O	O
mo	O	O	O
after	O	O	O
the	O	O	O
rhBMP-7	O	O	B-T116
application	O	O	B-T169
(	O	O	O
range	O	O	O
3	O	O	O
-	O	O	O
12	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
heterotopic	O	O	B-T046
ossification	O	O	I-T046
was	O	O	O
located	O	O	O
at	O	O	O
the	O	O	O
femur	O	O	B-T023
in	O	O	O
8	O	O	O
cases	O	O	B-T077
,	O	O	O
at	O	O	O
the	O	O	O
tibia	O	O	B-T023
in	O	O	O
6	O	O	O
,	O	O	O
and	O	O	O
at	O	O	O
the	O	O	O
humerus	O	O	B-T023
in	O	O	O
Î¿ne	O	O	O
patient	O	O	B-T101
.	O	O	O

In	O	O	O
4	O	O	O
patients	O	O	B-T101
a	O	O	O
palpable	O	O	B-T033
mass	O	O	I-T033
was	O	O	O
present	O	O	O
and	O	O	O
only	O	O	O
in	O	O	O
one	O	O	O
patient	O	O	B-T101
,	O	O	O
with	O	O	O
a	O	O	O
para-articular	O	O	B-T033
knee	O	O	I-T033
nonunion	O	O	I-T033
treated	O	O	B-T169
with	O	O	O
rhBMP-7	O	O	B-T116
,	O	O	O
the	O	O	O
size	O	O	B-T082
of	O	O	O
heterotopic	O	O	B-T046
ossification	O	O	I-T046
affected	O	O	O
the	O	O	O
knee	O	O	B-T033
range	O	O	I-T033
of	O	O	I-T033
motion	O	O	I-T033
.	O	O	O

All	O	O	O
the	O	O	O
patients	O	O	B-T101
with	O	O	O
heterotopic	O	O	B-T046
ossification	O	O	I-T046
were	O	O	O
male	O	O	B-T032
.	O	O	O

Statistical	O	O	B-T062
analysis	O	O	I-T062
proved	O	O	O
that	O	O	O
patient	O	O	B-T101
's	O	O	I-T101
gender	O	O	B-T032
was	O	O	O
the	O	O	O
only	O	O	O
important	O	O	O
factor	O	O	B-T169
for	O	O	O
the	O	O	O
development	O	O	B-T169
of	O	O	O
heterotopic	O	O	B-T046
ossification	O	O	I-T046
(	O	O	O
P	O	O	O
=	O	O	O
0.007	O	O	O
)	O	O	O
.	O	O	O

Heterotopic	O	O	B-T046
ossification	O	O	I-T046
after	O	O	O
the	O	O	O
use	O	O	O
of	O	O	O
rhBMP-7	O	O	B-T116
in	O	O	O
nonunions	O	O	B-T033
was	O	O	O
common	O	O	O
but	O	O	O
it	O	O	O
did	O	O	O
not	O	O	O
compromise	O	O	O
the	O	O	O
final	O	O	O
clinical	O	O	B-T169
outcome	O	O	I-T169
in	O	O	O
most	O	O	O
cases	O	O	B-T077
,	O	O	O
and	O	O	O
affected	O	O	O
only	O	O	O
male	O	O	B-T032
patients	O	O	B-T101
.	O	O	O

-DOCSTART- (28145492)

Hypocretin/Orexin	O	O	B-T116
Peptides	O	O	I-T116
Excite	O	O	B-T052
Rat	O	O	B-T015
Neuroendocrine	O	O	B-T022
Dopamine	O	O	B-T025
Neurons	O	O	I-T025
through	O	O	O
Orexin	O	O	B-T116
2	O	O	I-T116
Receptor	O	O	I-T116
-Mediated	O	O	O
Activation	O	O	B-T052
of	O	O	O
a	O	O	O
Mixed	O	O	B-T169
Cation	O	O	B-T104
Current	O	O	O

Hypocretin/Orexin	O	O	B-T116
(	O	O	O
H/O	O	O	B-T116
)	O	O	O
neurons	O	O	B-T025
of	O	O	O
the	O	O	O
lateral	O	O	B-T029
hypothalamus	O	O	I-T029
are	O	O	O
compelling	O	O	B-UnknownType
modulator	O	O	B-T098
candidates	O	O	I-T098
for	O	O	O
the	O	O	O
chronobiology	O	O	B-T091
of	O	O	O
neuroendocrine	O	O	B-T022
output	O	O	B-T077
and	O	O	O
,	O	O	O
as	O	O	O
a	O	O	O
consequence	O	O	B-T169
,	O	O	O
hormone	O	O	B-T125
release	O	O	I-T125
from	O	O	O
the	O	O	O
anterior	O	O	B-T023
pituitary	O	O	I-T023
.	O	O	O

Here	O	O	O
we	O	O	O
investigate	O	O	O
the	O	O	O
effects	O	O	B-T080
of	O	O	O
H/O	O	O	B-T116
peptides	O	O	I-T116
upon	O	O	O
tuberoinfundibular	O	O	B-T025
dopamine	O	O	I-T025
(	O	O	I-T025
TIDA	O	O	I-T025
)	O	O	I-T025
neurons	O	O	I-T025
-	O	O	O
cells	O	O	B-T025
which	O	O	O
control	O	O	B-T080
,	O	O	O
via	O	O	O
inhibition	O	O	B-T052
,	O	O	O
the	O	O	O
pituitary	O	O	B-T023
secretion	O	O	B-T043
of	O	O	I-T043
prolactin	O	O	I-T043
.	O	O	O

In	O	O	O
whole	O	O	B-T062
cell	O	O	I-T062
recordings	O	O	I-T062
performed	O	O	B-T169
in	O	O	O
male	O	O	B-T032
rat	O	O	B-T015
hypothalamic	O	O	B-T082
slices	O	O	I-T082
,	O	O	O
application	O	O	O
of	O	O	O
H/O-A	O	O	B-T116
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
H/O-B	O	O	B-T116
,	O	O	O
excited	O	O	B-T052
oscillating	O	O	O
TIDA	O	O	B-T025
neurons	O	O	I-T025
,	O	O	O
inducing	O	O	B-T169
a	O	O	O
reversible	O	O	B-T169
depolarising	O	O	B-T046
switch	O	O	O
from	O	O	O
phasic	O	O	B-T082
to	O	O	I-T082
tonic	O	O	I-T082
discharge	O	O	I-T082
.	O	O	O

The	O	O	O
H/O	O	O	B-T116
-	O	O	O
induced	O	O	B-T169
inward	O	O	B-T082
current	O	O	B-T043
underpinning	O	O	B-T077
this	O	O	O
effect	O	O	B-T080
was	O	O	O
post-synaptic	O	O	B-T026
(	O	O	O
as	O	O	O
it	O	O	O
endured	O	O	O
in	O	O	O
the	O	O	O
presence	O	O	B-T033
of	O	O	O
tetrodotoxin	O	O	B-T109
)	O	O	O
,	O	O	O
appeared	O	O	B-T080
to	O	O	O
be	O	O	O
carried	O	O	O
by	O	O	O
a	O	O	O
Na(+	O	O	B-T116
)	O	O	I-T116
-	O	O	O
dependent	O	O	B-T080
transient	O	O	B-T116
receptor	O	O	I-T116
potential-like	O	O	I-T116
channel	O	O	I-T116
(	O	O	O
as	O	O	O
it	O	O	O
was	O	O	O
blocked	O	O	B-T169
by	O	O	O
2-APB	O	O	B-T109
and	O	O	O
was	O	O	O
diminished	O	O	B-T081
by	O	O	O
removal	O	O	B-T052
of	O	O	O
extracellular	O	O	B-T026
Na(+	O	O	O
)	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
was	O	O	O
a	O	O	O
consequence	O	O	B-T169
of	O	O	I-T169
OX2R	O	O	B-T116
receptor	O	O	I-T116
activation	O	O	B-T052
(	O	O	O
as	O	O	O
it	O	O	O
was	O	O	O
blocked	O	O	O
by	O	O	O
the	O	O	O
OX2R	O	O	O
receptor	O	O	O
antagonist	O	O	B-T120
TCS	O	O	B-T109
OX2	O	O	I-T109
29	O	O	I-T109
,	O	O	O
but	O	O	O
not	O	O	O
the	O	O	O
OX1R	O	O	B-T116
receptor	O	O	I-T116
antagonist	O	O	O
SB	O	O	B-T109
334867	O	O	I-T109
)	O	O	O
.	O	O	O

Application	O	O	B-T058
of	O	O	O
the	O	O	O
hormone	O	O	B-T125
,	O	O	O
melatonin	O	O	B-T125
,	O	O	O
failed	O	O	B-T169
to	O	O	O
alter	O	O	B-T169
TIDA	O	O	B-T025
membrane	O	O	B-T043
potential	O	O	I-T043
or	O	O	O
oscillatory	O	O	B-T061
activity	O	O	I-T061
.	O	O	O

This	O	O	O
first	O	O	O
description	O	O	B-T170
of	O	O	O
the	O	O	O
electrophysiological	O	O	B-T060
effects	O	O	I-T060
of	O	O	O
H/Os	O	O	B-T116
upon	O	O	O
the	O	O	O
TIDA	O	O	B-T025
network	O	O	I-T025
identifies	O	O	B-T080
cellular	O	O	B-T044
mechanisms	O	O	I-T044
that	O	O	O
may	O	O	O
contribute	O	O	B-T052
to	O	O	O
the	O	O	O
circadian	O	O	B-T040
rhythmicity	O	O	I-T040
of	O	O	O
prolactin	O	O	B-T043
secretion	O	O	I-T043
.	O	O	O

-DOCSTART- (28145617)

Improving	O	O	B-T080
exchange	O	O	O
with	O	O	O
consumers	O	O	B-T098
within	O	O	O
mental	O	O	B-T093
health	O	O	I-T093
organizations	O	O	I-T093
:	O	O	O
Recognizing	O	O	O
mental	O	O	B-T048
ill	O	O	I-T048
health	O	O	I-T048
experience	O	O	O
as	O	O	O
a	O	O	O
'	O	O	O
sneaky	O	O	O
,	O	O	O
special	O	O	O
degree	O	O	O
'	O	O	O

Stigmatizing	O	O	B-T033
views	O	O	O
towards	O	O	O
consumers	O	O	B-T098
may	O	O	O
be	O	O	O
held	O	O	O
even	O	O	O
by	O	O	O
those	O	O	O
working	O	O	B-T057
within	O	O	O
mental	O	O	B-T093
health	O	O	I-T093
organizations	O	O	I-T093
.	O	O	O

Contemporary	O	O	O
mental	O	O	B-T170
health	O	O	I-T170
policies	O	O	I-T170
require	O	O	O
organizations	O	O	B-T093
to	O	O	O
work	O	O	B-T057
collaboratively	O	O	B-T054
with	O	O	O
consumers	O	O	B-T098
in	O	O	O
producing	O	O	B-T169
and	O	O	O
delivering	O	O	B-T058
services	O	O	B-T057
.	O	O	O

Using	O	O	O
social	O	O	B-UnknownType
exchange	O	O	B-T054
theory	O	O	I-UnknownType
,	O	O	O
which	O	O	O
emphasises	O	O	O
mutual	O	O	B-T080
exchange	O	O	O
to	O	O	O
maximise	O	O	B-T081
benefits	O	O	B-T081
in	O	O	O
partnership	O	O	B-T054
,	O	O	O
the	O	O	O
current	O	O	B-T079
study	O	O	B-T062
explores	O	O	O
the	O	O	O
perspectives	O	O	B-UnknownType
of	O	O	O
those	O	O	O
working	O	O	B-T057
within	O	O	O
organizations	O	O	B-T093
that	O	O	O
have	O	O	O
some	O	O	O
level	O	O	B-T080
of	O	O	O
consumer	O	O	B-T098
leadership	O	O	B-T054
.	O	O	O

Interviews	O	O	B-T052
were	O	O	O
conducted	O	O	O
with	O	O	O
14	O	O	O
participants	O	O	B-T098
from	O	O	O
a	O	O	O
range	O	O	B-T081
of	O	O	O
mental	O	O	B-T093
health	O	O	I-T093
organizations	O	O	I-T093
.	O	O	O

Data	O	O	B-T078
were	O	O	O
transcribed	O	O	O
,	O	O	O
and	O	O	O
analyzed	O	O	B-T062
using	O	O	O
thematic	O	O	B-T062
analytic	O	O	I-T062
and	O	O	O
discursive	O	O	B-T033
psychological	O	O	B-T060
techniques	O	O	I-T060
.	O	O	O

Findings	O	O	B-T033
suggest	O	O	O
stigma	O	O	B-T033
is	O	O	O
still	O	O	O
prevalent	O	O	O
even	O	O	O
in	O	O	O
organizations	O	O	B-T093
that	O	O	O
have	O	O	O
consumers	O	O	B-T098
in	O	O	O
leadership	O	O	B-T054
positions	O	O	I-T054
,	O	O	O
and	O	O	O
consumers	O	O	O
are	O	O	O
often	O	O	O
perceived	O	O	B-T041
as	O	O	O
less	O	O	O
able	O	O	O
to	O	O	O
work	O	O	B-T057
in	O	O	O
mental	O	O	B-T093
health	O	O	I-T093
organizations	O	O	I-T093
than	O	O	O
non-consumers	O	O	O
.	O	O	O

Several	O	O	O
discourses	O	O	B-T054
challenged	O	O	O
such	O	O	O
a	O	O	O
view	O	O	O
-	O	O	O
showing	O	O	O
how	O	O	O
consumers	O	O	B-T098
bring	O	O	O
value	O	O	O
to	O	O	O
mental	O	O	B-T093
health	O	O	I-T093
organizations	O	O	I-T093
through	O	O	O
their	O	O	O
expertise	O	O	O
in	O	O	O
the	O	O	O
mental	O	O	B-T093
health	O	O	I-T093
system	O	O	I-T093
,	O	O	O
and	O	O	O
their	O	O	O
ability	O	O	B-T032
to	O	O	O
provide	O	O	O
safety	O	O	B-T058
and	O	O	O
support	O	O	B-T054
to	O	O	O
other	O	O	O
consumers	O	O	O
.	O	O	O

Through	O	O	O
a	O	O	O
social	O	O	B-UnknownType
exchange	O	O	I-UnknownType
theory	O	O	I-UnknownType
lens	O	O	O
,	O	O	O
the	O	O	O
authors	O	O	B-T097
call	O	O	O
for	O	O	O
organizations	O	O	B-T093
to	O	O	O
challenge	O	O	O
stigma	O	O	B-T033
and	O	O	O
promote	O	O	B-T052
the	O	O	O
value	O	O	O
that	O	O	O
consumers	O	O	B-T098
can	O	O	O
bring	O	O	O
to	O	O	O
maximize	O	O	B-T081
mutual	O	O	B-T080
benefits	O	O	B-T081
.	O	O	O

-DOCSTART- (28148830)

Does	O	O	O
sex	O	O	B-T032
really	O	O	O
matter	O	O	O
?	O	O	O
Explaining	O	O	O
intraspecies	O	O	B-T185
variation	O	O	B-T080
in	O	O	O
ocean	O	O	B-T083
acidification	O	O	B-T067
responses	O	O	O

Explaining	O	O	O
intraspecies	O	O	B-T185
variation	O	O	B-T080
in	O	O	O
ocean	O	O	B-T083
acidification	O	O	B-T067
responses	O	O	B-T032
Ocean	O	O	B-T083
acidification	O	O	O
(	O	O	O
OA	O	O	B-T067
)	O	O	O
poses	O	O	O
a	O	O	O
major	O	O	B-T078
threat	O	O	I-T078
to	O	O	O
marine	O	O	O
ecosystems	O	O	B-T070
globally	O	O	B-T080
,	O	O	O
having	O	O	O
significant	O	O	B-T078
ecological	O	O	B-T070
and	O	O	O
economic	O	O	B-T169
importance	O	O	B-T080
.	O	O	O

The	O	O	O
number	O	O	B-T081
and	O	O	O
complexity	O	O	B-T169
of	O	O	O
experiments	O	O	B-T062
examining	O	O	B-T033
the	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
OA	O	O	B-T067
has	O	O	O
substantially	O	O	B-T078
increased	O	O	B-T081
over	O	O	O
the	O	O	O
past	O	O	B-T079
decade	O	O	B-T081
,	O	O	O
in	O	O	O
an	O	O	O
attempt	O	O	B-T051
to	O	O	O
address	O	O	B-T078
multi-stressor	O	O	B-T078
interactions	O	O	B-T169
and	O	O	O
long-term	O	O	B-T079
responses	O	O	B-T032
in	O	O	O
an	O	O	O
increasing	O	O	B-T169
range	O	O	B-T081
of	O	O	O
aquatic	O	O	B-T001
organisms	O	O	I-T001
.	O	O	O

However	O	O	O
,	O	O	O
differences	O	O	B-T080
in	O	O	O
the	O	O	O
response	O	O	B-T032
of	O	O	O
males	O	O	B-T032
and	O	O	O
females	O	O	B-T032
to	O	O	O
elevated	O	O	B-T033
pCO2	O	O	I-T033
have	O	O	O
been	O	O	O
investigated	O	O	B-T169
in	O	O	O
fewer	O	O	B-T081
than	O	O	O
4	O	O	O
%	O	O	O
of	O	O	O
studies	O	O	O
to	O	O	O
date	O	O	B-T079
,	O	O	O
often	O	O	O
being	O	O	O
precluded	O	O	O
by	O	O	O
the	O	O	O
difficulty	O	O	B-T080
of	O	O	O
determining	O	O	O
sex	O	O	B-T032
non-destructively	O	O	B-T078
,	O	O	O
particularly	O	O	O
in	O	O	O
early	O	O	B-T079
life	O	O	I-T079
stages	O	O	I-T079
.	O	O	O

Here	O	O	O
we	O	O	O
highlight	O	O	O
that	O	O	O
sex	O	O	B-T032
can	O	O	O
significantly	O	O	B-T078
impact	O	O	B-T080
organism	O	O	B-T001
responses	O	O	B-T032
to	O	O	O
OA	O	O	B-T067
,	O	O	O
differentially	O	O	O
affecting	O	O	B-T169
physiology	O	O	B-T039
,	O	O	O
reproduction	O	O	B-T040
,	O	O	O
biochemistry	O	O	B-T169
and	O	O	O
ultimately	O	O	B-T169
survival	O	O	I-T169
.	O	O	O

What	O	O	O
is	O	O	O
more	O	O	O
,	O	O	O
these	O	O	O
impacts	O	O	B-T080
do	O	O	O
not	O	O	O
always	O	O	O
conform	O	O	O
to	O	O	O
ecological	O	O	B-T078
theory	O	O	I-T078
based	O	O	O
on	O	O	O
differential	O	O	B-T080
resource	O	O	B-T081
allocation	O	O	I-T081
towards	O	O	O
reproduction	O	O	B-T040
,	O	O	O
which	O	O	O
would	O	O	O
predict	O	O	B-T078
females	O	O	B-T032
to	O	O	O
be	O	O	O
more	O	O	O
sensitive	O	O	B-T169
to	O	O	O
OA	O	O	B-T067
owing	O	O	O
to	O	O	O
the	O	O	O
higher	O	O	O
production	O	O	B-T169
cost	O	O	I-T169
of	O	O	O
eggs	O	O	B-T025
compared	O	O	B-T052
with	O	O	O
sperm	O	O	B-T025
.	O	O	O

Therefore	O	O	O
,	O	O	O
non-	O	O	O
sex	O	O	B-T032
-	O	O	O
specific	O	O	B-T062
studies	O	O	I-T062
may	O	O	O
overlook	O	O	O
subtle	O	O	O
but	O	O	O
ecologically	O	O	O
significant	O	O	B-T078
differences	O	O	B-T080
in	O	O	O
the	O	O	O
responses	O	O	B-T032
of	O	O	O
males	O	O	B-T032
and	O	O	O
females	O	O	B-T032
to	O	O	O
OA	O	O	B-T067
,	O	O	O
with	O	O	O
consequences	O	O	B-T169
for	O	O	O
forecasting	O	O	B-T079
the	O	O	O
fate	O	O	O
of	O	O	O
natural	O	O	B-T169
populations	O	O	B-T098
in	O	O	O
a	O	O	O
near-future	O	O	B-T079
ocean	O	O	B-T083
.	O	O	O

-DOCSTART- (28149055)

Computational	O	O	B-T059
analysis	O	O	I-T059
of	O	O	O
conserved	O	O	B-T082
coil	O	O	I-T082
functional	O	O	B-T077
residues	O	O	I-T077
in	O	O	O
the	O	O	O
mitochondrial	O	O	B-T059
genomic	O	O	I-T059
sequences	O	O	I-T059
of	O	O	O
dermatophytes	O	O	O

Dermatophyte	O	O	B-T004
is	O	O	O
a	O	O	O
group	O	O	O
of	O	O	O
closely	O	O	O
related	O	O	O
fungi	O	O	B-T004
that	O	O	O
have	O	O	O
the	O	O	O
capacity	O	O	O
to	O	O	O
invade	O	O	B-T080
keratinized	O	O	B-T169
tissue	O	O	B-T024
of	O	O	O
humans	O	O	B-T016
and	O	O	O
other	O	O	O
animals	O	O	B-T008
.	O	O	O

The	O	O	O
infection	O	O	B-T046
known	O	O	O
as	O	O	O
dermatophytosis	O	O	B-T047
,	O	O	O
caused	O	O	O
by	O	O	O
members	O	O	O
of	O	O	O
the	O	O	O
genera	O	O	B-T185
Microsporum	O	O	B-T004
,	O	O	O
Trichophyton	O	O	B-T004
,	O	O	O
and	O	O	O
Epidermophyton	O	O	B-T004
includes	O	O	O
infection	O	O	O
to	O	O	O
the	O	O	O
groin	O	O	B-T029
(	O	O	O
tinea	O	O	B-T047
cruris	O	O	I-T047
)	O	O	O
,	O	O	O
beard	O	O	B-T023
(	O	O	O
tinea	O	O	B-T047
barbae	O	O	I-T047
)	O	O	O
,	O	O	O
scalp	O	O	B-T023
(	O	O	O
tinea	O	O	B-T047
capitis	O	O	I-T047
)	O	O	O
,	O	O	O
feet	O	O	B-T023
(	O	O	O
tinea	O	O	B-T047
pedis	O	O	I-T047
)	O	O	O
,	O	O	O
glabrous	O	O	B-T023
skin	O	O	I-T023
(	O	O	O
tinea	O	O	B-T047
corporis	O	O	I-T047
)	O	O	O
,	O	O	O
nail	O	O	B-T023
(	O	O	O
tinea	O	O	B-T047
unguium	O	O	I-T047
)	O	O	O
,	O	O	O
and	O	O	O
hand	O	O	B-T023
(	O	O	O
tinea	O	O	B-T047
manuum	O	O	I-T047
)	O	O	O
.	O	O	O

The	O	O	O
identification	O	O	O
of	O	O	O
evolutionary	O	O	B-T045
relationship	O	O	B-T080
between	O	O	O
these	O	O	O
three	O	O	B-T185
genera	O	O	I-T185
of	O	O	O
dermatophyte	O	O	B-T004
is	O	O	O
epidemiologically	O	O	B-T169
important	O	O	I-T169
to	O	O	O
understand	O	O	O
their	O	O	O
pathogenicity	O	O	B-T032
.	O	O	O

Mitochondrial	O	O	B-T114
DNA	O	O	I-T114
evolves	O	O	B-T038
more	O	O	B-T080
rapidly	O	O	I-T080
than	O	O	O
a	O	O	O
nuclear	O	O	B-T114
DNA	O	O	I-T114
due	O	O	O
to	O	O	O
higher	O	O	O
rate	O	O	B-T080
of	O	O	I-T080
mutation	O	O	I-T080
but	O	O	O
is	O	O	O
very	O	O	O
less	O	O	B-T169
affected	O	O	I-T169
by	O	O	O
genetic	O	O	B-T045
recombination	O	O	I-T045
,	O	O	O
making	O	O	O
it	O	O	O
an	O	O	O
important	O	O	B-T073
tool	O	O	I-T073
for	O	O	O
phylogenetic	O	O	B-T062
studies	O	O	I-T062
.	O	O	O

Thus	O	O	O
,	O	O	O
here	O	O	O
we	O	O	O
present	O	O	O
a	O	O	O
novel	O	O	O
scheme	O	O	O
to	O	O	O
identify	O	O	O
the	O	O	O
conserved	O	O	B-T082
coil	O	O	I-T082
functional	O	O	B-T077
residues	O	O	I-T077
of	O	O	O
Trichophyton	O	O	B-T004
rubrum	O	O	I-T004
,	O	O	O
Trichophyton	O	O	B-T004
mentagrophytes	O	O	I-T004
,	O	O	O
Epidermophyton	O	O	B-T004
floccosum	O	O	I-T004
and	O	O	O
Microsporum	O	O	B-T004
canis	O	O	I-T004
.	O	O	O

Protein	O	O	B-T028
coding	O	O	I-T028
sequences	O	O	I-T028
of	O	O	O
the	O	O	O
mitochondrial	O	O	B-T028
genome	O	O	I-T028
were	O	O	O
aligned	O	O	O
for	O	O	O
their	O	O	O
similar	O	O	B-T086
sequences	O	O	I-T086
and	O	O	O
homology	O	O	B-T063
modelling	O	O	I-T063
was	O	O	O
performed	O	O	O
for	O	O	O
structure	O	O	B-T116
and	O	O	O
pocket	O	O	B-T087
identification	O	O	B-T062
.	O	O	O

The	O	O	O
results	O	O	O
obtained	O	O	O
from	O	O	O
comparative	O	O	B-T062
analysis	O	O	I-T062
of	O	O	O
the	O	O	O
protein	O	O	B-T087
sequences	O	O	I-T087
revealed	O	O	O
the	O	O	O
presence	O	O	O
of	O	O	O
functionally	O	O	O
active	O	O	B-T169
sites	O	O	I-T169
in	O	O	O
all	O	O	O
the	O	O	O
species	O	O	O
of	O	O	O
the	O	O	O
genera	O	O	B-T185
Trichophyton	O	O	B-T004
and	O	O	O
Microsporum	O	O	B-T004
.	O	O	O

However	O	O	O
in	O	O	O
Epidermophyton	O	O	B-T004
floccosum	O	O	I-T004
it	O	O	O
was	O	O	O
observed	O	O	O
in	O	O	O
three	O	O	O
protein	O	O	B-T087
sequences	O	O	I-T087
of	O	O	O
the	O	O	O
five	O	O	O
studied	O	O	O
.	O	O	O

The	O	O	O
absence	O	O	O
of	O	O	O
these	O	O	O
conserved	O	O	B-T082
coil	O	O	I-T082
functional	O	O	B-T077
residues	O	O	I-T077
in	O	O	O
E.	O	O	B-T004
floccusum	O	O	I-T004
may	O	O	O
be	O	O	O
correlated	O	O	O
with	O	O	O
lesser	O	O	B-T080
infectivity	O	O	I-T080
of	O	O	O
this	O	O	O
organism	O	O	B-T001
.	O	O	O

The	O	O	O
functional	O	O	B-T077
residues	O	O	I-T077
identified	O	O	O
in	O	O	O
the	O	O	O
present	O	O	O
study	O	O	O
could	O	O	O
be	O	O	O
responsible	O	O	O
for	O	O	O
the	O	O	O
disease	O	O	B-T047
and	O	O	O
thus	O	O	O
can	O	O	O
act	O	O	O
as	O	O	O
putative	O	O	B-T169
target	O	O	I-T169
sites	O	O	I-T169
for	O	O	O
drug	O	O	B-T090
designing	O	O	I-T090
.	O	O	O

-DOCSTART- (28149591)

Non-intubated	O	O	B-T061
subxiphoid	O	O	B-T082
uniportal	O	O	B-T061
video-assisted	O	O	I-T061
thoracoscopic	O	O	I-T061
thymectomy	O	O	B-T061
using	O	O	O
glasses-free	O	O	B-T033
3D	O	O	B-T082
vision	O	O	O

Trans-sternal	O	O	B-T061
thymectomy	O	O	I-T061
has	O	O	O
long	O	O	O
been	O	O	O
accepted	O	O	B-T080
as	O	O	O
the	O	O	O
standard	O	O	B-T080
surgical	O	O	B-T061
procedure	O	O	I-T061
for	O	O	O
thymic	O	O	B-T023
masses	O	O	I-T023
.	O	O	O

Recently	O	O	B-T079
,	O	O	O
minimally	O	O	B-T080
invasive	O	O	B-T169
methods	O	O	B-T170
,	O	O	O
such	O	O	O
as	O	O	O
video-assisted	O	O	B-T061
thoracoscopic	O	O	I-T061
surgery	O	O	I-T061
(	O	O	B-T061
VATS	O	O	I-T061
)	O	O	I-T061
and	O	O	O
,	O	O	O
even	O	O	O
more	O	O	O
recently	O	O	O
,	O	O	O
non-intubated	O	O	B-T061
anesthesia	O	O	B-T061
,	O	O	O
have	O	O	O
emerged	O	O	B-T080
.	O	O	O

These	O	O	O
methods	O	O	B-T170
provide	O	O	O
advantages	O	O	B-T081
including	O	O	B-T169
reductions	O	O	B-T080
in	O	O	O
surgical	O	O	B-T033
trauma	O	O	I-T033
,	O	O	O
postoperative	O	O	B-T184
associated	O	O	I-T184
pain	O	O	I-T184
,	O	O	O
and	O	O	O
in	O	O	O
regards	O	O	O
to	O	O	O
VATS	O	O	B-T061
,	O	O	O
provide	O	O	O
certain	O	O	O
cosmetic	O	O	B-T061
benefits	O	O	B-T081
.	O	O	O

Considering	O	O	B-T078
these	O	O	O
advantages	O	O	B-T081
,	O	O	O
we	O	O	O
herein	O	O	O
present	O	O	O
a	O	O	O
case	O	O	O
of	O	O	O
subxiphoid	O	O	B-T082
uniportal	O	O	B-T061
VATS	O	O	I-T061
for	O	O	O
thymic	O	O	B-T024
mass	O	O	I-T024
using	O	O	O
a	O	O	O
glasses-free	O	O	B-T033
3D	O	O	B-T082
thoracoscopic	O	O	B-T082
display	O	O	B-T170
system	O	O	I-T170
.	O	O	O

-DOCSTART- (28150347)

Trends	O	O	B-T079
in	O	O	O
dietary	O	O	B-T040
intake	O	O	I-T040
among	O	O	O
adults	O	O	B-T100
with	O	O	O
type	O	O	B-T047
2	O	O	I-T047
diabetes	O	O	I-T047
:	O	O	O
NHANES	O	O	B-T062
1988	O	O	O
-	O	O	O
2012	O	O	O

Dietary	O	O	B-T168
recommendations	O	O	B-T078
for	O	O	O
adults	O	O	B-T100
with	O	O	O
diabetes	O	O	B-T047
are	O	O	O
to	O	O	O
follow	O	O	O
a	O	O	O
healthy	O	O	B-T061
diet	O	O	I-T061
in	O	O	O
appropriate	O	O	O
portion	O	O	B-T081
sizes	O	O	I-T081
.	O	O	O

We	O	O	O
determined	O	O	O
recent	O	O	O
trends	O	O	B-T079
in	O	O	O
energy	O	O	B-T081
and	O	O	O
nutrient	O	O	B-T081
intakes	O	O	I-T081
among	O	O	O
a	O	O	O
nationally	O	O	O
representative	O	O	O
sample	O	O	O
of	O	O	O
US	O	O	B-T083
adults	O	O	B-T100
with	O	O	O
and	O	O	O
without	O	O	O
type	O	O	B-T047
2	O	O	I-T047
diabetes	O	O	I-T047
.	O	O	O

Participants	O	O	B-T098
were	O	O	O
adults	O	O	B-T100
aged	O	O	B-T032
â¥20	O	O	O
years	O	O	B-T079
from	O	O	O
the	O	O	O
cross-sectional	O	O	B-T062
National	O	O	I-T062
Health	O	O	I-T062
and	O	O	I-T062
Nutrition	O	O	I-T062
Examination	O	O	I-T062
Surveys	O	O	I-T062
,	O	O	O
1988	O	O	O
-	O	O	O
2012	O	O	O
(	O	O	O
N	O	O	O
=	O	O	O
49	O	O	O
770	O	O	O
)	O	O	O
.	O	O	O

Diabetes	O	O	B-T047
was	O	O	O
determined	O	O	O
by	O	O	O
self-report	O	O	B-T062
of	O	O	O
a	O	O	O
physician	O	O	B-T097
's	O	O	I-T097
diagnosis	O	O	B-T033
(	O	O	O
n	O	O	O
=	O	O	O
4885	O	O	O
)	O	O	O
.	O	O	O

Intake	O	O	B-T081
of	O	O	I-T081
energy	O	O	I-T081
and	O	O	O
nutrients	O	O	B-T168
were	O	O	O
determined	O	O	O
from	O	O	O
a	O	O	O
24-	O	O	O
h	O	O	B-T079
recall	O	O	O
by	O	O	O
participants	O	O	B-T098
of	O	O	O
all	O	O	O
food	O	O	B-T168
consumed	O	O	O
.	O	O	O

Linear	O	O	B-T081
regression	O	O	I-T081
was	O	O	O
used	O	O	O
to	O	O	O
test	O	O	B-T169
for	O	O	O
trends	O	O	B-T079
in	O	O	O
mean	O	O	O
intake	O	O	B-T040
over	O	O	O
time	O	O	B-T079
for	O	O	O
all	O	O	O
participants	O	O	B-T098
and	O	O	O
by	O	O	O
demographic	O	O	B-T102
characteristics	O	O	I-T102
.	O	O	O

Among	O	O	O
adults	O	O	B-T100
with	O	O	O
diabetes	O	O	B-T047
,	O	O	O
overall	O	O	O
total	O	O	O
energy	O	O	B-T081
intake	O	O	I-T081
increased	O	O	B-T081
between	O	O	O
1988	O	O	O
-	O	O	O
1994	O	O	O
and	O	O	O
2011	O	O	O
-	O	O	O
2012	O	O	O
(	O	O	O
1689	O	O	B-T081
kcal	O	O	I-T081
versus	O	O	O
1895	O	O	B-T081
kcal	O	O	I-T081
;	O	O	O
Ptrend	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
with	O	O	O
evidence	O	O	O
of	O	O	O
a	O	O	O
plateau	O	O	B-T081
between	O	O	O
2003	O	O	O
-	O	O	O
2006	O	O	O
and	O	O	O
2011	O	O	O
-	O	O	O
2012	O	O	O
.	O	O	O

In	O	O	O
2007	O	O	O
-	O	O	O
2012	O	O	O
,	O	O	O
energy	O	O	B-T081
intake	O	O	I-T081
was	O	O	O
greater	O	O	O
for	O	O	O
younger	O	O	B-T100
than	O	O	O
older	O	O	B-T098
adults	O	O	I-T098
,	O	O	O
for	O	O	O
men	O	O	B-T098
than	O	O	O
women	O	O	B-T098
,	O	O	O
and	O	O	O
for	O	O	O
non-Hispanic	O	O	B-T098
whites	O	O	I-T098
versus	O	O	O
non-Hispanic	O	O	B-T098
blacks	O	O	I-T098
.	O	O	O

There	O	O	O
was	O	O	O
no	O	O	O
change	O	O	O
in	O	O	O
the	O	O	O
percentage	O	O	B-T081
of	O	O	O
calories	O	O	B-T081
from	O	O	O
carbohydrate	O	O	B-T168
,	O	O	O
total	O	O	B-T109
fat	O	O	I-T109
or	O	O	O
protein	O	O	B-T168
.	O	O	O

Percentage	O	O	B-T081
of	O	O	O
calories	O	O	B-T081
from	O	O	O
saturated	O	O	B-UnknownType
fat	O	O	I-UnknownType
was	O	O	O
similar	O	O	O
across	O	O	O
study	O	O	B-T062
periods	O	O	B-T079
but	O	O	O
remained	O	O	O
above	O	O	O
recommendations	O	O	B-T078
(	O	O	O
11.2	O	O	O
%	O	O	O
in	O	O	O
2011	O	O	O
-	O	O	O
2012	O	O	O
)	O	O	O
.	O	O	O

Fibre	O	O	B-T033
intake	O	O	I-T033
significantly	O	O	O
decreased	O	O	O
and	O	O	O
remained	O	O	O
below	O	O	O
recommendations	O	O	B-T078
(	O	O	O
Ptrend	O	O	O
=	O	O	O
0.002	O	O	O
)	O	O	O
.	O	O	O

Sodium	O	O	B-T168
,	O	O	O
cholesterol	O	O	B-T109
and	O	O	O
calcium	O	O	B-T197
intakes	O	O	B-T040
increased	O	O	B-T081
.	O	O	O

There	O	O	O
was	O	O	O
no	O	O	O
change	O	O	O
in	O	O	O
energy	O	O	B-T081
intake	O	O	I-T081
among	O	O	O
adults	O	O	B-T100
without	O	O	O
diabetes	O	O	B-T047
and	O	O	O
dietary	O	O	B-T168
trends	O	O	B-T079
were	O	O	O
similar	O	O	O
to	O	O	O
those	O	O	O
with	O	O	O
diabetes	O	O	O
.	O	O	O

Future	O	O	O
data	O	O	B-T078
are	O	O	O
needed	O	O	O
to	O	O	O
confirm	O	O	O
a	O	O	O
plateau	O	O	B-T081
in	O	O	O
energy	O	O	B-T081
intake	O	O	I-T081
among	O	O	O
adults	O	O	B-T100
with	O	O	O
diabetes	O	O	B-T047
,	O	O	O
although	O	O	O
the	O	O	O
opportunity	O	O	O
exists	O	O	O
to	O	O	O
increase	O	O	B-T169
fibre	O	O	B-T168
and	O	O	O
reduce	O	O	B-T081
saturated	O	O	B-UnknownType
fat	O	O	I-UnknownType
.	O	O	O

-DOCSTART- (28152029)

Clonal	O	O	B-T024
and	O	O	O
serotype	O	O	B-T170
dynamics	O	O	B-T070
of	O	O	O
serogroup	O	O	B-T007
6	O	O	I-T007
isolates	O	O	B-T123
causing	O	O	O
invasive	O	O	B-T047
pneumococcal	O	O	I-T047
disease	O	O	I-T047
in	O	O	O
Portugal	O	O	B-T083
:	O	O	O
1999	O	O	O
-	O	O	O
2012	O	O	O

Although	O	O	O
serogroup	O	O	B-T007
6	O	O	I-T007
was	O	O	O
among	O	O	O
the	O	O	O
first	O	O	O
to	O	O	O
be	O	O	O
recognized	O	O	O
among	O	O	O
Streptococcus	O	O	B-T007
pneumoniae	O	O	I-T007
,	O	O	O
several	O	O	O
new	O	O	O
serotypes	O	O	B-T170
were	O	O	O
identified	O	O	B-T080
since	O	O	O
the	O	O	O
introduction	O	O	B-T169
of	O	O	O
pneumococcal	O	O	B-T129
conjugate	O	O	I-T129
vaccines	O	O	I-T129
(	O	O	O
PCVs	O	O	B-T129
)	O	O	O
.	O	O	O

A	O	O	O
decrease	O	O	B-T081
of	O	O	O
the	O	O	O
6B-2	O	O	B-T080
variant	O	O	I-T080
among	O	O	O
invasive	O	O	B-T047
pneumococcal	O	O	I-T047
disease	O	O	I-T047
(	O	O	O
IPD	O	O	B-T047
)	O	O	O
,	O	O	O
but	O	O	O
not	O	O	O
6B-1	O	O	B-T080
,	O	O	O
was	O	O	O
noted	O	O	O
post	O	O	B-T079
conjugate	O	O	B-T129
vaccine	O	O	I-T129
introduction	O	O	B-T169
,	O	O	O
underpinned	O	O	O
by	O	O	O
a	O	O	O
decrease	O	O	O
of	O	O	O
CC273	O	O	B-T123
isolates	O	O	I-T123
.	O	O	O

Serotype	O	O	B-T007
6C	O	O	I-T007
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
adult	O	O	B-T100
IPD	O	O	B-T047
and	O	O	O
increased	O	O	B-T081
in	O	O	O
this	O	O	O
age	O	O	B-T100
group	O	O	I-T100
representing	O	O	O
two	O	O	O
lineages	O	O	B-T078
(	O	O	O
CC315	O	O	B-T078
and	O	O	O
CC395	O	O	B-T078
)	O	O	O
,	O	O	O
while	O	O	O
the	O	O	O
same	O	O	O
lineages	O	O	O
expressed	O	O	B-T045
other	O	O	O
serogroup	O	O	B-T007
6	O	O	I-T007
serotypes	O	O	B-T170
in	O	O	O
children	O	O	B-T100
.	O	O	O

Taken	O	O	O
together	O	O	O
,	O	O	O
these	O	O	O
findings	O	O	B-T169
suggest	O	O	O
a	O	O	O
potential	O	O	O
cross-protection	O	O	B-T044
of	O	O	O
PCVs	O	O	B-T129
against	O	O	O
serotype	O	O	B-T007
6C	O	O	I-T007
IPD	O	O	B-T047
among	O	O	O
vaccinated	O	O	B-T033
children	O	O	B-T100
but	O	O	O
not	O	O	O
among	O	O	O
adults	O	O	B-T100
.	O	O	O

Serotype	O	O	B-T007
6A	O	O	I-T007
became	O	O	O
the	O	O	O
most	O	O	O
important	O	O	O
serogroup	O	O	B-T007
6	O	O	I-T007
serotype	O	O	B-T170
in	O	O	O
children	O	O	B-T100
but	O	O	O
it	O	O	O
decreased	O	O	B-T081
in	O	O	O
adult	O	O	B-T100
IPD	O	O	B-T047
.	O	O	O

No	O	O	O
other	O	O	O
serogroup	O	O	B-T007
6	O	O	I-T007
serotypes	O	O	B-T170
were	O	O	O
detected	O	O	B-T033
,	O	O	O
so	O	O	O
available	O	O	O
phenotypic	O	O	B-T032
or	O	O	O
simple	O	O	O
genotypic	O	O	B-T032
assays	O	O	B-T059
remain	O	O	O
adequate	O	O	B-T080
for	O	O	O
distinguishing	O	O	O
serotypes	O	O	O
within	O	O	O
serogroup	O	O	O
6	O	O	O
isolates	O	O	B-T123
.	O	O	O

-DOCSTART- (28152097)

Minimally	O	O	B-T169
invasive	O	O	I-T169
percutaneous	O	O	B-T061
nephrolithotomy	O	O	I-T061
improves	O	O	O
stone-free	O	O	O
rates	O	O	O
for	O	O	O
impacted	O	O	B-T169
proximal	O	O	B-T082
ureteral	O	O	B-T047
stones	O	O	I-T047
:	O	O	O
A	O	O	O
systematic	O	O	B-T170
review	O	O	I-T170
and	O	O	O
meta-analysis	O	O	O

Urinary	O	O	B-T047
stones	O	O	I-T047
are	O	O	O
common	O	O	O
medical	O	O	B-T169
disorders	O	O	B-T047
and	O	O	O
the	O	O	O
treatment	O	O	B-T169
of	O	O	O
impacted	O	O	B-T047
proximal	O	O	B-T082
ureteral	O	O	I-T047
stones	O	O	I-T047
(	O	O	O
IPUS	O	O	B-T047
)	O	O	O
is	O	O	O
still	O	O	O
a	O	O	O
challenge	O	O	O
for	O	O	O
urologists	O	O	B-T097
.	O	O	O

The	O	O	O
aim	O	O	B-T078
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
compare	O	O	B-T062
the	O	O	I-T062
efficacy	O	O	I-T062
and	O	O	O
safety	O	O	B-T062
of	O	O	O
minimally	O	O	B-T169
invasive	O	O	I-T169
percutaneous	O	O	B-T061
nephrolithotomy	O	O	I-T061
(	O	O	O
MI	O	O	B-T169
-	O	O	O
PCNL	O	O	B-T061
)	O	O	O
and	O	O	O
ureteroscopic	O	O	B-T061
lithotripsy	O	O	I-T061
(	O	O	O
URL	O	O	B-T061
)	O	O	O
in	O	O	O
the	O	O	O
treatment	O	O	B-T169
of	O	O	O
IPUS	O	O	B-T047
via	O	O	O
a	O	O	O
meta-analysis	O	O	B-T062
.	O	O	O

We	O	O	O
collected	O	O	O
studies	O	O	B-T062
using	O	O	O
PubMed	O	O	B-T170
,	O	O	O
Embase	O	O	B-T170
,	O	O	O
and	O	O	O
Cochrane	O	O	B-T170
Library	O	O	I-T170
from	O	O	O
1978	O	O	B-T079
to	O	O	I-T079
November	O	O	I-T079
2016	O	O	I-T079
and	O	O	O
analyzed	O	O	B-T062
them	O	O	O
using	O	O	O
Stata	O	O	B-T170
12.0	O	O	I-T170
and	O	O	O
RevMan	O	O	B-T170
5.3	O	O	I-T170
.	O	O	O

Odds	O	O	B-T081
ratios	O	O	I-T081
(	O	O	O
OR	O	O	B-T081
s	O	O	O
)	O	O	O
and	O	O	O
standard	O	O	B-T081
mean	O	O	I-T081
difference	O	O	I-T081
(	O	O	O
SMD	O	O	B-T081
)	O	O	O
were	O	O	O
calculated	O	O	O
for	O	O	O
binary	O	O	B-T080
and	O	O	O
continuous	O	O	B-T081
variables	O	O	I-T081
respectively	O	O	O
,	O	O	O
accompanied	O	O	O
with	O	O	O
95	O	O	O
%	O	O	O
confidence	O	O	B-T081
intervals	O	O	I-T081
(	O	O	O
CIs	O	O	B-T081
)	O	O	O
.	O	O	O

All	O	O	O
study	O	O	B-T062
procedures	O	O	O
followed	O	O	O
the	O	O	O
PRISMA	O	O	B-T170
guidelines	O	O	I-T170
.	O	O	O

Five	O	O	O
prospective	O	O	B-T062
studies	O	O	I-T062
were	O	O	O
included	O	O	B-T169
in	O	O	O
our	O	O	O
meta-analysis	O	O	B-T062
,	O	O	O
with	O	O	O
242	O	O	O
MI	O	O	B-T169
-	O	O	O
PCNL	O	O	B-T061
and	O	O	O
256	O	O	O
URL	O	O	B-T061
cases	O	O	O
.	O	O	O

MI	O	O	B-T169
-	O	O	O
PCNL	O	O	B-T061
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
a	O	O	O
longer	O	O	B-T079
postoperative	O	O	I-T079
hospital	O	O	B-T079
stay	O	O	I-T079
than	O	O	O
URL	O	O	B-T061
(	O	O	O
SMD	O	O	B-T081
,	O	O	O
3.14	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
,	O	O	O
1.27	O	O	O
to	O	O	O
5.55	O	O	O
)	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
no	O	O	O
significant	O	O	O
difference	O	O	B-T080
was	O	O	O
observed	O	O	B-T169
in	O	O	O
operative	O	O	B-T079
time	O	O	I-T079
(	O	O	O
SMD	O	O	B-T081
,	O	O	O
-0.38	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
,	O	O	O
-3.15	O	O	O
to	O	O	O
2.38	O	O	O
)	O	O	O
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
MI	O	O	B-T169
-	O	O	O
PCNL	O	O	B-T061
had	O	O	O
higher	O	O	O
initial	O	O	O
(	O	O	O
OR	O	O	B-T081
,	O	O	O
11.12	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
,	O	O	O
5.56	O	O	O
to	O	O	O
22.24	O	O	O
)	O	O	O
and	O	O	O
overall	O	O	O
stone-free	O	O	O
rates	O	O	O
(	O	O	O
OR	O	O	O
,	O	O	O
8.70	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
,	O	O	O
3.23	O	O	O
to	O	O	O
23.45	O	O	O
)	O	O	O
than	O	O	O
URL	O	O	B-T061
,	O	O	O
along	O	O	O
with	O	O	O
lower	O	O	O
possibilities	O	O	O
of	O	O	O
surgical	O	O	B-T061
conversion	O	O	I-T061
(	O	O	O
OR	O	O	O
,	O	O	O
0.11	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
,	O	O	O
0.03	O	O	O
to	O	O	O
0.49	O	O	O
)	O	O	O
and	O	O	O
postoperative	O	O	B-T079
shock	O	O	B-T061
wave	O	O	I-T061
lithotripsy	O	O	I-T061
(	O	O	O
OR	O	O	O
,	O	O	O
0.06	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
,	O	O	O
0.02	O	O	O
to	O	O	O
0.18	O	O	O
)	O	O	O
.	O	O	O

Regarding	O	O	O
complications	O	O	B-T046
,	O	O	O
no	O	O	O
significant	O	O	O
differences	O	O	B-T080
were	O	O	O
observed	O	O	B-T169
between	O	O	B-T082
MI	O	O	B-T169
-	O	O	O
PCNL	O	O	B-T061
and	O	O	O
URL	O	O	B-T061
(	O	O	O
OR	O	O	B-T081
,	O	O	O
1.39	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
,	O	O	O
0.93	O	O	O
to	O	O	O
2.10	O	O	O
)	O	O	O
,	O	O	O
except	O	O	O
for	O	O	O
hematuria	O	O	B-T047
(	O	O	O
OR	O	O	O
,	O	O	O
4.80	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
,	O	O	O
1.45	O	O	O
to	O	O	O
15.94	O	O	O
)	O	O	O
.	O	O	O

MI	O	O	B-T169
-	O	O	O
PCNL	O	O	B-T061
is	O	O	O
optimal	O	O	B-T080
and	O	O	O
should	O	O	O
be	O	O	O
considered	O	O	B-T078
as	O	O	O
the	O	O	O
preferred	O	O	B-T078
treatment	O	O	B-T061
method	O	O	I-T061
for	O	O	O
IPUS	O	O	B-T047
,	O	O	O
as	O	O	O
it	O	O	O
has	O	O	O
better	O	O	B-T080
efficacy	O	O	I-T080
and	O	O	O
a	O	O	O
safety	O	O	B-T062
profile	O	O	O
similar	O	O	O
to	O	O	O
that	O	O	O
of	O	O	O
URL	O	O	B-T061
.	O	O	O

However	O	O	O
,	O	O	O
further	O	O	O
high	O	O	O
quality	O	O	O
studies	O	O	O
with	O	O	O
larger	O	O	O
sample	O	O	O
size	O	O	O
are	O	O	O
required	O	O	B-T169
in	O	O	O
future	O	O	B-T079
.	O	O	O

-DOCSTART- (28154341)

Predictive	O	O	B-T170
Factors	O	O	I-T170
for	O	O	O
Long-term	O	O	B-T079
Outcome	O	O	B-T169
of	O	O	O
Subthalamic	O	O	B-T023
Nucleus	O	O	I-T023
Deep	O	O	B-T061
Brain	O	O	I-T061
Stimulation	O	O	I-T061
for	O	O	O
Parkinson	O	O	O
's	O	O	O
Disease	O	O	O

Despite	O	O	O
the	O	O	O
recognition	O	O	O
of	O	O	O
the	O	O	O
usefulness	O	O	B-T080
of	O	O	O
subthalamic	O	O	B-T023
nucleus	O	O	I-T023
deep	O	O	B-T061
brain	O	O	I-T061
stimulation	O	O	I-T061
(	O	O	O
STN	O	O	B-T023
-	O	O	O
DBS	O	O	B-T061
)	O	O	O
for	O	O	O
the	O	O	O
treatment	O	O	B-T169
of	O	O	O
Parkinson	O	O	B-T047
's	O	O	I-T047
disease	O	O	I-T047
(	O	O	O
PD	O	O	B-T047
)	O	O	O
,	O	O	O
preoperative	O	O	B-T079
predictive	O	O	B-T170
factors	O	O	I-T170
for	O	O	O
the	O	O	O
long-term	O	O	B-T079
outcome	O	O	B-T169
of	O	O	O
STN	O	O	O
-	O	O	O
DBS	O	O	O
are	O	O	O
not	O	O	B-T169
sufficiently	O	O	B-T080
established	O	O	B-T080
.	O	O	O

We	O	O	O
performed	O	O	O
this	O	O	O
study	O	O	B-T062
to	O	O	O
determine	O	O	O
such	O	O	O
predictive	O	O	B-T170
factors	O	O	I-T170
.	O	O	O

The	O	O	O
subjects	O	O	B-T096
were	O	O	O
66	O	O	O
patients	O	O	B-T101
who	O	O	O
were	O	O	O
classified	O	O	B-T185
into	O	O	O
two	O	O	B-T081
groups	O	O	B-UnknownType
on	O	O	O
the	O	O	O
basis	O	O	B-T169
of	O	O	O
their	O	O	O
activities	O	O	B-T056
of	O	O	I-T056
daily	O	O	I-T056
living	O	O	I-T056
(	O	O	O
ADL	O	O	B-T056
)	O	O	O
evaluated	O	O	O
five	O	O	B-T079
years	O	O	I-T079
after	O	O	B-T079
the	O	O	O
STN	O	O	B-T023
-	O	O	O
DBS	O	O	B-T061
surgery	O	O	B-T061
:	O	O	O
33	O	O	O
patients	O	O	O
were	O	O	O
assigned	O	O	B-T169
to	O	O	O
the	O	O	O
independent	O	O	B-T169
ADL	O	O	O
group	O	O	B-UnknownType
(	O	O	O
group	O	O	B-UnknownType
I	O	O	I-UnknownType
)	O	O	O
and	O	O	O
the	O	O	O
remaining	O	O	O
33	O	O	O
patients	O	O	O
to	O	O	O
the	O	O	O
dependent	O	O	B-T169
ADL	O	O	O
group	O	O	O
(	O	O	O
group	O	O	B-UnknownType
D	O	O	I-UnknownType
)	O	O	O
.	O	O	O

Group	O	O	B-UnknownType
I	O	O	I-UnknownType
patients	O	O	B-T101
showed	O	O	O
a	O	O	O
Schwab	O	O	B-T170
and	O	O	I-T170
England	O	O	I-T170
(	O	O	I-T170
S&E	O	O	B-T170
)	O	O	I-T170
scale	O	O	I-T170
score	O	O	B-T081
of	O	O	O
more	O	O	O
than	O	O	O
70	O	O	O
during	O	O	B-T079
the	O	O	O
off-period	O	O	B-T079
,	O	O	O
indicating	O	O	O
that	O	O	O
these	O	O	O
patients	O	O	O
can	O	O	O
maintain	O	O	O
their	O	O	O
independent	O	O	B-T169
ADL	O	O	B-T056
all	O	O	B-T079
the	O	O	I-T079
time	O	O	I-T079
.	O	O	O

Group	O	O	B-UnknownType
D	O	O	I-UnknownType
patients	O	O	B-T101
showed	O	O	O
a	O	O	O
score	O	O	B-T081
of	O	O	O
70	O	O	O
or	O	O	O
lower	O	O	B-T080
during	O	O	B-T079
the	O	O	O
off-period	O	O	B-T079
,	O	O	O
indicating	O	O	O
that	O	O	O
these	O	O	O
patients	O	O	O
can	O	O	O
not	O	O	O
maintain	O	O	O
their	O	O	O
independent	O	O	B-T169
ADL	O	O	B-T056
for	O	O	O
an	O	O	O
entire	O	O	B-T081
day	O	O	B-T079
.	O	O	O

We	O	O	O
studied	O	O	B-T062
the	O	O	O
differences	O	O	B-T080
in	O	O	O
the	O	O	O
preoperative	O	O	B-T033
state	O	O	I-T033
between	O	O	O
these	O	O	O
two	O	O	B-T081
groups	O	O	B-UnknownType
.	O	O	O

Statistically	O	O	B-T081
significant	O	O	I-T081
differences	O	O	B-T080
were	O	O	O
noted	O	O	O
in	O	O	O
PD	O	O	B-T047
onset	O	O	B-T081
age	O	O	B-T032
,	O	O	O
age	O	O	O
at	O	O	O
surgery	O	O	B-T061
,	O	O	O
preoperative	O	O	B-T079
unified	O	O	B-T170
Parkinson	O	O	I-T170
's	O	O	I-T170
disease	O	O	I-T170
rating	O	O	I-T170
scale	O	O	I-T170
(	O	O	O
UPDRS	O	O	B-T170
)	O	O	O
part	O	O	B-T082
I	O	O	I-T082
score	O	O	B-T081
,	O	O	O
part	O	O	B-T082
II	O	O	I-T082
score	O	O	O
,	O	O	O
total	O	O	B-T080
subscore	O	O	B-T081
for	O	O	O
axial	O	O	B-T033
symptoms	O	O	I-T033
in	O	O	O
part	O	O	B-T082
III	O	O	I-T082
,	O	O	O
mini-mental	O	O	B-T033
state	O	O	I-T033
examination	O	O	I-T033
(	O	O	I-T033
MMSE	O	O	I-T033
)	O	O	I-T033
score	O	O	I-T033
and	O	O	O
S&E	O	O	B-T170
score	O	O	O
.	O	O	O

Multiple	O	O	O
logistic	O	O	B-UnknownType
regression	O	O	I-UnknownType
analysis	O	O	I-UnknownType
showed	O	O	O
that	O	O	O
the	O	O	O
significant	O	O	B-T078
independent	O	O	B-T169
variables	O	O	B-T080
related	O	O	O
to	O	O	O
long-term	O	O	B-T079
independent	O	O	O
ADL	O	O	B-T056
were	O	O	O
the	O	O	O
age	O	O	B-T032
at	O	O	O
surgery	O	O	B-T061
,	O	O	O
MMSE	O	O	B-T033
score	O	O	B-T081
and	O	O	O
preoperative	O	O	B-T079
S&E	O	O	B-T170
scale	O	O	I-T170
score	O	O	O
during	O	O	B-T079
the	O	O	O
off-period	O	O	B-T079
.	O	O	O

The	O	O	O
PD	O	O	B-T047
onset	O	O	B-T081
age	O	O	B-T032
,	O	O	O
age	O	O	O
at	O	O	O
surgery	O	O	B-T061
,	O	O	O
preoperative	O	O	B-T079
high	O	O	B-T080
-	O	O	O
level	O	O	B-T080
ADL	O	O	B-T056
,	O	O	O
cognitive	O	O	B-T041
function	O	O	I-T041
,	O	O	O
and	O	O	O
axial	O	O	B-T033
symptoms	O	O	I-T033
are	O	O	O
important	O	O	B-T080
predictive	O	O	B-T170
factors	O	O	I-T170
for	O	O	O
the	O	O	O
long-term	O	O	B-T079
outcome	O	O	B-T169
of	O	O	O
STN	O	O	B-T023
-	O	O	O
DBS	O	O	B-T061
.	O	O	O

-DOCSTART- (28157408)

Who	O	O	O
Persuades	O	O	B-T078
Who	O	O	O
?	O	O	O
An	O	O	O
Analysis	O	O	B-T062
of	O	O	O
Persuasion	O	O	B-T078
Choices	O	O	B-T055
Related	O	O	O
to	O	O	O
Antibiotic	O	O	B-T195
-	O	O	O
Free	O	O	B-T080
Food	O	O	O

Personal	O	O	B-T054
communication	O	O	I-T054
,	O	O	O
in	O	O	O
which	O	O	O
one	O	O	O
person	O	O	B-T098
persuades	O	O	B-T078
another	O	O	O
to	O	O	O
engage	O	O	O
in	O	O	O
a	O	O	O
particular	O	O	O
behavior	O	O	B-T053
,	O	O	O
is	O	O	O
one	O	O	O
means	O	O	O
through	O	O	O
which	O	O	O
behaviors	O	O	B-T053
spread	O	O	B-T080
.	O	O	O

To	O	O	O
better	O	O	O
understand	O	O	B-T041
how	O	O	O
personal	O	O	B-T054
communication	O	O	I-T054
spreads	O	O	B-T080
behavior	O	O	B-T053
,	O	O	O
we	O	O	O
investigated	O	O	B-T169
adults	O	O	B-T100
'	O	O	I-T100
(	O	O	O
N	O	O	O
=	O	O	O
228	O	O	O
)	O	O	O
likelihood	O	O	B-T081
of	O	O	O
persuading	O	O	B-T078
others	O	O	O
in	O	O	O
a	O	O	O
fictitious	O	O	O
social	O	O	B-T098
network	O	O	I-T098
to	O	O	O
buy	O	O	B-T052
antibiotic	O	O	B-T195
-	O	O	O
free	O	O	B-T080
food	O	O	B-T168
,	O	O	O
and	O	O	O
who	O	O	O
they	O	O	O
attempted	O	O	B-T051
to	O	O	O
persuade	O	O	B-T078
,	O	O	O
based	O	O	O
on	O	O	O
behavioral	O	O	B-T053
determinants	O	O	B-T169
,	O	O	O
homophily	O	O	B-T080
,	O	O	O
and	O	O	O
superdiffuser	O	O	B-T080
traits	O	O	B-T055
.	O	O	O

For	O	O	O
potential	O	O	B-T080
consumers	O	O	B-T098
,	O	O	O
the	O	O	O
findings	O	O	B-T033
showed	O	O	O
that	O	O	O
behavioral	O	O	B-T053
determinants	O	O	B-T169
,	O	O	O
behavioral	O	O	O
intentions	O	O	B-T041
,	O	O	O
and	O	O	O
mavenism	O	O	B-T080
predicted	O	O	B-T078
intentions	O	O	O
to	O	O	O
persuade	O	O	B-T078
others	O	O	O
.	O	O	O

Homophily	O	O	B-T080
,	O	O	O
mavenism	O	O	B-T080
,	O	O	O
and	O	O	O
connectivity	O	O	B-T169
predicted	O	O	B-T078
patterns	O	O	B-T082
of	O	O	O
interpersonal	O	O	B-T054
persuasion	O	O	B-T078
.	O	O	O

For	O	O	O
vegetarians	O	O	B-T098
(	O	O	O
without	O	O	O
homophily	O	O	B-T080
in	O	O	O
action	O	O	B-T052
)	O	O	O
,	O	O	O
behavioral	O	O	B-T053
determinants	O	O	B-T169
and	O	O	O
mavenism	O	O	B-T080
predicted	O	O	B-T078
persuasion	O	O	B-T078
intentions	O	O	B-T041
.	O	O	O

Persuasiveness	O	O	B-T078
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
targeting	O	O	B-T169
more	O	O	O
network	O	O	B-T098
members	O	O	B-T098
;	O	O	O
mavenism	O	O	B-T080
was	O	O	O
associated	O	O	O
with	O	O	O
selecting	O	O	O
structurally	O	O	B-T082
central	O	O	B-T082
members	O	O	O
.	O	O	O

-DOCSTART- (28158248)

Modeling	O	O	B-T062
the	O	O	O
flux	O	O	B-T070
of	O	O	O
metabolites	O	O	B-T123
in	O	O	O
the	O	O	O
juvenile	O	O	B-T125
hormone	O	O	I-T125
biosynthesis	O	O	B-T038
pathway	O	O	B-T044
using	O	O	O
generalized	O	O	B-T075
additive	O	O	I-T075
models	O	O	I-T075
and	O	O	O
ordinary	O	O	O
differential	O	O	O
equations	O	O	O

Juvenile	O	O	B-T125
hormone	O	O	I-T125
(	O	O	O
JH	O	O	B-T125
)	O	O	O
regulates	O	O	O
development	O	O	B-T169
and	O	O	O
reproductive	O	O	B-T040
maturation	O	O	I-T040
in	O	O	O
insects	O	O	B-T204
.	O	O	O

The	O	O	O
corpora	O	O	B-T023
allata	O	O	I-T023
(	O	O	O
CA	O	O	B-T023
)	O	O	O
from	O	O	O
female	O	O	B-T032
adult	O	O	B-T204
mosquitoes	O	O	I-T204
synthesize	O	O	O
fluctuating	O	O	B-T079
levels	O	O	B-T080
of	O	O	O
JH	O	O	B-T125
,	O	O	O
which	O	O	O
have	O	O	O
been	O	O	O
linked	O	O	O
to	O	O	O
the	O	O	O
ovarian	O	O	B-T042
development	O	O	I-T042
and	O	O	O
are	O	O	O
influenced	O	O	O
by	O	O	O
nutritional	O	O	B-T080
signals	O	O	B-T043
.	O	O	O

The	O	O	O
rate	O	O	B-T081
of	O	O	O
JH	O	O	B-T125
biosynthesis	O	O	B-T038
is	O	O	O
controlled	O	O	O
by	O	O	O
the	O	O	O
rate	O	O	O
of	O	O	O
flux	O	O	B-T070
of	O	O	O
isoprenoids	O	O	B-T109
in	O	O	O
the	O	O	O
pathway	O	O	B-T044
,	O	O	O
which	O	O	O
is	O	O	O
the	O	O	O
outcome	O	O	O
of	O	O	O
a	O	O	O
complex	O	O	O
interplay	O	O	O
of	O	O	O
changes	O	O	B-T169
in	O	O	O
precursor	O	O	B-T167
pools	O	O	O
and	O	O	O
enzyme	O	O	B-T116
levels	O	O	B-T080
.	O	O	O

A	O	O	O
comprehensive	O	O	B-T080
study	O	O	B-T062
of	O	O	O
the	O	O	O
changes	O	O	B-T169
in	O	O	O
enzymatic	O	O	B-T044
activities	O	O	I-T044
and	O	O	O
precursor	O	O	B-T167
pool	O	O	O
sizes	O	O	O
have	O	O	O
been	O	O	O
previously	O	O	O
reported	O	O	O
for	O	O	O
the	O	O	O
mosquito	O	O	B-T204
Aedes	O	O	B-T204
aegypti	O	O	I-T204
JH	O	O	B-T125
biosynthesis	O	O	B-T038
pathway	O	O	B-T044
.	O	O	O

In	O	O	O
the	O	O	O
present	O	O	O
studies	O	O	B-T062
,	O	O	O
we	O	O	O
used	O	O	O
two	O	O	O
different	O	O	O
quantitative	O	O	B-UnknownType
approaches	O	O	I-UnknownType
to	O	O	O
describe	O	O	O
and	O	O	O
predict	O	O	O
how	O	O	O
changes	O	O	B-T169
in	O	O	O
the	O	O	O
individual	O	O	O
metabolic	O	O	B-T169
reactions	O	O	B-T169
in	O	O	O
the	O	O	O
pathway	O	O	B-T044
affect	O	O	O
JH	O	O	B-T125
synthesis	O	O	B-T038
.	O	O	O

First	O	O	O
,	O	O	O
we	O	O	O
constructed	O	O	O
generalized	O	O	B-T075
additive	O	O	I-T075
models	O	O	I-T075
(	O	O	O
GAMs	O	O	B-T075
)	O	O	O
that	O	O	O
described	O	O	O
the	O	O	O
association	O	O	O
between	O	O	O
changes	O	O	B-T169
in	O	O	O
specific	O	O	O
metabolite	O	O	B-T123
concentrations	O	O	B-T081
with	O	O	O
changes	O	O	O
in	O	O	O
enzymatic	O	O	B-T044
activities	O	O	I-T044
and	O	O	O
substrate	O	O	B-T167
concentrations	O	O	O
.	O	O	O

Changes	O	O	B-T169
in	O	O	O
substrate	O	O	B-T167
concentrations	O	O	B-T081
explained	O	O	O
50	O	O	O
%	O	O	O
or	O	O	O
more	O	O	O
of	O	O	O
the	O	O	O
model	O	O	B-T075
deviances	O	O	O
in	O	O	O
7	O	O	O
of	O	O	O
the	O	O	O
13	O	O	O
metabolic	O	O	B-T169
steps	O	O	B-T077
analyzed	O	O	B-T062
.	O	O	O

Addition	O	O	O
of	O	O	O
information	O	O	O
on	O	O	O
enzymatic	O	O	B-T044
activities	O	O	I-T044
almost	O	O	O
always	O	O	O
improved	O	O	O
the	O	O	O
fitness	O	O	B-T052
of	O	O	O
GAMs	O	O	B-T075
built	O	O	O
solely	O	O	O
based	O	O	O
on	O	O	O
substrate	O	O	B-T167
concentrations	O	O	B-T081
.	O	O	O

GAMs	O	O	B-T075
were	O	O	O
validated	O	O	O
using	O	O	O
experimental	O	O	B-T080
data	O	O	B-T078
that	O	O	O
were	O	O	O
not	O	O	O
included	O	O	O
when	O	O	O
the	O	O	O
model	O	O	O
was	O	O	O
built	O	O	O
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
a	O	O	O
system	O	O	O
of	O	O	O
ordinary	O	O	B-T170
differential	O	O	I-T170
equations	O	O	I-T170
(	O	O	O
ODE	O	O	B-T170
)	O	O	O
was	O	O	O
developed	O	O	O
to	O	O	O
describe	O	O	O
the	O	O	O
instantaneous	O	O	O
changes	O	O	B-T169
in	O	O	O
metabolites	O	O	B-T123
as	O	O	O
a	O	O	O
function	O	O	B-T169
of	O	O	O
the	O	O	O
levels	O	O	B-T080
of	O	O	O
enzymatic	O	O	B-T044
catalytic	O	O	I-T044
activities	O	O	I-T044
.	O	O	O

The	O	O	O
results	O	O	B-T169
demonstrated	O	O	O
the	O	O	O
ability	O	O	O
of	O	O	O
the	O	O	O
models	O	O	B-T075
to	O	O	O
predict	O	O	O
changes	O	O	B-T169
in	O	O	O
the	O	O	O
flux	O	O	B-T070
of	O	O	O
metabolites	O	O	B-T123
in	O	O	O
the	O	O	O
JH	O	O	B-T125
pathway	O	O	B-T044
,	O	O	O
and	O	O	O
can	O	O	O
be	O	O	O
used	O	O	O
in	O	O	O
the	O	O	O
future	O	O	O
to	O	O	O
design	O	O	B-T052
and	O	O	O
validate	O	O	B-T062
experimental	O	O	B-T080
manipulations	O	O	B-T169
of	O	O	O
JH	O	O	O
synthesis	O	O	B-T038
.	O	O	O

-DOCSTART- (28160457)

Associations	O	O	B-T080
between	O	O	O
human	O	O	B-T109
breast	O	O	I-T109
milk	O	O	I-T109
hormones	O	O	B-T125
and	O	O	O
adipocytokines	O	O	B-T116
and	O	O	O
infant	O	O	B-T039
growth	O	O	I-T039
and	O	O	O
body	O	O	B-T032
composition	O	O	I-T032
in	O	O	O
the	O	O	O
first	O	O	O
6	O	O	O
months	O	O	O
of	O	O	O
life	O	O	O

Much	O	O	O
is	O	O	O
to	O	O	O
be	O	O	O
learnt	O	O	O
about	O	O	O
human	O	O	B-T109
breast	O	O	I-T109
milk	O	O	I-T109
(	O	O	O
HBM	O	O	B-T109
)	O	O	O
.	O	O	O

The	O	O	O
purpose	O	O	O
of	O	O	O
this	O	O	O
study	O	O	O
is	O	O	O
to	O	O	O
extend	O	O	O
our	O	O	O
knowledge	O	O	O
of	O	O	O
HBM	O	O	B-T109
by	O	O	O
investigating	O	O	O
the	O	O	O
role	O	O	O
of	O	O	O
maternal	O	O	B-T033
body	O	O	B-T201
mass	O	O	I-T201
index	O	O	I-T201
(	O	O	O
BMI	O	O	B-T201
)	O	O	O
,	O	O	O
sex	O	O	B-T032
and	O	O	O
stage	O	O	B-T042
of	O	O	I-T042
lactation	O	O	I-T042
(	O	O	O
month	O	O	O
1	O	O	O
vs.	O	O	O
6	O	O	O
)	O	O	O
on	O	O	O
HBM	O	O	O
insulin	O	O	B-T116
,	O	O	O
glucose	O	O	B-T109
,	O	O	O
leptin	O	O	B-T116
,	O	O	O
IL-6	O	O	B-T116
and	O	O	O
TNF-Î±	O	O	B-T116
and	O	O	O
their	O	O	O
associations	O	O	B-T080
with	O	O	O
infant	O	O	B-T100
body	O	O	B-T032
composition	O	O	I-T032
.	O	O	O

Thirty-seven	O	O	O
exclusively	O	O	O
breastfeeding	O	O	B-T033
infants	O	O	I-T033
(	O	O	O
n	O	O	O
=	O	O	O
37	O	O	O
;	O	O	O
16	O	O	O
â	O	O	O
,	O	O	O
21	O	O	O
â	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
their	O	O	O
mothers	O	O	B-T033
(	O	O	O
19	O	O	O
-	O	O	O
47	O	O	O
kg	O	O	O
m(-2	O	O	O
)	O	O	O
)	O	O	O
were	O	O	O
studied	O	O	O
at	O	O	O
1	O	O	O
and	O	O	O
6	O	O	O
months	O	O	O
of	O	O	O
lactation	O	O	B-T042
.	O	O	O

Infants	O	O	B-T100
had	O	O	O
body	O	O	B-T201
composition	O	O	I-T201
measured	O	O	I-T201
(	O	O	O
using	O	O	O
dual-energy	O	O	B-T060
X-ray	O	O	I-T060
absorptiometry	O	O	I-T060
)	O	O	O
and	O	O	O
HBM	O	O	B-T109
collected	O	O	O
.	O	O	O

A	O	O	O
significant	O	O	O
interaction	O	O	B-T169
between	O	O	O
maternal	O	O	B-T033
BMI	O	O	B-T201
and	O	O	O
infant	O	O	B-T032
sex	O	O	I-T032
on	O	O	O
insulin	O	O	B-T059
levels	O	O	I-T059
(	O	O	O
p	O	O	O
=	O	O	O
0.0322	O	O	O
)	O	O	O
was	O	O	O
observed	O	O	O
such	O	O	O
that	O	O	O
insulin	O	O	B-T034
was	O	O	I-T034
229	O	O	I-T034
%	O	O	I-T034
higher	O	O	I-T034
in	O	O	O
obese	O	O	B-T047
mothers	O	O	B-T099
nursing	O	O	B-T040
female	O	O	B-T033
infants	O	O	I-T033
than	O	O	O
in	O	O	O
normal	O	O	B-T033
weight	O	O	I-T033
mothers	O	O	O
nursing	O	O	O
female	O	O	O
infants	O	O	O
and	O	O	O
179	O	O	O
%	O	O	O
higher	O	O	O
than	O	O	O
obese	O	O	O
mothers	O	O	O
nursing	O	O	O
male	O	O	B-T033
infants	O	O	I-T033
.	O	O	O

For	O	O	O
leptin	O	O	B-T116
,	O	O	O
a	O	O	O
significant	O	O	O
association	O	O	B-T080
with	O	O	O
BMI	O	O	B-T201
category	O	O	O
was	O	O	O
observed	O	O	O
(	O	O	O
p	O	O	O
<	O	O	O
0.0001	O	O	O
)	O	O	O
such	O	O	O
that	O	O	O
overweight	O	O	B-T184
and	O	O	O
obese	O	O	B-T047
mothers	O	O	B-T099
had	O	O	O
96.5	O	O	O
%	O	O	O
and	O	O	O
315.1	O	O	O
%	O	O	O
higher	O	O	B-T033
leptin	O	O	I-T033
levels	O	O	I-T033
than	O	O	O
normal	O	O	B-T033
weight	O	O	I-T033
mothers	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

Leptin	O	O	B-T116
was	O	O	O
also	O	O	O
found	O	O	O
to	O	O	O
have	O	O	O
a	O	O	O
significant	O	O	O
(	O	O	O
p	O	O	O
=	O	O	O
0.0004	O	O	O
)	O	O	O
33.7	O	O	O
%	O	O	O
decrease	O	O	O
from	O	O	O
months	O	O	O
1	O	O	O
to	O	O	O
6	O	O	O
,	O	O	O
controlling	O	O	O
for	O	O	O
BMI	O	O	B-T201
category	O	O	O
and	O	O	O
sex	O	O	B-T032
.	O	O	O

A	O	O	O
significant	O	O	O
inverse	O	O	B-T080
relationship	O	O	B-T080
between	O	O	O
month	O	O	O
1	O	O	O
leptin	O	O	B-T116
levels	O	O	B-T080
and	O	O	O
infant	O	O	B-T033
length	O	O	I-T033
(	O	O	O
p	O	O	O
=	O	O	O
0.0257	O	O	O
)	O	O	O
,	O	O	O
percent	O	O	B-T033
fat	O	O	I-T033
(	O	O	O
p	O	O	O
=	O	O	O
0.0223	O	O	O
)	O	O	O
,	O	O	O
total	O	O	B-T032
fat	O	O	I-T032
mass	O	O	I-T032
(	O	O	O
p	O	O	O
=	O	O	O
0.0226	O	O	O
)	O	O	O
and	O	O	O
trunk	O	O	B-T032
fat	O	O	I-T032
mass	O	O	I-T032
(	O	O	O
p	O	O	O
=	O	O	O
0.0111	O	O	O
)	O	O	O
at	O	O	O
month	O	O	O
6	O	O	O
was	O	O	O
also	O	O	O
found	O	O	O
.	O	O	O

No	O	O	O
associations	O	O	B-T080
or	O	O	O
interactions	O	O	B-T169
were	O	O	O
observed	O	O	O
for	O	O	O
glucose	O	O	B-T109
,	O	O	O
TNF-Î±	O	O	B-T116
or	O	O	O
IL-6	O	O	B-T116
.	O	O	O

These	O	O	O
data	O	O	O
demonstrate	O	O	O
that	O	O	O
maternal	O	O	B-T033
BMI	O	O	B-T201
,	O	O	O
infant	O	O	B-T100
sex	O	O	B-T032
and	O	O	O
stage	O	O	B-T042
of	O	O	I-T042
lactation	O	O	I-T042
affect	O	O	O
the	O	O	O
compositional	O	O	O
make-up	O	O	O
of	O	O	O
insulin	O	O	B-T116
and	O	O	O
leptin	O	O	B-T116
.	O	O	O

-DOCSTART- (28161861)

Aryl	O	O	B-T028
hydrocarbon	O	O	I-T028
receptor	O	O	I-T028
(	O	O	I-T028
AhR	O	O	I-T028
)	O	O	I-T028
rs2066853	O	O	I-T028
gene	O	O	B-T045
polymorphism	O	O	I-T045
association	O	O	O
with	O	O	O
infertile	O	O	B-T046
oligoasthenoteratozoospermic	O	O	B-T047
men	O	O	B-T098
and	O	O	O
seminal	O	O	B-T201
oxidative	O	O	O
stress	O	O	O

This	O	O	O
study	O	O	O
aimed	O	O	O
to	O	O	O
assess	O	O	O
the	O	O	O
association	O	O	O
between	O	O	O
aryl	O	O	B-T028
hydrocarbon	O	O	I-T028
receptor	O	O	I-T028
(	O	O	I-T028
AhR	O	O	I-T028
)	O	O	I-T028
rs2066853	O	O	I-T028
gene	O	O	B-T045
polymorphism	O	O	I-T045
with	O	O	O
infertile	O	O	B-T046
oligoasthenoteratozoospermic	O	O	B-T047
(	O	O	O
OAT	O	O	B-T047
)	O	O	O
men	O	O	B-T098
and	O	O	O
seminal	O	O	B-T201
oxidative	O	O	B-T049
stress	O	O	I-T049
(	O	O	O
OS	O	O	B-T049
)	O	O	O
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
170	O	O	O
Egyptian	O	O	B-T098
men	O	O	B-T098
were	O	O	O
allocated	O	O	O
according	O	O	O
to	O	O	O
their	O	O	O
semen	O	O	B-T059
analysis	O	O	I-T059
into	O	O	O
fertile	O	O	B-T040
normozoospermic	O	O	B-T033
controls	O	O	I-T033
(	O	O	O
n	O	O	O
=	O	O	O
50	O	O	O
)	O	O	O
and	O	O	O
infertile	O	O	B-T046
OAT	O	O	B-T047
men	O	O	O
(	O	O	O
n	O	O	O
=	O	O	O
120	O	O	O
)	O	O	O
.	O	O	O

They	O	O	O
were	O	O	O
subjected	O	O	O
to	O	O	O
history	O	O	B-T058
taking	O	O	I-T058
,	O	O	O
clinical	O	O	B-T201
examination	O	O	I-T201
,	O	O	O
semen	O	O	B-T059
analysis	O	O	I-T059
,	O	O	O
estimation	O	O	B-T081
of	O	O	O
seminal	O	O	B-T201
glutathione	O	O	B-T116
peroxidase	O	O	I-T116
(	O	O	O
GPx	O	O	B-T116
)	O	O	O
,	O	O	O
and	O	O	O
malondialdehyde	O	O	B-T109
(	O	O	O
MDA	O	O	B-T109
)	O	O	O
.	O	O	O

AhR	O	O	B-T028
rs2066853	O	O	I-T028
gene	O	O	B-T045
polymorphism	O	O	I-T045
was	O	O	O
identified	O	O	O
in	O	O	O
the	O	O	O
blood	O	O	B-T031
by	O	O	O
PCR	O	O	B-T063
-	O	O	O
RFLP	O	O	B-T049
.	O	O	O

Comparing	O	O	O
infertile	O	O	B-T046
OAT	O	O	B-T047
men	O	O	B-T098
with	O	O	O
fertile	O	O	B-T040
controls	O	O	B-T096
,	O	O	O
AhR	O	O	B-T028
rs2066853	O	O	I-T028
genotypes	O	O	B-T032
showed	O	O	O
decreased	O	O	B-T081
prevalence	O	O	B-T081
for	O	O	O
wild	O	O	B-T028
homozygous	O	O	B-T032
genotype	O	O	I-T032
GG	O	O	I-T032
(	O	O	O
35.8	O	O	O
vs	O	O	O
56	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
for	O	O	O
heterozygous	O	O	B-T032
genotype	O	O	I-T032
GA	O	O	I-T032
(	O	O	O
17.5	O	O	O
vs	O	O	O
30	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
an	O	O	O
increased	O	O	B-T081
prevalence	O	O	O
for	O	O	O
homozygous	O	O	B-T032
genotype	O	O	I-T032
AA	O	O	I-T032
(	O	O	O
46.7	O	O	O
vs	O	O	O
14	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

Distribution	O	O	O
of	O	O	O
alleles	O	O	B-T028
of	O	O	O
AhR	O	O	B-T028
rs2066853	O	O	I-T028
among	O	O	O
OAT	O	O	B-T047
men	O	O	B-T098
compared	O	O	O
with	O	O	O
fertile	O	O	B-T040
men	O	O	O
showed	O	O	O
decreased	O	O	B-T081
prevalence	O	O	B-T081
of	O	O	O
G	O	O	B-T028
allele	O	O	I-T028
(	O	O	O
44.6	O	O	O
vs	O	O	O
71	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
an	O	O	O
increased	O	O	B-T081
prevalence	O	O	O
of	O	O	O
A	O	O	B-T028
allele	O	O	I-T028
(	O	O	O
55.4	O	O	O
vs	O	O	O
29	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

Seminal	O	O	B-T201
MDA	O	O	B-T109
demonstrated	O	O	O
significant	O	O	O
increase	O	O	B-T081
whereas	O	O	O
seminal	O	O	B-T201
GPx	O	O	B-T116
demonstrated	O	O	O
significant	O	O	O
decrease	O	O	B-T081
in	O	O	O
cases	O	O	O
with	O	O	O
AA	O	O	B-T032
and	O	O	O
GA	O	O	B-T032
/	O	O	O
AA	O	O	B-T032
genotypes	O	O	I-T032
compared	O	O	O
to	O	O	O
cases	O	O	O
with	O	O	O
GG	O	O	B-T032
genotype	O	O	I-T032
.	O	O	O

It	O	O	O
is	O	O	O
concluded	O	O	O
that	O	O	O
there	O	O	O
is	O	O	O
a	O	O	O
significant	O	O	O
association	O	O	O
between	O	O	O
AhR	O	O	B-T028
rs2066853	O	O	I-T028
genotype	O	O	B-T032
polymorphism	O	O	B-T045
with	O	O	O
decreased	O	O	B-T081
sperm	O	O	B-T025
parameters	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
increased	O	O	B-T081
seminal	O	O	B-T201
oxidative	O	O	B-T049
stress	O	O	I-T049
in	O	O	O
infertile	O	O	B-T046
OAT	O	O	B-T047
men	O	O	B-T098
.	O	O	O

-DOCSTART- (28161910)

Associations	O	O	B-T080
of	O	O	O
gender	O	O	B-T032
and	O	O	O
a	O	O	O
proxy	O	O	B-T096
of	O	O	O
female	O	O	B-T032
menopausal	O	O	B-T201
status	O	O	I-T201
with	O	O	O
histological	O	O	B-T169
features	O	O	B-T080
of	O	O	O
drug-induced	O	O	O
liver	O	O	O
injury	O	O	O

Gender	O	O	B-T032
and	O	O	O
menopause	O	O	B-T039
may	O	O	O
contribute	O	O	O
to	O	O	O
type	O	O	B-T080
and	O	O	O
severity	O	O	B-T080
of	O	O	O
drug-induced	O	O	B-T047
liver	O	O	I-T047
injury	O	O	B-T037
(	O	O	O
DILI	O	O	B-T047
)	O	O	O
by	O	O	O
influencing	O	O	B-T077
host	O	O	B-T001
responses	O	O	B-T033
to	O	O	O
injury	O	O	O
.	O	O	O

The	O	O	O
aim	O	O	B-T078
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
assess	O	O	B-T052
the	O	O	O
associations	O	O	B-T080
of	O	O	O
gender	O	O	B-T032
and	O	O	O
female	O	O	B-T032
age	O	O	B-T032
50	O	O	O
[	O	O	O
a	O	O	O
proxy	O	O	B-T096
of	O	O	O
menopause	O	O	B-T039
]	O	O	O
with	O	O	O
histological	O	O	B-T169
features	O	O	B-T080
of	O	O	O
liver	O	O	B-T037
injury	O	O	I-T037
in	O	O	O
212	O	O	O
adults	O	O	B-T100
enrolled	O	O	O
in	O	O	O
the	O	O	O
Drug-Induced	O	O	B-T047
Liver	O	O	I-T047
Injury	O	O	I-T047
Network	O	O	B-T169
(	O	O	O
DILIN	O	O	B-T169
)	O	O	O
registry	O	O	B-T170
.	O	O	O

All	O	O	O
participants	O	O	B-T098
had	O	O	O
a	O	O	O
causality	O	O	B-T169
score	O	O	B-T081
of	O	O	O
at	O	O	O
least	O	O	O
'	O	O	O
probable	O	O	B-T033
'	O	O	O
,	O	O	O
a	O	O	O
liver	O	O	B-T060
biopsy	O	O	I-T060
within	O	O	O
30	O	O	O
days	O	O	O
of	O	O	O
DILI	O	O	B-T047
onset	O	O	O
,	O	O	O
and	O	O	O
no	O	O	O
prior	O	O	O
chronic	O	O	B-T047
liver	O	O	I-T047
disease	O	O	I-T047
.	O	O	O

Biochemical	O	O	B-T169
and	O	O	O
histological	O	O	B-T169
injury	O	O	B-T037
types	O	O	B-T080
were	O	O	O
classified	O	O	O
as	O	O	O
hepatocellular	O	O	B-T046
or	O	O	O
cholestatic/mixed	O	O	B-T047
injury	O	O	I-T047
.	O	O	O

The	O	O	O
cohort	O	O	B-T098
was	O	O	O
divided	O	O	B-T169
into	O	O	O
three	O	O	O
gender	O	O	B-T032
/	O	O	O
age	O	O	B-T032
categories	O	O	B-T170
:	O	O	O
men	O	O	B-T098
(	O	O	O
41.0	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
women	O	O	B-T098
<	O	O	O
50	O	O	O
years	O	O	O
(	O	O	O
27.4	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
women	O	O	O
â¥50	O	O	O
years	O	O	O
of	O	O	O
age	O	O	O
(	O	O	O
31.6	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

Interaction	O	O	B-T169
of	O	O	O
gender	O	O	B-T032
and	O	O	O
age	O	O	B-T032
category	O	O	B-T170
(	O	O	O
â¥50	O	O	O
or	O	O	O
not	O	O	O
)	O	O	O
was	O	O	O
assessed	O	O	B-T052
.	O	O	O

Hepatocellular	O	O	B-T046
injury	O	O	I-T046
was	O	O	O
more	O	O	O
prevalent	O	O	O
in	O	O	O
women	O	O	B-T098
<	O	O	O
50	O	O	O
years	O	O	O
vs.	O	O	O
others	O	O	O
(	O	O	O
P=.002	O	O	O
)	O	O	O
.	O	O	O

After	O	O	O
adjusting	O	O	O
for	O	O	O
biochemical	O	O	B-T169
injury	O	O	B-T037
types	O	O	B-T080
,	O	O	O
black	O	O	B-T098
race	O	O	I-T098
and	O	O	O
possible	O	O	B-T033
ageing	O	O	B-T040
effects	O	O	B-T080
,	O	O	O
more	O	O	O
severe	O	O	B-T080
interface	O	O	O
hepatitis	O	O	B-T047
was	O	O	O
noted	O	O	O
in	O	O	O
biopsies	O	O	B-T060
of	O	O	O
women	O	O	B-T098
<	O	O	O
50	O	O	O
years	O	O	O
compared	O	O	B-T052
to	O	O	O
those	O	O	O
of	O	O	O
men	O	O	B-T098
and	O	O	O
women	O	O	O
â¥50	O	O	O
years	O	O	O
(	O	O	O
P=.009	O	O	O
and	O	O	O
P=.055	O	O	O
respectively	O	O	O
)	O	O	O
.	O	O	O

Compared	O	O	B-T052
to	O	O	O
those	O	O	O
of	O	O	O
men	O	O	B-T098
,	O	O	O
biopsies	O	O	B-T060
of	O	O	O
women	O	O	B-T098
showed	O	O	O
greater	O	O	B-T081
plasma	O	O	B-T047
cell	O	O	I-T047
infiltration	O	O	I-T047
,	O	O	O
hepatocyte	O	O	B-T025
apoptosis	O	O	I-T043
,	O	O	O
hepatocyte	O	O	O
rosettes	O	O	B-T033
and	O	O	O
lobular	O	O	B-T080
disarray	O	O	O
but	O	O	O
less	O	O	O
iron	O	O	B-T121
-	O	O	O
positive	O	O	B-T033
hepatocytes	O	O	B-T025
and	O	O	O
histological	O	O	B-T169
cholestasis	O	O	B-T047
(	O	O	O
P<.05	O	O	O
)	O	O	O
.	O	O	O

These	O	O	O
associations	O	O	B-T080
persisted	O	O	O
after	O	O	O
excluding	O	O	O
cases	O	O	B-T169
of	O	O	O
amoxicillin/clavulanic	O	O	B-T121
acid	O	O	I-T121
,	O	O	O
anabolic	O	O	B-T109
steroids	O	O	I-T109
or	O	O	O
nitrofurantoin	O	O	B-T109
DILI	O	O	B-T047
which	O	O	O
showed	O	O	O
gender	O	O	B-T032
-specific	O	O	O
distributions	O	O	B-T169
.	O	O	O

Gender	O	O	B-T032
and	O	O	O
a	O	O	O
proxy	O	O	B-T096
of	O	O	O
menopause	O	O	B-T039
were	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
various	O	O	O
features	O	O	B-T080
of	O	O	O
inflammation	O	O	B-T046
and	O	O	O
injury	O	O	B-T037
in	O	O	O
DILI	O	O	B-T047
.	O	O	O

-DOCSTART- (28165738)

A	O	O	O
Novel	O	O	O
Potent	O	O	O
Anticancer	O	O	B-T109
Compound	O	O	I-T109
Optimized	O	O	O
from	O	O	O
a	O	O	O
Natural	O	O	B-T169
Oridonin	O	O	B-T109
Scaffold	O	O	O
Induces	O	O	O
Apoptosis	O	O	B-T043
and	O	O	O
Cell	O	O	B-T043
Cycle	O	O	I-T043
Arrest	O	O	I-T043
through	O	O	O
the	O	O	O
Mitochondrial	O	O	O
Pathway	O	O	O

The	O	O	O
cytotoxicity	O	O	B-T049
of	O	O	O
the	O	O	O
natural	O	O	B-T169
ent-kaurene	O	O	B-T121
diterpenoid	O	O	I-T121
,	O	O	O
oridonin	O	O	B-T109
,	O	O	O
has	O	O	O
been	O	O	O
extensively	O	O	O
studied	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
application	O	O	O
of	O	O	O
oridonin	O	O	B-T109
for	O	O	O
cancer	O	O	B-T061
therapy	O	O	I-T061
was	O	O	O
hampered	O	O	O
primarily	O	O	O
by	O	O	O
its	O	O	O
moderate	O	O	B-T038
potency	O	O	I-T038
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	O
,	O	O	O
a	O	O	O
series	O	O	O
of	O	O	O
oridonin	O	O	B-T109
A-ring	O	O	B-T104
modified	O	O	I-T104
analogues	O	O	I-T104
,	O	O	I-T104
and	O	O	I-T104
their	O	O	I-T104
derivatives	O	O	I-T104
bearing	O	O	O
various	O	O	O
substituents	O	O	B-T104
on	O	O	I-T104
14-OH	O	O	I-T104
position	O	O	I-T104
,	O	O	O
were	O	O	O
designed	O	O	O
,	O	O	O
synthesized	O	O	B-T052
,	O	O	O
and	O	O	O
evaluated	O	O	B-T058
for	O	O	O
anticancer	O	O	B-T109
efficacy	O	O	B-T080
.	O	O	O

Some	O	O	O
of	O	O	O
the	O	O	O
derivatives	O	O	B-T104
were	O	O	O
significantly	O	O	O
more	O	O	O
potent	O	O	O
than	O	O	O
oridonin	O	O	B-T109
against	O	O	O
both	O	O	O
drug	O	O	B-T121
-	O	O	O
sensitive	O	O	B-T169
and	O	O	O
drug-resistant	O	O	B-T038
cancer	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

The	O	O	O
most	O	O	O
potent	O	O	O
compound	O	O	B-T109
,	O	O	I-T109
13p	O	O	I-T109
,	O	O	O
was	O	O	O
200-fold	O	O	B-T079
more	O	O	O
efficacious	O	O	B-T080
than	O	O	O
oridonin	O	O	B-T109
in	O	O	O
MCF-7	O	O	B-T025
cancer	O	O	I-T025
cells	O	O	I-T025
.	O	O	O

Furthermore	O	O	O
,	O	O	O
13p	O	O	B-T109
induced	O	O	O
apoptosis	O	O	B-T043
and	O	O	O
cell	O	O	B-T043
cycle	O	O	I-T043
arrest	O	O	I-T043
at	O	O	O
the	O	O	O
G2/M	O	O	B-T043
phase	O	O	I-T043
.	O	O	O

A	O	O	O
decrease	O	O	O
in	O	O	O
mitochondrial	O	O	B-T043
membrane	O	O	I-T043
potential	O	O	I-T043
and	O	O	O
an	O	O	O
increase	O	O	O
in	O	O	O
Bax/Bcl-2	O	O	B-T116
ratio	O	O	O
,	O	O	O
accompanied	O	O	O
by	O	O	O
activated	O	O	B-T116
caspase-3	O	O	I-T116
cleavage	O	O	B-T044
,	O	O	O
were	O	O	O
observed	O	O	O
in	O	O	O
MCF-7	O	O	B-T025
cells	O	O	I-T025
after	O	O	O
treatment	O	O	B-T061
with	O	O	O
13p	O	O	B-T109
,	O	O	O
suggesting	O	O	O
that	O	O	O
the	O	O	O
mitochondrial	O	O	B-T045
pathway	O	O	I-T045
was	O	O	O
involved	O	O	O
in	O	O	O
the	O	O	O
13p	O	O	O
-mediated	O	O	O
apoptosis	O	O	B-T043
.	O	O	O

Moreover	O	O	O
,	O	O	O
13p	O	O	B-T109
significantly	O	O	O
inhibited	O	O	O
tumor	O	O	B-T191
growth	O	O	I-T191
in	O	O	O
mouse	O	O	B-T015
xenograft	O	O	B-T050
models	O	O	I-T050
and	O	O	O
had	O	O	O
no	O	O	B-T184
observable	O	O	I-T184
toxic	O	O	I-T184
effect	O	O	I-T184
.	O	O	O

-DOCSTART- (28166758)

Stromal	O	O	B-T033
alterations	O	O	I-T033
in	O	O	O
ovarian	O	O	B-T191
cancers	O	O	I-T191
via	O	O	O
wavelength	O	O	B-T081
dependent	O	O	B-T080
Second	O	O	B-T059
Harmonic	O	O	I-T059
Generation	O	O	I-T059
microscopy	O	O	I-T059
and	O	O	O
optical	O	O	O
scattering	O	O	O

Ovarian	O	O	B-T191
cancer	O	O	B-T191
remains	O	O	O
the	O	O	O
most	O	O	O
deadly	O	O	O
gynecological	O	O	B-T091
cancer	O	O	O
with	O	O	O
a	O	O	O
poor	O	O	O
aggregate	O	O	O
survival	O	O	B-T081
rate	O	O	I-T081
;	O	O	O
however	O	O	O
,	O	O	O
the	O	O	O
specific	O	O	B-T081
rates	O	O	I-T081
are	O	O	O
highly	O	O	O
dependent	O	O	B-T080
on	O	O	O
the	O	O	O
stage	O	O	O
of	O	O	O
the	O	O	O
disease	O	O	B-T047
upon	O	O	O
diagnosis	O	O	B-T033
.	O	O	O

Current	O	O	O
screening	O	O	B-T058
and	O	O	O
imaging	O	O	B-T074
tools	O	O	I-T074
are	O	O	O
insufficient	O	O	O
to	O	O	O
detect	O	O	O
early	O	O	B-T033
lesions	O	O	I-T033
and	O	O	O
are	O	O	O
not	O	O	O
capable	O	O	O
of	O	O	O
differentiating	O	O	O
the	O	O	O
subtypes	O	O	B-T185
of	O	O	O
ovarian	O	O	B-T191
cancer	O	O	I-T191
that	O	O	O
may	O	O	O
benefit	O	O	O
from	O	O	O
specific	O	O	O
treatments	O	O	B-T061
.	O	O	O

As	O	O	O
an	O	O	O
alternative	O	O	O
to	O	O	O
current	O	O	O
screening	O	O	B-T058
and	O	O	O
imaging	O	O	B-T074
tools	O	O	I-T074
,	O	O	O
we	O	O	O
utilized	O	O	O
wavelength	O	O	B-T081
dependent	O	O	B-T080
collagen	O	O	B-T116
-specific	O	O	O
Second	O	O	B-T059
Harmonic	O	O	I-T059
Generation	O	O	I-T059
(	O	O	I-T059
SHG	O	O	I-T059
)	O	O	I-T059
imaging	O	O	I-T059
microscopy	O	O	I-T059
and	O	O	O
optical	O	O	B-T059
scattering	O	O	I-T059
measurements	O	O	I-T059
to	O	O	O
probe	O	O	O
the	O	O	O
structural	O	O	B-T116
differences	O	O	B-T080
in	O	O	O
the	O	O	O
extracellular	O	O	B-T024
matrix	O	O	I-T024
(	O	O	O
ECM	O	O	B-T024
)	O	O	O
of	O	O	O
normal	O	O	O
stroma	O	O	B-T023
,	O	O	O
benign	O	O	B-T191
tumors	O	O	I-T191
,	O	O	O
endometrioid	O	O	B-T191
tumors	O	O	I-T191
,	O	O	O
and	O	O	O
low	O	O	B-T191
and	O	O	O
high-grade	O	O	B-T191
serous	O	O	I-T191
tumors	O	O	I-T191
.	O	O	O

The	O	O	O
SHG	O	O	B-T059
signatures	O	O	B-T169
of	O	O	O
the	O	O	O
emission	O	O	O
directionality	O	O	O
and	O	O	O
conversion	O	O	B-T169
efficiency	O	O	B-T081
as	O	O	O
well	O	O	O
as	O	O	O
the	O	O	O
optical	O	O	B-T067
scattering	O	O	I-T067
are	O	O	O
related	O	O	O
to	O	O	O
the	O	O	O
organization	O	O	B-T169
of	O	O	O
collagen	O	O	B-T116
on	O	O	O
the	O	O	O
sub-micron	O	O	B-T081
size	O	O	B-T170
scale	O	O	I-T170
and	O	O	O
encode	O	O	O
structural	O	O	B-T116
information	O	O	B-T078
.	O	O	O

The	O	O	O
wavelength	O	O	B-T081
dependence	O	O	B-T080
of	O	O	O
these	O	O	O
readouts	O	O	O
adds	O	O	O
additional	O	O	O
characterization	O	O	O
of	O	O	O
the	O	O	O
size	O	O	B-T082
and	O	O	O
distribution	O	O	B-T169
of	O	O	O
collagen	O	O	B-T024
fibrils	O	O	I-T024
/	O	O	O
fibers	O	O	B-T024
relative	O	O	O
to	O	O	O
the	O	O	O
interrogating	O	O	O
wavelengths	O	O	B-T081
.	O	O	O

We	O	O	O
found	O	O	O
a	O	O	O
strong	O	O	O
wavelength	O	O	B-T081
dependence	O	O	B-T080
of	O	O	O
these	O	O	O
metrics	O	O	B-T024
that	O	O	O
are	O	O	O
related	O	O	O
to	O	O	O
significant	O	O	O
structural	O	O	B-T116
differences	O	O	B-T080
in	O	O	O
the	O	O	O
collagen	O	O	B-T116
organization	O	O	B-T169
and	O	O	O
are	O	O	O
consistent	O	O	O
with	O	O	O
the	O	O	O
dualistic	O	O	O
classification	O	O	B-T185
of	O	O	O
type	O	O	B-T191
I	O	O	I-T191
and	O	O	I-T191
II	O	O	I-T191
serous	O	O	I-T191
tumors	O	O	I-T191
.	O	O	O

Moreover	O	O	O
,	O	O	O
type	O	O	B-T191
I	O	O	I-T191
endometrioid	O	O	I-T191
tumors	O	O	I-T191
have	O	O	O
strongly	O	O	O
differing	O	O	O
ECM	O	O	B-T024
architecture	O	O	O
than	O	O	O
the	O	O	O
serous	O	O	B-T191
malignancies	O	O	I-T191
.	O	O	O

The	O	O	O
SHG	O	O	B-T059
metrics	O	O	B-T024
and	O	O	O
optical	O	O	B-T059
scattering	O	O	I-T059
measurements	O	O	I-T059
were	O	O	O
used	O	O	O
to	O	O	O
form	O	O	O
a	O	O	O
linear	O	O	B-T170
discriminant	O	O	I-T170
model	O	O	I-T170
to	O	O	O
classify	O	O	O
the	O	O	O
tissues	O	O	B-T024
,	O	O	O
and	O	O	O
we	O	O	O
obtained	O	O	O
high	O	O	O
accuracy	O	O	O
(	O	O	O
>	O	O	O
90	O	O	O
%	O	O	O
)	O	O	O
between	O	O	O
high-grade	O	O	B-T191
serous	O	O	I-T191
tumors	O	O	I-T191
from	O	O	O
the	O	O	O
other	O	O	O
tissue	O	O	B-T024
types	O	O	I-T024
.	O	O	O

High-grade	O	O	B-T191
serous	O	O	I-T191
tumors	O	O	I-T191
account	O	O	O
for	O	O	O
~70	O	O	O
%	O	O	O
of	O	O	O
ovarian	O	O	B-T191
cancers	O	O	I-T191
,	O	O	O
and	O	O	O
this	O	O	O
delineation	O	O	O
has	O	O	O
potential	O	O	O
clinical	O	O	O
applications	O	O	O
in	O	O	O
terms	O	O	O
of	O	O	O
supplementing	O	O	O
histological	O	O	B-UnknownType
analysis	O	O	I-UnknownType
,	O	O	O
understanding	O	O	O
the	O	O	O
etiology	O	O	B-T169
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
development	O	O	O
of	O	O	O
an	O	O	O
in	O	O	B-T062
vivo	O	O	I-T062
screening	O	O	B-T058
tool	O	O	I-T058
.	O	O	O

SHG	O	O	B-T059
and	O	O	O
optical	O	O	B-T059
scattering	O	O	I-T059
measurements	O	O	I-T059
provide	O	O	O
sub-resolution	O	O	O
information	O	O	B-T078
and	O	O	O
when	O	O	O
combined	O	O	O
provide	O	O	O
superior	O	O	B-T060
diagnostic	O	O	I-T060
power	O	O	I-T060
over	O	O	O
clinical	O	O	B-T060
imaging	O	O	I-T060
modalities	O	O	B-T169
.	O	O	O

Additionally	O	O	O
the	O	O	O
measurements	O	O	B-T169
are	O	O	O
able	O	O	O
to	O	O	O
delineate	O	O	O
the	O	O	O
different	O	O	O
subtypes	O	O	B-T185
of	O	O	O
ovarian	O	O	B-T191
cancer	O	O	I-T191
and	O	O	O
may	O	O	O
potentially	O	O	O
assist	O	O	O
in	O	O	O
treatment	O	O	B-T061
protocols	O	O	I-T061
.	O	O	O

Understanding	O	O	O
the	O	O	O
altered	O	O	B-T078
collagen	O	O	B-T116
assembly	O	O	O
can	O	O	O
supplement	O	O	O
histological	O	O	B-UnknownType
analysis	O	O	I-UnknownType
and	O	O	O
provide	O	O	O
new	O	O	O
insight	O	O	O
into	O	O	O
the	O	O	O
etiology	O	O	B-T169
.	O	O	O

These	O	O	O
methods	O	O	O
could	O	O	O
become	O	O	O
an	O	O	O
in	O	O	B-T062
vivo	O	O	I-T062
screening	O	O	B-T058
tool	O	O	I-T058
for	O	O	O
earlier	O	O	O
detection	O	O	O
which	O	O	O
is	O	O	O
important	O	O	O
since	O	O	O
ovarian	O	O	B-T191
malignancies	O	O	I-T191
can	O	O	O
metastasize	O	O	B-T191
while	O	O	O
undetectable	O	O	O
by	O	O	O
current	O	O	O
clinical	O	O	B-T060
imaging	O	O	I-T060
resolution	O	O	O
.	O	O	O

-DOCSTART- (28167866)

The	O	O	O
Role	O	O	O
of	O	O	O
Metal-on-Metal	O	O	B-T074
Bearings	O	O	I-T074
in	O	O	O
Total	O	O	B-T061
Hip	O	O	I-T061
Arthroplasty	O	O	I-T061
and	O	O	O
Hip	O	O	B-T061
Resurfacing	O	O	I-T061
:	O	O	O
Review	O	O	O
Article	O	O	O

The	O	O	O
current	O	O	O
role	O	O	O
of	O	O	O
metal-on-metal	O	O	B-T074
(	O	O	I-T074
MoM	O	O	I-T074
)	O	O	I-T074
bearings	O	O	I-T074
in	O	O	O
hip	O	O	B-T061
arthroplasty	O	O	I-T061
remains	O	O	O
controversial	O	O	O
.	O	O	O

The	O	O	O
low	O	O	O
wear	O	O	O
offered	O	O	O
by	O	O	O
MoM	O	O	B-T074
bearings	O	O	I-T074
compared	O	O	O
to	O	O	O
metal-on-polyethylene	O	O	B-T074
and	O	O	O
the	O	O	O
possibility	O	O	O
of	O	O	O
a	O	O	O
lower	O	O	B-T081
risk	O	O	I-T081
of	O	O	I-T081
dislocation	O	O	B-T037
with	O	O	O
larger	O	O	B-T080
head	O	O	I-T080
sizes	O	O	I-T080
,	O	O	O
encouraged	O	O	O
a	O	O	O
trend	O	O	B-T079
towards	O	O	O
the	O	O	O
re-introduction	O	O	B-T061
of	O	O	O
the	O	O	O
MoM	O	O	B-T074
bearing	O	O	I-T074
couple	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
recent	O	O	O
evidence	O	O	B-T078
has	O	O	O
shown	O	O	O
that	O	O	O
not	O	O	O
all	O	O	O
designs	O	O	O
of	O	O	O
the	O	O	O
MoM	O	O	B-T074
bearing	O	O	I-T074
have	O	O	O
been	O	O	O
successful	O	O	B-T080
.	O	O	O

The	O	O	O
purpose	O	O	O
of	O	O	O
this	O	O	O
paper	O	O	O
is	O	O	O
to	O	O	O
provide	O	O	O
an	O	O	O
update	O	O	O
on	O	O	O
the	O	O	O
use	O	O	O
of	O	O	O
MoM	O	O	B-T074
bearings	O	O	I-T074
and	O	O	O
address	O	O	O
the	O	O	O
following	O	O	O
issues	O	O	O
:	O	O	O
(	O	O	O
1	O	O	O
)	O	O	O
the	O	O	O
reintroduction	O	O	B-T061
of	O	O	O
metal-on-metal	O	O	B-T074
bearings	O	O	I-T074
in	O	O	O
total	O	O	B-T061
hip	O	O	I-T061
arthroplasty	O	O	I-T061
,	O	O	O
(	O	O	O
2	O	O	O
)	O	O	O
the	O	O	O
failure	O	O	O
of	O	O	O
metal-on-metal	O	O	O
bearings	O	O	O
in	O	O	O
stemmed	O	O	B-T061
total	O	O	I-T061
hip	O	O	I-T061
arthroplasty	O	O	I-T061
,	O	O	O
(	O	O	O
3	O	O	O
)	O	O	O
the	O	O	O
role	O	O	O
of	O	O	O
metal-on-metal	O	O	B-T061
hip	O	O	I-T061
resurfacing	O	O	I-T061
in	O	O	O
modern	O	O	O
orthopaedics	O	O	B-T091
and	O	O	O
(	O	O	O
4	O	O	O
)	O	O	O
metal-on-metal	O	O	O
hip	O	O	O
resurfacing	O	O	O
versus	O	O	O
total	O	O	O
hip	O	O	O
arthroplasty	O	O	O
.	O	O	O

A	O	O	O
literature	O	O	B-T170
search	O	O	O
strategy	O	O	B-T041
was	O	O	O
conducted	O	O	O
using	O	O	O
various	O	O	O
search	O	O	O
terms	O	O	O
in	O	O	O
MEDLINE	O	O	B-T170
and	O	O	O
Embase	O	O	B-T170
.	O	O	O

The	O	O	O
highest	O	O	O
quality	O	O	B-T170
articles	O	O	I-T170
that	O	O	O
met	O	O	O
the	O	O	O
inclusion	O	O	B-T080
criteria	O	O	I-T080
and	O	O	O
best	O	O	O
answered	O	O	O
the	O	O	O
topics	O	O	O
of	O	O	O
focus	O	O	O
of	O	O	O
this	O	O	O
review	O	O	B-T170
were	O	O	O
selected	O	O	O
.	O	O	O

Key	O	O	O
search	O	O	O
terms	O	O	O
included	O	O	O
'	O	O	O
metal-on-metal	O	O	B-T074
'	O	O	O
,	O	O	O
'	O	O	O
total	O	O	B-T061
hip	O	O	I-T061
arthroplasty	O	O	I-T061
'	O	O	O
and	O	O	O
'	O	O	O
hip	O	O	B-T061
resurfacing	O	O	I-T061
'	O	O	O
.	O	O	O

The	O	O	O
initial	O	O	O
search	O	O	O
retrieved	O	O	O
1240	O	O	O
articles	O	O	B-T170
.	O	O	O

Twenty-two	O	O	O
articles	O	O	B-T170
were	O	O	O
selected	O	O	O
and	O	O	O
used	O	O	O
in	O	O	O
the	O	O	O
review	O	O	B-T170
.	O	O	O

Metal-on-metal	O	O	B-T074
hip	O	O	I-T074
resurfacing	O	O	I-T074
is	O	O	O
still	O	O	O
a	O	O	O
suitable	O	O	O
treatment	O	O	B-T061
option	O	O	O
in	O	O	O
specific	O	O	B-T080
patient	O	O	B-T081
populations	O	O	I-T081
with	O	O	O
the	O	O	O
appropriate	O	O	B-T080
implant	O	O	B-T061
design	O	O	I-T061
and	O	O	O
surgical	O	O	O
skill	O	O	O
,	O	O	O
while	O	O	O
stemmed	O	O	O
metal-on-metal	O	O	B-T074
total	O	O	I-T074
hip	O	O	I-T074
arthroplasty	O	O	I-T074
should	O	O	O
be	O	O	O
avoided	O	O	O
in	O	O	O
all	O	O	B-T081
patient	O	O	I-T081
populations	O	O	I-T081
.	O	O	O

Continued	O	O	O
follow-up	O	O	B-T058
of	O	O	O
patients	O	O	B-T101
undergoing	O	O	O
metal-on-metal	O	O	B-T061
hip	O	O	I-T061
resurfacing	O	O	I-T061
is	O	O	O
critical	O	O	B-T080
in	O	O	O
order	O	O	O
to	O	O	O
further	O	O	O
understand	O	O	O
the	O	O	O
long-term	O	O	B-T079
outcomes	O	O	B-T080
of	O	O	O
these	O	O	O
patients	O	O	O
and	O	O	O
why	O	O	O
certain	O	O	O
complications	O	O	B-T046
tend	O	O	O
to	O	O	O
occur	O	O	O
with	O	O	O
this	O	O	O
procedure	O	O	O
.	O	O	O

-DOCSTART- (28167893)

Morphogenetic	O	O	B-T040
Alterations	O	O	B-T078
of	O	O	O
Alternaria	O	O	B-T004
alternata	O	O	I-T004
Exposed	O	O	B-T080
to	O	O	I-T080
Dicarboximide	O	O	B-T131
Fungicide	O	O	I-T131
,	O	O	O
Iprodione	O	O	O

Fungicide-resistant	O	O	B-T169
Alternaria	O	O	B-T004
alternata	O	O	I-T004
impede	O	O	O
the	O	O	O
practical	O	O	O
control	O	O	B-T169
of	O	O	O
the	O	O	O
Alternaria	O	O	B-T047
diseases	O	O	I-T047
in	O	O	O
crop	O	O	B-T002
fields	O	O	B-T090
.	O	O	O

This	O	O	O
study	O	O	O
aimed	O	O	O
to	O	O	O
investigate	O	O	B-T169
cytological	O	O	B-T169
fungicide	O	O	B-T131
resistance	O	O	B-T039
mechanisms	O	O	B-T169
of	O	O	O
A.	O	O	B-T004
alternata	O	O	I-T004
against	O	O	O
dicarboximide	O	O	B-T131
fungicide	O	O	I-T131
iprodione	O	O	B-T109
.	O	O	O

A.	O	O	B-T004
alternata	O	O	I-T004
isolated	O	O	B-T169
from	O	O	O
cactus	O	O	B-T002
brown	O	O	B-T077
spot	O	O	I-T077
was	O	O	O
cultured	O	O	B-T059
on	O	O	O
potato-dextrose	O	O	B-T130
agar	O	O	I-T130
(	O	O	O
PDA	O	O	B-T130
)	O	O	O
with	O	O	O
or	O	O	O
without	O	O	B-T080
iprodione	O	O	B-T109
,	O	O	O
and	O	O	O
the	O	O	O
fungal	O	O	B-T059
cultures	O	O	I-T059
with	O	O	O
different	O	O	B-T080
growth	O	O	B-T040
characteristics	O	O	B-T080
from	O	O	O
no	O	O	B-T034
,	O	O	O
initial	O	O	B-T079
and	O	O	O
full	O	O	B-T080
growth	O	O	O
were	O	O	O
observed	O	O	B-T169
by	O	O	O
light	O	O	B-T059
and	O	O	O
electron	O	O	B-T059
microscopy	O	O	I-T059
.	O	O	O

Mycelia	O	O	B-T004
began	O	O	O
to	O	O	O
grow	O	O	B-T040
from	O	O	O
one	O	O	B-T079
day	O	O	I-T079
after	O	O	I-T079
incubation	O	O	I-T079
(	O	O	O
DAI	O	O	B-T079
)	O	O	O
and	O	O	O
continued	O	O	B-T078
to	O	O	O
be	O	O	O
in	O	O	O
full	O	O	B-T080
growth	O	O	B-T040
(	O	O	O
control-growth	O	O	B-T040
,	O	O	O
Con-G	O	O	B-T040
)	O	O	O
on	O	O	O
PDA	O	O	B-T130
without	O	O	O
fungicide	O	O	B-T131
,	O	O	O
while	O	O	O
on	O	O	O
PDA	O	O	O
with	O	O	O
iprodione	O	O	B-T109
,	O	O	O
no	O	O	B-T034
fungal	O	O	I-T034
growth	O	O	I-T034
(	O	O	O
iprodione-no	O	O	B-T034
growth	O	O	I-T034
,	O	O	O
Ipr-N	O	O	B-T034
)	O	O	O
occurred	O	O	O
for	O	O	O
the	O	O	O
first	O	O	O
3	O	O	O
DAI	O	O	O
,	O	O	O
but	O	O	O
once	O	O	O
the	O	O	O
initial	O	O	B-T079
growth	O	O	O
(	O	O	O
iprodione-initial	O	O	B-T040
growth	O	O	I-T040
,	O	O	O
Ipr-I	O	O	B-T040
)	O	O	O
began	O	O	O
at	O	O	O
4	O	O	O
-	O	O	O
5	O	O	O
DAI	O	O	O
,	O	O	O
the	O	O	O
colonies	O	O	B-T025
grew	O	O	O
and	O	O	O
expanded	O	O	B-T082
continuously	O	O	B-T078
to	O	O	O
be	O	O	O
in	O	O	O
full	O	O	O
growth	O	O	O
(	O	O	O
iprodione-growth	O	O	B-T040
,	O	O	O
Ipr-G	O	O	B-T040
)	O	O	O
,	O	O	O
suggesting	O	O	O
Ipr-I	O	O	O
may	O	O	O
be	O	O	O
a	O	O	O
turning	O	O	O
moment	O	O	O
of	O	O	O
the	O	O	O
morphogenetic	O	O	B-T040
changes	O	O	B-T169
resisting	O	O	B-T039
fungicidal	O	O	B-T044
toxicity	O	O	B-T080
.	O	O	O

Con-G	O	O	B-T040
formed	O	O	O
multicellular	O	O	B-T004
conidia	O	O	I-T004
with	O	O	O
cell	O	O	B-T026
walls	O	O	I-T026
and	O	O	O
septa	O	O	B-T026
and	O	O	O
intact	O	O	B-T080
dense	O	O	B-T080
cytoplasm	O	O	B-T026
.	O	O	O

In	O	O	O
Ipr-N	O	O	B-T034
,	O	O	O
fungal	O	O	B-T004
sporulation	O	O	B-T043
was	O	O	O
inhibited	O	O	B-T080
by	O	O	O
forming	O	O	O
mostly	O	O	O
undeveloped	O	O	B-T033
unicellular	O	O	B-T004
conidia	O	O	I-T004
with	O	O	O
degraded	O	O	B-T033
and	O	O	O
necrotic	O	O	B-T042
cytoplasm	O	O	B-T026
.	O	O	O

However	O	O	O
,	O	O	O
in	O	O	O
Ipr-I	O	O	B-T040
,	O	O	O
conspicuous	O	O	B-T049
cellular	O	O	I-T049
changes	O	O	I-T049
occurred	O	O	O
during	O	O	O
sporulation	O	O	B-T043
by	O	O	O
forming	O	O	O
multicellular	O	O	B-T004
conidia	O	O	I-T004
with	O	O	O
double	O	O	B-T033
layered	O	O	I-T033
(	O	O	O
thickened	O	O	B-T033
)	O	O	O
cell	O	O	B-T026
walls	O	O	I-T026
and	O	O	O
accumulation	O	O	B-T033
of	O	O	O
proliferated	O	O	B-T169
lipid	O	O	B-T026
bodies	O	O	I-T026
in	O	O	O
the	O	O	O
conidial	O	O	B-T004
cytoplasm	O	O	B-T026
,	O	O	O
which	O	O	O
may	O	O	O
inhibit	O	O	B-T080
the	O	O	O
penetration	O	O	B-T169
of	O	O	O
the	O	O	O
fungicide	O	O	B-T131
into	O	O	O
conidial	O	O	O
cells	O	O	B-T025
,	O	O	O
reducing	O	O	O
fungicide	O	O	O
-	O	O	O
associated	O	O	B-T080
toxicity	O	O	B-T080
,	O	O	O
and	O	O	O
may	O	O	O
be	O	O	O
utilized	O	O	O
as	O	O	O
energy	O	O	B-T081
and	O	O	O
nutritional	O	O	B-T080
sources	O	O	B-T033
,	O	O	O
respectively	O	O	O
,	O	O	O
for	O	O	O
the	O	O	O
further	O	O	O
fungal	O	O	B-T004
growth	O	O	B-T040
to	O	O	O
form	O	O	O
mature	O	O	B-T079
colonies	O	O	B-T025
as	O	O	O
in	O	O	O
Ipr-G	O	O	B-T040
that	O	O	O
formed	O	O	O
multicellular	O	O	O
conidia	O	O	O
with	O	O	O
cell	O	O	O
walls	O	O	O
and	O	O	O
intact	O	O	B-T080
cytoplasm	O	O	O
with	O	O	O
lipid	O	O	O
bodies	O	O	O
as	O	O	O
in	O	O	O
Con-G.	O	O	O

-DOCSTART- (28168514)

Limits	O	O	O
of	O	O	O
the	O	O	O
possible	O	O	O
:	O	O	O
diagnostic	O	O	B-T078
image	O	O	I-T078
quality	O	O	B-T080
in	O	O	O
coronary	O	O	B-T060
angiography	O	O	I-T060
with	O	O	O
third-generation	O	O	O
dual-source	O	O	O
CT	O	O	O

The	O	O	O
usage	O	O	B-T169
of	O	O	O
coronary	O	O	B-T060
CT	O	O	I-T060
angiography	O	O	I-T060
(	O	O	O
CTA	O	O	B-T060
)	O	O	O
is	O	O	O
appropriate	O	O	O
in	O	O	O
patients	O	O	B-T101
with	O	O	O
acute	O	O	B-T184
or	O	O	O
chronic	O	O	B-T184
chest	O	O	I-T184
pain	O	O	I-T184
;	O	O	O
however	O	O	O
the	O	O	O
diagnostic	O	O	B-T080
accuracy	O	O	I-T080
may	O	O	O
be	O	O	O
challenged	O	O	O
with	O	O	O
increased	O	O	O
Agatston	O	O	B-T081
score	O	O	I-T081
(	O	O	O
AS	O	O	B-T081
)	O	O	O
,	O	O	O
increased	O	O	O
heart	O	O	B-T201
rate	O	O	I-T201
,	O	O	O
arrhythmia	O	O	B-T033
and	O	O	O
severe	O	O	B-T047
obesity	O	O	I-T047
.	O	O	O

Thus	O	O	O
,	O	O	O
we	O	O	O
aim	O	O	O
to	O	O	O
determine	O	O	O
the	O	O	O
potential	O	O	O
of	O	O	O
the	O	O	O
recently	O	O	O
introduced	O	O	O
third-generation	O	O	B-T060
dual-source	O	O	I-T060
CT	O	O	I-T060
(	O	O	O
DSCT	O	O	B-T060
)	O	O	O
for	O	O	O
CTA	O	O	B-T060
in	O	O	O
a	O	O	O
'	O	O	O
real-life	O	O	O
'	O	O	O
clinical	O	O	B-T082
setting	O	O	I-T082
.	O	O	O

Two	O	O	O
hundred	O	O	O
and	O	O	O
sixty-eight	O	O	O
consecutive	O	O	O
patients	O	O	B-T101
(	O	O	O
age	O	O	O
:	O	O	O
67	O	O	O
Â±	O	O	O
10	O	O	O
years	O	O	O
;	O	O	O
BMI	O	O	B-T201
:	O	O	O
27	O	O	O
Â±	O	O	O
5	O	O	O
kg/mÂ²	O	O	O
;	O	O	O
61	O	O	O
%	O	O	O
male	O	O	B-T098
)	O	O	O
undergoing	O	O	O
clinically	O	O	O
indicated	O	O	O
CTA	O	O	B-T060
with	O	O	O
DSCT	O	O	B-T060
were	O	O	O
included	O	O	O
in	O	O	O
the	O	O	O
retrospective	O	O	B-T062
single-center	O	O	I-T062
analysis	O	O	I-T062
.	O	O	O

A	O	O	O
contrast-enhanced	O	O	B-T170
volume	O	O	I-T170
dataset	O	O	I-T170
was	O	O	O
acquired	O	O	O
in	O	O	O
sequential	O	O	B-T060
(	O	O	O
SSM	O	O	B-T060
)	O	O	O
(	O	O	O
n	O	O	O
=	O	O	O
151	O	O	O
)	O	O	O
or	O	O	O
helical	O	O	B-T060
scan	O	O	I-T060
mode	O	O	I-T060
(	O	O	O
HSM	O	O	B-T060
)	O	O	O
(	O	O	O
n	O	O	O
=	O	O	O
117	O	O	O
)	O	O	O
.	O	O	O

Coronary	O	O	B-T023
segments	O	O	I-T023
were	O	O	O
classified	O	O	O
in	O	O	O
diagnostic	O	O	B-T080
or	O	O	O
non-diagnostic	O	O	B-T080
image	O	O	I-T080
quality	O	O	I-T080
.	O	O	O

A	O	O	O
subset	O	O	O
underwent	O	O	O
invasive	O	O	B-T060
angiography	O	O	I-T060
to	O	O	O
determine	O	O	O
the	O	O	O
diagnostic	O	O	B-T080
accuracy	O	O	I-T080
of	O	O	O
CTA	O	O	B-T060
.	O	O	O

SSM	O	O	B-T060
(	O	O	O
96.8	O	O	O
Â±	O	O	O
6	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
HSM	O	O	B-T060
(	O	O	O
97.5	O	O	O
Â±	O	O	O
8	O	O	O
%	O	O	O
)	O	O	O
provided	O	O	O
no	O	O	O
significant	O	O	O
differences	O	O	O
in	O	O	O
the	O	O	O
overall	O	O	O
diagnostic	O	O	B-T078
image	O	O	I-T078
quality	O	O	B-T080
.	O	O	O

However	O	O	O
,	O	O	O
AS	O	O	B-T081
had	O	O	O
significant	O	O	O
influence	O	O	B-T077
on	O	O	O
diagnostic	O	O	B-T078
image	O	O	I-T078
quality	O	O	B-T080
exclusively	O	O	O
in	O	O	O
SSM	O	O	B-T060
(	O	O	O
B	O	O	O
=	O	O	O
0.003	O	O	O
;	O	O	O
p	O	O	O
=	O	O	O
0.0001	O	O	O
)	O	O	O
,	O	O	O
but	O	O	O
not	O	O	O
in	O	O	O
HSM	O	O	B-T060
.	O	O	O

Diagnostic	O	O	B-T078
image	O	O	I-T078
quality	O	O	B-T080
significantly	O	O	O
decreased	O	O	O
in	O	O	O
SSM	O	O	B-T060
in	O	O	O
patients	O	O	B-T101
with	O	O	O
AS	O	O	B-T081
â¥2,000	O	O	O
(	O	O	O
p	O	O	O
=	O	O	O
0.03	O	O	O
)	O	O	O
.	O	O	O

SSM	O	O	B-T060
(	O	O	O
sensitivity	O	O	B-T081
:	O	O	O
93.9	O	O	O
%	O	O	O
;	O	O	O
specificity	O	O	B-T081
:	O	O	O
96.7	O	O	O
%	O	O	O
;	O	O	O
PPV	O	O	B-T081
:	O	O	O
88.6	O	O	O
%	O	O	O
;	O	O	O
NPV	O	O	B-T081
:	O	O	O
98.3	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
HSM	O	O	B-T060
(	O	O	O
sensitivity	O	O	O
:	O	O	O
97.4	O	O	O
%	O	O	O
;	O	O	O
specificity	O	O	O
:	O	O	O
94.3	O	O	O
%	O	O	O
;	O	O	O
PPV	O	O	O
:	O	O	O
86.0	O	O	O
%	O	O	O
;	O	O	O
NPV	O	O	O
:	O	O	O
99.0	O	O	O
%	O	O	O
)	O	O	O
provided	O	O	O
comparable	O	O	O
diagnostic	O	O	B-T080
accuracy	O	O	I-T080
(	O	O	O
p	O	O	O
=	O	O	O
n.s	O	O	O
.	O	O	O
)	O	O	O
.	O	O	O

SSM	O	O	B-T060
yielded	O	O	O
significantly	O	O	O
lower	O	O	O
radiation	O	O	B-T081
doses	O	O	I-T081
as	O	O	O
compared	O	O	O
to	O	O	O
HSM	O	O	B-T060
(	O	O	O
2.1	O	O	O
Â±	O	O	O
2.0	O	O	O
vs.	O	O	O
5.1	O	O	O
Â±	O	O	O
3.3	O	O	O
mSv	O	O	O
;	O	O	O
p	O	O	O
=	O	O	O
0.0001	O	O	O
)	O	O	O
in	O	O	O
age	O	O	B-T098
and	O	O	O
BMI	O	O	B-T201
-matched	O	O	O
cohorts	O	O	B-T098
.	O	O	O

SSM	O	O	B-T060
in	O	O	O
third-generation	O	O	B-T060
DSCT	O	O	I-T060
enables	O	O	O
significant	O	O	O
dose	O	O	B-T081
savings	O	O	O
and	O	O	O
provides	O	O	O
robust	O	O	O
diagnostic	O	O	B-T078
image	O	O	I-T078
quality	O	O	B-T080
in	O	O	O
patients	O	O	B-T101
with	O	O	O
AS	O	O	B-T081
â¤2000	O	O	O
independent	O	O	O
of	O	O	O
heart	O	O	B-T201
rate	O	O	I-T201
,	O	O	O
heart	O	O	B-T042
rhythm	O	O	I-T042
or	O	O	O
obesity	O	O	B-T047
.	O	O	O

-DOCSTART- (28171748)

Antagonistic	O	O	B-T044
Self-Organizing	O	O	B-T045
Patterning	O	O	I-T045
Systems	O	O	O
Control	O	O	B-T169
Maintenance	O	O	B-T039
and	O	O	O
Regeneration	O	O	B-T042
of	O	O	O
the	O	O	O
Anteroposterior	O	O	B-T082
Axis	O	O	B-T082
in	O	O	O
Planarians	O	O	O

Planarian	O	O	B-T204
flatworms	O	O	B-T204
maintain	O	O	B-T039
their	O	O	O
body	O	O	B-T017
plan	O	O	O
in	O	O	O
the	O	O	O
face	O	O	O
of	O	O	O
constant	O	O	O
internal	O	O	O
turnover	O	O	O
and	O	O	O
can	O	O	O
regenerate	O	O	B-T169
from	O	O	O
arbitrary	O	O	B-T080
tissue	O	O	B-T024
fragments	O	O	B-T031
.	O	O	O

Both	O	O	O
phenomena	O	O	B-T067
require	O	O	O
self-maintaining	O	O	B-T052
and	O	O	O
self-organizing	O	O	B-T045
patterning	O	O	I-T045
mechanisms	O	O	B-T169
,	O	O	O
the	O	O	O
molecular	O	O	B-T080
mechanisms	O	O	O
of	O	O	O
which	O	O	O
remain	O	O	O
poorly	O	O	O
understood	O	O	O
.	O	O	O

We	O	O	O
show	O	O	O
that	O	O	O
a	O	O	O
morphogenic	O	O	B-T044
gradient	O	O	B-T081
of	O	O	O
canonical	O	O	B-T044
Wnt	O	O	I-T044
signaling	O	O	I-T044
patterns	O	O	O
gene	O	O	B-T045
expression	O	O	I-T045
along	O	O	O
the	O	O	O
planarian	O	O	B-T204
anteroposterior	O	O	B-T082
(	O	O	O
A/P	O	O	B-T082
)	O	O	O
axis	O	O	B-T082
.	O	O	O

Our	O	O	O
results	O	O	B-T033
demonstrate	O	O	O
that	O	O	O
gradient	O	O	B-T081
formation	O	O	B-T169
likely	O	O	O
occurs	O	O	O
autonomously	O	O	B-T169
in	O	O	O
the	O	O	O
tail	O	O	B-T023
and	O	O	O
that	O	O	O
an	O	O	O
autoregulatory	O	O	B-T038
module	O	O	O
of	O	O	O
Wnt	O	O	B-T116
-mediated	O	O	O
Wnt	O	O	O
expression	O	O	B-T045
both	O	O	O
shapes	O	O	O
the	O	O	O
gradient	O	O	O
at	O	O	O
steady	O	O	B-T070
state	O	O	I-T070
and	O	O	O
governs	O	O	O
its	O	O	O
re-establishment	O	O	O
during	O	O	O
regeneration	O	O	B-T042
.	O	O	O

Functional	O	O	B-T169
antagonism	O	O	B-T044
between	O	O	O
the	O	O	O
tail	O	O	B-T023
Wnt	O	O	B-T116
gradient	O	O	B-T081
and	O	O	O
an	O	O	O
unknown	O	O	B-T080
head	O	O	B-T029
patterning	O	O	B-T045
system	O	O	O
further	O	O	O
determines	O	O	O
the	O	O	O
spatial	O	O	B-T082
proportions	O	O	B-T081
of	O	O	O
the	O	O	O
planarian	O	O	B-T204
A/P	O	O	B-T082
axis	O	O	B-T082
and	O	O	O
mediates	O	O	O
mutually	O	O	B-T080
exclusive	O	O	B-T078
molecular	O	O	B-T044
fate	O	O	I-T044
choices	O	O	O
during	O	O	B-T079
regeneration	O	O	B-T042
.	O	O	O

Overall	O	O	O
,	O	O	O
our	O	O	O
results	O	O	B-T033
suggest	O	O	O
that	O	O	O
the	O	O	O
planarian	O	O	B-T204
A/P	O	O	B-T082
axis	O	O	B-T082
is	O	O	O
patterned	O	O	O
by	O	O	O
self-organizing	O	O	B-T045
patterning	O	O	I-T045
systems	O	O	O
deployed	O	O	B-T052
from	O	O	O
either	O	O	O
end	O	O	O
that	O	O	O
are	O	O	O
functionally	O	O	B-T169
coupled	O	O	B-T169
by	O	O	O
mutual	O	O	B-T080
antagonism	O	O	B-T044
.	O	O	O

-DOCSTART- (28179911)

Characterization	O	O	B-T052
and	O	O	O
Ectopic	O	O	B-T045
Expression	O	O	I-T045
of	O	O	O
CoWRI1	O	O	B-T028
,	O	O	O
an	O	O	O
AP2/EREBP	O	O	B-T028
Domain-Containing	O	O	O
Transcription	O	O	B-T116
Factor	O	O	I-T116
from	O	O	O
Coconut	O	O	B-T002
(	O	O	O
Cocos	O	O	B-T002
nucifera	O	O	I-T002
L	O	O	I-T002
.	O	O	O
)	O	O	O
Endosperm	O	O	B-T002
,	O	O	O
Changes	O	O	O
the	O	O	O
Seeds	O	O	B-T002
Oil	O	O	B-T109
Content	O	O	O
in	O	O	O
Transgenic	O	O	B-T002
Arabidopsis	O	O	B-T002
thaliana	O	O	I-T002
and	O	O	O
Rice	O	O	B-T002
(	O	O	O
Oryza	O	O	B-T002
sativa	O	O	I-T002
L	O	O	I-T002
.	O	O	O
)	O	O	O

Coconut	O	O	B-T002
(	O	O	O
Cocos	O	O	B-T002
nucifera	O	O	I-T002
L.	O	O	I-T002
)	O	O	O
is	O	O	O
a	O	O	O
key	O	O	O
tropical	O	O	B-T070
crop	O	O	B-T002
and	O	O	O
a	O	O	O
member	O	O	O
of	O	O	O
the	O	O	O
monocotyledonous	O	O	B-T077
family	O	O	I-T077
Arecaceae	O	O	B-T002
(	O	O	O
Palmaceae	O	O	B-T002
)	O	O	O
.	O	O	O

Few	O	O	O
genes	O	O	B-T028
and	O	O	O
related	O	O	O
metabolic	O	O	B-T040
processes	O	O	I-T040
involved	O	O	O
in	O	O	O
coconut	O	O	B-T002
endosperm	O	O	B-T002
development	O	O	O
have	O	O	O
been	O	O	O
investigated	O	O	B-T169
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
a	O	O	O
new	O	O	O
member	O	O	O
of	O	O	O
the	O	O	O
WRI1	O	O	B-T028
gene	O	O	B-T028
family	O	O	I-T028
was	O	O	O
isolated	O	O	O
from	O	O	O
coconut	O	O	B-T002
endosperm	O	O	B-T002
and	O	O	O
was	O	O	O
named	O	O	O
CoWRI1	O	O	B-T028
.	O	O	O

Its	O	O	O
transcriptional	O	O	B-T045
activities	O	O	B-T052
and	O	O	O
interactions	O	O	B-T169
with	O	O	O
the	O	O	O
acetyl-CoA	O	O	B-T116
carboxylase	O	O	I-T116
(	O	O	O
BCCP2	O	O	B-T116
)	O	O	O
promoter	O	O	B-T114
of	O	O	O
CoWRI1	O	O	B-T028
were	O	O	O
confirmed	O	O	O
by	O	O	O
the	O	O	O
yeast	O	O	B-T063
two-hybrid	O	O	I-T063
and	O	O	O
yeast	O	O	B-T063
one-hybrid	O	O	I-T063
approaches	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

Functional	O	O	O
characterization	O	O	B-T052
was	O	O	O
carried	O	O	O
out	O	O	O
through	O	O	O
seed	O	O	B-T002
-specific	O	O	O
expression	O	O	B-T045
in	O	O	O
Arabidopsis	O	O	B-T002
and	O	O	O
endosperm	O	O	B-T002
-specific	O	O	O
expression	O	O	O
in	O	O	O
rice	O	O	B-T002
.	O	O	O

In	O	O	O
transgenic	O	O	B-T002
Arabidopsis	O	O	B-T002
,	O	O	O
high	O	O	O
over-expressions	O	O	B-T045
of	O	O	O
CoWRI1	O	O	B-T028
in	O	O	O
seven	O	O	O
independent	O	O	O
T2	O	O	B-T002
lines	O	O	B-T002
were	O	O	O
detected	O	O	O
by	O	O	O
quantitative	O	O	B-T063
real-time	O	O	I-T063
PCR	O	O	I-T063
.	O	O	O

The	O	O	O
relative	O	O	O
mRNA	O	O	B-T114
accumulation	O	O	O
of	O	O	O
genes	O	O	B-T028
encoding	O	O	B-T052
enzymes	O	O	B-T116
involved	O	O	O
in	O	O	O
either	O	O	O
fatty	O	O	B-T044
acid	O	O	I-T044
biosynthesis	O	O	I-T044
or	O	O	O
triacylglycerols	O	O	B-T109
assembly	O	O	O
(	O	O	O
BCCP2	O	O	B-T028
,	O	O	O
KASI	O	O	B-T028
,	O	O	O
MAT	O	O	B-T028
,	O	O	O
ENR	O	O	B-T028
,	O	O	O
FATA	O	O	B-T028
,	O	O	O
and	O	O	O
GPDH	O	O	B-T028
)	O	O	O
were	O	O	O
also	O	O	O
assayed	O	O	B-T059
in	O	O	O
mature	O	O	O
seeds	O	O	B-T002
.	O	O	O

Furthermore	O	O	O
,	O	O	O
lipid	O	O	B-T109
and	O	O	O
fatty	O	O	B-T109
acids	O	O	I-T109
C16:0	O	O	B-T109
and	O	O	O
C18:0	O	O	B-T109
significantly	O	O	O
increased	O	O	O
.	O	O	O

In	O	O	O
two	O	O	O
homozygous	O	O	B-T032
T2	O	O	B-T002
transgenic	O	O	B-T002
rice	O	O	B-T002
lines	O	O	I-T002
(	O	O	O
G5	O	O	B-T002
and	O	O	O
G2	O	O	B-T002
)	O	O	O
,	O	O	O
different	O	O	O
CoWRI1	O	O	B-T028
expression	O	O	B-T045
levels	O	O	O
were	O	O	O
detected	O	O	O
,	O	O	O
but	O	O	O
no	O	O	O
CoWRI1	O	O	O
transcripts	O	O	B-T114
were	O	O	O
detected	O	O	O
in	O	O	O
the	O	O	O
wild	O	O	B-T028
type	O	O	I-T028
.	O	O	O

Analyses	O	O	B-T062
of	O	O	O
the	O	O	O
seed	O	O	B-T002
oil	O	O	B-T109
content	O	O	O
,	O	O	O
starch	O	O	B-T109
content	O	O	O
,	O	O	O
and	O	O	O
total	O	O	O
protein	O	O	B-T116
content	O	O	O
indicated	O	O	O
that	O	O	O
the	O	O	O
two	O	O	O
T2	O	O	B-T002
transgenic	O	O	B-T002
lines	O	O	I-T002
showed	O	O	O
a	O	O	O
significant	O	O	O
increase	O	O	O
(	O	O	O
P	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
in	O	O	O
seed	O	O	O
oil	O	O	O
content	O	O	O
.	O	O	O

The	O	O	O
transgenic	O	O	B-T002
lines	O	O	I-T002
also	O	O	O
showed	O	O	O
a	O	O	O
significant	O	O	O
increase	O	O	O
in	O	O	O
starch	O	O	B-T109
content	O	O	O
,	O	O	O
whereas	O	O	O
total	O	O	O
protein	O	O	B-T116
content	O	O	O
decreased	O	O	O
significantly	O	O	O
.	O	O	O

Further	O	O	O
analysis	O	O	B-T062
of	O	O	O
the	O	O	O
fatty	O	O	B-T109
acid	O	O	I-T109
composition	O	O	O
revealed	O	O	O
that	O	O	O
palmitic	O	O	B-T109
acid	O	O	I-T109
(	O	O	O
C16:0	O	O	B-T109
)	O	O	O
and	O	O	O
linolenic	O	O	B-T109
acid	O	O	I-T109
(	O	O	O
C18:3	O	O	B-T109
)	O	O	O
increased	O	O	O
significantly	O	O	O
in	O	O	O
the	O	O	O
seeds	O	O	B-T002
of	O	O	O
the	O	O	O
transgenic	O	O	B-T002
rice	O	O	B-T002
lines	O	O	I-T002
,	O	O	O
but	O	O	O
oleic	O	O	B-T109
acid	O	O	I-T109
(	O	O	O
C18:1	O	O	B-T109
)	O	O	O
levels	O	O	O
significantly	O	O	O
declined	O	O	O
.	O	O	O

-DOCSTART- (28179929)

Tooth	O	O	B-T033
Discoloration	O	O	I-T033
Resulting	O	O	B-T169
from	O	O	O
a	O	O	O
Nano	O	O	B-T081
Zinc	O	O	B-T122
Oxide-Eugenol	O	O	I-T122
Sealer	O	O	O

A	O	O	O
desirable	O	O	O
quality	O	O	B-T080
of	O	O	O
any	O	O	O
endodontic	O	O	B-T122
sealer	O	O	I-T122
is	O	O	O
its	O	O	O
ability	O	O	O
to	O	O	O
be	O	O	O
tooth	O	O	B-T033
color	O	O	I-T033
friendly	O	O	B-T080
.	O	O	O

Therefore	O	O	O
the	O	O	O
aim	O	O	O
of	O	O	O
the	O	O	O
present	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
evaluate	O	O	O
the	O	O	O
tooth	O	O	B-T033
discoloration	O	O	I-T033
potential	O	O	B-T080
of	O	O	O
a	O	O	O
nano	O	O	B-T081
zinc	O	O	B-T122
oxide-eugenol	O	O	I-T122
(	O	O	O
NZOE	O	O	B-T122
)	O	O	O
sealer	O	O	B-T122
.	O	O	O

In	O	O	O
order	O	O	O
to	O	O	O
evaluate	O	O	O
tooth	O	O	B-T033
discoloration	O	O	I-T033
,	O	O	O
the	O	O	O
pulp	O	O	B-T030
chamber	O	O	I-T030
of	O	O	O
60	O	O	O
human	O	O	B-T016
maxillary	O	O	B-T023
central	O	O	I-T023
and	O	O	O
lateral	O	O	B-T023
incisors	O	O	I-T023
were	O	O	O
filled	O	O	B-T052
with	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
sealers	O	O	B-T122
,	O	O	O
naming	O	O	O
AH-26	O	O	B-T122
(	O	O	O
resin-based	O	O	B-T122
sealer	O	O	B-T122
)	O	O	O
,	O	O	O
Pulpdent	O	O	B-T122
sealer	O	O	O
(	O	O	O
ZOE	O	O	B-T122
-based	O	O	O
)	O	O	O
and	O	O	O
a	O	O	O
NZOE	O	O	B-T122
experimental	O	O	O
sealer	O	O	O
.	O	O	O

Color	O	O	B-T080
measurements	O	O	B-T169
was	O	O	O
assessed	O	O	O
at	O	O	O
the	O	O	O
baseline	O	O	B-T081
(	O	O	O
before	O	O	B-T080
placement	O	O	I-T080
of	O	O	O
sealers	O	O	B-T122
)	O	O	O
(	O	O	O
T0	O	O	O
)	O	O	O
,	O	O	O
24	O	O	O
h	O	O	B-T079
(	O	O	O
T1	O	O	O
)	O	O	O
and	O	O	O
72	O	O	O
h	O	O	O
(	O	O	O
T2	O	O	O
)	O	O	O
h	O	O	O
,	O	O	O
1-	O	O	O
week	O	O	B-T079
(	O	O	O
T3	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
1-	O	O	O
month	O	O	B-T079
(	O	O	O
T4	O	O	O
)	O	O	O
after	O	O	O
the	O	O	O
placement	O	O	O
of	O	O	O
sealers	O	O	O
using	O	O	O
the	O	O	O
Easy	O	O	B-T074
Shade	O	O	I-T074
spectrophotometer	O	O	I-T074
.	O	O	O

Data	O	O	B-T078
were	O	O	O
analyzed	O	O	B-T062
in	O	O	O
SPSS	O	O	B-T073
software	O	O	I-T073
using	O	O	O
one-way	O	O	B-T081
ANOVA	O	O	B-T081
,	O	O	O
and	O	O	O
repeated	O	O	O
measured	O	O	O
ANOVA	O	O	O
.	O	O	O

No	O	O	O
significant	O	O	O
differences	O	O	O
were	O	O	O
observed	O	O	B-T169
when	O	O	O
the	O	O	O
paired	O	O	B-T170
comparison	O	O	I-T170
test	O	O	I-T170
was	O	O	O
performed	O	O	O
(	O	O	O
P>0.05	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
tested	O	O	O
NZOE	O	O	B-T122
sealer	O	O	B-T122
had	O	O	O
similar	O	O	O
tooth	O	O	B-T033
discoloration	O	O	I-T033
potential	O	O	B-T080
in	O	O	O
comparison	O	O	B-T052
with	O	O	O
AH-26	O	O	B-T122
and	O	O	O
ZOE	O	O	B-T122
sealer	O	O	O
.	O	O	O

-DOCSTART- (28183116)

On	O	O	O
the	O	O	O
identity	O	O	B-T078
of	O	O	O
the	O	O	O
Palearctic	O	O	B-UnknownType
species	O	O	B-T185
of	O	O	O
the	O	O	O
wolf	O	O	B-T204
spider	O	O	I-T204
genus	O	O	B-T185
<	O	O	O
i	O	O	O
>	O	O	O
Trebacosa	O	O	B-T204
<	O	O	O
/i>(Araneae	O	O	O
:	O	O	O
Lycosidae	O	O	B-T204
)	O	O	O

In	O	O	O
this	O	O	O
paper	O	O	B-T170
we	O	O	O
propose	O	O	O
Trebacosa	O	O	B-T204
brunhesi	O	O	I-T204
Villepoux	O	O	O
,	O	O	O
2007	O	O	O
as	O	O	O
a	O	O	O
junior	O	O	O
synonym	O	O	B-T077
of	O	O	O
Trebacosa	O	O	B-T204
europaea	O	O	I-T204
SzinetÃ¡r	O	O	O
&	O	O	O
Kan-csal	O	O	O
,	O	O	O
2007	O	O	O
based	O	O	O
on	O	O	O
the	O	O	O
examination	O	O	B-T169
of	O	O	O
specimens	O	O	B-T167
from	O	O	O
all	O	O	O
the	O	O	O
localities	O	O	B-T083
from	O	O	O
where	O	O	O
those	O	O	O
species	O	O	B-T185
are	O	O	O
known	O	O	O
.	O	O	O

Illustration	O	O	O
of	O	O	O
the	O	O	O
type	O	O	B-T080
species	O	O	B-T185
of	O	O	O
the	O	O	O
genus	O	O	B-T185
,	O	O	O
Trebacosa	O	O	B-T204
marxi	O	O	I-T204
(	O	O	O
Stone	O	O	O
,	O	O	O
1890	O	O	O
)	O	O	O
and	O	O	O
specimens	O	O	B-T167
from	O	O	O
all	O	O	O
known	O	O	O
localities	O	O	B-T083
of	O	O	O
T.	O	O	B-T204
europaea	O	O	I-T204
are	O	O	O
given	O	O	O
to	O	O	O
show	O	O	O
both	O	O	O
the	O	O	O
inter-	O	O	B-T080
and	O	O	O
the	O	O	O
intraspecific	O	O	B-T080
differences	O	O	I-T080
of	O	O	O
the	O	O	O
genus	O	O	O
.	O	O	O

Scanning	O	O	B-T059
electron	O	O	I-T059
micrographs	O	O	I-T059
were	O	O	O
used	O	O	O
to	O	O	O
illustrate	O	O	O
the	O	O	O
detailed	O	O	O
structure	O	O	B-T082
of	O	O	O
the	O	O	O
female	O	O	B-T023
's	O	O	I-T023
genitalia	O	O	I-T023
.	O	O	O

-DOCSTART- (28183596)

A	O	O	O
numerical	O	O	B-T081
study	O	O	B-T062
on	O	O	O
the	O	O	O
application	O	O	O
of	O	O	O
the	O	O	O
functionally	O	O	B-T073
graded	O	O	I-T073
materials	O	O	I-T073
in	O	O	O
the	O	O	O
stent	O	O	B-T074
design	O	O	O

Undesirable	O	O	B-T080
deformation	O	O	B-T080
of	O	O	O
the	O	O	O
stent	O	O	B-T074
can	O	O	O
induce	O	O	O
a	O	O	O
significant	O	O	B-T037
amount	O	O	O
of	O	O	O
injure	O	O	B-T037
not	O	O	O
only	O	O	O
to	O	O	O
the	O	O	O
blood	O	O	B-T023
vessel	O	O	I-T023
but	O	O	O
also	O	O	O
to	O	O	O
the	O	O	O
plaque	O	O	B-T033
.	O	O	O

The	O	O	O
objective	O	O	O
of	O	O	O
this	O	O	O
study	O	O	O
was	O	O	O
to	O	O	O
reduce/minimize	O	O	B-T033
these	O	O	O
undesirable	O	O	B-T080
deformations	O	O	B-T080
by	O	O	O
the	O	O	O
application	O	O	O
of	O	O	O
Functionally	O	O	B-T073
Graded	O	O	I-T073
Materials	O	O	I-T073
(	O	O	O
FGM	O	O	B-T073
)	O	O	O
.	O	O	O

To	O	O	O
do	O	O	O
this	O	O	O
,	O	O	O
Finite	O	O	B-T170
Element	O	O	I-T170
(	O	O	I-T170
FE	O	O	I-T170
)	O	O	I-T170
method	O	O	I-T170
was	O	O	O
employed	O	O	B-T033
to	O	O	O
simulate	O	O	B-T062
the	O	O	O
expansion	O	O	B-T169
of	O	O	O
a	O	O	O
stent	O	O	B-T074
and	O	O	O
the	O	O	O
corresponding	O	O	O
displacement	O	O	B-T067
of	O	O	O
the	O	O	O
stenosis	O	O	B-T046
plaque	O	O	B-T033
.	O	O	O

Three	O	O	O
hyperelastic	O	O	B-T073
plaque	O	O	B-T033
types	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
five	O	O	O
elastoplastic	O	O	B-T074
stents	O	O	I-T074
were	O	O	O
simulated	O	O	O
.	O	O	O

Dogboning	O	O	B-T169
,	O	O	O
foreshortening	O	O	B-T033
,	O	O	O
maximum	O	O	B-T081
stress	O	O	B-T033
in	O	O	O
the	O	O	O
plaque	O	O	B-T033
,	O	O	O
and	O	O	O
the	O	O	O
pressure	O	O	B-T067
which	O	O	O
is	O	O	O
needed	O	O	O
to	O	O	O
fully	O	O	O
expand	O	O	B-T082
the	O	O	O
stent	O	O	B-T074
for	O	O	O
different	O	O	O
stent	O	O	O
materials	O	O	B-T167
,	O	O	O
were	O	O	O
acquired	O	O	O
.	O	O	O

While	O	O	O
all	O	O	O
FGMs	O	O	B-T073
had	O	O	O
lower	O	O	B-T080
dogboning	O	O	B-T169
in	O	O	O
comparison	O	O	O
to	O	O	O
the	O	O	O
stents	O	O	B-T074
made	O	O	O
of	O	O	O
the	O	O	O
uniform	O	O	B-T080
materials	O	O	B-T167
,	O	O	O
the	O	O	O
stent	O	O	B-T074
with	O	O	O
the	O	O	O
lowest	O	O	B-T080
heterogeneous	O	O	B-T170
index	O	O	I-T170
displayed	O	O	O
the	O	O	O
lowest	O	O	O
amount	O	O	O
of	O	O	O
dogboning	O	O	O
.	O	O	O

Steel	O	O	B-T122
stent	O	O	B-T074
showed	O	O	O
the	O	O	O
lowest	O	O	B-T080
foreshortening	O	O	B-T033
and	O	O	O
fully	O	O	O
expansion	O	O	B-T081
pressure	O	O	I-T081
but	O	O	O
the	O	O	O
difference	O	O	B-T081
was	O	O	O
much	O	O	O
lower	O	O	B-T080
than	O	O	O
that	O	O	O
the	O	O	O
one	O	O	O
for	O	O	O
dogboning	O	O	B-T169
.	O	O	O

Therefore	O	O	O
,	O	O	O
the	O	O	O
FGM	O	O	B-T073
with	O	O	O
the	O	O	O
heterogeneous	O	O	B-T170
index	O	O	I-T170
of	O	O	O
0.5	O	O	O
is	O	O	O
expected	O	O	O
to	O	O	O
exhibit	O	O	O
the	O	O	O
most	O	O	O
suitable	O	O	B-T080
results	O	O	B-T169
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
the	O	O	O
results	O	O	B-T169
revealed	O	O	O
that	O	O	O
the	O	O	O
material	O	O	B-T167
parameters	O	O	B-T077
has	O	O	O
crucial	O	O	B-T080
effects	O	O	B-T080
on	O	O	O
the	O	O	O
deformation	O	O	B-T080
of	O	O	O
the	O	O	O
stent	O	O	B-T074
and	O	O	O
,	O	O	O
as	O	O	O
a	O	O	O
result	O	O	B-T169
,	O	O	O
as	O	O	O
a	O	O	O
design	O	O	B-T052
point	O	O	O
of	O	O	O
view	O	O	O
the	O	O	O
FGM	O	O	B-T073
parameters	O	O	O
can	O	O	O
be	O	O	O
tailored	O	O	O
to	O	O	O
achieve	O	O	O
the	O	O	O
goal	O	O	O
of	O	O	O
the	O	O	O
biomechanical	O	O	B-T081
optimization	O	O	B-T052
.	O	O	O

-DOCSTART- (28186384)

Women	O	O	B-T098
's	O	O	I-T098
perspectives	O	O	O
on	O	O	O
human	O	O	B-T005
papillomavirus	O	O	I-T005
self-sampling	O	O	B-T060
in	O	O	O
the	O	O	O
context	O	O	O
of	O	O	O
the	O	O	O
UK	O	O	B-T083
cervical	O	O	B-T023
screening	O	O	O
programme	O	O	O

Testing	O	O	B-T169
for	O	O	O
human	O	O	B-T005
papillomavirus	O	O	I-T005
(	O	O	O
HPV	O	O	B-T005
)	O	O	O
is	O	O	O
being	O	O	O
incorporated	O	O	O
into	O	O	O
the	O	O	O
cervical	O	O	B-T023
screening	O	O	B-T058
programme	O	O	I-T058
,	O	O	O
with	O	O	O
the	O	O	O
probable	O	O	O
future	O	O	O
introduction	O	O	O
of	O	O	O
HPV	O	O	O
as	O	O	O
a	O	O	O
primary	O	O	O
test	O	O	O
and	O	O	O
a	O	O	O
possibility	O	O	O
of	O	O	O
HPV	O	O	O
self-sampling	O	O	B-T060
.	O	O	O

In	O	O	O
anticipation	O	O	O
of	O	O	O
this	O	O	O
development	O	O	O
,	O	O	O
we	O	O	O
sought	O	O	O
to	O	O	O
inform	O	O	O
future	O	O	O
policy	O	O	B-T170
and	O	O	O
practice	O	O	B-T041
by	O	O	O
identifying	O	O	O
potential	O	O	B-T080
barriers	O	O	B-T033
to	O	O	O
HPV	O	O	B-T005
self-sampling	O	O	B-T060
.	O	O	O

A	O	O	O
cross-sectional	O	O	B-T062
survey	O	O	I-T062
of	O	O	O
194	O	O	O
women	O	O	B-T098
aged	O	O	O
20	O	O	O
-	O	O	O
64	O	O	O
years	O	O	O
was	O	O	O
conducted	O	O	O
.	O	O	O

Logistic	O	O	B-UnknownType
regression	O	O	I-UnknownType
analysis	O	O	I-UnknownType
was	O	O	O
used	O	O	O
to	O	O	O
identify	O	O	O
determinants	O	O	B-T169
of	O	O	O
self-sampling	O	O	B-T060
intentions	O	O	O
.	O	O	O

A	O	O	O
purposive	O	O	O
subsample	O	O	O
of	O	O	O
19	O	O	O
women	O	O	B-T098
who	O	O	O
reported	O	O	O
low	O	O	O
self-sampling	O	O	B-T060
intentions	O	O	O
were	O	O	O
interviewed	O	O	O
.	O	O	O

Interviews	O	O	B-T052
were	O	O	O
framework-analysed	O	O	O
.	O	O	O

Most	O	O	O
survey	O	O	B-T170
participants	O	O	B-T098
(	O	O	O
N=133	O	O	O
,	O	O	O
69.3	O	O	O
%	O	O	O
)	O	O	O
intended	O	O	O
to	O	O	O
HPV	O	O	B-T005
self-sample	O	O	O
.	O	O	O

Lower	O	O	B-T080
intention	O	O	B-T041
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
lower	O	O	B-T080
self-efficacy	O	O	O
(	O	O	O
OR=24.96	O	O	O
,	O	O	O
Pâ¤.001	O	O	O
)	O	O	O
,	O	O	O
lower	O	O	O
education	O	O	B-T065
(	O	O	O
OR=6.06	O	O	O
,	O	O	O
Pâ¤.05	O	O	O
)	O	O	O
and	O	O	O
lower	O	O	O
perceived	O	O	B-T041
importance	O	O	O
of	O	O	O
HPV	O	O	B-T005
as	O	O	O
a	O	O	O
cause	O	O	O
of	O	O	O
cervical	O	O	B-T191
cancer	O	O	I-T191
(	O	O	O
OR=2.33	O	O	O
,	O	O	O
Pâ¤.05	O	O	O
)	O	O	O
.	O	O	O

Interviews	O	O	B-T052
revealed	O	O	O
personal	O	O	B-T032
and	O	O	O
system-related	O	O	O
barriers	O	O	B-T033
.	O	O	O

Personal	O	O	B-T032
barriers	O	O	B-T033
included	O	O	O
a	O	O	O
lack	O	O	O
of	O	O	O
knowledge	O	O	B-T170
about	O	O	O
HPV	O	O	B-T005
self-sampling	O	O	B-T060
,	O	O	O
women	O	O	B-T098
's	O	O	I-T098
low	O	O	B-T033
confidence	O	O	I-T033
in	O	O	O
their	O	O	O
ability	O	O	O
to	O	O	O
self-sample	O	O	O
correctly	O	O	O
and	O	O	O
low	O	O	O
confidence	O	O	O
in	O	O	O
the	O	O	O
subsequent	O	O	O
results	O	O	O
.	O	O	O

System-related	O	O	O
factors	O	O	O
included	O	O	O
a	O	O	O
lack	O	O	B-T033
of	O	O	I-T033
confidence	O	O	I-T033
in	O	O	O
the	O	O	O
rationale	O	O	O
for	O	O	O
modifying	O	O	O
the	O	O	O
current	O	O	O
cervical	O	O	B-T023
screening	O	O	B-T058
programme	O	O	I-T058
,	O	O	O
and	O	O	O
concerns	O	O	O
about	O	O	O
sample	O	O	B-T167
contamination	O	O	B-T078
and	O	O	O
identity	O	O	B-T054
theft	O	O	I-T054
.	O	O	O

Insights	O	O	O
gained	O	O	O
from	O	O	O
this	O	O	O
research	O	O	B-T062
can	O	O	O
be	O	O	O
used	O	O	O
to	O	O	O
guide	O	O	O
further	O	O	O
enquiry	O	O	O
into	O	O	O
the	O	O	O
possibility	O	O	O
of	O	O	O
HPV	O	O	B-T005
self-sampling	O	O	B-T060
and	O	O	O
to	O	O	O
help	O	O	O
inform	O	O	O
future	O	O	O
policy	O	O	B-T170
and	O	O	O
practice	O	O	B-T041
.	O	O	O

Personal	O	O	B-T032
and	O	O	O
system-related	O	O	B-T033
barriers	O	O	I-T033
including	O	O	O
low	O	O	B-T033
confidence	O	O	I-T033
in	O	O	O
the	O	O	O
reasons	O	O	O
for	O	O	O
changing	O	O	O
current	O	O	O
cervical	O	O	B-T023
screening	O	O	B-T058
provision	O	O	O
need	O	O	O
to	O	O	O
be	O	O	O
addressed	O	O	O
,	O	O	O
should	O	O	O
HPV	O	O	B-T005
self-sampling	O	O	B-T060
be	O	O	O
incorporated	O	O	O
into	O	O	O
the	O	O	O
cervical	O	O	O
screening	O	O	B-T058
programme	O	O	I-T058
.	O	O	O

-DOCSTART- (28186729)

N-Terminal	O	O	B-T087
Hypothesis	O	O	B-T078
for	O	O	O
Alzheimer	O	O	O
's	O	O	O
Disease	O	O	O

Although	O	O	O
the	O	O	O
amyloid	O	O	B-T116
(	O	O	O
abeta	O	O	B-T116
peptide	O	O	I-T116
,	O	O	O
AÎ²	O	O	B-T116
)	O	O	O
hypothesis	O	O	B-T078
is	O	O	O
25	O	O	O
years	O	O	B-T079
old	O	O	O
,	O	O	O
is	O	O	O
the	O	O	O
dominant	O	O	B-T169
model	O	O	B-T170
of	O	O	O
Alzheimer	O	O	B-T047
's	O	O	I-T047
disease	O	O	I-T047
(	O	O	O
AD	O	O	B-T047
)	O	O	O
pathogenesis	O	O	B-T046
,	O	O	O
and	O	O	O
guides	O	O	O
the	O	O	O
development	O	O	B-T169
of	O	O	O
potential	O	O	O
treatments	O	O	B-T061
,	O	O	O
it	O	O	O
is	O	O	O
still	O	O	O
controversial	O	O	B-T054
.	O	O	O

One	O	O	O
possible	O	O	O
reason	O	O	O
is	O	O	O
a	O	O	O
lack	O	O	B-T080
of	O	O	O
a	O	O	O
mechanistic	O	O	B-T169
path	O	O	I-T169
from	O	O	O
the	O	O	O
cleavage	O	O	B-T167
products	O	O	I-T167
of	O	O	O
the	O	O	O
amyloid	O	O	B-T116
precursor	O	O	I-T116
protein	O	O	I-T116
(	O	O	O
APP	O	O	B-T116
)	O	O	O
such	O	O	O
as	O	O	O
soluble	O	O	B-T080
AÎ²	O	O	B-T116
monomer	O	O	I-T116
and	O	O	O
soluble	O	O	O
molecular	O	O	B-T080
fragments	O	O	B-T169
to	O	O	O
the	O	O	O
deleterious	O	O	B-T080
effects	O	O	I-T080
on	O	O	O
synaptic	O	O	B-T042
form	O	O	I-T042
and	O	O	O
function	O	O	B-T169
.	O	O	O

From	O	O	O
a	O	O	O
review	O	O	B-T169
of	O	O	I-T169
the	O	O	O
recent	O	O	O
literature	O	O	B-T170
and	O	O	O
our	O	O	O
own	O	O	O
published	O	O	B-T073
work	O	O	I-T073
including	O	O	O
aggregation	O	O	B-T070
kinetics	O	O	I-T070
and	O	O	O
structural	O	O	B-T082
morphology	O	O	B-T080
,	O	O	O
AÎ²	O	O	B-T116
clearance	O	O	B-T080
,	O	O	O
molecular	O	O	B-T080
simulations	O	O	B-T062
,	O	O	O
long-term	O	O	B-T042
potentiation	O	O	I-T042
measurements	O	O	B-T169
with	O	O	O
inhibition	O	O	B-T044
binding	O	O	B-T044
,	O	O	O
and	O	O	O
the	O	O	O
binding	O	O	O
of	O	O	O
a	O	O	O
commercial	O	O	O
monoclonal	O	O	B-T116
antibody	O	O	I-T116
,	O	O	O
aducanumab	O	O	B-T129
,	O	O	O
we	O	O	O
hypothesize	O	O	B-T078
that	O	O	O
the	O	O	O
N-terminal	O	O	B-T087
domains	O	O	I-T087
of	O	O	O
neurotoxic	O	O	B-T131
AÎ²	O	O	B-T116
oligomers	O	O	I-T116
are	O	O	O
implicated	O	O	O
in	O	O	O
causing	O	O	B-T169
the	O	O	O
disease	O	O	B-T047
.	O	O	O

-DOCSTART- (28188533)

Generation	O	O	B-T052
of	O	O	O
High-Quality	O	O	B-T080
SWATH	O	O	B-T170
(	O	O	I-T170
Â®	O	O	I-T170
)	O	O	I-T170
Acquisition	O	O	B-T052
Data	O	O	B-T078
for	O	O	O
Label-free	O	O	B-T033
Quantitative	O	O	B-T081
Proteomics	O	O	B-T091
Studies	O	O	I-T091
Using	O	O	O
TripleTOF	O	O	O
(	O	O	O
Â®	O	O	O
)	O	O	O
Mass	O	O	O
Spectrometers	O	O	O

Data	O	O	B-T078
-	O	O	O
independent	O	O	B-T169
acquisition	O	O	B-T052
is	O	O	O
a	O	O	O
powerful	O	O	O
mass	O	O	B-T059
spectrometry	O	O	I-T059
technique	O	O	I-T059
that	O	O	O
enables	O	O	O
comprehensive	O	O	O
MS	O	O	B-T059
and	O	O	O
MS/MS	O	O	B-T063
analysis	O	O	B-T062
of	O	O	O
all	O	O	O
detectable	O	O	B-T201
species	O	O	B-T071
,	O	O	O
providing	O	O	O
an	O	O	O
information	O	O	B-T078
rich	O	O	O
data	O	O	B-T078
file	O	O	O
that	O	O	O
can	O	O	O
be	O	O	O
mined	O	O	B-T066
deeply	O	O	O
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
describe	O	O	O
how	O	O	O
to	O	O	O
acquire	O	O	B-T052
high-quality	O	O	B-T080
SWATH	O	O	B-T170
(	O	O	I-T170
Â®	O	O	I-T170
)	O	O	I-T170
Acquisition	O	O	B-T052
data	O	O	B-T078
to	O	O	O
be	O	O	O
used	O	O	O
for	O	O	O
large	O	O	B-T081
quantitative	O	O	B-T081
proteomic	O	O	B-T091
studies	O	O	I-T091
.	O	O	O

We	O	O	O
specifically	O	O	O
focus	O	O	O
on	O	O	O
using	O	O	O
variable	O	O	B-T080
sized	O	O	B-T082
Q1	O	O	B-T170
windows	O	O	I-T170
for	O	O	O
acquisition	O	O	B-T052
of	O	O	O
MS/MS	O	O	B-T063
data	O	O	B-T078
for	O	O	O
generating	O	O	B-T052
higher	O	O	O
specificity	O	O	B-T081
quantitative	O	O	B-T081
data	O	O	O
.	O	O	O

-DOCSTART- (28192171)

A	O	O	O
new	O	O	O
light	O	O	O
on	O	O	O
Alkaptonuria	O	O	B-T047
:	O	O	O
A	O	O	O
Fourier-transform	O	O	B-T059
infrared	O	O	I-T059
microscopy	O	O	I-T059
(	O	O	O
FTIRM	O	O	B-T059
)	O	O	O
and	O	O	O
low	O	O	B-T059
energy	O	O	I-T059
X-ray	O	O	I-T059
fluorescence	O	O	I-T059
microscopy	O	O	I-T059
(	O	O	O
LEXRF	O	O	B-T059
)	O	O	O
correlative	O	O	B-T062
study	O	O	I-T062
on	O	O	O
a	O	O	O
rare	O	O	O
disease	O	O	O

Alkaptonuria	O	O	B-T047
(	O	O	O
AKU	O	O	B-T047
)	O	O	O
is	O	O	O
an	O	O	O
ultra-rare	O	O	B-T047
disease	O	O	I-T047
associated	O	O	B-T080
to	O	O	O
the	O	O	O
lack	O	O	B-T080
of	O	O	O
an	O	O	O
enzyme	O	O	B-T116
involved	O	O	O
in	O	O	O
tyrosine	O	O	B-T044
catabolism	O	O	I-T044
.	O	O	O

This	O	O	O
deficiency	O	O	B-T169
results	O	O	O
in	O	O	O
the	O	O	O
accumulation	O	O	B-T033
of	O	O	O
homogentisic	O	O	B-T109
acid	O	O	I-T109
(	O	O	O
HGA	O	O	B-T109
)	O	O	O
in	O	O	O
the	O	O	O
form	O	O	O
of	O	O	O
ochronotic	O	O	B-UnknownType
pigment	O	O	I-UnknownType
in	O	O	O
joint	O	O	B-T030
cartilage	O	O	B-T024
,	O	O	O
leading	O	O	O
to	O	O	O
a	O	O	O
severe	O	O	B-T080
arthropathy	O	O	B-T047
.	O	O	O

Secondary	O	O	B-T047
amyloidosis	O	O	I-T047
has	O	O	O
been	O	O	O
also	O	O	O
unequivocally	O	O	B-T080
assessed	O	O	B-T052
as	O	O	O
a	O	O	O
comorbidity	O	O	B-T078
of	O	O	O
AKU	O	O	B-T047
arthropathy	O	O	B-T047
.	O	O	O

Composition	O	O	O
of	O	O	O
ochronotic	O	O	B-UnknownType
pigment	O	O	I-UnknownType
and	O	O	O
how	O	O	O
it	O	O	O
is	O	O	O
structurally	O	O	B-T082
related	O	O	O
to	O	O	O
amyloid	O	O	B-T116
is	O	O	O
still	O	O	O
unknown	O	O	O
.	O	O	O

We	O	O	O
exploited	O	O	O
Synchrotron	O	O	B-T067
Radiation	O	O	I-T067
Infrared	O	O	B-T059
and	O	O	O
X-Ray	O	O	B-T059
Fluorescence	O	O	I-T059
microscopies	O	O	I-T059
in	O	O	O
combination	O	O	O
with	O	O	O
conventional	O	O	O
bio-assays	O	O	B-T059
and	O	O	O
analytical	O	O	B-T062
tools	O	O	O
to	O	O	O
characterize	O	O	O
chemical	O	O	B-T070
composition	O	O	I-T070
and	O	O	O
morphology	O	O	B-T080
of	O	O	O
AKU	O	O	B-T047
cartilage	O	O	B-T024
.	O	O	O

We	O	O	O
evinced	O	O	B-T169
that	O	O	O
AKU	O	O	B-T047
cartilage	O	O	B-T024
is	O	O	O
characterized	O	O	O
by	O	O	O
proteoglycans	O	O	B-T116
depletion	O	O	B-T169
,	O	O	O
increased	O	O	B-T033
Sodium	O	O	I-T033
levels	O	O	I-T033
,	O	O	O
accumulation	O	O	B-T033
of	O	O	O
lipids	O	O	B-T109
in	O	O	O
the	O	O	O
peri-lacunar	O	O	B-T030
regions	O	O	I-T030
and	O	O	O
amyloid	O	O	B-T116
formation	O	O	B-T169
.	O	O	O

We	O	O	O
also	O	O	O
highlighted	O	O	O
an	O	O	O
increase	O	O	B-T169
of	O	O	O
aromatic	O	O	B-T109
compounds	O	O	I-T109
and	O	O	O
oxygen-containing	O	O	B-T197
species	O	O	I-T197
,	O	O	O
depletion	O	O	B-T169
in	O	O	O
overall	O	O	O
Magnesium	O	O	B-T123
content	O	O	B-T081
(	O	O	O
although	O	O	O
localized	O	O	B-T082
in	O	O	O
the	O	O	O
peri-lacunar	O	O	B-T030
region	O	O	I-T030
)	O	O	O
and	O	O	O
the	O	O	O
presence	O	O	B-T033
of	O	O	O
calcium	O	O	B-T121
carbonate	O	O	I-T121
fragments	O	O	O
in	O	O	O
proximity	O	O	B-T082
of	O	O	O
cartilage	O	O	B-T030
lacunae	O	O	I-T030
.	O	O	O

We	O	O	O
highlighted	O	O	O
common	O	O	B-T081
features	O	O	O
between	O	O	O
AKU	O	O	B-T047
and	O	O	O
arthropathy	O	O	B-T047
,	O	O	O
but	O	O	O
also	O	O	O
specific	O	O	O
signatures	O	O	O
of	O	O	O
the	O	O	O
disease	O	O	B-T047
,	O	O	O
like	O	O	O
presence	O	O	B-T033
of	O	O	O
amyloids	O	O	B-T116
and	O	O	O
peculiar	O	O	B-T033
calcifications	O	O	B-T042
.	O	O	O

Our	O	O	O
analyses	O	O	B-T062
provide	O	O	O
a	O	O	O
unified	O	O	O
picture	O	O	O
of	O	O	O
AKU	O	O	B-T047
cartilage	O	O	B-T024
,	O	O	O
shedding	O	O	O
a	O	O	O
new	O	O	B-T080
light	O	O	O
on	O	O	O
the	O	O	O
disease	O	O	B-T047
and	O	O	O
opening	O	O	O
new	O	O	O
perspectives	O	O	O
.	O	O	O

Ochronotic	O	O	B-UnknownType
pigment	O	O	I-UnknownType
is	O	O	O
a	O	O	O
hallmark	O	O	O
of	O	O	O
AKU	O	O	B-T047
and	O	O	O
responsible	O	O	O
of	O	O	O
tissue	O	O	B-T042
degeneration	O	O	I-T042
.	O	O	O

Conventional	O	O	O
bio-assays	O	O	B-T059
have	O	O	O
not	O	O	O
yet	O	O	O
clarified	O	O	O
its	O	O	O
composition	O	O	B-T070
and	O	O	O
its	O	O	O
structural	O	O	B-T082
relationship	O	O	B-T080
with	O	O	O
amyloids	O	O	B-T116
.	O	O	O

The	O	O	O
present	O	O	B-T079
work	O	O	B-T062
proposes	O	O	O
new	O	O	O
strategies	O	O	O
for	O	O	O
filling	O	O	O
the	O	O	O
aforementioned	O	O	O
gap	O	O	O
that	O	O	O
encompass	O	O	O
the	O	O	O
integration	O	O	B-T169
of	O	O	O
new	O	O	O
analytical	O	O	B-T062
approaches	O	O	O
with	O	O	O
standardized	O	O	B-T080
analyses	O	O	B-T062
.	O	O	O

-DOCSTART- (28193256)

Unbiased	O	O	B-T062
estimates	O	O	I-T062
of	O	O	O
cerebrospinal	O	O	B-T031
fluid	O	O	I-T031
Î²-amyloid	O	O	B-T116
1	O	O	I-T116
-	O	O	I-T116
42	O	O	I-T116
cutoffs	O	O	B-T169
in	O	O	O
a	O	O	O
large	O	O	O
memory	O	O	B-T093
clinic	O	O	I-T093
population	O	O	O

We	O	O	O
sought	O	O	O
to	O	O	O
define	O	O	O
a	O	O	O
cutoff	O	O	B-T169
for	O	O	O
Î²-amyloid	O	O	B-T116
1	O	O	I-T116
-	O	O	I-T116
42	O	O	I-T116
in	O	O	O
cerebrospinal	O	O	B-T031
fluid	O	O	I-T031
(	O	O	O
CSF	O	O	B-T031
)	O	O	O
,	O	O	O
a	O	O	O
key	O	O	O
marker	O	O	B-T201
for	O	O	O
Alzheimer	O	O	B-T047
's	O	O	I-T047
disease	O	O	I-T047
(	O	O	O
AD	O	O	B-T047
)	O	O	O
,	O	O	O
with	O	O	O
data-driven	O	O	B-T080
Gaussian	O	O	B-T081
mixture	O	O	I-T081
modeling	O	O	I-T081
in	O	O	O
a	O	O	O
memory	O	O	B-T093
clinic	O	O	I-T093
population	O	O	B-T098
.	O	O	O

We	O	O	O
performed	O	O	O
a	O	O	O
combined	O	O	O
cross-sectional	O	O	B-T062
and	O	O	O
prospective	O	O	B-T062
cohort	O	O	I-T062
study	O	O	I-T062
.	O	O	O

We	O	O	O
selected	O	O	O
2462	O	O	O
subjects	O	O	B-T098
with	O	O	O
subjective	O	O	B-T046
cognitive	O	O	I-T046
decline	O	O	I-T046
,	O	O	O
mild	O	O	B-T048
cognitive	O	O	I-T048
impairment	O	O	I-T048
,	O	O	O
AD	O	O	B-T047
-type	O	O	O
dementia	O	O	B-T048
,	O	O	O
and	O	O	O
dementia	O	O	O
other	O	O	O
than	O	O	O
AD	O	O	O
from	O	O	O
the	O	O	O
Amsterdam	O	O	B-UnknownType
Dementia	O	O	B-T048
Cohort	O	O	B-T098
.	O	O	O

We	O	O	O
defined	O	O	O
CSF	O	O	B-T031
Î²-amyloid	O	O	B-T116
1	O	O	I-T116
-	O	O	I-T116
42	O	O	I-T116
cutoffs	O	O	B-T169
by	O	O	O
data-driven	O	O	B-T080
Gaussian	O	O	B-T081
mixture	O	O	I-T081
modeling	O	O	I-T081
in	O	O	O
the	O	O	O
total	O	O	B-T081
population	O	O	I-T081
and	O	O	O
in	O	O	O
subgroups	O	O	B-T185
based	O	O	O
on	O	O	O
clinical	O	O	B-T060
diagnosis	O	O	I-T060
,	O	O	O
age	O	O	B-T032
,	O	O	O
and	O	O	O
apolipoprotein	O	O	B-T059
E	O	O	I-T059
(	O	O	I-T059
APOE	O	O	I-T059
)	O	O	I-T059
genotype	O	O	I-T059
.	O	O	O

We	O	O	O
investigated	O	O	B-T169
whether	O	O	O
abnormal	O	O	B-T033
Î²-amyloid	O	O	B-T116
1	O	O	I-T116
-	O	O	I-T116
42	O	O	I-T116
as	O	O	O
defined	O	O	O
by	O	O	O
the	O	O	O
data-driven	O	O	B-T080
cutoff	O	O	B-T169
could	O	O	O
better	O	O	O
predict	O	O	B-T078
progression	O	O	B-T169
to	O	O	O
AD	O	O	B-T047
-type	O	O	O
dementia	O	O	B-T048
than	O	O	O
abnormal	O	O	O
Î²-amyloid	O	O	O
1	O	O	O
-	O	O	O
42	O	O	O
defined	O	O	O
by	O	O	O
a	O	O	O
clinical	O	O	B-T060
diagnosis	O	O	I-T060
-based	O	O	O
cutoff	O	O	O
using	O	O	O
Cox	O	O	B-T081
proportional	O	O	I-T081
hazards	O	O	I-T081
regression	O	O	I-T081
.	O	O	O

In	O	O	O
the	O	O	O
total	O	O	O
group	O	O	B-T078
of	O	O	O
patients	O	O	B-T101
,	O	O	O
we	O	O	O
found	O	O	O
a	O	O	O
cutoff	O	O	B-T169
for	O	O	O
abnormal	O	O	B-T033
CSF	O	O	B-T031
Î²-amyloid	O	O	B-T116
1	O	O	I-T116
-	O	O	I-T116
42	O	O	I-T116
of	O	O	O
680	O	O	O
pg/ml	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
660	O	O	O
-	O	O	O
705	O	O	O
pg/ml	O	O	O
)	O	O	O
.	O	O	O

Similar	O	O	O
cutoffs	O	O	B-T169
were	O	O	O
found	O	O	O
within	O	O	O
diagnostic	O	O	B-T033
and	O	O	O
APOE	O	O	B-T059
genotype	O	O	I-T059
subgroups	O	O	B-T185
.	O	O	O

The	O	O	O
cutoff	O	O	B-T169
was	O	O	O
higher	O	O	B-T080
in	O	O	O
elderly	O	O	B-T098
subjects	O	O	B-T098
than	O	O	O
in	O	O	O
younger	O	O	O
subjects	O	O	O
.	O	O	O

The	O	O	O
data-driven	O	O	B-T080
cutoff	O	O	B-T169
was	O	O	O
higher	O	O	B-T080
than	O	O	O
our	O	O	O
clinical	O	O	B-T060
diagnosis	O	O	I-T060
-based	O	O	O
cutoff	O	O	O
and	O	O	O
had	O	O	O
a	O	O	O
better	O	O	O
predictive	O	O	B-T080
accuracy	O	O	B-T080
for	O	O	O
progression	O	O	B-T169
to	O	O	O
AD	O	O	B-T047
-type	O	O	O
dementia	O	O	B-T048
in	O	O	O
nondemented	O	O	O
subjects	O	O	B-T098
(	O	O	O
HR	O	O	B-T081
7.6	O	O	O
versus	O	O	O
5.2	O	O	O
,	O	O	O
p	O	O	B-T081
<	O	O	O
0.01	O	O	O
)	O	O	O
.	O	O	O

Mixture	O	O	B-T081
modeling	O	O	I-T081
is	O	O	O
a	O	O	O
robust	O	O	B-T080
method	O	O	B-T170
to	O	O	O
determine	O	O	O
cutoffs	O	O	B-T169
for	O	O	O
CSF	O	O	B-T031
Î²-amyloid	O	O	B-T116
1	O	O	I-T116
-	O	O	I-T116
42	O	O	I-T116
.	O	O	O

It	O	O	O
might	O	O	O
better	O	O	O
capture	O	O	O
biological	O	O	B-T080
changes	O	O	B-T169
that	O	O	O
are	O	O	O
related	O	O	O
to	O	O	O
AD	O	O	B-T047
than	O	O	O
cutoffs	O	O	B-T169
based	O	O	O
on	O	O	O
clinical	O	O	B-T060
diagnosis	O	O	I-T060
.	O	O	O

-DOCSTART- (28195652)

Identification	O	O	B-T080
of	O	O	O
the	O	O	O
anti-mycobacterial	O	O	B-T121
functional	O	O	B-T169
properties	O	O	B-T080
of	O	O	O
piperidinol	O	O	O
derivatives	O	O	O

Tuberculosis	O	O	B-T047
(	O	O	O
TB	O	O	B-T047
)	O	O	O
remains	O	O	O
a	O	O	O
major	O	O	O
global	O	O	B-T080
health	O	O	B-T078
threat	O	O	B-T078
and	O	O	O
is	O	O	O
now	O	O	O
the	O	O	O
leading	O	O	O
cause	O	O	B-T033
of	O	O	I-T033
death	O	O	I-T033
from	O	O	O
a	O	O	O
single	O	O	O
infectious	O	O	B-T001
agent	O	O	I-T001
worldwide	O	O	B-T080
.	O	O	O

The	O	O	O
current	O	O	O
TB	O	O	B-T047
drug	O	O	B-T121
regimen	O	O	B-T061
is	O	O	O
inadequate	O	O	B-T080
,	O	O	O
and	O	O	O
new	O	O	O
anti-tubercular	O	O	B-T121
agents	O	O	I-T121
are	O	O	O
urgently	O	O	O
required	O	O	O
to	O	O	O
be	O	O	O
able	O	O	O
to	O	O	O
successfully	O	O	O
combat	O	O	O
the	O	O	O
increasing	O	O	O
prevalence	O	O	B-T081
of	O	O	O
drug-resistant	O	O	B-T047
TB	O	O	I-T047
.	O	O	O

The	O	O	O
purpose	O	O	O
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
investigate	O	O	B-T169
a	O	O	O
piperidinol	O	O	B-T121
compound	O	O	I-T121
derivative	O	O	I-T121
that	O	O	O
is	O	O	O
highly	O	O	O
active	O	O	B-T169
against	O	O	O
the	O	O	O
Mycobacterium	O	O	B-T007
tuberculosis	O	O	I-T007
bacillus	O	O	B-T007
.	O	O	O

The	O	O	O
antibacterial	O	O	B-T195
properties	O	O	B-T080
of	O	O	O
the	O	O	O
piperidinol	O	O	B-T121
compound	O	O	I-T121
and	O	O	O
its	O	O	O
corresponding	O	O	O
bis-Mannich	O	O	B-T109
base	O	O	I-T109
analogue	O	O	B-T104
were	O	O	O
evaluated	O	O	B-T058
against	O	O	O
M.	O	O	B-T007
smegmatis	O	O	I-T007
and	O	O	O
Gram-negative	O	O	B-T007
organisms	O	O	I-T007
.	O	O	O

Cytotoxicity	O	O	B-T049
studies	O	O	B-T062
were	O	O	O
undertaken	O	O	O
in	O	O	O
order	O	O	O
to	O	O	O
determine	O	O	O
the	O	O	O
selectivity	O	O	B-T170
index	O	O	I-T170
for	O	O	O
these	O	O	O
compounds	O	O	B-T121
.	O	O	O

Spontaneous	O	O	O
resistant	O	O	B-T169
mutants	O	O	B-T049
of	O	O	O
M.	O	O	B-T007
smegmatis	O	O	I-T007
were	O	O	O
generated	O	O	O
against	O	O	O
the	O	O	O
piperidinol	O	O	B-T121
and	O	O	O
corresponding	O	O	O
bis-Mannich	O	O	B-T121
base	O	O	I-T121
lead	O	O	I-T121
derivatives	O	O	I-T121
and	O	O	O
whole	O	O	O
genome	O	O	B-T063
sequencing	O	O	I-T063
employed	O	O	O
to	O	O	O
determine	O	O	O
the	O	O	O
genetic	O	O	B-T063
modifications	O	O	I-T063
that	O	O	O
lead	O	O	O
to	O	O	O
selection	O	O	O
pressure	O	O	O
in	O	O	O
the	O	O	O
presence	O	O	O
of	O	O	O
these	O	O	O
compounds	O	O	B-T121
.	O	O	O

The	O	O	O
piperidinol	O	O	B-T121
and	O	O	O
the	O	O	O
bis-Mannich	O	O	B-T121
base	O	O	I-T121
analogue	O	O	I-T121
were	O	O	O
found	O	O	O
to	O	O	O
be	O	O	O
selective	O	O	O
for	O	O	O
mycobacteria	O	O	B-T007
and	O	O	O
rapidly	O	O	O
kill	O	O	O
this	O	O	O
organism	O	O	B-T001
with	O	O	O
a	O	O	O
cytotoxicity	O	O	B-T049
selectivity	O	O	B-T170
index	O	O	I-T170
for	O	O	O
mycobacteria	O	O	O
of	O	O	O
>	O	O	O
30-fold	O	O	O
.	O	O	O

Whole	O	O	O
genome	O	O	B-T063
sequencing	O	O	I-T063
of	O	O	O
M.	O	O	B-T007
smegmatis	O	O	I-T007
strains	O	O	B-T001
resistant	O	O	B-T169
to	O	O	O
the	O	O	O
lead	O	O	B-T121
compounds	O	O	I-T121
led	O	O	O
to	O	O	O
the	O	O	O
identification	O	O	B-T080
of	O	O	O
a	O	O	O
number	O	O	O
of	O	O	O
single	O	O	B-T086
nucleotide	O	O	I-T086
polymorphisms	O	O	I-T086
indicating	O	O	O
multiple	O	O	O
targets	O	O	O
.	O	O	O

Our	O	O	O
results	O	O	B-T033
indicate	O	O	O
that	O	O	O
the	O	O	O
piperidinol	O	O	B-T121
moiety	O	O	I-T121
represents	O	O	O
an	O	O	O
attractive	O	O	O
compound	O	O	B-T121
class	O	O	I-T121
in	O	O	O
the	O	O	O
pursuit	O	O	O
of	O	O	O
novel	O	O	O
anti-tubercular	O	O	B-T121
agents	O	O	I-T121
.	O	O	O

-DOCSTART- (28197133)

Metatranscriptomics	O	O	B-T059
Reveals	O	O	O
the	O	O	O
Active	O	O	O
Bacterial	O	O	B-T007
and	O	O	O
Eukaryotic	O	O	B-T007
Fibrolytic	O	O	I-T007
Communities	O	O	I-T007
in	O	O	O
the	O	O	O
Rumen	O	O	B-T023
of	O	O	O
Dairy	O	O	B-T015
Cow	O	O	I-T015
Fed	O	O	O
a	O	O	O
Mixed	O	O	B-T169
Diet	O	O	O

Ruminants	O	O	B-T015
have	O	O	O
a	O	O	O
unique	O	O	O
ability	O	O	O
to	O	O	O
derive	O	O	O
energy	O	O	B-T081
from	O	O	O
the	O	O	O
degradation	O	O	B-T169
of	O	O	O
plant	O	O	B-T002
polysaccharides	O	O	B-T109
through	O	O	O
the	O	O	O
activity	O	O	B-T052
of	O	O	O
the	O	O	O
rumen	O	O	B-T023
microbiota	O	O	B-T002
.	O	O	O

Although	O	O	O
this	O	O	O
process	O	O	B-T067
is	O	O	O
well	O	O	O
studied	O	O	O
in	O	O	B-T080
vitro	O	O	I-T080
,	O	O	O
knowledge	O	O	O
gaps	O	O	O
remain	O	O	O
regarding	O	O	O
the	O	O	O
relative	O	O	O
contribution	O	O	O
of	O	O	O
the	O	O	O
microbiota	O	O	B-T002
members	O	O	I-T002
and	O	O	O
enzymes	O	O	B-T116
in	O	O	B-T082
vivo	O	O	I-T082
.	O	O	O

The	O	O	O
present	O	O	O
study	O	O	O
used	O	O	O
RNA-sequencing	O	O	B-T059
to	O	O	O
reveal	O	O	O
both	O	O	O
the	O	O	O
expression	O	O	B-T045
of	O	O	O
genes	O	O	B-T028
encoding	O	O	O
carbohydrate-active	O	O	B-T116
enzymes	O	O	I-T116
(	O	O	O
CAZymes	O	O	B-T116
)	O	O	O
by	O	O	O
the	O	O	O
rumen	O	O	B-T023
microbiota	O	O	B-T002
of	O	O	O
a	O	O	O
lactating	O	O	B-T015
dairy	O	O	I-T015
cow	O	O	I-T015
and	O	O	O
the	O	O	O
microorganisms	O	O	B-T001
forming	O	O	O
the	O	O	O
fiber	O	O	B-T002
-degrading	O	O	O
community	O	O	B-T096
.	O	O	O

Functional	O	O	B-T062
analysis	O	O	I-T062
identified	O	O	O
12,237	O	O	O
CAZymes	O	O	B-T116
,	O	O	O
accounting	O	O	O
for	O	O	O
1	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
transcripts	O	O	B-T114
.	O	O	O

The	O	O	O
CAZyme	O	O	B-T116
profile	O	O	O
was	O	O	O
dominated	O	O	O
by	O	O	O
families	O	O	O
GH94	O	O	B-T116
(	O	O	O
cellobiose-phosphorylase	O	O	B-T116
)	O	O	O
,	O	O	O
GH13	O	O	B-T116
(	O	O	O
amylase	O	O	B-T116
)	O	O	O
,	O	O	O
GH43	O	O	B-T116
and	O	O	O
GH10	O	O	B-T116
(	O	O	O
hemicellulases	O	O	B-T116
)	O	O	O
,	O	O	O
GH9	O	O	B-T116
and	O	O	O
GH48	O	O	B-T116
(	O	O	O
cellulases	O	O	B-T116
)	O	O	O
,	O	O	O
PL11	O	O	B-T116
(	O	O	O
pectinase	O	O	B-T116
)	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
GH2	O	O	B-T116
and	O	O	O
GH3	O	O	B-T116
(	O	O	O
oligosaccharidases	O	O	B-T116
)	O	O	O
.	O	O	O

Our	O	O	O
data	O	O	O
support	O	O	O
the	O	O	O
pivotal	O	O	O
role	O	O	O
of	O	O	O
the	O	O	O
most	O	O	O
characterized	O	O	O
fibrolytic	O	O	B-T007
bacteria	O	O	I-T007
(	O	O	O
Prevotella	O	O	B-T007
,	O	O	O
Ruminocccus	O	O	B-T007
and	O	O	O
Fibrobacter	O	O	B-T007
)	O	O	O
,	O	O	O
and	O	O	O
highlight	O	O	O
a	O	O	O
substantial	O	O	O
,	O	O	O
although	O	O	O
most	O	O	O
probably	O	O	O
underestimated	O	O	O
,	O	O	O
contribution	O	O	B-T052
of	O	O	O
fungi	O	O	B-T004
and	O	O	O
ciliate	O	O	B-T204
protozoa	O	O	I-T204
to	O	O	O
polysaccharide	O	O	B-T109
degradation	O	O	B-T169
.	O	O	O

Particularly	O	O	O
these	O	O	O
results	O	O	O
may	O	O	O
motivate	O	O	O
further	O	O	O
exploration	O	O	O
of	O	O	O
the	O	O	O
role	O	O	O
and	O	O	O
the	O	O	O
functions	O	O	O
of	O	O	O
protozoa	O	O	B-T204
in	O	O	O
the	O	O	O
rumen	O	O	B-T023
.	O	O	O

Moreover	O	O	O
,	O	O	O
an	O	O	O
important	O	O	O
part	O	O	O
of	O	O	O
the	O	O	O
fibrolytic	O	O	B-T007
bacterial	O	O	I-T007
community	O	O	I-T007
remains	O	O	O
to	O	O	O
be	O	O	O
characterized	O	O	O
since	O	O	O
one	O	O	O
third	O	O	O
of	O	O	O
the	O	O	O
CAZyme	O	O	B-T116
transcripts	O	O	B-T114
originated	O	O	O
from	O	O	O
distantly	O	O	O
related	O	O	O
strains	O	O	B-T007
.	O	O	O

These	O	O	O
findings	O	O	O
are	O	O	O
used	O	O	O
to	O	O	O
highlight	O	O	O
limitations	O	O	O
of	O	O	O
current	O	O	O
metatranscriptomics	O	O	B-T059
approaches	O	O	O
to	O	O	O
understand	O	O	O
the	O	O	O
functional	O	O	O
rumen	O	O	B-T023
microbial	O	O	B-T001
community	O	O	I-T001
and	O	O	O
opportunities	O	O	O
to	O	O	O
circumvent	O	O	O
them	O	O	O
.	O	O	O

-DOCSTART- (28197156)

Fine	O	O	B-T052
Mapping	O	O	I-T052
of	O	O	O
Carbon	O	O	B-T028
Assimilation	O	O	I-T028
Rate	O	O	I-T028
8	O	O	I-T028
,	O	O	O
a	O	O	O
Quantitative	O	O	B-T028
Trait	O	O	I-T028
Locus	O	O	I-T028
for	O	O	O
Flag	O	O	B-T002
Leaf	O	O	I-T002
Nitrogen	O	O	B-T123
Content	O	O	B-T077
,	O	O	O
Stomatal	O	O	B-T002
Conductance	O	O	B-T081
and	O	O	O
Photosynthesis	O	O	B-T070
in	O	O	O
Rice	O	O	O

Increasing	O	O	B-T169
the	O	O	O
rate	O	O	B-T081
of	O	O	O
leaf	O	O	B-T070
photosynthesis	O	O	I-T070
is	O	O	O
one	O	O	O
important	O	O	O
approach	O	O	O
for	O	O	O
increasing	O	O	O
grain	O	O	B-T081
yield	O	O	I-T081
in	O	O	O
rice	O	O	B-T002
(	O	O	O
Oryza	O	O	B-T002
sativa	O	O	I-T002
)	O	O	O
.	O	O	O

Exploiting	O	O	O
the	O	O	O
natural	O	O	O
variation	O	O	B-T080
in	O	O	O
CO2	O	O	B-T081
assimilation	O	O	I-T081
rate	O	O	I-T081
(	O	O	O
A	O	O	O
)	O	O	O
between	O	O	O
rice	O	O	B-T002
cultivars	O	O	I-T002
using	O	O	O
quantitative	O	O	B-T090
genetics	O	O	I-T090
is	O	O	O
one	O	O	O
promising	O	O	O
means	O	O	O
to	O	O	O
identify	O	O	O
genes	O	O	B-T028
contributing	O	O	O
to	O	O	O
higher	O	O	O
photosynthesis	O	O	B-T070
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	O
,	O	O	O
we	O	O	O
determined	O	O	O
precise	O	O	O
location	O	O	B-T082
of	O	O	O
Carbon	O	O	B-T028
Assimilation	O	O	I-T028
Rate	O	O	I-T028
8	O	O	I-T028
(	O	O	O
CAR8	O	O	B-T028
)	O	O	O
by	O	O	O
crossing	O	O	B-T045
a	O	O	O
high-yielding	O	O	O
indica	O	O	B-T002
cultivar	O	O	B-T002
with	O	O	O
a	O	O	O
Japanese	O	O	B-T083
commercial	O	O	B-T170
cultivar	O	O	O
.	O	O	O

Fine	O	O	B-T052
mapping	O	O	I-T052
suggested	O	O	O
that	O	O	O
CAR8	O	O	B-T028
encodes	O	O	B-T052
a	O	O	O
putative	O	O	B-T116
Heme	O	O	I-T116
Activator	O	O	I-T116
Protein	O	O	I-T116
3	O	O	I-T116
(	O	O	O
OsHAP3	O	O	B-T116
)	O	O	O
subunit	O	O	O
of	O	O	O
a	O	O	O
CCAAT-box-binding	O	O	B-T116
transcription	O	O	I-T116
factor	O	O	I-T116
called	O	O	O
OsHAP3H	O	O	B-T028
.	O	O	O

Sequencing	O	O	B-T063
analysis	O	O	I-T063
revealed	O	O	O
that	O	O	O
the	O	O	O
indica	O	O	B-T002
allele	O	O	B-T028
of	O	O	O
CAR8	O	O	B-T028
has	O	O	O
a	O	O	O
1-bp	O	O	B-T049
deletion	O	O	I-T049
at	O	O	O
322	O	O	O
bp	O	O	B-T044
from	O	O	O
the	O	O	O
start	O	O	B-T086
codon	O	O	I-T086
,	O	O	O
resulting	O	O	O
in	O	O	O
a	O	O	O
truncated	O	O	B-T116
protein	O	O	I-T116
of	O	O	O
125	O	O	O
amino	O	O	B-T116
acids	O	O	I-T116
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
CAR8	O	O	B-T028
is	O	O	O
identical	O	O	B-T080
to	O	O	O
DTH8	O	O	B-T028
/	O	O	O
Ghd8	O	O	B-T028
/	O	O	O
LHD1	O	O	B-T028
,	O	O	O
which	O	O	O
was	O	O	O
reported	O	O	O
to	O	O	O
control	O	O	O
rice	O	O	B-T002
flowering	O	O	B-T040
date	O	O	B-T079
.	O	O	O

The	O	O	O
increase	O	O	B-T169
of	O	O	O
A	O	O	B-T081
is	O	O	O
largely	O	O	O
due	O	O	O
to	O	O	O
an	O	O	O
increase	O	O	O
of	O	O	O
RuBP	O	O	B-T081
regeneration	O	O	I-T081
rate	O	O	I-T081
via	O	O	O
increased	O	O	B-T081
leaf	O	O	B-T002
nitrogen	O	O	B-T123
content	O	O	B-T077
,	O	O	O
and	O	O	O
partially	O	O	O
explained	O	O	O
by	O	O	O
reduced	O	O	B-T080
stomatal	O	O	B-T002
limitation	O	O	B-T169
via	O	O	O
increased	O	O	O
stomatal	O	O	O
conductance	O	O	B-T081
relative	O	O	O
to	O	O	O
A.	O	O	O
This	O	O	O
allele	O	O	B-T028
also	O	O	O
increases	O	O	O
hydraulic	O	O	B-T080
conductivity	O	O	I-T080
,	O	O	O
which	O	O	O
would	O	O	O
promote	O	O	B-T052
higher	O	O	O
stomatal	O	O	O
conductance	O	O	O
.	O	O	O

This	O	O	O
indicates	O	O	O
that	O	O	O
CAR8	O	O	B-T028
affects	O	O	O
multiple	O	O	O
physiological	O	O	B-T039
aspects	O	O	I-T039
relating	O	O	O
to	O	O	O
photosynthesis	O	O	B-T070
.	O	O	O

The	O	O	O
detailed	O	O	O
analysis	O	O	B-T062
of	O	O	O
molecular	O	O	B-T044
functions	O	O	I-T044
of	O	O	O
CAR8	O	O	B-T028
would	O	O	O
help	O	O	O
to	O	O	O
understand	O	O	O
the	O	O	O
association	O	O	B-T080
between	O	O	O
photosynthesis	O	O	B-T070
and	O	O	O
flowering	O	O	B-T040
and	O	O	O
demonstrate	O	O	O
specific	O	O	O
genetic	O	O	B-T169
mechanisms	O	O	B-T169
that	O	O	O
can	O	O	O
be	O	O	O
exploited	O	O	O
to	O	O	O
improve	O	O	B-T033
photosynthesis	O	O	O
in	O	O	O
rice	O	O	B-T002
and	O	O	O
potentially	O	O	O
other	O	O	O
crops	O	O	B-UnknownType
.	O	O	O

-DOCSTART- (28197965)

Allogeneic	O	O	B-T061
stem	O	O	I-T061
cell	O	O	I-T061
transplantation	O	O	I-T061
for	O	O	O
adult	O	O	B-T100
patients	O	O	B-T101
with	O	O	O
acute	O	O	B-T191
lymphoblastic	O	O	I-T191
leukemia	O	O	I-T191
who	O	O	O
had	O	O	O
central	O	O	B-T033
nervous	O	O	I-T033
system	O	O	I-T033
involvement	O	O	I-T033
:	O	O	O
a	O	O	O
study	O	O	B-T062
from	O	O	O
the	O	O	O
Adult	O	O	B-T100
ALL	O	O	B-T191
Working	O	O	B-T098
Group	O	O	I-T098
of	O	O	O
the	O	O	O
Japan	O	O	B-T083
Society	O	O	B-T092
for	O	O	O
Hematopoietic	O	O	O
Cell	O	O	O
Transplantation	O	O	O

The	O	O	O
prognosis	O	O	B-T058
for	O	O	O
adult	O	O	B-T100
acute	O	O	B-T191
lymphoblastic	O	O	I-T191
leukemia	O	O	I-T191
(	O	O	O
ALL	O	O	B-T191
)	O	O	O
patients	O	O	B-T101
with	O	O	O
central	O	O	B-T033
nervous	O	O	I-T033
system	O	O	I-T033
(	O	O	I-T033
CNS	O	O	I-T033
)	O	O	I-T033
involvement	O	O	I-T033
(	O	O	O
CNS+	O	O	B-T033
)	O	O	O
who	O	O	O
received	O	O	O
allogeneic	O	O	B-T061
hematopoietic	O	O	I-T061
stem	O	O	I-T061
cell	O	O	I-T061
transplantation	O	O	I-T061
(	O	O	O
allo-SCT	O	O	B-T061
)	O	O	O
remains	O	O	O
unclear	O	O	O
.	O	O	O

We	O	O	O
retrospectively	O	O	B-T080
compared	O	O	O
the	O	O	O
outcomes	O	O	B-T080
of	O	O	O
allo-SCT	O	O	B-T061
for	O	O	O
patients	O	O	B-T101
with	O	O	O
CNS	O	O	B-T033
involvement	O	O	I-T033
and	O	O	O
for	O	O	O
patients	O	O	O
without	O	O	B-T080
CNS	O	O	O
involvement	O	O	O
(	O	O	O
CNS-	O	O	B-T033
)	O	O	O
using	O	O	O
a	O	O	O
database	O	O	B-T170
in	O	O	O
Japan	O	O	B-T083
.	O	O	O

The	O	O	O
eligibility	O	O	O
criteria	O	O	B-T078
for	O	O	O
this	O	O	O
study	O	O	B-T062
were	O	O	O
as	O	O	O
follows	O	O	O
:	O	O	O
diagnosis	O	O	B-T062
of	O	O	O
ALL	O	O	B-T191
,	O	O	O
aged	O	O	O
more	O	O	O
than	O	O	O
16	O	O	O
years	O	O	B-T079
,	O	O	O
allo-SCT	O	O	B-T061
between	O	O	O
2005	O	O	O
and	O	O	O
2012	O	O	O
,	O	O	O
and	O	O	O
first	O	O	B-T081
SCT	O	O	B-T061
.	O	O	O

Data	O	O	B-T078
for	O	O	O
2582	O	O	O
patients	O	O	B-T101
including	O	O	O
136	O	O	O
CNS+	O	O	B-T101
patients	O	O	I-T101
and	O	O	O
2446	O	O	O
CNS-	O	O	B-T101
patients	O	O	I-T101
were	O	O	O
used	O	O	O
for	O	O	O
analyses	O	O	B-T062
.	O	O	O

As	O	O	O
compared	O	O	O
with	O	O	O
CNS-	O	O	B-T101
patients	O	O	I-T101
,	O	O	O
CNS+	O	O	B-T101
patients	O	O	I-T101
were	O	O	O
younger	O	O	B-T079
,	O	O	O
had	O	O	O
worse	O	O	B-T033
disease	O	O	B-T047
status	O	O	B-T080
at	O	O	O
SCT	O	O	B-T061
and	O	O	O
had	O	O	O
poorer	O	O	O
performance	O	O	B-T201
status	O	O	I-T201
(	O	O	O
PS	O	O	B-T201
)	O	O	O
at	O	O	O
SCT	O	O	O
(	O	O	O
P	O	O	O
<	O	O	O
0.01	O	O	O
)	O	O	O
.	O	O	O

Incidence	O	O	B-T081
of	O	O	O
relapse	O	O	B-T067
was	O	O	O
higher	O	O	O
in	O	O	O
CNS+	O	O	B-T101
patients	O	O	I-T101
(	O	O	O
P	O	O	O
=	O	O	O
0.02	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
incidence	O	O	B-T081
of	O	O	O
CNS	O	O	B-T022
relapse	O	O	O
was	O	O	O
also	O	O	O
higher	O	O	O
(	O	O	O
P	O	O	O
<	O	O	O
0.01	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
probability	O	O	B-T081
of	O	O	O
3-	O	O	O
year	O	O	B-T079
overall	O	O	B-T081
survival	O	O	I-T081
(	O	O	O
OS	O	O	B-T081
)	O	O	O
was	O	O	O
better	O	O	O
in	O	O	O
CNS-	O	O	B-T101
patients	O	O	I-T101
(	O	O	O
P	O	O	O
<	O	O	O
0.01	O	O	O
)	O	O	O
by	O	O	O
univariate	O	O	B-T062
analysis	O	O	I-T062
.	O	O	O

However	O	O	O
,	O	O	O
in	O	O	O
patients	O	O	B-T101
who	O	O	O
received	O	O	B-T080
SCT	O	O	B-T061
in	O	O	O
CR	O	O	B-T033
,	O	O	O
there	O	O	O
was	O	O	O
no	O	O	B-T033
difference	O	O	I-T033
in	O	O	O
the	O	O	O
probability	O	O	B-T081
of	O	O	O
OS	O	O	B-T081
between	O	O	O
CNS+	O	O	B-T033
and	O	O	O
CNS-	O	O	B-T033
patients	O	O	O
(	O	O	O
P	O	O	O
=	O	O	O
0.38	O	O	O
)	O	O	O
and	O	O	O
CNS	O	O	B-T033
involvement	O	O	I-T033
did	O	O	O
not	O	O	O
have	O	O	O
an	O	O	O
unfavorable	O	O	B-T080
effect	O	O	B-T080
on	O	O	O
OS	O	O	O
by	O	O	O
multivariate	O	O	B-T081
analysis	O	O	I-T081
.	O	O	O

CNS+	O	O	B-T101
patients	O	O	I-T101
who	O	O	O
achieved	O	O	O
CR	O	O	B-T033
showed	O	O	O
OS	O	O	B-T081
comparable	O	O	O
to	O	O	O
that	O	O	O
of	O	O	O
CNS-	O	O	B-T101
patients	O	O	I-T101
.	O	O	O

-DOCSTART- (28203067)

Silent	O	O	B-T054
strain	O	O	I-T054
of	O	O	I-T054
caregiving	O	O	I-T054
:	O	O	O
exploring	O	O	O
the	O	O	O
best	O	O	B-T033
predictors	O	O	I-T033
of	O	O	O
distress	O	O	B-T033
in	O	O	O
family	O	O	B-T099
carers	O	O	I-T099
of	O	O	O
geriatric	O	O	O
patients	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
this	O	O	O
article	O	O	O
was	O	O	O
to	O	O	O
identify	O	O	O
the	O	O	O
best	O	O	B-T033
predictors	O	O	I-T033
of	O	O	O
distress	O	O	B-T033
suffered	O	O	I-T033
by	O	O	O
family	O	O	B-T099
carers	O	O	I-T099
(	O	O	O
FCs	O	O	B-T099
)	O	O	O
of	O	O	O
geriatric	O	O	B-T101
patients	O	O	I-T101
.	O	O	O

A	O	O	O
cross-sectional	O	O	B-T062
study	O	O	I-T062
of	O	O	O
100	O	O	O
FC	O	O	B-T099
-	O	O	O
geriatric	O	O	B-T101
patient	O	O	I-T101
dyads	O	O	B-T098
was	O	O	O
conducted	O	O	O
.	O	O	O

The	O	O	O
negative	O	O	B-T033
impact	O	O	I-T033
of	O	O	I-T033
care	O	O	I-T033
(	O	O	O
NIoC	O	O	B-T033
)	O	O	O
subscale	O	O	B-T081
of	O	O	O
the	O	O	O
COPE	O	O	B-T081
index	O	O	I-T081
was	O	O	O
dichotomized	O	O	O
to	O	O	O
identify	O	O	O
lower	O	O	B-T033
stress	O	O	I-T033
(	O	O	O
score	O	O	O
of	O	O	O
â¤15	O	O	O
on	O	O	O
the	O	O	O
scale	O	O	O
)	O	O	O
and	O	O	O
higher	O	O	B-T033
stress	O	O	I-T033
(	O	O	O
score	O	O	O
of	O	O	O
â¥16	O	O	O
on	O	O	O
the	O	O	O
scale	O	O	O
)	O	O	O
exerted	O	O	O
on	O	O	O
FCs	O	O	B-T099
by	O	O	O
the	O	O	O
process	O	O	B-T058
of	O	O	I-T058
providing	O	O	I-T058
care	O	O	I-T058
.	O	O	O

The	O	O	O
set	O	O	O
of	O	O	O
explanatory	O	O	B-T170
variables	O	O	B-T033
comprised	O	O	O
a	O	O	O
wide	O	O	O
range	O	O	O
of	O	O	O
sociodemographic	O	O	B-T078
and	O	O	O
care-related	O	O	B-T058
attributes	O	O	I-T058
,	O	O	O
including	O	O	O
patient-related	O	O	B-T033
results	O	O	I-T033
from	O	O	O
comprehensive	O	O	O
geriatric	O	O	B-T058
assessments	O	O	I-T058
and	O	O	O
disease	O	O	B-T047
profiles	O	O	B-T058
.	O	O	O

The	O	O	O
best	O	O	O
combination	O	O	O
of	O	O	O
explanatory	O	O	B-T170
variables	O	O	B-T033
that	O	O	O
provided	O	O	O
the	O	O	O
highest	O	O	B-T080
predictive	O	O	I-T080
powe	O	O	I-T080
r	O	O	O
for	O	O	O
distress	O	O	B-T033
among	O	O	O
FCs	O	O	B-T099
in	O	O	O
the	O	O	O
multiple	O	O	B-UnknownType
logistic	O	O	I-UnknownType
regression	O	O	I-UnknownType
(	O	O	I-UnknownType
LR	O	O	B-UnknownType
)	O	O	I-UnknownType
model	O	O	I-UnknownType
was	O	O	O
determined	O	O	O
according	O	O	O
to	O	O	O
statistical	O	O	B-T081
information	O	O	I-T081
criteria	O	O	I-T081
.	O	O	O

The	O	O	O
statistical	O	O	B-T081
robustness	O	O	I-T081
of	O	O	O
the	O	O	O
observed	O	O	O
relationships	O	O	O
and	O	O	O
the	O	O	O
discriminative	O	O	B-T169
power	O	O	I-T169
of	O	O	O
the	O	O	O
model	O	O	B-T075
were	O	O	O
verified	O	O	O
with	O	O	O
the	O	O	O
cross-validation	O	O	B-T062
method	O	O	I-T062
.	O	O	O

The	O	O	O
mean	O	O	O
age	O	O	B-T032
of	O	O	O
FCs	O	O	B-T099
was	O	O	O
57.2	O	O	O
(	O	O	O
Â±10.6	O	O	O
)	O	O	O
years	O	O	O
,	O	O	O
whereas	O	O	O
that	O	O	O
of	O	O	O
geriatric	O	O	B-T101
patients	O	O	I-T101
was	O	O	O
81.7	O	O	O
(	O	O	O
Â±6.4	O	O	O
)	O	O	O
years	O	O	O
.	O	O	O

Despite	O	O	O
the	O	O	O
broad	O	O	O
initial	O	O	O
set	O	O	O
of	O	O	O
potential	O	O	O
explanatory	O	O	B-T170
variables	O	O	B-T033
,	O	O	O
only	O	O	O
five	O	O	O
predictors	O	O	B-T033
were	O	O	O
jointly	O	O	O
selected	O	O	O
for	O	O	O
the	O	O	O
best	O	O	O
statistical	O	O	B-T081
model	O	O	I-T081
.	O	O	O

A	O	O	O
higher	O	O	O
level	O	O	O
of	O	O	O
distress	O	O	B-T033
was	O	O	O
independently	O	O	O
predicted	O	O	O
by	O	O	O
lower	O	O	B-T080
self-evaluation	O	O	I-T058
of	O	O	I-T058
health	O	O	I-T058
;	O	O	O
worse	O	O	O
self-appraisal	O	O	B-T041
of	O	O	O
coping	O	O	B-T055
well	O	O	O
as	O	O	O
a	O	O	O
caregiver	O	O	B-T099
;	O	O	O
lower	O	O	O
sense	O	O	O
of	O	O	O
general	O	O	B-T058
support	O	O	I-T058
;	O	O	O
more	O	O	O
hours	O	O	O
of	O	O	O
care	O	O	B-T052
per	O	O	O
week	O	O	O
;	O	O	O
and	O	O	O
the	O	O	O
motor	O	O	B-T033
retardation	O	O	I-T033
of	O	O	O
the	O	O	O
cared	O	O	B-T052
-for	O	O	O
person	O	O	O
measured	O	O	O
with	O	O	O
the	O	O	O
speed	O	O	O
of	O	O	O
the	O	O	O
Timed	O	O	B-T060
Up	O	O	I-T060
and	O	O	I-T060
Go	O	O	I-T060
(	O	O	I-T060
TUG	O	O	I-T060
)	O	O	I-T060
test	O	O	I-T060
.	O	O	O

Worse	O	O	O
performance	O	O	O
on	O	O	O
the	O	O	O
TUG	O	O	B-T060
test	O	O	I-T060
was	O	O	O
only	O	O	O
the	O	O	O
patient	O	O	B-T101
-related	O	O	O
predictor	O	O	B-T033
of	O	O	O
distress	O	O	B-T033
among	O	O	O
the	O	O	O
variables	O	O	B-T033
examined	O	O	O
as	O	O	O
contributors	O	O	O
to	O	O	O
the	O	O	O
higher	O	O	O
NIoC.	O	O	O
Enhancing	O	O	O
the	O	O	O
mobility	O	O	B-T061
of	O	O	I-T061
geriatric	O	O	I-T061
patients	O	O	I-T061
through	O	O	O
suitably	O	O	O
tailored	O	O	O
kinesitherapeutic	O	O	B-T061
methods	O	O	I-T061
during	O	O	O
their	O	O	O
hospital	O	O	B-T079
stay	O	O	I-T079
may	O	O	O
mitigate	O	O	O
the	O	O	O
burden	O	O	O
endured	O	O	O
by	O	O	O
FCs	O	O	B-T099
.	O	O	O

-DOCSTART- (28203549)

Microbiological	O	O	B-T170
and	O	O	O
Clinical	O	O	B-T201
Characteristics	O	O	I-T201
of	O	O	O
Hypermucoviscous	O	O	B-T007
Klebsiella	O	O	I-T007
pneumoniae	O	O	I-T007
Isolates	O	O	B-T123
Associated	O	O	B-T080
with	O	O	I-T080
Invasive	O	O	B-T047
Infections	O	O	I-T047
in	O	O	O
China	O	O	O

A	O	O	O
distinctive	O	O	B-T047
syndrome	O	O	I-T047
caused	O	O	B-T169
by	O	O	I-T169
hypermucoviscous	O	O	B-T007
Klebsiella	O	O	I-T007
pneumoniae	O	O	I-T007
(	O	O	O
HMKP	O	O	B-T007
)	O	O	O
including	O	O	O
pyogenic	O	O	B-T047
liver	O	O	I-T047
abscess	O	O	I-T047
(	O	O	O
PLA	O	O	B-T047
)	O	O	O
is	O	O	O
now	O	O	O
becoming	O	O	O
a	O	O	O
globally	O	O	B-T047
emerging	O	O	I-T047
disease	O	O	I-T047
.	O	O	O

In	O	O	O
the	O	O	O
present	O	O	O
study	O	O	B-T062
,	O	O	O
22.8	O	O	O
%	O	O	O
(	O	O	O
84/369	O	O	O
)	O	O	O
of	O	O	O
K.	O	O	B-T007
pneumoniae	O	O	I-T007
clinical	O	O	O
isolates	O	O	B-T123
associated	O	O	B-T080
with	O	O	I-T080
various	O	O	B-T080
types	O	O	I-T080
of	O	O	O
invasive	O	O	B-T047
infections	O	O	I-T047
were	O	O	O
identified	O	O	O
as	O	O	O
HMKP	O	O	B-T007
,	O	O	O
with	O	O	O
45.2	O	O	O
%	O	O	O
associated	O	O	O
with	O	O	O
PLA	O	O	B-T047
.	O	O	O

Multivariate	O	O	B-T081
regression	O	O	I-T081
analysis	O	O	I-T081
showed	O	O	O
that	O	O	O
male	O	O	B-T032
patients	O	O	I-T032
with	O	O	O
41	O	O	O
-	O	O	O
50	O	O	O
years	O	O	B-T079
,	O	O	O
PLA	O	O	B-T047
,	O	O	O
diabetes	O	O	B-T047
mellitus	O	O	I-T047
,	O	O	O
and	O	O	O
hypertension	O	O	B-T047
were	O	O	O
independent	O	O	B-T078
risk	O	O	B-T033
factors	O	O	I-T033
for	O	O	O
HMKP	O	O	B-T047
infections	O	O	I-T047
.	O	O	O

K2	O	O	B-T170
(	O	O	O
42.9	O	O	O
%	O	O	O
,	O	O	O
36/84	O	O	O
)	O	O	O
was	O	O	O
the	O	O	O
most	O	O	O
common	O	O	O
capsular	O	O	B-T082
serotype	O	O	B-T170
among	O	O	O
HMKP	O	O	B-T007
isolates	O	O	B-T123
,	O	O	O
followed	O	O	O
by	O	O	O
K1	O	O	B-T170
(	O	O	O
23.8	O	O	O
%	O	O	O
,	O	O	O
20/84	O	O	O
)	O	O	O
.	O	O	O

Seventy-five	O	O	B-T081
percentage	O	O	I-T081
of	O	O	O
K1	O	O	B-T170
HMKP	O	O	B-T007
isolates	O	O	B-T123
were	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
PLA	O	O	B-T047
,	O	O	O
while	O	O	O
K2	O	O	B-T170
HMKP	O	O	O
isolates	O	O	O
accounted	O	O	B-T078
for	O	O	O
more	O	O	B-T080
types	O	O	I-T080
of	O	O	O
invasive	O	O	B-T047
infections	O	O	I-T047
.	O	O	O

The	O	O	O
positive	O	O	B-T033
rates	O	O	B-T081
of	O	O	O
iutA	O	O	B-T028
,	O	O	O
mrkD	O	O	B-T028
,	O	O	O
aerobactin	O	O	B-T028
,	O	O	O
iroN	O	O	B-T028
,	O	O	O
and	O	O	O
rmpA	O	O	B-T028
among	O	O	O
HMKP	O	O	B-T007
isolates	O	O	B-T123
were	O	O	O
significantly	O	O	B-T081
higher	O	O	I-T081
than	O	O	O
those	O	O	O
among	O	O	O
non-HMKP	O	O	B-T007
isolates	O	O	O
(	O	O	O
p	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
.	O	O	O

There	O	O	O
was	O	O	O
a	O	O	O
correlation	O	O	B-T080
between	O	O	O
magA	O	O	B-T028
,	O	O	O
ybtS	O	O	B-T028
,	O	O	O
alls	O	O	B-T028
,	O	O	O
and	O	O	O
wcaG	O	O	B-T028
and	O	O	O
K1	O	O	B-T170
isolates	O	O	B-T123
.	O	O	O

Interestingly	O	O	O
,	O	O	O
mrkD	O	O	B-T028
was	O	O	O
exclusively	O	O	B-T033
detected	O	O	I-T033
among	O	O	O
HMKP	O	O	B-T007
(	O	O	O
32.1	O	O	O
%	O	O	O
,	O	O	O
27/84	O	O	O
)	O	O	O
and	O	O	O
K2	O	O	B-T170
isolates	O	O	B-T123
(	O	O	O
65.9	O	O	O
%	O	O	O
,	O	O	O
27/41	O	O	O
)	O	O	O
.	O	O	O

All	O	O	O
K1	O	O	B-T170
and	O	O	O
K2	O	O	B-T170
HMKP	O	O	B-T007
and	O	O	O
non-HMKP	O	O	B-T007
isolates	O	O	B-T123
were	O	O	O
positive	O	O	B-T033
for	O	O	O
rmpA.	O	O	O
Aerobactin	O	O	B-T028
was	O	O	O
found	O	O	B-T033
among	O	O	O
95.0	O	O	O
and	O	O	O
97.5	O	O	O
%	O	O	O
of	O	O	O
K1	O	O	O
and	O	O	O
K2	O	O	O
isolates	O	O	O
.	O	O	O

ST23	O	O	B-T170
was	O	O	O
found	O	O	B-T033
to	O	O	O
be	O	O	O
the	O	O	O
most	O	O	B-T079
prevalent	O	O	I-T079
ST	O	O	B-T170
among	O	O	O
69	O	O	O
HMKP	O	O	B-T007
isolates	O	O	B-T123
with	O	O	O
K1	O	O	B-T170
,	O	O	O
K2	O	O	B-T170
,	O	O	O
K5	O	O	B-T170
,	O	O	O
K20	O	O	B-T170
,	O	O	O
and	O	O	O
K57	O	O	B-T170
(	O	O	O
27.5	O	O	O
%	O	O	O
,	O	O	O
19/69	O	O	O
)	O	O	O
and	O	O	O
was	O	O	O
only	O	O	O
found	O	O	O
among	O	O	O
K1	O	O	O
isolates	O	O	O
.	O	O	O

ST65	O	O	B-T170
was	O	O	O
the	O	O	O
second	O	O	O
most	O	O	B-T079
prevalent	O	O	I-T079
ST	O	O	B-T170
(	O	O	O
26.1	O	O	O
%	O	O	O
,	O	O	O
18/69	O	O	O
)	O	O	O
and	O	O	O
was	O	O	O
also	O	O	O
only	O	O	O
found	O	O	B-T033
among	O	O	O
K2	O	O	B-T170
isolates	O	O	B-T123
.	O	O	O

ST23-K1	O	O	B-T170
HMKP	O	O	B-T007
isolates	O	O	B-T123
(	O	O	O
84.2	O	O	O
%	O	O	O
,	O	O	O
16/19	O	O	O
)	O	O	O
were	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
PLA	O	O	B-T047
,	O	O	O
while	O	O	O
ST65-K2	O	O	B-T170
isolates	O	O	O
were	O	O	O
correlated	O	O	B-T080
with	O	O	O
more	O	O	O
types	O	O	B-T185
of	O	O	I-T185
infections	O	O	I-T185
relative	O	O	O
to	O	O	O
ST23-K1	O	O	O
isolates	O	O	O
.	O	O	O

PFGE	O	O	B-T059
results	O	O	B-T169
showed	O	O	O
that	O	O	O
the	O	O	O
homology	O	O	B-T080
of	O	O	O
84	O	O	O
HMKP	O	O	B-T007
isolates	O	O	B-T123
was	O	O	O
diverse	O	O	B-T080
.	O	O	O

Only	O	O	O
five	O	O	B-T081
PFGE	O	O	B-T059
clusters	O	O	B-T081
with	O	O	O
more	O	O	O
than	O	O	O
75	O	O	O
%	O	O	O
similarity	O	O	B-T080
accounted	O	O	B-T078
for	O	O	O
more	O	O	O
than	O	O	O
three	O	O	B-T081
isolates	O	O	B-T123
.	O	O	O

These	O	O	O
five	O	O	B-T081
PFGE	O	O	B-T059
clusters	O	O	B-T081
only	O	O	O
accounted	O	O	B-T078
for	O	O	O
35	O	O	O
(	O	O	O
41.7	O	O	O
%	O	O	O
,	O	O	O
35/84	O	O	O
)	O	O	O
isolates	O	O	B-T123
.	O	O	O

In	O	O	O
conclusion	O	O	O
,	O	O	O
our	O	O	O
study	O	O	B-T062
first	O	O	O
found	O	O	B-T033
that	O	O	O
hypertension	O	O	B-T047
and	O	O	O
male	O	O	B-T032
patients	O	O	I-T032
with	O	O	O
41	O	O	O
-	O	O	O
50	O	O	O
years	O	O	B-T079
old	O	O	B-T079
were	O	O	O
independent	O	O	B-T078
risk	O	O	B-T033
factors	O	O	I-T033
.	O	O	O

The	O	O	O
composition	O	O	B-T201
of	O	O	O
ST	O	O	B-T170
types	O	O	I-T170
and	O	O	O
PFGE	O	O	B-T059
clusters	O	O	B-T081
among	O	O	O
K.	O	O	B-T007
pneumoniae	O	O	I-T007
K2	O	O	B-T170
isolates	O	O	B-T123
was	O	O	O
more	O	O	O
diverse	O	O	B-T080
than	O	O	O
K1	O	O	B-T170
isolates	O	O	O
.	O	O	O

K1	O	O	B-T170
and	O	O	O
K2	O	O	B-T170
HMKP	O	O	B-T007
isolates	O	O	B-T123
had	O	O	O
respective	O	O	O
specific	O	O	B-T169
profiles	O	O	I-T169
of	O	O	O
virulence	O	O	B-T038
-	O	O	O
associated	O	O	B-T078
genes	O	O	B-T028
.	O	O	O

-DOCSTART- (28208888)

Haemoglobinopathies	O	O	B-T047
and	O	O	O
Î²-Thalassaemia	O	O	B-T047
among	O	O	O
the	O	O	O
Tribals	O	O	B-T098
Working	O	O	B-T057
in	O	O	O
the	O	O	O
Tea	O	O	B-T168
Gardens	O	O	B-T080
of	O	O	O
Assam	O	O	B-UnknownType
,	O	O	O
India	O	O	O

Prevalence	O	O	B-T081
of	O	O	O
haemoglobinopathies	O	O	B-T047
and	O	O	O
Î²-thalassaemia	O	O	B-T047
are	O	O	O
very	O	O	B-T080
high	O	O	I-T080
in	O	O	O
India	O	O	B-T083
but	O	O	O
information	O	O	B-T078
about	O	O	O
its	O	O	O
status	O	O	O
among	O	O	O
the	O	O	O
tribals	O	O	B-T098
working	O	O	B-T057
in	O	O	O
the	O	O	O
tea	O	O	B-T168
gardens	O	O	B-T080
of	O	O	O
Assam	O	O	B-UnknownType
is	O	O	O
very	O	O	B-T080
less	O	O	I-T080
.	O	O	O

The	O	O	O
present	O	O	O
study	O	O	B-T062
was	O	O	O
carried	O	O	O
out	O	O	O
to	O	O	O
determine	O	O	O
the	O	O	O
prevalence	O	O	B-T081
of	O	O	O
haemoglobinopathies	O	O	B-T047
and	O	O	O
Î²-thalassaemia	O	O	B-T047
among	O	O	O
the	O	O	O
tribals	O	O	B-T098
working	O	O	B-T057
in	O	O	O
the	O	O	O
tea	O	O	B-T168
gardens	O	O	B-T080
of	O	O	O
Assam	O	O	B-UnknownType
.	O	O	O

A	O	O	O
total	O	O	O
1204	O	O	O
samples	O	O	O
from	O	O	O
the	O	O	O
tribals	O	O	B-T098
working	O	O	B-T057
in	O	O	O
tea	O	O	B-T168
gardens	O	O	B-T080
of	O	O	O
Assam	O	O	B-UnknownType
were	O	O	O
analysed	O	O	B-T062
for	O	O	O
both	O	O	O
Complete	O	O	B-T059
Blood	O	O	I-T059
Count	O	O	I-T059
(	O	O	O
CBC	O	O	B-T059
)	O	O	O
and	O	O	O
High	O	O	B-T059
Pressure	O	O	I-T059
Liquid	O	O	I-T059
Chromatography	O	O	I-T059
(	O	O	O
HPLC	O	O	B-T059
)	O	O	O
for	O	O	O
detection	O	O	B-T061
of	O	O	O
haemoglobinopathies	O	O	B-T047
and	O	O	O
Î²-thalassaemia	O	O	B-T047
.	O	O	O

This	O	O	O
study	O	O	B-T062
showed	O	O	O
that	O	O	O
the	O	O	O
prevalence	O	O	B-T081
of	O	O	O
sickle	O	O	B-T047
cell	O	O	I-T047
anaemia	O	O	I-T047
and	O	O	O
Î²-thalassaemia	O	O	B-T047
were	O	O	O
very	O	O	B-T080
high	O	O	I-T080
among	O	O	O
this	O	O	O
population	O	O	B-T098
.	O	O	O

Our	O	O	O
results	O	O	B-T169
indicated	O	O	B-T033
a	O	O	O
higher	O	O	O
prevalence	O	O	B-T081
of	O	O	O
Î²-thalassaemia	O	O	B-T047
(	O	O	O
3.07	O	O	O
%	O	O	O
)	O	O	O
among	O	O	O
the	O	O	O
Munda	O	O	B-T098
ethnic	O	O	I-T098
group	O	O	I-T098
and	O	O	O
higher	O	O	O
prevalence	O	O	O
of	O	O	O
sickle	O	O	B-T047
cell	O	O	I-T047
anaemia	O	O	I-T047
(	O	O	O
4.73	O	O	O
%	O	O	O
)	O	O	O
among	O	O	O
the	O	O	O
Lohar	O	O	B-T098
ethnic	O	O	I-T098
group	O	O	I-T098
.	O	O	O

This	O	O	O
was	O	O	O
the	O	O	O
first	O	O	O
study	O	O	B-T062
to	O	O	O
report	O	O	O
the	O	O	O
presence	O	O	B-T033
of	O	O	O
HbE	O	O	B-T116
among	O	O	O
the	O	O	O
tribals	O	O	B-T098
working	O	O	B-T057
in	O	O	O
the	O	O	O
tea	O	O	B-T168
gardens	O	O	B-T080
of	O	O	O
Assam	O	O	B-UnknownType
.	O	O	O

Based	O	O	O
on	O	O	O
the	O	O	O
present	O	O	O
findings	O	O	B-T033
,	O	O	O
sickle	O	O	B-T047
cell	O	O	I-T047
anaemia	O	O	I-T047
and	O	O	O
Î²-thalassaemia	O	O	B-T047
were	O	O	O
major	O	O	O
health	O	O	B-T078
problem	O	O	B-T033
for	O	O	O
the	O	O	O
tribals	O	O	B-T098
working	O	O	B-T057
in	O	O	O
the	O	O	O
tea	O	O	B-T168
gardens	O	O	B-T080
of	O	O	O
Assam	O	O	B-UnknownType
.	O	O	O

Proper	O	O	O
diagnostic	O	O	B-T058
facilities	O	O	I-T058
for	O	O	O
haemoglobinopathy	O	O	B-T047
and	O	O	O
thalassaemia	O	O	B-T047
should	O	O	O
be	O	O	O
established	O	O	B-T080
in	O	O	O
these	O	O	O
areas	O	O	B-T082
,	O	O	O
including	O	O	O
establishment	O	O	O
of	O	O	O
haemoglobinopathy	O	O	O
and	O	O	O
thalassaemia	O	O	O
database	O	O	B-T170
collection	O	O	B-T169
,	O	O	O
haematological	O	O	B-T093
analysis	O	O	I-T093
laboratories	O	O	I-T093
,	O	O	O
genetic	O	O	B-T093
counselling	O	O	I-T093
clinics	O	O	I-T093
,	O	O	O
prenatal	O	O	B-T093
diagnosis	O	O	I-T093
centres	O	O	I-T093
and	O	O	O
neonatal	O	O	B-T093
screening	O	O	I-T093
centres	O	O	I-T093
.	O	O	O

-DOCSTART- (28208923)

Long	O	O	B-T079
Term	O	O	I-T079
Outcome	O	O	B-T169
in	O	O	O
Patients	O	O	B-T101
with	O	O	O
Esophageal	O	O	B-T061
Stenting	O	O	I-T061
for	O	O	O
Cancer	O	O	B-T191
Esophagus	O	O	I-T191
-	O	O	O
Our	O	O	O
Experience	O	O	O
at	O	O	O
a	O	O	O
Rural	O	O	B-T093
Hospital	O	O	I-T093
of	O	O	O
Punjab	O	O	B-UnknownType
,	O	O	O
India	O	O	O

Cancer	O	O	B-T191
of	O	O	I-T191
the	O	O	I-T191
esophagus	O	O	I-T191
is	O	O	O
among	O	O	O
the	O	O	O
leading	O	O	O
cause	O	O	B-T078
of	O	O	O
cancer	O	O	B-T081
deaths	O	O	I-T081
in	O	O	O
Punjab	O	O	B-UnknownType
,	O	O	O
India	O	O	B-T083
.	O	O	O

Patients	O	O	B-T101
generally	O	O	O
present	O	O	B-T033
with	O	O	O
dysphagia	O	O	B-T047
as	O	O	O
their	O	O	O
first	O	O	O
symptom	O	O	B-T184
and	O	O	O
more	O	O	O
often	O	O	O
they	O	O	O
have	O	O	O
advanced	O	O	B-UnknownType
disease	O	O	I-UnknownType
at	O	O	O
the	O	O	O
time	O	O	B-T079
of	O	O	O
presentation	O	O	B-T078
to	O	O	O
a	O	O	O
tertiary	O	O	B-T093
care	O	O	I-T093
centre	O	O	I-T093
.	O	O	O

Palliative	O	O	B-T061
procedures	O	O	I-T061
have	O	O	O
important	O	O	B-T080
roles	O	O	O
in	O	O	O
this	O	O	O
setting	O	O	O
.	O	O	O

Stenting	O	O	B-T061
is	O	O	O
the	O	O	O
best	O	O	O
option	O	O	B-T169
to	O	O	O
palliate	O	O	B-T080
the	O	O	O
symptoms	O	O	B-T184
of	O	O	O
dysphagia	O	O	B-T047
,	O	O	O
from	O	O	O
which	O	O	O
patient	O	O	B-T101
is	O	O	O
suffering	O	O	B-T033
the	O	O	I-T033
most	O	O	I-T033
.	O	O	O

To	O	O	O
know	O	O	O
the	O	O	O
success	O	O	B-T080
rate	O	O	B-T081
,	O	O	O
early	O	O	B-T184
and	O	O	O
long	O	O	B-T079
term	O	O	I-T079
complications	O	O	B-T046
and	O	O	O
mortality	O	O	B-T081
in	O	O	O
esophageal	O	O	B-T061
stenting	O	O	I-T061
,	O	O	O
when	O	O	O
it	O	O	O
was	O	O	O
done	O	O	O
in	O	O	O
malignant	O	O	B-T047
esophageal	O	O	I-T047
stricture	O	O	I-T047
patients	O	O	B-T101
.	O	O	O

One	O	O	B-T081
hundred	O	O	I-T081
patients	O	O	B-T101
,	O	O	O
who	O	O	O
had	O	O	O
undergone	O	O	O
esophageal	O	O	B-T061
stenting	O	O	I-T061
from	O	O	O
January	O	O	B-T080
2012	O	O	O
to	O	O	O
January	O	O	O
2015	O	O	O
,	O	O	O
were	O	O	O
included	O	O	B-T169
in	O	O	O
the	O	O	O
study	O	O	B-T062
.	O	O	O

We	O	O	O
retrospectively	O	O	B-T062
analysed	O	O	I-T062
the	O	O	O
data	O	O	B-T078
for	O	O	O
patient	O	O	B-T101
characteristics	O	O	B-T080
,	O	O	O
causes	O	O	B-T169
of	O	O	O
non-operability	O	O	B-T080
,	O	O	O
early	O	O	B-T184
and	O	O	O
long	O	O	B-T079
term	O	O	I-T079
complications	O	O	B-T046
,	O	O	O
re-interventions	O	O	B-T061
,	O	O	O
efficacy	O	O	B-T080
and	O	O	O
mortality	O	O	B-T081
.	O	O	O

Out	O	O	O
of	O	O	O
100	O	O	O
patients	O	O	B-T101
,	O	O	O
indications	O	O	B-T078
for	O	O	O
stenting	O	O	B-T061
were	O	O	O
locally	O	O	O
advanced	O	O	B-UnknownType
disease	O	O	I-UnknownType
not	O	O	O
amenable	O	O	B-T080
to	O	O	O
surgery	O	O	B-T061
(	O	O	O
52	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
metastatic	O	O	B-T191
disease	O	O	I-T191
(	O	O	O
35	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
CVA	O	O	B-T047
(	O	O	O
1	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
cardiac	O	O	B-T033
and	O	O	O
respiratory	O	O	B-T184
problem	O	O	I-T184
(	O	O	O
8	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
un-willing	O	O	O
for	O	O	O
surgery	O	O	O
in	O	O	O
5	O	O	O
%	O	O	O
of	O	O	O
patients	O	O	O
.	O	O	O

Majority	O	O	O
of	O	O	O
patients	O	O	B-T101
(	O	O	O
94	O	O	O
%	O	O	O
)	O	O	O
had	O	O	O
squamous	O	O	B-T191
cell	O	O	I-T191
carcinoma	O	O	I-T191
,	O	O	O
while	O	O	O
only	O	O	O
6	O	O	O
%	O	O	O
had	O	O	O
adenocarcinoma	O	O	B-T191
.	O	O	O

84	O	O	O
%	O	O	O
of	O	O	O
patients	O	O	B-T101
presented	O	O	B-T078
with	O	O	O
dysphagia	O	O	B-T047
with	O	O	O
or	O	O	O
without	O	O	O
chest	O	O	B-T184
pain	O	O	I-T184
and	O	O	O
recurrent	O	O	B-T033
cough	O	O	I-T033
while	O	O	O
16	O	O	O
%	O	O	O
had	O	O	O
recurrent	O	O	B-T184
vomiting	O	O	I-T184
.	O	O	O

58	O	O	O
%	O	O	O
had	O	O	O
dysphagia	O	O	B-T047
to	O	O	O
liquids	O	O	B-T167
and	O	O	O
solids	O	O	B-T167
and	O	O	O
17	O	O	O
%	O	O	O
had	O	O	O
complete	O	O	B-T047
dysphagia	O	O	I-T047
.	O	O	O

After	O	O	O
stenting	O	O	B-T061
93	O	O	O
%	O	O	O
had	O	O	O
significant	O	O	B-T078
improvement	O	O	B-T077
in	O	O	O
dysphagia	O	O	B-T047
score	O	O	B-T081
from	O	O	O
median	O	O	O
of	O	O	O
3	O	O	O
to	O	O	O
1	O	O	O
.	O	O	O

Post	O	O	B-T079
procedure	O	O	I-T079
stay	O	O	B-T079
was	O	O	O
3.61Â±1.0	O	O	O
days	O	O	B-T079
.	O	O	O

One	O	O	O
patient	O	O	B-T101
had	O	O	O
procedure	O	O	B-T061
related	O	O	O
major	O	O	O
complication	O	O	B-T046
in	O	O	O
the	O	O	O
form	O	O	O
of	O	O	O
post	O	O	B-T037
procedural	O	O	I-T037
bleed	O	O	I-T037
(	O	O	O
after	O	O	O
16	O	O	O
days	O	O	B-T079
of	O	O	O
stenting	O	O	B-T061
)	O	O	O
leading	O	O	O
to	O	O	O
death	O	O	B-T033
of	O	O	O
that	O	O	O
patient	O	O	O
.	O	O	O

Minor	O	O	B-T041
complications	O	O	B-T046
were	O	O	O
present	O	O	B-T033
in	O	O	O
52	O	O	O
patients	O	O	B-T101
treated	O	O	B-T169
conservatively	O	O	O
not	O	O	O
affecting	O	O	B-T169
the	O	O	O
efficacy	O	O	B-T080
of	O	O	O
procedure	O	O	B-T061
.	O	O	O

These	O	O	O
include	O	O	B-T052
pain	O	O	B-T184
after	O	O	O
stenting	O	O	B-T061
(	O	O	O
38	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
stent	O	O	B-T046
obstruction	O	O	I-T046
(	O	O	O
23	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
stent	O	O	B-T046
migration	O	O	I-T046
(	O	O	O
6	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

All	O	O	O
the	O	O	O
minor	O	O	B-T041
complications	O	O	B-T046
were	O	O	O
treated	O	O	B-T169
conservatively	O	O	O
except	O	O	B-T169
in	O	O	O
six	O	O	O
patients	O	O	B-T101
in	O	O	O
whom	O	O	O
re-stenting	O	O	B-T061
was	O	O	O
done	O	O	O
.	O	O	O

Esophageal	O	O	B-T061
stenting	O	O	I-T061
is	O	O	O
relatively	O	O	O
safe	O	O	O
procedure	O	O	B-T061
with	O	O	O
short	O	O	O
stay	O	O	B-T079
of	O	O	O
the	O	O	O
patient	O	O	B-T101
in	O	O	O
the	O	O	O
hospital	O	O	B-T093
.	O	O	O

Although	O	O	O
,	O	O	O
it	O	O	O
helps	O	O	O
in	O	O	O
alleviating	O	O	O
patients	O	O	B-T101
'	O	O	O
morbidity	O	O	B-T081
very	O	O	O
effectively	O	O	B-T080
and	O	O	O
reliably	O	O	O
,	O	O	O
there	O	O	O
are	O	O	O
many	O	O	O
technical	O	O	B-T067
glitches	O	O	I-T067
,	O	O	O
which	O	O	O
needs	O	O	O
to	O	O	O
be	O	O	O
kept	O	O	O
into	O	O	O
account	O	O	O
and	O	O	O
patient	O	O	B-T101
should	O	O	O
be	O	O	O
properly	O	O	O
counseled	O	O	B-T061
before	O	O	O
the	O	O	O
procedure	O	O	B-T061
to	O	O	O
prevent	O	O	B-T169
and	O	O	O
manage	O	O	B-T169
post	O	O	B-T079
procedure	O	O	I-T079
complications	O	O	B-T046
and	O	O	O
medico	O	O	O
legal	O	O	O
aspects	O	O	O
.	O	O	O

-DOCSTART- (28209454)

Treatment	O	O	B-T169
of	O	O	O
Carcinoma	O	O	B-T191
In	O	O	I-T191
Situ	O	O	I-T191
of	O	O	I-T191
the	O	O	I-T191
Glans	O	O	I-T191
Penis	O	O	I-T191
With	O	O	O
Topical	O	O	B-T200
Imiquimod	O	O	I-T200
Followed	O	O	O
by	O	O	O
Carbon	O	O	B-T074
Dioxide	O	O	I-T074
Laser	O	O	I-T074
Excision	O	O	O

Different	O	O	B-T080
approaches	O	O	B-T169
have	O	O	O
been	O	O	O
described	O	O	B-T078
in	O	O	O
published	O	O	O
studies	O	O	O
for	O	O	O
carcinoma	O	O	B-T191
in	O	O	I-T191
situ	O	O	I-T191
(	O	O	I-T191
CIS	O	O	I-T191
)	O	O	I-T191
of	O	O	I-T191
the	O	O	I-T191
glans	O	O	I-T191
penis	O	O	I-T191
(	O	O	O
erythroplasia	O	O	B-T191
of	O	O	I-T191
Queyrat	O	O	I-T191
)	O	O	O
,	O	O	O
including	O	O	B-T169
topical	O	O	B-T061
chemotherapy	O	O	I-T061
or	O	O	O
immunotherapy	O	O	B-T061
and	O	O	O
laser	O	O	B-UnknownType
or	O	O	O
surgical	O	O	B-T061
excision	O	O	I-T061
.	O	O	O

We	O	O	O
evaluated	O	O	B-T061
the	O	O	O
efficacy	O	O	B-T080
of	O	O	O
topical	O	O	B-T200
imiquimod	O	O	I-T200
(	O	O	O
IQ	O	O	B-T200
)	O	O	O
followed	O	O	O
by	O	O	O
carbon	O	O	B-T074
dioxide	O	O	I-T074
laser	O	O	I-T074
ablation	O	O	B-T061
of	O	O	O
the	O	O	O
lesion	O	O	B-T033
.	O	O	O

From	O	O	O
2010	O	O	O
to	O	O	O
2015	O	O	O
,	O	O	O
10	O	O	O
patients	O	O	B-T080
affected	O	O	I-T080
by	O	O	O
CIS	O	O	B-T191
of	O	O	O
the	O	O	O
glans	O	O	B-T023
were	O	O	O
treated	O	O	B-T061
by	O	O	O
IQ	O	O	B-T200
,	O	O	O
followed	O	O	O
by	O	O	O
carbon	O	O	B-T074
dioxide	O	O	I-T074
laser	O	O	I-T074
ablation	O	O	B-T061
.	O	O	O

For	O	O	O
every	O	O	O
patient	O	O	B-T101
,	O	O	O
we	O	O	O
performed	O	O	B-T169
histologic	O	O	B-T059
examination	O	O	I-T059
before	O	O	B-T079
and	O	O	O
after	O	O	B-T079
IQ	O	O	B-T200
.	O	O	O

Local	O	O	O
toxicity	O	O	B-T037
and	O	O	O
adverse	O	O	B-T046
effects	O	O	I-T046
were	O	O	O
recorded	O	O	O
.	O	O	O

After	O	O	B-T079
treatment	O	O	I-T079
,	O	O	O
histologic	O	O	B-T059
examination	O	O	I-T059
showed	O	O	O
no	O	O	B-T034
residual	O	O	I-T034
tumor	O	O	I-T034
in	O	O	O
6	O	O	O
patients	O	O	B-T101
(	O	O	O
complete	O	O	B-T033
response	O	O	I-T033
[	O	O	O
CR	O	O	B-T033
]	O	O	O
)	O	O	O
,	O	O	O
stable	O	O	B-T033
disease	O	O	I-T033
in	O	O	O
2	O	O	O
patients	O	O	O
,	O	O	O
and	O	O	O
progressive	O	O	B-T047
disease	O	O	I-T047
in	O	O	O
2	O	O	O
patients	O	O	O
.	O	O	O

Those	O	O	O
with	O	O	O
a	O	O	O
CR	O	O	B-T033
had	O	O	O
human	O	O	B-T005
papillomavirus	O	O	I-T005
-	O	O	O
related	O	O	B-T080
lesions	O	O	B-T033
,	O	O	O
and	O	O	O
they	O	O	O
had	O	O	O
no	O	O	B-T033
experienced	O	O	O
relapses	O	O	B-T067
after	O	O	B-T079
a	O	O	O
mean	O	O	O
follow-up	O	O	B-T058
of	O	O	O
26	O	O	O
months	O	O	B-T079
.	O	O	O

The	O	O	O
2	O	O	O
patients	O	O	B-T101
with	O	O	O
progressive	O	O	B-T047
disease	O	O	I-T047
underwent	O	O	O
total	O	O	O
penectomy	O	O	B-T061
.	O	O	O

All	O	O	O
patients	O	O	B-T101
were	O	O	O
alive	O	O	B-T033
at	O	O	O
the	O	O	O
last	O	O	O
follow-up	O	O	B-T033
examination	O	O	I-T033
.	O	O	O

All	O	O	O
patients	O	O	B-T101
experienced	O	O	O
a	O	O	O
mild	O	O	B-T080
local	O	O	O
toxicity	O	O	B-T037
(	O	O	O
burning	O	O	B-T184
erythema	O	O	I-T184
)	O	O	O
but	O	O	O
no	O	O	B-T033
major	O	O	B-T080
adverse	O	O	B-T046
effects	O	O	I-T046
.	O	O	O

Local	O	O	O
treatment	O	O	B-T169
with	O	O	O
IQ	O	O	B-T200
for	O	O	O
glans	O	O	B-T023
CIS	O	O	B-T191
is	O	O	O
effective	O	O	B-T080
mainly	O	O	O
for	O	O	O
human	O	O	B-T005
papillomavirus	O	O	I-T005
-	O	O	O
related	O	O	B-T080
lesions	O	O	B-T033
.	O	O	O

The	O	O	O
present	O	O	O
study	O	O	O
is	O	O	O
the	O	O	O
first	O	O	O
to	O	O	O
record	O	O	O
the	O	O	O
histologic	O	O	B-T059
examination	O	O	I-T059
findings	O	O	O
before	O	O	B-T079
and	O	O	O
after	O	O	B-T079
IQ	O	O	B-T200
treatment	O	O	B-T169
.	O	O	O

The	O	O	O
small	O	O	O
number	O	O	O
of	O	O	O
patients	O	O	B-T101
,	O	O	O
owing	O	O	O
to	O	O	O
the	O	O	O
rarity	O	O	B-T080
of	O	O	O
this	O	O	O
disease	O	O	B-T047
,	O	O	O
was	O	O	O
the	O	O	O
main	O	O	O
limitation	O	O	B-T169
of	O	O	O
the	O	O	O
present	O	O	O
study	O	O	O
.	O	O	O

IQ	O	O	B-T200
must	O	O	O
be	O	O	O
used	O	O	O
carefully	O	O	O
,	O	O	O
and	O	O	O
a	O	O	O
close	O	O	O
follow-up	O	O	B-T058
protocol	O	O	B-T170
is	O	O	O
mandatory	O	O	B-T061
because	O	O	O
of	O	O	O
the	O	O	O
lack	O	O	B-T080
of	O	O	O
long-term	O	O	B-T079
efficacy	O	O	B-T080
data	O	O	O
.	O	O	O

-DOCSTART- (28209459)

Progressive	O	O	B-T169
subcortical	O	O	B-T029
calcifications	O	O	B-T042
secondary	O	O	O
to	O	O	O
venous	O	O	B-T047
hypertension	O	O	I-T047
in	O	O	O
an	O	O	O
intracranial	O	O	B-T029
dural	O	O	O
arteriovenous	O	O	O
fistula	O	O	O

Intracranial	O	O	B-T029
dural	O	O	B-T190
arteriovenous	O	O	I-T190
fistulas	O	O	I-T190
(	O	O	O
dAVF	O	O	B-T190
)	O	O	O
are	O	O	O
acquired	O	O	B-T033
lesions	O	O	I-T033
,	O	O	O
with	O	O	O
the	O	O	O
most	O	O	O
commonly	O	O	O
reported	O	O	B-T058
findings	O	O	B-T033
on	O	O	O
CT	O	O	B-T060
haemorrhage	O	O	B-T046
or	O	O	O
focal	O	O	B-T046
oedema	O	O	I-T046
.	O	O	O

We	O	O	O
describe	O	O	O
a	O	O	O
case	O	O	O
of	O	O	O
progressive	O	O	B-T169
subcortical	O	O	B-T029
calcification	O	O	B-T042
on	O	O	O
CT	O	O	B-T060
secondary	O	O	O
to	O	O	O
venous	O	O	B-T047
hypertension	O	O	I-T047
from	O	O	O
a	O	O	O
high	O	O	O
grade	O	O	O
dAVF	O	O	B-T190
.	O	O	O

-DOCSTART- (28209945)

Effects	O	O	O
of	O	O	O
Static	O	O	B-T059
Cold	O	O	I-T059
Storage	O	O	I-T059
and	O	O	O
Hypothermic	O	O	B-T061
Machine	O	O	I-T061
Perfusion	O	O	I-T061
on	O	O	O
Oxidative	O	O	B-T059
Stress	O	O	I-T059
Factors	O	O	I-T059
,	O	O	O
Adhesion	O	O	B-T116
Molecules	O	O	I-T116
,	O	O	O
and	O	O	O
Zinc	O	O	B-T116
Finger	O	O	I-T116
Transcription	O	O	I-T116
Factor	O	O	I-T116
Proteins	O	O	I-T116
Before	O	O	O
and	O	O	O
After	O	O	O
Liver	O	O	O
Transplantation	O	O	O

BACKGROUND	O	O	O
This	O	O	O
study	O	O	O
aimed	O	O	O
to	O	O	O
investigate	O	O	O
the	O	O	O
effects	O	O	O
of	O	O	O
static	O	O	B-T059
cold	O	O	I-T059
storage	O	O	I-T059
(	O	O	O
SCS	O	O	B-T059
)	O	O	O
and	O	O	O
hypothermic	O	O	B-T061
machine	O	O	I-T061
perfusion	O	O	I-T061
(	O	O	O
HMP	O	O	B-T061
)	O	O	O
on	O	O	O
the	O	O	O
oxidative	O	O	B-T059
stress	O	O	I-T059
factors	O	O	I-T059
(	O	O	O
OSF	O	O	B-T059
)	O	O	O
,	O	O	O
adhesion	O	O	B-T116
molecules	O	O	I-T116
(	O	O	O
AM	O	O	B-T116
)	O	O	O
,	O	O	O
and	O	O	O
zinc	O	O	B-T116
finger	O	O	I-T116
transcription	O	O	I-T116
factor	O	O	I-T116
(	O	O	O
Snail	O	O	B-T116
)	O	O	O
before	O	O	O
and	O	O	O
after	O	O	O
liver	O	O	B-T061
transplantation	O	O	I-T061
.	O	O	O

MATERIAL	O	O	O
AND	O	O	O
METHODS	O	O	O
Experimental	O	O	O
dogs	O	O	B-T015
were	O	O	O
randomly	O	O	O
divided	O	O	O
into	O	O	O
donor	O	O	B-T058
(	O	O	O
group	O	O	B-T078
A	O	O	O
)	O	O	O
,	O	O	O
SCS	O	O	B-T059
(	O	O	O
group	O	O	O
B	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
HMP	O	O	B-T061
(	O	O	O
group	O	O	O
C	O	O	O
)	O	O	O
(	O	O	O
n=30	O	O	O
)	O	O	O
groups	O	O	B-T078
.	O	O	O

Livers	O	O	B-T061
retrieved	O	O	I-T061
from	O	O	O
group	O	O	B-T078
A	O	O	O
were	O	O	O
transplanted	O	O	B-T061
into	O	O	O
group	O	O	O
B	O	O	O
after	O	O	O
SCS	O	O	B-T059
,	O	O	O
and	O	O	O
the	O	O	O
livers	O	O	B-T023
sampled	O	O	O
from	O	O	O
group	O	O	O
B	O	O	O
were	O	O	O
transplanted	O	O	O
into	O	O	O
group	O	O	O
C	O	O	O
after	O	O	O
HMP	O	O	B-T061
.	O	O	O

The	O	O	O
dogs	O	O	O
in	O	O	O
group	O	O	B-T078
A	O	O	O
were	O	O	O
euthanized	O	O	B-T058
and	O	O	O
discarded	O	O	O
,	O	O	O
and	O	O	O
the	O	O	O
livers	O	O	B-T023
sampled	O	O	O
from	O	O	O
group	O	O	O
C	O	O	O
were	O	O	O
used	O	O	O
for	O	O	O
other	O	O	O
experiments	O	O	O
.	O	O	O

Twenty	O	O	O
dogs	O	O	B-T015
with	O	O	O
successful	O	O	O
liver	O	O	B-T061
transplants	O	O	I-T061
were	O	O	O
randomly	O	O	O
selected	O	O	O
from	O	O	O
groups	O	O	B-T078
B	O	O	O
and	O	O	O
C	O	O	O
for	O	O	O
analysis	O	O	O
.	O	O	O

RESULTS	O	O	O
During	O	O	O
the	O	O	O
liver	O	O	B-T023
sampling	O	O	B-T062
process	O	O	I-T062
,	O	O	O
the	O	O	O
levels	O	O	O
of	O	O	O
OSF	O	O	B-T059
,	O	O	O
AM	O	O	B-T116
,	O	O	O
and	O	O	O
Snail	O	O	B-T116
between	O	O	O
the	O	O	O
2	O	O	O
groups	O	O	B-T078
showed	O	O	O
no	O	O	B-T033
significant	O	O	I-T033
differences	O	O	I-T033
(	O	O	O
P>0.05	O	O	O
)	O	O	O
;	O	O	O
before	O	O	O
the	O	O	O
transplantation	O	O	B-T061
,	O	O	O
the	O	O	O
levels	O	O	O
of	O	O	O
chemokine	O	O	B-T116
CXCL14	O	O	I-T116
and	O	O	O
Snail	O	O	O
between	O	O	O
the	O	O	O
2	O	O	O
groups	O	O	O
showed	O	O	O
no	O	O	O
significant	O	O	O
differences	O	O	O
(	O	O	O
P>0.05	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
compared	O	O	O
with	O	O	O
group	O	O	B-T078
B	O	O	O
,	O	O	O
HIF-1Î±	O	O	B-T116
and	O	O	O
P-selectin	O	O	B-T116
in	O	O	O
group	O	O	O
C	O	O	O
were	O	O	O
lower	O	O	O
(	O	O	O
P<0.01	O	O	O
)	O	O	O
;	O	O	O
60	O	O	O
min	O	O	O
after	O	O	O
the	O	O	O
transplantation	O	O	O
,	O	O	O
HIF-1Î±	O	O	O
,	O	O	O
chemokine	O	O	O
CXCL14	O	O	O
,	O	O	O
P-selectin	O	O	O
,	O	O	O
and	O	O	O
Snail	O	O	O
in	O	O	O
group	O	O	O
C	O	O	O
were	O	O	O
lower	O	O	O
than	O	O	O
that	O	O	O
in	O	O	O
group	O	O	O
B	O	O	O
(	O	O	O
P<0.01	O	O	O
)	O	O	O
.	O	O	O

CONCLUSIONS	O	O	O
HMP	O	O	B-T061
can	O	O	O
significantly	O	O	O
reduce	O	O	O
the	O	O	O
levels	O	O	O
of	O	O	O
OSF	O	O	B-T059
and	O	O	O
inflammatory	O	O	B-T169
factors	O	O	I-T169
,	O	O	O
which	O	O	O
is	O	O	O
conducive	O	O	B-T033
for	O	O	O
liver	O	O	B-T061
transplantation	O	O	I-T061
.	O	O	O

-DOCSTART- (28210319)

Physiology	O	O	B-T039
of	O	O	O
respiratory	O	O	B-T033
disturbances	O	O	I-T033
in	O	O	O
muscular	O	O	O
dystrophies	O	O	O

Muscular	O	O	B-T047
dystrophy	O	O	I-T047
is	O	O	O
a	O	O	O
group	O	O	O
of	O	O	O
inherited	O	O	O
myopathies	O	O	B-T047
characterised	O	O	O
by	O	O	O
progressive	O	O	B-T169
skeletal	O	O	B-T046
muscle	O	O	I-T046
wasting	O	O	I-T046
,	O	O	O
including	O	O	O
of	O	O	O
the	O	O	O
respiratory	O	O	B-T023
muscles	O	O	I-T023
.	O	O	O

Respiratory	O	O	B-T047
failure	O	O	B-T047
,	O	O	O
i.e.	O	O	O
when	O	O	O
the	O	O	O
respiratory	O	O	B-T022
system	O	O	I-T022
fails	O	O	B-T169
in	O	O	O
its	O	O	O
gas	O	O	B-UnknownType
exchange	O	O	I-UnknownType
functions	O	O	I-UnknownType
,	O	O	O
is	O	O	O
a	O	O	O
common	O	O	O
feature	O	O	B-T080
in	O	O	O
muscular	O	O	B-T047
dystrophy	O	O	I-T047
,	O	O	O
being	O	O	O
the	O	O	O
main	O	O	O
cause	O	O	O
of	O	O	O
death	O	O	B-T033
,	O	O	O
and	O	O	O
it	O	O	O
is	O	O	O
a	O	O	O
consequence	O	O	B-T169
of	O	O	I-T169
lung	O	O	B-T023
failure	O	O	O
,	O	O	O
pump	O	O	B-T047
failure	O	O	I-T047
or	O	O	O
a	O	O	O
combination	O	O	O
of	O	O	O
the	O	O	O
two	O	O	O
.	O	O	O

The	O	O	O
former	O	O	O
is	O	O	O
due	O	O	O
to	O	O	O
recurrent	O	O	B-T079
aspiration	O	O	B-T046
,	O	O	O
the	O	O	O
latter	O	O	O
to	O	O	O
progressive	O	O	B-T169
weakness	O	O	B-T033
of	O	O	I-T033
respiratory	O	O	I-T033
muscles	O	O	I-T033
and	O	O	O
an	O	O	O
increase	O	O	B-T169
in	O	O	O
the	O	O	O
load	O	O	O
against	O	O	O
which	O	O	O
they	O	O	O
must	O	O	O
contract	O	O	B-UnknownType
.	O	O	O

In	O	O	O
fact	O	O	O
,	O	O	O
both	O	O	O
the	O	O	O
resistive	O	O	B-T080
and	O	O	I-T080
elastic	O	O	I-T080
components	O	O	I-T080
of	O	O	O
the	O	O	O
work	O	O	O
of	O	O	O
breathing	O	O	B-T039
increase	O	O	B-T169
due	O	O	O
to	O	O	O
airway	O	O	B-T047
obstruction	O	O	I-T047
and	O	O	O
chest	O	O	B-T023
wall	O	O	I-T023
and	O	O	O
lung	O	O	B-T023
stiffening	O	O	B-T184
,	O	O	O
respectively	O	O	O
.	O	O	O

The	O	O	O
respiratory	O	O	B-T033
disturbances	O	O	I-T033
in	O	O	O
muscular	O	O	B-T047
dystrophy	O	O	I-T047
are	O	O	O
restrictive	O	O	B-T033
pulmonary	O	O	I-T033
function	O	O	I-T033
,	O	O	O
hypoventilation	O	O	B-T046
,	O	O	O
altered	O	O	O
thoracoabdominal	O	O	B-T082
pattern	O	O	O
,	O	O	O
hypercapnia	O	O	B-T033
,	O	O	O
dyspnoea	O	O	B-T184
,	O	O	O
impaired	O	O	B-UnknownType
regulation	O	O	I-UnknownType
of	O	O	I-UnknownType
breathing	O	O	I-UnknownType
,	O	O	O
inefficient	O	O	B-T033
cough	O	O	I-T033
and	O	O	O
sleep	O	O	B-T047
disordered	O	O	I-T047
breathing	O	O	I-T047
.	O	O	O

They	O	O	O
can	O	O	O
be	O	O	O
present	O	O	O
at	O	O	O
different	O	O	O
rates	O	O	O
according	O	O	O
to	O	O	O
the	O	O	O
type	O	O	O
of	O	O	O
muscular	O	O	B-T047
dystrophy	O	O	I-T047
and	O	O	O
its	O	O	O
progression	O	O	B-T046
,	O	O	O
leading	O	O	O
to	O	O	O
different	O	O	O
onset	O	O	O
of	O	O	O
each	O	O	O
symptom	O	O	B-T184
,	O	O	O
prognosis	O	O	B-T058
and	O	O	O
degree	O	O	B-T033
of	O	O	I-T033
respiratory	O	O	I-T033
involvement	O	O	I-T033
.	O	O	O

A	O	O	O
common	O	O	O
feature	O	O	B-T080
of	O	O	O
muscular	O	O	B-T047
dystrophy	O	O	I-T047
is	O	O	O
respiratory	O	O	B-T047
failure	O	O	I-T047
,	O	O	O
i.e.	O	O	O
the	O	O	O
inability	O	O	O
of	O	O	O
the	O	O	O
respiratory	O	O	B-T022
system	O	O	I-T022
to	O	O	O
provide	O	O	O
proper	O	O	O
oxygenation	O	O	B-T042
and	O	O	O
carbon	O	O	B-T039
dioxide	O	O	I-T039
elimination	O	O	I-T039
.In	O	O	O
the	O	O	O
lung	O	O	B-T023
,	O	O	O
respiratory	O	O	O
failure	O	O	O
is	O	O	O
caused	O	O	O
by	O	O	O
recurrent	O	O	B-T079
aspiration	O	O	B-T046
,	O	O	O
and	O	O	O
leads	O	O	O
to	O	O	O
hypoxaemia	O	O	B-T033
and	O	O	O
hypercarbia	O	O	B-T033
.	O	O	O

Ventilatory	O	O	B-T046
failure	O	O	I-T046
in	O	O	O
muscular	O	O	B-T047
dystrophy	O	O	I-T047
is	O	O	O
caused	O	O	O
by	O	O	O
increased	O	O	B-T081
respiratory	O	O	B-T033
load	O	O	I-T033
and	O	O	O
respiratory	O	O	B-T033
muscles	O	O	I-T033
weakness	O	O	I-T033
.	O	O	O

Respiratory	O	O	B-T033
load	O	O	I-T033
increases	O	O	B-T169
in	O	O	O
muscular	O	O	B-T047
dystrophy	O	O	I-T047
because	O	O	O
scoliosis	O	O	B-T190
makes	O	O	O
chest	O	O	B-T034
wall	O	O	I-T034
compliance	O	O	I-T034
decrease	O	O	B-T081
,	O	O	O
atelectasis	O	O	B-T046
and	O	O	O
fibrosis	O	O	B-T046
make	O	O	O
lung	O	O	B-T042
compliance	O	O	I-T042
decrease	O	O	O
,	O	O	O
and	O	O	O
airway	O	O	B-T047
obstruction	O	O	I-T047
makes	O	O	O
airway	O	O	B-T042
resistance	O	O	I-T042
increase	O	O	B-T169
.The	O	O	O
consequences	O	O	B-T169
of	O	O	I-T169
respiratory	O	O	B-T047
pump	O	O	I-T047
failure	O	O	I-T047
are	O	O	O
restrictive	O	O	B-T033
pulmonary	O	O	I-T033
function	O	O	I-T033
,	O	O	O
hypoventilation	O	O	B-T046
,	O	O	O
altered	O	O	O
thoracoabdominal	O	O	B-T082
pattern	O	O	O
,	O	O	O
hypercapnia	O	O	B-T033
,	O	O	O
dyspnoea	O	O	B-T184
,	O	O	O
impaired	O	O	B-UnknownType
regulation	O	O	I-UnknownType
of	O	O	I-UnknownType
breathing	O	O	I-UnknownType
,	O	O	O
inefficient	O	O	B-T033
cough	O	O	I-T033
and	O	O	O
sleep	O	O	B-T047
disordered	O	O	I-T047
breathing	O	O	I-T047
.	O	O	O

To	O	O	O
understand	O	O	O
the	O	O	O
mechanisms	O	O	B-T033
leading	O	O	O
to	O	O	O
respiratory	O	O	B-T033
disturbances	O	O	I-T033
in	O	O	O
patients	O	O	B-T101
with	O	O	O
muscular	O	O	B-T047
dystrophy	O	O	I-T047
.To	O	O	O
understand	O	O	O
the	O	O	O
impact	O	O	O
of	O	O	O
respiratory	O	O	O
disturbances	O	O	O
in	O	O	O
patients	O	O	O
with	O	O	O
muscular	O	O	O
dystrophy	O	O	O
.To	O	O	O
provide	O	O	O
a	O	O	O
brief	O	O	O
description	O	O	B-T170
of	O	O	O
the	O	O	O
main	O	O	O
forms	O	O	O
of	O	O	O
muscular	O	O	O
dystrophy	O	O	O
with	O	O	O
their	O	O	O
respiratory	O	O	B-T033
implications	O	O	I-T033
.	O	O	O

-DOCSTART- (28215507)

Significance	O	O	B-T078
of	O	O	O
uterine	O	O	B-T191
corpus	O	O	I-T191
tumor	O	O	I-T191
invasion	O	O	B-T033
in	O	O	O
early-stage	O	O	B-T185
cervical	O	O	O
cancer	O	O	O

To	O	O	O
examine	O	O	O
characteristics	O	O	B-T080
and	O	O	O
survival	O	O	B-T052
outcomes	O	O	B-T169
of	O	O	O
women	O	O	B-T098
with	O	O	O
surgically-treated	O	O	B-T061
cervical	O	O	B-T191
cancer	O	O	I-T191
exhibiting	O	O	O
uterine	O	O	B-T191
corpus	O	O	I-T191
tumor	O	O	I-T191
invasion	O	O	B-T033
.	O	O	O

We	O	O	O
utilized	O	O	O
The	O	O	O
Surveillance	O	O	B-T093
,	O	O	I-T093
Epidemiology	O	O	I-T093
,	O	O	I-T093
and	O	O	I-T093
End	O	O	I-T093
Results	O	O	I-T093
Program	O	O	I-T093
to	O	O	O
identify	O	O	O
cervical	O	O	B-T191
cancer	O	O	I-T191
patients	O	O	B-T101
who	O	O	O
underwent	O	O	O
hysterectomy	O	O	B-T061
between	O	O	O
1973	O	O	O
and	O	O	O
2003	O	O	O
.	O	O	O

Logistic	O	O	B-UnknownType
regression	O	O	I-UnknownType
models	O	O	I-UnknownType
were	O	O	O
used	O	O	O
to	O	O	O
identify	O	O	O
risk	O	O	B-T033
factors	O	O	I-T033
for	O	O	O
uterine	O	O	B-T191
corpus	O	O	I-T191
tumor	O	O	I-T191
invasion	O	O	B-T033
on	O	O	O
multivariable	O	O	B-T081
analysis	O	O	I-T081
.	O	O	O

Association	O	O	B-T080
of	O	O	O
uterine	O	O	B-T191
corpus	O	O	I-T191
tumor	O	O	I-T191
invasion	O	O	B-T033
and	O	O	O
cause-specific	O	O	B-T081
survival	O	O	I-T081
(	O	O	O
CSS	O	O	B-T081
)	O	O	O
from	O	O	O
cervical	O	O	B-T191
cancer	O	O	I-T191
was	O	O	O
examined	O	O	O
with	O	O	O
Cox	O	O	B-T170
proportional	O	O	I-T170
hazard	O	O	I-T170
regression	O	O	I-T170
models	O	O	I-T170
on	O	O	O
multivariable	O	O	B-T081
analysis	O	O	I-T081
.	O	O	O

We	O	O	O
identified	O	O	O
837	O	O	O
(	O	O	O
4.9	O	O	O
%	O	O	O
)	O	O	O
cases	O	O	O
of	O	O	O
uterine	O	O	B-T191
corpus	O	O	I-T191
invasion	O	O	B-T033
and	O	O	O
16,237	O	O	O
(	O	O	O
95.1	O	O	O
%	O	O	O
)	O	O	O
cases	O	O	O
of	O	O	O
non-invasion	O	O	B-T169
.	O	O	O

Median	O	O	B-T081
follow-up	O	O	B-T058
time	O	O	B-T079
was	O	O	O
14.0	O	O	O
years	O	O	O
.	O	O	O

There	O	O	O
were	O	O	O
1642	O	O	O
deaths	O	O	B-T040
due	O	O	O
to	O	O	O
cervical	O	O	B-T191
cancer	O	O	I-T191
.	O	O	O

Uterine	O	O	B-T191
corpus	O	O	I-T191
invasion	O	O	B-T033
was	O	O	O
independently	O	O	B-T078
associated	O	O	B-T080
with	O	O	I-T080
older	O	O	B-T032
age	O	O	I-T032
,	O	O	O
non-squamous	O	O	B-T169
histology	O	O	I-T169
,	O	O	O
high-grade	O	O	B-T191
tumors	O	O	I-T191
,	O	O	O
large	O	O	B-T082
tumor	O	O	I-T082
size	O	O	I-T082
,	O	O	O
and	O	O	O
nodal	O	O	B-T082
metastasis	O	O	B-T191
on	O	O	O
multivariable	O	O	B-T081
analysis	O	O	I-T081
(	O	O	O
all	O	O	O
,	O	O	O
P	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
.	O	O	O

On	O	O	O
univariable	O	O	B-T062
analysis	O	O	I-T062
,	O	O	O
uterine	O	O	B-T191
corpus	O	O	I-T191
tumor	O	O	I-T191
invasion	O	O	B-T033
was	O	O	O
significantly	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
decreased	O	O	B-T081
CSS	O	O	B-T081
compared	O	O	O
to	O	O	O
the	O	O	O
non-invasion	O	O	B-T169
(	O	O	O
5-year	O	O	O
rates	O	O	O
,	O	O	O
79.0	O	O	O
%	O	O	O
versus	O	O	O
94.5	O	O	O
%	O	O	O
,	O	O	O
P	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
.	O	O	O

After	O	O	O
controlling	O	O	B-T067
for	O	O	O
other	O	O	O
significant	O	O	B-T078
prognostic	O	O	B-T201
factors	O	O	I-T201
,	O	O	O
uterine	O	O	B-T191
corpus	O	O	I-T191
tumor	O	O	I-T191
invasion	O	O	B-T033
remained	O	O	O
an	O	O	O
independent	O	O	B-T078
prognostic	O	O	B-T201
factor	O	O	I-T201
for	O	O	O
decreased	O	O	B-T081
CSS	O	O	B-T081
(	O	O	O
adjusted-hazard	O	O	B-T081
ratio	O	O	I-T081
1.45	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
confidence	O	O	B-T081
interval	O	O	I-T081
1.21	O	O	O
-	O	O	O
1.74	O	O	O
)	O	O	O
.	O	O	O

Among	O	O	O
stage	O	O	B-T185
T1b	O	O	I-T185
cases	O	O	O
(	O	O	O
n	O	O	O
=	O	O	O
6730	O	O	O
)	O	O	O
,	O	O	O
uterine	O	O	B-T191
corpus	O	O	I-T191
tumor	O	O	I-T191
invasion	O	O	B-T033
remained	O	O	O
an	O	O	O
independent	O	O	B-T078
prognostic	O	O	B-T201
factor	O	O	I-T201
for	O	O	O
decreased	O	O	B-T081
CSS	O	O	B-T081
(	O	O	O
adjusted-hazard	O	O	B-T081
ratio	O	O	I-T081
1.95	O	O	O
,	O	O	O
95%CI	O	O	O
1.47	O	O	O
-	O	O	O
2.60	O	O	O
)	O	O	O
.	O	O	O

Uterine	O	O	B-T191
corpus	O	O	I-T191
tumor	O	O	I-T191
invasion	O	O	B-T033
was	O	O	O
significantly	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
decreased	O	O	B-T081
CSS	O	O	B-T081
in	O	O	O
stage	O	O	B-T170
T1b1	O	O	I-T170
disease	O	O	B-T191
(	O	O	O
74.5	O	O	O
%	O	O	O
versus	O	O	O
90.7	O	O	O
%	O	O	O
,	O	O	O
P	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
and	O	O	O
in	O	O	O
stage	O	O	B-T170
T1b2	O	O	I-T170
disease	O	O	O
(	O	O	O
67.0	O	O	O
%	O	O	O
versus	O	O	O
79.5	O	O	O
%	O	O	O
,	O	O	O
P	O	O	O
=	O	O	O
0.01	O	O	O
)	O	O	O
.	O	O	O

Uterine	O	O	B-T191
corpus	O	O	I-T191
tumor	O	O	I-T191
invasion	O	O	B-T033
is	O	O	O
an	O	O	O
independent	O	O	B-T078
prognostic	O	O	B-T201
factor	O	O	I-T201
for	O	O	O
decreased	O	O	B-T081
survival	O	O	B-T052
of	O	O	O
women	O	O	B-T098
with	O	O	O
early-stage	O	O	B-T185
cervical	O	O	B-T191
cancer	O	O	I-T191
.	O	O	O

-DOCSTART- (28220186)

Efficient	O	O	O
gene	O	O	B-T063
targeting	O	O	I-T063
in	O	O	O
non-homologous	O	O	B-T169
end-joining	O	O	I-T169
-deficient	O	O	O
Lipomyces	O	O	B-T004
starkeyi	O	O	I-T004
strains	O	O	O

Microbial	O	O	B-T001
lipids	O	O	B-T109
are	O	O	O
sustainable	O	O	O
feedstock	O	O	O
for	O	O	O
the	O	O	O
production	O	O	B-T057
of	O	O	O
oleochemicals	O	O	B-T103
and	O	O	O
biodiesel	O	O	B-T109
.	O	O	O

Oleaginous	O	O	B-T004
yeasts	O	O	I-T004
have	O	O	O
recently	O	O	O
been	O	O	O
proposed	O	O	O
as	O	O	O
alternative	O	O	B-T077
lipid	O	O	B-T109
producers	O	O	B-T004
to	O	O	O
plants	O	O	B-T002
and	O	O	O
animals	O	O	B-T008
to	O	O	O
promote	O	O	O
sustainability	O	O	O
in	O	O	O
the	O	O	O
chemical	O	O	B-T092
and	O	O	O
fuel	O	O	B-T057
industries	O	O	I-T057
.	O	O	O

The	O	O	O
oleaginous	O	O	B-T004
yeast	O	O	I-T004
Lipomyces	O	O	B-T004
starkeyi	O	O	I-T004
has	O	O	O
great	O	O	O
industrial	O	O	O
potential	O	O	O
as	O	O	O
an	O	O	O
excellent	O	O	O
lipid	O	O	B-T109
producer	O	O	B-T004
.	O	O	O

However	O	O	O
,	O	O	O
improvement	O	O	O
of	O	O	O
its	O	O	O
lipid	O	O	B-T109
productivity	O	O	B-T052
is	O	O	O
essential	O	O	O
for	O	O	O
the	O	O	O
cost-effective	O	O	B-T057
production	O	O	I-T057
of	O	O	O
oleochemicals	O	O	B-T103
and	O	O	O
fuels	O	O	B-T073
.	O	O	O

Genetic	O	O	B-T063
and	O	O	O
metabolic	O	O	B-T063
engineering	O	O	I-T063
of	O	O	O
L.	O	O	B-T004
starkeyi	O	O	I-T004
via	O	O	O
gene	O	O	O
manipulation	O	O	O
techniques	O	O	O
may	O	O	O
result	O	O	O
in	O	O	O
improvements	O	O	O
in	O	O	O
lipid	O	O	B-T109
production	O	O	B-T057
and	O	O	O
our	O	O	O
understanding	O	O	O
of	O	O	O
the	O	O	O
mechanisms	O	O	B-T169
behind	O	O	O
lipid	O	O	O
biosynthesis	O	O	B-T169
pathways	O	O	I-T169
.	O	O	O

We	O	O	O
previously	O	O	O
described	O	O	O
an	O	O	O
integrative	O	O	B-T169
transformation	O	O	I-T169
system	O	O	I-T169
using	O	O	O
a	O	O	O
drug	O	O	B-T121
-resistant	O	O	O
marker	O	O	B-T045
for	O	O	O
L.	O	O	B-T004
starkeyi	O	O	I-T004
.	O	O	O

However	O	O	O
,	O	O	O
gene-targeting	O	O	B-T063
frequencies	O	O	B-T081
were	O	O	O
very	O	O	O
low	O	O	O
because	O	O	O
non-homologous	O	O	B-T045
recombination	O	O	I-T045
is	O	O	O
probably	O	O	O
predominant	O	O	O
in	O	O	O
L.	O	O	B-T004
starkeyi	O	O	I-T004
.	O	O	O

Genetic	O	O	B-T063
engineering	O	O	I-T063
tools	O	O	I-T063
for	O	O	O
L.	O	O	B-T004
starkeyi	O	O	I-T004
have	O	O	O
not	O	O	O
been	O	O	O
sufficiently	O	O	O
developed	O	O	O
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	O
,	O	O	O
we	O	O	O
describe	O	O	O
a	O	O	O
new	O	O	O
genetic	O	O	B-T063
tool	O	O	I-T063
and	O	O	O
its	O	O	O
application	O	O	B-T169
in	O	O	O
L.	O	O	B-T004
starkeyi	O	O	I-T004
.	O	O	O

To	O	O	O
develop	O	O	O
a	O	O	O
highly	O	O	O
efficient	O	O	O
gene-targeting	O	O	B-T063
system	O	O	I-T063
for	O	O	O
L.	O	O	B-T004
starkeyi	O	O	I-T004
,	O	O	O
we	O	O	O
constructed	O	O	O
a	O	O	O
series	O	O	O
of	O	O	O
mutants	O	O	B-T028
by	O	O	O
disrupting	O	O	B-T080
genes	O	O	B-T028
for	O	O	O
LsKu70p	O	O	B-T116
,	O	O	O
LsKu80p	O	O	B-T116
,	O	O	O
and/or	O	O	O
LsLig4p	O	O	B-T116
,	O	O	O
which	O	O	O
share	O	O	O
homology	O	O	B-T080
with	O	O	O
other	O	O	O
yeasts	O	O	B-T004
Ku70p	O	O	B-T116
,	O	O	O
Ku80p	O	O	B-T116
,	O	O	O
and	O	O	O
Lig4p	O	O	B-T116
,	O	O	O
respectively	O	O	O
,	O	O	O
being	O	O	O
involved	O	O	O
in	O	O	O
non-homologous	O	O	B-T169
end-joining	O	O	I-T169
pathway	O	O	I-T169
.	O	O	O

Deletion	O	O	B-T045
of	O	O	O
the	O	O	O
LsLIG4	O	O	B-T028
gene	O	O	I-T028
dramatically	O	O	O
improved	O	O	O
the	O	O	O
homologous	O	O	B-T045
recombination	O	O	I-T045
efficiency	O	O	B-T081
(	O	O	O
80.0	O	O	O
%	O	O	O
)	O	O	O
at	O	O	O
the	O	O	O
LsURA3	O	O	B-T028
locus	O	O	B-T082
compared	O	O	O
with	O	O	O
that	O	O	O
in	O	O	O
the	O	O	O
wild-type	O	O	B-T028
strain	O	O	B-T001
(	O	O	O
1.4	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
when	O	O	O
2000-bp	O	O	B-T086
homologous	O	O	I-T086
flanking	O	O	I-T086
regions	O	O	I-T086
were	O	O	O
used	O	O	O
.	O	O	O

The	O	O	O
homologous	O	O	B-T045
recombination	O	O	I-T045
efficiencies	O	O	B-T081
of	O	O	O
the	O	O	O
double	O	O	O
mutant	O	O	B-T028
âl	O	O	B-T028
sku70âlslig4	O	O	I-T028
and	O	O	O
the	O	O	O
triple	O	O	O
mutant	O	O	O
âlsku70âlsku80âlslig4	O	O	B-T028
were	O	O	O
also	O	O	O
markedly	O	O	O
enhanced	O	O	O
.	O	O	O

Therefore	O	O	O
,	O	O	O
the	O	O	O
L.	O	O	B-T004
starkeyi	O	O	I-T004
âlslig4	O	O	B-T028
background	O	O	O
strains	O	O	B-T001
have	O	O	O
promise	O	O	O
as	O	O	O
efficient	O	O	O
recipient	O	O	B-T001
strains	O	O	I-T001
for	O	O	O
genetic	O	O	B-T063
and	O	O	O
metabolic	O	O	B-T063
engineering	O	O	I-T063
approaches	O	O	B-T169
in	O	O	O
this	O	O	O
yeast	O	O	B-T004
.	O	O	O

-DOCSTART- (28220959)

Evaluating	O	O	O
clinical	O	O	B-T080
,	O	O	O
dietary	O	O	B-T168
and	O	O	O
psychological	O	O	B-T169
risk	O	O	B-T033
factors	O	O	I-T033
for	O	O	O
relapse	O	O	B-T067
of	O	O	O
ulcerative	O	O	B-T047
colitis	O	O	I-T047
in	O	O	O
clinical	O	O	O
,	O	O	O
endoscopic	O	O	B-T082
and	O	O	O
histological	O	O	B-T169
remission	O	O	O

The	O	O	O
literature	O	O	O
on	O	O	O
possible	O	O	O
factors	O	O	O
that	O	O	O
could	O	O	O
trigger	O	O	O
a	O	O	O
relapse	O	O	B-T067
in	O	O	O
patients	O	O	B-T101
with	O	O	O
ulcerative	O	O	B-T047
colitis	O	O	I-T047
(	O	O	O
UC	O	O	B-T047
)	O	O	O
in	O	O	O
clinical	O	O	B-T080
,	O	O	O
endoscopic	O	O	B-T082
and	O	O	O
histological	O	O	B-T169
remission	O	O	B-T046
on	O	O	O
long	O	O	O
term	O	O	O
follow	O	O	B-T058
up	O	O	I-T058
is	O	O	O
scarce	O	O	O
.	O	O	O

To	O	O	O
determine	O	O	O
the	O	O	O
relapse	O	O	B-T067
rate	O	O	O
in	O	O	O
patients	O	O	B-T101
with	O	O	O
UC	O	O	B-T047
in	O	O	O
clinical	O	O	B-T080
,	O	O	O
endoscopic	O	O	B-T082
and	O	O	O
histological	O	O	B-T169
remission	O	O	B-T046
and	O	O	O
identify	O	O	O
factors	O	O	O
that	O	O	O
may	O	O	O
influence	O	O	O
the	O	O	O
risk	O	O	B-T078
of	O	O	O
relapse	O	O	O
.	O	O	O

Patients	O	O	B-T101
with	O	O	O
UC	O	O	B-T047
in	O	O	O
clinical	O	O	B-T080
,	O	O	O
endoscopic	O	O	B-T082
and	O	O	O
histological	O	O	B-T169
remission	O	O	B-T046
were	O	O	O
enrolled	O	O	O
between	O	O	O
January-July	O	O	O
2010	O	O	O
and	O	O	O
followed	O	O	B-T058
up	O	O	I-T058
for	O	O	O
1	O	O	O
year	O	O	B-T079
to	O	O	O
determine	O	O	O
the	O	O	O
effect	O	O	O
of	O	O	O
clinical	O	O	O
,	O	O	O
dietary	O	O	B-T168
and	O	O	O
psychological	O	O	B-T169
factors	O	O	B-T033
on	O	O	O
relapse	O	O	B-T067
.	O	O	O

Information	O	O	O
regarding	O	O	O
factors	O	O	O
that	O	O	O
may	O	O	O
affect	O	O	O
relapse	O	O	B-T067
such	O	O	O
as	O	O	O
infection	O	O	B-T046
,	O	O	O
antibiotic	O	O	B-T195
or	O	O	O
NSAIDs	O	O	B-T121
use	O	O	O
and	O	O	O
any	O	O	O
other	O	O	O
factor	O	O	O
which	O	O	O
the	O	O	O
patient	O	O	B-T101
felt	O	O	O
important	O	O	O
,	O	O	O
and	O	O	O
compliance	O	O	B-T055
with	O	O	O
medications	O	O	B-T058
was	O	O	O
obtained	O	O	O
.	O	O	O

97	O	O	O
patients	O	O	B-T101
(	O	O	O
59	O	O	O
males	O	O	B-T098
,	O	O	O
mean	O	O	O
age	O	O	B-T032
39	O	O	O
+	O	O	O
11.9	O	O	O
years	O	O	B-T079
)	O	O	O
were	O	O	O
followed	O	O	B-T058
up	O	O	I-T058
for	O	O	O
a	O	O	O
mean	O	O	O
duration	O	O	O
of	O	O	O
9	O	O	O
+	O	O	O
2.3	O	O	O
months	O	O	B-T079
.	O	O	O

18(18.6	O	O	O
%	O	O	O
)	O	O	O
relapsed	O	O	B-T067
with	O	O	O
the	O	O	O
median	O	O	O
time	O	O	O
to	O	O	O
relapse	O	O	B-T067
being	O	O	O
3.5	O	O	O
months	O	O	B-T079
.	O	O	O

On	O	O	O
univariate	O	O	B-T062
analysis	O	O	I-T062
more	O	O	O
relapsers	O	O	O
had	O	O	O
significantly	O	O	O
higher	O	O	O
NSAIDs	O	O	B-T121
use	O	O	O
within	O	O	O
15	O	O	O
days	O	O	B-T079
of	O	O	O
relapse	O	O	B-T067
,	O	O	O
respiratory	O	O	B-T047
tract	O	O	I-T047
infection	O	O	I-T047
within	O	O	O
4	O	O	O
weeks	O	O	B-T079
,	O	O	O
use	O	O	O
of	O	O	O
steroids	O	O	B-T109
more	O	O	O
than	O	O	O
once	O	O	O
in	O	O	O
past	O	O	O
,	O	O	O
higher	O	O	O
consumption	O	O	B-T039
of	O	O	O
calcium	O	O	B-T121
,	O	O	O
riboflavin	O	O	B-T127
,	O	O	O
vitamin	O	O	B-T127
A	O	O	I-T127
and	O	O	O
lower	O	O	O
consumption	O	O	O
of	O	O	O
sugars	O	O	B-T109
.	O	O	O

On	O	O	O
multivariate	O	O	B-T081
analysis	O	O	I-T081
,	O	O	O
NSAIDs	O	O	B-T121
use	O	O	O
[HR(95%CI):6.41(1.88	O	O	O
-	O	O	O
21.9)]and	O	O	O
intake	O	O	B-T169
of	O	O	O
Vitamin	O	O	B-T127
A	O	O	I-T127
[	O	O	O
HR(95%CI):1.008(1.000	O	O	O
-	O	O	O
1.016	O	O	O
)	O	O	O
]	O	O	O
were	O	O	O
statistically	O	O	O
significant	O	O	O
predictors	O	O	B-T078
of	O	O	O
relapse	O	O	B-T067
.	O	O	O

With	O	O	O
a	O	O	O
relapse	O	O	B-T067
rate	O	O	O
of	O	O	O
18.6	O	O	O
%	O	O	O
over	O	O	O
a	O	O	O
follow	O	O	B-T058
up	O	O	I-T058
of	O	O	O
9	O	O	O
months	O	O	B-T079
in	O	O	O
patients	O	O	B-T101
with	O	O	O
UC	O	O	B-T047
in	O	O	O
clinical	O	O	B-T080
,	O	O	O
endoscopic	O	O	B-T082
and	O	O	O
histological	O	O	B-T169
remission	O	O	B-T046
,	O	O	O
independent	O	O	O
predictors	O	O	B-T078
of	O	O	O
relapse	O	O	O
were	O	O	O
history	O	O	O
of	O	O	O
NSAIDs	O	O	B-T121
use	O	O	O
within	O	O	O
15	O	O	O
days	O	O	B-T079
of	O	O	O
relapse	O	O	O
and	O	O	O
higher	O	O	O
intake	O	O	O
of	O	O	O
Vitamin	O	O	O
A.	O	O	O

-DOCSTART- (28221032)

High	O	O	O
Performance	O	O	O
Reduction	O	O	B-T070
of	O	O	O
H2O2	O	O	B-T121
with	O	O	O
an	O	O	O
Electron	O	O	B-T044
Transport	O	O	I-T044
Decaheme	O	O	B-T116
Cytochrome	O	O	I-T116
on	O	O	O
a	O	O	O
Porous	O	O	O
ITO	O	O	B-T197
Electrode	O	O	O

The	O	O	O
decaheme	O	O	B-T116
cytochrome	O	O	I-T116
MtrC	O	O	I-T116
from	O	O	O
Shewanella	O	O	B-T007
oneidensis	O	O	I-T007
MR-1	O	O	I-T007
immobilized	O	O	B-T116
on	O	O	O
an	O	O	O
ITO	O	O	B-T197
electrode	O	O	B-T073
displays	O	O	O
unprecedented	O	O	O
H2O2	O	O	B-T121
reduction	O	O	B-T070
activity	O	O	O
.	O	O	O

Although	O	O	O
MtrC	O	O	B-T116
showed	O	O	O
lower	O	O	O
peroxidase	O	O	B-T044
activity	O	O	I-T044
in	O	O	O
solution	O	O	O
compared	O	O	O
to	O	O	O
horseradish	O	O	B-T116
peroxidase	O	O	I-T116
,	O	O	O
the	O	O	O
ten	O	O	O
heme	O	O	B-T109
cofactors	O	O	B-T109
enable	O	O	O
excellent	O	O	O
electronic	O	O	B-T170
communication	O	O	I-T170
and	O	O	O
a	O	O	O
superior	O	O	O
activity	O	O	O
on	O	O	O
the	O	O	O
electrode	O	O	B-T073
surface	O	O	O
.	O	O	O

A	O	O	O
hierarchical	O	O	O
ITO	O	O	B-T197
electrode	O	O	B-T073
enabled	O	O	O
optimal	O	O	O
immobilization	O	O	B-T067
of	O	O	O
MtrC	O	O	B-T116
and	O	O	O
a	O	O	O
high	O	O	O
current	O	O	B-T081
density	O	O	I-T081
of	O	O	O
1	O	O	O
mA	O	O	O
cm(-2	O	O	O
)	O	O	O
at	O	O	O
0.4	O	O	O
V	O	O	O
vs	O	O	O
SHE	O	O	B-T073
could	O	O	O
be	O	O	O
obtained	O	O	O
at	O	O	O
pH	O	O	O
6.5	O	O	O
(	O	O	O
Eonset	O	O	O
=	O	O	O
0.72	O	O	O
V	O	O	O
)	O	O	O
.	O	O	O

UV-visible	O	O	B-T070
and	O	O	O
Resonance	O	O	B-T059
Raman	O	O	I-T059
spectroelectrochemical	O	O	I-T059
studies	O	O	I-T059
suggest	O	O	O
the	O	O	O
formation	O	O	O
of	O	O	O
a	O	O	O
high	O	O	O
valent	O	O	O
iron-oxo	O	O	O
species	O	O	O
as	O	O	O
the	O	O	O
catalytic	O	O	B-T070
intermediate	O	O	O
.	O	O	O

Our	O	O	O
findings	O	O	O
demonstrate	O	O	O
the	O	O	O
potential	O	O	B-T080
of	O	O	O
multiheme	O	O	B-T116
cytochromes	O	O	I-T116
to	O	O	O
catalyze	O	O	B-T070
technologically	O	O	B-UnknownType
relevant	O	O	O
reactions	O	O	O
and	O	O	O
establish	O	O	O
MtrC	O	O	B-T116
as	O	O	O
a	O	O	O
new	O	O	O
benchmark	O	O	O
in	O	O	O
biotechnological	O	O	B-T091
H2O2	O	O	B-T121
reduction	O	O	B-T070
with	O	O	O
scope	O	O	O
for	O	O	O
applications	O	O	O
in	O	O	O
fuel	O	O	B-T073
cells	O	O	I-T073
and	O	O	O
biosensors	O	O	B-T075
.	O	O	O

-DOCSTART- (28221291)

Ophthalmic	O	O	B-T184
Manifestations	O	O	I-T184
of	O	O	O
Facial	O	O	B-T029
Dog	O	O	B-T037
Bites	O	O	I-T037
in	O	O	O
Children	O	O	O

To	O	O	O
characterize	O	O	O
ophthalmic	O	O	B-T184
manifestations	O	O	I-T184
and	O	O	O
periocular	O	O	B-T037
injuries	O	O	I-T037
of	O	O	O
pediatric	O	O	B-T080
facial	O	O	B-T029
dog	O	O	B-T037
bites	O	O	I-T037
.	O	O	O

A	O	O	O
retrospective	O	O	B-T080
review	O	O	B-T170
of	O	O	O
all	O	O	O
children	O	O	B-T100
younger	O	O	B-T079
than	O	O	O
18	O	O	O
years	O	O	B-T079
who	O	O	O
sought	O	O	O
medical	O	O	B-T169
attention	O	O	B-T041
after	O	O	O
a	O	O	O
dog	O	O	B-T037
bite	O	O	I-T037
to	O	O	O
the	O	O	O
face	O	O	B-T029
between	O	O	O
January	O	O	B-T080
1	O	O	O
,	O	O	O
2003	O	O	O
and	O	O	O
May	O	O	B-T079
22	O	O	O
,	O	O	O
2014	O	O	O
was	O	O	O
performed	O	O	B-T169
at	O	O	O
a	O	O	O
large	O	O	B-T081
tertiary	O	O	I-T081
pediatric	O	O	B-T093
hospital	O	O	I-T093
.	O	O	O

Data	O	O	B-T078
on	O	O	O
type	O	O	B-T080
and	O	O	O
location	O	O	B-T033
of	O	O	I-T033
injury	O	O	I-T033
,	O	O	O
surgical	O	O	B-T033
intervention	O	O	I-T033
,	O	O	O
and	O	O	O
complications	O	O	B-T046
were	O	O	O
collected	O	O	B-T169
.	O	O	O

A	O	O	O
total	O	O	B-T080
of	O	O	O
1,989	O	O	O
children	O	O	B-T100
aged	O	O	B-T032
0.19	O	O	O
to	O	O	O
17	O	O	O
years	O	O	B-T079
were	O	O	O
identified	O	O	B-T080
with	O	O	O
dog	O	O	B-T037
bite	O	O	I-T037
s.	O	O	O
Dog	O	O	B-T037
bite	O	O	I-T037
s	O	O	O
to	O	O	O
the	O	O	O
face	O	O	B-T029
occurred	O	O	B-T079
in	O	O	O
most	O	O	B-T081
patients	O	O	B-T101
(	O	O	O
n	O	O	O
=	O	O	O
1	O	O	O
,	O	O	O
414	O	O	O
[	O	O	O
71	O	O	O
%	O	O	O
]	O	O	O
)	O	O	O
.	O	O	O

Of	O	O	O
those	O	O	O
children	O	O	B-T100
with	O	O	O
facial	O	O	B-T029
dog	O	O	B-T037
bite	O	O	I-T037
injuries	O	O	I-T037
,	O	O	O
230	O	O	O
(	O	O	O
16	O	O	O
%	O	O	O
)	O	O	O
suffered	O	O	B-T048
ophthalmic	O	O	B-T184
manifestations	O	O	I-T184
.	O	O	O

The	O	O	O
average	O	O	B-T081
age	O	O	B-T032
was	O	O	O
4.3	O	O	O
years	O	O	B-T079
.	O	O	O

Eyelid	O	O	B-T037
injuries	O	O	B-T037
occurred	O	O	B-T079
in	O	O	O
227	O	O	O
(	O	O	O
99	O	O	O
%	O	O	O
)	O	O	O
of	O	O	O
children	O	O	B-T100
,	O	O	O
47	O	O	O
(	O	O	O
20	O	O	O
%	O	O	O
)	O	O	O
sustained	O	O	B-T169
canalicular	O	O	B-T022
system	O	O	I-T022
injuries	O	O	O
,	O	O	O
3	O	O	O
(	O	O	O
1.3	O	O	O
%	O	O	O
)	O	O	O
suffered	O	O	B-T048
corneal	O	O	B-T037
abrasions	O	O	I-T037
,	O	O	O
and	O	O	O
2	O	O	O
patients	O	O	B-T101
sustained	O	O	O
facial	O	O	B-T029
nerve	O	O	B-T037
injury	O	O	I-T037
resulting	O	O	B-T169
in	O	O	I-T169
lagophthalmos	O	O	B-T047
.	O	O	O

No	O	O	O
patients	O	O	B-T101
suffered	O	O	B-T048
vision	O	O	B-T033
loss	O	O	I-T033
.	O	O	O

Complications	O	O	B-T046
occurred	O	O	B-T079
in	O	O	O
32	O	O	O
patients	O	O	B-T101
(	O	O	O
14	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
with	O	O	O
the	O	O	O
most	O	O	B-T081
common	O	O	B-T169
being	O	O	O
epiphora	O	O	B-T204
in	O	O	O
9	O	O	O
patients	O	O	O
(	O	O	O
28	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
upper	O	O	B-UnknownType
eyelid	O	O	I-UnknownType
ptosis	O	O	I-UnknownType
in	O	O	O
8	O	O	O
(	O	O	O
25	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
prominent	O	O	B-T080
scar	O	O	B-T033
formation	O	O	I-T033
in	O	O	O
4	O	O	O
patients	O	O	O
(	O	O	O
13	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

Thirteen	O	O	O
children	O	O	B-T100
(	O	O	O
5.7	O	O	O
%	O	O	O
)	O	O	O
needed	O	O	B-T080
one	O	O	O
or	O	O	O
more	O	O	O
secondary	O	O	B-T061
procedure	O	O	I-T061
to	O	O	O
correct	O	O	B-T080
complications	O	O	B-T046
.	O	O	O

The	O	O	O
authors	O	O	B-T097
report	O	O	B-T170
the	O	O	O
clinical	O	O	B-T080
features	O	O	I-T080
and	O	O	O
management	O	O	B-T090
on	O	O	O
the	O	O	O
largest	O	O	B-T081
series	O	O	I-T081
of	O	O	O
ophthalmic	O	O	B-T037
and	O	O	O
periocular	O	O	B-T037
injuries	O	O	B-T037
associated	O	O	B-T080
with	O	O	I-T080
pediatric	O	O	B-T080
facial	O	O	B-T029
dog	O	O	B-T037
bite	O	O	I-T037
s.	O	O	O
These	O	O	O
injuries	O	O	O
occur	O	O	B-T079
in	O	O	O
about	O	O	O
1	O	O	O
in	O	O	O
6	O	O	O
dog	O	O	B-T037
bite	O	O	I-T037
s	O	O	I-T037
to	O	O	O
the	O	O	O
face	O	O	B-T029
and	O	O	O
primarily	O	O	O
involve	O	O	O
the	O	O	O
ocular	O	O	B-T023
adnexa	O	O	I-T023
.	O	O	O

Despite	O	O	O
early	O	O	B-T079
and	O	O	O
appropriate	O	O	B-T080
surgical	O	O	B-T058
management	O	O	I-T058
,	O	O	O
complications	O	O	B-T046
and	O	O	O
the	O	O	O
need	O	O	B-T080
for	O	O	O
revision	O	O	B-T061
surgery	O	O	I-T061
are	O	O	O
relatively	O	O	O
common	O	O	B-T169
.	O	O	O

-DOCSTART- (28222192)

Blastocystis	O	O	B-T204
subtyping	O	O	I-T204
and	O	O	O
its	O	O	O
association	O	O	O
with	O	O	O
intestinal	O	O	B-T047
parasites	O	O	I-T047
in	O	O	O
children	O	O	B-T100
from	O	O	O
different	O	O	O
geographical	O	O	O
regions	O	O	O
of	O	O	O
Colombia	O	O	O

Blastocystis	O	O	B-T204
is	O	O	O
a	O	O	O
common	O	O	O
enteric	O	O	B-T033
protist	O	O	I-T033
colonizing	O	O	I-T033
probably	O	O	O
more	O	O	O
than	O	O	O
1	O	O	O
billion	O	O	O
people	O	O	B-T098
with	O	O	O
a	O	O	O
large	O	O	O
variety	O	O	O
of	O	O	O
non-human	O	O	B-T001
hosts	O	O	I-T001
.	O	O	O

Remarkable	O	O	O
genetic	O	O	B-T070
diversity	O	O	I-T070
has	O	O	O
been	O	O	O
observed	O	O	O
,	O	O	O
leading	O	O	O
to	O	O	O
the	O	O	O
subdivision	O	O	B-T185
of	O	O	I-T185
the	O	O	I-T185
genus	O	O	I-T185
into	O	O	O
multiple	O	O	B-T185
subtypes	O	O	I-T185
(	O	O	O
ST	O	O	B-T185
)	O	O	O
,	O	O	O
some	O	O	O
of	O	O	O
which	O	O	O
are	O	O	O
exclusively	O	O	O
found	O	O	O
in	O	O	O
non-human	O	O	B-T001
hosts	O	O	I-T001
.	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
this	O	O	O
study	O	O	O
was	O	O	O
to	O	O	O
determine	O	O	O
the	O	O	O
distribution	O	O	O
of	O	O	O
Blastocystis	O	O	B-T204
STs	O	O	I-T204
/	O	O	O
18S	O	O	B-T028
alleles	O	O	I-T028
in	O	O	O
symptomatic	O	O	B-T169
(	O	O	O
abdominal	O	O	B-T184
pain	O	O	I-T184
,	O	O	O
anal	O	O	B-T184
pruritus	O	O	I-T184
,	O	O	O
diarrhea	O	O	B-T184
,	O	O	O
headache	O	O	B-T184
,	O	O	O
nauseas	O	O	B-T184
and/or	O	O	O
vomit	O	O	B-T184
)	O	O	O
and	O	O	O
asymptomatic	O	O	B-T033
children	O	O	B-T100
from	O	O	O
nine	O	O	O
geographical	O	O	B-T083
regions	O	O	I-T083
of	O	O	I-T083
Colombia	O	O	I-T083
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
2026	O	O	O
fecal	O	O	B-T058
samples	O	O	I-T058
were	O	O	O
collected	O	O	O
as	O	O	O
part	O	O	O
of	O	O	O
a	O	O	O
national	O	O	B-T062
survey	O	O	I-T062
to	O	O	O
estimate	O	O	O
the	O	O	O
frequency	O	O	O
of	O	O	O
intestinal	O	O	B-T047
parasites	O	O	I-T047
in	O	O	O
children	O	O	B-T100
.	O	O	O

A	O	O	O
set	O	O	O
of	O	O	O
256	O	O	O
samples	O	O	O
that	O	O	O
were	O	O	O
Blastocystis	O	O	B-T204
positive	O	O	I-T204
was	O	O	O
finally	O	O	O
selected	O	O	O
.	O	O	O

The	O	O	O
samples	O	O	O
were	O	O	O
submitted	O	O	O
to	O	O	O
DNA	O	O	B-T063
extraction	O	O	I-T063
,	O	O	O
Real	O	O	B-T063
Time	O	O	I-T063
PCR	O	O	I-T063
and	O	O	O
sequencing	O	O	B-T059
using	O	O	O
Blastocystis	O	O	B-T047
-specific	O	O	O
primers	O	O	B-T114
targeting	O	O	O
the	O	O	O
small	O	O	B-T026
subunit	O	O	I-T026
rRNA	O	O	B-T028
gene	O	O	I-T028
for	O	O	O
ST	O	O	B-T059
identification	O	O	I-T059
.	O	O	O

DNA	O	O	B-T114
of	O	O	O
Ascaris	O	O	B-T204
lumbricoides	O	O	I-T204
(	O	O	O
16.4	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
Trichuris	O	O	B-T204
trichiura	O	O	I-T204
(	O	O	O
8.2	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
hookworms	O	O	B-T204
(	O	O	O
Necator	O	O	B-T204
americanus	O	O	I-T204
/	O	O	O
Ancylostoma	O	O	B-T204
duodenale	O	O	I-T204
)	O	O	O
(	O	O	O
7.3	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
Giardia	O	O	B-T204
duodenalis	O	O	I-T204
(	O	O	O
23.1	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
Entamoeba	O	O	B-T204
complex	O	O	I-T204
(	O	O	O
82	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
Entamoeba	O	O	B-T204
coli	O	O	I-T204
(	O	O	O
55	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
Hymenolepis	O	O	B-T204
nana	O	O	I-T204
(	O	O	O
0.8	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
Endolimax	O	O	B-T204
nana	O	O	I-T204
(	O	O	O
33.2	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
Neobalantidium	O	O	B-T204
coli	O	O	I-T204
(	O	O	O
2.7	O	O	O
%	O	O	O
)	O	O	O
was	O	O	O
detected	O	O	O
in	O	O	O
the	O	O	O
Blastocystis	O	O	B-T204
-	O	O	O
positive	O	O	B-T033
samples	O	O	I-T033
.	O	O	O

We	O	O	O
detected	O	O	O
ST1	O	O	B-T204
(	O	O	O
21.4	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
ST2	O	O	B-T204
(	O	O	O
19.5	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
ST3	O	O	B-T204
(	O	O	O
55.5	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
ST4	O	O	B-T204
(	O	O	O
0.8	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
ST6	O	O	B-T204
(	O	O	O
2	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
ST7	O	O	B-T204
(	O	O	O
0.8	O	O	O
%	O	O	O
)	O	O	O
;	O	O	O
alleles	O	O	B-T028
1	O	O	O
,	O	O	O
2	O	O	O
,	O	O	O
4	O	O	O
,	O	O	O
81	O	O	O
,	O	O	O
82	O	O	O
and	O	O	O
83	O	O	O
for	O	O	O
ST1	O	O	O
;	O	O	O
alleles	O	O	O
9	O	O	O
,	O	O	O
11	O	O	O
,	O	O	O
12	O	O	O
,	O	O	O
15	O	O	O
,	O	O	O
67	O	O	O
,	O	O	O
71	O	O	O
and	O	O	O
73	O	O	O
for	O	O	O
ST2	O	O	O
;	O	O	O
alleles	O	O	O
34	O	O	O
,	O	O	O
36	O	O	O
,	O	O	O
38	O	O	O
,	O	O	O
45	O	O	O
,	O	O	O
49	O	O	O
,	O	O	O
55	O	O	O
,	O	O	O
134	O	O	O
and	O	O	O
128	O	O	O
for	O	O	O
ST3	O	O	O
;	O	O	O
allele	O	O	B-T028
42	O	O	O
for	O	O	O
ST4	O	O	O
;	O	O	O
allele	O	O	O
122	O	O	O
for	O	O	O
ST6	O	O	O
,	O	O	O
and	O	O	O
allele	O	O	O
142	O	O	O
for	O	O	O
ST7	O	O	O
.	O	O	O

Further	O	O	O
studies	O	O	O
implementing	O	O	O
high-resolution	O	O	B-T059
molecular	O	O	B-T201
markers	O	O	I-T201
are	O	O	O
necessary	O	O	O
to	O	O	O
understand	O	O	O
the	O	O	O
dynamics	O	O	O
of	O	O	O
Blastocystis	O	O	B-T204
transmission	O	O	B-T070
and	O	O	O
the	O	O	O
role	O	O	O
of	O	O	O
this	O	O	O
Stramenopila	O	O	B-T204
in	O	O	O
health	O	O	B-T070
and	O	O	I-T070
disease	O	O	I-T070
.	O	O	O

-DOCSTART- (28223077)

Did	O	O	O
municipal	O	O	B-T167
solid	O	O	I-T167
waste	O	O	I-T167
landfill	O	O	B-T083
have	O	O	O
obvious	O	O	O
influence	O	O	B-T077
on	O	O	O
polychlorinated	O	O	B-T109
dibenzo-p-dioxins	O	O	I-T109
and	O	O	O
polychlorinated	O	O	B-T109
dibenzofurans	O	O	I-T109
(	O	O	O
PCDD	O	O	B-T109
/	O	O	O
Fs	O	O	B-T109
)	O	O	O
in	O	O	O
ambient	O	O	B-T167
air	O	O	I-T167
:	O	O	O
A	O	O	O
case	O	O	B-T170
study	O	O	I-T170
in	O	O	O
East	O	O	O
China	O	O	O

Municipal	O	O	B-T167
solid	O	O	I-T167
waste	O	O	I-T167
(	O	O	O
MSW	O	O	B-T167
)	O	O	O
landfill	O	O	B-T083
was	O	O	O
a	O	O	O
main	O	O	O
way	O	O	O
to	O	O	O
disposal	O	O	B-T052
of	O	O	O
MSW	O	O	O
and	O	O	O
almost	O	O	O
95	O	O	O
%	O	O	O
of	O	O	O
MSW	O	O	O
was	O	O	O
disposed	O	O	B-T052
by	O	O	O
landfills	O	O	B-T083
in	O	O	O
the	O	O	O
world	O	O	B-T098
.	O	O	O

In	O	O	O
order	O	O	O
to	O	O	O
understand	O	O	O
the	O	O	O
influence	O	O	B-T077
of	O	O	O
MSW	O	O	B-T167
landfill	O	O	B-T083
on	O	O	O
polychlorinated	O	O	B-T109
dibenzo-p-dioxins	O	O	I-T109
and	O	O	O
polychlorinated	O	O	B-T109
dibenzofurans	O	O	I-T109
(	O	O	O
PCDD	O	O	B-T109
/	O	O	O
Fs	O	O	B-T109
)	O	O	O
in	O	O	O
surrounding	O	O	B-T070
atmosphere	O	O	I-T070
,	O	O	O
42	O	O	O
ambient	O	O	B-T167
air	O	O	I-T167
samples	O	O	O
were	O	O	O
collected	O	O	O
and	O	O	O
analyzed	O	O	B-T062
from	O	O	O
surrounding	O	O	B-T082
sites	O	O	I-T082
,	O	O	O
background	O	O	B-T082
site	O	O	I-T082
,	O	O	O
upwind	O	O	B-T082
site	O	O	I-T082
and	O	O	O
downwind	O	O	B-T082
site	O	O	I-T082
of	O	O	O
a	O	O	O
MSW	O	O	O
landfill	O	O	O
in	O	O	O
East	O	O	B-T083
China	O	O	I-T083
.	O	O	O

The	O	O	O
results	O	O	O
of	O	O	O
present	O	O	O
study	O	O	B-T062
were	O	O	O
summarized	O	O	O
as	O	O	O
follows	O	O	O
.	O	O	O

(	O	O	O
1	O	O	O
)	O	O	O
The	O	O	O
total	O	O	O
concentrations	O	O	B-T081
of	O	O	O
PCDD	O	O	B-T109
/	O	O	O
Fs	O	O	B-T109
(	O	O	O
â	O	O	O
PCDD	O	O	O
/	O	O	O
Fs	O	O	O
)	O	O	O
in	O	O	O
ambient	O	O	B-T167
air	O	O	I-T167
from	O	O	O
surrounding	O	O	B-T082
sites	O	O	I-T082
,	O	O	O
background	O	O	B-T082
site	O	O	I-T082
,	O	O	O
upwind	O	O	B-T082
site	O	O	I-T082
and	O	O	O
downwind	O	O	B-T082
site	O	O	I-T082
were	O	O	O
2.215Â±1.004	O	O	O
,	O	O	O
2.058Â±0.458	O	O	O
,	O	O	O
2.617Â±1.092	O	O	O
and	O	O	O
1.822Â±0.566pgNm(-3	O	O	O
)	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

(	O	O	O
2	O	O	O
)	O	O	O
The	O	O	O
toxic	O	O	B-T081
equivalent	O	O	I-T081
concentrations	O	O	I-T081
(	O	O	O
TEQ	O	O	B-T081
)	O	O	O
of	O	O	O
PCDD	O	O	B-T109
/	O	O	O
Fs	O	O	B-T109
in	O	O	O
ambient	O	O	B-T167
air	O	O	I-T167
from	O	O	O
surrounding	O	O	B-T082
sites	O	O	I-T082
,	O	O	O
background	O	O	B-T082
site	O	O	I-T082
,	O	O	O
upwind	O	O	B-T082
site	O	O	I-T082
and	O	O	O
downwind	O	O	B-T082
site	O	O	I-T082
were	O	O	O
0.103Â±0.017	O	O	O
,	O	O	O
0.096Â±0.015	O	O	O
,	O	O	O
0.120Â±0.024	O	O	O
and	O	O	O
0.108Â±0.014pg	O	O	O
I-TEQNm(-3	O	O	O
)	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

(	O	O	O
3	O	O	O
)	O	O	O
The	O	O	O
congener	O	O	B-T059
profiles	O	O	I-T059
,	O	O	O
â	O	O	O
PCDD	O	O	B-T109
/	O	O	O
Fs	O	O	B-T109
and	O	O	O
TEQ	O	O	B-T081
between	O	O	O
background	O	O	B-T070
atmosphere	O	O	I-T070
and	O	O	O
surrounding	O	O	B-T070
atmosphere	O	O	I-T070
of	O	O	O
landfill	O	O	B-T083
did	O	O	O
not	O	O	O
show	O	O	O
statistically	O	O	B-T081
significant	O	O	I-T081
difference	O	O	O
.	O	O	O

(	O	O	O
4	O	O	O
)	O	O	O
The	O	O	O
â	O	O	O
PCDD	O	O	B-T109
/	O	O	O
Fs	O	O	B-T109
and	O	O	O
TEQ	O	O	B-T081
in	O	O	O
ambient	O	O	B-T167
air	O	O	I-T167
of	O	O	O
downwind	O	O	B-T082
site	O	O	I-T082
were	O	O	O
not	O	O	O
higher	O	O	O
than	O	O	O
that	O	O	O
of	O	O	O
upwind	O	O	B-T082
site	O	O	I-T082
,	O	O	O
suggesting	O	O	O
that	O	O	O
studied	O	O	O
landfill	O	O	B-T083
did	O	O	O
not	O	O	O
have	O	O	O
obvious	O	O	O
influence	O	O	B-T077
on	O	O	O
PCDD	O	O	O
/	O	O	O
Fs	O	O	O
in	O	O	O
ambient	O	O	O
air	O	O	O
from	O	O	O
downwind	O	O	O
site	O	O	O
.	O	O	O

(	O	O	O
5	O	O	O
)	O	O	O
The	O	O	O
95th	O	O	O
percentile	O	O	B-T081
carcinogenic	O	O	B-T081
risk	O	O	I-T081
(	O	O	O
CR	O	O	B-T081
)	O	O	O
of	O	O	O
PCDD	O	O	B-T109
/	O	O	O
Fs	O	O	B-T109
in	O	O	O
ambient	O	O	B-T167
air	O	O	I-T167
from	O	O	O
s	O	O	O
urrounding	O	O	B-T082
sites	O	O	I-T082
,	O	O	O
background	O	O	B-T082
site	O	O	I-T082
,	O	O	O
upwind	O	O	B-T082
site	O	O	I-T082
and	O	O	O
downwind	O	O	B-T082
site	O	O	I-T082
were	O	O	O
8.03	O	O	O
Ã	O	O	O
10(-9	O	O	O
)	O	O	O
,	O	O	O
7.57	O	O	O
Ã	O	O	O
10(-9	O	O	O
)	O	O	O
,	O	O	O
9.69	O	O	O
Ã	O	O	O
10(-9	O	O	O
)	O	O	O
and	O	O	O
8.15	O	O	O
Ã	O	O	O
10(-9	O	O	O
)	O	O	O
,	O	O	O
respectively	O	O	O
,	O	O	O
which	O	O	O
were	O	O	O
much	O	O	B-T080
lower	O	O	I-T080
than	O	O	I-T080
the	O	O	I-T080
threshold	O	O	I-T080
value	O	O	I-T080
of	O	O	O
CR	O	O	O
(	O	O	O
10(-6	O	O	O
)	O	O	O
)	O	O	O
,	O	O	O
suggesting	O	O	O
that	O	O	O
studied	O	O	O
landfill	O	O	B-T083
did	O	O	O
not	O	O	O
influence	O	O	B-T077
the	O	O	O
CR	O	O	O
of	O	O	O
PCDD	O	O	O
/	O	O	O
Fs	O	O	O
in	O	O	O
surrounding	O	O	B-T070
atmosphere	O	O	I-T070
and	O	O	O
negligible	O	O	O
cancer	O	O	O
risk	O	O	O

occurred	O	O	O
.	O	O	O

(	O	O	O
6	O	O	O
)	O	O	O
The	O	O	O
non-carcinogenic	O	O	B-T033
risk	O	O	I-T033
(	O	O	O
non-CR	O	O	B-T033
)	O	O	O
analysis	O	O	B-T062
indicated	O	O	O
that	O	O	O
landfill	O	O	B-T083
did	O	O	O
not	O	O	O
have	O	O	O
influence	O	O	B-T077
on	O	O	O
the	O	O	O
non-CR	O	O	O
of	O	O	O
PCDD	O	O	B-T109
/	O	O	O
Fs	O	O	B-T109
in	O	O	O
surrounding	O	O	B-T070
atmosphere	O	O	I-T070
and	O	O	O
no	O	O	O
obvious	O	O	O
non-carcinogenic	O	O	B-T080
effects	O	O	I-T080
developed	O	O	O
.	O	O	O

-DOCSTART- (28224642)

Methodological	O	O	B-T080
considerations	O	O	I-T080
for	O	O	O
designing	O	O	O
a	O	O	O
community	O	O	B-T096
water	O	O	B-T069
fluoridation	O	O	I-T069
cessation	O	O	B-T052
study	O	O	O

High-quality	O	O	B-T062
,	O	O	O
up-to-date	O	O	O
research	O	O	B-T062
on	O	O	O
community	O	O	B-T096
water	O	O	B-T069
fluoridation	O	O	I-T069
(	O	O	O
CWF	O	O	B-T069
)	O	O	O
,	O	O	O
and	O	O	O
especially	O	O	O
on	O	O	O
the	O	O	O
implications	O	O	O
of	O	O	O
CWF	O	O	O
cessation	O	O	B-T052
for	O	O	O
dental	O	O	B-T058
health	O	O	I-T058
,	O	O	O
is	O	O	O
limited	O	O	O
.	O	O	O

Although	O	O	O
CWF	O	O	B-T069
cessation	O	O	B-T052
studies	O	O	B-T062
have	O	O	O
been	O	O	O
conducted	O	O	O
,	O	O	O
they	O	O	O
are	O	O	O
few	O	O	O
in	O	O	O
number	O	O	O
;	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
major	O	O	O
reasons	O	O	O
is	O	O	O
the	O	O	O
methodological	O	O	B-T169
complexity	O	O	I-T169
of	O	O	O
conducting	O	O	O
such	O	O	O
a	O	O	O
study	O	O	B-T062
.	O	O	O

This	O	O	O
article	O	O	O
draws	O	O	O
on	O	O	O
a	O	O	O
systematic	O	O	B-T170
review	O	O	I-T170
of	O	O	O
existing	O	O	O
cessation	O	O	B-T052
studies	O	O	B-T062
(	O	O	O
n=15	O	O	O
)	O	O	O
to	O	O	O
explore	O	O	O
methodological	O	O	B-T080
considerations	O	O	I-T080
of	O	O	O
conducting	O	O	O
CWF	O	O	B-T069
cessation	O	O	O
studies	O	O	O
in	O	O	O
future	O	O	B-T079
.	O	O	O

We	O	O	O
review	O	O	O
nine	O	O	O
important	O	O	O
methodological	O	O	B-T080
aspects	O	O	I-T080
(	O	O	O
study	O	O	B-T062
design	O	O	I-T062
,	O	O	O
comparison	O	O	B-T096
community	O	O	I-T096
,	O	O	O
target	O	O	B-T098
population	O	O	I-T098
,	O	O	O
time	O	O	B-T079
frame	O	O	I-T079
,	O	O	O
sampling	O	O	B-T170
strategy	O	O	I-T170
,	O	O	O
clinical	O	O	B-T169
indicators	O	O	I-T169
,	O	O	O
assessment	O	O	B-T170
criteria	O	O	I-T170
,	O	O	O
covariates	O	O	O
and	O	O	O
biomarkers	O	O	B-T201
)	O	O	O
and	O	O	O
provide	O	O	O
recommendations	O	O	B-T078
for	O	O	O
planning	O	O	B-T058
future	O	O	B-T079
CWF	O	O	B-T069
cessation	O	O	B-T052
studies	O	O	B-T062
that	O	O	O
examine	O	O	O
effects	O	O	O
on	O	O	O
dental	O	O	B-T047
caries	O	O	I-T047
.	O	O	O

There	O	O	O
is	O	O	O
no	O	O	O
one	O	O	O
ideal	O	O	O
study	O	O	B-T062
design	O	O	I-T062
to	O	O	O
answer	O	O	O
a	O	O	O
research	O	O	B-T078
question	O	O	I-T078
.	O	O	O

However	O	O	O
,	O	O	O
recommendations	O	O	B-T078
proposed	O	O	O
regarding	O	O	O
methodological	O	O	B-T080
aspects	O	O	I-T080
to	O	O	O
conduct	O	O	O
an	O	O	O
epidemiological	O	O	B-T062
study	O	O	B-T062
to	O	O	O
observe	O	O	O
the	O	O	O
effects	O	O	O
of	O	O	O
CWF	O	O	B-T069
cessation	O	O	B-T052
on	O	O	O
dental	O	O	B-T047
caries	O	O	I-T047
,	O	O	O
coupled	O	O	O
with	O	O	O
our	O	O	O
identification	O	O	O
of	O	O	O
important	O	O	O
methodological	O	O	O
gaps	O	O	O
,	O	O	O
will	O	O	O
be	O	O	O
useful	O	O	O
for	O	O	O
researchers	O	O	B-T097
who	O	O	O
are	O	O	O
looking	O	O	O
to	O	O	O
optimize	O	O	B-T052
resources	O	O	B-T078
to	O	O	O
conduct	O	O	O
such	O	O	O
a	O	O	O
study	O	O	O
with	O	O	O
standards	O	O	O
of	O	O	O
rigour	O	O	O
.	O	O	O

-DOCSTART- (28229061)

Central	O	O	B-T191
Myxoma	O	O	I-T191
/	O	O	O
Myxofibroma	O	O	B-T191
of	O	O	O
the	O	O	O
Jaws	O	O	B-T023
:	O	O	O
A	O	O	O
Clinico	O	O	B-T093
-	O	O	O
Epidemiologic	O	O	B-T169
Review	O	O	O

Myxomas	O	O	B-T191
are	O	O	O
a	O	O	O
group	O	O	O
of	O	O	O
benign	O	O	B-T080
rare	O	O	B-T047
tumors	O	O	I-T047
of	O	O	O
connective-tissue	O	O	B-T024
origin	O	O	B-T079
that	O	O	O
occur	O	O	O
in	O	O	O
both	O	O	O
hard	O	O	B-T024
(	O	O	I-T024
central	O	O	I-T024
)	O	O	I-T024
and	O	O	O
soft	O	O	B-T024
tissues	O	O	I-T024
of	O	O	O
the	O	O	O
body	O	O	B-T016
.	O	O	O

The	O	O	O
aim	O	O	B-T078
of	O	O	O
this	O	O	O
study	O	O	B-T062
is	O	O	O
to	O	O	O
highlight	O	O	O
our	O	O	O
experience	O	O	O
in	O	O	O
the	O	O	O
management	O	O	O
of	O	O	O
central	O	O	B-T191
myxoma	O	O	I-T191
of	O	O	I-T191
the	O	O	I-T191
jaw	O	O	I-T191
,	O	O	O
with	O	O	O
emphasis	O	O	O
on	O	O	O
its	O	O	O
clinic	O	O	B-T093
-	O	O	O
epidemiologic	O	O	B-T169
features	O	O	O
as	O	O	O
seen	O	O	O
in	O	O	O
our	O	O	O
environment	O	O	B-T082
.	O	O	O

All	O	O	O
patients	O	O	B-T101
who	O	O	O
were	O	O	O
managed	O	O	O
for	O	O	O
central	O	O	B-T191
myxoma	O	O	I-T191
of	O	O	I-T191
the	O	O	I-T191
jaw	O	O	I-T191
at	O	O	O
the	O	O	O
Oral	O	O	B-T092
and	O	O	I-T092
Maxillofacial	O	O	I-T092
Surgery	O	O	I-T092
department	O	O	I-T092
of	O	O	O
a	O	O	O
regional	O	O	B-T093
University	O	O	I-T093
Teaching	O	O	I-T093
Hospital	O	O	I-T093
between	O	O	O
September	O	O	O
1997	O	O	O
and	O	O	O
October	O	O	O
2015	O	O	O
were	O	O	O
retrospectively	O	O	B-T062
studied	O	O	I-T062
.	O	O	O

Details	O	O	O
sourced	O	O	O
included	O	O	O
age	O	O	B-T032
,	O	O	O
sex	O	O	B-T032
,	O	O	O
site	O	O	B-T082
of	O	O	I-T082
tumor	O	O	I-T082
,	O	O	O
duration	O	O	B-T079
,	O	O	O
signs/symptoms	O	O	B-T033
,	O	O	O
treatment	O	O	B-T033
given	O	O	I-T033
,	O	O	O
and	O	O	O
complications	O	O	B-T046
.	O	O	O

Data	O	O	B-T078
were	O	O	O
analyzed	O	O	B-T062
using	O	O	O
Statistical	O	O	B-T073
Package	O	O	I-T073
for	O	O	I-T073
Social	O	O	I-T073
Sciences	O	O	I-T073
(	O	O	I-T073
SPSS	O	O	I-T073
)	O	O	I-T073
version	O	O	I-T073
16	O	O	I-T073
(	O	O	O
SPSS	O	O	B-T073
Inc	O	O	I-T073
.	O	O	O
,	O	O	O
Chicago	O	O	B-T083
,	O	O	O
IL	O	O	B-T083
,	O	O	O
USA	O	O	B-T083
)	O	O	O
and	O	O	O
Microsoft	O	O	B-T073
Excel	O	O	I-T073
2007	O	O	I-T073
(	O	O	O
Microsoft	O	O	O
,	O	O	O
Redmond	O	O	B-T083
,	O	O	O
WA	O	O	B-T083
,	O	O	O
USA	O	O	O
)	O	O	O
.	O	O	O

Results	O	O	B-T169
from	O	O	O
descriptive	O	O	B-T081
statistics	O	O	I-T081
were	O	O	O
represented	O	O	O
in	O	O	O
the	O	O	O
form	O	O	O
of	O	O	O
tables	O	O	B-T170
and	O	O	O
charts	O	O	B-T170
,	O	O	O
with	O	O	O
a	O	O	O
test	O	O	B-T170
for	O	O	I-T170
significance	O	O	I-T170
(	O	O	O
Ï	O	O	O
)	O	O	O
using	O	O	O
Pearson	O	O	B-T170
Chi-square	O	O	I-T170
(	O	O	O
Ï(2	O	O	O
)	O	O	O
)	O	O	O
set	O	O	O
at	O	O	O
0.05	O	O	O
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
16	O	O	O
patients	O	O	B-T101
were	O	O	O
managed	O	O	O
within	O	O	O
the	O	O	O
period	O	O	B-T079
reviewed	O	O	B-T080
,	O	O	O
consisting	O	O	O
of	O	O	O
10	O	O	O
(	O	O	O
62.5	O	O	O
%	O	O	O
)	O	O	O
females	O	O	B-T032
and	O	O	O
six	O	O	O
(	O	O	O
37.5	O	O	O
%	O	O	O
)	O	O	O
males	O	O	B-T032
,	O	O	O
giving	O	O	O
a	O	O	O
male-to-female	O	O	B-UnknownType
ratio	O	O	I-UnknownType
of	O	O	O
1:1.7	O	O	O
.	O	O	O

The	O	O	O
ages	O	O	B-T032
of	O	O	O
patients	O	O	B-T101
ranged	O	O	B-T081
from	O	O	O
5	O	O	O
to	O	O	O
70	O	O	O
years	O	O	B-T079
,	O	O	O
with	O	O	O
a	O	O	O
mean	O	O	O
of	O	O	O
27.06Â±15.45	O	O	O
years	O	O	O
.	O	O	O

The	O	O	O
mandible	O	O	B-T023
accounted	O	O	O
for	O	O	O
nine	O	O	O
(	O	O	O
56.3	O	O	O
%	O	O	O
)	O	O	O
cases	O	O	B-T169
and	O	O	O
the	O	O	O
maxilla	O	O	B-T023
for	O	O	O
six	O	O	O
(	O	O	O
37.5	O	O	O
%	O	O	O
)	O	O	O
cases	O	O	O
,	O	O	O
while	O	O	O
a	O	O	O
combination	O	O	B-T080
of	O	O	O
the	O	O	O
maxilla	O	O	O
and	O	O	O
the	O	O	O
zygoma	O	O	B-T023
were	O	O	O
involved	O	O	O
in	O	O	O
one	O	O	O
(	O	O	O
6.3	O	O	O
%	O	O	O
)	O	O	O
case	O	O	B-T169
.	O	O	O

Bucco-lingual	O	O	B-T023
or	O	O	O
bucco-palatal	O	O	B-T023
expansion	O	O	B-T082
were	O	O	O
the	O	O	O
most	O	O	O
common	O	O	O
presentation	O	O	O
(	O	O	O
six	O	O	O
[	O	O	O
46.2	O	O	O
%	O	O	O
]	O	O	O
cases	O	O	B-T169
each	O	O	O
)	O	O	O
.	O	O	O

Histological	O	O	B-T169
assessment	O	O	B-T058
of	O	O	O
tissue	O	O	B-T024
specimens	O	O	I-T024
showed	O	O	O
that	O	O	O
fibromyxoma	O	O	B-T191
accounted	O	O	B-T078
for	O	O	O
seven	O	O	O
(	O	O	O
43.8	O	O	O
%	O	O	O
)	O	O	O
cases	O	O	B-T169
,	O	O	O
while	O	O	O
the	O	O	O
remaining	O	O	O
nine	O	O	O
(	O	O	O
56.3	O	O	O
%	O	O	O
)	O	O	O
cases	O	O	O
were	O	O	O
diagnosed	O	O	B-T033
as	O	O	O
myxoma	O	O	B-T191
.	O	O	O

All	O	O	O
patients	O	O	B-T101
had	O	O	O
jaw	O	O	B-T061
resections	O	O	I-T061
,	O	O	O
and	O	O	O
these	O	O	O
consisted	O	O	O
of	O	O	O
mandibulectomies	O	O	B-T061
in	O	O	O
nine	O	O	O
(	O	O	O
60.0	O	O	O
%	O	O	O
)	O	O	O
patients	O	O	O
and	O	O	O
maxillectomies	O	O	B-T061
in	O	O	O
six	O	O	O
(	O	O	O
40.0	O	O	O
%	O	O	O
)	O	O	O
patients	O	O	O
.	O	O	O

The	O	O	O
duration	O	O	B-T079
of	O	O	I-T079
hospital	O	O	I-T079
stay	O	O	I-T079
ranged	O	O	B-T081
from	O	O	O
5	O	O	O
to	O	O	O
29	O	O	O
days	O	O	B-T079
,	O	O	O
with	O	O	O
a	O	O	O
mean	O	O	O
of	O	O	O
17.86Â±7.68	O	O	O
days	O	O	O
.	O	O	O

Complications	O	O	B-T046
were	O	O	O
noted	O	O	O
in	O	O	O
three	O	O	O
patients	O	O	B-T101
,	O	O	O
and	O	O	O
all	O	O	O
were	O	O	O
surgical	O	O	B-T046
wound	O	O	I-T046
infections	O	O	I-T046
.	O	O	O

Most	O	O	O
patients	O	O	B-T101
in	O	O	O
our	O	O	O
environment	O	O	B-T082
present	O	O	O
late	O	O	O
with	O	O	O
large	O	O	B-T080
tumors	O	O	I-T080
and	O	O	O
are	O	O	O
usually	O	O	O
not	O	O	O
compliant	O	O	O
with	O	O	O
follow-up	O	O	B-T058
review	O	O	B-T078
.	O	O	O

Thus	O	O	O
,	O	O	O
a	O	O	O
radical	O	O	B-T080
approach	O	O	O
is	O	O	O
favored	O	O	O
in	O	O	O
most	O	O	O
patients	O	O	B-T101
.	O	O	O

-DOCSTART- (28229097)

Pediatric	O	O	B-T080
Hypovitaminosis	O	O	B-T047
D	O	O	I-T047
:	O	O	O
Molecular	O	O	O
Perspectives	O	O	B-T080
and	O	O	O
Clinical	O	O	B-T201
Implications	O	O	O

Vitamin	O	O	B-T127
D	O	O	I-T127
,	O	O	O
a	O	O	O
secosteroid	O	O	B-T109
,	O	O	O
is	O	O	O
essential	O	O	B-T080
for	O	O	O
the	O	O	O
development	O	O	B-T040
and	O	O	O
maintenance	O	O	B-T052
of	O	O	O
healthy	O	O	B-T080
bone	O	O	B-T023
in	O	O	O
both	O	O	O
the	O	O	O
adult	O	O	B-T100
and	O	O	O
pediatric	O	O	B-T080
populations	O	O	B-T098
.	O	O	O

Low	O	O	B-T081
level	O	O	I-T081
of	O	O	O
25-hydroxy	O	O	B-T127
vitamin	O	O	I-T127
D	O	O	I-T127
(	O	O	O
25-(OH)-D	O	O	B-T127
)	O	O	O
is	O	O	O
highly	O	O	O
prevalent	O	O	O
in	O	O	O
children	O	O	B-T100
worldwide	O	O	O
and	O	O	O
has	O	O	O
been	O	O	O
linked	O	O	O
to	O	O	O
various	O	O	O
adverse	O	O	B-T046
health	O	O	B-T170
outcomes	O	O	I-T170
including	O	O	O
rickets	O	O	B-T047
,	O	O	O
osteomalacia	O	O	B-T047
,	O	O	O
osteomalacic	O	O	B-T047
myopathy	O	O	I-T047
,	O	O	O
sarcopenia	O	O	B-T047
,	O	O	O
and	O	O	O
weakness	O	O	B-T184
,	O	O	O
growth	O	O	B-T046
retardation	O	O	I-T046
,	O	O	O
hypocalcemia	O	O	B-T047
,	O	O	O
seizure	O	O	B-T184
and	O	O	O
tetany	O	O	B-T047
,	O	O	O
autism	O	O	B-T048
,	O	O	O
cardiovascular	O	O	B-T047
diseases	O	O	I-T047
,	O	O	O
diabetes	O	O	B-T047
mellitus	O	O	I-T047
,	O	O	O
cancers	O	O	B-T191
(	O	O	O
prostate	O	O	B-T191
,	O	O	O
colon	O	O	B-T191
,	O	O	O
breast	O	O	B-T191
)	O	O	O
,	O	O	O
infectious	O	O	B-T047
diseases	O	O	I-T047
(	O	O	O
viral	O	O	B-T047
,	O	O	O
tuberculosis	O	O	B-T047
)	O	O	O
,	O	O	O
and	O	O	O
autoimmune	O	O	B-T047
diseases	O	O	I-T047
,	O	O	I-T047
such	O	O	O
as	O	O	O
multiple	O	O	B-T047
sclerosis	O	O	I-T047
and	O	O	O
Hashimoto	O	O	B-T047
's	O	O	I-T047
thyroiditis	O	O	I-T047
.	O	O	O

Risk	O	O	B-T033
factors	O	O	I-T033
for	O	O	O
hypovitaminosis	O	O	B-T047
D	O	O	I-T047
are	O	O	O
people	O	O	B-T098
with	O	O	O
darker	O	O	B-T042
skin	O	O	I-T042
pigmentation	O	O	I-T042
,	O	O	O
use	O	O	B-T169
of	O	O	O
sunscreen	O	O	B-T167
,	O	O	O
insufficient	O	O	B-T080
ultraviolet	O	O	B-T070
B	O	O	I-T070
exposure	O	O	B-T080
,	O	O	O
prematurity	O	O	B-T047
,	O	O	O
living	O	O	B-T082
in	O	O	I-T082
northern	O	O	I-T082
latitudes	O	O	I-T082
,	O	O	O
malnutrition	O	O	B-T047
,	O	O	O
obesity	O	O	B-T047
,	O	O	O
exclusive	O	O	B-T055
breastfeeding	O	O	I-T055
,	O	O	O
low	O	O	B-T033
maternal	O	O	I-T033
vitamin	O	O	I-T033
D	O	O	I-T033
level	O	O	I-T033
,	O	O	O
certain	O	O	O
medications	O	O	B-T121
,	O	O	O
drinking	O	O	B-T040
unfortified	O	O	B-T168
cow	O	O	I-T168
's	O	O	I-T168
milk	O	O	I-T168
,	O	O	O
liver	O	O	B-T047
failure	O	O	I-T047
,	O	O	O
chronic	O	O	B-T047
renal	O	O	I-T047
insufficiency	O	O	I-T047
,	O	O	O
cystic	O	O	B-T047
fibrosis	O	O	I-T047
,	O	O	O
asthma	O	O	B-T047
,	O	O	O
and	O	O	O
sickle	O	O	B-T047
cell	O	O	I-T047
hemoglobinopathy	O	O	I-T047
.	O	O	O

This	O	O	O
review	O	O	B-T170
highlights	O	O	O
and	O	O	O
summarizes	O	O	O
the	O	O	O
molecular	O	O	O
perspectives	O	O	O
of	O	O	O
vitamin	O	O	B-T047
D	O	O	I-T047
deficiency	O	O	I-T047
and	O	O	O
its	O	O	O
potential	O	O	O
adverse	O	O	B-T046
health	O	O	B-T170
outcomes	O	O	I-T170
in	O	O	O
pediatric	O	O	B-T080
age	O	O	B-T100
groups	O	O	I-T100
.	O	O	O

The	O	O	O
recommended	O	O	B-T033
treatment	O	O	I-T033
regimen	O	O	I-T033
is	O	O	O
beyond	O	O	O
the	O	O	O
scope	O	O	O
of	O	O	O
this	O	O	O
review	O	O	B-T170
.	O	O	O

-DOCSTART- (28232316)

Causes	O	O	O
of	O	O	O
ecological	O	O	B-T082
gradients	O	O	B-T081
in	O	O	O
leaf	O	O	B-T002
margin	O	O	B-T082
entirety	O	O	B-T081
:	O	O	O
Evaluating	O	O	B-T170
the	O	O	O
roles	O	O	B-T077
of	O	O	O
biomechanics	O	O	B-T091
,	O	O	O
hydraulics	O	O	B-T090
,	O	O	O
vein	O	O	B-T090
geometry	O	O	I-T090
,	O	O	O
and	O	O	O
bud	O	O	B-T002
packing	O	O	O

A	O	O	O
recent	O	O	B-T079
commentary	O	O	B-T170
by	O	O	O
Edwards	O	O	O
et	O	O	O
al.	O	O	O
(	O	O	O
Am	O	O	O
.	O	O	O
J.	O	O	O
Bot	O	O	O
.	O	O	O
103	O	O	O
:	O	O	O
975	O	O	O
-	O	O	O
978	O	O	O
)	O	O	O
proposed	O	O	B-T080
that	O	O	O
constraints	O	O	B-T169
imposed	O	O	O
by	O	O	O
the	O	O	O
packing	O	O	B-T052
of	O	O	O
young	O	O	B-T079
leaves	O	O	B-T002
in	O	O	O
buds	O	O	B-T002
could	O	O	O
explain	O	O	O
the	O	O	O
positive	O	O	B-T033
association	O	O	B-T078
between	O	O	O
non-entire	O	O	B-T080
leaf	O	O	B-T002
margins	O	O	B-T082
and	O	O	O
latitude	O	O	B-T081
but	O	O	O
did	O	O	O
not	O	O	O
thoroughly	O	O	O
consider	O	O	B-T078
alternative	O	O	B-T077
explanations	O	O	B-T170
.	O	O	O

We	O	O	O
review	O	O	B-T078
the	O	O	O
logic	O	O	B-T078
and	O	O	O
evidence	O	O	B-T078
underlying	O	O	O
six	O	O	O
major	O	O	B-T080
hypotheses	O	O	B-T078
for	O	O	O
the	O	O	O
functional	O	O	B-T169
significance	O	O	B-T078
of	O	O	O
marginal	O	O	B-T082
teeth	O	O	B-T002
,	O	O	O
involving	O	O	O
putative	O	O	B-T078
effects	O	O	B-T080
on	O	O	O
(	O	O	O
1	O	O	O
)	O	O	O
leaf	O	O	B-T002
cooling	O	O	B-T070
,	O	O	O
(	O	O	O
2	O	O	O
)	O	O	O
optimal	O	O	B-T080
support	O	O	O
and	O	O	O
supply	O	O	O
of	O	O	O
the	O	O	O
areas	O	O	B-T082
served	O	O	O
by	O	O	O
major	O	O	O
veins	O	O	B-T023
,	O	O	O
(	O	O	O
3	O	O	O
)	O	O	O
enhanced	O	O	B-T081
leaf	O	O	O
-	O	O	O
margin	O	O	B-T082
photosynthesis	O	O	B-T070
,	O	O	O
(	O	O	O
4	O	O	O
)	O	O	O
hydathodal	O	O	B-T043
function	O	O	I-T043
,	O	O	O
(	O	O	O
5	O	O	O
)	O	O	O
defense	O	O	B-T077
against	O	O	B-T080
herbivores	O	O	B-T008
,	O	O	O
and	O	O	O
(	O	O	O
6	O	O	O
)	O	O	O
bud	O	O	B-T002
packing	O	O	B-T052
.	O	O	O

Theoretical	O	O	B-T078
and	O	O	O
empirical	O	O	B-T080
problems	O	O	B-T033
undermine	O	O	O
all	O	O	O
hypotheses	O	O	B-T078
except	O	O	B-T169
the	O	O	O
support-supply	O	O	B-T078
hypothesis	O	O	I-T078
,	O	O	O
which	O	O	O
implies	O	O	O
that	O	O	O
thinner	O	O	B-T080
leaves	O	O	B-T002
should	O	O	O
have	O	O	O
non-entire	O	O	B-T080
margins	O	O	B-T082
.	O	O	O

Phylogenetically	O	O	B-T078
structured	O	O	B-T062
analyses	O	O	I-T062
across	O	O	O
angiosperms	O	O	B-T002
,	O	O	O
the	O	O	O
El	O	O	B-UnknownType
Yunque	O	O	I-UnknownType
flora	O	O	B-T033
,	O	O	O
and	O	O	O
the	O	O	O
genus	O	O	B-T185
Viburnum	O	O	B-T002
all	O	O	O
demonstrate	O	O	O
that	O	O	O
non-entire	O	O	B-T080
margins	O	O	B-T082
are	O	O	O
indeed	O	O	B-T080
more	O	O	O
common	O	O	B-T081
in	O	O	O
thinner	O	O	B-T080
leaves	O	O	B-T002
.	O	O	O

Across	O	O	O
angiosperms	O	O	B-T002
,	O	O	O
the	O	O	O
association	O	O	B-T078
of	O	O	O
leaf	O	O	B-T002
thickness	O	O	B-T080
with	O	O	O
non-entire	O	O	B-T080
leaf	O	O	O
margins	O	O	B-T082
is	O	O	O
stronger	O	O	B-T080
than	O	O	O
that	O	O	O
of	O	O	O
latitude	O	O	B-T081
.	O	O	O

We	O	O	O
outline	O	O	B-T170
a	O	O	O
synthetic	O	O	B-T170
model	O	O	I-T170
showing	O	O	O
how	O	O	O
biomechanics	O	O	B-T091
,	O	O	O
hydraulics	O	O	B-T090
,	O	O	O
vein	O	O	B-T023
geometry	O	O	B-T090
,	O	O	O
rates	O	O	B-T079
of	O	O	O
leaf	O	O	B-T002
expansion	O	O	B-T043
,	O	O	O
and	O	O	O
length	O	O	O
of	O	O	O
development	O	O	B-T169
within	O	O	O
resting	O	O	B-T033
buds	O	O	B-T002
,	O	O	O
all	O	O	O
tied	O	O	O
to	O	O	O
leaf	O	O	O
thickness	O	O	B-T080
,	O	O	O
drive	O	O	B-T033
patterns	O	O	B-T082
in	O	O	O
the	O	O	O
distribution	O	O	B-T082
of	O	O	O
entire	O	O	B-T081
vs.	O	O	O
non-entire	O	O	B-T080
leaf	O	O	O
margins	O	O	B-T082
.	O	O	O

Our	O	O	O
model	O	O	B-T170
accounts	O	O	O
for	O	O	O
dominance	O	O	B-T078
of	O	O	O
entire	O	O	B-T081
margins	O	O	B-T082
in	O	O	O
the	O	O	O
tropics	O	O	B-UnknownType
,	O	O	O
Mediterranean	O	O	B-T083
scrub	O	O	I-T083
,	O	O	O
and	O	O	O
tundra	O	O	B-T083
,	O	O	O
non-entire	O	O	B-T080
margins	O	O	O
in	O	O	O
cold	O	O	B-T070
temperate	O	O	I-T070
deciduous	O	O	B-T070
forests	O	O	I-T070
and	O	O	O
tropical	O	O	B-UnknownType
vines	O	O	B-T002
and	O	O	O
early-successional	O	O	B-T002
trees	O	O	I-T002
,	O	O	O
and	O	O	O
entire	O	O	O
leaf	O	O	B-T002
margins	O	O	O
in	O	O	O
monocots	O	O	B-T002
.	O	O	O

Spinose-toothed	O	O	B-T002
leaves	O	O	I-T002
should	O	O	O
be	O	O	O
favored	O	O	O
in	O	O	O
short-statured	O	O	B-T033
evergreen	O	O	B-T002
trees	O	O	I-T002
and	O	O	O
shrubs	O	O	B-T002
,	O	O	O
primarily	O	O	O
in	O	O	O
Mediterranean	O	O	B-T083
scrub	O	O	I-T083
and	O	O	O
related	O	O	O
semiarid	O	O	B-T082
habitats	O	O	I-T082
.	O	O	O

-DOCSTART- (28233508)

Viral	O	O	B-T121
Vector	O	O	I-T121
Biosafety	O	O	B-T170
in	O	O	O
Laboratory	O	O	O
Animal	O	O	O
Research	O	O	O

Viral	O	O	B-T121
vector	O	O	I-T121
research	O	O	B-T062
presents	O	O	B-T078
unique	O	O	B-T080
occupational	O	O	B-T091
health	O	O	I-T091
and	O	O	O
safety	O	O	B-T068
challenges	O	O	B-T058
to	O	O	O
institutions	O	O	B-T093
due	O	O	O
to	O	O	O
the	O	O	O
rapid	O	O	B-T080
development	O	O	B-T169
ofboth	O	O	O
in	O	O	B-T082
vivo	O	O	I-T082
and	O	O	O
in	O	O	B-T080
vitro	O	O	I-T080
gene-editing	O	O	B-T063
technologies	O	O	I-T063
.	O	O	O

Risks	O	O	B-T078
to	O	O	O
human	O	O	B-T016
and	O	O	O
animal	O	O	B-T008
health	O	O	B-T078
make	O	O	O
it	O	O	O
incumbent	O	O	B-T080
on	O	O	O
institutions	O	O	B-T093
to	O	O	O
appropriately	O	O	B-T080
evaluate	O	O	B-T058
viral	O	O	B-T121
vector	O	O	I-T121
usage	O	O	B-T169
in	O	O	O
research	O	O	B-T062
on	O	O	O
the	O	O	O
basis	O	O	B-T169
of	O	O	O
available	O	O	B-T169
information	O	O	B-T078
and	O	O	O
governmental	O	O	B-T064
regulations	O	O	I-T064
and	O	O	O
guidelines	O	O	B-T170
.Here	O	O	O
we	O	O	O
review	O	O	B-T078
the	O	O	O
factors	O	O	B-T169
related	O	O	O
to	O	O	O
risk	O	O	B-T058
assessment	O	O	I-T058
regarding	O	O	O
viral	O	O	O
vector	O	O	O
usage	O	O	O
in	O	O	O
animals	O	O	B-T008
and	O	O	O
the	O	O	O
relevant	O	O	B-T080
regulatory	O	O	B-T170
documents	O	O	I-T170
associated	O	O	B-T080
with	O	O	I-T080
this	O	O	O
research	O	O	O
,	O	O	O
and	O	O	O
we	O	O	O
highlight	O	O	O
the	O	O	O
most	O	O	B-T081
commonly	O	O	B-T081
used	O	O	O
viral	O	O	B-T121
vectors	O	O	I-T121
in	O	O	O
research	O	O	O
today	O	O	O
.	O	O	O

This	O	O	O
review	O	O	B-T078
is	O	O	O
particularly	O	O	B-T080
focused	O	O	B-T169
on	O	O	O
the	O	O	O
background	O	O	B-T077
,	O	O	O
use	O	O	O
in	O	O	O
research	O	O	B-T062
and	O	O	O
associated	O	O	B-T080
health	O	O	B-T078
and	O	O	O
environmental	O	O	B-T080
risks	O	O	I-T080
related	O	O	B-T080
to	O	O	O
adenoviral	O	O	B-T005
,	O	O	O
adeno-associated	O	O	B-T005
viral	O	O	I-T005
,	O	O	O
lentiviral	O	O	B-T005
,	O	O	O
and	O	O	O
herpesviral	O	O	B-T005
vectors	O	O	B-T121
.	O	O	O

-DOCSTART- (28234635)

Liver	O	O	B-T047
Inflammation	O	O	I-T047
Relates	O	O	O
to	O	O	O
Decreased	O	O	B-T081
Canalicular	O	O	B-T023
Bile	O	O	B-T116
Transporter	O	O	I-T116
Expression	O	O	B-T045
in	O	O	O
Pediatric	O	O	B-T080
Onset	O	O	B-T081
Intestinal	O	O	O
Failure	O	O	O

Although	O	O	O
liver	O	O	B-T047
disease	O	O	I-T047
is	O	O	O
a	O	O	O
major	O	O	O
complication	O	O	B-T046
of	O	O	O
parenteral	O	O	B-T061
nutrition	O	O	I-T061
(	O	O	O
PN	O	O	B-T061
)	O	O	O
for	O	O	O
intestinal	O	O	B-T047
failure	O	O	I-T047
(	O	O	O
IF	O	O	B-T047
)	O	O	O
,	O	O	O
its	O	O	O
pathogenesis	O	O	B-T046
remains	O	O	O
unclear	O	O	O
.	O	O	O

We	O	O	O
investigated	O	O	B-T169
potential	O	O	O
molecular	O	O	B-T080
mechanisms	O	O	B-T169
of	O	O	O
liver	O	O	B-T037
injury	O	O	I-T037
in	O	O	O
pediatric	O	O	B-T080
onset	O	O	B-T081
IF	O	O	B-T047
.	O	O	O

Liver	O	O	B-T023
expression	O	O	B-T045
of	O	O	O
canalicular	O	O	B-T023
phospholipid	O	O	B-T109
(	O	O	O
ABCB4	O	O	B-T116
)	O	O	O
,	O	O	O
bile	O	O	B-T109
acid	O	O	I-T109
(	O	O	O
ABCB11	O	O	B-T116
)	O	O	O
,	O	O	O
and	O	O	O
sterol	O	O	B-T109
(	O	O	O
ABCG5/8	O	O	B-T116
)	O	O	O
transporters	O	O	B-T116
,	O	O	O
their	O	O	O
upstream	O	O	B-T116
regulators	O	O	I-T116
LXR	O	O	B-T116
and	O	O	O
FXR	O	O	B-T116
as	O	O	O
well	O	O	O
as	O	O	O
pro-inflammatory	O	O	B-T116
cytokines	O	O	I-T116
interleukin-6	O	O	B-T116
(	O	O	O
IL6	O	O	B-T116
)	O	O	O
and	O	O	O
tumor	O	O	B-T116
necrosis	O	O	I-T116
factor	O	O	I-T116
(	O	O	O
TNF	O	O	B-T116
)	O	O	O
were	O	O	O
investigated	O	O	B-T169
among	O	O	O
patients	O	O	B-T101
with	O	O	O
IF	O	O	B-T047
[	O	O	O
age	O	O	B-T032
median	O	O	O
3.8	O	O	O
(	O	O	O
IQR	O	O	B-T081
1.2	O	O	O
to	O	O	O
11	O	O	O
)	O	O	O
]	O	O	O
in	O	O	O
relation	O	O	O
to	O	O	O
biochemical	O	O	B-T169
and	O	O	O
histologic	O	O	B-T169
liver	O	O	B-T037
injury	O	O	I-T037
,	O	O	O
PN	O	O	B-T061
,	O	O	O
serum	O	O	B-T031
plant	O	O	B-T109
sterols	O	O	I-T109
,	O	O	O
fibroblast	O	O	B-T116
growth	O	O	I-T116
factor	O	O	I-T116
19	O	O	I-T116
,	O	O	O
and	O	O	O
Î±-tocopherol	O	O	B-T127
.	O	O	O

Patients	O	O	B-T101
receiving	O	O	O
PN	O	O	B-T061
currently	O	O	O
(	O	O	O
n	O	O	O
=	O	O	O
18	O	O	O
)	O	O	O
showed	O	O	O
more	O	O	O
advanced	O	O	O
liver	O	O	B-T037
injury	O	O	I-T037
than	O	O	O
patients	O	O	B-T101
after	O	O	O
weaning	O	O	B-T033
off	O	O	O
PN	O	O	O
(	O	O	O
n	O	O	O
=	O	O	O
30	O	O	O
)	O	O	O
.	O	O	O

Histologic	O	O	B-T169
portal	O	O	B-T033
inflammation	O	O	I-T033
strongly	O	O	O
segregated	O	O	O
PN	O	O	B-T061
-	O	O	O
dependent	O	O	B-T169
(	O	O	O
44	O	O	O
%	O	O	O
)	O	O	O
from	O	O	O
weaned	O	O	B-T033
off	O	O	O
patients	O	O	B-T101
(	O	O	O
3	O	O	O
%	O	O	O
,	O	O	O
P	O	O	O
=	O	O	O
0.001	O	O	O
)	O	O	O
and	O	O	O
coupled	O	O	O
with	O	O	O
progression	O	O	B-T046
of	O	O	O
cholestasis	O	O	B-T047
and	O	O	O
liver	O	O	B-T047
fibrosis	O	O	I-T047
.	O	O	O

Patients	O	O	B-T101
with	O	O	O
portal	O	O	B-T033
inflammation	O	O	I-T033
demonstrated	O	O	O
markedly	O	O	O
induced	O	O	O
liver	O	O	B-T023
RNA	O	O	B-T045
expression	O	O	I-T045
of	O	O	O
IL6	O	O	B-T028
and	O	O	O
TNF	O	O	B-T028
,	O	O	O
repression	O	O	B-T045
of	O	O	O
FXR	O	O	B-T116
and	O	O	O
its	O	O	O
canalicular	O	O	B-T023
bile	O	O	B-T116
transporter	O	O	I-T116
target	O	O	O
gene	O	O	B-T028
RNA	O	O	O
expression	O	O	O
,	O	O	O
including	O	O	O
ABCB4	O	O	B-T028
and	O	O	O
ABCB11	O	O	B-T028
as	O	O	O
well	O	O	O
as	O	O	O
decreased	O	O	B-T081
protein	O	O	B-T045
expression	O	O	I-T045
of	O	O	O
ABCB11	O	O	O
and	O	O	O
ABCB4	O	O	O
.	O	O	O

Furthermore	O	O	O
,	O	O	O
upregulation	O	O	B-T044
of	O	O	O
LXR	O	O	B-T116
and	O	O	O
ABCG5/8	O	O	B-T028
RNA	O	O	B-T045
expression	O	O	I-T045
was	O	O	O
suppressed	O	O	B-T169
in	O	O	O
patients	O	O	B-T101
with	O	O	O
portal	O	O	B-T033
inflammation	O	O	I-T033
.	O	O	O

Current	O	O	O
PN	O	O	B-T061
,	O	O	O
increased	O	O	B-T081
serum	O	O	B-T031
levels	O	O	B-T080
of	O	O	O
plant	O	O	B-T109
sterols	O	O	I-T109
stigmasterol	O	O	B-T109
,	O	O	O
avenasterol	O	O	B-T109
,	O	O	O
and	O	O	O
sitosterol	O	O	B-T109
along	O	O	O
with	O	O	O
serum	O	O	O
citrulline	O	O	B-T116
,	O	O	O
a	O	O	O
marker	O	O	B-T201
of	O	O	O
enterocyte	O	O	B-T025
mass	O	O	I-T025
,	O	O	O
predicted	O	O	O
portal	O	O	B-T033
inflammation	O	O	I-T033
.	O	O	O

In	O	O	O
pediatric	O	O	B-T080
onset	O	O	B-T081
IF	O	O	B-T047
,	O	O	O
current	O	O	O
PN	O	O	B-T061
delivery	O	O	O
synergistically	O	O	O
with	O	O	O
intestinal	O	O	B-T023
compromise	O	O	B-T033
promote	O	O	O
liver	O	O	B-T047
inflammation	O	O	I-T047
,	O	O	O
which	O	O	O
associates	O	O	B-T080
with	O	O	O
progression	O	O	B-T046
of	O	O	O
biochemical	O	O	B-T169
and	O	O	O
histologic	O	O	B-T169
liver	O	O	B-T037
injury	O	O	I-T037
,	O	O	O
while	O	O	O
reducing	O	O	B-T080
expression	O	O	B-T045
of	O	O	O
canalicular	O	O	B-T023
bile	O	O	B-T116
transporters	O	O	I-T116
.	O	O	O

-DOCSTART- (28236586)

Impaired	O	O	B-T033
mobility	O	O	I-T033
,	O	O	O
depressed	O	O	B-T033
mood	O	O	I-T033
,	O	O	O
cognitive	O	O	B-T048
impairment	O	O	I-T048
and	O	O	O
polypharmacy	O	O	B-T033
are	O	O	O
independently	O	O	O
associated	O	O	O
with	O	O	O
disability	O	O	B-T033
in	O	O	O
older	O	O	O
cancer	O	O	B-T191
outpatients	O	O	B-T101
:	O	O	O
The	O	O	O
prospective	O	O	O
Physical	O	O	B-T033
Frailty	O	O	I-T033
in	O	O	O
Elderly	O	O	B-T098
Cancer	O	O	B-T101
patients	O	O	I-T101
(	O	O	O
PF	O	O	B-T033
-	O	O	O
EC	O	O	B-T101
)	O	O	O
cohort	O	O	O
study	O	O	O

To	O	O	O
assess	O	O	O
the	O	O	O
prevalence	O	O	O
of	O	O	O
disability	O	O	B-T033
and	O	O	O
the	O	O	O
oncologic	O	O	B-T033
factors	O	O	I-T033
associated	O	O	O
with	O	O	O
disability	O	O	O
in	O	O	O
older	O	O	O
outpatients	O	O	B-T101
with	O	O	O
cancer	O	O	B-T191
.	O	O	O

The	O	O	O
Physical	O	O	B-T033
Frailty	O	O	I-T033
in	O	O	O
Elderly	O	O	B-T098
Cancer	O	O	B-T101
patients	O	O	I-T101
(	O	O	O
PF	O	O	B-T033
-	O	O	O
EC	O	O	B-T101
)	O	O	O
study	O	O	O
(	O	O	O
France	O	O	B-T083
)	O	O	O
is	O	O	O
a	O	O	O
prospective	O	O	B-T062
bicentric	O	O	I-T062
observational	O	O	I-T062
cohort	O	O	I-T062
study	O	O	I-T062
.	O	O	O

Two	O	O	O
hundred	O	O	O
and	O	O	O
ninety	O	O	O
outpatients	O	O	B-T101
with	O	O	O
cancer	O	O	B-T191
were	O	O	O
included	O	O	O
.	O	O	O

A	O	O	O
cross-sectional	O	O	B-T062
analysis	O	O	I-T062
of	O	O	O
oncologic	O	O	B-T033
factors	O	O	I-T033
and	O	O	O
geriatric	O	O	B-T080
variables	O	O	B-T080
associated	O	O	O
with	O	O	O
disability	O	O	B-T033
that	O	O	O
were	O	O	O
collected	O	O	O
using	O	O	O
a	O	O	O
comprehensive	O	O	B-T080
geriatric	O	O	B-T058
assessment	O	O	I-T058
(	O	O	O
CGA	O	O	B-T058
)	O	O	O
was	O	O	O
conducted	O	O	O
.	O	O	O

Disability	O	O	B-T033
was	O	O	O
defined	O	O	O
as	O	O	O
impairment	O	O	B-T169
in	O	O	O
activities	O	O	B-T056
of	O	O	I-T056
daily	O	O	I-T056
living	O	O	I-T056
(	O	O	O
ADL	O	O	B-T056
)	O	O	O
and/or	O	O	O
instrumental	O	O	B-T033
activities	O	O	I-T033
of	O	O	I-T033
daily	O	O	I-T033
living	O	O	I-T033
(	O	O	B-T033
IADL	O	O	I-T033
)	O	O	O
,	O	O	O
simplified	O	O	O
to	O	O	O
four	O	O	O
items	O	O	O
.	O	O	O

Univariate	O	O	B-T062
and	O	O	O
multivariate	O	O	B-T081
logistic	O	O	B-T081
models	O	O	I-T081
of	O	O	O
disabled	O	O	B-T101
patients	O	O	I-T101
were	O	O	O
performed	O	O	O
.	O	O	O

The	O	O	O
three	O	O	O
final	O	O	O
multivariate	O	O	B-T081
models	O	O	B-T081
were	O	O	O
compared	O	O	O
using	O	O	O
the	O	O	O
area	O	O	O
under	O	O	O
the	O	O	O
receiver	O	O	B-T081
operating	O	O	I-T081
characteristic	O	O	I-T081
curve	O	O	I-T081
(	O	O	O
AUC	O	O	B-T081
/	O	O	O
ROC	O	O	B-T081
)	O	O	O
of	O	O	O
the	O	O	O
logistic	O	O	B-T081
model	O	O	I-T081
.	O	O	O

The	O	O	O
mean	O	O	O
age	O	O	O
was	O	O	O
80.6years	O	O	O
,	O	O	O
and	O	O	O
51	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
patients	O	O	O
were	O	O	O
women	O	O	B-T098
with	O	O	O
various	O	O	O
types	O	O	O
of	O	O	O
cancer	O	O	B-T191
.	O	O	O

The	O	O	O
prevalence	O	O	O
of	O	O	O
disability	O	O	B-T033
was	O	O	O
67.6	O	O	O
%	O	O	O
.	O	O	O

No	O	O	O
oncologic	O	O	B-T033
factors	O	O	I-T033
(	O	O	O
cancer	O	O	B-T082
site	O	O	I-T082
,	O	O	O
cancer	O	O	B-T191
extension	O	O	I-T191
)	O	O	O
were	O	O	O
associated	O	O	O
with	O	O	O
disability	O	O	B-T033
.	O	O	O

Impaired	O	O	B-T033
mobility	O	O	I-T033
,	O	O	O
poor	O	O	B-T033
functional	O	O	I-T033
status	O	O	I-T033
,	O	O	O
depressive	O	O	B-T033
mood	O	O	I-T033
,	O	O	O
cognitive	O	O	B-T048
impairment	O	O	I-T048
and	O	O	O
polypharmacy	O	O	B-T033
were	O	O	O
independently	O	O	O
associated	O	O	O
with	O	O	O
disability	O	O	B-T033
(	O	O	O
P<0.05	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
AUC/ROC	O	O	O
of	O	O	O
the	O	O	O
final	O	O	O
models	O	O	O
was	O	O	O
similar	O	O	O
.	O	O	O

Disability	O	O	B-T033
was	O	O	O
highly	O	O	O
prevalent	O	O	O
in	O	O	O
older	O	O	O
cancer	O	O	B-T191
outpatients	O	O	B-T101
before	O	O	O
cancer	O	O	B-T061
treatment	O	O	I-T061
but	O	O	O
was	O	O	O
not	O	O	O
associated	O	O	O
with	O	O	O
oncologic	O	O	B-T033
factors	O	O	I-T033
.	O	O	O

Impaired	O	O	B-T033
mobility	O	O	I-T033
,	O	O	O
depressed	O	O	B-T033
mood	O	O	I-T033
,	O	O	O
cognitive	O	O	B-T048
impairment	O	O	I-T048
and	O	O	O
polypharmacy	O	O	B-T033
were	O	O	O
the	O	O	O
geriatric	O	O	O
variables	O	O	O
significantly	O	O	O
and	O	O	O
independently	O	O	O
associated	O	O	O
with	O	O	O
disability	O	O	B-T033
.	O	O	O

Identifying	O	O	O
these	O	O	O
factors	O	O	O
prior	O	O	O
to	O	O	O
cancer	O	O	B-T061
treatment	O	O	B-T061
could	O	O	O
enable	O	O	O
the	O	O	O
implementation	O	O	O
of	O	O	O
corrective	O	O	B-T169
actions	O	O	I-T169
to	O	O	O
improve	O	O	O
patient	O	O	B-T101
autonomy	O	O	B-T041
before	O	O	O
treatment	O	O	O
and	O	O	O
during	O	O	O
follow-up	O	O	B-T058
.	O	O	O

-DOCSTART- (28237762)

Synthesis	O	O	B-T070
,	O	O	O
SAR	O	O	B-T080
and	O	O	O
molecular	O	O	B-T063
docking	O	O	I-T063
study	O	O	B-T062
of	O	O	O
novel	O	O	O
non-Î²-lactam	O	O	B-T121
inhibitors	O	O	I-T121
of	O	O	O
TEM	O	O	O
type	O	O	O
Î²-lactamase	O	O	O

The	O	O	O
novel	O	O	O
classes	O	O	O
of	O	O	O
acylated	O	O	B-T121
phenoxyanilide	O	O	I-T121
and	O	O	O
thiourea	O	O	B-T121
compounds	O	O	I-T121
were	O	O	O
investigated	O	O	B-T169
for	O	O	O
their	O	O	O
ability	O	O	O
to	O	O	O
inhibit	O	O	B-T039
TEM	O	O	B-T116
type	O	O	I-T116
Î²-lactamase	O	O	I-T116
enzyme	O	O	I-T116
.	O	O	O

Two	O	O	O
compounds	O	O	B-T121
4	O	O	I-T121
g	O	O	I-T121
and	O	O	O
5c	O	O	B-T121
reveal	O	O	O
the	O	O	O
inhibition	O	O	B-T039
potency	O	O	B-T081
in	O	O	O
micromolar	O	O	B-T081
range	O	O	O
and	O	O	O
show	O	O	O
their	O	O	O
action	O	O	B-T052
by	O	O	O
non-covalent	O	O	B-T044
binding	O	O	I-T044
in	O	O	O
the	O	O	O
vicinity	O	O	O
of	O	O	O
the	O	O	O
TEM-171	O	O	B-T116
active	O	O	B-T169
site	O	O	I-T169
.	O	O	O

The	O	O	O
structure	O	O	B-T080
activity	O	O	I-T080
relationship	O	O	I-T080
around	O	O	O
carbon	O	O	B-T081
chain	O	O	I-T081
length	O	O	I-T081
and	O	O	O
different	O	O	O
substituents	O	O	B-UnknownType
in	O	O	I-UnknownType
ortho-	O	O	I-UnknownType
and	O	O	I-UnknownType
para-positions	O	O	I-UnknownType
of	O	O	O
acylated	O	O	B-T121
phenoxyanilide	O	O	I-T121
as	O	O	O
well	O	O	O
as	O	O	O
molecular	O	O	B-T062
modelling	O	O	I-T062
study	O	O	B-T062
has	O	O	O
been	O	O	O
performed	O	O	O
.	O	O	O

-DOCSTART- (28237781)

Metabolic	O	O	B-T033
responses	O	O	I-T033
of	O	O	O
the	O	O	O
growing	O	O	O
Daphnia	O	O	B-T204
similis	O	O	I-T204
to	O	O	O
chronic	O	O	B-T079
AgNPs	O	O	B-T073
exposure	O	O	O
as	O	O	O
revealed	O	O	O
by	O	O	O
GC-Q-TOF/MS	O	O	B-T059
and	O	O	O
LC-Q-TOF/MS	O	O	O

Silver	O	O	B-T196
nanoparticles	O	O	B-T073
(	O	O	O
AgNPs	O	O	B-T073
)	O	O	O
are	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
most	O	O	O
widely	O	O	O
used	O	O	O
nanomaterials	O	O	B-T073
.	O	O	O

Their	O	O	O
fast-growing	O	O	B-T033
utilization	O	O	O
has	O	O	O
increased	O	O	B-T081
the	O	O	O
occurrence	O	O	O
of	O	O	O
AgNPs	O	O	B-T073
in	O	O	O
the	O	O	O
environment	O	O	B-T082
,	O	O	O
posing	O	O	O
potential	O	O	O
health	O	O	B-T078
and	O	O	I-T078
ecological	O	O	I-T078
risks	O	O	I-T078
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	O
,	O	O	O
we	O	O	O
conducted	O	O	O
chronic	O	O	B-T060
toxicity	O	O	I-T060
tests	O	O	I-T060
and	O	O	O
investigated	O	O	O
the	O	O	O
metabolic	O	O	B-T123
changes	O	O	B-T169
of	O	O	O
the	O	O	O
growing	O	O	O
Daphna	O	O	B-T204
similis	O	O	I-T204
with	O	O	O
exposure	O	O	B-T080
to	O	O	I-T080
0	O	O	O
,	O	O	O
0.02	O	O	O
,	O	O	O
and	O	O	O
1	O	O	O
ppb	O	O	O
AgNPs	O	O	B-T073
,	O	O	O
using	O	O	O
non-targeted	O	O	B-T059
mass	O	O	I-T059
spectrometry	O	O	I-T059
-based	O	O	O
metabolomics	O	O	B-T091
.	O	O	O

To	O	O	O
the	O	O	O
best	O	O	O
of	O	O	O
our	O	O	O
knowledge	O	O	O
,	O	O	O
this	O	O	O
study	O	O	O
is	O	O	O
the	O	O	O
first	O	O	O
to	O	O	O
report	O	O	O
the	O	O	O
baseline	O	O	B-T081
metabolite	O	O	B-T123
change	O	O	B-T169
of	O	O	O
a	O	O	O
common	O	O	O
aquatic	O	O	B-T001
organism	O	O	I-T001
Daphnia	O	O	B-T204
crustacean	O	O	I-T204
through	O	O	O
its	O	O	O
life-cycle	O	O	B-T079
.	O	O	O

The	O	O	O
results	O	O	O
show	O	O	O
a	O	O	O
dynamic	O	O	B-T033
kinetic	O	O	I-T033
pattern	O	O	I-T033
of	O	O	O
the	O	O	O
growing	O	O	O
Daphnia	O	O	B-T204
's	O	O	I-T204
metabolome	O	O	B-T070
underwent	O	O	O
a	O	O	O
cycle	O	O	B-T079
from	O	O	O
day	O	O	B-T079
0	O	O	O
to	O	O	O
day	O	O	O
21	O	O	O
,	O	O	O
with	O	O	O
the	O	O	O
level	O	O	B-T080
of	O	O	O
metabolites	O	O	B-T123
gradually	O	O	O
increasing	O	O	B-T169
from	O	O	O
day	O	O	O
0	O	O	O
to	O	O	O
day	O	O	O
13	O	O	O
,	O	O	O
before	O	O	O
falling	O	O	O
back	O	O	O
to	O	O	O
the	O	O	O
baseline	O	O	B-T081
level	O	O	O
of	O	O	O
day	O	O	O
0	O	O	O
on	O	O	O
day	O	O	O
21	O	O	O
.	O	O	O

As	O	O	O
for	O	O	O
the	O	O	O
samples	O	O	B-T167
exposed	O	O	B-T080
to	O	O	I-T080
environmental	O	O	B-T081
concentrations	O	O	I-T081
of	O	O	O
AgNPs	O	O	B-T073
,	O	O	O
although	O	O	O
without	O	O	O
morphological	O	O	B-T033
or	O	O	I-T033
structural	O	O	I-T033
changes	O	O	B-T169
,	O	O	O
numerous	O	O	O
metabolite	O	O	B-T123
changes	O	O	O
occurred	O	O	O
abruptly	O	O	O
during	O	O	O
the	O	O	O
first	O	O	O
10	O	O	O
days	O	O	B-T079
,	O	O	O
and	O	O	O
these	O	O	O
changes	O	O	O
reached	O	O	O
steady	O	O	B-T070
state	O	O	I-T070
by	O	O	O
day	O	O	B-T079
13	O	O	O
.	O	O	O

The	O	O	O
significant	O	O	O
changes	O	O	B-T169
in	O	O	O
certain	O	O	O
metabolites	O	O	B-T123
,	O	O	O
such	O	O	O
as	O	O	O
amino	O	O	B-T116
acids	O	O	I-T116
(	O	O	O
serine	O	O	B-T116
,	O	O	O
threonine	O	O	B-T116
and	O	O	O
tyrosine	O	O	B-T116
)	O	O	O
,	O	O	O
sugars	O	O	B-T109
(	O	O	O
d-allose	O	O	B-T109
)	O	O	O
and	O	O	O
fatty	O	O	B-T109
acids	O	O	I-T109
(	O	O	O
arachidonic	O	O	B-T109
acid	O	O	I-T109
)	O	O	O
revealed	O	O	O
new	O	O	O
insights	O	O	O
into	O	O	O
how	O	O	O
these	O	O	O
metabolites	O	O	O
in	O	O	O
Daphnia	O	O	B-T204
respond	O	O	O
to	O	O	O
chronic	O	O	B-T079
AgNPs	O	O	B-T073
stress	O	O	B-T070
.	O	O	O

These	O	O	O
findings	O	O	B-T169
highlight	O	O	O
the	O	O	O
capability	O	O	B-T080
of	O	O	O
metabolomics	O	O	B-T091
to	O	O	O
discover	O	O	O
early	O	O	O
metabolic	O	O	B-T033
responses	O	O	I-T033
to	O	O	O
environmental	O	O	B-T082
silver	O	O	B-T196
nanoparticles	O	O	B-T073
.	O	O	O

-DOCSTART- (28237953)

Evaluating	O	O	O
the	O	O	O
relative	O	O	B-T081
effectiveness	O	O	I-T081
of	O	O	O
high-intensity	O	O	B-T185
and	O	O	O
low-intensity	O	O	B-T081
models	O	O	I-T081
of	O	O	O
behaviour	O	O	B-T055
change	O	O	I-T055
communication	O	O	B-T061
interventions	O	O	I-T061
for	O	O	O
abortion	O	O	B-T033
care-seeking	O	O	B-T055
in	O	O	O
Bihar	O	O	B-UnknownType
and	O	O	O
Jharkhand	O	O	B-UnknownType
,	O	O	O
India	O	O	B-T083
:	O	O	O
a	O	O	O
cross-sectional	O	O	O
study	O	O	O

This	O	O	O
study	O	O	O
aimed	O	O	O
to	O	O	O
compare	O	O	O
the	O	O	O
effectiveness	O	O	B-T080
of	O	O	O
a	O	O	O
high-intensity	O	O	B-T185
model	O	O	I-T185
(	O	O	O
HIM	O	O	B-T185
)	O	O	O
and	O	O	O
a	O	O	O
low-intensity	O	O	B-T081
model	O	O	I-T081
(	O	O	O
LIM	O	O	B-T081
)	O	O	O
of	O	O	O
behaviour	O	O	B-T055
change	O	O	I-T055
communication	O	O	B-T061
interventions	O	O	I-T061
in	O	O	O
Bihar	O	O	B-UnknownType
and	O	O	O
Jharkhand	O	O	B-UnknownType
states	O	O	O
of	O	O	O
India	O	O	B-T083
designed	O	O	O
to	O	O	O
improve	O	O	O
women	O	O	B-T098
's	O	O	I-T098
knowledge	O	O	B-T033
and	O	O	O
usage	O	O	O
of	O	O	O
safe	O	O	B-T033
abortion	O	O	I-T033
services	O	O	O
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
the	O	O	O
dose	O	O	B-UnknownType
effect	O	O	I-UnknownType
of	O	O	O
intervention	O	O	B-T061
exposure	O	O	O
.	O	O	O

We	O	O	O
conducted	O	O	O
two	O	O	O
cross-sectional	O	O	B-T062
household	O	O	I-T062
surveys	O	O	I-T062
among	O	O	O
married	O	O	B-T033
women	O	O	B-T098
aged	O	O	B-T032
15	O	O	O
-	O	O	O
49	O	O	O
years	O	O	O
in	O	O	O
intervention	O	O	B-T061
and	O	O	O
comparison	O	O	O
districts	O	O	B-UnknownType
.	O	O	O

Difference-in-difference	O	O	B-T081
models	O	O	I-T081
were	O	O	O
used	O	O	O
to	O	O	O
assess	O	O	O
the	O	O	O
efficacy	O	O	B-T080
of	O	O	O
the	O	O	O
intervention	O	O	B-T061
,	O	O	O
adjusting	O	O	O
for	O	O	O
sociodemographic	O	O	B-T033
characteristics	O	O	I-T033
.	O	O	O

Although	O	O	O
both	O	O	O
intervention	O	O	B-T061
types	O	O	O
improved	O	O	O
abortion	O	O	B-T033
knowledge	O	O	B-T170
,	O	O	O
the	O	O	O
HIM	O	O	B-T185
intervention	O	O	O
was	O	O	O
more	O	O	O
effective	O	O	O
in	O	O	O
improving	O	O	O
comprehensive	O	O	B-T170
knowledge	O	O	I-T170
about	O	O	O
abortion	O	O	O
.	O	O	O

In	O	O	O
particular	O	O	O
,	O	O	O
there	O	O	O
were	O	O	O
improvements	O	O	O
in	O	O	O
knowledge	O	O	B-T170
on	O	O	O
legality	O	O	B-T061
of	O	O	I-T061
abortion	O	O	I-T061
(	O	O	O
AOR=2.2	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
1.6	O	O	O
to	O	O	O
2.9	O	O	O
)	O	O	O
and	O	O	O
nearby	O	O	O
sources	O	O	O
of	O	O	O
safe	O	O	B-T058
abortion	O	O	I-T058
care	O	O	I-T058
(	O	O	O
AOR=1.7	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
1.2	O	O	O
to	O	O	O
1.3	O	O	O
)	O	O	O
.	O	O	O

Higher	O	O	O
level	O	O	O
of	O	O	O
exposure	O	O	O
to	O	O	O
abortion-related	O	O	O
messages	O	O	O
was	O	O	O
related	O	O	O
to	O	O	O
more	O	O	O
accurate	O	O	O
knowledge	O	O	B-T170
about	O	O	O
abortion	O	O	B-T033
within	O	O	O
both	O	O	O
intervention	O	O	B-T061
groups	O	O	O
.	O	O	O

Evidence	O	O	O
was	O	O	O
mixed	O	O	O
on	O	O	O
changes	O	O	O
in	O	O	O
abortion	O	O	B-T033
care-seeking	O	O	B-T055
behaviour	O	O	B-T053
.	O	O	O

More	O	O	O
work	O	O	O
is	O	O	O
needed	O	O	O
to	O	O	O
ensure	O	O	O
that	O	O	O
women	O	O	B-T098
seek	O	O	O
safe	O	O	B-T033
abortion	O	O	I-T033
services	O	O	O
in	O	O	O
lieu	O	O	O
of	O	O	O
informal	O	O	O
services	O	O	O
that	O	O	O
may	O	O	O
be	O	O	O
more	O	O	O
likely	O	O	O
to	O	O	O
lead	O	O	O
to	O	O	O
postabortion	O	O	B-T046
complications	O	O	I-T046
.	O	O	O

-DOCSTART- (28239461)

Tissue	O	O	B-T024
MicroRNA	O	O	B-T114
profiles	O	O	O
as	O	O	O
diagnostic	O	O	B-T201
and	O	O	O
prognostic	O	O	B-T080
biomarkers	O	O	I-T080
in	O	O	O
patients	O	O	B-T101
with	O	O	O
resectable	O	O	B-T061
pancreatic	O	O	B-T191
ductal	O	O	I-T191
adenocarcinoma	O	O	I-T191
and	O	O	O
periampullary	O	O	O
cancers	O	O	O

The	O	O	O
aim	O	O	B-T078
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
validate	O	O	O
previously	O	O	O
described	O	O	O
diagnostic	O	O	B-T169
and	O	O	O
prognostic	O	O	B-T170
microRNA	O	O	B-T114
expression	O	O	B-T081
profiles	O	O	I-T081
in	O	O	O
tissue	O	O	B-T024
samples	O	O	O
from	O	O	O
patients	O	O	B-T101
with	O	O	O
pancreatic	O	O	B-T191
cancer	O	O	I-T191
and	O	O	O
other	O	O	O
periampullary	O	O	B-T191
cancers	O	O	I-T191
.	O	O	O

Expression	O	O	B-T045
of	O	O	O
46	O	O	O
selected	O	O	O
microRNAs	O	O	B-T114
was	O	O	O
studied	O	O	O
in	O	O	O
formalin	O	O	B-T109
-fixed	O	O	O
paraffin-embedded	O	O	B-T024
tissue	O	O	I-T024
from	O	O	O
patients	O	O	B-T101
with	O	O	O
resected	O	O	B-T061
pancreatic	O	O	B-T191
ductal	O	O	I-T191
adenocarcinoma	O	O	I-T191
(	O	O	O
n	O	O	O
=	O	O	O
165	O	O	O
)	O	O	O
,	O	O	O
ampullary	O	O	B-T191
cancer	O	O	I-T191
(	O	O	O
n=59	O	O	O
)	O	O	O
,	O	O	O
duodenal	O	O	B-T191
cancer	O	O	I-T191
(	O	O	O
n	O	O	O
=	O	O	O
6	O	O	O
)	O	O	O
,	O	O	O
distal	O	O	B-T082
common	O	O	B-T191
bile	O	O	I-T191
duct	O	O	I-T191
cancer	O	O	I-T191
(	O	O	O
n	O	O	O
=	O	O	O
21	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
gastric	O	O	B-T191
cancer	O	O	I-T191
(	O	O	O
n	O	O	O
=	O	O	O
20	O	O	O
)	O	O	O
;	O	O	O
chronic	O	O	B-T047
pancreatitis	O	O	I-T047
(	O	O	O
n	O	O	O
=	O	O	O
39	O	O	O
)	O	O	O
;	O	O	O
and	O	O	O
normal	O	O	B-T033
pancreas	O	O	I-T033
(	O	O	O
n	O	O	O
=	O	O	O
35	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
microRNAs	O	O	B-T114
were	O	O	O
analyzed	O	O	O
by	O	O	O
PCR	O	O	B-T063
using	O	O	O
the	O	O	O
Fluidigm	O	O	B-T170
platform	O	O	I-T170
.	O	O	O

Twenty-two	O	O	O
microRNAs	O	O	B-T114
were	O	O	O
significantly	O	O	O
differently	O	O	O
expressed	O	O	B-T045
in	O	O	O
patients	O	O	B-T101
with	O	O	O
pancreatic	O	O	B-T191
cancer	O	O	I-T191
when	O	O	O
compared	O	O	O
to	O	O	O
healthy	O	O	B-T080
controls	O	O	I-T080
and	O	O	O
chronic	O	O	B-T047
pancreatitis	O	O	I-T047
patients	O	O	O
;	O	O	O
17	O	O	O
miRNAs	O	O	B-T114
were	O	O	O
upregulated	O	O	B-T044
(	O	O	O
miR-21	O	O	B-T028
-	O	O	I-T028
5p	O	O	I-T028
,	O	O	O
-	O	O	O
23a-3p	O	O	B-T028
,	O	O	O
-	O	O	O
31	O	O	B-T028
-	O	O	I-T028
5p	O	O	I-T028
,	O	O	O
-	O	O	O
34c-5p	O	O	B-T028
,	O	O	O
-	O	O	O
93	O	O	B-T028
-	O	O	I-T028
3p	O	O	I-T028
,	O	O	O
-	O	O	O
135b-3p	O	O	B-T028
,	O	O	O
-	O	O	O
155	O	O	B-T028
-	O	O	I-T028
5p	O	O	I-T028
,	O	O	O
-	O	O	O
186	O	O	B-T028
-	O	O	I-T028
5p	O	O	I-T028
,	O	O	O
-	O	O	O
196b-5p	O	O	B-T028
,	O	O	I-T028
-	O	O	O
203	O	O	B-T028
,	O	O	O
-	O	O	O
205	O	O	B-T114
-	O	O	I-T114
5p	O	O	I-T114
,	O	O	O
-	O	O	O
210	O	O	B-T028
,	O	O	O
-	O	O	O
222	O	O	B-T028
-	O	O	I-T028
3p	O	O	I-T028
,	O	O	O
-	O	O	O
451	O	O	B-T028
,	O	O	O
-	O	O	O
492	O	O	B-T028
,	O	O	O
-	O	O	O
614	O	O	B-T028
,	O	O	O
and	O	O	O
miR-622	O	O	B-T028
)	O	O	O
and	O	O	O
5	O	O	O
were	O	O	O
downregulated	O	O	B-T044
(	O	O	O
miR-122	O	O	B-T028
-	O	O	I-T028
5p	O	O	I-T028
,	O	O	O
-	O	O	O
130b-3p	O	O	B-T028
,	O	O	O
-	O	O	O
216b	O	O	B-T028
,	O	O	O
-	O	O	O
217	O	O	B-T028
,	O	O	O
and	O	O	O
miR-375	O	O	B-T028
)	O	O	O
.	O	O	O

MicroRNAs	O	O	B-T114
were	O	O	O
grouped	O	O	O
into	O	O	O
diagnostic	O	O	B-T169
indices	O	O	O
of	O	O	O
varying	O	O	O
complexity	O	O	B-T080
.	O	O	O

Ten	O	O	O
microRNAs	O	O	B-T114
associated	O	O	B-T080
with	O	O	I-T080
prognosis	O	O	B-T058
were	O	O	O
identified	O	O	O
(	O	O	O
let-7	O	O	B-T114
g	O	O	I-T114
,	O	O	O
miR-29a-5p	O	O	B-T028
,	O	O	O
-	O	O	O
34a-5p	O	O	B-T028
,	O	O	O
-	O	O	O
125a-3p	O	O	B-T028
,	O	O	O
-	O	O	O
146a-5p	O	O	B-T028
,	O	O	O
-	O	O	O
187	O	O	B-T028
,	O	O	O
-	O	O	O
205	O	O	B-T114
-	O	O	I-T114
5p	O	O	I-T114
,	O	O	O
-	O	O	O
212	O	O	B-T028
-	O	O	I-T028
3p	O	O	I-T028
,	O	O	O
-	O	O	O
222	O	O	B-T028
-	O	O	I-T028
5p	O	O	I-T028
,	O	O	O
and	O	O	O
miR-450b-5p	O	O	B-T028
)	O	O	O
.	O	O	O

Prognostic	O	O	B-T081
indices	O	O	I-T081
based	O	O	O
on	O	O	O
differences	O	O	O
in	O	O	O
expression	O	O	B-T045
of	O	O	O
2	O	O	O
different	O	O	O
microRNAs	O	O	B-T114
were	O	O	O
constructed	O	O	O
for	O	O	O
pancreatic	O	O	B-T191
and	O	O	O
ampullary	O	O	B-T191
cancer	O	O	I-T191
combined	O	O	O
and	O	O	O
separately	O	O	O
(	O	O	O
30	O	O	O
,	O	O	O
5	O	O	O
,	O	O	O
and	O	O	O
21	O	O	O
indices	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
study	O	O	B-T062
confirms	O	O	O
that	O	O	O
pancreatic	O	O	B-T191
cancer	O	O	I-T191
tissue	O	O	B-T024
has	O	O	O
a	O	O	O
microRNA	O	O	B-T114
expression	O	O	B-T081
profile	O	O	I-T081
that	O	O	O
is	O	O	O
different	O	O	O
from	O	O	O
that	O	O	O
of	O	O	O
other	O	O	O
periampullary	O	O	B-T191
cancers	O	O	I-T191
,	O	O	O
chronic	O	O	B-T047
pancreatitis	O	O	I-T047
,	O	O	O
and	O	O	O
normal	O	O	B-T033
pancreas	O	O	I-T033
.	O	O	O

We	O	O	O
identified	O	O	O
prognostic	O	O	B-T170
microRNAs	O	O	B-T114
and	O	O	O
microRNA	O	O	B-T114
indices	O	O	O
that	O	O	O
were	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
shorter	O	O	O
overall	O	O	B-T081
survival	O	O	I-T081
in	O	O	O
patients	O	O	B-T101
with	O	O	O
radically	O	O	O
resected	O	O	B-T061
pancreatic	O	O	B-T191
cancer	O	O	I-T191
.	O	O	O

-DOCSTART- (28239481)

Effectiveness	O	O	B-T080
of	O	O	O
workers	O	O	B-T098
'	O	O	O
general	O	O	B-T060
health	O	O	I-T060
examination	O	O	I-T060
in	O	O	O
Korea	O	O	B-T083
by	O	O	O
health	O	O	B-T058
examination	O	O	I-T058
period	O	O	I-T058
and	O	O	O
compliance	O	O	B-T033
:	O	O	O
retrospective	O	O	B-T062
cohort	O	O	I-T062
study	O	O	I-T062
using	O	O	O
nationwide	O	O	O
data	O	O	O

Our	O	O	O
study	O	O	O
evaluated	O	O	B-T058
the	O	O	O
effectiveness	O	O	B-T080
of	O	O	O
the	O	O	O
Workers	O	O	B-T098
'	O	O	O
General	O	O	B-T060
Health	O	O	I-T060
Examination	O	O	I-T060
by	O	O	O
health	O	O	B-T058
examination	O	O	I-T058
period	O	O	I-T058
and	O	O	O
compliance	O	O	B-T033
.	O	O	O

A	O	O	O
retrospective	O	O	B-T062
cohort	O	O	I-T062
of	O	O	O
the	O	O	O
health	O	O	B-T058
examination	O	O	I-T058
participants	O	O	B-T098
in	O	O	O
2006	O	O	O
(	O	O	O
baseline	O	O	O
year	O	O	O
:	O	O	O
N	O	O	O
ï¿½	O	O	O
â¬â°=	O	O	O
ï¿½	O	O	O
â¬â°6,527,045	O	O	O
)	O	O	O
was	O	O	O
used	O	O	O
.	O	O	O

We	O	O	O
identified	O	O	O
newly	O	O	O
occurring	O	O	O
cardio	O	O	B-T047
-	O	O	O
cerebrovascular	O	O	B-T047
disease	O	O	I-T047
over	O	O	O
7	O	O	O
years	O	O	O
(	O	O	O
from	O	O	O
2007	O	O	O
to	O	O	O
2013	O	O	O
)	O	O	O
.	O	O	O

After	O	O	O
stratification	O	O	B-T062
by	O	O	O
age	O	O	B-T032
,	O	O	O
sex	O	O	B-T032
,	O	O	O
and	O	O	O
national	O	O	B-T058
health	O	O	I-T058
insurance	O	O	I-T058
type	O	O	I-T058
,	O	O	O
we	O	O	O
identified	O	O	O
7	O	O	O
years	O	O	O
'	O	O	O
cumulative	O	O	B-T080
incidence	O	O	B-T081
of	O	O	O
cardio	O	O	B-T047
-	O	O	O
cerebrovascular	O	O	B-T047
disease	O	O	I-T047
by	O	O	O
health	O	O	B-T058
examination	O	O	I-T058
compliance	O	O	B-T033
and	O	O	O
estimated	O	O	O
its	O	O	O
relative	O	O	O
risk	O	O	O
by	O	O	O
health	O	O	B-T058
examination	O	O	I-T058
period	O	O	I-T058
and	O	O	O
compliance	O	O	O
.	O	O	O

The	O	O	O
compliant	O	O	B-T098
group	O	O	I-T098
presented	O	O	O
a	O	O	O
lower	O	O	O
cumulative	O	O	B-T080
incidence	O	O	B-T081
of	O	O	O
cardio	O	O	B-T047
-	O	O	O
cerebrovascular	O	O	B-T047
disease	O	O	I-T047
than	O	O	O
the	O	O	O
non-compliant	O	O	B-T098
group	O	O	I-T098
;	O	O	O
this	O	O	O
result	O	O	O
was	O	O	O
consistent	O	O	O
across	O	O	O
sex	O	O	B-T032
,	O	O	O
working	O	O	B-T057
age	O	O	B-T032
(	O	O	O
40s	O	O	O
and	O	O	O
50s	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
workplace	O	O	B-T082
policyholder	O	O	B-T078
.	O	O	O

Relative	O	O	O
risk	O	O	O
of	O	O	O
cardio	O	O	B-T047
-	O	O	O
cerebrovascular	O	O	B-T047
disease	O	O	I-T047
by	O	O	O
health	O	O	B-T058
examination	O	O	I-T058
period	O	O	I-T058
(	O	O	O
1	O	O	O
and	O	O	O
2	O	O	O
years	O	O	O
)	O	O	O
showed	O	O	O
statistically	O	O	B-T081
significant	O	O	I-T081
results	O	O	O
in	O	O	O
ischemic	O	O	B-T047
heart	O	O	I-T047
disease	O	O	I-T047
for	O	O	O
male	O	O	O
participants	O	O	B-T098
.	O	O	O

Of	O	O	O
men	O	O	B-T098
in	O	O	O
their	O	O	O
40s	O	O	O
,	O	O	O
office	O	O	B-T033
workers	O	O	I-T033
(	O	O	O
over	O	O	O
a	O	O	O
2-year	O	O	O
period	O	O	O
)	O	O	O
presented	O	O	O
statistically	O	O	O
higher	O	O	B-T033
relative	O	O	I-T033
risk	O	O	I-T033
of	O	O	I-T033
ischemic	O	O	B-T047
heart	O	O	I-T047
disease	O	O	I-T047
than	O	O	O
non-office	O	O	B-T098
workers	O	O	I-T098
(	O	O	O
over	O	O	O
a	O	O	O
1-year	O	O	O
period	O	O	O
:	O	O	O
1.03	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
confidence	O	O	B-T081
interval	O	O	I-T081
,	O	O	O
1.02	O	O	O
-	O	O	O
1.03	O	O	O
)	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
there	O	O	O
were	O	O	O
no	O	O	O
consistent	O	O	O
results	O	O	O
in	O	O	O
ischemic	O	O	B-T169
cerebrovascular	O	O	B-T047
disease	O	O	I-T047
and	O	O	O
hemorrhagic	O	O	B-T080
cerebrovascular	O	O	O
disease	O	O	O
for	O	O	O
men	O	O	B-T098
or	O	O	O
cardio	O	O	B-T047
-	O	O	O
cerebrovascular	O	O	O
disease	O	O	O
for	O	O	O
women	O	O	B-T098
.	O	O	O

A	O	O	O
1-year	O	O	O
period	O	O	O
of	O	O	O
Workers	O	O	B-T098
'	O	O	O
General	O	O	B-T060
Health	O	O	I-T060
Examinations	O	O	I-T060
in	O	O	O
non-office	O	O	B-T098
workers	O	O	I-T098
had	O	O	O
a	O	O	O
more	O	O	O
significant	O	O	O
prevention	O	O	B-T061
effect	O	O	O
on	O	O	O
ischemic	O	O	B-T047
heart	O	O	I-T047
disease	O	O	I-T047
than	O	O	O
a	O	O	O
2-year	O	O	O
period	O	O	O
in	O	O	O
office	O	O	B-T033
workers	O	O	I-T033
among	O	O	O
working	O	O	O
age	O	O	B-T032
(	O	O	O
40s-50s	O	O	O
)	O	O	O
men	O	O	B-T098
.	O	O	O

It	O	O	O
is	O	O	O
,	O	O	O
however	O	O	O
,	O	O	O
necessary	O	O	O
to	O	O	O
consider	O	O	O
that	O	O	O
prevention	O	O	B-T061
of	O	O	O
cardio	O	O	B-T047
-	O	O	O
cerebrovascular	O	O	B-T047
disease	O	O	I-T047
can	O	O	O
be	O	O	O
partially	O	O	O
explained	O	O	O
by	O	O	O
their	O	O	O
occupational	O	O	B-T169
characteristics	O	O	I-T169
rather	O	O	O
than	O	O	O
by	O	O	O
health	O	O	B-T058
examination	O	O	I-T058
period	O	O	I-T058
.	O	O	O

-DOCSTART- (28240704)

Calibration	O	O	B-T081
of	O	O	O
Self-Report	O	O	B-T062
Measures	O	O	B-T081
of	O	O	O
Physical	O	O	B-T056
Activity	O	O	I-T056
and	O	O	O
Sedentary	O	O	O
Behavior	O	O	O

Calibration	O	O	B-T081
equations	O	O	B-T077
offer	O	O	O
potential	O	O	B-T080
to	O	O	O
improve	O	O	B-T080
the	O	O	O
accuracy	O	O	B-T080
and	O	O	O
utility	O	O	O
of	O	O	O
self-report	O	O	B-T062
measures	O	O	B-T081
of	O	O	O
physical	O	O	B-T056
activity	O	O	I-T056
(	O	O	O
PA	O	O	B-T056
)	O	O	O
and	O	O	O
sedentary	O	O	B-T033
behavior	O	O	I-T033
(	O	O	O
SB	O	O	B-T033
)	O	O	O
by	O	O	O
re-scaling	O	O	B-T052
potentially	O	O	B-T080
biased	O	O	O
estimates	O	O	B-T081
.	O	O	O

The	O	O	O
present	O	O	O
study	O	O	O
evaluates	O	O	O
calibration	O	O	B-T081
models	O	O	B-T081
designed	O	O	O
to	O	O	O
estimate	O	O	B-T081
PA	O	O	B-T056
and	O	O	O
SB	O	O	B-T033
in	O	O	O
a	O	O	O
representative	O	O	B-T081
sample	O	O	O
of	O	O	O
adults	O	O	B-T100
from	O	O	O
the	O	O	O
Physical	O	O	B-T056
Activity	O	O	I-T056
Measurement	O	O	B-T062
Survey	O	O	I-T062
(	O	O	O
PAMS	O	O	B-T062
)	O	O	O
.	O	O	O

Participants	O	O	B-T098
in	O	O	O
the	O	O	O
PAMS	O	O	B-T062
project	O	O	O
completed	O	O	O
replicate	O	O	O
single	O	O	O
day	O	O	O
trials	O	O	B-T062
that	O	O	O
involved	O	O	O
wearing	O	O	O
a	O	O	O
Sensewear	O	O	B-T073
armband	O	O	I-T073
(	O	O	I-T073
SWA	O	O	I-T073
)	O	O	I-T073
monitor	O	O	B-T074
for	O	O	O
24	O	O	B-T079
hours	O	O	I-T079
followed	O	O	O
by	O	O	O
a	O	O	O
telephone	O	O	B-T062
administered	O	O	B-T169
24-hour	O	O	O
physical	O	O	B-T058
activity	O	O	I-T058
recall	O	O	I-T058
(	O	O	O
PAR	O	O	B-T058
)	O	O	O
.	O	O	O

Comprehensive	O	O	O
statistical	O	O	B-T081
model	O	O	I-T081
selection	O	O	O
and	O	O	O
validation	O	O	B-T169
procedures	O	O	B-T169
were	O	O	O
used	O	O	O
to	O	O	O
develop	O	O	O
and	O	O	O
test	O	O	O
separate	O	O	O
calibration	O	O	B-T081
models	O	O	B-T081
designed	O	O	O
to	O	O	O
predict	O	O	B-UnknownType
objectively	O	O	B-T062
-	O	O	O
measured	O	O	B-T081
SB	O	O	B-T033
and	O	O	O
moderate	O	O	B-T056
to	O	O	I-T056
vigorous	O	O	I-T056
PA	O	O	I-T056
(	O	O	O
MVPA	O	O	B-T056
from	O	O	O
self-reported	O	O	B-T062
PAR	O	O	B-T058
data	O	O	O
.	O	O	O

Equivalence	O	O	B-UnknownType
testing	O	O	O
was	O	O	O
used	O	O	O
to	O	O	O
evaluate	O	O	O
the	O	O	O
equivalence	O	O	B-UnknownType
of	O	O	O
the	O	O	O
model-	O	O	O
predicted	O	O	B-UnknownType
values	O	O	O
with	O	O	O
the	O	O	O
objective	O	O	B-T062
measures	O	O	B-T081
in	O	O	O
a	O	O	O
separate	O	O	O
holdout	O	O	O
sample	O	O	O
.	O	O	O

The	O	O	O
final	O	O	O
prediction	O	O	O
model	O	O	O
for	O	O	O
both	O	O	O
SB	O	O	B-T033
and	O	O	O
MVPA	O	O	B-T056
included	O	O	O
reported	O	O	O
time	O	O	O
spent	O	O	O
in	O	O	O
SB	O	O	O
and	O	O	O
MVPA	O	O	O
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
terms	O	O	O
capturing	O	O	O
sex	O	O	B-T032
,	O	O	O
age	O	O	B-T033
,	O	O	O
education	O	O	B-T033
,	O	O	O
and	O	O	O
BMI	O	O	B-T201
.	O	O	O

Cross-validation	O	O	B-T062
analyses	O	O	B-T081
on	O	O	O
an	O	O	O
independent	O	O	O
sample	O	O	O
exhibited	O	O	O
high	O	O	O
correlations	O	O	O
with	O	O	O
observed	O	O	O
SB	O	O	B-T033
(	O	O	O
r	O	O	O
=	O	O	O
0.72	O	O	O
)	O	O	O
and	O	O	O
MVPA	O	O	B-T056
(	O	O	O
r	O	O	O
=	O	O	O
0.75	O	O	O
)	O	O	O
.	O	O	O

Equivalence	O	O	B-UnknownType
testing	O	O	O
demonstrated	O	O	O
that	O	O	O
the	O	O	O
model-	O	O	O
predicted	O	O	B-UnknownType
values	O	O	O
were	O	O	O
statistically	O	O	B-T081
equivalent	O	O	O
to	O	O	O
the	O	O	O
corresponding	O	O	O
objective	O	O	B-T062
values	O	O	O
for	O	O	O
both	O	O	O
SB	O	O	B-T033
and	O	O	O
MVPA	O	O	B-T056
.	O	O	O

The	O	O	O
results	O	O	O
demonstrate	O	O	O
that	O	O	O
simple	O	O	O
regression	O	O	B-T170
models	O	O	B-T081
can	O	O	O
be	O	O	O
used	O	O	O
to	O	O	O
statistically	O	O	B-T081
adjust	O	O	O
for	O	O	O
over	O	O	O
or	O	O	O
underestimation	O	O	O
in	O	O	O
self-report	O	O	B-T062
measures	O	O	B-T081
among	O	O	O
different	O	O	O
segments	O	O	O
of	O	O	O
the	O	O	O
population	O	O	B-T098
.	O	O	O

The	O	O	O
models	O	O	B-T081
produced	O	O	O
group	O	O	O
estimates	O	O	B-T081
from	O	O	O
the	O	O	O
PAR	O	O	B-T058
that	O	O	O
were	O	O	O
statistically	O	O	B-T081
equivalent	O	O	O
to	O	O	O
the	O	O	O
observed	O	O	O
time	O	O	O
spent	O	O	O
in	O	O	O
SB	O	O	B-T033
and	O	O	O
MVPA	O	O	B-T056
obtained	O	O	O
from	O	O	O
the	O	O	O
objective	O	O	O
SWA	O	O	B-T073
monitor	O	O	B-T074
;	O	O	O
however	O	O	O
additional	O	O	O
work	O	O	O
is	O	O	O
needed	O	O	O
to	O	O	O
correct	O	O	O
for	O	O	O
estimates	O	O	O
of	O	O	O
individual	O	O	B-T055
behavior	O	O	I-T055
.	O	O	O

-DOCSTART- (28241859)

Human	O	O	B-T016
amnion	O	O	B-T018
epithelial	O	O	B-T025
cells	O	O	I-T025
rescue	O	O	O
cell	O	O	B-T043
death	O	O	I-T043
via	O	O	O
immunomodulation	O	O	B-T061
of	O	O	O
microglia	O	O	B-T025
in	O	O	O
a	O	O	O
mouse	O	O	B-T050
model	O	O	I-T050
of	O	O	O
perinatal	O	O	O
brain	O	O	O
injury	O	O	O

Human	O	O	B-T016
amnion	O	O	B-T018
epithelial	O	O	B-T025
cells	O	O	I-T025
(	O	O	O
hAECs	O	O	B-T025
)	O	O	O
are	O	O	O
clonogenic	O	O	B-T081
and	O	O	O
have	O	O	O
been	O	O	O
proposed	O	O	O
to	O	O	O
reduce	O	O	B-T081
inflammatory	O	O	B-T046
-	O	O	O
induced	O	O	B-T169
tissue	O	O	B-T037
injury	O	O	I-T037
.	O	O	O

Perturbation	O	O	B-T169
of	O	O	O
the	O	O	O
immune	O	O	B-T042
response	O	O	B-T042
is	O	O	O
implicated	O	O	O
in	O	O	O
the	O	O	O
pathogenesis	O	O	B-T046
of	O	O	O
perinatal	O	O	B-T037
brain	O	O	I-T037
injury	O	O	B-T037
;	O	O	O
modulating	O	O	B-T082
this	O	O	O
response	O	O	O
could	O	O	O
thus	O	O	O
be	O	O	O
a	O	O	O
novel	O	O	B-T080
therapy	O	O	B-T061
for	O	O	O
treating	O	O	B-T169
or	O	O	O
preventing	O	O	O
such	O	O	O
injury	O	O	O
.	O	O	O

The	O	O	O
immunomodulatory	O	O	B-T061
properties	O	O	O
of	O	O	O
hAECs	O	O	B-T025
have	O	O	O
been	O	O	O
shown	O	O	O
in	O	O	O
other	O	O	O
animal	O	O	B-T008
models	O	O	I-T008
,	O	O	O
but	O	O	O
a	O	O	O
detailed	O	O	O
investigation	O	O	B-T058
of	O	O	O
the	O	O	O
effects	O	O	B-T080
on	O	O	O
brain	O	O	B-T023
immune	O	O	B-T169
cells	O	O	B-T025
following	O	O	O
injury	O	O	B-T037
has	O	O	O
not	O	O	O
been	O	O	O
undertaken	O	O	O
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
investigate	O	O	B-T058
the	O	O	O
effects	O	O	B-T080
of	O	O	O
hAECs	O	O	B-T025
on	O	O	O
microglia	O	O	B-T025
,	O	O	O
the	O	O	O
first	O	O	O
immune	O	O	B-T042
responders	O	O	I-T042
to	O	O	O
injury	O	O	B-T037
within	O	O	O
the	O	O	O
brain	O	O	B-T023
.	O	O	O

We	O	O	O
generated	O	O	O
a	O	O	O
mouse	O	O	B-T050
model	O	O	I-T050
combining	O	O	O
neonatal	O	O	B-T079
inflammation	O	O	B-T046
and	O	O	O
perinatal	O	O	B-T079
hyperoxia	O	O	B-T184
,	O	O	O
both	O	O	O
of	O	O	O
which	O	O	O
are	O	O	O
risk	O	O	B-T033
factors	O	O	I-T033
associated	O	O	O
with	O	O	O
perinatal	O	O	B-T037
brain	O	O	I-T037
injury	O	O	I-T037
.	O	O	O

On	O	O	O
embryonic	O	O	B-T042
day	O	O	B-T079
16	O	O	O
we	O	O	O
administered	O	O	B-T061
lipopolysaccharide	O	O	B-T109
(	O	O	O
LPS	O	O	B-T109
)	O	O	O
,	O	O	O
or	O	O	O
saline	O	O	B-T167
(	O	O	O
control	O	O	B-T167
)	O	O	O
,	O	O	O
intra-amniotically	O	O	B-T169
to	O	O	O
C57Bl/6	O	O	B-T015
J	O	O	I-T015
mouse	O	O	I-T015
pups	O	O	I-T015
.	O	O	O

On	O	O	O
postnatal	O	O	B-T079
day	O	O	B-T079
(P)0	O	O	O
,	O	O	O
LPS	O	O	B-T109
pups	O	O	B-T015
were	O	O	O
placed	O	O	O
in	O	O	O
hyperoxia	O	O	B-T184
(	O	O	O
65	O	O	O
%	O	O	O
oxygen	O	O	B-T121
)	O	O	O
and	O	O	O
control	O	O	B-T096
pups	O	O	I-T096
in	O	O	O
normoxia	O	O	B-T070
for	O	O	O
14	O	O	O
days	O	O	B-T079
.	O	O	O

Pups	O	O	B-T015
were	O	O	O
given	O	O	O
either	O	O	O
hAECs	O	O	B-T025
or	O	O	O
saline	O	O	B-T167
intravenously	O	O	B-T061
on	O	O	O
P4	O	O	O
.	O	O	O

At	O	O	O
P14	O	O	O
,	O	O	O
relative	O	O	O
to	O	O	O
controls	O	O	B-T096
,	O	O	O
LPS	O	O	B-T109
and	O	O	O
hyperoxia	O	O	B-T184
pups	O	O	B-T015
had	O	O	O
reduced	O	O	B-T081
body	O	O	B-T032
weight	O	O	I-T032
,	O	O	O
increased	O	O	B-T081
density	O	O	B-T081
of	O	O	O
apoptotic	O	O	B-T080
cells	O	O	B-T025
(	O	O	O
TUNEL	O	O	B-T063
)	O	O	O
in	O	O	O
the	O	O	O
cortex	O	O	B-T023
,	O	O	O
striatum	O	O	B-T023
and	O	O	O
white	O	O	B-T024
matter	O	O	I-T024
,	O	O	O
astrocytes	O	O	B-T025
(	O	O	O
GFAP	O	O	B-T116
)	O	O	O
in	O	O	O
the	O	O	O
white	O	O	O
matter	O	O	O
and	O	O	O
activated	O	O	B-T169
microglia	O	O	B-T025
(	O	O	O
CD68	O	O	B-T116
)	O	O	O
in	O	O	O
the	O	O	O
cortex	O	O	O
and	O	O	O
striatum	O	O	O
,	O	O	O
but	O	O	O
no	O	O	O
change	O	O	O
in	O	O	O
total	O	O	O
microglia	O	O	O
density	O	O	O
(	O	O	O
Iba1	O	O	B-T116
)	O	O	O
.	O	O	O

hAEC	O	O	B-T025
administration	O	O	B-T061
rescued	O	O	O
the	O	O	O
decreased	O	O	B-T081
body	O	O	B-T032
weight	O	O	I-T032
and	O	O	O
reduced	O	O	B-T081
apoptosis	O	O	B-T043
and	O	O	O
astrocyte	O	O	B-T025
areal	O	O	B-T169
coverage	O	O	I-T169
in	O	O	O
the	O	O	O
white	O	O	B-T024
matter	O	O	I-T024
,	O	O	O
but	O	O	O
increased	O	O	B-T081
the	O	O	O
density	O	O	B-T081
of	O	O	O
total	O	O	O
and	O	O	O
activated	O	O	B-T169
microglia	O	O	B-T025
.	O	O	O

We	O	O	O
then	O	O	O
stimulated	O	O	O
primary	O	O	B-T080
microglia	O	O	B-T025
(	O	O	O
CD45	O	O	B-T116
(	O	O	O
low	O	O	O
)	O	O	O
CD11b	O	O	B-T116
(	O	O	O
+	O	O	O
)	O	O	O
)	O	O	O
with	O	O	O
LPS	O	O	B-T109
for	O	O	O
24	O	O	O
h	O	O	O
,	O	O	O
followed	O	O	O
by	O	O	O
co-culture	O	O	B-T059
with	O	O	O
hAEC	O	O	B-T025
conditioned	O	O	B-T130
medium	O	O	I-T130
for	O	O	O
48	O	O	O
h.	O	O	O
hAEC	O	O	O
conditioned	O	O	O
medium	O	O	O
increased	O	O	B-T081
microglial	O	O	B-T025
phagocytic	O	O	B-T043
activity	O	O	I-T043
,	O	O	O
decreased	O	O	B-T081
microglia	O	O	O
apoptosis	O	O	B-T043
and	O	O	O
decreased	O	O	O
M1	O	O	B-T043
activation	O	O	I-T043
markers	O	O	I-T043
(	O	O	O
CD86	O	O	B-T116
)	O	O	O
.	O	O	O

Stimulating	O	O	O
hAECs	O	O	B-T025
for	O	O	O
24	O	O	O
h	O	O	O
with	O	O	O
LPS	O	O	B-T109
did	O	O	O
not	O	O	O
alter	O	O	O
release	O	O	B-T061
of	O	O	O
cytokines	O	O	B-T116
known	O	O	O
to	O	O	O
modulate	O	O	B-T082
microglia	O	O	B-T025
activity	O	O	B-T052
.	O	O	O

These	O	O	O
data	O	O	B-T078
demonstrate	O	O	O
that	O	O	O
hAECs	O	O	B-T025
can	O	O	O
directly	O	O	O
immunomodulate	O	O	B-T061
brain	O	O	B-T023
microglia	O	O	B-T025
,	O	O	O
probably	O	O	O
via	O	O	O
release	O	O	B-T061
of	O	O	O
trophic	O	O	B-T116
factors	O	O	I-T116
.	O	O	O

This	O	O	O
observation	O	O	B-T062
offers	O	O	O
promise	O	O	O
that	O	O	O
hAECs	O	O	B-T025
may	O	O	O
afford	O	O	O
therapeutic	O	O	B-T061
utility	O	O	I-T061
in	O	O	O
the	O	O	O
management	O	O	B-T058
of	O	O	O
perinatal	O	O	B-T037
brain	O	O	I-T037
injury	O	O	I-T037
.	O	O	O

-DOCSTART- (28243201)

Identification	O	O	B-T080
of	O	O	O
Predictive	O	O	O
DNA	O	O	B-T044
Methylation	O	O	I-T044
Biomarkers	O	O	B-T123
for	O	O	O
Chemotherapy	O	O	B-T061
Response	O	O	B-T201
in	O	O	O
Colorectal	O	O	O
Cancer	O	O	O

Resistance	O	O	B-T038
to	O	O	O
5-Fluorouracil	O	O	B-T114
(	O	O	O
5-FU	O	O	B-T114
)	O	O	O
is	O	O	O
a	O	O	O
major	O	O	O
obstacle	O	O	O
to	O	O	O
the	O	O	O
successful	O	O	O
treatment	O	O	B-T169
of	O	O	O
colorectal	O	O	B-T191
cancer	O	O	I-T191
(	O	O	O
CRC	O	O	B-T191
)	O	O	O
and	O	O	O
posed	O	O	O
an	O	O	O
increased	O	O	O
risk	O	O	B-T081
of	O	O	I-T081
recurrence	O	O	I-T081
.	O	O	O

DNA	O	O	B-T044
methylation	O	O	I-T044
has	O	O	O
been	O	O	O
suggested	O	O	O
as	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
underlying	O	O	O
mechanisms	O	O	B-T046
for	O	O	O
recurrent	O	O	B-T047
disease	O	O	I-T047
and	O	O	O
its	O	O	O
contribution	O	O	B-T052
to	O	O	O
the	O	O	O
development	O	O	O
of	O	O	O
drug	O	O	B-T038
resistance	O	O	I-T038
remains	O	O	O
to	O	O	O
be	O	O	O
clarified	O	O	B-T052
.	O	O	O

This	O	O	O
study	O	O	B-T062
aimed	O	O	O
to	O	O	O
determine	O	O	O
the	O	O	O
methylation	O	O	B-T044
phenotype	O	O	B-T032
in	O	O	O
CRC	O	O	B-T191
for	O	O	O
identification	O	O	B-T080
of	O	O	O
predictive	O	O	O
markers	O	O	B-T123
for	O	O	O
chemotherapy	O	O	B-T061
response	O	O	B-T201
.	O	O	O

We	O	O	O
performed	O	O	O
DNA	O	O	B-T044
methylation	O	O	I-T044
profiling	O	O	B-T169
on	O	O	O
43	O	O	O
non-recurrent	O	O	B-T079
and	O	O	O
five	O	O	O
recurrent	O	O	B-T079
CRC	O	O	B-T191
patients	O	O	B-T101
using	O	O	O
the	O	O	O
Illumina	O	O	B-T063
Infinium	O	O	I-T063
HumanMethylation450	O	O	I-T063
Beadchip	O	O	I-T063
assay	O	O	I-T063
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
CRC	O	O	B-T191
cells	O	O	B-T025
with	O	O	O
different	O	O	O
genetic	O	O	B-T032
backgrounds	O	O	I-T032
,	O	O	O
response	O	O	B-T201
to	O	O	O
5-FU	O	O	B-T114
and	O	O	O
global	O	O	B-T044
methylation	O	O	I-T044
levels	O	O	B-T080
(	O	O	O
HT29	O	O	B-T025
and	O	O	O
SW48	O	O	B-T025
)	O	O	O
were	O	O	O
treated	O	O	B-T169
with	O	O	O
5-FU	O	O	O
and	O	O	O
DNA	O	O	B-T044
methylation	O	O	I-T044
inhibitor	O	O	B-T080
5-aza-2'-deoxycytidine	O	O	B-T114
(	O	O	O
5-azadC	O	O	B-T114
)	O	O	O
.	O	O	O

The	O	O	O
singular	O	O	O
and	O	O	O
combined	O	O	O
effects	O	O	B-T080
of	O	O	O
these	O	O	O
two	O	O	O
drug	O	O	B-T121
classes	O	O	B-T170
on	O	O	O
cell	O	O	B-T043
viability	O	O	I-T043
and	O	O	O
global	O	O	B-T044
methylation	O	O	I-T044
profiles	O	O	B-T059
were	O	O	O
investigated	O	O	O
.	O	O	O

Our	O	O	O
genome-wide	O	O	B-T063
methylation	O	O	B-T044
study	O	O	I-T063
on	O	O	O
the	O	O	O
clinical	O	O	B-T080
specimens	O	O	B-T167
showed	O	O	O
that	O	O	O
recurrent	O	O	B-T079
CRCs	O	O	B-T191
exhibited	O	O	O
higher	O	O	O
methylation	O	O	O
levels	O	O	B-T080
compared	O	O	O
to	O	O	O
non-recurrent	O	O	B-T079
CRCs	O	O	O
.	O	O	O

We	O	O	O
identified	O	O	B-T080
4787	O	O	O
significantly	O	O	O
differentially	O	O	O
methylated	O	O	B-T028
genes	O	O	B-T028
(	O	O	O
P	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
;	O	O	O
3112	O	O	O
genes	O	O	O
were	O	O	O
hyper	O	O	B-T033
-	O	O	O
while	O	O	O
1675	O	O	O
genes	O	O	O
were	O	O	O
hypomethylated	O	O	B-T033
in	O	O	O
the	O	O	O
recurrent	O	O	B-T079
group	O	O	B-T078
compared	O	O	O
to	O	O	O
the	O	O	O
non-recurrent	O	O	B-T079
.	O	O	O

Fifty	O	O	O
eight	O	O	O
and	O	O	O
47	O	O	O
of	O	O	O
the	O	O	O
significantly	O	O	O
hypermethylated	O	O	B-T028
and	O	O	I-T028
hypomethylated	O	O	I-T028
genes	O	O	I-T028
have	O	O	O
an	O	O	O
absolute	O	O	O
recurrent	O	O	B-T079
/	O	O	O
non-recurrent	O	O	B-T079
methylation	O	O	B-T044
difference	O	O	O
of	O	O	O
â¥20	O	O	O
%	O	O	O
.	O	O	O

Most	O	O	O
of	O	O	O
the	O	O	O
hypermethylated	O	O	B-T028
genes	O	O	I-T028
were	O	O	O
involved	O	O	O
in	O	O	O
the	O	O	O
MAPK	O	O	B-T043
signaling	O	O	I-T043
pathway	O	O	I-T043
which	O	O	O
is	O	O	O
a	O	O	O
key	O	O	O
regulator	O	O	B-T077
for	O	O	O
apoptosis	O	O	B-T043
while	O	O	O
the	O	O	O
hypomethylated	O	O	B-T028
genes	O	O	I-T028
were	O	O	O
involved	O	O	O
in	O	O	O
the	O	O	O
PI3K-AKT	O	O	B-T044
signaling	O	O	I-T044
pathway	O	O	I-T044
and	O	O	O
proliferation	O	O	B-T169
process	O	O	I-T169
.	O	O	O

We	O	O	O
also	O	O	O
demonstrate	O	O	O
that	O	O	O
5-azadC	O	O	B-T114
treatment	O	O	B-T169
enhanced	O	O	O
response	O	O	B-T201
to	O	O	O
5-FU	O	O	B-T114
which	O	O	O
resulted	O	O	O
in	O	O	O
significant	O	O	O
growth	O	O	B-T043
inhibition	O	O	I-T043
compared	O	O	O
to	O	O	O
5-FU	O	O	O
alone	O	O	O
in	O	O	O
hypermethylated	O	O	B-T025
cell	O	O	I-T025
lines	O	O	I-T025
SW48	O	O	I-T025
.	O	O	O

In	O	O	O
conclusion	O	O	O
,	O	O	O
we	O	O	O
found	O	O	O
the	O	O	O
evidence	O	O	O
of	O	O	O
five	O	O	O
potentially	O	O	O
biologically	O	O	O
important	O	O	O
genes	O	O	B-T028
in	O	O	O
recurrent	O	O	B-T079
CRCs	O	O	B-T191
that	O	O	O
could	O	O	O
possibly	O	O	O
serve	O	O	O
as	O	O	O
a	O	O	O
new	O	O	O
potential	O	O	O
therapeutic	O	O	B-T061
targets	O	O	B-T169
for	O	O	O
patients	O	O	B-T101
with	O	O	O
chemoresistance	O	O	B-T038
.	O	O	O

We	O	O	O
postulate	O	O	O
that	O	O	O
aberrant	O	O	B-T080
methylation	O	O	B-T044
of	O	O	O
CCNEI	O	O	B-T028
,	O	O	O
CCNDBP1	O	O	B-T028
,	O	O	O
PON3	O	O	B-T028
,	O	O	O
DDX43	O	O	B-T028
,	O	O	O
and	O	O	O
CHL1	O	O	B-T028
in	O	O	O
CRC	O	O	B-T191
might	O	O	O
be	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
the	O	O	O
recurrence	O	O	B-T067
of	O	O	O
CRC	O	O	O
and	O	O	O
5-azadC	O	O	B-T114
-mediated	O	O	O
restoration	O	O	O
of	O	O	O
5-FU	O	O	B-T114
sensitivity	O	O	O
is	O	O	O
mediated	O	O	O
at	O	O	O
least	O	O	O
in	O	O	O
part	O	O	O
by	O	O	O
MAPK	O	O	B-T043
signaling	O	O	I-T043
pathway	O	O	I-T043
.	O	O	O

-DOCSTART- (28243909)

Effect	O	O	B-T080
of	O	O	O
Successive	O	O	B-T061
Administration	O	O	I-T061
of	O	O	O
Vancomycin	O	O	B-T116
and	O	O	O
Amikacin	O	O	B-T195
on	O	O	O
Auditory	O	O	B-T039
Function	O	O	I-T039
of	O	O	O
Immature	O	O	O
Animals	O	O	O

Effect	O	O	B-T080
of	O	O	O
successive	O	O	B-T061
administration	O	O	B-T058
vancomycin	O	O	B-T116
and	O	O	O
amikacin	O	O	B-T195
in	O	O	O
therapeutic	O	O	B-T169
doses	O	O	B-T081
on	O	O	O
immature	O	O	B-T080
auditory	O	O	B-T022
organ	O	O	I-T022
was	O	O	O
compared	O	O	B-T052
to	O	O	O
single	O	O	B-T081
administration	O	O	O
of	O	O	O
the	O	O	O
same	O	O	B-T080
drugs	O	O	B-T121
in	O	O	O
chronic	O	O	B-T079
experiments	O	O	B-T062
on	O	O	O
immature	O	O	O
rabbits	O	O	B-T015
by	O	O	O
recording	O	O	B-T080
of	O	O	O
short-latency	O	O	B-T079
auditory	O	O	B-T201
brainstem	O	O	I-T201
response	O	O	I-T201
(	O	O	O
ABR	O	O	B-T201
)	O	O	O
and	O	O	O
distortion	O	O	B-T060
product	O	O	I-T060
otoacoustic	O	O	I-T060
emission	O	O	I-T060
(	O	O	O
DPOAE	O	O	B-T060
)	O	O	O
.	O	O	O

Drug	O	O	B-T058
administration	O	O	I-T058
always	O	O	O
increased	O	O	B-T081
significantly	O	O	O
the	O	O	O
ABR	O	O	B-T201
peak	O	O	O
I	O	O	O
threshold	O	O	B-T081
.	O	O	O

Ototoxic	O	O	B-T037
antibiotics	O	O	B-T195
did	O	O	O
not	O	O	O
change	O	O	O
DPOAE	O	O	B-T060
,	O	O	O
but	O	O	O
selectively	O	O	O
affected	O	O	B-T169
activity	O	O	B-T033
of	O	O	O
outer	O	O	B-T025
hair	O	O	I-T025
cells	O	O	I-T025
.	O	O	O

No	O	O	B-T033
enhancement	O	O	B-T052
of	O	O	O
the	O	O	O
ototoxic	O	O	B-T037
effects	O	O	I-T037
was	O	O	O
observed	O	O	B-T169
after	O	O	O
successive	O	O	B-T061
administration	O	O	I-T061
of	O	O	O
the	O	O	O
two	O	O	O
antibiotics	O	O	B-T195
.	O	O	O

-DOCSTART- (28244578)

Water	O	O	B-T121
safety	O	O	B-T068
in	O	O	O
healthcare	O	O	B-T093
facilities	O	O	I-T093
.	O	O	O
The	O	O	O
Vieste	O	O	O
Charter	O	O	O

The	O	O	O
Vieste	O	O	B-T170
Charter	O	O	I-T170
The	O	O	O
Study	O	O	B-T097
Group	O	O	I-T097
on	O	O	O
Hospital	O	O	B-T093
Hygiene	O	O	B-T091
of	O	O	O
the	O	O	O
Italian	O	O	B-T093
Society	O	O	I-T093
of	O	O	I-T093
Hygiene	O	O	I-T093
,	O	O	I-T093
Preventive	O	O	I-T093
Medicine	O	O	I-T093
and	O	O	I-T093
Public	O	O	I-T093
Health	O	O	I-T093
(	O	O	O
GISIO-SItI	O	O	B-T093
)	O	O	O
and	O	O	O
the	O	O	O
Local	O	O	B-T093
Health	O	O	I-T093
Authority	O	O	I-T093
of	O	O	O
Foggia	O	O	B-T083
,	O	O	O
Apulia	O	O	B-T083
,	O	O	O
Italy	O	O	B-T083
,	O	O	O
after	O	O	O
the	O	O	O
National	O	O	B-T068
Convention	O	O	I-T068
"	O	O	O
Safe	O	O	O
water	O	O	B-T121
in	O	O	O
healthcare	O	O	B-T093
facilities	O	O	I-T093
"	O	O	O
held	O	O	O
in	O	O	O
Vieste-Pugnochiuso	O	O	B-T083
on	O	O	O
27	O	O	O
-	O	O	O
28	O	O	O
May	O	O	O
2016	O	O	O
,	O	O	O
present	O	O	O
the	O	O	O
"	O	O	O
Vieste	O	O	O
Charter	O	O	O
"	O	O	O
,	O	O	O
drawn	O	O	O
up	O	O	O
in	O	O	O
collaboration	O	O	B-T054
with	O	O	O
experts	O	O	B-T097
from	O	O	O
the	O	O	O
National	O	O	B-T093
Institute	O	O	I-T093
of	O	O	I-T093
Health	O	O	I-T093
and	O	O	O
the	O	O	B-UnknownType
Ministry	O	O	I-UnknownType
of	O	O	I-UnknownType
Health	O	O	I-UnknownType
.	O	O	O

This	O	O	O
paper	O	O	O
considers	O	O	O
the	O	O	O
risk	O	O	B-T033
factors	O	O	I-T033
that	O	O	O
may	O	O	O
affect	O	O	B-T058
the	O	O	O
water	O	O	B-T121
safety	O	O	B-T068
in	O	O	O
healthcare	O	O	B-T093
facilities	O	O	I-T093
and	O	O	O
reports	O	O	O
the	O	O	O
current	O	O	O
regulatory	O	O	B-T170
frameworks	O	O	I-T170
governing	O	O	O
the	O	O	O
management	O	O	B-T058
of	O	O	I-T058
installations	O	O	I-T058
and	O	O	O
the	O	O	O
quality	O	O	B-T080
of	O	O	O
the	O	O	O
water	O	O	O
.	O	O	O

The	O	O	O
Authors	O	O	O
promote	O	O	O
a	O	O	O
careful	O	O	O
analysis	O	O	O
of	O	O	O
the	O	O	O
risks	O	O	B-T078
that	O	O	O
characterize	O	O	O
the	O	O	O
health	O	O	B-T093
facilities	O	O	B-T093
,	O	O	O
for	O	O	O
the	O	O	O
control	O	O	O
of	O	O	O
which	O	O	O
specific	O	O	O
actions	O	O	O
are	O	O	O
recommended	O	O	O
in	O	O	O
various	O	O	O
areas	O	O	O
,	O	O	O
including	O	O	O
water	O	O	B-T089
safety	O	O	I-T089
plans	O	O	I-T089
;	O	O	O
approval	O	O	O
of	O	O	O
treatments	O	O	B-T169
;	O	O	O
healthcare	O	O	B-T093
facilities	O	O	I-T093
responsibility	O	O	B-T055
,	O	O	O
installation	O	O	O
and	O	O	O
maintenance	O	O	B-T052
of	O	O	O
facilities	O	O	O
;	O	O	O
multidisciplinary	O	O	B-T082
approach	O	O	I-T082
;	O	O	O
education	O	O	B-T065
and	O	O	O
research	O	O	B-T062
;	O	O	O
regional	O	O	B-T169
and	O	O	I-T169
national	O	O	I-T169
coordination	O	O	I-T169
;	O	O	O
communication	O	O	B-T054
.	O	O	O

-DOCSTART- (28244917)

In	O	O	B-T082
Vivo	O	O	I-T082
Three-Dimensional	O	O	B-T082
Patellar	O	O	B-T023
Mechanics	O	O	B-T070
:	O	O	O
Normal	O	O	B-T080
Knees	O	O	B-T023
Compared	O	O	B-T052
with	O	O	O
Domed	O	O	B-T082
and	O	O	O
Anatomic	O	O	B-T080
Patellar	O	O	O
Components	O	O	O

Patellofemoral	O	O	B-T030
complications	O	O	B-T169
are	O	O	O
a	O	O	O
major	O	O	O
cause	O	O	O
of	O	O	O
revision	O	O	B-T061
surgery	O	O	I-T061
following	O	O	B-T079
total	O	O	B-T061
knee	O	O	I-T061
arthroplasty	O	O	I-T061
(	O	O	O
TKA	O	O	B-T061
)	O	O	O
.	O	O	O

High	O	O	B-T080
forces	O	O	B-T067
occurring	O	O	O
at	O	O	O
the	O	O	O
patellofemoral	O	O	B-T030
articulation	O	O	I-T030
coupled	O	O	B-T169
with	O	O	O
a	O	O	O
small	O	O	B-T081
patellofemoral	O	O	O
contact	O	O	B-T082
area	O	O	I-T082
pose	O	O	O
substantial	O	O	O
design	O	O	B-T052
challenges	O	O	O
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
the	O	O	O
three-dimensional	O	O	B-T082
(	O	O	O
3D	O	O	B-T082
)	O	O	O
in	O	O	B-T082
vivo	O	O	I-T082
mechanics	O	O	B-T070
of	O	O	O
domed	O	O	B-T082
and	O	O	O
anatomically	O	O	B-T080
shaped	O	O	B-T082
patellar	O	O	B-T023
components	O	O	B-T073
were	O	O	O
compared	O	O	B-T052
with	O	O	O
those	O	O	O
of	O	O	O
native	O	O	B-T169
patellae	O	O	B-T023
.	O	O	O

Ten	O	O	O
normal	O	O	B-T080
knees	O	O	B-T023
,	O	O	O
10	O	O	O
treated	O	O	B-T061
with	O	O	I-T061
an	O	O	O
LCS-PS	O	O	B-T061
(	O	O	I-T061
low	O	O	I-T061
contact	O	O	I-T061
stress-posterior	O	O	I-T061
stabilized	O	O	I-T061
)	O	O	I-T061
TKA	O	O	I-T061
(	O	O	O
anatomically	O	O	B-T080
shaped	O	O	B-T082
patellar	O	O	B-T023
component	O	O	B-T073
)	O	O	O
,	O	O	O
and	O	O	O
10	O	O	O
treated	O	O	O
with	O	O	O
a	O	O	O
PFC	O	O	B-T061
Sigma	O	O	I-T061
RP-PS	O	O	I-T061
(	O	O	I-T061
press-fit	O	O	I-T061
condylar	O	O	I-T061
Sigma	O	O	I-T061
rotating	O	O	I-T061
platform-posterior	O	O	I-T061
stabilized	O	O	I-T061
)	O	O	I-T061
TKA	O	O	I-T061
(	O	O	O
domed	O	O	B-T082
patellar	O	O	O
component	O	O	O
)	O	O	O
were	O	O	O
analyzed	O	O	B-T062
under	O	O	O
fluoroscopic	O	O	B-T060
surveillance	O	O	B-T169
while	O	O	O
the	O	O	O
patient	O	O	B-T101
performed	O	O	B-T169
a	O	O	O
weight-bearing	O	O	B-T033
deep	O	O	B-T082
knee	O	O	B-T033
bend	O	O	I-T033
from	O	O	O
full	O	O	B-T080
knee	O	O	B-T033
extension	O	O	I-T033
to	O	O	O
maximum	O	O	B-T081
knee	O	O	B-T033
flexion	O	O	I-T033
.	O	O	O

Relevant	O	O	O
bone	O	O	O
geometries	O	O	O
were	O	O	O
segmented	O	O	B-T082
out	O	O	O
from	O	O	O
computed	O	O	B-T060
tomography	O	O	I-T060
(	O	O	O
CT	O	O	B-T060
)	O	O	O
scans	O	O	B-T060
,	O	O	O
and	O	O	O
computer-assisted-design	O	O	B-T066
(	O	O	O
CAD	O	O	B-T066
)	O	O	O
models	O	O	B-T170
of	O	O	O
the	O	O	O
implanted	O	O	B-T074
components	O	O	B-T073
were	O	O	O
obtained	O	O	O
from	O	O	O
the	O	O	O
manufacturer	O	O	O
.	O	O	O

Three-dimensional	O	O	B-T082
patellofemoral	O	O	B-T030
kinematics	O	O	B-T091
were	O	O	O
obtained	O	O	O
using	O	O	O
a	O	O	O
3D	O	O	B-T082
-to-	O	O	O
2D	O	O	B-T082
registration	O	O	O
process	O	O	O
.	O	O	O

Contact	O	O	B-T070
mechanics	O	O	I-T070
were	O	O	O
calculated	O	O	B-T052
using	O	O	O
a	O	O	O
distance	O	O	B-T073
map	O	O	I-T073
between	O	O	O
the	O	O	O
articulating	O	O	B-T023
patellar	O	O	I-T023
and	O	O	O
femoral	O	O	B-T029
surfaces	O	O	I-T029
.	O	O	O

Both	O	O	O
patellar	O	O	B-T023
component	O	O	B-T073
designs	O	O	O
exhibited	O	O	O
good	O	O	B-T080
rotational	O	O	B-T091
kinematics	O	O	I-T091
and	O	O	O
tracked	O	O	O
well	O	O	O
within	O	O	O
the	O	O	O
femoral	O	O	B-T023
trochlea	O	O	I-T023
when	O	O	O
compared	O	O	B-T052
with	O	O	O
the	O	O	O
normal	O	O	B-T080
patella	O	O	B-T023
.	O	O	O

The	O	O	O
contact	O	O	B-T082
areas	O	O	B-T082
in	O	O	O
the	O	O	O
TKA	O	O	B-T061
groups	O	O	B-T078
peaked	O	O	O
at	O	O	O
60	O	O	O
Â°	O	O	O
of	O	O	O
knee	O	O	B-T033
flexion	O	O	I-T033
(	O	O	O
mean	O	O	B-T081
and	O	O	O
standard	O	O	B-T081
deviation	O	O	I-T081
,	O	O	O
201	O	O	O
Â±	O	O	O
63.4	O	O	O
mm	O	O	O
for	O	O	O
the	O	O	O
LCS-PS	O	O	B-T078
group	O	O	I-T078
and	O	O	O
218	O	O	O
Â±	O	O	O
95.4	O	O	O
mm	O	O	O
for	O	O	O
the	O	O	O
Sigma	O	O	B-T078
RP-PS	O	O	I-T078
group	O	O	I-T078
)	O	O	O
,	O	O	O
and	O	O	O
the	O	O	O
areas	O	O	O
were	O	O	O
substantially	O	O	O
smaller	O	O	B-T080
than	O	O	O
those	O	O	O
previously	O	O	O
reported	O	O	B-T170
for	O	O	O
the	O	O	O
normal	O	O	B-T080
patella	O	O	B-T023
.	O	O	O

Contact	O	O	B-T082
points	O	O	I-T082
in	O	O	O
the	O	O	O
TKA	O	O	B-T061
groups	O	O	B-T078
stayed	O	O	O
close	O	O	O
to	O	O	O
the	O	O	O
center	O	O	B-T082
of	O	O	O
the	O	O	O
patellar	O	O	B-T023
components	O	O	B-T073
.	O	O	O

Both	O	O	O
designs	O	O	B-T052
performed	O	O	B-T169
satisfactorily	O	O	B-T080
,	O	O	O
although	O	O	O
patellofemoral	O	O	B-T030
contact	O	O	B-T082
areas	O	O	I-T082
were	O	O	O
reduced	O	O	B-T080
in	O	O	O
comparison	O	O	B-T052
with	O	O	O
those	O	O	O
in	O	O	O
the	O	O	O
native	O	O	B-T169
patella	O	O	B-T023
.	O	O	O

Therapeutic	O	O	O
Level	O	O	O
III	O	O	O
.	O	O	O

See	O	O	O
Instructions	O	O	O
for	O	O	O
Authors	O	O	O
for	O	O	O
a	O	O	O
complete	O	O	O
description	O	O	O
of	O	O	O
levels	O	O	O
of	O	O	O
evidence	O	O	O
.	O	O	O

-DOCSTART- (28245342)

Assessment	O	O	B-T052
of	O	O	O
the	O	O	O
Extravascular	O	O	B-T074
Implantable	O	O	I-T074
Defibrillator	O	O	I-T074
:	O	O	O
Feasibility	O	O	B-T080
of	O	O	O
Substernal	O	O	O
Ventricular	O	O	O
Pacing	O	O	O

The	O	O	O
objective	O	O	B-T170
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
assess	O	O	B-T052
feasibility	O	O	B-T080
of	O	O	O
ventricular	O	O	B-T061
pacing	O	O	B-T061
and	O	O	O
thresholds	O	O	B-T080
from	O	O	O
within	O	O	B-T082
the	O	O	O
substernal	O	O	B-T029
space	O	O	I-T029
to	O	O	O
examine	O	O	O
a	O	O	O
new	O	O	B-T080
extravascular	O	O	B-T074
ICD	O	O	I-T074
configuration	O	O	B-T082
with	O	O	O
pacing	O	O	O
capabilities	O	O	B-T080
.	O	O	O

In	O	O	O
patients	O	O	B-T101
undergoing	O	O	O
midline	O	O	B-T061
sternotomy	O	O	I-T061
,	O	O	O
a	O	O	O
duodecapolar	O	O	B-T074
diagnostic	O	O	I-T074
pacing	O	O	I-T074
catheter	O	O	I-T074
was	O	O	O
positioned	O	O	B-T082
in	O	O	O
the	O	O	O
substernal	O	O	B-T029
space	O	O	I-T029
anterior	O	O	B-T082
to	O	O	O
the	O	O	O
pericardium	O	O	B-T023
,	O	O	O
and	O	O	O
a	O	O	O
cutaneous	O	O	B-T033
patch	O	O	I-T033
in	O	O	O
left	O	O	B-T082
lateral	O	O	I-T082
position	O	O	I-T082
.	O	O	O

Different	O	O	B-T080
unipolar	O	O	B-T082
and	O	O	O
bipolar	O	O	B-T082
pacing	O	O	B-T061
configurations	O	O	B-T082
were	O	O	O
assessed	O	O	B-T052
.	O	O	O

Strength-duration	O	O	B-T059
curves	O	O	I-T059
were	O	O	O
performed	O	O	B-T169
to	O	O	O
identify	O	O	O
the	O	O	O
optimal	O	O	B-T080
output	O	O	B-T060
,	O	O	O
starting	O	O	O
at	O	O	O
25	O	O	O
mA	O	O	B-T081
with	O	O	O
a	O	O	O
pulse	O	O	B-T081
width	O	O	I-T081
of	O	O	O
10	O	O	O
milliseconds	O	O	B-T079
.	O	O	O

Eight	O	O	O
patients	O	O	B-T101
with	O	O	O
mean	O	O	B-T081
age	O	O	B-T032
69	O	O	O
Â±	O	O	O
9	O	O	O
years	O	O	B-T079
were	O	O	O
included	O	O	B-T169
.	O	O	O

In	O	O	O
5	O	O	O
,	O	O	O
ventricular	O	O	B-T082
capture	O	O	O
was	O	O	O
achieved	O	O	O
in	O	O	O
â¥1	O	O	O
configuration	O	O	B-T082
.	O	O	O

The	O	O	O
mean	O	O	B-T081
bipolar	O	O	B-T082
pacing	O	O	B-T061
thresholds	O	O	B-T080
at	O	O	O
PW	O	O	O
10	O	O	O
,	O	O	O
5	O	O	O
,	O	O	O
3	O	O	O
,	O	O	O
1	O	O	O
milliseconds	O	O	B-T079
were	O	O	O
12.4	O	O	O
Â±	O	O	O
3.7	O	O	O
mA	O	O	B-T081
(	O	O	O
5	O	O	O
patients	O	O	B-T101
)	O	O	O
,	O	O	O
13.3	O	O	O
Â±	O	O	O
5.8	O	O	O
mA	O	O	O
(	O	O	O
3	O	O	O
patients	O	O	O
)	O	O	O
,	O	O	O
18.3	O	O	O
Â±	O	O	O
5.7	O	O	O
mA	O	O	O
(	O	O	O
3	O	O	O
patients	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
25	O	O	O
Â±	O	O	O
0	O	O	O
mA	O	O	O
(	O	O	O
2	O	O	O
patients	O	O	O
)	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

The	O	O	O
60-mm	O	O	O
electrode	O	O	B-T074
spacing	O	O	B-T081
was	O	O	O
the	O	O	O
most	O	O	O
successful	O	O	B-T080
bipolar	O	O	B-T082
configuration	O	O	B-T082
.	O	O	O

Unipolar	O	O	B-T082
pacing	O	O	B-T061
was	O	O	O
successful	O	O	B-T080
in	O	O	O
3	O	O	O
out	O	O	O
of	O	O	O
4	O	O	O
patients	O	O	B-T101
with	O	O	O
mean	O	O	B-T081
thresholds	O	O	B-T080
of	O	O	O
10	O	O	O
Â±	O	O	O
0	O	O	O
mA	O	O	B-T081
at	O	O	O
10	O	O	O
milliseconds	O	O	B-T079
(	O	O	O
3	O	O	O
patients	O	O	O
)	O	O	O
,	O	O	O
15	O	O	O
Â±	O	O	O
0	O	O	O
mA	O	O	O
at	O	O	O
5	O	O	O
milliseconds	O	O	O
(	O	O	O
3	O	O	O
patients	O	O	O
)	O	O	O
,	O	O	O
16.7	O	O	O
Â±	O	O	O
2.9	O	O	O
mA	O	O	O
at	O	O	O
3	O	O	O
milliseconds	O	O	O
(	O	O	O
3	O	O	O
patients	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
20	O	O	O
Â±	O	O	O
7.1	O	O	O
mA	O	O	O
at	O	O	O
1	O	O	O
milliseconds	O	O	O
(	O	O	O
2	O	O	O
patients	O	O	O
)	O	O	O
.	O	O	O

Ventricular	O	O	B-T061
pacing	O	O	B-T061
from	O	O	O
the	O	O	O
substernal	O	O	B-T029
space	O	O	I-T029
in	O	O	O
patients	O	O	B-T101
with	O	O	O
midline	O	O	B-T061
sternotomy	O	O	I-T061
is	O	O	O
feasible	O	O	B-T080
.	O	O	O

Closed	O	O	B-T169
sternum	O	O	B-T023
studies	O	O	B-T062
are	O	O	O
needed	O	O	B-T080
to	O	O	O
determine	O	O	O
pacing	O	O	B-T061
thresholds	O	O	B-T080
more	O	O	O
accurately	O	O	B-T080
.	O	O	O

-DOCSTART- (28249376)

Effects	O	O	B-T080
of	O	O	O
a	O	O	O
specific	O	O	B-T167
blend	O	O	I-T167
of	O	O	O
essential	O	O	B-T109
oils	O	O	I-T109
on	O	O	O
apparent	O	O	B-T078
nutrient	O	O	B-T168
digestion	O	O	B-T040
,	O	O	O
rumen	O	O	B-T023
fermentation	O	O	B-T044
and	O	O	O
rumen	O	O	O
microbial	O	O	B-T001
populations	O	O	I-T001
in	O	O	O
sheep	O	O	B-T015
fed	O	O	O
a	O	O	O
50:50	O	O	O
alfalfa	O	O	B-T002
hay	O	O	I-T002
:	O	O	O
concentrate	O	O	O
diet	O	O	O

An	O	O	O
experiment	O	O	B-T062
was	O	O	O
conducted	O	O	O
to	O	O	O
investigate	O	O	B-T169
the	O	O	O
effects	O	O	B-T080
of	O	O	O
a	O	O	O
specific	O	O	O
mixture	O	O	B-T167
of	O	O	O
essential	O	O	B-T109
oils	O	O	I-T109
(	O	O	O
MEO	O	O	B-T109
)	O	O	O
,	O	O	O
containing	O	O	O
thyme	O	O	B-T109
,	O	O	O
clove	O	O	B-T109
and	O	O	O
cinnamon	O	O	B-T109
EO	O	O	I-T109
,	O	O	O
on	O	O	O
rumen	O	O	B-T023
microbial	O	O	B-T044
fermentation	O	O	I-T044
,	O	O	O
nutrient	O	O	B-T168
apparent	O	O	B-T078
digestibility	O	O	B-T033
and	O	O	O
blood	O	O	B-T031
metabolites	O	O	B-T123
in	O	O	O
fistulated	O	O	B-T015
sheep	O	O	I-T015
.	O	O	O

Six	O	O	O
sheep	O	O	B-T015
fitted	O	O	O
with	O	O	O
ruminal	O	O	B-T190
fistulas	O	O	I-T190
were	O	O	O
used	O	O	O
in	O	O	O
a	O	O	O
repeated	O	O	B-T170
measurement	O	O	I-T170
design	O	O	I-T170
with	O	O	O
two	O	O	O
24-d	O	O	O
periods	O	O	B-T079
to	O	O	O
investigate	O	O	O
the	O	O	O
effect	O	O	B-T080
of	O	O	O
adding	O	O	O
MEO	O	O	B-T109
at	O	O	O
0	O	O	O
(	O	O	O
control	O	O	O
)	O	O	O
,	O	O	O
0.8	O	O	O
,	O	O	O
and	O	O	O
1.6	O	O	O
mL/d	O	O	O
on	O	O	O
apparent	O	O	B-T078
nutrient	O	O	B-T168
digestibility	O	O	B-T033
,	O	O	O
rumen	O	O	B-T023
fermentation	O	O	B-T044
characteristics	O	O	B-T080
,	O	O	O
rumen	O	O	O
microbial	O	O	B-T001
population	O	O	I-T001
and	O	O	O
blood	O	O	B-T031
chemical	O	O	B-T123
metabolites	O	O	I-T123
.	O	O	O

Animals	O	O	B-T008
were	O	O	O
fed	O	O	O
with	O	O	O
a	O	O	O
50:50	O	O	O
alfalfa	O	O	B-T002
hay	O	O	I-T002
:	O	O	O
concentrate	O	O	B-T168
diet	O	O	I-T168
.	O	O	O

Ruminal	O	O	B-T081
pH	O	O	I-T081
,	O	O	O
total	O	O	O
volatile	O	O	B-T109
fatty	O	O	I-T109
acids	O	O	I-T109
(	O	O	O
VFA	O	O	B-T109
)	O	O	O
concentration	O	O	B-T081
,	O	O	O
molar	O	O	B-T081
proportion	O	O	I-T081
of	O	O	I-T081
individual	O	O	I-T081
VFA	O	O	O
,	O	O	O
acetate	O	O	B-T081
:	O	O	I-T081
propionate	O	O	I-T081
ratio	O	O	I-T081
and	O	O	O
methane	O	O	B-T040
production	O	O	I-T040
were	O	O	O
not	O	O	O
affected	O	O	O
with	O	O	O
MEO	O	O	B-T109
.	O	O	O

Relative	O	O	O
to	O	O	O
the	O	O	O
control	O	O	B-T096
,	O	O	O
Small	O	O	B-T081
peptides	O	O	I-T081
plus	O	O	I-T081
amino	O	O	I-T081
acid	O	O	I-T081
nitrogen	O	O	I-T081
and	O	O	O
large	O	O	B-T081
peptides	O	O	I-T081
nitrogen	O	O	I-T081
concentration	O	O	B-T081
in	O	O	O
rumen	O	O	B-T031
fluid	O	O	I-T031
were	O	O	O
not	O	O	O
affected	O	O	O
with	O	O	O
MEO	O	O	B-T109
supplementation	O	O	B-T061
;	O	O	O
while	O	O	O
,	O	O	O
rumen	O	O	O
fluid	O	O	O
ammonia	O	O	B-T121
nitrogen	O	O	O
concentration	O	O	O
at	O	O	O
0	O	O	O
and	O	O	O
6	O	O	O
h	O	O	O
after	O	O	O
morning	O	O	B-T052
feeding	O	O	I-T052
in	O	O	O
sheep	O	O	B-T015
fed	O	O	O
with	O	O	O
1.6	O	O	O
mL/d	O	O	O
of	O	O	O
MEO	O	O	O
was	O	O	O
lower	O	O	O
(	O	O	O
p<0.05	O	O	O
)	O	O	O
compared	O	O	O
to	O	O	O
the	O	O	O
control	O	O	O
and	O	O	O
0.8	O	O	O
mL/d	O	O	O
of	O	O	O
MEO	O	O	O
.	O	O	O

At	O	O	O
0	O	O	O
h	O	O	O
after	O	O	O
morning	O	O	B-T052
feeding	O	O	I-T052
,	O	O	O
ammonia	O	O	B-T121
nitrogen	O	O	B-T081
concentration	O	O	I-T081
was	O	O	O
higher	O	O	O
(	O	O	O
p<0.05	O	O	O
)	O	O	O
in	O	O	O
sheep	O	O	B-T015
fed	O	O	O
0.8	O	O	O
mL/d	O	O	O
of	O	O	O
MEO	O	O	B-T109
relative	O	O	O
to	O	O	O
1.6	O	O	O
mL/d	O	O	O
and	O	O	O
control	O	O	B-T096
diet	O	O	B-T168
.	O	O	O

Ruminal	O	O	B-T204
protozoa	O	O	I-T204
and	O	O	O
hyper	O	O	B-T007
ammonia	O	O	I-T007
producing	O	O	I-T007
(	O	O	I-T007
HAP	O	O	I-T007
)	O	O	I-T007
bacteria	O	O	I-T007
counts	O	O	B-T059
were	O	O	O
not	O	O	O
affected	O	O	O
by	O	O	O
addition	O	O	O
of	O	O	O
MEO	O	O	B-T109
in	O	O	O
the	O	O	O
diet	O	O	B-T168
.	O	O	O

Relative	O	O	O
to	O	O	O
the	O	O	O
control	O	O	B-T096
,	O	O	O
no	O	O	O
changes	O	O	O
were	O	O	O
observed	O	O	O
in	O	O	O
the	O	O	O
red	O	O	B-T059
and	O	O	O
white	O	O	B-T034
blood	O	O	I-T034
cells	O	O	I-T034
,	O	O	O
hemoglobin	O	O	B-T059
,	O	O	O
hematocrit	O	O	B-T033
,	O	O	O
glucose	O	O	B-T059
,	O	O	O
beta-hydroxybutyric	O	O	B-T109
acid	O	O	I-T109
,	O	O	O
cholesterol	O	O	B-T059
,	O	O	O
total	O	O	B-T059
protein	O	O	I-T059
,	O	O	O
albumin	O	O	B-T059
,	O	O	O
blood	O	O	B-T059
urea	O	O	I-T059
nitrogen	O	O	I-T059
and	O	O	O
aspartate	O	O	B-T059
aminotransferase	O	O	I-T059
and	O	O	O
alanine	O	O	B-T059
aminotransferase	O	O	I-T059
concentration	O	O	B-T081
.	O	O	O

Apparent	O	O	B-T078
total	O	O	B-T033
tract	O	O	I-T033
digestibility	O	O	I-T033
of	O	O	O
dry	O	O	B-T167
matter	O	O	I-T167
,	O	O	O
crude	O	O	B-T116
proten	O	O	I-T116
,	O	O	O
organic	O	O	B-T167
matter	O	O	I-T167
,	O	O	O
and	O	O	O
neutral	O	O	B-T167
detergent	O	O	I-T167
fiber	O	O	I-T167
were	O	O	O
not	O	O	O
influenced	O	O	O
by	O	O	O
MEO	O	O	B-T109
supplementation	O	O	B-T061
.	O	O	O

The	O	O	O
results	O	O	O
of	O	O	O
the	O	O	O
present	O	O	O
study	O	O	O
suggested	O	O	O
that	O	O	O
supplementation	O	O	B-T061
of	O	O	O
MEO	O	O	B-T109
may	O	O	O
have	O	O	O
limited	O	O	B-T080
effects	O	O	I-T080
on	O	O	O
apparent	O	O	B-T078
nutrient	O	O	B-T168
digestibility	O	O	B-T033
,	O	O	O
ruminal	O	O	B-T044
fermentation	O	O	I-T044
and	O	O	O
protozoa	O	O	B-T204
and	O	O	O
HAP	O	O	B-T007
bacteria	O	O	I-T007
count	O	O	B-T059
,	O	O	O
blood	O	O	B-T025
cells	O	O	I-T025
and	O	O	O
metabolites	O	O	B-T123
.	O	O	O

-DOCSTART- (28249723)

High	O	O	B-T060
throughput	O	O	I-T060
selection	O	O	B-T052
of	O	O	O
antibiotic-resistant	O	O	B-T032
transgenic	O	O	B-T002
Arabidopsis	O	O	O
plants	O	O	O

Kanamycin	O	O	B-T195
resistance	O	O	B-T032
is	O	O	O
the	O	O	O
most	O	O	B-T081
frequently	O	O	B-T079
used	O	O	O
antibiotic-resistance	O	O	B-T032
marker	O	O	B-T201
for	O	O	O
Arabidopsis	O	O	B-T002
transformations	O	O	B-T039
,	O	O	O
however	O	O	O
,	O	O	O
this	O	O	O
method	O	O	B-T170
frequently	O	O	O
causes	O	O	O
escape	O	O	B-T055
of	O	O	O
untransformed	O	O	B-T002
plants	O	O	I-T002
,	O	O	O
particularly	O	O	O
at	O	O	O
the	O	O	O
high	O	O	B-T080
seedling	O	O	B-T002
density	O	O	B-T081
during	O	O	O
the	O	O	O
selection	O	O	B-T052
.	O	O	O

Here	O	O	O
we	O	O	O
developed	O	O	B-T169
a	O	O	O
robust	O	O	B-T080
high	O	O	B-T080
-	O	O	O
density	O	O	B-T081
selection	O	O	B-T052
method	O	O	B-T170
using	O	O	O
top	O	O	B-T082
agar	O	O	B-T109
for	O	O	O
Arabidopsis	O	O	B-T002
thaliana	O	O	I-T002
.	O	O	O

Top	O	O	B-T082
agar	O	O	B-T109
effectively	O	O	B-T080
suppressed	O	O	B-T080
growth	O	O	B-T039
of	O	O	O
untransformed	O	O	B-T002
wild-type	O	O	I-T002
plants	O	O	I-T002
on	O	O	O
selection	O	O	B-T052
media	O	O	B-T130
at	O	O	O
high	O	O	B-T080
density	O	O	B-T081
.	O	O	O

Survival	O	O	B-T052
of	O	O	O
the	O	O	O
transformed	O	O	B-T039
plants	O	O	B-T002
during	O	O	O
the	O	O	O
selection	O	O	B-T052
were	O	O	O
confirmed	O	O	B-T033
by	O	O	O
production	O	O	O
of	O	O	O
green	O	O	B-T080
true	O	O	B-T080
leaves	O	O	B-T002
and	O	O	O
expression	O	O	B-T045
of	O	O	O
a	O	O	O
firefly	O	O	B-T116
luciferase	O	O	I-T116
reporter	O	O	B-T028
gene	O	O	I-T028
.	O	O	O

Top	O	O	B-T082
agar	O	O	B-T109
method	O	O	B-T170
allowed	O	O	O
selection	O	O	B-T052
using	O	O	O
a	O	O	O
large	O	O	B-T081
amount	O	O	B-T081
of	O	O	O
seeds	O	O	B-T002
in	O	O	O
Arabidopsis	O	O	B-T002
transformation	O	O	B-T039
.	O	O	O

-DOCSTART- (28251683)

Limb	O	O	B-T023
remote	O	O	B-T061
ischaemic	O	O	I-T061
postconditioning	O	O	I-T061
-	O	O	O
induced	O	O	B-T169
elevation	O	O	B-T081
of	O	O	O
fibulin-5	O	O	B-T116
confers	O	O	O
neuroprotection	O	O	B-T043
to	O	O	O
rats	O	O	B-T015
with	O	O	O
cerebral	O	O	B-T047
ischaemia	O	O	I-T047
/	O	O	O
reperfusion	O	O	B-T037
injury	O	O	I-T037
:	O	O	O
Activation	O	O	B-T052
of	O	O	O
the	O	O	O
AKT	O	O	O
pathway	O	O	O

Limb	O	O	B-T023
remote	O	O	B-T061
ischaemic	O	O	I-T061
postconditioning	O	O	I-T061
(	O	O	O
RIPostC	O	O	B-T061
)	O	O	O
is	O	O	O
an	O	O	O
effective	O	O	O
and	O	O	O
well-acknowledged	O	O	O
treatment	O	O	B-T061
for	O	O	O
brain	O	O	B-T037
ischaemia	O	O	I-T037
injury	O	O	I-T037
.	O	O	O

The	O	O	O
present	O	O	O
study	O	O	B-T062
aimed	O	O	O
to	O	O	O
evaluate	O	O	O
the	O	O	O
role	O	O	O
of	O	O	O
fibulin-5	O	O	B-T116
in	O	O	O
the	O	O	O
neuroprotection	O	O	B-T043
of	O	O	O
RIPostC	O	O	B-T061
against	O	O	O
cerebral	O	O	B-T047
ischaemia	O	O	I-T047
/	O	O	O
reperfusion	O	O	B-T037
(	O	O	I-T037
I/R	O	O	I-T037
)	O	O	I-T037
injury	O	O	I-T037
in	O	O	O
rats	O	O	B-T015
.	O	O	O

The	O	O	O
middle	O	O	B-T020
cerebral	O	O	I-T020
artery	O	O	I-T020
occlusion	O	O	B-T020
(	O	O	O
MCAO	O	O	B-T020
)	O	O	O
model	O	O	B-T075
was	O	O	O
established	O	O	O
in	O	O	O
rats	O	O	B-T015
and	O	O	O
then	O	O	O
RIPostC	O	O	B-T061
was	O	O	O
carried	O	O	O
out	O	O	O
by	O	O	O
three	O	O	O
cycles	O	O	O
of	O	O	O
10	O	O	O
minutes	O	O	B-T079
occlusion	O	O	O
/10	O	O	O
minutes	O	O	O
release	O	O	O
of	O	O	O
the	O	O	O
bilateral	O	O	B-T082
femoral	O	O	B-T023
artery	O	O	I-T023
at	O	O	O
the	O	O	O
beginning	O	O	O
of	O	O	O
the	O	O	O
reperfusion	O	O	B-T061
.	O	O	O

To	O	O	O
downregulate	O	O	B-T044
the	O	O	O
fibulin-5	O	O	B-T116
level	O	O	B-T080
,	O	O	O
fibulin-5	O	O	B-T114
siRNA	O	O	I-T114
was	O	O	O
injected	O	O	B-T061
into	O	O	O
the	O	O	O
lateral	O	O	B-T030
ventricle	O	O	I-T030
24	O	O	O
hours	O	O	B-T079
before	O	O	O
MCAO	O	O	B-T020
.	O	O	O

According	O	O	O
to	O	O	O
our	O	O	O
present	O	O	O
study	O	O	B-T062
,	O	O	O
RIPostC	O	O	B-T061
attenuated	O	O	B-T052
cerebral	O	O	B-T047
I	O	O	I-T047
/	O	O	O
R	O	O	B-T037
injury	O	O	I-T037
by	O	O	O
decreasing	O	O	B-T033
infarct	O	O	B-T046
volume	O	O	B-T081
,	O	O	O
improving	O	O	O
neurobehavioral	O	O	B-T081
score	O	O	I-T081
and	O	O	O
suppressing	O	O	B-T169
blood	O	O	B-T023
brain	O	O	I-T023
barrier	O	O	I-T023
(	O	O	O
BBB	O	O	B-T023
)	O	O	O
leakage	O	O	B-T046
.	O	O	O

Moreover	O	O	O
,	O	O	O
the	O	O	O
mRNA	O	O	B-T114
and	O	O	O
protein	O	O	B-T034
levels	O	O	I-T034
of	O	O	O
fibulin-5	O	O	B-T116
were	O	O	O
upregulated	O	O	B-T044
by	O	O	O
RIPostC	O	O	B-T061
at	O	O	O
24	O	O	O
hours	O	O	B-T079
and	O	O	O
72	O	O	O
hours	O	O	O
after	O	O	O
reperfusion	O	O	B-T061
.	O	O	O

Downregulation	O	O	B-T044
of	O	O	O
fibulin-5	O	O	B-T116
attenuated	O	O	B-T052
the	O	O	O
neuroprotection	O	O	B-T043
of	O	O	O
RIPostC.	O	O	O
Finally	O	O	O
,	O	O	O
the	O	O	O
result	O	O	O
showed	O	O	O
that	O	O	O
fibulin-5	O	O	O
was	O	O	O
upregulated	O	O	B-T044
by	O	O	O
RIPostC	O	O	B-T061
via	O	O	O
activation	O	O	B-T052
of	O	O	O
the	O	O	O
PI3K/AKT	O	O	B-T044
pathway	O	O	I-T044
.	O	O	O

Taken	O	O	O
together	O	O	O
,	O	O	O
these	O	O	O
results	O	O	B-T169
provide	O	O	O
evidence	O	O	B-T078
that	O	O	O
upregulation	O	O	B-T044
of	O	O	O
fibulin-5	O	O	B-T116
is	O	O	O
involved	O	O	O
in	O	O	O
the	O	O	O
beneficial	O	O	O
effect	O	O	O
of	O	O	O
RIPostC	O	O	B-T061
against	O	O	O
cerebral	O	O	B-T047
I	O	O	I-T047
/	O	O	O
R	O	O	B-T037
injury	O	O	I-T037
.	O	O	O

-DOCSTART- (28251753)

Optomechanical	O	O	B-T169
Control	O	O	I-T169
of	O	O	O
Quantum	O	O	B-T081
Yield	O	O	I-T081
in	O	O	O
Trans-Cis	O	O	B-T044
Ultrafast	O	O	I-T044
Photoisomerization	O	O	I-T044
of	O	O	O
a	O	O	O
Retinal	O	O	B-T127
Chromophore	O	O	B-T120
Model	O	O	O

The	O	O	O
quantum	O	O	B-T081
yield	O	O	I-T081
of	O	O	O
a	O	O	O
photochemical	O	O	B-T070
reaction	O	O	I-T070
is	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
most	O	O	O
fundamental	O	O	B-T081
quantities	O	O	I-T081
in	O	O	O
photochemistry	O	O	B-T090
,	O	O	O
as	O	O	O
it	O	O	O
measures	O	O	O
the	O	O	O
efficiency	O	O	O
of	O	O	O
the	O	O	O
transduction	O	O	B-T043
of	O	O	I-T043
light	O	O	I-T043
energy	O	O	I-T043
into	O	O	I-T043
chemical	O	O	I-T043
energy	O	O	I-T043
.	O	O	O

Nature	O	O	B-T078
has	O	O	O
evolved	O	O	O
photoreceptors	O	O	B-T025
in	O	O	O
which	O	O	O
the	O	O	O
reactivity	O	O	B-UnknownType
of	O	O	O
a	O	O	O
chromophore	O	O	B-T120
is	O	O	O
enhanced	O	O	O
by	O	O	O
its	O	O	O
molecular	O	O	B-T082
environment	O	O	I-T082
to	O	O	O
achieve	O	O	O
high	O	O	O
quantum	O	O	B-T081
yields	O	O	I-T081
.	O	O	O

The	O	O	O
retinal	O	O	B-T127
chromophore	O	O	B-T120
sterically	O	O	O
constrained	O	O	O
inside	O	O	O
rhodopsin	O	O	B-T116
proteins	O	O	I-T116
represents	O	O	O
an	O	O	O
outstanding	O	O	O
example	O	O	O
of	O	O	O
such	O	O	O
a	O	O	O
control	O	O	O
.	O	O	O

In	O	O	O
a	O	O	O
more	O	O	O
general	O	O	O
framework	O	O	O
,	O	O	O
mechanical	O	O	B-T067
forces	O	O	I-T067
acting	O	O	O
on	O	O	O
a	O	O	O
molecular	O	O	B-T080
system	O	O	I-T080
can	O	O	O
strongly	O	O	O
modify	O	O	O
its	O	O	O
reactivity	O	O	B-UnknownType
.	O	O	O

Herein	O	O	O
,	O	O	O
we	O	O	O
show	O	O	O
that	O	O	O
the	O	O	O
exertion	O	O	O
of	O	O	O
tensile	O	O	B-T081
forces	O	O	I-T081
on	O	O	O
a	O	O	O
simplified	O	O	O
retinal	O	O	B-T127
chromophore	O	O	B-T120
model	O	O	B-T075
provokes	O	O	O
a	O	O	O
substantial	O	O	B-T080
and	O	O	I-T080
regular	O	O	I-T080
increase	O	O	I-T080
in	O	O	O
the	O	O	O
trans-to-cis	O	O	B-T044
photoisomerization	O	O	I-T044
quantum	O	O	B-T081
yield	O	O	I-T081
in	O	O	O
a	O	O	O
counterintuitive	O	O	O
way	O	O	O
,	O	O	O
as	O	O	O
these	O	O	O
extension	O	O	O
forces	O	O	O
facilitate	O	O	O
the	O	O	O
formation	O	O	O
of	O	O	O
the	O	O	O
more	O	O	O
compressed	O	O	O
cis	O	O	B-T104
photoisomer	O	O	I-T104
.	O	O	O

A	O	O	O
rationale	O	O	B-T078
for	O	O	O
the	O	O	O
mechanochemical	O	O	B-T070
effect	O	O	I-T070
on	O	O	O
this	O	O	O
photoisomerization	O	O	B-T070
mechanism	O	O	I-T070
is	O	O	O
also	O	O	O
proposed	O	O	O
.	O	O	O

-DOCSTART- (28252207)

Quality	O	O	B-T080
of	O	O	O
nursing	O	O	B-T073
intensity	O	O	I-T073
data	O	O	I-T073
:	O	O	O
inter-rater	O	O	B-T081
reliability	O	O	I-T081
of	O	O	O
the	O	O	O
patient	O	O	B-T101
classification	O	O	B-T185
after	O	O	O
two	O	O	B-T081
decades	O	O	I-T081
in	O	O	O
clinical	O	O	B-T080
use	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
measure	O	O	B-T081
the	O	O	O
inter-rater	O	O	B-T081
reliability	O	O	I-T081
of	O	O	O
the	O	O	O
Oulu	O	O	B-T185
Patient	O	O	I-T185
Classification	O	O	I-T185
and	O	O	O
to	O	O	O
discuss	O	O	O
existing	O	O	O
methods	O	O	B-T169
of	O	O	O
reliability	O	O	B-T081
testing	O	O	I-T081
.	O	O	O

The	O	O	O
Oulu	O	O	B-T185
Patient	O	O	I-T185
Classification	O	O	I-T185
,	O	O	O
part	O	O	O
of	O	O	O
the	O	O	O
RAFAELA	O	O	B-T170
(	O	O	I-T170
Â®	O	O	I-T170
)	O	O	I-T170
System	O	O	I-T170
,	O	O	O
has	O	O	O
been	O	O	O
developed	O	O	O
to	O	O	O
assist	O	O	B-T080
nursing	O	O	B-T058
managers	O	O	I-T097
with	O	O	O
the	O	O	O
proper	O	O	O
allocation	O	O	B-T052
of	O	O	O
nursing	O	O	O
resources	O	O	B-T078
.	O	O	O

Due	O	O	O
to	O	O	O
the	O	O	O
increased	O	O	B-T081
intensity	O	O	B-T080
of	O	O	O
inpatient	O	O	B-T058
care	O	O	I-T058
during	O	O	O
recent	O	O	O
years	O	O	B-T079
,	O	O	O
there	O	O	O
is	O	O	O
a	O	O	O
need	O	O	O
for	O	O	O
the	O	O	O
reliability	O	O	B-T081
testing	O	O	I-T081
of	O	O	O
the	O	O	O
classification	O	O	B-T185
,	O	O	O
which	O	O	O
has	O	O	O
been	O	O	O
in	O	O	O
clinical	O	O	B-T080
use	O	O	B-T169
for	O	O	O
20	O	O	O
years	O	O	O
.	O	O	O

Retrospective	O	O	B-T080
statistical	O	O	B-T170
study	O	O	I-T170
.	O	O	O

To	O	O	O
test	O	O	B-T081
inter-rater	O	O	B-T081
reliability	O	O	I-T081
,	O	O	O
a	O	O	O
pair	O	O	O
of	O	O	O
nurses	O	O	B-T097
classified	O	O	B-T185
the	O	O	O
same	O	O	O
patients	O	O	B-T101
,	O	O	O
without	O	O	O
knowledge	O	O	O
of	O	O	O
each	O	O	O
other	O	O	O
's	O	O	O
ratings	O	O	B-T052
,	O	O	O
as	O	O	O
a	O	O	O
part	O	O	O
of	O	O	O
annually	O	O	B-T079
conducted	O	O	O
standardization	O	O	B-T062
.	O	O	O

Data	O	O	B-T078
on	O	O	O
the	O	O	O
parallel	O	O	B-T185
classifications	O	O	I-T185
(	O	O	O
n	O	O	O
=	O	O	O
19,997	O	O	O
)	O	O	O
was	O	O	O
obtained	O	O	B-T169
from	O	O	O
inpatient	O	O	B-T101
units	O	O	O
(	O	O	O
n	O	O	O
=	O	O	O
32	O	O	O
)	O	O	O
with	O	O	O
different	O	O	B-T080
specialties	O	O	B-T091
at	O	O	O
a	O	O	O
university	O	O	B-T093
hospital	O	O	I-T093
in	O	O	O
Finland	O	O	B-T083
during	O	O	O
2010	O	O	O
-	O	O	O
2015	O	O	O
.	O	O	O

Parallel	O	O	B-T185
classification	O	O	I-T185
practices	O	O	B-T091
were	O	O	O
also	O	O	O
analysed	O	O	O
.	O	O	O

The	O	O	O
reliability	O	O	B-T081
of	O	O	O
the	O	O	O
overall	O	O	O
classification	O	O	B-T185
and	O	O	O
its	O	O	O
subareas	O	O	O
were	O	O	O
calculated	O	O	B-T052
using	O	O	O
suitable	O	O	O
statistical	O	O	B-T081
coefficients	O	O	I-T081
.	O	O	O

Inter-rater	O	O	B-T081
reliability	O	O	I-T081
coefficients	O	O	B-T081
were	O	O	O
a	O	O	O
reliable	O	O	O
or	O	O	O
almost	O	O	O
perfect	O	O	O
means	O	O	O
of	O	O	O
considering	O	O	O
the	O	O	O
nursing	O	O	B-T058
intensity	O	O	B-T080
category	O	O	B-T170
and	O	O	O
various	O	O	O
practices	O	O	B-T091
,	O	O	O
but	O	O	O
there	O	O	O
were	O	O	O
detectable	O	O	B-T033
differences	O	O	B-T080
between	O	O	O
subareas	O	O	O
.	O	O	O

The	O	O	O
lowest	O	O	O
agreement	O	O	B-T080
levels	O	O	B-T080
occurred	O	O	B-T052
in	O	O	O
the	O	O	O
subareas	O	O	O
'	O	O	O
Planning	O	O	B-T058
and	O	O	I-T058
Coordination	O	O	I-T058
of	O	O	I-T058
Nursing	O	O	I-T058
Care	O	O	I-T058
'	O	O	O
and	O	O	O
'	O	O	O
Guiding	O	O	B-T058
of	O	O	I-T058
Care	O	O	I-T058
/	O	O	O
Continued	O	O	B-T058
Care	O	O	I-T058
and	O	O	O
Emotional	O	O	B-T058
Support	O	O	I-T058
'	O	O	O
.	O	O	O

There	O	O	O
is	O	O	O
a	O	O	O
need	O	O	O
to	O	O	O
develop	O	O	O
the	O	O	O
descriptions	O	O	B-T170
of	O	O	O
subareas	O	O	O
and	O	O	O
to	O	O	O
clarify	O	O	B-T052
the	O	O	O
related	O	O	O
concepts	O	O	B-T078
.	O	O	O

Precise	O	O	O
nursing	O	O	B-T058
documentation	O	O	I-T058
can	O	O	O
promote	O	O	B-T052
a	O	O	O
high	O	O	O
level	O	O	B-T080
of	O	O	O
agreement	O	O	B-T080
and	O	O	O
reliable	O	O	O
results	O	O	B-T169
.	O	O	O

The	O	O	O
traditional	O	O	O
overall	O	O	O
proportion	O	O	O
of	O	O	O
agreement	O	O	B-T080
does	O	O	O
not	O	O	O
provide	O	O	O
an	O	O	O
adequate	O	O	O
picture	O	O	O
of	O	O	O
reliability	O	O	O
-	O	O	O
weighted	O	O	O
kappa	O	O	B-T081
coefficients	O	O	I-T081
should	O	O	O
be	O	O	O
used	O	O	O
instead	O	O	O
.	O	O	O

-DOCSTART- (28253085)

Water	O	O	B-T073
pipe	O	O	I-T073
(	O	O	O
Shisha	O	O	O
,	O	O	O
Hookah	O	O	O
,	O	O	O
Arghile	O	O	O
)	O	O	O
Smoking	O	O	B-T055
and	O	O	O
Secondhand	O	O	B-T037
Tobacco	O	O	I-T037
Smoke	O	O	I-T037
Effects	O	O	B-T080
on	O	O	O
CYP1A2	O	O	B-T116
and	O	O	O
CYP2A6	O	O	B-T116
Phenotypes	O	O	B-T032
as	O	O	O
Measured	O	O	O
by	O	O	O
Caffeine	O	O	O
Urine	O	O	O
Test	O	O	O

Public	O	O	B-T097
policies	O	O	I-T097
to	O	O	O
stop	O	O	O
or	O	O	O
reduce	O	O	O
cigarette	O	O	B-T055
smoking	O	O	I-T055
and	O	O	O
exposure	O	O	B-T080
to	O	O	O
secondhand	O	O	B-T037
smoke	O	O	I-T037
and	O	O	O
associated	O	O	B-T046
diseases	O	O	I-T046
have	O	O	O
yielded	O	O	O
successful	O	O	O
results	O	O	O
over	O	O	O
the	O	O	O
past	O	O	O
decade	O	O	O
.	O	O	O

Yet	O	O	O
,	O	O	O
the	O	O	O
growing	O	O	O
worldwide	O	O	O
popularity	O	O	O
of	O	O	O
another	O	O	O
form	O	O	O
of	O	O	O
tobacco	O	O	B-T055
consumption	O	O	I-T055
,	O	O	O
water	O	O	B-T073
pipe	O	O	I-T073
smoking	O	O	B-T055
,	O	O	O
has	O	O	O
received	O	O	O
relatively	O	O	O
less	O	O	O
attention	O	O	O
.	O	O	O

To	O	O	O
the	O	O	O
best	O	O	O
of	O	O	O
our	O	O	O
knowledge	O	O	O
,	O	O	O
no	O	O	O
study	O	O	O
to	O	O	O
date	O	O	O
has	O	O	O
evaluated	O	O	O
the	O	O	O
effects	O	O	O
of	O	O	O
water	O	O	B-T073
pipe	O	O	I-T073
smoking	O	O	B-T055
on	O	O	O
cytochrome	O	O	B-T044
P450	O	O	I-T044
(	O	O	I-T044
CYP450	O	O	I-T044
)	O	O	I-T044
activities	O	O	I-T044
and	O	O	O
drug	O	O	B-T044
interaction	O	O	I-T044
potential	O	O	B-T080
in	O	O	O
humans	O	O	B-T016
,	O	O	O
whereas	O	O	O
only	O	O	O
limited	O	O	O
information	O	O	O
is	O	O	O
available	O	O	O
on	O	O	O
the	O	O	O
impact	O	O	O
of	O	O	O
secondhand	O	O	B-T037
smoke	O	O	I-T037
on	O	O	O
drug	O	O	B-T044
metabolism	O	O	I-T044
.	O	O	O

In	O	O	O
a	O	O	O
sample	O	O	O
of	O	O	O
99	O	O	O
healthy	O	O	B-T098
volunteers	O	O	I-T098
(	O	O	O
28	O	O	O
water	O	O	B-T055
pipe	O	O	I-T055
smokers	O	O	I-T055
,	O	O	O
30	O	O	O
secondhand	O	O	B-T037
tobacco	O	O	I-T037
smoke	O	O	I-T037
exposed	O	O	O
persons	O	O	B-T098
,	O	O	O
and	O	O	O
41	O	O	O
controls	O	O	B-T096
)	O	O	O
,	O	O	O
we	O	O	O
systematically	O	O	B-T052
compared	O	O	I-T052
CYP1A2	O	O	B-T116
and	O	O	O
CYP2A6	O	O	B-T116
enzyme	O	O	B-T044
activities	O	O	I-T044
in	O	O	B-T082
vivo	O	O	I-T082
using	O	O	O
caffeine	O	O	B-T059
urine	O	O	I-T059
test	O	O	I-T059
.	O	O	O

The	O	O	O
median	O	O	O
self-reported	O	O	B-T062
duration	O	O	B-T079
of	O	O	O
water	O	O	B-T073
pipe	O	O	I-T073
smoking	O	O	B-T055
was	O	O	O
7.5	O	O	O
h	O	O	B-T079
/	O	O	O
week	O	O	B-T079
and	O	O	O
3	O	O	O
years	O	O	B-T079
of	O	O	O
exposure	O	O	B-T080
in	O	O	O
total	O	O	O
.	O	O	O

The	O	O	O
secondhand	O	O	B-T037
smoke	O	O	I-T037
group	O	O	B-T098
had	O	O	O
a	O	O	O
median	O	O	O
of	O	O	O
14	O	O	O
h	O	O	B-T079
of	O	O	O
self-reported	O	O	B-T062
weekly	O	O	B-T079
exposure	O	O	B-T080
to	O	O	O
tobacco	O	O	B-T131
smoke	O	O	I-T131
indoor	O	O	O
where	O	O	O
a	O	O	O
minimum	O	O	O
of	O	O	O
five	O	O	O
cigarettes	O	O	B-T073
were	O	O	O
smoked	O	O	B-T131
/	O	O	O
hour	O	O	B-T079
for	O	O	O
a	O	O	O
total	O	O	O
of	O	O	O
3.5	O	O	O
years	O	O	B-T079
(	O	O	O
median	O	O	O
)	O	O	O
.	O	O	O

Analysis	O	O	B-T062
of	O	O	O
variance	O	O	B-T080
did	O	O	O
not	O	O	O
find	O	O	O
a	O	O	O
significant	O	O	O
difference	O	O	O
in	O	O	O
CYP1A2	O	O	B-T116
and	O	O	O
CYP2A6	O	O	B-T116
activities	O	O	B-T044
among	O	O	O
the	O	O	O
three	O	O	O
study	O	O	B-T062
groups	O	O	B-T098
(	O	O	O
p	O	O	O
>	O	O	O
0.05	O	O	O
)	O	O	O
.	O	O	O

Nor	O	O	O

was	O	O	O
there	O	O	O
a	O	O	O
significant	O	O	O
association	O	O	O
between	O	O	O
the	O	O	O
extent	O	O	O
of	O	O	O
water	O	O	B-T073
pipe	O	O	I-T073
or	O	O	O
secondhand	O	O	B-T037
smoke	O	O	I-T037
exposure	O	O	B-T080
and	O	O	O
the	O	O	O
CYP1A2	O	O	B-T116
and	O	O	O
CYP2A6	O	O	B-T116
activities	O	O	B-T044
(	O	O	O
p	O	O	O
>	O	O	O
0.05	O	O	O
)	O	O	O
.	O	O	O

Further	O	O	O
analysis	O	O	B-T062
in	O	O	O
a	O	O	O
subsample	O	O	O
with	O	O	O
smoke	O	O	O
exposure	O	O	B-T080
more	O	O	O
than	O	O	O
the	O	O	O
median	O	O	O
values	O	O	O
also	O	O	O
did	O	O	O
not	O	O	O
reveal	O	O	O
a	O	O	O
significant	O	O	O
difference	O	O	O
from	O	O	O
the	O	O	O
controls	O	O	B-T096
.	O	O	O

Although	O	O	O
we	O	O	O
do	O	O	O
not	O	O	O
rule	O	O	O
out	O	O	O
an	O	O	O
appreciable	O	O	O
possible	O	O	O
impact	O	O	O
of	O	O	O
water	O	O	B-T073
pipe	O	O	I-T073
smoke	O	O	O
and	O	O	O
secondhand	O	O	B-T037
smoke	O	O	I-T037
on	O	O	O
in	O	O	B-T082
vivo	O	O	I-T082
activities	O	O	B-T044
of	O	O	O
these	O	O	O
two	O	O	O
drug	O	O	B-T044
metabolism	O	O	I-T044
pathways	O	O	B-T044
,	O	O	O
variability	O	O	O
in	O	O	O
smoke	O	O	O
constituents	O	O	B-T167
from	O	O	O
different	O	O	O
tobacco	O	O	B-T055
consumption	O	O	I-T055
methods	O	O	O
(	O	O	O
e.g.	O	O	O
,	O	O	O
water	O	O	O
pipe	O	O	O
)	O	O	O
might	O	O	O
affect	O	O	O
drug	O	O	O
metabolism	O	O	O
in	O	O	O
ways	O	O	O
that	O	O	O
might	O	O	O
differ	O	O	O
from	O	O	O
that	O	O	O
of	O	O	O
cigarette	O	O	B-T131
smoke	O	O	I-T131
.	O	O	O

Further	O	O	O
studies	O	O	B-T062
in	O	O	O
larger	O	O	O
prospective	O	O	O
samples	O	O	O
are	O	O	O
recommended	O	O	O
to	O	O	O
evaluate	O	O	O
water	O	O	B-T073
pipe	O	O	I-T073
and	O	O	O
secondhand	O	O	B-T037
tobacco	O	O	I-T037
smoke	O	O	B-T131
effects	O	O	O
on	O	O	O
CYP450	O	O	B-T116
function	O	O	O
,	O	O	O
particularly	O	O	O
at	O	O	O
higher	O	O	O
smoke	O	O	O
exposure	O	O	B-T080
conditions	O	O	O
.	O	O	O

-DOCSTART- (28254329)

How	O	O	O
do	O	O	O
wettability	O	O	B-T080
,	O	O	O
zeta	O	O	B-T067
potential	O	O	I-T067
and	O	O	O
hydroxylation	O	O	B-T070
degree	O	O	O
affect	O	O	O
the	O	O	O
biological	O	O	B-T033
response	O	O	I-T033
of	O	O	O
biomaterials	O	O	B-T122
?	O	O	O

It	O	O	O
is	O	O	O
well	O	O	O
known	O	O	O
that	O	O	O
composition	O	O	B-T080
,	O	O	O
electric	O	O	B-T070
charge	O	O	I-T070
,	O	O	O
wettability	O	O	B-T080
and	O	O	O
roughness	O	O	B-T080
of	O	O	O
implant	O	O	B-T074
surfaces	O	O	B-T082
have	O	O	O
great	O	O	O
influence	O	O	B-T077
on	O	O	O
their	O	O	O
interaction	O	O	B-T169
with	O	O	O
the	O	O	O
biological	O	O	B-T031
fluids	O	O	I-T031
and	O	O	O
tissues	O	O	B-T024
,	O	O	O
but	O	O	O
systematic	O	O	B-T062
studies	O	O	I-T062
of	O	O	O
different	O	O	O
materials	O	O	B-T167
in	O	O	O
the	O	O	O
same	O	O	O
experimental	O	O	B-T080
conditions	O	O	I-T080
are	O	O	O
still	O	O	O
lacking	O	O	B-T080
in	O	O	O
the	O	O	O
scientific	O	O	B-T170
literature	O	O	I-T170
.	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
this	O	O	O
research	O	O	B-T062
is	O	O	O
to	O	O	O
investigate	O	O	B-T169
the	O	O	O
correlations	O	O	B-T080
between	O	O	O
some	O	O	O
surface	O	O	B-T080
characteristics	O	O	I-T080
(	O	O	O
wettability	O	O	B-T080
,	O	O	O
zeta	O	O	B-T067
potential	O	O	I-T067
and	O	O	O
hydroxylation	O	O	B-T070
degree	O	O	O
)	O	O	O
and	O	O	O
the	O	O	O
biological	O	O	B-T033
response	O	O	I-T033
(	O	O	O
protein	O	O	B-T116
adsorption	O	O	O
,	O	O	O
blood	O	O	B-T031
wettability	O	O	O
,	O	O	O
cell	O	O	B-T043
and	O	O	O
bacterial	O	O	B-T040
adhesion	O	O	I-T040
)	O	O	O
to	O	O	O
some	O	O	O
model	O	O	O
biomaterials	O	O	B-T122
.	O	O	O

The	O	O	O
resulting	O	O	O
knowledge	O	O	O
can	O	O	O
be	O	O	O
applied	O	O	O
for	O	O	O
the	O	O	O
development	O	O	O
of	O	O	O
future	O	O	O
innovative	O	O	O
surfaces	O	O	B-T082
for	O	O	O
implantable	O	O	B-T122
biomaterials	O	O	I-T122
.	O	O	O

Roughness	O	O	B-T080
was	O	O	O
not	O	O	O
considered	O	O	O
as	O	O	O
a	O	O	O
variable	O	O	O
because	O	O	O
it	O	O	O
is	O	O	O
a	O	O	O
widely	O	O	O
explored	O	O	O
feature	O	O	O
:	O	O	O
smooth	O	O	B-T082
surfaces	O	O	I-T082
prepared	O	O	O
by	O	O	O
a	O	O	O
controlled	O	O	B-T170
protocol	O	O	I-T170
were	O	O	O
compared	O	O	O
in	O	O	O
order	O	O	O
to	O	O	O
have	O	O	O
no	O	O	O
roughness	O	O	B-T080
effects	O	O	I-T080
.	O	O	O

Three	O	O	O
oxides	O	O	B-T197
(	O	O	O
ZrO2	O	O	B-T197
,	O	O	O
Al2O3	O	O	B-T122
,	O	O	O
SiO2	O	O	B-T122
)	O	O	O
,	O	O	O
three	O	O	O
metals	O	O	B-T197
(	O	O	O
316LSS	O	O	B-T122
steel	O	O	I-T122
,	O	O	O
Ti	O	O	B-T196
,	O	O	O
Nb	O	O	B-T196
)	O	O	O
and	O	O	O
two	O	O	O
polymers	O	O	B-T122
(	O	O	O
corona	O	O	B-T109
treated	O	O	I-T109
polystyrene	O	O	I-T109
for	O	O	O
cell	O	O	B-T059
culture	O	O	I-T059
and	O	O	O
untreated	O	O	B-T109
polystyrene	O	O	I-T109
for	O	O	O
bacteria	O	O	B-T059
culture	O	O	I-T059
)	O	O	O
,	O	O	O
widely	O	O	O
used	O	O	O
for	O	O	O
biomedical	O	O	B-T073
applications	O	O	I-T073
,	O	O	O
were	O	O	O
considered	O	O	O
.	O	O	O

The	O	O	O
surfaces	O	O	B-T082
were	O	O	O
characterized	O	O	B-T052
by	O	O	O
contact	O	O	B-T062
profilometry	O	O	I-T062
,	O	O	O
SEM	O	O	B-T059
-	O	O	O
EDS	O	O	B-T059
,	O	O	O
XPS	O	O	B-T059
,	O	O	O
FTIR	O	O	B-T062
,	O	O	O
zeta	O	O	B-T067
potential	O	O	I-T067
and	O	O	O
wettability	O	O	B-T080
with	O	O	O
different	O	O	O
fluids	O	O	B-T167
.	O	O	O

Protein	O	O	B-T116
adsorption	O	O	O
,	O	O	O
blood	O	O	B-T031
wettability	O	O	B-T080
,	O	O	O
bacterial	O	O	B-T040
and	O	O	O
cell	O	O	B-T043
adhesion	O	O	I-T043
were	O	O	O
evaluated	O	O	O
in	O	O	O
order	O	O	O
to	O	O	O
investigate	O	O	B-T169
the	O	O	O
correlations	O	O	B-T080
between	O	O	O
the	O	O	O
surface	O	O	B-T070
physiochemical	O	O	I-T070
properties	O	O	I-T070
and	O	O	O
biological	O	O	B-T033
responses	O	O	I-T033
.	O	O	O

From	O	O	O
a	O	O	O
methodological	O	O	O
standpoint	O	O	O
,	O	O	O
XPS	O	O	B-T059
and	O	O	O
electrokinetic	O	O	B-T081
measurements	O	O	I-T081
emerged	O	O	O
as	O	O	O
the	O	O	O
more	O	O	O
suitable	O	O	O
techniques	O	O	B-T169
respectively	O	O	O
for	O	O	O
the	O	O	O
evaluation	O	O	O
of	O	O	O
hydroxylation	O	O	B-T070
degree	O	O	O
and	O	O	O
surface	O	O	B-T081
charge	O	O	I-T081
/	O	O	O
isoelectric	O	O	B-T081
point	O	O	I-T081
.	O	O	O

Moreover	O	O	O
,	O	O	O
determination	O	O	O
of	O	O	O
wettability	O	O	B-T080
by	O	O	O
blood	O	O	B-T031
appeared	O	O	O
a	O	O	O
specific	O	O	O
and	O	O	O
crucial	O	O	O
test	O	O	B-T170
,	O	O	O
the	O	O	O
results	O	O	O
of	O	O	O
which	O	O	O
are	O	O	O
not	O	O	O
easily	O	O	O
predictable	O	O	O
by	O	O	O
using	O	O	O
other	O	O	O
type	O	O	O
of	O	O	O
tests	O	O	B-T170
.	O	O	O

Hydroxylation	O	O	B-T070
degree	O	O	O
resulted	O	O	O
correlated	O	O	O
to	O	O	O
the	O	O	O
wettability	O	O	B-T080
by	O	O	O
water	O	O	B-T121
,	O	O	O
but	O	O	O
not	O	O	O
directly	O	O	O
to	O	O	O
surface	O	O	B-T081
charge	O	O	I-T081
.	O	O	O

Wetting	O	O	B-T062
tests	O	O	I-T062
with	O	O	O
different	O	O	O
media	O	O	B-T167
showed	O	O	O
the	O	O	O
possibility	O	O	O
to	O	O	O
highlight	O	O	O
some	O	O	O
differences	O	O	O
among	O	O	O
look-alike	O	O	O
materials	O	O	B-T167
.	O	O	O

A	O	O	O
dependence	O	O	O
of	O	O	O
protein	O	O	B-T116
absorption	O	O	O
on	O	O	O
hydroxylation	O	O	B-T070
degree	O	O	O
,	O	O	O
charge	O	O	B-T081
and	O	O	O
wettability	O	O	B-T080
was	O	O	O
evidenced	O	O	O
and	O	O	O
its	O	O	O
maximum	O	O	B-T081
was	O	O	O
registered	O	O	O
for	O	O	O
surfaces	O	O	B-T082
with	O	O	O
low	O	O	O
wettability	O	O	O
in	O	O	O
both	O	O	O
water	O	O	B-T121
based	O	O	O
and	O	O	O
protein	O	O	O
containing	O	O	O
media	O	O	B-T167
and	O	O	O
a	O	O	O
moderate	O	O	O
surface	O	O	B-T081
charge	O	O	I-T081
.	O	O	O

As	O	O	O
far	O	O	O
as	O	O	O
bacterial	O	O	B-T040
adhesion	O	O	I-T040
is	O	O	O
concerned	O	O	O
,	O	O	O
no	O	O	B-T080
effect	O	O	I-T080
of	O	O	O
surface	O	O	B-T081
charge	O	O	I-T081
or	O	O	O
protein	O	O	B-T116
adsorption	O	O	O
was	O	O	O
evidenced	O	O	O
,	O	O	O
while	O	O	O
the	O	O	O
presence	O	O	O
of	O	O	O
a	O	O	O
high	O	O	O
acid	O	O	B-T080
component	O	O	I-T080
of	O	O	O
the	O	O	O
surface	O	O	B-T081
energy	O	O	I-T081
appeared	O	O	O
significant	O	O	O
.	O	O	O

Finally	O	O	O
,	O	O	O
the	O	O	O
combination	O	O	O
of	O	O	O
hydroxylation	O	O	B-T070
degree	O	O	O
,	O	O	O
wettability	O	O	B-T080
,	O	O	O
surface	O	O	B-T081
charge	O	O	I-T081
and	O	O	O
energy	O	O	B-T081
(	O	O	O
polar	O	O	B-T080
component	O	O	I-T080
)	O	O	O
emerged	O	O	O
as	O	O	O
a	O	O	O
key	O	O	O
parameter	O	O	O
for	O	O	O
cell	O	O	B-T043
adhesion	O	O	I-T043
and	O	O	O
viability	O	O	B-T043
.	O	O	O

-DOCSTART- (28254935)

Persistent	O	O	B-T079
effects	O	O	B-T080
of	O	O	O
pre-Columbian	O	O	B-T081
plant	O	O	B-T002
domestication	O	O	B-T078
on	O	O	O
Amazonian	O	O	B-T070
forest	O	O	I-T070
composition	O	O	O

The	O	O	O
extent	O	O	O
to	O	O	O
which	O	O	O
pre-Columbian	O	O	B-T081
societies	O	O	B-T092
altered	O	O	O
Amazonian	O	O	B-T070
landscapes	O	O	B-T082
is	O	O	O
hotly	O	O	O
debated	O	O	O
.	O	O	O

We	O	O	O
performed	O	O	O
a	O	O	O
basin-wide	O	O	B-T062
analysis	O	O	I-T062
of	O	O	O
pre-Columbian	O	O	B-T081
impacts	O	O	B-T080
on	O	O	O
Amazonian	O	O	B-T070
forests	O	O	I-T070
by	O	O	O
overlaying	O	O	O
known	O	O	O
archaeological	O	O	B-T082
sites	O	O	I-T082
in	O	O	O
Amazonia	O	O	B-UnknownType
with	O	O	O
the	O	O	O
distributions	O	O	O
and	O	O	O
abundances	O	O	B-T080
of	O	O	O
85	O	O	O
woody	O	O	B-T002
species	O	O	B-T185
domesticated	O	O	B-T078
by	O	O	O
pre-Columbian	O	O	O
peoples	O	O	B-T098
.	O	O	O

Domesticated	O	O	B-T078
species	O	O	B-T185
are	O	O	O
five	O	O	O
times	O	O	O
more	O	O	O
likely	O	O	O
than	O	O	O
nondomesticated	O	O	B-T185
species	O	O	I-T185
to	O	O	O
be	O	O	O
hyperdominant	O	O	B-T169
.	O	O	O

Across	O	O	O
the	O	O	O
basin	O	O	O
,	O	O	O
the	O	O	O
relative	O	O	O
abundance	O	O	B-T080
and	O	O	O
richness	O	O	B-T080
of	O	O	O
domesticated	O	O	B-T078
species	O	O	B-T185
increase	O	O	O
in	O	O	O
forests	O	O	B-T070
on	O	O	O
and	O	O	O
around	O	O	O
archaeological	O	O	B-T082
sites	O	O	I-T082
.	O	O	O

In	O	O	O
southwestern	O	O	B-UnknownType
and	O	O	I-UnknownType
eastern	O	O	I-UnknownType
Amazonia	O	O	I-UnknownType
,	O	O	O
distance	O	O	O
to	O	O	O
archaeological	O	O	B-T082
sites	O	O	I-T082
strongly	O	O	O
influences	O	O	O
the	O	O	O
relative	O	O	O
abundance	O	O	B-T080
and	O	O	O
richness	O	O	O
of	O	O	O
domesticated	O	O	B-T078
species	O	O	B-T185
.	O	O	O

Our	O	O	O
analyses	O	O	B-T062
indicate	O	O	O
that	O	O	O
modern	O	O	O
tree	O	O	B-T002
communities	O	O	B-T096
in	O	O	O
Amazonia	O	O	B-UnknownType
are	O	O	O
structured	O	O	O
to	O	O	O
an	O	O	O
important	O	O	O
extent	O	O	O
by	O	O	O
a	O	O	O
long	O	O	O
history	O	O	B-T169
of	O	O	O
plant	O	O	B-T002
domestication	O	O	B-T078
by	O	O	O
Amazonian	O	O	B-T070
peoples	O	O	B-T098
.	O	O	O

-DOCSTART- (28256742)

Halogenated	O	O	B-T109
phenolic	O	O	I-T109
compounds	O	O	I-T109
in	O	O	O
wild	O	O	B-T013
fish	O	O	I-T013
from	O	O	O
Canadian	O	O	B-T083
Areas	O	O	I-T083
of	O	O	O
Concern	O	O	O

Concentrations	O	O	O
of	O	O	O
halogenated	O	O	B-T109
phenolic	O	O	I-T109
compounds	O	O	I-T109
were	O	O	O
measured	O	O	O
in	O	O	O
the	O	O	O
plasma	O	O	B-T031
of	O	O	O
brown	O	O	B-T013
bullhead	O	O	I-T013
(	O	O	O
Ameiurus	O	O	B-T013
nebulosus	O	O	I-T013
)	O	O	O
from	O	O	O
4	O	O	O
Canadian	O	O	B-T083
Areas	O	O	I-T083
of	O	O	O
Concern	O	O	B-T078
(	O	O	O
AOCs	O	O	B-T083
)	O	O	O
,	O	O	O
to	O	O	O
assess	O	O	O
exposure	O	O	O
to	O	O	O
suspected	O	O	O
thyroid	O	O	B-T023
-	O	O	O
disrupting	O	O	B-T131
chemicals	O	O	I-T131
.	O	O	O

Hydroxylated	O	O	B-T109
polychlorinated	O	O	I-T109
biphenyls	O	O	I-T109
(	O	O	O
OH-PCBs	O	O	B-T109
)	O	O	O
were	O	O	O
detected	O	O	O
in	O	O	O
every	O	O	O
sample	O	O	O
collected	O	O	O
in	O	O	O
3	O	O	O
of	O	O	O
the	O	O	O
AOCs	O	O	B-T083
;	O	O	O
the	O	O	O
detection	O	O	B-T061
frequency	O	O	B-T079
was	O	O	O
lower	O	O	O
in	O	O	O
samples	O	O	O
from	O	O	O
the	O	O	O
Detroit	O	O	B-T070
River	O	O	I-T070
AOC	O	O	B-T083
.	O	O	O

The	O	O	O
OH-PCBs	O	O	B-T109
most	O	O	O
frequently	O	O	O
detected	O	O	O
were	O	O	O
pentachloro	O	O	B-T104
,	O	O	I-T104
hexachloro	O	O	I-T104
,	O	O	I-T104
and	O	O	I-T104
heptachloro	O	O	I-T104
congeners	O	O	I-T104
,	O	O	O
which	O	O	O
are	O	O	O
structurally	O	O	O
similar	O	O	O
to	O	O	O
thyroid	O	O	B-T116
hormones	O	O	I-T116
.	O	O	O

Pentachlorophenol	O	O	B-T109
(	O	O	O
PCP	O	O	B-T109
)	O	O	O
was	O	O	O
detected	O	O	O
at	O	O	O
highest	O	O	O
concentrations	O	O	O
(	O	O	O
1.8	O	O	O
ng/g	O	O	O
)	O	O	O
in	O	O	O
fish	O	O	B-T013
from	O	O	O
Prince	O	O	B-T083
Edward	O	O	I-T083
Bay	O	O	I-T083
,	O	O	O
the	O	O	O
Bay	O	O	B-T083
of	O	O	I-T083
Quinte	O	O	I-T083
Lake	O	O	I-T083
reference	O	O	I-T083
site	O	O	I-T083
,	O	O	O
and	O	O	O
Hillman	O	O	B-T073
Marsh	O	O	I-T073
(	O	O	O
the	O	O	B-T073
Wheatley	O	O	I-T073
Harbour	O	O	I-T073
reference	O	O	I-T073
site	O	O	I-T073
)	O	O	O
,	O	O	O
suggesting	O	O	O
local	O	O	O
sources	O	O	B-T057
of	O	O	I-T057
contamination	O	O	I-T057
.	O	O	O

Elevated	O	O	B-T059
PCP	O	O	I-T059
concentrations	O	O	I-T059
were	O	O	O
also	O	O	O
detected	O	O	O
in	O	O	O
the	O	O	O
plasma	O	O	B-T031
of	O	O	O
brown	O	O	B-T013
bullhead	O	O	I-T013
from	O	O	O
exposed	O	O	O
sites	O	O	O
in	O	O	O
the	O	O	O
Toronto	O	O	B-T083
and	O	O	I-T083
Region	O	O	I-T083
AOC	O	O	I-T083
(	O	O	O
0.4	O	O	O
-	O	O	O
0.6	O	O	O
ng/g	O	O	O
)	O	O	O
.	O	O	O

Triclosan	O	O	B-T109
was	O	O	O
consistently	O	O	O
detected	O	O	O
in	O	O	O
the	O	O	O
Toronto	O	O	B-T083
and	O	O	I-T083
Region	O	O	I-T083
AOC	O	O	I-T083
(	O	O	O
0.05	O	O	O
-	O	O	O
0.9	O	O	O
ng/g	O	O	O
)	O	O	O
,	O	O	O
consistent	O	O	O
with	O	O	O
wastewater	O	O	B-T083
emission	O	O	O
.	O	O	O

Greater	O	O	O
concentrations	O	O	O
were	O	O	O
occasionally	O	O	O
detected	O	O	O
in	O	O	O
the	O	O	O
plasma	O	O	B-T031
of	O	O	O
brown	O	O	B-T013
bullhead	O	O	I-T013
from	O	O	O
the	O	O	O
Bay	O	O	B-T083
of	O	O	I-T083
Quinte	O	O	I-T083
AOC	O	O	B-T083
.	O	O	O

Concentrations	O	O	O
of	O	O	O
polybrominated	O	O	B-T109
diphenyl	O	O	I-T109
ethers	O	O	I-T109
were	O	O	O
highest	O	O	O
in	O	O	O
the	O	O	O
Toronto	O	O	B-T083
and	O	O	I-T083
Region	O	O	I-T083
AOC	O	O	B-T083
,	O	O	O
and	O	O	O
at	O	O	O
2	O	O	O
of	O	O	O
the	O	O	O
Bay	O	O	B-T083
of	O	O	I-T083
Quinte	O	O	I-T083
AOC	O	O	O
exposed	O	O	O
sites	O	O	O
near	O	O	O
Trenton	O	O	B-T083
and	O	O	I-T083
Belleville	O	O	I-T083
.	O	O	O

Distribution	O	O	B-T082
patterns	O	O	I-T082
reflected	O	O	O
the	O	O	O
properties	O	O	B-T070
and	O	O	O
usage	O	O	B-T169
of	O	O	O
the	O	O	O
compounds	O	O	O
under	O	O	O
investigation	O	O	B-T062
and	O	O	O
the	O	O	O
characteristics	O	O	B-T080
of	O	O	O
each	O	O	O
AOC	O	O	B-T083
.	O	O	O

Environ	O	O	O
Toxicol	O	O	O
Chem	O	O	O
2017;9999:1	O	O	O
-	O	O	O
8	O	O	O
.	O	O	O

Â©	O	O	O
2017	O	O	O
SETAC	O	O	O
.	O	O	O

-DOCSTART- (28257468)

The	O	O	O
genetic	O	O	B-T169
basis	O	O	O
for	O	O	O
variation	O	O	B-T070
in	O	O	O
resistance	O	O	B-T039
to	O	O	O
infection	O	O	B-T046
in	O	O	O
the	O	O	O
Drosophila	O	O	O
melanogaster	O	O	O
genetic	O	O	O
reference	O	O	O
panel	O	O	O

Individuals	O	O	B-T098
vary	O	O	O
extensively	O	O	O
in	O	O	O
the	O	O	O
way	O	O	O
they	O	O	O
respond	O	O	O
to	O	O	O
disease	O	O	B-T047
but	O	O	O
the	O	O	O
genetic	O	O	B-T169
basis	O	O	O
of	O	O	O
this	O	O	O
variation	O	O	B-T070
is	O	O	O
not	O	O	O
fully	O	O	O
understood	O	O	O
.	O	O	O

We	O	O	O
found	O	O	O
substantial	O	O	O
individual	O	O	B-T098
variation	O	O	B-T070
in	O	O	O
resistance	O	O	B-T039
and	O	O	O
tolerance	O	O	B-T080
to	O	O	O
the	O	O	O
fungal	O	O	B-T004
pathogen	O	O	I-T004
Metarhizium	O	O	I-T004
anisopliae	O	O	I-T004
Ma549	O	O	I-T004
using	O	O	O
the	O	O	O
Drosophila	O	O	B-T204
melanogaster	O	O	I-T204
Genetic	O	O	I-T204
Reference	O	O	I-T204
Panel	O	O	I-T204
(	O	O	O
DGRP	O	O	B-T204
)	O	O	O
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
we	O	O	O
found	O	O	O
that	O	O	O
host	O	O	B-T042
defense	O	O	B-T077
to	O	O	O
Ma549	O	O	B-T004
was	O	O	O
correlated	O	O	O
with	O	O	O
defense	O	O	O
to	O	O	O
the	O	O	O
bacterium	O	O	B-T007
Pseudomonas	O	O	B-T007
aeruginosa	O	O	I-T007
Pa14	O	O	I-T007
,	O	O	O
and	O	O	O
several	O	O	O
previously	O	O	O
published	O	O	O
DGRP	O	O	B-T204
phenotypes	O	O	B-T032
including	O	O	O
oxidative	O	O	B-T049
stress	O	O	I-T049
sensitivity	O	O	B-T169
,	O	O	O
starvation	O	O	B-T033
stress	O	O	B-UnknownType
resistance	O	O	I-UnknownType
,	O	O	O
hemolymph	O	O	B-T031
glucose	O	O	B-T059
levels	O	O	I-T059
,	O	O	O
and	O	O	O
sleep	O	O	B-T040
indices	O	O	B-T170
.	O	O	O

We	O	O	O
identified	O	O	O
polymorphisms	O	O	B-T045
associated	O	O	B-T080
with	O	O	I-T080
differences	O	O	B-T080
between	O	O	O
lines	O	O	O
in	O	O	O
both	O	O	O
their	O	O	O
mean	O	O	B-T081
survival	O	O	I-T081
times	O	O	I-T081
and	O	O	O
microenvironmental	O	O	B-T082
plasticity	O	O	B-T070
,	O	O	O
suggesting	O	O	O
that	O	O	O
lines	O	O	O
differ	O	O	B-T080
in	O	O	O
their	O	O	O
ability	O	O	B-T032
to	O	O	O
adapt	O	O	B-T038
to	O	O	O
variable	O	O	B-T080
pathogen	O	O	B-T001
exposures	O	O	B-T080
.	O	O	O

The	O	O	O
majority	O	O	O
of	O	O	O
polymorphisms	O	O	B-T045
increasing	O	O	B-T169
resistance	O	O	B-T039
to	O	O	O
Ma549	O	O	B-T004
were	O	O	O
sex	O	O	B-T078
biased	O	O	I-T078
,	O	O	O
located	O	O	O
in	O	O	O
non-coding	O	O	B-T114
regions	O	O	I-T114
,	O	O	O
had	O	O	O
moderately	O	O	O
large	O	O	O
effect	O	O	B-T080
and	O	O	O
were	O	O	O
rare	O	O	O
,	O	O	O
suggesting	O	O	O
that	O	O	O
there	O	O	O
is	O	O	O
a	O	O	O
general	O	O	O
cost	O	O	O
to	O	O	O
defense	O	O	B-T077
.	O	O	O

Nevertheless	O	O	O
,	O	O	O
host	O	O	B-T042
defense	O	O	I-T042
was	O	O	O
not	O	O	O
negatively	O	O	O
correlated	O	O	B-T080
with	O	O	O
overall	O	O	O
longevity	O	O	B-T079
and	O	O	O
fecundity	O	O	B-T040
.	O	O	O

In	O	O	O
contrast	O	O	O
to	O	O	O
Ma549	O	O	B-T004
,	O	O	O
minor	O	O	B-T028
alleles	O	O	I-T028
were	O	O	O
concentrated	O	O	O
in	O	O	O
the	O	O	O
most	O	O	O
Pa14	O	O	B-T007
-	O	O	O
susceptible	O	O	B-T169
as	O	O	O
well	O	O	O
as	O	O	O
the	O	O	O
most	O	O	O
Pa14	O	O	O
-	O	O	O
resistant	O	O	B-T039
lines	O	O	O
.	O	O	O

A	O	O	O
pathway	O	O	B-T077
based	O	O	O
analysis	O	O	B-T062
revealed	O	O	O
a	O	O	O
network	O	O	O
of	O	O	O
Pa14	O	O	B-T007
and	O	O	O
Ma549	O	O	B-T004
-	O	O	O
resistance	O	O	B-T039
genes	O	O	B-T028
that	O	O	O
are	O	O	O
functionally	O	O	B-T169
connected	O	O	O
through	O	O	O
processes	O	O	B-T067
that	O	O	O
encompass	O	O	O
phagocytosis	O	O	B-T043
and	O	O	O
engulfment	O	O	B-T043
,	O	O	O
cell	O	O	B-T043
mobility	O	O	I-T043
,	O	O	O
intermediary	O	O	B-T040
metabolism	O	O	I-T040
,	O	O	O
protein	O	O	B-T044
phosphorylation	O	O	I-T044
,	O	O	O
axon	O	O	B-T043
guidance	O	O	I-T043
,	O	O	O
response	O	O	B-T043
to	O	O	I-T043
DNA	O	O	I-T043
damage	O	O	I-T043
,	O	O	O
and	O	O	O
drug	O	O	B-T044
metabolism	O	O	I-T044
.	O	O	O

Functional	O	O	B-T169
testing	O	O	B-T169
with	O	O	O
insertional	O	O	B-T045
mutagenesis	O	O	I-T045
lines	O	O	O
indicates	O	O	O
that	O	O	O
12/13	O	O	O
candidate	O	O	B-T028
genes	O	O	I-T028
tested	O	O	B-T169
influence	O	O	B-T077
susceptibility	O	O	B-T169
to	O	O	O
Ma549	O	O	B-T004
.	O	O	O

Many	O	O	O
candidate	O	O	B-T028
genes	O	O	B-T028
have	O	O	O
homologs	O	O	B-T085
identified	O	O	O
in	O	O	O
studies	O	O	B-T062
of	O	O	O
human	O	O	B-T016
disease	O	O	B-T047
,	O	O	O
suggesting	O	O	O
that	O	O	O
genes	O	O	O
affecting	O	O	O
variation	O	O	B-T070
in	O	O	O
susceptibility	O	O	B-T169
are	O	O	O
conserved	O	O	O
across	O	O	O
species	O	O	B-T185
.	O	O	O

-DOCSTART- (28260547)

Surrogate	O	O	B-T099
inaccuracy	O	O	B-T080
in	O	O	O
predicting	O	O	O
older	O	O	B-T098
adults	O	O	I-T098
'	O	O	I-T098
desire	O	O	B-T041
for	O	O	O
life-sustaining	O	O	B-T061
interventions	O	O	I-T061
in	O	O	O
the	O	O	O
event	O	O	O
of	O	O	O
decisional	O	O	B-T041
incapacity	O	O	B-T201
:	O	O	O
is	O	O	O
it	O	O	O
due	O	O	O
in	O	O	O
part	O	O	O
to	O	O	O
erroneous	O	O	B-T078
quality-of-life	O	O	B-T060
assessments	O	O	I-T060
?	O	O	O

Family	O	O	B-T099
members	O	O	I-T099
are	O	O	O
often	O	O	O
called	O	O	O
upon	O	O	O
to	O	O	O
make	O	O	O
decisions	O	O	B-T041
for	O	O	O
an	O	O	O
incapacitated	O	O	O
relative	O	O	B-T099
.	O	O	O

Yet	O	O	O
they	O	O	O
have	O	O	O
difficulty	O	O	O
predicting	O	O	O
a	O	O	O
loved	O	O	O
one	O	O	O
's	O	O	O
desire	O	O	B-T041
to	O	O	O
receive	O	O	O
treatments	O	O	B-T061
in	O	O	O
hypothetical	O	O	O
situations	O	O	O
.	O	O	O

We	O	O	O
tested	O	O	O
the	O	O	O
hypothesis	O	O	O
that	O	O	O
this	O	O	O
difficulty	O	O	O
could	O	O	O
in	O	O	O
part	O	O	O
be	O	O	O
explained	O	O	O
by	O	O	O
discrepant	O	O	O
quality-of-life	O	O	B-T060
assessments	O	O	I-T060
.	O	O	O

The	O	O	O
data	O	O	B-T078
come	O	O	O
from	O	O	O
235	O	O	O
community-dwelling	O	O	B-T056
adults	O	O	B-T100
aged	O	O	O
70	O	O	O
years	O	O	B-T079
and	O	O	O
over	O	O	O
who	O	O	O
rated	O	O	O
their	O	O	O
quality	O	O	B-T078
of	O	O	I-T078
life	O	O	I-T078
and	O	O	O
desire	O	O	B-T041
for	O	O	O
specified	O	O	O
interventions	O	O	B-T061
in	O	O	O
four	O	O	O
health	O	O	B-T033
states	O	O	I-T033
(	O	O	O
current	O	O	B-T033
state	O	O	I-T033
,	O	O	O
mild	O	O	B-T080
to	O	O	O
moderate	O	O	B-T080
stroke	O	O	B-T047
,	O	O	O
incurable	O	O	O
brain	O	O	B-T191
cancer	O	O	I-T191
,	O	O	O
and	O	O	O
severe	O	O	B-T080
dementia	O	O	B-T048
)	O	O	O
.	O	O	O

All	O	O	O
ratings	O	O	B-T052
were	O	O	O
made	O	O	O
on	O	O	O
Likert-type	O	O	B-T170
scales	O	O	I-T170
.	O	O	O

Using	O	O	O
identical	O	O	O
rating	O	O	B-T081
scales	O	O	I-T081
,	O	O	O
a	O	O	O
surrogate	O	O	B-T099
chosen	O	O	O
by	O	O	O
the	O	O	O
older	O	O	B-T098
adult	O	O	I-T098
was	O	O	O
asked	O	O	O
to	O	O	O
predict	O	O	O
the	O	O	O
latter	O	O	O
's	O	O	O
responses	O	O	O
.	O	O	O

Linear	O	O	O
mixed	O	O	O
models	O	O	O
were	O	O	O
fitted	O	O	O
to	O	O	O
determine	O	O	O
whether	O	O	O
differences	O	O	O
in	O	O	O
quality-of-life	O	O	B-T078
ratings	O	O	B-T052
between	O	O	O
the	O	O	O
older	O	O	B-T098
adult	O	O	I-T098
and	O	O	O
surrogate	O	O	B-T099
were	O	O	O
associated	O	O	O
with	O	O	O
surrogates	O	O	B-T099
'	O	O	I-T099
inaccuracy	O	O	B-T080
in	O	O	O
predicting	O	O	O
desire	O	O	B-T041
for	O	O	O
treatment	O	O	B-T061
.	O	O	O

The	O	O	O
difference	O	O	O
in	O	O	O
quality-of-life	O	O	B-T078
ratings	O	O	B-T052
was	O	O	O
a	O	O	O
significant	O	O	O
predictor	O	O	B-T078
of	O	O	O
prediction	O	O	O
inaccuracy	O	O	B-T080
for	O	O	O
the	O	O	O
three	O	O	O
hypothetical	O	O	O
health	O	O	B-T033
states	O	O	I-T033
(	O	O	O
p	O	O	O
<	O	O	O
0.01	O	O	O
)	O	O	O
and	O	O	O
nearly	O	O	O
significant	O	O	O
for	O	O	O
the	O	O	O
current	O	O	B-T033
health	O	O	I-T033
state	O	O	I-T033
(	O	O	O
p	O	O	O
=	O	O	O
0.077	O	O	O
)	O	O	O
.	O	O	O

All	O	O	O
regression	O	O	B-T081
coefficients	O	O	I-T081
were	O	O	O
negative	O	O	B-T033
,	O	O	O
implying	O	O	O
that	O	O	O
the	O	O	O
more	O	O	O
the	O	O	O
surrogate	O	O	B-T099
overestimated	O	O	O
quality	O	O	B-T078
of	O	O	I-T078
life	O	O	I-T078
compared	O	O	O
to	O	O	O
the	O	O	O
older	O	O	B-T098
adult	O	O	I-T098
,	O	O	O
the	O	O	O
more	O	O	O
he	O	O	O
or	O	O	O
she	O	O	O
overestimated	O	O	O
the	O	O	O
older	O	O	O
adult	O	O	O
's	O	O	O
desire	O	O	B-T041
to	O	O	O
be	O	O	O
treated	O	O	O
.	O	O	O

Discrepant	O	O	O
quality-of-life	O	O	B-T078
ratings	O	O	B-T052
are	O	O	O
associated	O	O	O
with	O	O	O
surrogates	O	O	B-T099
'	O	O	I-T099
difficulty	O	O	O
in	O	O	O
predicting	O	O	O
desire	O	O	B-T041
for	O	O	O
life-sustaining	O	O	B-T061
interventions	O	O	I-T061
in	O	O	O
hypothetical	O	O	O
situations	O	O	O
.	O	O	O

This	O	O	O
finding	O	O	O
underscores	O	O	O
the	O	O	O
importance	O	O	O
of	O	O	O
discussing	O	O	O
anticipated	O	O	O
quality	O	O	B-T078
of	O	O	I-T078
life	O	O	I-T078
in	O	O	O
states	O	O	O
of	O	O	O
cognitive	O	O	B-T046
decline	O	O	I-T046
,	O	O	O
to	O	O	O
better	O	O	O
prepare	O	O	O
family	O	O	B-T099
members	O	O	I-T099
for	O	O	O
making	O	O	O
difficult	O	O	O
decisions	O	O	B-T041
for	O	O	O
their	O	O	O
loved	O	O	O
ones	O	O	O
.	O	O	O

ISRCTN89993391	O	O	O
.	O	O	O

-DOCSTART- (28262340)

Gain-of-function	O	O	B-T045
mutation	O	O	I-T045
in	O	O	O
SCN5A	O	O	B-T028
causes	O	O	O
ventricular	O	O	B-T047
arrhythmias	O	O	I-T047
and	O	O	O
early	O	O	B-T033
onset	O	O	I-T033
atrial	O	O	O
fibrillation	O	O	O

Mutations	O	O	B-T045
in	O	O	O
SCN5A	O	O	B-T028
,	O	O	O
the	O	O	O
gene	O	O	B-T028
encoding	O	O	B-T052
the	O	O	O
Î±-subunit	O	O	O
of	O	O	O
the	O	O	O
cardiac	O	O	B-T023
sodium	O	O	B-T116
channel	O	O	I-T116
(	O	O	I-T116
NaV1.5	O	O	I-T116
)	O	O	I-T116
,	O	O	O
are	O	O	O
associated	O	O	O
with	O	O	O
a	O	O	O
broad	O	O	O
spectrum	O	O	B-T077
of	O	O	O
inherited	O	O	B-T169
cardiac	O	O	B-T033
arrhythmia	O	O	I-T033
disorders	O	O	I-T033
.	O	O	O

The	O	O	O
purpose	O	O	O
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
identify	O	O	O
the	O	O	O
genetic	O	O	B-T169
and	O	O	O
functional	O	O	B-T169
determinants	O	O	I-T169
underlying	O	O	O
a	O	O	O
Dutch	O	O	B-T098
family	O	O	B-T099
that	O	O	O
presented	O	O	O
with	O	O	O
a	O	O	O
combined	O	O	O
phenotype	O	O	B-T032
of	O	O	O
ventricular	O	O	B-T047
arrhythmias	O	O	I-T047
with	O	O	O
a	O	O	O
likely	O	O	O
adrenergic	O	O	B-T169
component	O	O	B-T077
,	O	O	O
either	O	O	O
in	O	O	O
isolation	O	O	B-T169
or	O	O	O
in	O	O	O
combination	O	O	B-T080
with	O	O	O
a	O	O	O
mildly	O	O	O
decreased	O	O	O
heart	O	O	B-T042
function	O	O	I-T042
and	O	O	O
early	O	O	B-T033
onset	O	O	I-T033
(	O	O	O
<	O	O	O
55	O	O	O
years	O	O	B-T079
)	O	O	O
atrial	O	O	B-T047
fibrillation	O	O	I-T047
.	O	O	O

We	O	O	O
performed	O	O	O
next	O	O	O
generation	O	O	B-T079
sequencing	O	O	B-T086
in	O	O	O
the	O	O	O
proband	O	O	B-T099
of	O	O	O
a	O	O	O
two-	O	O	O
generation	O	O	O
Dutch	O	O	B-T098
family	O	O	B-T099
and	O	O	O
demonstrated	O	O	O
a	O	O	O
novel	O	O	O
missense	O	O	B-T045
mutation	O	O	I-T045
in	O	O	O
SCN5A-(p	O	O	O
.	O	O	O

M1851V	O	O	O
)	O	O	O
which	O	O	O
co-segregated	O	O	O
with	O	O	O
the	O	O	O
clinical	O	O	B-T080
phenotype	O	O	B-T032
in	O	O	O
the	O	O	O
family	O	O	B-T099
.	O	O	O

We	O	O	O
functionally	O	O	B-T169
evaluated	O	O	O
the	O	O	O
putative	O	O	O
genetic	O	O	B-T169
defect	O	O	B-T169
by	O	O	O
patch	O	O	B-T062
clamp	O	O	I-T062
electrophysiological	O	O	B-T060
studies	O	O	I-T060
in	O	O	O
human	O	O	B-T018
embryonic	O	O	I-T018
kidney	O	O	B-T025
cells	O	O	I-T025
transfected	O	O	B-T063
with	O	O	O
mutant	O	O	B-T049
or	O	O	O
wild-type	O	O	B-T028
Nav1.5	O	O	I-T028
.	O	O	O

The	O	O	O
current	O	O	B-T070
inactivation	O	O	B-T169
was	O	O	O
slower	O	O	O
and	O	O	O
recovery	O	O	O
from	O	O	O
inactivation	O	O	O
was	O	O	O
faster	O	O	O
in	O	O	O
SCN5A-M1851V	O	O	B-T116
channels	O	O	I-T116
.	O	O	O

The	O	O	O
voltage	O	O	B-T081
dependence	O	O	B-T169
of	O	O	O
inactivation	O	O	B-T169
was	O	O	O
shifted	O	O	O
towards	O	O	O
more	O	O	O
positive	O	O	B-T033
potentials	O	O	B-T080
and	O	O	O
consequently	O	O	O
,	O	O	O
a	O	O	O
larger	O	O	O
TTX	O	O	B-T109
-	O	O	O
sensitive	O	O	B-T169
window	O	O	B-T070
current	O	O	I-T070
was	O	O	O
observed	O	O	O
in	O	O	O
SCN5A-M1851V	O	O	B-T116
channels	O	O	I-T116
.	O	O	O

Furthermore	O	O	O
,	O	O	O
a	O	O	O
higher	O	O	O
upstroke	O	O	B-T081
velocity	O	O	I-T081
was	O	O	O
observed	O	O	O
for	O	O	O
the	O	O	O
SCN5A-M1851V	O	O	B-T116
channels	O	O	I-T116
,	O	O	O
while	O	O	O
the	O	O	O
depolarization	O	O	B-T081
voltage	O	O	I-T081
was	O	O	O
more	O	O	O
negative	O	O	B-T033
,	O	O	O
both	O	O	O
indicating	O	O	O
increased	O	O	O
excitability	O	O	O
.	O	O	O

This	O	O	O
mutation	O	O	B-T045
leads	O	O	O
to	O	O	O
a	O	O	O
gain-of-function	O	O	B-T169
mechanism	O	O	I-T169
based	O	O	O
on	O	O	O
increased	O	O	O
channel	O	O	B-T116
availability	O	O	O
and	O	O	O
increased	O	O	O
window	O	O	B-T070
current	O	O	I-T070
,	O	O	O
fitting	O	O	O
the	O	O	O
observed	O	O	O
clinical	O	O	B-T080
phenotype	O	O	B-T032
of	O	O	O
(	O	O	O
likely	O	O	O
adrenergic-induced	O	O	O
)	O	O	O
ventricular	O	O	B-T047
arrhythmias	O	O	I-T047
and	O	O	O
atrial	O	O	B-T047
fibrillation	O	O	I-T047
.	O	O	O

These	O	O	O
findings	O	O	B-T033
further	O	O	O
expand	O	O	O
the	O	O	O
range	O	O	O
of	O	O	O
cardiac	O	O	B-T033
arrhythmias	O	O	I-T033
associated	O	O	O
with	O	O	O
mutations	O	O	B-T045
in	O	O	O
SCN5A	O	O	B-T028
.	O	O	O

-DOCSTART- (28263181)

The	O	O	O
cancer	O	O	B-T191
Warburg	O	O	B-T049
effect	O	O	I-T049
may	O	O	O
be	O	O	O
a	O	O	O
testable	O	O	B-T169
example	O	O	B-T077
of	O	O	O
the	O	O	O
minimum	O	O	B-T080
entropy	O	O	B-T067
production	O	O	B-T081
rate	O	O	I-T081
principle	O	O	O

Cancer	O	O	B-T025
cells	O	O	I-T025
consume	O	O	B-T169
more	O	O	O
glucose	O	O	B-T109
by	O	O	O
glycolytic	O	O	B-T044
fermentation	O	O	I-T044
to	O	O	O
lactate	O	O	B-T109
than	O	O	O
by	O	O	O
respiration	O	O	B-T039
,	O	O	O
a	O	O	O
characteristic	O	O	B-T080
known	O	O	O
as	O	O	O
the	O	O	O
Warburg	O	O	B-T049
effect	O	O	I-T049
.	O	O	O

In	O	O	O
contrast	O	O	O
with	O	O	O
the	O	O	O
34	O	O	O
moles	O	O	B-T081
of	O	O	O
ATP	O	O	B-T114
produced	O	O	O
by	O	O	O
respiration	O	O	B-T039
,	O	O	O
fermentation	O	O	B-T044
produces	O	O	O
two	O	O	O
moles	O	O	O
of	O	O	O
ATP	O	O	O
per	O	O	O
mole	O	O	B-T081
of	O	O	O
glucose	O	O	B-T109
consumed	O	O	B-T169
,	O	O	O
which	O	O	O
poses	O	O	O
a	O	O	O
puzzle	O	O	O
on	O	O	O
the	O	O	O
function	O	O	B-T169
of	O	O	O
the	O	O	O
Warburg	O	O	B-T049
effect	O	O	I-T049
.	O	O	O

Productions	O	O	B-T169
of	O	O	O
free	O	O	B-T070
energy	O	O	I-T070
(	O	O	O
ÎG	O	O	B-T070
)	O	O	O
,	O	O	O
enthalpy	O	O	B-T081
(	O	O	O
ÎH	O	O	B-T081
)	O	O	O
and	O	O	O
entropy	O	O	B-T067
(	O	O	O
ÎS	O	O	B-T080
)	O	O	O
per	O	O	O
mole	O	O	B-T081
linearly	O	O	B-T082
vary	O	O	O
with	O	O	O
the	O	O	O
fraction	O	O	B-T081
(	O	O	I-T081
x	O	O	I-T081
)	O	O	I-T081
of	O	O	I-T081
glucose	O	O	B-T109
consumed	O	O	B-T169
by	O	O	O
fermentation	O	O	B-T044
that	O	O	O
is	O	O	O
frequently	O	O	B-T079
estimated	O	O	B-T081
around	O	O	O
0.9	O	O	O
.	O	O	O

Hence	O	O	O
,	O	O	O
calculation	O	O	B-T052
shows	O	O	O
that	O	O	O
,	O	O	O
in	O	O	O
respect	O	O	O
to	O	O	O
pure	O	O	B-T080
respiration	O	O	B-T039
,	O	O	O
the	O	O	O
predominant	O	O	O
fermentative	O	O	B-T044
metabolism	O	O	B-T040
decreases	O	O	B-T081
around	O	O	O
10	O	O	O
%	O	O	O
the	O	O	O
production	O	O	B-T169
of	O	O	O
entropy	O	O	B-T067
per	O	O	O
mole	O	O	B-T081
of	O	O	O
glucose	O	O	B-T109
consumed	O	O	B-T169
in	O	O	O
cancer	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

We	O	O	O
hypothesize	O	O	B-T078
that	O	O	O
increased	O	O	B-T081
fermentation	O	O	B-T044
could	O	O	O
allow	O	O	O
cancer	O	O	B-T025
cells	O	O	I-T025
to	O	O	O
accomplish	O	O	B-T080
the	O	O	O
Prigogine	O	O	B-T170
theorem	O	O	I-T170
of	O	O	O
the	O	O	O
trend	O	O	B-T079
to	O	O	O
minimize	O	O	B-T081
the	O	O	O
rate	O	O	B-T081
of	O	O	O
production	O	O	B-T169
of	O	O	O
entropy	O	O	B-T067
.	O	O	O

According	O	O	O
the	O	O	O
theorem	O	O	B-T170
,	O	O	O
open	O	O	B-T025
cellular	O	O	I-T025
systems	O	O	I-T025
near	O	O	O
the	O	O	O
steady	O	O	B-T070
state	O	O	I-T070
could	O	O	O
evolve	O	O	B-T169
to	O	O	O
minimize	O	O	B-T081
the	O	O	O
rates	O	O	B-T081
of	O	O	O
entropy	O	O	B-T067
production	O	O	B-T169
that	O	O	O
may	O	O	O
be	O	O	O
reached	O	O	O
by	O	O	O
modified	O	O	B-T033
replicating	O	O	B-T080
cells	O	O	B-T025
producing	O	O	O
entropy	O	O	O
at	O	O	O
low	O	O	O
rate	O	O	B-T081
.	O	O	O

Remarkably	O	O	O
,	O	O	O
at	O	O	O
CO2	O	O	B-T123
concentrations	O	O	B-T081
above	O	O	O
930	O	O	O
ppm	O	O	B-T081
,	O	O	O
glucose	O	O	B-T109
respiration	O	O	B-T039
produces	O	O	O
less	O	O	O
entropy	O	O	B-T067
than	O	O	O
fermentation	O	O	B-T044
,	O	O	O
which	O	O	O
suggests	O	O	O
experimental	O	O	B-T080
tests	O	O	B-T059
to	O	O	O
validate	O	O	B-T080
the	O	O	O
hypothesis	O	O	B-T078
of	O	O	O
minimization	O	O	B-T081
of	O	O	O
the	O	O	O
rate	O	O	B-T081
of	O	O	O
entropy	O	O	O
production	O	O	B-T169
through	O	O	O
the	O	O	O
Warburg	O	O	B-T049
effect	O	O	I-T049
.	O	O	O

-DOCSTART- (28263519)

Potential	O	O	B-T080
drug-drug	O	O	B-T044
interactions	O	O	I-T044
among	O	O	O
prescriptions	O	O	B-T058
for	O	O	O
elderly	O	O	B-T098
patients	O	O	B-T101
in	O	O	O
primary	O	O	O
health	O	O	O
care	O	O	O

Elderly	O	O	B-T098
patients	O	O	B-T101
are	O	O	O
at	O	O	O
high	O	O	B-T033
risk	O	O	I-T033
from	O	O	O
drug-drug	O	O	B-T044
interactions	O	O	I-T044
(	O	O	O
DDIs	O	O	B-T044
)	O	O	O
.	O	O	O

This	O	O	O
study	O	O	B-T062
evaluates	O	O	B-T058
the	O	O	O
potential	O	O	B-T080
DDIs	O	O	B-T044
in	O	O	O
Turkish	O	O	O
elderly	O	O	B-T098
patients	O	O	B-T101
at	O	O	O
a	O	O	O
primary	O	O	B-T058
health	O	O	I-T058
care	O	O	I-T058
outpatient	O	O	B-T093
clinic	O	O	I-T093
.	O	O	O

Online	O	O	B-T170
database	O	O	I-T170
systems	O	O	I-T170
were	O	O	O
used	O	O	O
to	O	O	O
examine	O	O	O
DDIs	O	O	B-T044
on	O	O	O
the	O	O	O
prescriptions	O	O	B-T058
of	O	O	O
patients	O	O	B-T101
(	O	O	O
n	O	O	O
=	O	O	O
1206	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
clinical	O	O	B-T033
severity	O	O	I-T033
of	O	O	O
DDIs	O	O	B-T044
was	O	O	O
classified	O	O	O
by	O	O	O
the	O	O	O
Lexi-Interact	O	O	B-T170
Online	O	O	I-T170
database	O	O	I-T170
.	O	O	O

Of	O	O	O
the	O	O	O
5059	O	O	O
prescriptions	O	O	B-T058
,	O	O	O
33	O	O	O
%	O	O	O
were	O	O	O
found	O	O	O
to	O	O	O
have	O	O	O
DDIs	O	O	B-T044
.	O	O	O

We	O	O	O
detected	O	O	B-T033
29	O	O	O
(	O	O	O
0.9	O	O	O
%	O	O	O
)	O	O	O
A	O	O	O
,	O	O	O
380	O	O	O
(	O	O	O
11.8	O	O	O
%	O	O	O
)	O	O	O
B	O	O	O
,	O	O	O
2494	O	O	O
(	O	O	O
77.7	O	O	O
%	O	O	O
)	O	O	O
C	O	O	O
,	O	O	O
289	O	O	O
(	O	O	O
9	O	O	O
%	O	O	O
)	O	O	O
D	O	O	O
,	O	O	O
and	O	O	O
18	O	O	O
(	O	O	O
0.6	O	O	O
%	O	O	O
)	O	O	O
X	O	O	O
risk	O	O	O
rating	O	O	O
category	O	O	O
DDIs	O	O	B-T044
among	O	O	O
the	O	O	O
prescriptions	O	O	B-T058
.	O	O	O

Prescriptions	O	O	B-T058
of	O	O	O
female	O	O	O
patients	O	O	B-T101
and	O	O	O
patients	O	O	O
aged	O	O	O
between	O	O	O
65	O	O	O
and	O	O	O
72	O	O	O
years	O	O	O
showed	O	O	O
significantly	O	O	B-T081
higher	O	O	I-T081
number	O	O	O
of	O	O	O
DDIs	O	O	B-T044
.	O	O	O

The	O	O	O
frequency	O	O	B-T079
of	O	O	O
DDIs	O	O	B-T044
increased	O	O	B-T081
both	O	O	O
with	O	O	O
the	O	O	O
number	O	O	O
of	O	O	O
drugs	O	O	B-T121
and	O	O	O
combined	O	O	O
preparations	O	O	O
per	O	O	O
prescription	O	O	B-T058
.	O	O	O

Acetylsalicylic	O	O	B-T109
acid	O	O	I-T109
and	O	O	O
salbutamol	O	O	B-T109
were	O	O	O
the	O	O	O
most	O	O	O
frequently	O	O	B-T079
prescribed	O	O	B-T058
drugs	O	O	B-T121
contributing	O	O	O
to	O	O	O
clinically	O	O	B-T033
important	O	O	I-T033
DDIs	O	O	B-T044
.	O	O	O

Additionally	O	O	O
,	O	O	O
acetylsalicylic	O	O	B-T109
acid	O	O	I-T109
and	O	O	O
escitalopram	O	O	B-T109
,	O	O	O
which	O	O	O
interact	O	O	B-T169
with	O	O	O
each	O	O	O
other	O	O	O
,	O	O	O
were	O	O	O
found	O	O	O
on	O	O	O
the	O	O	O
list	O	O	O
of	O	O	O
Beers	O	O	B-T080
criteria	O	O	I-T080
.	O	O	O

The	O	O	O
most	O	O	O
predicted	O	O	B-T033
clinical	O	O	I-T033
outcomes	O	O	I-T033
of	O	O	O
DDIs	O	O	B-T044
were	O	O	O
increase	O	O	O
in	O	O	O
therapeutic	O	O	B-T080
efficacy	O	O	I-T080
and	O	O	O
adverse	O	O	B-T046
/	O	O	O
toxic	O	O	B-T033
reactions	O	O	I-T033
.	O	O	O

Conclusions	O	O	O
:	O	O	O
Prediction	O	O	B-T078
of	O	O	O
DDIs	O	O	B-T044
in	O	O	O
elderly	O	O	B-T098
patients	O	O	B-T101
will	O	O	O
provide	O	O	O
better	O	O	O
prescribing	O	O	B-T058
and	O	O	O
drug	O	O	B-T080
safety	O	O	I-T080
.	O	O	O

Use	O	O	O
of	O	O	O
nonsteroidal	O	O	B-T121
anti-inflammatory	O	O	I-T121
agents	O	O	I-T121
,	O	O	O
selective	O	O	B-T121
serotonin	O	O	I-T121
reuptake	O	O	I-T121
inhibitors	O	O	I-T121
,	O	O	O
and	O	O	O
beta-2	O	O	B-T121
adrenergic	O	O	I-T121
receptor	O	O	I-T121
agonists	O	O	I-T121
should	O	O	O
be	O	O	O
closely	O	O	O
monitored	O	O	O
.	O	O	O

-DOCSTART- (28265530)

Discontinued	O	O	B-T033
Splenogonadal	O	O	B-T019
Fusion	O	O	I-T019
and	O	O	O
Bilateral	O	O	B-T019
Empty	O	O	I-T019
Scrotum	O	O	I-T019
in	O	O	O
an	O	O	O
18-	O	O	O
Month	O	O	B-T032
-Old	O	O	O
Boy	O	O	O

Splenogonadal	O	O	B-T019
fusion	O	O	I-T019
is	O	O	O
a	O	O	O
rare	O	O	B-T080
benign	O	O	O
congenital	O	O	B-T019
anomaly	O	O	I-T019
defined	O	O	O
as	O	O	O
the	O	O	O
presence	O	O	O
of	O	O	O
splenic	O	O	B-T024
tissue	O	O	I-T024
adherent	O	O	B-T169
to	O	O	O
gonads	O	O	B-T023
.	O	O	O

It	O	O	O
was	O	O	O
first	O	O	O
described	O	O	O
in	O	O	O
1883	O	O	O
by	O	O	O
Bostroem	O	O	B-T016
,	O	O	O
a	O	O	O
German	O	O	B-T098
pathologist	O	O	B-T097
.	O	O	O

We	O	O	O
present	O	O	O
a	O	O	O
case	O	O	B-T077
of	O	O	O
an	O	O	O
18-	O	O	O
month	O	O	B-T032
-old	O	O	O
boy	O	O	B-T100
who	O	O	O
was	O	O	O
referred	O	O	O
as	O	O	O
a	O	O	O
case	O	O	O
of	O	O	O
bilateral	O	O	B-T019
empty	O	O	I-T019
scrotum	O	O	I-T019
since	O	O	O
birth	O	O	O
.	O	O	O

During	O	O	O
routine	O	O	B-T080
laparoscopic	O	O	B-T060
exploration	O	O	B-T061
,	O	O	O
right	O	O	B-T023
vas	O	O	B-T023
deferens	O	O	I-T023
and	O	O	O
testicular	O	O	B-T023
vessels	O	O	I-T023
were	O	O	O
entering	O	O	O
the	O	O	O
right	O	O	B-T023
internal	O	O	I-T023
inguinal	O	O	I-T023
ring	O	O	I-T023
so	O	O	O
right	O	O	B-T029
inguinal	O	O	I-T029
exploration	O	O	O
was	O	O	O
done	O	O	O
,	O	O	O
which	O	O	O
revealed	O	O	O
blind	O	O	B-T033
ending	O	O	I-T033
vas	O	O	O
deferens	O	O	O
and	O	O	O
testicular	O	O	O
vessels	O	O	O
and	O	O	O
the	O	O	O
left	O	O	B-T023
testis	O	O	I-T023
was	O	O	O
found	O	O	O
intra-abdominally	O	O	B-T082
near	O	O	O
the	O	O	O
left	O	O	O
internal	O	O	B-T030
ring	O	O	I-T030
with	O	O	O
a	O	O	O
mass	O	O	B-T184
on	O	O	O
its	O	O	O
upper	O	O	B-T023
pole	O	O	I-T023
.	O	O	O

Wedge	O	O	B-T060
biopsy	O	O	I-T060
was	O	O	O
taken	O	O	O
from	O	O	O
the	O	O	O
upper	O	O	B-T023
pole	O	O	I-T023
of	O	O	I-T023
the	O	O	I-T023
testicle	O	O	I-T023
(	O	O	O
site	O	O	B-T029
of	O	O	O
the	O	O	O
mass	O	O	B-T184
)	O	O	O
for	O	O	O
tissue	O	O	B-T185
diagnosis	O	O	I-T185
followed	O	O	O
by	O	O	O
orchidopexy	O	O	B-T061
.	O	O	O

Histology	O	O	B-T059
showed	O	O	O
splenic	O	O	B-T024
tissue	O	O	I-T024
.	O	O	O

Although	O	O	O
splenogonadal	O	O	B-T019
fusion	O	O	I-T019
is	O	O	O
a	O	O	O
rare	O	O	B-T080
condition	O	O	B-T047
,	O	O	O
surgeons	O	O	B-T097
should	O	O	O
be	O	O	O
aware	O	O	O
of	O	O	O
this	O	O	O
rare	O	O	B-T047
disease	O	O	I-T047
entity	O	O	O
to	O	O	O
avoid	O	O	O
unnecessary	O	O	B-T058
aggressive	O	O	O
interventions	O	O	B-T061
such	O	O	O
as	O	O	O
orchiectomy	O	O	B-T061
.	O	O	O

-DOCSTART- (28267199)

Real-world	O	O	B-T080
impact	O	O	I-T080
of	O	O	O
non-breast	O	O	B-T033
cancer-specific	O	O	I-T033
death	O	O	I-T033
on	O	O	O
overall	O	O	B-T081
survival	O	O	I-T081
in	O	O	O
resectable	O	O	B-T080
breast	O	O	O
cancer	O	O	O

The	O	O	O
real-world	O	O	O
occurrence	O	O	B-T081
rate	O	O	I-T081
of	O	O	O
non-breast	O	O	B-T033
cancer-specific	O	O	I-T033
death	O	O	I-T033
(	O	O	O
non-BCSD	O	O	B-T033
)	O	O	O
and	O	O	O
its	O	O	O
impact	O	O	B-T080
on	O	O	O
patients	O	O	B-T101
with	O	O	O
breast	O	O	B-T191
cancer	O	O	I-T191
are	O	O	O
poorly	O	O	O
recognized	O	O	O
.	O	O	O

Women	O	O	B-T098
with	O	O	O
resectable	O	O	B-T080
breast	O	O	B-T191
cancer	O	O	I-T191
from	O	O	O
1990	O	O	O
to	O	O	O
2007	O	O	O
in	O	O	O
the	O	O	O
Surveillance	O	O	B-T093
,	O	O	I-T093
Epidemiology	O	O	I-T093
,	O	O	I-T093
and	O	O	I-T093
End	O	O	I-T093
Results	O	O	I-T093
database	O	O	I-T093
(	O	O	O
n	O	O	O
=	O	O	O
199,963	O	O	O
)	O	O	O
were	O	O	O
analyzed	O	O	B-T062
.	O	O	O

The	O	O	O
outcome	O	O	B-T169
events	O	O	B-T051
of	O	O	O
breast	O	O	B-T191
cancer	O	O	I-T191
were	O	O	O
classified	O	O	O
as	O	O	O
breast	O	O	B-T081
cancer-specific	O	O	I-T081
death	O	O	I-T081
(	O	O	O
BCSD	O	O	B-T081
)	O	O	O
,	O	O	O
non-BCSD	O	O	B-T033
,	O	O	O
or	O	O	O
survival	O	O	B-T052
.	O	O	O

Binary	O	O	B-T062
logistics	O	O	I-T062
was	O	O	O
used	O	O	O
to	O	O	O
estimate	O	O	B-T081
the	O	O	O
occurrence	O	O	B-T081
rates	O	O	I-T081
of	O	O	O
non-BCSD	O	O	B-T033
and	O	O	O
BCSD	O	O	B-T081
with	O	O	O
different	O	O	O
clinicopathological	O	O	B-T169
factors	O	O	I-T169
.	O	O	O

The	O	O	O
Gray	O	O	B-T170
method	O	O	I-T170
was	O	O	O
used	O	O	O
to	O	O	O
measure	O	O	B-T081
the	O	O	O
cumulative	O	O	B-T081
incidence	O	O	I-T081
of	O	O	O
non-BCSD	O	O	B-T033
and	O	O	O
BCSD	O	O	B-T081
.	O	O	O

The	O	O	O
ratio	O	O	B-T081
of	O	O	O
non-BCSDs	O	O	B-T033
to	O	O	O
all	O	O	O
causes	O	O	B-T033
of	O	O	I-T033
death	O	O	I-T033
and	O	O	O
stacked	O	O	B-T082
cumulative	O	O	B-T081
incidence	O	O	I-T081
function	O	O	B-T170
plots	O	O	I-T170
were	O	O	O
used	O	O	O
to	O	O	O
present	O	O	O
the	O	O	O
impact	O	O	B-T080
of	O	O	O
non-BCSD	O	O	B-T033
on	O	O	O
overall	O	O	B-T081
survival	O	O	I-T081
(	O	O	O
OS	O	O	B-T081
)	O	O	O
.	O	O	O

Models	O	O	B-T081
of	O	O	I-T081
Cox	O	O	I-T081
proportional	O	O	I-T081
hazards	O	O	I-T081
regression	O	O	I-T081
and	O	O	O
competing	O	O	B-T170
risk	O	O	I-T170
regression	O	O	I-T170
were	O	O	O
compared	O	O	O
to	O	O	O
highlight	O	O	O
the	O	O	O
suitable	O	O	B-T170
model	O	O	I-T170
.	O	O	O

There	O	O	O
were	O	O	O
12,879	O	O	O
non-BCSDs	O	O	B-T033
(	O	O	O
6.44	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
28,784	O	O	O
BCSDs	O	O	B-T081
(	O	O	O
14.39	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
oldest	O	O	B-T100
age	O	O	I-T100
group	O	O	I-T100
(	O	O	O
>	O	O	O
62	O	O	O
years	O	O	O
)	O	O	O
,	O	O	O
black	O	O	B-T098
race	O	O	I-T098
,	O	O	O
and	O	O	O
a	O	O	O
single	O	O	B-T033
or	O	O	I-T033
divorced	O	O	I-T033
marital	O	O	I-T033
status	O	O	I-T033
were	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
more	O	O	O
non-BCSDs	O	O	B-T033
.	O	O	O

With	O	O	O
adjustments	O	O	O
for	O	O	O
age	O	O	B-T032
,	O	O	O
a	O	O	O
hormone	O	O	B-T191
receptor-positive	O	O	I-T191
(	O	O	I-T191
HoR+	O	O	I-T191
)	O	O	I-T191
status	O	O	I-T191
was	O	O	O
no	O	O	O
longer	O	O	O
related	O	O	O
to	O	O	O
increased	O	O	B-T081
non-BCSD	O	O	B-T033
s.	O	O	O
In	O	O	O
patients	O	O	B-T101
with	O	O	O
grade	O	O	B-T047
1	O	O	I-T047
,	O	O	I-T047
stage	O	O	I-T047
I	O	O	I-T047
disease	O	O	I-T047
and	O	O	O
an	O	O	O
HoR+	O	O	B-T191
status	O	O	I-T191
as	O	O	O
well	O	O	O
as	O	O	O
the	O	O	O
oldest	O	O	O
subgroup	O	O	O
,	O	O	O
a	O	O	O
great	O	O	O
dilution	O	O	O
of	O	O	O
non-BCSD	O	O	O
on	O	O	O
all	O	O	O
causes	O	O	B-T033
of	O	O	I-T033
death	O	O	I-T033
could	O	O	O
be	O	O	O
observed	O	O	O
,	O	O	O
and	O	O	O
this	O	O	O
led	O	O	O
to	O	O	O
incorrect	O	O	B-T033
interpretations	O	O	I-T033
.	O	O	O

The	O	O	O
inaccuracy	O	O	B-T080
,	O	O	O
caused	O	O	O
by	O	O	O
the	O	O	O
commonly	O	O	O
used	O	O	O
Cox	O	O	B-T081
proportional	O	O	I-T081
hazards	O	O	I-T081
model	O	O	I-T081
,	O	O	O
could	O	O	O
be	O	O	O
corrected	O	O	O
by	O	O	O
a	O	O	O
competing	O	O	B-T170
risk	O	O	I-T170
model	O	O	I-T170
.	O	O	O

OS	O	O	B-T081
was	O	O	O
largely	O	O	O
impaired	O	O	B-T169
by	O	O	O
non-BCSD	O	O	B-T033
during	O	O	O
early	O	O	O
breast	O	O	B-T191
cancer	O	O	I-T191
.	O	O	O

For	O	O	O
some	O	O	O
future	O	O	O
clinical	O	O	B-T062
trial	O	O	I-T062
planning	O	O	B-T058
,	O	O	O
especially	O	O	O
for	O	O	O
the	O	O	O
oldest	O	O	B-T100
patients	O	O	B-T101
and	O	O	O
those	O	O	O
with	O	O	O
HoR+	O	O	B-T191
breast	O	O	B-T191
cancer	O	O	I-T191
,	O	O	O
non-BCSD	O	O	B-T033
should	O	O	O
be	O	O	O
considered	O	O	O
a	O	O	O
competing	O	O	B-UnknownType
risk	O	O	I-UnknownType
event	O	O	I-UnknownType
.	O	O	O

Cancer	O	O	O
2017	O	O	O
.	O	O	O

Â©	O	O	O
2017	O	O	O
American	O	O	B-T094
Cancer	O	O	I-T094
Society	O	O	I-T094
.	O	O	O

-DOCSTART- (28268504)

Hip	O	O	B-T023
segmentation	O	O	B-T066
from	O	O	O
MRI	O	O	B-T060
volumes	O	O	O
in	O	O	O
infants	O	O	B-T100
for	O	O	O
DDH	O	O	B-T019
diagnosis	O	O	B-T033
and	O	O	O
treatment	O	O	O
planning	O	O	O

Diagnosis	O	O	B-T033
and	O	O	O
surgical	O	O	B-T058
management	O	O	I-T058
of	O	O	O
Developmental	O	O	B-T019
Dysplasia	O	O	I-T019
of	O	O	I-T019
the	O	O	I-T019
Hip	O	O	I-T019
(	O	O	O
DDH	O	O	B-T019
)	O	O	O
relies	O	O	O
on	O	O	O
physical	O	O	B-T058
examination	O	O	I-T058
and	O	O	O
2D	O	O	O
ultrasound	O	O	B-T060
scanning	O	O	I-T060
.	O	O	O

Magnetic	O	O	B-T060
Resonance	O	O	I-T060
Imaging	O	O	I-T060
(	O	O	O
MRI	O	O	B-T060
)	O	O	O
can	O	O	O
be	O	O	O
used	O	O	O
to	O	O	O
complement	O	O	O
existing	O	O	O
techniques	O	O	B-T169
and	O	O	O
could	O	O	O
be	O	O	O
advantageous	O	O	O
in	O	O	O
treatment	O	O	B-T170
planning	O	O	I-T170
due	O	O	O
to	O	O	O
its	O	O	O
larger	O	O	O
field	O	O	O
of	O	O	O
view	O	O	O
.	O	O	O

In	O	O	O
this	O	O	O
paper	O	O	O
we	O	O	O
propose	O	O	O
a	O	O	O
semi-automatic	O	O	B-T169
method	O	O	B-T170
to	O	O	O
segment	O	O	B-T170
surface	O	O	I-T170
models	O	O	I-T170
of	O	O	O
the	O	O	O
acetabulum	O	O	B-T023
from	O	O	O
MRI	O	O	B-T060
images	O	O	B-T078
.	O	O	O

The	O	O	O
method	O	O	B-T170
incorporates	O	O	O
clinical	O	O	B-T080
knowledge	O	O	B-T170
in	O	O	O
the	O	O	O
form	O	O	O
of	O	O	O
intensity	O	O	B-T170
priors	O	O	I-T170
which	O	O	O
are	O	O	O
integrated	O	O	O
into	O	O	O
a	O	O	O
Random	O	O	B-T170
Walker	O	O	I-T170
(	O	O	I-T170
RW	O	O	I-T170
)	O	O	I-T170
formulation	O	O	I-T170
.	O	O	O

We	O	O	O
use	O	O	O
a	O	O	O
modified	O	O	B-T169
RW	O	O	B-T170
framework	O	O	O
which	O	O	O
compensates	O	O	B-T080
for	O	O	O
incomplete	O	O	B-T080
or	O	O	O
blurred	O	O	B-T080
boundaries	O	O	B-T185
in	O	O	O
the	O	O	O
image	O	O	B-T078
by	O	O	O
using	O	O	O
information	O	O	B-T078
from	O	O	O
neighboring	O	O	B-T082
slices	O	O	I-T082
in	O	O	O
the	O	O	O
sequence	O	O	B-T169
incorporated	O	O	O
as	O	O	O
node	O	O	B-T081
weights	O	O	I-T081
.	O	O	O

We	O	O	O
conducted	O	O	O
a	O	O	O
pilot	O	O	B-T062
study	O	O	I-T062
to	O	O	O
evaluate	O	O	B-T058
the	O	O	O
segmentation	O	O	B-T066
on	O	O	O
a	O	O	O
set	O	O	O
of	O	O	O
10	O	O	O
infant	O	O	B-T100
hip	O	O	B-T023
MRI	O	O	B-T060
sequences	O	O	B-T169
using	O	O	O
a	O	O	O
1.5	O	O	O
Tesla	O	O	O
MR	O	O	B-T074
scanner	O	O	I-T074
.	O	O	O

Contours	O	O	B-T082
obtained	O	O	O
from	O	O	O
the	O	O	O
semi-automated	O	O	B-T169
segmentation	O	O	B-T066
were	O	O	O
compared	O	O	B-T052
against	O	O	O
manually	O	O	B-T033
segmented	O	O	B-T066
hip	O	O	B-T023
contours	O	O	B-T082
using	O	O	O
Dice	O	O	B-T081
Ratio	O	O	I-T081
(	O	O	O
DR	O	O	B-T081
)	O	O	O
,	O	O	O
Hausdorff	O	O	B-T081
Distance	O	O	I-T081
(	O	O	O
HD	O	O	B-T081
)	O	O	O
and	O	O	O
Root	O	O	B-T081
Mean	O	O	I-T081
Square	O	O	I-T081
(	O	O	O
RMS	O	O	B-T081
)	O	O	O
distance	O	O	O
.	O	O	O

The	O	O	O
proposed	O	O	O
method	O	O	B-T170
gave	O	O	O
values	O	O	O
of	O	O	O
(	O	O	O
DR	O	O	B-T081
=	O	O	O
0.84	O	O	O
Â±	O	O	O
0.5	O	O	O
,	O	O	O
HD	O	O	B-T081
=	O	O	O
3.0	O	O	O
Â±	O	O	O
0.7	O	O	O
,	O	O	O
RMS	O	O	B-T081
=	O	O	O
1.9	O	O	O
Â±	O	O	O
0.3	O	O	O
)	O	O	O
and	O	O	O
(	O	O	O
DR	O	O	O
=	O	O	O
0.86	O	O	O
Â±	O	O	O
0.2	O	O	O
,	O	O	O
HD	O	O	O
=	O	O	O
3.0	O	O	O
Â±	O	O	O
0.1	O	O	O
,	O	O	O
RMS	O	O	O
=	O	O	O
2.0	O	O	O
Â±	O	O	O
0.6	O	O	O
)	O	O	O
for	O	O	O
right	O	O	B-T029
and	O	O	O
left	O	O	B-T029
acetabular	O	O	I-T029
contours	O	O	I-T029
respectively	O	O	O
which	O	O	O
was	O	O	O
higher	O	O	B-T080
than	O	O	O
the	O	O	O
corresponding	O	O	O
values	O	O	O
obtained	O	O	O
from	O	O	O
conventional	O	O	B-T080
RW	O	O	B-T170
segmentation	O	O	B-T066
.	O	O	O

The	O	O	O
execution	O	O	B-T052
time	O	O	B-T079
of	O	O	O
the	O	O	O
segmentation	O	O	B-T066
algorithm	O	O	B-T170
was	O	O	O
less	O	O	O
than	O	O	O
~4	O	O	O
seconds	O	O	B-T079
on	O	O	O
a	O	O	O
3.5	O	O	O
GHz	O	O	O
CPU	O	O	B-T073
.	O	O	O

-DOCSTART- (28268917)

Automated	O	O	O
basal	O	O	B-T191
cell	O	O	I-T191
carcinoma	O	O	I-T191
detection	O	O	O
in	O	O	O
high-definition	O	O	O
optical	O	O	O
coherence	O	O	O
tomography	O	O	O

Basal	O	O	B-T191
cell	O	O	I-T191
carcinoma	O	O	I-T191
(	O	O	O
BCC	O	O	B-T191
)	O	O	O
is	O	O	O
the	O	O	O
most	O	O	O
common	O	O	O
non-melanoma	O	O	B-T191
skin	O	O	I-T191
cancer	O	O	I-T191
.	O	O	O

Conventional	O	O	O
diagnosis	O	O	O
of	O	O	O
BCC	O	O	B-T191
requires	O	O	O
invasive	O	O	B-T080
biopsies	O	O	B-T060
.	O	O	O

Recently	O	O	O
,	O	O	O
a	O	O	O
high-definition	O	O	B-T060
optical	O	O	I-T060
coherence	O	O	I-T060
tomography	O	O	I-T060
(	O	O	O
HD-OCT	O	O	B-T060
)	O	O	O
technique	O	O	O
has	O	O	O
been	O	O	O
developed	O	O	O
,	O	O	O
which	O	O	O
provides	O	O	O
a	O	O	O
non-invasive	O	O	B-T169
in	O	O	B-T059
vivo	O	O	I-T059
imaging	O	O	I-T059
method	O	O	I-T059
of	O	O	O
skin	O	O	B-T022
.	O	O	O

Good	O	O	O
agreements	O	O	O
of	O	O	O
BCC	O	O	B-T191
features	O	O	O
between	O	O	O
HD-OCT	O	O	B-T060
images	O	O	B-T078
and	O	O	O
histopathological	O	O	B-T169
architecture	O	O	I-T169
have	O	O	O
been	O	O	O
found	O	O	O
.	O	O	O

Therefore	O	O	O
it	O	O	O
is	O	O	O
possible	O	O	O
to	O	O	O
automatically	O	O	O
detect	O	O	O
BCC	O	O	B-T191
using	O	O	O
HD-OCT	O	O	B-T060
.	O	O	O

This	O	O	O
paper	O	O	O
presents	O	O	O
a	O	O	O
novel	O	O	O
BCC	O	O	B-T191
detection	O	O	B-T060
method	O	O	I-T060
that	O	O	O
consists	O	O	O
of	O	O	O
four	O	O	O
steps	O	O	O
:	O	O	O
graph	O	O	O
based	O	O	O
skin	O	O	B-T029
surface	O	O	I-T029
segmentation	O	O	B-T058
,	O	O	O
surface	O	O	B-T169
flattening	O	O	I-T169
,	O	O	O
deep	O	O	O
feature	O	O	O
extraction	O	O	O
and	O	O	O
the	O	O	O
BCC	O	O	O
classification	O	O	O
.	O	O	O

The	O	O	O
effectiveness	O	O	B-T080
of	O	O	O
the	O	O	O
proposed	O	O	O
method	O	O	O
is	O	O	O
well	O	O	O
demonstrated	O	O	O
on	O	O	O
a	O	O	O
dataset	O	O	O
of	O	O	O
5,040	O	O	O
images	O	O	O
.	O	O	O

It	O	O	O
can	O	O	O
therefore	O	O	O
serve	O	O	O
as	O	O	O
an	O	O	O
automatic	O	O	O
tool	O	O	O
for	O	O	O
screening	O	O	O
BCC	O	O	B-T191
.	O	O	O

-DOCSTART- (28269352)

Fall	O	O	B-T033
risk	O	O	B-T033
factors	O	O	I-T033
analysis	O	O	B-T062
based	O	O	O
on	O	O	O
sample	O	O	B-T067
entropy	O	O	I-T067
of	O	O	O
plantar	O	O	B-T029
kinematic	O	O	B-T070
signal	O	O	B-T067
during	O	O	O
stance	O	O	O
phase	O	O	O

Falls	O	O	B-T033
are	O	O	O
a	O	O	O
multi-causal	O	O	B-T067
phenomenon	O	O	I-T067
with	O	O	O
a	O	O	O
complex	O	O	B-T080
interaction	O	O	B-T169
.	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
our	O	O	O
research	O	O	B-T062
is	O	O	O
to	O	O	O
study	O	O	B-T062
the	O	O	O
effect	O	O	B-T080
of	O	O	O
multiple	O	O	B-T081
variables	O	O	B-T080
for	O	O	O
potential	O	O	B-T080
risk	O	O	B-T033
of	O	O	I-T033
falls	O	O	I-T033
and	O	O	O
construct	O	O	B-T185
an	O	O	O
elderly	O	O	B-T170
fall	O	O	I-T170
risk	O	O	I-T170
assessment	O	O	I-T170
model	O	O	I-T170
based	O	O	O
on	O	O	O
demographics	O	O	B-T090
data	O	O	B-T078
and	O	O	O
gait	O	O	B-T033
characteristics	O	O	I-T033
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
101	O	O	O
subjects	O	O	B-T098
,	O	O	O
whom	O	O	O
belong	O	O	O
to	O	O	O
Malianwa	O	O	B-T073
Street	O	O	I-T073
,	O	O	O
aged	O	O	B-T032
above	O	O	O
50	O	O	O
years	O	O	B-T079
old	O	O	I-T079
and	O	O	O
participated	O	O	B-T169
in	O	O	O
questionnaire	O	O	B-T170
survey	O	O	B-T170
.	O	O	O

Participants	O	O	B-T098
were	O	O	O
classified	O	O	O
into	O	O	O
three	O	O	O
groups	O	O	B-T078
(	O	O	O
high	O	O	B-T098
,	O	O	O
medium	O	O	B-T098
and	O	O	O
low	O	O	B-T081
risk	O	O	I-T081
group	O	O	B-T078
)	O	O	O
according	O	O	O
to	O	O	O
the	O	O	O
score	O	O	B-T081
of	O	O	O
elderly	O	O	B-T170
fall	O	O	I-T170
risk	O	O	I-T170
assessment	O	O	I-T170
scale	O	O	I-T170
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
the	O	O	O
data	O	O	B-T078
of	O	O	O
ground	O	O	B-T070
reaction	O	O	I-T070
force	O	O	I-T070
(	O	O	O
GRF	O	O	B-T070
)	O	O	O
and	O	O	O
ground	O	O	B-T070
reaction	O	O	I-T070
moment	O	O	I-T070
(	O	O	O
GRM	O	O	B-T070
)	O	O	O
was	O	O	O
record	O	O	B-T080
when	O	O	O
they	O	O	O
performed	O	O	B-T169
walking	O	O	B-T056
at	O	O	O
comfortable	O	O	B-T033
state	O	O	I-T033
.	O	O	O

The	O	O	O
demographic	O	O	B-T102
variables	O	O	B-T080
,	O	O	O
sample	O	O	B-T067
entropy	O	O	I-T067
of	O	O	O
GRF	O	O	B-T070
and	O	O	O
GRM	O	O	B-T070
,	O	O	O
and	O	O	O
impulse	O	O	B-T081
difference	O	O	I-T081
of	O	O	O
bilateral	O	O	B-T023
foot	O	O	I-T023
were	O	O	O
considered	O	O	O
as	O	O	O
potential	O	O	B-T080
explanatory	O	O	B-T170
variables	O	O	O
of	O	O	O
risk	O	O	B-T058
assessment	O	O	I-T058
model	O	O	B-T170
.	O	O	O

Firstly	O	O	O
,	O	O	O
we	O	O	O
investigated	O	O	B-T169
whether	O	O	O
different	O	O	O
groups	O	O	B-T078
could	O	O	O
present	O	O	O
difference	O	O	B-T081
in	O	O	O
every	O	O	O
variable	O	O	B-T080
.	O	O	O

Statistical	O	O	B-T081
differences	O	O	I-T081
were	O	O	O
found	O	O	B-T033
for	O	O	O
the	O	O	O
following	O	O	O
variables	O	O	B-T080
:	O	O	O
age	O	O	B-T032
(	O	O	O
p=2.28e-05	O	O	O
)	O	O	O
;	O	O	O
impulse	O	O	B-T081
difference	O	O	I-T081
(	O	O	O
p=0.02036	O	O	O
)	O	O	O
;	O	O	O
sample	O	O	B-T067
entropy	O	O	I-T067
of	O	O	O
GRF	O	O	B-T070
in	O	O	O
vertical	O	O	B-T082
direction	O	O	B-T082
(	O	O	O
p=0.0144	O	O	O
)	O	O	O
;	O	O	O
sample	O	O	O
entropy	O	O	O
of	O	O	O
GRM	O	O	B-T070
in	O	O	O
anterior-posterior	O	O	B-T082
direction	O	O	O
(	O	O	O
p=0.0387	O	O	O
)	O	O	O
.	O	O	O

Finally	O	O	O
,	O	O	O
the	O	O	O
multiple	O	O	B-T081
regression	O	O	B-T170
analysis	O	O	I-T170
results	O	O	B-T169
indicated	O	O	B-T033
that	O	O	O
age	O	O	B-T032
,	O	O	O
impulse	O	O	B-T081
difference	O	O	I-T081
and	O	O	O
sample	O	O	B-T067
entropy	O	O	I-T067
of	O	O	O
resultant	O	O	O
GRM	O	O	B-T070
could	O	O	O
identify	O	O	O
individuals	O	O	B-T098
who	O	O	O
had	O	O	O
different	O	O	O
levels	O	O	B-T058
of	O	O	I-T058
fall	O	O	I-T058
risk	O	O	I-T058
.	O	O	O

Therefore	O	O	O
,	O	O	O
those	O	O	O
results	O	O	B-T169
could	O	O	O
potentially	O	O	B-T080
be	O	O	O
useful	O	O	B-T080
in	O	O	O
the	O	O	O
fall	O	O	B-T058
risk	O	O	I-T058
assessment	O	O	I-T058
and	O	O	O
monitor	O	O	B-T058
the	O	O	O
state	O	O	B-T169
of	O	O	O
physical	O	O	B-T033
function	O	O	I-T033
in	O	O	O
elderly	O	O	B-T098
population	O	O	I-T098
.	O	O	O

-DOCSTART- (28269453)

Endurance	O	O	B-T033
based	O	O	O
personalized	O	O	O
fitness	O	O	O
planner	O	O	O

Endurance	O	O	B-T033
is	O	O	O
an	O	O	O
important	O	O	B-T080
factor	O	O	B-T169
of	O	O	O
cardiovascular	O	O	B-T040
fitness	O	O	I-T040
indicating	O	O	O
the	O	O	O
capacity	O	O	B-T081
of	O	O	O
an	O	O	O
individual	O	O	B-T098
to	O	O	O
perform	O	O	B-T169
exercise	O	O	B-T056
for	O	O	O
a	O	O	O
longer	O	O	B-T079
duration	O	O	I-T079
with	O	O	O
increased	O	O	B-T081
intensity	O	O	B-T080
.	O	O	O

Various	O	O	O
subject	O	O	B-T080
specific	O	O	I-T080
and	O	O	O
exercise	O	O	B-T056
related	O	O	O
parameters	O	O	B-T077
affect	O	O	O
endurance	O	O	B-T033
of	O	O	O
an	O	O	O
individual	O	O	B-T098
.	O	O	O

In	O	O	O
this	O	O	O
work	O	O	O
,	O	O	O
we	O	O	O
propose	O	O	O
a	O	O	O
statistical	O	O	B-T062
technique	O	O	I-T062
to	O	O	O
model	O	O	B-T170
endurance	O	O	B-T033
as	O	O	O
a	O	O	O
function	O	O	O
of	O	O	O
these	O	O	O
factors	O	O	B-T169
incorporating	O	O	O
the	O	O	O
serial	O	O	O
dependence	O	O	O
of	O	O	O
observations	O	O	B-T062
generated	O	O	O
by	O	O	O
individuals	O	O	B-T098
over	O	O	B-T079
time	O	O	I-T079
.	O	O	O

The	O	O	O
proposed	O	O	B-T080
model	O	O	B-T170
provides	O	O	O
a	O	O	O
device	O	O	B-T074
to	O	O	O
predict	O	O	O
future	O	O	O
endurance	O	O	B-T033
of	O	O	O
a	O	O	O
test	O	O	O
subject	O	O	B-T096
following	O	O	O
particular	O	O	O
exercise	O	O	B-T061
regime	O	O	I-T061
.	O	O	O

This	O	O	O
facilitates	O	O	O
a	O	O	O
test	O	O	B-T078
user	O	O	I-T078
with	O	O	O
a	O	O	O
fitness	O	O	B-T056
planner	O	O	I-T170
with	O	O	O
the	O	O	O
provision	O	O	O
to	O	O	O
fix	O	O	O
exercise	O	O	B-T061
regimes	O	O	I-T061
to	O	O	O
reach	O	O	O
a	O	O	O
set	O	O	O
fitness	O	O	O
goal	O	O	B-T170
.	O	O	O

-DOCSTART- (28269712)

Heart	O	O	B-T201
rate	O	O	I-T201
variability	O	O	B-T077
as	O	O	O
a	O	O	O
biomarker	O	O	B-T201
for	O	O	O
sedation	O	O	B-T033
depth	O	O	I-T033
estimation	O	O	B-T081
in	O	O	O
ICU	O	O	B-T093
patients	O	O	O

An	O	O	O
automated	O	O	B-T170
patient-specific	O	O	I-T170
system	O	O	I-T170
to	O	O	O
classify	O	O	O
the	O	O	O
level	O	O	B-T033
of	O	O	I-T033
sedation	O	O	I-T033
in	O	O	O
ICU	O	O	B-T093
patients	O	O	B-T101
using	O	O	O
heart	O	O	B-T201
rate	O	O	I-T201
variability	O	O	B-T077
signal	O	O	B-T067
is	O	O	O
presented	O	O	B-T078
in	O	O	O
this	O	O	O
paper	O	O	B-T170
.	O	O	O

ECG	O	O	B-T033
from	O	O	O
70	O	O	O
mechanically	O	O	B-T061
ventilated	O	O	I-T061
adult	O	O	B-T100
patients	O	O	B-T101
with	O	O	O
administered	O	O	B-T169
sedatives	O	O	B-T121
in	O	O	O
an	O	O	O
ICU	O	O	B-T093
setting	O	O	I-T093
were	O	O	O
used	O	O	O
to	O	O	O
develop	O	O	O
a	O	O	O
support	O	O	B-T081
vector	O	O	I-T081
machine	O	O	I-T081
based	O	O	O
system	O	O	O
for	O	O	O
sedation	O	O	B-T033
depth	O	O	I-T033
monitoring	O	O	B-T058
using	O	O	O
several	O	O	O
heart	O	O	B-T201
rate	O	O	I-T201
variability	O	O	B-T077
measures	O	O	B-T081
.	O	O	O

A	O	O	O
leave-one-subject-out	O	O	B-T062
cross	O	O	I-T062
validation	O	O	I-T062
was	O	O	O
used	O	O	O
for	O	O	O
classifier	O	O	B-T169
training	O	O	B-T065
and	O	O	O
performance	O	O	B-T052
evaluations	O	O	B-T058
.	O	O	O

The	O	O	O
proposed	O	O	O
patient-specific	O	O	B-T170
system	O	O	I-T170
provided	O	O	B-T052
a	O	O	O
sensitivity	O	O	B-T081
,	O	O	O
specificity	O	O	B-T081
and	O	O	O
an	O	O	O
AUC	O	O	B-T081
of	O	O	O
64	O	O	O
%	O	O	O
,	O	O	O
84.8	O	O	O
%	O	O	O
and	O	O	O
0.72	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

It	O	O	O
is	O	O	O
hoped	O	O	O
that	O	O	O
with	O	O	O
the	O	O	O
help	O	O	O
of	O	O	O
additional	O	O	O
physiological	O	O	B-T169
signals	O	O	B-T067
the	O	O	O
proposed	O	O	O
patient	O	O	B-T101
-	O	O	O
specific	O	O	B-T080
sedation	O	O	B-T033
level	O	O	I-T033
prediction	O	O	B-T078
system	O	O	B-T169
could	O	O	O
lead	O	O	O
to	O	O	O
a	O	O	O
fully	O	O	O
automated	O	O	B-T170
multimodal	O	O	I-T170
system	O	O	I-T170
to	O	O	O
assist	O	O	O
clinical	O	O	B-T080
staff	O	O	B-T097
in	O	O	O
ICUs	O	O	B-T093
to	O	O	O
interpret	O	O	B-T169
the	O	O	O
sedation	O	O	O
level	O	O	O
of	O	O	O
the	O	O	O
patient	O	O	O
.	O	O	O

-DOCSTART- (28270369)

RELIABILITY	O	O	B-T080
AND	O	O	I-T080
VALIDITY	O	O	I-T080
OF	O	O	O
THE	O	O	O
DIABETES	O	O	B-T058
EATING	O	O	I-T058
PROBLEM	O	O	I-T058
SURVEY-REVISED	O	O	I-T058
ON	O	O	O
TURKISH	O	O	B-T098
CHILDREN	O	O	B-T100
AND	O	O	O
ADOLESCENTS	O	O	B-T100
WITH	O	O	O
TYPE	O	O	O
1	O	O	O
DIABETES	O	O	O
MELLITUS	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
examine	O	O	B-T169
the	O	O	O
reliability	O	O	B-T080
and	O	O	I-T080
validity	O	O	I-T080
of	O	O	O
Turkish	O	O	B-T098
version	O	O	B-T170
of	O	O	O
Diabetes	O	O	B-T058
Eating	O	O	I-T058
Problem	O	O	I-T058
Survey-Revised	O	O	I-T058
(	O	O	O
DEPS-R	O	O	B-T058
)	O	O	O
for	O	O	O
children	O	O	B-T100
and	O	O	O
adolescent	O	O	B-T100
with	O	O	O
Type	O	O	B-T047
1	O	O	I-T047
Diabetes	O	O	I-T047
Mellitus	O	O	I-T047
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
200	O	O	O
children	O	O	B-T100
and	O	O	O
adolescents	O	O	B-T100
with	O	O	O
type	O	O	B-T047
1	O	O	I-T047
diabetes	O	O	I-T047
,	O	O	O
ages	O	O	B-T032
9	O	O	O
-	O	O	O
18	O	O	O
years	O	O	B-T079
,	O	O	O
completed	O	O	O
the	O	O	O
DEPS-R	O	O	B-T058
Turkish	O	O	B-T098
version	O	O	B-T170
.	O	O	O

In	O	O	O
addition	O	O	O
to	O	O	O
tests	O	O	B-T169
of	O	O	O
validity	O	O	B-T081
,	O	O	O
confirmatory	O	O	B-T080
factor	O	O	I-T080
analysis	O	O	I-T080
was	O	O	O
conducted	O	O	O
to	O	O	O
investigate	O	O	B-T169
the	O	O	O
factor	O	O	B-T081
structure	O	O	I-T081
of	O	O	O
the	O	O	O
16-item	O	O	O
Turkish	O	O	B-T098
version	O	O	B-T170
of	O	O	O
DEPS-R.	O	O	O
The	O	O	O
Turkish	O	O	O
version	O	O	O
of	O	O	O
DEPS-R	O	O	B-T058
demonstrated	O	O	O
satisfactory	O	O	B-T080
Cronbach	O	O	B-T081
's	O	O	I-T081
â	O	O	O
(	O	O	O
0.847	O	O	O
)	O	O	O
and	O	O	O
was	O	O	O
significantly	O	O	O
correlated	O	O	B-T080
with	O	O	O
ag	O	O	B-T032
e	O	O	O
(	O	O	O
r=0.194	O	O	O
;	O	O	O
p<0.01	O	O	O
)	O	O	O
,	O	O	O
hemoglobin	O	O	B-T034
A1c	O	O	I-T034
levels	O	O	I-T034
(	O	O	O
r=0.303	O	O	O
;	O	O	O
p<0.01	O	O	O
)	O	O	O
and	O	O	O
BMI	O	O	B-T201
-	O	O	O
SDS	O	O	B-T081
(	O	O	O
r=0.412	O	O	O
;	O	O	O
p<0.01	O	O	O
)	O	O	O
indicating	O	O	O
criterion	O	O	B-T081
validity	O	O	I-T081
.	O	O	O

Median	O	O	O
DEPS-R	O	O	B-T058
scores	O	O	B-T081
of	O	O	O
Turkish	O	O	B-T098
version	O	O	B-T170
for	O	O	O
the	O	O	O
total	O	O	O
samples	O	O	B-T098
,	O	O	O
females	O	O	B-T032
and	O	O	O
males	O	O	B-T032
were	O	O	O
as	O	O	O
follows	O	O	O
:	O	O	O
11.0	O	O	O
,	O	O	O
11.5	O	O	O
and	O	O	O
10.5	O	O	O
respectively	O	O	O
.	O	O	O

Disturbed	O	O	B-T048
eating	O	O	I-T048
behaviors	O	O	I-T048
and	O	O	O
insulin	O	O	B-T116
restriction	O	O	B-T169
were	O	O	O
associated	O	O	O
with	O	O	O
poor	O	O	O
metabolic	O	O	B-T044
control	O	O	I-T044
.	O	O	O

A	O	O	O
short	O	O	O
,	O	O	O
self-administered	O	O	B-T169
diabetes	O	O	B-T047
specific	O	O	O
screening	O	O	B-T058
tool	O	O	O
for	O	O	O
disordered	O	O	B-T048
eating	O	O	I-T048
behavior	O	O	I-T048
can	O	O	O
be	O	O	O
used	O	O	O
routinely	O	O	O
in	O	O	O
the	O	O	O
clinical	O	O	B-T080
care	O	O	B-T058
of	O	O	O
adolescents	O	O	B-T100
with	O	O	O
type	O	O	B-T047
1	O	O	I-T047
diabetes	O	O	I-T047
.	O	O	O

The	O	O	O
Turkish	O	O	B-T098
version	O	O	B-T170
of	O	O	O
DEPS-R	O	O	B-T058
is	O	O	O
a	O	O	O
valid	O	O	O
screening	O	O	B-T058
tool	O	O	O
for	O	O	O
disordered	O	O	B-T048
eating	O	O	I-T048
behaviors	O	O	I-T048
in	O	O	O
type	O	O	B-T047
1	O	O	I-T047
diabetes	O	O	I-T047
and	O	O	O
it	O	O	O
is	O	O	O
potentially	O	O	O
important	O	O	O
to	O	O	O
early	O	O	O
detect	O	O	O
disordered	O	O	O
eating	O	O	O
behaviors	O	O	O
.	O	O	O

-DOCSTART- (28271342)

A	O	O	O
comparison	O	O	B-T052
of	O	O	O
the	O	O	O
localization	O	O	B-T169
of	O	O	O
rectal	O	O	B-T191
carcinomas	O	O	I-T191
according	O	O	O
to	O	O	O
the	O	O	O
general	O	O	B-T082
rules	O	O	B-T170
of	O	O	O
the	O	O	O
Japanese	O	O	B-T185
classification	O	O	I-T185
of	O	O	I-T185
colorectal	O	O	I-T185
carcinoma	O	O	I-T185
(	O	O	O
JCCRC	O	O	B-T185
)	O	O	O
and	O	O	O
Western	O	O	B-T082
guidelines	O	O	O

The	O	O	O
aim	O	O	B-T078
of	O	O	O
this	O	O	O
study	O	O	O
was	O	O	O
to	O	O	O
compare	O	O	B-T052
the	O	O	O
localization	O	O	B-T169
of	O	O	O
rectal	O	O	B-T191
cancers	O	O	I-T191
as	O	O	O
classified	O	O	B-T185
according	O	O	O
to	O	O	O
the	O	O	O
general	O	O	B-T082
rules	O	O	B-T170
of	O	O	O
the	O	O	O
Japanese	O	O	B-T185
classification	O	O	I-T185
of	O	O	I-T185
colorectal	O	O	I-T185
carcinoma	O	O	I-T185
(	O	O	O
JCCRC	O	O	B-T185
)	O	O	O
and	O	O	O
also	O	O	O
according	O	O	O
to	O	O	O
the	O	O	O
European	O	O	B-T093
Society	O	O	I-T093
for	O	O	I-T093
Medical	O	O	I-T093
Oncology	O	O	I-T093
(	O	O	O
ESMO	O	O	B-T093
)	O	O	O
and	O	O	O
the	O	O	O
National	O	O	B-T093
Comprehensive	O	O	I-T093
Cancer	O	O	I-T093
Network	O	O	I-T093
(	O	O	O
NCCN	O	O	B-T093
)	O	O	O
guidelines	O	O	B-T170
,	O	O	O
which	O	O	O
are	O	O	O
based	O	O	O
on	O	O	O
rigid	O	O	B-T060
endoscopic	O	O	I-T060
measurements	O	O	B-T169
.	O	O	O

The	O	O	O
medical	O	O	B-T170
records	O	O	I-T170
of	O	O	O
patients	O	O	B-T101
scheduled	O	O	B-T080
to	O	O	O
receive	O	O	B-T080
curative	O	O	B-T061
surgery	O	O	I-T061
for	O	O	O
histologically	O	O	B-T169
proven	O	O	O
rectal	O	O	B-T191
adenocarcinoma	O	O	I-T191
during	O	O	B-T079
2009	O	O	O
-	O	O	O
2015	O	O	O
were	O	O	O
investigated	O	O	B-T169
(	O	O	O
n	O	O	O
=	O	O	O
230	O	O	O
)	O	O	O
.	O	O	O

Rigid	O	O	B-T060
proctoscopy	O	O	I-T060
was	O	O	O
performed	O	O	B-T169
in	O	O	O
patients	O	O	B-T101
with	O	O	O
rectal	O	O	B-T191
cancer	O	O	I-T191
located	O	O	B-T082
in	O	O	I-T082
the	O	O	O
upper	O	O	B-T082
(	O	O	O
Ra	O	O	B-T082
)	O	O	O
or	O	O	O
lower	O	O	B-T082
(	O	O	O
Rb	O	O	B-T082
)	O	O	O
division	O	O	B-T061
using	O	O	O
double-contrast	O	O	B-T060
barium	O	O	I-T060
enema	O	O	I-T060
.	O	O	O

The	O	O	O
median	O	O	B-T081
values	O	O	O
of	O	O	O
height	O	O	B-T032
from	O	O	O
the	O	O	O
anal	O	O	B-T023
verge	O	O	I-T023
were	O	O	O
7.5	O	O	O
cm	O	O	O
(	O	O	O
range	O	O	B-T081
2	O	O	O
-	O	O	O
12	O	O	O
)	O	O	O
and	O	O	O
3	O	O	O
cm	O	O	O
(	O	O	O
0	O	O	O
-	O	O	O
9.5	O	O	O
)	O	O	O
on	O	O	O
rigid	O	O	B-T060
proctoscopy	O	O	I-T060
for	O	O	O
cancers	O	O	B-T191
assigned	O	O	B-T169
as	O	O	O
Ra	O	O	B-T082
and	O	O	O
Rb	O	O	B-T082
,	O	O	O
respectively	O	O	O
.	O	O	O

All	O	O	O
159	O	O	O
cancers	O	O	B-T191
at	O	O	O
Ra	O	O	B-T082
or	O	O	O
Rb	O	O	B-T082
were	O	O	O
located	O	O	B-T082
within	O	O	B-T082
12	O	O	O
cm	O	O	O
from	O	O	O
the	O	O	O
anal	O	O	B-T023
verge	O	O	I-T023
by	O	O	O
rigid	O	O	B-T060
proctoscopy	O	O	I-T060
,	O	O	O
while	O	O	O
only	O	O	O
79.7	O	O	O
%	O	O	O
of	O	O	O
Ra	O	O	O
or	O	O	O
82.1	O	O	O
%	O	O	O
of	O	O	O
Rb	O	O	O
cancers	O	O	O
were	O	O	O
located	O	O	B-T082
in	O	O	I-T082
the	O	O	O
mid	O	O	B-T082
(	O	O	O
5.1	O	O	O
-	O	O	O
10	O	O	O
cm	O	O	O
)	O	O	O
or	O	O	O
low	O	O	B-T080
(	O	O	O
â¤5	O	O	O
cm	O	O	O
)	O	O	O
rectum	O	O	B-T023
,	O	O	O
respectively	O	O	O
.	O	O	O

Ra	O	O	B-T082
and	O	O	O
Rb	O	O	B-T082
cancers	O	O	B-T191
are	O	O	O
deemed	O	O	O
to	O	O	O
be	O	O	O
rectal	O	O	B-T191
cancers	O	O	I-T191
according	O	O	O
to	O	O	O
NCCN	O	O	B-T093
guidelines	O	O	B-T170
,	O	O	O
but	O	O	O
these	O	O	O
classifications	O	O	B-T185
are	O	O	O
not	O	O	O
interchangeable	O	O	O
with	O	O	O
mid-	O	O	B-T082
and	O	O	O
low	O	O	B-T080
-	O	O	O
rectal	O	O	O
cancers	O	O	O
,	O	O	O
respectively	O	O	O
,	O	O	O
according	O	O	O
to	O	O	O
the	O	O	O
ESMO	O	O	B-T093
guidelines	O	O	O
.	O	O	O

-DOCSTART- (28271600)

Natural	O	O	B-T061
orifice	O	O	I-T061
transluminal	O	O	I-T061
endoscopic	O	O	I-T061
surgery	O	O	I-T061
with	O	O	O
a	O	O	O
snake-mechanism	O	O	B-T169
using	O	O	O
a	O	O	O
movable	O	O	O
pulley	O	O	O

Natural	O	O	B-T061
orifice	O	O	I-T061
transluminal	O	O	I-T061
endoscopic	O	O	I-T061
surgery	O	O	I-T061
is	O	O	O
an	O	O	O
emerging	O	O	O
technique	O	O	B-T169
.	O	O	O

We	O	O	O
aimed	O	O	O
to	O	O	O
develop	O	O	B-T169
an	O	O	O
advanced	O	O	B-T080
surgical	O	O	B-T074
robot	O	O	I-T074
mechanism	O	O	B-T169
for	O	O	O
natural	O	O	B-T061
orifice	O	O	I-T061
surgery	O	O	I-T061
.	O	O	O

We	O	O	O
propose	O	O	O
the	O	O	O
active-controlled	O	O	B-T075
overtube-type	O	O	I-T075
platform	O	O	I-T075
with	O	O	O
multiple	O	O	O
channels	O	O	B-T082
for	O	O	O
an	O	O	O
endoscopic	O	O	B-T074
camera	O	O	I-T074
and	O	O	O
surgical	O	O	B-T061
tools	O	O	B-T073
.	O	O	O

To	O	O	O
make	O	O	O
such	O	O	O
a	O	O	O
platform	O	O	B-T075
,	O	O	O
we	O	O	O
suggest	O	O	B-T078
an	O	O	O
advanced	O	O	B-T080
snake	O	O	B-T169
mechanism	O	O	I-T169
comprising	O	O	O
movable	O	O	B-T074
pulleys	O	O	I-T074
to	O	O	O
make	O	O	O
a	O	O	O
snake	O	O	O
mechanism	O	O	O
with	O	O	O
multiple	O	O	O
degrees	O	O	B-T169
of	O	O	I-T169
freedom	O	O	I-T169
and	O	O	O
high	O	O	O
operating	O	O	O
force	O	O	O
.	O	O	O

The	O	O	O
stiffness	O	O	B-T080
and	O	O	O
maneuverability	O	O	B-T080
of	O	O	O
the	O	O	O
active-controlled	O	O	B-T075
platform	O	O	I-T075
appeared	O	O	O
satisfactory	O	O	B-T080
.	O	O	O

Using	O	O	O
prototypes	O	O	B-T170
and	O	O	O
ex	O	O	B-T169
vivo	O	O	I-T169
experiments	O	O	B-T062
,	O	O	O
we	O	O	O
confirmed	O	O	O
that	O	O	O
the	O	O	O
mechanism	O	O	B-T169
was	O	O	O
suitable	O	O	O
for	O	O	O
a	O	O	O
snake-like	O	O	B-T073
robotic	O	O	I-T073
platform	O	O	B-T075
for	O	O	O
natural	O	O	B-T061
orifice	O	O	I-T061
surgery	O	O	I-T061
.	O	O	O

The	O	O	O
suggested	O	O	B-T078
snake	O	O	B-T169
mechanism	O	O	I-T169
using	O	O	O
movable	O	O	B-T074
pulleys	O	O	I-T074
has	O	O	O
the	O	O	O
advantages	O	O	O
of	O	O	O
stiffness	O	O	B-T080
and	O	O	O
maneuverability	O	O	B-T080
.	O	O	O

This	O	O	O
new	O	O	O
mechanism	O	O	B-T169
can	O	O	O
be	O	O	O
an	O	O	O
alternative	O	O	B-T077
platform	O	O	B-T075
for	O	O	O
natural	O	O	B-T061
orifice	O	O	I-T061
surgery	O	O	I-T061
.	O	O	O

-DOCSTART- (28272254)

Real	O	O	O
role	O	O	O
of	O	O	O
Î²-blockers	O	O	B-T121
in	O	O	O
regression	O	O	B-T046
of	O	O	O
left	O	O	B-T033
ventricular	O	O	I-T033
mass	O	O	I-T033
in	O	O	O
hypertension	O	O	B-T047
patients	O	O	B-T101
:	O	O	O
Bayesian	O	O	B-T081
network	O	O	I-T081
meta-analysis	O	O	O

Left	O	O	B-T047
ventricular	O	O	I-T047
hypertrophy	O	O	I-T047
(	O	O	O
LVH	O	O	B-T047
)	O	O	O
is	O	O	O
commonly	O	O	O
present	O	O	O
in	O	O	O
patients	O	O	B-T101
with	O	O	O
hypertension	O	O	B-T047
(	O	O	O
HT	O	O	B-T047
)	O	O	O
.	O	O	O

According	O	O	O
to	O	O	O
the	O	O	O
expert	O	O	B-T170
consensus	O	O	I-T170
document	O	O	I-T170
from	O	O	O
American	O	O	B-T098
,	O	O	O
angiotensin-converting	O	O	B-T121
enzyme	O	O	I-T121
inhibitor	O	O	I-T121
(	O	O	O
ACEI	O	O	B-T121
)	O	O	O
and	O	O	O
angiotensin	O	O	B-T121
receptor	O	O	I-T121
blockers	O	O	I-T121
(	O	O	O
ARBs	O	O	B-T121
)	O	O	O
were	O	O	O
recommended	O	O	O
as	O	O	O
1st-line	O	O	O
therapeutic	O	O	B-T121
drugs	O	O	I-T121
.	O	O	O

However	O	O	O
,	O	O	O
none	O	O	O
noticed	O	O	O
the	O	O	O
different	O	O	O
efficacy	O	O	B-T080
between	O	O	O
fat-soluble	O	O	B-T121
and	O	O	I-T121
selective	O	O	I-T121
Î²1-receptor	O	O	I-T121
blockers	O	O	I-T121
(	O	O	O
FS-Î²-B	O	O	B-T121
)	O	O	O
and	O	O	O
other	O	O	O
Î²-blockers	O	O	B-T121
on	O	O	O
regression	O	O	B-T046
of	O	O	O
LVH	O	O	B-T047
before	O	O	O
.	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
this	O	O	O
analysis	O	O	B-T062
was	O	O	O
to	O	O	O
compare	O	O	B-T052
the	O	O	O
efficacy	O	O	B-T080
of	O	O	O
FS-Î²-B	O	O	B-T121
with	O	O	O
the	O	O	O
other	O	O	O
4	O	O	O
different	O	O	O
classes	O	O	O
of	O	O	O
antihypertensive	O	O	B-T121
drugs	O	O	I-T121
(	O	O	O
ACEI	O	O	B-T121
,	O	O	O
ARBs	O	O	B-T121
,	O	O	O
calcium	O	O	B-T121
channel	O	O	I-T121
blockers	O	O	I-T121
[	O	O	O
CCBs	O	O	B-T121
]	O	O	O
,	O	O	O
and	O	O	O
diuretics	O	O	B-T121
)	O	O	O
on	O	O	O
regression	O	O	B-T046
of	O	O	O
LVH	O	O	B-T047
.	O	O	O

Relative	O	O	B-T080
trials	O	O	B-T062
were	O	O	O
identified	O	O	O
in	O	O	O
the	O	O	O
PubMed	O	O	B-T170
,	O	O	O
Web	O	O	B-T170
of	O	O	I-T170
Science	O	O	I-T170
,	O	O	O
OVID	O	O	B-T170
EBM	O	O	I-T170
Reviews	O	O	I-T170
and	O	O	O
Cochrane	O	O	B-T170
databases	O	O	I-T170
,	O	O	O
and	O	O	O
the	O	O	O
relevant	O	O	O
papers	O	O	B-T170
were	O	O	O
examined	O	O	B-T169
.	O	O	O

We	O	O	O
performed	O	O	O
both	O	O	O
traditional	O	O	O
and	O	O	O
Bayesian	O	O	B-T081
meta-analysis	O	O	B-T062
of	O	O	O
randomized	O	O	B-T062
controlled	O	O	I-T062
trials	O	O	I-T062
(	O	O	O
RCTs	O	O	B-T062
)	O	O	O
about	O	O	O
the	O	O	O
regression	O	O	B-T046
of	O	O	O
LVH	O	O	B-T047
.	O	O	O

Sensitivity	O	O	B-T062
analysis	O	O	I-T062
and	O	O	O
regression	O	O	B-T170
analysis	O	O	I-T170
were	O	O	O
performed	O	O	O
to	O	O	O
explore	O	O	O
possible	O	O	O
sources	O	O	O
of	O	O	O
heterogeneity	O	O	B-T080
.	O	O	O

Inconsistency	O	O	B-T062
analysis	O	O	B-T062
was	O	O	O
performed	O	O	O
to	O	O	O
check	O	O	O
whether	O	O	O
the	O	O	O
analysis	O	O	O
of	O	O	O
the	O	O	O
trials	O	O	B-T062
in	O	O	O
the	O	O	O
network	O	O	B-T081
was	O	O	O
indeed	O	O	O
consistent	O	O	B-T078
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
41	O	O	O
RCTs	O	O	B-T062
involving	O	O	O
2566	O	O	O
patients	O	O	B-T101
with	O	O	O
HT	O	O	B-T047
and	O	O	O
LVH	O	O	B-T047
were	O	O	O
included	O	O	O
in	O	O	O
this	O	O	O
analysis	O	O	B-T062
.	O	O	O

Bayesian	O	O	B-T081
network	O	O	I-T081
meta-analysis	O	O	B-T062
indicated	O	O	O
no	O	O	O
statistically	O	O	B-T081
significant	O	O	I-T081
differences	O	O	O
between	O	O	O
these	O	O	O
groups	O	O	B-T078
:	O	O	O
FS-Î²-B	O	O	B-T121
and	O	O	O
ACEI	O	O	B-T121
(	O	O	O
MD	O	O	O
,	O	O	O
-7.09	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
,	O	O	O
-14.99	O	O	O
,	O	O	O
1.27	O	O	O
)	O	O	O
;	O	O	O
FS-Î²-B	O	O	O
and	O	O	O
ARB	O	O	B-T121
(	O	O	O
MD	O	O	O
,	O	O	O
-2.66	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
Cl	O	O	B-T081
,	O	O	O
-12.02	O	O	O
,	O	O	O
6.31	O	O	O
)	O	O	O
.	O	O	O

Although	O	O	O
FS-Î²-B	O	O	B-T121
showed	O	O	O
greater	O	O	O
efficacy	O	O	B-T080
when	O	O	O
compared	O	O	B-T052
with	O	O	O
diuretic	O	O	B-T121
(	O	O	O
MD	O	O	O
,	O	O	O
13.04	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
,	O	O	O
3.38	O	O	O
,	O	O	O
22.59	O	O	O
)	O	O	O
or	O	O	O
CCB	O	O	B-T121
(	O	O	O
MD	O	O	O
,	O	O	O
10.90	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
,	O	O	O
1.98	O	O	O
,	O	O	O
19.49	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
probabilities	O	O	B-T081
of	O	O	O
being	O	O	O
among	O	O	O
the	O	O	O
most	O	O	O
efficacious	O	O	B-T080
treatments	O	O	B-T061
were	O	O	O
:	O	O	O
FS-Î²-B	O	O	B-T121
(	O	O	O
72	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
ARB	O	O	B-T121
(	O	O	O
27	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
ACEI	O	O	B-T121
(	O	O	O
0.01	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
CCB	O	O	B-T121
(	O	O	O
0.00	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
diuretic	O	O	B-T121
(	O	O	O
0.00	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

Evidence	O	O	O
from	O	O	O
our	O	O	O
analysis	O	O	B-T062
reveals	O	O	O
that	O	O	O
FS-Î²-B	O	O	B-T121
have	O	O	O
potential	O	O	O
to	O	O	O
become	O	O	O
1st-line	O	O	O
therapeutic	O	O	B-T121
drugs	O	O	I-T121
in	O	O	O
HT	O	O	B-T047
and	O	O	O
LVH	O	O	B-T047
patients	O	O	B-T101
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
real	O	O	O
efficacy	O	O	B-T080
of	O	O	O
FS-Î²-B	O	O	B-T121
on	O	O	O
regression	O	O	B-T046
of	O	O	O
LVH	O	O	B-T047
should	O	O	O
be	O	O	O
confirmed	O	O	O
by	O	O	O
further	O	O	O
large	O	O	O
,	O	O	O
high	O	O	O
quality	O	O	B-T080
trials	O	O	B-T062
considering	O	O	O
the	O	O	O
limitation	O	O	O
of	O	O	O
the	O	O	O
study	O	O	O
number	O	O	O
.	O	O	O

-DOCSTART- (28272842)

Improved	O	O	B-T033
risk	O	O	B-T078
stratification	O	O	B-T062
for	O	O	O
patients	O	O	B-T101
with	O	O	O
high-grade	O	O	O
urothelial	O	O	B-T191
carcinoma	O	O	I-T191
following	O	O	O
application	O	O	O
of	O	O	O
the	O	O	O
Paris	O	O	B-T083
System	O	O	B-T169
for	O	O	O
Reporting	O	O	B-T058
Urinary	O	O	O
Cytology	O	O	O

The	O	O	O
Paris	O	O	B-T083
System	O	O	B-T169
for	O	O	O
Reporting	O	O	B-T058
Urinary	O	O	B-T059
Cytology	O	O	I-T059
(	O	O	O
TPS	O	O	B-T059
)	O	O	O
requires	O	O	O
4	O	O	O
cytomorphologic	O	O	B-T026
criteria	O	O	B-T078
for	O	O	O
a	O	O	O
definitive	O	O	O
diagnosis	O	O	B-T033
of	O	O	O
high-grade	O	O	B-T191
urothelial	O	O	I-T191
carcinoma	O	O	I-T191
(	O	O	O
HGUC	O	O	B-T191
)	O	O	O
in	O	O	O
urinary	O	O	B-T059
tract	O	O	I-T059
cytology	O	O	I-T059
(	O	O	O
UTC	O	O	B-T059
)	O	O	O
specimens	O	O	B-T167
:	O	O	O
an	O	O	O
elevated	O	O	B-T080
nuclear-to-cytoplasmic	O	O	B-T049
(	O	O	I-T049
N/C	O	O	I-T049
)	O	O	I-T049
ratio	O	O	I-T049
(	O	O	O
at	O	O	O
or	O	O	O
above	O	O	O
0.7	O	O	O
)	O	O	O
,	O	O	O
markedly	O	O	O
atypical	O	O	B-T080
nuclear	O	O	B-T026
borders	O	O	B-T082
,	O	O	O
moderate	O	O	B-T080
to	O	O	O
severe	O	O	B-T080
hyperchromasia	O	O	B-T033
,	O	O	O
and	O	O	O
coarse	O	O	B-T033
chromatin	O	O	I-T033
.	O	O	O

However	O	O	O
,	O	O	O
malignant	O	O	B-T080
UTC	O	O	B-T059
specimens	O	O	B-T167
often	O	O	O
contain	O	O	O
degenerative	O	O	B-T169
changes	O	O	B-T169
,	O	O	O
and	O	O	O
this	O	O	O
limits	O	O	O
the	O	O	O
number	O	O	O
of	O	O	O
malignant	O	O	B-T025
cells	O	O	I-T025
meeting	O	O	O
all	O	O	O
4	O	O	O
TPS	O	O	B-T059
cytomorphologic	O	O	B-T026
criteria	O	O	B-T078
.	O	O	O

One	O	O	O
hundred	O	O	O
twelve	O	O	O
UTC	O	O	B-T059
specimens	O	O	B-T167
from	O	O	O
patients	O	O	B-T101
with	O	O	O
a	O	O	O
subsequent	O	O	O
diagnosis	O	O	B-T033
of	O	O	O
HGUC	O	O	B-T191
were	O	O	O
reviewed	O	O	B-T080
and	O	O	O
reclassified	O	O	B-T080
according	O	O	O
to	O	O	O
TPS	O	O	B-T059
criteria	O	O	B-T078
.	O	O	O

The	O	O	O
presence	O	O	B-T033
of	O	O	O
TPS	O	O	B-T059
cytomorphologic	O	O	B-T026
criteria	O	O	B-T078
for	O	O	O
HGUC	O	O	B-T191
in	O	O	O
each	O	O	O
specimen	O	O	B-T167
was	O	O	O
recorded	O	O	O
,	O	O	O
as	O	O	O
was	O	O	O
the	O	O	O
proportion	O	O	O
of	O	O	O
atypical	O	O	B-T080
cells	O	O	B-T025
meeting	O	O	O
all	O	O	O
4	O	O	O
criteria	O	O	O
.	O	O	O

The	O	O	O
number	O	O	O
of	O	O	O
specimens	O	O	B-T167
definitively	O	O	O
diagnosed	O	O	B-T033
as	O	O	O
HGUC	O	O	B-T191
did	O	O	O
not	O	O	O
significantly	O	O	B-T078
change	O	O	B-T169
upon	O	O	O
reclassification	O	O	B-T185
.	O	O	O

However	O	O	O
,	O	O	O
approximately	O	O	B-T080
40	O	O	O
%	O	O	O
of	O	O	O
indeterminate	O	O	B-T078
specimens	O	O	B-T167
(	O	O	O
21	O	O	O
of	O	O	O
51	O	O	O
)	O	O	O
were	O	O	O
reclassified	O	O	B-T080
into	O	O	O
a	O	O	O
higher	O	O	O
risk	O	O	B-T078
category	O	O	B-T170
.	O	O	O

The	O	O	O
most	O	O	O
restrictive	O	O	O
cytomorphologic	O	O	B-T026
criterion	O	O	O
was	O	O	O
an	O	O	O
N/C	O	O	B-T049
ratio	O	O	I-T049
of	O	O	O
0.7	O	O	O
or	O	O	O
higher	O	O	O
(	O	O	O
seen	O	O	O
in	O	O	O
78	O	O	O
%	O	O	O
of	O	O	O
specimens	O	O	B-T167
)	O	O	O
,	O	O	O
and	O	O	O
approximately	O	O	B-T080
half	O	O	O
of	O	O	O
specimens	O	O	O
containing	O	O	O
all	O	O	O
4	O	O	O
cytomorphologic	O	O	O
criteria	O	O	B-T078
did	O	O	O
not	O	O	O
meet	O	O	O
TPS	O	O	B-T059
's	O	O	O
numerical	O	O	O
criterion	O	O	O
for	O	O	O
HGUC	O	O	B-T191
(	O	O	O
at	O	O	O
least	O	O	O
5	O	O	O
malignant	O	O	B-T025
cells	O	O	I-T025
)	O	O	O
.	O	O	O

In	O	O	O
the	O	O	O
majority	O	O	O
of	O	O	O
specimens	O	O	B-T167
qualifying	O	O	O
for	O	O	O
HGUC	O	O	B-T191
by	O	O	O
TPS	O	O	B-T059
standards	O	O	O
,	O	O	O
only	O	O	O
a	O	O	O
small	O	O	O
fraction	O	O	B-T081
of	O	O	I-T081
atypical	O	O	B-T080
cells	O	O	B-T025
(	O	O	O
10%-20	O	O	O
%	O	O	O
)	O	O	O
met	O	O	O
all	O	O	O
the	O	O	O
criteria	O	O	B-T078
.	O	O	O

When	O	O	O
applied	O	O	O
to	O	O	O
malignant	O	O	B-T080
UTC	O	O	B-T059
specimens	O	O	B-T167
,	O	O	O
TPS	O	O	B-T059
criteria	O	O	B-T078
improved	O	O	B-T033
specimen	O	O	B-T167
risk	O	O	B-T078
stratification	O	O	B-T062
by	O	O	O
upgrading	O	O	O
approximately	O	O	B-T080
40	O	O	O
%	O	O	O
of	O	O	O
indeterminate	O	O	B-T078
specimens	O	O	O
into	O	O	O
higher	O	O	O
risk	O	O	O
categories	O	O	B-T170
while	O	O	O
not	O	O	O
significantly	O	O	B-T078
changing	O	O	B-T169
the	O	O	O
frequency	O	O	B-T079
of	O	O	O
HGUC	O	O	B-T191
diagnoses	O	O	B-T033
.	O	O	O

Cancer	O	O	B-T191
Cytopathol	O	O	O
2017	O	O	O
.	O	O	O

Â©	O	O	O
2017	O	O	O
American	O	O	B-T094
Cancer	O	O	I-T094
Society	O	O	I-T094
.	O	O	O

-DOCSTART- (28273336)

Questionable	O	O	O
diagnostic	O	O	B-T169
benefit	O	O	B-T081
of	O	O	O
the	O	O	O
commercially	O	O	O
available	O	O	O
panel	O	O	O
of	O	O	O
bee	O	O	B-T116
venom	O	O	I-T116
components	O	O	O

For	O	O	O
many	O	O	O
years	O	O	B-T079
,	O	O	O
only	O	O	O
the	O	O	O
major	O	O	O
allergen	O	O	B-T129
rApi	O	O	B-T129
m	O	O	I-T129
1	O	O	I-T129
has	O	O	O
been	O	O	O
available	O	O	O
on	O	O	O
the	O	O	O
ImmunoCAP	O	O	B-T170
system	O	O	I-T170
for	O	O	O
routine	O	O	O
diagnosis	O	O	B-T033
of	O	O	O
bee	O	O	B-T046
venom	O	O	I-T046
(	O	O	I-T046
BV	O	O	I-T046
)	O	O	I-T046
allergy	O	O	I-T046
.	O	O	O

Now	O	O	O
,	O	O	O
there	O	O	O
are	O	O	O
five	O	O	O
components	O	O	B-T077
available	O	O	O
,	O	O	O
and	O	O	O
we	O	O	O
aimed	O	O	O
to	O	O	O
detect	O	O	O
the	O	O	O
sensitivity	O	O	B-T081
and	O	O	O
specificity	O	O	B-T081
of	O	O	O
rApi	O	O	B-T129
m	O	O	I-T129
1	O	O	I-T129
,	O	O	O
2	O	O	B-T129
,	O	O	O
3	O	O	B-T129
,	O	O	O
5	O	O	B-T129
,	O	O	O
and	O	O	O
10	O	O	B-T129
in	O	O	O
BV-allergic	O	O	B-T046
patients	O	O	B-T101
.	O	O	O

We	O	O	O
further	O	O	O
evaluated	O	O	O
the	O	O	O
sensitivity	O	O	B-T081
of	O	O	O
rApi	O	O	B-T129
m	O	O	I-T129
1	O	O	I-T129
and	O	O	O
2	O	O	B-T129
of	O	O	O
an	O	O	O
alternative	O	O	O
platform	O	O	O
and	O	O	O
investigated	O	O	B-T169
possible	O	O	O
differences	O	O	O
in	O	O	O
the	O	O	O
sensitization	O	O	B-T040
profile	O	O	O
between	O	O	O
monosensitization	O	O	B-T040
and	O	O	O
clinically	O	O	O
relevant	O	O	O
double	O	O	B-T040
sensitization	O	O	I-T040
.	O	O	O

Analysis	O	O	B-T062
of	O	O	O
the	O	O	O
whole	O	O	O
panel	O	O	O
of	O	O	O
BV	O	O	B-T116
allergens	O	O	B-T129
of	O	O	O
the	O	O	O
CAP	O	O	B-T170
system	O	O	I-T170
still	O	O	O
resulted	O	O	O
in	O	O	O
a	O	O	O
lower	O	O	O
sensitivity	O	O	B-T081
than	O	O	O
analysis	O	O	B-T062
of	O	O	O
the	O	O	O
combination	O	O	O
of	O	O	O
rApi	O	O	B-T129
m	O	O	I-T129
1	O	O	I-T129
and	O	O	O
2	O	O	B-T129
of	O	O	O
the	O	O	O
Immulite	O	O	B-T073
(	O	O	O
71.6	O	O	O
%	O	O	O
vs	O	O	O
85.8	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

Sensitization	O	O	B-T040
rate	O	O	B-T081
of	O	O	O
rApi	O	O	B-T129
m	O	O	I-T129
5	O	O	I-T129
was	O	O	O
more	O	O	O
than	O	O	O
doubled	O	O	O
in	O	O	O
double-sensitized	O	O	B-T040
patients	O	O	B-T101
,	O	O	O
while	O	O	O
there	O	O	O
was	O	O	O
no	O	O	O
difference	O	O	O
for	O	O	O
rApi	O	O	B-T129
m	O	O	I-T129
2	O	O	I-T129
.	O	O	O

The	O	O	O
benefit	O	O	B-T081
of	O	O	O
the	O	O	O
commercially	O	O	O
available	O	O	O
panel	O	O	O
of	O	O	O
BV	O	O	B-T116
components	O	O	B-T077
is	O	O	O
questionable	O	O	O
,	O	O	O
due	O	O	O
to	O	O	O
the	O	O	O
insufficient	O	O	B-T080
sensitivity	O	O	B-T081
and	O	O	O
still	O	O	O
unavailable	O	O	O
important	O	O	O
cross-reacting	O	O	B-T044
allergens	O	O	B-T129
.	O	O	O

-DOCSTART- (28273482)

Orai1	O	O	B-T116
-Mediated	O	O	O
Antimicrobial	O	O	B-T121
Secretion	O	O	B-T031
from	O	O	O
Pancreatic	O	O	B-T023
Acini	O	O	I-T023
Shapes	O	O	O
the	O	O	O
Gut	O	O	B-T023
Microbiome	O	O	I-T001
and	O	O	O
Regulates	O	O	B-T040
Gut	O	O	O
Innate	O	O	O
Immunity	O	O	O

The	O	O	O
gut	O	O	B-T001
microbiome	O	O	I-T001
participates	O	O	O
in	O	O	O
numerous	O	O	O
physiologic	O	O	B-T039
functions	O	O	I-T039
and	O	O	O
communicates	O	O	B-T033
intimately	O	O	O
with	O	O	O
the	O	O	O
host	O	O	B-T001
immune	O	O	B-T022
system	O	O	I-T022
.	O	O	O

Antimicrobial	O	O	B-T116
peptides	O	O	I-T116
are	O	O	O
critica	O	O	B-T080
l	O	O	O
components	O	O	B-T116
of	O	O	O
intestinal	O	O	B-T023
innate	O	O	B-T032
immunity	O	O	I-T032
.	O	O	O

We	O	O	O
report	O	O	O
a	O	O	O
prominent	O	O	B-T080
role	O	O	O
for	O	O	O
antimicrobials	O	O	B-T043
secreted	O	O	I-T043
by	O	O	O
pancreatic	O	O	B-T023
acini	O	O	I-T023
in	O	O	O
shaping	O	O	O
the	O	O	O
gut	O	O	B-T001
microbiome	O	O	I-T001
that	O	O	O
is	O	O	O
essential	O	O	O
for	O	O	O
intestinal	O	O	B-T023
innate	O	O	B-T032
immunity	O	O	I-T032
,	O	O	O
barrier	O	O	B-T042
function	O	O	I-T042
,	O	O	O
and	O	O	O
survival	O	O	B-T169
.	O	O	O

Deletion	O	O	B-T052
of	O	O	O
the	O	O	O
Ca(2	O	O	B-T028
+	O	O	I-T028
)	O	O	I-T028
channel	O	O	I-T028
Orai1	O	O	I-T028
in	O	O	O
pancreatic	O	O	B-T023
acini	O	O	I-T023
of	O	O	O
adult	O	O	O
mice	O	O	B-T015
resulted	O	O	O
in	O	O	O
60%-70	O	O	O
%	O	O	O
mortality	O	O	B-T081
within	O	O	O
3	O	O	O
weeks	O	O	O
.	O	O	O

Despite	O	O	O
robust	O	O	O
activation	O	O	B-T040
of	O	O	I-T040
the	O	O	I-T040
intestinal	O	O	B-T023
innate	O	O	I-T040
immune	O	O	I-T040
response	O	O	I-T040
,	O	O	O
mice	O	O	B-T015
lacking	O	O	O
acinar	O	O	B-T082
Orai1	O	O	B-T028
exhibited	O	O	O
intestinal	O	O	O
bacterial	O	O	B-T080
outgrowth	O	O	B-T043
and	O	O	O
dysbiosis	O	O	B-T184
,	O	O	O
ultimately	O	O	O
causing	O	O	O
systemic	O	O	B-T169
translocation	O	O	B-T043
,	O	O	O
inflammation	O	O	B-T046
,	O	O	O
and	O	O	O
death	O	O	B-T040
.	O	O	O

While	O	O	O
digestive	O	O	B-T116
enzyme	O	O	I-T116
supplementation	O	O	B-T061
was	O	O	O
ineffective	O	O	B-T078
,	O	O	O
treatments	O	O	B-T061
constraining	O	O	O
bacterial	O	O	B-T080
outgrowth	O	O	B-T043
(	O	O	O
purified	O	O	B-T169
liquid	O	O	B-T061
diet	O	O	I-T061
,	O	O	O
broad-spectrum	O	O	B-T195
antibiotics	O	O	I-T195
)	O	O	O
rescued	O	O	O
survival	O	O	B-T169
,	O	O	O
feeding	O	O	B-T052
,	O	O	O
and	O	O	O
weight	O	O	B-T033
gain	O	O	I-T033
.	O	O	O

Pancreatic	O	O	B-T034
levels	O	O	I-T034
of	O	O	O
cathelicidin	O	O	B-T116
-related	O	O	O
antimicrobial	O	O	B-T116
peptide	O	O	I-T116
(	O	O	O
CRAMP	O	O	B-T116
)	O	O	O
were	O	O	O
reduced	O	O	B-T080
,	O	O	O
and	O	O	O
supplement	O	O	B-T169
of	O	O	O
synthetic	O	O	O
CRAMP	O	O	O
prevented	O	O	O
intestinal	O	O	B-T047
disease	O	O	I-T047
.	O	O	O

These	O	O	O
findings	O	O	B-T033
reveal	O	O	O
a	O	O	O
critical	O	O	B-T080
role	O	O	O
for	O	O	O
antimicrobial	O	O	B-T121
pancreatic	O	O	B-T042
secretion	O	O	I-T042
in	O	O	O
gut	O	O	B-T023
innate	O	O	B-T032
immunity	O	O	I-T032
.	O	O	O

-DOCSTART- (28274077)

Palliative	O	O	B-T091
Care	O	O	I-T091
with	O	O	O
Attachment	O	O	B-T052
Hybrid	O	O	O
Removable	O	O	O
Prosthesis	O	O	O

Abutment	O	O	B-T023
injury	O	O	B-T037
,	O	O	O
unsatisfactory	O	O	B-T080
aesthetics	O	O	B-T090
and	O	O	O
lesser	O	O	O
retention	O	O	B-T061
exist	O	O	O
with	O	O	O
the	O	O	O
cast	O	O	B-UnknownType
partial	O	O	I-UnknownType
denture	O	O	I-UnknownType
.	O	O	O

Though	O	O	O
these	O	O	O
constraints	O	O	O
exist	O	O	O
in	O	O	O
the	O	O	O
Removable	O	O	B-T074
Partial	O	O	I-T074
Denture	O	O	I-T074
(	O	O	O
RPD	O	O	B-T074
)	O	O	O
it	O	O	O
is	O	O	O
still	O	O	O
widely	O	O	O
used	O	O	O
because	O	O	O
of	O	O	O
the	O	O	O
simplicity	O	O	O
in	O	O	O
design	O	O	B-T058
,	O	O	O
fabrication	O	O	B-T067
,	O	O	O
economics	O	O	B-T169
and	O	O	O
patient	O	O	B-T058
comfort	O	O	I-T058
.	O	O	O

This	O	O	O
clinical	O	O	B-T170
report	O	O	I-T170
describes	O	O	O
a	O	O	O
hybrid	O	O	O
RPD	O	O	B-T074
technique	O	O	B-T169
which	O	O	O
uses	O	O	O
extra	O	O	O
coronal	O	O	B-T082
attachment	O	O	B-T052
that	O	O	O
reduces	O	O	B-T080
the	O	O	O
limitations	O	O	O
and	O	O	O
provides	O	O	O
better	O	O	O
comfort	O	O	B-T041
for	O	O	O
the	O	O	O
patient	O	O	B-T101
.	O	O	O

-DOCSTART- (28277189)

CXCL5	O	O	B-T116
Plays	O	O	O
a	O	O	O
Promoting	O	O	O
Role	O	O	O
in	O	O	O
Osteosarcoma	O	O	B-T191
Cell	O	O	B-T191
Migration	O	O	I-T191
and	O	O	I-T191
Invasion	O	O	I-T191
in	O	O	O
Autocrine	O	O	B-T042
-	O	O	O
and	O	O	O
Paracrine	O	O	B-T039
-Dependent	O	O	O
Manners	O	O	O

CXCL5	O	O	B-T116
,	O	O	O
a	O	O	O
CXC-type	O	O	B-T116
chemokine	O	O	I-T116
,	O	O	O
is	O	O	O
an	O	O	O
important	O	O	O
attractant	O	O	O
for	O	O	O
granulocytic	O	O	B-T025
immune	O	O	I-T025
cells	O	O	I-T025
by	O	O	O
binding	O	O	B-T044
to	O	O	I-T044
its	O	O	I-T044
receptor	O	O	I-T044
CXCR2	O	O	I-T044
.	O	O	O

Recently	O	O	O
,	O	O	O
CXCL5	O	O	B-T116
/	O	O	O
CXCR2	O	O	B-T116
has	O	O	O
been	O	O	O
found	O	O	O
to	O	O	O
play	O	O	O
an	O	O	O
oncogenic	O	O	B-T116
role	O	O	O
in	O	O	O
many	O	O	O
human	O	O	B-T016
cancers	O	O	B-T191
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
exact	O	O	O
role	O	O	O
of	O	O	O
CXCL5	O	O	B-T116
in	O	O	O
osteosarcoma	O	O	B-T191
cell	O	O	B-T191
migration	O	O	I-T191
and	O	O	I-T191
invasion	O	O	I-T191
has	O	O	O
not	O	O	O
been	O	O	O
revealed	O	O	O
.	O	O	O

Here	O	O	O
we	O	O	O
found	O	O	O
that	O	O	O
the	O	O	O
protein	O	O	B-T045
expression	O	O	I-T045
of	O	O	O
CXCL5	O	O	B-T116
was	O	O	O
significantly	O	O	O
increased	O	O	B-T081
in	O	O	O
osteosarcoma	O	O	B-T191
tissues	O	O	B-T024
compared	O	O	O
with	O	O	O
that	O	O	O
in	O	O	O
matched	O	O	B-T024
adjacent	O	O	I-T024
nontumor	O	O	I-T024
tissues	O	O	I-T024
.	O	O	O

Moreover	O	O	O
,	O	O	O
the	O	O	O
expression	O	O	B-T045
of	O	O	O
CXCL5	O	O	B-T116
was	O	O	O
significantly	O	O	O
associated	O	O	O
with	O	O	O
advanced	O	O	B-T079
clinical	O	O	I-T079
stage	O	O	I-T079
and	O	O	O
metastasis	O	O	B-T046
.	O	O	O

Further	O	O	O
investigation	O	O	O
showed	O	O	O
that	O	O	O
the	O	O	O
CXCL5	O	O	B-T116
expression	O	O	B-T081
levels	O	O	I-T081
were	O	O	O
also	O	O	O
significantly	O	O	O
increased	O	O	B-T081
in	O	O	O
osteosarcoma	O	O	B-T191
cell	O	O	B-T025
lines	O	O	I-T025
,	O	O	O
including	O	O	O
Saos-2	O	O	B-T025
,	O	O	O
MG63	O	O	B-T025
,	O	O	O
U2OS	O	O	B-T025
,	O	O	O
and	O	O	O
SW1353	O	O	B-T025
,	O	O	O
when	O	O	O
compared	O	O	O
with	O	O	O
those	O	O	O
in	O	O	O
normal	O	O	B-T025
osteoblast	O	O	I-T025
hFoB1.19	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

U2OS	O	O	B-T025
cells	O	O	I-T025
were	O	O	O
further	O	O	O
transfected	O	O	B-T045
with	O	O	O
CXCL5	O	O	B-T028
-	O	O	O
specific	O	O	B-T114
siRNA	O	O	I-T114
or	O	O	O
overexpression	O	O	B-T045
plasmid	O	O	B-T114
.	O	O	O

Knockdown	O	O	B-T063
of	O	O	O
CXCL5	O	O	B-T028
significantly	O	O	O
suppressed	O	O	B-T169
U2OS	O	O	B-T025
cell	O	O	B-T191
migration	O	O	I-T191
and	O	O	I-T191
invasion	O	O	I-T191
.	O	O	O

On	O	O	O
the	O	O	O
contrary	O	O	O
,	O	O	O
overexpression	O	O	B-T045
of	O	O	O
CXLC5	O	O	B-T116
remarkably	O	O	O
promoted	O	O	O
the	O	O	O
migration	O	O	B-T191
and	O	O	I-T191
invasion	O	O	I-T191
of	O	O	O
U2OS	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

Interestingly	O	O	O
,	O	O	O
both	O	O	O
exogenous	O	O	B-T169
CXCL5	O	O	B-T116
treatment	O	O	B-T169
and	O	O	O
the	O	O	O
conditioned	O	O	O
medium	O	O	O
of	O	O	O
CXCL5	O	O	O
-	O	O	O
overexpressing	O	O	B-T045
hFoB1.19	O	O	B-T025
cells	O	O	I-T025
could	O	O	O
also	O	O	O
enhance	O	O	O
the	O	O	O
migration	O	O	B-T191
and	O	O	I-T191
invasion	O	O	I-T191
of	O	O	O
U2OS	O	O	B-T025
cells	O	O	I-T025
,	O	O	O
suggesting	O	O	O
that	O	O	O
the	O	O	O
promoting	O	O	O
role	O	O	O
of	O	O	O
CXCL5	O	O	O
in	O	O	O
U2OS	O	O	O
cell	O	O	B-T191
migration	O	O	I-T191
and	O	O	I-T191
invasion	O	O	I-T191
is	O	O	O
also	O	O	O
in	O	O	O
a	O	O	O
paracrine	O	O	B-T039
-dependent	O	O	O
manner	O	O	O
.	O	O	O

According	O	O	O
to	O	O	O
these	O	O	O
data	O	O	O
,	O	O	O
our	O	O	O
study	O	O	O
demonstrates	O	O	O
that	O	O	O
CXCL5	O	O	B-T116
is	O	O	O
upregulated	O	O	O
in	O	O	O
osteosarcoma	O	O	B-T191
and	O	O	O
may	O	O	O
play	O	O	O
an	O	O	O
oncogenic	O	O	B-T116
role	O	O	O
in	O	O	O
osteosarcoma	O	O	O
metastasis	O	O	B-T046
.	O	O	O

Therefore	O	O	O
,	O	O	O
CXCL5	O	O	B-T116
may	O	O	O
become	O	O	O
a	O	O	O
potential	O	O	B-T080
therapeutic	O	O	B-T169
target	O	O	I-T169
for	O	O	O
osteosarcoma	O	O	B-T191
treatment	O	O	B-T169
.	O	O	O

-DOCSTART- (28278150)

Integrating	O	O	B-T052
molecular	O	O	B-T080
QTL	O	O	B-T028
data	O	O	B-T078
into	O	O	O
genome-wide	O	O	B-T063
genetic	O	O	I-T063
association	O	O	I-T063
analysis	O	O	I-T063
:	O	O	O
Probabilistic	O	O	B-T081
assessment	O	O	B-T169
of	O	O	O
enrichment	O	O	B-T077
and	O	O	O
colocalization	O	O	O

We	O	O	O
propose	O	O	O
a	O	O	O
novel	O	O	O
statistical	O	O	B-T081
framework	O	O	I-T081
for	O	O	O
integrating	O	O	B-T052
the	O	O	O
result	O	O	B-T169
from	O	O	O
molecular	O	O	B-T080
quantitative	O	O	B-T028
trait	O	O	B-T032
loci	O	O	I-T028
(	O	O	O
QTL	O	O	B-T028
)	O	O	O
mapping	O	O	B-T052
into	O	O	O
genome-wide	O	O	B-T063
genetic	O	O	I-T063
association	O	O	B-T080
analysis	O	O	I-T063
of	O	O	O
complex	O	O	B-T080
traits	O	O	B-T032
,	O	O	O
with	O	O	O
the	O	O	O
primary	O	O	O
objectives	O	O	O
of	O	O	O
quantitatively	O	O	B-T081
assessing	O	O	B-T169
the	O	O	O
enrichment	O	O	B-T077
of	O	O	O
the	O	O	O
molecular	O	O	O
QTLs	O	O	B-T028
in	O	O	O
complex	O	O	O
trait	O	O	O
-	O	O	O
associated	O	O	B-T080
genetic	O	O	B-T028
variants	O	O	I-T028
and	O	O	O
the	O	O	O
colocalizations	O	O	B-T169
of	O	O	O
the	O	O	O
two	O	O	O
types	O	O	B-T080
of	O	O	O
association	O	O	O
signals	O	O	B-T067
.	O	O	O

We	O	O	O
introduce	O	O	O
a	O	O	O
natural	O	O	B-T081
Bayesian	O	O	I-T081
hierarchical	O	O	I-T081
model	O	O	I-T081
that	O	O	O
treats	O	O	O
the	O	O	O
latent	O	O	O
association	O	O	B-T080
status	O	O	O
of	O	O	O
molecular	O	O	B-T080
QTLs	O	O	B-T028
as	O	O	O
SNP	O	O	B-T086
-	O	O	O
level	O	O	B-T080
annotations	O	O	O
for	O	O	O
candidate	O	O	O
SNPs	O	O	B-T086
of	O	O	O
complex	O	O	B-T080
traits	O	O	B-T032
.	O	O	O

We	O	O	O
detail	O	O	O
a	O	O	O
computational	O	O	B-T052
procedure	O	O	B-T169
to	O	O	O
seamlessly	O	O	O
perform	O	O	O
enrichment	O	O	B-T077
,	O	O	O
fine-mapping	O	O	B-T052
and	O	O	O
colocalization	O	O	B-T169
analyses	O	O	B-T062
,	O	O	O
which	O	O	O
is	O	O	O
a	O	O	O
distinct	O	O	B-T080
feature	O	O	I-T080
compared	O	O	B-T052
to	O	O	O
the	O	O	O
existing	O	O	O
colocalization	O	O	O
analysis	O	O	B-T062
procedures	O	O	B-T169
in	O	O	O
the	O	O	O
literature	O	O	B-T170
.	O	O	O

The	O	O	O
proposed	O	O	O
approach	O	O	B-T082
is	O	O	O
computationally	O	O	B-T052
efficient	O	O	B-T080
and	O	O	O
requires	O	O	O
only	O	O	O
summary	O	O	B-T170
-	O	O	O
level	O	O	B-T080
statistics	O	O	B-T081
.	O	O	O

We	O	O	O
evaluate	O	O	B-T169
and	O	O	O
demonstrate	O	O	O
the	O	O	O
proposed	O	O	O
computational	O	O	B-T052
approach	O	O	B-T082
through	O	O	O
extensive	O	O	B-T080
simulation	O	O	B-T066
studies	O	O	B-T062
and	O	O	O
analyses	O	O	B-T062
of	O	O	O
blood	O	O	B-T109
lipid	O	O	I-T109
data	O	O	B-T078
and	O	O	O
the	O	O	O
whole	O	O	B-T031
blood	O	O	I-T031
eQTL	O	O	B-T028
data	O	O	O
from	O	O	O
the	O	O	O
GTEx	O	O	B-T062
project	O	O	I-T062
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
a	O	O	O
useful	O	O	O
utility	O	O	B-T170
from	O	O	O
our	O	O	O
proposed	O	O	O
method	O	O	B-T170
enables	O	O	O
the	O	O	O
computation	O	O	B-T052
of	O	O	O
expected	O	O	O
colocalization	O	O	B-T169
signals	O	O	B-T067
using	O	O	O
simple	O	O	O
characteristics	O	O	B-T080
of	O	O	O
the	O	O	O
association	O	O	B-T080
data	O	O	B-T078
.	O	O	O

Using	O	O	O
this	O	O	O
utility	O	O	B-T170
,	O	O	O
we	O	O	O
further	O	O	O
illustrate	O	O	O
the	O	O	O
importance	O	O	O
of	O	O	O
enrichment	O	O	B-T077
analysis	O	O	B-T062
on	O	O	O
the	O	O	O
ability	O	O	O
to	O	O	O
discover	O	O	O
colocalized	O	O	B-T169
signals	O	O	B-T067
and	O	O	O
the	O	O	O
potential	O	O	B-T080
limitations	O	O	B-T169
of	O	O	O
currently	O	O	O
available	O	O	O
molecular	O	O	B-T080
QTL	O	O	B-T028
data	O	O	B-T078
.	O	O	O

The	O	O	O
software	O	O	B-T073
pipeline	O	O	O
that	O	O	O
implements	O	O	O
the	O	O	O
proposed	O	O	O
computation	O	O	B-T052
procedures	O	O	B-T169
,	O	O	O
enloc	O	O	B-T170
,	O	O	O
is	O	O	O
freely	O	O	O
available	O	O	O
at	O	O	O
https://github.com/xqwen/integrative	O	O	B-T170
.	O	O	O

-DOCSTART- (28280149)

Engineering	O	O	B-T063
the	O	O	O
ribosomal	O	O	B-T114
DNA	O	O	I-T114
in	O	O	O
a	O	O	O
megabase	O	O	O
synthetic	O	O	O
chromosome	O	O	O

We	O	O	O
designed	O	O	O
and	O	O	O
synthesized	O	O	O
a	O	O	O
976,067-base	O	O	B-T075
pair	O	O	I-T075
linear	O	O	I-T075
chromosome	O	O	B-T026
,	O	O	O
synXII	O	O	B-T075
,	O	O	O
based	O	O	O
on	O	O	O
native	O	O	O
chromosome	O	O	B-T026
XII	O	O	I-T026
in	O	O	O
Saccharomyces	O	O	B-T004
cerevisiae	O	O	I-T004
SynXII	O	O	B-T075
was	O	O	O
assembled	O	O	O
using	O	O	O
a	O	O	O
two-step	O	O	B-T169
method	O	O	I-T169
,	O	O	O
specified	O	O	O
by	O	O	O
successive	O	O	O
megachunk	O	O	B-T063
integration	O	O	I-T063
and	O	O	O
meiotic	O	O	B-T063
recombination-mediated	O	O	I-T063
assembly	O	O	I-T063
,	O	O	O
producing	O	O	O
a	O	O	O
functional	O	O	B-T169
chromosome	O	O	O
in	O	O	O
S.	O	O	B-T004
cerevisiae	O	O	I-T004
.	O	O	O

Minor	O	O	B-T169
growth	O	O	I-T169
defect	O	O	I-T169
"	O	O	O
bugs	O	O	B-T169
"	O	O	O
detected	O	O	B-T033
in	O	O	O
synXII	O	O	B-T075
,	O	O	O
caused	O	O	O
by	O	O	O
deletion	O	O	B-T045
of	O	O	O
tRNA	O	O	B-T114
genes	O	O	B-T028
,	O	O	O
were	O	O	O
rescued	O	O	O
by	O	O	O
introducing	O	O	O
an	O	O	O
ectopic	O	O	B-T028
copy	O	O	I-T028
of	O	O	O
a	O	O	O
single	O	O	B-T114
tRNA	O	O	I-T114
gene	O	O	B-T028
.	O	O	O

The	O	O	O
ribosomal	O	O	B-T028
gene	O	O	I-T028
cluster	O	O	I-T028
(	O	O	O
rDNA	O	O	B-T028
)	O	O	O
on	O	O	O
synXII	O	O	B-T075
was	O	O	O
left	O	O	O
intact	O	O	O
during	O	O	O
the	O	O	O
assembly	O	O	B-T063
process	O	O	I-T063
and	O	O	O
subsequently	O	O	O
replaced	O	O	O
by	O	O	O
a	O	O	O
modified	O	O	B-T169
rDNA	O	O	O
unit	O	O	O
used	O	O	O
to	O	O	O
regenerate	O	O	B-T169
rDNA	O	O	O
at	O	O	O
three	O	O	O
distinct	O	O	O
chromosomal	O	O	B-T026
locations	O	O	I-T026
.	O	O	O

The	O	O	O
signature	O	O	O
sequences	O	O	B-T086
within	O	O	O
rDNA	O	O	B-T028
,	O	O	O
which	O	O	O
can	O	O	O
be	O	O	O
used	O	O	O
to	O	O	O
determine	O	O	O
species	O	O	B-T185
identity	O	O	B-T033
,	O	O	O
were	O	O	O
swapped	O	O	O
to	O	O	O
generate	O	O	O
a	O	O	O
Saccharomyces	O	O	B-T004
synXII	O	O	B-T075
strain	O	O	B-T001
that	O	O	O
would	O	O	O
be	O	O	O
identified	O	O	B-T080
as	O	O	O
Saccharomyces	O	O	B-T004
bayanus	O	O	I-T004
by	O	O	O
standard	O	O	B-T080
DNA	O	O	O
barcoding	O	O	O
procedures	O	O	O
.	O	O	O

-DOCSTART- (28281646)

Reversible	O	O	O
Humidity	O	O	B-T070
Sensitive	O	O	B-T169
Clothing	O	O	B-T073
for	O	O	O
Personal	O	O	O
Thermoregulation	O	O	O

Two	O	O	O
kinds	O	O	O
of	O	O	O
humidity	O	O	B-T070
-	O	O	O
induced	O	O	B-T169
,	O	O	O
bendable	O	O	O
smart	O	O	B-T073
clothing	O	O	I-T073
have	O	O	O
been	O	O	O
designed	O	O	B-T062
to	O	O	I-T062
reversibly	O	O	I-T062
adapt	O	O	I-T062
their	O	O	O
thermal	O	O	B-T073
insulation	O	O	I-T073
functionality	O	O	I-T073
.	O	O	O

The	O	O	O
first	O	O	O
design	O	O	O
mimics	O	O	O
the	O	O	O
pores	O	O	B-T023
in	O	O	O
human	O	O	B-T022
skin	O	O	I-T022
,	O	O	O
in	O	O	O
which	O	O	O
pre-cut	O	O	O
flaps	O	O	O
open	O	O	O
to	O	O	O
produce	O	O	O
pores	O	O	O
in	O	O	O
Nafion	O	O	B-T109
sheets	O	O	B-T073
when	O	O	O
humidity	O	O	B-T070
increases	O	O	O
,	O	O	O
as	O	O	O
might	O	O	O
occur	O	O	O
during	O	O	O
human	O	O	B-T033
sweating	O	O	I-T033
thus	O	O	O
permitting	O	O	O
air	O	O	B-T067
flow	O	O	I-T067
and	O	O	O
reducing	O	O	O
both	O	O	O
the	O	O	O
humidity	O	O	O
level	O	O	O
and	O	O	O
the	O	O	O
apparent	O	O	B-T081
temperature	O	O	I-T081
.	O	O	O

Like	O	O	O
the	O	O	O
smart	O	O	O
human	O	O	B-T023
sweating	O	O	I-T023
pores	O	O	I-T023
,	O	O	O
the	O	O	O
flaps	O	O	O
can	O	O	O
close	O	O	O
automatically	O	O	O
after	O	O	O
the	O	O	O
perspiration	O	O	B-T033
to	O	O	O
keep	O	O	O
the	O	O	O
wearer	O	O	B-T073
warm	O	O	I-T073
.	O	O	O

The	O	O	O
second	O	O	O
design	O	O	O
involves	O	O	O
thickness	O	O	B-T080
adjustable	O	O	B-T073
clothes	O	O	I-T073
by	O	O	O
inserting	O	O	O
the	O	O	O
bent	O	O	B-T073
polymer	O	O	I-T073
sheets	O	O	I-T073
between	O	O	O
two	O	O	O
fabrics	O	O	B-T073
.	O	O	O

As	O	O	O
the	O	O	O
humidity	O	O	B-T070
increases	O	O	O
,	O	O	O
the	O	O	O
sheets	O	O	B-T073
become	O	O	O
thinner	O	O	O
,	O	O	O
thus	O	O	O
reducing	O	O	O
the	O	O	O
gap	O	O	O
between	O	O	O
the	O	O	O
two	O	O	O
fabrics	O	O	B-T073
to	O	O	O
reduce	O	O	O
the	O	O	O
thermal	O	O	B-T169
insulation	O	O	I-T169
.	O	O	O

The	O	O	O
insulation	O	O	B-T073
layer	O	O	I-T073
can	O	O	O
recover	O	O	O
its	O	O	O
original	O	O	O
thickness	O	O	B-T080
upon	O	O	O
humidity	O	O	B-T070
reduction	O	O	O
to	O	O	O
restore	O	O	O
its	O	O	O
warmth-preservation	O	O	B-T039
function	O	O	O
.	O	O	O

Such	O	O	O
humidity	O	O	B-T070
sensitive	O	O	B-T169
smart	O	O	O
polymer	O	O	B-T073
materials	O	O	I-T073
can	O	O	O
be	O	O	O
utilized	O	O	O
to	O	O	O
adjust	O	O	O
personal	O	O	B-T041
comfort	O	O	I-T041
,	O	O	O
and	O	O	O
be	O	O	O
effective	O	O	O
in	O	O	O
reducing	O	O	B-T033
energy	O	O	I-T033
consumption	O	O	I-T033
for	O	O	O
building	O	O	O
heating	O	O	B-T169
or	O	O	I-T169
cooling	O	O	I-T169
with	O	O	O
numerous	O	O	O
smart	O	O	B-T052
design	O	O	I-T052
.	O	O	O

-DOCSTART- (28282592)

Development	O	O	B-T039
of	O	O	O
an	O	O	O
automaton	O	O	B-T075
model	O	O	I-T075
of	O	O	O
rotational	O	O	B-T052
activity	O	O	I-T052
driving	O	O	O
atrial	O	O	O
fibrillation	O	O	O

Atrial	O	O	B-T047
fibrillation	O	O	I-T047
(	O	O	O
AF	O	O	B-T047
)	O	O	O
is	O	O	O
difficult	O	O	O
to	O	O	O
treat	O	O	B-T061
effectively	O	O	B-T080
,	O	O	O
owing	O	O	O
to	O	O	O
uncertainty	O	O	B-T033
in	O	O	O
where	O	O	O
to	O	O	O
best	O	O	O
ablate	O	O	B-T061
to	O	O	O
eliminate	O	O	B-T052
arrhythmogenic	O	O	B-T046
substrate	O	O	B-T167
.	O	O	O

A	O	O	O
model	O	O	B-T075
providing	O	O	O
insight	O	O	O
into	O	O	O
the	O	O	O
electrical	O	O	B-T169
activation	O	O	B-T052
events	O	O	B-T051
would	O	O	O
be	O	O	O
useful	O	O	O
to	O	O	O
guide	O	O	O
catheter	O	O	B-T061
ablation	O	O	I-T061
strategy	O	O	I-T061
.	O	O	O

Method	O	O	O
A	O	O	O
two-dimensional	O	O	B-T082
,	O	O	O
576	O	O	B-T073
Ã	O	O	I-T073
576	O	O	I-T073
node	O	O	I-T073
automaton	O	O	I-T073
was	O	O	O
developed	O	O	O
to	O	O	O
simulate	O	O	B-T052
atrial	O	O	B-T042
electrical	O	O	I-T042
activity	O	O	I-T042
.	O	O	O

The	O	O	O
substrate	O	O	B-T167
field	O	O	O
was	O	O	O
altered	O	O	O
by	O	O	O
the	O	O	O
presence	O	O	O
of	O	O	O
differing	O	O	B-T080
refractory	O	O	B-T043
period	O	O	I-T043
at	O	O	O
varying	O	O	O
locations	O	O	B-T082
.	O	O	O

Fibrosis	O	O	B-T046
was	O	O	O
added	O	O	O
in	O	O	O
the	O	O	O
form	O	O	O
of	O	O	O
short	O	O	O
,	O	O	O
randomly	O	O	O
positioned	O	O	O
lines	O	O	O
of	O	O	O
conduction	O	O	B-T042
block	O	O	B-T047
.	O	O	O

Larger	O	O	B-T081
areas	O	O	B-T082
of	O	O	O
block	O	O	B-T046
were	O	O	O
used	O	O	O
to	O	O	O
simulate	O	O	B-T052
ablation	O	O	B-T033
lesions	O	O	I-T033
.	O	O	O

Anisotropy	O	O	B-T070
was	O	O	O
imposed	O	O	O
in	O	O	O
a	O	O	O
2:1	O	O	O
ratio	O	O	B-T081
.	O	O	O

A	O	O	O
premature	O	O	B-T079
electrical	O	O	B-T043
impulse	O	O	I-T043
from	O	O	O
one	O	O	O
of	O	O	O
four	O	O	O
grid	O	O	O
corners	O	O	O
was	O	O	O
utilized	O	O	O
to	O	O	O
initiate	O	O	B-T078
activation	O	O	B-T052
.	O	O	O

Rotational	O	O	B-T052
activity	O	O	I-T052
was	O	O	O
uninducible	O	O	O
when	O	O	O
refractory	O	O	B-T081
patch	O	O	I-T081
dimensions	O	O	I-T081
were	O	O	O
less	O	O	O
than	O	O	O
20	O	O	O
Ã	O	O	O
20	O	O	O
mm	O	O	O
.	O	O	O

For	O	O	O
larger	O	O	B-T081
refractory	O	O	B-T082
regions	O	O	I-T082
,	O	O	O
a	O	O	O
single	O	O	O
premature	O	O	B-T079
stimulus	O	O	B-T067
was	O	O	O
capable	O	O	O
of	O	O	O
inducing	O	O	B-T169
an	O	O	O
average	O	O	B-T081
of	O	O	O
1.19Â±1.10	O	O	O
rotors	O	O	B-T074
,	O	O	O
which	O	O	O
often	O	O	O
formed	O	O	O
near	O	O	O
the	O	O	O
patch	O	O	B-T082
edges	O	O	I-T082
.	O	O	O

A	O	O	O
maximum	O	O	B-T081
of	O	O	O
5	O	O	O
rotors	O	O	B-T074
formed	O	O	O
when	O	O	O
refractory	O	O	B-T081
patch	O	O	I-T081
dimensions	O	O	I-T081
approached	O	O	O
the	O	O	O
size	O	O	B-T082
of	O	O	O
the	O	O	O
entire	O	O	O
left	O	O	B-T023
atrial	O	O	I-T023
virtual	O	O	B-T082
field	O	O	I-T082
.	O	O	O

Rotors	O	O	B-T074
formed	O	O	O
along	O	O	O
a	O	O	O
refractory	O	O	B-T082
patch	O	O	I-T082
edge	O	O	I-T082
,	O	O	O
after	O	O	O
wavefront	O	O	B-T033
arrival	O	O	I-T033
was	O	O	I-T033
delayed	O	O	I-T033
at	O	O	O
turning	O	O	O
points	O	O	O
or	O	O	O
due	O	O	O
to	O	O	O
the	O	O	O
presence	O	O	O
of	O	O	O
a	O	O	O
fiber	O	O	B-T024
cluster	O	O	B-T081
of	O	O	O
sufficient	O	O	O
size	O	O	B-T082
.	O	O	O

However	O	O	O
,	O	O	O
rotational	O	O	B-T052
activity	O	O	I-T052
could	O	O	O
also	O	O	O
occur	O	O	O
around	O	O	O
a	O	O	O
large	O	O	B-T081
fiber	O	O	B-T024
cluster	O	O	B-T081
without	O	O	O
the	O	O	O
need	O	O	O
of	O	O	O
spatially	O	O	B-T080
variable	O	O	I-T080
refractoriness	O	O	I-T080
.	O	O	O

When	O	O	O
obstacles	O	O	B-T080
to	O	O	O
conduction	O	O	B-T042
were	O	O	O
lacking	O	O	B-T080
in	O	O	O
size	O	O	B-T082
,	O	O	O
nascent	O	O	B-T074
rotors	O	O	I-T074
drifted	O	O	O
and	O	O	O
either	O	O	O
extinguished	O	O	O
,	O	O	O
or	O	O	O
stabilized	O	O	B-T033
upon	O	O	O
anchoring	O	O	B-T044
at	O	O	O
a	O	O	O
sufficiently	O	O	O
large	O	O	B-T081
fiber	O	O	B-T024
cluster	O	O	B-T081
elsewhere	O	O	O
in	O	O	O
the	O	O	O
field	O	O	O
.	O	O	O

Transient	O	O	B-T079
rotors	O	O	B-T074
terminated	O	O	O
when	O	O	O
traversing	O	O	B-T052
a	O	O	O
region	O	O	B-T082
with	O	O	O
differing	O	O	O
refractory	O	O	B-T043
periods	O	O	I-T043
,	O	O	O
if	O	O	O
no	O	O	O
obstacle	O	O	B-T080
to	O	O	O
conduction	O	O	B-T042
was	O	O	O
present	O	O	O
to	O	O	O
sufficiently	O	O	O
delay	O	O	B-T033
wavefront	O	O	I-T033
arrival	O	O	I-T033
beyond	O	O	O
the	O	O	O
longest	O	O	B-T080
refractory	O	O	B-T043
period	O	O	I-T043
.	O	O	O

Other	O	O	O
rotors	O	O	B-T074
were	O	O	O
annihilated	O	O	O
when	O	O	O
a	O	O	O
nearby	O	O	O
rotor	O	O	B-T074
with	O	O	O
faster	O	O	O
spin	O	O	B-T081
rate	O	O	I-T081
gradually	O	O	O
interrupted	O	O	O
the	O	O	O
activation	O	O	B-T044
pathway	O	O	I-T044
.	O	O	O

Elimination	O	O	B-T052
of	O	O	O
anchors	O	O	B-T061
by	O	O	O
removal	O	O	B-T061
,	O	O	O
or	O	O	O
by	O	O	O
simulated	O	O	O
ablation	O	O	B-T061
over	O	O	O
a	O	O	O
sufficient	O	O	O
region	O	O	B-T082
,	O	O	O
prevented	O	O	O
rotor	O	O	B-T074
onset	O	O	B-T080
at	O	O	O
a	O	O	O
particular	O	O	O
location	O	O	B-T029
where	O	O	O
it	O	O	O
would	O	O	O
otherwise	O	O	O
form	O	O	O
.	O	O	O

The	O	O	O
presence	O	O	O
of	O	O	O
obstacles	O	O	B-T080
to	O	O	O
conduction	O	O	B-T042
and	O	O	O
spatial	O	O	B-T033
differences	O	O	I-T033
in	O	O	O
refractory	O	O	B-T043
period	O	O	I-T043
are	O	O	O
important	O	O	O
parameters	O	O	B-T078
for	O	O	O
initiating	O	O	O
and	O	O	O
maintaining	O	O	B-T169
rotational	O	O	B-T052
activity	O	O	I-T052
in	O	O	O
this	O	O	O
simulation	O	O	B-T062
of	O	O	O
an	O	O	O
atrial	O	O	B-T023
substrate	O	O	B-T167
.	O	O	O

-DOCSTART- (28282963)

Multimodal	O	O	B-T060
brain	O	O	I-T060
imaging	O	O	I-T060
with	O	O	O
magnetoencephalography	O	O	B-T060
:	O	O	O
A	O	O	O
method	O	O	B-T060
for	O	O	O
measuring	O	O	B-T169
blood	O	O	B-T040
pressure	O	O	I-T040
and	O	O	O
cardiorespiratory	O	O	O
oscillations	O	O	O

Studies	O	O	B-T062
with	O	O	O
magnetoencephalography	O	O	B-T060
(	O	O	O
MEG	O	O	B-T060
)	O	O	O
are	O	O	O
still	O	O	O
quite	O	O	O
rarely	O	O	O
combined	O	O	O
simultaneously	O	O	O
with	O	O	O
methods	O	O	B-T060
that	O	O	O
can	O	O	O
provide	O	O	O
a	O	O	O
metabolic	O	O	B-T169
dimension	O	O	I-T169
to	O	O	O
MEG	O	O	O
investigation	O	O	B-T058
s.	O	O	O
In	O	O	O
addition	O	O	O
,	O	O	O
continuous	O	O	O
blood	O	O	B-T058
pressure	O	O	I-T058
measurements	O	O	I-T058
which	O	O	O
comply	O	O	O
with	O	O	O
MEG	O	O	O
compatibility	O	O	O
requirements	O	O	O
are	O	O	O
lacking	O	O	O
.	O	O	O

For	O	O	O
instance	O	O	O
,	O	O	O
by	O	O	O
combining	O	O	O
methods	O	O	B-T060
reflecting	O	O	O
neurovascular	O	O	B-T058
status	O	O	I-T058
one	O	O	O
could	O	O	O
obtain	O	O	O
more	O	O	O
information	O	O	O
on	O	O	O
low	O	O	B-T079
frequency	O	O	I-T079
fluctuations	O	O	B-T184
that	O	O	O
have	O	O	O
recently	O	O	O
gained	O	O	O
increasing	O	O	O
interest	O	O	O
as	O	O	O
a	O	O	O
mediator	O	O	O
of	O	O	O
functional	O	O	B-T169
connectivity	O	O	I-T169
within	O	O	O
brain	O	O	B-T023
networks	O	O	I-T023
.	O	O	O

This	O	O	O
paper	O	O	O
presents	O	O	O
a	O	O	O
multimodal	O	O	B-T060
brain	O	O	I-T060
imaging	O	O	I-T060
setup	O	O	O
,	O	O	O
capable	O	O	O
to	O	O	O
non-invasively	O	O	B-T169
and	O	O	O
continuously	O	O	O
measure	O	O	O
cerebral	O	O	B-T023
hemodynamic	O	O	B-T042
,	O	O	O
cardiorespiratory	O	O	B-T060
and	O	O	O
blood	O	O	B-T040
pressure	O	O	I-T040
oscillations	O	O	B-T040
simultaneously	O	O	O
with	O	O	O
MEG	O	O	B-T060
.	O	O	O

In	O	O	O
the	O	O	O
setup	O	O	O
,	O	O	O
all	O	O	O
methods	O	O	B-T060
apart	O	O	O
from	O	O	O
MEG	O	O	B-T060
rely	O	O	O
on	O	O	O
the	O	O	O
use	O	O	O
of	O	O	O
fibre	O	O	B-T090
optics	O	O	I-T090
.	O	O	O

In	O	O	O
particular	O	O	O
,	O	O	O
we	O	O	O
present	O	O	O
a	O	O	O
method	O	O	B-T060
for	O	O	O
measuring	O	O	B-T169
of	O	O	O
blood	O	O	B-T040
pressure	O	O	I-T040
and	O	O	O
cardiorespiratory	O	O	B-T040
oscillations	O	O	I-T040
continuously	O	O	O
with	O	O	O
MEG	O	O	B-T060
.	O	O	O

The	O	O	O
potential	O	O	B-T080
of	O	O	O
this	O	O	O
type	O	O	O
of	O	O	O
multimodal	O	O	B-T060
setup	O	O	O
for	O	O	O
brain	O	O	B-T062
research	O	O	I-T062
is	O	O	O
demonstrated	O	O	O
by	O	O	O
our	O	O	O
preliminary	O	O	O
studies	O	O	O
on	O	O	O
human	O	O	B-T016
,	O	O	O
showing	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
mild	O	O	B-T033
hypercapnia	O	O	I-T033
,	O	O	O
gathered	O	O	O
simultaneously	O	O	O
with	O	O	O
the	O	O	O
presented	O	O	O
modalities	O	O	B-T169
.	O	O	O

-DOCSTART- (28283668)

Effect	O	O	B-T080
of	O	O	I-T080
peritoneal	O	O	B-T058
lavage	O	O	I-T058
solution	O	O	B-T167
temperature	O	O	B-T081
on	O	O	O
body	O	O	B-T032
temperature	O	O	I-T032
in	O	O	O
anaesthetised	O	O	B-T033
cats	O	O	B-T015
and	O	O	O
small	O	O	O
dogs	O	O	O

A	O	O	O
prospective	O	O	B-T062
,	O	O	O
randomised	O	O	B-T062
,	O	O	O
non-blinded	O	O	B-T062
,	O	O	O
clinical	O	O	B-T062
study	O	O	I-T062
to	O	O	O
assess	O	O	O
the	O	O	O
effect	O	O	B-T080
of	O	O	I-T080
peritoneal	O	O	B-T058
lavage	O	O	I-T058
using	O	O	O
warmed	O	O	B-T070
fluid	O	O	B-T167
on	O	O	O
body	O	O	B-T032
temperature	O	O	I-T032
in	O	O	O
anesthetised	O	O	B-T033
cats	O	O	B-T015
and	O	O	O
dogs	O	O	B-T015
of	O	O	O
less	O	O	O
than	O	O	O
10	O	O	O
kg	O	O	O
body	O	O	B-T033
mass	O	O	I-T033
undergoing	O	O	O
coeliotomy	O	O	B-T061
.	O	O	O

A	O	O	O
standardised	O	O	B-T170
anaesthetic	O	O	I-T170
protocol	O	O	I-T170
was	O	O	O
used	O	O	O
.	O	O	O

Oesophageal	O	O	B-T058
and	O	O	O
rectal	O	O	B-T033
temperatures	O	O	I-T033
were	O	O	O
measured	O	O	B-T080
at	O	O	O
various	O	O	B-T079
time	O	O	I-T079
points	O	O	I-T079
.	O	O	O

At	O	O	O
the	O	O	O
end	O	O	O
of	O	O	O
surgery	O	O	B-T061
,	O	O	O
group	O	O	B-T096
1	O	O	I-T101
patients	O	O	I-T101
(	O	O	O
n=10	O	O	O
)	O	O	O
were	O	O	O
lavaged	O	O	B-T061
with	O	O	O
200	O	O	O
ml/kg	O	O	O
sterile	O	O	B-T080
isotonic	O	O	B-T121
saline	O	O	I-T121
at	O	O	O
34Â±1	O	O	O
Â°	O	O	O
C	O	O	O
and	O	O	O
group	O	O	O
2	O	O	O
(	O	O	O
n=10	O	O	O
)	O	O	O
at	O	O	O
40Â±1	O	O	O
Â°	O	O	O
C	O	O	O
.	O	O	O

Groups	O	O	B-T096
were	O	O	O
similar	O	O	O
with	O	O	O
respect	O	O	O
to	O	O	O
age	O	O	B-T100
,	O	O	O
mass	O	O	B-T081
,	O	O	O
body	O	O	B-T033
condition	O	O	I-T033
and	O	O	O
surgical	O	O	B-T061
incision	O	O	I-T061
length	O	O	O
.	O	O	O

Duration	O	O	B-T079
of	O	O	O
anaesthesia	O	O	B-T061
,	O	O	O
surgical	O	O	B-T061
procedures	O	O	I-T061
and	O	O	O
peritoneal	O	O	B-T058
lavage	O	O	I-T058
was	O	O	O
similar	O	O	O
between	O	O	O
groups	O	O	B-T096
.	O	O	O

Linear	O	O	B-T081
regression	O	O	I-T081
showed	O	O	O
no	O	O	B-T033
significant	O	O	I-T033
change	O	O	I-T033
in	O	O	O
oesophageal	O	O	B-T058
temperature	O	O	I-T058
during	O	O	O
the	O	O	O
lavage	O	O	B-T061
period	O	O	B-T079
for	O	O	O
group	O	O	B-T096
1	O	O	O
(	O	O	O
P=0.64	O	O	O
)	O	O	O
,	O	O	O
but	O	O	O
a	O	O	O
significant	O	O	O
increase	O	O	O
for	O	O	O
group	O	O	B-T101
2	O	O	I-T101
patients	O	O	I-T101
(	O	O	O
P<0.0001	O	O	O
)	O	O	O
,	O	O	O
with	O	O	O
mean	O	O	B-T081
temperature	O	O	B-T080
changes	O	O	I-T080
of	O	O	O
-0.5	O	O	O
Â°	O	O	O
C	O	O	O
(	O	O	O
from	O	O	O
(	O	O	O
36.3	O	O	O
Â°	O	O	O
C	O	O	O
to	O	O	O
35.9	O	O	O
Â°	O	O	O
C	O	O	O
)	O	O	O
and	O	O	O
+	O	O	O
0.9	O	O	O
Â°	O	O	O
C	O	O	O
(	O	O	O
from	O	O	O
35.4	O	O	O
Â°	O	O	O
C	O	O	O
to	O	O	O
36.3	O	O	O
Â°	O	O	O
C	O	O	O
)	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

Similar	O	O	O
results	O	O	B-T033
were	O	O	O
found	O	O	O
for	O	O	O
rectal	O	O	B-T033
temperature	O	O	I-T033
,	O	O	O
with	O	O	O
mean	O	O	B-T081
changes	O	O	O
of	O	O	O
-0.5	O	O	O
Â°	O	O	O
C	O	O	O
and	O	O	O
+	O	O	O
0.8	O	O	O
Â°	O	O	O
C	O	O	O
(	O	O	O
P=0.922	O	O	O
and	O	O	O
0.045	O	O	O
)	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

The	O	O	O
use	O	O	O
of	O	O	O
isotonic	O	O	B-T121
crystalloid	O	O	B-T121
solution	O	O	I-T121
for	O	O	O
peritoneal	O	O	B-T058
lavage	O	O	B-T061
at	O	O	O
a	O	O	O
temperature	O	O	B-T081
of	O	O	O
40Â±1	O	O	O
Â°	O	O	O
C	O	O	O
significantly	O	O	O
warms	O	O	B-T070
small	O	O	B-T101
animal	O	O	I-T101
patients	O	O	I-T101
,	O	O	O
when	O	O	O
applied	O	O	O
in	O	O	O
a	O	O	O
clinical	O	O	B-T082
setting	O	O	I-T082
,	O	O	O
compared	O	O	O
with	O	O	O
lavage	O	O	O
solution	O	O	O
at	O	O	O
34Â±1	O	O	O
Â°	O	O	O
C	O	O	O
.	O	O	O

-DOCSTART- (28284875)

Bioengineered	O	O	B-T090
3D	O	O	B-T082
Models	O	O	B-T075
for	O	O	O
Studying	O	O	B-T062
Human	O	O	B-T016
Cell	O	O	B-T025
-	O	O	O
Tuberculosis	O	O	B-T007
Interactions	O	O	O

In	O	O	B-T082
vivo	O	O	I-T082
animal	O	O	B-T008
models	O	O	I-T008
have	O	O	O
intrinsic	O	O	O
limitations	O	O	O
for	O	O	O
studying	O	O	B-T062
relationships	O	O	B-T080
between	O	O	O
tuberculosis	O	O	B-T007
and	O	O	O
its	O	O	O
host	O	O	B-T001
and	O	O	O
there	O	O	O
is	O	O	O
a	O	O	O
need	O	O	O
for	O	O	O
alternative	O	O	O
,	O	O	O
in	O	O	B-T080
vitro	O	O	I-T080
cellular	O	O	B-T075
models	O	O	I-T075
.	O	O	O

A	O	O	O
microsphere	O	O	B-T074
-based	O	O	O
3D	O	O	B-T082
in	O	O	B-T080
vitro	O	O	I-T080
culture	O	O	B-T063
system	O	O	I-T063
of	O	O	O
Mycobacterium	O	O	B-T007
tuberculosis	O	O	I-T007
-infected	O	O	O
human	O	O	B-T016
blood	O	O	B-T031
mononuclear	O	O	B-T025
cells	O	O	I-T025
was	O	O	O
reported	O	O	O
to	O	O	O
address	O	O	O
specific	O	O	O
aspects	O	O	O
of	O	O	O
host	O	O	B-T001
-	O	O	O
pathogen	O	O	B-T001
interactions	O	O	B-T169
.	O	O	O

-DOCSTART- (28285800)

Perspectives	O	O	B-T078
on	O	O	O
cardiovascular	O	O	B-T022
effects	O	O	B-T080
of	O	O	I-T080
incretin	O	O	B-T116
-based	O	O	O
drugs	O	O	B-T121
:	O	O	O
From	O	O	O
bedside	O	O	O
to	O	O	O
bench	O	O	O
,	O	O	O
return	O	O	O
trip	O	O	O

Recently	O	O	O
,	O	O	O
cardiovascular	O	O	B-T022
outcome	O	O	B-T169
trials	O	O	B-T062
with	O	O	O
glucose	O	O	B-T109
-lowering	O	O	O
drugs	O	O	B-T121
used	O	O	O
in	O	O	O
type	O	O	B-T047
2	O	O	I-T047
diabetes	O	O	I-T047
mellitus	O	O	I-T047
,	O	O	O
namely	O	O	O
glucagon-like	O	O	B-T192
peptide-1	O	O	I-T192
receptor	O	O	I-T192
agonists	O	O	B-T121
(	O	O	O
GLP-1RA	O	O	B-T121
)	O	O	O
,	O	O	O
liraglutide	O	O	B-T116
and	O	O	O
semaglutide	O	O	B-T116
,	O	O	O
showed	O	O	O
a	O	O	O
reduction	O	O	B-T081
in	O	O	O
cardiovascular	O	O	B-T033
events	O	O	I-T033
,	O	O	O
which	O	O	O
had	O	O	O
not	O	O	O
been	O	O	O
observed	O	O	O
in	O	O	O
trials	O	O	O
with	O	O	O
other	O	O	O
incretin	O	O	B-T116
-based	O	O	O
drugs	O	O	O
,	O	O	O
such	O	O	O
as	O	O	O
lixisenatide	O	O	B-T116
or	O	O	O
with	O	O	O
dipeptidyl	O	O	B-T121
peptidase-4	O	O	I-T121
inhibitors	O	O	I-T121
(	O	O	O
DPP4i	O	O	B-T121
)	O	O	O
.	O	O	O

Mechanisms	O	O	B-T169
underlying	O	O	O
the	O	O	O
observed	O	O	O
cardiovascular	O	O	B-T022
differences	O	O	B-T080
between	O	O	O
DPP4i	O	O	B-T121
and	O	O	O
GLP1-RA	O	O	B-T121
,	O	O	O
and	O	O	O
across	O	O	O
individual	O	O	O
GLP1-RA	O	O	O
are	O	O	O
poorly	O	O	O
understood	O	O	O
.	O	O	O

This	O	O	O
review	O	O	B-T170
is	O	O	O
aimed	O	O	O
at	O	O	O
collecting	O	O	O
and	O	O	O
summarizing	O	O	O
available	O	O	O
evidence	O	O	B-T078
from	O	O	O
experimental	O	O	B-T062
and	O	O	O
mechanistic	O	O	B-T062
studies	O	O	I-T062
on	O	O	O
the	O	O	O
action	O	O	B-T052
of	O	O	O
GLP1-RA	O	O	B-T121
and	O	O	O
DPP4i	O	O	B-T121
on	O	O	O
the	O	O	O
cardiovascular	O	O	B-T022
system	O	O	I-T022
,	O	O	O
both	O	O	O
deriving	O	O	O
from	O	O	O
clinical	O	O	B-T081
and	O	O	O
pre-clinical	O	O	B-T081
sources	O	O	I-T081
.	O	O	O

The	O	O	O
results	O	O	B-T169
of	O	O	O
cardiovascular	O	O	B-T022
outcome	O	O	B-T169
trials	O	O	B-T062
are	O	O	O
interpreted	O	O	O
on	O	O	O
the	O	O	O
basis	O	O	O
of	O	O	O
the	O	O	O
experimental	O	O	B-T062
preclinical	O	O	B-T170
data	O	O	I-T170
available	O	O	O
,	O	O	O
paying	O	O	O
particular	O	O	O
attention	O	O	O
to	O	O	O
the	O	O	O
heart	O	O	B-T047
failure	O	O	I-T047
results	O	O	O
,	O	O	O
and	O	O	O
suggesting	O	O	O
some	O	O	O
novel	O	O	O
intriguing	O	O	O
hypotheses	O	O	B-T078
to	O	O	O
explain	O	O	O
some	O	O	O
of	O	O	O
the	O	O	O
unexpected	O	O	O
findings	O	O	B-T169
of	O	O	O
cardioprotection	O	O	B-T169
of	O	O	O
incretin	O	O	B-T116
-based	O	O	O
drugs	O	O	B-T121
.	O	O	O

In	O	O	O
particular	O	O	O
,	O	O	O
we	O	O	O
discuss	O	O	O
the	O	O	O
possible	O	O	O
contribution	O	O	O
to	O	O	O
the	O	O	O
incretin	O	O	B-T116
cardiovascular	O	O	B-T022
effects	O	O	B-T080
of	O	O	I-T080
a	O	O	O
direct	O	O	O
cardiac	O	O	B-T023
action	O	O	B-T052
of	O	O	O
GLP-1	O	O	B-T116
metabolites	O	O	B-T123
through	O	O	O
GLP-1	O	O	B-T192
receptor	O	O	I-T192
-independent	O	O	O
pathways	O	O	B-T044
,	O	O	O
and	O	O	O
of	O	O	O
DPP4	O	O	B-T116
substrates	O	O	B-T167
other	O	O	O
than	O	O	O
GLP-1	O	O	O
.	O	O	O

-DOCSTART- (28286021)

Role	O	O	O
of	O	O	O
breast	O	O	B-T060
magnetic	O	O	I-T060
resonance	O	O	I-T060
imaging	O	O	I-T060
in	O	O	O
predicting	O	O	B-T078
residual	O	O	B-T080
lobular	O	O	B-T191
carcinoma	O	O	I-T191
in	O	O	I-T191
situ	O	O	I-T191
after	O	O	O
initial	O	O	B-T079
excision	O	O	O

Breast	O	O	B-T060
magnetic	O	O	I-T060
resonance	O	O	I-T060
(	O	O	I-T060
MR	O	O	I-T060
)	O	O	I-T060
imaging	O	O	I-T060
is	O	O	O
a	O	O	O
useful	O	O	O
screening	O	O	B-T060
modality	O	O	B-T078
in	O	O	O
detecting	O	O	B-T061
suspicious	O	O	B-T033
lesions	O	O	B-T033
in	O	O	O
patients	O	O	B-T101
with	O	O	O
a	O	O	O
history	O	O	B-T033
of	O	O	O
lobular	O	O	B-T191
carcinoma	O	O	I-T191
in	O	O	I-T191
situ	O	O	I-T191
(	O	O	O
LCIS	O	O	B-T191
)	O	O	O
.	O	O	O

This	O	O	O
study	O	O	B-T062
aimed	O	O	B-T078
to	O	O	O
evaluate	O	O	B-T058
the	O	O	O
effectiveness	O	O	B-T080
of	O	O	O
breast	O	O	B-T060
MR	O	O	I-T060
imaging	O	O	I-T060
in	O	O	O
detecting	O	O	B-T061
remnant	O	O	B-T018
LCIS	O	O	B-T191
lesions	O	O	B-T033
after	O	O	B-T079
initial	O	O	B-T079
excision	O	O	B-T061
.	O	O	O

Between	O	O	O
2011	O	O	O
and	O	O	O
2015	O	O	O
,	O	O	O
29	O	O	O
patients	O	O	B-T101
with	O	O	O
LCIS	O	O	B-T191
who	O	O	O
underwent	O	O	B-T033
initial	O	O	B-T079
excision	O	O	B-T061
were	O	O	O
enrolled	O	O	O
.	O	O	O

Breast	O	O	B-T060
ultrasonography	O	O	I-T060
and	O	O	O
breast	O	O	B-T060
MR	O	O	I-T060
imaging	O	O	I-T060
was	O	O	O
conducted	O	O	O
after	O	O	B-T079
initial	O	O	B-T079
excision	O	O	B-T061
.	O	O	O

Imaging	O	O	B-T034
findings	O	O	I-T034
were	O	O	O
compared	O	O	B-T052
with	O	O	O
pathologic	O	O	B-T046
results	O	O	B-T169
.	O	O	O

There	O	O	O
were	O	O	O
nine	O	O	O
(	O	O	O
31.0	O	O	O
%	O	O	O
)	O	O	O
cases	O	O	B-T077
with	O	O	O
positive	O	O	B-T033
margins	O	O	I-T033
after	O	O	B-T079
initial	O	O	B-T079
excision	O	O	B-T061
;	O	O	O
they	O	O	O
were	O	O	O
LCIS	O	O	B-T191
(	O	O	O
n=8	O	O	O
)	O	O	O
and	O	O	O
atypical	O	O	B-T046
lobular	O	O	I-T046
hyperplasia	O	O	I-T046
(	O	O	O
n=1	O	O	O
)	O	O	O
.	O	O	O

Residual	O	O	B-T080
lesions	O	O	B-T033
were	O	O	O
identified	O	O	B-T080
in	O	O	O
12	O	O	O
cases	O	O	B-T077
;	O	O	O
they	O	O	O
were	O	O	O
invasive	O	O	B-T191
lobular	O	O	I-T191
carcinoma	O	O	I-T191
(	O	O	O
n=1	O	O	O
;	O	O	O
3.4	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
LCIS	O	O	B-T191
(	O	O	O
n=9	O	O	O
;	O	O	O
31.0	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
atypical	O	O	B-T046
lobular	O	O	I-T046
hyperplasia	O	O	I-T046
(	O	O	O
n=1	O	O	O
;	O	O	O
3.4	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
papillary	O	O	B-T191
carcinoma	O	O	I-T191
in	O	O	I-T191
situ	O	O	I-T191
(	O	O	O
n=1	O	O	O
;	O	O	O
3.4	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

Prior	O	O	B-T079
to	O	O	O
the	O	O	O
second	O	O	B-T081
operation	O	O	B-T061
,	O	O	O
these	O	O	O
lesions	O	O	B-T033
could	O	O	O
be	O	O	O
detected	O	O	O
in	O	O	O
seven	O	O	O
cases	O	O	B-T077
using	O	O	O
ultrasonography	O	O	B-T060
(	O	O	O
sensitivity	O	O	B-T081
,	O	O	O
53.3	O	O	O
%	O	O	O
;	O	O	O
specificity	O	O	B-T081
,	O	O	O
100	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
in	O	O	O
10	O	O	O
cases	O	O	O
using	O	O	O
breast	O	O	B-T060
MR	O	O	I-T060
imaging	O	O	I-T060
(	O	O	O
sensitivity	O	O	O
,	O	O	O
83.3	O	O	O
%	O	O	O
;	O	O	O
specificity	O	O	O
,	O	O	O
100	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

Breast	O	O	B-T060
MR	O	O	I-T060
imaging	O	O	I-T060
showed	O	O	O
higher	O	O	B-T080
sensitivity	O	O	B-T081
than	O	O	O
breast	O	O	B-T060
ultrasonography	O	O	I-T060
in	O	O	O
detecting	O	O	B-T061
remnant	O	O	B-T018
LCIS	O	O	B-T191
lesions	O	O	B-T033
.	O	O	O

If	O	O	O
a	O	O	O
suspicious	O	O	B-T033
lesion	O	O	B-T033
was	O	O	O
found	O	O	O
using	O	O	O
breast	O	O	B-T060
MR	O	O	I-T060
imaging	O	O	I-T060
,	O	O	O
a	O	O	O
second	O	O	B-T081
operation	O	O	B-T061
should	O	O	O
be	O	O	O
considered	O	O	B-T078
because	O	O	O
of	O	O	O
the	O	O	O
possibility	O	O	B-T033
of	O	O	O
multifocality	O	O	B-T033
,	O	O	O
even	O	O	O
if	O	O	O
LCIS	O	O	B-T191
was	O	O	O
confirmed	O	O	B-T033
at	O	O	O
the	O	O	O
initial	O	O	B-T079
operation	O	O	O
.	O	O	O

-DOCSTART- (28286958)

Construction	O	O	B-T070
of	O	O	O
Fused	O	O	B-T104
Polyheterocycles	O	O	I-T104
through	O	O	O
Sequential	O	O	B-T080
[	O	O	O
4	O	O	O
+	O	O	O
2	O	O	O
]	O	O	O
and	O	O	O
[	O	O	O
3	O	O	O
+	O	O	O
2	O	O	O
]	O	O	O
Cycloadditions	O	O	O

A	O	O	O
method	O	O	O
for	O	O	O
Pd	O	O	B-T196
-	O	O	O
catalyzed	O	O	B-T070
aerobic	O	O	B-T080
oxidative	O	O	B-T044
reaction	O	O	I-T044
of	O	O	O
quinazolinones	O	O	B-T109
and	O	O	O
alkynes	O	O	B-T109
has	O	O	O
been	O	O	O
developed	O	O	O
for	O	O	O
sequential	O	O	B-T080
[	O	O	B-T067
4	O	O	I-T067
+	O	O	I-T067
2	O	O	I-T067
]	O	O	I-T067
and	O	O	I-T067
[	O	O	I-T067
3	O	O	I-T067
+	O	O	I-T067
2	O	O	I-T067
]	O	O	I-T067
cycloadditions	O	O	I-T067
to	O	O	O
assemble	O	O	B-T052
a	O	O	O
novel	O	O	B-T080
fused-polycyclic	O	O	B-T104
system	O	O	I-T104
containing	O	O	O
tetrahydropyridine	O	O	B-T109
and	O	O	O
dihydrofuran	O	O	B-T109
rings	O	O	I-T109
.	O	O	O

The	O	O	O
reaction	O	O	B-T067
process	O	O	I-T067
involves	O	O	O
C-H	O	O	B-T044
and	O	O	I-T044
N-H	O	O	I-T044
bond	O	O	I-T044
functionalization	O	O	O
for	O	O	O
the	O	O	O
formation	O	O	B-T169
of	O	O	O
tetrahydropyridine	O	O	B-T109
and	O	O	O
an	O	O	O
oxygen	O	O	B-T121
radical	O	O	I-T121
cyclization	O	O	B-T070
for	O	O	O
the	O	O	O
dihydrofuran	O	O	B-T109
ring	O	O	I-T109
.	O	O	O

This	O	O	O
atom	O	O	B-T196
-	O	O	O
and	O	O	O
step-	O	O	O
economical	O	O	B-T090
synthesis	O	O	I-T090
is	O	O	O
highly	O	O	O
efficient	O	O	O
and	O	O	O
has	O	O	O
good	O	O	O
substrate	O	O	B-T167
tolerance	O	O	B-T080
,	O	O	O
which	O	O	O
provides	O	O	O
a	O	O	O
new	O	O	O
approach	O	O	O
for	O	O	O
the	O	O	O
construction	O	O	B-T070
of	O	O	O
polycyclic	O	O	B-T104
molecules	O	O	I-T104
with	O	O	O
potential	O	O	O
pharmaceutical	O	O	O
interest	O	O	O
.	O	O	O

-DOCSTART- (28287035)

Biological	O	O	B-T080
basis	O	O	B-T121
of	O	O	O
radiation	O	O	B-T061
protection	O	O	I-T061
needs	O	O	O
rejuvenation	O	O	O

Human	O	O	B-T016
beings	O	O	I-T016
encounter	O	O	O
radiation	O	O	B-T070
in	O	O	O
many	O	O	O
different	O	O	O
situations	O	O	O
-	O	O	O
from	O	O	O
proximity	O	O	B-T082
to	O	O	O
radioactive	O	O	B-T131
waste	O	O	I-T131
sites	O	O	B-T082
to	O	O	O
participation	O	O	B-T169
in	O	O	O
medical	O	O	B-T058
procedures	O	O	I-T058
using	O	O	O
X-rays	O	O	B-T070
etc	O	O	O
.	O	O	O

Limits	O	O	O
for	O	O	O
radiation	O	O	B-T070
exposures	O	O	I-T037
are	O	O	O
legally	O	O	B-T064
regulated	O	O	I-T064
;	O	O	O
however	O	O	O
,	O	O	O
current	O	O	O
radiation	O	O	B-T061
protection	O	O	I-T061
policy	O	O	B-T170
does	O	O	O
not	O	O	O
explicitly	O	O	O
acknowledge	O	O	O
that	O	O	O
biological	O	O	B-T080
,	O	O	O
cellular	O	O	B-T059
and	O	O	O
molecular	O	O	B-T080
effects	O	O	B-T080
of	O	O	I-T080
low	O	O	B-T081
doses	O	O	I-T081
and	O	O	O
low	O	O	O
dose	O	O	B-T081
rates	O	O	I-T081
of	O	O	O
radiation	O	O	O
differ	O	O	O
from	O	O	O
effects	O	O	O
induced	O	O	O
by	O	O	O
medium	O	O	O
and	O	O	O
high	O	O	B-T081
dose	O	O	I-T081
radiation	O	O	B-T037
exposures	O	O	I-T037
.	O	O	O

Recent	O	O	O
technical	O	O	B-T169
developments	O	O	I-T169
in	O	O	O
biology	O	O	B-T091
and	O	O	O
medicine	O	O	B-T091
,	O	O	O
from	O	O	O
single	O	O	B-T059
cell	O	O	I-T059
techniques	O	O	I-T059
to	O	O	O
big	O	O	B-T059
data	O	O	I-T059
computational	O	O	I-T059
research	O	O	I-T059
,	O	O	O
have	O	O	O
enabled	O	O	O
new	O	O	O
approaches	O	O	B-T169
for	O	O	O
study	O	O	B-T062
of	O	O	O
biology	O	O	O
of	O	O	O
low	O	O	B-T081
doses	O	O	I-T081
of	O	O	O
radiation	O	O	B-T070
.	O	O	O

Results	O	O	O
of	O	O	O
the	O	O	O
work	O	O	O
done	O	O	O
so	O	O	O
far	O	O	O
support	O	O	B-T077
the	O	O	O
idea	O	O	B-T078
that	O	O	O
low	O	O	B-T081
doses	O	O	I-T081
of	O	O	O
radiation	O	O	B-T070
have	O	O	O
effects	O	O	O
that	O	O	O
differ	O	O	O
from	O	O	O
those	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
high	O	O	B-T081
dose	O	O	I-T081
exposures	O	O	B-T037
;	O	O	O
this	O	O	O
work	O	O	O
,	O	O	O
however	O	O	O
,	O	O	O
is	O	O	O
far	O	O	O
from	O	O	O
sufficient	O	O	B-T080
for	O	O	O
the	O	O	O
development	O	O	B-T169
of	O	O	O
a	O	O	O
new	O	O	O
theoretical	O	O	B-T170
framework	O	O	I-T170
needed	O	O	O
for	O	O	O
the	O	O	O
understanding	O	O	O
of	O	O	O
low	O	O	B-T081
dose	O	O	I-T081
radiation	O	O	B-T037
exposures	O	O	I-T037
.	O	O	O

Mechanistic	O	O	O
understanding	O	O	O
of	O	O	O
radiation	O	O	B-T067
effects	O	O	I-T067
at	O	O	O
low	O	O	B-T081
doses	O	O	I-T081
is	O	O	O
necessary	O	O	O
in	O	O	O
order	O	O	O
to	O	O	O
develop	O	O	O
better	O	O	O
radiation	O	O	B-T061
protection	O	O	I-T061
policy	O	O	B-T170
.	O	O	O

-DOCSTART- (28289065)

Gleason	O	O	B-T185
grade	O	O	I-T185
grouping	O	O	I-T185
of	O	O	O
prostate	O	O	B-T191
cancer	O	O	I-T191
is	O	O	O
of	O	O	O
prognostic	O	O	B-T201
value	O	O	I-T201
in	O	O	O
Asian	O	O	B-T098
men	O	O	O

The	O	O	O
International	O	O	B-T093
Society	O	O	I-T093
of	O	O	I-T093
Urological	O	O	I-T093
Pathology	O	O	I-T093
made	O	O	O
recommendations	O	O	O
for	O	O	O
the	O	O	O
use	O	O	O
of	O	O	O
Grade	O	O	B-T185
Groups	O	O	I-T185
(	O	O	O
GG	O	O	B-T185
)	O	O	O
originally	O	O	O
described	O	O	O
by	O	O	O
Epstein	O	O	B-T170
and	O	O	O
colleagues	O	O	B-T098
over	O	O	O
Gleason	O	O	B-T033
score	O	O	I-T033
(	O	O	O
GS	O	O	B-T033
)	O	O	O
alone	O	O	O
in	O	O	O
2014	O	O	O
,	O	O	O
which	O	O	O
was	O	O	O
subsequently	O	O	O
adopted	O	O	B-T033
by	O	O	O
the	O	O	O
WHO	O	O	B-T185
classification	O	O	I-T185
in	O	O	O
2016	O	O	O
.	O	O	O

The	O	O	O
majority	O	O	O
of	O	O	O
studies	O	O	B-T062
validating	O	O	O
this	O	O	O
revision	O	O	B-T079
have	O	O	O
been	O	O	O
in	O	O	O
Caucasian	O	O	B-T098
populations	O	O	I-T098
.	O	O	O

We	O	O	O
therefore	O	O	O
asked	O	O	O
whether	O	O	O
the	O	O	O
new	O	O	O
GG	O	O	B-T185
system	O	O	I-T185
was	O	O	O
retrospectively	O	O	O
associated	O	O	O
with	O	O	O
biochemical	O	O	B-T081
disease-free	O	O	I-T081
survival	O	O	I-T081
in	O	O	O
a	O	O	O
mixed-ethnicity	O	O	B-T098
cohort	O	O	B-T098
of	O	O	O
Asian	O	O	B-T098
men	O	O	B-T098
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
680	O	O	O
radical	O	O	B-T061
prostatectomies	O	O	I-T061
(	O	O	O
RPs	O	O	B-T061
)	O	O	O
from	O	O	O
2005	O	O	O
to	O	O	O
2014	O	O	O
were	O	O	O
included	O	O	O
.	O	O	O

GS	O	O	B-T033
from	O	O	O
initial	O	O	O
biopsy	O	O	B-T060
and	O	O	O
RP	O	O	B-T061
were	O	O	O
compared	O	O	O
and	O	O	O
used	O	O	O
to	O	O	O
allocate	O	O	O
cases	O	O	B-T169
to	O	O	O
GG	O	O	B-T185
,	O	O	O
defined	O	O	O
as	O	O	O
:	O	O	O
1	O	O	O
(	O	O	O
GS	O	O	O
â¤6	O	O	O
)	O	O	O
;	O	O	O
2	O	O	O
(	O	O	O
GS	O	O	O
3	O	O	O
+	O	O	O
4=7	O	O	O
)	O	O	O
;	O	O	O
3	O	O	O
(	O	O	O
GS	O	O	O
4	O	O	O
+	O	O	O
3=7	O	O	O
)	O	O	O
;	O	O	O
4	O	O	O
(	O	O	O
GS	O	O	O
4	O	O	O
+	O	O	O
4=8/5	O	O	O
+	O	O	O
3=8/3	O	O	O
+	O	O	O
5=8	O	O	O
)	O	O	O
and	O	O	O
5	O	O	O
(	O	O	O
GS	O	O	O
9	O	O	O
-	O	O	O
10	O	O	O
)	O	O	O
.	O	O	O

Biochemical	O	O	B-T033
recurrence	O	O	I-T033
was	O	O	O
defined	O	O	O
as	O	O	O
two	O	O	O
consecutive	O	O	O
post-	O	O	O
RP	O	O	B-T061
prostate-specific	O	O	B-T116
antigen	O	O	I-T116
(	O	O	O
PSA	O	O	B-T116
)	O	O	O
levels	O	O	O
of	O	O	O
>	O	O	O
0.2	O	O	O
ng/mL	O	O	O
after	O	O	O
post-	O	O	O
RP	O	O	O
PSA	O	O	O
reaching	O	O	O
the	O	O	O
nadir	O	O	B-T080
of	O	O	O
<	O	O	O
0.1	O	O	O
ng/mL.	O	O	O
Our	O	O	O
data	O	O	B-T078
showed	O	O	O
that	O	O	O
Kaplan-Meier	O	O	B-T081
analysis	O	O	I-T081
revealed	O	O	O
significant	O	O	O
differences	O	O	O
in	O	O	O
biochemical	O	O	B-T033
recurrence	O	O	I-T033
within	O	O	O
Gleason	O	O	B-T185
GG	O	O	I-T185
based	O	O	O
on	O	O	O
either	O	O	O
biopsy	O	O	B-T060
or	O	O	O
prostatectomy	O	O	B-T061
scoring	O	O	B-T081
.	O	O	O

Multivariate	O	O	B-T081
analysis	O	O	I-T081
further	O	O	O
confirmed	O	O	O
that	O	O	O
a	O	O	O
higher	O	O	O
GG	O	O	B-T185
was	O	O	O
significantly	O	O	O
associated	O	O	O
with	O	O	O
risk	O	O	B-T078
of	O	O	O
biochemical	O	O	B-T033
recurrence	O	O	I-T033
.	O	O	O

This	O	O	O
GG	O	O	B-T185
system	O	O	I-T185
had	O	O	O
a	O	O	O
higher	O	O	O
prognostic	O	O	B-T081
discrimination	O	O	B-T169
for	O	O	O
both	O	O	O
initial	O	O	O
biopsy	O	O	B-T060
and	O	O	O
RP	O	O	B-T061
than	O	O	O
GS	O	O	B-T033
.	O	O	O

Our	O	O	O
study	O	O	B-T062
validates	O	O	B-T062
the	O	O	O
use	O	O	O
of	O	O	O
the	O	O	O
revised	O	O	B-T079
and	O	O	O
updated	O	O	B-T079
GG	O	O	B-T185
system	O	O	I-T185
in	O	O	O
a	O	O	O
mixed-ethnicity	O	O	B-T098
population	O	O	I-T098
of	O	O	O
Asian	O	O	B-T098
men	O	O	B-T098
.	O	O	O

Higher	O	O	O
GG	O	O	B-T185
was	O	O	O
significantly	O	O	O
associated	O	O	O
with	O	O	O
increased	O	O	O
risk	O	O	B-T078
of	O	O	O
biochemical	O	O	B-T033
recurrence	O	O	I-T033
.	O	O	O

We	O	O	O
therefore	O	O	O
recommend	O	O	O
its	O	O	O
use	O	O	O
to	O	O	O
inform	O	O	O
clinical	O	O	B-T058
management	O	O	I-T058
for	O	O	O
patients	O	O	B-T101
with	O	O	O
prostate	O	O	B-T191
cancer	O	O	I-T191
.	O	O	O

-DOCSTART- (28289091)

Membrane	O	O	B-T026
nanoclusters	O	O	B-T081
of	O	O	O
FcÎ³RI	O	O	B-T116
segregate	O	O	O
from	O	O	O
inhibitory	O	O	B-T052
SIRPÎ±	O	O	B-T116
upon	O	O	O
activation	O	O	O
of	O	O	O
human	O	O	O
macrophages	O	O	O

Signal	O	O	B-T043
integration	O	O	I-T043
between	O	O	O
activating	O	O	B-T052
Fc	O	O	B-T116
receptors	O	O	I-T116
and	O	O	O
inhibitory	O	O	B-T052
signal	O	O	B-T116
regulatory	O	O	I-T116
protein	O	O	I-T116
Î±	O	O	I-T116
(	O	O	O
SIRPÎ±	O	O	B-T116
)	O	O	O
controls	O	O	O
macrophage	O	O	B-T025
phagocytosis	O	O	B-T043
.	O	O	O

Here	O	O	O
,	O	O	O
using	O	O	O
dual-color	O	O	B-T059
direct	O	O	I-T059
stochastic	O	O	I-T059
optical	O	O	I-T059
reconstruction	O	O	I-T059
microscopy	O	O	I-T059
,	O	O	O
we	O	O	O
report	O	O	O
that	O	O	O
FcÎ³	O	O	B-T116
receptor	O	O	I-T116
I	O	O	I-T116
(	O	O	O
FcÎ³RI	O	O	B-T116
)	O	O	O
,	O	O	O
FcÎ³RII	O	O	B-T116
,	O	O	O
and	O	O	O
SIRPÎ±	O	O	B-T116
are	O	O	O
not	O	O	O
homogeneously	O	O	B-T080
distributed	O	O	O
at	O	O	O
macrophage	O	O	B-T025
surfaces	O	O	B-T026
but	O	O	O
are	O	O	O
organized	O	O	O
in	O	O	O
discrete	O	O	B-T080
nanoclusters	O	O	B-T081
,	O	O	O
with	O	O	O
a	O	O	O
mean	O	O	O
radius	O	O	O
of	O	O	O
71	O	O	O
Â±	O	O	O
11	O	O	O
nm	O	O	O
,	O	O	O
60	O	O	O
Â±	O	O	O
6	O	O	O
nm	O	O	O
,	O	O	O
and	O	O	O
48	O	O	O
Â±	O	O	O
3	O	O	O
nm	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

Nanoclusters	O	O	B-T081
of	O	O	O
FcÎ³RI	O	O	B-T116
,	O	O	O
but	O	O	O
not	O	O	O
FcÎ³RII	O	O	B-T116
,	O	O	O
are	O	O	O
constitutively	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
nanoclusters	O	O	B-T081
of	O	O	O
SIRPÎ±	O	O	B-T116
,	O	O	O
within	O	O	O
62	O	O	O
Â±	O	O	O
5	O	O	O
nm	O	O	O
,	O	O	O
mediated	O	O	O
by	O	O	O
the	O	O	O
actin	O	O	B-T026
cytoskeleton	O	O	I-T026
.	O	O	O

Upon	O	O	O
Fc	O	O	B-T116
receptor	O	O	I-T116
activation	O	O	B-T043
,	O	O	O
Src-family	O	O	B-T116
kinase	O	O	I-T116
signaling	O	O	B-T043
leads	O	O	O
to	O	O	O
segregation	O	O	O
of	O	O	O
FcÎ³RI	O	O	B-T116
and	O	O	O
SIRPÎ±	O	O	B-T116
nanoclusters	O	O	B-T081
to	O	O	O
be	O	O	O
197	O	O	O
Â±	O	O	O
3	O	O	O
nm	O	O	O
apart	O	O	O
.	O	O	O

Co-ligation	O	O	B-T044
of	O	O	O
SIRPÎ±	O	O	B-T116
with	O	O	O
CD47	O	O	B-T116
abrogates	O	O	O
nanocluster	O	O	B-T081
segregation	O	O	O
.	O	O	O

If	O	O	O
the	O	O	O
balance	O	O	O
of	O	O	O
signals	O	O	B-T043
favors	O	O	O
activation	O	O	B-T052
,	O	O	O
FcÎ³RI	O	O	B-T116
nanoclusters	O	O	B-T081
reorganize	O	O	B-T078
into	O	O	O
periodically	O	O	B-T079
spaced	O	O	O
concentric	O	O	B-T082
rings	O	O	I-T082
.	O	O	O

Thus	O	O	O
,	O	O	O
a	O	O	O
nanometer	O	O	B-T081
-	O	O	O
and	O	O	O
micron-scale	O	O	B-T081
reorganization	O	O	B-T078
of	O	O	O
activating	O	O	B-T052
and	O	O	O
inhibitory	O	O	B-T052
receptors	O	O	B-T116
occurs	O	O	O
at	O	O	O
the	O	O	O
surface	O	O	O
of	O	O	O
human	O	O	B-T025
macrophages	O	O	I-T025
concurrent	O	O	B-T079
with	O	O	O
signal	O	O	B-T043
integration	O	O	I-T043
.	O	O	O

-DOCSTART- (28289914)

Firecracker	O	O	B-T073
eye	O	O	B-T033
exposure	O	O	I-T033
:	O	O	O
experimental	O	O	B-T062
study	O	O	I-T062
and	O	O	O
simulation	O	O	O

Understanding	O	O	O
the	O	O	O
mechanisms	O	O	B-T169
of	O	O	O
traumatic	O	O	B-T169
ocular	O	O	B-T037
injury	O	O	I-T037
is	O	O	O
helpful	O	O	O
to	O	O	O
make	O	O	O
accurate	O	O	B-T080
diagnoses	O	O	B-T033
before	O	O	O
the	O	O	O
symptoms	O	O	B-T184
emerge	O	O	O
and	O	O	O
to	O	O	O
develop	O	O	O
specific	O	O	O
eye	O	O	B-T073
protection	O	O	I-T073
.	O	O	O

The	O	O	O
comprehension	O	O	B-T041
of	O	O	O
the	O	O	O
dynamics	O	O	B-T070
of	O	O	O
primary	O	O	B-T080
blast	O	O	B-T037
injury	O	O	I-T037
mechanisms	O	O	B-T169
is	O	O	O
a	O	O	O
challenging	O	O	O
issue	O	O	B-T033
.	O	O	O

The	O	O	O
question	O	O	O
is	O	O	O
whether	O	O	O
the	O	O	O
pressure	O	O	B-T067
wave	O	O	B-T070
propagation	O	O	B-T067
and	O	O	O
reflection	O	O	B-T081
alone	O	O	O
could	O	O	O
cause	O	O	B-T078
ocular	O	O	B-T033
damage	O	O	I-T033
.	O	O	O

To	O	O	O
date	O	O	O
,	O	O	O
there	O	O	O
are	O	O	O
dissenting	O	O	B-T054
opinions	O	O	B-T041
and	O	O	O
no	O	O	O
conclusive	O	O	B-T080
evidence	O	O	B-T078
thereupon	O	O	O
.	O	O	O

A	O	O	O
previous	O	O	O
numerical	O	O	B-T058
investigation	O	O	I-T058
of	O	O	O
blast	O	O	B-T070
trauma	O	O	B-T037
highlighted	O	O	O
the	O	O	O
dynamic	O	O	B-T169
effect	O	O	B-T080
of	O	O	O
pressure	O	O	B-T067
propagation	O	O	B-T067
and	O	O	O
its	O	O	O
amplification	O	O	B-T067
by	O	O	O
the	O	O	O
geometry	O	O	B-T090
of	O	O	O
the	O	O	O
bony	O	O	B-T023
orbit	O	O	I-T023
,	O	O	O
inducing	O	O	B-T169
a	O	O	O
resonance	O	O	B-T070
cavity	O	O	B-T030
effect	O	O	O
and	O	O	O
a	O	O	O
standing	O	O	B-T070
wave	O	O	I-T070
hazardous	O	O	B-T080
for	O	O	O
eye	O	O	B-T023
tissues	O	O	B-T024
.	O	O	O

The	O	O	O
objective	O	O	O
of	O	O	O
the	O	O	O
current	O	O	O
work	O	O	O
is	O	O	O
to	O	O	O
find	O	O	O
experimental	O	O	B-T080
evidence	O	O	B-T078
of	O	O	O
the	O	O	O
numerically	O	O	B-T081
identified	O	O	B-T080
phenomenon	O	O	B-T067
.	O	O	O

Therefore	O	O	O
,	O	O	O
tests	O	O	B-T170
aimed	O	O	O
at	O	O	O
evaluating	O	O	B-T058
the	O	O	O
response	O	O	B-T032
of	O	O	O
porcine	O	O	B-T015
eyes	O	O	B-T023
to	O	O	O
blast	O	O	B-T070
overpressure	O	O	B-T067
generated	O	O	O
by	O	O	O
firecrackers	O	O	B-T073
explosion	O	O	B-T067
were	O	O	O
performed	O	O	B-T169
.	O	O	O

The	O	O	O
orbital	O	O	B-T030
cavity	O	O	I-T030
effect	O	O	B-T080
was	O	O	O
considered	O	O	O
mounting	O	O	O
the	O	O	O
enucleated	O	O	B-T037
eyes	O	O	I-T037
inside	O	O	O
a	O	O	O
dummy	O	O	O
orbit	O	O	B-T030
.	O	O	O

The	O	O	O
experimental	O	O	B-T080
measurements	O	O	B-T169
obtained	O	O	B-T169
during	O	O	O
the	O	O	O
explosion	O	O	B-T067
tests	O	O	B-T170
presented	O	O	O
in	O	O	O
this	O	O	O
paper	O	O	B-T170
corroborate	O	O	B-T080
the	O	O	O
numerical	O	O	B-T078
evidence	O	O	I-T078
of	O	O	O
a	O	O	O
high-frequency	O	O	B-T079
pressure	O	O	B-T067
amplification	O	O	B-T067
,	O	O	O
enhancing	O	O	B-T052
the	O	O	O
loading	O	O	O
on	O	O	O
the	O	O	O
ocular	O	O	B-T023
tissues	O	O	B-T024
,	O	O	O
attributable	O	O	B-T041
to	O	O	O
the	O	O	O
orbital	O	O	B-T029
bony	O	O	I-T029
walls	O	O	I-T029
surrounding	O	O	O
the	O	O	O
eye	O	O	B-T023
.	O	O	O

-DOCSTART- (28294559)

The	O	O	O
platelet-activating	O	O	B-T116
receptor	O	O	I-T116
C-type	O	O	B-T116
lectin	O	O	I-T116
receptor-2	O	O	I-T116
plays	O	O	O
an	O	O	O
essential	O	O	O
role	O	O	B-T077
in	O	O	O
liver	O	O	B-T042
regeneration	O	O	I-T042
after	O	O	O
partial	O	O	B-T061
hepatectomy	O	O	I-T061
in	O	O	O
mice	O	O	O

Essentials	O	O	O
Regeneration	O	O	B-T042
role	O	O	B-T077
of	O	O	O
C-type	O	O	B-T116
lectin	O	O	I-T116
receptor-2	O	O	I-T116
(	O	O	O
CLEC-2	O	O	B-T116
)	O	O	O
after	O	O	O
70	O	O	B-T061
%	O	O	I-T061
hepatectomy	O	O	I-T061
(	O	O	O
HPx	O	O	B-T061
)	O	O	O
was	O	O	O
investigated	O	O	O
.	O	O	O

Wild-type	O	O	B-T028
or	O	O	O
CLEC-2	O	O	B-T028
deleted	O	O	B-T045
from	O	O	O
platelets	O	O	B-T025
of	O	O	O
chimeric	O	O	B-T015
mice	O	O	I-T015
(	O	O	O
flKO	O	O	B-T015
)	O	O	O
underwent	O	O	O
HPx	O	O	B-T061
.	O	O	O

The	O	O	O
liver/body	O	O	B-T081
weight	O	O	I-T081
ratio	O	O	I-T081
was	O	O	O
significantly	O	O	O
lower	O	O	O
in	O	O	O
the	O	O	O
flKO	O	O	B-T015
than	O	O	O
in	O	O	O
the	O	O	O
wild-type	O	O	B-T015
.	O	O	O

CLEC-2	O	O	B-T116
plays	O	O	O
an	O	O	O
essential	O	O	O
role	O	O	B-T077
in	O	O	O
liver	O	O	B-T042
regeneration	O	O	I-T042
after	O	O	O
HPx	O	O	B-T061
.	O	O	O

Background	O	O	O
and	O	O	O
aim	O	O	O
The	O	O	O
aim	O	O	O
of	O	O	O
the	O	O	O
present	O	O	O
study	O	O	O
was	O	O	O
to	O	O	O
investigate	O	O	O
the	O	O	O
role	O	O	B-T077
of	O	O	O
C-type	O	O	B-T116
lectin	O	O	I-T116
receptor	O	O	I-T116
(CLEC)-2	O	O	I-T116
in	O	O	O
liver	O	O	B-T042
regeneration	O	O	I-T042
following	O	O	O
partial	O	O	B-T061
liver	O	O	I-T061
resection	O	O	I-T061
in	O	O	O
mice	O	O	B-T015
.	O	O	O

Materials	O	O	O
and	O	O	O
methods	O	O	O
Irradiated	O	O	O
chimeric	O	O	B-T015
mice	O	O	B-T015
transplanted	O	O	B-T169
with	O	O	O
fetal	O	O	B-T169
liver	O	O	B-T025
cells	O	O	I-T025
from	O	O	O
wild-type	O	O	B-T015
(	O	O	I-T015
WT	O	O	I-T015
)	O	O	I-T015
mice	O	O	I-T015
,	O	O	O
CLEC-2	O	O	B-T028
-	O	O	O
deleted	O	O	B-T045
(	O	O	O
KO	O	O	O
)	O	O	O
mice	O	O	O
or	O	O	O
mice	O	O	O
with	O	O	O
CLEC-2	O	O	O
deleted	O	O	O
specifically	O	O	O
from	O	O	O
platelets	O	O	B-T025
(	O	O	O
flKO	O	O	O
)	O	O	O
were	O	O	O
generated	O	O	B-T052
.	O	O	O

Mice	O	O	B-T015
underwent	O	O	O
70	O	O	B-T061
%	O	O	I-T061
partial	O	O	I-T061
hepatectomy	O	O	I-T061
(	O	O	O
PH	O	O	B-T061
)	O	O	O
.	O	O	O

Immunohistochemical	O	O	B-T059
staining	O	O	I-T059
was	O	O	O
performed	O	O	O
to	O	O	O
investigate	O	O	O
the	O	O	O
expression	O	O	B-T045
of	O	O	O
the	O	O	O
endogenous	O	O	B-T169
ligand	O	O	B-T103
for	O	O	O
CLEC-2	O	O	B-T116
,	O	O	O
podoplanin	O	O	B-T116
.	O	O	O

The	O	O	O
accumulation	O	O	B-T043
of	O	O	O
platelets	O	O	B-T025
in	O	O	O
the	O	O	O
liver	O	O	B-T023
was	O	O	O
also	O	O	O
quantified	O	O	B-T081
.	O	O	O

The	O	O	O
hepatic	O	O	B-T029
expression	O	O	B-T045
of	O	O	O
the	O	O	O
IL-6	O	O	B-T116
/	O	O	O
gp130	O	O	B-T116
and	O	O	O
STAT3	O	O	B-T116
,	O	O	O
Akt	O	O	B-T116
and	O	O	O
ERK1/2	O	O	B-T116
was	O	O	O
also	O	O	O
examined	O	O	O
.	O	O	O

Results	O	O	O
The	O	O	O
liver/body	O	O	B-T081
weight	O	O	I-T081
ratio	O	O	I-T081
and	O	O	O
expression	O	O	B-T045
of	O	O	O
all	O	O	O
cell	O	O	B-T043
proliferation	O	O	I-T043
markers	O	O	B-T059
were	O	O	O
significantly	O	O	O
lower	O	O	O
in	O	O	O
the	O	O	O
flKO	O	O	B-T015
group	O	O	I-T015
than	O	O	O
in	O	O	O
the	O	O	O
WT	O	O	B-T015
group	O	O	I-T015
.	O	O	O

The	O	O	O
expression	O	O	B-T045
of	O	O	O
phosphorylated	O	O	B-T116
(	O	O	I-T116
p	O	O	I-T116
)	O	O	I-T116
Akt	O	O	I-T116
and	O	O	O
pERK1	O	O	B-T116
/2	O	O	O
was	O	O	O
similar	O	O	O
in	O	O	O
the	O	O	O
WT	O	O	B-T015
and	O	O	O
flKO	O	O	B-T015
groups	O	O	I-T015
.	O	O	O

On	O	O	O
the	O	O	O
other	O	O	O
hand	O	O	O
,	O	O	O
the	O	O	O
expression	O	O	B-T045
of	O	O	O
pSTAT3	O	O	B-T116
and	O	O	O
IL-6	O	O	B-T116
was	O	O	O
significantly	O	O	O
stronger	O	O	O
in	O	O	O
the	O	O	O
WT	O	O	B-T015
group	O	O	I-T015
than	O	O	O
in	O	O	O
the	O	O	O
flKO	O	O	B-T015
group	O	O	I-T015
.	O	O	O

The	O	O	O
expression	O	O	B-T045
of	O	O	O
podoplanin	O	O	B-T116
was	O	O	O
detected	O	O	O
in	O	O	O
the	O	O	O
hepatic	O	O	B-T023
sinusoids	O	O	I-T023
of	O	O	O
both	O	O	O
groups	O	O	B-T078
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
extent	O	O	O
to	O	O	O
which	O	O	O
platelets	O	O	B-T025
accumulated	O	O	O
in	O	O	O
hepatic	O	O	B-T023
sinusoids	O	O	I-T023
was	O	O	O
significantly	O	O	O
less	O	O	O
in	O	O	O
the	O	O	O
flKO	O	O	B-T015
group	O	O	I-T015
than	O	O	O
in	O	O	O
the	O	O	O
WT	O	O	B-T015
group	O	O	I-T015
.	O	O	O

Conclusion	O	O	O
CLEC-2	O	O	B-T116
was	O	O	O
involved	O	O	O
in	O	O	O
hepatic	O	O	B-T042
regeneration	O	O	I-T042
after	O	O	O
liver	O	O	B-T061
resection	O	O	I-T061
and	O	O	O
CLEC-2	O	O	O
-related	O	O	O
liver	O	O	B-T042
regeneration	O	O	I-T042
was	O	O	O
attributed	O	O	O
to	O	O	O
the	O	O	O
interaction	O	O	O
between	O	O	O
platelets	O	O	B-T025
and	O	O	O
sinusoidal	O	O	B-T030
endothelial	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

-DOCSTART- (28295414)

Temporal	O	O	B-T079
Stability	O	O	B-T080
of	O	O	O
Heavy	O	O	B-T033
Drinking	O	O	B-T055
Days	O	O	O
and	O	O	O
Drinking	O	O	O
Reductions	O	O	B-T061
Among	O	O	O
Heavy	O	O	B-T055
Drinkers	O	O	I-T055
in	O	O	O
the	O	O	O
COMBINE	O	O	O
Study	O	O	O

Recently	O	O	O
,	O	O	O
the	O	O	O
Food	O	O	B-T093
and	O	O	I-T093
Drug	O	O	I-T093
Administration	O	O	I-T093
(	O	O	O
FDA	O	O	B-T093
)	O	O	O
proposed	O	O	O
to	O	O	O
expand	O	O	B-T082
the	O	O	O
options	O	O	O
for	O	O	O
primary	O	O	B-T080
end	O	O	B-T080
points	O	O	I-T080
in	O	O	O
the	O	O	O
development	O	O	B-T169
of	O	O	O
medications	O	O	B-T058
for	O	O	O
alcohol	O	O	B-T168
use	O	O	I-T048
disorder	O	O	I-T048
to	O	O	O
include	O	O	O
either	O	O	O
abstinence	O	O	B-T061
from	O	O	O
alcohol	O	O	O
or	O	O	O
a	O	O	O
nonabstinent	O	O	B-T033
outcome	O	O	B-T169
:	O	O	O
no	O	O	O
heavy	O	O	B-T033
drinking	O	O	I-T033
days	O	O	O
(	O	O	O
with	O	O	O
a	O	O	O
heavy	O	O	O
drinking	O	O	O
day	O	O	O
defined	O	O	B-T170
as	O	O	O
more	O	O	O
than	O	O	O
3	O	O	O
drinks	O	O	B-T168
per	O	O	O
day	O	O	O
for	O	O	O
women	O	O	B-T098
and	O	O	O
more	O	O	O
than	O	O	O
4	O	O	O
drinks	O	O	O
per	O	O	O
day	O	O	O
for	O	O	O
men	O	O	B-T098
[	O	O	O
>	O	O	O
3/>4	O	O	O
cutoff	O	O	B-T169
]	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
FDA	O	O	B-T093
also	O	O	O
suggested	O	O	B-T078
that	O	O	O
6	O	O	O
months	O	O	B-T079
would	O	O	O
be	O	O	O
the	O	O	O
most	O	O	O
appropriate	O	O	B-T080
length	O	O	B-T062
for	O	O	I-T062
a	O	O	I-T062
clinical	O	O	I-T062
trial	O	O	I-T062
to	O	O	O
demonstrate	O	O	O
the	O	O	O
stability	O	O	B-T080
of	O	O	O
this	O	O	O
nonabstinent	O	O	B-T033
drinking	O	O	B-T055
outcome	O	O	B-T169
.	O	O	O

However	O	O	O
,	O	O	O
few	O	O	O
alcohol	O	O	O
clinical	O	O	B-T062
trials	O	O	I-T062
have	O	O	O
examined	O	O	B-T033
the	O	O	O
stability	O	O	B-T080
of	O	O	O
nonheavy	O	O	B-T033
drinking	O	O	I-T033
during	O	O	B-T079
and	O	O	O
after	O	O	B-T058
treatment	O	O	I-T058
.	O	O	O

In	O	O	O
a	O	O	O
secondary	O	O	B-UnknownType
analysis	O	O	I-UnknownType
of	O	O	O
the	O	O	O
COMBINE	O	O	B-T062
study	O	O	I-T062
data	O	O	B-T078
(	O	O	O
n	O	O	O
=	O	O	O
1,383	O	O	O
)	O	O	O
,	O	O	O
we	O	O	O
examined	O	O	B-T033
transitions	O	O	B-T052
in	O	O	O
heavy	O	O	B-T033
drinking	O	O	I-T033
days	O	O	O
during	O	O	B-T079
the	O	O	I-T079
course	O	O	I-T079
of	O	O	I-T079
treatment	O	O	B-T061
(	O	O	O
months	O	O	B-T079
1	O	O	O
through	O	O	O
4	O	O	O
)	O	O	O
,	O	O	O
during	O	O	O
the	O	O	O
transition	O	O	B-T052
out	O	O	O
of	O	O	O
treatment	O	O	O
(	O	O	O
months	O	O	O
4	O	O	O
through	O	O	O
7	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
up	O	O	O
to	O	O	O
12	O	O	O
months	O	O	O
afterward	O	O	O
(	O	O	O
months	O	O	O
13	O	O	O
through	O	O	O
16	O	O	O
)	O	O	O
using	O	O	O
latent	O	O	B-UnknownType
variable	O	O	I-UnknownType
mixture	O	O	I-UnknownType
models	O	O	I-UnknownType
.	O	O	O

Heavy	O	O	B-T033
drinking	O	O	I-T033
and	O	O	O
nonheavy	O	O	B-T033
drinking	O	O	I-T033
were	O	O	O
relatively	O	O	O
stable	O	O	B-T080
in	O	O	O
consecutive	O	O	B-T080
months	O	O	B-T079
(	O	O	O
minimum	O	O	B-T080
agreement	O	O	O
[	O	O	O
kappa	O	O	O
]	O	O	O
=	O	O	O
0.64	O	O	O
for	O	O	O
months	O	O	O
1	O	O	O
to	O	O	O
2	O	O	O
)	O	O	O
.	O	O	O

Most	O	O	O
individuals	O	O	B-T098
were	O	O	O
stable	O	O	B-T080
low-risk	O	O	B-T081
drinkers	O	O	B-T033
/	O	O	O
abstainers	O	O	B-UnknownType
or	O	O	O
heavy	O	O	B-T055
drinkers	O	O	I-T055
by	O	O	O
the	O	O	O
end	O	O	O
of	O	O	O
treatment	O	O	B-T061
,	O	O	O
as	O	O	O
characterized	O	O	B-T052
by	O	O	O
a	O	O	O
10	O	O	O
%	O	O	O
probability	O	O	B-T081
(	O	O	O
or	O	O	O
less	O	O	O
)	O	O	O
of	O	O	O
transitioning	O	O	B-T052
out	O	O	O
of	O	O	O
either	O	O	O
a	O	O	O
no	O	O	O
heavy	O	O	B-T033
drinking	O	O	I-T033
state	O	O	B-T169
or	O	O	O
a	O	O	O
heavy	O	O	O
drinking	O	O	O
state	O	O	O
.	O	O	O

More	O	O	O
than	O	O	O
two-thirds	O	O	O
of	O	O	O
the	O	O	O
heavy	O	O	B-T055
drinkers	O	O	I-T055
who	O	O	O
exceeded	O	O	O
the	O	O	O
heavy	O	O	B-T033
drinking	O	O	B-T055
threshold	O	O	B-T080
during	O	O	B-T079
treatment	O	O	I-T079
reported	O	O	B-T058
,	O	O	O
on	O	O	O
average	O	O	B-T081
,	O	O	O
a	O	O	O
64	O	O	O
%	O	O	O
reduction	O	O	B-T061
in	O	O	O
drinking	O	O	B-T033
frequency	O	O	I-T033
and	O	O	O
a	O	O	O
38	O	O	O
%	O	O	O
reduction	O	O	O
in	O	O	O
drinking	O	O	O
intensity	O	O	O
from	O	O	O
pretreatment	O	O	B-T052
drinking	O	O	O
levels	O	O	B-T080
.	O	O	O

The	O	O	O
results	O	O	B-T034
show	O	O	O
stability	O	O	B-T080
of	O	O	O
no	O	O	O
heavy	O	O	B-T033
drinking	O	O	I-T033
as	O	O	O
an	O	O	O
outcome	O	O	B-T169
within	O	O	O
the	O	O	O
first	O	O	O
4	O	O	O
months	O	O	B-T079
of	O	O	O
treatment	O	O	B-T061
and	O	O	O
that	O	O	O
the	O	O	O
>	O	O	O
3/>4	O	O	O
drink	O	O	B-T168
cutoff	O	O	B-T169
may	O	O	O
mask	O	O	O
substantial	O	O	O
reductions	O	O	B-T061
in	O	O	O
alcohol	O	O	B-T055
consumption	O	O	I-T055
among	O	O	O
some	O	O	O
patients	O	O	B-T101
.	O	O	O

Future	O	O	O
studies	O	O	B-T062
should	O	O	O
explore	O	O	O
the	O	O	O
clinical	O	O	B-T080
utility	O	O	O
of	O	O	O
reduction	O	O	B-T061
end	O	O	B-T080
points	O	O	I-T080
.	O	O	O

-DOCSTART- (28296885)

Oral	O	O	B-T058
health	O	O	I-T058
in	O	O	O
transition	O	O	B-T052
:	O	O	O
The	O	O	O
Hadza	O	O	B-T098
foragers	O	O	I-T098
of	O	O	O
Tanzania	O	O	O

Conventional	O	O	B-T080
wisdom	O	O	O
holds	O	O	O
that	O	O	O
a	O	O	O
decline	O	O	B-T081
in	O	O	O
oral	O	O	B-T058
health	O	O	I-T058
accompanies	O	O	O
the	O	O	O
transition	O	O	B-T052
from	O	O	O
hunting	O	O	B-T056
and	O	O	O
gathering	O	O	B-T056
to	O	O	O
agriculture	O	O	B-T090
,	O	O	O
given	O	O	O
increased	O	O	B-T081
consumption	O	O	B-T039
of	O	O	O
carbohydrates	O	O	B-T109
.	O	O	O

This	O	O	O
widely	O	O	O
touted	O	O	O
example	O	O	B-T077
of	O	O	O
the	O	O	O
mismatch	O	O	B-T080
between	O	O	O
our	O	O	O
biology	O	O	B-T091
and	O	O	O
modern	O	O	B-T054
lifestyle	O	O	I-T054
has	O	O	O
been	O	O	O
intuited	O	O	O
largely	O	O	O
from	O	O	O
the	O	O	O
bioarchaeological	O	O	B-T170
record	O	O	I-T170
of	O	O	O
the	O	O	O
Neolithic	O	O	B-T109
Revolution	O	O	I-T109
in	O	O	O
the	O	O	O
New	O	O	B-T098
World	O	O	I-T098
.	O	O	O

Recent	O	O	O
studies	O	O	B-T062
of	O	O	O
other	O	O	O
populations	O	O	B-T081
have	O	O	O
,	O	O	O
however	O	O	O
,	O	O	O
challenged	O	O	O
the	O	O	O
universality	O	O	O
of	O	O	O
this	O	O	O
assertion	O	O	B-T080
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
present	O	O	O
the	O	O	O
first	O	O	O
comprehensive	O	O	B-T080
study	O	O	B-T062
of	O	O	O
oral	O	O	B-T058
health	O	O	I-T058
among	O	O	O
a	O	O	O
living	O	O	B-T098
population	O	O	I-T098
in	O	O	O
transition	O	O	B-T052
from	O	O	O
the	O	O	O
bush	O	O	B-T002
to	O	O	O
village	O	O	B-T054
life	O	O	I-T054
,	O	O	O
the	O	O	O
Hadza	O	O	B-T098
hunter	O	O	B-T097
-	O	O	O
gatherers	O	O	B-T098
of	O	O	O
Tanzania	O	O	B-T083
,	O	O	O
to	O	O	O
test	O	O	O
the	O	O	O
hypothesis	O	O	B-T078
that	O	O	O
the	O	O	O
shift	O	O	B-T052
from	O	O	O
foraging	O	O	B-T055
to	O	O	O
farming	O	O	B-T090
,	O	O	O
or	O	O	O
agricultural	O	O	B-T090
intensification	O	O	I-T090
,	O	O	O
inevitably	O	O	O
leads	O	O	O
to	O	O	O
increased	O	O	B-T081
periodontal	O	O	B-T047
disease	O	O	I-T047
,	O	O	O
caries	O	O	B-T047
,	O	O	O
and	O	O	O
orthodontic	O	O	B-T169
disorders	O	O	B-T047
.	O	O	O

Our	O	O	O
results	O	O	B-T169
showed	O	O	O
that	O	O	O
women	O	O	B-T098
living	O	O	B-T080
in	O	O	O
villages	O	O	B-T083
consuming	O	O	B-T039
a	O	O	O
mostly	O	O	O
agricultural	O	O	B-T002
diet	O	O	B-T168
exhibited	O	O	O
more	O	O	O
caries	O	O	B-T047
and	O	O	O
periodontal	O	O	B-T047
disease	O	O	I-T047
than	O	O	O
those	O	O	O
living	O	O	O
in	O	O	O
the	O	O	O
bush	O	O	B-T002
consuming	O	O	O
a	O	O	O
mostly	O	O	O
wild-food	O	O	B-T168
diet	O	O	I-T168
.	O	O	O

Furthermore	O	O	O
,	O	O	O
men	O	O	B-T098
living	O	O	B-T080
in	O	O	O
the	O	O	O
bush	O	O	B-T002
consuming	O	O	B-T039
mostly	O	O	O
a	O	O	O
wild-food	O	O	B-T168
diet	O	O	B-T168
had	O	O	O
more	O	O	O
than	O	O	O
those	O	O	O
living	O	O	O
in	O	O	O
the	O	O	O
village	O	O	B-T083
consuming	O	O	O
a	O	O	O
mostly	O	O	O
agricultural	O	O	B-T002
diet	O	O	O
.	O	O	O

These	O	O	O
findings	O	O	B-T033
are	O	O	O
explained	O	O	O
by	O	O	O
the	O	O	O
high	O	O	B-T080
incidence	O	O	B-T081
of	O	O	O
maize	O	O	B-T168
consumption	O	O	B-T039
in	O	O	O
village	O	O	B-T083
settings	O	O	O
,	O	O	O
along	O	O	O
with	O	O	O
previously	O	O	O
recognized	O	O	O
variation	O	O	B-T080
in	O	O	O
rate	O	O	B-T081
of	O	O	O
caries	O	O	B-T047
between	O	O	O
men	O	O	B-T098
and	O	O	O
women	O	O	B-T098
.	O	O	O

The	O	O	O
unexpected	O	O	O
discovery	O	O	O
of	O	O	O
high	O	O	B-T080
caries	O	O	B-T047
incidences	O	O	B-T081
for	O	O	O
men	O	O	B-T098
in	O	O	O
the	O	O	O
bush	O	O	B-T002
is	O	O	O
likely	O	O	O
explained	O	O	O
by	O	O	O
heavy	O	O	O
reliance	O	O	O
on	O	O	O
honey	O	O	B-T168
,	O	O	O
and	O	O	O
perhaps	O	O	O
differential	O	O	O
access	O	O	O
to	O	O	O
tobacco	O	O	B-T167
and	O	O	O
marijuana	O	O	O
.	O	O	O

These	O	O	O
data	O	O	B-T078
support	O	O	O
the	O	O	O
notions	O	O	O
that	O	O	O
mechanisms	O	O	B-T169
of	O	O	O
cariogenesis	O	O	B-T047
are	O	O	O
multifactorial	O	O	B-T033
and	O	O	O
that	O	O	O
the	O	O	O
relationships	O	O	B-T080
between	O	O	O
oral	O	O	B-T058
health	O	O	I-T058
and	O	O	O
the	O	O	O
shift	O	O	B-T052
from	O	O	O
a	O	O	O
predominantly	O	O	O
wild-food	O	O	B-T168
diet	O	O	I-T168
to	O	O	O
one	O	O	O
dominated	O	O	O
by	O	O	O
cultigens	O	O	B-T002
are	O	O	O
nuanced	O	O	O
.	O	O	O

-DOCSTART- (28299441)

The	O	O	O
R2R3MYB	O	O	B-T116
VvMYBPA1	O	O	B-T116
from	O	O	O
grape	O	O	B-T002
reprograms	O	O	O
the	O	O	O
phenylpropanoid	O	O	B-T044
pathway	O	O	I-T044
in	O	O	O
tobacco	O	O	B-T002
flowers	O	O	O

This	O	O	O
work	O	O	O
shows	O	O	O
that	O	O	O
,	O	O	O
in	O	O	O
tobacco	O	O	B-T002
,	O	O	O
the	O	O	O
ectopic	O	O	B-T045
expression	O	O	I-T045
of	O	O	O
VvMYBPA1	O	O	B-T116
,	O	O	O
a	O	O	O
grape	O	O	B-T002
regulator	O	O	B-T077
of	O	O	O
proanthocyanidin	O	O	B-T109
biosynthesis	O	O	O
,	O	O	O
up-	O	O	B-T043
or	O	O	I-T043
down-regulates	O	O	I-T043
different	O	O	O
branches	O	O	O
of	O	O	O
the	O	O	O
phenylproanoid	O	O	B-T044
pathway	O	O	I-T044
,	O	O	O
in	O	O	O
a	O	O	O
structure-specific	O	O	O
fashion	O	O	O
.	O	O	O

Proanthocyanidins	O	O	B-T109
are	O	O	O
flavonoids	O	O	B-T109
of	O	O	O
paramount	O	O	O
importance	O	O	O
for	O	O	O
animal	O	O	B-T168
and	O	O	O
human	O	O	B-T168
diet	O	O	I-T168
.	O	O	O

Research	O	O	B-T062
interest	O	O	O
increasingly	O	O	O
tilts	O	O	O
towards	O	O	O
generating	O	O	O
crops	O	O	B-T002
enriched	O	O	O
with	O	O	O
these	O	O	O
health	O	O	B-T078
-promoting	O	O	O
compounds	O	O	B-T080
.	O	O	O

Flavonoids	O	O	B-T109
synthesis	O	O	B-T052
is	O	O	O
regulated	O	O	O
by	O	O	O
the	O	O	O
MBW	O	O	B-T026
transcriptional	O	O	B-T026
complex	O	O	B-T104
,	O	O	O
made	O	O	O
of	O	O	O
R2R3MYB	O	O	B-T116
,	O	O	O
bHLH	O	O	B-T116
and	O	O	O
WD40	O	O	B-T116
proteins	O	O	I-T116
,	O	O	O
with	O	O	O
the	O	O	O
MYB	O	O	B-T116
components	O	O	O
liable	O	O	O
for	O	O	O
channeling	O	O	B-T082
the	O	O	O
complex	O	O	O
towards	O	O	O
specific	O	O	O
branches	O	O	O
of	O	O	O
the	O	O	O
pathway	O	O	B-T044
.	O	O	O

Hence	O	O	O
,	O	O	O
using	O	O	O
tobacco	O	O	B-T002
as	O	O	O
a	O	O	O
model	O	O	B-T075
,	O	O	O
here	O	O	O
,	O	O	O
we	O	O	O
tested	O	O	B-T169
if	O	O	O
the	O	O	O
ectopic	O	O	B-T045
expression	O	O	I-T045
of	O	O	O
the	O	O	O
proanthocyanidin	O	O	B-T109
regulator	O	O	B-T077
VvMYBPA1	O	O	B-T116
from	O	O	O
grape	O	O	B-T002
induces	O	O	B-T169
the	O	O	O
biosynthesis	O	O	B-T169
of	O	O	O
these	O	O	O
compounds	O	O	B-T080
in	O	O	O
not-naturally	O	O	O
committed	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
show	O	O	O
,	O	O	O
via	O	O	O
targeted	O	O	O
transcriptomic	O	O	B-T045
and	O	O	O
metabolic	O	O	B-T169
analyses	O	O	B-T062
of	O	O	O
primary	O	O	O
transgenic	O	O	B-T002
lines	O	O	I-T002
and	O	O	O
their	O	O	O
progeny	O	O	B-T099
,	O	O	O
that	O	O	O
VvMYBPA1	O	O	B-T116
alters	O	O	O
the	O	O	O
phenylpropanoid	O	O	B-T044
pathway	O	O	I-T044
in	O	O	O
tobacco	O	O	B-T002
floral	O	O	B-T002
organs	O	O	I-T002
,	O	O	O
in	O	O	O
a	O	O	O
structure-specific	O	O	O
fashion	O	O	O
.	O	O	O

We	O	O	O
also	O	O	O
report	O	O	O
that	O	O	O
a	O	O	O
modest	O	O	O
VvMYBPA1	O	O	B-T116
expression	O	O	B-T045
is	O	O	O
sufficient	O	O	O
to	O	O	O
induce	O	O	O
the	O	O	O
expression	O	O	O
of	O	O	O
both	O	O	O
proanthocyanidin	O	O	B-T109
-specific	O	O	O
and	O	O	O
early	O	O	B-T028
genes	O	O	I-T028
of	O	O	O
the	O	O	O
phenylpropanoid	O	O	B-T044
pathway	O	O	I-T044
.	O	O	O

Consequently	O	O	O
,	O	O	O
proanthocyanidins	O	O	B-T109
and	O	O	O
chlorogenic	O	O	B-T109
acids	O	O	I-T109
are	O	O	O
induced	O	O	O
or	O	O	O
de	O	O	B-T078
novo	O	O	I-T078
synthetised	O	O	O
in	O	O	O
floral	O	O	B-T002
limbs	O	O	I-T002
,	O	O	I-T002
tubes	O	O	I-T002
and	O	O	O
stamens	O	O	B-T002
.	O	O	O

Other	O	O	O
phenylpropanoid	O	O	B-T044
branches	O	O	I-T044
are	O	O	O
conversely	O	O	O
induced	O	O	O
or	O	O	O
depleted	O	O	B-T169
according	O	O	O
to	O	O	O
the	O	O	O
floral	O	O	B-T002
structure	O	O	I-T002
.	O	O	O

Our	O	O	O
study	O	O	O
documents	O	O	O
a	O	O	O
novel	O	O	B-T080
and	O	O	O
distinct	O	O	O
function	O	O	O
of	O	O	O
VvMYBPA1	O	O	B-T116
with	O	O	O
respect	O	O	O
to	O	O	O
other	O	O	O
MYBs	O	O	B-T116
regulating	O	O	O
proanthocyanidins	O	O	B-T109
.	O	O	O

Present	O	O	O
findings	O	O	B-T169
may	O	O	O
have	O	O	O
major	O	O	O
implications	O	O	O
in	O	O	O
designing	O	O	B-T041
strategies	O	O	I-T041
for	O	O	O
enriching	O	O	O
crops	O	O	B-T002
with	O	O	O
health	O	O	B-T078
-promoting	O	O	O
compounds	O	O	B-T080
.	O	O	O

-DOCSTART- (28301509)

Genome-wide	O	O	B-T063
association	O	O	I-T063
mapping	O	O	I-T063
in	O	O	O
winter	O	O	B-T002
barley	O	O	I-T002
for	O	O	O
grain	O	O	B-T002
yield	O	O	B-T081
and	O	O	O
culm	O	O	B-T002
cell	O	O	B-T026
wall	O	O	I-T026
polymer	O	O	B-UnknownType
content	O	O	B-T081
using	O	O	O
the	O	O	O
high-throughput	O	O	O
CoMPP	O	O	O
technique	O	O	O

A	O	O	O
collection	O	O	B-T169
of	O	O	O
112	O	O	O
winter	O	O	B-T002
barley	O	O	I-T002
varieties	O	O	I-T002
(	O	O	O
Hordeum	O	O	B-T002
vulgare	O	O	I-T002
L.	O	O	I-T002
)	O	O	O
was	O	O	O
grown	O	O	B-T040
in	O	O	O
the	O	O	O
field	O	O	B-T082
for	O	O	O
two	O	O	O
years	O	O	B-T079
(	O	O	O
2008/09	O	O	O
and	O	O	O
2009/10	O	O	O
)	O	O	O
in	O	O	O
northern	O	O	B-T082
Italy	O	O	B-T083
and	O	O	O
grain	O	O	B-T002
and	O	O	O
straw	O	O	B-T109
yields	O	O	B-T081
recorded	O	O	O
.	O	O	O

In	O	O	O
the	O	O	O
first	O	O	O
year	O	O	B-T079
of	O	O	O
the	O	O	O
trial	O	O	O
,	O	O	O
a	O	O	O
severe	O	O	O
attack	O	O	O
of	O	O	O
barley	O	O	B-T005
yellow	O	O	I-T005
mosaic	O	O	I-T005
virus	O	O	I-T005
(	O	O	O
BaYMV	O	O	B-T005
)	O	O	O
strongly	O	O	O
influenced	O	O	B-T077
final	O	O	O
performances	O	O	B-T052
with	O	O	O
an	O	O	O
average	O	O	B-T081
reduction	O	O	B-T080
of	O	O	O
~	O	O	O
50	O	O	O
%	O	O	O
for	O	O	O
grain	O	O	B-T002
and	O	O	O
straw	O	O	B-T109
harvested	O	O	B-T169
in	O	O	O
comparison	O	O	B-T052
to	O	O	O
the	O	O	O
second	O	O	B-T081
year	O	O	O
.	O	O	O

The	O	O	O
genetic	O	O	B-T059
determination	O	O	I-T059
(	O	O	O
GD	O	O	B-T059
)	O	O	O
for	O	O	O
grain	O	O	B-T002
yield	O	O	B-T081
was	O	O	O
0.49	O	O	O
and	O	O	O
0.70	O	O	O
,	O	O	O
for	O	O	O
the	O	O	O
two	O	O	O
years	O	O	B-T079
respectively	O	O	O
,	O	O	O
and	O	O	O
for	O	O	O
straw	O	O	B-T109
yield	O	O	O
GD	O	O	O
was	O	O	O
low	O	O	O
in	O	O	O
2009	O	O	O
(	O	O	O
0.09	O	O	O
)	O	O	O
and	O	O	O
higher	O	O	O
in	O	O	O
2010	O	O	O
(	O	O	O
0.29	O	O	O
)	O	O	O
.	O	O	O

Cell	O	O	B-T026
wall	O	O	I-T026
polymers	O	O	B-UnknownType
in	O	O	O
culms	O	O	B-T002
were	O	O	O
quantified	O	O	B-T081
by	O	O	O
means	O	O	O
of	O	O	O
the	O	O	O
monoclonal	O	O	B-T116
antibodies	O	O	I-T116
LM6	O	O	B-T129
,	O	O	O
LM11	O	O	B-T129
,	O	O	O
JIM13	O	O	B-T129
and	O	O	O
BS-400	O	O	B-T129
-	O	O	I-T129
3	O	O	I-T129
and	O	O	O
the	O	O	O
carbohydrate-binding	O	O	B-T129
module	O	O	I-T129
CBM3a	O	O	I-T129
using	O	O	O
the	O	O	O
high-throughput	O	O	O
CoMPP	O	O	B-T059
technique	O	O	I-T059
.	O	O	O

Of	O	O	O
these	O	O	O
,	O	O	O
LM6	O	O	B-T129
,	O	O	O
which	O	O	O
detects	O	O	B-T033
arabinan	O	O	B-T109
components	O	O	B-T077
,	O	O	O
showed	O	O	O
a	O	O	O
relatively	O	O	O
high	O	O	O
GD	O	O	B-T059
in	O	O	O
both	O	O	O
years	O	O	B-T079
and	O	O	O
a	O	O	O
significantly	O	O	B-T078
negative	O	O	B-T033
correlation	O	O	B-T080
with	O	O	O
grain	O	O	B-T002
yield	O	O	B-T081
(	O	O	O
GYLD	O	O	B-T081
)	O	O	O
.	O	O	O

Overall	O	O	O
,	O	O	O
heritability	O	O	B-T081
(	O	O	O
H2	O	O	B-T081
)	O	O	O
was	O	O	O
calculated	O	O	B-T052
for	O	O	O
GYLD	O	O	B-T081
,	O	O	O
LM6	O	O	B-T129
and	O	O	O
JIM	O	O	B-T129
and	O	O	O
resulted	O	O	O
to	O	O	O
be	O	O	O
0.42	O	O	O
,	O	O	O
0.32	O	O	O
and	O	O	O
0.20	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

A	O	O	O
total	O	O	B-T080
of	O	O	O
4,976	O	O	O
SNPs	O	O	B-T086
from	O	O	O
the	O	O	O
9	O	O	O
K	O	O	O
iSelect	O	O	O
array	O	O	O
were	O	O	O
used	O	O	O
in	O	O	O
the	O	O	O
study	O	O	B-T062
for	O	O	O
the	O	O	O
analysis	O	O	O
of	O	O	O
population	O	O	B-T090
structure	O	O	I-T090
,	O	O	O
linkage	O	O	B-T081
disequilibrium	O	O	I-T081
(	O	O	O
LD	O	O	B-T081
)	O	O	O
and	O	O	O
genome-wide	O	O	B-T063
association	O	O	I-T063
study	O	O	I-T063
(	O	O	O
GWAS	O	O	B-T063
)	O	O	O
.	O	O	O

Marker-trait	O	O	B-T090
associations	O	O	I-T090
(	O	O	O
MTA	O	O	B-T090
)	O	O	O
were	O	O	O
analyzed	O	O	O
for	O	O	O
grain	O	O	B-T002
yield	O	O	B-T081
and	O	O	O
cell	O	O	B-T026
wall	O	O	I-T026
determination	O	O	O
by	O	O	O
LM6	O	O	B-T129
and	O	O	O
JIM13	O	O	B-T129
as	O	O	O
these	O	O	O
were	O	O	O
the	O	O	O
traits	O	O	O
showing	O	O	O
significant	O	O	B-T078
correlations	O	O	B-T080
between	O	O	O
the	O	O	O
years	O	O	B-T079
.	O	O	O

A	O	O	O
single	O	O	B-T028
QTL	O	O	I-T028
for	O	O	O
GYLD	O	O	B-T081
containing	O	O	O
three	O	O	O
MTAs	O	O	B-T090
was	O	O	O
found	O	O	O
on	O	O	O
chromosome	O	O	B-T026
3H	O	O	I-T026
located	O	O	O
close	O	O	O
to	O	O	O
the	O	O	O
Hv-eIF4E	O	O	B-T028
gene	O	O	I-T028
,	O	O	O
which	O	O	O
is	O	O	O
known	O	O	O
to	O	O	O
regulate	O	O	O
resistance	O	O	B-T169
to	O	O	O
BaYMV	O	O	B-T005
.	O	O	O

Subsequently	O	O	O
the	O	O	O
QTL	O	O	B-T028
was	O	O	O
shown	O	O	O
to	O	O	O
be	O	O	O
tightly	O	O	O
linked	O	O	O
to	O	O	O
rym4	O	O	B-T028
,	O	O	O
a	O	O	O
locus	O	O	B-T082
for	O	O	O
resistance	O	O	B-T169
to	O	O	O
the	O	O	O
virus	O	O	B-T005
.	O	O	O

GWAs	O	O	B-T063
on	O	O	O
arabinans	O	O	B-T109
quantified	O	O	B-T081
by	O	O	O
LM6	O	O	B-T129
resulted	O	O	O
in	O	O	O
the	O	O	O
identification	O	O	B-T080
of	O	O	O
major	O	O	B-T080
QTLs	O	O	B-T028
closely	O	O	O
located	O	O	O
on	O	O	O
3H	O	O	B-T026
and	O	O	O
hypotheses	O	O	O
regarding	O	O	O
putative	O	O	B-T028
candidate	O	O	I-T028
genes	O	O	I-T028
were	O	O	O
formulated	O	O	O
through	O	O	O
the	O	O	O
study	O	O	B-T062
of	O	O	O
gene	O	O	B-T045
expression	O	O	I-T045
levels	O	O	B-T081
based	O	O	O
on	O	O	O
bioinformatics	O	O	B-T091
tools	O	O	O
.	O	O	O

-DOCSTART- (28301911)

The	O	O	O
Prevalence	O	O	B-T081
and	O	O	O
Clinical	O	O	B-T080
Relevance	O	O	B-T080
of	O	O	O
ASA	O	O	B-T109
Nonresponse	O	O	B-T033
After	O	O	O
Cardiac	O	O	O
Surgery	O	O	O

We	O	O	O
aimed	O	O	O
to	O	O	O
identify	O	O	O
the	O	O	O
prevalence	O	O	B-T081
of	O	O	O
acetylsalicylic	O	O	B-T109
acid	O	O	I-T109
(	O	O	O
ASA	O	O	B-T109
)	O	O	O
nonresponse	O	O	B-T033
in	O	O	O
patients	O	O	B-T101
after	O	O	O
coronary	O	O	B-T061
artery	O	O	I-T061
bypass	O	O	I-T061
graft	O	O	I-T061
(	O	O	I-T061
CABG	O	O	I-T061
)	O	O	I-T061
surgery	O	O	I-T061
and	O	O	O
the	O	O	O
possible	O	O	O
consequences	O	O	B-T169
for	O	O	O
the	O	O	O
rate	O	O	O
of	O	O	O
major	O	O	O
cardiovascular	O	O	B-T033
events	O	O	I-T033
.	O	O	O

This	O	O	O
prospective	O	O	B-T062
,	O	O	O
observational	O	O	B-T062
,	O	O	O
bicentric	O	O	B-T081
cohort	O	O	I-T081
study	O	O	I-T081
was	O	O	O
conducted	O	O	O
in	O	O	O
two	O	O	O
German	O	O	B-T093
University	O	O	I-T093
hospitals	O	O	I-T093
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
400	O	O	O
patients	O	O	B-T101
(	O	O	O
200	O	O	O
in	O	O	O
each	O	O	O
study	O	O	O
center	O	O	O
)	O	O	O
undergoing	O	O	O
elective	O	O	B-T061
CABG	O	O	B-T061
surgery	O	O	I-T061
were	O	O	O
enrolled	O	O	O
after	O	O	O
written	O	O	O
informed	O	O	O
consent	O	O	O
.	O	O	O

Platelet	O	O	B-T043
function	O	O	I-T043
was	O	O	O
analyzed	O	O	O
on	O	O	O
day	O	O	O
3	O	O	O
(	O	O	O
d3	O	O	O
)	O	O	O
and	O	O	O
day	O	O	O
5	O	O	O
(	O	O	O
d5	O	O	O
)	O	O	O
postoperatively	O	O	B-T079
following	O	O	O
stimulation	O	O	O
with	O	O	O
arachidonic	O	O	B-T109
acid	O	O	I-T109
(	O	O	O
ASPItest	O	O	B-T059
)	O	O	O
and	O	O	O
with	O	O	O
thrombin	O	O	B-T116
receptor-activating	O	O	I-T116
peptide	O	O	I-T116
6	O	O	I-T116
(	O	O	O
TRAPtest	O	O	B-T059
)	O	O	O
using	O	O	O
multiple	O	O	B-T059
electrode	O	O	I-T059
aggregometry	O	O	I-T059
(	O	O	O
Multiplate	O	O	B-T059
)	O	O	O
.	O	O	O

Individuals	O	O	O
with	O	O	O
an	O	O	O
ASPItest	O	O	B-T059
â¥40	O	O	O
AUÂ·min	O	O	O
were	O	O	O
categorized	O	O	O
as	O	O	O
ASA	O	O	B-T109
nonresponders	O	O	B-T033
.	O	O	O

A	O	O	O
1-year	O	O	O
follow-up	O	O	B-T058
recorded	O	O	O
the	O	O	O
combined	O	O	O
end	O	O	O
point	O	O	O
of	O	O	O
cardiovascular	O	O	B-T033
events	O	O	I-T033
,	O	O	O
hospital	O	O	B-T058
admissions	O	O	I-T058
,	O	O	O
or	O	O	O
deaths	O	O	B-T033
related	O	O	O
to	O	O	O
cardiovascular	O	O	B-T047
disease	O	O	I-T047
.	O	O	O

The	O	O	O
prevalence	O	O	B-T081
of	O	O	O
ASA	O	O	B-T109
nonresponse	O	O	B-T033
was	O	O	O
51.5	O	O	O
%	O	O	O
on	O	O	O
d3	O	O	O
,	O	O	O
and	O	O	O
it	O	O	O
significantly	O	O	B-T078
increased	O	O	B-T081
to	O	O	O
71.3	O	O	O
%	O	O	O
on	O	O	O
d5	O	O	O
(	O	O	O
P	O	O	O
=	O	O	O
.0049	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
area	O	O	O
under	O	O	O
the	O	O	O
aggregation	O	O	B-T059
curve	O	O	I-T059
in	O	O	O
the	O	O	O
TRAPtest	O	O	B-T059
(	O	O	O
P	O	O	O
<	O	O	O
.0001	O	O	O
)	O	O	O
,	O	O	O
the	O	O	O
platelet	O	O	B-T059
count	O	O	I-T059
on	O	O	O
d5	O	O	O
(	O	O	O
P	O	O	O
=	O	O	O
.009	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
the	O	O	O
cardiopulmonary	O	O	B-T033
bypass	O	O	I-T033
time	O	O	I-T033
(	O	O	O
P	O	O	O
=	O	O	O
.01	O	O	O
)	O	O	O
were	O	O	O
identified	O	O	O
as	O	O	O
independent	O	O	O
predictors	O	O	O
of	O	O	O
an	O	O	O
ASA	O	O	B-T109
nonresponse	O	O	B-T033
.	O	O	O

A	O	O	O
1-year	O	O	O
follow-up	O	O	B-T058
recorded	O	O	O
54	O	O	O
events	O	O	O
fulfilling	O	O	O
criteria	O	O	O
for	O	O	O
the	O	O	O
combined	O	O	O
end	O	O	B-T080
point	O	O	I-T080
with	O	O	O
no	O	O	O
difference	O	O	O
between	O	O	O
ASA	O	O	B-T109
responders	O	O	B-T033
and	O	O	O
nonresponders	O	O	B-T033
.	O	O	O

This	O	O	O
study	O	O	B-T062
indicates	O	O	O
a	O	O	O
high	O	O	O
incidence	O	O	O
of	O	O	O
perioperative	O	O	B-T079
ASA	O	O	B-T109
nonresponse	O	O	B-T033
in	O	O	O
patients	O	O	B-T101
following	O	O	O
CABG	O	O	B-T061
.	O	O	O

No	O	O	O
effect	O	O	O
on	O	O	O
the	O	O	O
incidence	O	O	O
of	O	O	O
cardiovascular	O	O	B-T033
events	O	O	I-T033
was	O	O	O
recorded	O	O	O
in	O	O	O
the	O	O	O
1-year	O	O	O
follow-up	O	O	B-T058
.	O	O	O

Therefore	O	O	O
,	O	O	O
a	O	O	O
randomized	O	O	B-T062
dosage	O	O	I-T062
adjustment	O	O	I-T062
trial	O	O	I-T062
should	O	O	O
elucidate	O	O	O
whether	O	O	O
a	O	O	O
tailored	O	O	O
ASA	O	O	B-T109
treatment	O	O	B-T061
after	O	O	O
CABG	O	O	B-T061
surgery	O	O	I-T061
represents	O	O	O
a	O	O	O
useful	O	O	O
concept	O	O	O
.	O	O	O

-DOCSTART- (28302782)

Genome	O	O	B-T085
Sequences	O	O	I-T085
of	O	O	O
Mycobacteriophages	O	O	B-T005
Jane	O	O	I-T005
and	O	O	I-T005
Sneeze	O	O	I-T005
,	O	O	O
New	O	O	O
Members	O	O	O
of	O	O	O
Cluster	O	O	O
G	O	O	O

Jane	O	O	O
and	O	O	O
Sneeze	O	O	O
are	O	O	O
newly	O	O	O
isolated	O	O	B-T169
phages	O	O	B-T005
of	O	O	O
Mycobacterium	O	O	B-T007
smegmatis	O	O	I-T007
mc(2)155	O	O	I-T007
from	O	O	O
Hillsborough	O	O	B-T083
,	O	O	O
NJ	O	O	B-T083
,	O	O	O
and	O	O	O
Palo	O	O	B-T083
Verde	O	O	I-T083
,	O	O	O
Costa	O	O	B-T083
Rica	O	O	I-T083
,	O	O	O
respectively	O	O	O
.	O	O	O

Both	O	O	O
are	O	O	O
cluster	O	O	O
G	O	O	O
,	O	O	O
subcluster	O	O	O
G1	O	O	O
mycobacteriophages	O	O	B-T005
.	O	O	O

Notable	O	O	O
nucleotide	O	O	B-T114
differences	O	O	B-T080
exist	O	O	O
between	O	O	O
genomes	O	O	B-T028
in	O	O	O
the	O	O	O
right	O	O	O
half	O	O	O
,	O	O	O
including	O	O	O
the	O	O	O
presence	O	O	O
of	O	O	O
mycobacteriophage	O	O	B-T005
mobile	O	O	B-T114
element	O	O	I-T114
1	O	O	I-T114
(	O	O	O
MPME1	O	O	O
)	O	O	O
in	O	O	O
Jane	O	O	O
.	O	O	O

-DOCSTART- (28316382)

Effect	O	O	B-T080
of	O	O	O
Punica	O	O	B-T002
granatum	O	O	I-T002
fruit	O	O	B-T168
peel	O	O	I-T168
on	O	O	O
glucose-6-phosphate	O	O	B-T116
dehydrogenase	O	O	I-T116
and	O	O	O
malate	O	O	B-T116
dehydrogenase	O	O	I-T116
in	O	O	O
amphistome	O	O	B-T204
Gastrothylax	O	O	O
indicus	O	O	O

Increasing	O	O	B-T169
anthelmintic	O	O	B-T121
resistance	O	O	B-T038
and	O	O	O
the	O	O	O
impact	O	O	B-T080
of	O	O	O
conventional	O	O	O
anthelmintics	O	O	B-T121
on	O	O	O
the	O	O	O
environment	O	O	B-T082
,	O	O	O
it	O	O	O
is	O	O	O
important	O	O	O
to	O	O	O
look	O	O	O
for	O	O	O
alternative	O	O	O
strategies	O	O	O
against	O	O	O
helminth	O	O	B-T204
parasite	O	O	I-T204
in	O	O	O
sheep	O	O	B-T015
.	O	O	O

Important	O	O	O
lipogenic	O	O	B-T116
enzymes	O	O	I-T116
like	O	O	O
glucose-6-phosphate	O	O	B-T116
dehydrogenase	O	O	I-T116
(	O	O	O
G-6-PDH	O	O	B-T116
)	O	O	O
and	O	O	O
malate	O	O	B-T116
dehydrogenase	O	O	I-T116
(	O	O	O
MDH	O	O	B-T116
)	O	O	O
show	O	O	O
subcellular	O	O	B-T026
distribution	O	O	B-T082
pattern	O	O	I-T082
.	O	O	O

Activity	O	O	B-T044
of	O	O	O
G-6-PDH	O	O	B-T116
was	O	O	O
largely	O	O	O
restricted	O	O	O
to	O	O	O
cytosolic	O	O	B-T026
fraction	O	O	I-T026
while	O	O	O
MDH	O	O	B-T116
was	O	O	O
found	O	O	O
in	O	O	O
both	O	O	O
cytosolic	O	O	O
and	O	O	O
mitochondrial	O	O	B-T026
fraction	O	O	I-T026
in	O	O	O
Gastrothylax	O	O	B-T204
indicus	O	O	I-T204
.	O	O	O

Following	O	O	O
in	O	O	B-T080
vitro	O	O	I-T080
treatment	O	O	B-T169
with	O	O	O
ethanolic	O	O	B-T109
and	O	O	O
aqueous	O	O	B-T167
extracts	O	O	I-T167
of	O	O	O
Punica	O	O	B-T002
granatum	O	O	I-T002
fruit	O	O	B-T168
peel	O	O	I-T168
and	O	O	O
commercial	O	O	O
anthelmintic	O	O	B-T121
,	O	O	O
albendazole	O	O	B-T109
G-6-PDH	O	O	B-T116
activity	O	O	B-T044
was	O	O	O
decreased	O	O	B-T080
by	O	O	O
19	O	O	O
-	O	O	O
32	O	O	O
%	O	O	O
,	O	O	O
whereas	O	O	O
MDH	O	O	B-T116
was	O	O	O
suppressed	O	O	B-T169
by	O	O	O
24	O	O	O
-	O	O	O
41	O	O	O
%	O	O	O
,	O	O	O
compared	O	O	O
to	O	O	O
the	O	O	O
respective	O	O	O
control	O	O	B-T167
.	O	O	O

Albendazole	O	O	B-T109
was	O	O	O
quite	O	O	O
effective	O	O	B-T080
when	O	O	O
compared	O	O	O
with	O	O	O
negative	O	O	B-T077
control	O	O	I-T077
and	O	O	O
both	O	O	O
the	O	O	O
extracts	O	O	B-T167
.	O	O	O

The	O	O	O
results	O	O	B-T169
indicate	O	O	O
that	O	O	O
phytochemicals	O	O	B-T109
of	O	O	O
plant	O	O	B-T002
may	O	O	O
act	O	O	O
as	O	O	O
potential	O	O	B-T080
vermifuge	O	O	B-T121
or	O	O	O
vermicide	O	O	B-T131
.	O	O	O

-DOCSTART- (28319502)

Remitting	O	O	B-T047
Seronegative	O	O	I-T047
Symmetrical	O	O	I-T047
Synovitis	O	O	I-T047
With	O	O	I-T047
Pitting	O	O	I-T047
Edema	O	O	I-T047
:	O	O	O
Appearance	O	O	O
on	O	O	O
FDG	O	O	O
PET/CT	O	O	O

Remitting	O	O	B-T047
seronegative	O	O	I-T047
symmetrical	O	O	I-T047
synovitis	O	O	I-T047
with	O	O	I-T047
pitting	O	O	I-T047
edema	O	O	I-T047
(	O	O	O
RS3PE	O	O	B-T047
)	O	O	O
is	O	O	O
a	O	O	O
rare	O	O	B-T047
condition	O	O	I-T047
in	O	O	O
the	O	O	O
elderly	O	O	B-T098
and	O	O	O
can	O	O	O
appear	O	O	O
as	O	O	O
a	O	O	O
first	O	O	O
presentation	O	O	O
of	O	O	O
various	O	O	O
types	O	O	B-T080
of	O	O	O
rheumatic	O	O	B-T047
and	O	O	O
malignant	O	O	B-T047
diseases	O	O	I-T047
.	O	O	O

We	O	O	O
presented	O	O	O
a	O	O	O
62-	O	O	O
year	O	O	B-T079
-old	O	O	O
man	O	O	B-T098
with	O	O	O
the	O	O	O
diagnosis	O	O	B-T033
of	O	O	O
RS3PE	O	O	B-T047
based	O	O	O
on	O	O	O
the	O	O	O
clinical	O	O	B-T184
sign	O	O	I-T184
and	O	O	O
laboratory	O	O	B-T078
data	O	O	I-T078
.	O	O	O

Because	O	O	O
of	O	O	O
the	O	O	O
possibility	O	O	O
of	O	O	O
associated	O	O	O
malignancies	O	O	B-T191
in	O	O	O
RS3PE	O	O	B-T047
,	O	O	O
FDG	O	O	B-T060
PET/CT	O	O	I-T060
was	O	O	O
performed	O	O	O
to	O	O	O
exclude	O	O	O
occult	O	O	B-T191
tumors	O	O	I-T191
.	O	O	O

The	O	O	O
images	O	O	B-T170
showed	O	O	O
multiple	O	O	B-T081
,	O	O	O
symmetrically	O	O	B-T033
,	O	O	O
diffusely	O	O	B-T082
increased	O	O	B-T081
F-FDG	O	O	B-T109
uptake	O	O	B-T039
in	O	O	O
the	O	O	O
soft	O	O	B-T024
tissue	O	O	I-T024
around	O	O	O
joints	O	O	B-T030
and	O	O	O
bones	O	O	B-T023
in	O	O	O
the	O	O	O
shoulders	O	O	B-T029
,	O	O	O
hips	O	O	B-T023
,	O	O	O
knees	O	O	B-T023
,	O	O	O
and	O	O	O
ankles	O	O	B-T029
.	O	O	O

-DOCSTART- (28322666)

Parks	O	O	B-T073
as	O	O	O
Social	O	O	B-T169
and	O	O	O
Cultural	O	O	B-T169
Spaces	O	O	B-T082
Among	O	O	O
U.S	O	O	B-T083
.-	O	O	O
and	O	O	O
Foreign	O	O	B-T080
-	O	O	O
Born	O	O	B-T040
Latinas	O	O	O

Parks	O	O	B-T073
provide	O	O	O
opportunities	O	O	B-UnknownType
for	O	O	O
people	O	O	B-T098
to	O	O	O
engage	O	O	O
in	O	O	O
activities	O	O	B-T052
that	O	O	O
can	O	O	O
promote	O	O	B-T052
physical	O	O	B-T169
and	O	O	O
emotional	O	O	B-T033
well-being	O	O	B-T078
.	O	O	O

Using	O	O	O
focus	O	O	B-T096
groups	O	O	I-T096
and	O	O	O
personal	O	O	B-T032
interviews	O	O	B-T052
conducted	O	O	O
in	O	O	O
selected	O	O	O
neighborhoods	O	O	O
of	O	O	O
a	O	O	O
Northeastern	O	O	B-T082
city	O	O	B-T083
with	O	O	O
a	O	O	O
high	O	O	B-T080
rate	O	O	B-T081
of	O	O	O
obesity	O	O	B-T047
,	O	O	O
we	O	O	O
examined	O	O	B-T033
perceptions	O	O	B-T041
of	O	O	O
barriers	O	O	B-T078
and	O	O	O
facilitators	O	O	B-T080
regarding	O	O	O
the	O	O	O
use	O	O	B-T169
of	O	O	I-T169
parks	O	O	B-T073
and	O	O	O
park	O	O	B-T073
features	O	O	B-T080
that	O	O	O
would	O	O	O
promote	O	O	B-T052
physical	O	O	B-T056
activity	O	O	I-T056
among	O	O	O
Latina	O	O	B-T098
women	O	O	B-T098
(	O	O	O
N	O	O	O
=	O	O	O
39	O	O	O
)	O	O	O
.	O	O	O

Foreign	O	O	B-T080
-	O	O	O
born	O	O	B-T040
Latinas	O	O	B-T098
emphasized	O	O	O
the	O	O	O
environmental	O	O	B-T082
characteristics	O	O	B-T080
of	O	O	O
parks	O	O	B-T073
and	O	O	O
the	O	O	O
types	O	O	B-T080
of	O	O	O
amenities	O	O	B-T073
that	O	O	O
can	O	O	O
support	O	O	O
preferred	O	O	O
cultural	O	O	B-T052
and	O	O	O
social	O	O	B-T054
activities	O	O	I-T054
,	O	O	O
while	O	O	O
U.S.	O	O	B-T083
-	O	O	O
born	O	O	O
Latinas	O	O	O
emphasized	O	O	O
the	O	O	O
use	O	O	O
of	O	O	O
parks	O	O	O
for	O	O	O
physical	O	O	B-T056
activity	O	O	I-T056
and	O	O	O
weight	O	O	B-T032
management	O	O	B-T052
.	O	O	O

Most	O	O	O
striking	O	O	O
were	O	O	O
the	O	O	O
different	O	O	O
ways	O	O	O
in	O	O	O
which	O	O	O
foreign	O	O	B-T080
-	O	O	O
born	O	O	B-T040
participants	O	O	B-T098
conceptualized	O	O	B-T041
parks	O	O	B-T073
as	O	O	O
sociocultural	O	O	B-T082
family	O	O	I-T082
centers	O	O	I-T082
,	O	O	O
extending	O	O	O
more	O	O	O
common	O	O	B-T081
conceptualizations	O	O	B-T041
centered	O	O	O
on	O	O	O
exercise	O	O	B-T056
or	O	O	O
individual	O	O	B-T098
health	O	O	B-T078
gain	O	O	B-T081
.	O	O	O

These	O	O	O
findings	O	O	B-T169
suggest	O	O	O
the	O	O	O
need	O	O	O
for	O	O	O
new	O	O	B-T080
policies	O	O	B-T170
that	O	O	O
incorporate	O	O	O
culturally	O	O	B-T169
specific	O	O	B-T080
park	O	O	B-T073
programming	O	O	B-T077
to	O	O	O
promote	O	O	B-T052
national	O	O	O
goals	O	O	B-T170
of	O	O	O
increasing	O	O	B-T169
levels	O	O	B-T080
of	O	O	O
physical	O	O	B-T056
activity	O	O	I-T056
for	O	O	O
health	O	O	B-T078
.	O	O	O

-DOCSTART- (28326653)

The	O	O	O
impact	O	O	B-T080
of	O	O	O
childhood	O	O	B-T048
maltreatment	O	O	I-T048
on	O	O	O
the	O	O	O
differential	O	O	B-T080
efficacy	O	O	B-T080
of	O	O	O
CBASP	O	O	B-T061
versus	O	O	O
escitalopram	O	O	B-T109
in	O	O	O
patients	O	O	B-T101
with	O	O	O
chronic	O	O	B-T048
depression	O	O	I-T048
:	O	O	O
A	O	O	O
secondary	O	O	O
analysis	O	O	O

Childhood	O	O	B-T048
maltreatment	O	O	I-T048
(	O	O	O
CM	O	O	B-T048
)	O	O	O
has	O	O	O
been	O	O	O
indicated	O	O	B-T033
as	O	O	O
a	O	O	O
predictor	O	O	B-T078
of	O	O	O
a	O	O	O
differential	O	O	B-T080
response	O	O	B-T032
to	O	O	O
antidepressant	O	O	B-T061
treatment	O	O	I-T061
with	O	O	O
psychotherapy	O	O	B-T061
compared	O	O	B-T052
to	O	O	O
medication	O	O	B-T121
.	O	O	O

In	O	O	O
this	O	O	O
secondary	O	O	B-UnknownType
analysis	O	O	I-UnknownType
,	O	O	O
we	O	O	O
investigated	O	O	B-T169
whether	O	O	O
the	O	O	O
presence	O	O	B-T080
of	O	O	O
CM	O	O	B-T048
results	O	O	B-T169
in	O	O	O
a	O	O	O
differential	O	O	B-T080
indication	O	O	B-T078
for	O	O	O
the	O	O	O
Cognitive	O	O	B-T061
Behavioral	O	O	I-T061
Analysis	O	O	I-T061
System	O	O	I-T061
of	O	O	I-T061
Psychotherapy	O	O	I-T061
(	O	O	O
CBASP	O	O	B-T061
)	O	O	O
or	O	O	O
escitalopram	O	O	B-T109
plus	O	O	O
clinical	O	O	B-T058
management	O	O	I-T058
(	O	O	O
ESC	O	O	B-T109
)	O	O	O
.	O	O	O

Sixty	O	O	O
patients	O	O	B-T101
with	O	O	O
chronic	O	O	B-T048
depression	O	O	I-T048
were	O	O	O
randomized	O	O	B-T062
to	O	O	O
either	O	O	O
22	O	O	O
sessions	O	O	B-T077
of	O	O	O
CBASP	O	O	B-T061
or	O	O	O
ESC	O	O	B-T109
over	O	O	O
the	O	O	O
course	O	O	B-T079
of	O	O	O
8	O	O	B-T079
weeks	O	O	I-T079
of	O	O	O
acute	O	O	B-T079
and	O	O	O
20	O	O	B-T079
weeks	O	O	I-T079
of	O	O	O
extended	O	O	B-T169
treatment	O	O	B-T061
at	O	O	O
2	O	O	O
German	O	O	B-T083
treatment	O	O	B-T082
sites	O	O	I-T082
.	O	O	O

CM	O	O	B-T048
was	O	O	O
assessed	O	O	B-T052
using	O	O	O
the	O	O	O
Childhood	O	O	B-T079
Trauma	O	O	B-T080
Questionnaire	O	O	B-T170
and	O	O	O
the	O	O	O
clinician	O	O	B-T097
rated	O	O	B-T052
Early	O	O	B-T170
Trauma	O	O	I-T170
Inventory	O	O	I-T170
.	O	O	O

Intention-to-treat	O	O	B-T062
analyses	O	O	I-T062
were	O	O	O
used	O	O	O
to	O	O	O
examine	O	O	O
the	O	O	O
impact	O	O	B-T080
of	O	O	O
CM	O	O	B-T048
on	O	O	O
depression	O	O	B-T048
,	O	O	O
global	O	O	B-T060
functioning	O	O	I-T060
,	O	O	O
and	O	O	O
quality	O	O	B-T078
of	O	O	I-T078
life	O	O	I-T078
.	O	O	O

The	O	O	O
presence	O	O	B-T080
of	O	O	O
CM	O	O	B-T048
did	O	O	O
not	O	O	O
result	O	O	B-T169
in	O	O	O
significant	O	O	B-T078
differences	O	O	B-T080
in	O	O	O
treatment	O	O	B-T061
response	O	O	I-T201
to	O	O	O
CBASP	O	O	B-T061
or	O	O	O
ESC	O	O	B-T109
on	O	O	O
any	O	O	O
outcome	O	O	B-T081
measure	O	O	I-T081
after	O	O	O
28	O	O	B-T079
weeks	O	O	I-T079
of	O	O	O
treatment	O	O	O
independent	O	O	B-T169
of	O	O	I-T169
the	O	O	O
type	O	O	O
of	O	O	O
CM	O	O	O
assessment	O	O	B-T058
.	O	O	O

After	O	O	O
8	O	O	B-T079
weeks	O	O	I-T079
,	O	O	O
a	O	O	O
significant	O	O	B-T078
CM	O	O	B-T048
Ã	O	O	O
treatment	O	O	B-T061
interaction	O	O	B-T169
was	O	O	O
found	O	O	B-T033
for	O	O	O
scores	O	O	B-T081
on	O	O	O
the	O	O	O
Montgomery-Asberg	O	O	B-T170
Depression	O	O	I-T170
Rating	O	O	I-T170
Scale	O	O	I-T170
.	O	O	O

Patients	O	O	B-T101
with	O	O	O
a	O	O	O
history	O	O	B-T033
of	O	O	O
CM	O	O	B-T048
receiving	O	O	B-T080
CBASP	O	O	B-T061
had	O	O	O
a	O	O	O
significantly	O	O	B-T081
lower	O	O	I-T081
response	O	O	B-T079
rate	O	O	I-T079
compared	O	O	B-T052
to	O	O	O
patients	O	O	B-T101
without	O	O	O
CM	O	O	O
and	O	O	O
to	O	O	O
those	O	O	O
receiving	O	O	O
ESC	O	O	B-T109
after	O	O	O
8	O	O	B-T079
weeks	O	O	I-T079
.	O	O	O

Conclusively	O	O	B-T080
,	O	O	O
CBASP	O	O	B-T061
and	O	O	O
ESC	O	O	B-T109
are	O	O	O
equally	O	O	O
effective	O	O	B-T080
treatment	O	O	B-T061
options	O	O	O
for	O	O	O
the	O	O	O
difficult	O	O	B-T080
to	O	O	O
treat	O	O	B-T169
subgroup	O	O	B-T185
of	O	O	O
patients	O	O	B-T101
with	O	O	O
chronic	O	O	B-T048
depression	O	O	I-T048
and	O	O	O
a	O	O	O
history	O	O	B-T033
of	O	O	O
CM	O	O	B-T048
.	O	O	O

CM	O	O	B-T048
may	O	O	O
be	O	O	O
a	O	O	O
predictor	O	O	B-T078
of	O	O	O
a	O	O	O
longer	O	O	B-T080
latency	O	O	B-T079
of	O	O	O
treatment	O	O	B-T201
response	O	O	I-T201
in	O	O	O
the	O	O	O
case	O	O	B-T169
of	O	O	O
psychotherapy	O	O	B-T061
.	O	O	O

CBASP	O	O	B-T061
and	O	O	O
escitalopram	O	O	B-T109
are	O	O	O
equally	O	O	O
effective	O	O	B-T080
treatment	O	O	B-T061
options	O	O	O
for	O	O	O
chronic	O	O	B-T048
depression	O	O	I-T048
.	O	O	O

Both	O	O	O
treatments	O	O	B-T061
are	O	O	O
also	O	O	O
equally	O	O	O
effective	O	O	B-T080
for	O	O	O
the	O	O	O
difficult	O	O	B-T080
to	O	O	O
treat	O	O	B-T169
subgroup	O	O	B-T185
of	O	O	O
patients	O	O	B-T101
with	O	O	O
chronic	O	O	B-T048
depression	O	O	I-T048
and	O	O	O
a	O	O	O
history	O	O	B-T033
of	O	O	O
childhood	O	O	B-T048
maltreatment	O	O	I-T048
.	O	O	O

Childhood	O	O	B-T048
maltreatment	O	O	I-T048
may	O	O	O
result	O	O	B-T169
in	O	O	O
a	O	O	O
longer	O	O	B-T080
latency	O	O	B-T079
of	O	O	O
treatment	O	O	B-T201
response	O	O	I-T201
in	O	O	O
the	O	O	O
case	O	O	B-T169
of	O	O	O
psychotherapy	O	O	B-T061
.	O	O	O

-DOCSTART- (28326936)

A	O	O	O
role	O	O	O
for	O	O	O
the	O	O	O
locus	O	O	B-T023
coeruleus	O	O	I-T023
in	O	O	O
the	O	O	O
analgesic	O	O	B-T033
efficacy	O	O	I-T033
of	O	O	O
N-acetylaspartylglutamate	O	O	B-T116
peptidase	O	O	I-T116
(	O	O	O
GCPII	O	O	B-T116
)	O	O	O
inhibitors	O	O	B-T121
ZJ43	O	O	B-T109
and	O	O	O
2-PMPA	O	O	O

N-acetylaspartylglutamate	O	O	B-T116
(	O	O	O
NAAG	O	O	B-T116
)	O	O	O
is	O	O	O
the	O	O	O
third	O	O	O
most	O	O	O
prevalent	O	O	O
and	O	O	O
widely	O	O	O
distributed	O	O	O
neurotransmitter	O	O	B-T123
in	O	O	O
the	O	O	O
mammalian	O	O	B-T015
nervous	O	O	B-T022
system	O	O	I-T022
.	O	O	O

NAAG	O	O	B-T116
activates	O	O	B-T052
a	O	O	O
group	O	O	B-T116
II	O	O	I-T116
metabotropic	O	O	I-T116
glutamate	O	O	I-T116
receptor	O	O	I-T116
(	O	O	O
mGluR3	O	O	B-T116
)	O	O	O
and	O	O	O
is	O	O	O
inactivated	O	O	O
by	O	O	O
an	O	O	O
extracellular	O	O	B-T116
enzyme	O	O	I-T116
,	O	O	I-T116
glutamate	O	O	I-T116
carboxypeptidase	O	O	I-T116
II	O	O	I-T116
(	O	O	O
GCPII	O	O	B-T116
)	O	O	O
in	O	O	B-T082
vivo	O	O	I-T082
.	O	O	O

Inhibitors	O	O	B-T121
of	O	O	I-T121
this	O	O	I-T121
enzyme	O	O	I-T121
are	O	O	O
analgesic	O	O	B-T109
in	O	O	O
animal	O	O	B-T008
models	O	O	I-T008
of	O	O	O
inflammatory	O	O	B-T184
,	O	O	O
neuropathic	O	O	B-T033
and	O	O	O
bone	O	O	B-T191
cancer	O	O	I-T191
pain	O	O	B-T184
.	O	O	O

NAAG	O	O	B-T116
and	O	O	O
GCPII	O	O	B-T116
are	O	O	O
present	O	O	O
in	O	O	O
the	O	O	O
locus	O	O	B-T023
coeruleus	O	O	I-T023
,	O	O	O
a	O	O	O
center	O	O	O
for	O	O	O
the	O	O	O
descending	O	O	O
noradrenergic	O	O	B-T044
inhibitory	O	O	B-T052
pain	O	O	O
system	O	O	O
.	O	O	O

In	O	O	O
the	O	O	O
formalin	O	O	B-T109
footpad	O	O	B-T023
model	O	O	B-T050
,	O	O	O
systemic	O	O	B-T169
treatment	O	O	B-T169
with	O	O	O
GCPII	O	O	B-T121
inhibitors	O	O	I-T121
reduces	O	O	O
both	O	O	O
phases	O	O	O
of	O	O	O
the	O	O	O
inflammatory	O	O	B-T184
pain	O	O	I-T184
response	O	O	B-T032
and	O	O	O
increases	O	O	O
release	O	O	O
of	O	O	O
spinal	O	O	B-T082
noradrenaline	O	O	B-T125
.	O	O	O

This	O	O	O
analgesic	O	O	B-T033
efficacy	O	O	I-T033
is	O	O	O
blocked	O	O	B-T169
by	O	O	O
systemic	O	O	B-T169
injection	O	O	B-T061
of	O	O	O
a	O	O	O
group	O	O	B-T116
II	O	O	I-T116
mGluR	O	O	I-T116
antagonist	O	O	B-T121
,	O	O	O
by	O	O	O
intrathecal	O	O	B-T061
(	O	O	I-T061
spinal	O	O	I-T061
)	O	O	I-T061
injection	O	O	I-T061
of	O	O	O
an	O	O	O
alpha	O	O	B-T121
2	O	O	I-T121
adrenergic	O	O	I-T121
receptor	O	O	I-T121
antagonist	O	O	I-T121
and	O	O	O
by	O	O	O
microinjection	O	O	B-T061
of	O	O	O
an	O	O	O
Î±-amino-3-hydroxy-5-methylisoxazole-4-propionic	O	O	B-T121
acid	O	O	I-T121
(	O	O	I-T121
AMPA	O	O	I-T121
)	O	O	I-T121
receptor	O	O	I-T121
antagonist	O	O	I-T121
directly	O	O	O
into	O	O	O
the	O	O	O
contralateral	O	O	B-T082
locus	O	O	B-T023
coeruleus	O	O	I-T023
.	O	O	O

Footpad	O	O	B-T023
inflammation	O	O	B-T046
increases	O	O	O
release	O	O	O
of	O	O	O
glutamate	O	O	B-T116
in	O	O	O
the	O	O	O
contralateral	O	O	B-T082
locus	O	O	B-T023
coeruleu	O	O	I-T023
s	O	O	O
and	O	O	O
systemic	O	O	B-T169
treatment	O	O	B-T169
with	O	O	O
a	O	O	O
GCPII	O	O	B-T121
inhibitor	O	O	I-T121
blocks	O	O	B-T169
this	O	O	O
increase	O	O	O
.	O	O	O

Direct	O	O	B-T080
injection	O	O	B-T061
of	O	O	O
GCPII	O	O	B-T121
inhibitors	O	O	I-T121
into	O	O	O
the	O	O	O
contralateral	O	O	B-T082
or	O	O	O
ipsilatera	O	O	B-T082
l	O	O	O
locus	O	O	B-T023
coeruleus	O	O	I-T023
reduces	O	O	O
both	O	O	O
phases	O	O	O
of	O	O	O
the	O	O	O
inflammatory	O	O	B-T184
pain	O	O	I-T184
response	O	O	B-T032
in	O	O	O
a	O	O	O
dose-dependent	O	O	B-T081
manner	O	O	O
and	O	O	O
the	O	O	O
contralateral	O	O	O
effect	O	O	B-T080
also	O	O	O
is	O	O	O
blocked	O	O	B-T169
by	O	O	O
intrathecal	O	O	B-T061
injection	O	O	I-T061
of	O	O	O
an	O	O	O
alpha	O	O	B-T121
2	O	O	I-T121
adrenergic	O	O	I-T121
receptor	O	O	I-T121
antagonist	O	O	I-T121
.	O	O	O

These	O	O	O
data	O	O	O
support	O	O	O
the	O	O	O
hypothesis	O	O	B-T078
that	O	O	O
the	O	O	O
analgesic	O	O	B-T033
efficacy	O	O	I-T033
of	O	O	O
systemically	O	O	O
administered	O	O	O
GCPII	O	O	B-T121
inhibitors	O	O	I-T121
is	O	O	O
mediated	O	O	O
,	O	O	O
at	O	O	O
least	O	O	O
in	O	O	O
part	O	O	O
,	O	O	O
by	O	O	O
the	O	O	O
contralatera	O	O	B-T082
l	O	O	O
locus	O	O	B-T023
coeruleus	O	O	I-T023
via	O	O	O
group	O	O	B-T116
II	O	O	I-T116
mGluR	O	O	I-T116
,	O	O	O
AMPA	O	O	B-T116
and	O	O	O
alpha	O	O	B-T116
2	O	O	I-T116
adrenergic	O	O	I-T116
receptors	O	O	I-T116
.	O	O	O

-DOCSTART- (28327105)

Association	O	O	B-T080
of	O	O	O
physical	O	O	B-T056
activity	O	O	I-T056
on	O	O	O
body	O	O	B-T032
composition	O	O	I-T032
,	O	O	O
cardiometabolic	O	O	B-T033
risk	O	O	I-T033
factors	O	O	I-T033
,	O	O	O
and	O	O	O
prevalence	O	O	B-T081
of	O	O	O
cardiovascular	O	O	B-T047
disease	O	O	I-T047
in	O	O	O
the	O	O	O
Korean	O	O	B-T098
population	O	O	I-T098
(	O	O	O
from	O	O	O
the	O	O	O
fifth	O	O	O
Korea	O	O	B-T083
national	O	O	B-T062
health	O	O	I-T062
and	O	O	I-T062
nutrition	O	O	I-T062
examination	O	O	I-T062
survey	O	O	I-T062
,	O	O	O
2008	O	O	O
-	O	O	O
2011	O	O	O
)	O	O	O

Data	O	O	B-T078
regarding	O	O	O
associations	O	O	B-T080
among	O	O	O
physical	O	O	B-T056
activity	O	O	I-T056
(	O	O	O
PA	O	O	B-T056
)	O	O	O
level	O	O	B-T080
,	O	O	O
body	O	O	B-T032
composition	O	O	I-T032
,	O	O	O
and	O	O	O
prevalence	O	O	B-T081
of	O	O	O
cardiovascular	O	O	B-T047
diseases	O	O	I-T047
in	O	O	O
Asian	O	O	B-T081
populations	O	O	I-T081
are	O	O	O
rare	O	O	B-T080
.	O	O	O

The	O	O	O
International	O	O	B-T170
Physical	O	O	I-T170
Activity	O	O	I-T170
Questionnaire	O	O	I-T170
(	O	O	O
IPAQ	O	O	B-T170
)	O	O	O
was	O	O	O
utilized	O	O	O
to	O	O	O
estimate	O	O	B-T081
PA	O	O	B-T056
levels	O	O	B-T080
and	O	O	O
analyze	O	O	B-T062
the	O	O	O
association	O	O	B-T080
of	O	O	O
PA	O	O	O
level	O	O	B-T080
with	O	O	O
various	O	O	O
body	O	O	B-T032
composition	O	O	I-T032
parameters	O	O	B-T077
and	O	O	O
the	O	O	O
prevalence	O	O	B-T081
of	O	O	O
cardiovascular	O	O	B-T047
diseases	O	O	I-T047
by	O	O	O
using	O	O	O
data	O	O	B-T078
from	O	O	O
the	O	O	O
Korean	O	O	B-T083
National	O	O	B-T062
Health	O	O	I-T062
and	O	O	I-T062
Nutrition	O	O	I-T062
Examination	O	O	I-T062
Survey	O	O	I-T062
from	O	O	O
2008	O	O	O
to	O	O	O
2011	O	O	O
.	O	O	O

Moderate	O	O	B-T080
and	O	O	O
high	O	O	B-T080
PA	O	O	B-T056
levels	O	O	B-T080
were	O	O	O
associated	O	O	B-T080
with	O	O	O
lower	O	O	B-T080
prevalence	O	O	I-T081
of	O	O	O
hypertension	O	O	B-T047
and	O	O	O
diabetes	O	O	B-T047
mellitus	O	O	I-T047
,	O	O	O
and	O	O	O
lower	O	O	O
concentrations	O	O	B-T081
of	O	O	O
serum	O	O	B-T033
ferritin	O	O	I-T033
,	O	O	O
parathyroid	O	O	B-T033
hormone	O	O	I-T033
,	O	O	O
and	O	O	O
alkaline	O	O	B-T033
phosphatase	O	O	I-T033
.	O	O	O

Sarcopenia	O	O	B-T047
(	O	O	O
low	O	O	B-T080
vs.	O	O	O
moderate	O	O	B-T080
vs.	O	O	O
high	O	O	B-T080
PA	O	O	B-T056
group	O	O	B-T078
:	O	O	O
14.3	O	O	O
%	O	O	O
vs.	O	O	O
10.5	O	O	O
%	O	O	O
vs.	O	O	O
7.3	O	O	O
%	O	O	O
,	O	O	O
p	O	O	B-T081
=	O	O	O
0.001	O	O	O
)	O	O	O
,	O	O	O
underweight	O	O	B-T033
(	O	O	O
5.7	O	O	O
%	O	O	O
vs.	O	O	O
4.9	O	O	O
%	O	O	O
vs.	O	O	O
3.5	O	O	O
%	O	O	O
,	O	O	O
p	O	O	O
=	O	O	O
0.001	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
central	O	O	B-T033
obesity	O	O	I-T033
(	O	O	O
7.8	O	O	O
%	O	O	O
vs.	O	O	O
6.9	O	O	O
%	O	O	O
vs.	O	O	O
6.3	O	O	O
%	O	O	O
,	O	O	O
p	O	O	O
=	O	O	O
0.002	O	O	O
)	O	O	O
were	O	O	O
more	O	O	O
often	O	O	O
observed	O	O	B-T169
in	O	O	O
the	O	O	O
low	O	O	O
PA	O	O	O
group	O	O	O
.	O	O	O

The	O	O	O
prevalence	O	O	B-T081
rates	O	O	B-T081
of	O	O	O
cardiovascular	O	O	B-T047
diseases	O	O	I-T047
were	O	O	O
lower	O	O	B-T080
in	O	O	O
the	O	O	O
moderate	O	O	B-T080
(	O	O	O
odds	O	O	B-T081
ratio	O	O	I-T081
[	O	O	O
OR	O	O	B-T081
]	O	O	O
,	O	O	O
0.822	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
confidence	O	O	B-T081
interval	O	O	I-T081
[	O	O	O
CI	O	O	B-T081
]	O	O	O
,	O	O	O
0.737	O	O	O
-	O	O	O
0.916	O	O	O
;	O	O	O
p	O	O	B-T081
=	O	O	O
0.001	O	O	O
)	O	O	O
and	O	O	O
high	O	O	B-T080
activity	O	O	B-T056
groups	O	O	B-T078
(	O	O	O
OR	O	O	O
,	O	O	O
0.663	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
,	O	O	O
0.589	O	O	O
-	O	O	O
0.748	O	O	O
;	O	O	O
p	O	O	O
=	O	O	O
0.001	O	O	O
)	O	O	O
than	O	O	O
in	O	O	O
the	O	O	O
low	O	O	B-T080
activity	O	O	O
group	O	O	B-T078
,	O	O	O
even	O	O	O
after	O	O	O
adjusting	O	O	O
for	O	O	O
age	O	O	B-T032
,	O	O	O
sex	O	O	B-T032
,	O	O	O
smoking	O	O	B-T055
,	O	O	O
underlying	O	O	B-T047
disease	O	O	I-T047
,	O	O	O
and	O	O	O
general	O	O	B-T047
or	O	O	O
abdominal	O	O	B-T033
obesity	O	O	I-T033
and	O	O	O
muscle	O	O	B-T033
mass	O	O	I-T033
.	O	O	O

Regular	O	O	B-UnknownType
physical	O	O	I-UnknownType
activity	O	O	I-UnknownType
was	O	O	O
associated	O	O	B-T080
with	O	O	O
a	O	O	O
low	O	O	B-T081
prevalence	O	O	I-T081
of	O	O	O
cardiovascular	O	O	B-T047
diseases	O	O	I-T047
(	O	O	O
stroke	O	O	B-T037
,	O	O	O
myocardial	O	O	B-T047
infarction	O	O	I-T047
,	O	O	O
stable	O	O	B-T047
angina	O	O	I-T047
,	O	O	O
and	O	O	O
chronic	O	O	B-T047
renal	O	O	I-T047
disease	O	O	I-T047
)	O	O	O
,	O	O	O
which	O	O	O
was	O	O	O
independent	O	O	B-T169
of	O	O	I-T169
body	O	O	B-T032
composition	O	O	I-T032
and	O	O	O
conventional	O	O	O
risk	O	O	B-T033
factors	O	O	I-T033
in	O	O	O
the	O	O	O
Korean	O	O	B-T098
population	O	O	I-T098
,	O	O	O
with	O	O	O
a	O	O	O
positive	O	O	B-T033
dose-response	O	O	B-T038
relationship	O	O	I-T038
.	O	O	O

-DOCSTART- (28328236)

Treated	O	O	B-T061
Prevalence	O	O	B-T081
of	O	O	O
Attention-Deficit/Hyperactivity	O	O	B-T048
Disorder	O	O	I-T048
Increased	O	O	B-T081
from	O	O	O
2009	O	O	O
to	O	O	O
2015	O	O	O
Among	O	O	O
School-Aged	O	O	B-T100
Children	O	O	I-T100
and	O	O	O
Adolescents	O	O	B-T100
in	O	O	O
the	O	O	O
United	O	O	O
States	O	O	O

The	O	O	O
purpose	O	O	B-T169
of	O	O	O
this	O	O	O
brief	O	O	O
is	O	O	O
to	O	O	O
describe	O	O	B-T078
changes	O	O	B-T169
in	O	O	O
the	O	O	O
treated	O	O	B-T061
prevalence	O	O	B-T081
of	O	O	O
medically	O	O	B-T169
managed	O	O	B-T058
attention-deficit/hyperactivity	O	O	B-T048
disorder	O	O	I-T048
(	O	O	O
ADHD	O	O	B-T048
)	O	O	O
among	O	O	O
insured	O	O	B-T170
school-aged	O	O	B-T100
children	O	O	I-T100
and	O	O	O
adolescents	O	O	B-T100
in	O	O	O
the	O	O	O
United	O	O	B-T083
States	O	O	I-T083
from	O	O	O
2009	O	O	O
to	O	O	O
2015	O	O	O
.	O	O	O

We	O	O	O
examine	O	O	B-T033
the	O	O	O
differences	O	O	B-T081
between	O	O	O
those	O	O	O
with	O	O	O
employer-sponsored	O	O	B-T081
insurance	O	O	I-T081
(	O	O	O
ESI	O	O	B-T081
)	O	O	O
and	O	O	O
with	O	O	O
Medicaid	O	O	B-T058
insurance	O	O	I-T058
.	O	O	O

We	O	O	O
utilized	O	O	O
two	O	O	O
large	O	O	O
longitudinal	O	O	B-T082
administrative	O	O	B-T170
datasets	O	O	I-T170
containing	O	O	O
medical	O	O	B-T169
and	O	O	O
drug	O	O	B-T121
claims	O	O	B-T058
data	O	O	B-T078
on	O	O	O
individuals	O	O	B-T098
with	O	O	O
ESI	O	O	B-T081
and	O	O	O
Medicaid	O	O	B-T058
insurance	O	O	I-T058
from	O	O	O
Truven	O	O	B-T170
Health	O	O	I-T170
MarketScan	O	O	I-T170
(	O	O	I-T170
Â®	O	O	I-T170
)	O	O	I-T170
Administrative	O	O	I-T170
Claims	O	O	I-T170
Databases	O	O	I-T170
.	O	O	O

Treated	O	O	B-T061
prevalence	O	O	B-T081
was	O	O	O
measured	O	O	B-T080
as	O	O	O
the	O	O	O
percentage	O	O	B-T081
of	O	O	O
school-aged	O	O	B-T100
children	O	O	I-T100
and	O	O	O
adolescents	O	O	B-T100
enrolled	O	O	O
in	O	O	O
a	O	O	O
calendar	O	O	B-T079
year	O	O	I-T079
who	O	O	O
met	O	O	O
the	O	O	O
criteria	O	O	B-T078
for	O	O	O
medically	O	O	B-T169
managed	O	O	B-T058
ADHD	O	O	B-T048
in	O	O	O
the	O	O	O
same	O	O	O
calendar	O	O	O
year	O	O	O
.	O	O	O

Subjects	O	O	B-T098
were	O	O	O
eligible	O	O	B-T080
for	O	O	O
inclusion	O	O	B-T080
if	O	O	O
they	O	O	O
were	O	O	O
aged	O	O	B-T032
6	O	O	O
-	O	O	O
17	O	O	O
years	O	O	B-T079
and	O	O	O
were	O	O	O
continuously	O	O	B-T078
enrolled	O	O	O
during	O	O	O
a	O	O	O
calendar	O	O	B-T079
year	O	O	I-T079
.	O	O	O

The	O	O	O
annual	O	O	B-T079
prevalence	O	O	B-T081
of	O	O	O
treated	O	O	B-T061
ADHD	O	O	B-T048
among	O	O	O
school-aged	O	O	B-T100
children	O	O	I-T100
and	O	O	O
adolescents	O	O	B-T100
with	O	O	O
ESI	O	O	B-T081
increased	O	O	B-T081
from	O	O	O
4.5	O	O	O
%	O	O	O
in	O	O	O
2009	O	O	O
to	O	O	O
6.7	O	O	O
%	O	O	O
in	O	O	O
2015	O	O	O
.	O	O	O

Among	O	O	O
those	O	O	O
with	O	O	O
Medicaid	O	O	B-T058
it	O	O	O
increased	O	O	B-T081
from	O	O	O
11.3	O	O	O
%	O	O	O
in	O	O	O
2009	O	O	O
to	O	O	O
13.3	O	O	O
%	O	O	O
in	O	O	O
2012	O	O	O
,	O	O	O
and	O	O	O
fell	O	O	O
after	O	O	O
2012	O	O	O
,	O	O	O
remaining	O	O	O
steady	O	O	B-T080
from	O	O	O
2013	O	O	O
through	O	O	O
2015	O	O	O
.	O	O	O

Treated	O	O	B-T061
prevalence	O	O	B-T081
of	O	O	O
ADHD	O	O	B-T048
increased	O	O	B-T081
continuously	O	O	B-T078
over	O	O	O
time	O	O	B-T079
among	O	O	O
school-aged	O	O	B-T100
children	O	O	I-T100
and	O	O	O
adolescents	O	O	B-T100
with	O	O	O
ESI	O	O	B-T081
,	O	O	O
but	O	O	O
declined	O	O	B-T081
slightly	O	O	O
after	O	O	O
2012	O	O	O
among	O	O	O
those	O	O	O
in	O	O	O
the	O	O	O
Medicaid	O	O	B-T058
sample	O	O	I-T058
.	O	O	O

-DOCSTART- (28330678)

Acute	O	O	B-T079
macular	O	O	B-T047
edema	O	O	I-T047
and	O	O	O
peripapillary	O	O	B-T082
soft	O	O	B-T080
exudate	O	O	B-T031
after	O	O	O
pancreas	O	O	B-T061
transplantation	O	O	I-T061
with	O	O	O
accelerated	O	O	B-T169
progression	O	O	B-T046
of	O	O	O
diabetic	O	O	O
retinopathy	O	O	O

The	O	O	O
effect	O	O	O
of	O	O	O
pancreas	O	O	B-T061
transplantation	O	O	I-T061
on	O	O	O
diabetic	O	O	B-T047
retinopathy	O	O	I-T047
remains	O	O	O
inconclusive	O	O	B-T080
.	O	O	O

Herein	O	O	O
,	O	O	O
we	O	O	O
report	O	O	O
six	O	O	O
patients	O	O	B-T101
with	O	O	O
type	O	O	B-T047
1	O	O	I-T047
diabetes	O	O	I-T047
mellitus	O	O	I-T047
(	O	O	O
DM	O	O	B-T047
)	O	O	O
who	O	O	O
underwent	O	O	O
pancreas	O	O	B-T061
transplantation	O	O	I-T061
and	O	O	O
developed	O	O	O
acute	O	O	B-T079
macular	O	O	B-T047
edema	O	O	I-T047
and	O	O	O
peripapillary	O	O	B-T082
soft	O	O	B-T080
exudate	O	O	B-T031
with	O	O	O
rapid	O	O	B-T080
progression	O	O	B-T046
to	O	O	O
proliferative	O	O	B-T047
diabetic	O	O	I-T047
retinopathy	O	O	I-T047
.	O	O	O

In	O	O	O
this	O	O	O
retrospective	O	O	B-T062
observational	O	O	I-T062
study	O	O	I-T062
,	O	O	O
diabetic	O	O	B-T047
patients	O	O	B-T101
who	O	O	O
underwent	O	O	O
pancreas	O	O	B-T061
transplantation	O	O	I-T061
in	O	O	O
a	O	O	O
single	O	O	B-T081
medical	O	O	B-T093
center	O	O	I-T093
and	O	O	O
developed	O	O	O
symptomatic	O	O	B-T169
acute	O	O	B-T079
macular	O	O	B-T047
edema	O	O	I-T047
and	O	O	O
peripapillary	O	O	B-T082
soft	O	O	B-T080
exudate	O	O	B-T031
within	O	O	B-T082
3	O	O	B-T079
months	O	O	I-T079
after	O	O	B-T079
the	O	O	O
operation	O	O	B-T061
were	O	O	O
enrolled	O	O	O
.	O	O	O

The	O	O	O
complete	O	O	B-T080
ophthalmic	O	O	B-T079
course	O	O	I-T079
and	O	O	O
medical	O	O	B-T170
records	O	O	I-T170
of	O	O	O
the	O	O	O
patients	O	O	B-T101
were	O	O	O
retrospectively	O	O	B-T080
reviewed	O	O	B-T080
.	O	O	O

Diabetic	O	O	B-T047
retinopathy	O	O	I-T047
and	O	O	O
progression	O	O	B-T046
following	O	O	B-T079
treatment	O	O	B-T061
after	O	O	O
pancreas	O	O	B-T061
transplantation	O	O	I-T061
were	O	O	O
measured	O	O	B-T080
.	O	O	O

Six	O	O	O
Chinese	O	O	B-T098
women	O	O	B-T098
with	O	O	O
type	O	O	B-T047
1	O	O	I-T047
DM	O	O	I-T047
were	O	O	O
enrolled	O	O	O
in	O	O	O
this	O	O	O
study	O	O	B-T062
.	O	O	O

Mean	O	O	O
hemoglobin	O	O	B-T116
(	O	O	I-T116
Hb	O	O	I-T116
)	O	O	I-T116
A1c	O	O	I-T116
was	O	O	O
13.4	O	O	O
%	O	O	O
prior	O	O	O
to	O	O	O
transplantation	O	O	B-T061
and	O	O	O
decreased	O	O	B-T081
rapidly	O	O	B-T080
to	O	O	O
6.5	O	O	O
%	O	O	O
within	O	O	B-T082
2	O	O	B-T079
months	O	O	I-T079
postsurgery	O	O	B-T079
.	O	O	O

The	O	O	O
patients	O	O	B-T101
had	O	O	O
no	O	O	B-T169
or	O	O	O
mild	O	O	B-T080
pretransplant	O	O	B-T169
diabetic	O	O	B-T047
retinopathy	O	O	I-T047
and	O	O	O
developed	O	O	O
acute	O	O	B-T079
symptomatic	O	O	B-T169
macular	O	O	B-T047
edema	O	O	I-T047
and	O	O	O
peripapillary	O	O	B-T082
soft	O	O	B-T080
exudate	O	O	B-T031
in	O	O	O
both	O	O	B-T023
eyes	O	O	I-T023
after	O	O	O
pancreas	O	O	B-T061
transplantation	O	O	I-T061
.	O	O	O

All	O	O	O
macular	O	O	B-T047
edema	O	O	I-T047
resolved	O	O	B-T033
either	O	O	O
with	O	O	O
or	O	O	O
without	O	O	B-T080
treatment	O	O	B-T061
.	O	O	O

Five	O	O	O
cases	O	O	B-T169
progressed	O	O	B-T046
to	O	O	O
proliferative	O	O	B-T047
diabetic	O	O	I-T047
retinopathy	O	O	I-T047
and	O	O	O
received	O	O	B-T080
panretinal	O	O	B-T061
photocoagulation	O	O	I-T061
.	O	O	O

Diabetic	O	O	B-T047
retinopathy	O	O	I-T047
remained	O	O	O
stable	O	O	B-T080
in	O	O	O
all	O	O	B-T081
eyes	O	O	B-T023
after	O	O	B-T079
treatment	O	O	B-T061
,	O	O	O
and	O	O	O
the	O	O	O
visual	O	O	B-T169
prognosis	O	O	B-T033
was	O	O	I-T033
good	O	O	I-T033
,	O	O	O
except	O	O	B-T169
in	O	O	O
one	O	O	B-T081
eye	O	O	B-T023
that	O	O	O
had	O	O	O
macular	O	O	B-T082
branch	O	O	B-T047
retinal	O	O	I-T047
artery	O	O	I-T047
occlusion	O	O	I-T047
with	O	O	O
foveal	O	O	B-T023
involvement	O	O	B-T169
.	O	O	O

Acute	O	O	B-T079
macular	O	O	B-T047
edema	O	O	I-T047
after	O	O	O
pancreas	O	O	B-T061
transplantation	O	O	I-T061
has	O	O	O
a	O	O	O
favorable	O	O	B-T080
treatment	O	O	B-T080
outcome	O	O	I-T080
despite	O	O	O
rapid	O	O	O
progression	O	O	B-T046
to	O	O	O
proliferative	O	O	B-T047
diabetic	O	O	I-T047
retinopathy	O	O	I-T047
.	O	O	O

High	O	O	B-T080
pretransplant	O	O	B-T169
HbA1c	O	O	B-T116
and	O	O	O
abrupt	O	O	B-T080
blood	O	O	B-T109
sugar	O	O	I-T109
normalization	O	O	B-T169
may	O	O	O
be	O	O	O
related	O	O	O
to	O	O	O
the	O	O	O
disease	O	O	B-T046
course	O	O	I-T046
.	O	O	O

-DOCSTART- (28331620)

Anger	O	O	B-T041
and	O	O	O
aggression	O	O	B-T055
in	O	O	O
borderline	O	O	B-T048
personality	O	O	I-T048
disorder	O	O	I-T048
and	O	O	O
attention	O	O	B-T048
deficit	O	O	I-T048
hyperactivity	O	O	I-T048
disorder	O	O	I-T048
-	O	O	O
does	O	O	O
stress	O	O	B-T033
matter	O	O	O
?	O	O	O

The	O	O	O
impact	O	O	B-T080
of	O	O	O
stress	O	O	B-T033
on	O	O	O
anger	O	O	B-T041
and	O	O	O
aggression	O	O	B-T055
in	O	O	O
Borderline	O	O	B-T048
Personality	O	O	I-T048
Disorder	O	O	I-T048
(	O	O	O
BPD	O	O	B-T048
)	O	O	O
and	O	O	O
Attention	O	O	B-T048
Deficit	O	O	I-T048
Hyperactivity	O	O	I-T048
Disorder	O	O	I-T048
(	O	O	O
ADHD	O	O	B-T048
)	O	O	O
has	O	O	O
not	O	O	O
been	O	O	O
thoroughly	O	O	O
investigated	O	O	B-T169
.	O	O	O

The	O	O	O
goal	O	O	O
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
investigate	O	O	B-T169
different	O	O	O
aspects	O	O	O
of	O	O	O
anger	O	O	B-T041
and	O	O	O
aggression	O	O	B-T055
in	O	O	O
patients	O	O	B-T101
with	O	O	O
these	O	O	O
disorders	O	O	B-T047
.	O	O	O

Twenty-nine	O	O	O
unmedicated	O	O	B-T033
female	O	O	B-T032
BPD	O	O	B-T048
patients	O	O	B-T101
,	O	O	O
28	O	O	O
ADHD	O	O	B-T048
patients	O	O	O
and	O	O	O
30	O	O	O
healthy	O	O	B-T080
controls	O	O	I-T080
(	O	O	O
HC	O	O	B-T080
)	O	O	O
completed	O	O	O
self-reports	O	O	B-T062
measuring	O	O	B-T080
trait	O	O	B-T032
anger	O	O	B-T041
,	O	O	O
aggression	O	O	B-T055
and	O	O	O
emotion	O	O	B-T041
regulation	O	O	I-T041
capacities	O	O	O
.	O	O	O

A	O	O	O
modified	O	O	O
version	O	O	O
of	O	O	O
the	O	O	O
Point	O	O	B-T062
Subtraction	O	O	I-T062
Aggression	O	O	I-T062
Paradigm	O	O	I-T062
and	O	O	O
a	O	O	O
state	O	O	B-T062
anger	O	O	I-T062
measurement	O	O	I-T062
were	O	O	O
applied	O	O	O
under	O	O	O
resting	O	O	B-T080
and	O	O	O
stress	O	O	B-T080
conditions	O	O	I-T080
.	O	O	O

Stress	O	O	B-T033
was	O	O	O
induced	O	O	B-T169
by	O	O	O
the	O	O	O
Mannheim	O	O	B-T060
Multicomponent	O	O	I-T060
Stress	O	O	I-T060
Test	O	O	I-T060
(	O	O	O
MMST	O	O	B-T060
)	O	O	O
.	O	O	O

Both	O	O	O
patient	O	O	B-T101
groups	O	O	O
scored	O	O	B-T081
significantly	O	O	O
higher	O	O	O
on	O	O	O
all	O	O	O
self-report	O	O	B-T062
measures	O	O	B-T080
compared	O	O	B-T052
to	O	O	O
HCs	O	O	B-T080
.	O	O	O

Compared	O	O	B-T052
to	O	O	O
ADHD	O	O	B-T048
patients	O	O	B-T101
,	O	O	O
BPD	O	O	B-T048
patients	O	O	O
reported	O	O	O
higher	O	O	O
trait	O	O	B-T032
aggression	O	O	B-T055
and	O	O	O
hostility	O	O	B-T041
,	O	O	O
a	O	O	O
stronger	O	O	O
tendency	O	O	O
to	O	O	O
express	O	O	O
anger	O	O	B-T041
when	O	O	O
provoked	O	O	O
and	O	O	O
to	O	O	O
direct	O	O	O
anger	O	O	O
inwardly	O	O	O
.	O	O	O

Furthermore	O	O	O
,	O	O	O
BPD	O	O	B-T048
patients	O	O	B-T101
exhibited	O	O	O
higher	O	O	O
state	O	O	O
anger	O	O	B-T041
than	O	O	O
HCs	O	O	B-T080
and	O	O	O
ADHD	O	O	B-T048
patients	O	O	O
under	O	O	O
both	O	O	O
conditions	O	O	O
and	O	O	O
showed	O	O	O
a	O	O	O
stress-dependent	O	O	B-T169
anger	O	O	O
increase	O	O	O
.	O	O	O

At	O	O	O
the	O	O	O
behavioral	O	O	B-T053
level	O	O	I-T053
,	O	O	O
no	O	O	O
significant	O	O	O
effects	O	O	O
were	O	O	O
found	O	O	O
.	O	O	O

In	O	O	O
BPD	O	O	B-T048
patients	O	O	B-T101
,	O	O	O
aggression	O	O	B-T055
and	O	O	O
anger	O	O	B-T041
were	O	O	O
positively	O	O	O
correlated	O	O	O
with	O	O	O
emotion	O	O	B-T041
regulation	O	O	I-T041
deficits	O	O	B-T080
.	O	O	O

Our	O	O	O
findings	O	O	B-T033
suggest	O	O	O
a	O	O	O
significant	O	O	O
impact	O	O	B-T080
of	O	O	O
stress	O	O	B-T033
on	O	O	O
self-perceived	O	O	O
state	O	O	O
anger	O	O	B-T041
in	O	O	O
BPD	O	O	B-T048
patients	O	O	B-T101
but	O	O	O
not	O	O	O
on	O	O	O
aggressive	O	O	B-T055
behavior	O	O	I-T055
towards	O	O	O
others	O	O	O
in	O	O	O
females	O	O	B-T032
with	O	O	O
BPD	O	O	O
or	O	O	O
ADHD	O	O	B-T048
.	O	O	O

However	O	O	O
,	O	O	O
it	O	O	O
appears	O	O	O
to	O	O	O
be	O	O	O
pronounced	O	O	O
inwardly	O	O	O
directed	O	O	O
anger	O	O	B-T041
which	O	O	O
is	O	O	O
of	O	O	O
clinical	O	O	B-T080
importance	O	O	B-T080
in	O	O	O
BPD	O	O	B-T048
patients	O	O	B-T101
.	O	O	O

-DOCSTART- (28332776)

Interferon	O	O	B-T028
gamma	O	O	I-T028
and	O	O	O
interleukin	O	O	B-T028
10	O	O	I-T028
polymorphisms	O	O	B-T045
in	O	O	O
Chinese	O	O	B-T098
children	O	O	B-T100
with	O	O	O
hemophagocytic	O	O	O
lymphohistiocytosis	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
the	O	O	O
study	O	O	B-T062
is	O	O	O
to	O	O	O
investigate	O	O	B-T169
the	O	O	O
association	O	O	O
of	O	O	O
interferon	O	O	B-T028
gamma	O	O	I-T028
(	O	O	O
IFN-Î³	O	O	B-T028
)	O	O	O
and	O	O	O
interleukin-10	O	O	B-T028
(	O	O	O
IL-10	O	O	B-T028
)	O	O	O
gene	O	O	B-T028
single	O	O	B-T086
nucleotide	O	O	I-T086
polymorphisms	O	O	I-T086
with	O	O	O
the	O	O	O
susceptibility	O	O	B-T201
of	O	O	O
hemophagocytic	O	O	B-T047
lymphohistiocytosis	O	O	I-T047
(	O	O	O
HLH	O	O	B-T047
)	O	O	O
in	O	O	O
Chinese	O	O	B-T098
children	O	O	B-T100
without	O	O	B-T033
known	O	O	I-T033
family	O	O	I-T033
history	O	O	I-T033
of	O	O	I-T033
HLH	O	O	O
.	O	O	O

Forty	O	O	O
children	O	O	B-T100
with	O	O	O
HLH	O	O	B-T047
and	O	O	O
160	O	O	O
age	O	O	B-T032
-	O	O	O
and	O	O	O
gender	O	O	B-T032
-matched	O	O	O
healthy	O	O	B-T080
controls	O	O	I-T080
from	O	O	O
Xuzhou	O	O	B-T093
Children	O	O	I-T093
's	O	O	I-T093
Hospital	O	O	I-T093
were	O	O	O
enrolled	O	O	O
in	O	O	O
the	O	O	O
study	O	O	B-T062
.	O	O	O

Serum	O	O	B-T031
IFN-Î³	O	O	B-T116
and	O	O	O
IL-10	O	O	B-T116
levels	O	O	O
were	O	O	O
measured	O	O	B-T080
by	O	O	O
enzyme	O	O	B-T059
linked-immunosorbent	O	O	I-T059
assay	O	O	I-T059
.	O	O	O

Polymorphisms	O	O	B-T045
of	O	O	O
the	O	O	O
IFN-Î³	O	O	B-T028
gene	O	O	I-T028
at	O	O	O
position	O	O	O
+	O	O	O
874	O	O	O
and	O	O	O
+	O	O	O
2109	O	O	O
,	O	O	O
and	O	O	O
IL-10	O	O	B-T028
at	O	O	O
position	O	O	O
-1082	O	O	O
were	O	O	O
analyzed	O	O	B-T033
by	O	O	O
allele	O	O	B-T028
-	O	O	O
specific	O	O	B-T080
PCR	O	O	B-T063
.	O	O	O

Median	O	O	B-T031
serum	O	O	I-T031
concentrations	O	O	B-T081
of	O	O	O
IFN	O	O	B-T116
-Î³	O	O	I-T116
and	O	O	O
IL-10	O	O	B-T116
were	O	O	O
significantly	O	O	B-T081
higher	O	O	I-T081
in	O	O	O
children	O	O	B-T100
with	O	O	O
HLH	O	O	B-T047
compared	O	O	B-T052
to	O	O	O
healthy	O	O	B-T080
controls	O	O	I-T080
.	O	O	O

The	O	O	O
frequencies	O	O	B-T079
of	O	O	O
IFN-Î³	O	O	B-T028
+	O	O	O
874	O	O	O
T/A	O	O	B-T032
and	O	O	I-T032
T/T	O	O	I-T032
genotypes	O	O	I-T032
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
T	O	O	B-T028
allele	O	O	I-T028
,	O	O	O
were	O	O	O
significantly	O	O	B-T081
higher	O	O	I-T081
in	O	O	O
the	O	O	O
HLH	O	O	B-T047
group	O	O	O
compared	O	O	B-T052
with	O	O	O
those	O	O	O
in	O	O	O
the	O	O	O
control	O	O	B-T096
group	O	O	I-T096
.	O	O	O

The	O	O	O
frequencies	O	O	B-T079
of	O	O	O
IL-10	O	O	B-T028
-1082	O	O	O
G/A	O	O	B-T032
genotype	O	O	I-T032
and	O	O	O
G	O	O	B-T028
allele	O	O	I-T028
were	O	O	O
significantly	O	O	B-T081
increased	O	O	I-T081
in	O	O	O
HLH	O	O	B-T047
patients	O	O	B-T101
compared	O	O	B-T052
with	O	O	O
healthy	O	O	B-T080
controls	O	O	I-T080
.	O	O	O

No	O	O	B-T033
significant	O	O	I-T033
difference	O	O	B-T033
was	O	O	O
found	O	O	O
in	O	O	O
the	O	O	O
distribution	O	O	B-T169
of	O	O	O
IFN-Î³	O	O	B-T028
+	O	O	O
2109	O	O	O
G/A	O	O	B-T032
genotypes	O	O	I-T032
between	O	O	O
children	O	O	B-T100
with	O	O	O
HLH	O	O	B-T047
and	O	O	O
controls	O	O	B-T080
.	O	O	O

This	O	O	O
study	O	O	B-T062
presents	O	O	B-T033
preliminary	O	O	B-T079
evidence	O	O	B-T078
for	O	O	O
the	O	O	O
association	O	O	O
between	O	O	O
IFN	O	O	B-T028
+	O	O	O
874	O	O	O
T/A	O	O	B-T032
,	O	O	I-T032
T/T	O	O	I-T032
,	O	O	O
IL-10	O	O	B-T028
-1082	O	O	O
A/G	O	O	B-T032
genotypes	O	O	I-T032
,	O	O	O
and	O	O	O
HLH	O	O	B-T047
susceptibility	O	O	B-T201
in	O	O	O
Chinese	O	O	B-T098
children	O	O	B-T100
with	O	O	O
HLH	O	O	O
.	O	O	O

-DOCSTART- (28334564)

Data	O	O	B-T078
-Driven	O	O	O
Implementation	O	O	B-T052
of	O	O	O
Alarm	O	O	B-T074
Reduction	O	O	B-T080
Interventions	O	O	B-T061
in	O	O	O
a	O	O	O
Cardiovascular	O	O	O
Surgical	O	O	O
ICU	O	O	O

Alarm	O	O	B-T033
fatigue	O	O	I-T033
in	O	O	O
the	O	O	O
ICU	O	O	B-T093
setting	O	O	B-T082
has	O	O	O
been	O	O	O
well	O	O	O
documented	O	O	B-T058
in	O	O	O
the	O	O	O
literature	O	O	B-T170
.	O	O	O

The	O	O	O
ICU	O	O	B-T093
's	O	O	I-T093
high-intensity	O	O	B-T185
environment	O	O	B-T082
requires	O	O	O
staff	O	O	B-T097
's	O	O	I-T097
vigilant	O	O	B-T041
attention	O	O	B-T041
,	O	O	O
and	O	O	O
distraction	O	O	B-T053
from	O	O	O
false	O	O	B-T080
and	O	O	O
non-actionable	O	O	O
alarms	O	O	B-T074
pulls	O	O	O
staff	O	O	O
away	O	O	O
from	O	O	O
important	O	O	O
tasks	O	O	B-T057
,	O	O	O
creates	O	O	O
dissatisfaction	O	O	B-T041
,	O	O	O
and	O	O	O
is	O	O	O
a	O	O	O
potential	O	O	O
patient	O	O	B-T058
safety	O	O	I-T058
risk	O	O	B-T078
if	O	O	O
alarms	O	O	O
are	O	O	O
missed	O	O	B-T080
or	O	O	O
ignored	O	O	B-T078
.	O	O	O

This	O	O	O
project	O	O	O
was	O	O	O
intended	O	O	O
to	O	O	O
improve	O	O	O
patient	O	O	B-T058
safety	O	O	I-T058
by	O	O	O
optimizing	O	O	O
alarm	O	O	B-T074
systems	O	O	B-T169
in	O	O	O
a	O	O	O
cardiovascular	O	O	B-T093
surgical	O	O	I-T093
intensive	O	O	I-T093
care	O	O	I-T093
unit	O	O	I-T093
(	O	O	O
CVSICU	O	O	B-T093
)	O	O	O
.	O	O	O

Specific	O	O	O
aims	O	O	O
were	O	O	O
to	O	O	O
examine	O	O	B-T033
nurses	O	O	B-T097
'	O	O	O
attitudes	O	O	B-T041
toward	O	O	O
clinical	O	O	B-T080
alarm	O	O	B-T074
signals	O	O	B-T067
,	O	O	O
assess	O	O	O
nurses	O	O	O
'	O	O	O
ability	O	O	O
to	O	O	O
discriminate	O	O	O
audible	O	O	B-T073
alarm	O	O	I-T073
signals	O	O	O
,	O	O	O
and	O	O	O
implement	O	O	B-T052
a	O	O	O
bundled	O	O	O
set	O	O	O
of	O	O	O
best	O	O	B-T078
practices	O	O	I-T078
for	O	O	O
monitor	O	O	B-T033
alarm	O	O	I-T033
reduction	O	O	B-T080
without	O	O	O
undermining	O	O	O
patient	O	O	B-T058
safety	O	O	I-T058
.	O	O	O

CVSICU	O	O	B-T093
nurses	O	O	B-T097
completed	O	O	O
an	O	O	O
alarm	O	O	B-T074
perception	O	O	B-T170
survey	O	O	I-T170
and	O	O	O
participated	O	O	O
in	O	O	O
alarm	O	O	O
discriminability	O	O	B-T169
testing	O	O	I-T169
.	O	O	O

Nurse	O	O	B-T170
survey	O	O	I-T170
data	O	O	B-T078
and	O	O	O
baseline	O	O	B-T081
monitor	O	O	O
alarm	O	O	B-T074
data	O	O	O
were	O	O	O
used	O	O	O
to	O	O	O
select	O	O	O
targeted	O	O	B-T169
alarm	O	O	O
reduction	O	O	B-T080
interventions	O	O	B-T061
,	O	O	O
which	O	O	O
were	O	O	O
progressively	O	O	O
phased	O	O	O
in	O	O	O
.	O	O	O

Monitor	O	O	O
alarm	O	O	B-T074
data	O	O	B-T078
and	O	O	O
cardiorespiratory	O	O	B-T033
event	O	O	I-T033
data	O	O	O
were	O	O	O
trended	O	O	O
over	O	O	O
one	O	O	O
year	O	O	B-T079
.	O	O	O

Five	O	O	O
of	O	O	O
the	O	O	O
most	O	O	O
frequent	O	O	O
CVSICU	O	O	B-T093
monitor	O	O	B-T033
alarm	O	O	I-T033
types-	O	O	O
pulse	O	O	B-T060
oximetry	O	O	I-T060
,	O	O	O
heart	O	O	B-T201
rate	O	O	I-T201
,	O	O	O
systolic	O	O	B-T033
and	O	O	O
diastolic	O	O	B-T047
blood	O	O	I-T047
pressure	O	O	I-T047
,	O	O	O
pulse	O	O	O
oximetry	O	O	O
sensor	O	O	B-T073
,	O	O	O
and	O	O	O
ventricular	O	O	B-T047
tachycardia	O	O	I-T047
>	O	O	O
2-were	O	O	O
targeted	O	O	B-T169
.	O	O	O

After	O	O	O
implementation	O	O	B-T052
,	O	O	O
there	O	O	O
was	O	O	O
a	O	O	O
61	O	O	O
%	O	O	O
reduction	O	O	B-T080
in	O	O	O
average	O	O	O
alarms	O	O	B-T074
per	O	O	O
monitored	O	O	O
bed	O	O	B-T073
and	O	O	O
a	O	O	O
downward	O	O	O
trend	O	O	O
in	O	O	O
cardiorespiratory	O	O	B-T033
events	O	O	I-T033
.	O	O	O

To	O	O	O
reduce	O	O	B-T080
alarm	O	O	B-T074
fatigue	O	O	I-T033
it	O	O	O
is	O	O	O
important	O	O	O
to	O	O	O
decrease	O	O	B-T081
alarm	O	O	O
burden	O	O	B-T078
through	O	O	O
targeted	O	O	B-T169
interventions	O	O	B-T061
.	O	O	O

Methods	O	O	O
to	O	O	O
reduce	O	O	O
non-actionable	O	O	O
alarms	O	O	B-T074
include	O	O	O
adding	O	O	O
short	O	O	O
delays	O	O	B-T079
to	O	O	O
allow	O	O	O
alarm	O	O	B-T074
self-correction	O	O	B-T169
,	O	O	O
adjusting	O	O	O
default	O	O	O
alarm	O	O	O
threshold	O	O	B-T080
limits	O	O	B-T169
,	O	O	O
providing	O	O	O
alarm	O	O	O
notification	O	O	B-T058
through	O	O	O
a	O	O	O
secondary	O	O	B-T074
device	O	O	I-T074
,	O	O	O
and	O	O	O
teaching	O	O	B-T065
staff	O	O	B-T097
to	O	O	O
optimize	O	O	O
alarm	O	O	O
settings	O	O	O
for	O	O	O
individual	O	O	B-T098
patients	O	O	B-T101
.	O	O	O

-DOCSTART- (28334615)

The	O	O	O
NCAM1	O	O	B-T028
gene	O	O	I-T028
set	O	O	I-T028
is	O	O	O
linked	O	O	O
to	O	O	O
depressive	O	O	B-T184
symptoms	O	O	I-T184
and	O	O	O
their	O	O	O
brain	O	O	B-T023
structural	O	O	I-T023
correlates	O	O	B-T039
in	O	O	O
healthy	O	O	O
individuals	O	O	O

Depressive	O	O	B-T184
symptoms	O	O	I-T184
exist	O	O	O
on	O	O	O
a	O	O	O
continuum	O	O	O
,	O	O	O
the	O	O	O
far	O	O	O
end	O	O	O
of	O	O	O
which	O	O	O
is	O	O	O
found	O	O	O
in	O	O	O
depressive	O	O	B-T048
disorders	O	O	I-T048
.	O	O	O

Utilizing	O	O	O
the	O	O	O
continuous	O	O	B-T059
spectrum	O	O	I-T059
of	O	O	O
depressive	O	O	B-T184
symptoms	O	O	I-T184
may	O	O	O
therefore	O	O	O
contribute	O	O	O
to	O	O	O
the	O	O	O
understanding	O	O	O
of	O	O	O
the	O	O	O
biological	O	O	B-T033
underpinnings	O	O	I-T033
of	O	O	O
depression	O	O	B-T048
.	O	O	O

Gene	O	O	B-T059
set	O	O	I-T059
enrichment	O	O	I-T059
analysis	O	O	I-T059
(	O	O	O
GSEA	O	O	B-T059
)	O	O	O
is	O	O	O
an	O	O	O
important	O	O	O
tool	O	O	O
for	O	O	O
the	O	O	O
identification	O	O	O
of	O	O	O
gene	O	O	B-T028
groups	O	O	I-T028
linked	O	O	O
to	O	O	O
complex	O	O	B-T032
traits	O	O	I-T032
,	O	O	O
and	O	O	O
was	O	O	O
applied	O	O	O
in	O	O	O
the	O	O	O
present	O	O	O
study	O	O	O
on	O	O	O
genome-wide	O	O	B-T063
association	O	O	I-T063
study	O	O	I-T063
(	O	O	O
GWAS	O	O	B-T063
)	O	O	O
data	O	O	B-T033
of	O	O	I-T033
depression	O	O	I-T033
scores	O	O	I-T033
and	O	O	O
their	O	O	O
brain-level	O	O	B-T023
structural	O	O	I-T023
correlates	O	O	B-T039
in	O	O	O
healthy	O	O	B-T098
young	O	O	I-T098
individuals	O	O	I-T098
.	O	O	O

On	O	O	O
symptom	O	O	B-T033
level	O	O	I-T033
(	O	O	O
i.e.	O	O	O
depression	O	O	B-T033
scores	O	O	I-T033
)	O	O	O
,	O	O	O
robust	O	O	B-T080
enrichment	O	O	O
was	O	O	O
identified	O	O	O
for	O	O	O
two	O	O	O
gene	O	O	B-T028
sets	O	O	I-T028
:	O	O	O
NCAM1	O	O	B-T028
Interactions	O	O	B-T045
and	O	O	O
Collagen	O	O	B-T044
Formation	O	O	I-T044
.	O	O	O

Depression	O	O	B-T033
scores	O	O	I-T033
were	O	O	O
also	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
decreased	O	O	B-T081
fractional	O	O	B-T070
anisotropy	O	O	I-T070
(	O	O	O
FA	O	O	B-T070
)	O	O	O
-	O	O	O
a	O	O	O
brain	O	O	B-T023
white	O	O	I-T023
matter	O	O	I-T023
property	O	O	I-T023
-	O	O	O
within	O	O	B-T023
the	O	O	I-T023
forceps	O	O	I-T023
minor	O	O	I-T023
and	O	O	O
the	O	O	O
left	O	O	B-T023
superior	O	O	I-T023
temporal	O	O	I-T023
longitudinal	O	O	I-T023
fasciculus	O	O	I-T023
.	O	O	O

Within	O	O	O
each	O	O	O
of	O	O	O
these	O	O	O
tracts	O	O	O
,	O	O	O
mean	O	O	B-T070
FA	O	O	I-T070
value	O	O	O
of	O	O	O
depression	O	O	B-T033
score	O	O	I-T033
-	O	O	O
associated	O	O	B-T077
voxels	O	O	I-T077
was	O	O	O
used	O	O	O
as	O	O	O
a	O	O	O
phenotype	O	O	B-T032
in	O	O	O
a	O	O	O
subsequent	O	O	O
GSEA	O	O	B-T059
.	O	O	O

The	O	O	O
NCAM1	O	O	B-T028
Interactions	O	O	B-T045
gene	O	O	B-T028
set	O	O	I-T028
was	O	O	O
significantly	O	O	O
enriched	O	O	O
in	O	O	O
these	O	O	O
tracts	O	O	O
.	O	O	O

By	O	O	O
linking	O	O	O
the	O	O	O
NCAM1	O	O	B-T028
Interactions	O	O	B-T045
gene	O	O	B-T028
set	O	O	I-T028
to	O	O	O
depression	O	O	B-T033
scores	O	O	I-T033
and	O	O	O
their	O	O	O
structural	O	O	B-T023
brain	O	O	I-T023
correlates	O	O	B-T039
in	O	O	O
healthy	O	O	B-T098
participants	O	O	I-T098
,	O	O	O
the	O	O	O
current	O	O	O
study	O	O	O
contributes	O	O	O
to	O	O	O
the	O	O	O
understanding	O	O	O
of	O	O	O
the	O	O	O
molecular	O	O	B-T033
underpinnings	O	O	I-T033
of	O	O	O
depressive	O	O	B-T184
symptomatology	O	O	I-T184
.	O	O	O

-DOCSTART- (28334854)

The	O	O	O
burden	O	O	O
of	O	O	O
HPV	O	O	B-T005
-related	O	O	O
diseases	O	O	B-T047
in	O	O	O
Italy	O	O	B-T083
,	O	O	O
2001	O	O	O
-	O	O	O
12	O	O	O

Human	O	O	B-T047
papillomavirus	O	O	I-T047
(	O	O	I-T047
HPV	O	O	I-T047
)	O	O	I-T047
infection	O	O	I-T047
is	O	O	O
the	O	O	O
main	O	O	O
cause	O	O	O
of	O	O	O
cervical	O	O	B-T191
cancer	O	O	B-T191
and	O	O	O
plays	O	O	O
a	O	O	O
relevant	O	O	O
role	O	O	O
in	O	O	O
the	O	O	O
development	O	O	B-T169
of	O	O	O
genital	O	O	B-T047
warts	O	O	I-T047
and	O	O	O
of	O	O	O
the	O	O	O
cancer	O	O	O
of	O	O	O
penis	O	O	B-T023
and	O	O	O
anus	O	O	B-T023
,	O	O	O
head	O	O	B-T029
/	O	O	O
neck	O	O	B-T029
,	O	O	O
oropharynx	O	O	B-T029
and	O	O	O
genitourinary	O	O	B-T022
system	O	O	I-T022
.	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
this	O	O	O
study	O	O	B-T062
is	O	O	O
the	O	O	O
evaluation	O	O	B-T169
of	O	O	O
hospitalizations	O	O	B-T058
due	O	O	O
to	O	O	O
HPV-related	O	O	B-T047
pathologies	O	O	I-T047
in	O	O	O
2001	O	O	O
-	O	O	O
12	O	O	O
in	O	O	O
Italy	O	O	B-T083
.	O	O	O

The	O	O	O
national	O	O	B-T058
hospital	O	O	I-T058
discharge	O	O	I-T058
forms	O	O	B-T073
were	O	O	O
provided	O	O	O
by	O	O	O
the	O	O	O
Ministry	O	O	B-T093
of	O	O	I-T093
Health	O	O	I-T093
.	O	O	O

The	O	O	O
HPV	O	O	B-T005
-related	O	O	O
hospitalizations	O	O	B-T058
were	O	O	O
identified	O	O	O
using	O	O	O
specific	O	O	O
diagnostic	O	O	B-T169
codes	O	O	B-T170
,	O	O	O
accordingly	O	O	O
to	O	O	O
the	O	O	O
ICD-9-CM	O	O	B-T170
coding	O	O	B-T185
system	O	O	I-T185
.	O	O	O

The	O	O	O
proportion	O	O	O
of	O	O	O
hospitalizations	O	O	B-T058
of	O	O	O
potentially	O	O	O
HPV-related	O	O	B-T047
pathologies	O	O	I-T047
,	O	O	O
obtained	O	O	O
from	O	O	O
the	O	O	O
literature	O	O	B-T170
,	O	O	O
was	O	O	O
evaluated	O	O	B-T169
as	O	O	O
well	O	O	O
as	O	O	O
the	O	O	O
hospitalization	O	O	B-T081
rates	O	O	I-T081
(	O	O	O
hr	O	O	B-T081
)	O	O	O
and	O	O	O
their	O	O	O
trend	O	O	B-T079
over	O	O	O
time	O	O	B-T079
.	O	O	O

Uterine	O	O	B-T191
cervical	O	O	I-T191
cancer	O	O	I-T191
and	O	O	O
CIN	O	O	B-T191
III	O	O	I-T191
accounted	O	O	O
for	O	O	O
40	O	O	O
%	O	O	O
of	O	O	O
hospitalizations	O	O	B-T058
(	O	O	O
hr	O	O	B-T081
:	O	O	O
15.6/100	O	O	O
000	O	O	O
and	O	O	O
17.6/100	O	O	O
000	O	O	O
,	O	O	O
respectively	O	O	O
)	O	O	O
.	O	O	O

Head	O	O	B-T029
/	O	O	O
neck	O	O	B-T029
and	O	O	O
oropharynx	O	O	B-T029
pathologies	O	O	B-T169
accounted	O	O	O
for	O	O	O
24.5	O	O	O
%	O	O	O
of	O	O	O
cases	O	O	B-T169
(	O	O	O
hr	O	O	B-T081
:	O	O	O
16/100	O	O	O
000	O	O	O
and	O	O	O
3.9/100	O	O	O
000	O	O	O
,	O	O	O
in	O	O	O
males	O	O	B-T032
and	O	O	O
females	O	O	B-T032
,	O	O	O
respectively	O	O	O
)	O	O	O
,	O	O	O
followed	O	O	O
by	O	O	O
genital	O	O	B-T047
warts	O	O	I-T047
(	O	O	O
17.3	O	O	O
%	O	O	O
of	O	O	O
hospitalizations	O	O	B-T058
;	O	O	O
hr	O	O	O
:	O	O	O
7.5/100	O	O	O
000	O	O	O
in	O	O	O
males	O	O	O
and	O	O	O
8.52/100	O	O	O
000	O	O	O
in	O	O	O
females	O	O	O
)	O	O	O
,	O	O	O
anal	O	O	B-T191
(	O	O	O
8.1	O	O	O
%	O	O	O
of	O	O	O
hospitalizations	O	O	O
)	O	O	O
,	O	O	O
genitourinary	O	O	B-T191
(	O	O	O
7.7	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
penis	O	O	B-T191
cancers	O	O	I-T191
(	O	O	O
2.2	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
study	O	O	B-T062
,	O	O	O
even	O	O	O
if	O	O	O
limited	O	O	O
to	O	O	O
the	O	O	O
evaluation	O	O	B-T169
of	O	O	O
hospitalizations	O	O	B-T058
,	O	O	O
points	O	O	O
out	O	O	O
how	O	O	O
HPV-related	O	O	B-T047
pathologies	O	O	I-T047
continue	O	O	O
to	O	O	O
be	O	O	O
a	O	O	O
relevant	O	O	O
public	O	O	B-T078
health	O	O	I-T078
issue	O	O	B-T033
in	O	O	O
Italy	O	O	B-T083
with	O	O	O
a	O	O	O
high	O	O	O
impact	O	O	B-T080
on	O	O	O
population	O	O	B-T098
.	O	O	O

-DOCSTART- (28336141)

The	O	O	O
discovery	O	O	B-T052
of	O	O	O
potent	O	O	B-T080
and	O	O	O
selective	O	O	B-T080
kynurenine	O	O	B-T116
3-monooxygenase	O	O	I-T116
inhibitors	O	O	B-T121
for	O	O	O
the	O	O	O
treatment	O	O	B-T061
of	O	O	O
acute	O	O	O
pancreatitis	O	O	O

A	O	O	O
series	O	O	B-T081
of	O	O	O
potent	O	O	B-T080
,	O	O	O
competitive	O	O	B-T080
and	O	O	O
highly	O	O	B-T080
selective	O	O	B-T080
kynurenine	O	O	B-T116
monooxygenase	O	O	I-T116
inhibitors	O	O	B-T121
have	O	O	O
been	O	O	O
discovered	O	O	B-T052
via	O	O	O
a	O	O	O
substrate	O	O	B-T167
-based	O	O	O
approach	O	O	B-T082
for	O	O	O
the	O	O	O
treatment	O	O	B-T061
of	O	O	O
acute	O	O	B-T047
pancreatitis	O	O	I-T047
.	O	O	O

The	O	O	O
lead	O	O	B-T169
compound	O	O	B-T103
demonstrated	O	O	O
good	O	O	B-T080
cellular	O	O	B-T025
potency	O	O	B-T080
and	O	O	O
clear	O	O	O
pharmacodynamic	O	O	B-T038
activity	O	O	B-T052
in	O	O	B-T082
vivo	O	O	I-T082
.	O	O	O

-DOCSTART- (28336597)

Draft	O	O	B-T028
Genome	O	O	I-T028
Sequence	O	O	B-T086
of	O	O	O
Providencia	O	O	B-T007
stuartii	O	O	I-T007
PS71	O	O	I-T007
,	O	O	O
a	O	O	O
Multidrug-Resistant	O	O	B-T032
Strain	O	O	B-T001
Associated	O	O	B-T080
with	O	O	I-T080
Nosocomial	O	O	B-T047
Infections	O	O	I-T047
in	O	O	O
Greece	O	O	O

Providencia	O	O	B-T007
stuartii	O	O	I-T007
is	O	O	O
frequently	O	O	B-T079
associated	O	O	B-T080
with	O	O	I-T080
nosocomial	O	O	B-T047
outbreaks	O	O	I-T047
and	O	O	O
displays	O	O	O
intrinsic	O	O	B-T082
resistance	O	O	B-T169
to	O	O	O
many	O	O	O
commonly	O	O	B-T081
used	O	O	O
antimicrobials	O	O	B-T121
.	O	O	O

We	O	O	O
report	O	O	O
here	O	O	O
the	O	O	O
draft	O	O	B-T028
genome	O	O	I-T028
sequence	O	O	B-T086
of	O	O	O
a	O	O	O
P.	O	O	B-T007
stuartii	O	O	I-T007
strain	O	O	I-T007
carrying	O	O	O
acquired	O	O	B-T080
resistance	O	O	B-T028
genes	O	O	I-T028
conferring	O	O	O
panresistance	O	O	B-T169
to	O	O	O
cephalosporins	O	O	B-T195
(	O	O	O
blaSHV-5	O	O	B-T028
and	O	O	O
blaVEB-1	O	O	B-T028
)	O	O	O
,	O	O	O
carbapenems	O	O	B-T195
(	O	O	O
blaVIM-1	O	O	B-T028
)	O	O	O
,	O	O	O
and	O	O	O
aminoglycosides	O	O	B-T109
(	O	O	O
rmtB	O	O	B-T028
)	O	O	O
involved	O	O	O
in	O	O	O
an	O	O	O
outbreak	O	O	B-T067
in	O	O	O
Greek	O	O	B-T083
hospitals	O	O	B-T093
.	O	O	O

-DOCSTART- (28338247)

Impact	O	O	B-T080
of	O	O	O
diabetic	O	O	B-T047
ketoacidosis	O	O	I-T047
management	O	O	B-T058
in	O	O	O
the	O	O	O
medical	O	O	B-T093
intensive	O	O	I-T093
care	O	O	I-T093
unit	O	O	I-T093
after	O	O	O
order	O	O	B-T170
set	O	O	I-T170
implementation	O	O	O

To	O	O	O
determine	O	O	O
the	O	O	O
rate	O	O	B-T081
of	O	O	O
compliance	O	O	B-T058
to	O	O	O
the	O	O	O
2006	O	O	O
and	O	O	O
2009	O	O	O
ADA	O	O	B-T170
DKA	O	O	I-T170
guidelines	O	O	I-T170
in	O	O	O
the	O	O	O
medical	O	O	B-T093
intensive	O	O	I-T093
care	O	O	I-T093
unit	O	O	I-T093
(	O	O	O
MICU	O	O	B-T093
)	O	O	O
at	O	O	O
a	O	O	O
large	O	O	O
academic	O	O	B-T093
medical	O	O	I-T093
centre	O	O	I-T093
after	O	O	O
the	O	O	O
implementation	O	O	B-T052
of	O	O	O
a	O	O	O
computerised	O	O	B-T170
DKA	O	O	I-T170
order	O	O	I-T170
set	O	O	I-T170
and	O	O	O
protocol	O	O	B-T061
.	O	O	O

Retrospective	O	O	B-T080
chart	O	O	B-T170
review	O	O	I-T170
of	O	O	O
adult	O	O	B-T101
patients	O	O	I-T101
with	O	O	O
DKA	O	O	B-T047
admitted	O	O	B-T058
to	O	O	O
the	O	O	O
MICU	O	O	B-T093
.	O	O	O

Results	O	O	O
of	O	O	O
pre-order	O	O	B-T170
set	O	O	I-T170
(	O	O	O
PRE	O	O	B-T170
)	O	O	O
were	O	O	O
compared	O	O	O
to	O	O	O
those	O	O	O
of	O	O	O
data	O	O	O
post-order	O	O	B-T170
set	O	O	I-T170
(	O	O	O
POST	O	O	B-T170
)	O	O	O
.	O	O	O

The	O	O	O
primary	O	O	B-T169
outcome	O	O	I-T169
was	O	O	O
a	O	O	O
composite	O	O	O
administration	O	O	B-T061
of	O	O	O
intravenous	O	O	B-T061
fluid	O	O	I-T061
resuscitation	O	O	I-T061
in	O	O	O
the	O	O	O
first	O	O	O
24	O	O	O
h	O	O	O
,	O	O	O
insulin	O	O	B-T116
bolus	O	O	B-T061
and	O	O	O
initial	O	O	B-T079
insulin	O	O	O
infusion	O	O	B-T079
rate	O	O	I-T079
.	O	O	O

Twelve	O	O	O
of	O	O	O
60	O	O	O
patients	O	O	B-T101
(	O	O	O
20	O	O	O
%	O	O	O
)	O	O	O
in	O	O	O
the	O	O	O
PRE	O	O	B-UnknownType
group	O	O	I-UnknownType
received	O	O	O
treatment	O	O	B-T061
compliant	O	O	B-T080
with	O	O	O
the	O	O	O
2006	O	O	O
guidelines	O	O	B-T170
versus	O	O	O
14	O	O	O
of	O	O	O
55	O	O	O
patients	O	O	O
(	O	O	O
25.5	O	O	O
%	O	O	O
)	O	O	O
in	O	O	O
the	O	O	O
POST	O	O	B-UnknownType
group	O	O	I-UnknownType
(	O	O	O
OR	O	O	B-T081
1.22	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
0.44	O	O	O
to	O	O	O
3.4	O	O	O
,	O	O	O
P	O	O	O
=	O	O	O
0.51	O	O	O
)	O	O	O
.	O	O	O

Compliance	O	O	B-T058
to	O	O	O
the	O	O	O
2009	O	O	O
guidelines	O	O	B-T170
was	O	O	O
significantly	O	O	B-T081
higher	O	O	I-T081
in	O	O	O
the	O	O	O
POST	O	O	B-UnknownType
group	O	O	I-UnknownType
(	O	O	O
31.7	O	O	O
%	O	O	O
versus	O	O	O
65.5	O	O	O
%	O	O	O
,	O	O	O
OR	O	O	B-T081
4.44	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
1.8	O	O	O
to	O	O	O
10.92	O	O	O
,	O	O	O
P	O	O	O
=	O	O	O
0.0004	O	O	O
)	O	O	O
.	O	O	O

Compliance	O	O	B-T058
for	O	O	O
individual	O	O	O
components	O	O	O
was	O	O	O
26.7	O	O	O
%	O	O	O
versus	O	O	O
70.9	O	O	O
%	O	O	O
for	O	O	O
fluid	O	O	B-T061
resuscitation	O	O	I-T061
(	O	O	O
P	O	O	O
=	O	O	O
0.0001	O	O	O
)	O	O	O
,	O	O	O
55	O	O	O
%	O	O	O
versus	O	O	O
49.1	O	O	O
%	O	O	O
for	O	O	O
insulin	O	O	B-T116
bolus	O	O	B-T061
(	O	O	O
P	O	O	O
=	O	O	O
0.58	O	O	O
)	O	O	O
and	O	O	O
60	O	O	O
%	O	O	O
versus	O	O	O
81.3	O	O	O
%	O	O	O
for	O	O	O
initial	O	O	B-T079
insulin	O	O	O
infusion	O	O	B-T079
rate	O	O	I-T079
(	O	O	O
P	O	O	O
=	O	O	O
0.014	O	O	O
)	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

Time	O	O	B-T079
to	O	O	O
DKA	O	O	B-T047
resolution	O	O	B-T077
was	O	O	O
decreased	O	O	B-T081
(	O	O	O
P	O	O	O
=	O	O	O
0.04	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
hypoglycaemia	O	O	B-T047
was	O	O	O
increased	O	O	B-T081
(	O	O	O
P	O	O	O
=	O	O	O
0.0022	O	O	O
)	O	O	O
.	O	O	O

Implementation	O	O	B-T052
of	O	O	O
a	O	O	O
computerised	O	O	B-T170
DKA	O	O	B-T047
order	O	O	I-T170
set	O	O	I-T170
and	O	O	O
protocol	O	O	B-T061
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
improved	O	O	B-T033
compliance	O	O	B-T058
to	O	O	O
the	O	O	O
2009	O	O	O
ADA	O	O	B-T170
DKA	O	O	I-T170
guidelines	O	O	I-T170
,	O	O	O
24-h	O	O	O
fluid	O	O	B-T061
resuscitation	O	O	I-T061
,	O	O	O
initial	O	O	B-T079
insulin	O	O	B-T116
infusion	O	O	B-T079
rate	O	O	I-T079
,	O	O	O
time	O	O	B-T079
to	O	O	O
DKA	O	O	O
resolution	O	O	B-T077
and	O	O	O
appropriate	O	O	O
transition	O	O	B-T052
to	O	O	O
subcutaneous	O	O	B-T082
insulin	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
patients	O	O	B-T101
in	O	O	O
the	O	O	O
POST	O	O	B-UnknownType
implementation	O	O	I-UnknownType
group	O	O	I-UnknownType
were	O	O	O
more	O	O	O
likely	O	O	O
to	O	O	O
exhibit	O	O	O
hypoglycaemia	O	O	B-T047
.	O	O	O

Future	O	O	O
assessment	O	O	O
is	O	O	O
warranted	O	O	O
.	O	O	O

-DOCSTART- (28338634)

Construction	O	O	O
of	O	O	O
an	O	O	O
Acetylcholinesterase	O	O	B-T116
Sensor	O	O	B-T075
Based	O	O	O
on	O	O	O
Synthesized	O	O	B-T130
Paramagnetic	O	O	I-T130
Nanoparticles	O	O	I-T130
,	O	O	O
a	O	O	O
Simple	O	O	O
Tool	O	O	O
for	O	O	O
Neurotoxic	O	O	B-T131
Compounds	O	O	I-T131
Assay	O	O	O

Magnetic	O	O	B-T130
particles	O	O	I-T130
(	O	O	O
MPs	O	O	B-T130
)	O	O	O
have	O	O	O
been	O	O	O
widely	O	O	O
used	O	O	O
in	O	O	O
biological	O	O	B-T169
applications	O	O	I-T169
in	O	O	O
recent	O	O	O
years	O	O	O
as	O	O	O
a	O	O	O
carrier	O	O	O
for	O	O	O
various	O	O	O
molecules	O	O	B-T167
.	O	O	O

Their	O	O	O
big	O	O	O
advantage	O	O	O
is	O	O	O
in	O	O	O
repeated	O	O	O
use	O	O	O
of	O	O	O
immobilized	O	O	B-T067
molecules	O	O	B-T167
including	O	O	O
enzymes	O	O	B-T116
.	O	O	O

Acetylcholinesterase	O	O	B-T116
(	O	O	O
AChE	O	O	B-T116
)	O	O	O
is	O	O	O
an	O	O	O
enzyme	O	O	B-T116
playing	O	O	O
crucial	O	O	O
role	O	O	O
in	O	O	O
neurotransmission	O	O	B-T043
and	O	O	O
the	O	O	O
enzyme	O	O	O
is	O	O	O
targeted	O	O	B-T169
by	O	O	O
various	O	O	O
molecules	O	O	B-T167
like	O	O	O
Alzheimer	O	O	B-T047
's	O	O	I-T047
drugs	O	O	B-T121
,	O	O	O
pesticides	O	O	B-T131
and	O	O	O
warfare	O	O	B-T109
agents	O	O	I-T109
.	O	O	O

In	O	O	O
this	O	O	O
work	O	O	O
,	O	O	O
an	O	O	O
electrochemical	O	O	B-T075
biosensor	O	O	I-T075
having	O	O	O
AChE	O	O	B-T116
immobilized	O	O	B-T116
onto	O	O	O
MPs	O	O	B-T130
and	O	O	O
stabilized	O	O	B-T033
through	O	O	O
glutaraldehyde	O	O	B-T109
(	O	O	I-T109
GA	O	O	I-T109
)	O	O	I-T109
molecule	O	O	I-T109
was	O	O	O
proposed	O	O	O
for	O	O	O
assay	O	O	B-T059
of	O	O	O
the	O	O	O
neurotoxic	O	O	B-T131
compounds	O	O	I-T131
.	O	O	O

The	O	O	O
prepared	O	O	B-T073
nanoparticles	O	O	I-T073
were	O	O	O
modified	O	O	B-T080
by	O	O	I-T080
pure	O	O	B-T116
AChE	O	O	I-T116
and	O	O	O
they	O	O	O
were	O	O	O
used	O	O	O
for	O	O	O
the	O	O	O
measurement	O	O	B-T169
anti-Alzheimer	O	O	B-T033
's	O	O	I-T033
drug	O	O	B-T121
galantamine	O	O	B-T109
and	O	O	O
carbamate	O	O	B-T109
pesticide	O	O	I-T109
carbofuran	O	O	B-T109
with	O	O	O
limit	O	O	B-T078
of	O	O	O
detection	O	O	B-T033
1.5	O	O	O
ÂµM	O	O	O
and	O	O	O
20	O	O	O
nM	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

All	O	O	O
measurements	O	O	B-T169
were	O	O	O
carried	O	O	O
out	O	O	O
using	O	O	O
screen-printed	O	O	B-T075
sensor	O	O	I-T075
with	O	O	O
carbon	O	O	B-T196
working	O	O	B-T074
,	O	O	O
silver	O	O	B-T196
reference	O	O	B-T074
,	O	O	O
and	O	O	O
carbon	O	O	O
auxiliary	O	O	B-T074
electrode	O	O	I-T074
.	O	O	O

Standard	O	O	B-T059
Ellman	O	O	I-T059
's	O	O	I-T059
assay	O	O	I-T059
was	O	O	O
used	O	O	O
for	O	O	O
validation	O	O	B-T062
measurement	O	O	B-T169
of	O	O	O
both	O	O	O
inhibitors	O	O	B-T120
.	O	O	O

Part	O	O	O
of	O	O	O
this	O	O	O
work	O	O	O
was	O	O	O
the	O	O	O
elimination	O	O	B-T052
of	O	O	O
reversible	O	O	B-T169
inhibitors	O	O	B-T120
represented	O	O	O
by	O	O	O
galantamine	O	O	B-T109
from	O	O	O
the	O	O	O
active	O	O	B-T169
site	O	O	I-T169
of	O	O	O
AChE.	O	O	O
For	O	O	O
this	O	O	O
purpose	O	O	O
,	O	O	O
we	O	O	O
used	O	O	O
a	O	O	O
lower	O	O	B-T052
pH	O	O	B-T081
to	O	O	O
get	O	O	O
the	O	O	O
original	O	O	B-T078
activity	O	O	B-T052
of	O	O	O
AChE	O	O	B-T116
after	O	O	O
inhibition	O	O	B-T052
by	O	O	O
galantamine	O	O	O
.	O	O	O

We	O	O	O
also	O	O	O
observed	O	O	B-T169
decarbamylation	O	O	B-T067
of	O	O	O
the	O	O	O
AChE	O	O	B-T116
-	O	O	O
carbofuran	O	O	B-T109
adduct	O	O	B-T104
.	O	O	O

Influence	O	O	O
of	O	O	O
organic	O	O	B-T109
solvents	O	O	I-T109
to	O	O	O
AChE	O	O	B-T116
as	O	O	O
well	O	O	O
as	O	O	O
repeatability	O	O	O
of	O	O	O
measurement	O	O	B-T169
with	O	O	O
MPs	O	O	B-T130
with	O	O	O
AChE	O	O	O
was	O	O	O
also	O	O	O
established	O	O	O
.	O	O	O

-DOCSTART- (28339345)

Alanine	O	O	B-T116
Aminotransferase	O	O	I-T116
Is	O	O	O
a	O	O	O
Marker	O	O	B-T201
of	O	O	O
Lipotoxicity	O	O	B-T047
Consequences	O	O	B-T169
and	O	O	O
Hyperandrogenemia	O	O	B-T033
in	O	O	O
Women	O	O	B-T098
with	O	O	O
Polycystic	O	O	O
Ovary	O	O	O
Syndrome	O	O	O

Several	O	O	O
studies	O	O	B-T062
have	O	O	O
reported	O	O	O
higher	O	O	O
levels	O	O	O
of	O	O	O
Alanine	O	O	B-T116
aminotransferase	O	O	I-T116
(	O	O	O
ALT	O	O	B-T116
)	O	O	O
in	O	O	O
women	O	O	B-T098
with	O	O	O
polycystic	O	O	B-T047
ovary	O	O	I-T047
syndrome	O	O	I-T047
(	O	O	O
PCOS	O	O	B-T047
)	O	O	O
compared	O	O	O
with	O	O	O
control	O	O	B-T096
subjects	O	O	I-T096
.	O	O	O

Plasma	O	O	B-T059
ALT	O	O	I-T059
levels	O	O	I-T059
are	O	O	O
considered	O	O	O
a	O	O	O
marker	O	O	B-T201
of	O	O	O
hepatic	O	O	B-T029
lipotoxicity	O	O	B-T047
because	O	O	O
of	O	O	O
their	O	O	O
significant	O	O	O
associations	O	O	O
with	O	O	O
different	O	O	O
hepatic	O	O	O
metabolic	O	O	O
dysfunctions	O	O	O
,	O	O	O
such	O	O	O
as	O	O	O
hepatic	O	O	B-T047
steatosis	O	O	I-T047
and	O	O	O
hepatic	O	O	O
insulin	O	O	B-T046
resistance	O	O	I-T046
.	O	O	O

Retrospective	O	O	B-T170
chart	O	O	I-T170
review	O	O	O
aiming	O	O	O
to	O	O	O
assess	O	O	O
,	O	O	O
in	O	O	O
PCOS	O	O	B-T047
women	O	O	B-T098
,	O	O	O
the	O	O	O
relationship	O	O	O
between	O	O	O
ALT	O	O	B-T059
levels	O	O	I-T059
and	O	O	O
measures	O	O	O
of	O	O	O
lipotoxicity	O	O	B-T047
consequences	O	O	B-T169
that	O	O	O
are	O	O	O
available	O	O	O
clinically	O	O	O
,	O	O	O
both	O	O	O
during	O	O	O
fasting	O	O	B-T059
and	O	O	O
using	O	O	O
the	O	O	O
oral	O	O	B-T060
glucose	O	O	I-T060
tolerance	O	O	I-T060
test	O	O	I-T060
.	O	O	O

Women	O	O	B-T098
(	O	O	O
n	O	O	O
=	O	O	O
132	O	O	O
)	O	O	O
with	O	O	O
PCOS	O	O	B-T047
,	O	O	O
were	O	O	O
in	O	O	O
average	O	O	O
27.9	O	O	O
years	O	O	B-T079
of	O	O	O
age	O	O	B-T032
,	O	O	O
with	O	O	O
a	O	O	O
mean	O	O	O
body	O	O	B-T201
mass	O	O	I-T201
index	O	O	I-T201
of	O	O	O
34.1	O	O	O
kg/m(2	O	O	O
)	O	O	O
and	O	O	O
49	O	O	O
%	O	O	O
had	O	O	O
a	O	O	O
metabolic	O	O	B-T047
syndrome	O	O	I-T047
(	O	O	O
MetS	O	O	B-T047
)	O	O	O
.	O	O	O

ALT	O	O	B-T059
levels	O	O	I-T059
were	O	O	O
significantly	O	O	O
correlated	O	O	O
with	O	O	O
homeostatic	O	O	B-T059
model	O	O	I-T059
assessment	O	O	I-T059
for	O	O	I-T059
insulin	O	O	I-T059
resistance	O	O	I-T059
(	O	O	O
r	O	O	O
=	O	O	O
0.42	O	O	O
,	O	O	O
P	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
,	O	O	O
HDL-C	O	O	B-T109
(	O	O	O
r	O	O	O
=	O	O	O
-0.31	O	O	O
,	O	O	O
P	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
,	O	O	O
Matsuda	O	O	B-T170
index	O	O	I-T170
(	O	O	O
-0.45	O	O	O
,	O	O	O
P	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
,	O	O	O
insulin	O	O	B-T060
secretion-sensitivity	O	O	I-T060
index-2	O	O	I-T060
(	O	O	O
-0.26	O	O	O
,	O	O	O
P	O	O	O
=	O	O	O
0.043	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
free	O	O	B-T125
testosterone	O	O	I-T125
(	O	O	O
0.38	O	O	O
,	O	O	O
P	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
,	O	O	O
but	O	O	O
not	O	O	O
with	O	O	O
fasting	O	O	B-T034
glucose	O	O	I-T034
and	O	O	O
triglyceride	O	O	B-T034
levels	O	O	I-T034
.	O	O	O

ALT	O	O	B-T116
cutoff	O	O	O
â¥24	O	O	O
IU/L	O	O	O
was	O	O	O
associated	O	O	O
with	O	O	O
all	O	O	O
these	O	O	O
parameters	O	O	O
,	O	O	O
including	O	O	O
fasting	O	O	B-T034
glucose	O	O	I-T034
(	O	O	O
P	O	O	O
=	O	O	O
0.021	O	O	O
)	O	O	O
and	O	O	O
triglyceride	O	O	B-T034
levels	O	O	I-T034
(	O	O	O
P	O	O	O
=	O	O	O
0.041	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
detected	O	O	O
more	O	O	O
women	O	O	B-T098
with	O	O	O
the	O	O	O
MetS	O	O	B-T047
(	O	O	O
59.2	O	O	O
%	O	O	O
vs.	O	O	O
36.1	O	O	O
%	O	O	O
,	O	O	O
P	O	O	O
=	O	O	O
0.008	O	O	O
)	O	O	O
and	O	O	O
whole-body	O	O	B-T046
insulin	O	O	I-T046
resistance	O	O	I-T046
(	O	O	O
Matsuda	O	O	B-T170
index	O	O	I-T170
<	O	O	O
12.3	O	O	O
L(2)Â·10/mmol(2	O	O	O
)	O	O	O
,	O	O	O
85.3	O	O	O
%	O	O	O
vs.	O	O	O
51.9	O	O	O
%	O	O	O
,	O	O	O
P	O	O	O
=	O	O	O
0.004	O	O	O
)	O	O	O
.	O	O	O

Plasma	O	O	B-T059
ALT	O	O	I-T059
levels	O	O	I-T059
seem	O	O	O
to	O	O	O
be	O	O	O
a	O	O	O
strong	O	O	O
predictor	O	O	B-T078
not	O	O	O
only	O	O	O
of	O	O	O
liver	O	O	B-T023
lipotoxicity	O	O	B-T047
but	O	O	O
also	O	O	O
of	O	O	O
systemic	O	O	B-T047
lipotoxic	O	O	I-T047
consequences	O	O	B-T169
and	O	O	O
hyperandrogenemia	O	O	B-T033
in	O	O	O
women	O	O	B-T098
with	O	O	O
PCOS	O	O	B-T047
.	O	O	O

Although	O	O	O
it	O	O	O
requires	O	O	O
validation	O	O	B-T062
in	O	O	O
another	O	O	O
study	O	O	B-T062
,	O	O	O
an	O	O	O
ALT	O	O	B-T116
cutoff	O	O	O
of	O	O	O
â¥24	O	O	O
IU/L	O	O	O
may	O	O	O
help	O	O	O
clinicians	O	O	B-T097
identify	O	O	O
women	O	O	B-T098
with	O	O	O
increased	O	O	O
metabolic	O	O	B-T201
risks	O	O	I-T201
.	O	O	O

-DOCSTART- (28339928)

Opioid	O	O	B-T109
Use	O	O	O
in	O	O	O
Chronic	O	O	B-T184
Pain	O	O	I-T184
Patients	O	O	B-T101
with	O	O	O
Chronic	O	O	B-T047
Kidney	O	O	I-T047
Disease	O	O	I-T047
:	O	O	O
A	O	O	O
Systematic	O	O	O
Review	O	O	O

To	O	O	O
investigate	O	O	O
the	O	O	O
prevalence	O	O	B-T081
of	O	O	O
chronic	O	O	B-T184
pain	O	O	I-T184
and	O	O	O
opioid	O	O	B-T109
management	O	O	B-T058
among	O	O	O
patients	O	O	B-T101
with	O	O	O
chronic	O	O	B-T047
kidney	O	O	I-T047
disease	O	O	I-T047
(	O	O	O
CKD	O	O	B-T047
)	O	O	O
.	O	O	O

Systematic	O	O	B-T170
review	O	O	I-T170
.	O	O	O

A	O	O	O
systematic	O	O	O
search	O	O	O
was	O	O	O
performed	O	O	O
,	O	O	O
including	O	O	O
citations	O	O	O
from	O	O	O
1960	O	O	O
to	O	O	O
May	O	O	O
2015	O	O	O
.	O	O	O

The	O	O	O
review	O	O	O
highlights	O	O	O
methodological	O	O	B-UnknownType
quality	O	O	I-UnknownType
assessment	O	O	I-UnknownType
of	O	O	O
the	O	O	O
selected	O	O	O
studies	O	O	B-T170
;	O	O	O
prevalence	O	O	B-T081
of	O	O	O
pain	O	O	B-T184
;	O	O	O
type	O	O	B-T080
,	O	O	O
dose	O	O	B-T081
,	O	O	O
and	O	O	O
reason	O	O	O
for	O	O	O
opioid	O	O	B-T109
use	O	O	O
;	O	O	O
effectiveness	O	O	B-T080
of	O	O	O
pain	O	O	B-T061
control	O	O	I-T061
and	O	O	O
associated	O	O	O
adverse	O	O	B-T046
effects	O	O	I-T046
of	O	O	O
opioids	O	O	B-T109
in	O	O	O
CKD	O	O	B-T047
patients	O	O	B-T101
.	O	O	O

Twelve	O	O	O
of	O	O	O
131	O	O	O
articles	O	O	O
met	O	O	O
inclusion	O	O	B-T080
criteria	O	O	I-T080
.	O	O	O

There	O	O	O
were	O	O	O
no	O	O	O
randomized	O	O	B-T062
controlled	O	O	I-T062
trials	O	O	I-T062
(	O	O	O
RCT	O	O	B-T062
)	O	O	O
evaluable	O	O	O
,	O	O	O
and	O	O	O
12	O	O	O
were	O	O	O
observational	O	O	B-T170
studies	O	O	I-T170
.	O	O	O

Out	O	O	O
of	O	O	O
12	O	O	O
studies	O	O	B-T170
,	O	O	O
four	O	O	O
were	O	O	O
of	O	O	O
high	O	O	B-T080
quality	O	O	B-T080
,	O	O	O
six	O	O	O
were	O	O	O
of	O	O	O
moderate	O	O	B-T081
quality	O	O	O
,	O	O	O
and	O	O	O
the	O	O	O
remaining	O	O	O
two	O	O	O
were	O	O	O
low	O	O	B-T080
-	O	O	O
quality	O	O	O
studies	O	O	O
.	O	O	O

The	O	O	O
studies	O	O	B-T170
were	O	O	O
from	O	O	O
different	O	O	O
countries	O	O	B-T083
with	O	O	O
sample	O	O	B-T081
size	O	O	I-T081
ranging	O	O	O
from	O	O	O
10	O	O	O
to	O	O	O
12,782	O	O	O
.	O	O	O

Several	O	O	O
studies	O	O	B-T170
showed	O	O	O
a	O	O	O
high	O	O	O
prevalence	O	O	B-T081
of	O	O	O
chronic	O	O	B-T079
uncontrolled	O	O	B-T184
pain	O	O	I-T184
.	O	O	O

The	O	O	O
effectiveness	O	O	O
of	O	O	O
different	O	O	O
categories	O	O	O
of	O	O	O
opioids	O	O	B-T109
,	O	O	O
dose	O	O	B-T081
,	O	O	O
duration	O	O	B-T081
,	O	O	O
and	O	O	O
commonly	O	O	O
prescribed	O	O	B-T058
opioids	O	O	O
varied	O	O	O
across	O	O	O
studies	O	O	B-T170
.	O	O	O

Based	O	O	O
on	O	O	O
a	O	O	O
systematic	O	O	B-T170
review	O	O	I-T170
of	O	O	O
the	O	O	O
current	O	O	O
literature	O	O	O
,	O	O	O
there	O	O	O
is	O	O	O
fair	O	O	O
evidence	O	O	O
for	O	O	O
the	O	O	O
high	O	O	O
prevalence	O	O	B-T081
of	O	O	O
chronic	O	O	B-T184
pain	O	O	I-T184
among	O	O	O
patients	O	O	B-T101
with	O	O	O
CKD	O	O	B-T047
,	O	O	O
which	O	O	O
is	O	O	O
not	O	O	O
being	O	O	O
effectively	O	O	O
managed	O	O	O
,	O	O	O
probably	O	O	O
due	O	O	O
to	O	O	O
underprescription	O	O	B-UnknownType
of	O	O	O
analgesics	O	O	B-T109
or	O	O	O
opioids	O	O	B-T109
in	O	O	O
the	O	O	O
CKD	O	O	O
population	O	O	B-T081
.	O	O	O

Clinicians	O	O	B-T097
are	O	O	O
in	O	O	O
need	O	O	O
of	O	O	O
additional	O	O	O
and	O	O	O
well-designed	O	O	O
randomized	O	O	B-T062
control	O	O	I-T062
trials	O	O	I-T062
that	O	O	O
focus	O	O	O
on	O	O	O
the	O	O	O
indications	O	O	O
for	O	O	O
opioid	O	O	B-T109
therapy	O	O	B-T061
,	O	O	O
appropriate	O	O	O
opioid	O	O	O
doses	O	O	B-T081
and	O	O	O
dosing	O	O	B-T081
intervals	O	O	B-T079
,	O	O	O
outcomes	O	O	O
with	O	O	O
adequacy	O	O	B-T080
of	O	O	O
symptom	O	O	B-T061
control	O	O	I-T061
,	O	O	O
and	O	O	O
reporting	O	O	O
on	O	O	O
the	O	O	O
incidence	O	O	O
of	O	O	O
adverse	O	O	B-T046
side	O	O	I-T046
effects	O	O	I-T046
.	O	O	O

-DOCSTART- (28342945)

Cognitive	O	O	B-T048
impairment	O	O	I-T048
in	O	O	O
first-episode	O	O	B-T079
drug-naÃ¯ve	O	O	B-T101
patients	O	O	I-T101
with	O	O	O
schizophrenia	O	O	B-T048
:	O	O	O
Relationships	O	O	B-T080
with	O	O	O
serum	O	O	B-T081
concentrations	O	O	I-T081
of	O	O	O
brain-derived	O	O	B-T116
neurotrophic	O	O	I-T116
factor	O	O	I-T116
and	O	O	O
glial	O	O	O
cell	O	O	O
line-derived	O	O	O
neurotrophic	O	O	O
factor	O	O	O

Evidence	O	O	O
suggests	O	O	O
that	O	O	O
brain-derived	O	O	B-T116
neurotrophic	O	O	I-T116
factor	O	O	I-T116
(	O	O	O
BDNF	O	O	B-T116
)	O	O	O
and	O	O	O
glial	O	O	B-T116
cell	O	O	I-T116
line	O	O	I-T116
-derived	O	O	I-T116
neurotrophic	O	O	I-T116
factor	O	O	I-T116
(	O	O	O
GDNF	O	O	B-T116
)	O	O	O
are	O	O	O
important	O	O	O
in	O	O	O
the	O	O	O
regulation	O	O	B-T042
of	O	O	I-T042
synaptic	O	O	I-T042
plasticity	O	O	I-T042
,	O	O	O
which	O	O	O
plays	O	O	O
a	O	O	O
key	O	O	O
role	O	O	O
in	O	O	O
the	O	O	O
cognitive	O	O	B-T041
processes	O	O	I-T041
in	O	O	O
psychiatric	O	O	B-T048
disorders	O	O	I-T048
.	O	O	O

Our	O	O	O
work	O	O	O
aimed	O	O	O
at	O	O	O
exploring	O	O	O
the	O	O	O
associations	O	O	B-T080
between	O	O	O
serum	O	O	B-T031
BDNF	O	O	B-T116
and	O	O	O
GDNF	O	O	B-T116
levels	O	O	O
and	O	O	O
cognitive	O	O	B-T041
functions	O	O	I-T041
in	O	O	O
first-episode	O	O	B-T101
drug-naÃ¯ve	O	O	I-T101
(	O	O	I-T101
FEDN	O	O	I-T101
)	O	O	I-T101
patients	O	O	I-T101
with	O	O	O
schizophrenia	O	O	B-T048
.	O	O	O

The	O	O	O
BDNF	O	O	B-T116
and	O	O	O
GDNF	O	O	B-T116
levels	O	O	O
of	O	O	O
58	O	O	O
FEDN	O	O	B-T101
patients	O	O	I-T101
and	O	O	O
55	O	O	O
age	O	O	B-T032
-	O	O	O
and	O	O	O
sex	O	O	B-T032
-matched	O	O	O
healthy	O	O	B-T080
controls	O	O	I-T080
were	O	O	O
measured	O	O	O
and	O	O	O
test	O	O	B-T096
subjects	O	O	I-T096
were	O	O	O
examined	O	O	O
using	O	O	O
several	O	O	O
neurocognitive	O	O	B-T060
tests	O	O	I-T060
including	O	O	O
the	O	O	O
verbal	O	O	B-T060
fluency	O	O	I-T060
test	O	O	I-T060
(	O	O	O
VFT	O	O	B-T060
)	O	O	O
,	O	O	O
the	O	O	O
trail	O	O	B-T170
making	O	O	I-T170
test	O	O	I-T170
(	O	O	O
TMT	O	O	B-T170
)	O	O	O
,	O	O	O
the	O	O	O
digit	O	O	B-T170
span	O	O	I-T170
test	O	O	I-T170
(	O	O	O
DST	O	O	B-T170
)	O	O	O
,	O	O	O
and	O	O	O
the	O	O	O
Stroop	O	O	B-T060
test	O	O	I-T060
.	O	O	O

Patients	O	O	B-T101
performed	O	O	O
significantly	O	O	O
worse	O	O	O
than	O	O	O
controls	O	O	B-T096
in	O	O	O
nearly	O	O	O
all	O	O	O
neurocognitive	O	O	B-T060
performances	O	O	I-T060
except	O	O	O
the	O	O	O
forward	O	O	O
subscale	O	O	O
part	O	O	O
of	O	O	O
the	O	O	O
DST	O	O	B-T170
.	O	O	O

BDNF	O	O	B-T116
levels	O	O	B-T080
were	O	O	O
inversely	O	O	O
correlated	O	O	O
to	O	O	O
TMT-part	O	O	B-T080
B	O	O	I-T080
scores	O	O	I-T080
and	O	O	O
positively	O	O	O
correlated	O	O	O
to	O	O	O
VFT-action	O	O	B-T060
in	O	O	O
the	O	O	O
FEDN	O	O	O
group	O	O	O
.	O	O	O

GDNF	O	O	B-T116
levels	O	O	B-T080
showed	O	O	O
a	O	O	O
positive	O	O	O
correlation	O	O	O
with	O	O	O
VFT-action	O	O	B-T080
scores	O	O	I-T080
and	O	O	O
a	O	O	O
negative	O	O	O
correlation	O	O	O
with	O	O	O
TMT-part	O	O	B-T080
B	O	O	I-T080
scores	O	O	I-T080
of	O	O	O
these	O	O	O
patients	O	O	B-T101
.	O	O	O

Current	O	O	O
data	O	O	O
suggests	O	O	O
that	O	O	O
cognitive	O	O	B-T048
dysfunction	O	O	I-T048
widely	O	O	O
exists	O	O	O
in	O	O	O
the	O	O	O
early	O	O	B-T079
stages	O	O	I-T079
of	O	O	O
schizophrenia	O	O	B-T048
.	O	O	O

BDNF	O	O	B-T116
and	O	O	O
GDNF	O	O	B-T116
may	O	O	O
be	O	O	O
jointly	O	O	O
contributed	O	O	O
to	O	O	O
the	O	O	O
pathological	O	O	B-T169
mechanisms	O	O	B-T169
involved	O	O	O
in	O	O	O
cognitive	O	O	B-T048
impairment	O	O	I-T048
in	O	O	O
FEDN	O	O	B-T101
patients	O	O	I-T101
with	O	O	O
schizophrenia	O	O	B-T048
.	O	O	O

-DOCSTART- (28343001)

Comprehensive	O	O	B-T080
functional	O	O	B-T062
analysis	O	O	I-T062
of	O	O	O
large	O	O	O
lists	O	O	O
of	O	O	O
genes	O	O	B-T028
and	O	O	O
proteins	O	O	O

The	O	O	O
interpretation	O	O	B-T170
of	O	O	O
high	O	O	B-T170
dimensional	O	O	I-T170
datasets	O	O	I-T170
resulting	O	O	O
from	O	O	O
genomic	O	O	B-T062
and	O	O	O
proteomic	O	O	B-T062
experiments	O	O	I-T062
in	O	O	O
a	O	O	O
timely	O	O	O
and	O	O	O
efficient	O	O	O
manner	O	O	O
is	O	O	O
challenging	O	O	O
.	O	O	O

ClueGO	O	O	B-T073
software	O	O	I-T073
is	O	O	O
a	O	O	O
Cytoscape	O	O	B-T170
App	O	O	I-T170
that	O	O	O
extracts	O	O	O
representative	O	O	O
functional	O	O	O
biological	O	O	B-T080
information	O	O	B-T078
for	O	O	O
large	O	O	O
lists	O	O	O
of	O	O	O
genes	O	O	B-T028
or	O	O	O
proteins	O	O	B-T116
.	O	O	O

The	O	O	O
functional	O	O	B-T062
enrichment	O	O	I-T062
analysis	O	O	I-T062
is	O	O	O
based	O	O	O
on	O	O	O
the	O	O	O
latest	O	O	O
publicly	O	O	O
available	O	O	O
data	O	O	B-T078
from	O	O	O
multiple	O	O	O
annotation	O	O	B-T170
and	O	O	O
ontology	O	O	B-T090
resources	O	O	B-T078
that	O	O	O
can	O	O	O
be	O	O	O
automatically	O	O	B-T169
accessed	O	O	B-T082
through	O	O	O
ClueGO	O	O	B-T073
.	O	O	O

Predefined	O	O	B-T170
settings	O	O	I-T170
for	O	O	O
the	O	O	O
selection	O	O	B-T052
of	O	O	O
the	O	O	O
terms	O	O	B-T078
are	O	O	O
provided	O	O	O
to	O	O	O
facilitate	O	O	O
the	O	O	O
analysis	O	O	B-T062
.	O	O	O

Results	O	O	B-T169
are	O	O	O
visualized	O	O	O
as	O	O	O
networks	O	O	B-T169
in	O	O	O
which	O	O	O
Gene	O	O	B-T170
Ontology	O	O	I-T170
(	O	O	O
GO	O	O	B-T170
)	O	O	O
terms	O	O	O
and	O	O	O
pathways	O	O	B-T077
are	O	O	O
grouped	O	O	O
based	O	O	O
on	O	O	O
their	O	O	O
biological	O	O	O
role	O	O	O
.	O	O	O

Many	O	O	O
species	O	O	B-T185
are	O	O	O
now	O	O	O
supported	O	O	O
by	O	O	O
ClueGO	O	O	B-T073
and	O	O	O
additional	O	O	O
organisms	O	O	B-T001
are	O	O	O
added	O	O	O
on	O	O	O
demand	O	O	O
.	O	O	O

ClueGO	O	O	B-T073
can	O	O	O
be	O	O	O
used	O	O	O
together	O	O	O
with	O	O	O
the	O	O	O
CluePedia	O	O	B-T170
App	O	O	I-T170
to	O	O	O
enable	O	O	O
the	O	O	O
visualization	O	O	O
of	O	O	O
protein-protein	O	O	B-T044
interactions	O	O	I-T044
within	O	O	O
or	O	O	O
between	O	O	O
pathways	O	O	B-T077
.	O	O	O

-DOCSTART- (28343423)

Management	O	O	B-T061
of	O	O	O
precipitated	O	O	B-T048
opiate	O	O	B-T121
withdrawal	O	O	I-T048
syndrome	O	O	I-T048
induced	O	O	B-T169
by	O	O	O
nalmefene	O	O	B-T109
mistakenly	O	O	O
prescribed	O	O	B-T058
in	O	O	O
opiate	O	O	O
-	O	O	O
dependent	O	O	B-T169
patients	O	O	I-T169
:	O	O	O
a	O	O	O
review	O	O	B-T170
for	O	O	O
clinicians	O	O	O

Nalmefene	O	O	B-T109
,	O	O	O
a	O	O	O
long-acting	O	O	B-T121
Âµ-opioid	O	O	I-T121
antagonist	O	O	I-T121
approved	O	O	B-T080
to	O	O	O
treat	O	O	B-T169
alcohol	O	O	B-T048
use	O	O	I-T048
disorder	O	O	I-T048
,	O	O	O
is	O	O	O
occasionally	O	O	B-T079
mistakenly	O	O	O
prescribed	O	O	B-T058
to	O	O	O
opiate	O	O	B-T121
-	O	O	O
dependent	O	O	B-T169
or	O	O	O
opioid	O	O	B-T109
-	O	O	O
treated	O	O	B-T169
patients	O	O	B-T101
.	O	O	O

We	O	O	O
review	O	O	B-T078
recent	O	O	O
literature	O	O	B-T170
on	O	O	O
drug-drug	O	O	B-T044
interactions	O	O	I-T044
between	O	O	O
nalmefene	O	O	B-T109
and	O	O	O
opioids	O	O	B-T109
that	O	O	O
lead	O	O	O
to	O	O	O
precipitated	O	O	B-T048
opioid	O	O	I-T048
withdrawal	O	O	I-T048
,	O	O	O
and	O	O	O
focus	O	O	O
on	O	O	O
its	O	O	O
management	O	O	B-T061
and	O	O	O
planning	O	O	B-T169
for	O	O	O
care	O	O	B-T058
at	O	O	O
discharge	O	O	B-T058
.	O	O	O

Areas	O	O	O
covered	O	O	O
:	O	O	O
This	O	O	O
article	O	O	O
provides	O	O	O
a	O	O	O
brief	O	O	O
and	O	O	O
comprehensive	O	O	B-T058
review	O	O	I-T058
of	O	O	O
management	O	O	O
of	O	O	O
precipitated	O	O	B-T048
opioid	O	O	B-T109
withdrawal	O	O	I-T048
syndrome	O	O	I-T048
when	O	O	O
nalmefene	O	O	B-T109
is	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
an	O	O	O
opioid	O	O	O
,	O	O	O
whether	O	O	O
misused	O	O	B-T033
or	O	O	O
legally	O	O	B-T169
prescribed	O	O	B-T058
.	O	O	O

Expert	O	O	B-T077
opinion	O	O	I-T077
:	O	O	O
When	O	O	O
treating	O	O	B-T169
an	O	O	O
opiate	O	O	B-T121
-	O	O	O
dependent	O	O	B-T169
patient	O	O	I-T169
with	O	O	O
co-occurring	O	O	O
alcohol	O	O	B-T048
use	O	O	I-T048
disorder	O	O	I-T048
,	O	O	O
both	O	O	O
conditions	O	O	B-T080
need	O	O	O
to	O	O	O
be	O	O	O
a	O	O	O
focus	O	O	O
of	O	O	O
clinical	O	O	B-T080
attention	O	O	I-T080
.	O	O	O

New	O	O	B-T080
drugs	O	O	B-T121
for	O	O	O
alcohol	O	O	B-T048
use	O	O	I-T048
disorder	O	O	I-T048
have	O	O	O
been	O	O	O
approved	O	O	B-T080
,	O	O	O
but	O	O	O
must	O	O	O
be	O	O	O
given	O	O	O
cautiously	O	O	O
and	O	O	O
with	O	O	O
a	O	O	O
full	O	O	O
understanding	O	O	O
of	O	O	O
their	O	O	O
potential	O	O	B-T080
drug-drug	O	O	B-T044
interactions	O	O	I-T044
with	O	O	O
opioid	O	O	B-T109
medications	O	O	B-T170
.	O	O	O

Opiate	O	O	B-T121
-	O	O	O
dependent	O	O	B-T169
patients	O	O	I-T169
should	O	O	O
be	O	O	O
intensively	O	O	O
monitored	O	O	O
for	O	O	O
risk	O	O	B-T033
factors	O	O	I-T033
of	O	O	O
alcohol	O	O	B-T048
use	O	O	I-T048
disorder	O	O	I-T048
and	O	O	O
should	O	O	O
be	O	O	O
continuously	O	O	O
motivated	O	O	O
for	O	O	O
treatment	O	O	B-T061
maintenance	O	O	I-T061
.	O	O	O

When	O	O	O
nalmefene	O	O	B-T109
is	O	O	O
administered	O	O	B-T058
to	O	O	O
opiate	O	O	B-T121
-	O	O	O
dependent	O	O	B-T169
patients	O	O	I-T169
,	O	O	O
acute	O	O	B-T079
opioid	O	O	B-T048
withdrawal	O	O	I-T048
syndrome	O	O	I-T048
may	O	O	O
occur	O	O	B-T052
.	O	O	O

Management	O	O	B-T061
of	O	O	O
precipitated	O	O	O
acute	O	O	B-T079
opioid	O	O	B-T048
withdrawal	O	O	I-T048
may	O	O	O
include	O	O	B-T052
short	O	O	O
or	O	O	O
long-acting	O	O	B-T044
Âµ-opioid	O	O	I-T044
agonists	O	O	I-T044
during	O	O	O
hospitalization	O	O	B-T058
,	O	O	O
in	O	O	O
addition	O	O	O
to	O	O	O
supportive	O	O	B-T061
treatment	O	O	I-T061
.	O	O	O

The	O	O	O
best	O	O	O
management	O	O	B-T058
of	O	O	O
polydrug	O	O	B-T033
abusers	O	O	I-T033
is	O	O	O
based	O	O	O
on	O	O	O
a	O	O	O
multidisciplinary	O	O	B-T060
approach	O	O	I-T060
,	O	O	O
which	O	O	O
should	O	O	O
be	O	O	O
pursued	O	O	O
and	O	O	O
improved	O	O	B-T033
through	O	O	B-T169
continuing	O	O	B-T078
medical	O	O	I-T078
education	O	O	I-T078
.	O	O	O

-DOCSTART- (28343993)

Discovering	O	O	O
key	O	O	O
residues	O	O	B-T077
of	O	O	O
dengue	O	O	B-T005
virus	O	O	I-T005
NS2b-NS3-protease	O	O	B-T116
:	O	O	O
New	O	O	O
binding	O	O	B-T192
sites	O	O	I-T192
for	O	O	O
antiviral	O	O	B-UnknownType
inhibitors	O	O	I-UnknownType
design	O	O	O

The	O	O	O
NS2B-NS3	O	O	B-T116
protease	O	O	I-T116
is	O	O	O
essential	O	O	O
for	O	O	O
the	O	O	O
Dengue	O	O	B-T005
Virus	O	O	I-T005
(	O	O	O
DENV	O	O	B-T005
)	O	O	O
replication	O	O	B-T045
process	O	O	I-T045
.	O	O	O

This	O	O	O
complex	O	O	B-T026
constitutes	O	O	O
a	O	O	O
target	O	O	B-T169
for	O	O	O
efficient	O	O	O
antiviral	O	O	B-T121
discovery	O	O	B-T052
because	O	O	O
a	O	O	O
drug	O	O	B-T121
could	O	O	O
inhibit	O	O	O
the	O	O	O
viral	O	O	B-T043
polyprotein	O	O	I-T043
processing	O	O	I-T043
.	O	O	O

Furthermore	O	O	O
,	O	O	O
since	O	O	O
the	O	O	O
protease	O	O	B-T116
is	O	O	O
highly	O	O	O
conserved	O	O	B-T086
between	O	O	O
the	O	O	O
four	O	O	O
Dengue	O	O	B-T005
virus	O	O	I-T005
serotypes	O	O	B-T170
,	O	O	O
it	O	O	O
is	O	O	O
probable	O	O	O
that	O	O	O
a	O	O	O
drug	O	O	B-T121
would	O	O	O
be	O	O	O
equally	O	O	O
effective	O	O	O
against	O	O	O
all	O	O	O
of	O	O	O
them	O	O	O
.	O	O	O

In	O	O	O
this	O	O	O
article	O	O	O
,	O	O	O
a	O	O	O
strategy	O	O	O
is	O	O	O
reported	O	O	O
that	O	O	O
allowed	O	O	O
us	O	O	O
to	O	O	O
identify	O	O	O
influential	O	O	B-T078
residues	O	O	B-T077
on	O	O	O
the	O	O	O
function	O	O	O
of	O	O	O
the	O	O	O
Dengue	O	O	B-T005
NS2b-NS3	O	O	B-T116
Protease	O	O	I-T116
.	O	O	O

Moreover	O	O	O
,	O	O	O
this	O	O	O
is	O	O	O
a	O	O	O
strategy	O	O	O
that	O	O	O
could	O	O	O
be	O	O	O
applied	O	O	O
to	O	O	O
virtually	O	O	O
any	O	O	O
protein	O	O	B-T116
for	O	O	O
the	O	O	O
search	O	O	O
of	O	O	O
alternative	O	O	O
influential	O	O	B-T078
residues	O	O	B-T077
,	O	O	O
and	O	O	O
for	O	O	O
non-competitive	O	O	B-UnknownType
inhibitor	O	O	I-UnknownType
development	O	O	B-T169
.	O	O	O

First	O	O	O
,	O	O	O
we	O	O	O
incorporated	O	O	O
several	O	O	O
features	O	O	O
derived	O	O	O
from	O	O	O
computational	O	O	B-T091
alanine	O	O	B-T116
scanning	O	O	B-T063
mutagenesis	O	O	I-T063
,	O	O	O
sequence	O	O	B-T086
,	O	O	O
structure	O	O	B-T082
conservation	O	O	I-T086
,	O	O	O
and	O	O	O
other	O	O	O
structure	O	O	O
-based	O	O	O
characteristics	O	O	B-T080
.	O	O	O

Second	O	O	O
,	O	O	O
these	O	O	O
features	O	O	O
were	O	O	O
used	O	O	O
as	O	O	O
variables	O	O	O
to	O	O	O
obtain	O	O	O
a	O	O	O
multilayer	O	O	B-T170
perceptron	O	O	I-T170
model	O	O	I-T170
to	O	O	O
identify	O	O	O
defined	O	O	O
groups	O	O	B-T078
(	O	O	O
clusters	O	O	O
)	O	O	O
of	O	O	O
key	O	O	O
residues	O	O	B-T077
as	O	O	O
possible	O	O	O
candidate	O	O	O
pockets	O	O	O
for	O	O	O
binding	O	O	B-T192
sites	O	O	I-T192
of	O	O	O
new	O	O	O
leads	O	O	O
on	O	O	O
the	O	O	O
DENV	O	O	B-T005
protease	O	O	B-T116
.	O	O	O

The	O	O	O
identified	O	O	O
residues	O	O	B-T077
included	O	O	O
:	O	O	O
i	O	O	O
)	O	O	O
amino	O	O	B-T116
acids	O	O	I-T116
close	O	O	O
to	O	O	O
the	O	O	O
beta	O	O	B-T082
sheet	O	O	I-T082
-loop-	O	O	O
beta	O	O	O
sheet	O	O	O
known	O	O	O
to	O	O	O
be	O	O	O
important	O	O	O
in	O	O	O
its	O	O	O
closed	O	O	B-T082
conformation	O	O	I-T082
for	O	O	O
NS2b	O	O	B-T116
ii	O	O	O
)	O	O	O
residues	O	O	O
close	O	O	O
to	O	O	O
the	O	O	O
active	O	O	B-T169
site	O	O	I-T169
,	O	O	O
iii	O	O	O
)	O	O	O
several	O	O	O
residues	O	O	O
evenly	O	O	O
spread	O	O	O
on	O	O	O
the	O	O	O
NS2b-NS3	O	O	B-T116
contact	O	O	O
surface	O	O	O
,	O	O	O
and	O	O	O
iv	O	O	O
)	O	O	O
some	O	O	O
inner	O	O	O
residues	O	O	O
most	O	O	O
likely	O	O	O
related	O	O	O
to	O	O	O
the	O	O	O
overall	O	O	O
stability	O	O	B-T080
of	O	O	O
the	O	O	O
protease	O	O	B-T116
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
we	O	O	O
found	O	O	O
concordance	O	O	O
on	O	O	O
our	O	O	O
list	O	O	O
of	O	O	O
residues	O	O	B-T077
with	O	O	O
previously	O	O	O
identified	O	O	O
amino	O	O	B-T116
acids	O	O	I-T116
part	O	O	O
of	O	O	O
a	O	O	O
highly	O	O	O
conserved	O	O	O
peptide	O	O	B-T116
studied	O	O	O
for	O	O	O
vaccine	O	O	B-T062
development	O	O	I-T062
.	O	O	O

-DOCSTART- (28344199)

Association	O	O	B-T080
of	O	O	O
Toll-Like	O	O	B-T116
Receptor	O	O	I-T116
4	O	O	I-T116
on	O	O	O
Human	O	O	B-T016
Monocyte	O	O	B-T025
Subsets	O	O	B-T185
and	O	O	O
Vulnerability	O	O	B-T033
Characteristics	O	O	B-T080
of	O	O	O
Coronary	O	O	B-T023
Plaque	O	O	B-T033
as	O	O	O
Assessed	O	O	B-T052
by	O	O	O
64-Slice	O	O	O
Multidetector	O	O	O
Computed	O	O	O
Tomography	O	O	O

Although	O	O	O
Toll-like	O	O	B-T116
receptor	O	O	I-T116
4	O	O	I-T116
(	O	O	O
TLR-4	O	O	B-T116
)	O	O	O
is	O	O	O
involved	O	O	O
in	O	O	O
monocyte	O	O	B-T025
activation	O	O	I-T043
in	O	O	O
patients	O	O	B-T101
with	O	O	O
accelerated	O	O	B-T169
forms	O	O	O
of	O	O	O
atherosclerosis	O	O	B-T047
,	O	O	O
the	O	O	O
relationship	O	O	B-T080
between	O	O	O
the	O	O	O
expression	O	O	B-T045
of	O	O	O
TLR-4	O	O	O
on	O	O	O
circulating	O	O	B-T169
monocyte	O	O	O
s	O	O	O
and	O	O	O
coronary	O	O	B-T023
plaque	O	O	B-T033
vulnerability	O	O	B-T033
has	O	O	O
not	O	O	O
previously	O	O	O
been	O	O	O
evaluated	O	O	B-T058
.	O	O	O

We	O	O	O
investigated	O	O	O
this	O	O	O
relationship	O	O	B-T080
using	O	O	O
64-slice	O	O	B-T060
multidetector	O	O	I-T060
computed	O	O	I-T060
tomography	O	O	I-T060
(	O	O	O
MDCT	O	O	B-T060
)	O	O	O
in	O	O	O
patients	O	O	B-T101
with	O	O	O
stable	O	O	B-T047
angina	O	O	I-T047
pectoris	O	O	I-T047
(SAP).Methods	O	O	O
and	O	O	O
Results	O	O	O
:	O	O	O
We	O	O	O
enrolled	O	O	O
65	O	O	O
patients	O	O	O
with	O	O	O
SAP	O	O	B-T047
who	O	O	O
underwent	O	O	O
MDCT	O	O	O
.	O	O	O

Three	O	O	O
monocyte	O	O	B-T025
subsets	O	O	B-T185
(	O	O	O
CD14(++)CD16(-	O	O	B-T025
)	O	O	I-T025
,	O	O	O
CD14(++)CD16(+	O	O	B-T025
)	O	O	I-T025
,	O	O	O
and	O	O	O
CD14(+)CD16(+	O	O	B-T025
)	O	O	I-T025
)	O	O	O
and	O	O	O
expression	O	O	B-T045
of	O	O	O
TLR-4	O	O	B-T116
were	O	O	O
measured	O	O	O
by	O	O	O
flow	O	O	B-T059
cytometry	O	O	I-T059
.	O	O	O

Intracoronary	O	O	B-T023
plaques	O	O	B-T033
were	O	O	O
assessed	O	O	B-T052
by	O	O	O
64-slice	O	O	B-T060
MDCT	O	O	I-T060
.	O	O	O

We	O	O	O
defined	O	O	O
vulnerability	O	O	B-T033
of	O	O	O
intracoronary	O	O	B-T023
plaques	O	O	B-T033
according	O	O	O
to	O	O	O
the	O	O	O
presence	O	O	O
of	O	O	O
positive	O	O	B-T046
remodeling	O	O	I-T046
(	O	O	O
remodeling	O	O	B-T033
index	O	O	I-T033
>	O	O	O
1.05	O	O	O
)	O	O	O
and/or	O	O	O
low	O	O	O
CT	O	O	B-T060
attenuation	O	O	B-T081
(	O	O	O
<	O	O	O
35	O	O	O
HU	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
circulating	O	O	B-T169
CD14(++)CD16(+)monocytes	O	O	B-T025
more	O	O	O
frequently	O	O	O
expressed	O	O	B-T045
TLR-4	O	O	B-T116
than	O	O	O
CD14(++)CD16(-	O	O	B-T025
)	O	O	I-T025
and	O	O	O
CD14(+)CD16(+)monocytes	O	O	B-T025
(	O	O	O
P<0.001	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
relative	O	O	O
proportion	O	O	O
of	O	O	O
the	O	O	O
expression	O	O	B-T045
of	O	O	O
TLR-4	O	O	B-T116
on	O	O	O
CD14(++)CD16(+)monocytes	O	O	B-T025
was	O	O	O
significantly	O	O	O
greater	O	O	O
in	O	O	O
patients	O	O	B-T101
with	O	O	O
vulnerable	O	O	B-T033
plaque	O	O	I-T033
compared	O	O	O
with	O	O	O
those	O	O	O
without	O	O	O
(	O	O	O
10.4	O	O	O
[	O	O	O
4.1	O	O	O
-	O	O	O
14.5	O	O	O
]	O	O	O
%	O	O	O
vs.	O	O	O
4.5	O	O	O
[	O	O	O
2.8	O	O	O
-	O	O	O
7.8	O	O	O
]	O	O	O
%	O	O	O
,	O	O	O
P=0.012	O	O	O
)	O	O	O
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
the	O	O	O
relative	O	O	O
proportion	O	O	O
of	O	O	O
TLR-4	O	O	B-T116
expression	O	O	B-T045
on	O	O	O
CD14(++)CD16(+)monocytes	O	O	B-T025
positively	O	O	O
correlated	O	O	B-T080
with	O	O	O
the	O	O	O
remodeling	O	O	B-T033
index	O	O	I-T033
(	O	O	O
r=0.28	O	O	O
,	O	O	O
P=0.025	O	O	O
)	O	O	O
and	O	O	O
negatively	O	O	O
correlated	O	O	O
with	O	O	O
CT	O	O	B-T060
attenuation	O	O	B-T081
value	O	O	I-T081
(	O	O	O
r=-0.31	O	O	O
,	O	O	O
P=0.013	O	O	O
)	O	O	O
.	O	O	O

Upregulation	O	O	B-T044
of	O	O	O
TLR-4	O	O	B-T116
on	O	O	O
CD14(++)CD16(+)monocytes	O	O	B-T025
might	O	O	O
be	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
coronary	O	O	B-T023
plaque	O	O	B-T033
vulnerability	O	O	B-T033
in	O	O	O
patients	O	O	B-T101
with	O	O	O
SAP	O	O	B-T047
.	O	O	O

-DOCSTART- (28348382)

Delta-frequency	O	O	B-T033
stimulation	O	O	B-T070
of	O	O	O
cerebellar	O	O	B-T023
projections	O	O	B-T082
can	O	O	O
compensate	O	O	B-T080
for	O	O	O
schizophrenia	O	O	B-T048
-related	O	O	O
medial	O	O	O
frontal	O	O	O
dysfunction	O	O	O

Schizophrenia	O	O	B-T048
involves	O	O	O
abnormalities	O	O	B-T033
in	O	O	O
the	O	O	O
medial	O	O	B-T023
frontal	O	O	I-T023
cortex	O	O	I-T023
that	O	O	O
lead	O	O	O
to	O	O	O
cognitive	O	O	B-T048
deficits	O	O	I-T048
.	O	O	O

Here	O	O	O
we	O	O	O
investigate	O	O	B-T169
a	O	O	O
novel	O	O	B-T080
strategy	O	O	B-T041
to	O	O	O
normalize	O	O	B-T062
medial	O	O	B-T024
frontal	O	O	I-T024
brain	O	O	I-T024
activity	O	O	B-T039
by	O	O	O
stimulating	O	O	B-T070
cerebellar	O	O	B-T023
projections	O	O	B-T082
.	O	O	O

We	O	O	O
used	O	O	O
an	O	O	O
interval	O	O	B-T079
timing	O	O	I-T079
task	O	O	O
to	O	O	O
study	O	O	B-T062
elementary	O	O	O
cognitive	O	O	B-T041
processing	O	O	I-T041
that	O	O	O
requires	O	O	O
both	O	O	O
frontal	O	O	B-T023
and	O	O	O
cerebellar	O	O	B-T023
networks	O	O	I-T023
that	O	O	O
are	O	O	O
disrupted	O	O	B-T080
in	O	O	O
patients	O	O	B-T101
with	O	O	O
schizophrenia	O	O	B-T048
.	O	O	O

We	O	O	O
report	O	O	O
three	O	O	O
novel	O	O	B-T080
findings	O	O	B-T033
.	O	O	O

First	O	O	O
,	O	O	O
patients	O	O	B-T101
with	O	O	O
schizophrenia	O	O	B-T048
had	O	O	O
dysfunctional	O	O	O
delta	O	O	B-T042
rhythms	O	O	I-T042
between	O	O	O
1	O	O	O
-	O	O	O
4	O	O	O
Hz	O	O	O
in	O	O	O
the	O	O	O
medial	O	O	B-T023
frontal	O	O	I-T023
cortex	O	O	I-T023
.	O	O	O

We	O	O	O
explored	O	O	O
cerebellar	O	O	B-T023
-	O	O	O
frontal	O	O	B-T023
interactions	O	O	B-T169
in	O	O	O
animal	O	O	B-T008
models	O	O	I-T008
and	O	O	O
found	O	O	O
that	O	O	O
both	O	O	O
frontal	O	O	O
and	O	O	O
cerebellar	O	O	B-T025
neurons	O	O	I-T025
were	O	O	O
modulated	O	O	B-T082
during	O	O	O
interval	O	O	B-T079
timing	O	O	I-T079
and	O	O	O
had	O	O	O
delta-frequency	O	O	B-T033
interactions	O	O	O
.	O	O	O

Finally	O	O	O
,	O	O	O
delta-frequency	O	O	B-T033
optogenetic	O	O	B-T063
stimulation	O	O	B-T070
of	O	O	O
thalamic	O	O	B-T023
synaptic	O	O	B-T026
terminals	O	O	I-T026
of	O	O	O
lateral	O	O	B-T082
cerebellar	O	O	B-T023
projection	O	O	B-T082
neurons	O	O	B-T025
rescued	O	O	O
timing	O	O	O
performance	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
medial	O	O	B-T024
frontal	O	O	I-T024
activity	O	O	B-T039
in	O	O	O
a	O	O	O
rodent	O	O	B-T050
model	O	O	I-T050
of	O	O	O
schizophrenia-related	O	O	B-T048
frontal	O	O	B-T048
dysfunction	O	O	I-T048
.	O	O	O

These	O	O	O
data	O	O	B-T078
provide	O	O	O
insight	O	O	O
into	O	O	O
how	O	O	O
the	O	O	O
cerebellum	O	O	B-T023
influences	O	O	B-T077
medial	O	O	B-T029
frontal	O	O	I-T029
networks	O	O	I-T029
and	O	O	O
the	O	O	O
role	O	O	O
of	O	O	O
the	O	O	O
cerebellum	O	O	O
in	O	O	O
cognitive	O	O	B-T041
processing	O	O	I-T041
.	O	O	O

-DOCSTART- (28351424)

Variables	O	O	B-T080
associated	O	O	B-T080
with	O	O	I-T080
unplanned	O	O	B-T080
general	O	O	B-T100
adult	O	O	I-T100
ICU	O	O	B-T058
admission	O	O	I-T058
in	O	O	O
hospitalised	O	O	B-T101
patients	O	O	I-T101
:	O	O	O
protocol	O	O	B-T170
for	O	O	O
a	O	O	O
systematic	O	O	B-T169
review	O	O	O

Failure	O	O	B-T169
to	O	O	O
promptly	O	O	O
identify	O	O	B-T080
deterioration	O	O	B-T067
in	O	O	O
hospitalised	O	O	B-T101
patients	O	O	I-T101
is	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
delayed	O	O	B-T079
admission	O	O	B-T058
to	O	O	I-T058
intensive	O	O	I-T058
care	O	O	I-T058
units	O	O	I-T058
(	O	O	O
ICUs	O	O	B-T093
)	O	O	O
and	O	O	O
poor	O	O	B-T080
outcomes	O	O	B-T080
.	O	O	O

Existing	O	O	B-T077
vital	O	O	B-T201
sign	O	O	I-T201
-based	O	O	O
Early	O	O	B-T081
Warning	O	O	I-T081
Score	O	O	I-T081
(	O	O	B-T081
EWS	O	O	I-T081
)	O	O	I-T081
algorithms	O	O	B-T170
do	O	O	O
not	O	O	O
have	O	O	O
a	O	O	O
sufficiently	O	O	B-T080
high	O	O	B-T080
positive	O	O	B-T077
predictive	O	O	B-T080
value	O	O	I-T080
to	O	O	O
be	O	O	O
used	O	O	O
for	O	O	O
automated	O	O	B-T169
activation	O	O	B-T052
of	O	O	O
an	O	O	O
ICU	O	O	B-T093
outreach	O	O	B-T097
team	O	O	I-T097
.	O	O	O

Incorporating	O	O	B-T169
additional	O	O	O
patient	O	O	B-T170
data	O	O	I-T170
might	O	O	O
improve	O	O	B-T033
the	O	O	O
predictive	O	O	B-T080
power	O	O	B-T081
of	O	O	O
EWS	O	O	B-T081
algorithms	O	O	B-T170
;	O	O	O
however	O	O	O
,	O	O	O
it	O	O	O
is	O	O	O
currently	O	O	B-T079
not	O	O	O
known	O	O	O
which	O	O	O
patient	O	O	O
data	O	O	O
(	O	O	O
or	O	O	O
variables	O	O	B-T080
)	O	O	O
are	O	O	O
most	O	O	O
predictive	O	O	O
of	O	O	O
ICU	O	O	B-T058
admission	O	O	I-T058
.	O	O	O

We	O	O	O
describe	O	O	O
the	O	O	O
protocol	O	O	B-T170
for	O	O	O
a	O	O	O
systematic	O	O	B-T169
review	O	O	B-T078
of	O	O	O
variables	O	O	B-T080
associated	O	O	B-T080
with	O	O	I-T080
ICU	O	O	B-T058
admission	O	O	I-T058
.	O	O	O

MEDLINE	O	O	B-T170
,	O	O	O
EMBASE	O	O	B-T170
,	O	O	O
CINAHL	O	O	B-T170
and	O	O	O
the	O	O	O
Cochrane	O	O	B-T170
Library	O	O	I-T170
,	O	O	O
including	O	O	B-T169
Cochrane	O	O	B-T170
Database	O	O	I-T170
of	O	O	I-T170
Systematic	O	O	I-T170
Reviews	O	O	I-T170
and	O	O	O
the	O	O	O
Cochrane	O	O	B-T170
Central	O	O	I-T170
Register	O	O	I-T170
of	O	O	I-T170
Controlled	O	O	I-T170
Trials	O	O	I-T170
(	O	O	B-T170
CENTRAL	O	O	I-T170
)	O	O	I-T170
will	O	O	O
be	O	O	O
searched	O	O	B-T052
for	O	O	O
studies	O	O	B-T062
that	O	O	O
assess	O	O	B-T058
the	O	O	O
association	O	O	B-T080
of	O	O	O
routinely	O	O	B-T080
recorded	O	O	B-T170
variables	O	O	B-T080
associated	O	O	B-T080
with	O	O	I-T080
subsequent	O	O	B-T079
unplanned	O	O	B-T080
ICU	O	O	B-T058
admission	O	O	I-T058
.	O	O	O

Only	O	O	O
studies	O	O	B-T062
involving	O	O	B-T169
adult	O	O	B-T100
patients	O	O	B-T101
admitted	O	O	B-T058
to	O	O	I-T058
general	O	O	B-T082
ICUs	O	O	B-T093
will	O	O	O
be	O	O	O
included	O	O	B-T169
.	O	O	O

We	O	O	O
will	O	O	O
extract	O	O	B-T080
data	O	O	B-T078
relating	O	O	B-T080
to	O	O	I-T080
the	O	O	O
statistical	O	O	B-T062
association	O	O	I-T062
between	O	O	O
ICU	O	O	B-T058
admission	O	O	I-T058
and	O	O	O
predictor	O	O	B-T078
variables	O	O	B-T080
,	O	O	O
the	O	O	O
quality	O	O	B-T080
of	O	O	O
the	O	O	O
studies	O	O	B-T062
and	O	O	O
the	O	O	O
generalisability	O	O	B-T082
of	O	O	O
the	O	O	O
findings	O	O	B-T033
.	O	O	O

The	O	O	O
results	O	O	B-T169
of	O	O	O
this	O	O	O
review	O	O	B-T078
will	O	O	O
aid	O	O	B-T080
the	O	O	O
development	O	O	B-T169
of	O	O	O
future	O	O	O
models	O	O	B-T170
which	O	O	O
predict	O	O	B-T078
the	O	O	O
risk	O	O	B-T078
of	O	O	O
unplanned	O	O	B-T080
ICU	O	O	B-T058
admission	O	O	I-T058
.	O	O	O

PROSPERO	O	O	O
:	O	O	O
CRD42015029617	O	O	O
.	O	O	O

-DOCSTART- (28351716)

Diagnosis	O	O	B-T033
of	O	O	O
retinal	O	O	B-T023
health	O	O	B-T078
in	O	O	O
digital	O	O	B-T060
fundus	O	O	I-T060
images	O	O	I-T060
using	O	O	O
continuous	O	O	B-T062
wavelet	O	O	I-T062
transform	O	O	I-T062
(	O	O	O
CWT	O	O	B-T062
)	O	O	O
and	O	O	O
entropies	O	O	O

Vision	O	O	B-T040
is	O	O	O
paramount	O	O	O
to	O	O	O
humans	O	O	B-T016
to	O	O	O
lead	O	O	O
an	O	O	O
active	O	O	O
personal	O	O	B-T032
and	O	O	O
professional	O	O	B-T090
life	O	O	I-T090
.	O	O	O

The	O	O	O
prevalence	O	O	B-T081
of	O	O	O
ocular	O	O	B-T047
diseases	O	O	B-T047
is	O	O	O
rising	O	O	O
,	O	O	O
and	O	O	O
diseases	O	O	O
such	O	O	O
as	O	O	O
glaucoma	O	O	B-T047
,	O	O	O
Diabetic	O	O	B-T047
Retinopathy	O	O	I-T047
(	O	O	O
DR	O	O	B-T047
)	O	O	O
and	O	O	O
Age-related	O	O	B-T047
Macular	O	O	I-T047
Degeneration	O	O	I-T047
(	O	O	O
AMD	O	O	B-T047
)	O	O	O
are	O	O	O
the	O	O	O
leading	O	O	B-T169
causes	O	O	B-T169
of	O	O	O
blindness	O	O	B-T033
in	O	O	O
developed	O	O	B-T080
countries	O	O	I-T080
.	O	O	O

Identifying	O	O	O
these	O	O	O
diseases	O	O	B-T047
in	O	O	O
mass	O	O	B-T058
screening	O	O	I-T058
programmes	O	O	I-T058
is	O	O	O
time-consuming	O	O	B-T080
,	O	O	O
labor	O	O	B-T057
-intensive	O	O	O
and	O	O	O
the	O	O	O
diagnosis	O	O	B-T033
can	O	O	O
be	O	O	O
subjective	O	O	B-T080
.	O	O	O

The	O	O	O
use	O	O	O
of	O	O	O
an	O	O	O
automated	O	O	B-T060
computer	O	O	I-T060
aided	O	O	I-T060
diagnosis	O	O	I-T060
system	O	O	I-T060
will	O	O	O
reduce	O	O	O
the	O	O	O
time	O	O	O
taken	O	O	O
for	O	O	O
analysis	O	O	B-T062
and	O	O	O
will	O	O	O
also	O	O	O
reduce	O	O	O
the	O	O	O
inter-observer	O	O	B-T081
subjective	O	O	I-T081
variabilities	O	O	I-T081
in	O	O	O
image	O	O	B-T060
interpretation	O	O	I-T060
.	O	O	O

In	O	O	O
this	O	O	O
work	O	O	O
,	O	O	O
we	O	O	O
propose	O	O	O
one	O	O	O
such	O	O	O
system	O	O	O
for	O	O	O
the	O	O	O
automatic	O	O	B-T169
classification	O	O	B-T185
of	O	O	O
normal	O	O	B-T080
from	O	O	O
abnormal	O	O	B-T033
(	O	O	O
DR	O	O	B-T047
,	O	O	O
AMD	O	O	B-T047
,	O	O	O
glaucoma	O	O	B-T047
)	O	O	O
images	O	O	B-T070
.	O	O	O

We	O	O	O
had	O	O	O
a	O	O	O
total	O	O	O
of	O	O	O
404	O	O	O
normal	O	O	B-T080
and	O	O	O
1082	O	O	O
abnormal	O	O	B-T033
fundus	O	O	B-T060
images	O	O	I-T060
in	O	O	O
our	O	O	O
database	O	O	B-T170
.	O	O	O

As	O	O	O
the	O	O	O
first	O	O	O
step	O	O	O
,	O	O	O
2D-Continuous	O	O	B-T062
Wavelet	O	O	I-T062
Transform	O	O	I-T062
(	O	O	O
CWT	O	O	B-T062
)	O	O	O
decomposition	O	O	O
on	O	O	O
the	O	O	O
fundus	O	O	B-T060
images	O	O	I-T060
of	O	O	O
two	O	O	O
classes	O	O	O
was	O	O	O
performed	O	O	O
.	O	O	O

Subsequently	O	O	O
,	O	O	O
energy	O	O	B-T081
features	O	O	O
and	O	O	O
various	O	O	O
entropies	O	O	B-T067
namely	O	O	O
Yager	O	O	O
,	O	O	O
Renyi	O	O	O
,	O	O	O
Kapoor	O	O	O
,	O	O	O
Shannon	O	O	O
,	O	O	O
and	O	O	O
Fuzzy	O	O	O
were	O	O	O
extracted	O	O	O
from	O	O	O
the	O	O	O
decomposed	O	O	O
images	O	O	B-T070
.	O	O	O

Then	O	O	O
,	O	O	O
adaptive	O	O	O
synthetic	O	O	O
sampling	O	O	B-T170
approach	O	O	I-T170
was	O	O	O
applied	O	O	O
to	O	O	O
balance	O	O	O
the	O	O	O
normal	O	O	B-T080
and	O	O	O
abnormal	O	O	B-T033
datasets	O	O	B-T170
.	O	O	O

Next	O	O	O
,	O	O	O
the	O	O	O
extracted	O	O	O
features	O	O	O
were	O	O	O
ranked	O	O	O
according	O	O	O
to	O	O	O
the	O	O	O
significances	O	O	O
using	O	O	O
Particle	O	O	B-T170
Swarm	O	O	I-T170
Optimization	O	O	I-T170
(	O	O	O
PSO	O	O	B-T170
)	O	O	O
.	O	O	O

Thereupon	O	O	O
,	O	O	O
the	O	O	O
ranked	O	O	O
and	O	O	O
selected	O	O	O
features	O	O	O
were	O	O	O
used	O	O	O
to	O	O	O
train	O	O	O
the	O	O	O
random	O	O	O
forest	O	O	O
classifier	O	O	O
using	O	O	O
stratified	O	O	B-T080
10-fold	O	O	O
cross	O	O	B-T062
validation	O	O	I-T062
.	O	O	O

Overall	O	O	O
,	O	O	O
the	O	O	O
proposed	O	O	O
system	O	O	O
presented	O	O	O
a	O	O	O
performance	O	O	B-T081
rate	O	O	I-T081
of	O	O	O
92.48	O	O	O
%	O	O	O
,	O	O	O
and	O	O	O
a	O	O	O
sensitivity	O	O	B-T081
and	O	O	O
specificity	O	O	B-T081
of	O	O	O
89.37	O	O	O
%	O	O	O
and	O	O	O
95.58	O	O	O
%	O	O	O
respectively	O	O	O
using	O	O	O
15	O	O	O
features	O	O	O
.	O	O	O

This	O	O	O
novel	O	O	O
system	O	O	O
shows	O	O	O
promise	O	O	O
in	O	O	O
detecting	O	O	O
abnormal	O	O	B-T033
fundus	O	O	B-T060
images	O	O	I-T060
,	O	O	O
and	O	O	O
hence	O	O	O
,	O	O	O
could	O	O	O
be	O	O	O
a	O	O	O
valuable	O	O	O
adjunct	O	O	O
eye	O	O	B-T023
health	O	O	B-T078
screening	O	O	B-T058
tool	O	O	I-T058
that	O	O	O
could	O	O	O
be	O	O	O
employed	O	O	O
in	O	O	O
polyclinics	O	O	B-T093
,	O	O	O
and	O	O	O
thereby	O	O	O
reduce	O	O	O
the	O	O	O
workload	O	O	B-T081
of	O	O	O
specialists	O	O	B-T097
at	O	O	O
hospitals	O	O	B-T093
.	O	O	O

-DOCSTART- (28352958)

The	O	O	O
epigenetic	O	O	B-T045
landscape	O	O	I-T045
of	O	O	O
age	O	O	B-T032
-	O	O	O
related	O	O	B-T169
diseases	O	O	B-T047
:	O	O	O
the	O	O	O
geroscience	O	O	B-T090
perspective	O	O	O

In	O	O	O
this	O	O	O
review	O	O	B-T170
,	O	O	O
we	O	O	O
summarize	O	O	O
current	O	O	O
knowledge	O	O	O
regarding	O	O	O
the	O	O	O
epigenetics	O	O	B-T045
of	O	O	O
age	O	O	B-T032
-	O	O	O
related	O	O	B-T169
diseases	O	O	B-T047
,	O	O	O
focusing	O	O	O
on	O	O	O
those	O	O	O
studies	O	O	B-T062
that	O	O	O
have	O	O	O
described	O	O	O
DNA	O	O	B-T044
methylation	O	O	I-T044
landscape	O	O	I-T044
in	O	O	O
cardio-vascular	O	O	B-T047
diseases	O	O	I-T047
,	O	O	O
musculoskeletal	O	O	B-T042
function	O	O	I-T042
and	O	O	O
frailty	O	O	B-T033
.	O	O	O

We	O	O	O
stress	O	O	O
the	O	O	O
importance	O	O	O
of	O	O	O
adopting	O	O	O
the	O	O	O
conceptual	O	O	B-T077
framework	O	O	I-T077
of	O	O	O
"	O	O	O
geroscience	O	O	B-T090
"	O	O	O
,	O	O	O
which	O	O	O
starts	O	O	O
from	O	O	O
the	O	O	O
observation	O	O	O
that	O	O	O
advanced	O	O	B-T098
age	O	O	B-T032
is	O	O	O
the	O	O	O
major	O	O	O
risk	O	O	B-T033
factor	O	O	I-T033
for	O	O	O
several	O	O	O
of	O	O	O
these	O	O	O
pathologies	O	O	B-T169
and	O	O	O
aims	O	O	B-T078
at	O	O	O
identifying	O	O	O
the	O	O	O
mechanistic	O	O	B-T080
links	O	O	I-T080
between	O	O	O
aging	O	O	B-T040
and	O	O	O
age	O	O	O
-	O	O	O
related	O	O	B-T169
diseases	O	O	B-T047
.	O	O	O

DNA	O	O	B-T044
methylation	O	O	I-T044
undergoes	O	O	O
a	O	O	O
profound	O	O	O
remodeling	O	O	B-UnknownType
during	O	O	O
aging	O	O	B-T040
,	O	O	O
which	O	O	O
includes	O	O	O
global	O	O	B-T045
hypomethylation	O	O	I-T045
of	O	O	O
the	O	O	O
genome	O	O	B-T028
,	O	O	O
hypermethylation	O	O	B-T045
at	O	O	O
specific	O	O	B-T080
loci	O	O	B-T028
and	O	O	O
an	O	O	O
increase	O	O	B-T169
in	O	O	O
inter-individual	O	O	B-T070
variation	O	O	I-T070
and	O	O	O
in	O	O	O
stochastic	O	O	B-T081
changes	O	O	B-T169
of	O	O	O
DNA	O	O	O
methylation	O	O	O
values	O	O	B-T080
.	O	O	O

These	O	O	O
epigenetic	O	O	B-T045
modifications	O	O	B-T033
can	O	O	O
be	O	O	O
an	O	O	O
important	O	O	O
contributor	O	O	O
to	O	O	O
the	O	O	O
development	O	O	B-T169
of	O	O	O
age	O	O	B-T032
-	O	O	O
related	O	O	B-T169
diseases	O	O	B-T047
,	O	O	O
but	O	O	O
our	O	O	O
understanding	O	O	O
on	O	O	O
the	O	O	O
complex	O	O	B-T080
relationship	O	O	B-T080
between	O	O	O
the	O	O	O
epigenetic	O	O	B-T045
signatures	O	O	I-T045
of	O	O	O
aging	O	O	B-T040
and	O	O	O
age	O	O	O
-	O	O	O
related	O	O	O
disease	O	O	B-T047
is	O	O	O
still	O	O	O
poor	O	O	O
.	O	O	O

The	O	O	O
most	O	O	O
relevant	O	O	B-T080
results	O	O	B-T033
in	O	O	O
this	O	O	O
field	O	O	O
come	O	O	O
from	O	O	O
the	O	O	O
use	O	O	O
of	O	O	O
the	O	O	O
so	O	O	O
called	O	O	O
"	O	O	O
epigenetics	O	O	B-T045
clocks	O	O	I-T045
"	O	O	O
in	O	O	O
cohorts	O	O	B-T098
of	O	O	O
subjects	O	O	B-T098
affected	O	O	B-T169
by	O	O	O
age	O	O	B-T032
-	O	O	O
related	O	O	B-T169
diseases	O	O	B-T047
.	O	O	O

We	O	O	O
report	O	O	O
these	O	O	O
studies	O	O	B-T062
in	O	O	O
final	O	O	O
section	O	O	O
of	O	O	O
this	O	O	O
review	O	O	B-T170
.	O	O	O

-DOCSTART- (28353042)

Beneficial	O	O	B-T080
Effects	O	O	I-T080
of	O	O	O
Phyllanthus	O	O	B-T002
amarus	O	O	I-T002
Against	O	O	O
High	O	O	B-T168
Fructose	O	O	I-T168
Diet	O	O	I-T168
Induced	O	O	O
Insulin	O	O	B-T046
Resistance	O	O	I-T046
and	O	O	O
Hepatic	O	O	B-T049
Oxidative	O	O	I-T049
Stress	O	O	I-T049
in	O	O	O
Male	O	O	B-T032
Wistar	O	O	O
Rats	O	O	O

Insulin	O	O	B-T046
resistance	O	O	I-T046
(	O	O	O
IR	O	O	B-T046
)	O	O	O
is	O	O	O
a	O	O	O
characteristic	O	O	O
feature	O	O	O
of	O	O	O
obesity	O	O	B-T047
,	O	O	O
type	O	O	B-T047
2	O	O	I-T047
diabetes	O	O	I-T047
mellitus	O	O	I-T047
,	O	O	O
and	O	O	O
cardiovascular	O	O	B-T047
diseases	O	O	I-T047
.	O	O	O

Emerging	O	O	O
evidence	O	O	O
suggests	O	O	O
that	O	O	O
the	O	O	O
high-fructose	O	O	B-T109
consumption	O	O	B-T039
is	O	O	O
a	O	O	O
potential	O	O	B-T080
and	O	O	O
important	O	O	O
factor	O	O	B-T169
responsible	O	O	O
for	O	O	O
the	O	O	O
rising	O	O	B-T169
incidence	O	O	I-T169
of	O	O	O
IR	O	O	B-T046
.	O	O	O

The	O	O	O
present	O	O	O
study	O	O	B-T062
investigates	O	O	B-T169
the	O	O	O
beneficial	O	O	B-T080
effects	O	O	I-T080
of	O	O	O
aqueous	O	O	B-T167
extract	O	O	I-T167
of	O	O	O
Phyllanthus	O	O	B-T002
amaru	O	O	I-T002
s	O	O	O
(	O	O	O
PAAE	O	O	B-T167
)	O	O	O
on	O	O	O
IR	O	O	B-T046
and	O	O	O
oxidative	O	O	B-T049
stress	O	O	I-T049
in	O	O	O
high-fructose	O	O	B-T109
(	O	O	O
HF	O	O	B-T109
)	O	O	O
fed	O	O	O
male	O	O	B-T032
Wistar	O	O	B-T015
rats	O	O	I-T015
.	O	O	O

HF	O	O	B-T168
diet	O	O	I-T168
(	O	O	O
66	O	O	O
%	O	O	O
of	O	O	O
fructose	O	O	O
)	O	O	O
and	O	O	O
PAAE	O	O	B-T167
(	O	O	O
200	O	O	O
mg/kg	O	O	O
body	O	O	O
weight/day	O	O	O
)	O	O	O
were	O	O	O
given	O	O	O
concurrently	O	O	B-T079
to	O	O	O
the	O	O	O
rats	O	O	B-T015
for	O	O	O
a	O	O	O
period	O	O	O
of	O	O	O
60	O	O	O
days	O	O	O
.	O	O	O

Fructose-fed	O	O	B-T080
rats	O	O	B-T015
showed	O	O	O
weight	O	O	B-T033
gain	O	O	I-T033
,	O	O	O
hyperglycemia	O	O	B-T047
,	O	O	O
hyperinsulinemia	O	O	B-T047
,	O	O	O
impaired	O	O	B-T047
glucose	O	O	I-T047
tolerance	O	O	I-T047
,	O	O	O
impaired	O	O	B-T046
insulin	O	O	I-T046
sensitivity	O	O	I-T046
,	O	O	O
dyslipidemia	O	O	B-T047
,	O	O	O
hyperleptinemia	O	O	B-T047
,	O	O	O
and	O	O	O
hypoadiponectinemia	O	O	B-T047
(	O	O	O
P	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
after	O	O	O
60	O	O	O
days	O	O	O
.	O	O	O

Co-administration	O	O	B-T061
of	O	O	O
PAAE	O	O	B-T167
along	O	O	O
with	O	O	O
HF	O	O	B-T168
diet	O	O	I-T168
significantly	O	O	O
ameliorated	O	O	O
all	O	O	O
these	O	O	O
alterations	O	O	B-T078
.	O	O	O

Regarding	O	O	O
hepatic	O	O	B-T029
antioxidant	O	O	B-T044
status	O	O	I-T044
,	O	O	O
higher	O	O	O
lipid	O	O	B-T044
peroxidation	O	O	I-T044
and	O	O	O
protein	O	O	B-T044
oxidation	O	O	I-T044
,	O	O	O
lower	O	O	O
reduced	O	O	B-T034
glutathione	O	O	I-T034
levels	O	O	O
and	O	O	O
lower	O	O	B-T038
activities	O	O	I-T038
of	O	O	O
enzymatic	O	O	B-T121
antioxidants	O	O	I-T121
,	O	O	O
and	O	O	O
the	O	O	O
histopathological	O	O	B-T169
changes	O	O	I-T169
like	O	O	O
mild	O	O	O
to	O	O	O
severe	O	O	O
distortion	O	O	B-T080
of	O	O	O
the	O	O	O
normal	O	O	O
architecture	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
the	O	O	O
prominence	O	O	O
and	O	O	O
widening	O	O	O
of	O	O	O
the	O	O	O
liver	O	O	B-T023
sinusoids	O	O	I-T023
observed	O	O	O
in	O	O	O
the	O	O	O
HF	O	O	B-T168
diet	O	O	I-T168
-fed	O	O	O
rats	O	O	B-T015
were	O	O	O
significantly	O	O	O
prevented	O	O	O
by	O	O	O
PAAE	O	O	B-T167
treatment	O	O	B-T061
.	O	O	O

These	O	O	O
findings	O	O	O
indicate	O	O	O
that	O	O	O
PAAE	O	O	B-T167
is	O	O	O
beneficial	O	O	O
in	O	O	O
improving	O	O	O
insulin	O	O	B-T046
sensitivity	O	O	I-T046
and	O	O	O
attenuating	O	O	O
metabolic	O	O	B-T047
syndrome	O	O	I-T047
and	O	O	O
hepatic	O	O	B-T049
oxidative	O	O	I-T049
stress	O	O	I-T049
in	O	O	O
fructose-fed	O	O	B-T080
rats	O	O	B-T015
.	O	O	O

-DOCSTART- (28356035)

Environmental	O	O	B-T169
factors	O	O	I-T169
and	O	O	O
hypertension	O	O	O

Environmental	O	O	B-T169
factors	O	O	I-T169
are	O	O	O
a	O	O	O
major	O	O	O
cause	O	O	O
of	O	O	O
poor	O	O	B-T033
health	O	O	I-T033
worldwide	O	O	B-T098
.	O	O	O

The	O	O	O
most	O	O	O
solid	O	O	O
evidence	O	O	B-T078
is	O	O	O
for	O	O	O
air	O	O	B-T069
pollution	O	O	I-T069
,	O	O	O
leading	O	O	O
to	O	O	O
increased	O	O	O
disability-adjusted	O	O	B-UnknownType
life	O	O	I-UnknownType
years	O	O	I-UnknownType
.	O	O	O

Outdoor	O	O	B-UnknownType
temperature	O	O	B-T081
and	O	O	O
other	O	O	O
seasonal	O	O	B-T079
climate	O	O	B-T070
changes	O	O	I-T070
may	O	O	O
also	O	O	O
influence	O	O	O
cardiovascular	O	O	B-T029
health	O	O	B-T078
,	O	O	O
according	O	O	O
to	O	O	O
their	O	O	O
direct	O	O	O
modulation	O	O	O
of	O	O	O
air	O	O	B-T069
pollution	O	O	I-T069
.	O	O	O

Moreover	O	O	O
,	O	O	O
an	O	O	O
increasing	O	O	O
body	O	O	O
of	O	O	O
evidence	O	O	B-T078
associates	O	O	O
environmental	O	O	B-T037
exposure	O	O	I-T037
to	O	O	O
noise	O	O	B-T067
with	O	O	O
poor	O	O	B-T033
cardiovascular	O	O	I-T033
outcome	O	O	I-T033
,	O	O	O
and	O	O	O
in	O	O	O
particular	O	O	O
with	O	O	O
hypertension	O	O	B-T047
.	O	O	O

This	O	O	O
review	O	O	O
is	O	O	O
aimed	O	O	O
at	O	O	O
reviewing	O	O	O
current	O	O	O
evidence	O	O	B-T078
about	O	O	O
the	O	O	O
role	O	O	O
of	O	O	O
these	O	O	O
environmental	O	O	B-T169
factors	O	O	I-T169
in	O	O	O
cardiovascular	O	O	B-T047
disease	O	O	I-T047
and	O	O	O
specifically	O	O	O
hypertension	O	O	B-T047
.	O	O	O

In	O	O	O
particular	O	O	O
,	O	O	O
the	O	O	O
impact	O	O	B-T080
of	O	O	O
air	O	O	B-T069
pollution	O	O	I-T069
,	O	O	O
with	O	O	O
its	O	O	O
short-term	O	O	B-T079
and	O	O	O
long-term	O	O	B-T067
effects	O	O	I-T067
,	O	O	O
the	O	O	O
outdoor	O	O	B-UnknownType
temperature	O	O	B-T081
and	O	O	O
noise	O	O	B-T069
pollution	O	O	I-T069
will	O	O	O
be	O	O	O
investigated	O	O	O
.	O	O	O

People	O	O	B-T098
belonging	O	O	O
to	O	O	O
low	O	O	B-T080
social	O	O	B-T080
classes	O	O	I-T080
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
children	O	O	B-T100
,	O	O	O
women	O	O	B-T098
,	O	O	O
older	O	O	B-T098
people	O	O	I-T098
and	O	O	O
those	O	O	O
with	O	O	O
established	O	O	O
cardiovascular	O	O	B-T047
diseases	O	O	I-T047
,	O	O	O
seem	O	O	O
to	O	O	O
have	O	O	O
a	O	O	O
greater	O	O	O
susceptibility	O	O	B-T169
to	O	O	O
the	O	O	O
effects	O	O	B-T080
of	O	O	O
environmental	O	O	B-T033
stressors	O	O	I-T033
,	O	O	O
recalling	O	O	O
the	O	O	O
concept	O	O	B-T078
of	O	O	O
"	O	O	O
environmental	O	O	B-T078
justice	O	O	I-T078
"	O	O	O
.	O	O	O

The	O	O	O
accumulating	O	O	O
strong	O	O	O
scientific	O	O	O
evidence	O	O	B-T078
may	O	O	O
thus	O	O	O
support	O	O	O
public	O	O	B-T064
health	O	O	B-T078
policies	O	O	I-T064
aimed	O	O	O
at	O	O	O
reducing	O	O	O
social	O	O	B-T080
inequalities	O	O	I-T080
in	O	O	O
cardiovascular	O	O	B-T029
health	O	O	O
.	O	O	O

-DOCSTART- (28356129)

The	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
probiotic	O	O	B-T007
and	O	O	O
synbiotic	O	O	B-T168
supplementation	O	O	B-T061
on	O	O	O
metabolic	O	O	B-T047
syndrome	O	O	I-T047
indices	O	O	B-T078
in	O	O	O
adults	O	O	B-T100
at	O	O	O
risk	O	O	B-T078
of	O	O	O
type	O	O	B-T047
2	O	O	I-T047
diabetes	O	O	I-T047
:	O	O	O
study	O	O	B-T170
protocol	O	O	I-T170
for	O	O	O
a	O	O	O
randomized	O	O	O
controlled	O	O	O
trial	O	O	O

The	O	O	O
incidence	O	O	B-T081
of	O	O	O
type	O	O	B-T047
2	O	O	I-T047
diabetes	O	O	I-T047
,	O	O	O
cardiovascular	O	O	B-T047
diseases	O	O	I-T047
,	O	O	O
and	O	O	O
obesity	O	O	B-T047
has	O	O	O
been	O	O	O
rising	O	O	B-T169
dramatically	O	O	O
;	O	O	O
however	O	O	O
,	O	O	O
their	O	O	O
pathogenesis	O	O	B-T046
is	O	O	O
particularly	O	O	O
intriguing	O	O	B-T041
.	O	O	O

Recently	O	O	O
,	O	O	O
dysbiosis	O	O	B-T046
of	O	O	O
the	O	O	O
intestinal	O	O	B-T001
microbiota	O	O	I-T001
has	O	O	O
emerged	O	O	O
as	O	O	O
a	O	O	O
new	O	O	B-T080
candidate	O	O	B-T078
that	O	O	O
may	O	O	O
be	O	O	O
linked	O	O	O
to	O	O	O
metabolic	O	O	B-T047
diseases	O	O	I-T047
.	O	O	O

We	O	O	O
hypothesize	O	O	O
that	O	O	O
selective	O	O	O
modulation	O	O	O
of	O	O	O
the	O	O	O
intestinal	O	O	B-T001
microbiota	O	O	I-T001
by	O	O	O
probiotic	O	O	B-T007
or	O	O	O
synbiotic	O	O	B-T168
supplementation	O	O	B-T061
may	O	O	B-T080
improve	O	O	I-T080
metabolic	O	O	B-T047
dysfunction	O	O	I-T047
and	O	O	O
prevent	O	O	B-T080
diabetes	O	O	B-T047
in	O	O	O
prediabetics	O	O	B-T047
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
a	O	O	O
synthesis	O	O	B-T052
and	O	O	O
study	O	O	O
of	O	O	O
synbiotics	O	O	B-T168
will	O	O	O
be	O	O	O
carried	O	O	B-T052
out	O	O	O
for	O	O	O
the	O	O	O
first	O	O	O
time	O	O	O
in	O	O	O
Iran	O	O	B-T083
.	O	O	O

In	O	O	O
a	O	O	O
randomized	O	O	B-T062
triple-blind	O	O	I-T062
controlled	O	O	I-T062
clinical	O	O	I-T062
trial	O	O	I-T062
,	O	O	O
120	O	O	O
adults	O	O	B-T100
with	O	O	O
impaired	O	O	B-T047
glucose	O	O	I-T047
tolerance	O	O	I-T047
based	O	O	O
on	O	O	O
the	O	O	O
inclusion	O	O	B-T080
criteria	O	O	I-T080
will	O	O	O
be	O	O	O
selected	O	O	B-T052
by	O	O	O
a	O	O	O
simple	O	O	O
random	O	O	B-T080
sampling	O	O	B-T170
method	O	O	I-T170
and	O	O	O
will	O	O	O
be	O	O	O
randomly	O	O	B-T080
allocated	O	O	B-T052
to	O	O	O
6	O	O	O
months	O	O	B-T079
of	O	O	O
6	O	O	O
g/d	O	O	O
probiotic	O	O	B-T007
,	O	O	O
synbiotic	O	O	B-T168
or	O	O	O
placebo	O	O	B-T122
.	O	O	O

The	O	O	O
fecal	O	O	B-T031
abundance	O	O	B-T080
of	O	O	O
bacteria	O	O	B-T007
,	O	O	O
blood	O	O	B-T040
pressure	O	O	I-T040
,	O	O	O
height	O	O	B-T032
,	O	O	O
weight	O	O	B-T032
,	O	O	O
and	O	O	O
waist	O	O	B-T201
and	O	O	O
hip	O	O	B-T201
circumferences	O	O	I-T201
will	O	O	O
be	O	O	O
measured	O	O	B-T080
at	O	O	O
baseline	O	O	B-T081
and	O	O	O
following	O	O	B-T079
treatment	O	O	B-T061
.	O	O	O

Also	O	O	O
,	O	O	O
plasma	O	O	B-T059
lipid	O	O	I-T059
profiles	O	O	I-T059
,	O	O	O
HbA1C	O	O	B-T116
,	O	O	O
fasting	O	O	B-T059
plasma	O	O	I-T059
glucose	O	O	I-T059
,	O	O	O
and	O	O	O
insulin	O	O	B-T116
levels	O	O	B-T080
,	O	O	O
will	O	O	O
be	O	O	O
measured	O	O	B-T080
and	O	O	O
insulin	O	O	B-T059
resistance	O	O	I-T059
(	O	O	O
HOMA-IR	O	O	B-T059
)	O	O	O
and	O	O	O
beta-cell	O	O	B-T059
function	O	O	I-T059
(	O	O	O
HOMA-B	O	O	B-T059
)	O	O	O
will	O	O	O
be	O	O	O
calculated	O	O	B-T052
at	O	O	O
baseline	O	O	B-T081
and	O	O	O
will	O	O	O
be	O	O	O
repeated	O	O	B-T169
at	O	O	O
months	O	O	B-T079
3	O	O	O
,	O	O	O
6	O	O	O
,	O	O	O
12	O	O	O
,	O	O	O
and	O	O	O
18	O	O	O
.	O	O	O

The	O	O	O
data	O	O	B-T078
will	O	O	O
be	O	O	O
compared	O	O	B-T052
within	O	O	O
and	O	O	O
between	O	O	O
groups	O	O	B-UnknownType
using	O	O	B-T169
statistical	O	O	B-T062
methods	O	O	I-T062
.	O	O	O

The	O	O	O
results	O	O	B-T169
of	O	O	O
this	O	O	O
trial	O	O	B-T062
could	O	O	O
contribute	O	O	B-T052
to	O	O	O
the	O	O	O
evidence-based	O	O	B-T170
clinical	O	O	I-T170
guidelines	O	O	I-T170
that	O	O	O
address	O	O	O
gut	O	O	B-T001
microbiota	O	O	I-T001
manipulation	O	O	B-T061
to	O	O	O
maximize	O	O	B-T169
health	O	O	B-T081
benefits	O	O	I-T081
in	O	O	O
prevention	O	O	B-T061
and	O	O	O
management	O	O	B-T058
of	O	O	O
metabolic	O	O	B-T047
syndrome	O	O	I-T047
in	O	O	O
prediabetes	O	O	B-T047
.	O	O	O

Iranian	O	O	B-T170
Registry	O	O	I-T170
of	O	O	O
Clinical	O	O	B-T062
Trials	O	O	I-T062
:	O	O	O
IRCT201511032321N2	O	O	B-T170
.	O	O	O

Registered	O	O	O
on	O	O	O
27	O	O	O
February	O	O	O
2016	O	O	O
.	O	O	O

-DOCSTART- (28356622)

Evaluation	O	O	B-T052
of	O	O	O
the	O	O	O
relationship	O	O	B-T080
between	O	O	O
the	O	O	O
static	O	O	B-T080
measurement	O	O	B-T169
of	O	O	O
transverse	O	O	B-T029
arch	O	O	I-T029
flexibility	O	O	B-T080
of	O	O	O
the	O	O	O
forefoot	O	O	B-T023
and	O	O	O
gait	O	O	B-T033
parameters	O	O	B-T077
in	O	O	O
healthy	O	O	O
subjects	O	O	O

[	O	O	O
Purpose	O	O	B-UnknownType
]	O	O	O
To	O	O	O
investigate	O	O	B-T169
the	O	O	O
relationship	O	O	B-T080
between	O	O	O
the	O	O	O
static	O	O	B-T080
measurement	O	O	B-T169
of	O	O	O
the	O	O	O
transverse	O	O	B-T029
arch	O	O	I-T029
of	O	O	O
the	O	O	O
forefoot	O	O	B-T023
,	O	O	O
using	O	O	O
a	O	O	O
3-dimensional	O	O	B-T082
(	O	O	O
3D	O	O	B-T082
)	O	O	O
foot	O	O	B-T074
scanner	O	O	I-T074
,	O	O	O
and	O	O	O
kinetics	O	O	B-T070
and	O	O	O
kinematics	O	O	B-T091
of	O	O	O
gait	O	O	B-T033
parameters	O	O	B-T077
in	O	O	O
the	O	O	O
sagittal	O	O	B-T029
plane	O	O	I-T029
.	O	O	O

[	O	O	O
Subjects	O	O	B-T098
and	O	O	O
Methods	O	O	B-T170
]	O	O	O
Twenty	O	O	O
healthy	O	O	B-T098
subjects	O	O	I-T098
participated	O	O	O
in	O	O	O
this	O	O	O
study	O	O	B-T062
.	O	O	O

The	O	O	O
transverse	O	O	B-T029
arch	O	O	I-T029
of	O	O	O
the	O	O	O
forefoot	O	O	B-T023
was	O	O	O
measured	O	O	B-T080
under	O	O	O
three	O	O	O
conditions	O	O	B-T080
as	O	O	O
follows	O	O	O
:	O	O	O
condition	O	O	B-T080
1	O	O	O
,	O	O	O
sitting	O	O	B-T033
;	O	O	O
condition	O	O	O
2	O	O	O
,	O	O	O
standing	O	O	B-T082
;	O	O	O
and	O	O	O
condition	O	O	O
3	O	O	O
,	O	O	O
foot	O	O	B-T023
forward	O	O	B-T082
and	O	O	O
lower	O	O	B-T023
leg	O	O	I-T023
tilting	O	O	B-T080
anteriorly	O	O	B-T082
to	O	O	O
the	O	O	O
maximum	O	O	B-T081
position	O	O	B-T082
with	O	O	O
heel	O	O	B-T029
contact	O	O	B-T169
.	O	O	O

Gait	O	O	B-T033
parameters	O	O	B-T077
were	O	O	O
recorded	O	O	B-T081
using	O	O	O
a	O	O	O
3D	O	O	B-T073
motion	O	O	I-T073
analysis	O	O	I-T073
system	O	O	I-T073
and	O	O	O
force	O	O	B-T074
plate	O	O	I-T074
.	O	O	O

Correlation	O	O	B-T080
coefficients	O	O	B-T081
between	O	O	O
TAF	O	O	B-T080
for	O	O	O
each	O	O	O
comparison	O	O	B-T052
of	O	O	O
conditions	O	O	B-T080
and	O	O	O
gait	O	O	B-T033
parameters	O	O	B-T077
were	O	O	O
calculated	O	O	B-T052
using	O	O	O
the	O	O	O
Spearman	O	O	B-T062
correlation	O	O	I-T062
analysis	O	O	I-T062
.	O	O	O

[	O	O	O
Results	O	O	B-T169
]	O	O	O
Rates	O	O	B-T081
of	O	O	O
the	O	O	O
transverse	O	O	B-T029
arch	O	O	I-T029
of	O	O	O
the	O	O	O
forefoot	O	O	B-T023
width	O	O	B-T081
and	O	O	O
height	O	O	B-T032
between	O	O	O
condition	O	O	B-T080
2	O	O	O
and	O	O	O
condition	O	O	O
3	O	O	O
were	O	O	O
significantly	O	O	B-T080
correlated	O	O	I-T080
with	O	O	O
the	O	O	O
anterior	O	O	B-T082
and	O	O	O
posterior	O	O	B-T082
component	O	O	B-T077
of	O	O	O
ground	O	O	B-T067
reaction	O	O	I-T067
forces	O	O	I-T067
,	O	O	O
the	O	O	O
hip	O	O	B-T030
joint	O	O	I-T030
extension	O	O	B-T169
angle	O	O	B-T082
,	O	O	O
and	O	O	O
the	O	O	O
ankle	O	O	B-T029
plantar	O	O	B-T042
flexion	O	O	I-T042
moment	O	O	I-T042
.	O	O	O
[	O	O	O
Conclusion	O	O	B-T078
]	O	O	O
Our	O	O	O
study	O	O	B-T062
's	O	O	I-T062
findings	O	O	B-T033
indicated	O	O	B-T033
that	O	O	O
increased	O	O	B-T081
stiffness	O	O	B-T184
of	O	O	O
the	O	O	O
transverse	O	O	O
arch	O	O	O
of	O	O	O
the	O	O	O
forefoot	O	O	O
was	O	O	O
related	O	O	B-T080
to	O	O	O
the	O	O	O
increase	O	O	B-T169
in	O	O	O
ankle	O	O	O
plantar	O	O	B-T042
moment	O	O	I-T042
,	O	O	O
and	O	O	O
decreased	O	O	B-T081
stiffness	O	O	O
of	O	O	O
the	O	O	O
transverse	O	O	O
arch	O	O	O
of	O	O	O
the	O	O	O
forefoot	O	O	O
was	O	O	O
related	O	O	O
to	O	O	O
the	O	O	O
increase	O	O	O
in	O	O	O
hip	O	O	O
joint	O	O	O
extension	O	O	O
angle	O	O	O
during	O	O	O
gait	O	O	B-T033
.	O	O	O

-DOCSTART- (28358612)

Management	O	O	B-T058
and	O	O	O
Case	O	O	B-T062
Outcome	O	O	I-T062
of	O	O	O
Gastric	O	O	B-T020
Impaction	O	O	I-T020
in	O	O	O
Four	O	O	O
Raptors	O	O	B-T012
:	O	O	O
A	O	O	O
Case	O	O	O
Series	O	O	O

Four	O	O	O
captive	O	O	O
raptors	O	O	B-T012
,	O	O	O
an	O	O	O
American	O	O	B-T012
kestrel	O	O	I-T012
(	O	O	O
Falco	O	O	B-T012
sparverius	O	O	I-T012
)	O	O	O
,	O	O	O
peregrine	O	O	B-T012
falcon	O	O	I-T012
(	O	O	O
Falco	O	O	B-T012
peregrinus	O	O	I-T012
)	O	O	O
,	O	O	O
golden	O	O	B-T012
eagle	O	O	I-T012
(	O	O	O
Aquila	O	O	B-T012
chrysaetos	O	O	I-T012
)	O	O	O
,	O	O	O
and	O	O	O
barn	O	O	B-T012
owl	O	O	I-T012
(	O	O	O
Tyto	O	O	B-T012
alba	O	O	I-T012
)	O	O	O
,	O	O	O
were	O	O	O
diagnosed	O	O	B-T033
with	O	O	O
ventricular	O	O	B-T023
and/or	O	O	O
proventricular	O	O	B-T023
foreign	O	O	B-T037
material	O	O	I-T037
impactions	O	O	B-T046
consisting	O	O	O
of	O	O	O
artificial	O	O	B-T167
turf	O	O	I-T167
substrate	O	O	I-T167
,	O	O	O
paper	O	O	B-T073
and	O	O	O
plastic	O	O	B-T073
substrate	O	O	I-T073
,	O	O	O
grass	O	O	B-T002
,	O	O	O
and	O	O	O
newspaper	O	O	B-T073
.	O	O	O

Partial	O	O	B-T047
or	O	O	I-T047
total	O	O	I-T047
anorexia	O	O	I-T047
was	O	O	O
reported	O	O	O
in	O	O	O
all	O	O	O
birds	O	O	B-T012
and	O	O	O
decreased	O	O	B-T081
casting	O	O	B-T061
in	O	O	O
2	O	O	O
birds	O	O	O
.	O	O	O

Survey	O	O	B-T170
radiographs	O	O	B-T060
confirmed	O	O	O
presence	O	O	O
of	O	O	O
gastric	O	O	B-T023
enlargement	O	O	B-T061
in	O	O	O
all	O	O	O
4	O	O	O
birds	O	O	B-T012
.	O	O	O

The	O	O	O
kestrel	O	O	B-T012
and	O	O	O
eagle	O	O	B-T012
were	O	O	O
treated	O	O	B-T169
unsuccessfully	O	O	O
with	O	O	O
gastroscopy	O	O	B-T060
and	O	O	O
gastric	O	O	B-T061
lavage	O	O	I-T061
,	O	O	O
respectively	O	O	O
,	O	O	O
followed	O	O	O
by	O	O	O
surgical	O	O	B-T033
intervention	O	O	I-T033
to	O	O	O
remove	O	O	O
the	O	O	O
ventricular	O	O	B-T023
impactions	O	O	B-T046
.	O	O	O

Both	O	O	O
birds	O	O	B-T012
died	O	O	B-T033
of	O	O	I-T033
undetermined	O	O	I-T033
causes	O	O	I-T033
after	O	O	B-T079
surgery	O	O	I-T079
.	O	O	O

The	O	O	O
peregrine	O	O	B-T012
falcon	O	O	I-T012
died	O	O	B-T033
before	O	O	B-T061
medical	O	O	I-T061
or	O	O	O
surgical	O	O	B-T033
intervention	O	O	I-T033
was	O	O	O
started	O	O	O
,	O	O	O
and	O	O	O
the	O	O	O
owl	O	O	B-T012
was	O	O	O
managed	O	O	O
successfully	O	O	O
with	O	O	O
oral	O	O	B-T200
mineral	O	O	I-T200
oil	O	O	I-T200
and	O	O	O
liquid	O	O	B-T061
diet	O	O	I-T061
to	O	O	O
facilitate	O	O	B-T037
egestion	O	O	I-T037
of	O	O	I-T037
the	O	O	I-T037
foreign	O	O	I-T037
material	O	O	I-T037
as	O	O	O
a	O	O	O
pellet	O	O	B-T081
.	O	O	O

Lead	O	O	B-T037
poisoning	O	O	I-T037
was	O	O	O
suspected	O	O	O
as	O	O	O
the	O	O	O
predisposing	O	O	B-T079
cause	O	O	I-T079
for	O	O	O
foreign	O	O	B-T037
body	O	O	I-T037
ingestion	O	O	I-T037
in	O	O	O
the	O	O	O
eagle	O	O	B-T012
,	O	O	O
but	O	O	O
underlying	O	O	B-T169
causes	O	O	I-T169
for	O	O	O
pica	O	O	B-T048
in	O	O	O
the	O	O	O
other	O	O	O
birds	O	O	B-T012
were	O	O	O
not	O	O	B-T080
determined	O	O	I-T080
.	O	O	O

Radiographs	O	O	B-T060
can	O	O	O
provide	O	O	O
useful	O	O	O
diagnostic	O	O	B-T058
information	O	O	I-T058
in	O	O	O
sick	O	O	B-T184
raptors	O	O	B-T012
that	O	O	O
exhibit	O	O	B-T184
vomiting	O	O	I-T184
or	O	O	O
changes	O	O	B-T033
in	O	O	I-T033
appetite	O	O	I-T033
or	O	O	O
casting	O	O	B-T061
frequency	O	O	I-T061
,	O	O	O
and	O	O	O
may	O	O	O
help	O	O	O
guide	O	O	O
treatment	O	O	B-T061
decisions	O	O	I-T061
of	O	O	O
impacted	O	O	B-T169
birds	O	O	B-T012
.	O	O	O

Careful	O	O	O
consideration	O	O	B-T033
of	O	O	O
substrate	O	O	B-T167
,	O	O	O
enrichment	O	O	B-T073
items	O	O	I-T073
,	O	O	O
and	O	O	O
access	O	O	O
to	O	O	O
potential	O	O	B-T080
foreign	O	O	B-T037
material	O	O	I-T037
that	O	O	I-T037
could	O	O	I-T037
be	O	O	I-T037
ingested	O	O	I-T037
may	O	O	O
be	O	O	O
the	O	O	O
best	O	O	O
pre-emptive	O	O	O
management	O	O	B-T058
strategy	O	O	I-T058
in	O	O	O
captive	O	O	O
raptors	O	O	B-T012
.	O	O	O

-DOCSTART- (28358712)

Anti-inflammatory	O	O	B-T033
activity	O	O	B-T052
of	O	O	O
Elaeagnus	O	O	B-T002
angustifolia	O	O	I-T002
fruit	O	O	B-T109
extract	O	O	I-T109
on	O	O	O
rat	O	O	B-T015
paw	O	O	B-T023
edema	O	O	O

The	O	O	O
Elaeagnus	O	O	B-T002
angustifolia	O	O	I-T002
fruit	O	O	B-T168
has	O	O	O
been	O	O	O
traditionally	O	O	O
used	O	O	O
in	O	O	O
Iranian	O	O	B-T083
herbal	O	O	B-T121
medicine	O	O	I-T121
to	O	O	O
treat	O	O	B-T169
diarrhea	O	O	B-T184
and	O	O	O
rheumatoid	O	O	B-T047
arthritis	O	O	I-T047
.	O	O	O

In	O	O	O
the	O	O	O
present	O	O	O
study	O	O	O
,	O	O	O
the	O	O	O
effects	O	O	B-T080
of	O	O	O
E.	O	O	B-T002
angustifolia	O	O	I-T002
fruit	O	O	B-T109
extract	O	O	I-T109
on	O	O	O
the	O	O	O
acute	O	O	B-T079
and	O	O	O
chronic	O	O	B-T079
phases	O	O	I-T079
of	O	O	O
formalin	O	O	B-T109
-	O	O	O
induced	O	O	B-T169
rat	O	O	B-T015
paw	O	O	B-T023
edema	O	O	B-T184
were	O	O	O
examined	O	O	B-T033
.	O	O	O

The	O	O	O
acute	O	O	B-T079
and	O	O	O
chronic	O	O	B-T079
anti-inflammatory	O	O	B-T033
effects	O	O	I-T033
of	O	O	O
E.	O	O	B-T002
angustifolia	O	O	I-T002
fruit	O	O	B-T109
extract	O	O	I-T109
were	O	O	O
investigated	O	O	B-T169
through	O	O	O
the	O	O	O
subcutaneous	O	O	B-T169
injection	O	O	I-T169
of	O	O	O
100	O	O	O
Î¼L	O	O	O
of	O	O	O
formalin	O	O	B-T109
(	O	O	O
2.5	O	O	O
%	O	O	O
)	O	O	O
into	O	O	O
a	O	O	O
rat	O	O	B-T015
's	O	O	I-T015
hind	O	O	O
paw	O	O	B-T023
.	O	O	O

Thirty	O	O	B-T079
minutes	O	O	I-T079
before	O	O	O
the	O	O	O
procedure	O	O	B-T169
,	O	O	O
the	O	O	O
experimental	O	O	B-T080
groups	O	O	B-T078
were	O	O	O
treated	O	O	B-T169
intraperitoneally	O	O	B-T082
with	O	O	O
hydroalcoholic	O	O	B-T109
fruit	O	O	I-T109
extracts	O	O	I-T109
of	O	O	O
E.	O	O	B-T002
angustifolia	O	O	I-T002
(	O	O	O
concentrations	O	O	B-T081
of	O	O	O
100	O	O	O
,	O	O	O
300	O	O	O
,	O	O	O
700	O	O	O
,	O	O	O
and	O	O	O
1000	O	O	O
mg/kg	O	O	O
)	O	O	O
;	O	O	O
sodium	O	O	B-T109
salicylate	O	O	I-T109
(	O	O	O
SS	O	O	B-T109
,	O	O	O
400	O	O	O
mg/kg	O	O	O
)	O	O	O
and	O	O	O
distilled	O	O	B-T121
water	O	O	I-T121
were	O	O	O
used	O	O	O
as	O	O	O
positive	O	O	B-T033
and	O	O	O
negative	O	O	B-T033
control	O	O	B-T096
groups	O	O	I-T096
,	O	O	O
respectively	O	O	O
.	O	O	O

Treatment	O	O	B-T169
with	O	O	O
SS	O	O	B-T109
and	O	O	O
the	O	O	O
fruit	O	O	B-T109
extracts	O	O	I-T109
were	O	O	O
performed	O	O	B-T169
daily	O	O	B-T079
for	O	O	O
8	O	O	O
days	O	O	B-T079
,	O	O	O
and	O	O	O
the	O	O	O
degree	O	O	B-T081
of	O	O	O
edema	O	O	B-T184
was	O	O	O
measured	O	O	B-T080
by	O	O	O
using	O	O	O
mercury	O	O	B-T074
plethysmometer	O	O	I-T074
and	O	O	O
digital	O	O	B-T074
caliper	O	O	I-T074
.	O	O	O

In	O	O	O
the	O	O	O
acute	O	O	B-T079
anti-inflammatory	O	O	B-T033
study	O	O	B-T062
,	O	O	O
the	O	O	O
extract	O	O	B-T167
showed	O	O	O
a	O	O	O
significant	O	O	O
anti-inflammatory	O	O	B-T080
effect	O	O	I-T080
in	O	O	O
a	O	O	O
dose-dependent	O	O	B-T081
manner	O	O	O
.	O	O	O

The	O	O	O
results	O	O	B-T169
of	O	O	O
1000	O	O	O
mg/kg	O	O	O
of	O	O	O
the	O	O	O
extract	O	O	B-T167
was	O	O	O
significantly	O	O	O
different	O	O	B-T080
compared	O	O	B-T052
with	O	O	I-T052
the	O	O	O
negative	O	O	B-T033
control	O	O	B-T096
group	O	O	I-T096
(	O	O	O
p<0.05	O	O	O
)	O	O	O
and	O	O	O
was	O	O	O
comparable	O	O	O
to	O	O	O
sodium	O	O	B-T109
salicylate	O	O	I-T109
(	O	O	O
p<0.05	O	O	O
)	O	O	O
.	O	O	O

Results	O	O	B-T169
from	O	O	O
the	O	O	O
chronic	O	O	B-T079
study	O	O	B-T062
suggested	O	O	B-T078
that	O	O	O
E.	O	O	B-T002
angustifolia	O	O	I-T002
extract	O	O	B-T167
significantly	O	O	O
reduced	O	O	B-T080
paw	O	O	B-T023
edema	O	O	B-T184
and	O	O	O
inflammation	O	O	B-T046
in	O	O	O
a	O	O	O
dose-dependent	O	O	B-T081
manner	O	O	O
.	O	O	O

The	O	O	O
results	O	O	B-T169
also	O	O	O
showed	O	O	O
that	O	O	O
the	O	O	O
measurement	O	O	B-T169
by	O	O	O
digital	O	O	B-T074
caliper	O	O	I-T074
and	O	O	O
mercury	O	O	B-T074
plethysmometer	O	O	I-T074
were	O	O	O
both	O	O	O
reliable	O	O	O
and	O	O	O
might	O	O	O
be	O	O	O
applied	O	O	O
interchangeably	O	O	O
(	O	O	O
p<0.01	O	O	O
)	O	O	O
.	O	O	O

Phytochemical	O	O	B-T059
tests	O	O	I-T059
indicated	O	O	O
that	O	O	O
the	O	O	O
hydroalcoholic	O	O	B-T109
fruit	O	O	I-T109
extract	O	O	I-T109
of	O	O	O
E.	O	O	B-T002
angustifolia	O	O	I-T002
was	O	O	O
positive	O	O	B-T033
for	O	O	O
cardiac	O	O	B-T109
glycosides	O	O	I-T109
,	O	O	O
flavonoids	O	O	B-T109
,	O	O	O
terpenoids	O	O	B-T109
,	O	O	O
and	O	O	O
saponins	O	O	B-T109
.	O	O	O

Based	O	O	O
on	O	O	O
our	O	O	O
findings	O	O	B-T033
,	O	O	O
the	O	O	O
E.	O	O	B-T002
angustifolia	O	O	I-T002
fruit	O	O	B-T109
extract	O	O	I-T109
probably	O	O	O
has	O	O	O
acute	O	O	B-T079
and	O	O	O
chronic	O	O	B-T079
anti-inflammatory	O	O	B-T033
activities	O	O	B-T052
to	O	O	O
support	O	O	O
its	O	O	O
applications	O	O	O
in	O	O	O
folk	O	O	B-T061
medicine	O	O	I-T061
.	O	O	O

-DOCSTART- (28360122)

Increased	O	O	B-T081
cerebral	O	O	B-T032
blood	O	O	I-T032
volume	O	O	I-T032
pulsatility	O	O	B-T080
during	O	O	O
head-down	O	O	B-T082
tilt	O	O	I-T082
with	O	O	O
elevated	O	O	B-T033
carbon	O	O	I-T033
dioxide	O	O	I-T033
:	O	O	O
The	O	O	O
SPACECOT	O	O	O
Study	O	O	O

Astronauts	O	O	B-T097
aboard	O	O	O
the	O	O	O
International	O	O	O
Space	O	O	O
Station	O	O	O
(	O	O	O
ISS	O	O	O
)	O	O	O
have	O	O	O
exhibited	O	O	O
hyperopic	O	O	B-T047
shifts	O	O	I-T047
,	O	O	O
posterior	O	O	B-T082
eye	O	O	B-T023
globe	O	O	I-T023
flattening	O	O	B-T169
,	O	O	O
dilated	O	O	B-T033
optic	O	O	B-T023
nerve	O	O	I-T023
sheaths	O	O	I-T023
,	O	O	O
and	O	O	O
even	O	O	O
optic	O	O	B-T047
disc	O	O	I-T047
swelling	O	O	I-T047
from	O	O	O
spaceflight	O	O	B-T057
.	O	O	O

Elevated	O	O	B-T047
intracranial	O	O	I-T047
pressure	O	O	I-T047
(	O	O	O
ICP	O	O	B-T047
)	O	O	O
consequent	O	O	O
to	O	O	O
cephalad	O	O	B-T082
fluid	O	O	B-T039
shifts	O	O	I-T039
is	O	O	O
commonly	O	O	O
hypothesized	O	O	B-T078
as	O	O	O
contributing	O	O	O
to	O	O	O
these	O	O	O
ocular	O	O	B-T033
changes	O	O	I-T033
.	O	O	O

Head-down	O	O	B-T082
tilt	O	O	I-T082
(	O	O	O
HDT	O	O	B-T082
)	O	O	O
is	O	O	O
frequently	O	O	O
utilized	O	O	O
as	O	O	O
an	O	O	O
Earth	O	O	B-T083
-based	O	O	O
analog	O	O	O
to	O	O	O
study	O	O	O
similar	O	O	B-T080
fluid	O	O	B-T039
shifts	O	O	I-T039
.	O	O	O

Sealed	O	O	B-T082
environments	O	O	I-T082
like	O	O	O
the	O	O	O
ISS	O	O	O
also	O	O	O
exhibit	O	O	O
elevated	O	O	B-T080
carbon	O	O	B-T123
dioxide	O	O	I-T123
(	O	O	O
CO2	O	O	B-T123
)	O	O	O
,	O	O	O
a	O	O	O
potent	O	O	B-T080
arteriolar	O	O	B-T121
vasodilator	O	O	I-T121
that	O	O	O
could	O	O	O
further	O	O	O
affect	O	O	O
cerebral	O	O	B-T032
blood	O	O	I-T032
volume	O	O	I-T032
and	O	O	O
flow	O	O	B-T033
,	O	O	O
intracranial	O	O	B-T029
compliance	O	O	B-T033
,	O	O	O
and	O	O	O
ICP	O	O	B-T047
.	O	O	O

A	O	O	O
collaborative	O	O	B-T062
pilot	O	O	I-T062
study	O	O	I-T062
between	O	O	O
the	O	O	O
National	O	O	B-T093
Space	O	O	I-T093
Biomedical	O	O	I-T093
Research	O	O	I-T093
Institute	O	O	I-T093
and	O	O	O
the	O	O	O
German	O	O	B-T092
Aerospace	O	O	I-T092
Center	O	O	I-T092
tested	O	O	O
the	O	O	O
hypotheses	O	O	B-T078
that	O	O	O
:	O	O	O
(	O	O	O
1	O	O	O
)	O	O	O
HDT	O	O	B-T082
and	O	O	O
elevated	O	O	B-T080
CO2	O	O	B-T123
physiologically	O	O	B-T169
interact	O	O	B-T169
,	O	O	O
and	O	O	O
(	O	O	O
2	O	O	O
)	O	O	O
cerebrovascular	O	O	B-T080
pulsatility	O	O	B-T080
is	O	O	O
related	O	O	O
to	O	O	O
HDT	O	O	O
and/or	O	O	O
elevated	O	O	O
CO2	O	O	O
In	O	O	O
a	O	O	O
double-blind	O	O	B-T062
crossover	O	O	B-T062
study	O	O	I-T062
(	O	O	O
n=6	O	O	O
)	O	O	O
,	O	O	O
we	O	O	O
measured	O	O	O
cerebral	O	O	B-T032
blood	O	O	I-T032
volume	O	O	I-T032
(	O	O	O
CBV	O	O	B-T032
)	O	O	O
pulsatility	O	O	O
via	O	O	O
near-infrared	O	O	B-T059
spectroscopy	O	O	I-T059
,	O	O	O
alongside	O	O	O
non-invasive	O	O	B-T169
ICP	O	O	B-T047
and	O	O	O
intraocular	O	O	B-T042
pressure	O	O	I-T042
(	O	O	O
IOP	O	O	B-T042
)	O	O	O
during	O	O	O
28-hr	O	O	O
-12	O	O	O
Â°	O	O	O
HDT	O	O	O
at	O	O	O
both	O	O	O
nominal	O	O	B-T081
(	O	O	O
0.04	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
elevated	O	O	O
(	O	O	O
0.5	O	O	O
%	O	O	O
)	O	O	O
ambient	O	O	B-T080
CO2	O	O	O
In	O	O	O
our	O	O	O
cohort	O	O	B-T098
,	O	O	O
CBV	O	O	O
pulsatility	O	O	O
increased	O	O	B-T081
significantly	O	O	I-T081
over	O	O	O
time	O	O	O
at	O	O	O
cardiac	O	O	B-T082
frequencies	O	O	B-T079
(	O	O	O
0.031Â±0.009	O	O	O
Î¼M/hr	O	O	O
increase	O	O	B-T169
in	O	O	O
[	O	O	O
HbT	O	O	O
]	O	O	O
pulsatility	O	O	O
amplitude	O	O	B-T082
)	O	O	O
and	O	O	O
Mayer	O	O	B-T079
wave	O	O	I-T079
frequencies	O	O	I-T079
(	O	O	O
0.019Â±0.005	O	O	O
Î¼M/hr	O	O	O
increase	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
HDT	O	O	B-T082
-	O	O	O
CO2	O	O	B-T123
interaction	O	O	B-T169
on	O	O	O
pulsatility	O	O	B-T080
was	O	O	O
not	O	O	O
robust	O	O	O
,	O	O	O
but	O	O	O
rather	O	O	O
driven	O	O	O
by	O	O	O
an	O	O	O
individual	O	O	B-T098
.	O	O	O

Significant	O	O	O
differences	O	O	B-T080
between	O	O	O
atmospheres	O	O	B-T070
were	O	O	O
not	O	O	B-T033
detected	O	O	I-T033
in	O	O	O
ICP	O	O	B-T047
or	O	O	O
IOP	O	O	B-T042
.	O	O	O

Further	O	O	O
work	O	O	O
is	O	O	O
needed	O	O	O
to	O	O	O
reproduce	O	O	O
these	O	O	O
findings	O	O	O
in	O	O	O
a	O	O	O
larger	O	O	O
cohort	O	O	B-T098
,	O	O	O
to	O	O	O
determine	O	O	O
whether	O	O	O
a	O	O	O
"	O	O	B-T033
water	O	O	I-T033
hammer	O	O	I-T033
"	O	O	I-T033
effect	O	O	I-T033
in	O	O	O
cerebral	O	O	B-T023
pulsatility	O	O	B-T080
is	O	O	O
also	O	O	O
present	O	O	O
during	O	O	O
spaceflight	O	O	B-T057
,	O	O	O
and	O	O	O
whether	O	O	O
it	O	O	O
is	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
ocular	O	O	B-T033
changes	O	O	I-T033
in	O	O	O
astronauts	O	O	B-T097
.	O	O	O

-DOCSTART- (28360979)

Shift	O	O	B-T090
Work	O	O	I-T090
Is	O	O	O
Associated	O	O	B-T080
with	O	O	I-T080
Metabolic	O	O	B-T047
Syndrome	O	O	I-T047
in	O	O	O
Young	O	O	B-T079
Female	O	O	B-T032
Korean	O	O	B-T098
Workers	O	O	O

Shift	O	O	B-T090
work	O	O	I-T090
is	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
health	O	O	B-T078
problems	O	O	I-T078
,	O	O	O
including	O	O	O
metabolic	O	O	B-T047
syndrome	O	O	I-T047
.	O	O	O

This	O	O	O
study	O	O	B-T062
investigated	O	O	O
the	O	O	O
association	O	O	B-T080
between	O	O	O
shift	O	O	B-T090
work	O	O	I-T090
and	O	O	O
metabolic	O	O	B-T047
syndrome	O	O	I-T047
in	O	O	O
young	O	O	B-T079
workers	O	O	B-T090
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
3,317	O	O	O
subjects	O	O	B-T098
aged	O	O	O
20	O	O	O
-	O	O	O
40	O	O	O
years	O	O	O
enrolled	O	O	O
in	O	O	O
the	O	O	O
2011	O	O	O
-	O	O	O
2012	O	O	O
Korean	O	O	B-T098
National	O	O	B-T062
Health	O	O	I-T062
and	O	O	I-T062
Nutrition	O	O	I-T062
Examination	O	O	I-T062
Survey	O	O	I-T062
were	O	O	O
divided	O	O	O
into	O	O	O
shift	O	O	B-T033
and	O	O	O
day	O	O	B-T033
workers	O	O	I-T033
.	O	O	O

We	O	O	O
conducted	O	O	O
a	O	O	O
cross-sectional	O	O	B-T062
study	O	O	I-T062
and	O	O	O
calculated	O	O	B-T169
odds	O	O	B-T081
ratios	O	O	I-T081
using	O	O	O
multivariate	O	O	B-T081
logistic	O	O	B-UnknownType
regression	O	O	I-UnknownType
analysis	O	O	I-UnknownType
in	O	O	O
order	O	O	O
to	O	O	O
examine	O	O	B-T033
the	O	O	O
association	O	O	B-T080
between	O	O	O
shift	O	O	B-T090
work	O	O	I-T090
and	O	O	O
metabolic	O	O	B-T047
syndrome	O	O	I-T047
.	O	O	O

The	O	O	O
prevalence	O	O	B-T081
of	O	O	O
metabolic	O	O	B-T047
syndrome	O	O	I-T047
was	O	O	O
14.3	O	O	O
%	O	O	O
and	O	O	O
7.1	O	O	O
%	O	O	O
among	O	O	O
male	O	O	B-T032
and	O	O	O
female	O	O	B-T032
shift	O	O	B-T033
workers	O	O	I-T033
,	O	O	O
respectively	O	O	O
.	O	O	O

After	O	O	O
adjusting	O	O	O
for	O	O	O
confounding	O	O	B-T169
factors	O	O	I-T169
,	O	O	O
shift	O	O	B-T090
work	O	O	I-T090
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
metabolic	O	O	B-T047
syndrome	O	O	I-T047
in	O	O	O
female	O	O	B-T032
workers	O	O	B-T090
(	O	O	O
odds	O	O	B-T081
ratio	O	O	I-T081
,	O	O	O
2.53	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
confidence	O	O	B-T081
interval	O	O	I-T081
,	O	O	O
1.12	O	O	O
to	O	O	O
5.70	O	O	O
)	O	O	O
.	O	O	O

Shift	O	O	B-T090
work	O	O	I-T090
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
metabolic	O	O	B-T047
syndrome	O	O	I-T047
in	O	O	O
young	O	O	B-T079
women	O	O	B-T098
.	O	O	O

Timely	O	O	O
efforts	O	O	O
are	O	O	O
necessary	O	O	O
to	O	O	O
manage	O	O	B-T058
metabolic	O	O	B-T047
syndrome	O	O	I-T047
in	O	O	O
the	O	O	O
workplace	O	O	B-T082
.	O	O	O

-DOCSTART- (28362386)

In	O	O	B-T080
Vitro	O	O	I-T080
Differentiation	O	O	B-T043
of	O	O	O
Human	O	O	B-T016
Pluripotent	O	O	B-T025
Stem	O	O	I-T025
Cells	O	O	I-T025
into	O	O	O
Trophoblastic	O	O	O
Cells	O	O	O

The	O	O	O
placenta	O	O	B-T018
is	O	O	O
the	O	O	O
first	O	O	O
organ	O	O	B-T023
to	O	O	O
develop	O	O	O
during	O	O	O
embryogenesis	O	O	B-T042
and	O	O	O
is	O	O	O
required	O	O	O
for	O	O	O
the	O	O	O
survival	O	O	B-T052
of	O	O	O
the	O	O	O
developing	O	O	O
embryo	O	O	B-T018
.	O	O	O

The	O	O	O
placenta	O	O	B-T018
is	O	O	O
comprised	O	O	O
of	O	O	O
various	O	O	O
trophoblastic	O	O	B-T025
cells	O	O	I-T025
that	O	O	O
differentiate	O	O	B-T043
from	O	O	O
the	O	O	O
extra-embryonic	O	O	B-T043
trophectoderm	O	O	I-T043
cells	O	O	I-T043
of	O	O	O
the	O	O	O
preimplantation	O	O	B-T039
blastocyst	O	O	B-T018
.	O	O	O

As	O	O	O
such	O	O	O
,	O	O	O
our	O	O	O
understanding	O	O	O
of	O	O	O
the	O	O	O
early	O	O	O
differentiation	O	O	B-T043
events	O	O	I-T043
of	O	O	O
the	O	O	O
human	O	O	B-T016
placenta	O	O	B-T018
is	O	O	O
limited	O	O	O
because	O	O	O
of	O	O	O
ethical	O	O	O
and	O	O	O
legal	O	O	O
restrictions	O	O	O
on	O	O	O
the	O	O	O
isolation	O	O	B-T061
and	O	O	O
manipulation	O	O	B-T061
of	O	O	O
human	O	O	O
embryogenesis	O	O	B-T042
.	O	O	O

Human	O	O	B-T025
pluripotent	O	O	I-T025
stem	O	O	I-T025
cells	O	O	I-T025
(	O	O	O
hPSCs	O	O	B-T025
)	O	O	O
are	O	O	O
a	O	O	O
robust	O	O	O
model	O	O	B-T170
system	O	O	I-T170
for	O	O	O
investigating	O	O	O
human	O	O	B-T039
development	O	O	I-T039
and	O	O	O
can	O	O	O
also	O	O	O
be	O	O	O
differentiated	O	O	B-T043
in	O	O	B-T080
vitro	O	O	I-T080
into	O	O	O
trophoblastic	O	O	B-T025
cells	O	O	I-T025
that	O	O	O
express	O	O	O
markers	O	O	O
of	O	O	O
the	O	O	O
various	O	O	O
trophoblast	O	O	B-T025
cell	O	O	B-T025
types	O	O	I-T025
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
present	O	O	O
a	O	O	O
detailed	O	O	O
protocol	O	O	O
for	O	O	O
differentiating	O	O	B-T043
hPSCs	O	O	B-T025
into	O	O	O
trophoblastic	O	O	B-T025
cells	O	O	I-T025
using	O	O	O
bone	O	O	B-T116
morphogenic	O	O	I-T116
protein	O	O	I-T116
4	O	O	I-T116
and	O	O	O
inhibitors	O	O	B-T080
of	O	O	O
the	O	O	O
Activin	O	O	B-T116
/	O	O	O
Nodal	O	O	B-T044
signaling	O	O	I-T044
pathways	O	O	I-T044
.	O	O	O

This	O	O	O
protocol	O	O	O
generates	O	O	O
various	O	O	O
trophoblast	O	O	B-T025
cell	O	O	B-T025
types	O	O	I-T025
that	O	O	O
can	O	O	O
be	O	O	O
transfected	O	O	B-T063
with	O	O	O
siRNAs	O	O	B-T114
for	O	O	O
investigating	O	O	O
loss-of-function	O	O	O
phenotypes	O	O	B-T032
or	O	O	O
can	O	O	O
be	O	O	O
infected	O	O	B-T033
with	O	O	O
pathogens	O	O	B-T001
.	O	O	O

Additionally	O	O	O
,	O	O	O
hPSCs	O	O	B-T025
can	O	O	O
be	O	O	O
genetically	O	O	O
modified	O	O	O
and	O	O	O
then	O	O	O
differentiated	O	O	B-T043
into	O	O	O
trophoblast	O	O	B-T018
progenitors	O	O	B-T025
for	O	O	O
gain-of-function	O	O	O
analyses	O	O	O
.	O	O	O

This	O	O	O
in	O	O	B-T080
vitro	O	O	I-T080
differentiation	O	O	B-T043
method	O	O	I-T043
for	O	O	O
generating	O	O	O
human	O	O	B-T016
trophoblasts	O	O	B-T018
starting	O	O	O
from	O	O	O
hPSCs	O	O	B-T025
overcomes	O	O	O
the	O	O	O
ethical	O	O	O
and	O	O	O
legal	O	O	O
restrictions	O	O	B-T169
of	O	O	O
working	O	O	O
with	O	O	O
early	O	O	O
human	O	O	O
embryos	O	O	B-T018
,	O	O	O
and	O	O	O
this	O	O	O
system	O	O	O
can	O	O	O
be	O	O	O
used	O	O	O
for	O	O	O
a	O	O	O
variety	O	O	O
of	O	O	O
applications	O	O	O
,	O	O	O
including	O	O	O
drug	O	O	B-T062
discovery	O	O	I-T062
and	O	O	O
stem	O	O	B-T062
cell	O	O	I-T062
research	O	O	I-T062
.	O	O	O

-DOCSTART- (28364409)

Metabolomics	O	O	B-T123
analysis	O	O	B-T062
of	O	O	O
anaphylactoid	O	O	B-T046
reaction	O	O	I-T046
reveals	O	O	B-T080
its	O	O	O
mechanism	O	O	B-T169
in	O	O	O
a	O	O	O
rat	O	O	B-T015
model	O	O	O

Anaphylactoid	O	O	B-T046
reactions	O	O	I-T046
,	O	O	O
accounting	O	O	O
for	O	O	O
more	O	O	O
than	O	O	O
77	O	O	O
%	O	O	O
of	O	O	O
all	O	O	O
immune-mediated	O	O	B-T047
immediate	O	O	I-T047
hypersensitivity	O	O	I-T047
reactions	O	O	I-T047
,	O	O	O
have	O	O	O
become	O	O	O
a	O	O	O
serious	O	O	B-T080
threat	O	O	B-T078
to	O	O	O
public	O	O	B-T058
health	O	O	I-T058
,	O	O	O
but	O	O	O
their	O	O	O
effect	O	O	B-T080
mechanism	O	O	B-T169
is	O	O	O
not	O	O	B-T033
clear	O	O	I-T033
and	O	O	O
diagnostic	O	O	B-T060
tests	O	O	I-T060
are	O	O	O
limited	O	O	B-T169
.	O	O	O

Comprehensive	O	O	B-T080
metabolite	O	O	B-T123
analysis	O	O	B-T062
may	O	O	O
reveal	O	O	B-T080
the	O	O	O
anaphylactoid	O	O	B-T080
effect	O	O	B-T080
mechanism	O	O	B-T169
systematically	O	O	B-T169
and	O	O	O
provide	O	O	B-T052
reference	O	O	B-T081
for	O	O	O
future	O	O	B-T079
diagnostic	O	O	B-T169
purposes	O	O	B-T169
.	O	O	O

Plasma	O	O	B-T031
from	O	O	O
Brown	O	O	B-T015
Norway	O	O	I-T015
rats	O	O	I-T015
given	O	O	O
intravenous	O	O	B-T169
injection	O	O	I-T169
of	O	O	O
saline	O	O	B-T167
,	O	O	O
compound	O	O	B-T109
48/80	O	O	I-T109
(	O	O	O
2.5	O	O	O
mL/kg	O	O	O
)	O	O	O
or	O	O	O
ovalbumin	O	O	B-T116
(	O	O	O
20	O	O	O
mL/kg	O	O	O
)	O	O	O
in	O	O	O
20	O	O	O
s	O	O	O
for	O	O	O
the	O	O	O
first	O	O	O
time	O	O	O
was	O	O	O
used	O	O	B-T169
to	O	O	O
study	O	O	B-T062
the	O	O	O
effect	O	O	B-T080
mechanism	O	O	B-T169
of	O	O	O
anaphylactoid	O	O	B-T046
reactions	O	O	I-T046
through	O	O	O
metabolomics	O	O	B-T123
(	O	O	O
UPLC-qTOF-MS/MS	O	O	B-T063
)	O	O	O
.	O	O	O

Metabolomics	O	O	B-T123
integrated	O	O	O
with	O	O	O
proteomics	O	O	B-T170
data	O	O	I-T170
were	O	O	O
used	O	O	B-T169
to	O	O	O
analyze	O	O	B-T062
the	O	O	O
anaphylactoid	O	O	B-T080
pathways	O	O	B-T044
by	O	O	O
MetaboAnalyst	O	O	B-T170
followed	O	O	B-T079
by	O	O	I-T079
integrated	O	O	O
pathway	O	O	B-T170
analysis	O	O	I-T170
.	O	O	O

Thirty	O	O	O
metabolites	O	O	B-T123
were	O	O	O
identified	O	O	B-T080
through	O	O	O
the	O	O	O
METLIN	O	O	B-T170
database	O	O	I-T170
by	O	O	O
MS/MS	O	O	B-T063
and	O	O	O
18	O	O	O
of	O	O	O
them	O	O	O
were	O	O	O
confirmed	O	O	B-T080
by	O	O	I-T080
authentic	O	O	B-T081
standards	O	O	I-T081
.	O	O	O

The	O	O	O
results	O	O	B-T169
showed	O	O	O
that	O	O	O
adenosine	O	O	B-T114
,	O	O	O
histamine	O	O	B-T109
,	O	O	O
N-acetylhistamine	O	O	B-T109
,	O	O	O
N(Î±)-Î³-glutamylhistamine	O	O	B-T109
,	O	O	O
malate	O	O	B-T109
and	O	O	O
xanthine	O	O	B-T114
are	O	O	O
important	O	O	B-T080
indices	O	O	O
for	O	O	O
anaphylactoid	O	O	B-T046
reactions	O	O	I-T046
.	O	O	O

It	O	O	O
could	O	O	O
be	O	O	O
concluded	O	O	O
that	O	O	O
the	O	O	O
effect	O	O	B-T080
mechanism	O	O	B-T169
is	O	O	O
mainly	O	O	O
composed	O	O	O
of	O	O	O
histidine	O	O	B-T044
metabolism	O	O	I-T044
,	O	O	O
arachidonic	O	O	B-T044
acid	O	O	I-T044
metabolism	O	O	I-T044
,	O	O	O
energy	O	O	B-T039
metabolism	O	O	I-T039
,	O	O	O
purine	O	O	B-T169
metabolism	O	O	I-T169
and	O	O	O
other	O	O	B-T080
small	O	O	B-T081
molecules	O	O	B-T167
through	O	O	B-T169
30	O	O	O
metabolites	O	O	B-T123
.	O	O	O

Multiple	O	O	B-UnknownType
linear	O	O	I-UnknownType
regression	O	O	I-UnknownType
analysis	O	O	I-UnknownType
indicated	O	O	B-T033
that	O	O	O
not	O	O	B-T169
only	O	O	B-T081
histamine	O	O	B-T109
but	O	O	O
also	O	O	O
N(Î±)-Î³-glutamylhistamine	O	O	B-T109
and	O	O	O
arachidonic	O	O	B-T109
acid	O	O	I-T109
could	O	O	O
be	O	O	O
used	O	O	B-T169
to	O	O	O
evaluate	O	O	O
anaphylactoid	O	O	B-T080
symptoms	O	O	B-T184
of	O	O	O
animals	O	O	B-T008
.	O	O	O

Furthermore	O	O	O
,	O	O	O
the	O	O	O
citrate	O	O	B-T044
cycle	O	O	I-T044
,	O	O	O
histidine	O	O	B-T044
metabolism	O	O	I-T044
and	O	O	O
arachidonic	O	O	B-T044
acid	O	O	I-T044
metabolism	O	O	I-T044
could	O	O	O
be	O	O	O
the	O	O	O
main	O	O	B-T080
pathways	O	O	B-T044
of	O	O	O
anaphylactoid	O	O	B-T046
reactions	O	O	I-T046
as	O	O	O
determined	O	O	B-T080
by	O	O	I-T080
MetaboAnalyst	O	O	B-T170
.	O	O	O

The	O	O	O
results	O	O	B-T169
may	O	O	O
provide	O	O	B-T052
a	O	O	O
reference	O	O	B-T170
to	O	O	O
improve	O	O	B-T033
diagnostic	O	O	B-T080
accuracy	O	O	I-T080
and	O	O	O
predict	O	O	B-T078
and	O	O	O
monitor	O	O	O
treatment	O	O	B-T080
efficacy	O	O	I-T080
in	O	O	O
anaphylactoid	O	O	B-T046
reactions	O	O	I-T046
in	O	O	O
the	O	O	O
clinical	O	O	B-T082
setting	O	O	I-T082
.	O	O	O

-DOCSTART- (28364434)

The	O	O	O
Prevalence	O	O	B-T081
of	O	O	O
Sleep	O	O	B-T047
Apnea	O	O	I-T047
in	O	O	O
Type	O	O	B-T190
B	O	O	I-T190
Aortic	O	O	I-T190
Dissection	O	O	I-T190
:	O	O	O
Implications	O	O	O
for	O	O	O
False	O	O	B-T080
Lumen	O	O	B-T030
Thrombosis	O	O	O

Obstructive	O	O	B-T047
sleep	O	O	I-T047
apnea	O	O	I-T047
(	O	O	O
OSA	O	O	B-T047
)	O	O	O
has	O	O	O
been	O	O	O
implicated	O	O	O
in	O	O	O
aortic	O	O	B-T047
dissection	O	O	I-T047
.	O	O	O

Thrombosis	O	O	B-T046
of	O	O	O
the	O	O	O
false	O	O	B-T080
lumen	O	O	B-T030
is	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
a	O	O	O
prognosis	O	O	B-T058
of	O	O	O
type	O	O	B-T190
B	O	O	I-T190
aortic	O	O	I-T190
dissection	O	O	I-T190
(	O	O	O
AoD	O	O	B-T190
)	O	O	O
,	O	O	O
and	O	O	O
partial	O	O	B-T020
thrombosis	O	O	I-T020
has	O	O	O
been	O	O	O
reported	O	O	O
to	O	O	O
be	O	O	O
an	O	O	O
independent	O	O	O
predictor	O	O	B-T170
of	O	O	O
mortality	O	O	B-T081
.	O	O	O

This	O	O	O
study	O	O	B-T062
sought	O	O	O
to	O	O	O
explore	O	O	O
whether	O	O	O
the	O	O	O
severity	O	O	B-T080
of	O	O	O
OSA	O	O	B-T047
is	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
false	O	O	B-T080
lumen	O	O	B-T030
thrombosis	O	O	B-T046
.	O	O	O

In	O	O	O
this	O	O	O
observational	O	O	B-T062
study	O	O	I-T062
,	O	O	O
151	O	O	O
type	O	O	B-T190
B	O	O	I-T190
AoD	O	O	I-T190
patients	O	O	B-T101
were	O	O	O
recruited	O	O	O
consecutively	O	O	O
from	O	O	O
2013	O	O	O
to	O	O	O
2015	O	O	O
.	O	O	O

The	O	O	O
status	O	O	O
of	O	O	O
the	O	O	O
false	O	O	B-T080
lumen	O	O	B-T030
was	O	O	O
classified	O	O	O
as	O	O	O
patent	O	O	O
,	O	O	O
partially	O	O	B-T081
thrombosed	O	O	B-T046
,	O	O	O
or	O	O	O
completely	O	O	O
thrombosed	O	O	O
based	O	O	O
on	O	O	O
a	O	O	O
computer	O	O	B-T060
tomography	O	O	I-T060
angiography	O	O	I-T060
image	O	O	B-T078
.	O	O	O

Patients	O	O	B-T101
were	O	O	O
divided	O	O	O
into	O	O	O
non-OSA	O	O	B-UnknownType
group	O	O	I-UnknownType
(	O	O	O
apnea-hypopnea	O	O	B-T170
index	O	O	I-T170
[	O	O	O
AHI	O	O	B-T170
]	O	O	O
<	O	O	O
5	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
mild	O	O	B-UnknownType
(	O	O	O
5	O	O	O
â¤	O	O	O
AHI	O	O	O
â¤	O	O	O
15	O	O	O
)	O	O	O
,	O	O	O
moderate	O	O	B-UnknownType
(	O	O	O
15	O	O	O
<	O	O	O
AHI	O	O	O
â¤	O	O	O
30	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
severe	O	O	B-UnknownType
OSA	O	O	I-UnknownType
groups	O	O	I-UnknownType
(	O	O	O
AHI	O	O	O
>	O	O	O
30	O	O	O
)	O	O	O
using	O	O	O
the	O	O	O
AHI	O	O	O
.	O	O	O

The	O	O	O
prevalence	O	O	B-T081
of	O	O	O
OSA	O	O	B-T047
in	O	O	O
type	O	O	B-T190
B	O	O	I-T190
dissection	O	O	I-T190
was	O	O	O
66.2	O	O	O
%	O	O	O
.	O	O	O

Among	O	O	O
151	O	O	O
cases	O	O	B-T077
,	O	O	O
51	O	O	O
patients	O	O	B-T101
(	O	O	O
33.8	O	O	O
%	O	O	O
)	O	O	O
were	O	O	O
in	O	O	O
the	O	O	O
non-OSA	O	O	B-UnknownType
group	O	O	I-UnknownType
,	O	O	O
56	O	O	O
(	O	O	O
37.1	O	O	O
%	O	O	O
)	O	O	O
were	O	O	O
in	O	O	O
the	O	O	O
mild	O	O	B-UnknownType
group	O	O	I-UnknownType
,	O	O	O
21	O	O	O
(	O	O	O
13.9	O	O	O
%	O	O	O
)	O	O	O
were	O	O	O
in	O	O	O
the	O	O	O
moderate	O	O	B-UnknownType
group	O	O	I-UnknownType
,	O	O	O
and	O	O	O
23	O	O	O
(	O	O	O
15.2	O	O	O
%	O	O	O
)	O	O	O
were	O	O	O
in	O	O	O
the	O	O	O
severe	O	O	B-UnknownType
group	O	O	I-UnknownType
.	O	O	O

Additionally	O	O	O
,	O	O	O
a	O	O	O
partially	O	O	B-T081
thrombosed	O	O	B-T046
false	O	O	B-T080
lumen	O	O	B-T030
was	O	O	O
observed	O	O	O
in	O	O	O
88	O	O	O
patients	O	O	B-T101
(	O	O	O
58.3	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

Multivariable	O	O	B-T081
analysis	O	O	I-T081
revealed	O	O	O
that	O	O	O
OSA	O	O	B-T047
severity	O	O	B-T080
was	O	O	O
positively	O	O	B-T033
associated	O	O	B-T080
with	O	O	I-T080
partial	O	O	B-T081
thrombosis	O	O	B-T046
(	O	O	O
odds	O	O	B-T081
ratio	O	O	I-T081
,	O	O	O
1.784	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
confidence	O	O	B-T081
interval	O	O	I-T081
:	O	O	O
1.182	O	O	O
-	O	O	O
2.691	O	O	O
,	O	O	O
P	O	O	O
=	O	O	O
.006	O	O	O
)	O	O	O
after	O	O	O
adjusting	O	O	O
for	O	O	O
other	O	O	O
confounding	O	O	B-T169
factors	O	O	I-T169
.	O	O	O

OSA	O	O	B-T047
was	O	O	O
present	O	O	O
in	O	O	O
two-thirds	O	O	O
of	O	O	O
patients	O	O	B-T101
with	O	O	O
type	O	O	O
B	O	O	O
AoD.	O	O	O
The	O	O	O
severity	O	O	B-T080
of	O	O	O
OSA	O	O	O
was	O	O	O
significantly	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
an	O	O	O
increased	O	O	B-T081
risk	O	O	B-T078
of	O	O	O
partial	O	O	B-T081
false	O	O	B-T080
lumen	O	O	B-T030
thrombosis	O	O	B-T046
.	O	O	O

OSA	O	O	B-T047
may	O	O	O
therefore	O	O	O
be	O	O	O
implicated	O	O	O
in	O	O	O
both	O	O	O
the	O	O	O
etiology	O	O	B-T169
and	O	O	O
prognosis	O	O	B-T058
of	O	O	O
AoD.	O	O	O

-DOCSTART- (28368267)

Contextual	O	O	B-T041
Factors	O	O	I-T041
for	O	O	O
Stunting	O	O	B-T046
Among	O	O	O
Children	O	O	B-T100
of	O	O	O
Age	O	O	B-T032
6	O	O	O
to	O	O	O
24	O	O	O
Months	O	O	B-T079
in	O	O	O
an	O	O	O
Under-Privileged	O	O	B-T096
Community	O	O	I-T096
of	O	O	O
Dhaka	O	O	B-T083
,	O	O	O
Bangladesh	O	O	O

To	O	O	O
determine	O	O	O
factors	O	O	B-T169
associated	O	O	B-T080
with	O	O	I-T080
stunting	O	O	B-T046
among	O	O	O
children	O	O	B-T100
aged	O	O	B-T032
6	O	O	O
to	O	O	O
24	O	O	O
months	O	O	B-T079
in	O	O	O
a	O	O	O
slum	O	O	B-T080
of	O	O	O
Dhaka	O	O	B-T083
,	O	O	O
Bangladesh	O	O	B-T083
.	O	O	O

We	O	O	O
conducted	O	O	O
this	O	O	O
case	O	O	B-T062
control	O	O	I-T062
study	O	O	I-T062
during	O	O	O
November	O	O	O
2009	O	O	O
to	O	O	O
December	O	O	O
2012	O	O	O
.	O	O	O

Children	O	O	B-T100
were	O	O	O
classified	O	O	O
as	O	O	O
case	O	O	O
if	O	O	O
length-for-age	O	O	B-T081
Z-score	O	O	I-T081
(	O	O	O
LAZ	O	O	B-T081
)	O	O	O
was	O	O	O
<	O	O	O
-2	O	O	O
and	O	O	O
as	O	O	O
control	O	O	B-T096
if	O	O	O
LAZ	O	O	O
was	O	O	O
>	O	O	O
-1	O	O	O
SD	O	O	O
.	O	O	O

The	O	O	O
logistic	O	O	B-UnknownType
regression	O	O	I-UnknownType
model	O	O	I-UnknownType
was	O	O	O
used	O	O	O
to	O	O	O
find	O	O	O
the	O	O	O
factors	O	O	B-T169
associated	O	O	B-T080
with	O	O	I-T080
stunting	O	O	B-T046
.	O	O	O

The	O	O	O
significant	O	O	O
risk	O	O	B-T033
factors	O	O	I-T033
for	O	O	O
stunting	O	O	B-T046
were	O	O	O
:	O	O	O
child	O	O	B-T100
's	O	O	I-T100
age	O	O	B-T032
>	O	O	O
12	O	O	O
months	O	O	B-T079
,	O	O	O
maternal	O	O	B-T099
undernutrition	O	O	B-T047
,	O	O	O
mother	O	O	B-T033
's	O	O	I-T033
education	O	O	I-T033
<	O	O	O
5	O	O	O
years	O	O	B-T079
,	O	O	O
consumption	O	O	B-T040
of	O	O	O
untreated	O	O	B-T167
drinking	O	O	I-T167
water	O	O	I-T167
and	O	O	O
monthly	O	O	B-T079
family	O	O	B-T099
income	O	O	B-T081
<	O	O	O
100	O	O	O
USD	O	O	B-T081
.	O	O	O

The	O	O	O
findings	O	O	B-T033
of	O	O	O
this	O	O	O
study	O	O	B-T062
reiterated	O	O	O
the	O	O	O
role	O	O	O
of	O	O	O
maternal	O	O	B-T099
undernutrition	O	O	B-T047
and	O	O	O
less	O	O	B-T033
education	O	O	I-T033
,	O	O	O
consumption	O	O	B-T040
of	O	O	O
untreated	O	O	B-T167
drinking	O	O	I-T167
water	O	O	I-T167
and	O	O	O
poor	O	O	O
family	O	O	B-T099
income	O	O	B-T081
as	O	O	O
important	O	O	O
associated	O	O	B-T080
factors	O	O	B-T169
of	O	O	O
childhood	O	O	B-T079
stunting	O	O	B-T046
in	O	O	O
resource-poor	O	O	O
setting	O	O	O
.	O	O	O

-DOCSTART- (28373341)

Most	O	O	O
Americans	O	O	B-T098
Have	O	O	O
Good	O	O	B-T080
Health	O	O	I-T080
,	O	O	O
Little	O	O	O
Unmet	O	O	B-T033
Need	O	O	I-T033
,	O	O	O
And	O	O	O
Few	O	O	O
Health	O	O	O
Care	O	O	O
Expenses	O	O	O

The	O	O	O
distribution	O	O	O
of	O	O	O
health	O	O	B-T081
care	O	O	I-T081
expenditures	O	O	I-T081
remains	O	O	O
highly	O	O	O
concentrated	O	O	B-T081
,	O	O	O
but	O	O	O
most	O	O	O
Americans	O	O	B-T098
use	O	O	O
few	O	O	O
health	O	O	B-T078
care	O	O	I-T078
resources	O	O	I-T078
and	O	O	O
have	O	O	O
low	O	O	O
out-of-pocket	O	O	B-T054
spending	O	O	I-T054
.	O	O	O

More	O	O	O
than	O	O	O
93	O	O	O
percent	O	O	O
of	O	O	O
"	O	O	O
low	O	O	B-T098
spenders	O	O	I-T098
"	O	O	O
(	O	O	O
those	O	O	O
in	O	O	O
the	O	O	O
bottom	O	O	O
half	O	O	O
of	O	O	O
the	O	O	O
population	O	O	B-T098
)	O	O	O
believe	O	O	O
they	O	O	O
have	O	O	O
received	O	O	B-T080
all	O	O	O
needed	O	O	O
care	O	O	B-T058
in	O	O	O
a	O	O	O
timely	O	O	B-T080
manner	O	O	O
.	O	O	O

The	O	O	O
low	O	O	O
spending	O	O	B-T054
by	O	O	O
the	O	O	O
majority	O	O	O
of	O	O	O
the	O	O	O
population	O	O	B-T098
has	O	O	O
remained	O	O	O
almost	O	O	O
unchanged	O	O	O
during	O	O	O
the	O	O	O
thirty-seven-	O	O	O
year	O	O	B-T079
period	O	O	B-T079
examined	O	O	B-T033
.	O	O	O

-DOCSTART- (28373959)

Penile	O	O	B-T020
Erosion	O	O	I-T020
in	O	O	O
a	O	O	O
Paraplegic	O	O	B-T047
Man	O	O	B-T098
With	O	O	O
Indwelling	O	O	B-T074
Urinary	O	O	I-T074
Catheter	O	O	I-T074
and	O	O	O
Scrotal	O	O	O
Edema	O	O	O

The	O	O	O
chronic	O	O	B-T079
use	O	O	B-T169
of	O	O	I-T169
urinary	O	O	B-T074
indwelling	O	O	I-T074
catheters	O	O	I-T074
is	O	O	O
a	O	O	O
common	O	O	O
practice	O	O	O
in	O	O	O
the	O	O	O
setting	O	O	O
of	O	O	O
long-term	O	O	B-T079
patient	O	O	B-T058
care	O	O	I-T058
and	O	O	O
is	O	O	O
associated	O	O	O
with	O	O	O
numerous	O	O	O
complications	O	O	B-T046
.	O	O	O

More	O	O	O
awareness	O	O	B-T041
about	O	O	O
urogenital	O	O	B-T022
trauma	O	O	B-T037
from	O	O	O
urinary	O	O	B-T061
catheterization	O	O	I-T061
is	O	O	O
needed	O	O	O
,	O	O	O
as	O	O	O
it	O	O	O
is	O	O	O
as	O	O	O
common	O	O	O
as	O	O	O
symptomatic	O	O	B-T169
urinary	O	O	B-T047
tract	O	O	I-T047
infections	O	O	I-T047
.	O	O	O

There	O	O	O
are	O	O	O
a	O	O	O
number	O	O	O
of	O	O	O
preventable	O	O	B-T080
measures	O	O	I-T080
that	O	O	O
can	O	O	O
be	O	O	O
taken	O	O	O
to	O	O	O
decrease	O	O	B-T081
the	O	O	O
risk	O	O	B-T078
of	O	O	O
mechanical	O	O	B-T037
trauma	O	O	I-T037
to	O	O	O
the	O	O	O
urethra	O	O	B-T023
and	O	O	O
glans	O	O	B-T023
penis	O	O	I-T023
caused	O	O	O
by	O	O	O
chronic	O	O	B-T079
catheterization	O	O	B-T061
.	O	O	O

We	O	O	O
present	O	O	O
a	O	O	O
case	O	O	O
of	O	O	O
a	O	O	O
27-	O	O	O
year	O	O	B-T079
old	O	O	B-T079
paraplegic	O	O	B-T047
male	O	O	B-T032
needing	O	O	O
a	O	O	O
chronic	O	O	B-T079
indwelling	O	O	B-T074
catheter	O	O	I-T074
that	O	O	O
acquired	O	O	B-T080
ventral	O	O	B-T082
penile	O	O	B-T020
erosion	O	O	I-T020
while	O	O	O
being	O	O	O
cared	O	O	B-T052
for	O	O	O
in	O	O	O
the	O	O	O
ICU	O	O	B-T093
setting	O	O	I-T093
.	O	O	O

-DOCSTART- (28375449)

Modified	O	O	B-T169
anastomotic	O	O	B-T061
technique	O	O	I-T061
for	O	O	O
thoracolaparoscopic	O	O	B-T061
Ivor-Lewis	O	O	I-T061
esophagectomy	O	O	I-T061
:	O	O	O
early	O	O	B-T079
outcomes	O	O	B-T080
and	O	O	O
technical	O	O	O
details	O	O	O

Thoracoscopic	O	O	B-T061
intrathoracic	O	O	I-T061
esophagogastrostomy	O	O	I-T061
is	O	O	O
a	O	O	O
technically	O	O	O
demanding	O	O	O
operation	O	O	O
;	O	O	O
these	O	O	O
technical	O	O	B-UnknownType
requirements	O	O	I-UnknownType
restrict	O	O	O
the	O	O	O
extensive	O	O	O
application	O	O	B-T169
of	O	O	I-T169
minimally	O	O	B-T080
invasive	O	O	B-T080
Ivor-Lewis	O	O	B-T061
esophagectomy	O	O	I-T061
.	O	O	O

In	O	O	O
an	O	O	O
attempt	O	O	O
to	O	O	O
reduce	O	O	B-T081
the	O	O	O
difficulty	O	O	O
of	O	O	O
this	O	O	O
surgical	O	O	B-T061
procedure	O	O	I-T061
,	O	O	O
this	O	O	O
study	O	O	O
developed	O	O	O
a	O	O	O
modified	O	O	B-T169
anastomotic	O	O	B-T061
technique	O	O	I-T061
for	O	O	O
thoracolaparoscopic	O	O	B-T061
Ivor-Lewis	O	O	I-T061
esophagectomy	O	O	I-T061
.	O	O	O

During	O	O	O
the	O	O	O
entirety	O	O	O
of	O	O	O
this	O	O	O
modified	O	O	B-T169
approach	O	O	B-T169
,	O	O	O
neither	O	O	O
technically	O	O	O
challenging	O	O	O
operations	O	O	B-T061
such	O	O	O
as	O	O	O
intrathoracic	O	O	B-T061
suturing	O	O	I-T061
or	O	O	O
knotting	O	O	B-T061
,	O	O	O
nor	O	O	O
special	O	O	O
instruments	O	O	B-T074
such	O	O	O
as	O	O	O
an	O	O	O
OrVil	O	O	B-T074
system	O	O	I-T074
or	O	O	O
a	O	O	O
reverse-puncture	O	O	B-T074
head	O	O	I-T074
are	O	O	O
required	O	O	O
.	O	O	O

Between	O	O	O
October	O	O	O
2015	O	O	O
and	O	O	O
January	O	O	O
2016	O	O	O
,	O	O	O
15	O	O	O
consecutive	O	O	B-T080
patients	O	O	B-T101
with	O	O	O
cancer	O	O	B-T191
in	O	O	O
the	O	O	O
distal	O	O	B-T029
third	O	O	I-T029
of	O	O	I-T029
the	O	O	I-T029
esophagus	O	O	I-T029
or	O	O	O
the	O	O	O
gastric	O	O	B-T029
cardia	O	O	I-T029
underwent	O	O	O
this	O	O	O
modified	O	O	B-T169
surgical	O	O	B-T061
procedure	O	O	I-T061
.	O	O	O

The	O	O	O
good	O	O	O
short-term	O	O	B-T079
outcomes	O	O	B-T080
that	O	O	O
were	O	O	O
achieved	O	O	O
suggest	O	O	O
that	O	O	O
the	O	O	O
modified	O	O	B-T169
anastomotic	O	O	B-T061
technique	O	O	I-T061
is	O	O	O
safe	O	O	O
and	O	O	O
feasible	O	O	O
for	O	O	O
thoracolaparoscopic	O	O	B-T061
Ivor-Lewis	O	O	I-T061
esophagectomy	O	O	I-T061
.	O	O	O

-DOCSTART- (28375566)

Quantitative	O	O	B-UnknownType
analysis	O	O	I-UnknownType
of	O	O	O
cell	O	O	B-T043
proliferation	O	O	I-T043
by	O	O	O
a	O	O	O
dye	O	O	B-T060
dilution	O	O	I-T060
assay	O	O	I-T060
:	O	O	O
Application	O	O	B-T169
to	O	O	O
cell	O	O	B-T025
lines	O	O	I-T025
and	O	O	O
cocultures	O	O	O

Cell	O	O	B-T043
proliferation	O	O	I-T043
represents	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
most	O	O	O
fundamental	O	O	O
processes	O	O	B-T038
in	O	O	I-T038
biological	O	O	B-T091
systems	O	O	I-T038
,	O	O	O
thus	O	O	O
the	O	O	O
quantitative	O	O	B-UnknownType
analysis	O	O	I-UnknownType
of	O	O	O
cell	O	O	B-T043
proliferation	O	O	I-T043
is	O	O	O
important	O	O	O
in	O	O	O
many	O	O	O
biological	O	O	O
applications	O	O	B-T169
such	O	O	O
as	O	O	O
drug	O	O	B-T059
screening	O	O	I-T059
,	O	O	O
production	O	O	O
of	O	O	O
biologics	O	O	B-T121
,	O	O	O
and	O	O	O
assessment	O	O	B-T058
of	O	O	O
cytotoxicity	O	O	B-T049
.	O	O	O

Conventional	O	O	B-T080
proliferation	O	O	B-T062
assays	O	O	I-T062
mainly	O	O	O
quantify	O	O	O
cell	O	O	B-T059
number	O	O	I-T059
based	O	O	O
on	O	O	O
a	O	O	O
calibration	O	O	B-T081
curve	O	O	I-T081
of	O	O	O
a	O	O	O
homogeneous	O	O	B-T080
cell	O	O	B-T025
population	O	O	I-T025
,	O	O	O
and	O	O	O
therefore	O	O	O
are	O	O	O
not	O	O	O
applicable	O	O	O
for	O	O	O
the	O	O	O
analysis	O	O	B-T062
of	O	O	O
cocultured	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

Moreover	O	O	O
,	O	O	O
these	O	O	O
assays	O	O	B-T059
measure	O	O	B-T169
cell	O	O	B-T043
proliferation	O	O	I-T043
indirectly	O	O	O
,	O	O	O
based	O	O	O
on	O	O	O
cellular	O	O	B-T043
metabolic	O	O	I-T043
activity	O	O	I-T043
or	O	O	O
DNA	O	O	B-T081
content	O	O	I-T081
.	O	O	O

To	O	O	O
overcome	O	O	B-T052
these	O	O	O
shortcomings	O	O	O
,	O	O	O
a	O	O	O
dye	O	O	B-T060
dilution	O	O	I-T060
assay	O	O	I-T060
employing	O	O	O
fluorescent	O	O	B-T130
cell	O	O	I-T130
tracking	O	O	I-T130
dyes	O	O	I-T130
that	O	O	O
are	O	O	O
retained	O	O	B-T169
within	O	O	O
cells	O	O	B-T025
was	O	O	O
applied	O	O	O
and	O	O	O
was	O	O	O
diluted	O	O	B-T169
proportionally	O	O	B-T080
by	O	O	O
subsequent	O	O	O
cell	O	O	B-T043
divisions	O	O	I-T043
.	O	O	O

Here	O	O	O
,	O	O	O
it	O	O	O
was	O	O	O
demonstrated	O	O	O
that	O	O	O
this	O	O	O
assay	O	O	B-T059
could	O	O	O
be	O	O	O
implemented	O	O	O
to	O	O	O
quantitatively	O	O	B-UnknownType
analyze	O	O	B-T062
the	O	O	O
cell	O	O	B-T043
proliferation	O	O	B-T169
of	O	O	O
different	O	O	O
types	O	O	O
of	O	O	O
cell	O	O	B-T025
lines	O	O	I-T025
,	O	O	O
and	O	O	O
to	O	O	O
concurrently	O	O	B-T079
analyze	O	O	O
the	O	O	O
proliferation	O	O	O
of	O	O	O
two	O	O	O
types	O	O	O
of	O	O	O
cell	O	O	O
lines	O	O	O
in	O	O	O
coculture	O	O	B-T059
by	O	O	O
utilizing	O	O	O
cell	O	O	B-T062
tracking	O	O	I-T062
dyes	O	O	B-T130
with	O	O	O
different	O	O	O
spectral	O	O	B-T081
characteristics	O	O	B-T080
.	O	O	O

The	O	O	O
mean	O	O	B-T081
division	O	O	I-T081
time	O	O	I-T081
estimated	O	O	B-T081
by	O	O	O
the	O	O	O
dye	O	O	B-T060
dilution	O	O	I-T060
assay	O	O	I-T060
is	O	O	O
compared	O	O	O
with	O	O	O
the	O	O	O
population	O	O	B-T079
doubling	O	O	I-T079
time	O	O	I-T079
obtained	O	O	O
from	O	O	O
conventional	O	O	B-T080
methods	O	O	B-T170
and	O	O	O
values	O	O	B-UnknownType
from	O	O	O
literature	O	O	B-T170
.	O	O	O

Additionally	O	O	O
,	O	O	O
dye	O	O	B-T130
transfer	O	O	O
between	O	O	O
cocultured	O	O	B-T025
cells	O	O	B-T025
was	O	O	O
investigated	O	O	B-T169
and	O	O	O
it	O	O	O
was	O	O	O
found	O	O	O
that	O	O	O
it	O	O	O
is	O	O	O
a	O	O	O
characteristic	O	O	B-T080
of	O	O	O
the	O	O	O
cells	O	O	O
rather	O	O	O
than	O	O	O
a	O	O	O
characteristic	O	O	O
of	O	O	O
the	O	O	O
dye	O	O	O
.	O	O	O

It	O	O	O
was	O	O	O
suggested	O	O	O
that	O	O	O
this	O	O	O
method	O	O	O
can	O	O	O
be	O	O	O
easily	O	O	O
combined	O	O	O
with	O	O	O
other	O	O	O
flow	O	O	B-T059
cytometric	O	O	I-T059
analyses	O	O	I-T059
of	O	O	O
cellular	O	O	B-T025
properties	O	O	B-T080
,	O	O	O
providing	O	O	O
valuable	O	O	B-T080
information	O	O	B-T078
on	O	O	O
cell	O	O	B-T080
status	O	O	I-T080
under	O	O	O
diverse	O	O	B-T080
conditions	O	O	B-T080
.	O	O	O

Â©	O	O	O
2017	O	O	O
International	O	O	O
Society	O	O	O
for	O	O	O
Advancement	O	O	O
of	O	O	O
Cytometry	O	O	O
.	O	O	O

-DOCSTART- (28375743)

Engineering	O	O	B-T063
and	O	O	O
In	O	O	B-T082
Vivo	O	O	I-T082
Applications	O	O	B-T169
of	O	O	O
Riboswitches	O	O	O

Riboswitches	O	O	B-T114
are	O	O	O
common	O	O	B-T081
gene	O	O	B-T028
regulatory	O	O	I-T028
units	O	O	I-T028
mostly	O	O	O
found	O	O	O
in	O	O	O
bacteria	O	O	B-T007
that	O	O	O
are	O	O	O
capable	O	O	B-T080
of	O	O	O
altering	O	O	B-T078
gene	O	O	B-T045
expression	O	O	I-T045
in	O	O	O
response	O	O	B-T032
to	O	O	O
a	O	O	O
small	O	O	B-T109
molecule	O	O	I-T109
.	O	O	O

These	O	O	O
structured	O	O	B-T114
RNA	O	O	I-T114
elements	O	O	I-T114
consist	O	O	O
of	O	O	O
two	O	O	O
modular	O	O	B-T077
subunits	O	O	B-T081
:	O	O	O
an	O	O	O
aptamer	O	O	B-T114
domain	O	O	I-T114
that	O	O	O
binds	O	O	B-T044
with	O	O	O
high	O	O	B-T080
specificity	O	O	B-T081
and	O	O	O
affinity	O	O	B-T070
to	O	O	O
a	O	O	O
target	O	O	B-T169
ligand	O	O	B-T103
and	O	O	O
an	O	O	O
expression	O	O	B-T045
platform	O	O	O
that	O	O	O
transduces	O	O	B-T043
ligand	O	O	B-T044
binding	O	O	I-T044
to	O	O	O
a	O	O	O
gene	O	O	B-T045
expression	O	O	I-T045
output	O	O	O
.	O	O	O

Significant	O	O	B-T078
progress	O	O	B-T169
has	O	O	O
been	O	O	O
made	O	O	O
in	O	O	O
engineering	O	O	B-T063
novel	O	O	B-T080
aptamer	O	O	B-T114
domains	O	O	I-T114
for	O	O	O
new	O	O	B-T080
small	O	O	B-T109
molecule	O	O	I-T109
inducers	O	O	B-T167
of	O	O	O
gene	O	O	B-T045
expression	O	O	I-T045
.	O	O	O

Modified	O	O	B-T169
expression	O	O	B-T045
platforms	O	O	O
have	O	O	O
also	O	O	O
been	O	O	O
optimized	O	O	B-T052
to	O	O	O
function	O	O	B-T169
when	O	O	O
fused	O	O	B-T169
with	O	O	O
both	O	O	O
natural	O	O	B-T169
and	O	O	O
synthetic	O	O	B-T080
aptamer	O	O	B-T114
domains	O	O	I-T114
.	O	O	O

As	O	O	O
this	O	O	O
field	O	O	B-T077
expands	O	O	O
,	O	O	O
the	O	O	O
use	O	O	O
of	O	O	O
these	O	O	O
privileged	O	O	B-T078
scaffolds	O	O	B-T073
has	O	O	O
permitted	O	O	O
the	O	O	O
development	O	O	B-T169
of	O	O	O
tools	O	O	B-T073
such	O	O	O
as	O	O	O
RNA	O	O	B-T114
-based	O	O	O
fluorescent	O	O	B-T070
biosensors	O	O	B-T075
.	O	O	O

In	O	O	O
this	O	O	O
review	O	O	B-T170
,	O	O	O
we	O	O	O
summarize	O	O	B-T170
the	O	O	O
methods	O	O	B-T170
that	O	O	O
have	O	O	O
been	O	O	O
developed	O	O	O
to	O	O	O
engineer	O	O	B-T057
new	O	O	O
riboswitches	O	O	B-T114
and	O	O	O
highlight	O	O	O
applications	O	O	B-T169
of	O	O	O
natural	O	O	B-T169
and	O	O	O
synthetic	O	O	B-T080
riboswitches	O	O	O
in	O	O	O
enzyme	O	O	B-T059
and	O	O	O
strain	O	O	B-T091
engineering	O	O	I-T091
,	O	O	O
in	O	O	O
controlling	O	O	O
gene	O	O	B-T045
expression	O	O	I-T045
and	O	O	O
cellular	O	O	B-T043
physiology	O	O	I-T043
,	O	O	O
and	O	O	O
in	O	O	O
real-time	O	O	B-T060
imaging	O	O	I-T060
of	O	O	O
cellular	O	O	B-T123
metabolites	O	O	I-T123
and	O	O	O
signals	O	O	B-T044
.	O	O	O

Expected	O	O	O
final	O	O	O
online	O	O	O
publication	O	O	O
date	O	O	O
for	O	O	O
the	O	O	O
Annual	O	O	O
Review	O	O	O
of	O	O	O
Biochemistry	O	O	O
Volume	O	O	O
86	O	O	O
is	O	O	O
June	O	O	O
20	O	O	O
,	O	O	O
2017	O	O	O
.	O	O	O

Please	O	O	O
see	O	O	O
http://www.annualreviews.org/page/journal/pubdates	O	O	O
for	O	O	O
revised	O	O	O
estimates	O	O	O
.	O	O	O

-DOCSTART- (28376393)

A	O	O	O
novel	O	O	B-T080
assay	O	O	B-T059
to	O	O	O
measure	O	O	B-T081
tertiary	O	O	B-T197
and	O	O	O
quaternary	O	O	B-T109
amines	O	O	I-T109
in	O	O	O
wastewater	O	O	B-T069
:	O	O	O
An	O	O	O
indicator	O	O	B-T169
for	O	O	O
NDMA	O	O	B-T109
wastewater	O	O	O
precursors	O	O	O

This	O	O	O
study	O	O	B-T059
examined	O	O	B-T033
the	O	O	O
potential	O	O	B-T080
of	O	O	O
using	O	O	O
a	O	O	O
novel	O	O	B-T080
bulk	O	O	B-T059
amine	O	O	I-T059
assay	O	O	I-T059
as	O	O	O
an	O	O	O
approximation	O	O	B-T080
for	O	O	O
the	O	O	O
tertiary	O	O	B-T197
and	O	O	O
quaternary	O	O	B-T109
amine	O	O	I-T109
load	O	O	O
in	O	O	O
wastewaters	O	O	B-T069
and	O	O	O
surface	O	O	B-T082
water	O	O	B-T197
samples	O	O	I-T197
,	O	O	O
and	O	O	O
this	O	O	O
approximation	O	O	O
was	O	O	O
compared	O	O	B-T052
to	O	O	O
N-nitrosodimethylamine	O	O	B-T109
(	O	O	O
NDMA	O	O	B-T109
)	O	O	O
formation	O	O	B-T169
potential	O	O	O
using	O	O	O
chloramines	O	O	B-T109
.	O	O	O

An	O	O	O
existing	O	O	O
colorimetric	O	O	B-T059
method	O	O	I-T059
was	O	O	O
examined	O	O	B-T033
and	O	O	O
optimized	O	O	O
for	O	O	O
the	O	O	O
detection	O	O	B-T033
of	O	O	O
amines	O	O	B-T109
in	O	O	O
environmental	O	O	B-T082
water	O	O	B-T197
samples	O	O	I-T197
.	O	O	O

The	O	O	O
method	O	O	B-T059
consists	O	O	O
of	O	O	O
liquid-liquid	O	O	B-T059
extraction	O	O	I-T059
followed	O	O	O
by	O	O	O
a	O	O	O
catalyzed	O	O	B-T169
reaction	O	O	B-T067
to	O	O	O
form	O	O	O
a	O	O	O
yet-	O	O	O
undefined	O	O	B-T078
product	O	O	B-T071
that	O	O	O
is	O	O	O
known	O	O	O
to	O	O	O
be	O	O	O
both	O	O	O
a	O	O	O
strong	O	O	B-T080
chromophore	O	O	B-T120
and	O	O	O
fluorophore	O	O	B-T121
.	O	O	O

Previous	O	O	O
work	O	O	O
verified	O	O	O
that	O	O	O
this	O	O	O
reaction	O	O	B-T067
was	O	O	O
effectively	O	O	O
catalyzed	O	O	B-T169
by	O	O	O
a	O	O	O
number	O	O	B-T081
of	O	O	O
compounds	O	O	B-T080
containing	O	O	O
tertiary	O	O	B-T197
and	O	O	O
quaternary	O	O	B-T109
amine	O	O	I-T109
moieties	O	O	B-T077
.	O	O	O

Many	O	O	O
tertiary	O	O	B-T197
and	O	O	O
quaternary	O	O	B-T109
compounds	O	O	I-T109
are	O	O	O
also	O	O	O
efficient	O	O	B-T080
producers	O	O	B-T169
of	O	O	O
NDMA	O	O	B-T109
under	O	O	O
chloramination	O	O	B-T070
conditions	O	O	B-T080
,	O	O	O
and	O	O	O
a	O	O	O
linear	O	O	B-T080
correlation	O	O	I-T080
was	O	O	O
consequently	O	O	B-T033
derived	O	O	O
from	O	O	O
the	O	O	O
bulk	O	O	B-T067
amine	O	O	I-T067
signals	O	O	I-T067
vs.	O	O	O
NDMA	O	O	O
formation	O	O	B-T169
potential	O	O	B-T080
in	O	O	O
various	O	O	O
wastewater	O	O	B-T069
samples	O	O	B-T167
(	O	O	O
R(2	O	O	O
)	O	O	O
=	O	O	O
0.74	O	O	O
;	O	O	O
n	O	O	O
=	O	O	O
24	O	O	O
;	O	O	O
p-value	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
results	O	O	O
provide	O	O	O
evidence	O	O	B-T078
that	O	O	O
approximately	O	O	B-T080
2	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
tertiary	O	O	B-T197
and	O	O	O
quaternary	O	O	O
amines	O	O	O
measured	O	O	B-T080
can	O	O	O
form	O	O	O
NDMA	O	O	B-T109
and	O	O	O
an	O	O	O
estimated	O	O	B-T081
0.01	O	O	O
-	O	O	O
1.3	O	O	O
%	O	O	O
of	O	O	O
nitrogen	O	O	B-T123
in	O	O	O
dissolved	O	O	B-T109
organic	O	O	I-T109
nitrogen	O	O	I-T109
originates	O	O	I-T109
from	O	O	O
these	O	O	O
bulk	O	O	B-T109
amines	O	O	I-T109
.	O	O	O

The	O	O	O
normalization	O	O	B-T062
of	O	O	O
NDMA	O	O	B-T109
concentration	O	O	B-T081
by	O	O	O
the	O	O	O
amine	O	O	B-T109
measurement	O	O	B-T169
revealed	O	O	O
that	O	O	O
ozone	O	O	B-T103
effectively	O	O	B-T080
destroyed	O	O	B-T052
those	O	O	O
tertiary	O	O	B-T197
and	O	O	O
quaternary	O	O	B-T109
amine	O	O	I-T109
structures	O	O	B-T082
more	O	O	O
likely	O	O	O
to	O	O	O
form	O	O	O
NDMA	O	O	O
in	O	O	O
treated	O	O	B-T169
wastewater	O	O	B-T069
samples	O	O	B-T167
.	O	O	O

This	O	O	O
bulk	O	O	B-T059
amine	O	O	I-T059
assay	O	O	I-T059
illustrates	O	O	O
that	O	O	O
proxy	O	O	O
measurements	O	O	B-T169
of	O	O	O
tertiary	O	O	B-T197
and	O	O	O
quaternary	O	O	B-T109
amines	O	O	I-T109
can	O	O	O
be	O	O	O
linked	O	O	O
to	O	O	O
the	O	O	O
NDMA	O	O	B-T109
formation	O	O	B-T169
potential	O	O	B-T080
of	O	O	O
a	O	O	O
given	O	O	O
sample	O	O	B-T167
,	O	O	O
and	O	O	O
this	O	O	O
approach	O	O	O
may	O	O	O
prove	O	O	O
useful	O	O	B-T080
as	O	O	O
a	O	O	O
characterizing	O	O	B-T052
tool	O	O	B-T169
for	O	O	O
NDMA	O	O	O
precursors	O	O	B-T078
in	O	O	O
wastewater	O	O	B-T069
.	O	O	O

-DOCSTART- (28377051)

Chlamydia	O	O	B-T007
pneumoniae	O	O	I-T007
infection	O	O	B-T046
promotes	O	O	B-T052
vascular	O	O	B-T025
endothelial	O	O	I-T025
cell	O	O	I-T025
angiogenesis	O	O	B-T042
through	O	O	O
an	O	O	O
IQGAP1	O	O	B-T116
-related	O	O	O
signaling	O	O	O
pathway	O	O	O

Chlamydia	O	O	B-T007
pneumoniae	O	O	I-T007
(	O	O	O
C.	O	O	B-T007
pneumoniae	O	O	I-T007
)	O	O	O
infection	O	O	B-T046
plays	O	O	O
a	O	O	O
potential	O	O	B-T077
role	O	O	I-T077
in	O	O	O
angiogenesis	O	O	B-T042
.	O	O	O

However	O	O	O
,	O	O	O
it	O	O	O
is	O	O	O
still	O	O	O
an	O	O	O
enigma	O	O	O
how	O	O	O
C.	O	O	B-T007
pneumoniae	O	O	I-T007
is	O	O	O
involved	O	O	B-T169
in	O	O	O
this	O	O	O
process	O	O	B-T067
.	O	O	O

Therefore	O	O	O
,	O	O	O
we	O	O	O
investigated	O	O	B-T169
the	O	O	O
effect	O	O	B-T080
of	O	O	O
C.	O	O	B-T007
pneumoniae	O	O	I-T007
infection	O	O	B-T046
on	O	O	O
angiogenesis	O	O	B-T042
,	O	O	O
and	O	O	O
then	O	O	O
explored	O	O	O
the	O	O	O
roles	O	O	B-T077
of	O	O	O
IQGAP1	O	O	B-T116
-related	O	O	O
signaling	O	O	B-T044
in	O	O	O
C.	O	O	O
pneumoniae	O	O	O
infection	O	O	O
-	O	O	O
induced	O	O	B-T169
angiogenesis	O	O	O
.	O	O	O

C.	O	O	B-T007
pneumoniae	O	O	I-T007
infection	O	O	B-T046
significantly	O	O	B-T052
enhanced	O	O	I-T052
angiogenesis	O	O	B-T042
as	O	O	O
assessed	O	O	B-T052
by	O	O	O
the	O	O	O
tube	O	O	B-T059
formation	O	O	I-T059
assay	O	O	I-T059
possibly	O	O	B-T033
by	O	O	O
inducing	O	O	B-T169
vascular	O	O	B-T025
endothelial	O	O	I-T025
cell	O	O	I-T025
(	O	O	O
VEC	O	O	B-T025
)	O	O	O
migration	O	O	B-T052
in	O	O	O
the	O	O	O
wound	O	O	B-T040
healing	O	O	I-T040
and	O	O	O
Transwell	O	O	B-T059
migration	O	O	I-T059
assays	O	O	I-T059
.	O	O	O

Subsequently	O	O	B-T079
,	O	O	O
immunoprecipitation	O	O	B-T059
,	O	O	O
Western	O	O	B-T059
blot	O	O	I-T059
and	O	O	O
tube	O	O	B-T059
formation	O	O	I-T059
assay	O	O	I-T059
results	O	O	B-T034
showed	O	O	O
that	O	O	O
the	O	O	O
phosphorylation	O	O	B-T044
of	O	O	O
both	O	O	O
IQGAP1	O	O	B-T116
and	O	O	O
N-WASP	O	O	B-T116
was	O	O	O
required	O	O	B-T169
for	O	O	O
the	O	O	O
angiogenesis	O	O	B-T042
induced	O	O	B-T169
by	O	O	O
C.	O	O	B-T007
pneumoniae	O	O	I-T007
infection	O	O	B-T046
.	O	O	O

Our	O	O	O
co-immunoprecipitation	O	O	B-T059
study	O	O	B-T059
revealed	O	O	B-T080
that	O	O	O
IQGAP1	O	O	B-T116
physically	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
N-WASP	O	O	B-T116
after	O	O	O
C.	O	O	B-T007
pneumoniae	O	O	I-T007
infection	O	O	B-T046
of	O	O	O
VECs	O	O	B-T025
.	O	O	O

Actin	O	O	B-T043
polymerization	O	O	I-T043
assay	O	O	B-T059
further	O	O	O
showed	O	O	O
that	O	O	O
in	O	O	O
C.	O	O	B-T007
pneumoniae	O	O	I-T007
-	O	O	O
infected	O	O	B-T033
VECs	O	O	B-T025
,	O	O	O
both	O	O	O
IQGAP1	O	O	B-T116
and	O	O	O
N-WASP	O	O	B-T116
were	O	O	O
recruited	O	O	O
to	O	O	O
filamentous	O	O	B-T116
actin	O	O	I-T116
,	O	O	O
and	O	O	O
shared	O	O	O
some	O	O	O
common	O	O	B-T081
compartments	O	O	O
localized	O	O	B-T082
at	O	O	O
the	O	O	O
leading	O	O	B-T026
edge	O	O	I-T026
of	O	O	O
lamellipodia	O	O	B-T026
,	O	O	O
which	O	O	O
was	O	O	O
impaired	O	O	B-T169
after	O	O	O
the	O	O	O
depletion	O	O	B-T169
of	O	O	O
IQGAP1	O	O	O
by	O	O	O
using	O	O	O
the	O	O	O
small	O	O	B-T114
interference	O	O	I-T114
RNA	O	O	I-T114
.	O	O	O

Moreover	O	O	O
,	O	O	O
the	O	O	O
knockdown	O	O	B-T063
of	O	O	O
IQGAP1	O	O	B-T028
also	O	O	O
significantly	O	O	B-T081
decreased	O	O	I-T081
N-WASP	O	O	B-T116
phosphorylation	O	O	B-T044
at	O	O	O
Tyr256	O	O	B-T116
induced	O	O	B-T169
by	O	O	O
C.	O	O	B-T007
pneumoniae	O	O	I-T007
infection	O	O	B-T046
.	O	O	O

We	O	O	O
conclude	O	O	B-T078
that	O	O	O
C.	O	O	B-T007
pneumoniae	O	O	I-T007
infection	O	O	B-T046
promotes	O	O	B-T052
VEC	O	O	B-T025
migration	O	O	B-T052
and	O	O	O
angiogenesis	O	O	B-T042
presumably	O	O	O
through	O	O	O
the	O	O	O
IQGAP1	O	O	B-T116
-related	O	O	O
signaling	O	O	B-T044
pathway	O	O	I-T044
.	O	O	O

-DOCSTART- (28377738)

Four-Dimensional	O	O	B-T082
Graded	O	O	B-T185
Consciousness	O	O	O

Both	O	O	O
the	O	O	O
multidimensional	O	O	B-T082
phenomenon	O	O	B-T067
and	O	O	O
the	O	O	O
polysemous	O	O	B-T080
notion	O	O	I-T080
of	O	O	O
consciousness	O	O	B-T041
continue	O	O	O
to	O	O	O
prove	O	O	O
resistant	O	O	B-T169
to	O	O	O
consistent	O	O	B-T078
measurement	O	O	B-T169
and	O	O	O
unambiguous	O	O	B-T170
definition	O	O	I-T170
.	O	O	O

This	O	O	O
is	O	O	O
hardly	O	O	O
surprising	O	O	O
,	O	O	O
given	O	O	O
that	O	O	O
there	O	O	O
is	O	O	O
no	O	O	B-T033
agreement	O	O	I-T033
even	O	O	O
as	O	O	O
regards	O	O	O
the	O	O	O
most	O	O	O
fundamental	O	O	O
issues	O	O	B-T033
they	O	O	O
involve	O	O	O
.	O	O	O

One	O	O	O
of	O	O	O
the	O	O	O
basic	O	O	O
disagreements	O	O	B-T054
present	O	O	O
in	O	O	O
the	O	O	O
continuing	O	O	O
debate	O	O	B-T052
about	O	O	O
consciousness	O	O	B-T041
pertains	O	O	O
to	O	O	O
its	O	O	O
gradational	O	O	B-T185
nature	O	O	B-T078
.	O	O	O

The	O	O	O
general	O	O	O
aim	O	O	O
of	O	O	O
this	O	O	O
article	O	O	B-T170
is	O	O	O
to	O	O	O
show	O	O	O
how	O	O	O
consciousness	O	O	B-T041
might	O	O	O
be	O	O	O
graded	O	O	B-T185
and	O	O	O
multidimensional	O	O	B-T082
at	O	O	O
the	O	O	O
same	O	O	O
time	O	O	B-T079
.	O	O	O

We	O	O	O
therefore	O	O	O
focus	O	O	O
on	O	O	O
the	O	O	O
question	O	O	B-T170
of	O	O	O
what	O	O	O
it	O	O	O
is	O	O	O
,	O	O	O
exactly	O	O	O
,	O	O	O
that	O	O	O
is	O	O	O
or	O	O	O
could	O	O	O
be	O	O	O
graded	O	O	B-T185
in	O	O	O
cases	O	O	B-T169
of	O	O	O
consciousness	O	O	B-T041
,	O	O	O
and	O	O	O
how	O	O	O
we	O	O	O
can	O	O	O
measure	O	O	B-T081
it	O	O	O
.	O	O	O

Ultimately	O	O	O
,	O	O	O
four	O	O	O
different	O	O	O
gradable	O	O	B-T185
aspects	O	O	B-T080
of	O	O	O
consciousness	O	O	B-T041
will	O	O	O
be	O	O	O
described	O	O	O
:	O	O	O
quality	O	O	B-T080
,	O	O	O
abstractness	O	O	B-T170
,	O	O	O
complexity	O	O	B-T041
and	O	O	O
usefulness	O	O	B-T080
,	O	O	O
which	O	O	O
belong	O	O	O
to	O	O	O
four	O	O	O
different	O	O	O
dimensions	O	O	B-T081
,	O	O	O
these	O	O	O
being	O	O	O
understood	O	O	O
,	O	O	O
respectively	O	O	O
,	O	O	O
as	O	O	O
phenomenal	O	O	B-T080
,	O	O	O
semantic	O	O	B-T078
,	O	O	O
physiological	O	O	B-T169
,	O	O	O
and	O	O	O
functional	O	O	B-T169
.	O	O	O

Consequently	O	O	O
,	O	O	O
consciousness	O	O	B-T041
may	O	O	O
be	O	O	O
said	O	O	O
to	O	O	O
vary	O	O	O
with	O	O	O
respect	O	O	O
to	O	O	O
phenomenal	O	O	B-T080
quality	O	O	B-T080
,	O	O	O
semantic	O	O	B-T078
abstraction	O	O	B-T170
,	O	O	O
physiological	O	O	B-T169
complexity	O	O	B-T041
,	O	O	O
and	O	O	O
functional	O	O	B-T169
usefulness	O	O	B-T080
.	O	O	O

It	O	O	O
is	O	O	O
hoped	O	O	O
that	O	O	O
such	O	O	O
a	O	O	O
four-dimensional	O	O	B-T082
approach	O	O	O
will	O	O	O
help	O	O	O
to	O	O	O
clarify	O	O	O
and	O	O	O
justify	O	O	O
claims	O	O	O
about	O	O	O
the	O	O	O
hierarchical	O	O	B-T078
nature	O	O	I-T078
of	O	O	O
consciousness	O	O	B-T041
.	O	O	O

The	O	O	O
approach	O	O	B-T082
also	O	O	O
proves	O	O	O
explanatorily	O	O	O
advantageous	O	O	B-T080
,	O	O	O
as	O	O	O
it	O	O	O
enables	O	O	O
us	O	O	O
not	O	O	O
only	O	O	O
to	O	O	O
draw	O	O	O
attention	O	O	B-T041
to	O	O	O
certain	O	O	O
new	O	O	O
and	O	O	O
important	O	O	B-T080
differences	O	O	B-T080
in	O	O	O
respect	O	O	O
of	O	O	O
subjective	O	O	B-T080
measures	O	O	B-T081
of	O	O	O
awareness	O	O	B-T041
and	O	O	O
to	O	O	O
justify	O	O	O
how	O	O	O
a	O	O	O
given	O	O	O
creature	O	O	B-T008
may	O	O	O
be	O	O	O
ranked	O	O	B-T170
higher	O	O	B-T080
in	O	O	O
one	O	O	O
dimension	O	O	O
of	O	O	O
consciousness	O	O	B-T041
and	O	O	O
lower	O	O	O
in	O	O	O
terms	O	O	O
of	O	O	O
another	O	O	O
,	O	O	O
but	O	O	O
also	O	O	O
allows	O	O	O
for	O	O	O
innovative	O	O	B-T170
explanations	O	O	I-T170
of	O	O	O
a	O	O	O
variety	O	O	O
of	O	O	O
well-known	O	O	O
phenomena	O	O	B-T067
(	O	O	O
amongst	O	O	O
these	O	O	O
,	O	O	O
the	O	O	O
interpretations	O	O	B-T170
of	O	O	O
blindsight	O	O	B-T080
and	O	O	O
locked-in	O	O	B-T047
syndrome	O	O	I-T047
will	O	O	O
be	O	O	O
briefly	O	O	O
outlined	O	O	O
here	O	O	O
)	O	O	O
.	O	O	O

Moreover	O	O	O
,	O	O	O
a	O	O	O
4D	O	O	B-T082
framework	O	O	O
makes	O	O	O
possible	O	O	O
many	O	O	O
predictions	O	O	B-T078
and	O	O	O
hypotheses	O	O	B-T078
that	O	O	O
may	O	O	O
be	O	O	O
experimentally	O	O	B-T062
tested	O	O	B-T169
(	O	O	O
We	O	O	O
point	O	O	O
out	O	O	O
a	O	O	O
few	O	O	O
such	O	O	O
possibilities	O	O	O
pertaining	O	O	O
to	O	O	O
interdimensional	O	O	B-T169
dependencies	O	O	I-T169
)	O	O	O
.	O	O	O

-DOCSTART- (28380217)

Synthesis	O	O	B-T052
of	O	O	O
Some	O	O	O
Unique	O	O	O
Carbamate	O	O	B-T109
Derivatives	O	O	B-T104
bearing	O	O	O
2-Furoyl-1-piperazine	O	O	B-T123
as	O	O	O
a	O	O	O
Valuable	O	O	O
Therapeutic	O	O	O
Agents	O	O	O

The	O	O	O
aim	O	O	B-T078
of	O	O	O
the	O	O	O
research	O	O	B-T062
work	O	O	I-T062
was	O	O	O
to	O	O	O
synthesize	O	O	O
different	O	O	O
biologically	O	O	B-T123
active	O	O	I-T123
carbamate	O	O	B-T109
derivatives	O	O	B-T104
bearing	O	O	O
2-furoyl-1-piperazine	O	O	B-T123
and	O	O	O
having	O	O	O
modest	O	O	O
toxicity	O	O	B-T037
.	O	O	O

The	O	O	O
synthesis	O	O	B-T052
was	O	O	O
completed	O	O	O
as	O	O	O
a	O	O	O
multiple	O	O	B-T169
sequence	O	O	I-T169
.	O	O	O

The	O	O	O
structural	O	O	B-T082
confirmation	O	O	B-T033
of	O	O	O
all	O	O	O
the	O	O	O
synthesized	O	O	O
compounds	O	O	O
was	O	O	O
obtained	O	O	O
by	O	O	O
EI-MS	O	O	B-T059
,	O	O	O
IR	O	O	B-T059
and	O	O	O
1H-NMR	O	O	B-T060
spectral	O	O	O
data	O	O	O
.	O	O	O

The	O	O	O
enzyme	O	O	B-T039
inhibition	O	O	I-T039
and	O	O	O
antibacterial	O	O	B-T033
potential	O	O	I-T033
of	O	O	O
the	O	O	O
synthesized	O	O	B-T123
compounds	O	O	I-T123
was	O	O	O
evaluated	O	O	B-T058
.	O	O	O

To	O	O	O
find	O	O	O
the	O	O	O
utility	O	O	O
of	O	O	O
the	O	O	O
prepared	O	O	O
compounds	O	O	B-T123
as	O	O	O
possible	O	O	O
therapeutic	O	O	B-T121
agents	O	O	I-T121
their	O	O	O
cytotoxicity	O	O	B-T049
was	O	O	O
also	O	O	O
checked	O	O	O
.	O	O	O

All	O	O	O
the	O	O	O
compounds	O	O	B-T123
were	O	O	O
active	O	O	B-T169
against	O	O	O
acetylcholinesterase	O	O	B-T116
enzyme	O	O	I-T116
,	O	O	O
especially	O	O	O
12	O	O	B-T123
and	O	O	O
14	O	O	B-T123
showed	O	O	O
very	O	O	O
good	O	O	B-T080
inhibitory	O	O	B-T042
potential	O	O	I-T042
relative	O	O	O
to	O	O	O
Eserine	O	O	B-T109
,	O	O	O
a	O	O	O
reference	O	O	B-T081
standard	O	O	I-T081
.	O	O	O

Almost	O	O	O
all	O	O	O
the	O	O	O
compounds	O	O	B-T123
showed	O	O	O
good	O	O	O
activities	O	O	O
against	O	O	O
both	O	O	O
Gram-positive	O	O	B-T007
and	O	O	O
Gram-negative	O	O	B-T007
bacterial	O	O	I-T007
strains	O	O	I-T007
.	O	O	O

-DOCSTART- (28385178)

Epidemiology	O	O	B-T091
and	O	O	O
outcomes	O	O	B-T057
of	O	O	O
injuries	O	O	B-T037
in	O	O	O
Kenya	O	O	B-T083
:	O	O	O
A	O	O	O
multisite	O	O	O
surveillance	O	O	O
study	O	O	O

Injury	O	O	B-T037
is	O	O	O
a	O	O	O
leading	O	O	O
cause	O	O	O
of	O	O	O
disability	O	O	B-T033
and	O	O	O
death	O	O	B-T033
worldwide	O	O	O
,	O	O	O
accounting	O	O	O
for	O	O	O
over	O	O	O
5	O	O	O
million	O	O	O
deaths	O	O	B-T033
each	O	O	O
year	O	O	B-T079
.	O	O	O

The	O	O	O
injury	O	O	B-T037
burden	O	O	B-T078
is	O	O	O
higher	O	O	O
in	O	O	O
low-	O	O	B-T083
and	O	O	I-T083
middle-income	O	O	I-T083
countries	O	O	I-T083
where	O	O	O
more	O	O	O
than	O	O	O
90	O	O	O
%	O	O	O
of	O	O	O
injury	O	O	B-T033
-related	O	O	I-T033
deaths	O	O	I-T033
occur	O	O	O
.	O	O	O

Despite	O	O	O
this	O	O	O
burden	O	O	B-T078
,	O	O	O
the	O	O	O
use	O	O	O
of	O	O	O
prospective	O	O	O
trauma	O	O	B-T037
registries	O	O	B-T170
to	O	O	O
describe	O	O	O
injury	O	O	B-T037
epidemiology	O	O	B-T091
and	O	O	O
outcomes	O	O	B-T057
is	O	O	O
limited	O	O	O
in	O	O	O
low-	O	O	B-T083
and	O	O	I-T083
middle-income	O	O	I-T083
countries	O	O	I-T083
.	O	O	O

Kenya	O	O	B-T083
lacks	O	O	O
robust	O	O	O
data	O	O	B-T078
to	O	O	O
describe	O	O	O
injury	O	O	B-T037
epidemiology	O	O	B-T091
and	O	O	O
care	O	O	B-T052
.	O	O	O

The	O	O	O
objective	O	O	B-T170
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
investigate	O	O	B-T169
the	O	O	O
epidemiology	O	O	B-T091
and	O	O	O
outcomes	O	O	B-T057
of	O	O	O
injuries	O	O	B-T037
at	O	O	O
4	O	O	O
referral	O	O	B-T093
hospitals	O	O	I-T093
in	O	O	O
Kenya	O	O	B-T083
using	O	O	O
hospital	O	O	B-T093
-based	O	O	O
trauma	O	O	B-T037
registries	O	O	B-T170
.	O	O	O

From	O	O	O
January	O	O	B-T080
2014	O	O	O
to	O	O	O
May	O	O	B-T079
2015	O	O	O
,	O	O	O
all	O	O	O
injured	O	O	B-T101
patients	O	O	I-T101
presenting	O	O	O
to	O	O	O
the	O	O	O
casualty	O	O	B-T093
departments	O	O	I-T093
of	O	O	O
Kenyatta	O	O	B-T093
National	O	O	I-T093
,	O	O	O
Thika	O	O	B-T093
Level	O	O	I-T093
5	O	O	I-T093
,	O	O	O
Machakos	O	O	B-T093
Level	O	O	I-T093
5	O	O	I-T093
,	O	O	O
and	O	O	O
Meru	O	O	B-T093
Level	O	O	I-T093
5	O	O	I-T093
Hospitals	O	O	I-T093
were	O	O	O
enrolled	O	O	O
prospectively	O	O	O
.	O	O	O

Data	O	O	B-T062
collected	O	O	I-T062
included	O	O	O
demographic	O	O	B-T102
characteristics	O	O	I-T102
,	O	O	O
type	O	O	B-T080
of	O	O	O
prehospital	O	O	B-T058
care	O	O	I-T058
received	O	O	B-T080
,	O	O	O
prehospital	O	O	B-T079
time	O	O	I-T079
,	O	O	O
injury	O	O	B-T037
pattern	O	O	I-T037
,	O	O	O
and	O	O	O
outcomes	O	O	B-T057
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
14,237	O	O	O
patients	O	O	B-T101
were	O	O	O
enrolled	O	O	O
in	O	O	O
our	O	O	O
study	O	O	O
.	O	O	O

Patients	O	O	B-T101
were	O	O	O
predominantly	O	O	O
male	O	O	B-T032
(	O	O	O
76.1	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
young	O	O	B-T079
(	O	O	O
mean	O	O	B-T032
age	O	O	I-T032
28	O	O	O
years	O	O	B-T079
)	O	O	O
.	O	O	O

The	O	O	O
most	O	O	O
common	O	O	O
mechanisms	O	O	B-T169
of	O	O	I-T169
injury	O	O	I-T169
were	O	O	O
road	O	O	B-T073
traffic	O	O	B-T037
injuries	O	O	I-T037
(	O	O	O
36.8	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
falls	O	O	B-T037
(	O	O	O
26.4	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
being	O	O	O
struck/hit	O	O	B-T169
by	O	O	I-T169
a	O	O	O
person	O	O	B-T098
or	O	O	O
object	O	O	B-T072
(	O	O	O
20.1	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

Burn	O	O	B-T037
was	O	O	O
the	O	O	O
most	O	O	O
common	O	O	O
mechanism	O	O	B-T169
of	O	O	I-T169
injury	O	O	I-T169
in	O	O	O
the	O	O	O
age	O	O	B-T032
category	O	O	B-T170
under	O	O	O
5	O	O	O
years	O	O	B-T079
.	O	O	O

Body	O	O	B-T029
regions	O	O	I-T029
commonly	O	O	O
injured	O	O	B-T169
were	O	O	O
lower	O	O	B-T023
extremity	O	O	I-T023
(	O	O	O
35.1	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
upper	O	O	B-T023
extremity	O	O	I-T023
(	O	O	O
33.4	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
head	O	O	B-T029
(	O	O	O
26.0	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
overall	O	O	O
mortality	O	O	B-T081
rate	O	O	I-T081
was	O	O	O
2.4	O	O	O
%	O	O	O
.	O	O	O

Significant	O	O	B-T078
predictors	O	O	I-T078
of	O	O	O
mortality	O	O	B-T081
from	O	O	O
multivariate	O	O	B-T081
analysis	O	O	I-T081
were	O	O	O
Glasgow	O	O	B-T033
Coma	O	O	I-T033
Scale	O	O	I-T033
â¤12	O	O	I-T033
,	O	O	O
estimated	O	O	O
injury	O	O	B-T170
severity	O	O	I-T170
score	O	O	I-T170
â¥9	O	O	O
,	O	O	O
burns	O	O	B-T037
,	O	O	O
and	O	O	O
gunshot	O	O	B-T037
injuries	O	O	I-T037
.	O	O	O

Hospital	O	O	B-T093
-based	O	O	O
trauma	O	O	B-T037
registries	O	O	B-T170
can	O	O	O
be	O	O	O
important	O	O	O
sources	O	O	B-T081
of	O	O	I-T081
data	O	O	I-T081
to	O	O	O
study	O	O	B-T062
the	O	O	I-T062
epidemiology	O	O	I-T062
of	O	O	O
injuries	O	O	B-T037
in	O	O	O
low-	O	O	B-T083
and	O	O	I-T083
middle-income	O	O	I-T083
countries	O	O	I-T083
.	O	O	O

Data	O	O	B-T078
from	O	O	O
such	O	O	O
trauma	O	O	B-T037
registries	O	O	B-T170
can	O	O	O
highlight	O	O	O
key	O	O	O
needs	O	O	O
and	O	O	O
be	O	O	O
used	O	O	O
to	O	O	O
design	O	O	O
public	O	O	B-T092
health	O	O	B-T078
interventions	O	O	B-T061
and	O	O	O
quality-of-care	O	O	B-T058
improvement	O	O	I-T058
programs	O	O	I-T058
.	O	O	O

-DOCSTART- (28386663)

A	O	O	O
child	O	O	B-T100
with	O	O	O
phenylketonuria	O	O	B-T047
and	O	O	O
focal	O	O	B-T047
segmental	O	O	I-T047
glomerulosclerosis	O	O	I-T047
,	O	O	O
the	O	O	O
bright	O	O	O
side	O	O	O
of	O	O	O
proteinuria	O	O	O

Phenylketonuria	O	O	B-T047
(	O	O	O
PKU	O	O	B-T047
)	O	O	O
is	O	O	O
the	O	O	O
most	O	O	O
common	O	O	B-T081
inborn	O	O	B-T047
error	O	O	I-T047
of	O	O	I-T047
amino	O	O	I-T047
acid	O	O	I-T047
metabolism	O	O	I-T047
.	O	O	O

Phenylalanine	O	O	B-T116
hydroxylase	O	O	I-T116
is	O	O	O
the	O	O	O
underlying	O	O	O
deficient	O	O	B-T169
enzyme	O	O	B-T116
.	O	O	O

If	O	O	O
left	O	O	O
untreated	O	O	B-T033
,	O	O	O
growth	O	O	B-T047
failure	O	O	I-T047
,	O	O	O
microcephaly	O	O	B-T019
,	O	O	O
global	O	O	B-T048
developmental	O	O	I-T048
delay	O	O	I-T048
,	O	O	O
seizures	O	O	B-T184
and	O	O	O
severe	O	O	B-T048
intellectual	O	O	I-T048
impairment	O	O	I-T048
would	O	O	O
characterize	O	O	B-T052
the	O	O	O
clinical	O	O	B-T201
picture	O	O	I-T201
of	O	O	O
PKU	O	O	B-T047
.	O	O	O

On	O	O	O
the	O	O	O
other	O	O	O
side	O	O	O
of	O	O	O
protein	O	O	B-T116
homeostasis	O	O	B-T038
lies	O	O	O
nephrotic	O	O	B-T047
syndrome	O	O	I-T047
.	O	O	O

It	O	O	O
is	O	O	O
a	O	O	O
well-known	O	O	O
quantitative	O	O	B-T081
defect	O	O	B-T169
due	O	O	O
to	O	O	O
significant	O	O	B-T078
proteinuria	O	O	B-T033
.	O	O	O

Focal	O	O	B-T047
segmental	O	O	I-T047
glomerulosclerosis	O	O	I-T047
(	O	O	O
FSGS	O	O	B-T047
)	O	O	O
is	O	O	O
a	O	O	O
special	O	O	B-T080
congenital	O	O	B-T080
variant	O	O	B-T080
affecting	O	O	B-T169
children	O	O	B-T100
and	O	O	O
adults	O	O	B-T100
.	O	O	O

Hereby	O	O	O
,	O	O	O
we	O	O	O
describe	O	O	O
a	O	O	O
three-	O	O	O
year	O	O	O
old	O	O	O
male	O	O	B-T032
child	O	O	B-T100
who	O	O	O
presented	O	O	B-T033
with	O	O	O
generalized	O	O	B-T033
edema	O	O	I-T033
and	O	O	O
global	O	O	B-T048
developmental	O	O	I-T048
delay	O	O	I-T048
.	O	O	O

Investigations	O	O	B-T058
revealed	O	O	B-T080
PKU	O	O	B-T047
along	O	O	O
with	O	O	O
FSGS	O	O	B-T047
.	O	O	O

We	O	O	O
assume	O	O	O
that	O	O	O
congenital	O	O	B-T047
nephrosis	O	O	I-T047
ameliorated	O	O	B-T033
the	O	O	O
picture	O	O	O
of	O	O	O
PKU	O	O	B-T047
,	O	O	O
and	O	O	O
had	O	O	O
a	O	O	O
salutary	O	O	B-T080
effect	O	O	I-T080
on	O	O	O
the	O	O	O
growth	O	O	B-T040
and	O	O	I-T040
development	O	O	I-T040
.	O	O	O

Such	O	O	O
coexistence	O	O	O
between	O	O	O
PKU	O	O	B-T047
and	O	O	O
FSGS	O	O	B-T047
has	O	O	O
n't	O	O	O
been	O	O	O
described	O	O	O
before	O	O	O
.	O	O	O

-DOCSTART- (28386950)

Gastrointestinal	O	O	B-T047
disorders	O	O	I-T047
in	O	O	O
Curry-Jones	O	O	B-T047
syndrome	O	O	I-T047
:	O	O	O
Clinical	O	O	B-T080
and	O	O	O
molecular	O	O	B-T080
insights	O	O	B-T041
from	O	O	O
an	O	O	O
affected	O	O	B-T169
newborn	O	O	O

Curry-Jones	O	O	B-T047
syndrome	O	O	I-T047
(	O	O	O
CJS	O	O	B-T047
)	O	O	O
is	O	O	O
a	O	O	O
pattern	O	O	B-T082
of	O	O	O
malformation	O	O	B-T190
that	O	O	O
includes	O	O	O
craniosynostosis	O	O	B-T047
,	O	O	O
pre-axial	O	O	B-T033
polysyndactyly	O	O	I-T033
,	O	O	O
agenesis	O	O	B-T019
of	O	O	I-T019
the	O	O	I-T019
corpus	O	O	I-T019
callosum	O	O	I-T019
,	O	O	O
cutaneous	O	O	B-T033
and	O	O	O
gastrointestinal	O	O	B-T082
abnormalities	O	O	O
.	O	O	O

A	O	O	O
recurrent	O	O	B-T079
,	O	O	O
mosaic	O	O	B-T045
mutation	O	O	I-T045
of	O	O	O
SMO	O	O	B-T049
(	O	O	I-T049
c.1234	O	O	I-T049
C	O	O	I-T049
>	O	O	I-T049
T	O	O	I-T049
;	O	O	I-T049
p.	O	O	I-T049
Leu412Phe	O	O	I-T049
)	O	O	I-T049
causes	O	O	B-T169
CJS	O	O	B-T047
.	O	O	O

This	O	O	O
report	O	O	B-T170
describes	O	O	O
the	O	O	O
gastrointestinal	O	O	B-T082
and	O	O	O
surgical	O	O	B-T033
findings	O	O	I-T033
in	O	O	O
a	O	O	O
baby	O	O	B-T100
with	O	O	O
CJS	O	O	B-T047
who	O	O	O
presented	O	O	O
with	O	O	O
abdominal	O	O	B-T047
obstruction	O	O	I-T047
and	O	O	O
reviews	O	O	B-T169
the	O	O	O
spectrum	O	O	B-T033
of	O	O	I-T033
gastrointestinal	O	O	I-T033
malformations	O	O	I-T033
in	O	O	O
this	O	O	O
rare	O	O	B-T047
disorder	O	O	I-T047
.	O	O	O

A	O	O	O
41-	O	O	O
week	O	O	B-T079
,	O	O	O
4,165	O	O	O
g	O	O	O
,	O	O	O
female	O	O	B-T032
presented	O	O	O
with	O	O	O
craniosynostosis	O	O	B-T047
,	O	O	O
pre-axial	O	O	B-T033
polysyndactyly	O	O	I-T033
,	O	O	O
and	O	O	O
cutaneous	O	O	B-T033
findings	O	O	I-T033
consistent	O	O	O
with	O	O	O
a	O	O	O
clinical	O	O	B-T060
diagnosis	O	O	I-T060
of	O	O	O
CJS	O	O	B-T047
.	O	O	O

The	O	O	O
infant	O	O	B-T100
developed	O	O	O
abdominal	O	O	B-T033
distension	O	O	I-T033
beginning	O	O	B-T079
on	O	O	O
the	O	O	O
second	O	O	B-T081
day	O	O	B-T079
of	O	O	O
life	O	O	B-T078
.	O	O	O

Surgical	O	O	B-T060
exploration	O	O	I-T060
revealed	O	O	B-T080
an	O	O	O
intestinal	O	O	B-T019
malrotation	O	O	I-T019
for	O	O	O
which	O	O	O
she	O	O	O
underwent	O	O	O
a	O	O	O
Ladd	O	O	B-T061
procedure	O	O	I-T061
.	O	O	O

Multiple	O	O	B-T033
small	O	O	I-T033
nodules	O	O	I-T033
were	O	O	O
found	O	O	B-T033
on	O	O	O
the	O	O	O
surface	O	O	B-T029
of	O	O	I-T029
the	O	O	I-T029
small	O	O	I-T029
and	O	O	I-T029
large	O	O	I-T029
bowel	O	O	I-T029
in	O	O	B-T169
addition	O	O	I-T169
to	O	O	I-T169
an	O	O	O
apparent	O	O	B-T078
intestinal	O	O	B-T019
duplication	O	O	I-T019
that	O	O	O
seemed	O	O	O
to	O	O	O
originate	O	O	O
posterior	O	O	B-T082
to	O	O	O
the	O	O	O
pancreas	O	O	B-T023
.	O	O	O

Histopathology	O	O	B-T169
of	O	O	O
serosal	O	O	B-T029
nodules	O	O	B-T020
revealed	O	O	B-T080
bundles	O	O	B-T024
of	O	O	I-T024
smooth	O	O	I-T024
muscle	O	O	I-T024
with	O	O	B-T080
associated	O	O	I-T080
ganglion	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

Molecular	O	O	B-T063
analysis	O	O	I-T063
demonstrated	O	O	O
the	O	O	O
SMO	O	O	B-T049
c.1234	O	O	I-T049
C	O	O	I-T049
>	O	O	I-T049
T	O	O	I-T049
mutation	O	O	I-T049
in	O	O	O
varying	O	O	O
amounts	O	O	O
in	O	O	O
affected	O	O	B-T169
skin	O	O	B-T022
(	O	O	O
up	O	O	O
to	O	O	O
35	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
intestinal	O	O	B-T191
hamartoma	O	O	I-T191
(	O	O	O
26	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

Gastrointestinal	O	O	B-T082
features	O	O	B-T033
including	O	O	O
structural	O	O	B-T033
malformations	O	O	B-T190
,	O	O	O
motility	O	O	B-T046
disorders	O	O	I-T046
,	O	O	O
and	O	O	O
upper	O	O	B-T046
GI	O	O	I-T046
bleeding	O	O	I-T046
are	O	O	O
major	O	O	O
causes	O	O	B-T169
of	O	O	O
morbidity	O	O	B-T081
in	O	O	O
CJS	O	O	B-T047
.	O	O	O

Smooth	O	O	B-T024
muscle	O	O	I-T024
hamartomas	O	O	O
are	O	O	O
a	O	O	O
recognized	O	O	B-T033
feature	O	O	I-T033
of	O	O	O
children	O	O	B-T100
with	O	O	O
CJS	O	O	B-T047
typically	O	O	O
presenting	O	O	O
with	O	O	O
abdominal	O	O	B-T047
obstruction	O	O	I-T047
requiring	O	O	B-T033
surgical	O	O	I-T033
intervention	O	O	I-T033
.	O	O	O

A	O	O	O
somatic	O	O	B-T049
mutation	O	O	I-T049
in	O	O	O
SMO	O	O	B-T028
likely	O	O	O
accounts	O	O	O
for	O	O	O
the	O	O	O
structural	O	O	B-T033
malformations	O	O	B-T190
and	O	O	O
predisposition	O	O	B-T032
to	O	O	O
form	O	O	O
bowel	O	O	B-T191
hamartomas	O	O	I-T191
and	O	O	O
myofibromas	O	O	B-T191
.	O	O	O

The	O	O	O
mutation	O	O	B-T045
burden	O	O	B-T078
in	O	O	O
the	O	O	O
involved	O	O	B-T169
tissues	O	O	B-T024
likely	O	O	O
accounts	O	O	O
for	O	O	O
the	O	O	O
variable	O	O	B-T033
manifestations	O	O	I-T033
.	O	O	O

-DOCSTART- (28387468)

Sella	O	O	B-T190
turcica	O	O	I-T190
bridging	O	O	I-T190
and	O	O	O
dental	O	O	B-T033
anomalies	O	O	I-T033
:	O	O	O
is	O	O	O
there	O	O	O
an	O	O	O
association	O	O	B-T080
?	O	O	O

is	O	O	O
there	O	O	O
an	O	O	O
association	O	O	B-T080
?	O	O	O

Sella	O	O	B-T190
turcica	O	O	I-T190
bridging	O	O	I-T190
(	O	O	O
STB	O	O	B-T190
)	O	O	O
,	O	O	O
or	O	O	O
calcification	O	O	B-T042
of	O	O	O
the	O	O	O
interclinoid	O	O	B-T024
ligament	O	O	I-T024
of	O	O	O
sella	O	O	B-T023
turcica	O	O	I-T023
,	O	O	O
has	O	O	O
been	O	O	O
reported	O	O	O
to	O	O	O
be	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
some	O	O	O
dental	O	O	B-T033
anomalies	O	O	I-T033
(	O	O	O
palatal	O	O	B-T033
canine	O	O	I-T033
impaction	O	O	B-T190
and	O	O	O
transposition	O	O	B-T190
)	O	O	O
.	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
the	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
find	O	O	O
any	O	O	O
association	O	O	B-T080
between	O	O	O
canine	O	O	B-T033
impaction	O	O	B-T190
,	O	O	O
hyperdontia	O	O	B-T033
or	O	O	O
hypodontia	O	O	B-T019
and	O	O	O
sellar	O	O	B-T023
dimensions	O	O	B-T081
or	O	O	O
bridging	O	O	B-T190
.	O	O	O

Lateral	O	O	B-T082
cephalometric	O	O	B-T060
radiographs	O	O	B-T060
from	O	O	O
78	O	O	O
patients	O	O	B-T101
with	O	O	O
impacted	O	O	B-T190
canines	O	O	B-T033
,	O	O	O
68	O	O	O
with	O	O	O
dental	O	O	B-T019
agenesis	O	O	I-T019
and	O	O	O
17	O	O	O
with	O	O	O
hyperdontia	O	O	B-T033
were	O	O	O
collected	O	O	O
.	O	O	O

Linear	O	O	B-T082
dimensions	O	O	B-T081
of	O	O	O
sella	O	O	B-T023
turcica	O	O	I-T023
were	O	O	O
calculated	O	O	O
and	O	O	O
compared	O	O	O
to	O	O	O
those	O	O	O
of	O	O	O
a	O	O	O
control	O	O	B-T096
group	O	O	I-T096
(	O	O	O
47	O	O	O
individuals	O	O	B-T098
)	O	O	O
.	O	O	O

A	O	O	O
standardize	O	O	B-T170
scoring	O	O	I-T170
scale	O	O	I-T170
was	O	O	O
used	O	O	O
to	O	O	O
quantify	O	O	O
the	O	O	O
extent	O	O	O
of	O	O	O
STB	O	O	B-T190
from	O	O	O
each	O	O	O
radiographs	O	O	B-T060
.	O	O	O

The	O	O	O
frequency	O	O	B-T079
of	O	O	O
partial	O	O	B-T081
and	O	O	O
complete	O	O	B-T080
calcifications	O	O	B-T042
of	O	O	O
sella	O	O	B-T023
in	O	O	O
patients	O	O	B-T101
with	O	O	O
dental	O	O	B-T033
anomalies	O	O	I-T033
is	O	O	O
increased	O	O	B-T081
when	O	O	O
compared	O	O	O
to	O	O	O
controls	O	O	B-T096
.	O	O	O

STB	O	O	B-T190
can	O	O	O
influence	O	O	O
the	O	O	O
interclinoid	O	O	B-T081
distance	O	O	I-T081
but	O	O	O
does	O	O	O
not	O	O	O
affect	O	O	O
other	O	O	O
linear	O	O	B-T082
dimensions	O	O	B-T081
of	O	O	O
sella	O	O	B-T023
.	O	O	O

No	O	O	O
statistically	O	O	B-T081
significant	O	O	I-T081
difference	O	O	O
has	O	O	O
been	O	O	O
found	O	O	O
in	O	O	O
sellar	O	O	B-T023
dimensions	O	O	B-T081
and	O	O	O
STB	O	O	B-T190
expression	O	O	O
when	O	O	O
evaluating	O	O	O
radiographs	O	O	B-T060
at	O	O	O
different	O	O	O
ages	O	O	B-T032
.	O	O	O

STB	O	O	B-T190
is	O	O	O
frequently	O	O	O
found	O	O	O
in	O	O	O
patients	O	O	B-T101
with	O	O	O
dental	O	O	B-T033
abnormalities	O	O	I-T033
.	O	O	O

-DOCSTART- (28387835)

Coxiella	O	O	B-T007
burnetii	O	O	I-T007
isolates	O	O	B-T123
originating	O	O	O
from	O	O	O
infected	O	O	B-T015
cattle	O	O	I-T015
induce	O	O	B-T169
a	O	O	O
more	O	O	O
pronounced	O	O	O
proinflammatory	O	O	B-T043
cytokine	O	O	I-T043
response	O	O	I-T043
compared	O	O	O
to	O	O	O
isolates	O	O	O
from	O	O	O
infected	O	O	B-T015
goats	O	O	I-T015
and	O	O	O
sheep	O	O	O

Coxiella	O	O	B-T007
burnetii	O	O	I-T007
is	O	O	O
the	O	O	O
causative	O	O	B-T033
agent	O	O	I-T033
of	O	O	O
Q	O	O	B-T047
fever	O	O	I-T047
.	O	O	O

Although	O	O	O
the	O	O	O
prevalence	O	O	B-T081
of	O	O	O
C.	O	O	B-T007
burnetii	O	O	I-T007
in	O	O	O
cattle	O	O	B-T015
is	O	O	O
much	O	O	O
higher	O	O	O
than	O	O	O
in	O	O	O
goats	O	O	B-T015
and	O	O	O
sheep	O	O	B-T015
,	O	O	O
infected	O	O	B-T015
cattle	O	O	I-T015
are	O	O	O
rarely	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
human	O	O	B-T016
outbreaks	O	O	B-T067
.	O	O	O

We	O	O	O
investigated	O	O	B-T169
whether	O	O	O
the	O	O	O
immune	O	O	B-T042
response	O	O	I-T042
of	O	O	O
humans	O	O	B-T016
differs	O	O	O
after	O	O	O
contact	O	O	O
with	O	O	O
C.	O	O	B-T007
burnetii	O	O	I-T007
isolates	O	O	B-T123
from	O	O	O
different	O	O	O
host	O	O	B-T001
origins	O	O	I-T001
or	O	O	O
with	O	O	O
different	O	O	O
multilocus	O	O	B-T059
variable	O	O	I-T059
number	O	O	I-T059
of	O	O	I-T059
tandem	O	O	I-T059
repeat	O	O	I-T059
analysis	O	O	I-T059
(	O	O	O
MLVA	O	O	B-T059
)	O	O	O
genotypes	O	O	B-T032
.	O	O	O

Cytokine	O	O	B-T043
responses	O	O	I-T043
were	O	O	O
measured	O	O	O
in	O	O	O
human	O	O	B-T016
peripheral	O	O	B-T025
blood	O	O	I-T025
mononuclear	O	O	I-T025
cells	O	O	I-T025
(	O	O	O
PBMCs	O	O	B-T025
)	O	O	O
stimulated	O	O	B-T070
with	O	O	O
16	O	O	O
C.	O	O	B-T007
burnetii	O	O	I-T007
isolates	O	O	B-T123
with	O	O	O
known	O	O	O
MLVA	O	O	B-T059
genotype	O	O	B-T032
from	O	O	O
goats	O	O	B-T015
,	O	O	O
sheep	O	O	B-T015
,	O	O	O
cattle	O	O	B-T015
,	O	O	O
acute	O	O	B-T047
and	O	O	O
chronic	O	O	B-T047
Q	O	O	I-T047
fever	O	O	I-T047
patients	O	O	B-T101
.	O	O	O

Coxiella	O	O	B-T007
burnetii	O	O	I-T007
isolates	O	O	B-T123
originating	O	O	O
from	O	O	O
cattle	O	O	B-T015
induce	O	O	B-T169
significantly	O	O	O
more	O	O	O
IL-1Î²	O	O	B-T116
,	O	O	O
TNF-Î±	O	O	B-T116
and	O	O	O
IL-22	O	O	B-T116
than	O	O	O
the	O	O	O
isolates	O	O	O
from	O	O	O
goats	O	O	B-T015
,	O	O	O
sheep	O	O	B-T015
or	O	O	O
chronic	O	O	B-T047
Q	O	O	I-T047
fever	O	O	I-T047
patients	O	O	B-T101
.	O	O	O

Comparing	O	O	O
the	O	O	O
cytokine	O	O	B-T116
induction	O	O	B-T169
of	O	O	O
the	O	O	O
isolates	O	O	B-T123
based	O	O	O
on	O	O	O
their	O	O	O
MVLA	O	O	B-T059
genotype	O	O	B-T032
did	O	O	O
not	O	O	O
reveal	O	O	O
differences	O	O	O
in	O	O	O
response	O	O	B-T043
between	O	O	O
the	O	O	O
MLVA	O	O	B-T059
genotypes	O	O	B-T032
.	O	O	O

The	O	O	O
proinflammatory	O	O	B-T043
cytokine	O	O	I-T043
response	O	O	I-T043
induced	O	O	B-T169
in	O	O	O
human	O	O	B-T016
PBMCs	O	O	B-T025
by	O	O	O
C.	O	O	B-T007
burnetii	O	O	I-T007
isolates	O	O	B-T123
from	O	O	O
cattle	O	O	B-T015
may	O	O	O
explain	O	O	O
the	O	O	O
low	O	O	O
incidence	O	O	B-T081
of	O	O	O
human	O	O	O
Q	O	O	B-T047
fever	O	O	I-T047
outbreaks	O	O	B-T067
caused	O	O	O
by	O	O	O
cattle	O	O	O
.	O	O	O

The	O	O	O
cytokine	O	O	B-T116
profile	O	O	O
of	O	O	O
PBMCs	O	O	B-T025
stimulated	O	O	B-T070
with	O	O	O
C.	O	O	B-T007
burnetii	O	O	I-T007
isolates	O	O	B-T123
from	O	O	O
chronic	O	O	B-T047
Q	O	O	I-T047
fever	O	O	I-T047
patients	O	O	B-T101
resembles	O	O	O
isolates	O	O	O
from	O	O	O
goats	O	O	B-T015
.	O	O	O

Furthermore	O	O	O
,	O	O	O
cytokine	O	O	B-T043
responses	O	O	I-T043
seem	O	O	O
to	O	O	O
be	O	O	O
depending	O	O	O
on	O	O	O
host	O	O	B-T001
origin	O	O	I-T001
than	O	O	O
on	O	O	O
MLVA	O	O	B-T059
genotype	O	O	B-T032
.	O	O	O

-DOCSTART- (28389374)

A	O	O	O
Novel	O	O	O
BRCA1-Associated	O	O	B-T116
Protein-1	O	O	I-T116
Isoform	O	O	B-T116
Affects	O	O	B-T077
Response	O	O	B-T032
of	O	O	O
Mesothelioma	O	O	B-T191
Cells	O	O	I-T191
to	O	O	O
Drugs	O	O	B-T121
Impairing	O	O	B-T169
BRCA1	O	O	B-T116
-Mediated	O	O	O
DNA	O	O	O
Repair	O	O	O

BRCA1	O	O	B-T116
associated	O	O	I-T116
protein1	O	O	I-T116
(	O	O	O
BAP1	O	O	B-T116
)	O	O	O
is	O	O	O
a	O	O	O
tumor	O	O	B-T116
suppressor	O	O	I-T116
involved	O	O	O
in	O	O	O
multiple	O	O	B-T081
cellular	O	O	B-T043
processes	O	O	I-T043
such	O	O	O
as	O	O	O
transcriptional	O	O	B-T045
regulation	O	O	I-T045
,	O	O	O
chromatin	O	O	B-T045
modification	O	O	I-T045
by	O	O	O
deubiquitinating	O	O	B-T044
histone	O	O	B-T116
2A	O	O	I-T116
,	O	O	O
and	O	O	O
DNA	O	O	B-T045
repair	O	O	I-T045
.	O	O	O

BAP1	O	O	B-T116
mutations	O	O	B-T045
are	O	O	O
frequent	O	O	B-T079
in	O	O	O
malignant	O	O	B-T191
pleural	O	O	I-T191
mesothelioma	O	O	I-T191
(	O	O	O
MPM	O	O	B-T191
)	O	O	O
.	O	O	O

Our	O	O	O
aim	O	O	B-T078
was	O	O	O
to	O	O	O
functionally	O	O	B-T169
characterize	O	O	B-T080
a	O	O	O
newly	O	O	O
identified	O	O	B-T080
isoform	O	O	B-T116
of	O	O	B-T116
BAP1	O	O	I-T116
and	O	O	O
investigate	O	O	B-T169
the	O	O	O
effects	O	O	B-T080
of	O	O	O
its	O	O	O
expression	O	O	B-T045
on	O	O	O
drug	O	O	B-T032
sensitivity	O	O	I-T032
in	O	O	O
MPM	O	O	B-T191
.	O	O	O

Expression	O	O	B-T045
of	O	O	O
BAP1	O	O	B-T116
isoforms	O	O	O
was	O	O	O
detected	O	O	B-T033
by	O	O	O
quantitative	O	O	B-T059
polymerase	O	O	I-T059
chain	O	O	I-T059
reaction	O	O	I-T059
in	O	O	O
MPM	O	O	B-T191
and	O	O	O
normal	O	O	B-T080
mesothelium	O	O	B-T024
cell	O	O	B-T025
lines	O	O	I-T025
and	O	O	O
tumor	O	O	B-T024
and	O	O	O
nontumor	O	O	B-T024
samples	O	O	I-T024
.	O	O	O

Histone	O	O	B-T116
H2A	O	O	I-T116
ubiquitination	O	O	B-T044
levels	O	O	B-T080
were	O	O	O
analyzed	O	O	B-T062
by	O	O	O
Western	O	O	B-T059
blot	O	O	I-T059
after	O	O	O
acidic	O	O	B-T059
extraction	O	O	I-T059
of	O	O	O
core	O	O	B-T116
histones	O	O	I-T116
.	O	O	O

Subcellular	O	O	B-T026
localization	O	O	B-T169
of	O	O	O
BAP1	O	O	B-T116
isoforms	O	O	B-T116
was	O	O	O
examined	O	O	B-T033
by	O	O	O
immunofluorescence	O	O	B-T059
.	O	O	O

MPM	O	O	B-T191
cell	O	O	B-T043
survival	O	O	I-T043
in	O	O	O
response	O	O	B-T032
to	O	O	O
poly(adenosine	O	O	B-T116
diphosphate-ribose	O	O	I-T116
)	O	O	I-T116
polymerase	O	O	I-T116
(	O	O	O
PARP	O	O	B-T116
)	O	O	O
and	O	O	O
dual	O	O	O
phosphoinositide	O	O	B-T116
3-kinase	O	O	I-T116
(PI3K)-	O	O	O
mammalian	O	O	B-T116
target	O	O	I-T116
of	O	O	I-T116
rapamycin	O	O	I-T116
(	O	O	O
mTOR	O	O	B-T116
)	O	O	O
inhibitors	O	O	B-T121
was	O	O	O
analyzed	O	O	B-T062
by	O	O	O
in	O	O	B-T062
vitro	O	O	I-T062
assays	O	O	I-T062
.	O	O	O

We	O	O	O
have	O	O	O
identified	O	O	B-T080
a	O	O	O
novel	O	O	O
alternative	O	O	B-T116
splice	O	O	I-T116
isoform	O	O	I-T116
of	O	O	O
BAP1	O	O	B-T116
(	O	O	O
BAP1Î	O	O	B-T028
)	O	O	O
that	O	O	O
misses	O	O	O
part	O	O	O
of	O	O	O
the	O	O	O
catalytic	O	O	B-T087
domain	O	O	I-T087
.	O	O	O

Cells	O	O	B-T025
transfected	O	O	B-T063
with	O	O	O
BAP1Î	O	O	B-T028
showed	O	O	O
reduced	O	O	B-T080
deubiquitinating	O	O	B-T044
activity	O	O	I-T044
compared	O	O	B-T052
with	O	O	O
full-length	O	O	O
BAP1	O	O	B-T116
.	O	O	O

The	O	O	O
expression	O	O	B-T045
of	O	O	O
BAP1Î	O	O	B-T028
transcript	O	O	B-T114
is	O	O	O
more	O	O	O
abundant	O	O	B-T080
in	O	O	O
nontumor	O	O	B-T024
than	O	O	O
in	O	O	O
tumor	O	O	O
samples	O	O	O
.	O	O	O

MPM	O	O	B-T191
cell	O	O	B-T025
lines	O	O	I-T025
expressing	O	O	B-T045
more	O	O	O
than	O	O	O
20	O	O	O
%	O	O	O
of	O	O	O
BAP1Î	O	O	B-T028
are	O	O	O
more	O	O	O
sensitive	O	O	B-T169
to	O	O	O
olaparib	O	O	B-T109
(	O	O	O
a	O	O	O
PARP1	O	O	B-T116
inhibitor	O	O	B-T121
)	O	O	O
cytotoxicity	O	O	B-T049
,	O	O	O
and	O	O	O
this	O	O	O
sensitivity	O	O	B-T169
is	O	O	O
enhanced	O	O	B-T052
when	O	O	O
olaparib	O	O	O
treatment	O	O	B-T058
is	O	O	O
combined	O	O	B-T080
with	O	O	O
GDC0980	O	O	B-T121
(	O	O	O
a	O	O	O
dual	O	O	O
PI3	O	O	B-T116
K	O	O	I-T116
-	O	O	O
mTOR	O	O	B-T116
inhibitor	O	O	O
)	O	O	O
,	O	O	O
which	O	O	O
induces	O	O	B-T169
downregulation	O	O	B-T044
of	O	O	O
BRCA1	O	O	B-T116
.	O	O	O

These	O	O	O
observations	O	O	B-T062
suggest	O	O	O
that	O	O	O
BAP1Î	O	O	B-T028
does	O	O	O
regulate	O	O	B-T043
DNA	O	O	I-T043
damage	O	O	I-T043
response	O	O	I-T043
and	O	O	O
influences	O	O	B-T077
drug	O	O	B-T032
sensitivity	O	O	I-T032
.	O	O	O

It	O	O	O
might	O	O	O
therefore	O	O	O
be	O	O	O
relevant	O	O	B-T080
to	O	O	O
investigate	O	O	B-T169
whether	O	O	O
patients	O	O	B-T101
with	O	O	O
high	O	O	B-T080
expression	O	O	B-T045
of	O	O	O
BAP1Î	O	O	B-T028
may	O	O	O
be	O	O	O
responsive	O	O	B-T201
to	O	O	O
PARP	O	O	B-T116
/	O	O	O
PI3	O	O	B-T116
K	O	O	I-T116
-	O	O	O
mTOR	O	O	B-T116
inhibitors	O	O	B-T121
.	O	O	O

-DOCSTART- (28390176)

Cucurbitacin	O	O	B-T109
B	O	O	I-T109
Protects	O	O	O
Against	O	O	O
Pressure	O	O	B-T184
Overload	O	O	B-UnknownType
Induced	O	O	O
Cardiac	O	O	O
Hypertrophy	O	O	O

Lack	O	O	O
of	O	O	O
effective	O	O	O
anti-cardiac	O	O	B-T121
hypertrophy	O	O	I-T121
drugs	O	O	I-T121
creates	O	O	O
a	O	O	O
major	O	O	O
cause	O	O	B-T169
for	O	O	O
the	O	O	O
increasing	O	O	O
prevalence	O	O	B-T081
of	O	O	O
heart	O	O	B-T047
failure	O	O	I-T047
.	O	O	O

In	O	O	O
the	O	O	O
present	O	O	O
study	O	O	O
,	O	O	O
we	O	O	O
determined	O	O	O
the	O	O	O
anti-hypertrophy	O	O	B-T033
and	O	O	O
anti-fibrosis	O	O	B-T033
potential	O	O	B-T080
of	O	O	O
a	O	O	O
natural	O	O	B-T002
plant	O	O	I-T002
triterpenoid	O	O	B-T109
,	O	O	O
Cucurbitacin	O	O	B-T109
B	O	O	I-T109
both	O	O	O
in	O	O	B-T062
vitro	O	O	I-T062
and	O	O	O
in	O	O	B-T062
vivo	O	O	I-T062
.	O	O	O

Aortic	O	O	B-T061
banding	O	O	I-T061
(	O	O	O
AB	O	O	B-T061
)	O	O	O
was	O	O	O
performed	O	O	O
to	O	O	O
induce	O	O	O
cardiac	O	O	B-T046
hypertrophy	O	O	I-T046
.	O	O	O

After	O	O	O
1	O	O	O
week	O	O	O
of	O	O	O
surgery	O	O	B-T061
,	O	O	O
mice	O	O	B-T015
were	O	O	O
receive	O	O	O
cucurbitacin	O	O	B-T109
B	O	O	I-T109
treatment	O	O	B-T061
(	O	O	O
Gavage	O	O	B-T169
,	O	O	O
0.2	O	O	O
mg/kg	O	O	O
body	O	O	B-T032
weight	O	O	I-T032
/2	O	O	O
day	O	O	O
)	O	O	O
.	O	O	O

After	O	O	O
4	O	O	O
weeks	O	O	O
of	O	O	O
AB	O	O	B-T061
,	O	O	O
cucurbitacin	O	O	B-T109
B	O	O	I-T109
demonstrated	O	O	O
a	O	O	O
strong	O	O	O
anti-hypertrophy	O	O	B-T033
and	O	O	O
-fibrosis	O	O	B-T033
ability	O	O	O
as	O	O	O
evidenced	O	O	O
by	O	O	O
decreased	O	O	O
of	O	O	O
heart	O	O	B-T023
weight	O	O	B-T081
,	O	O	O
myocardial	O	O	B-T025
cell	O	O	I-T025
cross-sectional	O	O	B-T201
area	O	O	I-T201
and	O	O	O
interstitial	O	O	B-T046
fibrosis	O	O	I-T046
,	O	O	O
ameliorated	O	O	O
of	O	O	O
systolic	O	O	B-T079
and	O	O	O
diastolic	O	O	B-T201
abnormalities	O	O	B-T033
,	O	O	O
normalized	O	O	O
in	O	O	O
gene	O	O	B-T045
expression	O	O	I-T045
of	O	O	O
hypertrophic	O	O	B-T046
and	O	O	O
fibrotic	O	O	B-T169
markers	O	O	B-T201
,	O	O	O
reserved	O	O	O
microvascular	O	O	B-T080
density	O	O	I-T080
in	O	O	O
pressure	O	O	B-T184
overload	O	O	B-UnknownType
induced	O	O	O
hypertrophic	O	O	O
mice	O	O	B-T015
.	O	O	O

Cucurbitacin	O	O	B-T109
B	O	O	I-T109
also	O	O	O
showed	O	O	O
significant	O	O	O
hypertrophy	O	O	B-T046
inhibitory	O	O	B-T033
effect	O	O	I-T033
in	O	O	O
phenylephrine	O	O	B-T109
stimulated	O	O	B-T070
cardiomyocytes	O	O	B-T025
.	O	O	O

The	O	O	O
Cucurbitacin	O	O	B-T109
B	O	O	I-T109
-mediated	O	O	O
mitigated	O	O	B-T067
cardiac	O	O	B-T046
hypertrophy	O	O	I-T046
was	O	O	O
attributable	O	O	O
to	O	O	O
the	O	O	O
increasing	O	O	O
level	O	O	O
of	O	O	O
autophagy	O	O	B-T043
,	O	O	O
which	O	O	O
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
the	O	O	O
blockade	O	O	B-T169
of	O	O	O
Akt	O	O	B-T116
/	O	O	O
mTOR	O	O	B-T116
/	O	O	O
FoxO3a	O	O	B-T116
signal	O	O	B-T044
pathway	O	O	I-T044
,	O	O	O
validated	O	O	O
by	O	O	O
SC79	O	O	B-T109
,	O	O	O
MK2206	O	O	B-T109
,	O	O	O
and	O	O	O
3-MA	O	O	B-T114
,	O	O	O
the	O	O	O
Akt	O	O	O
agonist	O	O	B-T121
,	O	O	O
inhibitor	O	O	B-T120
and	O	O	O
autophagy	O	O	O
inhibitor	O	O	O
in	O	O	B-T062
vitro	O	O	I-T062
.	O	O	O

The	O	O	O
overexpression	O	O	B-T045
of	O	O	O
constitutively	O	O	O
active	O	O	O
Akt	O	O	B-T116
completely	O	O	O
abolished	O	O	O
the	O	O	O
Cucurbitacin	O	O	B-T109
B	O	O	I-T109
-mediated	O	O	O
protection	O	O	O
of	O	O	O
cardiac	O	O	B-T046
hypertrophy	O	O	I-T046
in	O	O	O
human	O	O	B-T016
cardiomyocytes	O	O	B-T025
AC16	O	O	I-T025
.	O	O	O

Collectively	O	O	O
,	O	O	O
our	O	O	O
findings	O	O	O
suggest	O	O	O
that	O	O	O
cucurbitacin	O	O	B-T109
B	O	O	I-T109
protects	O	O	O
against	O	O	O
cardiac	O	O	B-T046
hypertrophy	O	O	I-T046
through	O	O	O
increasing	O	O	O
the	O	O	O
autophagy	O	O	B-T043
level	O	O	O
in	O	O	O
cardiomyocytes	O	O	B-T025
,	O	O	O
which	O	O	O
is	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
the	O	O	O
inhibition	O	O	B-T043
of	O	O	O
Akt	O	O	B-T116
/	O	O	O
mTOR	O	O	B-T116
/	O	O	O
FoxO3a	O	O	B-T116
signal	O	O	B-T044
axis	O	O	I-T044
.	O	O	O

J.	O	O	O
Cell	O	O	O
.	O	O	O
Biochem	O	O	O
.	O	O	O
9999	O	O	O
:	O	O	O
1	O	O	O
-	O	O	O
12	O	O	O
,	O	O	O
2017	O	O	O
.	O	O	O

Â©	O	O	O
2017	O	O	O
Wiley	O	O	O
Periodicals	O	O	O
,	O	O	O
Inc.	O	O	O

-DOCSTART- (28391514)

Inflammatory	O	O	B-T169
and	O	O	O
Oxidative	O	O	B-T049
Stress	O	O	I-T049
Markers	O	O	B-T201
in	O	O	O
Experimental	O	O	B-T080
Allergic	O	O	O
Asthma	O	O	O

Ovalbumin	O	O	B-T116
-	O	O	O
induced	O	O	B-T169
allergic	O	O	B-T047
lung	O	O	I-T047
inflammation	O	O	I-T047
(	O	O	O
ALI	O	O	B-T047
)	O	O	O
is	O	O	O
a	O	O	O
condition	O	O	B-T080
believed	O	O	O
to	O	O	O
be	O	O	O
mediated	O	O	O
by	O	O	O
cytokines	O	O	B-T116
,	O	O	O
extracellular	O	O	B-T024
matrix	O	O	I-T024
remodeling	O	O	B-T038
,	O	O	O
and	O	O	O
redox	O	O	B-T044
imbalance	O	O	B-T184
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
we	O	O	O
evaluated	O	O	B-T058
pulmonary	O	O	B-T042
function	O	O	I-T042
together	O	O	O
with	O	O	O
inflammatory	O	O	B-T169
markers	O	O	B-T201
as	O	O	O
interleukin-4	O	O	B-T116
(	O	O	O
IL-4	O	O	B-T116
)	O	O	O
,	O	O	O
myeloperoxidase	O	O	B-T116
(	O	O	O
MPO	O	O	B-T116
)	O	O	O
,	O	O	O
eosinophil	O	O	B-T025
cells	O	O	I-T025
,	O	O	O
and	O	O	O
redox	O	O	B-T044
markers	O	O	O
in	O	O	O
the	O	O	O
lungs	O	O	B-T023
of	O	O	O
BALB/c	O	O	B-T015
mice	O	O	I-T015
after	O	O	O
ovalbumin	O	O	B-T116
(	O	O	O
OVA	O	O	B-T116
)	O	O	O
sensitization	O	O	B-T040
and	O	O	O
challenge	O	O	B-T059
.	O	O	O

Our	O	O	O
results	O	O	B-T169
showed	O	O	O
an	O	O	O
increase	O	O	B-T169
in	O	O	O
bronchial	O	O	B-T047
hyperresponsiveness	O	O	I-T047
stimulated	O	O	B-T070
by	O	O	O
methacholine	O	O	B-T109
(	O	O	O
Mch	O	O	B-T109
)	O	O	O
,	O	O	O
inflammatory	O	O	B-T169
cell	O	O	B-T043
influx	O	O	I-T043
,	O	O	O
especially	O	O	O
eosinophils	O	O	B-T025
together	O	O	O
with	O	O	O
an	O	O	O
increase	O	O	O
of	O	O	O
high	O	O	B-T116
mobility	O	O	I-T116
group	O	O	B-UnknownType
box	O	O	I-T116
1	O	O	I-T116
(	O	O	O
HMGB1	O	O	B-T116
)	O	O	O
and	O	O	O
altered	O	O	O
lipid	O	O	B-T044
peroxidation	O	O	I-T044
(	O	O	O
LP	O	O	B-T044
)	O	O	O
and	O	O	O
antioxidant	O	O	B-T121
defenses	O	O	B-T077
in	O	O	O
the	O	O	O
OVA	O	O	B-T116
group	O	O	O
compared	O	O	O
to	O	O	O
the	O	O	O
control	O	O	B-T096
group	O	O	I-T096
(	O	O	O
p	O	O	O
â¤	O	O	O
0.5	O	O	O
)	O	O	O
.	O	O	O

Thus	O	O	O
,	O	O	O
we	O	O	O
demonstrated	O	O	O
that	O	O	O
OVA	O	O	B-T116
-	O	O	O
induced	O	O	B-T169
ALI	O	O	B-T047
altered	O	O	O
redox	O	O	B-T044
status	O	O	O
concomitantly	O	O	B-T079
with	O	O	O
impaired	O	O	B-T169
lung	O	O	B-T039
function	O	O	I-T039
,	O	O	O
which	O	O	O
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
HMGB1	O	O	B-T116
expression	O	O	B-T045
and	O	O	O
proteolytic	O	O	B-T044
remodeling	O	O	B-T038
.	O	O	O

Taken	O	O	O
together	O	O	O
all	O	O	O
results	O	O	B-T169
found	O	O	O
here	O	O	O
,	O	O	O
we	O	O	O
may	O	O	O
suggest	O	O	O
HMGB1	O	O	B-T116
is	O	O	O
an	O	O	O
important	O	O	B-T080
therapeutic	O	O	B-T169
target	O	O	B-T169
for	O	O	O
asthma	O	O	B-T047
,	O	O	O
once	O	O	O
orchestrates	O	O	B-T080
the	O	O	O
redox	O	O	B-T044
signaling	O	O	B-T038
,	O	O	O
inflammation	O	O	B-T046
,	O	O	O
and	O	O	O
remodeling	O	O	B-T038
that	O	O	O
contribute	O	O	O
to	O	O	O
the	O	O	O
disease	O	O	B-T047
development	O	O	B-T169
.	O	O	O

-DOCSTART- (28391546)

Association	O	O	B-T080
among	O	O	O
prematurity	O	O	B-T047
(	O	O	O
<	O	O	B-T032
30	O	O	I-T032
weeks	O	O	I-T032
'	O	O	I-T032
gestational	O	O	I-T032
age	O	O	I-T032
)	O	O	O
,	O	O	O
blood	O	O	B-T040
pressure	O	O	I-T040
,	O	O	O
urinary	O	O	B-T080
albumin	O	O	B-T116
,	O	O	O
calcium	O	O	B-T121
,	O	O	O
and	O	O	O
phosphate	O	O	B-T121
in	O	O	O
early	O	O	O
childhood	O	O	O

There	O	O	O
is	O	O	O
a	O	O	O
paucity	O	O	O
of	O	O	O
data	O	O	B-T078
on	O	O	O
blood	O	O	B-T040
pressures	O	O	I-T040
(	O	O	O
BP	O	O	B-T040
)	O	O	O
,	O	O	O
urinary	O	O	B-T080
albumin	O	O	B-T116
,	O	O	O
and	O	O	O
mineral	O	O	B-T197
excretion	O	O	B-T039
in	O	O	O
early	O	O	B-T079
childhood	O	O	I-T079
in	O	O	O
contemporary	O	O	B-T079
cohorts	O	O	B-T098
of	O	O	O
extremely	O	O	B-T080
low	O	O	B-T080
gestational	O	O	B-T032
age	O	O	I-T032
(	O	O	O
GA	O	O	B-T032
)	O	O	O
neonates	O	O	B-T100
.	O	O	O

Our	O	O	O
aim	O	O	O
was	O	O	O
to	O	O	O
compare	O	O	B-T052
BPs	O	O	B-T040
and	O	O	O
the	O	O	O
urinary	O	O	B-T080
excretion	O	O	B-T039
of	O	O	O
albumin	O	O	B-T116
,	O	O	O
calcium	O	O	B-T121
,	O	O	O
and	O	O	O
phosphate	O	O	B-T121
in	O	O	O
preterm	O	O	B-T079
and	O	O	O
term-born	O	O	B-T040
cohorts	O	O	B-T098
in	O	O	O
early	O	O	B-T079
childhood	O	O	I-T079
.	O	O	O

This	O	O	O
was	O	O	O
a	O	O	O
prospective	O	O	B-T062
observational	O	O	I-T062
study	O	O	I-T062
conducted	O	O	O
at	O	O	O
a	O	O	O
single	O	O	B-T081
center	O	O	B-T093
,	O	O	O
involving	O	O	B-T169
children	O	O	B-T100
<	O	O	B-T032
5	O	O	I-T032
years	O	O	I-T032
age	O	O	I-T032
,	O	O	O
born	O	O	B-T033
preterm	O	O	I-T033
(	O	O	O
GA	O	O	B-T033
<	O	O	I-T033
30	O	O	I-T033
weeks	O	O	I-T033
)	O	O	O
or	O	O	O
at	O	O	B-T040
term	O	O	I-T040
(	O	O	O
â¥37	O	O	B-T033
weeks	O	O	I-T033
'	O	O	I-T033
GA	O	O	I-T033
)	O	O	O
.	O	O	O

Urinary	O	O	B-T034
albumin	O	O	I-T034
(	O	O	O
mg/L	O	O	O
)	O	O	O
,	O	O	O
calcium	O	O	B-T034
and	O	O	O
phosphate	O	O	B-T034
levels	O	O	I-T034
indexed	O	O	B-T170
to	O	O	O
creatinine	O	O	B-T109
(	O	O	O
mg/dL	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
BP	O	O	B-T040
were	O	O	O
measured	O	O	B-T080
.	O	O	O

The	O	O	O
median	O	O	B-T082
(	O	O	O
IQR	O	O	B-T081
)	O	O	O
follow-up	O	O	B-T058
age	O	O	B-T032
of	O	O	O
our	O	O	O
cohort	O	O	B-T098
(	O	O	O
n	O	O	O
=	O	O	O
106	O	O	O
)	O	O	O
was	O	O	O
30	O	O	O
(	O	O	O
16	O	O	O
-	O	O	O
48	O	O	O
)	O	O	O
months	O	O	B-T079
.	O	O	O

Preterm-born	O	O	B-T100
children	O	O	I-T100
(	O	O	O
n	O	O	O
=	O	O	O
55	O	O	O
)	O	O	O
had	O	O	O
a	O	O	O
significantly	O	O	B-T081
lower	O	O	I-T081
mean	O	O	B-T081
GA	O	O	B-T032
and	O	O	O
birth	O	O	B-T032
weight	O	O	I-T032
and	O	O	O
higher	O	O	B-T080
mean	O	O	O
systolic	O	O	B-T201
,	O	O	O
diastolic	O	O	B-T201
,	O	O	O
and	O	O	O
mean	O	O	B-T033
BPs	O	O	I-T033
,	O	O	O
compared	O	O	B-T052
with	O	O	O
term	O	O	B-T040
(	O	O	O
n	O	O	O
=	O	O	O
51	O	O	O
)	O	O	O
controls	O	O	B-T096
.	O	O	O

A	O	O	O
significantly	O	O	B-T081
higher	O	O	I-T081
proportion	O	O	B-T081
of	O	O	O
preterm-born	O	O	B-T100
children	O	O	I-T100
weighed	O	O	B-T032
<	O	O	B-T033
10th	O	O	I-T033
centile	O	O	I-T033
and	O	O	O
had	O	O	O
systolic	O	O	B-T201
BP	O	O	I-T201
>	O	O	B-T033
95th	O	O	I-T033
centile	O	O	I-T033
at	O	O	O
follow-up	O	O	B-T058
.	O	O	O

Albumin	O	O	B-T116
and	O	O	O
calcium	O	O	B-T121
excretion	O	O	B-T039
did	O	O	O
not	O	O	B-T033
differ	O	O	I-T033
between	O	O	O
the	O	O	O
groups	O	O	B-UnknownType
;	O	O	O
median	O	O	B-T081
urine-phosphate	O	O	B-T201
creatinine	O	O	I-T201
ratios	O	O	I-T201
were	O	O	O
higher	O	O	B-T080
in	O	O	O
the	O	O	O
preterm	O	O	B-T100
group	O	O	I-T100
.	O	O	O

On	O	O	O
logistic	O	O	B-T062
regression	O	O	I-T062
,	O	O	O
lower	O	O	B-T080
GA	O	O	B-T032
and	O	O	O
younger	O	O	B-T079
age	O	O	B-T032
at	O	O	O
follow-up	O	O	B-T058
were	O	O	O
significantly	O	O	B-T078
associated	O	O	B-T080
with	O	O	I-T080
an	O	O	O
increased	O	O	B-T081
risk	O	O	B-T078
of	O	O	O
systolic	O	O	B-T201
and	O	O	O
diastolic	O	O	B-T201
BP	O	O	I-T201
above	O	O	O
the	O	O	O
95th	O	O	B-T033
centile	O	O	I-T033
;	O	O	O
male	O	O	B-T032
gender	O	O	I-T032
was	O	O	O
associated	O	O	O
with	O	O	O
decreased	O	O	B-T081
risk	O	O	O
of	O	O	O
diastolic	O	O	B-T047
hypertension	O	O	I-T047
.	O	O	O

Even	O	O	O
in	O	O	O
early	O	O	B-T079
childhood	O	O	I-T079
,	O	O	O
children	O	O	B-T100
born	O	O	I-T100
preterm	O	O	I-T100
had	O	O	O
significantly	O	O	B-T078
elevated	O	O	B-T080
BP	O	O	B-T040
,	O	O	O
compared	O	O	B-T052
with	O	O	O
their	O	O	O
term-born	O	O	B-T040
counterparts	O	O	B-T096
.	O	O	O

Closer	O	O	O
monitoring	O	O	B-T058
of	O	O	O
BPs	O	O	B-T040
in	O	O	O
this	O	O	O
population	O	O	B-T098
may	O	O	O
be	O	O	O
warranted	O	O	O
.	O	O	O

-DOCSTART- (28391978)

Recombinant	O	O	B-T116
protein	O	O	B-T087
transduction	O	O	I-T087
domain	O	O	I-T087
-	O	O	O
Cu/Zn	O	O	B-T116
superoxide	O	O	I-T116
dismutase	O	O	I-T116
alleviates	O	O	B-T080
bone	O	O	B-T191
cancer	O	O	I-T191
pain	O	O	B-T184
via	O	O	O
peroxiredoxin	O	O	B-T116
4	O	O	I-T116
modulation	O	O	B-T044
and	O	O	O
antioxidation	O	O	O

Bone	O	O	B-T191
cancer	O	O	I-T191
pain	O	O	B-T184
(	O	O	O
BCP	O	O	B-T184
)	O	O	O
is	O	O	O
a	O	O	O
serious	O	O	B-T080
chronic	O	O	B-T079
clinical	O	O	B-T080
condition	O	O	I-T080
and	O	O	O
reactive	O	O	B-T123
oxygen	O	O	I-T123
species	O	O	I-T123
(	O	O	O
ROS	O	O	B-T123
)	O	O	O
were	O	O	O
considered	O	O	B-T078
to	O	O	O
be	O	O	O
involved	O	O	B-T169
in	O	O	O
its	O	O	O
development	O	O	B-T169
and	O	O	O
persistency	O	O	B-T079
.	O	O	O

Normally	O	O	B-T080
,	O	O	O
superoxide	O	O	B-T116
dismutase	O	O	I-T116
(	O	O	O
SOD	O	O	B-T116
)	O	O	O
converts	O	O	O
superoxide	O	O	B-T196
anions	O	O	I-T196
to	O	O	O
hydrogen	O	O	B-T121
peroxide	O	O	I-T121
(	O	O	O
H2O2	O	O	B-T121
)	O	O	O
and	O	O	O
H2O2	O	O	O
is	O	O	O
then	O	O	O
naturalized	O	O	O
to	O	O	O
be	O	O	O
water	O	O	B-T121
by	O	O	O
peroxiredoxin	O	O	B-T116
4	O	O	I-T116
.	O	O	O

We	O	O	O
reported	O	O	B-T170
previously	O	O	O
that	O	O	O
recombinant	O	O	B-T116
protein	O	O	B-T087
transduction	O	O	I-T087
domain	O	O	I-T087
(PTD)-	O	O	O
Cu/Zn	O	O	B-T116
SOD	O	O	I-T116
effectively	O	O	B-T080
scavenged	O	O	B-T044
excessive	O	O	B-T080
ROS	O	O	B-T123
and	O	O	O
prevented	O	O	B-T169
cardiomyocytes	O	O	B-T025
from	O	O	O
hypoxia-reoxygenation	O	O	B-T169
damage	O	O	B-T169
.	O	O	O

However	O	O	O
,	O	O	O
whether	O	O	O
PTD	O	O	B-T087
-	O	O	O
Cu/Zn	O	O	B-T116
SOD	O	O	I-T116
would	O	O	O
prevent	O	O	B-T169
BCP	O	O	B-T184
development	O	O	B-T169
is	O	O	O
unknown	O	O	B-T080
.	O	O	O

In	O	O	O
the	O	O	O
current	O	O	B-T079
study	O	O	B-T062
,	O	O	O
we	O	O	O
found	O	O	B-T033
that	O	O	O
an	O	O	O
implanted	O	O	B-T074
carcinoma	O	O	B-T191
in	O	O	O
the	O	O	O
rat	O	O	B-T015
tibia	O	O	B-T023
induced	O	O	B-T169
remarkable	O	O	O
hyperalgesia	O	O	B-T184
,	O	O	O
increased	O	O	B-T081
H2O2	O	O	B-T121
levels	O	O	B-T080
and	O	O	O
decreased	O	O	B-T081
SOD	O	O	B-T116
and	O	O	O
peroxiredoxin	O	O	B-T116
4	O	O	I-T116
levels	O	O	O
.	O	O	O

After	O	O	O
administration	O	O	B-T169
of	O	O	O
recombinant	O	O	B-T116
PTD	O	O	B-T087
-	O	O	O
Cu/Zn	O	O	B-T116
SOD	O	O	I-T116
to	O	O	O
these	O	O	O
tumor-burden	O	O	B-T081
rats	O	O	B-T015
,	O	O	O
their	O	O	O
hyperalgesia	O	O	B-T184
was	O	O	O
significantly	O	O	B-T078
attenuated	O	O	B-T052
and	O	O	O
peroxiredoxin	O	O	B-T116
4	O	O	I-T116
expression	O	O	B-T045
was	O	O	O
significantly	O	O	B-T081
increased	O	O	I-T081
.	O	O	O

In	O	O	B-T169
addition	O	O	I-T169
,	O	O	O
an	O	O	O
increased	O	O	B-T081
expression	O	O	B-T045
of	O	O	O
N-methyl-d-aspartic	O	O	B-T116
acid	O	O	I-T116
(	O	O	I-T116
NMDA	O	O	I-T116
)	O	O	I-T116
receptors	O	O	I-T116
and	O	O	O
a	O	O	O
decreased	O	O	B-T081
expression	O	O	O
of	O	O	O
Î³-aminobutyric	O	O	B-T116
acid	O	O	I-T116
(	O	O	I-T116
GABA	O	O	I-T116
)	O	O	I-T116
receptors	O	O	I-T116
in	O	O	O
this	O	O	O
cancer	O	O	B-T184
pain	O	O	I-T184
were	O	O	O
prevented	O	O	B-T169
by	O	O	O
PTD	O	O	B-T087
-	O	O	O
Cu/Zn	O	O	B-T116
SOD	O	O	I-T116
administration	O	O	B-T169
or	O	O	O
peroxiredoxin	O	O	B-T116
4	O	O	I-T116
overexpression	O	O	B-T045
.	O	O	O

Our	O	O	O
data	O	O	B-T078
suggested	O	O	B-T078
that	O	O	O
reactive	O	O	B-T123
oxygen	O	O	I-T123
species	O	O	I-T123
,	O	O	O
at	O	O	O
least	O	O	O
in	O	O	O
part	O	O	O
,	O	O	O
play	O	O	O
a	O	O	O
role	O	O	B-T077
in	O	O	O
cancer	O	O	B-T191
metastatic	O	O	I-T191
pain	O	O	B-T184
development	O	O	B-T169
and	O	O	O
persistency	O	O	B-T079
which	O	O	O
can	O	O	O
be	O	O	O
attenuated	O	O	B-T080
by	O	O	I-T080
the	O	O	O
adminstration	O	O	B-T169
of	O	O	O
recombinant	O	O	B-T116
PTD	O	O	I-T116
-	O	O	O
Cu/Zn	O	O	B-T116
SOD	O	O	I-T116
via	O	O	O
the	O	O	O
peroxiredoxin	O	O	B-T116
4	O	O	I-T116
modulation	O	O	B-T044
from	O	O	O
oxidative	O	O	B-T049
stress	O	O	I-T049
.	O	O	O

-DOCSTART- (28392427)

Immune	O	O	B-T033
dysregulation	O	O	I-T033
in	O	O	O
offspring	O	O	B-T099
of	O	O	O
a	O	O	O
bipolar	O	O	B-T048
parent	O	O	B-T099
.	O	O	O
Altered	O	O	O
serum	O	O	B-T031
levels	O	O	B-T080
of	O	O	O
immune	O	O	B-T169
growth	O	O	B-T116
factors	O	O	I-T116
at	O	O	O
adolescent	O	O	O
age	O	O	O

Altered	O	O	O
serum	O	O	B-T031
levels	O	O	B-T080
of	O	O	O
immune	O	O	B-T169
growth	O	O	B-T116
factors	O	O	I-T116
at	O	O	O
adolescent	O	O	B-T100
age	O	O	I-T100
Immune	O	O	B-T033
dysregulation	O	O	I-T033
plays	O	O	O
a	O	O	O
role	O	O	O
in	O	O	O
the	O	O	O
vulnerability	O	O	B-T033
for	O	O	O
mood	O	O	B-T048
disorders	O	O	I-T048
.	O	O	O

Immune	O	O	B-T169
growth	O	O	B-T116
factors	O	O	I-T116
,	O	O	O
such	O	O	O
as	O	O	O
Stem	O	O	B-T116
Cell	O	O	I-T116
Factor	O	O	I-T116
(	O	O	O
SCF	O	O	B-T116
)	O	O	O
,	O	O	O
Insulin-like	O	O	B-T116
Growth	O	O	I-T116
Factor-Binding	O	O	I-T116
Protein-2	O	O	I-T116
(	O	O	O
IGF-BP2	O	O	B-T116
)	O	O	O
,	O	O	O
Epidermal	O	O	B-T116
Growth	O	O	I-T116
Factor	O	O	I-T116
(	O	O	O
EGF	O	O	B-T116
)	O	O	O
,	O	O	O
IL-7	O	O	B-T116
and	O	O	O
sCD25	O	O	B-T116
have	O	O	O
repeatedly	O	O	O
been	O	O	O
reported	O	O	O
altered	O	O	B-T169
in	O	O	O
patients	O	O	B-T101
with	O	O	O
mood	O	O	B-T048
disorders	O	O	I-T048
.	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
investigate	O	O	B-T169
levels	O	O	B-T080
of	O	O	O
these	O	O	O
factors	O	O	B-T116
in	O	O	O
serum	O	O	B-T031
of	O	O	O
adolescent	O	O	B-T100
bipolar	O	O	B-T048
offspring	O	O	B-T099
,	O	O	O
who	O	O	O
have	O	O	O
a	O	O	O
heightened	O	O	B-T080
risk	O	O	B-T078
for	O	O	O
mood	O	O	B-T048
disorder	O	O	I-T048
development	O	O	B-T169
and	O	O	O
to	O	O	O
also	O	O	O
analyze	O	O	B-T062
the	O	O	O
data	O	O	B-T078
combined	O	O	O
with	O	O	O
previously	O	O	O
published	O	O	B-T170
data	O	O	I-T170
.	O	O	O

Growth	O	O	B-T116
factors	O	O	I-T116
were	O	O	O
assessed	O	O	B-T052
by	O	O	O
CBA	O	O	B-T059
/	O	O	O
ELISA	O	O	B-T059
in	O	O	O
adolescent	O	O	B-T100
bipolar	O	O	B-T048
offspring	O	O	B-T099
(	O	O	O
n=96	O	O	O
,	O	O	O
mean	O	O	B-T081
age	O	O	B-T032
=	O	O	O
16	O	O	O
years	O	O	B-T079
)	O	O	O
and	O	O	O
in	O	O	O
age	O	O	O
-	O	O	O
and	O	O	O
gender	O	O	B-T032
-	O	O	O
matched	O	O	B-T080
healthy	O	O	B-T080
controls	O	O	B-T096
(	O	O	O
n=50	O	O	O
)	O	O	O
.	O	O	O

EGF	O	O	B-T116
belonged	O	O	O
to	O	O	O
a	O	O	O
mutually	O	O	O
correlating	O	O	B-T080
cluster	O	O	B-T081
of	O	O	O
mainly	O	O	O
neurotrophic	O	O	B-T116
compounds	O	O	I-T116
including	O	O	O
S100B	O	O	B-T116
and	O	O	O
BDNF	O	O	B-T116
,	O	O	O
which	O	O	O
were	O	O	O
in	O	O	O
general	O	O	O
decreased	O	O	B-T081
in	O	O	O
serum	O	O	B-T031
.	O	O	O

IL-7	O	O	B-T116
,	O	O	O
SCF	O	O	B-T116
,	O	O	O
IGF-BP2	O	O	B-T116
and	O	O	O
sCD25	O	O	B-T116
,	O	O	O
belonged	O	O	O
to	O	O	O
a	O	O	O
different	O	O	O
mutually	O	O	O
correlating	O	O	B-T080
cluster	O	O	B-T081
of	O	O	O
immune	O	O	B-T169
growth	O	O	B-T116
factors	O	O	I-T116
,	O	O	O
which	O	O	O
were	O	O	O
in	O	O	O
general	O	O	O
increased	O	O	B-T081
:	O	O	O
IGF-BP2	O	O	O
significantly	O	O	B-T078
in	O	O	O
serum	O	O	B-T031
of	O	O	O
offspring	O	O	B-T099
without	O	O	O
a	O	O	O
mood	O	O	B-T048
disorder	O	O	I-T048
,	O	O	O
IL-7	O	O	O
and	O	O	O
SCF	O	O	O
in	O	O	O
serum	O	O	O
of	O	O	O
offspring	O	O	O
who	O	O	O
had	O	O	O
expirienced	O	O	B-T041
a	O	O	O
mood	O	O	B-T048
episode	O	O	I-T048
.	O	O	O

This	O	O	O
pattern	O	O	B-T082
of	O	O	O
de	O	O	B-T081
-	O	O	O
and	O	O	O
increases	O	O	B-T169
was	O	O	O
not	O	O	O
different	O	O	O
between	O	O	O
bipolar	O	O	B-T048
offspring	O	O	B-T099
that	O	O	O
developed	O	O	O
or	O	O	O
did	O	O	O
not	O	O	O
develop	O	O	O
a	O	O	O
mood	O	O	B-T048
disorder	O	O	I-T048
over	O	O	O
time	O	O	B-T079
,	O	O	O
apart	O	O	O
from	O	O	O
the	O	O	O
IGF-BP2	O	O	B-T116
level	O	O	B-T080
,	O	O	O
which	O	O	O
was	O	O	O
near	O	O	O
significantly	O	O	B-T078
higher	O	O	O
in	O	O	O
offspring	O	O	O
later	O	O	O
developing	O	O	O
a	O	O	O
mood	O	O	O
disorder	O	O	O
.	O	O	O

Correlations	O	O	B-T080
with	O	O	O
the	O	O	O
previously	O	O	O
published	O	O	B-T170
immune-cellular	O	O	B-T190
abnormalities	O	O	I-T190
were	O	O	O
not	O	O	O
found	O	O	O
.	O	O	O

In	O	O	O
conclusion	O	O	B-T078
non-affected	O	O	O
adolescents	O	O	B-T100
at	O	O	O
familial	O	O	B-T169
mood	O	O	B-T048
disorder	O	O	I-T048
development	O	O	B-T169
risk	O	O	B-T078
were	O	O	O
characterized	O	O	B-T052
by	O	O	O
a	O	O	O
distinct	O	O	O
pattern	O	O	B-T082
of	O	O	O
a	O	O	O
series	O	O	O
of	O	O	O
compounds	O	O	B-T116
operating	O	O	O
in	O	O	O
a	O	O	O
network	O	O	B-T169
of	O	O	O
hematopoiesis	O	O	B-T042
,	O	O	O
neurogenesis	O	O	B-T040
and	O	O	O
inflammation	O	O	B-T046
.	O	O	O

-DOCSTART- (28394935)

eNOS	O	O	B-T116
S-nitrosylates	O	O	B-T044
Î²-actin	O	O	B-T116
on	O	O	O
Cys374	O	O	B-T116
and	O	O	O
regulates	O	O	B-T044
PKC-Î¸	O	O	B-T116
at	O	O	O
the	O	O	O
immune	O	O	B-T026
synapse	O	O	I-T026
by	O	O	O
impairing	O	O	B-T169
actin	O	O	B-T044
binding	O	O	I-T044
to	O	O	O
profilin-1	O	O	O

The	O	O	O
actin	O	O	B-T043
cytoskeleton	O	O	I-T043
coordinates	O	O	I-T043
the	O	O	I-T043
organization	O	O	I-T043
of	O	O	O
signaling	O	O	B-T129
microclusters	O	O	I-T129
at	O	O	O
the	O	O	O
immune	O	O	B-T026
synapse	O	O	I-T026
(	O	O	O
IS	O	O	B-T026
)	O	O	O
;	O	O	O
however	O	O	O
,	O	O	O
the	O	O	O
mechanisms	O	O	B-T044
involved	O	O	O
remain	O	O	O
poorly	O	O	O
understood	O	O	O
.	O	O	O

We	O	O	O
show	O	O	O
here	O	O	O
that	O	O	O
nitric	O	O	B-T121
oxide	O	O	I-T121
(	O	O	O
NO	O	O	B-T121
)	O	O	O
generated	O	O	O
by	O	O	O
endothelial	O	O	B-T116
nitric	O	O	I-T116
oxide	O	O	I-T116
synthase	O	O	I-T116
(	O	O	O
eNOS	O	O	B-T116
)	O	O	O
controls	O	O	O
the	O	O	O
coalescence	O	O	O
of	O	O	O
protein	O	O	B-T116
kinase	O	O	I-T116
C-Î¸	O	O	I-T116
(	O	O	O
PKC-Î¸	O	O	B-T116
)	O	O	O
at	O	O	O
the	O	O	O
central	O	O	B-T026
supramolecular	O	O	I-T026
activation	O	O	I-T026
cluster	O	O	I-T026
(	O	O	O
c-SMAC	O	O	B-T026
)	O	O	O
of	O	O	O
the	O	O	O
IS	O	O	B-T026
.	O	O	O

eNOS	O	O	B-T116
translocated	O	O	B-T043
with	O	O	O
the	O	O	O
Golgi	O	O	B-T026
to	O	O	O
the	O	O	O
IS	O	O	B-T026
and	O	O	O
partially	O	O	O
colocalized	O	O	B-T082
with	O	O	O
F-actin	O	O	B-T116
around	O	O	O
the	O	O	O
c-SMAC	O	O	B-T026
.	O	O	O

This	O	O	O
resulted	O	O	O
in	O	O	O
reduced	O	O	O
actin	O	O	B-T043
polymerization	O	O	I-T043
and	O	O	O
centripetal	O	O	O
retrograde	O	O	B-T067
flow	O	O	I-T067
of	O	O	O
Î²-actin	O	O	B-T116
and	O	O	O
PKC-Î¸	O	O	B-T116
from	O	O	O
the	O	O	O
lamellipodium-like	O	O	B-T026
distal	O	O	B-T082
(d)-SMAC	O	O	B-T026
,	O	O	O
promoting	O	O	B-T052
PKC-Î¸	O	O	O
activation	O	O	B-T044
.	O	O	O

Furthermore	O	O	O
,	O	O	O
eNOS	O	O	B-T116
-derived	O	O	O
NO	O	O	B-T121
S-nitrosylated	O	O	B-T044
Î²-actin	O	O	B-T116
on	O	O	O
Cys374	O	O	B-T116
and	O	O	O
impaired	O	O	B-T169
actin	O	O	B-T044
binding	O	O	I-T044
to	O	O	O
profilin-1	O	O	B-T116
(	O	O	O
PFN1	O	O	B-T116
)	O	O	O
,	O	O	O
as	O	O	O
confirmed	O	O	O
with	O	O	O
the	O	O	O
transnitrosylating	O	O	B-T044
agent	O	O	O
S-nitroso-L-cysteine	O	O	B-T109
(	O	O	O
Cys-NO	O	O	B-T109
)	O	O	O
.	O	O	O

The	O	O	O
importance	O	O	O
of	O	O	O
NO	O	O	B-T121
and	O	O	O
the	O	O	O
formation	O	O	O
of	O	O	O
PFN1-actin	O	O	B-T116
complexes	O	O	I-T116
on	O	O	O
the	O	O	O
regulation	O	O	B-T044
of	O	O	O
PKC-Î¸	O	O	B-T116
was	O	O	O
corroborated	O	O	O
by	O	O	O
overexpression	O	O	B-T045
of	O	O	O
PFN1	O	O	B-T028
-	O	O	O
and	O	O	O
actin-binding	O	O	B-T044
defective	O	O	O
mutants	O	O	B-T049
of	O	O	O
Î²-actin	O	O	B-T028
(	O	O	I-T028
C374S	O	O	I-T028
)	O	O	I-T028
and	O	O	O
PFN1	O	O	B-T028
(	O	O	I-T028
H119E	O	O	I-T028
)	O	O	I-T028
,	O	O	O
respectively	O	O	O
,	O	O	O
which	O	O	O
reduced	O	O	O
the	O	O	O
coalescence	O	O	O
of	O	O	O
PKC-Î¸	O	O	O
at	O	O	O
the	O	O	O
c-SMAC	O	O	B-T026
.	O	O	O

These	O	O	O
findings	O	O	O
unveil	O	O	O
a	O	O	O
novel	O	O	O
NO	O	O	B-T121
-dependent	O	O	O
mechanism	O	O	B-T044
by	O	O	O
which	O	O	O
the	O	O	O
actin	O	O	B-T043
cytoskeleton	O	O	I-T043
controls	O	O	I-T043
the	O	O	I-T043
organization	O	O	I-T043
and	O	O	O
activation	O	O	B-T052
of	O	O	O
signaling	O	O	B-T129
microclusters	O	O	I-T129
at	O	O	O
the	O	O	O
IS	O	O	B-T026
.	O	O	O

-DOCSTART- (28395912)

Dobutamine	O	O	B-T060
Stress	O	O	I-T060
Echocardiography	O	O	I-T060
:	O	O	O
Impact	O	O	B-T080
of	O	O	O
Abnormal	O	O	B-T033
Blood	O	O	B-T034
Potassium	O	O	I-T034
Levels	O	O	I-T034
on	O	O	O
Cardiac	O	O	O
Arrhythmias	O	O	O

Guidelines	O	O	B-T170
suggest	O	O	O
that	O	O	O
an	O	O	O
abnormal	O	O	B-T033
blood	O	O	B-T034
potassium	O	O	I-T034
level	O	O	I-T034
is	O	O	O
a	O	O	O
relative	O	O	O
contraindication	O	O	B-T080
to	O	O	O
performing	O	O	B-T169
dobutamine	O	O	B-T060
stress	O	O	I-T060
echocardiography	O	O	I-T060
(	O	O	O
DSE	O	O	B-T060
)	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
this	O	O	O
has	O	O	O
not	O	O	O
been	O	O	O
previously	O	O	O
studied	O	O	O
.	O	O	O

We	O	O	O
reviewed	O	O	B-T080
a	O	O	O
consecutive	O	O	B-T062
series	O	O	I-T062
of	O	O	I-T062
patients	O	O	I-T062
who	O	O	O
had	O	O	O
potassium	O	O	B-T123
testing	O	O	B-T169
within	O	O	O
48	O	O	O
hours	O	O	B-T079
of	O	O	O
undergoing	O	O	O
DSE	O	O	B-T060
for	O	O	O
the	O	O	O
evaluation	O	O	B-T058
of	O	O	O
myocardial	O	O	B-T047
ischemia	O	O	I-T047
over	O	O	O
a	O	O	O
10-	O	O	O
year	O	O	B-T079
period	O	O	B-T079
(	O	O	O
N	O	O	O
=	O	O	O
13,198	O	O	O
)	O	O	O
.	O	O	O

Normal	O	O	O
potassium	O	O	B-T123
range	O	O	B-T081
in	O	O	O
our	O	O	O
laboratory	O	O	B-T093
is	O	O	O
3.6	O	O	O
-	O	O	O
5.2	O	O	O
mmol/L.	O	O	O
Hemolyzed	O	O	B-T033
samples	O	O	I-T033
were	O	O	O
not	O	O	O
included	O	O	O
.	O	O	O

The	O	O	O
association	O	O	B-T080
of	O	O	O
potassium	O	O	B-T033
levels	O	O	I-T033
with	O	O	O
the	O	O	O
development	O	O	B-T169
of	O	O	O
supraventricular	O	O	B-T046
and	O	O	O
ventricular	O	O	B-T047
arrhythmias	O	O	I-T047
was	O	O	O
assessed	O	O	B-T052
.	O	O	O

The	O	O	O
incidence	O	O	O
of	O	O	O
clinically	O	O	O
significant	O	O	O
arrhythmias	O	O	B-T033
was	O	O	O
very	O	O	O
low	O	O	B-T080
(	O	O	O
supraventricular	O	O	B-T047
tachycardia	O	O	I-T047
/	O	O	O
atrial	O	O	B-T047
fibrillation	O	O	I-T047
,	O	O	O
4.9	O	O	O
%	O	O	O
;	O	O	O
nonsustained	O	O	B-T046
ventricular	O	O	I-T046
tachycardia	O	O	I-T046
,	O	O	O
2.9	O	O	O
%	O	O	O
;	O	O	O
sustained	O	O	B-T047
ventricular	O	O	I-T047
tachycardia	O	O	I-T047
or	O	O	O
ventricular	O	O	B-T047
fibrillation	O	O	I-T047
,	O	O	O
0.1	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
confirming	O	O	O
the	O	O	O
overall	O	O	B-T068
safety	O	O	I-T068
of	O	O	O
DSE	O	O	B-T060
.	O	O	O

Most	O	O	O
arrhythmias	O	O	B-T033
(	O	O	O
88	O	O	O
%	O	O	O
)	O	O	O
occurred	O	O	O
in	O	O	O
patients	O	O	B-T101
with	O	O	O
normal	O	O	O
potassium	O	O	B-T123
levels	O	O	I-T033
,	O	O	O
and	O	O	O
arrhythmia	O	O	B-T033
rates	O	O	B-T081
remained	O	O	O
low	O	O	B-T080
in	O	O	O
patients	O	O	O
with	O	O	O
potassium	O	O	O
abnormalities	O	O	B-T033
.	O	O	O

Patients	O	O	B-T101
with	O	O	O
hyperkalemia	O	O	B-T033
had	O	O	O
a	O	O	O
lower	O	O	O
risk	O	O	B-T078
of	O	O	O
developing	O	O	O
mild	O	O	B-T080
(	O	O	O
odds	O	O	B-T081
ratio	O	O	I-T081
[	O	O	O
OR	O	O	B-T081
]	O	O	O
,	O	O	O
0.39	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
,	O	O	O
0.22	O	O	O
-	O	O	O
0.71	O	O	O
)	O	O	O
and	O	O	O
severe	O	O	B-T080
(	O	O	O
OR	O	O	O
,	O	O	O
0.13	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
,	O	O	O
0.01	O	O	O
-	O	O	O
0.68	O	O	O
)	O	O	O
supraventricular	O	O	B-T046
arrhythmias	O	O	I-T046
as	O	O	O
well	O	O	O
as	O	O	O
mild	O	O	O
ventricular	O	O	B-T047
arrhythmias	O	O	I-T047
(	O	O	O
OR	O	O	O
,	O	O	O
0.58	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
,	O	O	O
0.40	O	O	O
-	O	O	O
0.83	O	O	O
)	O	O	O
.	O	O	O

Even	O	O	O
though	O	O	O
events	O	O	O
were	O	O	O
rare	O	O	B-T080
,	O	O	O
patients	O	O	B-T101
with	O	O	O
severe	O	O	B-T080
hypokalemia	O	O	B-T033
(	O	O	O
potassium	O	O	B-T033
levels	O	O	I-T033
â¤	O	O	O
3.1	O	O	O
mmol/L	O	O	O
)	O	O	O
had	O	O	O
an	O	O	O
increased	O	O	B-T081
risk	O	O	B-T078
of	O	O	O
supraventricular	O	O	B-T046
arrhythmia	O	O	I-T046
and	O	O	O
ventricular	O	O	B-T047
ectopy	O	O	I-T047
.	O	O	O

DSE	O	O	B-T060
is	O	O	O
safe	O	O	O
even	O	O	O
in	O	O	O
the	O	O	O
setting	O	O	O
of	O	O	O
abnormalities	O	O	B-T033
in	O	O	O
blood	O	O	B-T034
potassium	O	O	B-T123
concentrations	O	O	I-T034
,	O	O	O
and	O	O	O
hence	O	O	O
cancellation	O	O	O
of	O	O	O
DSE	O	O	O
in	O	O	O
patients	O	O	B-T101
with	O	O	O
potassium	O	O	O
abnormalities	O	O	O
does	O	O	O
not	O	O	O
appear	O	O	O
warranted	O	O	O
.	O	O	O

Elevated	O	O	B-T080
potassium	O	O	B-T033
levels	O	O	I-T033
are	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
lower	O	O	O
rates	O	O	O
of	O	O	O
clinically	O	O	O
significant	O	O	O
supraventricular	O	O	B-T046
and	O	O	O
ventricular	O	O	B-T047
arrhythmias	O	O	I-T047
.	O	O	O

While	O	O	O
remaining	O	O	O
at	O	O	O
relatively	O	O	O
low	O	O	B-T080
risk	O	O	B-T078
,	O	O	O
patients	O	O	B-T101
with	O	O	O
very	O	O	O
low	O	O	O
potassium	O	O	B-T033
levels	O	O	I-T033
(	O	O	O
â¤3.1	O	O	O
mmol/L	O	O	O
)	O	O	O
at	O	O	O
the	O	O	O
time	O	O	O
of	O	O	O
DSE	O	O	B-T060
have	O	O	O
a	O	O	O
modestly	O	O	O
increased	O	O	B-T081
risk	O	O	O
of	O	O	O
arrhythmia	O	O	B-T033
.	O	O	O

Consideration	O	O	O
could	O	O	O
be	O	O	O
given	O	O	O
to	O	O	O
correcting	O	O	O
severe	O	O	B-T080
hypokalemia	O	O	B-T033
prior	O	O	B-T079
to	O	O	O
DSE	O	O	B-T060
.	O	O	O

-DOCSTART- (28397323)

Anatomical	O	O	B-T080
subgroup	O	O	B-T185
analysis	O	O	B-T062
of	O	O	O
the	O	O	O
MERIDIAN	O	O	B-UnknownType
cohort	O	O	B-T098
:	O	O	O
Posterior	O	O	O
fossa	O	O	O
abnormalities	O	O	O

To	O	O	O
assess	O	O	B-T058
the	O	O	O
diagnostic	O	O	B-T169
and	O	O	O
clinical	O	O	B-T080
contribution	O	O	B-T052
of	O	O	O
in	O	O	B-T060
utero	O	O	I-T060
magnetic	O	O	I-T060
resonance	O	O	I-T060
(	O	O	I-T060
iuMR	O	O	I-T060
)	O	O	I-T060
imaging	O	O	I-T060
in	O	O	O
fetuses	O	O	B-T018
diagnosed	O	O	B-T033
with	O	O	O
abnormalities	O	O	B-T033
of	O	O	I-T033
the	O	O	I-T033
posterior	O	O	I-T033
fossa	O	O	I-T033
as	O	O	O
the	O	O	O
only	O	O	O
intracranial	O	O	B-T033
abnormality	O	O	I-T033
recognised	O	O	O
on	O	O	O
antenatal	O	O	B-T060
ultrasonography	O	O	I-T060
(	O	O	O
USS	O	O	B-T060
)	O	O	O
.	O	O	O

We	O	O	O
report	O	O	B-T170
a	O	O	O
sub-group	O	O	B-T185
analysis	O	O	B-T062
of	O	O	O
fetuses	O	O	B-T018
with	O	O	O
abnormalities	O	O	B-T033
of	O	O	I-T033
the	O	O	I-T033
posterior	O	O	I-T033
fossa	O	O	I-T033
diagnosed	O	O	B-T033
on	O	O	O
antenatal	O	O	B-T060
USS	O	O	B-T060
(	O	O	O
with	O	O	O
or	O	O	O
without	O	O	O
ventriculomegaly	O	O	B-UnknownType
)	O	O	O
from	O	O	O
the	O	O	O
MERIDIAN	O	O	B-UnknownType
cohort	O	O	B-T098
who	O	O	O
had	O	O	O
iuMR	O	O	B-T060
imaging	O	O	I-T060
within	O	O	O
2	O	O	O
weeks	O	O	O
of	O	O	O
USS	O	O	O
and	O	O	O
outcome	O	O	B-T080
reference	O	O	B-T078
data	O	O	I-T078
were	O	O	O
available	O	O	B-T169
.	O	O	O

The	O	O	O
diagnostic	O	O	B-T080
accuracy	O	O	I-T080
of	O	O	O
USS	O	O	B-T060
and	O	O	O
iuMR	O	O	B-T060
are	O	O	O
reported	O	O	B-T170
as	O	O	O
well	O	O	O
as	O	O	O
indicators	O	O	B-T130
of	O	O	O
diagnostic	O	O	B-T080
confidence	O	O	I-T080
and	O	O	O
effects	O	O	B-T080
on	O	O	O
prognosis	O	O	B-T058
and	O	O	O
clinical	O	O	B-T058
management	O	O	I-T058
.	O	O	O

Abnormalities	O	O	B-T033
confined	O	O	I-T033
to	O	O	I-T033
the	O	O	I-T033
posterior	O	O	I-T033
fossa	O	O	I-T033
according	O	O	O
to	O	O	O
USS	O	O	B-T060
were	O	O	O
found	O	O	O
in	O	O	O
81	O	O	O
fetuses	O	O	B-T018
(	O	O	O
67	O	O	O
with	O	O	O
parenchymal	O	O	B-T025
and	O	O	O
14	O	O	O
with	O	O	O
CSF	O	O	B-T031
-containing	O	O	O
lesions	O	O	B-T033
)	O	O	O
.	O	O	O

The	O	O	O
overall	O	O	O
diagnostic	O	O	B-T080
accuracy	O	O	I-T080
for	O	O	O
detecting	O	O	B-T033
an	O	O	O
isolated	O	O	B-T169
posterior	O	O	B-T033
fossa	O	O	I-T033
abnormality	O	O	I-T033
was	O	O	O
65	O	O	O
%	O	O	O
for	O	O	O
USS	O	O	B-T060
and	O	O	O
88	O	O	O
%	O	O	O
for	O	O	O
iuMR	O	O	B-T060
(	O	O	O
difference	O	O	B-T081
=	O	O	O
22	O	O	O
%	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
:	O	O	O
14.0	O	O	O
to	O	O	O
30.5	O	O	O
%	O	O	O
,	O	O	O
p	O	O	O
<	O	O	O
0.0001	O	O	O
)	O	O	O
.	O	O	O

There	O	O	O
was	O	O	O
an	O	O	O
improvement	O	O	B-T077
in	O	O	O
'	O	O	O
appropriate	O	O	B-T080
'	O	O	O
diagnostic	O	O	B-T080
confidence	O	O	I-T080
as	O	O	O
assessed	O	O	B-T058
by	O	O	O
a	O	O	O
score	O	O	B-T081
-	O	O	O
based	O	O	B-T169
weighted	O	O	B-T081
average	O	O	B-T081
'	O	O	O
method	O	O	B-T170
(	O	O	O
p	O	O	O
<	O	O	O
0.0001	O	O	O
)	O	O	O
and	O	O	O
a	O	O	O
three-fold	O	O	O
reduction	O	O	B-T061
in	O	O	O
'	O	O	B-T080
high	O	O	I-T080
confidence	O	O	O
but	O	O	O
incorrect	O	O	B-T080
diagnoses	O	O	B-T033
'	O	O	O
was	O	O	O
achieved	O	O	O
by	O	O	O
using	O	O	O
iuMR	O	O	B-T060
imaging	O	O	I-T060
.	O	O	O

The	O	O	O
prognostic	O	O	B-T058
information	O	O	I-T058
given	O	O	O
to	O	O	O
the	O	O	O
women	O	O	B-T098
after	O	O	O
iuMR	O	O	B-T060
imaging	O	O	I-T060
changed	O	O	O
in	O	O	O
44	O	O	O
%	O	O	O
of	O	O	O
cases	O	O	B-T077
and	O	O	O
the	O	O	O
overall	O	O	B-T080
effect	O	O	B-T080
of	O	O	O
iuMR	O	O	O
on	O	O	O
clinical	O	O	B-T058
management	O	O	I-T058
was	O	O	O
considered	O	O	O
to	O	O	O
be	O	O	O
'	O	O	O
significant	O	O	B-T078
'	O	O	O
,	O	O	O
'	O	O	O
major	O	O	B-T080
'	O	O	O
or	O	O	O
'	O	O	O
decisive	O	O	B-T033
'	O	O	O
in	O	O	O
35	O	O	O
%	O	O	O
of	O	O	O
cases	O	O	O
.	O	O	O

Our	O	O	O
data	O	O	B-T078
suggests	O	O	O
that	O	O	O
any	O	O	O
woman	O	O	B-T098
whose	O	O	O
fetus	O	O	B-T018
has	O	O	O
a	O	O	O
posterior	O	O	B-T033
fossa	O	O	I-T033
abnormality	O	O	I-T033
as	O	O	O
the	O	O	O
only	O	O	O
intracranial	O	O	B-T033
finding	O	O	I-T033
on	O	O	O
USS	O	O	B-T060
should	O	O	O
have	O	O	O
iuMR	O	O	B-T060
imaging	O	O	I-T060
for	O	O	O
further	O	O	O
evaluation	O	O	B-T058
.	O	O	O

This	O	O	O
is	O	O	O
on	O	O	O
the	O	O	O
basis	O	O	B-T169
of	O	O	O
improved	O	O	B-T033
diagnostic	O	O	B-T080
accuracy	O	O	I-T080
and	O	O	O
confidence	O	O	B-T080
which	O	O	O
has	O	O	O
substantial	O	O	B-T080
effects	O	O	B-T080
on	O	O	O
the	O	O	O
prognostic	O	O	B-T058
information	O	O	I-T058
given	O	O	O
to	O	O	O
women	O	O	B-T098
and	O	O	O
changes	O	O	O
in	O	O	O
clinical	O	O	B-T058
management	O	O	I-T058
.	O	O	O

-DOCSTART- (28399452)

Design	O	O	B-T052
,	O	O	O
synthesis	O	O	B-T052
,	O	O	O
and	O	O	O
evaluation	O	O	B-T058
of	O	O	O
curcumin	O	O	B-T109
derivatives	O	O	B-T104
as	O	O	O
Nrf2	O	O	B-T116
activators	O	O	B-T045
and	O	O	O
cytoprotectors	O	O	B-T039
against	O	O	O
oxidative	O	O	O
death	O	O	O

Activation	O	O	B-T045
of	O	O	O
nuclear	O	O	B-T116
factor	O	O	I-T116
erythroid-2-related	O	O	I-T116
factor	O	O	I-T116
2	O	O	I-T116
(	O	O	O
Nrf2	O	O	B-T116
)	O	O	O
has	O	O	O
been	O	O	O
proven	O	O	O
to	O	O	O
be	O	O	O
an	O	O	O
effective	O	O	O
means	O	O	O
to	O	O	O
prevent	O	O	O
the	O	O	O
development	O	O	O
of	O	O	O
cancer	O	O	B-T191
,	O	O	O
and	O	O	O
natural	O	O	O
curcumin	O	O	B-T109
stands	O	O	O
out	O	O	O
as	O	O	O
a	O	O	O
potent	O	O	O
Nrf2	O	O	O
activator	O	O	B-T045
and	O	O	O
cancer	O	O	O
chemopreventive	O	O	B-T121
agent	O	O	I-T121
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
we	O	O	O
synthesized	O	O	O
a	O	O	O
series	O	O	O
of	O	O	O
curcumin	O	O	B-T109
analogs	O	O	B-T104
by	O	O	O
introducing	O	O	O
the	O	O	O
geminal	O	O	B-T104
dimethyl	O	O	I-T104
substituents	O	O	I-T104
on	O	O	I-T104
the	O	O	I-T104
active	O	O	I-T104
methylene	O	O	I-T104
group	O	O	I-T104
to	O	O	O
find	O	O	O
more	O	O	O
potent	O	O	O
Nrf2	O	O	B-T116
activators	O	O	B-T045
and	O	O	O
cytoprotectors	O	O	B-T039
against	O	O	O
oxidative	O	O	B-T043
death	O	O	I-T043
.	O	O	O

The	O	O	O
geminally	O	O	B-T104
dimethylated	O	O	I-T104
and	O	O	O
catechol	O	O	B-T109
-type	O	O	O
curcumin	O	O	B-T109
analog	O	O	B-T104
(	O	O	O
compound	O	O	B-T121
3	O	O	I-T121
)	O	O	O
was	O	O	O
identified	O	O	O
as	O	O	O
a	O	O	O
promising	O	O	O
lead	O	O	B-T121
molecule	O	O	I-T121
in	O	O	O
terms	O	O	O
of	O	O	O
its	O	O	O
increased	O	O	O
stability	O	O	B-T044
and	O	O	O
cytoprotective	O	O	B-T039
activity	O	O	B-T052
against	O	O	O
the	O	O	O
tert-butyl	O	O	B-T109
hydroperoxide	O	O	I-T109
(t-BHP)-induced	O	O	O
death	O	O	B-T043
of	O	O	O
HepG2	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

Mechanism	O	O	B-T169
studies	O	O	B-T062
indicate	O	O	O
that	O	O	O
its	O	O	O
cytoprotective	O	O	B-T039
effects	O	O	B-T080
are	O	O	O
mediated	O	O	O
by	O	O	O
activating	O	O	B-T052
the	O	O	O
Nrf2	O	O	B-T116
signaling	O	O	B-T044
pathway	O	O	I-T044
in	O	O	O
the	O	O	O
Michael	O	O	B-T121
acceptor	O	O	I-T121
-	O	O	O
and	O	O	O
catechol	O	O	B-T109
-dependent	O	O	O
manners	O	O	O
.	O	O	O

Additionally	O	O	O
,	O	O	O
we	O	O	O
verified	O	O	O
by	O	O	O
using	O	O	O
copper	O	O	B-T121
and	O	O	O
iron	O	O	B-T121
ion	O	O	B-T196
chelators	O	O	B-T121
that	O	O	O
the	O	O	O
two	O	O	O
metal	O	O	B-T197
ion	O	O	O
-mediated	O	O	O
oxidations	O	O	B-T044
of	O	O	O
compound	O	O	B-T121
3	O	O	I-T121
to	O	O	O
its	O	O	O
corresponding	O	O	O
electrophilic	O	O	O
o-quinone	O	O	B-T109
,	O	O	O
contribute	O	O	O
significantly	O	O	O
to	O	O	O
its	O	O	O
Nrf2	O	O	B-T116
-dependent	O	O	O
cytoprotection	O	O	B-T039
.	O	O	O

This	O	O	O
work	O	O	O
provides	O	O	O
an	O	O	O
example	O	O	O
of	O	O	O
successfully	O	O	O
designing	O	O	B-T052
natural	O	O	B-T169
curcumin	O	O	B-T109
-directed	O	O	O
Nrf2	O	O	B-T116
activators	O	O	B-T045
by	O	O	O
a	O	O	O
stability	O	O	B-T044
-increasing	O	O	O
and	O	O	O
proelectrophilic	O	O	B-T070
strategy	O	O	O
.	O	O	O

-DOCSTART- (28399751)

Safe	O	O	B-T068
with	O	O	O
Self-Injury	O	O	B-T037
:	O	O	O
A	O	O	O
Practical	O	O	B-T170
Guide	O	O	I-T170
to	O	O	O
Understanding	O	O	B-T041
,	O	O	O
Responding	O	O	B-T053
and	O	O	O
Harm-reduction	O	O	B-T061
Inckle	O	O	B-T170
Kay	O	O	I-T170
Safe	O	O	O
with	O	O	O
Self-Injury	O	O	O
:	O	O	O
A	O	O	O
Practical	O	O	O
Guide	O	O	O
to	O	O	O
Understanding	O	O	O
,	O	O	O
Responding	O	O	O
and	O	O	O
Harm-reduction	O	O	O
274pp	O	O	O
Â£	O	O	O
23.99	O	O	O
PCCS	O	O	O
Books	O	O	O
9781910919163	O	O	O
1910919160	O	O	O
[	O	O	O
Formula	O	O	O
:	O	O	O
see	O	O	O
text	O	O	O

The	O	O	O
author	O	O	B-T097
begins	O	O	O
her	O	O	O
book	O	O	B-T170
with	O	O	O
a	O	O	O
concise	O	O	B-T081
exploration	O	O	B-T169
of	O	O	O
the	O	O	O
stereotypes	O	O	B-T041
and	O	O	O
truths	O	O	B-T080
of	O	O	O
self-harm	O	O	B-T037
.	O	O	O

In	O	O	O
the	O	O	O
following	O	O	O
seven	O	O	O
chapters	O	O	B-T170
,	O	O	O
she	O	O	O
sets	O	O	O
out	O	O	O
a	O	O	O
grounded	O	O	B-T170
and	O	O	O
often	O	O	O
challenging	O	O	B-T082
view	O	O	I-T082
of	O	O	O
how	O	O	O
self-harm	O	O	B-T037
is	O	O	O
understood	O	O	B-T041
from	O	O	O
differing	O	O	O
perspectives	O	O	B-T041
.	O	O	O

-DOCSTART- (28400033)

Pre-hospital	O	O	B-T079
policies	O	O	B-T170
for	O	O	O
the	O	O	O
care	O	O	B-T058
of	O	O	I-T058
patients	O	O	I-T058
with	O	O	O
acute	O	O	B-T047
coronary	O	O	I-T047
syndromes	O	O	I-T047
in	O	O	O
India	O	O	B-T083
:	O	O	O
A	O	O	O
policy	O	O	B-T170
document	O	O	B-T170
analysis	O	O	O

Ischemic	O	O	B-T184
heart	O	O	I-T184
disease	O	O	I-T184
is	O	O	O
the	O	O	O
leading	O	O	B-T169
cause	O	O	B-T033
of	O	O	I-T033
death	O	O	I-T033
in	O	O	O
India	O	O	B-T083
.	O	O	O

In	O	O	O
high-income	O	O	B-T033
countries	O	O	B-T083
,	O	O	O
pre-hospital	O	O	B-T058
systems	O	O	I-T058
of	O	O	I-T058
care	O	O	I-T058
have	O	O	O
been	O	O	O
developed	O	O	O
to	O	O	O
manage	O	O	B-T058
acute	O	O	B-T079
manifestations	O	O	B-T080
of	O	O	I-T080
ischemic	O	O	B-T184
heart	O	O	I-T184
disease	O	O	I-T184
,	O	O	O
such	O	O	O
as	O	O	O
acute	O	O	B-T047
coronary	O	O	I-T047
syndrome	O	O	I-T047
(	O	O	O
ACS	O	O	B-T047
)	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
it	O	O	O
is	O	O	O
unknown	O	O	B-T080
whether	O	O	O
guidelines	O	O	B-T170
,	O	O	O
policies	O	O	B-T170
,	O	O	O
regulations	O	O	B-T064
,	O	O	O
or	O	O	O
laws	O	O	B-T089
exist	O	O	B-T077
to	O	O	O
guide	O	O	O
pre-hospital	O	O	B-T079
ACS	O	O	B-T047
care	O	O	B-T058
in	O	O	O
India	O	O	B-T083
.	O	O	O

We	O	O	O
undertook	O	O	O
a	O	O	O
nation-wide	O	O	B-T082
document	O	O	B-T170
analysis	O	O	B-T062
to	O	O	O
address	O	O	O
this	O	O	O
gap	O	O	O
in	O	O	O
knowledge	O	O	B-T170
.	O	O	O

From	O	O	O
November	O	O	B-T079
2014	O	O	O
to	O	O	O
May	O	O	B-T079
2016	O	O	O
,	O	O	O
we	O	O	O
searched	O	O	B-T052
for	O	O	O
publicly	O	O	B-T080
available	O	O	B-T169
emergency	O	O	B-T061
care	O	O	B-T058
guidelines	O	O	B-T170
and	O	O	O
legislation	O	O	B-T170
addressing	O	O	O
pre-hospital	O	O	B-T079
ACS	O	O	B-T047
care	O	O	O
in	O	O	O
all	O	O	O
29	O	O	O
Indian	O	O	B-T083
states	O	O	B-T083
and	O	O	O
7	O	O	O
Union	O	O	B-T083
Territories	O	O	I-T083
via	O	O	O
Internet	O	O	B-T073
search	O	O	B-T052
and	O	O	O
direct	O	O	B-T080
correspondence	O	O	B-T170
.	O	O	O

We	O	O	O
found	O	O	B-T033
two	O	O	O
documents	O	O	B-T170
addressing	O	O	O
pre-hospital	O	O	B-T079
ACS	O	O	B-T047
care	O	O	B-T058
.	O	O	O

Though	O	O	O
India	O	O	B-T083
has	O	O	O
legislation	O	O	B-UnknownType
mandating	O	O	I-UnknownType
acute	O	O	B-T058
care	O	O	B-T058
for	O	O	O
emergencies	O	O	B-T067
such	O	O	O
as	O	O	O
trauma	O	O	B-T037
,	O	O	O
regulations	O	O	B-T064
or	O	O	O
laws	O	O	B-T089
to	O	O	O
guide	O	O	O
pre-hospital	O	O	B-T079
ACS	O	O	B-T047
care	O	O	O
are	O	O	O
largely	O	O	O
absent	O	O	B-T169
.	O	O	O

Policy	O	O	B-T097
makers	O	O	I-T097
urgently	O	O	B-T079
need	O	O	B-T080
to	O	O	O
develop	O	O	O
comprehensive	O	O	B-T080
,	O	O	O
multi-stakeholder	O	O	B-T080
policies	O	O	B-T170
for	O	O	O
pre-hospital	O	O	B-T079
emergency	O	O	B-T067
cardiovascular	O	O	B-T058
care	O	O	I-T058
in	O	O	O
India	O	O	B-T083
.	O	O	O

-DOCSTART- (28400056)

Lack	O	O	B-T080
of	O	O	O
antimicrobial	O	O	B-T034
efficacy	O	O	B-T080
of	O	O	O
mecetronium	O	O	B-T109
etilsulfate	O	O	I-T109
in	O	O	O
propanol	O	O	B-T109
-based	O	O	O
hand	O	O	B-T121
rubs	O	O	I-T121
for	O	O	O
surgical	O	O	B-T061
hand	O	O	O
disinfection	O	O	O

The	O	O	O
aim	O	O	B-T078
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
determine	O	O	O
if	O	O	O
mecetronium	O	O	B-T109
etilsulfate	O	O	I-T109
(	O	O	O
MES	O	O	B-T109
)	O	O	O
contributes	O	O	O
to	O	O	O
overall	O	O	O
efficacy	O	O	B-T080
in	O	O	O
surgical	O	O	B-T061
hand	O	O	B-T058
disinfection	O	O	I-T058
.	O	O	O

Three	O	O	O
blinded	O	O	O
hand	O	O	B-T121
rubs	O	O	I-T121
(	O	O	O
45	O	O	O
%	O	O	O
iso-propanol	O	O	B-T109
,	O	O	O
30	O	O	O
%	O	O	O
n-propanol	O	O	B-T109
)	O	O	O
were	O	O	O
applied	O	O	B-T169
for	O	O	O
1.5	O	O	O
min	O	O	O
and	O	O	O
compared	O	O	B-T052
with	O	O	O
the	O	O	O
EN	O	O	B-T121
12791	O	O	I-T121
reference	O	O	O
procedure	O	O	B-T169
(	O	O	O
crossover	O	O	B-T062
design	O	O	I-T062
)	O	O	O
.	O	O	O

One	O	O	O
commercial	O	O	B-T170
hand	O	O	B-T121
rub	O	O	I-T121
contained	O	O	O
0.2	O	O	O
%	O	O	O
MES	O	O	B-T109
,	O	O	O
and	O	O	O
the	O	O	O
two	O	O	O
other	O	O	O
hand	O	O	B-T121
rubs	O	O	I-T121
were	O	O	O
identical	O	O	B-T080
apart	O	O	O
from	O	O	O
0.2	O	O	O
%	O	O	O
MES	O	O	O
.	O	O	O

None	O	O	O
of	O	O	O
the	O	O	O
formulations	O	O	B-T077
had	O	O	O
a	O	O	O
log10	O	O	B-T081
reduction	O	O	B-T080
after	O	O	O
3	O	O	O
h	O	O	O
that	O	O	O
was	O	O	O
significantly	O	O	O
better	O	O	B-T080
compared	O	O	B-T052
with	O	O	O
the	O	O	O
reference	O	O	O
procedure	O	O	B-T169
[	O	O	O
mean	O	O	B-T081
1.72	O	O	O
(	O	O	O
standard	O	O	B-T081
deviation	O	O	I-T081
1.15	O	O	O
)	O	O	O
]	O	O	O
.	O	O	O

The	O	O	O
antimicrobial	O	O	B-T034
contribution	O	O	B-T052
of	O	O	O
MES	O	O	B-T109
in	O	O	O
hand	O	O	B-T121
rubs	O	O	I-T121
is	O	O	O
questionable	O	O	O
.	O	O	O

-DOCSTART- (28403387)

Skin	O	O	B-T042
Conductance	O	O	I-T042
Responses	O	O	B-T032
and	O	O	O
Neural	O	O	B-T169
Activations	O	O	B-T052
During	O	O	O
Fear	O	O	B-T041
Conditioning	O	O	B-T041
and	O	O	O
Extinction	O	O	B-T041
Recall	O	O	B-T041
Across	O	O	O
Anxiety	O	O	O
Disorders	O	O	O

The	O	O	O
fear	O	O	B-T041
conditioning	O	O	B-T041
and	O	O	O
extinction	O	O	B-T041
neurocircuitry	O	O	B-T062
has	O	O	O
been	O	O	O
extensively	O	O	B-T080
studied	O	O	B-T062
in	O	O	O
healthy	O	O	B-T080
and	O	O	O
clinical	O	O	B-T080
populations	O	O	B-T098
,	O	O	O
with	O	O	O
a	O	O	O
particular	O	O	B-T082
focus	O	O	I-T082
on	O	O	O
posttraumatic	O	O	B-T048
stress	O	O	I-T048
disorder	O	O	I-T048
.	O	O	O

Despite	O	O	O
significant	O	O	B-T078
overlap	O	O	B-T079
of	O	O	O
symptoms	O	O	B-T184
between	O	O	O
posttraumatic	O	O	B-T048
stress	O	O	I-T048
disorder	O	O	I-T048
and	O	O	O
anxiety	O	O	B-T048
disorders	O	O	I-T048
,	O	O	O
the	O	O	O
latter	O	O	O
has	O	O	O
received	O	O	B-T080
less	O	O	B-T081
attention	O	O	B-T041
.	O	O	O

Given	O	O	O
that	O	O	O
dysregulated	O	O	O
fear	O	O	B-T041
levels	O	O	B-T080
characterize	O	O	B-T052
anxiety	O	O	B-T048
disorders	O	O	I-T048
,	O	O	O
examining	O	O	B-T058
the	O	O	O
neural	O	O	B-T169
correlates	O	O	B-T080
of	O	O	O
fear	O	O	O
and	O	O	O
extinction	O	O	B-T041
learning	O	O	B-T041
may	O	O	O
shed	O	O	O
light	O	O	O
on	O	O	O
the	O	O	O
pathogenesis	O	O	B-T046
of	O	O	O
underlying	O	O	O
anxiety	O	O	O
disorders	O	O	O
.	O	O	O

To	O	O	O
investigate	O	O	B-T169
the	O	O	O
psychophysiological	O	O	B-T041
and	O	O	O
neural	O	O	B-T169
correlates	O	O	B-T080
of	O	O	O
fear	O	O	B-T041
conditioning	O	O	B-T041
and	O	O	O
extinction	O	O	B-T041
recall	O	O	B-T041
in	O	O	O
anxiety	O	O	B-T033
disorders	O	O	I-T048
and	O	O	O
to	O	O	O
document	O	O	B-T170
how	O	O	O
these	O	O	O
features	O	O	B-T080
differ	O	O	O
as	O	O	O
a	O	O	O
function	O	O	B-T169
of	O	O	O
multiple	O	O	B-T081
diagnoses	O	O	B-T033
or	O	O	O
anxiety	O	O	O
severity	O	O	B-T080
.	O	O	O

This	O	O	O
investigation	O	O	B-T058
was	O	O	O
a	O	O	O
cross-sectional	O	O	B-T062
,	O	O	O
case-control	O	O	B-T058
,	O	O	O
functional	O	O	B-T060
magnetic	O	O	I-T060
resonance	O	O	I-T060
imaging	O	O	I-T060
study	O	O	B-T062
at	O	O	O
an	O	O	O
academic	O	O	B-T093
medical	O	O	I-T093
center	O	O	I-T093
.	O	O	O

Participants	O	O	B-T098
were	O	O	O
healthy	O	O	B-T080
controls	O	O	B-T096
and	O	O	O
individuals	O	O	B-T098
with	O	O	O
at	O	O	O
least	O	O	O
1	O	O	O
of	O	O	O
the	O	O	O
following	O	O	B-T079
anxiety	O	O	B-T048
disorders	O	O	I-T048
:	O	O	O
generalized	O	O	B-T048
anxiety	O	O	I-T048
disorder	O	O	I-T048
,	O	O	O
social	O	O	B-T048
anxiety	O	O	I-T048
disorder	O	O	I-T048
,	O	O	O
specific	O	O	B-T048
phobia	O	O	I-T048
,	O	O	O
and	O	O	O
panic	O	O	B-T048
disorder	O	O	I-T048
.	O	O	O

The	O	O	O
study	O	O	B-T062
dates	O	O	B-T079
were	O	O	O
between	O	O	O
March	O	O	O
2013	O	O	O
and	O	O	O
May	O	O	O
2015	O	O	O
.	O	O	O

Two-day	O	O	O
fear	O	O	B-T041
conditioning	O	O	B-T041
and	O	O	O
extinction	O	O	B-T041
paradigm	O	O	B-T062
.	O	O	O

Skin	O	O	B-T042
conductance	O	O	I-T042
responses	O	O	B-T032
,	O	O	O
blood	O	O	B-T042
oxygenation	O	O	I-T042
level-dependent	O	O	I-T042
responses	O	O	O
,	O	O	O
trait	O	O	B-T032
anxiety	O	O	B-T033
scores	O	O	I-T033
from	O	O	O
the	O	O	O
State	O	O	B-T060
Trait	O	O	B-T032
Anxiety	O	O	I-T060
Inventory	O	O	I-T060
-	O	O	O
Trait	O	O	O
Form	O	O	B-T080
,	O	O	O
and	O	O	O
functiona	O	O	B-T169
l	O	O	O
connectivity	O	O	B-T169
.	O	O	O

This	O	O	O
study	O	O	B-T062
included	O	O	B-T052
21	O	O	O
healthy	O	O	B-T080
controls	O	O	B-T096
(	O	O	O
10	O	O	O
women	O	O	B-T098
)	O	O	O
and	O	O	O
61	O	O	O
individuals	O	O	B-T098
with	O	O	O
anxiety	O	O	B-T048
disorders	O	O	I-T048
(	O	O	O
36	O	O	O
women	O	O	O
)	O	O	O
.	O	O	O

P	O	O	B-T081
values	O	O	I-T081
reported	O	O	B-T058
for	O	O	O
the	O	O	O
neuroimaging	O	O	B-T060
results	O	O	B-T034
are	O	O	O
all	O	O	O
familywise	O	O	B-T099
error	O	O	B-T080
corrected	O	O	B-T080
.	O	O	O

Skin	O	O	B-T042
conductance	O	O	I-T042
responses	O	O	B-T032
during	O	O	O
extinction	O	O	B-T041
recall	O	O	B-T041
did	O	O	O
not	O	O	O
differ	O	O	O
between	O	O	O
individuals	O	O	B-T098
with	O	O	O
anxiety	O	O	B-T048
disorders	O	O	I-T048
and	O	O	O
healthy	O	O	B-T080
controls	O	O	B-T096
(	O	O	O
Î·p2	O	O	B-T081
=	O	O	O
0.001	O	O	O
,	O	O	O
P	O	O	O
=	O	O	O
.79	O	O	O
)	O	O	O
,	O	O	O
where	O	O	O
Î·p2	O	O	O
is	O	O	O
partial	O	O	B-T081
eta	O	O	I-T081
squared	O	O	I-T081
.	O	O	O

The	O	O	O
anxiety	O	O	B-T033
group	O	O	B-T098
had	O	O	O
lower	O	O	B-T080
activation	O	O	B-T052
of	O	O	O
the	O	O	O
ventromedial	O	O	B-T023
prefrontal	O	O	I-T023
cortex	O	O	I-T023
(	O	O	O
vmPFC	O	O	B-T023
)	O	O	O
during	O	O	O
extinction	O	O	B-T041
recall	O	O	B-T041
(	O	O	O
Î·p2	O	O	B-T081
=	O	O	O
0.178	O	O	O
,	O	O	O
P	O	O	O
=	O	O	O
.02	O	O	O
)	O	O	O
.	O	O	O

A	O	O	O
similar	O	O	O
hypoactive	O	O	B-T033
pattern	O	O	B-T082
was	O	O	O
found	O	O	O
during	O	O	O
early	O	O	B-T079
conditioning	O	O	B-T041
(	O	O	O
Î·p2	O	O	B-T081
=	O	O	O
0.106	O	O	O
,	O	O	O
P	O	O	O
=	O	O	O
.009	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
vmPFC	O	O	B-T023
hypoactivation	O	O	B-T052
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
anxiety	O	O	B-T033
symptom	O	O	I-T033
severity	O	O	B-T080
(	O	O	O
r	O	O	O
=	O	O	O
-0.420	O	O	O
,	O	O	O
P	O	O	O
=	O	O	O
.01	O	O	O
for	O	O	O
conditioning	O	O	B-T041
and	O	O	O
r	O	O	O
=	O	O	O
-0.464	O	O	O
,	O	O	O
P	O	O	O
=	O	O	O
.004	O	O	O
for	O	O	O
extinction	O	O	B-T041
recall	O	O	B-T041
)	O	O	O
and	O	O	O
the	O	O	O
number	O	O	B-T081
of	O	O	O
co-occuring	O	O	B-T052
anxiety	O	O	B-T048
disorders	O	O	I-T048
diagnosed	O	O	B-T033
(	O	O	O
Î·p2	O	O	B-T081
=	O	O	O
0.137	O	O	O
,	O	O	O
P	O	O	O
=	O	O	O
.009	O	O	O
for	O	O	O
conditioning	O	O	O
and	O	O	O
Î·p2	O	O	O
=	O	O	O
0.227	O	O	O
,	O	O	O
P	O	O	O
=	O	O	O
.004	O	O	O
for	O	O	O
extinction	O	O	O
recall	O	O	O
)	O	O	O
.	O	O	O

Psychophysiological	O	O	B-T041
interaction	O	O	B-T081
analyses	O	O	I-T081
revealed	O	O	B-T080
that	O	O	O
the	O	O	O
fear	O	O	B-T041
network	O	O	B-T040
connectivity	O	O	I-T040
differed	O	O	O
between	O	O	O
healthy	O	O	B-T080
controls	O	O	B-T096
and	O	O	O
the	O	O	O
anxiety	O	O	B-T033
group	O	O	B-T098
during	O	O	O
fear	O	O	O
learning	O	O	B-T041
(	O	O	O
Î·p2	O	O	B-T081
range	O	O	B-T081
between	O	O	O
0.088	O	O	O
and	O	O	O
0.176	O	O	O
and	O	O	O
P	O	O	B-T081
range	O	O	O
between	O	O	O
0.02	O	O	O
and	O	O	O
0.003	O	O	O
)	O	O	O
and	O	O	O
extinction	O	O	B-T041
recall	O	O	B-T041
(	O	O	O
Î·p2	O	O	O
range	O	O	O
between	O	O	O
0.111	O	O	O
and	O	O	O
0.235	O	O	O
and	O	O	O
P	O	O	O
range	O	O	O
between	O	O	O
0.02	O	O	O
and	O	O	O
0.002	O	O	O
)	O	O	O
.	O	O	O

Despite	O	O	O
no	O	O	O
skin	O	O	B-T042
conductance	O	O	I-T042
response	O	O	B-T032
group	O	O	B-T098
differences	O	O	B-T081
during	O	O	O
extinction	O	O	B-T041
recall	O	O	B-T041
,	O	O	O
brain	O	O	B-T023
activation	O	O	B-T052
patterns	O	O	B-T082
between	O	O	O
anxious	O	O	B-T048
and	O	O	O
healthy	O	O	B-T080
individuals	O	O	B-T098
differed	O	O	O
.	O	O	O

These	O	O	O
findings	O	O	B-T033
encourage	O	O	O
future	O	O	B-T079
studies	O	O	B-T062
to	O	O	O
examine	O	O	B-T058
the	O	O	O
conditions	O	O	B-T080
longitudinally	O	O	B-T062
and	O	O	O
in	O	O	O
the	O	O	O
context	O	O	B-T078
of	O	O	O
treatment	O	O	B-T062
trials	O	O	I-T062
to	O	O	O
improve	O	O	B-T033
and	O	O	O
guide	O	O	B-T061
therapeutics	O	O	I-T061
via	O	O	O
advanced	O	O	B-T080
neurobiological	O	O	B-T091
understanding	O	O	B-T041
of	O	O	O
each	O	O	O
disorder	O	O	B-T047
.	O	O	O

-DOCSTART- (28407355)

Extracellular	O	O	B-T026
vesicles	O	O	I-T026
from	O	O	O
bone	O	O	B-T024
marrow	O	O	I-T024
derived	O	O	O
mesenchymal	O	O	B-T025
stem	O	O	I-T025
cells	O	O	I-T025
protect	O	O	B-T033
against	O	O	O
murine	O	O	B-T015
hepatic	O	O	B-T046
ischemia	O	O	I-T046
-	O	O	O
reperfusion	O	O	O
injury	O	O	O

Hepatic	O	O	B-T037
ischemia-reperfusion	O	O	I-T037
injury	O	O	I-T037
(	O	O	O
IRI	O	O	B-T037
)	O	O	O
and	O	O	O
associated	O	O	B-T046
inflammation	O	O	I-T046
contributes	O	O	O
to	O	O	O
liver	O	O	B-T046
dysfunction	O	O	I-T046
and	O	O	O
complications	O	O	B-T046
after	O	O	O
liver	O	O	B-T061
surgery	O	O	I-T061
and	O	O	O
transplantation	O	O	B-T061
.	O	O	O

Mesenchymal	O	O	B-T025
stem	O	O	I-T025
cells	O	O	I-T025
(	O	O	O
MSC	O	O	B-T025
)	O	O	O
have	O	O	O
been	O	O	O
reported	O	O	O
to	O	O	O
reduce	O	O	B-T080
hepatic	O	O	B-T037
IRI	O	O	I-T037
because	O	O	O
of	O	O	O
their	O	O	O
reparative	O	O	B-T058
immunomodulatory	O	O	B-T129
effects	O	O	O
in	O	O	O
injured	O	O	B-T169
tissues	O	O	B-T024
.	O	O	O

Recent	O	O	O
studies	O	O	O
have	O	O	O
highlighted	O	O	O
beneficial	O	O	B-T080
effects	O	O	I-T080
of	O	O	O
extracellular	O	O	B-T026
vesicles	O	O	I-T026
from	O	O	O
MSCs	O	O	B-T025
(	O	O	O
MSC	O	O	B-T025
-	O	O	O
EV	O	O	B-T026
)	O	O	O
on	O	O	O
tissue	O	O	B-T033
injury	O	O	I-T033
.	O	O	O

The	O	O	O
effects	O	O	O
of	O	O	O
systemically	O	O	B-UnknownType
administered	O	O	I-UnknownType
mouse	O	O	B-T024
bone	O	O	I-T024
marrow	O	O	I-T024
derived	O	O	O
MSC	O	O	B-T025
-	O	O	O
EV	O	O	B-T026
were	O	O	O
evaluated	O	O	B-T062
in	O	O	O
an	O	O	O
experimental	O	O	B-T008
murine	O	O	I-T008
model	O	O	I-T008
of	O	O	O
hepatic	O	O	B-T037
IRI	O	O	I-T037
induced	O	O	B-T169
by	O	O	O
cross	O	O	B-T169
clamping	O	O	I-T169
the	O	O	O
hepatic	O	O	B-T023
artery	O	O	I-T023
and	O	O	O
portal	O	O	B-T023
vein	O	O	I-T023
for	O	O	O
90	O	O	O
minutes	O	O	B-T079
followed	O	O	O
by	O	O	O
reperfusion	O	O	B-T061
for	O	O	O
periods	O	O	B-T079
of	O	O	O
upto	O	O	O
6	O	O	O
hours	O	O	B-T079
.	O	O	O

Compared	O	O	O
with	O	O	O
controls	O	O	B-T082
,	O	O	I-T082
intravenous	O	O	I-T082
administration	O	O	I-T082
of	O	O	O
MSC	O	O	B-T025
-	O	O	O
EV	O	O	B-T026
30	O	O	O
minutes	O	O	B-T079
prior	O	O	O
to	O	O	O
IRI	O	O	B-T037
dramatically	O	O	B-T080
reduced	O	O	B-T080
the	O	O	O
extent	O	O	O
of	O	O	O
tissue	O	O	B-T042
necrosis	O	O	I-T042
,	O	O	O
decreased	O	O	B-T081
caspase-3	O	O	B-T116
positive	O	O	I-T116
and	O	O	O
apoptotic	O	O	B-T026
cells	O	O	I-T026
,	O	O	O
and	O	O	O
reduced	O	O	O
serum	O	O	O
aminotransferase	O	O	B-T116
levels	O	O	O
.	O	O	O

MSC	O	O	B-T025
-	O	O	O
EV	O	O	B-T026
increased	O	O	B-T081
hepatic	O	O	B-T029
mRNA	O	O	B-T045
expression	O	O	I-T045
of	O	O	O
NACHT	O	O	B-T028
,	O	O	I-T028
LRR	O	O	I-T028
and	O	O	I-T028
PYD	O	O	I-T028
domains-containing	O	O	I-T028
protein	O	O	I-T028
12	O	O	I-T028
(	O	O	O
Nlrp12	O	O	B-T028
)	O	O	O
,	O	O	O
and	O	O	O
the	O	O	O
chemokine	O	O	B-T028
(	O	O	I-T028
C-X-C	O	O	I-T028
motif	O	O	I-T028
)	O	O	I-T028
ligand	O	O	I-T028
1	O	O	I-T028
(	O	O	O
CXCL1	O	O	B-T028
)	O	O	O
,	O	O	O
and	O	O	O
reduced	O	O	B-T080
mRNA	O	O	O
expression	O	O	O
of	O	O	O
several	O	O	O
inflammatory	O	O	B-T169
cytokines	O	O	B-T116
such	O	O	O
as	O	O	O
IL-6	O	O	B-T116
during	O	O	O
IRI	O	O	B-T037
.	O	O	O

MSC	O	O	B-T025
-	O	O	O
EV	O	O	B-T026
increased	O	O	B-T081
cell	O	O	B-T043
viability	O	O	I-T043
and	O	O	O
suppressed	O	O	B-T169
both	O	O	O
oxidative	O	O	B-T169
injury	O	O	B-T080
and	O	O	O
NF-ÎºB	O	O	B-T116
activity	O	O	B-T052
in	O	O	O
AML12	O	O	B-T025
murine	O	O	I-T025
hepatocytes	O	O	I-T025
in	O	O	B-T080
vitro	O	O	I-T080
.	O	O	O

In	O	O	O
conclusion	O	O	O
,	O	O	O
the	O	O	O
administration	O	O	B-T061
of	O	O	O
EV	O	O	B-T026
derived	O	O	O
from	O	O	O
bone	O	O	B-T024
marrow	O	O	I-T024
derived	O	O	O
MSCs	O	O	B-T025
may	O	O	O
ameliorate	O	O	B-T033
hepatic	O	O	B-T037
IRI	O	O	I-T037
by	O	O	O
reducing	O	O	B-T080
hepatic	O	O	B-T037
injury	O	O	I-T037
through	O	O	O
modulation	O	O	B-T082
of	O	O	O
the	O	O	O
inflammatory	O	O	B-T046
response	O	O	I-T046
.	O	O	O

This	O	O	O
article	O	O	O
is	O	O	O
protected	O	O	O
by	O	O	O
copyright	O	O	O
.	O	O	O

All	O	O	O
rights	O	O	O
reserved	O	O	O
.	O	O	O

-DOCSTART- (28408723)

Nucleic	O	O	B-T059
acid	O	O	I-T059
detection	O	O	I-T059
with	O	O	O
CRISPR	O	O	B-T114
-	O	O	O
Cas13a	O	O	B-T116
/	O	O	O
C2c2	O	O	O

Rapid	O	O	B-T080
,	O	O	O
inexpensive	O	O	O
,	O	O	O
and	O	O	O
sensitive	O	O	B-T169
nucleic	O	O	B-T059
acid	O	O	I-T059
detection	O	O	B-T061
may	O	O	O
aid	O	O	B-T080
point-of-care	O	O	B-T078
pathogen	O	O	B-T001
detection	O	O	O
,	O	O	O
genotyping	O	O	B-T059
,	O	O	O
and	O	O	O
disease	O	O	B-T047
monitoring	O	O	B-T058
.	O	O	O

The	O	O	O
RNA	O	O	B-T114
-guided	O	O	O
,	O	O	O
RNA	O	O	O
-	O	O	O
targeting	O	O	B-T169
clustered	O	O	B-T114
regularly	O	O	I-T114
interspaced	O	O	I-T114
short	O	O	I-T114
palindromic	O	O	I-T114
repeats	O	O	I-T114
(	O	O	O
CRISPR	O	O	B-T114
)	O	O	O
effector	O	O	B-T116
Cas13a	O	O	B-T116
(	O	O	O
previously	O	O	O
known	O	O	O
as	O	O	O
C2c2	O	O	B-T116
)	O	O	O
exhibits	O	O	O
a	O	O	O
"	O	O	O
collateral	O	O	B-T082
effect	O	O	B-T080
"	O	O	O
of	O	O	O
promiscuous	O	O	O
ribonuclease	O	O	B-T045
activity	O	O	I-T045
upon	O	O	O
target	O	O	B-T169
recognition	O	O	B-T044
.	O	O	O

We	O	O	O
combine	O	O	B-T080
the	O	O	O
collateral	O	O	B-T082
effect	O	O	B-T080
of	O	O	O
Cas13a	O	O	B-T116
with	O	O	O
isothermal	O	O	B-T059
amplification	O	O	I-T059
to	O	O	O
establish	O	O	B-T080
a	O	O	O
CRISPR	O	O	B-T114
-based	O	O	O
diagnostic	O	O	B-T169
(	O	O	O
CRISPR	O	O	O
-	O	O	O
Dx	O	O	B-T169
)	O	O	O
,	O	O	O
providing	O	O	O
rapid	O	O	B-T080
DNA	O	O	B-T114
or	O	O	O
RNA	O	O	B-T114
detection	O	O	B-T061
with	O	O	O
attomolar	O	O	B-T081
sensitivity	O	O	I-T081
and	O	O	O
single-base	O	O	B-T114
mismatch	O	O	B-T080
specificity	O	O	B-T081
.	O	O	O

We	O	O	O
use	O	O	O
this	O	O	O
Cas13a	O	O	B-T116
-based	O	O	O
molecular	O	O	B-T080
detection	O	O	B-T061
platform	O	O	B-T075
,	O	O	O
termed	O	O	O
Specific	O	O	B-T075
High-Sensitivity	O	O	I-T075
Enzymatic	O	O	I-T075
Reporter	O	O	I-T075
UnLOCKing	O	O	I-T075
(	O	O	O
SHERLOCK	O	O	B-T075
)	O	O	O
,	O	O	O
to	O	O	O
detect	O	O	B-T033
specific	O	O	B-T080
strains	O	O	B-T001
of	O	O	O
Zika	O	O	B-T005
and	O	O	O
Dengue	O	O	B-T005
virus	O	O	I-T005
,	O	O	O
distinguish	O	O	O
pathogenic	O	O	B-T001
bacteria	O	O	B-T007
,	O	O	O
genotype	O	O	B-T032
human	O	O	B-T016
DNA	O	O	B-T114
,	O	O	O
and	O	O	O
identify	O	O	B-T080
mutations	O	O	B-T045
in	O	O	O
cell-free	O	O	B-T026
tumor	O	O	B-T114
DNA	O	O	I-T114
.	O	O	O

Furthermore	O	O	O
,	O	O	O
SHERLOCK	O	O	B-T075
reaction	O	O	B-T169
reagents	O	O	B-T130
can	O	O	O
be	O	O	O
lyophilized	O	O	B-T059
for	O	O	O
cold-chain	O	O	B-T066
independence	O	O	O
and	O	O	O
long-term	O	O	B-T079
storage	O	O	B-T169
and	O	O	O
be	O	O	O
readily	O	O	O
reconstituted	O	O	O
on	O	O	O
paper	O	O	O
for	O	O	O
field	O	O	B-UnknownType
applications	O	O	I-UnknownType
.	O	O	O

-DOCSTART- (28409370)

A	O	O	O
plea	O	O	O
for	O	O	O
thoracoscopic	O	O	B-T058
resection	O	O	B-T061
of	O	O	O
solitary	O	O	B-T191
pulmonary	O	O	I-T191
nodule	O	O	I-T191
in	O	O	O
cancer	O	O	B-T191
patients	O	O	O

Solitary	O	O	B-T191
pulmonary	O	O	I-T191
nodules	O	O	I-T191
(	O	O	O
SPN	O	O	B-T191
)	O	O	O
are	O	O	O
frequently	O	O	O
detected	O	O	B-T033
in	O	O	O
cancer	O	O	B-T191
patients	O	O	B-T101
.	O	O	O

These	O	O	O
lesions	O	O	B-T033
are	O	O	O
often	O	O	O
considered	O	O	O
as	O	O	O
pulmonary	O	O	B-T191
metastases	O	O	I-T191
and	O	O	O
increasingly	O	O	B-T169
treated	O	O	B-T169
by	O	O	O
non-surgical	O	O	B-T061
techniques	O	O	I-T061
without	O	O	O
histological	O	O	B-T169
confirmation	O	O	B-T033
.	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
this	O	O	O
study	O	O	O
is	O	O	O
to	O	O	O
determine	O	O	O
the	O	O	O
histological	O	O	B-T169
nature	O	O	B-T169
of	O	O	O
SPN	O	O	B-T191
resected	O	O	B-T080
by	O	O	O
thoracoscopy	O	O	B-T058
and	O	O	O
to	O	O	O
identify	O	O	O
risk	O	O	B-T033
factors	O	O	I-T033
of	O	O	O
malignancy	O	O	B-T191
.	O	O	O

Single-institution	O	O	B-T062
retrospective	O	O	I-T062
analysis	O	O	I-T062
of	O	O	O
all	O	O	O
consecutive	O	O	B-T080
patients	O	O	B-T101
with	O	O	O
previously	O	O	O
known	O	O	O
malignancies	O	O	B-T191
who	O	O	O
underwent	O	O	O
thoracoscopic	O	O	B-T058
resection	O	O	B-T061
of	O	O	O
SPN	O	O	B-T191
with	O	O	O
unknown	O	O	B-T080
diagnosis	O	O	B-T033
between	O	O	O
2001	O	O	O
and	O	O	O
2014	O	O	O
.	O	O	O

One	O	O	O
hundred	O	O	O
and	O	O	O
forty	O	O	O
cancer	O	O	B-T191
patients	O	O	B-T101
underwent	O	O	O
thoracoscopic	O	O	B-T058
resection	O	O	B-T061
of	O	O	O
a	O	O	O
SPN	O	O	B-T191
.	O	O	O

The	O	O	O
resected	O	O	B-T080
SPN	O	O	B-T191
was	O	O	O
benign	O	O	B-T080
in	O	O	O
34	O	O	O
patients	O	O	B-T101
(	O	O	O
24.3	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
malignant	O	O	B-T080
in	O	O	O
106	O	O	O
patients	O	O	O
.	O	O	O

The	O	O	O
latter	O	O	O
were	O	O	O
metastasis	O	O	B-T191
in	O	O	O
70	O	O	O
patients	O	O	B-T101
(	O	O	O
50	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
a	O	O	O
primary	O	O	B-T080
lung	O	O	B-T191
cancer	O	O	I-T191
in	O	O	O
36	O	O	O
patients	O	O	O
(	O	O	O
25.7	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

Upon	O	O	O
univariate	O	O	B-T062
analysis	O	O	I-T062
,	O	O	O
malignancy	O	O	B-T191
was	O	O	O
significantly	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
age	O	O	B-T032
>	O	O	O
60	O	O	O
years	O	O	B-T079
,	O	O	O
disease	O	O	B-T047
-free	O	O	O
interval	O	O	B-T079
â¥24	O	O	O
months	O	O	B-T079
,	O	O	O
SPN	O	O	B-T191
size	O	O	B-T082
>	O	O	O
8	O	O	O
mm	O	O	O
,	O	O	O
upper	O	O	B-T023
lobe	O	O	I-T023
localization	O	O	B-T169
and	O	O	O
SUVmax	O	O	B-T081
>	O	O	O
2.5	O	O	O
on	O	O	O
PET-CT	O	O	B-T060
.	O	O	O

Upon	O	O	O
multivariate	O	O	B-T081
analysis	O	O	I-T081
,	O	O	O
upper	O	O	B-T023
lobe	O	O	I-T023
localization	O	O	B-T169
and	O	O	O
SUVmax	O	O	B-T081
>	O	O	O
2.5	O	O	O
were	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
malignancy	O	O	B-T191
.	O	O	O

Smoking	O	O	B-T055
was	O	O	O
significantly	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
SPN	O	O	B-T191
containing	O	O	O
primary	O	O	B-T080
lung	O	O	B-T191
cancer	O	O	I-T191
.	O	O	O

In	O	O	O
this	O	O	O
series	O	O	B-T081
,	O	O	O
only	O	O	O
50	O	O	O
%	O	O	O
of	O	O	O
SPN	O	O	B-T191
in	O	O	O
patients	O	O	B-T101
with	O	O	O
known	O	O	O
malignant	O	O	B-T047
disease	O	O	I-T047
were	O	O	O
pulmonary	O	O	B-T191
metastases	O	O	I-T191
and	O	O	O
25	O	O	O
%	O	O	O
had	O	O	O
a	O	O	O
newly	O	O	B-T080
diagnosed	O	O	I-T080
NSCLC	O	O	B-T191
.	O	O	O

Smoking	O	O	B-T055
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
primary	O	O	B-T080
lung	O	O	B-T191
cancer	O	O	I-T191
but	O	O	O
no	O	O	B-T033
other	O	O	O
predictor	O	O	B-T078
was	O	O	O
found	O	O	O
to	O	O	O
allow	O	O	O
the	O	O	O
distinction	O	O	O
between	O	O	O
pulmonary	O	O	B-T191
metastasis	O	O	I-T191
and	O	O	O
lung	O	O	O
cancer	O	O	O
.	O	O	O

These	O	O	O
results	O	O	O
endorse	O	O	O
the	O	O	O
need	O	O	O
of	O	O	O
histological	O	O	B-T169
confirmation	O	O	B-T033
of	O	O	O
SPN	O	O	B-T191
in	O	O	O
patients	O	O	B-T101
with	O	O	O
previous	O	O	B-T079
malignancies	O	O	B-T191
to	O	O	O
avoid	O	O	O
diagnostic	O	O	B-T169
uncertainty	O	O	B-T033
and	O	O	O
suboptimal	O	O	B-T080
treatments	O	O	B-T061
.	O	O	O

-DOCSTART- (28409651)

Reliability	O	O	B-T080
of	O	O	O
Fear	O	O	B-T058
Assessment	O	O	I-T058
in	O	O	O
Growing	O	O	B-T033
Pigs	O	O	B-T015
Exposed	O	O	B-T080
to	O	O	I-T080
a	O	O	O
Novel	O	O	B-T080
Object	O	O	B-T072
Test	O	O	B-T169
in	O	O	O
Commercial	O	O	B-T170
Conditions	O	O	O

The	O	O	O
objective	O	O	B-T170
of	O	O	O
this	O	O	O
study	O	O	O
was	O	O	O
to	O	O	O
assess	O	O	B-T052
the	O	O	O
reliability	O	O	B-T080
and	O	O	O
feasibility	O	O	B-T062
of	O	O	O
a	O	O	O
novel	O	O	B-T080
object	O	O	B-T072
test	O	O	B-T169
assessing	O	O	B-T058
fear	O	O	I-T058
in	O	O	O
pigs	O	O	B-T015
in	O	O	O
commercial	O	O	B-T170
conditions	O	O	B-T080
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
18	O	O	O
commercial	O	O	B-T170
farms	O	O	B-T082
were	O	O	O
visited	O	O	O
,	O	O	O
and	O	O	O
321	O	O	O
pens	O	O	B-T073
housing	O	O	I-T073
4,220	O	O	O
growing	O	O	B-T033
pigs	O	O	B-T015
were	O	O	O
assessed	O	O	B-T052
.	O	O	O

Three	O	O	O
balloons	O	O	B-T073
were	O	O	O
used	O	O	O
as	O	O	O
a	O	O	O
novel	O	O	B-T015
stimulus	O	O	B-T067
.	O	O	O

Measures	O	O	B-T081
were	O	O	O
(	O	O	O
a	O	O	O
)	O	O	O
the	O	O	O
time	O	O	B-T079
it	O	O	O
took	O	O	O
for	O	O	O
the	O	O	O
first	O	O	O
pig	O	O	B-T015
to	O	O	O
contact	O	O	B-T067
1	O	O	O
of	O	O	O
the	O	O	O
balloons	O	O	B-T073
,	O	O	O
(	O	O	O
b	O	O	O
)	O	O	O
percentage	O	O	O
of	O	O	O
nonhuman	O	O	B-T015
animals	O	O	B-T008
watching	O	O	B-T041
the	O	O	O
balloons	O	O	O
each	O	O	O
for	O	O	O
10	O	O	O
s	O	O	O
,	O	O	O
and	O	O	O
(	O	O	O
c	O	O	O
)	O	O	O
percentage	O	O	O
of	O	O	O
animals	O	O	O
touching	O	O	B-T169
the	O	O	O
balloons	O	O	O
during	O	O	O
periods	O	O	B-T079
of	O	O	O
5	O	O	O
s.	O	O	O
The	O	O	O
time	O	O	O
of	O	O	O
the	O	O	O
first	O	O	O
pig	O	O	O
to	O	O	O
contact	O	O	O
1	O	O	O
of	O	O	O
the	O	O	O
balloons	O	O	O
ranged	O	O	B-T081
from	O	O	O
0	O	O	O
s	O	O	O
to	O	O	O
362	O	O	O
s.	O	O	O
An	O	O	O
effect	O	O	B-T080
of	O	O	O
the	O	O	O
farm	O	O	B-T082
was	O	O	O
found	O	O	O
(	O	O	O
p	O	O	O
<	O	O	O
.0001	O	O	O
)	O	O	O
for	O	O	O
contact	O	O	O
latency	O	O	B-T079
,	O	O	O
ranging	O	O	B-T081
from	O	O	O
6.8	O	O	O
s	O	O	O
to	O	O	O
73.3	O	O	O
s	O	O	O
,	O	O	O
but	O	O	O
little	O	O	O
difference	O	O	B-T080
was	O	O	O
found	O	O	O
in	O	O	O
terms	O	O	O
of	O	O	O
intrafarm	O	O	B-T082
variability	O	O	B-T077
.	O	O	O

Interobserver	O	O	B-T170
repeatability	O	O	I-T170
was	O	O	O
also	O	O	O
high	O	O	B-T080
in	O	O	O
this	O	O	O
measure	O	O	B-T081
,	O	O	O
ranging	O	O	B-T081
from	O	O	O
r	O	O	O
=	O	O	O
.74	O	O	O
to	O	O	O
r	O	O	O
=	O	O	O
.96	O	O	O
.	O	O	O

As	O	O	O
a	O	O	O
result	O	O	O
,	O	O	O
it	O	O	O
is	O	O	O
concluded	O	O	O
that	O	O	O
contact	O	O	B-T067
latency	O	O	B-T079
could	O	O	O
be	O	O	O
a	O	O	O
good	O	O	O
measure	O	O	B-T081
to	O	O	O
assess	O	O	B-T052
fear	O	O	B-T041
of	O	O	O
a	O	O	O
novel	O	O	O
stimulus	O	O	B-T067
in	O	O	O
commercial	O	O	B-T170
farms	O	O	B-T082
.	O	O	O

-DOCSTART- (28412023)

Precise	O	O	O
prediction	O	O	B-T078
of	O	O	O
activators	O	O	B-T121
for	O	O	O
the	O	O	O
human	O	O	B-T016
constitutive	O	O	B-T116
androstane	O	O	I-T116
receptor	O	O	I-T116
using	O	O	O
structure	O	O	B-T085
-based	O	O	O
three-dimensional	O	O	B-T081
quantitative	O	O	I-T081
structure-activity	O	O	I-T081
relationship	O	O	I-T081
methods	O	O	O

The	O	O	O
constitutive	O	O	B-T116
androstane	O	O	I-T116
receptor	O	O	I-T116
(	O	O	O
CAR	O	O	B-T116
,	O	O	O
NR1I3	O	O	B-T116
)	O	O	I-T116
regulates	O	O	B-T045
the	O	O	I-T045
expression	O	O	I-T045
of	O	O	O
numerous	O	O	B-T081
drug-metabolizing	O	O	B-T044
enzymes	O	O	B-T116
and	O	O	O
transporters	O	O	B-T116
.	O	O	O

The	O	O	O
upregulation	O	O	B-T044
of	O	O	O
various	O	O	O
enzymes	O	O	B-T116
,	O	O	O
including	O	O	O
CYP2B6	O	O	B-T116
,	O	O	O
by	O	O	O
CAR	O	O	B-T116
activators	O	O	B-T121
is	O	O	O
a	O	O	O
critical	O	O	O
problem	O	O	O
leading	O	O	O
to	O	O	O
clinically	O	O	O
severe	O	O	B-T080
drug-drug	O	O	B-T044
interactions	O	O	I-T044
(	O	O	O
DDIs	O	O	B-T044
)	O	O	O
.	O	O	O

To	O	O	O
date	O	O	O
,	O	O	O
however	O	O	O
,	O	O	O
few	O	O	O
effective	O	O	B-T080
computational	O	O	B-T062
approaches	O	O	I-T062
for	O	O	O
identifying	O	O	O
CAR	O	O	B-T116
activators	O	O	O
exist	O	O	O
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	O
,	O	O	O
we	O	O	O
aimed	O	O	O
to	O	O	O
develop	O	O	O
three-dimensional	O	O	B-T081
quantitative	O	O	I-T081
structure-activity	O	O	I-T081
relationship	O	O	I-T081
(	O	O	O
3D-QSAR	O	O	B-T081
)	O	O	O
models	O	O	B-T170
to	O	O	O
predict	O	O	O
the	O	O	O
CAR	O	O	B-T116
activating	O	O	B-T043
potency	O	O	B-T080
of	O	O	O
compounds	O	O	B-T121
emerging	O	O	O
in	O	O	O
the	O	O	O
drug-discovery	O	O	B-T062
process	O	O	B-T067
.	O	O	O

Models	O	O	B-T170
were	O	O	O
constructed	O	O	O
using	O	O	O
comparative	O	O	B-T063
molecular	O	O	B-T167
field	O	O	I-T063
analysis	O	O	I-T063
(	O	O	O
CoMFA	O	O	B-T063
)	O	O	O
based	O	O	O
on	O	O	O
the	O	O	O
molecular	O	O	O
alignments	O	O	B-T081
of	O	O	O
ligands	O	O	B-T044
binding	O	O	I-T044
to	O	O	O
CAR	O	O	B-T116
,	O	O	O
which	O	O	O
were	O	O	O
obtained	O	O	O
from	O	O	O
ensemble	O	O	O
ligand-docking	O	O	B-T044
using	O	O	O
28	O	O	B-T121
compounds	O	O	I-T121
as	O	O	O
a	O	O	O
training	O	O	O
set	O	O	O
.	O	O	O

The	O	O	O
CoMFA	O	O	B-T063
model	O	O	B-T170
,	O	O	O
modified	O	O	B-T080
by	O	O	I-T080
adding	O	O	O
a	O	O	O
lipophilic	O	O	B-T081
parameter	O	O	B-T081
with	O	O	O
calculated	O	O	O
logD7.4	O	O	O
(	O	O	O
S+logD7.4	O	O	O
)	O	O	O
,	O	O	O
demonstrated	O	O	O
statistically	O	O	O
good	O	O	O
predictive	O	O	B-T080
ability	O	O	I-T080
(	O	O	O
r(2	O	O	O
)	O	O	O
=	O	O	O
0.99	O	O	O
,	O	O	O
q(2	O	O	O
)	O	O	O
=	O	O	O
0.74	O	O	O
)	O	O	O
.	O	O	O

We	O	O	O
also	O	O	O
confirmed	O	O	O
the	O	O	O
excellent	O	O	O
predictability	O	O	B-T081
of	O	O	O
the	O	O	O
3D-QSAR	O	O	B-T081
model	O	O	B-T170
for	O	O	O
CAR	O	O	B-T116
activation	O	O	B-T043
(	O	O	O
r(2)pred	O	O	O
=	O	O	O
0.71	O	O	O
)	O	O	O
using	O	O	O
seven	O	O	O
compounds	O	O	B-T121
as	O	O	O
a	O	O	O
test	O	O	O
set	O	O	O
for	O	O	O
external	O	O	B-T062
validation	O	O	I-T062
.	O	O	O

Collectively	O	O	O
,	O	O	O
our	O	O	O
results	O	O	B-T169
indicate	O	O	O
that	O	O	O
the	O	O	O
3D-QSAR	O	O	B-T081
model	O	O	B-T170
developed	O	O	O
in	O	O	O
this	O	O	O
study	O	O	O
provides	O	O	O
precise	O	O	B-T080
prediction	O	O	B-T078
of	O	O	O
CAR	O	O	B-T116
activating	O	O	B-T043
potency	O	O	B-T080
and	O	O	O
,	O	O	O
thus	O	O	O
,	O	O	O
should	O	O	O
be	O	O	O
useful	O	O	O
for	O	O	O
selecting	O	O	O
drug	O	O	B-T121
candidates	O	O	I-T121
with	O	O	O
minimized	O	O	B-T080
DDI	O	O	B-T044
risk	O	O	B-T078
related	O	O	O
to	O	O	O
enzyme-induction	O	O	B-T045
in	O	O	O
the	O	O	O
early	O	O	B-T079
drug-discovery	O	O	B-T062
stage	O	O	B-T079
.	O	O	O

-DOCSTART- (28413509)

Effects	O	O	B-T080
of	O	O	I-T080
siRNA	O	O	B-T114
-mediated	O	O	O
suppression	O	O	B-T045
of	O	O	O
HPV-11	O	O	B-T028
L1	O	O	I-T028
expression	O	O	B-T045
on	O	O	O
the	O	O	O
proliferation	O	O	B-T043
and	O	O	O
apoptosis	O	O	B-T043
of	O	O	O
vaginal	O	O	O
epithelial	O	O	O
cells	O	O	O

The	O	O	O
aim	O	O	B-T078
of	O	O	O
the	O	O	O
present	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
investigate	O	O	B-T169
the	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
human	O	O	B-T047
papillomavirus	O	O	I-T047
(	O	O	I-T047
HPV	O	O	B-T005
)	O	O	I-T047
infection	O	O	I-T047
on	O	O	O
the	O	O	O
gynecological	O	O	B-T047
disease	O	O	I-T047
of	O	O	O
vaginitis	O	O	B-T047
and	O	O	O
to	O	O	O
demonstrate	O	O	O
how	O	O	O
the	O	O	O
small	O	O	B-T114
interfering	O	O	I-T114
RNA	O	O	I-T114
(	O	O	O
siRNA	O	O	B-T114
)	O	O	O
method	O	O	O
may	O	O	O
be	O	O	O
used	O	O	O
for	O	O	O
HPV	O	O	O
prevention	O	O	B-T061
in	O	O	O
the	O	O	O
clinic	O	O	B-T093
.	O	O	O

Human	O	O	B-T016
vaginal	O	O	B-T025
epithelial	O	O	I-T025
cells	O	O	I-T025
were	O	O	O
transfected	O	O	B-T063
with	O	O	O
HPV-11	O	O	B-T028
L1	O	O	I-T028
expression	O	O	B-T114
vector	O	O	I-T114
and	O	O	O
siRNA	O	O	B-T114
-	O	O	O
HPV-11	O	O	O
L1	O	O	O
vectors	O	O	B-T114
and	O	O	O
a	O	O	O
control	O	O	B-T096
group	O	O	I-T096
was	O	O	O
transfected	O	O	O
with	O	O	O
scrambled	O	O	O
siRNA	O	O	O
.	O	O	O

Cell	O	O	B-T043
proliferation	O	O	I-T043
in	O	O	O
each	O	O	O
group	O	O	O
was	O	O	O
analyzed	O	O	O
using	O	O	O
the	O	O	O
MTT	O	O	B-T059
assay	O	O	I-T059
and	O	O	O
the	O	O	O
expression	O	O	B-T045
of	O	O	O
apoptosis	O	O	B-T043
-associated	O	O	O
proteins	O	O	B-T116
was	O	O	O
measured	O	O	B-T080
by	O	O	O
western	O	O	B-T059
blot	O	O	I-T059
analysis	O	O	I-T059
.	O	O	O

Compared	O	O	B-T052
with	O	O	O
the	O	O	O
control	O	O	B-T096
group	O	O	I-T096
,	O	O	O
HPV-11	O	O	B-T028
L1	O	O	I-T028
mRNA	O	O	B-T114
and	O	O	O
protein	O	O	B-T034
levels	O	O	I-T034
were	O	O	O
significantly	O	O	O
increased	O	O	B-T081
following	O	O	O
transfection	O	O	B-T063
with	O	O	O
the	O	O	O
HPV-11	O	O	O
L1	O	O	O
expression	O	O	B-T114
vector	O	O	I-T114
in	O	O	O
cells	O	O	B-T025
(	O	O	O
P<0.05	O	O	O
)	O	O	O
,	O	O	O
but	O	O	O
this	O	O	O
result	O	O	O
was	O	O	O
significantly	O	O	O
reversed	O	O	O
by	O	O	O
silencing	O	O	B-T045
of	O	O	O
HPV-11	O	O	O
L1	O	O	O
(	O	O	O
P<0.05	O	O	O
)	O	O	O
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
cell	O	O	B-T043
proliferation	O	O	I-T043
in	O	O	O
the	O	O	O
HPV-11	O	O	B-T078
group	O	O	I-T078
was	O	O	O
lower	O	O	B-T080
than	O	O	O
that	O	O	O
in	O	O	O
the	O	O	O
control	O	O	B-T096
group	O	O	I-T096
;	O	O	O
however	O	O	O
,	O	O	O
cell	O	O	O
proliferation	O	O	O
was	O	O	O
significantly	O	O	O
increased	O	O	B-T081
in	O	O	O
cells	O	O	B-T025
transfected	O	O	B-T063
with	O	O	O
silenced	O	O	B-T045
L1	O	O	B-T028
compared	O	O	O
with	O	O	O
that	O	O	O
in	O	O	O
the	O	O	O
control	O	O	O
group	O	O	O
(	O	O	O
P<0.05	O	O	O
)	O	O	O
.	O	O	O

Furthermore	O	O	O
,	O	O	O
silencing	O	O	B-T045
of	O	O	O
HPV-11	O	O	B-T028
L1	O	O	I-T028
significantly	O	O	O
decreased	O	O	B-T081
caspase-3	O	O	B-T028
and	O	O	O
caspase-9	O	O	B-T028
expressions	O	O	B-T045
in	O	O	O
cells	O	O	B-T025
,	O	O	O
whereas	O	O	O
the	O	O	O
expression	O	O	B-T045
was	O	O	O
increased	O	O	B-T081
in	O	O	O
the	O	O	O
HPV-11	O	O	O
L1	O	O	O
group	O	O	O
(	O	O	O
P<0.05	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
present	O	O	O
study	O	O	B-T062
suggested	O	O	O
that	O	O	O
siRNA	O	O	B-T114
-mediated	O	O	O
silencing	O	O	B-T045
of	O	O	O
HPV-11	O	O	B-T005
L1	O	O	I-T028
may	O	O	O
have	O	O	O
potential	O	O	O
therapeutic	O	O	B-T061
applications	O	O	I-T061
for	O	O	O
treating	O	O	O
gynecological	O	O	B-T047
diseases	O	O	I-T047
associated	O	O	B-T080
with	O	O	I-T080
HPV-11	O	O	O
infection	O	O	B-T046
.	O	O	O

-DOCSTART- (28413529)

An	O	O	O
evaluation	O	O	B-T058
of	O	O	O
neuroendocrine	O	O	B-T022
dysfunction	O	O	B-T077
following	O	O	O
acute	O	O	B-T079
aneurysmal	O	O	B-T046
subarachnoid	O	O	I-T046
hemorrhage	O	O	I-T046
:	O	O	O
A	O	O	O
prospective	O	O	O
study	O	O	O

The	O	O	O
aim	O	O	B-T078
was	O	O	O
to	O	O	O
investigate	O	O	B-T169
the	O	O	O
incidence	O	O	O
and	O	O	O
pattern	O	O	B-T082
of	O	O	O
neuroendocrine	O	O	B-T022
changes	O	O	O
in	O	O	O
cases	O	O	B-T101
of	O	O	O
acute	O	O	B-T079
aneurysmal	O	O	B-T046
subarachnoid	O	O	I-T046
hemorrhage	O	O	I-T046
(	O	O	O
SAH	O	O	B-T046
)	O	O	O
.	O	O	O

Endocrine	O	O	B-T022
assessment	O	O	B-T058
was	O	O	O
performed	O	O	O
in	O	O	O
100	O	O	O
consecutive	O	O	O
cases	O	O	B-T101
of	O	O	O
acute	O	O	B-T079
aneurysmal	O	O	B-T046
SAH	O	O	I-T046
presenting	O	O	O
within	O	O	O
7	O	O	O
days	O	O	B-T079
of	O	O	O
ictus	O	O	B-T047
.	O	O	O

The	O	O	O
gonadotropic	O	O	B-T116
,	O	O	O
somatotrophic	O	O	B-T116
,	O	O	O
thyrotropic	O	O	B-T116
,	O	O	O
and	O	O	O
corticotrophic	O	O	B-T116
axes	O	O	O
were	O	O	O
evaluated	O	O	B-T058
for	O	O	O
their	O	O	O
possible	O	O	O
dysfunction	O	O	B-T077
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
100	O	O	O
cases	O	O	B-T101
(	O	O	O
38	O	O	O
males	O	O	B-T032
,	O	O	O
62	O	O	O
females	O	O	B-T032
;	O	O	O
age	O	O	B-T032
range	O	O	B-T081
-	O	O	O
17	O	O	O
-	O	O	O
76	O	O	O
years	O	O	B-T079
;	O	O	O
mean	O	O	B-T081
age	O	O	O
-	O	O	O
43.6	O	O	O
years	O	O	O
)	O	O	O
of	O	O	O
acute	O	O	B-T079
SAH	O	O	B-T046
were	O	O	O
studied	O	O	B-T062
.	O	O	O

The	O	O	O
aneurysms	O	O	B-T047
were	O	O	O
located	O	O	O
in	O	O	O
the	O	O	O
anterior	O	O	B-T042
circulation	O	O	I-T042
(	O	O	O
n	O	O	O
=	O	O	O
95	O	O	O
)	O	O	O
and	O	O	O
posterior	O	O	B-T042
circulation	O	O	I-T042
(	O	O	O
n	O	O	O
=	O	O	O
5	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
most	O	O	O
common	O	O	O
hormone	O	O	B-T047
deficiency	O	O	I-T047
was	O	O	O
of	O	O	O
growth	O	O	B-T116
hormone	O	O	I-T116
(	O	O	O
n	O	O	O
=	O	O	O
67	O	O	O
)	O	O	O
,	O	O	O
followed	O	O	O
by	O	O	O
gonadotrophin	O	O	B-T116
(	O	O	O
n	O	O	O
=	O	O	O
50	O	O	O
)	O	O	O
,	O	O	O
corticotrophin	O	O	B-T116
(	O	O	O
n	O	O	O
=	O	O	O
49	O	O	O
)	O	O	O
and	O	O	O
thyrotrophin	O	O	B-T116
(	O	O	O
n	O	O	O
=	O	O	O
35	O	O	O
)	O	O	O
.	O	O	O

Hyperprolactinemia	O	O	B-T047
was	O	O	O
noted	O	O	O
in	O	O	O
10	O	O	O
cases	O	O	B-T101
.	O	O	O

One-pituitary	O	O	B-T033
hormone	O	O	I-T033
axis	O	O	I-T033
deficiency	O	O	I-T033
was	O	O	O
noted	O	O	O
in	O	O	O
26	O	O	O
cases	O	O	B-T101
while	O	O	O
67	O	O	O
cases	O	O	O
had	O	O	O
two	O	O	O
or	O	O	O
more	O	O	O
pituitary	O	O	B-T116
hormone	O	O	I-T116
axes	O	O	O
dysfunction	O	O	B-T077
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
93	O	O	O
cases	O	O	B-T101
had	O	O	O
hormonal	O	O	B-T125
dysfunction	O	O	B-T077
in	O	O	O
one	O	O	O
or	O	O	O
more	O	O	O
pituitary	O	O	B-T116
hormone	O	O	I-T116
axes	O	O	I-T116
,	O	O	O
and	O	O	O
seven	O	O	O
cases	O	O	O
had	O	O	O
no	O	O	O
hormonal	O	O	O
dysfunction	O	O	O
.	O	O	O

Endocrine	O	O	B-T047
dysfunction	O	O	B-T077
occurs	O	O	O
in	O	O	O
93	O	O	O
%	O	O	O
cases	O	O	B-T101
of	O	O	O
acute	O	O	B-T079
SAH	O	O	B-T046
and	O	O	O
multiple	O	O	O
pituitary	O	O	B-T116
hormone	O	O	I-T116
axes	O	O	I-T116
dysfunction	O	O	O
occurs	O	O	O
in	O	O	O
67	O	O	O
%	O	O	O
cases	O	O	O
.	O	O	O

It	O	O	O
is	O	O	O
suggested	O	O	O
that	O	O	O
hormonal	O	O	B-T125
evaluation	O	O	B-T058
should	O	O	O
be	O	O	O
considered	O	O	O
as	O	O	O
part	O	O	O
of	O	O	O
management	O	O	O
of	O	O	O
acute	O	O	B-T079
SAH	O	O	B-T046
.	O	O	O

-DOCSTART- (28415987)

Validity	O	O	B-T081
and	O	O	O
reliability	O	O	B-T081
of	O	O	O
fluoroscopy	O	O	B-T060
for	O	O	O
digital	O	O	B-T060
radiography	O	O	I-T060
:	O	O	O
a	O	O	O
new	O	O	O
way	O	O	O
to	O	O	O
evaluate	O	O	B-T058
diaphragmatic	O	O	B-T023
mobility	O	O	O

Fluoroscopy	O	O	B-T060
is	O	O	O
considered	O	O	O
the	O	O	O
most	O	O	O
accurate	O	O	O
method	O	O	B-T062
to	O	O	O
evaluate	O	O	B-T058
the	O	O	O
diaphragm	O	O	B-T023
,	O	O	O
yet	O	O	O
most	O	O	O
existing	O	O	O
methods	O	O	B-T062
for	O	O	O
measuring	O	O	O
diaphragmatic	O	O	B-T023
mobility	O	O	B-T070
using	O	O	O
fluoroscopy	O	O	B-T060
are	O	O	O
complex	O	O	O
.	O	O	O

To	O	O	O
assess	O	O	O
the	O	O	O
validity	O	O	B-T081
and	O	O	O
reliability	O	O	B-T081
of	O	O	O
a	O	O	O
new	O	O	O
evaluation	O	O	B-T062
method	O	O	I-T062
of	O	O	O
diaphragmatic	O	O	B-T023
motion	O	O	B-T070
using	O	O	O
fluoroscopy	O	O	B-T060
by	O	O	O
digital	O	O	B-T060
radiography	O	O	I-T060
of	O	O	O
healthy	O	O	B-T080
adults	O	O	B-T100
.	O	O	O

Twenty-six	O	O	O
adults	O	O	B-T100
were	O	O	O
evaluated	O	O	B-T058
,	O	O	O
according	O	O	O
to	O	O	O
the	O	O	O
parameters	O	O	O
:	O	O	O
anthropometry	O	O	B-T062
and	O	O	O
pulmonary	O	O	B-T060
function	O	O	I-T060
test	O	O	I-T060
.	O	O	O

The	O	O	O
evaluation	O	O	B-T058
of	O	O	O
diaphragm	O	O	B-T023
mobility	O	O	B-T070
by	O	O	O
means	O	O	O
of	O	O	O
fluoroscopy	O	O	B-T060
by	O	O	O
digital	O	O	B-T060
radiography	O	O	I-T060
method	O	O	B-T062
was	O	O	O
randomly	O	O	O
conducted	O	O	O
by	O	O	O
two	O	O	O
raters	O	O	O
(	O	O	O
A	O	O	O
and	O	O	O
B	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
Pearson	O	O	B-T081
correlation	O	O	I-T081
coefficient	O	O	I-T081
and	O	O	O
the	O	O	O
intraclass	O	O	B-T081
correlation	O	O	I-T081
coefficient	O	O	I-T081
(	O	O	O
ICC	O	O	B-T081
)	O	O	O
were	O	O	O
used	O	O	O
to	O	O	O
assess	O	O	O
the	O	O	O
concurrent	O	O	O
validity	O	O	B-T081
.	O	O	O

The	O	O	O
inter-rater	O	O	O
and	O	O	O
intra-rater	O	O	O
reliability	O	O	B-T081
of	O	O	O
the	O	O	O
measurement	O	O	B-T169
of	O	O	O
diaphragmatic	O	O	B-T023
motion	O	O	B-T070
was	O	O	O
determined	O	O	O
using	O	O	O
ICC	O	O	B-T081
and	O	O	O
a	O	O	O
confidence	O	O	O
interval	O	O	O
of	O	O	O
95	O	O	O
%	O	O	O
.	O	O	O

There	O	O	O
was	O	O	O
a	O	O	O
relationship	O	O	B-T080
in	O	O	O
the	O	O	O
assessment	O	O	B-T058
of	O	O	O
the	O	O	O
concurrent	O	O	O
validity	O	O	B-T081
.	O	O	O

There	O	O	O
was	O	O	O
good	O	O	O
inter-rater	O	O	O
reliability	O	O	B-T081
for	O	O	O
right	O	O	O
hemidiaphragm	O	O	B-T023
mobility	O	O	B-T070
and	O	O	O
moderate	O	O	O
reliability	O	O	O
for	O	O	O
left	O	O	B-T023
hemidiaphragm	O	O	I-T023
in	O	O	O
the	O	O	O
first	O	O	O
assessment	O	O	B-T058
.	O	O	O

In	O	O	O
the	O	O	O
second	O	O	O
assessment	O	O	B-T058
,	O	O	O
there	O	O	O
was	O	O	O
good	O	O	O
reliability	O	O	B-T081
for	O	O	O
the	O	O	O
mobility	O	O	B-T070
of	O	O	O
both	O	O	O
hemidiaphragms	O	O	B-T023
.	O	O	O

There	O	O	O
was	O	O	O
good	O	O	O
intra-rater	O	O	O
reliability	O	O	B-T081
in	O	O	O
the	O	O	O
mobility	O	O	B-T070
of	O	O	O
both	O	O	O
hemidiaphragms	O	O	B-T023
for	O	O	O
raters	O	O	O
A	O	O	O
and	O	O	O
B.	O	O	O
The	O	O	O
evaluation	O	O	B-T058
of	O	O	O
diaphragmatic	O	O	B-T023
motion	O	O	B-T070
using	O	O	O
fluoroscopy	O	O	B-T060
by	O	O	O
digital	O	O	B-T060
radiography	O	O	I-T060
proved	O	O	O
to	O	O	O
be	O	O	O
a	O	O	O
valid	O	O	B-T080
and	O	O	O
reliable	O	O	B-T080
method	O	O	B-T062
of	O	O	O
healthy	O	O	B-T080
adults	O	O	B-T100
.	O	O	O

-DOCSTART- (28418943)

Loss	O	O	B-T080
of	O	O	I-T080
control	O	O	I-T080
over	O	O	O
alcohol	O	O	B-UnknownType
seeking	O	O	I-UnknownType
in	O	O	O
rats	O	O	B-T015
depends	O	O	O
on	O	O	O
individual	O	O	B-T098
vulnerability	O	O	B-T033
and	O	O	O
duration	O	O	O
of	O	O	O
alcohol	O	O	B-T055
consumption	O	O	I-T055
experience	O	O	O

Alcohol	O	O	B-T048
use	O	O	I-T048
disorder	O	O	I-T048
(	O	O	O
AUD	O	O	B-T048
)	O	O	O
is	O	O	O
characterized	O	O	O
by	O	O	O
excessive	O	O	B-T033
alcohol	O	O	I-T033
use	O	O	I-T033
and	O	O	O
persistent	O	O	B-T079
alcohol	O	O	B-UnknownType
seeking	O	O	I-UnknownType
despite	O	O	O
knowledge	O	O	O
of	O	O	O
its	O	O	O
negative	O	O	O
consequences	O	O	O
.	O	O	O

Importantly	O	O	O
,	O	O	O
AUD	O	O	B-T048
typically	O	O	O
develops	O	O	O
after	O	O	O
chronic	O	O	B-T079
excessive	O	O	B-T033
alcohol	O	O	I-T033
use	O	O	I-T033
in	O	O	O
a	O	O	O
subgroup	O	O	B-T185
of	O	O	O
individuals	O	O	B-T098
who	O	O	O
drink	O	O	B-T033
alcohol	O	O	I-T033
,	O	O	O
suggesting	O	O	O
that	O	O	O
AUD	O	O	O
results	O	O	O
from	O	O	O
an	O	O	O
interaction	O	O	B-T169
between	O	O	O
individual	O	O	B-T098
vulnerability	O	O	B-T033
and	O	O	O
prolonged	O	O	B-T051
alcohol	O	O	I-T051
exposure	O	O	I-T051
.	O	O	O

The	O	O	O
present	O	O	O
study	O	O	B-T062
assessed	O	O	B-T052
the	O	O	O
contribution	O	O	O
of	O	O	O
prolonged	O	O	B-T051
exposure	O	O	I-T051
to	O	O	I-T051
alcohol	O	O	I-T051
and	O	O	O
individual	O	O	B-T055
levels	O	O	I-T055
of	O	O	I-T055
alcohol	O	O	I-T055
intake	O	O	I-T055
to	O	O	O
the	O	O	O
development	O	O	B-T169
of	O	O	O
loss	O	O	B-T080
of	O	O	I-T080
control	O	O	I-T080
over	O	O	O
alcohol	O	O	B-UnknownType
seeking	O	O	I-UnknownType
in	O	O	O
a	O	O	O
conditioned	O	O	B-T170
suppression	O	O	I-T170
model	O	O	I-T170
.	O	O	O

To	O	O	O
investigate	O	O	B-T169
the	O	O	O
impact	O	O	O
of	O	O	O
prolonged	O	O	B-T051
alcohol	O	O	I-T051
exposure	O	O	I-T051
,	O	O	O
conditioned	O	O	B-T169
suppression	O	O	I-T169
of	O	O	O
alcohol	O	O	B-UnknownType
seeking	O	O	I-UnknownType
was	O	O	O
assessed	O	O	B-T052
after	O	O	O
2	O	O	O
and	O	O	O
4	O	O	O
months	O	O	O
of	O	O	O
intermittent	O	O	B-T079
alcohol	O	O	I-T079
access	O	O	I-T079
(	O	O	O
IAA	O	O	B-T079
)	O	O	O
in	O	O	O
a	O	O	O
subgroup	O	O	B-T185
of	O	O	O
rats	O	O	B-T015
drinking	O	O	O
moderate	O	O	O
amounts	O	O	O
of	O	O	O
alcohol	O	O	O
.	O	O	O

We	O	O	O
observed	O	O	O
that	O	O	O
suppression	O	O	B-T169
of	O	O	O
alcohol	O	O	B-UnknownType
seeking	O	O	I-UnknownType
was	O	O	O
reduced	O	O	O
after	O	O	O
4	O	O	O
months	O	O	O
compared	O	O	O
with	O	O	O
2	O	O	O
months	O	O	O
of	O	O	O
IAA	O	O	B-T079
.	O	O	O

The	O	O	O
influence	O	O	B-T077
of	O	O	O
individual	O	O	O
levels	O	O	O
of	O	O	O
alcohol	O	O	B-T055
intake	O	O	I-T055
on	O	O	O
loss	O	O	B-T080
of	O	O	I-T080
control	O	O	I-T080
over	O	O	O
alcohol	O	O	B-UnknownType
seeking	O	O	I-UnknownType
was	O	O	O
subsequently	O	O	O
determined	O	O	B-T080
by	O	O	I-T080
assessing	O	O	B-T052
conditioned	O	O	B-T169
suppression	O	O	I-T169
in	O	O	O
subgroups	O	O	B-T185
of	O	O	O
low	O	O	B-T080
and	O	O	I-T080
high	O	O	I-T080
alcohol	O	O	I-T080
drinking	O	O	I-T080
rats	O	O	B-T015
.	O	O	O

Unlike	O	O	O
the	O	O	O
low	O	O	B-T080
alcohol	O	O	I-T080
drinking	O	O	I-T080
rats	O	O	B-T015
,	O	O	O
the	O	O	O
high	O	O	B-T080
alcohol	O	O	I-T080
drinking	O	O	I-T080
rats	O	O	O
showed	O	O	O
aversion-resistant	O	O	B-T169
alcohol	O	O	B-UnknownType
seeking	O	O	I-UnknownType
after	O	O	O
2	O	O	O
months	O	O	O
of	O	O	O
IAA	O	O	B-T079
,	O	O	O
although	O	O	O
both	O	O	O
groups	O	O	B-T078
showed	O	O	O
comparable	O	O	O
levels	O	O	O
of	O	O	O
conditioned	O	O	O
freezing	O	O	O
.	O	O	O

These	O	O	O
findings	O	O	O
show	O	O	O
that	O	O	O
the	O	O	O
development	O	O	O
of	O	O	O
loss	O	O	B-T080
of	O	O	I-T080
control	O	O	I-T080
over	O	O	O
alcohol	O	O	B-UnknownType
seeking	O	O	I-UnknownType
,	O	O	O
a	O	O	O
key	O	O	O
characteristic	O	O	O
of	O	O	O
AUD	O	O	B-T048
in	O	O	O
humans	O	O	B-T016
,	O	O	O
is	O	O	O
dependent	O	O	O
on	O	O	O
both	O	O	O
the	O	O	O
extent	O	O	O
of	O	O	O
alcohol	O	O	B-T051
exposure	O	O	I-T051
and	O	O	O
the	O	O	O
individual	O	O	B-T098
's	O	O	I-T098
propensity	O	O	O
to	O	O	O
consume	O	O	O
alcohol	O	O	O
.	O	O	O

-DOCSTART- (28419641)

Neural	O	O	B-T169
correlates	O	O	B-T041
of	O	O	O
experimental	O	O	B-T080
trauma	O	O	B-T037
memory	O	O	O
retrieval	O	O	O

Traumatic	O	O	B-T169
memories	O	O	B-T041
such	O	O	O
as	O	O	O
intrusions	O	O	B-T185
and	O	O	O
flashbacks	O	O	B-T033
play	O	O	O
a	O	O	O
major	O	O	O
role	O	O	O
in	O	O	O
the	O	O	O
development	O	O	B-T169
and	O	O	O
maintenance	O	O	B-T052
of	O	O	O
post-traumatic	O	O	B-T048
stress	O	O	I-T048
disorder	O	O	I-T048
(	O	O	O
PTSD	O	O	B-T048
)	O	O	O
.	O	O	O

A	O	O	O
thorough	O	O	O
understanding	O	O	O
of	O	O	O
the	O	O	O
neural	O	O	B-T169
mechanisms	O	O	B-T169
underlying	O	O	O
traumatic	O	O	B-T169
memories	O	O	B-T041
is	O	O	O
indispensable	O	O	O
for	O	O	O
precise	O	O	O
diagnosis	O	O	B-T033
,	O	O	O
for	O	O	O
personalized	O	O	B-T080
treatment	O	O	B-T061
and	O	O	O
prevention	O	O	B-T061
.	O	O	O

In	O	O	O
particular	O	O	O
,	O	O	O
the	O	O	O
identification	O	O	B-T080
of	O	O	O
early	O	O	O
neural	O	O	B-T169
predictor	O	O	B-T170
variables	O	O	I-T170
for	O	O	O
intrusion	O	O	B-T185
development	O	O	B-T169
shortly	O	O	O
after	O	O	O
trauma	O	O	B-T037
exposure	O	O	B-T080
requires	O	O	O
detailed	O	O	O
investigation	O	O	B-T058
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
examined	O	O	B-T033
the	O	O	O
neural	O	O	B-T041
correlates	O	O	I-T041
of	O	O	O
early	O	O	O
experimental	O	O	B-T080
trauma	O	O	B-T037
memory	O	O	B-T041
retrieval	O	O	I-T041
in	O	O	O
a	O	O	O
traumatic	O	O	B-T062
film	O	O	I-T062
paradigm	O	O	I-T062
in	O	O	O
42	O	O	O
young	O	O	O
healthy	O	O	B-T080
females	O	O	B-T032
,	O	O	O
using	O	O	O
both	O	O	O
implicit	O	O	B-T033
and	O	O	O
explicit	O	O	B-T041
retrieval	O	O	B-T041
tasks	O	O	I-T041
.	O	O	O

We	O	O	O
show	O	O	O
that	O	O	O
implicit	O	O	B-T033
experimental	O	O	B-T080
trauma	O	O	B-T037
retrieval	O	O	B-T041
specifically	O	O	O
involved	O	O	O
the	O	O	O
retrosplenial	O	O	B-T023
cortex	O	O	I-T023
and	O	O	O
the	O	O	O
anterior	O	O	B-T023
cingulate	O	O	I-T023
cortex	O	O	I-T023
(	O	O	O
ACC	O	O	B-T023
)	O	O	O
,	O	O	O
while	O	O	O
both	O	O	O
retrieval	O	O	B-T041
tasks	O	O	I-T041
resulted	O	O	O
in	O	O	O
trauma-related	O	O	B-T033
activity	O	O	B-T052
in	O	O	O
the	O	O	O
posterior	O	O	B-T023
cingulate	O	O	I-T023
cortex	O	O	I-T023
(	O	O	O
PCC	O	O	B-T023
)	O	O	O
and	O	O	O
the	O	O	O
precuneus	O	O	B-T023
.	O	O	O

Importantly	O	O	O
,	O	O	O
neural	O	O	B-T169
activity	O	O	B-T052
early	O	O	O
after	O	O	O
experimental	O	O	B-T080
trauma	O	O	B-T037
exposure	O	O	B-T080
predicted	O	O	B-T078
later	O	O	O
intrusion	O	O	B-T185
development	O	O	B-T169
,	O	O	O
with	O	O	O
independent	O	O	B-T078
contributions	O	O	B-T052
from	O	O	O
activity	O	O	O
in	O	O	O
the	O	O	O
retrosplenial	O	O	B-T023
cortex	O	O	I-T023
(	O	O	O
implicit	O	O	B-T033
retrieval	O	O	B-T041
)	O	O	O
and	O	O	O
the	O	O	O
PCC	O	O	B-T023
(	O	O	O
explicit	O	O	B-T041
retrieval	O	O	O
)	O	O	O
.	O	O	O

Additional	O	O	B-T169
analyses	O	O	B-T062
revealed	O	O	B-T080
a	O	O	O
stronger	O	O	O
connectivity	O	O	B-T169
between	O	O	O
the	O	O	O
bilateral	O	O	B-T023
amygdala	O	O	I-T023
and	O	O	O
the	O	O	O
supplementary	O	O	B-T029
motor	O	O	I-T029
area	O	O	I-T029
,	O	O	O
precentral	O	O	B-T023
and	O	O	O
paracentral	O	O	B-T023
lobule	O	O	I-T023
for	O	O	O
the	O	O	O
control	O	O	B-T096
group	O	O	B-T078
compared	O	O	O
to	O	O	O
the	O	O	O
experimental	O	O	B-T080
trauma	O	O	B-T037
group	O	O	O
.	O	O	O

Our	O	O	O
study	O	O	B-T062
gives	O	O	O
new	O	O	O
insights	O	O	O
in	O	O	O
the	O	O	O
neural	O	O	B-T169
correlates	O	O	B-T041
of	O	O	O
experimental	O	O	B-T080
trauma	O	O	B-T037
memory	O	O	B-T041
retrieval	O	O	I-T041
and	O	O	O
their	O	O	O
predictive	O	O	B-T080
value	O	O	I-T080
for	O	O	O
subsequent	O	O	B-T079
symptom	O	O	B-T184
development	O	O	B-T169
.	O	O	O

Our	O	O	O
results	O	O	B-T169
could	O	O	O
provide	O	O	O
the	O	O	O
basis	O	O	O
for	O	O	O
personalized	O	O	B-T080
early	O	O	B-UnknownType
treatment	O	O	I-UnknownType
and	O	O	O
prevention	O	O	B-T080
of	O	O	O
PTSD	O	O	B-T048
.	O	O	O

Hum	O	O	O
Brain	O	O	O
Mapp	O	O	O
,	O	O	O
2017	O	O	O
.	O	O	O

Â©	O	O	O
2017	O	O	O
Wiley	O	O	O
Periodicals	O	O	O
,	O	O	O
Inc.	O	O	O

-DOCSTART- (28421738)

Targeting	O	O	B-T044
the	O	O	O
Nrf2	O	O	B-T116
/	O	O	O
Amyloid-Beta	O	O	B-T044
Liaison	O	O	I-T044
in	O	O	O
Alzheimer	O	O	B-T047
's	O	O	I-T047
Disease	O	O	I-T047
:	O	O	O
A	O	O	O
Rational	O	O	O
Approach	O	O	O

Amyloid	O	O	B-T116
is	O	O	O
a	O	O	O
prominent	O	O	B-T080
feature	O	O	B-T080
of	O	O	O
Alzheimer	O	O	B-T047
's	O	O	I-T047
disease	O	O	I-T047
(	O	O	O
AD	O	O	B-T047
)	O	O	O
.	O	O	O

Yet	O	O	O
,	O	O	O
a	O	O	O
linear	O	O	B-T082
linkage	O	O	B-T080
between	O	O	O
amyloid-Î²	O	O	B-T116
peptide	O	O	I-T116
(	O	O	O
AÎ²	O	O	B-T116
)	O	O	O
and	O	O	O
the	O	O	O
disease	O	O	B-T079
onset	O	O	I-T079
and	O	O	O
progression	O	O	B-T046
has	O	O	O
recently	O	O	O
been	O	O	O
questioned	O	O	O
.	O	O	O

In	O	O	O
this	O	O	O
context	O	O	B-T078
,	O	O	O
the	O	O	O
crucial	O	O	O
partnership	O	O	B-T080
between	O	O	O
AÎ²	O	O	B-T044
and	O	O	O
Nrf2	O	O	B-T044
pathways	O	O	I-T044
is	O	O	O
acquiring	O	O	B-T080
paramount	O	O	B-T080
importance	O	O	B-T080
,	O	O	O
offering	O	O	O
prospects	O	O	O
for	O	O	O
deciphering	O	O	B-T169
the	O	O	O
AÎ²	O	O	O
-centered	O	O	O
disease	O	O	B-T047
network	O	O	B-T169
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
report	O	O	O
on	O	O	O
a	O	O	O
new	O	O	B-T080
class	O	O	O
of	O	O	O
antiaggregating	O	O	B-T121
agents	O	O	I-T121
rationally	O	O	O
designed	O	O	O
to	O	O	O
simultaneously	O	O	B-T079
activate	O	O	B-T045
transcription	O	O	I-T045
-based	O	O	O
antioxidant	O	O	B-T121
responses	O	O	B-T040
,	O	O	O
whose	O	O	O
lead	O	O	B-T121
1	O	O	I-T121
showed	O	O	O
interesting	O	O	O
properties	O	O	B-T080
in	O	O	O
a	O	O	O
preliminary	O	O	B-T079
investigation	O	O	O
.	O	O	O

Relying	O	O	O
on	O	O	O
the	O	O	O
requirements	O	O	B-T033
of	O	O	O
AÎ²	O	O	B-T116
recognition	O	O	B-T044
,	O	O	O
we	O	O	O
identified	O	O	B-T080
the	O	O	O
catechol	O	O	B-T121
derivative	O	O	I-T121
12	O	O	I-T121
.	O	O	O

In	O	O	O
SH-SY5Y	O	O	B-UnknownType
neuroblastoma	O	O	I-UnknownType
cells	O	O	I-UnknownType
,	O	O	O
12	O	O	B-T121
combined	O	O	B-T080
remarkable	O	O	O
free	O	O	B-T120
radical	O	O	I-T120
scavenger	O	O	I-T120
properties	O	O	B-T080
to	O	O	O
the	O	O	O
ability	O	O	O
to	O	O	O
trigger	O	O	B-T080
the	O	O	O
Nrf2	O	O	B-T116
pathway	O	O	I-T044
and	O	O	O
induce	O	O	B-T045
the	O	O	O
Nrf2	O	O	O
-	O	O	O
dependent	O	O	B-T169
defensive	O	O	B-T033
gene	O	O	B-T028
NQO1	O	O	I-T028
by	O	O	O
means	O	O	O
of	O	O	O
electrophilic	O	O	B-T070
activation	O	O	I-T070
of	O	O	O
the	O	O	O
transcriptional	O	O	B-T045
response	O	O	I-T045
.	O	O	O

Moreover	O	O	O
,	O	O	O
12	O	O	O
prevented	O	O	O
the	O	O	O
formation	O	O	B-T169
of	O	O	O
cytotoxic	O	O	B-T169
stable	O	O	B-T080
oligomeric	O	O	B-T121
intermediates	O	O	I-T121
,	O	O	O
being	O	O	O
significantly	O	O	B-T078
more	O	O	B-T081
effective	O	O	B-T080
,	O	O	O
and	O	O	O
per	O	O	O
se	O	O	O
less	O	O	B-T037
toxic	O	O	I-T037
,	O	O	O
than	O	O	O
prototype	O	O	B-T121
1	O	O	I-T121
.	O	O	O

More	O	O	O
importantly	O	O	O
,	O	O	O
as	O	O	O
different	O	O	B-T080
chemical	O	O	B-T070
features	O	O	I-T070
were	O	O	O
exploited	O	O	O
to	O	O	O
regulate	O	O	B-T045
Nrf2	O	O	I-T045
and	O	O	O
AÎ²	O	O	B-T116
activities	O	O	B-T044
,	O	O	O
the	O	O	O
two	O	O	O
pathways	O	O	B-T044
could	O	O	O
be	O	O	O
tuned	O	O	O
independently	O	O	O
.	O	O	O

These	O	O	O
findings	O	O	O
point	O	O	O
to	O	O	O
compound	O	O	B-T121
12	O	O	I-T121
and	O	O	O
its	O	O	O
derivatives	O	O	B-T121
as	O	O	O
promising	O	O	O
tools	O	O	O
for	O	O	O
investigating	O	O	O
the	O	O	O
therapeutic	O	O	B-T169
potential	O	O	B-T080
of	O	O	O
the	O	O	O
Nrf2	O	O	B-T116
/	O	O	O
AÎ²	O	O	B-T116
cellular	O	O	B-T025
network	O	O	B-T169
,	O	O	O
laying	O	O	O
foundation	O	O	O
for	O	O	O
generating	O	O	B-T052
new	O	O	O
drug	O	O	B-T121
leads	O	O	I-T121
to	O	O	O
confront	O	O	O
AD	O	O	B-T047
.	O	O	O

-DOCSTART- (28424061)

Young	O	O	B-T079
people	O	O	B-T098
,	O	O	O
mental	O	O	B-T041
health	O	O	I-T041
practitioners	O	O	B-T097
and	O	O	O
researchers	O	O	B-T097
co-produce	O	O	O
a	O	O	O
Transition	O	O	B-T170
Preparation	O	O	I-T170
Programme	O	O	I-T170
to	O	O	O
improve	O	O	O
outcomes	O	O	B-T169
and	O	O	O
experience	O	O	B-T041
for	O	O	O
young	O	O	B-T079
people	O	O	O
leaving	O	O	O
Child	O	O	B-T058
and	O	O	I-T058
Adolescent	O	O	I-T058
Mental	O	O	I-T058
Health	O	O	I-T058
Services	O	O	I-T058
(	O	O	O
CAMHS	O	O	B-T058
)	O	O	O

In	O	O	O
the	O	O	O
UK	O	O	B-T083
young	O	O	B-T079
people	O	O	B-T098
attending	O	O	O
child	O	O	B-T058
and	O	O	I-T058
adolescent	O	O	I-T058
mental	O	O	I-T058
health	O	O	I-T058
services	O	O	I-T058
(	O	O	O
CAMHS	O	O	B-T058
)	O	O	O
are	O	O	O
required	O	O	O
to	O	O	O
move	O	O	O
on	O	O	O
,	O	O	O
either	O	O	O
through	O	O	O
discharge	O	O	B-T079
or	O	O	O
referral	O	O	B-T058
to	O	O	I-T058
an	O	O	O
adult	O	O	B-T058
service	O	O	I-T058
,	O	O	O
at	O	O	O
age	O	O	B-T032
17/18	O	O	O
,	O	O	O
a	O	O	O
period	O	O	B-T079
of	O	O	O
increased	O	O	B-T081
risk	O	O	B-T078
for	O	O	O
onset	O	O	B-T080
of	O	O	I-T080
mental	O	O	B-T033
health	O	O	I-T033
problems	O	O	I-T033
and	O	O	O
other	O	O	O
complex	O	O	B-T080
psychosocial	O	O	B-T169
and	O	O	O
physical	O	O	B-T169
changes	O	O	B-T169
.	O	O	O

CAMHS	O	O	B-T058
transitions	O	O	B-T052
are	O	O	O
often	O	O	O
poorly	O	O	O
managed	O	O	O
with	O	O	O
negative	O	O	B-T033
outcomes	O	O	B-T169
for	O	O	O
young	O	O	B-T079
people	O	O	B-T098
.	O	O	O

Better	O	O	O
preparation	O	O	B-T052
may	O	O	O
improve	O	O	O
outcomes	O	O	B-T169
and	O	O	O
experience	O	O	B-T041
.	O	O	O

This	O	O	O
study	O	O	B-T062
aimed	O	O	O
to	O	O	O
co-produce	O	O	O
,	O	O	O
with	O	O	O
young	O	O	B-T079
people	O	O	B-T098
who	O	O	O
had	O	O	O
transitioned	O	O	B-T052
or	O	O	O
were	O	O	O
facing	O	O	O
transition	O	O	B-T052
from	O	O	O
CAMHS	O	O	B-T058
,	O	O	O
a	O	O	O
CAMHS	O	O	O
Transition	O	O	B-T170
Preparation	O	O	I-T170
Programme	O	O	I-T170
(	O	O	O
TPP	O	O	B-T170
)	O	O	O
,	O	O	O
deliverable	O	O	O
in	O	O	O
routine	O	O	B-T080
NHS	O	O	B-T058
settings	O	O	O
.	O	O	O

Eighteen	O	O	O
young	O	O	B-T079
people	O	O	B-T098
,	O	O	O
aged	O	O	O
17	O	O	O
-	O	O	O
22	O	O	O
,	O	O	O
from	O	O	O
three	O	O	O
UK	O	O	B-T083
National	O	O	B-T058
Health	O	O	I-T058
Service	O	O	I-T058
(	O	O	O
NHS	O	O	B-T058
)	O	O	O
mental	O	O	O
health	O	O	O
foundation	O	O	O
trusts	O	O	O
participated	O	O	O
in	O	O	O
creative	O	O	O
,	O	O	O
participatory	O	O	B-T065
research	O	O	I-T065
workshops	O	O	I-T065
.	O	O	O

Seven	O	O	O
parents	O	O	B-T099
completed	O	O	O
short	O	O	O
questionnaires	O	O	B-T170
.	O	O	O

Thirty	O	O	O
clinical	O	O	B-T097
staff	O	O	I-T097
from	O	O	O
two	O	O	O
trusts	O	O	O
took	O	O	O
part	O	O	O
in	O	O	O
workshops	O	O	B-T065
to	O	O	O
ensure	O	O	O
deliverability	O	O	O
of	O	O	O
young	O	O	B-T079
people	O	O	B-T098
's	O	O	I-T098
ideas	O	O	B-T078
.	O	O	O

Young	O	O	B-T079
people	O	O	B-T098
were	O	O	O
offered	O	O	O
co-research	O	O	B-T062
opportunities	O	O	I-T062
.	O	O	O

Most	O	O	O
young	O	O	B-T079
people	O	O	B-T098
felt	O	O	O
anxious	O	O	B-T033
,	O	O	O
fearful	O	O	B-T041
and	O	O	O
uncertain	O	O	O
on	O	O	O
leaving	O	O	O
CAMHS	O	O	B-T058
and	O	O	O
perceived	O	O	B-T041
mental	O	O	B-T058
health	O	O	I-T058
services	O	O	I-T058
as	O	O	O
uncaring	O	O	O
.	O	O	O

Participants	O	O	B-T098
outlined	O	O	O
transition	O	O	B-T052
procedures	O	O	B-T169
and	O	O	O
drafted	O	O	O
a	O	O	O
range	O	O	O
of	O	O	O
preparation	O	O	B-T052
activities	O	O	I-T052
,	O	O	O
centred	O	O	O
around	O	O	O
dedicated	O	O	O
Transition	O	O	B-T052
Peer	O	O	B-T061
Support	O	O	I-T061
and	O	O	O
a	O	O	O
transition	O	O	O
booklet	O	O	B-T073
,	O	O	O
which	O	O	O
should	O	O	O
be	O	O	O
offered	O	O	O
to	O	O	O
all	O	O	O
CAMHS	O	O	B-T058
leavers	O	O	B-T098
,	O	O	O
irrespective	O	O	O
of	O	O	O
discharge	O	O	B-T079
or	O	O	O
transfer	O	O	B-T078
to	O	O	O
an	O	O	O
adult	O	O	B-T058
service	O	O	I-T058
.	O	O	O

Preparation	O	O	B-T052
should	O	O	O
aim	O	O	O
to	O	O	O
build	O	O	O
confidence	O	O	B-T041
to	O	O	O
help	O	O	O
young	O	O	B-T079
people	O	O	B-T098
take	O	O	O
responsibility	O	O	B-T055
for	O	O	O
themselves	O	O	O
and	O	O	O
flourish	O	O	O
in	O	O	O
the	O	O	O
adult	O	O	B-T100
world	O	O	B-T098
:	O	O	O
coping	O	O	O
or	O	O	O
getting	O	O	O
through	O	O	O
it	O	O	O
was	O	O	O
not	O	O	O
enough	O	O	O
.	O	O	O

Some	O	O	O
clinicians	O	O	B-T097
also	O	O	O
felt	O	O	O
anxious	O	O	B-T033
at	O	O	O
transition	O	O	B-T052
and	O	O	O
recognised	O	O	O
the	O	O	O
potential	O	O	O
impact	O	O	B-T080
on	O	O	O
young	O	O	B-T079
people	O	O	B-T098
of	O	O	O
poor	O	O	O
communication	O	O	B-T054
and	O	O	O
lack	O	O	B-T080
of	O	O	O
understanding	O	O	O
between	O	O	O
services	O	O	B-T058
.	O	O	O

Parents	O	O	B-T099
would	O	O	O
appreciate	O	O	O
help	O	O	O
to	O	O	O
support	O	O	B-T054
their	O	O	O
offspring	O	O	B-T099
during	O	O	O
the	O	O	O
transition	O	O	B-T052
period	O	O	B-T079
.	O	O	O

Clinicians	O	O	B-T097
cited	O	O	O
lack	O	O	B-T080
of	O	O	O
funding	O	O	O
and	O	O	O
inflexible	O	O	O
NHS	O	O	B-T058
procedures	O	O	B-T169
and	O	O	O
policies	O	O	B-T170
as	O	O	O
potential	O	O	O
barriers	O	O	B-T080
to	O	O	O
the	O	O	O
implementation	O	O	B-T052
of	O	O	O
young	O	O	B-T079
people	O	O	B-T098
's	O	O	I-T098
ideas	O	O	B-T078
.	O	O	O

Nine	O	O	O
young	O	O	B-T079
people	O	O	B-T098
took	O	O	O
up	O	O	O
co-research	O	O	B-T062
opportunities	O	O	I-T062
.	O	O	O

Mental	O	O	B-T058
health	O	O	I-T058
services	O	O	I-T058
underestimate	O	O	O
the	O	O	O
anxiety	O	O	B-T033
of	O	O	O
CAMHS	O	O	B-T058
leavers	O	O	B-T098
.	O	O	O

Young	O	O	B-T079
people	O	O	B-T098
have	O	O	O
clear	O	O	O
ideas	O	O	B-T078
about	O	O	O
the	O	O	O
preparation	O	O	B-T052
they	O	O	O
require	O	O	O
to	O	O	O
leave	O	O	O
CAMHS	O	O	B-T058
with	O	O	O
the	O	O	O
confidence	O	O	B-T041
to	O	O	O
take	O	O	O
responsibility	O	O	B-T055
for	O	O	O
their	O	O	O
own	O	O	O
health	O	O	B-T058
care	O	O	I-T058
.	O	O	O

Close	O	O	O
collaboration	O	O	B-T054
of	O	O	O
NHS	O	O	B-T058
staff	O	O	B-T097
and	O	O	O
researchers	O	O	B-T097
facilitates	O	O	O
the	O	O	O
implementation	O	O	B-T052
of	O	O	O
research	O	O	B-T062
findings	O	O	B-T169
.	O	O	O

-DOCSTART- (28424240)

The	O	O	O
Histone	O	O	B-T116
Acetyltransferase	O	O	I-T116
Gcn5	O	O	I-T116
Positively	O	O	O
Regulates	O	O	O
T	O	O	O
Cell	O	O	O
Activation	O	O	O

Histone	O	O	B-T116
acetyltransferases	O	O	I-T116
(	O	O	O
HATs	O	O	B-T116
)	O	O	O
regulate	O	O	B-T045
inducible	O	O	I-T045
transcription	O	O	I-T045
in	O	O	O
multiple	O	O	B-T081
cellular	O	O	B-T043
processes	O	O	I-T043
and	O	O	O
during	O	O	O
inflammatory	O	O	B-T046
and	O	O	O
immune	O	O	B-T042
response	O	O	I-T042
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
functions	O	O	B-T044
of	O	O	O
general	O	O	B-T116
control	O	O	I-T116
nonrepressed-protein	O	O	I-T116
5	O	O	I-T116
(	O	O	O
Gcn5	O	O	B-T116
)	O	O	O
,	O	O	O
an	O	O	O
evolutionarily	O	O	O
conserved	O	O	O
HAT	O	O	B-T116
from	O	O	O
yeast	O	O	B-T004
to	O	O	O
human	O	O	B-T016
,	O	O	O
in	O	O	O
immune	O	O	B-T040
regulation	O	O	I-T040
remain	O	O	O
unappreciated	O	O	O
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
we	O	O	O
conditionally	O	O	O
deleted	O	O	B-T045
Gcn5	O	O	B-T116
(	O	O	O
encoded	O	O	B-T052
by	O	O	O
the	O	O	O
Kat2a	O	O	B-T028
gene	O	O	I-T028
)	O	O	O
specifically	O	O	O
in	O	O	O
T	O	O	B-T025
lymphocytes	O	O	I-T025
by	O	O	O
crossing	O	O	B-T045
floxed	O	O	B-T028
Gcn5	O	O	I-T028
and	O	O	O
Lck-Cre	O	O	B-T028
mice	O	O	B-T015
,	O	O	O
and	O	O	O
demonstrated	O	O	O
that	O	O	O
Gcn5	O	O	O
plays	O	O	O
important	O	O	B-T077
roles	O	O	I-T077
in	O	O	O
multiple	O	O	O
stages	O	O	B-T079
of	O	O	O
T	O	O	B-T043
cell	O	O	I-T043
functions	O	O	I-T043
including	O	O	O
development	O	O	B-T043
,	O	O	O
clonal	O	O	B-T046
expansion	O	O	I-T046
,	O	O	O
and	O	O	O
differentiation	O	O	B-T043
.	O	O	O

Loss	O	O	B-T033
of	O	O	I-T033
Gcn5	O	O	B-T116
functions	O	O	O
impaired	O	O	B-T049
T	O	O	I-T049
cell	O	O	I-T049
proliferation	O	O	I-T049
,	O	O	O
IL-2	O	O	B-T040
production	O	O	I-T040
,	O	O	O
and	O	O	O
Th1	O	O	B-T025
/	O	O	O
Th17	O	O	B-T025
,	O	O	O
but	O	O	O
not	O	O	O
Th2	O	O	B-T025
and	O	O	O
regulatory	O	O	B-T043
T	O	O	I-T043
cell	O	O	I-T043
differentiation	O	O	I-T043
.	O	O	O

Gcn5	O	O	B-T116
is	O	O	O
recruited	O	O	O
onto	O	O	O
the	O	O	O
il-2	O	O	B-T028
promoter	O	O	B-T114
by	O	O	O
interacting	O	O	B-T169
with	O	O	O
the	O	O	O
NFAT	O	O	B-T116
in	O	O	O
T	O	O	B-T025
cells	O	O	I-T025
upon	O	O	O
TCR	O	O	B-T116
stimulation	O	O	O
.	O	O	O

Interestingly	O	O	O
,	O	O	O
instead	O	O	O
of	O	O	O
directly	O	O	O
acetylating	O	O	B-T044
NFAT	O	O	B-T116
,	O	O	O
Gcn5	O	O	B-T116
catalyzes	O	O	B-T070
histone	O	O	B-T044
H3	O	O	I-T044
lysine	O	O	I-T044
H9	O	O	I-T044
acetylation	O	O	I-T044
to	O	O	O
promote	O	O	B-T052
IL-2	O	O	B-T040
production	O	O	I-T040
.	O	O	O

T	O	O	B-T025
cell	O	O	I-T025
-specific	O	O	O
suppression	O	O	B-T169
of	O	O	O
Gcn5	O	O	B-T116
partially	O	O	O
protected	O	O	O
mice	O	O	B-T015
from	O	O	O
myelin	O	O	B-T116
oligodendrocyte	O	O	I-T116
glycoprotein	O	O	I-T116
-	O	O	O
induced	O	O	B-T169
experimental	O	O	B-T050
autoimmune	O	O	I-T050
encephalomyelitis	O	O	I-T050
,	O	O	O
an	O	O	O
experimental	O	O	B-T170
model	O	O	I-T170
for	O	O	O
human	O	O	B-T016
multiple	O	O	B-T047
sclerosis	O	O	I-T047
.	O	O	O

Our	O	O	O
study	O	O	O
reveals	O	O	B-T080
previously	O	O	O
unknown	O	O	O
physiological	O	O	B-T039
functions	O	O	B-T044
for	O	O	O
Gcn5	O	O	B-T116
and	O	O	O
a	O	O	O
molecular	O	O	B-T044
mechanism	O	O	I-T044
underlying	O	O	O
these	O	O	O
functions	O	O	O
in	O	O	O
regulating	O	O	B-T038
T	O	O	I-T038
cell	O	O	I-T038
immunity	O	O	I-T038
.	O	O	O

Hence	O	O	O
Gcn5	O	O	B-T116
may	O	O	O
be	O	O	O
an	O	O	O
important	O	O	O
new	O	O	O
target	O	O	O
for	O	O	O
autoimmune	O	O	B-T047
disease	O	O	I-T047
therapy	O	O	B-T061
.	O	O	O

-DOCSTART- (28424384)

Minor	O	O	B-T019
physical	O	O	I-T019
anomalies	O	O	I-T019
and	O	O	O
dermatoglyphic	O	O	B-T029
signs	O	O	O
in	O	O	O
affective	O	O	B-T048
disorders	O	O	I-T048
:	O	O	O
A	O	O	O
systematic	O	O	O
review	O	O	O

The	O	O	O
increased	O	O	B-T081
prevalence	O	O	B-T081
of	O	O	O
minor	O	O	B-T019
physical	O	O	B-T169
anomalies	O	O	I-T019
(	O	O	O
MPAs	O	O	B-T019
)	O	O	O
and	O	O	O
the	O	O	O
abnormalities	O	O	B-T019
of	O	O	I-T019
dermatoglyphic	O	O	I-T019
patterns	O	O	I-T019
may	O	O	O
be	O	O	O
physical	O	O	O
manifestations	O	O	B-T169
of	O	O	O
neurodevelopmental	O	O	B-UnknownType
disruption	O	O	I-UnknownType
in	O	O	O
affective	O	O	B-T048
disorders	O	O	I-T048
.	O	O	O

This	O	O	O
paper	O	O	O
aims	O	O	O
to	O	O	O
review	O	O	B-T170
the	O	O	O
current	O	O	O
state	O	O	O
of	O	O	O
knowledge	O	O	O
on	O	O	O
the	O	O	O
frequency	O	O	B-T079
of	O	O	O
MPAs	O	O	B-T019
and	O	O	O
dermatoglyphic	O	O	B-T019
abnormalities	O	O	I-T019
in	O	O	O
mood	O	O	B-T048
disorders	O	O	I-T048
.	O	O	O

A	O	O	O
MEDLINE	O	O	B-T170
,	O	O	O
PsychInfo	O	O	B-T170
and	O	O	O
Web	O	O	B-T170
of	O	O	I-T170
Science	O	O	I-T170
search	O	O	I-T170
was	O	O	O
carried	O	O	O
out	O	O	O
to	O	O	O
collect	O	O	O
all	O	O	O
publications	O	O	B-T073
on	O	O	O
the	O	O	O
frequency	O	O	B-T079
of	O	O	O
MPAs	O	O	B-T019
and	O	O	O
on	O	O	O
dermatoglyphic	O	O	B-T190
traits	O	O	I-T190
in	O	O	O
bipolar	O	O	B-T048
disorder	O	O	I-T048
and	O	O	O
unipolar	O	O	B-T048
depression	O	O	I-T048
.	O	O	O

24	O	O	O
studies	O	O	B-T062
on	O	O	O
MPAs	O	O	B-T019
,	O	O	O
19	O	O	O
on	O	O	O
dermatoglyphics	O	O	B-T059
,	O	O	O
and	O	O	O
5	O	O	O
dealing	O	O	O
with	O	O	O
both	O	O	O
were	O	O	O
found	O	O	O
with	O	O	O
discrepant	O	O	B-T033
findings	O	O	B-T169
.	O	O	O

The	O	O	O
relative	O	O	B-T080
contribution	O	O	B-T052
of	O	O	O
neurodevelopmental	O	O	B-UnknownType
retardation	O	O	I-UnknownType
to	O	O	O
the	O	O	O
aetiology	O	O	B-T169
of	O	O	O
affective	O	O	B-T048
disorders	O	O	I-T048
remains	O	O	O
undetermined	O	O	O
,	O	O	O
the	O	O	O
field	O	O	O
is	O	O	O
open	O	O	O
for	O	O	O
further	O	O	O
research	O	O	B-T062
.	O	O	O

Increased	O	O	B-T169
recognition	O	O	B-T041
of	O	O	O
neurodevelopmental	O	O	B-T042
processes	O	O	B-T067
in	O	O	O
the	O	O	O
origin	O	O	B-T079
of	O	O	O
affective	O	O	B-T048
disorders	O	O	I-T048
may	O	O	O
allow	O	O	O
for	O	O	O
earlier	O	O	O
and	O	O	O
more	O	O	O
effective	O	O	B-T080
intervention	O	O	B-T061
and	O	O	O
prevention	O	O	B-T061
.	O	O	O

-DOCSTART- (28424683)

Novel	O	O	B-T062
Strategy	O	O	I-T062
to	O	O	O
Expand	O	O	O
Super-Charged	O	O	B-T025
NK	O	O	I-T025
Cells	O	O	I-T025
with	O	O	O
Significant	O	O	B-T080
Potential	O	O	I-T080
to	O	O	O
Lyse	O	O	B-T046
and	O	O	O
Differentiate	O	O	B-T080
Cancer	O	O	B-T025
Stem	O	O	I-T025
Cells	O	O	I-T025
:	O	O	O
Differences	O	O	B-T081
in	O	O	O
NK	O	O	B-T043
Expansion	O	O	I-T043
and	O	O	O
Function	O	O	B-T169
between	O	O	O
Healthy	O	O	B-T098
and	O	O	O
Cancer	O	O	O
Patients	O	O	O

Natural	O	O	B-T025
killer	O	O	I-T025
(	O	O	I-T025
NK	O	O	I-T025
)	O	O	I-T025
cells	O	O	I-T025
are	O	O	O
known	O	O	O
to	O	O	O
target	O	O	O
cancer	O	O	B-T025
stem	O	O	I-T025
cells	O	O	I-T025
and	O	O	O
undifferentiated	O	O	B-T191
tumors	O	O	I-T191
.	O	O	O

In	O	O	O
this	O	O	O
paper	O	O	O
,	O	O	O
we	O	O	O
provide	O	O	O
a	O	O	O
novel	O	O	B-T062
strategy	O	O	I-T062
for	O	O	O
expanding	O	O	O
large	O	O	O
numbers	O	O	O
of	O	O	O
super-charged	O	O	B-T025
NK	O	O	I-T025
cells	O	O	I-T025
with	O	O	O
significant	O	O	B-T080
potential	O	O	I-T080
to	O	O	O
lyse	O	O	B-T046
and	O	O	O
differentiate	O	O	B-T080
cancer	O	O	B-T025
stem	O	O	I-T025
cells	O	O	I-T025
and	O	O	O
demonstrate	O	O	O
the	O	O	O
differences	O	O	B-T081
in	O	O	O
the	O	O	O
dynamics	O	O	B-T070
of	O	O	O
NK	O	O	B-T025
cell	O	O	I-T025
expansion	O	O	B-T043
between	O	O	O
healthy	O	O	B-T098
donors	O	O	I-T098
and	O	O	O
cancer	O	O	B-T101
patients	O	O	I-T101
.	O	O	O

Decline	O	O	B-T033
in	O	O	I-T033
cytotoxicity	O	O	I-T033
and	O	O	O
lower	O	O	B-T082
interferon	O	O	B-T043
(IFN)-Î³	O	O	I-T043
secretion	O	O	I-T043
by	O	O	O
osteoclast	O	O	B-T025
(OC)-expanded	O	O	O
NK	O	O	B-T025
cells	O	O	I-T025
from	O	O	O
cancer	O	O	B-T101
patients	O	O	I-T101
correlates	O	O	O
with	O	O	O
faster	O	O	B-T080
expansion	O	O	B-T043
of	O	O	O
residual	O	O	O
contaminating	O	O	B-T169
T	O	O	B-T025
cells	O	O	I-T025
within	O	O	O
purified	O	O	B-T169
NK	O	O	O
cells	O	O	O
,	O	O	O
whereas	O	O	O
healthy	O	O	B-T098
donors	O	O	I-T098
'	O	O	O
OCs	O	O	B-T025
continue	O	O	O
expanding	O	O	O
super-charged	O	O	B-T025
NK	O	O	I-T025
cells	O	O	I-T025
while	O	O	O
limiting	O	O	O
T	O	O	B-T025
cell	O	O	I-T025
expansion	O	O	O
for	O	O	O
up	O	O	O
to	O	O	O
60	O	O	O
days	O	O	B-T079
.	O	O	O

Similar	O	O	O
to	O	O	O
patient	O	O	B-T101
NK	O	O	B-T025
cells	O	O	I-T025
,	O	O	O
NK	O	O	O
cells	O	O	O
from	O	O	O
tumor	O	O	B-T191
-bearing	O	O	O
BLT-humanized	O	O	B-T050
mice	O	O	B-T015
promote	O	O	O
faster	O	O	B-T080
expansion	O	O	B-T043
of	O	O	O
residual	O	O	O
T	O	O	B-T033
cells	O	O	I-T033
resulting	O	O	I-T033
in	O	O	I-T033
decreased	O	O	I-T033
numbers	O	O	I-T033
and	O	O	O
function	O	O	B-T169
of	O	O	O
NK	O	O	O
cells	O	O	O
,	O	O	O
whereas	O	O	O
NK	O	O	O
cells	O	O	O
from	O	O	O
mice	O	O	O
with	O	O	O
no	O	O	B-T033
tumor	O	O	O
continue	O	O	O
expanding	O	O	B-T043
NK	O	O	O
cells	O	O	O
and	O	O	O
retain	O	O	O
their	O	O	O
cytotoxicity	O	O	B-T049
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
dendritic	O	O	B-T025
cells	O	O	I-T025
(	O	O	O
DCs	O	O	B-T025
)	O	O	O
in	O	O	O
contrast	O	O	O
to	O	O	O
OCs	O	O	B-T025
are	O	O	O
found	O	O	O
to	O	O	O
promote	O	O	O
faster	O	O	B-T080
expansion	O	O	B-T043
of	O	O	O
residual	O	O	O
T	O	O	B-T025
cells	O	O	I-T025
within	O	O	O
purified	O	O	B-T169
NK	O	O	B-T025
cells	O	O	I-T025
resulting	O	O	O
in	O	O	O
the	O	O	O
decline	O	O	B-T033
in	O	O	I-T033
NK	O	O	I-T033
cell	O	O	I-T033
numbers	O	O	I-T033
from	O	O	O
healthy	O	O	B-T098
individuals	O	O	I-T098
.	O	O	O

Addition	O	O	O
of	O	O	O
anti-CD3	O	O	B-T116
mAb	O	O	I-T116
inhibits	O	O	O
T	O	O	B-T043
cell	O	O	I-T043
proliferation	O	O	I-T043
while	O	O	O
enhancing	O	O	B-T052
NK	O	O	B-T025
cell	O	O	I-T025
expansion	O	O	B-T043
;	O	O	O
however	O	O	O
,	O	O	O
expanding	O	O	B-T043
NK	O	O	B-T025
cells	O	O	I-T025
have	O	O	O
lower	O	O	B-T082
cytotoxicity	O	O	B-T049
but	O	O	O
higher	O	O	B-T080
secretion	O	O	B-T043
of	O	O	I-T043
IFN-Î³	O	O	I-T043
.	O	O	O

Expansion	O	O	B-T043
and	O	O	O
functional	O	O	B-T169
activation	O	O	B-T052
of	O	O	O
super-charged	O	O	B-T025
NK	O	O	I-T025
cells	O	O	I-T025
by	O	O	O
OCs	O	O	B-T025
is	O	O	O
dependent	O	O	B-T080
on	O	O	O
interleukin	O	O	B-T116
(IL)-12	O	O	I-T116
and	O	O	O
IL-15	O	O	B-T116
.	O	O	O

Thus	O	O	O
,	O	O	O
in	O	O	O
this	O	O	O
report	O	O	O
,	O	O	O
we	O	O	O
not	O	O	O
only	O	O	O
provide	O	O	O
a	O	O	O
novel	O	O	B-T062
strategy	O	O	I-T062
to	O	O	O
expand	O	O	B-T043
super-charged	O	O	B-T025
NK	O	O	B-T025
cells	O	O	I-T025
,	O	O	O
but	O	O	O
also	O	O	O
demonstrate	O	O	O
that	O	O	O
rapid	O	O	B-T043
and	O	O	I-T043
sustained	O	O	I-T043
expansion	O	O	B-T043
of	O	O	O
residual	O	O	O
T	O	O	B-T025
cells	O	O	I-T025
within	O	O	O
the	O	O	O
purified	O	O	B-T169
NK	O	O	O
cells	O	O	O
during	O	O	O
expansion	O	O	O
with	O	O	O
DCs	O	O	B-T025
or	O	O	O
OCs	O	O	B-T025
could	O	O	O
be	O	O	O
a	O	O	O
potential	O	O	B-T080
mechanism	O	O	B-T169
by	O	O	O
which	O	O	O
the	O	O	O
numbers	O	O	B-T081
and	O	O	O
function	O	O	B-T169
of	O	O	O
NK	O	O	B-T033
cells	O	O	I-T033
decline	O	O	I-T033
in	O	O	O
cancer	O	O	B-T101
patients	O	O	I-T101
and	O	O	O
in	O	O	O
BLT-humanized	O	O	B-T050
mice	O	O	I-T050
.	O	O	O

-DOCSTART- (28424986)

Extremely	O	O	B-T080
Giant	O	O	B-T191
Liver	O	O	I-T191
Hemangioma	O	O	I-T191
(	O	O	O
50	O	O	O
cm	O	O	O
)	O	O	O
with	O	O	O
Kasabach-Merritt	O	O	O
Syndrome	O	O	O

A	O	O	O
33-	O	O	O
year	O	O	B-T079
-	O	O	O
old	O	O	B-T079
male	O	O	B-T032
has	O	O	O
been	O	O	O
found	O	O	B-T033
with	O	O	O
a	O	O	O
giant	O	O	B-T191
liver	O	O	I-T191
hemangioma	O	O	I-T191
of	O	O	O
initial	O	O	B-T079
size	O	O	B-T082
29	O	O	O
cm	O	O	O
for	O	O	O
5	O	O	O
years	O	O	B-T079
.	O	O	O

He	O	O	O
received	O	O	B-T080
arterial	O	O	B-T061
embolization	O	O	I-T061
twice	O	O	B-T081
in	O	O	O
order	O	O	O
to	O	O	O
shrink	O	O	B-T082
the	O	O	O
tumor	O	O	B-T191
;	O	O	O
however	O	O	O
,	O	O	O
no	O	O	B-T080
effect	O	O	I-T080
was	O	O	O
obtained	O	O	B-T169
.	O	O	O

The	O	O	O
tumor	O	O	B-T191
had	O	O	O
rapidly	O	O	B-T080
grown	O	O	B-T067
to	O	O	O
50	O	O	O
cm	O	O	O
and	O	O	O
caused	O	O	O
abnormalities	O	O	B-T033
in	O	O	O
the	O	O	O
hematological	O	O	B-T022
and	O	O	O
coagulative	O	O	B-T042
systems	O	O	B-T169
.	O	O	O

Preoperative	O	O	B-T079
computed	O	O	B-T060
tomography	O	O	I-T060
revealed	O	O	B-T080
that	O	O	O
the	O	O	O
right	O	O	B-T082
hepatic	O	O	B-T023
vein	O	O	I-T023
,	O	O	O
right	O	O	O
hepatic	O	O	B-T023
artery	O	O	I-T023
,	O	O	O
and	O	O	O
right	O	O	O
portal	O	O	B-T023
vein	O	O	I-T023
were	O	O	O
not	O	O	B-T033
involved	O	O	I-T033
by	O	O	O
the	O	O	O
hemangioma	O	O	B-T191
.	O	O	O

Resection	O	O	B-T061
of	O	O	O
the	O	O	O
giant	O	O	B-T191
liver	O	O	I-T191
hemangioma	O	O	I-T191
was	O	O	O
successfully	O	O	B-T080
performed	O	O	B-T169
after	O	O	O
intraoperative	O	O	B-T079
intentional	O	O	B-T080
bloodletting	O	O	B-T061
with	O	O	O
concurrent	O	O	B-T079
blood	O	O	B-T061
salvage	O	O	I-T061
.	O	O	O

All	O	O	O
hematological	O	O	B-T022
and	O	O	O
coagulative	O	O	B-T042
abnormalities	O	O	B-T033
had	O	O	O
returned	O	O	B-T080
to	O	O	O
normal	O	O	B-T080
after	O	O	O
the	O	O	O
procedure	O	O	B-T061
.	O	O	O

-DOCSTART- (28425861)

Role	O	O	B-T077
of	O	O	O
cysteine	O	O	B-T116
residues	O	O	B-T077
in	O	O	O
regulation	O	O	B-T169
of	O	O	O
peptidyl-prolyl	O	O	B-T044
cis-trans	O	O	I-T044
isomerase	O	O	I-T044
activity	O	O	I-T044
of	O	O	O
wheat	O	O	B-T168
cyclophilin	O	O	B-T116
TaCYPA-1	O	O	O

Oxidative	O	O	B-T169
conditions	O	O	B-T080
result	O	O	O
in	O	O	O
inhibition	O	O	B-T052
of	O	O	O
peptidyl-prolyl	O	O	B-T044
cis-trans	O	O	I-T044
isomerase	O	O	I-T044
(	O	O	I-T044
PPIase	O	O	I-T044
)	O	O	I-T044
activity	O	O	I-T044
of	O	O	O
several	O	O	O
cyclophilins	O	O	B-T116
.	O	O	O

Thiol	O	O	B-T109
groups	O	O	O
have	O	O	O
been	O	O	O
implicated	O	O	O
in	O	O	O
redox	O	O	B-T044
regulation	O	O	B-T169
of	O	O	O
these	O	O	O
proteins	O	O	B-T116
.	O	O	O

In	O	O	O
our	O	O	O
previous	O	O	O
study	O	O	O
,	O	O	O
we	O	O	O
proposed	O	O	O
that	O	O	O
activity	O	O	B-T044
of	O	O	O
wheat	O	O	B-T168
cyclophilin	O	O	B-T116
,	O	O	O
TaCYPA-1	O	O	B-T028
,	O	O	O
may	O	O	O
be	O	O	O
modulated	O	O	B-T082
through	O	O	O
a	O	O	O
novel	O	O	O
dual	O	O	O
mechanism	O	O	B-T169
of	O	O	O
redox	O	O	B-T044
regulation	O	O	B-T169
.	O	O	O

To	O	O	O
further	O	O	O
understand	O	O	O
the	O	O	O
regulation	O	O	B-T169
of	O	O	O
PPIase	O	O	B-T044
activity	O	O	I-T044
of	O	O	O
TaCYPA-1	O	O	B-T028
,	O	O	O
we	O	O	O
generated	O	O	O
mutants	O	O	B-T049
of	O	O	O
TaCYPA-1	O	O	O
by	O	O	O
substituting	O	O	B-T052
cysteine	O	O	B-T116
residues	O	O	B-T077
at	O	O	O
positions	O	O	B-T082
-40	O	O	O
and	O	O	O
-122	O	O	O
with	O	O	O
serine	O	O	B-T116
,	O	O	O
and	O	O	O
at	O	O	O
-126	O	O	O
with	O	O	O
proline	O	O	B-T116
.	O	O	O

Comparative	O	O	B-T062
analysis	O	O	I-T062
of	O	O	O
their	O	O	O
PPIase	O	O	B-T044
activity	O	O	I-T044
revealed	O	O	O
that	O	O	O
catalytic	O	O	B-T070
efficiencies	O	O	B-T081
(	O	O	O
Kcat/Km	O	O	O
)	O	O	O
of	O	O	O
TaCYPA-1C40S	O	O	B-T116
(	O	O	O
0.37	O	O	O
X	O	O	O
106	O	O	O
M-1	O	O	O
s-1	O	O	O
)	O	O	O
and	O	O	O
TaCYPA-1C122S	O	O	B-T116
(	O	O	O
0.31	O	O	O
X	O	O	O
106	O	O	O
M-1	O	O	O
s-1	O	O	O
)	O	O	O
were	O	O	O
significantly	O	O	B-T081
lower	O	O	I-T081
as	O	O	O
compared	O	O	O
to	O	O	O
the	O	O	O
native	O	O	O
TaCYPA-1	O	O	B-T116
(	O	O	O
1.33	O	O	O
X	O	O	O
106	O	O	O
M-1	O	O	O
s-1	O	O	O
)	O	O	O
,	O	O	O
whereas	O	O	O
Kcat/Km	O	O	O
of	O	O	O
the	O	O	O
double	O	O	O
mutant	O	O	B-T049
TaCYPA-1C40S/C122S	O	O	B-T116
was	O	O	O
significantly	O	O	B-T081
higher	O	O	I-T081
(	O	O	O
2.36	O	O	O
X	O	O	O
106	O	O	O
M-1	O	O	O
s-1	O	O	O
)	O	O	O
.	O	O	O

Compared	O	O	O
to	O	O	O
wild-type	O	O	B-T028
TaCYPA-1	O	O	B-T028
,	O	O	O
the	O	O	O
different	O	O	O
mutants	O	O	B-T049
also	O	O	O
showed	O	O	O
differential	O	O	B-T080
sensitivity	O	O	B-T169
to	O	O	O
Cu2	O	O	B-T121
+	O	O	I-T121
.	O	O	O

Furthermore	O	O	O
,	O	O	O
the	O	O	O
results	O	O	B-T169
of	O	O	O
this	O	O	O
study	O	O	B-T062
also	O	O	O
revealed	O	O	B-T080
that	O	O	O
despite	O	O	O
lacking	O	O	B-T080
PPIase	O	O	B-T044
activity	O	O	I-T044
,	O	O	O
the	O	O	O
mutant	O	O	B-T049
TaCYPA-1C126P	O	O	B-T028
was	O	O	O
able	O	O	O
to	O	O	O
confer	O	O	O
partial	O	O	B-T081
protection	O	O	B-T033
against	O	O	O
heat	O	O	B-T039
stress	O	O	I-T039
.	O	O	O

These	O	O	O
observations	O	O	B-T062
suggest	O	O	O
that	O	O	O
the	O	O	O
mechanism	O	O	B-T169
of	O	O	O
TaCYPA-1	O	O	B-T028
-induced	O	O	O
thermotolerance	O	O	B-T039
may	O	O	O
also	O	O	O
involve	O	O	O
other	O	O	O
activities	O	O	B-T052
besides	O	O	O
cis	O	O	B-T044
to	O	O	I-T044
trans	O	O	I-T044
isomerisation	O	O	I-T044
,	O	O	O
which	O	O	O
needs	O	O	O
to	O	O	O
be	O	O	O
identified	O	O	B-T080
further	O	O	O
.	O	O	O

-DOCSTART- (28427273)

Association	O	O	B-T080
of	O	O	O
Exclusive	O	O	B-T055
Breastfeeding	O	O	I-T055
Duration	O	O	B-T079
With	O	O	O
Systemic	O	O	B-T047
Inflammation	O	O	I-T047
Markers	O	O	B-T201
in	O	O	O
Adolescents	O	O	B-T100
:	O	O	O
A	O	O	O
Cross-Sectional	O	O	O
Study	O	O	O

Breastfeeding	O	O	B-T033
duration	O	O	I-T033
has	O	O	O
been	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
less	O	O	B-T081
low-grade	O	O	B-T080
inflammation	O	O	B-T046
in	O	O	O
healthy	O	O	B-T080
adolescents	O	O	B-T100
,	O	O	O
but	O	O	O
there	O	O	O
is	O	O	O
scarce	O	O	B-T080
information	O	O	B-T078
regarding	O	O	O
obese	O	O	B-T047
subjects	O	O	O
.	O	O	O

This	O	O	O
study	O	O	O
aimed	O	O	O
to	O	O	O
evaluate	O	O	O
whether	O	O	O
exclusive	O	O	B-T055
breastfeeding	O	O	I-T055
is	O	O	O
related	O	O	O
to	O	O	O
serum	O	O	B-T081
concentrations	O	O	I-T081
of	O	O	O
inflammatory	O	O	B-T169
markers	O	O	B-T201
in	O	O	O
a	O	O	O
population	O	O	B-T098
of	O	O	O
Spanish	O	O	B-T098
adolescents	O	O	B-T100
.	O	O	O

A	O	O	O
cross-sectional	O	O	B-T062
study	O	O	I-T062
was	O	O	O
performed	O	O	B-T169
on	O	O	O
1,001	O	O	O
adolescents	O	O	B-T100
(	O	O	O
13.2	O	O	O
Â±	O	O	O
1.2	O	O	O
years	O	O	O
)	O	O	O
randomly	O	O	O
recruited	O	O	O
from	O	O	O
schools	O	O	B-T073
in	O	O	O
southeast	O	O	B-T082
Spain	O	O	B-T083
.	O	O	O

Data	O	O	B-T078
on	O	O	O
breastfeeding	O	O	B-T033
duration	O	O	I-T033
were	O	O	O
collected	O	O	B-T169
via	O	O	O
a	O	O	O
parental	O	O	B-T170
questionnaire	O	O	I-T170
.	O	O	O

Interleukin-6	O	O	B-T116
(	O	O	O
IL-6	O	O	B-T116
)	O	O	O
and	O	O	O
tumor	O	O	B-T116
necrosis	O	O	I-T116
factor-alpha	O	O	I-T116
(	O	O	O
TNF-Î±	O	O	B-T116
)	O	O	O
were	O	O	O
determined	O	O	B-T080
by	O	O	I-T080
enzyme-linked	O	O	B-T059
immunosorbent	O	O	I-T059
assay	O	O	I-T059
.	O	O	O

C-reactive	O	O	B-T116
protein	O	O	I-T116
(	O	O	O
CRP	O	O	B-T116
)	O	O	O
was	O	O	O
determined	O	O	B-T080
by	O	O	I-T080
solid-phase	O	O	B-T059
chemiluminescent	O	O	I-T059
immunometric	O	O	I-T059
assay	O	O	I-T059
.	O	O	O

Nonadjusted	O	O	O
and	O	O	O
adjusted	O	O	O
multivariate	O	O	B-T081
correlation	O	O	B-T062
analyses	O	O	I-T062
confirmed	O	O	B-T080
a	O	O	O
strong	O	O	B-T080
association	O	O	B-T080
(	O	O	O
p	O	O	O
<	O	O	O
.001	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
confidence	O	O	B-T081
interval	O	O	I-T081
)	O	O	O
between	O	O	O
the	O	O	O
three	O	O	O
markers	O	O	B-T201
of	O	O	O
inflammation	O	O	B-T046
and	O	O	O
exclusive	O	O	B-T055
breastfeeding	O	O	I-T055
duration	O	O	B-T079
.	O	O	O

No	O	O	B-T033
significant	O	O	I-T033
differences	O	O	B-T080
were	O	O	O
observed	O	O	B-T169
for	O	O	O
IL-6	O	O	B-T116
,	O	O	O
TNF-Î±	O	O	B-T116
,	O	O	O
and	O	O	O
CRP	O	O	B-T116
serum	O	O	B-T081
concentrations	O	O	I-T081
among	O	O	O
normal	O	O	B-T201
weight	O	O	I-T201
,	O	O	O
overweight	O	O	B-T184
,	O	O	O
and	O	O	O
obese	O	O	B-T047
adolescents	O	O	B-T100
,	O	O	O
except	O	O	B-T169
for	O	O	I-T169
IL-6	O	O	O
between	O	O	O
normal	O	O	O
weight	O	O	O
and	O	O	O
obese	O	O	O
subjects	O	O	B-T100
.	O	O	O

Likewise	O	O	O
,	O	O	O
no	O	O	B-T033
significant	O	O	I-T033
association	O	O	B-T080
was	O	O	O
found	O	O	B-T033
between	O	O	O
these	O	O	O
markers	O	O	B-T201
of	O	O	O
inflammation	O	O	B-T046
and	O	O	O
body	O	O	B-T201
mass	O	O	I-T201
index	O	O	I-T201
(	O	O	O
BMI	O	O	B-T201
)	O	O	O
z-score	O	O	B-T081
.	O	O	O

We	O	O	O
found	O	O	B-T033
a	O	O	O
possible	O	O	B-T033
association	O	O	B-T080
between	O	O	O
inflammatory	O	O	B-T169
markers	O	O	B-T201
and	O	O	O
exclusive	O	O	B-T055
breastfeeding	O	O	I-T055
duration	O	O	B-T079
in	O	O	O
adolescents	O	O	B-T100
,	O	O	O
regardless	O	O	B-T080
of	O	O	O
their	O	O	O
BMI	O	O	B-T201
.	O	O	O

This	O	O	O
finding	O	O	B-T033
suggests	O	O	B-T078
that	O	O	O
increased	O	O	B-T081
body	O	O	B-T032
weight	O	O	I-T032
or	O	O	O
obesity	O	O	B-T047
might	O	O	O
not	O	O	O
mediate	O	O	O
the	O	O	O
association	O	O	B-T080
between	O	O	O
breastfeeding	O	O	B-T040
and	O	O	O
inflammation	O	O	B-T046
.	O	O	O

These	O	O	O
results	O	O	B-T169
contribute	O	O	O
to	O	O	O
the	O	O	O
understanding	O	O	B-T041
of	O	O	O
the	O	O	O
relationship	O	O	B-T080
between	O	O	O
breastfeeding	O	O	B-T040
and	O	O	O
inflammatory	O	O	B-T169
markers	O	O	B-T201
in	O	O	O
adolescents	O	O	B-T100
.	O	O	O

-DOCSTART- (28427655)

Effect	O	O	B-T080
of	O	O	O
ultrasound	O	O	B-T070
and	O	O	O
enzymatic	O	O	B-T116
pre-treatment	O	O	B-T052
on	O	O	O
yield	O	O	B-T081
and	O	O	O
properties	O	O	B-T080
of	O	O	O
banana	O	O	B-T168
juice	O	O	O

Effect	O	O	B-T080
of	O	O	O
ultrasound	O	O	B-T070
and	O	O	O
enzymatic	O	O	B-T116
pre-treatments	O	O	B-T052
with	O	O	O
cellulase	O	O	B-T116
and	O	O	O
pectinase	O	O	B-T116
on	O	O	O
yield	O	O	B-T081
and	O	O	O
properties	O	O	B-T080
of	O	O	O
banana	O	O	B-T168
juice	O	O	B-T168
were	O	O	O
investigated	O	O	B-T169
.	O	O	O

A	O	O	O
two-level	O	O	B-UnknownType
full	O	O	I-UnknownType
factorial	O	O	I-UnknownType
design	O	O	I-UnknownType
was	O	O	O
employed	O	O	O
.	O	O	O

The	O	O	O
factors	O	O	O
selected	O	O	O
were	O	O	O
ultrasonication	O	O	B-T079
time	O	O	I-T079
(	O	O	O
0	O	O	O
and	O	O	O
30	O	O	O
min	O	O	B-T079
)	O	O	O
,	O	O	O
cellulase	O	O	B-T116
concentration	O	O	B-T081
(	O	O	O
0	O	O	O
and	O	O	O
0.2	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
pectinase	O	O	B-T116
concentration	O	O	O
(	O	O	O
0	O	O	O
and	O	O	O
0.2	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
responses	O	O	O
studied	O	O	O
were	O	O	O
yield	O	O	B-T081
,	O	O	O
viscosity	O	O	B-T070
,	O	O	O
clarity	O	O	B-T059
,	O	O	O
total	O	O	B-T081
soluble	O	O	I-T081
solids	O	O	I-T081
(	O	O	O
TSS	O	O	B-T081
)	O	O	O
and	O	O	O
pH.	O	O	O
It	O	O	O
was	O	O	O
observed	O	O	O
that	O	O	O
pectinase	O	O	B-T116
was	O	O	O
more	O	O	O
effective	O	O	B-T080
in	O	O	O
increasing	O	O	B-T169
the	O	O	O
yield	O	O	O
of	O	O	O
juice	O	O	B-T168
compared	O	O	O
to	O	O	O
cellulase	O	O	B-T116
.	O	O	O

Ultrasonic	O	O	B-T052
pre-treatment	O	O	I-T052
alone	O	O	O
did	O	O	O
not	O	O	B-T033
significantly	O	O	B-T169
increase	O	O	I-T169
the	O	O	O
yield	O	O	B-T081
of	O	O	O
juice	O	O	B-T168
.	O	O	O

When	O	O	O
ultrasound	O	O	B-T070
was	O	O	O
combined	O	O	O
with	O	O	O
pre-treatment	O	O	B-T052
with	O	O	O
both	O	O	O
the	O	O	O
enzymes	O	O	B-T116
maximum	O	O	B-T081
yield	O	O	I-T081
of	O	O	O
89.40	O	O	O
%	O	O	O
was	O	O	O
obtained	O	O	O
compared	O	O	O
to	O	O	O
47.30	O	O	O
%	O	O	O
in	O	O	O
the	O	O	O
control	O	O	B-T096
.	O	O	O

The	O	O	O
viscosity	O	O	B-T070
of	O	O	O
the	O	O	O
juice	O	O	B-T168
decreased	O	O	B-T081
with	O	O	O
addition	O	O	O
of	O	O	O
enzymes	O	O	B-T116
and	O	O	O
with	O	O	O
application	O	O	O
of	O	O	O
ultrasound	O	O	B-T070
.	O	O	O

The	O	O	O
clarity	O	O	B-T080
of	O	O	O
the	O	O	O
juice	O	O	B-T168
was	O	O	O
not	O	O	O
affected	O	O	O
by	O	O	O
cellulase	O	O	B-T116
treatment	O	O	B-T169
,	O	O	O
but	O	O	O
improved	O	O	B-T033
with	O	O	O
pectinase	O	O	B-T116
treatment	O	O	O
.	O	O	O

Ultrasonication	O	O	B-T070
alone	O	O	O
was	O	O	O
found	O	O	O
to	O	O	O
be	O	O	O
more	O	O	O
effective	O	O	B-T080
than	O	O	O
pectinase	O	O	B-T116
or	O	O	O
cellulase	O	O	B-T116
treatment	O	O	B-T169
in	O	O	O
improving	O	O	B-T080
the	O	O	O
clarity	O	O	B-T201
of	O	O	O
the	O	O	O
juice	O	O	B-T168
.	O	O	O

The	O	O	O
TSS	O	O	B-T081
increased	O	O	B-T081
with	O	O	O
enzymatic	O	O	B-T116
treatment	O	O	B-T169
,	O	O	O
ultrasonication	O	O	B-T070
and	O	O	O
their	O	O	O
combination	O	O	O
.	O	O	O

pH	O	O	B-T081
was	O	O	O
not	O	O	O
affected	O	O	O
by	O	O	O
treatment	O	O	B-T169
type	O	O	O
,	O	O	O
but	O	O	O
was	O	O	O
found	O	O	O
to	O	O	O
be	O	O	O
lower	O	O	O
for	O	O	O
the	O	O	O
treated	O	O	B-T169
juices	O	O	B-T168
.	O	O	O

Significant	O	O	B-T080
correlations	O	O	I-T080
were	O	O	O
observed	O	O	O
between	O	O	O
the	O	O	O
various	O	O	O
responses	O	O	O
.	O	O	O

-DOCSTART- (28429500)

Electrocardiographic	O	O	B-T034
appearance	O	O	I-T034
of	O	O	O
aortic	O	O	B-T047
stenosis	O	O	I-T047
before	O	O	O
and	O	O	O
after	O	O	O
aortic	O	O	O
valve	O	O	O
replacement	O	O	O

So	O	O	O
far	O	O	O
,	O	O	O
the	O	O	O
specific	O	O	O
appearance	O	O	O
of	O	O	O
QRS	O	O	B-T033
complex	O	O	I-T033
,	O	O	O
ST-segment	O	O	B-T033
,	O	O	O
and	O	O	O
T	O	O	B-T033
wave	O	O	I-T033
was	O	O	O
observed	O	O	B-T169
in	O	O	O
aortic	O	O	B-T047
stenosis	O	O	I-T047
(	O	O	O
AS	O	O	B-T047
)	O	O	O
.	O	O	O

S-wave	O	O	B-T033
dynamic	O	O	B-T169
change	O	O	B-T169
in	O	O	O
leads	O	O	B-T029
V1	O	O	I-T029
-	O	O	O
V3	O	O	B-T029
was	O	O	O
not	O	O	O
reported	O	O	O
in	O	O	O
AS	O	O	B-T047
.	O	O	O

In	O	O	O
a	O	O	O
single-center	O	O	O
,	O	O	O
prospective	O	O	B-T062
study	O	O	I-T062
,	O	O	O
we	O	O	O
included	O	O	O
a	O	O	O
total	O	O	O
number	O	O	O
of	O	O	O
1.175	O	O	O
patients	O	O	B-T101
who	O	O	O
underwent	O	O	O
surgical	O	O	B-T061
aortic	O	O	B-T061
valve	O	O	I-T061
replacement	O	O	I-T061
(	O	O	O
AVR	O	O	B-T061
)	O	O	O
.	O	O	O

We	O	O	O
conducted	O	O	O
3-year	O	O	O
gathering	O	O	O
of	O	O	O
patients	O	O	B-T101
with	O	O	O
symptomatic	O	O	B-T169
and	O	O	O
asymptomatic	O	O	B-T033
severe	O	O	O
AS	O	O	B-T047
,	O	O	O
and	O	O	O
separated	O	O	O
them	O	O	O
by	O	O	O
hemodynamic	O	O	B-T039
stability	O	O	I-T039
into	O	O	O
groups	O	O	O
A	O	O	O
and	O	O	O
B	O	O	O
,	O	O	O
through	O	O	O
EFLV	O	O	B-T201
(	O	O	O
of	O	O	O
more	O	O	O
or	O	O	O
less	O	O	O
than	O	O	O
50	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
AVA	O	O	B-T032
(	O	O	O
of	O	O	O
more	O	O	O
or	O	O	O
less	O	O	O
than	O	O	O
0.9	O	O	O
cm(2	O	O	O
)	O	O	O
)	O	O	O
,	O	O	O
PG	O	O	B-T201
(	O	O	O
between	O	O	O
55	O	O	O
and	O	O	O
75	O	O	O
mm	O	O	B-T081
Hg	O	O	I-T081
or	O	O	O
over	O	O	O
75	O	O	O
mm	O	O	O
Hg	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
end-diastolic	O	O	B-T033
LV	O	O	I-T033
dimension	O	O	I-T033
(	O	O	O
of	O	O	O
more	O	O	O
or	O	O	O
less	O	O	O
than	O	O	O
56	O	O	O
mm	O	O	O
)	O	O	O
.	O	O	O

We	O	O	O
evaluated	O	O	B-T058
the	O	O	O
impact	O	O	B-T080
of	O	O	O
S-wave	O	O	B-T033
magnitude	O	O	B-T081
in	O	O	O
right	O	O	B-T184
precordial	O	O	I-T184
leads	O	O	O
before	O	O	O
and	O	O	O
after	O	O	O
AVR	O	O	B-T061
in	O	O	O
all	O	O	O
patients	O	O	B-T101
.	O	O	O

We	O	O	O
followed	O	O	O
S-wave	O	O	B-T033
changes	O	O	B-T169
in	O	O	O
electrocardiogram	O	O	B-T033
altogether	O	O	O
with	O	O	O
hemodynamic	O	O	B-T061
measurements	O	O	I-T061
derived	O	O	O
from	O	O	O
echocardiography	O	O	B-T060
.	O	O	O

Analysis	O	O	B-T062
of	O	O	O
echocardiographic	O	O	B-T060
parameters	O	O	B-T033
,	O	O	O
measured	O	O	B-T080
in	O	O	O
patients	O	O	B-T101
before	O	O	O
surgery	O	O	B-T061
,	O	O	O
did	O	O	O
not	O	O	O
show	O	O	O
statistical	O	O	B-T081
significance	O	O	I-T081
between	O	O	O
asymptomatic	O	O	B-T033
and	O	O	O
symptomatic	O	O	B-T169
group	O	O	O
.	O	O	O

The	O	O	O
statistical	O	O	B-T081
significance	O	O	I-T081
was	O	O	O
observed	O	O	B-T169
in	O	O	O
the	O	O	O
change	O	O	B-T169
in	O	O	O
S-wave	O	O	B-T033
magnitude	O	O	B-T081
in	O	O	O
the	O	O	O
right	O	O	B-T184
precordial	O	O	I-T184
leads	O	O	O
in	O	O	O
both	O	O	O
subsets	O	O	O
of	O	O	O
patients	O	O	B-T101
before	O	O	O
AVR	O	O	B-T061
.	O	O	O

We	O	O	O
found	O	O	O
statistically	O	O	B-T081
significant	O	O	I-T081
predictive	O	O	B-T080
value	O	O	I-T080
of	O	O	O
S-wave	O	O	B-T033
magnitude	O	O	B-T081
in	O	O	O
leads	O	O	B-T029
V2	O	O	I-T029
-	O	O	O
V3	O	O	B-T029
for	O	O	O
dependent	O	O	B-T169
variables	O	O	I-T169
PG	O	O	B-T201
and	O	O	O
end-diastolic	O	O	B-T033
LV	O	O	I-T033
dimension	O	O	I-T033
.	O	O	O

S-wave	O	O	B-T033
changes	O	O	O
in	O	O	O
right	O	O	B-T184
precordial	O	O	I-T184
leads	O	O	O
can	O	O	O
predict	O	O	O
increase	O	O	B-T169
in	O	O	O
PG	O	O	B-T201
and	O	O	O
critical	O	O	O
narrowing	O	O	O
of	O	O	O
AVA	O	O	B-T032
,	O	O	O
suggestive	O	O	B-T169
of	O	O	I-T169
timely	O	O	O
referral	O	O	B-T058
for	O	O	I-T058
AVR	O	O	B-T061
.	O	O	O

-DOCSTART- (28433448)

Anemia	O	O	B-T047
complicating	O	O	B-T169
type	O	O	B-T047
2	O	O	I-T047
diabetes	O	O	I-T047
:	O	O	O
Prevalence	O	O	B-T081
,	O	O	O
risk	O	O	B-T033
factors	O	O	I-T033
and	O	O	O
prognosis	O	O	O

To	O	O	O
determine	O	O	O
the	O	O	O
prevalence	O	O	B-T081
,	O	O	O
risk	O	O	B-T033
factors	O	O	I-T033
and	O	O	O
prognosis	O	O	B-T058
of	O	O	O
anemia	O	O	B-T047
in	O	O	O
representative	O	O	B-T097
community-based	O	O	O
patients	O	O	B-T101
with	O	O	O
type	O	O	B-T047
2	O	O	I-T047
diabetes	O	O	I-T047
.	O	O	O

Data	O	O	O
from	O	O	O
the	O	O	O
Fremantle	O	O	B-T062
Diabetes	O	O	I-T062
Study	O	O	I-T062
Phase	O	O	I-T062
II	O	O	I-T062
(	O	O	O
FDS2	O	O	B-T062
;	O	O	O
n=1551	O	O	O
,	O	O	O
mean	O	O	O
age	O	O	O
65.7years	O	O	O
,	O	O	O
51.9	O	O	O
%	O	O	O
males	O	O	B-T032
)	O	O	O
and	O	O	O
Busselton	O	O	B-T062
Diabetes	O	O	I-T062
Study	O	O	I-T062
(	O	O	O
BDS	O	O	B-T062
;	O	O	O
n=186	O	O	O
,	O	O	O
mean	O	O	O
age	O	O	O
70.2years	O	O	O
,	O	O	O
50.0	O	O	O
%	O	O	O
males	O	O	O
)	O	O	O
cohorts	O	O	B-T098
,	O	O	O
and	O	O	O
from	O	O	O
186	O	O	O
matched	O	O	O
BDS	O	O	O
participants	O	O	B-T098
without	O	O	O
diabetes	O	O	B-T047
,	O	O	O
were	O	O	O
analyzed	O	O	B-T062
.	O	O	O

The	O	O	O
prevalence	O	O	B-T081
of	O	O	O
anemia	O	O	B-T047
(	O	O	O
hemoglobin	O	O	B-T116
â¤130g/L	O	O	O
males	O	O	B-T032
,	O	O	O
â¤120g/L	O	O	O
females	O	O	B-T032
)	O	O	O
was	O	O	O
determined	O	O	B-T080
in	O	O	O
each	O	O	O
sample	O	O	B-T031
.	O	O	O

In	O	O	O
FDS2	O	O	B-T062
,	O	O	O
associates	O	O	O
of	O	O	O
anemia	O	O	B-T047
were	O	O	O
assessed	O	O	B-T052
using	O	O	O
multiple	O	O	O
logistic	O	O	B-T062
regression	O	O	I-T062
and	O	O	O
Cox	O	O	B-T081
proportional	O	O	I-T081
hazards	O	O	I-T081
modeling	O	O	I-T081
identified	O	O	O
predictors	O	O	B-T033
of	O	O	O
death	O	O	B-T040
during	O	O	O
4.3Â±1.2years	O	O	O
post-recruitment	O	O	O
.	O	O	O

The	O	O	O
prevalence	O	O	B-T081
of	O	O	O
anemia	O	O	B-T047
at	O	O	O
baseline	O	O	O
was	O	O	O
11.5	O	O	O
%	O	O	O
in	O	O	O
FDS2	O	O	B-T062
participants	O	O	B-T098
,	O	O	O
17.8	O	O	O
%	O	O	O
in	O	O	O
BDS	O	O	B-T062
type	O	O	O
2	O	O	O
patients	O	O	B-T101
and	O	O	O
5.4	O	O	O
%	O	O	O
in	O	O	O
BDS	O	O	O
participants	O	O	O
without	O	O	O
diabetes	O	O	B-T047
.	O	O	O

In	O	O	O
FDS2	O	O	B-T062
,	O	O	O
163	O	O	O
of	O	O	O
178	O	O	O
patients	O	O	B-T101
with	O	O	O
anemia	O	O	B-T047
(	O	O	O
91.6	O	O	O
%	O	O	O
)	O	O	O
had	O	O	O
at	O	O	O
least	O	O	O
one	O	O	O
other	O	O	O
risk	O	O	B-T033
factor	O	O	I-T033
(	O	O	O
serum	O	O	B-T059
vitamin	O	O	I-T059
B12	O	O	I-T059
<	O	O	O
140pmol/L	O	O	O
,	O	O	O
serum	O	O	B-T033
ferritin	O	O	I-T033
<	O	O	O
30Î¼g/L	O	O	O
and/or	O	O	O
transferrin	O	O	B-T059
saturation	O	O	I-T059
<	O	O	O
20	O	O	O
%	O	O	O
,	O	O	O
serum	O	O	B-T059
testosterone	O	O	I-T059
<	O	O	O
10nmol/L	O	O	O
(	O	O	O
males	O	O	B-T032
)	O	O	O
,	O	O	O
glitazone	O	O	B-T109
therapy	O	O	B-T061
,	O	O	O
estimated	O	O	B-T059
glomerular	O	O	I-T059
filtration	O	O	I-T059
rate	O	O	I-T059
(	O	O	O
eGFR	O	O	B-T059
)	O	O	O
<	O	O	O
60mL/min	O	O	O
1.73m(2	O	O	O
)	O	O	O
,	O	O	O
malignancy	O	O	B-T191
,	O	O	O
hemoglobinopathy	O	O	B-T047
)	O	O	O
.	O	O	O

More	O	O	O
anemic	O	O	B-T033
than	O	O	O
non-anemic	O	O	B-T033
FDS2	O	O	B-T062
patients	O	O	B-T101
died	O	O	O
(	O	O	O
28.7	O	O	O
%	O	O	O
versus	O	O	O
8.0	O	O	O
%	O	O	O
;	O	O	O
P<0.001	O	O	O
)	O	O	O
.	O	O	O

After	O	O	O
adjustment	O	O	O
for	O	O	O
other	O	O	O
independent	O	O	O
predictors	O	O	B-T033
(	O	O	O
age	O	O	O
as	O	O	O
time-scale	O	O	O
,	O	O	O
male	O	O	O
sex	O	O	O
,	O	O	O
Aboriginality	O	O	B-T033
,	O	O	O
marital	O	O	B-T102
status	O	O	I-T102
,	O	O	O
smoking	O	O	B-T055
,	O	O	O
eGFR	O	O	B-T059
)	O	O	O
,	O	O	O
anemia	O	O	B-T047
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
a	O	O	O
57	O	O	O
%	O	O	O
increase	O	O	B-T169
in	O	O	O
mortality	O	O	O
(	O	O	O
P=0.015	O	O	O
)	O	O	O
.	O	O	O

Type	O	O	B-T047
2	O	O	I-T047
diabetes	O	O	I-T047
at	O	O	O
least	O	O	O
doubles	O	O	O
the	O	O	O
risk	O	O	O
of	O	O	O
anemia	O	O	B-T047
but	O	O	O
other	O	O	O
mostly	O	O	O
modifiable	O	O	O
risk	O	O	B-T033
factors	O	O	I-T033
are	O	O	O
usually	O	O	O
present	O	O	B-T033
.	O	O	O

Anemia	O	O	B-T047
is	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
an	O	O	O
increased	O	O	B-T033
risk	O	O	I-T033
of	O	O	I-T033
death	O	O	I-T033
after	O	O	O
adjustment	O	O	O
for	O	O	O
other	O	O	O
predictors	O	O	B-T033
.	O	O	O

-DOCSTART- (28433910)

Succinic	O	O	B-T109
acid	O	O	I-T109
production	O	O	B-T052
by	O	O	O
immobilized	O	O	B-T025
cultures	O	O	B-T059
using	O	O	O
spent	O	O	B-T167
sulphite	O	O	I-T167
liquor	O	O	I-T167
as	O	O	O
fermentation	O	O	B-T044
medium	O	O	O

Spent	O	O	B-T130
sulphite	O	O	I-T130
liquor	O	O	I-T130
(	O	O	O
SSL	O	O	B-T130
)	O	O	O
was	O	O	O
used	O	O	O
as	O	O	O
carbon	O	O	B-T196
source	O	O	B-T033
for	O	O	O
the	O	O	O
production	O	O	B-T052
of	O	O	O
succinic	O	O	B-T109
acid	O	O	I-T109
using	O	O	O
immobilized	O	O	B-T025
cultures	O	O	B-T059
of	O	O	O
Actinobacillus	O	O	B-T007
succinogenes	O	O	I-T007
and	O	O	O
Basfia	O	O	B-T007
succiniciproducens	O	O	I-T007
on	O	O	O
two	O	O	O
different	O	O	O
supports	O	O	B-T167
,	O	O	O
delignified	O	O	B-T121
cellulosic	O	O	I-T121
material	O	O	I-T121
(	O	O	O
DCM	O	O	B-T121
)	O	O	O
and	O	O	O
alginate	O	O	B-T109
beads	O	O	B-T167
.	O	O	O

Fed-batch	O	O	B-T059
immobilized	O	O	B-T025
cultures	O	O	B-T059
with	O	O	O
A.	O	O	B-T007
succinogenes	O	O	I-T007
in	O	O	O
alginates	O	O	B-T109
resulted	O	O	O
in	O	O	O
higher	O	O	B-T080
sugar	O	O	B-T109
to	O	O	O
succinic	O	O	B-T109
acid	O	O	I-T109
conversion	O	O	B-T081
yield	O	O	B-T081
(	O	O	O
0.81g/g	O	O	O
)	O	O	O
than	O	O	O
the	O	O	O
respective	O	O	O
yield	O	O	O
achieved	O	O	O
(	O	O	O
0.65g/g	O	O	O
)	O	O	O
when	O	O	O
DCM	O	O	B-T121
immobilized	O	O	O
cultures	O	O	O
were	O	O	O
used	O	O	O
.	O	O	O

The	O	O	O
final	O	O	O
succinic	O	O	B-T109
acid	O	O	I-T109
concentration	O	O	B-T081
and	O	O	O
yield	O	O	B-T081
achieved	O	O	O
in	O	O	O
fed-batch	O	O	B-T059
with	O	O	O
immobilized	O	O	B-T025
cultures	O	O	B-T059
of	O	O	O
B.	O	O	B-T007
succiniciproducens	O	O	I-T007
in	O	O	O
alginates	O	O	B-T109
(	O	O	O
45g/L	O	O	O
and	O	O	O
0.66g/g	O	O	O
)	O	O	O
were	O	O	O
higher	O	O	B-T080
than	O	O	O
A.	O	O	B-T007
succinogenes	O	O	I-T007
immobilized	O	O	O
cultures	O	O	O
(	O	O	O
35.4g/L	O	O	O
and	O	O	O
0.61g/g	O	O	O
)	O	O	O
using	O	O	O
nano	O	O	B-T081
-	O	O	O
filtrated	O	O	B-T167
SSL	O	O	I-T167
as	O	O	O
fermentation	O	O	B-T044
medium	O	O	B-T167
.	O	O	O

Immobilized	O	O	B-T025
cultures	O	O	B-T059
of	O	O	O
B.	O	O	B-T007
succiniciproducens	O	O	I-T007
in	O	O	O
alginate	O	O	B-T109
beads	O	O	B-T167
were	O	O	O
reused	O	O	O
in	O	O	O
four	O	O	O
sequential	O	O	B-T059
fed-batch	O	O	I-T059
fermentations	O	O	B-T044
of	O	O	O
nano	O	O	B-T081
-	O	O	O
filtrated	O	O	B-T130
SSL	O	O	I-T130
leading	O	O	O
to	O	O	O
the	O	O	O
production	O	O	B-T052
of	O	O	O
64.7	O	O	O
g	O	O	O
of	O	O	O
succinic	O	O	B-T109
acid	O	O	I-T109
with	O	O	O
a	O	O	O
yield	O	O	B-T081
range	O	O	O
of	O	O	O
0.42	O	O	O
-	O	O	O
0.67g/g	O	O	O
and	O	O	O
productivity	O	O	B-T081
range	O	O	O
of	O	O	O
0.29	O	O	O
-	O	O	O
0.65g/L/h	O	O	O
.	O	O	O

The	O	O	O
immobilized	O	O	B-T025
cultures	O	O	B-T059
improved	O	O	O
the	O	O	O
efficiency	O	O	B-T081
of	O	O	O
succinic	O	O	B-T109
acid	O	O	I-T109
production	O	O	B-T052
as	O	O	O
compared	O	O	B-T052
to	O	O	O
free	O	O	B-T059
cell	O	O	I-T059
cultures	O	O	I-T059
.	O	O	O

-DOCSTART- (28436264)

Interventions	O	O	B-T058
to	O	O	O
Improve	O	O	B-T033
Grandparent	O	O	B-T099
Caregivers	O	O	B-T099
'	O	O	I-T099
Mental	O	O	B-T041
and	O	O	O
Physical	O	O	B-T033
Health	O	O	I-T033
:	O	O	O
An	O	O	O
Integrative	O	O	O
Review	O	O	O

The	O	O	O
aim	O	O	B-T078
of	O	O	O
this	O	O	O
integrative	O	O	B-T170
review	O	O	I-T170
is	O	O	O
to	O	O	O
appraise	O	O	O
grandparent	O	O	B-T099
caregiver	O	O	B-T099
interventions	O	O	B-T058
that	O	O	O
are	O	O	O
designed	O	O	O
to	O	O	O
improve	O	O	B-T033
their	O	O	O
physical	O	O	B-T033
and	O	O	O
mental	O	O	B-T041
health	O	O	I-T041
.	O	O	O

A	O	O	O
database	O	O	B-T170
search	O	O	B-T052
was	O	O	O
performed	O	O	O
to	O	O	O
identify	O	O	O
relevant	O	O	B-T080
studies	O	O	B-T062
published	O	O	B-T057
between	O	O	O
January	O	O	O
1	O	O	O
,	O	O	O
1980	O	O	O
,	O	O	O
and	O	O	O
December	O	O	O
31	O	O	O
,	O	O	O
2014	O	O	O
.	O	O	O

Thirteen	O	O	O
publications	O	O	B-T073
,	O	O	O
including	O	O	O
11	O	O	O
studies	O	O	B-T062
,	O	O	O
met	O	O	O
all	O	O	O
inclusion	O	O	B-T080
and	O	O	O
exclusion	O	O	B-T169
criteria	O	O	I-T169
.	O	O	O

All	O	O	O
studies	O	O	B-T062
included	O	O	O
grandparent	O	O	B-T099
mental	O	O	B-T041
health	O	O	I-T041
outcomes	O	O	B-T169
with	O	O	O
fewer	O	O	O
focusing	O	O	O
on	O	O	O
physical	O	O	B-T033
health	O	O	I-T033
and	O	O	O
social	O	O	B-T098
relations	O	O	I-T098
.	O	O	O

Improvements	O	O	B-T077
were	O	O	O
found	O	O	O
in	O	O	O
all	O	O	O
three	O	O	O
areas	O	O	B-T082
with	O	O	O
fewer	O	O	O
improvements	O	O	B-T077
seen	O	O	O
in	O	O	O
physical	O	O	B-T033
health	O	O	I-T033
.	O	O	O

However	O	O	O
,	O	O	O
small	O	O	B-T081
effect	O	O	I-T081
sizes	O	O	I-T081
were	O	O	O
seen	O	O	O
with	O	O	O
most	O	O	O
measures	O	O	B-T169
of	O	O	O
these	O	O	O
outcomes	O	O	B-T169
.	O	O	O

Although	O	O	O
the	O	O	O
interventions	O	O	B-T058
led	O	O	O
to	O	O	O
positive	O	O	O
grandparent	O	O	B-T099
caregiver	O	O	B-T099
outcomes	O	O	O
,	O	O	O
the	O	O	O
studies	O	O	B-T062
were	O	O	O
limited	O	O	B-T169
by	O	O	O
their	O	O	O
design	O	O	B-T052
,	O	O	O
only	O	O	O
one	O	O	O
of	O	O	O
which	O	O	O
was	O	O	O
a	O	O	O
randomized	O	O	B-T062
controlled	O	O	I-T062
trial	O	O	I-T062
.	O	O	O

Also	O	O	O
,	O	O	O
interventions	O	O	B-T058
did	O	O	O
not	O	O	O
consider	O	O	O
variations	O	O	B-T080
in	O	O	O
the	O	O	O
grandchild	O	O	B-T099
's	O	O	I-T099
or	O	O	O
parent	O	O	B-T099
's	O	O	I-T099
ages	O	O	B-T032
or	O	O	O
if	O	O	O
the	O	O	O
grandparent	O	O	B-T099
provided	O	O	O
primary	O	O	B-T080
or	O	O	O
shared	O	O	B-T054
care	O	O	B-T052
.	O	O	O

These	O	O	O
gaps	O	O	O
should	O	O	O
be	O	O	O
addressed	O	O	O
in	O	O	O
future	O	O	B-T079
research	O	O	B-T062
.	O	O	O

-DOCSTART- (28436493)

An	O	O	O
attenuated	O	O	B-T052
Mycobacterium	O	O	B-T007
tuberculosis	O	O	I-T007
clinical	O	O	B-T080
strain	O	O	B-T001
with	O	O	O
a	O	O	O
defect	O	O	B-T169
in	O	O	O
ESX-1	O	O	B-T116
secretion	O	O	B-T038
induces	O	O	O
minimal	O	O	B-T080
host	O	O	B-T001
immune	O	O	B-T042
responses	O	O	I-T042
and	O	O	O
pathology	O	O	O

Although	O	O	O
Mycobacterium	O	O	B-T007
tuberculosis	O	O	I-T007
(	O	O	I-T007
M.tb	O	O	I-T007
)	O	O	I-T007
DK9897	O	O	I-T007
is	O	O	O
an	O	O	O
attenuated	O	O	B-T052
strain	O	O	B-T001
,	O	O	O
it	O	O	O
was	O	O	O
isolated	O	O	B-T169
from	O	O	O
a	O	O	O
patient	O	O	B-T101
with	O	O	O
extrapulmonary	O	O	B-T047
tuberculosis	O	O	I-T047
and	O	O	O
vaccination	O	O	B-T061
with	O	O	O
a	O	O	O
subunit	O	O	B-T129
vaccine	O	O	I-T129
(	O	O	O
H56	O	O	B-T129
)	O	O	O
induced	O	O	B-T169
poor	O	O	B-T080
protection	O	O	B-T033
against	O	O	O
it	O	O	O
.	O	O	O

Both	O	O	O
attenuation	O	O	B-T052
and	O	O	O
lack	O	O	B-T080
of	O	O	O
protection	O	O	B-T033
are	O	O	O
because	O	O	O
M.tb	O	O	B-T007
DK9897	O	O	I-T007
can	O	O	O
not	O	O	O
secrete	O	O	B-T038
the	O	O	O
EsxA	O	O	B-T116
virulence	O	O	B-T109
factor	O	O	I-T109
nor	O	O	O
induce	O	O	O
a	O	O	O
host	O	O	B-T042
response	O	O	I-T042
against	O	O	O
it	O	O	O
.	O	O	O

Genome	O	O	B-T063
sequencing	O	O	I-T063
identified	O	O	O
a	O	O	O
frameshift	O	O	B-T049
mutation	O	O	I-T049
in	O	O	O
the	O	O	O
eccCa1	O	O	B-T028
gene	O	O	I-T028
.	O	O	O

Since	O	O	O
the	O	O	O
encoded	O	O	B-T052
EccCa1	O	O	B-T116
protein	O	O	I-T116
provides	O	O	O
energy	O	O	B-T081
for	O	O	O
ESX-1	O	O	B-T116
secretion	O	O	B-T038
,	O	O	O
it	O	O	O
suggested	O	O	O
a	O	O	O
defect	O	O	B-T169
in	O	O	O
the	O	O	O
ESX-1	O	O	O
type	O	O	B-T043
VII	O	O	I-T043
secretion	O	O	I-T043
system	O	O	I-T043
.	O	O	O

Genetic	O	O	B-T045
complementation	O	O	I-T045
with	O	O	O
a	O	O	O
plasmid	O	O	B-T114
carrying	O	O	O
the	O	O	O
M.tb	O	O	B-T007
H37Rv	O	O	I-T007
sequence	O	O	O
of	O	O	O
eccCa1-eccCb1-pe35	O	O	B-T114
re-established	O	O	O
EsxA	O	O	B-T116
secretion	O	O	B-T038
,	O	O	O
host	O	O	B-T001
specific	O	O	O
EsxA	O	O	O
T-cell	O	O	B-T025
responses	O	O	B-T042
,	O	O	O
and	O	O	O
increased	O	O	B-T081
strain	O	O	B-T001
virulence	O	O	B-T038
.	O	O	O

The	O	O	O
ESX-1	O	O	B-T116
secretion	O	O	B-T038
defect	O	O	B-T169
prevents	O	O	B-T169
several	O	O	O
virulence	O	O	B-T109
factors	O	O	I-T109
from	O	O	O
being	O	O	O
functional	O	O	O
during	O	O	O
infection	O	O	B-T046
and	O	O	O
therefore	O	O	O
attenuates	O	O	B-T052
M.tb	O	O	B-T007
.	O	O	O

It	O	O	O
precludes	O	O	O
specific	O	O	O
T-cell	O	O	B-T025
responses	O	O	B-T042
against	O	O	O
strong	O	O	O
antigens	O	O	B-T129
and	O	O	O
we	O	O	O
found	O	O	O
very	O	O	O
little	O	O	O
in	O	O	B-T082
vivo	O	O	I-T082
cytokine	O	O	B-T040
production	O	O	I-T040
,	O	O	O
gross	O	O	B-T034
pathology	O	O	I-T034
or	O	O	O
granuloma	O	O	B-T038
formation	O	O	I-T038
in	O	O	O
lungs	O	O	B-T023
from	O	O	O
M.tb	O	O	B-T007
DK9897	O	O	I-T007
infected	O	O	B-T033
animals	O	O	I-T033
.	O	O	O

This	O	O	O
coincides	O	O	O
with	O	O	O
M.tb	O	O	B-T007
DK9897	O	O	I-T007
being	O	O	O
unable	O	O	O
to	O	O	O
disrupt	O	O	O
the	O	O	O
phagosome	O	O	B-T026
membrane	O	O	I-T026
and	O	O	O
make	O	O	O
contact	O	O	O
to	O	O	O
the	O	O	O
cytosol	O	O	B-T026
.	O	O	O

-DOCSTART- (28436593)

Results	O	O	B-T033
for	O	O	O
patients	O	O	B-T101
with	O	O	O
sarcoma	O	O	B-T191
not	O	O	B-T080
otherwise	O	O	I-T080
specified	O	O	I-T080
and	O	O	O
other	O	O	O
diagnoses	O	O	B-T033
than	O	O	O
Ewing	O	O	B-T191
sarcoma	O	O	I-T191
treated	O	O	B-T033
according	O	O	O
to	O	O	O
the	O	O	O
Euro-EWING	O	O	O
99	O	O	O
trial	O	O	O

Euro-EWING	O	O	B-T062
99	O	O	I-T062
trial	O	O	I-T062
of	O	O	O
the	O	O	O
European	O	O	B-T098
Ewing	O	O	B-T191
tumor	O	O	I-T191
Working	O	O	B-T057
Initiative	O	O	B-T033
of	O	O	O
National	O	O	B-T092
Groups	O	O	B-T078
(	O	O	O
EE99	O	O	B-T170
)	O	O	O
was	O	O	O
an	O	O	O
international	O	O	B-T078
phase	O	O	B-T062
III	O	O	I-T062
study	O	O	I-T062
in	O	O	O
patients	O	O	B-T101
with	O	O	O
Ewing	O	O	B-T191
sarcoma	O	O	I-T191
.	O	O	O

The	O	O	O
German	O	O	B-T093
Society	O	O	I-T093
of	O	O	I-T093
Pediatric	O	O	I-T093
Oncology	O	O	I-T093
and	O	O	I-T093
Hematology	O	O	I-T093
(	O	O	I-T093
GPOH	O	O	I-T093
)	O	O	I-T093
data	O	O	I-T093
center	O	O	I-T093
registered	O	O	B-T058
and	O	O	O
followed	O	O	O
patients	O	O	B-T101
with	O	O	O
other	O	O	O
diagnoses	O	O	B-T033
than	O	O	O
Ewing	O	O	B-T191
sarcoma	O	O	I-T191
who	O	O	O
were	O	O	O
treated	O	O	B-T033
according	O	O	O
to	O	O	O
the	O	O	O
EE99	O	O	B-T170
protocol	O	O	I-T170
in	O	O	O
an	O	O	O
additional	O	O	O
non-Ewing	O	O	B-T170
database	O	O	I-T170
.	O	O	O

Data	O	O	B-T078
of	O	O	O
27	O	O	O
patients	O	O	B-T101
with	O	O	O
other	O	O	O
diagnoses	O	O	B-T033
than	O	O	O
Ewing	O	O	B-T191
sarcoma	O	O	I-T191
treated	O	O	B-T033
according	O	O	O
to	O	O	O
the	O	O	O
EE99	O	O	B-T170
protocol	O	O	I-T170
were	O	O	O
analyzed	O	O	B-T062
.	O	O	O

Patients	O	O	B-T101
had	O	O	O
miscellaneous	O	O	B-T080
histologic	O	O	B-T169
diagnoses	O	O	B-T033
,	O	O	O
the	O	O	O
majority	O	O	B-T081
were	O	O	O
diagnosed	O	O	B-T033
with	O	O	O
sarcoma	O	O	B-T191
not	O	O	B-T080
otherwise	O	O	I-T080
specified	O	O	I-T080
(	O	O	O
NOS	O	O	B-T080
)	O	O	O
arising	O	O	O
in	O	O	O
bone	O	O	B-T024
and	O	O	O
soft	O	O	B-T024
tissue	O	O	I-T024
(	O	O	O
63	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
median	O	O	B-T081
age	O	O	B-T032
at	O	O	O
diagnosis	O	O	B-T033
was	O	O	O
16.9	O	O	O
years	O	O	O
(	O	O	O
range	O	O	O
4.5	O	O	O
-	O	O	O
41.4	O	O	O
)	O	O	O
.	O	O	O

Localized	O	O	B-T047
disease	O	O	I-T047
was	O	O	O
diagnosed	O	O	B-T033
in	O	O	O
61.5	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
patients	O	O	B-T101
and	O	O	O
38.5	O	O	O
%	O	O	O
had	O	O	O
distant	O	O	B-T191
metastases	O	O	I-T191
at	O	O	O
time	O	O	O
of	O	O	O
primary	O	O	B-T080
diagnosis	O	O	B-T033
.	O	O	O

The	O	O	O
median	O	O	B-T081
follow-up	O	O	B-T058
time	O	O	B-T079
was	O	O	O
3.7	O	O	O
years	O	O	O
(	O	O	O
range	O	O	O
0.5	O	O	O
-	O	O	O
9.5	O	O	O
)	O	O	O
.	O	O	O

Patients	O	O	B-T101
with	O	O	O
localized	O	O	B-T047
disease	O	O	I-T047
showed	O	O	O
a	O	O	O
3-year	O	O	O
event-free	O	O	B-T081
survival	O	O	I-T081
(	O	O	O
EFS	O	O	B-T081
)	O	O	O
of	O	O	O
68	O	O	O
%	O	O	O
,	O	O	O
compared	O	O	O
to	O	O	O
3-year	O	O	O
EFS	O	O	O
of	O	O	O
20	O	O	O
%	O	O	O
in	O	O	O
patients	O	O	B-T101
with	O	O	O
metastases	O	O	B-T191
(	O	O	O
P	O	O	O
=	O	O	O
0.042	O	O	O
)	O	O	O
.	O	O	O

Three-year	O	O	O
EFS	O	O	B-T081
for	O	O	O
patients	O	O	B-T101
with	O	O	O
sarcoma	O	O	B-T191
NOS	O	O	B-T080
was	O	O	O
52	O	O	O
%	O	O	O
,	O	O	O
patients	O	O	O
with	O	O	O
localized	O	O	B-T047
and	O	O	O
metastatic	O	O	B-T191
disease	O	O	I-T191
showed	O	O	O
3-year	O	O	O
EFS	O	O	O
of	O	O	O
66	O	O	O
and	O	O	O
20	O	O	O
%	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

EFS	O	O	B-T081
in	O	O	O
patients	O	O	B-T101
with	O	O	O
other	O	O	O
diagnoses	O	O	B-T033
than	O	O	O
Ewing	O	O	B-T191
sarcoma	O	O	I-T191
treated	O	O	B-T033
according	O	O	O
to	O	O	O
EE99	O	O	B-T170
was	O	O	O
significantly	O	O	B-T078
higher	O	O	O
in	O	O	O
patients	O	O	O
with	O	O	O
localized	O	O	B-T047
than	O	O	O
metastatic	O	O	B-T191
disease	O	O	I-T191
.	O	O	O

Sarcomas	O	O	B-T191
of	O	O	O
soft	O	O	B-T024
tissue	O	O	I-T024
and	O	O	O
bone	O	O	B-T024
that	O	O	O
can	O	O	O
not	O	O	O
be	O	O	O
classified	O	O	B-T185
to	O	O	O
current	O	O	B-T079
diagnostic	O	O	B-T185
categories	O	O	I-T185
constitute	O	O	O
a	O	O	O
therapeutic	O	O	B-T169
challenge	O	O	B-T058
.	O	O	O

-DOCSTART- (28437231)

Capsular	O	O	B-T129
Polysaccharide	O	O	I-T129
Types	O	O	B-T080
and	O	O	O
Virulence-Related	O	O	B-T038
Traits	O	O	B-T032
of	O	O	O
Epidemic	O	O	B-T067
KPC	O	O	B-T047
-	O	O	O
Producing	O	O	B-T169
Klebsiella	O	O	B-T007
pneumoniae	O	O	I-T007
Isolates	O	O	B-T123
in	O	O	O
a	O	O	O
Chinese	O	O	B-T083
University	O	O	O
Hospital	O	O	O

Klebsiella	O	O	B-T007
pneumoniae	O	O	I-T007
is	O	O	O
an	O	O	O
important	O	O	B-T080
human	O	O	B-T016
pathogen	O	O	B-T001
associated	O	O	B-T080
with	O	O	I-T080
a	O	O	O
variety	O	O	B-T077
of	O	O	O
diseases	O	O	B-T047
and	O	O	O
the	O	O	O
prevalence	O	O	B-T081
of	O	O	O
blaKPC	O	O	B-T028
carrying	O	O	O
K.	O	O	B-T007
pneumoniae	O	O	I-T007
(	O	O	O
KPC-Kp	O	O	B-T007
)	O	O	O
is	O	O	O
rapidly	O	O	B-T169
increasing	O	O	I-T169
.	O	O	O

Capsule	O	O	B-T116
is	O	O	O
an	O	O	O
important	O	O	B-T080
virulence	O	O	B-T109
factor	O	O	I-T109
in	O	O	O
K.	O	O	B-T007
pneumoniae	O	O	I-T007
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
we	O	O	O
determined	O	O	O
to	O	O	O
first	O	O	O
systematically	O	O	B-T169
characterize	O	O	B-T052
capsular	O	O	B-T129
polysaccharide	O	O	I-T129
(	O	O	O
CPS	O	O	B-T129
)	O	O	O
and	O	O	O
virulence	O	O	B-T038
traits	O	O	B-T032
in	O	O	O
KPC-Kp	O	O	B-T007
strains	O	O	B-T001
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
56	O	O	O
KPC-Kp	O	O	B-T007
isolates	O	O	B-T123
were	O	O	O
recovered	O	O	B-T080
from	O	O	O
clinical	O	O	B-T167
samples	O	O	I-T167
in	O	O	O
a	O	O	O
Chinese	O	O	B-T093
hospital	O	O	I-T093
,	O	O	O
which	O	O	O
were	O	O	O
assigned	O	O	B-T169
to	O	O	O
clonal	O	O	B-T078
lineages	O	O	I-T078
by	O	O	O
multilocus	O	O	B-T062
sequence	O	O	I-T062
typing	O	O	I-T062
(	O	O	O
MLST	O	O	B-T062
)	O	O	O
.	O	O	O

Capsule	O	O	B-T116
typing	O	O	B-T058
(	O	O	O
wzi	O	O	B-T059
sequencing	O	O	I-T059
and	O	O	O
wzc	O	O	B-T063
polymerase	O	O	I-T063
chain	O	O	I-T063
reaction	O	O	I-T063
[	O	O	O
PCR	O	O	B-T063
]	O	O	O
)	O	O	O
and	O	O	O
virulence	O	O	B-T038
genes	O	O	B-T028
were	O	O	O
characterized	O	O	B-T052
by	O	O	O
molecular	O	O	B-T059
approaches	O	O	I-T059
.	O	O	O

The	O	O	O
virulence	O	O	B-T038
of	O	O	O
these	O	O	O
strains	O	O	B-T001
was	O	O	O
determined	O	O	O
by	O	O	O
biofilm	O	O	B-T043
formation	O	O	I-T043
,	O	O	O
serum	O	O	B-T031
killing	O	O	B-T043
resistance	O	O	B-T169
,	O	O	O
phagocytosis	O	O	B-T043
,	O	O	O
and	O	O	O
infection	O	O	B-T046
models	O	O	B-T170
.	O	O	O

Six	O	O	O
different	O	O	O
STs	O	O	B-T033
were	O	O	O
found	O	O	B-T033
among	O	O	O
56	O	O	O
KPC-Kp	O	O	B-T007
isolates	O	O	B-T123
:	O	O	O
76.8	O	O	O
%	O	O	O
(	O	O	O
43	O	O	O
of	O	O	O
56	O	O	O
isolates	O	O	O
)	O	O	O
belonged	O	O	O
to	O	O	O
ST11	O	O	B-T033
,	O	O	O
6	O	O	B-T033
isolates	O	O	O
belonged	O	O	O
to	O	O	O
ST147	O	O	B-T033
,	O	O	O
4	O	O	O
isolates	O	O	O
belonged	O	O	O
to	O	O	O
ST15	O	O	B-T033
,	O	O	O
1	O	O	O
isolate	O	O	O
belonged	O	O	O
to	O	O	O
ST1456	O	O	B-T033
,	O	O	O
1	O	O	O
isolate	O	O	O
belonged	O	O	O
to	O	O	O
ST65	O	O	B-T033
,	O	O	O
and	O	O	O
1	O	O	O
isolate	O	O	O
was	O	O	O
ST23	O	O	B-T033
.	O	O	O

Based	O	O	O
on	O	O	O
the	O	O	O
wzi	O	O	B-T059
gene	O	O	I-T059
DNA	O	O	I-T059
sequences	O	O	I-T059
and	O	O	O
wzc	O	O	B-T063
PCR	O	O	I-T063
,	O	O	O
these	O	O	O
56	O	O	O
strains	O	O	B-T001
were	O	O	O
classified	O	O	O
as	O	O	O
capsular	O	O	B-T116
type	O	O	B-T080
wzi47-K47	O	O	B-T116
(	O	O	O
n	O	O	O
=	O	O	O
37	O	O	O
)	O	O	O
,	O	O	O
wzi64-K64	O	O	B-T116
(	O	O	O
n	O	O	O
=	O	O	O
8)	O	O	O
,	O	O	O
wzi8-K8	O	O	B-T116
(	O	O	O
n	O	O	O
=	O	O	O
4	O	O	O
)	O	O	O
,	O	O	O
wzi37-K37	O	O	B-T116
(	O	O	O
n	O	O	O
=	O	O	O
4	O	O	O
)	O	O	O
,	O	O	O
wzi53-K53	O	O	B-T116
(	O	O	O
n	O	O	O
=	O	O	O
1	O	O	O
)	O	O	O
,	O	O	O
wzi125-K2	O	O	B-T116
(	O	O	O
n	O	O	O
=	O	O	O
1	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
wzi1-K1	O	O	B-T116
(	O	O	O
n	O	O	O
=	O	O	O
1	O	O	O
)	O	O	O
.	O	O	O

Heterogeneity	O	O	B-T032
was	O	O	O
detected	O	O	B-T033
in	O	O	O
biofilm	O	O	B-T043
formation	O	O	I-T043
and	O	O	O
phagocytosis	O	O	B-T043
among	O	O	O
different	O	O	O
CPS	O	O	B-T129
types	O	O	B-T080
.	O	O	O

ST11	O	O	B-T033
strains	O	O	B-T001
were	O	O	O
less	O	O	O
virulent	O	O	B-T080
than	O	O	O
other	O	O	O
ST	O	O	B-T033
strains	O	O	O
.	O	O	O

KPC-Kp	O	O	B-T007
strains	O	O	B-T001
exhibit	O	O	O
variability	O	O	B-T077
of	O	O	O
virulence-associated	O	O	B-T038
traits	O	O	B-T032
.	O	O	O

Differences	O	O	O
were	O	O	O
associated	O	O	O
with	O	O	O
the	O	O	O
ST	O	O	B-T033
types	O	O	B-T080
and	O	O	O
CPS	O	O	B-T129
.	O	O	O

-DOCSTART- (28437254)

Interaction-driven	O	O	B-T169
distinctive	O	O	O
electronic	O	O	B-T082
states	O	O	I-T082
of	O	O	O
artificial	O	O	B-T196
atoms	O	O	I-T196
at	O	O	O
the	O	O	O
ZnO	O	O	B-T121
interface	O	O	O

We	O	O	O
have	O	O	O
investigated	O	O	B-T169
the	O	O	O
electronic	O	O	B-T082
states	O	O	I-T082
of	O	O	O
planar	O	O	B-T073
quantum	O	O	I-T073
dots	O	O	I-T073
at	O	O	O
the	O	O	O
ZnO	O	O	B-T121
interface	O	O	B-T080
containing	O	O	O
a	O	O	O
few	O	O	O
interacting	O	O	B-T169
electrons	O	O	B-T196
in	O	O	O
an	O	O	O
externally	O	O	B-T169
applied	O	O	I-T169
magnetic	O	O	B-T070
field	O	O	I-T070
.	O	O	O

The	O	O	O
electron-electron	O	O	B-T196
interaction	O	O	B-T169
effects	O	O	B-T080
are	O	O	O
expected	O	O	O
to	O	O	O
be	O	O	O
much	O	O	B-T080
stronger	O	O	I-T080
in	O	O	O
this	O	O	O
case	O	O	B-T169
than	O	O	O
in	O	O	O
traditional	O	O	B-T169
semiconductor	O	O	I-T169
quantum	O	O	I-T169
systems	O	O	I-T169
,	O	O	O
such	O	O	O
as	O	O	O
in	O	O	O
GaAs	O	O	B-T197
or	O	O	O
InAs	O	O	B-T197
quantum	O	O	B-T073
dots	O	O	I-T073
.	O	O	O

In	O	O	O
order	O	O	O
to	O	O	O
highlight	O	O	O
that	O	O	O
stronger	O	O	B-T080
Coulomb	O	O	B-T080
effects	O	O	I-T080
in	O	O	O
the	O	O	O
ZnO	O	O	B-T121
quantum	O	O	B-T073
dots	O	O	I-T073
,	O	O	O
we	O	O	O
have	O	O	O
compared	O	O	B-T052
the	O	O	O
energy	O	O	B-T067
spectra	O	O	I-T067
and	O	O	O
the	O	O	O
magnetization	O	O	B-T070
in	O	O	O
this	O	O	O
system	O	O	B-T169
to	O	O	O
those	O	O	O
of	O	O	O
the	O	O	O
InAs	O	O	B-T197
quantum	O	O	O
dots	O	O	O
.	O	O	O

We	O	O	O
have	O	O	O
found	O	O	O
that	O	O	O
in	O	O	O
the	O	O	O
ZnO	O	O	B-T121
quantum	O	O	B-T073
dots	O	O	I-T073
the	O	O	O
signatures	O	O	O
of	O	O	O
stronger	O	O	B-T080
Coulomb	O	O	B-T169
interaction	O	O	I-T169
manifests	O	O	B-T169
in	O	O	O
an	O	O	O
unique	O	O	B-T080
ground	O	O	B-T082
state	O	O	I-T082
that	O	O	O
has	O	O	O
very	O	O	O
different	O	O	B-T080
properties	O	O	B-T077
than	O	O	O
the	O	O	O
corresponding	O	O	O
ones	O	O	O
in	O	O	O
the	O	O	O
InAs	O	O	B-T197
dot	O	O	B-T073
.	O	O	O

Our	O	O	O
results	O	O	B-T169
for	O	O	O
the	O	O	O
magnetization	O	O	B-T070
also	O	O	O
exhibits	O	O	B-T080
behaviors	O	O	I-T080
never	O	O	B-T079
before	O	O	B-T079
observed	O	O	B-T169
in	O	O	O
a	O	O	O
quantum	O	O	B-T073
dot	O	O	I-T073
for	O	O	O
a	O	O	O
realistic	O	O	B-T081
set	O	O	I-T081
of	O	O	I-T081
parameters	O	O	I-T081
.	O	O	O

We	O	O	O
have	O	O	O
found	O	O	O
a	O	O	O
stronger	O	O	B-T080
temperature	O	O	B-T081
dependence	O	O	B-T080
and	O	O	O
other	O	O	O
unexpected	O	O	B-T080
features	O	O	I-T080
,	O	O	O
such	O	O	O
as	O	O	O
paramagnetic-like	O	O	B-T070
behavior	O	O	I-T070
at	O	O	O
high	O	O	B-T081
temperatures	O	O	I-T081
for	O	O	O
a	O	O	O
quantum-dot	O	O	B-T073
helium	O	O	B-T121
.	O	O	O

-DOCSTART- (28438037)

Evaluation	O	O	B-T058
of	O	O	O
Tobacco	O	O	B-T064
Control	O	O	I-T064
Policies	O	O	I-T064
in	O	O	O
San	O	O	B-T083
Francisco	O	O	I-T083
Homeless	O	O	B-T098
Housing	O	O	O
Programs	O	O	O

The	O	O	O
2014	O	O	O
Surgeon	O	O	B-T170
General	O	O	I-T170
's	O	O	I-T170
Report	O	O	I-T170
noted	O	O	B-T080
that	O	O	O
high	O	O	B-T080
smoking	O	O	B-T055
rates	O	O	I-T033
in	O	O	O
vulnerable	O	O	B-T098
populations	O	O	I-T098
such	O	O	O
as	O	O	O
the	O	O	O
homeless	O	O	B-T098
have	O	O	O
been	O	O	O
a	O	O	O
persistent	O	O	B-T079
public	O	O	B-T092
health	O	O	B-T033
problem	O	O	I-T033
;	O	O	O
smoking	O	O	O
prevalence	O	O	B-T081
among	O	O	O
individuals	O	O	B-T098
experiencing	O	O	B-T055
homelessness	O	O	B-T033
exceeds	O	O	O
70	O	O	O
%	O	O	O
.	O	O	O

Historically	O	O	O
,	O	O	O
service	O	O	B-T058
providers	O	O	I-T058
for	O	O	O
the	O	O	O
homeless	O	O	B-T098
have	O	O	O
not	O	O	O
enacted	O	O	O
comprehensive	O	O	B-T080
tobacco	O	O	B-T064
control	O	O	I-T064
policies	O	O	I-T064
.	O	O	O

We	O	O	O
conducted	O	O	B-T169
a	O	O	O
qualitative	O	O	B-T062
study	O	O	I-T062
of	O	O	O
homeless	O	O	B-T098
housing	O	O	B-UnknownType
programs	O	O	I-UnknownType
in	O	O	O
San	O	O	B-T083
Francisco	O	O	I-T083
.	O	O	O

Administrators	O	O	B-T097
representing	O	O	B-T052
9	O	O	O
of	O	O	O
the	O	O	O
city	O	O	O
's	O	O	O
11	O	O	O
homeless	O	O	B-T092
service	O	O	I-T092
agencies	O	O	I-T092
were	O	O	O
interviewed	O	O	B-T052
to	O	O	O
assess	O	O	B-T058
institutional	O	O	B-T078
smoking	O	O	B-T055
-related	O	O	O
policies	O	O	B-T170
and	O	O	O
cessation	O	O	B-T055
programs	O	O	B-T169
and	O	O	O
perceived	O	O	B-T041
barriers	O	O	B-T080
and	O	O	O
receptivity	O	O	B-T169
to	O	O	O
instituting	O	O	B-T078
tobacco	O	O	B-T109
control	O	O	B-T169
interventions	O	O	B-T061
.	O	O	O

Respondents	O	O	B-T098
indicated	O	O	B-T033
that	O	O	O
although	O	O	O
most	O	O	O
programs	O	O	B-T169
had	O	O	O
adopted	O	O	B-T080
smoke	O	O	B-T131
-	O	O	O
free	O	O	B-T169
grounds	O	O	B-T082
and	O	O	O
some	O	O	O
had	O	O	O
eliminated	O	O	B-T080
evidence	O	O	B-T078
of	O	O	O
staff	O	O	B-T097
smoking	O	O	B-T055
,	O	O	O
the	O	O	O
smoking	O	O	O
status	O	O	B-T080
of	O	O	O
clients	O	O	B-T096
was	O	O	O
assessed	O	O	B-T052
only	O	O	O
when	O	O	O
required	O	O	B-T169
by	O	O	O
funders	O	O	O
.	O	O	O

None	O	O	O
of	O	O	O
the	O	O	O
programs	O	O	B-T169
offered	O	O	B-T033
smoking	O	O	B-T055
cessation	O	O	I-T055
interventions	O	O	B-T061
.	O	O	O

Most	O	O	O
administrators	O	O	B-T097
were	O	O	O
receptive	O	O	B-T169
to	O	O	O
adopting	O	O	B-T080
policies	O	O	B-T170
that	O	O	O
would	O	O	O
promote	O	O	B-T052
a	O	O	O
tobacco	O	O	B-T109
-	O	O	O
free	O	O	B-T169
culture	O	O	B-T092
;	O	O	O
however	O	O	O
,	O	O	O
they	O	O	O
noted	O	O	B-T080
that	O	O	O
their	O	O	O
clients	O	O	B-T096
had	O	O	O
unique	O	O	B-T080
challenges	O	O	B-T058
that	O	O	O
made	O	O	O
traditional	O	O	B-T169
smoking	O	O	B-T055
cessation	O	O	I-T055
programs	O	O	B-T169
unfeasible	O	O	O
.	O	O	O

Homeless	O	O	B-T098
housing	O	O	B-UnknownType
programs	O	O	I-UnknownType
in	O	O	O
San	O	O	B-T083
Francisco	O	O	I-T083
have	O	O	O
not	O	O	O
yet	O	O	O
adopted	O	O	B-T080
a	O	O	O
tobacco	O	O	B-T109
-	O	O	O
free	O	O	B-T169
culture	O	O	B-T092
.	O	O	O

Existing	O	O	B-T077
policies	O	O	B-T170
were	O	O	O
created	O	O	B-T052
in	O	O	O
response	O	O	B-T032
to	O	O	O
external	O	O	B-T082
mandates	O	O	B-T170
,	O	O	O
and	O	O	O
smoking	O	O	B-T055
cessation	O	O	I-T055
programs	O	O	B-T169
may	O	O	O
need	O	O	O
to	O	O	O
be	O	O	O
modified	O	O	B-T169
in	O	O	O
order	O	O	O
to	O	O	O
effectively	O	O	B-T080
reach	O	O	O
clients	O	O	B-T096
.	O	O	O

-DOCSTART- (28438542)

Identification	O	O	O
of	O	O	O
low	O	O	O
micromolar	O	O	B-T081
dual	O	O	O
inhibitors	O	O	B-T121
for	O	O	O
aldose	O	O	B-T116
reductase	O	O	I-T116
(	O	O	O
ALR2	O	O	B-T116
)	O	O	O
and	O	O	O
poly	O	O	B-T116
(	O	O	I-T116
ADP-ribose	O	O	I-T116
)	O	O	I-T116
polymerase	O	O	I-T116
(	O	O	O
PARP-1	O	O	B-T116
)	O	O	O
using	O	O	O
structure	O	O	B-T082
based	O	O	O
design	O	O	B-T052
approach	O	O	O

Clinical	O	O	B-T062
studies	O	O	I-T062
have	O	O	O
revealed	O	O	O
that	O	O	O
diabetic	O	O	B-T047
retinopathy	O	O	I-T047
is	O	O	O
a	O	O	O
multifactorial	O	O	O
disorder	O	O	B-T047
.	O	O	O

Moreover	O	O	O
,	O	O	O
studies	O	O	O
also	O	O	O
suggest	O	O	O
that	O	O	O
ALR2	O	O	B-T116
and	O	O	O
PARP-1	O	O	B-T116
co-occur	O	O	O
in	O	O	O
retinal	O	O	B-T023
cells	O	O	B-T025
,	O	O	O
making	O	O	O
them	O	O	O
appropriate	O	O	O
targets	O	O	B-T169
for	O	O	O
the	O	O	O
treatment	O	O	B-T061
of	O	O	O
diabetic	O	O	B-T047
retinopathy	O	O	I-T047
.	O	O	O

To	O	O	O
find	O	O	O
the	O	O	O
dual	O	O	O
inhibitors	O	O	B-T121
of	O	O	O
ALR2	O	O	B-T116
and	O	O	O
PARP-1	O	O	B-T116
,	O	O	O
the	O	O	O
structure	O	O	B-T082
based	O	O	O
design	O	O	B-T052
was	O	O	O
carried	O	O	O
out	O	O	O
in	O	O	O
parallel	O	O	O
for	O	O	O
both	O	O	O
the	O	O	O
target	O	O	B-T169
proteins	O	O	B-T116
.	O	O	O

A	O	O	O
series	O	O	O
of	O	O	O
novel	O	O	O
thiazolidine-2,4-dione	O	O	B-T109
(	O	O	O
TZD	O	O	B-T109
)	O	O	O
derivatives	O	O	B-T169
were	O	O	O
therefore	O	O	O
rationally	O	O	O
designed	O	O	B-T052
,	O	O	O
synthesized	O	O	B-T052
and	O	O	O
their	O	O	O
in	O	O	B-T080
vitro	O	O	I-T080
inhibitory	O	O	B-T044
activities	O	O	I-T044
against	O	O	O
ALR2	O	O	B-T116
and	O	O	O
PARP-1	O	O	B-T116
were	O	O	O
evaluated	O	O	O
.	O	O	O

The	O	O	O
experimental	O	O	B-T033
results	O	O	I-T033
showed	O	O	O
that	O	O	O
compounds	O	O	B-T121
5b	O	O	I-T121
and	O	O	O
5f	O	O	B-T121
,	O	O	O
with	O	O	O
2-chloro	O	O	O
and	O	O	O
4-fluoro	O	O	O
substitutions	O	O	O
,	O	O	O
showed	O	O	O
biochemical	O	O	B-T169
activities	O	O	B-T052
in	O	O	O
micromolar	O	O	B-T081
and	O	O	O
submicromolar	O	O	B-T081
range	O	O	B-T081
(	O	O	O
IC50	O	O	B-T081
1.34	O	O	O
-	O	O	O
5.03Î¼M	O	O	O
)	O	O	O
against	O	O	O
both	O	O	O
the	O	O	O
targeted	O	O	B-T169
enzymes	O	O	B-T116
.	O	O	O

The	O	O	O
structure-activity	O	O	B-T080
relationship	O	O	I-T080
elucidated	O	O	O
for	O	O	O
these	O	O	O
novel	O	O	O
inhibitors	O	O	B-T121
against	O	O	O
both	O	O	O
the	O	O	O
enzymes	O	O	B-T116
provide	O	O	O
new	O	O	O
insight	O	O	O
into	O	O	O
the	O	O	O
binding	O	O	B-T044
mode	O	O	B-T169
of	O	O	O
the	O	O	O
inhibitors	O	O	O
to	O	O	O
the	O	O	O
active	O	O	B-T169
sites	O	O	I-T169
of	O	O	O
enzymes	O	O	O
.	O	O	O

The	O	O	O
positive	O	O	B-T033
results	O	O	B-T033
of	O	O	O
the	O	O	O
biochemical	O	O	B-T169
assay	O	O	B-T059
suggest	O	O	O
that	O	O	O
these	O	O	O
compounds	O	O	B-T121
may	O	O	O
be	O	O	O
further	O	O	O
optimized	O	O	B-T052
and	O	O	O
utilized	O	O	B-T169
for	O	O	O
the	O	O	O
treatment	O	O	B-T061
of	O	O	O
diabetic	O	O	B-T047
retinopathy	O	O	I-T047
.	O	O	O

-DOCSTART- (28440108)

Microbiology	O	O	B-T059
of	O	O	O
the	O	O	O
Upper	O	O	B-T030
and	O	O	O
Lower	O	O	B-T039
Airways	O	O	I-T039
in	O	O	O
Pediatric	O	O	B-T080
Cystic	O	O	B-T047
Fibrosis	O	O	I-T047
Patients	O	O	O

Objective	O	O	O
To	O	O	O
evaluate	O	O	O
the	O	O	O
microbiology	O	O	O
of	O	O	O
the	O	O	O
upper	O	O	O
and	O	O	O
lower	O	O	O
airways	O	O	O
in	O	O	O
pediatric	O	O	B-T080
cystic	O	O	B-T047
fibrosis	O	O	I-T047
(	O	O	O
CF	O	O	B-T047
)	O	O	O
patients	O	O	B-T101
who	O	O	O
underwent	O	O	O
sinus	O	O	B-T061
surgery	O	O	I-T061
.	O	O	O

Study	O	O	O
Design	O	O	O
Retrospective	O	O	B-T062
case	O	O	O
series	O	O	O
with	O	O	O
chart	O	O	O
review	O	O	O
.	O	O	O

Setting	O	O	O
Tertiary	O	O	B-T093
care	O	O	I-T093
children	O	O	B-T093
's	O	O	I-T093
hospital	O	O	I-T093
.	O	O	O

Subjects	O	O	O
and	O	O	O
Methods	O	O	O
A	O	O	O
total	O	O	O
of	O	O	O
201	O	O	O
paired	O	O	O
sinus	O	O	B-T059
and	O	O	O
pulmonary	O	O	B-T059
cultures	O	O	I-T059
from	O	O	O
105	O	O	O
CF	O	O	B-T047
patients	O	O	B-T101
were	O	O	O
identified	O	O	O
between	O	O	O
1996	O	O	O
and	O	O	O
2014	O	O	O
.	O	O	O

Demographics	O	O	B-T062
and	O	O	O
culture	O	O	B-T059
results	O	O	B-T169
were	O	O	O
analyzed	O	O	B-UnknownType
.	O	O	O

Results	O	O	B-T169
The	O	O	O
mean	O	O	O
age	O	O	O
of	O	O	O
patients	O	O	B-T101
was	O	O	O
11.2	O	O	O
Â±	O	O	O
5.4	O	O	O
years	O	O	O
(	O	O	O
range	O	O	O
,	O	O	O
1	O	O	O
-	O	O	O
27	O	O	O
years	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
approximately	O	O	O
one-half	O	O	O
were	O	O	O
female	O	O	B-T098
.	O	O	O

Methicillin	O	O	B-T195
-	O	O	O
sensitive	O	O	B-T169
Staphylococcus	O	O	B-T007
aureus	O	O	I-T007
was	O	O	O
the	O	O	O
most	O	O	O
common	O	O	O
pathogen	O	O	B-T001
overall	O	O	O
.	O	O	O

A	O	O	O
significantly	O	O	O
higher	O	O	O
prevalence	O	O	B-T081
of	O	O	O
Pseudomonas	O	O	B-T007
aeruginosa	O	O	I-T007
(	O	O	O
32	O	O	O
%	O	O	O
for	O	O	O
pulmonary	O	O	B-T059
and	O	O	O
37	O	O	O
%	O	O	O
for	O	O	O
sinus	O	O	B-T059
cultures	O	O	I-T059
)	O	O	O
was	O	O	O
observed	O	O	O
in	O	O	O
older	O	O	B-T098
patients	O	O	B-T101
versus	O	O	O
younger	O	O	B-T100
patients	O	O	O
(	O	O	O
P	O	O	B-T081
<	O	O	O
.001	O	O	O
)	O	O	O
.	O	O	O

There	O	O	O
was	O	O	O
low	O	O	O
to	O	O	O
moderate	O	O	B-T080
agreement	O	O	B-T080
between	O	O	O
sinus	O	O	B-T059
and	O	O	O
pulmonary	O	O	B-T059
cultures	O	O	I-T059
(	O	O	O
Kappa	O	O	B-T170
statistic	O	O	B-T081
range	O	O	I-T081
,	O	O	O
0.03	O	O	O
-	O	O	O
0.56	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
prevalence	O	O	B-T081
of	O	O	O
methicillin-resistant	O	O	B-T007
S	O	O	I-T007
aureus	O	O	I-T007
(	O	O	O
MRSA	O	O	B-T007
)	O	O	O
increased	O	O	O
significantly	O	O	B-T081
for	O	O	O
lower	O	O	B-T059
respiratory	O	O	I-T059
tract	O	O	I-T059
culture	O	O	I-T059
(	O	O	O
from	O	O	O
5	O	O	O
%	O	O	O
to	O	O	O
16	O	O	O
%	O	O	O
)	O	O	O
and	O	O	O
sinus	O	O	B-T059
culture	O	O	I-T059
(	O	O	O
from	O	O	O
5	O	O	O
%	O	O	O
to	O	O	O
27	O	O	O
%	O	O	O
)	O	O	O
between	O	O	O
1996	O	O	O
-	O	O	O
2004	O	O	O
and	O	O	O
2010	O	O	O
-	O	O	O
2014	O	O	O
(	O	O	O
P	O	O	B-T081
=	O	O	O
.016	O	O	O
and	O	O	O
P	O	O	O
<	O	O	O
.001	O	O	O
,	O	O	O
respectively	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
prevalence	O	O	B-T081
of	O	O	O
positive	O	O	B-T033
sinus	O	O	B-T059
cultures	O	O	I-T059
increased	O	O	O
from	O	O	O
40	O	O	O
%	O	O	O
to	O	O	O
85	O	O	O
%	O	O	O
between	O	O	O
1996	O	O	O
-	O	O	O
2004	O	O	O
and	O	O	O
2010	O	O	O
-	O	O	O
2014	O	O	O
(	O	O	O
P	O	O	B-T081
=	O	O	O
.018	O	O	O
)	O	O	O
.	O	O	O

Patients	O	O	B-T101
with	O	O	O
pulmonary	O	O	B-T080
MRSA	O	O	B-T007
were	O	O	O
more	O	O	O
likely	O	O	O
to	O	O	O
be	O	O	O
coinfected	O	O	B-T047
with	O	O	O
pulmonary	O	O	O
P	O	O	B-T007
aeruginosa	O	O	I-T007
(	O	O	O
risk	O	O	B-T081
ratio	O	O	I-T081
,	O	O	O
2.4	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	B-T081
,	O	O	O
1.2	O	O	O
-	O	O	O
4.8	O	O	O
;	O	O	O
P	O	O	O
=	O	O	O
.015	O	O	O
)	O	O	O
or	O	O	O
Aspergillus	O	O	B-T004
fumigatus	O	O	I-T004
(	O	O	O
risk	O	O	O
ratio	O	O	O
,	O	O	O
2.2	O	O	O
;	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
,	O	O	O
1.2	O	O	O
-	O	O	O
4.8	O	O	O
;	O	O	O
P	O	O	O
=	O	O	O
.035	O	O	O
)	O	O	O
.	O	O	O

Conclusions	O	O	O
There	O	O	O
is	O	O	O
low	O	O	O
to	O	O	O
moderate	O	O	B-T080
correlation	O	O	B-T080
between	O	O	O
pulmonary	O	O	B-T080
and	O	O	O
sinus	O	O	B-T030
pathogens	O	O	B-T001
in	O	O	O
CF	O	O	B-T047
patients	O	O	B-T101
.	O	O	O

This	O	O	O
is	O	O	O
important	O	O	O
to	O	O	O
consider	O	O	O
when	O	O	O
treating	O	O	B-T061
infections	O	O	B-T046
.	O	O	O

The	O	O	O
prevalence	O	O	B-T081
of	O	O	O
MRSA	O	O	B-T007
in	O	O	O
sinus	O	O	B-T059
cultures	O	O	I-T059
has	O	O	O
increased	O	O	O
over	O	O	O
time	O	O	O
and	O	O	O
warrants	O	O	O
further	O	O	O
investigation	O	O	B-T058
.	O	O	O

-DOCSTART- (28440461)

The	O	O	O
role	O	O	O
of	O	O	O
miR-451	O	O	B-T114
in	O	O	O
the	O	O	O
switching	O	O	O
between	O	O	O
proliferation	O	O	B-T169
and	O	O	O
migration	O	O	B-T039
in	O	O	O
malignant	O	O	B-T191
glioma	O	O	I-T191
cells	O	O	B-T025
:	O	O	O
AMPK	O	O	B-T116
signaling	O	O	B-T038
,	O	O	O
mTOR	O	O	B-T116
modulation	O	O	B-T082
and	O	O	O
Rac1	O	O	B-T116
activation	O	O	B-T045
required	O	O	O

Glioblastoma	O	O	B-T191
multiforme	O	O	I-T191
(	O	O	O
GBM	O	O	B-T191
)	O	O	O
,	O	O	O
WHO	O	O	B-T191
grade	O	O	I-T191
IV	O	O	I-T191
astrocytoma	O	O	I-T191
,	O	O	O
is	O	O	O
the	O	O	O
most	O	O	O
common	O	O	O
primary	O	O	B-T191
neoplasm	O	O	I-T191
of	O	O	O
the	O	O	O
central	O	O	B-T022
nervous	O	O	I-T022
system	O	O	I-T022
(	O	O	O
CNS	O	O	B-T022
)	O	O	O
and	O	O	O
has	O	O	O
the	O	O	O
highest	O	O	O
malignancy	O	O	B-T191
and	O	O	O
mortality	O	O	B-T081
rates	O	O	I-T081
.	O	O	O

The	O	O	O
invasive	O	O	B-T080
nature	O	O	I-T080
of	O	O	O
GBM	O	O	B-T191
complicates	O	O	O
surgical	O	O	B-T061
resection	O	O	I-T061
and	O	O	O
restricts	O	O	O
chemotherapeutic	O	O	B-T061
access	O	O	I-T061
,	O	O	O
contributing	O	O	O
to	O	O	O
poor	O	O	O
patient	O	O	B-T101
prognosis	O	O	B-T058
.	O	O	O

The	O	O	O
migration	O	O	B-T039
of	O	O	O
tumor	O	O	B-T025
cells	O	O	I-T025
is	O	O	O
closely	O	O	O
related	O	O	O
to	O	O	O
the	O	O	O
tumor	O	O	B-T025
cell	O	O	I-T025
proliferation	O	O	B-T169
.	O	O	O

The	O	O	O
acquisition	O	O	B-T052
of	O	O	O
migratory	O	O	B-T169
capability	O	O	B-T080
,	O	O	O
in	O	O	O
addition	O	O	O
to	O	O	O
intracellular	O	O	B-T082
factors	O	O	B-T169
,	O	O	O
is	O	O	O
proposed	O	O	O
to	O	O	O
be	O	O	O
a	O	O	O
crucial	O	O	B-T169
mechanism	O	O	I-T169
during	O	O	O
the	O	O	O
progression	O	O	B-T169
of	O	O	O
invasion	O	O	B-T033
.	O	O	O

Using	O	O	O
qRT-PCR	O	O	B-T063
analysis	O	O	B-T062
,	O	O	O
we	O	O	O
determined	O	O	O
that	O	O	O
the	O	O	O
expression	O	O	B-T045
of	O	O	O
miR-451	O	O	B-T028
in	O	O	O
glioma	O	O	B-T191
tissue	O	O	B-T024
was	O	O	O
lower	O	O	O
than	O	O	O
in	O	O	O
control	O	O	B-T023
brain	O	O	I-T023
tissue	O	O	I-T023
,	O	O	O
especially	O	O	O
in	O	O	O
the	O	O	O
central	O	O	B-T082
portions	O	O	B-T082
of	O	O	O
the	O	O	O
tumor	O	O	B-T191
.	O	O	O

In	O	O	O
glioma	O	O	B-T191
cell	O	O	B-T025
lines	O	O	I-T025
,	O	O	O
we	O	O	O
found	O	O	O
that	O	O	O
decreased	O	O	B-T081
miR-451	O	O	B-T028
expression	O	O	B-T045
suppressed	O	O	B-T169
tumor	O	O	B-T025
cell	O	O	I-T025
proliferation	O	O	B-T169
but	O	O	O
enhanced	O	O	O
migration	O	O	B-T039
with	O	O	O
a	O	O	O
concomitant	O	O	B-T079
low	O	O	O
level	O	O	O
of	O	O	O
CAB39	O	O	B-T116
/	O	O	O
AMPK	O	O	B-T116
/	O	O	O
mTOR	O	O	B-T116
pathway	O	O	B-T169
activation	O	O	I-T169
and	O	O	O
high	O	O	O
level	O	O	O
of	O	O	O
Rac1	O	O	B-T116
/	O	O	O
cofilin	O	O	B-T116
pathway	O	O	O
activation	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

Notably	O	O	O
,	O	O	O
the	O	O	O
effect	O	O	O
of	O	O	O
miR-451	O	O	B-T114
on	O	O	O
cytological	O	O	B-T169
behavior	O	O	I-T169
and	O	O	O
on	O	O	O
the	O	O	O
activation	O	O	B-T045
of	O	O	O
mTOR	O	O	B-T116
and	O	O	O
Rac1	O	O	B-T116
was	O	O	O
limited	O	O	O
when	O	O	O
AMPKÎ±1	O	O	B-T116
expression	O	O	B-T045
was	O	O	O
knocked-down	O	O	O
with	O	O	O
a	O	O	O
synthetic	O	O	B-T052
shRNA	O	O	B-T114
.	O	O	O

We	O	O	O
suggest	O	O	O
that	O	O	O
the	O	O	O
glioma	O	O	B-T191
microenvironment	O	O	B-T070
results	O	O	O
in	O	O	O
heterogeneity	O	O	B-T080
of	O	O	O
miR-451	O	O	B-T028
expression	O	O	B-T045
.	O	O	O

Our	O	O	O
data	O	O	O
indicated	O	O	O
that	O	O	O
miR-451	O	O	B-T114
relays	O	O	O
environmental	O	O	O
signals	O	O	O
by	O	O	O
upregulating	O	O	B-T044
the	O	O	O
activity	O	O	O
of	O	O	O
AMPK	O	O	B-T116
signaling	O	O	B-T038
,	O	O	O
thereby	O	O	O
modulating	O	O	B-T082
the	O	O	O
activation	O	O	B-T045
of	O	O	O
mTOR	O	O	B-T116
and	O	O	O
Rac1	O	O	B-T116
/	O	O	O
cofilin	O	O	B-T116
which	O	O	O
,	O	O	O
in	O	O	O
turn	O	O	O
,	O	O	O
play	O	O	O
key	O	O	O
roles	O	O	O
in	O	O	O
glioma	O	O	B-T191
cell	O	O	O
proliferation	O	O	B-T169
and	O	O	O
migration	O	O	B-T039
,	O	O	O
respectively	O	O	O
.	O	O	O

Our	O	O	O
results	O	O	O
highlight	O	O	O
the	O	O	O
need	O	O	O
to	O	O	O
consider	O	O	O
opposing	O	O	O
roles	O	O	O
of	O	O	O
a	O	O	O
therapeutic	O	O	B-T169
target	O	O	O
which	O	O	O
,	O	O	O
while	O	O	O
suppressing	O	O	B-T169
tumor	O	O	B-T025
cell	O	O	B-T025
proliferation	O	O	B-T169
,	O	O	O
could	O	O	O
also	O	O	O
promote	O	O	O
cell	O	O	O
infiltration	O	O	B-T046
.	O	O	O

-DOCSTART- (28441489)

Comparison	O	O	B-T052
of	O	O	O
Gasoline	O	O	B-T073
Direct-Injection	O	O	I-T073
(	O	O	O
GDI	O	O	B-T073
)	O	O	O
and	O	O	O
Port	O	O	B-T073
Fuel	O	O	I-T073
Injection	O	O	I-T073
(	O	O	O
PFI	O	O	B-T073
)	O	O	O
Vehicle	O	O	B-T131
Emissions	O	O	I-T131
:	O	O	O
Emission	O	O	B-T131
Certification	O	O	B-T064
Standards	O	O	B-T170
,	O	O	O
Cold-Start	O	O	B-T033
,	O	O	O
Secondary	O	O	O
Organic	O	O	B-T080
Aerosol	O	O	B-T073
Formation	O	O	B-T169
Potential	O	O	B-T080
,	O	O	O
and	O	O	O
Potential	O	O	O
Climate	O	O	B-T070
Impacts	O	O	O

Recent	O	O	O
increases	O	O	B-T081
in	O	O	O
the	O	O	O
Corporate	O	O	B-T080
Average	O	O	B-T081
Fuel	O	O	I-T081
Economy	O	O	I-T081
standards	O	O	B-T170
have	O	O	O
led	O	O	O
to	O	O	O
widespread	O	O	B-T082
adoption	O	O	O
of	O	O	O
vehicles	O	O	B-T073
equipped	O	O	O
with	O	O	O
gasoline	O	O	B-T073
direct-injection	O	O	I-T073
(	O	O	O
GDI	O	O	B-T073
)	O	O	O
engines	O	O	B-T073
.	O	O	O

Changes	O	O	O
in	O	O	O
engine	O	O	B-T073
technologies	O	O	B-T090
can	O	O	O
alter	O	O	O
emissions	O	O	B-T131
.	O	O	O

To	O	O	O
quantify	O	O	B-T081
these	O	O	O
effects	O	O	B-T080
,	O	O	O
we	O	O	O
measured	O	O	B-T080
gas-	O	O	B-T104
and	O	O	O
particle-phase	O	O	B-T104
emissions	O	O	B-T131
from	O	O	O
82	O	O	O
light-duty	O	O	B-T080
gasoline	O	O	B-T073
vehicles	O	O	B-T073
recruited	O	O	O
from	O	O	O
the	O	O	O
California	O	O	B-T083
in-use	O	O	O
fleet	O	O	O
tested	O	O	B-T170
on	O	O	O
a	O	O	O
chassis	O	O	B-T073
dynamometer	O	O	B-T073
using	O	O	O
the	O	O	O
cold-start	O	O	B-T033
unified	O	O	O
cycle	O	O	O
.	O	O	O

The	O	O	O
fleet	O	O	O
included	O	O	O
15	O	O	O
GDI	O	O	B-T073
vehicles	O	O	B-T073
,	O	O	O
including	O	O	O
8	O	O	O
GDIs	O	O	B-T073
certified	O	O	B-T064
to	O	O	O
the	O	O	O
most-stringent	O	O	O
emissions	O	O	B-T131
standard	O	O	B-T170
,	O	O	O
superultra-low-emission	O	O	B-T185
vehicles	O	O	I-T185
(	O	O	O
SULEV	O	O	B-T185
)	O	O	O
.	O	O	O

We	O	O	O
quantified	O	O	B-T081
the	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
engine	O	O	B-T073
technology	O	O	B-T090
,	O	O	O
emission	O	O	B-T131
certification	O	O	B-T064
standards	O	O	B-T170
,	O	O	O
and	O	O	O
cold-start	O	O	B-T033
on	O	O	O
emissions	O	O	B-T131
.	O	O	O

For	O	O	O
vehicles	O	O	B-T073
certified	O	O	B-T064
to	O	O	O
the	O	O	O
same	O	O	O
emissions	O	O	B-T131
standard	O	O	B-T170
,	O	O	O
there	O	O	O
is	O	O	O
no	O	O	O
statistical	O	O	B-T090
difference	O	O	B-T081
of	O	O	O
regulated	O	O	O
gas-phase	O	O	B-T104
pollutant	O	O	B-T131
emissions	O	O	O
between	O	O	O
PFIs	O	O	B-T073
and	O	O	O
GDIs	O	O	B-T073
.	O	O	O

However	O	O	O
,	O	O	O
GDIs	O	O	B-T073
had	O	O	O
,	O	O	O
on	O	O	O
average	O	O	B-T081
,	O	O	O
a	O	O	O
factor	O	O	B-T169
of	O	O	O
2	O	O	O
higher	O	O	O
particulate	O	O	B-T167
matter	O	O	I-T167
(	O	O	O
PM	O	O	B-T167
)	O	O	O
mass	O	O	O
emissions	O	O	B-T131
than	O	O	O
PFIs	O	O	B-T073
due	O	O	O
to	O	O	O
higher	O	O	O
elemental	O	O	B-T196
carbon	O	O	I-T196
(	O	O	O
EC	O	O	B-T196
)	O	O	O
emissions	O	O	O
.	O	O	O

SULEV	O	O	B-T185
certified	O	O	B-T064
GDIs	O	O	B-T073
have	O	O	O
a	O	O	O
factor	O	O	B-T169
of	O	O	O
2	O	O	O
lower	O	O	O
PM	O	O	B-T167
mass	O	O	O
emissions	O	O	B-T131
than	O	O	O
GDIs	O	O	O
certified	O	O	O
as	O	O	O
ultralow-emission	O	O	B-T185
vehicles	O	O	I-T185
(	O	O	O
3.0	O	O	O
Â±	O	O	O
1.1	O	O	O
versus	O	O	O
6.3	O	O	O
Â±	O	O	O
1.1	O	O	O
mg/mi	O	O	O
)	O	O	O
,	O	O	O
suggesting	O	O	O
improvements	O	O	B-T077
in	O	O	O
engine	O	O	B-T073
design	O	O	B-T052
and	O	O	O
calibration	O	O	B-T081
.	O	O	O

Comprehensive	O	O	B-T080
organic	O	O	B-T080
speciation	O	O	O
revealed	O	O	B-T080
no	O	O	O
statistically	O	O	B-T081
significant	O	O	I-T081
differences	O	O	B-T081
in	O	O	O
the	O	O	O
composition	O	O	B-T070
of	O	O	O
the	O	O	O
volatile	O	O	B-T080
organic	O	O	B-T109
compounds	O	O	I-T109
emissions	O	O	B-T131
between	O	O	O
PFI	O	O	B-T073
and	O	O	O
GDIs	O	O	B-T073
,	O	O	O
including	O	O	O
benzene	O	O	B-T109
,	O	O	O
toluene	O	O	B-T109
,	O	O	O
ethylbenzene	O	O	B-T109
,	O	O	O
and	O	O	O
xylenes	O	O	B-T109
(	O	O	O
BTEX	O	O	B-T109
)	O	O	O
.	O	O	O

Therefore	O	O	O
,	O	O	O
the	O	O	O
secondary	O	O	O
organic	O	O	B-T080
aerosol	O	O	B-T073
and	O	O	O
ozone	O	O	B-T103
formation	O	O	B-T169
potential	O	O	B-T080
of	O	O	O
the	O	O	O
exhaust	O	O	B-T131
does	O	O	O
not	O	O	O
depend	O	O	O
on	O	O	O
engine	O	O	B-T073
technology	O	O	B-T090
.	O	O	O

Cold-start	O	O	B-T033
contributes	O	O	B-T052
a	O	O	O
larger	O	O	B-T081
fraction	O	O	B-T081
of	O	O	I-T081
the	O	O	O
total	O	O	O
unified	O	O	O
cycle	O	O	O
emissions	O	O	B-T131
for	O	O	O
vehicles	O	O	B-T073
meeting	O	O	O
more-stringent	O	O	O
emission	O	O	B-T131
standards	O	O	B-T170
.	O	O	O

Organic	O	O	B-T080
gas	O	O	B-T104
emissions	O	O	B-T131
were	O	O	O
the	O	O	O
most	O	O	O
sensitive	O	O	B-T169
to	O	O	O
cold-start	O	O	B-T033
compared	O	O	B-T052
to	O	O	O
the	O	O	O
other	O	O	O
pollutants	O	O	B-T131
tested	O	O	B-T170
here	O	O	O
.	O	O	O

There	O	O	O
were	O	O	O
no	O	O	O
statistically	O	O	B-T081
significant	O	O	I-T081
differences	O	O	B-T081
in	O	O	O
the	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
cold-start	O	O	B-T033
on	O	O	O
GDIs	O	O	B-T073
and	O	O	O
PFIs	O	O	B-T073
.	O	O	O

For	O	O	O
our	O	O	O
test	O	O	O
fleet	O	O	O
,	O	O	O
the	O	O	O
measured	O	O	B-T080
14.5	O	O	O
%	O	O	O
decrease	O	O	B-T081
in	O	O	O
CO2	O	O	B-T123
emissions	O	O	B-T131
from	O	O	O
GDIs	O	O	B-T073
was	O	O	O
much	O	O	O
greater	O	O	B-T081
than	O	O	O
the	O	O	O
potential	O	O	B-T080
climate	O	O	B-T070
forcing	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
higher	O	O	O
black	O	O	B-T121
carbon	O	O	I-T121
emissions	O	O	O
.	O	O	O

Thus	O	O	O
,	O	O	O
switching	O	O	O
from	O	O	O
PFI	O	O	B-T073
to	O	O	O
GDI	O	O	B-T073
vehicles	O	O	B-T073
will	O	O	O
likely	O	O	O
lead	O	O	O
to	O	O	O
a	O	O	O
reduction	O	O	B-T080
in	O	O	O
net	O	O	O
global	O	O	B-T069
warming	O	O	I-T069
.	O	O	O

-DOCSTART- (28442401)

TRIB3	O	O	B-T116
downregulation	O	O	B-T044
enhances	O	O	B-T052
doxorubicin	O	O	B-T195
-	O	O	O
induced	O	O	B-T169
cytotoxicity	O	O	B-T049
in	O	O	O
gastric	O	O	B-T191
cancer	O	O	I-T191
cells	O	O	O

TRIB3	O	O	B-T116
,	O	O	O
which	O	O	O
is	O	O	O
a	O	O	O
pseudokinase	O	O	B-T116
known	O	O	O
to	O	O	O
regulate	O	O	B-T038
multiple	O	O	I-T038
pro-survival	O	O	I-T038
pathways	O	O	I-T038
,	O	O	O
appears	O	O	O
to	O	O	O
be	O	O	O
a	O	O	O
potential	O	O	O
therapeutic	O	O	B-T061
target	O	O	B-T169
for	O	O	O
the	O	O	O
treatment	O	O	B-T061
of	O	O	O
human	O	O	B-T016
tumors	O	O	B-T191
.	O	O	O

However	O	O	O
,	O	O	O
its	O	O	O
precise	O	O	O
role	O	O	O
in	O	O	O
cancer	O	O	B-T191
is	O	O	O
controversial	O	O	O
,	O	O	O
as	O	O	O
TRIB3	O	O	B-T116
protein	O	O	B-T034
levels	O	O	I-T034
have	O	O	O
been	O	O	O
associated	O	O	O
with	O	O	O
both	O	O	O
good	O	O	B-T033
and	O	O	O
poor	O	O	B-T033
prognosis	O	O	I-T033
in	O	O	O
cancer	O	O	B-T101
patients	O	O	I-T101
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
investigated	O	O	O
the	O	O	O
significance	O	O	O
of	O	O	O
TRIB3	O	O	B-T116
expression	O	O	B-T045
in	O	O	O
the	O	O	O
survival	O	O	B-T043
of	O	O	O
gastric	O	O	B-T191
cancer	O	O	I-T191
cells	O	O	B-T025
exposed	O	O	O
to	O	O	O
anticancer	O	O	B-T109
drugs	O	O	I-T109
.	O	O	O

We	O	O	O
found	O	O	O
that	O	O	O
the	O	O	O
tested	O	O	B-T169
anticancer	O	O	B-T109
drug	O	O	I-T109
,	O	O	O
doxorubicin	O	O	B-T195
,	O	O	O
induced	O	O	B-T169
cytotoxicity	O	O	B-T049
by	O	O	O
decreasing	O	O	O
TRIB3	O	O	B-T028
transcription	O	O	B-T045
,	O	O	O
which	O	O	O
was	O	O	O
followed	O	O	O
by	O	O	O
apoptotic	O	O	B-T043
cell	O	O	I-T043
death	O	O	I-T043
.	O	O	O

Moreover	O	O	O
,	O	O	O
TRIB3	O	O	B-T114
siRNA	O	O	I-T114
knockdown	O	O	B-T063
appeared	O	O	O
to	O	O	O
enhance	O	O	B-T052
doxorubicin	O	O	B-T195
-	O	O	O
induced	O	O	B-T169
apoptosis	O	O	B-T043
in	O	O	O
gastric	O	O	B-T191
cancer	O	O	I-T191
cells	O	O	B-T025
,	O	O	O
concurrently	O	O	O
with	O	O	O
altering	O	O	O
the	O	O	O
expression	O	O	B-T045
of	O	O	O
downstream	O	O	B-T082
apoptotic	O	O	B-T116
factors	O	O	I-T116
.	O	O	O

Conversely	O	O	O
,	O	O	O
overexpression	O	O	B-T045
of	O	O	O
TRIB3	O	O	B-T116
significantly	O	O	O
protected	O	O	B-T025
cells	O	O	I-T025
against	O	O	O
doxorubicin	O	O	B-T195
-	O	O	O
induced	O	O	B-T169
apoptosis	O	O	B-T043
.	O	O	O

Our	O	O	O
results	O	O	O
indicate	O	O	O
that	O	O	O
downregulation	O	O	B-T044
of	O	O	O
TRIB3	O	O	B-T116
appears	O	O	O
to	O	O	O
promote	O	O	B-T052
cell	O	O	B-T043
death	O	O	I-T043
and	O	O	O
enhance	O	O	B-T052
doxorubicin	O	O	B-T195
-	O	O	O
induced	O	O	B-T169
apoptosis	O	O	B-T043
,	O	O	O
supporting	O	O	O
the	O	O	O
anti-apoptotic	O	O	B-T120
role	O	O	O
of	O	O	O
TRIB3	O	O	O
.	O	O	O

The	O	O	O
inductions	O	O	B-T045
of	O	O	O
three	O	O	O
classes	O	O	O
of	O	O	O
MAPKs	O	O	B-T116
failed	O	O	O
to	O	O	O
affect	O	O	O
doxorubicin	O	O	B-T195
-mediated	O	O	O
TRIB3	O	O	B-T116
downregulation	O	O	B-T044
,	O	O	O
while	O	O	O
TRIB3	O	O	O
overexpression	O	O	B-T045
did	O	O	O
not	O	O	O
affect	O	O	O
doxorubicin	O	O	O
-	O	O	O
induced	O	O	B-T169
MAPK	O	O	B-T044
activation	O	O	I-T044
.	O	O	O

In	O	O	O
sum	O	O	O
,	O	O	O
our	O	O	O
findings	O	O	B-T033
indicate	O	O	O
that	O	O	O
TRIB3	O	O	B-T116
plays	O	O	O
an	O	O	O
anti-apoptotic	O	O	B-T120
role	O	O	O
in	O	O	O
doxorubicin	O	O	B-T195
-treated	O	O	O
gastric	O	O	B-T191
cancer	O	O	I-T191
cell	O	O	B-T025
lines	O	O	I-T025
,	O	O	O
perhaps	O	O	O
indicating	O	O	O
that	O	O	O
the	O	O	O
status	O	O	O
of	O	O	O
TRIB3	O	O	O
expression	O	O	B-T045
in	O	O	O
response	O	O	O
to	O	O	O
anticancer	O	O	B-T109
drugs	O	O	I-T109
,	O	O	O
such	O	O	O
as	O	O	O
doxorubicin	O	O	O
,	O	O	O
irinotecan	O	O	B-T109
or	O	O	O
oxaliplatin	O	O	B-T109
,	O	O	O
may	O	O	O
reflect	O	O	O
the	O	O	O
efficiency	O	O	O
for	O	O	O
cancer	O	O	B-T061
therapy	O	O	I-T061
.	O	O	O

-DOCSTART- (28442859)

Digital	O	O	B-T023
Myopericytoma	O	O	B-T191
:	O	O	O
A	O	O	O
Case	O	O	B-T170
Report	O	O	I-T170
and	O	O	O
Systematic	O	O	O
Literature	O	O	O
Review	O	O	O

A	O	O	O
myopericytoma	O	O	B-T191
(	O	O	O
MP	O	O	B-T191
)	O	O	O
is	O	O	O
an	O	O	O
exceedingly	O	O	O
rare	O	O	O
perivascular	O	O	B-T191
tumor	O	O	I-T191
of	O	O	O
unknown	O	O	B-T033
etiology	O	O	I-T033
.	O	O	O

Given	O	O	O
their	O	O	O
potential	O	O	B-T080
for	O	O	O
mimicry	O	O	B-T044
and	O	O	O
malignancy	O	O	B-T191
,	O	O	O
MP	O	O	B-T191
tumors	O	O	I-T191
pose	O	O	O
a	O	O	O
unique	O	O	O
challenge	O	O	O
for	O	O	O
surgeons	O	O	B-T097
and	O	O	O
may	O	O	O
be	O	O	O
overlooked	O	O	O
on	O	O	O
differential	O	O	B-T060
diagnosis	O	O	I-T060
.	O	O	O

We	O	O	O
present	O	O	O
a	O	O	O
case	O	O	B-T170
report	O	O	I-T170
of	O	O	O
an	O	O	O
otherwise	O	O	O
healthy	O	O	B-T080
33-year-old	O	O	O
right-hand	O	O	B-T032
dominant	O	O	I-T032
male	O	O	B-T098
who	O	O	O
presented	O	O	O
to	O	O	O
our	O	O	O
outpatient	O	O	B-T093
clinic	O	O	I-T093
with	O	O	O
a	O	O	O
2-month	O	O	O
history	O	O	O
of	O	O	O
painless	O	O	B-T169
swelling	O	O	B-T033
and	O	O	O
erythema	O	O	B-T033
of	O	O	I-T033
the	O	O	I-T033
pulp	O	O	I-T033
of	O	O	I-T033
his	O	O	I-T033
left	O	O	I-T033
index	O	O	I-T033
finger	O	O	I-T033
.	O	O	O

Subsequent	O	O	O
plain	O	O	B-T060
film	O	O	I-T060
X-ray	O	O	I-T060
showed	O	O	O
near-complete	O	O	B-T080
bony	O	O	B-T033
destruction	O	O	I-T033
of	O	O	O
his	O	O	O
distal	O	O	B-T023
phalanx	O	O	I-T023
.	O	O	O

Pathological	O	O	B-T046
evaluation	O	O	B-T058
of	O	O	O
an	O	O	O
incisional	O	O	B-T060
biopsy	O	O	I-T060
showed	O	O	O
a	O	O	O
benign	O	O	B-T191
variant	O	O	I-T191
of	O	O	O
MP	O	O	B-T191
.	O	O	O

The	O	O	O
lesion	O	O	B-T033
was	O	O	O
treated	O	O	O
by	O	O	O
excision	O	O	B-T061
with	O	O	O
tumor	O	O	B-T191
shelling	O	O	B-T061
,	O	O	O
and	O	O	O
there	O	O	O
was	O	O	O
no	O	O	B-T080
evidence	O	O	I-T080
of	O	O	I-T080
recurrence	O	O	B-T067
81	O	O	O
days	O	O	O
postoperatively	O	O	B-T079
.	O	O	O

A	O	O	O
systematic	O	O	O
literature	O	O	O
review	O	O	O
of	O	O	O
the	O	O	O
management	O	O	B-T058
and	O	O	O
outcome	O	O	B-T080
of	O	O	O
all	O	O	O
known	O	O	O
cases	O	O	B-T170
of	O	O	O
hand	O	O	B-T029
and	O	O	I-T029
wrist	O	O	I-T029
MP	O	O	B-T191
is	O	O	O
presented	O	O	O
.	O	O	O

-DOCSTART- (28444830)

Gene	O	O	B-T045
expression	O	O	I-T045
reveals	O	O	O
evidence	O	O	B-T078
for	O	O	O
EGFR	O	O	B-T116
-dependent	O	O	O
proximal-distal	O	O	B-T023
limb	O	O	I-T023
patterning	O	O	B-T045
in	O	O	O
a	O	O	O
myriapod	O	O	O

Evolution	O	O	B-T045
of	O	O	O
segmented	O	O	B-T023
limbs	O	O	I-T023
is	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
key	O	O	O
innovations	O	O	O
of	O	O	O
Arthropoda	O	O	B-T204
,	O	O	O
allowing	O	O	O
development	O	O	O
of	O	O	O
functionally	O	O	O
specific	O	O	O
specialized	O	O	O
head	O	O	B-T029
and	O	O	O
trunk	O	O	B-T029
appendages	O	O	B-T023
,	O	O	O
a	O	O	O
major	O	O	O
factor	O	O	O
behind	O	O	O
their	O	O	O
unmatched	O	O	O
evolutionary	O	O	O
success	O	O	O
.	O	O	O

Proximodistal	O	O	B-T023
limb	O	O	I-T023
patterning	O	O	B-T045
is	O	O	O
controlled	O	O	O
by	O	O	O
two	O	O	O
regulatory	O	O	B-T044
networks	O	O	I-T044
in	O	O	O
the	O	O	O
vinegar	O	O	B-T204
fly	O	O	I-T204
Drosophila	O	O	B-T204
melanogaster	O	O	I-T204
,	O	O	O
and	O	O	O
other	O	O	O
insects	O	O	B-T204
.	O	O	O

The	O	O	O
first	O	O	O
is	O	O	O
represented	O	O	O
by	O	O	O
the	O	O	O
function	O	O	O
of	O	O	O
the	O	O	O
morphogens	O	O	B-T123
Wingless	O	O	B-T116
(	O	O	O
Wg	O	O	B-T116
)	O	O	O
and	O	O	O
Decapentaplegic	O	O	B-T116
(	O	O	O
Dpp	O	O	B-T116
)	O	O	O
;	O	O	O
the	O	O	O
second	O	O	O
by	O	O	O
the	O	O	O
EGFR-signaling	O	O	B-T044
cascade	O	O	I-T044
.	O	O	O

While	O	O	O
the	O	O	O
role	O	O	O
of	O	O	O
Wg	O	O	B-T116
and	O	O	O
Dpp	O	O	B-T116
has	O	O	O
been	O	O	O
studied	O	O	B-T062
in	O	O	O
a	O	O	O
wide	O	O	O
range	O	O	O
of	O	O	O
arthropods	O	O	B-T204
representing	O	O	O
all	O	O	O
main	O	O	O
branches	O	O	O
,	O	O	O
that	O	O	O
is	O	O	O
,	O	O	O
Pancrustacea	O	O	B-T204
(=	O	O	O
Hexapoda	O	O	B-T204
+	O	O	O
Crustacea	O	O	B-T204
)	O	O	O
,	O	O	O
Myriapoda	O	O	B-T204
and	O	O	O
Chelicerata	O	O	B-T204
,	O	O	O
investigation	O	O	B-T169
of	O	O	O
the	O	O	O
potential	O	O	O
role	O	O	O
of	O	O	O
EGFR-signaling	O	O	B-T044
is	O	O	O
restricted	O	O	O
to	O	O	O
insects	O	O	B-T204
(	O	O	O
Hexapoda	O	O	O
)	O	O	O
.	O	O	O

Gene	O	O	B-T063
expression	O	O	I-T063
analysis	O	O	I-T063
of	O	O	O
Egfr	O	O	B-T116
,	O	O	O
its	O	O	O
potential	O	O	B-T080
ligands	O	O	B-T103
,	O	O	O
and	O	O	O
putative	O	O	B-T116
downstream	O	O	I-T116
factors	O	O	I-T116
in	O	O	O
the	O	O	O
pill	O	O	B-T204
millipede	O	O	I-T204
Glomeris	O	O	B-T204
marginata	O	O	I-T204
(	O	O	O
Myriapoda	O	O	B-T204
:	O	O	O
Diplopoda	O	O	B-T204
)	O	O	O
,	O	O	O
reveals	O	O	O
that-in	O	O	O
at	O	O	O
least	O	O	O
mandibulate	O	O	B-T204
arthropods	O	O	B-T204
-	O	O	O
EGFR-signaling	O	O	B-T044
is	O	O	O
likely	O	O	O
a	O	O	O
conserved	O	O	O
regulatory	O	O	B-T033
mechanism	O	O	I-T033
in	O	O	O
proximodistal	O	O	B-T023
limb	O	O	I-T023
patterning	O	O	B-T045
.	O	O	O

-DOCSTART- (28445938)

Pirfenidone	O	O	B-T109
normalizes	O	O	B-T169
the	O	O	O
tumor	O	O	B-T070
microenvironment	O	O	I-T070
to	O	O	O
improve	O	O	O
chemotherapy	O	O	O

Normalization	O	O	B-T061
of	O	O	O
the	O	O	O
tumor	O	O	B-T191
microenvironment	O	O	I-T070
by	O	O	O
selectively	O	O	O
targeting	O	O	B-T169
components	O	O	B-T026
of	O	O	O
the	O	O	O
tumor	O	O	O
extracellular	O	O	B-T024
matrix	O	O	I-T024
has	O	O	O
been	O	O	O
recently	O	O	O
proposed	O	O	O
to	O	O	O
have	O	O	O
the	O	O	O
potential	O	O	B-T080
to	O	O	O
decompress	O	O	B-T169
tumor	O	O	O
blood	O	O	B-T023
vessels	O	O	I-T023
,	O	O	O
increase	O	O	B-T169
vessel	O	O	B-T023
perfusion	O	O	B-T042
and	O	O	O
thus	O	O	O
,	O	O	O
improve	O	O	O
drug	O	O	B-T061
delivery	O	O	I-T061
and	O	O	O
the	O	O	O
efficacy	O	O	B-T080
of	O	O	O
cancer	O	O	B-T061
therapy	O	O	I-T061
.	O	O	O

Therefore	O	O	O
,	O	O	O
we	O	O	O
now	O	O	O
need	O	O	O
to	O	O	O
identify	O	O	B-T080
safe	O	O	O
and	O	O	O
well	O	O	O
tolerated	O	O	B-T033
pharmaceutical	O	O	B-T121
agents	O	O	I-T121
that	O	O	O
are	O	O	O
able	O	O	O
to	O	O	O
remodel	O	O	O
the	O	O	O
microenvironment	O	O	B-T070
of	O	O	O
solid	O	O	B-T191
tumors	O	O	I-T191
and	O	O	O
enhance	O	O	B-T052
chemotherapy	O	O	B-T061
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
we	O	O	O
repurposed	O	O	O
Pirfenidone	O	O	B-T109
,	O	O	O
a	O	O	O
clinically	O	O	B-T080
approved	O	O	B-T080
anti-fibrotic	O	O	B-T121
drug	O	O	I-T121
for	O	O	O
the	O	O	O
treatment	O	O	B-T061
of	O	O	O
idiopathic	O	O	B-T047
pulmonary	O	O	I-T047
fibrosis	O	O	I-T047
,	O	O	O
to	O	O	O
investigate	O	O	B-T169
its	O	O	O
possible	O	O	O
role	O	O	O
on	O	O	O
tumor	O	O	B-T070
microenvironment	O	O	I-T070
normalization	O	O	B-T061
.	O	O	O

Using	O	O	O
two	O	O	O
orthotopic	O	O	B-T082
mammary	O	O	B-T023
tumor	O	O	B-T170
models	O	O	I-T170
we	O	O	O
demonstrate	O	O	O
that	O	O	O
Pirfenidone	O	O	B-T109
reduces	O	O	B-T081
collagen	O	O	B-T116
and	O	O	O
hyaluronan	O	O	B-T109
levels	O	O	B-T080
and	O	O	O
,	O	O	O
as	O	O	O
a	O	O	O
result	O	O	B-T169
,	O	O	O
significantly	O	O	B-T078
increases	O	O	B-T169
blood	O	O	B-T023
vessel	O	O	I-T023
functionality	O	O	B-T169
and	O	O	O
perfusion	O	O	B-T042
and	O	O	O
improves	O	O	O
the	O	O	O
anti-tumor	O	O	B-T080
efficacy	O	O	I-T080
of	O	O	O
doxorubicin	O	O	B-T195
.	O	O	O

Reduction	O	O	B-T080
of	O	O	O
extracellular	O	O	B-T026
matrix	O	O	I-T026
components	O	O	I-T026
were	O	O	O
mediated	O	O	O
via	O	O	O
TGFÎ²	O	O	B-T169
signaling	O	O	I-T169
pathway	O	O	I-T169
inhibition	O	O	B-T052
due	O	O	O
to	O	O	O
downregulation	O	O	B-T044
of	O	O	O
TGFÎ²1	O	O	B-T028
,	O	O	O
COL1A1	O	O	B-T028
,	O	O	O
COL3A1	O	O	B-T028
,	O	O	O
HAS2	O	O	B-T028
,	O	O	O
HAS3	O	O	B-T028
expression	O	O	B-T045
levels	O	O	B-T080
.	O	O	O

Our	O	O	O
findings	O	O	B-T033
provide	O	O	O
evidence	O	O	B-T078
that	O	O	O
repurposing	O	O	O
Pirfenidone	O	O	B-T109
could	O	O	O
be	O	O	O
used	O	O	O
as	O	O	O
a	O	O	O
promising	O	O	O
strategy	O	O	B-T062
to	O	O	O
enhance	O	O	B-T052
drug	O	O	B-T061
delivery	O	O	I-T061
to	O	O	O
solid	O	O	B-T191
tumors	O	O	I-T191
by	O	O	O
normalizing	O	O	B-T061
the	O	O	O
tumor	O	O	B-T070
microenvironment	O	O	I-T070
.	O	O	O

-DOCSTART- (28447586)

Serum	O	O	B-T031
vascular	O	O	B-T116
endothelial	O	O	I-T116
growth	O	O	I-T116
factor	O	O	I-T116
receptor-3	O	O	I-T116
levels	O	O	B-T081
in	O	O	O
patients	O	O	B-T101
with	O	O	O
esophageal	O	O	O
squamous	O	O	O
cell	O	O	O
cancer	O	O	O

Esophageal	O	O	B-T191
cancer	O	O	I-T191
is	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
most	O	O	O
aggressive	O	O	O
tumors	O	O	B-T191
of	O	O	I-T191
the	O	O	I-T191
gastrointestinal	O	O	I-T191
tract	O	O	I-T191
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	O
,	O	O	O
we	O	O	O
quantified	O	O	O
the	O	O	O
serum	O	O	B-T031
vascular	O	O	B-T116
endothelial	O	O	I-T116
growth	O	O	I-T116
factor-3	O	O	I-T116
(	O	O	O
VEGFR-3	O	O	B-T116
)	O	O	O
expression	O	O	B-T045
in	O	O	O
patients	O	O	B-T101
with	O	O	O
esophageal	O	O	B-T191
squamous	O	O	I-T191
cell	O	O	I-T191
carcinoma	O	O	I-T191
(	O	O	O
ESCC	O	O	B-T191
)	O	O	O
to	O	O	O
evaluate	O	O	O
the	O	O	O
role	O	O	O
of	O	O	O
VEGFR-3	O	O	O
in	O	O	O
ESCC	O	O	O
.	O	O	O

Ninety	O	O	O
five	O	O	O
patients	O	O	B-T101
with	O	O	O
ESCC	O	O	B-T191
were	O	O	O
studied	O	O	O
.	O	O	O

Pre-therapy	O	O	B-T079
and	O	O	O
preoperative	O	O	B-T079
samples	O	O	B-T031
were	O	O	O
stored	O	O	O
and	O	O	O
ELISA	O	O	B-T059
was	O	O	O
used	O	O	O
to	O	O	O
designate	O	O	O
the	O	O	O
concentrations	O	O	O
of	O	O	O
VEGFR-3	O	O	B-T116
.	O	O	O

The	O	O	O
serum	O	O	B-T081
values	O	O	I-T081
of	O	O	O
VEGFR-3	O	O	B-T116
were	O	O	O
significantly	O	O	O
higher	O	O	O
in	O	O	O
patients	O	O	B-T101
with	O	O	O
ESCC	O	O	B-T191
than	O	O	O
in	O	O	O
healthy	O	O	B-T080
donors	O	O	B-T098
(	O	O	O
p<0.0001	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
results	O	O	O
imply	O	O	O
a	O	O	O
very	O	O	O
good	O	O	O
sensitivity	O	O	B-T081
of	O	O	O
VEGFR-3	O	O	B-T116
in	O	O	O
ESCC	O	O	B-T191
.	O	O	O

VEGFR-3	O	O	B-T116
may	O	O	O
be	O	O	O
a	O	O	O
good	O	O	O
diagnostic	O	O	B-T169
biomarker	O	O	B-T201
for	O	O	O
ESCC	O	O	B-T191
.	O	O	O

Biomarker	O	O	B-T201
,	O	O	O
ESCC	O	O	B-T191
,	O	O	O
VEGFR-3	O	O	B-T116
.	O	O	O

-DOCSTART- (28448263)

Zinc	O	O	B-T121
and	O	O	O
Wound	O	O	B-T040
Healing	O	O	I-T040
:	O	O	O
A	O	O	O
Review	O	O	B-T169
of	O	O	I-T169
Zinc	O	O	O
Physiology	O	O	B-T039
and	O	O	O
Clinical	O	O	O
Applications	O	O	O

Our	O	O	O
understanding	O	O	B-T041
of	O	O	O
the	O	O	O
role	O	O	O
of	O	O	O
zinc	O	O	B-T121
in	O	O	O
normal	O	O	O
human	O	O	B-T016
physiology	O	O	B-T039
is	O	O	O
constantly	O	O	B-T080
expanding	O	O	O
,	O	O	O
yet	O	O	O
there	O	O	O
are	O	O	O
major	O	O	O
gaps	O	O	B-T082
in	O	O	O
our	O	O	O
knowledge	O	O	O
with	O	O	O
regard	O	O	O
to	O	O	O
the	O	O	O
function	O	O	B-T169
of	O	O	O
zinc	O	O	O
in	O	O	O
wound	O	O	B-T040
healing	O	O	I-T040
.	O	O	O

This	O	O	O
review	O	O	B-T170
aims	O	O	B-T078
to	O	O	O
provide	O	O	O
the	O	O	O
clinician	O	O	B-T097
with	O	O	O
sufficient	O	O	B-T080
understanding	O	O	O
of	O	O	O
zinc	O	O	B-T121
biology	O	O	B-T091
and	O	O	O
an	O	O	O
up-to-date	O	O	O
perspective	O	O	O
on	O	O	O
the	O	O	O
role	O	O	O
of	O	O	O
zinc	O	O	O
in	O	O	O
wound	O	O	B-T040
healing	O	O	I-T040
.	O	O	O

Zinc	O	O	B-T121
is	O	O	O
an	O	O	O
essential	O	O	O
ion	O	O	B-T196
that	O	O	O
is	O	O	O
crucial	O	O	O
for	O	O	O
maintenance	O	O	O
of	O	O	O
normal	O	O	O
physiology	O	O	B-T039
,	O	O	O
and	O	O	O
zinc	O	O	B-T047
deficiency	O	O	I-T047
has	O	O	O
many	O	O	O
manifestations	O	O	B-T169
ranging	O	O	O
from	O	O	O
delayed	O	O	B-T079
wound	O	O	B-T040
healing	O	O	I-T040
to	O	O	O
immune	O	O	B-T047
dysfunction	O	O	I-T047
and	O	O	O
impairment	O	O	B-T169
of	O	O	O
multiple	O	O	B-T081
sensory	O	O	B-T022
systems	O	O	I-T022
.	O	O	O

While	O	O	O
consensus	O	O	B-T054
has	O	O	O
been	O	O	O
reached	O	O	O
regarding	O	O	O
the	O	O	O
detrimental	O	O	B-T080
effects	O	O	I-T080
of	O	O	O
zinc	O	O	B-T121
deficiency	O	O	I-T047
on	O	O	O
wound	O	O	B-T040
healing	O	O	I-T040
,	O	O	O
there	O	O	O
is	O	O	O
considerable	O	O	O
discord	O	O	B-T054
in	O	O	O
the	O	O	O
literature	O	O	B-T170
on	O	O	O
the	O	O	O
optimal	O	O	B-T170
methods	O	O	I-T170
and	O	O	O
true	O	O	B-T081
benefits	O	O	I-T081
of	O	O	O
zinc	O	O	O
supplementation	O	O	O
.	O	O	O

-DOCSTART- (28450196)

Receipt	O	O	O
of	O	O	O
thyroid	O	O	B-T047
hormone	O	O	I-T047
deficiency	O	O	I-T047
treatment	O	O	B-T061
and	O	O	O
risk	O	O	B-T078
of	O	O	O
herpes	O	O	O
zoster	O	O	O

Thyroid	O	O	B-T116
hormone	O	O	I-T116
(	O	O	O
TH	O	O	B-T116
)	O	O	O
has	O	O	O
been	O	O	O
suggested	O	O	O
to	O	O	O
control	O	O	O
herpes	O	O	B-T005
virus	O	O	I-T005
gene	O	O	B-T045
expression	O	O	I-T045
and	O	O	O
replication	O	O	B-T045
in	O	O	O
neurons	O	O	B-T025
via	O	O	O
epigenetics	O	O	B-T045
through	O	O	O
its	O	O	O
nuclear	O	O	B-T116
receptors	O	O	I-T116
.	O	O	O

It	O	O	O
has	O	O	O
previously	O	O	O
been	O	O	O
shown	O	O	O
that	O	O	O
patients	O	O	B-T101
with	O	O	O
hypothyroidism	O	O	B-T047
are	O	O	O
predisposed	O	O	O
to	O	O	O
herpes	O	O	B-T047
zoster	O	O	I-T047
(	O	O	O
HZ	O	O	B-T047
)	O	O	O
,	O	O	O
suggesting	O	O	O
that	O	O	O
the	O	O	O
TH	O	O	B-T047
deficiency	O	O	I-T047
may	O	O	O
be	O	O	O
a	O	O	O
risk	O	O	B-T033
factor	O	O	I-T033
for	O	O	O
varicella	O	O	B-T005
zoster	O	O	I-T005
virus	O	O	I-T005
(	O	O	O
VZV	O	O	B-T005
)	O	O	O
reactivation	O	O	B-T052
.	O	O	O

The	O	O	O
aim	O	O	B-T078
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
test	O	O	O
the	O	O	O
hypothesis	O	O	B-T078
that	O	O	O
TH	O	O	B-T061
treatment	O	O	I-T061
will	O	O	O
ameliorate	O	O	O
the	O	O	O
complication	O	O	B-T046
of	O	O	O
HZ	O	O	B-T047
.	O	O	O

This	O	O	O
study	O	O	B-T062
investigated	O	O	B-T169
the	O	O	O
hypothesis	O	O	B-T078
by	O	O	O
enquiring	O	O	O
into	O	O	O
a	O	O	O
comprehensive	O	O	B-T170
medical	O	O	I-T170
database	O	O	I-T170
at	O	O	O
Kaiser	O	O	B-T093
Permanente	O	O	I-T093
Southern	O	O	I-T093
California	O	O	I-T093
(	O	O	O
KPSC	O	O	B-T093
)	O	O	O
to	O	O	O
verify	O	O	O
whether	O	O	O
patients	O	O	B-T101
taking	O	O	O
TH	O	O	B-T116
medication	O	O	B-T058
experience	O	O	O
a	O	O	O
reduction	O	O	O
in	O	O	O
HZ	O	O	B-T047
occurrence	O	O	O
.	O	O	O

It	O	O	O
was	O	O	O
shown	O	O	O
by	O	O	O
Kaplan-Meier	O	O	B-T081
analysis	O	O	I-T081
that	O	O	O
hypothyroidism	O	O	B-T047
patients	O	O	B-T101
taking	O	O	O
TH	O	O	B-T116
medicines	O	O	B-T121
had	O	O	O
a	O	O	O
lower	O	O	O
risk	O	O	B-T078
of	O	O	O
HZ	O	O	B-T047
.	O	O	O

The	O	O	O
fully	O	O	O
adjusted	O	O	O
analysis	O	O	B-T062
indicated	O	O	O
that	O	O	O
patients	O	O	B-T101
receiving	O	O	O
medication	O	O	B-T058
for	O	O	O
the	O	O	O
treatment	O	O	B-T061
of	O	O	O
TH	O	O	B-T047
deficiency	O	O	I-T047
exhibited	O	O	O
a	O	O	O
reduced	O	O	O
risk	O	O	B-T078
of	O	O	O
HZ	O	O	B-T047
(	O	O	O
hazard	O	O	B-T081
ratio	O	O	I-T081
0.60	O	O	O
,	O	O	O
95	O	O	O
%	O	O	O
confidence	O	O	B-T081
interval	O	O	I-T081
0.51	O	O	O
-	O	O	O
0.71	O	O	O
)	O	O	O
.	O	O	O

This	O	O	O
lower	O	O	O
risk	O	O	B-T078
of	O	O	O
HZ	O	O	B-T047
was	O	O	O
significant	O	O	O
in	O	O	O
all	O	O	O
age	O	O	B-T100
groups	O	O	I-T100
except	O	O	O
the	O	O	O
18	O	O	O
-	O	O	O
39	O	O	O
years	O	O	B-T079
cohort	O	O	B-T098
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
female	O	O	B-T032
patients	O	O	B-T101
taking	O	O	O
TH	O	O	B-T061
treatment	O	O	I-T061
exhibited	O	O	O
a	O	O	O
lower	O	O	O
risk	O	O	B-T078
than	O	O	O
their	O	O	O
male	O	O	B-T032
counterparts	O	O	O
.	O	O	O

Together	O	O	O
these	O	O	O
findings	O	O	B-T033
support	O	O	O
the	O	O	O
hypothesis	O	O	B-T078
that	O	O	O
a	O	O	O
constant	O	O	O
level	O	O	O
of	O	O	O
TH	O	O	B-T116
will	O	O	O
provide	O	O	O
a	O	O	O
degree	O	O	O
of	O	O	O
protection	O	O	O
from	O	O	O
contracting	O	O	O
HZ	O	O	B-T047
.	O	O	O

More	O	O	O
studies	O	O	B-T062
are	O	O	O
underway	O	O	O
to	O	O	O
evaluate	O	O	B-T058
the	O	O	I-T058
laboratory	O	O	I-T058
data	O	O	I-T058
for	O	O	O
an	O	O	O
analysis	O	O	B-T062
of	O	O	O
hormonal	O	O	B-T080
effects	O	O	B-T080
on	O	O	O
individuals	O	O	B-T098
.	O	O	O

-DOCSTART- (28451941)

Peer	O	O	B-T098
Exclusion	O	O	B-T052
During	O	O	O
the	O	O	O
Pubertal	O	O	B-T033
Transition	O	O	B-T052
:	O	O	O
The	O	O	O
Role	O	O	O
of	O	O	O
Social	O	O	O
Competence	O	O	O

For	O	O	O
some	O	O	O
youth	O	O	B-T100
,	O	O	O
early	O	O	B-T047
puberty	O	O	I-T047
is	O	O	O
accompanied	O	O	O
by	O	O	O
peer	O	O	B-T098
exclusion	O	O	B-T052
.	O	O	O

Yet	O	O	O
early	O	O	B-T079
developers	O	O	B-T098
may	O	O	O
experience	O	O	B-T041
less	O	O	O
peer	O	O	B-T098
exclusion	O	O	B-T052
if	O	O	O
they	O	O	O
have	O	O	O
social	O	O	B-T054
competence	O	O	I-T054
,	O	O	O
which	O	O	O
would	O	O	O
bolster	O	O	B-T169
their	O	O	O
ability	O	O	O
to	O	O	O
develop	O	O	B-T169
and	O	O	O
maintain	O	O	B-T052
positive	O	O	B-T033
relationships	O	O	B-T080
with	O	O	O
their	O	O	O
peers	O	O	B-T098
.	O	O	O

Accordingly	O	O	O
,	O	O	O
the	O	O	O
present	O	O	B-T033
study	O	O	B-T062
tests	O	O	O
whether	O	O	O
pubertal	O	O	B-T033
timing	O	O	B-T079
and	O	O	O
tempo	O	O	B-T079
predicts	O	O	B-T078
decrements	O	O	B-T080
in	O	O	O
children	O	O	B-T100
's	O	O	I-T100
social	O	O	B-T054
competence	O	O	I-T054
and	O	O	O
whether	O	O	O
decrements	O	O	O
in	O	O	O
social	O	O	O
competence	O	O	O
account	O	O	O
for	O	O	O
associations	O	O	B-T080
between	O	O	O
puberty	O	O	B-T039
(	O	O	O
timing	O	O	O
and	O	O	O
tempo	O	O	O
)	O	O	O
and	O	O	O
peer	O	O	B-T098
exclusion	O	O	B-T052
over	O	O	O
time	O	O	B-T079
.	O	O	O

Longitudinal	O	O	B-T062
data	O	O	B-T078
were	O	O	O
drawn	O	O	O
from	O	O	O
1364	O	O	O
families	O	O	B-T099
(	O	O	O
48	O	O	O
%	O	O	O
female	O	O	B-T098
;	O	O	O
76	O	O	O
%	O	O	O
White	O	O	B-T098
;	O	O	O
M	O	O	O
=	O	O	O
9.32	O	O	O
years	O	O	B-T079
,	O	O	O
SD	O	O	O
=	O	O	O
.48	O	O	O
,	O	O	O
at	O	O	O
Wave	O	O	O
3	O	O	O
)	O	O	O
who	O	O	O
participated	O	O	B-T169
in	O	O	O
Waves	O	O	O
3	O	O	O
-	O	O	O
5	O	O	O
(	O	O	O
i.e.	O	O	O
,	O	O	O
grades	O	O	O
4	O	O	O
-	O	O	O
6	O	O	O
)	O	O	O
of	O	O	O
Phase	O	O	B-T062
III	O	O	I-T062
of	O	O	O
the	O	O	O
NICHD	O	O	B-T093
-	O	O	O
SECCYD	O	O	B-T062
.	O	O	O

The	O	O	O
results	O	O	B-T169
from	O	O	O
latent	O	O	B-UnknownType
growth	O	O	I-UnknownType
curve	O	O	I-UnknownType
models	O	O	I-UnknownType
indicated	O	O	O
that	O	O	O
earlier	O	O	B-T079
pubertal	O	O	B-T033
timing	O	O	B-T079
and	O	O	O
more	O	O	O
rapid	O	O	B-T080
pubertal	O	O	O
tempo	O	O	B-T079
among	O	O	O
girls	O	O	B-T100
were	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
high	O	O	B-T080
initial	O	O	B-T079
levels	O	O	B-T080
of	O	O	O
peer	O	O	B-T098
exclusion	O	O	B-T052
.	O	O	O

Moreover	O	O	O
,	O	O	O
mediation	O	O	B-UnknownType
analyses	O	O	I-UnknownType
revealed	O	O	O
that	O	O	O
early	O	O	B-T079
developers	O	O	B-T098
'	O	O	I-T098
susceptibility	O	O	B-T169
to	O	O	O
peer	O	O	B-T098
exclusion	O	O	B-T052
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
their	O	O	O
initial	O	O	B-T079
level	O	O	B-T080
of	O	O	O
social	O	O	B-T054
competence	O	O	I-T054
.	O	O	O

In	O	O	O
boys	O	O	B-T100
,	O	O	O
pubertal	O	O	B-T033
timing	O	O	B-T079
and	O	O	O
tempo	O	O	B-T079
were	O	O	O
not	O	O	O
directly	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
peer	O	O	B-T098
exclusion	O	O	B-T052
;	O	O	O
instead	O	O	O
,	O	O	O
indirect	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
pubertal	O	O	O
timing	O	O	O
on	O	O	O
peer	O	O	O
exclusion	O	O	O
(	O	O	O
intercept	O	O	B-T081
,	O	O	O
slope	O	O	B-T081
)	O	O	O
occurred	O	O	O
through	O	O	O
initial	O	O	B-T079
levels	O	O	B-T080
of	O	O	O
social	O	O	B-T054
competence	O	O	I-T054
.	O	O	O

On	O	O	O
average	O	O	B-T081
,	O	O	O
early	O	O	B-T079
developers	O	O	B-T098
'	O	O	I-T098
who	O	O	O
had	O	O	O
low	O	O	B-T080
levels	O	O	B-T080
of	O	O	O
social	O	O	B-T054
competence	O	O	I-T054
also	O	O	O
had	O	O	O
high	O	O	B-T080
initial	O	O	B-T079
levels	O	O	O
of	O	O	O
peer	O	O	B-T098
exclusion	O	O	B-T052
but	O	O	O
experienced	O	O	B-T041
decrements	O	O	B-T080
in	O	O	O
peer	O	O	O
exclusion	O	O	O
over	O	O	O
time	O	O	O
.	O	O	O

The	O	O	O
association	O	O	B-T080
between	O	O	O
the	O	O	O
intercepts	O	O	B-T081
for	O	O	O
puberty	O	O	B-T039
and	O	O	O
peer	O	O	B-T098
exclusion	O	O	B-T052
and	O	O	O
the	O	O	O
slopes	O	O	B-T081
for	O	O	O
social	O	O	B-T054
competence	O	O	I-T054
and	O	O	O
peer	O	O	O
exclusion	O	O	O
were	O	O	O
stronger	O	O	B-T080
for	O	O	O
boys	O	O	B-T100
than	O	O	O
girls	O	O	B-T100
.	O	O	O

Overall	O	O	O
,	O	O	O
our	O	O	O
findings	O	O	B-T033
suggest	O	O	O
that	O	O	O
early	O	O	B-T079
developers	O	O	B-T098
'	O	O	I-T098
susceptibility	O	O	B-T169
to	O	O	O
and	O	O	O
experiences	O	O	B-T041
of	O	O	O
peer	O	O	B-T098
exclusion	O	O	B-T052
are	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
their	O	O	O
development	O	O	B-T169
of	O	O	O
social	O	O	B-T054
competence	O	O	I-T054
.	O	O	O

-DOCSTART- (28454015)

Air	O	O	B-T069
pollution	O	O	I-T069
characteristics	O	O	B-T080
and	O	O	O
health	O	O	B-T061
risks	O	O	I-T061
in	O	O	O
Henan	O	O	B-T083
Province	O	O	I-T083
,	O	O	O
China	O	O	O

Events	O	O	O
of	O	O	O
severe	O	O	B-T080
air	O	O	B-T069
pollution	O	O	I-T069
occurred	O	O	O
frequently	O	O	O
in	O	O	O
China	O	O	B-T083
recently	O	O	O
,	O	O	O
thus	O	O	O
understanding	O	O	O
of	O	O	O
the	O	O	O
air	O	O	O
pollution	O	O	O
characteristics	O	O	B-T080
and	O	O	O
its	O	O	O
health	O	O	B-T078
risks	O	O	B-T078
is	O	O	O
very	O	O	O
important	O	O	O
.	O	O	O

In	O	O	O
this	O	O	O
work	O	O	O
,	O	O	O
we	O	O	O
analyzed	O	O	O
a	O	O	O
two-year	O	O	O
dataset	O	O	B-T170
(	O	O	O
March	O	O	O
2014	O	O	O
-	O	O	O
February	O	O	O
2016	O	O	O
)	O	O	O
including	O	O	O
daily	O	O	B-T079
concentrations	O	O	B-T081
of	O	O	O
six	O	O	O
criteria	O	O	O
pollutants	O	O	B-T131
(	O	O	O
PM2.5	O	O	B-T167
,	O	O	O
PM10	O	O	B-T167
,	O	O	O
CO	O	O	B-T131
,	O	O	O
SO2	O	O	B-T131
,	O	O	O
NO2	O	O	B-T131
,	O	O	O
and	O	O	O
O3	O	O	B-T103
)	O	O	O
from	O	O	O
18	O	O	O
cities	O	O	O
in	O	O	O
Henan	O	O	B-T083
province	O	O	I-T083
.	O	O	O

Results	O	O	O
reveal	O	O	O
the	O	O	O
serious	O	O	O
air	O	O	B-T069
pollution	O	O	I-T069
status	O	O	B-T080
in	O	O	O
Henan	O	O	B-T083
province	O	O	I-T083
,	O	O	O
especially	O	O	O
the	O	O	O
northern	O	O	B-T082
part	O	O	I-T082
,	O	O	O
and	O	O	O
Zhengzhou	O	O	B-T083
is	O	O	O
the	O	O	O
city	O	O	B-T083
with	O	O	O
the	O	O	O
worst	O	O	B-T080
air	O	O	B-T080
quality	O	O	I-T080
.	O	O	O

Annual	O	O	O
average	O	O	O
PM2.5	O	O	B-T167
concentrations	O	O	B-T081
exceed	O	O	O
the	O	O	O
second	O	O	O
grade	O	O	O
of	O	O	O
Chinese	O	O	B-T081
Ambient	O	O	I-T081
Air	O	O	I-T081
Quality	O	O	I-T081
Standard	O	O	I-T081
(	O	O	O
75Î¼g/m(3	O	O	O
)	O	O	O
)	O	O	O
at	O	O	O
both	O	O	O
2014	O	O	O
and	O	O	O
2015	O	O	O
.	O	O	O

PM2.5	O	O	B-T167
is	O	O	O
typically	O	O	O
the	O	O	O
major	O	O	O
pollutant	O	O	B-T131
,	O	O	O
but	O	O	O
ozone	O	O	B-T103
pollution	O	O	B-T069
can	O	O	O
be	O	O	O
significant	O	O	O
during	O	O	O
summer	O	O	B-T079
.	O	O	O

Furthermore	O	O	O
,	O	O	O
as	O	O	O
the	O	O	O
commonly	O	O	O
used	O	O	O
air	O	O	B-T170
quality	O	O	I-T170
index	O	O	I-T170
(	O	O	O
AQI	O	O	B-T170
)	O	O	O
neglects	O	O	O
the	O	O	O
mutual	O	O	O
health	O	O	B-T078
effects	O	O	O
from	O	O	O
multiple	O	O	O
pollutants	O	O	B-T131
,	O	O	O
we	O	O	O
introduced	O	O	O
the	O	O	O
aggregate	O	O	B-T170
air	O	O	I-T170
quality	O	O	I-T170
index	O	O	I-T170
(	O	O	O
AAQI	O	O	B-T170
)	O	O	O
and	O	O	O
health-risk	O	O	B-T170
based	O	O	I-T170
air	O	O	I-T170
quality	O	O	I-T170
index	O	O	I-T170
(	O	O	O
HAQI	O	O	B-T170
)	O	O	O
to	O	O	O
evaluate	O	O	B-T061
the	O	O	I-T061
health	O	O	I-T061
risks	O	O	I-T061
.	O	O	O

Results	O	O	O
show	O	O	O
that	O	O	O
based	O	O	O
on	O	O	O
HAQI	O	O	B-T170
,	O	O	O
the	O	O	O
current	O	O	O
AQI	O	O	B-T170
system	O	O	O
likely	O	O	O
significantly	O	O	O
underestimate	O	O	O
the	O	O	O
health	O	O	B-T078
risks	O	O	B-T078
of	O	O	O
air	O	O	B-T069
pollution	O	O	I-T069
,	O	O	O
highlighting	O	O	O
that	O	O	O
the	O	O	O
general	O	O	B-T098
public	O	O	I-T098
may	O	O	O
need	O	O	O
stricter	O	O	O
health	O	O	B-T058
protection	O	O	I-T058
measures	O	O	I-T058
.	O	O	O

The	O	O	O
population	O	O	B-T081
-weighted	O	O	O
two-year	O	O	O
average	O	O	O
HAQI	O	O	B-T170
data	O	O	O
further	O	O	O
demonstrates	O	O	O
that	O	O	O
all	O	O	O
population	O	O	O
in	O	O	O
the	O	O	O
studied	O	O	O
cities	O	O	B-T083
in	O	O	O
Henan	O	O	B-T083
province	O	O	I-T083
live	O	O	O
with	O	O	O
polluted	O	O	B-T069
air	O	O	B-T167
-	O	O	O
72	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
population	O	O	O
is	O	O	O
exposed	O	O	B-T080
to	O	O	I-T080
air	O	O	O
that	O	O	O
is	O	O	O
unhealthy	O	O	B-T033
for	O	O	O
sensitive	O	O	B-T169
people	O	O	B-T098
,	O	O	O
while	O	O	O
28	O	O	O
%	O	O	O
of	O	O	O
people	O	O	O
is	O	O	O
exposed	O	O	O
to	O	O	O
air	O	O	O
that	O	O	O
can	O	O	O
be	O	O	O
harmful	O	O	O
to	O	O	O
healthy	O	O	B-T080
people	O	O	O
;	O	O	O
and	O	O	O
the	O	O	O
health	O	O	B-T078
risks	O	O	B-T078
are	O	O	O
much	O	O	O
greater	O	O	O
during	O	O	O
winter	O	O	B-T079
than	O	O	O
during	O	O	O
other	O	O	O
seasons	O	O	B-T079
.	O	O	O

Future	O	O	O
works	O	O	O
should	O	O	O
further	O	O	O
improve	O	O	O
the	O	O	O
HAQI	O	O	B-T170
algorithm	O	O	B-T170
,	O	O	O
and	O	O	O
validate	O	O	O
the	O	O	O
links	O	O	O
between	O	O	O
the	O	O	O
clinical	O	O	B-T170
/	O	O	O
epidemiologic	O	O	B-T169
data	O	O	B-T170
and	O	O	O
the	O	O	O
HAQI	O	O	O
values	O	O	O
.	O	O	O

-DOCSTART- (28456611)

Increased	O	O	B-T081
risk	O	O	B-T078
of	O	O	O
PTLD	O	O	B-T191
in	O	O	O
lung	O	O	B-T033
transplant	O	O	I-T033
recipients	O	O	I-T033
with	O	O	O
cystic	O	O	O
fibrosis	O	O	O

Post-transplant	O	O	B-T191
lymphoproliferative	O	O	I-T191
disease	O	O	I-T191
(	O	O	O
PTLD	O	O	B-T191
)	O	O	O
is	O	O	O
an	O	O	O
important	O	O	O
cause	O	O	O
of	O	O	O
morbidity	O	O	B-T081
and	O	O	O
mortality	O	O	B-T081
following	O	O	O
lung	O	O	B-T061
transplantation	O	O	I-T061
.	O	O	O

Recipients	O	O	B-T101
with	O	O	O
cystic	O	O	B-T047
fibrosis	O	O	I-T047
(	O	O	O
CF	O	O	B-T047
)	O	O	O
may	O	O	O
have	O	O	O
an	O	O	O
increased	O	O	B-T081
risk	O	O	B-T078
of	O	O	O
PTLD	O	O	B-T191
although	O	O	O
the	O	O	O
literature	O	O	B-T170
is	O	O	O
limited	O	O	O
to	O	O	O
single	O	O	B-T098
center	O	O	I-T098
cohorts	O	O	I-T098
.	O	O	O

Our	O	O	O
primary	O	O	O
aim	O	O	O
is	O	O	O
to	O	O	O
examine	O	O	O
PTLD	O	O	B-T191
in	O	O	O
an	O	O	O
adult	O	O	B-T100
lung	O	O	B-T061
transplant	O	O	I-T061
population	O	O	B-T098
by	O	O	O
utilizing	O	O	O
the	O	O	O
International	O	O	B-T170
Society	O	O	I-T170
for	O	O	I-T170
Heart	O	O	I-T170
and	O	O	I-T170
Lung	O	O	I-T170
Transplantation	O	O	I-T170
Registry	O	O	I-T170
.	O	O	O

We	O	O	O
studied	O	O	B-T062
30,598	O	O	O
adult	O	O	B-T100
recipients	O	O	B-T098
of	O	O	O
lung	O	O	B-T061
transplants	O	O	I-T061
performed	O	O	O
between	O	O	O
1999	O	O	O
and	O	O	O
2011	O	O	O
.	O	O	O

The	O	O	O
primary	O	O	O
outcome	O	O	B-T169
was	O	O	O
development	O	O	B-T169
of	O	O	O
and	O	O	O
time	O	O	B-T079
to	O	O	O
PTLD	O	O	B-T191
.	O	O	O

In	O	O	O
addition	O	O	O
to	O	O	O
indication	O	O	O
for	O	O	O
transplant	O	O	B-T061
,	O	O	O
other	O	O	O
predictors	O	O	B-T078
examined	O	O	O
included	O	O	O
Epstein-Barr	O	O	B-T005
virus	O	O	I-T005
(	O	O	O
EBV	O	O	B-T005
)	O	O	O
and	O	O	O
cytomegalovirus	O	O	B-T005
(	O	O	O
CMV	O	O	B-T005
)	O	O	O
serostatus	O	O	B-T201
,	O	O	O
gender	O	O	B-T032
,	O	O	O
and	O	O	O
age	O	O	B-T032
.	O	O	O

Outcomes	O	O	B-T169
were	O	O	O
assessed	O	O	B-T052
with	O	O	O
univariable	O	O	B-T062
and	O	O	O
multivariable	O	O	B-T081
Cox	O	O	I-T081
proportional	O	O	I-T081
hazard	O	O	I-T081
models	O	O	I-T081
to	O	O	O
obtain	O	O	O
hazard	O	O	B-T081
ratios	O	O	I-T081
(	O	O	O
HR	O	O	B-T081
)	O	O	O
.	O	O	O

17	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
cohort	O	O	B-T098
had	O	O	O
a	O	O	O
diagnosis	O	O	B-T033
of	O	O	O
CF	O	O	B-T047
.	O	O	O

PTLD	O	O	B-T191
developed	O	O	O
in	O	O	O
2	O	O	O
%	O	O	O
of	O	O	O
CF	O	O	B-T047
recipients	O	O	B-T101
compared	O	O	O
to	O	O	O
1	O	O	O
%	O	O	O
for	O	O	O
non-CF	O	O	B-T033
recipients	O	O	I-T033
(	O	O	O
p<0.001	O	O	O
)	O	O	O
.	O	O	O

Compared	O	O	O
to	O	O	O
non-CF	O	O	B-T033
recipients	O	O	B-T101
,	O	O	O
CF	O	O	B-T047
recipients	O	O	O
had	O	O	O
higher	O	O	B-T081
prevalence	O	O	I-T081
of	O	O	O
EBV	O	O	B-T005
and	O	O	O
CMV	O	O	B-T005
seronegativity	O	O	I-T034
and	O	O	O
higher	O	O	B-T081
prevalences	O	O	I-T081
of	O	O	O
high	O	O	B-T078
risk	O	O	I-T078
EBV	O	O	O
and	O	O	O
CMV	O	O	O
mismatch	O	O	O
(	O	O	O
D+/R-	O	O	O
)	O	O	O
.	O	O	O

There	O	O	O
is	O	O	O
a	O	O	O
significant	O	O	O
association	O	O	O
between	O	O	O
CF	O	O	B-T047
and	O	O	O
the	O	O	O
development	O	O	B-T169
of	O	O	O
PTLD	O	O	B-T191
[	O	O	O
HR	O	O	B-T081
1.66	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
CI	O	O	O
1.30	O	O	O
-	O	O	O
2.12	O	O	O
)	O	O	O
]	O	O	O
.	O	O	O

Stratified	O	O	B-T081
multivariable	O	O	I-T081
analysis	O	O	I-T081
controlling	O	O	O
for	O	O	O
age	O	O	B-T032
revealed	O	O	O
EBV	O	O	B-T005
negative	O	O	B-T033
non-CF	O	O	B-T033
recipients	O	O	B-T101
have	O	O	O
an	O	O	O
almost	O	O	O
2	O	O	O
fold	O	O	O
increased	O	O	B-T081
risk	O	O	B-T078
of	O	O	O
developing	O	O	O
PTLD	O	O	B-T191
,	O	O	O
whereas	O	O	O
EBV	O	O	O
negative	O	O	O
CF	O	O	B-T047
recipients	O	O	O
had	O	O	O
an	O	O	O
almost	O	O	O
6.5	O	O	O
fold	O	O	O
increased	O	O	O
risk	O	O	O
.	O	O	O

CF	O	O	B-T047
recipients	O	O	B-T101
have	O	O	O
a	O	O	O
higher	O	O	O
risk	O	O	B-T078
for	O	O	O
PTLD	O	O	B-T191
compared	O	O	O
to	O	O	O
non-CF	O	O	B-T033
recipients	O	O	I-T033
.	O	O	O

Further	O	O	O
studies	O	O	B-T062
are	O	O	O
needed	O	O	O
to	O	O	O
account	O	O	O
for	O	O	O
additional	O	O	O
risk	O	O	B-T033
factors	O	O	I-T033
and	O	O	O
management	O	O	B-T058
in	O	O	O
this	O	O	O
population	O	O	B-T033
post-transplant	O	O	I-T033
.	O	O	O

-DOCSTART- (28456751)

Methods	O	O	B-T170
,	O	O	O
tools	O	O	B-UnknownType
and	O	O	O
current	O	O	B-T079
perspectives	O	O	B-T078
in	O	O	O
proteogenomics	O	O	O

With	O	O	O
combined	O	O	O
technological	O	O	B-UnknownType
advancements	O	O	I-UnknownType
in	O	O	O
high-throughput	O	O	B-T063
next-generation	O	O	I-T063
sequencing	O	O	I-T063
and	O	O	O
deep	O	O	B-T059
mass	O	O	I-T059
spectrometry	O	O	I-T059
-based	O	O	O
proteomics	O	O	B-T091
,	O	O	O
proteogenomics	O	O	B-T091
,	O	O	O
i.e.	O	O	O
,	O	O	O
the	O	O	O
integrative	O	O	B-T062
analysis	O	O	I-T062
of	O	O	O
proteomic	O	O	B-T078
and	O	O	I-T078
genomic	O	O	I-T078
data	O	O	I-T078
,	O	O	O
has	O	O	O
emerged	O	O	O
as	O	O	O
a	O	O	O
new	O	O	O
research	O	O	B-UnknownType
field	O	O	I-UnknownType
.	O	O	O

Early	O	O	O
efforts	O	O	O
in	O	O	O
the	O	O	O
field	O	O	B-UnknownType
were	O	O	O
focused	O	O	O
on	O	O	O
improving	O	O	O
protein	O	O	B-T116
identification	O	O	B-T080
using	O	O	O
sample-specific	O	O	B-T170
genomic	O	O	I-T170
and	O	O	O
transcriptomic	O	O	B-T170
sequencing	O	O	I-T170
data	O	O	I-T170
.	O	O	O

More	O	O	O
recently	O	O	O
,	O	O	O
integrative	O	O	B-T062
analysis	O	O	I-T062
of	O	O	O
quantitative	O	O	B-T081
measurements	O	O	B-T169
from	O	O	O
genomic	O	O	B-T062
and	O	O	I-T062
proteomic	O	O	I-T062
studies	O	O	I-T062
have	O	O	O
identified	O	O	B-T080
novel	O	O	O
insights	O	O	O
into	O	O	O
gene	O	O	B-T045
expression	O	O	I-T045
regulation	O	O	I-T045
,	O	O	O
cell	O	O	B-T043
signaling	O	O	I-T043
,	O	O	O
and	O	O	O
disease	O	O	B-T047
.	O	O	O

Many	O	O	O
methods	O	O	B-T170
and	O	O	O
tools	O	O	B-UnknownType
have	O	O	O
been	O	O	O
developed	O	O	O
or	O	O	O
adapted	O	O	O
to	O	O	O
enable	O	O	O
an	O	O	O
array	O	O	B-T082
of	O	O	O
integrative	O	O	B-T169
proteogenomic	O	O	I-T169
approaches	O	O	I-T169
and	O	O	O
in	O	O	O
this	O	O	O
article	O	O	B-T170
,	O	O	O
we	O	O	O
systematically	O	O	B-T169
classify	O	O	B-T185
published	O	O	B-T057
methods	O	O	O
and	O	O	O
tools	O	O	O
into	O	O	O
four	O	O	O
major	O	O	B-T185
categories	O	O	I-T185
,	O	O	O
(	O	O	O
1	O	O	O
)	O	O	O
Sequence	O	O	B-T091
-centric	O	O	I-T091
proteogenomics	O	O	I-T091
;	O	O	O
(	O	O	O
2	O	O	O
)	O	O	O
Analysis	O	O	B-T062
of	O	O	O
proteogenomic	O	O	B-T080
relationships	O	O	I-T080
;	O	O	O
(	O	O	O
3	O	O	O
)	O	O	O
Integrative	O	O	B-T062
modeling	O	O	I-T062
of	O	O	O
proteogenomic	O	O	B-T078
data	O	O	I-T078
;	O	O	O
and	O	O	O
(	O	O	O
4	O	O	O
)	O	O	O
Data	O	O	B-T054
sharing	O	O	I-T054
and	O	O	O
visualization	O	O	B-T041
.	O	O	O

We	O	O	O
provide	O	O	O
a	O	O	O
comprehensive	O	O	B-T080
review	O	O	B-T169
of	O	O	I-T169
methods	O	O	B-T170
and	O	O	O
available	O	O	B-T169
tools	O	O	B-UnknownType
in	O	O	O
each	O	O	O
category	O	O	B-T170
and	O	O	O
highlight	O	O	O
their	O	O	O
typical	O	O	B-T080
applications	O	O	B-T169
.	O	O	O

-DOCSTART- (28457334)

Plasma	O	O	B-T031
DNA	O	O	B-T114
and	O	O	O
RNA	O	O	B-T114
differentially	O	O	B-T080
impact	O	O	B-T080
coagulation	O	O	B-T042
during	O	O	O
abdominal	O	O	B-T047
sepsis	O	O	I-T047
-an	O	O	O
explorative	O	O	O
study	O	O	O

Cell-free	O	O	B-T114
DNA	O	O	I-T114
(	O	O	O
cfDNA	O	O	B-T114
)	O	O	O
and	O	O	O
extracellular	O	O	B-T026
RNA	O	O	B-T114
(	O	O	O
exRNA	O	O	B-T114
)	O	O	O

are	O	O	O
both	O	O	O
suspected	O	O	B-T078
to	O	O	O
activate	O	O	B-T169
coagulation	O	O	B-T047
cascades	O	O	I-T047
in	O	O	O
sepsis	O	O	B-T047
.	O	O	O

Therefore	O	O	O
,	O	O	O
our	O	O	O
study	O	O	B-T062
investigated	O	O	B-T169
the	O	O	O
influence	O	O	B-T077
of	O	O	O
plasmatic	O	O	B-T031
nucleic	O	O	B-T114
acids	O	O	I-T114
on	O	O	O
coagulation	O	O	B-T042
in	O	O	O
septic	O	O	B-T169
patients	O	O	B-T101
in	O	O	O
comparison	O	O	B-T052
to	O	O	O
patients	O	O	O
after	O	O	O
major	O	O	O
abdominal	O	O	B-T061
surgery	O	O	I-T061
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
15	O	O	O
patients	O	O	B-T101
with	O	O	O
sepsis	O	O	B-T047
,	O	O	O
10	O	O	O
postoperative	O	O	B-T079
patients	O	O	O
,	O	O	O
and	O	O	O
10	O	O	O
healthy	O	O	B-T098
volunteers	O	O	I-T098
were	O	O	O
included	O	O	B-T169
in	O	O	O
this	O	O	O
longitudinal	O	O	B-T062
study	O	O	I-T062
.	O	O	O

Blood	O	O	B-T031
was	O	O	O
collected	O	O	B-T078
at	O	O	O
sepsis	O	O	B-T047
onset	O	O	B-T079
and	O	O	O
after	O	O	O
surgery	O	O	B-T061
respectively	O	O	O
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
after	O	O	O
24	O	O	O
,	O	O	O
72	O	O	O
and	O	O	O
168	O	O	O
h.	O	O	O
Levels	O	O	B-T080
of	O	O	O
cfDNA	O	O	B-T114
and	O	O	O
exRNA	O	O	B-T114
were	O	O	O
measured	O	O	B-T080
by	O	O	O
quantitative	O	O	B-T081
probe-based	O	O	B-T074
polymerase	O	O	B-T063
chain	O	O	I-T063
reaction	O	O	I-T063
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
thromboelastography	O	O	B-T059
for	O	O	O
coagulation	O	O	B-T042
as	O	O	O
well	O	O	O
as	O	O	O
thromboaggregometry	O	O	B-T059
for	O	O	O
platelet	O	O	B-T043
function	O	O	I-T043
was	O	O	O
conducted	O	O	O
.	O	O	O

Both	O	O	O
cfDNA	O	O	B-T114
and	O	O	O
exRNA	O	O	B-T114
were	O	O	O
elevated	O	O	B-T080
in	O	O	O
patients	O	O	B-T101
with	O	O	O
sepsis	O	O	B-T047
compared	O	O	B-T052
with	O	O	O
postoperative	O	O	B-T079
patients	O	O	O
and	O	O	O
healthy	O	O	B-T098
volunteers	O	O	I-T098
.	O	O	O

While	O	O	O
higher	O	O	B-T080
exRNA	O	O	B-T114
levels	O	O	B-T080
correlated	O	O	B-T080
with	O	O	O
a	O	O	O
faster	O	O	B-T034
clotting	O	O	I-T034
time	O	O	I-T034
and	O	O	O
more	O	O	O
stable	O	O	B-T046
clots	O	O	I-T046
,	O	O	O
cfDNA	O	O	B-T114
correlated	O	O	O
with	O	O	O
a	O	O	O
shorter	O	O	B-T034
clotting	O	O	I-T034
time	O	O	I-T034
but	O	O	O
also	O	O	O
less	O	O	O
fibrinolysis	O	O	B-T039
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
higher	O	O	B-T080
cfDNA	O	O	B-T114
seems	O	O	O
to	O	O	O
be	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
kidney	O	O	B-T046
dysfunction	O	O	I-T046
as	O	O	O
well	O	O	O
as	O	O	O
with	O	O	O
general	O	O	O
markers	O	O	B-T201
of	O	O	O
cell	O	O	B-T049
damage	O	O	I-T049
(	O	O	O
lactate	O	O	B-T109
dehydrogenase	O	O	I-T116
and	O	O	O
lactate	O	O	O
)	O	O	O
.	O	O	O

Both	O	O	O
nucleic	O	O	B-T114
acid	O	O	I-T114
species	O	O	O
might	O	O	O
be	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
different	O	O	B-T080
effects	O	O	B-T080
on	O	O	O
coagulation	O	O	B-T042
during	O	O	O
sepsis	O	O	B-T047
,	O	O	O
with	O	O	O
an	O	O	O
overall	O	O	B-T080
procoagulatory	O	O	B-T042
influence	O	O	B-T077
.	O	O	O

For	O	O	O
this	O	O	O
reason	O	O	O
,	O	O	O
individualized	O	O	B-T080
therapeutic	O	O	B-T061
approaches	O	O	I-T061
in	O	O	O
patients	O	O	B-T101
suffering	O	O	B-T184
from	O	O	O
coagulation	O	O	B-T042
-	O	O	O
associated	O	O	B-T033
organ	O	O	B-T047
dysfunction	O	O	I-T047
might	O	O	O
be	O	O	O
feasible	O	O	O
.	O	O	O

-DOCSTART- (28459029)

Association	O	O	B-T080
of	O	O	O
Fat	O	O	B-T032
Mass	O	O	I-T032
and	O	O	O
Obesity	O	O	B-T047
-	O	O	O
associated	O	O	B-T080
Gene	O	O	B-T028
Variant	O	O	I-T028
with	O	O	O
Lifestyle	O	O	B-T054
Factors	O	O	B-T169
and	O	O	O
Body	O	O	B-T201
Fat	O	O	I-T201
in	O	O	O
Indian	O	O	B-T098
Children	O	O	O

Common	O	O	O
intronic	O	O	B-T028
variants	O	O	I-T028
of	O	O	O
the	O	O	O
fat	O	O	B-T032
mass	O	O	I-T032
and	O	O	O
obesity	O	O	B-T047
-	O	O	O
associated	O	O	B-T080
(	O	O	B-T028
FTO	O	O	I-T028
)	O	O	I-T028
gene	O	O	I-T028
have	O	O	O
been	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
obesity	O	O	O
-related	O	O	O
traits	O	O	B-T032
in	O	O	O
humans	O	O	B-T016
.	O	O	O

(	O	O	O
1	O	O	O
)	O	O	O
The	O	O	O
aim	O	O	O
of	O	O	O
this	O	O	O
study	O	O	B-T062
is	O	O	O
to	O	O	O
study	O	O	O
the	O	O	O
distribution	O	O	O
of	O	O	O
FTO	O	O	B-T028
gene	O	O	I-T028
variants	O	O	B-T028
across	O	O	O
different	O	O	O
body	O	O	B-T201
mass	O	O	I-T201
index	O	O	I-T201
(	O	O	O
BMI	O	O	B-T201
)	O	O	O
categories	O	O	O
and	O	O	O
(	O	O	O
2	O	O	O
)	O	O	O
to	O	O	O
explore	O	O	O
the	O	O	O
association	O	O	B-T080
between	O	O	O
FTO	O	O	O
gene	O	O	O
variants	O	O	O
and	O	O	O
lifestyle	O	O	B-T054
factors	O	O	B-T169
in	O	O	O
obese	O	O	B-T047
and	O	O	O
normal	O	O	B-T033
weight	O	O	I-T033
Indian	O	O	B-T098
children	O	O	B-T100
.	O	O	O

Fifty-six	O	O	O
children	O	O	B-T100
(	O	O	O
26	O	O	O
boys	O	O	B-T100
,	O	O	O
mean	O	O	O
age	O	O	B-T032
10.3	O	O	O
Â±	O	O	O
2.2	O	O	O
years	O	O	B-T079
)	O	O	O
were	O	O	O
studied	O	O	B-T062
.	O	O	O

Height	O	O	B-T032
,	O	O	O
weight	O	O	B-T032
,	O	O	O
and	O	O	O
waist	O	O	B-T201
and	O	O	O
hip	O	O	B-T201
circumference	O	O	I-T201
were	O	O	O
measured	O	O	B-T080
.	O	O	O

Physical	O	O	B-T056
activity	O	O	I-T056
(	O	O	O
questionnaire	O	O	B-T170
)	O	O	O
and	O	O	O
food	O	O	B-T168
intake	O	O	B-T169
(	O	O	O
food	O	O	B-T170
frequency	O	O	I-T170
questionnaire	O	O	I-T170
)	O	O	O
were	O	O	O
assessed	O	O	B-T052
.	O	O	O

Body	O	O	B-T201
fat	O	O	I-T201
percentage	O	O	I-T201
(	O	O	O
%	O	O	B-T201
BF	O	O	I-T201
)	O	O	O
was	O	O	O
measured	O	O	O
by	O	O	O
dual-energy	O	O	B-T060
X-ray	O	O	I-T060
absorptiometry	O	O	I-T060
.	O	O	O

FTO	O	O	B-T028
allelic	O	O	I-T028
variants	O	O	I-T028
at	O	O	O
rs9939609	O	O	B-T082
site	O	O	I-T082
were	O	O	O
detected	O	O	O
by	O	O	O
SYBR	O	O	B-T063
Green	O	O	I-T063
Amplification	O	O	I-T063
Refractory	O	O	I-T063
Mutation	O	O	I-T063
System	O	O	I-T063
real-time	O	O	I-T063
polymerase	O	O	I-T063
chain	O	O	I-T063
reaction	O	O	I-T063
using	O	O	O
allele	O	O	B-T028
-	O	O	O
specific	O	O	B-T080
primers	O	O	B-T114
.	O	O	O

Generalized	O	O	B-T081
linear	O	O	I-T081
model	O	O	I-T081
was	O	O	O
used	O	O	O
to	O	O	O
investigate	O	O	B-T169
the	O	O	O
simultaneous	O	O	B-T079
influence	O	O	B-T077
of	O	O	O
genetic	O	O	B-T169
and	O	O	O
lifestyle	O	O	B-T054
factors	O	O	B-T169
on	O	O	O
%	O	O	B-T201
BF	O	O	I-T201
.	O	O	O

Mean	O	O	O
height	O	O	B-T032
,	O	O	O
weight	O	O	B-T032
,	O	O	O
and	O	O	O
BMI	O	O	B-T201
of	O	O	O
normal	O	O	B-T080
and	O	O	O
obese	O	O	B-T047
children	O	O	B-T100
were	O	O	O
130.6	O	O	O
Â±	O	O	O
7.1	O	O	O
versus	O	O	O
143.2	O	O	O
Â±	O	O	O
15.6	O	O	O
,	O	O	O
24.0	O	O	O
Â±	O	O	O
5.2	O	O	O
versus	O	O	O
53.1	O	O	O
Â±	O	O	O
15.8	O	O	O
,	O	O	O
and	O	O	O
13.9	O	O	O
Â±	O	O	O
2.1	O	O	O
versus	O	O	O
25.3	O	O	O
Â±	O	O	O
3.2	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

The	O	O	O
frequency	O	O	O
of	O	O	O
AA	O	O	B-T028
allele	O	O	I-T028
was	O	O	O
57	O	O	O
%	O	O	O
among	O	O	O
obese	O	O	B-T047
children	O	O	B-T100
and	O	O	O
35	O	O	O
%	O	O	O
in	O	O	O
normal	O	O	B-T033
weight	O	O	I-T033
children	O	O	O
.	O	O	O

Children	O	O	B-T100
with	O	O	O
the	O	O	O
AA	O	O	B-T028
allele	O	O	I-T028
who	O	O	O
were	O	O	O
obese	O	O	B-T047
had	O	O	O
least	O	O	O
physical	O	O	B-T056
activity	O	O	I-T056
,	O	O	O
whereas	O	O	O
children	O	O	B-T100
with	O	O	O
AT	O	O	B-T028
allele	O	O	I-T028
and	O	O	O
obesity	O	O	B-T047
had	O	O	O
the	O	O	O
highest	O	O	B-T080
intake	O	O	B-T081
of	O	O	I-T081
calories	O	O	I-T081
when	O	O	O
compared	O	O	B-T052
to	O	O	O
children	O	O	O
who	O	O	O
had	O	O	O
AT	O	O	O
allele	O	O	O
and	O	O	O
were	O	O	O
normal	O	O	B-T080
.	O	O	O

%	O	O	B-T201
BF	O	O	I-T201
was	O	O	O
positively	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
AA	O	O	B-T028
alleles	O	O	I-T028
and	O	O	O
junk	O	O	B-T168
food	O	O	B-T168
intake	O	O	B-T169
and	O	O	O
negatively	O	O	O
with	O	O	O
healthy	O	O	B-T080
food	O	O	O
intake	O	O	O
and	O	O	O
moderate	O	O	O
physical	O	O	B-T056
activity	O	O	I-T056
.	O	O	O

Healthy	O	O	B-T055
lifestyle	O	O	I-T055
with	O	O	O
high	O	O	O
physical	O	O	B-T056
activity	O	O	I-T056
and	O	O	O
diet	O	O	B-T168
low	O	O	B-T080
in	O	O	O
calories	O	O	B-T081
and	O	O	O
fat	O	O	B-T109
may	O	O	O
help	O	O	O
in	O	O	O
modifying	O	O	B-T169
the	O	O	O
risk	O	O	B-T078
imposed	O	O	O
by	O	O	O
FTO	O	O	B-T028
variants	O	O	I-T028
in	O	O	O
children	O	O	B-T100
.	O	O	O

-DOCSTART- (28459124)

Museum	O	O	B-T073
specimen	O	O	B-T167
data	O	O	B-T078
reveal	O	O	O
emergence	O	O	O
of	O	O	O
a	O	O	O
plant	O	O	B-T047
disease	O	O	I-T047
may	O	O	O
be	O	O	O
linked	O	O	O
to	O	O	O
increases	O	O	B-T169
in	O	O	O
the	O	O	O
insect	O	O	B-T204
vector	O	O	I-T204
population	O	O	O

The	O	O	O
emergence	O	O	B-T081
rate	O	O	I-T081
of	O	O	O
new	O	O	O
plant	O	O	B-T047
diseases	O	O	I-T047
is	O	O	O
increasing	O	O	B-T169
due	O	O	O
to	O	O	O
novel	O	O	O
introductions	O	O	O
,	O	O	O
climate	O	O	B-T070
change	O	O	I-T070
,	O	O	O
and	O	O	O
changes	O	O	B-T169
in	O	O	O
vector	O	O	B-T098
populations	O	O	I-T098
,	O	O	O
posing	O	O	O
risks	O	O	B-T078
to	O	O	O
agricultural	O	O	B-T090
sustainability	O	O	O
.	O	O	O

Assessing	O	O	B-T052
and	O	O	I-T052
managing	O	O	I-T052
future	O	O	O
disease	O	O	B-T047
risks	O	O	B-T078
depends	O	O	O
on	O	O	O
understanding	O	O	O
the	O	O	O
causes	O	O	O
of	O	O	O
contemporary	O	O	B-T051
and	O	O	I-T051
historical	O	O	I-T051
emergence	O	O	I-T051
events	O	O	I-T051
.	O	O	O

Since	O	O	O
the	O	O	O
mid-1990s	O	O	O
,	O	O	O
potato	O	O	B-T097
growers	O	O	I-T097
in	O	O	O
the	O	O	O
western	O	O	B-T083
United	O	O	I-T083
States	O	O	I-T083
,	O	O	O
Mexico	O	O	B-T083
,	O	O	O
and	O	O	O
Central	O	O	B-T083
America	O	O	I-T083
have	O	O	O
experienced	O	O	O
severe	O	O	O
yield	O	O	B-T081
loss	O	O	I-T081
from	O	O	O
Zebra	O	O	B-T047
Chip	O	O	I-T047
disease	O	O	I-T047
and	O	O	O
have	O	O	O
responded	O	O	O
by	O	O	O
increasing	O	O	O
insecticide	O	O	B-T131
use	O	O	O
to	O	O	O
suppress	O	O	O
populations	O	O	B-T098
of	O	O	O
the	O	O	O
insect	O	O	B-T204
vector	O	O	I-T204
,	O	O	O
the	O	O	O
potato	O	O	B-T204
psyllid	O	O	I-T204
,	O	O	O
Bactericera	O	O	B-T204
cockerelli	O	O	I-T204
(	O	O	O
Hemiptera	O	O	B-T204
:	O	O	O
Triozidae	O	O	B-T204
)	O	O	O
.	O	O	O

Despite	O	O	O
the	O	O	O
severe	O	O	O
nature	O	O	O
of	O	O	O
Zebra	O	O	B-T047
Chip	O	O	I-T047
outbreaks	O	O	B-T067
,	O	O	O
the	O	O	O
causes	O	O	O
of	O	O	O
emergence	O	O	O
remain	O	O	O
unknown	O	O	O
.	O	O	O

We	O	O	O
tested	O	O	O
the	O	O	O
hypotheses	O	O	B-T078
that	O	O	O
1	O	O	O
)	O	O	O
B.	O	O	B-T204
cockerelli	O	O	I-T204
occupancy	O	O	B-T080
has	O	O	O
increased	O	O	B-T081
over	O	O	O
the	O	O	O
last	O	O	O
century	O	O	B-T127
in	O	O	O
California	O	O	B-T083
and	O	O	O
2	O	O	O
)	O	O	O
such	O	O	O
increases	O	O	O
are	O	O	O
related	O	O	O
to	O	O	O
climate	O	O	B-T070
change	O	O	I-T070
,	O	O	O
specifically	O	O	O
warmer	O	O	B-T079
winters	O	O	I-T079
.	O	O	O

We	O	O	O
compiled	O	O	O
a	O	O	O
dataset	O	O	B-T170
of	O	O	O
87,000	O	O	O
museum	O	O	B-T073
specimen	O	O	B-T167
occurrence	O	O	O
records	O	O	B-T170
across	O	O	O
the	O	O	O
order	O	O	O
Hemiptera	O	O	B-T204
collected	O	O	O
between	O	O	O
1900	O	O	O
and	O	O	O
2014	O	O	O
.	O	O	O

We	O	O	O
then	O	O	O
analyzed	O	O	B-T062
changes	O	O	O
in	O	O	O
B.	O	O	B-T204
cockerelli	O	O	I-T204
distribution	O	O	O
using	O	O	O
a	O	O	O
hierarchical	O	O	B-T170
occupancy	O	O	I-T170
model	O	O	I-T170
using	O	O	O
changes	O	O	O
in	O	O	O
background	O	O	O
species	O	O	B-T185
lists	O	O	O
to	O	O	O
correct	O	O	O
for	O	O	O
collecting	O	O	O
effort	O	O	O
.	O	O	O

We	O	O	O
found	O	O	O
evidence	O	O	B-T078
that	O	O	O
B.	O	O	B-T204
cockerelli	O	O	I-T204
occupancy	O	O	B-T080
has	O	O	O
increased	O	O	B-T081
over	O	O	O
the	O	O	O
last	O	O	O
century	O	O	B-T127
.	O	O	O

However	O	O	O
,	O	O	O
these	O	O	O
changes	O	O	O
appear	O	O	O
to	O	O	O
be	O	O	O
unrelated	O	O	O
to	O	O	O
climate	O	O	B-T070
changes	O	O	I-T070
,	O	O	O
at	O	O	O
least	O	O	O
at	O	O	O
the	O	O	O
scale	O	O	O
of	O	O	O
our	O	O	O
analysis	O	O	B-T062
.	O	O	O

To	O	O	O
the	O	O	O
extent	O	O	O
that	O	O	O
species	O	O	B-T185
occupancy	O	O	B-T080
is	O	O	O
related	O	O	O
to	O	O	O
abundance	O	O	O
,	O	O	O
our	O	O	O
analysis	O	O	B-T062
provides	O	O	O
the	O	O	O
first	O	O	O
quantitative	O	O	O
support	O	O	O
for	O	O	O
the	O	O	O
hypothesis	O	O	B-T078
that	O	O	O
B.	O	O	B-T204
cockerelli	O	O	I-T204
population	O	O	B-T098
abundance	O	O	O
has	O	O	O
increased	O	O	B-T081
,	O	O	O
but	O	O	O
further	O	O	O
work	O	O	O
is	O	O	O
needed	O	O	O
to	O	O	O
link	O	O	O
B.	O	O	O
cockerelli	O	O	O
population	O	O	O
dynamics	O	O	B-T070
to	O	O	O
Zebra	O	O	B-T047
Chip	O	O	I-T047
epidemics	O	O	O
.	O	O	O

Finally	O	O	O
,	O	O	O
we	O	O	O
demonstrate	O	O	O
how	O	O	O
this	O	O	O
historical	O	O	B-T082
macro-ecological	O	O	I-T082
approach	O	O	I-T082
provides	O	O	O
a	O	O	O
general	O	O	O
framework	O	O	O
for	O	O	O
comparative	O	O	B-T058
risk	O	O	I-T058
assessment	O	O	I-T058
of	O	O	O
future	O	O	O
pest	O	O	B-T204
and	O	O	O
insect	O	O	B-T204
vector	O	O	I-T204
outbreaks	O	O	B-T067
.	O	O	O

This	O	O	O
article	O	O	O
is	O	O	O
protected	O	O	O
by	O	O	O
copyright	O	O	O
.	O	O	O

All	O	O	O
rights	O	O	O
reserved	O	O	O
.	O	O	O

-DOCSTART- (28460054)

Effect	O	O	B-T080
of	O	O	O
halotolerant	O	O	B-T007
rhizobacteria	O	O	I-T007
isolated	O	O	B-T169
from	O	O	O
halophytes	O	O	B-T002
on	O	O	O
the	O	O	O
growth	O	O	B-T040
of	O	O	O
sugar	O	O	B-T002
beet	O	O	I-T002
(	O	O	O
Beta	O	O	B-T002
vulgaris	O	O	I-T002
L	O	O	I-T002
.	O	O	O
)	O	O	O
under	O	O	O
salt	O	O	O
stress	O	O	O

Utilization	O	O	B-T169
of	O	O	O
rhizobacteria	O	O	B-T007
that	O	O	O
have	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
plant	O	O	B-T002
roots	O	O	I-T002
in	O	O	O
harsh	O	O	B-T033
environments	O	O	B-T082
could	O	O	O
be	O	O	O
a	O	O	O
feasible	O	O	B-T062
strategy	O	O	I-T062
to	O	O	O
deal	O	O	O
with	O	O	O
limits	O	O	O
to	O	O	O
agricultural	O	O	B-T090
production	O	O	I-T090
caused	O	O	O
by	O	O	O
soil	O	O	B-T167
salinity	O	O	B-T034
.	O	O	O

Halophytes	O	O	B-T002
occur	O	O	O
naturally	O	O	O
in	O	O	O
high	O	O	B-T080
-	O	O	O
salt	O	O	B-T082
environments	O	O	I-T082
,	O	O	O
and	O	O	O
their	O	O	O
roots	O	O	B-T002
may	O	O	O
be	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
promising	O	O	O
microbial	O	O	B-T001
candidates	O	O	I-T001
for	O	O	O
promoting	O	O	B-T052
growth	O	O	B-T040
and	O	O	O
salt	O	O	B-T043
tolerance	O	O	I-T043
in	O	O	O
crops	O	O	B-T002
.	O	O	O

This	O	O	O
study	O	O	B-T062
aimed	O	O	O
to	O	O	O
isolate	O	O	B-T169
efficient	O	O	O
halotolerant	O	O	B-T002
plant	O	O	I-T002
-	O	O	O
growth	O	O	B-T040
-	O	O	O
promoting	O	O	B-T052
rhizobacterial	O	O	B-T080
strains	O	O	B-T001
from	O	O	O
halophytes	O	O	B-T002
and	O	O	O
evaluate	O	O	B-T052
their	O	O	O
activity	O	O	B-T052
and	O	O	O
effects	O	O	B-T080
on	O	O	O
sugar	O	O	B-T002
beet	O	O	I-T002
(	O	O	O
Beta	O	O	B-T002
vulgaris	O	O	I-T002
L	O	O	I-T002
.	O	O	O
)	O	O	O
growth	O	O	O
under	O	O	O
salinity	O	O	B-T043
stress	O	O	I-T043
.	O	O	O

A	O	O	O
total	O	O	O
of	O	O	O
23	O	O	O
isolates	O	O	B-T123
were	O	O	O
initially	O	O	O
screened	O	O	O
for	O	O	O
their	O	O	O
ability	O	O	B-T032
to	O	O	O
secrete	O	O	O
1-aminocyclopropane-1-carboxylate	O	O	B-T116
deaminase	O	O	I-T116
(	O	O	O
ACD	O	O	B-T116
)	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
other	O	O	O
plant-growth	O	O	B-T040
-	O	O	O
promoting	O	O	B-T052
characteristics	O	O	B-T080
and	O	O	O
subsequently	O	O	O
identified	O	O	B-T080
by	O	O	O
sequencing	O	O	B-T169
the	O	O	O
16S	O	O	B-T114
rRNA	O	O	I-T114
gene	O	O	B-T028
.	O	O	O

Three	O	O	O
isolates	O	O	B-T123
,	O	O	O
identified	O	O	O
as	O	O	O
Micrococcus	O	O	B-T007
yunnanensis	O	O	I-T007
,	O	O	O
Planococcus	O	O	B-T007
rifietoensis	O	O	I-T007
and	O	O	O
Variovorax	O	O	B-T007
paradoxus	O	O	I-T007
,	O	O	O
enhanced	O	O	B-T052
salt	O	O	B-T043
stress	O	O	B-T033
tolerance	O	O	B-T080
remarkably	O	O	O
in	O	O	O
sugar	O	O	B-T002
beet	O	O	I-T002
,	O	O	O
resulting	O	O	B-T169
in	O	O	I-T169
greater	O	O	B-T081
seed	O	O	B-T040
germination	O	O	I-T040
and	O	O	O
plant	O	O	B-T002
biomass	O	O	B-T081
,	O	O	O
higher	O	O	B-T080
photosynthetic	O	O	B-T070
capacity	O	O	B-T081
and	O	O	O
lower	O	O	B-T080
stress	O	O	O
-	O	O	O
induced	O	O	B-T169
ethylene	O	O	B-T109
production	O	O	B-T169
at	O	O	O
different	O	O	B-T080
NaCl	O	O	B-T121
concentrations	O	O	B-T081
(	O	O	O
50	O	O	O
-	O	O	O
125	O	O	O
mM	O	O	O
)	O	O	O
.	O	O	O

These	O	O	O
results	O	O	B-T169
demonstrate	O	O	O
that	O	O	O
salinity	O	O	B-T034
-	O	O	O
adapted	O	O	B-T038
,	O	O	O
ACD	O	O	B-T116
-producing	O	O	O
bacteria	O	O	B-T007
isolated	O	O	B-T169
from	O	O	O
halophytes	O	O	B-T002
could	O	O	O
promote	O	O	B-T052
sugar	O	O	B-T002
beet	O	O	I-T002
growth	O	O	B-T040
under	O	O	O
saline	O	O	B-T043
stress	O	O	I-T043
conditions	O	O	I-T043
.	O	O	O

-DOCSTART- (28461000)

Potential	O	O	B-T080
Sunitinib	O	O	B-T109
-	O	O	O
Induced	O	O	B-T169
Coronary	O	O	B-T023
Artery	O	O	I-T023
and	O	O	O
Aortic	O	O	O
Dissections	O	O	O

Small-molecule	O	O	B-T061
multitargeted	O	O	I-T061
tyrosine	O	O	I-T061
kinase	O	O	I-T061
inhibitor	O	O	I-T061
(	O	O	I-T061
TKI	O	O	I-T061
)	O	O	I-T061
therapy	O	O	I-T061
is	O	O	O
used	O	O	O
in	O	O	O
different	O	O	O
types	O	O	O
of	O	O	O
cancer	O	O	B-T191
.	O	O	O

These	O	O	O
drugs	O	O	B-T121
have	O	O	O
been	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
cardiovascular	O	O	B-T037
toxicity	O	O	I-T037
,	O	O	O
including	O	O	O
aortic	O	O	B-T047
dissection	O	O	I-T047
.	O	O	O

To	O	O	O
our	O	O	O
knowledge	O	O	B-T170
,	O	O	O
this	O	O	O
is	O	O	O
the	O	O	O
first	O	O	B-T079
time	O	O	I-T079
that	O	O	O
a	O	O	O
coronary	O	O	B-T047
dissection	O	O	I-T047
potentially	O	O	B-T080
associated	O	O	B-T080
with	O	O	I-T080
a	O	O	O
TKI	O	O	B-T061
treatment	O	O	I-T061
has	O	O	O
been	O	O	O
described	O	O	O
.	O	O	O

-DOCSTART- (28463704)

Recovery	O	O	B-T052
of	O	O	I-T052
orthographic	O	O	B-T090
processing	O	O	B-T041
after	O	O	O
stroke	O	O	B-T047
:	O	O	O
A	O	O	O
longitudinal	O	O	B-T062
fMRI	O	O	B-T060
study	O	O	O

An	O	O	O
intact	O	O	O
orthographic	O	O	B-T090
processing	O	O	B-T041
system	O	O	O
is	O	O	O
critical	O	O	O
for	O	O	O
normal	O	O	B-T048
reading	O	O	I-T048
and	O	O	I-T048
spelling	O	O	I-T048
.	O	O	O

Here	O	O	O
we	O	O	O
investigate	O	O	O
the	O	O	O
neural	O	O	B-T169
changes	O	O	I-T169
associated	O	O	O
with	O	O	O
impairment	O	O	B-T169
and	O	O	O
subsequent	O	O	O
recovery	O	O	B-T052
of	O	O	O
the	O	O	O
orthographic	O	O	B-T090
lexical	O	O	B-T041
processing	O	O	I-T041
system	O	O	O
in	O	O	O
an	O	O	O
individual	O	O	O
with	O	O	O
an	O	O	O
ischemic	O	O	B-T046
left	O	O	B-T047
posterior	O	O	I-T047
cerebral	O	O	I-T047
artery	O	O	I-T047
(	O	O	I-T047
PCA	O	O	I-T047
)	O	O	I-T047
stroke	O	O	I-T047
.	O	O	O

This	O	O	O
work	O	O	O
describes	O	O	O
a	O	O	O
longitudinal	O	O	B-T062
case	O	O	I-T062
study	O	O	I-T062
of	O	O	O
a	O	O	O
patient	O	O	O
,	O	O	O
whose	O	O	O
initials	O	O	O
are	O	O	O
MMY	O	O	B-T016
,	O	O	O
with	O	O	O
impairments	O	O	B-T169
in	O	O	O
orthographic	O	O	B-T090
lexical	O	O	B-T041
processing	O	O	I-T041
for	O	O	O
reading	O	O	B-T048
and	O	O	I-T048
spelling	O	O	I-T048
at	O	O	O
stroke	O	O	B-T047
onset	O	O	B-T079
,	O	O	O
and	O	O	O
who	O	O	O
recovered	O	O	O
these	O	O	O
skills	O	O	O
within	O	O	O
1	O	O	O
year	O	O	O
post	O	O	O
stroke	O	O	O
.	O	O	O

We	O	O	O
tested	O	O	O
the	O	O	O
hypothesis	O	O	B-T078
that	O	O	O
this	O	O	O
acute	O	O	B-T079
impairment	O	O	B-T169
to	O	O	O
reading	O	O	B-T048
and	O	O	I-T048
spelling	O	O	I-T048
would	O	O	O
be	O	O	O
associated	O	O	O
with	O	O	O
a	O	O	O
selective	O	O	O
loss	O	O	B-T081
of	O	O	I-T081
neural	O	O	B-T169
activation	O	O	I-T169
in	O	O	O
the	O	O	O
left	O	O	B-T023
fusiform	O	O	I-T023
gyrus	O	O	I-T023
(	O	O	O
FG	O	O	B-T023
)	O	O	O
,	O	O	O
and	O	O	O
that	O	O	O
subsequent	O	O	O
recovery	O	O	O
would	O	O	O
be	O	O	O
associated	O	O	O
with	O	O	O
a	O	O	O
gain	O	O	B-T081
of	O	O	I-T081
neural	O	O	O
activation	O	O	O
in	O	O	O
this	O	O	O
region	O	O	O
.	O	O	O

MMY	O	O	B-T016
's	O	O	I-T016
case	O	O	O
provided	O	O	O
a	O	O	O
unique	O	O	O
opportunity	O	O	O
to	O	O	O
assess	O	O	O
the	O	O	O
selectivity	O	O	O
of	O	O	O
neural	O	O	B-T169
changes	O	O	I-T169
because	O	O	O
she	O	O	O
demonstrated	O	O	O
a	O	O	O
behavioral	O	O	B-T053
recovery	O	O	B-T040
of	O	O	I-T040
naming	O	O	I-T040
as	O	O	I-T040
well	O	O	I-T040
;	O	O	O
i.e.	O	O	O
,	O	O	O
if	O	O	O
there	O	O	O
is	O	O	O
neural	O	O	B-T169
recovery	O	O	I-T169
for	O	O	O
reading	O	O	B-T048
and	O	O	I-T048
spelling	O	O	I-T048
,	O	O	O
but	O	O	O
not	O	O	O
naming	O	O	O
,	O	O	O
then	O	O	O
these	O	O	O
neural	O	O	O
changes	O	O	O
are	O	O	O
selective	O	O	O
to	O	O	O
the	O	O	O
recovery	O	O	O
of	O	O	O
orthographic	O	O	B-T090
processing	O	O	B-T041
.	O	O	O

To	O	O	O
test	O	O	O
our	O	O	O
hypothesis	O	O	O
,	O	O	O
we	O	O	O
examined	O	O	O
longitudinal	O	O	B-T062
behavioral	O	O	I-T062
and	O	O	O
functional	O	O	B-T060
magnetic	O	O	I-T060
resonance	O	O	I-T060
imaging	O	O	I-T060
(	O	O	O
fMRI	O	O	B-T060
)	O	O	O
data	O	O	O
of	O	O	O
reading	O	O	B-T041
,	O	O	O
spelling	O	O	B-UnknownType
,	O	O	O
and	O	O	O
visual	O	O	B-T170
object	O	O	I-T170
naming	O	O	I-T170
acquired	O	O	O
acutely	O	O	O
,	O	O	O
3	O	O	O
weeks	O	O	O
,	O	O	O
5	O	O	O
months	O	O	O
,	O	O	O
and	O	O	O
one	O	O	O
year	O	O	O
post	O	O	O
stroke	O	O	B-T047
.	O	O	O

In	O	O	O
confirmation	O	O	O
of	O	O	O
our	O	O	O
hypothesis	O	O	B-T078
,	O	O	O
the	O	O	O
loss	O	O	O
and	O	O	O
subsequent	O	O	O
gain	O	O	O
of	O	O	O
orthographic	O	O	B-T090
lexical	O	O	B-T041
processing	O	O	I-T041
was	O	O	O
associated	O	O	O
with	O	O	O
up-regulation	O	O	B-T044
of	O	O	O
neural	O	O	B-T169
activation	O	O	I-T169
in	O	O	O
areas	O	O	O
previously	O	O	O
associated	O	O	O
with	O	O	O
orthographic	O	O	O
lexical	O	O	O
processing	O	O	O
:	O	O	O
i.e.	O	O	O
,	O	O	O
the	O	O	O
left	O	O	B-T029
mid-FG	O	O	I-T029
and	O	O	O
inferior	O	O	B-T023
frontal	O	O	I-T023
junction	O	O	I-T023
(	O	O	O
IFJ	O	O	B-T023
)	O	O	O
.	O	O	O

Furthermore	O	O	O
,	O	O	O
these	O	O	O
neural	O	O	B-T169
changes	O	O	I-T169
were	O	O	O
found	O	O	O
to	O	O	O
be	O	O	O
selective	O	O	O
to	O	O	O
orthographic	O	O	B-T090
processing	O	O	B-T041
,	O	O	O
as	O	O	O
they	O	O	O
were	O	O	O
observed	O	O	O
for	O	O	O
reading	O	O	B-T041
and	O	O	O
spelling	O	O	B-UnknownType
,	O	O	O
but	O	O	O
not	O	O	O
for	O	O	O
visual	O	O	B-T170
object	O	O	I-T170
naming	O	O	I-T170
within	O	O	O
the	O	O	O
left	O	O	B-T029
mid-FG	O	O	I-T029
.	O	O	O

This	O	O	O
work	O	O	O
shows	O	O	O
that	O	O	O
left	O	O	B-T047
PCA	O	O	I-T047
stroke	O	O	B-T047
can	O	O	O
temporarily	O	O	O
and	O	O	O
selectively	O	O	O
disrupt	O	O	O
the	O	O	O
orthographic	O	O	B-T090
lexical	O	O	B-T041
processing	O	O	B-T041
system	O	O	O
,	O	O	O
not	O	O	O
only	O	O	O
in	O	O	O
the	O	O	O
posterior	O	O	B-T082
region	O	O	I-T082
adjacent	O	O	B-T082
to	O	O	O
the	O	O	O
stroke	O	O	O
,	O	O	O
but	O	O	O
also	O	O	O
in	O	O	O
relatively	O	O	O
distant	O	O	B-T082
frontal	O	O	I-T082
orthographic	O	O	O
processing	O	O	O
regions	O	O	O
.	O	O	O

-DOCSTART- (28464907)

Nodal	O	O	B-T082
skip	O	O	B-T033
metastasis	O	O	B-T191
in	O	O	O
thoracic	O	O	B-T191
esophageal	O	O	I-T191
squamous	O	O	I-T191
cell	O	O	I-T191
carcinoma	O	O	I-T191
:	O	O	O
a	O	O	O
cohort	O	O	O
study	O	O	O

Nodal	O	O	B-T082
skip	O	O	B-T033
metastasis	O	O	B-T191
is	O	O	O
a	O	O	O
prognostic	O	O	B-T201
factor	O	O	I-T201
in	O	O	O
some	O	O	O
sites	O	O	O
of	O	O	O
malignancies	O	O	B-T191
,	O	O	O
but	O	O	O
its	O	O	O
role	O	O	O
in	O	O	O
esophageal	O	O	B-T191
cancer	O	O	I-T191
is	O	O	O
still	O	O	O
unclear	O	O	B-T033
.	O	O	O

The	O	O	O
present	O	O	O
study	O	O	O
aimed	O	O	O
to	O	O	O
investigate	O	O	B-T169
occurrence	O	O	O
and	O	O	O
effect	O	O	B-T080
of	O	O	O
nodal	O	O	B-T082
skip	O	O	B-T033
metastases	O	O	O
in	O	O	O
thoracic	O	O	B-T191
esophageal	O	O	I-T191
squamous	O	O	I-T191
cell	O	O	I-T191
carcinoma	O	O	I-T191
.	O	O	O

All	O	O	O
578	O	O	O
patients	O	O	B-T101
undergoing	O	O	O
esophagectomy	O	O	B-T061
for	O	O	O
thoracic	O	O	B-T191
esophageal	O	O	I-T191
squamous	O	O	I-T191
cell	O	O	I-T191
carcinoma	O	O	I-T191
at	O	O	O
the	O	O	O
Center	O	O	B-T093
for	O	O	I-T093
Esophageal	O	O	I-T093
Diseases	O	O	I-T093
located	O	O	O
in	O	O	O
Padova	O	O	B-UnknownType
between	O	O	O
January	O	O	B-T080
1992	O	O	O
and	O	O	O
December	O	O	B-T080
2010	O	O	O
were	O	O	O
retrospectively	O	O	B-T062
evaluated	O	O	I-T062
.	O	O	O

Selection	O	O	B-T080
criteria	O	O	I-T080
were	O	O	O
R0	O	O	B-T033
resection	O	O	I-T033
,	O	O	O
pathological	O	O	B-T169
M0	O	O	B-T033
stage	O	O	I-T033
and	O	O	O
pathological	O	O	O
lymph	O	O	B-T033
node	O	O	I-T033
involvement	O	O	I-T033
.	O	O	O

Patients	O	O	B-T101
receiving	O	O	O
neoadjuvant	O	O	B-T061
therapy	O	O	I-T061
were	O	O	O
excluded	O	O	O
.	O	O	O

The	O	O	O
selection	O	O	O
identified	O	O	O
88	O	O	O
patients	O	O	B-T101
with	O	O	O
lymph	O	O	B-T033
node	O	O	I-T033
involvement	O	O	I-T033
confirmed	O	O	O
by	O	O	O
pathological	O	O	B-T169
evaluation	O	O	B-T058
.	O	O	O

Sixteen	O	O	O
patients	O	O	B-T101
(	O	O	O
18.2	O	O	O
%	O	O	O
)	O	O	O
had	O	O	O
nodal	O	O	B-T082
skip	O	O	B-T033
metastasis	O	O	B-T191
.	O	O	O

Adjusting	O	O	O
for	O	O	O
the	O	O	O
number	O	O	O
of	O	O	O
lymph	O	O	B-T191
node	O	O	I-T191
metastases	O	O	I-T191
,	O	O	O
patient	O	O	B-T101
with	O	O	O
nodal	O	O	B-T082
skip	O	O	B-T033
metastasis	O	O	B-T191
had	O	O	O
similar	O	O	O
5-year	O	O	O
overall	O	O	B-T081
survival	O	O	I-T081
(	O	O	O
14	O	O	O
%	O	O	O
vs.	O	O	O
13	O	O	O
%	O	O	O
,	O	O	O
p	O	O	O
=	O	O	O
0.93	O	O	O
)	O	O	O
and	O	O	O
5-year	O	O	O
disease	O	O	B-T081
free	O	O	I-T081
survival	O	O	I-T081
(	O	O	O
14	O	O	O
%	O	O	O
vs.	O	O	O
9	O	O	O
%	O	O	O
,	O	O	O
p	O	O	O
=	O	O	O
0.48	O	O	O
)	O	O	O
compared	O	O	O
to	O	O	O
patients	O	O	B-T101
with	O	O	O
both	O	O	O
peritumoral	O	O	B-T082
and	O	O	O
distant	O	O	B-T082
lymph	O	O	O
node	O	O	O
metastases	O	O	O
.	O	O	O

The	O	O	O
risk	O	O	O
difference	O	O	O
of	O	O	O
nodal	O	O	B-T082
skip	O	O	B-T033
metastasis	O	O	B-T191
was	O	O	O
:	O	O	O
-24.1	O	O	O
%	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
C.I.	O	O	B-T081
-43.1	O	O	O
%	O	O	O
to	O	O	O
-5.2	O	O	O
%	O	O	O
)	O	O	O
in	O	O	O
patients	O	O	B-T101
with	O	O	O
more	O	O	O
than	O	O	O
one	O	O	O
lymph	O	O	B-T191
node	O	O	I-T191
metastasis	O	O	I-T191
compared	O	O	O
to	O	O	O
those	O	O	O
with	O	O	O
one	O	O	O
lymph	O	O	O
node	O	O	O
metastasis	O	O	O
;	O	O	O
-2.3	O	O	O
%	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
C.I.	O	O	O
-29.8	O	O	O
%	O	O	O
to	O	O	O
25.2	O	O	O
%	O	O	O
)	O	O	O
in	O	O	O
middle	O	O	B-T082
thoracic	O	O	B-T023
esophagus	O	O	I-T023
and	O	O	O
-23.0	O	O	O
%	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
C.I.	O	O	O
-47.8	O	O	O
%	O	O	O
to	O	O	O
1.8	O	O	O
%	O	O	O
)	O	O	O
in	O	O	O
lower	O	O	B-T082
thoracic	O	O	O
esophagus	O	O	O
compared	O	O	O
to	O	O	O
upper	O	O	B-T082
thoracic	O	O	O
esophagus	O	O	O
;	O	O	O
18.1	O	O	O
%	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
C.I.	O	O	O
3.2	O	O	O
%	O	O	O
to	O	O	O
33.0	O	O	O
%	O	O	O
)	O	O	O
in	O	O	O
clinical	O	O	B-T080
N0	O	O	B-T033
stage	O	O	I-T033
vs.	O	O	O
clinical	O	O	O
N+	O	O	B-T033
stage	O	O	I-T033
.	O	O	O

Nodal	O	O	B-T082
skip	O	O	B-T033
metastasis	O	O	B-T191
is	O	O	O
a	O	O	O
common	O	O	O
pattern	O	O	O
of	O	O	O
metastatic	O	O	B-T033
lymph	O	O	I-T033
involvement	O	O	I-T033
in	O	O	O
thoracic	O	O	B-T191
esophageal	O	O	I-T191
squamous	O	O	I-T191
cell	O	O	I-T191
carcinoma	O	O	I-T191
.	O	O	O

However	O	O	O
,	O	O	O
neither	O	O	B-T080
overall	O	O	B-T081
survival	O	O	I-T081
nor	O	O	O
disease	O	O	B-T081
free	O	O	I-T081
survival	O	O	I-T081
are	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
nodal	O	O	B-T082
skip	O	O	B-T033
metastasis	O	O	B-T191
occurrence	O	O	O
.	O	O	O

-DOCSTART- (28466814)

Association	O	O	B-T080
of	O	O	O
leukemia	O	O	B-T028
inhibitory	O	O	I-T028
factor	O	O	I-T028
gene	O	O	I-T028
polymorphism	O	O	B-T045
and	O	O	O
in	O	O	B-T080
vitro	O	O	I-T080
fertilization	O	O	B-T040
outcome	O	O	B-T169
in	O	O	O
a	O	O	O
population	O	O	B-T098
in	O	O	O
northern	O	O	O
Iran	O	O	O

Several	O	O	O
studies	O	O	B-T062
have	O	O	O
been	O	O	O
demonstrated	O	O	O
that	O	O	O
endometrial	O	O	B-T082
leukemia	O	O	B-T116
inhibitory	O	O	I-T116
factor	O	O	I-T116
(	O	O	O
LIF	O	O	B-T116
)	O	O	O
is	O	O	O
important	O	O	O
in	O	O	O
embryo	O	O	B-T040
implantation	O	O	I-T040
.	O	O	O

LIF	O	O	B-T116
is	O	O	O
a	O	O	O
secreted	O	O	O
glycoprotein	O	O	B-T116
with	O	O	O
a	O	O	O
variety	O	O	O
of	O	O	O
biological	O	O	B-T038
functions	O	O	I-T038
including	O	O	O
stimulation	O	O	B-T070
of	O	O	O
cell	O	O	B-T043
proliferation	O	O	I-T043
,	O	O	O
differentiation	O	O	B-T043
and	O	O	O
survival	O	O	B-T043
that	O	O	O
are	O	O	O
all	O	O	O
essential	O	O	B-T080
for	O	O	O
blastocyete	O	O	B-T018
development	O	O	B-T169
and	O	O	O
implantation	O	O	B-T040
.	O	O	O

The	O	O	O
LIF	O	O	B-T116
receptor	O	O	I-T116
activates	O	O	B-T052
several	O	O	O
signaling	O	O	B-T044
pathways	O	O	B-T044
in	O	O	O
diverse	O	O	B-T170
cell	O	O	I-T170
types	O	O	I-T170
,	O	O	O
including	O	O	O
Jak/STAT	O	O	B-T169
,	O	O	O
MAPK	O	O	B-T116
and	O	O	O
PI3-kinase	O	O	B-T116
pathways	O	O	O
in	O	O	O
the	O	O	O
endometrium	O	O	B-T023
of	O	O	O
fertile	O	O	B-T040
woman	O	O	B-T098
.	O	O	O

It	O	O	O
has	O	O	O
been	O	O	O
suggested	O	O	O
that	O	O	O
the	O	O	O
initial	O	O	O
lower	O	O	O
expression	O	O	B-T045
of	O	O	O
LIF	O	O	B-T116
in	O	O	O
proliferative	O	O	B-T046
phase	O	O	B-T079
may	O	O	O
be	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
causes	O	O	O
for	O	O	O
multiple	O	O	O
failure	O	O	B-T169
of	O	O	O
implantation	O	O	B-T061
.	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
evaluate	O	O	O
the	O	O	O
association	O	O	B-T080
between	O	O	O
maternal	O	O	B-T033
genotype	O	O	B-T032
of	O	O	O
SNP	O	O	B-T086
3951C/T	O	O	I-T086
LIF	O	O	B-T116
and	O	O	O
in	O	O	B-T061
vitro	O	O	I-T061
fertilization	O	O	I-T061
and	O	O	O
embryo	O	O	B-T061
transfer	O	O	I-T061
(	O	O	O
IVF	O	O	B-T061
-	O	O	O
ET	O	O	B-T061
)	O	O	O
outcome	O	O	B-T080
in	O	O	O
infertile	O	O	B-T046
women	O	O	B-T098
.	O	O	O

This	O	O	O
case-control	O	O	B-T062
study	O	O	I-T062
was	O	O	O
comprised	O	O	O
of	O	O	O
infertile	O	O	B-T046
patients	O	O	B-T101
(	O	O	O
n=70	O	O	O
)	O	O	O
and	O	O	O
women	O	O	B-T098
having	O	O	O
one	O	O	O
healthy	O	O	B-T033
child	O	O	I-T033
as	O	O	O
controls	O	O	B-T096
(	O	O	O
n=73	O	O	O
)	O	O	O
.	O	O	O

Genotyping	O	O	B-T059
for	O	O	O
SNP-3951C/T	O	O	B-T086
was	O	O	O
performed	O	O	O
by	O	O	O
PCR/RFLP	O	O	B-T059
.	O	O	O

Allele	O	O	B-T028
and	O	O	O
genotype	O	O	B-T032
distribution	O	O	B-T169
did	O	O	O
not	O	O	O
differ	O	O	O
significantly	O	O	O
between	O	O	O
patients	O	O	B-T101
and	O	O	O
controls	O	O	B-T096
(	O	O	O
P>0.05	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
LIF	O	O	B-T116
genotype	O	O	B-T032
frequencies	O	O	B-T081
amongst	O	O	O
the	O	O	O
70	O	O	O
cases	O	O	B-T169
were	O	O	O
C/C	O	O	B-T086
=	O	O	O
40	O	O	O
%	O	O	O
,	O	O	O
C/T	O	O	B-T086
=	O	O	O
52.8	O	O	O
%	O	O	O
and	O	O	O
T/T	O	O	B-T086
=	O	O	O
7.2	O	O	O
%	O	O	O
;	O	O	O
the	O	O	O
C	O	O	O
and	O	O	O
T	O	O	O
allele	O	O	B-T028
frequencies	O	O	O
were	O	O	O
66	O	O	O
%	O	O	O
and	O	O	O
34	O	O	O
%	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

The	O	O	O
LIF	O	O	B-T116
genotype	O	O	B-T032
frequencies	O	O	B-T081
amongst	O	O	O
the	O	O	O
73	O	O	O
controls	O	O	B-T096
were	O	O	O
C/C	O	O	B-T086
=	O	O	O
45.20	O	O	O
%	O	O	O
,	O	O	O
C/T	O	O	B-T086
=	O	O	O
50.70	O	O	O
%	O	O	O
and	O	O	O
T/T	O	O	B-T086
=	O	O	O
4.1	O	O	O
%	O	O	O
;	O	O	O
the	O	O	O
C	O	O	O
and	O	O	O
T	O	O	O
allele	O	O	B-T028
frequencies	O	O	O
were	O	O	O
70	O	O	O
%	O	O	O
and	O	O	O
30	O	O	O
%	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

In	O	O	O
conclusion	O	O	O
,	O	O	O
the	O	O	O
results	O	O	B-T169
of	O	O	O
this	O	O	O
study	O	O	O
indicate	O	O	O
that	O	O	O
SNP	O	O	B-T086
3951C/T	O	O	I-T086
of	O	O	O
LIF	O	O	B-T116
may	O	O	O
not	O	O	O
be	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
IVF	O	O	B-T061
-	O	O	O
ET	O	O	B-T061
outcome	O	O	B-T080
in	O	O	O
this	O	O	O
population	O	O	B-T098
.	O	O	O

Although	O	O	O
more	O	O	O
studies	O	O	B-T062
should	O	O	O
be	O	O	O
considered	O	O	O
with	O	O	O
larger	O	O	O
number	O	O	O
of	O	O	O
patients	O	O	B-T101
and	O	O	O
control	O	O	B-T096
subjects	O	O	I-T096
to	O	O	O
confirm	O	O	B-T080
our	O	O	O
results	O	O	B-T169
.	O	O	O

-DOCSTART- (28467858)

ANTI	O	O	B-T033
ANGIOGENIC	O	O	I-T033
EFFECT	O	O	I-T033
OF	O	O	O
CHEBULAGIC	O	O	B-T109
ACID	O	O	I-T109
INVOLVES	O	O	O
INHIBITION	O	O	B-T052
OF	O	O	O
VEGFR2	O	O	B-T044
AND	O	O	O
GSK3Î²	O	O	O
DEPENDENT	O	O	O
SIGNALING	O	O	O
PATHWAYS	O	O	O

Inhibition	O	O	B-T052
of	O	O	O
angiogenesis	O	O	B-T042
is	O	O	O
a	O	O	O
useful	O	O	O
strategy	O	O	B-T170
to	O	O	O
prevent	O	O	B-T080
cancer	O	O	B-T191
growth	O	O	I-T191
,	O	O	O
which	O	O	O
targets	O	O	B-T169
new	O	O	O
vessels	O	O	B-T023
that	O	O	O
grow	O	O	O
to	O	O	O
nourish	O	O	O
actively	O	O	O
proliferating	O	O	B-T169
tumor	O	O	B-T025
cells	O	O	I-T025
.	O	O	O

Endothelial	O	O	B-T025
cells	O	O	I-T025
can	O	O	O
use	O	O	O
a	O	O	O
number	O	O	O
of	O	O	O
different	O	O	O
pathways	O	O	B-T044
to	O	O	O
cause	O	O	O
angiogenesis	O	O	B-T042
and	O	O	O
each	O	O	O
step	O	O	O
in	O	O	O
these	O	O	O
pathways	O	O	O
can	O	O	O
be	O	O	O
targeted	O	O	B-T169
.	O	O	O

The	O	O	O
use	O	O	O
of	O	O	O
multi	O	O	B-T121
targeted	O	O	I-T121
drugs	O	O	I-T121
is	O	O	O
gaining	O	O	O
much	O	O	O
importance	O	O	O
in	O	O	O
this	O	O	O
scenario	O	O	O
.	O	O	O

Our	O	O	O
previous	O	O	O
results	O	O	O
have	O	O	O
shown	O	O	O
the	O	O	O
anti	O	O	B-T033
angiogenic	O	O	I-T033
effect	O	O	I-T033
of	O	O	O
Chebulagic	O	O	B-T109
acid	O	O	I-T109
-	O	O	O
a	O	O	O
benzopyran	O	O	B-T109
tannin	O	O	B-T109
present	O	O	O
in	O	O	O
the	O	O	O
fruits	O	O	B-T168
of	O	O	O
Terminalia	O	O	B-T002
chebula	O	O	I-T002
.	O	O	O

The	O	O	O
present	O	O	O
study	O	O	O
was	O	O	O
designed	O	O	O
to	O	O	O
examine	O	O	O
the	O	O	O
molecular	O	O	B-T044
mechanism	O	O	I-T044
of	O	O	O
the	O	O	O
anti	O	O	B-T033
angiogenic	O	O	I-T033
effect	O	O	I-T033
of	O	O	O
chebulagic	O	O	B-T109
acid	O	O	I-T109
.	O	O	O

Results	O	O	O
of	O	O	O
our	O	O	O
investigations	O	O	O
using	O	O	O
molecular	O	O	B-T170
docking	O	O	I-T170
studies	O	O	I-T170
and	O	O	O
HUVECs	O	O	B-T025
in	O	O	O
culture	O	O	B-T059
suggested	O	O	O
that	O	O	O
Chebulagic	O	O	B-T109
acid	O	O	I-T109
inhibited	O	O	B-T052
GSK-3Î²	O	O	B-T116
dependent	O	O	B-T169
Î²-catenin	O	O	B-T116
phosphorylation	O	O	B-T044
,	O	O	O
an	O	O	O
important	O	O	O
mediator	O	O	O
of	O	O	O
VE-cadherin	O	O	B-T116
/	O	O	O
Î²-catenin	O	O	O
signaling	O	O	B-T044
and	O	O	O
VEGFR2	O	O	B-T116
phosphorylation	O	O	O
which	O	O	O
is	O	O	O
an	O	O	O
important	O	O	O
step	O	O	O
involved	O	O	O
in	O	O	O
VEGF	O	O	B-T044
signaling	O	O	I-T044
.	O	O	O

Chebulagic	O	O	B-T109
acid	O	O	I-T109
inhibits	O	O	B-T052
angiogenesis	O	O	B-T042
by	O	O	O
blocking	O	O	B-T169
both	O	O	O
VEGF	O	O	B-T116
/	O	O	O
VEGFR2	O	O	B-T116
and	O	O	O
cell-cell	O	O	B-T044
contact	O	O	I-T044
dependent	O	O	I-T044
downstream	O	O	I-T044
signaling	O	O	I-T044
pathway	O	O	I-T044
.	O	O	O

-DOCSTART- (28468980)

Identification	O	O	O
of	O	O	O
protective	O	O	O
B-cell	O	O	B-T129
epitopes	O	O	I-T129
within	O	O	O
the	O	O	O
novel	O	O	O
malaria	O	O	B-T129
vaccine	O	O	I-T129
candidate	O	O	O
P.	O	O	O
falciparum	O	O	O
Schizont	O	O	O
Egress	O	O	O
Antigen-1	O	O	O

Naturally	O	O	B-T169
-acquired	O	O	O
antibodies	O	O	B-T116
to	O	O	O
PfSEA-1A	O	O	B-T116
are	O	O	O
associated	O	O	O
with	O	O	O
protection	O	O	O
against	O	O	O
severe	O	O	O
malaria	O	O	B-T047
in	O	O	O
children	O	O	B-T100
.	O	O	O

Vaccination	O	O	B-T061
of	O	O	O
mice	O	O	B-T015
with	O	O	O
PbSEA-1A	O	O	B-T129
decreases	O	O	O
parasitemia	O	O	B-T047
and	O	O	O
prolongs	O	O	O
survival	O	O	O
following	O	O	O
Plasmodium	O	O	B-T204
berghei	O	O	I-T204
ANKA	O	O	I-T204
challenge	O	O	O
.	O	O	O

To	O	O	O
enhance	O	O	O
the	O	O	O
immunogenicity	O	O	B-T038
of	O	O	O
PfSEA-1A	O	O	B-T116
,	O	O	O
we	O	O	O
identified	O	O	O
five	O	O	O
linear	O	O	O
,	O	O	O
B-cell	O	O	B-T129
epitopes	O	O	I-T129
using	O	O	O
peptide	O	O	B-T116
microarrays	O	O	B-T075
probed	O	O	O
with	O	O	O
anti-sera	O	O	B-T116
from	O	O	O
rPfSEA-1A	O	O	B-T116
-	O	O	O
vaccinated	O	O	B-T033
non-human	O	O	O
primates	O	O	B-T015
.	O	O	O

We	O	O	O
evaluated	O	O	B-T058
the	O	O	O
relationship	O	O	O
between	O	O	O
epitope	O	O	B-T129
-specific	O	O	O
antibody	O	O	B-T116
levels	O	O	O
and	O	O	O
protection	O	O	O
from	O	O	O
parasitemia	O	O	B-T047
in	O	O	O
a	O	O	O
longitudinal	O	O	O
treatment	O	O	B-T061
-	O	O	O
reinfection	O	O	B-T169
cohort	O	O	B-T098
in	O	O	O
Western	O	O	B-T083
Kenya	O	O	I-T083
.	O	O	O

Antibodies	O	O	B-T116
to	O	O	O
three	O	O	O
epitopes	O	O	B-T129
were	O	O	O
associated	O	O	O
with	O	O	O
16	O	O	O
-	O	O	O
17	O	O	O
%	O	O	O
decreased	O	O	O
parasitemia	O	O	B-T047
over	O	O	O
an	O	O	O
18-	O	O	O
week	O	O	B-T079
high	O	O	O
transmission	O	O	B-T070
season	O	O	O
.	O	O	O

We	O	O	O
are	O	O	O
currently	O	O	O
designing	O	O	O
immunogens	O	O	B-T116
to	O	O	O
enhance	O	O	O
antibody	O	O	B-T038
responses	O	O	I-T038
to	O	O	O
these	O	O	O
three	O	O	O
epitopes	O	O	B-T129
.	O	O	O

-DOCSTART- (28469263)

Estrogen	O	O	B-T125
deficiency	O	O	B-T169
accelerates	O	O	B-T169
lumbar	O	O	B-T030
facet	O	O	I-T030
joints	O	O	I-T030
arthritis	O	O	O

Dramatic	O	O	O
increase	O	O	B-T169
in	O	O	O
the	O	O	O
prevalence	O	O	B-T081
of	O	O	O
lumbar	O	O	B-T030
facet	O	O	I-T030
joint	O	O	I-T030
(	O	O	O
LFJ	O	O	B-T030
)	O	O	O
arthritis	O	O	B-T047
in	O	O	O
women	O	O	B-T098
around	O	O	O
the	O	O	O
age	O	O	B-T032
of	O	O	O
menopause	O	O	B-T039
indicates	O	O	O
a	O	O	O
protective	O	O	B-T078
role	O	O	I-T078
for	O	O	O
estrogen	O	O	B-T125
in	O	O	O
LFJ	O	O	O
arthritis	O	O	O
.	O	O	O

To	O	O	O
date	O	O	O
,	O	O	O
there	O	O	O
is	O	O	O
no	O	O	B-T080
evidence	O	O	I-T080
for	O	O	O
this	O	O	O
indication	O	O	B-T078
and	O	O	O
the	O	O	O
mechanism	O	O	B-T169
of	O	O	O
such	O	O	O
an	O	O	O
effect	O	O	B-T080
remains	O	O	O
poorly	O	O	O
understood	O	O	O
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
ovariectomized	O	O	B-T015
(	O	O	I-T015
OVX	O	O	I-T015
)	O	O	I-T015
mice	O	O	I-T015
were	O	O	O
used	O	O	O
to	O	O	O
mimic	O	O	O
the	O	O	O
estrogen	O	O	B-T125
-	O	O	O
deficient	O	O	B-T169
status	O	O	B-T080
of	O	O	O
post-menopausal	O	O	B-T040
women	O	O	B-T098
.	O	O	O

Micro-CT	O	O	B-T060
and	O	O	O
immunohistochemistry	O	O	B-T060
was	O	O	O
employed	O	O	O
to	O	O	O
assess	O	O	B-T058
the	O	O	O
morphological	O	O	B-T082
and	O	O	O
molecular	O	O	B-T080
changes	O	O	B-T169
in	O	O	O
ovariectomy	O	O	B-T061
-	O	O	O
induced	O	O	B-T169
LFJ	O	O	B-T030
arthritis	O	O	B-T047
.	O	O	O

The	O	O	O
results	O	O	B-T169
show	O	O	O
that	O	O	O
the	O	O	O
LFJ	O	O	B-T030
subchondral	O	O	B-T023
bone	O	O	I-T023
mass	O	O	I-T201
was	O	O	O
significantly	O	O	O
decreased	O	O	B-T081
in	O	O	O
OVX	O	O	B-T015
mice	O	O	I-T015
,	O	O	O
with	O	O	O
increased	O	O	B-T081
cavities	O	O	B-T030
on	O	O	O
the	O	O	O
interface	O	O	B-T082
of	O	O	O
the	O	O	O
subchondral	O	O	O
bone	O	O	O
.	O	O	O

Severe	O	O	B-T080
cartilage	O	O	B-T024
degradation	O	O	B-T169
was	O	O	O
observed	O	O	O
in	O	O	O
ovariectomy	O	O	B-T061
-	O	O	O
induced	O	O	B-T169
LFJ	O	O	B-T030
arthritis	O	O	B-T047
.	O	O	O

Increased	O	O	B-T081
blood	O	O	B-T023
vessels	O	O	I-T023
and	O	O	O
innervations	O	O	B-T080
were	O	O	O
also	O	O	O
found	O	O	O
in	O	O	O
degenerated	O	O	B-T046
LFJ	O	O	B-T030
,	O	O	O
particularly	O	O	O
in	O	O	O
the	O	O	O
subchondral	O	O	B-T023
bone	O	O	I-T023
area	O	O	B-T029
.	O	O	O

17Î²-Estradiol	O	O	B-T125
treatment	O	O	B-T061
efficiently	O	O	O
suppressed	O	O	B-T169
LFJ	O	O	B-T030
subchondral	O	O	B-T033
bone	O	O	I-T033
turnover	O	O	I-T033
,	O	O	O
markedly	O	O	O
inhibited	O	O	B-T080
cartilage	O	O	B-T024
degradation	O	O	B-T169
,	O	O	O
and	O	O	O
increased	O	O	B-T081
blood	O	O	B-T023
vessel	O	O	I-T023
and	O	O	O
nerve	O	O	B-T026
ending	O	O	I-T026
growth	O	O	B-T040
in	O	O	O
degenerated	O	O	B-T046
LFJ	O	O	O
in	O	O	O
OVX	O	O	B-T015
mice	O	O	I-T015
.	O	O	O

Our	O	O	O
study	O	O	B-T062
reveals	O	O	O
that	O	O	O
estrogen	O	O	B-T125
is	O	O	O
a	O	O	O
key	O	O	O
factor	O	O	B-T169
in	O	O	O
regulating	O	O	B-T169
LFJ	O	O	I-T169
metabolism	O	O	I-T169
.	O	O	O

Severe	O	O	B-T080
LFJ	O	O	B-T030
degeneration	O	O	B-T046
occurs	O	O	O
when	O	O	O
estrogen	O	O	B-T125
is	O	O	O
absent	O	O	B-T169
in	O	O	B-T082
vivo	O	O	I-T082
.	O	O	O

Collapsed	O	O	B-T169
subchondral	O	O	B-T023
bone	O	O	I-T023
may	O	O	O
be	O	O	O
the	O	O	O
initiation	O	O	B-T169
of	O	O	O
this	O	O	O
process	O	O	B-T067
,	O	O	O
and	O	O	O
estrogen	O	O	B-T125
replacement	O	O	I-T061
therapy	O	O	I-T061
can	O	O	O
effectively	O	O	O
prevent	O	O	O
degeneration	O	O	B-T046
of	O	O	O
LFJ	O	O	B-T030
under	O	O	O
estrogen	O	O	O
-	O	O	O
deficient	O	O	B-T169
conditions	O	O	B-T080
.	O	O	O

-DOCSTART- (28470100)

Dexmedetomidine	O	O	B-T109
Effect	O	O	B-T080
on	O	O	O
Emergence	O	O	B-T048
Agitation	O	O	I-T048
and	O	O	O
Delirium	O	O	B-T048
in	O	O	O
Children	O	O	B-T100
Undergoing	O	O	O
Laparoscopic	O	O	B-T061
Hernia	O	O	I-T061
Repair	O	O	I-T061
:	O	O	O
a	O	O	O
Preliminary	O	O	B-T079
Study	O	O	O

Objective	O	O	O
To	O	O	O
evaluate	O	O	O
the	O	O	O
safety	O	O	B-T080
and	O	O	O
efficacy	O	O	B-T080
of	O	O	O
dexmedetomidine	O	O	B-T109
(	O	O	O
Dex	O	O	B-T109
)	O	O	O
to	O	O	O
prevent	O	O	O
emergence	O	O	B-T048
agitation	O	O	I-T048
(	O	O	O
EA	O	O	B-T048
)	O	O	O
and	O	O	O
delirium	O	O	B-T048
(	O	O	O
ED	O	O	B-T048
)	O	O	O
in	O	O	O
children	O	O	B-T100
undergoing	O	O	O
laparoscopic	O	O	B-T061
hernia	O	O	I-T061
repair	O	O	I-T061
under	O	O	O
general	O	O	B-T061
anesthesia	O	O	I-T061
.	O	O	O

Methods	O	O	O
100	O	O	O
children	O	O	B-T100
(	O	O	O
1	O	O	O
-	O	O	O
5	O	O	O
years	O	O	B-T079
,	O	O	O
10	O	O	O
-	O	O	O
25	O	O	O
kg	O	O	O
)	O	O	O
were	O	O	O
randomized	O	O	B-T062
into	O	O	O
four	O	O	O
groups	O	O	B-T078
:	O	O	O
controls	O	O	B-T096
(	O	O	O
saline	O	O	B-T167
)	O	O	O
and	O	O	O
intravenous	O	O	B-T082
Dex	O	O	B-T109
at	O	O	O
0.25	O	O	O
,	O	O	O
0.5	O	O	O
,	O	O	O
and	O	O	O
1.0	O	O	O
Âµg/kg	O	O	O
(	O	O	O
D1	O	O	B-T081
,	O	O	O
D2	O	O	B-T081
,	O	O	O
D3	O	O	B-T081
,	O	O	O
respectively	O	O	O
)	O	O	O
.	O	O	O

Dex	O	O	B-T109
/	O	O	O
saline	O	O	B-T167
infusion	O	O	B-T061
was	O	O	O
started	O	O	O
following	O	O	O
anesthesia	O	O	B-T121
.	O	O	O

EA	O	O	B-T048
and	O	O	O
ED	O	O	B-T048
were	O	O	O
evaluated	O	O	O
on	O	O	O
a	O	O	O
5-point	O	O	B-T170
scale	O	O	I-T170
.	O	O	O

Results	O	O	O
For	O	O	O
the	O	O	O
C	O	O	B-T096
,	O	O	O
D1	O	O	B-T081
,	O	O	O
D2	O	O	B-T081
,	O	O	O
and	O	O	O
D3	O	O	B-T081
groups	O	O	B-T078
,	O	O	O
respectively	O	O	O
,	O	O	O
EA	O	O	B-T048
frequencies	O	O	B-T079
were	O	O	O
45.8	O	O	O
%	O	O	O
,	O	O	O
30.4	O	O	O
%	O	O	O
,	O	O	O
12	O	O	O
%	O	O	O
,	O	O	O
4	O	O	O
%	O	O	O
;	O	O	O
ED	O	O	B-T048
frequencies	O	O	O
29.1	O	O	O
%	O	O	O
,	O	O	O
13	O	O	O
%	O	O	O
,	O	O	O
4	O	O	O
%	O	O	O
,	O	O	O
4	O	O	O
%	O	O	O
;	O	O	O
CHIPPS	O	O	B-T170
scores	O	O	B-T081
8	O	O	O
,	O	O	O
6	O	O	O
,	O	O	O
3	O	O	O
,	O	O	O
3	O	O	O
;	O	O	O
sevoflurane	O	O	B-T109
doses	O	O	B-T081
from	O	O	O
13.2	O	O	O
Â±	O	O	O
3.4	O	O	O
(	O	O	O
controls	O	O	B-T096
)	O	O	O
to	O	O	O
9.4	O	O	O
Â±	O	O	O
3.5	O	O	O
ml	O	O	O
(	O	O	O
D3	O	O	O
)	O	O	O
.	O	O	O

Intervals	O	O	B-T079
until	O	O	O
mask	O	O	B-T074
removal	O	O	B-T052
/	O	O	O
spontaneous	O	O	B-T082
eye	O	O	I-T082
opening	O	O	I-T082
were	O	O	O
significantly	O	O	O
longer	O	O	B-T080
for	O	O	O
D2	O	O	B-T081
and	O	O	O
D3	O	O	B-T081
than	O	O	O
controls	O	O	B-T096
.	O	O	O

PACU	O	O	B-T093
stay	O	O	B-T079
was	O	O	O
longer	O	O	B-T080
for	O	O	O
D3	O	O	B-T081
.	O	O	O

Conclusions	O	O	O
There	O	O	O
was	O	O	O
significantly	O	O	O
less	O	O	O
postoperative	O	O	B-T079
EA	O	O	B-T048
and	O	O	O
pain	O	O	B-T184
,	O	O	O
with	O	O	O
less	O	O	O
sevoflurane	O	O	B-T109
required	O	O	O
,	O	O	O
using	O	O	O
Dex	O	O	B-T109
.	O	O	O

-DOCSTART- (28471040)

Farnesylthiosalicylic	O	O	B-T109
acid	O	O	I-T109
-loaded	O	O	O
lipid-polyethylene	O	O	B-T121
glycol-polymer	O	O	I-T121
hybrid	O	O	I-T121
nanoparticles	O	O	I-T121
for	O	O	O
treatment	O	O	B-T061
of	O	O	O
glioblastoma	O	O	O

We	O	O	O
aimed	O	O	O
to	O	O	O
develop	O	O	O
lipid-polyethylene	O	O	B-T121
glycol	O	O	I-T121
(PEG)-polymer	O	O	I-T121
hybrid	O	O	I-T121
nanoparticles	O	O	I-T121
,	O	O	O
which	O	O	O
have	O	O	O
high	O	O	O
affinity	O	O	O
to	O	O	O
tumour	O	O	B-T024
tissue	O	O	I-T024
with	O	O	O
active	O	O	B-T120
ingredient	O	O	I-T120
,	O	O	O
a	O	O	O
new	O	O	O
generation	O	O	B-T079
antineoplastic	O	O	B-T109
drug	O	O	I-T109
,	O	O	O
farnesylthiosalicylic	O	O	B-T109
acid	O	O	I-T109
(	O	O	O
FTA	O	O	B-T109
)	O	O	O
for	O	O	O
treatment	O	O	B-T061
of	O	O	O
glioblastoma	O	O	B-T191
.	O	O	O

Farnesylthiosalicylic	O	O	B-T109
acid	O	O	I-T109
-loaded	O	O	O
poly(lactic-co-glycolic	O	O	B-T121
acid)-1,2	O	O	I-T121
distearoyl-glycerol-3-phospho-ethanolamine-N	O	O	I-T121
[	O	O	I-T121
methoxy	O	O	I-T121
(PEG)-2000	O	O	I-T121
]	O	O	I-T121
ammonium	O	O	I-T121
salt	O	O	I-T121
(	O	O	O
PLGA-DSPE-PEG	O	O	B-T121
)	O	O	O
with	O	O	O
or	O	O	O
without	O	O	O
1,2-dioleoyl-3-trimethylammonium-propane	O	O	B-T121
(	O	O	I-T121
DOTAP	O	O	I-T121
)	O	O	I-T121
hybrid	O	O	I-T121
nanoparticles	O	O	I-T121
has	O	O	O
been	O	O	O
prepared	O	O	B-T033
and	O	O	O
evaluated	O	O	B-T058
for	O	O	O
in-vitro	O	O	B-T062
characterization	O	O	I-T062
.	O	O	O

Cytotoxicity	O	O	B-T049
of	O	O	O
FTA-loaded	O	O	B-T109
nanoparticles	O	O	I-T109
along	O	O	O
with	O	O	O
its	O	O	O
efficacy	O	O	B-T081
on	O	O	O
rat	O	O	B-T025
glioma-2	O	O	I-T025
(	O	O	I-T025
RG2	O	O	I-T025
)	O	O	I-T025
cells	O	O	I-T025
was	O	O	O
also	O	O	O
evaluated	O	O	B-T058
both	O	O	O
in	O	O	B-T062
vitro	O	O	I-T062
(	O	O	O
in	O	O	O
comparison	O	O	O
with	O	O	O
non-malignant	O	O	B-T025
cell	O	O	I-T025
line	O	O	I-T025
,	O	O	I-T025
L929	O	O	I-T025
)	O	O	O
and	O	O	O
in	O	O	B-T062
vivo	O	O	I-T062
.	O	O	O

Scanning	O	O	B-T059
electron	O	O	I-T059
microscopy	O	O	I-T059
studies	O	O	I-T059
showed	O	O	O
that	O	O	O
all	O	O	O
formulations	O	O	B-T077
prepared	O	O	I-T077
had	O	O	O
smooth	O	O	B-T201
surface	O	O	I-T201
and	O	O	O
spherical	O	O	B-T082
in	O	O	I-T082
shape	O	O	I-T082
.	O	O	O

FTA	O	O	B-T109
and	O	O	O
FTA-loaded	O	O	B-T109
nanoparticles	O	O	I-T109
have	O	O	O
cytotoxic	O	O	B-T049
activity	O	O	I-T049
against	O	O	O
RG2	O	O	B-T025
glioma	O	O	I-T025
cell	O	O	I-T025
lines	O	O	I-T025
in	O	O	O
cell	O	O	B-UnknownType
culture	O	O	I-UnknownType
studies	O	O	I-UnknownType
,	O	O	O
which	O	O	O
further	O	O	O
increases	O	O	O
with	O	O	O
addition	O	O	O
of	O	O	O
DOTAP	O	O	B-T121
.	O	O	O

Magnetic	O	O	B-T060
resonance	O	O	I-T060
imaging	O	O	I-T060
and	O	O	O
histopathologic	O	O	B-T091
evaluation	O	O	B-T058
on	O	O	O
RG2	O	O	B-T025
tumour	O	O	I-T025
cells	O	O	I-T025
in	O	O	O
rat	O	O	B-T050
glioma	O	O	I-T050
model	O	O	I-T050
(	O	O	O
49	O	O	O
female	O	O	O
Wistar	O	O	B-T015
rats	O	O	I-T015
,	O	O	O
250	O	O	O
-	O	O	O
300	O	O	O
g	O	O	O
)	O	O	O
comparing	O	O	O
intravenous	O	O	B-T169
and	O	O	O
intratumoral	O	O	B-T169
injections	O	O	I-T169
of	O	O	O
the	O	O	O
drug	O	O	B-T121
have	O	O	O
been	O	O	O
performed	O	O	O
and	O	O	O
FTA-loaded	O	O	B-T109
nanoparticles	O	O	I-T109
reduced	O	O	O
tumour	O	O	B-T082
size	O	O	I-T082
significantly	O	O	O
in	O	O	O
in-vivo	O	O	B-T062
studies	O	O	I-T062
,	O	O	O
with	O	O	O
higher	O	O	O
efficiency	O	O	B-T081
of	O	O	O
intratumoral	O	O	B-T169
administration	O	O	I-T169
than	O	O	O
intravenous	O	O	B-T169
route	O	O	I-T169
.	O	O	O

Farnesylthiosalicylic	O	O	B-T109
acid	O	O	I-T109
-loaded	O	O	O
PLGA-DSPE-PEG-DOTAP	O	O	B-T121
hybrid	O	O	I-T121
nanoparticles	O	O	I-T121
are	O	O	O
proven	O	O	O
to	O	O	O
be	O	O	O
effective	O	O	B-T080
against	O	O	O
glioblastoma	O	O	B-T191
in	O	O	O
both	O	O	O
in-vitro	O	O	B-T062
and	O	O	O
in-vivo	O	O	B-T062
experiments	O	O	I-T062
.	O	O	O

-DOCSTART- (28471296)

Map	O	O	B-T041
learning	O	O	I-T041
and	O	O	O
working	O	O	B-T041
memory	O	O	I-T041
:	O	O	O
Multimodal	O	O	O
learning	O	O	O
strategies	O	O	O

The	O	O	O
current	O	O	O
research	O	O	B-T062
investigated	O	O	O
whether	O	O	O
learning	O	O	B-T041
spatial	O	O	I-T041
information	O	O	B-T078
from	O	O	O
a	O	O	O
map	O	O	B-T073
involves	O	O	O
different	O	O	B-T169
modalities	O	O	I-T169
,	O	O	O
which	O	O	O
are	O	O	O
managed	O	O	O
by	O	O	O
discrete	O	O	O
components	O	O	O
in	O	O	O
working	O	O	B-T041
memory	O	O	I-T041
.	O	O	O

In	O	O	O
four	O	O	O
experiments	O	O	O
,	O	O	O
participants	O	O	B-T098
studied	O	O	O
a	O	O	O
map	O	O	O
either	O	O	O
while	O	O	O
performing	O	O	O
a	O	O	O
simultaneous	O	O	B-T079
interference	O	O	B-T041
task	O	O	I-T041
(	O	O	O
high	O	O	O
cognitive	O	O	B-T081
load	O	O	I-T081
)	O	O	O
or	O	O	O
without	O	O	B-T041
interference	O	O	I-T041
(	O	O	O
low	O	O	O
cognitive	O	O	O
load	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
modality	O	O	B-T078
of	O	O	O
interference	O	O	B-T041
varied	O	O	O
between	O	O	O
experiments	O	O	O
.	O	O	O

Experiment	O	O	O
1	O	O	O
used	O	O	O
a	O	O	O
tapping	O	O	B-T041
task	O	O	I-T041
(	O	O	O
visuospatial	O	O	B-T041
)	O	O	O
,	O	O	O
Experiment	O	O	O
2	O	O	O
a	O	O	O
backwards	O	O	B-T041
counting	O	O	I-T041
task	O	O	I-T041
(	O	O	O
verbal	O	O	B-T080
)	O	O	O
,	O	O	O
Experiment	O	O	O
3	O	O	O
an	O	O	O
articulatory	O	O	B-T048
suppression	O	O	B-T059
task	O	O	I-T059
(	O	O	O
verbal	O	O	O
)	O	O	O
and	O	O	O
Experiment	O	O	O
4	O	O	O
an	O	O	O
n-back	O	O	B-T041
task	O	O	I-T041
(	O	O	O
central	O	O	B-T041
executive	O	O	I-T041
)	O	O	O
.	O	O	O

Spatial	O	O	B-T033
recall	O	O	I-T033
was	O	O	O
assessed	O	O	B-T052
in	O	O	O
two	O	O	O
tests	O	O	O
,	O	O	O
directional	O	O	B-T041
judgements	O	O	I-T041
and	O	O	O
map	O	O	B-UnknownType
drawing	O	O	I-UnknownType
.	O	O	O

Cognitive	O	O	B-T081
load	O	O	I-T081
was	O	O	O
found	O	O	O
to	O	O	O
affect	O	O	O
spatial	O	O	B-T033
recall	O	O	I-T033
detrimentally	O	O	O
regardless	O	O	B-T080
of	O	O	O
interference	O	O	B-T041
modality	O	O	B-T078
.	O	O	O

The	O	O	O
findings	O	O	O
suggest	O	O	O
that	O	O	O
when	O	O	O
learning	O	O	B-T041
maps	O	O	I-T041
people	O	O	O
use	O	O	O
a	O	O	O
multimodal	O	O	O
learning	O	O	B-T065
strategy	O	O	I-T065
,	O	O	O
utilising	O	O	O
resources	O	O	B-T078
from	O	O	O
all	O	O	O
components	O	O	O
of	O	O	O
working	O	O	B-T041
memory	O	O	I-T041
.	O	O	O

-DOCSTART- (28471656)

4-Anilino-2-pyridylquinazolines	O	O	B-T109
and	O	O	O
-	O	O	O
pyrimidines	O	O	B-T114
as	O	O	O
Highly	O	O	O
Potent	O	O	B-T080
and	O	O	O
Nontoxic	O	O	B-T080
Inhibitors	O	O	B-T120
of	O	O	O
Breast	O	O	B-T116
Cancer	O	O	I-T116
Resistance	O	O	I-T116
Protein	O	O	I-T116
(	O	O	O
ABCG2	O	O	B-T116
)	O	O	O

Multidrug	O	O	B-T032
resistance	O	O	I-T032
(	O	O	O
MDR	O	O	B-T032
)	O	O	O
mediated	O	O	O
by	O	O	O
ATP-binding	O	O	B-T116
cassette	O	O	I-T116
(	O	O	I-T116
ABC	O	O	I-T116
)	O	O	I-T116
transport	O	O	I-T116
proteins	O	O	I-T116
remains	O	O	O
a	O	O	O
major	O	O	O
problem	O	O	O
in	O	O	O
the	O	O	O
chemotherapeutic	O	O	B-T061
treatment	O	O	I-T061
of	O	O	O
cancer	O	O	B-T191
and	O	O	O
might	O	O	O
be	O	O	O
overcome	O	O	B-T052
by	O	O	O
inhibition	O	O	B-T052
of	O	O	O
the	O	O	O
transporter	O	O	B-T116
.	O	O	O

Because	O	O	O
of	O	O	O
the	O	O	O
lack	O	O	O
of	O	O	O
understanding	O	O	O
,	O	O	O
the	O	O	O
complex	O	O	O
mechanisms	O	O	B-T169
involved	O	O	O
in	O	O	O
the	O	O	O
transport	O	O	B-T044
process	O	O	I-T044
,	O	O	O
in	O	O	O
particular	O	O	O
for	O	O	O
breast	O	O	B-T116
cancer	O	O	I-T116
resistance	O	O	I-T116
protein	O	O	I-T116
(	O	O	O
BCRP	O	O	B-T116
/	O	O	O
ABCG2	O	O	B-T116
)	O	O	O
,	O	O	O
there	O	O	O
is	O	O	O
a	O	O	O
persistent	O	O	O
need	O	O	O
for	O	O	O
studies	O	O	O
of	O	O	O
inhibitors	O	O	B-T120
of	O	O	O
ABCG2	O	O	O
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	O
,	O	O	O
we	O	O	O
investigated	O	O	B-T169
a	O	O	O
systematic	O	O	O
series	O	O	O
of	O	O	O
4-substituted-2-pyridylquinazolines	O	O	B-T109
in	O	O	O
terms	O	O	O
of	O	O	O
their	O	O	O
inhibitory	O	O	B-T052
potency	O	O	B-T080
as	O	O	O
well	O	O	O
as	O	O	O
selectivity	O	O	B-T081
toward	O	O	O
ABCG2	O	O	B-T116
.	O	O	O

For	O	O	O
comparison	O	O	O
,	O	O	O
the	O	O	O
quinazoline	O	O	B-T109
scaffold	O	O	I-T109
was	O	O	O
reduced	O	O	O
to	O	O	O
the	O	O	O
significantly	O	O	O
smaller	O	O	O
4-methylpyrimidine	O	O	B-T114
basic	O	O	O
structure	O	O	O
.	O	O	O

Furthermore	O	O	O
,	O	O	O
the	O	O	O
cytotoxicity	O	O	B-T049
and	O	O	O
the	O	O	O
ability	O	O	O
to	O	O	O
reverse	O	O	B-T169
MDR	O	O	B-T032
was	O	O	O
tested	O	O	O
with	O	O	O
the	O	O	O
chemotherapeutic	O	O	B-T121
agents	O	O	I-T121
SN-38	O	O	B-T109
and	O	O	O
mitoxantrone	O	O	B-T109
(	O	O	O
MX	O	O	B-T109
)	O	O	O
.	O	O	O

Interaction	O	O	B-T169
of	O	O	O
the	O	O	O
compounds	O	O	B-T103
with	O	O	O
ABCG2	O	O	B-T116
was	O	O	O
investigated	O	O	B-T169
by	O	O	O
a	O	O	O
colorimetric	O	O	B-T059
ATPase	O	O	B-T116
assay	O	O	B-T059
.	O	O	O

Enzyme	O	O	B-T090
kinetic	O	O	I-T090
studies	O	O	I-T090
were	O	O	O
carried	O	O	O
out	O	O	O
with	O	O	O
Hoechst	O	O	B-T121
33342	O	O	I-T121
as	O	O	O
fluorescent	O	O	B-T130
dye	O	O	I-T130
and	O	O	O
substrate	O	O	B-T167
of	O	O	O
ABCG2	O	O	B-T116
to	O	O	O
elucidate	O	O	O
the	O	O	O
compounds	O	O	B-T103
binding	O	O	B-T052
modes	O	O	I-T052
.	O	O	O

-DOCSTART- (28472521)

The	O	O	O
Value	O	O	O
of	O	O	O
Biosamples	O	O	B-T077
in	O	O	O
Smoking	O	O	B-T055
Cessation	O	O	I-T055
Trials	O	O	B-T062
:	O	O	O
A	O	O	O
Review	O	O	O
of	O	O	O
Genetic	O	O	B-T034
,	O	O	O
Metabolomic	O	O	B-T091
,	O	O	O
and	O	O	O
Epigenetic	O	O	B-T045
Findings	O	O	O

Evidence	O	O	O
is	O	O	O
emerging	O	O	O
that	O	O	O
certain	O	O	O
genotypes	O	O	B-T032
and	O	O	O
biomarkers	O	O	B-T201
are	O	O	O
associated	O	O	O
with	O	O	O
smoking	O	O	B-T055
cessation	O	O	I-T055
success	O	O	O
and	O	O	O
efficacy	O	O	O
of	O	O	O
smoking	O	O	B-T061
cessation	O	O	I-T061
treatments	O	O	I-T061
.	O	O	O

We	O	O	O
review	O	O	O
key	O	O	O
findings	O	O	O
that	O	O	O
open	O	O	O
potential	O	O	O
avenues	O	O	O
for	O	O	O
personalizing	O	O	O
smoking	O	O	B-T061
cessation	O	O	I-T061
treatment	O	O	I-T061
according	O	O	O
to	O	O	O
an	O	O	O
individual	O	O	B-T098
's	O	O	I-T098
genetic	O	O	B-T059
or	O	O	O
metabolic	O	O	B-T039
profile	O	O	I-T039
.	O	O	O

These	O	O	O
results	O	O	O
provide	O	O	O
important	O	O	O
incentive	O	O	B-T080
for	O	O	O
smoking	O	O	B-T055
cessation	O	O	I-T055
researchers	O	O	B-T097
to	O	O	O
collect	O	O	O
biosamples	O	O	B-T077
and	O	O	O
perform	O	O	O
genotyping	O	O	B-T059
in	O	O	O
research	O	O	B-T062
studies	O	O	I-T062
and	O	O	O
clinical	O	O	B-T062
trials	O	O	I-T062
.	O	O	O

-DOCSTART- (28473083)

ACR	O	O	B-T094
Appropriateness	O	O	B-T078
Criteria	O	O	I-T078
(	O	O	O
Â®	O	O	O
)	O	O	O
Radiologic	O	O	B-T169
Management	O	O	B-T058
of	O	O	O
Mesenteric	O	O	O
Ischemia	O	O	O

Mesenteric	O	O	B-T047
vascular	O	O	I-T047
insufficiency	O	O	I-T047
is	O	O	O
a	O	O	O
serious	O	O	O
medical	O	O	B-T033
condition	O	O	I-T033
that	O	O	O
may	O	O	O
lead	O	O	O
to	O	O	O
bowel	O	O	B-T047
infarction	O	O	I-T047
,	O	O	O
morbidity	O	O	B-T081
,	O	O	O
and	O	O	O
mortality	O	O	B-T081
that	O	O	O
may	O	O	O
approach	O	O	B-T082
50	O	O	O
%	O	O	O
.	O	O	O

Recommended	O	O	O
therapy	O	O	B-T061
for	O	O	O
acute	O	O	B-T047
mesenteric	O	O	I-T047
ischemia	O	O	I-T047
includes	O	O	O
aspiration	O	O	B-T061
embolectomy	O	O	B-T061
,	O	O	O
transcatheter	O	O	B-T061
thrombolysis	O	O	B-T061
,	O	O	O
and	O	O	O
angioplasty	O	O	B-T061
with	O	O	O
or	O	O	O
without	O	O	O
stenting	O	O	B-T061
for	O	O	O
the	O	O	O
treatment	O	O	B-T061
of	O	O	O
underlying	O	O	O
arterial	O	O	B-T190
stenosis	O	O	I-T190
.	O	O	O

Nonocclusive	O	O	B-T047
mesenteric	O	O	I-T047
ischemia	O	O	I-T047
may	O	O	O
respond	O	O	O
to	O	O	O
transarterial	O	O	B-T061
infusion	O	O	I-T061
of	O	O	O
vasodilators	O	O	B-T121
such	O	O	O
as	O	O	O
nitroglycerin	O	O	B-T109
,	O	O	O
papaverine	O	O	B-T109
,	O	O	O
glucagon	O	O	B-T116
,	O	O	O
and	O	O	O
prostaglandin	O	O	B-T109
E1	O	O	I-T109
.	O	O	O

Recommended	O	O	O
therapy	O	O	B-T061
for	O	O	O
chronic	O	O	B-T047
mesenteric	O	O	I-T047
ischemia	O	O	I-T047
includes	O	O	O
angioplasty	O	O	B-T061
with	O	O	O
or	O	O	O
without	O	O	O
stent	O	O	B-T061
placement	O	O	I-T061
and	O	O	O
,	O	O	O
if	O	O	O
an	O	O	O
endovascular	O	O	B-T061
approach	O	O	I-T061
is	O	O	O
not	O	O	O
possible	O	O	O
,	O	O	O
surgical	O	O	B-T061
bypass	O	O	I-T061
or	O	O	O
endarterectomy	O	O	B-T061
.	O	O	O

The	O	O	O
diagnosis	O	O	B-T033
of	O	O	O
median	O	O	B-T047
arcuate	O	O	I-T047
ligament	O	O	I-T047
syndrome	O	O	I-T047
is	O	O	O
controversial	O	O	O
,	O	O	O
but	O	O	O
surgical	O	O	B-T061
release	O	O	O
may	O	O	O
be	O	O	O
appropriate	O	O	O
depending	O	O	O
on	O	O	O
the	O	O	O
clinical	O	O	B-T080
situation	O	O	I-T080
.	O	O	O

Venous	O	O	B-T082
mesenteric	O	O	B-T047
ischemia	O	O	I-T047
may	O	O	O
respond	O	O	O
to	O	O	O
systemic	O	O	B-T169
anticoagulation	O	O	B-T061
alone	O	O	O
.	O	O	O

Transhepatic	O	O	B-T082
or	O	O	O
transjugular	O	O	B-T082
superior	O	O	B-T023
mesenteric	O	O	I-T023
vein	O	O	I-T023
catheterization	O	O	B-T060
and	O	O	I-T060
thrombolytic	O	O	I-T060
infusion	O	O	I-T060
can	O	O	O
be	O	O	O
offered	O	O	O
depending	O	O	O
on	O	O	O
the	O	O	O
severity	O	O	O
of	O	O	O
symptoms	O	O	B-T184
,	O	O	O
condition	O	O	B-T033
of	O	O	I-T033
the	O	O	I-T033
patient	O	O	I-T033
,	O	O	O
and	O	O	O
response	O	O	B-T032
to	O	O	O
systemic	O	O	B-T169
anticoagulation	O	O	B-T061
.	O	O	O

Adjunct	O	O	B-T169
transjugular	O	O	B-T061
intrahepatic	O	O	I-T061
portosystemic	O	O	I-T061
shunt	O	O	I-T061
creation	O	O	I-T061
can	O	O	O
be	O	O	O
considered	O	O	O
for	O	O	O
outflow	O	O	O
improvement	O	O	B-T077
.	O	O	O

The	O	O	O
American	O	O	B-T094
College	O	O	I-T094
of	O	O	I-T094
Radiology	O	O	I-T094
Appropriateness	O	O	B-T078
Criteria	O	O	I-T078
are	O	O	O
evidence-based	O	O	B-T169
guidelines	O	O	B-T170
for	O	O	O
specific	O	O	O
clinical	O	O	B-T033
conditions	O	O	I-T033
that	O	O	O
are	O	O	O
reviewed	O	O	B-T080
annually	O	O	B-T079
by	O	O	O
a	O	O	O
multidisciplinary	O	O	B-T097
expert	O	O	I-T097
panel	O	O	I-T097
.	O	O	O

The	O	O	O
guideline	O	O	B-T170
development	O	O	B-T169
and	O	O	O
revision	O	O	B-T079
include	O	O	O
an	O	O	O
extensive	O	O	B-T062
analysis	O	O	I-T062
of	O	O	O
current	O	O	O
medical	O	O	B-T078
literature	O	O	I-T078
from	O	O	O
peer-reviewed	O	O	B-T170
journals	O	O	I-T170
and	O	O	O
the	O	O	O
application	O	O	O
of	O	O	O
well-established	O	O	O
methodologies	O	O	B-T062
(	O	O	O
RAND	O	O	B-T170
/	O	O	O
UCLA	O	O	B-T170
Appropriateness	O	O	B-T080
Method	O	O	O
and	O	O	O
Grading	O	O	B-T170
of	O	O	I-T170
Recommendations	O	O	I-T170
Assessment	O	O	I-T170
,	O	O	I-T170
Development	O	O	I-T170
,	O	O	I-T170
and	O	O	I-T170
Evaluation	O	O	I-T170
or	O	O	O
GRADE	O	O	B-T170
)	O	O	O
to	O	O	O
rate	O	O	O
the	O	O	O
appropriateness	O	O	B-T080
of	O	O	O
imaging	O	O	B-T060
and	O	O	O
treatment	O	O	B-T061
procedures	O	O	I-T061
for	O	O	O
specific	O	O	O
clinical	O	O	B-T080
scenarios	O	O	B-T169
.	O	O	O

In	O	O	O
those	O	O	O
instances	O	O	B-T078
where	O	O	O
evidence	O	O	B-T078
is	O	O	O
lacking	O	O	B-T080
or	O	O	O
equivocal	O	O	B-T080
,	O	O	O
expert	O	O	B-T077
opinion	O	O	I-T077
may	O	O	O
supplement	O	O	B-T169
the	O	O	O
available	O	O	O
evidence	O	O	O
to	O	O	O
recommend	O	O	O
imaging	O	O	B-T060
or	O	O	O
treatment	O	O	B-T061
.	O	O	O

-DOCSTART- (28476060)

Blur	O	O	B-T080
perception	O	O	B-T041
throughout	O	O	O
the	O	O	O
visual	O	O	B-T082
field	O	O	I-T082
in	O	O	O
myopia	O	O	B-T047
and	O	O	O
emmetropia	O	O	O

We	O	O	O
evaluated	O	O	B-T058
the	O	O	O
ability	O	O	B-T032
of	O	O	O
emmetropic	O	O	B-T033
and	O	O	O
myopic	O	O	B-T047
observers	O	O	B-T096
to	O	O	O
detect	O	O	B-T033
and	O	O	O
discriminate	O	O	B-T080
blur	O	O	B-T080
across	O	O	O
the	O	O	O
retina	O	O	B-T023
under	O	O	O
monocular	O	O	B-T042
or	O	O	O
binocular	O	O	B-T041
viewing	O	O	I-T041
conditions	O	O	B-T080
.	O	O	O

We	O	O	O
recruited	O	O	B-T052
39	O	O	O
young	O	O	B-T079
(	O	O	O
23	O	O	O
-	O	O	O
30	O	O	O
years	O	O	O
)	O	O	O
healthy	O	O	B-T033
adults	O	O	I-T033
(	O	O	O
n	O	O	O
=	O	O	O
19	O	O	O
myopes	O	O	B-T047
)	O	O	O
with	O	O	O
best-corrected	O	O	B-T080
visual	O	O	B-T201
acuity	O	O	I-T201
0.0	O	O	O
LogMAR	O	O	B-T074
(	O	O	I-T074
20/20	O	O	I-T074
)	O	O	I-T074
or	O	O	O
better	O	O	B-T080
in	O	O	O
each	O	O	O
eye	O	O	B-T023
and	O	O	O
no	O	O	B-T033
binocular	O	O	I-T033
or	O	O	O
accommodative	O	O	B-T033
dysfunction	O	O	I-T033
.	O	O	O

Monocular	O	O	B-T042
and	O	O	O
binocular	O	O	B-T041
blur	O	O	B-T080
discrimination	O	O	B-T080
thresholds	O	O	B-T080
were	O	O	O
measured	O	O	B-T080
as	O	O	O
a	O	O	O
function	O	O	B-T170
of	O	O	O
pedestal	O	O	B-T080
blur	O	O	I-T080
using	O	O	O
naturalistic	O	O	B-T169
stimuli	O	O	B-T067
with	O	O	O
an	O	O	O
adaptive	O	O	B-T060
4AFC	O	O	I-T060
procedure	O	O	I-T060
.	O	O	O

Stimuli	O	O	B-T067
were	O	O	O
presented	O	O	B-T078
in	O	O	O
a	O	O	O
46	O	O	O
Â°	O	O	O
diameter	O	O	B-T081
window	O	O	O
at	O	O	O
40	O	O	O
cm	O	O	O
.	O	O	O

Gaussian	O	O	B-T080
blur	O	O	B-T080
pedestals	O	O	I-T080
were	O	O	O
confined	O	O	B-T169
to	O	O	O
an	O	O	O
annulus	O	O	B-T073
at	O	O	O
either	O	O	O
0	O	O	O
Â°	O	O	O
,	O	O	O
4	O	O	O
Â°	O	O	O
,	O	O	O
8	O	O	O
Â°	O	O	O
,	O	O	O
or	O	O	O
12	O	O	O
Â°	O	O	O
eccentricity	O	O	B-T042
,	O	O	O
with	O	O	O
a	O	O	O
blur	O	O	O
increment	O	O	B-T081
applied	O	O	B-T169
to	O	O	O
only	O	O	O
one	O	O	B-T082
quadrant	O	O	I-T082
of	O	O	O
the	O	O	O
image	O	O	B-T170
.	O	O	O

The	O	O	O
adaptive	O	O	B-T060
procedure	O	O	I-T060
efficiently	O	O	B-T080
estimated	O	O	B-T081
a	O	O	O
dipper	O	O	B-T033
shaped	O	O	I-T033
blur	O	O	B-T080
discrimination	O	O	B-T080
threshold	O	O	B-T080
function	O	O	B-T170
with	O	O	O
two	O	O	B-T081
parameters	O	O	B-T077
:	O	O	O
intrinsic	O	O	B-T082
blur	O	O	O
and	O	O	O
blur	O	O	O
sensitivity	O	O	B-T169
.	O	O	O

The	O	O	O
amount	O	O	B-T081
of	O	O	O
intrinsic	O	O	B-T082
blur	O	O	B-T080
increased	O	O	B-T081
for	O	O	O
retinal	O	O	B-T042
eccentricities	O	O	I-T042
beyond	O	O	O
4	O	O	O
Â°	O	O	O
(	O	O	O
p	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
and	O	O	O
was	O	O	O
lower	O	O	B-T052
in	O	O	O
binocular	O	O	B-T041
than	O	O	O
monocular	O	O	B-T042
conditions	O	O	B-T080
(	O	O	O
p	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
,	O	O	O
but	O	O	O
was	O	O	O
similar	O	O	B-T080
across	O	O	O
refractive	O	O	B-T042
groups	O	O	B-T078
(	O	O	O
p	O	O	O
=	O	O	O
0.47	O	O	O
)	O	O	O
.	O	O	O

Blur	O	O	B-T080
sensitivity	O	O	B-T169
decreased	O	O	B-T081
with	O	O	O
retinal	O	O	B-T042
eccentricity	O	O	I-T042
(	O	O	O
p	O	O	O
<	O	O	O
0.001	O	O	O
)	O	O	O
and	O	O	O
was	O	O	O
highest	O	O	B-T080
for	O	O	O
binocular	O	O	B-T041
viewing	O	O	O
,	O	O	O
but	O	O	O
only	O	O	O
for	O	O	O
central	O	O	B-T042
vision	O	O	I-T042
(	O	O	O
p	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
.	O	O	O

Myopes	O	O	B-T047
showed	O	O	O
worse	O	O	B-T033
blur	O	O	B-T080
sensitivity	O	O	B-T169
than	O	O	O
emmetropes	O	O	B-T033
monocularly	O	O	B-T042
(	O	O	O
p	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
but	O	O	O
not	O	O	O
binocularly	O	O	B-T041
(	O	O	O
p	O	O	O
=	O	O	O
0.66	O	O	O
)	O	O	O
.	O	O	O

As	O	O	O
expected	O	O	O
,	O	O	O
blur	O	O	B-T080
perception	O	O	B-T041
worsens	O	O	B-T033
in	O	O	O
the	O	O	O
visual	O	O	B-T041
periphery	O	O	I-T041
and	O	O	O
binocular	O	O	B-T041
summation	O	O	B-T042
is	O	O	O
most	O	O	O
evident	O	O	B-T078
in	O	O	O
central	O	O	B-T042
vision	O	O	I-T042
.	O	O	O

Furthermore	O	O	O
,	O	O	O
myopes	O	O	B-T047
exhibit	O	O	O
a	O	O	O
monocular	O	O	B-T042
impairment	O	O	B-T169
in	O	O	O
blur	O	O	B-T080
sensitivity	O	O	B-T169
that	O	O	O
improves	O	O	B-T033
under	O	O	O
binocular	O	O	B-T041
conditions	O	O	B-T080
.	O	O	O

Implications	O	O	B-T041
for	O	O	O
the	O	O	O
development	O	O	B-T169
of	O	O	O
myopia	O	O	B-T047
are	O	O	O
discussed	O	O	O
.	O	O	O

-DOCSTART- (28476508)

Risk	O	O	B-T033
Factors	O	O	I-T033
of	O	O	O
Neurological	O	O	B-T184
Deterioration	O	O	I-T184
in	O	O	O
Patients	O	O	B-T101
with	O	O	O
Cerebral	O	O	B-T047
Infarction	O	O	I-T047
due	O	O	O
to	O	O	O
Large-Artery	O	O	O
Atherosclerosis	O	O	O

In	O	O	O
some	O	O	O
patients	O	O	B-T101
with	O	O	O
acute	O	O	B-T079
ischemic	O	O	B-T047
stroke	O	O	I-T047
,	O	O	O
neurological	O	O	B-T184
deterioration	O	O	I-T184
(	O	O	O
ND	O	O	B-T184
)	O	O	O
is	O	O	O
observed	O	O	B-T169
,	O	O	O
and	O	O	O
it	O	O	O
is	O	O	O
difficult	O	O	B-T080
to	O	O	O
predict	O	O	B-T078
at	O	O	O
the	O	O	O
time	O	O	B-T079
of	O	O	I-T079
admission	O	O	I-T079
.	O	O	O

Especially	O	O	O
in	O	O	O
some	O	O	O
patients	O	O	B-T101
with	O	O	O
large-artery	O	O	B-T047
atherosclerosis	O	O	I-T047
(	O	O	O
LAA	O	O	B-T047
)	O	O	O
,	O	O	O
aggressive	O	O	B-T079
medical	O	O	B-T058
treatments	O	O	I-T058
and	O	O	O
surgical	O	O	B-T058
interventions	O	O	I-T058
might	O	O	O
be	O	O	O
helpful	O	O	B-T080
to	O	O	O
prevent	O	O	O
ND	O	O	B-T184
.	O	O	O

Therefore	O	O	O
,	O	O	O
we	O	O	O
investigated	O	O	B-T169
factors	O	O	B-T169
associated	O	O	B-T080
with	O	O	I-T080
ND	O	O	B-T184
in	O	O	O
patients	O	O	B-T101
with	O	O	O
LAA	O	O	B-T047
.	O	O	O

We	O	O	O
studied	O	O	B-T062
patients	O	O	B-T101
with	O	O	O
LAA	O	O	B-T047
who	O	O	O
were	O	O	O
admitted	O	O	B-T058
to	O	O	I-T058
our	O	O	I-T058
hospital	O	O	I-T058
.	O	O	O

We	O	O	O
divided	O	O	B-T169
them	O	O	O
into	O	O	O
2	O	O	O
groups	O	O	B-T078
with	O	O	O
(	O	O	O
group	O	O	B-T078
1	O	O	O
)	O	O	O
and	O	O	O
without	O	O	O
deterioration	O	O	B-T046
(	O	O	O
group	O	O	O
2	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
evaluated	O	O	B-T058
their	O	O	O
medical	O	O	B-T170
records	O	O	I-T170
,	O	O	O
risk	O	O	B-T033
factors	O	O	I-T033
,	O	O	O
and	O	O	O
radiological	O	O	B-T077
findings	O	O	B-T033
,	O	O	O
such	O	O	O
as	O	O	O
number	O	O	O
of	O	O	O
diffusion	O	O	B-T070
-	O	O	O
positive	O	O	B-T033
lesion	O	O	B-T033
and	O	O	O
degree	O	O	B-T201
of	O	O	I-T201
stenosis	O	O	I-T201
.	O	O	O

Our	O	O	O
study	O	O	B-T098
population	O	O	I-T098
consisted	O	O	O
of	O	O	O
171	O	O	O
patients	O	O	B-T101
;	O	O	O
71	O	O	O
(	O	O	O
41.5	O	O	O
%	O	O	O
)	O	O	O
did	O	O	O
and	O	O	O
100	O	O	O
(	O	O	O
58.5	O	O	O
%	O	O	O
)	O	O	O
did	O	O	O
not	O	O	O
suffer	O	O	B-T048
deterioration	O	O	B-T046
.	O	O	O

By	O	O	O
univariate	O	O	B-T062
analysis	O	O	I-T062
,	O	O	O
blood	O	O	B-T040
pressure	O	O	I-T040
(	O	O	O
BP	O	O	B-T040
)	O	O	O
,	O	O	O
heart	O	O	B-T201
rate	O	O	I-T201
,	O	O	O
National	O	O	B-T033
Institutes	O	O	I-T033
of	O	O	I-T033
Health	O	O	I-T033
Stroke	O	O	I-T033
Scale	O	O	I-T033
(	O	O	I-T033
NIHSS	O	O	I-T033
)	O	O	I-T033
score	O	O	I-T033
,	O	O	O
number	O	O	O
of	O	O	O
diffusion	O	O	B-T070
-	O	O	O
positive	O	O	B-T033
lesion	O	O	B-T033
,	O	O	O
count	O	O	B-T059
of	O	O	I-T059
red	O	O	I-T059
blood	O	O	I-T059
cell	O	O	I-T059
,	O	O	O
high-density	O	O	B-T116
lipoprotein	O	O	I-T116
,	O	O	O
and	O	O	O
degree	O	O	B-T201
of	O	O	I-T201
stenosis	O	O	I-T201
differed	O	O	O
significantly	O	O	B-T078
between	O	O	O
the	O	O	O
2	O	O	O
groups	O	O	B-T078
.	O	O	O

By	O	O	O
multivariate	O	O	B-T081
analysis	O	O	I-T081
,	O	O	O
systolic	O	O	B-T201
BP	O	O	I-T201
(	O	O	O
â¥170	O	O	O
mm	O	O	O
Hg	O	O	O
,	O	O	O
odds	O	O	B-T081
ratio	O	O	I-T081
:	O	O	O
7.20	O	O	O
,	O	O	O
P	O	O	O
<	O	O	O
.001	O	O	O
)	O	O	O
was	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
ND	O	O	B-T184
.	O	O	O

Furthermore	O	O	O
,	O	O	O
number	O	O	O
of	O	O	O
diffusion-weighted	O	O	B-T060
image	O	O	I-T060
(DWI)-	O	O	O
positive	O	O	B-T033
lesion	O	O	B-T033
(	O	O	O
â¥8	O	O	O
)	O	O	O
,	O	O	O
degree	O	O	B-T201
of	O	O	I-T201
stenosis	O	O	I-T201
(	O	O	O
>	O	O	O
80.0	O	O	O
%	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
NIHSS	O	O	B-T033
score	O	O	I-T033
(	O	O	O
â¥4	O	O	O
)	O	O	O
were	O	O	O
also	O	O	O
independent	O	O	B-T078
factors	O	O	B-T169
associated	O	O	B-T080
with	O	O	I-T080
ND	O	O	B-T184
.	O	O	O

High	O	O	B-T047
BP	O	O	I-T047
,	O	O	O
severity	O	O	B-T080
of	O	O	O
neurological	O	O	B-T033
deficit	O	O	I-T033
at	O	O	O
the	O	O	O
time	O	O	B-T079
of	O	O	I-T079
admission	O	O	I-T079
,	O	O	O
and	O	O	O
radiological	O	O	B-T077
findings	O	O	B-T033
,	O	O	O
such	O	O	O
as	O	O	O
degree	O	O	B-T201
of	O	O	I-T201
stenosis	O	O	I-T201
and	O	O	O
number	O	O	O
of	O	O	O
DWI	O	O	B-T060
-	O	O	O
positive	O	O	B-T033
lesion	O	O	B-T033
,	O	O	O
are	O	O	O
independently	O	O	B-T033
associated	O	O	B-T080
with	O	O	I-T080
ND	O	O	B-T184
in	O	O	O
patients	O	O	B-T101
with	O	O	O
LAA	O	O	B-T047
.	O	O	O

-DOCSTART- (28477843)

Development	O	O	B-T169
and	O	O	O
validation	O	O	B-T062
of	O	O	O
an	O	O	O
easy-to-use	O	O	O
risk	O	O	B-T058
assessment	O	O	I-T058
tool	O	O	I-T058
for	O	O	O
cumulative	O	O	O
low	O	O	B-T023
back	O	O	I-T023
loading	O	O	B-T032
:	O	O	O
The	O	O	O
Lifting	O	O	B-T122
Fatigue	O	O	I-T122
Failure	O	O	I-T122
Tool	O	O	I-T122
(	O	O	O
LiFFT	O	O	B-T122
)	O	O	O

Recent	O	O	O
evidence	O	O	O
suggests	O	O	O
that	O	O	O
musculoskeletal	O	O	B-T047
disorders	O	O	I-T047
(	O	O	O
MSDs	O	O	B-T047
)	O	O	O
may	O	O	O
be	O	O	O
the	O	O	O
result	O	O	O
of	O	O	O
a	O	O	O
fatigue	O	O	B-T184
failure	O	O	B-T169
process	O	O	I-T169
in	O	O	O
affected	O	O	B-T169
tissues	O	O	B-T024
.	O	O	O

This	O	O	O
paper	O	O	O
describes	O	O	O
a	O	O	O
new	O	O	O
low	O	O	B-T023
back	O	O	I-T023
exposure	O	O	I-T032
assessment	O	O	B-T122
tool	O	O	I-T122
(	O	O	O
the	O	O	O
Lifting	O	O	B-T122
Fatigue	O	O	I-T122
Failure	O	O	I-T122
Tool	O	O	I-T122
[	O	O	O
LiFFT	O	O	B-T122
]	O	O	O
)	O	O	O
,	O	O	O
which	O	O	O
estimates	O	O	O
a	O	O	O
"	O	O	O
daily	O	O	B-T081
dose	O	O	I-T081
"	O	O	O
of	O	O	O
cumulative	O	O	B-T080
loading	O	O	B-T032
on	O	O	O
the	O	O	O
low	O	O	O
back	O	O	O
using	O	O	O
fatigue	O	O	B-T184
failure	O	O	B-T169
principles	O	O	B-T078
.	O	O	O

Only	O	O	O
three	O	O	O
variables	O	O	B-T080
are	O	O	O
necessary	O	O	O
to	O	O	O
derive	O	O	O
the	O	O	O
cumulative	O	O	B-T080
load	O	O	B-T032
associated	O	O	B-T080
with	O	O	I-T080
a	O	O	O
lifting	O	O	B-T052
task	O	O	B-T057
:	O	O	O
the	O	O	O
weight	O	O	B-T081
of	O	O	I-T081
the	O	O	I-T081
load	O	O	I-T081
,	O	O	O
the	O	O	O
maximum	O	O	O
horizontal	O	O	B-T081
distance	O	O	I-T081
from	O	O	O
the	O	O	O
spine	O	O	B-T023
to	O	O	B-T032
the	O	O	I-T032
load	O	O	I-T032
,	O	O	O
and	O	O	O
the	O	O	O
number	O	O	O
of	O	O	O
repetitions	O	O	B-T169
for	O	O	O
tasks	O	O	B-T061
performed	O	O	I-T061
during	O	O	O
the	O	O	O
workday	O	O	B-T079
.	O	O	O

The	O	O	O
new	O	O	B-T122
tool	O	O	I-T122
was	O	O	O
validated	O	O	B-T062
using	O	O	O
two	O	O	O
existing	O	O	O
epidemiological	O	O	B-T169
databases	O	O	B-T170
:	O	O	O
the	O	O	O
Lumbar	O	O	B-T033
Motion	O	O	I-T033
Monitor	O	O	O
(	O	O	O
LMM	O	O	B-T033
)	O	O	O
database	O	O	B-T170
,	O	O	O
and	O	O	O
a	O	O	O
database	O	O	O
from	O	O	O
a	O	O	O
U.S.	O	O	O
automotive	O	O	B-T090
manufacturer	O	O	I-T090
.	O	O	O

The	O	O	O
LiFFT	O	O	B-T122
cumulative	O	O	B-T058
damage	O	O	I-T058
metric	O	O	I-T058
explained	O	O	O
92	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
deviance	O	O	O
in	O	O	O
low	O	O	B-T184
back	O	O	I-T184
disorders	O	O	I-T184
(	O	O	O
LBDs	O	O	B-T184
)	O	O	O
in	O	O	O
the	O	O	O
LMM	O	O	B-UnknownType
database	O	O	I-UnknownType
and	O	O	O
72	O	O	O
-	O	O	O
95	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
deviance	O	O	O
in	O	O	O
low	O	O	B-T080
back	O	O	I-T080
outcomes	O	O	I-T080
in	O	O	O
the	O	O	O
automotive	O	O	B-T073
database	O	O	I-T073
(	O	O	O
depending	O	O	O
on	O	O	O
the	O	O	O
outcome	O	O	B-T081
measure	O	O	I-T081
)	O	O	O
.	O	O	O

Thus	O	O	O
,	O	O	O
LiFFT	O	O	B-T122
is	O	O	O
practitioner	O	O	B-T080
friendly	O	O	I-T080
and	O	O	O
its	O	O	O
cumulative	O	O	B-T080
damage	O	O	B-T058
metric	O	O	I-T058
highly	O	O	O
related	O	O	O
to	O	O	O
low	O	O	B-T080
back	O	O	I-T080
outcomes	O	O	I-T080
.	O	O	O

-DOCSTART- (28478603)

Genetic	O	O	B-T070
Diversity	O	O	I-T070
in	O	O	O
Various	O	O	O
Accessions	O	O	B-T170
of	O	O	O
Pineapple	O	O	B-T002
[	O	O	O
Ananas	O	O	B-T002
comosus	O	O	I-T002
(	O	O	I-T002
L.	O	O	I-T002
)	O	O	I-T002
Merr	O	O	I-T002
.	O	O	I-T002
]	O	O	O
Using	O	O	O
ISSR	O	O	B-T114
and	O	O	O
SSR	O	O	B-T114
Markers	O	O	O

Inter	O	O	B-T114
simple	O	O	B-T114
sequence	O	O	I-T114
repeat	O	O	I-T114
(	O	O	O
ISSR	O	O	B-T114
)	O	O	O
and	O	O	O
simple	O	O	O
sequence	O	O	O
repeat	O	O	O
(	O	O	O
SSR	O	O	B-T114
)	O	O	O
markers	O	O	B-T086
were	O	O	O
used	O	O	O
to	O	O	O
assess	O	O	O
the	O	O	O
genetic	O	O	B-T070
diversity	O	O	I-T070
of	O	O	O
36	O	O	O
pineapple	O	O	B-T002
accessions	O	O	B-T170
that	O	O	O
were	O	O	O
introduced	O	O	O
from	O	O	O
10	O	O	O
countries	O	O	B-T083
/	O	O	O
regions	O	O	B-T083
.	O	O	O

Thirteen	O	O	O
ISSR	O	O	B-T114
primers	O	O	B-T114
amplified	O	O	B-T059
96	O	O	O
bands	O	O	O
,	O	O	O
of	O	O	O
which	O	O	O
91	O	O	O
(	O	O	O
93.65	O	O	O
%	O	O	O
)	O	O	O
were	O	O	O
polymorphic	O	O	B-T080
,	O	O	O
whereas	O	O	O
20	O	O	O
SSR	O	O	B-T114
primers	O	O	O
amplified	O	O	O
73	O	O	O
bands	O	O	O
,	O	O	O
of	O	O	O
which	O	O	O
70	O	O	O
(	O	O	O
96.50	O	O	O
%	O	O	O
)	O	O	O
were	O	O	O
polymorphic	O	O	O
.	O	O	O

Nei	O	O	B-T170
's	O	O	I-T170
gene	O	O	I-T170
diversity	O	O	I-T170
(	O	O	O
h	O	O	B-T170
=	O	O	O
0.28	O	O	O
)	O	O	O
,	O	O	O
Shannon	O	O	B-T170
's	O	O	I-T170
information	O	O	I-T170
index	O	O	I-T170
(	O	O	O
I	O	O	B-T170
=	O	O	O
0.43	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
polymorphism	O	O	B-T170
information	O	O	I-T170
content	O	O	I-T170
(	O	O	O
PIC	O	O	B-T170
=	O	O	O
0.29	O	O	O
)	O	O	O
generated	O	O	O
using	O	O	O
the	O	O	O
SSR	O	O	B-T114
primers	O	O	B-T114
were	O	O	O
higher	O	O	O
than	O	O	O
that	O	O	O
with	O	O	O
ISSR	O	O	B-T114
primers	O	O	O
(	O	O	O
h	O	O	O
=	O	O	O
0.23	O	O	O
,	O	O	O
I	O	O	O
=	O	O	O
0.37	O	O	O
,	O	O	O
PIC	O	O	O
=	O	O	O
0.24	O	O	O
)	O	O	O
,	O	O	O
thereby	O	O	O
suggesting	O	O	O
that	O	O	O
the	O	O	O
SSR	O	O	B-T114
system	O	O	I-T114
is	O	O	O
more	O	O	O
efficient	O	O	O
than	O	O	O
the	O	O	O
ISSR	O	O	B-T114
system	O	O	I-T114
in	O	O	O
assessing	O	O	O
genetic	O	O	B-T070
diversity	O	O	I-T070
in	O	O	O
various	O	O	O
pineapple	O	O	B-T002
accessions	O	O	B-T170
.	O	O	O

Mean	O	O	O
genetic	O	O	B-T169
similarities	O	O	B-T080
were	O	O	O
0.74	O	O	O
,	O	O	O
0.61	O	O	O
,	O	O	O
and	O	O	O
0.69	O	O	O
,	O	O	O
as	O	O	O
determined	O	O	O
using	O	O	O
ISSR	O	O	B-T114
,	O	O	O
SSR	O	O	B-T114
,	O	O	O
and	O	O	O
combined	O	O	O
ISSR	O	O	O
/	O	O	O
SSR	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

These	O	O	O
results	O	O	O
suggest	O	O	O
that	O	O	O
the	O	O	O
genetic	O	O	B-T070
diversity	O	O	I-T070
among	O	O	O
pineapple	O	O	B-T002
accessions	O	O	B-T170
is	O	O	O
very	O	O	O
high	O	O	O
.	O	O	O

We	O	O	O
clustered	O	O	B-T062
the	O	O	O
36	O	O	O
pineapple	O	O	B-T002
accessions	O	O	B-T170
into	O	O	O
three	O	O	O
or	O	O	O
five	O	O	O
groups	O	O	O
on	O	O	O
the	O	O	O
basis	O	O	O
of	O	O	O
the	O	O	O
phylogenetic	O	O	B-T080
trees	O	O	I-T080
constructed	O	O	O
based	O	O	O
on	O	O	O
the	O	O	O
results	O	O	O
of	O	O	O
ISSR	O	O	B-T114
,	O	O	O
SSR	O	O	B-T114
,	O	O	O
and	O	O	O
combined	O	O	O
ISSR	O	O	O
/	O	O	O
SSR	O	O	O
analyses	O	O	B-T062
using	O	O	O
the	O	O	O
unweighted	O	O	B-T170
pair-group	O	O	I-T170
with	O	O	I-T170
arithmetic	O	O	I-T170
averaging	O	O	I-T170
(	O	O	I-T170
UPGMA	O	O	I-T170
)	O	O	I-T170
method	O	O	I-T170
.	O	O	O

The	O	O	O
results	O	O	O
of	O	O	O
principal	O	O	B-T081
components	O	O	I-T081
analysis	O	O	I-T081
(	O	O	O
PCA	O	O	B-T081
)	O	O	O
also	O	O	O
supported	O	O	O
the	O	O	O
UPGMA	O	O	B-T170
clustering	O	O	B-T062
.	O	O	O

These	O	O	O
results	O	O	O
will	O	O	O
be	O	O	O
useful	O	O	O
not	O	O	O
only	O	O	O
for	O	O	O
the	O	O	O
scientific	O	O	O
conservation	O	O	O
and	O	O	O
management	O	O	O
of	O	O	O
pineapple	O	O	B-T002
germplasm	O	O	B-T002
but	O	O	O
also	O	O	O
for	O	O	O
the	O	O	O
improvement	O	O	O
of	O	O	O
the	O	O	O
current	O	O	O
pineapple	O	O	O
breeding	O	O	B-T040
strategies	O	O	I-T040
.	O	O	O

-DOCSTART- (28478636)

Advanced	O	O	B-T098
age	O	O	I-T098
is	O	O	O
not	O	O	O
a	O	O	O
barrier	O	O	B-T169
to	O	O	O
creating	O	O	O
a	O	O	O
functional	O	O	B-T169
arteriovenous	O	O	B-T020
fistula	O	O	I-T020
:	O	O	O
a	O	O	O
retrospective	O	O	O
study	O	O	O

Arteriovenous	O	O	B-T020
fistulas	O	O	I-T020
(	O	O	O
AVFs	O	O	B-T020
)	O	O	O
are	O	O	O
the	O	O	O
recommended	O	O	O
form	O	O	O
of	O	O	O
vascular	O	O	B-T074
access	O	O	I-T074
for	O	O	O
hemodialysis	O	O	B-T061
.	O	O	O

However	O	O	O
,	O	O	O
controversy	O	O	B-T054
exists	O	O	O
regarding	O	O	O
whether	O	O	O
AVFs	O	O	B-T020
are	O	O	O
suitable	O	O	O
for	O	O	O
elderly	O	O	B-T098
patients	O	O	B-T101
.	O	O	O

Single-center	O	O	B-T062
retrospective	O	O	I-T062
review	O	O	I-T062
to	O	O	O
investigate	O	O	B-T169
the	O	O	O
impact	O	O	B-T080
of	O	O	O
age	O	O	B-T032
on	O	O	O
AVF	O	O	B-T020
outcomes	O	O	B-T169
.	O	O	O

Five	O	O	O
hundred	O	O	O
and	O	O	O
twenty-five	O	O	O
patients	O	O	B-T101
with	O	O	O
AVF	O	O	B-T020
creation	O	O	B-T052
were	O	O	O
stratified	O	O	B-T080
based	O	O	O
on	O	O	O
age	O	O	B-T032
<	O	O	B-T100
65	O	O	I-T100
,	O	O	O
65	O	O	B-T100
-	O	O	I-T100
75	O	O	I-T100
,	O	O	O
and	O	O	O
>	O	O	B-T100
75	O	O	I-T100
years	O	O	B-T079
.	O	O	O

AVF	O	O	B-T020
outcomes	O	O	B-T169
including	O	O	O
primary	O	O	B-T080
failure	O	O	B-T169
,	O	O	O
AVF	O	O	O
patency	O	O	B-T042
(	O	O	O
primary	O	O	O
,	O	O	O
secondary	O	O	B-T080
,	O	O	O
and	O	O	O
functional	O	O	B-T169
)	O	O	O
,	O	O	O
and	O	O	O
AVF	O	O	O
complications	O	O	B-T046
were	O	O	O
studied	O	O	O
for	O	O	O
3	O	O	O
years	O	O	B-T079
following	O	O	O
AVF	O	O	O
creation	O	O	B-T052
.	O	O	O

The	O	O	O
cohort	O	O	B-T098
was	O	O	O
63	O	O	O
%	O	O	O
male	O	O	B-T098
,	O	O	O
44	O	O	O
%	O	O	O
Caucasian	O	O	B-T098
,	O	O	O
and	O	O	O
55	O	O	O
%	O	O	O
had	O	O	O
diabetes	O	O	B-T047
or	O	O	O
cardiovascular	O	O	B-T047
disease	O	O	I-T047
.	O	O	O

39	O	O	O
%	O	O	O
were	O	O	O
aged	O	O	B-T032
<	O	O	B-T100
65	O	O	I-T100
years	O	O	B-T079
,	O	O	O
33	O	O	O
%	O	O	O
65	O	O	B-T100
-	O	O	I-T100
75	O	O	I-T100
years	O	O	O
,	O	O	O
and	O	O	O
28	O	O	O
%	O	O	O
were	O	O	O
aged	O	O	O
>	O	O	B-T100
75	O	O	I-T100
years	O	O	O
.	O	O	O

No	O	O	O
differences	O	O	O
in	O	O	O
rates	O	O	O
of	O	O	O
primary	O	O	B-T080
failure	O	O	B-T169
,	O	O	O
loss	O	O	O
of	O	O	O
primary	O	O	O
patency	O	O	B-T042
,	O	O	O
complications	O	O	B-T046
,	O	O	O
or	O	O	O
need	O	O	O
for	O	O	O
intervention	O	O	B-T061
were	O	O	O
observed	O	O	O
between	O	O	O
age	O	O	B-T100
groups	O	O	I-T100
.	O	O	O

There	O	O	O
was	O	O	O
a	O	O	O
significant	O	O	O
association	O	O	B-T080
of	O	O	O
age	O	O	B-T032
with	O	O	O
secondary	O	O	B-T080
patency	O	O	B-T042
and	O	O	O
functional	O	O	B-T169
patency	O	O	O
,	O	O	O
with	O	O	O
age	O	O	O
>	O	O	B-T100
75	O	O	I-T100
being	O	O	O
an	O	O	O
independent	O	O	O
risk	O	O	B-T033
factor	O	O	I-T033
for	O	O	O
shortened	O	O	B-T080
lifespan	O	O	B-T079
of	O	O	O
the	O	O	O
fistula	O	O	O
.	O	O	O

For	O	O	O
patients	O	O	B-T101
aged	O	O	B-T032
>	O	O	B-T100
75	O	O	I-T100
years	O	O	B-T079
,	O	O	O
secondary	O	O	B-T080
patency	O	O	B-T042
at	O	O	O
3	O	O	O
years	O	O	O
was	O	O	O
64	O	O	O
%	O	O	O
compared	O	O	O
to	O	O	O
75%-78	O	O	O
%	O	O	O
for	O	O	O
younger	O	O	B-T079
patients	O	O	O
.	O	O	O

Functional	O	O	B-T169
patency	O	O	B-T042
at	O	O	O
2	O	O	O
years	O	O	B-T079
was	O	O	O
69	O	O	O
%	O	O	O
for	O	O	O
those	O	O	O
aged	O	O	B-T032
>	O	O	B-T100
75	O	O	I-T100
years	O	O	O
compared	O	O	O
to	O	O	O
78%-81	O	O	O
%	O	O	O
for	O	O	O
younger	O	O	B-T079
patients	O	O	B-T101
.	O	O	O

We	O	O	O
found	O	O	O
no	O	O	O
difference	O	O	O
in	O	O	O
AVF	O	O	B-T020
maturation	O	O	B-T039
,	O	O	O
primary	O	O	B-T080
patency	O	O	B-T042
,	O	O	O
complications	O	O	B-T046
,	O	O	O
or	O	O	O
interventions	O	O	B-T061
in	O	O	O
those	O	O	O
over	O	O	O
the	O	O	O
age	O	O	B-T032
of	O	O	O
75	O	O	B-T100
compared	O	O	O
to	O	O	O
younger	O	O	B-T079
counterparts	O	O	O
.	O	O	O

While	O	O	O
secondary	O	O	B-T080
and	O	O	O
functional	O	O	B-T169
patency	O	O	B-T042
rates	O	O	B-T081
were	O	O	O
significantly	O	O	O
lower	O	O	O
in	O	O	O
those	O	O	O
aged	O	O	B-T032
>	O	O	B-T100
75	O	O	I-T100
years	O	O	B-T079
,	O	O	O
the	O	O	O
magnitude	O	O	O
of	O	O	O
difference	O	O	O
is	O	O	O
likely	O	O	O
not	O	O	O
clinically	O	O	O
relevant	O	O	O
.	O	O	O

Therefore	O	O	O
,	O	O	O
we	O	O	O
recommend	O	O	O
that	O	O	O
advanced	O	O	B-T098
age	O	O	I-T098
alone	O	O	O
should	O	O	O
not	O	O	O
preclude	O	O	O
patients	O	O	B-T101
from	O	O	O
AVF	O	O	B-T020
creation	O	O	B-T052
.	O	O	O

-DOCSTART- (28479312)

A	O	O	O
modified	O	O	B-T169
ESBL	O	O	B-T059
Nordmann/Dortet/Poirel-based	O	O	I-T059
protocol	O	O	I-T059
to	O	O	O
optimize	O	O	B-T052
early	O	O	B-T079
sepsis	O	O	B-T047
management	O	O	O

We	O	O	O
evaluated	O	O	B-T169
a	O	O	O
modification	O	O	B-T169
of	O	O	O
a	O	O	O
colorimetric	O	O	B-T059
test	O	O	I-T059
recently	O	O	O
described	O	O	O
by	O	O	O
Dortet	O	O	O
et	O	O	O
al.	O	O	O
(	O	O	O
2015	O	O	O
)	O	O	O
for	O	O	O
the	O	O	O
rapid	O	O	O
detection	O	O	B-T061
of	O	O	O
ESBL	O	O	B-T116
-producing	O	O	O
Enterobacteriaceae	O	O	B-T007
directly	O	O	O
from	O	O	O
positive	O	O	B-T033
blood	O	O	B-T059
cultures	O	O	I-T059
that	O	O	O
requires	O	O	O
less	O	O	O
manipulation	O	O	B-T059
,	O	O	O
materials	O	O	B-T167
and	O	O	O
hands-on	O	O	O
time	O	O	B-T079
.	O	O	O

The	O	O	O
simplified	O	O	O
protocol	O	O	B-T059
showed	O	O	O
a	O	O	O
sensitivity	O	O	B-T169
and	O	O	O
specificity	O	O	B-T081
of	O	O	O
100	O	O	O
%	O	O	O
and	O	O	O
95.7	O	O	O
%	O	O	O
respectively	O	O	O
.	O	O	O

-DOCSTART- (28480148)

The	O	O	O
use	O	O	O
of	O	O	O
informativity	O	O	O
in	O	O	O
the	O	O	O
development	O	O	B-T169
of	O	O	O
robust	O	O	B-T028
viromics	O	O	I-T028
-based	O	O	O
examinations	O	O	O

Metagenomics	O	O	B-T090
-based	O	O	O
studies	O	O	O
have	O	O	O
provided	O	O	O
insight	O	O	O
into	O	O	O
many	O	O	O
of	O	O	O
the	O	O	O
complex	O	O	O
microbial	O	O	B-T001
communities	O	O	I-T001
responsible	O	O	O
for	O	O	O
maintaining	O	O	B-T058
life	O	O	I-T058
on	O	O	I-T058
this	O	O	I-T058
planet	O	O	I-T058
.	O	O	O

Sequencing	O	O	B-T063
efforts	O	O	O
often	O	O	O
uncover	O	O	O
novel	O	O	O
genetic	O	O	B-T114
content	O	O	I-T114
;	O	O	O
this	O	O	O
is	O	O	O
most	O	O	O
evident	O	O	O
for	O	O	O
phage	O	O	B-T005
communities	O	O	I-T005
,	O	O	O
in	O	O	O
which	O	O	O
upwards	O	O	O
of	O	O	O
90	O	O	O
%	O	O	O
of	O	O	O
all	O	O	O
sequences	O	O	B-T059
exhibit	O	O	O
no	O	O	O
similarity	O	O	O
to	O	O	O
any	O	O	O
sequence	O	O	B-T059
in	O	O	O
current	O	O	O
data	O	O	B-T073
repositories	O	O	I-T073
.	O	O	O

For	O	O	O
the	O	O	O
small	O	O	B-T081
fraction	O	O	I-T081
that	O	O	O
can	O	O	O
be	O	O	O
identified	O	O	O
,	O	O	O
the	O	O	O
top	O	O	O
BLAST	O	O	B-T170
hit	O	O	O
is	O	O	O
generally	O	O	O
posited	O	O	O
as	O	O	O
being	O	O	O
representative	O	O	B-T052
of	O	O	O
a	O	O	O
viral	O	O	B-T170
taxon	O	O	I-T170
present	O	O	O
in	O	O	O
the	O	O	O
sample	O	O	O
of	O	O	O
origin	O	O	O
.	O	O	O

Homology	O	O	B-T080
-based	O	O	O
classification	O	O	B-T185
,	O	O	O
however	O	O	O
,	O	O	O
can	O	O	O
be	O	O	O
misleading	O	O	O
as	O	O	O
sequence	O	O	B-T170
repositories	O	O	I-T170
capture	O	O	O
but	O	O	O
a	O	O	O
small	O	O	B-T081
fraction	O	O	I-T081
of	O	O	O
phage	O	O	B-T005
diversity	O	O	I-T005
.	O	O	O

Furthermore	O	O	O
,	O	O	O
lateral	O	O	B-T082
gene	O	O	B-T063
transfer	O	O	I-T063
is	O	O	O
pervasive	O	O	B-T082
within	O	O	O
phage	O	O	B-T005
communities	O	O	I-T005
.	O	O	O

As	O	O	O
such	O	O	O
,	O	O	O
the	O	O	O
presence	O	O	O
of	O	O	O
a	O	O	O
particular	O	O	B-T028
gene	O	O	I-T028
may	O	O	O
not	O	O	O
be	O	O	O
indicative	O	O	O
of	O	O	O
the	O	O	O
presence	O	O	O
of	O	O	O
a	O	O	O
particular	O	O	B-T005
viral	O	O	I-T005
species	O	O	I-T005
.	O	O	O

Rather	O	O	O
,	O	O	O
it	O	O	O
is	O	O	O
just	O	O	O
that	O	O	O
:	O	O	O
an	O	O	O
indication	O	O	B-T078
of	O	O	O
the	O	O	O
presence	O	O	O
of	O	O	O
a	O	O	O
specific	O	O	B-T028
gene	O	O	I-T028
.	O	O	O

To	O	O	O
circumvent	O	O	O
this	O	O	O
limitation	O	O	B-T169
,	O	O	O
we	O	O	O
have	O	O	O
developed	O	O	O
a	O	O	O
new	O	O	O
method	O	O	O
for	O	O	O
the	O	O	O
analysis	O	O	B-T059
of	O	O	I-T059
viral	O	O	I-T059
metagenomic	O	O	I-T059
datasets	O	O	I-T059
.	O	O	O

BLAST	O	O	B-T170
hits	O	O	O
are	O	O	O
weighted	O	O	O
,	O	O	O
integrating	O	O	B-T170
the	O	O	I-T170
sequence	O	O	I-T170
identity	O	O	I-T170
and	O	O	O
length	O	O	B-T063
of	O	O	I-T063
alignments	O	O	I-T063
as	O	O	O
well	O	O	O
as	O	O	O
a	O	O	O
taxonomic	O	O	B-T169
signal	O	O	I-T169
,	O	O	O
such	O	O	O
that	O	O	O
each	O	O	B-T028
gene	O	O	I-T028
is	O	O	O
evaluated	O	O	O
with	O	O	O
respect	O	O	O
to	O	O	O
its	O	O	O
information	O	O	B-T078
content	O	O	I-T078
.	O	O	O

Through	O	O	O
this	O	O	O
quantifiable	O	O	B-T081
metric	O	O	I-T081
,	O	O	O
predictions	O	O	B-T078
of	O	O	O
viral	O	O	B-T001
community	O	O	I-T001
structure	O	O	O
can	O	O	O
be	O	O	O
made	O	O	O
with	O	O	O
confidence	O	O	O
.	O	O	O

As	O	O	O
a	O	O	O
proof-of-concept	O	O	B-T078
,	O	O	O
the	O	O	O
approach	O	O	O
presented	O	O	O
here	O	O	O
was	O	O	O
implemented	O	O	B-T052
and	O	O	O
applied	O	O	O
to	O	O	O
seven	O	O	O
freshwater	O	O	B-T028
viral	O	O	I-T028
metagenomes	O	O	I-T028
.	O	O	O

While	O	O	O
providing	O	O	O
a	O	O	O
robust	O	O	B-T080
method	O	O	I-T080
for	O	O	O
evaluating	O	O	O
viral	O	O	B-T090
metagenomic	O	O	I-T090
data	O	O	I-T090
,	O	O	O
the	O	O	O
tool	O	O	B-T170
is	O	O	O
versatile	O	O	B-T080
and	O	O	O
can	O	O	O
easily	O	O	O
be	O	O	O
customized	O	O	B-T052
to	O	O	O
investigations	O	O	B-T058
of	O	O	O
any	O	O	O
environment	O	O	B-T082
or	O	O	O
biome	O	O	B-T001
.	O	O	O

-DOCSTART- (28480413)

PRESENCE	O	O	B-T033
OF	O	O	I-T033
CITRININ	O	O	B-T195
IN	O	O	O
GRAINS	O	O	B-T168
AND	O	O	O
ITS	O	O	O
POSSIBLE	O	O	B-T033
HEALTH	O	O	B-T078
EFFECTS	O	O	O

Citrinin	O	O	B-T195
is	O	O	O
a	O	O	O
mycotoxin	O	O	B-T109
produced	O	O	B-T169
by	O	O	O
several	O	O	O
species	O	O	B-T185
of	O	O	O
the	O	O	O
genera	O	O	B-T004
Aspergillus	O	O	I-T004
,	O	O	O
Penicillium	O	O	B-T004
and	O	O	O
Monascus	O	O	B-T004
and	O	O	O
it	O	O	O
occurs	O	O	B-T052
mainly	O	O	O
in	O	O	O
stored	O	O	B-T168
grain	O	O	I-T168
.	O	O	O

Citrinin	O	O	B-T195
is	O	O	O
generally	O	O	O
formed	O	O	B-T169
after	O	O	O
harvest	O	O	B-T169
and	O	O	O
occurs	O	O	B-T052
mainly	O	O	O
in	O	O	O
stored	O	O	B-T168
grains	O	O	I-T168
,	O	O	O
it	O	O	O
also	O	O	O
occurs	O	O	O
in	O	O	O
other	O	O	B-UnknownType
plant	O	O	I-UnknownType
products	O	O	I-UnknownType
.	O	O	O

Often	O	O	O
,	O	O	O
the	O	O	O
co-occurrence	O	O	B-T079
with	O	O	O
other	O	O	O
mycotoxins	O	O	B-T109
is	O	O	O
observed	O	O	B-T169
,	O	O	O
especially	O	O	O
ochratoxin	O	O	B-T109
A	O	O	I-T109
,	O	O	O
which	O	O	O
is	O	O	O
usually	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
endemic	O	O	B-T047
nephropathy	O	O	I-T047
.	O	O	O

At	O	O	O
the	O	O	O
European	O	O	B-T092
Union	O	O	I-T092
level	O	O	B-T080
,	O	O	O
systematic	O	O	B-T169
monitoring	O	O	B-T058
of	O	O	O
Citrinin	O	O	B-T195
in	O	O	O
grains	O	O	B-T168
began	O	O	O
with	O	O	O
the	O	O	O
aim	O	O	B-T078
of	O	O	O
determining	O	O	B-T080
its	O	O	O
highest	O	O	O
permissible	O	O	B-T081
amount	O	O	I-T081
in	O	O	O
food	O	O	B-T168
.	O	O	O

Thus	O	O	O
,	O	O	O
far	O	O	O
the	O	O	O
systematic	O	O	B-T169
monitoring	O	O	B-T058
of	O	O	O
the	O	O	O
above	O	O	B-T195
mentioned	O	O	I-T195
mycotoxin	O	O	I-T195
in	O	O	O
Croatia	O	O	B-T083
is	O	O	O
yet	O	O	O
to	O	O	O
begin	O	O	B-T079
.	O	O	O

The	O	O	O
main	O	O	B-T170
goal	O	O	I-T170
of	O	O	O
this	O	O	O
study	O	O	B-T062
was	O	O	O
to	O	O	O
determine	O	O	B-T080
the	O	O	O
presence	O	O	B-T033
of	O	O	I-T033
Citrinin	O	O	B-T195
in	O	O	O
grains	O	O	B-T168
sampled	O	O	B-T078
in	O	O	O
the	O	O	O
area	O	O	B-T082
of	O	O	O
MeÄimurje	O	O	B-T083
,	O	O	O
Osijek-Baranja	O	O	B-T083
,	O	O	O
Vukovar-Srijem	O	O	B-T083
and	O	O	O
Brod-Posavina	O	O	B-T083
County	O	O	I-T083
.	O	O	O

For	O	O	O
the	O	O	O
purpose	O	O	B-T169
of	O	O	O
identification	O	O	B-T080
and	O	O	O
quantification	O	O	B-T081
of	O	O	O
citrinin	O	O	B-T195
,	O	O	O
high	O	O	B-T059
performance	O	O	I-T059
liquid	O	O	I-T059
chromatograph	O	O	I-T059
(	O	O	I-T059
HPLC	O	O	I-T059
)	O	O	I-T059
with	O	O	I-T059
fluorescence	O	O	I-T059
was	O	O	O
used	O	O	B-T033
(	O	O	O
Calibration	O	O	B-T081
curve	O	O	I-T081
k	O	O	O
>	O	O	O
0.999	O	O	O
;	O	O	O
Intra	O	O	B-T170
assay	O	O	I-T170
CV	O	O	I-T170
=	O	O	O
2.1	O	O	O
%	O	O	O
;	O	O	O
Inter	O	O	B-T170
assay	O	O	I-T170
CV	O	O	I-T170
=	O	O	O
4.3	O	O	O
%	O	O	O
;	O	O	O
LOQ	O	O	B-T081
<	O	O	O
1	O	O	O
Î¼g/kg	O	O	O
)	O	O	O
.	O	O	O

From	O	O	O
the	O	O	O
area	O	O	B-T082
of	O	O	O
MeÄimurje	O	O	B-T083
County	O	O	I-T083
,	O	O	O
10	O	O	O
samples	O	O	B-T167
of	O	O	O
corn	O	O	B-T168
and	O	O	O
10	O	O	O
samples	O	O	O
of	O	O	O
wheat	O	O	B-T168
were	O	O	O
analyzed	O	O	B-T062
.	O	O	O

None	O	O	O
of	O	O	O
the	O	O	O
samples	O	O	B-T167
contained	O	O	B-T052
Citrinin	O	O	B-T195
(	O	O	O
<	O	O	O
1	O	O	O
Î¼g/kg	O	O	O
)	O	O	O
.	O	O	O

From	O	O	O
the	O	O	O
area	O	O	B-T082
of	O	O	O
Osijek-Baranja	O	O	B-T083
and	O	O	O
Vukovar-Srijem	O	O	B-T083
County	O	O	B-T083
,	O	O	O
15	O	O	O
samples	O	O	B-T167
from	O	O	O
each	O	O	O
County	O	O	O
were	O	O	O
analyzed	O	O	B-T062
.	O	O	O

The	O	O	O
mean	O	O	B-T081
value	O	O	I-T081
for	O	O	O
the	O	O	O
samples	O	O	B-T167
of	O	O	O
Osijek-Baranja	O	O	B-T083
County	O	O	I-T083
was	O	O	O
19.63	O	O	O
Î¼g/kg	O	O	O
(	O	O	O
median	O	O	B-T081
=	O	O	O
15.8	O	O	O
Î¼g/kg	O	O	O
)	O	O	O
,	O	O	O
while	O	O	O
for	O	O	O
Vukovar-Srijem	O	O	B-T083
County	O	O	I-T083
the	O	O	O
mean	O	O	O
value	O	O	O
of	O	O	O
citrinin	O	O	B-T195
was	O	O	O
14,6	O	O	O
Î¼g/kg	O	O	O
(	O	O	O
median	O	O	O
=	O	O	O
1.23	O	O	O
Î¼g/kg	O	O	O
)	O	O	O
.	O	O	O

From	O	O	O
5	O	O	O
analyzed	O	O	B-T062
samples	O	O	B-T167
from	O	O	O
Brod-Posavina	O	O	B-T083
County	O	O	I-T083
,	O	O	O
one	O	O	O
of	O	O	O
the	O	O	O
samples	O	O	O
contained	O	O	B-T052
citrinin	O	O	B-T195
in	O	O	O
the	O	O	O
amount	O	O	B-T081
of	O	O	O
23.8	O	O	O
Î¼g/kg	O	O	O
,	O	O	O
while	O	O	O
the	O	O	O
registered	O	O	B-T058
amount	O	O	O
s	O	O	O
in	O	O	O
the	O	O	O
other	O	O	O
samples	O	O	O
were	O	O	O
<	O	O	O
1	O	O	O
Î¼g/kg	O	O	O
.	O	O	O

The	O	O	O
results	O	O	B-T169
show	O	O	O
that	O	O	O
grains	O	O	B-T168
from	O	O	O
several	O	O	B-T081
Counties	O	O	B-T083
contain	O	O	B-T052
certain	O	O	O
amounts	O	O	B-T081
of	O	O	O
Citrinin	O	O	B-T195
possibly	O	O	O
indicating	O	O	B-T033
a	O	O	O
significant	O	O	B-T078
intake	O	O	B-T169
of	O	O	O
citrinin	O	O	B-T195
in	O	O	O
humans	O	O	B-T016
.	O	O	O

It	O	O	O
must	O	O	O
be	O	O	O
stated	O	O	O
that	O	O	O
grains	O	O	B-T168
and	O	O	O
grain-based	O	O	B-T168
products	O	O	I-T168
are	O	O	O
the	O	O	O
basis	O	O	O
of	O	O	O
everyday	O	O	B-T079
diet	O	O	B-T168
of	O	O	O
all	O	O	O
age	O	O	B-T100
groups	O	O	I-T100
,	O	O	O
especially	O	O	O
small	O	O	B-T100
children	O	O	I-T100
,	O	O	O
where	O	O	O
higher	O	O	B-T080
intake	O	O	B-T169
of	O	O	O
citrinin	O	O	B-T195
can	O	O	O
occur	O	O	B-T052
.	O	O	O

Consequently	O	O	O
,	O	O	O
we	O	O	O
emphasize	O	O	B-T080
the	O	O	O
need	O	O	O
for	O	O	O
systematic	O	O	B-T169
analysis	O	O	B-T062
of	O	O	O
larger	O	O	B-T081
amount	O	O	I-T081
of	O	O	O
samples	O	O	B-T167
,	O	O	O
from	O	O	O
both	O	O	O
large	O	O	B-T168
grains	O	O	B-T168
and	O	O	O
small	O	O	B-T168
grains	O	O	I-T168
,	O	O	O
especially	O	O	O
in	O	O	O
the	O	O	O
area	O	O	B-T082
of	O	O	O
Brod-Posavina	O	O	B-T083
County	O	O	I-T083
,	O	O	O
in	O	O	O
order	O	O	O
to	O	O	O
obtain	O	O	O
more	O	O	O
realistic	O	O	O
notion	O	O	O
of	O	O	O
citrinin	O	O	B-T195
contamination	O	O	B-T078
of	O	O	O
grains	O	O	O
and	O	O	O
to	O	O	O
asses	O	O	B-T052
the	O	O	O
health	O	O	B-T078
risk	O	O	B-T078
in	O	O	O
humans	O	O	B-T016
.	O	O	O

-DOCSTART- (28481342)

Recurrent	O	O	B-T045
noncoding	O	O	I-T045
regulatory	O	O	I-T045
mutations	O	O	I-T045
in	O	O	O
pancreatic	O	O	O
ductal	O	O	O
adenocarcinoma	O	O	O

The	O	O	O
contributions	O	O	B-T052
of	O	O	O
coding	O	O	B-T045
mutations	O	O	I-T045
to	O	O	O
tumorigenesis	O	O	B-T191
are	O	O	O
relatively	O	O	O
well	O	O	O
known	O	O	O
;	O	O	O
however	O	O	O
,	O	O	O
little	O	O	O
is	O	O	O
known	O	O	O
about	O	O	O
somatic	O	O	B-T049
alterations	O	O	I-T049
in	O	O	O
noncoding	O	O	B-T114
DNA	O	O	I-T114
.	O	O	O

Here	O	O	O
we	O	O	O
describe	O	O	O
GECCO	O	O	O
(	O	O	O
Genomic	O	O	O
Enrichment	O	O	O
Computational	O	O	O
Clustering	O	O	O
Operation	O	O	O
)	O	O	O
to	O	O	O
analyze	O	O	O
somatic	O	O	B-T049
noncoding	O	O	I-T049
alterations	O	O	I-T049
in	O	O	O
308	O	O	O
pancreatic	O	O	B-T191
ductal	O	O	I-T191
adenocarcinomas	O	O	I-T191
(	O	O	O
PDAs	O	O	B-T191
)	O	O	O
and	O	O	O
identify	O	O	O
commonly	O	O	O
mutated	O	O	B-T086
regulatory	O	O	I-T086
regions	O	O	I-T086
.	O	O	O

We	O	O	O
find	O	O	O
recurrent	O	O	B-T045
noncoding	O	O	I-T045
mutations	O	O	I-T045
to	O	O	O
be	O	O	O
enriched	O	O	O
in	O	O	O
PDA	O	O	B-T191
pathways	O	O	B-T044
,	O	O	O
including	O	O	O
axon	O	O	B-T043
guidance	O	O	I-T043
and	O	O	O
cell	O	O	B-T043
adhesion	O	O	I-T043
,	O	O	O
and	O	O	O
newly	O	O	O
identified	O	O	B-T080
processes	O	O	B-T067
,	O	O	O
including	O	O	O
transcription	O	O	B-T045
and	O	O	O
homeobox	O	O	B-T028
genes	O	O	I-T028
.	O	O	O

We	O	O	O
identified	O	O	B-T080
mutations	O	O	B-T045
in	O	O	O
protein	O	O	B-T087
binding	O	O	I-T087
sites	O	O	I-T087
correlating	O	O	O
with	O	O	O
differential	O	O	B-T080
expression	O	O	B-T045
of	O	O	O
proximal	O	O	B-T082
genes	O	O	B-T028
and	O	O	O
experimentally	O	O	O
validated	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
mutations	O	O	O
on	O	O	O
expression	O	O	O
.	O	O	O

We	O	O	O
developed	O	O	O
an	O	O	O
expression	O	O	B-T081
modulation	O	O	I-T081
score	O	O	I-T081
that	O	O	O
quantifies	O	O	B-T081
the	O	O	O
strength	O	O	B-T078
of	O	O	O
gene	O	O	B-T045
regulation	O	O	I-T045
imposed	O	O	O
by	O	O	O
each	O	O	O
class	O	O	O
of	O	O	O
regulatory	O	O	B-T028
elements	O	O	B-T028
,	O	O	O
and	O	O	O
found	O	O	O
the	O	O	O
strongest	O	O	O
elements	O	O	O
were	O	O	O
most	O	O	O
frequently	O	O	O
mutated	O	O	O
,	O	O	O
suggesting	O	O	O
a	O	O	O
selective	O	O	O
advantage	O	O	O
.	O	O	O

Our	O	O	O
detailed	O	O	O
single-cancer	O	O	B-T059
analysis	O	O	I-T059
of	O	O	O
noncoding	O	O	B-T045
alterations	O	O	I-T045
identifies	O	O	O
regulatory	O	O	B-T045
mutations	O	O	I-T045
as	O	O	O
candidates	O	O	B-T080
for	O	O	O
diagnostic	O	O	B-T201
and	O	O	O
prognostic	O	O	B-T080
markers	O	O	I-T080
,	O	O	O
and	O	O	O
suggests	O	O	O
new	O	O	O
mechanisms	O	O	B-T169
for	O	O	O
tumor	O	O	B-T191
evolution	O	O	I-T191
.	O	O	O

-DOCSTART- (28484550)

Distal	O	O	B-T082
posterior	O	O	B-T023
cerebral	O	O	I-T023
artery	O	O	I-T023
revascularization	O	O	B-T061
for	O	O	O
a	O	O	O
fusiform	O	O	B-T077
PCA	O	O	B-T023
aneurysm	O	O	B-T047
:	O	O	O
A	O	O	O
lesson	O	O	O
learned	O	O	O

The	O	O	O
need	O	O	O
for	O	O	O
revascularization	O	O	B-T061
with	O	O	O
proximal	O	O	B-T082
posterior	O	O	B-T023
cerebral	O	O	I-T023
artery	O	O	I-T023
occlusion	O	O	B-T020
in	O	O	O
the	O	O	O
treatment	O	O	B-T169
of	O	O	O
giant	O	O	B-T047
and	O	O	O
fusiform	O	O	B-T190
aneurysms	O	O	I-T190
is	O	O	O
unclear	O	O	O
.	O	O	O

While	O	O	O
early	O	O	O
series	O	O	O
demonstrated	O	O	O
only	O	O	O
about	O	O	O
a	O	O	O
10	O	O	O
%	O	O	O
chance	O	O	O
of	O	O	O
infarction	O	O	B-T046
following	O	O	O
posterior	O	O	B-T023
cerebral	O	O	I-T023
artery	O	O	I-T023
occlusion	O	O	B-T020
,	O	O	O
recently	O	O	O
several	O	O	O
authors	O	O	B-T097
have	O	O	O
advocated	O	O	O
a	O	O	O
bypass	O	O	B-T061
prior	O	O	O
to	O	O	O
parent	O	O	O
vessel	O	O	B-T023
sacrifice	O	O	O
in	O	O	O
all	O	O	O
cases	O	O	O
.	O	O	O

We	O	O	O
present	O	O	O
the	O	O	O
case	O	O	O
of	O	O	O
an	O	O	O
adult	O	O	O
man	O	O	O
with	O	O	O
a	O	O	O
fusiform	O	O	B-T190
aneurysm	O	O	I-T190
of	O	O	O
the	O	O	O
right	O	O	O
posterior	O	O	B-T023
cerebral	O	O	I-T023
artery	O	O	I-T023
at	O	O	O
the	O	O	O
P2-P3	O	O	B-UnknownType
junction	O	O	I-UnknownType
.	O	O	O

He	O	O	O
clinically	O	O	B-T033
failed	O	O	I-T033
a	O	O	O
balloon	O	O	B-T058
test	O	O	I-T058
occlusion	O	O	I-T058
preoperatively	O	O	B-T079
and	O	O	O
therefore	O	O	O
underwent	O	O	O
an	O	O	O
occipital	O	O	B-T023
artery	O	O	I-T023
to	O	O	O
distal	O	O	B-T082
posterior	O	O	B-T023
cerebral	O	O	I-T023
artery	O	O	I-T023
bypass	O	O	B-T061
with	O	O	O
subsequent	O	O	O
endovascular	O	O	B-T061
occlusion	O	O	I-T061
of	O	O	I-T061
the	O	O	I-T061
parent	O	O	I-T061
vessel	O	O	I-T061
and	O	O	O
aneurysm	O	O	B-T047
.	O	O	O

Despite	O	O	O
the	O	O	O
fact	O	O	O
that	O	O	O
the	O	O	O
immediate	O	O	O
and	O	O	O
6	O	O	O
month	O	O	O
follow	O	O	B-T058
up	O	O	I-T058
cerebral	O	O	B-T060
angiography	O	O	I-T060
confirmed	O	O	O
a	O	O	O
patent	O	O	O
bypass	O	O	B-T061
,	O	O	O
the	O	O	O
patient	O	O	B-T101
still	O	O	O
developed	O	O	O
a	O	O	O
posterior	O	O	B-T023
cerebral	O	O	I-T023
artery	O	O	I-T023
territory	O	O	B-T047
stroke	O	O	I-T047
.	O	O	O

We	O	O	O
believe	O	O	O
this	O	O	O
case	O	O	O
demonstrates	O	O	O
that	O	O	O
successful	O	O	O
distal	O	O	B-T082
revascularization	O	O	B-T061
in	O	O	O
the	O	O	O
setting	O	O	O
of	O	O	O
proximal	O	O	B-T082
posterior	O	O	B-T023
cerebral	O	O	I-T023
artery	O	O	I-T023
occlusion	O	O	B-T020
does	O	O	O
not	O	O	O
guarantee	O	O	O
against	O	O	O
cerebral	O	O	B-T047
ischemia	O	O	I-T047
and	O	O	O
infarction	O	O	B-T046
even	O	O	O
in	O	O	O
those	O	O	O
patients	O	O	B-T101
that	O	O	O
fail	O	O	O
a	O	O	O
test	O	O	B-T058
occlusion	O	O	I-T058
.	O	O	O

-DOCSTART- (28487667)

When	O	O	O
Is	O	O	O
a	O	O	O
Test	O	O	B-T080
Score	O	O	I-T080
Fair	O	O	B-T080
for	O	O	O
the	O	O	O
Individual	O	O	B-T098
Who	O	O	O
Is	O	O	O
Being	O	O	O
Tested	O	O	B-T170
?	O	O	O
Effects	O	O	B-T080
of	O	O	I-T080
Different	O	O	O
Scoring	O	O	B-T062
Procedures	O	O	I-T062
across	O	O	O
Multiple	O	O	B-T081
Attempts	O	O	B-T051
When	O	O	O
Testing	O	O	B-T169
a	O	O	O
Motor	O	O	B-T040
Skill	O	O	I-T040
Task	O	O	O

Effects	O	O	B-T080
of	O	O	I-T080
Different	O	O	O
Scoring	O	O	B-T062
Procedures	O	O	I-T062
across	O	O	O
Multiple	O	O	B-T081
Attempts	O	O	B-T051
When	O	O	O
Testing	O	O	B-T169
a	O	O	O
Motor	O	O	B-T040
Skill	O	O	I-T040
Task	O	O	B-T057
Tests	O	O	B-T170
or	O	O	O
test	O	O	B-T170
batteries	O	O	I-T170
used	O	O	O
for	O	O	O
assessing	O	O	B-T052
motor	O	O	B-T040
skills	O	O	I-T040
,	O	O	O
either	O	O	O
in	O	O	O
research	O	O	B-T062
studies	O	O	I-T062
or	O	O	O
in	O	O	O
clinical	O	O	B-T062
settings	O	O	I-T062
,	O	O	O
apply	O	O	O
a	O	O	O
variety	O	O	O
of	O	O	O
procedures	O	O	B-T169
for	O	O	O
scoring	O	O	B-T062
performances	O	O	B-T055
,	O	O	O
including	O	O	O
everything	O	O	O
from	O	O	O
one	O	O	O
to	O	O	O
ten	O	O	O
attempts	O	O	B-T051
,	O	O	O
of	O	O	O
which	O	O	O
the	O	O	O
best	O	O	O
is	O	O	O
scored	O	O	B-T081
or	O	O	O
an	O	O	O
average	O	O	B-T081
is	O	O	O
computed	O	O	B-T059
.	O	O	O

The	O	O	O
rationale	O	O	O
behind	O	O	O
scoring	O	O	B-T062
procedures	O	O	B-T169
is	O	O	O
rarely	O	O	O
stated	O	O	O
,	O	O	O
and	O	O	O
it	O	O	O
seems	O	O	O
that	O	O	O
the	O	O	O
number	O	O	O
of	O	O	O
attempts	O	O	B-T051
allowed	O	O	O
is	O	O	O
decided	O	O	O
without	O	O	O
much	O	O	O
qualification	O	O	O
from	O	O	O
research	O	O	B-T062
.	O	O	O

It	O	O	O
is	O	O	O
uncertain	O	O	O
whether	O	O	O
procedures	O	O	B-T169
fairly	O	O	O
capture	O	O	O
an	O	O	O
individual	O	O	B-T098
's	O	O	I-T098
skill	O	O	B-T040
level	O	O	B-T080
.	O	O	O

Thus	O	O	O
,	O	O	O
the	O	O	O
validity	O	O	O
of	O	O	O
the	O	O	O
tests	O	O	B-T170
may	O	O	O
be	O	O	O
compromised	O	O	O
.	O	O	O

The	O	O	O
present	O	O	O
study	O	O	B-T062
tested	O	O	B-T170
24	O	O	O
young	O	O	O
female	O	O	B-T098
soccer	O	O	B-T056
players	O	O	B-T097
on	O	O	O
the	O	O	O
juggling	O	O	B-T056
of	O	O	O
a	O	O	O
soccer	O	O	B-T073
ball	O	O	I-T073
.	O	O	O

They	O	O	O
were	O	O	O
given	O	O	O
10	O	O	O
attempts	O	O	B-T051
,	O	O	O
and	O	O	O
trials	O	O	B-T062
were	O	O	O
scored	O	O	B-T081
according	O	O	O
to	O	O	O
nine	O	O	O
different	O	O	O
procedures	O	O	B-T169
including	O	O	O
the	O	O	O
'	O	O	O
best	O	O	B-T080
of	O	O	I-T080
'	O	O	O
or	O	O	O
'	O	O	O
mean	O	O	B-T081
of	O	O	I-T081
'	O	O	O
either	O	O	O
one	O	O	O
,	O	O	O
two	O	O	O
,	O	O	O
three	O	O	O
,	O	O	O
five	O	O	O
,	O	O	O
or	O	O	O
ten	O	O	O
attempts	O	O	O
.	O	O	O

Individual	O	O	B-T098
raw	O	O	B-T081
scores	O	O	I-T081
differed	O	O	O
widely	O	O	O
across	O	O	O
trials	O	O	B-T062
,	O	O	O
but	O	O	O
no	O	O	B-T080
general	O	O	I-T080
effect	O	O	I-T080
of	O	O	O
trials	O	O	O
was	O	O	O
found	O	O	O
.	O	O	O

The	O	O	O
mean	O	O	B-T081
(	O	O	I-T081
SD	O	O	I-T081
)	O	O	I-T081
percentage	O	O	I-T081
difference	O	O	I-T081
between	O	O	O
the	O	O	O
lowest	O	O	B-T080
and	O	O	O
highest	O	O	B-T080
scores	O	O	B-T081
was	O	O	O
27.7(9.9)%	O	O	O
,	O	O	O
with	O	O	O
17	O	O	O
players	O	O	B-T097
(	O	O	O
71	O	O	O
%	O	O	O
)	O	O	O
demonstrating	O	O	O
a	O	O	O
significant	O	O	B-T078
change	O	O	O
from	O	O	O
lowest	O	O	O
to	O	O	O
highest	O	O	O
score	O	O	B-T081
.	O	O	O

Correlations	O	O	B-T080
between	O	O	O
raw	O	O	B-T081
scores	O	O	I-T081
were	O	O	O
low	O	O	B-T080
across	O	O	O
trials	O	O	B-T062
,	O	O	O
while	O	O	O
they	O	O	O
were	O	O	O
generally	O	O	O
higher	O	O	B-T080
across	O	O	O
scoring	O	O	B-T062
procedures	O	O	B-T169
.	O	O	O

The	O	O	O
first	O	O	O
trial	O	O	B-T062
was	O	O	O
significantly	O	O	B-T078
different	O	O	B-T080
from	O	O	O
the	O	O	O
remaining	O	O	O
both	O	O	O
as	O	O	O
a	O	O	O
raw	O	O	B-T081
score	O	O	I-T081
and	O	O	O
as	O	O	O
scoring	O	O	B-T062
procedure	O	O	B-T169
.	O	O	O

The	O	O	O
mean	O	O	B-T081
percentage	O	O	I-T081
difference	O	O	B-T080
between	O	O	O
best-of-two	O	O	B-T081
and	O	O	O
best-of-ten	O	O	B-T081
scores	O	O	I-T081
was	O	O	O
95	O	O	O
%	O	O	O
,	O	O	O
with	O	O	O
50	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
players	O	O	B-T097
demonstrating	O	O	O
a	O	O	O
significant	O	O	B-T078
difference	O	O	O
between	O	O	O
the	O	O	O
two	O	O	O
scoring	O	O	B-T062
procedures	O	O	B-T169
.	O	O	O

No	O	O	B-T033
significant	O	O	I-T033
differences	O	O	I-T033
were	O	O	O
found	O	O	O
across	O	O	O
mean-of-rule	O	O	B-T081
scorings	O	O	I-T081
.	O	O	O

Best-of-rule	O	O	B-T081
and	O	O	O
mean-of-rule	O	O	B-T081
scorings	O	O	I-T081
were	O	O	O
significantly	O	O	B-T078
different	O	O	B-T080
except	O	O	O
for	O	O	O
the	O	O	O
best-of-two	O	O	B-T081
vs.	O	O	O
mean-of-two	O	O	B-T081
.	O	O	O

The	O	O	O
mean	O	O	B-T081
difference	O	O	I-T081
between	O	O	O
highest	O	O	B-T080
and	O	O	O
lowest	O	O	B-T080
rank	O	O	B-T170
across	O	O	O
players	O	O	B-T097
was	O	O	O
6.7	O	O	O
(	O	O	O
3.6	O	O	O
)	O	O	O
,	O	O	O
with	O	O	O
individual	O	O	B-T098
rankings	O	O	B-T170
within	O	O	O
the	O	O	O
group	O	O	B-T098
varying	O	O	O
33	O	O	O
%	O	O	O
on	O	O	O
average	O	O	O
across	O	O	O
procedures	O	O	B-T169
.	O	O	O

One	O	O	O
player	O	O	O
moved	O	O	O
from	O	O	O
3rd	O	O	O
to	O	O	O
23rd	O	O	O
place	O	O	O
because	O	O	O
of	O	O	O
procedural	O	O	B-T169
differences	O	O	B-T080
.	O	O	O

Therefore	O	O	O
,	O	O	O
it	O	O	O
is	O	O	O
concluded	O	O	O
that	O	O	O
scoring	O	O	B-T062
procedures	O	O	B-T169
affect	O	O	O
results	O	O	B-T034
and	O	O	O
may	O	O	O
have	O	O	O
an	O	O	O
impact	O	O	O
on	O	O	O
test	O	O	B-T034
outcomes	O	O	I-T034
.	O	O	O

This	O	O	O
may	O	O	O
present	O	O	O
consequences	O	O	O
for	O	O	O
decision-making	O	O	O
from	O	O	O
test	O	O	B-T034
results	O	O	I-T034
,	O	O	O
such	O	O	O
as	O	O	O
diagnosing	O	O	B-T033
and	O	O	O
selection	O	O	O
of	O	O	O
intervention	O	O	B-T061
groups	O	O	B-T078
.	O	O	O

We	O	O	O
hope	O	O	O
that	O	O	O
our	O	O	O
results	O	O	O
would	O	O	O
inspire	O	O	O
further	O	O	O
research	O	O	B-T062
into	O	O	O
the	O	O	O
scoring	O	O	B-T062
procedures	O	O	B-T169
of	O	O	O
the	O	O	O
vast	O	O	O
amount	O	O	O
of	O	O	O
tests	O	O	B-T170
and	O	O	O
tasks	O	O	O
in	O	O	O
common	O	O	O
use	O	O	O
.	O	O	O

-DOCSTART- (28493435)

A	O	O	O
Fast	O	O	B-T170
Peak-Searching	O	O	I-T170
Algorithm	O	O	I-T170
for	O	O	O
Ultrasonic	O	O	O
Elastography	O	O	O

Tissue	O	O	B-T060
axial	O	O	I-T060
strain	O	O	I-T060
estimation	O	O	I-T060
with	O	O	I-T060
ultrasound	O	O	I-T060
elastography	O	O	I-T060
has	O	O	O
become	O	O	O
a	O	O	O
hot	O	O	O
field	O	O	O
in	O	O	O
recent	O	O	O
years	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
for	O	O	O
keypoints	O	O	O
tracking-based	O	O	B-T170
elastography	O	O	I-T170
algorithms	O	O	I-T170
,	O	O	O
locating	O	O	B-T033
extrema	O	O	B-T080
in	O	O	O
multimodal	O	O	O
ultrasonic	O	O	B-T169
radiofrequency	O	O	B-T070
signals	O	O	B-T067
is	O	O	O
still	O	O	O
a	O	O	O
challenging	O	O	O
problem	O	O	B-T033
.	O	O	O

In	O	O	O
this	O	O	O
paper	O	O	O
,	O	O	O
a	O	O	O
new	O	O	O
method	O	O	O
is	O	O	O
proposed	O	O	B-T080
to	O	O	O
locate	O	O	B-T033
the	O	O	O
local	O	O	O
maxima	O	O	B-T081
and	O	O	O
minima	O	O	B-T080
of	O	O	O
the	O	O	O
RF	O	O	B-T070
signals	O	O	B-T067
directly	O	O	O
without	O	O	O
derivation	O	O	B-T080
operation	O	O	B-T052
.	O	O	O

This	O	O	O
algorithm	O	O	B-T170
can	O	O	O
accurately	O	O	O
locate	O	O	B-T033
extrema	O	O	B-T080
even	O	O	O
if	O	O	O
disturbed	O	O	O
peaks	O	O	B-T080
resulting	O	O	O
from	O	O	O
different	O	O	O
noise	O	O	B-T067
exist	O	O	O
.	O	O	O

Furthermore	O	O	O
,	O	O	O
the	O	O	O
new	O	O	O
algorithm	O	O	B-T170
can	O	O	O
speed	O	O	O
up	O	O	O
approximately	O	O	O
79	O	O	O
%	O	O	O
of	O	O	O
the	O	O	O
implementation	O	O	B-T052
process	O	O	O
as	O	O	O
compared	O	O	B-T052
with	O	O	O
the	O	O	O
standard	O	O	B-T062
cross-correlation	O	O	I-T062
method	O	O	I-T062
on	O	O	O
the	O	O	O
same	O	O	O
computing	O	O	B-T052
platform	O	O	O
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
the	O	O	O
elastographic	O	O	O
signal-to-noise	O	O	B-T081
ratio	O	O	I-T081
and	O	O	O
the	O	O	O
contrast-to-noise	O	O	B-T081
ratio	O	O	I-T081
are	O	O	O
also	O	O	O
significantly	O	O	O
improved	O	O	O
with	O	O	O
this	O	O	O
new	O	O	O
method	O	O	O
.	O	O	O

-DOCSTART- (28494223)

Audiovisual	O	O	B-T039
integration	O	O	B-T040
supports	O	O	O
face	O	O	B-T029
-	O	O	O
name	O	O	B-T170
associative	O	O	B-T041
memory	O	O	O
formation	O	O	O

Prior	O	O	O
multisensory	O	O	B-T080
experience	O	O	B-T041
influences	O	O	O
how	O	O	O
we	O	O	O
perceive	O	O	O
our	O	O	O
environment	O	O	B-T082
,	O	O	O
and	O	O	O
hence	O	O	O
how	O	O	O
memories	O	O	B-T041
are	O	O	O
encoded	O	O	O
for	O	O	O
subsequent	O	O	O
retrieval	O	O	B-T041
.	O	O	O

This	O	O	O
study	O	O	B-T062
investigated	O	O	O
if	O	O	O
audiovisual	O	O	B-T039
(	O	O	O
AV	O	O	B-T039
)	O	O	O
integration	O	O	B-T040
and	O	O	O
associative	O	O	B-T041
memory	O	O	B-T041
formation	O	O	I-T041
rely	O	O	O
on	O	O	O
overlapping	O	O	O
or	O	O	O
distinct	O	O	O
processes	O	O	O
.	O	O	O

Our	O	O	O
functional	O	O	O
magnetic	O	O	B-T060
resonance	O	O	I-T060
imaging	O	O	I-T060
results	O	O	O
demonstrate	O	O	O
that	O	O	O
the	O	O	O
neural	O	O	B-T025
mechanisms	O	O	B-T169
underlying	O	O	O
AV	O	O	B-T039
integration	O	O	B-T040
and	O	O	O
associative	O	O	B-T041
memory	O	O	B-T041
overlap	O	O	B-T079
substantially	O	O	O
.	O	O	O

In	O	O	O
particular	O	O	O
,	O	O	O
activity	O	O	B-T052
in	O	O	O
anterior	O	O	B-T030
superior	O	O	I-T030
temporal	O	O	I-T030
sulcus	O	O	I-T030
(	O	O	O
STS	O	O	B-T030
)	O	O	O
is	O	O	O
increased	O	O	O
during	O	O	O
AV	O	O	B-T039
integration	O	O	B-T040
and	O	O	O
also	O	O	O
determines	O	O	O
the	O	O	O
success	O	O	O
of	O	O	O
novel	O	O	O
AV	O	O	O
face	O	O	B-T029
-	O	O	O
name	O	O	B-T170
association	O	O	O
formation	O	O	O
.	O	O	O

Dynamic	O	O	B-UnknownType
causal	O	O	I-UnknownType
modeling	O	O	I-UnknownType
results	O	O	O
further	O	O	O
demonstrate	O	O	O
how	O	O	O
the	O	O	O
anterior	O	O	B-T030
STS	O	O	I-T030
interacts	O	O	O
with	O	O	O
the	O	O	O
associative	O	O	B-T041
memory	O	O	B-T041
system	O	O	I-T041
to	O	O	O
facilitate	O	O	O
successful	O	O	O
memory	O	O	B-T041
formation	O	O	I-T041
for	O	O	O
AV	O	O	B-T039
face	O	O	B-T029
-	O	O	O
name	O	O	B-T170
associations	O	O	B-T041
.	O	O	O

Specifically	O	O	O
,	O	O	O
the	O	O	O
connection	O	O	O
of	O	O	O
fusiform	O	O	B-T023
gyrus	O	O	I-T023
to	O	O	O
anterior	O	O	B-T030
STS	O	O	I-T030
is	O	O	O
enhanced	O	O	O
while	O	O	O
the	O	O	O
reverse	O	O	O
connection	O	O	O
is	O	O	O
reduced	O	O	O
when	O	O	O
participants	O	O	B-T098
subsequently	O	O	O
remembered	O	O	B-T041
both	O	O	O
face	O	O	B-T029
and	O	O	O
name	O	O	B-T170
.	O	O	O

Collectively	O	O	O
,	O	O	O
our	O	O	O
results	O	O	O
demonstrate	O	O	O
how	O	O	O
multisensory	O	O	B-T080
associative	O	O	B-T041
memories	O	O	B-T041
can	O	O	O
be	O	O	O
formed	O	O	O
for	O	O	O
subsequent	O	O	O
retrieval	O	O	B-T041
.	O	O	O

-DOCSTART- (28494350)

Liquid	O	O	B-T059
chromatography-tandem	O	O	I-T059
mass	O	O	I-T059
spectrometry	O	O	I-T059
quantification	O	O	B-T081
of	O	O	O
acetamiprid	O	O	B-T109
and	O	O	O
thiacloprid	O	O	B-T109
residues	O	O	B-T131
in	O	O	O
butterbur	O	O	B-T002
grown	O	O	O
under	O	O	O
regulated	O	O	O
conditions	O	O	O

An	O	O	O
analytical	O	O	B-T170
method	O	O	I-T170
was	O	O	O
developed	O	O	O
to	O	O	O
quantify	O	O	B-T081
the	O	O	O
residual	O	O	B-T131
levels	O	O	B-T080
of	O	O	O
the	O	O	O
neonicotinoid	O	O	B-T131
insecticides	O	O	I-T131
,	O	O	O
acetamiprid	O	O	B-T109
and	O	O	O
thiacloprid	O	O	B-T109
,	O	O	O
in	O	O	O
field-incurred	O	O	B-T169
butterbur	O	O	B-T002
samples	O	O	B-T167
using	O	O	O
liquid	O	O	B-T059
chromatography-tandem	O	O	I-T059
mass	O	O	I-T059
spectrometry	O	O	I-T059
(	O	O	O
LC-MS/MS	O	O	B-T059
)	O	O	O
.	O	O	O

Samples	O	O	B-T167
were	O	O	O
extracted	O	O	B-T059
with	O	O	O
acetonitrile	O	O	B-T109
and	O	O	O
partitioned	O	O	O
with	O	O	O
dichloromethane	O	O	B-T109
.	O	O	O

After	O	O	O
partitioning	O	O	O
,	O	O	O
purification	O	O	B-T169
was	O	O	O
conducted	O	O	O
using	O	O	O
a	O	O	O
Florisil	O	O	B-T074
(	O	O	I-T074
Â®	O	O	I-T074
)	O	O	I-T074
cartridge	O	O	I-T074
.	O	O	O

Linearity	O	O	B-T082
of	O	O	O
a	O	O	O
matrix-matched	O	O	B-T081
calibration	O	O	I-T081
curve	O	O	I-T081
of	O	O	O
the	O	O	O
two	O	O	O
compounds	O	O	B-T131
over	O	O	O
a	O	O	O
concentration	O	O	B-T081
range	O	O	B-T081
of	O	O	O
0.004	O	O	O
-	O	O	O
0.4Î¼g/g	O	O	O
was	O	O	O
excellent	O	O	O
,	O	O	O
with	O	O	O
determination	O	O	B-T081
coefficients	O	O	I-T081
(	O	O	O
R(2))â¥0.9998	O	O	O
.	O	O	O

The	O	O	O
limits	O	O	B-T081
of	O	O	I-T081
detection	O	O	I-T081
(	O	O	O
LOD	O	O	B-T081
)	O	O	O
and	O	O	O
quantitation	O	O	B-T081
(	O	O	O
LOQ	O	O	B-T081
)	O	O	O
for	O	O	O
both	O	O	O
acetamiprid	O	O	B-T109
and	O	O	O
thiacloprid	O	O	B-T109
were	O	O	O
0.0006	O	O	O
and	O	O	O
0.002mg/kg	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

The	O	O	O
average	O	O	O
recoveries	O	O	O
for	O	O	O
acetamiprid	O	O	B-T109
and	O	O	O
thiacloprid	O	O	B-T109
at	O	O	O
two	O	O	O
spiking	O	O	B-T080
levels	O	O	I-T080
(	O	O	O
0.02	O	O	O
and	O	O	O
0.1mg/kg	O	O	O
,	O	O	O
i.e.	O	O	O
,	O	O	O
10	O	O	O
Ã	O	O	O
LOQ	O	O	B-T081
and	O	O	O
50	O	O	O
Ã	O	O	O
LOQ	O	O	O
)	O	O	O
were	O	O	O
between	O	O	O
78.23	O	O	O
to	O	O	O
82.17	O	O	O
%	O	O	O
,	O	O	O
with	O	O	O
relative	O	O	B-T081
standard	O	O	I-T081
deviations	O	O	I-T081
(RSDs)â¤7.22	O	O	O
%	O	O	O
.	O	O	O

The	O	O	O
method	O	O	B-T170
was	O	O	O
successfully	O	O	O
applied	O	O	O
to	O	O	O
field-incurred	O	O	B-T169
samples	O	O	B-T167
treated	O	O	B-T169
with	O	O	O
a	O	O	O
commercial	O	O	B-T170
pesticide	O	O	B-T131
product	O	O	I-T131
,	O	O	O
either	O	O	O
once	O	O	O
(	O	O	O
zero	O	O	O
or	O	O	O
7	O	O	O
days	O	O	B-T079
before	O	O	O
harvest	O	O	B-T169
)	O	O	O
or	O	O	O
twice	O	O	O
(	O	O	O
0	O	O	O
and	O	O	O
7	O	O	O
,	O	O	O
7	O	O	O
and	O	O	O
14	O	O	O
,	O	O	O
or	O	O	O
14	O	O	O
and	O	O	O
21	O	O	O
days	O	O	O
before	O	O	O
harvest	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
highest	O	O	O
and	O	O	O
lowest	O	O	O
residues	O	O	B-T131
were	O	O	O
obtained	O	O	O
for	O	O	O
the	O	O	O
7	O	O	O
and	O	O	O
0	O	O	O
days	O	O	B-T079
'	O	O	O
treatment	O	O	B-T169
and	O	O	O
the	O	O	O
21	O	O	O
and	O	O	O
14	O	O	O
days	O	O	O
'	O	O	O
treatment	O	O	O
,	O	O	O
respectively	O	O	O
.	O	O	O

The	O	O	O
developed	O	O	O
method	O	O	B-T170
is	O	O	O
simple	O	O	O
and	O	O	O
accurate	O	O	B-T080
and	O	O	O
can	O	O	O
be	O	O	O
extrapolated	O	O	O
to	O	O	O
other	O	O	O
leafy	O	O	B-T168
vegetables	O	O	I-T168
.	O	O	O

-DOCSTART- (28495651)

Percentile	O	O	B-T081
categorization	O	O	B-T185
of	O	O	O
QT	O	O	B-T033
interval	O	O	I-T033
as	O	O	O
an	O	O	O
approach	O	O	B-T082
for	O	O	O
identifying	O	O	B-T058
adult	O	O	B-T100
patients	O	O	B-T101
at	O	O	O
risk	O	O	B-T078
for	O	O	O
cardiovascular	O	O	O
death	O	O	O

The	O	O	O
results	O	O	O
from	O	O	O
studies	O	O	O
of	O	O	O
the	O	O	O
association	O	O	O
of	O	O	O
QT	O	O	B-T033
prolongation	O	O	I-T033
with	O	O	O
cardiovascular	O	O	B-T201
death	O	O	I-T201
(	O	O	O
CVD	O	O	B-T201
)	O	O	O
have	O	O	O
been	O	O	O
inconsistent	O	O	B-T080
.	O	O	O

The	O	O	O
purpose	O	O	B-UnknownType
of	O	O	I-UnknownType
this	O	O	I-UnknownType
study	O	O	I-UnknownType
was	O	O	O
to	O	O	O
compare	O	O	B-T052
the	O	O	O
major	O	O	O
correction	O	O	B-T081
formulas	O	O	I-T081
to	O	O	O
percentile	O	O	B-T081
values	O	O	I-T081
of	O	O	O
QT	O	O	B-T081
for	O	O	O
heart	O	O	B-T201
rate	O	O	I-T201
ranges	O	O	B-T081
as	O	O	O
to	O	O	O
their	O	O	O
ability	O	O	B-T032
to	O	O	O
remove	O	O	B-T052
the	O	O	O
relationship	O	O	B-T080
of	O	O	O
QT	O	O	O
to	O	O	O
heart	O	O	O
rate	O	O	O
and	O	O	O
to	O	O	O
predict	O	O	O
CVD	O	O	B-T201
.	O	O	O

Participants	O	O	B-T098
were	O	O	O
16,531	O	O	O
veterans	O	O	B-T098
who	O	O	O
had	O	O	O
an	O	O	O
initial	O	O	O
ECG	O	O	B-T033
at	O	O	O
the	O	O	O
Veterans	O	O	B-T170
Affairs	O	O	I-T170
Medical	O	O	I-T170
Center	O	O	I-T170
,	O	O	O
Palo	O	O	B-T083
Alto	O	O	I-T083
,	O	O	O
between	O	O	O
March	O	O	B-T079
31	O	O	O
,	O	O	O
1987	O	O	O
,	O	O	O
and	O	O	O
December	O	O	B-T080
20	O	O	O
,	O	O	O
1999	O	O	O
,	O	O	O
and	O	O	O
were	O	O	O
followed	O	O	O
for	O	O	O
CVD	O	O	B-T201
.	O	O	O

The	O	O	O
4	O	O	O
major	O	O	O
correction	O	O	B-T081
formulas	O	O	I-T081
(	O	O	O
Bazett	O	O	B-T081
,	O	O	O
Fridericia	O	O	B-T081
,	O	O	O
Framingham	O	O	B-T081
,	O	O	O
and	O	O	O
Hodges	O	O	B-T081
)	O	O	O
were	O	O	O
used	O	O	O
to	O	O	O
correct	O	O	O
QT	O	O	B-T033
interval	O	O	I-T033
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
the	O	O	O
percentiles	O	O	B-T081
for	O	O	O
heart	O	O	B-T201
rate	O	O	I-T201
ranges	O	O	B-T081
as	O	O	O
proposed	O	O	O
by	O	O	O
Schwartz	O	O	B-T016
were	O	O	O
calculated	O	O	O
.	O	O	O

During	O	O	O
median	O	O	B-T082
follow-up	O	O	O
of	O	O	O
17.8	O	O	O
years	O	O	B-T079
,	O	O	O
455	O	O	O
CVD	O	O	B-T201
events	O	O	O
occurred	O	O	O
.	O	O	O

When	O	O	O
compared	O	O	O
to	O	O	O
the	O	O	O
other	O	O	O
equations	O	O	B-T077
,	O	O	O
QTc	O	O	O
Bazett	O	O	O
had	O	O	O
the	O	O	O
greatest	O	O	O
dependence	O	O	O
on	O	O	O
heart	O	O	B-T201
rate	O	O	I-T201
(	O	O	O
R(2	O	O	O
)	O	O	O
=	O	O	O
0.18	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
hazard	O	O	B-T081
ratio	O	O	I-T081
(	O	O	O
95	O	O	O
%	O	O	O
confidence	O	O	B-T081
interval	O	O	I-T081
)	O	O	O
for	O	O	O
CVD	O	O	B-T201
was	O	O	O
2.08	O	O	O
(	O	O	O
1.28	O	O	O
-	O	O	O
3.9	O	O	O
)	O	O	O
for	O	O	O
the	O	O	O
98th	O	O	O
percentile	O	O	B-T081
of	O	O	O
QT	O	O	B-T033
interval	O	O	I-T033
by	O	O	O
heart	O	O	B-T201
rate	O	O	I-T201
ranges	O	O	B-T081
,	O	O	O
2.05	O	O	O
(	O	O	O
1.27	O	O	O
-	O	O	O
3.33	O	O	O
)	O	O	O
for	O	O	O
QTc	O	O	B-T081
Bazett	O	O	I-T081
,	O	O	O
1.39	O	O	O
(	O	O	O
0.44	O	O	O
-	O	O	O
4.34	O	O	O
)	O	O	O
for	O	O	O
QTc	O	O	O
Fridericia	O	O	O
,	O	O	O
1.05	O	O	O
(	O	O	O
0.26	O	O	O
-	O	O	O
4.24	O	O	O
)	O	O	O
for	O	O	O
QTc	O	O	B-T081
Hodges	O	O	I-T081
,	O	O	O
and	O	O	O
1.12	O	O	O
(	O	O	O
0.28	O	O	O
-	O	O	O
4.52	O	O	O
)	O	O	O
for	O	O	O
QTc	O	O	B-T081
Framingham	O	O	I-T081
.	O	O	O

The	O	O	O
hazard	O	O	O
ratio	O	O	O
of	O	O	O
QTc	O	O	B-T081
Bazett	O	O	I-T081
was	O	O	O
significantly	O	O	B-T081
higher	O	O	I-T081
than	O	O	O
the	O	O	O
other	O	O	O
formulas	O	O	B-T170
except	O	O	O
for	O	O	O
the	O	O	O
98th	O	O	O
percentile	O	O	B-T081
method	O	O	O
.	O	O	O

The	O	O	O
Framingham	O	O	B-T081
,	O	O	O
Hodges	O	O	B-T081
,	O	O	O
and	O	O	O
Fridericia	O	O	B-T081
equations	O	O	I-T081
remove	O	O	B-T052
the	O	O	O
effect	O	O	B-T080
of	O	O	O
heart	O	O	B-T201
rate	O	O	I-T201
on	O	O	O
QT	O	O	B-T033
interval	O	O	I-T033
significantly	O	O	O
better	O	O	O
than	O	O	O
the	O	O	O
Bazett	O	O	B-T081
equation	O	O	I-T081
.	O	O	O

Using	O	O	O
QT-interval	O	O	B-T033
percentiles	O	O	B-T081
based	O	O	O
on	O	O	O
heart	O	O	B-T201
rate	O	O	I-T201
provides	O	O	O
a	O	O	O
consistent	O	O	O
approach	O	O	B-T082
both	O	O	O
for	O	O	O
identifying	O	O	O
those	O	O	O
whose	O	O	O
QT	O	O	B-T033
intervals	O	O	I-T033
prolong	O	O	O
due	O	O	O
to	O	O	O
drugs	O	O	B-T061
or	O	O	O
other	O	O	O
stressors	O	O	B-T078
and	O	O	O
for	O	O	O
assessing	O	O	O
CVD	O	O	B-T201
risk	O	O	B-T078
.	O	O	O

-DOCSTART- (28495934)

How	O	O	O
Should	O	O	O
I	O	O	O
Study	O	O	O
for	O	O	O
the	O	O	O
Exam	O	O	B-UnknownType
?	O	O	O
Self-Regulated	O	O	B-T041
Learning	O	O	I-T041
Strategies	O	O	B-T065
and	O	O	O
Achievement	O	O	B-T065
in	O	O	O
Introductory	O	O	O
Biology	O	O	O

In	O	O	O
college	O	O	B-T073
introductory	O	O	B-T090
science	O	O	I-T090
courses	O	O	B-T065
,	O	O	O
students	O	O	B-T098
are	O	O	O
challenged	O	O	O
with	O	O	O
mastering	O	O	O
large	O	O	O
amounts	O	O	O
of	O	O	O
disciplinary	O	O	B-T080
content	O	O	I-T080
while	O	O	O
developing	O	O	O
as	O	O	O
autonomous	O	O	B-UnknownType
and	O	O	O
effective	O	O	B-T080
learners	O	O	B-T098
.	O	O	O

Self-regulated	O	O	B-T041
learning	O	O	I-T041
(	O	O	O
SRL	O	O	B-T041
)	O	O	O
is	O	O	O
the	O	O	O
process	O	O	O
of	O	O	O
setting	O	O	O
learning	O	O	B-T078
goals	O	O	I-T078
,	O	O	O
monitoring	O	O	O
progress	O	O	B-T169
toward	O	O	O
them	O	O	O
,	O	O	O
and	O	O	O
applying	O	O	O
appropriate	O	O	O
study	O	O	B-T065
strategies	O	O	I-T065
.	O	O	O

SRL	O	O	B-T041
characterizes	O	O	O
successful	O	O	O
,	O	O	O
"	O	O	O
expert	O	O	O
"	O	O	O
learners	O	O	B-T098
,	O	O	O
and	O	O	O
develops	O	O	O
with	O	O	O
time	O	O	O
and	O	O	O
practice	O	O	O
.	O	O	O

In	O	O	O
a	O	O	O
large	O	O	O
,	O	O	O
undergraduate	O	O	B-T170
introductory	O	O	B-T091
biology	O	O	I-T091
course	O	O	B-T065
,	O	O	O
we	O	O	O
investigated	O	O	O
:	O	O	O
1	O	O	O
)	O	O	O
what	O	O	O
SRL	O	O	B-T041
strategies	O	O	B-T065
students	O	O	B-T098
reported	O	O	O
using	O	O	O
the	O	O	O
most	O	O	O
when	O	O	O
studying	O	O	O
for	O	O	O
exams	O	O	B-UnknownType
,	O	O	O
2	O	O	O
)	O	O	O
which	O	O	O
strategies	O	O	O
were	O	O	O
associated	O	O	O
with	O	O	O
higher	O	O	O
achievement	O	O	B-T053
and	O	O	O
with	O	O	O
grade	O	O	B-T185
improvement	O	O	B-T033
on	O	O	O
exams	O	O	O
,	O	O	O
and	O	O	O
3	O	O	O
)	O	O	O
what	O	O	O
study	O	O	O
approaches	O	O	O
students	O	O	O
proposed	O	O	O
to	O	O	O
use	O	O	O
for	O	O	O
future	O	O	O
exams	O	O	O
.	O	O	O

Higher	O	O	B-T080
-	O	O	O
achieving	O	O	B-T053
students	O	O	B-T098
,	O	O	O
and	O	O	O
students	O	O	O
whose	O	O	O
exam	O	O	B-UnknownType
grades	O	O	B-T185
improved	O	O	B-T033
in	O	O	O
the	O	O	O
first	O	O	B-T033
half	O	O	I-T033
of	O	O	O
the	O	O	O
semester	O	O	B-T079
,	O	O	O
reported	O	O	O
using	O	O	O
specific	O	O	O
cognitive	O	O	B-T041
and	O	O	O
metacognitive	O	O	B-T041
strategies	O	O	I-T041
significantly	O	O	O
more	O	O	O
frequently	O	O	B-T079
than	O	O	O
their	O	O	O
lower	O	O	B-T052
-	O	O	O
achieving	O	O	O
peers	O	O	B-T098
.	O	O	O

Lower	O	O	B-T052
-	O	O	O
achieving	O	O	B-T053
students	O	O	B-T098
more	O	O	O
frequently	O	O	B-T079
reported	O	O	O
that	O	O	O
they	O	O	O
did	O	O	O
not	O	O	O
implement	O	O	O
their	O	O	O
planned	O	O	O
strategies	O	O	B-T065
or	O	O	O
,	O	O	O
if	O	O	O
they	O	O	O
did	O	O	O
,	O	O	O
still	O	O	O
did	O	O	O
not	O	O	O
improve	O	O	O
their	O	O	O
outcomes	O	O	B-T169
.	O	O	O

These	O	O	O
results	O	O	O
suggest	O	O	O
that	O	O	O
many	O	O	O
students	O	O	B-T098
entering	O	O	O
introductory	O	O	B-T091
biology	O	O	I-T091
have	O	O	O
limited	O	O	B-T169
knowledge	O	O	B-T065
of	O	O	O
SRL	O	O	B-T041
strategies	O	O	B-T065
and/or	O	O	O
limited	O	O	O
ability	O	O	O
to	O	O	O
implement	O	O	O
them	O	O	O
,	O	O	O
which	O	O	O
can	O	O	O
impact	O	O	B-T080
their	O	O	O
achievement	O	O	B-T065
.	O	O	O

Course	O	O	B-T065
-specific	O	O	O
interventions	O	O	B-T058
that	O	O	O
promote	O	O	O
SRL	O	O	B-T041
development	O	O	O
should	O	O	O
be	O	O	O
considered	O	O	O
as	O	O	O
integral	O	O	O
pedagogical	O	O	B-T090
tools	O	O	I-T090
,	O	O	O
aimed	O	O	O
at	O	O	O
fostering	O	O	B-T056
development	O	O	O
of	O	O	O
students	O	O	B-T098
'	O	O	O
lifelong	O	O	B-T079
learning	O	O	B-T041
skills	O	O	I-T041
.	O	O	O

-DOCSTART- (28499120)

Characterising	O	O	B-T052
bias	O	O	B-T078
in	O	O	O
regulatory	O	O	B-T078
risk	O	O	I-T078
and	O	O	O
decision	O	O	B-T090
analysis	O	O	B-T062
:	O	O	O
An	O	O	O
analysis	O	O	O
of	O	O	O
heuristics	O	O	B-T170
applied	O	O	O
in	O	O	O
health	O	O	B-T058
technology	O	O	I-T058
appraisal	O	O	B-T058
,	O	O	O
chemicals	O	O	B-T103
regulation	O	O	B-T064
,	O	O	O
and	O	O	O
climate	O	O	B-T070
change	O	O	I-T070
governance	O	O	O

In	O	O	O
many	O	O	O
environmental	O	O	B-T185
and	O	O	O
public	O	O	B-T170
health	O	O	I-T170
domains	O	O	I-T170
,	O	O	O
heuristic	O	O	B-T170
methods	O	O	I-T170
of	O	O	O
risk	O	O	B-T078
and	O	O	O
decision	O	O	B-T090
analysis	O	O	I-T090
must	O	O	O
be	O	O	O
relied	O	O	O
upon	O	O	O
,	O	O	O
either	O	O	O
because	O	O	O
problem	O	O	B-T033
structures	O	O	I-T033
are	O	O	O
ambiguous	O	O	O
,	O	O	O
reliable	O	O	O
data	O	O	B-T078
is	O	O	O
lacking	O	O	B-T080
,	O	O	O
or	O	O	O
decisions	O	O	B-T041
are	O	O	O
urgent	O	O	O
.	O	O	O

This	O	O	O
introduces	O	O	O
an	O	O	O
additional	O	O	O
source	O	O	B-T033
of	O	O	O
uncertainty	O	O	B-T033
beyond	O	O	O
model	O	O	B-T170
and	O	O	O
measurement	O	O	B-T081
error	O	O	I-T081
-	O	O	O
uncertainty	O	O	O
stemming	O	O	O
from	O	O	O
relying	O	O	O
on	O	O	O
inexact	O	O	O
inference	O	O	B-T170
rules	O	O	I-T170
.	O	O	O

Here	O	O	O
we	O	O	O
identify	O	O	B-T169
and	O	O	O
analyse	O	O	B-T169
heuristics	O	O	B-T170
used	O	O	O
to	O	O	O
prioritise	O	O	O
risk	O	O	B-T078
objects	O	O	B-T077
,	O	O	O
to	O	O	O
discriminate	O	O	B-T080
between	O	O	O
signal	O	O	B-T067
and	O	O	O
noise	O	O	B-T067
,	O	O	O
to	O	O	O
weight	O	O	B-T081
evidence	O	O	B-T078
,	O	O	O
to	O	O	O
construct	O	O	O
models	O	O	B-T170
,	O	O	O
to	O	O	O
extrapolate	O	O	O
beyond	O	O	O
datasets	O	O	B-T170
,	O	O	O
and	O	O	O
to	O	O	O
make	O	O	O
policy	O	O	B-T170
.	O	O	O

Some	O	O	O
of	O	O	O
these	O	O	O
heuristics	O	O	B-T170
are	O	O	O
based	O	O	O
on	O	O	O
causal	O	O	O
generalisations	O	O	B-T080
,	O	O	O
yet	O	O	O
can	O	O	O
misfire	O	O	O
when	O	O	O
these	O	O	O
relationships	O	O	B-T080
are	O	O	O
presumed	O	O	O
rather	O	O	O
than	O	O	O
tested	O	O	O
(	O	O	O
e.g.	O	O	O
surrogates	O	O	B-T099
in	O	O	O
clinical	O	O	B-T062
trials	O	O	I-T062
)	O	O	O
.	O	O	O

Others	O	O	O
are	O	O	O
conventions	O	O	B-T080
designed	O	O	O
to	O	O	O
confer	O	O	O
stability	O	O	B-T080
to	O	O	O
decision	O	O	B-T090
analysis	O	O	I-T090
,	O	O	O
yet	O	O	O
which	O	O	O
may	O	O	O
introduce	O	O	O
serious	O	O	O
error	O	O	B-T080
when	O	O	O
applied	O	O	O
ritualistically	O	O	O
(	O	O	O
e.g.	O	O	O
significance	O	O	B-T169
testing	O	O	I-T169
)	O	O	O
.	O	O	O

Some	O	O	O
heuristics	O	O	B-T170
can	O	O	O
be	O	O	O
traced	O	O	O
back	O	O	O
to	O	O	O
formal	O	O	O
justifications	O	O	B-T078
,	O	O	O
but	O	O	O
only	O	O	O
subject	O	O	O
to	O	O	O
strong	O	O	O
assumptions	O	O	B-T078
that	O	O	O
are	O	O	O
often	O	O	O
violated	O	O	O
in	O	O	O
practical	O	O	B-T169
applications	O	O	I-T169
.	O	O	O

Heuristic	O	O	B-T170
decision	O	O	B-T170
rules	O	O	I-T170
(	O	O	O
e.g.	O	O	O
feasibility	O	O	B-T170
rules	O	O	I-T170
)	O	O	O
in	O	O	O
principle	O	O	O
act	O	O	O
as	O	O	O
surrogates	O	O	B-T099
for	O	O	O
utility	O	O	B-T080
maximisation	O	O	I-T080
or	O	O	O
distributional	O	O	B-T169
concerns	O	O	B-T078
,	O	O	O
yet	O	O	O
in	O	O	O
practice	O	O	B-T077
may	O	O	O
neglect	O	O	O
costs	O	O	B-T081
and	O	O	I-T081
benefits	O	O	I-T081
,	O	O	O
be	O	O	O
based	O	O	O
on	O	O	O
arbitrary	O	O	B-T080
thresholds	O	O	B-T080
,	O	O	O
and	O	O	O
be	O	O	O
prone	O	O	O
to	O	O	O
gaming	O	O	O
.	O	O	O

We	O	O	O
highlight	O	O	O
the	O	O	O
problem	O	O	B-T033
of	O	O	O
rule-entrenchment	O	O	B-T067
,	O	O	O
where	O	O	O
analytical	O	O	B-T052
choices	O	O	I-T052
that	O	O	O
are	O	O	O
in	O	O	O
principle	O	O	O
contestable	O	O	O
are	O	O	O
arbitrarily	O	O	O
fixed	O	O	O
in	O	O	O
practice	O	O	B-T077
,	O	O	O
masking	O	O	O
uncertainty	O	O	B-T033
and	O	O	O
potentially	O	O	O
introducing	O	O	O
bias	O	O	B-T078
.	O	O	O

Strategies	O	O	B-T041
for	O	O	O
making	O	O	O
risk	O	O	B-T078
and	O	O	O
decision	O	O	B-T090
analysis	O	O	B-T062
more	O	O	O
rigorous	O	O	O
include	O	O	O
:	O	O	O
formalising	O	O	O
the	O	O	O
assumptions	O	O	B-T078
and	O	O	O
scope	O	O	B-T077
conditions	O	O	B-T078
under	O	O	O
which	O	O	O
heuristics	O	O	B-T170
should	O	O	O
be	O	O	O
applied	O	O	O
;	O	O	O
testing	O	O	B-T169
rather	O	O	O
than	O	O	O
presuming	O	O	O
their	O	O	O
underlying	O	O	O
empirical	O	O	B-T078
or	O	O	O
theoretical	O	O	B-T078
justifications	O	O	I-T078
;	O	O	O
using	O	O	O
sensitivity	O	O	B-T081
analysis	O	O	O
,	O	O	O
simulations	O	O	B-T062
,	O	O	O
multiple	O	O	B-T062
bias	O	O	I-T062
analysis	O	O	I-T062
,	O	O	O
and	O	O	O
deductive	O	O	B-T170
systems	O	O	I-T170
of	O	O	I-T170
inference	O	O	I-T170
(	O	O	O
e.g.	O	O	O
directed	O	O	B-T170
acyclic	O	O	I-T170
graphs	O	O	I-T170
)	O	O	O
to	O	O	O
characterise	O	O	O
rule	O	O	B-T170
uncertainty	O	O	B-T033
and	O	O	O
refine	O	O	O
heuristics	O	O	O
;	O	O	O
adopting	O	O	O
"	O	O	O
recovery	O	O	B-T170
schemes	O	O	I-T170
"	O	O	O
to	O	O	O
correct	O	O	O
for	O	O	O
known	O	O	O
biases	O	O	B-T078
;	O	O	I-T078
and	O	O	O
basing	O	O	O
decision	O	O	B-T170
rules	O	O	I-T170
on	O	O	O
clearly	O	O	O
articulated	O	O	O
values	O	O	B-T080
and	O	O	O
evidence	O	O	B-T078
,	O	O	O
rather	O	O	O
than	O	O	O
convention	O	O	B-T080
.	O	O	O

-DOCSTART- (28501028)

Multicentric	O	O	B-T191
Castleman	O	O	I-T191
disease	O	O	I-T191
of	O	O	O
hyaline	O	O	B-T031
vascular	O	O	B-T023
variant	O	O	B-T080
presenting	O	O	O
with	O	O	O
unusual	O	O	B-T080
systemic	O	O	B-T169
manifestations	O	O	B-T080
:	O	O	O
a	O	O	O
case	O	O	O
report	O	O	O

Castleman	O	O	B-T191
disease	O	O	I-T191
is	O	O	O
a	O	O	O
rare	O	O	B-T080
lymphoproliferative	O	O	B-T191
disorder	O	O	I-T191
presenting	O	O	O
with	O	O	O
localized	O	O	B-T082
or	O	O	O
disseminated	O	O	B-T082
lymphadenopathy	O	O	B-T047
and	O	O	O
systemic	O	O	B-T169
manifestations	O	O	B-T080
.	O	O	O

It	O	O	O
can	O	O	O
be	O	O	O
categorized	O	O	B-T185
in	O	O	O
numerous	O	O	B-T081
ways	O	O	O
,	O	O	O
such	O	O	O
as	O	O	O
unicentric	O	O	B-T047
versus	O	O	O
multicentric	O	O	B-T191
,	O	O	O
histopathological	O	O	B-T169
variants	O	O	B-T080
(	O	O	O
hyaline	O	O	B-T031
-	O	O	O
vascular	O	O	B-T023
,	O	O	O
plasma	O	O	B-T025
cell	O	O	I-T025
,	O	O	O
and	O	O	O
mixed	O	O	B-T080
)	O	O	O
,	O	O	O
or	O	O	O
subtypes	O	O	B-T185
based	O	O	O
on	O	O	O
causative	O	O	B-T033
viral	O	O	B-T047
infections	O	O	I-T047
(	O	O	O
human	O	O	B-T005
immunodeficiency	O	O	I-T005
virus	O	O	I-T005
,	O	O	O
human	O	O	B-T005
herpesvirus-8	O	O	I-T005
,	O	O	O
or	O	O	O
Kaposi	O	O	B-T005
sarcoma	O	O	I-T005
herpesvirus	O	O	I-T005
)	O	O	O
.	O	O	O

Presentation	O	O	O
ranges	O	O	O
from	O	O	O
asymptomatic	O	O	B-T033
to	O	O	O
symptoms	O	O	B-T184
involving	O	O	O
multiple	O	O	B-T081
organs	O	O	B-T023
.	O	O	O

Even	O	O	O
though	O	O	O
the	O	O	O
exact	O	O	O
mechanism	O	O	B-T169
of	O	O	O
pathogenesis	O	O	B-T046
is	O	O	O
unknown	O	O	O
,	O	O	O
treatment	O	O	B-T169
is	O	O	O
directed	O	O	B-T080
toward	O	O	O
possible	O	O	O
etiologies	O	O	B-T169
such	O	O	O
as	O	O	O
interleukin-6	O	O	B-T116
,	O	O	O
cluster	O	O	B-T116
of	O	O	I-T116
differentiation	O	O	I-T116
20	O	O	I-T116
,	O	O	O
and	O	O	O
viral	O	O	B-T169
agents	O	O	I-T169
.	O	O	O

A	O	O	O
36-	O	O	O
year	O	O	B-T079
-old	O	O	O
Sri	O	O	B-T098
Lankan	O	O	I-T098
woman	O	O	B-T098
presented	O	O	O
with	O	O	O
generalized	O	O	O
body	O	O	B-T184
swelling	O	O	I-T184
and	O	O	O
foamy	O	O	B-T184
urine	O	O	I-T184
of	O	O	O
2	O	O	O
weeks	O	O	B-T079
'	O	O	O
duration	O	O	B-T079
.	O	O	O

Examination	O	O	B-T058
revealed	O	O	O
pallor	O	O	B-T033
;	O	O	O
generalized	O	O	B-T033
edema	O	O	I-T033
;	O	O	O
axillary	O	O	B-T029
,	O	O	O
cervical	O	O	B-T082
,	O	O	O
and	O	O	O
inguinal	O	O	B-T047
lymphadenopathy	O	O	I-T047
;	O	O	O
hypertension	O	O	B-T047
;	O	O	O
and	O	O	O
hepatomegaly	O	O	B-T033
.	O	O	O

Investigations	O	O	B-T058
showed	O	O	O
bicytopenia	O	O	B-T034
,	O	O	O
nephrotic	O	O	B-T033
range	O	O	I-T033
proteinuria	O	O	I-T033
with	O	O	O
hypoalbuminemia	O	O	B-T047
,	O	O	O
hypogammaglobulinemia	O	O	B-T047
,	O	O	O
and	O	O	O
features	O	O	B-T080
of	O	O	O
hyaline	O	O	B-T031
-	O	O	O
vascular	O	O	B-T023
type	O	O	B-T080
Castleman	O	O	B-T191
disease	O	O	I-T191
in	O	O	O
a	O	O	O
lymph	O	O	B-T060
node	O	O	I-T060
biopsy	O	O	I-T060
.	O	O	O

She	O	O	O
was	O	O	O
managed	O	O	B-T058
with	O	O	O
rituximab	O	O	B-T116
and	O	O	O
had	O	O	O
good	O	O	O
clinical	O	O	B-T080
improvement	O	O	B-T077
.	O	O	O

Castleman	O	O	B-T191
disease	O	O	B-T047
has	O	O	O
a	O	O	O
broad	O	O	B-T082
spectrum	O	O	B-T077
of	O	O	O
clinical	O	O	B-T080
manifestations	O	O	B-T080
,	O	O	O
disease	O	O	O
pathogeneses	O	O	B-T046
,	O	O	O
and	O	O	O
associations	O	O	B-T080
and/or	O	O	O
complications	O	O	B-T046
.	O	O	O

Medical	O	O	B-T169
professionals	O	O	B-T097
need	O	O	O
to	O	O	O
be	O	O	O
familiar	O	O	O
with	O	O	O
this	O	O	O
spectrum	O	O	B-T077
because	O	O	O
timely	O	O	O
diagnosis	O	O	B-T033
and	O	O	O
aggressive	O	O	B-T061
targeted	O	O	I-T061
therapy	O	O	I-T061
are	O	O	O
the	O	O	O
cornerstones	O	O	O
of	O	O	O
managing	O	O	O
these	O	O	O
patients	O	O	B-T101
.	O	O	O

-DOCSTART- (28501699)

The	O	O	O
AGES-Reykjavik	O	O	B-T073
study	O	O	I-T073
atlases	O	O	B-T073
:	O	O	O
Non-linear	O	O	B-T077
multi-spectral	O	O	B-T078
template	O	O	I-T078
and	O	O	O
atlases	O	O	O
for	O	O	O
studies	O	O	B-T062
of	O	O	O
the	O	O	O
ageing	O	O	B-T040
brain	O	O	O

Quantitative	O	O	B-T081
analyses	O	O	I-T081
of	O	O	O
brain	O	O	B-T023
structures	O	O	B-T082
from	O	O	O
Magnetic	O	O	B-T060
Resonance	O	O	I-T060
(	O	O	O
MR	O	O	B-T060
)	O	O	O
image	O	O	B-T060
data	O	O	B-T078
are	O	O	O
often	O	O	O
performed	O	O	O
using	O	O	O
automatic	O	O	B-T169
segmentation	O	O	B-T066
algorithms	O	O	B-T170
.	O	O	O

Many	O	O	O
of	O	O	O
these	O	O	O
algorithms	O	O	B-T170
rely	O	O	O
on	O	O	O
templates	O	O	B-T078
and	O	O	O
atlases	O	O	B-T073
in	O	O	O
a	O	O	O
common	O	O	O
coordinate	O	O	B-T170
space	O	O	I-T170
.	O	O	O

Most	O	O	O
freely	O	O	B-T080
available	O	O	B-T169
brain	O	O	B-T023
atlases	O	O	B-T073
are	O	O	O
generated	O	O	O
from	O	O	O
relatively	O	O	O
young	O	O	B-T079
individuals	O	O	B-T098
and	O	O	O
not	O	O	O
always	O	O	O
derived	O	O	O
from	O	O	O
well-defined	O	O	O
cohort	O	O	B-T081
studies	O	O	I-T081
.	O	O	O

In	O	O	O
this	O	O	O
paper	O	O	O
,	O	O	O
we	O	O	O
introduce	O	O	O
a	O	O	O
publicly	O	O	B-T092
available	O	O	B-T169
multi-spectral	O	O	B-T078
template	O	O	I-T078
with	O	O	O
corresponding	O	O	O
tissue	O	O	B-T024
probability	O	O	B-T081
atlases	O	O	B-T073
and	O	O	O
regional	O	O	B-T082
atlases	O	O	O
,	O	O	O
optimised	O	O	B-T052
to	O	O	O
use	O	O	O
in	O	O	O
studies	O	O	B-T062
of	O	O	O
ageing	O	O	B-T040
cohorts	O	O	B-T098
(	O	O	O
mean	O	O	O
age	O	O	O
75	O	O	O
Â±	O	O	O
5	O	O	O
years	O	O	O
)	O	O	O
.	O	O	O

Furthermore	O	O	O
,	O	O	O
we	O	O	O
provide	O	O	O
validation	O	O	B-T062
data	O	O	B-T078
from	O	O	O
a	O	O	O
regional	O	O	B-T082
segmentation	O	O	B-T066
pipeline	O	O	O
to	O	O	O
assure	O	O	O
the	O	O	O
integrity	O	O	B-T080
of	O	O	O
the	O	O	O
dataset	O	O	B-T170
.	O	O	O

-DOCSTART- (28502652)

Comparative	O	O	B-T062
and	O	O	O
evolutionary	O	O	B-T062
analysis	O	O	I-T062
of	O	O	O
an	O	O	O
adapter	O	O	B-T028
molecule	O	O	I-T028
MyD88	O	O	I-T028
in	O	O	O
invertebrate	O	O	B-T204
metazoans	O	O	O

The	O	O	O
myeloid	O	O	B-T028
differentiation	O	O	I-T028
factor	O	O	I-T028
88	O	O	I-T028
(	O	O	O
MyD88	O	O	B-T028
)	O	O	O
is	O	O	O
an	O	O	O
essential	O	O	O
adapter	O	O	O
in	O	O	O
Toll-like	O	O	B-T116
receptor	O	O	I-T116
(	O	O	O
TLR	O	O	B-T116
)	O	O	O
signalling	O	O	B-T043
pathways	O	O	I-T043
,	O	O	O
with	O	O	O
TLR	O	O	O
the	O	O	O
first	O	O	O
pattern-recognition	O	O	B-T116
receptor	O	O	I-T116
(	O	O	O
PRR	O	O	B-T116
)	O	O	O
that	O	O	O
was	O	O	O
discovered	O	O	O
in	O	O	O
Drosophila	O	O	B-T204
.	O	O	O

In	O	O	O
the	O	O	O
present	O	O	O
study	O	O	B-T062
,	O	O	O
a	O	O	O
MyD88	O	O	B-T028
gene	O	O	I-T028
was	O	O	O
identified	O	O	B-T080
and	O	O	O
characterized	O	O	B-T052
from	O	O	O
a	O	O	O
commercially	O	O	O
important	O	O	O
shellfish	O	O	B-T204
,	O	O	O
Scapharca	O	O	B-T204
subcrenata	O	O	I-T204
,	O	O	O
including	O	O	O
a	O	O	O
DEATH	O	O	B-T087
domain	O	O	I-T087
and	O	O	O
TIR	O	O	B-T082
domain	O	O	I-T082
conserved	O	O	O
within	O	O	O
other	O	O	O
molluscs	O	O	B-T204
.	O	O	O

Furthermore	O	O	O
,	O	O	O
comparative	O	O	B-T063
genomic	O	O	I-T063
evidence	O	O	I-T063
revealed	O	O	O
that	O	O	O
MyD88	O	O	B-T028
was	O	O	O
of	O	O	O
different	O	O	B-T080
lengths	O	O	B-T081
and	O	O	O
contained	O	O	O
quantitative	O	O	B-T081
exon	O	O	B-T114
and	O	O	O
intron	O	O	B-T114
regions	O	O	I-T114
,	O	O	O
which	O	O	O
might	O	O	O
be	O	O	O
involved	O	O	O
in	O	O	O
specific	O	O	B-T169
mechanisms	O	O	I-T169
.	O	O	O

To	O	O	O
further	O	O	O
explore	O	O	O
the	O	O	O
phylogenetic	O	O	B-T062
relationships	O	O	I-T062
of	O	O	O
invertebrate	O	O	B-T204
metazoan	O	O	B-T204
MyD88	O	O	B-T028
,	O	O	O
we	O	O	O
applied	O	O	O
MrBayes	O	O	B-T170
and	O	O	I-T170
PhyML	O	O	I-T170
software	O	O	I-T170
to	O	O	O
construct	O	O	B-T185
phylogenetic	O	O	B-T080
trees	O	O	I-T080
using	O	O	O
Bayesian	O	O	B-T081
and	O	O	O
maximum	O	O	B-T081
likelihood	O	O	I-T081
approaches	O	O	I-T081
,	O	O	O
respectively	O	O	O
,	O	O	O
which	O	O	O
suggested	O	O	O
that	O	O	O
the	O	O	O
MyD88	O	O	O
of	O	O	O
Arthropoda	O	O	B-T204
was	O	O	O
closely	O	O	O
related	O	O	O
to	O	O	O
lower	O	O	B-T080
invertebrates	O	O	B-T204
,	O	O	O
in	O	O	O
contrast	O	O	B-T080
to	O	O	O
morphological	O	O	B-T082
taxonomy	O	O	B-T090
.	O	O	O

Finally	O	O	O
,	O	O	O
we	O	O	O
investigated	O	O	B-T169
the	O	O	O
evolutionary	O	O	B-T045
patterns	O	O	I-T045
and	O	O	O
location	O	O	O
of	O	O	O
positive	O	O	B-T028
selection	O	O	I-T028
sites	O	O	I-T028
(	O	O	O
PSSs	O	O	B-T028
)	O	O	O
in	O	O	O
the	O	O	O
MyD88	O	O	B-T028
gene	O	O	I-T028
from	O	O	O
Arthropoda	O	O	B-T204
,	O	O	O
Mollusca	O	O	B-T204
and	O	O	O
Insecta	O	O	B-T204
using	O	O	O
PAML	O	O	B-T170
software	O	O	I-T170
with	O	O	O
the	O	O	O
maximum	O	O	B-T170
likelihood	O	O	I-T170
method	O	O	I-T170
.	O	O	O

The	O	O	O
data	O	O	B-T078
showed	O	O	O
that	O	O	O
positive	O	O	B-T028
selection	O	O	I-T028
sites	O	O	I-T028
were	O	O	O
detected	O	O	B-T033
in	O	O	O
these	O	O	O
groups	O	O	B-T098
,	O	O	O
and	O	O	O
partial	O	O	B-T087
sites	O	O	I-T087
were	O	O	O
located	O	O	O
in	O	O	O
the	O	O	O
TIR	O	O	B-T082
domain	O	O	I-T082
but	O	O	O
were	O	O	O
not	O	O	B-T033
found	O	O	I-T033
in	O	O	O
the	O	O	O
DEATH	O	O	B-T087
domain	O	O	I-T087
.	O	O	O

To	O	O	O
summarize	O	O	O
,	O	O	O
in	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
we	O	O	O
report	O	O	O
on	O	O	O
the	O	O	O
diversification	O	O	B-T057
of	O	O	O
MyD88	O	O	B-T028
in	O	O	O
invertebrate	O	O	B-T204
metazoans	O	O	B-T204
,	O	O	O
the	O	O	O
specific	O	O	B-T080
evolutionary	O	O	B-T045
position	O	O	I-T045
of	O	O	O
Arthropoda	O	O	B-T204
MyD88	O	O	O
,	O	O	O
and	O	O	O
the	O	O	O
positive	O	O	B-T033
selection	O	O	B-T045
pressures	O	O	I-T045
on	O	O	O
MyD88	O	O	O
of	O	O	O
Arthropoda	O	O	O
,	O	O	O
Mollusca	O	O	B-T204
and	O	O	O
Insecta	O	O	B-T204
.	O	O	O

These	O	O	O
results	O	O	B-T169
are	O	O	O
a	O	O	O
valuable	O	O	B-T052
contribution	O	O	I-T052
to	O	O	O
understand	O	O	O
and	O	O	O
clarify	O	O	B-T052
the	O	O	O
evolutionary	O	O	B-T045
pattern	O	O	I-T045
of	O	O	O
TLR	O	O	B-T116
/	O	O	O
MyD88	O	O	B-T028
signalling	O	O	B-T043
pathways	O	O	I-T043
in	O	O	O
invertebrate	O	O	B-T204
and	O	O	O
vertebrate	O	O	B-T010
taxa	O	O	I-T010
.	O	O	O

-DOCSTART- (28503387)

Rubinstein-Taybi	O	O	B-T047
Syndrome	O	O	I-T047
Associated	O	O	B-T080
with	O	O	I-T080
Pituitary	O	O	B-T191
Macroadenoma	O	O	I-T191
:	O	O	O
A	O	O	O
Case	O	O	O
Report	O	O	O

Rubinstein-Taybi	O	O	B-T047
Syndrome	O	O	I-T047
(	O	O	O
RSTS	O	O	B-T047
)	O	O	O
is	O	O	O
an	O	O	O
autosomal	O	O	B-T047
dominant	O	O	I-T047
disorder	O	O	I-T047
that	O	O	O
is	O	O	O
classically	O	O	O
characterized	O	O	B-T052
by	O	O	O
prenatal	O	O	B-T079
and	O	O	O
postnatal	O	O	B-T079
growth	O	O	B-T046
restriction	O	O	I-T046
,	O	O	O
microcephaly	O	O	B-T019
,	O	O	O
dysmorphic	O	O	B-T019
craniofacial	O	O	I-T019
features	O	O	I-T019
,	O	O	O
broad	O	O	B-T033
thumbs	O	O	I-T033
and	O	O	O
toes	O	O	B-T033
,	O	O	O
and	O	O	O
intellectual	O	O	B-T048
disability	O	O	I-T048
.	O	O	O

We	O	O	O
describe	O	O	O
the	O	O	O
first	O	O	O
reported	O	O	O
case	O	O	O
of	O	O	O
a	O	O	O
pituitary	O	O	B-T191
macroadenoma	O	O	I-T191
associated	O	O	B-T080
with	O	O	I-T080
RSTS	O	O	B-T047
.	O	O	O

A	O	O	O
39-year-old	O	O	O
Caucasian	O	O	B-T098
female	O	O	B-T098
with	O	O	O
a	O	O	O
past	O	O	B-T033
medical	O	O	I-T033
history	O	O	I-T033
of	O	O	O
RSTS	O	O	B-T047
diagnosed	O	O	B-T033
at	O	O	O
age	O	O	B-T032
two	O	O	O
was	O	O	O
found	O	O	O
to	O	O	O
have	O	O	O
a	O	O	O
gadolinium	O	O	B-T130
-enhancing	O	O	O
pituitary	O	O	B-T190
mass	O	O	I-T190
on	O	O	O
magnetic	O	O	B-T060
resonance	O	O	I-T060
imaging	O	O	I-T060
(	O	O	O
MRI	O	O	B-T060
)	O	O	O
of	O	O	O
the	O	O	O
brain	O	O	B-T023
three	O	O	O
years	O	O	B-T079
ago	O	O	O
during	O	O	O
workup	O	O	O
for	O	O	O
migraine-like	O	O	B-T184
headaches	O	O	I-T184
.	O	O	O

Subsequent	O	O	O
serial	O	O	O
imaging	O	O	B-T060
showed	O	O	O
radiographic	O	O	B-T078
evidence	O	O	I-T078
of	O	O	O
growth	O	O	B-T040
up	O	O	O
to	O	O	O
11.5	O	O	O
x	O	O	O
14.0	O	O	O
x	O	O	O
10.0	O	O	O
mm	O	O	O
in	O	O	O
size	O	O	B-T082
.	O	O	O

The	O	O	O
pituitary	O	O	B-T023
sellar	O	O	B-T033
lesion	O	O	I-T033
was	O	O	O
resected	O	O	B-T061
through	O	O	O
an	O	O	O
endoscopic	O	O	B-T082
transnasal	O	O	B-T082
transsphenoidal	O	O	B-T082
approach	O	O	I-T082
and	O	O	O
was	O	O	O
found	O	O	O
to	O	O	O
be	O	O	O
a	O	O	O
thyrotroph	O	O	B-T191
adenoma	O	O	I-T191
.	O	O	O

RSTS	O	O	B-T047
is	O	O	O
a	O	O	O
rare	O	O	B-T080
,	O	O	O
neurodevelopmental	O	O	B-T048
genetic	O	O	B-T047
disease	O	O	I-T047
where	O	O	O
most	O	O	O
patients	O	O	B-T101
with	O	O	I-T101
disabilities	O	O	I-T101
survive	O	O	B-T052
into	O	O	O
adulthood	O	O	B-T079
.	O	O	O

The	O	O	O
disorder	O	O	B-T047
is	O	O	O
associated	O	O	B-T080
with	O	O	I-T080
an	O	O	O
increased	O	O	B-T081
predisposition	O	O	B-T032
for	O	O	O
development	O	O	B-T169
of	O	O	O
nervous	O	O	B-T191
system	O	O	I-T191
tumors	O	O	I-T191
,	O	O	O
including	O	O	O
pituitary	O	O	B-T191
adenomas	O	O	I-T191
.	O	O	O

-DOCSTART- (28505177)

The	O	O	O
clinico-	O	O	O
radiological	O	O	B-T091
paradox	O	O	B-T033
of	O	O	O
cognitive	O	O	B-T041
function	O	O	I-T041
and	O	O	O
MRI	O	O	B-T060
burden	O	O	B-T078
of	O	O	O
white	O	O	B-T024
matter	O	O	I-T024
lesions	O	O	B-T033
in	O	O	O
people	O	O	B-T098
with	O	O	O
multiple	O	O	B-T047
sclerosis	O	O	I-T047
:	O	O	O
A	O	O	O
systematic	O	O	B-T170
review	O	O	I-T170
and	O	O	O
meta-analysis	O	O	O

Moderate	O	O	B-T080
correlation	O	O	B-T080
exists	O	O	O
between	O	O	O
the	O	O	O
imaging	O	O	B-T052
quantification	O	O	I-T052
of	O	O	O
brain	O	O	B-T023
white	O	O	B-T024
matter	O	O	I-T024
lesions	O	O	B-T033
and	O	O	O
cognitive	O	O	B-T169
performance	O	O	B-T055
in	O	O	O
people	O	O	B-T098
with	O	O	O
multiple	O	O	B-T047
sclerosis	O	O	I-T047
(	O	O	O
MS	O	O	B-T047
)	O	O	O
.	O	O	O

This	O	O	O
may	O	O	O
reflect	O	O	O
the	O	O	O
greater	O	O	O
importance	O	O	O
of	O	O	O
other	O	O	O
features	O	O	B-T080
,	O	O	O
including	O	O	O
subvisible	O	O	O
pathology	O	O	B-T091
,	O	O	O
or	O	O	O
methodological	O	O	B-T078
limitations	O	O	B-T169
of	O	O	O
the	O	O	O
primary	O	O	B-T080
literature	O	O	B-T170
.	O	O	O

To	O	O	O
summarise	O	O	O
the	O	O	O
cognitive	O	O	B-T169
clinico-	O	O	O
radiological	O	O	B-T091
paradox	O	O	B-T033
and	O	O	O
explore	O	O	O
the	O	O	O
potential	O	O	B-T080
methodological	O	O	B-T078
factors	O	O	B-T169
that	O	O	O
could	O	O	O
influence	O	O	O
the	O	O	O
assessment	O	O	B-T052
of	O	O	O
this	O	O	O
relationship	O	O	B-T080
.	O	O	O

Systematic	O	O	B-T170
review	O	O	I-T170
and	O	O	O
meta-analysis	O	O	B-T170
of	O	O	O
primary	O	O	B-T080
research	O	O	B-T062
relating	O	O	O
cognitive	O	O	B-T041
function	O	O	I-T041
to	O	O	O
white	O	O	B-T024
matter	O	O	I-T024
lesion	O	O	B-T033
burden	O	O	B-T078
.	O	O	O

Fifty	O	O	O
papers	O	O	B-T073
met	O	O	O
eligibility	O	O	B-T080
criteria	O	O	I-T080
for	O	O	O
review	O	O	B-T170
,	O	O	O
and	O	O	O
meta-analysis	O	O	B-T170
of	O	O	O
overall	O	O	O
results	O	O	B-T169
was	O	O	O
possible	O	O	O
in	O	O	O
thirty-two	O	O	O
(	O	O	O
2050	O	O	O
participants	O	O	B-T098
)	O	O	O
.	O	O	O

Aggregate	O	O	B-T080
correlation	O	O	B-T080
between	O	O	O
cognition	O	O	B-T041
and	O	O	O
T2	O	O	B-T033
lesion	O	O	B-T033
burden	O	O	B-T078
was	O	O	O
r	O	O	O
=	O	O	O
-0.30	O	O	O
(	O	O	O
95	O	O	O
%	O	O	O
confidence	O	O	B-T081
interval	O	O	I-T081
:	O	O	O
-0.34	O	O	O
,	O	O	O
-0.26	O	O	O
)	O	O	O
.	O	O	O

Wide	O	O	O
methodological	O	O	B-T078
variability	O	O	B-T077
was	O	O	O
seen	O	O	O
,	O	O	O
particularly	O	O	O
related	O	O	O
to	O	O	O
key	O	O	O
factors	O	O	B-T169
in	O	O	O
the	O	O	O
cognitive	O	O	B-T169
data	O	O	B-T078
capture	O	O	O
and	O	O	O
image	O	O	B-T059
analysis	O	O	I-T059
techniques	O	O	I-T059
.	O	O	O

Resolving	O	O	O
the	O	O	O
persistent	O	O	O
clinico-	O	O	O
radiological	O	O	B-T091
paradox	O	O	B-T033
will	O	O	O
likely	O	O	O
require	O	O	O
simultaneous	O	O	O
evaluation	O	O	B-T058
of	O	O	O
multiple	O	O	B-T081
components	O	O	B-T077
of	O	O	O
the	O	O	O
complex	O	O	B-T080
pathology	O	O	B-T091
using	O	O	O
optimum	O	O	B-T080
measurement	O	O	B-T169
techniques	O	O	B-T169
for	O	O	O
both	O	O	O
cognitive	O	O	B-T169
and	O	O	O
MRI	O	O	B-T060
feature	O	O	B-T080
quantification	O	O	B-T081
.	O	O	O

We	O	O	O
recommend	O	O	O
a	O	O	O
consensus	O	O	B-T054
initiative	O	O	O
to	O	O	O
support	O	O	O
common	O	O	O
standards	O	O	B-T080
for	O	O	O
image	O	O	B-T059
analysis	O	O	I-T059
in	O	O	O
MS	O	O	B-T047
,	O	O	O
enabling	O	O	O
benchmarking	O	O	B-T081
while	O	O	O
also	O	O	O
supporting	O	O	O
ongoing	O	O	O
innovation	O	O	B-T170
.	O	O	O

-DOCSTART- (28508329)

Long	O	O	B-T114
Non-Coding	O	O	I-T114
RNA	O	O	I-T114
SNHG6	O	O	B-T028
as	O	O	O
a	O	O	O
Potential	O	O	O
Biomarker	O	O	B-T123
for	O	O	O
Hepatocellular	O	O	O
Carcinoma	O	O	O

Long	O	O	B-T114
Non-coding	O	O	I-T114
RNAs	O	O	I-T114
(	O	O	O
lncRNAs	O	O	B-T114
)	O	O	O
refer	O	O	O
to	O	O	O
all	O	O	O
non-protein	O	O	B-T114
coding	O	O	I-T114
transcripts	O	O	B-T114
longer	O	O	O
than	O	O	O
200	O	O	O
nucleotides	O	O	B-T114
.	O	O	O

Their	O	O	O
critical	O	O	O
roles	O	O	O
in	O	O	O
different	O	O	O
biological	O	O	B-T080
pathways	O	O	B-T077
have	O	O	O
been	O	O	O
already	O	O	O
well	O	O	O
established	O	O	O
.	O	O	O

Altered	O	O	O
expression	O	O	B-T045
of	O	O	O
lncRNAs	O	O	B-T114
can	O	O	O
be	O	O	O
involved	O	O	O
in	O	O	O
the	O	O	O
cancer	O	O	B-T191
initiation	O	O	I-T191
and/or	O	O	O
progression	O	O	B-T191
.	O	O	O

Since	O	O	O
patients	O	O	B-T101
with	O	O	O
hepatocellular	O	O	B-T191
carcinoma	O	O	I-T191
(	O	O	O
HCC	O	O	B-T191
)	O	O	O
are	O	O	O
usually	O	O	O
diagnosed	O	O	B-T033
in	O	O	O
late	O	O	B-T079
stages	O	O	I-T079
,	O	O	O
developing	O	O	O
diagnostic	O	O	B-T060
methods	O	O	I-T060
seems	O	O	O
to	O	O	O
be	O	O	O
essential	O	O	O
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
the	O	O	O
expression	O	O	B-T045
levels	O	O	O
of	O	O	O
different	O	O	O
lncRNAs	O	O	B-T114
were	O	O	O
systematically	O	O	O
analysed	O	O	B-T062
in	O	O	O
different	O	O	O
genomic	O	O	B-T170
and	O	O	O
transcriptome	O	O	B-T170
datasets	O	O	I-T170
.	O	O	O

The	O	O	O
analyses	O	O	B-T062
showed	O	O	O
that	O	O	O
SNHG6	O	O	B-T028
is	O	O	O
among	O	O	O
the	O	O	O
lncRNAs	O	O	B-T114
with	O	O	O
distinctive	O	O	O
dysregulation	O	O	B-T045
of	O	O	O
expression	O	O	B-T045
and	O	O	O
copy	O	O	O
number	O	O	O
variation	O	O	O
in	O	O	O
HCC	O	O	B-T191
tumors	O	O	I-T191
compared	O	O	O
with	O	O	O
normal	O	O	B-T024
tissues	O	O	I-T024
.	O	O	O

The	O	O	O
results	O	O	O
also	O	O	O
suggest	O	O	O
that	O	O	O
the	O	O	O
dysregulation	O	O	B-T045
of	O	O	O
SNHG6	O	O	B-T028
is	O	O	O
highly	O	O	O
cancer	O	O	B-T191
type	O	O	O
specific	O	O	O
.	O	O	O

Through	O	O	O
co-occurrence	O	O	O
analyses	O	O	B-T062
,	O	O	O
we	O	O	O
found	O	O	O
that	O	O	O
SNHG6	O	O	B-T028
and	O	O	O
its	O	O	O
related	O	O	O
co-expressed	O	O	B-T045
genes	O	O	B-T028
on	O	O	O
8q	O	O	B-T086
are	O	O	O
involved	O	O	O
in	O	O	O
the	O	O	O
structural	O	O	B-T082
integrity	O	O	B-T080
of	O	O	O
ribosome	O	O	B-T026
and	O	O	O
translation	O	O	B-T045
.	O	O	O

This	O	O	O
comprehensive	O	O	B-T080
in	O	O	B-T066
silico	O	O	I-T066
analysis	O	O	B-T062
,	O	O	O
provides	O	O	O
a	O	O	O
resource	O	O	O
for	O	O	O
investigating	O	O	B-T169
SNHG6	O	O	B-T028
in	O	O	O
hepatocellular	O	O	B-T191
carcinoma	O	O	I-T191
and	O	O	O
lays	O	O	O
the	O	O	O
groundwork	O	O	O
for	O	O	O
design	O	O	O
of	O	O	O
next	O	O	O
researches	O	O	B-T062
.	O	O	O

-DOCSTART- (28512014)

Expressional	O	O	B-T045
divergence	O	O	B-T082
of	O	O	O
insect	O	O	B-T204
GOX	O	O	B-T028
genes	O	O	I-T028
:	O	O	O
From	O	O	O
specialist	O	O	O
to	O	O	O
generalist	O	O	O
glucose	O	O	O
oxidase	O	O	O

Insect	O	O	B-T204
herbivores	O	O	I-T204
often	O	O	O
secrete	O	O	B-T043
glucose	O	O	B-T116
oxidase	O	O	I-T116
(	O	O	O
GOX	O	O	B-T116
)	O	O	O
onto	O	O	O
plants	O	O	B-T002
to	O	O	O
counteract	O	O	B-T053
plant	O	O	B-T002
defenses	O	O	B-T077
and	O	O	O
potential	O	O	B-T080
pathogens	O	O	B-T001
.	O	O	O

Whether	O	O	O
generalist	O	O	O
herbivores	O	O	B-T204
always	O	O	O
have	O	O	O
significantly	O	O	B-T081
higher	O	O	I-T081
GOX	O	O	B-T116
activities	O	O	B-T052
than	O	O	O
their	O	O	O
specialist	O	O	O
counterparts	O	O	B-T053
at	O	O	O
any	O	O	O
comparable	O	O	O
stage	O	O	O
or	O	O	O
conditions	O	O	O
and	O	O	O
how	O	O	O
this	O	O	O
is	O	O	O
realized	O	O	O
remain	O	O	O
unknown	O	O	O
.	O	O	O

To	O	O	O
address	O	O	O
these	O	O	O
two	O	O	O
general	O	O	O
questions	O	O	O
,	O	O	O
we	O	O	O
subjected	O	O	O
larvae	O	O	B-T204
of	O	O	O
a	O	O	O
pair	O	O	O
of	O	O	O
sister	O	O	O
species	O	O	B-T185
differed	O	O	O
mainly	O	O	O
in	O	O	O
host	O	O	O
range	O	O	O
,	O	O	O
the	O	O	O
generalist	O	O	O
Helicoverpa	O	O	B-T204
armigera	O	O	I-T204
and	O	O	O
its	O	O	O
specialist	O	O	O
counterpart	O	O	B-T053
Helicoverpa	O	O	B-T204
assulta	O	O	I-T204
,	O	O	O
to	O	O	O
the	O	O	O
same	O	O	O
sets	O	O	O
of	O	O	O
stage	O	O	O
,	O	O	O
protein	O	O	B-T116
to	O	O	O
digestible	O	O	B-T040
carbohydrate	O	O	B-T168
(	O	O	O
P	O	O	O
:	O	O	O
C	O	O	O
)	O	O	O
ratio	O	O	O
,	O	O	O
allelochemical	O	O	B-T123
or	O	O	O
host	O	O	B-UnknownType
plant	O	O	I-UnknownType
treatments	O	O	B-T169
for	O	O	O
simultaneous	O	O	O
analyses	O	O	O
of	O	O	O
GOX	O	O	B-T028
transcripts	O	O	B-T114
and	O	O	O
activities	O	O	B-T052
in	O	O	O
their	O	O	O
labial	O	O	B-T023
glands	O	O	I-T023
.	O	O	O

GOX	O	O	B-T028
activity	O	O	B-T052
and	O	O	O
transcripts	O	O	B-T114
are	O	O	O
upregulated	O	O	B-T044
concurrently	O	O	O
with	O	O	O
food	O	O	B-T168
ingestion	O	O	B-T038
and	O	O	O
body	O	O	B-T040
growth	O	O	I-T040
,	O	O	O
downregulated	O	O	B-T044
with	O	O	O
stopping	O	O	O
ingestion	O	O	O
and	O	O	O
wandering	O	O	B-T053
for	O	O	O
pupation	O	O	B-T040
in	O	O	O
both	O	O	O
species	O	O	B-T185
.	O	O	O

The	O	O	O
three	O	O	O
tested	O	O	O
host	O	O	B-UnknownType
plants	O	O	I-UnknownType
upregulated	O	O	B-T044
GOX	O	O	B-T028
transcripts	O	O	B-T114
,	O	O	O
and	O	O	O
to	O	O	O
a	O	O	O
lesser	O	O	O
extent	O	O	O
,	O	O	O
GOX	O	O	O
activity	O	O	B-T052
in	O	O	O
both	O	O	O
species	O	O	B-T185
.	O	O	O

There	O	O	O
were	O	O	O
significant	O	O	O
differences	O	O	O
in	O	O	O
both	O	O	O
GOX	O	O	B-T028
transcripts	O	O	B-T114
and	O	O	O
activity	O	O	B-T052
elicited	O	O	O
by	O	O	O
allelochemicals	O	O	B-T123
,	O	O	O
but	O	O	O
only	O	O	O
in	O	O	O
GOX	O	O	O
transcripts	O	O	O
by	O	O	O
P	O	O	O
:	O	O	O
C	O	O	O
ratios	O	O	O
in	O	O	O
both	O	O	O
species	O	O	B-T185
.	O	O	O

GOX	O	O	B-T116
activities	O	O	B-T052
were	O	O	O
higher	O	O	O
in	O	O	O
H.	O	O	B-T204
armigera	O	O	I-T204
than	O	O	O
H.	O	O	B-T204
assulta	O	O	I-T204
in	O	O	O
all	O	O	O
the	O	O	O
comparable	O	O	O
treatments	O	O	O
,	O	O	O
but	O	O	O
GOX	O	O	O
transcripts	O	O	B-T114
were	O	O	O
significantly	O	O	B-T081
higher	O	O	I-T081
either	O	O	O
in	O	O	O
generalists	O	O	O
or	O	O	O
in	O	O	O
specialists	O	O	O
,	O	O	O
depending	O	O	O
on	O	O	O
the	O	O	O
developmental	O	O	B-T079
stages	O	O	I-T079
,	O	O	O
host	O	O	B-UnknownType
plants	O	O	I-UnknownType
,	O	O	O
P	O	O	O
:	O	O	O
C	O	O	O
ratio	O	O	O
and	O	O	O
allelochemicals	O	O	B-T123
they	O	O	O
encounter	O	O	B-T053
.	O	O	O

These	O	O	O
data	O	O	B-T078
indicate	O	O	O
that	O	O	O
the	O	O	O
greater	O	O	B-T081
GOX	O	O	B-T116
activity	O	O	B-T052
in	O	O	O
generalist	O	O	O
herbivores	O	O	B-T204
is	O	O	O
not	O	O	O
achieved	O	O	O
by	O	O	O
greater	O	O	O
transcription	O	O	B-T045
rate	O	O	O
,	O	O	O
but	O	O	O
by	O	O	O
greater	O	O	O
transcript	O	O	B-T114
stability	O	O	O
,	O	O	O
greater	O	O	O
translation	O	O	B-T045
rate	O	O	O
,	O	O	O
better	O	O	B-T044
enzyme	O	O	I-T044
stability	O	O	I-T044
and/or	O	O	O
their	O	O	O
combination	O	O	O
.	O	O	O

-DOCSTART- (28518001)

Propranolol	O	O	B-T109
Effects	O	O	O
on	O	O	O
Decompression	O	O	B-T047
Sickness	O	O	I-T047
in	O	O	O
a	O	O	O
Simulated	O	O	O
DISSUB	O	O	B-T073
Rescue	O	O	B-T057
in	O	O	O
Swine	O	O	O

Disabled	O	O	B-T073
submarine	O	O	I-T073
(	O	O	O
DISSUB	O	O	B-T073
)	O	O	O
survivors	O	O	B-T096
may	O	O	O
face	O	O	O
elevated	O	O	B-T033
CO2	O	O	B-T123
levels	O	O	I-T033
and	O	O	O
inert	O	O	B-UnknownType
gas	O	O	I-UnknownType
saturation	O	O	I-UnknownType
,	O	O	O
putting	O	O	O
them	O	O	O
at	O	O	O
risk	O	O	O
for	O	O	O
CO2	O	O	O
toxicity	O	O	B-T080
and	O	O	O
decompression	O	O	B-T047
sickness	O	O	I-T047
(	O	O	O
DCS	O	O	B-T047
)	O	O	O
.	O	O	O

Propranolol	O	O	B-T109
was	O	O	O
shown	O	O	O
to	O	O	O
reduce	O	O	B-T059
CO2	O	O	I-T059
production	O	O	I-T059
in	O	O	O
an	O	O	O
experimental	O	O	O
DISSUB	O	O	B-T073
model	O	O	B-T075
in	O	O	O
humans	O	O	B-T016
but	O	O	O
its	O	O	O
effects	O	O	O
on	O	O	O
DCS	O	O	B-T047
in	O	O	O
a	O	O	O
DISSUB	O	O	O
rescue	O	O	B-T057
scenario	O	O	I-T057
are	O	O	O
unknown	O	O	O
.	O	O	O

A	O	O	O
100	O	O	O
%	O	O	O
oxygen	O	O	B-T039
prebreathe	O	O	I-T039
(	O	O	O
OPB	O	O	B-T039
)	O	O	O
reduces	O	O	O
DCS	O	O	B-T047
incidence	O	O	O
and	O	O	O
severity	O	O	O
and	O	O	O
is	O	O	O
incorporated	O	O	O
into	O	O	O
some	O	O	O
DISSUB	O	O	B-T073
rescue	O	O	B-T057
protocols	O	O	I-T057
.	O	O	O

We	O	O	O
used	O	O	O
a	O	O	O
swine	O	O	B-T015
model	O	O	I-T015
of	O	O	O
DISSUB	O	O	B-T073
rescue	O	O	B-T057
to	O	O	O
study	O	O	O
the	O	O	O
effect	O	O	O
of	O	O	O
propranolol	O	O	B-T109
on	O	O	O
DCS	O	O	B-T047
incidence	O	O	O
and	O	O	O
mortality	O	O	B-T081
with	O	O	O
and	O	O	O
without	O	O	O
an	O	O	O
OPB	O	O	B-T039
.	O	O	O

In	O	O	O
Experiment	O	O	O
1	O	O	O
,	O	O	O
male	O	O	B-T032
Yorkshire	O	O	B-T015
Swine	O	O	I-T015
(	O	O	O
70	O	O	O
kg	O	O	O
)	O	O	O
were	O	O	O
pressurized	O	O	B-T067
to	O	O	O
2.8	O	O	O
ATA	O	O	O
for	O	O	O
22	O	O	O
h.	O	O	O
Propranolol	O	O	B-T109
1.0	O	O	O
mg	O	O	O
Â·	O	O	O
kg-1	O	O	O
(	O	O	O
IV	O	O	O
)	O	O	O
was	O	O	O
administered	O	O	B-T169
at	O	O	I-T169
21.25	O	O	O
h.	O	O	O
At	O	O	O
22	O	O	O
h	O	O	O
,	O	O	O
the	O	O	O
animal	O	O	B-T008
was	O	O	O
rapidly	O	O	B-T169
decompressed	O	O	I-T169
and	O	O	O
observed	O	O	O
for	O	O	O
DCS	O	O	B-T047
type	O	O	O
,	O	O	O
onset	O	O	B-T079
time	O	O	I-T079
,	O	O	O
and	O	O	O
mortality	O	O	B-T081
.	O	O	O

Experimental	O	O	O
animals	O	O	B-T008
(	O	O	O
N	O	O	O
=	O	O	O
21	O	O	O
;	O	O	O
69	O	O	O
Â±	O	O	O
4.1	O	O	O
kg	O	O	O
)	O	O	O
,	O	O	O
PROP1.0	O	O	B-T109
,	O	O	O
were	O	O	O
compared	O	O	O
to	O	O	O
PROP1.0	O	O	O
-	O	O	O
OPB45	O	O	B-T039
(	O	O	O
N	O	O	O
=	O	O	O
8	O	O	O
;	O	O	O
69	O	O	O
Â±	O	O	O
2.8	O	O	O
kg	O	O	O
)	O	O	O
with	O	O	O
the	O	O	O
same	O	O	O
dive	O	O	B-T032
profile	O	O	O
,	O	O	O
except	O	O	O
for	O	O	O
a	O	O	O
45	O	O	O
min	O	O	O
OPB	O	O	B-T039
prior	O	O	O
to	O	O	O
decompression	O	O	B-T169
.	O	O	O

In	O	O	O
Experiment	O	O	O
2	O	O	O
,	O	O	O
the	O	O	O
same	O	O	O
methodology	O	O	B-T078
was	O	O	O
used	O	O	O
with	O	O	O
the	O	O	O
following	O	O	O
changes	O	O	O
:	O	O	O
swine	O	O	B-T015
pressurized	O	O	B-T067
to	O	O	O
2.8	O	O	O
ATA	O	O	O
for	O	O	O
28	O	O	O
h	O	O	O
;	O	O	O
experimental	O	O	O
group	O	O	O
(	O	O	O
N	O	O	O
=	O	O	O
25	O	O	O
;	O	O	O
67	O	O	O
Â±	O	O	O
3.3	O	O	O
kg	O	O	O
)	O	O	O
,	O	O	O
PROP0.5	O	O	B-T109
bis	O	O	O
,	O	O	O
propranolol	O	O	B-T109
0.5	O	O	O
mg	O	O	O
Â·	O	O	O
kg-1	O	O	O
bis	O	O	O
(	O	O	O
twice	O	O	O
)	O	O	O
(	O	O	O
IV	O	O	O
)	O	O	O
was	O	O	O
administered	O	O	B-T169
at	O	O	I-T169
22	O	O	O
h	O	O	O
and	O	O	O
26	O	O	O
h.	O	O	O
Control	O	O	B-T008
animals	O	O	I-T008
(	O	O	O
N	O	O	O
=	O	O	O
25	O	O	O
;	O	O	O
67	O	O	O
Â±	O	O	O
3.9	O	O	O
kg	O	O	O
)	O	O	O
received	O	O	O
normal	O	O	B-T121
saline	O	O	I-T121
.	O	O	O

OPB	O	O	B-T039
reduced	O	O	B-T081
mortality	O	O	I-T081
in	O	O	O
PROP1.0	O	O	B-T109
-	O	O	O
OBP45	O	O	B-T039
compared	O	O	O
to	O	O	O
PROP1.0	O	O	O
(	O	O	O
0	O	O	O
%	O	O	O
vs.	O	O	O
71	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

PROP0.5	O	O	B-T109
bis	O	O	O
had	O	O	O
increased	O	O	B-T081
mortality	O	O	I-T081
compared	O	O	O
to	O	O	O
CONTROL	O	O	O
(	O	O	O
60-%	O	O	O
vs.	O	O	O
4	O	O	O
%	O	O	O
)	O	O	O
.	O	O	O

Administration	O	O	O
of	O	O	O
beta	O	O	B-T121
blockers	O	O	I-T121
prior	O	O	O
to	O	O	O
saturation	O	O	B-T169
decompression	O	O	I-T169
appears	O	O	O
to	O	O	O
increase	O	O	O
DCS	O	O	B-T047
and	O	O	O
worsen	O	O	B-T081
mortality	O	O	I-T081
in	O	O	O
a	O	O	O
swine	O	O	B-T015
model	O	O	B-T075
;	O	O	O
however	O	O	O
,	O	O	O
their	O	O	O
effects	O	O	O
in	O	O	O
bounce	O	O	B-T032
diving	O	O	I-T032
remain	O	O	O
unknown	O	O	O
.	O	O	O

Forbes	O	O	O
AS	O	O	O
,	O	O	O
Regis	O	O	O
DP	O	O	O
,	O	O	O
HallAA	O	O	O
,	O	O	O
Mahon	O	O	O
RT	O	O	O
,	O	O	O
Cronin	O	O	O
WA	O	O	O
.	O	O	O

Propranolol	O	O	O
effects	O	O	O
on	O	O	O
decompression	O	O	O
sickness	O	O	O
in	O	O	O
a	O	O	O
simulated	O	O	O
DISSUB	O	O	O
rescue	O	O	O
in	O	O	O
swine	O	O	O
.	O	O	O

Aerosp	O	O	O
Med	O	O	O
Hum	O	O	O
Perform	O	O	O
.	O	O	O

2017	O	O	O
;	O	O	O
88(4):385	O	O	O
-	O	O	O
391	O	O	O
.	O	O	O

-DOCSTART- (28520994)

Gut	O	O	B-T001
microbiota	O	O	I-T001
-mediated	O	O	O
protection	O	O	B-T033
against	O	O	O
diarrheal	O	O	B-T184
infections	O	O	O

The	O	O	O
mammalian	O	O	B-T015
gut	O	O	B-T001
microbiota	O	O	I-T001
is	O	O	O
a	O	O	O
highly	O	O	O
abundant	O	O	O
and	O	O	O
diverse	O	O	O
microbial	O	O	B-T001
community	O	O	B-T096
that	O	O	O
resides	O	O	B-T052
in	O	O	O
the	O	O	O
gastrointestinal	O	O	B-T022
tract	O	O	I-T022
.	O	O	O

One	O	O	O
major	O	O	O
benefit	O	O	O
that	O	O	O
the	O	O	O
gut	O	O	B-T001
microbiota	O	O	I-T001
provides	O	O	O
to	O	O	O
its	O	O	O
host	O	O	B-T001
is	O	O	O
colonization	O	O	B-T033
resistance	O	O	B-T169
-the	O	O	O
ability	O	O	O
to	O	O	O
prevent	O	O	B-T169
colonization	O	O	O
by	O	O	O
foreign	O	O	B-T001
microbes	O	O	I-T001
,	O	O	O
including	O	O	O
diarrheal	O	O	B-T184
pathogens	O	O	B-T001
such	O	O	O
as	O	O	O
Clostridium	O	O	B-T007
difficile	O	O	I-T007
,	O	O	O
Salmonella	O	O	B-T007
enterica	O	O	I-T007
serovar	O	O	I-T007
Typhimurium	O	O	I-T007
and	O	O	O
diarrheagenic	O	O	B-T007
Escherichia	O	O	I-T007
coli	O	O	I-T007
.	O	O	O

We	O	O	O
conducted	O	O	O
a	O	O	O
literature	O	O	B-T170
review	O	O	I-T170
of	O	O	O
the	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
the	O	O	O
gut	O	O	B-T001
microbiota	O	O	I-T001
on	O	O	O
infection	O	O	B-T046
by	O	O	O
diarrheal	O	O	B-T184
pathogens	O	O	B-T001
.	O	O	O

We	O	O	O
used	O	O	O
PubMed	O	O	B-T170
to	O	O	O
search	O	O	O
for	O	O	O
relevant	O	O	O
articles	O	O	B-T170
published	O	O	O
before	O	O	O
July	O	O	O
2016	O	O	O
,	O	O	O
as	O	O	O
well	O	O	O
as	O	O	O
incorporated	O	O	O
data	O	O	B-T078
from	O	O	O
our	O	O	O
laboratory	O	O	B-T093
.	O	O	O

The	O	O	O
gut	O	O	B-T001
microbiota	O	O	I-T001
provides	O	O	O
protection	O	O	B-T033
from	O	O	O
diarrheal	O	O	B-T184
infections	O	O	B-T046
both	O	O	O
by	O	O	O
direct	O	O	B-T080
inhibition	O	O	B-T052
of	O	O	O
pathogens	O	O	B-T001
and	O	O	O
by	O	O	O
indirect	O	O	B-T080
effects	O	O	B-T080
on	O	O	O
host	O	O	B-T001
functions	O	O	B-T169
.	O	O	O

Direct	O	O	B-T080
effects	O	O	B-T080
of	O	O	I-T080
the	O	O	O
microbiota	O	O	B-T001
on	O	O	O
diarrheal	O	O	B-T184
pathogens	O	O	B-T001
include	O	O	O
competing	O	O	O
for	O	O	O
nutrients	O	O	B-T168
and	O	O	O
producing	O	O	O
metabolites	O	O	B-T123
that	O	O	O
inhibit	O	O	B-T169
pathogen	O	O	B-T001
growth	O	O	B-T040
or	O	O	O
virulence	O	O	B-T038
.	O	O	O

Indirect	O	O	B-T080
effects	O	O	B-T080
of	O	O	I-T080
the	O	O	O
gut	O	O	B-T001
microbiota	O	O	I-T001
include	O	O	O
promoting	O	O	O
maintenance	O	O	B-T052
of	O	O	O
the	O	O	O
gut	O	O	B-T042
mucosal	O	O	I-T042
barrier	O	O	I-T042
and	O	O	O
stimulating	O	O	O
innate	O	O	B-T032
and	O	O	O
adaptive	O	O	B-T039
immunity	O	O	I-T039
.	O	O	O

Human	O	O	B-T016
epidemiological	O	O	B-T062
studies	O	O	I-T062
and	O	O	O
experimental	O	O	B-T080
infections	O	O	B-T046
of	O	O	O
laboratory	O	O	B-T008
animals	O	O	I-T008
both	O	O	O
demonstrate	O	O	O
that	O	O	O
antibiotic	O	O	B-T061
treatment	O	O	I-T061
can	O	O	O
alter	O	O	O
the	O	O	O
gut	O	O	B-T001
microbial	O	O	I-T001
community	O	O	B-T096
and	O	O	O
thereby	O	O	O
reduce	O	O	O
colonization	O	O	B-T033
resistance	O	O	B-T169
against	O	O	O
diarrheal	O	O	B-T184
pathogens	O	O	B-T001
.	O	O	O

Further	O	O	O
research	O	O	B-T062
might	O	O	O
lead	O	O	O
to	O	O	O
the	O	O	O
development	O	O	B-T169
of	O	O	O
next-generation	O	O	B-T007
probiotics	O	O	I-T007
that	O	O	O
could	O	O	O
be	O	O	O
used	O	O	O
to	O	O	O
bolster	O	O	O
colonization	O	O	B-T033
resistance	O	O	B-T169
and	O	O	O
thus	O	O	O
prevent	O	O	B-T169
travellers	O	O	B-T047
'	O	O	I-T047
diarrheal	O	O	I-T047
.	O	O	O

-DOCSTART- (28521168)

Ecotoxicity	O	O	B-T037
testing	O	O	B-T169
and	O	O	O
environmental	O	O	B-T058
risk	O	O	I-T058
assessment	O	O	I-T058
of	O	O	O
iron	O	O	B-T121
nanomaterials	O	O	B-T073
for	O	O	O
sub-surface	O	O	O
remediation	O	O	B-T069
-	O	O	O
Recommendations	O	O	B-T078
from	O	O	O
the	O	O	O
FP7	O	O	O
project	O	O	O
NanoRem	O	O	O

Nanoremediation	O	O	B-T069
with	O	O	O
iron	O	O	B-T121
(	O	O	O
Fe	O	O	B-T121
)	O	O	O
nanomaterials	O	O	B-T073
opens	O	O	O
new	O	O	O
doors	O	O	O
for	O	O	O
treating	O	O	B-T169
contaminated	O	O	B-T169
soil	O	O	B-T167
and	O	O	O
groundwater	O	O	B-T121
,	O	O	O
but	O	O	O
is	O	O	O
also	O	O	O
accompanied	O	O	O
by	O	O	O
new	O	O	O
potential	O	O	B-T078
risks	O	O	I-T078
as	O	O	O
large	O	O	O
quantities	O	O	O
of	O	O	O
engineered	O	O	B-T073
nanomaterials	O	O	I-T073
are	O	O	O
introduced	O	O	O
into	O	O	O
the	O	O	O
environment	O	O	B-T082
.	O	O	O

In	O	O	O
this	O	O	O
study	O	O	B-T062
,	O	O	O
we	O	O	O
have	O	O	O
assessed	O	O	B-T052
the	O	O	O
ecotoxicity	O	O	B-T037
of	O	O	O
four	O	O	O
engineered	O	O	O
Fe	O	O	B-T121
nanomaterials	O	O	B-T073
,	O	O	O
specifically	O	O	O
,	O	O	O
Nano-Goethite	O	O	B-T197
,	O	O	O
Trap-Ox	O	O	B-T121
Fe-zeolites	O	O	I-T121
,	O	O	O
Carbo-Iron	O	O	B-T121
(	O	O	O
Â®	O	O	O
)	O	O	O
and	O	O	O
FerMEG12	O	O	B-T121
,	O	O	O
developed	O	O	O
within	O	O	O
the	O	O	O
European	O	O	B-T062
FP7	O	O	I-T062
project	O	O	I-T062
NanoRem	O	O	I-T062
for	O	O	O
sub-surface	O	O	O
remediation	O	O	B-T069
towards	O	O	O
a	O	O	O
test	O	O	B-T059
battery	O	O	I-T059
consisting	O	O	O
of	O	O	O
eight	O	O	O
ecotoxicity	O	O	O
tests	O	O	B-T059
on	O	O	O
bacteria	O	O	B-T007
(	O	O	O
V.	O	O	B-T007
fisheri	O	O	I-T007
,	O	O	O
E.	O	O	B-T007
coli	O	O	I-T007
)	O	O	O
,	O	O	O
algae	O	O	B-T204
(	O	O	O
P.	O	O	B-T002
subcapitata	O	O	I-T002
,	O	O	O
Chlamydomonas	O	O	B-T002
sp.	O	O	I-T002
)	O	O	O
,	O	O	O
crustaceans	O	O	B-T204
(	O	O	O
D.	O	O	B-T204
magna	O	O	I-T204
)	O	O	O
,	O	O	O
worms	O	O	B-T204
(	O	O	O
E.	O	O	B-T204
fetida	O	O	I-T204
,	O	O	O
L.	O	O	B-T204
variegatus	O	O	I-T204
)	O	O	O
and	O	O	O
plants	O	O	B-T002
(	O	O	O
R.	O	O	B-T002
sativus	O	O	I-T002
,	O	O	O
L.	O	O	B-T002
multiflorum	O	O	I-T002
)	O	O	O
.	O	O	O

The	O	O	O
tested	O	O	O
materials	O	O	O
are	O	O	O
commercially	O	O	O
available	O	O	O
and	O	O	O
include	O	O	O
Fe	O	O	B-T121
oxide	O	O	I-T121
and	O	O	O
nanoscale	O	O	B-T121
zero	O	O	I-T121
valent	O	O	I-T121
iron	O	O	I-T121
(	O	O	O
nZVI	O	O	B-T121
)	O	O	O
,	O	O	O
but	O	O	O
also	O	O	O
hybrid	O	O	O
products	O	O	O
with	O	O	O
Fe	O	O	O
loaded	O	O	O
into	O	O	O
a	O	O	O
matrix	O	O	B-T082
.	O	O	O

All	O	O	O
but	O	O	O
one	O	O	O
material	O	O	B-T167
,	O	O	O
a	O	O	O
ball	O	O	B-T121
milled	O	O	I-T121
nZVI	O	O	I-T121
(	O	O	O
FerMEG12	O	O	B-T121
)	O	O	O
,	O	O	O
showed	O	O	O
no	O	O	B-T033
toxicity	O	O	I-T033
in	O	O	O
the	O	O	O
test	O	O	B-T059
battery	O	O	I-T059
when	O	O	O
tested	O	O	O
in	O	O	O
concentrations	O	O	B-T081
up	O	O	O
to	O	O	O
100	O	O	O
mg/L	O	O	O
,	O	O	O
which	O	O	O
is	O	O	O
the	O	O	O
cutoff	O	O	B-T169
for	O	O	O
hazard	O	O	B-T080
labeling	O	O	B-T064
in	O	O	O
chemicals	O	O	B-T064
regulation	O	O	I-T064
in	O	O	O
Europe	O	O	B-T083
.	O	O	O

However	O	O	O
it	O	O	O
should	O	O	O
be	O	O	O
noted	O	O	O
that	O	O	O
Fe	O	O	B-T121
nanomaterials	O	O	B-T073
proved	O	O	O
challenging	O	O	O
to	O	O	O
test	O	O	O
adequately	O	O	O
due	O	O	O
to	O	O	O
their	O	O	O
turbidity	O	O	B-T080
,	O	O	O
aggregation	O	O	B-T169
and	O	O	O
sedimentation	O	O	B-T070
behavior	O	O	I-T070
in	O	O	O
aqueous	O	O	B-T080
media	O	O	B-T167
.	O	O	O

This	O	O	O
paper	O	O	O
provides	O	O	O
a	O	O	O
number	O	O	O
of	O	O	O
recommendations	O	O	B-T078
concerning	O	O	O
future	O	O	B-T169
testing	O	O	I-T169
of	O	O	O
Fe	O	O	B-T121
nanomaterials	O	O	B-T073
and	O	O	O
discusses	O	O	O
environmental	O	O	B-T058
risk	O	O	I-T058
assessment	O	O	I-T058
considerations	O	O	O
related	O	O	O
to	O	O	O
these	O	O	O
.	O	O	O

-DOCSTART- (28522288)

Grade	O	O	B-T185
Group	O	O	I-T185
Underestimation	O	O	B-T033
in	O	O	O
Prostate	O	O	B-T060
Biopsy	O	O	I-T060
:	O	O	O
Predictive	O	O	B-T170
Factors	O	O	I-T170
and	O	O	O
Outcomes	O	O	B-T033
in	O	O	O
Candidates	O	O	B-T098
for	O	O	O
Active	O	O	O
Surveillance	O	O	O

We	O	O	O
intended	O	O	O
to	O	O	O
analyze	O	O	O
the	O	O	O
outcomes	O	O	B-T033
and	O	O	O
predictive	O	O	B-T170
factors	O	O	I-T170
for	O	O	O
underestimating	O	O	O
the	O	O	O
prostate	O	O	B-T191
cancer	O	O	I-T191
(	O	O	O
PCa	O	O	B-T191
)	O	O	O
grade	O	O	B-T185
group	O	O	I-T185
(	O	O	O
GG	O	O	B-T185
)	O	O	O
from	O	O	O
prostate	O	O	B-T060
biopsies	O	O	I-T060
in	O	O	O
a	O	O	O
large	O	O	O
monocentric	O	O	B-T098
cohort	O	O	I-T098
of	O	O	O
patients	O	O	B-T101
treated	O	O	B-T169
by	O	O	O
minimally	O	O	B-T061
invasive	O	O	I-T061
radical	O	O	I-T061
prostatectomy	O	O	I-T061
(	O	O	O
RP	O	O	B-T061
)	O	O	O
.	O	O	O

Using	O	O	O
a	O	O	O
monocentric	O	O	B-T170
prospectively	O	O	I-T170
maintained	O	O	I-T170
database	O	O	I-T170
,	O	O	O
we	O	O	O
included	O	O	O
3062	O	O	O
patients	O	O	B-T101
who	O	O	O
underwent	O	O	O
minimally	O	O	B-T061
invasive	O	O	I-T061
RP	O	O	I-T061
between	O	O	O
2006	O	O	O
and	O	O	O
2013	O	O	O
.	O	O	O

We	O	O	O
explored	O	O	O
clinicopathologic	O	O	O
features	O	O	O
and	O	O	O
outcomes	O	O	B-T033
associated	O	O	B-T080
with	O	O	I-T080
a	O	O	O
GG	O	O	B-T185
upgrade	O	O	O
from	O	O	O
biopsy	O	O	B-T060
to	O	O	O
RP	O	O	B-T061
.	O	O	O

Multivariate	O	O	B-T062
logistic	O	O	I-T062
regression	O	O	I-T062
was	O	O	O
used	O	O	O
to	O	O	O
develop	O	O	O
and	O	O	O
validate	O	O	O
a	O	O	O
nomogram	O	O	B-T170
to	O	O	O
predict	O	O	O
upgrading	O	O	O
for	O	O	O
GG1	O	O	B-T185
.	O	O	O

Biopsy	O	O	B-T060
GG	O	O	B-T185
was	O	O	O
upgraded	O	O	O
after	O	O	O
RP	O	O	B-T061
in	O	O	O
51.5	O	O	O
%	O	O	O
of	O	O	O
cases	O	O	O
.	O	O	O

Patients	O	O	B-T101
upgraded	O	O	O
from	O	O	O
GG1	O	O	B-T185
to	O	O	O
GG2	O	O	B-T185
or	O	O	O
GG3	O	O	B-T185
after	O	O	O
RP	O	O	B-T061
had	O	O	O
a	O	O	O
longer	O	O	B-T079
time	O	O	I-T079
to	O	O	O
biochemical	O	O	B-T033
recurrence	O	O	I-T033
than	O	O	O
those	O	O	O
with	O	O	O
GG2	O	O	O
or	O	O	O
GG3	O	O	O
respectively	O	O	O
,	O	O	O
on	O	O	O
both	O	O	O
biopsy	O	O	B-T060
and	O	O	O
RP	O	O	O
,	O	O	O
but	O	O	O
a	O	O	O
shorter	O	O	B-T079
time	O	O	I-T079
to	O	O	O
biochemical	O	O	O
recurrence	O	O	O
than	O	O	O
those	O	O	O
who	O	O	O
remained	O	O	O
GG1	O	O	O
after	O	O	O
RP	O	O	O
(	O	O	O
P	O	O	O
<	O	O	O
.0001	O	O	O
)	O	O	O
.	O	O	O

In	O	O	O
multivariate	O	O	B-T081
analyses	O	O	I-T081
,	O	O	O
variables	O	O	B-T081
predicting	O	O	O
upgrading	O	O	O
for	O	O	O
GG1	O	O	B-T185
PCa	O	O	B-T191
were	O	O	O
age	O	O	B-T032
(	O	O	O
P	O	O	O
=	O	O	O
.0014	O	O	O
)	O	O	O
,	O	O	O
abnormal	O	O	B-T060
digital	O	O	I-T060
rectal	O	O	I-T060
examination	O	O	I-T060
(	O	O	O
P	O	O	O
<	O	O	O
.0001	O	O	O
)	O	O	O
,	O	O	O
prostate	O	O	B-T033
-specific	O	O	I-T033
antigen	O	O	I-T033
density	O	O	I-T033
(	O	O	O
P	O	O	O
<	O	O	O
.0001	O	O	O
)	O	O	O
,	O	O	O
percentage	O	O	B-T033
of	O	O	I-T033
positive	O	O	I-T033
cores	O	O	I-T033
(	O	O	O
P	O	O	O
<	O	O	O
.0001	O	O	O
)	O	O	O
,	O	O	O
and	O	O	O
body	O	O	B-T170
mass	O	O	I-T170
index	O	O	I-T170
(	O	O	O
P	O	O	O
=	O	O	O
.037	O	O	O
)	O	O	O
.	O	O	O

A	O	O	O
nomogram	O	O	B-T170
was	O	O	O
generated	O	O	O
and	O	O	O
validated	O	O	O
internally	O	O	O
.	O	O	O

Biopsy	O	O	B-T060
grading	O	O	B-T058
system	O	O	I-T058
is	O	O	O
misleading	O	O	O
in	O	O	O
approximately	O	O	O
50	O	O	O
%	O	O	O
of	O	O	O
cases	O	O	O
.	O	O	O

Upgrading	O	O	O
GG	O	O	B-T185
from	O	O	O
biopsy	O	O	B-T060
to	O	O	O
RP	O	O	B-T061
may	O	O	O
have	O	O	O
consequences	O	O	O
on	O	O	O
clinical	O	O	B-T033
outcomes	O	O	I-T033
.	O	O	O

A	O	O	O
nomogram	O	O	B-T170
using	O	O	O
clinicopathologic	O	O	O
features	O	O	O
could	O	O	O
aid	O	O	O
the	O	O	O
probability	O	O	B-T081
of	O	O	O
needing	O	O	O
to	O	O	O
upgrade	O	O	O
GG1	O	O	B-T185
patients	O	O	B-T101
at	O	O	O
their	O	O	O
initial	O	O	O
evaluation	O	O	B-T058
.	O	O	O

-DOCSTART- (28523425)

Characterization	O	O	B-T052
of	O	O	O
electrocorticogram	O	O	B-T060
high	O	O	B-T080
-	O	O	O
gamma	O	O	B-T070
signal	O	O	B-T067
in	O	O	O
response	O	O	B-T032
to	O	O	O
varying	O	O	B-T080
upper	O	O	B-T023
extremity	O	O	I-T023
movement	O	O	B-T040
velocity	O	O	O

The	O	O	O
mechanism	O	O	B-T169
by	O	O	O
which	O	O	O
the	O	O	O
human	O	O	B-T016
primary	O	O	B-T029
motor	O	O	I-T029
cortex	O	O	I-T029
(	O	O	O
M1	O	O	B-T029
)	O	O	O
encodes	O	O	B-T052
upper	O	O	B-T023
extremity	O	O	I-T023
movement	O	O	B-T040
kinematics	O	O	B-T091
is	O	O	O
not	O	O	O
fully	O	O	O
understood	O	O	O
.	O	O	O

For	O	O	O
example	O	O	O
,	O	O	O
human	O	O	B-T016
electrocorticogram	O	O	B-T060
(	O	O	O
ECoG	O	O	B-T060
)	O	O	O
signals	O	O	B-T067
have	O	O	O
been	O	O	O
shown	O	O	O
to	O	O	O
modulate	O	O	B-T082
with	O	O	O
upper	O	O	B-T023
extremity	O	O	I-T023
movement	O	O	B-T040
s	O	O	O
;	O	O	O
however	O	O	O
,	O	O	O
this	O	O	O
relationship	O	O	B-T080
has	O	O	O
not	O	O	O
been	O	O	O
explicitly	O	O	B-T080
characterized	O	O	B-T052
.	O	O	O

To	O	O	O
address	O	O	O
this	O	O	O
issue	O	O	B-T033
,	O	O	O
we	O	O	O
recorded	O	O	B-T081
high	O	O	B-T080
-	O	O	O
density	O	O	B-T081
ECoG	O	O	B-T060
signals	O	O	B-T067
from	O	O	O
patients	O	O	B-T101
undergoing	O	O	O
epilepsy	O	O	B-T047
surgery	O	O	B-T061
evaluation	O	O	B-T058
as	O	O	O
they	O	O	O
performed	O	O	B-T169
elementary	O	O	B-T167
upper	O	O	B-T023
extremity	O	O	I-T023
movements	O	O	B-T040
while	O	O	O
systematically	O	O	B-T169
varying	O	O	B-T080
movement	O	O	B-T040
speed	O	O	B-T081
and	O	O	O
duration	O	O	B-T079
.	O	O	O

Specifically	O	O	B-T080
,	O	O	O
subjects	O	O	B-T096
performed	O	O	B-T169
intermittent	O	O	B-T079
pincer	O	O	B-T033
grasp	O	O	I-T033
/	O	O	O
release	O	O	B-T169
,	O	O	O
elbow	O	O	B-T033
flexion	O	O	I-T033
/	O	O	O
extension	O	O	B-T169
,	O	O	O
and	O	O	O
shoulder	O	O	B-T033
flexion	O	O	I-T033
/	O	O	O
extension	O	O	O
at	O	O	O
slow	O	O	B-T080
,	O	O	O
moderate	O	O	B-T080
,	O	O	O
and	O	O	O
fast	O	O	B-T080
speeds	O	O	B-T081
.	O	O	O

In	O	O	O
all	O	O	O
movements	O	O	B-T040
,	O	O	O
bursts	O	O	B-T081
of	O	O	O
power	O	O	B-T081
in	O	O	O
the	O	O	O
high	O	O	B-T080
-[Formula	O	O	O
:	O	O	O
see	O	O	O
text	O	O	O
]	O	O	O
band	O	O	O
(	O	O	O
80	O	O	O
-	O	O	O
160	O	O	O
Hz	O	O	O
)	O	O	O
were	O	O	O
observed	O	O	B-T169
in	O	O	O
M1	O	O	B-T029
.	O	O	O

In	O	O	O
addition	O	O	B-T169
,	O	O	O
the	O	O	O
amplitude	O	O	B-T082
of	O	O	O
these	O	O	O
power	O	O	B-T081
bursts	O	O	B-T081
and	O	O	O
the	O	O	O
area	O	O	B-T082
of	O	O	O
M1	O	O	B-T029
with	O	O	O
elevated	O	O	B-T080
high	O	O	B-T080
-[Formula	O	O	O
:	O	O	O
see	O	O	O
text	O	O	O
]	O	O	O
activity	O	O	B-T052
were	O	O	O
directly	O	O	B-T080
proportional	O	O	B-T080
to	O	O	O
the	O	O	O
movement	O	O	B-T040
speed	O	O	B-T081
.	O	O	O

Likewise	O	O	O
,	O	O	O
the	O	O	O
duration	O	O	B-T079
of	O	O	O
elevated	O	O	B-T080
high	O	O	B-T080
-[Formula	O	O	O
:	O	O	O
see	O	O	O
text	O	O	O
]	O	O	O
activity	O	O	B-T052
increased	O	O	B-T081
with	O	O	O
movement	O	O	B-T040
duration	O	O	O
.	O	O	O

Based	O	O	B-T169
on	O	O	O
linear	O	O	B-T081
regression	O	O	I-T081
,	O	O	O
M1	O	O	B-T029
high	O	O	B-T080
-[Formula	O	O	O
:	O	O	O
see	O	O	O
text	O	O	O
]	O	O	O
power	O	O	B-T081
amplitude	O	O	B-T082
and	O	O	O
duration	O	O	B-T079
covaried	O	O	B-T080
with	O	O	O
movement	O	O	B-T040
speed	O	O	B-T081
and	O	O	O
duration	O	O	O
,	O	O	O
respectively	O	O	O
,	O	O	O
with	O	O	O
an	O	O	O
average	O	O	B-T081
[	O	O	O
Formula	O	O	O
:	O	O	O
see	O	O	O
text	O	O	O
]	O	O	O
of	O	O	O
[	O	O	O
Formula	O	O	O
:	O	O	O
see	O	O	O
text	O	O	O
]	O	O	O
and	O	O	O
[	O	O	O
Formula	O	O	O
:	O	O	O
see	O	O	O
text	O	O	O
]	O	O	O
.	O	O	O

These	O	O	O
findings	O	O	B-T033
indicate	O	O	B-T078
that	O	O	O
the	O	O	O
encoding	O	O	B-T052
of	O	O	O
upper	O	O	B-T023
extremity	O	O	I-T023
movement	O	O	B-T040
speed	O	O	B-T081
by	O	O	O
M1	O	O	B-T029
high	O	O	B-T080
-[Formula	O	O	O
:	O	O	O
see	O	O	O
text	O	O	O
]	O	O	O
activity	O	O	B-T052
is	O	O	O
primarily	O	O	B-T080
linear	O	O	B-T082
.	O	O	O

Also	O	O	O
,	O	O	O
the	O	O	O
fact	O	O	O
that	O	O	O
this	O	O	O
activity	O	O	B-T052
remained	O	O	O
elevated	O	O	B-T080
throughout	O	O	O
a	O	O	O
movement	O	O	B-T040
suggests	O	O	O
that	O	O	O
M1	O	O	B-T029
does	O	O	O
not	O	O	O
merely	O	O	O
generate	O	O	O
transient	O	O	B-T079
instructions	O	O	B-T170
for	O	O	O
a	O	O	O
specific	O	O	B-T080
movement	O	O	O
duration	O	O	B-T079
,	O	O	O
but	O	O	O
instead	O	O	O
is	O	O	O
responsible	O	O	O
for	O	O	O
the	O	O	O
entirety	O	O	B-T081
of	O	O	O
the	O	O	O
movement	O	O	O
.	O	O	O

Finally	O	O	O
,	O	O	O
the	O	O	O
spatial	O	O	B-T082
distribution	O	O	I-T082
of	O	O	O
high	O	O	B-T080
-[Formula	O	O	O
:	O	O	O
see	O	O	O
text	O	O	O
]	O	O	O
activity	O	O	B-T052
suggests	O	O	O
the	O	O	O
presence	O	O	B-T033
of	O	O	O
a	O	O	O
recruitment	O	O	B-T052
phenomenon	O	O	B-T067
in	O	O	O
which	O	O	O
higher	O	O	B-T080
speeds	O	O	B-T081
or	O	O	O
increased	O	O	B-T081
muscle	O	O	B-T024
activity	O	O	O
involve	O	O	O
activation	O	O	B-T052
of	O	O	O
larger	O	O	O
M1	O	O	B-T029
area	O	O	B-T082
s.	O	O	O

-DOCSTART- (28523479)

Fatty	O	O	B-T109
Acids	O	O	I-T109
Have	O	O	O
Different	O	O	B-T080
Adipogenic	O	O	B-T044
Differentiation	O	O	I-T044
Potentials	O	O	B-T080
in	O	O	O
Stromal	O	O	B-T025
Vascular	O	O	I-T025
Cells	O	O	I-T025
Isolated	O	O	B-T169
from	O	O	O
Abdominal	O	O	B-T024
Fat	O	O	I-T024
in	O	O	O
Laying	O	O	B-T040
Hens	O	O	O

This	O	O	O
study	O	O	B-T062
was	O	O	O
conducted	O	O	O
to	O	O	O
examine	O	O	O
the	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
fatty	O	O	B-T109
acids	O	O	I-T109
(	O	O	O
FA	O	O	B-T109
)	O	O	O
with/without	O	O	O
chicken	O	O	B-T012
serum	O	O	I-T129
(	O	O	O
CS	O	O	B-T129
)	O	O	O
on	O	O	O
the	O	O	O
expression	O	O	B-T045
of	O	O	O
adipogenic	O	O	B-T044
transcripts	O	O	B-T114
and	O	O	O
adipogenesis	O	O	B-T044
in	O	O	O
chicken	O	O	O
stromal	O	O	B-T025
vascular	O	O	I-T025
cells	O	O	I-T025
(	O	O	O
SVC	O	O	B-T025
)	O	O	O
.	O	O	O

In	O	O	O
experiment	O	O	O
1	O	O	O
,	O	O	O
SVC	O	O	B-T025
were	O	O	O
grown	O	O	O
in	O	O	O
DMEM	O	O	B-T121
containing	O	O	O
10	O	O	O
%	O	O	O
FBS	O	O	B-T130
(	O	O	O
Control	O	O	B-T096
)	O	O	O
and	O	O	O
treated	O	O	B-T169
with	O	O	O
300	O	O	O
ÂµM	O	O	O
oleic	O	O	B-T109
acid	O	O	I-T109
(	O	O	O
OLA	O	O	B-T109
)	O	O	O
+	O	O	O
FBS	O	O	O
,	O	O	O
linoleic	O	O	B-T109
acid	O	O	I-T109
(	O	O	O
LNA	O	O	B-T109
)	O	O	O
+	O	O	O
FBS	O	O	O
,	O	O	O
palmitic	O	O	B-T109
acid	O	O	I-T109
(	O	O	O
PAM	O	O	B-T109
)	O	O	O
+	O	O	O
FBS	O	O	O
,	O	O	O
or	O	O	O
stearic	O	O	B-T109
acid	O	O	I-T109
(	O	O	O
STA	O	O	B-T109
)	O	O	O
+	O	O	O
FBS	O	O	O
for	O	O	O
48	O	O	O
h.	O	O	O
In	O	O	O
experiment	O	O	O
2	O	O	O
,	O	O	O
cells	O	O	B-T025
were	O	O	O
grown	O	O	O
in	O	O	O
DMEM	O	O	O
containing	O	O	O
5	O	O	O
%	O	O	O
CS	O	O	B-T129
and	O	O	O
treated	O	O	O
with	O	O	O
300	O	O	O
ÂµM	O	O	O
OLA	O	O	O
(	O	O	O
CS	O	O	O
+	O	O	O
OLA	O	O	O
)	O	O	O
,	O	O	O
PAM	O	O	O
(	O	O	O
CS	O	O	O
+	O	O	O
PAM	O	O	O
)	O	O	O
,	O	O	O
STA	O	O	O
(	O	O	O
CS	O	O	O
+	O	O	O
STA	O	O	O
)	O	O	O
or	O	O	O
200	O	O	O
ÂµM	O	O	O
LNA	O	O	O
(	O	O	O
CS	O	O	O
+	O	O	O
LNA	O	O	O
)	O	O	O
for	O	O	O
48	O	O	O
h.	O	O	O
Adipogenesis	O	O	B-T044
was	O	O	O
determined	O	O	O
using	O	O	O
Oil	O	O	B-T059
Red	O	O	I-T059
O	O	O	I-T059
staining	O	O	I-T059
and	O	O	O
glycerol-3-phosphate	O	O	B-T044
dehydrogenase	O	O	I-T044
(	O	O	I-T044
GPDH	O	O	I-T044
)	O	O	I-T044
activity	O	O	I-T044
.	O	O	O

The	O	O	O
proportion	O	O	O
of	O	O	O
OLA	O	O	B-T109
,	O	O	O
PAM	O	O	B-T109
,	O	O	O
or	O	O	O
STA	O	O	B-T109
was	O	O	O
increased	O	O	B-T081
(	O	O	O
P	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
in	O	O	O
SVC	O	O	B-T025
grown	O	O	O
in	O	O	O
either	O	O	O
FBS	O	O	B-T130
or	O	O	O
CS	O	O	B-T129
with	O	O	O
OLA	O	O	O
,	O	O	O
PAM	O	O	O
or	O	O	O
STA	O	O	O
.	O	O	O

Adipogenesis	O	O	B-T044
was	O	O	O
induced	O	O	B-T169
in	O	O	O
FBS	O	O	B-T130
+	O	O	O
OLA	O	O	B-T109
,	O	O	O
FBS	O	O	O
+	O	O	O
LNA	O	O	B-T109
,	O	O	O
FBS	O	O	O
+	O	O	O
PAM	O	O	B-T109
,	O	O	O
FBS	O	O	O
+	O	O	O
STA	O	O	B-T109
,	O	O	O
CS	O	O	B-T129
+	O	O	O
OLA	O	O	O
,	O	O	O
CS	O	O	O
+	O	O	O
LNA	O	O	O
,	O	O	O
CS	O	O	O
+	O	O	O
PAM	O	O	O
,	O	O	O
or	O	O	O
CS	O	O	O
+	O	O	O
STA	O	O	O
compared	O	O	O
to	O	O	O
FBS	O	O	O
.	O	O	O

GPDH	O	O	B-T044
activity	O	O	I-T044
was	O	O	O
significantly	O	O	B-T081
higher	O	O	I-T081
in	O	O	O
FBS	O	O	B-T130
+	O	O	O
OLA	O	O	B-T109
and	O	O	O
FBS	O	O	O
+	O	O	O
LNA	O	O	B-T109
than	O	O	O
one	O	O	O
in	O	O	O
FBS	O	O	O
.	O	O	O

Compared	O	O	O
to	O	O	O
FBS	O	O	B-T130
,	O	O	O
the	O	O	O
expression	O	O	B-T045
of	O	O	O
FABP4	O	O	B-T028
mRNA	O	O	B-T114
increased	O	O	B-T081
(	O	O	O
P	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
in	O	O	O
FBS	O	O	O
+	O	O	O
OLA	O	O	B-T109
,	O	O	O
FBS	O	O	O
+	O	O	O
LNA	O	O	B-T109
,	O	O	O
or	O	O	O
FBS	O	O	O
+	O	O	O
PAM	O	O	B-T109
,	O	O	O
whereas	O	O	O
that	O	O	O
of	O	O	O
C/EBPÎ±	O	O	B-T028
,	O	O	O
C/EBPÎ²	O	O	B-T028
,	O	O	O
and	O	O	O
ATGL	O	O	B-T028
increased	O	O	O
(	O	O	O
P	O	O	O
<	O	O	O
0.05	O	O	O
)	O	O	O
in	O	O	O
FBS	O	O	O
+	O	O	O
OLA	O	O	O
or	O	O	O
FBS	O	O	O
+	O	O	O
LNA	O	O	O
cells	O	O	B-T025
.	O	O	O

Expression	O	O	B-T045
of	O	O	O
FABP4	O	O	B-T028
and	O	O	O
C/EBPÎ²	O	O	B-T028
mRNA	O	O	B-T114
was	O	O	O
higher	O	O	B-T080
in	O	O	O
CS	O	O	B-T129
,	O	O	O
CS	O	O	O
+	O	O	O
OLA	O	O	B-T109
,	O	O	O
CS	O	O	O
+	O	O	O
LNA	O	O	B-T109
,	O	O	O
CS	O	O	O
+	O	O	O
PAM	O	O	B-T109
,	O	O	O
or	O	O	O
CS	O	O	O
+	O	O	O
STA	O	O	B-T109
compared	O	O	B-T052
with	O	O	O
(	O	O	O
FBS	O	O	B-T130
,	O	O	O
whereas	O	O	O
the	O	O	O
expression	O	O	B-T045
of	O	O	O
ATGL	O	O	B-T028
and	O	O	O
C/EBPÎ±	O	O	B-T028
was	O	O	O
higher	O	O	O
in	O	O	O
CS	O	O	O
,	O	O	O
CS	O	O	O
+	O	O	O
OLA	O	O	O
,	O	O	O
or	O	O	O
CS	O	O	O
+	O	O	O
LNA	O	O	O
than	O	O	O
FBS	O	O	O
cells	O	O	B-T025
.	O	O	O

In	O	O	O
conclusion	O	O	O
,	O	O	O
these	O	O	O
results	O	O	B-T033
showed	O	O	O
that	O	O	O
FA	O	O	B-T109
have	O	O	O
different	O	O	B-T080
potentials	O	O	B-T080
to	O	O	O
induce	O	O	B-T169
adipogenesis	O	O	B-T044
,	O	O	O
LNA	O	O	B-T109
is	O	O	O
the	O	O	O
most	O	O	O
potent	O	O	B-T080
among	O	O	O
the	O	O	O
tested	O	O	O
FA	O	O	O
,	O	O	O
and	O	O	O
these	O	O	O
potentials	O	O	O
can	O	O	O
be	O	O	O
improved	O	O	O
in	O	O	O
the	O	O	O
presence	O	O	B-T033
of	O	O	O
CS	O	O	B-T129
.	O	O	O

-DOCSTART- (28523846)

A	O	O	O
novel	O	O	B-T080
rapid	O	O	B-T080
analysis	O	O	B-T062
using	O	O	O
mass	O	O	B-T059
spectrometry	O	O	I-T059
to	O	O	O
evaluate	O	O	O
downstream	O	O	B-T082
refolding	O	O	B-T044
of	O	O	O
recombinant	O	O	B-T116
human	O	O	I-T116
insulin-like	O	O	I-T116
growth	O	O	I-T116
factor-1	O	O	I-T116
(	O	O	O
mecasermin	O	O	B-T116
)	O	O	O

Mecasermin	O	O	B-T116
is	O	O	O
used	O	O	O
to	O	O	O
treat	O	O	O
elevated	O	O	B-T047
blood	O	O	I-T047
sugar	O	O	I-T047
as	O	O	O
well	O	O	O
as	O	O	O
growth	O	O	B-T116
hormone	O	O	I-T116
-	O	O	O
resistant	O	O	B-T169
Laron-type	O	O	B-T047
dwarfism	O	O	I-T047
.	O	O	O

Mecasermin	O	O	B-T116
isolated	O	O	O
from	O	O	O
inclusion	O	O	B-T026
bodies	O	O	I-T026
in	O	O	O
extracts	O	O	O
of	O	O	O
E.coli	O	O	B-T007
must	O	O	O
be	O	O	O
refolded	O	O	O
to	O	O	O
acquire	O	O	O
sufficient	O	O	O
activity	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
there	O	O	O
is	O	O	O
no	O	O	O
rapid	O	O	B-T080
analytical	O	O	B-T170
method	O	O	I-T170
for	O	O	O
monitoring	O	O	O
refolding	O	O	B-T044
during	O	O	O
the	O	O	O
purification	O	O	B-T059
process	O	O	O
.	O	O	O

We	O	O	O
prepared	O	O	O
mecasermin	O	O	B-T116
drug	O	O	B-T121
product	O	O	I-T121
,	O	O	O
in-process	O	O	O
samples	O	O	B-T167
during	O	O	O
the	O	O	O
oxidation	O	O	B-T044
of	O	O	O
mecasermin	O	O	O
,	O	O	O
forced-reduced	O	O	O
mecasermin	O	O	O
,	O	O	O
and	O	O	O
aerially	O	O	O
oxidized	O	O	O
mecasermin	O	O	O
after	O	O	O
forced	O	O	O
reduction	O	O	B-T070
.	O	O	O

Desalted	O	O	O
mecasermin	O	O	B-T116
samples	O	O	B-T167
were	O	O	O
analyzed	O	O	O
using	O	O	O
MALDI-ISD	O	O	B-T059
.	O	O	O

The	O	O	O
peak	O	O	B-T081
intensity	O	O	I-T081
ratio	O	O	I-T081
of	O	O	O
product	O	O	O
to	O	O	O
precursor	O	O	O
ion	O	O	O
was	O	O	O
determined	O	O	O
.	O	O	O

The	O	O	O
charge	O	O	B-T080
state	O	O	I-T080
distribution	O	O	I-T080
(	O	O	O
CSD	O	O	B-T080
)	O	O	O
of	O	O	O
mecasermin	O	O	B-T116
ions	O	O	O
was	O	O	O
evaluated	O	O	O
using	O	O	O
ESI-MS	O	O	B-T059
coupled	O	O	O
with	O	O	O
SEC-mode	O	O	O
HPLC	O	O	B-T059
.	O	O	O

The	O	O	O
drift	O	O	B-T081
time	O	O	I-T081
and	O	O	O
collision	O	O	B-T081
cross-sectional	O	O	I-T081
areas	O	O	I-T081
(	O	O	O
CCS	O	O	B-T081
)	O	O	O
of	O	O	O
mecasermin	O	O	B-T116
ions	O	O	O
were	O	O	O
evaluated	O	O	O
using	O	O	O
ESI-IMS-MS	O	O	B-T059
coupled	O	O	B-T169
with	O	O	O
SEC-mode	O	O	O
HPLC	O	O	B-T059
.	O	O	O

MALDI-ISD	O	O	B-T059
data	O	O	O
,	O	O	O
CSD	O	O	B-T081
values	O	O	I-T081
determined	O	O	O
using	O	O	O
ESI-MS	O	O	B-T059
,	O	O	O
and	O	O	O
the	O	O	O
CCS	O	O	B-T081
acquired	O	O	O
using	O	O	O
ESI-IMS-MS	O	O	B-T059
revealed	O	O	O
the	O	O	O
relationship	O	O	B-T080
between	O	O	O
the	O	O	O
folded	O	O	B-T082
and	O	O	O
unfolded	O	O	B-T082
proteoforms	O	O	B-T116
of	O	O	O
forced-reduced	O	O	O
mecasermin	O	O	B-T116
and	O	O	O
aerially	O	O	O
oxidized	O	O	O
mecasermin	O	O	O
with	O	O	O
the	O	O	O
free-SH	O	O	B-T081
:	O	O	I-T081
protein	O	O	I-T081
ratio	O	O	I-T081
of	O	O	O
mecasermin	O	O	O
drug	O	O	B-T121
product	O	O	I-T121
.	O	O	O

The	O	O	O
collision	O	O	B-T081
cross-sectional	O	O	I-T081
area	O	O	I-T081
,	O	O	O
which	O	O	O
is	O	O	O
determined	O	O	O
using	O	O	O
ESI-IMS-MS	O	O	B-T059
,	O	O	O
provided	O	O	O
proteoform	O	O	B-T116
information	O	O	O
through	O	O	O
rapid	O	O	B-T080
monitoring	O	O	O
(	O	O	O
<	O	O	O
2	O	O	O
min	O	O	O
)	O	O	O
of	O	O	O
in-process	O	O	O
samples	O	O	B-T167
during	O	O	O
the	O	O	O
manufacture	O	O	O
of	O	O	O
mecasermin	O	O	B-T116
.	O	O	O

ESI-IMS-MS	O	O	B-T059
coupled	O	O	O
with	O	O	O
SEC-mode	O	O	O
HPLC	O	O	B-T059
is	O	O	O
a	O	O	O
rapid	O	O	B-T080
and	O	O	O
robust	O	O	B-T080
method	O	O	O
for	O	O	O
analyzing	O	O	O
the	O	O	O
free-SH	O	O	B-T081
:	O	O	I-T081
protein	O	O	I-T081
ratio	O	O	I-T081
of	O	O	O
mecasermin	O	O	B-T116
that	O	O	O
allows	O	O	O
evaluating	O	O	O
and	O	O	O
monitoring	O	O	O
proteoform	O	O	B-T116
changes	O	O	O
during	O	O	O
the	O	O	O
oxidation	O	O	B-T044
of	O	O	O
mecasermin	O	O	O
.	O	O	O

ESI-IMS-MS	O	O	B-T059
is	O	O	O
applicable	O	O	O
as	O	O	O
a	O	O	O
process	O	O	O
analytical	O	O	O
technology	O	O	O
tool	O	O	O
for	O	O	O
identifying	O	O	O
the	O	O	O
"	O	O	O
critical	O	O	B-T080
quality	O	O	B-T080
attributes	O	O	B-T080
"	O	O	O
and	O	O	O
implementing	O	O	O
"	O	O	O
quality	O	O	O
by	O	O	O
design	O	O	B-T052
"	O	O	O
for	O	O	O
manufacturing	O	O	O
mecasermin	O	O	B-T116
.	O	O	O

-DOCSTART- (28525754)

Regulated	O	O	B-T045
Intron	O	O	B-T114
Removal	O	O	B-T052
Integrates	O	O	O
Motivational	O	O	B-T041
State	O	O	I-T041
and	O	O	O
Experience	O	O	O

Myriad	O	O	O
experiences	O	O	B-T041
produce	O	O	O
transient	O	O	B-T041
memory	O	O	B-T041
,	O	O	O
yet	O	O	O
,	O	O	O
contingent	O	O	O
on	O	O	O
the	O	O	O
internal	O	O	B-T041
state	O	O	I-T041
of	O	O	O
the	O	O	O
organism	O	O	B-T001
and	O	O	O
the	O	O	O
saliency	O	O	O
of	O	O	O
the	O	O	O
experience	O	O	B-T041
,	O	O	O
only	O	O	O
some	O	O	O
memories	O	O	B-T041
persist	O	O	O
over	O	O	O
time	O	O	B-T079
.	O	O	O
How	O	O	O
experience	O	O	O
and	O	O	O
internal	O	O	O
state	O	O	O
influence	O	O	B-T077
the	O	O	O
duration	O	O	B-T079
of	O	O	O
memory	O	O	O
at	O	O	O
the	O	O	O
molecular	O	O	O
level	O	O	O
remains	O	O	O
unknown	O	O	O
.	O	O	O

A	O	O	O
self-assembled	O	O	B-T080
aggregated	O	O	I-T080
state	O	O	O
of	O	O	O
Drosophila	O	O	B-T116
Orb2A	O	O	I-T116
protein	O	O	I-T116
is	O	O	O
required	O	O	O
specifically	O	O	O
for	O	O	O
long-lasting	O	O	B-T041
memory	O	O	I-T041
.	O	O	O

We	O	O	O
report	O	O	O
that	O	O	O
in	O	O	O
the	O	O	O
adult	O	O	B-T204
fly	O	O	I-T204
brain	O	O	B-T023
the	O	O	O
mRNA	O	O	B-T114
encoding	O	O	B-T052
Orb2A	O	O	B-T116
protein	O	O	I-T116
exists	O	O	O
in	O	O	O
an	O	O	O
unspliced	O	O	B-T114
non-protein-coding	O	O	I-T114
form	O	O	I-T114
.	O	O	O

The	O	O	O
convergence	O	O	B-T052
of	O	O	O
experience	O	O	B-T041
and	O	O	O
internal	O	O	B-T041
drive	O	O	I-T041
transiently	O	O	O
increases	O	O	B-T169
the	O	O	O
spliced	O	O	B-T114
protein-coding	O	O	I-T114
Orb2A	O	O	I-T114
mRNA	O	O	I-T114
.	O	O	O

A	O	O	O
screen	O	O	O
identified	O	O	O
pasilla	O	O	B-T116
,	O	O	O
the	O	O	O
fly	O	O	B-T204
ortholog	O	O	O
of	O	O	O
mammalian	O	O	B-T015
Nova-1	O	O	B-T116
/	O	O	O
2	O	O	B-T116
,	O	O	O
as	O	O	O
a	O	O	O
mediator	O	O	B-T116
of	O	O	O
Orb2A	O	O	B-T114
mRNA	O	O	I-T114
processing	O	O	B-T045
.	O	O	O

A	O	O	O
single-nucleotide	O	O	B-T114
substitution	O	O	B-T044
in	O	O	O
the	O	O	O
intronic	O	O	B-T114
region	O	O	O
that	O	O	O
reduces	O	O	B-T080
Pasilla	O	O	B-T116
binding	O	O	B-T044
and	O	O	O
intron	O	O	B-T114
removal	O	O	B-T052
selectively	O	O	O
impairs	O	O	B-T169
long-term	O	O	B-T041
memory	O	O	I-T041
.	O	O	O

We	O	O	O
posit	O	O	O
that	O	O	O
pasilla	O	O	B-T116
-mediated	O	O	O
processing	O	O	B-T045
of	O	O	O
unspliced	O	O	B-T114
Orb2A	O	O	I-T114
mRNA	O	O	I-T114
integrates	O	O	O
experience	O	O	B-T041
and	O	O	O
internal	O	O	B-T041
state	O	O	I-T041
to	O	O	O
control	O	O	O
Orb2A	O	O	B-T116
protein	O	O	I-T116
abundance	O	O	B-T080
and	O	O	O
long-term	O	O	B-T041
memory	O	O	I-T041
formation	O	O	B-T169
.	O	O	O

-DOCSTART- (28526360)

The	O	O	O
FLASHE	O	O	B-T170
Study	O	O	I-T170
:	O	O	O
Survey	O	O	B-T170
Development	O	O	B-T169
,	O	O	O
Dyadic	O	O	B-T098
Perspectives	O	O	O
,	O	O	O
and	O	O	O
Participant	O	O	B-T098
Characteristics	O	O	O

The	O	O	O
National	O	O	B-T093
Cancer	O	O	I-T093
Institute	O	O	I-T093
developed	O	O	O
the	O	O	O
Family	O	O	B-T054
Life	O	O	I-T054
,	O	O	O
Activity	O	O	B-T052
,	O	O	O
Sun	O	O	B-T070
,	O	O	O
Health	O	O	B-T078
,	O	O	O
and	O	O	O
Eating	O	O	B-T040
(	O	O	O
FLASHE	O	O	B-T170
)	O	O	O
Study	O	O	B-T170
to	O	O	O
examine	O	O	O
multiple	O	O	O
cancer	O	O	B-T061
preventive	O	O	I-T061
behaviors	O	O	B-T055
within	O	O	O
parent	O	O	B-T099
-	O	O	O
adolescent	O	O	B-T100
dyads	O	O	B-T098
.	O	O	O

The	O	O	O
purpose	O	O	O
of	O	O	O
creating	O	O	O
FLASHE	O	O	B-T170
was	O	O	O
to	O	O	O
enable	O	O	O
the	O	O	O
examination	O	O	O
of	O	O	O
physical	O	O	B-T056
activity	O	O	I-T056
,	O	O	O
diet	O	O	B-T168
,	O	O	O
and	O	O	O
other	O	O	O
cancer	O	O	B-T061
preventive	O	O	I-T061
behaviors	O	O	I-T061
and	O	O	O
potential	O	O	O
correlates	O	O	O
among	O	O	O
parent	O	O	B-T099
-	O	O	O
adolescent	O	O	B-T100
dyads	O	O	B-T098
.	O	O	O

FLASHE	O	O	B-T170
surveys	O	O	I-T170
were	O	O	O
developed	O	O	O
from	O	O	O
a	O	O	O
process	O	O	O
involving	O	O	O
literature	O	O	B-T170
reviews	O	O	I-T170
,	O	O	O
scientific	O	O	B-T090
input	O	O	B-T077
from	O	O	O
experts	O	O	B-T097
in	O	O	O
the	O	O	O
field	O	O	O
,	O	O	O
cognitive	O	O	B-T060
testing	O	O	I-T060
,	O	O	O
and	O	O	O
usability	O	O	O
testing	O	O	O
.	O	O	O

This	O	O	O
cross-sectional	O	O	B-T062
,	O	O	O
web-based	O	O	B-T062
study	O	O	I-T062
of	O	O	O
parents	O	O	B-T099
and	O	O	O
their	O	O	O
adolescent	O	O	B-T100
children	O	O	B-T099
(	O	O	O
aged	O	O	O
12	O	O	O
-	O	O	O
17	O	O	O
years	O	O	O
)	O	O	O
was	O	O	O
administered	O	O	B-T169
between	O	O	O
April	O	O	B-T079
and	O	O	O
October	O	O	B-T079
2014	O	O	O
.	O	O	O

The	O	O	O
nationwide	O	O	O
sample	O	O	O
consisted	O	O	O
of	O	O	O
1,573	O	O	O
parent	O	O	B-T099
-	O	O	O
adolescent	O	O	B-T100
dyads	O	O	B-T098
(	O	O	O
1,699	O	O	O
parents	O	O	B-T099
and	O	O	O
1,581	O	O	O
adolescents	O	O	B-T100
)	O	O	O
who	O	O	O
returned	O	O	O
all	O	O	O
FLASHE	O	O	B-T170
surveys	O	O	I-T170
.	O	O	O

FLASHE	O	O	B-T170
assessed	O	O	O
parent	O	O	B-T099
and	O	O	O
adolescent	O	O	B-T100
reports	O	O	O
of	O	O	O
several	O	O	O
intrapersonal	O	O	O
and	O	O	O
interpersonal	O	O	B-T080
domains	O	O	O
(	O	O	O
including	O	O	O
psychosocial	O	O	B-T080
variables	O	O	I-T080
,	O	O	O
parenting	O	O	B-T054
,	O	O	O
and	O	O	O
the	O	O	O
community	O	O	B-T080
and	O	O	O
home	O	O	B-T082
environments	O	O	I-T082
)	O	O	O
.	O	O	O

On	O	O	O
a	O	O	O
subset	O	O	O
of	O	O	O
example	O	O	O
FLASHE	O	O	B-T170
items	O	O	O
across	O	O	O
these	O	O	O
domains	O	O	O
,	O	O	O
responses	O	O	B-T078
of	O	O	O
parents	O	O	B-T099
and	O	O	O
adolescents	O	O	B-T100
within	O	O	O
the	O	O	O
same	O	O	O
dyads	O	O	B-T098
were	O	O	O
positively	O	O	O
and	O	O	O
significantly	O	O	O
correlated	O	O	B-T081
(	O	O	O
r	O	O	O
=	O	O	O
0.32	O	O	O
-	O	O	O
0.63	O	O	O
)	O	O	O
.	O	O	O

Analyses	O	O	O
were	O	O	O
run	O	O	O
in	O	O	O
2015	O	O	O
-	O	O	O
2016	O	O	O
.	O	O	O

FLASHE	O	O	B-T170
data	O	O	O
present	O	O	O
multiple	O	O	O
opportunities	O	O	O
for	O	O	O
studying	O	O	O
research	O	O	B-T078
questions	O	O	I-T078
among	O	O	O
individuals	O	O	B-T098
or	O	O	O
dyads	O	O	B-T098
,	O	O	O
including	O	O	O
the	O	O	O
ability	O	O	B-T032
to	O	O	O
examine	O	O	O
similarity	O	O	B-T080
between	O	O	O
parents	O	O	B-T099
and	O	O	O
adolescents	O	O	B-T100
on	O	O	O
many	O	O	O
constructs	O	O	O
relevant	O	O	O
to	O	O	O
cancer	O	O	B-T061
preventive	O	O	I-T061
behaviors	O	O	I-T061
.	O	O	O

FLASHE	O	O	B-T170
data	O	O	O
are	O	O	O
publicly	O	O	O
available	O	O	O
for	O	O	O
researchers	O	O	B-T097
and	O	O	O
practitioners	O	O	B-T097
to	O	O	O
help	O	O	O
advance	O	O	O
research	O	O	B-T062
on	O	O	O
cancer	O	O	B-T061
preventive	O	O	I-T061
health	O	O	B-T055
behaviors	O	O	I-T055
.	O	O	O

-DOCSTART- (28527954)

Sex	O	O	B-T032
differences	O	O	I-T032
in	O	O	O
the	O	O	O
effect	O	O	B-T080
of	O	O	I-T080
chronic	O	O	B-UnknownType
mild	O	O	I-UnknownType
stress	O	O	I-UnknownType
on	O	O	O
mouse	O	O	B-T015
prefrontal	O	O	B-T023
cortical	O	O	I-T023
BDNF	O	O	B-T116
levels	O	O	O
:	O	O	O
A	O	O	O
role	O	O	O
of	O	O	O
major	O	O	O
ovarian	O	O	O
hormones	O	O	O

Depression	O	O	B-T048
induced	O	O	B-T169
by	O	O	O
stress	O	O	B-T033
is	O	O	O
affected	O	O	O
by	O	O	O
sex	O	O	B-T032
,	O	O	O
age	O	O	B-T032
and	O	O	O
hormonal	O	O	B-T080
status	O	O	O
of	O	O	O
the	O	O	O
animal	O	O	B-T008
and	O	O	O
also	O	O	O
by	O	O	O
duration	O	O	B-T079
and	O	O	O
type	O	O	O
of	O	O	O
the	O	O	O
stressors	O	O	B-T078
.	O	O	O

Moreover	O	O	O
,	O	O	O
higher	O	O	O
prevalence	O	O	O
of	O	O	O
depression	O	O	B-T048
and	O	O	O
comorbidities	O	O	B-T078
in	O	O	O
women	O	O	B-T098
than	O	O	O
men	O	O	B-T098
implies	O	O	O
the	O	O	O
need	O	O	O
to	O	O	O
include	O	O	O
the	O	O	O
sex	O	O	B-T032
variable	O	O	O
in	O	O	O
studies	O	O	O
on	O	O	O
animal	O	O	B-T008
models	O	O	I-T008
of	O	O	O
depression	O	O	O
.	O	O	O

The	O	O	O
present	O	O	O
study	O	O	O
was	O	O	O
therefore	O	O	O
initiated	O	O	O
to	O	O	O
evaluate	O	O	O
the	O	O	O
effect	O	O	B-T080
of	O	O	I-T080
sex	O	O	B-T032
and	O	O	O
ovarian	O	O	B-T125
hormones	O	O	I-T125
on	O	O	O
depression	O	O	B-T048
-like	O	O	O
phenotypes	O	O	B-T032
in	O	O	O
mice	O	O	B-T015
exposed	O	O	O
to	O	O	O
a	O	O	O
21-day	O	O	O
Chronic	O	O	B-UnknownType
Variable	O	O	I-UnknownType
Mild	O	O	I-UnknownType
Stress	O	O	I-UnknownType
(	O	O	O
CVMS	O	O	B-UnknownType
)	O	O	O
paradigm	O	O	B-T062
.	O	O	O

Adult	O	O	B-T100
male	O	O	B-T032
,	O	O	O
intact	O	O	B-T033
female	O	O	I-T033
and	O	O	O
,	O	O	O
ovariectomized	O	O	B-T033
(	O	O	I-T033
OVX	O	O	I-T033
)	O	O	I-T033
female	O	O	I-T033
mice	O	O	B-T015
exposed	O	O	O
to	O	O	O
CVMS	O	O	B-UnknownType
displayed	O	O	O
despair	O	O	O
behavior	O	O	B-T053
,	O	O	O
a	O	O	O
depression	O	O	B-T048
-like	O	O	O
phenotype	O	O	B-T032
,	O	O	O
in	O	O	O
all	O	O	O
the	O	O	O
groups	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
intact	O	O	B-T033
females	O	O	I-T033
alone	O	O	O
,	O	O	O
but	O	O	O
not	O	O	O
males	O	O	B-T032
and	O	O	O
OVX	O	O	B-T033
females	O	O	I-T033
,	O	O	O
showed	O	O	O
anhedonia	O	O	B-T048
,	O	O	O
another	O	O	O
depression	O	O	B-T048
-like	O	O	O
phenotype	O	O	B-T032
.	O	O	O

At	O	O	O
the	O	O	O
molecular	O	O	B-T081
level	O	O	I-T081
,	O	O	O
the	O	O	O
expression	O	O	B-T045
of	O	O	O
Brain-Derived	O	O	B-T116
Neurotrophic	O	O	I-T116
Factor	O	O	I-T116
(	O	O	O
BDNF	O	O	B-T116
)	O	O	O
,	O	O	O
a	O	O	O
neuropeptide	O	O	B-T116
associated	O	O	B-T080
with	O	O	I-T080
depression	O	O	B-T048
,	O	O	O
and	O	O	O
few	O	O	O
other	O	O	O
stress	O	O	B-T033
-specific	O	O	O
genes	O	O	B-T028
CRH	O	O	B-T028
,	O	O	O
NR3C1	O	O	B-T028
,	O	O	O
CART	O	O	B-T028
,	O	O	O
and	O	O	O
NPY	O	O	B-T028
were	O	O	O
measured	O	O	O
in	O	O	O
the	O	O	O
Prefrontal	O	O	B-T023
Cortex	O	O	I-T023
(	O	O	O
PFC	O	O	B-T023
)	O	O	O
region	O	O	O
of	O	O	O
the	O	O	O
reward	O	O	O
circuitry	O	O	O
.	O	O	O

There	O	O	O
was	O	O	O
a	O	O	O
significant	O	O	O
decrease	O	O	O
in	O	O	O
the	O	O	O
BDNF	O	O	B-T116
protein	O	O	B-T045
expression	O	O	I-T045
along	O	O	O
with	O	O	O
an	O	O	O
increase	O	O	O
in	O	O	O
the	O	O	O
mRNA	O	O	B-T045
expression	O	O	I-T045
of	O	O	O
CRH	O	O	B-T028
,	O	O	O
NR3C1	O	O	B-T028
,	O	O	O
CART	O	O	B-T028
,	O	O	O
and	O	O	O
NPY	O	O	B-T028
in	O	O	O
intact	O	O	B-T033
females	O	O	I-T033
,	O	O	O
but	O	O	O
not	O	O	O
in	O	O	O
the	O	O	O
other	O	O	O
two	O	O	O
groups	O	O	O
of	O	O	O
mice	O	O	B-T015
.	O	O	O

OVX	O	O	B-T033
females	O	O	I-T033
resembled	O	O	O
males	O	O	B-T032
in	O	O	O
behavioral	O	O	B-T033
and	O	O	O
molecular	O	O	B-T033
responses	O	O	I-T033
to	O	O	O
CVMS	O	O	B-UnknownType
.	O	O	O

17Î²-Estradiol	O	O	B-T125
(	O	O	O
E2	O	O	B-T125
)	O	O	O
administration	O	O	B-T061
,	O	O	O
not	O	O	O
Progesterone	O	O	B-T125
(	O	O	O
P4	O	O	B-T125
)	O	O	O
,	O	O	O
to	O	O	O
OVX	O	O	B-T033
female	O	O	I-T033
stress	O	O	B-T033
mice	O	O	B-T015
,	O	O	O
mitigated	O	O	O
despair	O	O	O
and	O	O	O
enhanced	O	O	O
hedonic	O	O	O
capacity	O	O	O
with	O	O	O
an	O	O	O
increased	O	O	O
expression	O	O	B-T045
of	O	O	O
BDNF	O	O	B-T116
in	O	O	O
PFC	O	O	B-T023
.	O	O	O

This	O	O	O
study	O	O	O
strengthens	O	O	O
the	O	O	O
evidence	O	O	O
for	O	O	O
the	O	O	O
beneficial	O	O	O
effects	O	O	B-T080
of	O	O	I-T080
E2	O	O	B-T125
administration	O	O	B-T061
in	O	O	O
stress	O	O	B-T033
condition	O	O	O
.	O	O	O

-DOCSTART- (28528555)

Development	O	O	B-T169
and	O	O	O
Evaluation	O	O	B-T062
of	O	O	O
the	O	O	O
ADHD	O	O	B-T170
Cognitions	O	O	I-T170
Scale	O	O	I-T170
for	O	O	O
Adults	O	O	O

The	O	O	O
clinical	O	O	B-T170
literature	O	O	B-T170
on	O	O	O
ADHD	O	O	B-T048
in	O	O	O
adults	O	O	B-T100
suggests	O	O	O
that	O	O	O
"	O	O	O
overly	O	O	B-T041
positive	O	O	I-T041
"	O	O	O
or	O	O	O
optimistic	O	O	B-T041
cognitions	O	O	I-T041
may	O	O	O
contribute	O	O	O
to	O	O	O
impairment	O	O	B-T169
and	O	O	O
failure	O	O	B-T055
to	O	O	O
use	O	O	O
self-regulation	O	O	B-T055
skills	O	O	I-T055
in	O	O	O
this	O	O	O
population	O	O	B-T098
,	O	O	O
yet	O	O	O
the	O	O	O
research	O	O	B-T062
literature	O	O	O
on	O	O	O
this	O	O	O
topic	O	O	O
is	O	O	O
limited	O	O	O
.	O	O	O

We	O	O	O
developed	O	O	O
the	O	O	O
ADHD	O	O	B-T170
Cognitions	O	O	I-T170
Scale	O	O	I-T170
(	O	O	O
ACS	O	O	B-T170
)	O	O	O
,	O	O	O
a	O	O	O
brief	O	O	O
self-report	O	O	B-T062
measure	O	O	B-T081
of	O	O	O
ADHD	O	O	O
-related	O	O	O
thoughts	O	O	B-T041
,	O	O	O
and	O	O	O
evaluated	O	O	O
its	O	O	O
psychometric	O	O	B-T080
properties	O	O	I-T080
.	O	O	O

We	O	O	O
collected	O	O	O
self-report	O	O	B-T062
measures	O	O	B-T081
,	O	O	O
inculding	O	O	O
the	O	O	O
ACS	O	O	B-T170
,	O	O	O
from	O	O	O
two	O	O	O
large	O	O	O
community	O	O	B-T096
samples	O	O	I-T096
(	O	O	O
Ns	O	O	O
=	O	O	O
262	O	O	O
,	O	O	O
304	O	O	O
)	O	O	O
.	O	O	O

The	O	O	O
measure	O	O	O
demonstrated	O	O	O
a	O	O	O
one-factor	O	O	B-T081
solution	O	O	I-T081
that	O	O	O
replicated	O	O	B-T169
in	O	O	O
the	O	O	O
second	O	O	O
sample	O	O	B-T096
.	O	O	O

Evidence	O	O	O
of	O	O	O
good	O	O	O
internal	O	O	B-T081
consistency	O	O	I-T081
and	O	O	O
also	O	O	O
convergent	O	O	B-T080
and	O	O	O
divergent	O	O	B-T080
validity	O	O	I-T080
was	O	O	O
obtained	O	O	O
for	O	O	O
both	O	O	O
samples	O	O	B-T096
.	O	O	O

Scores	O	O	B-T081
on	O	O	O
the	O	O	O
ACS	O	O	B-T170
correlated	O	O	O
with	O	O	O
functional	O	O	B-T033
impairment	O	O	I-T033
,	O	O	O
time	O	O	B-T033
management	O	O	I-T033
problems	O	O	I-T033
,	O	O	O
and	O	O	O
avoidant	O	O	B-T033
coping	O	O	I-T033
strategies	O	O	B-T041
.	O	O	O

With	O	O	O
additional	O	O	O
study	O	O	B-T062
,	O	O	O
the	O	O	O
ACS	O	O	B-T170
may	O	O	O
be	O	O	O
useful	O	O	O
to	O	O	O
identify	O	O	O
and	O	O	O
track	O	O	O
maladaptive	O	O	B-T033
ADHD	O	O	B-T048
-related	O	O	O
cognitions	O	O	B-T041
during	O	O	O
cognitive-behavioral	O	O	B-T061
treatment	O	O	I-T061
,	O	O	O
and	O	O	O
to	O	O	O
further	O	O	O
study	O	O	O
the	O	O	O
role	O	O	O
of	O	O	O
these	O	O	O
thoughts	O	O	B-T041
in	O	O	O
ADHD	O	O	B-T033
-related	O	O	I-T033
impairment	O	O	I-T033
.	O	O	O

-DOCSTART- (28532359)

Visual	O	O	B-T169
Confidence	O	O	O

Visual	O	O	B-T169
confidence	O	O	B-T041
refers	O	O	O
to	O	O	O
an	O	O	O
observer	O	O	B-T096
's	O	O	I-T096
ability	O	O	B-T032
to	O	O	O
judge	O	O	B-T041
the	O	O	O
accuracy	O	O	B-T080
of	O	O	O
her	O	O	O
perceptual	O	O	B-T041
decisions	O	O	I-T041
.	O	O	O

Even	O	O	O
though	O	O	O
confidence	O	O	B-T041
judgments	O	O	B-T041
have	O	O	O
been	O	O	O
recorded	O	O	O
since	O	O	O
the	O	O	O
early	O	O	O
days	O	O	O
of	O	O	O
psychophysics	O	O	B-T091
,	O	O	O
only	O	O	O
recently	O	O	O
have	O	O	O
they	O	O	O
been	O	O	O
recognized	O	O	O
as	O	O	O
essential	O	O	O
for	O	O	O
a	O	O	O
deeper	O	O	O
understanding	O	O	O
of	O	O	O
visual	O	O	B-T041
perception	O	O	I-T041
.	O	O	O

The	O	O	O
reluctance	O	O	O
to	O	O	O
study	O	O	O
visual	O	O	B-T169
confidence	O	O	B-T041
may	O	O	O
have	O	O	O
come	O	O	O
in	O	O	O
part	O	O	O
from	O	O	O
obtaining	O	O	O
convincing	O	O	O
experimental	O	O	B-T078
evidence	O	O	I-T078
in	O	O	O
favor	O	O	O
of	O	O	O
metacognitive	O	O	B-T041
abilities	O	O	I-T041
rather	O	O	O
than	O	O	O
just	O	O	O
perceptual	O	O	B-T041
sensitivity	O	O	I-T041
.	O	O	O

Some	O	O	O
effort	O	O	O
has	O	O	O
thus	O	O	O
been	O	O	O
dedicated	O	O	O
to	O	O	O
offer	O	O	O
different	O	O	O
experimental	O	O	B-T062
paradigms	O	O	I-T062
to	O	O	O
study	O	O	B-T062
visual	O	O	B-T169
confidence	O	O	B-T041
in	O	O	O
humans	O	O	B-T016
and	O	O	O
nonhuman	O	O	B-T008
animals	O	O	I-T008
.	O	O	O

To	O	O	O
understand	O	O	O
the	O	O	O
origins	O	O	B-T079
of	O	O	O
confidence	O	O	B-T041
judgments	O	O	B-T041
,	O	O	O
investigators	O	O	B-T097
have	O	O	O
developed	O	O	O
two	O	O	O
competing	O	O	O
frameworks	O	O	O
.	O	O	O

The	O	O	O
approach	O	O	O
based	O	O	O
on	O	O	O
signal	O	O	B-T170
decision	O	O	I-T170
theory	O	O	I-T170
is	O	O	O
popular	O	O	O
but	O	O	O
fails	O	O	B-T169
to	O	O	O
account	O	O	O
for	O	O	O
response	O	O	B-T079
times	O	O	I-T079
.	O	O	O

In	O	O	O
contrast	O	O	O
,	O	O	O
the	O	O	O
approach	O	O	O
based	O	O	O
on	O	O	O
accumulation	O	O	O
of	O	O	O
evidence	O	O	B-T078
models	O	O	B-T170
naturally	O	O	O
includes	O	O	O
the	O	O	O
dynamics	O	O	B-T070
of	O	O	O
perceptual	O	O	B-T041
decisions	O	O	I-T041
.	O	O	O

These	O	O	O
models	O	O	B-T170
can	O	O	O
explain	O	O	O
a	O	O	O
range	O	O	O
of	O	O	O
results	O	O	B-T169
,	O	O	O
including	O	O	O
the	O	O	O
apparently	O	O	O
paradoxical	O	O	B-T080
dissociation	O	O	B-T048
between	O	O	O
performance	O	O	B-T055
and	O	O	O
confidence	O	O	B-T041
that	O	O	O
is	O	O	O
sometimes	O	O	O
observed	O	O	O
.	O	O	O

-DOCSTART- (28533788)

Grapevine	O	O	B-T002
Subtilase	O	O	B-T116
Family	O	O	I-T116
:	O	O	O
Update	O	O	O
on	O	O	O
New	O	O	O
Sequences	O	O	B-T086
and	O	O	O
Nomenclature	O	O	O
Proposal	O	O	O

In	O	O	O
grapevine	O	O	B-T002
,	O	O	O
serine	O	O	B-T116
peptidases	O	O	I-T116
from	O	O	O
the	O	O	O
subtilase	O	O	B-T116
family	O	O	I-T116
were	O	O	O
recently	O	O	O
associated	O	O	O
to	O	O	O
Plasmopara	O	O	B-T002
viticola	O	O	I-T002
resistance	O	O	B-T169
.	O	O	O

This	O	O	O
family	O	O	O
in	O	O	O
grapevine	O	O	B-T002
,	O	O	O
first	O	O	O
characterized	O	O	O
in	O	O	O
2014	O	O	O
,	O	O	O
was	O	O	O
re-analyzed	O	O	B-T062
last	O	O	O
year	O	O	O
and	O	O	O
82	O	O	O
subtilase	O	O	B-T116
genes	O	O	B-T028
were	O	O	O
identified	O	O	O
.	O	O	O

However	O	O	O
,	O	O	O
in	O	O	O
November	O	O	O
of	O	O	O
2016	O	O	O
,	O	O	O
the	O	O	O
National	O	O	B-T092
Center	O	O	I-T092
for	O	O	I-T092
Biotechnology	O	O	I-T092
Information	O	O	I-T092
database	O	O	B-T170
(	O	O	O
NCBI	O	O	B-T092
)	O	O	O
made	O	O	O
a	O	O	O
new	O	O	O
public	O	O	O
release	O	O	O
of	O	O	O
the	O	O	O
grapevine	O	O	B-T002
genome	O	O	B-T063
annotation	O	O	I-T063
based	O	O	O
on	O	O	O
new	O	O	O
sequencing	O	O	B-T170
data	O	O	I-T170
and	O	O	O
better	O	O	O
prediction	O	O	B-T078
algorithms	O	O	B-T170
.	O	O	O

As	O	O	O
a	O	O	O
consequence	O	O	B-T169
,	O	O	O
some	O	O	O
gene	O	O	B-T063
annotations	O	O	I-T063
and	O	O	O
lengths	O	O	O
changed	O	O	O
.	O	O	O

Here	O	O	O
we	O	O	O
present	O	O	O
an	O	O	O
update	O	O	O
to	O	O	O
the	O	O	O
grapevine	O	O	B-T002
subtilase	O	O	B-T116
gene	O	O	B-T028
family	O	O	I-T028
sequences	O	O	B-T086
(	O	O	O
SBT	O	O	B-T116
)	O	O	O
,	O	O	O
namely	O	O	O
sequence	O	O	B-T170
identifiers	O	O	I-T170
,	O	O	O
bioinformatic	O	O	B-T091
predictions	O	O	B-T078
and	O	O	O
recommend	O	O	O
a	O	O	O
nomenclature	O	O	B-T170
for	O	O	O
the	O	O	O
grapevine	O	O	O
SBT	O	O	O
genes	O	O	B-T028
.	O	O	O

Our	O	O	O
results	O	O	B-T034
show	O	O	O
that	O	O	O
grapevine	O	O	B-T002
subtilase	O	O	B-T116
gene	O	O	B-T028
family	O	O	I-T028
is	O	O	O
now	O	O	O
constituted	O	O	O
by	O	O	O
87	O	O	O
subtilase	O	O	O
genes	O	O	B-T028
encoding	O	O	B-T052
for	O	O	O
109	O	O	O
subtilase	O	O	B-T116
proteins	O	O	I-T116
and	O	O	O
,	O	O	O
despite	O	O	O
the	O	O	O
reported	O	O	O
alterations	O	O	B-T045
,	O	O	O
expression	O	O	B-T045
data	O	O	B-T078
on	O	O	O
subtilases	O	O	B-T116
associated	O	O	O
to	O	O	O
grapevine	O	O	O
resistance	O	O	B-T169
to	O	O	O
P.	O	O	B-T002
viticola	O	O	I-T002
pathosystem	O	O	B-T001
did	O	O	O
not	O	O	O
suffer	O	O	O
any	O	O	O
alteration	O	O	B-T045
.	O	O	O

-DOCSTART- (28539192)

Shared	O	O	B-T041
Decision	O	O	I-T041
Making	O	O	I-T041
and	O	O	O
the	O	O	O
promise	O	O	B-T078
of	O	O	O
a	O	O	O
respectful	O	O	O
and	O	O	O
equitable	O	O	O
healthcare	O	O	B-T093
system	O	O	I-T093
in	O	O	O
Peru	O	O	O

Peru	O	O	B-T083
has	O	O	O
achieved	O	O	O
sustained	O	O	B-T070
development	O	O	I-T070
in	O	O	O
the	O	O	O
last	O	O	O
two	O	O	O
decades	O	O	B-T081
.	O	O	O

However	O	O	O
,	O	O	O
despite	O	O	O
this	O	O	O
achievement	O	O	O
,	O	O	O
it	O	O	O
has	O	O	O
not	O	O	O
been	O	O	O
matched	O	O	O
with	O	O	O
improvements	O	O	B-T057
in	O	O	O
the	O	O	O
quality	O	O	B-T080
of	O	O	I-T080
education	O	O	I-T080
and	O	O	O
health	O	O	B-T058
;	O	O	O
investment	O	O	O
in	O	O	O
both	O	O	O
sectors	O	O	B-T078
is	O	O	O
among	O	O	O
the	O	O	O
lowest	O	O	O
in	O	O	O
the	O	O	O
region	O	O	B-T083
.	O	O	O

This	O	O	O
situation	O	O	O
perpetuates	O	O	O
huge	O	O	O
gaps	O	O	B-T033
in	O	O	O
infrastructure	O	O	B-T058
and	O	O	O
also	O	O	O
conditions	O	O	O
a	O	O	O
poor	O	O	B-T033
literacy	O	O	I-T033
level	O	O	I-T033
of	O	O	O
the	O	O	O
population	O	O	B-T098
specifically	O	O	O
in	O	O	O
health	O	O	B-T078
.	O	O	O

Currently	O	O	O
,	O	O	O
there	O	O	O
is	O	O	O
a	O	O	O
fragmented	O	O	O
model	O	O	B-T170
of	O	O	O
patient	O	O	B-T058
care	O	O	I-T058
,	O	O	O
in	O	O	O
which	O	O	O
the	O	O	O
systems	O	O	B-T093
are	O	O	O
exclusive	O	O	O
of	O	O	O
each	O	O	O
other	O	O	O
.	O	O	O

They	O	O	O
do	O	O	O
not	O	O	O
cooperate	O	O	B-T054
or	O	O	O
communicate	O	O	B-T054
with	O	O	O
each	O	O	O
other	O	O	O
;	O	O	O
and	O	O	O
if	O	O	O
there	O	O	O
is	O	O	O
no	O	O	O
vertical	O	O	O
communication	O	O	B-T054
within	O	O	O
the	O	O	O
system	O	O	B-T093
,	O	O	O
preventing	O	O	O
referral	O	O	B-T058
of	O	O	I-T058
patients	O	O	I-T058
directly	O	O	O
from	O	O	O
the	O	O	O
basic	O	O	B-T033
level	O	O	I-T033
to	O	O	O
the	O	O	O
complex	O	O	B-T033
level	O	O	I-T033
of	O	O	O
care	O	O	B-T058
when	O	O	O
needed	O	O	O
.	O	O	O

In	O	O	O
addition	O	O	O
,	O	O	O
there	O	O	O
has	O	O	O
been	O	O	O
no	O	O	O
progress	O	O	O
in	O	O	O
the	O	O	O
development	O	O	B-T169
of	O	O	O
an	O	O	O
empathetic	O	O	O
,	O	O	O
respectful	O	O	O
or	O	O	O
person-centered	O	O	B-T058
clinical	O	O	B-T058
practice	O	O	I-T058
;	O	O	O
instead	O	O	O
,	O	O	O
economic	O	O	B-T169
,	O	O	O
social	O	O	B-T169
and	O	O	O
educational	O	O	B-T065
differences	O	O	O
perpetuate	O	O	O
a	O	O	O
paternalistic	O	O	O
clinical	O	O	O
practice	O	O	O
.	O	O	O

The	O	O	O
task	O	O	O
of	O	O	O
orienting	O	O	O
medical	O	O	B-T065
training	O	O	I-T065
towards	O	O	O
the	O	O	O
development	O	O	B-T169
of	O	O	O
humanism	O	O	B-T078
is	O	O	O
pending	O	O	O
.	O	O	O

The	O	O	O
patient	O	O	B-T101
is	O	O	O
the	O	O	O
center	O	O	O
of	O	O	O
the	O	O	O
medical	O	O	B-T062
act	O	O	I-T062
and	O	O	O
the	O	O	O
main	O	O	O
objective	O	O	O
of	O	O	O
doctors	O	O	B-T097
'	O	O	I-T097
actions	O	O	O
.	O	O	O

A	O	O	O
humanistic	O	O	B-T052
care	O	O	I-T052
approach	O	O	I-T052
will	O	O	O
not	O	O	O
only	O	O	O
empower	O	O	O
the	O	O	O
person	O	O	B-T098
in	O	O	O
the	O	O	O
clinical	O	O	O
encounter	O	O	O
-	O	O	O
to	O	O	O
participate	O	O	O
and	O	O	O
make	O	O	O
decisions	O	O	O
related	O	O	O
to	O	O	O
his/her	O	O	O
health	O	O	B-T058
care	O	O	I-T058
-	O	O	O
but	O	O	O
it	O	O	O
will	O	O	O
allow	O	O	O
us	O	O	O
to	O	O	O
move	O	O	O
towards	O	O	O
an	O	O	O
empathetic	O	O	O
,	O	O	O
caring	O	O	B-T055
,	O	O	O
respectful	O	O	B-T054
and	O	O	O
kind	O	O	O
model	O	O	B-T170
of	O	O	O
clinical	O	O	B-T058
practice	O	O	I-T058
.	O	O	O

-DOCSTART- (28540429)

Identification	O	O	O
of	O	O	O
markers	O	O	B-T201
for	O	O	O
quiescent	O	O	B-T080
pancreatic	O	O	B-T025
stellate	O	O	I-T025
cells	O	O	I-T025
in	O	O	O
the	O	O	O
normal	O	O	B-T080
human	O	O	B-T016
pancreas	O	O	O

Pancreatic	O	O	B-T025
stellate	O	O	I-T025
cells	O	O	I-T025
(	O	O	O
PSCs	O	O	B-T025
)	O	O	O
play	O	O	O
a	O	O	O
central	O	O	O
role	O	O	O
as	O	O	O
source	O	O	O
of	O	O	O
fibrogenic	O	O	B-T025
cells	O	O	I-T025
in	O	O	O
pancreatic	O	O	B-T191
cancer	O	O	I-T191
and	O	O	O
chronic	O	O	B-T047
pancreatitis	O	O	I-T047
.	O	O	O

In	O	O	O
contrast	O	O	O
to	O	O	O
quiescent	O	O	B-T080
hepatic	O	O	B-T025
stellate	O	O	I-T025
cells	O	O	I-T025
(	O	O	O
qHSCs	O	O	B-T025
)	O	O	O
,	O	O	O
a	O	O	O
specific	O	O	O
marker	O	O	B-T201
for	O	O	O
quiescent	O	O	O
PSCs	O	O	B-T025
(	O	O	O
qPSCs	O	O	B-T025
)	O	O	O
that	O	O	O
can	O	O	O
be	O	O	O
used	O	O	O
in	O	O	O
formalin-fixed	O	O	B-T024
and	O	O	I-T024
paraffin	O	O	I-T024
embedded	O	O	I-T024
(	O	O	I-T024
FFPE	O	O	I-T024
)	O	O	I-T024
normal	O	O	I-T024
human	O	O	I-T024
pancreatic	O	O	I-T024
tissue	O	O	I-T024
has	O	O	O
not	O	O	O
been	O	O	O
identified	O	O	O
.	O	O	O

The	O	O	O
aim	O	O	O
of	O	O	O
this	O	O	O
study	O	O	O
was	O	O	O
to	O	O	O
identify	O	O	O
a	O	O	O
marker	O	O	O
enabling	O	O	O
the	O	O	O
identification	O	O	O
of	O	O	O
qPSCs	O	O	B-T025
in	O	O	O
normal	O	O	B-T080
human	O	O	B-T016
FFPE	O	O	B-T024
pancreatic	O	O	I-T024
tissue	O	O	I-T024
.	O	O	O

Immunohistochemical	O	O	B-T059
(	O	O	O
IHC	O	O	B-T059
)	O	O	O
,	O	O	O
double-IHC	O	O	B-T059
,	O	O	O
immunofluorescence	O	O	B-T059
(	O	O	O
IF	O	O	B-T059
)	O	O	O
and	O	O	O
double-IF	O	O	B-T059
analyses	O	O	I-T059
were	O	O	O
carried	O	O	O
out	O	O	O
using	O	O	O
a	O	O	O
tissue	O	O	B-T075
microarray	O	O	I-T075
consisting	O	O	O
of	O	O	O
cores	O	O	O
with	O	O	O
normal	O	O	B-T080
human	O	O	B-T016
pancreatic	O	O	B-T024
tissue	O	O	I-T024
.	O	O	O

Cores	O	O	O
with	O	O	O
normal	O	O	B-T080
human	O	O	B-T016
liver	O	O	B-T023
served	O	O	O
as	O	O	O
control	O	O	B-T096
.	O	O	O

Antibodies	O	O	B-T116
directed	O	O	O
against	O	O	O
adipophilin	O	O	B-T116
,	O	O	O
Î±-SMA	O	O	B-T116
,	O	O	O
CD146	O	O	B-T116
,	O	O	O
CRBP-1	O	O	B-T116
,	O	O	O
cytoglobin	O	O	B-T116
,	O	O	O
desmin	O	O	B-T116
,	O	O	O
GFAP	O	O	B-T116
,	O	O	O
nestin	O	O	B-T116
,	O	O	O
S100A4	O	O	B-T116
and	O	O	O
vinculin	O	O	B-T116
were	O	O	O
examined	O	O	O
,	O	O	O
with	O	O	O
special	O	O	O
emphasis	O	O	O
on	O	O	O
their	O	O	O
expression	O	O	O
in	O	O	O
periacinar	O	O	B-T082
cells	O	O	B-T025
in	O	O	O
the	O	O	O
normal	O	O	B-T080
human	O	O	B-T016
pancreas	O	O	B-T023
and	O	O	O
perisinusoidal	O	O	B-T025
cells	O	O	I-T025
in	O	O	O
the	O	O	O
normal	O	O	O
human	O	O	O
liver	O	O	B-T023
.	O	O	O

The	O	O	O
immunolabelling	O	O	B-T059
capacity	O	O	B-T081
was	O	O	O
evaluated	O	O	O
according	O	O	O
to	O	O	O
a	O	O	O
semiquantitative	O	O	B-T057
scoring	O	O	I-T057
system	O	O	I-T057
.	O	O	O

Double-IF	O	O	B-T059
of	O	O	O
the	O	O	O
markers	O	O	B-T201
of	O	O	O
interest	O	O	O
together	O	O	O
with	O	O	O
markers	O	O	O
for	O	O	O
other	O	O	O
periacinar	O	O	B-T082
cells	O	O	B-T025
was	O	O	O
performed	O	O	O
.	O	O	O

Moreover	O	O	O
,	O	O	O
the	O	O	O
utility	O	O	O
of	O	O	O
histochemical	O	O	B-T059
stains	O	O	I-T059
for	O	O	O
the	O	O	O
identification	O	O	O
of	O	O	O
human	O	O	B-T016
qPSCs	O	O	B-T025
was	O	O	O
examined	O	O	O
,	O	O	O
and	O	O	O
their	O	O	O
ultrastructure	O	O	B-T078
was	O	O	O
revisited	O	O	O
by	O	O	O
electron	O	O	B-T059
microscopy	O	O	I-T059
.	O	O	O

Adipophilin	O	O	B-T116
,	O	O	O
CRBP-1	O	O	B-T116
,	O	O	O
cytoglobin	O	O	B-T116
and	O	O	O
vinculin	O	O	B-T116
were	O	O	O
expressed	O	O	O
in	O	O	O
qHSCs	O	O	B-T025
in	O	O	O
the	O	O	O
liver	O	O	B-T023
,	O	O	O
whereas	O	O	O
cytoglobin	O	O	O
and	O	O	O
adipophilin	O	O	B-T116
were	O	O	O
expressed	O	O	O
in	O	O	O
qPSCs	O	O	B-T025
in	O	O	O
the	O	O	O
pancreas	O	O	B-T023
.	O	O	O

Adipophilin	O	O	B-T116
immunohistochemistry	O	O	B-T060
was	O	O	O
highly	O	O	O
dependent	O	O	O
on	O	O	O
the	O	O	O
preanalytical	O	O	B-T079
time	O	O	I-T079
interval	O	O	I-T079
(	O	O	O
PATI	O	O	B-T079
)	O	O	O
from	O	O	O
removal	O	O	O
of	O	O	O
the	O	O	O
tissue	O	O	B-T024
to	O	O	O
formalin	O	O	B-T059
fixation	O	O	I-T059
.	O	O	O

Cytoglobin	O	O	B-T116
,	O	O	O
S100A4	O	O	B-T116
and	O	O	O
vinculin	O	O	B-T116
were	O	O	O
expressed	O	O	O
in	O	O	O
periacinar	O	O	B-T082
fibroblasts	O	O	B-T025
(	O	O	O
FBs	O	O	B-T025
)	O	O	O
.	O	O	O

The	O	O	O
other	O	O	O
examined	O	O	O
markers	O	O	B-T201
were	O	O	O
negative	O	O	O
in	O	O	O
human	O	O	B-T016
qPSCs	O	O	B-T025
.	O	O	O

Our	O	O	O
data	O	O	O
indicate	O	O	O
that	O	O	O
cytoglobin	O	O	B-T116
and	O	O	O
adipophilin	O	O	B-T116
are	O	O	O
markers	O	O	B-T201
of	O	O	O
qPSCs	O	O	B-T025
in	O	O	O
the	O	O	O
normal	O	O	B-T080
human	O	O	B-T016
pancreas	O	O	B-T023
.	O	O	O

However	O	O	O
,	O	O	O
the	O	O	O
use	O	O	O
of	O	O	O
adipophilin	O	O	B-T116
as	O	O	O
a	O	O	O
qPSC	O	O	B-T025
marker	O	O	O
may	O	O	O
be	O	O	O
limited	O	O	O
due	O	O	O
to	O	O	O
its	O	O	O
high	O	O	O
dependence	O	O	O
on	O	O	O
optimal	O	O	O
PATI	O	O	B-T079
.	O	O	O

Cytoglobin	O	O	B-T116
,	O	O	O
on	O	O	O
the	O	O	O
other	O	O	O
hand	O	O	O
,	O	O	O
is	O	O	O
a	O	O	O
sensitive	O	O	O
marker	O	O	B-T201
for	O	O	O
qPSCs	O	O	B-T025
but	O	O	O
is	O	O	O
expressed	O	O	O
in	O	O	O
FBs	O	O	B-T025
as	O	O	O
well	O	O	O
.	O	O	O

-DOCSTART- (28541679)

Biomagnetic	O	O	B-T059
monitoring	O	O	I-T059
of	O	O	O
atmospheric	O	O	B-UnknownType
pollution	O	O	I-UnknownType
:	O	O	O
a	O	O	O
review	O	O	B-T169
of	O	O	I-T169
magnetic	O	O	B-T070
signatures	O	O	O
from	O	O	O
biological	O	O	O
sensors	O	O	O

Biomagnetic	O	O	B-T059
monitoring	O	O	I-T059
of	O	O	O
atmospheric	O	O	B-UnknownType
pollution	O	O	I-UnknownType
is	O	O	O
a	O	O	O
growing	O	O	O
application	O	O	O
in	O	O	O
the	O	O	O
field	O	O	O
of	O	O	O
environmental	O	O	B-T082
magnetism	O	O	B-T070
.	O	O	O

Particulate	O	O	B-T167
matter	O	O	I-T167
(	O	O	O
PM	O	O	B-T167
)	O	O	O
in	O	O	O
atmospheric	O	O	B-UnknownType
pollution	O	O	I-UnknownType
contains	O	O	O
readily-	O	O	O
measurable	O	O	B-T169
concentrations	O	O	O
of	O	O	O
magnetic	O	O	B-T197
minerals	O	O	I-T197
.	O	O	O

Biological	O	O	B-T080
surfaces	O	O	B-T082
,	O	O	O
exposed	O	O	O
to	O	O	O
atmospheric	O	O	B-UnknownType
pollution	O	O	I-UnknownType
,	O	O	O
accumulate	O	O	O
magnetic	O	O	B-T070
particles	O	O	B-T104
over	O	O	O
time	O	O	O
,	O	O	O
providing	O	O	O
a	O	O	O
record	O	O	O
of	O	O	O
location	O	O	B-T082
-	O	O	O
specific	O	O	B-T080
,	O	O	O
time-integrated	O	O	B-T033
air	O	O	B-T080
quality	O	O	I-T080
information	O	O	B-T078
.	O	O	O

This	O	O	O
review	O	O	B-T170
summarizes	O	O	O
current	O	O	O
knowledge	O	O	O
of	O	O	O
biological	O	O	B-T075
material	O	O	I-T075
(	O	O	O
'	O	O	O
sensors	O	O	B-T075
'	O	O	O
)	O	O	O
used	O	O	O
for	O	O	O
biomagnetic	O	O	B-T059
monitoring	O	O	I-T059
purposes	O	O	O
.	O	O	O

Our	O	O	O
work	O	O	O
addresses	O	O	O
:	O	O	O
the	O	O	O
range	O	O	O
of	O	O	O
magnetic	O	O	B-T070
properties	O	O	I-T070
reported	O	O	O
for	O	O	O
lichens	O	O	B-T002
,	O	O	O
mosses	O	O	B-T002
,	O	O	O
leaves	O	O	B-T002
,	O	O	O
bark	O	O	B-T002
,	O	O	O
trunk	O	O	B-T002
wood	O	O	I-T002
,	O	O	O
insects	O	O	B-T204
,	O	O	O
crustaceans	O	O	B-T204
,	O	O	O
mammal	O	O	B-T015
and	O	O	O
human	O	O	B-T024
tissues	O	O	I-T024
;	O	O	O
their	O	O	O
associations	O	O	O
with	O	O	O
atmospheric	O	O	B-T131
pollutant	O	O	I-T131
species	O	O	I-T131
(	O	O	O
PM	O	O	B-T167
,	O	O	O
NOx	O	O	B-T197
,	O	O	O
trace	O	O	B-T123
elements	O	O	I-T123
,	O	O	O
PAHs	O	O	B-T109
)	O	O	O
;	O	O	O
the	O	O	O
pros	O	O	B-T033
and	O	O	I-T033
cons	O	O	I-T033
of	O	O	O
biomagnetic	O	O	B-T059
monitoring	O	O	I-T059
of	O	O	O
atmospheric	O	O	B-UnknownType
pollution	O	O	I-UnknownType
;	O	O	O
current	O	O	O
challenges	O	O	O
for	O	O	O
large-scale	O	O	B-UnknownType
implementation	O	O	I-UnknownType
of	O	O	O
biomagnetic	O	O	O
monitoring	O	O	O
;	O	O	O
and	O	O	O
future	O	O	B-T079
perspectives	O	O	O
.	O	O	O

A	O	O	O
summary	O	O	O
table	O	O	O
is	O	O	O
presented	O	O	O
,	O	O	O
with	O	O	O
the	O	O	O
aim	O	O	O
of	O	O	O
aiding	O	O	O
researchers	O	O	B-T097
and	O	O	O
policy	O	O	B-T097
makers	O	O	I-T097
in	O	O	O
selecting	O	O	O
the	O	O	O
most	O	O	O
suitable	O	O	O
biological	O	O	B-T075
sensor	O	O	I-T075
for	O	O	O
their	O	O	O
intended	O	O	O
biomagnetic	O	O	B-T059
monitoring	O	O	I-T059
purpose	O	O	O
.	O	O	O

-DOCSTART- (28545365)

Role	O	O	O
of	O	O	O
infrared	O	O	B-T059
spectroscopy	O	O	I-T059
and	O	O	O
imaging	O	O	B-T060
in	O	O	O
cancer	O	O	B-T191
diagnosis	O	O	O

FTIR	O	O	B-T062
imaging	O	O	B-T060
has	O	O	O
been	O	O	O
used	O	O	O
to	O	O	O
diagnose	O	O	B-T033
and	O	O	O
differentiate	O	O	B-T080
the	O	O	O
molecular	O	O	B-T080
differences	O	O	B-T080
between	O	O	O
normal	O	O	B-T024
and	O	O	O
diseased	O	O	B-T047
tissues	O	O	B-T024
.	O	O	O

The	O	O	O
differences	O	O	B-T080
correspond	O	O	O
to	O	O	O
the	O	O	O
distribution	O	O	B-T169
and	O	O	O
structure	O	O	B-T082
of	O	O	O
lipids	O	O	B-T109
,	O	O	O
proteins	O	O	B-T116
,	O	O	O
nucleic	O	O	B-T114
acids	O	O	I-T114
as	O	O	O
well	O	O	O
as	O	O	O
other	O	O	O
metabolites	O	O	B-T123
.	O	O	O

These	O	O	O
differences	O	O	B-T080
depended	O	O	O
on	O	O	O
the	O	O	O
type	O	O	B-T033
and	O	O	O
the	O	O	O
grade	O	O	O
of	O	O	O
cancer	O	O	B-T191
.	O	O	O

The	O	O	O
sensitivity	O	O	B-T169
of	O	O	O
chemotherapy	O	O	B-T061
drugs	O	O	B-T121
on	O	O	O
individual	O	O	B-T098
specific	O	O	O
was	O	O	O
also	O	O	O
discussed	O	O	O
.	O	O	O

Here	O	O	O
,	O	O	O
we	O	O	O
emphasize	O	O	O
that	O	O	O
FTIR	O	O	B-T062
spectroscopy	O	O	I-T062
and	O	O	O
imaging	O	O	B-T060
can	O	O	O
be	O	O	O
considered	O	O	O
as	O	O	O
a	O	O	O
promising	O	O	O
technique	O	O	B-T169
and	O	O	O
will	O	O	O
find	O	O	O
its	O	O	O
place	O	O	O
on	O	O	O
the	O	O	O
detection	O	O	B-T061
of	O	O	O
this	O	O	O
dreadful	O	O	B-T047
disease	O	O	I-T047
because	O	O	O
of	O	O	O
high	O	O	B-T059
sensitivity	O	O	I-T059
,	O	O	O
accuracy	O	O	B-T080
and	O	O	O
inexpensive	O	O	O
technique	O	O	O
.	O	O	O

Now	O	O	O
the	O	O	O
medical	O	O	B-T093
community	O	O	I-T093
started	O	O	O
using	O	O	O
and	O	O	O
accepting	O	O	O
this	O	O	O
technique	O	O	B-T169
for	O	O	O
early	O	O	B-T079
stage	O	O	I-T079
cancer	O	O	B-T191
detection	O	O	B-T061
.	O	O	O

But	O	O	O
,	O	O	O
this	O	O	O
technique	O	O	B-T169
endures	O	O	O
several	O	O	O
challenges	O	O	B-T058
on	O	O	O
its	O	O	O
application	O	O	O
into	O	O	O
the	O	O	O
diagnosis	O	O	B-T033
of	O	O	O
cancer	O	O	B-T191
in	O	O	O
regards	O	O	O
of	O	O	O
sample	O	O	B-T059
preparations	O	O	I-T059
,	O	O	O
data	O	O	B-T058
interpretation	O	O	I-T058
,	O	O	O
and	O	O	O
data	O	O	B-T057
analysis	O	O	I-T057
.	O	O	O

In	O	O	O
general	O	O	O
,	O	O	O
more	O	O	O
research	O	O	B-T062
is	O	O	O
needed	O	O	O
in	O	O	O
this	O	O	O
field	O	O	O
and	O	O	O
it	O	O	O
is	O	O	O
necessary	O	O	O
to	O	O	O
understand	O	O	O
the	O	O	O
morphology	O	O	B-T080
and	O	O	O
biology	O	O	B-T091
of	O	O	O
the	O	O	O
sample	O	O	O
before	O	O	O
using	O	O	O
the	O	O	O
spectroscopy	O	O	B-T062
and	O	O	O
imaging	O	O	B-T060
because	O	O	O
invaluable	O	O	B-T080
information	O	O	B-T078
to	O	O	O
be	O	O	O
figured	O	O	O
out	O	O	O
.	O	O	O

-DOCSTART- (28550165)

The	O	O	O
CLASP2	O	O	B-T116
Protein	O	O	B-T169
Interaction	O	O	I-T169
Network	O	O	I-T169
in	O	O	O
Adipocytes	O	O	B-T025
Links	O	O	O
CLIP2	O	O	B-T116
to	O	O	O
AGAP3	O	O	B-T116
,	O	O	O
CLASP2	O	O	O
to	O	O	O
G2L1	O	O	B-T116
,	O	O	O
MARK2	O	O	B-T116
,	O	O	O
and	O	O	O
SOGA1	O	O	B-T116
,	O	O	O
and	O	O	O
Identifies	O	O	O
SOGA1	O	O	O
as	O	O	O
a	O	O	O
Microtubule-Associated	O	O	O
Protein	O	O	O

CLASP2	O	O	B-T116
is	O	O	O
a	O	O	O
microtubule-associated	O	O	B-T116
protein	O	O	I-T116
that	O	O	O
undergoes	O	O	O
insulin	O	O	B-T116
-	O	O	O
stimulated	O	O	B-T045
phosphorylation	O	O	B-T044
and	O	O	O
co-localization	O	O	B-T169
with	O	O	O
reorganized	O	O	B-T078
actin	O	O	B-T116
and	O	O	O
GLUT4	O	O	B-T116
at	O	O	O
the	O	O	O
plasma	O	O	B-T026
membrane	O	O	I-T026
.	O	O	O

To	O	O	O
gain	O	O	B-T081
insight	O	O	B-T041
to	O	O	O
the	O	O	O
role	O	O	B-T077
of	O	O	O
CLASP2	O	O	B-T116
in	O	O	O
this	O	O	O
system	O	O	B-T043
,	O	O	O
we	O	O	O
developed	O	O	B-T169
and	O	O	O
successfully	O	O	B-T080
executed	O	O	B-T052
a	O	O	O
streamlined	O	O	B-T080
interactome	O	O	B-T044
approach	O	O	B-T082
and	O	O	O
built	O	O	O
a	O	O	O
CLASP2	O	O	O
protein	O	O	B-T169
network	O	O	I-T169
in	O	O	O
3T3-L1	O	O	B-T025
adipocytes	O	O	I-T025
.	O	O	O

Using	O	O	O
two	O	O	O
different	O	O	B-T080
commercially	O	O	B-T170
available	O	O	B-T169
antibodies	O	O	B-T116
for	O	O	O
CLASP2	O	O	B-T116
and	O	O	O
an	O	O	O
antibody	O	O	B-T116
for	O	O	O
epitope	O	O	B-T129
-tagged	O	O	O
,	O	O	O
overexpressed	O	O	B-T045
CLASP2	O	O	O
,	O	O	O
we	O	O	O
performed	O	O	B-T169
multiple	O	O	B-T081
affinity	O	O	B-T059
purification	O	O	I-T059
coupled	O	O	B-T169
with	O	O	O
mass	O	O	B-T059
spectrometry	O	O	I-T059
(	O	O	O
AP	O	O	B-T059
-	O	O	O
MS	O	O	B-T059
)	O	O	O
experiments	O	O	B-T062
in	O	O	O
combination	O	O	B-T080
with	O	O	O
label-free	O	O	B-T033
quantitative	O	O	B-T081
proteomics	O	O	B-T091
and	O	O	O
analyzed	O	O	B-T062
the	O	O	O
data	O	O	B-T078
with	O	O	O
the	O	O	O
bioinformatics	O	O	B-T091
tool	O	O	B-T170
Significance	O	O	B-T170
Analysis	O	O	I-T170
of	O	O	I-T170
Interactome	O	O	I-T170
(	O	O	O
SAINT	O	O	B-T170
)	O	O	O
.	O	O	O

We	O	O	O
discovered	O	O	B-T052
that	O	O	O
CLASP2	O	O	B-T116
co-immunoprecipitates	O	O	B-T129
(	O	O	O
co-IPs	O	O	B-T129
)	O	O	O
the	O	O	O
novel	O	O	O
protein	O	O	B-T116
SOGA1	O	O	B-T116
,	O	O	O
the	O	O	O
microtubule-associated	O	O	B-T116
protein	O	O	I-T116
kinase	O	O	I-T116
MARK2	O	O	B-T116
,	O	O	O
and	O	O	O
the	O	O	O
microtubule	O	O	B-T026
/	O	O	O
actin	O	O	B-T116
-	O	O	O
regulating	O	O	B-T038
protein	O	O	O
G2L1	O	O	B-T116
.	O	O	O

The	O	O	O
GTPase-activating	O	O	B-T116
proteins	O	O	I-T116
AGAP1	O	O	B-T116
and	O	O	O
AGAP3	O	O	B-T116
were	O	O	O
also	O	O	O
enriched	O	O	O
in	O	O	O
the	O	O	O
CLASP2	O	O	B-T116
interactome	O	O	B-T044
,	O	O	O
although	O	O	O
subsequent	O	O	B-T079
AGAP3	O	O	O
and	O	O	O
CLIP2	O	O	B-T116
interactome	O	O	O
analysis	O	O	B-T062
suggests	O	O	O
a	O	O	O
preference	O	O	B-T078
of	O	O	O
AGAP3	O	O	O
for	O	O	O
CLIP2	O	O	O
.	O	O	O

Follow-up	O	O	O
MARK2	O	O	B-T116
interactome	O	O	B-T044
analysis	O	O	B-T062
confirmed	O	O	B-T033
reciprocal	O	O	B-T080
co-IP	O	O	B-T129
of	O	O	O
CLASP2	O	O	B-T116
and	O	O	O
also	O	O	O
revealed	O	O	O
MARK2	O	O	O
can	O	O	O
co-IP	O	O	O
SOGA1	O	O	B-T116
,	O	O	O
glycogen	O	O	B-T116
synthase	O	O	I-T116
,	O	O	O
and	O	O	O
glycogenin	O	O	B-T116
.	O	O	O

Investigating	O	O	B-T169
the	O	O	O
SOGA1	O	O	B-T116
interactome	O	O	B-T044
confirmed	O	O	B-T033
SOGA1	O	O	O
can	O	O	O
reciprocal	O	O	B-T080
co-IP	O	O	B-T129
both	O	O	O
CLASP2	O	O	B-T116
and	O	O	O
MARK2	O	O	B-T116
as	O	O	O
well	O	O	O
as	O	O	O
glycogen	O	O	B-T116
synthase	O	O	I-T116
and	O	O	O
glycogenin	O	O	B-T116
.	O	O	O

SOGA1	O	O	B-T116
was	O	O	O
confirmed	O	O	B-T033
to	O	O	O
colocalize	O	O	B-T082
with	O	O	O
CLASP2	O	O	B-T116
and	O	O	O
also	O	O	O
with	O	O	O
tubulin	O	O	B-T116
,	O	O	O
which	O	O	O
identifies	O	O	O
SOGA1	O	O	O
as	O	O	O
a	O	O	O
new	O	O	O
microtubule-associated	O	O	B-T116
protein	O	O	I-T116
.	O	O	O

These	O	O	O
results	O	O	B-T033
introduce	O	O	O
the	O	O	O
metabolic	O	O	B-T044
function	O	O	I-T044
of	O	O	O
these	O	O	O
proposed	O	O	B-T080
novel	O	O	O
protein	O	O	B-T169
networks	O	O	I-T169
and	O	O	O
their	O	O	O
relationship	O	O	B-T080
with	O	O	O
microtubules	O	O	B-T026
as	O	O	O
new	O	O	O
fields	O	O	O
of	O	O	O
cytoskeleton	O	O	B-T026
-	O	O	O
associated	O	O	B-T080
protein	O	O	B-T091
biology	O	O	I-T091
.	O	O	O

